search_name,pubchem_cid,canonical_smiles,inchi,inchi_key,molecular_formula,molecular_weight,iupac_name,synonyms
NEVIRAPINE,4463,,"InChI=1S/C15H14N4O/c1-9-6-8-17-14-12(9)18-15(20)11-3-2-7-16-13(11)19(14)10-4-5-10/h2-3,6-8,10H,4-5H2,1H3,(H,18,20)",NQDJXKOVJZTUJA-UHFFFAOYSA-N,C15H14N4O,266.30,"2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one","nevirapine|129618-40-2|Viramune|BI-RG-587|Nevirapine anhydrous|Viramune XR|BIRG 0587|Nevirapine, anhydrous|Nevirapine teva|BIRG587|BIRG-0587|11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one|Nevirapina|11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE|99DK7FVK1H|Nevirapinum anhydrous|NSC-641530|DTXSID7031797|CHEBI:63613|NSC641530|6H-Dipyrido(3,2-b:2',3'-e)(1,4)diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-|BIRG0587|DTXCID9010787|2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,12,14-hexaen-10-one|BI RG 587|nevirapinum|2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo(9.4.0.0^(3,8))pentadeca-1(15),3,5,7,11,13-hexaen-10-one|2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-10-one|2-cyclopropyl-7-methyl-2,4,9,15-tetrazatricyclo(9.4.0.03,8)pentadeca-1(11),3,5,7,12,14-hexaen-10-one|6H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6-ONE, 11-CYCLOPROPYL-5,11-DIHYDRO-4-METHYL-|Hemihydrate, Nevirapine|RefChem:853798|J05AG01|NEVIRAPINE TABLETS FOR ORAL SUSPENSION|603-345-0|4-amino-1-((2R,4R)-2-(hydroxymethyl)-1,3-oxathiolan-4-yl)pyrimidin-2-one|11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepin-6-one|NVP|MFCD00866928|BI-RG 587|BIRG-587|CHEMBL57|11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one|NEV|11-CYCLOPROPYL-4-METHYL-5H-DIPYRIDO[3,2-B:2',3'-E][1,4]DIAZEPIN-6(11H)-ONE|MLS000084585|NCGC00065890-02|SMR000048458|2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one|Viramune(TM)|Viramune (TN)|CAS-129618-40-2|HSDB 7164|Nevirapine & CD4-IgG|Nevirapine & PRO 140|UNII-99DK7FVK1H|NSC 641530|Nevirapine (JAN/USP/INN)|Nevirapine)|11-cyclopropyl-4-methyl-5H-dipyrido[[?],[?]][1,4]diazepin-6-one|BIRG 587|NON-NUCLEOSIDE RT INHIBITOR NEVIRAPINE|Viramune IR|1vrt|2hny|Nevirapine [USAN:USP:INN:BAN]|BI-RG-587 & CD4-IgG|Nevirapine (Standard)|Nevirapine (Viramune)|Nevirapine (anhydrous)|NEVIRAPINE [MI]|Opera_ID_934|NEVIRAPINE [INN]|NEVIRAPINE [JAN]|NEVIRAPINE [HSDB]|NEVIRAPINE [USAN]|NEVIRAPINE [VANDF]|NEVIRAPINE [MART.]|SCHEMBL3318|NEVIRAPINE [WHO-DD]|MLS000759409|MLS001055309|MLS001201730|MLS001424058|MLS006011423|BIDD:GT0326|NEVIRAPINE [EMA EPAR]|BDBM1434|orb1308075|NEVIRAPINE [ORANGE BOOK]|SCHEMBL29393780|SCHEMBL29614675|SCHEMBL30267890|GTPL12676|NEVIRAPINE [EP MONOGRAPH]|NEVIRAPINE [USP IMPURITY]|Nevirapine for peak identification|HMS2051J09|HMS2231O23|HMS3264D21|HMS3371E03|HMS3393J09|HMS3655I08|HMS3715B10|HMS5079D22|NEVIRAPINE [USP MONOGRAPH]|Pharmakon1600-01503842|ALBB-027264|BCP05587|BSB41895|MSK10168|Tox21 110982|Tox21_110982|Tox21_200770|AC-643|AC1280|BBL010768|HY-10570R|NSC759902|STK580320|NEVIRAPINE ANHYDROUS [USP-RS]|NEVIRAPINE ANHYDROUS [WHO-IP]|AKOS005504351|Tox21_110982_1|AB07544|CCG-100939|DB00238|KS-5019|NC00189|NN15304|NSC-759902|NCGC00065890-03|NCGC00065890-04|NCGC00065890-05|NCGC00065890-07|NCGC00065890-14|NCGC00258324-01|11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one & PRO 140 (Anti-CCR5 monoclonal antibody)|HY-10570|N11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e]-[1,4]diazepin-6-one & CD4-immunoadhesin|Nevirapine 100 microg/mL in Acetonitrile|SY009679|BI-RG 587;NSC 641530;NVP|DB-041930|N0922|NEVIRAPINUM ANHYDROUS [WHO-IP LATIN]|NS00004959|S1742|SW197569-2|C07263|D00435|EN300-119500|AB00393001-13|AB00393001-15|AB00393001_16|AB00393001_17|618N402|F358078|Q263713|BRD-K15502390-001-19-1|BRD-K15502390-001-20-9|F2173-0607|Z1521553473|BI-RG-587; BIRG 0587; BIRG587; HSDB 7164; NSC 641530; NVP|Nevirapine (anhydrous), European Pharmacopoeia (EP) Reference Standard|Nevirapine anhydrous, United States Pharmacopeia (USP) Reference Standard|Nevirapine, Pharmaceutical Secondary Standard; Certified Reference Material|11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido-[3,2-b:2',3'-e][1,4]diazepin-6-one|11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b :2',3'-e][1,4 ]diazepin-6-one|11-cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2 ,3 -e][1,4]diazepin-6-one|11-Cyclopropyl-5,11-dihydro-4-methyl-6H-dipyrido[3,2-b:2', 3'-e][1,4]diazepin-6-one|6H-dipyrido[2,3-e:3',2'-b][1,4]diazepin-6-one, 11-cyclopropyl-5,11-dihydro-4-methyl-|Nevirapine for peak identification, European Pharmacopoeia (EP) Reference Standard|11-Cyclopropyl-4-methyl-5,11-dihydro-6H-dipyrido[3,2-b:2 inverted exclamation mark ,3 inverted exclamation mark -e][1,4]diazepin-6-one|2-cyclopropyl-7-methyl-2,4,9,15-tetraazatricyclo[9.4.0.0,3,8]pentadeca-1(15),3(8),4,6,11,13-hexaen-10-one"
EMIVIRINE,65013,,"InChI=1S/C17H22N2O3/c1-4-22-11-19-14(10-13-8-6-5-7-9-13)15(12(2)3)16(20)18-17(19)21/h5-9,12H,4,10-11H2,1-3H3,(H,18,20,21)",MLILORUFDVLTSP-UHFFFAOYSA-N,C17H22N2O3,302.37,"6-benzyl-1-(ethoxymethyl)-5-propan-2-ylpyrimidine-2,4-dione","Emivirine|149950-60-7|Coactinon|MKC-442|6-Benzyl-1-(ethoxymethyl)-5-isopropyluracil|Emivirina|2,4(1H,3H)-Pyrimidinedione, 1-(ethoxymethyl)-5-(1-methylethyl)-6-(phenylmethyl)-|X87G8IX72O|CHEBI:44143|1-(Ethoxymethyl)-5-(1-methylethyl)-6-(phenylmethyl)-2,4(1H,3H)-pyrimidinedione|6-benzyl-1-(ethoxymethyl)-5-(1-methylethyl)uracil|DTXSID80164437|1-(ethoxymethyl)-5-(1-methylethyl)-6-(phenylmethyl)pyrimidine-2,4(1H,3H)-dione|6-benzyl-1-ethoxymethyl-5-isopropyluracil|6-benzyl-1-(ethoxymethyl)-5-(propan-2-yl)pyrimidine-2,4(1H,3H)-dione|emivirinum|RefChem:590754|DTXCID5086928|6-benzyl-1-(ethoxymethyl)-5-isopropyl-uracil|I-EBU|6-benzyl-1-(ethoxymethyl)-5-isopropylpyrimidine-2,4(1H,3H)-dione|MKC442|6-BENZYL-1-ETHOXYMETHYL-5-ISOPROPYL URACIL|CHEMBL35033|HEPT deriv.|1EtOMe6Bz5i-Pr-U|Emivirine [USAN:INN]|6-benzyl-1-(ethoxymethyl)-5-(1-methylethyl)pyrimidine-2,4(1H,3H)-dione|DRG-0302|UNII-X87G8IX72O|Emivirine?|6-benzyl-1-(ethoxymethyl)-5-propan-2-ylpyrimidine-2,4-dione|Coactinon (TM)|Coactinon (TN)|1rt1|EMIVIRINE [INN]|Emivirine (USAN/INN)|EMIVIRINE [USAN]|EMIVIRINE [MART.]|EMIVIRINE [WHO-DD]|SCHEMBL140546|BDBM2337|orb1700653|MLILORUFDVLTSP-UHFFFAOYSA-N|GLXC-04845|EX-A9318|AKOS015913753|DB08188|SB58684|DA-63175|HY-15353|TS-08512|CS-0005980|NS00068595|D01055|Q906062|6-benzyl-1-(ethoxymethyl)-5-isopropyl-pyrimidine-2,4-dione|6-benzyl-1-(ethoxymethyl)-5-(propan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione"
DELAVIRDINE,5625,,"InChI=1S/C22H28N6O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20/h4-8,13-15,24-26H,9-12H2,1-3H3",WHBIGIKBNXZKFE-UHFFFAOYSA-N,C22H28N6O3S,456.6,N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide,"Delavirdine|136817-59-9|U 90152|Delavirdina|DOL5F9JD3E|2-(4-(5-Methanesulfonamido-1H-indol-2-ylcarbonyl)-1-piperazinyl)-N-(1-methylethyl)-3-pyridinamine|N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide|1-(3-((1-Methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)piperazine|DTXSID6022892|CHEBI:119573|DTXCID302892|N-(2-(1-(3-(isopropylamino)pyridin-2-yl)piperazine-4-carbonyl)-1H-indol-5-yl)methanesulfonamide|U90152|(N-[2-[4-[3-(1-methylethylamino)pyridin-2-yl]piperazin-1-yl]carbonyl-1H-indol-5-yl] methanesulfonamide)|N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide|Delavirdinum|(N-(2-(4-(3-(1-methylethylamino)pyridin-2-yl)piperazin-1-yl)carbonyl-1H-indol-5-yl) methanesulfonamide)|N-(2-((4-(3-((propan-2-yl)amino)pyridin-2-yl)piperazin-1-yl)carbonyl)-1H-indol-5-yl)methanesulfonamide|N-(2-(4-(3-(propan-2-ylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)methanesulfonamide|N-(2-(4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl)-1H-indol-5-yl)-methanesulfonamide|N-{2-[(4-{3-[(propan-2-yl)amino]pyridin-2-yl}piperazin-1-yl)carbonyl]-1H-indol-5-yl}methanesulfonamide|RefChem:585668|J05AG02|U90152S|Delavirdine [INN]|u-90152|N-(2-(4-(3-(Isopropylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)methanesulfonamide|C22H28N6O3S|Delavirdine (INN)|DLV|CHEMBL593|N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide|(1-(5-METHANSULPHONAMIDO-1H-INDOL-2-YL-CARBONYL)4-[METHYLAMINO)PYRIDINYL]PIPERAZINE|NCGC00168776-01|BHAP-U 90152|U 90152;BHAP-U 90152|N-[2-[4-[3-(isopropylamino)-2-pyridyl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide|N-[2-(4-{3-[(propan-2-yl)amino]pyridin-2-yl}piperazine-1-carbonyl)-1H-indol-5-yl]methanesulfonamide|UNII-DOL5F9JD3E|Rescriptor (TM)|CAS-136817-59-9|Delavirdine (*Mesylate salt*)|SR-05000001471|U90152S (*Mesylate salt*)|PNU-90152-T|MFCD00871405|Delavirdine(U-90152) & .a.IFN|DELAVIRDINE [MI]|DELAVIRDINE [VANDF]|SCHEMBL34420|DELAVIRDINE [WHO-DD]|BDBM1944|orb1685511|SCHEMBL29602259|SCHEMBL29714124|SCHEMBL30803764|GTPL12674|HMS2089F20|HMS3713A14|BCP08068|Tox21_112637|AKOS015965076|Tox21_112637_1|CS-1660|DB00705|DT-0031|NCGC00168776-02|NCGC00168776-03|NCGC00168776-10|HY-10571|N-{2-[(4-{3-[(1-methylethyl)amino]pyridin-2-yl}piperazin-1-yl)carbonyl]-1H-indol-5-yl}methanesulfonamide|NS00071587|C06941|D07782|AB01275468-01|EN300-7442125|Q370244|SR-05000001471-1|BRD-K34068325-066-01-1|BRD-K34068325-066-02-9|BRD-K34068325-066-03-7|Piperazine, 1-[3-[(1-methylethyl)amino]-2-pyridinyl]-4-[[5-[(methylsulfonyl)amino]-1H-indol-2-yl]carbonyl]- & alpha-Interferon"
TROVIRDINE,3000870,,"InChI=1S/C13H13BrN4S/c14-10-4-5-12(17-9-10)18-13(19)16-8-6-11-3-1-2-7-15-11/h1-5,7,9H,6,8H2,(H2,16,17,18,19)",HOCFDYZWQYGULA-UHFFFAOYSA-N,C13H13BrN4S,337.24,1-(5-bromopyridin-2-yl)-3-(2-pyridin-2-ylethyl)thiourea,"Trovirdine|149488-17-5|LY-300046|Trovirdina|ZE3K6J8614|DTXSID00869977|HI-142|1-(5-Bromo-2-pyridyl)-3-(2-(2-pyridyl)ethyl)-2-thiourea|trovirdinum|RefChem:933580|LY300046.HCl|DTXCID40817851|LY 300046|Troviridine|Trovirdine [INN]|1-(5-bromopyridin-2-yl)-3-(2-(pyridin-2-yl)ethyl)thiourea|1-(5-bromopyridin-2-yl)-3-(2-pyridin-2-ylethyl)thiourea|LY300046|UNII-ZE3K6J8614|Trovirdine (LY-300046)|MFCD00866930|TrovirdineLY300046?|CHEMBL39999|SCHEMBL636095|LY300046HCl|BDBM1866|orb1304461|LY-300046 HCl|GLXC-10701|BCP20663|LY-300046 (HCl)|AKOS030526567|CS-5538|NCGC00522539-01|AC-38085|HY-15349|MS-25108|DB-161556|NS00122002|N17007|BRD-K00989047-001-01-2|Q27295380|1-(5-bromo-2-pyridyl)-3-[2-(2-pyridyl)ethyl]thiourea|1-(5-bromo-2-pyridyl)-3-[2-(2-pyridyl)ethyl]isothiourea|N-(2-(2-Pyridylethyl))-N -(2-(5-bromopyridyl))thiourea|Thiourea, N-(5-bromo-2-pyridinyl)-N'-[2-(2-pyridinyl)ethyl]-|3-(5-bromopyridin-2-yl)-1-[2-(pyridin-2-yl)ethyl]thiourea hydrochloride"
EFAVIRENZ,64139,,"InChI=1S/C14H9ClF3NO2/c15-9-3-4-11-10(7-9)13(14(16,17)18,21-12(20)19-11)6-5-8-1-2-8/h3-4,7-8H,1-2H2,(H,19,20)/t13-/m0/s1",XPOQHMRABVBWPR-ZDUSSCGKSA-N,C14H9ClF3NO2,315.67,"(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one","efavirenz|154598-52-4|Sustiva|Stocrin|DMP-266|(-)-Efavirenz|Viraday|Efavirenz teva|(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one|(4S)-6-Chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one|L-743726|Efavirenzum|L-743,726|NSC-742403|JE6H2O27P8|(S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one|DTXSID9046029|CHEBI:119486|DTXCID7026029|TELURA COMPONENT EFAVIRENZ|(s)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-2H-3,1-benzoxazin-2-one|(S)-6-Chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo[d][1,3]oxazin-2-one|6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo[d][1,3]oxazin-2-one|(S)-6-chloro-4-cyclopropylethynyl-4-trifluoromethyl-1,4-dihydro-benzo(d)(1,3)oxazin-2-one|6-chloro-4-(2-cyclopropyl-1-ethynyl)-4-trifluoromethyl-(4S)-1,4-dihydro-2H-benzo(d)(1,3)oxazin-2-one|efavirenz, (S)-|Sustiva 600|RefChem:590606|L 743,726|J05AG03|EFAVIRENZ 200MG SCORED TABLETS|MK-0831|L743726|DMP 266|(4S)-6-Chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one|EFV|(S)-Efavirenz|MFCD05662344|(-)-6-CHLORO-4-CYCLOPROPYLETHYNYL-4-TRIFLUOROMETHYL-1,4-DIHYDRO-2H-3,1-BENZOXAZIN-2-ONE|(4S)-6-chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one|DMP266|(Rac)-Efavirenz|NSC742403|(S)-6-CHLORO-4-(CYCLOPROPYLETHYNYL)-4-(TRIFLUOROMETHYL)-1H-BENZO[D][1,3]OXAZIN-2(4H)-ONE|L 743726|(4S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one|2H-3,1-Benzoxazin-2-one, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-|ent Efavirenz|(Rac)-DMP 266; (Rac)-EFV; (Rac)-L-743726|Eravirenz|SMR000466351|Strocin (TM)|Sustiva (TM)|Sustiva (TN)|CAS-154598-52-4|HSDB 7163|SR-01000759360|Efavirenz [USP:INN:BAN]|UNII-JE6H2O27P8|Met-SDF-1.beta. & Efavirenz|1ikv|1ikw|NCGC00159337-02|Efavirenz, (S)|Efavirenz & PLGA|Efavirenz (Standard)|Efavirenz & IFNL1|Efavirenz & IFNL2|Efavirenz & IFNL3|Efavirenz & IL-29|EFAVIRENZ [INN]|EFAVIRENZ [JAN]|DMP-266; Efavirenz|Efavirenz & IL-28A|Efavirenz & IL-28B|EFAVIRENZ [MI]|EFAVIRENZ [HSDB]|EFAVIRENZ [USAN]|EFV & Interleukin 29|EFAVIRENZ [VANDF]|EFV & Interleukin 28A|EFV & Interleukin 28B|EFV & PLGA|EFAVIRENZ [MART.]|EFAVIRENZ [USP-RS]|EFAVIRENZ [WHO-DD]|EFAVIRENZ [WHO-IP]|EFV & IFNL1|EFV & IFNL2|EFV & IFNL3|Efavirenz (JAN/USP/INN)|EFV & Interferon lambda-1|EFV & Interferon lambda-2|EFV & Interferon lambda-3|Efavirenz & Interleukin 29|SCHEMBL37762|EFAVIRENZ [EMA EPAR]|Efavirenz & Interleukin 28A|Efavirenz & Interleukin 28B|MLS000759465|MLS001424087|BIDD:GT0383|Efavirenz - Bio-X trade mark|BDBM2483|CHEMBL223228|EFV & IL-28A|EFV & IL-28B|orb1305550|EFAVIRENZ [ORANGE BOOK]|Efavirenz, >=98% (HPLC)|Efavirenz & Interferon lambda-1|Efavirenz & Interferon lambda-2|Efavirenz & Interferon lambda-3|EFV & IL-29|GTPL11287|EFAVIRENZ [USP MONOGRAPH]|ATRIPLA COMPONENT EFAVIRENZ|BCPP000245|GLXC-04867|HMS2051J08|HMS2090N16|HMS3393J08|HMS3713M14|Met-Stromal Cell-derived Factor-1.beta. (Human) & Efavirenz|EFAVIRENZUM [WHO-IP LATIN]|2H-3,1-Benzoxazin-2-one, 6-chloro-4-(2-cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-|ALBB-038626|BCP27719|MSK10874|Tox21_111582|DL-535|HY-10572R|s4685|AKOS015894951|Tox21_111582_1|AB21723|BCP9000636|CCG-101011|DB00625|FC30275|KS-5380|NC00261|NSC 742403|Efavirenz 100 microg/mL in Acetonitrile|NCGC00159337-04|NCGC00159337-12|NCGC00271713-05|NCGC00271713-08|AC-25006|BC164402|HY-10572|SY009682|E0997|NS00000604|C08088|D00896|EN300-219935|F17329|AB00639956-06|AB00639956-08|598E524|A809555|Q422645|SR-01000759360-4|SR-01000759360-5|BRD-K40758068-001-08-2|Z2177953192|Efavirenz, United States Pharmacopeia (USP) Reference Standard|(4S)-6-chloranyl-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-1H-3,1-benzoxazin-2-one|2H-3, 6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-, (4S)-|(S)-6-Chloro-4-(2-cyclopropylethynyl)-4-(trifluoromethyl)-2,4-dihydro-1H-3,1-benzoxazin-2-one|(S)-6-Chloro-4-(cyclopropyl-ethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazine-2-one|(S)-6-chloro-4-(Cyclopropylethynyl)-1,4-dihydro-(S)-6-chloro-4-(cyclopropylethynyl)-1,4-dihydro-4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one4-(trifluoromethyl)-2H-3,1-benzoxazin-2-one|(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-ben zoxazin-2-one|(S)-6-chloro-4-(cyclopropylethynyl)-4-(trifluoromethyl)-1,4-dihydro-2H-3,1-benzoxazin-2-one"
DELAVIRDINE MESYLATE,441386,,"InChI=1S/C22H28N6O3S.CH4O3S/c1-15(2)24-19-5-4-8-23-21(19)27-9-11-28(12-10-27)22(29)20-14-16-13-17(26-32(3,30)31)6-7-18(16)25-20;1-5(2,3)4/h4-8,13-15,24-26H,9-12H2,1-3H3;1H3,(H,2,3,4)",MEPNHSOMXMALDZ-UHFFFAOYSA-N,C23H32N6O6S2,552.7,methanesulfonic acid;N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide,"DELAVIRDINE MESYLATE|147221-93-0|Delavirdine mesilate|Rescriptor|U-90152S|delavirdine methanesulfonate|Delavirdine monomethanesulfonate|CHEBI:4379|421105KRQE|1-(3-(Isopropylamino)-2-pyridyl)-4-((5-methanesulfonamidoindol-2-yl)carbonyl)piperazine monomethanesulfonate|DTXSID701017136|Piperazine, 1-(3-((1-methylethyl)amino)-2-pyridinyl)-4-((5-((methylsulfonyl)amino)-1H-indol-2-yl)carbonyl)-, monomethanesulfonate|1-[3-(Isopropylamino)-2-pyridyl]-4-[(5-methanesulfonamidoindol-2-yl)carbonyl]piperazine monomethanesulfonate|Mesylate, Delavirdine|RefChem:57382|DTXCID701475318|Delavirdine (mesylate)|Methanesulfonamide, N-[2-[[4-[3-[(1-methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]-, methanesulfonate (1:1)|N-(2-(4-(3-(isopropylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)methanesulfonamide methanesulfonate|Delavirdine mesylate [USAN]|MFCD00866948|Delavirdine mesilate (JAN)|Delavirdine mesylate (USAN)|U 90152 (mesylate);BHAP-U 90152 (mesylate)|DELAVIRDINE MESILATE [JAN]|UNII-421105KRQE|SR-05000001471|HSDB 7162|Rescriptor (TN)|DRG-0166|U 90152E|U 90152S|U 90152T|CHEMBL929|DELAVIRDINE, MESYLATE|SCHEMBL40522|orb1299973|SCHEMBL29585604|C23H32N6O6S2|HMS5085O22|DELAVIRDINE MESYLATE [HSDB]|BCP09460|DELAVIRDINE MESYLATE [VANDF]|DELAVIRDINE MESILATE [MART.]|HY-10571A|s6452|DELAVIRDINE MESYLATE [WHO-DD]|AKOS024458004|AT12830|CS-1661|Delavirdine mesylate, >=98% (HPLC)|FD20974|DELAVIRDINE METHANESULFONATE [MI]|AC-37638|BS-15144|DA-52421|DELAVIRDINE MESYLATE [ORANGE BOOK]|methanesulfonic acid;N-[2-[4-[3-(propan-2-ylamino)pyridin-2-yl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide|N-[2-[[4-[3-[(1-Methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]methanesulfonamide mesylate|SY273767|U-90152T|C08087|D00895|SBI-0654139.0001|EN300-19767275|SR-05000001471-2|Q27068164|Z3243811539|1-(3-(ISOPROPYLAMINO)-2-PYRIDYL)-4-((5-METHANESULPHONAMIDOINDOL-2-YL)CARBONYL)PIPERAZINE MONOMETHANESULPHONATE|1-[3-[(1-Methylethyl)amino]-2-pyridinyl]-4-[[5-[(methylsulfonyl)amino]-1H-indol-2-yl]carbonyl]-piperazine monomethanesulfonate|N-(2-(4-(3-(isopropylamino)pyridin-2-yl)piperazine-1-carbonyl)-1H-indol-5-yl)methanesulfonamidemethanesulfonate|N-[2-({4-[3-(propan-2-ylamino)pyridin-2-yl]piperazin-1-yl}carbonyl)-1H-indol-5-yl]methanesulfonamide methanesulfonate|N-[2-(4-{3-[(propan-2-yl)amino]pyridin-2-yl}piperazine-1-carbonyl)-1H-indol-5-yl]methanesulfonamide; methanesulfonic acid|N-[2-[[4-[3-[(1-Methylethyl)amino]-2-pyridinyl]-1-piperazinyl]carbonyl]-1H-indol-5-yl]methanesulfonamide methanesulfonate;U-90152S|N-[2-[4-[3-(isopropylamino)-2-pyridyl]piperazine-1-carbonyl]-1H-indol-5-yl]methanesulfonamide;methanesulfonic acid|N-{2-[4-(3-Isopropylamino-pyridin-2-yl)-piperazine-1-carbonyl]-1H-indol-5-yl}-methanesulfonamide; compound with methanesulfonic acid|PIPERAZINE, 1-(3-((1-METHYLETHYL)AMINO)-2-PYRIDINYL)-4-((5-((METHYLSULPHONYL)AMINO)-1H-INDOL-2-YL)CARBONYL)-, MONOMETHANESULPHONATE"
ZIDOVUDINE,35370,,"InChI=1S/C10H13N5O4/c1-5-3-15(10(18)12-9(5)17)8-2-6(13-14-11)7(4-16)19-8/h3,6-8,16H,2,4H2,1H3,(H,12,17,18)/t6-,7+,8+/m0/s1",HBOMLICNUCNMMY-XLPZGREQSA-N,C10H13N5O4,267.24,"1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione","zidovudine|Azidothymidine|30516-87-1|3'-Azido-3'-deoxythymidine|Retrovir|Thymidine, 3'-azido-3'-deoxy-|Zidovudinum|Compound S|Zidovudina|BW A509U|zidovudin|BWA509U|3'-Deoxy-3'-azidothymidine|BW-A509U|BW-A-509U|DRG-0004|3'-azt|DTXSID8020127|3'-Azidothymidine|NSC 602670|1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione|4B9XT59T7S|1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione|CHEBI:10110|BW-A 509U|NSC-602670|DTXCID60127|AZT Antiviral|TRIZIVIR COMPONENT ZIDOVUDINE|AZT, Antiviral|1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)-5-methylpyrimidine-2,4-(1H,3H)-dione|AZT (Antiviral)|Antiviral AZT|LAMIVUDINE/ZIDOVUDINE TEVA COMPONENT ZIDOVUDINE|BWA-509U|3'-Azido-2',3'-Dideoxythymidine|3' Azido 3' deoxythymidine|BWA 509U|3' Azido 2',3' Dideoxythymidine|1-((2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl)-5-methylpyrimidine-2,4-dione|1-((2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl)-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione|RefChem:6356|J05AF01|623-849-4|NSC602670|AZT|ZIDOVUDINE [AZT]|Trizivir|MFCD00006536|ZDV|Azidothymidine (AZT)|CHEMBL129|1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine|MLS000028548|1-((2R,4S,5S)-4-AZIDO-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE|NCGC00023945-05|Zidovudinum [Latin]|SMR000058351|Zidovudina [Spanish]|399024-19-2|Propolis+AZT|Retrovir(TM)|AZT & Li & EPO|Retrovir (TN)|CCRIS 105|Cpd S|Intron A & AZT|HSDB 6515|Racemic Liposomal AZT|Liposomal AZT-SN-1|Liposomal AZT-SN-3|Zidovudine+PRO 140|PC-SOD+AZT|AZT & srCD4|AZT & rIFN.alpha.2|AZT & rsT4|rIFN-beta seron & AZT|3'-Azido-3'-deoxythymidine (AIDS)|AZT & EPO|AZT & GM-CSF|AZT & HPA|AZT & sCD4|AZT & SST|zudovidine|UNII-4B9XT59T7S|AZT & Li & GM-CSF|AZT+PRO 140|Met-SDF-1.beta. & AZT|AZT & Li & IL-1|AZT & Li & IL-6|AZT & IL-1|AZT & IL-2|AZT & IL-6|AZT & Interferon-.alpha.-2|AZT & Concanavalin A (ConA)|AZT & Lymphoblastoid Interferon|AZT & PM-19|Met-SDF-1.beta. & Zidovudine|4lhm|1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AZT)|1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione [AZT]|AZT & rsCD4 & rIFN.alpha.A|3'-azido-3'-deoxythymidine, AZT|DS-4152 & AZT|1-((2R,4R,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione|1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione|5-methyl-1-[rac-(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione|AZT & Colony-stimulating factor 2|AZT & NP (from PHCA or HSA)|Zidovudine; 1-(3-Azido-2,3-dideoxy-ss-d-erythro-pentofuranosyl)-5-methylpyrimidine-2,4(1H,3H)-dione; Zidovudine (GR 63367X); BP Zidovudine and Lamivudine Impurity Standard|3''-azido-thymidine|K7 [P Ti2 W10 O40]|Zidovudine [USAN:USP:INN:BAN:JAN]|Zidovudine & IFNL1|Zidovudine & IFNL2|Zidovudine & IFNL3|Zidovudine (Retrovir)|Zidovudine (Standard)|COMPOUND-S|Spectrum_001348|AZT & CD4(178)-PE 40|AZT & IFN.alpha.|Zidovudine & IL-29|ZIDOVUDINE [MI]|Zidovudine & IL-28A|Zidovudine & IL-28B|AZT, ZDV|ZIDOVUDINE [INN]|ZIDOVUDINE [JAN]|AZT & Interleukin 29|Opera_ID_1602|Prestwick3_000333|Spectrum2_000927|Spectrum3_001507|Spectrum4_000332|Spectrum5_001101|3'azido-3'deoxythymidine|ZIDOVUDINE [HSDB]|ZIDOVUDINE [IARC]|ZIDOVUDINE [USAN]|3'-Azido-3'-deoxythymidine & Erythropoietin|3'-Azido-3'-deoxythymidine & Sho-Saiko-To|Azidothymidine; Zidovudine|Interferon AD + 3'-azido-3'-deoxythymidine|AZT & Interleukin 28A|AZT & Interleukin 28B|3'-Azido-3'-deoxythymidine & Concanavalin A|3'-Azido-3'-deoxythymidine & Interleukin-1|3'-Azido-3'-deoxythymidine & Interleukin-2|3'-Azido-3'-deoxythymidine & Interleukin-6|ZIDOVUDINE [VANDF]|3'-azido3'-deoxythymidine|AZT & IFNL1|AZT & IFNL2|AZT & IFNL3|ZIDOVUDINE [MART.]|AZT & Interferon lambda-1|AZT & Interferon lambda-2|AZT & Interferon lambda-3|ZIDOVUDINE [USP-RS]|ZIDOVUDINE [WHO-DD]|ZIDOVUDINE [WHO-IP]|3''-Deoxy-3-azidothymidine|BSPBio_000365|BSPBio_003153|KBioGR_000703|KBioSS_001828|MLS001055351|MLS001076358|MLS002153202|MLS002222249|Zidovudine & Interleukin 29|DivK1c_000524|SPECTRUM1502109|ZIDOVUDINE [EMA EPAR]|3'-deoxy-3'-azido-thymidine|SPBio_000834|Zidovudine & Interleukin 28A|Zidovudine & Interleukin 28B|AZT & IL-28A|AZT & IL-28B|BPBio1_000403|GTPL4825|orb1308679|Zidovudine (JP18/USP/INN)|3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin|3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1|3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6|3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon|SCHEMBL14615088|SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle)|SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle)|ZIDOVUDINE [EP IMPURITY]|ZIDOVUDINE [ORANGE BOOK]|AZT & IL-29|HMS501K06|KBio1_000524|KBio2_001828|KBio2_004396|KBio2_006964|KBio3_002653|racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle)|ZIDOVUDINE [EP MONOGRAPH]|3''-Azido-3''-deoxy-thymidine|NINDS_000524|Zidovudine & Interferon lambda-1|Zidovudine & Interferon lambda-2|Zidovudine & Interferon lambda-3|HMS1921J20|HMS2090G11|HMS2092D06|HMS2096C07|HMS2234K17|HMS3259H17|HMS3713C07|Pharmakon1600-01502109|ZIDOVUDINE [USP MONOGRAPH]|ZIDOVUDINUM [WHO-IP LATIN]|3'-azido-3'-deoxythymidine (azt)|COMBIVIR COMPONENT ZIDOVUDINE|MSK10681|3''azido-2''3''-dideoxythymidine|Tox21_110062|Tox21_110894|Tox21_202203|Tox21_300578|BBL033764|BDBM50002692|CCG-39924|HY-17413R|NSC758185|STK801891|AKOS005622576|AKOS015842610|Tox21_110062_1|3''-azido-2'',3''-dideoxythymidine|DB00495|NC00666|NSC-758185|IDI1_000524|NCGC00014918-01|NCGC00023945-03|NCGC00023945-04|NCGC00023945-06|NCGC00023945-07|NCGC00023945-08|NCGC00023945-09|NCGC00023945-10|NCGC00023945-12|NCGC00023945-13|NCGC00023945-24|NCGC00023945-25|NCGC00178237-01|NCGC00178237-02|NCGC00254276-01|NCGC00259752-01|AS-13019|SY065461|SBI-0051731.P002|DB-225998|NS00000600|Propolis & Thymidine, 3'-azido-3'-deoxy-|S2579|SW198799-2|EN300-52518|3'-Azido-3'-deoxythymidine, >=98% (HPLC)|C07210|D00413|D88500|3'-Azido-3'deoxythymidine & Interferon .alpha.|3'-Azido-3'-deoxythymidine, >=99.0% (HPLC)|F358376|Q198504|SR-01000000098|SR-05000001587|SR-01000000098-3|SR-05000001587-1|BRD-K72903603-001-04-6|BRD-K72903603-001-14-5|BRD-K72903603-001-24-4|Z754931264|Zidovudine, European Pharmacopoeia (EP) Reference Standard|3'-Azido-3'-deoxythymidine & Recombinant Interferon-.alpha.-2|Zidovudine, United States Pharmacopeia (USP) Reference Standard|3'-Azido-3'-deoxythymidine & CD4-Pseudomonas exotoxin A hybrid|Beta interferon(rIFN-beta seron) & 3'-Azido-3'-deoxythymidine(AZT)|Lecithinized superoxide dismutase & Thymidine, 3'-azido-3'-deoxy-|3'-Azido-2',3'-dideoxythymidine & sCD4(soluble recombinant protein)|Thymidine, 3'-azido-3'-deoxy- & PRO 140 (Anti-CCR5 monoclonal antibody)|Zidovudine, Pharmaceutical Secondary Standard; Certified Reference Material|(AZT) 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione|(AZT)1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione|1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione|1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(AZT)|3'-Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor|3'-Azido-3'-deoxythymidine & Lithium & Granulocyte-macrophage colony-stimulating factor|3'-Azido-3'deoxythymidine & Recombinant Soluble CD4 & Recombinant Interferon.alpha.A|4-(4-Azido-5-hydroxy-tetrahydro-furan-2-yl)-5-methyl-3H-pyrazine-2,6-dione|Met-Stromal Cell-derived Factor-1.beta. (Human) & 3'-Azido-3'-deoxythymidine|1-((2R,4S,5S)-4-(diazoamino)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione|1-((2R,4S,5S)-4-azido-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione|1-((2R,4S,5S)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione|1-((2R,5S)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione|1-((2S,4R,5R)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione|1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AzddThd, AZT)|1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (N3ddThd)|1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(3''-azido-2'',3''-dideoxythymidine)|1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(azidothymidine, AZT)|1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(Zidovudine, AZT)|3-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)triaz-1-en-2-ium-1-ide"
ZIDOVUDINE TRIPHOSPHATE,72187,,"InChI=1S/C10H16N5O13P3/c1-5-3-15(10(17)12-9(5)16)8-2-6(13-14-11)7(26-8)4-25-30(21,22)28-31(23,24)27-29(18,19)20/h3,6-8H,2,4H2,1H3,(H,21,22)(H,23,24)(H,12,16,17)(H2,18,19,20)/t6-,7+,8+/m0/s1",GLWHPRRGGYLLRV-XLPZGREQSA-N,C10H16N5O13P3,507.18,"[[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate","AZT triphosphate|Zidovudine triphosphate|92586-35-1|AZTTP|Azt-TP|3'-Azido-3'-deoxythymidine 5'-triphosphate|Azidothymidine triphosphate|Dttp(3'N3)|3'-Azidothymidine triphosphate|3'-Deoxy-3'-azidothymidine triphosphate|3'-Azido-2',3'-dideoxythymidine-5'-triphosphate|Thymidine 5'-(tetrahydrogen triphosphate), 3'-azido-3'-deoxy-|6RGF96R053|DTXSID80239053|ZDV-TP|RefChem:195956|DTXCID00161544|Threo-azt-TP|[[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate|Zidovudine 5'-triphosphate|3'-AZIDO-3'-DEOXYTHYMIDINE-5'-TRIPHOSPHATE|Erythro-azt-TP|3'-azido-3'-deoxythymidine triphosphate|106060-92-8|906479-25-2|UNII-6RGF96R053|AZT-triphospate|AZddTTP|1-(3'-Azido-2',3'-dideoxy-beta-D-xylofuranosyl)thymine 5'-triphosphate|3'-Azido-dTTP|N3dTTP|NSC742231|Zidovudine-5'-triphosphate|3'-N3-dTTP|orb572654|Azidothymidine-5'-triphosphate|CHEMBL193952|orb1733728|orb1907775|SCHEMBL19808965|GLWHPRRGGYLLRV-XLPZGREQSA-N|Zidovudine-triphosphate (AZT-TP)|BDBM50370476|NA32049|DA-50915|HY-116364|3'-Deoxy-3'-Azidothymidine-5'-triphosphate|CS-0065212|3'-Azido-2',3'-dideoxythymidine-5'- triphosphate|AZT triphosphate, AZT-TP, dTTP(3'N3), Combivir|Q27265380|3'-Azido-3'-deoxythymidine-5'-triphosphate lithium salt - 100mM aqueous solution|[[(2S,3S,5R)-3-azido-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate"
ETRAVIRINE,193962,,"InChI=1S/C20H15BrN6O/c1-11-7-14(10-23)8-12(2)17(11)28-19-16(21)18(24)26-20(27-19)25-15-5-3-13(9-22)4-6-15/h3-8H,1-2H3,(H3,24,25,26,27)",PYGWGZALEOIKDF-UHFFFAOYSA-N,C20H15BrN6O,435.3,"4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile","Etravirine|269055-15-4|Intelence|TMC-125|TMC125|TMC 125|R165335|R-165335|4-((6-Amino-5-bromo-2-((4-cyanophenyl)amino)pyrimidin-4-yl)oxy)-3,5-dimethylbenzonitrile|Etravirina|TMC125 cpd|4-({6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]PYRIMIDIN-4-YL}OXY)-3,5-DIMETHYLBENZONITRILE|0C50HW4FO1|CHEBI:63589|4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethylbenzonitrile|4-(6-Amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile|DTXSID30181412|4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-benzonitrile|Benzonitrile, 4-((6-amino-5-bromo-2-((4-cyanophenyl)amino)-4-pyrimidinyl)oxy)-3,5-dimethyl-|Benzonitrile, 4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-|etravirinum|4-(6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl)oxy-3,5-dimethylbenzonitrile|4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-benzonitrile|RefChem:57536|DTXCID40103903|J05AG04|682-331-6|Etravirine (TMC125)|Etravirine-d8|MFCD09837879|Benzonitrile,4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl-|C20H15BrN6O|CHEMBL308954|4-[6-amino-5-bromo-2-(4-cyanoanilino)pyrimidin-4-yl]oxy-3,5-dimethyl-benzonitrile|65B|Intelence(TM)|DAPY deriv|4-(6-amino-5-bromo-2-(4-cyanophenylamino)pyrimidin-4-yloxy)-3,5-dimethylbenzonitrile|Intelence (TN)|1142096-06-7|Diaminopyrimidine deriv|UNII-0C50HW4FO1|Etravirine (JAN/USAN/INN)|Etravirine [USAN:INN:BAN:JAN]|Etravirine [INN]|R 165335|Etravine; Etravirine|4-[[6-AMINO-5-BROMO-2-[(4-CYANOPHENYL)AMINO]-4-PYRIMIDINYL]OXY]-3,5-DIMETHYLBENZONITRILE|394729-17-0|R165335-TMC125|Etravirine (Standard)|3m8p|ETRAVIRINE [MI]|TMC-125/R-165335|ETRAVIRINE [JAN]|ETRAVIRINE [USAN]|ETRAVIRINE [VANDF]|ETRAVIRINE [MART.]|ETRAVIRINE [WHO-DD]|SCHEMBL52691|ETRAVIRINE [EMA EPAR]|Etravirine - Bio-X trade mark|orb1305326|ETRAVIRINE [ORANGE BOOK]|GTPL12675|PYGWGZALEOIKDF-UHFFFAOYSA-N|GLXC-04866|HMS3651P20|HMS5081G14|BCP03562|EX-A4282|SVB09593|BDBM50103642|HY-90005R|s3080|4-({6-amino-5-bromo-2-[(4-|AKOS015896355|AC-8503|BCP9000006|CCG-269074|CS-0435|DB06414|FA16346|HE-0088|PB32778|4-[[4-amino-5-bromo-6-(4-cyano-2,6-dimethylphenyloxy)-2-pyrimidinyl]amino]benzonitrile|NCGC00345885-02|NCGC00345885-04|BA164437|HY-90005|SY097013|BCP0726000193|DB-067700|DB-262849|cyanophenyl)amino]pyrimidin-4-yl}oxy)-3,5-|NS00008301|SW219570-1|D04112|SBI-0654096.0001|AB01566873_01|A818671|EN300-23542752|Q414762|SR-01000944895|SR-01000944895-1|BRD-K74717603-001-02-2|4-(6-amino-5-bromo-2-(4-cyanophenylamino)pyrimidin-4-ylamino)-3,5-dimethylbenzonitrile|4-[[4-amino 5-bromo-6-(4-cyano-2,6-dimethylphenyloxy)-2-pyrimidinyl]amino]benzonitrile|4-[[4-amino-5-bromo-6-(4-cyano-2,6-dimethylphenyloxy)-2-pyrimidinyl]-amino]benzonitrile|4-[[6-amino-5-bromo-2-(4-cyanoanilino)-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile|4-[[6-amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3, 5-dimethylbenzonitrile|4-[6-amino-5-bromo-2-(4-cyano-phenylamino)-pyrimidin-4-yloxy]-3,5-dimethyl-benzonitrile|4-[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]pyrimidin-4-yl ]oxy-3,5-dimethyl-benzonitrile|4-((6-amino-5-bromo-2-((4-cyanophenyl) amino) pyrimidin-4-yl) oxy)-3, 5-dimethylbenzonitrile|4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl -benzonitrile|4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethyl -benzonitrile;Intelence;Etravirine;R 165335;TMC 125|4-[6-azanyl-5-bromanyl-2-[(4-cyanophenyl)amino]pyrimidin-4-yl]oxy-3,5-dimethyl-benzenecarbonitrile|Intelence;4-[[6-Amino-5-bromo-2-[(4-cyanophenyl)amino]-4-pyrimidinyl]oxy]-3,5-dimethylbenzonitrile;R 165335;TMC 125"
STAVUDINE,18283,,"InChI=1S/C10H12N2O4/c1-6-4-12(10(15)11-9(6)14)8-3-2-7(5-13)16-8/h2-4,7-8,13H,5H2,1H3,(H,11,14,15)/t7-,8+/m0/s1",XNKLLVCARDGLGL-JGVFFNPUSA-N,C10H12N2O4,224.21,"1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione","stavudine|3056-17-5|sanilvudine|Zerit|2',3'-Didehydro-3'-deoxythymidine|Estavudina|Stavudinum|Thymidine, 2',3'-didehydro-3'-deoxy-|Zerit Xr|BMY-27857|D 4T (nucleoside)|3'-Deoxy-2'-thymidinene|1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione|2',3'-Didehydro-3'-deoxythimidine|3'-Deoxy-2',3'-didehydrothymidine|BMY 27857|Dideoxydidehydrothymidine|Stavudine (d4T)|1-(2,3-Dideoxy-beta-D-glycero-pent-2-enofuranosyl)thymine|BO9LE4QFZF|DTXSID1023819|BMY27857|Stavudine (dt4)|2'-Thymidinene, 3'-deoxy-|NSC-759897|CHEBI:63581|NSC-163661|1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-dione|DTXCID803819|NSC163661|1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione|1-[(2R,5S)-5-(HYDROXYMETHYL)-2,5-DIHYDROFURAN-2-YL]-5-METHYL-1,2,3,4-TETRAHYDROPYRIMIDINE-2,4-DIONE|2',3' Didehydro 3' deoxythymidine|2',3'-Didehydro-2',3'-dideoxythmidine|1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4-dione|1-((2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione|Didehydrodeoxythymidine|RefChem:57733|1-(2,3-dideoxy-beta-glycero-pent-2-enofuranosyl)thymine|Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)-(7CI,8CI)|Lion|d4T|Stavudinum [INN-Latin]|Estavudina [INN-Spanish]|ddeThd|MFCD00132921|Sanilvudine (JAN)|STV|CHEMBL991|Zerut XR|MLS000028546|D-4T|NCGC00023212-07|SMR000058350|SANILVUDINE [JAN]|NSC 163661|1-[(2R,5S)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione|Stavudine [USAN:BAN:INN]|1-(2,3-Dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)thymine|D 4T|ddeTyd|1-(cis-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione|220020-60-0|CAS-3056-17-5|Zerit(TM)|Zerit (TN)|HSDB 7338|SR-01000075802|UNII-BO9LE4QFZF|Stavudine (USAN/INN)|BRN 0618327|D4T & GM-CSF|Stavudine [USAN:USP:INN:BAN]|D4TMBY-27857-3|Stavudine (Standard)|STAVUDINE [INN]|STAVUDINE [MI]|STAVUDINE [HSDB]|STAVUDINE [USAN]|Opera_ID_1281|STAVUDINE [MART.]|D 1413|cid_5155|STAVUDINE [USP-RS]|STAVUDINE [WHO-DD]|STAVUDINE [WHO-IP]|3''-deoxy-2''-thymidine|Lopac0_000336|SCHEMBL38661|STAVUDINE [EMA EPAR]|cid_18283|MLS000759504|MLS001055348|MLS001077292|MLS001424091|MLS006011922|BIDD:GT0082|Stavudine - Bio-X trade mark|2',3'-Anhydrothymidine; d4T|STAVUDINE [EP IMPURITY]|STAVUDINE [ORANGE BOOK]|STAVUDINE [EP MONOGRAPH]|GTPL12678|HY-B0116R|1-(2,3-Dideoxy-beta-D-glycero-2-pentenofuranosyl)thymine|STAVUDINE [USP MONOGRAPH]|STAVUDINUM [WHO-IP LATIN]|HMS2051O20|HMS2234C10|HMS3039O05|HMS3259L21|HMS3261C13|HMS3428C07|HMS3714N22|Pharmakon1600-01502339|STAVUDINE (D4T) [VANDF]|STAVUDINE (DT4) [VANDF]|BCP02952|HY-B0116|Tox21_110886|Tox21_201393|Tox21_300583|Tox21_500336|BBL033763|BDBM50013111|NSC759897|Stavudine(Zidovudine EP Impurity A)|STK801888|AKOS005622554|Tox21_110886_1|AC-5263|CCG-100902|CS-1872|DB00649|KS-1115|LP00336|NC00152|NC00684|ND07118|SDCCGSBI-0050324.P002|ZIDOVUDINE IMPURITY A [WHO-IP]|1-((2R,5S)-5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione|2'',3''-didehydro-3''-deoxythymidine|3''-deoxy-2'',3''-didehydrothymidine|3'-Deoxy-2',3'-didehydro-D-thymidine|NCGC00023212-03|NCGC00023212-04|NCGC00023212-05|NCGC00023212-08|NCGC00023212-09|NCGC00023212-10|NCGC00023212-11|NCGC00023212-12|NCGC00023212-13|NCGC00023212-14|NCGC00023212-25|NCGC00023212-30|NCGC00254372-01|NCGC00258944-01|NCGC00261021-01|Stavudine 100 microg/mL in Acetonitrile|1-[5-(hydroxymethyl)-2,5-dihydro-2-furanyl]-5-methyl-2,4(1H,3H)-pyrimidinedione & Colony-stimulating factor 2|BD164571|SMR000673569|SY057970|2',3'-didehydro-2',3'-dideoxythymidine|Thymidine, 2',3'-didehydro-, 3'-deoxy-|ZIDOVUDINE IMPURITY A [EP IMPURITY]|D3580|EU-0100336|NS00002353|2'',3''-dideoxy-2'',3''-didehydrothymidine|C07312|D00445|EN300-120634|AB00383018_18|056S175|F404709|Q423984|SR-01000075802-1|SR-01000075802-4|2',3'-Didehydro-3'-deoxythymidine, >=98% (TLC)|BRD-K93880783-001-26-6|Z1530425068|Stavudine, European Pharmacopoeia (EP) Reference Standard|Stavudine, United States Pharmacopeia (USP) Reference Standard|Thymine, 1-(2,3-dideoxy-beta-D-glycero-pent-2-enofuranosyl)-|1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione|1-(5-Hydroxymethyl-2,5-dihydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (ddeThd)|3'- Azido-3'-deoxythymidine & Granulocyte-macrophage colony-stimulating factor|Stavudine for system suitability, European Pharmacopoeia (EP) Reference Standard|1-[(2R,5S)-5-(Hydroxymethyl)-2,5-dihydrofuran-2-yl]-5-methylpyrimidine-2,4-(1H,3H)-dione|Sanilvudine;2',3'-Didehydro-2',3'-dideoxythymidine;3'-Deoxy-2',3'-didehydro-D-thymidine;2',3'-Didehydro-3'-deoxythymidine|Zidovudine Related Compound A;Sanilvudine;3'-Deoxy-2',3'-didehydro-D-thymidine;2',3'-Didehydro-3'-deoxythymidine"
MOZENAVIR,154044,,"InChI=1S/C33H36N4O3/c34-27-15-7-13-25(17-27)21-36-29(19-23-9-3-1-4-10-23)31(38)32(39)30(20-24-11-5-2-6-12-24)37(33(36)40)22-26-14-8-16-28(35)18-26/h1-18,29-32,38-39H,19-22,34-35H2/t29-,30-,31+,32+/m1/s1",KYRSNWPSSXSNEP-ZRTHHSRSSA-N,C33H36N4O3,536.7,"(4R,5S,6S,7R)-1,3-bis[(3-aminophenyl)methyl]-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one","Mozenavir|Mozenavir [INN]|174391-92-5|64OO8946ER|Mozenavir (INN)|DTXSID40169822|MOZENAVIRUM|RefChem:819555|DTXCID1092313|DMP-450|UNII-64OO8946ER|dmp450|(4R,5S,6S,7R)-1,3-bis[(3-aminophenyl)methyl]-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one|CHEMBL223824|(4R,5S,6S,7R)-1,3-Bis(3-aminobenzyl)-4,7-dibenzylhexahydro-5,6-dihydroxy-2H-1,3-diazepin-2-one|(4R,5S,6S,7R)-1,3-bis(3-aminobenzyl)-4,7-dibenzyl-5,6-dihydroxy-1,3-diazepan-2-one|[4-R-(-4-ALPHA,5-ALPHA,6-BETA,7-BETA)]-HEXAHYDRO-5,6-BIS(HYDROXY)-1,3-BIS([(3-AMINO)PHENYL]METHYL)-4,7-BIS(PHENYLMETHYL)-2H-1,3-DIAZEPINONE|2H-1,3-Diazepin-2-one, 1,3-bis[(3-aminophenyl)methyl]hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-, (4R,5S,6S,7R)-|1dmp|BDBM151|SCHEMBL3455127|Mozenavir (*Bismesylate salt*)|SCHEMBL29370379|KYRSNWPSSXSNEP-ZRTHHSRSSA-N|XM412|DB02102|DMP450(INHIBITOR OF DUPONT MERCK)|NS00069362|D05538|Q63390512|[4R-(4.alpha.,5.alpha.,6.beta.,7.beta.)]-1,3- bis[(3-Aminophenyl)methyl]-hexahydro-5,6-dihydroxy-4,7-bis(phenylmethyl)-2H-1,3-diazepin-2-one dimethanesulfonate"
SAQUINAVIR,441243,,"InChI=1S/C38H50N6O5/c1-38(2,3)43-37(49)32-20-26-14-7-8-15-27(26)22-44(32)23-33(45)30(19-24-11-5-4-6-12-24)41-36(48)31(21-34(39)46)42-35(47)29-18-17-25-13-9-10-16-28(25)40-29/h4-6,9-13,16-18,26-27,30-33,45H,7-8,14-15,19-23H2,1-3H3,(H2,39,46)(H,41,48)(H,42,47)(H,43,49)/t26-,27+,30-,31-,32-,33+/m0/s1",QWAXKHKRTORLEM-UGJKXSETSA-N,C38H50N6O5,670.8,"(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide","SAQUINAVIR|127779-20-8|Fortovase|Saquinavirum|CHEBI:63621|L3JE09KZ2F|Ro 31-8959/000|SCH-52852|DTXSID6044012|NSC722663|Ro-31-8959/000|Butanediamide, N1-(3-(3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (3S-(2(1R*(R*),2S*),3alpha,4aalpha,8aalpha))-|N(1)-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N(2)-(quinolin-2-ylcarbonyl)-L-aspartamide|Saquinivir|saquinaviri mesilas|N(1)-((2S,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-phenylbutan-2-yl)-N(2)-(quinolin-2-ylcarbonyl)-L-aspartamide|RefChem:57420|Monomethanesulfonate, Saquinavir|DTXCID4024012|J05AE01|Invirase|Ro-31-8959|Ro 318959|MFCD00866925|(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinoline-2-carbonylamino)butanediamide|CHEMBL114|C38H50N6O5|(S)-N1-((2S,3R)-4-((3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl)-3-hydroxy-1-phenylbutan-2-yl)-2-(quinoline-2-carboxamido)succinamide|(2S)-N-[(1S,2R)-3-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-1-benzyl-2-hydroxy-propyl]-2-(quinoline-2-carbonylamino)butanediamide|ROC|Fortovase(TM)|Fortovase (TN)|(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-(quinolin-2-ylformamido)butanediamide|Butanediamide, N1-[(1S,2R)-3-[(3S,4aS,8aS)-3-[[(1,1-dimethylethyl)amino]carbonyl]octahydro-2(1H)-isoquinolinyl]-2-hydroxy-1-(phenylmethyl)propyl]-2-[(2-quinolinylcarbonyl)amino]-, (2S)-|SMR000469157|Saquinavir [USAN]|UNII-L3JE09KZ2F|Invirase(TM)(monomesylate)|Saquinavir (JAN/USP/INN)|Saquinavir?|Sch 52852|HSDB 7161|1hxb|2fgu|2fgv|Saquinavir [USAN:USP:INN:BAN]|(2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1 -phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide|(S)-N-((IS)-I-((1R)-2-((3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl)-1-hydroxyethyl)phenethyl)-2-quinaldamidosuccinamide|(S)-N-[(IS)-I-[(1R)-2-[(3S,4aS,8aS)-3-(tert-Butylcarbamoyl)octahydro-2(1H)-isoquinolyl]-1-hydroxyethyl]phenethyl]-2-quinaldamidosuccinamide|Butanediamide, N1-((1S,2R)-3-((3S,4aS,8aS)-3-(((1,1-dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)-, (2S)-|Saquinavir (Standard)|PLCG-SQV|Ro 31 8959|NP-SQV|SAQUINAVIR [MI]|SAQUINAVIR [INN]|SAQUINAVIR [JAN]|Prestwick0_001114|Prestwick1_001114|Prestwick2_001114|Prestwick3_001114|SAQUINAVIR [HSDB]|SAQUINAVIR [VANDF]|SAQUINAVIR [MART.]|SCHEMBL6881|SAQUINAVIR [WHO-DD]|SAQUINAVIR [WHO-IP]|BIDD:PXR0010|BDBM519|BSPBio_001248|MLS001195635|MLS001304735|BIDD:GT0323|SAQUINAVIR [EMA EPAR]|SPBio_003114|BPBio1_001373|GTPL4813|Saquinavir - Bio-X trade mark|SAQUINAVIR [ORANGE BOOK]|SCHEMBL28019529|SCHEMBL29357501|SAQUINAVIR [USP IMPURITY]|HMS2232L04|SAQUINAVIRUM [WHO-IP LATIN]|BDBM50213021|HY-17007R|AKOS000280831|CS-1180|DB01232|FS61498|MRF-0000273|NCGC00091469-02|NCGC00091469-15|AC-26377|BS164390|Fortovase; SAQUINAVIR; RO 31-8959|HY-17007|Ro-318959000|AB00514056|NS00007140|D00429|779S208|EN300-19767269|Q422654|BRD-K09963420-066-03-4|-phenyl-butan-2-yl]-2-(quinolin-2-ylcarbonylamino)butanediamide|(2S)-N-[(2S,3R)-4-[(2S,3S,4aS,8aS)-3-(tert-butylcarbamoyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinolin-2-yl]-3-hydroxy-1|(2S)-N-[(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)-decahydroisoquinolin-2-yl]-3-hydroxy-1-phenylbutan-2-yl]-2-[(quinolin-2-yl)formamido]butanediamide|(3S-(2(1R*(R*),2S*),3I,4athetav,8athetav))-N(sup 1)-(3-(3-(((1,1-Dimethylethyl)amino)carbonyl)octahydro-2(1H)-isoquinolinyl)-2-hydroxy-1-(phenylmethyl)propyl)-2-((2-quinolinylcarbonyl)amino)butanediamide|(S)-N-((.ALPHA.S)-.ALPHA.-((1R)-2-((3S,4AS,8AS)-3-(TERT-BUTYLCARBAMOYL)OCTAHYDRO-2(1H)-ISOQUINOLYL)-1-HYDROXYETHYL)PHENETHYL)-2-QUINALDAMIDOSUCCINAMIDE|BUTANEDIAMIDE, N(SUP 1)-(3-(3-(((1,1-DIMETHYLETHYL)AMINO)CARBONYL)OCTAHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-2-((2-QUINOLINYLCARBONYL)AMINO)-, (3S-(2(1R*(R*),2S*),3.ALPHA.,4A.BETA.,8A.BETA.))-|N-tert.butyl-decahydro -2- [2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl) -L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide|N-tert.butyl-decahydro-2-[2(R)-hydroxy-4-phenyl-3(S)-[[N-(2-quinolylcarbonyl)-L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide|N-tert.butyl-decahydro-2[2(R)-hydroxy-4-phenyl-3-(S)-[[N-(2-quinolylcarbonyl)-L-asparaginyl]amino]butyl]-(4aS,8aS)-isoquinoline-3(S)-carboxamide|N~1~-{(2S,3R)-4-[(3S,4aS,8aS)-3-(tert-butylcarbamoyl)octahydroisoquinolin-2(1H)-yl]-3-hydroxy-1-phenylbutan-2-yl}-N~2~-(quinolin-2-ylcarbonyl)-L-aspartamide"
INDINAVIR,5362440,,"InChI=1S/C36H47N5O4/c1-36(2,3)39-35(45)31-24-40(22-26-12-9-15-37-21-26)16-17-41(31)23-29(42)19-28(18-25-10-5-4-6-11-25)34(44)38-33-30-14-8-7-13-27(30)20-32(33)43/h4-15,21,28-29,31-33,42-43H,16-20,22-24H2,1-3H3,(H,38,44)(H,39,45)/t28-,29+,31+,32-,33+/m1/s1",CBVCZFGXHXORBI-PXQQMZJSSA-N,C36H47N5O4,613.8,"(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide","indinavir|150378-17-9|Compound J|Indinavir anhydrous|CHEBI:44032|9MG78X43ZT|(1(1S,2R),5(S))-2,3,5-Trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-D-erythro-Pentonamide|Indinavir System Suitability|(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino]-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide|D-erythro-Pentonamide, 2,3,5-trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-, (1(1S,2R),5(S))-|DTXSID4043802|L 735,524|indinavirum|(2S)-1-((2S,4R)-4-benzyl-2-hydroxy-5-(((1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)amino)-5-oxopentyl)-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide|(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide|RefChem:790918|DTXCID2023802|J05AE02|L735 524|L 735 524|180683-37-8|5W6YA9PKKH|D-erythro-Pentonamide, 2,3,5-trideoxy-N-(2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-(2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-, monohydrate, (1(1S,2R),5(S))-|Indinavir monohydrate|Crixivan|MK-639|MK639|D-erythro-Pentonamide, 2,3,5-trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-|C36H47N5O4|CHEMBL115|Indinavir [USAN:INN:BAN]|(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide|(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-[[(1S,2R)-2-hydroxyindan-1-yl]amino]-5-oxo-pentyl]-N-tert-butyl-4-(3-pyridylmethyl)piperazine-2-carboxamide|D-erythro-Pentonamide, 2,3,5-trideoxy-N-((1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl)-5-((2S)-2-(((1,1-dimethylethyl)amino)carbonyl)-4-(3-pyridinylmethyl)-1-piperazinyl)-2-(phenylmethyl)-|N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE|UNII-9MG78X43ZT|Indinavir?|1hsg|1hsh|1sdt|1sdu|1sdv|1sgu|2avo|2avs|2avv|2bpx|Propolis+Indinavir|Crixivan (TM)|Indinavir, 19|MFCD00866938|Indinavir & IFNL1|Indinavir & IFNL2|Indinavir & IFNL3|1c6y|1k6c|Indinavir & IL-29|INDINAVIR [INN]|Indinavir & IL-28A|Indinavir & IL-28B|INDINAVIR [MI]|INDINAVIR [WHO-DD]|SCHEMBL6317|BIDD:PXR0141|Indinavir & Interleukin 29|BDBM517|Indinavir & Interleukin 28A|Indinavir & Interleukin 28B|BIDD:GT0378|L735,524|orb1689860|SCHEMBL29359155|SCHEMBL29714123|GTPL12684|Indinavir & Interferon lambda-1|Indinavir & Interferon lambda-2|Indinavir & Interferon lambda-3|Indinavir (*1:1 Sulfate salt*)|HY-B0689|BDBM50067593|MSK162416|RS-253|AKOS000280989|AT13874|DB00224|KS-5060|NCGC00159460-01|NCGC00159460-03|NCGC00159460-10|NCGC00159460-13|(S)-1-((2S,4R)-4-benzyl-2-hydroxy-5-(((1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl)amino)-5-oxopentyl)-N-(tert-butyl)-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide|AC-20034|AC-37652|C07051|AB00698241-07|378I179|EN300-19767270|Q425490|BRD-K33226500-001-01-0|L-735, 524|N-[2(R)-HYDROXY-1(S)-INDANYL]-5-[(2(S)-TERTIARY|(.ALPHA.R,.GAMMA.S,2S)-.ALPHA.-BENZYL-2-(TERT-BUTYLCARBAMOYL)-.GAMMA.-HYDROXY-N-((1S,2R)-2-HYDROXY-1-INDANYL)-4-(3-PYRIDYLMETHYL)-1-PIPERAZINEVALERAMIDE|(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-4-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]carbamoyl}butyl]-N-tert-butyl-4-[(pyridin-3-yl)methyl]piperazine-2-carboxamide|(2S)-1-[(2S,4R)-4-benzyl-2-hydroxy-5-{[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]amino}-5-oxopentyl]-N-tert-butyl-4-(pyridin-3-ylmethyl)piperazine-2-carboxamide (non-preferred name)|2,3,5-Trideoxy-N-[(1S,2R)-2,3-dihydro-2-hydroxy-1H-inden-1-yl]-5-[(2S)-2-[[(1,1-dimethylethyl)amino]carbonyl]-4-(3-pyridinylmethyl)-1-piperazinyl]-2-(phenylmethyl)-D-erythro-pentonamide sulfate|2-benzyl-5-[(2S)-2-(tert-butylcarbamoyl)-4-(pyridin-3-ylmethyl)piperazin-1-yl]-2,3,5-trideoxy-N-[(1S,2R)-2-hydroxy-2,3-dihydro-1H-inden-1-yl]-D-erythro-pentonamide|BUTYLAMINOCARBONYL)-4(3-PYRIDYLMETHYL)PIPERAZINO]-4(S)-HYDROXY-2(R)-PHENYLMETHYLPENTANAMIDE|Propolis & 4-Hydroxy-N-(2-hydroxy-2,3-dihydro-1H-1-indanyl)-N'-(1,1-dimethylethyl)-2-phenylmethyl-5-[4-(3-pyridylmethyl)-1-piperzinyl]hexanediamide"
AMPRENAVIR,65016,,"InChI=1S/C25H35N3O6S/c1-18(2)15-28(35(31,32)22-10-8-20(26)9-11-22)16-24(29)23(14-19-6-4-3-5-7-19)27-25(30)34-21-12-13-33-17-21/h3-11,18,21,23-24,29H,12-17,26H2,1-2H3,(H,27,30)/t21-,23-,24+/m0/s1",YMARZQAQMVYCKC-OEMFJLHTSA-N,C25H35N3O6S,505.6,"[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate","amprenavir|161814-49-9|Agenerase|Prozei|VX-478|Vertex VX478|141W94|KVX-478|VX 478|CHEBI:40050|5S0W860XNR|(3S)-Tetrahydro-3-furanyl ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)carbamate|J05AE05|Tetrahydro-3-furyl N-(3-(4-amino-N-isobutylbenzenesulfonamido)-1-benzyl-2-hydroxypropyl)carbamate|(3S-(3R*(1R*,2S*)))-(3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl) tetrahydro-3-furanyl carbamate|[(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate|DTXSID5046061|(3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-1-phenylbutan-2-yl]carbamate|Amprenavirum|((3S)-oxolan-3-yl) N-((2S,3R)-4-((4-aminophenyl)sulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-phenylbutan-2-yl)carbamate|(3S)-oxolan-3-yl N-((2S,3R)-3-hydroxy-4-(N-(2-methylpropyl)(4-aminobenzene)sulfonamido)-1-phenylbutan-2-yl)carbamate|(3S)-oxolan-3-yl N-((2S,3R)-3-hydroxy-4-(N-(2-methylpropyl)4-aminobenzenesulfonamido)-1-phenylbutan-2-yl)carbamate|(3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate|RefChem:54192|GlyTouCan:G27511PE|KVX 478|DTXCID601765661|G27511PE|827-179-5|Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(-phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))-|C25H35N3O6S|VX478|MFCD00934214|Carbamic acid, N-[(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3S)-tetrahydro-3-furanyl ester|(S)-tetrahydrofuran-3-yl ((2S,3R)-4-((4-amino-N-isobutylphenyl)sulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate|AMV|Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester|Amprenavir [USAN]|Amprenavir (agenerase)|141 W94|[(3S)-tetrahydrofuran-3-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate|{3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER|DRG-0258|Agenerase (TM)|Agenerase (TN)|GNA & Amprenavir|HHA & Amprenavir|HSDB 7157|UNII-5S0W860XNR|Amprenavir (JAN/USAN/INN)|Amprenavir [USAN:INN:BAN]|1hpv|3ekp|3ekv|3nuj|3nuo|NCGC00159461-02|1t7j|3nu3|3nu4|3nu5|3nu6|3nu9|3sm2|AMPRENAVIR [MI]|AMPRENAVIR [INN]|AMPRENAVIR [JAN]|AMPRENAVIR [HSDB]|AMPRENAVIR [VANDF]|APV & AAG|APV & HSA|CHEMBL116|AMPRENAVIR [MART.]|AMPRENAVIR [WHO-DD]|SCHEMBL34151|(3S)-Tetrahydro-3-furyl ((alphaS)-alpha-((1R-1-hydroxy-2-(N(sup 1)-isobutylsulfanilamido)ethyl)phenethyl)carbamate|MLS006011492|AMPRENAVIR [EMA EPAR]|BIDD:GT0398|orb1300812|AMPRENAVIR [ORANGE BOOK]|EX-A6824B|GTPL12681|3s43|3s45|GLXC-06443|HMS2090N10|BDBM50215393|s1639|Amprenavir & alpha1-acid glycoprotein|AKOS000280844|BCP9000297|CCG-269742|CS-1410|DB00701|FA17892|NCGC00159461-07|NCGC00159461-08|4-Amino-N-((2 syn,3S)-2-hydroxy-4-phenyl-3-((S)-tetrahydrofuran-3-yloxycarbonylamino)-butyl)-N-isobutyl-benzenesulfonamide|Amprenavir 100 microg/mL in Acetonitrile|AS-30915|Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Galanthus nivalis agglutinin (GNA)|Carbamic acid, (3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, tetrahydro-3-furanyl ester, (3S-(3R*(1S*,2R*)))-|HY-17430|SMR003885056|BCP0726000051|NS00004082|SW219687-1|C08086|D00894|EN300-123443|SBI-0653847.0001|AB01275534-01|AB01275534_02|814A499|Q422198|SR-05000001530|SR-05000001530-1|BRD-K47827687-001-02-2|Z1551900491|(3S)-oxolan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)-4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate|(3S)-Tetrahydro-3-furyl [(alphaS)-alpha-[(1R-1-hydroxy-2-(N1-isobutylsulfanilamido)ethyl]phenethyl]carbamate|(3S)-tetrahydrofuran-3-yl [(1S,2R)-3-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-1-benzyl-2-hydroxypropyl]carbamate|(3S)-tetrahydrofuran-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate|(S)-tetrahydrofuran-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3S)-tetrahydro-3-furanyl ester & Hippeastrum hybrid agglutinin( HHA)|N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic acid (3S)-tetrahydro-3-furan yl ester;141W94;KVX-478|N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic Acid (3S)-Tetrahydro-3-furanyl Ester|N-[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]carbamic acid (3S)-tetrahydro-3-furanyl ester, VX-478"
RITONAVIR,392622,,"InChI=1S/C37H48N6O5S2/c1-24(2)33(42-36(46)43(5)20-29-22-49-35(40-29)25(3)4)34(45)39-28(16-26-12-8-6-9-13-26)18-32(44)31(17-27-14-10-7-11-15-27)41-37(47)48-21-30-19-38-23-50-30/h6-15,19,22-25,28,31-33,44H,16-18,20-21H2,1-5H3,(H,39,45)(H,41,47)(H,42,46)/t28-,31-,32-,33-/m0/s1",NCDNCNXCDXHOMX-XGKFQTDJSA-N,C37H48N6O5S2,720.9,"1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate","ritonavir|155213-67-5|Norvir|ABT-538|A-84538|Abbott 84538|ABBOTT-84538|Empetus|Ritomune|Ritovir|Viekirax|Viriton|Ritonavirum|ABT538|CHEBI:45409|NSC-693184|DTXSID1048627|O3J8G9O825|NSC693184|DTXCID8028553|PAXLOVID COMPONENT RITONAVIR|VIEKIRAX COMPONENT RITONAVIR|XIANNUOXIN COMPONENT RITONAVIR|2,4,7,12-Tetraazatridecan-13-oic acid, 10-hydroxy-2-methyl-5-(1-methylethyl)-1-(2-(1-methylethyl)-4-thiazolyl)-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (5S-(5R*,8R*,10R*,11R*))-|1,3-thiazol-5-ylmethyl N-((2S,3S,5S)-3-hydroxy-5-(((2S)-3-methyl-2-((methyl-((2-propan-2-yl-1,3-thiazol-4-yl)methyl)carbamoyl)amino)butanoyl)amino)-1,6-di(phenyl)hexan-2-yl)carbamate|1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-di(phenyl)hexan-2-yl]carbamate|2,4,7,12-Tetraazatridecan-13-oic acid, 10-hydroxy-2-methyl-5-(1-methylethyl)-1-[2-(1-methylethyl)-4-thiazolyl]-3,6-dioxo-8,11-bis(phenylmethyl)-, 5-thiazolylmethyl ester, [5S-(5R*,8R*,10R*,11R*)]-|ritonavir 100 mg|Ritonavir film coated|RefChem:6492|J05AE03|MFCD00927142|RTV|2,7,10,12-Tetraazatridecanoic acid, 4-hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-, 5-thiazolylmethyl ester, (3S,4S,6S,9S)-|CHEMBL163|C37H48N6O5S2|1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamate|thiazol-5-ylmethyl N-[(1S,2S,4S)-1-benzyl-2-hydroxy-4-[[(2S)-2-[[(2-isopropylthiazol-4-yl)methyl-methyl-carbamoyl]amino]-3-methyl-butanoyl]amino]-5-phenyl-pentyl]carbamate|Ritonavir [USAN]|NCGC00159462-02|NCGC00183130-01|Norvir Softgel|1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate|5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S)-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate|N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N~2~-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide|RIT|thiazol-5-ylmethyl ((2S,3S,5S)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl)carbamate|DRG-0244|SMR000466395|Norvir (TM)|Norvir (TN)|CAS-155213-67-5|HSDB 7160|TMC 114r|UNII-O3J8G9O825|1hxw|3prs|3tne|4eyr|ABT 538|Ritonavir [USAN:USP:INN:BAN]|2,7,10,12-TETRAAZATRIDECANOIC ACID, 4-HYDROXY-12-METHYL-9-(1-METHYLETHYL)-13-(2-(1-METHYLETHYL)-4-THIAZOLYL)-8,11-DIOXO-3,6-BIS(PHENYLMETHYL)-, 5-THIAZOLYLMETHYL ESTER, (3S,4S,6S,9S)-|5-Thiazolylmethyl [(alphaS)-alpha-[(1S,3S)-1-hydroxy-3-[(2S)-2-[3-[(2-isopropyl-4-thiazolyl)methyl]-3-methylureido]-3-methylbutyramido]-4-phenylbutyl]phenethyl]carbamate|Ritonavir & PLGA|Ritonavir (Standard)|5-Thiazolylmethyl ((alphaS)-alpha-((1S,3S-1-hydroxy-3-((2S)-2-(3-((2-isopropyl-4-thiazolyl)methyl)-3-methylureido)-3-methylbutyramido)-4-phenylbutyl)phenethyl)carbamate|Norvir, Norvir Softgel|1sh9|RITONAVIR [INN]|RITONAVIR [JAN]|RITONAVIR [MI]|RTV, r|RITONAVIR [HSDB]|RITONAVIR [VANDF]|RITONAVIR [MART.]|RITONAVIR [USP-RS]|RITONAVIR [WHO-DD]|RITONAVIR [WHO-IP]|SCHEMBL6679|Ritonavir (JAN/USP/INN)|BIDD:PXR0023|BDBM520|RITONAVIR [EMA EPAR]|MLS000759541|MLS001424063|MLS006011764|BIDD:GT0387|Ritonavir - Bio-X trade mark|GTPL8804|orb1308324|RITONAVIR [ORANGE BOOK]|RITONAVIR [USP IMPURITY]|Ritonavir, >=98% (HPLC)|RITONAVIR [USP MONOGRAPH]|KALETRA COMPONENT RITONAVIR|NCDNCNXCDXHOMX-XGKFQTDJSA-N|GLXC-02733|HMS2051B08|HMS2235O10|HMS3715L22|Pharmakon1600-01502391|RITONAVIRUM [WHO-IP LATIN]|MSK11461|Tox21_112969|Tox21_113431|AC-733|BDBM50088504|HB6070|HY-90001R|NSC760369|s1185|STK634209|AKOS000280930|Tox21_112969_1|CCG-101007|CS-0432|DB00503|FR16561|KS-5017|NC00257|NSC 693184|NSC 760369|NSC-760369|MRF-0000287|A 84538;ABT 538|NCGC00159462-03|NCGC00159462-04|NCGC00159462-07|NCGC00159462-20|Ritonavir 100 microg/mL in Acetonitrile|BR164353|HY-90001|SY073242|MLS000759541-02|R0116|SW197637-2|C07240|D00427|EN300-119505|AB00639991-06|AB00639991-08|AB00639991_09|AB00639991_10|213R675|F358080|Q422618|BRD-K51485625-001-07-6|BRD-K51485625-001-08-4|Z1521553599|(1,3-thiazol-5-yl)methyl N-[(2S,3S,5S)-3-hydroxy-5-[(2S)-3-methyl-2-{[methyl({[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl})carbamoyl]amino}butanamido]-1,6-diphenylhexan-2-yl]carbamate|(2S, 3S, 5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinvl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane|(2S,3S,5S )-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl) methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl) methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane|(2S,3S,5S)-5-(N-(N((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane|(2S,3S,5S)-5-(N-(N-((N-MethyI-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1.6-diphenyl-3-hydroxyhexane|(2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl) methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane|(2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino )-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane|(2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1 .6-diphenyl-3-hydroxyhexane|(2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane|(2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3hydroxyhexane|(2S,3S,5S)-5-(N-(N-((N-Methyl-N-((2-isopropyl-4-thiazolyl)methyl)amino)carbonyl)valinyl)amino)-2-(N-((5-thiazolyl)methoxycarbonyl)amino)-1.6-diphenyl-3-hydroxyhexane|(3S,4S,6S,9S)-4-Hydroxy-12-methyl-9-(1-methylethyl)-13-[2-(1-methylethyl)-4-thiazolyl]-8,11-dioxo-3,6-bis(phenylmethyl)-2,7,10,12-te traazatridecanoic acid 5-thiazolylmethyl ester;A 84538;ABT 538|1,3-thiazol-5-ylmethyl N-[(2S,3S,5S)-3-hydroxy-5-[[(2S)-3-methyl-2-[[methyl-[(2-propan-2-yl-1,3-thiazol-4-yl)methyl]carbamoyl]amino]butanoyl]amino]-1,6-diphenylhexan-2-yl]carbamateEE|2,4,7,12-TETRAAZATRIDECAN-13-OIC ACID, 10-HYDROXY-2-METHYL-5-(1-METHYLETHYL)-1-(2-(1-METHYLETHYL)-4-THIAZOLYL)-3,6-DIOXO-8,11-BIS(PHENYLMETHYL)-5-THIAZOLYLMETHYL ESTER (5S-(5R*,8R*,10R*,11R*))-|5-Thiazolylmethyl [(2S,3S,5S)-3-Hydroxy-5-[(S)-2-[3-[(2-isopropyl-4-thiazolyl)methyl]-3-methylureido]-3-methylbutanamido]-1,6-diphenyl-2-hexyl]carbamate|N-[(2S,4S,5S)-4-hydroxy-1,6-diphenyl-5-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}hexan-2-yl]-N(2)-(methyl{[2-(propan-2-yl)-1,3-thiazol-4-yl]methyl}carbamoyl)-L-valinamide|N1-((1S,3S,4S)-1-benzyl-3-hydroxy-5-phenyl-4-{[(1,3-thiazol-5-ylmethoxy)carbonyl]amino}pentyl)-N2-{[[(2-isopropyl-1,3-thiazol-4-yl)methyl](methyl)amino]carbonyl}-L-valinamide|thiazol-5-ylmethyl (2S,3S,5S)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-ylcarbamate|thiazol-5-ylmethyl((2S,3S,5S)-3-hydroxy-5-((S)-2-(3-((2-isopropylthiazol-4-yl)methyl)-3-methylureido)-3-methylbutanamido)-1,6-diphenylhexan-2-yl)carbamate"
NELFINAVIR,64143,,"InChI=1S/C32H45N3O4S/c1-21-25(15-10-16-28(21)36)30(38)33-26(20-40-24-13-6-5-7-14-24)29(37)19-35-18-23-12-9-8-11-22(23)17-27(35)31(39)34-32(2,3)4/h5-7,10,13-16,22-23,26-27,29,36-37H,8-9,11-12,17-20H2,1-4H3,(H,33,38)(H,34,39)/t22-,23+,26-,27-,29+/m0/s1",QAGYKUNXZHXKMR-HKWSIXNMSA-N,C32H45N3O4S,567.8,"(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide","nelfinavir|159989-64-7|HO3OGH5D7I|(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-phenylsulfanylbutyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide|NSC-747167|CHEBI:7496|DTXSID5035080|3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S-(2-(2S*,3S*),3-alpha,4a-beta,8a-beta))-|nelfinavirum|(3S,4aS,8aS)-N-tert-butyl-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-phenylsulfanylbutyl)-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide|RefChem:57161|DTXCID3015080|J05AE04|Viracept|Viracept (TN)|Nelfinavir (INN)|AG-1343|CHEMBL584|C32H45N3O4S|AG1341|MFCD01938163|(3S,4aS,8aS)-N-(tert-Butyl)-2-((2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzamido)-4-(phenylthio)butyl)decahydroisoquinoline-3-carboxamide|(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide|1UN|2-[2-HYDROXY-3-(3-HYDROXY-2-METHYL-BENZOYLAMINO)-4-PHENYL SULFANYL-BUTYL]-DECAHYDRO-ISOQUINOLINE-3-CARBOXYLIC ACID TERT-BUTYLAMIDE|3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-|NLF|NELFINAVIR [INN]|Nelfinavir [INN:BAN]|NFV|(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methyl-benzoyl)amino]-4-phenylsulfanyl-butyl]-3,4,4a,5,6,7,8,8a-octahydro-1H-isoquinoline-3-carboxamide|CHEMBL1205|3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2-((2R,3R)-2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-, (3S,4aS,8aS)-|SMR000596515|NCGC00090782-03|NELFINAVIR MESYLATE AG1343|UNII-HO3OGH5D7I|Nelfinavir?|Met-SDF-1.beta. & Nelfinavir|1ohr|(3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide|Nelfinavir (Standard)|NELFINAVIR [MI]|NELFINAVIR [VANDF]|NELFINAVIR [WHO-DD]|BIDD:PXR0143|SCHEMBL38218|BDBM518|MLS001195634|MLS001304729|N-(1,1-Dimethylethyl)decahydro-2-(2-hydroxy-3-((3-hydroxy-2-methylbenzoyl)amino)-4-(phenylthio)butyl)-3-isoquinolinecarboxamide (3S-(2(2S*,3S*),3alpha,4abeta,8abeta))-|BIDD:GT0395|NELFINAVIR [EMA EPAR]|orb1299514|nelfinavir & nelfinavir mesylate|SCHEMBL29359793|GTPL11090|GLXC-27474|HMS2232I04|Met-Stromal Cell-derived Factor-1.beta. (Human) & Nelfinavir|BDBM50061306|HY-15287R|NSC747167|AKOS000280862|CS-0677|DB00220|NSC 747167|MRF-0000208|NCGC00090782-04|NCGC00090782-05|NCGC00090782-17|AC-20032|AC-37645|AS-75258|HY-15287|NS00003195|89N647|C07257|C73027|D08259|AB00698259-15|EN300-18530973|Q423366|BRD-K74117820-066-10-8|(3S, 4aS, 8aS)-2-[(2R, 3R)-2-Hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide|(3S, 4aS, 8aS)-2-[(2R, 3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide|(3S,4aS,8aS)-2-[(2R,3R)-2-Hydroxy-3-(3-hydroxy-2-methyl-benzoylamino)-4-phenylsulfanyl-butyl]-decahydro-isoquinoline-3-carboxylic acid tert-butylamide; compound with methanesulfonic acid|(3S,4aS,8aS)-2-[(2R,3R)-2-hydroxy-3-(3-hydroxy-2-methylbenzoylamino)-4-phenylthiobutyl]decahydroisoquinoline-3-carboxylic acid t-butylamide|(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide|(3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-{[(3-hydroxy-2-methylphenyl)carbonyl]amino}-4-(phenylsulfanyl)butyl]decahydroisoquinoline-3-carboxamide|3-Isoquinolinecarboxamide, N-(1,1-dimethylethyl)decahydro-2- [(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-|3-Isoquinolinecarboxamide,1-dimethyl ethyl)decahydro-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, (3S,4aS,8aS)-|3-Isoquinolinecarboxamide,1-dimethylethyl)decahydro-2-[2-hydroxy-3-[(3-hydroxy-2-methylbenzoyl)amino]-4-(phenylthio)butyl]-, [3S-[2(2S*,3S*),3.alpha.,4a.beta.,8a.beta.]]-"
LOPINAVIR,92727,,"InChI=1S/C37H48N4O5/c1-25(2)34(41-20-12-19-38-37(41)45)36(44)39-30(21-28-15-7-5-8-16-28)23-32(42)31(22-29-17-9-6-10-18-29)40-33(43)24-46-35-26(3)13-11-14-27(35)4/h5-11,13-18,25,30-32,34,42H,12,19-24H2,1-4H3,(H,38,45)(H,39,44)(H,40,43)/t30-,31-,32-,34-/m0/s1",KJHKTHWMRKYKJE-SUGCFTRWSA-N,C37H48N4O5,628.8,"(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide","Lopinavir|192725-17-0|ABT-378|Aluviran|Koletra|A 157378.0|A-157378.0|Lopinavirum|CHEBI:31781|A-157378-0|ABT378|DTXSID8046456|Lopinavir, (s-(2s,4s,5s))-|(alphaS)-Tetrahydro-N-((alphaS)-alpha-((2S,3S)-2-hydroxy-4-phenyl-3-(2-(2,6-xylyloxy)acetamido)butyl)phenethyl)-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide|2494G1JF75|DTXCID6026456|(1S-(1R*(R*),3R*,4R*))-N-(4-(((2,6-Dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide|(2S)-N-[(2S,4S,5S)-5-[[2-(2,6-dimethylphenoxy)acetyl]amino]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide|1(2H)-Pyrimidineacetamide, N-((1S,3S,4S)-4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahyrdo-alpha-1-methylethyl)-2-oxo-, (alphaS)-|(2S)-N-((2S,4S,5S)-5-((2-(2,6-dimethylphenoxy)acetyl)amino)-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide|(alphaS)-Tetrahydro-N-[(alphaS)-alpha-[(2S,3S)-2-hydroxy-4-phenyl-3-[2-(2,6-xylyloxy)acetamido]butyl]phenethyl]-alpha-isopropyl-2-oxo-1(2H)-pyrimidineacetamide|N-(4-(((2,6-dimethylphenoxy)acetyl)amino)-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl)tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pydrimidineacetamide|RefChem:5960|ABT-378/r|A157378.0|J05AE06|ABT 378|RS-346|(S)-N-((2S,4S,5S)-5-(2-(2,6-dimethylphenoxy)acetamido)-4-hydroxy-1,6-diphenylhexan-2-yl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide|(2S)-N-[(2S,4S,5S)-5-[2-(2,6-dimethylphenoxy)acetamido]-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxo-1,3-diazinan-1-yl)butanamide|LPV|A 157378|MFCD22628840|(alphaS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide|N-{1-BENZYL-4-[2-(2,6-DIMETHYL-PHENOXY)-ACETYLAMINO]-3-HYDROXY-5-PHENYL-PENTYL}-3-METHYL-2-(2-OXO-TETRAHYDRO-PYRIMIDIN-1-YL)-BUTYRAMIDE|NCGC00164576-02|C37H48N4O5|(2S)-N-[(1S,3S,4S)-1-benzyl-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-pentyl]-3-methyl-2-(2-oxohexahydropyrimidin-1-yl)butanamide|SMR002529581|CAS-192725-17-0|MFCD22373646|Lopinavir-|Lopinavir?|UNII-2494G1JF75|HSDB 8138|1mui|2qhc|2rkf|2rkg|3ogq|Lopinavir [USAN:USP:INN:BAN]|AIDS032937|(2S)-N-((1S,3S,4S)-1-benzyl-4-{[(2,6-dimethylphenoxy)acetyl]amino}-3-hydroxy-5-phenylpentyl)-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide|(2S)-N-[(1S,3S,4S)-1-benzyl-4-{[(2,6-dimethylphenoxy)acetyl]amino}-3-hydroxy-5-phenylpentyl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide|Lopinavir & PLGA|Lopinavir (Standard)|Kaletra (LPV+RTV)|2o4s|2q5k|4l1a|LOPINAVIR [INN]|LOPINAVIR [JAN]|LOPINAVIR [MI]|LOPINAVIR [USAN]|LOPINAVIR [VANDF]|Lopinavir (ABT-378)|CHEMBL729|LOPINAVIR [MART.]|LPV & AAG|LOPINAVIR [USP-RS]|LOPINAVIR [WHO-DD]|LOPINAVIR [WHO-IP]|Lopinavir (JAN/USP/INN)|SCHEMBL21775|LOPINAVIR [EMA EPAR]|MLS003915624|MLS004774152|MLS006011206|ABT-378; LOPINAVIR|Lopinavir - Bio-X trade mark|orb1307985|LOPINAVIR [ORANGE BOOK]|LOPINAVIR [EP MONOGRAPH]|GTPL11504|LOPINAVIR [USP MONOGRAPH]|KALETRA COMPONENT LOPINAVIR|KJHKTHWMRKYKJE-SUGCFTRWSA-N|BCPP000184|GLXC-02734|LOPINAVIRUM [WHO-IP LATIN]|EX-A4008|MSK10437|Tox21_112204|BDBM50180655|HB7108|HY-14588R|Lopinavir & alpha1-acid glycoprotein|s1380|AKOS025243115|Tox21_112204_1|BCP9000857|CCG-270285|CS-2077|DB01601|FL16558|KS-1436|Lopinavir 100 microg/mL in Acetonitrile|NCGC00164576-01|NCGC00164576-03|NCGC00164576-04|BL164636|HY-14588|SY073885|L0377|NS00008581|SW219767-1|D01425|SBI-0654097.0001|AB01274785-01|AB01274785_02|EN300-7402887|Q422585|SR-01000931910|SR-01000931910-2|A-1573780|BRD-K99451608-001-02-4|BRD-K99451608-001-07-3|Z2235801862|(?-S)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5 -phenyl-1-(phenylmethyl)pentyl]tetrahydro-?-(1-methylethyl)- 2-oxo-1(2H)-pyrimidineacetamide;A 157378.0;ABT 378|(?-S)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-?-(1-methylethyl)-|(|AS)-N-[(1S,3S,4S)-4-[[2-(2,6-Dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-|A-(1-methylethyl)-2-oxo-1(2H)-pyrimidineacetamide|(1S-(1R*(R*),3R*,4R*))-N-(4-(((2,6-DIMETHYLPHENOXY)ACETYL)AMINO)-3-HYDROXY-5-PHENYL-1-(PHENYLMETHYL)PENTYL)TETRAHYDRO-.ALPHA.-(1-METHYLETHYL)-2-OXO-1(2H)-PYRIMIDINEACETAMIDE|(2S)-N-[(2S,4S,5S)-5-{[(2,6-dimethylphenoxy)acetyl]amino}-4-hydroxy-1,6-diphenylhexan-2-yl]-3-methyl-2-(2-oxotetrahydropyrimidin-1(2H)-yl)butanamide|1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-.alpha.-(1-methylethyl)-2-oxo-, (aS)-|1(2H)-Pyrimidineacetamide, N-[(1S,3S,4S)-4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)- (9CI)|1(2H)-pyrimidineacetamide, N-[(1S,3S,4S)-4-[[2-(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, (alphaS)-|1(2H)-Pyrimidineacetamide, N-[4-[[(2,6-dimethylphenoxy)acetyl]amino]-3-hydroxy-5-phenyl-1-(phenylmethyl)pentyl]tetrahydro-alpha-(1-methylethyl)-2-oxo-, [1S-[1R*(R*),3R*,4R*]]-"
ATAZANAVIR,148192,,"InChI=1S/C38H52N6O7/c1-37(2,3)31(41-35(48)50-7)33(46)40-29(22-25-14-10-9-11-15-25)30(45)24-44(43-34(47)32(38(4,5)6)42-36(49)51-8)23-26-17-19-27(20-18-26)28-16-12-13-21-39-28/h9-21,29-32,45H,22-24H2,1-8H3,(H,40,46)(H,41,48)(H,42,49)(H,43,47)/t29-,30-,31+,32+/m0/s1",AXRYRYVKAWYZBR-GASGPIRDSA-N,C38H52N6O7,704.9,"methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate","Atazanavir|198904-31-3|Latazanavir|Zrivada|BMS-232632|atazanavirum|QZU4H47A3S|DTXSID9048691|CHEBI:37924|DTXCID5028617|2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-((4-(2-pyridinyl)phenyl)methyl)-, dimethyl ester, (3S-(3R*,8R*,9R*,12R*))-|methyl N-[(1S)-1-{N'-[(2S,3S)-2-hydroxy-3-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethylbutanamido]-4-phenylbutyl]-N'-{[4-(pyridin-2-yl)phenyl]methyl}hydrazinecarbonyl}-2,2-dimethylpropyl]carbamate|methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]amino]-3,3-dimethyl-1-oxobutan-2-yl]carbamate|methyl N-((1S)-1-(N'-((2S,3S)-2-hydroxy-3-((2S)-2-((methoxycarbonyl)amino)-3,3-dimethylbutanamido)-4-phenylbutyl)-N'-((4-(pyridin-2-yl)phenyl)methyl)hydrazinecarbonyl)-2,2-dimethylpropyl)carbamate|methyl N-((2S)-1-(((2S,3S)-3-hydroxy-4-((((2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl)amino)-((4-pyridin-2-ylphenyl)methyl)amino)-1-phenylbutan-2-yl)amino)-3,3-dimethyl-1-oxobutan-2-yl)carbamate|RefChem:54330|J05AE08|Reyataz|CGP 73547|CGP-73547|ATV|Atazanavir (INN)|BMS 232632|Reyataz (TN)|CHEMBL1163|1,14-Dimethyl (3S,8S,9S,12S)-3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-2,5,6,10,13-pentaazatetradecanedioate|NCGC00182552-01|ATAZANAVIR [INN]|MFCD08435966|methyl N-[(2S)-1-[2-[(2S,3S)-2-hydroxy-3-[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate|Atazanavir [INN:BAN]|DR7|methyl N-[(1S)-1-[[(1S,2S)-1-benzyl-2-hydroxy-3-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[[4-(2-pyridyl)phenyl]methyl]amino]propyl]carbamoyl]-2,2-dimethyl-propyl]carbamate|methyl N-[1-[2-[2-hydroxy-3-[[2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-4-phenylbutyl]-2-[(4-pyridin-2-ylphenyl)methyl]hydrazinyl]-3,3-dimethyl-1-oxobutan-2-yl]carbamate|C38H52N6O7|Atazanavir Base|CAS-198904-31-3|HSDB 7339|UNII-QZU4H47A3S|Atazanavir?|2aqu|Reyataz(TM) (*1:1 sulfate*)|(3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5, 6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER|Atazanavir (Standard)|ATAZANAVIR [MI]|ATAZANAVIR [HSDB]|ATAZANAVIR [VANDF]|ATV & AAG|ATV & HSA|ATAZANAVIR [WHO-DD]|SCHEMBL41696|Atazanavir - Bio-X trade mark|orb1310936|Atazanavir, >=98% (HPLC)|SCHEMBL29368691|BDBM13934|GTPL11138|AXRYRYVKAWYZBR-GASGPIRDSA-N|GLXC-06687|HMS2089P22|Tox21_113081|HY-17367R|Atazanavir & alpha1-acid glycoprotein|AKOS025396423|Tox21_113081_1|CCG-270390|CS-0945|DB01072|FA18006|NCGC00182552-02|NCGC00182552-03|NCGC00182552-14|(2S)-N-(3-{[(2S)-2-(Methoxycarbonylamino)-3,3-dimethylbutanoylamino][(4-(2-pyridyl)phenyl)methyl]amino}(1S,2S)-2-hydroxy-1-benzylpropyl)-2-(methoxycarbonylamino)-3,3-dimethylbutanamide|BA300025|BS-16315|dimethyl (3S,8S,9S,12S)-9-benzyl-3,12-di-tert-butyl-8-hydroxy-4,11-dioxo-6-[4-(2-pyridyl)benzyl]-2,5,6,10,13-pentaazatetradecanedioate|HY-17367|methyl ((5S,8S,9S,14S)-8-benzyl-5-(tert-butyl)-9-hydroxy-15,15-dimethyl-3,6,13-trioxo-11-(4-(pyridin-2-yl)benzyl)-2-oxa-4,7,11,12-tetraazahexadecan-14-yl)carbamate|SY009728|NS00000470|S4662|D07471|AB01274792-01|AB01274792-02|AB01274792-03|AB01274792_04|EN300-20600002|Q423467|SR-01000930924|SR-01000930924-2|BRD-K09757388-065-04-0|Z1258932192|(3S,8S, 9S, 12S)- 2,5,6,13-Pentaazatetradecanedioic acid|6,10,13-PENTAAZATETRADECANEDIOIC ACID DIMETHYL ESTER|(3S,8S,9S,12S)-3,12-BIS(1,1-DIMETHYLETHYL)-8-HYDROXY-4,11-DIOXO-9-(PHENYLMETHYL)-6-[[4-(2-PYRIDINYL)PHENYL]METHYL]-2,5,|2,5,6,10,13-Pentaazatetradecanedioic acid, 3,12-bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-, 1,14-dimethyl ester, (3S,8S,9S,12S)-|3,12-Bis(1,1-dimethylethyl)-8-hydroxy-4,11-dioxo-9-(phenylmethyl)-6-[[4-(2-pyridinyl)phenyl]methyl]-dimethyl ester;(3S,8S, 9S, 12S)- 2,5,6,13-Pentaazatetradecanedioic acid;BMS-232632|methyl [(1S,4S,5S,10S)-4-benzyl-1,10-di-tert-butyl-5-hydroxy-2,9,12-trioxo-7-(4-pyridin-2-ylbenzyl)-13-oxa-3,7,8,11-tetraazatetradec-1-yl]carbamate (non-preferred name)|Methyl [(5S,10S,11S,14S)-11-benzyl-5-tert-butyl-10-hydroxy-15,15-dimethyl-3,6,13-trioxo-8-[[4-(pyridin-2-yl)phenyl]methyl]-2-oxa-4,7,8,12-tetraazahexadecan-14-yl]carbamate|methyl N-[(1S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethyl-butanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenyl-butan-2-yl]carbamoyl]-2,2-dimethyl-propyl]carbamate|Methyl N-[(1S)-1-{[(2S,3S)-3-Hydroxy-4-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-N inverted exclamation mark -{[4-(pyridin-2-yl)phenyl]methyl}butanehydrazido]-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate|methyl N-[(1S)-1-{[(2S,3S)-3-hydroxy-4-[(2S)-2-[(methoxycarbonyl)amino]-3,3-dimethyl-N''-{[4-(pyridin-2-yl)phenyl]methyl}butanehydrazido]-1-phenylbutan-2-yl]carbamoyl}-2,2-dimethylpropyl]carbamate|Methyl N-[(2S)-1-[[(2S,3S)-3-hydroxy-4-[[[(2S)-2-(methoxycarbonylamino)-3,3-dimethylbutanoyl]amino]-[(4-pyridin-2-ylphenyl)methyl]amino]-1-phenylbutan-2-yl]ami"
DARUNAVIR,213039,,"InChI=1S/C27H37N3O7S/c1-18(2)15-30(38(33,34)21-10-8-20(28)9-11-21)16-24(31)23(14-19-6-4-3-5-7-19)29-27(32)37-25-17-36-26-22(25)12-13-35-26/h3-11,18,22-26,31H,12-17,28H2,1-2H3,(H,29,32)/t22-,23-,24+,25-,26+/m0/s1",CJBJHOAVZSMMDJ-HEXNFIEUSA-N,C27H37N3O7S,547.7,"[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate","Darunavir|206361-99-1|TMC114|TMC-114|UIC-94017|TMC 114|Darunavirum|(-)-DARUNAVIR|UIC 94017|DTXSID0046779|CHEBI:367163|TMC-41629|YO603Y8113|N-((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-benzylpropyl)((1S,2R,5R)-4,6-dioxabicyclo(3.3.0)oct-2-yloxy)carboxamide|DTXCID8026779|(3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate|(3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3aS,6aR)-tetrahydro-2H-furo[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(S)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-2-hydroxy-1-((R)-phenylmethyl)-propyl]-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester|{(1S,2R)-3-[(4-Amino-benzenesulfonyl)-isobutyl-amino]-1-benzyl-2-hydroxy-propyl}-carbamic acid (3R,3aS,6aR)-(hexahydro-furo[2,3-b]furan-3-yl) ester|((1S,2R)-3-((4-Amino-benzenesulfonyl)-isobutyl-amino)-1-benzyl-2-hydroxy-propyl)-carbamic acid (3R,3aS,6aR)-(hexahydro-furo(2,3-b)furan-3-yl) ester|((3R,3aS,6aR)-2,3,3a,4,5,6a-hexahydrofuro(5,4-b)furan-3-yl) N-((2S,3R)-4-((4-aminophenyl)sulfonyl-(2-methylpropyl)amino)-3-hydroxy-1-phenylbutan-2-yl)carbamate|((S)-3-((4-Amino-benzenesulfonyl)-isobutyl-amino)-2-hydroxy-1-((R)-phenylmethyl)-propyl)-carbamic acid (3R,3aS,6aR)-(hexahydro-furo(2,3-b)furan-3-yl) ester|(3R,3aS,6aR)-hexahydrofuro(2,3-b)furan-3-yl N-((2S,3R)-3-hydroxy-4-(N-(2-methylpropyl)(4-aminobenzene)sulfonamido)-1-phenylbutan-2-yl)carbamate|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N1-isobutylsulfanilamido)propyl)carbamate|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)(4-aminobenzene)sulfonamido]-1-phenylbutan-2-yl]carbamate|(3R,3aS,6aR)-tetrahydro-2H-furo(2,3-b)furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3aS,6aR)-tetrahydro-2H-furo(2,3-b)furan-3-yl (2S,3R)-4-(4-amino-N-neopentylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|[(3R,3aS,6aR)-2,3,3a,4,5,6a-hexahydrofuro[5,4-b]furan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate|UIC94017|Ethanolate, Darunavir|(3-((4-aminobenzenesulfonyl)isobutylamino)-1-benzyl-2-hydroxypropyl)carbamic acid hexahydrofuro(2,3-b)furan-3-yl ester|RefChem:585195|J05AE10|114, TMC|Prezista|Darunavirum [INN-Latin]|Derunavir|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate|MFCD09260006|CHEMBL1323|(3R,3AS,6AR)-HEXAHYDROFURO[2,3-B]FURAN-3-YL(1S,2R)-3-[[(4-AMINOPHENYL)SULFONYL](ISOBUTYL)AMINO]-1-BENZYL-2-HYDROXYPROPYLCARBAMATE|C27H37N3O7S|[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-3-hydroxy-1-phenylbutan-2-yl]carbamate|Darunavir [USAN]|NCGC00168773-01|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl [(2S,3R)-4-{[(4-aminophenyl)sulfonyl](2-methylpropyl)amino}-3-hydroxy-1-phenylbutan-2-yl]carbamate|[(3aS,4R,6aR)-2,3,3a,4,5,6a-hexahydrofuro[2,3-b]furan-4-yl] N-[(1S,2R)-3-[(4-aminophenyl)sulfonyl-isobutyl-amino]-1-benzyl-2-hydroxy-propyl]carbamate|Carbamic acid, [(1S,2R)-3-[[(4-aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenylmethyl)propyl]-, (3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl ester|DRV|Prezista(TM)|Darunavir [INN]|AIDS073035|Darunavir (USAN/INN)|Darunavir [USAN:INN:BAN]|Prezista Naive|Darunavir?|UNII-YO603Y8113|HSDB 7788|2idw|2ien|3bvb|3cyw|3ekt|3ggu|3lzs|3lzu|3lzv|3ogp|3pwm|3qoz|3tkw|3ttp|4hla|Darunavir (TN)|Darunavir (DRV)|TMC41629|TMC 41629|UIC-96017|2f8g|2hs1|2hs2|3d1z|3so9|3t3c|3u7s|4ll3|DARUNAVIR [MI]|DARUNAVIR [HSDB]|DARUNAVIR [VANDF]|DARUNAVIR [MART.]|DRV & AAG|DRV & HSA|DARUNAVIR [WHO-DD]|DARUNAVIR [EMA EPAR]|SCHEMBL118546|BDBM8125|orb1305688|UIC-940T|DARUNAVIR [ORANGE BOOK]|Darunavir, >=98% (HPLC)|GTPL11243|2f80|2f81|3d20|3s53|3s54|CJBJHOAVZSMMDJ-HEXNFIEUSA-N|GLXC-05003|HMS3715I13|EX-A4009|IVB37837|Tox21_112634|US10806794, Compound Darunavir|Darunavir & alpha1-acid glycoprotein|MC-114|MSK169308|s5250|206361-99-1 (free)|AKOS015966592|BCP9000587|CCG-269991|CS-0749|DB01264|FH20801|KS-1469|NCGC00388284-07|NCGC00388284-08|NCGC00388284-10|NCGC00388284-12|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(1)-isobutylsulfanilamido)propyl)carbamate|AC-26778|HY-17040|BCP0726000058|CAS-206361-99-1|NS00000472|D03656|AB01565837_02|361D991|EN300-20600172|F547231|Q3765251|BRD-K84986517-001-01-8|Z2301684748|((1S,2R)-3-(((4-Aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-carbamic acid (3R,3aS,6aR)-hexahydrofurano(2,3-b)furan-3-yl ester|((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(2-METHYLPROPYL)AMINO)-2-HYDROXY-1-(PHENYLMETHYL)PROPYL)-CARBAMIC ACID (3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ESTER|(3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ((1S,2R)-3-(((4-AMINOPHENYL)SULFONYL)(ISOBUTYL)AMINO)-1-BENZYL-2-HYDROXYPROPYL)CARBAMATE|(3R,3AS,6AR)-HEXAHYDROFURO(2,3-B)FURAN-3-YL ((2S,3R)-4-((4-AMINO-N-ISOBUTYLPHENYL)SULFONAMIDO)-3-HYDROXY-1-PHENYLBUTAN-2-YL)CARBAMATE|(3R,3aS,6aR)-Hexahydrofuro(2,3-b)furan-3-yl N-((1S,2R)-1-benzyl-2-hydroxy-3-(N(sup 1)-isobutylsulfanilamido)propyl)carbamate|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl (2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-ylcarbamate|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)-4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-3-hydroxy-4-[N-(2-methylpropyl)4-aminobenzenesulfonamido]-1-phenylbutan-2-yl]carbamate|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl N-[(2S,3R)-4-[(4-aminobenzene)(2-methylpropyl)sulfonamido]-3-hydroxy-1-phenylbutan-2-yl]carbamate|(3R,3aS,6aR)-hexahydrofuro[2,3-b]furan-3-yl((2S,3R)-4-(4-amino-N-isobutylphenylsulfonamido)-3-hydroxy-1-phenylbutan-2-yl)carbamate|[(1S,2R)-3-[[(4-Aminophenyl)sulfonyl](2-methylpropyl)amino]-2-hydroxy-1-(phenyl-methyl)propyl]carabamic acid (3R,3aS,6aR)-hexahydrofuro[2,3-b]-furan-3-yl ester|Carbamic acid, ((1S,2R)-3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-2-hydroxy-1-(phenylmethyl)propyl)-, (3R,3aS,6aR)-hexahydrofurano(2,3-b)furan-3-yl ester"
ELLAGIC ACID,5281855,,"InChI=1S/C14H6O8/c15-5-1-3-7-8-4(14(20)22-11(7)9(5)17)2-6(16)10(18)12(8)21-13(3)19/h1-2,15-18H",AFSDNFLWKVMVRB-UHFFFAOYSA-N,C14H6O8,302.19,"6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione","ellagic acid|476-66-4|Benzoaric acid|Lagistase|Eleagic acid|Elagostasine|Alizarine Yellow|2,3,7,8-Tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione|Gallogen|Acide ellagique|Acido elagico|Llagic acid|Acidum ellagicum|Gallogen (astringent)|C.I. 55005|C.I. 75270|DTXSID2020557|19YRN3ZS9P|NSC407286|NSC-407286|NSC-656272|CHEBI:4775|NSC656272|2,3,7,8-Tetrahydroxy(1)benzopyrano(5,4,3-cde)(1)benzopyran-5,10-dione|DTXCID60557|(1)Benzopyrano(5,4,3-cde)(1)benzopyran-5,10-dione, 2,3,7,8-tetrahydroxy-|6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.04,16.011,15]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione|Acid, Benzoaric|[1]Benzopyrano[5,4,3-cde][1]benzopyran-5,10-dione, 2,3,7,8-tetrahydroxy-|2,3,7,8-tetrahydroxy[1]benzopyrano[5,4,3-cde][1]benzopyran-5,10-dione|Acid, Ellagic|2,3,7,8-tetrahydroxychromeno(5,4,3-cde)chromene-5,10-dione|6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo(6.6.2.0^(4,16).0^(11,15))hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione|6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo(6.6.2.04,16.011,15)hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione|6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),4,6,8(16),11,13-hexaene-3,10-dione|RefChem:5789|4,4',5,5',6,6'-Hexahydrodiphenic acid 2,6,2',6'-dilactone|2,3,7,8-Tetrahydroxy(1)benzopyrano(5,4,3-cde)(1)-benzopyran-5,10-dione|207-508-3|Ellagicacid|Ellagate|MFCD00006914|Gallogen, astringent|MLS000069632|CHEMBL6246|SMR000058244|4,4',5,5',6,6'-hexahydroxydiphenic acid 2,6,2',6'-dilactone|tetrahydroxy[?]dione|NCGC00017245-02|2,3,7,8-Tetrahydroxy(1)benzopyrano(5,4,3-cde)-(1)benzopyran-5,10-dione|Gallogen (VAN)|C14H6O8|Pomegranate juice|Ellagic acid [INN:DCF]|CAS-476-66-4|Acido elagico [INN-Spanish]|CCRIS 774|Acide ellagique [INN-French]|Acidum ellagicum [INN-Latin]|SR-01000721925|EINECS 207-508-3|UNII-19YRN3ZS9P|NSC 407286|NSC 656272|BRN 0047549|Benzoarate|Ellagsaeure|Eleagate|Ellagic|Llagate|ellagic-acid|Elagic Acid|HSDB 7574|2zjw|REF|Ellagic acid, 96%|Spectrum_001194|Ellagic acid - 97%|Ellagic acid (Standard)|Diphenic acid, 4,4',5,5',6,6'-hexahydroxy-, di-delta-lactone|Spectrum2_000905|Spectrum3_001535|Spectrum4_000750|Spectrum5_000959|ELLAGIC ACID [MI]|ELLAGIC ACID [INN]|ELLAGIC ACID [HSDB]|Oprea1_032884|SCHEMBL20429|BSPBio_002950|KBioGR_001080|KBioSS_001674|5-19-07-00108 (Beilstein Handbook Reference)|MLS006011868|BIDD:ER0482|BIDD:GT0565|SPECTRUM1502245|SPBio_000750|ELLAGIC ACID [WHO-DD]|BDBM4078|LTK-20|orb1310586|SCHEMBL29439360|SCHEMBL30475160|BCBcMAP01_000154|cid_5281855|GTPL13035|HY-B0183R|KBio2_001674|KBio2_004242|KBio2_006810|KBio3_002450|Ellagic acid, analytical standard|HMS1921N20|HMS3673M09|HMS6019K05|Pharmakon1600-01502245|BCP10830|HY-B0183|MSK40019|TNP00132|Tox21_110805|BBL009292|CCG-36358|NSC758198|s1327|SBB006501|STK801964|Ellagic acid, >=96.0% (HPCE)|AKOS004120045|Tox21_110805_1|CS-2067|DB08846|FE11568|NSC-758198|SDCCGMLS-0066664.P001|SMP1_000111|NCGC00017245-01|NCGC00017245-03|NCGC00017245-04|NCGC00017245-05|NCGC00017245-06|NCGC00017245-07|NCGC00017245-08|NCGC00017245-09|NCGC00017245-10|NCGC00017245-12|NCGC00094975-01|NCGC00094975-02|NCGC00094975-03|NCGC00094975-04|NCGC00178375-01|AC-11647|AC-30710|AS-35095|FE164947|NCI60_003869|ST057073|SY075791|SBI-0051742.P002|E0375|Ellagic Acid, Dihydrate - CAS 476-66-4|NS00015154|MLS-0066664.0001|AB00052292_11|AB00052292_12|EN300-6472707|F387721|Q422044|SR-01000721925-3|SR-01000721925-4|SR-01000721925-5|SR-01000721925-6|SR-01000721925-7|BRD-K30466858-001-05-4|BRD-K30466858-001-08-8|BRD-K30466858-001-09-6|BRD-K30466858-001-10-4|Ellagic acid, primary pharmaceutical reference standard|Diphenic acid,4',5,5',6,6'-hexahydroxy-, di-.delta.-lactone|2,3,7,8-Tetrahydroxychromeno[5,4,3-cde]chromene-5,10-dione #|Diphenic acid, 4,4',5,5',6,6'-hexahydroxy-, di-.delta.-lactone|[1]Benzopyrano[5,3-cde][1]benzopyran-5,10-dione, 2,3,7,8-tetrahydroxy-|2,3,7,8-Tetrahydroxy[1]benzopyrano-[5,4,3-cde][1]benzopyran-5,10-dione|[1,2'-dicarboxylic acid, 4,4',5,5',6,6'-hexahydroxy-, di-.delta.-lactone|(1,1'-Biphenyl)-2,2'-dicarboxylic acid, 4,4',5,5',6,6'-hexahydroxy-, di-.delta.-lactone|122328-15-8|6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(14),4(16),5,7,11(15),12-hexaene-3,10-dione|6,7,13,14-tetrahydroxy-2,9-dioxatetracyclo[6.6.2.0^{4,16}.0^{11,15}]hexadeca-1(15),4(16),5,7,11,13-hexaene-3,10-dione"
LY-294002,3973,,"InChI=1S/C19H17NO3/c21-17-13-18(20-9-11-22-12-10-20)23-19-15(7-4-8-16(17)19)14-5-2-1-3-6-14/h1-8,13H,9-12H2",CZQHHVNHHHRRDU-UHFFFAOYSA-N,C19H17NO3,307.3,2-morpholin-4-yl-8-phenylchromen-4-one,"154447-36-6|LY294002|LY 294002|2-(4-Morpholinyl)-8-phenyl-4H-1-benzopyran-4-one|LY-294002|2-morpholin-4-yl-8-phenylchromen-4-one|31M2U1DVID|DTXSID6042650|CHEBI:65329|4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl-|NSC-697286|SF-1101|RefChem:458194|DTXCID4022650|PI3K/BET INHIBITOR LY294002|2-morpholino-8-phenyl-4H-chromen-4-one|2-morpholin-4-yl-8-phenyl-4H-chromen-4-one|MFCD00270881|LY-294,002|2-(morpholin-4-yl)-8-phenyl-4H-chromen-4-one|15447-36-6|2-(morpholin-4-yl)-8-phenylchromen-4-one|2-morpholino-8-phenyl-chromen-4-one|2-MORPHOLIN-4-YL-7-PHENYL-4H-CHROMEN-4-ONE|CHEMBL98350|NSC 697286|LY2|2-Morpholin-4-yl-8-phenyl-chromen-4-one|UNII-31M2U1DVID|BMK1-D5|Lys 294002|4azt|Kinome_3543|Tocris-1130|1yi3|BiomolKI_000029|Lopac-L-9908|8-Phenyl-2-(morpholin-4-yl)-chromen-4-one|BiomolKI2_000037|CBiol_002046|Lopac0_000710|SCHEMBL94377|BSPBio_001223|KBioGR_000563|KBioSS_000563|MLS006010131|2-Morpholino-8-phenylchromone|4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl|GTPL6004|orb1306761|SCHEMBL29424167|BCBcMAP01_000117|BDBM12915|KBio2_000563|KBio2_003131|KBio2_005699|KBio3_001005|KBio3_001006|EX-A073|BCPP000177|Bio1_000332|Bio1_000821|Bio1_001310|Bio2_000442|Bio2_000922|HMS1362M05|HMS1792M05|HMS1990M05|HMS3229G17|HMS3403M05|HMS3649E04|HMS3654M21|BCP00195|HSCI1_000206|NSC697286|NSC755769|s1105|AKOS017344742|BCP9000880|CCG-100633|CS-0150|DB02656|NSC-755769|SB10965|SDCCGSBI-0050688.P003|SDCCGSBI-0050688.P009|SF 1101|IDI1_002197|NCGC00015622-01|NCGC00015622-02|NCGC00015622-03|NCGC00015622-04|NCGC00015622-05|NCGC00015622-06|NCGC00015622-07|NCGC00015622-23|NCGC00015622-27|NCGC00025020-01|NCGC00025020-02|NCGC00025020-03|NCGC00025020-04|NCGC00179253-01|AC-30295|AS-16252|HY-10108|NCI60_034712|SMR002530642|SY052711|DB-228223|LY-924002|LY294002?|M2410|NS00068117|SW217688-2|2-(4-Morpholinyl)-8-phenyl-4H-chromen-4-one|2-Morpholino-8-phenyl-4-oxo-4H-1-benzopyran|K00235|EN300-1692893|Q4042503|SR-01000076245-7|BRD-K27305650-001-05-9|BRD-K27305650-001-16-6|BRD-K27305650-003-02-2|LY-294,002 hydrochloride, solid, >=98% (HPLC)|Z211317670|LY 294002 - CAS 154447-36-6|4H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl- (9CI)|H-1-Benzopyran-4-one, 2-(4-morpholinyl)-8-phenyl- (9CI)|LY 294002; 2-(4-Morpholino)-8-phenyl-4H-1-benzopyran-4-one"
ACETAZOLAMIDE,1986,,"InChI=1S/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)",BZKPWHYZMXOIDC-UHFFFAOYSA-N,C4H6N4O3S2,222.3,"N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide","acetazolamide|59-66-5|Acetamox|Glaupax|Defiltran|Nephramide|Edemox|N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide|Acetazolamid|Diacarb|Phonurit|Donmox|Didoc|Diuriwas|Cidamex|Diluran|Dehydratin|Natrionex|Nephramid|Diakarb|Diuramid|Diutazol|Duiramid|Eumicton|Fonurit|Glupax|5-Acetamido-1,3,4-thiadiazole-2-sulfonamide|Acetazolamida|Acetazolamidum|Acetazoleamide|Diureticum-holzinger|Acetamidothiadiazolesulfonamide|4-Diamox|Atenezo|Acetamide, N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]-|Carbonic Anhydrase Inhibitor No. 6063|2-Acetylamino-1,3,4-thiadiazole-5-sulfonamide|2-Acetamido-5-sulfonamido-1,3,4-thiadiazole|N-[5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide|DTXSID7022544|1,3,4-Thiadiazole-2-sulfonamide, 5-acetamido-|5-Acetamide-1,3,4-thiadiazole-2-sulfonamide|N-(5-(Aminosulfonyl)-1,3,4-thiadiazol-2-yl)acetamide|NSC-145177|O3FX965V0I|CHEBI:27690|Acetamide, N-(5-(aminosulfonyl)-1,3,4-thiadiazol-2-yl)-|Acetamide, N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)-|DTXCID002544|5-acetylamino-1,3,4-thiadiazole-2-sulfonamide|L 579486|NSC145177|HumaZolamide|ApoAcetazolamide|Huma Zolamide|AkZol|Apo Acetazolamide|Ak Zol|N-(5-[Aminosulfonyl]-1,3,4-thiadiazol-2-yl)acetamide|N-[5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl]acetamide|N-[5-Sulfamoyl-1,3,4-thiadiazol-2-yl]acetamide|N-(5-(aminosulfonyl)-1,3,5-thiadiazol-2-yl)acetamide|Eytazox|Diamox sr|RefChem:5507|Acetazolamide Extended-Release|S01EC01|200-440-5|Diamox|Vetamox|SK-acetazolamide|Acetozalamide|C4H6N4O3S2|Carbonic anhydrase inhibitor 6063|MFCD00003105|NSC 145177|Acetazolamide (Standard)|CHEMBL20|Diamox (TN)|MLS000028435|CAS-59-66-5|NCGC00015074-10|Acetazolamine|Acetazolam|Atenezol|Glaumox|SMR000058394|Diamox Sequels|Apo-Acetazolamide|Ak-Zol|Acetazolamidum [INN-Latin]|Acetazolamida [INN-Spanish]|CCRIS 5811|Acetazolamide (AAZ)|HSDB 3002|SR-01000000065|EINECS 200-440-5|UNII-O3FX965V0I|AI3-52458|Prestwick_4|1azm|1yda|1ydb|1ydd|1zsb|2xtk|3czv|3ucj|Acetazolamide, 5|Acetazolamide [USP:INN:BAN:JAN]|Acerazolamide, AAZ|Acetazolamide, AAZ|Acetazolamide, AZA|Acetazolamide, AZM|Spectrum_000018|1jd0|2h4n|2uy4|3dc3|3hs4|3ml5|4g0c|Opera_ID_288|AZA2|Prestwick0_000003|Prestwick1_000003|Prestwick2_000003|Prestwick3_000003|Spectrum2_000082|Spectrum3_000284|Spectrum4_000139|Spectrum5_000738|Lopac-A-6011|ACETAZOLAMIDE [MI]|A 6011|ACETAZOLAMIDE [INN]|ACETAZOLAMIDE [JAN]|ACETAZOLAMIDE [HSDB]|Lopac0_000039|SCHEMBL23219|ACETAZOLAMIDE [VANDF]|BSPBio_000005|BSPBio_001788|KBioGR_000558|KBioSS_000358|MLS001148438|orb341938|ACETAZOLAMIDE [MART.]|BIDD:GT0643|DivK1c_000017|SPECTRUM1500102|N-(5-Sulfamoyl-[1,3,4]thiadiazol-2-yl)-acetamide|SPBio_000004|SPBio_001926|ACETAZOLAMIDE [USP-RS]|ACETAZOLAMIDE [WHO-DD]|ACETAZOLAMIDE [WHO-IP]|BPBio1_000007|GTPL6792|orb2815843|Acetazolamide, >=99%, powder|SCHEMBL11049053|BDBM10880|BZKPWHYZMXOIDC-UHFFFAOYSA-|HMS500A19|HY-B0782R|KBio1_000017|KBio2_000358|KBio2_002926|KBio2_005494|KBio3_001288|Acetazolamide (JP18/USP/INN)|Acetazolamide, analytical standard|NINDS_000017|HMS1568A07|HMS1920A05|HMS2091G05|HMS2095A07|HMS2232G23|HMS3259I13|HMS3260G19|HMS3370P01|HMS3712A07|HMS3744A21|HMS5083D03|Pharmakon1600-01500102|WLN: T5NN DSJ CSZW EMV1|ACETAZOLAMIDE [EP IMPURITY]|ACETAZOLAMIDE [ORANGE BOOK]|ALBB-023617|BCP29616|HY-B0782|MSK10519|ACETAZOLAMIDE [EP MONOGRAPH]|Tox21_110078|Tox21_201559|Tox21_302773|Tox21_500039|ACETAZOLAMIDE [USP MONOGRAPH]|CCG-38900|NSC755854|s4506|SBB056640|ACETAZOLAMIDUM [WHO-IP LATIN]|AKOS000715163|Tox21_110078_1|CS-3568|DB00819|FA16948|LP00039|NC00491|NSC-755854|SDCCGSBI-0050028.P005|IDI1_000017|NCGC00015074-01|NCGC00015074-02|NCGC00015074-03|NCGC00015074-04|NCGC00015074-05|NCGC00015074-06|NCGC00015074-07|NCGC00015074-08|NCGC00015074-09|NCGC00015074-11|NCGC00015074-12|NCGC00015074-14|NCGC00015074-15|NCGC00015074-17|NCGC00015074-22|NCGC00023455-03|NCGC00023455-04|NCGC00023455-05|NCGC00023455-06|NCGC00023455-07|NCGC00256374-01|NCGC00259108-01|NCGC00260724-01|AC-12779|AS-13169|SBI-0050028.P004|2-Acetamido-5-sulfonamido-1,4-thiadiazole|5-Acetamide-1,4-thiadiazole-2-sulfonamide|DB-053437|5-Acetamido-1,3,4-thiadiazol-2-sulfonamide|A2598|AB00051906|CS-0694998|EU-0100039|NS00008947|ST45022057|1,4-Thiadiazole-2-sulfonamide, 5-acetamido-|C06805|D00218|D88526|EN300-119493|AB00051906_15|003A105|A832415|N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)ethanamide|Q413690|SR-01000000065-2|SR-01000000065-4|SR-01000000065-6|BRD-K43457670-001-22-9|BRD-K43457670-001-26-0|BRD-K43457670-001-27-8|Z277559108|(1z)-N-(5-sulfamoyl-1,3,4-thiadiazol-2-yl)ethanimidic acid|Acetazolamide, European Pharmacopoeia (EP) Reference Standard|Acetazolamide, United States Pharmacopeia (USP) Reference Standard|Acetazolamide for system suitability, European Pharmacopoeia (EP) Reference Standard|Acetazolamide, Pharmaceutical Secondary Standard; Certified Reference Material|124442-28-0|5-Acetamido-1,3,4-thiadiazole-2-sulfonamide;N-(5-[Aminosulfonyl]-1,3,4-thiadiazol-2-yl)acetamide;N-(5-Sulfamoyl-1,3,4-thiadiazol-2-yl)acetamide|InChI=1/C4H6N4O3S2/c1-2(9)6-3-7-8-4(12-3)13(5,10)11/h1H3,(H2,5,10,11)(H,6,7,9)|N-[5-Aminosulfonyl)-1,3,4-thiadiazol-2-yl]acetamide;5-Acetamido-1,3,4-thiadiazole-2-sulfonamide;Acetamox"
PHENOL,996,,"InChI=1S/C6H6O/c7-6-4-2-1-3-5-6/h1-5,7H",ISWSIDIOOBJBQZ-UHFFFAOYSA-N,C6H6O,94.11,phenol,"phenol|108-95-2|carbolic acid|Hydroxybenzene|Phenic acid|Oxybenzene|Phenylic acid|Phenylic alcohol|Benzenol|Monophenol|Phenyl hydrate|Phenyl hydroxide|PhOH|Monohydroxybenzene|Phenyl alcohol|Paoscle|Phenole|Izal|Phenol alcohol|Phenol, liquefied|Acide carbolique|Fenolo|Carbolsaure|Fenol|Liquid phenol|Liquefied phenol|Phenol, pure|Fenosmolin|Fenosmoline|Rcra waste number U188|Liquified Phenol|Phenol, molten|Carbolicum acidum|NCI-C50124|Baker's P & S liquid & Ointment|Baker's P and S Liquid and Ointment|Caswell No. 649|2-allphenol|Phenol, liquified|Carbolsaeure|Karbolsaeure|DTXSID5021124|Phenol,liquified|NSC-36808|339NCG44TV|CHEBI:15882|ENT-1814|DTXCID501124|NSC36808|Phylorinol|Topcare|Ulcerease|Carbol|Acid Carbolicum|Fungus Fighter|Fungus Fighte|Liver Supplement|Sore Throat|Fortinia ID|Acidum Carbolicum|ABC Sore Throat|CVS Sore Throat|HEB Sore Throat|Phenolate, Sodium|Sore Throat Spray|Meijer Sore Throat|Sore Throat Cherry|Rugby Cherry Flavor|Sore Throat Menthol|Topcare Sore Throat|S.b. ward|PUBLIX Sore Throat|Walgreens Sore Throat|TopCare Cherry Flavor|RefChem:6668|Sore Throat Readyincase|Vortex Moisturizer Oral|DRx Choice Sore Throat|CVS Sore Throat Cherry|Wild Horse 777 Oral|Castellani Paint 1.5%|Good Neighbor Sore Throat|Sore Throat Relief Cherry|Pain Relieving Petro Carbo|Sore Throat Relief Menthol|NICE SORE THROAT Cherry|CEPASTAT EXTRA STRENGTH|NICE SORE THROAT Spearmint|CHLORASEPTIC SORE THROAT|HEB Sore Throat Cherry Flavor|Chloraseptic Sore Throat Cherry|Chloraseptic Sore Throat Citrus|ABC Sore Throat Menthol Flavor|CVS Sore Throat Menthol Flavor|HEB Sore Throat Menthol Flavor|Chloraseptic Sore Throat Menthol|Chloraseptic Warming Sore Throat|NICE SORE THROAT Honey Lemon|Sore Throat Relief Cherry Flavor|Diabetic Tussin Sore Throat Cherry|phenol 0.6% anesthetic oral rinse|PUBLIX Sore Throat Menthol Flavor|Topcare Sore Throat Menthol Flavor|Walgreens Sore Throat Cherry Flavor|DRx Choice Sore Throat Menthol Flavor|Eos Medicated Pain Relieving Lip Balm|Sterile Diluent for Allergenic Extract|Bestmade Natural Products Carbolic Acid|Good Neighbor Sore Throat Cherry Flavor|Chloraseptic Childrens Sore Throat Cherry|PUBLIX Sore Throat Fast Relief Oral Anesthetic|CVS Health Sore Throat Fast Relief Oral Anesthetic|203-632-7|hydron;phenoxide|Phenosmolin|Benzene, hydroxy-|Fenolo [Italian]|Phenole [German]|Campho-Phenique Gel|Phenol [JAN]|Phenic|Carbolsaure [German]|Campho-Phenique Liquid|Fenol [Dutch, Polish]|MFCD00002143|Monohydroxy benzene|UN 2312 (molten)|Acide carbolique [French]|UN 1671 (solid)|NSC 36808|Campho-Phenique Cold Sore Gel|Phenic alcohol|Synthetic phenol|Phenol, dimer|RCRA waste no. U188|UN2312|UN2821|AI3-01814|27073-41-2|CHEMBL14060|Phenol, Glass Distilled Under Argon|Phenol, solid [UN1671]  [Poison]|Phenol, molten [UN2312]  [Poison]|NCGC00091454-04|Phenol, >=99.0%|17442-59-0|phenylalcohol|hydroxy benzene|Phenol 100 microg/mL in Methanol|Phenol, liquid|Phenol, solid|Benzenol; Hydroxybenzene; NSC 36808|Baker's p and s|CAS-108-95-2|CCRIS 504|FEMA No. 3223|HSDB 113|(14C)Phenol|Phenol [USP:JAN]|PHENOL (2,3,4,5,6-D5)|EINECS 203-632-7|EPA Pesticide Chemical Code 064001|arenols|UNII-339NCG44TV|Benzophenol|acide phenique|Hydroxy-benzene|Phenol liquid|Phenol molten|Phenol synthetic|Pandy's reagent|Cepastat lozenges|Phenol, labeled with carbon-14|Phenol (liquid)|2-phenyl alcohol|Phenol, synthetic|Phenol, ultrapure|Phenol ACS grade|Liquefied phenol BP|Paoscle (TN)|Carbolic acid liquid|Phenol (TN)|Phenol, ACS reagent|Carbolic acid, liquid|63496-48-0|Water-Saturated Phenol|1ai7|1li2|4i7l|Liquefied phenol (TN)|PHENOL [VANDF]|PHENOL [FHFI]|PHENOL [HSDB]|PHENOL [IARC]|SCHEMBL48|Phenol (JP18/USP)|PHENOL [USP-RS]|PHENOL [WHO-DD]|Phenol, detached crystals|PHENOL [II]|PHENOL [MI]|Phenol, >=99%|PHENOL [MART.]|WLN: QR|Liquefied phenol (JP18)|Salicylic Acid Impurity 9|bmse000290|bmse010026|C6H5OH|Fenol(DUTCH, POLISH)|EC 203-632-7|SCHEMBL2350|SCHEMBL3290|SCHEMBL4037|PHENOL, 80% in ethanol|Phenol, LR, >=99%|SCHEMBL10428|MLS001065591|Phenol (CGA 73330)|Phenol, for molecular biology|BIDD:ER0293|PHENOL [EP MONOGRAPH]|Phenol for disinfection (TN)|SCHEMBL167552|SCHEMBL496777|SCHEMBL744464|Phenol, natural, 97%, FG|PHENOL [USP MONOGRAPH]|SCHEMBL1642833|SCHEMBL1644243|SCHEMBL1644245|SCHEMBL1713042|SCHEMBL2640831|Cuticura pain relieving ointment|CARBOLICUM ACIDUM [HPUS]|Phenol, AR, >=99.5%|PHENOL,LIQUIFIED [VANDF]|SCHEMBL10939954|SCHEMBL20421902|SCHEMBL22284125|SCHEMBL22284137|BDBM26187|CHEBI:33853|Phenol for disinfection (JP18)|MSK7905|3f39|Phenol 10 microg/mL in Methanol|Benzenol;Hydrozybenzene;NSC 36808|Tox21_113463|Tox21_201639|Tox21_300042|Phenol 5000 microg/mL in Methanol|STL194294|AKOS000119025|Tox21_113463_1|DB03255|FP01241|NA 2821|Phenol, BioXtra, >=99.5% (GC)|Phenol, SAJ first grade, >=98.0%|UN 1671|UN 2312|UN 2821|NCGC00091454-01|NCGC00091454-02|NCGC00091454-03|NCGC00091454-05|NCGC00091454-06|NCGC00091454-07|NCGC00254019-01|NCGC00259188-01|Phenol, JIS special grade, >=99.0%|73607-76-8|BP-30160|METHYL SALICYLATE IMPURITY B [EP]|SMR000568492|Phenol 1000 microg/mL in Dichloromethane|Phenol, PESTANAL(R), analytical standard|Liquified Phenol (contains 7-10 % water)|METACRESOL IMPURITY A [EP IMPURITY]|NS00010045|P1610|P2771|EN300-19432|C00146|D00033|Phenol, unstabilized, ReagentPlus(R), >=99%|R00328|SALICYLIC ACID IMPURITY C [EP IMPURITY]|SBI-0653931.0001|HEXYLRESORCINOL IMPURITY A [EP IMPURITY]|Phenol, p.a., ACS reagent, 99.5-100.5%|Q130336|Phenol, for molecular biology, ~90% (T), liquid|BRD-K76549667-001-04-6|F1908-0106|Phenol, unstabilized, purified by redistillation, >=99%|Z104473830|InChI=1/C6H6O/c7-6-4-2-1-3-5-6/h1-5,7|Phenol, BioUltra, for molecular biology, >=99.5% (GC)|Phenol, United States Pharmacopeia (USP) Reference Standard|Liquified Phenol, meets USP testing specifications, >=89.0%|Phenol, BioUltra, for molecular biology, TE-saturated, ~73% (T)|phenol;phenol [jan];phenol, pure;phenol phenol [jan] phenol, pure|Phenol water-saturated, stabilised and with separate Tris buffer solution|Phenol, puriss. p.a., ACS reagent, reag. Ph. Eur., 99.0-100.5%|Phenol, contains hypophosphorous as stabilizer, loose crystals, ACS reagent, >=99.0%|Phenol, puriss., meets analytical specification of Ph. Eur., BP, USP, 99.5-100.5% (GC)|Phenol, puriss., meets analytical specification of Ph. Eur., BP, USP, >=99.5% (GC), crystalline (detached)"
THEOPHYLLINE,2153,,"InChI=1S/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9)",ZFXYFBGIUFBOJW-UHFFFAOYSA-N,C7H8N4O2,180.16,"1,3-dimethyl-7H-purine-2,6-dione","theophylline|58-55-9|1,3-Dimethylxanthine|Elixophyllin|Theophyllin|Theolair|Theophylline anhydrous|Nuelin|Respbid|Elixophylline|Lanophyllin|Pseudotheophylline|Solosin|Theocin|Theo-dur|Liquophylline|Parkophyllin|Doraphyllin|Elixicon|Maphylline|Medaphyllin|Optiphyllin|Teofyllamin|Theacitin|Theocontin|Theograd|Theovent|Xantivent|Austyn|Elixex|Teolair|Theofol|Uniphyl|Acet-theocin|Slo-phyllin|Slo-bid|Accurbron|Aerolate III|Armophylline|Bronkodyl|Theophyl-225|Uniphyllin|Aerolate|Duraphyl|Theobid|Theophylline, anhydrous|1,3-dimethyl-7H-purine-2,6-dione|Euphylong|Sustaire|Teofilina|Theochron|Asmax|Quibron T/SR|Somophyllin-t|Theal tablets|Bronkodyl SR|Constant-T|Theoclair-SR|Theoclear LA|Quibron-T|Spophyllin retard|Theophyline|Theoclear 80|Theostat 80|Synophylate-L.A. Cenules|Theo-Dur-Sprinkle|Aquaphyllin|Elixomin|Theodel|Theolixir|Theophyl|LaBID|Elixophyllin SR|Theophylline-SR|LASMA|Pro-vent|Somophyllin-CRT|3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione|Aerolate SR|Theolair-SR|Theophyl-SR|Theona P|Uni-Dur|Theoclear-80|Quibron-T/SR|T-Phyl|Theoclear-200|Constant T|Nuelin SA|Theobid Jr.|Theo-24|Uniphyllin continus|Theoclear L.A.-130|Xanthine, 1,3-dimethyl-|1,3-dimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione|Theobid Duracap|Somophyllin T|NSC 2066|Quibron|1H-Purine-2,6-dione, 3,7-dihydro-1,3-dimethyl-|Theo 24|Purine-2,6(1H,3H)-dione, 1,3-dimethyl-|Doxophylline metabolite m3|Theophylline melting point standard|NSC-2066|1,3-dimethyl-1H-purine-2,6(3H,7H)-dione|Theophylline,anhydrous|DTXSID5021336|CHEBI:28177|0I55128JYK|Theophylline [USP]|NSC-757346|AEROLATE JR|DTXCID001336|THEOCLEAR-100|NSC2066|THEOCLEAR L.A.-260|Theophylline (USP)|SloPhyllin|SomophyllinT|ConstantT|Slo Phyllin|Theodur G|Theo Dur|Quibron TSR|ct, theo von|von ct, theo|THEOPHYLLINE AND DEXTROSE 5% IN PLASTIC CONTAINER|THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER|Quibron T SR|Theo24|THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER|THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER|THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER|THEOPHYLLINE 0.2% AND DEXTROSE 5% IN PLASTIC CONTAINER|THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER|THEOPHYLLINE 0.4% AND DEXTROSE 5% IN PLASTIC CONTAINER|Theophylline (anhydrous)|Senophylline|Nuelin sa-250|Anhydrous, Theophylline|RefChem:6299|Theophyllinate, Glycine|Glycinate, Theophylline Sodium|Sodium Glycinate, Theophylline|THEOPHYLLINE ANHYDROUS, CHOLINE|3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione monohydrate|200-385-7|1,3 Dimethylxanthine|1,3-Dimethylxanthine Monohydrate|C137DTR5RG|Theolix|Choledyl SA|Theo-11|Theospan|Aerobin|Tefamin|Theopek|Unifyl|Euphylline|Bronkotabs|Theo-Organidin|GS 2591A|1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione|Dimethylxanthine|MFCD00079619|X 115|Theal tabl.|2,6-Dihydroxy-1,3-dimethylpurine|1,3-dimethyl-1H-purine-2,6(3H,9H)-dione|CHEMBL190|1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydropurine|MLS000069390|1,3-Dimethylxanthine;Theo-24|75448-53-2|Duraphyllin|Diffumal|Theodur|58-55-9 (ANHYDROUS)|Theophylline (1,3-dimethylxanthine)|Teofilina [Polish]|NCGC00018117-07|NCGC00018117-17|Mudrane|Pulmidur|SMR000058537|Teonova|Theokin|Theostat|Hylate|Bronchodid Duracap|1,3-dimethyl-1,3,7-trihydropurine-2,6-dione|50857-74-4|1H-Purine-2,6-dione, 3,9-dihydro-1,3-dimethyl-|1246816-25-0|Teocen 200|Elixophyllin(e)|CAS-58-55-9|Theolair (TN)|Elixophyllin (TN)|Uniphyl (TN)|Quibron-t (TN)|Theodur G (TN)|CCRIS 4729|HSDB 3399|SR-01000075195|EINECS 200-385-7|Theo-24 (TN)|Telbans|Physpa|UNII-0I55128JYK|AI3-50216|Unicontin CR|4eoh|Aescin-IIA|Caffeine Impurity 6|Theophylline form II|theophylline solu-tion|component of Primatene|Xanthine,3-dimethyl-|Opera_ID_76|Spectrum_001038|Theophylline (JP18)|2a3a|Theophylline (Standard)|Prestwick0_000820|Prestwick0_000873|Prestwick1_000820|Prestwick1_000873|Prestwick2_000820|Prestwick2_000873|Prestwick3_000820|Prestwick3_000873|Spectrum2_000842|Spectrum3_000672|Spectrum4_000353|Spectrum5_001232|THEOPHYLLINE [MI]|8-(2-Furyl)theophylline|UPCMLD-DP123|component of Theo-Organidin|EC 200-385-7|SCHEMBL4915|Lopac0_000014|BSPBio_000719|BSPBio_000945|BSPBio_002363|component of Dicurin Procaine|GTPL413|KBioGR_000785|KBioSS_001518|Pentoxifylline EP Impurity F|MLS002152943|MLS002153487|MLS004491910|MLS006011970|BIDD:ER0557|BIDD:GT0151|DivK1c_000203|SPECTRUM1500568|THEOPHYLLINE [USP-RS]|THEOPHYLLINE [WHO-DD]|SPBio_000823|SPBio_002640|SPBio_002866|BPBio1_000791|BPBio1_001041|orb1309828|SCHEMBL2136940|SCHEMBL4435082|SCHEMBL5711097|SCHEMBL8312163|SCHEMBL8595167|component of Tedral (Salt/Mix)|UPCMLD-DP123:001|BCBcMAP01_000071|BDBM10847|BDBM82053|component of Quibron (Salt/Mix)|HMS500K05|HY-B0809R|KBio1_000203|KBio2_001518|KBio2_004086|KBio2_006654|KBio3_001583|component of Hecadrol (Salt/Mix)|NINDS_000203|Theophylline, 1mg/ml in Methanol|HMS1921E03|HMS2089A06|HMS2092M05|HMS2233E16|HMS3259O06|HMS3369N14|Pharmakon1600-01500568|component of Primatene (Salt/Mix)|ALBB-036665|BCP30664|component of Bronkotabs (Salt/Mix)|HY-B0809|MSK10355|STR01537|Theophylline 1.0 mg/ml in Methanol|Theophylline, >=99.0% (HPLC)|Tox21_110827|Tox21_202375|Tox21_300028|CCG-20301|HB2849|NSC757346|PDSP1_001018|PDSP1_001234|PDSP2_001002|PDSP2_001218|STK397040|THEOPHYLLINE ANHYDROUS [HSDB]|THEOPHYLLINE,ANHYDROUS [VANDF]|AKOS000120961|AKOS005434016|component of Quibron Plus (Salt/Mix)|Tox21_110827_1|component of Quibron-T/SR (Salt/Mix)|component of Theo-organdin (Salt/Mix)|component of Theolair plus (Salt/Mix)|CS-4158|DB00277|NC00542|Purine-2,3H)-dione, 1,3-dimethyl-|SDCCGMLS-0066620.P001|SDCCGSBI-0050003.P005|component of Theo-Organidin (Salt/Mix)|IDI1_000203|SMP1_000291|component of Slo-phyllin GG (Salt/Mix)|NCGC00018117-01|NCGC00018117-02|NCGC00018117-03|NCGC00018117-04|NCGC00018117-05|NCGC00018117-06|NCGC00018117-08|NCGC00018117-09|NCGC00018117-10|NCGC00018117-11|NCGC00018117-12|NCGC00018117-13|NCGC00018117-14|NCGC00018117-15|NCGC00018117-16|NCGC00018117-18|NCGC00018117-19|NCGC00018117-20|NCGC00018117-23|NCGC00018117-37|NCGC00022112-03|NCGC00022112-04|NCGC00022112-05|NCGC00022112-07|NCGC00022112-08|NCGC00022112-09|NCGC00022112-10|NCGC00022112-11|NCGC00022112-12|NCGC00254040-01|NCGC00259924-01|WLN: T56 BM DN FNVNVJ F1 H1|AC-20328|component of Dicurin Procaine (Salt/Mix)|NCI60_001736|SMR003435989|ST024762|SY066799|Theophylline, anhydrous, >=99%, powder|component of Primatene tablets (Salt/Mix)|Purine,6(1H,3H)-dione, 1,3-dimethyl-|SBI-0050003.P004|component of Mudrane GG elixir (Salt/Mix)|DB-053224|Theophylline 100 microg/mL in Acetonitrile|Theophylline(Discontinued,See C4X-13306)|1H-Purine-2, 3,7-dihydro-1,3-dimethyl-|AB00052106|NS00010258|T0179|EN300-21503|C07130|D00371|D85002|DIMENHYDRINATE IMPURITY A [EP IMPURITY]|PENTOXIFYLLINE IMPURITY C [EP IMPURITY]|AB00052106-20|AB00052106-22|AB00052106-23|AB00052106_24|AB00052106_25|AB00052106_26|1,3-dimethyl-3,9-dihydro-1H-purine-2,6-dione|F095062|L000595|Q407308|1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione #|SR-01000075195-1|SR-01000075195-3|SR-01000075195-5|BRD-K97799481-001-02-0|BRD-K97799481-001-12-9|BRD-K97799481-001-16-0|BRD-K97799481-002-03-6|BRD-K97799481-205-01-9|BRD-K97799481-205-02-7|BRD-K97799481-230-01-7|F2173-0145|Z203045518|A3133D49-AAB6-49A1-B60B-B5198F327D3F|Theophylline, British Pharmacopoeia (BP) Reference Standard|Theophylline, European Pharmacopoeia (EP) Reference Standard|Theophylline melting point standard, United States Pharmacopeia (USP) Reference Standard|Theophylline, Pharmaceutical Secondary Standard; Certified Reference Material|Theophylline;1,3-Dimethylxanthine; 3,7-Dihydro-1,3-dimethyl-1H-purine-2,6-dione|8061-56-1|InChI=1/C7H8N4O2/c1-10-5-4(8-3-9-5)6(12)11(2)7(10)13/h3H,1-2H3,(H,8,9|Theo-24;1,3-Dimethyl-3,7-dihydro-1H-purine-2,6-dione ;1,3-Dimethylxanthine;1,3-dimethyl-xanthin|Theophylline melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material|Theophylline, certified reference material, United States Pharmacopeia (USP) Reference Standard"
CAFFEINE,2519,,"InChI=1S/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H3",RYYVLZVUVIJVGH-UHFFFAOYSA-N,C8H10N4O2,194.19,"1,3,7-trimethylpurine-2,6-dione","caffeine|58-08-2|Guaranine|1,3,7-Trimethylxanthine|Methyltheobromine|Theine|Thein|Cafeina|Koffein|Mateina|Alert-pep|Caffein|Cafipel|Coffeine|Refresh'n|Caffedrine|Vivarin|Stim|Anhydrous caffeine|Cafamil|Cafecon|Caffine|Dexitac|Nodaca|No-Doz|Eldiatric C|Durvitan|Hycomine|Organex|7-Methyltheophylline|Nix Nap|Methyltheobromide|Coffeinum|Coffein|3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione|Tirend|1,3,7-Trimethylpurine-2,6-dione|1,3,7-Trimethyl-2,6-dioxopurine|Tri-Aqua|Kofein|Caffeine, anhydrous|1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-|1-methyltheobromine|Methylxanthine theophylline|teina|Caffeina|NCI-C02733|Quick Pep|1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione|1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione|CAFFEINE ANHYDROUS|FEMA No. 2224|cafeine|Caffeinum|DTXSID0020232|NSC-5036|Caffeine melting point standard|1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione|CHEBI:27732|3G6A5W338E|DTXCID40232|TREZIX COMPONENT CAFFEINE|NSC5036|NoDoz Caplets and Chewable Tablets|5-26-13-00558 (Beilstein Handbook Reference)|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion|QuickPep|NODOZ|Zanthine|Awake|NoSnooze|Allertness Aid|Diurex Ultimate|trimethylxanthine|Uplift Chewable|Alertness Aid|Diurex Ultra|Yeast-vite|Caffeine,|Conrx Alert|Pro-plus|Sprayable Energy|Stay Awake|Alert Aid|Hair Care|Nano Ppc|Caffeine 200mg|Diurex Water Pills|Topcare Stay Awake|Alert Alertness Aid|NoDoz Alertness Aid|Sohmed Alertness Aid|357 Super Magnum|Caffeine 1508|Awake Maximum Strength|RefChem:6623|Diurex Water Pills XPL|Caffeine 200 mg Tablets|Jet Alert Double Strength|Jet Alert Regular Strength|Caffeine Tablets, 200 mg|Stay Awake Maximum Strength|Caffeine tablet, film-coated|CHEBI:27134|Topcare Stay Awake Maximum Strength|GROWTH Hair Serum Serum Capillaire|NoDoz Alertness Aid Maximum Strength|Valumeds Maximum Strength Stay Awake|FEELSHION 6% Caffeine 1% Retinol Eye Cream|200-362-1|619-173-4|BIOTIN; CITRUS AURANTIUM BERGAMIA (BERGAMOT) FRUIT OIL; CITRUS TANGERINA (TANGERINE) FRUIT; CURCUMA LONGA (TURMERIC) ROOT; LEMON; LYSYLTHREONYLTHREONYLLYSYLSERINE; NICOTIANA BENTHAMIANA WHOLE; TOBACCO LEAF; TRIFOLIUM PRATENSE LEAF|Phensal|Caffeine, synthetic|Quick-Pep|Synalgos|Wigraine|Theophylline, 7-methyl|DHCplus|Miudol|Theobromine, 1-methyl-|Propoxyphene Compound 65|Kofein [Czech]|Coffein [German]|Koffein [German]|Caffeine (natural)|Xanthine, 1,3,7-trimethyl|Caffeina [Italian]|Theophylline Me|Theobromine Me|SK-65 Compound|Lanorinal|Anacin|Anacin Maximum Strength|P-A-C Analgesic Tablets|HSDB 36|BRN 0017705|NSC 5036|MFCD00005758|A.S.A. and Codeine Compound|AI3-20154|CHEMBL113|CFF|Caffeine-13C3|caffenium|SK 65 Compound|Caffeine [BAN:JAN]|1,3,7-trimethyl-1,3,7-trihydropurine-2,6-dione|Propoxyphene Compound-65|CAS-58-08-2|Caffeine (USP)|SMR000326667|Darvon compound-65|CCRIS 1314|SR-01000075187|Anhydrous caffeine (TN)|EINECS 200-362-1|Monomethyl derivative of Theophylline|Caffeine [USP:BAN:JAN]|Anhydrous caffeine (JP15)|metilteobromina|Kafeina|trimetilksantina|UNII-3G6A5W338E|1gfz|Caffeine, BioXtra|TNP00310|Monohydrate Caffeine|Respia (TN)|1-methyl-Theobromine|7-methyl Theophylline|Cafergot (Salt/Mix)|1,7-Trimethylxanthine|Spectrum_001301|1l5q|1l7x|2a3b|3g6m|3,7-dihydro-1,3,7-trimethyl-1H-purine|CAFFEINE [FHFI]|CAFFEINE [HSDB]|CAFFEINE [IARC]|CAFFEINE [FCC]|Xanthine,3,7-trimethyl|CAFFEINE [II]|CAFFEINE [MI]|1 3 7-trimetilksantina|CAFFEINE [VANDF]|CAFFEINUM [HPUS]|1,3,7-Trimethylxantine|Spectrum2_001261|Spectrum3_000321|Spectrum4_001782|Spectrum5_000423|Lopac-C-0750|1 3 7-Trimethylxanthine|CAFFEINE [MART.]|bmse000206|CAFFEINE [USP-RS]|CAFFEINE [WHO-DD]|CAFFEINE [WHO-IP]|MolMap_000054|Probes1_000150|Probes2_000128|C 0750|EC 200-362-1|SCHEMBL5671|Anhydrous caffeine (JP18)|NCIOpen2_008255|BIDD:PXR0172|Lopac0_000228|BSPBio_001921|GTPL407|KBioGR_002325|KBioSS_001781|MLS001055341|MLS001056714|MLS001066409|orb422048|BIDD:ER0554|BIDD:GT0632|Caffeine, 1mg/ml in methanol|DivK1c_000730|SPECTRUM1500155|CU-01000012617-3|SPBio_001222|CAFFEINE [ORANGE BOOK]|ESGIC COMPONENT CAFFEINE|TRIAD COMPONENT CAFFEINE|829 - Tea quality parameters|MEGxp0_001350|SCHEMBL1341011|SCHEMBL6362289|CAFFEINE [EP MONOGRAPH]|DIMENHYDRINATE IMPURITY C|FEMCET COMPONENT CAFFEINE|1,3,7-trimethyl-2,6-dioxo-1,2,3,6-tetrahydropurine|ANHYDROUS CAFFEINE [JAN]|CAFFEINE [USP MONOGRAPH]|component of Dilone (Salt/Mix)|1,7-Trimethyl-2,6-dioxopurine|ACon1_000085|ANOQUAN COMPONENT CAFFEINE|BDBM10849|HMS502E12|KBio1_000730|KBio2_001781|KBio2_004349|KBio2_006917|KBio3_001141|Caffeine 1.0 mg/ml in Methanol|CAFFEINE(3-METHYL-13C)|COFFEINUM [WHO-IP LATIN]|CAFERGOT COMPONENT CAFFEINE|Caffeine, powder, ReagentPlus(R)|component of Percodan (Salt/Mix)|EXCEDRIN COMPONENT CAFFEINE|FIORICET COMPONENT CAFFEINE|FIORINAL COMPONENT CAFFEINE|MIGERGOT COMPONENT CAFFEINE|NINDS_000730|NORGESIC COMPONENT CAFFEINE|WIGRAINE COMPONENT CAFFEINE|Bio1_000473|Bio1_000962|Bio1_001451|DHC PLUS COMPONENT CAFFEINE|HMS1920I09|HMS2091O11|HMS2232M13|HMS3260N17|HMS3372J18|HMS3435F10|HMS3715D13|HMS5091J20|Pharmakon1600-01500155|INVAGESIC COMPONENT CAFFEINE|LANORINAL COMPONENT CAFFEINE|Caffeine 10 microg/mL in Methanol|CAFFEINE ANHYDROUS [WHO-IP]|CIA28298|CS-M0795|DDA07266|XCA23885|Tox21_201685|Tox21_300010|Tox21_500228|caffeine (1,3,7-trimethylxanthine)|Caffeine 100 microg/mL in Methanol|CCG-38825|HB2846|NSC755917|ORPHENGESIC COMPONENT CAFFEINE|PDSP1_001016|PDSP1_001235|PDSP2_001000|PDSP2_001219|SBB006474|STK177283|Propoxyphene Compound 65 (Salt/Mix)|SYNALGOS-DC COMPONENT CAFFEINE|AKOS000121334|5-26-13-00558 (Beilstein)|Bayer Select Headache Pain (Salt/Mix)|Caffeine, anhydrous, 99%, FCC, FG|DB00201|FT05891|LP00228|NSC-755917|SDCCGMLS-0064595.P001|SDCCGMLS-0064595.P002|SDCCGSBI-0050216.P005|IDI1_000730|MEDIGESIC PLUS COMPONENT CAFFEINE|SYNALGOS-DC-A COMPONENT CAFFEINE|3,3,7-trimethyl-1H-purine-2,6-dione|DARVON COMPOUND COMPONENT CAFFEINE|INVAGESIC FORTE COMPONENT CAFFEINE|NCGC00015208-01|NCGC00015208-02|NCGC00015208-03|NCGC00015208-04|NCGC00015208-05|NCGC00015208-06|NCGC00015208-07|NCGC00015208-08|NCGC00015208-10|NCGC00015208-11|NCGC00015208-12|NCGC00015208-13|NCGC00015208-14|NCGC00015208-15|NCGC00015208-16|NCGC00015208-17|NCGC00015208-18|NCGC00015208-20|NCGC00015208-27|NCGC00015208-29|NCGC00090699-01|NCGC00090699-02|NCGC00090699-03|NCGC00090699-04|NCGC00090699-05|NCGC00090699-06|NCGC00090699-07|NCGC00090699-08|NCGC00090699-09|NCGC00168808-01|NCGC00168808-02|NCGC00254057-01|NCGC00259234-01|NCGC00260913-01|95789-13-2|AC-12774|AS-15340|Caffeine, SAJ special grade, >=98.5%|component of P-A-C Compound (Salt/Mix)|ST057528|component of A.S.A. Compound (Salt/Mix)|ORPHENGESIC FORTE COMPONENT CAFFEINE|SBI-0050216.P004|DB-023002|WLN: T56 BN DN FNVNVJ B1 F1 H1|C2042|EU-0100228|NS00000273|THEOPHYLLINE IMPURITY A [EP IMPURITY]|526 - Nutritional Analysis of Energy Drinks|EN300-21663|BIM-0050216.0001|C07481|D00528|DIMENHYDRINATE IMPURITY C [EP IMPURITY]|PENTOXIFYLLINE IMPURITY F [EP IMPURITY]|Q60235|1,3,7-trimethyl-3,7-dihydropurine-2,6-dione|1H-Purine-2, 3,7-dihydro-1,3,7-trimethyl-|AB00051930-09|AB00051930_10|Caffeine, purum, anhydrous, >=99.0% (HPLC)|3,7-dihydro-1,3,7-trimethyl-1H-purine (9CI)|Caffeine, anhydrous, tested according to Ph.Eur.|L000155|Caffeine, Sigma Reference Standard, vial of 250 mg|SR-01000075187-1|SR-01000075187-4|SR-01000075187-7|SR-01000075187-8|BRD-K02404261-001-02-7|BRD-K02404261-001-03-5|BRD-K02404261-001-07-6|BRD-K02404261-001-16-7|Caffeine, certified reference material, TraceCERT(R)|Caffeine, meets USP testing specifications, anhydrous|Melting point standard 235-237C, analytical standard|1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione #|Caffeine, British Pharmacopoeia (BP) Reference Standard|Caffeine, European Pharmacopoeia (EP) Reference Standard|F3371-0262|THEOPHYLLINE MONOHYDRATE IMPURITY A [EP IMPURITY]|Z104507896|07E4FB58-FD79-4175-8E3D-05BF96954522|3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion (coffein)|Caffeine, United States Pharmacopeia (USP) Reference Standard|Caffeine, Pharmaceutical Secondary Standard; Certified Reference Material|Caffeine anhydrous;3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione;7-Methyltheophylline|Caffeine for system suitability, European Pharmacopoeia (EP) Reference Standard|Caffeine melting point standard, United States Pharmacopeia (USP) Reference Standard|InChI=1/C8H10N4O2/c1-10-4-9-6-5(10)7(13)12(3)8(14)11(6)2/h4H,1-3H|114303-55-8|Caffeine Melting Point Standard, Pharmaceutical Secondary Standard; Certified Reference Material|Mettler-Toledo Calibration substance ME 18872, Caffeine, analytical standard, for the calibration of the thermosystem 900, traceable to primary standards (LGC)"
ROLOFYLLINE,11948288,,"InChI=1S/C20H28N4O2/c1-3-5-23-16-15(17(25)24(6-4-2)19(23)26)21-18(22-16)20-10-12-7-13(11-20)9-14(20)8-12/h12-14H,3-11H2,1-2H3,(H,21,22)/t12-,13+,14?,20?",PJBFVWGQFLYWCB-QUYAXPHCSA-N,C20H28N4O2,356.5,"1,3-dipropyl-8-[(1R,5S)-3-tricyclo[3.3.1.03,7]nonanyl]-7H-purine-2,6-dione","KW-3902|1,3-Dnax|136199-02-5|7805S5HIHX|1,3-Dipropyl-8-(3-noradamantyl)xanthine|8-(3-Noradamantyl)-1,3-dipropylxanthine|8-(Noradamantan-3-yl)-1,3-dipropylxanthine|MK-7418|Rolofyllina|1,3-DIPROPYL-8-(TRICYCLO(3.3.1.0(SUP 3,7))NON-3-YL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE|3,7-DIHYDRO-1,3-DIPROPYL-8-(3-TRICYCLO(3.3.1.0(SUP 3,7))NONYL)-1H-PURINE-2,6-DIONE|rolofyllinum|MK7418|RefChem:883689|1,3-dipropyl-8-((1R,5S)-tricyclo(3.3.1.0^(3,7))nonan-3-yl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione|663-792-2|KW 3902|KW3902|Rolofylline|Rolofylline [USAN]|1H-Purine-2,6-dione, 8-(hexahydro-2,5-methanopentalen-3a(1H)-yl)-3,7-dihydro-1,3-dipropyl-|ROLOFYLLINE [INN]|Rolofylline [USAN:INN]|UNII-7805S5HIHX|ROLOFYLLINE [WHO-DD]|DB12670|PD132541|NS00073717|KW-3902, >=98% (HPLC)|1,3-Dipropyl-8-(tricyclo(3.3.1.0(3,7))non-3-yl)-3,7-dihydro-1H-purine-2,6-dione|1,3-dipropyl-8-[(1R,5S)-3-tricyclo[3.3.1.03,7]nonanyl]-7H-purine-2,6-dione|3,7-Dihydro-1,3-dipropyl-8-(3-tricyclo(3.3.1.0(3,7))nonyl)-1H-purine-2,6-dione|8-((2R,3as,5S,6as)-hexahydro-2,5-methanopentalen-3a(1H)-yl)-1,3-dipropyl-3,7-dihydro-1H-purine-2,6-dione"
ST1535,9860294,,"InChI=1S/C12H16N8/c1-3-4-5-8-16-10(13)9-11(17-8)19(2)12(18-9)20-14-6-7-15-20/h6-7H,3-5H2,1-2H3,(H2,13,16,17)",CYYQMAWUIRPCNW-UHFFFAOYSA-N,C12H16N8,272.31,2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine,"ST-1535|496955-42-1|2-butyl-9-methyl-8-(triazol-2-yl)purin-6-amine|ST 1535|ST1535|NTK8WWM73W|CT-1500|DTXSID60432000|RefChem:185246|DTXCID20382830|2-butyl-9-methyl-8-(2H-1,2,3-triazol-2-yl)-9H-purin-6-amine|MFCD27987937|CHEMBL197669|ST 1535 - Bio-X|GTPL5613|orb1304889|SCHEMBL5362208|SCHEMBL29362910|GLXC-05701|2-n-butyl-9-methyl-8-(1,2,3)triazol-2-yl-9H-purin-6-ylamine|BDBM50176058|AKOS030562134|SB16783|AS-35290|DA-69749|HY-105003|L001675|Q27088881|2-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine|2-butyl-9-methyl-8-(2h-1,2,3-triazol-2-yl)-9h-purin-6-ylamine|9H-Purin-6-amine, 2-butyl-9-methyl-8-(2H-1,2,3-triazol-2-yl)-2-Butyl-9-methyl-8-(triazol-2-yl)purin-6-amine"
PRELADENANT,10117987,,"InChI=1S/C25H29N9O3/c1-35-15-16-36-19-6-4-18(5-7-19)32-11-8-31(9-12-32)10-13-33-23-20(17-27-33)24-28-22(21-3-2-14-37-21)30-34(24)25(26)29-23/h2-7,14,17H,8-13,15-16H2,1H3,(H2,26,29)",DTYWJKSSUANMHD-UHFFFAOYSA-N,C25H29N9O3,503.6,"4-(furan-2-yl)-10-[2-[4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl]ethyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine","Preladenant|377727-87-2|SCH-420814|Sch 420814|SCH420814|MK-3814|950O97NUPO|DTXSID90191219|7H-Pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amine, 2-(2-furanyl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)-1-piperazinyl)ethyl)-|preladenantum|RefChem:868474|DTXCID50113710|4-(furan-2-yl)-10-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-3,5,6,8,10,11-hexaazatricyclo(7.3.0.0^(2,6))dodeca-1(9),2,4,7,11-pentaen-7-amine|UNII-950O97NUPO|MFCD17167056|2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine|CHEMBL240624|2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)-ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine|5-Amino-2-(2-furanyl)-7-[2-[4-[4-(2-methoxyethoxy)phenyl]-1-piperazinyl]ethyl]-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine|4-(furan-2-yl)-10-[2-[4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl]ethyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine|Preladenant [USAN:INN]|C25H29N9O3|2-(Furan-2-yl)-7-(2-(4-(4-(2-methoxyethoxy)phenyl)piperazin-1-yl)ethyl)-7H-pyrazolo(4,3-e)(1,2,4)triazolo(1,5-c)pyrimidin-5-amine|2-(Furan-2-yl)-7-[2-[4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl]ethyl]-7H-pyrazolo[4,3-E][1,2,4]triazolo[1,5-c]pyrimidin-5-amine|PRELADENANT [INN]|Preladenant (USAN/INN)|PRELADENANT [USAN]|Preladenant(SCH420814)|PRELADENANT [WHO-DD]|Preladenant(SCH420814)?|GTPL5614|orb1302982|SCHEMBL2856554|BCP05239|EX-A1325|BDBM50202986|s6910|AKOS016006028|CS-0999|DB11864|FP27156|SB36921|NCGC00378857-01|NCGC00378857-02|2-(2-Furanyl)-7-[2-[4-[4-(2-methoxyethoxy)phenyl]-1-piperazinyl]ethyl]-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine|AC-28199|DA-42600|DS-14327|HY-10889|SY031359|NS00072631|D09717|L021041|Q7240024|BRD-K46290096-001-01-1|2-furan-2-yl-7-(2-{4-[4-(2-methoxy-ethoxy)-phenyl]-piperazin-1-yl}-ethyl)-2,7-dihydro-3H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-ylamine|2-furan-2-yl-7-(2-{4-[4-(2-methoxy-ethoxy)-phenyl]-piperazin-1-yl}-ethyl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-ylamine|4-(2-furyl)-10-[2-[4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl]ethyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,7,11-pentaen-7-amine|4-(furan-2-yl)-10-[2-[4-[4-(2-methoxyethoxy)phenyl]piperazin-1-yl]ethyl]-3,5,6,8,10,11-hexazatricyclo[7.3.0.0^{2,6]dodeca-1(9),2,4,7,11-pentaen-7-amine|7-(2-(4-(2,4-difluorophenyl)piperazin-1-yl)ethyl)-2-(furan-2-yl)-7H-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidin-5-amine"
NAMODENOSON,3035850,,"InChI=1S/C18H18ClIN6O4/c1-21-16(29)13-11(27)12(28)17(30-13)26-7-23-10-14(24-18(19)25-15(10)26)22-6-8-3-2-4-9(20)5-8/h2-5,7,11-13,17,27-28H,6H2,1H3,(H,21,29)(H,22,24,25)/t11-,12+,13-,17+/m0/s1",IPSYPUKKXMNCNQ-PFHKOEEOSA-N,C18H18ClIN6O4,544.7,"(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide","2-Cl-IB-Meca|163042-96-4|Namodenoson|Cl-IB-MECA|CF-102|CF102|C-Ibza-MU|2-Chloro-N(6)-(3-iodobenzyl)adenosine-5'-N-methyluronamide|Z07JR07J6C|DTXSID80167504|2-Chloro-N6-(3-iodobenzyl)adenosine-5'-N-methylcarboxamide|2-Chloro-N(6)-(3-iodobenzyl)-9-(5-(methylcarbamoyl)-beta-D-ribofuranosyl)adenine|beta-D-Ribofuranuronamide, 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-|2-chloro-N6-(3-iodobenzyl)adenosine-5'-N-methyluronamide|1-[2-CHLORO-6-[[(3-IODOPHENYL)METHYL]AMINO]-9H-PURIN-9-YL]-1-DEOXY-N-METHYL-BETA-D-RIBOFURANURONAMIDE|beta-D-Ribofuranuronamide, 1-(2-chloro-6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-1-deoxy-N-methyl-|CF102 compound|1-(2-Chloro-6-(((3-iodophenyl)methyl)amino)-9H-purin-9-yl)-1-deoxy-N-methyl-beta-D-Ribofuranuronamide|namodenosonum|RefChem:831715|A3AdR Agonist CF102|DTXCID4089995|Adenosine Receptor A3 Agonist CF102|634-077-2|Chloro-ib-meca|(2S,3S,4R,5R)-5-(2-Chloro-6-((3-iodobenzyl)amino)-9H-purin-9-yl)-3,4-dihydroxy-N-methyltetrahydrofuran-2-carboxamide|CI-IB-MECA|(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyloxolane-2-carboxamide|Namodenoson [USAN]|2Cl-IB-MECA|MFCD01861178|CHEMBL431733|2-Chloro-N6-(3-iodobenzyl)-adenosine-5'-N-methyluronamide|C18H18ClIN6O4|UNII-Z07JR07J6C|XS0|CF 102|Namodenoson (Standard)|NAMODENOSON [INN]|Namodenoson (CF-102)|Namodenoson (USAN/INN)|C1-IB-MECA|Namodenoson (CF-102)?|GTPL457|NAMODENOSON [WHO-DD]|MLS002153535|orb1300378|SCHEMBL1170028|SCHEMBL29376760|SCHEMBL29383836|BDBM21221|CF-102;2-Cl-IB-MECA|HMS2235L10|HMS3412I05|HMS3676I05|EX-A2882|HY-12365R|NSC856467|AKOS022181265|CS-5932|DB12885|NC30706|NSC-856467|NCGC00025001-02|(2S,3S,4R,5R)-5-[2-chloro-6-[(3-iodophenyl)methylamino]purin-9-yl]-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide|AC-27390|DA-69763|DS-16397|HY-12365|SMR001230862|Chloro-IB-MECA, solid, >=98% (HPLC)|C3601|NS00069749|S0498|D11128|P10208|BRD-K52396582-001-06-7|Q27076097|2-chloro-N6-(3-iodobenzyl)adenosine-5-N-methylcarboxamide|(2S,3S,4R,5R)-5-(2-chloro-6-{[(3-iodophenyl)methyl]amino}-9H-purin-9-yl)-3,4-dihydroxy-N-methyloxolane-2-carboxamide|(2S,3S,4R,5R)-5-(6-(3-iodobenzylamino)-2-chloro-9H-purin-9-yl)-3,4-dihydroxy-N-methyl-tetrahydrofuran-2-carboxamide|.BETA.-D-RIBOFURANURONAMIDE, 1-(2-CHLORO-6-(((3-IODOPHENYL)METHYL)AMINO)-9H-PURIN-9-YL)-1-DEOXY-N-METHYL-||A-D-Ribofuranuronamide, 1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy-N-methyl-|1-(2-CHLORO-6-(((3-IODOPHENYL)METHYL)AMINO)-9H-PURIN-9-YL)-1-DEOXY-N-METHYL-.BETA.-D-RIBOFURANURONAMIDE|1-[2-chloro-6-[[(3-iodophenyl)methyl]amino]-9H-purin-9-yl]-1-deoxy- N-methyl-(2)-D-Ribofuranuronamide"
ENPROFYLLINE,1676,,"InChI=1S/C8H10N4O2/c1-2-3-12-6-5(9-4-10-6)7(13)11-8(12)14/h4H,2-3H2,1H3,(H,9,10)(H,11,13,14)",SIQPXVQCUCHWDI-UHFFFAOYSA-N,C8H10N4O2,194.19,"3-propyl-7H-purine-2,6-dione","ENPROFYLLINE|41078-02-8|3-Propylxanthine|3-n-Propylxanthine|Enprofilina|Enprofyllinum|1H-Purine-2,6-dione, 3,7-dihydro-3-propyl-|3,7-Dihydro-3-propyl-1H-purine-2,6-dione|D-4028|DTXSID9045186|3-Propyl-3,7-dihydro-purine-2,6-dione|DT7DT5E518|CHEBI:126237|D 4028|3-propyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione|DTXCID7025186|RefChem:590853|255-201-8|Enprofilina [INN-Spanish]|Enprofyllinum [INN-Latin]|3-propyl-7H-purine-2,6-dione|Nilyph|CHEMBL279898|3-propyl-3,7-dihydro-1H-purine-2,6-dione|MFCD00043205|NCGC00015824-07|Enprofylline [USAN:INN]|EINECS 255-201-8|Enprofylline (USAN/INN)|UNII-DT7DT5E518|3,7-Dihydro-3-propyl-1H-purine-2,6-dione; 3-Propylxanthine; D 4028; 3,9-Dihydro-3-propyl-1H-purine-2,6-dione; 3-propyl-1H-purine-2,6(3H,7H)-dione|Lopac-P-5679|ENPROFYLLINE [INN]|ENPROFYLLINE [USAN]|P 5679|A1BD3|Lopac0_000910|ENPROFYLLINE [MART.]|MLS000069700|ENPROFYLLINE [WHO-DD]|SCHEMBL156402|orb1306380|3-Propylxanthine (enprofylline)|SCHEMBL18029491|HMS2234D09|HMS3262F22|HMS3369J09|BCP14343|Tox21_110232|Tox21_500910|BDBM50001493|PDSP1_001019|PDSP1_001202|PDSP2_001003|PDSP2_001186|AKOS006271777|AKOS013464325|CCG-204992|DB00824|FE38970|LP00910|SDCCGSBI-0050885.P002|NCGC00015824-01|NCGC00015824-02|NCGC00015824-03|NCGC00015824-04|NCGC00015824-05|NCGC00015824-06|NCGC00015824-08|NCGC00015824-09|NCGC00022716-03|NCGC00022716-04|NCGC00022716-05|NCGC00261595-01|HY-14117|MS-23050|SMR000058496|CAS-41078-02-8|DB-049711|CS-0003206|EU-0100910|NS00030914|D04006|EN300-132307|G56441|F600194|L000242|SR-01000000173|Q5379482|SR-01000000173-2|3-Propyl-3,7-dihydro-purine-2,6-dione(enprofylline)|BRD-K35007173-001-07-5|Z1198148417"
GS 6201,11270783,,"InChI=1S/C21H21F3N6O2/c1-3-8-30-19(31)16-18(29(4-2)20(30)32)27-17(26-16)14-10-25-28(12-14)11-13-6-5-7-15(9-13)21(22,23)24/h5-7,9-10,12H,3-4,8,11H2,1-2H3,(H,26,27)",KOYXXLLNCXWUNF-UHFFFAOYSA-N,C21H21F3N6O2,446.4,"3-ethyl-1-propyl-8-[1-[[3-(trifluoromethyl)phenyl]methyl]pyrazol-4-yl]-7H-purine-2,6-dione","CVT-6883|67CKV7X08G|3-ethyl-1-propyl-8-[1-[[3-(trifluoromethyl)phenyl]methyl]pyrazol-4-yl]-7H-purine-2,6-dione|3-Ethyl-1-propyl-8-(1-(3-trifluoromethylbenzyl)-1H-pyrazol-4-yl)-3,7-dihydropurine-2,6-dione|1H-Purine-2,6-dione, 3-ethyl-3,9-dihydro-1-propyl-8-(1-((3-(trifluoromethyl)phenyl)methyl)-1H-pyrazol-4-yl)-|3-ethyl-1-propyl-8-(1-((3-(trifluoromethyl)phenyl)methyl)pyrazol-4-yl)-7H-purine-2,6-dione|RefChem:128980|3-ethyl-1-propyl-8-(1-((3-(trifluoromethyl)phenyl)methyl)-1H-pyrazol-4-yl)-2,3,6,7-tetrahydro-1H-purine-2,6-dione|752222-83-6|GS-6201|GS 6201|CVT6883|CVT 6883|CHEMBL260933|3-ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-1H-purine-2,6(3H,7H)-dione|3-Ethyl-1-propyl-8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3,7-dihydro-1H-purine-2,6-dione|3-Ethyl-3,9-dihydro-1-propyl-8-[1-[[3-(trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-1H-purine-2,6-dione|Kinome_3621|UNII-67CKV7X08G|SCHEMBL238694|GTPL5615|orb1308258|SCHEMBL3394050|SCHEMBL29504135|SCHEMBL29504136|SCHEMBL29504137|SCHEMBL29504138|KOYXXLLNCXWUNF-UHFFFAOYSA-N|GLXC-03506|BDBM50236738|AKOS024458311|AKOS037643538|DB05936|FC34579|NCGC00345800-01|NCGC00345800-05|AS-16811|DA-73881|HY-10081|CS-0002439|NS00071875|G13720|222C836|BRD-K68453341-001-01-1|Q27076932|1215343-16-0|3-Ethyl-3,9-dihydro-1-propyl-8-[1-[[3-(trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-1H-purine-2,6-dione; 3-Ethyl-3,9-dihydro-1-propyl-8-[1-[[3-(trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-1H-purine-2,6-dione|8-(1-(3-(trifluoromethyl)benzyl)-1H-pyrazol-4-yl)-3-ethyl-1-propyl-1H-purine-2,6(3H,7H)-dione"
QUERCETIN,5280343,,"InChI=1S/C15H10O7/c16-7-4-10(19)12-11(5-7)22-15(14(21)13(12)20)6-1-2-8(17)9(18)3-6/h1-5,16-19,21H",REFJWTPEDVJJIY-UHFFFAOYSA-N,C15H10O7,302.23,"2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one","quercetin|117-39-5|Meletin|Sophoretin|Quercetine|Xanthaurine|Quercetol|Quertine|Quercitin|2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one|3,3',4',5,7-Pentahydroxyflavone|Cyanidelonon 1522|Flavin meletin|3,5,7,3',4'-Pentahydroxyflavone|Quertin|T-Gelb bzw. grun 1|C.I. Natural Yellow 10|C.I. 75670|C.I. Natural red 1|Corvitin|Cyanidenolon 1522|2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxychromen-4-one|2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-1-benzopyran-4-one|Korvitin|Lipoflavon|3',4',5,7-Tetrahydroxyflavan-3-ol|Flavone, 3,3',4',5,7-pentahydroxy-|NSC 9219|4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-|NCI-C60106|3'-hydroxykaempferol|CHEBI:16243|NSC9219|3,5,7-Trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-on|NSC-9219|9IKM0I5T1E|CI 75670|DTXSID4021218|Ci-75670|NSC-57655|LDN-0052529|Flavone, 3,4',5,5',7-pentahydroxy-|DTXCID001218|Quercetin (constituent of ginkgo)|Dikvertin|Quercetin,|Quercetin Phenolic|flavan-3,4-diols|Quercetin 1540|RefChem:6678|204-187-1|Quercetin content|Kvercetin|C.I. Natural yellow 10 & 13|MFCD00006828|CCRIS 1639|HSDB 3529|Quercetin (GMP)|2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromen-4-one|3',4',5,7-tetrahydroxyflavon-3-ol|AI3-26018|CHEMBL50|2-(3,4-Dihydroxy-phenyl)-3,5,7-trihydroxy-chromen-4-one|Kvercetin [Czech]|Natural Yellow 10|3,5,7-trihydroxy-2-(3,4-dihydroxyphenyl)-4H-chromen-4-one|CI Natural Yellow 10|QUE|BRD9794|BRD-9794|CAS-117-39-5|NSC57655|NSC58588|SR-01000076098|EINECS 204-187-1|UNII-9IKM0I5T1E|MixCom3_000183|BRN 0317313|Ritacetin|Quer|74893-81-5|4dfu|4mra|Quercetin2H2O|Meletin;Sophoretin|KUC104418N|KUC107684N|3,3',4,5,7-Pentahydroxyflavone|LIM-5662|LNS-5662|TNP00070|TNP00089|KSC-23-76|Quercetin (Standard)|Quercetin_sathishkumar|KSC-10-126|Quercetin (Sophoretin)|Spectrum_000124|Tocris-1125|3cf8|QUERCETIN [DSC]|QUERCETIN [MI]|BiomolKI_000062|QUERCETIN [HSDB]|QUERCETIN [IARC]|Maybridge1_008992|Prestwick0_000507|Prestwick1_000507|Prestwick2_000507|Prestwick3_000507|Spectrum2_000059|Spectrum3_000642|Spectrum4_000807|Spectrum5_001389|Lopac-Q-0125|QUERCETIN [VANDF]|P0042|C.I. natural yellow 13|BiomolKI2_000068|Enicostemma Littorale Blume|UPCMLD-DP081|Q 0125|QUERCETIN [USP-RS]|QUERCETIN [WHO-DD]|NCIOpen2_007628|NCIOpen2_007882|BIDD:PXR0007|Lopac0_000999|SCHEMBL19723|BSPBio_000433|BSPBio_001068|BSPBio_002243|KBioGR_000408|KBioGR_001293|KBioSS_000408|KBioSS_000584|5-18-05-00494 (Beilstein Handbook Reference)|MLS006011766|BIDD:ER0315|DivK1c_000485|SCHEMBL219729|SPECTRUM1500672|CU-01000012502-3|SPBio_000217|SPBio_002354|BDBM7460|BPBio1_000477|GTPL5346|MEGxp0_000381|orb1306219|SGCUT00001|3,4',5,7-Pentahydroxyflavone|NIOSH/LK8760000|SCHEMBL11230710|SCHEMBL29351036|SCHEMBL29353785|SCHEMBL29723041|UPCMLD-DP081:001|ACon1_000560|HMS501I07|KBio1_000485|KBio2_000408|KBio2_000584|KBio2_002976|KBio2_003152|KBio2_005544|KBio2_005720|KBio3_000775|KBio3_000776|KBio3_001463|MSK7403|3,7,3',4'-Pentahydroxyflavone|NINDS_000485|3',5,7-Tetrahydroxyflavan-3-ol|Bio1_000369|Bio1_000858|Bio1_001347|Bio2_000374|Bio2_000854|HMS1362F09|HMS1792F09|HMS1923O19|HMS1990F09|HMS3263G19|HMS3267M12|HMS3414J21|HMS3649D04|HMS3656C15|HMS3678J19|HMS5080F22|HMS6019K04|to_000078|3,5,7,3',4'-Pentahydroxyflavon|Tox21_202308|Tox21_300285|Tox21_500999|BBL005513|CCG-40054|Flavone,3',4',5,7-pentahydroxy-|HB0542|HY-18085G|HY-18085R|LMPK12110004|NSC 57655|NSC324608|NSC756660|s2391|SBB012521|STK365650|Quercetin, >=95% (HPLC), solid|3,4',5,5',7-pentahydroxy-Flavone|AKOS000511724|Quercetin 1000 microg/mL in Acetone|CS-3981|DB04216|DS-3416|FQ32160|LP00999|NSC-756660|SDCCGSBI-0050972.P003|SDCCGSBI-0050972.P010|IDI1_000485|IDI1_002129|LDN 0052529|SMP1_000252|NCGC00015870-01|NCGC00015870-02|NCGC00015870-03|NCGC00015870-04|NCGC00015870-05|NCGC00015870-06|NCGC00015870-07|NCGC00015870-08|NCGC00015870-09|NCGC00015870-10|NCGC00015870-11|NCGC00015870-12|NCGC00015870-13|NCGC00015870-14|NCGC00015870-15|NCGC00015870-16|NCGC00015870-17|NCGC00015870-18|NCGC00015870-19|NCGC00015870-21|NCGC00015870-22|NCGC00015870-23|NCGC00015870-24|NCGC00015870-25|NCGC00015870-28|NCGC00015870-36|NCGC00015870-48|NCGC00015870-50|NCGC00025016-01|NCGC00025016-02|NCGC00025016-03|NCGC00025016-04|NCGC00025016-05|NCGC00025016-06|NCGC00025016-07|NCGC00025016-08|NCGC00168962-01|NCGC00168962-02|NCGC00168962-03|NCGC00168962-04|NCGC00254218-01|NCGC00259857-01|NCGC00261684-01|Quercetin 100 microg/mL in Acetonitrile|AC-19596|AC-29756|HY-18085|NCI60_042036|SMR000112559|ST024706|ST057237|SY057722|(+)-3,3',4',5,7-Pentahydroxyflavone|Quercetin, Sophoretin, Meletin, Quercetine|CS-0638666|EU-0100999|LK87600000|NS00001142|Q0025|SW148203-4|Quercetin; 3,3',4',5,7-Pentahydroxyflavone|17Q395|C00389|EN300-199773|K00029|S00057|QUERCETIN (CONSTITUENT OF GINKGO) [DSC]|WLN: T66 BO EVJ CR CQ DQ & DQ GQ IQ|AH-357/03514064|F047268|Flavone, 3,3',4',5,7-pentahydroxy-, (+)-|Q409478|SR-01000076098-1|SR-01000076098-3|SR-01000076098-7|SR-01000076098-8|BRD-K97399794-001-02-1|BRD-K97399794-001-07-0|BRD-K97399794-001-09-6|BRD-K97399794-001-11-2|BRD-K97399794-001-14-6|BRD-K97399794-001-15-3|BRD-K97399794-001-16-1|BRD-K97399794-335-03-1|BRD-K97399794-335-05-6|BRD-K97399794-335-06-4|SR-01000076098-11|Z57176222|2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-chromone;hydrate|49643640-FD4C-4B93-BD28-0D7C2021CC52|2-(3,4-Dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one #|(+)-4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-|2-(3,4-DIHYDROXYPHENYL)-3,5,7-TRIHYDROXY-4H-BENZOPYRAN-4-ONE|4H-1-Benzopyran-4-one,2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-,zirconium(2+)salt(1:1)"
LUTEOLIN,5280445,,"InChI=1S/C15H10O6/c16-8-4-11(19)15-12(20)6-13(21-14(15)5-8)7-1-2-9(17)10(18)3-7/h1-6,16-19H",IQPNAANSBPBGFQ-UHFFFAOYSA-N,C15H10O6,286.24,"2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one","luteolin|491-70-3|3',4',5,7-Tetrahydroxyflavone|Digitoflavone|Luteolol|2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one|Flacitran|Luteoline|Salifazide|Weld Lake|Yama kariyasu|5,7,3',4'-Tetrahydroxyflavone|2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one|Cyanidenon-1470|4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-|2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-benzopyrone|KUX1ZNC9J2|DTXSID4074988|CHEBI:15864|3',4',5,7-Tetrahydroxy-Flavone|RefChem:6458|DTXCID6040668|207-741-0|Cyanidenon 1470|Bismite|MFCD00017309|Luteolin (Standard)|CHEMBL151|2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-chromen-4-one|FLAVONE, 3',4',5,7-TETRAHYDROXY-|2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-chromenone|1318-21-4|C.I. Natural Yellow 2|SMR000326896|7-Tetrahydroxyflavone|CCRIS 3790|SR-01000779333|EINECS 207-741-0|UNII-KUX1ZNC9J2|BRN 0292084|Luteoin|Lutl|Luteolin?|C.I. 75590|4dew|4dgn|4hkn|LU2|Prestwick_122|DIOSMETIN_met006|2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4H-1-benzopyran-4-one|LUTEOLIN [MI]|Prestwick0_000870|Prestwick1_000870|Prestwick2_000870|Prestwick3_000870|LUTEOLIN [WHO-DD]|BIDD:PXR0059|Lopac0_000660|Oprea1_849964|SCHEMBL20426|BSPBio_000919|Luteolin, analytical standard|MLS000697655|MLS000860038|MLS002154043|MLS006011917|BIDD:ER0122|SPBio_002840|BDBM7459|BPBio1_001011|GTPL5215|MEGxp0_000143|orb1310014|SCHEMBL29352380|SCHEMBL29376494|SCHEMBL30045580|ACon1_000223|cid_5280445|HY-N0162R|GLXC-06558|HMS1570N21|HMS2097N21|HMS2220C06|HMS3356L02|HMS3561N09|HMS3649N21|HMS3656A05|HMS3714N21|HMS5080H10|Luteolin, >=99.0% (TLC)|BCP03511|HY-N0162|MSK40243|TNP00073|Luteolin, >=98% (TLC), powder|BBL027837|LMPK12110006|s2320|SBB066117|STK801923|AKOS002140588|AC-1125|BCP9000865|CCG-208309|CS-4611|DB15584|FL24959|KS-5202|Luteolin 100 microg/mL in Acetonitrile|SMP2_000042|NCGC00016467-01|NCGC00016467-02|NCGC00016467-03|NCGC00016467-04|NCGC00016467-05|NCGC00016467-06|NCGC00016467-07|NCGC00016467-08|NCGC00016467-12|NCGC00016467-21|NCGC00142375-01|NCGC00142375-02|NCGC00142375-03|NCGC00179375-01|NCGC00179375-02|CAS-491-70-3|ST024703|SY030155|BCP0726000198|CS-0694839|NS00015143|SW196433-3|T2682|91L703|C01514|L 9283|S00110|EN300-1659559|AM-721/20737006|F079506|Luteolin, primary pharmaceutical reference standard|Q415011|SR-01000779333-4|SR-01000779333-5|SR-01000779333-7|BRD-K05236810-001-05-9|BRD-K05236810-001-19-0|23A002A4-B47B-46CD-848C-65042EACF3FF|Z1741977179|2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-benzopyrone-4-one|2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one #|4H-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-|Luteolin (Digitoflavone; Daphneflavonol; Flavopurpol; Luteolol)|3',4',5,7-Tetrahydroxyflavone;Digitoflavone;Flacitran;2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4H-chromen-4-one"
FISETIN,5281614,,"InChI=1S/C15H10O6/c16-8-2-3-9-12(6-8)21-15(14(20)13(9)19)7-1-4-10(17)11(18)5-7/h1-6,16-18,20H",XHEFDIBZLJXQHF-UHFFFAOYSA-N,C15H10O6,286.24,"2-(3,4-dihydroxyphenyl)-3,7-dihydroxychromen-4-one","Fisetin|528-48-3|2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one|5-Desoxyquercetin|3,3',4',7-Tetrahydroxyflavone|Fustel|Viset|Fisetholz|Superfustel|Cotinin|Fietin|Fustet|3,7,3',4'-Tetrahydroxyflavone|Junger fustik|C.I. Natural Brown 1|C.I. 75620|2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-1-benzopyran-4-one|Fisidenolon 1521|7,3',4'-Trihydroxyflavonol|2-(3,4-dihydroxyphenyl)-3,7-dihydroxychromen-4-one|NSC-407010|NSC-656275|OO2ABO9578|CHEBI:42567|DTXSID4022317|5-Desoxy-quercetin|RefChem:599234|7,3',4'-Flavon-3-ol|DTXCID902317|3,3',4',7-Tetrahydroxy-flavone|2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-1-benzopyrylium|208-434-4|Ventin sumach|Young fustic|Zante fustic|Superfustel K|Ungarisches gelbholz|Young fustic crystals|Bois bleu de Honqrie|4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-|MFCD00006829|Fisetin (Standard)|NSC 407010|NSC 656275|NSC407010|2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chromen-4-one|CHEMBL31574|FLAVONE, 3,3',4',7-TETRAHYDROXY-|TNP00284|Fisetin hydrate|NSC656275|BOIS bleude honqrie|5-Deoxyquercetin|FSE|CCRIS 9034|SR-05000002249|EINECS 208-434-4|BRN 0292829|UNII-OO2ABO9578|Fisetine|Natural Brown 1|Fisetin (Fustel)|Fisetin, 15|Spectrum_001196|1xo2|SpecPlus_000460|FISETIN [MI]|Spectrum2_001160|Spectrum3_001536|Spectrum4_001070|Spectrum5_001797|FISETIN [WHO-DD]|NCIMech_000006|SCHEMBL39454|3,3'4'7-tetOH-Flavone|3,4',7-Tetrahydroxyflavone|BSPBio_002952|KBioGR_001400|KBioSS_001676|5-18-05-00291 (Beilstein Handbook Reference)|MLS006011782|BIDD:ER0141|DivK1c_006556|SPECTRUM1502247|SPBio_001119|BDBM7457|GTPL5182|orb1304898|SCHEMBL29349742|SCHEMBL29381611|SCHEMBL29394036|HY-N0182R|KBio1_001500|KBio2_001676|KBio2_004244|KBio2_006812|KBio3_002452|Flavone,3',4',7-tetrahydroxy-|HMS3604H03|HMS3655L22|HY-N0182|TNP00004|3,3',4',7-Tetra-hydroxy-flavone|BBL027612|CCG-35267|LMPK12111566|s2298|SBB066118|STL146392|AKOS000277885|CS-7840|DB07795|FF29463|SDCCGMLS-0066657.P001|NCGC00017344-01|NCGC00017344-02|NCGC00017344-03|NCGC00017344-04|NCGC00017344-05|NCGC00017344-06|NCGC00017344-14|NCGC00095663-01|NCGC00095663-02|NCGC00178374-01|AC-34567|AS-15520|NCI60_003865|SMR001835029|ST057233|SY050263|CS-0694983|NS00018308|SW219914-1|T0121|28F483|C10041|S00056|3,3',4',7-Tetrahydroxyflavone;5-Deoxyquercetin|F212841|Q418384|SR-05000002249-2|SR-05000002249-3|BRD-K31836715-001-05-0|BRD-K31836715-001-06-8|2-(3,4-dihydroxyphenyl)-3,7-dihydroxy-chromone;dihydrate|4H-1-Benzopyran-4-one,4-dihydroxyphenyl)-3,7-dihydroxy-|2-(3,4-Dihydroxyphenyl)-3,7-dihydroxy-4H-chromen-4-one #|3,7-Dihydroxy-2-(3,4-dihydroxyphenyl)-4H-1-benzopyran-4-one|Fisetin; 2-(3,4-DIHYDROXYPHENYL)-3,7-DIHYDROXY-4H-CHROMEN-4-ONE|Fisetin;  5-Deoxyquercetin;  3,3?,4?,7-Tetra??hydroxy??flavone; Natural Brown 1|InChI=1/C15H10O6/c16-8-2-3-9-12(6-8)21-15(14(20)13(9)19)7-1-4-10(17)11(18)5-7/h1-6,16-18,20"
EPIGALOCATECHIN GALLATE,65064,,"InChI=1S/C22H18O11/c23-10-5-12(24)11-7-18(33-22(31)9-3-15(27)20(30)16(28)4-9)21(32-17(11)6-10)8-1-13(25)19(29)14(26)2-8/h1-6,18,21,23-30H,7H2/t18-,21-/m1/s1",WMBWREPUVVBILR-WIYYLYMNSA-N,C22H18O11,458.4,"[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate","(-)-Epigallocatechin gallate|989-51-5|EGCG|Epigallocatechin gallate|Tea catechin|Epigallocatechin-3-gallate|(-)-Epigallocatechin-3-o-gallate|Teavigo|(-)-Epigallocatechol gallate|L-Epigallocatechin gallate|PF-EGCg 90|NVP-XAA 723|DTXSID1029889|BQM438CTEL|epigallocatechin-3-O-gallate|CHEBI:4806|Epigallocatechingallate|Epigallocatechin-gallate|DTXCID80567|3-O-Galloyl-(-)-epigallocatechin|EPIGALLOCATECHIN 3-O-GALLATE|(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3-yl 3,4,5-trihydroxybenzoate|EGCG cpd|epigallo-catechin gallate|RefChem:5796|GlyTouCan:G31622WS|(-)-Epigallocatechin-3-gallate|((2S,3S)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl) 3,4,5-trihydroxybenzoate|G31622WS|((2R,3R)-2-(3,4,5-trihydroxyphenyl)-5,7-dihydroxy-chroman-3-yl) 3,4,5-trihydroxybenzoate|(2R-cis)-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl 3,4,5-Trihydroxybenzoate|Epigallocatechin 3-gallate|Epigallocatechin-3-monogallate|(-)-epigallocatechin 3-gallate|MFCD00075940|(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxybenzoate|Catechin deriv.|[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybenzoate|(-)-epigallocatechin 3-O-gallate|(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl 3,4,5-trihydroxybenzoate|[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 3,4,5-trihydroxybenzoate|CHEMBL297453|C22H18O11|Benzoic acid, 3,4,5-trihydroxy-,(2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester|(-)-Epigallocatechin Gallate (Standard)|M01719|Benzoic acid, 3,4,5-trihydroxy-, (2R,3R)-3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester|(-)-cis-3,3',4',5,5',7-Hexahydroxy-flavane-3-gallate|(-)-cis-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-gallate|CAS-989-51-5|SMR000449288|CCRIS 3729|SR-01000759328|UNII-BQM438CTEL|Epigallocate|Sunphenon|EPIGALOCATECHIN GALLATE|(-)-EGCG|Epigallocic acid|2kdh|3oob|4awm|KDH|Epigallocatechol, 3-gallate, (-)-|Epigallocatcchin Gallate|Spectrum_000316|SpecPlus_000277|Spectrum2_000168|Spectrum3_000244|Spectrum4_001541|Spectrum5_000102|Galloyl-L-epigallocatechol|EGCG [WHO-DD]|EGCG [MI]|(-)-Epigallocatechin gallat|(-)-Epigallocatehin gallate|SCHEMBL35258|BSPBio_001628|epigallocatechin-gallate-(-)|KBioGR_002002|KBioSS_000796|SPECTRUM210239|cid_65064|MLS000758300|MLS001424000|DivK1c_006373|SPBio_000035|Epigallocatechin monogallate, B|GTPL7002|MEGxp0_001166|orb1304766|SCHEMBL30014282|ACon1_001054|KBio1_001317|KBio2_000796|KBio2_003364|KBio2_005932|KBio3_001128|GLXC-04918|HMS2051K21|HMS3649E08|MSK40118|Tox21_201468|Tox21_303457|BDBM50070942|CCG-38378|FR-109|HY-13653R|LMPK12030005|s2250|AKOS015918182|CS-1258|DB12116|DS-9030|FE09970|NC00078|SDCCGMLS-0066550.P001|(-)-Epigallocatechin gallate, >=95%|(-)-Epigallocatechin-3-gallate; EGCG|NCGC00164319-01|NCGC00164319-02|NCGC00164319-03|NCGC00164319-04|NCGC00164319-06|NCGC00164319-07|NCGC00164319-10|NCGC00257243-01|NCGC00259019-01|(-)-Epigallocatechin gallate (85% (-)-epigallocatechin gallate, 10% (-)-epigallocatechin, 5% (-)- epicatechin gallate)|AC-34075|BP-30205|HY-13653|ST097428|SY029068|CS-0694875|E0694|NS00015163|SW197458-3|C09731|(-)-Epigallocatechin gallate, >=97.0% (HPLC)|(-)-Epigallocatechin gallate, analytical standard|989E515|Gallic acid, 3-ester with epigallocatechol, (-)-|Q393339|SR-01000946601|(-)-EPIGALLOCATECHIN-3-O-GALLATE [USP-RS]|SR-01000759328-5|SR-01000759328-6|SR-01000946601-1|BRD-K55591206-001-18-1|BRD-K55591206-001-19-9|BRD-K55591206-001-20-7|Epigallocatechin-3-gallate 1000 microg/mL in Acetonitrile|(-)-Epigallocatechin gallate, >=80% (HPLC), from green tea|Epigallocatechin gallate, primary pharmaceutical reference standard|(-)-Epigallocatechin-3-O-gallate, United States Pharmacopeia (USP) Reference Standard|(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl 3,4,5-trihydroxyb enzoate|(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl3,4,5-trihydroxybenzoate|[5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)chroman-3-yl] 2,3,4-trihydroxybenzoate|Epigallocatechin gallate, Pharmaceutical Secondary Standard; Certified Reference Material|(-)-cis-3,4-Dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-1(2H)-benzopyran-3-yl Gallate|(-)-EPIGALLOCATECHIN GALLATE (85% (-)-EPIGALLOCATECHIN GALLATE, 10% (-)-EPIGALLOCATECHIN, 5% (-)-EPICATECHIN GALLATE)|(2R,3R)-5,7-Dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl-3,4,5-trihydroxybenzoate|[(2R,3R)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl]3,4,5-trihydroxybenzoate|2041570-28-7|3,4-Dihydro-5,7-dihydroxy-2R-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3R-yl-3,4,5-trihydroxybenzoate|Benzoic acid, 3,4,5-trihydroxy-, 3,4-dihydro-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-2H-1-benzopyran-3-yl ester, (2R-cis)-"
SORBINIL,337359,,"InChI=1S/C11H9FN2O3/c12-6-1-2-8-7(5-6)11(3-4-17-8)9(15)13-10(16)14-11/h1-2,5H,3-4H2,(H2,13,14,15,16)/t11-/m0/s1",LXANPKRCLVQAOG-NSHDSACASA-N,C11H9FN2O3,236.20,"(4S)-6-fluorospiro[2,3-dihydrochromene-4,5'-imidazolidine]-2',4'-dione","Sorbinil|68367-52-2|Sorbinilo|Sorbinilum|CP-45634|NSC-355082|(S)-6-Fluorospiro(chroman-4,4'-imidazolidine)-2',5'-dione|DTXSID0023587|CP-45,634|CHEBI:102029|G4186B906P|(4S)-6-fluoro-2,3-dihydro-2'H,5'H-spiro[chromene-4,4'-imidazolidine]-2',5'-dione|CP 45,634|DTXCID503587|NSC355082|Spiro(4H-1-benzopyran-4,4'-imidazolidine)-2',5'-dione, 6-fluoro-2,3-dihydro-, (S)-|(4S)-6-fluorospiro(chroman-4,5'-imidazolidine)-2',4'-dione|(4S)-6-fluorospiro[chroman-4,5'-imidazolidine]-2',4'-dione|(4S)-6-fluoro-2,3-dihydro-2'H,5'H-spiro(chromene-4,4'-imidazolidine)-2',5'-dione|D-6-fluoro-spiro(chroman-4,4'-imidazolidine)-2',5'-dione|RefChem:888265|684-722-7|CP 45634|MFCD00867380|(4S)-6-fluorospiro[2,3-dihydrochromene-4,5'-imidazolidine]-2',4'-dione|CHEMBL266497|NCGC00159452-02|112420-09-4|SBI|Sorbinilum [Latin]|Sorbinilo [Spanish]|(S)-6-fluorospiro[chromane-4,4'-imidazolidine]-2',5'-dione|(+)-(4S)-6-Fluorospiro[chroman-4,4'-imidazolidine]-2',5'-dione|.beta.-L-Gulopyranose, 1,6-anhydro-2,3-O-(phenylmethylene)-, (S)-|CAS-68367-52-2|Sorbinil (USAN/INN)|MLS003171137|Sorbinil [USAN:INN:BAN]|UNII-G4186B906P|NSC 355082|starbld0009657|SORBINIL [USAN]|SORBINIL [INN]|SORBINIL [MI]|SORBINIL [MART.]|SORBINIL [WHO-DD]|SCHEMBL48877|GTPL7415|orb1307734|cp45634|Sorbinil, >=98% (HPLC)|SCHEMBL29599732|BDBM16312|HMS3260F11|Tox21_111679|Tox21_500185|AKOS000280386|Tox21_111679_1|CCG-221489|DB02712|NCGC00159452-03|NCGC00159452-05|NCGC00260870-01|DA-58007|HY-50289|MS-23366|CS-0002274|NS00068081|D05893|G12752|Q1259458|(4S)-6-fluorospiro[chromane-4,5'-imidazolidine]-2',4'-dione|(S)(+)-6-fluoro-spiro-[chroman-4,4'-imidazolidine]-2',5'-dione|(4S)-6-Fluoro-2,3-dihydro-spiro[4H-1-benzopyran-4,4'-imidazolidine]-2',5'-dione|(4S)-6-fluoro-2,3-dihydrospiro[1-benzopyran-4,4''-imidazolidine]-2'',5''-dione"
TOLRESTAT,53359,,"InChI=1S/C16H14F3NO3S/c1-20(8-13(21)22)15(24)11-5-3-4-10-9(11)6-7-12(23-2)14(10)16(17,18)19/h3-7H,8H2,1-2H3,(H,21,22)",LUBHDINQXIHVLS-UHFFFAOYSA-N,C16H14F3NO3S,357.3,2-[[6-methoxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]-methylamino]acetic acid,"TOLRESTAT|82964-04-3|Alredase|AY-27773|Tolrestatum|AY-27,773|0T93LG5NMK|CHEBI:48549|2-[[6-methoxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]-methylamino]acetic acid|N-(6-Methoxythio-5-(trifluoromethyl)-1-naphthoyl)sarcosine|DTXSID80904890|N-{[6-methoxy-5-(trifluoromethyl)naphthalen-1-yl]carbonothioyl}-N-methylglycine|Glycine, N-((6-methoxy-5-(trifluoromethyl)-1-naphthalenyl)thioxomethyl)-N-methyl-|N-((5-(trifluoromethyl)-6-methoxy-1-naphthalenyl)thioxomethyl)-N-methylglycine|N-[6-Methoxythio-5-(trifluoromethyl)-1-naphthoyl]sarcosine|Alderase|2-((6-methoxy-5-(trifluoromethyl)naphthalene-1-carbothioyl)-methylamino)acetic acid|Glycine, N-[[6-methoxy-5-(trifluoromethyl)-1-naphthalenyl]thioxomethyl]-N-methyl-|N-((6-methoxy-5-(trifluoromethyl)naphthalen-1-yl)carbonothioyl)-N-methylglycine|N-[[5-(Trifluoromethyl)-6-methoxy-1-naphthalenyl]thioxomethyl]-N-methylglycine|N-5-trifluoromethyl-6-methoxy-1-thionaphthoyl-N-methylglycine|RefChem:898551|DTXCID3028760|A10XA01|Lorestat|Tolrestatin|AY 27773|CHEMBL436|N-(6-methoxy-5-(trifluoromethyl)naphthalene-1-carbonothioyl)-N-methylglycine|Tolrestatum [Latin]|N-{[6-methoxy-5-(trifluoromethyl)-1-naphthyl]carbonothioyl}-N-methylglycine|2-{1-[6-methoxy-5-(trifluoromethyl)naphthalen-1-yl]-N-methylmethanethioamido}acetic acid|N-((6-methoxy-5-(trifluoromethyl)-1-naphthalenyl)thioxomethyl)-N-methylglycine|N-[[6-Methoxy-5-(trifluoromethyl)-1-naphthalenyl]thioxomethyl]-N-methylglycine|TOL|2-(6-Methoxy-N-methyl-5-(trifluoromethyl)naphthalene-1-carbothioamido)acetic acid|UNII-0T93LG5NMK|Alrestin|Tolrestat [USAN:INN:BAN]|Tolrestat?|Alredase (TN)|Tolrestat (Standard)|TOLRESTAT [INN]|TOLRESTAT [MI]|Tolrestat (USAN/INN)|TOLRESTAT [USAN]|TOLRESTAT [MART.]|TOLRESTAT [WHO-DD]|SCHEMBL49326|GTPL7404|orb1307661|SCHEMBL29375449|BDBM16314|BCPP000039|GLXC-03766|ADA82008|BCP02377|EX-A11150|HY-16500R|AKOS005146007|CS-2040|DB02383|FT63881|VS-0127|2-[[6-methoxy-5-(trifluoromethyl)naphthalene-1-carbothioyl]-methyl-amino]acetic acid|HY-16500|C01621|D02323|964T043|Q7814620|BRD-K85693895-001-01-1|BRD-K85693895-001-02-9|[([6-Methoxy-5-(trifluoromethyl)-1-naphthyl]carbothioyl)(methyl)amino]acetic acid #|[(6-Methoxy-5-trifluoromethyl-naphthalene-1-carbothioyl)-methyl-amino]-acetic acid|2-{[6-methoxy-5-(trifluoromethyl)naphthalen-1-yl]-N-methylmethanethioamido}acetic acid"
ZOPOLRESTAT,1613,,"InChI=1S/C19H12F3N3O3S/c20-19(21,22)10-5-6-15-14(7-10)23-16(29-15)9-25-18(28)12-4-2-1-3-11(12)13(24-25)8-17(26)27/h1-7H,8-9H2,(H,26,27)",BCSVCWVQNOXFGL-UHFFFAOYSA-N,C19H12F3N3O3S,419.4,"2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid","ZOPOLRESTAT|110703-94-1|Alond|CP-73850|CP 73850|Zopolrestatum|2-[4-oxo-3-[[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl]phthalazin-1-yl]acetic acid|1PV3S9WP3D|3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-1-phthalazineacetic acid|CP-73,850|DTXSID80149365|3,4-Dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-1-phthalazineacetic acid|2-(4-oxo-3-((5-(trifluoromethyl)-1,3-benzothiazol-2-yl)methyl)phthalazin-1-yl)acetic acid|RefChem:905383|3,4-dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-1-phthalazine-acetic acid|DTXCID3071856|682-922-9|Xedia|Zopolrestatum [INN-Latin]|1-Phthalazineaceticacid, 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-|MFCD00865476|CHEMBL10372|2-(4-oxo-3-((5-(trifluoromethyl)benzo[d]thiazol-2-yl)methyl)-3,4-dihydrophthalazin-1-yl)acetic acid|3,4-dihydro-4-oxo-3-((5-trifluoromethyl-2-benzothiazolyl)methyl)-1-phthalazine acetic acid|1-Phthalazineacetic acid, 3,4-dihydro-4-oxo-3-((5-(trifluoromethyl)-2-benzothiazolyl)methyl)-|(4-oxo-3-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-3,4-dihydrophthalazin-1-yl)acetic acid|C19H12F3N3O3S|1-Phthalazineacetic acid, 3,4-dihydro-4-oxo-3-[[5-(trifluoromethyl)-2-benzothiazolyl]methyl]-|ZST|UNII-1PV3S9WP3D|Zopolrestat [USAN:INN:BAN]|4kyh|Alond (TN)|ZOPOLRESTAT [MI]|ZOPOLRESTAT [INN]|Zopolrestat (USAN/INN)|ZOPOLRESTAT [USAN]|SCHEMBL49012|ZOPOLRESTAT [WHO-DD]|MLS006010619|GTPL7419|orb1304115|SCHEMBL29353641|BDBM16452|Zopolrestat, >=98% (HPLC)|AKOS040754579|DB08772|DA-72363|HY-19687|MS-27339|SMR002529706|CS-0016207|NS00068308|C01865|D02328|G12704|BRD-K47710001-001-01-1|Q27089300|[4-oxo-(5-trifluoromethyl-benzothiazol-2-ylmethyl)-3,4-dihydro-phthalazin-1-yl]-acetic acid|3-(5-trifluoromethylbenzothiazol-2-ylmethyl)-4-oxo-phthalazin-1-ylacetic acid|2-(4-oxo-3-{[5-(trifluoromethyl)-1,3-benzothiazol-2-yl]methyl}-3,4-dihydrophthalazin-1-yl)acetic acid"
MINALRESTAT,190816,,"InChI=1S/C19H11BrF2N2O4/c20-10-2-1-9(14(22)5-10)8-24-16(26)12-4-3-11(21)6-13(12)19(18(24)28)7-15(25)23-17(19)27/h1-6H,7-8H2,(H,23,25,27)",BMHZAHGTGIZZCT-UHFFFAOYSA-N,C19H11BrF2N2O4,449.2,"2-[(4-bromo-2-fluorophenyl)methyl]-6-fluorospiro[isoquinoline-4,3'-pyrrolidine]-1,2',3,5'-tetrone","Minalrestat|129688-50-2|WAY-ARI-509|G44PE6QB31|DTXSID201021572|Spiro(isoquinoline-4(1H),3'-pyrrolidine)-1,2',3,5'(2H)-tetrone, 2-((4-Bromo-2-fluorophenyl)methyl)-6-fluoro-|minalrestatum|RefChem:925913|DTXCID50817701|way-ari 509|155683-53-7|2-[(4-bromo-2-fluorophenyl)methyl]-6-fluorospiro[isoquinoline-4,3'-pyrrolidine]-1,2',3,5'-tetrone|2-(4-Bromo-2-fluorobenzyl)-6-fluoro-1H-spiro[isoquinoline-4,3'-pyrrolidine]-1,2',3,5'(2H)-tetraone|2-(4-Bromo-2-fluorobenzyl)-6-fluorospiro(isoquinoline-4(1H),3'-pyrrolidine)-1,2',3,5'(2H)-tetrone|Minalrestat [USAN:INN]|2-((4-Bromo-2-fluorophenyl)methyl)-6-fluorospiro(isoquinoline-4(1H),3'-pyrrolidine)-1,2',3,5'(2H)-tetrone|2-((4-bromo-2-fluorophenyl)methyl)-6-fluorospiro(isoquinoline-4(1H),3/'-pyrrolidine)-1,2/',3,5/'(2H)|UNII-G44PE6QB31|Bffipt|Minalrestat (2)|MINALRESTAT [INN]|Minalrestat (USAN/INN)|MINALRESTAT [USAN]|SCHEMBL49649|MINALRESTAT [WHO-DD]|CHEMBL273910|orb1696099|SCHEMBL29212046|SCHEMBL30602643|ARI-509|CHEBI:177696|BDBM228819|AKOS022180622|SB19712|WAY-121509|DA-75548|Spiro(isoquinoline-4(1H),3'-pyrrolidine)-1,2',3,5'(2H)-tetrone, 2-((4-bromo-2-fluorophenyl)-methyl)-6-fluoro-;|HY-106877|CS-0026817|D03805|Q27278718|2-[(4-bromo-2-luorophenyl)methyl]-6-luorospiro[isoquinoline-4,3'-pyrrolidine]-1,2',3,5'-tetrone"
FIDARESTAT,160024,,"InChI=1S/C12H10FN3O4/c13-5-1-2-7-6(3-5)12(4-8(20-7)9(14)17)10(18)15-11(19)16-12/h1-3,8H,4H2,(H2,14,17)(H2,15,16,18,19)/t8-,12-/m0/s1",WAAPEIZFCHNLKK-UFBFGSQYSA-N,C12H10FN3O4,279.22,"(2S,4S)-6-fluoro-2',5'-dioxospiro[2,3-dihydrochromene-4,4'-imidazolidine]-2-carboxamide","Fidarestat|136087-85-9|Aldos|SNK-860|DTXSID4046654|8SH8T1164U|DTXCID2026654|(2S,4S)-6-fluoro-2',5'-dioxospiro(chroman-4,4'-imidazolidine)-2-carboxamide|Spiro(4H-1-benzopyran-4,4'-imidazolidine)-2-carboxamide, 6-fluoro-2,3-dihydro-2',5'-dioxo-, (2S-cis)-|(2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide|fidarestatum|RefChem:599193|Snk 860|Fidarestat [INN]|CHEMBL84446|(2S,4S)-2-AMINOFORMYL-6-FLUORO-SPIRO[CHROMAN-4,4'-IMIDAZOLIDINE]-2',5'-DIONE|Spiro[4H-1-benzopyran-4,4'-imidazolidine]-2-carboxamide,6-fluoro-2,3-dihydro-2',5'-dioxo-, (2S,4S)-|(+)-(2S,4S)-6-Fluoro-2',5'-dioxospiro(chroman-4,4'-imidazolidine)-2-carboxamide|(2S,4S)-6-fluoro-2',5'-dioxospiro[2,3-dihydrochromene-4,4'-imidazolidine]-2-carboxamide|FID|(2S,4S)-6-fluoro-2',5'-dioxospiro[chromane-4,4'-imidazolidine]-2-carboxamide|SK 860|Aldos (TN)|Fidarestat (JAN/INN)|UNII-8SH8T1164U|SNK860|NCGC00167477-01|(S,S)-fidarestat|(2S,4S)-6-Fluoro-2',5'-dioxospiro(3,4-dihydro-2H-1-benzopyran-4,4'-imidazolidine)-2-carboxamide|FIDARESTAT [MI]|FIDARESTAT [JAN]|SCHEMBL48827|orb1707312|SCHEMBL29546775|BDBM16512|BCP07501|EX-A9393|Tox21_112481|MFCD00919183|AKOS016011245|DB02021|(2S,4S)-6-fluoro-2',5'-dioxo-2,3-dihydrospiro[chromene-4,4'-imidazolidine]-2-carboxamide|(2S,4S)-6-fluoro-2,5-dioxo-2,3-dihydrospiro[chromene-4,4-imidazolidine]-2-carboxamide|AS-84120|BS160360|DA-73363|Spiro(4H-1-benzopyran-4,4'-imidazolidine)-2-carboxamide, 2,3-dihydro-2',5'-dioxo-6-fluoro-, (2S-cis)-|HY-105185|CAS-136087-85-9|CS-0025231|NS00069198|D01842|D86149|087F859|Q15633938|((2S,4S)-6-fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide|(2S,4S)-6-fluoro-2',5'-dioxo-spiro[chromane-4,4'-imidazolidine]-2-carboxamide|(2S,4S)-6-Fluoro-2',5'-dioxospiro[chroman-4,4'-imidazolidine]-2-carboxamide;Fidarestat|(2S,4S)-6-fluoro-2'',5''-dioxo-2,3-dihydrospiro[1-benzopyran-4,4''-imidazolidine]-2-carboxamide"
GENISTEIN,5280961,,"InChI=1S/C15H10O5/c16-9-3-1-8(2-4-9)11-7-20-13-6-10(17)5-12(18)14(13)15(11)19/h1-7,16-18H",TZBJGXHYKVUXJN-UHFFFAOYSA-N,C15H10O5,270.24,"5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one","genistein|446-72-0|4',5,7-Trihydroxyisoflavone|Prunetol|Genisterin|Genisteol|Sophoricol|5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one|5,7,4'-Trihydroxyisoflavone|Bonistein|5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one|4H-1-Benzopyran-4-one, 5,7-dihydroxy-3-(4-hydroxyphenyl)-|Genestein|5,7-Dihydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|4',5, 7-Trihydroxyisoflavone|DTXSID5022308|NSC36586|NSC-36586|DH2M523P0H|NPI-031L|CHEBI:28088|BIO-300|SIPI-807-1|FW-635I-2|DTXCID002308|5,7-dihydroxy-3-(4-hydroxyphenyl)-chromen-4-one|RefChem:5853|TEMPO HOT FLASH RELIEF|alpha-ISOSPARTEINE, (-)-|SPARTEINE L-alpha-ISOSPARTEINE|207-174-9|NSC-366737|Differenol A|MFCD00016952|NPI 031L|C.I. 75610|SIPI 807-1|NSC 36586|Genistein [USAN]|5,7-Dihydroxy-3-(4-hydroxyphenyl)-4-benzopyrone|Genistein (Standard)|CHEMBL44|Bio 300|ISOFLAVONE, 4',5,7-TRIHYDROXY-|MLS000738127|GEN|Genistein (USAN)|NCGC00015479-09|690224-00-1|CAS-446-72-0|Lactoferrin-genistein|CCRIS 7675|SR-01000075498|EINECS 207-174-9|BRN 0263823|UNII-DH2M523P0H|Genisteina|Genistein?|STO514|HSDB 7475|PTI G4660|PTI-G4660|SIPI-9764-I|3kgt|3kgu|Genistein, 8|PTI-G 4660|Genistein (GEN)|TNP00151|Spectrum_000320|Tocris-1110|1x7r|2qa8|Genistein 85% HPLC|GENISTEIN [INN]|SpecPlus_000305|GENISTEIN [MI]|GENISTEIN [HSDB]|Spectrum2_000638|Spectrum3_000678|Spectrum4_001543|Spectrum5_000106|Lopac-G-6649|4',7-Trihydroxyisoflavone|GENISTEIN [MART.]|MolMap_000022|UPCMLD-DP096|G 6649|G10000|GENISTEIN [USP-RS]|GENISTEIN [WHO-DD]|Isoflavone,5,7-trihydroxy-|Lopac0_000520|Oprea1_224620|Oprea1_437815|SCHEMBL19166|BSPBio_002375|KBioGR_002006|KBioGR_002564|KBioSS_000800|KBioSS_002573|NPI031L|SPECTRUM210296|5-18-04-00594 (Beilstein Handbook Reference)|BIDD:ER0113|DivK1c_006401|Genistein, analytical standard|SPBio_000636|4',5,7-.Trihydroxyisoflavone|4',5,7-trihydroxy-Isoflavone|GTPL2826|MEGxp0_000568|orb1307572|4,5,7-Trihydroxy Iso-Flavone|SCHEMBL29352944|UPCMLD-DP096:001|ACon1_001065|BDBM19459|cid_5280961|KBio1_001345|KBio2_000800|KBio2_002564|KBio2_003368|KBio2_005132|KBio2_005936|KBio2_007700|KBio3_001595|KBio3_003042|CHEBI: 28088|cMAP_000086|Bio1_000445|Bio1_000934|Bio1_001423|GLXC-06701|HMS2271K09|HMS3261H21|HMS3267K14|HMS3412I13|HMS3428M01|HMS3649B22|HMS3654D17|HMS3676I13|HMS3742I07|HMS5079F13|ALBB-015886|BCP07581|MSK40142|Tox21_110161|Tox21_201428|Tox21_300585|Tox21_500520|AC-472|BBL010484|CCG-38551|HB2775|HY-14596R|LMPK12050218|s1342|SBB066115|STK801619|WHO 11073|AKOS001590147|Tox21_110161_1|CS-1534|DB01645|FG09961|KS-5128|LP00520|SB17235|SDCCGSBI-0050503.P003|SMP1_000133|Genistein; 4',5,7-Trihydroxyisoflavone|NCGC00015479-01|NCGC00015479-02|NCGC00015479-04|NCGC00015479-05|NCGC00015479-06|NCGC00015479-07|NCGC00015479-08|NCGC00015479-10|NCGC00015479-11|NCGC00015479-12|NCGC00015479-13|NCGC00015479-14|NCGC00015479-15|NCGC00015479-16|NCGC00015479-17|NCGC00015479-18|NCGC00015479-19|NCGC00015479-20|NCGC00015479-38|NCGC00025005-01|NCGC00025005-02|NCGC00025005-03|NCGC00025005-04|NCGC00025005-05|NCGC00025005-06|NCGC00025005-07|NCGC00169711-01|NCGC00169711-02|NCGC00254275-01|NCGC00258979-01|NCGC00261205-01|HY-14596|NCI60_003369|SMR000112580|ST056352|SY050124|CS-0694819|EU-0100520|G0272|NS00009870|SW203763-2|46G720|C06563|D11680|EN300-210743|G-2535|Genistein, synthetic, >=98% (HPLC), powder|K00046|M01798|US8552057, 2|AB00052696_09|AB00052696_12|AE-848/20772043|Q415957|GENISTEIN (CONSTITUENT OF RED CLOVER) [DSC]|Genistein, primary pharmaceutical reference standard|SR-01000075498-1|SR-01000075498-3|SR-01000075498-6|BRD-K43797669-001-02-3|BRD-K43797669-001-03-1|BRD-K43797669-001-10-6|BRD-K43797669-001-28-8|BRD-K43797669-001-29-6|BRD-K43797669-001-30-4|Genistein, from Glycine max (soybean), ~98% (HPLC)|SR-01000075498-10|F0001-2388|GENISTEIN (CONSTITUENT OF SOY ISOFLAVONES) [DSC]|4H-1-Benzopyran-4-one,7-dihydroxy-3-(4-hydroxyphenyl)-|Genistein, United States Pharmacopeia (USP) Reference Standard|Genistein, Pharmaceutical Secondary Standard; Certified Reference Material"
HYDRALAZINE,3637,,"InChI=1S/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)",RPTUSVTUFVMDQK-UHFFFAOYSA-N,C8H8N4,160.18,phthalazin-1-ylhydrazine,"hydralazine|1-Hydrazinophthalazine|86-54-4|1-Hydrazinylphthalazine|Hypophthalin|Hydralazin|phthalazin-1-ylhydrazine|Hydrazinophthalazine|Apresolin|Aprezolin|Hidralazin|Hidralazina|Idralazina|6-Hydralazine|Hydrallazine|1-Phthalazinylhydrazine|1(2H)-Phthalazinone, hydrazone|Hydralazinum|Phthalazine, 1-hydrazino-|Ciba 5968|Hydrazone 1(2H)-phthalazinone|Hidral|(2H)-Phthalazinone hydrazone|1(2H)-Phthalazinone hydrazone|CHEBI:5775|C 5968|NSC-126699|26NAK24LS8|DTXSID4023129|5-25-17-00412 (Beilstein Handbook Reference)|NSC126699|1-hydrazinylidene-1,2-dihydrophthalazine|Hydrallazin|RefChem:55329|Hydralazine mono Hydrochloride|mono-Hydrochloride, Hydralazine|DTXCID703129|C02DB02|201-680-3|59275-69-3|Apresoline|(E)-1-Hydrazono-1,2-dihydrophthalazine|Apressin (pharmaceutical)|Praparat 5968|C-5968|(1Z)-1(2H)-Phthalazinone hydrazone|Hydralazine (INN)|NSC 126699|Apresolin; Apresoline; Apressin|1044569-46-1|C-5068|phthalazinylhydrazine|Idralazina [DCIT]|phthalazine, 1-hydrazino-, hydrochloride|Idralazina [Italian]|Hidralazina [Spanish]|HYDRALAZINE [INN]|(E)-1-Hydrazineylidene-1,2-dihydrophthalazine|Hydralazine [INN:BAN]|Hydralazinum [INN-Latin]|Hidralazina [INN-Spanish]|Hidral (TN)|CCRIS 5385|NCGC00015501-02|CAS-304-20-1|EINECS 201-680-3|BRN 0132615|UNII-26NAK24LS8|phthalazone hydrazone|Hydralazine polistirex|1-hydrazonophthalazine|Spectrum_000875|HYDRALAZINE [MI]|Prestwick0_000169|Prestwick1_000169|Prestwick2_000169|Spectrum2_000969|Spectrum3_000455|Spectrum4_000005|Spectrum5_000822|Lopac-H-1753|HYDRALAZINE [IARC]|Epitope ID:137349|HYDRALAZINE [VANDF]|SCHEMBL7810|NCIOpen2_001484|Lopac0_000593|Oprea1_207681|Oprea1_416878|BSPBio_002130|HYDRALAZINE [WHO-DD]|KBioGR_000349|KBioSS_001355|WLN: T66 CNNJ BMZ|DivK1c_000117|SPBio_000977|SPBio_001958|Discontinued See: H716531|CHEMBL276832|GTPL7326|orb1308014|orb1705271|SCHEMBL2609687|SCHEMBL6617758|SCHEMBL6617760|BDBM81461|HY-B0464A|KBio1_000117|KBio2_001355|KBio2_003923|KBio2_006491|KBio3_001350|RPTUSVTUFVMDQK-UHFFFAOYSA-|1(2H)-Phthalazinone hydrazone #|NINDS_000117|ALBB-023848|NSC_3637|SBB071765|STK246900|Hydralazine; phthalazin-1-ylhydrazine|AKOS000122609|AKOS016843064|AKOS028109138|CCG-204682|DB01275|SDCCGSBI-0050575.P005|CAS_86-54-4|IDI1_000117|NCGC00015501-01|NCGC00015501-03|NCGC00015501-04|NCGC00015501-05|NCGC00015501-06|NCGC00015501-07|NCGC00015501-17|NCGC00162199-01|HLZ|LS-13412|SBI-0050575.P004|DB-328941|CS-0013620|NS00007527|ST45026967|EN300-34025|(1E)-1-hydrazinylidene-1,2-dihydrophthalazine|(Z)-1-Hydrazineylidene-1,2-dihydrophthalazine|C07040|D08044|AB00053483_03|AB01274815-01|AB01274815_02|599H497|Q419987|BRD-K82103381-003-03-7|BRD-K82103381-003-06-0|BRD-K82103381-003-07-8|BRD-K82103381-003-08-6|BRD-K82103381-003-09-4|DIHYDRALAZINE SULFATE, HYDRATED IMPURITY B [EP IMPURITY]|InChI=1/C8H8N4/c9-11-8-7-4-2-1-3-6(7)5-10-12-8/h1-5H,9H2,(H,11,12)"
TRICLOSAN,5564,,"InChI=1S/C12H7Cl3O2/c13-7-1-3-11(9(15)5-7)17-12-4-2-8(14)6-10(12)16/h1-6,16H",XEFQLINVKFYRCS-UHFFFAOYSA-N,C12H7Cl3O2,289.5,"5-chloro-2-(2,4-dichlorophenoxy)phenol","triclosan|3380-34-5|5-CHLORO-2-(2,4-DICHLOROPHENOXY)PHENOL|Cloxifenolum|2,4,4'-Trichloro-2'-hydroxydiphenyl ether|Triclosanum|Irgasan DP300|Stri-Dex Cleansing Bar|Stri-Dex Face Wash|CH 3565|Phenol, 5-chloro-2-(2,4-dichlorophenoxy)-|Lexol 300|5-Chloro-2-(2,4-dichloro-phenoxy)-phenol|CHEBI:164200|Phenyl ether, 2'-hydroxy-2,4,4'-trichloro-|NSC-759151|CH-3565|DTXSID5032498|4NM5039Y5X|DNDI1246774|DTXCID3012498|triclosano|Germasidol|Clearskin|Dermacare|Freshands|Germicida|Pacific|Panache|Prevens|Quiksan|Skinsan|Tegusept|Tricolsan|Innoxa|Derma-glove|Equaline Liquid|Jabonito Fresh|Pacific Garden|Sbs Ultragreen|Cv Medicated|Forest Fresh|Fresh Citrus|Hand Cleanse|Sbs Ultrapink|Stoko Refresh|Tork Premium|Vanilla Cream|Foamy Mango|Health Stat|Holiday Elegance|Image Essentials|Purgo Ultra|Satin Pink|Nutri Vet|Deb Gold|Le Techniq Pear|Rite Aid Liquid|Servo-stat Te|Thera Rx|Health-stat Foam|Servo-stat T|Purgo Satin Foam|Purgo Ultra Foam|Antimicrobial Foam|Antibac Foam Wash|Deluxe All-purpose|Scott Antibacterial|Topco Antibacterial|Servo-stat T Foam|Antibacterial Refill|Ben E. Keith|Hand Cleanse Refill|Liquid Hand Cleanse|Market Basket Ultra|Safeway Care Refill|Antibacterial Foaming|Astound Antibacterial|Careone Antibacterial|Wegmans Antibacterial|Anchor Foaming Mango|DERMAPROT|Ecocare 250|Fu ER Jie|Irgasan-DP300|Noxzema Triple Clean|Wegmans Orange Scent|Antibacterial Mandarin|Deluxe Dish Detergent|Dg Body Antibacterial|Dt Antibacterial Hand|Harris Teeter Foaming|Raggedy Ann and Andy|DP300, Irgasan|PRICE CHOPPER|SPARKLING MIST|Anti-bacterial Foaming|TRICLOTREX-B|Dermaprot Triclotrex-B|Germicida Antimicrobial|Handtastic Foamy Mango|Rite Aid Antibacterial|Medicated Soft N Sure|Rite Aid Foaming Hand|Rite Aid Renewal Pear|Antibacterial Body Wash|Antibacterial Sunblossom|Bodycology Coconut Lime|RefChem:6323|White Tea Antibacterial|Body Wash Clear Spring|Kiwi Crate Liquid Hand|Simply Right Body Care|Triclosan, 0.30%|Antibacterial Fresh Pear|Le Techniq Spring Fresh|Medspa Antibacterial Bar|Nutri Vet Medicated Dog|Proformance Antibacterial|Anti-bacterial Hand Wash|Antibacterial Foamy Mango|Bodycology Cherry Blossom|Bodycology Cucumber Melon|Bodycology White Gardenia|Hand Cleanse-Ocean Fresh|Protect Antibacterial Bar|Safeway Home Lemon Scent|Shop Rite Ultra So-soft|ANTIBACTERIAL HSOAP|CVS Antibacterial Foaming|Antibacterial Citrus Fresh|Antibacterial Hand Cleanse|bobbarker antibacterial bar|Cvs Pharmacy Antibacterial|Foaming Antibacterial Pear|Hand Antibacterial Premium|Natural Concept Body Wash|Publix Ultradish Detergent|Safeway Home Orange Scent|Simply Right Antibacterial|Triclotrex-B Antibacterial|CVS Phramacy Antibacterial|Studio 35 Spring Morning|EZ Foam 6793|Family Dollar Antibacterial|Harris Teeter Antibacterial|My Essentials Citrus Scent|Pro Advantage Antibacterial|Naturals Cucumber and Melon|Antibacterial Citrus Coconut|Antibacterial Cucumber Melon|Antibacterial Foaming Refill|Antibacterial Gel Hand Wash|Antibacterial Passion Flower|Antibacterial Sparkling Mist|Careone Vanilla Brown Sugar|Equate Antibacterial Foaming|Meijer Antibacterial Foaming|Rite Aid Renewal White Tea|Royal Antibacterial (mango)|Simply Right Sparkling Mist|Spasoap Liquid Antibacterial|1014 Foaming Antimicrobial|Antibacterial Hand-Aloe Vera|Clean and Refresh Body Wash|Cvs Pharmacy Mandarin Citrus|Cvs Pharmacy Pear White Tea|Dial Aloe Antibacterial Soap|Dial Gold Antibacterial Soap|Lucky Antibacterial Deodorant|Lucky Supersoft Antibacterial|Red Apple Antibacterial Hand|Topcare Antibacterial Foaming|Antibaceterial Hand Soap Rose|Antibacterial Amber Hand Soap|Antibacterial for The Kitchen|Dermacen Antimicrobial-T Hand|Image Essentials Spring Fresh|Lemon Zest Antibacterial Hand|Lucky Antibacterial Hand Soap|Antibacterial Foaming Complete|Antibacterial Foaming Original|Antibacterial Foaming Plumeria|Foaming Antibacterial Plumeria|Image Essentials Antibacterial|Skintegrity Antibacterial Hand|Freds Antibacterial Fresh Pear|Naturals Pomegranate and Mango|Pear Barlet Antibacterial Hand|Rite Aid Renewal Antibacterial|Rite Aid Renewal Clear Spring|Roccos Old School Tattoo Balm|White Tea Hand and Body Wash|Antibacterial Foaming Cranberry|Antibacterial Pamegranate Apple|KooBoos Instant Hand Sanitizer|LE TECHNIQ ANTIBACTERIAL|Anti-bacterial Bubble Gum Hand|Anti-bacterial Fresh Aloe Hand|Anti-bacterial Lemon Drop Hand|Antibacterial Foaming Green Tea|Clean and Refreshing Body Wash|Essential Everyday Orange Scent|Foaming Antiseptic Hand Cleaner|Hand Cleanse Fresh Peach Scent|Hand Cleanse Water Melon Scent|Orchid Cactus Flower and Mango|Panache Antibacterial Body Wash|Reeva Antibacterial Green Apple|Smith and Johnson Antibacterial|Antibacterial Light Moisturizers|Proformance Series Antibacterial|Aire-Master Foaming AB handsoap|Anti-Bacterial Moisturizing Hand|Antibacterial Foaming Fresh Pear|Antibacterial Foaming Pear Scent|Antibacterial Liquid Soap Refill|Cvs Pharmacy Clean Antibacterial|Cvs Phramacy Antibacterial Melon|Family Dollar Antibacterial Hand|Hand Cleanse Citrus Blast Scent|Hand Guard Foaming Antimicrobial|Stoko Refresh Food Handler Foam|Topcare Antibacterial Fresh Pear|Xtracare Foaming Facial Cleanser|ANTIBACTERIAL FOAMING PEAR|Antibacterial Foaming Pomegranate|Bacti-free Tm Antibacterial Hand|Holiday EleganceFrosted Gingerbre|Jisberry Antibacterial Handlotion|Antibaceterial Hand Soap Lavender|Antibacterial Mandarin and Pomelo|Cvs Antibacterial Foaming Kitchen|D08AE04|D09AA06|DG BODY ANTIBACTERIAL HAND|Oil Free Foaming Facial Cleanser|Powerhouse Fresh Scent Ultra Dish|Antibacterial Foaming Berry Medley|Lucky Supersoft Antibacterial Hand|Mandarin Orange Antibacterial Hand|Noxzema Bacteria Fighting Cleanser|Raggedy Ann and Andy Cotton Candy|Zep Professional Healthcare Worker|Anti-bacterial Blue Raspberry Hand|Antibacterial Foaming Hand Cleanser|Clearskin Pore Penetrating Cleanser|Dignity Health Medspa Antibacterial|Dt Antibacterial Foaming Hand Wash|Equate Spring Showers Antibacterial|Exchange Select Ultra Citrus Scent|Hand Cleanse-Strawberry Pomegranate|Health Smart Antibacterial Original|Image Essentials Antibacterial Gold|Simple Pleasures Antibacterial Hand|Skintegrity Antibacterial Hand Blue|Anti-bacterial Strawberry Kiss Hand|Aurora Antibacterial Basil Key Lime|Bebelle for Kids Antibacterial Hand|XtraCare Antibacterial Hand Cleanse|Antibacterial Body Wash Moisturizing|Antibacterial Foaming Cucumber Melon|ANTIBACTERIAL FOAMING HAND SP|Foaming Antibacterial Cucumber Melon|Wegmans Antibacterial Cucumber Melon|Antibacterial Foaming Olive and Aloe|Antibacterial Hand-Ocean Fresh Scent|Antibacterial Mandarin and Grapefruit|Antibacterial With Light Moisturizers|Dial Spring Water Antibacterial Soap|Hill Country Essentials Antibacterial|Nu Skin Antibacterial Body Cleansing|Simply Right Body Care Antibacterial|Triclotrex-B Antibacterial (neutral)|Deb Med Antibacterial Foam Hand Wash|Dermacen Foaming Antimicrobial-T Hand|Island Spring Antibacterial Body Wash|Le Techniq Foaming Antibacterial Hand|Liquid Nature Antibacterial Hand Soap|Moisturizing Anti-bacterial Hand Soap|Raggedy Ann and Andy Tropical Breeze|Spa Originals Antibacterial Gold Hand|Antibacterial Hand-Vanilla Brown Sugar|Dial Mountain Fresh Antibacterial Soap|Health Smart Antibacterial Spring Rain|Simply Right Body Care Sparkling Mist|Wegmans Ultra Dishwashing Orange Scent|Antibacterial Light Moisturizers Refill|Royal Antibacterial (coconut and Lime)|Theochem White Tea Hand and Body Wash|Wegmans Antibacterial With Moisturizers|Aurora Antibacterial Apple Summer Berry|Candy Apple Anti Bacterial Foaming Hand|Dial Country Orchard Antibacterial Soap|Healthy Accents Antibacterial Body Wash|Lucky Antibacterial Hand Soap Supersoft|Natural Concept Body Wash Spring Breeze|Scott Clear Antibacterial Skin Cleanser|Antibacterial Foaming Hand Sp Lemongrass|Aurora Antibacterial Vanilla Brown Sugar|Ben E. Keith Antibacterial Hand Cleaner|Clean and Refresh Body Wash Moisturizing|Cotton Candy Anti Bacterial Foaming Hand|Ecosave Lavender Antibacterial Hand Soap|Image Essentials Antibacterial Hand Gold|Pear Blossom Antibacterial Gel Hand Wash|Piranha Brand Foaming Antibacterial Hand|Shopko Antibacterial Deep Cleansing Hand|Aire-Master Antibacterial Liquid Handsoap|Antibaceterial Hand Soap Golden Sunflower|CARE ONE Antibacterial Foaming Hand Soap|Health Smart Antibacterial Cucumber Melon|Mango Madness Anti Bacterial Foaming Hand|Orchid By H E B White Lavender and Mint|Antibacterial Hand Soap for Sensitive Skin|Clario Foaming Antibacterial Skin Cleanser|Dalan Antibacterial Deodorant Ocean Breeze|Dalan Ocean Breeze Antibacterial Deodorant|Debmed Antimicrobial Body Wash and Shampoo|Le Techniq Morning Mist Antibacterial Hand|Naturals Antibacterial Liquid Soap Vanilla|Personal Care Antibacterial Hand-Raspberry|Royal Antibacterial Raspberry Hand Cleanse|Shopko Antibacterial Foaming Hand Cleanser|Source Antibacterial Foaming Hand Original|Aurora Antibacterial Japanese Flower Garden|Dial Mountain Fresh Antibacterial Body Wash|Health Smart Antibacterial Sweet Pea Orchid|Husky 575 Foaming Antiseptic Hand Cleaner|Kindest Kare Antimicrobial Foaming Handwash|Rite Aid Renewal Antibacterial Clear Spring|Shopko Antibacterial Foaming Hand Sanitizer|Simple Pleasures Antibacterial Foaming Hand|Vanilla Cupcake Anti Bacterial Foaming Hand|Antibacterial Foaming Hand Sp Clean and Mild|Aurora Antibacterial Coconut Tropical Island|Caribbean Escape Anti Bacterial Foaming Hand|Clean and Refreshing Body Wash Spring Fresh|Dalan Antibacterial Deodorant Golden Tropics|Dalan Golden Tropics Antibacterial Deodorant|Dial Tropical Escape Antibacterial Body Wash|Health Smart Antibacterial Lavender Chamomile|Hill Country Essentials Antibacterial Foaming|Hill Country Essentials Lavender and Jasmine|Instant Hand Sanitizing Spray with Aloe Vera|Jasmine Tea and Basil Antibacterial Hand Sp|Le Techniq Antibacterial Vanilla Brown Sugar|Personal Care Antibacterial Hand-Fresh Melon|Personal Care Antibacterial Hand-Fresh Peach|Prevail Lemongrass Scented Antibacterial Hand|Prevail White Tea Scented Antibacterial Hand|Publix Ultradish Detergent Green Apple Scent|Xtracare Antibacterial Hand Cleanse Original|Antibacterial Body Wash Spring Water 2 In 1|Antibacterial Hand Sp With Light Moisturizers|Antibacterial Mandarin and Grapefruit Handsoap|Dalan Antibacterial Deodorant Spring Freshness|Dalan Spring Freshness Antibacterial Deodorant|Dial Aloe Antibacterial Soap With Moisturizer|Dial Gold Antibacterial Soap With Moisturizer|Family Dollar Foaming Antibacterial Hand Wash|Gold Antibacterial Hand Soap With Moisturizer|Personal Care Antibacterial Foaming Hand Wash|Prevail Pomegranate Scented Antibacterial Hand|Royal Antibacterial Orange Berry Hand Cleanse|Royal Antibacterial Passion Plum Hand Cleanse|Antibacterial Foaming Hand Sp Cherry and Almond|Antibacterial Hand Soap With Light Moisturizers|Antibacterial Hand-Strawberry Pomegranate Scent|Aromafields Jasmine Scented Anti-bacterial Hand|Dial Clear and Refresh Antibacterial Hand Soap|Holiday ElegancePeppermint TwistPeppermint Twist|Naturals Cucumber and Melon Anti Bacterial Hand|Personal Care Oil Free Foaming Facial Cleanser|Royal Antibacterial Tropical Fruit Hand Cleanse|Softone Luxury Foam Antibacterial Skin Cleanser|Antibacterial Foaming Hand Sp Cucumber and Melon|Aromafields Lavender Scented Anti-bacterial Hand|Aromafields Plumeria Scented Anti-bacterial Hand|Cardinal Health Antimicrobial Soap With Triclosan|Dalan Covex Antibacterial Deodorant Soft Hygiene|Dalan Therapy Antibacterial and Odor Neutralizer|Dial Pomeganate and Tangerine Antibacterial Soap|Elf Milk and Honey Cleansing Anti-bacterial Hand|Hand Wash Nettoyant Pour Les Mains Orange Pekoe|Healing Waters Sweet Pea Antibacterial Hand Soap|Jasmine Rose Hand Wash Nettoyant Pour Les Mains|Natural Extensions Antibacterial Liquid Hand Wash|Pacific Anti-bacterial Hand Cleanse Kiwi Essence|Price Chopper Pumpkin Spice Antibacterial Foaming|Signature Care Antibacterial Foaming Moisturizing|Xtracare Antibacterial Hand Cleanse Fresh Citrus|Aromafields Tiger Lily Scented Anti-bacterial Hand|Holiday EleganceFrosted GingerbreFrosted Gingerbre|Home 360 Ultra Dish Detergent Green Apple Scent|Natural Extensions Antibacterial Foaming Hand Wash|Naturals Pomegranate and Mango Anti-Bacterial Hand|Pacific Anti-bacterial Hand Cleanse Peach Essence|Roccos Old School Tattoo Balm Anti Bacterial Wash|Aeroscent Milk and Honey Antibacterial Moisturizing|Antibacterial Hand Sp With Light Moisturizers Refill|Aromafields Jasmine Scented Antibacterial Hand Wash|Aromafields Lavender Scented Antibacterial Hand Wash|Aromafields Plumeria Scented Antibacterial Hand Wash|Care One Antibacterial Foaming Hand Soap Green Tea|Dalan Covex Antibacterial Deodorant Maximum Hygiene|Dalan Covex Antibacterial Deodorant Natural Hygiene|Hand Wash Nettoyant Pour Les Mains Citrus Cilantro|Hand Wash Nettoyant Pour Les Mains Plum Grapefruit|Hand Wash Nettoyant Pour Les Mains Vallina Tuberose|Healing Waters Cucumber Mint Antibacterial Hand Soap|Healthy Accents Antibacterial Body Wash Spring Fresh|Holiday Elegancefrosted Gingerbre Frosted Gingerbread|Medicated Soft N Sure Healthcare Personnel Handwash|Pier 1 Imports Lily Flower Anti-bacterial Hand Wash|Pier 1 Imports Ocean Water Anti-bacterial Hand Wash|Pier 1 Imports Sweet Grape Anti-bacterial Hand Wash|Signature Care Antibacterial Foaming Hand Pear Scent|Xtracare Antibacterial Hand Cleanse Mountain Spring|Anti-bacterial Moisturizing Hand Pumpkin Caramel Latte|Aromafields Tiger Lily Scented Antibacterial Hand Wash|Dial Clear and Refresh Antibacterial Hand Soap Clear|Dial Spring Water Antibacterial Soap With Moisturizer|Dial White Tea and Vitamin E Antibacterial Hand Soap|Fresh Picked Strawberries Anti Bacterial Foaming Hand|Hand Wash Nettoyant Pour Les Mains Orange Pekoe None|Jasmine Rose Hand Wash Nettoyant Pour Les Mains None|Our Family Dish and Antibacterial Citrus Burst Scent|Pacific Anti-bacterial Hand Cleanse Blueberry Essence|Pacific Anti-bacterial Hand Cleanse Strawberry Essence|Pacific Garden Antimicrobial, Pacific Citrus, Mandarin|Pier 1 Imports Sweet Cherry Anti-bacterial Hand Wash|Pier 1 Imports Sweet Orange Anti-bacterial Hand Wash|Pier 1 Imports Warm Vanilla Anti-bacterial Hand Wash|ANTIBACTERIAL HSOAP FRESH AND LIGHT SCENT-REFILL|CHINESE HERB ESSENCE BACTERIOSTATIC FOAMING AGENT|Dalan Antibacterial Deodorant Ocean Breeze Regenerating|Dial Country Orchard Antibacterial Soap With Moisturizer|Dial Mountain Fresh Antibacterial Soap With Moisturizers|Foaming Antibacterial Hand Soap with Aloe and Vitamin E|Hand Wash Nettoyant Pour Les Mains Citrus Cilantro None|Hand Wash Nettoyant Pour Les Mains Plum Grapefruit None|Hand Wash Nettoyant Pour Les Mains Vallina Tuberose None|Healing Waters Mandarin Vanilla Antibacterial Hand Soap|Island Spring Antibacterial Body Wash With Moisturizers|Pacific Garden Antimicrobial, Fragrance Free, Dye Free|Pier 1 Imports Coconut Breeze Anti-bacterial Hand Wash|Pier 1 Imports Cool Watermelon Anti-bacterial Hand Wash|Pier 1 Imports Lily Flower Anti-bacterial Hand Wash N/a|Pier 1 Imports Ocean Water Anti-bacterial Hand Wash N/a|Pier 1 Imports Sweet Grape Anti-bacterial Hand Wash N/a|Sparkling Mist Antibacterial Cleanser With Moisturizers|All Day Freshness Antibacterial Body Wash With Moisturizer|Berkley Jensen Hypoallergenic Antibacterial Hand Soap Soap|Bodycology White Gardenia Anti-bacterial Foaming Hand Soap|Dial Complete Antibacterial Foaming Hand Wash Hello Kitty|Dial Complete Antibacterial Foaming Hand Wash with Lotion|Dial Lavender and Twilight Jasmine Antibacterial Body Wash|Image Essentials Antibacterial Hand Mandarin and Grapefruit|Orchid By H E B Antibacterial Hand White Lavender and Mint|Pier 1 Imports Coconut Breeze Anti-bacterial Hand Wash N/a|Pier 1 Imports Granny Smith Apple Anti-bacterial Hand Wash|Pier 1 Imports Sweet Cherry Anti-bacterial Hand Wash N/a|Pier 1 Imports Sweet Orange Anti-bacterial Hand Wash N/a|Pier 1 Imports Warm Vanilla Anti-bacterial Hand Wash N/a|White Lavender and Mint Antibacterial Moisturizing Hand Sp|Xtracare Antibacterial Hand Cleanse Strawberry Pomegranate|Bodycology Peppermint Sugar Anti-bacterial Scrubbing Hand Soap|Bodycology White Gardenia Anti-bacterial Scrubbing Hand Soap|Cactus Flower and Mango Antibacterial Deep Cleansing Hand Sp|Cactus Flower and Mango Antibacterial Gentle Foaming Hand Sp|Ecosave Grapefruit and Lemongrass Soap Antibacterial Hand Soap|Ecosave Japanese Cherry Blossom Soap Antibacterial Hand Soap|Enmotion Antimicrobial With Moisturizers, Tranquil Aloe, Green|Pier 1 Imports Citrus and Sunflowers Anti-bacterial Hand Wash|Pier 1 Imports Cool Watermelon Anti-bacterial Hand Wash N/a|Pier 1 Imports Granny Smith Apple Anti-bacterial Hand Wash N/a|Royal Antibacterial (apple and Pear) Moisturizing Hand Cleanse|White Lavendar and Mint Antibacterial Gentle Foaming Hand Sp|Bodycology Sparkling Cranberry Anti-bacterial Scrubbing Hand Soap|Dial Pomeganate and Tangerine Antibacterial Soap With Moisturizer|Enmotion Antimicrobial With Moisturizers, Fragrance Free, Dye Free|Holiday ElegancePeppermint TwistPeppermint Twist Peppermint Twist|Orchid By H E B Antibacterial Moisturizing Vanilla and Apple Blossom|Pier 1 Imports Citrus and Sunflowers Anti-bacterial Hand Wash N/a|Royal Antibacterial (coconut and Lime) Moisturizing Hand Cleanse|Vanilla Cream and Apple Blossom Antibacterial Moisturizing Hand Sp|Antibacterial Mandarin and Grapefruit Handsoap Gentle Cleansing Formula|Dial Complete Antibacterial Foaming Hand Wash White Tea and Vitamin E|Dial Complete Antibacterial Foaming Hand Washholiday line holiday line|Holiday Elegancefrosted Gingerbrefrosted Gingerbre Frosted Gingerbread|Kindest Kare Antimicrobial Foaming Handwash Healthcare Personnel Handwash|Orchid By H E B Cactus Flower and Mango Antibacterial Gentle Foaming Hand|Dial Complete Antibacterial Foaming Hand Wash With Lotion Clean Citrus, Gentle On Skin|Dial Complete Antibacterial Foaming Hand Wash With Lotion Cool Plum, Gentle On Skin|Dial Complete Antibacterial Foaming Hand Wash With Lotion Cranberry With Antioxidants|Dial Complete Antibacterial Foaming Hand Wash With Lotion Fresh Pear With Lotion|Dial Complete Antibacterial Foaming Hand Wash With Lotion Iced Cranberry, Gentle On Skin|Dial Complete Antibacterial Foaming Hand Wash With Lotion Original Scent, Gentle On Skin|Dial Complete Antibacterial Foaming Hand Wash With Lotion Soothing White Tea, Gentle On Skin|Dial Complete Antibacterial Foaming Hand Washholiday Line Holiday Line Holiday Line|Dial Complete Antibacterial Foaming Hand Washkitchen crisp limkitchen crisp lim|222-182-2|Berkley Jensen Hypoallergenic Antibacterial Hand Soap Soap Enriched With Vitamin E and Aloe Vera Moisturizers|Dial Complete Antibacterial Foaming Hand Wash With Lotion Gentle On Skin, Frosted Pear With Lotion|Dial Complete Antibacterial Foaming Hand Washkitchen Crisp Limkitchen Crisp Lim Kitchen Crisp Lime|Coral|Manusept|Irgasan|C12H7Cl3O2|Trichlorosan|2,4,4'-Trichloro-2'-hydroxy diphenyl ether|MFCD00800992|Ether, 2'-hydroxy-2,4,4'-trichlorodiphenyl|CHEMBL849|Triclosan 10 microg/mL in Cyclohexane|TCL|NCGC00159417-02|NCGC00159417-05|NCGC00159417-06|Triclosanum [INN-Latin]|DP-300|Caswell No. 186A|Cloxifenol|Sapoderm|2-(2,4-dichlorophenoxy)-5-chlorophenol|SMR000471847|TCS|CAS-3380-34-5|HSDB 7194|Triclosan (USP/INN)|SR-01000762974|EINECS 222-182-2|88032-08-0|EPA Pesticide Chemical Code 054901|BRN 2057142|Sterzac|Stri-Dex cleansing bar (TN)|UNII-4NM5039Y5X|CCRIS 9253|1nhg|Triclosan [USAN:USP:INN:BAN]|Triclosan; Irgasan|Irgasan DP 30|Triclosan (Standard)|Neostrata Antibacterial Facial Cleanser|3p9t|4w9n|TRICLOSAN [INN]|TRICLOSAN [MI]|TRICLOSAN [HSDB]|TRICLOSAN [USAN]|TRICLOSAN [VANDF]|Epitope ID:119683|TRICLOSAN [MART.]|SCHEMBL3269|TRICLOSAN [USP-RS]|TRICLOSAN [WHO-DD]|MLS001066347|MLS001074876|MLS001335937|MLS001335938|BDBM8726|orb1309014|TRICLOSAN [ORANGE BOOK]|SCHEMBL29354475|SCHEMBL29356111|SCHEMBL29367506|HY-B1119R|TRICLOSAN [USP MONOGRAPH]|HMS2093L17|HMS2270M06|HMS3259K19|HMS3715H11|HMS3872N03|HMS5083F09|Pharmakon1600-01505465|Irgasan, >=97.0% (HPLC)|HY-B1119|MSK21048|Tox21_111648|Tox21_400079|DP 300|NSC759151|s4541|SBB058565|STL451034|AKOS015850380|Tox21_111648_1|CCG-213459|CH-3635|CS-4718|DB08604|FT02357|FT62533|KS-5356|NC00516|NSC 759151|COLGATE TOTAL COMPONENT TRICLOSAN|NCGC00159417-03|NCGC00159417-04|NCGC00159417-07|NCGC00159417-08|2,4,4'-trichloro-2'-hydroxydiphenylethe|AC-10667|5-chloro-2-(2, 4-dichlorophenoxy)phenol|SBI-0206807.P001|DB-358809|5-chloro-2-(2,4-di-chloro-phenoxy)-phenol|NS00010282|ST50826110|T1872|D06226|D70549|S00100|5-Chloro-2-(2,4-dichlorophenoxy)phenol, 97%|AB00698074_08|EN300-1272333|380T345|A821950|F787608|Q408646|2-[2,4-bis(chloranyl)phenoxy]-5-chloranyl-phenol|SR-01000762974-2|SR-01000762974-3|BRD-K41731458-001-04-5|BRD-K41731458-001-09-4|BRD-K41731458-001-15-1|Triclosan, certified reference material, TraceCERT(R)|F2173-0825|Triclosan, United States Pharmacopeia (USP) Reference Standard|Triclosan, Pharmaceutical Secondary Standard; Certified Reference Material|5-Chloro-2-(2,4-dichloro-3,5,6-d3-phenoxy)phenol;2,4,4'-Trichloro-2'-hydroxydiphenyl ether|Phosphoric acid tricresyl ester (mixture of isomers);Phosphoric acid tritolyl ester (mixture of isomers);Tritolyl phosphate (mixture   of isomers)"
PROGESTERONE,5994,,"InChI=1S/C21H30O2/c1-13(22)17-6-7-18-16-5-4-14-12-15(23)8-10-20(14,2)19(16)9-11-21(17,18)3/h12,16-19H,4-11H2,1-3H3/t16-,17+,18-,19-,20-,21+/m0/s1",RJKFOVLPORLFTN-LEKSSAKUSA-N,C21H30O2,314.5,"(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","progesterone|57-83-0|Pregn-4-ene-3,20-dione|Agolutin|Crinone|4-Pregnene-3,20-dione|Utrogestan|Prometrium|Syngesterone|Progestin|Luteol|Cyclogest|Gestormone|Glanducorpin|Pregnenedione|Progestasert|Progesterol|Progesteronum|Progestone|Progestron|Corlutin|Gestone|Hormoflaveine|Lutociclina|Methylpregnone|Progestosol|Progestronol|Syngestrets|Corlutina|Corluvite|Corporin|Flavolutan|Fologenon|Gesterol|Gestron|Gynlutin|Gynolutone|Hormoluton|Lingusorbs|Lucorteum|Luteodyn|Luteogan|Luteopur|Luteosan|Luteostab|Luteovis|Lutidon|Lutocyclin|Lutocylin|Lutoform|Lutogyl|Lutromone|Membrettes|Nalutron|Piaponon|Primolut|Progekan|Prolets|Prolidon|Proluton|Protormone|Syntolutan|Lutren|Lucorteum Sol|Bio-luton|Lutocyclin M|Lipo-Lutin|Luteocrin normale|Luteinique|Prochieve|Prolutone|Lutin|17alpha-Progesterone|Synovex S|Gynoluton|Projestaject|Percutacrine Luteinique|Gesterol 100|Akrolutin|Endometrin|Pregnene-3,20-dione|Progesteron|Progestogel|Progeston|(S)-Progesterone|3,20-Pregnene-4|Gelbkoerperhormon|Gestiron|Lutocylol|Progestol|Crinone progesterone gel|Progesterona|Vitarrine|Luteum|NSC-9704|(S)-4-Pregnene-3,20-dione|Delta(4)-pregnene-3,20-dione|(S)-Pregn-4-en-3,20-dione|Lutogynon|Progesterone, micronized|DTXSID3022370|CHEBI:17026|beta-Progesterone|17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione|NSC-64377|delta4-Pregnene-3,20-dione|MILPROSA|4G7DS2Q64Y|(8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one|NSC9704|delta(Sup4)-pregnene-3,20-dione|NSC64377|U 3672|DTXCID902370|Natural Progesterone|Syngestrone|Lutigest|Progesta-care|Progesto-Life|Lutocylin M|Progesterone Combo|Serenity for women|(8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta(a)phenanthren-3-one|Progesterone Phenolic|Synthetic Progestagen|Progesterone 1538|RefChem:6165|Therapeutic Progesterone|P25 Progesterone Cream|P50 Progesterone Cream|P75 Progesterone Cream|EAZI-BREED CIDR Sheep|EAZI-BREED CIDR Cattle|P75 Lav Progesterone Cream|Advanced Formula Progesto-Life|CHEBI:59826|EAZI-BREED CIDR Sheep Insert|EAZI-BREED CIDR Cattle Insert|G03DA04|DTXCID801775313|P75 Maxx with Retinol All Natural Progesterone 75 Cream|(1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadec-6-en-5-one|200-350-6|DTXSID001346637|Lutex|Gesterol 50|Cyclogesterin|Prolutin|Colprosterone|Lugesteron|Luteol (VAN)|Lutocuclin M|.beta.-Progesterone|Percutacrine|Progeffik|Utrogest|Progesteronum [INN-Latin]|Progesterona [INN-Spanish]|delta(sup 4)-Pregnene-3,20-dione|C21H30O2|CCRIS 533|Prontogest|Estima|17.alpha.-Progesterone|HSDB 3389|Progesterone [Progestins]|AI3-51682|Prometrium (TN)|Pregn-4-en-3,20-dione|MFCD00003658|Crinone (TN)|6alpha-Methylpregn-4-en-17alpha-ol-3,20-dione|.delta.4-Pregnene-3,20-dione|Progesterone (Standard)|Pregn-4-ene-3,20-dione, 17alpha-hydroxy-6alpha-methyl-|component of Cyclogesterin|4-Pregnen-3,20-dione|.delta.(sup4)-Pregnene-3,20-dione|CHEMBL103|D4-Pregnene-3,20-dione|MLS000028517|NCGC00015785-04|SMR000058345|6.alpha.-Methylpregn-4-en-17.alpha.-ol-3,20-dione|17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione|17a-Progesterone|Progestan|Pregn-4-ene-3,20-dione, 17.alpha.-hydroxy-6.alpha.-methyl-|(1S,10S,11S,14S,15S,2R)-14-acetyl-2,15-dimethyl-5-oxotetracyclo[8.7.0.0<2,7>.0 <11,15>]heptadec-6-ene|SMR000653542|Progesterone (Prometrium)|WLN: L E5 B666 OV MUTJ A1 E1 FV1|SR-01000000088|SR-01000076054|NSC 9704|EINECS 200-350-6|NSC 64377|Pregn-4-ene-3, 17.alpha.-hydroxy-6.alpha.-methyl-|BHR-100|UNII-4G7DS2Q64Y|Duraprogen|Progestrel|Lipolutin|Lutinus|1dbb|CAS-57-83-0|Progesterone [USP:INN:BAN:JAN]|racemic progesterone|Prestwick_411|Progesterone solution|CIDR|mpp22|2aa6|4bb2|Opera_ID_292|Progesterone, >=99%|Prestwick0_000477|Prestwick1_000477|Prestwick2_000477|Prestwick3_000477|Spectrum5_002053|PROGESTERONE [MI]|Cyclogesterin (Salt/Mix)|PROGESTERONE [INN]|PROGESTERONE [JAN]|bmse000482|Epitope ID:116051|EC 200-350-6|PROGESTERONE [HSDB]|SCHEMBL7671|PROGESTERONE [VANDF]|BIDD:PXR0094|Lopac0_000895|BSPBio_000614|PROGESTERONE [MART.]|MLS000758277|MLS001074187|MLS001423982|MLS002222367|BIDD:ER0547|P0130_SIGMA|PROGESTERONE [USP-RS]|PROGESTERONE [WHO-DD]|PROGESTERONE [WHO-IP]|SPBio_002553|.delta.-Pregnene-3,20-dione|BDBM8903|BPBio1_000676|GTPL2377|Hydroxyprogesterone Caproic acid|orb1310573|SCHEMBL7610853|SCHEMBL8711607|HY-N0437R|Progesterone (JP18/USP/INN)|BHR-310|ETI-411|MSK2223|PROGESTERONE [GREEN BOOK]|1a28|1h60|HMS1569O16|HMS2051O05|HMS2090J07|HMS2096O16|HMS2230F23|HMS2233P11|HMS3262D12|HMS3713O16|Pregnene, 3,20-dione-delta^4-|PROGESTERONE [ORANGE BOOK]|PROGESTERONE [EP MONOGRAPH]|BCP22000|BIJUVA COMPONENT PROGESTERONE|HY-N0437|PROGESTERONE [USP MONOGRAPH]|Tox21_113157|Tox21_201792|Tox21_300307|Tox21_500895|AC-700|CMC_13406|LMST02030159|Progesterone, 1mg/ml in Acetonitrile|PROGESTERONUM [WHO-IP LATIN]|s1705|SBB012538|AKOS015894908|Progesterone; 4-Pregnene-3,20-dione|CCG-100766|CS-1937|DB00396|DR-2011|FD12045|FP27173|LP00895|NC00016|SDCCGSBI-0050870.P002|Progesterone 1.0 mg/ml in Acetonitrile|NCGC00022185-03|NCGC00022185-04|NCGC00022185-05|NCGC00022185-06|NCGC00022185-07|NCGC00022185-08|NCGC00022185-09|NCGC00022185-10|NCGC00022185-11|NCGC00022185-12|NCGC00022185-14|NCGC00022185-21|NCGC00090798-01|NCGC00090798-02|NCGC00254120-01|NCGC00259341-01|NCGC00261580-01|(8S,9S,10R,13S,14S,17S)-17-acetyl-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one|(8S,9S,10R,13S,14S,17S)-17-Acetyl-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one|AS-12660|CPD000058345|NCI60_042166|ST069329|FE-999913|CS-0694805|EU-0100895|NS00010899|P0478|(14beta,17alpha)-pregn-4-ene-3,20-dione|Progesterone, meets USP testing specifications|Progesterone, Vetec(TM) reagent grade, 98%|C00410|D00066|P 0130|Q26963|S00293|Progesterone, VETRANAL(TM), analytical standard|F374675|SR-01000000088-5|SR-01000000088-6|SR-01000076054-1|SR-01000076054-4|BRD-K64994968-001-03-6|32104FB6-BF81-4F6E-83C2-024DEEAEB272|Z1501485353|Pregn-4-ene-3,20-dione;?4-Pregnene-3,20-dione;Agolutin|Progesterone, British Pharmacopoeia (BP) Reference Standard|Progesterone, powder, BioReagent, suitable for cell culture|Progesterone, European Pharmacopoeia (EP) Reference Standard|Progesterone, gamma-irradiated, BioXtra, suitable for cell culture|Progesterone, United States Pharmacopeia (USP) Reference Standard|Progesterone-Water Soluble, powder, BioReagent, suitable for cell culture|Progesterone for peak identification, European Pharmacopoeia (EP) Reference Standard|Progesterone for system suitability, European Pharmacopoeia (EP) Reference Standard|Progesterone, Pharmaceutical Secondary Standard; Certified Reference Material|(1S,2R,10S,11S,14S,15S)-14-acetyl-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one|137940-28-4|753497-20-0"
MEDROXYPROGESTERONE ACETATE,6279,,"InChI=1S/C24H34O4/c1-14-12-18-19(22(4)9-6-17(27)13-21(14)22)7-10-23(5)20(18)8-11-24(23,15(2)25)28-16(3)26/h13-14,18-20H,6-12H2,1-5H3/t14-,18+,19-,20-,22+,23-,24-/m0/s1",PSGAAPLEWMOORI-PEINSRQWSA-N,C24H34O4,386.5,"[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate","Medroxyprogesterone acetate|71-58-9|Medroxyprogesterone 17-acetate|Provera|Metigestrona|Depo-Provera|Farlutin|Amen|Methylacetoxyprogesterone|Medroxyacetate progesterone|Gestapuran|Progestalfa|Clinovir|Lutopolar|Nadigest|Nidaxin|Oragest|Perlutex|Prodasone|Progevera|Proverone|Repromix|Sirprogen|Veramix|Clinofem|Repromap|Depo-progestin|Provera dosepak|Depo-Progevera|Depot-medroxyprogesterone acetate|6-alpha-Methyl-17-alpha-acetoxyprogesterone|MAP (steroid)|Depo-Subq Provera 104|NSC-26386|6-alpha-Methyl-17-alpha-hydroxyprogesterone acetate|Cycrin|17alpha-Hydroxy-6alpha-methylprogesterone acetate|6alpha-Methyl-17alpha-hydroxyprogesterone acetate|Depo-subq provera|Depot medroxyprogesterone acetate|6alpha-Methyl-4-pregnene-3,20-dion-17alpha-ol acetate|Aragest|Hysron|17-Acetoxy-6alpha-methylprogesterone|Depo-clinovir|6alpha-Methyl-17-acetoxy progesterone|Depo-Medroxyprogesterone acetate|Nogest|C2QI4IOI2G|Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6alpha)-|6alpha-Methyl-17-acetoxyprogesterone|NSC-21171|17-Acetoxy-6-alpha-methylprogesterone|U 8839|6-alpha-Methyl-17-acetoxy progesterone|CHEBI:6716|DTXSID0025527|(6alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|(6alpha)-6-methyl-3,20-dioxopregn-4-en-17-yl acetate|17-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate|Medroxyprogesteroni acetas|Progesterone, 17-hydroxy-6alpha-methyl-, acetate|17-alpha-Hydroxy-6-alpha-methylprogesterone acetate|TV-46046|17-alpha-Acetoxy-6-alpha-methylpregn-4-ene-3,20-dione|6-alpha-Methyl-17-alpha-acetoxypregn-4-ene-3,20-dione|Progesterone, 17-alpha-hydroxy-6-alpha-methyl-, acetate|Medroxyprogesterone 17 Acetate|DTXCID905527|6-alpha-Methyl-4-pregnene-3,20-dion-17-alpha-ol acetate|17-alpha-Hydroxy-6-alpha-methylpregn-4-ene-3,20-dione acetate|NSC21171|NSC26386|17alpha-Acetoxy-6alpha-methylprogesterone|(6-alpha)-Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-|Pregn-4-ene-3,20-dione, 17-hydroxy-6alpha-methyl-, acetate|Metipregnone|PREMPRO COMPONENT MEDROXYPROGESTERONE ACETATE|g-Farlutal|PREMPHASE COMPONENT MEDROXYPROGESTERONE ACETATE|Sodelut G|Ciclotal|Climanor|DepoProvera|Sayana press|Depo Provera|Nadigest (vet)|Nidaxin (vet)|Farlutal 100|Farlutal 200|Farlutal 250|Farlutal 500|Depo-provera oncology|RefChem:810842|6-alpha-Methyl-17alpha-hydroxyprogesterone Acetate|Depo Medroxyprogesterone Acetate|Depot-Medroxyprogestereone Acetate|6-Alpha-methyl-17alpha-acetoxyprogesterone|Medroxyprogesterone Acetate Injectable Suspension|6 alpha Methyl 17alpha hydroxyprogesterone Acetate|6alpha-Methyl-3,20-dioxopregn-4-en-17-yl acetate|17-(Acetyloxy)-6alpha-methylpregn-4-ene-3,20-dione|(6 alpha)-17-(Acetoxy)-6-methylpregn-4-ene-3,20-dione|(6alpha)-17-(Acetyloxy)-6-methylpregn-4-ene-3,20-dione|(1S,2R,8S,10R,11S,14R,15S)-14-acetyl-2,8,15-trimethyl-5-oxotetracyclo(8.7.0.02,7.011,15)heptadec-6-en-14-yl acetate|200-757-9|Farlutal|NSC-27408|Depcorlutin|Deporone|Supprestral|Depo-Promone|Promone-E|Medroxyprogesteroneacetate|DP150|Ralovera|Medroxyprogesterone-17-acetate|Depo-Ralovera|MLS000069442|MLS001148217|Medroxy Progesterone 17-Acetate|ONCO-Provera|Medroxyprogesterone acetate (Standard)|[(6S,8R,9S,10R,13S,14S,17R)-17-acetyl-6,10,13-trimethyl-3-oxo-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate|Medrosterona|Cykrina|Depocon|Indivina|Mepastat|Meprate|SMR000059125|Sumiferm|Suprestral|Veraplex|Dugen|Depo-Prodasone|Perlutex Leo|MFCD00010483|Depo-Map|Aragest 5|Med-Pro|MPA-beta|MPA Hexal|MPA-Noury|(6S,8R,9S,10R,13S,14S,17R)-17-Acetyl-6,10,13-trimethyl-3-oxo-2,3,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate|Depomedroxyprogesterone acetate|MPA GYM|CAS-71-58-9|CCRIS 371|17.alpha.-Acetoxy-6.alpha.-methylprogesterone|Medroxyprogesterone acetate [JAN]|EINECS 200-757-9|UNII-C2QI4IOI2G|NSC 21171|Depo-Provera Contraceptive|(6.alpha.-Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-|17.alpha.-Hydroxy-6-.alpha.-methylprogesterone acetate|Pregn-4-ene-3, 17-hydroxy-6.alpha.-methyl-, acetate|BRN 2066112|Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-, (6.alpha.)-|AI3-60127|Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6.alpha.)-|17-Acetoxy-6.alpha.-methylprogesterone|6.alpha.-Methyl-17-acetoxyprogesterone|NCGC00094713-01|17alpha-Hydroxy-6-alpha-methylprogesterone acetate|Provera (TN)|Depo-provera (TN)|6alpha-Methyl-17alpha-acetoxypregn-4-ene-3,20-dione|Medroxyprogesterone acetate [USP:JAN]|17alpha-Acetoxy-6-alpha-methylpregn-4-ene-3,20-dione|Medroxyprogesterone acetate [Progestins]|6.alpha.-Methyl-17.alpha.-acetoxyprogesterone|(6-alpha)-17-(Acetyloxy)-6-methylpreg-4-ene-3,20-dione|17alpha-Hydroxy-6alpha-methylpregn-4-ene-3,20-dione acetate|6alpha-Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-|CPD000653524|Pregn-4-ene-3,20-dione, 17-(acetyloxy)-6-methyl-, (6a)-|Opera_ID_1110|medroxyprogesterone-acetate|17.alpha.-Hydroxy-6.alpha.-methylprogesterone acetate|6.alpha.-Methyl-17.alpha.-hydroxyprogesterone acetate|Medroxiprogesterone Acetate|CHEMBL717|SCHEMBL4276|6.alpha.-Methyl-17.alpha.-acetoxypregn-4-ene-3,20-dione|Medroxyprogesterone (acetate)|17.alpha.-Acetoxy-6-.alpha.-methylpregn-4-ene-3,20-dione|4-08-00-02212 (Beilstein Handbook Reference)|6.alpha.-Methyl-4-pregnene-3,20-dion-17.alpha.-ol acetate|MLS002207115|17.alpha.-Hydroxy-6.alpha.-methylpregn-4-ene-3,20-dione acetate|Depo-subq provera 104 (TN)|orb1309193|HY-B0469R|MSK2210|HMS2233O07|HMS2235E05|HMS3259O14|HMS3884B10|CBP-1011|HY-B0469|Tox21_111319|Tox21_200141|BDBM50067678|s2567|AKOS015894870|Tox21_111319_1|AC-2174|CCG-264965|DB00603|FM25036|NC00574|Medroxyprogesterone acetate (JP18/USP)|MRF-0000023|NCGC00022037-03|NCGC00022037-04|NCGC00022037-05|NCGC00022037-07|NCGC00257695-01|NCGC00263480-01|AS-13981|MEDROXYPROGESTERONE ACETATE [IARC]|SMR000653524|SY077009|MEDROXYPROGESTERONE ACETATE [MART.]|MEDROXYPROGESTERONE ACETATE [VANDF]|MEDROXYPROGESTERONE 17-ACETATE [MI]|MEDROXYPROGESTERONE ACETATE [USP-RS]|MEDROXYPROGESTERONE ACETATE [WHO-DD]|MEDROXYPROGESTERONE ACETATE [WHO-IP]|CS-0694837|NS00006415|C08150|C76275|D00951|AB00384270-14|AB00384270_15|EN300-7480751|Medroxyprogesterone 17-acetate, >=97% (HPLC)|MEDROXYPROGESTERONE ACETATE [ORANGE BOOK]|MEDROXYPROGESTERONI ACETAS [WHO-IP LATIN]|010M483|F787593|MEDROXYPROGESTERONE ACETATE [EP MONOGRAPH]|MEDROXYPROGESTERONE ACETATE [USP MONOGRAPH]|MEGESTROL ACETATE IMPURITY A [EP IMPURITY]|LUNELLE COMPONENT MEDROXYPROGESTERONE ACETATE|Q2823834|6.alpha.-Pregn-4-ene-3, 17-(acetyloxy)-6-methyl-|Medroxyprogesterone-17-acetate 100 microg/mL in Acetonitrile|Medroxyprogesterone 17-acetate, VETRANAL(TM), analytical standard|Medroxyprogesterone acetate, European Pharmacopoeia (EP) Reference Standard|Medroxyprogesterone Acetate, Pharmaceutical Secondary Standard; Certified Reference Material|Medroxyprogesterone acetate, United States Pharmacopeia (USP) Reference Standard|(1R,3aS,3bR,5S,9aR,9bS,11aS)-1-acetyl-5,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl acetate|(6?)-17-(Acetyloxy)-6-methyl-pregn-4-ene-3,20-dione;17?-Acetoxy-6?-methylpregn-4-ene-3,20-dione;17?-Acetoxy-6?-methylprogesterone|1301724-98-0|Medroxyprogesterone acetate for peak identification, European Pharmacopoeia (EP) Reference Standard|Medroxyprogesterone acetate for system suitability, European Pharmacopoeia (EP) Reference Standard"
MIFEPRISTONE,55245,,"InChI=1S/C29H35NO2/c1-5-15-29(32)16-14-26-24-12-8-20-17-22(31)11-13-23(20)27(24)25(18-28(26,29)2)19-6-9-21(10-7-19)30(3)4/h6-7,9-10,17,24-26,32H,8,11-14,16,18H2,1-4H3/t24-,25+,26-,28-,29-/m0/s1",VKHAHZOOUSRJNA-GCNJZUOMSA-N,C29H35NO2,429.6,"(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","mifepristone|84371-65-3|Mifegyne|Mifeprex|RU-486|Korlym|RU 486|Mifepristona|RU 38486|RU-38486|Mifepristonum|DTXSID5023322|320T6RNW1F|CHEBI:50692|NSC-759862|DTXCID303322|(8S,11R,13S,14S,17S)-11-(4-dimethylaminophenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one|11-(4-DIMETHYLAMINO-PHENYL)-17-HYDROXY-13-METHYL-17-PROP-1-YNYL-1,2,6,7,8,11,12,13,14,15,16,17-DODEC AHYDRO-CYCLOPENTA[A]PHENANTHREN-3-ONE|Estra-4,9-dien-3-one, 11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-, (11-beta,17-beta)-|ZK98296|NSC652104|R38486|(8S,11R,13S,14S,17S)-11-(4-dimethylaminophenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-3-one|11-(4-DIMETHYLAMINO-PHENYL)-17-HYDROXY-13-METHYL-17-PROP-1-YNYL-1,2,6,7,8,11,12,13,14,15,16,17-DODEC AHYDRO-CYCLOPENTA(A)PHENANTHREN-3-ONE|RU38486|ZK 98296|RefChem:55643|Estra-4,9-dien-3-one, 11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-, (11beta,17beta)-|G03XB01|11-((4-dimethylamino) phenyl)-17-Hydroxy-17-(1-propynyl) Estra-4,9-dien-3-one|(10S,11S,14S,15S,17R)-17-(4-(dimethylamino)phenyl)-14-hydroxy-15-methyl-14-(prop-1-yn-1-yl)tetracyclo(8.7.0.02,7.011,15)heptadeca-1,6-dien-5-one|(aa Beta, 17 beta)-11-(4-(dimethylamino)-phenyl)-17-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one|11 Beta-(4-(N,N-dimethylamino)phenyl)-17alpha-(propyl-1-ynyl)-delta-4,9-estradiene-17 beta-ol-3-one|RU486|Corlux|Mifepriston|C29H35NO2|(11beta,17beta)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-17-(1-propyn-1-yl)estra-4,9-dien-3-one|MFCD00867226|Mifepristone (Standard)|MLS000069785|VGX-410C|VGX-410|NCGC00025179-05|SMR000058481|Mifepristonum [Latin]|Mifepristona [Spanish]|(8S,11R,13S,14S,17S)-11-(4-(dimethylamino)phenyl)-17-hydroxy-13-methyl-17-(prop-1-yn-1-yl)-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one|(8S,11R,13S,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one|(10S,11S,14S,15S,17R)-17-[4-(dimethylamino)phenyl]-14-hydroxy-15-methyl-14-(prop-1-yn-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-1,6-dien-5-one|(11beta,17beta)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-prop-1-yn-1-ylestra-4,9-dien-3-one|RU486 (tetramethyl-rhodamine conjugated)|Mifepristone [USAN:INN:BAN]|HSDB 6841|SR-01000076011|R 38486|BRN 5779404|UNII-320T6RNW1F|Pictovir|RU 486-6|CCRIS 9332|1nhz|11beta-(p-(Dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one|Mifeprex (TN)|Pictovir (TM)|Prestwick_570|CAS-84371-65-3|Korlym (TN)|2w8y|Mifepristone (Mifeprex)|Opera_ID_562|Mifepristone, >=98%|Prestwick0_000299|Prestwick1_000299|Prestwick2_000299|Prestwick3_000299|Spectrum5_002045|MIFEPRISTONE [MI]|MIFEPRISTONE [INN]|MIFEPRISTONE [JAN]|MIFEPRISTONE [HSDB]|MIFEPRISTONE [USAN]|11beta-(4-(Dimethylamino)phenyl)-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-on|17-beta-Hydroxy-11-beta-(4-dimethylaminophenyl-1)-17-alpha-(prop-1-ynyl)oestra-4,9-dien-3-one|MIFEPRISTONE [VANDF]|BIDD:PXR0123|Lopac0_000801|SCHEMBL16087|BSPBio_000238|MIFEPRISTONE [MART.]|11beta-(4-(Dimethylamino)phenyl)-17-hydroxy-21-methyl-19-nor-17alpha-pregna-4,9-dien-20-m-3-on|11beta-(4-(N,N-Dimethylamino)phenyl)-17alpha-(prop-1-ynyl)-delta4,9-estradiene-17beta-ol-3-one|MLS001074115|MLS001424271|MIFEPRISTONE [USP-RS]|MIFEPRISTONE [WHO-DD]|SPBio_002457|RU-486; MIFEPRISTONE|BPBio1_000262|CHEMBL438575|GTPL2805|Mifepristone (JAN/USAN/INN)|CHEMBL1276308|BDBM18627|MSK8539|GLXC-05981|HMS1568L20|HMS2052L05|HMS2090L22|HMS2095L20|HMS2230P21|HMS3262B03|HMS3412D17|HMS3649J08|HMS3676D17|HMS3712L20|HMS3884D12|MIFEPRISTONE [ORANGE BOOK]|ALBB-038643|BCP02145|Tox21_110952|Tox21_301841|Tox21_500801|BDBM50072024|HB2783|HSCI1_000369|HY-13683R|s2606|VX-410|AKOS015895416|Tox21_110952_1|CCG-101164|CI-1073|CS-1435|DB00834|FM26002|LP00801|NC00414|NSC 759862|SDCCGSBI-0050778.P002|Mifepristone 1.0 mg/ml in Acetonitrile|NCGC00025179-06|NCGC00025179-07|NCGC00025179-08|NCGC00025179-09|NCGC00025179-12|NCGC00025179-13|NCGC00025179-23|NCGC00179632-01|NCGC00255152-01|NCGC00261486-01|(11beta,17beta)-11-(4-(Dimethylamino)phenyl)-17-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one|AS-13938|CPD000058481|HY-13683|RU486;C-1073|SY077658|CS-0694789|EU-0100801|C-1073|C07652|D00585|EN300-117256|M 8046|371M653|Q411240|SR-01000721888|SR-01000076011-1|SR-01000076011-3|SR-01000076011-5|SR-01000076011-9|SR-01000721888-4|BRD-K37270826-001-04-5|BRD-K37270826-001-26-8|BRD-K37270826-001-27-6|BRD-K37270826-001-31-8|Z1501480424|Mifepristone, United States Pharmacopeia (USP) Reference Standard|11.beta.-[4-(Dimethylamino)phenyl]-17.beta.-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one|11b-(4-Dimethyl-amino)-phenyl-17b-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one|11beta-(4-Dimethyl-amino)-phenyl-17beta-hydroxy-17-(1-propynyl)-estra-4,9-dien-3-one|11beta-(4-Dimethylamino)phenyl-17beta-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one|11ss-[p-(Dimethylamino)fenyl]-17ss-hydroxy- 17-(1-propynyl)estra-4,9-dien-3-on|(11|A,17|A)-11-[4-(Dimethylamino)phenyl]-17-hydroxy-17-(1-propyn-1-yl)estra-4,9-dien-3-one|(11R,13S,14S,17S)-11-(4-Dimethylamino-phenyl)-17-hydroxy-13-methyl-17-prop-1-ynyl-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-cyclopenta[a]phenanthren-3-one|(1S,3aS,3bS,10R,11aS)-10-[4-(dimethylamino)phenyl]-1-hydroxy-11a-methyl-1-(prop-1-yn-1-yl)-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,10H,11H,11aH-cyclopenta[a]phenanthren-7-one|122742-25-0|17beta-Hydroxy-11beta-[4-(dimethylamino)-phenyl]-17alpha-(prop-1-ynyl)-estra-4,9-dien-3-one|83203-42-3|Estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propyn-1-yl)-, (11.beta.,17.beta.)-|Estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propyn-1-yl)-, (11beta,17beta)-|Estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(1-propynyl)-, (11b,17b)-"
VERAPAMIL,2520,,"InChI=1S/C27H38N2O4/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6/h9-12,17-18,20H,8,13-16H2,1-7H3",SGTNSNPWRIOYBX-UHFFFAOYSA-N,C27H38N2O4,454.6,"2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile","VERAPAMIL|52-53-9|Iproveratril|Dilacoran|Verapamilo|Verapamilum|Isoptine|Cardibeltin|Securon|D-365|Cardiagutt|Dignover|Veramex|Verpamil|Quasar|dl-Verapamil|Novo-Veramil|r,s-verapamil|Apo-Verap|Nu-Verap|CP-16533-1|Manidon|Verapamil slow release|Cardiabeltin|Cardioprotect|Durasoptin|Hexasoptin|Veroptinstada|Calaptin|Caveril|Civicor|Coraver|Corpamil|Harteze|Hormitol|Ikapress|Inselon|Isoptino|Jenapamil|Lodixal|Magotiron|Praecicor|Robatelan|Vasomil|Vasopten|Verabeta|Veracor|Verahexal|Veraloc|Veramil|Verapin|Verasal|Verasifar|Verdilac|Vetrimil|2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile|5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile|Elthon|Flamon|Ikacor|Univex|Vortac|Ormil|Rapam|Civicor Retard|Isoptin Retard|Manidon Retard|Vera-Sanorania|Verapamil Acis|Verapamil Atid|Verapamil Ebewe|Verapamil Riker|Verapamil Verla|Verapamil Basics|Verapamil Nordic|Verapamil-AbZ|Novapamyl LP|Verapamil NM|Verapamil PB|Verapamil SR|Cordilox SR|Dilacoran HTA|Veracaps SR|Verapamil MSD|Arpamyl LP|Hexasoptin Retard|Verapamil Henning|Verelan SR|Verapamil Injection|Akilen|Verapamil NM Pharma|CJ0O37KU29|Calaptin 240 SR|Verapress 240 SR|CHEBI:77733|Verapamil AL|CP-16,533-1|2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile|Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-|alpha-((N-Methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile|CP-165331|Valeronitrile, 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-|Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino) propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-|5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile|Zolvera|2-(3,4-dimethoxyphenyl)-5-((2-(3,4-dimethoxyphenyl)ethyl)(methyl)amino)-2-(propan-2-yl)pentanenitrile|2-(3,4-dimethoxyphenyl)-5-(2-(3,4-dimethoxyphenyl)ethyl-methylamino)-2-propan-2-ylpentanenitrile|RefChem:6348|Hydrochloride, Verapamil|CHEBI:9948|C08DA01|200-145-1|alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile|Vasolan|Falicard|Finoptin|Cordilox|Isoptin|Calan|Isotopin|Lekoptin|Calcan|(+/-)-VERAPAMIL|5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile|C27H38N2O4|Berkatens|Geangin|Izoptin|Univer|Covera-HS|Isoptimo|MFCD00056240|Tarka|DTXSID9041152|Veratensin|Verapamilum [INN-Latin]|NCGC00016083-09|Verapamilo [INN-Spanish]|2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-isopropyl-pentanenitrile|Benzeneacetonitrile, .alpha.-[3-[[2-(3,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-|(+/-)-Verapamil hydrochlorid|DTXCID7021152|Verapamil [USAN:INN:BAN]|(+/-)-Verapamil;CP-16533-1|CAS-52-53-9|CCRIS 6749|Verapamil (USAN/INN)|EINECS 200-145-1|UNII-CJ0O37KU29|Ansyr|NSC 272306NA|EINECS 260-462-6|Calan (Salt/Mix)|Akilen (Salt/Mix)|Isoptin (Salt/Mix)|alpha-(3-((2-(3,4-Dimethoxyphenyl)ethyl)-methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile|alpha-Isopropyl-alpha-((N-methyl-N-homoveratryl)-gamma-aminopropyl)-3,4-dimethoxyphenylacetonitrile|Cordilox (Salt/Mix)|delta-365|VERAPAMIL [INN]|VERAPAMIL [MI]|Covera-HS (Salt/Mix)|VERAPAMIL [USAN]|Prestwick0_000141|Prestwick1_000141|Prestwick2_000141|Prestwick3_000141|Spectrum2_001740|Spectrum4_000906|Spectrum5_001786|VERAPAMIL [VANDF]|()-Verapamil hydrochlorid|CP 16533-1|D 365|VERAPAMIL [WHO-DD]|CHEMBL6966|Lopac0_001237|SCHEMBL16742|BSPBio_000242|BSPBio_001513|BSPBio_002358|KBioGR_000233|KBioGR_001372|KBioGR_002343|KBioSS_000233|KBioSS_002346|56949-77-0|MLS006011414|DivK1c_000399|SPBio_001820|SPBio_002181|BPBio1_000268|GTPL2406|orb1306580|CP 16533-1 (Verapamil)|SCHEMBL13287282|SCHEMBL29440902|(A+/-)-Verapamil hydrochloride|BDBM81939|HSDB 3928|KBio1_000399|KBio2_000233|KBio2_002343|KBio2_002801|KBio2_004911|KBio2_005369|KBio2_007479|KBio3_000465|KBio3_000466|KBio3_002823|()-Verapamil;CP-16533-1|cMAP_000023|NINDS_000399|NSC-272306NA|Bio1_000425|Bio1_000914|Bio1_001403|Bio2_000233|Bio2_000713|HMS1791L15|HMS1989L15|HMS2089H17|HMS3402L15|Tox21_110300|MSK160274|NSC_62969|STK538085|AKOS005468962|Tox21_110300_1|CCG-205311|DB00661|FV02354|SDCCGSBI-0051204.P005|CAS_52-53-9|IDI1_000399|IDI1_033983|NCGC00016083-04|NCGC00016083-05|NCGC00016083-06|NCGC00016083-07|NCGC00016083-08|NCGC00016083-10|NCGC00016083-11|NCGC00016083-13|NCGC00016083-14|NCGC00016083-15|NCGC00016083-16|NCGC00016083-17|NCGC00016083-18|NCGC00016083-20|NCGC00016083-25|NCGC00016083-34|NCGC00024710-04|NCGC00024710-05|NCGC00024710-06|NCGC00024710-07|NCGC00024710-08|NCGC00024710-09|NCGC00344584-01|2-(3,4-Dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-(1-methylethyl) pentanenitrile|AC-16016|BP-21223|HY-14275|NCI60_020143|SMR001550201|SBI-0051204.P003|(-)-3-(3,4-dimethoxyphenyl)-6-[(5,6-dimethoxyphenethyl)methylamino]hexane-3-carbonitrile|DB-349548|AB00053495|CS-0002967|NS00000313|ST50826367|52V114|C07188|D02356|E75969|EN300-708774|AB00053495-20|AB00053495_21|L001330|Q410291|BRD-A09533288-001-02-7|BRD-A09533288-003-05-6|BRD-A09533288-003-29-6|BRD-A09533288-003-31-2|CP-165331 /  CP-16533-1|F2173-0851|VERAPAMIL, Dexverapamil, Verapamyl hydrochloride, VERAPAMIL HYDROCHLORIDE|.alpha.-((N-Methyl-N-homoveratryl)-.gamma.-aminopropyl)-3,4-dimethoxyphenylacetonitrile|(+/-)-5-((3,4-DIMETHOXYPHENETHYL)METHYLAMINO)-2-(3,4-DIMETHOXYPHENYL)-2-ISOPROPYLVALERONITRILE|2-(3,4-Dimethoxyphenyl)-5-((2-(3,4-dimethoxyphenyl)ethyl)(methyl)amino)-2-isopropylpentanenitrile, (+/-)-|2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino]-2-isopropylpentanenitrile #|2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]methylamino}-2-(methy lethyl)pentanenitrile"
DILTIAZEM,39186,,"InChI=1S/C22H26N2O4S/c1-15(25)28-20-21(16-9-11-17(27-4)12-10-16)29-19-8-6-5-7-18(19)24(22(20)26)14-13-23(2)3/h5-12,20-21H,13-14H2,1-4H3/t20-,21+/m1/s1",HSUGRBWQSSZJOP-RTWAWAEBSA-N,C22H26N2O4S,414.5,"[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate","diltiazem|42399-41-7|d-cis-Diltiazem|Dilcontin|Dilticard|Acalix|Anoheal|Incoril AP|Diltiazemum|Surazem|Dilacor-XR|(2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-yl acetate|Herbesser|Ditiaz|Diltiazem extended release|EE92BBP03H|CHEBI:101278|Diltia XT|(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate|[(2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate|Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|(+)-cis-5-[2-(dimethylamino)ethyl]-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester|(2S-cis)-3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one|CRD401|1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-, (2S-cis)-|DTXSID50881104|((2S,3S)-5-(2-dimethylaminoethyl)-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl) acetate|(+)-cis-5-(2-(dimethylamino)ethyl)-2,3-dihydro-3-hydroxy-2-(p-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one acetate ester|(2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate|(2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo(b)(1,4)thiazepin-3-yl acetate|(2S-cis)-3-(acetyloxy)-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one|Acetic acid (2S,3S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo(b)(1,4)thiazepin-3-yl ester|RefChem:5757|C05AE03|C08DB01|DTXCID30196864|255-796-4|Cardizem|Dilt-cd|Cardil|Dilren|Tiazac|(+)-diltiazem|Diltiazem free base|(+)-cis-diltiazem|Diltiazem (INN)|CHEMBL23|Endrydil|Dilzen|Dilta-Hexal|DTXSID9022940|42399-41-7 (free base)|MFCD00868239|[(2S,3S)-5-[2-(dimethylamino)ethyl]-2-(4-methoxyphenyl)-4-oxo-2,3-dihydro-1,5-benzothiazepin-3-yl] acetate|NCGC00024309-05|DILTIAZEM [INN]|Diltiazem [INN:BAN]|Diltiazemum [INN-Latin]|DTXCID202940|Surazem (TN)|CAS-42399-41-7|HSDB 6528|Cardizem (Hydrochloride)|MK-793 (Malate)|EINECS 255-796-4|UNII-EE92BBP03H|BRN 3573079|Diltiazen|RG 83606 (Hydrochloride)|C22H26N2O4S|1,5-Benzothiazepin-4(5H)-one, 3-(acetyloxy)-5-[2-(dimethylamino)ethyl]-2,3-dihydro-2-(4-methoxyphenyl)-, (2S,3S)-|56209-45-1|C9F|D-(cis)-diltiazem|Diltiazem (Standard)|Tocris-0685|DILTIAZEM [MI]|DITIAZ [VANDF]|DILTIAZEM [HSDB]|Prestwick0_000134|Prestwick1_000134|Prestwick2_000134|Prestwick3_000134|DILTIAZEM [VANDF]|DILTIAZEM [WHO-DD]|Lopac0_000327|SCHEMBL17776|BSPBio_000208|BSPBio_001311|BIDD:GT0548|SPBio_002147|BPBio1_000230|GTPL2298|orb1710752|SCHEMBL29353951|HY-B0632R|Bio1_000371|Bio1_000860|Bio1_001349|HMS1791B13|HMS1989B13|HMS2089H09|(+)-5-(2-(DIMETHYLAMINO)ETHYL)-CIS-2,3-DIHYDRO-3-HYDROXY-2-(P-METHOXYPHENYL)-1,5-BENZOTHIAZEPIN-4(5H)-ONE ACETATE (ESTER)|Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|cis-3-Acetoxy-5-(2-(dimethylamino)ethyl)-2,3-dihydro-2-(4-methoxyphenyl)-1,5-benzothiazepin-4(5H)-one|HY-B0632|MSK10027|EINECS 260-060-0|Tox21_110898|AC-936|BDBM50004704|AKOS015897257|Tox21_110898_1|CCG-204422|DB00343|SDCCGSBI-0050315.P002|NCGC00024309-02|NCGC00024309-04|NCGC00024309-06|NCGC00024309-07|NCGC00024309-08|NCGC00024309-09|NCGC00024309-10|NCGC00024309-11|NCGC00024309-17|NCGC00024309-21|NCGC00024309-27|NCGC00024309-30|(2S,3S)-5-[2-(dimethylamino)ethyl]-2-[4-(methyloxy)phenyl]-4-oxo-2,3,4,5-tetrahydro-1,5-benzothiazepin-3-yl acetate|SY075605|CS-0009567|NS00068380|ethyl 3-amino-1,2,4-triazole-1-carboxylate|C06958|D07845|G12770|A825887|EN300-22049448|Q422229|BRD-K24023109-001-02-5|BRD-K24023109-003-03-9|BRD-K24023109-003-11-2|BRD-K24023109-003-20-3|BRD-K24023109-003-25-2|BRD-K24023109-003-26-0|8-Chloro-1-methyl-6-phenyl-4H-2,3,5,10b-tetraaza-benzo[e]azulene|(2S,3S)-5-(2-(dimethylamino)ethyl)-2-(4-methoxyphenyl)-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]thiazepin-3-ylacetate|1,5-BENZOTHIAZEPIN-4(5H)-ONE, 3-(ACETYLOXY)-5-(U2-(DIMETHYLAMINO)ETHYL)-2,3-DIHYDRO-2-(4-METHOXYPHENYL)-, (+)-CIS-|5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester(Diltiazem)Acetic acid|Acetic acid (S)-5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester (Diltiazem)|Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester(cis-(+)-Diltiazem)|Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester; hydrochloride|cis-Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester|diltiazem;Acetic acid 5-(2-dimethylamino-ethyl)-2-(4-methoxy-phenyl)-4-oxo-2,3,4,5-tetrahydro-benzo[b][1,4]thiazepin-3-yl ester"
IMATINIB,5291,,"InChI=1S/C29H31N7O/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34)",KTUFNOKKBVMGRW-UHFFFAOYSA-N,C29H31N7O,493.6,4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide,"Imatinib|152459-95-5|N-(4-Methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide|Glamox|BKJ8M8G5HI|NSC-743414|NSC-759854|CHEBI:45783|4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide|DTXSID3037125|Benzamide, 4-((4-methyl)-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-|N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)-4-[(4-methylpiperazin-1-yl)methyl]benzamide|alpha-(4-methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-toluidide|Imatinibum|4-((4-Methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)benzamide|RefChem:76|DTXCID1017125|L01XE01|Imatinib (STI571)|Imatinib free base|C29H31N7O|MFCD05662257|Imatinib (INN)|Imatinib Methansulfonate|4-(4-METHYL-PIPERAZIN-1-YLMETHYL)-N-[4-METHYL-3-(4-PYRIDIN-3-YL-PYRIMIDIN-2-YLAMINO)-PHENYL]-BENZAMIDE|CGP 57148B|152459-95-5 (free base)|4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide|CHEMBL941|imatinib-CD3|NSC743414|4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide|IMATINIB [INN]|Imatinib [INN:BAN]|4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide|4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide|STI|Glamox (TN)|CCRIS 9076|SR-01000763561|NCGC00159456-02|UNII-BKJ8M8G5HI|ST1571|ST 1571|Imatinib base|1iep|1xbb|Gleevec(TM)|4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide; CGP 57148; Genfatinib; Imatinib, Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-|4-[(4-methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl)-benzamide|4-[(4-methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl}-benzamide|4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[(4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide|Imatinib (Gleevec)|Imatinib, 21|Imatinib (Standard)|Imatinib, Free base|Kinome_3724|112GI019|IMATINIB [MI]|IMATINIB [VANDF]|IMATINIB [WHO-DD]|Gleevec (TN) (Novartis)|cid_5291|SCHEMBL3827|IMATINIB [EMA EPAR]|STI-571; IMATINIB|BIDD:GT0047|GTPL5687|orb1300957|SCHEMBL29351601|SCHEMBL29355523|BDBM13530|EX-A063|BCPP000205|GLXC-05177|HMS2089D03|HMS3244P06|HMS3244P10|HMS3244P14|HMS3656K04|HMS3715P03|HMS5081I09|Imatinib base - Bio-X trade mark|Pharmakon1600-01502276|BCP01542|AC-524|HY-15463R|MSK159951|NSC759854|NSC800772|STK617705|AKOS000280662|BCP9000775|CCG-101289|CS-0964|DB00619|ES-0058|FM10813|NSC 743414|NSC 759854|NSC-800772|PA-5291|SB17306|SDCCGSBI-0634386.P009|MRF-0000449|NCGC00159456-01|NCGC00159456-03|NCGC00159456-04|NCGC00159456-05|NCGC00159456-06|NCGC00159456-07|NCGC00159456-09|NCGC00159456-16|4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide methanesulfonate|4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide|BI164570|HY-15463|N-(3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)-4-methylphenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide|N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide|SY028029|I0906|NS00009172|S2475|SW197805-5|D08066|EN300-123057|AB00698388-07|AB00698388-10|AB00698388-11|AB00698388-12|AB00698388-13|AB00698388_15|AB00698388_16|459I955|Q177094|SR-01000763561-4|SR-01000763561-6|BRD-K92723993-001-06-7|BRD-K92723993-001-12-5|BRD-K92723993-066-02-9|BRD-K92723993-066-04-5|BRD-K92723993-066-22-7|Z1546624232|1080014-82-9|4-(4-Me-piperazin-1-ylmethyl)-N-[4-Me-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-phenyl]-benzamide|4-(4-Methylpiperazin-1-yl)methyl-N-4-methyl-3-(4-pyridin-3-ylpyrimidin-2-yl)aminophenylbenzamide|4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide|4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3- pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide|4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide|4-[(4-methyl-1-piperazinyl)methyl]-n[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide|BENZAMIDE, 4-((4-METHYL-1-PIPERAZINYL)METHYL)-N-(4-METHYL-3-((4-(3-PYRIDINYL)-2-PYRIMIDINYL)AMINOPHENYL)-|benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-|Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]- (9CI)|N-[4-Methyl-3-[[4-(3-pyridyl)-2-pyrimidyl]amino]phenyl]-4-[(4-methyl-1-piperazinyl)methyl]benzamide"
ONAPRISTONE,5311505,,"InChI=1S/C29H39NO3/c1-28-18-25(19-5-8-21(9-6-19)30(2)3)27-23-12-10-22(32)17-20(23)7-11-24(27)26(28)13-15-29(28,33)14-4-16-31/h5-6,8-9,17,24-26,31,33H,4,7,10-16,18H2,1-3H3/t24-,25+,26-,28+,29+/m0/s1",IEXUMDBQLIVNHZ-YOUGDJEHSA-N,C29H39NO3,449.6,"(8S,11R,13R,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one","Onapristone|96346-61-1|Onapristona|ZK-98299|Onapristonum|ZK-299|ZK 98299|ZK299|ZK98299|H6H7G23O3N|DTXSID90242210|11 beta-(4-dimethylaminophenyl)-17 alpha-hydroxy-17 beta-(3-hydroxypropyl)-13 alpha-methyl-4,9-gonadien-3-one|(8S,11R,13R,14S,17S)-11-(4-dimethylaminophenyl)-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one|(8S,11R,13R,14S,17S)-11-(4-dimethylaminophenyl)-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta(a)phenanthren-3-one|RefChem:168240|Estra-4,9-dien-3-one, 11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(3-hydroxypropyl)-, (11beta,13alpha,17alpha)-|DTXCID90164701|(10S,11S,14S,15R,17R)-17-(4-(dimethylamino)phenyl)-14-hydroxy-14-(3-hydroxypropyl)-15-methyltetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-1,6-dien-5-one|Onapristone [INN]|Onapristone (INN)|(8S,11R,13R,14S,17S)-11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,14,15,16-decahydrocyclopenta[a]phenanthren-3-one|Onapristonum [Latin]|Onapristona [Spanish]|ZK 299|(8S,11R,13R,14S,17S)-11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(3-hydroxypropyl)-13-methyl-1,2,6,7,8,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one|Estra-4,9-dien-3-one,11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-,(11b,13a,17a)-|CCRIS 6530|UNII-H6H7G23O3N|ZK 98.299|Xe 299|ZK 299; ZK 98299|ONAPRISTONE [MI]|SCHEMBL8740|ONAPRISTONE [WHO-DD]|GTPL2882|orb1699773|CHEMBL1908373|CHEBI:229800|EX-A8027|IVV-1001|BDBM50366558|NSC792824|AKOS025311420|DB12637|NSC-792824|11beta-(p-(Dimethylamino)phenyl)-17alpha-hydroxy-17-(3-hydroxypropyl)-13alpha-estra-4,9-dien-3-one|BO161274|Estra-4,9-dien-3-one, 11-(4-(dimethylamino)phenyl)-17-hydroxy-17-(3-hydroxypropyl)-, (11-beta,13-alpha,17-alpha)-|HY-106389|CS-0025702|NS00069361|D09571|Q27088181|11.BETA.-(P-(DIMETHYLAMINO)PHENYL)-17.ALPHA.-HYDROXY-17-(3-HYDROXYPROPYL)-13.ALPHA.-ESTRA-4,9-DIEN-3-ONE|Estra-4,9-dien-3-one, 11-[4-(dimethylamino)phenyl]-17-hydroxy-17-(3-hydroxypropyl)-, (11.beta.,13.alpha.,17.alpha.)-"
RESERPINE,5770,,"InChI=1S/C33H40N2O9/c1-38-19-7-8-20-21-9-10-35-16-18-13-27(44-32(36)17-11-25(39-2)30(41-4)26(12-17)40-3)31(42-5)28(33(37)43-6)22(18)15-24(35)29(21)34-23(20)14-19/h7-8,11-12,14,18,22,24,27-28,31,34H,9-10,13,15-16H2,1-6H3/t18-,22+,24-,27-,28+,31+/m1/s1",QEVHRUUCFGRFIF-MDEJGZGSSA-N,C33H40N2O9,608.7,"methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate","reserpine|50-55-5|Serpalan|Serpasil|Apoplon|Serpivite|Alserin|Sandril|Elserpine|Hiserpia|Rau-Sed|Raunervil|Raupasil|Rausedil|Rausedyl|Rauwasedin|Reserpin|Reserpina|Serpanray|Resine|Rivasin|Serpate|(-)-Reserpine|Austrapine|Bioserpine|Carditivo|Carrserp|Enipresser|Escaspere|Eserpine|Eskaserp|Helfoserpin|Hiposerpil|Interpina|Lemiserp|Loweserp|Maviserpin|Mayserpine|Mephaserpin|Neoserfin|Purserpine|Quiescin|Rauloydin|Raumorine|Raunorine|Rauserpine|Rauserpol|Rausingle|Rauwilid|Rauwipur|Rauwoleaf|Resedrex|Reserbal|Resercaps|Resercen|Reserfia|Reserlor|Reserpamed|Reserpene|Reserpex|Reserpil|Reserpoid|Respital|Roxinoid|Alkarau|Apsical|Banasil|Benazyl|Kitine|Raucap|Raugal|Raulen|Raupoid|Raurine|Rausan|Rautrin|Reserp|Restran|Riserpa|Crystoserpine|Klimanosid|Mallopress|Reserpinum|Carpacil|Gilucard|Hydropine|Hydroserp|Naquival|Rauwita|Recipin|Resaltex|Resedril|Serpine|Hydromox-R|Rese-lar|Diurese-R|Hydrosine 25|Hydroserpalan|Deserpine|Sedaraupin|Serolfia|Serpaloid|Serpasol|Serpentina|Serpicon|Serpiloid|Serfin|Serpen|Sertabs|Sertina|Diupres 250|Diupres 500|Vio-Serpine|Hydroserpine Plus|T-Serp|Chloroserp-250|Chloroserp-500|Chloroserpin-250|3,4,5-Trimethoxybenzoyl methyl reserpate|Chloroserpine-500|Hydro-Reserpine-25|Hydro-Reserpine-50|ENT 50146|NCI-C50157|H 520|DTXSID7021237|Serpasil premix|NSC-59272|Banisil|Diupres|NSC-237659|8B1QWR724A|CHEBI:28487|NSC59272|ENT-50146|DTXCID201237|Reserpic acid methyl ester 3,4,5-trimethoxybenzoate (ester)|Yohimban-16-carboxylic acid, 11,17-dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)-, methyl ester, (3beta,16beta,17alpha,18beta,20alpha)-|(3beta,16beta,17alpha,18beta,20alpha)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylic acid methyl ester|methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate|V Serp|3-beta,20-alpha-Yohimban-16-beta-carboxylic acid, 18-beta-hydroxy-11,17-alpha-dimethoxy-, methyl ester, 3,4,5-trimethoxybenzoate (ester)|methyl (3beta,16beta,17alpha,18beta,20alpha)-11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]yohimban-16-carboxylate|methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyloxy)-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate|(3beta,16beta,17alpha,18beta,20alpha)-11,17-Dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)yohimban-16-carboxylic acid methyl ester|methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-((3,4,5-trimethoxyphenyl)carbonyloxy)-3,13-diazapentacyclo(11.8.0.0^(2,10).0^(4,9).0^(15,20))henicosa-2(10),4,6,8-tetraene-19-carboxylate|methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyloxy)-3,13-diazapentacyclo(11.8.0.0^(2,10).0^(4,9).0^(15,20))henicosa-2(10),4,6,8-tetraene-19-carboxylate|methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-[(3,4,5-trimethoxyphenyl)carbonyloxy]-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate|METHYL (3beta,16beta,17alpha,18beta,20alpha)-11,17-DIMETHOXY-18-((3,4,5-TRIMETHOXYBENZOYL)OXY)YOHIMBAN-16-CARBOXYLATE|RefChem:6196|C02AA02|200-047-9|3beta,20alpha-Yohimban-16beta-carboxylic acid, 18beta-hydroxy-11,17alpha-dimethoxy-methyl ester 3,4,5-trimethoxybenzoate (ester)|methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyloxy)-3,13-diazapentacyclo(11.8.0.02,10.04,9.015,20)henicosa-2(10),4(9),5,7-tetraene-19-carboxylate|Methyl (3R,16S,17R,18R,20S)-11,17-dimethoxy-18-(3,4,5-trimethoxybenzoyloxy)yohimban-16-carboxylate|Hydropres|Hypersil|Ascoserpina|Eskaserpine|Reserpanca|Hypersine|Idsoserp|Neoserp|Raudiford|Raudixoid|Rausedan|Rauvlid|Rawilid|Reserjen|Reserpal|Key-serpine|3P Reserp|Neo-antitensol|Rauserpin-Alk|Ryser|Diutensen-R|V-Serp|Reserpidefe|MFCD00005091|Raunova|Residin|Serpivate|Reser-ar|Sedaraupina|Temposerpine|Eberpine|Raudixin|Reserpur|Residine|Resocalm|Resperine|Rezerpin|Sandron|Sedserp|Serfolia|Serpazol|Serpena|Serpentil|Serpogen|Serpoid|Serpone|Sertens|Triserpin|Unilord|Roxel|Hydromox R|SK-Reserpine|Renese R|C33H40N2O9|Yohimban-16-carboxylic acid,11,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester,(3b,16b,17a,18b,20a)-|CHEMBL772|Broserpine|R-e-s|Sederaupin|Serpaneurona|Tefaserpina|Tenserpinie|Tepserpine|Eberspine|Reserpka|Resiatric|Resperin|Rivased|Rolserp|Roxynoid|Serpazil|Serpedin|Serpentin|Serpipur|Serpyrit|Sertensin|Serpil|Tempo-Reserpina|50-55-5 (free)|Rcra waste number U200|.gamma.-Serpine|Metatensin #2|Metatensin #4|component of Naquival|component of Regroton|Hydropres 25|Hydropres 50|Usaf cb-27|component of Renese R|component of Metatensin|NCGC00091250-04|l-Carpserp|component of Butiserpazide|Hydroserpine #1|(1S,2R,3R,4aS,13bR,14aS)-methyl 2,11-dimethoxy-3-((3,4,5-trimethoxybenzoyl)oxy)-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylate|methyl (1S,2R,3R,4aS,13bR,14aS)-2,11-dimethoxy-3-((3,4,5-trimethoxybenzoyl)oxy)-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylate|Hydro-Fluserpine #1|l -Carpserp|Caswell No. 722A|Serp-AFD|Reserpina [INN-Spanish]|3,5-Trimethoxybenzoyl methyl reserpate|methyl (3beta,16beta,17alpha,18beta,20alpha)-11,17-bis(methyloxy)-18-({[3,4,5-tris(methyloxy)phenyl]carbonyl}oxy)yohimban-16-carboxylate|SMR000059122|Apoplon (TN)|CCRIS 550|Serpine (pharmaceutical)|HSDB 213|Methyl reserpate 3,5-trimethyloxybenzoic acid|11,17-Dimethoxy-18-((3,4,5-trimethoxybenzoyl)oxy)yohimban-16-carboxylic acid methyl ester|Methyl reserpate 3,5-trimethoxybenzoic acid ester|EINECS 200-047-9|RCRA waste no. U200|EPA Pesticide Chemical Code 123101|NSC 237659|BRN 0102014|UNII-8B1QWR724A|AI3-50146|Reserpine?|WLN: T F6 D5 C666 EM ON&&TTTJ HO1 SOVR CO1 DO1 EO1& TO1 UVO1|Reserpine [USP:INN:BAN:JAN]|CAS-50-55-5|Serpalan (TN)|3-.beta., 18-.beta.-hydroxy-11,17-.alpha.-dimethoxy-,methyl ester, 3,4,5-trimethoxybenzoate (ester)|3.beta., 18.beta.-hydroxy-11,17.alpha.-dimethoxy- methyl ester 3,4,5-trimethoxybenzoate (ester)|Benz[g]indolo[2, 1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydro-3-hydroxy-2,11-dimethoxy-, methyl ester, 3,4,5-trimethoxybenzoate|methyl (3beta,16beta,17alpha,18beta,20alpha)-11,17-dimethoxy-18-{[(3,4,5-trimethoxyphenyl)carbonyl]oxy}yohimban-16-carboxylate|Yohimban-16-carboxylic acid,17-dimethoxy-18-[(3,4,5-trimethoxybenzoyl)oxy]-, methyl ester, (3.beta.,16.beta.,17.alpha.,18.beta.,20.alpha.)-|Prestwick_147|Methyl reserpate 3,4,5-trimethoxybenzoic acid ester|Reserpine, 99%|Reserpine (Standard)|Spectrum_000109|RESERPINE [INN]|RESERPINE [JAN]|RESERPINE [MI]|79 more names available|RESERPINE [HSDB]|RESERPINE [IARC]|Prestwick0_000875|Prestwick1_000875|Prestwick2_000875|Prestwick3_000875|Spectrum3_000894|Spectrum4_000989|Spectrum5_001415|RESERPINE [VANDF]|RESERPINUM [HPUS]|RESERPINE [MART.]|R 0875|RESERPINE [USP-RS]|RESERPINE [WHO-DD]|RESERPINE [WHO-IP]|SCHEMBL2589|Lopac0_000073|BSPBio_000949|KBioGR_001397|KBioSS_000549|4-25-00-01319 (Beilstein Handbook Reference)|Methyl 18beta-hydroxy-11,17alpha-dimethoxy-3beta,20alpha-yohimban-16beta-carboxylate 3,4,5-trimethoxybenzoate (ester)|methyl dimethoxy-(3,4,5-trimethoxybenzoyl)oxy-[?]carboxylate|MLS002154046|MLS006011754|DivK1c_000012|SPECTRUM1500526|Reserpine - Bio-X trade mark|SPBio_002870|Reserpine (JP18/USP/INN)|BPBio1_001045|GTPL4823|MEGxp0_001904|orb1310288|RESERPINE [ORANGE BOOK]|RESERPINE [EP MONOGRAPH]|SCHEMBL29433537|ACon1_000086|HMS500A14|HY-N0480R|KBio1_000012|KBio2_000549|KBio2_003117|KBio2_005685|KBio3_001808|RESERPINE [USP MONOGRAPH]|NINDS_000012|RESERPINUM [WHO-IP LATIN]|UNIPRES COMPONENT RESERPINE|GLXC-06082|HMS1570P11|HMS1920P04|HMS2092G05|HMS2097P11|HMS2234E24|HMS3260O07|HMS3413D20|HMS3677D20|HMS3714P11|HMS3884I21|Pharmakon1600-01500526|DRALSERP COMPONENT RESERPINE|NAQUIVAL COMPONENT RESERPINE|REGROTON COMPONENT RESERPINE|HY-N0480|HYDROPRES COMPONENT RESERPINE|MSK10079|RENESE-R COMPONENT RESERPINE|Reserpine, Vetec(TM) reagent grade|RKL10049|HYDRAP-ES COMPONENT RESERPINE|Tox21_111107|Tox21_202395|Tox21_300537|Tox21_500073|BBL028800|BDBM50017712|CAM-AP-ES COMPONENT RESERPINE|H.R.-50 COMPONENT RESERPINE|HB1895|METATENSIN COMPONENT RESERPINE|NSC237659|NSC757309|SALUTENSIN COMPONENT RESERPINE|SER-A-GEN COMPONENT RESERPINE|SER-AP-ES COMPONENT RESERPINE|STK801975|HYDROMOX R COMPONENT RESERPINE|AKOS000277559|DIUTENSEN-R COMPONENT RESERPINE|Tox21_111107_1|CCG-204168|CS-1913|DB00206|FR09862|HYDRO-RESERP COMPONENT RESERPINE|KS-5106|LP00073|NSC-757309|SDCCGSBI-0050061.P005|DEMI-REGROTON COMPONENT RESERPINE|IDI1_000012|NCGC00091250-01|NCGC00091250-02|NCGC00091250-03|NCGC00091250-05|NCGC00091250-06|NCGC00091250-07|NCGC00091250-08|NCGC00091250-09|NCGC00091250-10|NCGC00091250-12|NCGC00091250-14|NCGC00091250-25|NCGC00254489-01|NCGC00259944-01|NCGC00260758-01|3beta,20alpha-Yohimban-16beta-carboxylic acid, 18beta-hydroxy-11,17alpha-dimethoxy- methyl ester 3,4,5-trimethoxybenzoate (ester)|AC-13142|AC-34405|BR164333|NCI60_004446|SBI-0050061.P004|SERPASIL-ESIDRIX COMPONENT RESERPINE|EU-0100073|NS00000355|Reserpine, crystallized, >=99.0% (HPLC)|SW196458-3|UNM000011053801|EN300-84477|SERPASIL-APRESOLINE COMPONENT RESERPINE|C06539|D00197|AB01562943_01|005R091|AE-508/21131019|AJ-160/21107004|Q407841|BRD-K95921201-001-07-0|BRD-K95921201-001-12-0|BRD-K95921201-001-13-8|BRD-K95921201-001-14-6|BRD-K95921201-001-15-3|HYDROSERPINE PLUS (R-H-H) COMPONENT RESERPINE|Methyl reserpate; 3,4,5-Trimethoxybenzoic acid ester|Reserpine, certified reference material, TraceCERT(R)|Z1251172867|Reserpine, European Pharmacopoeia (EP) Reference Standard|Reserpine Standard for LC-MS, analytical standard, for LC-MS|Reserpine, United States Pharmacopeia (USP) Reference Standard|Reserpine, Pharmaceutical Secondary Standard; Certified Reference Material|HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE COMPONENT RESERPINE|(1S,2R,3R,4aS,13bR,14aS)-methyl2,11-dimethoxy-3-((3,4,5-trimethoxybenzoyl)oxy)-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydroindolo[2',3':3,4]pyrido[1,2-b]isoquinoline-1-carboxylate|methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylateEE|methyl (1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyloxy)-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate|METHYL (3.BETA.,16.BETA.,17.ALPHA.,18.BETA.,20.ALPHA.)-11,17-DIMETHOXY-18-((3,4,5-TRIMETHOXYBENZOYL)OXY)YOHIMBAN-16-CARBOXYLATE|methyl (4R)-11,17beta-dimethoxy-18beta-[(3,4,5-trimethoxybenzoyl)oxy]-3beta,20alpha-yohimban-16beta-carboxylate|METHYL 18.BETA.-HYDROXY-11,17.ALPHA.-DIMETHOXY-3.BETA.,20.ALPHA.-YOHIMBAN-16.BETA.-CARBOXYLATE 3,4,5-TRIMETHOXYBENZOATE (ESTER).|methyl(1R,15S,17R,18R,19S,20S)-6,18-dimethoxy-17-(3,4,5-trimethoxybenzoyl)oxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate"
NICARDIPINE,4474,,"InChI=1S/C26H29N3O6/c1-17-22(25(30)34-4)24(20-11-8-12-21(15-20)29(32)33)23(18(2)27-17)26(31)35-14-13-28(3)16-19-9-6-5-7-10-19/h5-12,15,24,27H,13-14,16H2,1-4H3",ZBBHBTPTTSWHBA-UHFFFAOYSA-N,C26H29N3O6,479.5,"5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","nicardipine|55985-32-5|Nicardipino|Nicardipinum|Perpidine|Nicardipine (stn)|CHEBI:7550|DTXSID6023363|CZ5312222S|DTXCID903363|3-(2-(benzyl(methyl)amino)ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|5-O-[2-[benzyl(methyl)amino]ethyl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester|3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-[methyl(phenylmethyl)amino]ethyl ester|3-{2-[benzyl(methyl)amino]ethyl} 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|nicardipina|LA, Nicardipine|5-O-(2-(benzyl(methyl)amino)ethyl) 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|O5-methyl O3-(2-(methyl-(phenylmethyl)amino)ethyl) 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|O5-methyl O3-[2-(methyl-(phenylmethyl)amino)ethyl] 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|RefChem:56587|Hydrochloride, Nicardipine|C08CA04|259-932-3|Nicardipinum [INN-Latin]|Nicardipino [INN-Spanish]|Cardene|Nicardipine (INN)|YC-93 (free base)|Cardene (TN)|MFCD00216027|2-(Benzylmethylamino)ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)pyridine-3,5-dicarboxylate|3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-(benzylmethylamino)ethyl methyl ester|NCGC00015747-03|NICARDIPINE [INN]|Nicardipine [INN:BAN]|Methyl 2-(benzyl-methyl-amino)ethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|CAS-55985-32-5|(+/-)-Nicardipine|EINECS 259-932-3|BRN 0504321|UNII-CZ5312222S|(R,S)-nicardipine|Spectrum_001372|NICARDIPINE [MI]|Prestwick0_000383|Prestwick1_000383|Prestwick2_000383|Prestwick3_000383|Spectrum2_001415|Spectrum3_001452|Spectrum4_000422|Spectrum5_001320|NICARDIPINE [VANDF]|CHEMBL1484|CBiol_001802|Lopac0_000809|Oprea1_436998|SCHEMBL34277|BSPBio_000565|BSPBio_001389|BSPBio_002943|KBioGR_000109|KBioGR_000744|KBioSS_000109|KBioSS_001852|NICARDIPINE [WHO-DD]|BIDD:GT0621|DivK1c_000540|SPBio_001490|SPBio_002486|BPBio1_000623|GTPL2559|orb1306351|CHEMBL3302409|SCHEMBL29430153|KBio1_000540|KBio2_000109|KBio2_001852|KBio2_002677|KBio2_004420|KBio2_005245|KBio2_006988|KBio3_000217|KBio3_000218|KBio3_002443|CHEBI:180905|NINDS_000540|Bio1_000088|Bio1_000577|Bio1_001066|Bio2_000109|Bio2_000589|HMS1791F11|HMS1989F11|HMS2089C09|HMS3886G17|HMS5084P19|BCP21397|EX-A4680|MSK10213|Tox21_110211|BDBM50101815|s5255|AKOS001637090|AKOS040744847|Tox21_110211_1|CCG-204893|CS-3685|DB00622|FN65103|SDCCGSBI-0050786.P004|IDI1_000540|IDI1_033859|NCGC00015747-02|NCGC00015747-04|NCGC00015747-05|NCGC00015747-06|NCGC00015747-07|NCGC00015747-09|NCGC00015747-11|NCGC00015747-18|NCGC00162262-01|NCGC00162262-02|NCGC00162262-03|NCGC00162262-04|AC-19947|AC-36578|AS-56335|HY-12515|methyl 2-[methyl(phenylmethyl)amino]ethyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|O5-[2-[benzyl(methyl)amino]ethyl] O3-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|PD033077|PD156023|SY284542|SBI-0050786.P003|DB-052833|AB00514658|NS00002168|A12641|C07264|D08270|EN300-708781|AB00053604-03|AB00053604_04|AB00053604_05|985N325|L000715|Q729213|BRD-A26711594-001-02-7|BRD-A26711594-003-05-6|BRD-A26711594-003-06-4|BRD-A26711594-003-08-0|BRD-A26711594-003-10-6|106664-28-2|2,6-dimethyl-3-methoxycarbonyl-4-(3-nitrophenyl)-5-[ 2-(N-benzyl-N-methylamino)ethoxycarbonyl]-1,4-dihydropyridine|2-(Benzylmethylamino) ethyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|2-(Benzylmethylamino)ethyl methyl 1.4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|2-(N-benzyl-N-methylamino)ethyl methyl 2,6-dimethyl-4(m-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|2-[benzyl(methyl)amino]ethyl methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|3,5-PYRIDINEDICARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-, 3-METHYL 5-(2-(METHYL(PHENYLMETHYL)AMINO)ETHYL) ESTER|3,5_Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, methyl 2-(methyl(phenylmethyl)amino)ethyl ester|3-(2-[Benzyl(methyl)amino]ethyl) 5-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate #|5-O-[2-[Benzyl(methyl)amino]ethyl] 3-O-methyl-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate"
TARIQUIDAR,148201,,"InChI=1S/C38H38N4O6/c1-45-33-18-25-14-16-42(23-28(25)19-34(33)46-2)15-13-24-9-11-29(12-10-24)40-38(44)30-20-35(47-3)36(48-4)21-32(30)41-37(43)27-17-26-7-5-6-8-31(26)39-22-27/h5-12,17-22H,13-16,23H2,1-4H3,(H,40,44)(H,41,43)",LGGHDPFKSSRQNS-UHFFFAOYSA-N,C38H38N4O6,646.7,"N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide","Tariquidar|206873-63-4|XR9576|XR 9576|N-(2-((4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)carbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide|N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide|XR-9576|J58862DTVD|DTXSID10174746|tariquidarth|tariquidarum|N-(2-((4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)carbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide|N-(2-((4-(2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl)phenyl)carbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide|N-[2-({4-[2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]phenyl}carbamoyl)-4,5-dimethoxyphenyl]quinoline-3-carboxamide|N-[2-[[4-[2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl]phenyl]carbamoyl]-4,5-dimethoxyphenyl]quinoline-3-carboxamide|RefChem:891172|DTXCID6097237|110-912-1|C38H38N4O6|MFCD09837824|3-QUINOLINECARBOXAMIDE, N-[2-[[[4-[2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL]PHENYL]AMINO]CARBONYL]-4,5-DIMETHOXYPHENYL]-|CHEMBL348475|3-Quinolinecarboxamide,N-(2-(((4-(2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)amino)carbonyl)-4,5-dimethoxyphenyl)-|Tariquidar [USAN]|Tariquidar (USAN/INN)|UNII-J58862DTVD|Tariquidar [USAN:INN:BAN]|3-Quinolinecarboxamide, N-(2-(((4-(2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)amino)carbonyl)-4,5-dimethoxyphenyl)-|N-[2-[[[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]amino]carbonyl]-4,5-dimethoxyphenyl]-3-quinolinecarboxamide; XR 9576;|R1H|TARIQUIDAR [MI]|TARIQUIDAR [INN]|Tariquidar (XR9576)?|TARIQUIDAR [WHO-DD]|MLS006011218|N-[2-[[4-[2-(6,7-DIMETHOXY-3,4-DIHYDRO-1H-ISOQUINOLIN-2-YL)ETHYL]PHENYL]CARBAMOYL]-4,5-DIMETHOXY-PHENYL]QUINOLINE-3-CARBOXAMIDE|SCHEMBL104163|orb1300901|SCHEMBL21545178|SCHEMBL29387021|SCHEMBL29558585|Tariquidar, >=98% (HPLC)|GTPL11787|EX-A231|CHEBI:177609|HMS3653L21|BCP06102|BDBM50075373|s8028|AKOS016008964|CCG-270326|compound 2 [PMID: 10098671]|CS-0722|DB06240|FT46245|PB29709|NCGC00346448-01|NCGC00346448-06|NCGC00346448-08|AC-31048|AS-75190|DA-08376|HY-10550|N-(2-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenylcarbamoyl)-4,5-dimethoxyphenyl)quinoline-3-carboxamide|SMR004702980|NS00069844|SW219804-1|D06008|873T634|Q7686198|BRD-K09353376-001-02-1|BRD-K09353376-001-03-9|1N-{4-[2-(6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolinyl)ethyl]phenyl}-4,5-dimethoxy-2-(3-quinolylcarboxamido)benzamide"
HALOPERIDOL,3559,,"InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2",LNEPOXFFQSENCJ-UHFFFAOYSA-N,C21H23ClFNO2,375.9,4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one,"haloperidol|52-86-8|Serenace|Aloperidin|Eukystol|Brotopon|Serenase|Serenelfi|Linton|Dozic|Einalon S|Aloperidolo|Galoperidol|Halopoidol|Halopal|Keselan|Ulcolind|Uliolind|Pernox|Sernas|Sernel|Aldo|Bioperidolo|Sigaperidol|Peluces|Haldol Solutab|Haloperidolum|Fortunan|Halosten|McN-JR-1625|4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-1-(4-fluorophenyl)butan-1-one|R-1625|4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-1-(4-fluorophenyl)butan-1-one|R 1625|1-(3-p-Fluorobenzoylpropyl)-4-p-chlorophenyl-4-hydroxypiperidine|4'-Fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidinyl)butyrophenone|4'-Fluoro-4-(4-hydroxy-4-(4'-chlorophenyl)piperidino)butyrophenone|NSC-170973|NSC-615296|CHEBI:5613|DTXSID4034150|J6292F8L3D|4-(4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-1-butanone|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone|NSC170973|4-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|1-Butanone, 4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl)-1-(4-fluorophenyl)-|DTXCID2014150|4'-Fluoro-4-(4-hydroxy-4-p-chlorophenylpiperidino)butyrophenone|4-(4-(para-Chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|4-[4-(p-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone|gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorbutyrophenone|gamma-(4-(p-Chlorophenyl)-4-hydroxypiperidino)-p-fluorobutyrophenone|Butyrophenone, 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluoro-|1-Butanone, 4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-|VESALIUM COMPONENT HALOPERIDOL|gamma-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone|4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)-butan-1-one|Butyrophenone, 4-[4-(p-chlorophenyl)-4-hydroxypiperidino]-4'-fluoro-|Kentace|Keselen|Dolpin|4'-Fluoro-4-[4-hydroxy-4-(4'-chlorophenyl)piperidino]butyrophenone|gamma-[4-(p-chlorophenyl)-4-hydroxypiperidino]-p-fluorobutyrophenone|4-[4-(para-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone|4-(4-(4-chlorophenyl)-4-hydroxy-1-piperidyl)-1-(4-fluorophenyl)-butan-1-one|RefChem:5876|N05AD01|200-155-6|Aloperidol|Halojust|Mixidol|Lealgin compositum|Aloperidon|C21H23ClFNO2|177716-59-5|MFCD00051423|Haloperidol (Haldol)|CHEMBL54|Haldol (TN)|4-(4-Hydroxy-4'-chloro-4-phenylpiperidino)-4'-fluorobutyrophenone|MLS000028450|Butyrophenone, 4'-fluoro-4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-|MDMO-PPV|4-[4-(4-chlorophenyl)-4-hydroxy-1-piperidyl]-1-(4-fluorophenyl)butan-1-one|NSC615296|CAS-52-86-8|NCGC00015500-10|Aloperidolo [DCIT]|Halidol|Halopidol|Pekuces|SMR000058303|Halol|Aloperidolo [Italian]|Epoxy resins|4-[4-(4-Chlorophenyl)-4-hydroxypiperidino]-4'-fluorobutyrophenone|Haloperidolum [INN-Latin]|Neurodol|NSC 170973|CCRIS 1630|HSDB 3093|SR-01000003076|EINECS 200-155-6|NSC 615296|BRN 0331267|Duraperidol|UNII-J6292F8L3D|Picroside-III|Haloperidol, 1|Haloperidol, powder|Prestwick_250|Haloperidol [USAN:USP:INN:BAN:JAN]|PS14 - Haloperidol|Haloperidol (Standard)|Spectrum_000861|Tocris-0931|starbld0018801|Opera_ID_446|HALOPERIDOL [MI]|4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-1-(4-fluoro-phenyl)-butan-1-one;propionate(HCl)|Prestwick0_000115|Prestwick1_000115|Prestwick2_000115|Prestwick3_000115|Spectrum2_001268|Spectrum3_000448|Spectrum4_000570|Spectrum5_000788|HALOPERIDOL [INN]|HALOPERIDOL [JAN]|Lopac-H-1512|HALOPERIDOL [HSDB]|HALOPERIDOL [USAN]|Biomol-NT_000035|GTPL86|Probes1_000255|Probes2_000296|H 1512|HALOPERIDOL [VANDF]|SCHEMBL8264|HALOPERIDOL [MART.]|Lopac0_000583|Oprea1_509923|BSPBio_000130|BSPBio_002096|HALOPERIDOL [USP-RS]|HALOPERIDOL [WHO-DD]|HALOPERIDOL [WHO-IP]|KBioGR_000980|KBioGR_002390|KBioSS_001341|KBioSS_002395|5-21-02-00377 (Beilstein Handbook Reference)|MLS001146904|BIDD:GT0128|DivK1c_000654|SPECTRUM1500325|SPBio_001236|SPBio_002069|McM-JR-1625|BPBio1_000144|BPBio1_001231|orb1311010|Haloperidol (JP18/USP/INN)|Haloperidol - Bio-X trade mark|BDBM21398|Haloperidol, 1mg/ml in Methanol|HMS502A16|KBio1_000654|KBio2_001341|KBio2_002390|KBio2_003909|KBio2_004958|KBio2_006477|KBio2_007526|KBio3_001316|KBio3_002869|LNEPOXFFQSENCJ-UHFFFAOYSA-|HALOPERIDOL [ORANGE BOOK]|MSK7134|cMAP_000037|Haloperidol for system suitability|NINDS_000654|AC250|GLXC-06536|HALOPERIDOL [EP MONOGRAPH]|HALOPERIDOL [USP IMPURITY]|Haloperidol for peak identification|HMS1568G12|HMS1920D03|HMS2089M15|HMS2091J09|HMS2095G12|HMS2234P08|HMS3261F08|HMS3370H11|HMS3657I13|HMS3712G12|HMS5080H05|Pharmakon1600-01500325|HALOPERIDOL [USP MONOGRAPH]|BCP33202|Haloperidol 1.0 mg/ml in Methanol|STR04750|Tox21_110162|Tox21_300475|Tox21_500583|A0H334|CCG-36042|CCG-39111|HALOPERIDOLUM [WHO-IP LATIN]|HY-14538R|NSC757054|STL417208|AKOS000280660|Samarium(III) acetylacetonate xhydrate|Tox21_110162_1|AT13670|CS-1971|DB00502|FH23734|LP00583|NSC-757054|SDCCGSBI-0050565.P005|IDI1_000654|MRF-0000027|QTL1_000042|WLN: T6NTJ A3VR DF& DQ DR DG|NCGC00015500-01|NCGC00015500-02|NCGC00015500-03|NCGC00015500-04|NCGC00015500-05|NCGC00015500-06|NCGC00015500-07|NCGC00015500-08|NCGC00015500-09|NCGC00015500-11|NCGC00015500-12|NCGC00015500-13|NCGC00015500-14|NCGC00015500-15|NCGC00015500-16|NCGC00015500-17|NCGC00015500-19|NCGC00015500-24|NCGC00015500-32|NCGC00016234-01|NCGC00023875-02|NCGC00023875-04|NCGC00023875-05|NCGC00023875-06|NCGC00023875-07|NCGC00023875-08|NCGC00023875-09|NCGC00254503-01|NCGC00261268-01|AC-19691|BH166165|DA-74000|HY-14538|SY052276|SBI-0050565.P004|Haloperidol decanoate impurity, haloperidol-|SC 170973|AB00052008|EU-0100583|H0912|NS00010402|S1920|ST50319916|SW196557-4|C01814|D00136|M04089|VU0239704-10|AB00052008-21|AB00052008-22|AB00052008_23|AB00052008_24|L000288|Q251347|SR-01000003076-2|SR-01000003076-8|BRD-K67783091-001-04-8|BRD-K67783091-001-05-5|BRD-K67783091-001-25-3|BRD-K67783091-001-26-1|BRD-K67783091-003-03-6|BRD-K67783091-003-07-7|HALOPERIDOL DECANOATE IMPURITY G [EP IMPURITY]|SR-01000003076-11|Z1590789254|Haloperidol, European Pharmacopoeia (EP) Reference Standard|.gamma.-[4-(p-Chlorphenyl)-4-hydroxpiperidino]-p-fluorbutyrophenone|HALOPERIDOL DECANOATE IMPURITY, HALOPERIDOL- [USP IMPURITY]|Haloperidol, United States Pharmacopeia (USP) Reference Standard|.gamma.-(4-(p-Chlorophenyl)-4-hydroxpiperidino)-p-fluorbutyrophenone|4-[4-(4-chlorophenyl)-4-hydroxypiperidyl]-1-(4-fluorophenyl)butan-1-one|Haloperidol, Pharmaceutical Secondary Standard; Certified Reference Material|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl) -1-butanone|Haloperidol for peak identification, European Pharmacopoeia (EP) Reference Standard|Haloperidol for system suitability, European Pharmacopoeia (EP) Reference Standard|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-1-(4-fluorophenyl)-1-butanone;R-1625;Aloperidin|4-4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl-1-(4-fluorophenyl)-1-butanone;R-1625;Aloperidin|InChI=1/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2|Poly[2-methoxy-5-(3 inverted exclamation marka,7 inverted exclamation marka-dimethyloctyloxy)-1,4-phenylenevinylene]"
STANOLONE,10635,,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h12,14-17,21H,3-11H2,1-2H3/t12-,14-,15-,16-,17-,18-,19-/m0/s1",NVKAWKQGWWIWPM-ABEVXSGRSA-N,C19H30O2,290.4,"(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one","STANOLONE|Androstanolone|dihydrotestosterone|521-18-6|Andractim|Anabolex|Androlone|Neodrol|4-Dihydrotestosterone|Anaboleen|Stanaprol|Proteina|Protona|Cristerona MB|5alpha-Dihydrotestosterone|17beta-Hydroxy-5alpha-androstan-3-one|Androstanolona|Androstanolonum|5-alpha-Dihydrotestosterone|5alpha-Androstan-17beta-ol-3-one|Testosterone, dihydro-|4,5alpha-Dihydrotestosterone|Dihydrotestosteron|5alpha-DHT|Androstalone|17beta-Hydroxy-3-androstanone|dihydrotestosterone (dht)|Androstan-17beta-ol-3-one|5alpha,17beta-Hydroxyandrostan-3-one|CHEBI:16330|NSC-10972|DTXSID9022364|08J2K08A3Y|Androstan-3-one, 17-hydroxy-, (5alpha,17beta)-|17beta-Hydroxy-5alpha-androstane-3-one|DTXCID202364|(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-3-one|(5alpha,17beta)-17-hydroxyandrostan-3-one|NSC10972|(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta(a)phenanthren-3-one|17 beta Hydroxy 5 beta Androstan 3 One|5 alpha DHT|5-alpha-DHT|RefChem:587772|5 beta Dihydrotestosterone|5 alpha Dihydrotestosterone|5 alpha-Dihydrotestosterone|5-alpha Dihydrotestosterone|Dihydrotestosterone, 5-alpha|THERAPEUTIC ANDROSTANOLONE|A14AA01|G03BB02|LG152|17beta Hydroxy 5alpha Androstan 3 One|beta-Hydroxy-5 beta-Androstan-3-One, 17|(1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadecan-5-one|208-307-3|DHT|Stanorone|NSC 10972|Androstanolone [INN]|17-beta-Hydroxy-5-alpha-androstan-3-one|17beta-Hydroxyandrostan-3-one|5alpha-dihydrotesosterone|5alpha dihydrotestosterone|5.alpha.-Dihydrotestosterone|5alpha-Androstan-3-one, 17beta-hydroxy-|CHEMBL27769|4,5.alpha.-Dihydrotestosterone|17beta-Hydroxy-androstan-3-one|5-alpha-Androstan-3-one, 17-beta-hydroxy-|521-18-6 (free)|17.beta.-Hydroxy-3-androstanone|Androstanolone (INN)|5.alpha.-Androstan-17.beta.-ol-3-one|NCGC00091013-01|Stanolon|5.alpha.,17.beta.-Hydroxyandrostan-3-one|[3H]DHT|BDBM50366473|5alpha-Dihydroxytestosterone|Androstanolone (1mg/ml in Acetonitrile)|Androstanolonum [INN-Latin]|(1S,2S,7S,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-5-one|(5S,8R,9S,10S,13S,14S,17S)-17-hydroxy-10,13-dimethylhexadecahydro-3H-cyclopenta[a]phenanthren-3-one|CAS-521-18-6|Androstanolona [INN-Spanish]|4,5-alpha-Dihydrotestosterone|5-.alpha.-Androstanolone|Androstanolone (1.0 mg/mL in Acetonitrile)|5.alpha.-Androstan-3-one, 17.beta.-hydroxy-|[3H]dihydrotestosterone|[3H]-dihydrotestosterone|EINECS 208-307-3|5alpha,17eta-Hydroxyandrostan-3-one|Androstan-17.beta.-ol-3-one|5-alpha-Androstan-17-beta-ol-3-one|17-beta-hydroxyandrostan-3-one|Androstan-3-one, 17-hydroxy-, (5.alpha.,17.beta.)-|Andrin|UNII-08J2K08A3Y|(+)-Androstan-17.beta.-ol-3-one|1kdk|2ama|Androstan-3-one, 17-hydroxy-, (5a,17b)-|(5-alpha,17-beta)-17-Hydroxyandrostan-3-one|Andractim (TN)|5-a-Androstanolone|5alpha-Androstanolone|5a-Dihydrotestosterone|Androstanolone (DHT)|17-.beta.-Hydroxy-5-.alpha.-androstan-3-one|5-alpha-Androstanolone|1d2s|1t5z|1t7r|STANOLONE [MI]|(5.alpha.,17.beta.)-17-Hydroxy-androstan-3-one|4,5a-Dihydrotestosterone|Androstan-17b-ol-3-one|Epitope ID:135868|17-Hydroxyandrostan-3-one, (5.alpha.,17.beta.)- #|EC 208-307-3|17b-Hydroxy-3-androstanone|BIDD:PXR0075|SCHEMBL15163|17-Hydroxy-androstan-3-one|MLS001304063|5a-Androstan-17b-ol-3-one|BIDD:ER0136|5.alpha.-Dihydroxytestosterone|5A-Androstan-3-on-17B-ol|5B-Androstan-3-on-17B-ol|ANDROSTANOLONE [MART.]|GTPL2856|GTPL3455|orb2647466|ANDROSTANOLONE [WHO-DD]|BDBM18161|1t63|(+)-Androstan-17beta-ol-3-one|HMS2272H05|HY-A0120|Tox21_111056|Tox21_200987|Tox21_303655|LMST02020042|MSK8502-100A|s4757|AKOS015894892|CCG-267385|CS-5096|DB02901|FA17912|GS-6587|NCGC00091013-02|NCGC00091013-03|NCGC00257456-01|NCGC00258540-01|17beta-hydroxy-3-oxo-5alpha-androstanone|AC-16144|AC-33095|SMR000058342|NS00005234|TESTOSTERONE IMPURITY F [EP IMPURITY]|5alpha-Androstan-17beta-ol-3-one, >=97.5%|C03917|D07456|521S186|5Alpha-Dihydrotestosterone, 1mg/ml in Acetonitrile|Q411054|17.BETA.-HYDROXY-5.ALPHA.-ANDROSTAN-3-ONE|17.BETA.-HYDROXY-5.ALPHA.-ANDROSTANE-3-ONE|Androstanolone (5alpha-Dihydrotestosterone, Stanolone)|BRD-K22525962-001-05-0|Dihydrotestosterone Solution in Acetonitrile, 100ug/mL|5alpha-Androstan-17beta-ol-3-one, purum, >=99.0% (TLC)|5alpha-Androstan-17beta-ol-3-one, VETRANAL(TM), analytical standard|(5a,17b)-17-Hydroxyandrostan-3-one;Dihydrotestosterone;5a-Dihydrotestosterone|Androstanolone (5alpha-Dihydrotestosterone, Stanolone) 1.0 mg/ml in Acetonitrile|(5S,8R,10S,13S,17S)-17-Hydroxy-10,13-dimethyl-hexadecahydro-cyclopenta[a]phenanthren-3-one|17-hydroxy-10,13-dimethyl-1,2,4,5,6,7,8,9,10,11,12,13,14,15,16, 17-hexadecahydrocyclopenta[a]phenanthren-3-one"
METRIBOLONE,261000,,"InChI=1S/C19H24O2/c1-18-9-7-15-14-6-4-13(20)11-12(14)3-5-16(15)17(18)8-10-19(18,2)21/h7,9,11,16-17,21H,3-6,8,10H2,1-2H3/t16-,17+,18+,19+/m1/s1",CCCIJQPRIXGQOE-XWSJACJDSA-N,C19H24O2,284.4,"(8S,13S,14S,17S)-17-hydroxy-13,17-dimethyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one","Methyltrienolone|METRIBOLONE|965-93-5|Metribolona|R1881|17alpha-Methyltrienolone|Metribolonum|R 1881|RU 1881|Ru-1881|17-beta-Hydroxy-17-methylestra-4,9,11-trien-3-one|NSC-92858|DTXSID8034162|2C323EGI97|(8S,13S,14S,17S)-17-hydroxy-13,17-dimethyl-1,2,6,7,8,14,15,16-octahydrocyclopenta[a]phenanthren-3-one|estra-4,9,11-trien-3-one, 17-hydroxy-17-methyl-, (17beta)-|Ru1881|(8S,13S,14S,17S)-17-hydroxy-13,17-dimethyl-1,2,6,7,8,14,15,16-octahydrocyclopenta(a)phenanthren-3-one|RefChem:389124|DTXCID6014162|17 beta-Hydroxy-17 alpha-methylestra-4,9,11-trien-3-one|663-842-3|R-1881|17beta-Hydroxy-17-methylestra-4,9,11-trien-3-one|[3H]methyltrienolone|(17BETA)-17-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE|R1881 (synthetic androgen)|CHEBI:379896|17-methyloestra-4,9,11-trien-3-one,17beta-ol|(8S,13S,14S,17S)-17-hydroxy-13,17-dimethyl-1,2,6,7,8,13,14,15,16,17-decahydro-3H-cyclopenta[a]phenanthren-3-one|Metribolone (1.0mg/ml in Acetonitrile)|MLS002695156|Metribolone [INN:DCF]|Metribolonum [INN-Latin]|Metribolona [INN-Spanish]|UNII-2C323EGI97|Methyl trienolone|1xow|NSC 92858|1e3g|2ao6|Estra-4,9,11-trien-3-one, 17-hydroxy-17-methyl-, (17b)-|[3H]R1881|METRIBOLONE [INN]|[3H]-R1881|17.alpha.-Methyltrienolone|METRIBOLONE [MART.]|17-.alpha.-Methyltrienolone|METHYLTRIENOLONE [MI]|METRIBOLONE [WHO-DD]|SCHEMBL114862|CHEMBL166444|GTPL2857|GTPL3457|GLXC-02541|(1S,3aS,3bS,11aS)-1-hydroxy-1,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,11aH-cyclopenta[a]phenanthren-7-one|NSC92858|BDBM50367916|AKOS015840270|DB02998|AC-32028|R1881, >=98% (HPLC)|965M935|A845615|Q3333717|17-.beta.-Hydroxy-17-methylestra-4,11-trien-3-one|17alpha-Methyl-3-oxo-4,9,11-estratrien-17beta-ol|17alpha-methyl-4,9,11,estratrien-17beta-ol-3-one|3-Oxo-17beta-hydroxy-17-methylestra-4,9,11-triene|17alpha-Methyl-17beta-hydroxyestr-4,9,11-trien-3-one|17alpha-Methyl-17beta-hydroxyestra-4,9,11-trien-3-one|Estra-4,11-trien-3-one, 17.beta.-hydroxy-17-methyl-|Estra-4,9,11-trien-3-one, 17beta-hydroxy-17-methyl-|17alpha-methyl-17beta-hydroxy-estra-4,9,11-trien-3-one|3-Oxo-17beta-hydroxy-17alpha-methylestra-4,9,11-triene|(17beta)-17-hydroxy-17-methyl-estra-4,9,11-triene-3-one|17-beta-hydroxy-17-methylestra-4,9,11-trien-3-one (9CI)|17.BETA.-HYDROXY-17-METHYLESTRA-4,9,11-TRIEN-3-ONE|17alpha-Methyl-17beta-hydroxyestra-4,9(10),11-trien-3-one|Estra-4,9,11-trien-3-one, 17beta-hydroxy-17-methyl- (8CI)|17-beta-hydroxy-17-methyl-19-norandrosta-4,9,11-triene-3-one|Estra-4,11-trien-3-one, 17-hydroxy-17-methyl-, (17.beta.)-|Estra-4,9,11-trien-3-one, 17beta-hydroxy-17-methyl- (7CI,8CI)|Estra-4,9,11-trien-3-one, 17-hydroxy-17-methyl-, (17beta)- (9CI)|METHYLTRIENOLONE; 17BETA-HYDROXY-17METHYL-19NORANDROSTA-4,9,11-TRIEN-3-ONE; R1881"
ENZALUTAMIDE,15951529,,"InChI=1S/C21H16F4N4O2S/c1-20(2)18(31)28(12-5-4-11(10-26)15(8-12)21(23,24)25)19(32)29(20)13-6-7-14(16(22)9-13)17(30)27-3/h4-9H,1-3H3,(H,27,30)",WXCXUHSOUPDCQV-UHFFFAOYSA-N,C21H16F4N4O2S,464.4,"4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide","Enzalutamide|915087-33-1|MDV3100|4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)-2-fluoro-N-methylbenzamide|MDV-3100|MDV 3100|XTANDI|Enzalutamida|93T0T9GKNU|CHEBI:68534|DTXSID10912307|4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl}-2-fluoro-N-methylbenzamide|4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl]-2-fluoro-N-methylbenzamide|4-{3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl}-2-fluoro-N-methylbenzamide|Benzamide, 4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-|enzalutamidum|4-(3-(4-Cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-sulfanylideneimidazolidin-1-yl)-2-fluoro-N-methylbenzamide|Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-|RefChem:58964|ASP9785|L02BB04|DTXCID301341329|4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl)-2-fluoro-N-methyl-benzamide|805-022-1|Enzalutamide (MDV3100)|MDV3100 (Enzalutamide)|C21H16F4N4O2S|MFCD14155804|4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]-2-fluoro-N-methyl-benzamide|MDV 3100 (Enzalutamide)|MDV 3100-d3|Enzalutamide [USAN]|Enzalutamide [USAN:INN]|UNII-93T0T9GKNU|Benzamide, 4-[3-[4-cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methyl-; 4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide; Enzalutamide; MDV 3100; Xtandi|Xtandi (TN)|Enzalutamide (Standard)|ENZALUTAMIDE [MI]|Enzalutamide; MDV3100|Enzalutamide (JAN/USAN)|ENZALUTAMIDE [INN]|ENZALUTAMIDE [JAN]|ENZALUTAMIDE [VANDF]|Enzalutamide (MDV3100)?|MLS006010067|ENZALUTAMIDE [WHO-DD]|SCHEMBL189749|GTPL6812|orb1301219|CHEMBL1082407|SCHEMBL29352764|EX-A046|BCPP000169|ENZALUTAMIDE [ORANGE BOOK]|HMS3654L07|HMS3672M13|HMS3744C19|HMS5079M21|NC-54|ASP-9785|BCP02361|THC33182|BBL102957|BDBM50425732|HY-70002R|NSC755605|NSC766085|s1250|STL556766|AKOS015851022|MDV-3100;Enzalutamide;MDV 3100|BCP9000901|CCG-264879|CS-0317|DB08899|FC65076|NSC-755605|NSC-766085|SB20413|NCGC00263120-01|AC-26924|AS-17047|HY-70002|MDV3100, 95%|SMR004701227|NS00040668|SW219288-1|D10218|AB01565849_02|EN300-20605530|SR-01000941580|Q1996756|SR-01000941580-1|BRD-K56851771-001-01-9|BRD-K56851771-001-06-8|4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide|4-[3-[4-Cyano-3-(trifluoromethyl)phenyl]-5,5-dimethyl-4-oxo-2-thioxo-1-imidazolidinyl]-2-fluoro-N-methylbenzamide;MDV 3100"
FLUOXETINE,3386,,"InChI=1S/C17H18F3NO/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20/h2-10,16,21H,11-12H2,1H3",RTHCYVBBDHJXIQ-UHFFFAOYSA-N,C17H18F3NO,309.33,N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine,"fluoxetine|54910-89-3|Fluoxetina|Animex-On|Fluval|N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine|Fluoxetinum|Fluoxetin|Fluoxetin ratiopharm|Methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine|(+-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|(+-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine|01K63SUP8D|DTXSID7023067|CHEBI:86990|NSC-758685|CHEBI:5118|DTXCID903067|n-methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine|Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-|DL-N-METHYL-3-(P-TRIFLUOROMETHYLPHENOXY)-3-PHENYLPROPYLAMINE|methyl((3-phenyl-3-(4-(trifluoromethyl)phenoxy)propyl))amine|RefChem:5838|N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|Lilly110140|N06AB03|N-methyl-gamma-(4-(trifluoromethyl)-phenoxy)-benzenepropanamine|Pulvules|Portal|Eufor|Fluoxetina [Spanish]|Fluoxetinum [INN-Latin]|Fluoxetina [INN-Spanish]|Fluoxetine-d5|N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine|CHEMBL41|dl-3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine|MFCD00072041|57226-07-0|NSC-283480|N-methyl-3-[4-(trifluoromethyl)phenoxy]-3-(3-tritiophenyl)propan-1-amine|(+/-)-Fluoxetine|HSDB 6633|NCGC00015428-08|Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine|Fluoxetine [USAN:INN:BAN]|N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine|methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amine hydrochloride|Fluoxetine (TN)|CAS-54910-89-3|Fluoxetine (USAN/INN)|fluoexetine|methyl{3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl}amine|UNII-01K63SUP8D|Spectrum_001679|FLUOXETINE [MI]|SpecPlus_000723|FLUOXETINE [INN]|Prestwick0_000511|Prestwick1_000511|Prestwick2_000511|Prestwick3_000511|Spectrum2_001658|Spectrum3_001648|Spectrum4_000613|Spectrum5_001518|FLUOXETINE [USAN]|Benzenepropamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, (+-)-|FLUOXETINE [VANDF]|Biomol-NT_000152|Epitope ID:224550|(+) or (-)-N-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine|SCHEMBL8353|LY-110140 free base|(+) or (-)-N-Methyl-3-phenyl-3-((alpha,alpha,alpha-trifluoro-p-tolyl)oxy)propylamine|FLUOXETINE [WHO-DD]|Lopac0_000558|BSPBio_000461|BSPBio_003375|GTPL203|KBioGR_001166|KBioSS_002159|cid_62857|DivK1c_006819|SPBio_001815|SPBio_002382|BPBio1_000354|BPBio1_000509|orb1310603|BDBM30130|KBio1_001763|KBio2_002159|KBio2_004727|KBio2_007295|KBio3_002595|3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine|PS06 - Fluoxetine/Norfluoxetine|HMS2090H14|(+/-)-N-Methyl-3-(p-trifluoromethylphenoxy)-3-phenylpropylamine|ALBB-025606|BCP28440|HY-B0102|MSK10030|Tox21_110144|(+/-)-N-Methyl-3-p-(p-trifluoromethylphenoxy)-3-phenylpropylamine|(+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine]|(+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine|AB9783|BBL012251|NS-140|NSC283480|SBB017267|STK734483|AKOS003663021|Tox21_110144_1|AC-8478|CCG-204648|DB00472|NSC 283480|NSC 758685|SDCCGSBI-0050541.P004|(+/-)-N-Methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine|FLUOXETINE [EMA EPAR VETERINARY]|NCGC00015428-06|NCGC00015428-07|NCGC00015428-10|NCGC00015428-11|NCGC00015428-12|NCGC00015428-13|NCGC00015428-15|NCGC00015428-27|NCGC00024879-03|NCGC00024879-04|AS-44989|FF100299|ST076807|SBI-0050541.P003|DB-015148|AB00053774|NS00000284|D00326|EN300-199668|AB00053774-13|AB00053774-14|AB00053774_15|AB00053774_16|L000931|Q422244|BRD-A31159102-001-01-9|BRD-A31159102-003-05-6|BRD-A31159102-003-16-3|BRD-A31159102-003-28-8|BRD-A31159102-003-29-6|BRD-A31159102-003-30-4|SR-01000002988-18|LY-110140;LY 110140;LY110140|N-methyl 3-(p-trifluoromethylphenoxy)-3-phenylpropylamine|N-Methyl-3-phenyl-3-(p-trifluoromethylphenoxy)propylamine|Benzenepropanamine, N-methyl-?-[4-(trifluoromethyl)phenoxy]-|benzenepropanamine, N-methyl-gamma-[4-(trifluoromethyl)phenoxy]-|N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propanamine #|Benzenepropanamine, N-methyl-gamma-[4-(trifluoromethyl)phenoxy]-, (+/-)-|N-METHYL-.GAMMA.-(4-(TRIFLUOROMETHYL)PHENOXY)BENZENEPROPANAMINE|N-methyl-3-phenyl-3-[(alpha,alpha,alpha-trifluoro-p-tolyl)oxy]propylamine|(.+/-.)-N-Methyl-3-phenyl-3-[(.alpha.,.alpha.,.alpha.-trifluoro-p-tolyl)oxy]propylamine|(.+/-.)-N-Methyl-3-phenyl-3-[(.alpha.,la,.alpha.-trifluoro-p-tolyl)oxy]propylamine|Benzenepropanamine, N-methyl-.gamma.-[4-(trifluoromethyl)phenoxy]-, (.+/-.)-|BENZENEPROPANAMINE, N-METHYL-G-(4-(TRIFLUOROMETHYL)PHENOXY)-, (+/-)-|(+/-)-N-METHYL-3-PHENYL-3-((.ALPHA.,ALPHA.,.ALPHA.-TRIFLUORO-P-TOLYL)OXY)PROPYLAMINE"
COCAINE,446220,,"InChI=1S/C17H21NO4/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11/h3-7,12-15H,8-10H2,1-2H3/t12-,13+,14-,15+/m0/s1",ZPUCINDJVBIVPJ-LJISPDSOSA-N,C17H21NO4,303.35,"methyl (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate","cocaine|Benzoylmethylecgonine|Neurocaine|Kokain|L-Cocaine|Cocain|Cocaina|beta-Cocain|(-)-Cocaine|cocainum|Methyl Benzoylecgonine|l-Cocain|Eritroxilina|Erytroxylin|Bernies|Kokayeen|Burese|Corine|Kokan|Dama blanca|Pimp's drug|White girl or lady|Snow|Nose candy|50-36-2|Girl [Street Name]|Rock [Street Name]|Toot [Street Name]|Flake [Street Name]|(r)-(-)-cocaine|CHEBI:27958|Ecgonine, methyl ester, benzoate (ester)|Gold dust [Street Name]|2-beta-Carbomethoxy-3-beta-benzoxytropane|Happy dust [Street Name]|I5Y540LHVR|2beta-Carbomethoxy-3beta-benzoxytropane|IDS-NC-004|3-Tropanylbenzoate-2-carboxylic acid methyl ester|(1R,2R,3S,5S)-2-Methoxycarbonyltropan-3-yl benzoate|RX0041|Star dust [Street Name]|Green gold [Street Name]|RX-0041|Happy trails [Street Name]|DTXSID2038443|2-Methyl-3beta-hydroxy-1alphaH,5alphaH-tropane-2beta-carboxylate benzoate (ester)|3beta-Hydroxy-1alphaH,5alphaH-tropane-2beta-carboxylic acid methyl ester benzoate|1-alpha-H,5-alpha-H-Tropane-2-beta-carboxylic acid, 3-beta-hydroxy-, methyl ester, benzoate|3-(Benzoyloxy)-8-methyl-8-azabicyclo-(3.2.1)octane-2-carboxylic acid methyl ether|methyl (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|Methyl 3-beta-hydroxy-1-alpha-H,5-alpha-H-tropane-2-beta-carboxylate benzoate (ester)|Girl (Street Name)|Rock (Street Name)|Toot (Street Name)|Flake (Street Name)|Gold dust (Street Name)|Star dust (Street Name)|Green gold (Street Name)|Happy dust (Street Name)|Happy trails (Street Name)|methyl [1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R-(exo,exo))-|[1R-(exo,exo)]-3-(benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid, methyl ester|methyl (1R,2R,3S,5S)-3-(benzoyloxy)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylate|methyl (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylate|methyl (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|methyl (1R-(exo,exo))-3-(benzoyloxy)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylate|methyl (1S,3S,4R,5R)-3-benzoyloxy-8-methyl-8-azabicyclo(3.2.1)octane-4-carboxylate|methyl (1S,3S,4R,5R)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-4-carboxylate|(1R-(exo,exo))-3-(benzoyloxy)-8-methyl-8-azabicyclo(3.2.1)octane-2-carboxylic acid, methyl ester|RefChem:6631|DTXCID501030562|200-032-7|Leaf|Cocaine free base|1-Cocaine|Star-spangled powder|Coke|Cocaine, l-|Bernice|Cholly|Cecil|Girl|Happy dust|Gold dust|Star dust|HSDB 6469|2-beta-Tropanecarboxylic acid, 3-beta-hydroxy-, methyl ester, benzoate (ester)|Methyl 3beta-hydroxy-1alphaH,5alphaH-tropane-2beta-carboxylate benzoate (ester)|COC|Jam|Crack|Flake|Blow|Crack cocaine|Lady|Toot|Happy trails|Green gold|C"" Carrie|Blow [Street Name]|Lady [Street Name]|Cecil [Street Name]|Sleighride|Badrock|Bazooka|Bernice [Street Name]|Blizzard|Cabello|Charlie|Cocktail|Goofball|Moonrocks|Blast|Candy|Caviar|Freeze|Heaven|Snort|Trails|Coca|Cola|Hell|Toke|Yeyo|Bouncing Powder|Chicken Scratch|Happy powder|Florida Snow|Sweet Stuff|L-Cocaine (1.0 mg/ml in Methanol)|Prime Time|C Carrie|Foo Foo|Kibbles n' Bits|Snow (birds)|G-Rock|methyl (1R,2R,3S,5S)-8-methyl-3-[(phenylcarbonyl)oxy]-8-azabicyclo[3.2.1]octane-2-carboxylate|Cholly [Street Name]|Cocaine [USP:BAN]|UNII-I5Y540LHVR|Line|EINECS 200-032-7|Cocaine (-)|1i7z|COCAINE [VANDF]|COCAINUM [HPUS]|COCAINE [HSDB]|COCAINE [MI]|COCAINE [MART.]|COCAINE [WHO-DD]|Epitope ID:158626|SCHEMBL21930|CHEMBL370805|GTPL2286|COCAINE [USP MONOGRAPH]|DEA No. 9041|BDBM22418|Cocaine, 1mg/ml in Acetonitrile|(1R,2R,3S,5S)-2-(methoxycarbonyl)tropan-3-yl benzoate|1q72|Cocaine 0.1 mg/ml in Acetonitrile|Cocaine 1.0 mg/ml in Acetonitrile|AKOS015965554|DB00907|FC111889|NS00000403|C01416|Q41576|[1R-(exo,exo)]-3-(Benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic Acid|3.BETA.-HYDROXY-2.BETA.-TROPANECARBOXYLIC ACID METHYL ESTER BENZOATE (ESTER)|METHYL 3B-HYDROXY-1.ALPHA.H,5.ALPHA.H-TROPANE-2.BETA.-CARBOXYLATE BENZOATE (ESTER)|1-alpha-H,5-alpha-H-Tropane-2-beta-carboxylic acid, 3-beta-hydroxy-, methyl ester, benzoate (ester) (8CI)|8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, (1R,2R,3S,5S)- (9CI)|METHYL (1R,2R,3S,5S)-3-(BENZOYLOXY)-8-METHYL-8-AZABICYCLO(3.2.1) OCTANE-2-CARBOXYLATE"
CLOZAPINE,135398737,,"InChI=1S/C18H19ClN4/c1-22-8-10-23(11-9-22)18-14-4-2-3-5-15(14)20-16-7-6-13(19)12-17(16)21-18/h2-7,12,20H,8-11H2,1H3",QZUDBNBUXVUHMW-UHFFFAOYSA-N,C18H19ClN4,326.8,"3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine","clozapine|5786-21-0|Leponex|Clozapin|CLOZARIL|Fazaclo|Clorazil|Clozapina|Clozapinum|Fazaclo ODT|HF 1854|HF-1854|Versacloz|Clozapine (Clozaril)|DTXSID5022855|8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine|8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine|J60AR2IKIC|Clozapine (udl)|Clozapine (ivax)|Clozapine (teva)|Clozapine (mylan)|5H-Dibenzo[b,e][1,4]diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-|Clozapine (caraco)|Clozapine (fazaclo)|NSC-757429|CHEBI:3766|Clozapine (versacloz)|5H-Dibenzo(b,e)(1,4)diazepine, 8-chloro-11-(4-methyl-1-piperazinyl)-|8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo(b,e)(1,4)diazepine|DTXCID302855|Zaponex|8-chloro-11-(4-methylpiperazin-1-yl)-5H-dibenzo(b,e)(1,4)diazepine|6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo(9.4.0.03,8)pentadeca-1(11),3,5,7,9,12,14-heptaene|6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.03,8]pentadeca-1(11),3,5,7,9,12,14-heptaene|RefChem:5701|N05AH02|227-313-7|6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,9,11,13-heptaene|Clonex|Iprox|MFCD00153785|W-801|3-chloro-6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepine|CHEMBL42|3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepine|MLS000028472|Asaleptin|Lepotex|8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]-diazepine|NCGC00015254-12|SMR000058365|CAS-5786-21-0|CLZ-ChemoNM|8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine|Clozapinum [INN-Latin]|Clozapina [INN-Spanish]|Azaleptine|Clozaril (TN)|1333667-72-3|CCRIS 9171|HSDB 6478|SR-01000000096|EINECS 227-313-7|UNII-J60AR2IKIC|BRN 0764984|Clozapine (JAN/USP/INN)|LX 100-129|Clozapine, solid|LEX-123|Clozapine [USAN:USP:INN:BAN]|Prestwick_693|Clozapine (Standard)|KS-1166|Spectrum_000139|Tocris-0444|CPD000058365|CLOZAPINE [INN]|CLOZAPINE [JAN]|Opera_ID_482|CLOZAPINE [MI]|CLOZAPINE [HSDB]|CLOZAPINE [USAN]|Prestwick0_000350|Prestwick1_000350|Spectrum2_000919|Spectrum3_001828|Spectrum4_000898|CLOZAPINE [VANDF]|Lopac-C-6305|CLOZAPINE [MART.]|GTPL38|C 6305|CLOZAPINE [USP-RS]|CLOZAPINE [WHO-DD]|SCHEMBL8397|REGID_for_CID_2818|SCHEMBL33323|KBioGR_000310|KBioGR_001336|KBioSS_000310|KBioSS_000599|MLS001077282|DivK1c_000343|SPECTRUM1500685|Clozapine - Bio-X trade mark|SPBio_000798|SPBio_002340|Clozapine, 1mg/ml in Methanol|orb1310596|CLOZAPINE [ORANGE BOOK]|PS04 - Clozapine/Norclozapine|CLOZAPINE [EP MONOGRAPH]|SCHEMBL29360001|SCHEMBL29433929|SCHEMBL29590817|BDBM22869|CHEBI:92657|Clozapine for peak identification|HMS501B05|KBio1_000343|KBio2_000310|KBio2_000599|KBio2_002878|KBio2_003167|KBio2_005446|KBio2_005735|KBio3_000619|KBio3_000620|KBio3_002979|CLOZAPINE (UDL) [VANDF]|CLOZAPINE [USP MONOGRAPH]|CLOZAPINE (IVAX) [VANDF]|CLOZAPINE (TEVA) [VANDF]|NINDS_000343|Bio1_000436|Bio1_000925|Bio1_001414|Bio2_000310|Bio2_000790|DTXSID401020663|GLXC-06516|HMS1361P12|HMS1569E21|HMS1791P12|HMS1921C16|HMS1989P12|HMS2089L13|HMS2092I16|HMS2096E21|HMS2235E19|HMS3259J17|HMS3260H14|HMS3266A10|HMS3371H05|HMS3402P12|HMS3414F09|HMS3657E15|HMS3678F09|HMS3713E21|HMS3742K03|HMS5081G07|Pharmakon1600-01500685|CLOZAPINE (MYLAN) [VANDF]|BCP25196|CLOZAPINE (CARACO) [VANDF]|KXB05350|CLOZAPINE (FAZACLO) [VANDF]|Tox21_110113|Tox21_500276|BDBM50001884|CCG-39881|HB1607|HY-14539R|MSK000866|NSC757429|s2459|CLOZAPINE (CLOZARIL) [VANDF]|Clozapine 1.0 mg/ml in Acetonitrile|8-Chloro-11-(4-methyl)-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine|AKOS005064444|AKOS026749900|CLOZAPINE (VERSACLOZ) [VANDF]|Tox21_110113_1|CS-0644|DB00363|FC20526|LP00276|NC00667|NSC 757429|SDCCGSBI-0050264.P005|NCGC00015254-01|NCGC00015254-02|NCGC00015254-03|NCGC00015254-04|NCGC00015254-05|NCGC00015254-06|NCGC00015254-07|NCGC00015254-08|NCGC00015254-09|NCGC00015254-10|NCGC00015254-11|NCGC00015254-13|NCGC00015254-14|NCGC00015254-15|NCGC00015254-16|NCGC00015254-17|NCGC00015254-18|NCGC00015254-20|NCGC00015254-31|NCGC00022902-02|NCGC00022902-04|NCGC00022902-05|NCGC00022902-06|NCGC00022902-07|NCGC00022902-08|NCGC00022902-09|NCGC00022902-10|NCGC00022902-11|NCGC00022902-12|NCGC00022902-13|NCGC00188978-01|NCGC00260961-01|BC164328|HY-14539|SY052613|SBI-0050264.P004|DB-053121|C2547|D-107|EU-0100276|NS00000413|SW220247-1|EN300-52510|C06924|D00283|H10436|M01464|AB00052158-13|AB00052158-14|AB00052158_15|AB00052158_16|786C210|Clozapine, drug standard, 1.0 mg/mL in methanol|L000195|L013417|Q221361|SR-01000000096-2|SR-01000000096-4|SR-01000000096-5|SR-01000000096-8|BRD-K37289225-001-09-1|BRD-K37289225-001-23-2|BRD-K37289225-001-34-9|BRD-K37289225-001-35-6|BRD-K37289225-001-36-4|BRD-K37289225-001-37-2|Clozapine, British Pharmacopoeia (BP) Reference Standard|Z754926488|Clozapine, European Pharmacopoeia (EP) Reference Standard|Clozapine, United States Pharmacopeia (USP) Reference Standard|8-Chloro-11-(4-methylpiperazino)-5H-dibenzo[b,e][1,4]diazepine|3-chloro-6-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine|8-Chloro-11-(4-methyl-1-piperazinyl)-10H-dibenzo[b,e][1,4]diazepine|8-chloro-11-(4-methyl-piperazin-1-yl)-10H-dibenzo[b,e][1,4]diazepine|3-Hydroxy-2-phenyl-propionic acid 8-methyl-8-aza-bicyclo[3.2.1]oct-3-yl ester|8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine; HF-1854|8-Chloro-11-(4-methyl-1-piperazinyl)-5H-dibenzo[b,e][1,4]diazepine;HF-1854;Leponex|8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine (Clozapine)|8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine( Clozepine )|8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine(Ciozapine)|8-Chloro-11-(4-methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepine(Clopazine)|Clozapine for peak identification, European Pharmacopoeia (EP) Reference Standard|CLOZAPINE, 8-CHLORO-11-(4-METHYL-PIPERAZIN-1-YL)-5H-DIBENZO[B,E][1,4]DIAZEPINE|6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0,3,8]pentadeca-1,3(8),4,6,10,12,14-heptaene|6-chloro-10-(4-methylpiperazin-1-yl)-2,9-diazatricyclo[9.4.0.0^{3,8}]pentadeca-1,3(8),4,6,10,12,14-heptaene"
ZIPRASIDONE,60854,,"InChI=1S/C21H21ClN4OS/c22-17-13-18-15(12-20(27)23-18)11-14(17)5-6-25-7-9-26(10-8-25)21-16-3-1-2-4-19(16)28-24-21/h1-4,11,13H,5-10,12H2,(H,23,27)",MVWVFYHBGMAFLY-UHFFFAOYSA-N,C21H21ClN4OS,412.9,"5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one","Ziprasidone|146939-27-7|ziprasidona|Zipradon|ziprasidonum|6UKA5VEJ6X|2H-Indol-2-one, 5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-|5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one|DTXSID4023753|CHEBI:10119|5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-2,3-dihydro-1H-indol-2-one|DTXCID403753|CP-88059|ziprazidone|2H-Indol-2-one, 5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-|CP-88,059|5-(2-(4-(1,2-benzothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloro-1,3-dihydroindol-2-one|CP-88,059-01|5-(2-(4-(1,2-benzothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloro-2,3-dihydro-1H-indol-2-one|RefChem:56241|N05AE04|5-(2-(4-(3-benzisothiazolyl)piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one|Geodon|Ziprasidone (INN)|C21H21ClN4OS|Ziprasidone free base|CHEMBL708|5-(2-(4-(benzo[d]isothiazol-3-yl)piperazin-1-yl)ethyl)-6-chloroindolin-2-one|MFCD06795476|ZIPRASIDONE [INN]|Ziprasidone [INN:BAN]|Zipradon (TN)|5-[2-[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one|CAS-146939-27-7|NCGC00186050-01|UNII-6UKA5VEJ6X|CP-88059-27|Ziprasidone NX|HSDB 7745|MFCD00866661|5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2h-indol-2-one|Ziprasidone Impurity 66|ZIPRASIDONE [MI]|5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-1,3-dihydroindol-2-one;hydrate;hydrochloride|ZIPRASIDONE [HSDB]|GTPL59|C07568|ZIPRASIDONE [VANDF]|ZIPRASIDONE [MART.]|SCHEMBL28028|ZIPRASIDONE [WHO-DD]|MLS000759435|BIDD:GT0042|orb1311002|SCHEMBL29368426|Ziprasidone - Bio-X trade mark|HMS3742M19|ARD10222|MSK10222|Tox21_112194|Tox21_113525|BDBM50048803|AKOS015900383|Tox21_112194_1|DB00246|FZ39584|SDCCGSBI-0633778.P001|5-[2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl]-6-chloro-indolin-2-one|5-{2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one|5-{2-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]ethyl}-6-chloro-1,3-dihydro-2H-indol-2-one|NCGC00263539-01|NCGC00263539-03|NCGC00263539-05|NCGC00263539-13|AC-23360|BZ164575|HY-14542|SMR000466328|SY116115|NS00004565|Z0034|VU0286234-2|D08687|D92803|AB00639925-02|AB00639925-04|AB00639925_05|AB00639925_06|EN300-7415908|883Z936|L000659|Q205517|BRD-K29582115-003-03-1|BRD-K29582115-066-01-2|5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one|5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)-ethyl)-6-chloro-1,3-dihydro-2H-indol-2-one|5-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)ethyl)-6-chloro-1,3-dihydro-2H-indole-2-one|5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one (Ziprasidone)|5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-chloro-1,3-dihydro-indol-2-one(Norastemizole)|5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one|CP 88059;5-[2-[4-(1,2-Benzisothiazol-3yl)-1-piperazinyl]ethyl]-6-chloro-1,3-dihydro-2H-indol-2-one"
VANOXERINE,3455,,"InChI=1S/C28H32F2N2O/c29-26-12-8-24(9-13-26)28(25-10-14-27(30)15-11-25)33-22-21-32-19-17-31(18-20-32)16-4-7-23-5-2-1-3-6-23/h1-3,5-6,8-15,28H,4,7,16-22H2",NAUWTFJOPJWYOT-UHFFFAOYSA-N,C28H32F2N2O,450.6,1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine,"Vanoxerine|67469-69-6|Gbr 12909|Vanoxerina|Vanoxerinum|Vanoxeamine|GBR12909|GBR-12909|1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)piperazine|CHEBI:64089|90X28IKH43|1-(2-(Bis(p-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine|DTXSID8045143|1-{2-[bis(4-fluorophenyl)methoxy]ethyl}-4-(3-phenylpropyl)piperazine|1-(2-(bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine|RefChem:193710|DTXCID6025143|1-(2 (bis(4-fluorophenyl)methoxy)ethyl)-4-(3-phenylpropyl)piperazine|Vanoxerine [INN]|CHEMBL281594|67469-69-9 (free base)|GBR 12909;I893|Vanoxerinum [INN-Latin]|Vanoxerina [INN-Spanish]|CAS-67469-78-7|UNII-90X28IKH43|Tocris-0421|SpecPlus_000900|Lopac-D-052|Prestwick0_000386|Prestwick1_000386|Prestwick2_000386|Prestwick3_000386|Biomol-NT_000010|Piperazine, 1-[2-[bis(4-fluorophenyl)methoxy]ethyl]-4-(3-phenylpropyl)-|A1D5S|Lopac0_000446|BSPBio_000571|DivK1c_006996|SCHEMBL246574|SPBio_002492|BPBio1_000629|BPBio1_001141|GTPL9983|orb1703943|BDBM22165|KBio1_001940|NAUWTFJOPJWYOT-UHFFFAOYSA-N|BCPP000022|HMS3742I03|BCP21322|HY-13217A|AKOS003588978|CCG-204538|DB03701|SB16842|SDCCGSBI-0050431.P003|NCGC00015300-01|NCGC00015300-02|NCGC00015300-03|NCGC00015300-04|NCGC00015300-07|NCGC00015300-08|NCGC00015300-17|NCGC00024581-01|NCGC00024581-02|NCGC00024581-03|NCI60_038175|AB00053750|NS00071657|Q2510480|BRD-K32501161-001-01-7|BRD-K32501161-300-03-9|BRD-K32501161-300-04-7|BRD-K32501161-300-06-2|GBR-12909; GBR12909; GBR 12909; I-893; I 893; I893|110872-73-6"
AMITRIPTYLINE,2160,,"InChI=1S/C20H23N/c1-21(2)15-7-12-20-18-10-5-3-8-16(18)13-14-17-9-4-6-11-19(17)20/h3-6,8-12H,7,13-15H2,1-2H3",KRMDCWKBEZIMAB-UHFFFAOYSA-N,C20H23N,277.4,"N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine","amitriptyline|50-48-6|Amitriptylin|Damitriptyline|Triptanol|Flavyl|Seroten|Proheptadiene|Damilen|Lantron|Triptisol|Tryptanol|Adepress|Adepril|Elavil|Amitryptiline|Triptilin|Laroxyl|Redomex|Amitriptilina|Amytriptylin|Amitriptylinum|Amitryptyline|Ro 4-1575|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene|3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|10,11-Dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo(a,d)cycloheptene|N 750|CHEBI:2666|5-(3'-Dimethylaminopropylidene)-dibenzo-(a,d)(1,4)-cycloheptadiene|3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yliden)-N,N-dimethylpropylamin|5H-Dibenzo(a,d)cycloheptene-delta5,gamma-propylamine, 10,11-dihydro-N,N-dimethyl-|1806D8D52K|5-(gamma-Dimethylaminopropylidine)-5H-dibenzo(a,d)(1,4)cycloheptadiene|5-(3-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptatriene|5-(gamma-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene|1-Propanamine, 3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethyl-|10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-delta(sup 5),gamma-propylamine|DTXSID7022594|5-(gamma-Dimethylaminopropylidene)-5H-Dibenzo[a,d][1,4]cycloheptadiene|10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-delta(5),gamma-propylamine|1-Propanamine, 3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo(a,d)(1,4)cycloheptadiene|3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|5H-Dibenzo(a,d)cycloheptene-delta(sup 5),gamma-propylamine, 10,11-dihydro-N,N-dimethyl-|5-(3'-Dimethylaminopropylidene)-dibenzo-[a,d][1,4]-cycloheptadiene|10,11-dihydro-5-(gamma-dimethylaminopropylidene)-5H-dibenzo[a,d]cycloheptene|3-(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine|dimethyl({3-[(2Z)-tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene]propyl})amine|Apo Amitriptyline|3-(10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-ylidene)-N,N-dimethylpropan-1-amine|RPh, Amitriptylin|dimethyl((3-((2E)-tricyclo(9.4.0.0^(3,8))pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene)propyl))amine|dimethyl((3-((2Z)-tricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)propyl))amine|dimethyl({3-[(2E)-tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene]propyl})amine|Desitin, Amitriptylin|Amitriptylin neuraxpharm|RefChem:5544|DTXCID502594|N06AA09|200-041-6|dimethyl(3-(tricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene)propyl)amine|Tryptizol|Amitriprolidine|Damilan|Sarotex|MK 230|3-(10,11-dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)-N,N-dimethylpropan-1-amine|Amitriptyline (INN)|HSDB 3007|CHEMBL629|N,N-dimethyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenylidene)propan-1-amine|Amytriptiline|Laroxil|Elanil|Amitriptylin [German]|Amitriptilina [Italian]|AMITRIPTYLINE [INN]|Amitriptyline [INN:BAN]|Amitriptylinum [INN-Latin]|Amitriptilina [INN-Spanish]|5H-Dibenzo[a,d]cycloheptene-.delta.5,.gamma.-propylamine, 10,11-dihydro-N,N-dimethyl-|TP0|Laroxyl (TN)|CCRIS 9174|NCGC00015095-09|CAS-549-18-8|EINECS 200-041-6|BRN 2217885|UNII-1806D8D52K|Domical (Salt/Mix)|Laroxyl (Salt/Mix)|Lentizol (Salt/Mix)|Vanatrip (Salt/Mix)|Triptizol (Salt/Mix)|Spectrum_000044|Prestwick0_000074|Prestwick1_000074|Prestwick2_000074|Prestwick3_000074|Spectrum2_000101|Spectrum3_000298|Spectrum4_000146|Spectrum5_000806|Lopac-A-8404|AMITRIPTYLINE [MI]|EC 200-041-6|SCHEMBL7824|Lopac0_000112|Oprea1_479304|AMITRIPTYLINE [VANDF]|BSPBio_000287|BSPBio_001836|GTPL200|KBioGR_000592|KBioGR_002261|KBioSS_000424|KBioSS_002262|AMITRIPTYLINE [MART.]|BIDD:GT0115|DivK1c_000766|SPBio_000082|SPBio_002208|AMITRIPTYLINE [WHO-DD]|BPBio1_000317|orb1306054|SCHEMBL29359365|KBio1_000766|KBio2_000424|KBio2_002261|KBio2_002992|KBio2_004829|KBio2_005560|KBio2_007397|KBio3_001336|KBio3_002741|cMAP_000001|NINDS_000766|HMS5087O07|5-(3-dimethylaminopropylidene)dibenzo[a,d][1,4]-cycloheptadiene|BCP09083|HY-B0527|MSK10058|PS01 - Amitriptyline/Nortriptyline|AMITRIPTYLINE [USP IMPURITY]|BDBM50020712|MFCD00412072|PDSP1_001564|PDSP2_001548|s5947|SBB080793|STK525215|5-(3-Dimethylaminopropylidene)-5H-dibenzo[a,d]-10,11-dihydrocycloheptene|5-(gamma-Dimethylaminopropylidene)-5H-dibenzo[a,d]10,11-dihydrocycloheptene|AKOS000512694|CCG-204207|DB00321|SDCCGSBI-0050100.P005|IDI1_000766|MRF-0000533|NCGC00015095-01|NCGC00015095-02|NCGC00015095-03|NCGC00015095-04|NCGC00015095-05|NCGC00015095-06|NCGC00015095-07|NCGC00015095-08|NCGC00015095-10|NCGC00015095-11|NCGC00015095-12|NCGC00015095-14|NCGC00015095-26|NCGC00024433-04|NCGC00183047-01|DA-50424|SBI-0050100.P004|3B - Known Drug Blood Quantification Sample|AB00514631|AmitriptylineMK-230, N-750, Ro41575|CS-0009498|NS00000032|C06824|D07448|Q58397|AB00053417-12|AB00053417_13|AB00053417_14|412A072|L001041|BRD-K53737926-003-05-4|BRD-K53737926-003-14-6|BRD-K53737926-003-25-2|BRD-K53737926-003-27-8|NORTRIPTYLINE HYDROCHLORIDE IMPURITY F [EP IMPURITY]|(3-(5,6-dihydrodibenzo[b,f][7]annulen-11-ylidene)propyl)dimethylamine|5-(.gamma.-Dimethylaminopropylidene)-5H-Dibenzo[a,d][1,4]cycloheptadiene|5-(.gamma.-Dimethylaminopropylidine)-5H-dibenzo(a,d)(1,4)cycloheptadiene|10,11-Dihydro-5-(.gamma.-dimethylaminopropylidene)-5H-dibenzo(a,d)cycloheptene|10,11-dihydro-N,N-dimethl-5H-dibenzo[a,d]cycloheptene-(delta(5, gamma))-propylamine|10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-.DELTA.5,.gamma.-propylamine|10,11-Dihydro-N,N-dimethyl-5H-dibenzo(a,d)heptalene-delta5,gamma-propylamine|3-(5,6-dihydrodibenzo[[?],[?]][7]annulen-11-ylidene)-N,N-dimethyl-propan-1-amine|5-(.gamma.-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo(a,d)cycloheptene|5-(.gamma.-Dimethylaminopropylidene)-5H-dibenzo(a,d)-10,11-dihydrocycloheptene|N-[3-(10,11-DIHYDRO-5H-DIBENZO[A,D]CYCLOHEPTEN-5-YLIDEN)PROPYL]-N,N-DIMETHYLAMINE|3-(10,11-Dihydro-5H-dibenzo-[a,d]cyclohepten-5-ylidene)-N,N-dimethyl-1-propanamine, hydrochloride|5H-Dibenzo(a,d)cycloheptene-.delta.(sup 5),.gamma.-propylamine, 10,11-dihydro-N,N-dimethyl-|5H-Dibenzo[a,d]cycloheptene-Delta5,gamma-propylamine, 10,11-dihydro-N,N-dimethyl- (6CI,8CI) 5-(gamma-Dimethylaminopropylidene)-10,11-dihydro-5H-dibenzo[a,d]cycloheptene"
MAZINDOL,4020,,"InChI=1S/C16H13ClN2O/c17-12-7-5-11(6-8-12)16(20)14-4-2-1-3-13(14)15-18-9-10-19(15)16/h1-8,20H,9-10H2",ZPXSCAKFGYXMGA-UHFFFAOYSA-N,C16H13ClN2O,284.74,"5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol","mazindol|Mazanor|Sanorex|22232-71-9|Mazildene|Teronac|Magrilon|Dimagrir|Terenac|Mazindole|Mazindolum|AN 448|Mazindol civ|AN-448|SAH 42548|SaH-42548|SA 42-548|5-p-Chlorophenyl-2,3-dihydro-5H-imidazo(2,1-a)isoindol-5-ol|DTXSID1023237|3H-Imidazo(2,1-a)isoindol-5-ol, 5-(4-chlorophenyl)-2,5-dihydro-|C56709M5NH|5H-Imidazo(2,1-a)isoindol-5-ol, 5-(4-chlorophenyl)-2,3-dihydro|Sanjorex|Teronak|3H-Imidazo(2,1-a)isoindol-5-ol, 5-(p-chlorophenyl)-2,5-dihydro-|3H-Imidazo[2,1-a]isoindol-5-ol, 5-(4-chlorophenyl)-2,5-dihydro-|5-(4-chlorophenyl)-2H,3H,5H-imidazo[2,1-a]isoindol-5-ol|3H-Imidazo[2,1-a]isoindol-5-ol, 5-(p-chlorophenyl)-2,5-dihydro-|AN448|Mazindolo|5-(4-chlorophenyl)-2H,3H,5H-imidazo(2,1-a)isoindol-5-ol|RefChem:56634|DTXCID403237|A08AA05|244-857-0|5-(4-chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol|5-(4-Chlorophenyl)-3,5-dihydro-2H-imidazo[2,1-a]isoindol-5-ol|5-(4-Chlorophenyl)-2,3-dihydro-5-hydroxy-5H-imidazo[2,1-a]isoindole|CHEMBL781|5-(4-Chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol|5-(p-Chlorophenyl)-2,5-dihydro-3H-imidazo(2,1-a)isoindol-5-ol|5-(4-Chlorophenyl)-2,3-dihydro-5-hydroxy-5H-imidazo(2,1-a)isoindole|MFCD00864480|Mazindolum [INN-Latin]|Mazindol (1mg/ml in Acetonitrile)|Mazindol (1.0 mg/mL in Methanol)|[3H]-mazindol|CCRIS 3152|DEA No. 1605|HSDB 3112|[3H]MAZINDOL|SANOREX (TN)|EINECS 244-857-0|S 42548|Mazindol (JAN/USP/INN)|BRN 0546547|UNII-C56709M5NH|5-(p-Chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol|Mazindol [USAN:USP:INN:BAN]|Mazindol; 5-(4-Chlorophenyl)-2,5-dihydro-3H-imidazol[2,1-a]isoindol-5-ol; 5-(4-Chlorophenyl)-2,3-dihydroimidazo[1,2-b]isoindol-5-ol|MAZINDOL [HSDB]|MAZINDOL [USAN]|MAZINDOL [INN]|MAZINDOL [JAN]|MAZINDOL [MI]|MAZINDOL [VANDF]|(+-)-5-(p-Chlorophenyl)-2,5-dihydro-3H-imidazo(2,1-a)isoindol-5-ol|3H-Imidazo(2,1-a)isoindol-5-ol, 2,5-dihydro-5-(4-chlorophenyl)-|MAZINDOL [MART.]|Mazindol, 1mg/ml in Dmf|MAZINDOL [WHO-DD]|SCHEMBL27849|MLS003899228|MAZINDOL [ORANGE BOOK]|CHEBI:6702|GTPL4591|GTPL4797|MAZINDOL [USP IMPURITY]|SCHEMBL29393735|WZB81550|Mazindol, >=98% (TLC), powder|BDBM50005536|3H-Imidazo(2,1-a)isoindol-5-ol, 5-(4-chlorophenyl)-2,5-dihydro-, (+-)-|AKOS015895573|DB00579|NCGC00378886-01|FM156784|HY-15279|SMR000238174|NS00003468|D00367|232M719|A816031|Q255680|BRD-A68464583-001-02-5|Mazindol, United States Pharmacopeia (USP) Reference Standard|5-(4-Chloro-phenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol|5-(4-chlorophenyl)-2,3-dihydro-5H-imidazo [2,1-a]isoindol-5-ol|5-(4-chlorophenyl)-2,3-dihydro-5H-imidazo[2,1-a]isoindol-5-ol|5-(4-Chlorophenyl)-2,5-dihydro-3H-imidazo[2,1-a]isoindol-5-ol #|5H-Imidazo(2,1-a)isoindol-5-ol, 5-(4-chlorophenyl)-2,3-dihydro-|5-Thiophen-2-yl-2,3,5,6-tetrahydro-imidazo[2,1-a]isoquinolin-5-ol|(+/-)-5-(P-CHLOROPHENYL)-2,5-DIHYDRO-3H-IMIDAZO(2,1-A)ISOINDOL-5-OL|3H-IMIDAZO(2,1-A)ISOINDOL-5-OL, 5-(4-CHLOROPHENYL)-2,5-DIHYDRO-, (+/-)-"
PERHEXILINE,4746,,"InChI=1S/C19H35N/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18/h16-20H,1-15H2",CYXKNKQEMFBLER-UHFFFAOYSA-N,C19H35N,277.5,"2-(2,2-dicyclohexylethyl)piperidine","PERHEXILINE|Perhexilene|2-(2,2-Dicyclohexylethyl)piperidine|6621-47-2|Perhexilina|Piperidine, 2-(2,2-dicyclohexylethyl)-|Perhexilinum|DTXSID7023439|CHEBI:35553|KU65374X44|RefChem:860305|DTXCID603439|C08EX02|229-569-5|(+)-2-(2,2-Dicyclohexylethyl)piperidine|Perhexilinum [INN-Latin]|Perhexilina [INN-Spanish]|(-)-2-(2,2-Dicyclohexylethyl)piperidine|39648-48-1|Perhexiline (INN)|CHEMBL75880|perhexilline|PERHEXILINE [INN]|Perhexiline [INN:BAN]|39648-47-0|10118-35-1|EINECS 229-569-5|UNII-KU65374X44|2-[2,2-DICYCLOHEXYLETHYL]PIPERIDINE MALEATE SALT|EINECS 252-426-3|EINECS 254-558-7|EINECS 254-559-2|Piperidine, 2-(2,2-dicyclohexylethyl)-, (2Z)-2-butenedioate (1:1)|Spectrum_000013|(1)-2-(2,2-Dicyclohexylethyl)piperidine|PERHEXILINE [MI]|Prestwick0_000286|Prestwick1_000286|Prestwick2_000286|Prestwick3_000286|Spectrum2_001539|Spectrum3_001579|Spectrum4_000173|Spectrum5_001084|Oprea1_365504|BSPBio_000192|BSPBio_003118|KBioGR_000685|KBioSS_000353|PERHEXILINE [WHO-DD]|DivK1c_000542|SCHEMBL114894|SPBio_001358|SPBio_002411|BPBio1_000212|orb1689514|BDBM61402|cid_5284439|KBio1_000542|KBio2_000353|KBio2_002921|KBio2_005489|KBio3_002618|NINDS_000542|HY-B1334|DB01074|IDI1_000542|NCGC00018261-02|NCGC00018261-05|35193-73-8|DA-66583|SBI-0051794.P002|AB00053656|CS-0013087|NS00008350|D08340|2-(2,2-dicyclohexylethyl)piperidine;maleic acid|AB00053656_22|EN300-18567360|(+/-)-2-(2,2-DICYCLOHEXYLETHYL)PIPERIDINE|Q1232737|BRD-A19633847-050-32-1|(Z)-2-butenedioic acid;2-(2,2-dicyclohexylethyl)piperidine"
CHLORPROMAZINE,2726,,"InChI=1S/C17H19ClN2S/c1-19(2)10-5-11-20-14-6-3-4-7-16(14)21-17-9-8-13(18)12-15(17)20/h3-4,6-9,12H,5,10-11H2,1-2H3",ZPEIMTDSQAKGNT-UHFFFAOYSA-N,C17H19ClN2S,318.9,"3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine","chlorpromazine|50-53-3|Largactil|Chloropromazine|Aminazine|Contomin|Chlorderazin|Propaphenin|Chlorpromados|Fenactil|Sanopron|Wintermin|Esmind|Largactilothiazine|Megaphen|Novomazina|Chlorpromazinum|Clorpromazina|Largactyl|Phenactyl|Promactil|Elmarin|Fenaktyl|Promazil|2-Chloropromazine|Proma|Prozil|Chlor-Promanyl|Fraction AB|3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine|10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-|SKF 2601-A|Chlor-PZ|HL 5746|3-(2-chlorophenothiazin-10-yl)-N,N-dimethylpropan-1-amine|N-(3-Dimethylaminopropyl)-3-chlorophenothiazine|3-(2-chlorophenothiazin-10-yl)-N,N-dimethyl-propan-1-amine|CHEBI:3647|[3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine|U42B7VYA4P|Hibanil|NSC-167745|3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine|DTXSID0022808|2-Chloro-10-(3-(dimethylamino)propyl)phenothiazine|2-Chloro-10-[3-(dimethylamino)propyl]phenothiazine|SKF-2601A|NSC-226514|J2.794D|Phenothiazine, 2-chloro-10-(3-(dimethylamino)propyl)-|DTXCID002808|NSC167745|Phenothiazine, 2-chloro-10-[3-(dimethylamino)propyl]-|(3-(2-chloro-10H-phenothiazin-10-yl)propyl)dimethylamine|RefChem:5676|Hydrochloride, Chlorpromazine|A10BB02|N05AA01|N05AF03|Aminazinum (for the hydrochloride)|200-045-8|Thorazine|Chlorpromazin|Aminazin|Torazina|Amplictil|Cromedazine|Plegomasine|Aminasine|Amplicitil|BC 135|CPZ|HSDB 3033|4560 R.P.|Hemoglobin kodaira|MFCD00133295|Propaphen|34468-21-8|2-chloro-N,N-dimethyl-10H-Phenothiazine-10-propanamine|2-Cloro-10 (3-dimetilaminopropil)fenotiazina|CHEMBL71|Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine|Thorazine hydrochloride|Phenothiazine hydrochloride|Unitensen|NCGC00015273-11|Thorazine Suppositories|Clorpromazina [Italian]|146702-01-4|4560 Rp hydrochloride|Chlorpromazinum [INN-Latin]|Clorpromazina [INN-Spanish]|Prazilpromactil|Chlordelazin|Phenathyl|chlorpromethazine|CAS-50-53-3|Thorazine (TN)|Z80|chlorpromazine cation|CCRIS 3711|[3-(2-chloro-10H-phenothiazin-10-yl)propyl]dimethylamine hydrochloride|3-(2-chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan-1-amine hydrochloride|CAS-69-09-0|EINECS 200-045-8|phenothiazine, 2-chloro-10-(3-dimethylaminopropyl)-|Chlorpromazine (USP/INN)|UNII-U42B7VYA4P|NSC 167745|Chlorpromazine cation radical|Chlropromados|Fraction|2-Cloro-10 (3-dimetilaminopropil)fenotiazina [Italian]|JHICC02042|Chlorpromazine [USP:INN:BAN]|Chloro-3 (dimethylamino-3 propyl)-10 phenothiazine [French]|SKF 2601A|SKF-2601|GG 407|Hibernal (Salt/Mix)|Lomazine (Salt/Mix)|Tranzine (Salt/Mix)|Norcozine (Salt/Mix)|Spectrum_000142|Prestwick0_000064|Prestwick1_000064|Prestwick2_000064|Prestwick3_000064|Spectrum2_001156|Spectrum3_000346|Spectrum4_000283|Spectrum5_000717|Lopac-C-8138|Biomol-NT_000020|Epitope ID:136898|GTPL83|10H-Phenothiazine-10-propanamine, 2-chloro-N,N-dimethyl-, radical ion(1+)|CHLORPROMAZINE [MI]|SCHEMBL8321|CHLORPROMAZINE [INN]|10-(3-Dimethylaminopropyl)-2-chlorophenothiazine|2-Chloro-10-(3-dimethylaminopropyl)phenothiazine|Lopac0_000249|Oprea1_110255|BSPBio_000247|BSPBio_002011|CHLORPROMAZINE [HSDB]|KBioGR_000806|KBioGR_002312|KBioSS_000622|KBioSS_002314|MLS003166901|CHLORPROMAZINE [VANDF]|CHLORPROMAZINUM [HPUS]|DivK1c_000624|SPECTRUM1500184|2-chloro-10-(3-(dimethylamino)propyl)-phenothiazine|SPBio_001111|SPBio_002168|CHLORPROMAZINE [MART.]|BPBio1_000273|BPBio1_001181|QSPL 401|CHLORPROMAZINE [WHO-DD]|SCHEMBL29358018|SCHEMBL29367385|HMS501P06|KBio1_000624|KBio2_000622|KBio2_002312|KBio2_003190|KBio2_004880|KBio2_005758|KBio2_007448|KBio3_001231|KBio3_002792|MSK7128|cMAP_000017|NINDS_000624|Bio1_000457|Bio1_000946|Bio1_001435|HMS1920M03|HMS2089C12|HMS2091E06|HMS3430C19|HMS3886G22|HMS5085D03|KUC112482N|Pharmakon1600-01500184|ALBB-022464|BCP03610|CHLORPROMAZINE [ORANGE BOOK]|Tox21_110120|BBL028251|BDBM50001888|CCG-40059|NSC756661|NSC756689|s5749|STK182870|CHLORPROMAZINE [USP MONOGRAPH]|AKOS001490972|Tox21_110120_1|DB00477|FC40106|KS-5101|NSC-756661|NSC-756689|RP-4560|SDCCGSBI-0050237.P005|IDI1_000624|PS31 - Chlorpromazine/Norchlorpromazine|QTL1_000021|NCGC00015273-01|NCGC00015273-02|NCGC00015273-03|NCGC00015273-04|NCGC00015273-05|NCGC00015273-06|NCGC00015273-07|NCGC00015273-08|NCGC00015273-09|NCGC00015273-10|NCGC00015273-12|NCGC00015273-13|NCGC00015273-14|NCGC00015273-15|NCGC00015273-16|NCGC00015273-17|NCGC00015273-19|NCGC00015273-31|NCGC00024409-04|NCGC00024409-05|NCGC00024409-06|NCGC00024409-07|NCGC00024409-08|KSC-315-032-|SMR001453710|SY275102|2-chloro-10-[3-(dimethylamino)propyl]-|SBI-0050237.P004|WLN: T C666 BN ISJ B3N1&1 EG|2601A|AB00051943|CS-0012285|NS00001759|2601-A|C06906|D00270|G77950|AB00051943-15|AB00051943-16|AB00051943_17|AB00051943_18|L000182|Q407972|SR-01000000012-5|SR-01000000012-6|2-Chloro-10-(N-dimethylamino-n-propyl)-phenothiazine|BRD-K89997465-001-05-3|BRD-K89997465-001-10-3|BRD-K89997465-003-43-0|BRD-K89997465-003-44-8|1N,1N-dimethyl-3-(2-chloro-10H-10-phenothiazinyl)-1-propanamine|3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethyl-1-propanamine #|3-(2-Chloro-10H-phenothiazin-10-yl)-N,N-dimethylpropan1-amine|(chloropromazine) [3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine|(chlorpromazine)[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine|[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine (chlor-promazine)|[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine( Chlorpromazine)|[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine(clorpromazine)|Chlorpromazine;[3-(2-Chloro-phenothiazin-10-yl)-propyl]-dimethyl-amine"
CITALOPRAM,2771,,"InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3",WSEQXVZVJXJVFP-UHFFFAOYSA-N,C20H21FN2O,324.4,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile,"citalopram|59729-33-8|Nitalapram|Cipram|Citalopramum|Citadur|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile|0DHU5B8D6V|Lu 10-171|CHEBI:77397|1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile|1,3-Dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-5-isobenzofurancarbonitrile|DTXSID8022826|Cytalopram|5-Isobenzofurancarbonitrile, 1,3-dihydro-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-|5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-|5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-|1-[3-(dimethylamino)propyl]-1-(p-fluorophenyl)-5-phthalancarbonitrile|1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile|1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile|RefChem:5691|CHEBI:3723|DTXCID802826|N06AB04|Lu10171|261-891-1|Cipramil|Citox|Celexa|Bonitrile|1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile|[3H]Citalopram|5-Isobenzofurancarbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-|MFCD00865398|CHEMBL549|Lu-10-171|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile|[3H]-Citalopram|Citalopramum [INN-Latin]|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carb onitrile|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile|SMR000465669|Citadur (TN)|Citalopram (USP/INN)|EINECS 261-891-1|UNII-0DHU5B8D6V|Citalopram [USP:INN:BAN]|[3H]Cytalopram|[3H]Escitalopram|[3H]Lexapro|(+/-)-citalopram|CITALOPRAM [MI]|CITALOPRAM [INN]|Prestwick3_000692|SCHEMBL946|CITALOPRAM [VANDF]|CITALOPRAM [MART.]|CITALOPRAM [WHO-DD]|Lopac0_000258|BSPBio_000843|AE-641/00603021|MLS000028578|MLS006011858|BPBio1_000929|GTPL4621|GTPL7547|orb1705387|SCHEMBL29494157|BDBM25870|HSDB 7042|WSEQXVZVJXJVFP-UHFFFAOYSA-|CITALOPRAM [USP IMPURITY]|PS18 - Citalopram/Norcitalopram|HMS2090O09|HMS2093A14|HMS3259B10|MSK10296|QXB00326|UYB90884|BBL029066|LU-10171B|STL058639|AKOS005711003|AC-8894|CCG-204353|DB00215|NC00711|SDCCGSBI-0050246.P003|1-(3-dimethylaminopropyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile|MRF-0000302|NCGC00015267-04|NCGC00015267-05|NCGC00015267-07|NCGC00015267-09|NCGC00015267-11|NCGC00015267-12|NCGC00015267-20|NCGC00015267-26|NCGC00025160-02|AS-76503|ST069372|SY347033|SBI-0050246.P002|HY-121203|AB00513896|C3149|CS-0081223|NS00000035|C07572|D07704|EN300-304884|AB00513896-09|AB00513896-11|AB00513896_12|AB00513896_13|729C338|A832440|AE-641/00605044|F604217|L001223|Q409672|SR-01000003129-8|BRD-A47598013-004-02-0|BRD-A47598013-004-06-1|BRD-A47598013-004-16-0|BRD-A47598013-004-17-8|BRD-A47598013-004-18-6|BRD-A47598013-034-02-7|1-(3'-dimethylaminopropyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile|1-(3-(dimethylamino)propyl)-1-(4'-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile|1-(3-Dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile|1-[3-(dimethylamino) propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro[3,4]benzofuran-5-carbonitrile|5-Cyano-1-(4-fluorophenyl)-1-(3-dimethylaminopropyl)-1,3-dihydro-isobenzofuran|InChI=1/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3"
TERFENADINE,5405,,"InChI=1S/C32H41NO2/c1-31(2,3)26-18-16-25(17-19-26)30(34)15-10-22-33-23-20-29(21-24-33)32(35,27-11-6-4-7-12-27)28-13-8-5-9-14-28/h4-9,11-14,16-19,29-30,34-35H,10,15,20-24H2,1-3H3",GUGOEEXESWIERI-UHFFFAOYSA-N,C32H41NO2,471.7,1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol,"terfenadine|50679-08-8|Seldane|Ternadin|Triludan|Teldane|Allerplus|Teldanex|Aldaban|Terdin|Terfenadina|Terfen|RMI 9918|Terfenadinum|Terfex|RMI-9918|Terfenadinum [INN-Latin]|Terfenadina [INN-Spanish]|MDL 9918|Terfenadin|DTXSID2023642|NSC-665802|NSC-758627|7BA5G9Y06Q|alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol|alpha-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol|1-Piperidinebutanol, alpha-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-|DTXCID503642|1-(4-tert-butylphenyl)-4-[4-(hydroxydiphenylmethyl)piperidin-1-yl]butan-1-ol|NSC665802|Terfenadinum (INN-Latin)|Terfenadina (INN-Spanish)|1-(4-tert-butylphenyl)-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butan-1-ol|alpha-(4-[1,1-Dimethylethyl]phenyl)-4-[hydroxydiphenylmethyl]-1-piperidinebutanol|Terfenadin Ratiopharm|RMI9918|Histafen|Terfenor|Terfenor fte|Triludan fte|(RS)-1-(4-tert-butylphenyl)-4-(4-(hydroxy(diphenyl)methyl)piperidin-1-yl)-butan-1-ol|(RS)-1-(4-tert-butylphenyl)-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}-butan-1-ol|1-(4-tert-butylphenyl)-4-(4-(hydroxy-di(phenyl)methyl)piperidin-1-yl)butan-1-ol|1-(4-tert-butylphenyl)-4-[4-[hydroxy-di(phenyl)methyl]piperidin-1-yl]butan-1-ol|Terfinax 60|alpha-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperdinebutanol|Histafen 120|Terfinax 120|RefChem:891400|R06AX12|256-710-8|Nebralin|Terfenidine|Cyater|MFCD00079622|1-(4-(tert-butyl)phenyl)-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butan-1-ol|1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butan-1-ol|MDL-9918|alpha-(p-tert-Butylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol|CHEMBL17157|1-Piperidinebutanol, .alpha.-[4-(1,1-dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-|MLS000028499|CHEBI:9453|NCGC00016064-04|NCGC00016064-06|SMR000058260|1-(4-tert-butylphenyl)-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butan-1-ol|1-(4-(tert-Butyl)phenyl)-4-(4-(hydroxydiphenylmethyl)-piperidin-1-yl)butan-1-ol|C32H41NO2|Seldane (TN)|BRN 5857899|HSDB 6508|SR-01000000104|EINECS 256-710-8|teraenadine|UNII-7BA5G9Y06Q|Terfenadine (JAN/USAN/INN)|a-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-piperidinebutanol|1-PIPERIDINEBUTANOL, .ALPHA.-(4-(1,1-DIMETHYLETHYL)PHENYL)-4-(HYDROXYDIPHENYLMETHYL)-|Prestwick_460|1-(4-tert-Butylphenyl)-4-(4-(alpha-hydroxybenzhydryl)piperidino)-butan-1-ol|1-(p-tert-Butylphenyl)-4-(4'-(alpha-hydroxydiphenylmethyl)-1'-piperidyl)butanol|CAS-50679-08-8|Terfenadine [USAN:USP:INN:BAN:JAN]|Terfenadine (Standard)|Opera_ID_334|TERFENADINE [MI]|Prestwick0_000138|Prestwick1_000138|Prestwick2_000138|Prestwick3_000138|TERFENADINE [INN]|TERFENADINE [JAN]|(.+/-.)-Terfenadine|TERFENADINE [HSDB]|TERFENADINE [USAN]|T 9652|TERFENADINE [VANDF]|SCHEMBL5152|TERFENADINE [MART.]|Lopac0_001213|Oprea1_343139|BSPBio_000216|TERFENADINE [WHO-DD]|MLS001148415|DivK1c_001011|SPBio_002155|BPBio1_000238|GTPL2608|orb1309179|HMS503K03|HY-B1193R|KBio1_001011|TERFENADINE [EP IMPURITY]|NINDS_001011|Terfenadine  - Bio-X trade mark|HMS1568K18|HMS2089I14|HMS2093I11|HMS2095K18|HMS2231N07|HMS3263D08|HMS3373J07|HMS3712K18|HMS5083M13|Pharmakon1600-01503708|TERFENADINE [EP MONOGRAPH]|HY-B1193|MSK10149|Tox21_110295|Tox21_110296|Tox21_501213|AC-928|BDBM50017376|NSC758627|s4353|AKOS015962091|Tox21_110295_1|CCG-205287|CS-4800|DB00342|FD28043|LP01213|NSC 665802|NSC 758627|SDCCGSBI-0051180.P004|1-[4-(1,1-dimethylethyl)phenyl]-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butan-1-ol|IDI1_001011|NCGC00016064-03|NCGC00016064-05|NCGC00016064-08|NCGC00016064-09|NCGC00016064-12|NCGC00016064-19|NCGC00089746-02|NCGC00089746-03|NCGC00089746-04|NCGC00261898-01|AC-15791|AS-75636|BT166253|NCI60_022784|SBI-0051180.P003|DB-051821|AB00052367|EU-0101213|NS00006817|ST50307835|SW196677-3|T3977|BIM-0051180.0001|C07463|D00521|D82079|AB00052367-16|AB00052367_17|AB00052367_18|EN300-22527913|L000888|Q417909|( inverted exclamation markA)-Terfenadine;MDL-991|SR-01000000104-2|SR-01000000104-4|SR-01000000104-7|BRD-A06352418-001-03-6|BRD-A06352418-001-15-0|BRD-A06352418-001-24-2|BRD-A06352418-001-25-9|Terfenadine, European Pharmacopoeia (EP) Reference Standard|Terfenadine, United States Pharmacopeia (USP) Reference Standard|.alpha.-(p-tert-Butylphenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol|1-[4-(tert-butyl)phenyl]-4-[4-(hydroxydiphenylmethyl)piperidyl]butan-1-ol|(+/-)1-(4-tert-butylphenyl)-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butan-1-ol|.alpha.-(4-(1,1-dimethylethyl)phenyl)-4-(hydroxydiphenyl-methyl)-1-piperidine butanol|.alpha.-(4-(1,1-Dimethylethyl)phenyl)-4-(hydroxydiphenylmethyl)-1-piperidinebutanol|1-(4-tert-Butyl-phenyl)-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butan-1-ol|1-(4-tert-Butylphenyl)-4-(4-[hydroxy(diphenyl)methyl]-1-piperidinyl)-1-butanol #|a-[4-(1,1-Dimethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol|alpha-[4-(1,1-Dmethylethyl)phenyl]-4-(hydroxydiphenylmethyl)-1-piperidinebutanol|1-(4-tert-Butyl-phenyl)-4-[4-(hydroxy-diphenyl-methyl)-piperidin-1-yl]-butan-1-ol(Terfenadine)"
GRANISETRON,multiply,multiply,multiply,multiply,multiply,multiply,multiply,multiply
CISAPRIDE,6917698,,"InChI=1S/C23H29ClFN3O4/c1-30-21-13-19(26)18(24)12-17(21)23(29)27-20-8-10-28(14-22(20)31-2)9-3-11-32-16-6-4-15(25)5-7-16/h4-7,12-13,20,22H,3,8-11,14,26H2,1-2H3,(H,27,29)/t20-,22+/m1/s1",DCSUBABJRXZOMT-IRLDBZIGSA-N,C23H29ClFN3O4,465.9,"4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide","cisapride|81098-60-4|Cisaprida|Cisapridum|Pridesia|Prepulsid|CHEBI:3720|R 51619|Enteropride|Kinestase|UVL329170W|cis-4-Amino-5-chloro-N-(1-(3-(p-fluorophenoxy)propyl)-3-methoxy-4-piperidyl)-o-anisamide|DTXSID3022825|R-51,619|R-51619|4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl]-2-methoxybenzamide|Propulsid Quicksolv|4-amino-5-chloro-N-((3S,4R)-1-(3-(4-fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|Benzamide, 4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxy-, cis-|Prepulsid quicklet|cis-4-amino-5-chloro-N-(1-(3-(p-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-o-anisamide|cis-4-amino-5-chloro-N-{1-[3-(p-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-o-anisamide|cis-4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxy-4-piperidinyl)-2-methoxybenzamide|cis-4-amino-5-chloro-N-{1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|RefChem:54832|R51619|A03FA02|DTXCID501508501|4-Amino-5-chloro-N-(1-(3-(4-fluoro-phenoxy)-propyl)-3-methoxy-piperidin-4-yl)-2-methoxy-benzamide|4-Amino-5-chloro-N-{1-[3-(4-fluoro-phenoxy)-propyl]-3-methoxy-piperidin-4-yl}-2-methoxy-benzamide|279-689-7|623-862-5|4-amino-5-chloro-N-(1-(3-(4-fluorophenoxy)propyl)-3-methoxypiperidin-4-yl)-2-methoxybenzamide|(+-)-Cisapride|Risamol|86718-70-9|CHEMBL560739|C23H29ClFN3O4|Acenalin|Propulsin|Acpulsif|Alipride|Cipride|Cisapron|Cisawal|Colinorm|Kaudalit|Rapulid|Syspride|Unipride|Vomiprid|Vomipride|Dispep|Esorid|Guptro|Presid|Pulsid|Unamol|Alimix Forte|4-Amino-5-chloro-N-{(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidinyl}-2-methoxybenzamide|Cisapridum [Latin]|Cisaprida [Spanish]|T 1341|SR-01000597514|Cisapridum [INN-Latin]|Cisaprida [INN-Spanish]|CISAPRIDE [JAN]|UNII-UVL329170W|HSDB 3571|EINECS 279-689-7|Cisapride (Standard)|Cisapride [USAN:USP:INN:BAN:JAN]|CISAPRIDE [INN]|CISAPRIDE [MI]|CISAPRIDE [HSDB]|CISAPRIDE [USAN]|CISAPRIDE [VANDF]|CISAPRIDE [USP-RS]|CISAPRIDE [WHO-DD]|SCHEMBL16132|104860-66-4|BIDD:GT0774|orb1309100|SCHEMBL29389140|CISAPRIDE [USP MONOGRAPH]|DCSUBABJRXZOMT-IRLDBZIGSA-N|HMS3268O13|HMS3412B22|HMS3676B22|GDA09860|MSK10215|BDBM50462032|HY-14149R|NSC785572|AKOS024456750|DB00604|NSC-785572|AS-56067|Q425295|R 51619;( inverted exclamation markA)-Cisaprid|SR-01000597514-1|SR-01000597514-3|BRD-K06895174-001-01-0|BRD-K06895174-001-02-8|4-amino-5-chloro-N-[(3S,4R)-1-[3-(4-fluorophenoxy)propyl]-3-methoxy-4-piperidyl]-2-methoxy-benzamide|4-amino-5-chloro-N-{cis-1-[3-(4-fluorophenoxy)propyl]-3-methoxypiperidin-4-yl}-2-methoxybenzamide|BENZAMIDE, 4-AMINO-5-CHLORO-N-(1-(3-(4-FLUOROPHENOXY)PROPYL)-3-METHOXY-4-PIPERIDINYL)-2-METHOXY-, CIS"
THIORIDAZINE,5452,,"InChI=1S/C21H26N2S2/c1-22-13-6-5-7-16(22)12-14-23-18-8-3-4-9-20(18)25-21-11-10-17(24-2)15-19(21)23/h3-4,8-11,15-16H,5-7,12-14H2,1-2H3",KLBQZWRITKRQQV-UHFFFAOYSA-N,C21H26N2S2,370.6,10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine,"thioridazine|50-52-2|Mellaril|Thioridazin|Mellerette|Sonapax|Mellaril-S|Malloryl|Melleril|Meleril|dl-Thioridazine|Mellerets|Mallorol|Melleretten|Tioridazina|TP-21|Novoridazine|Thioridazinum|Melleryl|Thioridazine prolongatum|Orsanil|Thioril|2-Methylmercapto-10-(2-(N-methyl-2-piperidyl)ethyl)phenothiazine|3-Methylmercapto-N-(2'-(N-methyl-2-piperidyl)ethyl)phenothiazine|10-[2-(1-methylpiperidin-2-yl)ethyl]-2-methylsulfanylphenothiazine|N3D6TG58NI|CHEBI:9566|10-(2-(1-Methyl-2-piperidyl)ethyl)-2-(methylthio)phenothiazine|DTXSID6023656|10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylsulfanyl-phenothiazine|10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine|DTXCID403656|Phenothiazine, 10-((1-methyl-2-piperidyl)ethyl)-2-(methylthio)-|ApoThioridazine|10-(2-(1-methyl-2-piperidyl)ethyl)-2-methylsulfanyl-phenothiazine|10-(2-(1-methylpiperidin-2-yl)ethyl)-2-methylsulfanylphenothiazine|10-[2-(1-Methyl-2-piperidyl)ethyl]-2-(methylthio)phenothiazine|Apo Thioridazine|10-(2-(1-methylpiperidin-2-yl)ethyl)-2-(methylsulfanyl)-10H-phenothiazine|Thioridazineneurazpharm|Thioridazine neurazpharm|RefChem:56611|N05AC02|200-044-2|10-(2-(1-Methylpiperidin-2-yl)ethyl)-2-(methylthio)-10H-phenothiazine|Melleril (liquid)|Aldazine|CHEMBL479|10H-Phenothiazine, 10-(2-(1-methyl-2-piperidinyl)ethyl)-2-(methylthio)-|NCGC00016059-05|(+-)-Thioridazine|Mellarit|Malloryl; Meleril; Mellaril S; Mellerets|10H-Phenothiazine, 10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)-|Thioridazinum [INN-Latin]|Tioridazina [INN-Spanish]|Thioxidazine|Thiozine|Thioridazine, prolongatum|Phenothiazine, 10-[2-(1-methyl-2-piperidyl)ethyl]-2-(methylthio)-|C21H26N2S2|10-[2-(1-methyl-2-piperidinyl)ethyl]-2-(methylthio)-10h-phenothiazine|10-[2-(1-methylpiperidin-2-yl)ethyl]-2-(methylthio)-10H-phenothiazine|CAS-50-52-2|Mellaril-S (TN)|HSDB 3189|EINECS 200-044-2|Thioridazine (USP/INN)|UNII-N3D6TG58NI|Mellaril (*Hydrochloride*)|AI3-51923|Thioridazine [USAN:USP:INN:BAN]|Mellaril (Salt/Mix)|PS13 - Thioridazine|Spectrum_001066|Prestwick0_000078|Prestwick1_000078|Prestwick2_000078|Prestwick3_000078|Spectrum2_001332|Spectrum3_000585|Spectrum4_000356|Spectrum5_001062|THIORIDAZINE [MI]|(.+/-.)-Thioridazine|THIORIDAZINE [INN]|Biomol-NT_000017|THIORIDAZINE [HSDB]|THIORIDAZINE [USAN]|SCHEMBL9566|THIORIDAZINE [VANDF]|Lopac0_001252|BSPBio_000295|BSPBio_002030|GTPL100|KBioGR_000791|KBioGR_002308|KBioSS_001546|KBioSS_002310|THIORIDAZINE [MART.]|(+/-)-THIORIDAZINE|DivK1c_000066|THIORIDAZINE [USP-RS]|THIORIDAZINE [WHO-DD]|SPBio_001483|SPBio_002216|BPBio1_000325|BPBio1_001175|orb1688560|SCHEMBL12434241|SCHEMBL29384252|HY-B0965A|KBio1_000066|KBio2_001546|KBio2_002308|KBio2_004114|KBio2_004876|KBio2_006682|KBio2_007444|KBio3_001530|KBio3_002788|cMAP_000015|NINDS_000066|HMS2090J04|THIORIDAZINE [ORANGE BOOK]|THIORIDAZINE [EP MONOGRAPH]|BCP19922|MSK11382|THIORIDAZINE [USP MONOGRAPH]|Tox21_110294|BDBM50002338|NS-835|Tox21_110294_1|CCG-205326|DB00679|SDCCGSBI-0051219.P005|IDI1_000066|NCGC00016059-03|NCGC00016059-04|NCGC00016059-07|NCGC00016059-08|NCGC00016059-09|NCGC00016059-10|NCGC00016059-11|NCGC00016059-13|NCGC00016059-14|NCGC00016059-24|NCGC00089809-02|NCGC00089809-03|AS-77485|DA-68160|SBI-0051219.P004|AB00053553|CS-0013830|NS00004673|D00373|D94995|EN300-708788|Q58375|AB00053553-16|AB00053553_17|AB00053553_18|242T875|L001321|BRD-A84481105-003-17-2|BRD-A84481105-003-31-3|BRD-A84481105-003-32-1|phenothiazine, 10-[2-(N-methyl)piperidinyl]ethyl-2-methylthio-|10-[2-(1-Methyl-2-piperidinyl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine|10-[2-(1-methyl-piperidin-2-yl)-ethyl]-2-methylsulfanyl-10h-phenothiazine|10H-Phenothiazine, 10-[2-(1-methyl-2-piperidyl)ethyl]-2-methylthio-|(Thioridazine)10-[2-(1-Methyl-piperidin-2-yl)-ethyl]-2-methylsulfanyl-10H-phenothiazine|10-[2-(1-Methyl-2-piperidinyl)ethyl]-2-(methylsulfanyl)-10H-phenothiazine #|10-[2-(1-Methyl-piperidin-2-yl)-ethyl]-2-methylsulfanyl-10H-phenothiazine (thioridazine)|107388-89-6"
MIZOLASTINE,65906,,"InChI=1S/C24H25FN6O/c1-29(23-26-13-10-22(32)28-23)19-11-14-30(15-12-19)24-27-20-4-2-3-5-21(20)31(24)16-17-6-8-18(25)9-7-17/h2-10,13,19H,11-12,14-16H2,1H3,(H,26,28,32)",PVLJETXTTWAYEW-UHFFFAOYSA-N,C24H25FN6O,432.5,2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methylamino]-1H-pyrimidin-6-one,"Mizolastine|108612-45-9|Mizollen|Mizolastina|Mistalin|Mizolastinum|Mizolen|Zolim|SL 85.0324|SL-85.0324|2-((1-(1-(p-Fluorobenzyl)-2-benzimidazolyl)-4-piperidyl)methylamino)-4(3H)-pyrimidinone|DTXSID5046801|244O1F90NA|DTXCID3026801|2-[(1-{1-[(4-fluorophenyl)methyl]-1H-1,3-benzodiazol-2-yl}piperidin-4-yl)(methyl)amino]-3,4-dihydropyrimidin-4-one|2-((1-(1-((4-fluorophenyl)methyl)-1H-1,3-benzodiazol-2-yl)piperidin-4-yl)(methyl)amino)-3,4-dihydropyrimidin-4-one|RefChem:819015|R06AX25|Zolistan|C24H25FN6O|Mistamine|2-((1-(1-(4-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)piperidin-4-yl)(methyl)amino)pyrimidin-4(1H)-one|Mizolastine (Mizollen)|MKC-431|CHEMBL94454|2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]-methylamino]-1H-pyrimidin-6-one|Mizolastine [INN]|NCGC00181013-01|Mizolastinum [INN-Latin]|Mizolastina [INN-Spanish]|Zolistam|2-{1-[1-(4-Fluorobenzyl)-1H-benzimidazol-2-yl]-4-piperidyl(methyl)amino}pyrimidin-4(1H)-one|Mizollen (TN)|2-((1-(1-(4-fluorobenzyl)-1H-benzo[d]imidazol-2-yl)piperidin-4-yl)(methyl)amino)pyrimidin-4(3H)-one|CAS-108612-45-9|Mizolastine (JAN/INN)|Mizolastine [INN:BAN]|UNII-244O1F90NA|CCRIS 8410|MFCD23140913|Mizolastine (Standard)|MIZOLASTINE [MI]|MIZOLASTINE [JAN]|SCHEMBL5061|MIZOLASTINE [MART.]|MIZOLASTINE [WHO-DD]|MLS006010068|MKC431|orb1310920|SCHEMBL4443891|SCHEMBL6273027|SCHEMBL29369194|BDBM22877|CHEBI:31857|GTPL10102|HY-B0164R|PVLJETXTTWAYEW-UHFFFAOYSA-N|GLXC-03037|HMS3713N04|HY-B0164|MSK10898|Tox21_112663|AC-634|MFCD00864625|AKOS005145756|AKOS016003409|Tox21_112663_1|CCG-220621|CS-1997|DB12523|KS-1139|NCGC00344565-01|NCGC00344565-04|2-((1-(1-(4-Fluorobenzyl)-1H-benzo[d]imidazol-2-yl)-piperidin-4-yl)(methyl)amino)pyrimidin-4(1H)-one|2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]-4-piperidyl]-methyl-amino]-1H-pyrimidin-6-one|4(1H)-Pyrimidinone, 2-((1-(1-((4-fluorophenyl)methyl)-1H-benzimidazol-2-yl)-4-piperidinyl)methylamino)-|SL850324|SMR003965484|SL-850324|M2756|NS00002280|D01117|T71584|AB01566892_01|EN300-7396250|612M459|Q417830|BRD-K21884483-001-01-1|BRD-K21884483-001-03-7|2-({1-[1-(4-Fluoro-benzyl)-1H-benzoimidazol-2-yl]-piperidin-4-yl}-methyl-amino)-3H-pyrimidin-4-one|2-({1-[1-(4-fluorobenzyl)-1H-benzimidazol-2-yl]-piperidin-4-yl}-methylamino)-4(1H) pyrimidinone|2-[[1-[1-[(4-fluorophenyl)methyl]benzimidazol-2-yl]piperidin-4-yl]- methylamino]-1H-pyrimidin-6-one"
METHYLPHENIDATE HYDROCHLORIDE,9280,,"InChI=1S/C14H19NO2.ClH/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12;/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3;1H",JUMYIBMBTDDLNG-UHFFFAOYSA-N,C14H20ClNO2,269.77,methyl 2-phenyl-2-piperidin-2-ylacetate;hydrochloride,"METHYLPHENIDATE HYDROCHLORIDE|298-59-9|Methylphenidate HCl|Ritalin SR|Metadate CD|Ritalin-SR|Metadate|Metadate ER|Methylin ER|Quillivant XR|Ritalin LA|QuilliChew ER|Ritalin|Quillichew|Quillivant|Aptensio|Foquest|Medikinet|Methylphenidylacetate hydrochloride|Oros mph|Aptensio XR|DTXSID8020886|NSC-169868|Methyl alpha-phenyl-2-piperidineacetate hydrochloride|DTXCID20886|SPD544|CHEBI:31836|SPD-544|NSC169868|Equasym|ADHANSIA XR|JORNAY PM|Tranquilyn|Delmosart|Matoride xl|Xenidate xl|Medikinet XL|RELEXXII|RefChem:57373|JORNAY PM Extended-Release|Hydrochloride, Methylphenidate|Methylphenidate Hydrochloride CD|Methylphenidate Hydrochloride (cd)|Methylphenidate Hydrochloride (la)|alpha-phenyl-2-piperidineacetic acid methyl ester hydrochloride|Methylphenidate Hydrochloride Extended Release|Methylphenidate Hydrochloride Extended-release|206-065-3|2-(2-methoxy-2-oxo-1-phenylethyl)piperidinium chloride|4B3SC438HI|Equasym xl|Centedrine|Centedrin|Methylphenidate.HCl|Concerta|Methylin|H-Tic-OtBu.HCl|Threo-methylphenidate hydrochloride|Methylphenidate(Ritalin)|Methylphenidate (hydrochloride)|Ritalin hydrochloride|methyl 2-phenyl-2-piperidin-2-ylacetate;hydrochloride|NCGC00091942-01|Rilaline|d,l-Methylphenidate.HCl|methyl phenyl(piperidin-2-yl)acetate hydrochloride|Meridil hydrochloride|Rilatine|CAS-298-59-9|NSC 169868|CCRIS 6258|Methyl 2-phenyl-2-(piperidin-2-yl)acetate hydrochloride|EINECS 206-065-3|Methylphenidate Hydrochloride (1.0 mg/mL in Methanol)|Methylphenidate Hydrochloride ER|Concerta (TN)|Metadate (TN)|Ritalin (TN)|Quillivant xr (TN)|Methylphenidate hydrochloride [USP:JAN]|CHEMBL1722|SCHEMBL41067|MLS003922100|DL-Methylphenidate hydrochloride|Methylphenidate hydrochloride cii|HY-B1091A|Methylphenidate-d10 hydrochloride|Pharmakon1600-01505907|BCP34044|EBA41996|WZB81919|Tox21_111186|Tox21_200309|2-Piperidineacetic acid, alpha-phenyl-, methyl ester, hydrochloride|MFCD00058191|NSC759278|AKOS016010356|CCG-213572|CS-4658|FM35271|NSC-759278|SB13180|WLN: T6MTJ BYR & VO1 & GH|2-Piperidineacetic acid, alpha-phenyl-, methyl ester, hydrochloride, (R*,R*)-(+-)-|Methylphenidate hydrochloride (JAN/USP)|NCGC00257863-01|SMR000058998|NS00079660|D01296|298M599|2-Piperidineacetic acid, methyl ester, hydrochloride|methyl 2-phenyl-2-(2-piperidyl)acetate;hydrochloride|Methylphenidate HCl;Threo-methylphenidate hydrochloride|Q26840773|Methyl .alpha.-phenyl-2-piperidineacetate hydrochloride|d,l-Methylphenidate.HCl, 1mg/ml in Methanol (as free base)|Methylphenidate hydrochloride, European Pharmacopoeia (EP) Reference Standard"
BENZTROPINE,1201549,,"InChI=1S/C21H25NO/c1-22-18-12-13-19(22)15-20(14-18)23-21(16-8-4-2-5-9-16)17-10-6-3-7-11-17/h2-11,18-21H,12-15H2,1H3/t18-,19+,20?",GIJXKZJWITVLHI-YOFSQIOKSA-N,C21H25NO,307.4,"(1S,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane","benztropine|Benzatropine|86-13-5|Cobrentin|Tropine benzohydryl ether|Benzatropina|Benzatropinum|Cogentine|Cogentinol|Pseudobenztropine|3endo-benzhydryloxytropane|Benzatropinum [INN-Latin]|Benzatropina [INN-Spanish]|Benztropinum|Akitan|3alpha-(diphenylmethoxy)tropane|HSDB 3014|NK 02|(1R,5S)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|1NHL2J4X8K|Apo Benztropine|CHEBI:3048|DTXSID9022659|3alpha-(Diphenylmethoxy)-1alphaH,5alphaH-tropane|med.21724, Compound Benztropine|NK-02|Benzatropine (INN)|Benzatropine [INN]|802597-90-6|Benzhydryl 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ether|3alpha-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|NCGC00159471-02|(3-endo)-3-(diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane|Benzatropine mesilate|DTXCID502659|(1S,5R)-3-benzhydryloxy-8-methyl-8-azabicyclo[3.2.1]octane|CAS-86-13-5|Benzatropine [INN:BAN]|UNII-1NHL2J4X8K|8-Azabicyclo(3.2.1)octane, 3-(diphenylmethoxy)-8-methyl-, endo-|8-Azabicyclo[3.2.1]octane, 3-(diphenylmethoxy)-8-methyl-, (3-endo)-|8-AZABICYCLO(3.2.1)OCTANE, 3-(DIPHENYLMETHOXY)-8-METHYL-, (3-ENDO)-|benztropine-mesylate|CXQ|BENZTROPINE [MI]|NCGC00094600-01|RefChem:1088905|BENZTROPINE [HSDB]|BENZTROPINE [VANDF]|3alpha-diphenylmethoxytropane|1.alpha.H,5.alpha.H-Tropane, 3.alpha.-(diphenylmethoxy)-|SCHEMBL35388|BENZATROPINE [WHO-DD]|1alphaH,5alphaH-tropane, 3alpha-(diphenylmethoxy)-|8-Azabicyclo[3.2.1]octane, 3-(diphenylmethoxy)-8-methyl-, endo-|CHEMBL438151|GTPL7601|orb1703693|SCHEMBL5960155|SCHEMBL8659140|8-Azabicyclo[3.2.1]octane,3-(diphenylmethoxy)-8-methyl-, (3-endo)-|CHEMBL1201203|CHEMBL1618180|3-alpha-(diphenylmethoxy)tropane|CHEBI:94707|BDBM429529|GLXC-20406|Tox21_111303|Tox21_111695|BDBM50366775|AKOS025310493|DB00245|NCGC00013495-15|NCGC00013495-18|NCGC00373219-02|NCGC00507745-01|C06846|D07511|AB01566865_01|EN300-6492989|Q415026|BRD-K68804560-066-01-2|1-alpha-H,5-alpha-H-Tropane, 3-alpha-(diphenylmethoxy)-|(1R,3r,5S)-3-(Diphenylmethoxy)-8-methyl-8-azabicyclo[3.2.1]octane|(1R,5S)-3-[di(phenyl)methoxy]-8-methyl-8-azabicyclo[3.2.1]octane|(3-endo)-3-[(diphenylmethyl)oxy]-8-methyl-8-azabicyclo[3.2.1]octane"
DESIPRAMINE,2995,,"InChI=1S/C18H22N2/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20/h2-5,7-10,19H,6,11-14H2,1H3",HCYAFALTSJYZDH-UHFFFAOYSA-N,C18H22N2,266.4,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine","desipramine|Norimipramine|50-47-5|Monodemethylimipramine|Desmethylimipramine|Desipramin|Demethylimipramine|Desimipramine|Dimethylimipramine|Dezipramine|Desipramina|Methylaminopropyliminodibenzyl|Imipramine, demethyl-|desipraminum|Desimpramine|N-(3-Methylaminopropyl)iminobibenzyl|Desipramine (D4)|3-(10,11-DIHYDRO-5H-DIBENZO[B,F]AZEPIN-5-YL)-N-METHYLPROPAN-1-AMINE|5-(gamma-Methylaminopropyl)iminodibenzyl|DMI 50475|N-desmethylimipramine|3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine|CHEBI:47781|TG537D343B|DTXSID6022896|5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(methylamino)propyl)-|Pertrofran|Apo Desipramine|Nu Desipramine|3-(5,6-dihydrobenzo(b)(1)benzazepin-11-yl)-N-methylpropan-1-amine|5H-Dibenz[b,f]azepine, 10,11-dihydro-5-[3-(methylamino)propyl]-|Novo Desipramine|PMS Desipramine|3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N-methylpropan-1-amine|Ratio Desipramine|(3-(2-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)propyl)(methyl)amine|(3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}propyl)(methyl)amine|RefChem:54946|DTXCID902896|N06AA01|(3-(2-azatricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,11,13-hexaen-2-yl)propyl)(methyl)amine|200-040-0|Norpramine|Sertofran|DMI (pharmaceutical)|Desipramine (INN)|CHEMBL72|10,11-Dihydro-5-(3-methylaminopropyl)-5H-dibenz(b,f)azepine|5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N-methyl-|5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N-methyl-|(3-(10H,11H-Dibenzo[b,f]azepin-5-yl)propyl)methylamine|Pertrofane|DESIPRAMINE [INN]|Desipramine [INN:BAN]|Desipraminum [INN-Latin]|Desipramina [INN-Spanish]|Desmethylimipramine;Imipramine,demethyl-;Methylaminopropyliminodibenzyl|CCRIS 7091|HSDB 3052|CAS-58-28-6|NCGC00015340-02|EINECS 200-040-0|BRN 1432747|Treyzafagit|UNII-TG537D343B|Imipramine-M Nor|Desipramine;Norpramin|Desipramine Free Base|Pertofran (Salt/Mix)|Spectrum_000441|Pertofrane (Salt/Mix)|IMIPRAMINE_met001|DESIPRAMINE [MI]|Prestwick0_000343|Prestwick1_000343|Prestwick2_000343|Prestwick3_000343|Spectrum2_000091|Spectrum3_000379|Spectrum4_000314|Spectrum5_000833|Lopac-D-3900|DESIPRAMINE [HSDB]|DESIPRAMINE [VANDF]|Lopac0_000358|SCHEMBL34384|BSPBio_000405|BSPBio_002137|DESIPRAMINE [WHO-DD]|KBioGR_000928|KBioSS_000921|DivK1c_000190|SPBio_000042|SPBio_002326|BPBio1_000447|GTPL2399|orb1689578|SCHEMBL29379525|BDBM35229|HY-B1272A|KBio1_000190|KBio2_000921|KBio2_003489|KBio2_006057|KBio3_001357|NINDS_000190|10, 11-Dihydro-N-methyl-5H-dibez[b,f]azepine-5-propanamine|HMS3430H03|HMS3742I19|ALBB-025959|3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-propan-1-amine|SBB002569|STK735144|AKOS001681456|CCG-118231|CS-8193|DB01151|SDCCGSBI-0050346.P005|IDI1_000190|NCGC00015340-01|NCGC00015340-03|NCGC00015340-04|NCGC00015340-05|NCGC00015340-06|NCGC00015340-07|NCGC00015340-08|NCGC00015340-09|NCGC00015340-10|NCGC00015340-11|NCGC00015340-13|NCGC00015340-22|NCGC00024375-04|AC-15977|ST052019|SBI-0050346.P004|AB00053450|NS00010406|C06943|D07791|AB00053450_14|050D475|EN300-18293453|L001089|Q423288|BRD-K60762818-003-15-3|BRD-K60762818-003-25-2|BRD-K60762818-003-26-0|IMIPRAMINE HYDROCHLORIDE IMPURITY A [EP IMPURITY]|5-(3-methylaminopropyl)-10,11-dihydro-5H-dibenzo[b,f]azepine|5H-Dibenz[b,f]azepine, 10,11-dihydro-5-(methylamino)propyl-|10,11-dihydro-5-(3-(methylamino)propyl)-5h-dibenz(b,f)azepine|5H-Dibenzo[b, f]azepine, N-(3-methylaminopropyl)-, 10,11-Dihydro|3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methyl-1-propanamine #|N-[3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N-methylamine|(3-{2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)(methyl)amine"
METHYLPHENIDATE,4158,,"InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3",DUGOZIWVEXMGBE-UHFFFAOYSA-N,C14H19NO2,233.31,methyl 2-phenyl-2-piperidin-2-ylacetate,"methylphenidate|Methylphenidan|Phenidylate|Calocain|113-45-1|Plimasine|Methyl phenidylacetate|Metilfenidato|Methylphenidatum|Daytrana|Methyl phenidate|Ritaline|4311/B Ciba|Methyl alpha-phenyl-alpha-(2-piperidyl)acetate|alpha-Phenyl-2-piperidineacetic acid methyl ester|methyl 2-phenyl-2-piperidin-2-ylacetate|NCI-C56280|Metilfenidat hydrochloride|2-Piperidineacetic acid, alpha-phenyl-, methyl ester|Cotempla XR-ODT|Methyl alpha-phenyl-alpha-2-piperidinylacetate|Methyl 2-phenyl-2-(piperidin-2-yl)acetate|Threo-dl-methylphenidate|alpha-Phenyl-alpha-(2-piperidyl)acetic acid methyl ester|Prc-063|Methylphenidate extended release|DTXSID5023299|RefChem:6033|CHEBI:6887|DTXCID003299|Methylphenidate Transdermal System|N06BA04|204-028-6|207ZZ9QZ49|Concerta|Metilfenidato [Italian]|Metilfenidato [INN-Spanish]|Methylphenidatum [INN-Latin]|Methyl phenidyl acetate|Methylin|methyl phenyl(piperidin-2-yl)acetate|CHEMBL796|2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester|Methylfenidan|CHEBI:84276|.alpha.-Phenyl-2-piperidineacetic acid methyl ester|d-methylphenidate HCl|Daytrana (TN)|HSDB 3126|Methyl (2-phenyl-2-(2-piperidyl)acetate)|EINECS 204-028-6|C 4311|Methylphenidate (USAN/INN)|Rubifen|Tuzulby|DEA No. 1724|Methylphenidate [USAN:INN:BAN]|Ritalin (Salt/Mix)|Methylin (Salt/Mix)|Ritaline (Salt/Mix)|Centedein (Salt/Mix)|Centedrin (Salt/Mix)|Centedrine (Salt/Mix)|SCHEMBL37178|GTPL7236|Jornay PM (a.k.a. HLD200)|BCP18286|HY-B1091|BDBM50062912|methyl alpha-piperid-2-ylphenylacetate|Methyl phenyl(2-piperidinyl)acetate #|CS-4657|DB00422|NCGC00248587-01|NCGC00248587-03|FM112030|Methyl .alpha.-phenyl-2-piperidineacetate|SBI-0206868.P001|Methyl .alpha.-phenyl-2-piperidine-acetate|NS00010412|C07196|D04999|phenyl-piperidin-2-yl-acetic acid methyl ester|AB01563134_01|2-Piperidineacetic acid, ?-phenyl-, methyl ester|L001307|Q422112|Methyl .alpha.-phenyl-.alpha.-(2-piperidyl)acetate|Methyl .alpha.-phenyl-.alpha.-2-piperidinylacetate|BRD-A19585813-003-01-7|BRD-A19585813-003-03-3"
PYROVALERONE,14373,,"InChI=1S/C16H23NO/c1-3-6-15(17-11-4-5-12-17)16(18)14-9-7-13(2)8-10-14/h7-10,15H,3-6,11-12H2,1-2H3",SWUVZKWCOBGPTH-UHFFFAOYSA-N,C16H23NO,245.36,1-(4-methylphenyl)-2-pyrrolidin-1-ylpentan-1-one,"PYROVALERONE|Pirovalerona|3563-49-3|Pyrovaleronum|4'-Methyl-2-(1-pyrrolidinyl)valerophenone|VOU69C02JP|1-Pentanone, 1-(4-methylphenyl)-2-(1-pyrrolidinyl)-|J8.659B|1-(4-methylphenyl)-2-pyrrolidin-1-yl-pentan-1-one|RefChem:871008|Pyrovalerone [INN]|CHEMBL201960|1-(4-methylphenyl)-2-(pyrrolidin-1-yl)pentan-1-one|DEA No. 1485|UNII-VOU69C02JP|Pyrovaleronum [INN-Latin]|Pirovalerona [INN-Spanish]|PYROVALERONE [MI]|Valerophenone, 4'-methyl-2-(1-pyrrolidinyl)-|PYROVALERONE [MART.]|1-(4-methylphenyl)-2-pyrrolidin-1-ylpentan-1-one|PYROVALERONE [WHO-DD]|SCHEMBL164376|DTXSID20863194|CHEBI:134998|SWUVZKWCOBGPTH-UHFFFAOYSA-N|DAA56349|BDBM50182555|HY-U00296|CS-7265|4'-methyl-alpha-pyrrolidinovalerophenone|NS00017901|1-P-TOLYL-1-OXO-2-PYRROLIDINO-N-PENTANE|Q410824|1-(4-Methylphenyl)-2-(1-pyrrolidinyl)-1-pentanone #"
IMIPRAMINE,3696,,"InChI=1S/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H3",BCGWQEUPMDMJNV-UHFFFAOYSA-N,C19H24N2,280.4,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine","imipramine|50-49-7|Melipramine|Antideprin|Berkomine|Imidobenzyle|Dimipressin|Melipramin|Dynaprin|Intalpram|Nelipramin|Timolet|Irmin|Dpid|Dyna-zina|Impramine|Censtim|Censtin|Imiprin|Promiben|Iramil|Imipramina|Imipraminum|Psychoforin|Eupramin|Imavate|Surplix|Imipramin|Imizinum|Imizine|Cristalia|Sermonil|N-(gamma-Dimethylaminopropyl)iminodibenzyl|N-(3-Dimethylaminopropyl)-o-iminodibenzyl|2,2'-(3-Dimethylaminopropylimino)bibenzyl|2,2'-(3-Dimethylaminopropylimino)dibenzyl|3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine|1-(3-Dimethylaminopropyl)-4,5-dihydro-2,3,6,7-dibenzazepine|5-(3-(Dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine|OGG85SX4E4|Feinalmin|Imilanyle|Teperine|NSC-169866|5,6-Dihydro-N-(3-(dimethylamino)propyl)-11H-dibenz(b,e)azepine|5-(3-Dimethylaminopropyl)-10,11-dihydro-5H-dibenzo(b,f)azepine|DTXSID1043881|CHEBI:47499|ORG-2463|10,11-Dihydro-N,N-dimethyl-5H-dibenz[b,f]azepine-5-propanamine|5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-|5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(dimethylamino)propyl)-|DTXCID9023881|5H-Dibenz(b,f)azepine, 5-(3-(dimethylamino)propyl)-10,11-dihydro-|NSC169866|3-(5H-DIBENZO[B,F]AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE|5H-Dibenz[b,f]azepine-5-propanamine, 10,11-dihydro-N,N-dimethyl-|5-[3-(dimethylamino)propyl]-10,11-dihydro-5H-dibenz[b,f]azepine|10,11-dihydro-N,N-dimethyl-5H-dibenz(b,f)azepine-5-propanamine|3-(5H-DIBENZO(B,F)AZEPIN-5-YL)-N,N-DIMETHYLPROPAN-1-AMINE|3-(5,6-dihydrobenzo(b)(1)benzazepin-11-yl)-N,N-dimethylpropan-1-amine|5H-Dibenz[b,f]azepine, 5-[3-(dimethylamino)propyl]-10,11-dihydro-|(3-(2-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)propyl)dimethylamine|(3-{2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}propyl)dimethylamine|RefChem:5903|imizinum (for the hydrochloride)|N06AA02|(3-(2-azatricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,11,13-hexaen-2-yl)propyl)dimethylamine|200-042-1|Chimoreptin|Norchlorimipramine|Janimine|Declomipramine|3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine|Tofranil, base|Imizin|Tofranil (free base)|SK-Pramine|Imipramine (INN)|NSC 169866|CHEMBL11|N-(.gamma.-Dimethylaminopropyl)iminodibenzyl|5,e)azepine|5,e]azepine|Imidol|NCGC00015563-07|Imipramina [Italian]|IMIPRAMINE [INN]|Tofranil (TN)|10,11-Dihydro-5-(3-(dimethylamino)propyl)-5H-dibenz[b,f]azepine|Imipramine [INN:BAN]|IMIPRAMINE-D3 HYDROCHLORIDE 98 ATOM % D|Imipraminum [INN-Latin]|Imipramina [INN-Spanish]|3-(10,11-dihydro-5h-dibenz[b,f]azepin-5-yl)propyldimethylamine|CAS-50-49-7|3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine;3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine|N,N-Dimethyl-10,11-dihydro-5H-dibenzo[b,f]azepine-5-propanamine-2,8-D2|CCRIS 9173|2241983-10-6|HSDB 3100|3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine|Janimine (hydrochloride)|Tofranil (hydrochloride)|CAS-113-52-0|EINECS 200-042-1|UNII-OGG85SX4E4|BRN 0256892|5H-Dibenz(b, 5-(3-(dimethylamino)propyl)-10,11-dihydro-|5H-Dibenz[b, 5-[3-(dimethylamino)propyl]-10,11-dihydro-|Tofranil base|IXX|Imizin (Salt/Mix)|Imavate (Salt/Mix)|Imizine (Salt/Mix)|Surplix (Salt/Mix)|Eupramin (Salt/Mix)|Imizinum (Salt/Mix)|Tofranil (Salt/Mix)|Spectrum_000915|IMIPRAMINE [MI]|Psychoforin (Salt/Mix)|Prestwick0_000072|Prestwick1_000072|Prestwick2_000072|Prestwick3_000072|SK-Pramine (Salt/Mix)|Spectrum2_000990|Spectrum3_000466|Spectrum4_000016|Spectrum5_000864|Clomipramine Impurity 10|IMIPRAMINE [HSDB]|Lopac-I-7379|IMIPRAMINE [VANDF]|IMIPRAMINE [MART.]|IMIPRAMINE [WHO-DD]|Lopac0_000702|Oprea1_200908|SCHEMBL34282|BSPBio_000283|BSPBio_002172|GTPL357|KBioGR_000391|KBioSS_001395|BIDD:GT0116|DivK1c_000559|SPBio_001059|SPBio_002204|G-22355 (Salt/Mix)|BPBio1_000313|orb1705856|SCHEMBL29350100|HY-B1490A|KBio1_000559|KBio2_001395|KBio2_003963|KBio2_006531|KBio3_001392|NINDS_000559|HMS2089G08|Tox21_110174|BDBM50010859|CCG-36485|MFCD00242921|STL416211|AKOS016010320|Tox21_110174_1|DB00458|SDCCGSBI-0050680.P005|IDI1_000559|MRF-0000592|NCGC00015563-01|NCGC00015563-02|NCGC00015563-03|NCGC00015563-04|NCGC00015563-05|NCGC00015563-06|NCGC00015563-08|NCGC00015563-09|NCGC00015563-10|NCGC00015563-11|NCGC00015563-13|NCGC00015563-25|NCGC00024253-03|NCGC00024253-04|5-(3-Dimethylaminopropyl)-10,f)azepine|DA-69850|FI176386|SY284544|Trimipramine maleate impurity, imipramine-|SBI-0050680.P004|WLN: T C676 BN&T&J B3N1&1|5-(3-(Dimethylamino)propyl)-10,f)azepine|AB00053486|CS-0013621|NS00008106|5H-Dibenz[b, 10,11-dihydro-N,N-dimethyl-|C07049|D08070|EN300-708790|G82405|Q58396|AB00053486-15|AB00053486_16|AB00053486_17|1-(3-Dimethylaminopropyl)-4,3,6,7-dibenzazepine|F600887|L000739|BRD-K38436528-003-05-5|BRD-K38436528-003-15-4|BRD-K38436528-003-25-3|BRD-K38436528-003-26-1|BRD-K38436528-003-27-9|TRIMIPRAMINE MALEATE IMPURITY D [EP IMPURITY]|5H-Dibenz(b, 10,11-dihydro-5-(3-(dimethylamino)propyl)-|CLOMIPRAMINE HYDROCHLORIDE IMPURITY B [EP IMPURITY]|5H-Dibenz[b,f]azepine, 5-(dimethylamino)propyl-10,11-dihydro-|TRIMIPRAMINE MALEATE IMPURITY, IMIPRAMINE- [USP IMPURITY]|3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine|3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine #|(3-{2-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}propyl)dimethylamine|InChI=1/C19H24N2/c1-20(2)14-7-15-21-18-10-5-3-8-16(18)12-13-17-9-4-6-11-19(17)21/h3-6,8-11H,7,12-15H2,1-2H"
BUPROPION,444,,"InChI=1S/C13H18ClNO/c1-9(15-13(2,3)4)12(16)10-6-5-7-11(14)8-10/h5-9,15H,1-4H3",SNPPWIUOZRMYNY-UHFFFAOYSA-N,C13H18ClNO,239.74,2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one,"bupropion|Amfebutamone|34911-55-2|2-(tert-butylamino)-1-(3-chlorophenyl)propan-1-one|Amfebutamon|amfebutamonum|Amfebutamona|(+-)-Bupropion|Elontril|Bupropion slow release|bupropione|Bupropion extended release|alpha-(tert-butylamino)-m-chloropropiophenone|01ZG3TPX31|CHEBI:3219|NSC-758686|(+-)-1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone|DTXSID7022706|(+-)-2-(tert-Butylamino)-3'-chlorpropiophenon|(+-)-2-(tert-Butylamino)-3'-chloropropiophenone|1-Propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, (+-)-|1-Propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-|1-Propanone, 1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]-|bupropionum|Zyban (Bupropion)|RefChem:5624|DTXCID002706|N06AX12|34841-39-9|Wellbutrin|Wellbatrin|Zyban|AMFEBUTAMONE HCl|Bupropion SR|Bupropion (INN)|CHEMBL894|BUPROPION [INN]|Bupropion [INN:BAN]|Amfebutamonum [INN-Latin]|Amfebutamona [INN-Spanish]|1-(3-chlorophenyl)-2-[(1,1-dimethylethyl)amino]propan-1-one|Bupropion (R)-Isomer|Bupropion (USAN)|BRN 2101062|UNII-01ZG3TPX31|Zyban (Salt/Mix)|Budeprion (Salt/Mix)|Amfebutamone(Bupropion)|Spectrum_001663|Wellbutrin (Salt/Mix)|SpecPlus_000954|BUPROPION [MI]|(.+/-.)-Bupropion|2-(Tert-Butylamino)-3'-chloropropiophenone|Prestwick0_000249|Prestwick1_000249|Prestwick2_000249|Prestwick3_000249|Spectrum2_001659|Spectrum3_000644|Spectrum4_000614|Spectrum5_001406|BUPROPION [VANDF]|BUPROPION [MART.]|BUPROPION [WHO-DD]|Lopac0_000166|SCHEMBL38777|BSPBio_000038|BSPBio_002247|KBioGR_001168|KBioSS_002143|MLS001424015|DivK1c_007050|SPBio_001817|SPBio_002257|BPBio1_000042|GTPL7135|SCHEMBL29354885|HSDB 6988|KBio1_001994|KBio2_002143|KBio2_004711|KBio2_007279|KBio3_001467|HMS2051G10|HMS2089G14|HMS2232P04|HMS3369P11|HMS3393G10|BCP24193|AC-197|BBL029065|BDBM50048392|MFCD00865373|STL373006|AKOS015961770|CCG-100858|CCG-204261|DB01156|NC00108|NSC 758686|SDCCGSBI-0050154.P004|MRF-0000143|NCGC00015122-03|NCGC00015122-04|NCGC00015122-06|NCGC00015122-07|NCGC00015122-09|NCGC00015122-14|NCGC00015122-20|NCGC00089751-02|NCI60_002714|SMR000472526|SBI-0050154.P003|DB-048697|AB00053756|NS00000397|.alpha.-(tert-Butylamino)-m-chloropropiophenone|C06860|D07591|Propiophenone, 2-(tert-butylamino)-3'-chloro-|AB00053756-16|AB00053756-18|AB00053756-19|AB00053756_20|AB00053756_21|EN300-1707781|2-tert-Butylamino-1-(3-chlorophenyl)propan-1-one|L000725|Q834280|(+/-)-2-(tert-butylamino)-3'-chloropropiophenone|(.+/-.)-2-(tert-Butylamino)-3'-chloropropiophenone|BRD-A05186015-003-05-7|BRD-A05186015-003-09-9|BRD-A05186015-003-19-8|BRD-A05186015-003-20-6|2-(tert-Butylamino)-1-(3-chlorophenyl)-1-propanone #|1-(3-Chlorophenyl)-2-((1,1-dimethylethyl)amino)-1-propanone|1-Propanone, 1-(3-chlorophenyl)-2-[(1, 1-dimethylethyl)amino]-|1-PROPANONE, 1-(3-CHLOROPHENYL)-2-((1,1-DIMETHYLETHYL)AMINO)-(+/-)-|1-Propanone, 1-(3-chlorophenyl)-2-((1,1-dimethylethyl)amino)-, (.+/-.)-"
NOMIFENSINE,4528,,"InChI=1S/C16H18N2/c1-18-10-14(12-6-3-2-4-7-12)13-8-5-9-16(17)15(13)11-18/h2-9,14H,10-11,17H2,1H3",XXPANQJNYNUNES-UHFFFAOYSA-N,C16H18N2,238.33,"2-methyl-4-phenyl-3,4-dihydro-1H-isoquinolin-8-amine","Nomifensine|24526-64-5|nomifensin|Linamiphen|(+-)-Nomifensin|(+-)-Nomifensine|Nomifensina|Nomifensinum|8-Isoquinolinamine, 1,2,3,4-tetrahydro-2-methyl-4-phenyl-|D,L-nomifensine|8-Amino-2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinoline|2-methyl-4-phenyl-3,4-dihydro-1H-isoquinolin-8-amine|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine|1LGS5JRP31|DTXSID0023377|CHEBI:116225|Isoquinoline, 1,2,3,4-tetrahydro-8-amino-2-methyl-4-phenyl-|DTXCID803377|RefChem:166402|N06AX04|2-methyl-4-phenyl-1,2,3,4-tetrahydroisoquinolin-8-amine|MFCD00242716|CHEMBL273575|Nomifenison|Nomifensinum [INN-Latin]|Nomifensina [INN-Spanish]|(+/-)-Nomifensine maleat|Nomifensine [INN:BAN]|Nomiphensine|R/S-nomifensine|CCRIS 9179|(+/-)-Nomifensin|(+/-)-Nomifensine|Nomifensine maleate(USAN)|UNII-1LGS5JRP31|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisochinolin|8-Amino-1,2,3,4-tetrahydro-2-methyl-4-phenylisoquinoline|HSDB 7702|()-Nomifensine maleat|1,2,3,4-Tetrahydro-2-methyl-4-phenyl-8-isoquinolinamine|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine|Spectrum_000899|NOMIFENSINE [MI]|Prestwick0_000108|Prestwick1_000108|Prestwick2_000108|Prestwick3_000108|Spectrum2_001548|Spectrum3_000963|Spectrum4_001079|Spectrum5_001004|NOMIFENSINE [INN]|NOMIFENSINE [HSDB]|Lopac0_000875|SCHEMBL49380|BSPBio_000096|BSPBio_002565|KBioGR_001438|KBioSS_001379|NOMIFENSINE [WHO-DD]|DivK1c_000789|SPBio_001396|SPBio_002035|BPBio1_000106|GTPL4792|orb1299934|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine(Nomifensine)|SCHEMBL29355061|KBio1_000789|KBio2_001379|KBio2_003947|KBio2_006515|KBio3_001785|NINDS_000789|BCP13731|HY-B1110|Isoquinoline, 8-amino-1,2,3,4-tetrahydro-2-methyl-4-phenyl-|Tox21_301755|BDBM50005548|EX-A10994|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-8-isoquinolinamine 2-butenedioate|AKOS015919487|CCG-204957|CS-4708|DB04821|SDCCGSBI-0050850.P004|IDI1_000789|NCGC00015727-03|NCGC00015727-04|NCGC00015727-06|NCGC00015727-07|NCGC00015727-15|NCGC00089794-02|NCGC00255316-01|AC-31222|BS-22102|DA-18354|SBI-0050850.P003|CAS-24526-64-5|AB00053664|NS00099754|AB00053664_13|AB00053664_14|EN300-7376971|L001242|Q409948|BRD-A29644307-050-05-5|BRD-A29644307-050-10-5|BRD-A29644307-050-16-2|BRD-A29644307-050-17-0|BRD-A29644307-050-18-8|((c)I)-Nomifensin B(Z)-4-Hydroxy-4-Oxo-But-2-Enoate|2-Methyl-4-phenyl-1,2,3,4-tetrahydroquinolin-8-amine|Z2216900850|8-amino-4-phenyl-2-methyl-1,2,3,4-tetrahydro-isoquinoline|(+)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine|(+/-)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine|(-)-2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine|2-METHYL-4-PHENYL-1,2,3,4-TETRAHYDROISOQUINOLIN-8-YLAMINE|(Nomifensine) 2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine|2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine (Nomifensine)|NOMIFENSINE2-Methyl-4-phenyl-1,2,3,4-tetrahydro-isoquinolin-8-ylamine|2-Methyl-4-phenyl-1 pound not2 pound not3 pound not4-tetrahydroisoquinolin-8-amine|118184-50-2"
TENAMFETAMINE,1614,,"InChI=1S/C10H13NO2/c1-7(11)4-8-2-3-9-10(5-8)13-6-12-9/h2-3,5,7H,4,6,11H2,1H3",NGBBVGZWCFBOGO-UHFFFAOYSA-N,C10H13NO2,179.22,"1-(1,3-benzodioxol-5-yl)propan-2-amine","Tenamfetamine|3,4-methylenedioxyamphetamine|Methylenedioxyamphetamine|4764-17-4|Tenamfetaminum|Love|methylene dioxyamphetamine|1,3-Benzodioxole-5-ethanamine, alpha-methyl-|Tenanfetamina|EA-1299|alpha-Methyl-1,3-benzodioxole-5-ethanamine|XJZ28FJ27W|ALPHA-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE|1-(2H-1,3-benzodioxol-5-yl)propan-2-amine|3,4 Methylenedioxyamphetamine|RefChem:891348|3,4-Methylenedioxy-amphetamine|Tenamfetamine [INN]|MDA (pharmaceutical)|1-(1,3-benzodioxol-5-yl)propan-2-amine|BRN 0150196|DEA No. 7400|AI3-24882|MDA (PSYCHEDELIC)|CHEMBL6731|51497-09-7|1,3-Benzodioxole-5-ethanamine, .alpha.-methyl-|5-19-08-00417 (Beilstein Handbook Reference)|Phenethylamine, alpha-methyl-3,4-(methylenedioxy)-|Tenamfetamine (INN)|(+/-)-3,4-(Methylenedioxy)amphetamine|alpha-Methyl-3,4-methylenedioxyphenethylamine|Phenethylamine, .alpha.-methyl-3,4-(methylenedioxy)-|Tenamfetamina|Tenamfetaminum [Latin]|Tenamfetamina [Spanish]|(-)-Tenamfetamine|NCGC00168264-01|MDA,R(-)|UNII-XJZ28FJ27W|HSDB 7593|DTXSID40859958|3-(1,3-benzodioxol-5-yl)-1,1,1,2,3-pentadeuteriopropan-2-amine|MDA [MI]|SKF-5|DivK1c_000964|SCHEMBL393456|TENAMFETAMINE [MART.]|TENAMFETAMINE [WHO-DD]|MDA, (R,S)|SCHEMBL29392330|KBio1_000964|CHEBI:166520|NINDS_000964|BDBM50005247|PDSP1_001410|PDSP2_001394|(R,S)-3,4-Methylenedioxyamphetamine|3,4-Methylenedioxyamphetamine (MDA)|5-(2-Aminopropyl)-1,3-benzodioxole|AKOS002433952|DB01509|IDI1_000964|DB-290498|DS-015925|1-(3,4-Methylenedioxyphenyl)-2-propylamine|NS00010421|.alpha.-Methyl-3,4-methylenedioxyphenethylamine|2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine|D12715|benzene, 1-(2-amino)propyl-3,4-methylenedioxy-|(-)2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine|.alpha.-Methyl-3,4-(methylenedioxy)phenethylamine|3,4-(Methylenedioxy)-alpha-methylphenylethylamine|Q223020|(+/-)2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine|1,3-Benzodioxole-5-ethanamine, alpha-methyl- (9CI)|3,4-methylenedioxy-alpha-methyl-beta-phenylethylamine|DL-alpha-Methyl-3,4-(methylenedioxy)phenylethylamine|(R)-(-)-2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine|(S)-(+)-2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine|1,3-Benzodioxole,5-ethanamine-.alpha.-methyl-(.+/-.)|2-Benzo[1,3]dioxol-5-yl-1-methyl-ethylamine((R)-(-)-MDA)|(+/-)-.ALPHA.-METHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE|rac-MDA (rac-3,4-Methylenedioxyamphetamine) 1.0 mg/ml in Methanol"
VENLAFAXINE,5656,,"InChI=1S/C17H27NO2/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14/h7-10,16,19H,4-6,11-13H2,1-3H3",PNVNVHUZROJLTJ-UHFFFAOYSA-N,C17H27NO2,277.4,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol,"venlafaxine|93413-69-5|Venlafaxina|Elafax|Venlafaxinum|Efectin|velafax|Trevilor|Venlafexine|Kanghong|Venlor|1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol|GRZ5RCB1QG|NSC-758676|CHEBI:9943|DTXSID6023737|DTXCID403737|Efexor XL|Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, (+-)-|1-(2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexan-1-ol|Viepax|Mentaven xl|Ranfaxine xl|Sunveniz xl|Tardcaps xl|Tonpular xl|Venlablue xl|Venladex xl|Venlalic xl|Venlaneo xl|Alventa xl|Amphero xl|Bonilux xl|Depefex xl|Foraven xl|Politid xl|Rodomel xl|Tifaxin xl|Vaxalin xl|Vexarin xl|Trixat xl|Venaxx xl|Vensir xl|Viepax xl|Winfex xl|RefChem:6347|N06AX16|618-944-2|Efexor|D,L-Venlafaxine|1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol|1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol|Venlafaxine (INN)|Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-|MFCD00864385|Venlafaxine [INN:BAN]|NCGC00095109-01|Venlafaxinum [INN-Latin]|Venlafaxina [INN-Spanish]|VENLAFAXINE [INN]|Venlafaxin|Efectin (TN)|CAS-93413-69-5|SR-01000762930|UNII-GRZ5RCB1QG|DL-Venlafaxine|CYCLOHEXANOL, 1-(2-(DIMETHYLAMINO)-1-(4-METHOXYPHENYL)ETHYL)-|HSDB 6699|Spectrum_001671|SpecPlus_000842|VENLAFAXINE [MI]|Spectrum2_000542|Spectrum3_000989|Spectrum4_001115|Spectrum5_001516|CHEMBL637|EC 618-944-2|VENLAFAXINE [VANDF]|SCHEMBL35154|BSPBio_002657|KBioGR_001590|KBioSS_002151|VENLAFAXINE [WHO-DD]|MLS006011859|DivK1c_006938|SPECTRUM1504171|SPBio_000583|GTPL7321|orb1305912|SCHEMBL6925857|BDBM82071|KBio1_001882|KBio2_002151|KBio2_004719|KBio2_007287|KBio3_001877|HMS1922F05|HMS2090F04|HMS2093A12|HMS3714K11|HMS3886K14|HMS5085M07|Pharmakon1600-01504171|1-{2-(dimethylamino)-1-[4-(methyloxy)phenyl]ethyl}cyclohexanol|HY-B0196|Tox21_111425|CCG-39577|N,N-dimethyl-2-(1-hydroxycyclohexyl)-2-(4-methoxyphenyl)ethylamine|NSC_62923|NSC758676|s5655|STK621394|AKOS005555049|Tox21_111425_1|AC-1547|DB00285|FV28676|NSC 758676|SDCCGSBI-0052740.P003|NCGC00095109-02|NCGC00095109-03|NCGC00095109-04|NCGC00095109-05|NCGC00095109-06|NCGC00095109-08|NCGC00095109-20|AS-76254|SMR002204138|WY-45655|SBI-0052740.P002|CAS_93413-69-5|CAS_99300-78-4|DB-057399|DB-226024|NS00000031|C07187|D08670|D82446|EN300-708795|AB00053751-08|AB00053751-10|AB00053751-11|AB00053751_12|AB00053751_13|413V695|F242417|Q898407|SR-01000762930-3|SR-01000762930-4|BRD-A51714012-001-02-3|BRD-A51714012-003-01-1|BRD-A51714012-003-12-8|BRD-A51714012-003-13-6|1-[2-dimethylamino-1-(4-methoxylphenyl)ethyl]cyclohexanol|(RS)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol|(+/-)-1-(.ALPHA.-((DIMETHYLAMINO)METHYL)-P-METHOXYBENZYL)CYCLOHEXANOL|1-[2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol;(+/-)-Venlafaxine;Trevilor|540726-98-5"
MIDOMAFETAMINE,1615,,"InChI=1S/C11H15NO2/c1-8(12-2)5-9-3-4-10-11(6-9)14-7-13-10/h3-4,6,8,12H,5,7H2,1-2H3",SHXWCVYOXRDMCX-UHFFFAOYSA-N,C11H15NO2,193.24,"1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine","MDMA|Ecstasy|3,4-methylenedioxymethamphetamine|Midomafetamine|42542-10-9|Methylenedioxymethamphetamine|DL-(3,4-Methylenedioxy)methamphetamine|N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE|(RS)-3,4-(methylenedioxy)methamphetamine|N,alpha-Dimethyl-1,3-benzodioxole-5-ethanamine|1-(1,3-benzodioxol-5-yl)-N-methylpropan-2-amine|midomafetamina|CHEBI:1391|KE1SEN21RM|Methylenedioxymetamphetamine|Methylenedioxymethamfetamine|(+-)-(3,4-Methylenedioxy)methamphetamine|1,3-Benzodioxole-5-ethanamine, N,alpha-dimethyl-|3,4-methylenedioxymetamphetamine|Mandy [Street Name]|Molly [Street Name]|XTC [Street Name]|Phenethylamine, N,alpha-dimethyl-3,4-methylenedioxy-|3,4-Methylenedioxy-N,alpha-dimethyl-beta-phenylethylamine|(+-)-N-Methyl-1-(3,4-methylenedioxyphenyl)-2-aminopropane|Mandy (Street Name)|Molly (Street Name)|XTC (Street Name)|Ecstasy (Drug)|midomafetaminum|(1-(2H-1,3-benzodioxol-5-yl)propan-2-yl)(methyl)amine|[1-(2H-1,3-benzodioxol-5-yl)propan-2-yl](methyl)amine|RefChem:6368|N Methyl 3,4 methylenedioxyamphetamine|N Methyl 3,4 methylenedioxyamphetamine Hydrochloride|Hydrochloride, N-Methyl-3,4-methylenedioxyamphetamine|980-806-5|Molly|HSDB 6929|MANDY|DEA No. 7405|Midomafetamine [USAN]|(+-)-N-Methyl-3,4-(methylenedioxy)amphetamine|1-(1,3-Benzodioxol-5-yl)-N-methyl-2-propanamine|CHEMBL43048|XTC|1,3-Benzodioxole-5-ethanamine, N,.alpha.-dimethyl-|NCGC00168266-02|UNII-KE1SEN21RM|CCRIS 9277|(+)-3,4-methylenedioxymethamphetamine|MDMA (Ecstasy)|rac-3,4-Methylenedioxymethamphetamine-D5|(+/-)-(3,4-Methylenedioxy)methamphetamine|Midomafetamine [WHO-DD]|Epitope ID:178091|MDMA [MI]|Midomafetamine (USAN/INN)|MIDOMAFETAMINE [INN]|SCHEMBL44210|Methylenedioxy Methamphetamine|DivK1c_000962|3,4-MDMA|GTPL4574|SCHEMBL29353930|KBio1_000962|DTXSID90860791|NINDS_000962|BDBM707600|LFA76543|RCA14289|BDBM50010588|PDSP1_001522|PDSP2_001506|3,4-methylenedioxy-n-methylamphetamine|AKOS006283463|DB01454|IDI1_000962|NCGC00168266-01|METHYLENEDIOXYMETHAMFETAMINE [MART.]|D,L-3,4-METHYLENEDIOXYMETHAMPHETAMINE|NS00010441|C07577|D11172|Q69488|(+/-)-3,4-METHYLENEDIOXYMETHAMPHETAMINE|(+/-)-N-Methyl-3,4-(methylenedioxy)amphetamine|N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE [HSDB]|PHENETHYLAMINE, N,.ALPHA.-DIMETHYL-3,4-METHYLENEDIOXY-|(RS)-1-(BENZO(D)(1,3)DIOXOL-5-YL)-N-METHYLPROPAN-2-AMINE|(+/-)-N,.ALPHA.-DIMETHYL-3,4-(METHYLENEDIOXY)PHENETHYLAMINE|(+/-)-N-METHYL-1-(3,4-METHYLENEDIOXYPHENYL)-2-AMINOPROPANE"
MODAFINIL,4236,,"InChI=1S/C15H15NO2S/c16-14(17)11-19(18)15(12-7-3-1-4-8-12)13-9-5-2-6-10-13/h1-10,15H,11H2,(H2,16,17)",YFGHCGITMMYXAQ-UHFFFAOYSA-N,C15H15NO2S,273.4,2-benzhydrylsulfinylacetamide,"modafinil|68693-11-8|Provigil|Modiodal|2-[(diphenylmethyl)sulfinyl]acetamide|2-(Benzhydrylsulfinyl)acetamide|2-benzhydrylsulfinylacetamide|CRL 40476|modaphonil|Modafinilo|(+-)-Modafinil|CRL-40476|Modafinilum|Modafinil civ|R Modafinil|CEP 1538|2-((Diphenylmethyl)sulfinyl)acetamide|CEP-1538|R3UK8X3U3D|NSC-751178|NSC-759110|DTXSID0023329|CHEBI:77585|Acetamide, 2-((diphenylmethyl)sulfinyl)-|THN102 COMPONENT MODAFINIL|DEP-1538|THN-102 COMPONENT MODAFINIL|CRC-40476|DTXCID103329|2-diphenylmethanesulfinylacetamide|2-(diphenylmethane)sulfinylacetamide|2-(di(phenyl)methylsulfinyl)acetamide|2-[di(phenyl)methylsulfinyl]acetamide|Acetamide, 2-[(diphenylmethyl)sulfinyl]-|RefChem:56581|2 Benzhydrylsulfinylacetamide|CHEBI:31859|N06BA07|640-968-7|Modafinilum [Latin]|Modafinilo [Spanish]|Alertec|Sparlon|Modavigil|112111-49-6|CHEMBL1373|MFCD00868082|2-(Diphenyl-methanesulfinyl)-acetamide|NCGC00095176-03|Modafinil [USAN:INN]|Moderateafinil|SMR000058957|CAS-68693-11-8|(+/-)-Modafinil|SR-01000759419|NH 02D|NH-02D|UNII-R3UK8X3U3D|Attenace|Modalert|Modasomil|CRL 40983|CRL-40983|DEA No. 1680|HSDB 7585|Armodafinil D10|Modafinil [USAN:USP:INN:BAN]|2-(diphenylmethyl)sulfinylacetamide|Provigil (TN)|MODAFINIL [INN]|MODAFINIL [JAN]|MODAFINIL [MI]|MODAFINIL [HSDB]|MODAFINIL [USAN]|Spectrum2_001712|MODAFINIL [VANDF]|MODAFINIL [MART.]|MODAFINIL [WHO-DD]|Modafinil (JAN/USP/INN)|UNII-152JRG3T0U|SCHEMBL34488|BSPBio_002270|MLS000759427|MLS001424049|BIDD:GT0714|SPECTRUM1505361|(-)benzhydrylsulphinylacetamide|SPBio_001724|GTPL7555|MODAFINIL [ORANGE BOOK]|MODAFINIL CIV [USP-RS]|MODAFINIL [EP MONOGRAPH]|Modafinil, >=98% (HPLC)|AFT-801|MODAFINIL [USP MONOGRAPH]|HMS1922F12|HMS2051P17|HMS2093D15|HMS3264I03|HMS3393P17|HMS3713C12|Pharmakon1600-01504283|Pharmakon1600-01505361|2-(diphenylmethyl)sulfinylethanamide|BCP28422|Tox21_111470|BDBM50156055|CCG-39511|CN 801|CN-801|GRL 40476|HB0860|HY-15201A|NSC751178|NSC751850|NSC758711|NSC759110|Modafinil 1.0 mg/ml in Acetonitrile|AKOS004118314|Tox21_111470_1|2-[(diphenylmethyl)sulfinyl]-acetamide|AC-1382|DB00745|FM02798|NC00224|NSC 751178|NSC 759110|NCGC00095176-01|NCGC00095176-02|NCGC00095176-04|NCGC00095176-05|NCGC00095176-06|NCGC00095176-08|AS-17039|SBI-0206841.P001|DB-116344|NS00003986|ST45021999|D01832|AB00639993_03|AB00639993_04|693M118|A836219|L001269|Q410441|SR-01000759419-3|SR-01000759419-4|BRD-A16332958-001-02-4|BRD-A16332958-001-04-0|BRD-A16332958-001-09-9|F2173-0797|Modafinil, European Pharmacopoeia (EP) Reference Standard|Modafinil for system suitability, European Pharmacopoeia (EP) Reference Standard|Alertec pound>> Modavigil pound>> Modiodal pound>> Provigil pound>> Modalert pound>> CRL-40476"
PIRITREXIM,54369,,"InChI=1S/C17H19N5O2/c1-9-11(6-10-7-12(23-2)4-5-13(10)24-3)8-20-16-14(9)15(18)21-17(19)22-16/h4-5,7-8H,6H2,1-3H3,(H4,18,19,20,21,22)",VJXSSYDSOJBUAV-UHFFFAOYSA-N,C17H19N5O2,325.4,"6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine","Piritrexim|72732-56-0|Piritrexima|Piritrexime|BW 301U|Piritreximum|BW-301U|MK2A783ZUT|6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine|Pyrido(2,3-d)pyrimidine-2,4-diamine, 6-((2,5-dimethoxyphenyl)methyl)-5-methyl-|DTXSID20223032|6-((2,5-Dimethoxyphenyl)methyl)-5-methylpyrido(2,3-d)pyrimidine-2,4-diamine|2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido(2,3-d)pyrimidine|2,4-diamino-6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine|BW301U|6-((2,5-dimethoxyphenyl)methyl)-5-methylpyrido(3,2-e)pyrimidine-2,4-diamine|6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[3,2-e]pyrimidine-2,4-diamine|RefChem:174546|DTXCID20145523|6-(2,5-dimethoxybenzyl)-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine|Piritrexim [INN]|TCMDC-137235|CHEMBL7492|BW 301U; NSC 351521|6-(2,5-DIMETHOXY-BENZYL)-5-METHYL-PYRIDO[2,3-D]PYRIMIDINE-2,4-DIAMINE|Piritrexime [French]|Piritreximum [Latin]|Piritrexima [Spanish]|MXA|UNII-MK2A783ZUT|BRN 5768301|PIRITREXIM [MI]|2,4-Diamino-5-methyl-6-(2,5-dimethoxybenzyl)pyrido(2,3-d)pyrimidine|SCHEMBL8124|PIRITREXIM [WHO-DD]|GTPL7414|orb1702937|SCHEMBL29365922|SCHEMBL29462191|BDBM18224|BW 301U;BW301U|1u71|BCP29680|XCA73256|AKOS016845844|DB03695|TS-08392|HY-106434|CS-0025801|NS00068056|301U74|Q27088402|6-[(2,5-dimethoxyphenyl)methyl]-5-methyl-pyrido[2,3-d]pyrimidine-2,4-diamine|[2-amino-6-(2,5-dimethoxybenzyl)-5-methyl-pyrido[2,3-d]pyrimidin-4-yl]amine;2-hydroxyethanesulfonic acid|6-[(2,5-Dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d]pyrimidine-2,4-diamine mono(2-hydroxyethanesulfonate)"
TRIMETHOPRIM,5578,,"InChI=1S/C14H18N4O3/c1-19-10-5-8(6-11(20-2)12(10)21-3)4-9-7-17-14(16)18-13(9)15/h5-7H,4H2,1-3H3,(H4,15,16,17,18)",IEDVJHCEMCRBQM-UHFFFAOYSA-N,C14H18N4O3,290.32,"5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine","trimethoprim|738-70-5|Proloprim|Trimpex|Trimetoprim|2,4-Diamino-5-(3,4,5-trimethoxybenzyl)pyrimidine|Monotrim|Trimopan|Wellcoprim|Monoprim|Syraprim|Uretrim|Trimethoprime|Trimethoprimum|Trimetoprima|5-[(3,4,5-trimethoxyphenyl)methyl]pyrimidine-2,4-diamine|Trimpex 200|NSC-106568|NIH 204|Trimogal|Tiempe|BW 56-72|Infectotrimet|2,4-Pyrimidinediamine, 5-[(3,4,5-trimethoxyphenyl)methyl]-|DTXSID3023712|CHEBI:45924|BW-56-72|5-(3,4,5-Trimethoxybenzyl)-2,4-diaminopyrimidine|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine|AN164J8Y0X|2,4-Pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)methyl)-|NIH-204|Pyrimidine, 2,4-diamino-5-(3,4,5-trimethoxybenzyl)-|5-((3,4,5-Trimethoxyphenyl)methyl)-2,4-pyrimidinediamine|NSC106568|DTXCID803712|5-((3,4,5-trimethoxyphenyl)methyl)pyrimidine-2,4-diamine|Ledatrim|Proloprin|Triprimix 200|RefChem:6327|J01EA01|212-006-2|Monotrimin|Triprim|5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4-diamine|component of Bactrim|MFCD00036761|TCMDC-125538|NSC 106568|CHEMBL22|Trimpex (TN)|Abaprim|BW 5672|Trimethoprim-d3 (Major)|MLS000079023|Briscotrim|Novotrimel|Streptoplus|Sulfoxaprim|Trimethioprim|Urobactrim|Wellcoprin|Anitrim|Antrima|Antrimox|Bacidal|Bacticel|Bactoprim|Bencole|Bethaprim|Biosulten|Chemotrin|Colizole|Conprim|Cotrimel|Duocide|Esbesul|Espectrin|Euctrim|Exbesul|Fermagex|Fortrim|Ikaprim|Kombinax|Lagatrim|Lastrim|Metoprim|Pancidim|Protrin|Resprim|Salvatrim|Setprin|Sinotrim|Sugaprim|Sulfamar|Sulthrim|Sultrex|Trimexol|Trimezol|Trimono|Trisulcom|Trisulfam|Trisural|Utetrin|Velaten|Xeroprim|Zamboprim|Bacdan|Bacide|Deprim|Omstat|Purbal|Roubac|Roubal|Stopan|Toprim|Trisul|Bacin|Bacta|Futin|Co-Trimoxizole|Lagatrim Forte|Septrin Forte|Alcorim-F|Colizole DS|Septrin S|Septrin DS|Smz-Tmp|Trimez-IFSA|U-Prin|component of Septra|NCGC00016055-05|Trimethopriom|Bactifor|CAS-738-70-5|Dosulfin|Instalac|SMR000035999|Trimetoprim [DCIT]|Lescot|Trimetoprim [Polish]|Resprim Forte|Trimethoprim 100 microg/mL in Acetonitrile|Uro-D S|Tmp Smx|Trimethoprime [INN-French]|Trimethoprimum [INN-Latin]|Trimetoprima [INN-Spanish]|Bacterial [Antibiotic]|NIH 204 (VAN)|Proloprim (TN)|WR 5949|CCRIS 2410|HSDB 6781|Trimethoprim D3 (4-methoxy D3)|SR-01000075652|EINECS 212-006-2|5-(3, 4, 5-Trimethoxybenzyl)-2, 4-pyrimidinediamine|Trimethoprim & VRC3375|5-(3,4,5-Trimethoxybenzyl)-2,4-pyrimidinediamine|BRN 0625127|UNII-AN164J8Y0X|Trimethoprim (JAN/USP/INN)|5-{[3,4,5-tris(methyloxy)phenyl]methyl}pyrimidine-2,4-diamine|AI3-52594|B-Lock|KUC103659N|Prestwick_485|KSC-4-158|Trimethoprim (TMP)|Bactrim (Salt/Mix)|Spectrum_000167|Tocris-0650|Trimethoprim [USAN:USP:INN:BAN:JAN]|2w9h|3fl9|3n0h|3s3v|4km2|Trimethoprim (Standard)|Trimethoprim D3 (4-methoxy D3) 100 microg/mL in Acetonitrile|2,4-Pyrimidinediamine, 5-((3,4,5-trimethoxyphenyl)-methyl)-|Opera_ID_1760|Prestwick0_000208|Prestwick1_000208|Prestwick2_000208|Prestwick3_000208|Spectrum2_000937|Spectrum3_000643|Spectrum4_000372|Spectrum5_001559|Lopac-T-7883|TRIMETHOPRIM [MI]|TRIMETHOPRIM [INN]|TRIMETHOPRIM [JAN]|Epitope ID:119684|UPCMLD-DP132|T 7883|TRIMETHOPRIM [HSDB]|TRIMETHOPRIM [USAN]|TRIMETHOPRIM [VANDF]|Lopac0_001271|Oprea1_495058|SCHEMBL24506|BSPBio_000195|BSPBio_002245|KBioGR_000863|KBioSS_000647|TRIMETHOPRIM [MART.]|5-25-13-00429 (Beilstein Handbook Reference)|MLS001201740|MLS002303068|MLS002548881|BIDD:GT0190|DivK1c_000589|SPECTRUM1500595|TRIMETHOPRIM [USP-RS]|TRIMETHOPRIM [WHO-DD]|SPBio_000874|SPBio_002116|BPBio1_000215|orb1309588|SCHEMBL28042088|SCHEMBL28636448|SCHEMBL29462189|UPCMLD-DP132:001|BDBM18069|GTPL10931|HMS501N11|HY-B0510R|KBio1_000589|KBio2_000647|KBio2_003215|KBio2_005783|KBio3_001465|MSK4009|TRIMETHOPRIM [GREEN BOOK]|Trimethoprim, >=98% (HPLC)|NINDS_000589|2,4,5-trimethoxybenzyl)pyrimidine|HMS1568J17|HMS1921I03|HMS2090D14|HMS2092A10|HMS2095J17|HMS2230L06|HMS3259I11|HMS3263P04|HMS3371O18|HMS3652E03|HMS3712J17|HMS5081C18|Pharmakon1600-01500595|TRIMETHOPRIM [EP IMPURITY]|TRIMETHOPRIM [ORANGE BOOK]|Trimethoprim for system suitability|TRIMETHOPRIM [EP MONOGRAPH]|2,4,5-trimethoxyphenzyl)pyrimidine|ALBB-028968|BCP12148|COTRIM COMPONENT TRIMETHOPRIM|HY-B0510|PXB92338|SEPTRA COMPONENT TRIMETHOPRIM|Co-trimoxazole component trimethoprim|Tox21_110291|Tox21_200157|Tox21_501271|TRIMETHOPRIM [USP MONOGRAPH]|BACTRIM COMPONENT TRIMETHOPRIM|BBL005584|CCG-40335|NSC752719|NSC757370|s3129|SBB080617|STK177322|STL455117|UROPLUS COMPONENT TRIMETHOPRIM|TRIMETHOPRIMUM [WHO-IP LATIN]|AKOS001650069|SULFATRIM COMPONENT TRIMETHOPRIM|SULMEPRIM COMPONENT TRIMETHOPRIM|Tox21_110291_1|AC-8427|BW-5672|DB00440|KS-1145|LP01271|NC00483|NSC-752719|NSC-757370|SDCCGSBI-0051237.P004|BACTRIM DS COMPONENT TRIMETHOPRIM|IDI1_000589|SMP2_000262|NCGC00016055-01|NCGC00016055-02|NCGC00016055-03|NCGC00016055-04|NCGC00016055-06|NCGC00016055-07|NCGC00016055-08|NCGC00016055-09|NCGC00016055-10|NCGC00016055-11|NCGC00016055-12|NCGC00016055-13|NCGC00016055-14|NCGC00016055-16|NCGC00016055-17|NCGC00016055-27|NCGC00024707-01|NCGC00024707-03|NCGC00024707-04|NCGC00024707-05|NCGC00024707-06|NCGC00024707-07|NCGC00024707-08|NCGC00257711-01|NCGC00261956-01|COTRIM D.S. COMPONENT TRIMETHOPRIM|ST024737|SY031734|Trimethoprim/sulfamethoxazole (commercial)|SBI-0051237.P003|DB-055812|SULFAMETHOPRIM COMPONENT TRIMETHOPRIM|2, 5-[(3,4,5-trimethoxyphenyl)methyl]-|AB00052118|EU-0101271|NS00000211|SW196690-3|T2286|Trimethoprim 1000 microg/mL in Acetonitrile|BACTRIM PEDIATRIC COMPONENT TRIMETHOPRIM|C01965|D00145|EN300-118703|Trimethoprim, crystallized, >=99.0% (HPLC)|WLN: T6N CNJ BZ DZ E1R CO1 DO1 EO1|5-(3,5-Trimethoxybenzyl)-2,4-diaminopyrimidine|AB00052118-30|AB00052118-32|AB00052118_33|AB00052118_34|Trimethoprim, VETRANAL(TM), analytical standard|738T705|Q422665|2,4-diamino-5-(3,4,5-trimethoxybenzyl)-pyrimidine|Pyrimidine,4-diamino-5-(3,4,5-trimethoxybenzyl)-|SR-01000075652-1|SR-01000075652-3|SR-01000075652-6|5-(3,4,5-Trimethoxybenzyl)-2,4-pyrimidinediamine #|BRD-K07208025-001-06-5|BRD-K07208025-001-29-7|BRD-K07208025-001-31-3|SR-01000075652-10|2,4-Diamino-5-(3',4',5'-trimethoxybenzyl)pyrimidine|F0914-5266|Trimethoprim, certified reference material, TraceCERT(R)|Z1515385071|5-(3,4,5-trimethoxybenzyl)pyrimidine-2,4(1H,3H)-diimine|pyrimidine, 2,4-diamino-5-(3',4',5'-trimethoxybenzyl)-|Trimethoprim, British Pharmacopoeia (BP) Reference Standard|Trimethoprim, European Pharmacopoeia (EP) Reference Standard|Trimethoprim, United States Pharmacopeia (USP) Reference Standard|5-[(3,4,5-Trimethoxyphenyl)methyl]-2,4-pyrimidinediamine;Instalac;Proloprim|Trimethoprim for system suitability, European Pharmacopoeia (EP) Reference Standard|Trimethoprim, Pharmaceutical Secondary Standard; Certified Reference Material"
TRIMETREXATE,5583,,"InChI=1S/C19H23N5O3/c1-10-11(5-6-13-16(10)18(20)24-19(21)23-13)9-22-12-7-14(25-2)17(27-4)15(8-12)26-3/h5-8,22H,9H2,1-4H3,(H4,20,21,23,24)",NOYPYLRCIDNJJB-UHFFFAOYSA-N,C19H23N5O3,369.4,"5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine","trimetrexate|52128-35-5|Trimetrexato|Trimetrexatum|NSC-249008|NSC 249008|UPN4ITI8T4|5-methyl-6-(((3,4,5-trimethoxyphenyl)amino)methyl)quinazoline-2,4-diamine|NSC249008|2,4-Diamino-5-methyl-6-((3,4,5-trimethoxyanilino)methyl)quinazoline|5-Methyl-6-(((3,4,5-trimethoxyphenyl)amino)methyl)-2,4-quinazolinediamine|DTXSID3023714|2,4-Quinazolinediamine, 5-methyl-6-(((3,4,5-trimethoxyphenyl)amino)methyl)-|5-methyl-6-{[(3,4,5-trimethoxyphenyl)amino]methyl}quinazoline-2,4-diamine|2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline|5-methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]quinazoline-2,4-diamine|NSC328564|Trimexate|Hydrate, Trimetrexate|RefChem:899934|DTXCID603714|JB11|P01AX07|CI898|Monohydrate, Monoacetate Trimetrexate|CI-898|Trimetrexatum [INN-Latin]|Trimetrexato [INN-Spanish]|Jb-11|TMQ|5-methyl-6-[(3,4,5-trimethoxyanilino)methyl]quinazoline-2,4-diamine|CHEMBL119|CI 898|JB 11|Trimetrexate Hydrate|HSDB 6545|NCGC00161419-02|UNII-UPN4ITI8T4|Trimetrexate (USAN/INN)|Trimetrexate [USAN:INN:BAN]|251301-18-5|TRIMETREXATE [MI]|TRIMETREXATE [INN]|TRIMETREXATE [HSDB]|TRIMETREXATE [USAN]|SCHEMBL3983|TRIMETREXATE [VANDF]|BIDD:GT0129|TRIMETREXATE [WHO-DD]|CHEBI:9737|GTPL7613|orb1706514|SCHEMBL29376841|SCHEMBL29403928|BDBM18268|BCP15515|EX-A10496|MFCD00866404|2,4-Quinazolinediamine,5-methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]-|6-[((3,4,5-Trimethoxyphenyl)amino)methyl]-5-methyl-2,4-quinazolinediamine|AKOS030257627|DB01157|5-methyl-6-({[3,4,5-tris(methyloxy)phenyl]amino}methyl)quinazoline-2,4-diamine|NCGC00161419-01|NCGC00161419-03|NCGC00161419-04|NCGC00161419-07|72828-03-6|HY-10373|MS-25931|DB-242472|NS00068348|D06238|F85148|EN300-7481403|Q7842225|2, 5-methyl-6-[[(3,4,5-trimethoxyphenyl)amino]methyl]-|2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyphenylamino)methyl]quinazoline"
PYRIMETHAMINE,4993,,"InChI=1S/C12H13ClN4/c1-2-9-10(11(14)17-12(15)16-9)7-3-5-8(13)6-4-7/h3-6H,2H2,1H3,(H4,14,15,16,17)",WKSAUQYGYAYLPV-UHFFFAOYSA-N,C12H13ClN4,248.71,"5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine","pyrimethamine|58-14-0|Daraprim|Chloridine|5-(4-chlorophenyl)-6-ethylpyrimidine-2,4-diamine|Diaminopyritamin|Ethylpyrimidine|Chloridin|Pirimecidan|Pirimetamin|Pirimetamina|Chloridyn|Darachlor|Erbaprelina|Khloridin|Primethamine|Pyrimethamin|Malocid|Tindurin|Pyrimethaminum|5-(4-CHLOROPHENYL)-6-ETHYL-2,4-PYRIMIDINEDIAMINE|2,4-Pyrimidinediamine, 5-(4-chlorophenyl)-6-ethyl-|Pyremethamine|2,4-Diamino-5-(p-chlorophenyl)-6-ethylpyrimidine|TCMDC-125860|2,4-Diamino-5-chlorophenyl-6-ethylpyrimidine|BW 50-63|2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine|RP 4753|NCI-C01683|5-(4'-Chlorophenyl)-2,4-diamino-6-ethylpyrimidine|GNF-Pf-5586|WR 2978|NSC-3061|5-(4-Chlorophenyl)-6-ethyl-2,4-diaminopyrimidine|DTXSID9021217|4753 R.P.|NSC 3061|CHEBI:8673|Z3614QOX8W|2,4-Pyrimidinediamine, 5-(p-chlorophenyl)-6-ethyl-|NSC3061|Pyrimidine, 2,4-diamino-5-(p-chlorophenyl)-6-ethyl-|RP-4753|WR-2978|DTXCID601217|5-25-12-00255 (Beilstein Handbook Reference)|5-[4-Chlorophenyl]-6-ethyl-2,4-pyrimidinediamine|RefChem:55950|P01BD01|200-364-2|Malocide|Darapram|Daraprime|Malacid|Maloprim|MFCD00057350|TCMDC-123831|CHEMBL36|5-(4-CHLORO-PHENYL)-6-ETHYL-PYRIMIDINE-2,4-DIAMINE|MLS000028606|MLS002701881|Daraclor|5-(4-chlorophenyl)-6-ethyl-pyrimidine-2,4-diamine|CAS-58-14-0|NCGC00016256-08|SMR000058714|Tinduring|Pirimetamina [Spanish]|CP6|Pirimetamina [INN-Spanish]|Pyrimethaminum [INN-Latin]|BRD9204|BRD-9204|Daraprim (TN)|CCRIS 546|Pyrimethamine (Pyr)|SR-01000003150|EINECS 200-364-2|BRN 0219864|UNII-Z3614QOX8W|CRL-8131 & Pyrimethamine|CRL-8142 & Pyrimethamine|Lactoferrin B & Pyrimethamine|Lactoferrin H & Pyrimethamine|AI3-25005|Pyrimethamine (JAN/USP/INN)|AZT + Pyrimethamine combination|HSDB 8042|EXR-101|Pyrimethamine [USP:INN:BAN:JAN]|Prestwick_504|BW 5063|Daraclor (Salt/Mix)|Spectrum_000906|4km0|CPD000058714|Pyrimethamine (Standard)|Opera_ID_1437|Prestwick0_000037|Prestwick1_000037|Prestwick2_000037|Prestwick3_000037|Spectrum2_000886|Spectrum3_001701|Spectrum4_000494|Spectrum5_001447|PYRIMETHAMINE [MI]|PYRIMETHAMINE [INN]|PYRIMETHAMINE [JAN]|cid_4993|NCIOpen2_008313|PYRIMETHAMINE [IARC]|BIDD:PXR0173|SCHEMBL25129|BSPBio_000133|BSPBio_003282|KBioGR_001007|KBioSS_001386|PYRIMETHAMINE [VANDF]|MLS001148621|MLS002454446|BIDD:GT0149|DivK1c_000652|PYRIMETHAMINE [MART.]|SPECTRUM1500520|SPBio_000672|SPBio_002054|PYRIMETHAMINE [USP-RS]|PYRIMETHAMINE [WHO-DD]|PYRIMETHAMINE [WHO-IP]|BPBio1_000147|GTPL4800|orb1310237|SCHEMBL29381161|BDBM18512|HMS502A14|KBio1_000652|KBio2_001386|KBio2_003954|KBio2_006522|KBio3_002502|MSK7147|NINDS_000652|Pirimecidan;Pirimetamin;RP 4753|HMS1568G15|HMS1920N12|HMS2092E13|HMS2095G15|HMS2235A17|HMS3259C04|HMS3371L07|HMS3655D09|HMS3675P11|HMS3712G15|HMS3743O05|HMS3871I03|HMS5080P13|Pharmakon1600-01500520|PYRIMETHAMINE [GREEN BOOK]|PYRIMETHAMINE [ORANGE BOOK]|2, 5-(p-chlorophenyl)-6-ethyl-|PXB93699|2, 5-(4-chlorophenyl)-6-ethyl-|PYRIMETHAMINE [EP MONOGRAPH]|Tox21_110332|Tox21_201834|Tox21_300129|CCG-39626|HY-18062R|NSC757306|PYRIMETHAMINE [USP MONOGRAPH]|PYRIMETHAMINUM [WHO-IP LATIN]|AKOS015892534|FANSIDAR COMPONENT PYRIMETHAMINE|Tox21_110332_1|AB02313|AC-7879|CS-1717|DB00205|FP27346|KS-5223|NC00528|NSC-757306|IDI1_000652|NCGC00016256-01|NCGC00016256-02|NCGC00016256-03|NCGC00016256-04|NCGC00016256-05|NCGC00016256-06|NCGC00016256-07|NCGC00016256-09|NCGC00016256-10|NCGC00016256-11|NCGC00016256-12|NCGC00016256-13|NCGC00016256-14|NCGC00016256-16|NCGC00016256-17|NCGC00023188-03|NCGC00023188-04|NCGC00023188-05|NCGC00023188-06|NCGC00023188-07|NCGC00254199-01|NCGC00259383-01|WLN: T6N CNJ BZ DZ ER DG& F2|HY-18062|NCI60_002604|SBI-0051500.P003|DB-053158|AB00052084|NS00001824|P2037|S2006|SW196698-3|C07391|D00488|EN300-118717|MLS-0002822.0001|AB00052084-21|AB00052084_22|AB00052084_25|057P350|2,4-diamino-5(4-chlorophenyl)-6-ethylpyrimidine|F211965|L000713|Pyrimethamine, VETRANAL(TM), analytical standard|Pyrimidine,4-diamino-5-(p-chlorophenyl)-6-ethyl-|Q421072|2,4,-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine|2,4-diamino-5-(4-chloro-phenyl)-6-ethylpyrimidine|2,4-diamino-6-ethyl-5-(4-chlorophenyl)pyrimidine|SR-01000003150-2|SR-01000003150-4|BRD-K88429204-001-05-4|BRD-K88429204-001-18-7|BRD-K88429204-001-21-1|BRD-K88429204-001-33-6|BRD-K88429204-001-34-4|BRD-K88429204-001-35-1|BRD-K88429204-001-36-9|Z1515385085|Pyrimethamine, European Pharmacopoeia (EP) Reference Standard|Pyrimethamine, United States Pharmacopeia (USP) Reference Standard|5-(4-Chlorophenyl)-6-ethyl-2,4-pyrimidinediamine;2,4-Diamino-5-(4-chlorophenyl)-6-ethylpyrimidine;Chloridin"
EPIROPRIM,68916,,"InChI=1S/C19H23N5O2/c1-3-25-15-10-13(9-14-12-22-19(21)23-18(14)20)11-16(26-4-2)17(15)24-7-5-6-8-24/h5-8,10-12H,3-4,9H2,1-2H3,(H4,20,21,22,23)",NMARPFMJVCXSAV-UHFFFAOYSA-N,C19H23N5O2,353.4,"5-[(3,5-diethoxy-4-pyrrol-1-ylphenyl)methyl]pyrimidine-2,4-diamine","Epiroprim|73090-70-7|TCMDC-137295|Epiroprima|Epiroprime|Ro 11-8958|Epiroprimum|5-[(3,5-diethoxy-4-pyrrol-1-ylphenyl)methyl]pyrimidine-2,4-diamine|Ro-11-8958|9G69D95443|DTXSID20223355|5-((3,5-diethoxy-4-pyrrol-1-ylphenyl)methyl)pyrimidine-2,4-diamine|RefChem:137284|DTXCID20145846|Epiroprim [INN]|CHEMBL280378|2,4-Diamino-5-(3,5-diethoxy-4-pyrrol-1-ylbenzyl)pyrimidine|5-(3,5-diethoxy-4-(1H-pyrrol-1-yl)benzyl)pyrimidine-2,4-diamine|Epiroprime [INN-French]|Epiroprimum [INN-Latin]|Epiroprima [INN-Spanish]|BRN 4273487|Epir|UNII-9G69D95443|5-((3,5-Diethoxy-4-(1H-pyrrol-1-yl)phenyl)methyl)-2,4-pyrimidinediamine|SCHEMBL75698|orb1702301|SCHEMBL29388523|GTPL12327|BDBM50029763|2,4-Pyrimidinediamine, 5-((3,5-diethoxy-4-(1H-pyrrol-1-yl)phenyl)methyl)-|AKOS015961333|DA-73155|HY-116039|NS00123792|Q27272519|2,4-Diamino-5-(3,5-diethoxy-4-N-pyrrolylbenzyl)pyrimidine|5-[(3,5-diethoxy-4-pyrrol-1-yl-phenyl)methyl]pyrimidine-2,4-diamine"
METHOTREXATE,126941,,"InChI=1S/C20H22N8O5/c1-28(9-11-8-23-17-15(24-11)16(21)26-20(22)27-17)12-4-2-10(3-5-12)18(31)25-13(19(32)33)6-7-14(29)30/h2-5,8,13H,6-7,9H2,1H3,(H,25,31)(H,29,30)(H,32,33)(H4,21,22,23,26,27)/t13-/m0/s1",FBOZXECLQNJBKD-ZDUSSCGKSA-N,C20H22N8O5,454.4,"(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid","methotrexate|59-05-2|Rheumatrex|Amethopterin|Metatrexan|Hdmtx|Ledertrexate|Methylaminopterinum|Methotrexatum|Metotrexato|Antifolan|Emtexate|Rasuvo|Amethopterine|Maxtrex|L-Amethopterin|NSC-740|Farmitrexat|Medsatrexate|Methoblastin|Methotextrate|Methotrexat|Brimexate|Emthexat|Emthexate|Fauldexato|Lantarel|Lumexon|Metrotex|Novatrex|Otrexup|Tremetex|Trexeron|Trixilem|Texate|Metex|CL-14377|NCI-C04671|JYLAMVO|EMT 25,299|CL 14377|NSC 740|YL5FZ2Y5U1|R 9985|REDITREX|NSC740|DTXSID4020822|CHEBI:44185|ADX-2191|WR-19039|4-amino-N(10)-methylpteroylglutamic acid|DTXCID80822|(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methylamino]benzoyl]amino]pentanedioic acid|R-9985|N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-L-glutamic acid|Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-L-glutamova|Glutamic acid, N-(p-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-, L-|L-Glutamic acid, N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-|4-Amino-N10-methylpteroylglutamic acid|Ebetrex|Metoject|Zlatal|Emtexate pf|Emtexate high-pot|(2S)-2-((4-((2,4-diaminopteridin-6-yl)methyl-methylamino)benzoyl)amino)pentanedioic acid|N-(4-(((2,4-diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-glutamic acid|Hydrate, Methotrexate|OTREXUP PFS|RefChem:6017|Metex 6013|Dicesium Salt Methotrexate|Methotrexate Methylaminopterin|L01BA01|L04AX03|GLUTAMIC ACID, N-(P-(((2,4-DIAMINO-6-PTERIDINYL)METHYL)METHYLAMINO)BENZOYL)-, L-(+)-|4-Amino-4-deoxy-10-methylpteroyl-L-glutamic Acid|4-AMINO-4-DEOXY-N(SUP 10)-METHYLPTEROYLGLUTAMATE|4-AMINO-4-DEOXY-N(SUP 10)-METHYLPTEROYLGLUTAMIC ACID|N-(4-((2,4-Diaminopteridin-6-ylmethyl)(methyl)amino)benzoyl)-L-glutamic acid|200-413-8|Methylaminopterin|(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)(methyl)amino)benzamido)pentanedioic acid|Mexate|MTX|4-Amino-10-methylfolic acid|N-Bismethylpteroylglutamic acid|Folex|Xatmep|133073-73-1|C20H22N8O5|Methotrexat-Ebewe|TCMDC-125858|MFCD00064370|CHEMBL34259|MFCD00150847|N-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)carbonyl]-L-glutamic acid|NCGC00025060-04|A-Methopterin|A-Methpterin|Amethopterin L-|Folex-Pfs|(2S)-2-[(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}phenyl)formamido]pentanedioic acid|Methotrexate, L-|Methotrexate (hydrate)|X 133|Metotressato [DCIT]|Metotressato|MLS001401431|Methotrexatum [INN-Latin]|Metotrexato [INN-Spanish]|[3H]methotrexate|SMR000112001|[3H]-methotrexate|folic acid antagonist|CCRIS 1109|4-Amino-10-methylfolic acid hydrate|4-Aminomethylpteroylglutamic acid|HSDB 3123|L-(+)-N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)glutamic acid|N-(p-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-(+)-glutamic acid|SR-01000075682|SMR000449324|EINECS 200-413-8|Methotrexate (1.0mg/mL in Methanol with 0.1N NaOH)|UNII-YL5FZ2Y5U1|TCMDC-125488|Metolate|Nordimet|AI3-25299|Antifolan hydrate|Intradose-MTX|MTX hydrate|4-Amino-N(sup 10)-methylpteroylglutamic acid|1dhi|1dhj|2drc|4ocx|(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]pentanedioic acid|CAS-59-05-2|MPI-2505|Prestwick_322|Otrexup (TN)|Xatmep (TN)|Kyselina 4-amino-N(sup 10)-methylpteroylglutamova [Czech]|Methylaminopterin; MTX|DL-Amethopterin hydrate|Methotrexate [USAN:USP:INN:BAN:JAN]|Spectrum_001836|Tocris-1230|4kn0|Methotrexate (Standard)|Methylaminopterin hydrate|Prestwick0_000135|Prestwick1_000135|Prestwick2_000135|Spectrum2_001077|Spectrum3_000497|Spectrum4_000616|Spectrum5_000958|Abitrexate (Methotrexate)|METHOTREXATE [MI]|N-(p-(((2,4-Diamino-6-pteridyl)methyl)methylamino)benzoyl)glutamic acid|METHOTREXATE [INN]|METHOTREXATE [JAN]|METHOTREXATE [HSDB]|METHOTREXATE [IARC]|METHOTREXATE [USAN]|N-(4-(((2,4-Diamino-6-pteridinyl)methyl)methylamino)benzoyl)-L-glutamicacid|NCIMech_000767|SCHEMBL3711|Kyselina N-(p-((2,4-diamino-6-pteridinylmethyl)methylamino)benzoyl)-L-glutamova [Czech]|METHOTREXATE [VANDF]|BIDD:PXR0175|Lopac0_000020|KBioGR_001172|KBioSS_002341|METHOTREXATE [MART.]|Kyselina 4-amino-N(sup 10)-methylpteroylglutamova|MLS000049968|MLS002154208|DivK1c_000114|METHOTREXATE [USP-RS]|METHOTREXATE [WHO-DD]|METHOTREXATE [WHO-IP]|SPBio_001094|SPBio_002149|Amethopterin (hydrate); CL14377 (hydrate); WR19039 (hydrate)|cid_126941|cid_165528|GTPL4674|GTPL4815|orb1308506|SCHEMBL12421860|SCHEMBL23111732|SCHEMBL29349432|BDBM18050|BDBM66082|HMS500F16|KBio1_000114|KBio2_002338|KBio2_004906|KBio2_007474|KBio3_001493|Methotrexate (JP18/USP/INN)|g301|NINDS_000114|Bio1_000486|Bio1_000975|Bio1_001464|GLXC-06696|HMS1568K12|HMS2095K12|HMS2233O18|HMS3260C21|HMS3414L09|HMS3678L07|HMS3712K12|METHOTREXATE [ORANGE BOOK]|METHOTREXATE [EP MONOGRAPH]|METHOTREXATE [USP IMPURITY]|APC-2002|BCP13701|MPI-5004|MSK10330|METHOTREXATE [USP MONOGRAPH]|Tox21_110944|Tox21_300269|Tox21_500020|CCG-35800|EMT-25299|HY-14519R|METHOTREXATUM [WHO-IP LATIN]|s1210|STL535338|AKOS016340329|Tox21_110944_1|CL14377|CS-1732|DB00563|KS-5093|LP00020|SDCCGSBI-0050009.P003|IDI1_000114|SMP2_000020|NCGC00025060-01|NCGC00025060-02|NCGC00025060-03|NCGC00025060-05|NCGC00025060-06|NCGC00025060-07|NCGC00025060-08|NCGC00025060-09|NCGC00025060-10|NCGC00025060-11|NCGC00025060-12|NCGC00025060-13|NCGC00025060-15|NCGC00025060-16|NCGC00254216-01|NCGC00260705-01|HY-14519|EU-0100020|G-301|NS00098764|SW198601-3|Methotrexate 1.0 mg/ml in Dimethyl Sulfoxide|73M731|C01937|D00142|EN300-119523|DL-4-Amino-N10-methylpteroylglutamic acid hydrate|Q422232|SR-01000597411|W-60383|SR-01000075682-1|SR-01000075682-2|SR-01000075682-6|SR-01000597411-1|BRD-K59456551-001-09-3|BRD-K59456551-001-11-9|BRD-K59456551-001-19-2|BRD-K59456551-001-20-0|BRD-K59456551-001-22-6|WLN: T66 BN DN GN JNJ CZ EZ H1N1&R DVMYVQ2VQ|Z1521553982|Methotrexate, European Pharmacopoeia (EP) Reference Standard|Methotrexate, United States Pharmacopeia (USP) Reference Standard|Glutamic acid,4-diamino-6-pteridinyl)methyl] methylamino]benzoyl]-, L-(+)-|L-Glutamic acid,4-diamino-6-pteridinyl)methyl]- methylamino]benzoyl]-|(S)-2-(4-(((2,4-Diaminopteridin-6-yl)methyl)-(methyl)amino)benzamido)pentanedioic acid|L-Glutamic acid,N-[4-[[(2,4-diamino-6-pteridinyl)methyl]methylamino]benzoyl]-,hydrate(9ci)|Methotrexate for peak identification, European Pharmacopoeia (EP) Reference Standard|Methotrexate for system suitability, European Pharmacopoeia (EP) Reference Standard|Methotrexate, Pharmaceutical Secondary Standard; Certified Reference Material|N-(4-{[(2,4-diaminopteridin-6-yl)methyl](methyl)amino}benzoyl)-L-glutamic acid|N-[4-[[(2,4-Diamino-6-pteridinyl)methyl] methylamino]benzoyl]-L-glutamic acid|(2S)-2-((4-(((2,4-DIAMINOPTERIDIN-6-YL)METHYL)(METHYL)AMINO)BENZOYL)AMINO)PENTANEDIOIC ACID|(2S)-2-[[[4-[(2,4-diamino-6-pteridinyl)methyl-methylamino]phenyl]-oxomethyl]amino]pentanedioic acid;hydrate|(2S)-2-[[4-[(2,4-diaminopteridin-6-yl)methyl-methyl-amino]benzoyl]amino]glutaric acid;hydrate|(2S)-2-[[4-[[2,4-bis(azanyl)pteridin-6-yl]methyl-methyl-amino]phenyl]carbonylamino]pentanedioic acid;hydrate|102613-64-9"
PEMETREXED,135410875,,"InChI=1S/C20H21N5O6/c21-20-24-16-15(18(29)25-20)12(9-22-16)6-3-10-1-4-11(5-2-10)17(28)23-13(19(30)31)7-8-14(26)27/h1-2,4-5,9,13H,3,6-8H2,(H,23,28)(H,26,27)(H,30,31)(H4,21,22,24,25,29)/t13-/m0/s1",WBXPDJSOTKVWSJ-ZDUSSCGKSA-N,C20H21N5O6,427.4,"(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid","Pemetrexed|137281-23-3|LY231514|CHEBI:63616|LY-231514|04Q9AIZ7NO|NSC-698037|PEMFEXY|DTXSID2048329|N-(4-(2-(2-Amino-3,4-dihydro-4-oxo-7H-pyrrolo(2,3-d)pyrimdin-5-yl)ethyl)benzoyl)glutamic acid|Pemetrexed Sodium|L-Glutamic acid, N-(4-(2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-|N-{4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl}-L-glutamic acid|pemetrexedum|N-(4-(2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)-L-glutamic acid|AXTLE|Multitargeted Antifolate|RefChem:6105|LY-231,514|PEMETREXED FOR INJECTION|DTXCID7028304|(2R)-2-((4-(2-(2-amino-4-oxo-1,7-dihydropyrrolo(4,5-e)pyrimidin-5-yl)ethyl)benzoyl)amino)pentanedioic acid|231514, LY|231,514, LY|L-Glutamic Acid, N-(4-(2-(2-Amino-4,7-dihydro-4-oxo-1H-pyrrolo(2,3-d)pyrimidin-5-yl)ethyl)benzoyl)|Alimta|(S)-2-(4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioic acid|N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid|L-Glutamic acid, N-[4-[2-(2-amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-|Pemetrexed (INN)|LY 231514|LY-2315|N-[4-[2-(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid|PEMETREXED [INN]|Alimta (TN)|(2S)-2-[[4-[2-(2-amino-4-oxo-1,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid|(2S)-2-[[4-[2-(2-amino-4-oxo-3,7-dihydropyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]amino]pentanedioic acid|2-{4-[2-(2-AMINO-4-OXO-4,7-DIHYDRO-3H-PYRROLO[2,3-D]PYRIMIDIN-5-YL)-ETHYL]-BENZOYLAMINO}-PENTANEDIOIC ACID|(2S)-2-{[4-(2-{2-amino-4-oxo-3H,4H,7H-pyrrolo[2,3-d]pyrimidin-5-yl}ethyl)phenyl]formamido}pentanedioic acid|LYA|Pemetrexed [INN:BAN]|UNII-04Q9AIZ7NO|MFCD19105065|HSDB 7316|1juj|Pemetrexed Hydrate|Pemetrexed (TN)|(S)-2-[4-[2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzamido]pentanedioic Acid|L-GLUTAMIC ACID, N-(4-(2-(2-AMINO-4,7-DIHYDRO-4-OXO-3H-PYRROLO(2,3-D)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-|N-(4-(2-(2-AMINO-4,7-DIHYDRO-4-OXO-1H-PYRROLO(2,3-D)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-L-GLUTAMIC ACID|N-(4-[2-(2-amino-4,7-Dihydro-4-Oxo-1H-Pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl)-L-Glutamic Acid|Pemfexy (TN)|Pemetrexed (Standard)|PEMETREXED [MI]|Alimta (TN) (Lilly)|PEMETREXED [HSDB]|PEMETREXED [VANDF]|SCHEMBL7968|PEMETREXED [WHO-DD]|US9422297, Pemetrexed|PEMETREXED [EMA EPAR]|SCHEMBL209720|CHEMBL225072|orb1310854|Pemetrexed - Bio-X trade mark|SCHEMBL7848273|SCHEMBL7848278|PEMETREXED [ORANGE BOOK]|Premetrexed [Common mis-spelling]|WBXPDJSOTKVWSJ-ZDUSSCGKSA-N|BDBM50027656|HY-10820R|s5971|AKOS015896253|AKOS016842348|AC-1701|CS-1297|DB00642|FP37935|NCGC00166414-11|NCGC00167517-01|NCGC00242485-01|(S)-2-(4-(2-(2-Amino-4-oxo-4,7-dihydro-1H-pyrrolo-[2,3-d]pyrimidin-5-yl)ethyl)benzamido)pentanedioic acid|AS-30680|BP164240|HY-10820|N-[4-[2(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid|SY105930|DB-024764|P2288|D07472|AB01273937-01|EN300-7396246|281P233|Q415220|L-Glutamic acid,3-d]pyrimidin-5-yl]ethyl]benzoyl]-|BRD-K32842773-304-03-9|BRD-K32842773-304-04-7|BRD-K32842773-434-01-8|1006872-74-7|N-({4-[2-(2-amino-4-oxo-4,7-dihydro-1H-pyrrolo[2,3-d]pyrimidin-5-yl)ethyl]phenyl}carbonyl)-L-glutamic acid|N-(P-(2-(2-AMINO-4,7-DIHYDRO-4-OXO-1H-PYRROLO(2,3-D)PYRIMIDIN-5-YL)ETHYL)BENZOYL)-L-GLUTAMATE|N-[4-[2(2-amino-4,7-dihydro-4-oxo-1H-pyrrolo [2,3-d]pyrimidin-5-yl)ethyl]benzoyl]-L-glutamic acid|N-[4-[2-(2-amino-3,4-dihydro-4-oxo-7h-pyrrolo[2,3-d]pyrimi-din-5-yl)ethyl]benzoyl]l-glutamic acid|N-[4-[2-[2-Amino-4,7-dihydro-4-oxo-3H-pyrrolo[2,3-d]pyrimidin-5-yl]ethyl]benzoyl]glutamic acid"
DIAVERIDINE,21453,,"InChI=1S/C13H16N4O2/c1-18-10-4-3-8(6-11(10)19-2)5-9-7-16-13(15)17-12(9)14/h3-4,6-7H,5H2,1-2H3,(H4,14,15,16,17)",LDBTVAXGKYIFHO-UHFFFAOYSA-N,C13H16N4O2,260.29,"5-[(3,4-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine","DIAVERIDINE|5355-16-8|Diaveridin|Diaveridina|Diaveridinum|2,4-Diamino-5-veratrylpyrimidine|5-(3,4-dimethoxybenzyl)pyrimidine-2,4-diamine|BW 49-210|2,4-Diamino-5-(3,4-dimethoxybenzyl)pyrimidine|5-((3,4-Dimethoxyphenyl)methyl)-2,4-pyrimidinediamine|NSC-408735|CHEBI:123115|7KVX81XA87|DTXSID2046200|2,4-Pyrimidinediamine, 5-[(3,4-dimethoxyphenyl)methyl]-|BW-49210|BW-49-210|2,4-Pyrimidinediamine, 5-((3,4-dimethoxyphenyl)methyl)-|DTXCID0026200|RefChem:586320|226-333-3|5-[(3,4-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine|EGIS-5645|Pyrimidine, 2,4-diamino-5-veratryl-|AI3-23935|MFCD00057349|5-(3,4-Dimethoxy-benzyl)-pyrimidine-2,4-diamine|CHEMBL19633|NSC408735|NCGC00160517-01|Diaveridine 10 microg/mL in Acetonitrile|Diaveridinum [INN-Latin]|Diaveridina [INN-Spanish]|CAS-5355-16-8|Diaveridine [USAN:INN:BAN]|CCRIS 3784|EGIS 5645|EINECS 226-333-3|NSC 408735|BRN 0258464|UNII-7KVX81XA87|Diverdine|Diaveridine (Standard)|DIAVERIDINE [MI]|DIAVERIDINE [INN]|Diaveridine (USAN/INN)|DIAVERIDINE [USAN]|Epitope ID:119685|5-(3,4-Dimethoxybenzyl)-2,4-pyrimidinediamine|DIAVERIDINE [MART.]|SCHEMBL93896|DIAVERIDINE [USP-RS]|2,4-Diamino-5-(3',4'-dimethoxybenzyl)pyrimidine|5-25-13-00391 (Beilstein Handbook Reference)|MLS004712092|orb321035|2,4-dimethoxybenzyl)pyrimidine|orb1306113|SCHEMBL29527560|HY-B1902R|Pyrimidine,4-diamino-5-veratryl-|HMS3264I16|HMS5084B13|Pharmakon1600-01502300|HY-B1902|Tox21_111866|BBL009897|BDBM50138691|NSC759634|s5200|STK711076|AKOS005530708|Tox21_111866_1|CCG-213021|FD66116|NSC-759634|2, 5-[(3,4-dimethoxyphenyl)methyl]-|NCGC00160517-02|NCGC00160517-03|AC-12110|AS-56306|BW 49210|SMR002529995|ST082353|CS-0013961|NS00000684|210U49|D03771|D81857|AB01562957_01|Diaveridine, VETRANAL(TM), analytical standard|EN300-7440332|355D168|5-(3,4-Dimethoxybenzyl)-2,4-pyrimidinediamine #|A829660|SR-01000939849|2,4-diamino-5-(3',4'-dimethoxybenzyl) pyrimidine|2,4-diamino-5-(3',4'-dimethoxybenzyl)-pyrimidine|Diaveridine, analytical standard, >=99.0% (TLC)|SR-01000939849-2|BRD-K97464279-001-03-5|Q27212503|Z2681892420|5-[(3,4-Dimethoxyphenyl)methyl]-2,4-pyrimidine- diamine HCl|Diaveridine, United States Pharmacopeia (USP) Reference Standard|KUP"
ICLAPRIM,213043,,"InChI=1S/C19H22N4O3/c1-24-15-8-11(7-12-9-22-19(21)23-18(12)20)13-5-6-14(10-3-4-10)26-16(13)17(15)25-2/h5-6,8-10,14H,3-4,7H2,1-2H3,(H4,20,21,22,23)",HWJPWWYTGBZDEG-UHFFFAOYSA-N,C19H22N4O3,354.4,"5-[(2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl]pyrimidine-2,4-diamine","Iclaprim|192314-93-5|AR-100|5-[(2-cyclopropyl-7,8-dimethoxy-2h-chromen-5-yl)methyl]pyrimidine-2,4-diamine|RO-48-2622|Iclaprime|5-((2-Cyclopropyl-7,8-dimethoxy-2H-chromen-5-yl)methyl)pyrimidine-2,4-diamine|42445HUU0O|AR 100|Ro-482622|2,4-Pyrimidinediamine, 5-[(2-cyclopropyl-7,8-dimethoxy-2H-1-benzopyran-5-yl)methyl]-|AR-100.001|RO 48-2622|CHEBI:131751|2,4-Pyrimidinediamine, 5-((2-cyclopropyl-7,8-dimethoxy-2H-1-benzopyran-5-yl)methyl)-|5-((2RS)-2-cyclopropyl-7,8-dimethoxy-2H-chromen-5-ylmethyl)pyrimidine-2,4-diamine|iclaprimum|RefChem:789653|J01EA03|CHEBI:131724|5-((2-cyclopropyl-7,8-dimethoxy-2H-1-benzopyran-5-yl)methyl)-2,4-Pyrimidinediamine|606-269-6|Mersarex|MFCD09837803|Ro 63-9141;BAL 9141|Iclaprim [INN]|AR-101|Iclaprim [USAN]|Iclaprim (USAN/INN)|Iclaprim [USAN:INN]|UNII-42445HUU0O|Iclaprim (Standard)|5-(2-Cyclopropyl-7,8-dimethoxy-2H-chromen-5-ylmethyl)-pyrimidine-2,4-diamine (ICLAPRIM]|ICLAPRIM [MI]|ICLAPRIM [MART.]|ICLAPRIM [WHO-DD]|SCHEMBL379386|CHEMBL134561|orb1296194|SCHEMBL12899446|SCHEMBL29462190|SCHEMBL30253885|BDBM18070|GTPL10820|DTXSID70870191|HMS3749A21|BCP04499|EX-A10696|AKOS027422438|CS-7873|DB06358|FI24533|HY-101479R|SB17354|AS-74032|DA-38934|HY-101479|D08337|W16646|Q907480|5-[(2-cyclopropyl-7,8-dimethoxy-2H-1-benzopyran-5-yl)methyl]-2,4-pyrimidine- diamine|5-[(2-Cyclopropyl-7,8-dimethoxy-2H-1-benzopyran-5-yl)methyl]-2,4-pyrimidine-diamine|5-[(2-Cyclopropyl-7,8-dimethoxy-2H-1-benzopyran-5-yl)methyl]pyrimidine-2,4-diamine|5-[(2-CYCLOPROPYL-7,8-DIMETHOXY-2H-CHROMEN-5-YL)METHYL]PYRIMIDINE-2,4- DIAMINE|5-{[(2RS)-2-Cyclopropyl-7,8-dimethoxy-2H-1-benzopyran-5-yl]methyl}pyrimidine-2,4-diamine|5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid,7-[[(2Z)-2-(5-aMino-1,2,4-thiadiazol-3-yl)-2-(hydroxyiMino)acetyl]aMino]-8-oxo-3-[(E)-[(3'R)-2-oxo[1,3'-bipyrrolidin]-3-ylidene]Methyl]-,(6R,7R)-"
CYCLOGUANIL,9049,,"InChI=1S/C11H14ClN5/c1-11(2)16-9(13)15-10(14)17(11)8-5-3-7(12)4-6-8/h3-6H,1-2H3,(H4,13,14,15,16)",QMNFFXRFOJIOKZ-UHFFFAOYSA-N,C11H14ClN5,251.71,"1-(4-chlorophenyl)-6,6-dimethyl-1,3,5-triazine-2,4-diamine","Cycloguanil|516-21-2|Cycloguanyl|Chlorguanide triazine|1-(4-chlorophenyl)-6,6-dimethyl-1,6-dihydro-1,3,5-triazine-2,4-diamine|BN2410|1-(4-chlorophenyl)-6,6-dimethyl-1,3,5-triazine-2,4-diamine|WR 5473|26RM326WVN|1-(p-Chlorophenyl)-4,6-diamino-2,2-dimethyl-1,2-dihydro-s-triazine|DTXSID9022867|CHEBI:135029|cycloquanil|RefChem:129488|1-(4-chlorophenyl)-1,6-dihydro-6,6-dimethyl-1,2,5-triazine-2,4-diamine|DTXCID402867|Chlorcycloguanil|CHEMBL747|s-Triazine, 1,2-dihydro-1-(p-chlorophenyl)-4,6-diamino-2,2-dimethyl-|CGT|Cycloguanilum|1-(4-Chlorophenyl)-1,6-dihydro-6,6-dimethyl-1,3,5-triazine-2,4-diamine|GNF-PF-2519|NSC3074|BN-24-10|BRN 0229760|UNII-26RM326WVN|1CY|CYCLOGUANIL [MI]|1-p-Chlorophenyl-1,2-dihydro-2,2-dimethyl-4,6-diamino-s-triazine|Maybridge1_004316|4-Amino-6-p-chloroanilino-1,2-dwuhydro-2,2-dwumethylo-1,3,5-trojazyna [Polish]|CYCLOGUANIL [WHO-DD]|4-26-00-01176 (Beilstein Handbook Reference)|SCHEMBL140230|orb1689890|BDBM18792|GTPL10027|4,6-diamino-1-(p-chlorophenyl)-1,2-dihydro-2,2-dimethyl-s-triazine|ARD159613|1,3,5-Triazine-2,4-diamine, 1,6-dihydro-1-(4-chlorophenyl)-6,6-dimethyl-|4-Amino-6-p-chloroanilino-1,2-dwuhydro-2,2-dwumethylo-1,3,5-trojazyna|AKOS001637073|CCG-250330|DB14763|SB73658|HY-12784|LS-13958|DB-190486|CS-0012453|NS00115897|EN300-818812|H53302|AE-848/09807008|Q5198706|BRD-K75179562-003-01-1|1,3,5-Triazine-2,4-diamine,1-(4-chlorophenyl)-1,6-dihydro-6,6-dimethyl-|1-(4-Chlorophenyl)-1,6-dihydro-6,6-dimethyl-1,3, 5-triazine-2,4-diamine|1,3,5-Triazine-2,4-diamine, 1-(4-chlorophenyl)-1,6-dihydro-6,6-dimethyl-|VIL"
NALTREXONE,5360515,,"InChI=1S/C20H23NO4/c22-13-4-3-12-9-15-20(24)6-5-14(23)18-19(20,16(12)17(13)25-18)7-8-21(15)10-11-1-2-11/h3-4,11,15,18,22,24H,1-2,5-10H2/t15-,18+,19+,20-/m1/s1",DQCKKXVULJGBQN-XFWGSAIBSA-N,C20H23NO4,341.4,"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","naltrexone|16590-41-3|Vivitrol|Vivitrex|Celupan|N-Cyclopropylmethylnoroxymorphone|Naltrexona|Naltrexonum|Nemexin|N-Cyclopropylmethyl-14-hydroxydihydromorphinone|17-(Cyclopropylmethyl)-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one|UM-792|5S6W795CQM|CHEBI:7465|EN-1639A FREE BASE|DTXSID4046313|(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one|NSC-758439|DTXCID2026313|Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5alpha)-|(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one|Adepend|Opizone|Trexal|(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7(18),8,10-trien-14-one|(4R,4aS,7aR,12bS)-3-(Cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinolin-7-one|RefChem:56739|EN1639A|N07BB04|(1S,5R,13R,17S)-4-(cyclopropylmethyl)-10,17-dihydroxy-12-oxa-4-azapentacyclo(9.6.1.01,13.05,17.07,18)octadeca-7(18),8,10-trien-14-one|240-649-9|Nalorex|ReVia|Naltrexonum [INN-Latin]|(4R,4As,7aR)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one|Naltrexona [INN-Spanish]|Naltrexone (1.0 mg/mL in Methanol)|Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-, (5.alpha.)-|Naltrexone [USAN:INN:BAN]|Naltrexone base anhydrous|CAS-16590-41-3|CCRIS 3506|HSDB 6750|EINECS 240-649-9|BRN 3596648|UNII-5S6W795CQM|(-)naltrexone|PTI-555|NCGC00162274-02|(-)-Naltrexone|Vivitrol (TN)|MFCD00242996|NALTREXONE [MI]|NALTREXONE [INN]|Naltrexone (USAN/INN)|Prestwick0_000116|Prestwick1_000116|Prestwick2_000116|Prestwick3_000116|NALTREXONE [HSDB]|NALTREXONE [USAN]|NALTREXONE [VANDF]|NALTREXONE [MART.]|NALTREXONE [USP-RS]|NALTREXONE [WHO-DD]|US9107954, naltrexone|SCHEMBL34681|BSPBio_000132|orb611377|BIDD:GT0405|CHEMBL19019|SPBio_002071|BPBio1_000146|GTPL1639|NALTREXONE [ORANGE BOOK]|SCHEMBL29366199|BDBM60212|cid_5485201|cyclopropylmethyl(dihydroxy)[?]one|HMS2089O11|BCP07022|EX-A4863|Tox21_112007|BDBM50000787|PDSP2_000847|AKOS015994596|Morphinan-6-one, 17-(cyclopropylmethyl)-4,5-alpha-epoxy-3,14-dihydroxy-|Tox21_112007_1|CS-0880|DB00704|HS-0002|NSC 758439|SMP1_000206|NCGC00024427-03|NCGC00024427-04|NCGC00024427-05|AC-36726|DA-55992|HY-76711|NS00009185|C07253|D05113|AB00174152-14|AB00174152_17|EN300-19748946|Q409587|BRD-K88172511-003-19-5|BRD-K88172511-003-20-3|BRD-K88172511-003-21-1|BRD-K88172511-310-03-8|3,14-dihydroxy-17-(cyclopropylmethyl)-4,5alpha-epoxymorphinan-6-one|17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxmorphinan-6-one, (5.alpha.)-|(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-bis(oxidanyl)-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride|(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,3,4,4a,5,6-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7(7aH)-one|(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride"
NALOXONE,5284596,,"InChI=1S/C19H21NO4/c1-2-8-20-9-7-18-15-11-3-4-12(21)16(15)24-17(18)13(22)5-6-19(18,23)14(20)10-11/h2-4,14,17,21,23H,1,5-10H2/t14-,17+,18+,19-/m1/s1",UZHSEJADLWPNLE-GRGSLBFTSA-N,C19H21NO4,327.4,"(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","naloxone|465-65-6|l-Naloxone|n-Allylnoroxymorphone|(-)-Naloxone|Naloxona|EN 1530 base|Naloxonum|Nalossone|N-Allyl-noroxymorphone|DBL Naloxone|1-N-Allyl-14-hydroxynordihydromorphinone|Naloxone Nasal Spray|1-N-Allyl-7,8-dihydro-14-hydroxynormorphinone|l-N-Allyl-14-hydroxynordihydromorphinone|NSC-70413|17-Allyl-4,5alpha-epoxy-3,14-dihydroxymorphinan-6-one|17-Allyl-4,5-alpha-epoxy-3,14-dihydroxymorphinan-6-one|l-N-Allyl-7,8-dihydro-14-hydroxynormorphinone|36B82AMQ7N|CHEBI:7459|DTXSID8023349|N-Allyl-4,5alpha-epoxy-3,14-dihydroxy-6-morphinanon|12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro(4,5-bcd)furanone|Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy-|Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-|Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)-|17-allyl-3,14-dihydroxy-4,5alpha-epoxymorphinan-6-one|Normorphinone, N-allyl-7,8-dihydro-14-hydroxy-, (-)-|DTXCID703349|(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one|Morphinan-6-one, 4,5-alpha-epoxy-3,14-dihydroxy-17-(2-propenyl)-|(1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one|Abello, Naloxone|Curamed, Naloxon|Naloxon ratiopharm|(1S,5R,13R,17S)-10,17-dihydroxy-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7(18),8,10-trien-14-one|(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinolin-7-one|naloxoni hydrochloridum|Hydrobromide, Naloxone|RefChem:6051|MRZ 2593Br|MRZ 2593 Br|MRZ 2593-Br|A06AH04|Dihydride, Naloxone Hydrochloride|Hydrochloride Dihydride, Naloxone|MRZ2593|V03AB15|MRZ 2593|(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinoline-7-one|207-365-7|Narcan|Nalossone [DCIT]|Naloxonum [INN-Latin]|Naloxona [INN-Spanish]|Nalone|HSDB 3279|Naloxone (INN)|NIOSH/QD2135000|RAM-301|Narcon|NALOXONE [INN]|7,8-Dihydro-N-allyl-14-hydroxynormorphinone|Naloxone [INN:BAN]|NSC 70413|QD21350000|Normorphinone, 7,8-dihydro-N-allyl-14-hydroxy-|17-Allyl-3,14-dihydroxy-4,5-alpha-epoxymorphinan-6-one|Morphinan-6-one, 17-allyl-3,14-dihydroxy-4,5-alpha-epoxy-|MLS000069540|(5alpha)-3,14-dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one|[3H]naloxone|CAS-465-65-6|DBL Naloxone (TN)|MLS000736771|SMR000058766|EINECS 207-365-7|BRN 1089071|UNII-36B82AMQ7N|Nyxoid|[N-allyl-2,3-3H]naloxone|NCGC00162267-02|Normorphinone, N-allyl-dihydro-14-hydroxy-|NALOXONE [HSDB]|NALOXONE [MI]|CHEMBL80|NALOXONE [VANDF]|NLX|Prestwick0_000111|Prestwick1_000111|Prestwick2_000111|Prestwick3_000111|NALOXONE [USP-RS]|NALOXONE [WHO-DD]|NALOXONE [EMA EPAR]|SCHEMBL34284|BSPBio_000122|(-)-N-allyl-14-hydroxynordihydroxymorphinan-6-one|BIDD:GT0110|SPBio_002061|NALOXONE [ORANGE BOOK]|BPBio1_000136|GTPL1638|GTPL1676|SCHEMBL29427581|BDBM54795|cid_5464092|Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-|BDBM579486|HMS2090F20|US11484525, Compound Naloxone|Tox21_112006|(5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propenyl)morphinan-6-one|3,14-dihydroxy-17-(prop-2-en-1-yl)-4,5alpha-epoxymorphinan-6-one|BDBM50000788|HY-17417A|PDSP2_001520|AKOS016009988|Tox21_112006_1|DB01183|FN61467|SMP1_000205|NCGC00024674-02|NCGC00024674-03|NCGC00024674-14|NCGC00274058-01|12-Allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-4aH-8,9c-iminoethanophenanthro[4,5-bcd]furan-5(6H)-one|DA-65917|4683B|CS-0012343|Kloxxado (naloxone hydrochloride nasal spray)|NS00002914|C07252|D08249|465N656|EN300-19748912|Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-|Q282902|(-)-N-ALLYL-14-HYDROXYNORDIHYDROMORPHINONE|BRD-K67511046-001-02-3|BRD-K67511046-003-03-7|BRD-K67511046-003-14-4|BRD-K67511046-003-15-1|BRD-K67511046-003-16-9|17-ALLYL-4,5A-EPOXY-3,14-DIHYDROXYMORPHINAN-6-ONE|(5?)-3,14-Dihydroxy-17-prop-2-en-1-yl-4,5-epoxymorphinan-6-one|Morphinan-6-one, 17-allyl-4,5alpha-epoxy-3,14-dihydroxy- (8CI)|Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-17-(2-propenyl)-|(5alpha)-4,5-Epoxy-3,14-dihydroxy-17-(2-propen-1-yl)morphinan-6-one|[17-(2,3-3H-2-propenyl)]-4, 5a -epoxy-3,14-dihydroxymorphinan-6-one|MORPHINAN-6-ONE, 4,5-EPOXY-3,14-DIHYDROXY-17-(2-PROPENYL)-|Morphinan-6-one,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5.alpha.)-|4aH-8,5-bcd]furan-5(6H)-one, N-allyl-7,7a,8,9-tetrahydro-3,7a-dihydroxy-|Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-(2-propenyl)-, (5alpha)- (9CI)|(4R,4aS,7aR,12bS)-3-allyl-4a,9-dihydroxy-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride|(4R,4aS,7aR,12bS)-4a,9-bis(oxidanyl)-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride|(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-prop-2-enyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one;hydrochloride|(naloxone) 4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one|(naloxone)4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one|(naloxone)4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one|4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one|4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one (naloxone)|4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one( Naloxone)|4-allyl-10,17-dihydroxy-(1S,5R,13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(Naxolone)|4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one|4-allyl-10,17-dihydroxy-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(naloxone)C2H2O4"
MORPHINE,5288826,,"InChI=1S/C17H19NO3/c1-18-7-6-17-10-3-5-13(20)16(17)21-15-12(19)4-2-9(14(15)17)8-11(10)18/h2-5,10-11,13,16,19-20H,6-8H2,1H3/t10-,11+,13-,16-,17-/m0/s1",BQJCRHHNABKAKU-KBQPJGBKSA-N,C17H19NO3,285.34,"(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol","morphine|Morphia|Morphium|Morphin|Morphinum|(-)-Morphine|Morphina|Ospalivina|Duromorph|57-27-2|Meconium|Morphinism|Nepenthe|Dulcontin|Morfina|Roxanol|Morpho|Statex SR|M-Eslon|Anhydrous morphine|Aguettant|Dinamorf|Dimorf|Morphine anhydrous|Morphine (anhydrous)|(5R,6S,9R,13S,14R)-4,5-Epoxy-N-methyl-7-morphinen-3,6-diol|CHEBI:17303|Morphine extended release|IDS-NM-009|4,5alpha-Epoxy-17-methyl-7-morphinen-3,6alpha-diol|N02AA01|76I7G6D29C|7,8-Didehydro-4,5-epoxy-17-methyl-morphinan-3,6-diol|(5alpha,6alpha)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|(7R,7AS,12BS)-3-METHYL-2,3,4,4A,7,7A-HEXAHYDRO-1H-4,12-METHANO[1]BENZOFURO[3,2-E]ISOQUINOLINE-7,9-DIOL|DTXSID9023336|(5alpha,6alpha)-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol|9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4a,5,7a,8-tetrahydro-12-methyl-|Chloride, Morphine|morphine tincture|Contin, MS|(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7(18),8,10,15-tetraene-10,14-diol|(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7,9,11(18),15-tetraene-10,14-diol|(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraene-10,14-diol|(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18),15-tetraene-10,14-diol|(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinoline-7,9-diol|(4R,4aR,7S,7aR,12bS)-3-methyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol|(7R,7AS,12bs)-3-methyl-2,3,4,4a,7,7a-hexahydro-1H-4,12-methano(1)benzofuro(3,2-e)isoquinoline-7,9-diol|SDZ202-250|MORPHINE BASE|RefChem:6656|Opium Tincture Deodorized|DTXCID203336|SDZ202250|SDZ 202250|SDZ202 250|SDZ 202 250|Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-(5alpha,6alpha)-|(1S,5R,13R,14S,17R)-4-methyl-12-oxa-4-azapentacyclo(9.6.1.01,13.05,17.07,18)octadeca-7(18),8,10,15-tetraene-10,14-diol|200-320-2|NSC11411|l-Morphine|MS Contin|Dreamer|Hocus|Unkie|Cube juice|Hard stuff|Ms Emma|Morphin [German]|Morfina [Italian]|Morphina [Italian]|Morphine [BAN]|CCRIS 5762|HSDB 2134|CHEMBL70|Morphine Anhydrate|Morphine (BAN)|RMS|Morphinan-3,6-alpha-diol, 7,8-didehydro-4,5-alpha-epoxy-17-methyl-|Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl-, (5alpha,6alpha)-|methyl[?]diol|Morphine (1.0 mg/mL in Methanol)|(5alpha,6alpha)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol|Morphine (1.0mg/ml in Acetonitrile)|MOI|D-(-)-Morphine|EINECS 200-320-2|UNII-76I7G6D29C|DEA No. 9300|(Morphine)|Morphine polistirex|Substitol (TN)|(-)-(etorphine)|(-)Morphine sulfate|Morfina Dosa (TN)|MORPHINE [HSDB]|MORPHINE [MI]|MORPHINE [VANDF]|MORPHINE [MART.]|Epitope ID:116646|MORPHINE [WHO-DD]|SCHEMBL2997|BIDD:GT0147|GTPL1627|SCHEMBL4740781|(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol|SCHEMBL11684914|SCHEMBL27850914|SCHEMBL29350575|Morphine 0.1 mg/ml in Methanol|Morphine 1.0 mg/ml in Methanol|BDBM579485|US11484525, Compound Morphine|BDBM50000092|MORPHINE (ANHYDROUS) [VANDF]|AKOS015966554|DB00295|NS00000380|C01516|D08233|Hydromorphone hydrochloride impurity, morphine-|Q81225|CODEINE MONOHYDRATE IMPURITY B [EP IMPURITY]|7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol|ETHYLMORPHINE HYDROCHLORIDE IMPURITY B [EP IMPURITY]|HYDROMORPHONE HYDROCHLORIDE IMPURITY C [EP IMPURITY]|17-methyl-7,8-didehydro-4,5alpha-epoxymorphinan-3,6alpha-diol|CODEINE HYDROCHLORIDE DIHYDRATE IMPURITY B [EP IMPURITY]|CODEINE PHOSPHATE HEMIHYDRATE IMPURITY B [EP IMPURITY]|CODEINE PHOSPHATE SESQUIHYDRATE IMPURITY B [EP IMPURITY]|7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol(morphine)|DIHYDROCODEINE HYDROGEN TARTRATE IMPURITY B [EP IMPURITY]|(5alpha,6beta)-17-methyl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|3-(4-Hydroxy-phenyl)-1-propyl-piperidine-3-carboxylic acid ethyl ester|4,5.ALPHA.-EPOXY-17-METHYL-7,8-DIDEHYDROMORPHINAN-3,6.ALPHA.-DIO|6-tert-Butyl-3-methyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocine|7,8-DIDEHYDRO-4,5alpha-EPOXY-17-METHYLMORPHINAN-3,6alpha-DIOL|APOMORPHINE HYDROCHLORIDE HEMIHYDRATE IMPURITY B [EP IMPURITY]|HYDROCODONE HYDROGEN TARTRATE 2.5-HYDRATE IMPURITY A [EP IMPURITY]|HYDROMORPHONE HYDROCHLORIDE IMPURITY, MORPHINE- [USP IMPURITY]|(-)(5.alpha.,6.alpha.)-7,8-Didehydro-4,5-epoxy-17-methylmorphinan-3,6-diol|MORPHINAN-3,6-DIOL, 7,8-DIDEHYDRO-4,5-EPOXY-17-METHYL, (5.ALPHA.,6.ALPHA.)-|Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-methyl- (5..alpha.,6.alpha.)-|(1S,5R,13R,14S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol|(morphine) 4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol|2-{4-[2,4-diamino-6-pteridinylmethyl(methyl)amino]phenylcarboxamido}pentanedioic acid(morphine)|4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol|4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol ; HydroChloride|4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol ;sulphate salt(morphine)|4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol((Morphine))|4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(morphine sulfate)|4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(morphine)|4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(Morphine)(HCl)|4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol,sulfate(Morphinesulfate)|4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diolMorphine|4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol|4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol (morphine)|4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol(Morphine)|6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol(Morphine)|9H-9,9c-Iminoethanophenanthro(4,5-bcd)furan-3,5-diol, 4alpha,5,7alpha,8-tetrahydro-12-methyl-|Morphine;4-methyl-(1S,5R,13R,14S,17R)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10,15-tetraene-10,14-diol"
CYCLAZOCINE,19143,,"InChI=1S/C18H25NO/c1-12-17-9-14-5-6-15(20)10-16(14)18(12,2)7-8-19(17)11-13-3-4-13/h5-6,10,12-13,17,20H,3-4,7-9,11H2,1-2H3",YQYVFVRQLZMJKJ-UHFFFAOYSA-N,C18H25NO,271.4,"10-(cyclopropylmethyl)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol","CYCLAZOCINE|3572-80-3|Ciclazocina|Cyclazocinum|NSC-107429|WIN 20,740|2,6-Methano-3-benzazocin-8-ol, 3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-|DTXSID9022863|J5W1B1159C|NSC107429|WIN-20740|RefChem:388904|DTXCID802863|222-689-9|NIH 7981|UM 407|WIN 20740|2-Cyclopropylmethyl-2'-hydroxy-5,9-dimethyl-6,7-benzomorphan|3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol|MLS002703971|2-Cyclopropylmethyl-5,9-dimethyl-2'-hydroxy-6,7-benzomorphan|3-Cyclopropylmethyl-6(eq),11(ax)-dimethyl-2,6-methano-3-benzazocin-8-ol|10-(cyclopropylmethyl)-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol|2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-3-(cyclopropylmethyl)-6,11-dimethyl-|Cyclazocine (+)|Cyclazocine [USAN:INN]|Cyclazocinum [INN-Latin]|Ciclazocina [INN-Spanish]|CYCLAZOCINE (-)|EINECS 222-689-9|7346-09-0|NSC 107429|UNII-J5W1B1159C|Rac-Cyclazocine|EINECS 230-866-7|(+/-)-Cyclazocine|CYCLAZOCINE [MI]|CYCLAZOCINE [INN]|Cyclazocine (USAN/INN)|CYCLAZOCINE [USAN]|SCHEMBL37996|CHEMBL289683|orb1740110|cyclopropylmethyl(dimethyl)[?]ol|3-Cyclopropylmethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol|(cyclazocine)2-{4-[(2,4-Diamino-pteridin-6-ylmethyl)-methyl-amino]-benzoylamino}-pentanedioic acid|10-cyclopropylmethyl-1,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol(Cyclazocine)|2,6-Methano-3-benzazocin-8-ol,3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-,(2S,6S,11S)-|3-Cyclopropylmethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol (cyclazocine)|3-Cyclopropylmethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol(Cyclazocine)|BDBM50018731|NSC172134|2-Cyclopropylmethyl-5,7-beneomorphan|NSC-172134|(2alpha,6alpha,11R*)-(1)-3-(Cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol|SMR001395644|NS00029907|NS00080844|D03618|2-Cyclopropylmethyl-2'-hydroxy-5,7-benzomorphan|L001209|Q5198126|WLN: T C666 A KN&TTJ A1 B1 EQ K1- AL3TJ|3-Cyclopropylmethyl-6[eq],6-methano-3-benzazocin-8-ol|2-Cyclopropylmethyl-5,9-dimethyl-2'-hydroxy-6,7-beneomorphan|2, 1,2,3,4,5,6-hexahydro-3-(cyclopropylmethyl)-6,11-dimethyl-|2, 3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-|{3-Cyclopropylmethyl-6[eq],} {11[ax]-dimethyl-2,6-methano-3-benzazocin-8-ol}|3-(Cyclopropylmethyl)-1,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol|3-(cyclopropylmethyl)-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol|3-(Cyclopropylmethyl)1-1,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol|(Cyclazocine) 3-Cyclopropylmethyl-6,11-dimethyl-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol|2, 3-(cyclopropylmethyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-, (2.alpha.,6.alpha.,11R*)-|2, 6-Methano-3-benzazocin-8-ol, 1,2,3,4,5, 6-hexahydro-3-(cyclopropylmethyl)-6,11-dimethyl-|2, 6-Methano-3-benzazocin-8-ol, 3-(cyclopropylmethyl)-1,2,3,4,5, 6-hexahydro-6,11-dimethyl-|3-(Cyclopropylmethyl)-1,2,3, 4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol|3-(Cyclopropylmethyl)1-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2, 6-methano-3-benzazocin-8-ol"
ETORPHINE,644209,,"InChI=1S/C25H33NO4/c1-5-8-22(2,28)17-14-23-9-10-25(17,29-4)21-24(23)11-12-26(3)18(23)13-15-6-7-16(27)20(30-21)19(15)24/h6-7,9-10,17-18,21,27-28H,5,8,11-14H2,1-4H3/t17-,18-,21-,22-,23-,24+,25-/m1/s1",CAHCBJPUTCKATP-FAWZKKEFSA-N,C25H33NO4,411.5,"(1R,2S,6R,14R,15R,19R)-19-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11,16-tetraen-11-ol","Etorphine|19-Propylorvinol|Etorfina|(-)-Etorphine|Etorphinum|M99 Injection|Propylorvinol|14521-96-1|7-alpha-Etorphine|42M2Y6NU9O|IDS-NE-007|DTXSID40878669|M-99 FREE BASE|Tetrahydro-7-alpha-(2-hydroxy-2-pentyl)-6,14-endo-ethenooripavine|M. 99 FREE BASE|7-alpha-(1-(R)-Hydroxy-1-methylbutyl)-6,14-endo-ethenotetrahydrooripavine|7,8-Dihydro-7-alpha-(1-(R)-hydroxy-1-methylbutyl)-O(sup 6)-methyl-6,14-endo-ethenomorphine|CHEBI:4912|IDS-NE-007(SECT.3)|6,14-Ethenomorphinan-7-methanol, 4,5-epoxy-3-hydroxy-6-methoxy-alpha,17-dimethyl-alpha-propyl-, (5alpha,7alpha(R))-|6,14-endo-Ethenotetrahydrooripavine, 7-alpha-(1-hydroxy-1-methylbutyl)-|Ethorphine|Oripavine, 6,14-endo-ethylenetetrahydro-7-(1-hydroxy-1-methylbutyl)-|RefChem:139285|DTXCID601016711|tetrahydro-7alpha-(2-hydroxy-2-pentyl)-6,14-endo-ethenooripavine|tetrahydro-7alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine|(5ALPHA,7ALPHA(R))-4,5-EPOXY-3-HYDROXY-6-METHOXY-ALPHA,17-DIMETHYL-ALPHA-PROPYL-6,14-ETHENOMORPHINAN-7-METHANOL|238-535-9|2R-((4R,4aR,7R,7aR,12bS,14R)-7-methoxy-3-methyl-1,2,3,4,7,7a-hexahydro-4a,7-ethano-4,12-methano(1)benzofuro(3,2-e)isoquinolin-14-yl)pentan-2-ol|Etorfina [DCIT]|7alpha-Etorphine|DEA No. 9056|Etorphine (INN)|Etorphine (except hydrochloride salt)|ETORPHINE [INN]|Tetrahydro-7-alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine|6,7,8,14-Tetrahydro-7alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine|Etorphine [INN:BAN]|Etorphinum [INN-Latin]|UNII-42M2Y6NU9O|HSDB 7601|EINECS 238-535-9|ETORPHINE [MI]|ETORPHINE [HSDB]|M. 99 [as hydrochloride]|SCHEMBL20507|SCHEMBL140251|CHEMBL140050|6,7,8,14-Tetrahydro-7.alpha.-(1-hydroxy-1-methylbutyl)-6,14-endo-ethenooripavine|(5.ALPHA.,7.ALPHA.(R))-4,5-EPOXY-3-HYDROXY-6-METHOXY-.ALPHA.,17-DIMETHYL-.ALPHA.-PROPYL-6,14-ETHENOMORPHINAN-7-METHANOL|BDBM50123599|NS00068005|D07937|TETRAHYDRO-7.ALPHA.-(2-HYDROXY-2-PENTYL)-6,14-ENDO-ETHENOORIPAVINE|6,14-endo-Ethenotetrahydrooripavine, 7alpha-((R)-1-hydroxy-1-methylbutyl)- (8CI)|7.ALPHA.-(1(R)-HYDROXY-1-METHYLBUTYL)-6,14-ENDO-ETHENOTETRAHYDROORIPAVINE|Oripavine, 6,14-endo-ethylenetetrahydro-7-(1-hydroxy-1-methylbutyl)- (7CI)|TETRAHYDRO-7.ALPHA.-(1-HYDROXY-1-METHYLBUTYL)-6,14-ENDO-ETHENOORIPAVINE|(7R)-7-[(2R)-2-hydroxypentan-2-yl]-6-methoxy-17-methyl-5alpha-4,5-epoxy-6,14-ethenomorphinan-3-ol|6,14-ethenomorphinan-3-ol, 7,8-didehydro-4,5-epoxy-18,19-dihydro-18-[(1R)-1-hydroxy-1-methylbutyl]-6-methoxy-17-methyl-, (5alpha,6beta,14beta,18R)-|6,14-Ethenomorphinan-7-methanol, 4,5-epoxy-3-hydroxy-6-methoxy-alpha,17-dimethyl-a-propyl-, [5alpha,7alpha(R)]-|6,14-Ethenomorphinan-7-methanol, 4,5-epoxy-3-hydroxy-6-methoxy-alpha,17-dimethyl-alpha-propyl-, (alphaR,5alpha,7alpha)- (9CI)|7,8-DIHYDRO-7.ALPHA.-(1(R)-HYDROXY-1-METHYLBUTYL)-O SUP(6)-METHYL-6,14-ENDO-ETHENOMORPHINE"
BREMAZOCINE,443406,,"InChI=1S/C20H29NO2/c1-4-20-9-10-21(13-19(23)7-8-19)17(18(20,2)3)11-14-5-6-15(22)12-16(14)20/h5-6,12,17,22-23H,4,7-11,13H2,1-3H3/t17-,20+/m1/s1",ZDXGFIXMPOUDFF-XLIONFOSSA-N,C20H29NO2,315.4,"(1S,9R)-1-ethyl-10-[(1-hydroxycyclopropyl)methyl]-13,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol","Bremazocine|(-)-Bremazocine|75684-07-0|Bremazocine, (-)-|DTXSID001317125|2-(1-Hydroxy-cyclopropylmethyl)-5-ethyl-9,9-dimethyl-2'-hydroxy-6,7-benzomorphan|FDR3CJ69GC|CHEBI:3171|ISF76M2DBE|Bremazocina|2,6-Methano-3-benzazocin-8-ol, 6-ethyl-1,2,3,4,5,6-hexahydro-3-((1-hydroxycyclopropyl)methyl)-11,11-dimethyl-, (2R)-|bremazocinum|RefChem:905539|DTXCID401746942|(1S,9R)-1-ethyl-10-[(1-hydroxycyclopropyl)methyl]-13,13-dimethyl-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol|2,6-methano-3-benzazocin-8-ol, 6-ethyl-1,2,3,4,5,6-hexahydro-3-[(1-hydroxycyclopropyl)methyl]-11,11-dimethyl-, (2R,6S)-|SureCN157210|SCHEMBL157210|GTPL1603|orb1700959|83829-76-9|PDSP1_001586|PDSP2_001570|AKOS040748057|CS-0107342|Q27075484|(2R,6S)-6-Ethyl-1,2,3,4,5,6-hexahydro-3-[(1-hydroxycyclopropyl)methyl]-11,11-dimethyl-2,6-methano-3-benzazocin-8-ol|2,6-Methano-3-benzazocin-8-ol, 6-ethyl-1,2,3,4,5,6-hexahydro-3-((1-hydroxycyclopropyl)methyl)-11,11-dimethyl-,(2R)-|2,6-Methano-3-benzazocin-8-ol, 6-ethyl-1,2,3,4,5,6-hexahydro-3-[(1-hydroxycyclopropyl)methyl]-11,11-dimethyl-, (2R,6S)- (9CI)"
CARFENTANIL,62156,,"InChI=1S/C24H30N2O3/c1-3-22(27)26(21-12-8-5-9-13-21)24(23(28)29-2)15-18-25(19-16-24)17-14-20-10-6-4-7-11-20/h4-13H,3,14-19H2,1-2H3",YDSDEBIZUNNPOB-UHFFFAOYSA-N,C24H30N2O3,394.5,methyl 1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate,"CARFENTANIL|Carfentanyl|Wildnil|59708-52-0|Carfentanilum|Carfentanila|carfentanilo|4-carbomethoxyfentanyl|CHEBI:61084|Methyl 1-phenylethyl-4-(N-phenylpropionamido)isonipecotate|LA9DTA2L8F|(4-carbomethoxy fentanyl)|Methyl 4-(N-(1-oxopropyl)-N-phenylamino)-1-(2-phenylethyl)-4-piperidinecarboxylate|Methyl 4-(N-propionyl-N-phenylamino)-1-(2-phenylethyl)-4-piperidine-carboxylate|4-((1-Oxopropyl)phenylamino)-1-(2-phenylethyl)-4-piperidinecarboxylic acid methyl ester|R 31833|(4-methoxycarbonyl)fentanyl|DTXSID40208427|R-31833|R31833|methyl 1-(2-phenylethyl)-4-(phenyl-propanoylamino)piperidine-4-carboxylate|methyl 1-(2-phenylethyl)-4-[phenyl(propionyl)amino]piperidine-4-carboxylate|methyl 1-(2-phenylethyl)-4-(phenyl(propionyl)amino)piperidine-4-carboxylate|RefChem:5652|4-methoxycarbonylfentanyl|4-methoxycarbonyl fentanyl|DTXCID60130918|878-302-4|Carfentanil [INN]|CHEMBL290429|Carfentanil (INN)|Methyl 1-phenethyl-4-(N-phenylpropionamido)isonipecotate|methyl 1-(2-phenylethyl)-4-(N-propanoylanilino)piperidine-4-carboxylate|Carfentanila [Spanish]|Carfentanil (1.0mg/ml in Methanol)|Carfentanil (1mg/ml in Acetonitrile)|Carfentanilum [INN-Latin]|Carfentanila [INN-Spanish]|Carfentanil (0.1mg/mL in Acetonitrile)|UNII-LA9DTA2L8F|BRN 0456976|DEA No. 9743|4-Piperidinecarboxylic acid, 4-[(1-oxopropyl)phenylamino]-1-(2-phenylethyl)-, methyl ester; Carfentanil; Carfentanyl; R 31833|Epitope ID:153509|4-Piperidinecarboxylic acid, 4((1-oxopropyl)phenylamino)-1-(2-phenylethyl)-, methyl ester|SCHEMBL116222|GTPL10040|HSDB 8376|BDBM50012477|AKOS005067304|DB01535|NS00010361|D07620|Q423386|methyl 1-(2-phenylethyl)-4-(N-phenylpropanamido)piperidine-4-carboxylate|Methyl 1-(2-phenylethyl)-4-(propionylanilino)-4-piperidinecarboxylate #|1-Phenethyl-4-(phenyl-propionyl-amino)-piperidine-4-carboxylic acid methyl ester|Carfentanil1-Phenethyl-4-(phenyl-propionyl-amino)-piperidine-4-carboxylic acid methyl ester|1-Phenethyl-4-(phenyl-propionyl-amino)-piperidine-4-carboxylic acid methyl ester(Carefentanil)|4-PIPERIDINECARBOXYLIC ACID, 4-((1-OXOPROPYL)PHENYLAMINO)-1-(2-PHENYLETHYL)-, METHYL ESTER|84K"
OXYMORPHONE,5284604,,"InChI=1S/C17H19NO4/c1-18-7-6-16-13-9-2-3-10(19)14(13)22-15(16)11(20)4-5-17(16,21)12(18)8-9/h2-3,12,15,19,21H,4-8H2,1H3/t12-,15+,16+,17-/m1/s1",UQCNKQCJZOAFTQ-ISWURRPUSA-N,C17H19NO4,301.34,"(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","oxymorphone|76-41-5|Oximorphonum|14-Hydroxydihydromorphinone|Dihydroxymorphinone|Dihydrohydroxymorphinone|Oximorfona|7,8-Dihydro-14-hydroxymorphinone|Oxymorphonum|Oxymorphone cii|Dihydro-14-hydroxymorphinone|(14S)-14-Hydroxydihydromorphinone|(-)-Oxymorphone|Morphinone, dihydro-14-hydroxy-|NSC-19045|9VXA968E0C|IDS-NO-003|NIH 10323|DTXSID5023409|NSC19045|Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-methyl-, (5alpha)-|MORPHINAN-6-ONE, 4,5-EPOXY-3,14-DIHYDROXY-17-METHYL-|Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-methyl-, (5-alpha)-|(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one|oximorfone|(1S,5R,13R,17S)-10,17-dihydroxy-4-methyl-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7(18),8,10-trien-14-one|(1S,5R,13R,17S)-10,17-dihydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one|(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinolin-7-one|(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinoline-7-one|(4R,4aS,7aR,12bS)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one|RefChem:55796|DTXCID703409|4,5alpha-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one|(1S,5R,13R,17S)-10,17-dihydroxy-4-methyl-12-oxa-4-azapentacyclo(9.6.1.01,13.05,17.07,18)octadeca-7(18),8,10-trien-14-one|200-959-7|Numorphan|Opana|Oxymorphine|Numorphone|CHEMBL963|CHEBI:7865|NIH10323|Oxymorphone (INN)|3,14-Dihydroxy-4,5-alpha-epoxy-17-methylmorphinan-6-one|OXYMORPHONE [INN]|Ossimorfone|Morphinan-6-one, 3,14-dihydroxy-4,5-alpha-epoxy-17-methyl-|NSC 19045|Oxymorphone (1.0 mg/mL in Methanol)|Ossimorfone [DCIT]|Oxymorphone [INN:BAN]|Oximorfona [INN-Spanish]|Oxymorphonum [INN-Latin]|UNII-9VXA968E0C|HSDB 8060|EINECS 200-959-7|EN3202|BRN 0041588|OXYMORPHONE [MI]|OXYMORPHONE [VANDF]|SCHEMBL3571|4,5.alpha.-Epoxy-3,14-dihydroxy-17-methylmorphinan-6-one|OXYMORPHONE [WHO-DD]|GTPL7094|DEA No. 9652|SCHEMBL29633247|Oxymorphone, 1mg/ml in Methanol|OXYMORPHONE CII [USP-RS]|HY-B0618|Oxymorphone 0.1 mg/ml in Methanol|Oxymorphone 1.0 mg/ml in Methanol|BDBM50001707|AKOS015962232|DB01192|Oxycodone hydrochloride impurity, oxymorphone-|C08019|D08323|Q423380|4,5-Epoxy-3,14-dihydroxy-N-methyl-6-oxomorphinan|Morphinone, 7,8-dihydro-14-hydroxy- (6CI,7CI)|OXYCODONE HYDROCHLORIDE IMPURITY A [EP IMPURITY]|4,5alpha-Epoxy-3,14-dihydroxy-17-methyl morphinan-6-one|Morphinan-6-one,5.alpha.-epoxy-3,14-dihydroxy-17-methyl-|(5alpha)-3,14-dihydroxy-17-methyl-4,5-epoxymorphinan-6-one|(5alpha)-4,5-Epoxy-3,14-dihydroxyl-17-methylmorphinan-6-one|Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy-17-methyl-|Morphinan-6-one, 4,5alpha-epoxy-3,14-dihydroxy-17-methyl- (8CI)|Morphinan-6-one,5-epoxy-3,14-dihydroxy-17-methyl-, (5.alpha.)-|OXYCODONE HYDROCHLORIDE IMPURITY, OXYMORPHONE- [USP IMPURITY]|Morphinan-6-one, 4,5-epoxy-3,14-dihydroxy-17-methyl-, (5alpha)- (9CI)|10,17-dihydroxy-4-methyl-(13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one|10,17-dihydroxy-4-methyl-(13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(oxymorphone)|10,17-dihydroxy-4-methyl-(13R,17S)-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7(18),8,10-trien-14-one(xymorphone)|10,17-dihydroxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.01,13.05,17.07,18]octadeca-7,9,11(18)-trien-14-one"
SAMIDORPHAN,11667832,,"InChI=1S/C21H26N2O4/c22-19(26)15-4-3-13-9-16-21(27)6-5-14(24)10-20(21,17(13)18(15)25)7-8-23(16)11-12-1-2-12/h3-4,12,16,25,27H,1-2,5-11H2,(H2,22,26)/t16-,20-,21-/m1/s1",RYIDHLJADOKWFM-MAODMQOUSA-N,C21H26N2O4,370.4,"(1R,9R,10S)-17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide","SAMIDORPHAN|852626-89-2|ALKS 33|ALKS-33|samidorfano|RDC-0313-00|7W2581Z5L8|RDC-0313|ALKS-5461 COMPONENT SAMIDORPHAN|DTXSID401030402|(1R,9R,10S)-17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide|samidorphanum|(1R,9R,10S)-17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo(7.5.3.01,10.02,7)heptadeca-2(7),3,5-triene-4-carboxamide|RefChem:181100|DTXCID901515493|(1R,9R,10S)-17-(cyclopropylmethyl)-3,10-dihydroxy-13-oxo-17-azatetracyclo(7.5.3.0^(1,10).0^(2,7))heptadeca-2(7),3,5-triene-4-carboxamide|Samidorphan [USAN:INN]|ALKS33|Samidorphan [USAN]|UNII-7W2581Z5L8|Morphinan-3-carboxamide, 17-(cyclopropylmethyl)-4,14-dihydroxy-6-oxo-|RDC 0313|CHEMBL426084|17-(Cyclopropylmethyl)-4,14-dihydroxy-6-oxomorphinan-3-carboxamide|Samidorphan (USAN)|CHEMBL471243|(4bR,8aS,9R)-11-(cyclopropylmethyl)-4,8a-dihydroxy-6-oxo-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthrene-3-carboxamide|CCDC 710249, HCl salt|SAMIDORPHAN [INN]|SAMIDORPHAN [WHO-DD]|SCHEMBL2786239|SCHEMBL29356766|GTPL10651|CHEBI:177605|RYIDHLJADOKWFM-MAODMQOUSA-N|GLXC-10012|Lybalvi (olanzapine + samidorphan)|ARD193601|BDBM50165049|BDBM50278265|compound 5 [PMID:15808478]|DB12543|DA-77666|HY-123689|CS-0084345|NS00071817|D10162|Q7409428|17-cyclopropylmethyl-3,10-dihydroxy-13-oxo-(1R,9R,10S)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4-carboxamide"
NALBUPHINE,5311304,,"InChI=1S/C21H27NO4/c23-14-5-4-13-10-16-21(25)7-6-15(24)19-20(21,17(13)18(14)26-19)8-9-22(16)11-12-2-1-3-12/h4-5,12,15-16,19,23-25H,1-3,6-11H2/t15-,16+,19-,20-,21+/m0/s1",NETZHAKZCGBWSS-CEDHKZHLSA-N,C21H27NO4,357.4,"(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol","nalbuphine|20594-83-6|Nalbufina|Nalbuphinum|Intapan|L2T84IQI2K|CHEBI:7454|N-Cyclobutylmethyl-4,5alpha-epoxy-3,6alpha,14-morphinantriol|DTXSID8023345|DTXCID103345|(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,7,9-triol|17-(Cyclobutylmethyl)-4,5alpha-epoxymorphinan-3,6alpha,14-triol|Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, (5alpha,6alpha)-|(1S,5R,13R,14S,17S)-4-(cyclobutylmethyl)-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7,9,11(18)-triene-10,14,17-triol|(1S,5R,13R,14S,17S)-4-(cyclobutylmethyl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18)-triene-10,14,17-triol|(4R,4aS,7S,7aR,12bS)-3-(cyclobutylmethyl)-1,2,4,5,6,7,7a,13-octahydro-4,12-methanobenzofuro(3,2-e)isoquinoline-4a,7,9-triol|RefChem:57230|(1S,5R,13R,14S,17S)-4-(cyclobutylmethyl)-12-oxa-4-azapentacyclo(9.6.1.01,13.05,17.07,18)octadeca-7,9,11(18)-triene-10,14,17-triol|243-901-6|Nalbuphine (INN)|Nubain|CHEMBL895|17-cyclobutylmethyl-4,5alpha-epoxymorphinan-3,6alpha,14-triol|NALBUPHINE [INN]|Nalbuphine (1.0mg/ml in Acetonitrile)|Intapan (TN)|Nalbufina [DCIT]|Nalbuphine [INN:BAN]|Nalbuphinum [INN-Latin]|UNII-L2T84IQI2K|NCGC00162275-02|EINECS 243-901-6|NALBUPHINE [MI]|Prestwick0_000118|Prestwick1_000118|Prestwick2_000118|Prestwick3_000118|NALBUPHINE [VANDF]|SCHEMBL3766|NALBUPHINE [WHO-DD]|BSPBio_000136|BIDD:GT0060|SPBio_002075|BPBio1_000150|GTPL1663|SCHEMBL29389768|HMS2089I04|Tox21_112008|BDBM50105085|(5alpha,6alpha)-17-(cyclobutylmethyl)-4,5-epoxymorphinan-3,6,14-triol|DB00844|NCGC00179652-02|NCGC00179652-04|CAS-20594-83-6|NS00008318|C07251|D08246|EN300-19631168|Q277979|BRD-K66404838-003-03-8|BRD-K66404838-310-01-1|Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-|(-)-17-(cyclobutylmethyl)-4,5alpha-epoxymorphinan-3,6alpha,14-triol|17-(CYCLOBUTYLMETHYL)-4,5.ALPHA.-EPOXYMORPHINAN-3,6.ALPHA.,14-TRIOL|(1S,5R,13R,14S,17S)-4-(cyclobutylmethyl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,14,17-triol|Morphinan-3,6,14-triol, 17-(cyclobutylmethyl)-4,5-epoxy-, (5alpha,6alpha)- (9CI); Morphinan-3,6alpha,14-triol, 17-(cyclobutylmethyl)-4,5alpha-epoxy- (8CI); N-Cyclobutylmethyl-14-hydroxydihydronormorphine; Nalbuphine"
BUPRENORPHINE,644073,,"InChI=1S/C29H41NO4/c1-25(2,3)26(4,32)20-15-27-10-11-29(20,33-5)24-28(27)12-13-30(16-17-6-7-17)21(27)14-18-8-9-19(31)23(34-24)22(18)28/h8-9,17,20-21,24,31-32H,6-7,10-16H2,1-5H3/t20-,21-,24-,26+,27-,28+,29-/m1/s1",RMRJXGBAOAMLHD-IHFGGWKQSA-N,C29H41NO4,467.6,"(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol","buprenorphine|Temgesic|Buprenophine|Buprenorfina|Buprenorphinum|52485-79-7|Butrans|(-)-buprenorphine|buprenorphin|Sublocade|Brixadi|CHEBI:3216|40D3SCR4GZ|CAM2038|DTXSID2022705|Transtec|17-cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6-methoxy-6,14-endo-ethanomorphinan-3-ol|2-(N-cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-6alpha-yl)-3,3-dimethyl-2-butanol|21-cyclopropyl-7alpha-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine|ALKS-5461 COMPONENT BUPRENORPHINE|(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol|2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-3,3-dimethyl-2-butanol|6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5-alpha,7-alpha-(S))-|Hapoctasin|Bupeaze|Buplast|Panitaz|Prenotrix|Reletrans|Sevodyne|Tephine|Zorbium|Butec|(1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-((2S)-2-hydroxy-3,3-dimethylbutan-2-yl)-15-methoxy-13-oxa-3-azahexacyclo(13.2.2.1^(2,8).0^(1,6).0^(6,14).0^(7,12))icosa-7(12),8,10-trien-11-ol|(1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-((2S)-2-hydroxy-3,3-dimethylbutan-2-yl)-15-methoxy-13-oxa-3-azahexacyclo(13.2.2.1^(2,8).0^(1,6).0^(6,14).0^(7,12))icosa-7,9,11-trien-11-ol|(1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.1^{2,8}.0^{1,6}.0^{6,14}.0^{7,12}]icosa-7(12),8,10-trien-11-ol|(1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.1^{2,8}.0^{1,6}.0^{6,14}.0^{7,12}]icosa-7,9,11-trien-11-ol|(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-((2S)-2-hydroxy-3,3-dimethylbutan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo(13.2.2.12,8.01,6.02,14.012,20)icosa-8(20),9,11-trien-11-ol|2-(3-cyclopropylmethyl-11-hydroxy-15-methoxy-(14R)-13-oxa-3-azahexacyclo(13.2.2.12,8.01,6.06,14.07,12)icosa-7,9,11-trien-16-yl)-3,3-dimethyl-2-butanol|21-cyclopropyl-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl)-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine|RX-6029-M|RefChem:5623|buprenorphine transdermal system|DTXCID602705|N02AE01|N07BC01|RX6029M|RX 6029 M|6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (5alpha,7alpha(S))-|6029M|6029 M|(1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-((2S)-2-hydroxy-3,3-dimethylbutan-2-yl)-15-methoxy-13-oxa-3-azahexacyclo(13.2.2.12,8.01,6.06,14.07,12)icosa-7,9,11-trien-11-ol|257-950-6|Buprenex|Buprenorfina [INN-Spanish]|Buprenorphinum [INN-Latin]|DEA No. 9064|RX 6029M|Probuphenine|Buprenorphine (1.0mg/ml in Methanol)|Buprenorphine (1mg/ml in Acetonitrile)|Temgesic (TN)|Buprenorphine (JAN/INN)|CHEMBL560511|UNII-40D3SCR4GZ|Buvidal|Buprenorphine [INN:BAN:JAN]|6029-M|EINECS 257-950-6|BEMA|[5alpha,7alpha(S)]-|BUPRENORPHINE [MI]|BUPRENORPHINE [INN]|BUPRENORPHINE [JAN]|SCHEMBL15821|BUPRENORPHINE [VANDF]|17-Cyclopropylmethyl-4,5alpha-epoxy-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl-6-methoxy-6,14-endo-ethanomorphinan-3-ol|2-(N-Cyclopropylmethyl-4,5alpha-epoxy-3-hydroxy-6-methoxy-6,14-endo-ethanomorphinan-7alpha-yl)-3,3-dimethyl-2-butanol|21-(Cyclopropyl-7alpha-((S)-1-hydroxy-1,2,2-trimethylpropyl-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine|BUPRENORPHINE [MART.]|BUPRENORPHINE [WHO-DD]|GTPL1670|BUPRENORPHINE [EMA EPAR]|BUPRENORPHINE [EP IMPURITY]|BUPRENORPHINE [ORANGE BOOK]|Sixmo (buprenorphine hydrochloride)|RBP-6000|BUPRENORPHINE [EP MONOGRAPH]|BDBM50026603|Buprenorphine 0.1 mg/ml in Methanol|Buprenorphine 1.0 mg/ml in Methanol|DB00921|(5alpha,6beta,14beta,18R)-17-(cyclopropylmethyl)-18-[(2S)-2-hydroxy-3,3-dimethylbutan-2-yl]-6-methoxy-18,19-dihydro-4,5-epoxy-6,14-ethenomorphinan-3-ol|[5alpha,7alpha(S)]-17-(Cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-6,14-ethenomorphinan-7-methanol|21-cyclopropyl-7alpha-(2-hydroxy-3,3-dimethyl-2-butyl)-6,14-endo-ethano-6,7,8,14-tetrahydrooripavine|6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-.alpha.-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-.alpha.-methyl-, (.alpha.S,5.alpha.,7.alpha.)-|C08007|D07132|Q407721|SA1 - Drugs for the Treatment of substance related disorders 1|(2S)-2-[(5R,6R,7R,14S)-9alpha-Cyclopropylmethyl-3-hydroxy-6-methoxy-4,5-epoxy-6,14-ethanomorphinan-7-yl]-3,3-dimethylbutan-2-ol|[5?,7?(S)]-17-(Cyclopropylmethyl)-?-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-?-methyl-6,14-ethenomorphinan-7-methanol;|6,14-ethenomorphinan-3-ol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-7-[(1S)-1-hydroxy-1,2,2-trimethylpropyl]-6-methoxy-, (5alpha,7alpha)-|6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-,|6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-alpha-(1,1-dimethylethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha-methyl-, (alphaS,5alpha,7alpha)- (9CI)"
BUTORPHANOL,5361092,,"InChI=1S/C21H29NO2/c23-17-7-6-16-12-19-21(24)9-2-1-8-20(21,18(16)13-17)10-11-22(19)14-15-4-3-5-15/h6-7,13,15,19,23-24H,1-5,8-12,14H2/t19-,20+,21-/m1/s1",IFKLAQQSCNILHL-QHAWAJNXSA-N,C21H29NO2,327.5,"(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol","butorphanol|Butorfanol|(-)-butorphanol|42408-82-2|levo-BC-2627|Butorphanolum|(-)-17-(Cyclobutylmethyl)morphinan-3,14-diol|Morphinan-3,14-diol, 17-(cyclobutylmethyl)-|(-)-N-cyclobutylmethyl-3,14-dihydroxymorphinan|CHEBI:3242|QV897JC36D|DTXSID1022714|(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene-4,10-diol|butorfanolo|(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo(7.5.3.0^(1,10).0^(2,7))heptadeca-2(7),3,5-triene-4,10-diol|(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo(7.5.3.01,10.02,7)heptadeca-2(7),3,5-triene-4,10-diol|(1S,9R,10S)-17-(cyclobutylmethyl)-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-triene-4,10-diol|BC 2627|RefChem:56687|DTXCID502714|N02AF01|BC2627|255-808-8|17-(CYCLOBUTYLMETHYL)MORPHINAN-3,14-DIOL|Butorphanol (free base)|Butorfanol [INN-Spanish]|Butorphanolum [INN-Latin]|CHEMBL33986|l-BC 2627|DEA No. 9720|Beforal|EINECS 255-808-8|Butorphanol (USAN/INN)|UNII-QV897JC36D|Butorphanol [USAN:INN:BAN]|BUTORPHANOL [MI]|BUTORPHANOL [INN]|BUTORPHANOL [USAN]|BUTORPHANOL [VANDF]|SCHEMBL3749|BUTORPHANOL [WHO-DD]|BIDD:GT0549|GTPL7591|SCHEMBL29359664|42408-82-2 (free base)|BDBM50240437|N-cyclobutylmethyl-3,14-dihydroxymorphinan|DB-326245|NS00010339|L-N-Cyclobutylmethyl-3,14-dihydroxymorphinan|C06863|D03197|D-N-CYCLOBUTYLMETHYL-3,14-DIHYDROXYMORPHINAN|Q1185089|BRD-K42417338-045-01-9|(4bS,8aS,9R)-11-(cyclobutylmethyl)-5,6,7,8,9,10-hexahydro-8aH-9,4b-(epiminoethano)phenanthrene-3,8a-diol|58115-67-6"
NALMEFENE,5284594,,"InChI=1S/C21H25NO3/c1-12-6-7-21(24)16-10-14-4-5-15(23)18-17(14)20(21,19(12)25-18)8-9-22(16)11-13-2-3-13/h4-5,13,16,19,23-24H,1-3,6-11H2/t16-,19+,20+,21-/m1/s1",WJBLNOPPDWQMCH-MBPVOVBZSA-N,C21H25NO3,339.4,"(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol","nalmefene|55096-26-9|Nalmetrene|Nalmefeno|ORF-11676|Nalmefenum|ORF 11676|TOV02TDP9I|SRD174|DTXSID8023347|JKB-121|SRD-174|ORF 1167|ORF-1167|(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinon-3,14-diol|DTXCID903347|(1S,5R,13S,17S)-4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7,9,11(18)-triene-10,17-diol|(1S,5R,13S,17S)-4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7,9,11(18)-triene-10,17-diol|RefChem:57225|JF-1|Selincro|Nalmetrenum|Nalmetreno|CHEMBL982|17-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylenemorphinan-3,14-diol|MLS000069366|CHEBI:7457|NCGC00021666-03|SMR000058884|Selincro (TN)|JF 1|Nalmefenum [INN-Latin]|Nalmefeno [INN-Spanish]|Nalmetrenum [INN-Latin]|Nalmetreno [INN-Spanish]|Alcofene|Arthene|Cervene|Incystene|Soberal|Cessal|(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylene-1,2,3,4,5,6,7,7a-octahydro-4aH-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol|(4R,4aS,7aS,12bS)-3-(cyclopropylmethyl)-7-methylidene-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-4a,9-diol|CAS-55096-26-9|HSDB 6761|Nalmefene (USAN/INN)|UNII-TOV02TDP9I|Nalmefene [USAN:INN:BAN]|(5a)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol;|9a-(Cyclopropylmethyl)-4,5alpha-epoxy-6-methylen-3,14-morphinandiol|NIH-10365|NALMEFENE [INN]|Opera_ID_468|NALMEFENE [MI]|NALMEFENE [HSDB]|NALMEFENE [USAN]|NALMEFENE [VANDF]|NALMEFENE [MART.]|NALMEFENE [WHO-DD]|SCHEMBL35230|GTPL1628|orb2565730|Revex (nalmefene hydrochloride)|SCHEMBL29373615|cid_5284594|Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, (5.alpha.)-|HMS2232D07|BCP16723|Tox21_110873|BDBM50045776|MFCD00133650|MSK159678|PDSP2_001543|(5alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-6-methylenemorphinan-3,14-diol|(5alpha)-17-(cyclopropylmethyl)-6-methylidene-4,5-epoxymorphinan-3,14-diol|Tox21_110873_1|BN36715|DB06230|Morphinan-3,14-diol, 17-(cyclopropylmethyl)-4,5-epoxy-6-methylene-, (5alpha)-|NCGC00021666-04|DA-65915|HY-107744|Opvee (nalmefene hydrochloride nasal spray)|CS-0029442|NS00068285|C08027|D05111|AB00384250_10|096N269|EN300-18384909|Q4353252|(1S,5R,13S,17S)-4-(cyclopropylmethyl)-14-methylidene-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-triene-10,17-diol"
NALORPHINE,5284595,,"InChI=1S/C19H21NO3/c1-2-8-20-9-7-19-12-4-6-15(22)18(19)23-17-14(21)5-3-11(16(17)19)10-13(12)20/h2-6,12-13,15,18,21-22H,1,7-10H2/t12-,13+,15-,18-,19-/m0/s1",UIQMVEYFGZJHCZ-SSTWWWIQSA-N,C19H21NO3,311.4,"(4R,4aR,7S,7aR,12bS)-3-prop-2-enyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol","Nalorphine|Nalorfina|N-Allylnormorphine|62-67-9|Nalorphinum|Allylnormorphine|Nalorphine serb|Normorphine, N-allyl-|N-Allyl-N-desmethylmorphine|U59WB2WRY2|NANM|N-Allyl-7,8-dehydro-4,5-epoxy-3,6-dihydroxymorphinan|DTXSID3023348|Morphinan-3,6-alpha-diol, 17-allyl-7,8-didehydro-4,5-alpha-epoxy-|Morphinan-3,6-diol, 7,8-didehydro-4,5-epoxy-17-(2-propenyl)-, (5alpha,6alpha)-|(-)-Nalorphine|(1S,5R,13R,14S,17R)-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7(18),8,10,15-tetraene-10,14-diol|(1S,5R,13R,14S,17R)-4-(prop-2-en-1-yl)-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10,15-tetraene-10,14-diol|(4R,4aR,7S,7aR,12bS)-3-allyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinoline-7,9-diol|(4R,4aR,7S,7aR,12bS)-3-allyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol|(4R,4aR,7S,7aR,12bS)-3-prop-2-enyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinoline-7,9-diol|(4R,4aR,7S,7aR,12bS)-3-prop-2-enyl-2,4,4a,7,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7,9-diol|Hydrobromide, Nalorphine|Hydrochloride, Nalorphine|RefChem:164455|DTXCID303348|V03AB02|200-546-1|Allorphine|Nalorphinium|Anthorphine|Antorfin|Antorphin|Antorphine|Nalorphin|Anarcon|Nallin|Norfin|Acetorfin|CHEBI:7458|Nalorphine (INN)|DEA No. 9400|NALORPHINE [INN]|Acetorfin [Czech]|Nalorfina [DCIT]|Nalorphine [INN:BAN]|Nalorphinum [INN-Latin]|HSDB 3278|NCGC00168255-01|EINECS 200-546-1|UNII-U59WB2WRY2|N-allyl-normorphine|Nalorphine serb (TN)|NALORPHINE [MI]|7,8-Didehydro-4,5-epoxy-17-(2-propenyl)morphinan-3,6-diol|NALORPHINE [HSDB]|NALORPHINE [MART.]|NALORPHINE [WHO-DD]|SCHEMBL38920|CHEMBL415284|GTPL1629|BDBM50367061|PDSP2_001572|DB11490|NS00008614|D08247|Q2622916|(5alpha,6alpha)-17-prop-2-en-1-yl-7,8-didehydro-4,5-epoxymorphinan-3,6-diol|MORPHINAN-3,6-DIOL, 7,8-DIDEHYDRO-4,5-EPOXY-17-(2-PROPENYL)-(5.ALPHA.,6.ALPHA.)-"
JDTIC,9956146,,"InChI=1S/C28H39N3O3/c1-18(2)26(30-27(34)25-13-20-8-9-24(33)12-21(20)15-29-25)17-31-11-10-28(4,19(3)16-31)22-6-5-7-23(32)14-22/h5-9,12,14,18-19,25-26,29,32-33H,10-11,13,15-17H2,1-4H3,(H,30,34)/t19-,25+,26+,28+/m0/s1",ZLVXBBHTMQJRSX-VMGNSXQWSA-N,C28H39N3O3,465.6,"(3R)-7-hydroxy-N-[(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]-3-methylbutan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide","JDTic|361444-66-8|Rti-jdtic|3C6FZ6UXC8|(3R)-7-hydroxy-N-[(2S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]-3-methylbutan-2-yl]-1,2,3,4-tetrahydroisoquinoline-3-carboxamide|DTXSID70433301|compound 10 [PMID: 11495579]|(3R)-7-Hydroxy-N-((2S)-1-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)-3-methylbutan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide|3-Isoquinolinecarboxamide, 1,2,3,4-tetrahydro-7-hydroxy-N-((1S)-1-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-2-methylpropyl)-, (3R)-|compound 10 (PMID: 11495579)|(3r)-7-Hydroxy-N-{(2s)-1-[(3r,4r)-4-(3-Hydroxyphenyl)-3,4-Dimethylpiperidin-1-Yl]-3-Methylbutan-2-Yl}-1,2,3,4-Tetrahydroisoquinoline-3-Carboxamide|RefChem:150455|DTXCID90384129|CHEMBL415247|(R)-7-hydroxy-N-((S)-1-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)-3-methylbutan-2-yl)-1,2,3,4-tetrahydroisoquinoline-3-carboxamide|(3r)-7-hydroxy-n-((1s)-1-[[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide|(3R)-7-HYDROXY-N-((1S)-1-{[(3R,4R)-4-(3-HYDROXYPHENYL)-3,4-DIMETHYL-1-PIPERIDINYL]METHYL}-2-METHYLPROPYL)-1,2,3,4-TETRAHYDRO-3-ISOQUINOLINECARBOXAMIDE|(3R)-7-Hydroxy-N-[(1S)-1-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl)-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide|(3r)-7-hydroxy-n-[(1s)-1-{[(3r,4r)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl}-2-methylpropyl]-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide|JDC|CS-0537|UNII-3C6FZ6UXC8|GTPL7362|SCHEMBL3894627|SCHEMBL29484941|SCHEMBL30007617|ZLVXBBHTMQJRSX-VMGNSXQWSA-N|7-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid {1-[4-(3-hydroxy-phenyl)-3,4-dimethyl-piperidin-1-ylmethyl]-2-methyl-propyl}-amide|EX-A3812|BDBM50130563|AKOS027263824|NCGC00378654-01|HY-10486|Q909405|BRD-K95837862-300-01-7|atrans-(3R,4R)-dimethyl-4-(3-hydroxyphenyl) piperidine|(3R)-7-hydroxy-N-(1S)-1-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl-2-methylpropyl-1,2,3,4-tetrahydro-3-isoquinolinecarboxamide|7-Hydroxy-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid {(S)-1-[(3R,4R)-4-(3-hydroxy-phenyl)-3,4-dimethyl-piperidin-1-ylmethyl]-2-methyl-propyl}-amide"
DIPRENORPHINE,443408,,"InChI=1S/C26H35NO4/c1-23(2,29)18-13-24-8-9-26(18,30-3)22-25(24)10-11-27(14-15-4-5-15)19(24)12-16-6-7-17(28)21(31-22)20(16)25/h6-7,15,18-19,22,28-29H,4-5,8-14H2,1-3H3/t18-,19-,22-,24-,25+,26-/m1/s1",OIJXLIIMXHRJJH-KNLIIKEYSA-N,C26H35NO4,425.6,"(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol","Diprenorphine|14357-78-9|Diprenorfina|Diprenorfin|Diprenorphinum|Revivon|M50-50 Injection|1F0L5N25ZZ|M. 5050|M5050|DTXSID00903941|M-5050|(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol|6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)-|(1S,2S,6R,14R,15R,16R)-5-(cyclopropylmethyl)-16-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-5-azahexacyclo(13.2.2.12,8.01,6.02,14.012,20)icosa-8(20),9,11-trien-11-ol|RefChem:388941|DTXCID101331891|(1S,2R,6S,14R,15R,16R)-3-(cyclopropylmethyl)-16-(2-hydroxypropan-2-yl)-15-methoxy-13-oxa-3-azahexacyclo(13.2.2.12,?.01,?.0?,1?.0?,12)icosa-7,9,11-trien-11-ol|238-325-7|DEA No. 9058|CHEBI:4650|CHEMBL281786|RX 5050M|Diprenorphine (INN)|Diprenorphine [INN:BAN]|DIPRENORPHINE [INN]|Diprenorfina [INN-Spanish]|21-Cyclopropyl-6,7,8,14-tetrahydro-7alpha-(1-hydroxy-1-methylethyl)-6,14-endo-ethanooripavine|Diprenorphinum [INN-Latin]|UNII-1F0L5N25ZZ|EINECS 238-325-7|Diprenorphine; M 5050; M 5050 Injection|M 5050 Injection|DIPRENORPHINE-HCl|DIPRENORPHINE [MI]|M50-50|SCHEMBL164910|GTPL1617|SCHEMBL29631595|BDBM50001714|AKOS024457358|DB01548|FD03511|6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-.alpha.,.alpha.-dimethyl-, (5.alpha.,7.alpha.)-|DA-52578|HY-107742|NS00069824|D07863|M 5050|Q424009|epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)-|(5alpha,7alpha)-17-(Cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-6,14-ethenomorphinan-7-methanol|2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(1S,2R,6S,14R,15R,16R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-2-propanol|2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-(1S,2R,6S,14R,15R,16R)-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7,9,11-trien-16-yl]-2-propanol(diprenorphine)|2-[3-cyclopropylmethyl-11-hydroxy-15-methoxy-13-oxa-3-azahexacyclo[13.2.2.12,8.01,6.06,14.07,12]icosa-7(12),8,10-trien-16-yl]-2-propanol|6,14-endo-Ethanotetrahydrooripavine, 21-cyclopropyl-7a-(1-hydroxy-1-methylethyl)- (8CI) 1-N-Cyclopropylmethyl-6,7,8,14-tetrahydro-6,14-endoethano-7-(2'-hydroxy-2'-propyl)nororipavine|6,14-ethenomorphinan-3-ol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-18-(1-hydroxy-1-methylethyl)-6-methoxy-, (5alpha,6beta,14beta,18R)-|6,14-Ethenomorphinan-7-methanol, 17-(cyclopropylmethyl)-4,5-epoxy-18,19-dihydro-3-hydroxy-6-methoxy-alpha,alpha-dimethyl-, (5alpha,7alpha)- (9CI)"
METHYLNALTREXONE BROMIDE,5361917,,"InChI=1S/C21H25NO4.BrH/c1-22(11-12-2-3-12)9-8-20-17-13-4-5-14(23)18(17)26-19(20)15(24)6-7-21(20,25)16(22)10-13;/h4-5,12,16,19,25H,2-3,6-11H2,1H3;1H/t16-,19+,20+,21-,22?;/m1./s1",IFGIYSGOEZJNBE-KNLJMPJLSA-N,C21H26BrNO4,436.3,"(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one;bromide","Methylnaltrexone bromide|Naltrexone methobromide|Relistor|N-Methylnaltrexone Bromide|MRZ-2663BR|MOA-728|bromuro de metilnaltrexona|bromure de methylnaltrexone|MRZ2663BR|MOA728|DTXSID30868236|NALTREXONE METHYLBROMIDE|methylnaltrexoni bromidum|RefChem:56830|A06AH01|DTXCID40820845|morphinan-17-ium-6-one, 17-(cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-methyl-, bromide, (5alpha,17R)-|916055-92-0|RFO6IL3D3M|73232-52-7|Methylnaltrexone (Bromide)|MRZ 2663BR|N-Methyl Naltrexone Bromide|Relistor (TN)|(4R,4aS,7aR,12bS)-3-(cyclopropylmethyl)-4a,9-dihydroxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-3-ium-7-one;bromide|Naltrexone Methyl Bromide|N-Cyclopropylmethyl-noroxymorphone Methobromide|17-Methylnaltrexone Bromide|Methylnaltrexone (Bromide)?|MNTX-302|orb1306368|SCHEMBL2798188|CHEMBL1201770|IFGIYSGOEZJNBE-KNLJMPJLSA-N|ONO-3849|Methylnaltrexone bromide (JAN/USAN)|MFCD06407831|AKOS015896214|CS-0762|FM25532|AC-32482|HY-75766|TS-08151|Methylnaltrexone bromide, >=97% (HPLC)|NS00078680|D06618|Methylnaltrexone bromide, United States Pharmacopeia (USP) Reference Standard|(5a)-17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxy-17-methyl-6-oxomorphinanium bromide;Methylnaltrexone;Methylnaltrexone bromide"
PICTILISIB,17755052,,"InChI=1S/C23H27N7O3S2/c1-35(31,32)30-7-5-28(6-8-30)15-16-13-20-21(34-16)23(29-9-11-33-12-10-29)26-22(25-20)17-3-2-4-19-18(17)14-24-27-19/h2-4,13-14H,5-12,15H2,1H3,(H,24,27)",LHNIIDJUOCFXAP-UHFFFAOYSA-N,C23H27N7O3S2,513.6,"4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine","957054-30-7|GDC-0941|PICTILISIB|Pictrelisib|GDC0941|GDC 0941|4-(2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine|ICY00EMP8P|CHEBI:65326|CDC-0941|4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine|Thieno[3,2-d]pyrimidine, 2-(1H-indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)-|DTXSID40241930|2-(1H-indazol-4-yl)-6-((4-(methanesulfonyl)piperazin-1-yl)methyl)-4-(morpholin-4-yl)thieno(3,2-d)pyrimidine|4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno(3,2-d)pyrimidin-4-yl)morpholine|2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-(morpholin-4-yl)thieno[3,2-d]pyrimidine|THIENO(3,2-D)PYRIMIDINE, 2-(1H-INDAZOL-4-YL)-6-((4-(METHYLSULFONYL)-1-PIPERAZINYL)METHYL)-4-(4-MORPHOLINYL)-|Thieno(3,2-d)pyrimidine, 2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)-1-piperazinyl]methyl)-4-(4-morpholinyl)-|pictilisibum|2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-(morpholin-4-yl)thieno(3,2-d)pyrimidine|4-(2-(1H-indazol-4-yl)-6-((4-methylsulfonylpiperazin-1-yl)methyl)thieno(3,2-d)pyrimidin-4-yl)morpholine|RefChem:929266|DTXCID70164421|2-(1H-Indazol-4-yl)-6-(4-methanesulfonylpiperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine|GDC-0941 (Pictilisib)|Pictilisib (GDC-0941)|C23H27N7O3S2|MFCD11616196|957054-30-7 (free base)|2-(1H-Indazol-4-yl)-6-[[4-(methylsulfonyl)-1-piperazinyl]methyl]-4-(4-morpholinyl)thieno[3,2-d]pyrimidine|957054-50-1|2-(1h-Indazol-4-Yl)-6-{[4-(Methylsulfonyl)piperazin-1-Yl]methyl}-4-Morpholin-4-Yl-Thieno[3,2-D]pyrimidine|GD9|RG-7321|Pictilisib [USAN:INN]|UNII-ICY00EMP8P|Kinome_3719|PICTILISIB [MI]|GDC0941(Pictilisib)|PICTILISIB [INN]|Pictilisib (USAN/INN)|PICTILISIB [USAN]|GDC0941(Pictilisib)?|PICTILISIB [WHO-DD]|MLS006010057|SCHEMBL190812|CHEMBL521851|GTPL5682|orb1306809|SCHEMBL14859338|SCHEMBL29375636|SCHEMBL29387739|BDBM25028|EX-A167|LHNIIDJUOCFXAP-UHFFFAOYSA-N|HMS2043A16|HMS3244H06|HMS3244H10|HMS3244H14|HMS3265I05|HMS3265I06|HMS3265J05|HMS3265J06|HMS3654K13|HMS3744A19|BCP01714|EX-A1536|GNE 0941|NSC755385|NSC800852|RG7321|s1065|AKOS015966503|BCP9000715|CCG-264801|CS-0081|DB11663|FI32904|NSC-755385|NSC-800852|SB19941|SDCCGSBI-0654334.P001|NCGC00187482-01|NCGC00187482-03|NCGC00187482-10|2-(1H-Indazol-4-yl)-6-(4-methanesulfonyl-piperazin-1-ylmethyl)-4-morpholin-4-yl-thieno[3,2-d]pyrimidine|AC-32623|AS-19377|HY-50094|SMR004701219|NS00071518|SW202556-4|D10189|054G307|A845396|Pictilisib (GDC0941, RG7321, GNE0941))|BRD-K52911425-001-02-3|BRD-K52911425-001-09-8|Q27088388|2-(1H-Indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)-4-morpholinothieno[3,2-d]pyrimidine;Pictilisib|2-(1H-indazol-4-yl)-6-{[4-(methylsulfonyl)piperazin-1-yl]methyl}-4-morpholin-4-ylthieno[3,2-d]pyrimidine|4-[2-(1H-indazol-4-yl)-6-[(4-methanesulfonylpiperazin-1-yl)methyl]thieno[3,2-d]pyrimidin-4-yl]morpholine|4-[2-(1H-indazol-4-yl)-6-[(4-methylsulfonyl-1-piperazinyl)methyl]-4-thieno[3,2-d]pyrimidinyl]morpholine"
ZSTK-474,11647372,,"InChI=1S/C19H21F2N7O2/c20-15(21)16-22-13-3-1-2-4-14(13)28(16)19-24-17(26-5-9-29-10-6-26)23-18(25-19)27-7-11-30-12-8-27/h1-4,15H,5-12H2",HGVNLRPZOWWDKD-UHFFFAOYSA-N,C19H21F2N7O2,417.4,"4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine","ZSTK474|475110-96-4|ZSTK-474|ZSTK 474|TCMDC-137004|CHEBI:90545|K0068GK39A|2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-bis(morpholino)-1,3,5-triazine|DTXSID30197179|2-(difluoromethyl)-1-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-1H-benzimidazole|2-(difluoromethyl)-1-(4,6-di(morpholin-4-yl)-1,3,5-triazin-2-yl)benzimidazole|2-(difluoromethyl)-1-[4,6-di(morpholin-4-yl)-1,3,5-triazin-2-yl]benzimidazole|RefChem:909420|DTXCID90119670|1-(bis(morpholin-4-yl)-1,3,5-triazin-2-yl)-2-(difluoromethyl)-1H-1,3-benzodiazole|4,4'-(6-(2-(Difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine|2-(2-difluoromethylbenzimidazol-1-yl)-4,6-dimorpholino-1,3,5-triazine|MFCD08705334|CHEMBL586702|2-(Difluoromethyl)-1-(4,6-Dimorpholin-4-Yl-1,3,5-Triazin-2-Yl)-1h-Benzimidazole|4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholin-4-yl-1,3,5-triazin-2-yl]morpholine|2wxl|UNII-K0068GK39A|C19H21F2N7O2|ZSTK 474; 2-(2-Difluoromethylbenzimidazol-1-yl)-4,6-bis(morpholino)-1,3,5-triazine|SCHEMBL373282|GTPL7965|orb1301016|SCHEMBL29357859|HGVNLRPZOWWDKD-UHFFFAOYSA-N|BCPP000001|HMS2043A02|HMS3265I19|HMS3265I20|HMS3265J19|HMS3265J20|HMS3654I15|BCP01867|EX-A2207|BDBM50315213|NSC764516|NSC800993|AKOS005145982|CCG-264806|CS-0083|DB12904|EX-3329|FD34127|NSC-764516|NSC-800993|SB17043|SDCCGSBI-0654335.P001|2-(Difluoromethyl)-1-(4,6-dimorpholino-1,3,5-triazin-2-yl)-1H-benzo[d]imidazole|4-[4-[2-(difluoromethyl)benzimidazol-1-yl]-6-morpholino-1,3,5-triazin-2-yl]morpholine|NCGC00346484-01|NCGC00346484-08|AC-28418|AS-16245|HY-50847|NS00068780|S1072|SW220182-1|F15198|110Z964|BRD-K63068307-001-01-4|BRD-K63068307-001-08-9|Q27089303|1-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]-2-(difluoromethyl)-1H-benzimidazole|2-(difluoromethyl)-1-[4,6-di(4-morpholinyl)-1,3,5-triazin-2-yl]-1H-benzimidazole|4,4''-(6-(2-(difluoromethyl)-1H-benzo[d]imidazol-1-yl)-1,3,5-triazine-2,4-diyl)dimorpholine|ZS4"
IDELALISIB,11625818,,"InChI=1S/C22H18FN7O/c1-2-15(28-20-18-19(25-11-24-18)26-12-27-20)21-29-16-10-6-9-14(23)17(16)22(31)30(21)13-7-4-3-5-8-13/h3-12,15H,2H2,1H3,(H2,24,25,26,27,28)/t15-/m0/s1",IFSDAJWBUCMOAH-HNNXBMFYSA-N,C22H18FN7O,415.4,5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one,"Idelalisib|870281-82-6|CAL-101|Zydelig|GS-1101|CAL101|GS 1101|YG57I8T5M0|CHEBI:82701|5-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)propyl]quinazolin-4-one|5-Fluoro-3-phenyl-2-((S)-1-(9H-purin-6-ylamino)-propyl)-3H-quinazolin-4-one|DTXSID701007266|5-fluoro-3-phenyl-2-[(1S)-1-(3H-purin-6-ylamino)propyl]quinazolin-4(3H)-one|idelalisibum|5-fluoro-3-phenyl-2-((1S)-1-(7H-purin-6-ylamino)propyl)quinazolin-4-one|5-fluoro-3-phenyl-2-((1S)-1-((9H-purin-6-yl)amino)propyl)-3,4-dihydroquinazolin-4-one|5-fluoro-3-phenyl-2-((1S)-1-(3H-purin-6-ylamino)propyl)quinazolin-4(3H)-one|5-fluoro-3-phenyl-2-[(1S)-1-[(9H-purin-6-yl)amino]propyl]-3,4-dihydroquinazolin-4-one|RefChem:58018|L01XX47|DTXCID901434124|Phosphoinositide-3 Kinase Delta Inhibitor CAL-101|CAL 101|(S)-2-(1-((9H-Purin-6-yl)amino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one|Idelalisib (CAL-101)|CAL-101 (Idelalisib, GS-1101)|C22H18FN7O|MFCD19443647|(S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one|CHEMBL2216870|4(3H)-Quinazolinone,5-fluoro-3-phenyl-2-[(1S)-1-(1H-purin-6-ylamino)propyl]-|5-FLUORO-3-PHENYL-2-[(1S)-1-(9H-PURIN-6-YLAMINO)PROPYL]-4(3H)-QUINAZOLINONE|Idelalisib; CAL-101|GS-1101; Idelalisib; CAL-101|5-Fluoro-3-Phenyl-2-[(1s)-1-(7h-Purin-6-Ylamino)propyl]quinazolin-4(3h)-One|1453810-72-4|Idelalisib [INN]|Idelalisib [USAN:INN]|UNII-YG57I8T5M0|Idealisib|Zydelig (TN)|IDELALISIB [MI]|IDELALISIB [JAN]|IDELALISIB [USAN]|CAL-101 (Idelalisib)|IDELALISIB [VANDF]|IDELALISIB [WHO-DD]|MLS006010985|Idelalisib (JAN/USAN/INN)|SCHEMBL356400|GTPL6741|orb1307216|IDELALISIB [ORANGE BOOK]|SCHEMBL16782604|SCHEMBL29354482|SCHEMBL29411768|SCHEMBL29422886|HSDB 8408|CAL-101/CAL101|EX-A330|GS-11CAL-101|BCPP000307|BCP02532|EX-A1242|BDBM50403068|NSC759224|NSC762828|NSC800771|s2226|AKOS022186334|AKOS040744041|Idelalisib (CAL-101,GS-1101)|BCP9000471|CCG-264949|CS-0256|DB09054|FI29231|NSC-759224|NSC-762828|NSC-800771|SDCCGSBI-0654408.P001|CAL-101 (GS-1101)|NCGC00262603-01|NCGC00262603-02|NCGC00262603-04|AC-28394|AC-36641|HY-13026|IC489666|SMR004702787|DB-333007|NS00071041|SW219823-1|A-1138|D10560|EN300-7412931|Q5908266|BRD-K60866521-001-01-4|BRD-K60866521-001-07-1|(S)-5-fluoro-3-phenyl-2-[1-(9H-purin-6-ylamino)-propyl]-3H-quinazolin-4-one|4(3H)-Quinazolinone, 5-fluoro-3-phenyl-2-[(1S)-1-(9H-purin-6-ylamino)propyl]-|(S)-2-(1-(1-(9H-Purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3H)-one;CAL-101;GS-1101|40L"
GSK-2636771,56949517,,"InChI=1S/C22H22F3N3O3/c1-13-15(4-3-5-18(13)22(23,24)25)12-28-14(2)26-20-17(21(29)30)10-16(11-19(20)28)27-6-8-31-9-7-27/h3-5,10-11H,6-9,12H2,1-2H3,(H,29,30)",XTKLTGBKIDQGQL-UHFFFAOYSA-N,C22H22F3N3O3,433.4,2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylbenzimidazole-4-carboxylic acid,"GSK2636771|1372540-25-4|GSK-2636771|DW94IAT0LS|GSK 2636771|2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholin-4-ylbenzimidazole-4-carboxylic acid|DTXSID10160124|2-Methyl-1-((2-methyl-3-(trifluoromethyl)phenyl)methyl)-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid|2-Methyl-1-((2-methyl-3-(trifluoromethyl)phenyl)methyl)-6-morpholino-benzimidazole-4-carboxylic acid|2-Methyl-1-[[2-Methyl-3-(trifluoroMethyl)phenyl]Methyl]-6-(4-Morpholinyl)-1H-benziMidazole-4-carboxylic acid|2-methyl-1-{[2-methyl-3-(trifluoromethyl)phenyl]methyl}-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid|2-methyl-1-((2-methyl-3-(trifluoromethyl)phenyl)methyl)-6-morpholin-4-ylbenzimidazole-4-carboxylic acid|2-methyl-1-[[2-methyl-3-(trifluoromethyl)phenyl]methyl]-6-morpholino-benzimidazole-4-carboxylic acid|RefChem:144516|DTXCID9082615|PI3K-beta Inhibitor GSK2636771|2-methyl-1-((2-methyl-3-(trifluoromethyl)phenyl)methyl)-6-(morpholin-4-yl)-1H-1,3-benzodiazole-4-carboxylic acid|2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo[d]imidazole-4-carboxylic acid|MFCD22417098|C22H22F3N3O3|UNII-DW94IAT0LS|2-methyl-1-(2-methyl-3-(trifluoromethyl)benzyl)-6-morpholino-1H-benzo(d)imidazole-4-carboxylic acid|MLS006011177|GTPL7967|orb1306552|SCHEMBL1280998|CHEMBL3188551|SCHEMBL29352801|SCHEMBL29411881|EX-A434|HMS3653H17|HMS3673E13|HMS3749O03|BCP05688|BDBM50059637|NSC768508|NSC781258|NSC800110|s8002|AKOS026750339|BCP9000741|CCG-269050|CS-0747|DB11795|GSK 2636771 [WHO-DD]|NSC-768508|NSC-781258|NSC-800110|SB16472|GSK2636771?|NCGC00345796-01|NCGC00345796-10|AC-36648|AS-17013|DA-33589|HY-15245|SMR004702946|NS00072984|SW219650-1|BRD-K49215523-001-04-2|BRD-K49215523-001-05-9|Q27077889|2-Methyl-1-[2-methyl-3-(trifluoromethyl)benzyl]-6-(4-morpholinyl)-1H-benzimidazole-4-carboxylic acid"
PAROXETINE,43815,,"InChI=1S/C19H20FNO3/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18/h1-6,9,14,17,21H,7-8,10-12H2/t14-,17-/m0/s1",AHOUBRCZNHFOSL-YOEHRIQHSA-N,C19H20FNO3,329.4,"(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine","paroxetine|61869-08-7|Frosinor|Casbol|Motivan|PaxPar|Paroxetina|Paroxetinum|Aropax|(-)-Paroxetine|BRL 29060|Arketis|Besitram|Daparox|Parogen|Xetanor|Arotin|FG 7051|BRL-29060|(-)3s,4r-paroxetine|FG-7051|(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine|(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine|CHEBI:7936|DTXSID3023425|41VRH5220H|Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S,4R)-|(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)methyl)piperidine|DTXCID703425|(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3S-trans)-|(3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine|(-)-TRANS-4-(P-FLUOROPHENYL)-3-((3,4-(METHYLENEDIOXY)PHENOXY)METHYL)PIPERIDINE|(3S,4R)-3-((1,3-BENZODIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)PIPERIDINE|(3S,4R)-3-((2H-1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)-|Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S-trans)-|PAXILCR|RefChem:6104|Paxil (as hydrochloride)|N06AB05|BRL29060|FG7051|Paxil|Seroxat|Paroxetinum [INN-Latin]|Paroxetina [INN-Spanish]|Paxetil|(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine|(3s,4r)-3-((benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|(+/-)-Paroxetine|Paroxetine, (+/-)-|CHEMBL490|Paroxetine, trans-(+/-)-|32Q7TW8BX7|Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-,(3S,4R)-|MFCD00869588|Paroxetine (TN)|130855-15-1|Paroxetine [USAN:INN:BAN]|CHEMBL1708|Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, (3R,4S)-rel-|Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, trans-|Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, trans-(+/-)-|Rel-(3R,4S)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine|PAROXETINE HCL HEMIHYDRATE|CAS-61869-08-7|Paroxetine (USP/INN)|UNII-41VRH5220H|3h-paroxetine|Paroxetine.HCl|(3S,4R)-3-[(Benzo[d][1,3]dioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine|NCGC00182968-01|8PR|NNC-20-7051|Spectrum_001752|PAROXETINE [MI]|SpecPlus_000788|PAROXETINE [INN]|Prestwick3_000851|Spectrum5_001665|PAROXETINE [USAN]|PAROXETINE [VANDF]|PAROXETINE [MART.]|PAROXETINE [WHO-DD]|UNII-32Q7TW8BX7|SCHEMBL27799|BSPBio_000861|KBioSS_002232|BIDD:GT0673|DivK1c_006884|BPBio1_000949|GTPL4790|orb1909599|SCHEMBL29358021|BDBM22416|HSDB 7175|KBio1_001828|KBio2_002232|KBio2_004800|KBio2_007368|HMS2090H05|Tox21_113123|BDBM50331515|(-)-trans-4-(4-Fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)piperidine|AKOS015888636|Tox21_113123_1|AC-8185|DB00715|SDCCGSBI-0051908.P003|(-)-trans-4-(p-fluorophenyl)-3-[[3,4-(methylenedioxy)phenoxy]methyl]-piperidine|(3S-trans)-3-[(1,3-Benzodioxol-5-yl-oxy)methyl]-4-(4-fluorophenyl)piperidine|NCGC00025355-02|NCGC00025355-03|NCGC00025355-04|NCGC00025355-05|NCGC00025355-06|NCGC00025355-07|NCGC00025355-08|NCGC00025355-09|NCGC00025355-12|NCGC00025355-13|NCGC00025355-22|NCGC00025355-23|SY289602|SBI-0051908.P002|HY-122272|AB00514724|CS-0083299|NS00000037|C07415|D02362|EN300-150199|AB00053704-21|AB00053704_22|AB00053704_23|869P087|F615527|paroxetine hydrochloride (anhydrous or hemihydrate)|Q408471|BRD-K37991163-003-02-7|BRD-K37991163-003-13-4|BRD-K37991163-003-14-2|BRD-K37991163-050-05-1|BRD-K37991163-050-18-4|(3S,4R)-3-[(1,3-dioxaindan-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine"
DACTOLISIB,11977753,,"InChI=1S/C30H23N5O/c1-30(2,18-31)22-9-11-23(12-10-22)35-28-24-15-19(21-14-20-6-4-5-7-25(20)32-16-21)8-13-26(24)33-17-27(28)34(3)29(35)36/h4-17H,1-3H3",JOGKUKXHTYWRGZ-UHFFFAOYSA-N,C30H23N5O,469.5,"2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile","dactolisib|915019-65-7|NVP-BEZ235|BEZ235|NVP-BEZ 235|2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile|BEZ-235|NVPBEZ235|BEZ 235|NVP-BEZ-235|NVP BEZ235|RTB101|RTB-101|RUJ6Z9Y0DT|NSC-751249|CHEBI:71952|DTXSID10238599|2-methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo[4,5-c]quinolin-1-yl)phenyl]propanenitrile|2-methyl-2-(4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-1h-imidazo(4,5-c)quinolin-1-yl)phenyl)propanenitrile|2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo(4,5-c)quinolin-1-yl)phenyl)propanenitrile|2-methyl-2-{4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo[4,5-c]quinolin-1-yl]phenyl}propanenitrile|Benzeneacetonitrile, 4-(2,3-dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo(4,5-c)quinolin-1-yl)-alpha,alpha-dimethyl-|dactolisibum|2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-1H-imidazo(4,5-c)quinolin-1-yl)phenyl)propanenitrile|2-methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl)phenyl)propanenitrile|2-methyl-2-(4-(3-methyl-2-oxo-8-quinolin-3-ylimidazo(4,5-c)quinolin-1-yl)phenyl)propanenitrile|2-Methyl-2-(4-{3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl}phenyl)propanenitrile|RefChem:585151|DTXCID10161090|BEZ235 (NVP-BEZ235, Dactolisib)|MFCD10565944|915019-65-7 (free base)|2-Methyl-2-[4-(3-methyl-2-oxo-8-quinolin-3-yl-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)-phenyl]-propionitrile|S1009|BEZ235 (NVP-BEZ235)|2-methyl-2-[4-[3-methyl-2-oxo-8-(3-quinolyl)imidazo[4,5-c]quinolin-1-yl]phenyl]propanenitrile|2-Methyl-2-[4-[3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl]phenyl]propionitrile.|Dactolisib [USAN]|Dactolisib [USAN:INN]|UNII-RUJ6Z9Y0DT|C30H23N5O|Kinome_2911|CT-BEZ|Dactolisib (BEZ235)|DACTOLISIB [INN]|Dactolisib (USAN/INN)|Nvp-bez235, free base|mTOR Inhibitor, BEZ235|DACTOLISIB [WHO-DD]|NVP BEZ 235|NVP-BEZ235?|SCHEMBL143623|GTPL7950|orb1305985|CHEMBL1879463|SCHEMBL29370906|SCHEMBL30186162|BDBM92862|EX-A404|BCPP000344|HMS3244G21|HMS3244G22|HMS3244H21|HMS3672E19|BCP00216|IVB20674|NSC751249|NSC755807|NSC800085|SBB084062|AKOS005217097|BCP9000397|CCG-207981|CS-0080|DB11651|ES-0038|FD26487|NSC 751249|NSC-755807|NSC-800085|PB26555|SDCCGSBI-0646961.P003|Dactolisib (BEZ235, NVP-BEZ235)|NCGC00187481-01|NCGC00187481-02|NCGC00187481-04|NCGC00187481-05|NCGC00187481-06|NCGC00187481-11|NCGC00187481-15|2-(4-(2,3-dihydro-3-methyl-2-oxo-8-(quinolin-3-yl)imidazo[4,5-c]quinolin-1-yl)phenyl)-2-methylpropanenitrile|AC-25486|HY-50673|NS00071714|EN300-60135|D10552|Q4835503|BRD-K12184916-001-01-4|BRD-K12184916-001-15-4|BRD-K12184916-001-19-6|Z329731510|1028385-31-0|2-Methyl-2-(4-(3-methyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydro-imidazo[4,5-c]quinolin-1-yl)phenyl)propionitrile|2-methyl-2-[4-(3-methyl-2-oxo-8-(3-quinolyl)(4-imidazolino[4,5-c]quinolinyl))p henyl]propanenitrile|2-METHYL-2-{4-[3-METHYL-2-OXO-8-(QUINOLIN-3-YL)-1H,2H,3H-IMIDAZO[4,5-C]QUINOLIN-1-YL]PHENYL}PROPANENITRILE|4-[2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4, 5-c]quinolin-1-yl]-.alpha.,.alpha.-dimethylbenzeneacetonitrile|4-[2,3-Dihydro-3-methyl-2-oxo-8-(3-quinolinyl)-1H-imidazo[4,5-c]quinolin-1-yl]-?,?-dimethyl-benzeneacetonitrile;2-Methyl-2-[4-[3-met hyl-2-oxo-8-(quinolin-3-yl)-2,3-dihydroimidazo[4,5-c]quinolin-1-yl]phenyl]propionitrile;BEZ 235"
REBOXETINE,127151,,"InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m1/s1",CBQGYUDMJHNJBX-RTBURBONSA-N,C19H23NO3,313.4,(2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine,"Reboxetine|71620-89-8|947S0YZ36I|DTXSID1048257|Morpholine, 2-((R)-(2-ethoxyphenoxy)phenylmethyl)-, (2R)-rel-|Morpholine, 2-[(R)-(2-ethoxyphenoxy)phenylmethyl]-, (2R)-rel-|Reboxetina|reboxetinum|RefChem:930594|N06AX18|DTXCID301471552|Morpholine, 2-((R)-(2-ethoxyphenoxy)phenylmethyl)-, (2R)-|(2S)-2-((S)-2-ethoxyphenoxy(phenyl)methyl)morpholine|Edronax|Reboxetine [INN]|98769-81-4|(2R)-2-[(R)-(2-ethoxyphenoxy)-phenylmethyl]morpholine|105017-38-7|Reboxetine (INN)|(2r)-2-[(R)-(2-Ethoxyphenoxy)(Phenyl)methyl]morpholine|Reboxitine|(R)-2-((R)-(2-ethoxyphenoxy)(phenyl)methyl)morpholine|Reboxetine [INN:BAN]|UNII-947S0YZ36I|Reboxe- tine|Reboxetinemesylate|HSDB 7701|Edronax (TN)|Morpholine, 2-[(2-ethoxyphenoxy)phenylmethyl]-, (R*,R*)-|REBOXETINE [MI]|REBOXETINE [HSDB]|REBOXETINE [VANDF]|(R,R)-(-)-Reboxetine|REBOXETINE [WHO-DD]|SCHEMBL34533|CHEMBL383921|orb1701944|SCHEMBL29930185|(2R)-2-[(R)-(2-ethoxyphenoxy)-phenyl-methyl]morpholine|CHEBI:135342|BDBM388642|DTXSID401315414|BCP12060|MFCD09955493|AKOS015966368|DB00234|AS-56251|FR148959|HY-14560|US9944618, Compound ID No. 178|CS-0003444|2-[(2-ethoxyphenoxy)-phenyl-methyl]morpholine|D08472|D95753|AB00920697_06|EN300-19659906|BRD-K77224738-066-02-7|(+/-)-(2R*)-2-((.ALPHA.R*)-.ALPHA.-(O-ETHOXYPHENOXY)BENZYL)MORPHOLINE|41X"
DULOXETINE,60835,,"InChI=1S/C18H19NOS/c1-19-12-11-17(18-10-5-13-21-18)20-16-9-4-7-14-6-2-3-8-15(14)16/h2-10,13,17,19H,11-12H2,1H3/t17-/m0/s1",ZEUITGRIYCTCEM-KRWDZBQOSA-N,C18H19NOS,297.4,(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine,"duloxetine|116539-59-4|(S)-Duloxetine|Yentreve|2-Thiophenepropanamine, N-methyl-gamma-(1-naphthalenyloxy)-, (gammaS)-|Duloxetina|(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-ylpropan-1-amine|LY248686|methyl[(3S)-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl]amine|O5TNM5N07U|(3S)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propan-1-amine|CHEBI:36795|(S)-N-Methyl-gamma-(1-naphthalenyloxy)-2-thiophenepropanamine|DTXSID6048385|2-Thiophenepropanamine, N-methyl-gamma-(1-naphthalenyloxy)-, (S)-|duloxetinum|methyl((3S)-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propyl)amine|RefChem:5783|DTXCID7028358|N06AX21|116539-58-3|CHEBI:36796|Xeristar|Cymbalta|(S)-N-Methyl-3-(naphthalen-1-yloxy)-3-(thiophen-2-yl)propan-1-amine|LY 248686|MFCD06801358|Duloxetine (INN)|LY-248686|Yentreve (TN)|DULOXETINE [INN]|Duloxetine [INN:BAN]|(3s)-N-Methyl-3-(Naphthalen-1-Yloxy)-3-(Thiophen-2-Yl)propan-1-Amine|SMR000449282|HSDB 7368|NCGC00164559-01|UNII-O5TNM5N07U|Duloxetine?|29E|PS27 - Duloxetine|CPD000449282|DULOXETINE [MI]|DULOXETINE [HSDB]|DULOXETINE [VANDF]|SCHEMBL8291|CHEMBL1175|DULOXETINE [WHO-DD]|GTPL202|MLS000758267|MLS001423946|DULOXETINE [EMA EPAR]|orb1300102|SCHEMBL29355040|BDBM84745|(+)-(S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine monohydrochloride|HMS2051I05|HMS3886K11|HY-B0161|(3S)-N-methyl-3-(naphthalen-1-yloxy)-3-(2-thienyl)propan-1-amine|PDSP1_000969|PDSP1_001385|PDSP2_000953|PDSP2_001369|s5071|AKOS015851058|CCG-100763|DB00476|NC00013|NCGC00164559-02|NCGC00164559-04|AC-15704|AS-35259|SBI-0206832.P001|CAS_136434-34-9|NS00008615|D07880|EN300-150640|AB00639911-13|AB00639911_15|AB00639911_16|539D594|Q411932|BRD-K71103788-003-11-2|BRD-K71103788-003-12-0|(+)-(S)-N-Methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamin|(S)-(+)-N-methyl-3-(1-naphthyloxy)-3-(2-thienyl)propylamine|(S)-N-methyl-3-(1-naphthalenyloxy)-3-(2-thienyl) propanamine|(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1 amine|(3S)-N-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1-amine|(3s)-n-methyl-3-naphthalen-1-yloxy-3-thiophen-2-yl-propan-1amine|(S)-(+)-N-methyl-3-(1-naphthaleneoxy)-3-(2-thienyl)propanamine|2-Thiophenepropanamine, N-methyl-|A-(1-naphthalenyloxy)-, (|AS)-|(+)-(S)-N-METHYL-.GAMMA.(1-NAPHTHYLOXY)-2-THIOPHENEPROPYLAMINE|2-THIOPHENEPROPANAMINE, N-METHYL-.GAMMA.-(1-NAPHTHALENYLOXY)-, (S)-|Duloxetine; 2-Thiophenepropanamine, N-methyl-?-(1-naphthalenyloxy)-, (?S)-; 2-Thiophenepropanamine, N-methyl-?-(1-naphthalenyloxy)-, (S)-; (?S)-N-Methyl-?-(1-naphthalenyloxy)-2-thiophenepropanamine; (+)-Duloxetine; (S)-(+)-N-Methyl-3-(1-naphthyloxy)-3-(2-"
ATOMOXETINE,54841,,"InChI=1S/C17H21NO/c1-14-8-6-7-11-16(14)19-17(12-13-18-2)15-9-4-3-5-10-15/h3-11,17-18H,12-13H2,1-2H3/t17-/m1/s1",VHGCDTVCOLNTBX-QGZVFWFLSA-N,C17H21NO,255.35,(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine,"Atomoxetine|83015-26-3|Tomoxetine|(-)-Tomoxetine|Tomoxetina|Tomoxetinum|Tomoxetinum [Latin]|Atomoxetina|ASW034S0B8|CHEBI:127342|methyl[(3R)-3-(2-methylphenoxy)-3-phenylpropyl]amine|DTXSID9044297|Benzenepropanamine, N-methyl-gamma-(2-methylphenoxy)-, (gammaR)-|AD313 COMPONENT ATOMOXETINE|AD-313 COMPONENT ATOMOXETINE|Tomoxetinum (Latin)|methyl((3R)-3-(2-methylphenoxy)-3-phenylpropyl)amine|atomoxetinum|RefChem:56721|DTXCID7024297|N06BA09|Strattera|Tomoxetina [Spanish]|(3R)-N-methyl-3-(2-methylphenoxy)-3-phenylpropan-1-amine|(R)-Tomoxetine|(R)-N-methyl-3-phenyl-3-(o-tolyloxy)propan-1-amine|A1LX4|Tomoxetine [INN]|Atomoxetine [INN]|CHEMBL641|Atomoxetine [INN:BAN]|UNII-ASW034S0B8|HSDB 7352|MFCD06804608|Tocris-2011|Atomoxetine (USP/INN)|ATOMOXETINE [MI]|PST1 - Psychostimulants|ATOMOXETINE [HSDB]|ATOMOXETINE [VANDF]|SCHEMBL34268|ATOMOXETINE [WHO-DD]|(R)-N-methyl-3-(2-methylphenoxy)benzenepropanamine|GTPL7118|orb1705357|SCHEMBL29440242|VHGCDTVCOLNTBX-QGZVFWFLSA-N|(3R)-N-methyl-3-(2-methylphenoxy)-3-phenyl-propan-1-amine|AD109 COMPONENT ATOMOXETINE|BDBM50366567|PDSP1_000504|PDSP2_000502|AD-109 COMPONENT ATOMOXETINE|AKOS015961834|AC-5316|DB00289|NCGC00025345-01|AC-25548|HY-107370|NS00000414|D07473|AB00698501_08|940A512|EN300-17832026|N-methyl-3-(3-(o-tolyloxy)phenyl)propan-1-amine|Q417240|BRD-K20141153-001-01-6|BRD-K20141153-003-03-8|BRD-K20141153-003-12-9|BRD-K20141153-003-13-7|1027094-45-6"
NISOXETINE,4500,,"InChI=1S/C17H21NO2/c1-18-13-12-15(14-8-4-3-5-9-14)20-17-11-7-6-10-16(17)19-2/h3-11,15,18H,12-13H2,1-2H3",ITJNARMNRKSWTA-UHFFFAOYSA-N,C17H21NO2,271.35,3-(2-methoxyphenoxy)-N-methyl-3-phenylpropan-1-amine,"Nisoxetine|53179-07-0|Nisoxetina|Compound 89218|3-(2-methoxyphenoxy)-N-methyl-3-phenylpropan-1-amine|Nisoxetinum|3-(2-Methoxyphenoxy)-N-methyl-3-phenylpropylamine|NSC-283481|DTXSID0045175|CHEBI:73410|17NV064B2D|DL-N-Methyl-3-(o-methoxyphenoxy)-N-methyl-3-phenylpropylamine|3-(o-Methoxyphenoxy)-N-methyl-3-phenylpropylamine|N-Methyl-gamma-(2-methylphenoxy)phenylpropanolamine|COMPOUND-89218|DTXCID8025175|LY 94939|RefChem:854206|57226-61-6|CHEMBL295467|Benzenepropanamine, gamma-(2-methoxyphenoxy)-N-methyl-|Compound 89218; NSC 283481|NCGC00015715-04|Nisoxetine Inhibitor|Nisoxetine [USAN:INN]|CAS-53179-07-0|UNII-17NV064B2D|NSC 283481|NISOXETINE [INN]|Nisoxetine (USAN/INN)|Prestwick0_000910|Prestwick1_000910|Prestwick2_000910|Prestwick3_000910|NISOXETINE [USAN]|Lopac0_000901|BSPBio_000760|SCHEMBL124289|SPBio_002959|BPBio1_000836|GTPL4637|orb1740335|SCHEMBL29401038|BDBM22417|HMS2089K13|EX-A9581|Tox21 110203|Tox21_110203|NSC283481|PDSP1_000507|PDSP2_000505|Tox21_110203_1|CCG-204983|DB09186|SDCCGSBI-0050876.P002|NCGC00015715-03|NCGC00015715-05|NCGC00015715-06|NCGC00015715-08|NCGC00015715-15|NCGC00024945-02|NCGC00024945-03|AS-16468|DA-56190|AB00514644|NS00002148|D05173|AB00514644-07|N-methyl 3(o-methoxyphenoxy)-3-phenylpropylamine|N-methyl 3-(o-methoxyphenoxy)-3-phenylpropylamine|Q906885|[3-(2-methoxyphenoxy)-3-phenylpropyl](methyl)amine|N-methyl-3-phenyl-3-(o-methoxyphenoxy)-propylamine|BRD-A95696066-003-03-9|BRD-A95696066-003-06-2|BRD-A95696066-003-13-8|(+/-)-3-(O-METHOXYPHENOXY)-N-METHYL-3-PHENYLPROPYLAMINE|BENZENEPROPANAMINE, .GAMMA.-(2-METHOXYPHENOXY)-N-METHYL-, (+/-)-"
SERTRALINE,68617,,"InChI=1S/C17H17Cl2N/c1-20-17-9-7-12(13-4-2-3-5-14(13)17)11-6-8-15(18)16(19)10-11/h2-6,8,10,12,17,20H,7,9H2,1H3/t12-,17-/m0/s1",VGKDLMBJGBXTGI-SJCJKPOMSA-N,C17H17Cl2N,306.2,"(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine","sertraline|79617-96-2|(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine|Sertralina|(+)-Sertraline|Sertralinum|Cp 51974|cis-(+)-sertraline|(1S,4S)-sertraline|QUC7NX6WMB|(1S-cis)-1,2,3,4-Tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-1-naphthalenamine|CHEBI:9123|DTXSID6023577|1-Naphthalenamine, 1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-, (1S-cis)-|Altruline|Besitran|Apo Sertraline|Gen Sertraline|Novo Sertraline|ratio Sertraline|Rhoxal sertraline|RefChem:6215|DTXCID203577|N06AB06|1-Naphthalenamine,1,2,3,4-tetrahydro-4-(3,4-dichlorophenyl)-N-methyl-, (1S-cis)-|642-001-4|C17H17Cl2N|Sertraline (INN)|CHEMBL809|Sertralinum [Latin]|Sertralina [Spanish]|79617-95-1|(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-tetralin-1-amine|SERTRALINE [INN]|Apo-Sertraline|Sertraline [INN:BAN]|TBA-2010_Sertraline_1|cis-sertraline|(R,R)-Sertraline|MLS001401398|1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1S,4S)-|SMR000596516|SRE|HSDB 7037|UNII-QUC7NX6WMB|NCGC00092386-03|SMR000466298|BRN 5753709|(1R,4R)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine; (1R-cis)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-Naphthalenamine; (1R,4R)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine; CP 51973|Sertraline Free Base|(+/-)-sertraline|SERTRALINE [MI]|(1S,4S)-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride|Prestwick3_001014|Spectrum2_000493|Spectrum3_001079|Spectrum4_001232|SERTRALINE [HSDB]|Sertraline, (+/-)-|SERTRALINE [VANDF]|AM64MTB95A|SERTRALINE [WHO-DD]|BIDD:PXR0193|SCHEMBL28701|BSPBio_001167|BSPBio_002698|KBioGR_001724|cid_63009|MLS001195647|MLS002222308|BIDD:GT0768|REGID_for_CID_68617|SPBio_000385|BPBio1_001285|GTPL4798|orb1740797|cis-N-methyl-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthaleneamine|SCHEMBL29374222|BDBM79021|KBio3_001918|cp-51974|HMS2098K09|HMS2231I09|HMS3715K09|BDBM50028094|MFCD00865372|NCGC00092386|AKOS016842914|CCG-221014|DB01104|SDCCGSBI-0206734.P002|NCGC00092386-04|NCGC00092386-05|NCGC00092386-06|NCGC00092386-07|NCGC00092386-08|NCGC00092386-09|NCGC00092386-10|NCGC00092386-12|NCGC00092386-27|AC-15639|SBI-0206734.P001|CP-519741|AB00514002|NS00000030|C07246|D02360|EN300-150167|AB00514002_17|AB00514002_18|617S962|Q407617|SR-01000759296|SR-01000759296-5|BRD-K82036761-003-02-1|BRD-K82036761-003-07-0|BRD-K82036761-003-16-1|BRD-K82036761-003-17-9|BRD-K82036761-003-20-3|[(1S,4S)-4-(3,4-dichlorophenyl)tetralin-1-yl]-methyl-amine;hydrochloride|cis-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-naphthalenamine|syn-4-(3,4-dichlorophenyl)-N-methyl-1,2,3,4-tetrahydronaphthalen-1-amine|(1S-cis)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-naphthalenamine|1-Naphthalenamine, 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4R)-rel-|rel-(1R,4R)-4-(3,4-Dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-naphthalenamine|219736-80-8"
VENLAFAXINE HYDROCHLORIDE,62923,,"InChI=1S/C17H27NO2.ClH/c1-18(2)13-16(17(19)11-5-4-6-12-17)14-7-9-15(20-3)10-8-14;/h7-10,16,19H,4-6,11-13H2,1-3H3;1H",QYRYFNHXARDNFZ-UHFFFAOYSA-N,C17H28ClNO2,313.9,1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol;hydrochloride,"Venlafaxine hydrochloride|99300-78-4|VENLAFAXINE HCl|Effexor XR|Vandral|Wy-45030|Wy 45030|Wy-45,030|7D7RX5A8MO|1-(2-(Dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol hydrochloride|1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride|NSC-745751|Venlafaxine (as hydrochloride)|DTXSID8047397|Cyclohexanol, 1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)-, hydrochloride|CHEBI:9944|DTXCID6027397|Sila Venlafaxine|Venlafaxine HCL ER|RefChem:56206|Hydrochloride, Venlafaxine|Effexor XR Extended-release|Venlafaxine Hydrochloride ER|Wy45030|1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexanol HCl|Wy45,030|Wy 45,030|venlafaxine hydrochloride, extended release|Effexor|Dobupal|Venlafaxine (hydrochloride)|MFCD03658865|d,l-venlafaxine, hydrochloride|Wy 45030 hydrochloride|1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol hydrochloride|Venlafaxine.HCl|Venlafaxinehydrochloride|1-(2-(dimethylamino)-1-(4-methoxyphenyl)ethyl)cyclohexan-1-ol hydrochloride|Venlafaxine hydrochloride [USAN]|UNII-7D7RX5A8MO|Venlift|Vexor|Venlafaxine EA|Venlafaxine XR|Effexor LP|Effexor XL|Effexor (TN)|Venlafaxine hydrochloride [USAN:USP]|venlafaxine hydro chloride|DL-Venlafaxine hydrochloride|SCHEMBL41936|MLS001401454|HY-B0196AR|orb1310579|CHEMBL1201066|HY-B0196A|MSK10241A|Wy 453|BVF-012|GLXC-03750|HMS5079G06|BCP21401|Tox21_302508|Tox21_500449|HB1743|NSC745751|s1441|Venlafaxine hydrochloride (JAN/USP)|VENLAFAXINE HYDROCHLORIDE [MI]|1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexan-1-ol;hydrochloride|AKOS000280874|AKOS016340594|AC-1696|CCG-100979|CCG-213270|FV28680|H13V695|KS-5049|LP00449|NC00229|NSC 745751|PW-4112|Venlafaxine (hydrochloride) (Standard)|VENLAFAXINE HYDROCHLORIDE [JAN]|DL-Venlafaxine HCl - Bio-X trade mark|VENLAFAXINE HYDROCHLORIDE [HSDB]|NCGC00256703-01|NCGC00261134-01|VENLAFAXINE HYDROCHLORIDE [MART.]|VENLAFAXINE HYDROCHLORIDE [VANDF]|BV164514|SMR000469154|SY066899|VENLAFAXINE HYDROCHLORIDE [USP-RS]|VENLAFAXINE HYDROCHLORIDE [WHO-DD]|CAS-99300-78-4|NS00076435|SW197609-3|V0110|PF-00345408|D00821|EN300-124075|VENLAFAXINE HYDROCHLORIDE [EP IMPURITY]|VENLAFAXINE HYDROCHLORIDE [EP MONOGRAPH]|VENLAFAXINE HYDROCHLORIDE [ORANGE BOOK]|VENLAFAXINE HYDROCHLORIDE [USP MONOGRAPH]|Venlafaxine hydrochloride, >=98% (HPLC), powder|Venlafaxine.HCl, 1mg/ml in Methanol (as free base)|Q27108525|Venlafaxine hydrochloride 100 microg/mL in Acetonitrile|Z1557494602|1-[2-Dimethylamino-1-(4-methoxyphenyl)ethyl]cyclohexanol -HCl|Venlafaxine Hydrochloride 1.0 mg/ml in Methanol (as free base)|1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol;hydrochloride|1-[2-Dimethylamino-1-(4-methoxy-phenyl)-ethyl]-cyclohexanol hydrochloride|Venlafaxine hydrochloride, European Pharmacopoeia (EP) Reference Standard|(+/-)-1-(.ALPHA.-((DIMETHYLAMINO)METHYL)-P-METHOXYBENZYL)CYCLOHEXANOL HYDROCHLORIDE|(+/-)-1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]cyclohexanol hydrochloride|(RS)-1-(2-Dimethylamino-1-(4-methoxyphenyl)ethyl)cyclohexanol hydrochloride|Cyclohexanol, 1-[2-(dimethylamino)-1-(4-methoxyphenyl)ethyl]-, hydrochloride (1:1|Venlafaxine for system suitability, European Pharmacopoeia (EP) Reference Standard|Venlafaxine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material|Venlafaxine hydrochloride, United States Pharmacopeia (USP) Reference Standard"
ZAFIRLUKAST,5717,,"InChI=1S/C31H33N3O6S/c1-20-8-4-7-11-29(20)41(37,38)33-30(35)22-13-12-21(28(17-22)39-3)16-23-19-34(2)27-15-14-24(18-26(23)27)32-31(36)40-25-9-5-6-10-25/h4,7-8,11-15,17-19,25H,5-6,9-10,16H2,1-3H3,(H,32,36)(H,33,35)",YEEZWCHGZNKEEK-UHFFFAOYSA-N,C31H33N3O6S,575.7,cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate,"zafirlukast|107753-78-6|Accolate|ICI-204219|ICI 204,219|ICI 204219|DTXSID5023746|Cyclopentyl 3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methylindole-5-carbamate|CHEBI:10100|XZ629S5L50|ICI-204,219|4-(5-cyclopentyloxycarbonylamino-1-methyl-1H-indol-3-ylmethyl)-3-methoxy-N-o-tolylsulfonylbenzamide|DTXCID303746|cyclopentyl 3-[2-methoxy-4-[(o-tolylsulfonyl)carbamoyl]benzyl]-1-methylindole-5-carbamate|cyclopentyl N-{3-[(2-methoxy-4-{[(2-methylbenzene)sulfonyl]carbamoyl}phenyl)methyl]-1-methyl-1H-indol-5-yl}carbamate|zafirlukastum|cyclopentyl N-(3-((2-methoxy-4-(((2-methylbenzene)sulfonyl)carbamoyl)phenyl)methyl)-1-methyl-1H-indol-5-yl)carbamate|4-(5-cyclopentyloxycarbonylamino-2-methylindol-3-yl-methyl)-3-methoxy-N-O-tolylsulfonylbenzamide|RefChem:57963|R03DC01|Carbamic Acid,(3-((2-methoxy-4-((((2-methylphenyl)sulfonyl)amino)carbonyl)phenyl)methyl)-1-methyl-1H-indol-5-yl)-, Cyclopentyl Ester|Olmoran|Cyclopentyl (3-(2-methoxy-4-((o-tolylsulfonyl)carbamoyl)benzyl)-1-methyl-1H-indol-5-yl)carbamate|Accoleit|MFCD00864775|CHEMBL603|Aeronix|cyclopentyl N-[3-[[2-methoxy-4-[(2-methylphenyl)sulfonylcarbamoyl]phenyl]methyl]-1-methylindol-5-yl]carbamate|NCGC00164547-01|NCGC00164547-06|cyclopentyl 3-[2-methoxy-4-(2-methylphenylsulfonylcarbamoyl)benzyl]-1-methyl-1H-indol-5-ylcarbamate|cyclopentyl N-[3-[[2-methoxy-4-(o-tolylsulfonylcarbamoyl)phenyl]methyl]-1-methyl-indol-5-yl]carbamate|Vanticon|Zafirst|Respix|Accolate (TN)|Cyclopentyl 3-{2-methoxy-4-[(o-tolylsulfonyl)carbamoyl]benzyl}-1-methyl-1H-indol-5-ylcarbamate|N-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic Acid Cyclopentyl Ester|SMR000466316|CAS-107753-78-6|SR-01000759386|UNII-XZ629S5L50|Zafirlukast (JAN/USAN/INN)|Zafirlukast [USAN:INN:BAN]|ZLK|Zafirlukast(Accolate)|Zafirlukast (Accolate)|Zafirlukast (Standard)|CPD000466316|ZAFIRLUKAST [MI]|ZAFIRLUKAST [INN]|ZAFIRLUKAST [JAN]|ZAFIRLUKAST [USAN]|ZAFIRLUKAST [VANDF]|SCHEMBL4175|ZAFIRLUKAST [MART.]|ZAFIRLUKAST [WHO-DD]|Carbamic acid, (3-((2-methoxy-4-((((2-methylphenyl)sulfonyl)amino)carbonyl)phenyl)methyl)-1-methyl-1H-indol-5-yl)-, cyclopentyl ester|MLS000759421|MLS001424064|MLS006011771|BIDD:GT0267|GTPL3322|orb1300514|SCHEMBL29372773|SCHEMBL29861631|SCHEMBL30885065|Zafirlukast - Bio-X trade mark|Zafirlukast, >=98% (HPLC)|ZAFIRLUKAST [ORANGE BOOK]|HMS2051F12|HMS2089J10|HMS3393F12|HMS3650A04|HMS3655E13|HMS3713J08|HMS3745K03|HMS5079D04|BCP05226|SYB17418|Tox21_112176|BDBM50009073|HY-17492R|s1633|STK646780|AKOS005577888|Tox21_112176_1|AC-9018|CCG-101025|DB00549|FZ28747|NC00275|SB19079|NCGC00164547-02|NCGC00164547-03|NCGC00164547-04|NCGC00164547-05|NCGC00164547-11|AS-12943|BZ164562|cyclopentyl (1-methyl-3-{[2-(methyloxy)-4-({[(2-methylphenyl)sulfonyl]amino}carbonyl)phenyl]methyl}-1H-indol-5-yl)carbamate|cyclopentyl [3-(2-methoxy-4-{[(2-methylphenyl)sulfonyl]carbamoyl}benzyl)-1-methyl-1H-indol-5-yl]carbamate|HY-17492|MLS000759421-02|NS00068414|SW197655-3|Z0029|C07206|D00411|D92802|EN300-123042|AB00639922-06|AB00639922-08|AB00639922_09|753Z786|L001011|Q928378|SR-01000759386-4|SR-01000759386-5|SR-01000759386-9|BRD-K71289571-001-06-4|BRD-K71289571-001-11-4|Z1546616205|[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic acid cyclopentyl ester;IC   I-2204219;Accolate|[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamic acid cyclopentyl ester;IC I-2204219;Accolate|CARBAMIC ACID, (3-((2-METHOXY-4-(((2-METHYLPHENYL)SULFONYL)AMINO)CARBONYL)PHENYL)METHYL)-1-METHYL-1H-INDOL-5-YL)-, CYCLOPENTYL ESTER|Carbamic acid, N-[3-[[2-methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]-, cyclopentyl ester|Cyclopentyl (3-(2-methoxy-4-((o-tolylsulfonyl)-carbamoyl)benzyl)-1-methyl-1H-indol-5-yl)carbamate|cyclopentyl 3-(2-methoxy-4-(o-tolylsulfonylcarbamoyl)benzyl)-1-methyl-1H-indol-5-ylcarbamate|cyclopentyl N-[3-({2-methoxy-4-[(2-methylbenzenesulfonyl)carbamoyl]phenyl}methyl)-1-methyl-1H-indol-5-yl]carbamate|Cyclopentyl N-[3-[[2-Methoxy-4-[[[(2-methylphenyl)sulfonyl]amino]carbonyl]phenyl]methyl]-1-methyl-1H-indol-5-yl]carbamate"
TOMELUKAST,3969,,"InChI=1S/C16H22N4O3/c1-3-6-13-14(9-8-12(11(2)21)16(13)22)23-10-5-4-7-15-17-19-20-18-15/h8-9,22H,3-7,10H2,1-2H3,(H,17,18,19,20)",MWYHLEQJTQJHSS-UHFFFAOYSA-N,C16H22N4O3,318.37,1-[2-hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)butoxy]phenyl]ethanone,"Tomelukast|88107-10-2|LY 171883|LY-171883|LY171883|Tomelukastum|Lilly 171883|DTXSID7020344|ETHANONE, 1-(2-HYDROXY-3-PROPYL-4-(4-(1H-TETRAZOL-5-YL)BUTOXY)PHENYL)-|CHEBI:75310|59762X5CLS|1-[2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)butoxy]phenyl]ethanone|DTXCID30344|LY-171833|1-(2-Hydroxy-3-propyl-4-(4-(1H-tetrazol-5-yl)butoxy)phenyl)ethanone|1-{2-hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)butoxy]phenyl}ethanone|RefChem:898607|Tomelukastum [INN-Latin]|Compound LY171883|Ethanone,1-[2-hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)butoxy]phenyl]-|MLS000069512|CHEMBL162358|2'-Hydroxy-3'-propyl-4'-(4-(1H-tetrazol-5-yl)butoxy)acetophenone|MFCD00211057|NCGC00018122-08|SMR000058555|1-[2-hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)butoxy]phenyl]ethanone|Tomelukast [USAN:INN]|CAS-88107-10-2|SR-05000000448|BRN 4238438|UNII-59762X5CLS|CPD000058555|TOMELUKAST [INN]|Opera_ID_1639|Spectrum3_001918|Spectrum5_001969|Spectrum5_002024|Tomelukast (USAN/INN)|TOMELUKAST [USAN]|1-((2-hydroxy-3-propyl)-4-(1H-tetrazol-5-yl)butoxyphenyl)ethanone|Acetophenone, 2'-hydroxy-3'-propyl-4-(4-(1H-tetrazol-5-yl)butoxy)-|SCHEMBL3944|TOMELUKAST [MART.]|CBiol_001912|BSPBio_001402|BSPBio_003516|KBioGR_000122|KBioSS_000122|MLS000758272|MLS001423988|BML2-G05|SCHEMBL5325407|KBio2_000122|KBio2_002690|KBio2_005258|KBio3_000243|KBio3_000244|KBio3_003021|Bio1_000198|Bio1_000687|Bio1_001176|Bio2_000122|Bio2_000602|HMS1361G04|HMS1791G04|HMS1989G04|HMS2051G21|HMS2231F04|HMS3370J11|HMS3393G21|HMS3402G04|HMS3649C06|5-[4-(4-Acetyl-3-hydroxy-2-propylphenoxy)butyl]-1H-tetrazole|Tox21_110828|Tox21_302412|BDBM50006816|1-(2-hydroxy-3-propyl-4-{[4-(1H-tetrazol-5-yl)butyl]oxy}phenyl)ethanone|Tox21_110828_1|CCG-100826|NC00076|IDI1_033872|NCGC00018122-01|NCGC00018122-02|NCGC00018122-03|NCGC00018122-04|NCGC00018122-05|NCGC00018122-06|NCGC00018122-07|NCGC00018122-09|NCGC00018122-10|NCGC00018122-11|NCGC00022570-03|NCGC00022570-04|NCGC00022570-05|NCGC00022570-06|NCGC00022570-07|NCGC00022570-08|NCGC00255249-01|DA-65127|HY-111212|CS-0034652|LY-171,883|NS00123622|D02851|LY-171,883, >=98% (TLC)|SR-05000000448-2|SR-05000000448-3|BRD-K74765201-001-01-9|BRD-K74765201-001-03-5|BRD-K74765201-001-16-7|Q27145209|5-[4-(4-Acetyl-3-hydroxy-2-propylphenoxy)butyl]-tetrazole|5-[4-(4-Acetyl-3-hydroxy-2-propylphenoxy)-butyl]-tetrazole|1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone|1-{2-Hydroxy-3-propyl-4-[4-(2H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone|(LY-171883)1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone|1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone ( LY-171883)|1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone(LY 171,883)|1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone(LY-171883)|1-{2-Hydroxy-3-propyl-4-[4-(1H-tetrazol-5-yl)-butoxy]-phenyl}-ethanone(LY171883)"
ETICLOPRIDE,57267,,"InChI=1S/C17H25ClN2O3/c1-4-11-9-13(18)16(23-3)14(15(11)21)17(22)19-10-12-7-6-8-20(12)5-2/h9,12,21H,4-8,10H2,1-3H3,(H,19,22)/t12-/m0/s1",AADCDMQTJNYOSS-LBPRGKRZSA-N,C17H25ClN2O3,340.8,5-chloro-3-ethyl-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide,"Eticlopride|Eticloprida|Eticlopridum|84226-12-0|J8M468HBH4|5-chloro-3-ethyl-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide|DTXSID9048435|FLB-131|5-chloro-3-ethyl-N-((1-ethyl-2-pyrrolidinyl)methyl)-6-methoxysalicylamide|3-Chloro-5-Ethyl-N-{[(2s)-1-Ethylpyrrolidin-2-Yl]methyl}-6-Hydroxy-2-Methoxybenzamide|3-chloro-5-ethyl-N-(((2S)-1-ethylpyrrolidin-2-yl)methyl)-6-hydroxy-2-methoxybenzamide|5-chloro-3-ethyl-N-(((2S)-1-ethylpyrrolidin-2-yl)methyl)-2-hydroxy-6-methoxybenzamide|RefChem:139228|DTXCID10819923|Eticlopride [INN]|CHEMBL8946|(-)-(S)-5-Chloro-3-ethyl-N-((1-ethyl-2-pyrrolidinyl)methyl)-6-methoxysalicylamide|Eticlopridum [Latin]|Eticloprida [Spanish]|NCGC00016963-01|NCGC00161393-01|CAS-97612-24-3|R (+)-Eticloride hydrochloride|Prestwick3_000932|ETICLOPRIDE,S(-)|UNII-J8M468HBH4|BSPBio_000864|GTPL966|SCHEMBL572121|BPBio1_000952|orb2646273|SCHEMBL30874373|CHEBI:92874|BDBM50007518|PDSP1_000923|PDSP1_001517|PDSP2_000909|PDSP2_001501|DB15492|NCGC00161393-02|HY-121129|AB00514697|CS-0079513|NS00120002|BRD-K50417881-003-02-6|BRD-K50417881-003-05-9|BRD-K50417881-003-17-4|Q12745201|(S)-3-chloro-5-ethyl-N-((1-ethylpyrrolidin-2-yl)methyl)-6-hydroxy-2-methoxybenzamide|3-Chloro-5-ethyl-N-((S)-1-ethyl-pyrrolidin-2-ylmethyl)-6-hydroxy-2-methoxy-benzamide|3-Chloro-5-ethyl-N-(1-ethyl-pyrrolidin-2-ylmethyl)-6-hydroxy-2-methoxy-benzamide|3-Chloro-5-ethyl-N-(1-ethyl-pyrrolidin-2-ylmethyl)-6-hydroxy-2-methoxy-benzamide (etichlopride)|3-Chloro-5-ethyl-N-(1-ethyl-pyrrolidin-2-ylmethyl)-6-hydroxy-2-methoxy-benzamide(Eticlopride)|Eticlopride;3-Chloro-5-ethyl-N-(1-ethyl-pyrrolidin-2-ylmethyl)-6-hydroxy-2-methoxy-benzamide|ETQ"
RISPERIDONE,5073,,"InChI=1S/C23H27FN4O2/c1-15-18(23(29)28-10-3-2-4-21(28)25-15)9-13-27-11-7-16(8-12-27)22-19-6-5-17(24)14-20(19)30-26-22/h5-6,14,16H,2-4,7-13H2,1H3",RAPZEAPATHNIPO-UHFFFAOYSA-N,C23H27FN4O2,410.5,"3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one","risperidone|106266-06-2|Risperdal|Rispolept|Risperdal Consta|Risperin|Rispolin|Sequinan|Risperidona|Risperidal M-Tab|Risperidonum|Risperdal M-Tab|Spiron|R 64 766|Perseris|RYKINDO|UZEDY|R 64766|R-64766|R 64,766|DTXSID8045193|L6UH7ZF8HC|NSC-759895|RISVAN|CHEBI:8871|R-64,766|R-64-766|N05AX08|RCN3028|RCN-3028|LY-03004|DTXCID6025193|4H-Pyrido(1,2-a)pyrimidin-4-one, 3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-|Consta, Risperdal|4H-Pyrido(1,2-a)pyrimidin-4-one, 6,7,8,9-tetrahydro-3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-2-methyl-|3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one|3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-4H,6H,7H,8H,9H-pyrido[1,2-a]pyrimidin-4-one|4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-|Risperdal M|Risperdal quicklet|Risperidone M-tab|R64766|3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido(1,2-a)pyrimidin-4-one|3-(2-(4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-4H,6H,7H,8H,9H-pyrido(1,2-a)pyrimidin-4-one|3-(2-(4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydropyrido(2,1-b)pyrimidin-4-one|3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one|3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[2,1-b]pyrimidin-4-one|R64,766|PERSERIS KIT|RefChem:6202|Risperdal Consta Long Acting|Rykindo extended-release microspheres|Risperidal|MFCD00274576|Belivon|C23H27FN4O2|Risperidone impurity K|3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one|CHEMBL85|3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one|Apexidone|Risperidonum [Latin]|Risperidona [Spanish]|106266-06-2 (free base)|3-(2-(4-(6-Fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one|3-[2-[4-(6-fluoro-1,2-benzoxazol-3-yl)-1-piperidyl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one|NCGC00015883-05|CAS-106266-06-2|3-{2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one|3-{2-[4-(6-FLUORO-BENZO[D]ISOXAZOL-3-YL)-PIPERIDIN-1-YL]-ETHYL}-2-METHYL-6,7,8,9-TETRAHYDRO-PYRIDO[1,2-A]PYRIMIDIN-4-ONE|Psychodal|Zophrenal|Risperdal (TN)|3-[2-[4-(6-fluoranyl-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl]-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one|3-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino]ethyl}-6,7,8,9-tetrahydro-2-methylpyrido[1,2-a]pyrimidin-4-one|SMR000466323|SR-01000075399|UNII-L6UH7ZF8HC|BRN 4891881|Relday|Rispen|Okedi|Risperidone-ISM|HSDB 7580|Risperidone???|3-(2-(4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl)ethyl)-6,7,8,9-tetrahydro-2-methyl-4h-pyrido(1,2-a)pyrimidin-4-one|3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl}-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one|Risperidone [USAN:USP:INN:BAN]|Risperidone; 4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl- (9CI); 1,2-Benzisoxazole, 4H-pyrido[1,2-a]pyrimidin-4-one deriv.; R 64766; Risperdal; Spiron|3-(2-(4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperidino)ethyl)-6,7,8,9-tetrahydro-2-methyl-4H-pyrido(1,2-a)pyrimidin-4-one|KS-1106|Risperidone (Standard)|Risperidone (Risperdal)|Lopac-R-118|RISPERIDONE [MI]|Prestwick0_001029|Prestwick1_001029|RISPERIDONE [INN]|RISPERIDONE [JAN]|RISPERIDONE [HSDB]|RISPERIDONE [USAN]|GTPL96|RISPERIDONE [VANDF]|RISPERIDONE [MART.]|Risperidone(R 64 766)|SCHEMBL27911|RISPERIDONE [USP-RS]|RISPERIDONE [WHO-DD]|MLS000759429|MLS001165758|MLS001424081|US8802672, Risperidone|BIDD:GT0262|R 62 766|SPBio_003078|Risperidone;Apexidone;Psychodal|orb1310697|SCHEMBL3146202|Risperidone (JP17/USP/INN)|Risperidone - Bio-X trade mark|SCHEMBL29392548|Risperidone, 1mg/ml in Methanol|RISPERIDONE [EP IMPURITY]|RISPERIDONE [ORANGE BOOK]|GLXC-06632|HMS1571M19|HMS2051H07|HMS2089C22|HMS2098M19|HMS2233O11|HMS3373M18|HMS3393H07|HMS3657G13|HMS3715M19|HMS3753M15|HMS3887G15|HMS5087G17|Pharmakon1600-01506038|RISPERIDONE [EP MONOGRAPH]|RISPERIDONE [USP IMPURITY]|RISPERIDONE [USP MONOGRAPH]|ALBB-038668|BCP08161|MSK10162|Risperidone 1.0 mg/ml in Methanol|Tox21_110253|BDBM50001885|CP-018|HB1740|HY-11018R|NSC759895|NSC786035|NSC801188|s1615|STK646402|AKOS005577302|Tox21_110253_1|AC-1306|CCG-100930|CS-1619|DB00734|FR27737|LY03004|NC00180|NSC 759895|NSC-786035|NSC-801188|PB26023|Risperidone, >=98% (HPLC), powder|NCGC00015883-01|NCGC00015883-02|NCGC00015883-03|NCGC00015883-04|NCGC00015883-06|NCGC00015883-07|NCGC00015883-08|NCGC00015883-11|NCGC00094352-01|NCGC00094352-02|NCGC00094352-03|NCGC00179257-01|1026102-43-1|3-[2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)piperi-dino]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]-pyrimidin-4-one|3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one|BR164349|HY-11018|SY051250|AB00514010|EU-0101074|NS00000033|R0087|SW197348-4|66R062|D00426|EN300-117259|AB00514010-09|AB00514010-11|AB00514010-12|AB00514010_13|AB00514010_14|L000510|Q412443|SR-01000075399-2|SR-01000075399-8|BRD-K53857191-001-04-5|BRD-K53857191-001-10-2|BRD-K53857191-001-21-9|BRD-K53857191-001-22-7|Z1501480428|Risperidone, British Pharmacopoeia (BP) Reference Standard|Risperidone, European Pharmacopoeia (EP) Reference Standard|Risperidone, United States Pharmacopeia (USP) Reference Standard|Risperidone, Pharmaceutical Secondary Standard; Certified Reference Material|Risperidone for system suitability, European Pharmacopoeia (EP) Reference Standard|(risperidone)3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one|2-(2-(4-(benzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-7,8,9,9a-tetrahydro-1H-pyrido[1,2-a]pyrimidin-4(6H)-one|2-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-6,7,8,8a-tetrahydro-5H-naphthalen-1-one|3-(2-(4-(6-fluorobenzo[d]isoxazol-3-yl)piperidin-1-yl)ethyl)-2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one|3-[2-[4(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one|3-[2-[4(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl4H-pyrido[1,2-a]pyrimidin-4-one|3-[2-[4-(6 fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one|3-[2-[4-(6-fluoro- 1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl4H-pyrido[1,2-a]pyrimidin-4-one|3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidiny]ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one|3-[2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-ethyl]-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-A]pyrimidin-4-one|3-[2-4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one;Apexidone;Ps   ychodal|3-{2-[4-(6-Fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]-ethyl}- 6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimidin-4-one|3-{2-[4-(6-fluoro-1,2-benzisoxazol-3-yl)-1-piperidinyl]ethyl}-6,7,8,9-tetrahydro-2-methyl-4H-pyrido[1,2-a]pyrimid-in-4-one|3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (Resperidone)|3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one (risperidone)|3-{2-[4-(6-Fluoro-benzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-pyrido[1,2-a]pyrimidin-4-one(risperidone)|3-{2-[4-(6-fluorobenzo[d]isoxazol-3-yl)-piperidin-1-yl]-ethyl}-2-methyl-6,7,8,9-tetrahydro-4H-pyrido[1,2-a]pyrimidin-4-one|4H-Pyrido[1,2-a]pyrimidin-4-one, 3-[2-[4-(6-fluoro-1,2-benz-isoxazol-3-yl)-1-piperidinyl]ethyl]-6,7,8,9-tetrahydro-2-methyl-|5-[2-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-ethyl]-6-methyl-1,3-dihydro-indol-2-one(Norastemizole)"
LEVOSULPIRIDE,688272,,"InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)/t11-/m0/s1",BGRJTUBHPOOWDU-NSHDSACASA-N,C15H23N3O4S,341.4,N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide,"Levosulpiride|23672-07-3|(-)-Sulpiride|Levopraid|Levopride|Levosulpirida|Levobren|L-Sulpiride|lesuride|Levosulpiridum|Sulpiride, (s)-|Sulpiride, (-)-|JTG7R315LK|CHEBI:64119|(-)-N-(((S)-1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide|(S)-(-)-N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide|S-(-)-N-(1-Ethyl-2-pyrrolidinomethyl)-2-methoxy-5-sulfamoylebenzamide|Sulpiride l-|RefChem:153234|N05AL07|N-(((S)-1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide|(S)-(-)-sulpiride|S-(-)-Sulpiride|(S)-sulpiride|Levosulpiride [INN]|MFCD00055220|N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-methoxy-5-sulfamoylbenzamide|Sulpiride l-form|DTXSID0042583|RV-12309|(S)-(-)-5-aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide|Benzamide, 5-(aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-|N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoylbenzamide|Levosulpiride (INN)|NCGC00024853-05|(S)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide|Levosulpiridum [INN-Latin]|Levosulpirida [INN-Spanish]|DTXCID8022583|Nexipride|(S)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide|SMR000466366|CAS-23672-07-3|SULPIRIDE,(+)|UNII-JTG7R315LK|Levogastrol|Sulpiride-l|Sulpiride-S|(S)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide|BENZAMIDE, 5-(AMINOSULFONYL)-N-(((2S)-1-ETHYL-2-PYRROLIDINYL)METHYL)-2-METHOXY-|N-[((2S)-1-ethylpyrrolidin-2-yl)methyl](6-methoxy-3-sulfamoylphenyl)carboxamid e|Levopraid (TN)|CAS-15676-16-1|Tocris-0895|Sulpiride [L-(-)]|Biomol-NT_000030|Levosulpiride (Levogastrol)|Lopac0_001089|SCHEMBL70112|GTPL958|MLS000759490|MLS001424014|LEVOSULPIRIDE [MART.]|LEVOSULPIRIDE [WHO-DD]|SULPIRIDE L-FORM [MI]|BPBio1_001221|CHEMBL267044|orb1309390|SCHEMBL29406121|BDBM81774|Levosulpiride - Bio-X trade mark|HMS2051A08|HMS2089E04|HMS2232P10|HMS3263I20|HMS3266P14|HMS3411D20|HMS3675D20|HMS3884H07|HY-B1059|Tox21_110933|Tox21_501089|HB1836|PDSP1_000516|PDSP1_000620|PDSP1_001649|PDSP2_000514|PDSP2_000616|s2104|SBB058180|AKOS007930553|AKOS015897363|Tox21_110933_1|AC-6821|BCP9000853|CCG-100847|CS-4581|KS-5103|LP01089|NC00097|SDCCGSBI-0051059.P002|Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-, (S)-|Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoyl-, S-(-)-|NCGC00015966-10|NCGC00016718-01|NCGC00024853-01|NCGC00024853-02|NCGC00024853-03|NCGC00024853-04|NCGC00024853-06|NCGC00024853-09|NCGC00024853-11|NCGC00261774-01|BL166176|SY057391|BCP0726000072|CAS_15676-16-1|(S)-(-)-Sulpiride, >=98% (titration)|EU-0101089|I0821|NS00076154|ST50319539|SW197477-2|D07312|H11356|S 7771|AB00639965-06|AB00639965-08|AB00639965_09|EN300-7390775|672L073|A816834|SR-01000076136|SR-01000597436|Q1452256|SR-01000076136-2|SR-01000597436-1|BRD-K51671335-001-01-5|BRD-K51671335-001-04-9|BRD-K51671335-001-09-8|BRD-K51671335-001-10-6|(S)-(-)-Sulpiride, VETRANAL(TM), analytical standard|N-[(1-ethylpyrrolidin-2-yl)methyl]-5-methoxy-2-sulfamoyl-benzamide|(-)-5-Aminosulfonyl-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide|N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-methoxy-5-sulfamoyl-benzamide|o-ANISAMIDE, N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-5-SULFAMOYL-, (S)-(-)-|5-(Aminosulfonyl)-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-methoxy-benzamide;(-)-N-[(1-Ethyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-a nisamide;Levosulpiride|5-HT6 Serotonin Receptor from rat, recombinant, expressed in HEK 293 cells, membrane suspension|U6X"
RACLOPRIDE,3033769,,"InChI=1S/C15H20Cl2N2O3/c1-3-19-6-4-5-9(19)8-18-15(21)12-13(20)10(16)7-11(17)14(12)22-2/h7,9,20H,3-6,8H2,1-2H3,(H,18,21)/t9-/m0/s1",WAOQONBSWFLFPE-VIFPVBQESA-N,C15H20Cl2N2O3,347.2,"3,5-dichloro-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide","RACLOPRIDE|84225-95-6|Racloprida|Raclopridum|Raclopridum [Latin]|Racloprida [Spanish]|DTXSID9045687|Raclopride [INN:BAN]|S-raclopride|430K3SOZ7G|RACLOPRIDE [INN]|RACLOPRIDE [MART.]|RACLOPRIDE [WHO-DD]|DTXCID7025687|Raclopridum (Latin)|RACLOPRIDE (MART.)|raclopride c11 injection|RefChem:389259|Benzamide, 3,5-dichloro-N-((1-ethyl-2-pyrrolidinyl)-methyl)-2-hydroxy-6-methoxy-|(S)-3,5-dichloro-N-((1-ethylpyrrolidin-2-yl)methyl)-2-hydroxy-6-methoxybenzamide|S(-)-RACLOPRIDE L-TARTRATE|3,5-dichloro-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxybenzamide|MFCD02179386|CHEMBL8809|FLA 870|C15H20Cl2N2O3|NCGC00025303-03|[3H]raclopride|3,5-dichloro-N-{[(2s)-1-ethylpyrrolidin-2-yl]methyl}-2-hydroxy-6-methoxybenzamide|[3H]-raclopride|SMR000449275|CAS-84225-95-6|SR-01000597538|UNII-430K3SOZ7G|(S)-3,5-DICHLORO-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-2-HYDROXY-6-METHOXYBENZAMIDE|(S)-3,5-Dichloro-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-hydroxy-6-methoxybenzamide|(-)-raclopride|S-(-)-raclopride|Tocris-1810|Biomol-NT_000027|GTPL94|3,5-Dichloro-N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-6-methoxybenzamide|MLS000758220|MLS001423957|SCHEMBL116054|BPBio1_001215|GTPL3299|orb1299640|CHEBI:92070|3,5-Dichloro-N-(1-ethyl-pyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxy-benzamide(Raclopride)|GLXC-23557|HMS2051C03|HMS2089C20|HMS2232D05|HMS3268I08|HMS3412J08|HMS3676J08|HMS3713O20|EX-A5252|Tox21_110961|BDBM50005118|PDSP1_000924|AKOS015966951|Tox21_110961_1|CCG-100752|DB12518|NC00002|SDCCGSBI-0051054.P002|NCGC00025303-01|NCGC00025303-02|NCGC00025303-04|NCGC00025303-05|NCGC00025303-06|NCGC00025303-10|AS-73734|DA-77328|FR106321|SY106018|HY-103414|CS-0027846|NS00015036|R0094|D82063|AB00639928-12|A-40664|Q7279814|SR-01000597538-1|SR-01000597538-3|BRD-K04111260-001-01-9|BRD-K04111260-001-05-0|BRD-K04111260-001-10-0|(-)-(S)-3,5-Dichlor-N-((1-ethyl-2-pyrrolidinyl)methyl)-6-hydroxy-o-anisamid|(-)-(S)-3,5-Dichloro-N-((1-ethyl-2-pyrrolidinyl)methyl)-6-hydroxy-o-anisamide|(S)-3,5-DICHLORO-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)-6-HYDROXY-O-ANISAMIDE|(S)-3,5-Dichloro-N-(1-ethyl-pyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxy-benzamide|(S)3,5-Dichloro-N-(1-ethyl-pyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxy-benzamide|3,5-Dichloro-N-((S)-1-ethyl-pyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxy-benzamide|3,5-Dichloro-N-(1-ethyl-pyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxy-benzamide (raclopride)|3,5-dichloro-N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-6-methoxy-benzamide|Benzamide, 3,5-dichloro-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-hydroxy-6-methoxy-, (-)-|Raclopride;3,5-Dichloro-N-(1-ethyl-pyrrolidin-2-ylmethyl)-2-hydroxy-6-methoxy-benzamide|104953-11-9"
DOFETILIDE,71329,,"InChI=1S/C19H27N3O5S2/c1-22(13-12-16-4-6-17(7-5-16)20-28(2,23)24)14-15-27-19-10-8-18(9-11-19)21-29(3,25)26/h4-11,20-21H,12-15H2,1-3H3",IXTMWRCNAAVVAI-UHFFFAOYSA-N,C19H27N3O5S2,441.6,N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide,"Dofetilide|115256-11-6|Tikosyn|Dofetilida|Dofetilidum|UK-68,798|UK-68798|DTXSID5046433|Methanesulfonamide, N-[4-[2-[methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]-|R4Z9X1N2ND|beta-((p-Methanesulfonamidophenethyl)methylamino)methanesulfono-p-phenetidide|CHEBI:4681|DTXCID3026433|N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]methanesulfonamide|Methanesulfonamide, N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl)-|1-MSPMPE|N-(4-{2-[methyl(2-{4-[(methylsulfonyl)amino]phenoxy}ethyl)amino]ethyl}phenyl)methanesulfonamide|N-(4-(2-(2-(4-methanesulfonamidophenyl)ethyl-methylamino)ethoxy)phenyl)methanesulfonamide|N-[4-[2-[2-(4-methanesulfonamidophenyl)ethyl-methylamino]ethoxy]phenyl]methanesulfonamide|Dofetilide 0.5mg|N-(4-(2-((2-(4-methanesulfonamidophenoxy)ethyl)(methyl)amino)ethyl)phenyl)methanesulfonamide|N-(4-(2-(methyl(2-(4-((methylsulfonyl)amino)phenoxy)ethyl)amino)ethyl)phenyl)methanesulfonamide|N-[4-(2-{[2-(4-methanesulfonamidophenoxy)ethyl](methyl)amino}ethyl)phenyl]methanesulfonamide|DOFETILDE|1-(4-methanesulfonamidophenoxy)-2-(N-(4-methanesulfonamidophenethyl)-N-methylamine)ethane|Dofetilide 0.25mg|Dofetilide 0.125mg|RefChem:57792|C01BD04|Dofetilidum [INN-Latin]|Dofetilida [INN-Spanish]|UK 68798|N-(4-(2-(methyl(2-(4-(methylsulfonamido)phenoxy)ethyl)amino)ethyl)phenyl)methanesulfonamide|MFCD00869707|C19H27N3O5S2|CHEMBL473|N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methylamino]ethyl]phenyl]methanesulfonamide|NCGC00164549-01|Dofetilide (>90%)|Xelide|SMR000466333|Tikosyn (TN)|CAS-115256-11-6|UK 68,798|UNII-R4Z9X1N2ND|HSDB 7927|N-[4-[2-[Methyl[2-[4-(methylsulfonamido)phenoxy]ethyl]amino]ethyl]phenyl]methanesulfonamide|Dofetilide [USAN:USP:INN:BAN]|Dofetilide (Tikosyn)|UK68798|Dofetilide (Standard)|Dofetilide (Tikosyn)?|DOFETILIDE [MI]|DOFETILIDE [INN]|DOFETILIDE [JAN]|DOFETILIDE [USAN]|DOFETILIDE [VANDF]|DOFETILIDE [MART.]|1-(4-Methanesulphonamidophenoxy)-2-[N-(4-methanesulphonamidophenethyl)-N-methylamino]ethane|DOFETILIDE [USP-RS]|DOFETILIDE [WHO-DD]|SCHEMBL16135|Dofetilide (JAN/USP/INN)|MLS000759442|MLS001424185|MLS006010154|DOFETILIDE [EMA EPAR]|Dofetilide - Bio-X trade mark|GTPL2604|orb1300735|DOFETILIDE [ORANGE BOOK]|Dofetilide, >=98% (HPLC)|HY-B0232R|DOFETILIDE [USP MONOGRAPH]|GLXC-05217|HMS2051N14|HMS2089F03|HMS2232H19|HMS3261G03|HMS3370B18|HMS3393N14|HMS3655A17|HMS3715H20|HMS5079J08|BCP04770|HY-B0232|Tox21_112178|Tox21_500351|AC-385|BDBM50031720|HB1078|NSC786034|s1658|AKOS005259921|Tox21_112178_1|BCP9000619|CCG-101037|DB00204|FD09968|NC00287|NSC-786034|UK68789|MRF-0000317|N-[4-[2-[2-[4-(methanesulfonamido)phenoxy]ethyl-methyl-amino]ethyl]phenyl]methanesulfonamide|NCGC00164549-02|NCGC00261036-01|BD164377|SY227006|UK 68789|BCP0726000009|DB-041252|NS00068338|SW197667-2|C07751|D00647|H11953|AB00639976-06|AB00639976-08|AB00639976_09|256D116|EN300-19768191|SR-01000759368|Q3712521|SR-01000759368-4|BRD-K86887724-001-05-6|BRD-K86887724-001-09-8|BRD-K86887724-001-10-6|Dofetilide, United States Pharmacopeia (USP) Reference Standard|.BETA.-((P-METHANESULFONAMIDOPHENETHYL)METHYLAMINO)METHANESULFONO-P-PHENETIDIDE|1-(4-Methansulphonamidophenoxy)-2-[N-(4-methanesulphonamidophenethyl)-N-methylamino]ethane|(Dofetilide) N-[4-(2-{[2-(4-Methanesulfonylamino-phenyl)-ethyl]-methylamino}-ethoxy)-phenyl]-methanesulfonamide|1-(4-Methanesulphonamidophenoxy)-2-[N-(4-methanesulphonamidophenethyl)-N-methylamino]ethane; Dofetilide; Tikosyn|N-[4-(2-{[2-(4-methanesulfonamidophenyl)ethyl](methyl)amino}ethoxy)phenyl]methanesulfonamide|N-[4-(2-{[2-(4-methanesulfonylamino-phenoxy)-ethyl]-methyl-amino}-ethyl)-phenyl]-methanesulfonamide|N-[4-(2-{[2-(4-Methanesulfonylamino-phenyl)-ethyl]-methyl-amino}-ethoxy)-phenyl]-methanesulfonamide (dofetilide)|N-[4-(2-{[2-(4-Methanesulfonylamino-phenyl)-ethyl]-methyl-amino}-ethoxy)-phenyl]-methanesulfonamide (UK-68798)|N-[4-(2-{[2-(4-METHANESULFONYLAMINO-PHENYL)-ETHYL]-METHYL-AMINO}-ETHOXY)-PHENYL]-METHANESULFONAMIDE DOFETILIDE|N-[4-[2-[Methyl[2-[4-[(methylsulfonyl)amino]phenoxy]ethyl]amino]ethyl]phenyl]-methanesulfonamide; UK-68798; Tikosyn;"
SERTINDOLE,60149,,"InChI=1S/C24H26ClFN4O/c25-18-1-6-23-21(15-18)22(16-30(23)20-4-2-19(26)3-5-20)17-7-10-28(11-8-17)13-14-29-12-9-27-24(29)31/h1-6,15-17H,7-14H2,(H,27,31)",GZKLJWGUPQBVJQ-UHFFFAOYSA-N,C24H26ClFN4O,440.9,1-[2-[4-[5-chloro-1-(4-fluorophenyl)indol-3-yl]piperidin-1-yl]ethyl]imidazolidin-2-one,"SERTINDOLE|106516-24-9|SerLect|Serdolect|Sertindol|Sertindolum|Lu 23-174|zerdol|Lu-23-174|1-[2-[4-[5-chloro-1-(4-fluorophenyl)indol-3-yl]piperidin-1-yl]ethyl]imidazolidin-2-one|GVV4Z879SP|CHEBI:9122|1-(2-(4-(5-Chloro-1-(4-fluorophenyl)-1H-indol-3-yl)piperidin-1-yl)ethyl)imidazolidin-2-one|DTXSID6048967|1-(2-{4-[5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl]piperidin-1-yl}ethyl)imidazolidin-2-one|DTXCID3028893|1-(2-(4-(5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl)-1-piperidinyl)ethyl)-2-imidazolidinone|1-[2-[4-[5-chloro-1-(4-fluorophenyl)-indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|1-[2-[4-[5-chloro-1-(4-fluorophenyl)-1h-indol-3-yl]-1-piperidinyl]ethyl]-2-imidazolidinone|1-(2-(4-(5-chloro-1-(4-fluorophenyl)-indol-3-yl)-1-piperidyl)ethyl)imidazolidin-2-one|1-(2-(4-(5-chloro-1-(4-fluorophenyl)indol-3-yl)piperidin-1-yl)ethyl)imidazolidin-2-one|1-(2-{4-[5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl]-1-piperidinyl}ethyl)-2-imidazolidinone|RefChem:884944|N05AE03|Sertindol [INN-Spanish]|Sertindolum [INN-Latin]|MFCD00867749|CHEMBL12713|1-(2-(4-(5-Chloro-1-(p-fluorophenyl)indol-3-yl)piperidino)ethyl)-2-imidazolidinone|NCGC00181782-01|NCGC00181782-02|2-Imidazolidinone, 1-(2-(4-(5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl)-1-piperidinyl)ethyl)-|C24H26ClFN4O|1-(2-{4-[5-Chloro-1-(p-fluorophenyl)indol-3-yl]piperidino}ethyl)-2-imidazolidinone|2-Imidazolidinone, 1-[2-[4-[5-chloro-1-(4-fluorophenyl)-1H-indol-3-yl]-1-piperidinyl]ethyl]-|SerLect (TN)|CAS-106516-24-9|Sertindole (USAN/INN)|UNII-GVV4Z879SP|Sertindole [USAN:INN:BAN]|Sertindole?|1-(2-(4-(5-Chloro-1-(4-fluorophenyl)-1H-indole-3-yl)-1-piperidinyl)ethyl)-2-imidazolidinone|PS35 - Sertindole|SERTINDOLE [MI]|SERTINDOLE [INN]|SERTINDOLE [USAN]|SERTINDOLE [VANDF]|GTPL98|S-1991|SERTINDOLE [MART.]|SERTINDOLE [WHO-DD]|MLS003899237|SCHEMBL112092|orb1301425|SCHEMBL29360085|EX-A883|HMS3713P22|BCP27121|Sertindole, >=97.5% (HPLC)|UWC73742|Tox21_113408|Tox21_113421|BDBM50001786|MSK161657|PDSP1_001561|PDSP2_001545|AKOS015962616|Tox21_113421_1|CCG-220640|DB06144|FS65165|1-[2-[4-[5-chloro-1-(4-fluorophenyl)indol-3-yl]-1-piperidyl]ethyl]imidazolidin-2-one|5-chloro-1-(4-fluorophenyl)-3-[1-[2-(2-imidazolidinon-1-yl)ethyl]-4-piperidyl]-1H-indole|NCGC00181782-03|AC-32937|AS-56243|HY-14543|SMR002204118|NS00005623|S0942|C07567|D00561|EN300-19767761|L001396|Q418050|SR-01000872708|SR-01000872708-1|BRD-K69116396-001-04-1|5-Chloro-1-(4'-fluorophenyl)-3-(1-(2-(2imidazolidinon-1-yl)ethyl)-4-piperidyl)-1H-indole|5-Chloro-1-(4'-fluorophenyl)-3-(1-(2-imidazolidinon-1-ylethyl)-4-piperidyl)-1H-indole|1-(2-{4-[5-CHLORO-1-(4-FLUORO-PHENYL)-1H-INDOL-3-YL]-PIPERIDIN-1-YL}-ETHYL)-IMIDAZOLIDIN-2-ONE"
PIMOZIDE,16362,,"InChI=1S/C28H29F2N3O/c29-22-11-7-20(8-12-22)25(21-9-13-23(30)14-10-21)4-3-17-32-18-15-24(16-19-32)33-27-6-2-1-5-26(27)31-28(33)34/h1-2,5-14,24-25H,3-4,15-19H2,(H,31,34)",YVUQSNJEYSNKRX-UHFFFAOYSA-N,C28H29F2N3O,461.5,"3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one","pimozide|2062-78-4|Orap|Opiran|Pimozidum|pimozida|McN-JR-6238|Neoperidole|R-6238|R 6238|R6238|DTXSID8023474|1HIZ4DL86F|NSC-170984|CHEBI:8212|3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1H-benzimidazol-2-one|NSC170984|DTXCID803474|R 623|R-623|1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-2,3-dihydro-1H-1,3-benzodiazol-2-one|Orap forte|1-{1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl}-1,3-dihydro-2H-benzimidazol-2-one|3-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-1H-benzimidazol-2-one|1-(1-(4,4-Bis(4-fluorophenyl)butyl)piperidin-4-yl)-1,3-dihydro-2H-benzimidazol-2-one|1-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-one|RefChem:56650|N05AG02|218-171-7|Pimozidum [INN-Latin]|2H-Benzimidazol-2-one, 1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-|MFCD00055081|NSC 170984|McN-JR 6238|1-[1-[4,4-bis(4-Fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidazol-2-one|1-(1-(4,4-Bis(p-fluorophenyl)butyl)-4-piperidyl)-2-benzimidazolinone|1-[1-[4,4-Bis(p-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone|CHEMBL1423|1-(4,4-Bis(p-fluorophenyl)butyl)-4-(2-oxo-1-benzimidazolinyl)piperidine|MLS000028410|MLS002702058|1-(1-(4,4-bis(4-fluorophenyl)butyl)piperidin-4-yl)-1H-benzo[d]imidazol-2(3H)-one|2H-Benzimidazol-2-one, 1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-|NCGC00015802-08|NCGC00015802-18|Primozida|SMR000058385|CAS-2062-78-4|3-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidyl]-1H-benzimidazol-2-one|Primozida [INN-Spanish]|C28H29F2N3O|Primozide|Pimozida [INN-Spanish]|1-[4,4-Bis(p-fluorophenyl)butyl]-4-(2-oxo-1-benzimidazolinyl)piperidine|3-[1-[4,4-bis(4-fluorophenyl)butyl]piperidin-4-yl]-1~{H}-benzimidazol-2-one|CCRIS 9172|Orap (TN)|SR-01000075392|EINECS 218-171-7|UNII-1HIZ4DL86F|BRN 0729089|Pimozide?|1-(1-(4,4-bis(4-fluorophenyl)butyl)-4-piperidinyl)-1,3-dihydro-2H-benzimidazol-2-one|1II|Prestwick_395|Pimozide (Standard)|Pimozide [USAN:USP:INN:BAN:JAN]|Spectrum_000445|Tocris-0937|PIMOZIDE [USAN]|PIMOZIDE [INN]|PIMOZIDE [JAN]|PIMOZIDE [MI]|PIMOZIDE [VANDF]|Opera_ID_1580|Prestwick0_000308|Prestwick1_000308|Prestwick2_000308|Prestwick3_000308|Spectrum2_001026|Spectrum3_001451|Spectrum4_000420|Spectrum5_001308|Lopac-P-1793|PIMOZIDE [MART.]|GTPL90|PIMOZIDE [USP-RS]|PIMOZIDE [WHO-DD]|NCIMech_000356|P 1793|Lopac0_000946|SCHEMBL41584|BSPBio_000276|BSPBio_001439|BSPBio_002941|KBioGR_000720|KBioSS_000925|5-24-02-00367 (Beilstein Handbook Reference)|MLS001077311|BIDD:GT0435|DivK1c_000386|SPECTRUM1501134|Pimozide (JP18/USP/INN)|SPBio_001211|SPBio_002495|PIMOZIDE [ORANGE BOOK]|BPBio1_000304|orb1305335|SCHEMBL7519553|PIMOZIDE [EP MONOGRAPH]|PIMOZIDE [USP MONOGRAPH]|SCHEMBL29381325|BCBcMAP01_000043|HMS501D08|KBio1_000386|KBio2_000925|KBio2_003493|KBio2_006061|KBio3_002441|NINDS_000386|GLXC-06097|HMS1568N18|HMS1791H21|HMS1921H19|HMS1989H21|HMS2089C11|HMS2092F09|HMS2095N18|HMS2231P23|HMS3262N14|HMS3267E19|HMS3370N13|HMS3402H21|HMS3411J16|HMS3675J16|HMS3712N18|HMS5083C15|Pharmakon1600-01501134|DXC19357|MSK11217|Tox21_110224|Tox21_301586|Tox21_500946|BDBM50334150|CCG-35918|CCG-36461|CCG-39728|EX-A10246|HY-12987R|NSC757854|s4358|2-Benzimidazolinone, 1-[1-[4,4-bis(p-fluorophenyl)butyl]-4-piperidyl]-|AKOS024458706|Tox21_110224_1|DB01100|FP63878|LP00946|NSC-757854|SDCCGSBI-0050920.P004|IDI1_000386|SMP1_000241|NCGC00015802-01|NCGC00015802-02|NCGC00015802-03|NCGC00015802-04|NCGC00015802-05|NCGC00015802-06|NCGC00015802-07|NCGC00015802-09|NCGC00015802-10|NCGC00015802-11|NCGC00015802-12|NCGC00015802-13|NCGC00015802-14|NCGC00015802-15|NCGC00015802-16|NCGC00015802-26|NCGC00015802-29|NCGC00016601-01|NCGC00022282-03|NCGC00024888-01|NCGC00024888-02|NCGC00024888-03|NCGC00024888-04|NCGC00024888-05|NCGC00024888-06|NCGC00024888-07|NCGC00255294-01|NCGC00261631-01|AS-13916|DA-56876|HY-12987|SBI-0050920.P003|AB00052215|CS-0012921|EU-0100946|NS00003971|SW196639-3|C07566|D00560|EN300-127038|F70142|AB00052215-06|AB00052215_07|AB00052215_08|062P784|L000494|Q144085|WLN: T56 BMVNJ D- DT6NTJ A3YR DF&R DF|SR-01000075392-1|SR-01000075392-3|SR-01000075392-4|SR-01000075392-6|BRD-K01292756-001-06-0|BRD-K01292756-001-13-6|BRD-K01292756-001-23-5|BRD-K01292756-001-24-3|BRD-K01292756-001-25-0|Pimozide, European Pharmacopoeia (EP) Reference Standard|2-Benzimidazolinone,4-bis(p-fluorophenyl)butyl]-4-piperidyl]-|N-benzyl-N-(3-isobutoxy-2-(pyrrolidin-1-yl)propyl)benzenamine|Pimozide, United States Pharmacopeia (USP) Reference Standard|1-[1-[4,4-Bis(4-fluorophenyl)butyl]-4-piperidyl]-2-benzimidazolinone|1-[1-[4,4-Bis(p-flurophenyl)butyl]-4-piperidyl]-2-benzimidazolinone|1-[1-[4,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2h-benzimidazole-2-one|1-{1-[4,4-bis-(4-fluoro-phenyl)-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one|2H-Benzimidazol-2-one,4-bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-|1-{1-[4,4-Bis-(4-fluoro-phenyl)-butyl]-piperidin-4-yl}-1,3-dihydro-benzoimidazol-2-one(Pimozide)|2H-BENZIMIDAZOL-2-ONE, 1-(1-(4,4-BIS(4-FLUOROPHENYL)BUTYL)-4-PIPERIDINYL)-1,3-DIHYDRO|Pimozide (1-[1-[4,4-Bis(4-fluorophenyl)butyl]-4-piperidinyl]-1,3-dihydro-2H-benzimidaol-2-one)|PIMOZIDE1-{1-[4,4-BIS-(4-FLUORO-PHENYL)-BUTYL]-PIPERIDIN-4-YL}-1,3-DIHYDRO-BENZOIMIDAZOL-2-ONE"
DOPAMINE,681,,"InChI=1S/C8H11NO2/c9-4-3-6-1-2-7(10)8(11)5-6/h1-2,5,10-11H,3-4,9H2",VYFYYTLLBUKUHU-UHFFFAOYSA-N,C8H11NO2,153.18,"4-(2-aminoethyl)benzene-1,2-diol","dopamine|4-(2-Aminoethyl)benzene-1,2-diol|51-61-6|3-Hydroxytyramine|Oxytyramine|Hydroxytyramin|Dopamin|3,4-dihydroxyphenethylamine|hydroxytyramine|4-(2-Aminoethyl)catechol|2-(3,4-dihydroxyphenyl)ethylamine|Dopamina|Dopaminum|4-(2-Aminoethyl)pyrocatechol|3,4-Dihydroxyphenylethylamine|4-(2-Aminoethyl)-1,2-benzenediol|ASL 279|1,2-Benzenediol, 4-(2-aminoethyl)-|Dobutamine a|A-dopamine|alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane|Revivan|VTD58H1Z2X|NSC-173182|DTXSID6022420|CHEBI:18243|DTXCID602420|3,4 Dihydroxyphenethylamine|Dopamine 1515|RefChem:6423|200-110-0|Medopa|Dophamine|intropin|L-DOPAMINE|Pyrocatechol, 4-(2-aminoethyl)-|Dopaminum [INN-Latin]|Dopamina [INN-Spanish]|3-Hydroxtyramine|KW-3-060|4-(2-aminoethyl)-pyrocatechol|Dopamine (INN)|Dynatra|NSC 173182|a-(3,4-Dihydroxyphenyl)-b-aminoethane|4-(2-Aminoethyl)-1,2-bezenediol|MFCD00130258|50444-17-2|Revimine|LDP|NCGC00015519-05|Pyrocatechol, 4-(2-aminoethyl)- (8CI)|DOPAMINE [INN]|Dopamine [INN:BAN]|.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane|(3H)-Dopamine|Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride|62-31-7 (HYDROCHLORIDE)|CAS-51-61-6|Medopa (TN)|NSC169105|HSDB 3068|1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)|EINECS 200-110-0|UNII-VTD58H1Z2X|Intropin [*hydrochloride*]|4-(2-Aminoethyl)-1,2-benzenediol hydrochloride|SR-01000075366|.beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride|m-Hydroxytyramine-|Dopamine (USAN)(*hydrochloride*)|IP 498|Intropin (Salt/Mix)|Spectrum_001012|1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium|DOPAMINE [HSDB]|DOPAMINE [MI]|CHEMBL59|DOPAMINE [VANDF]|Spectrum2_001023|Spectrum3_000406|Spectrum4_000525|Spectrum5_000945|Lopac-H-8502|Biomol-NT_000001|bmse000909|bmse000933|DOPAMINE [WHO-DD]|SCHEMBL8505|1, 4-(2-aminoethyl)-|Lopac0_000586|Oprea1_088821|BSPBio_001932|GTPL940|KBioGR_001129|KBioGR_002388|KBioGR_002484|KBioSS_001492|KBioSS_002393|KBioSS_002491|cid_65340|BIDD:ER0506|DivK1c_000780|SPECTRUM1505155|SPBio_001205|BPBio1_001123|153C5321-5FEE-4B0B-8925-F388F0EEEBD1|SCHEMBL10383031|SCHEMBL28165888|SCHEMBL29362033|BDBM55121|KBio1_000780|KBio2_001492|KBio2_002388|KBio2_002484|KBio2_004060|KBio2_004956|KBio2_005052|KBio2_006628|KBio2_007524|KBio2_007620|KBio3_001152|KBio3_002867|KBio3_002962|cMAP_000036|cMAP_000065|NINDS_000780|HMS3743I03|BCP34189|Tox21_110167|2-(3, 4-Dihydroxyphenyl)ethylamine|2-(3,4-dihydroxyphenyl) ethylamine|BBL013043|SBB004044|STK301601|3,4-DihydroxyphenylA currencythylamin|AKOS003790978|Tox21_110167_1|CCG-204675|DB00988|FS-5341|MSK000570-100M|SDCCGSBI-0050568.P005|2-(3,4-Dihydroxyphenyl)-1-ethanamine|4-(2-Amino-ethyl)-benzene-1,2-diol|4-(2-Aminoethyl)-1,2-benzenediol #|IDI1_000780|UPCMLD0ENAT5885989:001|NCGC00015519-01|NCGC00015519-02|NCGC00015519-03|NCGC00015519-04|NCGC00015519-07|NCGC00015519-08|NCGC00015519-09|NCGC00015519-10|NCGC00015519-11|NCGC00015519-13|NCGC00015519-25|NCGC00096050-01|NCGC00096050-02|NCGC00096050-03|NCGC00096050-04|NCGC00096050-05|BP-23276|Dopamine Solution in Methanol, 100ug/mL|ST048774|4-(2-aminoethyl)pyrocatechol;hydrochloride|SBI-0050568.P004|benzene, 1-(2-amino)ethyl-3,4-dihydroxy-|NS00000608|EN300-35022|C03758|D07870|F21485|4-(2-azanylethyl)benzene-1,2-diol;hydrochloride|AB00053463-12|AB00053463_13|AB00053463_14|F221308|L000232|Q170304|SR-01000075366-7|BRD-K43887077-003-25-5|BRD-K43887077-003-26-3|BRD-K43887077-003-27-1|NORADRENALINE TARTRATE IMPURITY C [EP IMPURITY]|DOBUTAMINE HYDROCHLORIDE IMPURITY A [EP IMPURITY]|DOBUTAMINE HYDROCHLORIDESPECIFIED IMPURITY A [EP IMPURITY]|Oseltamivir-d3;Hydroxytyramin;4-(2-Aminoethyl)benzene-1,2-diol|86389-83-5"
FEXOFENADINE,3348,,"InChI=1S/C32H39NO4/c1-31(2,30(35)36)25-17-15-24(16-18-25)29(34)14-9-21-33-22-19-28(20-23-33)32(37,26-10-5-3-6-11-26)27-12-7-4-8-13-27/h3-8,10-13,15-18,28-29,34,37H,9,14,19-23H2,1-2H3,(H,35,36)",RWTNPBWLLIMQHL-UHFFFAOYSA-N,C32H39NO4,501.7,2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid,"fexofenadine|83799-24-0|Carboxyterfenadine|Terfenadine carboxylate|Terfenadine-COOH|Terfenadine acid metabolite|Telfast|Fexofenadina|2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid|4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethylbenzeneacetic acid|2-(4-{1-HYDROXY-4-[4-(HYDROXYDIPHENYLMETHYL)PIPERIDIN-1-YL]BUTYL}PHENYL)-2-METHYLPROPANOIC ACID|MDL 16455|CHEBI:5050|E6582LOH6V|2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]piperidin-1-yl]butyl]phenyl]-2-methylpropanoic acid|DTXSID00861411|MDL-16455|2-[4-(1-hydroxy-4-{4-[hydroxy(diphenyl)methyl]piperidin-1-yl}butyl)phenyl]-2-methylpropanoic acid|Benzeneacetic acid, 4-(1-hydroxy-4-(4-(hydroxydiphenylmethyl)-1-piperidinyl)butyl)-alpha,alpha-dimethyl-|fexofenadinum|2-(4-(1-hydroxy-4-(4-(hydroxy(diphenyl)methyl)piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid|RefChem:5830|DTXCID50197277|R06AX26|alpha-(4-(1-carboxy-1-methylethyl)phenyl)-4-hydroxydiphenylmethyl-1-piperidinebutanol|2-(4-(1-hydroxy-4-(4-(hydroxy(diphenyl)methyl)piperidin-1-ium-1-yl)butyl)phenyl)-2-methylpropanoate|801-893-7|Allegra|Fexofenadine (INN)|CHEMBL914|83799-24-0 (free base)|Benzeneacetic acid,4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-a,a-dimethyl-|MDL-16455; Terfenadine carboxylate|Fexofendine|FEXOFENADINE [INN]|Fexofenadine [INN:BAN]|2-[4-[1-hydroxy-4-[4-[hydroxy(diphenyl)methyl]-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid|Fexofenidine hydrochloride|MDL 16455 hydrochloride|Telfast (TN)|Terfenidine carboxylate hydrochloride|HSDB 7486|NCGC00015453-05|UNII-E6582LOH6V|SR-01000075889|MFCD00871892|Terfenidine carboxylate, MDL 16455|Spectrum_001914|Spectrum2_001179|Spectrum3_001921|Spectrum4_000204|Spectrum5_001474|FEXOFENADINE [MI]|EC 801-893-7|F 9427|FEXOFENADINE [HSDB]|SCHEMBL4900|FEXOFENADINE [VANDF]|Lopac0_000488|BSPBio_003521|KBioGR_000807|KBioSS_002456|FEXOFENADINE [USP-RS]|FEXOFENADINE [WHO-DD]|SPBio_001197|GTPL4819|orb1306379|BDBM22874|KBio2_002449|KBio2_005017|KBio2_007585|KBio3_002742|HMS3261B17|HMS3370C16|BCP11806|HY-B0801|Tox21_500488|BBL029080|STK624102|AKOS005557315|BCP9000683|CCG-204579|DB00950|FF23281|LP00488|SDCCGSBI-0050472.P003|NCGC00015453-03|NCGC00015453-04|NCGC00015453-06|NCGC00015453-10|NCGC00015453-19|NCGC00092389-02|NCGC00092389-03|NCGC00092389-04|NCGC00261173-01|(+/-)-4-(1-Hydroxy-4-(4-(hydroxydiphenyl-methyl)-1- piperidinyl)butyl)-alpha-dimethylbenzeneacetic acid|2-(4-(1-Hydroxy-4-(4-(hydroxydiphenylmethyl)-piperidin-1-yl)butyl)phenyl)-2-methylpropanoic acid|AC-37658|AS-35188|SBI-0050472.P002|DB-016658|DB-226998|CS-0012429|EU-0100488|NS00010515|EN300-58439|C06999|D07958|AB00876239_06|AB00876239_07|439F408|799F240|L000869|Q415122|SR-01000075889-1|BRD-A73368467-003-02-8|BRD-A73368467-003-07-7|BRD-A73368467-003-16-8|BRD-A73368467-003-17-6|BRD-A73368467-003-18-4|(+)-4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzeneacetic-acid|(+/-)-P-(1-HYDROXY-4-(4-(HYDROXYDIPHENYLMETHYL)PIPERIDINO)BUTYL)-.ALPHA.-METHYLHYDRATROPIC ACID|1319714-86-7|2-[4-(1-Hydroxy-4-{4-[hydroxy(diphenyl)methyl]-1-piperidinyl}butyl)phenyl]-2-methylpropanoic acid|2-[4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidyl]butyl]phenyl]-2-methyl-propanoic acid|4-[1-Hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]butyl]-alpha,alpha-dimethyl-benzene-acetic Acid|4-[4-(4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha, alpha-dimethylbenzeneacetic acid|4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl] -alpha,alpha-dimethylbenzeneacetic acid|4-[4-[4-(Hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzeneacetic acid|4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylphenylacetic acid|4-[4[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzeneacetic acid|BENZENEACETIC ACID, 4-(1-HYDROXY-4-(4-(HYDROXYDIPHENYLMETHYL)-1-PIPERIDINYL)BUTYL)-.ALPHA.,.ALPHA.-DIMETHYL-, (+/-)-|racemic 4-[4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-1-hydroxybutyl]-alpha,alpha-dimethylbenzeneacetic acid"
SPIPERONE,5265,,"InChI=1S/C23H26FN3O2/c24-19-10-8-18(9-11-19)21(28)7-4-14-26-15-12-23(13-16-26)22(29)25-17-27(23)20-5-2-1-3-6-20/h1-3,5-6,8-11H,4,7,12-17H2,(H,25,29)",DKGZKTPJOSAWFA-UHFFFAOYSA-N,C23H26FN3O2,395.5,"8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one","spiperone|749-02-0|Spiropitan|Spiroperidol|Espiperona|Spiperonum|R 5147|DTXSID5045205|8-(3-(p-Fluorobenzoyl)propyl)-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one|8-(3-p-Fluorobenzoyl-1-propyl)-4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decane|NSC-170983|8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one|4X6E73CJ0Q|CHEBI:9233|1,3,8-Triazaspiro(4.5)decan-4-one, 8-(4-(4-fluorophenyl)-4-oxobutyl)-1-phenyl-|R-5147|DTXCID3025205|Spiroperone|8-[3-(p-Fluorobenzoyl)propyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one|1,3,8-Triazaspiro[4.5]decan-4-one, 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-|8-(4-(4-Fluorophenyl)-4-oxobutyl)-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one|8-(4-(4-fluorophenyl)-4-oxobutyl)-1-phenyl-1,3,8-triazaspiro(4.5)decan-4-one|RefChem:888546|212-024-0|[3H]spiperone|[3H]-spiperone|E 525|NSC 170983|MLS000028615|Spiroperidol;R-5147|SMR000058674|CHEMBL267930|Butyrophenone, 4'-fluoro-4-(4-oxo-1-phenyl-1,3,8-triazaspiro(4,5)decan-8-yl)-|NSC170983|NCGC00015964-09|CAS-749-02-0|1,3,8-Triazaspiro(4.5)decan-4-one, 8-(3-(p-fluorobenzoyl)propyl)-1-phenyl-|8-[4-(4-fluorophenyl)-4-oxidanylidene-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one|Spiroperidone|Spiperonum [INN-Latin]|Espiperona [INN-Spanish]|1,3,8-Triazaspiro[4.5]decan-4-one, 8-[3-(p-fluorobenzoyl)propyl]-1-phenyl-|Spiperone [USAN:INN:BAN:JAN]|EINECS 212-024-0|BRN 0632204|UNII-4X6E73CJ0Q|SR-01000000261|Spiperone, solid|Spiropitan (TN)|Prestwick_624|[3H]-Spiroperidol|Spectrum_001143|Tocris-0995|SPIPERONE [INN]|SPIPERONE [JAN]|SPIPERONE [MI]|Spiperone (JAN/USAN)|regid855701|SPIPERONE [USAN]|Opera_ID_1551|Prestwick0_000288|Prestwick1_000288|Prestwick2_000288|Prestwick3_000288|Spectrum2_001426|Spectrum3_001460|Spectrum4_000451|Spectrum5_000987|Lopac-S-7395|GTPL99|SPIPERONE [MART.]|4-Phenyl-8-[3-(4-fluorobenzoyl)propyl]-1-oxo-2,4,8-triazaspiro[4,5]decane|cid_5265|SPIPERONE [WHO-DD]|Lopac0_001069|REGID_for_CID_5265|BSPBio_000196|BSPBio_002959|KBioGR_000862|KBioSS_001623|MLS001076321|DivK1c_000566|SCHEMBL116031|SPECTRUM1501152|SPBio_001532|SPBio_002415|BPBio1_000216|GTPL3300|orb1310763|BDBM21397|HMS501M08|KBio1_000566|KBio2_001623|KBio2_004191|KBio2_006759|KBio3_002459|TQP0726|NINDS_000566|HMS1568J18|HMS1921L09|HMS2089E16|HMS2092H17|HMS2095J18|HMS2235E11|HMS3371L01|HMS3712J18|Pharmakon1600-01501152|HY-B1371|MSK11215|Tox21_110269|CCG-38975|MFCD00055099|NSC757864|AKOS024282958|Tox21_110269_1|NSC-757864|SDCCGSBI-0051039.P004|8-[4-(4-fluorophenyl)-4-oxo-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one|8-[4-(4-fluorophenyl)-4-oxobutyl]-4-phenyl-2,4,8-triazaspiro[4.5]decan-1-one|IDI1_000566|NCGC00015964-01|NCGC00015964-02|NCGC00015964-03|NCGC00015964-04|NCGC00015964-05|NCGC00015964-06|NCGC00015964-07|NCGC00015964-08|NCGC00015964-10|NCGC00015964-11|NCGC00015964-12|NCGC00015964-13|NCGC00015964-17|NCGC00015964-25|NCGC00016536-01|NCGC00022260-02|NCGC00022260-04|NCGC00022260-05|NCGC00022260-06|NCGC00022260-07|DA-77979|MS-26659|ST059306|SBI-0051039.P003|AB00052224|CS-0013110|NS00042134|D01051|AB00052224-15|AB00052224_16|L000569|Q3077150|SR-01000000261-5|SR-01000000261-8|BRD-K55468218-001-05-5|BRD-K55468218-001-26-1|BRD-K55468218-003-01-0|BRD-K55468218-003-02-8|WLN: T6N DXTJ A3VR DF& D-& CT5MVXN EHJ DR|8-[3-(p-Fluorobenzoyl)propyl]-1-phenyl-1,8-triazaspiro[4.5]decan-4-one|1,8-Triazaspiro[4.5]decan-4-one, 8-[3-(p-fluorobenzoyl)propyl]-1-phenyl-|1,8-Triazaspiro[4.5]decan-4-one, 8-[4-(4-fluorophenyl)-4-oxobutyl]-1-phenyl-|8-[4-(4-fluorophenyl)-4-keto-butyl]-1-phenyl-1,3,8-triazaspiro[4.5]decan-4-one|8-[4-(4-fluorophenyl)-4-oxo-butyl]-4-phenyl-2,4,8-triazaspiro[4.5]decan-1-one|1-(4-Fluorophenyl)-4-(4-hydroxy-1-phenyl-1,3,8-triazaspiro[4.5]dec-3-en-8-yl)-1-butanone #|SIP"
AZAPERONE,15443,,"InChI=1S/C19H22FN3O/c20-17-8-6-16(7-9-17)18(24)4-3-11-22-12-14-23(15-13-22)19-5-1-2-10-21-19/h1-2,5-10H,3-4,11-15H2",XTKDAFGWCDAMPY-UHFFFAOYSA-N,C19H22FN3O,327.4,1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one,"Azaperone|1649-18-9|Stresnil|Azaperon|Suicalm|Fluoperidol|Azaperona|R-1929|1-Butanone, 1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-|Azaperonum|NSC 170976|R 1929|1-(3-(4-Fluorobenzoyl)propyl)-4-(2-pyridyl)piperazine|4'-Fluoro-4-(4-(2-pyridyl)-1-piperazinyl)butyrophenone|DTXSID2045361|Azaperone for veterinary use|NSC-170976|19BV78AK7W|CHEBI:88301|1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone|1-Butanone, 1-(4-fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-|DTXCID0025361|1-(4-Fluorophenyl)-4-(4-(2-pyridinyl)-1-piperazinyl)-1-butanone|4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone|Stresnil Injection|RefChem:57775|SID11112496|216-715-8|R1929|Eucalmyl|Azeperone|Sedaperone vet|C19H22FN3O|1-(4-fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-1-one|MFCD00866692|MLS003106751|CHEMBL340211|1-(4-fluorophenyl)-4-(4-(pyridin-2-yl)piperazin-1-yl)butan-1-one|NSC170976|NCGC00016590-01|Azaperone 100 microg/mL in Acetonitrile|Butyrophenone, 4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-|CAS-1649-18-9|1-(4-fluorophenyl)-4-[4-(2-pyridyl)piperazin-1-yl]butan-1-one|1-(4-fluorophenyl)-4-[4-(pyridin-2-yl)piperazin-1-yl]butan-1-one|Azaperonum [INN-Latin]|BUTYROPHENONE, 4'-FLUORO-4-(4-(2-PYRIDYL)-1-PIPERAZINYL)-|Azaperona [INN-Spanish]|Azaperone (1.0 mg/mL in Methanol)|SMR001233462|CCRIS 1586|SR-05000001712|EINECS 216-715-8|BRN 0565491|UNII-19BV78AK7W|Azaperone [USAN:USP:INN:BAN]|Stresnil (TN)|Azaperone VETRANAL|Azaperone (Standard)|Azaperone (USP/INN)|AZAPERONE [INN]|AZAPERONE [MI]|AZAPERONE [USAN]|Prestwick0_001117|Prestwick1_001117|Prestwick2_001117|Prestwick3_001117|Spectrum2_001250|Spectrum3_001966|AZAPERONE [MART.]|AZAPERONE [USP-RS]|BSPBio_001254|BSPBio_003566|5-23-03-00041 (Beilstein Handbook Reference)|MLS002154163|SCHEMBL121134|SPECTRUM1505332|SPBio_001160|SPBio_003117|AZAPERONE [GREEN BOOK]|BPBio1_001379|orb1300802|AZAPERONE [USP IMPURITY]|SCHEMBL29437229|HY-B1470R|KBio3_002914|AZAPERONE [USP MONOGRAPH]|MSK7108|Lamotrigine 5-N-?-D-Glucuronide|HMS1571O16|HMS1922D20|HMS2090K03|HMS2093D03|HMS2098O16|HMS2230C17|HMS3369I10|HMS3652D15|HMS3715O16|HMS3885F11|HMS5082B14|Pharmakon1600-01505332|BCP12176|EX-A9409|HY-B1470|YWB02172|Tox21_110512|BBL011031|BDBM50036733|CCG-39158|NSC758969|PDSP1_000828|PDSP2_000815|s4219|STK802185|AKOS005622715|Tox21_110512_1|CS-5158|DB11376|FA18061|KS-5204|NSC-758969|NCGC00016590-02|NCGC00016590-03|NCGC00016590-04|NCGC00016590-06|NCGC00016590-08|NCGC00095171-01|NCGC00095171-02|NCGC00095171-03|SY067157|Azaperone 1000 microg/mL in Acetonitrile|SBI-0206748.P001|WLN: T6N DNTJ D3VR DF& A- BT6NJ|AB00514057|NS00000088|SW196387-3|Azaperone, VETRANAL(TM), analytical standard|C73189|D02620|AB00514057-06|AB00514057_07|649A189|L000791|Q4832244|SR-05000001712-1|SR-05000001712-3|BRD-K45861246-001-05-0|BRD-K45861246-001-08-4|BRD-K45861246-001-13-4|BRD-K45861246-001-14-2|BRD-K45861246-001-15-9|Azaperone, British Pharmacopoeia (BP) Reference Standard|{4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone}|4'-Fluoro-4-[4-(2-pyridinyl)-1-piperazinyl]butyrophenone|Azaperone, European Pharmacopoeia (EP) Reference Standard|1-(4-Fluorophenyl)-4-(4-pyridin-2-ylpiperazin-1-yl)butan-|Azaperone, United States Pharmacopeia (USP) Reference Standard|Butyrophenone, {4'-fluoro-4-[4-(2-pyridyl)-1-piperazinyl]-}|1-Butanone, {1-(4-fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-}|1-(4-Fluoro-phenyl)-4-(4-pyridin-2-yl-piperazin-1-yl)-butan-1-one(Azaperone)|1-(4-Fluorophenyl)-4-[4-(2-pyridinyl)-1-piperazinyl]-1-butanone;4'-Fluoro-4-[4-(2-pyridyl)-1-piperazinyl]butyrophenone;Fluoperidol"
MIANSERIN,4184,,"InChI=1S/C18H20N2/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19/h2-9,18H,10-13H2,1H3",UEQUQVLFIPOEMF-UHFFFAOYSA-N,C18H20N2,264.4,"5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene","mianserin|Mianserine|24219-97-4|Mianserina|Mianserinum|Tolvon|1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine|CHEBI:51137|250PJI13LM|DTXSID6023317|J16.389I|DTXCID003317|Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-|Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-|1,2,3,4,10,14b-hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine|1,2,3,4,10,14B-HEXAHYDRO-2-METHYLDIBENZO(C,F)-PYRAZINO(1,2-A)AZEPINE|5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(15),8(13),9,11,16,18-hexaene|5-methyl-2,5-diazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8,10,12,15,17-hexaene|5-methyl-2,5-diazatetracyclo(13.4.0.0^(2,7).0^(8,13))nonadeca-1(15),8(13),9,11,16,18-hexaene|5-methyl-2,5-diazatetracyclo(13.4.0.0^(2,7).0^(8,13))nonadeca-1(19),8,10,12,15,17-hexaene|RefChem:158482|N06AX03|246-088-6|Mianseryna [Polish]|Mianseryna|Mianserine [INN-French]|Mianserinum [INN-Latin]|Mianserina [INN-Spanish]|2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine|Mianserin (INN)|CHEMBL6437|NCGC00015656-06|MIANSERIN [INN]|Mianserin [INN:BAN]|5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene|(S)-(+)-Mianserin|CAS-24219-97-4|Tolvon (TN)|(+/-)-Mianserin|HSDB 7182|EINECS 246-088-6|BRN 0755346|UNII-250PJI13LM|mianserin a|Mianserin?|S(+)-Mianserin|(+-)-Athymil|Spectrum_001810|PS32 -  Mianserin|MIANSERIN [MI]|MIANSERIN [HSDB]|Prestwick0_000099|Prestwick1_000099|Prestwick2_000099|Prestwick3_000099|Spectrum2_001203|Spectrum3_001836|Spectrum4_001260|Spectrum5_001772|MIANSERIN [VANDF]|Biomol-NT_000135|MIANSERIN [WHO-DD]|Lopac0_000744|Oprea1_703627|SCHEMBL18020|BSPBio_000058|BSPBio_003511|GTPL135|KBioGR_001820|KBioSS_002303|cid_68551|DivK1c_000844|SPBio_000986|SPBio_001997|BPBio1_000064|BPBio1_000331|orb1705061|SCHEMBL29356897|BDBM31005|KBio1_000844|KBio2_002301|KBio2_004869|KBio2_007437|KBio3_003016|NINDS_000844|HMS2089A04|BCA15288|HY-B0188|Tox21_110191|AC-631|BDBM50222218|PDSP1_001532|PDSP2_001516|AKOS005216268|Tox21_110191_1|CCG-204829|CS-2078|DB06148|SDCCGSBI-0050722.P004|IDI1_000844|NCGC00015656-04|NCGC00015656-05|NCGC00015656-08|NCGC00015656-09|NCGC00015656-10|NCGC00015656-12|NCGC00015656-23|NCGC00024926-03|NCGC00024926-04|DA-65446|TS-08152|SBI-0050722.P003|NS00010650|D08216|EN300-18559884|L000736|Q416701|BRD-A19661776-001-01-5|BRD-A19661776-003-05-2|BRD-A19661776-003-16-9|BRD-A19661776-003-25-0|BRD-A19661776-003-26-8|BRD-A19661776-003-27-6|BRD-A19661776-003-28-4|2-Methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine #|Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-; 1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine; (+/-)-Mianserin; Mianserin; Mianserine"
MIRTAZAPINE,4205,,"InChI=1S/C17H19N3/c1-19-9-10-20-16(12-19)15-7-3-2-5-13(15)11-14-6-4-8-18-17(14)20/h2-8,16H,9-12H2,1H3",RONZAEMNMFQXRA-UHFFFAOYSA-N,C17H19N3,265.35,"5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene","mirtazapine|85650-52-8|Remeron|Zispin|6-Azamianserin|Mepirzepine|Remergil|Rexer|Promyrtil|Remergon|Norset|Avanza|Remeron SolTab|Mirtazapina|ORG 3770|Mirtazapinum|2-Methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine|Org-3770|Mirataz|Mirtazapin|Mirtazapine anhydrous|Mepirzapine|CHEBI:6950|DTXSID0023325|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)benzazepine|Pyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-|A051Q2099Q|Org3770|DTXCID503325|5-methyl-2,5,19-triazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(15),8,10,12,16,18-hexaene|Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-|5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8(13),9,11,15,17-hexaene|Remeronsoltab|6 Azamianserin|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c]benzazepine|2-methyl-1,2,3,4,10,14b-hexahydropyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine|5-methyl-2,5,19-triazatetracyclo(13.4.0.0^(2,7).0^(8,13))nonadeca-1(19),8(13),9,11,15,17-hexaene|5-methyl-2,5,19-triazatetracyclo(13.4.0.02,7.08,13)nonadeca-1(15),8,10,12,16,18-hexaene|RefChem:55652|N06AX11|61337-67-5|Mirtazepine|Mepirzapin|Mirtazipine|Mirtazapinum [INN-Latin]|Mirtazapina [INN-Spanish]|MFCD00865427|2-methyl-1,2,3,4,10,14b-hexahydrobenzo[c]pyrazino[1,2-a]pyrido[3,2-f]azepine|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine|CHEMBL654|Mirtazapine (Remeron, Avanza)|(S)-Org3770;(S)-6-Azamianserin|NCGC00025346-02|Azamianserin|Mirtazapine [USAN:BAN:INN]|Smilon|2-methyl-1,2,3,4,9,13b-hexahydro-2,4a,5-triaza-tribenzo[a,c,e]cycloheptene|SMR000466347|Remeron (TN)|SR-01000597530|EINECS 288-060-6|UNII-A051Q2099Q|(R)-Org3770;(R)-6-Azamianserin|6-Aza-mianserin|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c](2)benzazepine|1,2,3,4,10,14b-Hexahydro-2-methylpyrazino[2,1-a]pyrido[2,3-c][2]benzazepine;Mepirzepine;Org-3770|Mirtazapine [USAN:USP:INN:BAN]|Reflex (TN)|(1)-1,2,3,4,10,14b-Hexahydro-2-methylpyrazino(2,1-a)pyrido(2,3-c)(2)benzazepine|ME-2040|Mirtazapine (Standard)|MIRTAZAPINE [MI]|MIRTAZAPINE [INN]|MIRTAZAPINE [JAN]|MIRTAZAPINE [USAN]|MIRTAZAPINE [VANDF]|SCHEMBL35408|MIRTAZAPINE [USP-RS]|MIRTAZAPINE [WHO-DD]|MLS000759460|MLS001076676|MLS001424294|MLS006011449|orb322593|Mirtazapine (JAN/USP/INN)|GTPL7241|orb1310902|Mirtazapine - Bio-X trade mark|MIRTAZAPINE [GREEN BOOK]|SCHEMBL29484433|HY-B0352R|MIRTAZAPINE, (+/-)-|Mirtazapine, >=98% (HPLC)|Mirtazapine, 1mg/ml in Methanol|MIRTAZAPINE [ORANGE BOOK]|HMS2052H03|HMS2233K03|HMS3268F21|HMS3370B05|HMS3374J01|HMS3394H03|HMS3413C11|HMS3657M13|HMS3677C11|HMS3713P13|HMS3884O18|HMS5080H15|MIRTAZAPINE [EP MONOGRAPH]|MIRTAZAPINE [USP MONOGRAPH]|PS11 - Mirtazapine/Normirtazapine|BCP14560|BCP22244|HY-B0352|Mirtazapine 1.0 mg/ml in Methanol|MSK10500|Tox21_110965|BDBM50115644|PDSP1_001529|PDSP2_001513|s2016|STK711107|AKOS005530681|BCP9000930|CCG-101154|CCG-220556|DB00370|FM26014|KS-1086|NC00404|(14bR)-2-methyl-1,2,3,4,10,14b-hexahydropyrazino[2,1-a]pyrido[2,3-c][2]benzazepine|NCGC00025346-01|NCGC00025346-08|AC-15480|BM164672|SY002095|CAS-61337-67-5|M2151|NS00009441|SW197784-4|EN300-49851|C07570|D00563|AB00698265_08|337M675|L001294|Q421930|SR-01000597530-1|SR-01000597530-4|BRD-A64977602-001-01-9|BRD-A64977602-001-04-3|BRD-A64977602-001-13-4|BRD-A64977602-001-14-2|BRD-A64977602-001-15-9|Z905065772|Mirtazapine, European Pharmacopoeia (EP) Reference Standard|Mirtazapine, United States Pharmacopeia (USP) Reference Standard|(+/-)-12-Methyl-1,2,3,4,9,13b-hexahydro-2,4a,5-triaza-tribenzo[a,c,e]cycloheptene|2-Methyl-1,2,3,4,10,14b-hexahydrobenzo-[c]pyrazino[1,2-a]pyrido[3,2-f]azepine|Mirtazapine for system suitability, European Pharmacopoeia (EP) Reference Standard|5-methyl-2,5,19-triazatetracyclo[13.4.0.0?,?.0?,??]nonadeca-1(15),8,10,12,16,18-hexaene|5-methyl-2,5,19-triazatetracyclo[13.4.0.0^{2,7}.0^{8,13}]nonadeca-1(19),8,10,12,15,17-hexaene|Pyrazino[2,1-a]pyrido[2,3-c][2]benzazepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, (.+/-.)-"
OLANZAPINE,135398745,,"InChI=1S/C17H20N4S/c1-12-11-13-16(21-9-7-20(2)8-10-21)18-14-5-3-4-6-15(14)19-17(13)22-12/h3-6,11,19H,7-10H2,1-2H3",KVWDHTXUZHCGIO-UHFFFAOYSA-N,C17H20N4S,312.4,"2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine","olanzapine|132539-06-1|Olansek|Zalasta|Zyprexa Zydis|Zyprexa Velotab|Zyprexa Intramuscular|olanzapina|Olanzapine Mylan|LY-170053|Olazax|Olanzapine Teva|Olazax Disperzi|2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapine Glenmark|olanzapinum|LY 170053|Olanzapine cipla|Olanzapine apotex|10H-thieno[2,3-b][1,5]benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-|2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine|Olanzapin|LY170053|Olanzapine Glenmark Europe|N7U69T4SZR|CHEBI:7735|DTXSID9023388|2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno(2,3-b)(1,5)benzodiazepine|DTXCID503388|LYBALVI COMPONENT OLANZAPINE|10H-Thieno(2,3-b)(1,5)benzodiazepine, 2-methyl-4-(4-methyl-1-piperazinyl)-|Arkolamyl|2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno(2,3-b)(1,5)benzodiazepine|RefChem:6083|N05AH03|LY170052|LY 170052|5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo(8.4.0.03,7)tetradeca-1(14),3(7),5,8,10,12-hexaene|Deprex|Zyprexa|Zolafren|2-Methyl-4-(4-methylpiperazin-1-yl)-10H-benzo[b]thieno[2,3-e][1,4]diazepine|Olzapin|Lanzac|Oferta|C17H20N4S|MFCD00866702|2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[3,2-c][1,5]benzodiazepine|CHEMBL715|5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),5,8,11,13-hexaene|NCGC00096077-03|Midax|2-methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[3,2-c][1,5]benzodiazepine|Olanzapine  Teva|SMR000466345|Olanzapine Neopharma|Olanzapine ( 1.0 mg/mL in Acetonitrile)|CAS-132539-06-1|SR-01000759343|UNII-N7U69T4SZR|Olanzapine?|ALKS-7921|HSDB 8155|Olanzapine [USAN:USP:INN:BAN]|Olanzapine; 2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine; LY 170053; Lanzac; Zyprexa|Olanzapine (Zyprexa)|KS-1090|PS15 - Olanzapine|Olanzapine (Standard)|OLANZAPINE [MI]|OLANZAPINE [INN]|OLANZAPINE [JAN]|OLANZAPINE [USAN]|OLANZAPINE [VANDF]|GTPL47|OLANZAPINE [MART.]|OLANZAPINE [USP-RS]|OLANZAPINE [WHO-DD]|BIDD:PXR0138|SCHEMBL28763|Olanzapine (JAN/USP/INN)|US8802672, Olanzapine|MLS000759457|MLS001165781|MLS001195646|MLS001424057|BIDD:GT0332|OLANZAPINE [EMA EPAR]|SCHEMBL117695|SPECTRUM1505024|Olanzapine (LY-170053)|orb1308151|OLANZAPINE [ORANGE BOOK]|Olanzapine, >=98% (HPLC)|SCHEMBL29358280|BDBM35254|BDBM82479|CHEBI:94534|OLANZAPINE [EP MONOGRAPH]|GLXC-02527|HMS2051H05|HMS2089M04|HMS2093I04|HMS2233F24|HMS3374L02|HMS3393H05|HMS3657I15|HMS3714J03|HMS3743A09|HMS3884J21|HMS5081A13|OLANZAPINE [USP MONOGRAPH]|SYMBYAX COMPONENT OLANZAPINE|ALBB-027265|BCP04917|LGB68679|MSK10167|NSC_4585|Olanzapine, 1mg/ml in Acetonitrile|Tox21_111556|AC-665|HB1786|HY-14541R|NSC754829|NSC801187|s2493|STK634338|STL388024|2-Methyl-4-(4-methyl-1-piperazinyl)- 10H-thieno[2,3-b][1,5]benzodiazepine|2-methyl-4-(4-methylpiperazin-1-yl)-5H-thieno[2,3-b][1,5]benzodiazepine|AKOS000282888|AKOS005566122|Olanzapine 1.0 mg/ml in Acetonitrile|Tox21_111556_1|BCP9001021|CCG-100922|CS-1114|DB00334|FO26537|NC00172|NSC-754829|NSC-801187|NCGC00096077-01|NCGC00096077-04|NCGC00096077-05|NCGC00096077-06|NCGC00096077-18|NCGC00096077-20|NCGC00389791-02|HY-14541|SBI-0206786.P001|CAS_132539-06-1|NS00000036|O0393|SW220248-1|C07322|D00454|EN300-119499|AB00639907-06|AB00639907-07|AB00639907_08|AB00639907_09|539O061|A806453|L000455|L005958|Q201872|SR-01000759343-4|SR-01000759343-6|BRD-K18895904-001-15-3|BRD-K18895904-001-16-1|BRD-K18895904-001-17-9|Z1521553472|Olanzapine, European Pharmacopoeia (EP) Reference Standard|Olanzapine, United States Pharmacopeia (USP) Reference Standard|Olanzapine, Pharmaceutical Secondary Standard; Certified Reference Material|2-Methyl-10-(4-methyl-piperazin-1-yl)-4H-3-thia-4,9-diaza-benzo[f]azulene|2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno-[2,3-b][1,5]benzodiazepine|2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine #|2-Methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine;LY 170053|2-Methyl-4-(4-methylpiperazin-1-yl)-10H- thieno[2,3-b][1,5]benzodiazepin|Olanzapine for system suitability, European Pharmacopoeia (EP) Reference Standard|Olanzapine-d8, 100 mug/mL in acetonitrile, ampule of 1 mL, certified reference material|5-methyl-8-(4-methylpiperazin-1-yl)-4-thia-2,9-diazatricyclo[8.4.0.0,3,7]tetradeca-1(10),3(7),5,8,11,13-hexaene"
QUINPIROLE,54562,,"InChI=1S/C13H21N3/c1-2-5-16-6-3-4-10-7-12-11(8-13(10)16)9-14-15-12/h9-10,13H,2-8H2,1H3,(H,14,15)/t10-,13-/m1/s1",FTSUPYGMFAPCFZ-ZWNOBZJWSA-N,C13H21N3,219.33,"(4aR,8aR)-5-propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[3,4-g]quinoline","QUINPIROLE|80373-22-4|Quinpirol|Quinpirolum|CHEBI:75401|1H-Pyrazolo(3,4-g)quinoline, 4,4a,5,6,7,8,8a,9-octahydro-5-propyl-, (4aR-trans)-|20OP60125T|(4aR-trans)-4,4a,5,6,7,8,8a,9-Octahydro-5-propyl-1H-pyrazolo(3,4-g)quinoline|DTXSID9048229|(4aR,8aR)-5-propyl-1,4,4a,6,7,8,8a,9-octahydropyrido[2,3-f]indazole|(4aR,8aR)-5-propyl-1,4,4a,6,7,8,8a,9-octahydropyrido(2,3-f)indazole|RefChem:930496|DTXCID4028204|Quinpirole [INN]|(4aR,8aR)-5-propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[3,4-g]quinoline|CHEMBL240773|(4aR,8aR)-5-Propyl-4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo[3,4-g]quinoline|85760-74-3|Quinpirol [Spanish]|Quinpirolum [Latin]|NCGC00016954-05|(4aR-trans)-; (-)-Quinpirole|LY 156258|NSC_54562|UNII-20OP60125T|quinpirol-(-)|Quinpirole,(-)|Tocris-1061|GTPL2|Lopac-Q-102|Lopac-Q-111|Prestwick0_001093|Prestwick1_001093|Prestwick2_001093|Prestwick3_001093|Biomol-NT_000014|QUINPIROLE [WHO-DD]|Lopac0_000990|Lopac0_001030|SCHEMBL50905|BSPBio_001166|SPBio_003053|BPBio1_001169|BPBio1_001284|orb1740811|SCHEMBL11048143|BDBM84637|HMS2089L17|BDBM50018958|AKOS015895855|CCG-205070|SDCCGSBI-0050963.P003|NCGC00015866-01|NCGC00015866-02|NCGC00016954-01|NCGC00016954-02|NCGC00016954-06|NCGC00016954-07|NCGC00016954-08|NCGC00016954-17|NCGC00024974-01|1H-Pyrazolo(3,4-g)quinoline, 4,4a,5,6,7,8,8a,9-octahydro-5-propyl-, dihydrochloride, (E)-, (+-)-|74196-92-2|trans-(+-)-5-Propyl-4,4a,5,6,7,8,8a,9-octahydro-1H-pyrazolo(3,4-g)quinoline dihydrochloride|CAS-85760-74-3|CAS_85760-74-3|AB00514646|NS00121437|Q253187|BRD-K26548821-001-01-8|BRD-K26548821-003-03-0|BRD-K26548821-003-10-5|(4As,8as)-5-propyl-1,4,4a,6,7,8,8a,9-octahydropyrazolo[3,4-g]quinolinedihydrochloride|(-)-(4AR,8AR)-4,4A,5,6,7,8,8A,9-OCTAHYDRO-5-PROPYL-1H-PYRAZOLO(3,4-G)QUINOLINE"
BEPRIDIL,2351,,"InChI=1S/C24H34N2O/c1-21(2)19-27-20-24(25-15-9-10-16-25)18-26(23-13-7-4-8-14-23)17-22-11-5-3-6-12-22/h3-8,11-14,21,24H,9-10,15-20H2,1-2H3",UIEATEWHFDRYRU-UHFFFAOYSA-N,C24H34N2O,366.5,N-benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl]aniline,"bepridil|64706-54-3|CHEBI:3061|DTXSID3022663|755BO701MA|DTXCID402663|N-benzyl-N-[3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl]aniline|1-Pyrrolidineethanamine, beta-((2-methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-|1-(2-(N-BENZYLANILINO)-1-(ISOBUTOXYMETHYL)ETHYL)-PYRROLIDINE|bepridilum|Bedapin|N-benzyl-N-(3-(2-methylpropoxy)-2-(pyrrolidin-1-yl)propyl)aniline|Bepridil, alpha|N-(3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl)-N-(phenylmethyl)aniline|N-[3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl]-N-(phenylmethyl)aniline|RefChem:567017|Monohydrochloride, Bepridil|CERM1978|1978 CERM|1978-CERM|Bepridil Monohydrochloride, alpha|C08EA02|Monohydrochloride, alpha-Isomer Bepridil|1-PYRROLIDENEETHANAMINE, BETA-((2-METHYLPROPOXY)METHYL)-N-PHENYL-N-(PHENYLMETHYL)-|256-384-7|Bepadin|N-Benzyl-N-(3-isobutoxy-2-(pyrrolidin-1-yl)propyl)aniline|N-benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-ylpropyl]aniline|C24H34N2O|Bepridil free base|Bepridil (INN)|CERM 1978|64706-54-3 (free base)|NCGC00015155-03|BEPRIDIL [INN]|N-Benzyl-N-[3-(2-methylpropoxy)-2-pyrrolidin-1-yl-propyl]aniline hydrochloride|Org 5730|Bepadin (TN)|(+/-)-Bepridil;Org 5730; dl-Bepridil|CAS-64706-54-3|Bepridil [INN:BAN]|UNII-755BO701MA|beta-((2-Methylpropoxy)methyl)-N-phenyl-N-(phenylmethyl)-1-pyrrolidineethanamine|MFCD00868313|Spectrum_001745|BEPRIDIL [MI]|BEPRIDIL [VANDF]|Prestwick0_000368|Prestwick1_000368|Prestwick2_000368|Prestwick3_000368|Spectrum2_000901|Spectrum3_000747|Spectrum4_000797|Spectrum5_000978|BEPRIDIL [WHO-DD]|CHEMBL1008|Lopac0_000222|SCHEMBL34412|BSPBio_000495|BSPBio_001301|BSPBio_002334|KBioGR_000021|KBioGR_001274|KBioSS_000021|KBioSS_002225|cid_50088|DivK1c_000110|SPBio_000742|SPBio_002416|BPBio1_000545|GTPL2337|orb1689892|BCBcMAP01_000130|BDBM78577|KBio1_000110|KBio2_000021|KBio2_002225|KBio2_002589|KBio2_004793|KBio2_005157|KBio2_007361|KBio3_000041|KBio3_000042|KBio3_001554|NINDS_000110|Bio1_000388|Bio1_000877|Bio1_001366|Bio2_000021|Bio2_000501|HMS1361B03|HMS1791B03|HMS1989B03|HMS2089C05|Tox21 110089|Tox21_110089|HSCI1_000377|()-Bepridil;Org 5730; dl-Bepridil|AKOS015962267|N-{3-[(2-methylpropyl)oxy]-2-pyrrolidin-1-ylpropyl}-N-(phenylmethyl)aniline|Tox21_110089_1|CCG-204317|DB01244|SDCCGSBI-0050210.P003|IDI1_000110|IDI1_033771|NCGC00015155-02|NCGC00015155-04|NCGC00015155-05|NCGC00015155-06|NCGC00015155-07|NCGC00015155-08|NCGC00015155-11|NCGC00015155-13|NCGC00015155-19|NCGC00162097-01|NCGC00162097-02|NCGC00162097-03|NCGC00162097-04|864868-68-8|AC-16059|HY-16952|DB-054717|AB00053643|CS-0013008|NS00002270|C06847|D07520|AB00053643-14|AB00053643_15|EN300-22786142|Q4890934|BRD-A91008255-001-02-8|BRD-A91008255-003-16-4|BRD-A91008255-003-24-8|BRD-A91008255-003-25-5|N-benzyl-N-(3-isobutoxy-2-pyrrolidin-1-yl-propyl)aniline|benzyl-(3-isobutoxy-2-pyrrolidino-propyl)-phenyl-amine;hydrochloride|N-[3-(2-methylpropoxy)-2-(1-pyrrolidinyl)propyl]-N-(phenylmethyl)aniline;hydrochloride|N-[3-(2-methylpropoxy)-2-pyrrolidin-1-yl-propyl]-N-(phenylmethyl)aniline;hydrochloride|1-PYRROLIDENEETHANAMINE, .BETA.-((2-METHYLPROPOXY)METHYL)-N-PHENYL-N-(PHENYLMETHYL)-|1-Pyrrolidineethanamine, .beta.-[(2-methylpropoxy)methyl]-N-phenyl-N-(phenylmethyl)-, monohydrochloride"
ARIPIPRAZOLE,60795,,"InChI=1S/C23H27Cl2N3O2/c24-19-4-3-5-21(23(19)25)28-13-11-27(12-14-28)10-1-2-15-30-18-8-6-17-7-9-22(29)26-20(17)16-18/h3-6,8,16H,1-2,7,9-15H2,(H,26,29)",CEUORZQYGODEFX-UHFFFAOYSA-N,C23H27Cl2N3O2,448.4,"7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one","Aripiprazole|129722-12-9|Abilify|Abilitat|OPC-14597|Abilify Discmelt|aripiprazol|Discmelt|Opc 14597|Aripiprex|Abilify MyCite|OPC 31|Abilify Maintena|aripiprazolum|OPC-31|7-(4-(4-(2,3-DICHLOROPHENYL)PIPERAZIN-1-YL)BUTOXY)-3,4-DIHYDROQUINOLIN-2(1H)-ONE|Abilify Maintena Kit|2(1H)-Quinolinone, 7-[4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-|NSC-759266|7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone|DTXSID3046083|CHEBI:31236|82VFR53I78|7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-2(1H)-quinolinone|7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butyloxy)-3,4-dihydro-2(1H)-quinolinone|ABILIFY MYCITE KIT|7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-1,2,3,4-tetrahydroquinolin-2-one|DTXCID1026083|2(1H)-Quinolinone, 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydro-|7-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy}-3,4-dihydroquinolin-2(1H)-one|ABILIFY ASIMTUFII|Aripiprazole oral|7-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butoxy)-1,2,3,4-tetrahydroquinolin-2-one|7-(4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy)-3,4-dihydroquinolin-2(1H)-one|OPIPZA|RefChem:5563|Aripiprazole orally disintegrating|N05AX12|603-355-5|C23H27Cl2N3O2|7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril|7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one|AriprazoleImpurity|CHEMBL1112|129722-12-9 (free base)|7-(4-(4-(2,3-Dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril|MFCD00892072|NCGC00159510-02|Aripiprazole [USAN]|7-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-quinol in-2-one|1026778-41-5|7-[4-[4-[2,3-bis(chloranyl)phenyl]piperazin-1-yl]butoxy]-3,4-dihydro-1H-quinolin-2-one|SMR000466383|Abilify (TN)|CAS-129722-12-9|HSDB 7320|SR-01000759353|UNII-82VFR53I78|Abilify Digital|Aripiprazole [USAN:INN:BAN]|7-(4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy)-3,4-dihydrocarbostyril|7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril|Abilify OD|Aripiprazole Depot|9SC|MEZOFY|BMS-337039|KS-1030|Aripiprazole (Abilify)|CPD000466383|Aripiprazole (Standard)|ARIPIPRAZOLE [MI]|ARIPIPRAZOLE [INN]|ARIPIPRAZOLE [JAN]|GTPL34|ARIPIPRAZOLE [HSDB]|Aripiprazole-d8(butyl-d8)|SCHEMBL8255|Aripiprazole Crystal Form I|ARIPIPRAZOLE [VANDF]|ARIPIPRAZOLE [MART.]|MLS000759517|MLS001165779|MLS001195621|MLS001424078|MLS006011892|ARIPIPRAZOLE [USP-RS]|ARIPIPRAZOLE [WHO-DD]|orb1308154|ARIPIPRAZOLE [EMA EPAR]|Aristada (aripiprazole lauroxil)|SCHEMBL12961254|SCHEMBL29356997|SCHEMBL29438823|SCHEMBL29475637|SCHEMBL29475638|Aripiprazole (JP18/USP/INN)|Aripiprazole - Bio-X trade mark|ARIPIPRAZOLE [ORANGE BOOK]|GLXC-06844|HMS2051I18|HMS2089M20|HMS2093F22|HMS2230M18|HMS3373D04|HMS3393I18|HMS3657K13|HMS3715J07|HMS3744A13|HMS3884E18|HMS5080H11|Pharmakon1600-01505851|ARIPIPRAZOLE [EP MONOGRAPH]|BCP04902|MSK10169|PTB11506|ARIPIPRAZOLE [USP MONOGRAPH]|Tox21_111728|Aripiprazole, 1mg/ml in Acetonitrile|BBL029082|BDBM50130293|DL-178|HY-14546R|NSC759266|s1975|STK625160|AKOS005558247|Tox21_111728_1|AB07660|AC-1554|BCP9000317|CCG-100891|CS-0766|DB01238|FA17978|NC00141|NSC 759266|Aripiprazole 1.0 mg/ml in Acetonitrile|PS25 - Aripiprazole/Dehydroaripiprazole|NCGC00159510-03|NCGC00159510-04|NCGC00159510-05|BA164218|HY-14546|SY053146|SBI-0206870.P001|A2496|NS00001912|SW197521-3|D01164|EN300-119521|AB00639935-09|AB00639935_10|AB00639935_11|722A129|L001339|Q411188|SR-01000759353-4|SR-01000759353-6|BRD-K70358946-001-06-6|BRD-K70358946-001-14-0|BRD-K70358946-001-15-7|Z1521553846|7-[4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butoxy]-3,4-dihydro-2(1H)-quinolinone|7-[4-[4-(2,3-Dichlorophenyl)-1-Piperazinyl]Butoxy]3,4-Dihydro-2(1H)-Quinolinone|7-[4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butoxy]-3,4-dihydro-quinolin-2(1H)-one|7-{4-[-4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3,4-dihydrocarbostyril|7-{4-[4-(2,3-Dichloro-phenyl)-piperazin-1-yl]-butoxy}-3,4-dihydro-1H-quinolin-2-one|7-{4-[4-(2,3-dichlorophenyl)-1-piperazinyl]butoxy}-3, 4-dihydrocarbostyril|aripiprazole; 7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4-dihydrocarbostyril|24-29-3|7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydro-2(1H)-quinolinone;7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]- 3,4-dihydrocarbostyril;Abilify"
QUETIAPINE,5002,,"InChI=1S/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2",URKOMYMAXPYINW-UHFFFAOYSA-N,C21H25N3O2S,383.5,"2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol","quetiapine|111974-69-7|quetiapina|Norsic|quetiapinum|2-[2-(4-benzo[b][1,4]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol|BGL0JSY5SI|Quetiapine extended release|NSC-758918|CHEBI:8707|DTXSID9023546|2-[2-(4-Dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]ethanol|2-(2-(4-Dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)ethanol|Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-|DTXCID903546|Ethanol, 2-(2-(4-dibenzo(b,f)(1,4)thiazepin-11-yl-1-piperazinyl)ethoxy)-|Seroquel XL|2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethoxy]ethanol|2-(2-(4-DIBENZO(B,F)(1,4)THIAZEPIN-11-YLPIPERAZIN-1-YL)ETHOXY)ETHANOL|Tenprolide xl|Biquelle xl|Brancico xl|Mintreleq xl|Seotiapim xl|Atrolak xl|Ebesque xl|Psyquet xl|Sondate xl|Zaluron xl|2-(2-(4-benzo(b)(1,4)benzothiazepin-6-ylpiperazin-1-yl)ethoxy)ethanol|2-(2-(4-benzo(b)(1,5)benzothiazepin-6-ylpiperazin-1-yl)ethoxy)ethanol|2-[2-(4-benzo[b][1,5]benzothiazepin-6-ylpiperazin-1-yl)ethoxy]ethanol|2-(2-(4-(2-thia-9-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,9,12,14-heptaen-10-yl)piperazin-1-yl)ethoxy)ethan-1-ol|2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol|RefChem:6192|N05AH04|2-(2-(4-(2-thia-9-azatricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,9,11,13-heptaen-10-yl)piperazin-1-yl)ethoxy)ethan-1-ol|Seroquel|Quetiapine (INN)|2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol|Quetiapine-d4Hemifumarate|MFCD00866699|CHEMBL716|FK949E|NCGC00095911-03|QUETIAPINE [INN]|Co-Quetiapine|Quetiapine [INN:BAN]|2-{[2-(4-dibenzo[b,f][1,4]thiazepin-11-ylpiperazin-1-yl)ethyl]oxy}ethanol|2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,9,12,14-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol|SMR000550491|Norsic (TN)|Seroquel (Fumarate)|CAS-111974-69-7|SR-01000759335|UNII-BGL0JSY5SI|Ketipinor|2-{2-[4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl]ethoxy}ethanol|HSDB 7557|Dibenzo[b,f][1,4]thiazepine, ethanol deriv.; 2-[2-[4-(Dibenzo[b,f][1,4]thiazepin-11-yl)-1-piperazinyl]ethoxy]ethanol; Ketipinor; Quetiapine; Ethanol, 2-[2-(4-dibenzo[b,f][1,4]thiazepin-11-yl-1-piperazinyl)ethoxy]-|Quetiapine (Standard)|QUETIAPINE [MI]|QUETIAPINE [HSDB]|QUETIAPINE [VANDF]|GTPL50|SCHEMBL7932|QUETIAPINE [WHO-DD]|MLS001165710|MLS001195658|BIDD:GT0279|SPECTRUM1505187|orb1310882|SCHEMBL29360153|URKOMYMAXPYINW-UHFFFAOYSA-|GLXC-03199|HMS2093K06|HMS2231O11|HMS3372B05|HMS3744E21|HMS3886C22|HMS5085K21|Pharmakon1600-01505187|BCP23508|MSK10227|Tox21_111537|BBL029071|BDBM50095890|HY-14544R|NSC758918|NSC801189|s5741|STL373578|11-[4-[2-(2-Hydroxyethoxy)ethyl]-1-piperazinyl]dibenzo[b,f][1,4]thiazepine|AKOS003588973|Tox21_111537_1|CCG-213347|CS-1171|DB01224|FQ32483|NSC 758918|NSC-801189|MRF-0000010|NCGC00095911-01|NCGC00095911-04|NCGC00095911-06|AC-37642|AS-35258|HY-14544|SBI-0206776.P001|NS00010395|74Q697|C07397|D08456|EN300-708802|AB00640033-09|AB00640033-10|AB00640033_11|AB00640033_12|L001200|Q408535|SR-01000759335-5|SR-01000759335-7|BRD-K68867920-001-05-2|BRD-K68867920-001-11-0|BRD-K68867920-051-11-5|2-(2-(4-dibenzo[b,f]-[1,4]thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol|2-(2-(4-dibenzo[b,f][1,4] thiazepine-11-yl-1-piperazinyl)ethoxy)ethanol|(E)-2-(2-(4-(Dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethanol|2-(2-(4-(dibenzo[b,f][1,4]thiazepin-11-yl)piperazin-1-yl)ethoxy)ethan-1-ol|2-[2-(4-{2-thia-9-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-10-yl}piperazin-1-yl)ethoxy]ethan-1-ol|InChI=1/C21H25N3O2S/c25-14-16-26-15-13-23-9-11-24(12-10-23)21-17-5-1-3-7-19(17)27-20-8-4-2-6-18(20)22-21/h1-8,25H,9-16H2"
IFENPRODIL,3689,,"InChI=1S/C21H27NO2/c1-16(21(24)19-7-9-20(23)10-8-19)22-13-11-18(12-14-22)15-17-5-3-2-4-6-17/h2-10,16,18,21,23-24H,11-15H2,1H3",UYNVMODNBIQBMV-UHFFFAOYSA-N,C21H27NO2,325.4,4-[2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol,"Ifenprodil|23210-56-2|Vadilex|Ifenprodilum|4-(2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl)phenol|RC 61-91|4-[2-(4-benzylpiperidin-1-yl)-1-hydroxypropyl]phenol|R8OE3P6O5S|NP-120|DTXSID2045656|RC-61-91|2-(4-Benzylpiperidino)-1-(4-hydroxyphenyl)propanol|DTXCID0025656|4-Benzyl-alpha-(p-hydroxyphenyl)-beta-methyl-1-piperidineethanol|1-Piperidineethanol, 4-benzyl-alpha-(p-hydroxyphenyl)-beta-methyl-|alpha-(4-Hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidine ethanol|RefChem:147729|C04AX28|2-(4-benzylpiperidino)-1-(4-hydroxyphenyl)-2-methyl-1-ethanol|245-491-4|Dilvax|Ifenprodil (tartrate)|1-Piperidineethanol, alpha-(4-hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-|CHEMBL305187|Ifenprodil (INN)|NCGC00024643-03|Creocral|IFENPRODIL [INN]|(+/-)-Ifenprodil;RC 61-91|Ifenprodil [INN:DCF]|Ifenprodilum [INN-Latin]|CAS-23210-56-2|MFCD01529999|SR-01000075169|EINECS 245-491-4|UNII-R8OE3P6O5S|alpha-(4-Hydroxyphenyl)-beta-methyl-4-(phenylmethyl)-1-piperidineethanol; (+/-)-Ifenprodil; 1-Methyl-2-hydroxy-2-(4-hydroxyphenyl)ethyl-1-(4-benzylpiperidine); 2-(4-Benzylpiperidino)-1-(1-hydroxyphenyl)-1-propanol; RC 61-91;|(plusmn)-ifenprodil|IFENPRODIL [MI]|4-[2-(4-Benzyl-piperidin-1-yl)-1-hydroxy-propyl]-phenol|IFENPRODIL [WHO-DD]|SCHEMBL34010|()-Ifenprodil;RC 61-91|(+/-)-[2-(4-benzylpiperidino)-1-(4-hydroxyphenyl)-1-propanol]|ChEMBL_104385|GTPL5472|orb1309473|CHEBI:93829|HMS2089G05|YAA21058|Tox21_110915|BDBM50083351|PDSP1_000654|PDSP2_000646|AKOS015895174|Tox21_110915_1|CCG-204747|DB08954|FI65042|SDCCGSBI-0050640.P003|1-Piperidineethanol, .alpha.-(4-hydroxyphenyl)-.beta.-methyl-4-(phenylmethyl)-|MRF-0000097|NCGC00024643-02|NCGC00024643-04|NCGC00024643-05|NCGC00024643-06|NCGC00024643-07|NCGC00024643-10|NCGC00024643-12|NCGC00024643-20|TS-07829|SBI-0050640.P002|4605A|CS-0012741|NS00008388|D08064|210I562|EN300-18166867|L005364|Q5991156|SR-01000075169-1|SR-01000075169-3|4-[2-(4-benzyl-1-piperidyl)-1-hydroxy-propyl]phenol|BRD-A24191444-045-03-1|BRD-A24191444-045-10-6|BRD-A24191444-046-01-3|BRD-A24191444-046-02-1|BRD-A24191444-046-03-9|SR-01000075169-11|4-[1-hydroxy-2-[4-(phenylmethyl)-1-piperidinyl]propyl]phenol|1-Piperidineethanol, |A-(4-hydroxyphenyl)-|A-methyl-4-(phenylmethyl)-|4-BENZYL-.ALPHA.-(P-HYDROXYPHENYL)-.BETA.-METHYL-1-PIPERIDINEETHANOL|136172-79-7|4-[2-(4-Benzyl-1-piperidyl)-1-hydroxy-propyl]phenol; (2R,3R)-2,3-dihydroxybutanedioic acid"
APOMORPHINE,6005,,"InChI=1S/C17H17NO2/c1-18-8-7-10-3-2-4-12-15(10)13(18)9-11-5-6-14(19)17(20)16(11)12/h2-6,13,19-20H,7-9H2,1H3/t13-/m1/s1",VMWNQDUVQKEIOC-CYBMUJFWSA-N,C17H17NO2,267.32,"(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol","apomorphine|58-00-4|L-Apomorphine|Apomorfin|Apomorphin|R-(-)-Apomorphine|Ixense|(-)-Apomorphine|Apomorphinum|(-)-10,11-Dihydroxyaporphine|6abeta-Aporphine-10,11-diol|VR-040|(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|N21FAR7B4S|DTXSID8022614|CHEBI:48538|VR040|4H-Dibenzo(de,g)quinoline-10,11-diol, 5,6,6a,7-tetrahydro-6-methyl-, (R)-|DTXCID302614|(R)-5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo[de,g]quinoline-10,11-diol|(9R)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(17),2,4,6,13,15-hexaene-3,4-diol|(6aR)-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo(de,g)quinoline-10,11-diol|(R)-5,6,6a,7-tetrahydro-6-methyl-4H-dibenzo(de,g)quinoline-10,11-diol|(9R)-10-methyl-10-azatetracyclo(7.7.1.0^(2,7).0^(13,17))heptadeca-1(16),2(7),3,5,13(17),14-hexaene-3,4-diol|(9R)-10-methyl-10-azatetracyclo(7.7.1.0^(2,7).0^(13,17))heptadeca-1(17),2,4,6,13,15-hexaene-3,4-diol|(9R)-10-methyl-10-azatetracyclo[7.7.1.0^{2,7}.0^{13,17}]heptadeca-1(16),2(7),3,5,13(17),14-hexaene-3,4-diol|Apomorphin Teclapharm|RefChem:56684|(9R)-10-methyl-10-azatetracyclo(7.7.1.02,7.013,17)heptadeca-1(16),2(7),3,5,13(17),14-hexaene-3,4-diol|200-360-0|(R)-(-)-Apomorphine|Apomorphine [BAN]|Apomorphine free base|Apomorphine hydrochloride hemihydrate|CHEMBL53|APL-130277|Apormorphine|(6aR)-5,6,6a,7-Tetrahydro-6-methyl-4H-dibenzo(de,g)chinolin-10,11-diol|58-00-4 (free base)|6a.beta.-aporphine-10,11-diol|Apomorphine (BAN)|Apomorphinium chloride hemihydrate|NCGC00025349-02|Uprima (TN)|41372-20-7|(R)?-?(-?)?-?Apomorphine|CAS-58-00-4|6a-beta-Aporphine-10,11-diol|HSDB 3289|EINECS 200-360-0|R-(-)-Apomorphine hydrochloride hemihydrate|UNII-N21FAR7B4S|VR004|VR-400|Apomorphine (R,-)|Tocris-2073|APOMORPHINE [MI]|Prestwick0_000101|Prestwick1_000101|Prestwick2_000101|Prestwick3_000101|Kynmobi (sublingual film)|APOMORPHINE [HSDB]|Biomol-NT_000019|GTPL33|APOMORPHINE [VANDF]|APOMORPHINUM [HPUS]|SCHEMBL8541|APOMORPHINE [WHO-DD]|BSPBio_000082|SPBio_002021|BPBio1_000092|BPBio1_001179|SCHEMBL29358024|SCHEMBL29414090|BDBM29644|cid_6852399|(6AR)-5,6,6A,7-TETRAHYDRO-6-METHYL-4H-DIBENZO(DE,G)QUINOLINE-10,11-DIOL|HMS2089C10|NH001|Tox21_110967|BDBM50001955|PDSP1_000780|PDSP2_001488|AKOS040740360|Tox21_110967_1|DB00714|FA44559|SMP1_000027|NCGC00025349-01|NCGC00025349-03|NCGC00025349-04|NCGC00025349-05|DA-50067|CS-0012299|D07460|G91374|372A207|A727500|AE-641/11399027|EN300-18161186|Q269111|BRD-K76022557-001-01-3|BRD-K76022557-001-03-9|BRD-K76022557-003-02-7|BRD-K76022557-311-20-6|(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|Onapgo (apomorphine hydrochloride for continuous subcutaneous release)|(-)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(APO)|(Apomorphine) 6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|(apomorphine)6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine)|(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol (apomorphine)|(R)-6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol(apomorphine)|6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol ((R)-apomorphine)|6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol((R)-apomorphine)|APOMORPHINE6-Methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline-10,11-diol|OR9"
PRECLAMOL,5311189,,"InChI=1S/C14H21NO/c1-2-8-15-9-4-6-13(11-15)12-5-3-7-14(16)10-12/h3,5,7,10,13,16H,2,4,6,8-9,11H2,1H3/t13-/m1/s1",HTSNFXAICLXZMA-CYBMUJFWSA-N,C14H21NO,219.32,3-[(3S)-1-propylpiperidin-3-yl]phenol,"Preclamol|Preclamolum|85966-89-8|(-)-3ppp|9V2O6CRQ6Z|(-)-(S)-m-(1-Propyl-3-piperidyl)phenol|DTXSID7048453|n-N-propyl-3(N-hydroxyphenyl)piperidine|RefChem:905529|DTXCID3028427|(-)-3-PPP|3-(3-hydroxyphenyl)-N-n-propylpiperidine|Phenol, 3-(1-propyl-3-piperidinyl)-|Preclamol [INN]|CHEMBL7549|Preclamolum [Latin]|UNII-9V2O6CRQ6Z|3-(1-Propyl-piperidin-3-yl)-phenol|3-[(3S)-1-propylpiperidin-3-yl]phenol|Lopac0_000996|orb2815566|SCHEMBL1240854|SCHEMBL30730528|3PPP,(+)|3-PPP-(-)|BDBM50010617|PDSP1_000630|PDSP2_000626|CCG-205076|HY-145454A|SDCCGSBI-0050969.P002|(S)-3-(1-propylpiperidin-3-yl)phenol|NCGC00162308-01|NCGC00162310-02|NCGC00162310-03|(-)-3-(1-Propyl-piperidin-3-yl)-phenol|3-((S)-1-Propyl-piperidin-3-yl)-phenol|CS-0433080|(s)-(-)-3-(3-hydroxyphenyl)-n-propylpiperidine|Q27273260"
BIFEPRUNOX,208951,,"InChI=1S/C24H23N3O2/c28-24-25-21-10-5-11-22(23(21)29-24)27-14-12-26(13-15-27)17-18-6-4-9-20(16-18)19-7-2-1-3-8-19/h1-11,16H,12-15,17H2,(H,25,28)",CYGODHVAJQTCBG-UHFFFAOYSA-N,C24H23N3O2,385.5,"7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-3H-1,3-benzoxazol-2-one","Bifeprunox|350992-10-8|Bifeprunoxum|AP69E83Z79|7-(4-(Biphenyl-3-ylmethyl)piperazin-1-yl)benzoxazol-2(3H)-one|DTXSID80188592|7-[4-(Biphenyl-3-ylmethyl)piperazin-1-yl]benzoxazol-2(3H)-one|RefChem:568327|DTXCID40111083|1-(2-Oxo-benzoxazolin-7-yl)-4-(3-biphenyl)methylpiperazinemesylate|7-(4-((3-phenylphenyl)methyl)piperazin-1-yl)-2,3-dihydro-1,3-benzoxazol-2-one|7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-3H-1,3-benzoxazol-2-one|CHEMBL218166|7-[4-[(3-phenylphenyl)methyl]piperazin-1-yl]-3h-benzooxazol-2-one|7-[4-[(3-PHENYLPHENYL)METHYL]PIPERAZIN-1-YL]-3H-BENZO[D]OXAZOL-2-ONE|Bifeprunox [INN]|Bifeprunoxum [INN-Latin]|UNII-AP69E83Z79|Bifeprunox (USAN/INN)|Bifeprunox [USAN:INN]|Bifeprunox?|Bifeprunox Free Base|BIFEPRUNOX [MI]|BIFEPRUNOX [USAN]|BIFEPRUNOX [WHO-DD]|SCHEMBL114371|orb1710255|CHEBI:177517|CYGODHVAJQTCBG-UHFFFAOYSA-N|BDBM50241119|AKOS015904572|DB04888|HY-14547|DB-129564|CS-0003435|NS00072630|D06566|L001659|Q4904729|7-(4-Biphenyl-3-ylmethyl-piperazin-1-yl)-3H-benzooxazol-2-one|2(3H)-Benzoxazolone, 7-(4-((1,1'-biphenyl)-3-ylmethyl)-1-piperazinyl)-|7-[4-([1,1'-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3h)-benzoxazolone"
PRIDOPIDINE,9795739,,"InChI=1S/C15H23NO2S/c1-3-9-16-10-7-13(8-11-16)14-5-4-6-15(12-14)19(2,17)18/h4-6,12-13H,3,7-11H2,1-2H3",YGKUEOZJFIXDGI-UHFFFAOYSA-N,C15H23NO2S,281.4,4-(3-methylsulfonylphenyl)-1-propylpiperidine,"PRIDOPIDINE|346688-38-8|4-[3-(Methylsulfonyl)phenyl]-1-propylpiperidine|4-(3-(Methylsulfonyl)phenyl)-1-propylpiperidine|ACR-16|ACR16|ACR16 compound|Pridopidina|HD4TW8S2VK|DTXSID90188225|4-(3-methanesulfonylphenyl)-1-propylpiperidine|pridopidinum|RefChem:868501|DTXCID20110716|Huntexil|4-(3-Methylsulfonylphenyl)-1-propylpiperidine|MFCD09835586|CHEMBL596802|UNII-HD4TW8S2VK|ACR 16|Pridopidine [USAN]|Pridopidine [USAN:INN]|PRIDOPIDINE [MI]|PRIDOPIDINE [INN]|Pridopidine (USAN/INN)|4-(3-methylsulfonylphenyl)-1-propyl-piperidine|4-(3-Methanesulfonyl-phenyl)-1-propyl-piperidine|PRIDOPIDINE [WHO-DD]|SCHEMBL166748|orb1299893|SCHEMBL29664816|GTPL13833|BDBM50308028|EX-A10717|AKOS015891431|DB11947|FM25954|compound 12b [PMID: 20155917]|NCGC00386586-01|AS-50146|HY-10684|DB-014417|CS-0002733|NS00071661|D09953|O11067|F334938|Q7242858|ACR 16;4-(3-Methylsulfonylphenyl)-1-propylpiperidine|Piperidine, 4-(3-(methylsulfonyl)phenyl)-1-propyl-"
ASTEMIZOLE,2247,,"InChI=1S/C28H31FN4O/c1-34-25-12-8-21(9-13-25)14-17-32-18-15-24(16-19-32)30-28-31-26-4-2-3-5-27(26)33(28)20-22-6-10-23(29)11-7-22/h2-13,24H,14-20H2,1H3,(H,30,31)",GXDALQBWZGODGZ-UHFFFAOYSA-N,C28H31FN4O,458.6,1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]benzimidazol-2-amine,"astemizole|68844-77-9|Hismanal|Paralergin|Retolen|Astemison|Astemizol|Histamen|Astemizolum|Hestazol|Metodih|1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine|Astemizolum [INN-Latin]|DTXSID9020110|1-(p-Fluorobenzyl)-2-((1-(p-methoxyphenethyl)-4-piperidyl)amino)benzimidazole|R 42512|NSC-329963|NSC-759570|1-(p-Fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)benzimidazole|CHEBI:2896|1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl]benzimidazol-2-amine|R 43,512|DTXCID30110|1H-Benzimidazol-2-amine, 1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)-4-piperidinyl)-|7HU6337315|1H-Benzimidazol-2-amine, 1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)eth l)-4-piperidinyl)-|Astemizolum (INN-Latin)|Alonga, Astemizol|1-[(4-fluorophenyl)methyl]-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-1,3-benzodiazol-2-amine|1H-Benzimidazol-2-amine, 1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-|ratiopharm, Astemizol|1-(p-Fluorobenzyl)-2-[[1-(p-methoxyphenethyl)-4-piperidyl]amino]benzimidazole|astemizolo|R 43 512|Pollon-eze|R43512|1-((4-Fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)-4-piperidinyl)-1H-benzimidazol-2-amine|1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)-1H-1,3-benzodiazol-2-amine|1-((4-fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)piperidin-4-yl)benzimidazol-2-amine|RefChem:388811|R06AX11|272-441-9|Histaminos|Laridal|Alermizol|Kelp|MFCD00153919|GNF-PF-2461|Astemisan|MLS000028667|CHEMBL296419|Histazol|Wareezol|Novo-mastizol A|Astemizol [German]|NCGC00016913-08|Metodik|SMR000058911|Waruzol|CAS-68844-77-9|C28H31FN4O|1-[(4-fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidyl]benzimidazol-2-amine|Benzimidazole, 1-(p-fluorobenzyl)-2-((1-(2-(p-methoxyphenyl)ethyl)piperid-4-yl)amino)-|Astemizol [INN-Spanish]|R 43512|1-((4-Fluorophenyl)methyl)-N-(1-(2-(4-methoxyphenyl)ethyl)-4-piperidinyl)- 1H-benzimidazol-2-amine|Novo-nastizol a|[3H]Astemizole|1-(4-fluorobenzyl)-2-(1-(4-methoxyphenethyl)piperidin-4-yl)aminobenzimidazole|1-(4-Fluorobenzyl)-2-(1-[4-methoxyphenethyl]piperidin-4-yl)aminobenzimidazole|1-(4-fluorobenzyl)-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-amine|1-[(4-fluorophenyl)methyl]-N-(1-{2-[4-(methyloxy)phenyl]ethyl}piperidin-4-yl)-1H-benzimidazol-2-amine|1-[(4-Fluorophenyl)methyl]-N-{1-[2-(4-methoxyphenyl)ethyl]piperidin-4-yl}-1H-benzimidazol-2-amine|CCRIS 7595|HSDB 6799|SR-01000003168|HISMANAL (TN)|EINECS 272-441-9|BRN 4830190|Astemizole (JAN/USP/INN)|Astemizole?|MJD-30|Prestwick_35|UNII-7HU6337315|1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine;Astemisan;Hismanal|XB7|NSC 329963|Astemizole [USAN:USP:INN:BAN:JAN]|Astemizole (Standard)|Opera_ID_62|Spectrum_000448|ASTEMIZOLE [MI]|ASTEMIZOLE [INN]|ASTEMIZOLE [JAN]|Prestwick0_000136|Prestwick1_000136|Prestwick2_000136|Prestwick3_000136|Spectrum2_001732|Spectrum3_001072|Spectrum4_001223|Spectrum5_001239|ASTEMIZOLE [HSDB]|ASTEMIZOLE [USAN]|ASTEMIZOLE [VANDF]|UPCMLD-DP024|ASTEMIZOLE [MART.]|cid_2247|SCHEMBL4385|ASTEMIZOLE [WHO-DD]|REGID_for_CID_2247|BSPBio_000212|BSPBio_002684|KBioGR_001686|KBioSS_000928|Astemizole, [O-Methyl-3H]|MLS001148073|DivK1c_000039|SPECTRUM2300094|SPBio_001804|SPBio_002151|Astemizole - Bio-X trade mark|BPBio1_000234|GTPL2603|orb1309145|Astemizole, >=98% (HPLC)|UPCMLD-DP024:001|BDBM24226|HMS500B21|KBio1_000039|KBio2_000928|KBio2_003496|KBio2_006064|KBio3_001904|ASTEMIZOLE [USP IMPURITY]|NINDS_000039|HMS1568K14|HMS1922L12|HMS2090F14|HMS2093L18|HMS2095K14|HMS2234M17|HMS3373B08|HMS3413N12|HMS3677N12|HMS3712K14|HMS3751A17|HMS5086G06|Pharmakon1600-02300094|BCP16088|EX-A3350|MSK10142|Tox21_110680|Tox21_200095|CCG-39453|HY-12532R|NSC329963|NSC759570|STL301859|AKOS005064371|Tox21_110680_1|DB00637|FA18002|KS-5171|NSC 759570|IDI1_000039|QTL1_000010|NCGC00016913-01|NCGC00016913-02|NCGC00016913-03|NCGC00016913-04|NCGC00016913-05|NCGC00016913-06|NCGC00016913-07|NCGC00016913-09|NCGC00016913-10|NCGC00016913-11|NCGC00016913-12|NCGC00016913-14|NCGC00018288-01|NCGC00022520-03|NCGC00022520-04|NCGC00022520-05|NCGC00022520-06|NCGC00022520-07|NCGC00257649-01|AC-36371|BA300024|HY-12532|SBI-0051891.P002|AB00052413|CS-0011989|NS00008521|ST51014896|C06832|D00234|AB00052413-18|AB00052413_19|844A779|EN300-26506436|L001015|Q423437|SR-01000003168-2|SR-01000003168-4|BRD-K37249724-001-05-9|BRD-K37249724-001-16-6|BRD-K37249724-001-24-0|BRD-K37249724-001-25-7|Astemizole, United States Pharmacopeia (USP) Reference Standard|1-(4-fluorobenzyl)-N-(1-(4-methoxyphenethyl)piperidin-4-yl)-1H-benzo[d]imidazol-2-amine|{1-[(4-fluorophenyl)methyl]benzimidazol-2-yl}{1-[2-(4-methoxyphenyl)ethyl](4-p iperidyl)}amine|1-(4-Fluorobenzyl)-N-(1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl)-1H-benzimidazol-2-amine #|1-(4-fluorophenylmethyl)-N-{1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl}-1H-benzimidazol-2-amine|Hismanal;1-[(4-Fluorophenyl)methyl]-N-[1-[2-(4-methoxyphenyl)ethyl]-4-piperidinyl]-1H-benzimidazol-2-amine"
PENTAZOCINE,441278,,"InChI=1S/C19H27NO/c1-13(2)7-9-20-10-8-19(4)14(3)18(20)11-15-5-6-16(21)12-17(15)19/h5-7,12,14,18,21H,8-11H2,1-4H3/t14-,18+,19+/m0/s1",VOKSWYLNZZRQPF-GDIGMMSISA-N,C19H27NO,285.4,"(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol","pentazocine|Pentazocin|Pentazocinum|Fortalin|Fortral|Liticon|Pentagin|Sosigon|359-83-1|Pentazocina|Fortalgesic|II-C-2|Pentazocine civ|2-(3,3-Dimethylallyl)cyclazocine|NIH 7958|RP4A60D26L|WIN-20228|WIN 20,228|2-Dimethylallyl-5,9-dimethyl-2'-hydroxybenzomorphan|CHEBI:7982|(2R*,6R*,11R*)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol|2'-Hydroxy-5,9-dimethyl-2-(3,3-dimethylallyl)-6,7-benzomorphan|2-(3,3-Dimethylallyl)-2',2'-hydroxy-5,9-dimethyl-6,7-benzomorphan|WIN 20228|NIH-7958|3-(3-Methyl-2-butenyl)-1,2,3,4,5,6-hexahydro-6,11-dimethyl-2,6-methano-3-benzazocin-8-ol|2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-|1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-2,6-methano-3-benzazocin-8-ol|2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2alpha,6alpha,11R*)-|(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo(7.3.1.0^(2,7))trideca-2,4,6-trien-4-ol|(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0^{2,7}]trideca-2,4,6-trien-4-ol|Lactate, Pentazocine|RefChem:928798|N02AD01|(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo(7.3.1.02,7)trideca-2,4,6-trien-4-ol|206-634-6|NSC-107430|L-pentazocine|Pentazocine, (-)-|Levopentazocine|Pentazocine, L-|(-)-PENTAZOCINE|7488-49-5|dl-Pentazocine|cis-(-)-Pentazocine|(-)-cis-Pentazocine|Pentazocine 2R,6R,11R-form|(-)-alpha-Pentazocine|UNII-768DQ5A5AI|Pentazocaine|Pentazocine 2R,6R,11R-form [MI]|Sosegon|768DQ5A5AI|2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-|KF-1820|Pentazocina [DCIT]|Pentazocinum [INN-Latin]|(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-enyl)-10-azatricyclo[7.3.1.02,7]trideca-2(7),3,5-trien-4-ol|(2R,6R,11R)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-2,6-methano-3-benzazocin-8-ol|(2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methanobenzo[d]azocin-8-ol|2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-rel-|Fortral (TN)|PENTAZOCINE (+)|PENTAZOCINE (-)|UNII-RP4A60D26L|HSDB 3150|EINECS 206-634-6|(+-)-Pentazocine|(+/-)-pentazocine|NSC 107430|Pentazocine,(+/-)|Pentazocine [USAN:USP:INN:BAN:JAN]|cis-(+-)-Pentazocine|PENTAZOCINE [MI]|cis-(+/-)-Pentazocine|PENTAZOCINE [INN]|PENTAZOCINE [JAN]|PENTAZOCINE [HSDB]|PENTAZOCINE [USAN]|CHEMBL560|PENTAZOCINE [VANDF]|SCHEMBL2492|PENTAZOCINE [MART.]|PENTAZOCINE [WHO-DD]|GTPL1606|359-83-1 (free base)|Pentazocine (JP18/USP/INN)|DTXSID7023433|PENTAZOCINE [EP IMPURITY]|PENTAZOCINE CIV [USP-RS]|VOKSWYLNZZRQPF-GDIGMMSISA-N|(-)-.ALPHA.-PENTAZOCINE|PENTAZOCINE [EP MONOGRAPH]|Pentazocine (1mg/ml in Methaniol)|PENTAZOCINE [USP MONOGRAPH]|(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol|(6R,11S)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol|6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol|EINECS 244-593-6|BDBM50001028|DB00652|FP26817|FP26819|(2alpha,6alpha,11R*)-(1)-1,2,3,4,5,6-Hexahydro-6,11-dimethyl-3-(3-methylbut-2-enyl)-2,6-methano-3-benzazocin-8-ol|(2R,6R,11R)-6,11-dimethyl-3-(3-methylbut-2-en-1-yl)-1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-8-ol|NS00010467|C07421|D00498|Q415793|(-)-cis-Pentazocine; 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-, (2R,6R,11R)-; 2,6-Methano-3-benzazocin-8-ol, 1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-butenyl)-, (2R,6R,11R)- (9CI); 2,6-Methano-3-benzazocin-8-ol, 1,2|(1R,9R,13R)-1,13-dimethyl-10-(3-methylbut-2-en-1-yl)-10-azatricyclo[7.3.1.0?,?]trideca-2(7),3,5-trien-4-ol|(2R,6R,11R)-rel-1,2,3,4,5,6-hexahydro-6,11-dimethyl-3-(3-methyl-2-buten-1-yl)-2,6-methano-3-benzazocin-8-ol;Fortalgesic;Fortalin|2,6-METHANO-3-BENZAZOCIN-8-OL, 1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3-(3-METHYL-2-BUTENYL)-, (2R,6R,11R)-|2,6-METHANO-3-BENZAZOCIN-8-OL, 1,2,3,4,5,6-HEXAHYDRO-6,11-DIMETHYL-3-(3-METHYL-2-BUTENYL)-, CIS-(-)-|6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol(Pentazocine)|rel-(2R,6R,11R)-6,11-Dimethyl-3-(3-methyl-but-2-enyl)-1,2,3,4,5,6-hexahydro-2,6-methano-benzo[d]azocin-8-ol"
CARIPRAZINE,11154555,,"InChI=1S/C21H32Cl2N4O/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23/h3-5,16-17H,6-15H2,1-2H3,(H,24,28)",KPWSJANDNDDRMB-UHFFFAOYSA-N,C21H32Cl2N4O,427.4,"3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea","Cariprazine|839712-12-8|RGH-188|RGH 188|1480744-38-4|MP-214|3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea|MFCD19443701|Cariprazine (RGH-188)|Urea, N'-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N -diMethyl-|F6RJL8B278|CHEMBL3085826|GED-129|Fri-7000188|Cariprazine(RGH188)|3,3-dimethyl-1-[(1r,4r)-4-{2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl}cyclohexyl]urea|3-((1r,4r)-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea|3-[4-[2-[4-[2,3-bis(chloranyl)phenyl]piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethyl-urea|Cariprazine [INN]|Cariprazine [USAN:INN]|cariprazina|UNII-F6RJL8B278|Reagila|C21H32Cl2N4O|cis-Cariprazine|trans-Cariprazine|Urea, N'-[trans-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N-dimethyl-; N'-[trans-4-[2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N-dimethylurea; Cariprazine; RGH 188; [trans-4-[[2-[4-(2,3-Dichlorophenyl)piperazin-1-yl]ethyl]carbamoyl]cyclohexan-1-yl]-N,N-dimethylamine|MP 214|Cariprazine free base|Cariprazine Cis Isomer|Cariprazine (Standard)|Cariprazine Impurity 4|Cariprazine Impurity 9|CARIPRAZINE [MI]|RGH-188; Cariprazine|Cariprazine (USAN/INN)|CARIPRAZINE [USAN]|A5DF2K87MU|CARIPRAZINE [WHO-DD]|SCHEMBL184342|SCHEMBL184343|GTPL7671|orb1302742|CHEMBL2028019|SCHEMBL26301652|SCHEMBL29395059|CHEBI:90933|HSDB 8310|DTXSID80232867|KPWSJANDNDDRMB-QAQDUYKDSA-N|BDBM263449|BDBM707646|GLXC-90442|BCP14691|ICC27867|RGH-188;MP-214|ARD177960|BDBM50382290|BDBM50443094|BDBM50443101|HY-14763R|AKOS027250814|CS-1569|DB06016|EX-A1644-1|FC64969|SB16839|3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethyl-urea|N'-[trans-4-[2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N-dimethylurea|NCGC00379014-01|NCGC00379014-02|NCGC00379014-03|US12168007, Ref. Ex. 2|AC-35342|AS-74411|FD183080|HY-14763|US9550741, RGH-188|NS00073308|Cariprazine Cis Isomer;Cariprazine Impurity 8|C76682|D09997|EN300-7406880|Q2938837|BRD-K57764956-001-02-8|RGH-188; RGH188; RGH 188; MP-214; MP 214; MP214|3-(cis-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)-cyclohexyl)-1,1-dimethylurea|3-(cis-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea|3-(trans-4-(2-(4-(2,3-Dichlorophenyl)piperazin-1-yl)ethyl)-cyclohexyl)-1,1-dimethylurea|3-(trans-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea|N'-(trans-4-{2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl}cyclohexyl)-N,N-dimethylurea|N'-[cis-4-[2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N-dimethylurea|trans-N-[4-[2-[4-(2,3-di-chlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-N',N'-dimethylurea|Urea, N'-[cis-4-[2-[4-(2,3-dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-N,N-dimethyl-|7RU|Trans-1-{4-[2-[4-(2,3-dichlorophenyl)-piperazin-1-yl]-ethyl]-cyclohexyl}-3,3-dimethyl-urea|trans-N-{4-[2-[4-(2,3-dichlorophenyl)piperazine-1-yl]ethyl]cyclohexyl}-N',N'-dimethylurea hydrochloride|Urea, N'-(trans-4-(2-(4-(2,3-dichlorophenyl)-1-piperazinyl)ethyl)cyclohexyl)-N,N-dimethyl-"
BREXPIPRAZOLE,11978813,,"InChI=1S/C25H27N3O2S/c29-25-9-7-19-6-8-20(18-22(19)26-25)30-16-2-1-11-27-12-14-28(15-13-27)23-4-3-5-24-21(23)10-17-31-24/h3-10,17-18H,1-2,11-16H2,(H,26,29)",ZKIAIYBUSXZPLP-UHFFFAOYSA-N,C25H27N3O2S,433.6,7-[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one,"BREXPIPRAZOLE|913611-97-9|Rexulti|OPC-34712|OPC 34712|brexpiprazol|2J3YBM1K8C|7-(4-(4-(1-Benzothiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one|7-[4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one|DTXSID40238527|brexpiprazolum|7-(4-(4-(1-benzothiophen-4-yl)piperazin-1-yl)butoxy)-1H-quinolin-2-one|7-(4-(4-(1-benzothiophen-4-yl)piperazin-1-yl)butoxy)-1,2-dihydroquinolin-2-one|7-{4-[4-(1-benzothiophen-4-yl)piperazin-1-yl]butoxy}-1,2-dihydroquinolin-2-one|RefChem:58868|DTXCID90161018|N05AX16|945-906-5|7-(4-(4-(Benzo[b]thiophen-4-yl)piperazin-1-yl)butoxy)quinolin-2(1H)-one|MFCD27987920|C25H27N3O2S|Brexpiprazole-d8|Brexpiprazole [USAN]|UNII-2J3YBM1K8C|Brexpiprazole [USAN:INN]|Rxulti|2(1H)-Quinolinone, 7-[4-(4-benzo[b]thien-4-yl-1-piperazinyl)butoxy]-; 7-[4-(4-(Benzo[b]thien-4-yl)-piperazin-1-yl)butoxy]-1H-quinolin-2-one; Brexpiprazole; OPC 34712|Rexulti (TN)|Brexpiprazole.2H2O|PS33 - Brexpiprazole|Brexpiprazole (Standard)|BREXPIPRAZOLE [MI]|BREXPIPRAZOLE [INN]|BREXPIPRAZOLE [JAN]|Brexpiprazole Impurity 141|Brexpiprazole(OPC34712)|Brexpiprazole(OPC34712)?|Brexpiprazole; OPC-34712|BREXPIPRAZOLE [WHO-DD]|GTPL7672|orb1305739|SCHEMBL1037592|Brexpiprazole (JAN/USAN/INN)|CHEMBL2105760|SCHEMBL14772509|SCHEMBL27959775|SCHEMBL29350574|SCHEMBL29870341|CHEBI:134716|ZKIAIYBUSXZPLP-UHFFFAOYSA-N|HMS3885P12|HMS5083M06|BREXPIPRAZOLE [ORANGE BOOK]|BCP10218|BCP24077|EX-A2639|OPC34712|HY-15780R|s4639|AKOS025291100|AKOS037515802|CCG-269055|DB09128|SB16735|NCGC00378574-01|NCGC00378574-02|AC-30404|AS-56467|DA-35913|FB106463|HY-15780|SY047420|NS00073000|D10309|EN300-311582|Q2924764|BRD-K00911143-001-01-9|Z2373117814|7-[4-[4-(4-Benzothienyl)-1-piperazinyl]butoxy]quinolin-2(1H)-one|2(1H)-Quinolinone, 7-(4-(4-benzo(b)thien-4-yl-1-piperazinyl)butoxy)-|7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)-butoxy]-1H-quinolin-2-one|7-[4-(4-benzo[b]thiophen-4-yl-piperazin-1-yl)butoxy]-1H-quinolin-2-one|7-[4-(4-Benzo[b]thiophen-4-ylpiperazin-1-yl)butoxy]-1H-quinolin-2-one|7-[4-[4-(benzothiophen-4-yl)piperazin-1-yl]butoxy]-1H-quinolin-2-one"
SEROTONIN,5202,,"InChI=1S/C10H12N2O/c11-4-3-7-6-12-10-2-1-8(13)5-9(7)10/h1-2,5-6,12-13H,3-4,11H2",QZAYGJVTTNCVMB-UHFFFAOYSA-N,C10H12N2O,176.21,3-(2-aminoethyl)-1H-indol-5-ol,"serotonin|5-HYDROXYTRYPTAMINE|50-67-9|3-(2-Aminoethyl)-1H-indol-5-ol|Enteramine|Thrombotonin|Thrombocytin|Serotonine|1H-Indol-5-ol, 3-(2-aminoethyl)-|Hippophaine|3-(beta-Aminoethyl)-5-hydroxyindole|333DO1RDJY|CHEBI:28790|DTXSID8075330|3-(2-Aminoethyl)-1H-indol-5-o|Serotonin (Human)|5 Hydroxytryptamine|Serotonin 1543|RefChem:6493|DTXCID4040765|200-058-9|NSC58241|5-HT|Antemovis|Ds substance|Hippophain|Antemoqua|Substance DS|Substanz DS|5-Hta|Tryptamine, 5-hydroxy-|3-(2-Aminoethyl)indol-5-ol|Indol-5-ol, 3-(2-aminoethyl)-|Enteramin|5-Hydroxy-3-(beta-aminoethyl)indole|3-(2-Amino-ethyl)-1H-indol-5-ol|MFCD00055054|3-(.beta.-Aminoethyl)-5-hydroxyindole|5-Hydroxytryptamine, free base|Serotonin base; 3-(2-Aminoethyl)-5-hydroxyindole|EINECS 200-058-9|UNII-333DO1RDJY|BRN 0143524|5-hydroxytryptamin|5-Hydroxytriptamine|5-Hydroxyltryptamine|5-hydroxy-tryptamine|Enteramin; Enteramine|5-hydroxyl tryptamine|Lisinopril Impurity 21|GTPL5|SEROTONIN [MI]|CHEMBL39|Prestwick0_000481|Prestwick1_000481|Prestwick2_000481|Prestwick3_000481|Lopac-H-9523|5-Hydroxytryptamine;5-HT|Biomol-NT_000083|bmse000757|SEROTONIN [MART.]|SCHEMBL1495|SEROTONIN [WHO-DD]|Lopac0_000607|Oprea1_712368|BSPBio_000341|BSPBio_001112|KBioGR_000452|KBioGR_002472|KBioSS_000452|KBioSS_002479|5-22-12-00016 (Beilstein Handbook Reference)|Serotonin, analytical standard|SPBio_002262|BPBio1_000377|BPBio1_001079|orb1297148|SCHEMBL11339569|SCHEMBL29349412|BCBcMAP01_000198|BDBM10755|KBio2_000452|KBio2_002472|KBio2_003020|KBio2_005040|KBio2_005588|KBio2_007608|KBio3_000843|KBio3_000844|KBio3_002950|cMAP_000059|3-(b-Aminoethyl)-5-hydroxyindole|5-Hydroxy-3-(b-aminoethyl)indole|Bio1_000450|Bio1_000939|Bio1_001428|Bio2_000396|Bio2_000876|HMS1362H13|HMS1792H13|HMS1990H13|HMS3403H13|PDSP1_001512|PDSP2_001496|STK503758|AKOS001484724|3-(2-Aminoethyl)-1H-indol-5-ol #|CCG-204696|DB08839|FH52409|indole, 3-(2-aminoethyl)-5-hydroxy-|SDCCGSBI-0050589.P002|5-Hydroxy-3-(.beta.-aminoethyl)indole|IDI1_002151|SMP1_000272|5-hydroxy tryptamine creatinine disulfate|NCGC00015525-01|NCGC00015525-02|NCGC00015525-03|NCGC00015525-04|NCGC00015525-05|NCGC00015525-06|NCGC00015525-07|NCGC00015525-08|NCGC00015525-09|NCGC00015525-18|NCGC00015525-19|NCGC00142449-01|NCGC00142449-02|NCGC00142449-03|NCGC00142449-04|NCGC00142449-05|AS-75772|CAS-153-98-0|DB-051820|NS00007188|14C-5-hydroxy tryptamine creatinine disulfate|C00780|EN300-120141|G77704|H-8000|A828245|L000078|Q167934|BRD-K38580127-003-15-4|BRD-K38580127-003-16-2|BRD-K38580127-003-17-0|6F7FD5B4-A558-45F0-A20A-2D068A3EFE6A|2-imino-1-methylimidazolidin-4-one; 3-(2-aminoethyl)-1H-indol-5-ol; bis(sulfuric acid)|1094000-36-8"
KETANSERIN,3822,,"InChI=1S/C22H22FN3O3/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29)",FPCCSQOGAWCVBH-UHFFFAOYSA-N,C22H22FN3O3,395.4,"3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione","Ketanserin|74050-98-9|Ketanserina|Ketanserine|Ketanserinum|Ketaserin|3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)ethyl)quinazoline-2,4(1H,3H)-dione|Serefrex|R-41468|R-41,468|3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-1H-quinazoline-2,4-dione|DTXSID3023188|R 41468|R 41,468|97F9DE4CT4|CHEBI:6123|NSC-758959|3-(2-(4-(4-Fluorobenzoyl)piperidinol)ethyl)-2,4(1H,3H)-quinazolinedione|2,4(1H,3H)-Quinazolinedione, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-|DTXCID103188|R41,468|3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione|3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}quinazoline-2,4(1H,3H)-dione|2,4(1H,3H)-Quinazolinedione, 3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-|ketensin|3-(2-(4-(4-fluorobenzoyl)piperidin-1-yl)ethyl)-1H-quinazoline-2,4-dione|3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-1H-quinazoline-2,4-dione|3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-2,4(1H,3H)-quinazolinedione|3-{2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl}-2,4(1H,3H)-quinazolinedione|RefChem:389088|C02KD01|277-680-2|R41468|Ketanserin tartrate|C22H22FN3O3|MFCD00083392|[3H]-Ketanserin|CHEMBL51|3-(2-(4-(p-Fluorobenzoyl)piperidino)ethyl)-2,4-(1H,3H)-quinazolinedione|3-[2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl]-1H-quinazoline-2,4-dione|[3H]ketanserin|NCGC00021146-06|83846-83-7|3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)-1,2,3,4-tetrahydroquinazoline-2,4-dione|Ketanserine [INN-French]|Ketanserinum [INN-Latin]|Ketanserina [INN-Spanish]|Perketal|Taseron|Vulketan Gel|3-[2-[4-(4-fluorophenyl)carbonylpiperidin-1-yl]ethyl]-1~{H}-quinazoline-2,4-dione|CAS-74050-98-9|Ketanserin (USAN/INN)|EINECS 277-680-2|UNII-97F9DE4CT4|Kentanserin|Ketanserin [USAN:INN:BAN]|R-41-468|3-[2-[4-(p-Fluorobenzoyl)piperidino]ethyl]-2,4-(1H,3H)-quinazolinedione|3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione; Ketanserin; Ketensin; R 41468; Suffrexal; Vulketan Gel|Ketanserin (Standard)|Tocris-0908|KETANSERIN [MI]|KETANSERIN [INN]|Spectrum2_001713|KETANSERIN [USAN]|Ketanserin (Vulketan Gel)|Biomol-NT_000096|GTPL88|3-(2-(4-(4-Fluorobenzoyl)piperidin-1-yl)-ethyl)quinazoline-2,4(1H,3H)-dione|KETANSERIN [MART.]|KETANSERIN [WHO-DD]|SCHEMBL34294|GTPL197|MLS006010073|SPECTRUM1505346|SPBio_001726|BPBio1_001356|orb1309882|SCHEMBL29361038|BDBM21395|GLXC-06518|HMS1923O11|HMS2090H18|HMS2094I03|HMS3655H14|HMS3887G17|HMS5087J17|Pharmakon1600-01505346|Tox21_110865|CCG-39512|HY-10562R|NSC758959|PDSP1_000639|PDSP2_000634|s2232|AKOS015895130|Tox21_110865_1|AC-2024|CS-6055|DB12465|FF24757|GS-3601|SDCCGSBI-0051158.P004|(+)-3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4(1H,3H)-quinazolinedione|3-(2-{4-[(4-fluorophenyl)carbonyl]piperidin-1-yl}ethyl)quinazoline-2,4(1H,3H)-dione|NCGC00021146-01|NCGC00021146-02|NCGC00021146-03|NCGC00021146-04|NCGC00021146-05|NCGC00021146-07|NCGC00021146-08|NCGC00021146-09|NCGC00021146-12|NCGC00021146-22|NCGC00024865-01|NCGC00024865-02|NCGC00024865-03|NCGC00024865-04|NCGC00024865-05|HY-10562|SMR001550601|SY053064|SBI-0051158.P003|DB-055834|K0051|NS00001319|SW196882-3|C07464|D02363|050K989|L000764|Q415997|R41 468|BRD-K49671696-001-02-1|BRD-K49671696-001-05-4|BRD-K49671696-045-08-5|BRD-K49671696-046-01-8|BRD-K49671696-347-02-8|F2173-1039|Z2216887910|KETANSERIN, Ketanserin tartrate hydrate, KETANSERIN TARTRATE|3-(2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl)-2,4(1H,3H)-quinazolinedione #|3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]-ethyl]-2,4-[1H, 3H]-quinazolinedione|3-[2-[4-(4-fluorobenzoyl)-1-piperidinyl]ethyl]-2,4-(1H,3H)-quinazolinedione|3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,4[1H,3H]-quinazolinedione;R 41468|3-[2-[4-(4-Fluorobenzoyl)-1-piperidyl]ethyl]quinazoline-2,4(1H,3H)-dione|3-{2-[4-(4-fluoro-benzoyl)-piperidin-1-yl]-ethyl}-1h-quinazoline-2,4-dione|3-{2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl}-1,2,3,4-tetrahydroquinazoline-2,4-dione|UYX"
METITEPINE,4106,,"InChI=1S/C20H24N2S2/c1-21-9-11-22(12-10-21)18-13-15-5-3-4-6-19(15)24-20-8-7-16(23-2)14-17(18)20/h3-8,14,18H,9-13H2,1-2H3",RLJFTICUTYVZDG-UHFFFAOYSA-N,C20H24N2S2,356.6,"1-methyl-4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazine","methiothepin|Metitepine|20229-30-5|Metitepina|Metitepinum|Methiotepin|Ro-8-6837|Maleate, Methiothepin|DTXSID2044000|CHEBI:64203|(+-)-8-Methylthio-10-(4-methylpiperazino)-10,11-dihydrodibenzo(b,f)thiepin|(+-)-1-(10,11-Dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methylpiperazine|(+-)-10-(4-Methylpiperazinyl)-8-(methylthio)-10,11-dihydrodibenzo(b,f)thiepin|55D94103HL|NSC-759875|Ro 8-6837|Piperazine, 1-[10,11-dihydro-8-(methylthio)dibenzo[b,f]thiepin-10-yl]-4-methyl-|DTXCID0024000|1-methyl-4-[8-(methylsulfanyl)-10,11-dihydrodibenzo[b,f]thiepin-10-yl]piperazine|Piperazine, 1-(10,11-dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methyl-|1-methyl-4-(8-(methylsulfanyl)-10,11-dihydrodibenzo(b,f)thiepin-10-yl)piperazine|1-methyl-4-(8-methylsulfanyl-5,6-dihydrobenzo(b)(1)benzothiepin-6-yl)piperazine|1-methyl-4-(8-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-6-yl)piperazine|RefChem:157019|Methiothepine|Metitepine [INN]|METHIOTHEPINMALEATE|1-methyl-4-(3-methylsulfanyl-5,6-dihydrobenzo[b][1]benzothiepin-5-yl)piperazine|1-(10,11-Dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methylpiperazine|NCGC00024665-03|MLS000859918|Metitepinum [INN-Latin]|Metitepina [INN-Spanish]|1-[10,11-dihydro-8-(methylthio)dibenzo[b,f]thiepin-10-yl]-4-methylpiperazine|1-methyl-4-[8-(methylthio)-10,11-dihydrodibenzo[b,f]thiepin-10-yl]piperazine|CAS-20229-30-5|SMR000326779|BRN 0626221|UNII-55D94103HL|1-[10,11-Dihydro-8-(methylthio)dibenzo[b,f]thiepin-10-yl]-4-methylpiperazine mesylate salt|METITEPINE [MI]|Piperazine, 1-[10,11-dihydro-8-(methylthio)dibenzo[b,f]thiepin-10-yl]-4-methyl-, (2Z)-2-butenedioate (1:1)|Prestwick0_000375|Prestwick1_000375|Prestwick2_000375|Prestwick3_000375|Spectrum2_001967|Spectrum3_001602|Spectrum4_001092|Spectrum5_001832|Biomol-NT_000094|GTPL89|Dibenzo(b,f)thiepin, 10,11-dihydro-10-(4-methylpiperazinyl)-8-(methylthio)- (+-)|Lopac0_000804|BSPBio_000529|BSPBio_003203|KBioGR_001504|CHEMBL93240|DivK1c_000913|SCHEMBL113526|SPBio_002093|SPBio_002450|BPBio1_000583|BPBio1_001352|orb1739492|SCHEMBL29496251|BDBM78940|cid_3039995|KBio1_000913|KBio3_002423|VUFB-6276|NINDS_000913|HMS2089P11|Tox21 110916|Tox21_110916|AKOS005065442|Tox21_110916_1|AT37104|CCG-204888|NSC 759875|SDCCGSBI-0050781.P004|IDI1_000913|Piperazine, 1-(10,11-dihydro-8-(methylthio)dibenzo(b,f)thiepin-10-yl)-4-methyl-, (+-)-|NCGC00024665-02|NCGC00024665-04|NCGC00024665-05|NCGC00024665-06|NCGC00024665-07|NCGC00024665-10|NCGC00024665-17|NCI60_002300|SBI-0050781.P003|AB00053700|CS-0042227|AB00053700_19|EN300-2010375|AE-641/00612014|L000397|Q6824154|BRD-A07932845-001-01-1|BRD-A07932845-050-05-9|BRD-A07932845-050-15-8|BRD-A07932845-066-08-9|BRD-A07932845-066-11-3|BRD-A07932845-103-01-5|Z2681892982|mesylic acid;1-methyl-4-[3-(methylthio)-5,6-dihydrobenzo[b][1]benzothiepin-5-yl]piperazine|methyl 11-(4-methyl-1-piperazinyl)-10,11-dihydrodibenzo[b,f]thiepin-2-yl sulfide|1-methyl-4-[6-(methylsulfanyl)-2-thiatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-9-yl]piperazine|methanesulfonic acid;1-methyl-4-[3-(methylthio)-5,6-dihydrobenzo[b][1]benzothiepin-5-yl]piperazine"
GLEMANSERIN,71781,,"InChI=1S/C20H25NO/c22-20(18-9-5-2-6-10-18)19-12-15-21(16-13-19)14-11-17-7-3-1-4-8-17/h1-10,19-20,22H,11-16H2",AXNGJCOYCMDPQG-UHFFFAOYSA-N,C20H25NO,295.4,phenyl-[1-(2-phenylethyl)piperidin-4-yl]methanol,"Glemanserin|107703-78-6|MDL 11,939|Mdl-11,939|MDL-11939|132553-86-7|phenyl-[1-(2-phenylethyl)piperidin-4-yl]methanol|Glemanserina|Glemanserine|Glemanserin [USAN:INN]|X96LS7MC5Z|DTXSID4042624|4-Piperidinemethanol, alpha-phenyl-1-(2-phenylethyl)-|GLEMANSERIN [INN]|GLEMANSERIN [USAN]|phenyl-(1-(2-phenylethyl)piperidin-4-yl)methanol|glemanserinum|RefChem:663072|DTXCID2022624|alpha-Phenyl-1-(2-phenylethyl)-4-piperidinemethanol|Mdl 11939|CHEMBL18972|(+-)-1-Phenethyl-alpha-phenyl-4-piperidinemethanol|UNII-X96LS7MC5Z|Glemanserin (USAN/INN)|Glemanserin, MDL11939|phenyl-[1-(2-phenylethyl)-4-piperidyl]methanol|GTPL186|SCHEMBL120012|orb1704378|CHEBI:91790|HMS3266L14|HMS3411B04|HMS3675B04|4-Piperidinemethanol, alpha-phenyl-1-(2-phenylethyl)-, (+-)-|HEA70378|BDBM50004327|MDL11,939|MFCD00864701|PDSP1_001574|PDSP2_001558|AKOS024458672|MS-24232|DB-115176|HY-101250|CS-0021037|(1-Phenethyl-piperidin-4-yl)-phenyl-methanol|D04320|G78296|phenyl[1-(2-phenylethyl)piperidin-4-yl]methanol||A-Phenyl-1-(2-phenylethyl)-4-piperidinemethanol|4-Piperidinemethanol,a-phenyl-1-(2-phenylethyl)-|L002081|SR-01000597432|Q5567525|SR-01000597432-1|BRD-A62057054-001-01-5|BRD-A62057054-001-03-1|alpha-phenyl-[1-(2-phenylethyl )]-4-piperidinemethanol|alpha-phenyl-[1-(2-phenylethyl)]-4-piperidinemethanol|(+/-)-1-PHENETHYL-.ALPHA.-PHENYL-4-PIPERIDINEMETHANOL|MDL 11,939phenyl[1-(2-phenylethyl)piperidin-4-yl]methanol|4-PIPERIDINEMETHANOL, .ALPHA.-PHENYL-1-(2-PHENYLETHYL)-, (+/-)-|a-Phenyl-1-(2-phenylethyl)-4-piperidinemethanol; Glemanserin; MDL 11939;"
VOLINANSERIN,5311271,,"InChI=1S/C22H28FNO3/c1-26-20-5-3-4-19(22(20)27-2)21(25)17-11-14-24(15-12-17)13-10-16-6-8-18(23)9-7-16/h3-9,17,21,25H,10-15H2,1-2H3/t21-/m1/s1",HXTGXYRHXAGCFP-OAQYLSRUSA-N,C22H28FNO3,373.5,"(R)-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]methanol","Volinanserin|139290-65-6|MDL-100907|M100907|Volinanserina|Volinanserine|MDL100.907|MDL-100,907|Mdl 100,907|EW71EE171J|DTXSID6047363|(R)-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]piperidin-4-yl]methanol|M-100907|MDL-100.907|DTXCID4027363|alpha-(2,3-Dimethoxyphenyl)-1-(2-(4-fluorophenylethyl))-4-piperidine methanol|(R)-(2,3-dimethoxyphenyl)(1-(2-(4-fluorophenyl)ethyl)piperidin-4-yl)methanol|volinanserinum|(R)-(2,3-dimethoxyphenyl)-(1-(2-(4-fluorophenyl)ethyl)piperidin-4-yl)methanol|MDL100105|RefChem:902049|4-piperidinemethanol, alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (alpha-R)-|(+)-alpha-(2,3-Dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol|604-124-1|Mdl 100907|Volinanserin [INN]|MFCD00909060|MDL100907|CHEMBL74355|(R)-(2,3-Dimethoxyphenyl)(1-(4-fluorophenethyl)piperidin-4-yl)methanol|Volinanserin Hydrochloride Salt|4-Piperidinemethanol, alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-, (alphaR)-|C22H28FNO3|(R)-(2,3-Dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol|UNII-EW71EE171J|Serotonin 5-HT2 Receptor Antagonists|GTPL185|SCHEMBL675164|orb1301831|SCHEMBL29356737|(2,3-Dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol|HXTGXYRHXAGCFP-OAQYLSRUSA-N|EX-A3509|Tox21_300244|BDBM50095027|HB1780|AKOS022180892|FV28720|NCGC00247964-01|NCGC00254173-01|AC-36402|AS-35103|DA-59040|HY-14940|CAS-139290-65-6|CS-0003646|(R)-(+)-MDL 100907|M100907, >=98% (HPLC)|Q7940202|BRD-K23647661-001-02-2|(R)-(1-(4-fluorophenethyl)piperidin-4-yl)(2,3-dimethoxyphenyl)methanol|(R)-(2,3-Dimethoxyphenyl)-(1-(2-p-fluorophenylethyl)-piperidine-4-yl)-methanol|(R)-(2,3-dimethoxyphenyl)-[1-[2-(4-fluorophenyl)ethyl]-4-piperidyl]methanol|(R)-alpha-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol|4-Piperidinemethanol, |A-(2,3-dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-, (|AR)-|4-Piperidinemethanol, alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-, (+)-|(2,3-Dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol (M 100907)|(2,3-Dimethoxy-phenyl)-{1-[2-(4-fluoro-phenyl)-ethyl]-piperidin-4-yl}-methanol(MDL 100907)|(a-R)-a-(2,3-Dimethoxyphenyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol;M 100907;Volinanserin|4-PIPERIDINEMETHANOL, .ALPHA.-(2,3-DIMETHOXYPHENYL)-1-(2-(4-FLUOROPHENYL)ETHYL)-, (.ALPHA.R)-"
FANANSERIN,60785,,"InChI=1S/C23H24FN3O2S/c24-19-8-10-20(11-9-19)26-16-14-25(15-17-26)12-3-13-27-21-6-1-4-18-5-2-7-22(23(18)21)30(27,28)29/h1-2,4-11H,3,12-17H2",VGIGHGMPMUCLIQ-UHFFFAOYSA-N,C23H24FN3O2S,425.5,"3-[3-[4-(4-fluorophenyl)piperazin-1-yl]propyl]-2lambda6-thia-3-azatricyclo[6.3.1.04,12]dodeca-1(11),4,6,8(12),9-pentaene 2,2-dioxide","Fananserin|127625-29-0|RP 62203|RP-62203|FANANSERINE|Fananserina|DTXSID8046743|38QJ762ET6|RP62203|DTXCID6026743|3-[3-[4-(4-fluorophenyl)piperazin-1-yl]propyl]-2lambda6-thia-3-azatricyclo[6.3.1.04,12]dodeca-1(11),4,6,8(12),9-pentaene 2,2-dioxide|fananserinum|3-(3-(4-(4-fluorophenyl)piperazin-1-yl)propyl)-2$l^(6)-thia-3-azatricyclo(6.3.1.0^(4,12))dodeca-1(11),4(12),5,7,9-pentaene-2,2-dione|3-(3-(4-(4-fluorophenyl)piperazin-1-yl)propyl)-2lambda6-thia-3-azatricyclo(6.3.1.04,12)dodeca-1(11),4,6,8(12),9-pentaene 2,2-dioxide|3-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-2$l^{6}-thia-3-azatricyclo[6.3.1.0^{4,12}]dodeca-1(11),4(12),5,7,9-pentaene-2,2-dione|2-(3-(4-(4-fluorophenyl)-1-piperazinyl)propyl)-2H-naphth(1,8-cd)isothiazole 1,1-dioxide|RefChem:921463|2H-Naphth[1,8-cd]isothiazole, 2-[3-[4-(4-fluorophenyl)-1-piperazinyl]propyl]-, 1,1-dioxide|CHEMBL83894|2-(3-(4-(p-Fluorophenyl)-1-piperazinyl)propyl)-2H-naphth(1,8-cd)isothiazole 1,1-dioxide|2H-Naphth(1,8-cd)isothiazole, 2-(3-(4-(4-fluorophenyl)-1-piperazinyl)propyl)-, 1,1-dioxide|NCGC00167808-01|2-(3-(4-(4-fluorophenyl)piperazin-1-yl)propyl)-2H-naphtho[1,8-cd]isothiazole 1,1-dioxide|Fananserin [USAN:INN]|C23H24FN3O2S|[3H]fananserin|Fananserin [INN]|CAS-127625-29-0|Fananserin (USAN/INN)|UNII-38QJ762ET6|2-{3-[4-(4-Fluorophenyl)piperazin-1-yl]propyl}-2H-naphtho[1,8-cd]isothiazole 1,1-dioxide|[3H]RP62203|[3H]RP-62203|FANANSERIN [USAN]|SCHEMBL340722|ChEMBL_131689|GTPL3229|GTPL5434|orb1308312|CHEBI:92159|HMS3269J05|HMS3413N09|HMS3677N09|Tox21 112587|Tox21_112587|BDBM50010044|AKOS024457217|Tox21_112587_1|NCGC00167808-02|AS-74345|DA-63368|HY-103104|CS-0024310|NS00125953|D02656|D92863|L003900|Q5433633|BRD-K08998509-001-01-6|BRD-K08998509-001-02-4|BRD-K08998509-001-03-2|2-{3-[4-(4-Fluorophenyl)-1-piperazinyl]propyl}naphtho[1,8-cd]isothiazole 1,1-dioxide|2-{3-[4-(4-Fluorophenyl)-1piperazinyl]propyl}naphtho[1,8-cd]isothiazole 1,1-dioxide|2-(3-(4-(4-FLUOROPHENYL)-1-PIPERAZINYL)PROPYL)-2H-NAPHTHO(1,8-CD)ISOTHIAZOLE 1,1-DIOXIDE|2-{3-[4-(4-Fluoro-phenyl)-piperazin-1-yl]-propyl}-2H-naphtho[1,8-cd]isothiazole 1,1-dioxide|2-{3-[4-(4-Fluoro-phenyl)-piperazin-1-yl]-propyl}-2H-naphtho[1,8-cd]isothiazole 1,1-dioxide (Fenanserin)|2-{3-[4-(4-Fluoro-phenyl)-piperazin-1-yl]-propyl}-2H-naphtho[1,8-cd]isothiazole 1,1-dioxide(Fananserin)|2-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-2H-naphtho[1,8-cd][1,2]thiazole 1,1-dioxide|3-{3-[4-(4-fluorophenyl)piperazin-1-yl]propyl}-2??-thia-3-azatricyclo[6.3.1.0?,(1)(2)]dodeca-1(12),4,6,8,10-pentaene-2,2-dione"
HISTAMINE,774,,"InChI=1S/C5H9N3/c6-2-1-5-3-7-4-8-5/h3-4H,1-2,6H2,(H,7,8)",NTYJJOPFIAHURM-UHFFFAOYSA-N,C5H9N3,111.15,2-(1H-imidazol-5-yl)ethanamine,"histamine|51-45-6|2-(1H-imidazol-5-yl)ethanamine|Ergamine|Ergotidine|1H-Imidazole-4-ethanamine|2-(4-Imidazolyl)ethylamine|5-Imidazoleethylamine|Eramin|Theramine|Free histamine|beta-Aminoethylimidazole|Imidazole-4-ethylamine|4-(2-Aminoethyl)-1H-imidazole|beta-Aminoethylglyoxaline|4-Imidazoleethylamine|beta-Imidazolyl-4-ethylamine|Imidazole, 4-(2-aminoethyl)-|CHEBI:18295|2-[4-Imidazolyl]ethylamine|NSC-33792|DTXSID4023125|DTXCID103125|820484N8I3|2-(3H-imidazol-4-yl)ethanamine|NSC33792|ALEROFF|RefChem:5888|200-100-6|65592-96-3|2-(1H-Imidazol-4-yl)ethanamine|2-Imidazol-4-ylethylamine|2-(1H-imidazol-4-yl)ethan-1-amine|Histamine Base|Histamine, Free Base|Istamina|2-(3H-Imidazol-4-yl)-ethylamine|Ethylamine, 2-imidazol-4-yl-|1H-Imidazole-5-ethanamine|L-histamine|MFCD00005210|[3H]histamine|beta-aminothethylglyoxaline|L-Histamin base|.beta.-Aminoethylglyoxaline|NSC 33792|CHEMBL90|.beta.-Aminoethylimidazole|2-imidazol-5-ylethylamine|2-(1H-imidazol-5-yl)ethan-1-amine|4-(2-Aminoethyl)imidazole|MLS000069447|.beta.-Imidazolyl-4-ethylamine|2-(1H-Imidazol-4-yl)ethylamine|Histamine [USAN]|Istamina [Italian]|NCGC00015513-04|SMR000059091|[2-(1H-imidazol-5-yl)ethyl]amine dihydrochloride|imidazole, 4(5)-(2-aminoethyl)-|CAS-51-45-6|Histaminum (TN)|Histamine (DCF)|CCRIS 6535|HSDB 3338|EINECS 200-100-6|2-(1H-imidazol-5-yl)ethanamine dihydrochloride|3h-histamine|imido-|Racemic histamine|1avn|1qft|UNII-820484N8I3|ALBB-005968|Histamine (Standard)|Spectrum_000845|HISTAMINE [MI]|HISTAMINE [HSDB]|Opera_ID_1772|Spectrum2_000665|Spectrum3_000452|Spectrum4_000960|Spectrum5_000796|HISTAMINE [VANDF]|Lopac-H-7250|b-Imidazolyl-4-ethylamine|bmse000744|HISTAMINE [MART.]|Histamine, >=97.0%|HISTAMINE [WHO-DD]|SCHEMBL2279|748 - Fish based sample|2-(4-Imidazolyl)ethanamine|2-imidazol-4-yl-Ethylamine|Lopac0_000595|WLN: T5M CNJ D2Z|BSPBio_001117|BSPBio_002124|KBioGR_000457|KBioGR_001580|KBioSS_000457|KBioSS_001325|DivK1c_000308|Histamine, analytical standard|SCHEMBL288432|SPBio_000729|(1H-imidazol-4-yl)ethylamine|BDBM7966|GTPL1204|GTPL1247|orb1310123|SCHEMBL4763745|SCHEMBL5107846|SCHEMBL8772952|SCHEMBL9436072|SCHEMBL9739518|BCBcMAP01_000250|HY-B1204R|KBio1_000308|KBio2_000457|KBio2_001325|KBio2_003025|KBio2_003893|KBio2_005593|KBio2_006461|KBio3_000853|KBio3_000854|KBio3_001344|F411C768-A159-4FC0-A195-291A08BB03AA|2-(1H-Imidazol-5-yl)ethylamine|2-(3H-imidazol-4-yl)ethylamine|NINDS_000308|Bio1_000487|Bio1_000976|Bio1_001465|Bio2_000389|Bio2_000869|ethylamine, 2-(4'-imidazolyl)-|HMS1362G19|HMS1792G19|HMS1990G19|HMS3403G19|HMS3743G03|HMS3885M14|HMS5082B09|2-(1H-Imidazol-4-yl)-ethylamine|HY-B1204|Tox21_110166|[2-(1H-imidazol-4-yl)ethyl]amine|2-(1H-Imidazol-4-yl)ethanamine #|BBL004932|BDBM50121205|Histamine Dihydrochloride (Salt/Mix)|MFCD00128939|MSK000566|s3968|SBB012708|STK346752|AKOS000274386|AKOS009158347|HISTAMINE FREE BASE CRYSTALLINE|Histamine, base, >=97.0% (NT)|Tox21_110166_1|CCG-204684|CS-4697|DB05381|FS-5386|SDCCGMLS-0066601.P001|SDCCGSBI-0050577.P005|IDI1_000308|IDI1_002144|s10979|SMP1_000151|NCGC00015513-01|NCGC00015513-02|NCGC00015513-03|NCGC00015513-05|NCGC00015513-06|NCGC00015513-07|NCGC00015513-08|NCGC00015513-09|NCGC00015513-10|NCGC00015513-11|NCGC00015513-25|NCGC00093371-02|NCGC00093371-03|NCGC00093371-04|NCGC00093371-05|AC-13185|BP-11484|FH145712|Histamine, Free Base - CAS 51-45-6|ST073926|SY041787|SBI-0050577.P004|CS-0368357|NS00004684|2-(1H-IMIDAZOL-4-YL)-1-ETHANAMINE|EN300-78991|Histamine, Vetec(TM) reagent grade, >=97%|C00388|D08040|F10913|Q61233|AB00053481_20|AB00053481_21|056H928|714I940|F078943|L000292|BRD-K01674964-001-19-0|BRD-K01674964-300-06-3|BRD-K01674964-300-07-1|BRD-K01674964-300-08-9|BRD-K01674964-316-01-0|Histamine, EuropePharmacopoeia (EP) Reference Standard|F2173-0575|117932-92-0"
BUSPIRONE,2477,,"InChI=1S/C21H31N5O2/c27-18-16-21(6-1-2-7-21)17-19(28)26(18)11-4-3-10-24-12-14-25(15-13-24)20-22-8-5-9-23-20/h5,8-9H,1-4,6-7,10-17H2",QWCRAEMEVRGPNT-UHFFFAOYSA-N,C21H31N5O2,385.5,"8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione","buspirone|36505-84-7|Buspirona|Ansial|Buspironum|Gen-Buspirone|Bespar|8-(4-(4-(2-Pyrimidinyl)-1-piperizinyl)butyl)-8-azaspiro(4,5)decane-7,9-dione|8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4.5]decane-7,9-dione|TK65WKS8HL|8-(4-(4-(Pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro[4.5]decane-7,9-dione|CHEBI:3223|DTXSID2022707|BCI-024|8-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-8-azaspiro[4.5]decane-7,9-dione|8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-|DTXCID402707|8-Azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)piperizinyl)butyl)-|8-Azaspiro(4.5)decane-7,9-dione, 8-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-|ratio Buspirone|Novo Buspirone|Apo Buspirone|Gen Buspirone|Lin Buspirone|Nu Buspirone|PMS Buspirone|8-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)-8-azaspiro(4.5)decane-7,9-dione|8-(4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl)-8-azaspiro(4.5)decane-7,9-dione|RefChem:57602|N-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1-cyclopentanediacetamide|N05BE01|253-072-2|Buspironum [INN-Latin]|Buspirona [INN-Spanish]|Buspirone free base|buspin|Buspirone (INN)|8-Azaspiro[4.5]decane-7,9-dione,8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-|CHEMBL49|8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione|NCGC00015162-04|BUSPIRONE [INN]|Buspirone [INN:BAN]|116753-41-4|Buspirone-MDTS|CAS-36505-84-7|Gen-Buspirone (TN)|8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione|EINECS 253-072-2|UNII-TK65WKS8HL|BRN 0964904|Buspirone; 8-Azaspiro[4.5]decane-7,9-dione, 8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]- (9CI)|YLX|Buspirone (Standard)|Spectrum_001756|Tocris-0962|BUSPIRONE [MI]|Prestwick0_000369|Prestwick1_000369|Prestwick2_000369|Prestwick3_000369|BUSPIRONE [VANDF]|Lopac-B-7148|Biomol-NT_000108|GTPL36|BUSPIRONE [WHO-DD]|Lopac0_000223|SCHEMBL16398|BSPBio_000497|KBioSS_002236|BIDD:GT0519|DivK1c_000921|SPBio_002418|BPBio1_000547|BPBio1_001403|HY-B1115AR|orb1306479|EX-A8006F|HY-B1115A|KBio1_000921|KBio2_002236|KBio2_004804|KBio2_007372|NINDS_000921|GLXC-03404|HMS2090K19|Tox21_110092|Tox21_302371|BDBM50001859|STK086268|AKOS002313325|Tox21_110092_1|CCG-204318|DB00490|SDCCGSBI-0050211.P004|8-[4-[4-(pyrimidine-2-yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7,9-dione|IDI1_000921|MRF-0000691|Buspirone 100 microg/mL in Acetonitrile|NCGC00015162-01|NCGC00015162-02|NCGC00015162-03|NCGC00015162-05|NCGC00015162-06|NCGC00015162-07|NCGC00015162-08|NCGC00015162-10|NCGC00015162-11|NCGC00015162-22|NCGC00016820-01|NCGC00024905-01|NCGC00024905-02|NCGC00024905-03|NCGC00255227-01|FB172600|Buspirone 1000 microg/mL in Acetonitrile|SBI-0050211.P003|CAS-33386-08-2|AB00053432|NS00005411|ST50759566|C06861|D07593|G78140|AB00053432-12|AB00053432_13|505B847|EN300-19748949|L001110|Q412194|BRD-K93461745-001-01-5|BRD-K93461745-003-03-7|BRD-K93461745-003-14-4|BRD-K93461745-003-23-5|BRD-K93461745-003-24-3|BRD-K93461745-003-25-0|8-[4-(4-pyrimidin-2-ylpiperazinyl)butyl]-8-azaspiro[4.5]decane-7,9-dione|8-(4-[4-(2-Pyrimidinyl)-1-piperazinyl]butyl)-8-azaspiro[4.5]decane-7,9-dione #|8-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-8-azaspiro[4,5]decane-7,9-dione|8-[4-[4-(2-pyrimidinyl)-1-piperazinyl]-butyl]-8-azaspiro[4.5]decane-7,9-dione|8-[4-[4-(pyrimidine-2yl)-piperazine-1-yl]-butyl]-8-aza-spiro[4.5]decane-7.9-dione|(buspirone) 8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione|8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione : (Hydrochloride)|8-[4-(4-Pyrimidin-2-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione; Hydrochloride(Buspirone)"
SUMATRIPTAN,5358,,"InChI=1S/C14H21N3O2S/c1-15-20(18,19)10-11-4-5-14-13(8-11)12(9-16-14)6-7-17(2)3/h4-5,8-9,15-16H,6-7,10H2,1-3H3",KQKPFRSPSRPDEB-UHFFFAOYSA-N,C14H21N3O2S,295.40,1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide,"sumatriptan|103628-46-2|Imitrex|Sumatran|Sumax|Imigran|Sumatriptanum|1H-Indole-5-methanesulfonamide, 3-[2-(dimethylamino)ethyl]-N-methyl-|3-(2-(Dimethylamino)ethyl)-N-methyl-1H-indole-5-methanesulfonamide|Imigran Recovery|1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methyl-methanesulfonamide|1-{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide|TOSYMRA|8R78F6L9VO|DFN-11|3-[2-(Dimethylamino)ethyl]-N-methylindole-5-methanesulfonamide|DTXSID4023628|CHEBI:10650|N02CC01|1-(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide|DFN-11 (SUMATRIPTAN INJECTION)|DTXCID303628|3-[2-(Dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulfonamide|(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide|1-[3-(2-dimethylaminoethyl)-1H-indol-5-yl]-N-methylmethanesulfonamide|1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methylmethanesulfonamide|1H-Indole-5-methanesulfonamide, 3-(2-(dimethylamino)ethyl)-N-methyl-|3-(2-(Dimethylamino)ethyl)-N-methylindole-5-methanesulfonamide|Imigran Radis|(3-(2-(dimethylamino)ethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide|{3-[2-(dimethylamino)ethyl]-1H-indol-5-yl}-N-methylmethanesulfonamide|1-(3-(2-dimethylaminoethyl)-1H-indol-5-yl)-N-methyl-methanesulfonamide|1-(3-(2-dimethylaminoethyl)-1H-indol-5-yl)-N-methylmethanesulfonamide|GR43175|Succinate, Sumatriptan|RefChem:56076|600-462-9|GR-43175|GR 43175|Imitrex (TN)|CHEMBL128|MFCD00866222|NCGC00095838-01|Sumatriptanum [INN-Latin]|GR 43175X|SMR000596517|Imigran (TN)|CAS-103628-46-2|BRN 6930870|UNII-8R78F6L9VO|Sumatriptan (JAN/USP/INN)|Sumatriptan [USP:INN:BAN]|AVP825|HSDB 7742|AVP 825|AVP-825|Tosymra (nasal spray)|SUMATRIPTAN [MI]|SUMATRIPTAN [INN]|SUMATRIPTAN [JAN]|SUMATRIPTAN [HSDB]|GTPL54|SUMATRIPTAN [VANDF]|SCHEMBL1482|SUMATRIPTAN [MART.]|BSPBio_002304|SUMATRIPTAN [USP-RS]|SUMATRIPTAN [WHO-DD]|MLS001195659|MLS001304742|BIDD:GT0248|SPECTRUM1505372|orb1704027|SCHEMBL29450235|Sumatriptan - Bio-X trade mark|HY-B0121B|SUMATRIPTAN [ORANGE BOOK]|HMS2231B21|HMS3369A05|SUMATRIPTAN [USP MONOGRAPH]|ALBB-038603|BCP02237|MSK11291|Tox21_111528|BDBM50005835|STL451003|1-[3-[2-(dimethylamino)ethyl]-1H-indol-5-yl]-N-methyl-methanesulfonamide|AKOS015894924|Tox21_111528_1|CCG-230331|DB00669|NCGC00095838-02|NCGC00095838-03|NCGC00095838-04|BS164424|FD146133|SY398829|SBI-0206837.P001|CS-0009565|NS00009397|C07319|C90357|D00451|EN300-123008|AB00698285-12|AB00698285-13|AB00698285_14|AB00698285_15|628S462|F600616|L000584|Q416978|BRD-K50938287-001-01-7|BRD-K50938287-001-09-0|BRD-K50938287-036-12-0|BRD-K50938287-036-13-8|3-[2-(Dimethylamino)ethyl]-N-methy-1H-indole-5-methanesulfonamide|3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole-5-methanesulphonamide|(3-[2-(Dimethylamino)ethyl]-1H-indol-5-yl)-N-methylmethanesulfonamide #|1-[3-[2-(Dimethylamino)ethyl]-5-indolyl]-N-methylmethanesulfonamide|3-[2-(dimethylamino)ethyl]-N-methyl-1H-indole -5-methanesulphonamide"
U-50488 METHANE SULFONATE,135349,,"InChI=1S/C19H26Cl2N2O.CH4O3S/c1-22(19(24)13-14-8-9-15(20)16(21)12-14)17-6-2-3-7-18(17)23-10-4-5-11-23;1-5(2,3)4/h8-9,12,17-18H,2-7,10-11,13H2,1H3;1H3,(H,2,3,4)/t17-,18-;/m1./s1",OJPHNZCUXUUVKU-JAXOOIEVSA-N,C20H30Cl2N2O4S,465.4,"2-(3,4-dichlorophenyl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide;methanesulfonic acid","(+/-)-trans-U-50488 methanesulfonate salt|83913-06-8|U-50488 methane sulfonate|83913-05-7|MLS000069740|CHEMBL482811|SMR000058892|2-(3,4-dichlorophenyl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide;methanesulfonic acid|U50,488H|U 50488H|Opera_ID_588|Lopac-D-8040|MLS001076340|SCHEMBL548872|SCHEMBL29412563|DTXSID301004058|HMS2232L15|MFCD00133867|NCGC00016144-01|2-(3,4-Dichlorophenyl)-N-methyl-N-[trans-2-(1-pyrrolidinyl)cyclohexyl]acetamide Methanesulfonate|Benzeneacetamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, trans-(+-)-, monomethanesulfonate|SY395728|NCG-C00093883-01|Benzeneacetamide, 3,4-dichloro-N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]-, methanesulfonate (1:1)|trans-(+/-)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide hydrochloride"
LEVORPHANOL,5359272,,"InChI=1S/C17H23NO/c1-18-9-8-17-7-3-2-4-14(17)16(18)10-12-5-6-13(19)11-15(12)17/h5-6,11,14,16,19H,2-4,7-10H2,1H3/t14-,16+,17+/m0/s1",JAQUASYNZVUNQP-USXIJHARSA-N,C17H23NO,257.37,"(1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol","levorphanol|Levorphan|Aromarone|Levorfanol|17-Methylmorphinan-3-ol|Levorphanolum|Levorfanolo|Ro 1-5431|(-)-3-Hydroxy-N-methylmorphinan|77-07-6|(-)-N-Methylmorphinan-3-ol|DEA No. 9220|Morphinan-3-ol, 17-methyl-|Morphinan, 3-hydroxy-17-methyl-|IDS-NL-007|27618J1N2X|3 Hydroxy N methylmorphinan|DTXSID3023213|1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol, l-|2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-|2H-10,4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, l-|Levodroman|(1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-trien-4-ol|LevoDromoran|Levo Dromoran|L Dromoran|Levorphanol Dl-|(1R,9R,10R)-17-methyl-17-azatetracyclo(7.5.3.0^(1,10).0^(2,7))heptadeca-2(7),3,5-trien-4-ol|(1R,9R,10R)-17-methyl-17-azatetracyclo(7.5.3.01,10.02,7)heptadeca-2(7),3,5-trien-4-ol|(1R,9R,10R)-17-methyl-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2(7),3,5-trien-4-ol|RefChem:55484|DTXCID203213|201-002-6|Methorphinan|Dromoran|Cetarin|Racemic dromoran|Orphan|Methorfinan [Czech]|Levorfanolo [DCIT]|Racemorphan|Levorfanol [INN-Spanish]|Levorphanolum [INN-Latin]|Racemorfano [INN-Spanish]|N-Methyl-3-hydroxymorphinan|Antalgin|dl-3-Hydroxy-N-methylmorphinan|Levorphanol dl-form|Levorphanal|DEA No. 9733|NU 2206|Racemorphanum|Levorphanol (INN)|Levorphanol [INN]|297-90-5|CHEMBL592|V7R79HN3XD|CHEBI:6444|LEVORPHANOL HYDROCHLORIDE|Methorfinan|Racemorphan [INN:BAN]|Racemorphane [INN-French]|Racemorphanum [INN-Latin]|(+-)-17-Methylmorphinan-3-ol|HSDB 3349|(+-)-3-Hydroxy-N-methylmorphinan|Levorphanol [INN:BAN]|EINECS 201-002-6|EINECS 206-048-0|IDS-NR-003|UNII-V7R79HN3XD|DTXSID301016136|L-morphan|(+-)-N-Methylmorphinan-3-ol|UNII-27618J1N2X|NU-2206|Morphinan, 3-hydroxy-N-methyl, (+)-|Morphinan-3-ol, 17-methyl-, (+/-)-|d-Form of levorphanol|Morphinan-3-ol, 17-methyl-, (-)-|LEVORPHANOL-tartarate|Morphinan-3-ol, 17-methyl-, (+-)-|Morphinan, 3-hydroxy-N-methyl-, (+-)-|LEVORPHANOL [MI]|RACEMORPHAN [INN]|LEVORPHANOL [HSDB]|LEVORPHANOL [VANDF]|2H-10, 4a-Iminoethanophenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, dl-|SCHEMBL24335|LEVORPHANOL [WHO-DD]|GTPL7595|77-07-6 (free)|SCHEMBL29408781|BDBM82427|(+/-)-N-Methylmorphinan-3-ol|LEVORPHANOL DL-FORM [MI]|(+)-cis-1,3,4,9,10,10a-Hexahydro-11-methyl-2H-10,4a-iminoethanophenanthren-6-ol|(-) 3-hydroxy-N-methylmorphinan|2H-10,4a-(Iminoethano)phenanthren-6-ol, 1,3,4,9,10,10a-hexahydro-11-methyl-, (+)-|BDBM224028|(+/-)-3-Hydroxy-N-methylmorphinan|BDBM50017233|BDBM50369518|17-Methylmorphinan-3-ol, (+)- #|DB00854|CAS_5985-38-6|(+/-)-N-METHYL-3-HYDROXYMORPHINAN|NS00067936|C08014|D08123|Q2579108|9.alpha.,13.alpha.,14.alpha.-Morphinan-3-ol, 17-methyl-|(4bR,8aR,9R)-11-methyl-6,7,8,8a,9,10-hexahydro-5H-9,4b-(epiminoethano)phenanthren-3-ol"
LOSARTAN,3961,,"InChI=1S/C22H23ClN6O/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)",PSIFNNKUMBGKDQ-UHFFFAOYSA-N,C22H23ClN6O,422.9,[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol,"losartan|114798-26-4|allisartan|Angizaar|Losartic|Lozap|CHEBI:6541|DUP-89|DTXSID7023227|JMS50MPO89|NSC-758699|[2-butyl-5-chloro-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol|HGP1405|HGP-1405|(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-Butyl-4-chloro-1-((2'-(1H-etrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol|2-n-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|DTXCID103227|(2-Butyl-4-chloro-1-((4-(2-(2H-1,2,3,4-tetrazol-5-yl)phenyl)phenyl)methyl)-1H-imidazol-5-yl)methanol|1H-IMIDAZOLE-5-METHANOL, 2-BUTYL-4-CHLORO-1-((2'-(1H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-|2-BUTYL-4-CHLORO-1-[[2'-(1H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1H-IMIDAZOLE-5-METHANOL|MK954|losartanum|(2-butyl-5-chloro-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)imidazol-4-yl)methanol|(2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-5-yl)methanol|[2-butyl-4-chloro-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazol-5-yl]methanol|2-Butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol|2-n-butyl-4-chloro-5-hydroxymethyl-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)imidazole|RefChem:5963|C09CA01|601-329-8|DUP 89|Lortaan|MFCD00865831|Losartan (INN)|1H-imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-|(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol|MK-954|NCGC00095125-01|LOSARTAN [INN]|Losartan [INN:BAN]|1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'- biphenyl)-4-yl)methyl)-|[3H]losartan|Losartic (TN)|(1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol|[2-butyl-5-chloranyl-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol|[3H]-losartan|CAS-114798-26-4|SR-01000763170|UNII-JMS50MPO89|lorastan|2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol|Losartan; 2-Butyl-4-chloro-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol; 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol; 2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]-1H-imidazole-5-methanol; DUP 89; Lortaan|Losartan (Standard)|Dup89|Spectrum_001713|LOSARTAN [MI]|SCHEMBL60|LOSARTAN [VANDF]|Spectrum2_001677|Spectrum3_000998|Spectrum4_001126|Spectrum5_001466|Epitope ID:140137|LOSARTAN [WHO-DD]|EC 601-329-8|SCHEMBL4222|Oprea1_644635|US9624243, Losartin|BSPBio_002695|GTPL590|KBioGR_001611|KBioSS_002193|Losartan - Bio-X trade mark|BIDD:GT0286|SPECTRUM1504268|SPBio_001893|GTPL3941|orb1310825|SCHEMBL29383742|BDBM82258|HSDB 7043|KBio2_002193|KBio2_004761|KBio2_007329|KBio3_001915|BCPP000183|BDBM318822|EX 89|HMS1922J13|HMS2093E22|HMS3715L11|HMS5084K19|Pharmakon1600-01504268|BCP27731|MSK10069|NSC_3961|Tox21_111435|CCG-39095|HY-17512R|NSC758699|s5067|STL419984|2-butyl-4-chloro-1-[p-(o-1H-tetrazol-5ylphenyl)benzyl]imidazole-5-methanol|AKOS015917390|AKOS015994740|Tox21_111435_1|AB07507|BCP9000861|DB00678|FL39656|KS-5004|NSC 758699|2-n-butyl-4-chloro-5-hydroxymethyl-1-[[2'-(1H-tetrazol-5-yl)-biphenyl-4-yl]methyl]imidazole|NCGC00095125-02|NCGC00095125-03|NCGC00095125-05|NCGC00095125-08|NCGC00095125-10|NCGC00095125-15|(2-butyl-4-chloro-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol|2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl-1H-imidazole-5-methanol|BL164640|HY-17512|SBI-0206766.P001|CAS_114798-26-4|L0378|NS00008822|C07072|D08146|EN300-311953|AB01563296_01|798L264|L000351|Q410074|SR-01000763170-3|SR-01000763170-4|BRD-K76205745-001-02-5|BRD-K76205745-001-04-1|BRD-K76205745-001-06-6|BRD-K76205745-237-16-5|BRD-K76205745-237-18-1|F2173-0506|Z2417557127|2-BUTYL-4-CHLORO-1-(P-(O-1H-TETRAZOL-5-YLPHENYL)BENZYL)IMIDAZOLE-5-METHANOL|2-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)-biphenyl-4-yl)methyl]imidazole|2-butyl-4-chloro-5-hydroxymethyl-1-[(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl]imidazole|(1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol|(1-((2'-(2h-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1h-imidazol-5-yl)methanol|(2-butyl-4-chloro-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-5-yl)methanol|(2-butyl-4-chloro-1-{[2'-(2H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazol-5-yl)methanol|{2-Butyl-5-chloro-3-[2'-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-imidazol-4-yl}-methanol|1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]- (9CI)|2-butyl-4-chloro-1-[[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-imidazole-5-methanol|2-butyl-4-chloro-1-[2'-(2H-tetrazol-5-yl)-1,1'-biphenyl-4-ylmethyl]-1H- imidazole-5-methanol|2-butyl-4-chloro-5-(hydroxymethyl)-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]imidazole"
TELMISARTAN,65999,,"InChI=1S/C33H30N4O2/c1-4-9-30-35-31-21(2)18-24(32-34-27-12-7-8-13-28(27)36(32)3)19-29(31)37(30)20-22-14-16-23(17-15-22)25-10-5-6-11-26(25)33(38)39/h5-8,10-19H,4,9,20H2,1-3H3,(H,38,39)",RMMXLENWKUUMAY-UHFFFAOYSA-N,C33H30N4O2,514.6,2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid,"Telmisartan|144701-48-4|Micardis|Pritor|Kinzalmono|BIBR 277|Semintra|tolura|BIBR-277|Telmisartan Teva|Telmisartan Actavis|BIBR-277-SE|BIBR-277SE|BIBR 277 SE|4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl]biphenyl-2-carboxylic acid|[1,1'-Biphenyl]-2-carboxylic acid, 4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-|U5SYW473RQ|BIBR-277 SE|CHEBI:9434|4'-((4-Methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid|DTXSID8023636|C09CA07|4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|TELMISARTAN TEVA PHARMA|2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl]methyl]phenyl]benzoic acid|DTXCID803636|(1,1'-Biphenyl)-2-carboxylic acid, 4'-((1,4'-dimethyl-2'-propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-|ONDUARP COMPONENT TELMISARTAN|TOLUCOMBI COMPONENT TELMISARTAN|KINZALKOMB COMPONENT TELMISARTAN|PRITORPLUS COMPONENT TELMISARTAN|MICARDISPLUS COMPONENT TELMISARTAN|4'-[(1,4'-dimethyl-2'propyl[2,6'-bi-1H-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|2-(4-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}phenyl)benzoic acid|telmisartanum|2-(4-((4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl)methyl)phenyl)benzoic acid|2-(4-((4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propylbenzimidazol-1-yl)methyl)phenyl)benzoic acid|4'-((1,4'-dimethyl-2'propyl(2,6'-bi-1H-benzimidazol)-1'-yl)methyl)-(1,1'-biphenyl)-2-carboxylic acid|4'-((1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl)biphenyl-2-carboxylic acid|4'-((4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl)methyl)biphenyl-2-carboxylic acid|4'-[(1,4'-dimethyl-2'-propyl[2,6'-bi-1h-benzimidazol]-1'-yl)methyl]-[1,1'-biphenyl]-2-carboxylic acid|4'-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl]biphenyl-2-carboxylic Acid|4'-[[4-METHYL-6-(1-METHYL-2-BENZIMIDAZOLYL)-2-PROPYL-1-BENZIMIDAZOLYL]METHYL]-2-BIPHENYLCARBOXYLIC ACID|RefChem:6287|620-494-7|4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylic acid|BIBR 277SE|Telmisartan [INN]|C33H30N4O2|MFCD00918125|CHEMBL1017|NCGC00095150-01|Targit|2-[4-[[4-methyl-6-(1-methylbenzimidazol-2-yl)-2-propyl-benzimidazol-1-yl]methyl]phenyl]benzoic acid|4'[(1,4'-DIMETHYL-2'-PROPYL[2,6'-BI-1H-BENZIMIDAZOL]-1'-YL)METHYL][1,1'-BIPHENYL]-2-CARBOXYLIC ACID|Kinzal|Tazlok|Kinzal/Pritor|Micardis (TN)|4'-(1,7'-DIMETHYL-2'-PROPYL-1H-[2,5']BIBENZOIMIDAZOLYL-3'-YLMETHYL)-BIPHENYL-2-CARBOXYLIC ACID|SMR000466326|CAS-144701-48-4|Bay 68-9291|SR-01000759355|UNII-U5SYW473RQ|Telmisartana|Telmisartar|BIBR277|Telsite|Telday|HSDB 7590|Telmisartan [USAN:USP:INN:BAN]|YM-086|BAY68-9291|Telmisartan (Micardis)|Telmisartan (Standard)|CPD000466326|TELMISARTAN [MI]|Spectrum2_001976|Spectrum3_001089|Spectrum4_001261|Spectrum5_001053|TELMISARTAN [JAN]|TELMISARTAN [HSDB]|TELMISARTAN [USAN]|TELMISARTAN [VANDF]|SCHEMBL4464|TELMISARTAN [MART.]|BSPBio_002738|GTPL592|KBioGR_001842|TELMISARTAN [USP-RS]|TELMISARTAN [WHO-DD]|MLS000759432|MLS001076687|MLS001424174|MLS006011851|Widaplik component Telmisartan|BIDD:GT0365|SPECTRUM1505261|SPBio_002131|TELMISARTAN [EMA EPAR]|orb1308143|Telmisartan (JP17/USP/INN)|SCHEMBL29356790|SCHEMBL29414101|SCHEMBL29691699|Telmisartan - Bio-X trade mark|TELMISARTAN [GREEN BOOK]|KBio3_001958|TELMISARTAN [EP IMPURITY]|TELMISARTAN [ORANGE BOOK]|RMMXLENWKUUMAY-UHFFFAOYSA-N|Telmisartan for system suitability|GLXC-02564|HMS1922P07|HMS2051P16|HMS2090P17|HMS2093M22|HMS2231P07|HMS3393P16|HMS3655C08|HMS3715L17|HMS3750E19|HMS5079L20|Pharmakon1600-01505261|TELMISARTAN [EP MONOGRAPH]|Telmisartan for peak identification|TELMISARTAN [USP MONOGRAPH]|ALBB-028954|BCP04513|MSK10070|TWYNSTA COMPONENT TELMISARTAN|Tox21_111452|BBL029085|BDBM50043280|CCG-39514|DL-511|HB2558|HY-13955R|NSC759811|s1738|STK624049|AKOS005557501|Telmisartan, >=98% (HPLC), solid|Tox21_111452_1|AB07687|AC-2013|CS-1699|DB00966|FT15497|KS-1215|NC00296|NSC 759811|NSC-759811|BAY-68-9291|MICARDIS HCT COMPONENT TELMISARTAN|NCGC00095150-02|NCGC00095150-03|NCGC00095150-04|NCGC00095150-06|NCGC00095150-07|NCGC00095150-08|TELMISARTAN [EMA EPAR VETERINARY]|4'-[(1,7'-dimethyl-2'-propyl-1H,3'H-2,5'-bibenzimidazol-3'-yl)methyl][1,1'-biphenyl]-2-carboxylic acid|BT164444|HY-13955|SY052776|BCP0726000055|SBI-0206733.P001|NS00000398|SW197676-3|T2861|C07710|D00627|EN300-123532|AB00639941-06|AB00639941-07|AB00639941_08|AB00639941_09|701T484|L001035|Q733186|SR-01000759355-4|SR-01000759355-5|BRD-K73999723-001-02-2|BRD-K73999723-001-10-5|BRD-K73999723-001-11-3|Z1551967334|Telmisartan, European Pharmacopoeia (EP) Reference Standard|Telmisartan, United States Pharmacopeia (USP) Reference Standard|Telmisartan, Pharmaceutical Secondary Standard; Certified Reference Material|Telmisartan for peak identification, European Pharmacopoeia (EP) Reference Standard|Telmisartan for system suitability, European Pharmacopoeia (EP) Reference Standard|4''-((1,4''-dimethyl-2''-propyl(2,6''-bi-1H-benzimidazol)-1''-yl)methyl)-(1,1''-biphenyl)-2-carboxylic acid|4''-((4-methyl-6-(1-methyl-2-benzimidazolyl)-2-propyl-1-benzimidazolyl)methyl)-2-biphenylcarboxylic acid|4''-[(1,4''-dimethyl-2''propyl[2,6''-bi-1H-benzimidazol]-1''-yl)methyl]-[1,1''-biphenyl]-2-carboxylic acid|4''-[(1,7''-dimethyl-2''-propyl-1H,3''H-2,5''-bibenzimidazol-3''-yl)methyl][1,1''-biphenyl]-2-carboxylic acid|4''-[(1,7''-dimethyl-2''-propyl-1H,3''H-2,5''-bibenzimidazol-3''-yl)methyl]biphenyl-2-carboxylic acid|4'-((1,7'-Dimethyl-2'-propyl-1H,3'H-[2,5'-bibenzo[d]imidazol]-3'-yl)methyl)-[1,1'-biphenyl]-2-carboxylicacid|4'-((1,7'-DIMETHYL-2'-PROPYL-1H,3'H-2,5'-BIBENZO[D]IMIDAZOL-3'-YL)METHYL)BIPHENYL-2-CARBOXYLIC ACID|4'-[[2-n-Propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)-benzimidazol-1-yl]-methyl]-biphenyl-2-carboxylic acid|4'-[2-n-propyl-4-methyl-6-(1-methyl benzimidazol-2-yl)benzimidazol-1-yl methyl]biphenyl-2-carboxylic acid|4'-{[4-methyl-6-(1-methyl-1H-1,3-benzodiazol-2-yl)-2-propyl-1H-1,3-benzodiazol-1-yl]methyl}-[1,1'-biphenyl]-2-carboxylic acid|TLS"
CANDESARTAN,2541,,"InChI=1S/C24H20N6O3/c1-2-33-24-25-20-9-5-8-19(23(31)32)21(20)30(24)14-15-10-12-16(13-11-15)17-6-3-4-7-18(17)22-26-28-29-27-22/h3-13H,2,14H2,1H3,(H,31,32)(H,26,27,28,29)",HTQMVQVXFRQIKW-UHFFFAOYSA-N,C24H20N6O3,440.5,2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid,"candesartan|139481-59-7|CV-11974|2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid|CANDEMORE|DTXSID0022725|S8Q36MD2XX|NSC-759858|2-Ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylic acid|CHEBI:3347|DTXCID202725|1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-|2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-benzimidazole-7-carboxylic acid|2-ethoxy-1-({2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl}methyl)-1H-benzimidazole-7-carboxylic acid|CV11974|candesartanum|2-ethoxy-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)benzimidazole-4-carboxylic acid|2-ethoxy-1-((4-(2-(2H-1,2,3,4-tetrazol-5-yl)phenyl)phenyl)methyl)-1H-1,3-benzodiazole-7-carboxylic acid|2-ethoxy-1-({4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-1,3-benzodiazole-7-carboxylic acid|2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)(1,1'-biphenyl)-4-yl]methyl]-1h-benzimidazole-7-carboxylic acid|2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-benzimidazole-7-carboxylic acid|2-ethoxy-7-carboxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methylbenzimidazole|RefChem:56665|C09CA06|2-Ethoxy-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)-3H-benzoimidazole-4-carboxylic Acid|Blopress|1-((2'-(1H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid|C24H20N6O3|CV 11974|MFCD00864463|CHEMBL1016|1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid|NCGC00167474-01|[3H]candesartan|2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylic Acid (Candesartan)|2-ethoxy-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid|Candesartan [INN]|CAS-139481-59-7|SR-05000001447|Candesartan (USAN/INN)|UNII-S8Q36MD2XX|Candesartan [USAN:INN:BAN]|Candesartan cilexetil related compound G;Candesartan cilexetil impurity G|HSDB 7520|CELEXETIL|candesartan (Atacand)|KS-5003|Candesartan (Standard)|CANDESARTAN [MI]|TCV-116 (prodrug)|CANDESARTAN [HSDB]|CANDESARTAN [USAN]|CANDESARTAN [VANDF]|EC 604-138-8|SCHEMBL3938|2-ethoxy-3-[[4-[2-(1h-tetrazol-5-yl)phenyl]phenyl]methyl]-3h-benzoimidazole-4-carboxylic acid|SCHEMBL40832|CANDESARTAN [WHO-DD]|GTPL587|Candesartan 100 microg/mL in Acetonitrile:Methanol|MLS003915631|MLS004774041|BIDD:GT0350|GTPL6907|orb1308557|Candesartan - Bio-X trade mark|SCHEMBL29508236|SCHEMBL29682351|SCHEMBL29687505|HY-B0205R|BCPP000302|GLXC-07098|HMS2089M22|HMS3651C13|HMS3715F13|HMS5079M16|Pharmakon1600-01502288|BCP01137|HY-B0205|MSK10657|STR09609|Tox21_112478|BDBM50240609|NSC755311|NSC759858|s1578|AKOS015888154|AKOS025117340|Tox21_112478_1|AB07470|BCP9000479|CCG-213059|CCG-269122|DB13919|FC09818|NSC 759858|NSC-755311|2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylic acid|NCGC00167474-02|NCGC00167474-04|NCGC00167474-06|2-Ethoxy-3-[[4-[2-(1H-tetrazol-5-yl)phenyl]phenyl] methyl]-3H-benzoimidazole-4-carboxylic acid|BC164271|SMR002203608|SMR003500711|SY065768|NS00009281|SW199612-2|C07468|D00522|AB01275447-01|AB01275447_02|AB01275447_03|Candesartan Cilexetil EP Impurity G(Candesartan)|EN300-6491073|481C597|A808309|F787577|L000156|Q415970|SR-05000001447-1|SR-05000001447-2|SR-05000001447-5|BRD-K84091759-001-07-1|BRD-K84091759-001-08-9|CANDESARTAN CILEXETIL IMPURITY G [EP IMPURITY]|Z1741968269|2-Ethoxy-1-[[2'-(1 H-tetrazol-5-yl)biphenyl-4-yl]methyl]-benzimidazole-7-carboxylic acid|2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-benzimidazole-7-carboxylic acid|2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazole-7-carboxylic Acid|2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4ethyl]}-1H-benzimidazole-7-carboxylic acid|2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]-4-benzimidazolecarboxylic acid|2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzimidazole-4-carboxylic acid|1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid|1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylicacid|1-((2`-(1H-Tetrazol-5-yl)-[1,1`-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylic acid|1-[(2 inverted exclamation mark -(5-Tetrazolyl)-4-biphenylyl)methyl]-2-ethoxybenzimidazole-7-carboxylic Acid|2-Ethoxy-1-((2-(1H-tetrazole-5-yl)biphenyl-4-yl)methyl)-1H-benzamidazole-7-carboxylic acid.|2-ethoxy-1-[[2'-(2h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-benzimidazole-7-carboxylic acid|2-ethoxy-1-{[2'-(2H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylic acid|2-ethoxy-3-[[4-[2-(2H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylic acid|2-ethoxy-3-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid|2-Ethoxy-3-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid(CV-11974)|2-Ethoxy-3-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid|2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid"
SALVINORIN A,128563,,"InChI=1S/C23H28O8/c1-12(24)30-16-9-15(20(26)28-4)22(2)7-5-14-21(27)31-17(13-6-8-29-11-13)10-23(14,3)19(22)18(16)25/h6,8,11,14-17,19H,5,7,9-10H2,1-4H3/t14-,15-,16-,17-,19-,22-,23-/m0/s1",OBSYBRPAKCASQB-AGQYDFLVSA-N,C23H28O8,432.5,"methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-acetyloxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate","Salvinorin A|83729-01-5|Divinorin A|Salvinorin|(-)-Salvinorin A|T56W91NG6J|DTXSID80232584|methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-acetyloxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate|methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-acetyloxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo(f)isochromene-7-carboxylate|methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-acetyloxy-2-furan-3-yl-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo(f)isochromene-7-carboxylate|methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-acetyloxy-2-furan-3-yl-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate|RefChem:884499|DTXCID10155075|2H-Naphtho02,1-(c)pyran-7-carboxylic acid, 9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-, methyl ester, 02S-(2alpha,4aalpha,6abeta,7beta,9beta,10aalpha,10bbeta)-|methyl 9-(acetyloxy)-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-dodecahydro-1H-naphtho(2,1-c)pyran-7-carboxylate|salvinorin-A|CHEMBL445332|CHEBI:67900|MFCD05664742|2H-Naphtho(2,1-c)pyran-7-carboxylic acid, 9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-, methyl ester, (2S-(2alpha,4aalpha,6abeta,7beta,9beta,10aalpha,10bbeta))-|methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-acetoxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxododecahydro-2H-benzo[f]isochromene-7-carboxylate|UNII-T56W91NG6J|herbal ecstasy|Mexican mint|Salvonorin A|HSDB 7640|Ska Maria Pastora|(2S,4aR,6aR,7R,9S,10aS,10bR)-Methyl 9-acetoxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxododecahydro-1H-benzo[f]isochromene-7-carboxylate|2H-NAPHTHO(2,1-C)PYRAN-7-CARBOXYLIC ACID, 9-(ACETYLOXY)-2-(3-FURANYL)DODECAHYDRO-6A,10B-DIMETHYL-4,10-DIOXO-, METHYL ESTER, (2S,4AR,6AR,7R,9S,10AS,10BR)-|2H-naphtho[2,1-c]pyran-7-carboxylic acid, 9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-, methyl ester, (2S,4aR,6aR,7R,9S,10aS,10bR)-|2H-Naphtho[2,1-c]pyran-7-carboxylic acid, 9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-, methyl ester, [2S-(2alpha,4aalpha,6abeta,7beta,9beta,10aalpha,10bbeta)]-|SALVINORIN A [MI]|SALVINORIN A [HSDB]|SCHEMBL39147|GTPL1666|orb2813916|OBSYBRPAKCASQB-AGQYDFLVSA-N|GLXC-21002|METHYL (2S,4AR,6AR,7R,9S,10AS,10BR)-9-(ACETYLOXY)-2-(FURAN-3-YL)-6A,10B-DIMETHYL-4,10-DIOXO-DODECAHYDRO-1H-NAPHTHO[2,1-C]PYRAN-7-CARBOXYLATE|BDBM50159165|PDSP2_001236|AKOS027325800|CCG-214573|DB12327|NCGC00162442-03|Salvinorin A, >=98% (HPLC), powder|(2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(3-furanyl)dodechydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester|TS-08323|XS139259|CS-0020494|C20196|G91252|Q413512|SR-05000002668|SR-05000002668-1|BRD-K19284129-001-01-8|BRD-K19284129-001-02-6|(2S,4aR,6aR,7R,9S,10aS,10bR)-9-(Acetoxy)-2-(3-furanyl)-dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester|(2S,4aR,6aR,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(furan-3-yl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho-[2,1-c]pyran-7-carboxylic acid methyl ester|(2S,4aR,6aR,7R,9S,10aS,10bR)-methyl 9-(acetylthio)-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-dodecahydro-1H-benzo[f]isochromene-7-carboxylate|(2S,4aR,6aR,7R,9S,10aS,10bR)-methyl 9-acetoxy-2-(furan-3-yl)-6a,10b-dimethyl-4,10-dioxo-dodecahydro-1H-benzo[f]isochromene-7-carboxylate|(3S,4aR,4bS,6S,8R,8aR,10aR)-6-Acetoxy-3-furan-3-yl-4a,8a-dimethyl-1,5-dioxo-dodecahydro-2-oxa-phenanthrene-8-carboxylic acid methyl ester|2H-Naphtho[2,1-c]pyran-7-carboxylic acid, 9-(acetyloxy)-2-(3-furanyl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-, methyl ester, (2S,4aR,6aR,7R,9S,10aS,10bR)- (9CI)|2S,4aR,6a(R,7R,9S,10aS,10bR)-9-(acetyloxy)-2-(furan-3-yl)dodecahydro-6a,10b-dimethyl-4,10-dioxo-2H-naphtho[2,1-c]pyran-7-carboxylic acid methyl ester|methyl (2S,4aR,6aR,7R,9S,10aS,10bR)-9-acetoxy-2-(3-furyl)-6a,10b-dimethyl-4,10-dioxo-2,4a,5,6,7,8,9,10a-octahydro-1H-benzo[f]isochromene-7-carboxylate"
FLUTAMIDE,3397,,"InChI=1S/C11H11F3N2O3/c1-6(2)10(17)15-7-3-4-9(16(18)19)8(5-7)11(12,13)14/h3-6H,1-2H3,(H,15,17)",MKXKFYHWDHIYRV-UHFFFAOYSA-N,C11H11F3N2O3,276.21,2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,"flutamide|13311-84-7|Eulexin|Niftolide|2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide|Sch 13521|niftolid|Drogenil|NFBA|Flutamida|Flutamidum|Sch-13521|Eulexine|4'-Nitro-3'-trifluoromethylisobutyranilide|Propanamide, 2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-|SCH13521|2-Methyl-N-(4-nitro-3-[trifluoromethyl]phenyl)propanamide|DTXSID7032004|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide|NSC-215876|CHEBI:5132|Propanamide, 2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-|76W6J0943E|DTXCID9011121|Flutacell|ApoFlutamide|NovoFlutamide|Apo Flutamide|Fluta cell|Novo Flutamide|FlutaGRY|PMS Flutamide|Fluta GRY|2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)propanamide|RefChem:55220|L02BB01|236-341-9|Euflex|Niftholide|Flutamin|Cebatrol, veterinary|N-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)ISOBUTYRAMIDE|MFCD00072009|NSC 215876|CHEMBL806|4-Nitro-3-(trifluoromethyl)isobutyranilide|2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide|NCGC00015452-09|Chimax|4'-Nitro-3'-trifluoromethylisobutyramilide|CAS-13311-84-7|Ham's F-12 medium|Flutamidum [INN-Latin]|Flutamida [INN-Spanish]|Flutamide USP25|Prostandril|Odyne|.alpha.,.alpha.,.alpha.-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide|SMR000058187|Eulexin (TN)|CCRIS 7246|m-Propionotoluidide,.alpha.,.alpha.-trifluoro-|SR-01000075888|N-[4-Nitro-3-(trifluoromethyl)phenyl]isobutyramide|EINECS 236-341-9|BRN 2157663|.alpha.,.alpha.-Trifluoro-2-methyl-4'-nitro-m-propionotoluidide|m-Propionotoluidide,.alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-|UNII-76W6J0943E|4'-Nitro-3'-(trifluoromethyl)isobutyranilide|Flutamide [USAN:USP:INN:BAN]|Prestwick_228|Flutamide (Eulexin)|NK-601|Flutamide (Standard)|Spectrum_001210|CPD000058187|FLUTAMIDE [INN]|FLUTAMIDE [JAN]|FLUTAMIDE [MI]|FLUTAMIDE [USAN]|Prestwick0_000180|Prestwick1_000180|Prestwick2_000180|Prestwick3_000180|Spectrum2_001201|Spectrum3_001421|Spectrum4_000829|Spectrum5_001450|Lopac-F-9397|F0663|Flutamide (pubertal study)|FLUTAMIDE [MART.]|F 9397|FLUTAMIDE [USP-RS]|FLUTAMIDE [WHO-DD]|SCHEMBL3934|Lopac0_000557|BSPBio_000079|BSPBio_003122|KBioGR_001377|KBioSS_001690|MLS000069634|MLS001065596|MLS002548892|DivK1c_000459|SPECTRUM1500995|Flutamide - Bio-X trade mark|SPBio_000982|SPBio_002000|Flutamide (JP18/USP/INN)|BPBio1_000087|GTPL6943|orb1310563|FLUTAMIDE [EP IMPURITY]|FLUTAMIDE [ORANGE BOOK]|CHEMBL4759307|FLUTAMIDE [EP MONOGRAPH]|SCHEMBL12932289|SCHEMBL29349783|HMS501G21|HY-B0022R|KBio1_000459|KBio2_001690|KBio2_004258|KBio2_006826|KBio3_002342|FLUTAMIDE [USP MONOGRAPH]|NINDS_000459|HMS1568D21|HMS1921O16|HMS2090I18|HMS2092O14|HMS2095D21|HMS2230P19|HMS3259I03|HMS3261P15|HMS3373C12|HMS3655G22|HMS3712D21|HMS5080H03|Pharmakon1600-01500995|BCP23006|HY-B0022|MSK11432|YIA13472|Tox21_110154|Tox21_202169|Tox21_300536|Tox21_500557|BDBM50131270|CCG-39105|m-Propionotoluidide, 2-methyl-4'-nitro-alpha,alpha,alpha-triflouro-|m-Propionotoluidide, alpha,alpha,alpha-trifluoro-2-methyl-4'-nitro-|NSC147834|NSC215876|NSC757817|s1908|SBB006930|AKOS001025465|AKOS015994751|AKOS025243203|m-Propionotoluidide, .alpha.,.alpha.,.alpha.-trifluoro-2-methyl-4'-nitro-|Tox21_110154_1|AB02835|DB00499|FF23510|KS-5091|LP00557|NC00451|NSC-147834|NSC-757817|SDCCGSBI-0050540.P004|IDI1_000459|NCGC00015452-01|NCGC00015452-02|NCGC00015452-03|NCGC00015452-04|NCGC00015452-05|NCGC00015452-06|NCGC00015452-07|NCGC00015452-08|NCGC00015452-10|NCGC00015452-11|NCGC00015452-12|NCGC00015452-13|NCGC00015452-14|NCGC00015452-15|NCGC00015452-16|NCGC00015452-19|NCGC00015452-20|NCGC00015452-32|NCGC00091460-01|NCGC00091460-02|NCGC00091460-03|NCGC00091460-04|NCGC00091460-05|NCGC00091460-06|NCGC00091460-07|NCGC00091460-08|NCGC00091460-09|NCGC00254495-01|NCGC00259718-01|NCGC00261242-01|AC-24192|BF166239|ST058409|SY036411|SBI-0050540.P003|DB-042163|3'-Trifluoromethyl-4'-Nitro-Isobutyranilide|AB00052188|EU-0100557|NS00002675|SW196536-4|4''-nitro-3''-trifluoromethylisobutyranilide|A10796|C07653|D00586|EN300-119548|AB00052188-09|AB00052188_10|AB00052188_11|311F847|F358096|Q418669|SR-01000075888-1|SR-01000075888-6|SR-01000075888-7|SR-01000075888-9|BRD-K28307902-001-05-0|BRD-K28307902-001-20-9|BRD-K28307902-001-21-7|Flutamide, certified reference material, TraceCERT(R)|Z56755651|Flutamide, European Pharmacopoeia (EP) Reference Standard|N1-[4-nitro-3-(trifluoromethyl)phenyl]-2-methylpropanamide|2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide #|Flutamide, United States Pharmacopeia (USP) Reference Standard|alpha,alpha,alpha-trifluoro-2-methyl-4''-nitro-m-propionotoluidide|m-Propionotoluidide, 2-methyl-4'-nitro-.alpha.,.alpha.,.alpha.-trifluoro-|Flutamide for system suitability, European Pharmacopoeia (EP) Reference Standard|2-Methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide;N-(Isopropylcarbonyl)-4-nitro-3-trifluoromethylaniline;4'-Nitro-3'-trifluo romethylisobutyranilide|37209-54-4"
HYDROXYFLUTAMIDE,91649,,"InChI=1S/C11H11F3N2O4/c1-10(2,18)9(17)15-6-3-4-8(16(19)20)7(5-6)11(12,13)14/h3-5,18H,1-2H3,(H,15,17)",YPQLFJODEKMJEF-UHFFFAOYSA-N,C11H11F3N2O4,292.21,2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide,"Hydroxyflutamide|52806-53-8|2-hydroxyflutamide|hydroxy-flutamide|2-Hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)propanamide|Sch 16423|2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide|OH-flutamide|Sch-16423|DTXSID8033562|31D90UKP5Y|Propanamide, 2-hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-|DTXCID6013562|Propanamide, 2-hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-|alpha, alpha, alpha-trifluoro-2-methyl-4'-nitro-m-lactotoluidide|RefChem:147185|ALPHA-HYDROXYFLUTAMIDE|2-hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)propanimidic acid|641-868-6|Hydroxy Flutamide|Hydroxyniphtholide|2-Hydroxy-2-methyl-N-(4-nitro-3-(trifluoromethyl)-phenyl)propanamide|2-Hydroxy-flutamide|MFCD00563126|.alpha.-hydroxyflutamide|CHEMBL491|HFT|Liproca Depot|2-Hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide (2-Hydroxyflutamide)|SMR001227196|CAS-52806-53-8|UNII-31D90UKP5Y|2-Hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide; 2-Hydroxyflutamide|2ax6|alpha,alpha,alpha-Trifluoro-2-methyl-4'-nitro-m-lactotoluidide|2-HOF|cid_91649|MLS001061267|MLS006011954|BIDD:ER0519|GTPL2862|orb1299590|SCHEMBL3079778|SCHEMBL19117358|SCHEMBL29379312|BDBM35909|GLXC-02519|HMS3039A05|BCP12495|Hydroxyflutamide, >=98% (HPLC)|YIA13473|Tox21_201204|Tox21_303659|Hydroxyflutamide (Hydroxyniphtholide)|AKOS007930906|CS-W013988|FH24016|HY-W013272|SB17029|NCGC00091014-01|NCGC00091014-02|NCGC00091014-03|NCGC00091014-04|NCGC00091014-06|NCGC00257382-01|NCGC00258756-01|BS-17460|SY234851|A1728|H1600|NS00008047|EN300-127735|F791312|BRD-K82027074-001-07-5|BRD-K82027074-001-08-3|Q15633976|2-Hydroxy-4'-nitro-3'-(trifluoromethyl)isobutyranilide|Z1603855929|N-(4-Nitro-3-(trifluoromethyl)phenyl)2-hydroxy-2-methylpropionamide|2-Hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]-propanamide|2-Hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propionamide|2-Hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide (hydroxy flutamide)|2-Hydroxy-2-methyl-N-(4-nitro-3-trifluoromethyl-phenyl)-propionamide(Hydroxyflutamide)|2-HYDROXY-2-METHYL-N-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)PROPANAMIDE; HYDROXYNIPHTHOLIDE|2-Hydroxy-2-methyl-N-[4-nitro-3-(trifluoromethyl)phenyl]propanamide;Hydroxyniphtholide;Sch 16423"
NILUTAMIDE,4493,,"InChI=1S/C12H10F3N3O4/c1-11(2)9(19)17(10(20)16-11)6-3-4-8(18(21)22)7(5-6)12(13,14)15/h3-5H,1-2H3,(H,16,20)",XWXYUMMDTVBTOU-UHFFFAOYSA-N,C12H10F3N3O4,317.22,"5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione","nilutamide|63612-50-0|Anandron|Nilandron|5,5-dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)imidazolidine-2,4-dione|Nilutamida|Nilutamidum|RU-23908|5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione|RU 23908|5,5-Dimethyl-3-(alpha,alpha,alpha-trifluoro-4-nitro-m-tolyl)hydantoin|NSC-758683|CHEBI:7573|DTXSID3034165|51G6I8B902|5,5-Dimethyl-3-(4-nitro-3-(trifluoromethyl)phenyl)-2,4-imidazolidinedione|2,4-IMIDAZOLIDINEDIONE, 5,5-DIMETHYL-3-(4-NITRO-3-(TRIFLUOROMETHYL)PHENYL)-|DTXCID1014165|5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedione|Anadron|2,4-Imidazolidinedione, 5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-|RefChem:57769|L02BB02|NSC684588|1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazoline-3,5-dione|5,5-Dimethyl-3-(4-nitro-3-(trifluoro-methyl)phenyl)-2,4-imidazolidinedione|624-700-6|C12H10F3N3O4|MFCD00864670|Nilandrone|2,4-Imidazolidinedione,5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-|Nilandron;RU 23908|CHEMBL1274|Nilutamidum [Latin]|Nilutamida [Spanish]|NCGC00015754-08|CAS-63612-50-0|Nilutamide [USAN:INN:BAN]|5,5-Dimethyl-3-(4-nitro-3-(trifluoromethyl)-phenyl)imidazolidine-2,4-dione|5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-1,3-diazolidine-2,4-dione|Nilandron (TN)|RU 23908-10|SR-01000076034|Nilutamide (USAN/INN)|BRN 0841906|UNII-51G6I8B902|Nilutamide, solid|Nilutamide; 5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]imidazolidine-2,4-dione|1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazolidine-2,5-dione|Nilutamide (Standard)|Spectrum_001625|Tocris-1759|NILUTAMIDE [MI]|SpecPlus_000902|NILUTAMIDE [INN]|Prestwick0_000928|Prestwick1_000928|Prestwick2_000928|Prestwick3_000928|Spectrum2_001973|Spectrum3_001633|Spectrum4_000600|Spectrum5_001512|Lopac-N-8534|NILUTAMIDE [USAN]|NILUTAMIDE [VANDF]|N 8534|NILUTAMIDE [MART.]|NILUTAMIDE [USP-RS]|NILUTAMIDE [WHO-DD]|BIDD:PXR0177|Lopac0_000879|SCHEMBL12670|BSPBio_000836|BSPBio_003325|KBioGR_001100|KBioSS_002105|MLS002154066|BIDD:GT0683|DivK1c_006998|SPECTRUM1504152|SPBio_002125|SPBio_003015|BPBio1_000920|GTPL2864|Nilutamide - Bio-X trade mark|orb1310771|NILUTAMIDE [ORANGE BOOK]|SCHEMBL29351021|KBio1_001942|KBio2_002105|KBio2_004673|KBio2_007241|KBio3_002545|NILUTAMIDE [EP MONOGRAPH]|BCPP000148|HMS1570J18|HMS1922F03|HMS2093A10|HMS2097J18|HMS2230E03|HMS3262P19|HMS3268C18|HMS3369I02|HMS3414N15|HMS3678N13|HMS3714J18|HMS5083B12|NILUTAMIDE [USP MONOGRAPH]|Pharmakon1600-01504152|BCP26617|Tox21 110213|Tox21_110213|Tox21_301589|Tox21_500879|BDBM50135912|CCG-39427|HY-13702R|NSC758683|s4836|SBB067297|STK633161|AKOS005565152|AKOS025147305|Tox21_110213_1|AC-5260|BCP9000990|DB00665|FN26218|LP00879|NSC 758683|SB19036|SDCCGSBI-0050854.P004|NCGC00015754-01|NCGC00015754-02|NCGC00015754-03|NCGC00015754-04|NCGC00015754-05|NCGC00015754-06|NCGC00015754-07|NCGC00015754-09|NCGC00015754-10|NCGC00015754-11|NCGC00015754-12|NCGC00015754-15|NCGC00015754-16|NCGC00015754-22|NCGC00025280-01|NCGC00025280-02|NCGC00025280-03|NCGC00025280-04|NCGC00025280-05|NCGC00025280-06|NCGC00025280-07|NCGC00025280-08|NCGC00255271-01|NCGC00261564-01|AS-14123|BN166184|HY-13702|SMR001233381|ST075550|SBI-0050854.P003|AB00053180|CS-0007719|EU-0100879|N1212|NS00015500|C08164|D00965|EN300-316458|AB00053180_07|612N500|L000759|Q3877030|RU-23908;RU 23908;RU23908|SR-01000076034-1|SR-01000076034-3|SR-01000076034-5|SR-01000076034-6|SR-01000076034-9|BRD-K23566484-001-05-2|BRD-K23566484-001-09-4|BRD-K23566484-001-14-4|BRD-K23566484-001-15-1|Z2242164525|Nilutamide, European Pharmacopoeia (EP) Reference Standard|1-(3'-trifluoromethyl-4'-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione|1-(3'-trifluoromethyl-4'-nitrophenyl)4,4-dimethyl-imidazoline-2,5-dione|1-(3'-trifluoromethyl-4'nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione|1-(3'trifluoromethyl-4'-nitropheyl)-4,4-dimethyl-imidazoline-2,5-dione|1-(3-'trifluoromethyl-4'-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione|1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl imidazolidine-2,5-dione|1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl-imidazolidine-2,5-dione|1-(3-trifluoromethyl-4-nitro-phenyl)-4,4-dimethyl-imidazoline-2,5-dione|1-(3-trifluoromethyl-4-nitrophenyl)-4,4-dimethyl-imidazoline-2,5-dione|5,5-Dimethyl-3-(4-nitro-3-trifluoromethyl-phenyl)-imidazolidine-2,4-dione|5,5-DIMETHYL-3-(.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-4-NITRO-M-TOLYL)HYDANTOIN|5,5-dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-imidazolidine-2,4-dione|5,5-Dimethyl-3-[4-nitro-3-(trifluoromethyl)phenyl]-2,4-imidazolidinedion;1-3-Trifluoromethyl-4-nitrophenyl)-4,4-dimethylimidazoline- 2,5-dione;Anandron|5,5-Dimethyl-3-4-nitro-3-(trifluoromethyl)phenyl-2,4-imidazolidinedion;1-3-Trifluoromethyl-4-nitrophenyl)-4,4-dimethylimidazoline- 2 ,5-dione;Anandron"
OPAVIRALINE,154048,,"InChI=1S/C14H17FN2O3/c1-4-11-13(18)16-10-6-5-9(15)7-12(10)17(11)14(19)20-8(2)3/h5-8,11H,4H2,1-3H3,(H,16,18)/t11-/m0/s1",KELNNWMENBUHNS-NSHDSACASA-N,C14H17FN2O3,280.29,"propan-2-yl (2S)-2-ethyl-7-fluoro-3-oxo-2,4-dihydroquinoxaline-1-carboxylate","Opaviraline|178040-94-3|GW420867X|opaviralina|GW-420867X|Q3A8EU2NMU|HBY-1293|GW-420867|DTXSID60170415|Isopropyl (S)-2-ethyl-7-fluoro-3,4-dihydro-3-oxo-1(2H)-quinoxalinecarboxylate|propan-2-yl (2S)-2-ethyl-7-fluoro-3-oxo-1,2,3,4-tetrahydroquinoxaline-1-carboxylate|OPAVIRALINUM|RefChem:168323|DTXCID0092906|GW 420867X|Opaviraline [INN]|propan-2-yl (2S)-2-ethyl-7-fluoro-3-oxo-2,4-dihydroquinoxaline-1-carboxylate|1(2H)-Quinoxalinecarboxylic acid, 2-ethyl-7-fluoro-3,4-dihydro-3-oxo-, 1-methylethyl ester, (2S)-|Isopropyl (2s)-2-Ethyl-7-Fluoro-3-Oxo-3,4-Dihydroquinoxaline-1(2h)-Carboxylate|isopropyl (S)-2-ethyl-7-fluoro-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxylate|UNII-Q3A8EU2NMU|GW-867|HBQ|GW 420867; GW 420867X; HBY 1293|1(2H)-Quinoxalinecarboxylic acid,2-ethyl-7-fluoro-3,4-dihydro-3-oxo-,1-methylethyl ester,(2S)-|SCHEMBL464732|BDBM2955|CHEMBL301370|orb1699756|SCHEMBL29388810|GW 867X|HBY1293|GW867|HBY1293/GW867|AKOS027326866|isopropyl (2S)-2-ethyl-7-fluoro-3-oxo-2,4-dihydroquinoxaline-1-carboxylate|DB07884|TS-08596|HY-107003|CS-0027095|NS00069564|Q27097092|S-3-Ethyl-6-fluoro-4-isopropoxycarbonyl-3,4-dihydro-quinoxalin-2(1H)-one|(S)-2-ethyl-7-fluoro-3-oxo-3,4-dihydro-2H-quinoxalinecarboxylic acid isopropylester|1-methylethyl (2S)-2-ethyl-7-fluoro-3-oxo-3,4-dihydroquinoxaline-1(2H)-carboxylate|isopropyl (s)-2-ethyl-7-fluoro-3,4-dihydro-3-oxoquinoxalin-1(2h)-carboxylate"
GW-328267,9869857,,"InChI=1S/C21H26N10O4/c1-2-31-28-18(27-29-31)16-14(33)15(34)20(35-16)30-10-23-13-17(22)25-21(26-19(13)30)24-12(9-32)8-11-6-4-3-5-7-11/h3-7,10,12,14-16,20,32-34H,2,8-9H2,1H3,(H3,22,24,25,26)/t12-,14-,15+,16-,20+/m0/s1",FLBKPDIBGNWXMT-NIQZGXKPSA-N,C21H26N10O4,482.5,"(2R,3R,4S,5R)-2-[6-amino-2-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-5-(2-ethyltetrazol-5-yl)oxolane-3,4-diol","GW-328267|210237-78-8|DJF621DE4F|GW328267X|GW328267|J2.047.755E|3,4-Furandiol, 2-(6-amino-2-(((1S)-1-(hydroxymethyl)-2-phenylethyl)amino)-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-, (2R,3R,4S,5R)-|GW 328267|(S)-2-((6-Amino-9-(4-(2-ethyl-2H-tetrazole-5-yl)-4-de(hydroxymethyl)-1-deoxy-beta-D-ribofuranose-1-yl)-9H-purine-2-yl)amino)-3-phenyl-1-propanol|RefChem:144813|UNII-DJF621DE4F|CHEMBL186113|(2R,3R,4S,5R)-2-[6-amino-2-[[(2S)-1-hydroxy-3-phenylpropan-2-yl]amino]purin-9-yl]-5-(2-ethyltetrazol-5-yl)oxolane-3,4-diol|(2R,3R,4S,5R)-2-(6-amino-2-(((S)-1-hydroxy-3-phenylpropan-2-yl)amino)-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydrofuran-3,4-diol|orb1703400|SCHEMBL1979140|SCHEMBL29369354|(2R,3R,4S,5R)-2-[6-Amino-2-[[(1S)-1-(hydroxymethyl)-2-phenylethyl]amino]-9H-purin-9-yl]-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydro-3,4-furandiol|BDBM50150766|AKOS040745836|CS-0027508|Q27276430|(2R,3R,4S,5R)-2-(6-amino-2-((S)-1-hydroxy-3-phenylpropan-2-ylamino)-9H-purin-9-yl)-5-(2-ethyl-2H-tetrazol-5-yl)tetrahydrofuran-3,4-diol|(2r,3r,4s,5r)-2-(6-amino-2-{[(1s)-2-hydroxy-1-(phenylmethyl)ethyl]amino}-9h-purin-9-yl)-5-(2-ethyl-2h-tetrazol-5-yl)tetrahydro-3,4-furandiol|(2R,3R,4S,5R)-2-[6-Amino-2-((S)-1-hydroxymethyl-2-phenyl-ethylamino)-purin-9-yl]-5-(2-ethyl-2H-tetrazol-5-yl)-tetrahydro-furan-3,4-diol|(S)-2-((6-AMINO-9-(4-(2-ETHYL-2H-TETRAZOLE-5-YL)-4-DE(HYDROXYMETHYL)-1-DEOXY-.BETA.-D-RIBOFURANOSE-1-YL)-9H-PURINE-2-YL)AMINO)-3-PHENYL-1-PROPANOL"
VIPADENANT,21874557,,"InChI=1S/C16H15N7O/c1-9-7-10(4-5-11(9)17)8-23-15-14(21-22-23)13(19-16(18)20-15)12-3-2-6-24-12/h2-7H,8,17H2,1H3,(H2,18,19,20)",HQSBCDPYXDGTCL-UHFFFAOYSA-N,C16H15N7O,321.34,"3-[(4-amino-3-methylphenyl)methyl]-7-(furan-2-yl)triazolo[4,5-d]pyrimidin-5-amine","Vipadenant|442908-10-3|BIIB014|VER-ADO-49|CEB-4520|BIIB 014|BIIB-014|V2006|VER-A00-11|VER-A00049|VER-11135|LDR3USH1NJ|V-2006|VER-A-00-11|VER-A-00049|DTXSID90196103|3-((4-AMINO-3-METHYLPHENYL)METHYL)-7-(FURAN-2-YL)-3H-(1,2,3)TRIAZOLO(4,5-D)PYRIMIDIN-5-AMINE|vipadenantum|3-((4-amino-3-methylphenyl)methyl)-7-furan-2-yltriazolo(5,4-d)pyrimidin-5-amine|3-[(4-amino-3-methylphenyl)methyl]-7-furan-2-yltriazolo[5,4-d]pyrimidin-5-amine|RefChem:901982|DTXCID60118594|3-(4-amino-3-methylbenzyl)-7-(furan-2-yl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine|MFCD12024697|CHEMBL447664|BIIB-014; CEB-4520|3-[(4-amino-3-methylphenyl)methyl]-7-(furan-2-yl)triazolo[4,5-d]pyrimidin-5-amine|3-(4-Amino-3-methylbenzyl)-7-(2-furyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidine-5-amine|3-[(4-azanyl-3-methyl-phenyl)methyl]-7-(furan-2-yl)-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine|Vipadenant [INN]|UNII-LDR3USH1NJ|Vipadenant [USAN:INN]|Vipadenant?|3-(4-amino-3-methylbenzyl)-7-(2-furyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidine-5-amine|Vipadenant (USAN/INN)|VIPADENANT [USAN]|Vipadenant; BIIB-014|V 2006|VIPADENANT [WHO-DD]|GTPL5612|orb1305579|SCHEMBL2849027|SCHEMBL29359313|SCHEMBL29421124|HQSBCDPYXDGTCL-UHFFFAOYSA-N|BCP15984|EX-A1029|BIIB014; CEB-4520|BDBM50254013|AKOS026750454|DB06625|SB19840|VR-2006|AC-35302|AS-35055|DA-78896|HY-10857|NS00072466|D09991|BRD-K56565215-001-01-9|Q27089145|3-[(4-amino-3-methyl-phenyl)methyl]-7-(2-furyl)triazolo[4,5-d]pyrimidin-5-amine|3-[(4-amino-3-methylphenyl)methyl]-7-(2-furanyl)-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-amine|3H-1,2,3-TRIAZOLO(4,5-D)PYRIMIDIN-5-AMINE, 3-((4-AMINO-3-METHYLPHENYL)METHYL)-7-(2-FURANYL)-|9XT"
TOZADENANT,11618368,,"InChI=1S/C19H26N4O4S/c1-19(25)5-7-23(8-6-19)18(24)21-17-20-15-14(26-2)4-3-13(16(15)28-17)22-9-11-27-12-10-22/h3-4,25H,5-12H2,1-2H3,(H,20,21,24)",XNBRWUQWSKXMPW-UHFFFAOYSA-N,C19H26N4O4S,406.5,"4-hydroxy-N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methylpiperidine-1-carboxamide","TOZADENANT|870070-55-6|SYN-115|4-Hydroxy-N-(4-methoxy-7-morpholinobenzo[d]thiazol-2-yl)-4-methylpiperidine-1-carboxamide|RO-4494351|A2A (3)|RO4494351|D9K857J81I|Ro-4494351000|Ro-4494351-002|RO4494351-000|RO4494351-002|A2A-(3)|A-2A (3)|Ro-4494351-000|1-Piperidinecarboxamide, 4-hydroxy-N-(4-methoxy-7-(4-morpholinyl)-2-benzothiazolyl)-4-methyl-|4-hydroxy-N-(4-methoxy-7-morpholin-4-yl-1,3-benzothiazol-2-yl)-4-methylpiperidine-1-carboxamide|4-Hydroxy-N-(4-methoxy-7-morpholinobenzo(d)thiazol-2-yl)-4-methylpiperidine-1-carboxamide|tozadenantum|RefChem:190521|4-hydroxy-N-(4-methoxy-7-(morpholin-4-yl)-1,3-benzothiazol-2-yl)-4-methylpiperidine-1-carboxamide|SYN115|4-HYDROXY-N-[4-METHOXY-7-(4-MORPHOLINYL)-2-BENZOTHIAZOLYL]-4-METHYL-1-PIPERIDINECARBOXAMIDE|Tozadenant [USAN]|Tozadenant (USAN)|MFCD21642026|4-Hydroxy-N-[4-methoxy-7-(4-morpholinyl)-2-benzo-thiazolyl]-4-methyl-1-piperidinecarboxamide|4-Methoxy-7-morpholino-2-[(4-hydroxy-4-methylpiperidino)carbonylamino]benzothiazole|Tozadenant [USAN:INN]|UNII-D9K857J81I|C19H26N4O4S|TOZADENANT [INN]|TOZADENANT [WHO-DD]|GTPL5611|orb1299923|SCHEMBL1628246|CHEMBL2105747|SCHEMBL29361846|CHEBI:177494|XNBRWUQWSKXMPW-UHFFFAOYSA-N|BCP06963|BDBM50011294|EX-A11088|AKOS016005201|CS-0359|DB12203|PB19761|4-Hydroxy-N-(4-methoxy-7-morpholino-1,3-benzothiazol-2-yl)-4-methyl-piperidine-1-carboxamide|NCGC00378653-02|AS-34303|HY-10995|DB-332345|NS00071044|D10174|A862938|BRD-K93045741-001-01-0|Q27089009|RO-4494351; RO4494351; RO 4494351;SYN115; SYN 115; Tozadenant|4-hydroxy-4-methyl-piperidine-1-carboxylic acid(4-methoxy-7-morpholin-4-yl-benzothiazol-2-yl)-amide|9XW|A2A"
MELATONIN,896,,"InChI=1S/C13H16N2O2/c1-9(16)14-6-5-10-8-15-13-4-3-11(17-2)7-12(10)13/h3-4,7-8,15H,5-6H2,1-2H3,(H,14,16)",DRLFMBDRBRZALE-UHFFFAOYSA-N,C13H16N2O2,232.28,N-[2-(5-methoxy-1H-indol-3-yl)ethyl]acetamide,"Melatonin|73-31-4|Melatonine|N-Acetyl-5-methoxytryptamine|Circadin|N-[2-(5-Methoxy-1H-indol-3-yl)ethyl]acetamide|5-Methoxy-N-acetyltryptamine|Melatol|N-(2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide|Melovine|Melapure|Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-|N-[2-(5-methoxyindol-3-yl)ethyl]acetamide|N-acetyl-5-methoxy-tryptamine|N-(2-(5-Methoxyindol-3-yl)ethyl)acetamide|NSC 113928|DTXSID1022421|Acetamide, N-(2-(5-methoxyindol-3-yl)ethyl)-|JL5DK93RCL|Acetamide, N-(2-(5-methoxy-1H-indol-3-yl)ethyl)-|NSC-56423|5-methoxy n-acetyl-tryptamine|NSC-113928|CHEBI:16796|BCI-049|NSC113928|Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]-|J5.258B|DTXCID002421|NSC56423|N-[2-(5-Methoxy-1H-indol-3-yl)ethyl)acetamide|somease|Heidadouppi|Melaxen|Travelag|Vytalonin|Icenia|Vespro|General nutrit|Natures bounty|Quality health|Health aid|Amerix Melatonin|Life ext|Nature's blend|Safrel Melatonin|S.gard|Melatonin Phenolic|Melatonin 1527|Therapeutic Melatonin|MELATONIN CORD|RefChem:5990|MAX Sleep Junior Childrens SLEEP AID|200-797-7|NSC-302012|Regulin|8041-44-9|MFCD00005655|CHEMBL45|Melatonex|Melatonin (JAN)|CAS-73-31-4|NCGC00015680-11|MELATONIN [JAN]|M02088|Posidorm|Primex|WLN: T56 BMJ D2MV1 GO1|[3H]melatonin|Melatonina (TN)|[3H]-melatonin|ML1|SMR000326666|CCRIS 3472|N-(2-(5-methoxyindol-3-yl)ethyl)-Acetamide|N-[2-(5-methoxyindol-3-yl)ethyl]-Acetamide|SR-01000075559|EINECS 200-797-7|UNII-JL5DK93RCL|BRN 0205542|[3H]MLT|Melatonine?|3-(n-acetyl-2-aminoethyl)-5-methoxyindole|Guna-dermo|3-(N-Acetyl-2-aminoethyl)-5-methoxyindole;N-Acetyl-5-methoxytryptamine|HSDB 7509|Melatobel (TN)|TNP00300|Prestwick_312|N-[2-(5-Methoxy-1H-indol-3-yl)-ethyl]-acetamide|Spectrum_000185|MELATONIN [DSC]|Guna-dermo (Salt/Mix)|MELATONIN [MI]|MELATONIN [HSDB]|Prestwick0_000458|Prestwick1_000458|Prestwick2_000458|Prestwick3_000458|Spectrum2_001344|Spectrum3_001393|Spectrum4_000066|Spectrum5_001745|Lopac-M-5250|MELATONIN [VANDF]|M1105|ChemDiv2_003916|MELATONIN [MART.]|M 5250|Melatonin, >=99.5%|MELATONIN [USP-RS]|MELATONIN [WHO-DD]|Lopac0_000787|Oprea1_104553|Oprea1_814234|SCHEMBL19018|BSPBio_000536|BSPBio_003006|GTPL224|KBioGR_000591|KBioSS_000665|MELATONIN [EMA EPAR]|5-22-12-00042 (Beilstein Handbook Reference)|Acetamide, {N-[2-(5-methoxyindol-3-yl)ethyl]-}|MLS000859594|MLS001055382|MLS001240204|BIDD:ER0618|DivK1c_000353|SPECTRUM1500690|Melatonin - Bio-X trade mark|SPBio_001527|SPBio_002475|Melatonin (synth.) ultra-pure|MELATONIN [GREEN BOOK]|BDBM9019|BPBio1_000590|GTPL1357|orb1307851|Acetamide, {N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-}|SCHEMBL29349848|HMS501B15|KBio1_000353|KBio2_000665|KBio2_003233|KBio2_005801|KBio3_002226|Melatonin 1.0 mg/ml in Methanol|NINDS_000353|GLXC-25215|HMS1380B22|HMS1569K18|HMS1921E04|HMS2089F09|HMS2096K18|HMS2233D23|HMS3262M16|HMS3370J20|HMS3413P14|HMS3654A22|HMS3677P14|HMS3713K18|HMS3884M05|HMS5079K15|HMS6019H04|Melatonin (synth.) standard-grade|BCP28154|HY-B0075|MSK10126|Tox21_110195|Tox21_201527|Tox21_302926|Tox21_500787|CCG-38837|HSCI1_000400|Melatonin, powder, >=98% (TLC)|SBB003265|STK386880|AKOS000276269|Tox21_110195_1|CS-1769|DB01065|FA01297|KS-1454|LP00787|SDCCGMLS-0065812.P001|SDCCGMLS-0065812.P002|SDCCGSBI-0050765.P003|IDI1_000353|IDI1_002631|SMP2_000309|N-acetyl-5-methoxy-tryptamine Melatonine|NCGC00015680-01|NCGC00015680-02|NCGC00015680-03|NCGC00015680-04|NCGC00015680-05|NCGC00015680-06|NCGC00015680-07|NCGC00015680-08|NCGC00015680-09|NCGC00015680-10|NCGC00015680-12|NCGC00015680-13|NCGC00015680-14|NCGC00015680-15|NCGC00015680-16|NCGC00015680-18|NCGC00015680-34|NCGC00015680-35|NCGC00090727-01|NCGC00090727-02|NCGC00090727-03|NCGC00090727-04|NCGC00090727-05|NCGC00090727-06|NCGC00090727-07|NCGC00090727-08|NCGC00090727-09|NCGC00256404-01|NCGC00259077-01|NCGC00261472-01|AC-10019|BA164660|NCI60_004378|ST057260|SY051401|AB00053279|EU-0100787|NS00009598|S1204|SW196607-4|C01598|D08170|AB00053279-10|AB00053279_12|EN300-6486827|{N-[2-(5-methoxyindol-3-yl)ethyl]-} Acetamide|005M655|L001261|N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-Acetamide|Q180912|SR-01000075559-1|SR-01000075559-6|SR-01000075559-7|SR-01000075559-8|{N-[2-(5-methoxy-1H-indol-3-yl)ethyl]-} Acetamide|BRD-K97530723-001-07-6|BRD-K97530723-001-11-8|BRD-K97530723-001-19-1|BRD-K97530723-001-20-9|F1929-1777|Melatonin, British Pharmacopoeia (BP) Reference Standard|Z1191880499|0E2B08C1-B325-45B1-8939-6F9081EFDFA4|Acetamide, N-[2-(5-methoxyindol-3-yl)ethyl]- (6CI,8CI)|Acetamide, N-[2-(5-methoxy-1H-indol-3-yl)ethyl]- (9CI)|Melatonin, United States Pharmacopeia (USP) Reference Standard|Melatonin, Pharmaceutical Secondary Standard; Certified Reference Material"
AGOMELATINE,82148,,"InChI=1S/C15H17NO2/c1-11(17)16-9-8-13-5-3-4-12-6-7-14(18-2)10-15(12)13/h3-7,10H,8-9H2,1-2H3,(H,16,17)",YJYPHIXNFHFHND-UHFFFAOYSA-N,C15H17NO2,243.30,N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide,"Agomelatine|138112-76-2|Thymanax|Valdoxan|S20098|S-20098|AGO-178|S 20098|Agomelatina|N-(2-(7-methoxy-1-naphthyl)ethyl)acetamide|AGO178|DTXSID3057642|137R1N49AD|DTXCID4031431|N-[2-(7-methoxy-1-naphthyl)ethyl]acetamide|agomelatinum|RefChem:110192|N06AX22|N-(2-(7-Methoxynaphthalen-1-yl)ethyl)acetamide|N-[2-(7-methoxynaphthalen-1-yl)ethyl]acetamide|Agomelatine [INN]|MFCD00916659|Acetamide, N-[2-(7-methoxy-1-naphthalenyl)ethyl]-|N-(2-(7-Methoxynaphth-1-yl)ethyl)acetamide|N-(2-(7-Methoxy-1-naphthalenyl)ethyl)acetamide|CHEMBL10878|N-[2-(7-Methoxy-1-naphthalenyl)ethyl]acetamide|Agomelatine (INN)|NCGC00253646-01|Melitor|N-[2-(7-Methoxynaphth-1-Yl)Ethyl]Acetamide|AGO 178|Acetamide, N-(2-(7-methoxy-1-naphthalenyl)ethyl)-|N-[2-(7-Methoxy-naphthalen-1-yl)-ethyl]-acetamide|Valdoxan (TN)|SR-01000944938|Agomelatine [INN:BAN]|AGO178C|UNII-137R1N49AD|AWY|Agomelatine (Standard)|AGOMELATINE [MI]|AGOMELATINE [MART.]|AGOMELATINE [WHO-DD]|GTPL198|MLS006011913|SCHEMBL114476|AGOMELATINE [EMA EPAR]|orb1308595|Agomelatine - Bio-X trade mark|SCHEMBL27844916|SCHEMBL29930659|Agomelatine, >=98% (HPLC)|CHEBI:134990|BCPP000421|GLXC-03028|HMS3604N09|HMS3648G18|HMS3654B07|HMS3753C13|HMS3884A07|HMS5079G21|BCP02084|ETB38944|MSK10883|Tox21_113772|BBL029084|BDBM50035179|HY-17038R|PDSP1_001305|PDSP1_001784|PDSP2_001289|PDSP2_001767|s1243|STL237728|AKOS005145681|AC-3395|BCP9000250|CCG-221950|CS-0740|DB06594|FA17244|KS-1247|SB19508|NCGC00253646-10|BA167079|HY-17038|SMR002530056|SY053050|A2606|CAS-138112-76-2|NS00007664|SW219177-1|D02578|AB01274769-01|AB01274769_02|EN300-7405421|112A762|L000528|N-[2-(7-Methoxy-1-naphthalenyl)ethyl]-acetamide|Q395229|SR-01000944938-1|SR-01000944938-3|BRD-K84698278-001-03-4|N-[2-(7-Methoxynaphth-1-yl)ethyl]acetamide;S20098|F0001-2383|N-[2-(7-Methoxy-naphthalen-1-yl)-ethyl]-acetamide(Agomelatine)"
RAMELTEON,208902,,"InChI=1S/C16H21NO2/c1-2-15(18)17-9-7-12-4-3-11-5-6-14-13(16(11)12)8-10-19-14/h5-6,12H,2-4,7-10H2,1H3,(H,17,18)/t12-/m0/s1",YLXDSYKOBKBWJQ-LBPRGKRZSA-N,C16H21NO2,259.34,"N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide","Ramelteon|196597-26-9|Rozerem|TAK-375|TAK375|(S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno-(5,4)furan-8-yl)ethyl)propionamide|901AS54I69|DTXSID6045951|Propanamide, N-(2-((8S)-1,6,7,8-tetrahydro-2H-indeno(5,4-b)furan-8-yl)ethyl)-|N-{2-[(8S)-1H,2H,6H,7H,8H-INDENO[5,4-B]FURAN-8-YL]ETHYL}PROPANAMIDE|ramelteonum|N-(2-((8S)-1H,2H,6H,7H,8H-indeno(5,4-b)furan-8-yl)ethyl)propanamide|N-(2-((8S)-2,6,7,8-tetrahydro-1H-cyclopenta(e)(1)benzoxol-8-yl)ethyl)propanamide|N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzoxol-8-yl]ethyl]propanamide|RefChem:55966|N05CH02|DTXCID301508624|(S)-N-[2-(1,6,7,8-tetrahydro-2H-indeno-[5,4-b]furan-8-yl)ethyl]propionamide|(S)-N-(2-(1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl)propionamide|N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e][1]benzofuran-8-yl]ethyl]propanamide|MFCD08067736|CHEMBL1218|Ramelteon [USAN]|N-[2-[(8S)-2,6,7,8-tetrahydro-1H-cyclopenta[e]benzofuran-8-yl]ethyl]propanamide|N-{2-[(8S)-1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl}propanamide|SMR002544684|Rozerem (TN)|SR-05000001957|Ramelteon (JAN/USAN/INN)|UNII-901AS54I69|HSDB 7787|(S)-N-(2-[1,6,7,8-tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl)propionamide|(S)-N-[2-(1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl)ethyl]propionamide|Ramelteon [USAN:INN:BAN:JAN]|JEV|Ramelteon (Standard)|RAMELTEON [INN]|RAMELTEON [JAN]|RAMELTEON [HSDB]|RAMELTEON [VANDF]|Ramelteon (TAK-375)|RAMELTEON [MART.]|RAMELTEON [WHO-DD]|(-)-N-(2-(((8S)-1,6,7,8-Tetrahydro-2H-indeno(5,4-b)furan-8-yl)ethyl)propanamide|SCHEMBL29237|BSPBio_002318|MLS003915619|MLS006010029|TAK-375SL|SPECTRUM1505817|GTPL1356|orb1308555|RAMELTEON [ORANGE BOOK]|SCHEMBL29380213|HY-A0014R|CHEBI:109549|YLXDSYKOBKBWJQ-LBPRGKRZSA-N|HMS1922H18|HMS2093F12|HMS3884K07|HY-A0014|MSK11174|BDBM50118470|s1259|Ramelteon 1.0 mg/ml in Acetonitrile|AKOS015895741|AC-5275|CCG-213557|CS-0382|DB00980|FR27673|NCGC00095187-08|NCGC00095187-09|NCGC00178707-03|NCGC00178707-05|AS-15740|DA-57347|SBI-0206874.P001|NS00069667|R0216|SW219712-1|D02689|EN300-219936|AB01274760-01|AB01274760_02|AB01274760_03|597R269|Q417689|SR-05000001957-1|SR-05000001957-3|BRD-K28761891-001-01-0|BRD-K28761891-001-04-4|BRD-K28761891-001-09-3|BRD-K28761891-001-10-1|Z2037281108|N-[2-(1,6,7,8-Tetrahydro-2H-3-oxa-as-indacen-8-yl)-ethyl]-propionamide(S)-(-)-22b|(-)-N-(2-(((8S)-1,6,7,8-TETRAHYDRO-2H-INDENO(5,4-.BETA.)FURAN-8-YL)ETHYL)PROPANAMIDE|N-[-[(8S)-1,6,7,8-Tetrahydro-2H-indeno[5,4-b]furan-8-yl]ethyl]propanamide;TAK-375;Rozerem|PROPANAMIDE, N-(2-((8S)-1,6,7,8-TETRAHYDRO-2H-INDENO(5,4-.BETA.)FURAN-8-YL)ETHYL)-"
ALRESTATIN,2120,,"InChI=1S/C14H9NO4/c16-11(17)7-15-13(18)9-5-1-3-8-4-2-6-10(12(8)9)14(15)19/h1-6H,7H2,(H,16,17)",GCUCIFQCGJIRNT-UHFFFAOYSA-N,C14H9NO4,255.22,"2-(1,3-dioxobenzo[de]isoquinolin-2-yl)acetic acid","alrestatin|51411-04-2|Alrestatine|Alrestatinum|2-(1,3-dioxobenzo[de]isoquinolin-2-yl)acetic acid|Alrestatina|DTXSID7045655|NSC-299132|515DHK15LG|1,3-Dioxo-1H-benz(de)isoquinoline-2(3H)-acetate|DTXCID5025655|2-(1,3-dioxobenzo(de)isoquinolin-2-yl)acetic acid|RefChem:555988|AY22,284|Alrestatin [INN]|2-(1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetic acid|Alrestatin free acid|(1,3-Dioxo-1H,3H-benzo[de]isoquinolin-2-yl)-acetic acid|1,3-Dioxo-1H-benz(de)isoquinoline-2(3H)-acetic acid|Spectrum_001449|Tocris-0485|(1,3-Dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)acetic acid|AY-22284|CHEMBL63055|51411-04-2 (free acid)|NSC299132|NCGC00024613-01|1,3-dioxo-1H-benz[de]isoquinoline-2(3H)-acetic acid|F0863-0248|Alrestatino|Alrestatine [INN-French]|Alrestatinum [INN-Latin]|Alrestatino [INN-Spanish]|ALR|CAS-51411-04-2|SR-01000597621|NSC 299132|BRN 0244370|UNII-515DHK15LG|Alrestatin?|2-[1,3-DIOXO-1H-BENZO[DE]ISOQUINOLIN-2(3H)-YL]ACETIC ACID|MFCD00181399|2,3-Dihydro-1,3-dioxo-1H-benz(de)isochiolin-2-essigsaeure|SpecPlus_000666|Spectrum3_001880|Spectrum4_000089|Spectrum5_001248|ALRESTATIN [WHO-DD]|BSPBio_001144|BSPBio_003360|CBDivE_001884|CBDivE_003810|CBDivE_004382|KBioGR_000358|KBioGR_000484|KBioSS_000484|KBioSS_001929|4-21-00-05562 (Beilstein Handbook Reference)|DivK1c_006762|SCHEMBL450743|orb1302006|BDBM16415|KBio1_001706|KBio2_000484|KBio2_001929|KBio2_003052|KBio2_004497|KBio2_005620|KBio2_007065|KBio3_000887|KBio3_000888|KBio3_002862|1H-Benz(de)isoquinoline-2(3H)-acetic acid, 1,3-dioxo-|Bio2_000412|Bio2_000892|HMS1362J05|HMS1792J05|HMS1990J05|HMS2092B18|HMS3266E14|HMS3403J05|HMS3411O19|HMS3675O19|HMS3866E03|Pharmakon1600-01502053|SMSSF-0061890|BCA41104|BCP28030|EX-A2966|HY-B1202|Tox21_110913|NSC758180|s5803|SBB043177|STK395007|AKOS000143709|Tox21_110913_1|CCG-109865|CS-4830|DB02020|NSC-758180|IDI1_002167|NCGC00024613-02|NCGC00024613-03|NCGC00024613-04|NCGC00024613-06|AC-13697|AC-35588|BS-16959|SBI-0051717.P003|DB-051958|NS00069482|ST50331319|D81785|EN300-235766|AB00052267-02|AB00052267_03|AF-399/32018005|Q4735714|SR-01000597621-1|SR-01000597621-2|BRD-K35498378-001-03-8|BRD-K35498378-001-05-3|BRD-K35498378-001-06-1|BRD-K35498378-001-07-9|Z56756231|AY-22284 pound>> AY22284 pound>> AY 22284|(1,3-dioxo-2-aza-2,3-dihydro-1H-phenalen-2-yl)acetic acid|1H-BENZ(DE)ISOQUINOLINE-2(3H)ACETIC ACID, 1,3-DIOXO-|2-{2,4-dioxo-3-azatricyclo[7.3.1.0,5,13]trideca-1(13),5,7,9,11-pentaen-3-yl}acetic acid|2-{2,4-dioxo-3-azatricyclo[7.3.1.0;{5,13}]trideca-1(12),5,7,9(13),10-pentaen-3-yl}acetic acid"
MARIMASTAT,119031,,"InChI=1S/C15H29N3O5/c1-8(2)7-9(10(19)13(21)18-23)12(20)17-11(14(22)16-6)15(3,4)5/h8-11,19,23H,7H2,1-6H3,(H,16,22)(H,17,20)(H,18,21)/t9-,10+,11-/m1/s1",OCSMOTCMPXTDND-OUAUKWLOSA-N,C15H29N3O5,331.41,"(2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide","Marimastat|154039-60-8|BB-2516|BB 2516|BB2516|Marimistat|D5EQV23TDS|NSC-719333|CHEBI:50662|KB-R 8898|GI-5712|TA-2516|(2S,3R)-3-(((1S)-2,2-Dimethyl-1-(methylcarbamoxy)propyl)carboyl)-2-hydroxy-5-methylhexanohydroxamic acid|DTXSID20165524|GI5712|NSC689451|NSC719333|TA2516|(2S,3R)-N-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N',2-dihydroxy-3-(2-methylpropyl)butanediamide|marimastatum|(2S,3R)-N-((1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl)-N',2-dihydroxy-3-(2-methylpropyl)butanediamide|RefChem:810621|DTXCID3088015|(2S,3R)-3-((S)-(2,2-Dimethyl-1-(methylcarbamoyl) propyl)carbamoyl)-2-hydroxy-5-methylhexanohydroxamic acid|Marimastat (BB-2516)|(2R,3S)-N1-((S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl)-N4,3-dihydroxy-2-isobutylsuccinamide|(2R,3S)-N-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N',3-dihydroxy-2-(2-methylpropyl)butanediamide|MFCD00866242|BB2516;TA2516|CHEMBL279785|Marimastat [USAN]|(2S,3R)-3-(((1S)-2,2-Dimethyl-1-(methylcarbamoyl)propyl)carbamoyl)-2-hydroxy-5-methylhexanohydroxamic acid|(2S,3R)-N(4)-[(2S)-3,3-dimethyl-1-(methylamino)-1-oxobutan-2-yl]-N(1),2-dihydroxy-3-(2-methylpropyl)butanediamide|(2R)-N-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-2-[(1S)-1-hydroxy-2-(hydroxyamino)-2-oxo-ethyl]-4-methyl-pentanamide|(2s,3r)-N~4~-[(1s)-2,2-Dimethyl-1-(Methylcarbamoyl)propyl]-N~1~,2-Dihydroxy-3-(2-Methylpropyl)butanediamide|Butanediamide, N4-((1S)-2,2-dimethyl-1-((methylamino)carbonyl)propyl)-N1,2-dihydroxy-3-(2-methylpropyl)-, (2S,3R)-|Butanediamide, N4-[(1S)-2,2-dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)-, (2S,3R)-|SMR002530328|Marimastat (USAN/INN)|UNII-D5EQV23TDS|Marimastat [USAN:INN:BAN]|(2S,3R)-3-[[(1S)-2,2-Dimethyl-1-(methylcarbamoyl)propyl]carbamoyl]-2-hydroxy-5-methylhexanohydroxamic acid|Butaneamide,2-dimethyl-1-[(methylamino)carbonyl]propyl]- N1,2-dihydroxy-3-(2-methylpropyl)-, (2S,3R)-|3hy7|MARIMASTAT [MI]|MARIMASTAT [INN]|D03795|MARIMASTAT [MART.]|MARIMASTAT [WHO-DD]|SCHEMBL34033|MLS003899230|MLS006010669|cid_119031|GTPL5220|orb1300377|Marimastat, >=98% (HPLC)|EX-A643|GLXC-06760|BDBM50063917|s7156|AKOS024457206|CCG-267821|CS-3456|DB00786|GI 5712|NSC 719333|NSC-689451|TA 2516|Marimastat - CAS 154039-60-8|AC-35828|AS-57129|Butanediamide, N(sup 4)-(2,2-dimethyl-1-((methylamino)carbonyl)propyl)-N(sup 1),2-dihydroxy-3-(2-methylpropyl)-, (2S-(N(sup 4)(R*),2R*,3S*))-|Butanediamide, N4-(2,2-dimethyl-1-((methylamino)carbonyl)propyl)-N1,2-dihydroxy-3-(2-methylpropyl)-, (2S-(N4(R*),2R*,3S*))-|FM161188|HY-12169|NS00068619|Q6763659|BRD-K21396683-001-04-8|(2S,3R)-N'-[(1S)-2,2-dimethyl-1-(methylcarbamoyl)propyl]-N,2-dihydroxy-3-(2-methylpropyl)butanediamide|(2S,3R)-N4-[(1S)-2,2-Dimethyl-1-[(methylamino)carbonyl]propyl]-N1,2-dihydroxy-3-(2-methylpropyl)butanediamide;BB 2516;TA 2516|BB2516, (2S,3R)-N4-[(1S)-2,2-Dimethyl-1-[(methylamino)carbonyl] propyl]-N1,2-dihydroxy-3-(2-methylpropyl)butanediamide|BUTANEDIAMIDE, N(SUP 4)-(2,2-DIMETHYL-1-((METHYLAMINO)CARBONYL)PROPYL)-N1,2-DIHYDROXY-3-(2-METHYLPROPYL)-, (2S-(N4(R*),2R*,3S*))-"
PRINOMASTAT,466151,,"InChI=1S/C18H21N3O5S2/c1-18(2)16(17(22)20-23)21(11-12-27-18)28(24,25)15-5-3-13(4-6-15)26-14-7-9-19-10-8-14/h3-10,16,23H,11-12H2,1-2H3,(H,20,22)/t16-/m0/s1",YKPYIPVDTNNYCN-INIZCTEOSA-N,C18H21N3O5S2,423.5,"(3S)-N-hydroxy-2,2-dimethyl-4-(4-pyridin-4-yloxyphenyl)sulfonylthiomorpholine-3-carboxamide","Prinomastat|192329-42-3|AG-3340|AG3340|AG 3340|prinomastatum|10T6626FRK|(3S)-N-hydroxy-2,2-dimethyl-4-(4-pyridin-4-yloxyphenyl)sulfonylthiomorpholine-3-carboxamide|KB-R-9896|DTXSID3043946|CHEBI:138885|(S)-2,2-Dimethyl-4-((p-(4-pyridyloxy)phenyl)sulfonyl)-3-thiomorpholinecarbohydroxamic acid|(S)-2,2-dimethyl-4-{[p-(4-pyridyloxy)phenyl]sulfonyl}-3-thiomorpholinecarbohydroxamic acid|RefChem:868518|DTXCID1023946|(3S)-N-Hydroxy-2,2-dimethyl-4-((4-(4-piridinyloxy)phenyl)sulfonyl)-3-thiomorpholinecarboxamide|3-Thiomorpholinecarboxamide, N-hydroxy-2,2-dimethyl-4-[[4-(4-pyridinyloxy)phenyl]sulfonyl]-, (3S)-|CHEMBL75094|(S)-N-Hydroxy-2,2-dimethyl-4-((4-(pyridin-4-yloxy)phenyl)sulfonyl)thiomorpholine-3-carboxamide|(3s)-n-hydroxy-2,2-dimethyl-4-{[4-(pyridin-4-yloxy)phenyl]sulfonyl}thiomorpholine-3-carboxamide|3-Thiomorpholinecarboxamide, N-hydroxy-2,2-dimethyl-4-((4-(4-pyridinyloxy)phenyl)sulfonyl)-, (S)-|Prinomastat (USAN/INN)|Prinomastat [USAN:INN]|UNII-10T6626FRK|AG3340;KB-R9896|3-THIOMORPHOLINECARBOXAMIDE, N-HYDROXY-2,2-DIMETHYL-4-((4-(4-PYRIDINYLOXY)PHENYL)SULFONYL)-, (3S)-|PN0|KB-R 9896|AG-3354|AG-3362|PRINOMASTAT [MI]|PRINOMASTAT [INN]|PRINOMASTAT [USAN]|PRINOMASTAT [WHO-DD]|SCHEMBL115696|GTPL6505|orb1708811|GLXC-15454|SHA32942|BDBM50082556|AKOS000280753|CS-7961|DB05100|(3S)-2,2-dimethyl-4-[4-(4-pyridyloxy)phenyl]sulfonyl-thiomorpholine-3-carbohydroxamic acid|NCGC00485069-01|HY-12170|MS-27439|NS00068314|D03797|G13508|EN300-7503678|329P423|Q7245228|Z2724205456|(3S)-N-HYDROXY-2,2-DIMETHYL-4-[4-(PYRIDIN-4-YLOXY)BENZENESULFONYL]THIOMORPHOLINE-3-CARBOXAMIDE|(S)-2,2-Dimethyl-4-[4-(pyridin-4-yloxy)-benzenesulfonyl]-thiomorpholine-3-carboxylic acid hydroxyamide|(S)-N-hydroxy-2,2-dimethyl-4-(4-(pyridin-4-yloxy)phenylsulfonyl)thiomorpholine-3-carboxamide|2,2-Dimethyl-4-[4-(pyridin-4-yloxy)-benzenesulfonyl]-thiomorpholine-3-carboxylic acid hydroxyamide|2,2-Dimethyl-4-[4-(pyridin-4-yloxy)-benzenesulfonyl]-thiomorpholine-3-carboxylic acid hydroxyamide(AG 3340)|2,2-Dimethyl-4-[4-(pyridin-4-yloxy)-benzenesulfonyl]-thiomorpholine-3-carboxylic acid hydroxyamide(prinomastat)"
CTS-1027,3342298,,"InChI=1S/C19H20ClNO6S/c20-14-1-3-15(4-2-14)27-16-5-7-17(8-6-16)28(24,25)13-19(18(22)21-23)9-11-26-12-10-19/h1-8,23H,9-13H2,(H,21,22)",ROSNVSQTEGHUKU-UHFFFAOYSA-N,C19H20ClNO6S,425.9,4-[[4-(4-chlorophenoxy)phenyl]sulfonylmethyl]-N-hydroxyoxane-4-carboxamide,"CTS-1027|193022-04-7|RS-130830|Ro-1130830|2H-Pyran-4-carboxamide, 4-(((4-(4-chlorophenoxy)phenyl)sulfonyl)methyl)tetrahydro-N-hydroxy-|4-[4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL]-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE|2QD3F58224|DTXSID90172907|4-(4-(4-Chloro-phenoxy)-benzenesulfonylmethyl)-tetrahydro-pyran-4-carboxylic acid hydroxyamide|4-{[4-(4-chlorophenoxy)benzenesulfonyl]methyl}-N-hydroxyoxane-4-carboxamide|4-(((4-(4-CHLOROPHENOXY)PHENYL)SULFONYL)-METHYL) TETRAHYDRO-N-HYDROXY-2H-PYRAN-4-CARBOXAMIDE|4-((4-(4-chlorophenoxy)benzenesulfonyl)methyl)-N-hydroxyoxane-4-carboxamide|RefChem:579508|DTXCID4095398|CHEMBL440498|4-[[4-(4-chlorophenoxy)phenyl]sulfonylmethyl]-N-hydroxyoxane-4-carboxamide|Ro 1130830;RS 130830|4-(((4-(4-chlorophenoxy)phenyl)sulfonyl)methyl)-N-hydroxytetrahydro-2H-pyran-4-carboxamide|UNII-2QD3F58224|4-({[4-(4-chlorophenoxy)phenyl]sulfonyl}methyl)-N-hydroxytetrahydro-2H-pyran-4-carboxamide|RS 130830|orb1707421|SCHEMBL2381112|BDBM11863|830c|GLXC-06232|BCP13018|CTS 1027|THA02204|MFCD16657131|alpha-tetrahydropyran beta-sulfone 1B|AKOS030526690|CS-0281|DB08490|HY-10398|MS-27506|DB-114312|NS00068484|RS-130,830|F83499|Cts-1027 193022-04-7|BRD-K53508936-001-01-0|Q27097691|4-({[4-(4-chlorophenoxy)benzene]sulfonyl}methyl)-N-hydroxyoxane-4-carboxamide|4-[[4-(4-chlorophenoxy)phenyl]sulfonylmethyl]tetrahydropyran-4-carbohydroxamic acid|4-(4-(4-CHLORO-PHENOXY)-BENZENESULFONYLMETHYL )-TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID HYDROXYAMIDE"
CIPEMASTAT,9824350,,"InChI=1S/C22H36N4O5/c1-22(2)20(29)26(21(30)24(22)3)14-17(18(27)23-31)16(13-15-9-5-6-10-15)19(28)25-11-7-4-8-12-25/h15-17,31H,4-14H2,1-3H3,(H,23,27)/t16-,17+/m1/s1",GFUITADOEPNRML-SJORKVTESA-N,C22H36N4O5,436.5,"(2R,3R)-3-(cyclopentylmethyl)-N-hydroxy-4-oxo-4-piperidin-1-yl-2-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]butanamide","Cipemastat|190648-49-8|Ro 32-3555|Trocade|Ro 32-3555/000|02HQ4TYQ60|Ro-32-03555|Ro-323555000|(2R,3R)-3-(cyclopentylmethyl)-N-hydroxy-4-oxo-4-piperidin-1-yl-2-[(3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl]butanamide|DTXSID10897569|1-Piperidinebutanamide, beta-(cyclopentylmethyl)-N-hydroxy-gamma-oxo-alpha-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-, (alphaR,betaR)-|RO-32-3555/000|Cipemastat [USAN:INN]|cipemastatum|UNII-02HQ4TYQ60|C22H36N4O5|(2R,3R)-3-(cyclopentylmethyl)-N-hydroxy-4-oxo-4-piperidin-1-yl-2-((3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl)butanamide|(alphaR,betaR)-beta-(Cyclopentylmethyl)-gamma-oxo-alpha-((3,4,4-piperidinebutyrohydroxamic acid|(alphaR,betaR)-beta-(Cyclopentylmethyl)-gamma-oxo-alpha-[(3,4,4-piperidinebutyrohydroxamic acid|(alphaR,betaR)-beta-(Cyclopentylmethyl)-N-hydroxy-gamma-oxo-alpha-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-1-piperidinebutanamide; Cipemastat; Ro 32-3555/000; Trocade; Ro 32-3555|Trocade (TN)|CIPEMASTAT [INN]|Cipemastat (USAN/INN)|CIPEMASTAT [USAN]|RefChem:1100558|CIPEMASTAT [WHO-DD]|CHEMBL115653|GTPL6466|orb1710047|SCHEMBL7088217|BDBM30344|DTXCID001326916|GLXC-01794|EX-A9430|MFCD00944012|AKOS024457333|HY-19677|MS-27825|RO32-3555|CS-0016192|D03517|G12916|Q3885848|BRD-K95362002-001-01-1|(2R,3R)-3-(cyclopentylmethyl)-4-oxo-4-(1-piperidyl)-2-[(3,4,4-trimethyl-2,5-dioxo-imidazolidin-1-yl)methyl]butanehydroxamic acid|(2R,3R)-3-(cyclopentylmethyl)-N-hydroxy-4-oxo-4-(piperidin-1-yl)-2-((3,4,4-trimethyl-2,5-dioxoimidazolidin-1-yl)methyl)butanamide|(alphaR,betaR)-beta-(Cyclopentylmethyl)-N-hydroxy-gamma-oxo-alpha-((3,4,4-trimethyl-2,5-dioxo-1-imidazolidin-yl)methyl)-1-piperidinebutanamide|1-[3-cyclopentyl-2(R)-[1(R)-(hydroxycarbamoyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)-ethyl]propionyl]piperidine|1-[3-cyclopentyl-2(R)-[1(R)-(hydroxycarbamoyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]propionyl]piperdine|1-[3-cyclopentyl-2(R)-[1(R)-(hydroxycarbamoyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]propionyl]piperidine|1-[3-cyclopentyl-2(R)[1(R)-(hydroxycarbamoyl)-2-(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)ethyl]propionyl]piperidine|1-PIPERIDINEBUTANAMIDE, .BETA.-(CYCLOPENTYLMETHYL)-N-HYDROXY-.GAMMA.-OXO-.ALPHA.-((3,4,4-TRIMETHYL-2,5-DIOXO-1-IMIDAZOLIDINYL)METHYL)-, (R-(R*,R*))-|1-Piperidinebutanamide, .beta.-(cyclopentylmethyl)-N-hydroxy-.gamma.-oxo-.alpha.-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-, (.alpha.R,.beta.R)-|1-Piperidinebutanamide, |A-(cyclopentylmethyl)-N-hydroxy-|A-oxo-|A-[(3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl]-, (|AR,|AR)-|1-Piperidinebutanamide, beta-(cyclopentylmethyl)-N-hydroxy-gama-oxo-alpha-((3,4,4-trimethyl-2,5-dioxo-1-imidazolidinyl)methyl)-, (R-(R*,R*))-"
MEPERIDINE,4058,,"InChI=1S/C15H21NO2/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13/h4-8H,3,9-12H2,1-2H3",XADCESSVHJOZHK-UHFFFAOYSA-N,C15H21NO2,247.33,ethyl 1-methyl-4-phenylpiperidine-4-carboxylate,"meperidine|Pethidine|Isonipecaine|Meperidol|Pethanol|Pethidineter|Pethidin|Phetidine|Nemerol|Pipersal|57-42-1|Petydyna|Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate|Petidina|Pethidinum|Ethyl 1-methyl-4-phenylisonipecotate|Renaudin|Pethidine DBL|4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester|Dolsin|Lydol|Methyl phenylpiperidine carbonic acid ethyl ester|Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester|N-Methyl-4-phenyl-4-carbethoxypiperidine|1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester|1-Methyl-4-phenylisonipecotic acid, ethyl ester|IDS-NP-001|1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester|CHEBI:6754|9E338QE28F|1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester|DTXSID9023253|Isonipecain|Operidine EPJ I|RefChem:5997|DTXCID403253|N02AB02|200-329-1|Dolcontral|Dolosal|Demerol|HSDB 3116|Pethidine (INN)|CHEMBL607|Pethidine [INN]|meperidina|Meperidine-d5|Petydyna [Polish]|Demarol|Piperosal|Pethidinum [INN-Latin]|Petidina [INN-Spanish]|1-Methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester|Pethidine DBL (TN)|Pethidine [INN:BAN]|EINECS 200-329-1|UNII-9E338QE28F|DEA No. 9230|1-Methyl-4-phenyl-piperidin-4-carbon-saeure-aethylester [German]|Lidol (Salt/Mix)|Lydol (Salt/Mix)|Dolsin (Salt/Mix)|Pethidine impurity 6|Pethidine impurity 7|Dolaren (Salt/Mix)|Dolosal (Salt/Mix)|53484-75-6|Dispadol (Salt/Mix)|Dolantin (Salt/Mix)|Petantin (Salt/Mix)|Operidine (Salt/Mix)|Piridosal (Salt/Mix)|4-Carbethoxy-1-methyl-4-phenylpiperidine|Centralgin (Salt/Mix)|Dolcontral (Salt/Mix)|MEPERIDINE [MI]|MEPERIDINE [HSDB]|MEPERIDINE [VANDF]|1-methyl-4-phenylisonipecotic acid ethyl ester|PETHIDINE [WHO-DD]|SCHEMBL25431|DivK1c_000983|GTPL7221|KBio1_000983|NINDS_000983|YIsonipecotic acid, 1-methyl-4-phenyl-, ethyl ester (8CI)|BDBM50026752|DB00454|IDI1_000983|DB-053051|NS00009544|C07128|D08343|Pethidine (Meperidine) 0.1 mg/ml in Methanol|Pethidine (Meperidine) 1.0 mg/ml in Methanol|Q55434|4-Ethoxycarbonyl-1-methyl-4-phenyl-piperidinium|Ethyl 1-methyl-4-phenyl-4-piperidinecarboxylate|L000908|SR-01000944492|SR-01000944492-1|1-Methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester(Meperidine)"
RALTITREXED,135400182,,"InChI=1S/C21H22N4O6S/c1-11-22-14-4-3-12(9-13(14)19(28)23-11)10-25(2)17-7-6-16(32-17)20(29)24-15(21(30)31)5-8-18(26)27/h3-4,6-7,9,15H,5,8,10H2,1-2H3,(H,24,29)(H,26,27)(H,30,31)(H,22,23,28)/t15-/m0/s1",IVTVGDXNLFLDRM-HNNXBMFYSA-N,C21H22N4O6S,458.5,(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid,"Raltitrexed|112887-68-0|ZD1694|ZD-1694|ICI-D1694|D-1694|ZD-16|(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-1H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid|ICI D1694|D1694|FCB9EGG971|D 1694|DTXSID0046482|N-(5-(((3,4-Dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thenoyl)-L-glutamic acid|N-(5-(N-(3,4-Dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid|DTXCID8026482|L-Glutamic acid, N-((5-(((1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl)methylamino)-2-thienyl)carbonyl)-|N-(5-[N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino]-2-thenoyl)-L-glutamic acid|raltitrexedum|(2S)-2-((5-(methyl-((2-methyl-4-oxo-1H-quinazolin-6-yl)methyl)amino)thiophene-2-carbonyl)amino)pentanedioic acid|RefChem:930549|L01BA03|CHEBI:5847|Raltitrexed (Tomudex)|MFCD00864168|C21H22N4O6S|CHEMBL225071|ICI-D-1694|ZD 1694|NSC-639186|(S)-2-(5-(methyl((2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carboxamido)pentanedioic acid|NCGC00229704-01|(2S)-2-[(5-{methyl[(2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl]amino}thiophen-2-yl)formamido]pentanedioic acid|(2S)-2-[[5-[methyl-[(2-methyl-4-oxo-3H-quinazolin-6-yl)methyl]amino]thiophene-2-carbonyl]amino]pentanedioic acid|(S)-2-(5-(Methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)-methyl)amino)thiophene-2-carboxamido)pentanedioic acid|D16|CAS-112887-68-0|UNII-FCB9EGG971|Raltitrexed (JAN/USAN/INN)|1hvy|2kce|2tsr|ZN-D1694|KS-5069|ZD1694; Raltitrexed|RALTITREXED [MI]|RALTITREXED [INN]|RALTITREXED [JAN]|RALTITREXED [USAN]|SCHEMBL7438|SCHEMBL7439|RALTITREXED [MART.]|RALTITREXED [WHO-DD]|MLS001424225|MLS006010125|Raltitrexed [USAN:INN:BAN]|GTPL7403|orb1300600|SCHEMBL29454789|SCHEMBL29490413|BDBM18795|1i00|IVTVGDXNLFLDRM-HNNXBMFYSA-N|HMS2052I03|HMS3715P08|N-(5-(N-(3,4-dihydro-2-methyl-4-oxoquinazolin-6-ylmethyl)-N-methylamino)-2-thenoyl)-L-glutamic acid;(S)-2-(5-(Methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carboxamido)pentanedioic acid|Tox21_112237|BDBM50027655|NSC639186|s1192|AKOS015894877|AKOS015994729|Tox21_112237_1|CCG-101075|CCG-221273|DB00293|FR27671|NC00325|NCGC00229704-03|NCGC00263534-02|(S)-2-(5-(methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carboxamido)pentanedioic acid|HY-10821|L-Glutamic acid, N-[[5-[[(3,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-|NCI60_013008|SMR000469217|SMR002529608|BCP0726000267|NS00069368|R0208|SW197705-2|D01064|AB00698356-05|887R680|EN300-27032179|SR-01000763351|SR-01000763351-3|BRD-K89839824-001-01-2|BRD-K89839824-001-05-3|BRD-K89839824-001-06-1|Q15304877|(5-(Methyl((2-methyl-4-oxo-3,4-dihydroquinazolin-6-yl)methyl)amino)thiophene-2-carbonyl)-L-glutamic acid|N-[(5-{methyl[(2-methyl-4-oxo-1,4-dihydroquinazolin-6-yl)methyl]amino}thiophen-2-yl)carbonyl]-L-glutamic acid|N-[[5-[[(1,4-dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic acid|N-[[5-[[(1,4-Dihydro-2-methyl-4-oxo-6-quinazolinyl)methyl]methylamino]-2-thienyl]carbonyl]-L-glutamic acid;Tomudex;ICI-D-1694"
DAZOXIBEN,53001,,"InChI=1S/C12H12N2O3/c15-12(16)10-1-3-11(4-2-10)17-8-7-14-6-5-13-9-14/h1-6,9H,7-8H2,(H,15,16)",XQGZSYKGWHUSDH-UHFFFAOYSA-N,C12H12N2O3,232.23,4-(2-imidazol-1-ylethoxy)benzoic acid,"DAZOXIBEN|78218-09-4|Dazoxibene|Dazoxibenum|4-(2-(1H-Imidazol-1-yl)ethoxy)benzoic acid|p-(2-Imidazol-1-ylethoxy)benzoic acid|4-[2-(1H-imidazol-1-yl)ethoxy]benzoic acid|Benzoic acid, 4-(2-(1H-imidazol-1-yl)ethoxy)-|DTXSID9045639|09ZFC7974Q|DTXCID7025639|Benzoic acid, 4-[2-(1H-imidazol-1-yl)ethoxy]-|UK-37,248|RefChem:585214|UK-37248|4-(2-imidazol-1-ylethoxy)benzoic acid|Dazoxiben free base|103735-00-8|4-(2-(1-Imidazolyl)ethoxy)benzoic acid|CHEMBL267473|Dazoxiben [INN-Spanish]|NCGC00018938-03|Dazoxibene [INN-French]|Dazoxibenum [INN-Latin]|Dazoxiben [INN:BAN]|AH-P 719 (9CI)|4-(2-(1-Imidazolyl)ethoxy)benzoesaeure|UK 37248|UNII-09ZFC7974Q|AH-P 719|AH-P-719|1-[2-(4-carboxyphenoxy)ethyl]imidazole|DAZOXIBEN [INN]|Imidazole N-1 deriv. 13|Oprea1_249918|SCHEMBL11554|CBDivE_009681|MLS006010101|BDBM7962|GTPL5175|orb1705042|AH-P719|Tox21_110859|MFCD00866791|AKOS005872303|DB03052|FD35137|NCGC00018938-01|NCGC00018938-02|NCGC00023830-02|AS-14224|SMR000059716|4-(2-Imidazol-1-yl-ethoxy)-benzoic acid|4-[2-(imidazol-1-yl)ethoxy]benzoic acid|CAS-78218-09-4|DB-056294|CS-0024779|NS00073492|Benzoic acid,4-[2-(1H-imidazol-1-yl)ethoxy]-|218B094|Q5243688|BRD-K82767007-001-01-1|4-(2-Imidazol-1-yl-ethoxy)-benzoic acid; hydrochloride"
CHLOROQUINE,2719,,"InChI=1S/C18H26ClN3/c1-4-22(5-2)12-6-7-14(3)21-17-10-11-20-18-13-15(19)8-9-16(17)18/h8-11,13-14H,4-7,12H2,1-3H3,(H,20,21)",WHTVZRBIWZFKQO-UHFFFAOYSA-N,C18H26ClN3,319.9,"4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine","chloroquine|54-05-7|Aralen|Chloraquine|Chlorochin|Artrichin|Chloroquina|Chloroquinium|Capquin|Reumachlor|Chlorquin|Clorochina|Arthrochin|Gontochin|Bipiquin|Klorokin|Mesylith|Sanoquin|Trochin|Amokin|Nivaquine B|Bemaphate|Chingamin|Cloroquina|Resoquine|Chlorochine|Chloroquinum|Khingamin|Chlorochinum|RP 3377|CHEBI:3638|7-Chloro-4-((4-(diethylamino)-1-methylbutyl)amino)quinoline|N4-(7-Chloro-4-quinolinyl)-N1,N1-diethyl-1,4-pentanediamine|4-N-(7-chloroquinolin-4-yl)-1-N,1-N-diethylpentane-1,4-diamine|NSC-187208|886U3H6UFF|SN 7618|DTXSID2040446|7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline|Quinoline, 7-chloro-4-((4-(diethylamino)-1-methylbutyl)amino)-|1,4-Pentanediamine, N(4)-(7-chloro-4-quinolinyl)-N(1),N(1)-diethyl-|Chingaminum|Arechine|N(4)-(7-chloro-4-quinolinyl)-N(1),N(1)-diethyl-1,4-pentanediamine|N'-(7-chloroquinolin-4-yl)-N,N-diethylpentane-1,4-diamine|Quinoline, 7-chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]-|7-chloro-N-(5-(diethylamino)pentan-2-yl)quinolin-4-amine|7-CHLORO-N-[5-(DIETHYLAMINO)PENTAN-2-YL]QUINOLIN-4-AMINE|Sulfate, Chloroquine|Sulphate, Chloroquine|RefChem:6409|DTXCID0020446|P01BA01|200-191-2|Chemochin|Bemaco|Bemasulph|Benaquin|Cidanchin|Cocartrit|Dichinalex|Heliopar|Iroquine|Lapaquin|Pfizerquine|Quinachlor|Quinercyl|Quinilon|Quinoscan|Silbesan|Solprina|Sopaquin|Tresochin|Elestol|Imagon|Malaren|Malarex|Neochin|Roquine|Siragan|Quingamine|Ronaquine|N4-(7-chloroquinolin-4-yl)-N1,N1-diethylpentane-1,4-diamine|Avlochlor|Nivachine|Quinagamin|Quinagamine|Resochen|Resoquina|Reumaquin|Tanakan|WIN 244|1,4-Pentanediamine, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-|W 7618|{4-[(7-chloroquinolin-4-yl)amino]pentyl}diethylamine|MFCD00024009|Chloroin|Miniquine|Rivoquine|Tanakene|Arolen|C18H26ClN3|Gontochin phosphate|CHEMBL76|SN 6718|Ipsen 225|N(sup 4)-(7-Chloro-4-quinolinyl)-N(sup 1),N(sup 1)-diethyl-1,4-pentanediamine|NSC187208|Chloroquine (VAN)|Clorochina [DCIT]|N4-(7-chloro-4-quinolyl)-N1,N1-diethyl-pentane-1,4-diamine|3377 RP|1,4-Pentanediamine, N(sup 4)-(7-chloro-4-quinolinyl)-N(sup 1),N(sup 1)-diethyl-|ST 21 (pharmaceutical)|Chloroquinum [INN-Latin]|Cloroquina [INN-Spanish]|1246815-14-4|3377 RP opalate|Chloroquin|CQ|ST 21|1,4-pentanediamine, N~4~-(7-chloro-4-quinolinyl)-N~1~,N~1~-diethyl-, phosphate (1:2)|(+-)-Chloroquine|CCRIS 3439|HSDB 3029|Chloroquine (USP/INN)|EINECS 200-191-2|{4-[(7-chloro(4-quinolyl))amino]pentyl}diethylamine|Malaquin (*Diphosphate*)|NSC 187208|BRN 0482809|UNII-886U3H6UFF|Cloroquine|Chloroquine [USP:INN:BAN]|Chloroquine, 17|Arechin (Salt/Mix)|Delagil (Salt/Mix)|Tanakan (Salt/Mix)|RP-3377|Bemaphate (Salt/Mix)|Resoquine (Salt/Mix)|Chloroquine (Standard)|Spectrum_000132|Chloroquine + Proveblue|CHLOROQUINE [MI]|Prestwick0_000548|Prestwick1_000548|Prestwick2_000548|Prestwick3_000548|Spectrum2_000127|Spectrum3_000341|Spectrum4_000279|Spectrum5_000707|CHLOROQUINE [INN]|(.+/-.)-Chloroquine|CHLOROQUINE [HSDB]|Epitope ID:131785|MolMap_000009|CHLOROQUINE [VANDF]|SCHEMBL8933|CHLOROQUINE [MART.]|Lopac0_000296|BSPBio_000595|BSPBio_002001|CHLOROQUINE [WHO-DD]|KBioGR_000778|KBioSS_000592|DivK1c_000404|CU-01000012392-2|SPBio_000174|SPBio_002516|GNF-Pf-4216|BPBio1_000655|GTPL5535|orb1298711|SCHEMBL29363614|BDBM22985|KBio1_000404|KBio2_000592|KBio2_003160|KBio2_005728|KBio3_001221|NINDS_000404|CHLOROQUINE [USP IMPURITY]|HMS2090O03|HMS5087M13|HY-17589AR|CHLOROQUINE [USP MONOGRAPH]|ALBB-025694|MSK11158|HY-17589A|s6999|SBB072644|AKOS015935106|CCG-204391|CS-W004760|DB00608|KH-0005|SB73098|SDCCGSBI-0050284.P005|IDI1_000404|SMP2_000034|NCGC00015256-02|NCGC00015256-03|NCGC00015256-04|NCGC00015256-05|NCGC00015256-06|NCGC00015256-07|NCGC00015256-08|NCGC00015256-09|NCGC00015256-10|NCGC00015256-13|NCGC00015256-17|NCGC00015256-28|NCGC00162120-01|DA-51857|FC150960|NCI60_000894|SY086904|WLN: T66 BNJ EMY1&3N2&2 IG|SBI-0050284.P004|AB00053436|C3730|CS-0021871|NS00001540|ST45028748|C07625|D02366|EN300-120683|MLS-0466768.0001|AB00053436-05|AB00053436_06|AB00053436_07|1, N4-(7-chloro-4-quinolinyl)-N1,N1-diethyl-|F242503|Q422438|BRD-A91699651-065-01-1|BRD-A91699651-316-06-7|BRD-A91699651-316-09-1|BRD-A91699651-316-10-9|BRD-A91699651-316-11-7|n(sup4)-(7-chloro-4-quinolinyl)-n(sup1),4-pentanediamine|quinoline, 7-chloro-4-(4-diethylamino-1-methyl)butylamino-|Quinoline, 7-chloro-4-(4-diethylamino-1-methyl-butylamino)-|N(4)-(7-chloroquinolin-4-yl)-N(1),N(1)-diethylpentane-1,4-diamine|N~4~-(7-chloroquinolin-4-yl)-N~1~,N~1~-diethylpentane-1,4-diamine|1,4-PENTANEDIAMINE, N(SUP 4)-(7-CHLORO-4-QUINOLINYL)-N(SUP 1),N (SUP 1)-DIETHYL-|7-Chloro-4-[[4-(diethylamino)-1-methylbutyl]amino]quinoline;(+/-)-Chloroquine|N(sup4)-(7-chloro-4-quinolinyl)-N(sup1),N(sup1)-diethyl-1,4-pentanediamine|117399-83-4"
CHLOROPHENYLPIPERAZINE,22015046,,"InChI=1S/C10H13ClN2/c11-10-8-12-6-7-13(10)9-4-2-1-3-5-9/h1-5,10,12H,6-8H2",JQQKTEXFNXKDIQ-UHFFFAOYSA-N,C10H13ClN2,196.67,2-chloro-1-phenylpiperazine,CHLOROPHENYLPIPERAZINE|SCHEMBL988610|SCHEMBL2175936
NALUZOTAN,11430856,,"InChI=1S/C23H38N4O3S/c1-20(28)25-22-10-7-11-23(18-22)27-16-14-26(15-17-27)13-6-5-12-24-31(29,30)19-21-8-3-2-4-9-21/h7,10-11,18,21,24H,2-6,8-9,12-17,19H2,1H3,(H,25,28)",SPWZXWDPAWDKQE-UHFFFAOYSA-N,C23H38N4O3S,450.6,N-[3-[4-[4-(cyclohexylmethylsulfonylamino)butyl]piperazin-1-yl]phenyl]acetamide,"Naluzotan|740873-06-7|LQ54E5B4EW|PRX00023|DTXSID40995527|N-(3-(4-(4-Cyclohexylmethanesulfonylaminobutyl)piperazin-1-yl)phenyl)acetamide|naluzotanum|N-(3-[4-(4-Cyclohexylmethanesulfonylaminobutyl)piperazin-1-yl]phenyl)acetamide|RefChem:831712|DTXCID201422552|N-(3-(4-(4-(((Cyclohexylmethyl)sulfonyl)amino)butyl)-1-piperazinyl)phenyl)acetamide|N-(3-(4-(4-(cyclohexylmethanesulfonamido)butyl)piperazin-1-yl)phenyl)acetamide|PRX-00023|Naluzotan (free base)|Naluzotan [USAN:INN]|UNII-LQ54E5B4EW|N-[3-[4-[4-(cyclohexylmethylsulfonylamino)butyl]piperazin-1-yl]phenyl]acetamide|PRX 00023|N-[3-[4-[4-[(Cyclohexylmethylsulfonyl)amino]butyl]piperazin-1-yl]phenyl]acetamide|CHEMBL209821|Acetamide, N-(3-(4-(4-(((cyclohexylmethyl)sulfonyl)amino)butyl)-1-piperazinyl)phenyl)-|N-(3-(4-(4-(((cyclohexylmethyl)sulfonyl)amino)butyl)piperazin-1-yl)phenyl)acetamide|N-(3-(4-(4-((cyclohexylmethyl)sulfonamido)butyl)piperazin-1-yl)phenyl)acetamide|Naluzotan [USAN]|N-{3-[4-(4-{[(Cyclohexylmethyl)sulfonyl]amino}butyl)piperazin-1-yl]phenyl}acetamide|NALUZOTAN [INN]|Naluzotan (USAN/INN)|SCHEMBL678016|orb1706933|C23H38N4O3S|BCP20177|QEB87306|BDBM50187377|MFCD09833676|AKOS040742266|CS-6740|DB05562|SB16847|HY-14848|MS-28182|DB-115004|NS00069673|D09358|G13586|833C676|L001689|Q6961039|N-(3-(4-(4-(cyclohexylmethylsulfonamido)butyl)piperazin-1-yl)phenyl)acetamide|N-{3-[4-(4-cyclohexylmethanesulfonylamino-butyl)-piperazin-1-yl]-phenyl}-acetamide|Naluzotan; N-(3-[4-(4-Cyclohexylmethanesulfonylaminobutyl)piperazin-1-yl]phenyl)acetamide"
QUIPAZINE,5011,,"InChI=1S/C13H15N3/c1-2-4-12-11(3-1)5-6-13(15-12)16-9-7-14-8-10-16/h1-6,14H,7-10H2",XRXDAJYKGWNHTQ-UHFFFAOYSA-N,C13H15N3,213.28,2-piperazin-1-ylquinoline,"quipazine|4774-24-7|2-Piperazin-1-ylquinoline|2-(1-Piperazinyl)quinoline|Quipazina|Quinoline, 2-(1-piperazinyl)-|Quipazinum|4WCY05C0SJ|DTXSID3046952|RefChem:178376|DTXCID1026952|2-Piperazin-1-yl-quinoline|2-(piperazin-1-yl)quinoline|Quipazine [INN]|MFCD00242605|1-(2-Quinolyl)piperazine|1-(2-Quinolinyl)piperazine|CHEMBL18772|2-quinolylpiperazine|F3306-0004|130895-61-3|Quipazinum [INN-Latin]|Quipazina [INN-Spanish]|2-(1-Piperazinyl)chinolin|UNII-4WCY05C0SJ|BRN 0196945|2-(1-PIPERAZINO)QUINOLINE|Spectrum_001733|Tocris-0629|piperazin-1-yl-quinoline|Prestwick0_000617|Prestwick1_000617|Prestwick2_000617|Prestwick3_000617|Spectrum2_001182|Spectrum3_001824|Spectrum4_001259|Lopac-Q-1004|Biomol-NT_000103|Lopac0_001019|Oprea1_342540|BSPBio_000554|BSPBio_003467|GTPL173|KBioGR_001818|KBioSS_002213|1-(quinolin-2-yl)piperazine|2-(1-piperazinyl)-quinoline|5-23-03-00069 (Beilstein Handbook Reference)|DivK1c_000911|SCHEMBL322181|SPBio_001223|SPBio_002773|2-(piperazin-1-yl)-quinoline|BPBio1_000610|BPBio1_001393|orb1744248|SCHEMBL1366931|CHEBI:93368|KBio1_000911|KBio2_002213|KBio2_004781|KBio2_007349|KBio3_002971|NINDS_000911|SMSSF-0056366|BCP23281|BDBM50014407|SBB011283|STL308727|AKOS000124312|2-Piperazin-1-yl-quinoline(Quipazine)|AB05466|CCG-205099|HY-W028142|IDI1_000911|2-Piperazin-1-yl-quinoline (Quipazine)|NCGC00015872-01|NCGC00015872-02|NCGC00015872-03|NCGC00015872-04|NCGC00015872-06|NCGC00024694-01|NCGC00024694-02|NCGC00024694-03|AC-22858|AS-38262|SY238379|CAS-4774-24-7|SBI-0050992.P003|DB-021505|AB00053761|CS-0072166|ST50232723|EN300-39715|VU0005330-3|AB00053761-06|AB00053761_11|AB00053761_12|774P247|F227816|L000958|Q7272557|BRD-K77925998-001-01-3|BRD-K77925998-050-02-8|BRD-K77925998-050-14-3|BRD-K77925998-332-03-8|BRD-K77925998-332-04-6|BRD-K77925998-364-01-5|2-Piperazin-1-yl-quinoline;2-(piperazin-1-yl)quinoline"
VILAZODONE,6918314,,"InChI=1S/C26H27N5O2/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32/h4-7,13-15,17,29H,1-3,8-12H2,(H2,28,32)",SGEGOXDYSFKCPT-UHFFFAOYSA-N,C26H27N5O2,441.5,5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide,"Vilazodone|163521-12-8|5-(4-(4-(5-Cyano-1H-indol-3-yl)butyl)piperazin-1-yl)benzofuran-2-carboxamide|vilazodona|EMD 515259|vilazodonum|EMD-515259|EMD-68-843|5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]-1-benzofuran-2-carboxamide|5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl}-1-benzofuran-2-carboxamide|S239O2OOV3|CHEBI:70707|EMD 68843 BASE|DTXSID80870086|5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl]benzofuran-2-carboxamide|5-(4-(4-(5-Cyanoindol-3-yl)butyl)-1-piperazinyl)-2-benzofurancarboxamide|5-(4-(4-(5-cyano-1H-indol-3-yl)butyl)piperazin-1-yl)-1-benzofuran-2-carboxamide|5-(4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-yl)benzofuran-2-carboxamide|5-{4-[4-(5-Cyano-1H-indol-3-yl)butyl]piperazin-1-yl}benzofuran-2-carboxamide|RefChem:56210|DTXCID10817924|N06AX24|Viibryd|2-BENZOFURANCARBOXAMIDE, 5-[4-[4-(5-CYANO-1H-INDOL-3-YL)BUTYL]-1-PIPERAZINYL]-|MFCD09838919|CHEMBL439849|Vilazodone [INN]|EMD 68843 (Hydrochloride);SB659746A (Hydrochloride)|SB 659746A|Vilazodone [USAN:INN]|UNII-S239O2OOV3|HSDB 8197|2-BENZOFURANCARBOXAMIDE, 5-(4-(4-(5-CYANO-1H-INDOL-3-YL)BUTYL)-1-PIPERAZINYL)-|5-[4-[4-(5-cyano-1H-indol-3-yl)butyl]-1-piperazinyl]-2-Benzofurancarboxamide; 1-[4-(5-Cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine; EMD 515259; Vilazodone|Vilazodone (Standard)|VILAZODONE [MI]|Vilazodone (USAN/INN)|VILAZODONE [USAN]|VILAZODONE [VANDF]|VILAZODONE [MART.]|VILAZODONE [WHO-DD]|SCHEMBL650682|EMD-68843 BASE|GTPL7427|orb1309142|SCHEMBL29357448|SCHEMBL30051446|yl}-1-benzofuran-2-carboxamide|EX-A174|GLXC-04566|HMS3744C03|HMS3886N05|HMS5085F13|BCP05225|BDBM50151982|HY-14262R|s5858|1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl)piperazine|AKOS015924744|CS-0550|DB06684|PB25213|SB20296|NCGC00371130-03|NCGC00371130-06|AC-25886|AS-73542|DA-59010|HY-14262|EMD 68843;SB 659746A|NS00068607|D09698|AB01563299_01|EN300-7395058|L001518|Q408588|BRD-K58010567-003-01-4|BRD-K58010567-003-02-2|BRD-K58010567-003-03-0|5-{4-[4-(5-cyano-1H-indol-3-yl)butyl]piperazin-1-|F0001-2418|1-[4-(5-cyanoindol-3-yl)butyl]4-(2-carbamoyl-benzofuran-5-yl)-piperazine|5-{4-[4-(5-cyano-3-indolyl)butyl]-1-piperazinyl}benzo-furan-2-carboxamide|1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine|5 -(4-(4-(5 -Cyano-1H-indol-3 -yl)butyl)piperazin-1 -yl)benzofuran-2-carboxamide|5-{4-[4-(5-Cyano-1H-indol-3-yl)-butyl]-piperazin-1-yl}-benzofuran-2-carboxylic acid amide"
RIMCAZOLE,53389,,"InChI=1S/C21H27N3/c1-16-14-23(15-17(2)22-16)12-7-13-24-20-10-5-3-8-18(20)19-9-4-6-11-21(19)24/h3-6,8-11,16-17,22H,7,12-15H2,1-2H3/t16-,17+",GUDVQJXODNJRIJ-CALCHBBNSA-N,C21H27N3,321.5,"9-[3-[(3S,5R)-3,5-dimethylpiperazin-1-yl]propyl]carbazole","Rimcazole|75859-04-0|Rimcazol|Rimcazolum|BW-234U|BW 234U|C3N1PS8CX1|cis-9-(3-(3,5-dimethyl-1-piperazinyl)propyl)carbazole|DTXSID7048162|cis-9-[3-(3,5-dimethyl-1-piperazinyl)propyl]carbazole|RefChem:179466|DTXCID8028137|Rimcazole [INN]|9-[3-[(3S,5R)-3,5-dimethylpiperazin-1-yl]propyl]carbazole|CHEMBL275707|9-[3-[(3R,5S)-3,5-dimethylpiperazin-1-yl]propyl]carbazole|Rimcazol [INN-Spanish]|Rimcazolum [INN-Latin]|9-[3-[cis-3,5-dimethylpiperazin-1-yl]propyl]carbazole|NCGC00025187-01|UNII-C3N1PS8CX1|Tocris-1497|9-[3-(3,5-Dimethyl-piperazin-1-yl)-propyl]-9H-carbazole|SCHEMBL99084|9-[3-(3,5-dimethylpiperazin-1-yl)propyl]carbazole,hydrochloride|orb1702878|9-[3-(3,5-Dimethyl-piperazin-1-yl)-propyl]-9H-carbazole(rimcazole)|SCHEMBL29710924|CHEBI:94713|GUDVQJXODNJRIJ-CALCHBBNSA-N|GLXC-06496|9H-Carbazole, 9-(3-(3,5-dimethyl-1-piperazinyl)propyl)-, cis-|EX-A5687|BDBM50019742|AKOS040746287|BR177827|DA-67207|HY-121813|CS-0083477|NS00121747|9-[3-(3,5-cis-dimethylpiperazino)propyl]-carbazole|9-[3-(3,5-cis-dimethylpiperazino)propyl]carbazole|Q7334422|9-[3-(3,5-cis-dimethylpiperazino)-propyl]-carbazole|BRD-K70490179-300-01-2|9-(3-(CIS-3,5-DIMETHYL-1-PIPERAZINYL)PROPYL)CARBAZOLE|9-(3-((3S,5R)-3,5-dimethylpiperazin-1-yl)propyl)-9H-carbazole|9-{3-[(3R,5S)-3,5-dimethylpiperazin-1-yl]propyl}-9H-carbazole|9-[3-((3R,5R)-3,5-Dimethyl-piperazin-1-yl)-propyl]-9H-carbazole|9-[3-((3R,5S)-3,5-Dimethyl-piperazin-1-yl)-propyl]-9H-carbazole|9-[3-((3S,5R)-3,5-Dimethyl-piperazin-1-yl)-propyl]-9H-carbazole|9-[3-(3,5-Dimethyl-piperazin-1-yl)-propyl]-9H-carbazole (Rimcazole) (BW234U)|9-[3-(cis-3,5-Dimethyl-1-piperazinyl)propyl]-9H-carbazole dihydrochloride;BW 234U|9H-CARBAZOLE, 9-(3-((3R,5S)-3,5-DIMETHYL-1-PIPERAZINYL)PROPYL)-, REL-"
INTEPIRDINE,11256720,,"InChI=1S/C19H19N3O2S/c23-25(24,16-6-2-1-3-7-16)17-13-15-5-4-8-18(19(15)21-14-17)22-11-9-20-10-12-22/h1-8,13-14,20H,9-12H2",JJZFWROHYSMCMU-UHFFFAOYSA-N,C19H19N3O2S,353.4,3-(benzenesulfonyl)-8-piperazin-1-ylquinoline,"Intepirdine|607742-69-8|GSK-742457|RVT-101|Intepirdina|3-(benzenesulfonyl)-8-piperazin-1-ylquinoline|2IOB2M82HY|GSK742457|DTXSID30976249|intepirdinum|RefChem:791088|3-(BENZENESULFONYL)-8-(PIPERAZIN-1-YL)QUINOLINE|DTXCID201403627|SB-742457|SB742457|3-(PHENYLSULFONYL)-8-(PIPERAZIN-1-YL)QUINOLINE|SB 742457|Quinoline, 3-(phenylsulfonyl)-8-(1-piperazinyl)-|3-Phenylsulfonyl-8-(piperazin-1-yl)quinoline|MFCD12828872|GSK 742457|CHEMBL1083390|Intepirdine [USAN]|3-(benzenesulfonyl)-8-piperazin-1-yl-quinoline|UNII-2IOB2M82HY|3-benzenesulfonyl-8-piperazin-1-ylquinoline|INTEPIRDINE [INN]|Intepirdine (USAN/INN)|Intepirdine [USAN:INN]|Intepirdine(SB742457)|INTEPIRDINE [WHO-DD]|GTPL9444|orb1307467|SCHEMBL1683964|SCHEMBL29355057|EX-A623|JJZFWROHYSMCMU-UHFFFAOYSA-N|HMS3651H06|HMS3884H22|BCP27653|HZA74269|BDBM50318633|s2894|AKOS016340595|CCG-268069|DB12680|LG-0206|SB-742457RVT-101|SB16755|NCGC00386220-04|AC-30949|HY-14339|Intepirdine (SB-742457, RVT-101?|3-phenylsulfonyl-8-piperazin-1-yl-quinoline|NS00072548|SW220018-1|D10942|742S698|Q855449|BRD-K78941306-001-02-4|BRD-K78941306-001-03-2"
LATREPIRDINE,197033,,"InChI=1S/C21H25N3/c1-15-4-7-20-18(12-15)19-14-23(3)10-9-21(19)24(20)11-8-17-6-5-16(2)22-13-17/h4-7,12-13H,8-11,14H2,1-3H3",JNODQFNWMXFMEV-UHFFFAOYSA-N,C21H25N3,319.4,"2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-3,4-dihydro-1H-pyrido[4,3-b]indole","Dimebolin|Latrepirdine|3613-73-8|Dimebon|Dimebone|Latrepirdina|OD9237K1Z6|PF-01913539|DTXSID20189705|2,3,4,5-Tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)ethyl)-1H-pyrido(4,3-b)indole|latrepirdinum|2,3,4,5-tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-1H-pyrido[4,3-b]indole|5-(2-(2,8-dimethyl-1H,2H,3H,4H,5H-pyrido(4,3-b)indol-5-yl)ethyl)-2-methylpyridine|5-(2-{2,8-DIMETHYL-1H,2H,3H,4H,5H-PYRIDO[4,3-B]INDOL-5-YL}ETHYL)-2-METHYLPYRIDINE|RefChem:798539|DTXCID40112196|2,3,4,5-Tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)-ethyl)-1H-pyrid(4,3b)indole|PF1913539|PF01913539|2,8-Dimethyl-5-(2-(6-methylpyridin-3-yl)ethyl)-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole|2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-3,4-dihydro-1H-pyrido[4,3-b]indole|MFCD00387540|CHEMBL589390|2,8-Dimethyl-5-[2-(6-methyl-pyridin-3-yl)-ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole|Dimeboline|Preparation 84|1H-Pyrido[4,3-b]indole,2,3,4,5-tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-|2,3,4,5-Tetrahydro-2,8-dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-1H-pyrido[4,3-b]indole|C21H25N3|SMR001317776|Latrepirdine [USAN]|Latrepirdine [USAN:INN]|BRN 0622478|UNII-OD9237K1Z6|2,8-dimethyl-5-[2-(6-methylpyridin-3-yl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole|DIMEBOLIN [MI]|Latrepirdine (USAN/INN)|LATREPIRDINE [INN]|LATREPIRDINE [MART.]|MLS002264475|MLS006013366|LATREPIRDINE [WHO-DD]|SCHEMBL292354|orb1306328|LATREPIRDINE HYDROCHLORIDE|SCHEMBL29357222|SCHEMBL29717625|SCHEMBL29717663|CHEBI:92976|BCPP000257|GLXC-10857|HMS2200M23|HMS3327A20|BCP02189|EX-A1498|BDBM50305261|AKOS005146217|AC-5146|BCP9000611|DB11725|1H-Pyrido(4,3-b)indole, 2,3,4,5-tetrahydro-2,8-dimethyl-5-(2-(6-methyl-3-pyridyl)ethyl)-|2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-3,4-dihydro-1H-pyrido[4,3-b]indole|NCGC00182554-01|NCGC00182554-02|NCGC00182554-04|AS-35091|HY-14862|SY038470|DB-069323|DB-260452|NS00070385|D09917|613D738|Q408580|BRD-K55703048-001-07-7|BRD-K55703048-300-01-6|2,8-dimethyl-5-[2-(6-methyl-3-pyridyl)ethyl]-2,3,4,5-tetrahydro-1h-pyrido[4,3-b]indole|9-(2-(2-Methyl-5-pyridyl)ethyl)-3,6-dimethyl-1,2,3,4-tetrahydro-.gamma.-carboline|1227953-42-5|1H-PYRIDO(4,3-B)INDOLE, 2,3,4,5-TETRAHYDRO-2,8-DIMETHYL-5-(2-(6-METHYL-3-PYRIDINYL)ETHYL)-|2,8-Dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole|2,8-Dimethyl-5-[2-(6-methyl-3-pyridinyl)ethyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indole #"
IDALOPIRDINE,21071390,,"InChI=1S/C20H19F5N2O/c21-15-4-5-17-14(11-27-18(17)9-15)6-7-26-10-13-2-1-3-16(8-13)28-12-20(24,25)19(22)23/h1-5,8-9,11,19,26-27H,6-7,10,12H2",YBAWYTYNMZWMMJ-UHFFFAOYSA-N,C20H19F5N2O,398.4,"2-(6-fluoro-1H-indol-3-yl)-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]ethanamine","Idalopirdine|467459-31-0|Lu AE58054|LU-AE58054|2-(6-fluoro-1H-indol-3-yl)-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]ethanamine|Idalopirdina|59WCJ0YNWM|SGS518|LU AE-58054|LU-AE-58054|LY483518|LY-483518|DTXSID201026015|LuAE58054|idalopirdinum|2-(6-fluoro-1H-indol-3-yl)-N-((3-(2,2,3,3-tetrafluoropropoxy)phenyl)methyl)ethanamine|RefChem:789662|DTXCID30867143|(2-(6-fluoro-1H-indol-3-yl)ethyl)(((3-(2,2,3,3-tetrafluoropropoxy)phenyl)methyl))amine|813-768-4|1H-Indole-3-ethanamine, 6-fluoro-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]-|MFCD18633269|2-(6-FLUORO-1H-INDOL-3-YL)-N-(3-(2,2,3,3-TETRAFLUOROPROPOXY)BENZYL)ETHAN-1-AMINE|N-(2-(6-Fluoro-1H-indol-3-yl)ethyl)-3-(2,2,3,3-tetrafluoropropoxy)benzylamine|LU AE 58054|UNII-59WCJ0YNWM|Idalopirdine [USAN:INN]|Idlopirdine|C20H19F5N2O|1H-INDOLE-3-ETHANAMINE, 6-FLUORO-N-((3-(2,2,3,3-TETRAFLUOROPROPOXY)PHENYL)METHYL)-|Idalopirdine [USAN]|Idalopirdine (USAN/INN)|IDALOPIRDINE [INN]|Lu AE58054;Idalopirdine|IDALOPIRDINE [WHO-DD]|SCHEMBL762762|GTPL8689|Idalopirdine(Lu-AE-58054)|orb1300070|CHEMBL3286580|SCHEMBL29359411|SCHEMBL29431528|Idalopirdine(Lu-AE-58054)?|EX-A844|GLXC-10053|BCP08339|BDBM50019754|AKOS028114439|CS-1347|DB11957|SB16535|2-(6-Fluoro-1H-indol-3-yl)-N-(3-(2,2,3,3-tetrafluoropropoxy)benzyl)ethanamine|NCGC00378842-04|AC-30941|DA-21188|HY-14338|TS-09585|NS00073101|D10710|Q855545|BRD-K79102359-003-01-6|1H-Indole-3-ethanamine,6-fluoro-N-[[3-(2,2,3,3-tetrafluoropropoxy)phenyl]methyl]-"
PF-05212377,46203710,,"InChI=1S/C18H20N4O2S/c1-14-20-18-16(21-12-10-19-11-13-21)8-5-9-17(18)22(14)25(23,24)15-6-3-2-4-7-15/h2-9,19H,10-13H2,1H3",MAYQIFVKVAUMPD-UHFFFAOYSA-N,C18H20N4O2S,356.4,1-(benzenesulfonyl)-2-methyl-4-piperazin-1-ylbenzimidazole,"PF-05212377|1226793-34-5|SAM-760|PF-5212377|WYE-103760|RefChem:172244|4JEH3BL51N|CHEMBL3329435|1H-Benzimidazole, 2-methyl-1-(phenylsulfonyl)-4-(1-piperazinyl)-|2-Methyl-1-(phenylsulfonyl)-4-(piperazin-1-yl)-1H-benzo[d]imidazole|starbld0028709|UNII-4JEH3BL51N|orb2664145|SCHEMBL1250079|SCHEMBL29361567|BDBM50044615|HY-120464"
CERLAPIRDINE,16071605,,"InChI=1S/C22H23N3O3S/c1-25(2)13-6-14-28-17-11-12-20-19(15-17)22(24-23-20)29(26,27)21-10-5-8-16-7-3-4-9-18(16)21/h3-5,7-12,15H,6,13-14H2,1-2H3,(H,23,24)",NXQGEDVQXVTCDA-UHFFFAOYSA-N,C22H23N3O3S,409.5,"N,N-dimethyl-3-[(3-naphthalen-1-ylsulfonyl-2H-indazol-5-yl)oxy]propan-1-amine","Cerlapirdine|925448-93-7|SAM-531|WAY-262531|Cerlapirdina|PF-05212365|N,N-dimethyl-3-[(3-naphthalen-1-ylsulfonyl-2H-indazol-5-yl)oxy]propan-1-amine|SAM-531 FREE BASE|EK40PJ0V49|WAY-262,531|DTXSID201137232|cerlapirdinum|N,N-dimethyl-3-((3-naphthalen-1-ylsulfonyl-2H-indazol-5-yl)oxy)propan-1-amine|RefChem:575216|DTXCID901568866|dimethyl(3-((3-(naphthalene-1-sulfonyl)-1H-indazol-5-yl)oxy)propyl)amine|N,N-Dimethyl-3-((3-(1-naphthalenylsulfonyl)-1H-indazol-5-yl)oxy)-1-propanamine|Cerlapirdine [USAN]|925448-93-7 (free base)|Cerlapirdine (USAN)|N,N-Dimethyl-3-((3-(naphthalen-1-ylsulfonyl)-2H-indazol-5-yl)oxy)propan-1-amine|Cerlapirdine [USAN:INN]|UNII-EK40PJ0V49|SAM531|SAM 531|Cerlapirdine free base|PF-5212365|CERLAPIRDINE [INN]|CERLAPIRDINE [WHO-DD]|GTPL7356|orb1304562|SCHEMBL3534330|CHEMBL2103880|SCHEMBL21381542|SCHEMBL29375645|NXQGEDVQXVTCDA-UHFFFAOYSA-N|GLXC-15644|MFCD18782738|AKOS040751077|DB12229|DA-72096|HY-14431|CS-0003354|NS00072142|D10099|F88545|Q5064514|Dimethyl-{3-[3-(naphthalene-1-sulfonyl)-1H-indazol-5-yloxy]-propyl}-amine|1-PROPANAMINE, N,N-DIMETHYL-3-((3-(1-NAPHTHALENYLSULFONYL)-1H-INDAZOL-5-YL)OXY)-|N,N-DIMETHYL-3-((3-((NAPHTHALEN-1-YL)SULFONYL)-1H-INDAZOL-5-YL)OXY)PROPAN-1-AMINE|N,N-DIMETHYL-3-((3-(1-NAPHTHYLSULFONYL)-1H-INDAZOL-5-YL)OXY)PROPAN-1-AMINE|N,N-dimethyl-3-((3-(naphthalen-1-ylsulfonyl)-1H-indazol-5-yl)oxy)propan-1-amine|N,N-dimethyl-3-[[3-(1-naphthylsulfonyl)-2H-indazol-5-yl]oxy]propan-1-amine"
OXITRIPTAN,439280,,"InChI=1S/C11H12N2O3/c12-9(11(15)16)3-6-5-13-10-2-1-7(14)4-8(6)10/h1-2,4-5,9,13-14H,3,12H2,(H,15,16)/t9-/m0/s1",LDCYZAJDBXYCGN-VIFPVBQESA-N,C11H12N2O3,220.22,(2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid,"oxitriptan|Levothym|Pretonine|Oxyfan|Quietim|Levotinine|Serotonyl|Telesol|Triptene|Oxitriptano|Oxitriptanum|Tripten|(S)-5-Hydroxytryptophan|C1LJO185Q9|CCRIS 4418|CHEBI:17780|EINECS 224-411-1|Oxitriptanum [INN-Latin]|Oxitriptano [INN-Spanish]|BRN 0088200|UNII-C1LJO185Q9|Oxitriptanum (INN-Latin)|Oxitriptano (INN-Spanish)|OXITRIPTAN (MART.)|OXITRIPTAN [MART.]|5-HTP Phenolic|RefChem:56534|N06AX01|224-411-1|5-hydroxy-L-tryptophan|L-5-Hydroxytryptophan|4350-09-8|Cincofarm|L-5-Htp|(2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid|5-Hydroxytryptophan L-form|Tript-OH|L-Tryptophan, 5-hydroxy-|(S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoic acid|MFCD00064341|Oxitriptan [INN]|hydroxytryptophan|5-Hydroxyl-L-tryptophan|5-hydroxy l-tryptophan|Ro 3-5940 HCl|DTXSID1025437|Oxitriptan (INN)|NCGC00091062-04|Dl-oxitriptan|Tryptophan, 5-hydroxy-, L-|(2S)-2-amino-3-(5-hydroxyindol-3-yl)propanoic acid|DTXCID005437|L-2-Amino-3-(5-hydroxyindolyl)propionic acid|5-hydroxy-L-tryptophane|(S)-2-Amino-3-(5-hydroxy-1H-indol-3-yl)propanoic Acid (5-Hydroxytryptophan)|CAS-4350-09-8|5-hydroxytryptophan, dl-|5-Hydroxytryptophan L form|Tryptophan, 5-hydroxy-, dl|5-22-14-00278 (Beilstein Handbook Reference)|Serotain|Oxitriptan 1|Levothym (TN)|5-Hydroxytryptophane|Tryptophan Impurity 24|5HTP|Lopac-H-9772|bmse000457|H-Trp(5-OH)-OH|5-HYDROXY-TRYPTOPHAN|OXITRIPTAN [WHO-DD]|Lopac0_000627|SCHEMBL43243|MLS002153452|CHEMBL350221|GTPL4671|orb1308788|SCHEMBL6416715|5-Hydroxy-L-tryptophan, powder|SCHEMBL29366470|HY-B1716R|HYDROXYTRYPTOPHAN [VANDF]|MSK2945|L-5-Hydroxytryptophan (Standard)|HMS2231H15|HMS3261N16|HY-B1716|Tox21_111073|Tox21_201032|Tox21_500627|BDBM50403163|s4769|AKOS004119863|Tox21_111073_1|CCG-204715|CS-W019879|DB02959|LP00627|SDCCGSBI-0050608.P002|5-HYDROXY-L-TRYPTOPHAN [USP-RS]|5-HYDROXYTRYPTOPHAN L-FORM [MI]|NCGC00015526-01|NCGC00091062-01|NCGC00091062-02|NCGC00091062-03|NCGC00091062-05|NCGC00091062-06|NCGC00091062-07|NCGC00091062-08|NCGC00091062-09|NCGC00091062-12|NCGC00258585-01|NCGC00261312-01|NCGC00601952-15|AC-24420|AS-12269|SMR001230815|ST048776|SY030569|DB-139862|TRYPTOPHAN IMPURITY D [EP IMPURITY]|EU-0100627|H0531|NS00002848|50H098|C00643|D07339|H 9772|L-5-Hydroxytryptophan (L-5-HTP; Oxitriptan)|EN300-1720935|F218377|Q238544|SR-01000075584|N-ACETYLTRYPTOPHAN IMPURITY D [EP IMPURITY]|SR-01000075584-1|S(+)-1-alpha-Amino-5-hydroxyindole-3-propionic acid|2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoicacid|Z2044741046|(2S)-2-amino-3-(5-hydroxy-1H-indol-3-yl)propanoicacid|CDAD59D9-D915-46DD-8029-48C808976B7C|5-Hydroxy-L-tryptophan, United States Pharmacopeia (USP) Reference Standard|L-5-Hydroxytryptophan(Tryptophan EP Impurity D)(Discontinued,See C4X-137324)|4PQ"
IOLOPRIDE,107995,,"InChI=1S/C15H21IN2O3/c1-3-18-8-4-5-10(18)9-17-15(20)13-12(21-2)7-6-11(16)14(13)19/h6-7,10,19H,3-5,8-9H2,1-2H3,(H,17,20)/t10-/m0/s1",CANPFCFJURGKAX-JTQLQIEISA-N,C15H21IN2O3,404.24,N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-3-iodo-6-methoxybenzamide,"84226-06-2|9J5D4ZN1JK|DTXSID401144235|(S)-N-(1-Ethyl-2-pyrrolidinyl)methyl-2-hydroxy-3-iodo-6-methoxybenzamide|Benzamide, N-(((2S)-1-ethyl-2-pyrrolidinyl)methyl)-2-hydroxy-3-iodo-6-methoxy-|Benzamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-2-hydroxy-3-iodo-6-methoxy-, (S)-|3-Iodo-2-hydroxy-6-methoxy-N-((1-ethyl-2-pyrrolidinyl)methyl)benzamide|N-[[(2S)-1-Ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-3-iodo-6-methoxybenzamide|N-(((2S)-1-ETHYL-2-PYRROLIDINYL)METHYL)-2-HYDROXY-3-IODO-6-METHOXYBENZAMIDE|RefChem:926513|DTXCID101575833|3-iodo-N-(1-ethyl-2-pyrrolidinyl)methyl-2-hydroxy-6-methoxybenzamide|N-((1-ethyl-2-pyrrolidinyl)methyl)-2-hydroxy-3-iodo-6-methoxybenzamide|IBZM|IOLOPRIDE|(S)-(-)-IBZM|S(-)-IBZM|CHEMBL267723|(S)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-hydroxy-3-iodo-6-methoxybenzamide|N-[[(2S)-1-ethylpyrrolidin-2-yl]methyl]-2-hydroxy-3-iodo-6-methoxybenzamide|N-(((2S)-1-ETHYLPYRROLIDIN-2-YL)METHYL)-2-HYDROXY-3-IODO-6-METHOXYBENZAMIDE|BRN 4322848|UNII-9J5D4ZN1JK|Lopac0_000665|SCHEMBL3811169|N-(1-Ethyl-pyrrolidin-2-ylmethyl)-2-hydroxy-3-iodo-6-methoxy-benzamide|SCHEMBL27218457|Benzamide,N-[[(2S)-1-ethyl-2-pyrrolidinyl]methyl]-2-hydroxy-3-iodo-6-methoxy-|BDBM50012961|CCG-204751|I-139|NS00120606|SR-01000075463|Q3801336|SR-01000075463-1|(-)-(S)-N-((1-ethylpyrrolidin-2-yl)methyl)-2-hydroxy-3-iodo-6-methoxybenzamide|(S)-(-)-3-IODO-2-HYDROXY-6-METHOXY-N-((1-ETHYL-2-PYRROLIDINYL)METHYL)BENZAMIDE|(s)-N-[(1-ethyl-2-pyrrolidinyl)]methyl-2-hydroxy-3-iodo-6-methoxybenzamide|N-((S)-1-Ethyl-pyrrolidin-2-ylmethyl)-2-hydroxy-3-iodo-6-methoxy-benzamide|N-(1-Ethyl-pyrrolidin-2-ylmethyl)-2-hydroxy-3-iodo-6-methoxy-benzamide (IBZM)|N-(1-Ethyl-pyrrolidin-2-ylmethyl)-2-hydroxy-3-iodo-6-methoxy-benzamide( (S)-(-)IBZM)"
SUMANIROLE,9818479,,"InChI=1S/C11H13N3O/c1-12-8-5-7-3-2-4-9-10(7)14(6-8)11(15)13-9/h2-4,8,12H,5-6H2,1H3,(H,13,15)/t8-/m1/s1",RKZSNTNMEFVBDT-MRVPVSSYSA-N,C11H13N3O,203.24,"(10R)-10-(methylamino)-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-2-one","Sumanirole|179386-43-7|PNU-95666|sumanirol|3E93IV1U45|DTXSID00870144|sumanirolum|RefChem:186777|DTXCID801509827|(10R)-10-(methylamino)-1,3-diazatricyclo(6.3.1.0^(4,12))dodeca-4,6,8(12)-trien-2-one|(R)-5-(Methylamino)-5,6-dihydro-1H-imidazo[4,5,1-ij]quinolin-2(4H)-one|Sumanirole [INN]|CHEMBL419792|(10R)-10-(methylamino)-1,3-diazatricyclo[6.3.1.04,12]dodeca-4,6,8(12)-trien-2-one|(R)-5,6-Dihydro-5-(methylamino)-4H-imidazo(4,5,1-ij)quinolin-2(1H)-one|UNII-3E93IV1U45|SUMANIROLE [WHO-DD]|SCHEMBL154412|GTPL3949|orb2815484|SCHEMBL30503038|CS-M0030|BDBM50056443|AKOS016007107|DB06477|NCGC00346440-01|NCGC00346440-04|HY-70081|NS00069668|Q7636953|BRD-K30485548-050-01-6|(R)-5-(methylamino)-5,6-dihydro-4H-imidazo[4,5,1-ij]quinolin-2(1H)-one|(R)-5-Methylamino-5,6-dihydro-1H,4H-imidazo[4,5,1-ij]quinolin-2-one|4H-Imidazo(4,5,1-ij)quinolin-2(1H)-one, 5,6-Dihydro-5-(methylamino)-, (R)-"
DESIPRAMINE HYDROCHLORIDE,65327,,"InChI=1S/C18H22N2.ClH/c1-19-13-6-14-20-17-9-4-2-7-15(17)11-12-16-8-3-5-10-18(16)20;/h2-5,7-10,19H,6,11-14H2,1H3;1H",XAEWZDYWZHIUCT-UHFFFAOYSA-N,C18H23ClN2,302.8,"3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine;hydrochloride","Desipramine hydrochloride|58-28-6|Desipramine Hcl|DMI hydrochloride|Desmethylimipramine chloride|Desipramine monohydrochloride|RMI 9,384A|Demethylimipramine hydrochloride|Imipraminedemethyl hydrochloride|Desmethylimipramine hydrochloride|Desimipramine, hydrochloride|NSC-114901|EX 4355|Desmethylimipramine monohydrochloride|G-35020|JB-8181|N-(gamma-Methylaminopropyl)iminodibenzyl hydrochloride|1Y58DO4MY1|CHEBI:4449|DTXSID9046942|RMI-9384A|10,11-Dihydro-5-(3-(methylamino)propyl)-5H-dibenz(b,f)azepine monohydrochloride|EX-4355|10,11-Dihydro-5-(3-(methylamino)propyl)-5H-dibenz(b,f)azepine hydrochloride|DTXCID7026942|NSC114901|3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methylpropan-1-amine hydrochloride|3-(10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N-methylpropan-1-amine hydrochloride|RefChem:585797|Hydrochloride, Desipramine|200-373-1|Norpramin|Pertofrane|Pertofran|Norpolake|Nortimil|MFCD00058108|JB 8181|C18H23ClN2|G 35020|58-28-6 (HCl)|MLS000028418|Desipramine.HCl|5H-Dibenz(b,f)azepine-5-propanamine, 10,11-dihydro-N-methyl-, monohydrochloride|GMI|Pertofrin|Petylyl|SMR000036827|[3-(10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]methylamine hydrochloride|CAS-58-28-6|SR-01000003060|NCGC00015340-02|EINECS 200-373-1|NSC 114901|iren|UNII-1Y58DO4MY1|Pertrofan|Norpramin (TN)|Prestwick_706|CPD000036827|Desipramine hydrochloride [USAN:USP:JAN]|Opera_ID_943|Epitope ID:224551|10,f]azepine hydrochloride|5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(methylamino)propyl)-, hydrochloride|CHEMBL1696|SCHEMBL41992|MLS000038088|MLS001056757|MLS002222246|MLS002548871|SPECTRUM1500227|REGID_for_CID_65327|10,f]azepine monohydrochloride|orb1310096|Desmethylimipramine-hydrochloride|PS02 - Imipramine/Desipramine|SCHEMBL29364790|HY-B1272R|GLXC-07253|HMS1569E07|HMS1920C22|HMS5084J08|Pharmakon1600-01500227|BCP29731|EX-A3768|HY-B1272|MSK10534|Tox21_110129|Tox21_500358|CCG-38909|Desipramine hydrochloride (JAN/USP)|NSC756719|s5485|DESIPRAMINE HYDROCHLORIDE [MI]|AKOS015994722|Tox21_110129_1|CS-8201|Desipramine (hydrochloride) (Standard)|DESIPRAMINE HYDROCHLORIDE [JAN]|KS-1296|LP00358|NC00681|NSC-756719|3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine hydrochloride|5H-Dibenz(b,f)azepine, 10,11-dihydro-5-(3-(methylamino)propyl)-, monohydrochloride|DESIPRAMINE HYDROCHLORIDE [USAN]|DESIPRAMINE HYDROCHLORIDE [MART.]|DESIPRAMINE HYDROCHLORIDE [VANDF]|NCGC00015340-14|NCGC00093794-01|NCGC00093794-02|NCGC00093794-03|NCGC00093794-04|NCGC00093794-05|NCGC00261043-01|AC-33180|DESIPRAMINE HYDROCHLORIDE [USP-RS]|DESIPRAMINE HYDROCHLORIDE [WHO-DD]|SY465205|DB-053177|WLN: T C676 BN&T&J B3M1 &GH|EU-0100358|NS00079001|A12663|D 3900|D00812|DESIPRAMINE HYDROCHLORIDE [EP MONOGRAPH]|DESIPRAMINE HYDROCHLORIDE [ORANGE BOOK]|DESIPRAMINE HYDROCHLORIDE [USP MONOGRAPH]|EN300-7373300|Desipramine hydrochloride, >=98% (TLC), powder|Desipramine.HCl, 1mg/ml in Methanol (as free base)|SR-01000003060-2|SR-01000003060-8|Q27106387|N-(.gamma.-Methylaminopropyl)iminodibenzyl hydrochloride|Z2106607416|5H-Dibenz[b, 10,11-dihydro-N-methyl-, monohydrochloride|5-(3-Methylaminopropyl)-5H-dibenz[b,f]azepine hydrochloride|Desipramine Hydrochloride 1.0 mg/ml in Methanol (as free base)|5H-Dibenz[b, 10,11-dihydro-5-[3-(methylamino)propyl]-, hydrochloride|5H-Dibenz[b, 10,11-dihydro-5-[3-(methylamino)propyl]-, monohydrochloride|Desipramine hydrochloride, European Pharmacopoeia (EP) Reference Standard|10,11-Dihydro-N-methyl-5H-dibenz[b,f]azepine-5-propanamine monohydrochloride|10,11-Dihydro-N-methyl-5H-dibenz[b,f]azepine-5-propanamine;G-35020;JB-8181|3-(10,11-Dihydro-5H-dibenzo[b,f]azepin-5-yl)-N-methyl-1-propanamine Hydrochloride|3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methyl-propan-1-amine;hydrochloride|3-(5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N-methylpropan-1-amine;hydrochloride|5H-DIBENZ[B,F]AZEPINE-5-PROPANAMINE, 10,11-DIHYDRO-N-METHYL-,MONOHCL|Desipramine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material|Desipramine hydrochloride, United States Pharmacopeia (USP) Reference Standard|(3-{2-azatricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,11,13-hexaen-2-yl}propyl)(methyl)amine hydrochloride"
"1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)",24802842,,"InChI=1S/C14H17Cl2NO/c1-18-9-13-7-14(13,4-5-17-8-13)10-2-3-11(15)12(16)6-10/h2-3,6,17H,4-5,7-9H2,1H3/t13-,14-/m1/s1",ICXJGCSEMJXNQF-ZIAGYGMSSA-N,C14H17Cl2NO,286.2,"(1R,6S)-6-(3,4-dichlorophenyl)-1-(methoxymethyl)-3-azabicyclo[4.1.0]heptane","SCHEMBL3194096|CHEMBL1173532|BDBM50322698|1-(3,4-DICHLOROPHENYL)-6-(METHOXYMETHYL)-3-AZABICYCLO[4.1.0]HEPTANE (ENANTIOMERIC MIX)|PD178887|rel-1-(3,4-dichlorophenyl)-6-(methoxymethyl)-3-azabicyclo[4.1.0]heptane"
GW-274150,9797017,,"InChI=1S/C8H17N3O2S/c1-6(9)11-3-5-14-4-2-7(10)8(12)13/h7H,2-5,10H2,1H3,(H2,9,11)(H,12,13)/t7-/m0/s1",MOLOJNHYNHBPCW-ZETCQYMHSA-N,C8H17N3O2S,219.31,(2S)-2-amino-4-[2-(1-aminoethylideneamino)ethylsulfanyl]butanoic acid,"GW274150|210354-22-6|GW-274150|L-Homocysteine, S-(2-((1-iminoethyl)amino)ethyl)-|0ZZF1V8G63|CHEMBL114551|(2S)-2-amino-4-[2-(1-aminoethylideneamino)ethylsulfanyl]butanoic acid|(2S)-2-amino-4-((2-ethanimidamidoethyl)sulfanyl)butanoic acid|(2S)-2-AMINO-4-[(2-ETHANIMIDAMIDOETHYL)SULFANYL]BUTANOIC ACID|RefChem:1098212|UNII-0ZZF1V8G63|SCHEMBL120693|GTPL9849|orb1709511|SCHEMBL26908440|EX-A7835|BDBM50086467|AKOS030526714|CS-5419|DB12237|DA-63978|HY-12119|NS00068789|[2-[(1-iminoethyl) amino]ethyl]-L-homocysteine|S-(2-((1-Iminoethyl)amino)ethyl)-L-homocysteine|Q27251084|(S)-4-(2-Acetimidoylamino-ethylsulfanyl)-2-amino-butyric acid|(2S)-2-amino-4-({2-[(1-aminoethylidene)amino]ethyl}sulfanyl)butanoic acid"
ABIRATERONE,132971,,"InChI=1S/C24H31NO/c1-23-11-9-18(26)14-17(23)5-6-19-21-8-7-20(16-4-3-13-25-15-16)24(21,2)12-10-22(19)23/h3-5,7,13,15,18-19,21-22,26H,6,8-12,14H2,1-2H3/t18-,19-,21-,22-,23-,24+/m0/s1",GZOSMCIZMLWJML-VJLLXTKPSA-N,C24H31NO,349.5,"(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol","Abiraterone|154229-19-3|CB 7598|CB-7598|17-(3-Pyridyl)androsta-5,16-dien-3beta-ol|CB7598|Abiraterona|CHEBI:68642|G819A456D0|NSC-741232|(3beta)-17-(pyridin-3-yl)androsta-5,16-dien-3-ol|Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3beta)-|DTXSID80879993|17-(pyridin-3-yl)androsta-5,16-dien-3beta-ol|(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol|abirateronum|(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-pyridin-3-yl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta(a)phenanthren-3-ol|RefChem:57133|L02BX03|DTXCID501021626|(3beta)-17-(3-pyridinyl)-androsta-5,16-dien-3-ol|Abiraterone (CB-7598)|MFCD00924100|CHEMBL254328|(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol|154229-19-3 (Abiraterone)|17-(3-Pyridyl)androsta-5,16-dien-3.beta.-ol|(1S,2R,5S,10R,11S,15S)-2,15-dimethyl-14-(pyridin-3-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-7,13-dien-5-ol|(3-beta)-17-(3-Pyridinyl)-androsta-5,16-dien-3-ol|(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(pyridin-3-yl)-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol.|Abiraterone [INN:BAN]|UNII-G819A456D0|Abiraterone; CB 7598; (3beta)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol; 17-(3-Pyridinyl)-androsta-5,16-dien-3beta-ol|Androsta-5,16-dien-3-ol, 17-(3-pyridinyl)-, (3b)-|Abiraterone (Standard)|ABIRATERONE [MI]|ABIRATERONE [INN]|ABIRATERONE [VANDF]|CB 7630 [as acetate]|SCHEMBL61108|ABIRATERONE [WHO-DD]|MLS006010235|US9487554, Abiraterone|GTPL6745|orb1300971|Abiraterone - Bio-X trade mark|SCHEMBL29359971|BDBM25458|EX-A106|GZOSMCIZMLWJML-VJLLXTKPSA-N|ABIRATERONE [USP IMPURITY]|HY-70013R|NSC749226|s1123|AKOS005146525|CS-0156|DB05812|ES-0045|FA16899|NSC 741232|NSC-749226|US9611270, Example 5, abiraterone|(3S,8R,9S,10R,13S,14S)-10,13-dimethyl-17-(3-pyridyl)-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol|AC-25764|BA164060|HY-70013|SMR002530050|A2868|17-(3-Pyridyl)androsta-5.16-dien-3beta-ol|EN300-311691|AB01274738-01|AB01274738_02|229A193|F222701|Q321431|SR-01000941584|(3b)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol|SR-01000941584-1|BRD-K50071428-001-01-7|BRD-K50071428-001-03-3|Z2301684603|17-(PYRIDIN-3-YL)ANDROSTA-5,16-DIEN-3.BETA.-OL|(3b)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol;CB 7598|CB 7598;(3b)-17-(3-Pyridinyl)androsta-5,16-dien-3-ol|ANDROSTA-5,16-DIEN-3-OL, 17-(3-PYRIDINYL)-(3.BETA.)-|(3aS,3bR,7S,9aR,9bS,11aS)-9a,11a-dimethyl-1-(pyridin-3-yl)-3H,3aH,3bH,4H,6H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-ol"
RANITIDINE,3001055,,"InChI=1S/C13H22N4O3S/c1-14-13(9-17(18)19)15-6-7-21-10-12-5-4-11(20-12)8-16(2)3/h4-5,9,14-15H,6-8,10H2,1-3H3/b13-9+",VMXUWOKSQNHOCA-UKTHLTGXSA-N,C13H22N4O3S,314.41,"(E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine","ranitidine|66357-35-5|Ranitidina|Ranitidinum|Ranitidin|Gavilast|CHEBI:8776|1,1-Ethenediamine, N-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-|DTXSID8045191|DTXCID00820068|1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-|n-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-n'-methyl-2-nitro-1,1-ethenediamine|(E)-1-N'-[2-[[5-[(dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine|NSC-757851|dimethyl[(5-{[(2-{[(E)-1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}furan-2-yl)methyl]amine|AH19065|(E)-1-N'-(2-((5-((dimethylamino)methyl)furan-2-yl)methylsulfanyl)ethyl)-1-N-methyl-2-nitroethene-1,1-diamine|dimethyl((5-(((2-(((E)-1-(methylamino)-2-nitroethenyl)amino)ethyl)sulfanyl)methyl)furan-2-yl)methyl)amine|n-(2-(((5-((dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-n'-methyl-2-nitro-1,1-ethenediamine|N-(2-((5-(dimethylaminomethyl)furan-2-yl)methylsulfanyl)ethyl)-N'-methyl-2-nitroethene-1,1-diamine|N-[2-[[5-(dimethylaminomethyl)furan-2-yl]methylsulfanyl]ethyl]-N'-methyl-2-nitroethene-1,1-diamine|RefChem:6195|Hydrochloride, Ranitidine|N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine|A02BA02|266-332-5|884KT10YB7|Ranitidine bismutrex|Raticina|Ranitidine Base|Ratic|Quantor|Rantidine|Gastrosedol|Microtid|Ptinolin|Ranidine|Raniogas|Ranitiget|Rantacid|Taural|Zantic|Duractin|Ulceranin|Weichilin|Xanidine|Zantadin|Achedos|Acidex|Atural|Axoban|Ezopta|Istomar|Logast|Mauran|Quicran|Radinat|Randin|Ranisen|Raniter|Sampep|Urantac|Verlost|Vesyca|Vizerul|Weidos|Zantab|Ranin|Ul-Pep|Raniberl|Ranitidine free base|Ranitidinum [INN-Latin]|Ranitidina [INN-Spanish]|MFCD00081180|82530-72-1|Zantac (TN)|66357-35-5 (free base)|NCGC00015876-07|Sostril|N-(2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethyl)-N'-methyl-2-nitroethene-1,1-diamine|Ranitidine [USAN:BAN:INN]|RND|Ranitidine (TN)|({5-[(2-{[(1E)-1-(methylamino)-2-nitrovinyl]amino}ethylthio)methyl](2-furyl)}m ethyl)dimethylamine|{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}[(E)-1-(methylamino)-2-nitroethenyl]amine|CAS-66357-35-5|Ranitidin 1A Pharma|Ranitidine (USAN/INN)|SR-01000075288|(E)-ranitidine|Ranitidine Impurity J|Tocris-1967|Lopac-R-101|Prestwick2_000201|Spectrum5_001189|SCHEMBL826|(E)-N-(2-(((5-((Dimethylamino)methyl)furan-2-yl)methyl)thio)ethyl)-N-methyl-2-nitroethene-1,1-diamine|CHEMBL512|Epitope ID:127515|Ranitidine HCL 1/2 Type|Lopac0_001073|BIDD:GT0179|SPECTRUM1501151|GTPL1234|Ranitidine - Bio-X trade mark|BDBM22893|CHEBI:92246|HMS501F22|N-[2-[[5-[(Dimethylamino)methyl]furfuryl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethenediamine|BDBM237183|DTXSID101112063|HMS1921L07|HMS2092H15|HMS3886A16|HMS5085I09|Pharmakon1600-01501151|Ranitidine (Form I And Form Ii)|BCP21325|HY-B0693|MSK10019|Tox21_110250|Tox21_302372|CCG-39025|NSC757851|s5662|SBB006527|STK619092|AKOS005552967|Tox21_110250_1|FR65147|KS-5230|SDCCGSBI-0051043.P004|IDI1_000440|NCGC00015876-01|NCGC00015876-02|NCGC00015876-03|NCGC00015876-04|NCGC00015876-05|NCGC00015876-06|NCGC00015876-08|NCGC00015876-09|NCGC00015876-11|NCGC00015876-16|NCGC00018108-01|NCGC00018108-02|NCGC00018108-03|NCGC00024387-02|NCGC00094913-01|NCGC00094913-02|NCGC00094913-03|NCGC00094913-04|NCGC00094913-05|NCGC00256269-01|(E)-N-{2-[({5-[(dimethylamino)methyl]-2-furyl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine|(E)-N-{2-[({5-[(dimethylamino)methyl]furan-2-yl}methyl)sulfanyl]ethyl}-N'-methyl-2-nitroethene-1,1-diamine|AC-12712|BR166204|ST050299|SY113430|SBI-0051043.P003|CAS-66357-59-3|CS-0009591|NS00000209|EN300-97101|RAN|D00422|D97790|AB00052223-10|AB00052223_11|AB00052223_12|357R355|L000504|SR-01000075288-3|BRD-K70505054-001-02-9|BRD-K70505054-003-11-6|BRD-K70505054-003-12-4|BRD-K70505054-003-13-2|Q21971328|N-[2-[[5-[(Dimethylamino)methyl]furfuryl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethylenediamine|(1E)-N-[2-[[[5-[(Dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-Na(2)-methyl-2-nitro-1,1-ethenediamine|(E)-N1'-[2-[[5-(dimethylaminomethyl)-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine|(E)-N1'-[2-[[5-[(dimethylamino)methyl]-2-furyl]methylsulfanyl]ethyl]-N1-methyl-2-nitro-ethene-1,1-diamine|1,1-Ethenediamine, N-[2-[[[5-[(dimethylamino)methyl]-2-furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-, (E)-|dimethyl[(5-{[(2-{[1-(methylamino)-2-nitroethenyl]amino}ethyl)sulfanyl]methyl}furan-2-yl)methyl]amine|N-[2-[[[5-[(Dimethylamino)methyl]-2 -furanyl]methyl]thio]ethyl]-N'-methyl-2-nitro-1,1-ethanediamine|N1'-[2-[[5-[(dimethylamino)methyl]-2-furanyl]methylthio]ethyl]-N1-methyl-2-nitroethene-1,1-diamine"
KETOCONAZOLE,47576,,"InChI=1S/C26H28Cl2N4O4/c1-19(33)31-10-12-32(13-11-31)21-3-5-22(6-4-21)34-15-23-16-35-26(36-23,17-30-9-8-29-18-30)24-7-2-20(27)14-25(24)28/h2-9,14,18,23H,10-13,15-17H2,1H3/t23-,26-/m1/s1",XMAYWYJOQHXEEK-ZEQKJWHPSA-N,C26H28Cl2N4O4,531.4,"1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone","ketoconazole|Nizoral|Panfungol|Ketoderm|65277-42-1|Fungarest|Fungoral|Ketoisdin|Ketozole|Extina|Orifungal M|Nizoral a-D|Ketoconazol|Xolegel|Ketoconazolum|1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]ethanone|R9400W927I|Piperazine, 1-acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-, cis-|J02AB02|R 41,400|R-41400|Piperazine, 1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-, cis-|R 41400|(+-)-cis-1-Acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine|NSC317629|NSC-317629|ketoconazolo|Podiatrole|Dandrazol|Dandrid|DTXCID301437106|Ketodan|Ketopine|Ketosidin|Nizorelle|Daktarin gold|Daktarin intensiv|CeraSoothe KET|Ketoconazole Foam|Suffusion TRIS|T8 Keto Flush|1-(4-(4-(((2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)ethan-1-one|1-(4-(4-(((2S,4R)-2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)ethanone|1-[4-(4-{[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethan-1-one|Antifungal Treatment|Keto-C-Tris FLUSH|Keto-C-Tris WIPES|Ketomax TRIS FLUSH|BlooSkim Anti Dandruff|RefChem:5932|Scalp Treatment Shampoo|KETOCONAZOLE Shampoo|Ketoconazole Cream, 2%|TrizUltra and Keto Flush|GlyTouCan:G57819FA|TrizUltra Plus Keto Flush|R41400|Frisco Antiseptic Ear Flush|NIZORAL ANTI-DANDRUFF|R41,400|VETRASEB CERADERM TRIS|1% ketoconazole anti dandruff|Forticept Antiseptic Ear Flush|Forticept Antiseptic Ear Wipes|Iristar Anti dandruff Shampoo.|Ketoconazole 2% and Urea 20%|CHEBI:47519|TAGRlD Scalp Treatment Shampoo.|D01AC08|G01AF11|MySimplePetLab Infected Ear Relief|POAGCI Ketoconazole VCP-KAD001|G57819FA|Ketoconazole 0.2% Medicated Wipes|Paw Science MEDICATED EAR FLUSH|1% Ketoconazole Antifungal Treatment|1% ketoconazole anti dandruff shampoo|lanimpress1%ketoconazoleantidandruffshampoo|Pureskin Scalp Protection anti dandruff shampoo|Pureskin Scalp Protection anti dandruff shampoo.|ANTIBACTERIAL and ANTIFUNGAL MEDICATED TRIS FLUSH|1-(4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)ethan-1-one|1-Acetyl-4-(4-(((2RS, 4SR)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine|265-667-4|Cis-1-Acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H-imidazole-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine|1-(4-(4-((2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)ethanone|79156-75-5|DTXSID7029879|Levoketoconazole|(-)-Ketoconazole|142128-57-2|Normocort|2S,4R Ketoconazole|2S,4R-Ketoconazole|COR-003|(2S,4R)-ketoconazole|COR003|Ketoconazole, (2S,4R)-|(-)-(2S,4R)-Ketoconazole|Levoketoconazole [USAN]|DIO-902|Kuric|2DJ8R0NT7K|CHEMBL295698|CHEBI:47518|C26H28Cl2N4O4|1-(4-(4-(((2S,4R)-2-((1H-imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)ethan-1-one|cis-1-Acetyl-4-[4-[[2-(2,4-dichlorophenyl)-2-(imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazine|1-acetyl-4-(4-{[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine|Ethanone, 1-(4-(4-(((2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)-|Brizoral|Sebazole|Teryzolin|Terzolin|Onofin K|NSC 317629|1-(4-(4-(((2S,4R)-2-((1H-Imidazol-1-yl)methyl)-2-(2,4-dichlorophenyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)ethanone|Ketoconazol [INN-Spanish]|Ketoconazolum [INN-Latin]|(+-)-cis-1-acetyl-4-(p-((2-(2,4-dichlorophenyl)-2-(imidazol-1- ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazine|UNII-2DJ8R0NT7K|levoketoconazol|Recorlev|(+)-(2R,4S)-Ketoconazole|UNII-R9400W927I|HSDB 7447|NCGC00016907-01|Recorlev (TN)|1-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethan-1-one|EINECS 265-667-4|Nizoral (TN)|Xolegel (TN)|CAS-65277-42-1|KW-1414|BRN 4303081|M02048|Ketoconazole [USAN:USP:INN:BAN:JAN]|KETOCONAZOLE [MI]|Lopac-K-1003|KETOCONAZOLE [INN]|KETOCONAZOLE [JAN]|KETOCONAZOLE [HSDB]|KETOCONAZOLE [USAN]|Ketoconazole (JP18/USP)|KETOCONAZOLE [VANDF]|SCHEMBL41473|KETOCONAZOLE [MART.]|Levoketoconazole (USAN/INN)|MLS006010227|KETOCONAZOLE [USP-RS]|KETOCONAZOLE [WHO-DD]|LEVOKETOCONAZOLE [INN]|CORT-001|orb1708112|SCHEMBL29588034|BDBM31768|GTPL11829|HY-B0105B|DTXSID60161949|LEVOKETOCONAZOLE [WHO-DD]|XMAYWYJOQHXEEK-ZEQKJWHPSA-N|KETOCONAZOLE [EP IMPURITY]|KETOCONAZOLE [ORANGE BOOK]|KETOCONAZOLE [EP MONOGRAPH]|KETOCONAZOLE [USP IMPURITY]|KETOCONAZOLE [USP MONOGRAPH]|KETOCONAZOLUM [WHO-IP LATIN]|AKOS022172422|DB05667|DS-6676|NCGC00015577-01|NCGC00016907-02|NCGC00016907-03|NCGC00016907-04|NCGC00161836-01|NCGC00161836-02|DA-68953|SMR001819845|CS-0016830|NS00075575|D00351|D10950|G14246|EN300-1721056|Q27120779|Z3219503092|(+/-)-CIS-1-ACETYL-4-(P-((2-(2,4-DICHLOROPHENYL)-2-(IMIDAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)PIPERAZINE|(-)-Ketoconazole; Ethanone, 1-[4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]- (ACI); 1-[4-[4-[[(2S,4R)-2-(2,4-Dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]etha|(2S,4R)-1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine|72093-26-6|cis-1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H- imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-ketoconazol|Ethanone, 1-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]-, rel-|Piperazine, (-)-1-acetyl-4-[4-[[(2S,4R)-2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-|piperazine, 1-acetyl-4-(4-((2-(2,4-dichlorophenyl)-2-(1H- imidazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-, cis-|rac-1-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-[(1H-imidazol-1-yl)methyl]-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]ethan-1-one"
MECAMYLAMINE,4032,,"InChI=1S/C11H21N/c1-10(2)8-5-6-9(7-8)11(10,3)12-4/h8-9,12H,5-7H2,1-4H3",IMYZQPCYWPFTAG-UHFFFAOYSA-N,C11H21N,167.29,"N,2,3,3-tetramethylbicyclo[2.2.1]heptan-2-amine","mecamylamine|Versamine|Mecamilamina|60-40-2|Mecamylaminum|N,2,3,3-Tetramethylbicyclo[2.2.1]heptan-2-amine|DTXSID0023240|Bicyclo(2.2.1)heptan-2-amine, N,2,3,3-tetramethyl-|DTXCID903240|Bicyclo[2.2.1]heptan-2-amine, N,2,3,3-tetramethyl-|N,2,3,3-tetramethylbicyclo(2.2.1)heptan-2-amine|RefChem:56912|C02BB01|200-476-1|(1RS,2SR,4SR)-N,2,3,3-Tetramethylbicyclo(2.2.1)heptan-2-amine|6EE945D3OK|N,2,3,3-Tetramethyl-2-norbornanamine|Mecamine|Revertina|Mekamine|2-Methylaminoisocamphane|Mevasine|3-Methylaminoisocamphane|N-Methyl-2-isocamphanamine|2-Methylamino-2,3,3-trimethylnorbornane|N,2,3,3-Tetramethyl-2-norbornamine|N,2,3,3-Tetramethyl-2-norcamphanamine|2-Norbornanamine, N,2,3,3-tetramethyl-|CHEBI:6706|CHEMBL267936|NCGC00015703-03|Mecamilamina [DCIT]|Mecamilamina [Italian]|Mecamylamine [INN:BAN]|Mecamylaminum [INN-Latin]|3-Methylaminoisokamfan|3-Methylaminoisokamfan [Czech]|methyl(2,3,3-trimethylbicyclo[2.2.1]hept-2-yl)amine hydrochloride|CAS-60-40-2|EINECS 200-476-1|3-beta-Methylamino-2,2,3-trimethylbicyclo(2.2.1)heptane|Inversine (Salt/Mix)|Spectrum_000304|SpecPlus_000736|Prestwick0_001111|Prestwick1_001111|Prestwick2_001111|Prestwick3_001111|Spectrum3_000736|Spectrum4_001257|Spectrum5_001616|Lopac0_000841|SCHEMBL34252|BSPBio_001242|BSPBio_002292|KBioGR_001814|KBioSS_000784|DivK1c_006832|SPBio_003111|BPBio1_001367|GTPL3990|orb1740461|HY-B1395A|KBio1_001776|KBio2_000784|KBio2_003352|KBio2_005920|KBio3_001512|HMS3604D12|ALBB-023410|Tox21_110198|BDBM50061565|AKOS003662515|Tox21_110198_1|CCG-204924|DB00657|SDCCGSBI-0050817.P005|NCGC00015703-02|NCGC00015703-04|NCGC00015703-06|NCGC00015703-12|NCGC00162272-01|NCGC00162272-02|DA-75487|ST088032|SBI-0050817.P004|AB00053764|CS-0013657|NS00034351|C07511|EN300-267821|methyl(2,3,3-trimethyltrinorbornan-2-yl)amine|AB00053764_03|Q3332124|BRD-A20119038-001-01-5|BRD-A20119038-003-01-1|BRD-A20119038-003-07-8|N,2,3,3-Tetramethylbicyclo[2.2.1]heptan-2-amine #|methyl(2,3,3-trimethylbicyclo[2.2.1]hept-2-yl)amine|Methyl-(2,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-amine|(+)Methyl-(2,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-amine|(-)Methyl-(2,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-amine|3-.beta.-Methylamino-2,2,3-trimethylbicyclo(2.2.1)heptane|(+/-)Methyl-(2,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-amine|Methyl-(2,3,3-trimethyl-bicyclo[2.2.1]hept-2-yl)-amine(Mecamylamine)"
FADROZOLE,59693,,"InChI=1S/C14H13N3/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14/h4-7,9-10,14H,1-3H2",CLPFFLWZZBQMAO-UHFFFAOYSA-N,C14H13N3,223.27,"4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile","FADROZOLE|102676-47-1|4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile|Fadrozol|Fadrozolum|Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-|H3988M64PU|DTXSID5034141|Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-|CGS16949A|CGS020286A|4-(5,6,7,8-Tetrahydroimidazo(1,5-a)pyridin-5-yl)benzonitrile|4-(5,6,7,8-tetrahydroimidazo(5,1-f)pyridin-5-yl)benzonitrile|4-(5,6,7,8-tetrahydroimidazo[5,1-f]pyridin-5-yl)benzonitrile|RefChem:597144|FAD286|DTXCID3014141|CGS-020286A|FAD-286|CGS-16949A|Fadrozole [INN]|MFCD02313480|CHEMBL9298|FAD 286A|Fadrozole (INN)|R-FADROZOLE|4-{5H,6H,7H,8H-imidazo[1,5-a]pyridin-5-yl}benzonitrile|Fadrozol [INN-Spanish]|Fadrozolum [INN-Latin]|4-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile;4-(5,6,7,8-Tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile|UNII-H3988M64PU|CCRIS 8823|FADRAZOLE|5-p-cyanophenyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine|FADROZOLE [MI]|FADROZOLE [WHO-DD]|Fadrozole (CGS16949A)|SCHEMBL25491|MLS006010399|BDBM8611|GTPL8311|orb1299988|CHEBI:94355|FAD 286|HMS5086P19|CEA67647|CGS 16949 A|EX-A2624|Benzonitrile,4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-|HY-14247A|s9519|AKOS015904403|CS-7759|NCGC00390223-01|AC-35856|AS-76077|SMR004701403|NS00008735|D07940|EN300-114143|W18624|SR-01000945263|Q5429279|SR-01000945263-1|BRD-A25619068-003-01-8|BRD-A25619068-003-03-4|Z1430598234|5-(4-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine|5-(p-Cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]-pyridine|5-(p-Cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine|5-(p-Cyanophenyl)-5,6,7,8-tetrahydroimidazol[1,5-a]pyridine|5-(p-cyanophenyl)5,6,7,8-tetrahydroimidazo[1,5-a]pyridine|(+)-5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine|(+/-)-P-(5,6,7,8-TETRAHYDROIMIDAZO(1,5-A)PYRIDIN-5-YL)BENZONITRILE|BENZONITRILE, 4-(5,6,7,8-TETRAHYDROIMIDAZO(1,5-A)PYRIDIN-5-YL)-, (+/-)-"
GALETERONE,11188409,,"InChI=1S/C26H32N2O/c1-25-13-11-18(29)15-17(25)7-8-19-20-9-10-24(26(20,2)14-12-21(19)25)28-16-27-22-5-3-4-6-23(22)28/h3-7,10,16,18-21,29H,8-9,11-15H2,1-2H3/t18-,19-,20-,21-,25-,26-/m0/s1",PAFKTGFSEFKSQG-PAASFTFBSA-N,C26H32N2O,388.5,"(3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol","Galeterone|851983-85-2|TOK-001|VN/124-1|TOK 001|galeterona|VN/124|WA33E149SW|(3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta[a]phenanthren-3-ol|VN 124|VN-124|3-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|DTXSID101025602|17-(1H-Benzimidazol-1-yl)androsta-5,16-dien-3beta-ol|Androsta-5,16-dien-3-ol, 17-(1H-benzimidazol-1-yl)-, (3beta)-|galeteronum|(3S,8R,9S,10R,13S,14S)-17-(benzimidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15-decahydro-1H-cyclopenta(a)phenanthren-3-ol|RefChem:142163|DTXCID801509865|Specific Androgen Receptor Modulator/CYP17 Lyase Inhibitor TOK-001|(1S,2R,5S,10R,11S,15S)-14-(1H-1,3-benzodiazol-1-yl)-2,15-dimethyltetracyclo(8.7.0.02,?.011,1?)heptadeca-7,13-dien-5-ol|Galaterone|Galeterone [USAN]|Tok-001 (galeterone)|MFCD16660907|Galeterone (USAN)|(3S,8R,9S,10R,13S,14S)-17-(1H-Benzo[d]imidazol-1-yl)-10,13-dimethyl-2,3,4,7,8,9,10,11,12,13,14,15-dodecahydro-1H-cyclopenta[a]phenanthren-3-ol|Galeterone [USAN:INN]|UNII-WA33E149SW|TOK-001;VN-124-1|Galaterone;TOK 001|VN-124-1|TOK-001(Galeterone)|TOK-001; Galeterone|GALETERONE [INN]|TOK-001(Galeterone)?|GALETERONE [WHO-DD]|SCHEMBL939234|GTPL8638|orb1300706|CHEMBL2105738|Galeterone, >=98% (HPLC)|SCHEMBL29350724|CHEBI:177536|PAFKTGFSEFKSQG-PAASFTFBSA-N|3beta-hydroxy-17-(1H-benzimidazole-1-yl)androsta-5,16-diene|BCPP000040|BCP02827|EX-A1025|BDBM50435990|AKOS005146524|CS-0334|DB12415|FT65187|AC-26549|AS-56204|HY-70006|NS00070343|D10125|Q5518498|VN/124-1;TOK-001;VN 124;TOK001;TOK 001|3beta-Hydroxy-17-(1H-benzimidazol-1-yl)-androsta-5,16-diene|3beta-Hydroxy-17-(1H-benzimidazol-1-yl)androsta-5,16-diene|ANDROSTA-5,16-DIEN-3-OL, 17-(1H-BENZIMIDAZOL-1-YL)-, (3.BETA.)-"
ADENOSINE,60961,,"InChI=1S/C10H13N5O4/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(18)6(17)4(1-16)19-10/h2-4,6-7,10,16-18H,1H2,(H2,11,12,13)/t4-,6-,7-,10-/m1/s1",OIRDTQYFTABQOQ-KQYNXXCUSA-N,C10H13N5O4,267.24,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol","adenosine|58-61-7|Adenocard|Adenoscan|Adenine riboside|beta-D-Adenosine|Nucleocardyl|Adenosin|Sandesin|Boniton|Myocol|Adenine nucleoside|Adenocor|beta-Adenosine|9-beta-D-Ribofuranosyl-9H-purin-6-amine|9-beta-D-Ribofuranosyladenine|9-beta-D-Ribofuranosidoadenine|USAF CB-10|Ade-Rib|9beta-D-Ribofuranosyladenine|6-Amino-9-beta-D-ribofuranosyl-9H-purine|SR 96225|(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|6-Amino-9beta-D-ribofuranosyl-9H-purine|CHEBI:16335|Adenin riboside|DTXSID1022558|SR-96225|K72T3FS567|NSC-7652|DTXCID902558|NSC7652|NSC627048|Primerose Snail|Anti aging|CellExosome ST|Anti aging ample|Applicell Miracle|Stem Cell Renew|Limulus Nourishing|Biotoc Regen Peel|Biotoc Regen Serum|Adenosine Face Mask|CellExosome HE SR|B.S.c Ampul|Biotoc Regen Ampoule|CAVIALLCRYSTAL|U-max Wrinkle Serum|Applicell Perfect Eye|Tissen ICM 10|Tissen NF 10|SMART RECOVERY|YENAAN JINAEK|JUVEHEAL A Ampoule|ARMIYOU HYDROGEN|CELLPEDIA ATADIA|RefChem:5518|CONJU Princess Lifting|JDEW GREEN MOIST|Stem Cell Wrinkle Serum|Tenue 24k gold ampoule|Applicell Essential Toner|Applicell Intensive Serum|AN ADC SP F|INTOMEDI Amplance Hydro|Applicell Timeless Ampoule|purifying skin balancecream|MUSTUS NONI AMPOULE|PEPPLUS WRINKLE EYE|YENAAN JINAEK TONER|Return 10 MTSSOLUTION|MIZON PEPTIDE 500|FILL ME MICRO NEEDLE|adenosine injection, solution|Shieldlife Collagen Ion Mask|ARMIYOU HYDROGEN SERUM|ARMIYOU HYDROGEN TONER|Tosowoong Mens Booster Repair|INTOMEDI Amplance HydroCream|JDEW GREEN MOIST TONER|Dr.Different 131 Moisturizer|LANBELLE Hydrating Duo Serum|by Selected Recovering Almighty|by selected reinforce day serum|Callicos CellAwake Mask peptide|Dermall Matrix Quick Vitalizing|Mamachi Moms Stretch Mark Cream|DPC COLLAGEN BOOSTER MASK|INTOMEDI FIRST AMPOULE EGF|JEUNESSENG EYE BAG REMOVAL|Madeca Rejuvenating Calming Serum|Niveola 3d Animal Cat Mask Pack|Niveola 3d Animal Dog Mask Pack|SMART RECOVERY FIRMING EYE|by selected anti wrinkle day serum|Return 10 TIME LOCK PROGRAM|RUBELLI BEAUTY FACE PREMIUM|MIZON HYALURONIC ACID 100|SFERANGS COLLAGEN RECHARGING|All Nations A D C Special Program|CAVIALL PERFECT REPAIR SERUM|MEDI HYDRO DP B TOX AMPOULE|MULTI FUNCTION SLEEPING PACK|Nmc Staypot Double Programing Cream|SMART RECOVERY FIRMING SERUM|Super Amazing Revolution For Secret|DR. GLODERM TABRX WRINKLETOX|INNER SAVE Feminine Cleansing Mist|MIZON PEPTIDE AMPOULE CREA M|9tails Premium Wrinkle Power Lifting|AQUATO INTENSIVE MOISTURECREAM|Dr.Different CEQ Anti Oxidant Serum|rootree Golden Tree Prestige Empress|ARILAC Anti Wrinkle Mask Sheet Pack|Dermall Matrix Neck Dermal care Mask|Edge Cutimal Tiger Anti-Wrinkle Mask|Mioggi Healing Effector Rx Collagenic|SMART RECOVERY HYDRATING TONER|THE SKIN HOUSE Wrinkle SystemCream|THE SKINHOUSE WRINKLE COLLAGEN|THE SKINHOUSE WRINKLE EYE PLUS|INTOMEDI FIRST AMPOULE PLACENTA|LOB20 CELLPEDIA ATADIA AMPOULE|Dermall Matrix Facial Dermal care Mask|LOVELY GERANIUM AROMATHERAPY MASK|SFERANGS COLLAGEN RECHARGINGCREAM|SFERANGS COLLAGEN SYNERGY AMPOULE|THE SKIN HOUSE Wrinkle Collagen Toner|THE SKIN HOUSE Wrinkle System Essence|THE SKINHOUSE GREEN TEA COLLAGEN|YOMA AMPOULE PLUS ALOE MASK PACK|DARYOMI STEMCELL LIFT EYE PREMIUM|MIZON SNAIL RECOVERY GE L CREA M|ReOrganic Womans Inner Care Essence Gel|SFERANGS COLLAGEN RECHARGING SERUM|SFERANGS COLLAGEN RECHARGING TONER|Super Amazing Revolution For MultiLotion|THE SKINHOUSE BLACK SNAIL WRINKLE|YOMA AMPOULE PLUS SNAIL MASK PACK|Antibe Super Hydrating Moisturizing Cream|CONGJU PRINCESS LIFTING MASK SHEET|Dermall Matrix Eye zone Dermal care Mask|MIZON SNAIL REPAIR INTENSIVE TONER|THE SKIN HOUSE Wrinkle CollagenEmulsion|THE SKIN HOUSE Wrinkle System EyeCream|THE SKIN HOUSE Wrinkle Snail SystemCream|YOMA AMPOULE PLUS GINSENG MASK PACK|DR. GLODERM TIME TO WRINKLETOX MASK|MIZON SNAIL REPAIR INTENSIVE ESSENCE|rootree Golden Tree Royal Resplendent Serum|YOMA AMPOULE PLUS COLLAGEN MASK PACK|CAVIALL Superior Caviar Nourinkle Mask SET|LOVELY GERANIUM AROMATHERAPY MASK 30g|MIZON ALL IN ONE SNAIL REPAIR CREA M|THE SKINHOUSE REAL SNAIL WRINKLE FREE|Adenosine Injection, 6mg/2mL (3mg/mL) Vial|Mioggi Magic Advanced Skin Essential Activator|MIZON COLLAGEN POWER FIRMING EYE CREA M|Super Amazing Revolution For The Youth Ampoule|THE SKIN HOUSE WRINKLE COLLAGEN AMPOULE|THE SKINHOUSE WRINKLE COLLAGEN FREE SPOT|TRIPLE CROWN CORDYCEPS SUPER ESSENCE MASK|VECLAT OU C.GNATURE 3 Lighty Blending Ampoule|VECLAT OU C.GNATURE 3 Power Radiant Face Mask|MIZON COLLAGEN POWER FIRMING ENRICHED CREA M|JDEW HOMME ALL FOR YOU AQUA MARINE ALL IN ONE|MUSTUS DAILY HARVEST SQUEEZE LIFT UP MASK PACK|rootree Treetherapy Rejuvenating Eye and Neck Treatment|Mefactory 3Step Piggy Nose Pore Strip Step 01 Pore Opening Sheet|200-389-9|607-743-5|Adenosin [German]|(2R,3R,4S,5R)-2-(6-Aminopurin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|Caswell No. 010B|MFCD00005752|Adenosine [USAN:BAN]|beta-D-Ribofuranoside, adenine-9|(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol|Quinquefolan B|3H-adenosine|NSC 7652|Dehydran 240|9-.beta.-d-Ribofuranosyladenine|Adenosine (Adenocard)|AI3-52413|9H-Purin-6-amine, 9beta-D-ribofuranosyl-|CHEMBL477|Adenine riboside;D-Adenosine|beta-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-|adenine-D-ribose|CCRIS 2557|Adenine-9-beta-D-ribofuranoside|NCGC00023673-05|Pallacor|41547-82-4|109767-06-8|133248-01-8|D-Adenosine|.beta.-D-Adenosine|(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol|CAS-58-61-7|Adenocard (TN)|Adenoscan (TN)|SMR000058216|MEDR-640|Adenosine (JAN/USP)|SR-05000001981|EINECS 200-389-9|Adenine-beta-D-arabinofuranoside|NSC 627048|Adenogesic|Adenosine [USAN:USP:BAN]|UNII-K72T3FS567|.beta.-D-Ribofuranoside, adenine-9|9-.alpha.-D-Arabinofuranosyladenine|b-D-Adenosine|HSDB 7774|SUN-Y4001|N6-Methylado|1dgm|1odi|2fqy|2ydo|3axz|4cki|4ckj|beta-delta-Adenosine|[U-14C]adenosine|6-Amino-9.beta.-D-ribofuranosyl-9H-purine|Adenosine (Standard)|Bucladesine Impurity 4|2gl0|3ay0|4pd9|Adenosine, >=99%|ADENOSINE [JAN]|ADENOSINE [MI]|6-Amino-9-.beta.-ribofuranosyl-9H-purine|ADENOSINE [HSDB]|ADENOSINE [USAN]|Spectrum2_001257|Spectrum3_000288|ADENOSINE [VANDF]|cid_191|SCHEMBL731|ADENOSINE [MART.]|bmse000061|bmse000996|Epitope ID:140947|ADENOSINE [USP-RS]|ADENOSINE [WHO-DD]|4-Aminopyrazolo[3,4-d]pyrimidine ribonucleoside|9-ss-D-Ribofuranosyladenine|D-Adenosine;Adenine riboside|BSPBio_001796|.beta.-D-Ribofuranose, 1-(6-amino-9H-purin-9-yl)-1-deoxy-|cid_60961|MLS000069638|MLS002153227|MLS006010946|SPECTRUM1500107|Adenine-9-ss-D-ribofuranoside|REGID_for_CID_60961|SPBio_001194|adenine-9beta-D-Ribofuranoside|GTPL2844|SCHEMBL3366600|SCHEMBL9789587|9beta-delta-Ribofuranosyladenine|ADENOSINE [EP IMPURITY]|ADENOSINE [ORANGE BOOK]|ADENOSINE [EP MONOGRAPH]|SCHEMBL10361572|SCHEMBL16057823|SCHEMBL29483394|SCHEMBL29840889|BDBM14487|HY-B0228R|KBio3_001296|9-beta-delta-Ribofuranosyladenine|ADENOSINE [USP MONOGRAPH]|EA6C60C2-6AFB-4264-A2F0-541373DB950E|MSK6809|9-.beta.-D-Ribofuranosidoadenine|9-beta-delta-Ribofuranosidoadenine|adenine-9beta-delta-Ribofuranoside|Bio1_000437|Bio1_000926|Bio1_001415|HMS1920A13|HMS2091G13|HMS2235E24|HMS3884O04|Pharmakon1600-01500107|ALBB-032827|9-beta-delta-Arabinofuranosyladenine|Tox21_110891|AC7861|CCG-38824|HB2843|NSC755857|s1647|AKOS015888594|Tox21_110891_1|AC-8229|DB00640|NA01639|NA31619|NSC-755857|SDCCGMLS-0003108.P003|9beta-D-ribofuranosyl-9H-Purin-6-amine|NCGC00023673-03|NCGC00023673-04|NCGC00023673-06|NCGC00023673-07|NCGC00023673-10|NCGC00023673-20|NCGC00178869-03|AC-27494|AS-12664|BP-58619|NA106350|ST009496|SY001357|Adenosine, Vetec(TM) reagent grade, 98%|SBI-0206673.P002|9beta-delta-ribofuranosyl-9H-Purin-6-amine|DB-022408|6-Amino-9beta-delta-ribofuranosyl-9H-purine|9-.beta.-D-Ribofuranosyl-9H-purin-6-amine|9-beta-delta-Ribofuranosyl-9H-purin-6-amine|A0152|NS00098759|Adenosine - Endotoxin level below 100 EU/g|9H-Purin-6-amine, 9-.beta.-d-ribofuranosyl-|Adenosine - Endotoxin level below 1000 EU/g|C00212|D00045|EN300-100931|AB00384349-11|AB00384349_13|AB00384349_14|Adenosine, BioReagent, suitable for cell culture|F093333|Q190012|6-AMINO-9-.BETA.-D-RIBOFURANOSYL-9H-PURINE|SR-05000001981-1|SR-05000001981-2|BRD-K01577834-001-15-1|Z1341543331|1-(6-amino-9H-purin-9-yl)-1-deoxy-beta-D-Ribofuranose|Adenosine, European Pharmacopoeia (EP) Reference Standard|Formycin A, from Streptomyces kaniharaensis, >=98% (HPLC)|1-(6-amino-9H-purin-9-yl)-1-deoxy-beta-delta-Ribofuranose|Adenosine, United States Pharmacopeia (USP) Reference Standard|Adenosine, Pharmaceutical Secondary Standard; Certified Reference Material|142796-17-6"
APADENOSON,9805430,,"InChI=1S/C23H30N6O6/c1-3-25-21(32)18-16(30)17(31)22(35-18)29-11-26-15-19(24)27-14(28-20(15)29)6-4-5-12-7-9-13(10-8-12)23(33)34-2/h11-13,16-18,22,30-31H,3,5,7-10H2,1-2H3,(H,25,32)(H2,24,27,28)/t12?,13?,16-,17+,18-,22+/m0/s1",FLEVIENZILQUKB-DMJMAAGCSA-N,C23H30N6O6,486.5,"methyl 4-[3-[6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]prop-2-ynyl]cyclohexane-1-carboxylate","Apadenoson|250386-15-3|Stedivaze|ATL 146e|DWH 146e|DWH-146e|BMS068645|Apadenoson [USAN:INN]|UNII-BTS1Y6777M|BMS-068645|BTS1Y6777M|BMS 068645|CHEMBL1950649|ATL-146e|Apadenoson (USAN)|Apadenoson [USAN]|methyl 4-[3-[6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxyoxolan-2-yl]purin-2-yl]prop-2-ynyl]cyclohexane-1-carboxylate|methyl  trans-4-(3-(6-amino-9-(N-ethyl-b-D-ribofuranosyluronamide)-9H-purin-2-yl)prop-2-ynyl)cyclohexanecarboxylate|Methyl trans-4-(3-(6-amino-9-((2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl)prop-2-yn-1-yl)cyclohexane-1-carboxylate|ATL146e|BMS 068645; DWH 146e|APADENOSON [INN]|APADENOSON [WHO-DD]|GTPL3290|orb1701188|SCHEMBL1002620|SCHEMBL29369998|SCHEMBL29379112|FLEVIENZILQUKB-DMJMAAGCSA-N|BDBM50364063|EX-A11934|AKOS040747831|DB05009|4-(3-(6-amino-9-(5-ethylcarbamoyl-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl)prop-2-ynyl)cyclohexanecarboxylic acid methyl ester|NS00073695|D03212|Q27074477|CYCLOHEXANECARBOXYLIC ACID, 4-(3(6-AMINO-9-(N-ETHYL-.BETA.-D-RIBOFURANURONAMIDOSYL)-9H-PURIN-2-YL)-2-PROPNYL)-, METHYL ESTER, TRANS-|Cyclohexanecarboxylic acid, 4-(3-(6-amino-9-(N-ethyl-b-d-ribofuranuronamidosyl)-9H-purin-2-yl)-2-propynyl)-,  methyl  ester, trans-|methyl (1R,4r)-4-(3-(6-amino-9-((2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxytetrahydrofuran-2-yl)-9H-purin-2-yl)prop-2-yn-1-yl)cyclohexane-1-carboxylate|METHYL TRANS-4-(3(6-AMINO-9-(N-ETHYL-.BETA.-D-RIBOFURANOSYLURONAMIDE)-9H-PURIN-2-YL)PROP-2-YNYL)CYCLOHEXANECARBOXYLATE"
REGADENOSON ANHYDROUS,219024,,"InChI=1S/C15H18N8O5/c1-17-13(27)6-2-19-23(3-6)15-20-11(16)8-12(21-15)22(5-18-8)14-10(26)9(25)7(4-24)28-14/h2-3,5,7,9-10,14,24-26H,4H2,1H3,(H,17,27)(H2,16,20,21)/t7-,9-,10-,14-/m1/s1",LZPZPHGJDAGEJZ-AKAIJSEGSA-N,C15H18N8O5,390.35,"1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide","Regadenoson|313348-27-5|Lexiscan|Rapiscan|Regadenoson anhydrous|CVT-3146|CVT 3146|7AXV542LZ4|DTXSID4057712|DTXCID5031501|Adenosine, 2-[4-[(methylamino)carbonyl]-1H-pyrazol-1-yl]-|(1-(9-(3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-6-aminopurin-2-yl)pyrazol-4-yl)-N-methylcarboxamide|Adenosine, 2-(4-((methylamino)carbonyl)-1H-pyrazol-1-yl)-|1-{6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-9H-purin-2-yl}-N-methyl-1H-pyrazole-4-carboxamide|regadenosonum|1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide|RefChem:426699|C01EB21|LEXISCAN(R) (REGADENOSON)|2XLN4Y044H|CVT3146|Regadenoson monohydrate|1-(6-amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide|2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine|CHEMBL317052|Regadenoson (INN)|REGADENOSON [INN]|1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]purin-2-yl]-N-methylpyrazole-4-carboxamide|Regadenoson [USAN:INN]|UNII-7AXV542LZ4|2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]adenosine; CVT 3146; Lexiscan; Regadenoson|C15H18N8O5|MFCD09832544|Regadenoson (Standard)|Regadenoson Impurity 18|REGADENOSON [MI]|Regadenoson; CVT-3146|REGADENOSON [MART.]|SCHEMBL678893|GTPL5596|orb1305186|SCHEMBL29462353|HY-A0168R|CHEBI:135613|LZPZPHGJDAGEJZ-AKAIJSEGSA-N|GLXC-05958|HMS3886O21|EX-A2148|HY-A0168|Tox21_113668|BDBM50119132|s5358|AKOS026750593|CCG-268525|CS-5612|DB06213|NR07283|1-(6-Amino-9-beta-D-ribofuranosyl-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide|NCGC00249892-01|1-[6-amino-9-[(2R,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]purin-2-yl]-N-methyl-pyrazole-4-carboxamide|AC-35838|AS-56292|BP-58629|CAS-313348-27-5|D12568|348R275|EN300-19633972|Q7307897|2-[4-[(Methylamino)carbonyl]-1H-pyrazol-1-yl]-adenosine|(1-{9-[(4s,2r,3r,5r)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]-6-aminopurin-2-yl}pyrazol-4-yl)-n-methylcarboxamide|1-[6-Amino-9-((2R,3R,4S,5R)-3,4-dihydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-9H-purin-2-yl]-1H-pyrazole-4-carboxylic acid methylamide|6-Amino-2-[4-(methylcarbamoyl)-1H-pyrazol-1-yl]purine-9-yl-beta-D-ribofuranoside;1-(6-amino-9-((2S,3R,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yloxy)-9H-purin-2-yl)-N-methyl-1H-pyrazole-4-carboxamide"
SONEDENOSON,9910098,,"InChI=1S/C18H20ClN5O5/c19-10-3-1-9(2-4-10)5-6-28-18-22-15(20)12-16(23-18)24(8-21-12)17-14(27)13(26)11(7-25)29-17/h1-4,8,11,13-14,17,25-27H,5-7H2,(H2,20,22,23)/t11-,13-,14-,17-/m1/s1",WUCQGGOGHZRELS-LSCFUAHRSA-N,C18H20ClN5O5,421.8,"(2R,3R,4S,5R)-2-[6-amino-2-[2-(4-chlorophenyl)ethoxy]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol","Sonedenoson|131865-88-8|MRE0094|2OT4KAG5JL|Adenosine, 2-[2-(4-chlorophenyl)ethoxy]-|MRE-0094|DTXSID90157239|9-beta-D-Ribofuranosyl-2-(2-(4-chlorophenyl)ethoxy)-9H-purin-6-amine|ADENOSINE, 2-(2-(4-CHLOROPHENYL)ETHOXY)-|sonedenosonum|(2R,3R,4S,5R)-2-(6-amino-2-(2-(4-chlorophenyl)ethoxy)-9H-purin-9-yl)-5-(hydroxymethyl)oxolane-3,4-diol|(2R,3R,4S,5R)-2-{6-amino-2-[2-(4-chlorophenyl)ethoxy]-9H-purin-9-yl}-5-(hydroxymethyl)oxolane-3,4-diol|RefChem:184314|DTXCID8079730|2-[2-(4-Chlorophenyl)ethoxy]adenosine|UNII-2OT4KAG5JL|Sonedenoson [USAN:INN]|Sonedenoson [USAN]|2-(2-(4-chlorophenyl)ethoxy)adenosine|(2R,3R,4S,5R)-2-(6-Amino-2-(4-chlorophenethoxy)-9H-purin-9-yl)-5-(hydroxymethyl)tetrahydrofuran-3,4-diol|CHEMBL1950553|Sonedenoson (USAN)|(2R,3R,4S,5R)-2-[6-amino-2-[2-(4-chlorophenyl)ethoxy]purin-9-yl]-5-(hydroxymethyl)oxolane-3,4-diol|Sonedenoson; MRE 0094;|SONEDENOSON [INN]|SONEDENOSON [WHO-DD]|C18H20ClN5O5|orb1695182|SCHEMBL1094594|SCHEMBL29379294|WUCQGGOGHZRELS-LSCFUAHRSA-N|BDBM50364043|2-[2-(4chlorophenyl)ethoxy]adenosine|AKOS027446939|DB12443|NC16521|2-[2-(4-chlorophenyl)ethoxy]-adenosine|(2R,3R,4S,5R)-2-[6-amino-2-[2-(4-chlorophenyl)ethoxy]purin-9-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol|DB-302741|NS00069684|D09003|865C888|MRE 0094;2-[2-(4-Chlorophenyl)ethoxy]adenosine|Q27255265|9-.BETA.-D-RIBOFURANOSYL-2-(2-(4-CHLOROPHENYL)ETHOXY)-9H-PURIN-6-AMINE"
GS-9667,11561692,,"InChI=1S/C21H24FN5O4S/c22-11-4-1-2-7-15(11)32-8-14-17(29)18(30)21(31-14)27-10-25-16-19(23-9-24-20(16)27)26-12-5-3-6-13(12)28/h1-2,4,7,9-10,12-14,17-18,21,28-30H,3,5-6,8H2,(H,23,24,26)/t12-,13-,14-,17-,18-,21-/m1/s1",IZRXENCTXNMAMI-DIJFLQFKSA-N,C21H24FN5O4S,461.5,"(2S,3S,4R,5R)-2-[(2-fluorophenyl)sulfanylmethyl]-5-[6-[[(1R,2R)-2-hydroxycyclopentyl]amino]purin-9-yl]oxolane-3,4-diol","GS-9667|618380-90-8|CVT-3619|CVT 3619|GS9667|6E68796C40|DTXSID40210823|(2S,3S,4R,5R)-2-[(2-fluorophenyl)sulfanylmethyl]-5-[6-[[(1R,2R)-2-hydroxycyclopentyl]amino]purin-9-yl]oxolane-3,4-diol|(2S,3S,4R,5R)-2-((2-fluorophenyl)sulfanylmethyl)-5-(6-(((1R,2R)-2-hydroxycyclopentyl)amino)purin-9-yl)oxolane-3,4-diol|RefChem:144493|CVT3619|DTXCID70133314|UNII-6E68796C40|(2S,3S,4R,5R)-2-(((2-fluorophenyl)thio)methyl)-5-(6-(((1R,2R)-2-hydroxycyclopentyl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol|IZRXENCTXNMAMI-DIJFLQFKSA-N|GTPL5593|orb1700494|SCHEMBL1150300|CHEMBL3545011|SCHEMBL30348993|EX-A2686|BDBM50149592|AKOS040748448|HY-19842|TS-08530|CS-0017018|H20710|Q27077860|ADENOSINE, 5'-S-(2-FLUOROPHENYL)-N-((1R,2R)-2-HYDROXYCYCLOPENTYL)-5'-THIO|2-(6-((2-hydroxycyclopentyl)amino)purin-9-yl)-5-((2-fluorophenylthio)methyl)oxolane-3,4-diol"
TECADENOSON,158795,,"InChI=1S/C14H19N5O5/c20-3-8-10(21)11(22)14(24-8)19-6-17-9-12(15-5-16-13(9)19)18-7-1-2-23-4-7/h5-8,10-11,14,20-22H,1-4H2,(H,15,16,18)/t7-,8-,10-,11-,14-/m1/s1",OESBDSFYJMDRJY-BAYCTPFLSA-N,C14H19N5O5,337.33,"(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[[(3R)-oxolan-3-yl]amino]purin-9-yl]oxolane-3,4-diol","Tecadenoson|204512-90-3|CVT-510|N-(3-Tetrahydrofuranyl)-6-aminopurine riboside|GZ1X96601Z|(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[[(3R)-oxolan-3-yl]amino]purin-9-yl]oxolane-3,4-diol|DTXSID80174415|tecadenosonum|(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-(((3R)-oxolan-3-yl)amino)purin-9-yl)oxolane-3,4-diol|RefChem:891270|DTXCID8096906|(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-(((3R)-oxolan-3-yl)amino)-9H-purin-9-yl)oxolane-3,4-diol|MFCD08690887|CHEMBL392149|(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-(((R)-tetrahydrofuran-3-yl)amino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol|Adenosine, N-(3R)-tetrahydro-3-furanyl)-|BDBM50224766|2-(6-(((3R)Oxolan-3-yl)amino)purin-9-yl)(2R,4S,3R,5R)-5-(hydroxymethyl)oxolane-3,4-diol|Tecadenoson [USAN]|Tecadenoson (USAN/INN)|Tecadenoson [USAN:INN]|Tecadenoso|UNII-GZ1X96601Z|(2R,3R,4S,5R)-2-Hydroxymethyl)-5-(6-((3R)-(tetrahydrofuran-3-ylamino)-9H-purin-9-yl)tetrahydrofuran-3,4-diol|(2R,3R,4S,5R)-2-Hydroxymethyl)-5-[6-[(3R)-(tetrahydrofuran-3-ylamino]-9H-purin-9-yl]tetrahydrofuran-3,4-diol|TECADENOSON [MI]|TECADENOSON [INN]|SCHEMBL246787|CHEMBL356254|GTPL5592|orb1307689|CVT 510|EIA51290|BDBM50138530|AKOS040742699|DB04954|N6-[3-(R)-tetrahydrofuranyl]adenosine|AS-84224|BP-58666|DA-68019|HY-19661|Adenosine, N-(3R)-tetrahydro-3-furanyl-|CS-0016174|NS00069719|D06019|D80368|Q27088953|(2R,3R,5R)-2-Hydroxymethyl-5-{6-[(R)-(tetrahydro-furan-3-yl)amino]-purin-9-yl}-tetrahydro-furan-3,4-diol|(2R,3S,4R)-2-Hydroxymethyl-5-{6-[(R)-(tetrahydro-furan-3-yl)amino]-purin-9-yl}-tetrahydro-furan-3,4-diol|(2R,3S,4R,5R)-2-(hydroxymethyl)-5-(6-((R)-tetrahydrofuran-3-ylamino)-9H-purin-9-yl)-tetrahydrofuran-3,4-diol|(2R,3S,4R,5R)-2-(hydroxymethyl)-5-[6-[[(3R)-tetrahydrofuran-3-yl]amino]purin-9-yl]tetrahydrofuran-3,4-diol"
TRABODENOSON,11610599,,"InChI=1S/C15H20N6O6/c22-11-9(5-26-21(24)25)27-15(12(11)23)20-7-18-10-13(16-6-17-14(10)20)19-8-3-1-2-4-8/h6-9,11-12,15,22-23H,1-5H2,(H,16,17,19)/t9-,11-,12-,15-/m1/s1",AQLVRTWKJDTWQQ-SDBHATRESA-N,C15H20N6O6,380.36,"[(2R,3S,4R,5R)-5-[6-(cyclopentylamino)purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methyl nitrate","Trabodenoson|871108-05-3|INNO-8875|N-Cyclopentyladenosine 5'-nitrate|N6-Cyclopentyladenosine 5'-nitrate|1T237110W4|PJ-875|DTXSID90236139|trabodenosonum|RefChem:933236|DTXCID40158630|((2R,3S,4R,5R)-5-(6-(cyclopentylamino)-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl nitrate|Trabodenoson [USAN:INN]|INNO 8875|UNII-1T237110W4|MFCD28502082|PJ 875|((2r,3s,4r,5r)-5-(6-(cyclopentylamino)-9h-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl nitrate|INO-8875|[(2R,3S,4R,5R)-5-[6-(cyclopentylamino)purin-9-yl]-3,4-dihydroxyoxolan-2-yl]methyl nitrate|Trabodenoson [INN]|C15H20N6O6|Trabodenoson (USAN/INN)|TRABODENOSON [USAN]|SCHEMBL121828|orb1695021|CHEMBL3545407|SCHEMBL29359454|BDBM97464|N-Cyclopentyladenosine 5 -nitrate|BDBM108255|GLXC-15845|AKOS027337131|AKOS040754236|DB13122|AS-52370|US8470800, A|HY-106007|CS-0024616|NS00072168|D10493|P14975|US8609833, 17|US8609833, 86|Q27252846|[(2R,3S,4R,5R)-5-[6-(cyclopentylamino)purin-9-yl]-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl nitrate"
LOMETREXOL,135413518,,"InChI=1S/C21H25N5O6/c22-21-25-17-14(19(30)26-21)9-12(10-23-17)2-1-11-3-5-13(6-4-11)18(29)24-15(20(31)32)7-8-16(27)28/h3-6,12,15H,1-2,7-10H2,(H,24,29)(H,27,28)(H,31,32)(H4,22,23,25,26,30)/t12-,15+/m1/s1",ZUQBAQVRAURMCL-DOMZBBRYSA-N,C21H25N5O6,443.5,"(2S)-2-[[4-[2-[(6R)-2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl]amino]pentanedioic acid","Lometrexol|106400-81-1|Lometrexolum|6P3AVY8A7Q|5,10-dideazatetrahydrofolic acid|LY264618|5,10-dideazatetrahydrofolate|L-Glutamic acid, N-(4-(2-(2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido(2,3-d)pyrimidin-6-yl)ethyl)benzoyl)-, (R)-|L-Glutamic acid, N-(4-(2-((6R)-2-amino-1,4,5,6,7,8-hexahydro-4-oxopyrido(2,3-d)pyrimidin-6-yl)ethyl)benzoyl)-|5,10-Dideaza-5,6,7,8-tetrahydrofolic acid|NSC660025|5,10-DDTF|RefChem:800022|(6R)-DDATHF|6R-5,10-Dideazatetrahydrofolate|Pyrido(2,3-d)pyrimidine, L-glutamic acid derivative|DDATHF|(2S)-2-[[4-[2-[(6R)-2-amino-4-oxo-5,6,7,8-tetrahydro-1H-pyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl]amino]pentanedioic acid|(2S)-2-[[4-[2-[(6R)-2-amino-4-oxo-5,6,7,8-tetrahydro-3H-pyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl]amino]pentanedioic acid|(4-(2-((R)-2-Amino-4-oxo-3,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl)ethyl)benzoyl)-L-glutamic acid|Lometrexol [INN:BAN]|Lometrexolum [INN-Latin]|UNII-6P3AVY8A7Q|N-[4-[2-[(6R)-2-Amino-3,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl]-L-glutamic Acid Hydrate; LY 264618 Hydrate;|DDATHF-B|LY 264618|LOMETREXOL [INN]|LOMETREXOL [WHO-DD]|SCHEMBL18530|CHEMBL34412|orb1707028|SCHEMBL17520098|BDBM22590|DTXSID50909998|C21H25N5O6|GEA40081|L-Glutamic acid, N-[4-[2-[(6R)-2-amino-3,4,5,6,7,8-hexahydro-4-oxopyrido[2,3-d]pyrimidin-6-yl]ethyl]benzoyl]-|MFCD00866319|AKOS040741996|CCG-222045|DB12769|NCGC00485206-01|NCGC00485206-02|DA-75070|HY-14521|MS-27983|T-64|LY-264618|CS-0003423|NS00070452|G12728|BRD-K66036108-001-01-9|Q27265261|(2S)-2-[(4-{2-[(6R)-2-amino-4-oxo-1H,4H,5H,6H,7H,8H-pyrido[2,3-d]pyrimidin-6-yl]ethyl}phenyl)formamido]pentanedioic acid|L-GLUTAMIC ACID, N-(4-(2-(2-AMINO-3,4,5,6,7,8-HEXAHYDRO-4-OXOPYRIDO(2,3-D)PYRIMIDIN-6-YL)ETHYL)BENZOYL)-, (R)-|N-(P-(2-((R)-2-AMINO-3,4,5,6,7,8-HEXAHYDRO-4-OXOPYRIDO(2,3-D)PYRIMIDIN-6-YL)ETHYL)BENZOYL)-L-GLUTAMATE|N-[(4-{2-[(6R)-2-amino-4-oxo-1,4,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl]ethyl}phenyl)carbonyl]-L-glutamic acid|N-{4-[2-(4-Hydroxy-2-imino-1,2,5,6,7,8-hexahydropyrido[2,3-d]pyrimidin-6-yl)ethyl]benzoyl}glutamic acid"
PF-04455242,44599828,,"InChI=1S/C21H28N2O2S/c1-17(2)15-22-16-18-9-11-19(12-10-18)20-7-3-4-8-21(20)26(24,25)23-13-5-6-14-23/h3-4,7-12,17,22H,5-6,13-16H2,1-2H3",OWVIKBRKPCTDEP-UHFFFAOYSA-N,C21H28N2O2S,372.5,2-methyl-N-[[4-(2-pyrrolidin-1-ylsulfonylphenyl)phenyl]methyl]propan-1-amine,"PF-04455242|RefChem:172278|PF-4455242 free base|1202647-54-8|CHEMBL1818341|Y3530Z78QD|PF4455242|(1,1'-Biphenyl)-4-methanamine, N-(2-methylpropyl)-2'-(1-pyrrolidinylsulfonyl)-|2-Methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)-[1,1'-biphenyl]-4-yl)methyl)propan-1-amine|UNII-Y3530Z78QD|starbld0029788|PF 04455242|SCHEMBL3212512|SCHEMBL29664276|DTXSID30152783|BDBM50350976|EX-A12281|2-methyl-N-[[4-(2-pyrrolidin-1-ylsulfonylphenyl)phenyl]methyl]propan-1-amine|NCGC00485089-01|2-methyl-N-((2'-(pyrrolidin-1-ylsulfonyl)biphenyl-4-yl)methyl)propan-1-amine"
ATICAPRANT,44129648,,"InChI=1S/C26H27FN2O2/c1-17-12-18(2)14-21(13-17)24-4-3-11-29(24)16-19-5-8-22(9-6-19)31-25-10-7-20(26(28)30)15-23(25)27/h5-10,12-15,24H,3-4,11,16H2,1-2H3,(H2,28,30)/t24-/m0/s1",ZHPMYDSXGRRERG-DEOSSOPVSA-N,C26H27FN2O2,418.5,"4-[4-[[(2S)-2-(3,5-dimethylphenyl)pyrrolidin-1-yl]methyl]phenoxy]-3-fluorobenzamide","Aticaprant|1174130-61-0|LY-2456302|JSPA0658|JSPA-0658|DE4G8X55F5|4-[4-[[(2S)-2-(3,5-dimethylphenyl)pyrrolidin-1-yl]methyl]phenoxy]-3-fluorobenzamide|DTXSID90151777|aticaprantum|4-(4-(((2S)-2-(3,5-Dimethylphenyl)-1-pyrrolidinyl)methyl)phenoxy)-3-fluorobenzamide|4-(4-(((2S)-2-(3,5-dimethylphenyl)pyrrolidin-1-yl)methyl)phenoxy)-3-fluorobenzamide|4-(4-{[(2S)-2-(3,5-dimethylphenyl)pyrrolidin-1-yl]methyl}phenoxy)-3-fluorobenzamide|4-[4-[[(2S)-2-(3,5-Dimethylphenyl)-1-pyrrolidinyl]methyl]phenoxy]-3-fluorobenzamide|RefChem:560309|DTXCID5074268|(S)-4-(4-((2-(3,5-diMethylphenyl)pyrrolidin-1-yl)Methyl)phenoxy)-3-fluorobenzaMide|LY2456302|CERC-501|Aticaprant [USAN]|JNJ-67953964|UNII-DE4G8X55F5|Benzamide, 4-(4-(((2S)-2-(3,5-dimethylphenyl)-1-pyrrolidinyl)methyl)phenoxy)-3-fluoro-|MFCD22572355|CHEMBL1921847|JNJ-67953964-AAA|Aticaprant [WHO-DD]|ATICAPRANT [INN]|Aticaprant (USAN/INN)|CERC501|GTPL9194|orb1296218|SCHEMBL2638855|SCHEMBL29425177|C26H27FN2O2|EX-A2610|BDBM50358171|WHO 10582|CS-6653|DB12341|JNJ67953964|AC-36176|MS-27322|SY369306|CERC-501(LY-2456302,Aticaprant)?|CERC-501; LY-2456302|DB-353665|HY-101718|NS00072576|D11831|G14179|Q18344482|(s)-3-fluoro-4-(4-((2-(3,5-dimethylphenyl)pyrrolidin-1yl)methyl)-phenoxy)benzamide|(S)-4-[4-[[2-(3,5-Dimethylphenyl)-1-pyrrolidinyl]methyl]phenoxy]-3-fluorobenzamide|4-[4-[[(2S)-2-(3,5-dimethylphenyl)pyrrolidin-1-yl]methyl]phenoxy]-3-fluoro-benzamide"
RALOXIFENE,5035,,"InChI=1S/C28H27NO4S/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29/h4-13,18,30-31H,1-3,14-17H2",GZUITABIAKMVPG-UHFFFAOYSA-N,C28H27NO4S,473.6,[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone,"raloxifene|84449-90-1|Keoxifene|Raloxifeno|Raloxifenum|Raloxifenum [Latin]|Raloxiphene|Eviden|Raxeto|LY 139481|LY-139481|NSC-747974|CHEBI:8772|YX9162EO3I|DTXSID3023550|(2-(4-Hydroxyphenyl)-6-hydroxybenzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|J22.982B|Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)-|DTXCID803550|Raloxifenum (Latin)|Methanone, [6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-|[2-(4-Hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methanone|[2-(4-hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone|RefChem:56953|G03XC01|(6-Hydroxy-2-(4-hydroxyphenyl)-benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone|Raloxifeno [Spanish]|2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol|C28H27NO4S|CHEMBL81|MFCD00866415|(6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone|Keoxifene; LY 139481;|Raloxifene (INN)|[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone|RALOXIFENE [INN]|[6-hydroxy-2-(4-hydroxyphenyl)benzothiophen-3-yl]-[4-[2-(1-piperidyl)ethoxy]phenyl]methanone|Raloxifene [INN:BAN]|2-(4-hydroxyphenyl)-3-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)-1-benzothiophen-6-ol|CCRIS 7129|HSDB 7460|NCGC00015889-05|CAS-82640-04-8|UNII-YX9162EO3I|Pharoxifene|Raloxifene, 6|[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothien-3-yl]{4-[(2-piperidin-1-ylethyl)oxy]phenyl}methanone|[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone; Keoxifene; LY 139481; Raloxifene; [2-(4-Hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl][4-(2-(1-piperidinyl)ethoxy)phenyl]methanone|Eviden (TN)|Raxeto (TN)|Raloxifene (Standard)|RALOXIFENE [MI]|Prestwick0_000862|Prestwick1_000862|Prestwick2_000862|Prestwick3_000862|Lopac-R-1402|RALOXIFENE [HSDB]|RALOXIFENE [VANDF]|SCHEMBL6144|RALOXIFENE [WHO-DD]|Lopac0_001051|BSPBio_000903|KBioGR_002361|KBioSS_002364|BIDD:ER0216|BIDD:GT0795|SPBio_002824|BPBio1_000995|GTPL2820|orb1705643|SCHEMBL29362592|BDBM19441|KBio2_002361|KBio2_004929|KBio2_007497|KBio3_002840|cid_11071264|cMAP_000032|GLXC-05144|HMS2089F06|HMS3742O11|HMS5085J07|BCP09772|MSK10574|Tox21_202603|HY-13738R|NSC747974|NSC761389|s5781|AKOS015896267|AC-8399|CCG-205128|DB00481|NSC 747974|NSC-761389|SDCCGSBI-0051021.P003|MRF-0000684|SMP2_000095|NCGC00015889-01|NCGC00015889-02|NCGC00015889-04|NCGC00015889-06|NCGC00015889-07|NCGC00015889-08|NCGC00015889-10|NCGC00015889-22|NCGC00092353-02|NCGC00092353-04|NCGC00260151-01|[6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone|AS-35086|FR175031|HY-13738|SBI-0051021.P002|CAS-84449-90-1|5189B|CS-0007764|NS00005279|EN300-58333|VU0155042-3|C07228|D08465|449R901|A916152|Q425223|BRD-K63828191-003-11-5|BRD-K63828191-003-32-1|BRD-K63828191-003-33-9|BRD-K63828191-003-34-7|6-hydroxy-2-(4-hydoxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene|6-hydroxy-2-(4-hydoxyphenyl)-3[-4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene|6-Hydroxy-2-(4-Hydroxyphenyl)-3-[4(2-Piperidinoethoxy)benzoyl]benzo[b]thiophene|6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]-thiophene|6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene|6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2piperidinoethoxy)-benzoyl]benzo[b]thiophene|6-hydroxy-2-(4-hydroxyphenyl)-3[-4-(2-piperidinoethoxy)benzoyl]benzo [b]thiophene|6-hydroxy-2-(4-hydroxyphenyl)-3[-4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene|6-hydroxy-2-(4-hydroxyphenyl)-3[-4-(2piperidinoethoxy)benzoyl]benzo[b]thiophene|6-hydroxy-2-(4-hyroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene|[2-(4-Hydroxyphenyl)-6-hydroxybenzo[b]thien-3-yl] [4-[2-(1-piperidinyl)ethoxy]phenyl]methanone; Raloxifeno|[6-Hydroxy-2-(4-hydroxy-phenyl)-benzo[b]thiophen-3-yl]-[4-(2-piperidin-1-yl-ethoxy)-phenyl]-methanone|[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothien-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone|[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone|[6-hydroxy-2-(4-hydroxyphenyl)benzo-[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone|[6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1-piperidinyl)ethoxy]phenyl]methanone|[6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl]-[4-[2-(1piperidinyl)ethoxy]phenyl]methanone|6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl 4-[2-(1-piperidinyl)ethoxy]phenyl methanone"
BRODIMOPRIM,68760,,"InChI=1S/C13H15BrN4O2/c1-19-9-4-7(5-10(20-2)11(9)14)3-8-6-17-13(16)18-12(8)15/h4-6H,3H2,1-2H3,(H4,15,16,17,18)",BFCRRLMMHNLSCP-UHFFFAOYSA-N,C13H15BrN4O2,339.19,"5-[(4-bromo-3,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine","Brodimoprim|56518-41-3|Brodimoprima|Brodimoprime|Brodimoprimum|Ro 10-5970|2,4-Diamino-5-(4-bromo-3,5-dimethoxybenzyl)pyrimidine|Ro 105970|Ro-10-5970|V1YC7T6LLI|DTXSID20205070|5-[(4-bromo-3,5-dimethoxyphenyl)methyl]pyrimidine-2,4-diamine|CHEBI:131726|5-((4-bromo-3,5-dimethoxyphenyl)methyl)pyrimidine-2,4-diamine|RefChem:121485|DTXCID20127561|J01EA02|260-238-8|5-(4-bromo-3,5-dimethoxybenzyl)pyrimidine-2,4-diamine|Brodimoprim [INN]|C13H15BrN4O2|2,4-Pyrimidinediamine, 5-[(4-bromo-3,5-dimethoxyphenyl)methyl]-|CHEMBL31891|Bromdimoprim|Unitrim|5-((4-Bromo-3,5-dimethoxyphenyl)methyl)-2,4-pyrimidinediamine|Brodimoprim (INN)|Hyprim|5-[(4-Bromo-3,5-dimethoxyphenyl)methyl]-2,4-pyrimidinediamine|1346599-93-6|5-[(4-bromo-3,5-dimethoxy-phenyl)methyl]pyrimidine-2,4-diamine|2,4-Pyrimidinediamine, 5-((4-bromo-3,5-dimethoxyphenyl)methyl)-|Brodimoprime [INN-French]|Brodimoprimum [INN-Latin]|Brodimoprima [INN-Spanish]|EINECS 260-238-8|UNII-V1YC7T6LLI|BRN 0760113|MFCD00864849|Brodimoprim (Standard)|BRODIMOPRIM [MI]|BRODIMOPRIM [MART.]|SCHEMBL49613|BRODIMOPRIM [WHO-DD]|5-25-13-00394 (Beilstein Handbook Reference)|orb1306839|SCHEMBL30659008|GTPL12325|WDC59993|BDBM50027970|AKOS016013929|DB13795|FB19014|HY-121341R|NCGC00238470-01|DA-04825|MS-25161|SY398237|HY-121341|CS-0081497|NS00033532|D07238|G12685|518B413|Q4973047|2,4-diamino-5-(4-bromo-3,5-dimethoxybenzyl)-pyrimidine|5-(4-Bromo-3,5-dimethoxy-benzyl)-pyrimidine-2,4-diamine|5-(4-Bromo-3,5-dimethoxybenzyl)-2,4-pyrimidinediamine;Hyprim|5-[(4-Bromo-3,5-dimethoxyphenyl)methyl]-2,4-pyrimidinediamine;5-(4-Bromo-3,5-dimethoxybenzyl)-2,4-pyrimidinediamine;Hyprim"
AVASIMIBE,166558,,"InChI=1S/C29H43NO4S/c1-17(2)22-14-25(20(7)8)27(26(15-22)21(9)10)16-28(31)30-35(32,33)34-29-23(18(3)4)12-11-13-24(29)19(5)6/h11-15,17-21H,16H2,1-10H3,(H,30,31)",PTQXTEKSNBVPQJ-UHFFFAOYSA-N,C29H43NO4S,501.7,"[2,6-di(propan-2-yl)phenyl] N-[2-[2,4,6-tri(propan-2-yl)phenyl]acetyl]sulfamate","Avasimibe|166518-60-1|CI-1011|Avasimiba|28LQ20T5RC|DTXSID80168117|2,6-bis(1-methylethyl)phenyl ((2,4,6-tris(1-methylethyl)phenyl)acetyl)sulfamate|avasimibum|1-(((2,6-bis(propan-2-yl)phenoxy)sulfonyl)amino)-2-(2,4,6-tris(propan-2-yl)phenyl)ethan-1-one|1-({[2,6-bis(propan-2-yl)phenoxy]sulfonyl}amino)-2-[2,4,6-tris(propan-2-yl)phenyl]ethan-1-one|RefChem:560377|DTXCID7090608|MFCD00934956|2,6-Diisopropylphenyl (2-(2,4,6-triisopropylphenyl)acetyl)sulfamate|[2,6-di(propan-2-yl)phenyl] N-[2-[2,4,6-tri(propan-2-yl)phenyl]acetyl]sulfamate|Sulfamic acid, N-[2-[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester|CI 1011|((2,4,6-Tris(1-methylethyl)phenyl)acetyl)sulfamic acid 2,6-bis(1-methylethyl)phenyl ester|CHEMBL101309|2,6-Diisopropylphenyl (2-(2,4,6-triisopropylphenyl)-acetyl)sulfamate|N-((2,6-Bis(1-methylethyl)phenoxy)sulfonyl)-2,4,6-tris(1-methylethyl)-benzeneacetamide|Avasimibe [USAN]|Avasimibe(CI-1011)|SMR002530075|C29H43NO4S|Avasimibe [USAN:INN]|UNII-28LQ20T5RC|PD 148515|Avasimibe,CI-1011|AVASIMIBE [INN]|AVASIMIBE [MI]|Avasimibe (USAN/INN)|2,6-Diisopropylphenyl ((2,4,6-triisopropylphenyl)acetyl)sulfamate|2,6-diisopropylphenyl 2-(2,4,6-triisopropylphenyl)acetylsulfamate|Avasimibe (CI-1011)|AVASIMIBE [WHO-DD]|N-((2,6-Bis(1-methylethyl)phenoxy)sulfonyl)-2,4,6-tris(1-methylethyl)benzeneacetamide|Avasimibe (CI-1011)?|BIDD:PXR0029|SCHEMBL15876|MLS006010422|MLS006010991|orb1305068|Avasimibe, >=98% (HPLC)|CHEBI:177719|GLXC-05001|HMS3655H08|HMS3866C13|BCP02302|EX-A2230|BDBM50069900|s2187|(2,6-diisopropylphenyl) N-[2-(2,4,6-triisopropylphenyl)acetyl]sulfamate|AKOS015913985|BCP9000344|CCG-269706|CS-5695|DB06442|SB19572|Benzeneacetamide, N-((2,6-bis(1-methylethyl)phenoxy)sulfonyl)-2,4,6-tris(1-methylethyl)-|N-(2,6-DIPROPAN-2-YLPHENOXY)SULFONYL-2-(2,4,6-TRIPROPAN-2-YLPHENYL)ACETAMIDE|NCGC00346572-01|NCGC00346572-02|[[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester] sulfamic acid|AC-35841|AS-74646|Avasimibe; CI-1011; PD-148515|HY-13215|NS00068604|SW219628-1|C73212|D03012|518A601|SR-01000944953|SR-01000944953-1|BRD-K67901620-001-02-0|BRD-K67901620-001-03-8|Q27254327|[2,6-di(propan-2-yl)phenyl] N-[2-[2,4,6-tri(propan-2-yl)phenyl]acetyl]sulamate|[2-(2,4,6-Triisopropyl-phenyl)-acetyl]-sulfamic acid 2,6-diisopropyl-phenyl ester|CI-1011; PD 148515; [[2,4,6-tris(1-methylethyl)phenyl]acetyl]-, 2,6-bis(1-methylethyl)phenyl ester] sulfamic acid"
ETHOXZOLAMIDE,3295,,"InChI=1S/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13)",OUZWUKMCLIBBOG-UHFFFAOYSA-N,C9H10N2O3S2,258.3,"6-ethoxy-1,3-benzothiazole-2-sulfonamide","ethoxzolamide|452-35-7|6-Ethoxy-2-benzothiazolesulfonamide|Ethoxyzolamide|Ethoxazolamide|Ethamide|Cardrase|Etoxzolamide|6-Ethoxy-1,3-benzothiazole-2-sulfonamide|Glaucotensil|Diuretic C|Mingoral|2-Benzothiazolesulfonamide, 6-ethoxy-|U-4191|DTXSID1023021|NSC-10679|CHEBI:101096|Z52H4811WX|DTXCID303021|NSC10679|RefChem:55161|6-Ethoxyzolamide|6-Ethoxybenzo[d]thiazole-2-sulfonamide|6-Ethoxybenzothiazole-2-sulfonamide|MFCD00057089|NSC 10679|CHEMBL18|Redupresin;L-643786;PNU-4191|MLS000028637|6-Ethoxy-benzothiazole-2-sulfonic acid amide|NCGC00018249-04|Redupresin|SMR000059148|6-Ethoxybenzothiazole-2-sulphonamide|Cardrase (TN)|CAS-452-35-7|EZL|Ethoxzolamide [USP]|HSDB 3268|EINECS 207-199-5|BRN 0212240|Athamid|UNII-Z52H4811WX|AI3-50805|3caj|3dcw|3mdz|EZA|Ethoxzolamide, EZM|3dd0|Opera_ID_1207|ETHOXZOLAMIDE [MI]|6-(ethyloxy)-1,3-benzothiazole-2-sulfonamide|ETHOXZOLAMIDE [HSDB]|SCHEMBL63941|4-27-00-04404 (Beilstein Handbook Reference)|MLS001077357|6-Ethoxyzolamide;Ethoxzolamide|ETHOXZOLAMIDE [WHO-DD]|GTPL6814|orb1302170|SCHEMBL29581803|BDBM10882|GLXC-05684|HMS2093J03|HMS2094M03|HMS2233N09|HMS3373K15|HMS3715F20|HMS3746M15|HMS5083O09|Pharmakon1600-01505426|ETHOXZOLAMIDE [ORANGE BOOK]|BCP24088|HY-B1480|MSK10711|Tox21_110848|6-ethoxy-2-benzothiazole sulfonamide|NSC759129|WLN: T56 BN DSJ CSZW GO2|AKOS015915628|Tox21_110848_1|CCG-213432|CS-7836|DB00311|FE61560|NSC-759129|VS-0126|Benzothiazole, 6-ethoxy-2-sulfonamide-|NCGC00018249-01|NCGC00018249-02|NCGC00018249-03|NCGC00018249-05|NCGC00022533-04|NCGC00186657-01|ST086115|6-Ethoxy-2-benzothiazolesulfonamide, 97%|SBI-0206851.P001|DB-369276|6-Ethoxy-1,3-benzothiazole-2-sulfonamide #|NS00031505|ST51007023|SW220095-1|D02441|G12146|AB00383049_12|AB00383049_13|Q265352|SR-01000000236|SR-01000000236-2|BRD-K18131774-001-10-1|BRD-K18131774-001-17-6|BRD-K18131774-001-18-4|Z995241886|Ethoxzolamide, United States Pharmacopeia (USP) Reference Standard|InChI=1/C9H10N2O3S2/c1-2-14-6-3-4-7-8(5-6)15-9(11-7)16(10,12)13/h3-5H,2H2,1H3,(H2,10,12,13"
DORZOLAMIDE,5284549,,"InChI=1S/C10H16N2O4S3/c1-3-12-8-4-6(2)18(13,14)10-7(8)5-9(17-10)19(11,15)16/h5-6,8,12H,3-4H2,1-2H3,(H2,11,15,16)/t6-,8-/m0/s1",IAVUPMFITXYVAF-XPUUQOCRSA-N,C10H16N2O4S3,324.4,"(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide","dorzolamide|120279-96-1|4S,6S-Dorzolamide|Dorzolamida|Dorzolamide, trans-(-)-|9JDX055TW1|CHEBI:4702|DTXSID7022960|(4S,6S)-4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|(4S,trans)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno[2,3-b]thiopyran-2-sulfonic acid amide|4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno[2,3-b]thiopyran-2-sulfonic acid amide|4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, (4S-trans)-|Dorzolamidum|Dorzant|4-ethylamino-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno(5,4-b)thiopyran-2-sulfonamide|4-ethylamino-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[5,4-b]thiopyran-2-sulfonamide|(2S,4S)-4-(ethylamino)-2-methyl-1,1-dioxo-2H,3H,4H-1$l^(6),7-thieno(2,3-b)(1$l^(6))thiopyran-6-sulfonamide|(2S,4S)-4-(ethylamino)-2-methyl-1,1-dioxo-2H,3H,4H-1$l^{6},7-thieno[2,3-b][1$l^{6}]thiopyran-6-sulfonamide|(4S,6S)-4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno(2,3-b)thiopyran-2-sulfonic acid amide|(4S,trans)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno(2,3-b)thiopyran-2-sulfonamide 7,7-dioxide|4-Ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda*6*-thieno(2,3-b)thiopyran-2-sulfonic acid amide|4-ethylamino-6-methyl-7,7-dioxo-4,5,6,7-tetrahydro-7lambda6-thieno(2,3-b)thiopyran-2-sulfonic acid amide|RefChem:57214|DTXCID802960|S01EC03|4-ethylamino-5,6-dihydro-6-methyl-7,7-dioxide-4H-thieno(2,3-b)thiopyran-2-sulfonamide|5,6-dihydro-4-ethylamino-6-methyl-4H-thieno(2,3-b)thiopyran-2-sulfonamide-7,7-dioxide|(4S,6S)-4-(ethylamino)-6-methyl-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide 7,7-dioxide|Dorzolamide (INN)|(4S,6S)-4-(ethylamino)-6-methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-2-sulfonamide|Trusopt (TN)|(4S-TRANS)-4-(ETHYLAMINO)-5,6-DIHYDRO-6-METHYL-4H-THIENO(2,3-B)THIOPYRAN-2-SULFONAMIDE-7,7-DIOXIDE|DORZOLAMIDE [INN]|C10H16N2O4S3|4H-Thieno[2,3-b]thiopyran-2-sulfonamide,4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, (4S,6S)-|Dorzolamide (DZA)|Dorzolamide [INN:BAN]|UNII-9JDX055TW1|SR-05000001449|1cil|4H-Thieno(2,3-b)thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, (4S,6S)-|4H-Thieno[2,3-b]thiopyran-2-sulfonamide, 4-(ethylamino)-5,6-dihydro-6-methyl-, 7,7-dioxide, (4S,6S)-|DORZOLAMIDE [MI]|Prestwick0_001116|Prestwick1_001116|Prestwick2_001116|Prestwick3_001116|DORZOLAMIDE [VANDF]|UNII 9JDX055TW1|SCHEMBL24061|BSPBio_001252|DORZOLAMIDE [WHO-DD]|MLS006011430|BIDD:GT0306|SPBio_003116|BPBio1_001377|CHEMBL218490|GTPL6810|orb1704561|BDBM10884|Dorzolamide, >=98% (HPLC)|IAVUPMFITXYVAF-XPUUQOCRSA-N|GLXC-02997|HMS2089O06|HY-B0109|MSK11304|STK645522|AKOS005576255|CS-1859|DB00869|NCGC00179244-04|AS-14731|SMR004703245|AB00514687|NS00001504|C06969|D07871|AB00514687-06|AB00514687-07|AB00514687_08|A804484|EN300-19766577|Q415401|SR-05000001449-1|BRD-K48617017-003-03-1|(2S,4S)-4-(ethylamino)-2-methyl-1,1-dioxo-2H,3H,4H-1$l^{6},7-thieno[2,3-b]thiopyran-6-sulfonamide|(2S,4S)-4-(ethylamino)-2-methyl-1,1-dioxo-2H,3H,4H-1lambda6-thieno[2,3-b]thiopyran-6-sulfonamide|(4S,6S)-4-(ETHYLAMINO)-5,6-DIHYDRO-6-METHYL-4H-THIENO(2,3-B)THIOPYRAN-2-SULFONAMIDE 7,7-DIOXIDE|(4S,6S)-4-(ethylamino)-5,6-dihydro-6-methyl-4H-thieno[2,3-b]thiopyran-2-sulfonamide-7,7-dioxide"
PACTIMIBE,3081927,,"InChI=1S/C25H40N2O3/c1-7-8-9-10-11-12-14-27-15-13-19-17(2)20(16-21(28)29)18(3)22(23(19)27)26-24(30)25(4,5)6/h7-16H2,1-6H3,(H,26,30)(H,28,29)",TXIIZHHIOHVWJD-UHFFFAOYSA-N,C25H40N2O3,416.6,"2-[7-(2,2-dimethylpropanoylamino)-4,6-dimethyl-1-octyl-2,3-dihydroindol-5-yl]acetic acid","Pactimibe|189198-30-9|pactimiba|D874R9PZ9T|(7-(2,2-Dimethylpropanamido)-4,6-dimethyl-1-octylindolin-5-yl)acetic acid|DTXSID80172315|pactimibum|[7-(2,2-Dimethylpropanamido)-4,6-dimethyl-1-octylindolin-5-yl]acetic acid|RefChem:169502|DTXCID1094806|2-(7-(2,2-dimethylpropanamido)-4,6-dimethyl-1-octyl-2,3-dihydro-1H-indol-5-yl)acetic acid|UNII-D874R9PZ9T|Pactimibe [INN:BAN]|Pactimibe free base|1H-Indole-5-acetic acid, 7-[(2,2-dimethyl-1-oxopropyl)amino]-2,3-dihydro-4,6-dimethyl-1-octyl-|CHEMBL478858|189198-30-9 (free base)|2-[7-(2,2-dimethylpropanoylamino)-4,6-dimethyl-1-octyl-2,3-dihydroindol-5-yl]acetic acid|2-[7-(2,2-Dimethylpropanoylamino)-4,6-dimethyl-1-octyl-2,3-dihydroindo L-5-yl]acetic acid|1H-Indole-5-acetic acid, 7-((2,2-dimethyl-1-oxopropyl)amino)-2,3-dihydro-4,6-dimethyl-1-octyl-|(7-(2,2-dimethylpropanamido)-4,6-dimethyl-1-octylindolin-5-yl)acetic acid hemisulfate|PACTIMIBE [INN]|PACTIMIBE [WHO-DD]|SCHEMBL282098|orb1699725|SCHEMBL29376974|EX-A6395A|TXIIZHHIOHVWJD-UHFFFAOYSA-N|GLXC-27010|BDBM50263192|AKOS040749113|DB12971|MS-27258|HY-100401|CS-0018790|NS00068626|G13773|198P309|Q27276240|2-(4,6-Dimethyl-1-octyl-7-pivalamidoindolin-5-yl)acetic acid|N-(1- Octyl-5-carboxymethyl-4,6-dimethylindolin-7-yl)-2,2-dimethyl-propanamide|N-(1-Octyl-5-carboxymethyl-4,6-dimethylindolin-7-yl)-2,2-dimethyl-propanamide|N-(1-Octyl-5-carboxymethyl-4,6-dimethylindolin-7-yl)-2,2-dimethylpropanamide"
DICHLORPHENAMIDE,3038,,"InChI=1S/C6H6Cl2N2O4S2/c7-4-1-3(15(9,11)12)2-5(6(4)8)16(10,13)14/h1-2H,(H2,9,11,12)(H2,10,13,14)",GJQPMPFPNINLKP-UHFFFAOYSA-N,C6H6Cl2N2O4S2,305.2,"4,5-dichlorobenzene-1,3-disulfonamide","dichlorphenamide|Diclofenamide|120-97-8|4,5-dichlorobenzene-1,3-disulfonamide|Dichlofenamide|Dichlorophenamide|Daranide|1,3-Benzenedisulfonamide, 4,5-dichloro-|Dichlorphenamid|Antidrasi|Glaucol|Oratrol|Diclofenamida|Diclofenamid|Diclofenamidum|4,5-Dichloro-m-benzenedisulfonamide|1,3-Disulfamyl-4,5-dichlorobenzene|1,3-Disulfamoyl-4,5-dichlorobenzene|4,5-Dichloro-1,3-disulfamoylbenzene|Keveyis|3,4-Dichloro-5-sulfamylbenzenesulfonamide|4,5-Dichloro-1,3-benzenedisulfonamide|Dichlorphenamide (USP)|m-Benzenedisulfonamide, 4,5-dichloro-|DTXSID1022922|VVJ6673MHY|CHEBI:101085|Dichlorphenamide [USP]|4,5-Dichloro-benzene-1,3-disulfonic acid diamide|DTXCID402922|ORMALVI|RefChem:57674|S01EC02|204-440-6|Glauconide|Diclofenamidum [INN-Latin]|Diclofenamida [INN-Spanish]|CB 8000|MFCD00148948|Diclofenamide [INN]|C6H6Cl2N2O4S2|CHEMBL17|Barastonin|Dichlorphenamide (Diclofenamide)|Glajust|Glaumid|Glafco|NCGC00016371-01|CAS-120-97-8|Dasanide|Daranide (TN)|HSDB 3267|120D978|Dichlorophenamide (DCP)|EINECS 204-440-6|UNII-VVJ6673MHY|BRN 2703329|Diclorfenamida|Diclorfenammide|sulfonamide 4|2pou|4,5-Dichloro-m-benzendisulfonamide|Keveyis (TN)|Prestwick_1071|Dichlorophenamide, DCP|Prestwick0_000809|Prestwick1_000809|Prestwick2_000809|Prestwick3_000809|Diclofenamide (JAN/INN)|Dichlorphenamide (Standard)|DICLOFENAMIDE [JAN]|BSPBio_000677|DICHLORPHENAMIDE [MI]|MLS002154010|DICLOFENAMIDE [MART.]|SCHEMBL112376|SPBio_002598|DICHLORPHENAMIDE [HSDB]|DICLOFENAMIDE [WHO-DD]|BPBio1_000745|GTPL6807|orb1300741|SCHEMBL29355725|BDBM10883|HY-B0397R|Dichlorphenamide (Diclofenamide)?|DICHLORPHENAMIDE [USP-RS]|GLXC-02996|GLXC-22623|HMS1570B19|HMS2097B19|HMS2236I07|HMS3373G04|HMS3655H06|HMS3714B19|HMS3745K19|HMS5080A18|BCP22591|EX-A1311|HY-B0397|MSK10696|RFC05476|Tox21_110401|s2177|SBB058142|4,5-dichlorobenzene1,3-disulfonamide|DICHLORPHENAMIDE [ORANGE BOOK]|AKOS015899860|CCG-220809|DB01144|DICHLORPHENAMIDE [USP IMPURITY]|4,5-Dicholorobenzene-1,3-disulfonamide|DICHLORPHENAMIDE [USP MONOGRAPH]|NCGC00016371-02|NCGC00016371-04|NCGC00016371-05|NCGC00016371-06|NCGC00016371-08|AC-25007|AS-63955|I7A|SMR001233338|4,5-Dichloro-1,3-benzenedisulfonamide #|DICHLORPHENAMIDE, SECONDARY STANDARD|NS00004452|ST51014977|SW197138-3|C07459|D00518|EN300-761460|F90397|SR-01000841825|Q3706987|SR-01000841825-2|BRD-K71499074-001-03-8|BRD-K71499074-001-12-9|Z2037279821|Dichlorphenamide, United States Pharmacopeia (USP) Reference Standard|Diclofenamide; Dichlofenamide; Daranide; 4,5-dichlorobenzene-1,3-disulfonamide"
SULFANILAMIDE,5333,,"InChI=1S/C6H8N2O2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H2,8,9,10)",FDDDEECHVMSUSB-UHFFFAOYSA-N,C6H8N2O2S,172.21,4-aminobenzenesulfonamide,"sulfanilamide|4-Aminobenzenesulfonamide|63-74-1|Sulphanilamide|Sulfamine|p-Aminobenzenesulfonamide|Sulfonamide|Sulphonamide|Sulfonylamide|Prontylin|p-Aminobenzenesulfamide|Prontosil Album|4-Aminobenzene-1-Sulfonamide|Bacteramid|Streptasol|Streptocid|p-Sulfamoylaniline|Sulfonamide P|Benzenesulfonamide, 4-amino-|Prontosil I|Estreptocida|Exoseptoplix|Streptoclase|Sulfamidyl|Sulfanalone|Sulfanidyl|Sulfocidine|p-Sulfamidoaniline|Sulfana|Sulfanil|4-Sulfamoylaniline|Sulfanilimidic acid|p-Anilinesulfonamide|p-Aminophenylsulfonamide|Streptrocide|Ambeside|Antistrept|Astreptine|Astrocid|Bactesid|Collomide|Colsulanyde|Copticide|Deseptyl|Ergaseptine|Erysipan|Gombardol|Lysococcine|Neococcyl|Orgaseptine|Prontalbin|Proseptal|Proseptine|Proseptol|Pysococcine|Septanilam|Septinal|Septolix|Septoplex|Septoplix|Strepamide|Strepsan|Streptagol|Streptamid|Streptamin|Streptocide|Streptocom|Strepton|Streptopan|Streptosil|Streptozol|Streptozone|Sulfocidin|Therapol|Albexan|Albosal|Dipron|Gerison|Infepan|Sanamid|Stramid|Tolder|Lusil|Prontosil White|Septamide Album|Pronzin Album|Stopton Album|Streptocid album|Rubiazol A|White streptocide|4-Aminophenylsulfonamide|Streptocide White|PABS|Aniline-p-sulfonic amide|Fourneau 1162|Streptocidum|Sulfanilamida|Sulfanilamidum|Benzenesulfonamide, p-amino-|4-azanylbenzenesulfonamide|Solfanilamide|Sulphanilamidum|4-(Aminosulfonyl)aniline|para-aminobenzenesulfonamide|1162 F|A-349|F 1162|CHEBI:45373|4-aminobenzene sulfonic acid amide|NSC-7618|DTXSID4023622|NSC7618|F-1162|21240MF57M|DTXCID903622|4 aminobenzenesulfonamide|RefChem:6271|4-aminobenzenesulfonimidic acid|CHEBI:35358|D06BA05|J01EB06|200-563-4|p-Aminobenzenesulfonylamide|Sulfanilamide Vaginal Cream|MFCD00007939|p-Aminobenzensulfonamide|4-Amino-benzenesulfonamide|CHEMBL21|Sulfanilamide Melting Point Standard|AVC|(4-(Aminosulfonyl)phenyl)amine|F1162|Sulfanilamide (INN)|CAS-63-74-1|NCGC00016285-02|NCGC00016285-05|4-Aminobenzenesulphonamide (Sulphanilamide)|Sulfanilamide, >=99%|SULFANILAMIDE [INN]|Streptocide (VAN)|Solfanilamide [DCIT]|Caswell No. 809A|HSDB 223|Sulfanilamidum [INN-Latin]|Sulfanilamida [INN-Spanish]|AAS|SMR000059035|CCRIS 764|SR-01000763435|NSC 7618|EINECS 200-563-4|EPA Pesticide Chemical Code 077902|BRN 0511852|Sulfanilamide [INN:DCF:NF]|AI3-00952|sulphanilic amide|4-sulphanilamide|UNII-21240MF57M|Streptocid (TN)|delta-Sulfanilamide|Prestwick_36|4-sulfamoyl-aniline|4-sulphamoyl aniline|Spectrum_000489|4-aminobenzensulfonamide|aniline, 4-sulphamoyl-|Sulfanilamide (Standard)|WLN: ZSWR DZ|4-aminobenzenesulphonamide|p-aminobenzene sulfonamide|Prestwick0_000729|Prestwick1_000729|Prestwick2_000729|Prestwick3_000729|Spectrum2_000846|Spectrum3_001406|Spectrum4_000398|Spectrum5_001081|4-aminobenzene sulfonamide|4-aminobenzene-sulfonamide|p-aminosulfonyl phenylamine|SCHEMBL740|SULFANILAMIDE [MI]|4-amino-benzenesulphonamide|Epitope ID:122232|p-amino benzene sulfonamide|AVC (TN)|SULFANILAMIDE [HSDB]|Oprea1_273157|BSPBio_000658|BSPBio_003052|KBioGR_000955|KBioSS_000969|SULFANILAMIDE [VANDF]|4-14-00-02658 (Beilstein Handbook Reference)|MLS001074682|MLS002152940|BIDD:GT0170|DivK1c_000528|SPECTRUM1500646|SULFANILAMIDE [MART.]|SULPHANILAMIDUM [HPUS]|SPBio_000831|SPBio_002597|Sulfadimethoxine EP Impurity E|SULFANILAMIDE [USP-RS]|SULFANILAMIDE [WHO-DD]|aromatic sulfonamide compound 5|BPBio1_000724|halogenosulfanilamide deriv. 5a|orb1310915|SCHEMBL1408800|SCHEMBL1807855|SCHEMBL11521963|SCHEMBL11880061|BDBM10857|GTPL12631|HMS501K10|HY-B0242R|KBio1_000528|KBio2_000969|KBio2_003537|KBio2_006105|KBio3_002272|Sulfanilamide, p.a., 99.0%|MSK4015|NINDS_000528|HMS1570A20|HMS1921O07|HMS2092E20|HMS2097A20|HMS2233B19|HMS3370J16|HMS3655K19|HMS3714A20|HMS3744M13|HMS5079F12|Pharmakon1600-01500646|Ro13354|SULFANILAMIDE [ORANGE BOOK]|HY-B0242|SULFANILAMIDE [EP MONOGRAPH]|Tox21_110351|Tox21_201331|Tox21_303336|4-AMINO-1-BENZENESULFONAMIDE|AC9456|aromatic/heteroaromatic sulfonamide 2|BBL005257|c1264|CCG-40302|NSC757404|s1685|SBB008928|STK298902|AKOS000119305|Tox21_110351_1|DB00259|FS07881|NSC-757404|IDI1_000528|NCGC00016285-01|NCGC00016285-03|NCGC00016285-04|NCGC00016285-06|NCGC00016285-08|NCGC00091144-01|NCGC00091144-02|NCGC00091144-03|NCGC00257174-01|NCGC00258883-01|AS-13239|BP-12552|DA-58177|ST079295|Sulfanilamide (4-Aminobenzenesulfonamide)|SY009959|SBI-0051575.P002|AB00052138|NS00000007|S0381|S0833|SULFADIAZINE IMPURITY D [EP IMPURITY]|SW196353-3|EN300-16979|SULFADIMIDINE IMPURITY D [EP IMPURITY]|Sulfanilamide 1000 microg/mL in Acetonitrile|Sulfanilamide, JIS special grade, >=99.7%|Sulfanilamide, Vetec(TM) reagent grade, 97%|C07458|D08543|AB00052138-10|AB00052138_11|AB00052138_12|SULFADIMETHOXINE IMPURITY E [EP IMPURITY]|SULFAMETHOXAZOLE IMPURITY E [EP IMPURITY]|A834498|AC-907/25014139|F037364|Q423423|Sulfanilamide, VETRANAL(TM), analytical standard|SR-01000763435-2|SR-01000763435-3|SR-01000763435-4|BRD-K02594908-001-15-6|BRD-K02594908-001-16-4|SULFACETAMIDE SODIUM IMPURITY A [EP IMPURITY]|Sulfanilamide (166 degrees C) Melting Point Standard|Z56851240|F2190-0451|BENZENESULFONIC ACID,4-AMINO,AMIDE   SULFANILAMIDE|Sulfanilamide, European Pharmacopoeia (EP) Reference Standard|Sulfanilamide, United States Pharmacopeia (USP) Reference Standard|Reagecon Melting Point Sulphanilamide +164 to +166 degrees C Standard|SULFADIMETHOXINE SODIUM FOR VETERINARY USE IMPURITY E [EP IMPURITY]|InChI=1/C6H8N2O2S/c7-5-1-3-6(4-2-5)11(8,9)10/h1-4H,7H2,(H2,8,9,10|Sulfanilamide Melting Point Standard, United States Pharmacopeia (USP) Reference Standard|1337-39-9|Sulfanilamide melting point standard, Pharmaceutical Secondary Standard; Certified Reference Material"
BRINZOLAMIDE,68844,,"InChI=1S/C12H21N3O5S3/c1-3-14-10-8-15(5-4-6-20-2)23(18,19)12-9(10)7-11(21-12)22(13,16)17/h7,10,14H,3-6,8H2,1-2H3,(H2,13,16,17)/t10-/m0/s1",HCRKCZRJWPKOAR-JTQLQIEISA-N,C12H21N3O5S3,383.5,"(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide","Brinzolamide|138890-62-7|Azopt|AL-4862|AL 4862|Brinzolamida|CHEBI:3176|DTXSID6045531|NSC-760050|(R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide 1,1-dioxide|2H-Thieno(3,2-e)-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (R)-|DTXCID4025531|AZARGA COMPONENT BRINZOLAMIDE|9451Z89515|SIMBRINZA COMPONENT BRINZOLAMIDE|(R)-4-(Ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide|brinzolamidum|(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-2H,3H,4H-1$l^(6),7,2-thieno(3,2-e)(1$l^(6),2)thiazine-6-sulfonamide|(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-2H,3H,4H-1$l^{6},7,2-thieno[3,2-e][1$l^{6},2]thiazine-6-sulfonamide|(4R)-4-ethylamino-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno(4,5-e)thiazine-6-sulfonamide|(4R)-4-ethylamino-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[4,5-e]thiazine-6-sulfonamide|(R)-4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno(3,2-e)-1,2-thiazine-6-sulfonamide|RefChem:57193|S01EC04|(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-3,4-dihydrothieno[3,2-e]thiazine-6-sulfonamide|MFCD08067749|C12H21N3O5S3|138890-50-3|2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide, 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-, 1,1-dioxide, (4R)-|(4R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide|(R)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2H-thieno[3,2-e][1,2]thiazine-6-sulfonamide 1,1-dioxide|Birnzolamide|(+)-4-ETHYLAMINO-3,4-DIHYDRO-2-(METHOXY)PROPYL-2H-THIENO[3,2-E]-1,2-THIAZINE-6-SULFONAMIDE-1,1-DIOXIDE|Brinzolamide [USAN]|BZ1|(4R)-4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide|Brinzolamide (BRZ)|Azopt (TN)|Brinzolamide (JAN/USP/INN)|3znc|NCGC00016979-01|Brinzolamide [USAN:USP:INN:BAN]|UNII-9451Z89515|CAS-138890-62-7|Brinzolamide (Standard)|Prestwick0_000365|Prestwick1_000365|Prestwick2_000365|Prestwick3_000365|BRINZOLAMIDE [MI]|BRINZOLAMIDE [INN]|BRINZOLAMIDE [JAN]|BRINZOLAMIDE [VANDF]|SCHEMBL24636|BRINZOLAMIDE [MART.]|BSPBio_000489|MLS002153787|BIDD:GT0039|BRINZOLAMIDE [USP-RS]|BRINZOLAMIDE [WHO-DD]|SPBio_002410|BPBio1_000539|CHEMBL220491|GTPL6797|orb1310899|BRINZOLAMIDE [EMA EPAR]|BDBM10885|Brinzolamide - Bio-X trade mark|HY-B0588R|Brinzolamide, >=98% (HPLC)|MSK4066|HCRKCZRJWPKOAR-JTQLQIEISA-N|BRINZOLAMIDE [ORANGE BOOK]|GLXC-05158|HMS1569I11|HMS2096I11|HMS2234K06|HMS3713I11|HMS3885I11|BRINZOLAMIDE [USP IMPURITY]|BCP22330|HY-B0588|BRINZOLAMIDE [USP MONOGRAPH]|Tox21_110722|AL4862|s3178|AKOS005145708|Tox21_110722_1|AC-5277|CCG-220365|CCG-222516|DB01194|FB29475|NSC 760050|NCGC00179542-03|NCGC00179542-09|NCGC00179542-10|AS-35084|BB164262|SMR001233169|SY009759|AB00513824|B4258|NS00009895|SW197152-3|C07760|D00652|AB00513824_06|EN300-7404820|F387702|Q411517|SR-01000838832|SR-01000838832-2|BRD-K74913225-001-03-3|BRD-K74913225-001-12-4|BRD-K74913225-001-13-2|Brinzolamide, United States Pharmacopeia (USP) Reference Standard|(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-2H,3H,4H-1$l^{6},7,2-thieno[3,2-e][1,2]thiazine-6-sulfonamide|(4R)-4-(ethylamino)-2-(3-methoxypropyl)-1,1-dioxo-2H,3H,4H-1lambda6-thieno[3,2-e][1,2]thiazine-6-sulfonamide|(4r)-4-(ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-2h-thieno[3,2-e][1,2]thiazine-6-sulfonamide-1,1-dioxide|(5R)-5-ethylamino-3-(3-methoxypropyl)-2,2-dioxo-2,9-dithia-3-azabicyclo[4.3.0]nona-1(6)7-diene-8-sulfonamide|(5R)-5-Ethylamino-3-(3-methoxypropyl)-2,2-dioxo-2?6,9-dithia-3-azabicyclo[4.3.0]nona-7,10-diene-8-sulfonamide|(R)- 4-(ethylamino)-3,4-dihydro-2-(3-methoxypropyl)-2H-Thieno[3,2-e]-1,2-thiazine-6-sulfonamide 1,1-dioxide|(R)-3,4-Dihydro-4-ethylamino-2-(3-methoxypropyl)-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide-1,1-dioxide|(R)-4-(Ethylamino)-2-(3-methoxypropyl)-3,4-dihydro-1,1-dioxo-2H-thieno[3,2-e]-1,2-thiazine-6-sulfonamide"
CARZENIDE,8739,,"InChI=1S/C7H7NO4S/c8-13(11,12)6-3-1-5(2-4-6)7(9)10/h1-4H,(H,9,10)(H2,8,11,12)",UCAGLBKTLXCODC-UHFFFAOYSA-N,C7H7NO4S,201.20,4-sulfamoylbenzoic acid,"Carzenide|138-41-0|4-Carboxybenzenesulfonamide|4-(Aminosulfonyl)benzoic acid|Carzenid|Dirnate|p-Sulfamoylbenzoic acid|Carzenida|Carzenidum|NSC-22976|4-sulfamolybenzoic acid|Carcenida|30Z5HQB5A4|DTXSID1045089|DTXCID9025089|p-sulphamoylbenzoic acid|RefChem:574766|205-327-4|sulfamoylbenzoic acid|4-Sulfamoylbenzoic acid|Benzoic acid, 4-(aminosulfonyl)-|p-Carboxybenzenesulfonamide|p-Sulfamylbenzoic acid|4-Sulfamylbenzoic acid|Benzoic acid p-sulfamide|Carzenide [INN]|p-Sulfonamidobenzoic acid|4-Aminosulfonylbenzoic acid|MFCD00007938|Benzoic acid 4-sulfamide|BENZOIC ACID, p-SULFAMOYL-|NSC22976|NSC 22976|CHEMBL414|Carzenide (INN)|NSC683540|NCGC00013287-06|NCGC00013287-07|4-Sulfamoylbenzoesaeure|4-Sulfamoyl-benzoic acid|Carzenidum [INN-Latin]|Carzenida [INN-Spanish]|CAS-138-41-0|4-Sulfamidobenzoic acid|SR-01000000114|EINECS 205-327-4|BRN 1875393|UNII-30Z5HQB5A4|4SO|4-sulamoylbenzoic acid|CARZENIDE [MI]|Maybridge1_002385|4-Carboxyphenylsulfonamide|4-sulphamoyl-benzoic acid|Benzoic Acid deriv. 31|p-Aminosulfonylbenzoic acid|CARZENIDE [MART.]|4-carboxy-benzenesulfonamide|Cambridge id 5121815|CARZENIDE [WHO-DD]|benzoic acid, 4-sulfamoyl-|NCIStruc1_000566|NCIStruc2_000413|p-Aminosulfonyl-benzoic Acid|Oprea1_448551|4-carboxybenzenesulfonamide 1|Para-Carboxybenzenesulfonamide|JMC52646 Compound 23|MLS000069605|DivK1c_001137|SCHEMBL312419|4-Carboxybenzenesulfonamide (4-Sulfamoylbenzoic acid)|4-Sulfamoylbenzoic acid, 97%|BDBM4703|JMC522226 Compound 22|JMC523116 Compound 22|orb1310650|SCHEMBL1498149|P-SULFAMOYL-BENZOIC ACID|HMS548E09|UCAGLBKTLXCODC-UHFFFAOYSA-|4-(Aminosulfonyl)benzoic acid #|CHEBI:177418|HMS2234G21|HMS3264O07|HMS3369M14|HMS5083J11|Pharmakon1600-01504505|HY-B0989|NCI22976|Tox21_110021|BBL011102|CCG-38010|NCGC00013287|NSC758886|s4556|SBB003533|STK802346|AKOS000144547|aromatic/heteroaromatic sulfonamide 23|Tox21_110021_1|CS-4482|NSC-683540|NSC-758886|SB78174|CDS1_000097|NCGC00013287-02|NCGC00013287-03|NCGC00013287-04|NCGC00013287-05|NCGC00021607-03|NCGC00021607-04|AS-14571|NCI60_001869|SMR000059013|SY002923|SBI-0054135.P002|EU-0033692|NS00024481|ST45090251|EN300-16248|D09322|AB00384334_11|CS-009/03918038|F078955|SR-01000000114-2|SR-01000000114-3|SR-01000000114-4|BRD-K09295674-001-08-0|BRD-K09295674-001-09-8|Q27255987|Z53021532|F0347-1766|InChI=1/C7H7NO4S/c8-13(11,12)6-3-1-5(2-4-6)7(9)10/h1-4H,(H,9,10)(H2,8,11,12)"
INDISULAM,216468,,"InChI=1S/C14H12ClN3O4S2/c15-12-8-17-14-11(12)2-1-3-13(14)18-24(21,22)10-6-4-9(5-7-10)23(16,19)20/h1-8,17-18H,(H2,16,19,20)",SETFNECMODOHTO-UHFFFAOYSA-N,C14H12ClN3O4S2,385.8,"4-N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide","Indisulam|165668-41-7|N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide|E7070|E-7070|N1-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide|indisulamum|WJ98J3NM90|CHEBI:145431|DTXSID50168008|N-(3-chloro-7-indolyl)-1,4-benzenedisulphonamide|N-(3-chloro-7-indolyl)-1,4-benzenedisulfonamide|RefChem:790922|DTXCID2090499|N-(3-Chloro-7-indoyl)-1,4-Benzenedisulfonamide|4-N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide|N-(3-Chloro-1H-indol-7-yl)-1,4-benzenedisulfonamide|1,4-Benzenedisulfonamide, N1-(3-chloro-1H-indol-7-yl)-|MFCD00945325|CHEMBL77517|N~1~-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide|C14H12ClN3O4S2|indisulam (e7070)|E 7070|UNII-WJ98J3NM90|Indisulam (IND)|EF6|1,4-Benzenedisulfonamide, N-(3-chloro-1H-indol-7-yl)-|ER-35744|INDISULAM [INN]|INDISULAM [MI]|Indisulam (USAN/INN)|INDISULAM [USAN]|INDISULAM [WHO-DD]|SCHEMBL91389|Indisulam [USAN:INN:BAN]|GTPL7046|N-(3-Chloro-1H-indol-7-yl)benzene-1,4disulfonamide|orb1302953|Indisulam, >=98% (HPLC)|N4-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide|SCHEMBL29799438|BDBM10890|GLXC-01609|GLXC-10197|BCP06110|s9742|AKOS022181456|DB06370|SB16544|AC-36646|AS-69532|HY-13650|DB-064580|CS-0007710|NS00068354|C73201|D04522|EN300-7378250|668I417|BRD-K17610631-001-03-3|Q27078056|1-N-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide|Z2724205552|N(1)-(3-chloro-1H-indol-7-yl)benzene-1,4-disulfonamide|n-(3-chloro-1h-indol-7-yl)-4-sulfamoylbenzenesulfonamide|1,4-BENZENEDISULFONAMIDE, N-(3-CHLORO-1H-INDOL-7-YL)"
TOPIRAMATE,5284627,,"InChI=1S/C12H21NO8S/c1-10(2)18-7-5-16-12(6-17-22(13,14)15)9(8(7)19-10)20-11(3,4)21-12/h7-9H,5-6H2,1-4H3,(H2,13,14,15)/t7-,8-,9+,12+/m1/s1",KJADKKWYZYXHBB-XBWDGYHZSA-N,C12H21NO8S,339.36,"[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate","topiramate|97240-79-4|Topamax|Epitomax|Topamax Sprinkle|Tipiramate|Topiramato|Topiramatum|Topimax|Topina|Topomax|McN-4853|Tipiramato|Epitoma|Topamac|RWJ-17021|RWJ-17021-000|Sincronil|Qudexy|topiramate tablet|Trokendi XR|Qudexy XR|USL255|(-)-topiramate|USL-255|2,3:4,5-Bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|EPRONTIA|2,3:4,5-Di-O-isopropylidene-beta-D-fructopyranose sulfamate|DTXSID8023688|CHEBI:63631|0H73WJJ391|DTXCID103688|QSYMIA COMPONENT TOPIRAMATE|beta-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate|[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.02,6]dodecan-6-yl]methyl sulfamate|[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0^{2,6}]dodecan-6-yl]methyl sulfamate|McN4853|topiramate spinkle|((1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo(7.3.0.0^(2,6))dodecan-6-yl)methyl sulfamate|((1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo(7.3.0.02,6)dodecan-6-yl)methyl sulfamate|((3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi(1,3)dioxolo(4,5-a:5',3'-d)pyran-3a-yl)methyl sulfamate|[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyl-5,5a,8a,8b-tetrahydrodi[1,3]dioxolo[4,5-a:5',3'-d]pyran-3a-yl]methyl sulfamate|RefChem:56737|GlyTouCan:G44123KB|2,3-4,5-bis-O-(1-methylethylidene)-beta-D-fructopyranose sulfamate|N03AX11|G44123KB|MFCD00865320|McN 4853|C12H21NO8S|((3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis([1,3]dioxolo)[4,5-b:4',5'-d]pyran-3a-yl)methyl sulfamate|[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate|Tipiramate [French]|Tipiramato [Spanish]|Topiramatum [INN-Latin]|topiramatum [Latin]|Topiramato [INN-Spanish]|TPM|2,3:4,5-Di-O-isopropylidene-b-D-fructopyranose sulfamate|Topiragen|Topax|((3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl)methyl sulfamate|SMR000466325|Topiramate (TPM)|TOR|Topamax (TN)|CAS-97240-79-4|BRN 5988957|UNII-0H73WJJ391|HSDB 7531|McN 4853;RWJ 17021|Sulfamate 7|3hku|3lxe|USL 255|Topiramate [USAN:USP:INN:BAN]|NCGC00095181-01|Trokendi xr (TN)|RWJ 17021|KS-1122|Topiramate (Standard)|TOPIRAMATE [MI]|TOPIRAMATE [INN]|TOPIRAMATE [JAN]|Spectrum2_001128|TOPIRAMATE [HSDB]|TOPIRAMATE [USAN]|2,3:4,5-Bis-O-(1-methylethylidene)-36-D-fructo-pyranose sulfamate|TOPIRAMATE [VANDF]|CBChromo1_000352|TOPIRAMATE [MART.]|TOPIRAMATE [USP-RS]|TOPIRAMATE [WHO-DD]|BIDD:PXR0127|SCHEMBL34631|BSPBio_002306|Topiramate (JAN/USP/INN)|Eprontia (liquid formulation)|MLS000759431|MLS001424070|BIDD:GT0854|SPECTRUM1505801|SPBio_000995|CHEMBL220492|GTPL6849|orb1310396|TOPIRAMATE [ORANGE BOOK]|BDBM10887|HY-B0122R|TOPIRAMATE [EP MONOGRAPH]|TOPIRAMATE [USP IMPURITY]|HMS1922H06|HMS2051L09|HMS2093D20|HMS2232H21|HMS3414C15|HMS3678C15|HMS3715I12|HMS3884C17|Pharmakon1600-01505801|TOPIRAMATE [USP MONOGRAPH]|[(3aS,5aR,8aR,8bS)-2,2,7,7-tetramethyltetrahydro-3aH-bis[1,3]dioxolo[4,5-b:4',5'-d]pyran-3a-yl]methyl sulfamate (non-preferred name)|ALBB-022457|HY-B0122|MSK10313|Topiramate, 1mg/ml in Acetonitrile|Tox21_111472|Tox21_302401|HB0618|NSC759251|s1438|.beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, sulfamate|AKOS000424547|Topiramate 1.0 mg/ml in Acetonitrile|Topiramate, >=98% (HPLC), solid|Tox21_111472_1|CCG-100940|CS-1885|DB00273|MD03549|NC00190|NSC 759251|NSC-759251|NCGC00178714-01|NCGC00178714-04|NCGC00178714-18|NCGC00255221-01|SY028640|SBI-0206907.P001|NS00010259|SW197570-3|C07502|D00537|EN300-118319|F20536|AB00639961-06|AB00639961-08|AB00639961_09|AB00639961_10|240T794|Q221174|SR-01000759409|W-60376|SR-01000759409-4|BRD-K29653726-001-13-4|BRD-K29653726-001-14-2|BRD-K29653726-001-15-9|Z1511495258|Topiramate, United States Pharmacopeia (USP) Reference Standard|2,3:4,5-Bis-O-(1-methylethylidene) ?-D-fructopyranose sulfamate|2,3:4,5-DI-O-ISOPROPYLIDENE-.BETA.-D-FRUCTOPYRANOSE SULFAMATE|Topiramate, Pharmaceutical Secondary Standard; Certified Reference Material|.beta.-D-Fructopyranose, 2,3:4,5-bis-O-(1-methylethylidene)-, 1-sulfamate|[(1R,2S,6S,9R)-4,4,11,11-tetramethyl-3,5,7,10,12-pentaoxatricyclo[7.3.0.0,2,6]dodecan-6-yl]methyl sulfamate"
SULPIRIDE,5355,,"InChI=1S/C15H23N3O4S/c1-3-18-8-4-5-11(18)10-17-15(19)13-9-12(23(16,20)21)6-7-14(13)22-2/h6-7,9,11H,3-5,8,10H2,1-2H3,(H,17,19)(H2,16,20,21)",BGRJTUBHPOOWDU-UHFFFAOYSA-N,C15H23N3O4S,341.4,N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide,"sulpiride|15676-16-1|Sulpyrid|Sulpirid|Aiglonyl|Dolmatil|Dogmatil|Guastil|Dogmatyl|Mirbanil|Misulvan|Neogama|Omperan|Splotin|Sursumid|Abilit|Dobren|Meresa|Coolspan|Sernevin|Sulpitil|Sulpirida|Synedil|N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide|Pyrikappl|Sulpiridum|Sulpor|RD 1403|(+-)-sulpiride|N-((1-Ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-o-anisamide|DTXSID1042574|5-(Aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxybenzamide|N-((1-Ethyl-2-pyrrolidinyl)methyl)-2-methoxy-5-sulfamoylbenzamide|CHEBI:32168|N05AL01|7MNE9M8287|Benzamide, 5-(aminosulfonyl)-N-((1-ethyl-2-pyrrolidinyl)methyl)-2-methoxy-|o-Anisamide, N-((1-ethyl-2-pyrrolidinyl)methyl)-5-sulfamoyl-|NSC-757850|RD-1403|N-[(1-ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoyl-benzamide|DTXCID9022574|n-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoylbenzamide|Benzamide, 5-(aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-|Sulperide|vertigo neogama|vertigo-neogama|Vertigo Meresa|Vertigo-Meresa|N-((1-ethylpyrrolidin-2-yl)methyl)-2-methoxy-5-sulfamoyl-benzamide|RefChem:56075|N-(1-Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide|239-753-7|(+/-)-Sulpiride|Miradol|(RS)-(+/-)-sulpiride|Eglonyl|Psicocen|Pyrkappl|Sulpiridum [INN-Latin]|Sulpirida [INN-Spanish]|MFCD00055061|dl-sulpiride|R.D. 1403|CHEMBL26|rac Sulpiride|Calmoflorine|Championyl|Lisopiride|Stamonevrol|Alimoral|Darleton|Desmenat|Dresent|Eglonil|Equilid|Eusulpid|Fardalan|Fidelan|Isnamide|Kylistro|Mariastel|Norestran|Nufarol|Ozoderpin|Restful|Suprium|Valirem|Zemorcon|Enimon|Normum|Omiryl|Levosulpiridum [INN-Latin]|Levosulpirida [INN-Spanish]|Sulpiride-R|(+)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoyl-benzamide|SMR000038923|CCRIS 4248|SULPIRIDE,(+)|Sulpiride [USAN:INN:BAN:JAN]|SR-01000075402|EINECS 239-753-7|BRN 0494008|UNII-7MNE9M8287|CCRIS-4248|(y)-Sulpiride|Sulpiride, SLP|(plusmn)-sulpiride|Dogmatyl (TN)|Magnetic resonance imaging sulpiride|(?)-Sulpiride|Prestwick_431|CAS-15676-16-1|Sulpiride (Standard)|PS30 -  Sulpiride|SULPIRIDE [INN]|SULPIRIDE [JAN]|SULPIRIDE [MI]|SULPIRIDE [USAN]|(.+/-.)-Sulpiride|Prestwick0_000056|Prestwick1_000056|Prestwick2_000056|Prestwick3_000056|SULPIRIDE,(-)|Biomol-NT_000037|Biomol-NT_000162|SULPIRIDE [MART.]|SCHEMBL8421|SULPIRIDE [WHO-DD]|Lopac0_001050|Oprea1_602476|BSPBio_000211|5-22-08-00105 (Beilstein Handbook Reference)|MLS000069434|MLS001306443|DivK1c_000278|SPBio_002132|BPBio1_000233|BPBio1_000463|BPBio1_001255|GTPL5501|orb1309432|Sulpiride (JP18/USAN/INN)|SULPIRIDE [EP IMPURITY]|SCHEMBL29359128|SULPIRIDE [EP MONOGRAPH]|BDBM11638|HMS500N20|HY-B1019R|KBio1_000278|NINDS_000278|Sulpiride 1.0 mg/ml in Methanol|HMS1568K13|HMS2095K13|HMS2231K07|HMS3263A22|HMS3266P12|HMS3371P16|HMS3372O01|HMS3393A08|HMS3411D18|HMS3651G12|HMS3675D18|HMS3712K13|HMS3885J14|HMS5080O10|HMS5083A10|BCP04500|BCP13871|HY-B1019|MSK10053|STR09321|( inverted question mark)-Sulpiride|Tox21_302205|Tox21_501050|HB1835|s4655|STK368596|5-(Aminosufonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide|AKOS004912732|CCG-205127|CS-4534|DB00391|FS27973|LP01050|NSC 757850|SDCCGSBI-0051020.P002|( inverted exclamation markA)-Sulpiride|IDI1_000278|NCGC00015966-03|NCGC00015966-04|NCGC00015966-05|NCGC00015966-06|NCGC00015966-07|NCGC00015966-08|NCGC00015966-16|NCGC00024852-02|NCGC00024852-03|NCGC00024852-04|NCGC00024852-05|NCGC00255813-01|NCGC00261735-01|AC-12181|SY235220|DB-046215|EU-0001755|EU-0101050|NS00010476|R. D. 1403|D01226|S 8010|EN300-2010446|676S161|L000579|Q422418|SR-01000075402-2|SR-01000075402-3|SR-01000075402-6|BRD-A55272860-001-03-9|BRD-A55272860-001-04-7|BRD-A55272860-001-08-8|BRD-A55272860-001-14-6|BRD-A55272860-001-15-3|Z84655412|Sulpiride, British Pharmacopoeia (BP) Reference Standard|1-ethyl-2-(2-methoxy-5-sulfamoylbenzamidomethyl)pyrrolidine|Sulpiride, European Pharmacopoeia (EP) Reference Standard|N-(1-Ethyl-pyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoyl-benzamide|(+/-)-N-[(1-Ethylpyrrolidin-2-yl)methyl]-2-methoxy-5-sulfamoylbenzamide|(+/-)-N-1-(Ethylpyrrolidin-2-ylmethyl)-2-methoxy-5-sulfamoylbenzamide|N-(1-ETHYL-2-PYRROLIDINYLMETHYL)-2-METHOXY-5-SULFAMIDOBENZAMIDE|(+/-)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide|( inverted question mark)-5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxybenzamide|5-(Aminosulfonyl)-N-[(1-ethyl-2-pyrrolidinyl)methyl]-2-methoxy-benzamide ;N-(1-Ethyl-2-pyrrolidinylmethyl)-2-methoxy-5-sulfamidobenzamide"
P-TOLUENESULFONAMIDE,6269,,"InChI=1S/C7H9NO2S/c1-6-2-4-7(5-3-6)11(8,9)10/h2-5H,1H3,(H2,8,9,10)",LMYRWZFENFIFIT-UHFFFAOYSA-N,C7H9NO2S,171.22,4-methylbenzenesulfonamide,"P-TOLUENESULFONAMIDE|4-Methylbenzenesulfonamide|70-55-3|4-Toluenesulfonamide|Tosylamide|p-Tosylamide|Toluene-4-sulfonamide|Benzenesulfonamide, 4-methyl-|para-Toluenesulfonamide|p-Tolylsulfonamide|p-Methylbenzenesulfonamide|p-Toluenesulfonylamide|Tolylsulfonamide|Toluene-4-sulphonamide|Toluene-p-sulphonamide|4-Toluenesulfanamide|TOLUENESULFONAMIDE, P-|4-Toluenesulfonic acid, amide|NSC-9908|DTXSID8029105|CHEBI:34435|I8266RI90M|DTXCID109105|4-toluenesulfonylamide|para-toluenesulphonamide|RefChem:858209|PTS100|PTS 100|200-741-1|4-methylbenzene-1-sulfonamide|p-Toluenesulfamide|MFCD00011692|tosylamine|Gliclazide EP Impurity A|4-tolylsulfonamide|p-toluene sulphonamide|4-methylbenzenesulphonamide|CHEMBL574|CAS-70-55-3|HSDB 5203|NSC 9908|EINECS 200-741-1|BRN 0472689|UNII-I8266RI90M|AI3-19503|p-toluensulfonamide|4-tolylsulphonamide|4J8|p-Toluenesulphonamide|4-toluenesulphonamide|p-toluene sulfonamide|p-toluene-sulfonamide|PASAM|Toluene-p-sulfonamide|N-p-tolylsulfonylamine|Paratoulene sulfonamide|p-toluenesulfonic amide|para-toluen sulphonamide|para-toluene sulphonamide|4-methylphenylsulphonamide|4-methylphenyl sulfonamide|4-methyl benzenesulfonamide|4-methyl-benzenesulfonamide|WLN: ZSWR D1|4-methylphenylsulphonylamine|EC 200-741-1|p-methyl-benzene sulfonamide|SCHEMBL7370|SCHEMBL29058|4-11-00-00376 (Beilstein Handbook Reference)|MLS001065595|BIDD:ER0609|SCHEMBL351578|SCHEMBL428943|SCHEMBL4878659|SCHEMBL8432001|SCHEMBL27503287|BDBM10859|benzene, 1-methyl-4-sulphamoyl-|NSC9908|HMS3039B12|P-TOLUENESULFONAMIDE [HSDB]|Tox21_201594|Tox21_303506|aromatic/heteroaromatic sulfonamide 4|SBB058201|STK416410|P-TOLUENESULFONAMIDE [USP-RS]|AKOS000149655|FS-3585|NCGC00091435-01|NCGC00091435-02|NCGC00091435-03|NCGC00257435-01|NCGC00259143-01|BP-12584|HY-79602|NCI60_042220|p-Toluenesulfonamide, reagent grade, 98%|SMR000568494|GLICLAZIDE IMPURITY A [EP IMPURITY]|CS-0012133|NS00010636|ST45216288|T0281|TOLBUTAMIDE IMPURITY A [EP IMPURITY]|EN300-15721|p-Toluenesulfonamide, ReagentPlus(R), >=99%|AE-562/40173366|F216546|doi:10.14272/LMYRWZFENFIFIT-UHFFFAOYSA-N.1|p-Toluenesulfonamide, Vetec(TM) reagent grade, 98%|BRD-K62412084-001-07-1|Q23013959|Z45415564|F0722-8812|p-Toluenesulfonamide, United States Pharmacopeia (USP) Reference Standard|12552-95-3"
MAFENIDE,3998,,"InChI=1S/C7H10N2O2S/c8-5-6-1-3-7(4-2-6)12(9,10)11/h1-4H,5,8H2,(H2,9,10,11)",TYMRLRRVMHJFTF-UHFFFAOYSA-N,C7H10N2O2S,186.23,4-(aminomethyl)benzenesulfonamide,"mafenide|138-39-6|4-(Aminomethyl)benzenesulfonamide|Sulfamylon|Benzenesulfonamide, 4-(aminomethyl)-|Ambamide|Homosulfanilamide|Maphenid|Septicid|Mafenida|Bensulfamide|Mafenidum|p-(Aminomethyl)benzenesulfonamide|NSC-34632|alpha-Amino-p-toluenesulfonamide|D06BA03|58447S8P4L|DTXSID6047860|Sulfabenzamine|4 Homosulfanilamide|RefChem:55526|DTXCID2027836|205-326-9|4-Aminomethylbenzenesulfonamide|Emilene|Benzamsulfonamide|Malfamin|Maphenide|Homonal|Homosul|Marprontil|Mesudin|Mesudrin|Neofamid|Paramenyl|4-Homosulfanilamide|4-(aminomethyl)benzene-1-sulfonamide|4-sulfamoylbenzylamine|4-(aminosulfonyl)benzylamine|MFCD00072084|.alpha.-Amino-p-toluenesulfonamide|CHEMBL419|p-Aminomethylbenzenesulfonamide|CHEBI:6633|p-Toluenesulfonamide, .alpha.-amino-|Homosulfaminum|benzenesulfonamide, 4-(aminomethyl)-, acetate|Mafenidum [INN-Latin]|Mafenida [INN-Spanish]|Mafenide [USAN:INN:BAN]|NCGC00016403-01|CAS-138-37-4|EINECS 205-326-9|NSC 34632|Maphenidum|UNII-58447S8P4L|4-Homosufanilamide|p-Toluenesulfonamide, alpha-amino-|6LH|Masudin (Salt/Mix)|Marfanil (Salt/Mix)|Spectrum_000885|MAFENIDE [USAN]|Mafenide (USAN/INN)|MAFENIDE [INN]|MAFENIDE [MI]|4-sulfamoyl-benzyl-amine|MAFENIDE [VANDF]|Prestwick0_000166|Prestwick1_000166|Prestwick2_000166|Prestwick3_000166|Spectrum2_000095|Spectrum3_000482|Spectrum4_000034|Spectrum5_000916|Homosulfamine (Salt/Mix)|MAFENIDE [MART.]|MAFENIDE [WHO-DD]|benzylamine, 4-sulphamoyl-|Oprea1_593766|Oprea1_661906|SCHEMBL41628|BSPBio_000031|BSPBio_001943|KBioGR_000467|KBioSS_001365|BIDD:GT0346|DivK1c_000363|SPBio_000050|SPBio_001952|aromatic sulfonamide compound 6|BPBio1_000035|orb1705167|SCHEMBL3446438|4-Aminomethyl-benzenesulfonamide|4-aminomethyl-benzenesulphonamide|SCHEMBL27313684|SCHEMBL28258890|BDBM10860|GTPL12697|KBio1_000363|KBio2_001365|KBio2_003933|KBio2_006501|KBio3_001443|NINDS_000363|BCPP000172|ALBB-014887|HY-B0614|aromatic/heteroaromatic sulfonamide 5|BBL012326|SBB080602|STK083032|TQ0026|AKOS001074998|BCP9000891|DB06795|GS-4341|SDCCGMLS-0003097.P003|IDI1_000363|NCGC00016403-02|NCGC00016403-03|NCGC00016403-04|NCGC00016403-11|BCP0726000212|SBI-0051431.P003|DB-002011|4-(AMINOMETHYL)-1-BENZENESULFONAMIDE|AB00053492|NS00007705|ST45092407|EN300-35248|C07106|D02351|AB00053492_18|009M999|Q3843044|BRD-K30649484-003-13-7"
ZONISAMIDE,5734,,"InChI=1S/C8H8N2O3S/c9-14(11,12)5-7-6-3-1-2-4-8(6)13-10-7/h1-4H,5H2,(H2,9,11,12)",UBQNRHZMVUUOMG-UHFFFAOYSA-N,C8H8N2O3S,212.23,"1,2-benzoxazol-3-ylmethanesulfonamide","zonisamide|68291-97-4|Zonegran|1,2-Benzisoxazole-3-methanesulfonamide|1,2-benzoxazol-3-ylmethanesulfonamide|Exceglan|Excegram|Excegran|AD-810|Zonisamida|Zonisamidum|CI-912|3-(Sulfamoylmethyl)-1,2-benzisoxazole|PD-110843|ZONISADE|DTXSID9046023|CHEBI:10127|N03AX15|Benzo[d]isoxazol-3-yl-methanesulfonamide|459384H98V|DTXCID7026023|1,2-Benzisoxazol-3-ylmethanesulfonamide|Benzo(d)isoxazol-3-yl-methanesulfonamide|AD810|CI912|3 Sulfamoylmethyl 1,2 benzisoxazole|RefChem:57626|614-395-8|Zonisamidum [Latin]|Zonisamida [Spanish]|benzo[d]isoxazol-3-ylmethanesulfonamide|AD 810|PD 110843|MFCD00865316|1-(1,2-Benzoxazol-3-Yl)methanesulfonamide|CHEMBL750|SPR_2|1-(1,2-benzisoxazol-3-yl)methanesulfonamide|NCGC00159319-02|NCGC00159319-04|Tremode|Trerief|CI 912|Excegran (TN)|SMR000596519|Zonisamide (ZNS)|CAS-68291-97-4|HSDB 7293|SR-01000837537|BRN 1077076|Zonisamide, ZNS|1,2-Benzisoxazole-3-methanesulfonamide;3-(Sulfamoylmethyl)-1,2-benzisoxazole;AD 810|AD-810N|Zonisamide, 1|UNII-459384H98V|Zonisamide [USAN:USP:INN:BAN:JAN]|Zonisamide (Standard)|ZONISAMIDE [MI]|ZONISAMIDE [INN]|ZONISAMIDE [JAN]|ZONISAMIDE [HSDB]|ZONISAMIDE [USAN]|ZONISAMIDE [VANDF]|E-2090|ZONISAMIDE [MART.]|ZONISAMIDE [USP-RS]|ZONISAMIDE [WHO-DD]|BIDD:PXR0183|SCHEMBL35458|MLS001195632|MLS001306491|BIDD:GT0708|ZONISAMIDE [EMA EPAR]|GTPL7047|orb1310776|Zonisamide (JP18/USP/INN)|SCHEMBL29358822|ZONISAMIDE [ORANGE BOOK]|BDBM10888|HY-B0124R|Zonisamide  - Bio-X trade mark|HMS2089O07|HMS2235L13|HMS3259N09|HMS3269F21|HMS3413L09|HMS3657E03|HMS3677L09|HMS3714E19|HMS3742M15|HMS3884I17|HMS5079O06|ZONISAMIDE [USP MONOGRAPH]|Zonisamide 1.0 mg/ml in Methanol|BCP28480|HY-B0124|MSK10526|Tox21_111569|BBL010040|HB0675|s1445|SBB070483|STK711131|AKOS001312269|Tox21_111569_1|AC-1413|CCG-220669|CS-1888|DB00909|FB28784|KS-1142|NC00637|(1,2-benzoxazol-3-yl)methanesulfonamide|NCGC00159319-03|BZ164593|1,?2-?Benzisoxazole-?3-?methanesulfonamide|NS00000539|SW199135-2|Z0026|EN300-50288|C07504|C76163|D00538|AB00876297-09|AB00876297-10|AB00876297_11|Zonisamide pound>>CI-912 pound>>PD 110843|291Z974|A836085|F358363|Q219957|SR-01000837537-2|SR-01000837537-3|SR-01000837537-8|BRD-K48300629-001-03-8|BRD-K48300629-001-13-7|BRD-K48300629-001-14-5|Z223042524"
CELECOXIB,2662,,"InChI=1S/C17H14F3N3O2S/c1-11-2-4-12(5-3-11)15-10-16(17(18,19)20)22-23(15)13-6-8-14(9-7-13)26(21,24)25/h2-10H,1H3,(H2,21,24,25)",RZEKVGVHFLEQIL-UHFFFAOYSA-N,C17H14F3N3O2S,381.4,4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide,"celecoxib|169590-42-5|Celebrex|Celebra|Onsenal|184007-95-2|SC-58635|4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide|4-[5-(4-METHYLPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOL-1-YL]BENZENESULFONAMIDE|YM 177|p-(5-p-Tolyl-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|Celecoxibum|SC58635|DFN15|JCX84Q7J1L|4-(5-(4-Methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide|NSC-719627|NSC-758624|4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benzene-1-sulfonamide|ELYXYB|DFN-15|DTXSID0022777|CHEBI:41423|benzenesulfonamide, 4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-|DTXCID502777|CONSENSI COMPONENT CELECOXIB|NSC719627|Benzenesulfonamide, 4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)-|4-(5-(4-Methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl)benzenesulfonamide|4-(5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzene-1-sulfonamide|ELYXYB-celecoxib|Celecoxib 50 mg|Celecoxib 100 mg|Celecoxib 200 mg|Celecoxib 400 mg|RefChem:5656|L01XX33|M01AH01|685-962-5|Celocoxib|Celecox|SC 58635|YM177|MFCD00941298|HSDB 7038|194044-54-7|Celecoxib (GMP Like)|YM-177|CHEMBL118|4-[5-(4-methylphenyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonami de|4-(5-(p-tolyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide|Benzenesulfonamide,4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-|Celecoxib [USAN]|NCGC00091455-01|Xilebao|4-[5-(p-tolyl)-3-(trifluoromethyl)pyrazol-1-yl]benzenesulfonamide|4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]-benzenesulfonamide|Solexa|Celebrex (TN)|SMR000550473|CAS-169590-42-5|SR-01000837528|UNII-JCX84Q7J1L|Celecixib|Celecoxib [USAN:INN:BAN]|CCRIS 9330|Celecoxib?|TPI-336|Celecoxib (GMP)|Onsenal (TN)|AI-525|CEP-33222|CELEBCOXIB|Celecoxib (Standard)|Spectrum_000432|1oq5|CELECOXIB [INN]|CELECOXIB [JAN]|CELECOXIB [MI]|CELECOXIB [HSDB]|Spectrum2_001576|Spectrum3_001996|Spectrum4_000182|Spectrum5_001324|CELECOXIB [VANDF]|CELECOXIB [MART.]|CELECOXIB [USP-RS]|CELECOXIB [WHO-DD]|cid_2662|SCHEMBL3708|BSPBio_003596|CELECOXIB [EMA EPAR]|KBioGR_000723|KBioGR_002351|KBioSS_000912|KBioSS_002354|MLS001165684|MLS001195656|MLS001304708|MLS006011862|BIDD:GT0408|DivK1c_000893|SPECTRUM1503678|Celecoxib - Bio-X trade mark|SPBio_001512|Celecoxib (JP18/USP/INN)|GTPL2892|orb1310585|CELECOXIB [ORANGE BOOK]|CELECOXIB [EP MONOGRAPH]|BDBM11639|HMS502M15|KBio1_000893|KBio2_000912|KBio2_002351|KBio2_003480|KBio2_004919|KBio2_006048|KBio2_007487|KBio3_002830|KBio3_003037|CELECOXIB [USP MONOGRAPH]|EX-A175|MSK8005|cMAP_000027|NINDS_000893|BCPP000290|GLXC-05108|HMS1922G14|HMS2089L18|HMS2093I07|HMS2234N18|HMS3259L08|HMS3261A14|HMS3373A09|HMS3654H09|HMS3715F11|HMS3867I03|HMS3884M07|HMS5079P03|HY-14398GL|Pharmakon1600-01503678|ALBB-033772|BCP02156|UWA68620|UWA68621|Tox21_111135|Tox21_201964|Tox21_300599|Tox21_500406|US8741944, Comparative Compound|BBL029086|CCG-39354|HY-14398G|HY-14398R|NSC758624|s1261|STL373576|Celecoxib 1.0 mg/ml in Acetonitrile|AKOS015842517|Tox21_111135_1|AC-4228|BCP9000507|CS-0570|DB00482|FC11300|KS-1041|NC00708|NSC 719627|NSC 758624|SB19318|IDI1_000893|NCGC00091455-02|NCGC00091455-03|NCGC00091455-04|NCGC00091455-05|NCGC00091455-06|NCGC00091455-07|NCGC00091455-08|NCGC00091455-09|NCGC00091455-13|NCGC00254540-01|NCGC00259513-01|NCGC00261091-01|BC164295|BP-30217|HY-14398|NCI60_041049|PHA-00846533|SY064976|SBI-0051875.P002|CJ-016377|CP-598107|UNM-0000305813|C2816|CS-0901612|NS00002556|SW199611-3|PF-00345549|C07589|D00567|EN300-119504|AB00052396-07|AB00052396-08|AB00052396-09|AB00052396_10|AB00052396_11|590C425|Q408801|SR-01000837528-2|SR-01000837528-3|BRD-K02637541-001-02-4|BRD-K02637541-001-06-5|BRD-K02637541-001-17-2|BRD-K02637541-001-18-0|Z1258938406|Celecoxib, European Pharmacopoeia (EP) Reference Standard|Celecoxib, United States Pharmacopeia (USP) Reference Standard|4-[5-(p-Tolyl)-3-(trifluoromethyl)-1-pyrazolyl]benzenesulfonamide|4-(5-p-tolyl-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide|4-[5-(4-Methylphenyl)-3-(trifluoromethyl)-pyrazol-1-yl]benzenesulfonamide|5-(4-Methylphenyl)-1-(4-sulfamoylphenyl)-3-(trifluoromethyl)pyrazole|Celecoxib, Pharmaceutical Secondary Standard; Certified Reference Material|4-[5-(4-methylphenyl)-3-(trifluoromethyl)-1H-pyazol-1-yl]benezenesulfonamide|4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamide;Celebra|4-[5-(4-Methylphenyl)-3-trifluoromethyl)-1H-pyrazol-yl]benzenesulfonamid e; Celebra;Celocoxib;SC 58635; SC-58635"
VALDECOXIB,119607,,"InChI=1S/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20)",LNPDTQAFDNKSHK-UHFFFAOYSA-N,C16H14N2O3S,314.4,"4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide","Valdecoxib|181695-72-7|Bextra|4-(5-methyl-3-phenylisoxazol-4-yl)benzenesulfonamide|Valdyn|SC-65872|SC 65872|4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide|4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzenesulfonamide|valdecoxibum|p-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide|NSC-759846|DTXSID6044226|CHEBI:63634|4-(5-methyl-3-phenyl-isoxazol-4-yl)benzenesulfonamide|2919279Q3W|DTXCID4024226|4-[5-methyl-3-phenylisoxazol-4-yl]benzenesulfonamide|RefChem:56405|M01AH03|448-010-8|Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)-|Kudeq|MFCD00950568|YM-974|4-(5-methyl-3-phenyl-1,2-oxazol-4-yl)benzene-1-sulfonamide|CHEMBL865|COX|NCGC00095129-01|Valdecoxib [USAN]|Valecoxib|SMR000466327|CAS-181695-72-7|HSDB 7302|Valdecoxib (USAN/INN)|Valdecoxib [USAN:INN:BAN]|UNII-2919279Q3W|4-(5-methyl-3-phenyl-4-isoxazolyl) benzenesulfonamide|Parecoxib Impurity 2|ND-0214|Valdecoxib (Standard)|Spectrum_001747|2aw1|VALDECOXIB [MI]|VALDECOXIB [INN]|Spectrum2_000508|Spectrum3_001001|Spectrum4_001129|Spectrum5_001476|VALDECOXIB [HSDB]|VALDECOXIB [VANDF]|SCHEMBL3356|VALDECOXIB [MART.]|VALDECOXIB [WHO-DD]|BSPBio_002721|KBioGR_001617|KBioSS_002227|MLS000759433|MLS001165699|MLS001195631|MLS001424105|SPECTRUM1504302|VALDECOXIB [EMA EPAR]|SPBio_000435|4-(Methyl-3-phenyl-isoxazol-4-yl)-benzenesulfonamide|cid_119607|GTPL2894|orb1310822|VALDECOXIB [ORANGE BOOK]|Valdecoxib, >=98% (HPLC)|BDBM13063|KBio2_002227|KBio2_004795|KBio2_007363|KBio3_001941|EX-A241|MSK8007|GLXC-05758|HMS1922J21|HMS2051P07|HMS2232P23|HMS3372D12|HMS3393P07|HMS3652I04|HMS3715L18|HMS3885O20|HMS5082A04|Pharmakon1600-01504302|BCP02419|Tox21_111438|AC-120|CCG-39589|HY-15762R|NSC759846|s4049|AKOS000280920|Tox21_111438_1|CS-1674|DB00580|FV28650|NC00184|NSC 759846|SB19519|MRF-0000216|NCGC00095129-02|NCGC00095129-03|NCGC00095129-06|Valdecoxib, analytical reference material|HY-15762|SY115891|DB-044435|UNM-0000305814|NS00009831|SW197564-2|C21552|D02709|AB00639996-08|AB00639996_10|EN300-7393031|695V727|F320060|Q347613|SR-01000759421|SR-01000759421-4|4-[5-methyl-3-phenylisoxazol-4-yl]benzensulfonamide|BRD-K12994359-001-02-8|BRD-K12994359-001-14-3|BRD-K12994359-001-18-4|Benzenesulfonamide, 4-(5-methyl-3-phenyl-4-isoxazolyl)- (9CI)|Benzenesulfonamide, 4-?(5-?methyl-?3-?phenyl-?4-?isoxazolyl)?-|4-(5-Methyl-3-phenyl-4-isoxazolyl)benzenesulfonamide;Bextra;SC 65872|InChI=1/C16H14N2O3S/c1-11-15(12-7-9-14(10-8-12)22(17,19)20)16(18-21-11)13-5-3-2-4-6-13/h2-10H,1H3,(H2,17,19,20"
SACCHARIN,5143,,"InChI=1S/C7H5NO3S/c9-7-5-3-1-2-4-6(5)12(10,11)8-7/h1-4H,(H,8,9)",CVHZOJJKTDOEJC-UHFFFAOYSA-N,C7H5NO3S,183.19,"1,1-dioxo-1,2-benzothiazol-3-one","saccharin|81-07-2|o-Benzoic sulfimide|o-Sulfobenzimide|Saccharine|Saccharimide|Benzosulfimide|Garantose|o-Benzosulfimide|Benzoic sulfimide|Benzosulphimide|Saccharinol|Saccharinose|Gluside|Saccharin insoluble|Benzosulfinide|Hermesetas|Saccharol|Glucid|Saccharin acid|Benzoic sulphimide|Kandiset|Sacarina|Sucrette|Zaharina|Sykose|Saxin|o-Benzoyl sulfimide|Sucre edulcor|1,2-Benzisothiazol-3(2H)-one, 1,1-dioxide|Benzo-2-sulphimide|o-Benzoic sulphimide|Benzoylsulfonic Imide|o-Benzosulphimide|o-Sulfobenzoic acid imide|Insoluble saccharin|550 Saccharine|Natreen|Sacharin|o-Benzoyl sulphimide|2-Sulphobenzoic imide|Benzoic acid sulfimide|Anhydro-o-sulfaminebenzoic acid|2,3-Dihydro-3-oxobenzisosulfonazole|1,1-dioxo-1,2-benzothiazol-3-one|1,2-Dihydro-2-ketobenzisosulfonazole|3-Benzisothiazolinone 1,1-dioxide|Saccharinum|2,3-Dihydro-3-oxobenzisosulphonazole|1,2-Dihydro-2-ketobenzisosulphonazole|1,2-Benzisothiazolin-3-one 1,1-dioxide|3-Hydroxybenzisothiazole-S,S-dioxide|1,2-Benzisothiazolin-3-one, 1,1-dioxide|NSC-5349|FST467XS7D|DTXSID5021251|INS NO.954(I)|CHEBI:32111|1,1-Dioxo-1,2-benzisothiazol-3(2H)-one|INS-954(I)|E-954(I)|DTXCID401251|Calcium, Saccharin|2,3-dihydro-1$l^{6},2-benzothiazole-1,1,3-trione|2,3-dihydro-1$l^(6),2-benzothiazole-1,1,3-trione|RefChem:6208|201-321-0|Sweeta|1,2-Benzisothiazol-3(2H)-one 1,1-dioxide|Benzo[d]isothiazol-3(2H)-one 1,1-dioxide|3-Hydroxybenzisothiazole S,S-dioxide|2-Sulfobenzoic acid imide|Rcra waste number U202|Saccharin, insoluble|Syncal|o-Benzoic acid sulfimide|Benzo-sulphinide|Cristallose|Soluble saccharin|1,2-Benzothiazol-3(2H)-one 1,1-dioxide|MFCD00005866|Saccharin, sodium salt|1,1-Dioxide-1,2-benzisothiazolin-3-one|CHEMBL310671|1,1-Dioxo-1,2-dihydro-benzo[d]isothiazol-3-one|1,1-Diox-1,2-benzisothiazol-3-one|2,3-Dihydroxy-1,2-benzisothiazol-3-one-1,1-dioxide|NCGC00094918-03|1,1-Dioxo-1,2-dihydro-1lambda*6*-benzo[d]isothiazol-3-one|E954|Saccharin, soluble|1,2-Benzisothiazoline-3-one 1,1-dioxide|1,1-Dioxide-1,2-benzisothiazol-3(2H)-one|Sacharin [Czech]|Benzosulfimide, O-|Saccharin [USAN]|Sulfobenzimide, O-|2,3-Dihydro-1,2-benzoisothiazol-3-one-1,1-dioxide|Sodium 1,2 benzisothiazolin-3-one 1,1-dioxide|CAS-81-07-2|Saccharin [NF]|NSC5731|2-hydrobenzo[d]isothiazole-1,1,3-trione|LSA|HSDB 669|NSC 5349|NSC 5731|EINECS 201-321-0|RCRA waste no. U202|UNII-FST467XS7D|Glycophenol|Neosaccharin|AI3-38107|SR-01000389315|ulfonylurea TP3|Benzo-2-sulfiide|O-Benzoylsulfimide|2-Sulfobenzoicimide|M07 (saccharin)|O-Sulfobenzoic imide|Sweeta (TN)|o-sulphobenzoic imide|2-Sulfobenzoic imide|Oxasulfuron metabolite|Saccharin (Standard)|Spectrum_000213|Saccharin, >=98%|Saccharin, >=99%|SACCHARIN [FCC]|SACCHARIN [JAN]|SACCHARIN [II]|SACCHARIN [MI]|SACCHARIN [HSDB]|SACCHARIN [IARC]|Saccharin (JP15/NF)|Saccharin (JP17/NF)|Spectrum2_001432|Spectrum3_001475|Spectrum4_000449|Spectrum5_001181|SACCHARIN [VANDF]|1,2-benzisothiazol-3(2H)-one-1,1-dioxide|SACCHARINUM [HPUS]|SACCHARIN [MART.]|WLN: T56 BSWMVJ|EC 201-321-0|SACCHARIN [USP-RS]|SACCHARIN [WHO-DD]|SCHEMBL3816|Saccharin, puriss., 98%|NCIOpen2_005140|NCIOpen2_005180|Saccharin (IN-00581)|BSPBio_003029|KBioGR_000838|KBioSS_000693|DivK1c_000164|SCHEMBL574097|SPECTRUM1501171|SPBio_001564|GTPL5432|orb1310197|SCHEMBL4562664|SCHEMBL5907951|SCHEMBL7361433|SCHEMBL8810914|SACCHARIN [EP MONOGRAPH]|SCHEMBL29358404|BDBM29278|HMS500I06|HY-Y0272R|KBio1_000164|KBio2_000693|KBio2_003261|KBio2_005829|KBio3_002529|MSK5104|NSC5349|2q38|NINDS_000164|1,1-Dioxo-1,2-dihydro-1lambda*6*-benzo[d]-isothiazol-3-one|HMS1921N03|HMS2092J09|HMS5083B10|Pharmakon1600-01501171|BCP29068|HY-Y0272|LBC47901|PXB46617|STR03759|3-Benzisothiazolinone 1, 1-dioxide|o-Benzoic sulfimide;o-Sulfobenzimide|Tox21_111358|Tox21_201880|Tox21_302950|BBL015343|CCG-39011|NSC757878|s4819|SBB027246|STK803263|2, 3-Dihydro-3-oxobenzisosulfonazole|2,3-Dihydro-3-oxo-Benzisosulfonazole|AKOS000120481|AKOS017272711|Saccharin (only persons who manufacture are subject, no supplier notification)|Tox21_111358_1|1, 2-Dihydro-2-ketobenzisosulfonazole|DB12418|FS27775|NSC-757878|IDI1_000164|1.2-benzoisothiazole-3-on-1.1-dioxide|Benzisosulfonazole, 2,3-dihydro-3-oxo-|NCGC00094918-01|NCGC00094918-02|NCGC00094918-04|NCGC00094918-05|NCGC00094918-06|NCGC00094918-07|NCGC00094918-09|NCGC00256329-01|NCGC00259429-01|ST073992|1,2-benzisothiazoline-3-one-1,1-dioxide|1.2 -benzoisothiazole-3-on 1.1-dioxide|SBI-0051671.P002|1, 2-Benzisothiazolin-3-one 1,1-dioxide|1,2-benzisothiazol-3(2H)-one,1,1-dioxide|B0004|CS-0013120|NS00007781|1,2-Benzisothiazol-3(2H) one 1,1-dioxide|EN300-18624|D01085|D70140|1, 2-Benzisothiazol-3(2H)-one, 1,1-dioxide|3-keto-2H,3H-1,2-benzisothiazole 1,1-dioxide|AB00052233-04|AB00052233_05|2,3-dihydro-1??,2-benzothiazole-1,1,3-trione|F055150|Q191381|Saccharin (229 degrees C) Melting Point Standard|1,1-Dioxido-3-oxo-2,3-dihydrobenzo[d]isothiazole|1,2-Benzisothiazol-3(2H)-one 1,1-dioxide, 9CI|2,3-dihydro-1,2-benzisothiazol-3-one-1,1-dioxide|2,3-dihydro-3-oxo-1,2-benzisothiazol-1,1-dioxide|doi:10.14272/CVHZOJJKTDOEJC-UHFFFAOYSA-N.1|SR-01000389315-2|03AC8EC2-D02A-464C-A7C3-7CABD643CC1E|2,3-dihydro-1lambda6,2-benzothiazole-1,1,3-trione|BRD-K46493214-001-03-4|BRD-K46493214-001-06-7|1, 2-Benzisothiazolin-3-one, 1,1-dioxide, sodium salt|1, 2-Benzothiazol-3(2H)-one 1,1-dioxide sodium salt|F0001-2092|Z256708526|1, 2-Benzisothiazol-3(2H)-one, 1,1-dioxide, sodium salt|1,1-dioxo-1,2-dihydro-1lambda6-benzo[d]isothiazol-3-one|Saccharin, European Pharmacopoeia (EP) Reference Standard|Mettler-Toledo Calibration substance ME 51143091, Saccharin|Saccharin, United States Pharmacopeia (USP) Reference Standard|Saccharin, Pharmaceutical Secondary Standard; Certified Reference Material|InChI=1/C7H5NO3S/c9-7-5-3-1-2-4-6(5)12(10,11)8-7/h1-4H,(H,8,9|Mettler-Toledo Calibration substance ME 51143091, Saccharin, traceable to primary standards (LGC)"
INDAPAMIDE,3702,,"InChI=1S/C16H16ClN3O3S/c1-10-8-11-4-2-3-5-14(11)20(10)19-16(21)12-6-7-13(17)15(9-12)24(18,22)23/h2-7,9-10H,8H2,1H3,(H,19,21)(H2,18,22,23)",NDDAHWYSQHTHNT-UHFFFAOYSA-N,C16H16ClN3O3S,365.8,"4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide","indapamide|26807-65-8|Noranat|Veroxil|Lozol|Indaflex|Indamol|Tertensif|Arifon|Fludex|Bajaten|Ipamix|Tandix|Natrilix|Damide|Indapamida|Metindamide|Indapamidum|Natrix|flupamid|indamide|SE-1520|Fludin|Lorvas|SE 1520|S-1520|4-chloro-N-(2-methyl-2,3-dihydroindol-1-yl)-3-sulfamoylbenzamide|FLUBEST|Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)-|4-Chloro-N-(2-methyl-1-indolinyl)-3-sulfamoylbenzamide|DTXSID7044633|NSC-757075|CHEBI:5893|KYD-041|4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide|F089I0511L|DTXCID5024633|S1520|Ethibide xl|Natrilix sr|Cardide sr|Indipam xl|Mapemid xl|Tensaid xl|Varbim xl|Rawel xl|SE1520|Nindaxa 2.5|Opumide 2.5|Indaxa 2.5|RefChem:58774|S 1520|C03BA11|4-Chloro-N-((2RS)-2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzamide|248-012-7|Pressurai|Indapamidum [INN-Latin]|Indapamida [INN-Spanish]|1-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline|Indapamide (Lozol)|MFCD00079375|Cormil|N-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline|MLS000028554|26807-65-8(free base)|BENZAMIDE, 4-CHLORO-N-(2-METHYL-1-INDOLINYL)-3-SULFAMOYL-|NCGC00018172-03|SMR000058829|RAC INDAPAMIDE|RHC 2555|USV 2555|Natrix (TN)|Lozol (TN)|SR-01000003079|EINECS 248-012-7|BRN 1604026|UNII-F089I0511L|(RS)-Indapamide|Hypen SR|3-(Aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide|Indapamide [USAN:USP:INN:BAN:JAN]|Indapamide (Standard)|Spectrum_000917|INDAPAMIDE [MI]|Opera_ID_110|INDAPAMIDE [INN]|INDAPAMIDE [JAN]|Prestwick3_000220|Spectrum2_000980|Spectrum3_000467|Spectrum4_000017|Spectrum5_000866|INDAPAMIDE [USAN]|INDAPAMIDE [VANDF]|CHEMBL406|Indapamide (JP18/USP)|INDAPAMIDE [MART.]|INDAPAMIDE [USP-RS]|INDAPAMIDE [WHO-DD]|SCHEMBL41303|Widaplik component Indapamide|BSPBio_000239|BSPBio_002174|KBioGR_000393|KBioSS_001397|5-20-06-00348 (Beilstein Handbook Reference)|MLS001148152|MLS002222229|MLS006011900|orb134441|DivK1c_000508|SPECTRUM1500349|SPBio_001019|BPBio1_000263|BR-1015 component Indapamide|GTPL7203|Indapamide - Bio-X trade mark|INDAPAMIDE [ORANGE BOOK]|SCHEMBL29372690|SCHEMBL29377544|BDBM25901|HMS501J10|HY-B0259R|KBio1_000508|KBio2_001397|KBio2_003965|KBio2_006533|KBio3_001394|4-chloro-N-(2-methylindolin-1-yl)-3-sulfamoyl-benzamide|INDAPAMIDE [EP MONOGRAPH]|NINDS_000508|HMS1920F19|HMS2090M16|HMS2091N07|HMS2095L21|HMS2231G13|HMS3259C14|HMS3369J20|HMS3655E06|HMS3712L21|HMS3748K05|HMS5079N18|INDAPAMIDE [USP MONOGRAPH]|Pharmakon1600-01500349|Indapamide 1.0 mg/ml in Methanol|4-CHLORO-N-(2-METHYLINDOLIN-1-YL)-3-SULFAMOYLBENZAMIDE|BCP04140|HY-B0259|MSK10493|Tox21_110775|Tox21_113182|Tox21_302687|CCG-40198|NSC757075|s1730|STL257105|STL455045|3-(Aminosulfonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)benzamide|AKOS015888148|Tox21_110775_1|AB03037|AC-2073|DB00808|FI01202|KS-5219|NC00568|NSC 757075|Benzamide, 3-(aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-l-yl)-|IDI1_000508|NCGC00018172-02|NCGC00018172-04|NCGC00018172-06|NCGC00018172-08|NCGC00018172-09|NCGC00089727-02|NCGC00089727-03|NCGC00256884-01|BI300090|SBI-0051415.P003|DB-047020|AB00052021|I0730|NS00000696|ST51015024|SW198686-2|A23574|D00345|EN300-117260|AB00052021-14|AB00052021-15|AB00052021_16|AB00052021_17|807I658|Indapamide, analytical standard, for drug analysis|Q1078392|SR-01000003079-2|SR-01000003079-3|BRD-A95869247-001-04-6|BRD-A95869247-001-14-5|BRD-A95869247-001-25-1|BRD-A95869247-001-26-9|Z1501485351|Indapamide, British Pharmacopoeia (BP) Reference Standard|Indapamide, European Pharmacopoeia (EP) Reference Standard|(4-chloro-3-sulfamoylphenyl)-N-(2-methylindolinyl)carboxamide|Indapamide, United States Pharmacopeia (USP) Reference Standard|3-aminosulfonyl-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide|4-chloro-3-aminosulphonyl-N-(2,3-dihydro2-methyl-1H-indol-1-yl)benzamide|Indapamide, Pharmaceutical Secondary Standard; Certified Reference Material|3-(aminosulphonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1--yl)benzamide|3-(aminosulphonyl)-4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)benzamide|4-chloro-N-(2-methyl-2,3-dihydro-1H-indol-1-yl)-3-sulfamoylbenzenecarboximidic acid|N-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline;3-(Aminosulfonyl)-4-c hloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide; Racemic indapamide; Rac indapamide|N-(4-Chloro-3-sulfamoylbenzamido)-2-methylindoline;3-(Aminosulfonyl)-4-chloro-N-(2,3-dihydro-2-methyl-1H-indol-1-yl)benzamide;Racemi c indapamide;Rac indapamide"
SULTHIAME,5356,,"InChI=1S/C10H14N2O4S2/c11-18(15,16)10-5-3-9(4-6-10)12-7-1-2-8-17(12,13)14/h3-6H,1-2,7-8H2,(H2,11,15,16)",HMHVCUVYZFYAJI-UHFFFAOYSA-N,C10H14N2O4S2,290.4,"4-(1,1-dioxothiazinan-2-yl)benzenesulfonamide","sultiame|SULTHIAME|61-56-3|Ospolot|Trolone|sultiam|Conadil|Sultiamum|Riker 594|Sultiamo|p-(Tetrahydro-2H-1,2-thiazin-2-yl)benzenesulfonamide, S,S-dioxide|Benzenesulfonamide, 4-(tetrahydro-2H-1,2-thiazin-2-yl)-, S,S-dioxide|RIKER-594|DTXSID4023626|I00Q766CZ2|DTXCID503626|RefChem:186763|N03AX03|4-(1,1-dioxo-1??,2-thiazinan-2-yl)benzene-1-sulfonamide|4-(3,4,5,6-Tetrahydro-2H-1,2-thiazin-2-yl)benzenesulfonamide S,S-dioxide|200-511-0|Sulphenyltame|Sulthiamine|Contravul|Elisal|4-(1,1-dioxothiazinan-2-yl)benzenesulfonamide|4-(1,1-Dioxido-1,2-thiazinan-2-yl)benzenesulfonamide|Bayer A-168|Sulthiame [USAN]|Sultiame [INN]|RP-10284|R-594|CHEMBL328560|2-(p-Sulfamoylphenyl)-tetrahydro-2H-1,2-thiazine 1,1-dioxide|CHEBI:32171|2H-1,2-Thiazine, tetrahydro-2-(p-sulfamoylphenyl)-, 1,1-dioxide|Sulthiame (USAN)|Benzenesulfonamide, p-(tetrahydro-2H-1,2-thiazin-2-yl)-, dioxide|Sultiamum [INN-Latin]|Sultiamo [INN-Spanish]|EINECS 200-511-0|BRN 1222219|RP 10284|UNII-I00Q766CZ2|Sulthiame, 2|Sulthiame (SLT)|2-(4-Sulfamoylphenyl)-1,2-thiazixan 1,1-dioxid|Ospolot (TN)|Sultiame (Standard)|Sultiame (JP17)|2q1q|SULTHIAME [MI]|SULTIAME [JAN]|SULTIAME [MART.]|SULTIAME [WHO-DD]|Oprea1_326703|SCHEMBL38898|orb1307713|BDBM26999|GLXC-05683|HMS3746A19|BCP30158|Tox21_113683|4-(Tetrahydro-2H-1,2-thiazin-2-yl)benzenesulfonamide S,S-dioxide|MFCD00865304|MSK165347|AKOS040742661|CS-7868|DB08329|HY-108316R|CAS-61-56-3|Sultiame 100 microg/mL in Acetonitrile|NCGC00249907-01|AS-83082|DA-67857|HY-108316|NS00007900|D01787|G12699|SBI-0654157.0001|EN300-18563625|Q2364943|4-(1,1-Dioxido-1,2-thiazinan-2-yl)benzenesulfonamide #|4-(1,1-Dioxo-1I>>6-[1,2]thiazinan-2-yl)-benzenesulfonamide|4-(1,1-dioxo-1lambda6,2-thiazinan-2-yl)benzene-1-sulfonamide|p-(Tetrahydro-2H-1,2-thiazin-2-yl)benzenesulfonamide dioxide|4-(1,1-dioxo-1$l^{6},2-thiazinan-2-yl)benzene-1-sulfonamide|4-(Tetrahydro-1,1-dioxido-2H-1,2-thiazin-2-yl)benzenesulfonamide|4-(TETRAHYDRO-2H-1,2-THIAZIN-2-YL)BENZENESULFONAMIDE, S,S-DIOXIDE|OSP"
SLC-0111,310360,,"InChI=1S/C13H12FN3O3S/c14-9-1-3-10(4-2-9)16-13(18)17-11-5-7-12(8-6-11)21(15,19)20/h1-8H,(H2,15,19,20)(H2,16,17,18)",YJQZNWPYLCNRLP-UHFFFAOYSA-N,C13H12FN3O3S,309.32,1-(4-fluorophenyl)-3-(4-sulfamoylphenyl)urea,"178606-66-1|U-104|1-(4-fluorophenyl)-3-(4-sulfamoylphenyl)urea|SLC-0111|SLC0111|NSC-213841|ANM9DBL9JT|RefChem:183370|CAIX Inhibitor SLC-0111|4-(3-(4-fluorophenyl)ureido)benzenesulfonamide|4-{[(4-Fluorophenyl)carbamoyl]amino}benzenesulfonamide|mst-104|MFCD00159265|C13H12FN3O3S|U104|NSC213841|Carbonic Anhydrase IX/XII Inhibitor II(U-104)|CHEMBL1615281|4-{[(4'-Fluorophenyl)Carbamoyl]Amino}Benzenesulfonamide|4-[3-(4-Fluorophenyl)ureido]benzenesulfonamide|4-((((4-Fluorophenyl)amino)carbonyl)amino)benzenesulfonamide|4-[[[(4-Fluorophenyl)amino]carbonyl]amino]benzenesulfonamide|Benzenesulfonamide, 4-((((4-fluorophenyl)amino)carbonyl)amino)-|Benzenesulfonamide, 4-[[[(4-fluorophenyl)amino]carbonyl]amino]-|WWZ|3n4b|UNII-ANM9DBL9JT|U 104|SCHEMBL672955|3-(4-FLUOROPHENYL)-1-(4-SULFAMOYLPHENYL)UREA|orb1306733|GTPL10149|EX-A904|CHEBI:232342|YJQZNWPYLCNRLP-UHFFFAOYSA-N|4-[[[(4-Fluorophenyl)amino]carbonyl]amino]-benzenesulfonamide|GLXC-06014|HMS3651H21|HMS3872E13|BCP14895|SLC 0111|WBI-5111|BDBM50334354|s2866|4-fluorophenylureido-benzenesulfonamide|AKOS001123930|CCG-267573|compound 7 [PMID: 21361354]|CS-4495|NSC 213841|SB19580|NCGC00379154-03|AC-32932|AS-66547|DA-58843|HY-13513|4-(4-fluorophenylureido)-benzenesulfonamide|SW220124-1|U-104, >=98% (HPLC)|U-104;NSC213841;MST104|U-104?|EN300-6472708|BRD-K77867004-001-02-7|BRD-K77867004-001-03-5|Q27467365|Z55286485|4-(((4-Fluoroanilino)carbonyl)amino)benzenesulfonamide|4-{[(4''-Fluorophenyl)carbamoyl]amino}benzenesulfonamide|4-{[(4-fluorophenyl)carbamoyl]amino}benzene-1-sulfonamide"
HYDROCHLOROTHIAZIDE,3639,,"InChI=1S/C7H8ClN3O4S2/c8-4-1-5-7(2-6(4)16(9,12)13)17(14,15)11-3-10-5/h1-2,10-11H,3H2,(H2,9,12,13)",JZUFKLXOESDKRF-UHFFFAOYSA-N,C7H8ClN3O4S2,297.7,"6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide","hydrochlorothiazide|58-93-5|Esidrix|HCTZ|Hypothiazide|Hidrotiazida|Idrotiazide|Megadiuril|Servithiazid|Newtolide|Vetidrex|Oretic|Chlorosulthiadil|Esidrex|Dichlotiazid|Dichlotride|Hydrochlorothiazid|Hydrodiuretic|Hydrosaluric|Hypothiazid|Apresazide|Aquarills|Aquarius|Carozide|Diclotride|Disalunil|Maschitt|Thiuretic|Drenol|Hidril|Hydril|Nefrix|Hidrochlortiazid|HydroDIURIL|Hydro-Diuril|Hydro-Aquil|Jen-Diril|Dihydrochlorothiazide|Dihydrochlorothiazid|Chlorzide|Dichlorosal|Hidroronol|Hydrothide|Hydrozide|Microzide|Neoflumen|Urodiazin|Dihydrochlorothiazidum|Ivaugan|Panurin|Bremil|Cidrex|Direma|Fluvin|Ro-hydrazide|Neo-codema|Acuretic|Pantemon|Zide|Dihydrochlorurite|Hydro-D|Thiaretic|Hydrochlorothiazidum|3,4-Dihydrochlorothiazide|6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|Hidroclorotiazida|Apo-Hydro|Dihydrochlorurit|Hydrochlorthiazidum|Hydrochlorot|Idroclorotiazide|Su 5879|Hydrochlorothiazide Intensol|NCI-C55925|Copalia-hct|Exforge-hct|Imprida-hct|Rasilez-hct|Dafiro-hct|Hydrochlorothiaizide|Chlorsulfonamidodihydrobenzothiadiazine dioxide|DTXSID2020713|2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide|0J48LPH2TH|NSC-53477|6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6},2,4-benzothiadiazine-7-sulfonamide|6-chloro-1,1-dioxo-3,4-dihydro-2H-1lambda6,2,4-benzothiadiazine-7-sulfonamide|INZIRQO|CHEBI:5778|6-Chloro-7-sulfamoyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide|NSC53477|Dichlothiazide|SU-5879|3,4-Dihydro-6-chloro-7-sulfamyl-1,2,4-benzothiadiazine-1,1-dioxide|6-Chloro-3,4-dihydro-7-sulfamoyl-2H-1,2,4-benzothiadiazine 1,1-dioxide|DTXCID80713|HYDROCHLOROTHIAZIDE COMPONENT|2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1, 1-dioxide|RIPRAZO COMPONENT HYDROCHLOROTHIAZIDE|RASITRIO COMPONENT HYDROCHLOROTHIAZIDE|KERVEZIDE COMPONENT HYDROCHLOROTHIAZIDE|KINZALKOMB COMPONENT HYDROCHLOROTHIAZIDE|PRITORPLUS COMPONENT HYDROCHLOROTHIAZIDE|TOLUCOMBI COMPONENT HYDROCHLOROTHIAZIDE|TRIBENZOR COMPONENT HYDROCHLOROTHIAZIDE|IFIRMACOMBI COMPONENT HYDROCHLOROTHIAZIDE|MICARDISPLUS COMPONENT HYDROCHLOROTHIAZIDE|SPRIMEO-HCT COMPONENT HYDROCHLOROTHIAZIDE|IRBESARTAN/HYDROCHLOROTHIAZIDE TEVA COMPONENT HYDROCHLOROTHIAZIDE|IRBESARTAN/HYDROCHLOROTHIAZIDE-BMS COMPONENT HYDROCHLOROTHIAZIDE|IBERSARTAN/HYDROCHLOROTHIAZIDE ZENTIVA COMPONENT HYDROCHLOROTHIAZIDE|6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^(6),2,4-benzothiadiazine-7-sulfonamide|RefChem:5890|C03AA03|200-403-3|Hydrochlorthiazide|Lotensin HCT|Diaqua|Caplaril|Hydrocot|Thlaretic|Timolide|Ziac|Aquazide H|Vaseretic|Inderide|Prinzide|component of Cyclex|component of Esimil|Esidrix (TN)|component of Aldoril|component of Dyazide|component of Caplaril|HCZ|component of Aldactazide|MFCD00051765|component of Butizide Prestabs|HCT|Diu-melusin|MLS000069619|Chlorizide|Disothiazid|Hidrosaluretil|Novodiurex|Spironazide|Acesistem|Acuilix|Aldazida|Briazide|Catiazida|Chlothia|Clorana|Condiuren|Dihydran|Diurogen|Dixidrasi|Esoidrina|H.H. 25/25|H.H. 50/50|Hyclosid|Indroclor|Manuril|Medozide|Mictrin|Mikorten|Modurcen|Natrinax|Saldiuril|Selozide|Tandiur|Urozide|Didral|Hytrid|Nefrol|Unazid|Hidro-Niagrin|Hydro-Saluric|Raunova Plus|6-Chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine 1,1-dioxide|Concor Plus|Aquazide-H|Neo-Flumen|Neo-Minzil|Hydro Par|Hydro-T|HCT-Isis|CAS-58-93-5|Mazide 25 mg|NCGC00015508-08|Hydrochlorat|SMR000035778|Diu 25 Vigt|Hydrex-semi|Aldactazide 25/25|Aldectazide 50/50|Dihydroxychlorothiazidum|Inderide 80/25|Hydrochlorothiazide form II|2H-1,2,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-,1,1-dioxide|6-chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide-1,1-dioxide|Idroclorotiazide [DCIT]|Hydrochlorzide|Ezide|Hydrozide Injection, Veterinary|Hidroclorotiazida [INN-Spanish]|Hydrochlorothiazidum [INN-Latin]|6-chloro-1,1-dioxo-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide|Microzide (TN)|CCRIS 2082|HSDB 3096|SR-01000000119|EINECS 200-403-3|NSC 53477|UNII-0J48LPH2TH|BRN 0625101|Hydrokraft|Idrodiuvis|Manschitt|Urirex|6-Chloro-3,4-dihydro-(2H)-1,2,4-benzothiadiazine-7-sulfonamide 1,1-Dioxide|HydroPar|6-chloro-1,1-dioxo-2H,3H,4H-benzo[e]1,2,4-thiadiazine-7-sulfonamide|6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide;Aquarius;Bremil|Prestwick_263|Hydrochloro Thiazide|6-chloro-1,1-dioxo-3,4-dihydro-2H-1|E6,2,4-benzothiadiazine-7-sulfonamide|Hyzaar (Salt/Mix)|Aldoril (Salt/Mix)|Dutoprol (Salt/Mix)|Inderide (Salt/Mix)|Prinzide (Salt/Mix)|Accuretic (Salt/Mix)|Hydropres (Salt/Mix)|Thiazide, hydrochloro-|Hydrochlorothiazide [USP:INN:BAN:JAN]|Spectrum_000877|Opera_ID_168|Maybridge1_004336|Prestwick0_000009|Prestwick1_000009|Prestwick2_000009|Prestwick3_000009|Spectrum2_001040|Spectrum3_000456|Spectrum4_000006|Spectrum5_000824|Lopac-H-4759|CHEMBL435|Tekturna HCT (Salt/Mix)|H 4759|cid_3639|SCHEMBL9349|Lopac0_000614|Oprea1_357174|BSPBio_000017|BSPBio_002132|KBioGR_000351|KBioSS_001357|8049-49-8|AF-614/30832002|BIDD:GT0153|DivK1c_000289|Hydrochlorothiazide (Standard)|SPECTRUM1500335|BMCL182567 Compound 6a|SPBio_001259|SPBio_001938|BPBio1_000019|GTPL4836|Hydrochlorothiazide, crystalline|orb1707599|SCHEMBL3864597|HYDROCHLOROTHIAZIDE [MI]|SCHEMBL29366243|BDBM13076|component of Dyazide (Salt/Mix)|HMS500O11|HMS553N04|HY-B0252R|HYDROCHLOROTHIAZIDE [INN]|HYDROCHLOROTHIAZIDE [JAN]|KBio1_000289|KBio2_001357|KBio2_003925|KBio2_006493|KBio3_001352|HYDROCHLOROTHIAZIDE [HSDB]|HYDROCHLOROTHIAZIDE [IARC]|component of Caplaril (Salt/Mix)|NINDS_000289|GLXC-23542|HMS1568A19|HMS1920D19|HMS2091L05|HMS2095A19|HMS2235I09|HMS3259O17|HMS3261L10|HMS3370P11|HMS3428A05|HMS3655M21|HMS3712A19|HYDROCHLOROTHIAZIDE [VANDF]|Pharmakon1600-01500335|HYDROCHLOROTHIAZIDE [MART.]|ALBB-038636|BCP22001|HY-B0252|JFD00715|MSK10104|HYDROCHLOROTHIAZIDE [USP-RS]|HYDROCHLOROTHIAZIDE [WHO-DD]|HYDROCHLOROTHIAZIDE [WHO-IP]|Tox21_110165|Tox21_201565|Tox21_300292|Tox21_500614|3,4-dihydro-6-chloro-7-sulfamoyl-1,2,4-benzothiadiazine-1,1-dioxide|CCG-40240|NSC757059|s1708|SBB056984|STK315354|3,2,4-benzothiadiazine-1,1-dioxide|Hydrochlorothiazide (JP18/USP/INN)|HYDROCHLOROTHIAZIDE [EMA EPAR]|AKOS000121373|Tox21_110165_1|AC-8114|DB00999|FH23880|Hydrochlorothiazide - Bio-X trade mark|LP00614|NC00510|NSC-757059|PS-3162|SDCCGSBI-0050596.P005|6-chloro-1,1-dioxo-1,2,3,4-tetrahydro-1lambda~6~,2,4-benzothiadiazine-7-sulfonamide|6-chloro-3,4-dihydro-2H-benzo[e][1,2,4]thiadiazine-7-sulfonamide 1,1-dioxide|HYDROCHLOROTHIAZIDE [GREEN BOOK]|IDI1_000289|WLN: T66 BSWM EM DHJ HG ISZW|HYDROCHLOROTHIAZIDE [EP IMPURITY]|HYDROCHLOROTHIAZIDE [ORANGE BOOK]|NCGC00015508-01|NCGC00015508-02|NCGC00015508-03|NCGC00015508-04|NCGC00015508-05|NCGC00015508-06|NCGC00015508-07|NCGC00015508-09|NCGC00015508-10|NCGC00015508-11|NCGC00015508-12|NCGC00015508-13|NCGC00015508-14|NCGC00015508-16|NCGC00015508-17|NCGC00015508-25|NCGC00021906-03|NCGC00021906-04|NCGC00021906-05|NCGC00021906-06|NCGC00021906-07|NCGC00021906-08|NCGC00254017-01|NCGC00259114-01|NCGC00261299-01|ZIAC COMPONENT HYDROCHLOROTHIAZIDE|BH164522|HH-50/50|HYDROCHLOROTHIAZIDE [EP MONOGRAPH]|NCI60_004317|ST033548|component of Butizide Prestabs (Salt/Mix)|ESIMIL COMPONENT HYDROCHLOROTHIAZIDE|HYDROCHLOROTHIAZIDE [USP MONOGRAPH]|Hydrochlorothiazide 1.0 mg/ml in Methanol|HYDROCHLOROTHIAZIDUM [WHO-IP LATIN]|HYZAAR COMPONENT HYDROCHLOROTHIAZIDE|SBI-0050596.P004|ALDORIL COMPONENT HYDROCHLOROTHIAZIDE|AVALIDE COMPONENT HYDROCHLOROTHIAZIDE|DYAZIDE COMPONENT HYDROCHLOROTHIAZIDE|MAXZIDE COMPONENT HYDROCHLOROTHIAZIDE|UNIPRES COMPONENT HYDROCHLOROTHIAZIDE|AB00052012|DUTOPROL COMPONENT HYDROCHLOROTHIAZIDE|EU-0100614|H1274|NS00000343|PRINZIDE COMPONENT HYDROCHLOROTHIAZIDE|SW196569-3|UNIRETIC COMPONENT HYDROCHLOROTHIAZIDE|ACCURETIC COMPONENT HYDROCHLOROTHIAZIDE|AMTURNIDE COMPONENT HYDROCHLOROTHIAZIDE|APRESAZIDE COMPONENT HYDROCHLOROTHIAZIDE|CAM-AP-ES COMPONENT HYDROCHLOROTHIAZIDE|EN300-16641|H.R.-50 COMPONENT HYDROCHLOROTHIAZIDE|HYDRAP-ES COMPONENT HYDROCHLOROTHIAZIDE|HYDROPRES COMPONENT HYDROCHLOROTHIAZIDE|MODURETIC COMPONENT HYDROCHLOROTHIAZIDE|NORMOZIDE COMPONENT HYDROCHLOROTHIAZIDE|QUINARETIC COMPONENT HYDROCHLOROTHIAZIDE|SER-A-GEN COMPONENT HYDROCHLOROTHIAZIDE|SER-AP-ES COMPONENT HYDROCHLOROTHIAZIDE|VASERETIC COMPONENT HYDROCHLOROTHIAZIDE|VISKAZIDE COMPONENT HYDROCHLOROTHIAZIDE|ZESTORETIC COMPONENT HYDROCHLOROTHIAZIDE|6-Chloro-3,2,4-benzothiadiazine 1,1-dioxide|A19550|ALDACTAZIDE COMPONENT HYDROCHLOROTHIAZIDE|BENICAR HCT COMPONENT HYDROCHLOROTHIAZIDE|C07041|D00340|DIOVAN HCT COMPONENT HYDROCHLOROTHIAZIDE|EXFORGE HCT COMPONENT HYDROCHLOROTHIAZIDE|H10742|HYDRA-ZIDE COMPONENT HYDROCHLOROTHIAZIDE|HYDRO-RIDE COMPONENT HYDROCHLOROTHIAZIDE|TEVETEN HCT COMPONENT HYDROCHLOROTHIAZIDE|AB00052012-15|AB00052012_16|AB00052012_17|HYDRO-RESERP COMPONENT HYDROCHLOROTHIAZIDE|LOTENSIN HCT COMPONENT HYDROCHLOROTHIAZIDE|MICARDIS HCT COMPONENT HYDROCHLOROTHIAZIDE|MONOPRIL HCT COMPONENT HYDROCHLOROTHIAZIDE|TEKTURNA HCT COMPONENT HYDROCHLOROTHIAZIDE|051H765|LOPRESSOR HCT COMPONENT HYDROCHLOROTHIAZIDE|ORETICYL FORTE COMPONENT HYDROCHLOROTHIAZIDE|Q423930|Hydrochlorothiazide, meets USP testing specifications|SERPASIL-ESIDRIX COMPONENT HYDROCHLOROTHIAZIDE|SR-01000000119-2|SR-01000000119-4|SR-01000000119-6|APRESOLINE-ESIDRIX COMPONENT HYDROCHLOROTHIAZIDE|BRD-K13078532-001-05-2|BRD-K13078532-001-27-6|BRD-K13078532-001-28-4|Z56347248|6-Chloro-3,2,4-benzothiadiazine-7-sulfonamide 1,1-dioxide|6-Chloro-7-sulfamoyl-3,2,4-benzothiadiazine 1,1-dioxide|Hydrochlorothiazide, drug standard, 1.0 mg/mL in methanol|HYDROSERPINE PLUS (R-H-H) COMPONENT HYDROCHLOROTHIAZIDE|6-chloro-3,4-dihydro-1,1-dioxo-7-sulfamoyl-1,2,4-benzothiadiazine|Hydrochlorothiazide, British Pharmacopoeia (BP) Reference Standard|Hydrochlorothiazide, European Pharmacopoeia (EP) Reference Standard|3,4-Dihydro-6-chloro-7-sulfamyl-1,2, 4-benzothiadiazine-1,1-dioxide|6-Chloro-3,4-dihydro-7-sulfamoyl-2H-1,2, 4-benzothiadiazine 1,1-dioxide|6-Chloro-7-sulfamoyl-3, 4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide|6-Chloro-7-sulfamoyl-3,4-dihydro-(2H)-1,2,4-benzothiadiazine 1,1-Dioxide|6-Chloro-7-sulfamoyl-3,4-dihydrobenzo-1,2,4-thiadiazine-1,1-dioxide|6-Chloro-7-sulfamyl-3,4-dihydro-1,2,4-benzothiadiazine-1,1-dioxide|Hydrochlorothiazide, United States Pharmacopeia (USP) Reference Standard|2H-1,2, 4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1, 1-dioxide|2H-1,2,4-Benzothiadiazine, 6-chloro-3,4-dihydro-7-sulfamoyl-2, 1,1-dioxide|2H-1,4-Benzothiadiazine-7-sulfonamide, 6-chloro-3,4-dihydro-, 1,1-dioxide|6-chloro-1,1-dioxo-3,4-dihydro-2H-1$l^{6,2,4-benzothiadiazine-7-sulfonamide|6-Chloro-3,4-dihydro-2H-1,2,4-benzothiadiazine-7-sulfonamide 1, 1-dioxide|7-(Aminosulfonyl)-6-chloro-3,4-dihydro-(2H)-1,2,4-benzothiadiazine 1,1-Dioxide|HYDRALAZINE HYDROCHLORIDE-HYDROCHLOROTHIAZIDE-RESERPINE COMPONENT HYDROCHLOROTHIAZIDE|Hydrochlorothiazide for peak identification, European Pharmacopoeia (EP) Reference Standard|Hydrochlorothiazide, Pharmaceutical Secondary Standard; Certified Reference Material|125727-50-6"
COUMARIN,323,,InChI=1S/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6H,ZYGHJZDHTFUPRJ-UHFFFAOYSA-N,C9H6O2,146.14,chromen-2-one,"coumarin|91-64-5|2H-Chromen-2-one|2H-1-Benzopyran-2-one|cumarin|1,2-Benzopyrone|chromen-2-one|Tonka bean camphor|Rattex|Coumarinic anhydride|Coumarine|cis-o-Coumarinic acid lactone|o-Hydroxycinnamic acid lactone|Coumarinic lactone|Benzo-alpha-pyrone|o-Hydroxycinnamic lactone|2-Oxo-1,2-benzopyran|Kumarin|Benzo-a-pyrone|2H-Benzo(b)pyran-2-one|5,6-Benzo-2-pyrone|2H-1-Benzopyran, 2-oxo-|5,6-Benzo-alpha-pyrone|o-Coumaric acid lactone|o-Hydroxyzimtsaure-lacton|2H-Benzo[b]pyran-2-one|Coumarinum|cis-o-Coumaric acid anhydride|DTXSID7020348|2-Propenoic acid, 3-(2-hydroxyphenyl)-, delta-lactone|CHEBI:28794|2-oxo-2H-1-benzopyran|Cinnamic acid, o-hydroxy-, delta-lactone|NSC-8774|o-hydroxycinnamic acid delta-lactone|A4VZ22K1WT|Nci-c07103|Coumarin (prohibited)|NSC8774|DTXCID50348|Lodema|Coumarin Phenolic|Coumarin 1513|RefChem:5706|202-086-7|Kumarin [Czech]|1-Benzopyran-2-one|103802-83-1|Caswell No. 259C|NCI C07103|chromenone|MFCD00006850|o-Hydroxyzimtsaure-lacton [German]|NSC 8774|EPA Pesticide Chemical Code 127301|BRN 0383644|Benzo-.alpha.-pyrone|AI3-00753|3-(2-Hydroxyphenyl)-2-propenoic delta-lactone|CHEMBL6466|2-Propenoic acid, 3-(2-hydroxyphenyl)-delta-lactone|MLS000028741|NCGC00091502-01|Coumarin, >=98%|SMR000059040|ST023509|2h-chromene-2-one|2-Propenoic acid, 3-(2-hydroxyphenyl)-, d-lactone|2-Propenoic acid, 3-(2-hydroxyphenyl)-, .delta.-lactone|benzopyranone|CAS-91-64-5|Coumarin [NF]|COU|CCRIS 181|2H-Benzopyran-2-one|HSDB 1623|SR-01000721887|EINECS 202-086-7|UNII-A4VZ22K1WT|chromen-one|a coumarin|coumarin-|d-lactone|benzopyrylium olate|Coumarin (DCF)|1, 2-Benzopyrone|a 1,2-benzopyrone|Coumarin (Standard)|Venalot mono (TN)|Spectrum_001336|COUMARIN [HSDB]|COUMARIN [IARC]|Opera_ID_268|2H-Chromen-2-one #|3-(2-hydroxyphenyl)-|COUMARIN [MI]|2H-1-benzopyran-2-on|Spectrum2_000303|Spectrum3_001772|Spectrum4_001818|Spectrum5_000555|COUMARINUM [HPUS]|COUMARIN [MART.]|bmse000077|COUMARIN [WHO-DD]|Epitope ID:114082|EC 202-086-7|SCHEMBL6252|WLN: T66 BOVJ|SCHEMBL25909|BSPBio_003263|KBioGR_002460|KBioSS_001816|5-17-10-00143 (Beilstein Handbook Reference)|MLS001148422|MLS002454395|{2H-Benzo[b]pyran-2-one}|BIDD:ER0667|SCHEMBL154753|SCHEMBL157615|SCHEMBL158062|SCHEMBL159837|SCHEMBL453408|SPECTRUM1400208|SPBio_000266|orb1310304|SCHEMBL1038138|SCHEMBL1041307|SCHEMBL3441294|Cinnamic acid, .delta.-lactone|Coumarin, >=99% (HPLC)|SCHEMBL12612026|SCHEMBL12612153|SCHEMBL16908406|SCHEMBL29385611|BDBM12342|HY-N0709R|KBio2_001816|KBio2_004384|KBio2_006952|KBio3_002764|GLXC-19130|HMS1923M11|HMS2091E19|HMS2232H18|HMS3369L08|HMS3652B05|HMS3885D09|HMS5082H04|Pharmakon1600-01400208|HY-N0709|Tox21_111141|Tox21_202427|Tox21_300057|CCG-38580|NSC755852|s4170|SBB000094|STK066167|COUMARIN (PROHIBITED) [FHFI]|AKOS000120175|Tox21_111141_1|2H-chromen-2-one (ACD/Name 4.0)|CR-0048|CS-8148|DB04665|FC20572|NSC-755852|SDCCGMLS-0066912.P001|NCGC00091502-02|NCGC00091502-03|NCGC00091502-04|NCGC00091502-05|NCGC00091502-06|NCGC00091502-07|NCGC00091502-08|NCGC00091502-09|NCGC00091502-11|NCGC00091502-12|NCGC00091502-16|NCGC00254092-01|NCGC00259976-01|Coumarin 1000 microg/mL in Acetonitrile|NCI60_041938|SBI-0061760.P002|DB-057267|DB-261057|Cinnamic acid, o-hydroxy-, .delta.-lactone|Coumarin, Vetec(TM) reagent grade, >=99%|NS00002381|SW220278-1|EN300-18115|BIM-0061760.0001|C05851|D07751|D81844|AB00375898_11|AB00375898_12|AP-123/40186862|Coumarin, primary pharmaceutical reference standard|F239149|Q111812|CU-01000013121-2|SR-01000721887-2|SR-01000721887-3|BRD-K23913458-001-02-5|BRD-K23913458-001-13-2|BRD-K23913458-001-19-9|BRD-K23913458-001-20-7|Coumarin, certified reference material, TraceCERT(R)|Z57169486|Coumarin, European Pharmacopoeia (EP) Reference Standard|F3096-1712|2H-1-Benzopyran-2-one;1,2-Benzopyrone;5,6-Benzo-2-pyrone|COUMARIN (CONSTITUENT OF CINNAMOMUM CASSIA BARK) [DSC]|COUMARIN (CONSTITUENT OF CINNAMOMUM VERUM BARK) [DSC]|D3E956C4-9541-4F57-9435-7D915C38E19E|InChI=1/C9H6O2/c10-9-6-5-7-3-1-2-4-8(7)11-9/h1-6|2h-1-benzopyran-2-one;coumarin;2h-chromen-2-one;coumarin   ;coumarin (2h-1-benzopyran-2-one) (chromen-2-one);2h-1-benzopyran-2-one coumarin 2h-chromen-2-one coumarin    coumarin (2h-1-benzopyran-2-one) (chromen-2-one)"
ZOLEDRONIC ACID ANHYDROUS,68740,,"InChI=1S/C5H10N2O7P2/c8-5(15(9,10)11,16(12,13)14)3-7-2-1-6-4-7/h1-2,4,8H,3H2,(H2,9,10,11)(H2,12,13,14)",XRASPMIURGNCCH-UHFFFAOYSA-N,C5H10N2O7P2,272.09,(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid,"Zoledronic acid|118072-93-8|Zoledronate|Zometa|Reclast|Aclasta|(1-Hydroxy-2-imidazol-1-ylethylidene)diphosphonic acid|Phosphonic acid, [1-hydroxy-2-(1H-imidazol-1-yl)ethylidene]bis-|Zoledronic Acid Anhydrous|CGP 42446|Anhydrous Zoledronic Acid|DTXSID0042668|CHEBI:46557|ZOL 446|70HZ18PH24|NSC-721517|Zoledronic Acid Actavis|DTXCID8022668|(1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bisphosphonic acid|Phosphonic acid, (1-hydroxy-2-(1H-imidazol-1-yl)ethylidene)bis-|[1-hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl]phosphonic acid|Zoledronic Acid Teva Pharma|NSC721517|Acido zoledronico|Acide zoledronique|CGP-42446A|2-(imidazol-1-yl)-1-hydroxyethylidene-1,1-bisphosphonic acid|ZOLEDRONIC ACID TEVA GENERICS|CGP 42'446|CGP-42'446|Zerlinda|[1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]bisphosphonic acid|(1-hydroxy-2-(1H-imidazol-1-yl)-1-phosphonoethyl)phosphonic acid|NDC-Zoledronate|acidum zoledronicum|CGP42446|CGP42'446|RefChem:196214|CGP42446A|M05BA08|6XC1PAD3KF|AK-156|CGP-42446|Zoladrona acid mylan|Zoledronate hydrate|Zoledronic|Zoledronic acid accord|Zoledronic acid medac|Zoledronic acid teva|(1-Hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl)diphosphonic acid|(1-hydroxy-2-imidazol-1-yl-1-phosphonoethyl)phosphonic acid|C5H10N2O7P2|ZOL|Orazol|[1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl]bis(phosphonic acid)|Zoledronic acid (INN)|Reclast (TN)|MFCD00867791|Zometa (TN)|CHEMBL924|Zoledronic Acid, Anhydrous|NCGC00159521-02|Zoledronic acid [USAN:INN:BAN]|ZOLEDRONIC ACID [INN]|Zomera|Bisphosphonate 3|Zometa (Novartis)|Aclasta and Reclast|zoledronic-acid|UNII-70HZ18PH24|BPH 91|Zoledronic Acid?|[1-HYDROXY-2-(1H-IMIDAZOL-1-YL)-ETHYLIDENE]BISPHOSPHONIC ACID|Zoledronic Acid (Standard)|Zoledronic acid, Zoledronate|BIDD:PXR0134|SCHEMBL19054|ZOLEDRONIC ACID [MI]|BIDD:GT0292|Zoledronic Acid (Zoledronate)|GTPL3177|JMC515594 Compound 55|orb1300511|BDBM12578|ZOLEDRONIC ACID [WHO-DD]|(1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid|HMS2089O09|ALBB-038596|BCP22750|PXB69479|Tox21_111739|HB0674|HY-13777R|s1314|STL452893|AKOS005145739|AB07564|AC-1092|CS-1829|DB00399|HS-0091|NSC 721517|NCGC00159521-03|NCGC00159521-04|NCGC00159521-05|NCGC00159521-09|NCGC00159521-18|HY-13777|CAS-118072-93-8|NS00006387|Z0031|D08689|EN300-117269|H11422|S00092|AB01273947-01|AB01273947-02|AB01273947-03|AB01273947_04|072Z938|Q218507|SR-05000001436|SR-05000001436-1|BRD-K84253429-001-03-6|BRD-K84253429-001-04-4|1-Hydroxy-2-(1-imidazolyl)ethane-1,1-diphosphonic Acid|Z1501485360|(1-Hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyl)diphosphonicacid|1-hydroxy-2-(1H-imidazol-1-yl)ethane-1,1-diyldiphosphonic acid|1-Hydroxy-2-(1H-imidazol-1-yl)ethylidene]-bisphosphonic Acid Hydrate; 2-(Imidazol-1-yl)-1-hydroxyethane-1,1-diphosphonic Acid Hydrate;"
BENZYLSULFAMIDE,2755709,,"InChI=1S/C13H14N2O2S/c14-18(16,17)13-8-6-12(7-9-13)15-10-11-4-2-1-3-5-11/h1-9,15H,10H2,(H2,14,16,17)",HLIBJQGJVDHCNB-UHFFFAOYSA-N,C13H14N2O2S,262.33,4-(benzylamino)benzenesulfonamide,"Benzylsulfamide|4-(benzylamino)benzenesulfonamide|104-22-3|Bencilsulfamida|Proseptazine|Benzylsulfamidum|46 R.P.|BENZYLSULFANILAMIDE|AI9WDT80FQ|46 R.P|N4-Benzylsulfanilamide|46-RP|N(sup 4)-Benzylsulfanilamide|4-((Phenylmethyl)amino)benzenesulfonamide|4-(benzylamino)benzene-1-sulfonamide|Proseptasine|Chemodyn|Septasin|Septazine|Benzylsulfanilamidum|4-[(phenylmethyl)amino]benzenesulfonamide|Benzylsulfamidum [Latin]|Bencilsulfamida [Spanish]|UNII-AI9WDT80FQ|Benzylsulfamide [INN:DCF]|N(sup 4)Benzylsulfanilamide|benzilsofamide|4-Benzylaminobenzolsulfonamid|4-Benzylaminophenylsulfonamid|M. and B. 125|p-Benzylaminobenzenesulfonamide|RP 46|EINECS 203-186-3|BRN 2654538|4-Amino-N-(phenylmethyl)benzene sulfonamide|RefChem:1069680|Benzenesulfonamide, 4-((phenylmethyl)amino)-|p-Benzylaminobenzolsulfonamid|BENZYLSULFAMIDE [MI]|SCHEMBL49548|BENZYLSULFAMIDE [INN]|3-14-00-02026 (Beilstein Handbook Reference)|CHEMBL2104196|DTXSID80870445|CHEBI:135080|HLIBJQGJVDHCNB-UHFFFAOYSA-N|Sulfanilamide, N(sup 4)-benzyl-|BDBM50013789|STL507761|AKOS000236510|SB81817|DB-128728|EN300-3089828|Q27273938|Z57170671|203-186-3"
MAFENIDE HYDROCHLORIDE,67313,,"InChI=1S/C7H10N2O2S.ClH/c8-5-6-1-3-7(4-2-6)12(9,10)11;/h1-4H,5,8H2,(H2,9,10,11);1H",SIACJRVYIPXFKS-UHFFFAOYSA-N,C7H11ClN2O2S,222.69,4-(aminomethyl)benzenesulfonamide;hydrochloride,"Mafenide hydrochloride|138-37-4|4-Aminomethylbenzenesulfonamide hydrochloride|4-(Aminomethyl)benzenesulfonamide hydrochloride|Homosulfamine hydrochloride|Morfanil|Masudin|Mafenide HCl|Mesudin hydrochloride|4-Homosulfanilamide hydrochloride|Ambamide hydrochloride|Emilene hydrochloride|Sulfamylon hydrochloride|Sulfbenzamine hydrochloride|Mesudrin hydrochloride|Neofamid hydrochloride|Maphenide hydrochloride|Homosulfanilamide hydrochloride|Benzenesulfonamide, 4-(aminomethyl)-, monohydrochloride|p-Aminomethylphenylsulfonamide hydrochloride|NSC 3527|NSC-3527|EINECS 205-325-3|alpha-Amino-p-toluenesulfonamide hydrochloride|p-(Aminomethyl)benzenesulfonamide hydrochloride|p-(Aminomethyl)benzenesulfonamide monohydrochloride|DTXSID6045296|AI3-16157|UNII-3J751V0284|p-Toluenesulfonamide, alpha-amino-, hydrochloride|3J751V0284|DTXCID4025296|MAFENIDE HYDROCHLORIDE [MI]|p-Toluenesulfonamide, alpha-amino-, monohydrochloride|MAFENIDE HYDROCHLORIDE [WHO-DD]|p-Toluenesulfonamide, .alpha.-amino-, monohydrochloride|RefChem:155131|MAFENIDE HCL [INCI]|Benzenesulfonamide, 4-(aminomethyl)-, monohydrochloride (9CI)|205-325-3|Marfanil|Homosulfamine|MFCD00013005|Mafenide (hydrochloride)|49783-80-4|4-(aminomethyl)benzenesulfonamide;hydrochloride|4-Aminomethylbenzenesulfonamide, HCl|NCGC00016403-01|CAS-138-37-4|SR-01000003113|Prestwick_640|4-(AMINOMETHYL)BENZENESULFONAMIDE HCL|4-(Aminomethyl)benzenesulfonamideHydrochloride|MLS002222235|SCHEMBL425524|SPECTRUM1500372|orb1310016|WLN: ZSWR D1Z & GH|CHEMBL1593568|HY-B0614B|MSK10429A|NSC3527|HMS1568B13|HMS1920J11|HMS5081N20|p-Toluenesulfonamide, hydrochloride|Pharmakon1600-01500372|4-sulfamoylbenzylamine hydrochloride|BCP03071|Tox21_110423|CCG-39706|NSC757093|s3697|AKOS008967290|p-Toluenesulfonamide, monohydrochloride|Tox21_110423_1|4-aminosulfonylbenzylamine hydrochloride|CS-4481|GS-4340|NSC-757093|NCGC00016403-06|NCGC00094711-01|NCGC00094711-02|NCGC00094711-03|NCGC00094711-04|AC-29745|SMR001307253|SY020868|4-(aminosulfonyl)-benzylamine hydrochloride|DB-087235|H0522|NS00079597|p-aminomethyl-benzenesulfonamide hydrochloride|4-aminomethyl-benzenesulfonamide hydrochloride|p-Aminomethyl benzene sulfonamide hydrochloride|O11078|.alpha.-Amino-p-toluenesulfonamide hydrochloride|4-(aminomethyl)benzene-sulfonamide hydrochloride|F077657|4-(Aminomethyl)Benzene-1-Sulfonamide Hydrochloride|SR-01000003113-4|Q27257294|F0856-0073|Benzenesulfonamide, 4-(aminomethyl)-, hydrochloride (1:?)|4-Aminomethylbenzenesulfonamide hydrochloride, analytical standard, >=95%"
PROBENECID,4911,,"InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)",DBABZHXKTCFAPX-UHFFFAOYSA-N,C13H19NO4S,285.36,4-(dipropylsulfamoyl)benzoic acid,"probenecid|57-66-9|4-(Dipropylsulfamoyl)benzoic acid|Benemid|Probenecid acid|Probecid|Benecid|Probalan|Probenemid|Benuryl|p-(Dipropylsulfamoyl)benzoic acid|Probenecide|Prolongine|Apurina|Tubophan|Uricosid|Proben|Synergid R|Probenecidum|Probenecida|4-[(dipropylamino)sulfonyl]benzoic acid|4-((Dipropylamino)sulfonyl)benzoic acid|4-(Di-n-propylsulfamoyl)benzoesaeure|Probenate|4-(N,N-Dipropylsulfamoyl)benzoesaeure|NCI-C56097|Benzoic acid, p-(dipropylsulfamoyl)-|Benzoic acid, 4-[(dipropylamino)sulfonyl]-|p-(Dipropylsulfamyl)benzoic acid|Benzoic acid, 4-((dipropylamino)sulfonyl)-|CHEBI:8426|DTXSID9021188|NSC-18786|p-[Dipropylsulfamoyl]benzoic acid|PO572Z7917|DTXCID901188|4-11-00-00691 (Beilstein Handbook Reference)|NSC18786|ORLYNVAH COMPONENT PROBENECID|Probampicin|SK-Probenecid|RefChem:55914|M04AB01|probenate (see under pivampicillin)|4-(Dipropylaminosulfonyl)benzoic acid|200-344-3|Probexin|Probampacin|MFCD00038402|NSC 18786|Probenecid (Standard)|CHEMBL897|MLS000028496|4-Dipropylsulfamoyl-benzoic acid|Benemide|Probenid|Robenecid|CAS-57-66-9|probenicid|NCGC00016251-08|SMR000058280|Probenecide [INN-French]|Probenecidum [INN-Latin]|Probenecida [INN-Spanish]|Benemid (TN)|4-(N,N-Dipropylsulfamoyl)benzoic Acid|CCRIS 3643|HSDB 3387|SR-01000003108|EINECS 200-344-3|BRN 2815775|AI3-50078|UNII-PO572Z7917|Probenecid [USP:INN:BAN:JAN]|RTO|Prestwick_809|Probenecid (Benemid)|Spectrum_000834|ColBenemid (Salt/Mix)|Opera_ID_677|PROBENECID [MI]|PROBENECID [INN]|PROBENECID [JAN]|Prestwick0_000542|Prestwick1_000542|Prestwick2_000542|Prestwick3_000542|Spectrum2_001294|Spectrum3_000554|Spectrum4_000486|Spectrum5_001419|PROBENECID [HSDB]|Benemid; Benecid; Benuryl|Epitope ID:180853|PROBENECID [MART.]|SCHEMBL3663|PROBENECID [USP-RS]|PROBENECID [WHO-DD]|PROBENECID [WHO-IP]|BIDD:PXR0092|Oprea1_416955|WLN: QVR DSWN3&3|BSPBio_000583|BSPBio_002227|KBioGR_000971|KBioSS_001314|MLS001076472|BIDD:GT0626|DivK1c_000056|SPECTRUM1500502|SPBio_001327|SPBio_002504|BPBio1_000643|GTPL4357|orb1310594|Probenecid (JP18/USP/INN)|Probenecid - Bio-X trade mark|PROBENECID [EP IMPURITY]|PROBENECID [ORANGE BOOK]|SCHEMBL26599943|HMS500C18|HY-B0545R|KBio1_000056|KBio2_001314|KBio2_003882|KBio2_006450|KBio3_001727|Probenecide, 1mg/ml in Methanol|PROBENECID [EP MONOGRAPH]|PROBENECID [USP IMPURITY]|NINDS_000056|GLXC-06088|HMS1569N05|HMS1920J22|HMS2092C03|HMS2096N05|HMS2233N05|HMS3259G04|HMS3369L18|HMS3652O17|HMS3713N05|HMS3743E07|HMS3885I18|HMS5082L17|p-(Dipropylsulfamoyl) benzoic acid|Pharmakon1600-01500502|PROBENECID [USP MONOGRAPH]|ALBB-025846|BCP21785|HY-B0545|MSK10518|PROBENECIDUM [WHO-IP LATIN]|PXB65787|STR06053|PROBEN-C COMPONENT PROBENECID|Tox21_110328|Tox21_202110|Tox21_302928|BDBM50206509|CCG-39232|NSC757292|s4022|SBB028597|STL229614|COLBENEMID COMPONENT PROBENECID|4-Dipropylsulfamoyl-benzoic acid anion|AKOS000165123|PROBAMPACIN COMPONENT PROBENECID|Tox21_110328_1|AC-2023|DB01032|FD27163|HC 5006|NC00530|NSC-757292|SB17360|IDI1_000056|4-[(dipropylamino)sulphonyl]benzoic acid|NCGC00016251-01|NCGC00016251-02|NCGC00016251-03|NCGC00016251-04|NCGC00016251-05|NCGC00016251-06|NCGC00016251-07|NCGC00016251-09|NCGC00016251-10|NCGC00016251-13|NCGC00016251-17|NCGC00023829-03|NCGC00023829-04|NCGC00023829-05|NCGC00023829-06|NCGC00023829-07|NCGC00256441-01|NCGC00259659-01|BP166195|COL-PROBENECID COMPONENT PROBENECID|ST099094|4-(N,N-dipropylaminosulphonyl)benzoic acid|SBI-0051492.P003|4-Dipropylsulfamoyl-benzoic acid(probenecid)|AB00052080|CS-0695004|NS00004996|P1975|SW196943-3|EN300-69677|C07372|D00475|D92177|AB00052080_15|AB00052080_16|038P402|F358404|Q900898|SR-01000003108-2|SR-01000003108-3|BRD-K95237249-001-05-9|BRD-K95237249-001-15-8|BRD-K95237249-001-25-7|BRD-K95237249-001-26-5|Z53037954|Probenecid, European Pharmacopoeia (EP) Reference Standard|Probenecid, United States Pharmacopeia (USP) Reference Standard|4-(Dipropylamino)sulfonylbenzoic acid;p-(Dipropylsulfamoyl)benzoic acid;Apurina|4-[(Dipropylamino)sulfonyl]benzoic acid;p-(Dipropylsulfamoyl)benzoic acid;Apurina"
BORTEZOMIB,387447,,"InChI=1S/C19H25BN4O4/c1-13(2)10-17(20(27)28)24-18(25)15(11-14-6-4-3-5-7-14)23-19(26)16-12-21-8-9-22-16/h3-9,12-13,15,17,27-28H,10-11H2,1-2H3,(H,23,26)(H,24,25)/t15-,17-/m0/s1",GXJABQQUPOEUTA-RDJZCZTQSA-N,C19H25BN4O4,384.2,[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid,"Bortezomib|179324-69-7|Velcade|PS-341|LDP-341|Bortezomib accord|NSC-681239|LDP 341|69G8BD63PP|N-[(1R)-1-(DIHYDROXYBORYL)-3-METHYLBUTYL]-N-(PYRAZIN-2-YLCARBONYL)-L-PHENYLALANINAMIDE|DTXSID3040980|CHEBI:52717|DTXCID1020980|Boronic acid, ((1R)-3-methyl-1-(((2S)-1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-|N-((1S)-1-Benzyl-2-(((1R)-1-(dihydroxyboranyl)-3-methylbutyl)amino)-2-oxoethyl)pyrazinecarboxamide|((1R)-3-Methyl-1-(((2S)-3-phenyl-2-((pyrazinylcarbonyl)amino)propanoyl)amino)butyl)boronic acid|[(1R)-3-methyl-1-({(2S)-3-phenyl-2-[(pyrazin-2-ylcarbonyl)amino]propanoyl}amino)butyl]boronic acid|bortezomibum|Bortexomib|LDP341|N-((1R)-1-(DIHYDROXYBORYL)-3-methylbutyl)-N-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide|PS341|((1R)-3-methyl-1-(((2S)-3-phenyl-2-((pyrazin-2-ylcarbonyl)amino)propanoyl)amino)butyl)boronic acid|[(1R)-3-Methyl-1-[[(2S)-3-phenyl-2-[(pyrazinylcarbonyl)amino]propanoyl]amino]butyl]boronic acid|BORUZU|341, PS|RefChem:5614|Bortezomib for Injection|L01XX32|((1R)-3-methyl-1-((2S)-3-phenyl-2-(pyrazin-2-ylformamido)propanamido)butyl)boronic acid|Bortezomib (PS-341)|Ps 341|((R)-3-Methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronic acid|[(1R)-3-methyl-1-[[(2S)-3-phenyl-2-(pyrazine-2-carbonylamino)propanoyl]amino]butyl]boronic acid|Boronic acid, B-[(1R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propyl]amino]butyl]-|C19H25BN4O4|MFCD09056737|Bortezomib (Velcade)|MLN-341|MG-341|CHEMBL325041|Peptide boronate|NSC681239|NCGC00242506-02|S1013|N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-Nalpha-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide|radiciol|Pyz-Phe-boroLeu|(R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butylboronic acid|BORTEZOMIB HYDRATE [JAN]|Velcade (TN)|DPBA|CAS-179324-69-7|[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]boronic acid|PS 341 (pharmaceutical)|UNII-69G8BD63PP|PROSCRIPT BORONIC ACID|Bortezomib [USAN:INN:BAN]|HSDB 7666|Bortezomib hydrate|Bortezomib,Velcade|LPD 341|LPD-341|NCGC00168751-01|NCGC00181022-01|[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-boronic acid;Radiciol|Bortezomib [USAN]|MG 341|Velcade (Millenium)|NSC 681239|Bortezomib (Standard)|3mg0|BORTEZOMIB [MI]|BORTEZOMIB [INN]|BORTEZOMIB [JAN]|1610526-91-4|BORTEZOMIB [HSDB]|PS-341 [Bortezomib]|BORTEZOMIB [VANDF]|BORTEZOMIB [MART.]|BORTEZOMIB [WHO-DD]|MLS004774142|Bortezomib (JAN/USAN/INN)|BORTEZOMIB [EMA EPAR]|SCHEMBL192129|Bortezomib - Bio-X trade mark|GTPL6391|orb1305542|Bortezomib (Mixture of isomers)|BORTEZOMIB [ORANGE BOOK]|SCHEMBL29377226|GLXC-05159|EX-A8373|Tox21_112630|Tox21_112672|BDBM50069989|HB4036|HY-10227R|NSC756655|AKOS015909706|Tox21_112672_1|CCG-268449|DB00188|FM19000|NSC-756655|NCGC00242506-01|NCGC00242506-06|NCGC00242506-07|AS-15721|BB164258|HY-10227|NCI60_029010|SMR003500787|Bortezomib (Velcade,MG-341,PS-341)?|B5741|NS00006197|SW208077-3|D03150|EN300-657180|AB01273951-01|AB01273951-02|AB01273951_03|324B697|Q419319|SR-01000939863|SR-01000939863-2|BRD-K88510285-001-02-0|BRD-K88510285-001-11-1|BRD-K88510285-001-17-8|BRD-K88510285-001-18-6|Z2213886907|((R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-2-carboxamido)propanamido)butyl)boronicacid|(R)-3-methyl-1-((S)-3-phenyl-2-(pyrazine-6-carboxamido)propanamido)butylboronic acid|[(1R)-3-methyl-1-[(2S)-3-phenyl-2-[(pyrazin-2-yl)formamido]propanamido]butyl]boronic acid|(1R)-3-Methyl-1-({(2S)-3-phenyl-2-[(2-pyrazinylcarbonyl)amino]propanoyl}amino)butylboronic acid, AldrichCPR|(R)-3-METHYL-1-((S)-3-PHENYL-2-(PYRAZINE-2-CARBOXAMIDO)PROPANAMIDO)BUTAN-2-YLBORONIC ACID|[(1R)-3-Methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]-butyl]boronic acid|Boronic acid, (3-methyl-1-((1-oxo-3-phenyl-2-((pyrazinylcarbonyl)amino)propyl)amino)butyl)-, (S-(R*,S*))-|Boronic acid, [(1(R)-3-methyl-1-[[(2S)-1-oxo-3-phenyl-2-[(pyrazinylcarbonyl)amino]propyl]amino]butyl]-|N-((1S)-1-benzyl-2-(((1R)-1-(dihydroxyboranyl)-3-methylbutyl)amino)2-oxoethylpyrazinecarboxamide|N-[(1R)-1-(dihydroxyboranyl)-3-methylbutyl]-N(alpha)-(pyrazin-2-ylcarbonyl)-L-phenylalaninamide"
IROSUSTAT,5287541,,"InChI=1S/C14H15NO5S/c15-21(17,18)20-9-6-7-11-10-4-2-1-3-5-12(10)14(16)19-13(11)8-9/h6-8H,1-5H2,(H2,15,17,18)",DSLPMJSGSBLWRE-UHFFFAOYSA-N,C14H15NO5S,309.34,"(6-oxo-8,9,10,11-tetrahydro-7H-cyclohepta[c]chromen-3-yl) sulfamate","Irosustat|288628-05-7|STX64|667-Coumate|667 coumate|STX-64|BN83495|STX 64|BN-83495|BN 83495|Sulfamic acid, 6,7,8,9,10,11-hexahydro-6-oxobenzo[b]cyclohepta[d]pyran-3-yl ester|366037O6O7|DTXSID50183059|6-oxo-8,9,10,11-tetrahydro-7H-cyclohepta-(c)(1)benzopyran-3-O-sulfamate|Sulfamic acid, 6,7,8,9,10,11-hexahydro-6-oxobenzo(b)cyclohepta(d)pyran-3-yl ester|irosustatum|RefChem:791486|DTXCID10105550|Steroid Sulfatase Inhibitor BN 83495|6-oxo-6H,7H,8H,9H,10H,11H-cyclohepta(c)chromen-3-yl sulfamate|6,7,8,9,10,11-Hexahydro-6-oxobenzo(b)cyclohepta(d)pyran-3-yl sulfamate|6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate|(6-oxo-8,9,10,11-tetrahydro-7H-cyclohepta[c]chromen-3-yl) sulfamate|6-OXO-8,9,10,11-TETRAHYDRO-7H-CYCLOHEPTA[C][1]BENZOPYRAN-3-O-SULFAMATE|CHEMBL286738|STX64;BN83495;667-Coumate|6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-yl sulfamate.|STX64 compound|Irosustat [USAN]|Irosustat [USAN:INN]|1ttm|IrosustatSTX64|UNII-366037O6O7|IROSUSTAT [INN]|Irosustat (STX-64)|Irosustat (USAN/INN)|667COUMATE|IROSUSTAT [WHO-DD]|orb1302837|SCHEMBL1275983|SCHEMBL29379544|BDBM13058|DSLPMJSGSBLWRE-UHFFFAOYSA-N|GLXC-06889|HMS3751M21|BCP29882|NLA62805|Irosustat (STX64, BN83495)|MFCD12912443|s6558|AKOS032954035|AT25524|DB02292|SB17271|STX64, >=98% (HPLC)|BS-52172|DA-67815|HY-14586|CS-0003463|NS00068646|D09915|BRD-K87777313-001-02-2|Q27093313|6-oxo-6,7,8,9,10,11-hexahydrocyclohepta[c]chromen-3-ylsulfamate|6-Oxo-6,7,8,9,10,11-hexahydrocyclohepta[c][1]benzopyran-3-yl sulfamate|{9-oxo-8-oxatricyclo[8.5.0.0^{2,7}]pentadeca-1(10),2(7),3,5-tetraen-5-yl} sulfamate"
TALABOSTAT,6918572,,"InChI=1S/C9H19BN2O3/c1-6(2)8(11)9(13)12-5-3-4-7(12)10(14)15/h6-8,14-15H,3-5,11H2,1-2H3/t7-,8-/m0/s1",FKCMADOPPWWGNZ-YUMQZZPRSA-N,C9H19BN2O3,214.07,[(2R)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid,"Talabostat|149682-77-9|PT-100|Val-boroPro|valinyl-boroproline|PT100 cpd|KZ1O2SH88Z|[(2R)-1-[(2S)-2-amino-3-methylbutanoyl]pyrrolidin-2-yl]boronic acid|DTXSID70869984|((2R)-1-((2S)-2-amino-3-methylbutanoyl)pyrrolidin-2-yl)boronic acid|BXCL 701|talabostatum|RefChem:932519|BXCL701|BXCL-701|DTXCID801511379|Val-boro-pro|CHEMBL67279|L-valinyl-L-boroproline|((R)-1-(L-Valyl)pyrrolidin-2-yl)boronic acid|Pyrrolidine derivative|PT100|((R)-1-((S)-2-Amino-3-methylbutanoyl)pyrrolidin-2-yl)boronic acid|Val-boroPro;PT100|Talabostat [USAN]|Valinyl-L-Boroproline|Talabostat [USAN:INN]|PT 100|UNII-KZ1O2SH88Z|ValboroPro|Ketopyrrolidine derivative|TALABOSTAT [INN]|Talabostat (USAN/INN)|SCHEMBL393024|GTPL9892|orb1692521|GLXC-15210|EX-A3155|BDBM50050513|NSC762155|NSC840949|AKOS022185199|compound 1 [PMID: 18783201]|CS-6996|DB06182|NSC-762155|NSC-840949|HY-13233|NS00073513|D05989|BRD-K37419961-066-01-2|BRD-K37419961-066-02-0|Q27282515|((R)-1-((S)-2-Amino-3-methylbutanoyl)pyrrolidin-2-yl)boronicacid|(R)-1-((S)-2-amino-3-methylbutanoyl)pyrrolidin-2-ylboronic acid|(S)-2-Amino-3-methyl-2-boronic acid-1-pyrrolidin-1-yl-butan-1-one|(S)-2-Amino-1-((R)-2-dihydroxyboron-pyrrolidin-1-yl)-3-methyl-butan-1-one|BORONIC ACID, ((2R)-1-((2S)-2-AMINO-3-METHYL-1-OXOBUTYL)-2-PYRROLIDINYL)|Boronic acid, ((2R)-1-((2S)-2-amino-3-methyl-1-oxobutyl)-2-pyrrolidinyl)-|Boronic acid, (1-(2-amino-3-methyl-1-oxobutyl)-2-pyrrolidinyl)-, (R-(R*,S*))-"
VILDAGLIPTIN,6918537,,"InChI=1S/C17H25N3O2/c18-9-14-2-1-3-20(14)15(21)10-19-16-5-12-4-13(6-16)8-17(22,7-12)11-16/h12-14,19,22H,1-8,10-11H2/t12?,13?,14-,16?,17?/m0/s1",SYOKIDBDQMKNDQ-XWTIBIIYSA-N,C17H25N3O2,303.4,(2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile,"Vildagliptin|Galvus|274901-16-5|NVP-LAF237|Equa|LAF237|LAF-237|Vitagliptin|NVP-LAF 237|(2S)-1-[2-[(3-hydroxy-1-adamantyl)amino]acetyl]pyrrolidine-2-carbonitrile|vildagliptine|Vildagliptina|I6B4B2U96P|(2S)-(((3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile|DTXSID80881091|vildagliptinum|NVP LAF237|(2S)-{((3-Hydroxyadamantan-1-yl)amino)acetyl}pyrrolidine-2-carbonitrile|(2S)-1-(2-((3-hydroxy-1-adamantyl)amino)acetyl)pyrrolidine-2-carbonitrile|RefChem:6349|DTXCID501508682|Xiliarx|Jalra|Vildagliptin (LAF-237)|LAF 237|NVP-LAF-237|2-Pyrrolidinecarbonitrile, 1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-, (2S)-|CHEMBL142703|(2S)-1-{2-[(3-hydroxyadamantan-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile|2-Pyrrolidinecarbonitrile, 1-(((3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)amino)acetyl)-, (2S)-|Galvus (TN)|Vidagliptin (see Vildagliptin)|Vildagliptin [USAN]|UNII-I6B4B2U96P|Zomelis|Vildagliptin (JAN/USAN/INN)|Vildagliptin [USAN:INN:BAN:JAN]|Equa (TN)|VILDAGLIPTIN [MI]|VILDAGLIPTIN [INN]|VILDAGLIPTIN [JAN]|SCHEMBL16579|VILDAGLIPTIN [MART.]|VILDAGLIPTIN [WHO-DD]|GTPL6310|VILDAGLIPTIN [EMA EPAR]|BDBM11695|Vildagliptin - Bio-X trade mark|A10BD08|A10BH02|(S)-1-(2-(((1r,3R,5R,7S)-3-hydroxyadamantan-1-yl)amino)acetyl)pyrrolidine-2-carbonitrile|CHEBI:135285|SYOKIDBDQMKNDQ-XWTIBIIYSA-N|MSK11066|s3033|AKOS015898120|AC-1273|CCG-267505|CS-1465|DB04876|FV29102|NCGC00386200-01|NCGC00386200-02|BV164521|HY-14291|NS00010516|SW220049-1|D07080|AB01566863_01|EN300-18527744|Q421042|BRD-A94993966-001-04-4|BRD-A94993966-001-05-1|(2S)-1-[N-(3-Hydroxyadamantan-1-yl)glycyl]pyrrolidine-2-carbonitrile|(2S)-1-{[(3-hydroxyadamant-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile|(2S)-1-{2-[(3-Hydroxyadamant-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile|(2S)-1-[[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-pyrrolidine-2-carbonitrile|(2S)-1-{[(3-Hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl}pyrrolidine-2-carbonitrile|1-[2-[(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)amino]acetyl]-2S-pyrrolidinecarbonitrile|(-)-(2S)-1-(((3-HYDROXYTRICYCLO(3.3.1.1(SUP(3,7))DEC-1-YL)AMINO)ACETYL)PYRROLIDINE-2-CARBONITRILE|(2S)-1-(((3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)AMINO)ACETYL)PYRROLIDINE-2-CARBONITRILE|2-PYRROLIDINECARBONITRILE, 1-(((3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)AMINO)ACETYL)-, (2S)-|2S)-1-[[(3-Hydroxytricyclo[3.3.1.13,7]decane-1-yl)amino]acetyl]-2-pyrrolidinecarbonitrile"
SITAGLIPTIN,4369359,,"InChI=1S/C16H15F6N5O/c17-10-6-12(19)11(18)4-8(10)3-9(23)5-14(28)26-1-2-27-13(7-26)24-25-15(27)16(20,21)22/h4,6,9H,1-3,5,7,23H2/t9-/m1/s1",MFFMDFFZMYYVKS-SECBINFHSA-N,C16H15F6N5O,407.31,"(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one","Sitagliptin|486460-32-6|Januvia|sitagliptina|sitagliptine|Zituvio|LEZ763|sitagliptinum|QFP0P1DV7Z|(3R)-3-AMINO-1-[3-(TRIFLUOROMETHYL)-5H,6H,7H,8H-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7-YL]-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE|(3R)-3-amino-1-[3-(trifluoromethyl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one|CHEBI:40237|LEZ-763|(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE|DTXSID70197572|ZITUVIMET COMPONENT SITAGLIPTIN|(2R)-4-OXO-4-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO(1,2,4)TRIAZOLO(4,3-A)PYRAZIN-7(8H)-YL)-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE|1,2,4-Triazolo(4,3-a)pyrazine, 7-((3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl)-5,6,7,8-tetrahydor-3-(trifluoromethyl)-|(3R)-3-amino-1-(3-(trifluoromethyl)-5H,6H,7H,8H-(1,2,4)triazolo(4,3-a)pyrazin-7-yl)-4-(2,4,5-trifluorophenyl)butan-1-one|(3R)-3-amino-1-(3-(trifluoromethyl)-6,8-dihydro-5H-(1,2,4)triazolo(4,3-a)pyrazin-7-yl)-4-(2,4,5-trifluorophenyl)butan-1-one|RefChem:6227|DTXCID30120063|4-oxo-4-(3-(trifluoromethyl)-5,6-dihydro(1,2,4)triazolo(4,3-a)pyrazin-7(8H)-yl)-1-(2,4,5-trifluorophenyl)butan-2-amine|690-730-1|Xelevia|(R)-3-AMINO-1-(3-(TRIFLUOROMETHYL)-5,6-DIHYDRO-[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL)-4-(2,4,5-TRIFLUOROPHENYL)BUTAN-1-ONE|C16H15F6N5O|MFCD09838015|Sitagliptin (Metformin,MK-0431)|1,2,4-Triazolo[4,3-a]pyrazine,7-[(3R)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-|(3R)-3-Amino-1-[3-(trifluoromethyl)-5,6,7,8-tetrahydro-1,2,4-triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one|790712-60-6|Sitagliptin [INN]|UNII-QFP0P1DV7Z|SR-05000001748|HSDB 7516|LEZ 763|(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-A MINE|Sitagliptin (13)|Sitagliptin; MK0431|SITAGLIPTIN [MI]|Sitagliptin (USAN/INN)|SITAGLIPTIN [HSDB]|SITAGLIPTIN [USAN]|EC 690-730-1|SITAGLIPTIN [VANDF]|CHEMBL1422|SCHEMBL17783|BSPBio_002262|SITAGLIPTIN [WHO-DD]|MLS006011959|SITAGLIPTIN [EMA EPAR]|Sitagliptin [USAN:INN:BAN]|GTPL6286|orb1310801|SCHEMBL29365085|BDBM11162|1x70|GLXC-15213|HMS2093F20|(3R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one;(R)-3-amino-1-(3-(trifluoromethyl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)-4-(2,4,5-trifluorophenyl)butan-1-one|EX-A2816|MSK11067|WHO 8692|NSC813215|AKOS015888724|CCG-268731|DB01261|FA31666|NSC-813215|NCGC00178734-03|NCGC00178734-06|NCGC00178734-13|(3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one|7-((3R)-3-Amino-1-oxo-4-(2,4,5-trifluorophenyl)buyl)-5,6,7,8-tetrahydro-3-trifluoromethyl)-1,4-triazolo(4,3-a)|7-[(3r)-3-amino-1-oxo-4-(2,4,5-trifluorophenyl)butyl]-5,6,7,8-tetrahydro-3-(trifluoromethyl)-1,2,4-triazolo[4,3-a]pyrazine|AS-19118|HY-13749|SMR002546724|SBI-0206871.P001|Sitagliptin 100 microg/mL in Acetonitrile|NS00000425|S5079|D08516|EN300-119510|AB01563393_01|AR-270/43507782|F358083|Q419832|SR-05000001748-1|BRD-K19416115-001-01-2|BRD-K19416115-001-03-8|BRD-K19416115-001-05-3|BRD-K19416115-366-02-7|Z1521553713|(1R)-3-oxo-3-[3-(trifluoroethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorobenzyl)propylamine|(2r)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a] pyrazin-7(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|(2r)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8h)-yl]-1-(2,4,5-trifluorophenyl)butan-2-a|(2R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-alpha]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|(3R)-3-amino-1-[3-(trifluoromethyl)-5H,6H,7H,8H-[1,2,4]triazolo[3,4-a]pyrazin-7-yl]-4-(2,4,5-trifluorophenyl)butan-1-one hydrochloride|(R)-4-oxo-4-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine|1,2,4-TRIAZOLO(4,3-A)PYRAZINE-7(8H)-PROPANAMINE, 5,6-DIHYDRO-.GAMMA.-OXO-3-(TRIFLUOROMETHYL)-.ALPHA.-((2,4,5-TRIFLUOROPHENYL)METHYL)-, (.ALPHA.R)-|3-oxo-1-(2,4,5-trifluorobenzyl)-3-(3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl)propylamine"
LINAGLIPTIN,10096344,,"InChI=1S/C25H28N8O2/c1-4-5-13-32-21-22(29-24(32)31-12-8-9-17(26)14-31)30(3)25(35)33(23(21)34)15-20-27-16(2)18-10-6-7-11-19(18)28-20/h6-7,10-11,17H,8-9,12-15,26H2,1-3H3/t17-/m1/s1",LTXREWYXXSTFRX-QGZVFWFLSA-N,C25H28N8O2,472.5,"8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione","Linagliptin|668270-12-0|Tradjenta|BI-1356|BI 1356|Trajenta|Trazenta|BI-1356-BS|linagliptine|Linagliptina|BS 1356 BS|3X29ZEJ4R2|(R)-8-(3-Amino-piperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methyl-quinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione|CHEBI:68610|BI-1356BS|BI 1356 BS|BS-1356-BS|BI1356|DTXSID201021653|GLYXAMBI COMPONENT LINAGLIPTIN|(R)-8-(3-aminopiperidin-1-yl)-7-but-2-ynyl-3-methyl-1-(4-methylquinazolin-2-ylmethyl)-3,7-dihydro-purine-2,6-dione|1H-Purine-2,6-dione, 8-((3R)-3-amino-1-piperidinyl)-7-(2-butynyl)-3,7-dihydro-3-methyl-1-((4-methyl-2-quinazolinyl)methyl)-|TRIJARDY XR COMPONENT LINAGLIPTIN|8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione|linagliptinum|8-((3R)-3-AMINOPIPERIDIN-1-YL)-7-(BUT-2-YN-1-YL)-3-METHYL-1-((4-METHYLQUINAZOLIN-2-YL)METHYL)-3,7-DIHYDRO-1H-PURINE-2,6-DIONE|RefChem:5948|1356, BI|A10BH05|DTXCID801506661|Ondero|Linagliptin (BI-1356)|MFCD14635356|ione|CHEMBL237500|C25H28N8O2|(R)-8-(3-Aminopiperidin-1-yl)-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione|(R)-8-(3-aminopiperidin-1-yl)-7-(but-2-ynyl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione|1H-Purine-2,6-dione,8-[(3R)-3-amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-|8-[(3R)-3-aminopiperidin-1-yl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione|8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3- methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-dione|8-[(3r)-3-Aminopiperidin-1-Yl]-7-But-2-Yn-1-Yl-3-Methyl-1-[(4-Methylquinazolin-2-Yl)methyl]-3,7-Dihydro-1h-Purine-2,6-Dione|UNII-3X29ZEJ4R2|Linaglitpin|Linagliptin [USAN:INN:JAN]|HSDB 8204|Tradjenta (TN)|8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-d ione|Linagliptin (Standard)|LINAGLIPTIN [MI]|LINAGLIPTIN [INN]|LINAGLIPTIN [JAN]|LINAGLIPTIN [USAN]|LINAGLIPTIN [VANDF]|LINAGLIPTIN [MART.]|LINAGLIPTIN [WHO-DD]|Linagliptin (BI-1356)?|MLS006010217|SCHEMBL160188|Linagliptin (JAN/USAN/INN)|GTPL6318|orb1310851|Linagliptin - Bio-X trade mark|SCHEMBL29359185|EX-A076|LINAGLIPTIN [ORANGE BOOK]|LTXREWYXXSTFRX-QGZVFWFLSA-N|BCPP000185|GLXC-10521|BCP02462|MSK15589|BDBM50228403|HY-10284R|s3031|AKOS015951179|AKOS015995251|AC-8761|BCP9000854|CCG-269463|CS-0637|DB08882|FL24893|NCGC00346655-01|NCGC00346655-02|NCGC00346655-08|1h-purine-2,6-dione, 8-[(3r)-3-amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-|8-[(3R)-3-amino-1-piperidyl]-7-but-2-ynyl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]purine-2,6-dione|AS-35080|BL164627|DA-54932|HY-10284|SMR004701306|NS00098773|SW219813-1|D09566|AB01563307_01|AB01563307_03|EN300-6481354|270L120|Q909745|BRD-K96550715-001-02-6|BRD-K96550715-001-03-4|BRD-K96550715-001-04-2|BRD-K96550715-003-01-4|Z2235801970|1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)-aminopiperidin-1-yl)xanthine|1-[(4-methyl-quinazolin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-(3-(R)aminopiperidin-1-yl)xanthine|1-[(4-methyl-quinazolin-2yl) methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R) amino-piperidin-1-yl]-xanthine|1-[(4-Methylquinazolin-2-yl)-methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine|1-[(4-Methylquinazolin-2-yl)methyl]-3-methyl-7-(2-butin-1-yl)-8-(3-(R)-aminopiperidin-1-yl)-xanthine|1233245-11-8|8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione;8-[(3R) -3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione|8-[(3R)-3-aminopiperidin-1-yl]-7-(but-2-yn-1-yl)-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-2,3,6,7-tetrahydro-1H-purine-2,6-dione|8-[(3R)-3-Aminopiperidin-1-yl]-7-but-2-yn-1-yl-3-methyl-1-[(4-methylquinazolin-2-yl)methyl]-3,7-dihydro-1H-purine-2,6-d"
PHORBOL MYRISTATE ACETATE,27924,,"InChI=1S/C36H56O8/c1-7-8-9-10-11-12-13-14-15-16-17-18-29(39)43-32-24(3)35(42)27(30-33(5,6)36(30,32)44-25(4)38)20-26(22-37)21-34(41)28(35)19-23(2)31(34)40/h19-20,24,27-28,30,32,37,41-42H,7-18,21-22H2,1-6H3/t24-,27+,28-,30-,32-,34-,35-,36-/m1/s1",PHEDXBVPIONUQT-RGYGYFBISA-N,C36H56O8,616.8,"[(1S,2S,6R,10S,11R,13S,14R,15R)-13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate","Phorbol 12-myristate 13-acetate|16561-29-8|phorbol-12-myristate-13-acetate|12-O-Tetradecanoylphorbol-13-acetate|12-O-Tetradecanoylphorbol 13-acetate|Tetradecanoylphorbol acetate|Factor A1|Phorbol myristate acetate|phorbol 13-acetate 12-myristate|PMA (tumor promoter)|Phorbol 12-tetradecanoate 13-acetate|TPA (phorbol derivative)|Pma (phorbol ester)|Tpa (phorbol ester)|Phorbol-myristate acetate|Phorbol 12-myristate 13-acetate diester|13-O-Acetylphorbol 12-myristate|12-O-Tetradecanoyl phorbol acetate|beta-Phorbol 12-myristate 13-acetate|NSC 262244|12-Tetradecanoylphorbol 13-monoacetate|4beta-Phorbol 12-myristate 13-acetate|13-Tetradecanoylphorbol acetate|NI40JAQ945|DTXSID5023798|CHEBI:37537|Phorbol-12-myristate 13-acetate|12-Tetradecanoylphorbol-13-acetate|12-o-Tetradekanoylphorbol-13-acetat|NSC-262244|4beta-Phorbol-12-myristate-13-acetate|Phorbol monoacetate monomyristate|NSC262244|Pentahydroxy-tigliadienone-monoacetate(c)monomyristate(b)|Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (1aR-(1aalpha,1bbeta,4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha))-|5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a-beta,1b-alpha,4,4a,7a-beta,7b,8,9,9a-decahydro-4a-alpha,7b-beta,9-alpha,9a-beta-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-beta-tetramethyl-, 9a-acetate 9-myristate|Myristic acid, 9-ester with 1,1aalpha,1bbeta,4,4a,7aalpha,7b,8,9,9a-decahydro-4abeta,7balpha,9beta,9aalpha-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8alpha-tetramethyl-5H-cyclopropa(3,4)benz(1,2-e)azulen-5-one 9a-acetate, (+)-|[(1S,2S,6R,10S,11R,13S,14R,15R)-13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate|Myristic acid, 9-ester with 1,1a-alpha,1b-beta,4,4a,7a-alpha,7b,8,9,9a-decahydro-4a-beta,7b-alpha,9-beta,9a-alpha-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-alpha-tetramethyl-5H-cyclopropa(3,4)benz(1,2-e)azulen-5-one, 9a-acetate|Acetate, Phorbol Myristate|Myristate Acetate, Phorbol|Acetate, Tetradecanoylphorbol|12 Myristoyl 13 acetylphorbol|12-Myristoyl-13-acetylphorbol|((1S,2S,6R,10S,11R,13S,14R,15R)-13-acetyloxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo(8.5.0.02,6.011,13)pentadeca-3,8-dienyl) tetradecanoate|(1S,2S,6R,10S,11R,13S,14R,15R)-13-(acetyloxy)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo(8.5.0.0^(2,6).0^(11,13))pentadeca-3,8-dien-14-yl tetradecanoate|(1S,2S,6R,10S,11R,13S,14R,15R)-13-(acetyloxy)-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxotetracyclo[8.5.0.0^{2,6}.0^{11,13}]pentadeca-3,8-dien-14-yl tetradecanoate|12 O Tetradecanoyl Phorbol 13 Acetate|12-O-Tetradecanoyl Phorbol 13-Acetate|13-Acetate, 12-O-Tetradecanoyl Phorbol|Phorbol 13-Acetate, 12-O-Tetradecanoyl|RefChem:929146|DTXCID30819884|Tetradecanoylphorbol Acetate, 4a alpha|Phorbol acetate, myristate|Phorbol ester|12-Tetradecanoylphorbol 13-acetate|PMA|MFCD00036736|CCRIS 716|TPA|HSDB 3542|CHEMBL279115|(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-acetoxy-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-1H-cyclopropa[3,4]benzo[1,2-e]azulen-9-yl tetradecanoate|Phorbol 12-myristate 13-acetate (PMA)|C36H56O8|12-o-tetradecanoyl phorbol-13-acetate|yristate|UNII-NI40JAQ945|NSC626496|-yl ester|tetradecanoyl-beta-phorbol acetate|12-o-tetradecanoyl-phorbol-13-acetate|BRN 2407201|SpecPlus_000801|Spectrum2_001911|Spectrum4_000889|Spectrum5_001855|MolMap_000041|UPCMLD-DP069|12-O-Tetradekanoylphorbol-13-acetat [German]|BIDD:PXR0145|CBiol_002014|BSPBio_001024|KBioGR_000364|KBioGR_001298|KBioSS_000364|SPECTRUM330004|DivK1c_006897|SPBio_001902|1H-Cyclopropa[3,4]benz[1,2-e]azulene, tetradecanoic acid deriv.|GTPL2341|orb1296136|[acetoxy-dihydroxy-(hydroxymethyl)-tetramethyl-oxo-[?]yl] tetradecanoate|SCHEMBL29353795|UPCMLD-DP069:001|UPCMLD-DP069:002|BCBcMAP01_000182|KBio1_001841|KBio2_000364|KBio2_002932|KBio2_005500|KBio3_000707|KBio3_000708|Bio1_000300|Bio1_000789|Bio1_001278|Bio2_000352|Bio2_000832|HMS1362D05|HMS1792D05|HMS1990D05|HMS3403D05|Phorbol 13 Acetate 12 Myristate|BNB65429|EX-A6920|-one 9a-acetate, (+)- (8CI)|BDBM50099066|CCG-39863|HB0502|NSC262644|AKOS024418767|CS-6053|FP15184|FS-4842|LMPR0104330002|NSC-262644|NSC-626496|IDI1_002107|NCGC00161633-01|NCGC00161633-04|NCGC00161633-05|4-.beta.-Phorbol 12-myristate 13-OAc|AC-33957|DA-49086|HY-18739|Tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester|Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9, 9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa(3,4)benz(1,2-e)azulen-9-yl ester, (1aR-(1aa,1bb,4ab,7aa,7ba, 8a,9b,9aa))-|Phorbol 12-myristate 13-acetate (PMA)?|12-o-tetradecanoylphorbol-13-acetate (tpa)|NS00025422|P1585|PHORBOL-12-TETRADECANOYL-13-ACETATE|C05151|M02249|4abeta,7aalpha,7balpha,8alpha,9beta,9aalpha)]-|Q416716|12-O-TETRADECANOYLPHORBOL-13-ACETATE [HSDB]|BRD-K68552125-001-03-8|BRD-K68552125-001-04-6|BRD-K68552125-001-05-3|PHORBOL 12-MYRISTATE 13-ACETATE DIESTER [MI]|Phorbol-12-myristate-13-acetate - CAS 16561-29-8|Phorbol 12-myristate 13-acetate, synthetic, >=98.0% (TLC)|PMA, for use in molecular biology applications, >=99% (TLC)|Phorbol 12-myristate 13-acetate, >=99% (TLC), film or powder|12-O-tetradecanoyl phorbol-13-acetate;Cocarcinogen A1; Cocarcinogen C3|(1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(Acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl tetradecanoate|[(1S,2S,6R,10S,11R,13S,14R,15R)-13-acetoxy-1,6-dihydroxy-8-(hydroxymethyl)-4,12,12,15-tetramethyl-5-oxo-14-tetracyclo[8.5.0.02,6.011,13]pentadeca-3,8-dienyl] tetradecanoate|11016-13-0|4beta,9alpha,12beta,13alpha,20-Pentahydroxytiglia-1,6-dien-3-one 12-tetradecanoate 13-acetate|5H-Cyclopropa(3,4)benz(1,2-e)azulen-5-one, 1,1a-beta,1b-alpha,4,4a,7a-beta,7b,8,9,9a-decahydro-4a-alpha,7b-beta,9-alpha,9a-beta-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8-beta-tetramethyl-, 9a-acetate 9-m|Myristic acid, 9-ester with 1,1aalpha,1bbeta,4,4a,7aalpha,7b,8,9,9a-decahydro-4abeta,7balpha,9beta,9aalpha-tetrahydroxy-3-(hydroxymethyl)-1,1,6,8alpha-tetramethyl-5H-cyclopropa[3,4]benz[1,2-e]azulen-5|tetradecanoic acid, (1aR,1bS,4aR,7aS,7bS,8R,9R,9aS)-9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9|Tetradecanoic acid, 9a-(acetyloxy)-1a,1b,4,4a,5,7a,7b,8,9,9a-decahydro-4a,7b-dihydroxy-3-(hydroxymethyl)-1,1,6,8-tetramethyl-5-oxo-1H-cyclopropa[3,4]benz[1,2-e]azulen-9-yl ester, [1aR-(1aalpha,1bbeta,"
ALVIMOPAN,5488548,,"InChI=1S/C25H32N2O4/c1-18-16-27(12-11-25(18,2)21-9-6-10-22(28)14-21)17-20(24(31)26-15-23(29)30)13-19-7-4-3-5-8-19/h3-10,14,18,20,28H,11-13,15-17H2,1-2H3,(H,26,31)(H,29,30)/t18-,20-,25+/m0/s1",UPNUIXSCZBYVBB-JVFUWBCBSA-N,C25H32N2O4,424.5,"2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid","Alvimopan|156053-89-3|Alvimopan anhydrous|Entereg|anhydrous alvimopan|Adl 8-2698|LY246736|Glycine, N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-|trans-3,4-dimethyl-4-(3-hydroxyphenyl) piperidine|LY-246736|Q153V49P3Z|LY-246736 dihydrate|DTXSID60166035|ADL-8-2698|2-[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanamido]acetic acid|Glycine, N-((2S)-2-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl)methyl)-1-oxo-3-phenylpropyl)-|alvimopanum|2-(((2S)-2-(((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoyl)amino)acetic acid|2-((2S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetic acid|2-[[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl]-3-phenylpropanoyl]amino]acetic acid|ADL8-2698|RefChem:111766|DTXCID7088526|A06AH02|LY-246376|110-129-5|(((2S)-2-(((3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)methyl)-3-phenylpropanoyl)amino)acetic acid dihydrate|677C126AET|Alvimopan [INN]|2-((S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)acetic acid|MFCD09838268|145590-44-9|2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]propanoyl]amino]acetic acid|C25H32N2O4|((S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanoyl)glycine|N-[(2S)-2-{[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl]methyl}-3-phenylpropanoyl]glycine|UNII-Q153V49P3Z|LY 246736|Glycine, N-[(2S)-2-[[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-; Glycine, N-[2-[[4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]-, [3R-[1(S*),3a,4a]]-; ADL 8-2698; Alvimopan; Entereg; LY 246736|ALVIMOPAN [MI]|ALVIMOPAN [MART.]|ALVIMOPAN [WHO-DD]|SCHEMBL49578|CHEMBL270190|GTPL7471|orb1309266|Alvimopan, >=98% (HPLC)|HSDB 7704|CHEBI:135686|HMS3886B09|ANHYDROUS ALVIMOPAN [MART.]|BDBM50088381|s5935|AKOS015896476|CS-0536|DB06274|FA17336|NCGC00378640-01|NCGC00378640-02|NCGC00378640-03|AS-35088|HY-13243|NS00069226|ADL 8-2698;LY 246736|SBI-0654641.0001|EN300-7393122|053A893|SR-01000945029|Q4738021|SR-01000945029-1|BRD-K07857022-002-01-1|(((2S)-2-(((3R,4R)-4-(3-HYDROXYPHENYL)-3,4-DIMETHYLPIPERIDIN-1-YL)METHYL)-3-PHENYLPROPANOYL)AMINO)ACETIC ACID|((2(S)-((4(R)-(3-HYDROXYPHENYL)-3(R),4-DIMETHYL-1-PIPERIDINYL)METHYL)-1-OXO-3-PHENYLPROPYL)AMINO)ACETIC ACID|2-((S)-2-benzyl-3-((3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethylpiperidin-1-yl)propanamido)aceticacid|2-[[(2S)-2-benzyl-3-[(3R,4R)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidyl]propanoyl]amino]acetic acid|GLYCINE, N-(2-((4-(3-HYDROXYPHENYL)-3,4-DIMETHYL-1-PIPERIDINYL)METHYL)-1-OXO-3-PHENYLPROPYL)-, (3R-((S*),3.ALPHA.,4.ALPHA.))-|N-((2S)-2-(((3R,4R)-4-(3-HYDROXYPHENYL)-3,4-DIMETHYL-1-PIPERIDINYL)METHYL)-1-OXO-3-PHENYLPROPYL)GLYCINE|N-[(2S)-2-[[(3R,4R)-4-(3-Hydroxyphenyl)-3,4-dimethyl-1-piperidinyl]methyl]-1-oxo-3-phenylpropyl]glycine;ADL 8-2698;LY 246736|NG0"
INDOMETHACIN,3715,,"InChI=1S/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)",CGIGDMFJXJATDK-UHFFFAOYSA-N,C19H16ClNO4,357.8,2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid,"indomethacin|53-86-1|indometacin|Indomethacine|Indometacine|Indocid|Metindol|Reumacide|Indomethazine|Imbrilon|Tannex|Amuno|Artrinovo|Confortid|Idomethine|Indomecol|Indomethacinum|Metartril|Methazine|Mikametan|Artracin|Artrivia|Dolovin|Indacin|Indomed|Indomee|Indoptic|Indoptol|Inflazon|Infrocin|Metacen|Mobilan|Sadoreum|Inacid|Lausit|Indo-rectolmin|Indo-tablinen|Inteban sp|Indometacyna|Indometicina|Durametacin|Mezolin|Indo-Lemmon|Indometacinum|Indometacina|Indocin Sr|Osmosin|Aconip|Indomet 140|1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-|Rheumacin LA|2-(1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid|Tivorbex|Indomod|Indolar SR|1-(p-Chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|NCI-C56144|FLAM|2-[1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl]acetic acid|DTXSID9020740|1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid|XXE1CET956|NSC-757061|1-(p-Chlorobenzoyl)-2-methyl-5-methoxyindole-3-acetic acid|Indole-3-acetic acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl-|CHEBI:49662|N-p-Chlorbenzoyl-5-methoxy-2-methylindole-3-acetic acid|(1-p-Chlorobenzoyl-5-methoxy-2-methylindol-3-yl)acetic acid|NSC-77541|alpha-(1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolyl)acetic acid|DTXCID50740|1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico|1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolylacetic acid|Kwas 1-(p-chlorobenzoilo)-2-metylo-5-metoksy-3-indolilooctowy|[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid|{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1H-indol-3-yl}acetic acid|1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-essigsaeure|2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid|1-[p-Chlorobenzoyl]-5-methoxy-2-methylindole-3-acetic acid|(1-(4-CHLOROBENZOYL)-5-METHOXY-2-METHYL-1H-INDOL-3-YL)ACETIC ACID|NSC77541|Indoderm|Indoflex|Indolar|Ledmecin|Rimacid|Pardelprin mr|Artracin sr|Indocid ret|2-(1-(4-chlorobenzoyl)-5-methoxy-2-methylindol-3-yl)acetic acid|Indomethacin ER|Maximet sr|Indo-paed|Indocid-r|Slo-indo|(1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetic acid|Berlind 75 ret|Indotard mr 75|Indomax-25|Indomax-75 sr|Flexin-25 continus|Flexin-50 continus|Flexin-75 continus|RefChem:5905|Indomethacin Extended-release|C01EB03|M01AB01|M02AA23|S01BC01|1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1-H-indole-3-acetic acid|200-186-5|Indocin|Dolcidium|Elmetacin|Indomethine|Indorektal|Catlep|Indoxen|Vonum|Indo-phlogont|Chibro-amuno|MFCD00057095|CCRIS 3502|HSDB 3101|1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid|Indometacin [INN]|Indomethacin (Indocid, Indocin)|CHEMBL6|2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methyl-1h-indol-3-yl}acetic acid|IMN|MLS000069402|1-(p-Chlorobenzoyl)-2-methoxy-3-methyl-1H-indole-3-acetic Acid|CAS-53-86-1|NCGC00015562-18|Indmethacine|Indomethancin|Arthrexin|Bonidin|Bonidon|Indameth|Miametan|SMR000058195|Indomo|Flexin continus|Hicin|Chrono-indicid|Chrono-indocid|Indometacyna [Polish]|2-[1-(4-chlorobenzoyl)-5-methoxy-2-methyl-indol-3-yl]acetic acid|Bonidon Gel|Indometicina [Spanish]|Dolcidium PL|Indo-Spray|Indometacine [INN-French]|Indometacinum [INN-Latin]|Indometacina [INN-Spanish]|1-(4-chlorobenzoyl)-5-methoxy-2-methylindole-3-acetic acid|2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2-methylindol-3-yl}acetic acid|Indocin-SR|Indochron E-R|Indocin (TN)|Aconip (TN)|Indomethacin (USP)|Indocid (pharmaceutical)|SR-01000000014|EINECS 200-186-5|Indomethacin & MAP-30|Indomethacin [USAN:USP]|UNII-XXE1CET956|BRN 0497341|Indocollyre|Indonol|Innamit|Inteban|1-(p-Chlorobenzoyl)-5-methoxy-2-methyl-Indole-3-acetic acid|2-{1-((4-chlorophenyl)carbonyl)-5-methoxy-2-methylindol-3-yl}acetic acid|4kyk|Prestwick_597|Indomethacin (GMP)|USAN|Opera_ID_56|Spectrum_000919|Tocris-1708|1z9h|Indomethacin (Standard)|1-(p-Chlorbenzoyl)-5-methoxy-2-methylindol-3-essigsaeure [German]|1-p-Cloro-benzoil-5-metoxi-2-metilindol-3-acido acetico [Spanish]|Prestwick0_000272|Prestwick1_000272|Prestwick2_000272|Prestwick3_000272|Spectrum2_000970|Spectrum3_000468|Spectrum4_000018|Spectrum5_000868|INDOMETACIN [JAN]|INDOMETHACIN [MI]|Lopac-I-7378|Kwas 1-(p-chlorobenzoilo)-2-metylo-5-metoksy-3-indolilooctowy [Polish]|Indometacin (Indomethacin)|MolMap_000032|UPCMLD-DP023|EC 200-186-5|I 7378|Indometacin (JP18/INN)|INDOMETHACIN [HSDB]|INDOMETHACIN [USAN]|SCHEMBL9300|INDOMETACIN [MART.]|INDOMETHACIN [VANDF]|Lopac0_000692|Oprea1_686105|BSPBio_000144|BSPBio_001149|BSPBio_002176|INDOMETACIN [WHO-DD]|INDOMETACIN [WHO-IP]|Indomethacine impurity mixture|KBioGR_000395|KBioGR_000489|KBioSS_000489|KBioSS_001399|5-22-05-00239 (Beilstein Handbook Reference)|MLS001074194|MLS006011845|BIDD:GT0132|DivK1c_000271|INDOMETHACIN [USP-RS]|SPECTRUM1500350|SPBio_000979|SPBio_002363|BPBio1_000160|GTPL1909|orb1310593|Indomethacin, >=99% (TLC)|SCHEMBL11563010|SCHEMBL29353712|UPCMLD-DP023:001|BDBM17638|CGIGDMFJXJATDK-UHFFFAOYSA-|HMS500N13|KBio1_000271|KBio2_000489|KBio2_001399|KBio2_003057|KBio2_003967|KBio2_005625|KBio2_006535|KBio3_000897|KBio3_000898|KBio3_001396|MSK7168|Indomethacin - CAS 53-86-1|NINDS_000271|Bio2_000405|Bio2_000885|HMS1362I11|HMS1568H06|HMS1792I11|HMS1920F21|HMS1990I11|HMS2089N19|HMS2091N09|HMS2095H06|HMS2231J10|HMS3262K05|HMS3268A14|HMS3374F07|HMS3403I11|HMS3414N13|HMS3430L03|HMS3649K17|HMS3655O04|HMS3678N11|HMS3712H06|HMS3747K21|HMS3884E08|HMS5079F18|INDOMETACIN [EP MONOGRAPH]|Indomethacin  - Bio-X trade mark|INDOMETHACIN [ORANGE BOOK]|Indomethacin-d4(chlorobenzoyl-d4)|Pharmakon1600-01500350|BCP18951|MDA37708|INDOMETHACIN [USP MONOGRAPH]|Tox21_113109|Tox21_201791|Tox21_300266|Tox21_500692|AC-532|CCG-40186|HB4422|HY-14397G|HY-14397R|INDOMETACINUM [WHO-IP LATIN]|NSC757061|s1723|SBB057417|STL257874|AKOS000592893|Tox21_113109_1|AT13679|DB00328|FI24585|Indometacin 1.0 mg/ml in Acetonitrile|KS-5255|LP00692|NSC 757061|SDCCGSBI-0050670.P005|IDI1_000271|IDI1_002160|NCGC00015562-01|NCGC00015562-02|NCGC00015562-03|NCGC00015562-04|NCGC00015562-05|NCGC00015562-06|NCGC00015562-07|NCGC00015562-08|NCGC00015562-09|NCGC00015562-10|NCGC00015562-11|NCGC00015562-12|NCGC00015562-13|NCGC00015562-14|NCGC00015562-15|NCGC00015562-16|NCGC00015562-17|NCGC00015562-19|NCGC00015562-20|NCGC00015562-21|NCGC00015562-22|NCGC00015562-24|NCGC00015562-25|NCGC00015562-40|NCGC00024135-02|NCGC00024135-04|NCGC00024135-05|NCGC00024135-06|NCGC00024135-07|NCGC00024135-08|NCGC00024135-09|NCGC00024135-10|NCGC00024135-11|NCGC00024135-12|NCGC00024135-13|NCGC00024135-14|NCGC00024135-15|NCGC00254075-01|NCGC00259340-01|NCGC00261377-01|BI166166|BP-30207|HY-14397|NCI60_041708|O-Desmethyl-des-4-chlorobenzoylacemetacin|SBI-0050670.P004|ACEMETACIN IMPURITY B [EP IMPURITY]|DB-052413|AB00052022|EU-0100692|I0655|NS00000217|ST50320042|SW196768-5|EN300-16807|Indomethacin, meets USP testing specifications|BIM-0050670.0001|C01926|D00141|S00108|AB00052022-20|AB00052022-21|AB00052022_23|AB00052022_24|F358171|L000959|Q409231|SR-01000000014-2|SR-01000000014-4|SR-01000000014-6|BRD-K57222227-001-06-1|BRD-K57222227-001-18-6|BRD-K57222227-001-27-7|BRD-K57222227-001-28-5|BRD-K57222227-001-29-3|BRD-K57222227-001-30-1|SR-01000000014-10|SR-01000000014-16|Z56784896|1-p-chlorobenzoyl-2-methyl-5-methoxyindol-3-acetic acid|1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indoleacetic acid|1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetic acid|1-(p-Chlorobenzoyl)-5-methoxy-2-methylindol-3-acetic acid|1-(p-chlorobenzyl)-5-methoxy-2-methylindole-3-acetic acid|1-(4-chloro-benzoyl)-5-methoxy-2-methyl-3-indolyl-acetic acid|1-(4-Chlorobenzoyl)-2-methyl-5-methoxyindole-3-acetic acid|1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indole-acetic acid|1-(p-chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid|1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indol acetic acid|Indomethacin, European Pharmacopoeia (EP) Reference Standard|N-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolylacetic acid|Indomethacin, United States Pharmacopeia (USP) Reference Standard|.alpha.-(1-(p-Chlorobenzoyl)-2-methyl-5-methoxy-3-indolyl)acetic acid|[1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl]acetic acid #|1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid & MAP-30|1-(4-Chlorobenzoyl)-5-methoxy-2-methyl-1H-indole-3-acetic acid;Indometacin|1H-Indole-3-acetic acid, 1-(4-chlorobenzoyl)-5-methoxy-2-methyl- (9CI)|2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2 methylindol-3-yl}acetic acid|2-{1-[(4-chlorophenyl)carbonyl]-5-methoxy-2methylindol-3-yl}acetic acid|Indole-3-acetic acid, 1-(p-chlorobenzoyl)-5-methoxy-2-methyl- (8CI)|Indomethacin, Pharmaceutical Secondary Standard; Certified Reference Material|InChI=1/C19H16ClNO4/c1-11-15(10-18(22)23)16-9-14(25-2)7-8-17(16)21(11)19(24)12-3-5-13(20)6-4-12/h3-9H,10H2,1-2H3,(H,22,23)"
ERLOTINIB,176870,,"InChI=1S/C22H23N3O4/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25)",AAKJLRGGTJKAMG-UHFFFAOYSA-N,C22H23N3O4,393.4,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine","Erlotinib|183321-74-6|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine|4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-|erlotinibum|J4T82NDH7E|DTXSID8046454|CHEBI:114785|RG-1415|DTXCID6026454|CP-35877401|R-1415|[6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl-phenyl)-amine|(6,7-Bis-(2-methoxy-ethoxy)-quinazolin-4-yl)-(3-ethynyl-phenyl)-amine|RefChem:5799|L01XE03|Erlotinib free base|4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline|Erlotinib Base|Erlotinib [INN]|MFCD02089651|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine|Erlotinib, Free Base|183321-74-6 (free base)|CHEMBL553|[6,7-BIS(2-METHOXY-ETHOXY)QUINAZOLINE-4-YL]-(3-ETHYNYLPHENYL)AMINE|Erlotinib (INN)|NCGC00164574-01|R 1415|Erlotinib(Tarceva)|1429636-49-6|CAS-183321-74-6|Erlotinib [INN:BAN]|SR-05000001460|UNII-J4T82NDH7E|Erotinib|HSDB 8082|OSI 744|nchembio866-comp3|Erlotinib free base?|Erlotinib (Standard)|Kinome_3317|ERLOTINIB [MI]|ERLOTINIB [VANDF]|ERLOTINIB [WHO-DD]|SCHEMBL8413|ERLOTINIB [EMA EPAR]|BDBM5446|cid_176870|GTPL4920|orb1310678|SCHEMBL29351329|SCHEMBL30362833|AAKJLRGGTJKAMG-UHFFFAOYSA-N|HMS2089F05|HMS3244M19|HMS3244M20|HMS3244N19|HMS3295A19|HMS3713C22|HMS3745M05|HMS5085P20|MSK10717|Tox21_112202|AC-399|HY-50896R|NSC800097|s7786|STK623143|AKOS000282911|Tox21_112202_1|CCG-220420|CS-0620|DB00530|NSC-800097|Ro-508231|SB16916|SDCCGSBI-0634409.P005|NCGC00164574-03|NCGC00164574-05|NCGC00164574-06|NCGC00164574-14|NCGC00164574-25|AS-35132|BCB03_000783|BE164419|BP-43654|HY-50896|SY028059|NS00006169|D07907|EN300-708808|K00241|AB01273955-01|AB01273955-02|AB01273955-03|321E746|F050702|Q418369|SR-05000001460-1|SR-05000001460-2|SR-05000001460-3|SR-05000001460-6|BRD-K70401845-001-15-7|BRD-K70401845-003-04-7|BRD-K70401845-003-09-6|Z2588038919|4-[(3-Ethynylphenyl)amino]-6,7-bis(2-methoxyethoxy)quinazoline; N-(3-Ethynylphenyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine; Tarceva"
GEFITINIB,123631,,"InChI=1S/C22H24ClFN4O3/c1-29-20-13-19-16(12-21(20)31-8-2-5-28-6-9-30-10-7-28)22(26-14-25-19)27-15-3-4-18(24)17(23)11-15/h3-4,11-14H,2,5-10H2,1H3,(H,25,26,27)",XGALLCVXEZPNRQ-UHFFFAOYSA-N,C22H24ClFN4O3,446.9,N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine,"Gefitinib|184475-35-2|Iressa|ZD1839|Irressat|ZD 1839|ZD-1839|N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(morpholin-4-yl)propoxy]quinazolin-4-amine|gefitinibum|N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine|4-(3'-Chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)quinazoline|NSC-759856|N-(3-chloro-4-fluorophenyl)-7-methoxy-6-[3-(4-morpholinyl)propoxy]-4-quinazolinamine|S65743JHBS|DTXSID8041034|CHEBI:49668|DTXCID6021034|NSC715055|4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-|N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamine|N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-(morpholin-4-yl)propoxy)quinazolin-4-amine|RefChem:58462|N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholinyl)propoxy)-4-quinazolinamide|L01XE02|N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-(4-morpholin) propoxy)-4-quinazolinamine|643-034-7|N-(3-Chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine|gefitinib (zd1839)|C22H24ClFN4O3|MFCD04307832|Gefitinib (GMP)|N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine|CHEMBL939|Gefitinib [USAN]|NCGC00159455-02|N-(3-chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholinopropoxy)quinazolin-4-amine|3-Chloro-4-Fluoro-N-[(4z)-7-Methoxy-6-(3-Morpholin-4-Ylpropoxy)quinazolin-4(1h)-Ylidene]aniline|Iressa(TM)|IRE|Iressa (TN)|CCRIS 9011|CAS-184475-35-2|SR-00000000262|UNII-S65743JHBS|Gefitinib [USAN:INN:BAN]|Gefitini; Iressa|N-(3-Chloro-4-fluoro-phenyl)-7-methoxy-6-(3-morpholin-4 -ylpropoxy)quinazolin-4-amine|Gefitinib (Standard)|Iressa (AstraZeneca)|nchembio866-comp14|Kinome_3321|Kinome_3322|GEFITINIB [INN]|GEFITINIB [JAN]|GEFITINIB [MI]|GEFITINIB [VANDF]|Gefitinib (ZD1839)?|GEFITINIB [MART.]|GEFITINIB [WHO-DD]|SCHEMBL7866|Gefitinib,ZD-1839,Iressa|GEFITINIB [EMA EPAR]|KBioSS_002241|MLS003899193|CU-00000000396-1|Gefitinib - Bio-X trade mark|BDBM5447|cid_123631|GTPL4941|orb1309499|SCHEMBL4535121|SCHEMBL4535128|SCHEMBL4535134|Gefitinib (JP18/USAN/INN)|GEFITINIB [ORANGE BOOK]|GEFITINIB [EP MONOGRAPH]|Gefitinib, >=98% (HPLC)|SCHEMBL29351046|SCHEMBL29351336|BCPP000221|GLXC-05820|HMS2089B19|HMS3244M21|HMS3244M22|HMS3244N21|HMS3295A21|HMS3413H08|HMS3654A07|HMS3677H08|HMS3714A05|HMS3748E17|HMS5079C05|Pharmakon1600-01502274|BCP01365|YWB97640|Tox21_111683|HY-50895G|HY-50895R|MSK159193|NSC759856|NSC800105|s1025|STK621310|AKOS000280752|Tox21_111683_1|AB20814|AC-1556|BCP9000718|CCG-220642|CS-0124|DB00317|FG10816|KS-1204|NSC 759856|NSC-715055|NSC-800105|SDCCGSBI-0634411.P005|4-[(3-Chloro-4-fluorophenyl)amino]-7-methoxy-6-(3-morpholinopropoxy)quinazoline|4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-4-morpholin)propoxy)-|6-(3-morpholinopropoxy)-N-(3-chloro-4-fluorophenyl)-7-methoxyquinazolin-4-amine|NCGC00159455-03|NCGC00159455-04|NCGC00159455-05|NCGC00159455-06|NCGC00159455-08|NCGC00159455-09|NCGC00159455-14|BCB03_000781|BG164498|HY-50895|SMR002204119|SY002154|CS-0622782|G0546|NS00006312|SW199108-4|D01977|EN300-123024|G-4408|K00240|AB01273954-01|AB01273954-02|AB01273954-03|AB01273954_04|475G352|Q417824|SR-00000000262-2|SR-00000000262-3|BRD-K64052750-001-16-7|BRD-K64052750-001-17-5|BRD-K64052750-001-22-5|BRD-K64052750-001-23-3|Gefitinib, EuropePharmacopoeia (EP) Reference Standard|Z1546610485|4-(3'-chloro-4'-fluoroanilino)-7-methoxy-6-(3-morpholinopropoxy)-quinazoline|Gefitinib for system suitability, EuropePharmacopoeia (EP) Reference Standard|(3-CHLORO-4-FLUORO-PHENYL)-[7-METHOXY-6-(3-MORPHOLIN-4-YL-PROPOXY)-QUINAZOLIN-4-YL]-AMINE"
CANERTINIB DIHYDROCHLORIDE,156413,,"InChI=1S/C24H25ClFN5O3.2ClH/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16;;/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29);2*1H",JZZFDCXSFTVOJY-UHFFFAOYSA-N,C24H27Cl3FN5O3,558.9,N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;dihydrochloride,"Canertinib dihydrochloride|289499-45-2|PD-0183805|PD183805|CANERTINIB HYDROCHLORIDE|ICJ93X8X90|PD-0183805-002B|DTXSID80183143|N-(4-(3-chloro-4-fluorophenyl)amino)-7-(3-morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide dihydrochloride|N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide dihydrochloride|N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-2-PROPENAMIDE DIHYDROCHLORIDE|N-[4-(3-Chloro-4-fluorophenyl)amino]-7-(3-morpholin-4-yl)propoxy]quinazolin-6-yl]prop-2-enamide dihydrochloride|RefChem:202005|DTXCID90105634|663-691-3|N-(-4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(4-morpholinyl)propoxy)-6-quinazolinyl)-2-propenamide Dihydrochloride|PD-183805|Canertinib HCl|Canertinib (dihydrochloride)|CI-1033|Canertinib dihydrochloride [USAN]|MFCD09954112|2-Propenamide, N-[4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-, hydrochloride (1:2)|N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide dihydrochloride|N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide;dihydrochloride|289499-45-2 (HCl)|Canertinib 2HCl|CI-1033 dihydrochloride;PD-183805 dihydrochloride|CHEMBL545315|Canertinib dihydrochloride (USAN)|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide dihydrochloride|N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide dihydrochloride|PD 183805|SN-26606|UNII-ICJ93X8X90|Canertinib.2HCL|Canertinib dihydrochloride?|C24H27Cl3FN5O3|Canertinib dihydrochloride salt|orb1305388|SCHEMBL2052123|SCHEMBL30436576|GLXC-05016|HMS3295E05|BCP01902|CI-103|HY-10367A|AKOS015924656|AC-2414|CANERTINIB DIHYDROCHLORIDE [MI]|CS-0263|FC32740|2-Propenamide, N-(4-((3-chloro-4-fluorophenyl) amino)-7-(3-(4-morpholinyl) propoxy)-6-quinazolinyl)-, dihydrochloride|2-Propenamide, N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-(4-morpholinyl)propoxy)-6-quinazolinyl)-, dihydrochloride|AS-75065|N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide dihydrochloride|N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide dihydrochloride|CANERTINIB DIHYDROCHLORIDE [WHO-DD]|CI 1033;PD 183805|S0711|CI-1033, >=98% (HPLC)|D03350|EN300-19659633|F862305|Q27280663|2-PROPENAMIDE, N-(4-((3-CHLORO-4-FLUOROPHENYL) AMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-, DIHYDROCHLORIDE|N-[4-(3-chloro-4-fluoro-anilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]prop-2-enamide;dihydrochloride|N-[4-(3-Chloro-4-fluoro-phenylamino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide dihydrochloride"
LAPATINIB,208908,,"InChI=1S/C29H26ClFN4O4S/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35)",BCFGMOOMADDAQU-UHFFFAOYSA-N,C29H26ClFN4O4S,581.1,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine,"Lapatinib|231277-92-2|GW572016|GW 572016|GSK 572016|GW-572016|DTXSID7046675|N-{3-chloro-4-[(3-fluorophenyl)methoxy]phenyl}-6-(5-{[(2-methanesulfonylethyl)amino]methyl}furan-2-yl)quinazolin-4-amine|CHEBI:49603|0VUA21238F|GSK572016|GSK-572016|GW-572016X|n-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine|DTXCID5026675|4-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-|N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl)-4-quinazolinamine|lapatinibum|N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-methanesulfonylethyl)amino)methyl)furan-2-yl)quinazolin-4-amine|GW-282974X|RefChem:798502|L01XE07|GW2016|GW 2016|878-720-7|N-(3-chloro-4-(((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-methylsulfonyl)ethyl)amino)methyl)-2-furyl)-4-quinazolinamine|NSC727989|Tykerb|Lapatinib [INN]|MFCD09264194|Lapatinib base|C29H26ClFN4O4S|Lapatinib (INN)|Lapatinib free base|N-(3-chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine|N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine|Lapatinib (free base)|231277-92-2 (free base)|FMM|N-{3-CHLORO-4-[(3-FLUOROBENZYL)OXY]PHENYL}-6-[5-({[2-(METHYLSULFONYL)ETHYL]AMINO}METHYL)-2-FURYL]-4-QUINAZOLINAMINE|CHEMBL554|1210608-87-9|GW 282974X|NSC745750|N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine|NCGC00167507-01|913989-15-8|N-(3-Chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-((2-methylsulfonylethylamino)methyl)-2-furyl)quinazolin-4-amine|N-{3-chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine|CAS-231277-92-2|GW-2016|Lapatinib [INN:BAN]|UNII-0VUA21238F|Lapatinib?|HSDB 8209|1xkk|N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|Lapatinib ditosylate?|Lapatinib (Standard)|Lapatinib, Free base|nchembio866-comp20|Kinome_3684|Kinome_3685|LAPATINIB [MI]|LAPATINIB [VANDF]|LAPATINIB [WHO-DD]|SCHEMBL8100|Lapatinib (GW572016)|LAPATINIB [EMA EPAR]|BDBM5445|cid_208908|GTPL5692|orb1310962|SCHEMBL29351024|SCHEMBL29464189|EX-A402|BCFGMOOMADDAQU-UHFFFAOYSA-N|BCPP000188|BCPP000189|GLXC-06463|HMS2089H10|HMS3244N06|HMS3244N10|HMS3244N14|HMS3744K11|HMS5080G12|Tykerb (TN) (Glaxo Smith Kline)|BCP01874|Lapatinib base - Bio-X trade mark|Tox21_112505|HY-50898R|NSC800780|AKOS005145766|Tox21_112505_1|AC-1314|BCP9000837|BCP9000838|CCG-270133|DB01259|FC12433|NSC-745750|NSC-800780|SB16918|SDCCGSBI-0634417.P003|NCGC00167507-02|NCGC00167507-03|NCGC00167507-04|NCGC00167507-09|AS-14065|BC164610|BP-43661|HY-50898|N-(3-chloro-4-(3-fluorobenzyloxy)phenyl)-6-(5-((2-(methylsulfonyl)ethylamino)methyl)furan-2-yl)quinazolin-4-amine|N-(3-Chloro-4-{[(3-fluorophenyl)methyl]oxy}phenyl)-6-[5-({[2-(methylsulfonyl)ethyl]amino}methyl)-2-furanyl]-4-quinazolinamine|L0360|NS00003012|SW199101-5|D08108|EN300-117254|AB01273965-01|AB01273965-02|AB01273965-03|AB01273965_04|AB01273965_05|277L922|Q420323|SR-05000001472-1|BRD-K19687926-001-01-7|BRD-K19687926-001-04-1|BRD-K19687926-001-10-8|BRD-K19687926-379-02-5|BRD-K19687926-379-07-4|1092929-10-6|GW572016;N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl]quinazolin-4-amine|N-[3-chloro-4-(3-fluorobenzyloxy)phenyl]-6-[5-({[2-(methanesulfonyl)ethyl]amino}methyl)furan-2-yl]quinazolin-4-amine|N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]-2-furyl] quinazolin-4-amine|N-{3-chloro-4-[(3-fluoro-benzyl)oxy]phenyl}-6-[5-({2-(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methane sulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine|N-{3-Chloro-4[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methane sulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine"
TONAPOFYLLINE,216466,,"InChI=1S/C22H32N4O4/c1-3-13-25-17-16(18(29)26(14-4-2)20(25)30)23-19(24-17)22-10-7-21(8-11-22,9-12-22)6-5-15(27)28/h3-14H2,1-2H3,(H,23,24)(H,27,28)",ZWTVVWUOTJRXKM-UHFFFAOYSA-N,C22H32N4O4,416.5,"3-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-bicyclo[2.2.2]octanyl]propanoic acid","Tonapofylline|340021-17-2|Bg 9928|BG9928|BG-9928|Tonapofilina|83VNU4U44T|3-[4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-bicyclo[2.2.2]octanyl]propanoic acid|DTXSID30187611|3-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)bicyclo[2.2.2]octan-1-yl)propanoic acid|Bicyclo(2.2.2)octane-1-propanoic acid, 4-(2,3,6,7-tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)-|tonapofyllinum|3-(4-(2,6-dioxo-1,3-dipropyl-7H-purin-8-yl)-1-bicyclo(2.2.2)octanyl)propanoic acid|3-(4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)bicyclo(2.2.2)octan-1-yl)propanoic acid|RefChem:568026|BIO4683|BIO5770|BIO7505|BIO8170|BIO9002|DTXCID90110102|BIO-4683|BIO-5770|BIO-7505|BIO-8170|BIO-9002|3-(4-(2,6-DIOXO-1,3-DIPROPYL-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)BICYCLO(2.2.2)OCT-1-YL)PROPANOIC ACID|CHEMBL386974|CHEMBL414157|3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]-propionic acid|Tonapofylline [USAN:INN]|UNII-83VNU4U44T|TONAPOFYLLINE [INN]|Tonapofylline (USAN/INN)|TONAPOFYLLINE [USAN]|4-(2,3,6,7-Tetrahydro-2,6-dioxo-1,3-dipropyl-1H-purin-8-yl)bicyclo(2.2.2)octane-1-propanoic acid|GTPL5605|orb1706522|SCHEMBL1565483|SCHEMBL3063739|CHEBI:177398|ZWTVVWUOTJRXKM-UHFFFAOYSA-N|GLXC-07226|GLXC-25219|QNA02117|BDBM50199269|BDBM50199293|AKOS040742753|DB12569|DA-58652|HY-14873|MS-27251|CS-0003609|NS00068373|D09684|G13668|L001665|Q27089006|3-(4-(2,6-DIOXO-1,3-DIPROPYL-2,3,6,7-TETRAHYDRO-1H-PURIN-8-YL)BICYCLO(2.2.2)OCT-1- YL)PROPANOIC ACID|3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro 1H-purin-8-yl)-bicyclo-[2.2.2]oct-1-yl]-propionic acid|3-[4-(2,6-dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo-[2.2.2]oct-1-yl]-propionic acid|3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2 ]oct-1-yl]propionic acid|3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2] oct-1-yl]-propionic acid|3-[4-(2,6-Dioxo-1,3-dipropyl-2,3,6,7-tetrahydro-1H-purin-8-yl)-bicyclo[2.2.2]oct-1-yl]propionic acid|BICYCLO(2.2.2)OCTANE-1-PROPANOIC ACID, 4-(2,3,6,7-TETRAHYDRO-2,6-DIOXO-1,3-DIPROPYL-1H- PURIN-8-YL)-"
RITOLUKAST,60539,,"InChI=1S/C17H13F3N2O3S/c18-17(19,20)26(23,24)22-13-5-3-6-15(10-13)25-11-14-9-8-12-4-1-2-7-16(12)21-14/h1-10,22H,11H2",GOHUJGMYCZDYDF-UHFFFAOYSA-N,C17H13F3N2O3S,382.4,"1,1,1-trifluoro-N-[3-(quinolin-2-ylmethoxy)phenyl]methanesulfonamide","RITOLUKAST|111974-60-8|Wy-48252|1,1,1-trifluoro-N-[3-(quinolin-2-ylmethoxy)phenyl]methanesulfonamide|0E8R4GDE2Q|CHEMBL17344|Ritolukastum|Ritolukast [USAN:INN]|Wy 48252|Ritolukastum [INN-Latin]|UNII-0E8R4GDE2Q|1,1,1-Trifluoro-N-(3-(quinolin-2-ylmethoxy)phenyl)methanesulfonamide|RITOLUKAST [INN]|Ritolukast (USAN/INN)|RITOLUKAST [USAN]|SCHEMBL38043|orb2565348|1,1,1-Trifluoro-alpha-2-quinolylmethanesulfon-m-anisidide|DTXSID90149795|BDBM50006806|AKOS000278710|FR161381|HY-156978|CS-0905494|NS00121671|D02849|Q27236668|N-[3-[(2-Quinolinyl)methoxy]phenyl]trifluoromethane sulfonamide|1,1,1-trifluoro-N-(3-(2-quinolinylmethoxy)phenyl)methane sulfonamide|C,C,C-Trifluoro-N-[3-(quinolin-2-ylmethoxy)-phenyl]-methanesulfonamide|Methanesulfonamide, 1,1,1-trifluoro-N-(3-(2-quinolinylmethoxy)phenyl)-|C,C,C-Trifluoro-N-[3-(quinolin-2-ylmethoxy)-phenyl]-methanesulfonamide( Wy-48,252)|C,C,C-Trifluoro-N-[3-(quinolin-2-ylmethoxy)-phenyl]-methanesulfonamide(Wy 48252)|C,C,C-Trifluoro-N-[3-(quinolin-2-ylmethoxy)-phenyl]-methanesulfonamide(Wy-48,252)"
POBILUKAST,60842,,"InChI=1S/C26H34O5S/c27-23(28)18-19-32-25(24(29)26(30)31)22-17-11-10-16-21(22)15-9-4-2-1-3-6-12-20-13-7-5-8-14-20/h5,7-8,10-11,13-14,16-17,24-25,29H,1-4,6,9,12,15,18-19H2,(H,27,28)(H,30,31)/t24-,25-/m1/s1",PZIFPMYXXCAOCC-JWQCQUIFSA-N,C26H34O5S,458.6,"(2S,3R)-3-(2-carboxyethylsulfanyl)-2-hydroxy-3-[2-(8-phenyloctyl)phenyl]propanoic acid","Pobilukast|107023-41-6|SKF 104353|R2N8IH71HC|SK&F-104353|Benzenepropanoic acid, beta-((2-carboxyethyl)thio)-alpha-hydroxy-2-(8-phenyloctyl)-, (R-(R*,S*))-|(2s,3r)-3-[(2-carboxyethyl)sulfanyl]-2-hydroxy-3-[2-(8-phenyloctyl)phenyl]propanoic acid|pobilukastum|(2S,3R)-3-((2-carboxyethyl)sulfanyl)-2-hydroxy-3-(2-(8-phenyloctyl)phenyl)propanoic acid|RefChem:174975|2-hydroxy-3-((2-carboxyethyl)thio)-3-(2-(8-phenyloctyl)phenyl)propanoic acid|Pobilukast [INN]|CHEMBL22776|(2S,3R)-3-(2-carboxyethylsulfanyl)-2-hydroxy-3-[2-(8-phenyloctyl)phenyl]propanoic acid|SKF-104353|UNII-R2N8IH71HC|SKF104353|POBILUKAST [WHO-DD]|SCHEMBL125952|GTPL3334|orb1980193|SCHEMBL29473536|3-(2-Carboxy-ethylsulfanyl)-2-hydroxy-3-[2-(8-phenyl-octyl)-phenyl]-propionic acid|BDBM50009070|SK&F-104353-Z2|CS-0026553|NS00124577|Q27088425|(2S,3R)-3-((2-CARBOXYETHYL)THIO)-3-(O-(8-PHENYLOCTYL)PHENYL)LACTIC ACID|(2S,3R)-3-(2-Carboxy-ethylsulfanyl)-2-hydroxy-3-[2-(8-phenyl-octyl)-phenyl]-propionic acid|3-(2-Carboxy-ethylsulfanyl)-2-hydroxy-3-[2-(8-phenyl-octyl)-phenyl]-propionic acid(SKF 104353)"
PRANLUKAST,4887,,"InChI=1S/C27H23N5O4/c33-23-17-24(26-29-31-32-30-26)36-25-21(23)10-6-11-22(25)28-27(34)19-12-14-20(15-13-19)35-16-5-4-9-18-7-2-1-3-8-18/h1-3,6-8,10-15,17H,4-5,9,16H2,(H,28,34)(H,29,30,31,32)",NBQKINXMPLXUET-UHFFFAOYSA-N,C27H23N5O4,481.5,N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide,"Pranlukast|103177-37-3|Azlaire|Ono-1078|ONO 1078|Ono-RS-411|SB 205312|CCN 00401|RS 411|N-[4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl]-4-(4-phenylbutoxy)benzamide|DTXSID3043782|CCN-00401|RS-411|TB8Z891092|SB-205312|DTXCID1023782|N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-p-(4-phenylbutoxy)benzamide|pranlukastum|N-(4-oxo-2-(2H-tetrazol-5-yl)chromen-8-yl)-4-(4-phenylbutoxy)benzamide|RefChem:175724|R03DC02|8-(4 (4-phenylbutoxy)benzoyl)amino-2-(tetrazol-5'-yl)-4-oxo-4H-1-benzopyran|N-(4-oxo-2-(2H-1,2,3,4-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide|808-178-9|ONO-RS 411|Pranlukast (INN)|Onon|N-(4-OXO-2-(1H-TETRAZOL-5-YL)-4H-CHROMEN-8-YL)-4-(4-PHENYLBUTOXY)BENZAMIDE|C27H23N5O4|CHEMBL21333|MFCD24539454|NCGC00181765-01|PRANLUKAST [INN]|8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran;8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran|N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-P-(4-phenylbutoxy)benzamide;N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-P-(4-phenylbutoxy)benzamide|Azlaire (TN)|Pranlukast [INN:BAN]|SR-05000001474|4-Oxo-8-(4-(4-phenylbutoxy)benzoylamino)-2-(tetrazol-5-yl)-4H-1-benzopyran|UNII-TB8Z891092|Pranlukast (Standard)|PRANLUKAST [MI]|PRANLUKAST [MART.]|SCHEMBL3693|PRANLUKAST [WHO-DD]|MLS006010078|GTPL3634|ONO RS-411|orb1310378|SCHEMBL18058592|SCHEMBL29349894|CHEBI:94810|HY-B0290R|GLXC-21321|HMS2089H16|HMS3650A14|HMS3714E03|BCP04577|HY-B0290|Tox21_112952|AC-696|BDBM50023198|MFCD00864631|AKOS015967342|103177-37-3 (anhyd.)|CCG-220661|DB01411|FP27120|SB19080|N-(4-oxo-2-(2H-tetrazol-5-yl)-4H-chromen-8-yl)-4-(4-phenylbutoxy)benzamide|n-[4-oxo-2-(1h-tetrazol-5-yl)-4h-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide|AS-15105|DA-77034|SMR004701229|CAS-103177-37-3|NS00068609|P2115|C71133|D08408|AB01275471-01|177P373|L013134|Q7238392|SR-05000001474-1|SR-05000001474-2|SR-05000001474-3|BRD-K97045029-001-01-9|BRD-K97045029-001-02-7|BRD-K97045029-001-04-3|8-[4(4-phenylbutoxy)benzoyl]amino-2-(5-tetrazolyl)-4-oxo-4H-1-benzopyran|8-[4-(4-phenylbutyloxy)benzoyl]amino-2-(tetrazol-5-yl)-4-oxo-4H-1-benzopyran|Benzamide, N-(4-oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-4-(4-phenylbutoxy)-|N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide|N-[4-oxo-2-(2H-tetrazol-5-yl)-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide|BENZAMIDE, N-(4-OXO-2-(2H-TETRAZOL-5-YL)-4H-1-BENZOPYRAN-8-YL)-4-(4-PHENYLBUTOXY)-|KNT|N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide (ONO-RS-411)|N-[4-Oxo-2-(1H-tetrazol-5-yl)-4H-chromen-8-yl]-4-(4-phenyl-butoxy)-benzamide(ONO-RS-411)|N-{4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl]-4-(4-phenylbutoxy)benzamide;ONO-1078;ONO-RS-411"
MIBEFRADIL,60663,,"InChI=1S/C29H38FN3O3/c1-20(2)28-23-12-11-22(30)18-21(23)13-14-29(28,36-27(34)19-35-4)15-17-33(3)16-7-10-26-31-24-8-5-6-9-25(24)32-26/h5-6,8-9,11-12,18,20,28H,7,10,13-17,19H2,1-4H3,(H,31,32)/t28-,29-/m0/s1",HBNPJJILLOYFJU-VMPREFPWSA-N,C29H38FN3O3,495.6,"[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate","Mibefradil|116644-53-2|[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate|27B90X776A|Ro 405967|Ro 40 5967|DTXSID1023318|Acetic acid, methoxy-, 2-(2-((3-(1H-benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester, (1S-cis)-|(1S,2S)-(2-((3-(2-benzimidazolyl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-isopropyl-2-naphthyl methoxyacetate|[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methyl-amino]ethyl]-6-fluoro-1-isopropyl-tetralin-2-yl] 2-methoxyacetate|mibefradilum|((1S,2S)-2-(2-(3-(1H-benzimidazol-2-yl)propyl-methyl-amino)ethyl)-6-fluoro-1-isopropyl-tetralin-2-yl) 2-methoxyacetate|((1S,2S)-2-(2-(3-(1H-benzimidazol-2-yl)propyl-methylamino)ethyl)-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl) 2-methoxyacetate|Posicor 50|Posicor 100|RefChem:925843|DTXCID403318|C08CX01|Posicor|Mibefradil [INN:BAN]|Mibefradil (INN)|Mibefradil dihydrochloride hydrate|CHEMBL45816|CHEBI:6920|Acetic acid, methoxy-, (1S,2S)-2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl ester|MIBEFRADIL [INN]|C29H38FN3O3|MLS001056800|(1S,2S)-2-(2-((3-(1H-benzo[d]imidazol-2-yl)propyl)(methyl)amino)ethyl)-6-fluoro-1-isopropyl-1,2,3,4-tetrahydronaphthalen-2-yl 2-methoxyacetate|AC1L1TOE|SMR000326970|Lopac-M-5441|UNII-27B90X776A|(1S,2S)-2-(2-{[3-(1H-benzimidazol-2-yl)propyl](methyl)amino}ethyl)-6-fluoro-1-(propan-2-yl)-1,2,3,4-tetrahydronaphthalen-2-yl methoxyacetate|MIBEFRADIL [MI]|MIBEFRADIL [VANDF]|MIBEFRADIL [WHO-DD]|Lopac0_000748|SCHEMBL39551|(1S-cis)-2-(2-((3-(1H-Benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl methoxyacetate|2-(2-((3-(1H-Benzimidazol-2-yl)propyl)methylamino)ethyl)-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenyl methoxyacetate (1S-cis)-|GTPL2522|orb1679032|SCHEMBL29359482|SCHEMBL29364574|SCHEMBL30170543|BDBM78934|cid_16746591|Acetic acid, 2-methoxy-, (1S,2S)-2-[2-[[3-(1H-benzimidazol-2-yl)propyl]methylamino]ethyl]-6-fluoro-1,2,3,4-tetrahydro-1-(1-methylethyl)-2-naphthalenylester, hydrochloride (1:2)|BCP09875|ro40-5967|BDBM50117922|NSC760798|AKOS022185482|CCG-204833|CS-1218|DB01388|NSC-760798|SDCCGSBI-0050726.P002|NCGC00015683-01|NCGC00161420-01|NCGC00161420-03|NCGC00161420-04|NCGC00161420-12|HY-15553|NS00001714|Ro-405967-001|C07222|D08217|Q6827783|BRD-K09549677-300-01-8|BRD-K09549677-300-03-4|(1S,2S)-2-(2-{[3-(1H-benzimidazol-2-yl)propyl](methyl)amino}ethyl)-6-fluoro-1-(1-methylethyl)-1,2,3,4-tetrahydronaphthalen-2-yl (methyloxy)acetate|(1S,2S)-2-[2-{[3-(1H-benzimidazol-2-yl)propyl]-methylamino }ethyl]-6-fluoro- 1-isopropyl- 1,2,3,4-tetrahydronaphthalen-2-yl methoxyacetate|(1S,2S)-2-[2-{[3-(1H-benzimidazol-2-yl)propyl]-methylamino}ethyl]-6-fluoro-1-isopropyl-1,2,3,4-tetrahydronaphthalen-2-yl methoxyacetate|(1S,2S)-2-[2-{[3-(1H-benzimidazol-2-yl)propyl]methylamino}ethyl]-6-fluoro-1-isopropyl-1,2,3,4-tetrahydronaphthalen-2-yl methoxyacetate|[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methyl-amino]ethyl]-6-fluoranyl-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyethanoate;hydrate;hydrochloride|[(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] 2-methoxyacetate;hydrate;hydrochloride|2-{2-[3-(1H-benzoimidazol-2-yl)-propylamino]-ethyl}-6-fluoro-1-isopropyl-1,2,3,4-tetrahydro-naphthalen-2-yl ester(Mibefradil)Methoxy-acetic acid|2-methoxyacetic acid [(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methyl-amino]ethyl]-6-fluoro-1-isopropyl-tetralin-2-yl] ester;hydrate;hydrochloride|2-methoxyacetic acid [(1S,2S)-2-[2-[3-(1H-benzimidazol-2-yl)propyl-methylamino]ethyl]-6-fluoro-1-propan-2-yl-3,4-dihydro-1H-naphthalen-2-yl] ester;hydrate;hydrochloride|Methoxy-acetic acid (1S,2S)-2-(2-{[3-(1H-benzoimidazol-2-yl)-propyl]-methyl-amino}-ethyl)-6-fluoro-1-isopropyl-1,2,3,4-tetrahydro-naphthalen-2-yl ester|Methoxy-acetic acid 2-(2-{[3-(1H-benzoimidazol-2-yl)-propyl]-methyl-amino}-ethyl)-6-fluoro-1-isopropyl-1,2,3,4-tetrahydro-naphthalen-2-yl ester"
SELICICLIB,160355,,"InChI=1S/C19H26N6O/c1-4-15(11-26)22-19-23-17(20-10-14-8-6-5-7-9-14)16-18(24-19)25(12-21-16)13(2)3/h5-9,12-13,15,26H,4,10-11H2,1-3H3,(H2,20,22,23,24)/t15-/m1/s1",BTIHMVBBUGXLCJ-OAHLLOKOSA-N,C19H26N6O,354.4,(2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol,"roscovitine|Seliciclib|186692-46-6|R-Roscovitine|(R)-roscovitine|CYC202|CYC-202|Roscovitin|2-(R)-(1-Ethyl-2-hydroxyethylamino)-6-benzylamino-9-isopropylpurine|NSC-701554|AL-39256|0ES1C2KQ94|CHEBI:45307|(2R)-2-[[6-(benzylamino)-9-propan-2-ylpurin-2-yl]amino]butan-1-ol|DTXSID20171928|(2R)-2-((6-benzylamino-9-(propan-2-yl)-9h-purin-2-yl)amino)butan-1-ol|(2R)-2-{[6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl]amino}butan-1-ol|seliciclibum|R roscovitine|(2R)-2-((6-(benzylamino)-9-propan-2-ylpurin-2-yl)amino)butan-1-ol|(2R)-2-((6-(benzylamino)-9-(propan-2-yl)-9H-purin-2-yl)amino)butan-1-ol|RefChem:389269|DTXCID8094419|CYC 202|Seliciclib [INN]|Roscovitine (Seliciclib,CYC202)|(R)-2-((6-(Benzylamino)-9-isopropyl-9H-purin-2-yl)amino)butan-1-ol|Seliciclib (Roscovitine)|MFCD02266401|CHEMBL14762|(2R)-2-[[6-(benzylamino)-9-isopropyl-purin-2-yl]amino]butan-1-ol|NSC701554|RRC|C19H26N6O|Rosco|(2R)-2-{[6-(benzylamino)-9-(1-methylethyl)-9H-purin-2-yl]amino}butan-1-ol|NSC 701554|UNII-0ES1C2KQ94|BMK1-E12|1unl|3ddq|1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-, (2R)-|1-Butanol, 2-[[9-(1-methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-, (2R)-|2a4l|SELICICLIB [MI]|BiomolKI_000048|1-Butanol, (2R)-|ROSCOVITINE(Seliciclib)|BiomolKI2_000054|M02443|ROSCOVITINE(Seliciclib)?|SELICICLIB [WHO-DD]|CBiol_002016|Lopac0_001102|SCHEMBL94728|BSPBio_001078|KBioGR_000418|KBioSS_000418|MLS006011028|BDBM7533|cid_160355|GTPL6035|orb1306496|Roscovitine, >=98% (TLC)|BCBcMAP01_000013|KBio2_000418|KBio2_002986|KBio2_005554|KBio3_000795|KBio3_000796|EX-A052|BCPP000087|Bio1_000302|Bio1_000791|Bio1_001280|Bio2_000379|Bio2_000859|CC205|GLXC-04786|HMS1362F19|HMS1792F19|HMS1990F19|HMS3229N13|HMS3403F19|BCP01760|Roscovitine (Seliciclib, CYC202)|HSCI1_000092|MSK168158|NSC800881|6-(Benzylamino)-2(R)-[[1-(hydroxymethyl)propyl]amino]-9-isopropylpurine|AKOS005146319|AC-2416|CCG-100652|DB06195|NSC-800881|2-(R)-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]-9H-purin-2-yl]amino]-1-butanol|IDI1_002134|Roscovitine - CAS 186692-46-6|SMP1_000266|2,6,9-Trisubstituted purine deriv. 28|NCGC00094374-01|NCGC00094374-02|NCGC00094374-03|NCGC00094374-04|NCGC00094374-05|NCGC00094374-09|NCGC00094374-13|NCGC00094374-15|AS-56277|FR146851|HY-30237|NCI60_036420|SMR004702823|NS00068708|SW220195-1|K00020|692R466|EN300-26484982|Q3494619|BRD-K07691486-001-03-1|BRD-K07691486-001-05-6|BRD-K07691486-001-15-5|BRD-K07691486-001-19-7|Z1741982636|(2R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol|(2R)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-2-purinyl]amino]-1-butanol|(2R)-2-[[6-[(phenylmethyl)amino]-9-propan-2-yl-purin-2-yl]amino]butan-1-ol|(R)-2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-1-butanol|1-Butanol, 2-((9-(1-methylethyl)-6-((phenylmethyl)amino)-9H-purin-2-yl)amino)-, (R)-|2-[[9-(1-Methylethyl)-6-[(phenylmethyl)amino]- 9H-purin-2-yl]amino]-(R)-1-butanol"
LOSARTAN POTASSIUM,11751549,,"InChI=1S/C22H22ClN6O.K/c1-2-3-8-20-24-21(23)19(14-30)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22;/h4-7,9-12,30H,2-3,8,13-14H2,1H3;/q-1;+1",OXCMYAYHXIHQOA-UHFFFAOYSA-N,C22H22ClKN6O,461.0,"potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol","LOSARTAN POTASSIUM|124750-99-8|Cozaar|Losacar|Losaprex|Losata|Tancin|Nu-Lotan|Aradois|Zaart|Presartan-50|Losartan monopotassium salt|MK-0954|MK0954|DuP 753|DuP-753|L-158086|DuP753|DU PONT-753|3ST302B24A|E-3340|DTXSID3044209|2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol, monopotassium salt|Losatan Potassium|Losortan Potassium|Losartan Potatssium|2-Butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-1H-imidazole-5-methanol, Monopotassium Salt|Potassium, Losartan|RefChem:55520|losartan potassium tablet|Monopotassium Salt, Losartan|Salt, Losartan Monopotassium|DTXCID1024209|LOSARTAN POTASSIUM 25 mg|LOSARTAN POTASSIUM 50 mg|LOSARTAN POTASSIUM 100 mg|Losartan Potassium Tablets, 25 mg|Losartan Potassium Tablets, 50 mg|Losartan Potassium Tablets, 100 mg|658-044-7|Monopotassium 5-((4'-(2-butyl-4-chloro-5-hydroxymethyl-1H-imidazol-1-yl)methyl)biphenyl-2-yl)-1H-tetrazol-1-ide|losartan potassium salt|Lorzaar|MK 954|Lortaan|Losartan Potassium (DuP 753)|2-Butyl-4-chloro-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)imidazole-5-methanol, monopotassium salt|124750-99-8 (Ka+)|Lifezar|Lorzaan|Losacor|Tenopres|Lotim|Niten|Ocsaar|Neo Lotan|MK-954|Du Pont 753|Losartan potassium [USAN]|Covance|UNII-3ST302B24A|losartanpotassium|Losartan potassium [USAN:USP]|1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, monopotassium salt|1H-Imidazole-5-methanol, 2-butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-, monopotassium salt|Losartan potassium; Potassium 5-[4'-[[2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl]methyl]biphenyl-2-yl]tetrazol-1-ide|Losartan Potassium?|Cozaar (TN)|ARBLI|MK 0954|CHEMBL995|SCHEMBL42079|MLS001401407|potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,3-triaza-4-azanidacyclopenta-2,5-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol|Ex-89|orb1310826|LOSARTAN POTASSIUM [JAN]|Losartan potassium (JP17/USP)|LOSARTAN POTASSIUM [HSDB]|HMS2051M12|HMS2090O22|HMS2235F20|HMS3369F08|HMS3393M12|LOSARTAN POTASSIUM [VANDF]|LOSARTAN POTASSIUM [MART.]|BCP05332|BCP29397|LOSARTAN POTASSIUM [USP-RS]|LOSARTAN POTASSIUM [WHO-DD]|MSK10415|AKOS015955543|AKOS025310168|AC-1072|CCG-100869|FL24945|Losartan potassium - Bio-X trade mark|Losartan potassium, analytical standard|NC00119|2-Butyl-4-chloro-1-(2'-(tetrazol-5-yl)biphenyl-4-ylmethyl)-1H-imidazole-5-methanol potassium|LOSARTAN MONOPOTASSIUM SALT [MI]|LOSARTAN POTASSIUM [ORANGE BOOK]|LOSARTAN POTASSIUM [EP MONOGRAPH]|2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl]imidazole-5-methanol Potassium Salt|BL164642|HYZAAR COMPONENT LOSARTAN POTASSIUM|LOSARTAN POTASSIUM [USP MONOGRAPH]|potassium 5-(4'-((2-butyl-4-chloro-5-(hydroxymethyl)-1H-imidazol-1-yl)methyl)-[1,1'-biphenyl]-2-yl)tetrazol-1-ide|SMR000469593|L0232|NS00076270|D00357|AB01275507-01|750L998|SR-05000001514|SR-05000001514-1|Q27257991|Losartan potassium, European Pharmacopoeia (EP) Reference Standard|Losartan Potassium is known as a potent, synthetic AT1 receptor antagonist.|Losartan potassium, United States Pharmacopeia (USP) Reference Standard|Losartan Potassium, Pharmaceutical Secondary Standard; Certified Reference Material|2-Butyl-4-chloro-1-[[2'-(1H-tetrazol-5yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-methanol potassium;Cozaar;MK-954|2-Butyl-4-chloro-1-2'-(1H-tetrazol-5yl)1,1'-biphenyl-4-ylmethyl-1H-imidazole-5-methanol potassium salt;Cozaar;MK-954"
CANERTINIB,156414,,"InChI=1S/C24H25ClFN5O3/c1-2-23(32)30-21-13-17-20(14-22(21)34-9-3-6-31-7-10-33-11-8-31)27-15-28-24(17)29-16-4-5-19(26)18(25)12-16/h2,4-5,12-15H,1,3,6-11H2,(H,30,32)(H,27,28,29)",OMZCMEYTWSXEPZ-UHFFFAOYSA-N,C24H25ClFN5O3,485.9,N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide,"Canertinib|267243-28-7|C78W1K5ASF|N-{4-[(3-chloro-4-fluorophenyl)amino]-7-[3-(morpholin-4-yl)propoxy]quinazolin-6-yl}prop-2-enamide|DTXSID8048943|CHEBI:61399|N-(4-((3-Chloro-4-fluorophenyl)amino)-7-(3-(morpholin-4-yl)propoxy)quinazolin-6-yl)prop-2-enamide|DTXCID1028869|2-PROPENAMIDE, N-(4-((3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-(4-MORPHOLINYL)PROPOXY)-6-QUINAZOLINYL)-|canertinibum|RefChem:917970|CI 1033|CI-1033|Canertinib (CI-1033)|Canertinib free base|N-(4-(3-chloro-4-fluorophenylamino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide|N-[4-(3-chloro-4-fluoroanilino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]prop-2-enamide|MFCD09837878|CHEMBL31965|N-(4-((3-chloro-4-fluorophenyl)amino)-7-(3-morpholinopropoxy)quinazolin-6-yl)acrylamide|267243-28-7 (free base)|NCGC00182713-01|N-[4-(3-chloro-4-fluoro-anilino)-7-(3-morpholinopropoxy)quinazolin-6-yl]prop-2-enamide|Canertinib [INN]|Canertinib [INN:BAN]|SN-26606|CI-1033(Canertinib)|UNII-C78W1K5ASF|N-[4-[(3-Chloro-4-fluorophenyl)amino]-7-[3-(4-morpholinyl)propoxy]-6-quinazolinyl]-2-propenamide; N-[4-(3-Chloro-4-fluorophenylamino)-7-(3-morpholin-4-ylpropoxy)quinazolin-6-yl]acrylamide;|CI1033|CANETINIB|CANERTINIB [MI]|Caneritinib; CI-1033|CI-1033 (Canertinib)|CANERTINIB [WHO-DD]|SCHEMBL54837|MLS004774146|PD 183805 dihydrochloride|BDBM4779|cid_156414|GTPL5675|orb1301044|SCHEMBL29368458|SCHEMBL29623482|SCHEMBL29655741|EX-A078|OMZCMEYTWSXEPZ-UHFFFAOYSA-N|BCPP000301|GLXC-05819|HMS3244M17|HMS3244M18|HMS3244N17|BCP01790|Tox21_113361|NSC780019|NSC801011|s1019|AKOS005145818|BCP9000481|BCP9000482|BCP9000525|CCG-269588|CS-0121|DB05424|NSC-780019|NSC-801011|SB16594|SDCCGSBI-0654262.P002|NCGC00182713-02|NCGC00182713-07|NCGC00182713-18|AS-56189|HY-10367|SMR003500789|PD0183805|CAS-267243-28-7|NS00071801|EN300-6493001|499C452|Q5032274|BRD-K50168500-001-07-9|Z166624030|N-(4-(3-CHLORO-4-FLUOROPHENYL)AMINO)-7-(3-MORPHOLIN-4-YL)PROPOXY)QUINAZOLIN-6-YL)PROP-2-ENAMIDE|N-[4-(3-chloro-4-fluoro-phenyl-amino)-7-(3-morpholin-4-yl-propoxy)-quinazolin-6-yl]-acrylamide"
TIPLASININ,6450819,,"InChI=1S/C24H16F3NO4/c25-24(26,27)32-18-9-6-16(7-10-18)17-8-11-21-19(12-17)20(22(29)23(30)31)14-28(21)13-15-4-2-1-3-5-15/h1-12,14H,13H2,(H,30,31)",ODXQFEWQSHNQNI-UHFFFAOYSA-N,C24H16F3NO4,439.4,2-[1-benzyl-5-[4-(trifluoromethoxy)phenyl]indol-3-yl]-2-oxoacetic acid,"Tiplaxtinin|393105-53-8|Tiplasinin|PAI-039|tiplasinina|tiplasinine|L396QIB983|DTXSID30192548|(1-benzyl-5-(4-(trifluoromethoxy)phenyl)-1H-indol-3-yl)oxoacetic acid|PAI039 cpd|tiplasininum|[1-Benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl]oxoacetic acid|RefChem:190105|DTXCID70115039|PAI 039|1H-Indole-3-aceticacid, a-oxo-1-(phenylmethyl)-5-[4-(trifluoromethoxy)phenyl]-|2-(1-benzyl-5-(4-(trifluoromethoxy)phenyl)-1H-indol-3-yl)-2-oxoacetic acid|Tiplasinin [USAN]|PAI-039;Tiplasinin|MFCD09475615|CHEMBL325441|2-{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}-2-oxoacetic acid|Tiplasinin (USAN)|Tiplaxtinin(PAI-039)|[1-Benzyl-5-(4-trifluoromethoxy-phenyl)-1H-indol-3-yl]-oxo-acetic acid|2-[1-benzyl-5-[4-(trifluoromethoxy)phenyl]indol-3-yl]-2-oxo-acetic acid|2-[1-benzyl-5-[4-(trifluoromethoxy)phenyl]indol-3-yl]-2-oxoacetic acid|Tiplasinin [USAN:INN]|UNII-L396QIB983|TIPLASININ [INN]|Tiplaxtinin (PAI-039)|Tiplaxtinin(PAI-039)?|MLS006010332|orb1306703|SCHEMBL3052065|SCHEMBL29448190|C24H16F3NO4|Tiplaxtinin, >=98% (HPLC)|EX-A114|CHEBI:177718|BCPP000043|GLXC-04469|HMS3740E03|BCP02216|BDBM50149275|s7922|2-[1-Benzyl-5-[4-(trifluoromethoxy)phenyl]indol-3-yl]-2-oxo-acetic aci d|AKOS026750318|CCG-203023|CS-3928|NCGC00263142-01|NCGC00263142-04|PAI-039;PAI 039;PAI039|AC-32636|AS-73537|FT103155|HY-15253|SMR004701395|DB-069797|D06160|BRD-K30882994-001-01-6|Q27282648|[{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic acid|{1-Benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol-3-yl}(oxo)acetic Acid|2-[1-benzyl-5-[4-(triluoromethoxy)phenyl]indol-3-yl]-2-oxoacetic acid|2-{1-benzyl-5-[4-(trifluoromethoxy)phenyl]-1H-indol -3-yl}-2-oxoacetic acid|Tiplasinin; PAI 039; a-Oxo-1-(phenylmethyl)-5-[4-(trifluoromethoxy)phenyl]-1H-indole-3-acetic Acid;"
LAPATINIB DITOSYLATE,11557040,,"InChI=1S/C29H26ClFN4O4S.2C7H8O3S.H2O/c1-40(36,37)12-11-32-16-23-7-10-27(39-23)20-5-8-26-24(14-20)29(34-18-33-26)35-22-6-9-28(25(30)15-22)38-17-19-3-2-4-21(31)13-19;2*1-6-2-4-7(5-3-6)11(8,9)10;/h2-10,13-15,18,32H,11-12,16-17H2,1H3,(H,33,34,35);2*2-5H,1H3,(H,8,9,10);1H2",XNRVGTHNYCNCFF-UHFFFAOYSA-N,C43H44ClFN4O11S3,943.5,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid;hydrate,"Tyverb|Tycerb|lapatinib tosilate|GW572016F|Lapatinib tosilate hydrate|GW-572016F|G873GX646R|Lapatinib ditoluenesulfonate monohydrate|4-Quinazolinamine, N-(3-chloro-4-((3-fluorophenyl)methoxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)-2-furanyl), bis(4-methylbenzenesulfonate), monohydrate|N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine bis(4-methylbenzenesulfonate) monohydrate|N-[3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]furan-2-yl]quinazolin-4-amine bis(4-methylbenzenesulfonate) monohydrate|RefChem:55454|Lapatinib Ditosylate|388082-78-8|LAPATINIB DITOSYLATE MONOHYDRATE|Lapatinib ditosylate hydrate|Tykerb|Lapatinib Ditosylate [USAN]|4-Quinazolinamine,N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-, bis(4-methylbenzenesulfonate),monohydrate|N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-amine bis(4-methylbenzenesulfonate) hydrate|N-[3-chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid;hydrate|Lapatinib Ditosylate (Tykerb, Tyverb, GW-572016)|Lapatinib ditosylate (USAN)|Lapatinib tosilate hydrate (JAN)|LAPATINIB TOSILATE HYDRATE [JAN]|GW-2016|UNII-G873GX646R|Tykerb (TN)|Tyverb (TN)|C43H44ClFN4O11S3|orb1310961|SCHEMBL4926017|CHEMBL1201179|SCHEMBL29356338|SCHEMBL30680457|CHEBI:192581|HMS5084P17|LAPATINIB TOSILATE [MART.]|EX-A2821|s5241|AKOS015998638|CCG-270586|FL24843|KS-1300|LAPATINIB DITOSYLATE [ORANGE BOOK]|Lapatinib Ditosylate Hydrate;  GW-572016;|D04024|LAPATINIB DITOSYLATE MONOHYDRATE [WHO-DD]|LAPATINIB DITOLUENESULFONATE MONOHYDRATE [MI]|Q27278918|4-QUINAZOLINAMINE, N-(3-CHLORO-4-((3-FLUOROPHENYL)METHOXY)PHENYL)-6-(5-(((2-(METHYLSULFONYL)ETHYL)AMINO)METHYL)-2-FURANYL)-, 4-METHYLBENZENESULFONATE, HYDRATE (1:2:1)|4-QUINAZOLINAMINE, N-(3-CHLORO-4-((3-FLUOROPHENYL)METHOXY)PHENYL)-6-(5-(((2-(METHYLSULFONYL)ETHYL)AMINO)METHYL)-2-FURANYL)-, BIS(4-METHYLBENZENESULFONATE), MONOHYDRATE|4-QUINAZOLINAMINE, N-(3-CHLORO-4-((3-FLUOROPHENYL)METHOXY)PHENYL)-6-(5-(((2-(METHYLSULPHONYL)ETHYL)AMINO)METHYL)-2-FURANYL)-, BIS(4-METHYLBENZENESULPHONATE), MONOHYDRATE|N-(3-Chloro-4-((3-fluorobenzyl)oxy)phenyl)-6-(5-(((2-(methylsulfonyl)ethyl)amino)methyl)furan-2-yl)quinazolin-4-aminebis(4-methylbenzenesulfonate)hydrate|N-[3-chloranyl-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulfonylethylamino)methyl]furan-2-yl]quinazolin-4-amine;4-methylbenzenesulfonic acid;hydrate|N-[3-Chloro-4-[(3-fluorophenyl)methoxy]phenyl]-6-[5-[[[2-(methylsulfonyl)ethyl]amino]methyl]-2-furanyl]-4-quinazolinamine bis(4-|N-[3-chloro-4-[(3-luorophenyl)methoxy]phenyl]-6-[5-[(2-methylsulonylethylamino)methyl]uran-2-yl]quinazolin-4-amine;4-methylbenzenesulonic acid;hydrate|N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2-(methanesulphonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolin amine ditosylate monohydrate"
IBRUTINIB,24821094,,"InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1",XYFPWWZEPKGCCK-GOSISDBHSA-N,C25H24N6O2,440.5,"1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one","Ibrutinib|936563-96-1|PCI-32765|IMBRUVICA|PCI 32765|CRA-032765|PCI32765|ibrutinibum|Pc-32765|1X70OSD4VX|PCI-32765-00|CHEBI:76612|1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one|DTXSID60893450|2-Propen-1-one, 1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)-1-piperidinyl)-|1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl]prop-2-en-1-one|1-{(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1-yl}prop-2-en-1-one|1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one|1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one|2-Propen-1-one, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-|RefChem:57737|BTK Inhibitor PCI-32765|L01XE27|DTXCID601323465|805-642-2|Ibrutinib (PCI-32765)|(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one|MFCD20261150|PCI-32765 (Ibrutinib)|C25H24N6O2|(R)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one.|1-((3R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)piperidin-1- yl)prop-2-en-1-one|Ibrutinib [USAN]|Ibrutinib [USAN:INN]|UNII-1X70OSD4VX|JNJ 02|Imbruvica (TN)|1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one;PCI 32765|1-{(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]piperidin-1- yl}prop-2-en-1-one|Ibrutinib (Standard)|CRA 032765|Ibrutinib, Free Base|IBRUTINIB [INN]|IBRUTINIB [JAN]|IBRUTINIB [MI]|Ibrutinib (JAN/USAN)|IBRUTINIB [VANDF]|IBRUTINIB [WHO-DD]|Imbruvica; PCI-32765|MLS006010041|SCHEMBL201859|Ibrutinib - Bio-X trade mark|GTPL6912|orb1307353|PCI-32765 (Ibrutinib)?|IBRUTINIB [ORANGE BOOK]|CHEMBL1873475|HSDB 8260|EX-A066|XYFPWWZEPKGCCK-GOSISDBHSA-N|BDBM50357312|HY-10997R|NSC800769|AKOS022185476|DB09053|EX-5960|FA34130|NSC-800769|NCGC00187912-01|NCGC00187912-02|NCGC00187912-03|NCGC00187912-12|NCGC00187912-17|NCGC00187912-18|(R)-1-(3-(4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo-[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one|1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidyl]prop-2-en-1-one|AC-26942|BI164531|BP-43643|HY-10997|SMR004701213|NS00072153|SW218096-2|EN300-97039|D10223|F799864|A1-01649|Q5984881|BRD-K70301465-001-02-6|BRD-K70301465-001-05-9|Z1302446275|(R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-ylprop-2-en-1-one|1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one"
ROCILETINIB,57335384,,"InChI=1S/C27H28F3N7O3/c1-4-24(39)32-18-6-5-7-19(14-18)33-25-21(27(28,29)30)16-31-26(35-25)34-22-9-8-20(15-23(22)40-3)37-12-10-36(11-13-37)17(2)38/h4-9,14-16H,1,10-13H2,2-3H3,(H,32,39)(H2,31,33,34,35)",HUFOZJXAKZVRNJ-UHFFFAOYSA-N,C27H28F3N7O3,555.6,N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide,"Rociletinib|1374640-70-6|CO-1686|AVL-301|CNX-419|CS-1631|N-(3-((2-((4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)prop-2-enamide|72AH61702G|DTXSID801025958|rociletinibum|N-(3-{[2-{[4-(4-Acetylpiperazin-1-yl)-2-methoxyphenyl]amino}-5-(trifluoromethyl)pyrimidin-4-yl]amino}phenyl)prop-2-enamide|RefChem:883681|L01XE37|DTXCID701510209|N-(3-((2-((4-(4-acetylpiperazin-1-yl)-2-methoxyphenyl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)phenyl)acrylamide|CO-1686 (AVL-301)|MFCD26793864|CO 1686|Rociletinib (CO-1686)|N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxyanilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide|N-[3-[[2-[[4-(4-Acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2-propenamide|Rociletinib (CO-1686, AVL-301)|Rociletinib [USAN:INN]|UNII-72AH61702G|C27H28F3N7O3|CO1686|Rociletinib [USAN]|ROCILETINIB [INN]|CO-1686(Rociletinib)|Rociletinib (USAN/INN)|Rociletinib; CO-1686|ROCILETINIB [WHO-DD]|Rociletinib (CO-1686)?|GTPL7966|orb1305584|SCHEMBL4177736|CHEMBL3545308|SCHEMBL29350136|SCHEMBL29448192|EX-A228|HUFOZJXAKZVRNJ-UHFFFAOYSA-N|BDBM149404|HMS3653G08|BCP07085|NSC779405|NSC783605|NSC800872|s7284|AKOS025401943|AKOS032949985|CCG-270031|DB11907|NSC-779405|NSC-783605|NSC-800872|SB16488|NCGC00386293-08|AC-27467|AS-17009|DA-34963|FA103658|HY-15729|US8975249, I-4|NS00073137|SW219475-1|D10858|BRD-K33610132-001-02-9|Q27088606|2-PROPENAMIDE, N-(3-((2-((4-(4-ACETYL-1-PIPERAZINYL)-2-METHOXYPHENYL)AMINO)-5-(TRIFLUOROMETHYL)-4-PYRIMIDINYL)AMINO)PHENYL)-|N-[3-[[2-[4-(4-acetylpiperazin-1-yl)-2-methoxy-anilino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]phenyl]prop-2-enamide|N-[3Acetyl-1-piperazinyl)-2-methoxyphenyl]amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]phenyl]-2-propenamide"
TAK-285,11620908,,"InChI=1S/C26H25ClF3N5O3/c1-25(2,37)14-22(36)31-9-11-35-10-8-20-23(35)24(33-15-32-20)34-17-6-7-21(19(27)13-17)38-18-5-3-4-16(12-18)26(28,29)30/h3-8,10,12-13,15,37H,9,11,14H2,1-2H3,(H,31,36)(H,32,33,34)",ZYQXEVJIFYIBHZ-UHFFFAOYSA-N,C26H25ClF3N5O3,548.0,"N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-3-methylbutanamide","TAK-285|871026-44-7|TAK285|TAK 285|70CCB438L6|DTXSID10236136|RefChem:187187|DTXCID10158627|EGFR/HER2 Kinase Inhibitor TAK-285|N-(2-(4-((3-chloro-4-(3-(trifluoromethyl)phenoxy)phenyl)amino)-5H-pyrrolo[3,2-d]pyrimidin-5-yl)ethyl)-3-hydroxy-3-methylbutanamide|MFCD22124520|N-(2-(4-(3-CHLORO-4-(3-(TRIFLUOROMETHYL)PHENOXY)PHENYLAMINO)-5H-PYRROLO[3,2-D]PYRIMIDIN-5-YL)ETHYL)-3-HYDROXY-3-METHYLBUTANAMIDE|CHEMBL1614725|N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-3-methylbutanamide|N-{2-[4-({3-Chloro-4-[3-(Trifluoromethyl)phenoxy]phenyl}amino)-5h-Pyrrolo[3,2-D]pyrimidin-5-Yl]ethyl}-3-Hydroxy-3-Methylbutanamide|2-Benzamidoacetic acid, ((S)-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)-1-ethoxy-1-oxopr|C26H25ClF3N5O3|UNII-70CCB438L6|3poz|3rcd|03P|3w2o|MLS006011276|SCHEMBL982278|orb1301128|SCHEMBL29355721|TAK 285 [WHO-DD]|EX-A088|TAK285/TAK-285|HMS3656J08|HMS3750E17|BCP04168|BDBM50358430|NSC800938|s2784|AKOS026674251|CCG-269993|CS-0774|NSC-800938|SB19365|SDCCGSBI-0654472.P001|NCGC00346699-01|NCGC00346699-06|AC-32052|AS-16291|FT103851|HY-15196|SMR004703026|BCP0726000091|DB-361054|SW219902-1|BRD-K80343549-001-02-6|Q27265858|N-(2-{4-[3-chloro-4-(3-trifluoromethyl-phenoxy)-phenylamino]-pyrrolo[3,2-d]pyrimidin-5-yl}-ethyl)-3-hydroxy-3-methyl-butyramide|N-[2-[4-[3-chloro-4-[3-(trifluoromethyl)phenoxy]anilino]pyrrolo[3,2-d]pyrimidin-5-yl]ethyl]-3-hydroxy-3-methyl-butanamide|n-{2-[4-({3-chloro-4-[3-(trifluoromethyl)phenoxy]phenyl}amino)-5h-pyrrolo[3,2-d]pyrimidin-5-yl]ethyl}-3-hydroxy-3-methylbutaneamide"
OSIMERTINIB,71496458,,"InChI=1S/C28H33N7O2/c1-7-27(36)30-22-16-23(26(37-6)17-25(22)34(4)15-14-33(2)3)32-28-29-13-12-21(31-28)20-18-35(5)24-11-9-8-10-19(20)24/h7-13,16-18H,1,14-15H2,2-6H3,(H,30,36)(H,29,31,32)",DUYJMQONPNNFPI-UHFFFAOYSA-N,C28H33N7O2,499.6,N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide,"osimertinib|1421373-65-0|AZD-9291|AZD9291|Mereletinib|AZD 9291|osimertinibum|3C06JJ0Z2O|AZD-9291 FREE BASE|N-(2-{[2-(Dimethylamino)ethyl](Methyl)amino}-4-Methoxy-5-{[4-(1-Methyl-1h-Indol-3-Yl)pyrimidin-2-Yl]amino}phenyl)prop-2-Enamide|N-[2-[2-(dimethylamino)ethyl-methylamino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide|CHEBI:90943|DTXSID501025961|2-Propenamide, N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-|N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide|N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)prop-2-enamide|N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide|N-(2-(2-(dimethylamino)ethyl-methylamino)-4-methoxy-5-((4-(1-methylindol-3-yl)pyrimidin-2-yl)amino)phenyl)prop-2-enamide|RefChem:58257|L01XE35|DTXCID401510212|Osimertinib [USAN]|UNII-3C06JJ0Z2O|MFCD27988062|N-(2-((2-(Dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl)amino)phenyl)acrylamide|C28H33N7O2|Osimertinib (AZD9291)|AZD 9291(Osimertinib)|N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide|Mereletinib [INN]|2-Propenamide, N-[2-[[2-(dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-; N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide; AZD 9291; Osimertinib; Tagrisso|N-(2-{[2-(dimethylamino)ethyl](methyl)amino}-4-methoxy-5-{[4-(1-methyl-1H-indol-3-yl)pyrimidin-2-yl]amino}phenyl)acrylamide|Osimertinib (Standard)|OSIMERTINIB [MI]|OSIMERTINIB [INN]|Osimertinib; AZD 9291|Osimertinib; AZD-9291|mereletinib (obsolete INN)|AZD-9291(Osimertinib)?|OSIMERTINIB [WHO-DD]|GTPL7719|orb1305406|CHEMBL3353410|SCHEMBL14660911|SCHEMBL29350904|SCHEMBL29378405|EX-A314|MereletinibAZD-9291,Osimertinib|DUYJMQONPNNFPI-UHFFFAOYSA-N|GLXC-05459|HMS3653E10|HMS3672M05|HMS5085F14|BCP08626|MSK11040|NQC28144|TVB02091|BDBM50029668|HY-15772R|NSC779217|NSC781254|NSC800812|s7297|AKOS025290756|CCG-264683|CS-2018|DB09330|FD58317|NSC-779217|NSC-781254|NSC-800812|SB22952|NCGC00378622-03|NCGC00378622-04|NCGC00378622-10|AC-29019|AS-16943|BP-43647|HY-15772|4714B|NS00073136|SW219863-1|EN300-7382438|BRD-K42805893-001-04-9|Q21506464|N-(2-((2-(dimethylamino)ethyl)(methyl)amino)-4-methoxy-5-(4-(1-methyl-1H-indol-3-yl)pyrimidin-2-ylamino)phenyl)acrylamide|N-(2-{2-Dimethylaminoethyl-methylamino}-4-methoxy-5-{[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino}phenyl)prop-2-enamide|N-[2-[[2-(Dimethylamino)ethyl]methylamino]-4-methoxy-5-[[4- (1-methyl-1H-indol-3-yl)-2-pyrimidinyl]amino]phenyl]-2-propenamide|N-[2-[2-(dimethylamino)ethyl-methyl-amino]-4-methoxy-5-[[4-(1-methylindol-3-yl)pyrimidin-2-yl]amino]phenyl]prop-2-enamide"
POZIOTINIB,25127713,,"InChI=1S/C23H21Cl2FN4O3/c1-3-20(31)30-8-6-13(7-9-30)33-19-10-14-17(11-18(19)32-2)27-12-28-23(14)29-16-5-4-15(24)21(25)22(16)26/h3-5,10-13H,1,6-9H2,2H3,(H,27,28,29)",LPFWVDIFUFFKJU-UHFFFAOYSA-N,C23H21Cl2FN4O3,491.3,"1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one","Poziotinib|1092364-38-9|NOV120101|NOV-120101|1-(4-((4-((3,4-dichloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)prop-2-en-1-one|HM-781-36B|NOV-1201|poziotinibum|OEI6OOU6IK|1-[4-[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one|HM 781-36B|HM-781-36|DTXSID80148853|1-(4-(4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl)oxypiperidin-1-yl)prop-2-en-1-one|1-[4-({4-[(3,4-DICHLORO-2-FLUOROPHENYL)AMINO]-7-METHOXYQUINAZOLIN-6-YL}OXY)PIPERIDIN-1-YL]PROP-2-EN-1-ONE|RefChem:175663|DTXCID4071344|HM781-36B|UNII-OEI6OOU6IK|Poziotinib [INN]|1-[4-[[4-[(3,4-Dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one|MFCD28044290|Poziotinib (HM781-36B)|Poziotinib [USAN]|NOV 120101|2-Propen-1-one, 1-[4-[[4-[(3,4-dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-|1-(4-(4-(3,4-dichloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yloxy)piperidin-1-yl)prop-2-en-1-one|C23H21Cl2FN4O3|Poziotinib?|1-[4-[[4-[(3,4-Dichloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-1-piperidinyl]-2-propen-1-one; 1-[4-[4-(3,4-Dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]prop-2-en-1-one|2-PROPEN-1-ONE, 1-(4-((4-((3,4-DICHLORO-2-FLUOROPHENYL)AMINO)-7-METHOXY-6-QUINAZOLINYL)OXY)-1-PIPERIDINYL)-|Poziotinib (USAN/INN)|Poziotinib [USAN:INN]|POZIOTINIB [WHO-DD]|GTPL7903|orb1305243|SCHEMBL3391764|CHEMBL3545154|SCHEMBL29375341|SCHEMBL29453260|EX-A528|CHEBI:195559|LPFWVDIFUFFKJU-UHFFFAOYSA-N|HMS3673K03|BCP08270|WHO 9736|BDBM50468247|NSC783296|NSC800856|s7358|AKOS026674078|CCG-264748|CS-3942|DB12114|NSC-783296|NSC-800856|SB16882|NCGC00386427-01|NCGC00386427-02|NCGC00386427-06|AC-29021|AS-74851|BP161454|DA-47945|HY-15730|SY235762|HM 781-36|NS00073099|D12229|BRD-K50010139-001-01-5|BRD-K50010139-001-02-3|Q27088426|1- (4- ((4- ((3, 4-Dichloro- 2- fluorophenyl) amino) - 7- methoxyquinazolin- 6- yl) oxy) piperidin- 1- yl) prop- 2- en- 1- one;HM781 -36|1-(4-((4-(3,4-DICHLORO-2-FLUOROANILINO)-7-METHOXYQUINAZOLIN-6-YL)OXY(PIPERIDIN-1-YL)PROP-2-EN-1-ONE|1-(4-{[4-(3,4-dichloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxy}piperidin-1-yl)prop-2-en-1-one|1-[4-[4-(3,4-dichloro-2-fluoro-anilino)-7-methoxy-quinazolin-6-yl]oxy-1-piperidyl]prop-2-en-1-one"
BRIGATINIB,68165256,,"InChI=1S/C29H39ClN7O2P/c1-35-15-17-37(18-16-35)21-11-13-36(14-12-21)22-9-10-24(26(19-22)39-2)33-29-31-20-23(30)28(34-29)32-25-7-5-6-8-27(25)40(3,4)38/h5-10,19-21H,11-18H2,1-4H3,(H2,31,32,33,34)",AILRADAXUVEEIR-UHFFFAOYSA-N,C29H39ClN7O2P,584.1,"5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine","Brigatinib|1197953-54-0|ALUNBRIG|AP-26113|HYW8DB273J|AP 26113|2,4-Pyrimidinediamine, 5-chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-|5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]pyrimidine-2,4-diamine|DTXSID501027929|2,4-Pyrimidinediamine, 5-chloro-N4-(2-(dimethylphosphinyl)phenyl)-N2-(2-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)-|(2-((5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethyl-,delta5-phosphanone|5-Chloro-N4-(2-(dimethylphosphoryl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine|5-chloro-N4-[2-(dimethylphosphoryl)phenyl]-N2-{2-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}pyrimidine-2,4-diamine|brigatinibum|5-chloro-4-N-(2-dimethylphosphorylphenyl)-2-N-(2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine|RefChem:56949|L01XE43|DTXCID501513495|5-Chloro-N4-(2-(dimethylphosphoryl)phenyl)-N2-(2-methoxy-4(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine|Brigatinib [USAN]|Brigatinib (AP-26113)|(2-((5-chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine oxide|MFCD29472221|5-Chloro-N4-(2-(dimethylphosphoryl)phenyl)-N2-(2-methoxy-4-(4-(4-methylpiperazin-1- yl)piperidin-1-yl)phenyl)pyrimidine-2,4-diamine|5-Chloro-N~4~-[2-(Dimethylphosphoryl)phenyl]-N~2~-{2-Methoxy-4-[4-(4-Methylpiperazin-1-Yl)piperidin-1-Yl]phenyl}pyrimidine-2,4-Diamine|UNII-HYW8DB273J|Alunbrig (TN)|5-Chloro-N4-[2-(dimethylphosphinyl)phenyl]-N2-[2-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]-2,4-pyrimidinediamine; AP 26113|6GY|BRIGATINIB [MI]|BRIGATINIB [INN]|BRIGATINIB [JAN]|Brigatinib (JAN/USAN)|Brigatinib [USAN:INN]|Brigatinib; AP26113|Brigatinib (AP26113)|BRIGATINIB [WHO-DD]|C29H39ClN7O2P|Brigatinib (AP-26113)?|GTPL7741|orb1303989|BRIGATINIB [ORANGE BOOK]|CHEMBL3545311|SCHEMBL11916361|SCHEMBL29350096|SCHEMBL29432539|EX-A775|CHEBI:232810|HMS5087L16|BCP17214|BDBM50185140|NSC784728|NSC787457|AKOS030257612|CS-4278|DB12267|FC76643|NSC-784728|NSC-787457|SB40412|compound 11q [PMID: 27144831]|NCGC00483924-01|NCGC00483924-04|AC-29958|AS-75176|HY-12857|DB-118419|NS00073439|S8229|D10866|EN300-6477855|F807191|BRD-K56981171-001-01-0|Q27456393|Z2512157852|(2-((5-CHLORO-2-((2-METHOXY-4-(4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN-1-YL)PHENYL)AMINO)PYRIMIDIN-4-YL)AMINO)PHENYL)DIMETHYL-,.DELTA.5-PHOSPHANONE|2-((5-Chloro-2-((2-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)dimethylphosphine ox  ide|5-chloro-N4-(2-dimethylphosphorylphenyl)-N2-[2-methoxy-4-[4-(4-methylpiperazin-1-yl)-1-piperidyl]phenyl]pyrimidine-2,4-diamine"
VATALANIB,151194,,"InChI=1S/C20H15ClN4/c21-15-5-7-16(8-6-15)23-20-18-4-2-1-3-17(18)19(24-25-20)13-14-9-11-22-12-10-14/h1-12H,13H2,(H,23,25)",YCOYDOIWSSHVCK-UHFFFAOYSA-N,C20H15ClN4,346.8,N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine,"Vatalanib|212141-54-3|N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine|Pynasunate|Vatalinib|PTK787|CGP 79787|CGP-79787|ZK-232934|NVP-PTK787|DTXSID2046919|ZK222584|CHEBI:90620|5DX9U76296|BAY-86-5127|N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)-1-phthalazinamine|DTXCID0026919|K-222584|NSC719335|vatalanibum|CGP-797870|RefChem:933950|PTK787/ZK 222584|ZK232934|1-(4-chloroanilino)-4-(pyridylmethyl)phthalazine|1-(4-chloroanilino)-4-(pyridylmethyl)phthalazine dihydrochloride|Vatalanib base|Vatalanib free base|1-Phthalazinamine,N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-|Vatalanib (free base)|MFCD08458963|PTK/ZK|CHEMBL101253|Vatalanib (dihydrochloride)|NCGC00181350-01|PTK787 dihydrochloride;CGP-797870 dihydrochloride;ZK-222584 dihydrochloride|CAS-212141-54-3|SR-05000001457|F9995-0197|Vatalanib [USAN]|1-(4-chloroanilino)-4-(4-pyridylmethyl)phthalazine|Kinome_3657|VATALANIB [INN]|Vatalanib (PTK787)|VATALANIB [MI]|Vatalanib (USAN/INN)|Vatalanib [USAN:INN]|VATALANIB [WHO-DD]|SCHEMBL18286|BDBM4851|cid_151194|GTPL5705|orb1307623|SCHEMBL29350047|UNII-5DX9U76296|N-(4-chlorophenyl)-4-(4-pyridylmethyl)phthalazin-1-amine|(A) PTK787|1-Phtalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-|BCPP000021|HMS2089D11|HMS3713O04|HMS3745G07|N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)phtalazin-1-amine|SMSSF-0443881|1-Phthalazinamine, N-(4-chlorophenyl)-4-(4-pyridinylmethyl)-|BCP16436|CGP-7978|CGP79787|EX-A1398|MIA14154|N-(4-chlorophenyl)-4-[(pyridin-4-yl)methyl]phthalazin-1-amine|Tox21 112808|Tox21_112808|NSC800963|AKOS015896483|Tox21_112808_1|CCG-220471|CS-5248|DB04879|FV65204|NSC-800963|SB16582|SDCCGSBI-0636205.P002|NCGC00181350-03|NCGC00181350-06|AC-25025|AS-17435|HY-10203|DB-066452|NS00068132|VU0549317-1|D06285|AB01275455-01|EN300-7406749|141V543|1-(4-Chloranilino)-4-(4-pyridylmethyl)-phthalazin|1-(4-chloranilino)-4-(4-pyridylmethyl)-phthalazine|Q7917084|SR-05000001457-1|SR-05000001457-2|1 -(4-Chloroanilino)-4-(4-pyridylmethyl)phthalazine|BRD-K70163715-001-02-8|BRD-K70163715-036-01-6|BRD-K70163715-300-04-0|BRD-K70163715-300-05-7|F9995-0196|1-(4-chlor-anilino)-4-(pyridin-4-yl-methyl)-phthalazine|(4-chlorophenyl)-[4-(4-pyridylmethyl)phthalazin-1-yl]amine|(p-chlorophenyl){4-[(4-pyridyl)methyl]-1-phthalazinyl}amine|N-(4-Chlorophenyl)-4-(4-pyridinylmethyl)- 1-Phthalazinamine|N-(4-chlorophenyl)-4-(pyridin-4-ylmethyl)-1-phthalazinamine|N-(p-chlorophenyl)-4-(pyridin-4-ylmethyl)phthalazin-1-amine"
PAZOPANIB,10113978,,"InChI=1S/C21H23N7O2S/c1-13-5-6-15(11-19(13)31(22,29)30)24-21-23-10-9-20(25-21)27(3)16-7-8-17-14(2)28(4)26-18(17)12-16/h5-12H,1-4H3,(H2,22,29,30)(H,23,24,25)",CUIHSIWYWATEQL-UHFFFAOYSA-N,C21H23N7O2S,437.5,"5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide","Pazopanib|444731-52-6|GW786034|5-((4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-yl)amino)-2-methylbenzenesulfonamide|pazopanibum|7RN5DR86CK|NSC-752782|DTXSID8048733|CHEBI:71219|GW780604|GW-780604|DTXCID1028659|5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide|Benzenesulfonamide, 5-((4-((2,3-dimethyl-2H-indazol-6-yl)methylamino)-2-pyrimidinyl)amino)-2-methyl-|5-({4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzenesulfonamide|RefChem:55812|Votrient|790713-33-6|MFCD11616589|GW 786034|5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl}amino)-2-methylbenzene-1-sulfonamide|GW 78603|GW-786034|C21H23N7O2S|NCGC00188865-01|5-[[4-[(2,3-dimethylindazol-6-yl)-methylamino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide|5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide|Pazopanib [INN]|CAS-444731-52-6|Pazopanib [INN:BAN]|5-[4-[(2,3-Dimethyl-2H-indazol-6-yl)-methyl-amino]-pyrimidin-2-ylamino]-2-methyl-benzenesulfonamide|UNII-7RN5DR86CK|Pazopanib?|HSDB 8210|Benzenesulfonamide, 5-[[4-[(2,3-dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methylbenzenesulfonamide; 5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]pyrimidin-2-yl]amino]-2-methylbenzenesulfonamide; GW 786034; Pazopanib; Votrient|Pazopanib (Standard)|GW 786034B|indazolylpyrimidine 13|Pazopanib (free base)|Kinome_3790|PAZOPANIB [MI]|5-[[4-[(2,3-dimethyl-2h-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide|PAZOPANIB [VANDF]|PAZOPANIB [WHO-DD]|PAZOPANIB [EMA EPAR]|5-(4-((2,3-dimethyl-2H-indazol-6-yl)(methyl)amino)pyrimidin-2-ylamino)-2-methylbenzenesulfonamide|5-[[4-[(2,3-dimethylindazol-6-yl)-methyl-amino]pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide|SCHEMBL588608|Pazopanib - Bio-X trade mark|CHEMBL477772|GTPL5698|JMC514632 Compound 13|orb1310940|SCHEMBL29392503|BDBM26474|cid_10113978|CUIHSIWYWATEQL-UHFFFAOYSA-N|BCPP000129|HMS3244C21|HMS3244C22|HMS3244D21|HMS3656L14|HMS3745G05|HMS5081I04|BCP01839|EX-A1241|Tox21_113174|HY-10208R|NSC752782|NSC800839|s3012|AKOS005145819|Tox21_113174_1|AC-8522|BCP9001053|CCG-265010|CS-0269|DB06589|FD26771|NSC 752782|NSC-800839|SB17290|SDCCGSBI-0647656.P002|NCGC00188865-02|NCGC00188865-03|NCGC00188865-10|AS-11066|BD164238|BP-44038|HY-10208|NS00070516|SW218082-3|EN300-57325|P-6706|SBI-0647656.0001|AB01273967-01|AB01273967-02|AB01273967_05|AB01273967_06|AR-270/43507999|Q7157043|BRD-K74514084-001-03-9|BRD-K74514084-003-02-7|BRD-K74514084-003-09-2|Z1541638525|5-({4-[(2,3-dimethyl-2H-indazol-6-yl)(methyl)amino]-2-pyrimidinyl}amino)-2-methylbenzenesulfonamide|5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)(methyl)amino]-pyrimidin-2-yl]amino]-2-methyl-benzenesulfonamide|Votrient;5-[[4-[(2,3-Dimethyl-2H-indazol-6-yl)methylamino]-2-pyrimidinyl]amino]-2-methyl-benzenesulfonamide"
PF-06459988,71535003,,"InChI=1S/C19H22ClN7O3/c1-4-15(28)27-7-11(14(9-27)29-3)10-30-18-16-13(20)6-21-17(16)24-19(25-18)23-12-5-22-26(2)8-12/h4-6,8,11,14H,1,7,9-10H2,2-3H3,(H2,21,23,24,25)/t11-,14+/m1/s1",ODMXWZROLKITMS-RISCZKNCSA-N,C19H22ClN7O3,431.9,"1-[(3R,4R)-3-[[5-chloro-2-[(1-methylpyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxymethyl]-4-methoxypyrrolidin-1-yl]prop-2-en-1-one","PF-06459988|1428774-45-1|5IE92SK9EB|1-((3R,4R)-3-(((5-Chloro-2-((1-methyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)methyl)-4-methoxy-1-pyrrolidinyl)-2-propen-1-one|1-((3R,4R)-3-(((5-chloro-2-((1-methyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)methyl)-4-methoxypyrrolidin-1-yl)prop-2-en-1-one|2-Propen-1-one, 1-((3R,4R)-3-(((5-chloro-2-((1-methyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)methyl)-4-methoxy-1-pyrrolidinyl)-|1-((3R,4R)-3-(((5-chloro-2-((1-methyl-1H-pyrazol-4-yl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)methyl)-4-methoxypyrrolidin-1-yl)prop-2-en-1-one|RefChem:172256|Mutant-selective EGFR Inhibitor PF-06459988|UNII-5IE92SK9EB|MFCD28987462|CHEMBL3786098|1-[(3R,4R)-3-[[5-chloro-2-[(1-methylpyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxymethyl]-4-methoxypyrrolidin-1-yl]prop-2-en-1-one|orb1307899|SCHEMBL14800837|SCHEMBL29378347|DHC77445|EX-A2705|BDBM50159360|NSC810341|AKOS040742401|DB14768|NSC-810341|HY-19985|MS-27695|CS-0017709|G14590|PF-06459988, >=98% (HPLC)|1-[(3R,4R)-3-[[5-chloro-2-[(1-methylpyrazol-4-yl)amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxymethyl]-4-methoxy-pyrrolidin-1-yl]prop-2-en-1-one"
SARACATINIB,10302451,,"InChI=1S/C27H32ClN5O5/c1-32-6-8-33(9-7-32)10-13-35-19-14-21-24(23(15-19)38-18-4-11-34-12-5-18)27(30-16-29-21)31-25-20(28)2-3-22-26(25)37-17-36-22/h2-3,14-16,18H,4-13,17H2,1H3,(H,29,30,31)",OUKYUETWWIPKQR-UHFFFAOYSA-N,C27H32ClN5O5,542.0,"N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine","Saracatinib|379231-04-6|AZD0530|AZD-0530|AZD 0530|saracatinibum|9KD24QGH76|N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine|AZ-10353926|CHEBI:47458|DTXSID90191355|NSC735464|N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine|4-Quinazolinamine, N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methyl-1-piperazinyl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)-|N-(5-Chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine|N-(5-CHLORO-1,3-BENZODIOXOL-4-YL)-7-(2-(4-METHYLPIPERAZIN-1-YL)ETHOXY)-5-((OXAN-4-YL)OXY)QUINAZOLIN-4-AMINE|N-(5-chloro-2H-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-(oxan-4-yloxy)quinazolin-4-amine|N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(oxan-4-yloxy)quinazolin-4-amine|N-(5-chloro-2H-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(oxan-4-yloxy)quinazolin-4-amine|RefChem:884575|SRC Kinase Inhibitor AZD0530|DTXCID00113846|N-(5-Chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methyl-1-piperazinyl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)-4-quinazolinamine|N-(5-chloro-1,3-benzodioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)quinazolin-4-amine bi((2E)-but-2-enedioate)|Saracatinib (AZD0530)|N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine|SARACATINIB, FREE BASE|N-(5-chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine|MFCD09832698|CHEMBL217092|N-(5-chlorobenzo[d][1,3]dioxol-4-yl)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-((tetrahydro-2H-pyran-4-yl)oxy)quinazolin-4-amine|4-(6-Chloro-2,3-methylenedioxyanilino)-7-(2-(4-methylpiperazin-1-yl)ethoxy)-5-tetrahydropyran-4-yloxyquinazoline|N-(5-chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxy-quinazolin-4-amine|H8H|Saracatinib [USAN]|nchembio866-comp19|Saracatinib [USAN:INN]|UNII-9KD24QGH76|C27H32ClN5O5|4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline|2h8h|Saracatinib,AZD0530|SARACATINIB [INN]|Saracatinib (USAN/INN)|Saracatinib (AZD0530)?|SCHEMBL41547|SARACATINIB [WHO-DD]|MLS006011166|GTPL7731|orb1301093|SCHEMBL29357263|SCHEMBL29380648|SCHEMBL29487213|BDBM12255|AZD0350|OUKYUETWWIPKQR-UHFFFAOYSA-N|BCPP000364|GLXC-02825|HMS3265E21|HMS3265E22|HMS3265F21|HMS3265F22|HMS3654K03|HMS3747A05|HMS3884A03|BCP01733|EX-A1576|NSC758872|NSC800878|s1006|AKOS005145757|AC-5249|BCP9000358|CCG-264773|CS-0101|DB11805|FS27794|NSC-758872|NSC-800878|SB16503|SDCCGSBI-0654323.P001|NCGC00241099-01|NCGC00241099-03|NCGC00241099-06|NCGC00241099-13|AS-16692|HY-10234|SMR004702935|BCP0726000126|NS00071732|SW218134-2|D09664|231S046|BRD-K19540840-001-05-2|BRD-K19540840-001-09-4|Q21098957|N-(5-Chloro-1,3-benzodioxol-4-yl)-7-[2-(4-methyl-1-piperazinyl)ethoxy]-5-[(tetrahydro-2H-pyran-4-yl)oxy]-4-quinazolinamine;7-[2-[4-M    ethylpiperazin-1-yl]ethoxy]-5-[[tetrahydropyran-4-yl]oxy]-4-[[6-chloro-2,3-methylenedioxyphenyl]amino]quinazoline|N-(5-chloro-2H-1,3-benzodioxol-4-yl)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-[(oxan-4-yl)oxy]quinazolin-4-amine|N-(5-chlorobenzo[d][1,3]dioxol-4-yl)-7-(((4-methylpiperazin-1-yl)methoxy)methyl)-5-(tetrahydro-2H-pyran-4-yloxy)quinazolin-4-amine"
SAPITINIB,11488320,,"InChI=1S/C23H25ClFN5O3/c1-26-21(31)12-30-8-6-14(7-9-30)33-20-10-15-18(11-19(20)32-2)27-13-28-23(15)29-17-5-3-4-16(24)22(17)25/h3-5,10-11,13-14H,6-9,12H2,1-2H3,(H,26,31)(H,27,28,29)",DFJSJLGUIXFDJP-UHFFFAOYSA-N,C23H25ClFN5O3,473.9,2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide,Sapitinib|848942-61-0|AZD-8931|2-(4-((4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxy)piperidin-1-yl)-n-methylacetamide|sapitinibum|2-[4-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}oxy)piperidin-1-yl]-N-methylacetamide|CHEBI:132986|DTXSID50233942|2-(4-(4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)oxypiperidin-1-yl)-N-methylacetamide|2-[4-[4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide|RefChem:884560|DTXCID80156433|ErbB Kinase Inhibitor AZD8931|3499328002|AZD8931|AZD8931 (Sapitinib)|Sapitinib [INN]|Sapitinib [WHO-DD]|Sapitinib(AZD8931)|Sapitinib (AZD-8931)|C23H25ClFN5O3|CHEMBL2408045|2-[4-[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxypiperidin-1-yl]-N-methylacetamide|MFCD18385011|UNII-3499328002|Sapatinib|4-(3-chloro-2-fluoroanilino)-7-methoxy-6-[[1-(N-methylcarbamoylmethyl)piperidin-4-yl]oxy]quinazoline|AZD-8931(Sapitinib)|Sapitinib (AZD8931)|AZD-8931(Sapitinib)?|MLS006011283|SCHEMBL202358|GTPL7717|orb1301080|SCHEMBL29728247|SCHEMBL30362790|EX-A036|BCPP000365|HMS3655J08|BCP02835|BDBM50437353|NSC758005|NSC800876|s2192|AKOS025404911|BCP9000357|CCG-264744|CS-3951|DB12183|NSC-758005|NSC-800876|SB16597|SDCCGSBI-0654395.P001|NCGC00346573-01|NCGC00346573-05|AC-32815|AS-17066|HY-13050|SMR004703033|NS00072084|SW219260-1|BRD-K98572433-001-02-9|Q27088689|2-(4-{[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl]oxy}piperidin-1-yl)-N-methylacetamide|2-[4-[4-(3-chloro-2-fluoro-anilino)-7-methoxy-quinazolin-6-yl]oxy-1-piperidyl]-N-methyl-acetamide
SORAFENIB,216239,,"InChI=1S/C21H16ClF3N4O3/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25/h2-11H,1H3,(H,26,30)(H2,28,29,31)",MLDQJTXFUGDVEO-UHFFFAOYSA-N,C21H16ClF3N4O3,464.8,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide,"Sorafenib|284461-73-0|BAY 43-9006|sorafenibum|4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide|4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide|N-(4-Chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl)urea|9ZOQ3TZI87|BAY-43-9006|4-(4-((((4-Chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide|4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide|DTXSID7041128|CHEBI:50924|BAY 439006|BAY-439006|2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-|4-(4-{3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide|4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N(SUP 2)-METHYLPYRIDINE-2-CARBOXAMIDE|BAY-545-9085|2-Pyridinecarboxamide, 4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-|4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)phenoxy)-N-methylpyridine-2-carboxamide|4-(4-((4-chloro-3-(trifluoromethyl)phenyl)carbamoylamino)phenoxy)-N-methylpyridine-2-carboxamide|RefChem:6252|sorafenib tosilate hydrate|DTXCID5021128|L01XE05|BAY 673472|BAY5459085|BAY 43 9006|BAY 5459085|BAY 545 9085|BA4 43 9006|608-209-4|4-(4-(3-(4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)UREIDO)PHENOXY)-N-METHYLPICOLINAMIDE|MFCD06411450|Sorafenib free base|4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide|C21H16ClF3N4O3|284461-73-0 (free base)|CHEMBL1336|4-{4-[({[4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL]AMINO}CARBONYL)AMINO]PHENOXY}-N-METHYLPYRIDINE-2-CARBOXAMIDE|Sorafenib [INN]|Sorafenib (Nexavar)|BAX|NSC-724772|NCGC00167488-01|UNII-9ZOQ3TZI87|Sorafenib [USAN:INN:BAN]|SR-00000000529|HSDB 8173|1uwh|3gcs|3heg|4asd|Hit compound, 8|Sorafenib (Base)|Sorafenib, 4|4-[4-[[[[4-Chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]phenoxy]-N-methyl-2-pyridinecarboxamide; BAY 43-9006; N-[4-Chloro-3-(trifluoromethyl)phenyl]-N'-[4-[2-(N-methylcarbamoyl)-4-pyridyloxy]phenyl]urea; Nevaxar; Sorafenib|Manganese(4+), chloro[[4,4',4'',4'''-(21H,23H-porphine-5,10,15,20-tetrayl-kappaN21,kappaN22,kappaN23,kappaN24)tetrakis[1-methylpyridiniumato]](2-)]-, chloride (1:4), (SP-5-12)-|Sorafenib (Standard)|BAY43-9006|Kinome_766|SORAFENIB BASE|SORAFENIB [MI]|Sorafenib (USAN/INN)|SORAFENIB [USAN]|Nexavar (TN) (Bayer)|SORAFENIB [VANDF]|SORAFENIB [MART.]|EC 608-209-4|SCHEMBL8218|SORAFENIB [WHO-DD]|SORAFENIB [EMA EPAR]|Sorafenib - Bio-X trade mark|BAY 43-9006; Sorafenib|cid_216239|GTPL5711|orb1310944|SCHEMBL29349634|BDBM16673|BCPP000064|HMS2043A18|HMS3244A15|HMS3244A16|HMS3244B15|HMS3656N20|HMS5085J14|K00597a|BCP01767|BCP34023|EX-A2894|BAY439006|HY-10201R|NSC747971|NSC800934|s7397|STK627350|AKOS005560229|AC-1674|CCG-269400|CS-1590|DB00398|FS10807|NSC-747971|NSC-800934|PB14443|SB19942|SDCCGSBI-0634413.P005|SF-0529|BAY-43-0006|NCGC00167488-02|NCGC00167488-03|NCGC00167488-04|NCGC00167488-05|NCGC00167488-07|NCGC00167488-11|NCGC00167488-14|4(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N(sup 2)-methylpyridine-2-carboxamide|BP-44051|BS164413|DA-52659|HY-10201|N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcar bamoyl)-4-pyridyloxy)phenyl)urea|Sorafenib free base (BAY-43-9006)?|SY009239|PA-216239|NS00005946|SW202562-4|D08524|EN300-120647|AB00933189-05|AB00933189-06|AB00933189_08|461S730|Q421136|SR-00000000529-1|BRD-K23984367-001-01-8|BRD-K23984367-001-07-5|BRD-K23984367-075-15-2|Z89277543|BAY 439006; BAY439006; BAY-439006|Sorafenib (D3); CM-4307; CM 4307; CM4307;Bay 43-9006 (D3)|4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl) ureido) phenoxy)-N-methylpicolinamide|4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl) ureido)phenoxy)-N-methylpicolinamide|N-(3-trifluoromethyl-4-chlorophenyl)-N'-(4-(2-methylcarbamoyl pyridin-4-yl)oxyphenyl)urea|4-(4-{3-[4-chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)- N-methylpyridine-2-carboxamide|4-(4-{3-[4-Chloro-3-(trifluoromethyl)phenyl]ureido}phenoxy)-N2-methylpyridine-2-carboxamide|4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-picolinamide;tosylic acid|4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)-amino]phenoxy}-N-methylpyridine-2-carboxamide|4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methyl-pyridine-2-carboxamide|Manganese(4+), chloro[[4,4',4'',4'''-(21H,23H-porphine-5,10,15,20-tetrayl-N21,N22,N23,N24)tetrakis[1-methylpyridiniumato]](2-)]-, chloride (1:4), (SP-5-12)-|N-(4-chloro-3-(trifluoromethyl)phenyl)-N'-(4-(2-(N-methylcarbamoyl)-4-pyridyloxy)phenyl) urea"
BATIMASTAT,5362422,,"InChI=1S/C23H31N3O4S2/c1-15(2)12-17(18(22(28)26-30)14-32-20-10-7-11-31-20)21(27)25-19(23(29)24-3)13-16-8-5-4-6-9-16/h4-11,15,17-19,30H,12-14H2,1-3H3,(H,24,29)(H,25,27)(H,26,28)/t17-,18+,19+/m1/s1",XFILPEOLDIKJHX-QYZOEREBSA-N,C23H31N3O4S2,477.6,"(2S,3R)-N-hydroxy-N'-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-3-(2-methylpropyl)-2-(thiophen-2-ylsulfanylmethyl)butanediamide","batimastat|130370-60-4|BB-94|BB94|batimastatum|BK349F52C9|Butanediamide, N4-hydroxy-N1-(2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)-, (2R-(1(S*),2R*,3S*))-|DTXSID20156497|(2R,3S)-N-hydroxy-N'-[(1S)-1-(methylcarbamoyl)-2-phenylethyl]-2-(2-methylpropyl)-3-[(thiophen-2-ylsulfanyl)methyl]butanediamide|BB94 cpd|(2R,3S)-N'-hydroxy-N-((1S)-1-(methylcarbamoyl)-2-phenylethyl)-2-(2-methylpropyl)-3-((thiophen-2-ylsulfanyl)methyl)butanediamide|(2R,3S)-N'-hydroxy-N-[(1S)-1-(methylcarbamoyl)-2-phenylethyl]-2-(2-methylpropyl)-3-[(thiophen-2-ylsulfanyl)methyl]butanediamide|(2R,3S)-N-hydroxy-N'-((1S)-1-(methylcarbamoyl)-2-phenylethyl)-2-(2-methylpropyl)-3-((thiophen-2-ylsulfanyl)methyl)butanediamide|RefChem:561113|(4-(N-hydroxyamino)-2-isobutyl-3-(thiophen-2-ylthiomethyl)succinyl)phenylalanine-N-methylamide|DTXCID2078988|(2R,3S)-N(4)-Hydroxy-N(1)-((1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)butanediamide|(4-(N-Hydroxyamino)-2R-isobutyl-3S-(2-thienylthiomethyl)-succinyl)-L-phenylalanine-N-methylamide|(4-(N-Hydroxyamino)-2R-isobutyl-3S-(thiophen-2-ylthiomethyl)-succinyl)-L-phenylalanine-N-methylamide|Batimastat (BB-94)|BB 94|Batimastat (MMP Inhibitor)|Butanediamide, N4-hydroxy-N1-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]-, (2R,3S)-|MFCD00866533|(2S,3R)-N1-hydroxy-3-isobutyl-N4-((S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl)-2-((thiophen-2-ylthio)methyl)succinamide|(2S,3R)-N-hydroxy-N'-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-3-(2-methylpropyl)-2-(thiophen-2-ylsulfanylmethyl)butanediamide|CHEMBL279786|4-(N-HYDROXYAMINO)-2R-ISOBUTYL-2S-(2-THIENYLTHIOMETHYL)SUCCINYL-L-PHENYLALANINE-N-METHYLAMIDE|(2R)-N-[(1S)-1-benzyl-2-(methylamino)-2-oxo-ethyl]-2-[(1S)-2-(hydroxyamino)-2-oxo-1-(2-thienylsulfanylmethyl)ethyl]-4-methyl-pentanamide|C23H31N3O4S2|SMR002530309|Batimastat [USAN:INN:BAN]|UNII-BK349F52C9|Batimastat(BB-94)|1rm8|Batimastat(BB-94)?|BATIMASTAT [MI]|BATIMASTAT [INN]|Batimastat (USAN/INN)|BATIMASTAT [USAN]|BATIMASTAT; BB94|BATIMASTAT [MART.]|SCHEMBL4332|(2S,3R)-5-Methyl-3-(((alphaS)-alpha-(methylcarbamoyl)phenethyl)carbamoyl)-2-((2-thienylthio)methyl)hexanohydroxamic acid|MLS006010631|MLS006011226|GTPL5145|orb1301154|Batimastat, >=98% (HPLC)|ISV-120|ISV-615|2j83|CHEBI:195398|GLXC-07095|BB94, BB-94|EX-A1671|BDBM50063918|MSK168032|s7155|AKOS024457355|CCG-269520|CS-1655|DB03880|Batimastat - CAS 130370-60-4|NCGC00346877-01|(2r,3s)-n4-hydroxy-n1-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]butanediamide|AC-33099|AS-75198|BB162029|Butanediamide, N(sup 4)-hydroxy-N(sup 1)-(2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl)-2-(2-methylpropyl)-3-((2-thienylthio)methyl)-, (2R-(1(S*),2R*,3S*))-|DA-50944|HY-13564|NS00069199|A11441|D03061|370B604|BRD-K82818427-001-01-4|BRD-K82818427-001-02-2|BRD-K82818427-001-04-8|Q15303190|(2R,3S)-N(4)-hydroxy-N(1)-[(2S)-1-(methylamino)-1-oxo-3-phenylpropan-2-yl]-2-(2-methylpropyl)-3-[(thiophen-2-ylsulfanyl)methyl]butanediamide|(2R,3S)-N*4*-Hydroxy-2-isobutyl-N*1*-((S)-1-methylcarbamoyl-2-phenyl-ethyl)-3-(thiophen-2-ylsulfanylmethyl)-succinamide|(2R,3S)-N~1~-[(1S)-1-benzyl-2-(methylamino)-2-oxoethyl]-N~4~-hydroxy-2-(2-methylpropyl)-3-[(thiophen-2-ylsulfanyl)methyl]butanediamide|4-Methyl-2-[1-methyl-2-(thiophen-2-ylsulfanyl)-ethyl]-pentanoic acid (1-methylcarbamoyl-2-phenyl-ethyl)-amide|BB-94; (2R,3S)-N4-Hydroxy-N1-[(1S)-2-(methylamino)-2-oxo-1-(phenylmethyl)ethyl]-2-(2-methylpropyl)-3-[(2-thienylthio)methyl]butanediamide|N*4*-Hydroxy-2-isobutyl-N*1*-(1-methylcarbamoyl-2-phenyl-ethyl)-3-(thiophen-2-ylsulfanylmethyl)-succinamide"
DOVITINIB,135398510,,"InChI=1S/C21H21FN6O/c1-27-7-9-28(10-8-27)12-5-6-14-16(11-12)25-20(24-14)18-19(23)17-13(22)3-2-4-15(17)26-21(18)29/h2-6,11H,7-10H2,1H3,(H,24,25)(H3,23,26,29)",PIQCTGMSNWUMAF-UHFFFAOYSA-N,C21H21FN6O,392.4,4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one,"Dovitinib|405169-16-6|TKI-258|I35H55G906|GFKI-258|dovitinibum|4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-ylidene)-2,3-dihydroquinolin-2-one|4-amino-5-fluoro-3-(6-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl)-1,2-dihydroquinolin-2-one|4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-2,3-dihydro-1H-1,3-benzodiazol-2-ylidene]-2,3-dihydroquinolin-2-one|4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1H-1,3-benzodiazol-2-yl]-1,2-dihydroquinolin-2-one|RefChem:590385|Dovitinib (TKI-258, CHIR-258)|Dovitinib [INN]|4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one|Chir 258|CHIR258|Dovitinib lactate|MFCD10565680|804551-71-1|UNII-I35H55G906|4-Amino-5-Fluoro-3-(6-(4-Methylpiperazin-1-yl)-1H-Benzo[D]Imidazol-2-yl)Quinolin-2(1H)-One|TK-258|Dovitinib (TKI-258)|2(1H)-Quinolinone,4-amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-|CHEMBL522892|CHEMBL4578973|C21H21FN6O|1027263-12-2|4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzo[d]imidazol-2-yl)quinolin-2(1H)-one|4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one|(3Z)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one|Dovitinib, Free Base|Dovitinib base|38O|4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-1H-benzimidazol-2-yl]-2(1H)-quinolinone 2-Hydroxypropanoic Acid; CHIR 258; TKI 258;|Kinome_1513|DOVITINIB [WHO-DD]|NVP-TKI258|(3Z)-4-Amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydro-2H-benzimidazol-2-ylidene]-2(3H)-quinolinone|MLS006009991|SCHEMBL172687|SCHEMBL949705|GTPL5962|orb1300899|SCHEMBL9975396|SCHEMBL10330209|SCHEMBL20399550|SCHEMBL23876106|SCHEMBL29352967|SCHEMBL29424010|SCHEMBL30567813|BDBM25118|CHEBI:91395|BCPP000286|BDBM153731|CHIR-258(Dovitinib,TKI258)|Dovitinib,TKI258, CHIR-258|DTXSID901025925|GLXC-05017|HMS3295E21|HMS3651E03|BCP01981|EX-A2051|BDBM50507579|NSC759661|NSC800092|NSC807408|s1018|Dovitinib; TKI-258; CHIR-258|AKOS005146311|AKOS015951093|BCP9000518|CCG-264778|CS-0120|DB05928|FD22602|NSC-759661|NSC-800092|NSC-807408|PB13248|SB20297|SDCCGSBI-0654439.P001|NCGC00249685-01|NCGC00249685-02|NCGC00249685-11|(3E)-4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1,3-dihydrobenzimidazol-2-ylidene]quinolin-2-one|4-AMINO-5-FLUORO-3-[ 5- (4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL]QUINOLIN-2(1H)-ONE|AC-32059|AS-19556|HY-50905|SMR004701066|SY046274|NS00069284|SW219787-1|C75053|169A166|326D834|1,3-benzodiazol-2-yl]-1,2-dihydroquinolin-2-one|BRD-K85402309-001-01-7|BRD-K85402309-001-06-6|BRD-K85402309-001-07-4|BRD-K85402309-043-01-9|BRD-K85402309-389-03-2|BRD-K85402309-389-04-0|BRD-K85402309-406-01-8|Q27077102|Q27163255|Q27453625|4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-|4-amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]quinolin-2 (1h)-one|4-amino-5-fluoro-3-[6(4-methyl-1-piperazinyl)-1h-benzimidazol-2-yl]-2(1h)-quinolinone|4-Amino-5-fluoro-3-[6-(4-methyl-1-piperazinyl)-2-benzimidazolyl]quinolin-2(1H)-one|4-amino-5-fluoro-3-[6-(4-methyl-piperazin-1-yl)-1H-benzimidazol-2-yl]-1H-quinolin-2-one|(3Z)-4-amino-5-fluoro-3-[5-(4-methylpiperazino)-1,3-dihydrobenzimidazol-2-ylidene]carbostyril|(E)-4-Amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1,3-dihydro-2H-benzo[d]imidazol-2-ylidene)quinolin-2(3H)-one|4-AMINO-5-FLUORO-3-(6-(4-METHYLPIPERAZIN-1-YL)-1H-BENZIMIDAZOL-2-YL)QUINOLIN-2(1H)-ONE|4-amino-5-fluoro-3-[5-(4-methyl-1-piperazinyl)-1,3-dihydrobenzimidazol-2-ylidene]-2-quinolinone|4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one?Dovitinib base|Dovitinib; 4-Amino-5-fluoro-3-[5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl]quinolin-2(1H)-one"
DONEPEZIL,3152,,"InChI=1S/C24H29NO3/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18/h3-7,14-15,17,20H,8-13,16H2,1-2H3",ADEBPBSSDYVVLD-UHFFFAOYSA-N,C24H29NO3,379.5,"2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one","donepezil|120014-06-4|donepezilo|Donaz|donepezilum|Domepezil|1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-|CHEBI:53289|8SSC91326P|D-797|DTXSID8048317|1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-((1-(phenylmethyl)-4-piperidinyl)methyl)-|donezpil hydrochloride|5,6-dimethoxy-2-((1-(phenylmethyl)piperidin-4-yl)methyl)-2,3-dihydroinden-1-one|5,6-dimethoxy-2-[[1-(phenylmethyl)piperidin-4-yl]methyl]-2,3-dihydroinden-1-one|donepezil hydrochlorid|RefChem:5777|DTXCID0028292|N06DA02|2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one|Aricept|C24H29NO3|2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one|MFCD00912833|2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one|142057-79-2|HSDB 7743|CHEMBL502|Eranz|2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one|2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1h-inden-1-one|Donepezil [INN:BAN]|(RS)-2-[(1-BENZYL-4-PIPERIDYL)METHYL]-5,6-DIMETHOXYINDAN-1-ONE|NSC 737535|NSC 758882|NCGC00167537-01|(S)-E2020 (free base)|UNII-8SSC91326P|2,3-dihydro-5,6-dimethoxy-2-((1-(phenylmethyl)-4-piperidinyl)methyl)-1h-inden-1-one|Allydone (TN)|Donepezil; 2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one; 1-Benzyl-4-[(5,6-dimethoxy-1-oxoindan-2-yl)methyl]piperidine; (+/-)-E 2020|Donaz (TN)|Donepezil (Standard)|Spectrum_001664|Donepezil (JAN/INN)|DONEPEZIL [INN]|DONEPEZIL [JAN]|DONEPEZIL [MI]|DONEPEZIL [HSDB]|Spectrum5_001662|DONEPEZIL [VANDF]|DONEPEZIL [WHO-DD]|SCHEMBL2149|Oprea1_188452|KBioSS_002144|BDBM8960|GTPL6599|orb1300120|SCHEMBL8265876|KBio2_002144|KBio2_004712|KBio2_007280|CHEBI:145499|2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-one|BCPP000253|HMS3886M11|HMS5084C21|BCP07590|MSK11044|VEA01406|HY-14566R|s5073|STK003905|AKOS000277311|AKOS016842349|AC-6969|BCP9000622|CCG-268401|DB00843|FD29053|MRF-0000323|D797|HY-14566|SBI-0206789.P001|NS00008580|D07869|EN300-267872|AB00640013-07|AB00640013-08|AB00640013_09|AB00640013_10|014D064|Q415081|BRD-A49160188-003-04-4|BRD-A49160188-003-11-9|BRD-A49160188-003-12-7|Z1741977105|2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxyindan-1-one|(+/-)-2-((1-BENZYL-4-PIPERIDYL)METHYL)-5,6-DIMETHOXY-1-INDANONE|(+/-)-2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-indan-1-one|2-[(1-benzyl-4-piperidyl)methyl]- 5,6-dimethoxy-2,3-dihydroinden-1-one|2,3-dihydro-5,6-dimethoxy-2 [[1-(phenyl methyl)-4-piperidinyl]methyl]-1H-inden-1-one|2,3-dihydro-5,6-dimethoxy-2[[1-(phenyl methyl)-4-piperidinyl]methyl]-1H-inden-1-one|2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one hydrochlorideDonepezil Hcl|5,6-DIMETHOXY-2-((1-(PHENYLMETHYL)-4-PIPERIDINYL)METHYL)-2,3-DIHYDRO-1H-INDEN-1-ONE"
TACRINE,1935,,"InChI=1S/C13H14N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1,3,5,7H,2,4,6,8H2,(H2,14,15)",YLJREFDVOIBQDA-UHFFFAOYSA-N,C13H14N2,198.26,"1,2,3,4-tetrahydroacridin-9-amine","Tacrine|321-64-2|1,2,3,4-tetrahydroacridin-9-amine|1,2,3,4-TETRAHYDRO-9-ACRIDINAMINE|Tetrahydroaminacrine|Tetrahydroaminoacridine|Tetrahydroaminocrin|Tetrahydroaminocrine|9-amino-1,2,3,4-tetrahydroacridine|Tacrina|Tacrinal|Tacrinum|9-Acridinamine, 1,2,3,4-tetrahydro-|1,2,3,4-Tetrahydro-9-aminoacridine|5-Amino-6,7,8,9-tetrahydroacridine|4VX7YNB537|DTXSID1037272|CHEBI:45980|DTXCID9017272|1,2,3,4-Tetrahydroaminoacridine|RefChem:187116|N06DA01|206-291-2|693-573-7|Cognex|Romotal|CS 12602|MFCD00046923|Tacrine (INN)|Acridine, 1,2,3,4-tetrahydro-9-amino-|CHEMBL95|tha|tacrine.HCl|NCGC00015054-06|Acridine, 9-amino-1,2,3,4-tetrahydro-|TACRINE [INN]|Tacrine [INN:BAN]|Tacrinum [INN-Latin]|Tacrina [INN-Spanish]|5,6,7,8-tetrahydroacridine-9-ylamine|Tacrinal (TN)|CAS-321-64-2|EINECS 206-291-2|5-Amino-6,7,8,9-tetrahydroacridine (European)|BRN 0147610|UNII-4VX7YNB537|1,2,3,4-Tetrahydro-acridin-9-ylamine|Tracine|1acj|2aow|2aox|1,2,3,4-Tetrahydro-9-acridineamine|Romotal (Salt/Mix)|Spectrum_000416|Tocris-0965|1mx1|TACRINE [VANDF]|TACRINE [MI]|Prestwick0_000329|Prestwick1_000329|Prestwick2_000329|Prestwick3_000329|Spectrum2_001812|Spectrum3_001709|Spectrum4_000819|Spectrum5_001402|Lopac-A-3773|TACRINE [WHO-DD]|cid_1935|SCHEMBL2828|9-THA|NCIOpen2_003667|Lopac0_000036|Oprea1_008681|Acridine, 9-aminotetrahydro-|BSPBio_000337|BSPBio_003298|KBioGR_001337|KBioSS_000896|BIDD:GT0090|DivK1c_000936|SPBio_001823|SPBio_002258|BDBM8961|BPBio1_000371|GTPL6687|orb1306361|SCHEMBL27504775|SCHEMBL29594645|SCHEMBL29681895|KBio1_000936|KBio2_000896|KBio2_003464|KBio2_006032|KBio3_002518|NINDS_000936|HMS2089F19|HMS3743C11|HMS5081L12|AAA32164|BCP03564|Tox21_110073|Tox21_302277|PDSP1_000330|PDSP2_000328|SBB003560|STK101308|AKOS000277493|Tox21_110073_1|AB89727|BCP9000019|CCG-204132|DB00382|SDCCGSBI-0050025.P004|1,2,3,4-tetra -hydro-9-acridinamine|IDI1_000936|NCGC00015054-01|NCGC00015054-02|NCGC00015054-03|NCGC00015054-04|NCGC00015054-05|NCGC00015054-07|NCGC00015054-08|NCGC00015054-09|NCGC00015054-10|NCGC00015054-12|NCGC00024908-01|NCGC00024908-03|NCGC00024908-04|NCGC00024908-05|NCGC00255540-01|1,2,3,4-tetrahydro-acridin-9-yl-amine|BS-28027|ST083243|SY138494|SBI-0050025.P003|DB-000650|HY-111338|9-amino-1,2,3,4-tetrahydroacridine (THA)|AB00053524|C-110|EU-0010966|NS00007239|T3994|EN300-02105|C01453|D08555|AB00053524-17|AB00053524_18|AB00053524_19|AE-641/00604043|F210355|Q421076|BRD-K81473089-003-03-0|BRD-K81473089-003-04-8|BRD-K81473089-003-15-4|BRD-K81473089-003-24-6|BRD-K81473089-003-25-3|BRD-K81473089-003-26-1|SR-01000075593-13|Z56790573"
PHYSOSTIGMINE,5983,,"InChI=1S/C15H21N3O2/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2/h5-6,9,13H,7-8H2,1-4H3,(H,16,19)/t13-,15+/m1/s1",PIJVFDBKTWXHHD-HIFRSBDPSA-N,C15H21N3O2,275.35,"[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate","physostigmine|Eserine|57-47-6|Physostol|Esromiotin|(-)-physostigmine|Ezerin|Calabarine|Fysostigmin|Erserine|cogmine|eserin|Eserinum|Eserolein, methylcarbamate (ester)|DTXSID3023471|MCV 4484|NIH 10421|NSC-30782|9U1VM840SP|CHEBI:27953|Methyl-carbamic acid, ester with eseroline|Carbamic acid, methyl-, ester with eseroline|MCV-4484|DTXCID603471|(3aS-cis)-1,2,3,3a,8,8a-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-ol methylcarbamate (ester)|[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate|Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-|(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate|((3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo(2,3-b)indol-7-yl) N-methylcarbamate|(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo(2,3-b)indol-5-yl N-methylcarbamate|RefChem:56714|200-332-8|Antilirium|(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate|NSC30782|CHEMBL94|NCGC00093889-03|Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)|Fysostigmin [Czech]|CHEMBL537674|CAS-57-47-6|CCRIS 3422|HSDB 3161|EINECS 200-332-8|Eserolein, methylcarbamate|NSC 30782|Physostigmine [USP:BAN]|RCRA waste no. P204|physostigmin|UNII-9U1VM840SP|CS 58525|(-) physostigmine|Eserine (TN)|Physostigmine (USP)|Spectrum_000916|Spectrum_001789|ESERINUM [HPUS]|SpecPlus_000381|Prestwick0_000566|Prestwick1_000566|Prestwick2_000566|Prestwick3_000566|Spectrum2_000330|Spectrum2_000757|Spectrum2_001283|Spectrum3_000545|Spectrum3_000901|Spectrum4_000997|Spectrum4_001631|Spectrum4_001913|Spectrum5_000441|Spectrum5_000626|Spectrum5_001672|PHYSOSTIGMINE [MI]|physostigmine.salicylic acid|1,2,3,3abeta,8abeta-Hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)-indol-5-yl methylcarbamate|PHYSOSTIGMINE [HSDB]|Lopac0_000483|SCHEMBL24044|BSPBio_000352|BSPBio_002189|KBioGR_001433|KBioGR_002061|KBioGR_002533|KBioSS_001396|KBioSS_002279|PHYSOSTIGMINE [VANDF]|MLS001304022|orb104785|DivK1c_006477|PHYSOSTIGMINE [MART.]|SPECTRUM1500753|SPBio_000339|SPBio_000774|SPBio_001285|SPBio_002571|PHYSOSTIGMINE [WHO-DD]|BPBio1_000388|cid_657348|GTPL6598|MEGxp0_001872|SCHEMBL29482277|ACon1_000097|BDBM11023|KBio1_001421|KBio2_001396|KBio2_002278|KBio2_003964|KBio2_004846|KBio2_006532|KBio2_007414|KBio3_001689|KBio3_001842|Eserolein,methylcarbamate (ester)|HMS1921G06|HMS2089M11|HMS2236L08|HMS3261B07|BCP19735|Carbamic acid, ester with eseroline|HY-N6608|MSK40315|PHYSOSTIGMINE [USP IMPURITY]|Tox21_111228|Tox21_301591|Tox21_500483|BDBM50004000|BDBM50222010|CCG-38605|AKOS016843649|Tox21_111228_1|DB00981|FE59473|LP00483|SDCCGMLS-0066585.P001|SDCCGSBI-0050467.P005|NCGC00093889-01|NCGC00093889-02|NCGC00093889-04|NCGC00093889-05|NCGC00093889-06|NCGC00093889-07|NCGC00093889-08|NCGC00093889-09|NCGC00093889-10|NCGC00093889-12|NCGC00093889-13|NCGC00093889-20|NCGC00255345-01|NCGC00261168-01|AC-15983|AC-37456|DA-56831|Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS,8aR)-|SMR000718753|SBI-0050467.P004|CS-0034353|EU-0100483|NS00004015|P0406|Physostigmine 100 microg/mL in Acetonitrile|C06535|D00196|E 8375|G60920|EN300-23839407|Q410595|Eserine; Antilirium; Physostol; Esromiotin; Ezerin|SR-01000075341-1|WLN: T B556 EN GNTT&J B1 E1 G1 KOVM1|BRD-K25650355-001-02-5|BRD-K25650355-059-02-3|BRD-K25650355-059-12-2|BRD-K25650355-059-18-9|BRD-K25650355-065-02-0|(3aS,8aR)-1,3a,8-Trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl hydrogen methylcarbonimidate|(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate hydrochloride|(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-methylcarbamate; 2-hydroxybenzoic acid|1,2,3,3A.BETA.,8A.BETA.-HEXAHYDRO-1,3A,8-TRIMETHYLPYRROLO(2,3-B)-INDOL-5-YL METHYLCARBAMATE|Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, 5-(N-methylcarbamate), (3aS,8aR)-|Pyrrolo[2, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-"
GALANTAMINE,9651,,"InChI=1S/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1",ASUTZQLVASHGKV-JDFRZJQESA-N,C17H21NO3,287.35,"(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol","galanthamine|Galantamine|357-70-0|(-)-Galanthamine|Lycoremine|Galantamina|(-)-Galantamine|Galanthaminum|Galantaminum|0D3Q044KCA|CHEBI:42944|NSC-100058|(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol|(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro(3a,3,2-ef)(2)benzazepin-6-ol|DTXSID2045606|Reminyl XL|(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol|Galzemic xl|Lotprosin xl|Consion xl|Gatalin xl|Gazylan xl|Luventa xl|Zeebral xl|Acumor xl|Elmino xl|Galsya xl|(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo(8.6.1.01,12.06,17)heptadeca-6(17),7,9,15-tetraen-14-ol|RefChem:56716|DTXCID0025606|N06DA04|6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-|Reminyl|Lycoremin|Jilkon|Razadyne|(+/-)-Galantamine|Bodamine|(+/-)-Galanthamine|Reminyl (TN)|Galantamine, (+/-)-|MFCD00867189|Galanthamine, (+/-)-|CHEMBL659|23173-12-8|1T835Z585R|(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol|Galantaminum [INN-Latin]|GNT|Galantamina [INN-Spanish]|NSC 100058|(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6,8,10(17),15-tetraen-14-ol|6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aR,6S,8aR)-rel-|6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-|BRN 0093736|HSDB 7361|Galantamine (USAN/INN)|UNII-0D3Q044KCA|Galantamine [USAN:INN:BAN]|SR-05000001783|1qti|Galanthamine, 12|6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aS,6R,8aS)-|Spectrum_001271|1dx6|Galanthamine (Standard)|GALANTAMINE [MI]|Prestwick0_000588|Prestwick1_000588|Prestwick2_000588|Prestwick3_000588|Spectrum3_001738|Spectrum4_000839|Spectrum5_001673|GALANTAMINE [INN]|GALANTAMINE [HSDB]|GALANTAMINE [USAN]|Probes1_000055|Probes2_000395|GALANTAMINE [VANDF]|SCHEMBL2577|BSPBio_000436|BSPBio_003416|GALANTAMINE [WHO-DD]|KBioGR_001417|KBioSS_001751|4-27-00-02184 (Beilstein Handbook Reference)|BIDD:GT0517|DivK1c_000590|SPBio_002655|BPBio1_000480|GTPL6693|orb1302305|SCHEMBL4696585|SCHEMBL7166507|SCHEMBL29379520|UNII-1T835Z585R|ASUTZQLVASHGKV-JDFRZJQESA-|BDBM10404|KBio1_000590|KBio2_001751|KBio2_004319|KBio2_006887|KBio3_002636|NINDS_000590|GLXC-03030|HMS2089H03|HMS3885C10|Pharmakon1600-01501202|MSK10278|HY-76299R|NSC759861|s3866|AKOS015965330|CCG-212961|CS-1217|DB00674|FH15703|NSC-759861|SDCCGMLS-0066737.P001|IDI1_000590|SMP1_000131|NCGC00017256-05|NCGC00017256-11|NCGC00017256-17|NCGC00024731-02|(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofurol[3a,3,2,-ef][2]benzazepin-6-ol|AC-20240|AC-34328|AS-56354|HY-76299|SBI-0051689.P002|NS00003061|A11538|C08526|D04292|EN300-708805|AB00053614-09|AB00053614_10|357G700|AC-542/20973006|Q412690|Galanthamine ( Jilkon, Lycoremine, Nivalin and oth|SR-05000001783-4|BRD-K49481516-001-01-5|BRD-K49481516-004-03-5|BRD-K49481516-004-04-3|BRD-K49481516-004-09-2|BRD-K49481516-004-18-3|(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-14-ol|1008759-59-8|6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, (4A.ALPHA.,6.BETA.,8AR*)-|6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, (4aalpha,6beta,8ar*)-|6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, (4AS,6R,8AS)|InChI=1/C17H21NO3/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17/h3-6,12,14,19H,7-10H2,1-2H3/t12-,14-,17-/m0/s1"
RIVASTIGMINE,77991,,"InChI=1S/C14H22N2O2/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4/h7-11H,6H2,1-5H3/t11-/m0/s1",XSVMFMHYUFZWBK-NSHDSACASA-N,C14H22N2O2,250.34,[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate,"rivastigmine|123441-03-2|Prometax|ENA 713 free base|Rivastigmine Teva|Nimvastid|rivastigmine hexal|Rivastigmine sandoz|SDZ-ENA-713|Rivastigmina|SDZ-212-713|3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate|PKI06M3IW0|m-((S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|(S)-3-(1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Rivastigmine Transdermal System|SDZ 212-713|CHEBI:8874|ENA-713D|ONO-2540|SDZ-212713|RIVASTIGMINE 1 A PHARMA|DTXSID7023564|RIVASTIGMINE 3M HEALTH CARE LTD|3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl-N-methylcarbamate|rivastigminum|Erastig|Kerstipon|Somniton|Alzest|Eluden|Voleze|(3-((1S)-1-dimethylaminoethyl)phenyl) N-ethyl-N-methylcarbamate|[3-[(1S)-1-dimethylaminoethyl]phenyl] N-ethyl-N-methylcarbamate|RefChem:56914|713, SDZ ENA|DTXCID703564|ENA 713, SDZ|ENA713|Hydrogen Tartrate, Rivastigmine|Tartrate, Rivastigmine Hydrogen|N06DA03|(S)-N-ethyl-3-((1-dimethyl-amino)ethyl)-N-methylphenylcarbamate|713, ENA|Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1)|Exelon|(S)-Rivastigmine|(S)-3-(1-(dimethylamino)ethyl)phenyl ethyl(methyl)carbamate|[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate|MFCD00871496|CHEMBL636|Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester|Exelon Patch|Ethylmethylcarbamic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester|3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate|S-Rivastigmine|SR-05000001475|UNII-PKI06M3IW0|Prometax (TN)|Rivastigmine [USAN:INN:BAN:JAN]|Rivastigmine.tartrate|Rivastigmine impurity D|3-((1S)-1-(Dimethylamino)ethyl)phenyl ethylmethylcarbamate|Rivastigmine (Standard)|RIVASTIGMINE [MI]|Rivastigmine Impurity 11|RIVASTIGMINE [INN]|RIVASTIGMINE [JAN]|Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester|RIVASTIGMINE [USAN]|SCHEMBL2764|RIVASTIGMINE [VANDF]|RIVASTIGMINE [MART.]|ethylmethylcarbamic acid 3-[1-(dimethylamino)ethyl]phenyl ester|MLS003876822|BIDD:GT0316|RIVASTIGMINE [USP-RS]|RIVASTIGMINE [WHO-DD]|Rivastigmine (JAN/USP/INN)|GTPL6602|orb1310812|RIVASTIGMINE [EMA EPAR]|SCHEMBL29614698|BDBM10620|BDBM11682|XSVMFMHYUFZWBK-NSHDSACASA-N|HMS2089H18|HMS3715P15|HMS3885B18|RIVASTIGMINE [ORANGE BOOK]|RIVASTIGMINE [EP MONOGRAPH]|(S)-3-[1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate|MSK11179|RIVASTIGMINE [USP MONOGRAPH]|[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methyl-carbamate|HY-17368R|AKOS015896334|Carbamic acid, ethylmethyl-, 3-(1-(dimethylamino)ethyl)phenyl ester, (S)-|AC-8250|CCG-221197|CS-0946|DB00989|FR15397|NCGC00167531-03|NCGC00167531-17|AS-73448|HY-17368|SMR002203623|SY115835|NS00000463|R0250|S4687|D03822|D82061|AB01275472-01|AB01275472_02|AB01275472_03|EN300-7403044|101R548|F462714|Q411887|SR-05000001475-1|SR-05000001475-2|BRD-K10706131-046-02-8|BRD-K10706131-046-03-6|BRD-K10706131-046-04-4|3-[1-(Dimethylamino)ethyl]phenyl (S)-Ethyl(methyl)carbamate|3-((1S)-1-(Dimethylamino)ethyl)phenyl N-ethyl N-methyl carbamate|Ethyl-methyl-carbamic acid 3-(1-dimethylamino-ethyl)-phenyl ester|Ethyl-methyl-carbamic acid 3-((R)-1-dimethylamino-ethyl)-phenyl ester|Ethyl-methyl-carbamic acid 3-((S)-1-dimethylamino-ethyl)-phenyl ester|2,3-dihydroxybutanedioic acid; 3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate"
EPTASTIGMINE,65872,,"InChI=1S/C21H33N3O2/c1-5-6-7-8-9-13-22-20(25)26-16-10-11-18-17(15-16)21(2)12-14-23(3)19(21)24(18)4/h10-11,15,19H,5-9,12-14H2,1-4H3,(H,22,25)/t19-,21+/m1/s1",RRGMXBQMCUKRLH-CTNGQTDRSA-N,C21H33N3O2,359.5,"[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-heptylcarbamate","Eptastigmine|Eptastigmina|101246-68-8|heptastigmine|Eptastigminum|N-Demethyl-N-heptylphysostigmine|Heptylphysostigmine|Physostigmine heptyl|6PZZ52D76Q|DTXSID801317905|heptyl-physostigmine|heptyl physostigmine|RefChem:921076|DTXCID001747700|pyrrolo(2,3-b)indol-5-ol-1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl heptylcarbamate ester|Eptastigmine [INN]|CHEMBL433041|(-)-Heptylphysostigmine|Eptastigminum [INN-Latin]|Eptastigmina [INN-Spanish]|BRN 4883778|UNII-6PZZ52D76Q|EPTASTIGMINE [MI]|EPTASTIGMINE [MART.]|SCHEMBL195028|orb1980199|SCHEMBL29757156|BDBM10972|[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-heptylcarbamate|Carbamic acid, heptyl-, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethylpyrrolo(2,3-b)indol-5-yl ester, (3aS-cis)-|NS00125106|Q27265299|(3aS,8aR)-1,3a,8-trimethyl-1H,2H,3H,3aH,8H,8aH-pyrrolo[2,3-b]indol-5-yl N-heptylcarbamate"
TACRINE HYDROCHLORIDE,2723754,,"InChI=1S/C13H14N2.ClH/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13;/h1,3,5,7H,2,4,6,8H2,(H2,14,15);1H",ZUFVXZVXEJHHBN-UHFFFAOYSA-N,C13H15ClN2,234.72,"1,2,3,4-tetrahydroacridin-9-amine;hydrochloride","Tacrine hydrochloride|1684-40-8|Tacrine HCl|Hydroaminacrine|Tenakrin|CI-970|NSC-72108|9-Acridinamine, 1,2,3,4-tetrahydro-, monohydrochloride|4966RNG0BU|CI 970|1,2,3,4-Tetrahydro-9-aminoacridine hydrochloride|9-Amino-1,2,3,4-tetrahydroacridine monohydrochloride|NSC72108|Acridine, 9-amino-1,2,3,4-tetrahydro-, hydrochloride|Acridine, 9-amino-1,2,3,4-tetrahydro-, monohydrochloride|ACRIDINE, 1,2,3,4-TETRAHYDRO-9-AMINO-, MONOHYDROCHLORIDE|Alzyme|RefChem:57095|1,2,3,4-tetrahydro-9-acridinamine monohydrochloride monohydrate|216-867-5|1,2,3,4-tetrahydroacridin-9-amine hydrochloride|Cognex|9-AMINO-1,2,3,4-TETRAHYDROACRIDINE HYDROCHLORIDE|Romotal|9-Acridinamine, 1,2,3,4-tetrahydro-, hydrochloride (1:1)|Tacrine (hydrochloride)|MFCD00012657|tacrine.HCl|MLS000028845|9-amino-1,2,3,4-Tetrahydroacridine hydrochloride dihydrate|DTXSID1026112|1,2,3,4-Tetrahydro-9-acridinamine hydrochloride|SMR000059105|1,2,3,4-Tetrahydro-9-acridinamine monohydrochloride|SR-01000075593|tha|CAS-1684-40-8|UNII-4966RNG0BU|Tacrine hydrochloride [USAN]|CCRIS 7250|T.H.A.|OROS-tacrine|Tacrine hydrochloride [USAN:USP]|tacrine hydrochlorid|Tacrin hydrochloride|EINECS 216-867-5|Cognex (TN)|NSC 72108|THA.HCl|CPD000059105|Opera_ID_296|SCHEMBL3270|1,2,3,4-Tetrahydroacridin-9-aminehydrochloride|CHEMBL1677|1,2,3,4-tetrahydroacridin-9-amine;hydrochloride|Tacrine hydrochloride (USP)|MLS000758202|MLS001401372|SPECTRUM2300104|1,2,3,4-Tetrahydroacridin-9-amine monohydrochloride|DTXCID906112|orb1704785|SCHEMBL1044163|MSK163021WA|HMS5083A15|Pharmakon1600-02300104|TACRINE HYDROCHLORIDE [MI]|BCP29701|HY-B1488|Tox21_200299|Tox21_500036|CCG-39606|NSC759324|s4357|TACRINE HYDROCHLORIDE [VANDF]|TACRINE HYDROCHLORIDE [MART.]|AKOS015913476|TACRINE HYDROCHLORIDE [WHO-DD]|LP00036|NC00068|NSC-759324|Tacrine hydrochloride; THA hydrochloride|Tetrahydroaminoacridine Monohydrochloride|NCGC00024908-02|NCGC00093554-01|NCGC00093554-02|NCGC00093554-03|NCGC00093554-04|NCGC00257853-01|NCGC00260721-01|DS-16390|SY270553|TACRINE HYDROCHLORIDE [ORANGE BOOK]|DB-043738|TACRINE HYDROCHLORIDE [USP IMPURITY]|CS-0013186|EU-0100036|NS00081470|ST50319524|SW033163-6|A 3773|Acridine,2,3,4-tetrahydro-, monohydrochloride|D02068|F20766|1,2,3,4-tetrahydroacridin-9-ylammonium;chloride|5,6,7,8-tetrahydroacridine-9-ylamine, chloride|SR-01000075593-1|SR-01000075593-3|SR-01000075593-9|9-Acridinamine,2,3,4,-tetrahydro-, monohydrochloride|Q27259239|SR-01000075593-16|Tacrine HCl;Hydroaminacrine; NSC72108; NSC-72108; NSC72108"
DONEPEZIL HYDROCHLORIDE,5741,,"InChI=1S/C24H29NO3.ClH/c1-27-22-14-19-13-20(24(26)21(19)15-23(22)28-2)12-17-8-10-25(11-9-17)16-18-6-4-3-5-7-18;/h3-7,14-15,17,20H,8-13,16H2,1-2H3;1H",XWAIAVWHZJNZQQ-UHFFFAOYSA-N,C24H30ClNO3,416.0,"2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one;hydrochloride","Donepezil hydrochloride|120011-70-3|Donepezil HCl|BNAG|E-2020|Aricept ODT|E2020|ADLARITY|Aricept Evess|NSC-737535|NSC-758882|3O2T2PJ89D|DTXSID0046698|1-Benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hcl|CHEBI:4696|DTXCID8026698|NAMZARIC COMPONENT DONEPEZIL HYDROCHLORIDE|Donepezil Hyrochloride|RefChem:56499|Donepezil Hyrochloride 5mg|Donepezil Hydrochloride 10mg|Donepezil Hydrochloride 5 mg|1-benzyl-4-((5,6-dimethoxy-1-indanon)-2-yl)methylpiperidine hydrochloride|(2RS)-2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one monohydrochloride|Aricept|110119-84-1|2-((1-Benzylpiperidin-4-yl)methyl)-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one hydrochloride|E 2020|Donepezil (Hydrochloride)|Donepezil, HCl|1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-, hydrochloride (1:1)|MFCD00881312|Eranz|2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one hydrochloride|C24H30ClNO3|CHEMBL1678|2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one;hydrochloride|120011-70-3 (HCl)|E2020;E-2020|2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydro-1H-inden-1-one hydrochloride|2-(1-Benzyl-4-piperidylmethyl)-5,6-dimethoxy-1-indanone Hydrochloride|2-(1-Benzyl-piperidin-4-ylmethyl)-5,6-dimethoxy-indan-1-one hydrochloride|E 2020 (pharmaceutical)|1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-((1-(phenylmethyl)-4-piperidinyl)methyl)-, hydrochloride|SMR000449292|CAS-120011-70-3|Donepezil hydrochloride [USAN]|NSC 737535|NSC 758882|NCGC00167537-01|UNII-3O2T2PJ89D|Memorit|Memac|Donepezil,HCl|Aricept D|1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-, hydrochloride|Donepezil Hydrochloride; 1H-Inden-1-one, 2,3-dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-, hydrochloride (9CI); Aricept; Aricept D; BNAG; E 2020|Aricept (TN)|Donepezil hydrochloride [USAN:USP]|Donepezil hydrochloride?|Donepezil HCl (Aricept)|SCHEMBL1815|MLS000758276|MLS001401387|donepezil hydrochloride hydrate|orb1300734|SCHEMBL29424585|HY-B0034R|MSK11214A|GLXC-05176|Pharmakon1600-01504403|Donepezil HCl - Bio-X trade mark|BCP02205|BCP24884|HY-B0034|DONEPEZIL HYDROCHLORIDE [MI]|Tox21_112534|AC-913|Donepezil hydrochloride (JP18/USP)|DONEPEZIL HYDROCHLORIDE [JAN]|HB2083|NSC737535|NSC758882|s2462|Donepezil (Hydrochloride) (Standard)|AKOS000277343|AKOS016340656|Tox21_112534_1|CCG-101043|CCG-213309|CS-0863|DONEPEZIL HYDROCHLORIDE [MART.]|DONEPEZIL HYDROCHLORIDE [VANDF]|KS-1051|NC00293|(+-)-2-((1-Benzyl-4-piperidyl)methyl)-5,6-dimethoxy-1-indanone hydrochloride|2-[(1-benzylpiperidin-4-yl)methyl]-5,6-dimethoxy-2,3-dihydroinden-1-one hydrochloride|DONEPEZIL HYDROCHLORIDE [USP-RS]|DONEPEZIL HYDROCHLORIDE [WHO-DD]|NCGC00167537-02|BD164380|D4099|DONEPEZIL HYDROCHLORIDE [ORANGE BOOK]|DONEPEZIL HYDROCHLORIDE [EP MONOGRAPH]|D00670|DONEPEZIL HYDROCHLORIDE [USP MONOGRAPH]|E-2022|EN300-269733|119D841|F036568|Donepezil hydrochloride monohydrate, >=98% (HPLC)|Q27106438|884740-09-4 (.H2O)|Donepezil Hydrochloride 1.0 mg/ml in Methanol (as free base)|2-[(1-benzyl-4-piperidyl)methyl]-5,6-dimethoxy-indan-1-one;hydrochloride|(+/-)-2-((1-BENZYL-4-PIPERIDYL)METHYL)-5,6-DIMETHOXY-1-INDANONE HYDROCHLORIDE|2,3-Dihydro-5,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]-1H-inden-1-one|(+-)-2,6-dimethoxy-2-[[1-(phenylmethyl)-4-piperidinyl]methyl]-1H-inden-1-one hydrochloride"
ETHOPROPAZINE,3290,,"InChI=1S/C19H24N2S/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21/h6-13,15H,4-5,14H2,1-3H3",CDOZDBSBBXSXLB-UHFFFAOYSA-N,C19H24N2S,312.5,"N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine","ethopropazine|Profenamine|Ethopromazine|522-00-9|Profenaminum|Profenamina|2-Diethylamino-1-propyl-N-dibenzoparathiazine|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethanamine|7WI4P02YN1|10-[2-(Diethylamino)propyl]phenothiazine|CHEBI:313639|10-[2-(Diethylamino)-1-Propyl]phenothiazine|10H-Phenothiazine-10-ethanamine, N,N-diethyl-alpha-methyl-|10-[2-(Diethylamino)-2-methylethyl]phenothiazine|PHENOTHIAZINE, 10-(2-(DIETHYLAMINO)PROPYL)-|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine|DTXSID2023018|W-483|diethyl[1-(10H-phenothiazin-10-yl)propan-2-yl]amine|RP-3356|SC-2538|10-(2-(DIETHYLAMINO)PROPYL)PHENOTHIAZINE|10-(2-(diethylamino)-1-propyl)phenothiazine|Phenothiazine, 10-[2-(diethylamino)propyl]-|10-(2-(diethylamino)-2-methylethyl)phenothiazine|diethyl(1-(10H-phenothiazin-10-yl)propan-2-yl)amine|(+-)-Ethopropazine|RefChem:905508|DTXCID803018|N04AA05|208-320-4|Parsidol|Isothazine|Isothiazine|Phenopropazine|Prophenamine|Prophenaminum|Parsitan|Parfezine|Parsotil|Rodipal|Ethapropazine|Isopthazine|Profenamina [Italian]|Fempropazine|Profenaminum [INN-Latin]|Profenamina [INN-Spanish]|10-(2-Diethylaminopropyl)phenothiazine|SKF 2538|RP 3356|SC 2538|N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine|Profenamine (INN)|CHEMBL1206|10-[2-DIETHYLAMINOPROPYL]PHENOTHIAZINE|N,N-diethyl-1-(10H-phenothiazin-10-yl)propan-2-amine|Athapropazine|Athopropazin|Etopropezina|Fenpropazina|Phenoprozine|Prodierazine|Isotazin|10-(2-(Diethylamino)propyl)-phenothiazin|10H-Phenothiazine-10-ethanamine, N,N-diethyl-.alpha.-methyl-|Aethopropropazin|PROFENAMINE [INN]|Profenamine [INN:BAN]|N,N-Diethyl-.alpha.-methyl-10H-phenothiazine-10-ethanamine|W 483|EINECS 208-320-4|UNII-7WI4P02YN1|SR-05000001626|Dibutil (Salt/Mix)|Lysivane (Salt/Mix)|Pardisol (Salt/Mix)|Spectrum_000815|Parphezein (Salt/Mix)|Prodictazin (Salt/Mix)|Prestwick0_000840|Prestwick1_000840|Prestwick2_000840|Prestwick3_000840|Spectrum2_000984|Spectrum3_000429|Spectrum4_000548|Spectrum5_001592|(.+/-.)-Profenamine|ETHOPROPAZINE [MI]|NCIOpen2_008174|SCHEMBL34045|(+/-)-PROFENAMINE|BSPBio_000799|BSPBio_002018|ETHOPROPAZINE [VANDF]|KBioGR_001215|KBioSS_001295|PROFENAMINE [WHO-DD]|DivK1c_000061|(+/-)-ETHOPROPAZINE|SPBio_001047|SPBio_002720|BDBM8958|BPBio1_000879|GTPL7181|orb1695609|SCHEMBL29426328|KBio1_000061|KBio2_001295|KBio2_003863|KBio2_006431|KBio3_001238|NINDS_000061|AKOS040753613|DB00392|SDCCGSBI-0051378.P004|IDI1_000061|NCGC00178860-03|NCGC00178860-10|SBI-0051378.P003|phenothiazine, 10-(2-diethylaminopropyl)-|AB00053474|NS00006829|D08426|AB00053474_04|EN300-18530982|L001334|N,N-diethyl-1-phe-nothiazin-10-yl-propan-2-amine|Q7247908|SR-05000001626-4|BRD-A16311756-003-01-0|BRD-A16311756-003-08-5|BRD-A16311756-003-09-3|N,N-Diethyl-1-(10H-phenothiazin-10-yl)-2-propanamine #"
NEOSTIGMINE,4456,,"InChI=1S/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1",ALWKGYPQUAPLQC-UHFFFAOYSA-N,C12H19N2O2+,223.29,[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium,"NEOSTIGMINE|Eustigmin|Eustigmine|59-99-4|Vagostigmine|Prostigmine|Prostigmin|Juvastigmin|Neostigmin|m-Trimethylammoniumphenyldimethylcarbamate|3-Trimethylammoniumphenyl N,N-dimethylcarbamate|Neostigmine ion|Neostigmine cation|Neostigmine (cation)|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate|3-[(dimethylcarbamoyl)oxy]-N,N,N-trimethylanilinium|[3-(dimethylcarbamoyloxy)phenyl]-trimethylazanium|CHEBI:7514|3982TWQ96G|(m-Hydroxyphenyl)trimethylammonium dimethylcarbamate (ester)|Ammonium, (m-hydroxyphenyl)trimethyl-, dimethylcarbamate (ester)|Benzenaminium, 3-(((dimethylamino)carbonyl)oxy)-N,N,N-trimethyl-|DTXSID1023360|Prozerin|Benzenaminium, 3-[[(dimethylamino)carbonyl]oxy]-N,N,N-trimethyl-|(3-(dimethylcarbamoyloxy)phenyl)-trimethylazanium|3-((dimethylcarbamoyl)oxy)-N,N,N-trimethylanilinium|RefChem:55701|DTXCID703360|Normastigmin|Synstigmin|Neostigmine [BAN]|Neostigmine (BAN)|Prostigmin (TN)|CHEMBL278020|Neostigminum|[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium bromide|3-{[(dimethylamino)carbonyl]oxy}-N,N,N-trimethylanilinium|3-((dimethylcarbamoyl)oxy)-N,N,N-trimethylbenzenaminium|CCRIS 3079|[3-(dimethylcarbamoyloxy)phenyl]-trimethyl-azanium; sulfonatooxymethane|HSDB 3921|NCGC00163240-01|CAS-114-80-7|BRN 3615946|UNII-3982TWQ96G|Spectrum_001061|NEOSTIGMINE [MI]|Prestwick0_000468|Prestwick1_000468|Prestwick2_000468|Prestwick3_000468|Spectrum2_001278|Spectrum4_000072|Spectrum5_001234|Lopac-N-2001|NEOSTIGMINE [HSDB]|bmse000762|NEOSTIGMINE [VANDF]|NEOSTIGMINE [MART.]|Lopac0_000816|SCHEMBL34419|BSPBio_000576|KBioGR_000623|KBioSS_001541|DivK1c_000165|DivK1c_000198|SPBio_001276|SPBio_002515|BPBio1_000634|GTPL8993|orb1740451|SCHEMBL29603805|ALWKGYPQUAPLQC-UHFFFAOYSA-|KBio1_000165|KBio1_000198|KBio2_001541|KBio2_004109|KBio2_006677|NINDS_000165|NINDS_000198|HMS2089A22|BDBM50022775|STL058953|AKOS005711366|CCG-204900|DB01400|IDI1_000165|IDI1_000198|MLS-0002855|NCGC00015730-01|NCGC00015730-02|NCGC00015730-03|NCGC00015730-04|NCGC00015730-05|NCGC00015730-06|NCGC00015730-07|NCGC00015730-08|NCGC00015730-09|NCGC00015730-24|NCGC00021658-03|SBI-0050793.P004|AB00053807|NS00001580|C07258|D08261|AB00053807-25|AB00053807-26|AB00053807_27|AB00053807_28|AB00053807_29|Q410546|BRD-K18922609-004-04-1|BRD-K18922609-004-14-0|BRD-K18922609-004-22-3|BRD-K18922609-004-23-1|BRD-K18922609-004-24-9|InChI=1/C12H19N2O2/c1-13(2)12(15)16-11-8-6-7-10(9-11)14(3,4)5/h6-9H,1-5H3/q+1"
EBSELEN,3194,,InChI=1S/C13H9NOSe/c15-13-11-8-4-5-9-12(11)16-14(13)10-6-2-1-3-7-10/h1-9H,DYEFUKCXAQOFHX-UHFFFAOYSA-N,C13H9NOSe,274.19,"2-phenyl-1,2-benzoselenazol-3-one","ebselen|60940-34-3|2-phenyl-1,2-benzoselenazol-3-one|2-Phenyl-1,2-benzisoselenazol-3(2H)-one|Ebselene|Ebseleno|Ebselenum|SPI-1005|PZ 51|DR-3305|PZ-51|DR3305|2-phenyl-1,2-benzoisoselenazol-3(2H)-one|DTXSID7045150|40X2P7DPGH|NSC-639762|NSC-757883|CHEBI:77543|SPI1005|DTXCID5025150|SPI 1005|2-phenylbenzoisoselenazol-3(2H)-one|RefChem:590533|2-phenyl-2,3-dihydro-1,2-benzoselenazol-3-one|612-054-8|2-phenylbenzo[d][1,2]selenazol-3(2H)-one|Ebselen [INN]|Ebselene [French]|Ebselenum [Latin]|Harmokisane|Ebseleno [Spanish]|C13H9NOSe|PZ51|MFCD00210937|MLS000028488|CCRIS 3714|1,2-Benzisoselenazol-3(2H)-one, 2-phenyl-|DR 3305|2-Phenyl-1,2-benzisoselenazolin-3-one|SMR000058445|UNII-40X2P7DPGH|CHEMBL51085|NSC 639762|Prestwick_1057|SPI-3005|Prestwick0_000740|Prestwick1_000740|Prestwick2_000740|Prestwick3_000740|Spectrum2_001441|Spectrum3_000799|Spectrum4_000445|Spectrum5_001713|Lopac-E-3520|NSC639762|Lopac0_000541|NCGC00015412-06|BSPBio_000700|BSPBio_001342|BSPBio_002538|CPD000058445|KBioGR_000062|KBioGR_000830|KBioSS_000062|DivK1c_000951|SPBio_001301|SPBio_002639|CAS-60940-34-3|MLS001148646|BPBio1_000770|BCBcMAP01_000149|HMS502P13|KBio1_000951|KBio2_000062|KBio2_002630|KBio2_005198|KBio3_000123|KBio3_000124|KBio3_001758|NINDS_000951|E 3520|Bio2_000062|Bio2_000542|HMS1361D04|HMS1570C22|HMS1791D04|HMS1989D04|HMS2052N09|AC-1124|IDI1_000951|IDI1_033812|QTL1_000035|NCGC00015412-01|NCGC00015412-02|NCGC00015412-03|NCGC00015412-13|NCGC00024072-03|NCGC00024072-04|NCGC00024072-05|NCGC00178610-01|NCGC00178610-02|NCGC00178610-03|AB00053217|EU-0100541|MLS-0003066.0001|BRD-K29359156-001-06-1|RP 60931|2-Phenyl-1,2-benzoselenazol-3-one (Ebselen)|SR-01000003081|AC1L1FDW|Ebselen?|CID3194|2-Phenyl-1,2-benzoisoselenazol-3(2H)-one; CCG-39161; Ebselen; Lopac E 3520; NSC 639762; PZ 51|Ebselen (C5)|nchembio.109-comp1|2-phenyl-1,2-benzoselenazol-3(2h)-one|LS-33527|SAM001247071|EBSELEN [JAN]|EBSELEN [MI]|EBSELEN [MART.]|Opera_ID_1643|EBSELEN [WHO-DD]|Ebselen, cysteine modifier|cid_3194|C042986|SCHEMBL33829|MLS001424261|MLS006010108|E3520_SIGMA|I09-1611|orb1310258|SCHEMBL29370082|BDBM34233|GTPL10583|HMS2097C22|HMS2235A11|HMS3394N09|HMS3402D04|HMS3649O05|HMS3714C22|HMS3873N13|HMS5086A04|KUC112559N|Pharmakon1600-01501188|BCP17134|EX-A1447|SPI-1005;PZ-51|Tox21_110140|2-Phenyl-benzo[d]isoselenazol-3-one|CCG-39161|DAP001372|HB0270|NSC757883|s6676|AKOS015898841|CS-5534|DB12610|FE75162|LP00541|NC00431|SDCCGSBI-0050524.P004|KSC-325-014|NCGC00015412-04|NCGC00015412-05|NCGC00015412-07|NCGC00015412-08|NCGC00015412-09|NCGC00015412-10|NCGC00015412-11|NCGC00015412-12|NCGC00015412-21|phenyl-1,2-benzisoselenazol-3(2H)-one|2-phenyl-1,2-benzisoselazol-3(2H)-one|HY-13750|SY052687|SBI-0050524.P003|2-phenyl-1,2-benzisoselenazole-3(2H)-one|DB-072873|2-phenyl-1,2-benzoisoselenazole-3(2H)-one|E0946|NS00034501|2-phenyl-1,2-benzoisoselenazole-3-(2H)-one|2-Phenyl-1,2-benzoselenazol-3-one(Ebselen)|2-Phenyl-benzo[d]isoselenazol-3-one(Ebselen)|C75847|M01704|AB00053217_25|940E343|Q5332073|SR-01000003081-2|SR-01000003081-7|SR-01000003081-8|BRD-K29359156-001-23-6|BRD-K29359156-001-30-1|SR-01000003081-10|SR-01000003081-14"
SELEGILINE,26757,,"InChI=1S/C13H17N/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13/h1,5-9,12H,10-11H2,2-3H3/t12-/m1/s1",MEZLKOACVSPNER-GFCCVEGCSA-N,C13H17N,187.28,(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine,"selegiline|L-Deprenalin|(-)-selegiline|14611-51-9|L-Deprenyl|Selegilina|Selegilinum|(-)-Deprenil|L-Selegiline|CHEBI:9086|2K1V7GP655|N-methyl-N-[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-amine|DTXSID6023575|(-)-(N)-Methyl-N-((1R)-1-methyl-2-phenylethyl)prop-2-yn-1-amine|methyl(1-phenylpropan-2-yl)(prop-2-yn-1-yl)amine|Selegyline|N-methyl-N-((2R)-1-phenylpropan-2-yl)prop-2-yn-1-amine|Selegiline, (R)-|RefChem:56003|DTXCID403575|N04BD01|CHEBI:50217|E 250|Emsam|Eldepryl|Jumex|Zelapar|(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine|Selegilinum [INN-Latin]|Selegilina [INN-Spanish]|CHEMBL972|Carbex|Otrasel|methyl[(2R)-1-phenylpropan-2-yl](prop-2-yn-1-yl)amine|selgene|(R)-N-Methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-amine|Zalapar|l-E 250|(R)-(-)-Selegiline|Selegene|Selegiline [USAN:INN:BAN]|UNII-2K1V7GP655|(R)-(-)-N,alpha-Dimethyl-N-2-propinylphenethylamine|Emsam (TN)|(R)-(-)-N-Methyl-N-(1-phenyl-2-propyl)-2-propinylamin|SELEGILINE [MI]|SELEGILINE [INN]|Prestwick0_000552|Prestwick1_000552|Prestwick2_000552|Prestwick3_000552|Selegiline (USAN/INN)|SELEGILINE [USAN]|SELEGILINE [VANDF]|SELEGILINE [WHO-DD]|SCHEMBL22232|US8633208, Deprenyl|BSPBio_000623|BSPBio_001589|SPBio_002544|BPBio1_000687|GTPL6639|SELEGILINE [ORANGE BOOK]|BDBM15579|Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, (R)-|Benzeneethanamine, N,alpha-methyl-N-2-propynyl-, (alphaR)-|HMS1791P11|HMS1989P11|HMS2089D09|HMS3402P11|STK640578|AKOS000281115|DB01037|NCGC00024994-01|NCGC00024994-02|NCGC00024994-03|NCGC00024994-04|CS-0002918|NS00009550|C07245|D03731|EN300-4271449|(r)-(-)-n,2-dimethyl-n-2-propynylphenethylamine|BRD-K86434416-001-02-7|BRD-K86434416-003-03-1|BRD-K86434416-003-06-4|Q47495783|methyl[(2R)-1-phenylpropan-2-yl]prop-2-yn-1-ylamine|N-methyl-N-[(1R)-1-methyl-2-phenylethyl]prop-2-yn-1-amine|BENZENEETHANAMINE, N,.ALPHA.-METHYL-N-2-PROPYNYL-, (.ALPHA.R)-|102741-42-4"
CLORGILINE,4380,,"InChI=1S/C13H15Cl2NO/c1-3-7-16(2)8-4-9-17-13-6-5-11(14)10-12(13)15/h1,5-6,10H,4,7-9H2,2H3",BTFHLQRNAMSNLC-UHFFFAOYSA-N,C13H15Cl2NO,272.17,"3-(2,4-dichlorophenoxy)-N-methyl-N-prop-2-ynylpropan-1-amine","Clorgiline|CLORGYLINE|17780-72-2|Chlorgyline|Clorgilina|Clorgilinum|M and B 9302|M & B 9302|N-(3-(2,4-Dichlorophenoxy)propyl)-N-methyl-2-propynylamine|M&B 9302|LYJ16FZU9Q|CHEBI:3763|N-(3-(2,4-dichlorophenoxy)propyl)-N-methylprop-2-yn-1-amine|DTXSID3048445|2-Propyn-1-amine, N-(3-(2,4-dichlorophenoxy)propyl)-N-methyl-|Clorgilin|N-[3-(2,4-dichlorophenoxy)propyl]-N-methylprop-2-yn-1-amine|M&B-9302|RefChem:127097|DTXCID9028419|Clorgiline [INN]|n-methyl-n-propargyl-3-(2,4-dichlorophenoxy)propylamine|Clorgiline (INN)|CHEMBL8706|2-Propynylamine, N-(3-(2,4-dichlorophenoxy)propyl)-N-methyl-|Clorgilinum [INN-Latin]|Clorgilina [INN-Spanish]|2-Propyn-1-amine, N-(3-(2,4-dichlorophenoxy)propyl)-N-methyl- (9CI)|UNII-LYJ16FZU9Q|CAS-17780-75-5|BRN 1976758|3-(2,4-dichlorophenoxy)-N-methyl-N-prop-2-ynylpropan-1-amine|Clorgiline [INN:BAN]|Prestwick0_000344|Prestwick1_000344|Prestwick2_000344|Prestwick3_000344|Lopac-M-3778|Lopac0_000746|SCHEMBL61914|BSPBio_000407|US8633208, Clorgyline|SPBio_002328|BPBio1_000449|GTPL6636|orb1739274|SCHEMBL29489102|SCHEMBL29489103|BDBM15581|EX-A10906|CCG-204831|DB04017|SDCCGSBI-0050724.P003|NCGC00015669-01|NCGC00015669-02|NCGC00015669-03|NCGC00015669-04|NCGC00015669-11|NCGC00162235-01|AS-85980|HY-14197|SBI-0050724.P002|DB-266520|CS-0002917|NS00071662|D03248|L001342|Q2889652|BRD-K73251053-003-03-2|BRD-K73251053-003-13-1|BRD-K73251053-003-21-4|BRD-K73251053-003-22-2|[3-(2,4-Dichloro-phenoxy)-propyl]-methyl-prop-2-ynyl-amine|[3-(2,4-dichlorophenoxy)propyl](methyl)prop-2-yn-1-ylamine|N-[3-(2,4-dichlorophenoxy)propyl]-N-methyl-2-propyn-1-amine|N-[3-(2,4-dichlorophenoxy)propyl]-N-methyl-prop-2-yn-1-amine|3-(2,4-dichlorophenoxy)-N-methyl-N-prop-2-ynyl-propan-1-amine|CLG"
RIVASTIGMINE TARTRATE,6918078,,"InChI=1S/C14H22N2O2.C4H6O6/c1-6-16(5)14(17)18-13-9-7-8-12(10-13)11(2)15(3)4;5-1(3(7)8)2(6)4(9)10/h7-11H,6H2,1-5H3;1-2,5-6H,(H,7,8)(H,9,10)/t11-;1-,2-/m01/s1",GWHQHAUAXRMMOT-MBANBULQSA-N,C18H28N2O8,400.4,"(2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate","Rivastigmine tartrate|129101-54-8|Rivastigmine Hydrogen Tartrate|ENA 713|Rivastigmine bitartrate|SDZ-ENA 713|Rivastigmine hydrogentartrate|Rivastigmine actavis|9IY2357JPE|CHEBI:64358|Carbamic acid, N-ethyl-N-methyl-, 3-[(1S)-1-(dimethylamino)ethyl]phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)|CARBAMIC ACID, N-ETHYL-N-METHYL-, 3-((1S)-1-(DIMETHYLAMINO)ETHYL)PHENYL ESTER, (2R,3R)-2,3-DIHYDROXYBUTANEDIOATE (1:1)|DTXCID4027818|RefChem:56915|Carbamic Acid, Ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl Ester,(2R,3R)-2,3-dihydroxybutanedioate(1:1)|DTXSID8047840|ENA-713|Rivastigmine (tartrate)|(S)-3-(1-(Dimethylamino)ethyl)phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxysuccinate|Rivastigmine Tartrate Salt|MFCD03700731|Rivastigmine L-Tartrate|Rivastigmine tartrate (Exelon)|(2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methylcarbamate|(2R,3R)-2,3-dihydroxybutanedioic acid 3-[(1S)-1-(dimethylamino)ethyl]phenyl N-ethyl-N-methylcarbamate|UNII-9IY2357JPE|Rivastach|Exelon MR|Exelon TDS|Nimvastid (TN)|Rivastigmine tartrate [USP]|MLS006011143|orb1307975|CHEMBL1201092|SCHEMBL29779663|GWHQHAUAXRMMOT-MBANBULQSA-N|HMS3678F17|HMS3884H05|Rivastigmine for system suitability|MSK11245|Rivastigmine (tartrate) (Standard)|HY-11017R|RIVASTIGMINE TARTRATE [VANDF]|s2087|AKOS022179413|RIVASTIGMINE TARTRATE [USP-RS]|AC-3487|CCG-213410|CS-0947|FR15395|T01R548|AS-13921|BR164357|Carbamic acid, ethylmethyl-, 3-((1S)-1-(dimethylamino)ethyl)phenyl ester, (2R,3R)-2,3-dihydroxybutanedioate (1:1)|DA-67229|HY-11017|Rivastigmine tartrate - Bio-X trade mark|SMR004702920|RIVASTIGMINE (AS HYDROGEN TARTRATE)|RIVASTIGMINE HYDROGEN TARTRATE [MI]|RIVASTIGMINE TARTRATE [ORANGE BOOK]|R0093|RIVASTIGMINE TARTRATE [USP MONOGRAPH]|SW199663-2|RIVASTIGMINE HYDROGEN TARTRATE [MART.]|D02558|RIVASTIGMINE HYDROGEN TARTRATE [WHO-DD]|RIVASTIGMINE HYDROGEN TARTRATE [EMA EPAR]|RIVASTIGMINE HYDROGEN TARTRATE [EP MONOGRAPH]|Q27133236|3-[(S)-1-(Dimethylamino)ethyl]phenyl N-Ethyl-N-methylcarbamate L-Tartrate|N-Ethyl-N-methylcarbamic Acid 3-[(S)-1-(Dimethylamino)ethyl]phenyl Ester L-Tartrate|(1S)-1-(3-{[ethyl(methyl)carbamoyl]oxy}phenyl)-N,N-dimethylethanaminium (2R,3R)-3-carboxy-2,3-dihydroxypropanoate|(2R,3R)-2,3-dihydroxybutanedioic acid;[3-[(1S)-1-(dimethylamino)ethyl]phenyl] N-ethyl-N-methyl-carbamate|3-[(1S)-1-(dimethylamino)ethyl]phenyl ethyl(methyl)carbamate (2R,3R)-2,3-dihydroxybutanedioate"
PITOLISANT,9948102,,"InChI=1S/C17H26ClNO/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19/h7-10H,1-6,11-15H2",NNACHAUCXXVJSP-UHFFFAOYSA-N,C17H26ClNO,295.8,1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine,"Pitolisant|362665-56-3|TIPROLISANT|1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine|BF2.649|1-(3-(3-(4-Chlorophenyl)propoxy)propyl)piperidine|HBS-101|4BC83L4PIY|1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine|BF-2649|BF-2.649|DTXSID30957654|pitolisantum|Wakix, europe|RefChem:57771|DTXCID60207876|N07XX11|Pitolisant (BF2.649)|wakix|Piperidine, 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-|MFCD18782650|CHEMBL462605|3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether|Wakix (TN)|1-[3-[3-(4-Chlorophenyl)propoxy]propyl]-piperidinehydrochloride|Pitolisant [INN]|UNII-4BC83L4PIY|Tirolisant|Ozawade|PIPERIDINE, 1-(3-(3-(4-CHLOROPHENYL)PROPOXY)PROPYL)-|Piperidine, 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-; 1-[3-[3-(4-Chlorophenyl)propoxy]propyl]piperidine; 3-(4-Chlorophenyl)propyl 3-piperidinopropyl ether; Pitolisant|Ozawade (TN)|tiprolisant [USAN]|PITOLISANT [MI]|Pitolisant (USAN/INN)|Pitolisant [USAN:INN]|PITOLISANT [USAN]|PITOLISANT [WHO-DD]|SCHEMBL117648|GTPL8924|orb1909012|CHEBI:134709|NNACHAUCXXVJSP-UHFFFAOYSA-N|HMS3743C05|BCP13114|EX-A3601|BDBM50247053|AKOS028108820|CS-0666|DB11642|SB17037|NCGC00370823-03|AS-57273|FP168175|HY-12199|DB-115766|NS00072045|A11279|D10749|BF2649; BF-2649; BF 2649; Pitolisant|EN300-7385525|Q426044|1-[3-[3-(4-chlorophenyl)propoxy]propyl]-piperidine|BRD-K21673112-003-01-3"
GALANTAMINE HYDROBROMIDE,121587,,"InChI=1S/C17H21NO3.BrH/c1-18-8-7-17-6-5-12(19)9-14(17)21-16-13(20-2)4-3-11(10-18)15(16)17;/h3-6,12,14,19H,7-10H2,1-2H3;1H/t12-,14-,17-;/m0./s1",QORVDGQLPPAFRS-XPSHAMGMSA-N,C17H22BrNO3,368.3,"(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;hydrobromide","Galanthamine hydrobromide|Galantamine hydrobromide|1953-04-4|Nivaline|Nivalin|Lycoremine hydrobromide|Jilkon hydrobromide|Tamilin|(-)-Galantamine Hydrobromide|MJ4PTD2VVW|Razadyne ER|6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide (1:1), (4aS,6R,8aS)-|6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide (1:1), (4aS,6R,8aS)-|RefChem:56717|DTXCID001473878|Benzofuro(4,3,2-efg)(2)benzazocin-6-ol, 1,2,3,4,6,7,7a,11c-octahydro-9-methoxy-2-methyl-, hydrobromide|217-780-5|DTXSID4052768|Razadyne|MFCD00067672|Galanthamine (hydrobromide)|193146-85-9|Jilcon hydrobromide|(4aS,6R,8aS)-4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol Hydrobromide|Galanthamine HBr|(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;hydrobromide|5N4SA4KQX9|(+/-)-Galantamine hydrobromide|(+/-)-Galanthamine hydrobromide|Galantamine hydrobromide (racemic)|Galantamine hydrobromide, (+/-)-|Galanthamine-O-methyl-d3 Hydrobromide|Reminyl (TN)|rac Galanthamine Hydrobromide|(1S,12S,14R)-9-Methoxy-4-methyl-11-oxa-4-azoniatetracyclo[8.6.1.01,12.06,17]heptadeca-6(17),7,9,15-tetraen-14-ol;bromide|(4aS,6R,8aS)-3-methoxy-11-methyl-4a,5,9,10,11,12-hexahydro-6H-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol hydrobromide|1953-04-4 (HBr); 1953-04-4 (free base).|(1S,12S,14R)-9-methoxy-4-methyl-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-14-ol hydrobromide|6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide (1:1), (4aR,6S,8aR)-rel-|SMR000449267|Galanthamine hydrobromide from Lycoris sp.|SR-01000597844|Nivaline (pharmaceutical)|anti-Alzheimer|SR-05000001783|Nivalin;Razadyne|Galantamine hydrobromide [USAN]|Razadyne (TN)|Prestwick_236|EINECS 217-780-5|galanthamine  bromide|UNII-MJ4PTD2VVW|UNII-5N4SA4KQX9|1953-04-4 unlabeled|CHEMBL1555|Galanthamine-d3 Hydrobromide|MLS000758283|MLS001401401|SCHEMBL177993|SPECTRUM1501202|SCHEMBL29519916|HY-A0009R|MSK10278X|CHEBI:180473|GLXC-03041|HMS1569F18|HMS1921P21|HY-A0009|Galantamine hydrobromide (JAN/USP)|AC-469|CCG-38829|GALANTAMINE HYDROBROMIDE [MI]|Galantamine hydrobromide [USAN:USP]|s1339|GALANTAMINE HYDROBROMIDE [JAN]|AKOS007930166|AKOS015960209|CS-0378|FD10095|FH15701|GALANTAMINE HYDROBROMIDE [HSDB]|Galanthamine (hydrobromide) (Standard)|NC00061|GALANTAMINE HYDROBROMIDE [MART.]|GALANTAMINE HYDROBROMIDE [VANDF]|GALANTAMINE HYDROBROMIDE [USP-RS]|GALANTAMINE HYDROBROMIDE [WHO-DD]|AS-12155|GP-37267|G0293|NS00081782|GALANTAMINE HYDROBROMIDE [ORANGE BOOK]|D02173|EN300-123969|GALANTAMINE HYDROBROMIDE [EP MONOGRAPH]|GALANTAMINE HYDROBROMIDE [USP MONOGRAPH]|GALANTAMINE HYDROBROMIDE RACEMIC [USP-RS]|953G044|R-113675|SR-01000597844-1|SR-01000597844-5|SR-05000001783-3|Q47495772|Z1557400300|Galanthamine hydrobromide from Lycoris sp., >=94% (TLC)|(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-benzo[2,3]benzofuro[4,3-cd]azepin-6-ol hydrobromide|(4aS,6R,8aS)-3-Methoxy-11-methyl-5,6,9,10,11,12-hexahydro-4aH-benzo[2,3]benzofuro[4,3-cd]azepin-6-olhydrobromide|(4aS,6R,8aS)-4a,5,9,10,11,12-hexahydro-3-methoxy-d3-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol Hydrobromide|4a,5,9,10,11,12-Hexahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol hydrobromide;Galantamine hydrobromide|6H-BENZOFURO(3A,3,2-EF)(2)BENZAZEPIN-6-OL, 4A,5,9,10,11,12-HEXAHYDRO-3-METHOXY-11-METHYL-, HYDROBROMIDE, (4A.ALPHA.,6.BETA.,8AR*)-|6H-Benzofuro(3a,3,2-ef)(2)benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide, (4aalpha,6beta,8ar*)-|6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide, (4aR,6S,8aR)-rel- (9CI); 6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide, (4aa,6ss,8aR*)-; (+/-)-Galantamine hydrobromide; (+/-)-Galanthamine hydrobromide; rac-Galantamine Hydrobromide|6H-Benzofuro[3a,3,2-ef][2]benzazepin-6-ol, 4a,5,9,10,11,12-hexahydro-3-methoxy-11-methyl-, hydrobromide, (4aS,6R,8aS)-"
BERBERINE,2353,,"InChI=1S/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+1",YBHILYKTIRIUTE-UHFFFAOYSA-N,C20H18NO4+,336.4,"16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene","berberine|2086-83-1|Umbellatine|Berberin|Berbericine|Majarine|Thalsine|Umbellatin|Berberone|Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy-|0I8Y3P32UF|DTXSID9043857|CHEBI:16118|Benzo(g)-1,3-benzodioxolo(5,6-a)quinolizinium, 5,6-dihydro-9,10-dimethoxy-|16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo[11.8.0.02,10.04,8.015,20]henicosa-1(13),2,4(8),9,14,16,18,20-octaene|9,10-dimethoxy-5,6-dihydro[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ium|5,6-DIHYDRO-9,10-DIMETHOXY-1,3-BENZODIOXOLO(5,6-A)BENZO(G)QUINOLIZINIUM|9,10-DIMETHOXY-5,6-DIHYDRO(1,3)DIOXOLO(4,5-G)ISOQUINO(3,2-A)ISOQUINOLIN-7-IUM|16,17-dimethoxy-5,7-dioxa-13$l^(5)-azapentacyclo(11.8.0.0^(2,10).0^(4,8).0^(15,20))henicosa-1(13),2,4(8),9,14,16,18,20-octaen-13-ylium|16,17-dimethoxy-5,7-dioxa-13$l^{5}-azapentacyclo[11.8.0.0^{2,10}.0^{4,8}.0^{15,20}]henicosa-1(13),2,4(8),9,14,16,18,20-octaen-13-ylium|16,17-dimethoxy-5,7-dioxa-13-azoniapentacyclo(11.8.0.02,10.04,8.015,20)henicosa-1(13),2,4(8),9,14,16,18,20-octaene|RefChem:5599|DTXCID7023857|218-229-1|9,10-Dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium|MFCD01175817|Berberal|ST055798|9,10-Dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetrahydroberbinium|CHEMBL12089|GNF-PF-4545|BER|NSC646666|NCGC00016526-02|NCGC00016526-07|CAS-633-65-8|Berbinium|berberine dimer|Coptis rhizome|Berberinechloride|C20H18NO4|EINECS 218-229-1|Umbellatine (6CI)|BRN 3570374|Spectrum_001110|Berbinium, 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(methylenedioxy)-, chloride|BERBERINE [MI]|Prestwick0_000586|Prestwick1_000586|Prestwick2_000586|Prestwick3_000586|Spectrum2_000894|Spectrum3_000618|Spectrum4_000785|Spectrum5_001458|BERBERINE [VANDF]|BERBERINE [MART.]|UPCMLD-DP032|NCIMech_000354|BERBERINE [WHO-DD]|UNII-0I8Y3P32UF|SCHEMBL25632|BSPBio_000432|BSPBio_002156|KBioGR_001230|KBioSS_001590|cid_12456|DivK1c_000265|inverted exclamation markY97%|SPBio_000708|SPBio_002651|BPBio1_000476|CHEMBL295124|MEGxp0_001923|orb1302341|SCHEMBL29354144|SCHEMBL30153843|UPCMLD-DP032:001|ACon1_001957|BCBcMAP01_000112|GTPL11353|KBio1_000265|KBio2_001590|KBio2_004158|KBio2_006726|KBio3_001656|NINDS_000265|34MD1011DM|HMS3561D13|HMS5086K15|HY-N0716|AC-117|BBL029198|BDBM50203126|CCG-35898|s9046|STK870320|7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(methylenedioxy)berbinium|AKOS002141363|DB04115|SDCCGMLS-0066718.P001|9,10-Dimethoxy-5,6-dihydro-[1,3]dioxolo-[4,5-g]isoquinolino[3,2-a]isoquinolin-7-ium|BERBINIUM, 7,8,13,13a-TETRAHYDRO-9,10-DIMETHOXY-2,3-(METHYLENEDIOXY)-|IDI1_000265|SMP1_000298|NCGC00016526-01|NCGC00016526-03|NCGC00016526-04|NCGC00016526-05|NCGC00016526-06|NCGC00016526-08|NCGC00016526-11|NCGC00016526-13|NCGC00091896-03|NCI60_001050|NCI60_001224|NCI60_004319|SY232626|SBI-0051613.P002|DB-050153|CS-0009734|NS00009669|C00757|086B831|Q176525|BERBERINE (CONSTITUENT OF GOLDENSEAL) [DSC]|SR-01000711827-5|BRD-K14796088-003-06-0|BRD-K14796088-003-17-7|BRD-K14796088-003-25-0|BRD-K14796088-003-26-8|5,6-dihydro-9,10-dimethoxy-benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium|7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-[methylenebis(oxy)]berbinium|9,10-dimethoxy-2,3-(methylenedioxy)-7,8,13,13a-tetradehydroberbinium|Berbinium, 7,8,13,13a-tetradehydro-9,10-dimethoxy-2,3-(methylenedioxy)-|3,4-dimethoxy-6,7-dihydro-[1,3]dioxolo[4,5-g]pyrido[2,1-a]isoquinolin-5-ylium|5,6-DIHYDRO-9,10-DIMETHOXYBENZO(G)-1,3-BENZODIOXOLO(5,6-A)QUINOLIZINIUM|9,10-Dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ylium|9,10-dimethoxy-5,6-dihydro-2H-1,3-dioxoleno[4,5-g]isoquinolino[3,2-a]isoquinol ine|9,10-Dimethoxy-5,6-dihydro-7lambda~5~-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinoline|Benzo[g]-1,3-benzodioxolo[5,6-a]quinolizinium, 5,6-dihydro-9,10-dimethoxy- (9CI)|9,10-Dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ylium chloride|9,10-Dimethoxy-5,6-dihydro-[1,3]dioxolo[4,5-g]isoquino[3,2-a]isoquinolin-7-ylium; chloride|InChI=1/C20H18NO4/c1-22-17-4-3-12-7-16-14-9-19-18(24-11-25-19)8-13(14)5-6-21(16)10-15(12)20(17)23-2/h3-4,7-10H,5-6,11H2,1-2H3/q+"
AMINOGLUTETHIMIDE,2145,,"InChI=1S/C13H16N2O2/c1-2-13(8-7-11(16)15-12(13)17)9-3-5-10(14)6-4-9/h3-6H,2,7-8,14H2,1H3,(H,15,16,17)",ROBVIMPUHSLWNV-UHFFFAOYSA-N,C13H16N2O2,232.28,"3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione","aminoglutethimide|125-84-8|dl-Aminoglutethimide|Cytadren|Orimeten|p-Aminoglutethimide|Elipten|3-(4-aminophenyl)-3-ethylpiperidine-2,6-dione|Aminoglutetimida|2,6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl-|3-(4-Aminophenyl)-3-ethyl-2,6-piperidinedione|Aminoglutethimidum|2-(p-Aminophenyl)-2-ethylglutarimide|Ba-16038|Aminoglutetimide|3-Ethyl-3-(p-aminophenyl)-2,6-dioxopiperidine|NSC-330915|DTXSID8022589|CHEBI:2654|0O54ZQ14I9|alpha-(p-Aminophenyl)-alpha-ethylglutarimide|DTXCID202589|NSC330915|Aminoblastin|Mamomit|Orimenten|Orimetene|Rodazol|RefChem:57317|alpha-(4-Aminophenyl)-alpha-ethylglutarimide|204-756-4|MFCD00010122|Glutethimide, para-amino|3-(4-aminophenyl)-3-ethyl-piperidine-2,6-dione|AG-1|Glutarimide, 2-(p-aminophenyl)-2-ethyl-|CHEMBL488|(+/-)-p-AMINOGLUTETHIMIDE|.alpha.-(p-Aminophenyl)-.alpha.-ethylglutarimide|(RS)-2-(4-Amino-phenyl)-2-ethyl-glutarimide;(RS)-3-(4-Amino-phenyl)-3-ethyl-2,6-dioxo-piperidine|Aminoglutethimidum [INN-Latin]|Aminoglutetimida [INN-Spanish]|Ba 16038|Cytadren (TN)|SMR000326785|C 16038-BA|CCRIS 7562|aminoglutethimide (AG)|SR-01000075596|3-(4-Aminophenyl)-3-ethyl-2,6-piperidindion|EINECS 204-756-4|BRN 0210656|Aminoglutethimide (USP/INN)|UNII-0O54ZQ14I9|HSDB 7494|3-(p-Aminophenyl)-3-ethylpiperidine-2,6-dione|Aminoglutethimide [USP:INN:BAN]|NCGC00016379-01|CAS-125-84-8|Prestwick_243|Spectrum_000040|(y)-p-Aminoglutethimide|Aminoglutethimide AG, 4|(?)-p-Aminoglutethimide|Prestwick0_000244|Prestwick1_000244|Prestwick2_000244|Prestwick3_000244|Spectrum2_000093|Spectrum3_000296|Spectrum4_000144|Spectrum5_000802|A 9657|SCHEMBL4306|Aminoglutethimide (Cytadren)|Lopac0_000124|BSPBio_000028|BSPBio_001832|KBioGR_000588|KBioSS_000400|(A+/-)-p-Aminoglutethimide|MLS000859924|MLS001213216|AMINOGLUTETHIMIDE [MI]|DivK1c_000884|SPECTRUM1500115|SPBio_000046|SPBio_002247|AMINOGLUTETHIMIDE [INN]|BDBM9460|BPBio1_000032|GTPL7054|orb1309763|AMINOGLUTETHIMIDE [HSDB]|AMINOGLUTETHIMIDE [VANDF]|HMS502M06|KBio1_000884|KBio2_000400|KBio2_002968|KBio2_005536|KBio3_001332|AMINOGLUTETHIMIDE [MART.]|NINDS_000884|AMINOGLUTETHIMIDE [WHO-DD]|HMS1568B10|HMS1920C09|HMS2090I05|HMS2091I09|HMS2095B10|HMS2231M19|HMS3259H10|HMS3260I10|HMS3372M07|HMS3655O17|HMS3712B10|Pharmakon1600-01500115|BCP28501|HY-B0237|2, 3-(4-aminophenyl)-3-ethyl-|Tox21_110406|Tox21_303497|Tox21_500124|BBL010961|CCG-38911|NSC755868|SBB000711|STK802074|Aminoglutethimide - Bio-X trade mark|AKOS004120070|AKOS022060651|Tox21_110406_1|AMINOGLUTETHIMIDE [EP IMPURITY]|AMINOGLUTETHIMIDE [ORANGE BOOK]|DB00357|FA17754|LP00124|NC00714|NSC 330915|NSC 755868|NSC-755868|PB48252|SDCCGSBI-0050112.P005|AMINOGLUTETHIMIDE [EP MONOGRAPH]|AMINOGLUTETHIMIDE [USP IMPURITY]|IDI1_000884|SMP1_000017|NCGC00015110-02|NCGC00015110-03|NCGC00015110-04|NCGC00015110-05|NCGC00015110-06|NCGC00015110-07|NCGC00015110-09|NCGC00015110-12|NCGC00015110-21|NCGC00093615-01|NCGC00093615-02|NCGC00093615-03|NCGC00093615-04|NCGC00093615-05|NCGC00257263-01|NCGC00260809-01|AC-12456|AS-13282|BA164155|NCI60_002900|SBI-0050112.P004|DB-021640|DB-072002|DB-072275|A1947|AB00051935|EU-0100124|NS00010649|S1672|SW196550-3|( inverted question mark)-p-Aminoglutethimide|EN300-53368|VU0243029-3|C07617|D00574|D88489|AB00051935-09|AB00051935-11|AB00051935_12|AB00051935_13|125A848|Q241150|3-(4-aminophenyl)-3-ethylazaperhydroine-2,6-dione|SR-01000075596-1|SR-01000075596-4|SR-01000075596-6|BRD-A25234499-001-05-0|BRD-A25234499-001-09-2|BRD-A25234499-001-17-5|BRD-A25234499-001-18-3|BRD-A25234499-001-19-1|Z800191876|Aminoglutethimide, European Pharmacopoeia (EP) Reference Standard|Aminoglutethimide, United States Pharmacopeia (USP) Reference Standard"
VORINOSTAT,5311,,"InChI=1S/C14H20N2O3/c17-13(15-12-8-4-3-5-9-12)10-6-1-2-7-11-14(18)16-19/h3-5,8-9,19H,1-2,6-7,10-11H2,(H,15,17)(H,16,18)",WAEXFXRVDQXREF-UHFFFAOYSA-N,C14H20N2O3,264.32,N'-hydroxy-N-phenyloctanediamide,"Vorinostat|149647-78-9|SAHA|suberoylanilide hydroxamic acid|N-hydroxy-N'-phenyloctanediamide|Zolinza|N1-hydroxy-N8-phenyloctanediamide|Suberanilohydroxamic acid|MK-0683|MK0683|Octanediamide, N-hydroxy-N'-phenyl-|N'-hydroxy-N-phenyloctanediamide|OCTANEDIOIC ACID HYDROXYAMIDE PHENYLAMIDE|vorinostatum|NSC-701852|NSC-748799|NSC-759852|MK 0683|58IFB293JI|DTXSID6041133|CHEBI:45716|NSC701852|DTXCID4021133|NHNPODA|suberoyl anilide hydroxamic acid|N Hydroxy N' phenyloctanediamide|N1 Hydroxy N8 phenyloctanediamide|18F-suberoylanilide hydroxamic acid|18F Suberoylanilide Hydroxamic Acid|RefChem:389361|L01XX38|MSK-390|L-001079038|682-505-1|Vorinostat (SAHA, MK0683)|MFCD00945317|CCRIS 8456|N-Hyrdroxy-N'-phenyloctanediamide|Vorinostat (SAHA)|SHH|CHEMBL98|8-(hydroxyamino)-8-oxo-N-phenyl-octanamide|WIN64652|SAHA cpd|NCGC00168085-01|NCGC00168085-02|Vorinostat [USAN]|Zolinza (TN) (Merck)|N-hydroxy-N'-phenyl-octane-1,8-diotic acid diamide|Vorinostat MSD|SMR000486344|Zolinza (TN)|CAS-149647-78-9|SR-05000000373|Vorinostat (JAN/USAN)|Vorinostat [USAN:INN]|UNII-58IFB293JI|SKI390|HSDB 7930|4lxz|Vorinostat(SAHA)|Zolinza; SAHA|Vorinostat (GMP)|SAHA, Suberoylanilide hydroxamic acid|Vorinostat (SAHA)?|Vorinostat (Standard)|1zz1|VORINOSTAT [MI]|SW-064652|VORINOSTAT [INN]|VORINOSTAT [JAN]|VORINOSTAT [VANDF]|cid_5311|SCHEMBL9018|VORINOSTAT [MART.]|VORINOSTAT [WHO-DD]|Suberoylanilidehydroxamic Acid|MLS001065855|MLS006011941|GTPL6852|orb1308090|VORINOSTAT [ORANGE BOOK]|BDBM19149|Vorinostat  - Bio-X trade mark|Vorinostat (SAHA; MK0683)|n-hydroxy-n'-phenyl-octanediamide|SUBERANILOHYDROXAMINIC ACID|1t69|N-hydroxy-N''-phenyloctanediamide|BCPP000018|GLXC-05791|HMS2219L20|HMS3264D20|HMS3327C12|HMS3426G03|HMS3650D09|HMS3654G11|HMS3715E22|HMS3745M03|HMS5079I07|HMS6019F05|Pharmakon1600-01502267|BCP01858|EX-A2745|HVB74948|SAHA, >=98% (HPLC)|Vorinostat,SAHA,Zolinza,MK-0683|Tox21_112605|Tox21_113623|Vorinostat,CAS:149647-78-9|HB1396|HY-10221G|HY-10221R|NSC748799|NSC759852|Octanediamide, N1-hydroxy-N8-phenyl|s1047|SK1390|AKOS015966648|Tox21_112605_1|AC-1923|CCG-208659|CS-0589|DB02546|DG-0025|FH15949|NSC 701852|NSC 748799|NSC 759852|SB17319|NCGC00168085-03|NCGC00168085-04|NCGC00168085-05|NCGC00168085-13|BP-25652|BP-30216|BV164560|HY-10221|SY009383|H1388|NS00068618|SW199536-4|D06320|EN300-120641|M06303|N-Hydroxy-N'-phenyl-octanediamide;Zolinza;SAHA|AB00375377-07|AB00375377-08|AB00375377-09|AB01644613_25|647S789|Q905901|Vorinostat, SAHA, suberoylanilide hydroxamic acid|SR-05000000373-2|SR-05000000373-6|SR-05000000373-8|BRD-K81418486-001-01-2|BRD-K81418486-001-10-3|BRD-K81418486-001-12-9|BRD-K81418486-001-13-7|BRD-K81418486-001-17-8|BRD-K81418486-001-18-6|BRD-K81418486-001-44-2|BRD-K81418486-001-47-5|Z1530532755|N-Hydroxy-N inverted exclamation mark -phenyloctanediamide|N-Hydroxy-N'-phenyl-octanediamide; Suberoylanilide hydroxamic acid; SAHA|1227736-21-1"
ENTINOSTAT,4261,,"InChI=1S/C21H20N4O3/c22-18-5-1-2-6-19(18)25-20(26)17-9-7-15(8-10-17)13-24-21(27)28-14-16-4-3-11-23-12-16/h1-12H,13-14,22H2,(H,24,27)(H,25,26)",INVTYAOGFAGBOE-UHFFFAOYSA-N,C21H20N4O3,376.4,pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate,"Entinostat|209783-80-2|ms-275|SNDX-275|MS 275|MS-27-275|SNDX 275|MS 27-275|entinostatum|1ZNY4FKK9H|BAY 86-5274|Carbamic acid, N-[[4-[[(2-aminophenyl)amino]carbonyl]phenyl]methyl]-, 3-pyridinylmethyl ester|N-(2-aminophenyl)-4-(N-(pyridin-3-ylmethoxycarbonyl)aminomethyl)benzamide|pyridin-3-ylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate|NSC706995|BAY86-5274|MS-275-27|DTXSID0041068|CHEBI:132082|pyridin-3-ylmethyl N-({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate|N-[[4-[(2-aminoanilino)-oxomethyl]phenyl]methyl]carbamic acid 3-pyridinylmethyl ester|N-(2-aminophenyl)-4-[N-(pyridin-3-ylmethoxycarbonyl)aminomethyl]benzamide|pyridin-3-ylmethyl N-((4-((2-aminophenyl)carbamoyl)phenyl)methyl)carbamate|(pyridin-3-yl)methyl N-((4-((2-aminophenyl)carbamoyl)phenyl)methyl)carbamate|(pyridin-3-yl)methyl N-({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate|N-((4-((2-aminoanilino)-oxomethyl)phenyl)methyl)carbamic acid 3-pyridinylmethyl ester|CARBAMIC ACID, N-((4-(((2-AMINOPHENYL)AMINO)CARBONYL)PHENYL)METHYL)-, 3-PYRIDINYLMETHYL ESTER|RefChem:590863|HDAC inhibitor SNDX-275|DTXCID8021068|L01XX64|N-(2-Aminophenyl)-4-(N-(pyridin-3-yl-methoxycarbonyl)aminomethyl)b enzamide|630-693-0|Carbamic acid, ((4-(((2-aminophenyl)amino)carbonyl)phenyl) methyl)-, 3-pyridinylmethyl ester|Entinostat (MS-275)|pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate|MFCD08272435|CHEMBL27759|pyridin-3-ylmethyl {4-[(2-aminophenyl)carbamoyl]benzyl}carbamate|NSC-706995|pyridin-3-ylmethyl 4-(2-aminophenylcarbamoyl)benzylcarbamate|3-pyridylmethyl N-[[4-[(2-aminophenyl)carbamoyl]phenyl]methyl]carbamate|Carbamic acid, N-((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3- pyridinylmethyl ester|Entinostat(MS-27-275)|pyridin-3-ylmethyl 4-((2-aminophenyl)carbamoyl)benzylcarbamate.|Entinostat, free base|ENTINOSTAT [INN]|ENTINOSTAT [JAN]|Entinostat [USAN:INN]|UNII-1ZNY4FKK9H|ENTINOSTAT [USAN]|3-Pyridinylmethyl ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)carbamate|Entinostat (MS-275)?|benzamide-type inhibitor, 3|Carbamic acid, ((4-(((2-aminophenyl)amino)carbonyl)phenyl)methyl)-, 3-pyridinylmethyl ester|ENTINOSTAT [WHO-DD]|MLS006010183|Entinostat (JAN/USAN/INN)|SCHEMBL148309|Entinostat (MS-27-275)|GTPL7007|orb1300954|SCHEMBL29387345|SCHEMBL29499905|SCHEMBL29838042|BDBM19410|EX-A038|BCPP000155|GLXC-04607|HMS3426G07|HMS3648K12|HMS3654O11|HMS3744O17|HMS5079K07|BCP01824|HB3983|NSC756642|s1053|Entinostat (MS-275;SNDX-275)|[4-(2-Amino-phenylcarbamoyl)-benzyl]-carbamic acid pyridin-3-ylmethyl ester|AKOS024262667|N-(2-Aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl)aminomethyl]benzamide|AC-8968|BCP9000967|Carbamic acid, 3-pyridinylmethyl ester|CCG-208680|CS-0511|DB11841|Entinostat (MS-275, SNDX-275)|FE15194|NSC 706995|NSC-756642|SB16665|Carbamic acid, [[4-[[(2-aminophenyl)carbaonyl]phenyl]methyl]-, 3-pyridinylmethyl ester|NCGC00165833-01|NCGC00165833-02|NCGC00165833-03|NCGC00165833-04|NCGC00165833-11|NCGC00165833-13|AS-17906|BP-25653|HY-12163|NCI60_038022|SMR004458705|SY067823|MS-275, A HDAC1 and HDAC3 inhibitor|ZK 244894|E1454|NS00068485|SW219667-1|D09338|EN300-6488260|783M802|MS-275,Entinostat, SNDX-275, MS-27-275|SR-01000946382|Q1281020|SR-01000946382-1|BRD-K77908580-001-02-1|BRD-K77908580-001-04-7|BRD-K77908580-001-09-6|BRD-K77908580-001-10-4|Z2037280922|pyridin-3-ylmethyl4-((2-aminophenyl)carbamoyl)benzylcarbamate|Pyridin-3-ylmethyl ({4-[(2-aminophenyl)carbamoyl]phenyl}methyl)carbamate|N-[[4-[[(2-Aminophenyl)amino]carbonyl]phenyl]methyl]-3-pyridinylmethyl ester, carbamic acid|N-[[4-[[(2-Aminophenyl)amino]carbonyl]phenyl]methyl]carbamic acid 3-pyridinylmethyl ester;MS 27-275;MS 275"
GIVINOSTAT,9804992,,"InChI=1S/C24H27N3O4/c1-3-27(4-2)15-17-5-7-21-14-18(6-8-20(21)13-17)16-31-24(29)25-22-11-9-19(10-12-22)23(28)26-30/h5-14,30H,3-4,15-16H2,1-2H3,(H,25,29)(H,26,28)",YALNUENQHAQXEA-UHFFFAOYSA-N,C24H27N3O4,421.5,[6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate,"Givinostat|497833-27-9|Gavinostat|ITF-2357|5P60F84FBH|[6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate|DUVYZAT|DTXSID70198049|givinostatum|(6-(diethylaminomethyl)naphthalen-2-yl)methyl N-(4-(hydroxycarbamoyl)phenyl)carbamate|RefChem:143259|DTXCID50120540|ITF2357|Givinostat [INN]|Givinostat free base|UNII-5P60F84FBH|[4-[(Hydroxyamino)carbonyl]phenyl]carbamic acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester|CHEMBL1213492|497833-27-9 (free base)|(6-((diethylamino)methyl)naphthalen-2-yl)methyl (4-(hydroxycarbamoyl)phenyl)carbamate|(6-((Diethylamino)methyl)naphthalen-2-yl)methyl(4-(hydroxycarbamoyl)phenyl)carbamate|{6-[(diethylamino)methyl]naphthalen-2-yl}methyl [4-(hydroxycarbamoyl)phenyl]carbamate|4-[(Hydroxyamino)carbonyl]phenyl]carbamic acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester|Carbamic acid, (4-((hydroxyamino)carbonyl)phenyl)-, (6-((diethylamino)methyl)-2-naphthalenyl)methyl ester|Givinostat [WHO-DD]|Givinostat (USAN/INN)|GIVINOSTAT [USAN]|GTPL7490|SCHEMBL1555814|SCHEMBL29361624|CHEBI:94187|BCP29856|BDBM50105329|AKOS030526824|CS-4727|DB12645|EX-5958|[6-(diethylaminomethyl)-2-naphthyl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate|AC-31380|BCB04_000011|HY-14842|DB-310739|NS00069327|D12742|EN300-260030|G13884|833H279|Q426257|Gavinostat; ITF-2357; ITF2357; ITF 2357|BRD-K13810148-001-01-3|BRD-K13810148-311-03-2|{6-[(diethylamino)methyl]naphthalen-2-yl}methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate|Carbamic acid, N-[4-[(hydroxyamino)carbonyl]phenyl]-, [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester|Givinostat; [4-[(Hydroxyamino)carbonyl]phenyl]carbamic acid [6-[(diethylamino)methyl]-2-naphthalenyl]methyl ester|QCM"
MOCETINOSTAT,9865515,,"InChI=1S/C23H20N6O/c24-19-5-1-2-6-21(19)28-22(30)17-9-7-16(8-10-17)14-27-23-26-13-11-20(29-23)18-4-3-12-25-15-18/h1-13,15H,14,24H2,(H,28,30)(H,26,27,29)",HRNLUBSXIHFDHP-UHFFFAOYSA-N,C23H20N6O,396.4,N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide,"Mocetinostat|726169-73-9|MGCD0103|N-(2-AMINOPHENYL)-4-([[4-(PYRIDIN-3-YL)PYRIMIDIN-2-YL]AMINO]METHYL)BENZAMIDE|A6GWB8T96J|MG0103|MG-0103|N-(2-Aminophenyl)-4-((4-pyridin-3-ylpyrimidin-2-ylamino)methyl)benzamide|N-(2-aminophenyl)-4-(((4-(pyridin-3-yl)pyrimidin-2-yl)amino)methyl)benzamide|DTXSID80222945|N-(2-aminophenyl)-4-({[4-(pyridin-3-yl)pyrimidin-2-yl]amino}methyl)benzamide|Benzamide, N-(2-aminophenyl)-4-(((4-(3-pyridinyl)-2-pyrimidinyl)amino)methyl)-|n-(2-aminophenyl)-4-[(4-pyridin-3-ylpyrimidin-2-ylamino)methyl]benzamide|MG4230|MG4915|MG5206|MG-4230|MG-4915|MG-5026|mocetinostatum|RefChem:926017|DTXCID10145436|Peroxidase|MGCD-0103|9003-99-0|MGCD 0103|Mocetinostat (MGCD0103)|N-(2-aminophenyl)-4-[[(4-pyridin-3-ylpyrimidin-2-yl)amino]methyl]benzamide|MFCD10565970|Mocetinostat (MGCD-0103)|MG 0103|N-(2-aminophenyl)-4-[[[4-(3-pyridyl)pyrimidin-2-yl]amino]methyl]benzamide|CHEMBL272980|PEROXIDASE FROM HORSERADISH|726169-73-9 (free base)|Mocetinostat (USAN/INN)|Horseradish Peroxidase (HRP)|Mocetinostat [USAN]|Mocetinostat [USAN:INN]|UNII-A6GWB8T96J|MGCD0103 (Mocetinostat)|Peroxidase(POD)|MFCD00071339|Mocetinostat;Mgcd0103|Myeloperoxidase (USAN)|MGCD010,3Mocetinostat|MOCETINOSTAT [INN]|MLS006010181|MGCD0103 (Mocetinostat)?|MOCETINOSTAT [WHO-DD]|SCHEMBL157027|GTPL7008|orb1305374|SCHEMBL29454790|SCHEMBL29534132|BDBM24624|CHEBI:94525|EX-A049|BCPP000163|HMS3426I07|HMS3654K06|BCP01814|BBL102287|NSC760143|s1122|STL556086|AKOS016340325|BCP9000925|BD-0114|CCG-208763|CS-0502|DB11830|FM34131|NSC-760143|SB16666|NCGC00263182-01|NCGC00263182-02|NCGC00263182-11|AC-30281|BP-40070|HY-12164|SMR004701289|SY078174|NS00071043|SW218130-2|D09641|D09643|169M739|AU-004/43508107|Q424869|BRD-K16485616-001-01-4|BRD-K16485616-001-04-8|BRD-K16485616-001-08-9|BRD-K16485616-001-12-1|BRD-K16485616-001-13-9|N-(2-aminophenyl)-4-((4-(pyridin-3-yl)pyrimidin-2-ylamino)methyl)benzamide|N-(2-aminophenyl)-4-({[4-(3-pyridinyl)-2-pyrimidinyl]amino}methyl)benzamide|N-(2-Aminophenyl)-4-([[4-(pyridin-3-yl)pyrimidin-2-yl]amino]methyl)benzamide;MGCD0103;Mocetinostat;MGCD0103(Mocetinostat)"
RICOLINOSTAT,53340666,,"InChI=1S/C24H27N5O3/c30-22(28-32)15-9-1-2-10-16-25-23(31)19-17-26-24(27-18-19)29(20-11-5-3-6-12-20)21-13-7-4-8-14-21/h3-8,11-14,17-18,32H,1-2,9-10,15-16H2,(H,25,31)(H,28,30)",QGZYDVAGYRLSKP-UHFFFAOYSA-N,C24H27N5O3,433.5,N-[7-(hydroxyamino)-7-oxoheptyl]-2-(N-phenylanilino)pyrimidine-5-carboxamide,"1316214-52-4|Ricolinostat|ACY-1215|2-(Diphenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide|ACY-63|WKT909C62B|N-[7-(hydroxyamino)-7-oxoheptyl]-2-(N-phenylanilino)pyrimidine-5-carboxamide|DTXSID40157148|7-{[2-(DIPHENYLAMINO)PYRIMIDIN-5-YL]FORMAMIDO}-N-HYDROXYHEPTANAMIDE|2-(diphenylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]pyrimidine-5-carboxamide|ricolinostatum|7-((2-(diphenylamino)pyrimidin-5-yl)formamido)-N-hydroxyheptanamide|N-(7-(hydroxyamino)-7-oxoheptyl)-2-(N-phenylanilino)pyrimidine-5-carboxamide|RefChem:883628|DTXCID0079639|Histone Deacetylase 6 InhibitorACY-1215|Rocilinostat|Rocilinostat (ACY-1215)|MFCD22666356|2-(Diphenylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-5-pyrimidinecarboxamide|Ricolinostat (ACY-1215)|5-Pyrimidinecarboxamide, 2-(diphenylamino)-N-[7-(hydroxyamino)-7-oxoheptyl]-|5-Pyrimidinecarboxamide, 2-(diphenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)-|Ricolinostat [USAN]|Ricolinostat [USAN:INN]|UNII-WKT909C62B|Ricolinostat (USAN/INN)|RICOLINOSTAT [INN]|MLS006011181|RICOLINOSTAT [WHO-DD]|SCHEMBL574580|Ricolinostat (ACY-1215)?|GTPL7010|orb1305408|CHEMBL2364628|CHEBI:95073|EX-A139|HMS3426C09|HMS3653F17|HMS3886L21|ACY 1215|BCP06028|BDBM50439674|NSC767952|s8001|ACY 1215; ACY 63;|AKOS024259260|CCG-269054|CS-0965|DB12376|NSC-767952|SB17054|NCGC00345802-01|NCGC00345802-05|AC-30258|AS-73344|BA164806|BP-40073|HY-16026|SMR004702950|SY096614|DB-364210|NS00073045|SW219836-1|D10661|BRD-K82928847-001-04-7|Q27088553|N-[7-(hydroxyamino)-7-oxo-heptyl]-2-(N-phenylanilino)pyrimidine-5-carboxamide|Rocilinostat;2-(Diphenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide|AH4|US8609678, 2-(diphenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide [26]"
TACEDINALINE,2746,,"InChI=1S/C15H15N3O2/c1-10(19)17-12-8-6-11(7-9-12)15(20)18-14-5-3-2-4-13(14)16/h2-9H,16H2,1H3,(H,17,19)(H,18,20)",VAZAPHZUAVEOMC-UHFFFAOYSA-N,C15H15N3O2,269.30,4-acetamido-N-(2-aminophenyl)benzamide,"Tacedinaline|112522-64-2|ci-994|4-acetamido-N-(2-aminophenyl)benzamide|CI 994|Tacedinalina|N-acetyldinaline|Goe 5549|Goe-5549|PD-123654|4-(Acetylamino)-N-(2-aminophenyl)benzamide|PD 123654|C.I. 994|UMF554N5FG|CHEBI:90195|N-(2-aminophenyl)-4-acetamidobenzamide|DTXSID60150095|tacedinalinum|N-acetyl Dinaline|RefChem:890200|DTXCID8072586|GOE5549|Acetyldinaline|4-acetylamino-N-(2'-aminophenyl)benzamide|CI994 (Tacedinaline)|MFCD00866266|CI994|Tacedinaline (CI-994)|Tacedinaline [USAN:INN]|Tacedinalina [INN-Spanish]|Tacedinaline (USAN/INN)|UNII-UMF554N5FG|Tacedinaline (CI994)|CI994 (Tacedinaline)?|TACEDINALINE [INN]|TACEDINALINE [USAN]|Acetyldinaline, Tacedinaline|Benzamide, 4-(acetylamino)-N-(2-aminophenyl)-|MLS006010120|SCHEMBL144794|TACEDINALINE [WHO-DD]|CHEMBL235191|GTPL8367|orb1307262|SCHEMBL29482198|BDBM19422|EX-A224|VAZAPHZUAVEOMC-UHFFFAOYSA-N|BCPP000281|GLXC-04273|HMS3651P13|BCP02577|HB1385|s2818|AKOS015890391|BCP9000527|CCG-208757|CS-1280|DB12291|NCGC00263639-02|AC-32996|AS-19557|CI-994, >=98% (HPLC), powder|HY-50934|PD123654|SMR002530306|SY055269|4-Acetamino-N-(2'-aminophenyl)-benzamide|DB-006613|A2501|NS00068095|SW219372-1|D05988|EN300-657160|F11454|522A642|SR-01000944935|SR-01000944935-1|BRD-K52313696-001-01-6|BRD-K52313696-001-08-1|BRD-K52313696-001-12-3|Q27088920|Tacedinaline; 4-Acetylamino-N-(2'-aminophenyl)benzamide"
BISTHIANOSTAT,71468161,,"InChI=1S/C15H18N4O3S2/c20-10(19-22)3-1-2-6-16-13(21)11-12(9-4-5-9)24-15(18-11)14-17-7-8-23-14/h7-9,22H,1-6H2,(H,16,21)(H,19,20)",MVJAEZIEZVJAFM-UHFFFAOYSA-N,C15H18N4O3S2,366.5,"5-cyclopropyl-N-[5-(hydroxyamino)-5-oxopentyl]-2-(1,3-thiazol-2-yl)-1,3-thiazole-4-carboxamide",Bisthianostat|RefChem:120531|CFH367C|CFH367 C|CFH367-C|CF367|CHEMBL3287255|1408234-79-6|orb1738732|SCHEMBL15580258|BDBM50020897
QUISINOSTAT,11538455,,"InChI=1S/C21H26N6O2/c1-26-14-17(18-4-2-3-5-19(18)26)11-22-10-15-6-8-27(9-7-15)21-23-12-16(13-24-21)20(28)25-29/h2-5,12-15,22,29H,6-11H2,1H3,(H,25,28)",PAWIYAYFNXQGAP-UHFFFAOYSA-N,C21H26N6O2,394.5,N-hydroxy-2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]pyrimidine-5-carboxamide,"QUISINOSTAT|875320-29-9|JNJ-26481585|N-Hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)methyl)piperidin-1-yl)pyrimidine-5-carboxamide|JNJ26481585|9BJ85K1J8S|JNJ 26481585|N-hydroxy-2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]pyrimidine-5-carboxamide|DTXSID90236376|5-Pyrimidinecarboxamide, N-hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)methyl)-1-piperidinyl)-|quisinostatum|N-hydroxy-2-(4-(((1-methylindol-3-yl)methylamino)methyl)piperidin-1-yl)pyrimidine-5-carboxamide|N-Hydroxy-2-[4-({[(1-methyl-1H-indol-3-yl)methyl]amino}methyl)piperidin-1-yl]pyrimidine-5-carboxamide|RefChem:930503|DTXCID90158867|HDAC Inhibitor JNJ-26481585|Quisinostat (JNJ-26481585)|MFCD17010272|Quisinostat HCl|N-Hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)-methyl)piperidin-1-yl)pyrimidine-5-carboxamide|2-[4-[[(1-methylindol-3-yl)methylamino]methyl]piperidin-1-yl]-~{N}-oxidanyl-pyrimidine-5-carboxamide|JNJ-26481585-d3|Quisinostat [USAN]|Quisinostat [USAN:INN]|UNII-9BJ85K1J8S|GOK|QUISINOSTAT [INN]|Quisinostat (USAN/INN)|QUISINOSTAT [WHO-DD]|MLS006011096|GTPL7503|orb1301114|SCHEMBL2360460|CHEMBL2105763|SCHEMBL29355421|CHEBI:94771|JNJ 26481585 dihydrochloride|GLXC-03748|HMS3654M19|HMS3747E21|AKB32029|BCP01811|BDBM50105327|NSC759657|AKOS016004011|BCP9000803|CS-5065|DB12985|NSC-759657|SB16528|NCGC00346487-01|NCGC00346487-04|NCGC00346487-05|AC-27415|AS-16361|BP-40072|HY-15433|N-Hydroxy-2-(4-((((1-methyl-1H-indol-3-yl)methyl)amino)methyl)piperidin-1-yl)pyrimidine-5-carboxamid|N-hydroxy-2-(4-(((1-methyl-1H-indol-3-yl)methylamino)methyl)piperidin-1-yl)pyrimidine-5-carboxamide|SMR004702884|NS00072160|SW219796-1|D10321|Q7272620|BRD-K83837640-001-01-4|BRD-K83837640-001-04-8|2-[4-[[(1-methylindol-3-yl)methylamino]methyl]-1-piperidyl]pyrimidine-5-carbohydroxamic acid|N-hydroxy-2-(4-(((1-methyl-1H-indol-3-yl)methylamino)methyl)piperidin-1-yl)pyrimidine-5-carboxamide dihydrochloride"
FIMEPINOSTAT,54575456,,"InChI=1S/C23H24N8O4S/c1-30(23-25-11-15(12-26-23)22(32)29-33)13-16-9-17-19(36-16)21(31-5-7-35-8-6-31)28-20(27-17)14-3-4-18(34-2)24-10-14/h3-4,9-12,33H,5-8,13H2,1-2H3,(H,29,32)",JOWXJLIFIIOYMS-UHFFFAOYSA-N,C23H24N8O4S,508.6,"N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide","CUDC-907|Fimepinostat|1339928-25-4|CUDC907|CUDC 907|N-hydroxy-2-[[2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl-methylamino]pyrimidine-5-carboxamide|3S9RX35S5X|DTXSID90712307|PI3K/HDAC INHIBITOR CUDC-907|5-PYRIMIDINECARBOXAMIDE, N-HYDROXY-2-(((2-(6-METHOXY-3-PYRIDINYL)-4-(4-MORPHOLINYL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)METHYLAMINO)-|N-Hydroxy-2-[{[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino]pyrimidine-5-carboxamide|fimepinostatum|5-pyrimidinecarboxamide, N-hydroxy-2-[[[2-(6-methoxy-3-pyridinyl)-4-(4-morpholinyl)thieno[3,2-d]pyrimidin-6-yl]methyl]methylamino]-|N-HYDROXY-2-(((2-(6-METHOXYPYRIDIN-3-YL)-4-(MORPHOLIN-4-YL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)(METHYL)AMINO)PYRIMIDINE-5-CARBOXAMIDE|N-hydroxy-2-((2-(6-methoxypyridin-3-yl)-4-morpholin-4-ylthieno(3,2-d)pyrimidin-6-yl)methyl-methylamino)pyrimidine-5-carboxamide|N-hydroxy-2-({[2-(6-methoxypyridin-3-yl)-4-(morpholin-4-yl)thieno[3,2-d]pyrimidin-6-yl]methyl}(methyl)amino)pyrimidine-5-carboxamide|RefChem:599212|DTXCID00663053|PI3K/HDAC Inhibitor|N-hydroxy-2-(((2-(6-methoxypyridin-3-yl)-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)(methyl)amino)pyrimidine-5-carboxamide|Fimepinostat [USAN]|MFCD22420823|CHEMBL3622533|PI3K/HDAC Inhibitor centn|UNII-3S9RX35S5X|C23H24N8O4S|Fimepinostat (USAN/INN)|FIMEPINOSTAT [INN]|Fimepinostat (CUDC-907)|MLS006010994|FIMEPINOSTAT [WHO-DD]|GTPL8952|orb1306535|SCHEMBL1284705|SCHEMBL29353052|SCHEMBL29493089|EX-A742|JOWXJLIFIIOYMS-UHFFFAOYSA-N|GLXC-05006|HMS3656H04|HMS3673E03|BCP06870|BDBM50188961|NSC771751|s2759|AKOS026750340|CCG-269763|CS-1610|CUDC-907 (PI3K/HDAC InhibitorI)|DB11891|NSC-771751|SB16569|CUDC-907 (PI3K/HDAC InhibitorI)?|NCGC00346692-01|NCGC00346692-04|NCGC00346692-11|AC-30227|AS-57131|BP-40068|DA-34958|HY-13522|SMR004702794|DB-057451|NS00072982|SW219871-1|D11319|BRD-K77638923-001-02-0|Q27076926|2-[[2-(6-methoxy-3-pyridyl)-4-morpholino-thieno[3,2-d]pyrimidin-6-yl]methyl-methyl-amino]pyrimidine-5-carbohydroxamic acid"
CUDC-101,24756910,,"InChI=1S/C24H26N4O4/c1-3-17-9-8-10-18(13-17)27-24-19-14-22(21(31-2)15-20(19)25-16-26-24)32-12-7-5-4-6-11-23(29)28-30/h1,8-10,13-16,30H,4-7,11-12H2,2H3,(H,28,29)(H,25,26,27)",PLIVFNIUGLLCEK-UHFFFAOYSA-N,C24H26N4O4,434.5,7-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide,"CUDC-101|1012054-59-9|CUDC 101|CUDC101|1A7Y9MP123|7-[4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl]oxy-N-hydroxyheptanamide|7-((4-((3-ethynylphenyl)amino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide|DTXSID00143784|7-((4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl)oxy)-N-hydroxyheptanamide|7-({4-[(3-ethynylphenyl)amino]-7-methoxyquinazolin-6-yl}oxy)-N-hydroxyheptanamide|7-[[4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yl]oxy]-N-hydroxyheptanamide|7-(4-(3-ethynylanilino)-7-methoxyquinazolin-6-yl)oxy-N-hydroxyheptanamide|RefChem:128734|DTXCID7066275|HDAC/EGFR/HER2 Inhibitor CUDC-101|7-(4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6-yloxy)-N-hydroxyheptanamide|MFCD15528940|Heptanamide, 7-[[4-[(3-ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-hydroxy-|CHEMBL598797|UNII-1A7Y9MP123|CUDC-101, Free Base|SCHEMBL93769|MLS006010163|GTPL8894|orb1304532|CUDC 101 [WHO-DD]|SCHEMBL29350202|SCHEMBL29379912|CUDC-101?|EX-A842|GLXC-05386|HMS3654C20|BCP01935|BDBM50307768|NSC800081|s1194|AKOS022526176|BCP9000556|CCG-264856|compound 8 [PMID: 20143778]|DB12174|FC20592|NSC-800081|SB19287|NCGC00263177-01|NCGC00263177-05|NCGC00263177-12|1313875-12-5|AC-28428|AS-16955|BP-40066|HY-10223|SMR004701272|NS00072541|SW219934-1|BRD-K41278234-001-03-0|Q27076925|7-[4-(3-ethynylanilino)-7-methoxy-quinazolin-6-yl]oxyheptanehydroxamic acid|7-[[4-[(3-Ethynylphenyl)amino]-7-methoxy-6-quinazolinyl]oxy]-N-hydroxyheptanamide;7-[[4-(3-Ethynylphenylamino)-7-methoxyquinazolin-6  -yl]oxy]-N-hydroxyheptanamide"
R-306465,10309899,,"InChI=1S/C19H19N5O4S/c25-18(22-26)16-12-20-19(21-13-16)23-7-9-24(10-8-23)29(27,28)17-6-5-14-3-1-2-4-15(14)11-17/h1-6,11-13,26H,7-10H2,(H,22,25)",MUTBJZVSRNUIHA-UHFFFAOYSA-N,C19H19N5O4S,413.5,N-hydroxy-2-(4-naphthalen-2-ylsulfonylpiperazin-1-yl)pyrimidine-5-carboxamide,"604769-01-9|R306465|JNJ-16241199|R-306465|5WD7KK1IIQ|DTXSID00209218|5-Pyrimidinecarboxamide, N-hydroxy-2-(4-(2-naphthalenylsulfonyl)-1-piperazinyl)-|RefChem:178453|R 306465|DTXCID20131709|N-hydroxy-2-(4-(naphthalene-2-sulfonyl)piperazin-1-yl)pyrimidine-5-carboxamide|N-hydroxy-2-(4-(naphthalen-2-ylsulfonyl)piperazin-1-yl)pyrimidine-5-carboxamide|N-Hydroxy-2-(4-(naphthalen-2-ylsulfonyl)-piperazin-1-yl)pyrimidine-5-carboxamide|MFCD13186898|5-Pyrimidinecarboxamide, N-hydroxy-2-[4-(2-naphthalenylsulfonyl)-1-piperazinyl]- (9CI)|CHEMBL609583|N-hydroxy-2-(4-naphthalen-2-ylsulfonylpiperazin-1-yl)pyrimidine-5-carboxamide|N-Hydroxy-2-[4-(2-naphthalenylsulfonyl)-1-piperazinyl]-5-pyrimidinecarboxamide|UNII-5WD7KK1IIQ|C19H19N5O4S|MUTBJZVSRNUIHA-UHFFFAOYSA-N|orb1705131|SCHEMBL1663202|SCHEMBL31237823|EZA76901|BDBM50304782|NSC773264|AKOS015899841|DB12382|NSC-773264|NCGC00351481-01|HY-10226|DB-352567|CS-0002506|NS00069308|S10391|R306465(JNJ-16241199)|BRD-K86687746-001-01-3|Q27262965|R306465(JNJ-16241199)?|2-[4-(2-naphthylsulfonyl)piperazin-1-yl]pyrimidine-5-carbohydroxamic acid"
ABEXINOSTAT,11749858,,"InChI=1S/C21H23N3O5/c1-24(2)13-17-16-5-3-4-6-18(16)29-19(17)21(26)22-11-12-28-15-9-7-14(8-10-15)20(25)23-27/h3-10,27H,11-13H2,1-2H3,(H,22,26)(H,23,25)",MAUCONCHVWBMHK-UHFFFAOYSA-N,C21H23N3O5,397.4,3-[(dimethylamino)methyl]-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide,"ABEXINOSTAT|783355-60-2|PCI-24781|PCI 24781|CRA-024781|CRA 024781|PCI24781|CRA 24781|CRA024781|IYO470654U|PZP115891|S78454|PZP-115891|DTXSID30229005|S-78454|3-[(dimethylamino)methyl]-N-{2-[4-(hydroxycarbamoyl)phenoxy]ethyl}-1-benzofuran-2-carboxamide|2-Benzofurancarboxamide, 3-((dimethylamino)methyl)-N-(2-(4-((hydroxyamino)carbonyl)phenoxy)ethyl)-|3-[(dimethylamino)methyl]-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide|3-((DIMETHYLAMINO)METHYL)-N-(2-(4-(HYDROXYCARBAMOYL)PHENOXY)ETHYL)-1-BENZOFURAN-2-CARBOXAMIDE|abexinostatum|RefChem:108498|HDAC Inhibitor PCI-24781|DTXCID10151496|CRA-02478|3-((dimethylamino)methyl)-N-(2-(4-(hydroxycarbamoyl)phenoxy)ethyl)benzofuran-2-carboxamide|Abexinostat (PCI-24781)|PCI-24781 (Abexinostat)|Abexinostat [USAN]|3-((Dimethylamino)methyl)-N-(2-(4-(hydroxycarbamoyl)-phenoxy)ethyl)benzofuran-2-carboxamide|Abexinostat (USAN)|3-(dimethylaminomethyl)-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]-1-benzofuran-2-carboxamide|Abexinostat [USAN:INN]|UNII-IYO470654U|3-[(dimethylamino)methyl]-N-[2-[4-(hydroxycarbamoyl)phenoxy]ethyl]benzofuran-2-carboxamide|MFCD10565969|ABEXINOSTAT [INN]|ABEXINOSTAT [WHO-DD]|MLS006011097|SCHEMBL444280|GTPL8366|orb1310623|CHEMBL2103863|SCHEMBL29489677|BDBM24622|CHEBI:92223|MAUCONCHVWBMHK-UHFFFAOYSA-N|BCPP000128|HMS3654A19|EX-A2123|CRA-24781|FD5037|NSC764136|AKOS025149423|BCP9001054|CCG-264814|CS-0478|DB12565|FP26773|NSC-764136|SB16670|NCGC00346486-01|NCGC00346486-05|NCGC00346486-07|3-[(Dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-2-benzofurancarboxamide|AC-26866|BP-40063|BS-18153|HY-10990|SMR004702885|Abexinostat (PCI24781; CRA024781)|DB-075461|PCI-24781,CRA-024781|NS00070333|SW218266-2|D10060|EN300-204651|Q4667249|BRD-K12867552-001-01-3|BRD-K12867552-001-04-7|3-[(Dimethylamino)methyl]-N-[2-[4-[(hydroxyamino)carbonyl]phenoxy]ethyl]-2-benzofurancarboxamide;Abexinostat;CRA 24781"
BROMOCRIPTINE,31101,,"InChI=1S/C32H40BrN5O5/c1-16(2)12-24-29(40)37-11-7-10-25(37)32(42)38(24)30(41)31(43-32,17(3)4)35-28(39)18-13-20-19-8-6-9-22-26(19)21(27(33)34-22)14-23(20)36(5)15-18/h6,8-9,13,16-18,23-25,34,42H,7,10-12,14-15H2,1-5H3,(H,35,39)/t18-,23-,24+,25+,31-,32+/m1/s1",OZVBMTJYIDMWIL-AYFBDAFISA-N,C32H40BrN5O5,654.6,"(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","bromocriptine|25614-03-3|Bromoergocryptine|Bromocriptin|Bromergocryptine|Bromoergocriptine|Bromocriptina|2-Bromo-alpha-ergocryptine|Bromocriptinum|Ergoset|2-Bromo-alpha-ergokryptin|2-Bromo-alpha-ergokryptine|Ergocryptine, 2-bromo-|2-Bromoergocryptine|(+)-Bromocriptine|3A64E3G5ZO|CHEBI:3181|DTXSID1022687|SANDOZ 15-754|Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'alpha)-|DTXCID602687|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-3',6',18-trioxoergotaman|(5'alpha)-2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)ergotaman-3',6',18-trione|Bromocryptin|(5'alpha)-2-bromo-12'-hydroxy-5'-isobutyl-2'-isopropyl-3',6',18-trioxoergotaman|(6aR,9R)-5-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide|2-Bromoergokryptine|2 Bromo alpha ergocryptine|(4R,7R)-10-bromo-N-((1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo(7.3.0.0^(2,6))dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide|(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide|(6aR,9R)-5-bromo-N-((1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-propan-2-yl-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide|2 Bromoergocryptine|2 Bromoergokryptine|RefChem:56423|2 Bromo alpha ergokryptine|G02CB01|N04BC01|CB154|Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'alpha-(2-methylpropyl)-|(4R,7R)-10-bromo-N-((1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide|247-128-5|Bromocryptine|Bromocriptinum [INN-Latin]|Bromocriptina [INN-Spanish]|CB-154|Bromocriptine (mesylate)|Bromergon|Ergotaman-3',6',18-trione, 2-bromo-12'-hydroxy-2'-(1-methylethyl)-5'-(2-methylpropyl)-, (5'.alpha.)-|2-Bromo-.alpha.-ergocryptine|CCRIS 3244|NSC169774|EINECS 247-128-5|Bromocriptine (USAN/INN)|UNII-3A64E3G5ZO|Bromokryptine|SR-01000075356|Bromocriptine [USAN:INN:BAN]|NCGC00024584-03|08Y|2-Bromo-12'-hydroxy-2'-(1-methylethyl)-5'-alpha-(2-methylpropyl)ergotamin-3',6',18-trione|Bromocriptine+ (GTP-)|Prestwick0_000121|Prestwick1_000121|Prestwick2_000121|BROMOCRIPTINE [MI]|Biomol-NT_000005|CHEMBL493|GTPL35|BROMOCRIPTINE [INN]|BROMOCRIPTINE [USAN]|Lopac0_000171|SCHEMBL25297|BROMOCRIPTINE [VANDF]|BIDD:GT0464|SPBio_002101|BROMOCRIPTINE [WHO-DD]|BPBio1_001131|SCHEMBL29364057|BDBM81993|Tox21_110907|PDSP2_001500|AKOS015961273|CCG-204266|DB01200|SDCCGSBI-0050159.P003|NCGC00024584-04|NCGC00024584-05|NCGC00024584-07|NCGC00024584-09|NCGC00024584-17|(5'alpha)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-2'-(propan-2-yl)-3',6',18-trioxoergotaman|(6aR,9R)-5-Bromo-N-((2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxooctahydro-2H-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide|AC-13601|AC-37665|DA-61890|NCI60_001365|CAS-25614-03-3|CS-0012283|NS00001292|C06856|D03165|EN300-19768234|Q413581|SR-01000075356-5|BRD-K14496212-001-01-1|BRD-K14496212-066-02-2|BRD-K14496212-066-04-8|SAN 15-754; Sandoz 15-754; -Bromocryptine; -Bromoergocryptine; -Ergolactin|(4R,7R)-10-bromo-N-[(1S,2S,4R,7S)-2-hydroxy-7-(2-methylpropyl)-5,8-dioxo-4-(propan-2-yl)-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaene-4-carboxamide|(5alpha,5'beta)-2-bromo-12'-hydroxy-5'-(2-methylpropyl)-3',6',18-trioxo-2'-(propan-2-yl)ergotaman|N-[(2R,5S,10aS,10bS)-10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-bromo-methyl-[?]carboxamide"
PERGOLIDE,47811,,"InChI=1S/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3/t13-,16-,18-/m1/s1",YEHCICAEULNIGD-MZMPZRCHSA-N,C19H26N2S,314.5,"(6aR,9R,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline","pergolide|Pergolida|66104-22-1|Pergolidum|CHEBI:63617|24MJ822NZ9|DTXSID2023438|Parkotil|Ergoline, 8-((methylthio)methyl)-6-propyl-, (8beta)-|(2R,4R,7R)-4-[(methylsulfanyl)methyl]-6-propyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),9,12,14-tetraene|(2R,4R,7R)-4-((methylsulfanyl)methyl)-6-propyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),9,12,14-tetraene|RefChem:57298|DTXCID203438|N04BC02|(2R,4R,7R)-4-((methylsulfanyl)methyl)-6-propyl-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(16),9,12,14-tetraene|811-107-4|Permax|Pergolidum [INN-Latin]|Pergolida [INN-Spanish]|Pergolide (INN)|Permax (TN)|CHEMBL531|(6aR,9R,10aR)-9-(methylsulfanylmethyl)-7-propyl-6,6a,8,9,10,10a-hexahydro-4H-indolo[4,3-fg]quinoline|8beta-[(Methylthio)methyl]-6-propylergoline|(8beta)-8-[(methylsulfanyl)methyl]-6-propylergoline|PERGOLIDE [INN]|Pergolide [INN:BAN]|CHEMBL1275|LY 141B|NCGC00017366-04|TNP00315|UNII-24MJ822NZ9|SR-01000721840|Spectrum_001647|PERGOLIDE [MI]|Prestwick0_000295|Prestwick1_000295|Prestwick2_000295|Prestwick3_000295|Spectrum2_001970|Spectrum3_001588|Spectrum4_000835|Spectrum5_001649|PERGOLIDE [VANDF]|Biomol-NT_000025|GTPL48|PERGOLIDE [WHO-DD]|(8beta)-8-[(methylthio)methyl]-6-propylergoline|Lopac0_000984|SCHEMBL26921|BSPBio_000230|BSPBio_003156|KBioGR_001409|KBioSS_002127|cid_47811|BIDD:GT0177|DivK1c_000442|SPBio_002099|SPBio_002449|BPBio1_000254|BPBio1_001211|SCHEMBL29359856|KBio1_000442|KBio2_002127|KBio2_004695|KBio2_007263|KBio3_002656|NINDS_000442|HMS2089C18|BCP18331|BDBM50017543|BDBM50028421|AKOS040744817|CCG-205064|DB01186|SDCCGSBI-0050957.P004|IDI1_000442|NCGC00017366-02|NCGC00017366-03|NCGC00017366-05|NCGC00017366-06|NCGC00017366-10|NCGC00017366-13|NCGC00142538-01|NCGC00142538-02|NCGC00142538-03|(6aR,9R,10aR)-9-(Methylthiomethyl)-7-propyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinoline|HY-13720|ST057534|SBI-0050957.P003|[2-(1H-Indol-4-yl)-ethyl]-methyl-amine|CS-0007749|NS00098765|P2200|C07425|D-8beta-((Methylthio)methyl)-6-propylergoline|D08339|D92194|AB00053740-13|AB00053740_14|AB00053740_15|EN300-6482031|104P221|Q415752|SR-01000721840-8|BRD-K60770992-001-01-8|BRD-K60770992-066-05-2|BRD-K60770992-066-15-1|BRD-K60770992-066-25-0|9-Methylsulfanylmethyl-7-propyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinoline|(2R,4R,7R)-4-[(methylsulfanyl)methyl]-6-propyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),9,12(16),13-tetraene|(6aR,9R,10aR)-9-Methylsulfanylmethyl-7-propyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinolin-7-ium|(6aR,9R,10aR)-9-Methylsulfanylmethyl-7-propyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinoline|5-Bromo-7-methyl-4,6,6a,7,8,9-hexahydro-indolo[4,3-fg]quinoline-9-carboxylic acid (10b-hydroxy-5-isobutyl-2-isopropyl-3,6-dioxo-octahydro-oxazolo[3,2-a]pyrrolo[2,1-c]pyrazin-2-yl)-amide|9-Methylsulfanylmethyl-7-propyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinolin-7-ium(Pergolide)|9-Methylsulfanylmethyl-7-propyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinoline(pergolide)|9-Methylsulfanylmethyl-7-propyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinoline, mesylate (Pergolide)|9-Methylsulfanylmethyl-7-propyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinoline; compound with methanesulfonic acid|InChI=1/C19H26N2S/c1-3-7-21-11-13(12-22-2)8-16-15-5-4-6-17-19(15)14(10-20-17)9-18(16)21/h4-6,10,13,16,18,20H,3,7-9,11-12H2,1-2H3/t13-,16-,18-/m1/s"
LISURIDE,28864,,"InChI=1S/C20H26N4O/c1-4-24(5-2)20(25)22-14-10-16-15-7-6-8-17-19(15)13(11-21-17)9-18(16)23(3)12-14/h6-8,10-11,14,18,21H,4-5,9,12H2,1-3H3,(H,22,25)/t14-,18+/m0/s1",BKRGVLQUQGGVSM-KBXCAEBGSA-N,C20H26N4O,338.4,"3-[(6aR,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea","LISURIDE|Lysuride|18016-80-3|Lisurida|Lisuridum|Dopergin|N'-((8alpha)-9,10-Didehydro-6-methylergolin-8-yl)-N,N-diethylurea|E0QN3D755O|CHEBI:51164|DTXSID3023217|Methylergol Carbamide|Lysurid|Urea, N'-((8alpha)-9,10-didehydro-6-methylergolin-8-yl)-N,N-diethyl-|3,3-diethyl-1-[(4S,7R)-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaen-4-yl]urea|Mesylate, Lisuride|3,3-diethyl-1-((4S,7R)-6-methyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),2,9,12,14-pentaen-4-yl)urea|Revanil 200|Carbamide, Methylergol|Hydrochloride, Lisuride|RefChem:799371|DTXCID803217|G02CB02|N02CA07|241-925-1|Lisuride [INN]|Lisuride (INN)|Lisuride (S)(-)|CHEMBL157138|1,1-diethyl-3-[(8alpha)-6-methyl-9,10-didehydroergolin-8-yl]urea|Urea, N'-[(8a)-9,10-didehydro-6-methylergolin-8-yl]-N,N-diethyl-|18016-80-3 (free base)|Lisuridum [INN-Latin]|S-(-)-Lisuride|140387-89-9|Lisurida [INN-Spanish]|3-[(6aR,9S)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinolin-9-yl]-1,1-diethylurea|N,N-diethyl-N'-[(8alpha)-6-methyl-9,10-didehydroergolin-8-yl]urea|1,1-diethyl-3-((6ar,9s)-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinolin-9-yl)urea|Lisuride [INN:BAN]|EINECS 241-925-1|UNII-E0QN3D755O|DL-Lisuride|(+)-lisuride|H8G|lisuride, (S)|Prestwick_525|LISURIDE; Lysuride|3-(9,10-Didehydro-6-methylergolin-8alpha-yl)-1,1-diethylurea|LISURIDE [MI]|Prestwick0_000106|Prestwick1_000106|Prestwick2_000106|Prestwick3_000106|GTPL43|LISURIDE [WHO-DD]|Lopac0_000751|SCHEMBL43950|BSPBio_000092|SPBio_002031|BPBio1_000102|orb1688971|SCHEMBL29435356|DTXSID30274075|EX-A11202A|GLXC-21956|HMS1568E14|BDBM50056445|CCG-204836|DB00589|NCGC00179663-02|HY-12713|CS-0012290|NS00001952|D08132|EN300-19752568|Q424446|BRD-K67943528-050-01-4|1,1-diethyl-3-(9,10-didehydro-6-methyl-8alpha-ergolinyl)urea|3-(9,10-didehydro-6-methyl-8alpha-ergolinyl)-1,1-diethylurea|3-(9,10-DIDEHYDRO-6-METHYLERGOLIN-8.ALPHA.-YL)-1,1-DIETHYLUREA|N''-((8alpha)-9,10-Didehydro-6-methylergolin-8-yl)-N,N-diethylurea|3,3-diethyl-1-[(4S,7R)-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(15),2,9,12(16),13-pentaen-4-yl]urea"
CITARINOSTAT,53340426,,"InChI=1S/C24H26ClN5O3/c25-20-12-7-8-13-21(20)30(19-10-4-3-5-11-19)24-27-16-18(17-28-24)23(32)26-15-9-2-1-6-14-22(31)29-33/h3-5,7-8,10-13,16-17,33H,1-2,6,9,14-15H2,(H,26,32)(H,29,31)",VLIUIBXPEDFJRF-UHFFFAOYSA-N,C24H26ClN5O3,467.9,2-(N-(2-chlorophenyl)anilino)-N-[7-(hydroxyamino)-7-oxoheptyl]pyrimidine-5-carboxamide,"Citarinostat|1316215-12-9|ACY-241|HDAC-IN-2|2-(N-(2-chlorophenyl)anilino)-N-[7-(hydroxyamino)-7-oxoheptyl]pyrimidine-5-carboxamide|ACY241|441P620G3P|5-Pyrimidinecarboxamide, 2-[(2-chlorophenyl)phenylamino]-N-[7-(hydroxyamino)-7-oxoheptyl]-|2-((2-Chlorophenyl)phenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)-5-pyrimidinecarboxamide|5-Pyrimidinecarboxamide, 2-((2-chlorophenyl)phenylamino)-N-(7-(hydroxyamino)-7-oxoheptyl)-|2-[(2-Chlorophenyl)phenylamino]-N-[7-(hydroxyamino)-7-oxoheptyl]-5-pyrimidinecarboxamide|7-({2-[(2-chlorophenyl)(phenyl)amino]pyrimidin-5-yl}formamido)-N-hydroxyheptanamide|citarinostatum|2-(N-(2-chlorophenyl)anilino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide|7-((2-((2-chlorophenyl)(phenyl)amino)pyrimidin-5-yl)formamido)-N-hydroxyheptanamide|RefChem:126503|Histone Deacetylase Inhibitor ACY-241|CC-96241|2-((2-Chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide|Citarinostat [USAN]|Citarinostat(ACY-241)|MFCD28023593|Citarinostat (ACY-241)|2-[(2-chlorophenyl)(phenyl)amino]-N-[7-(hydroxyamino)-7-oxoheptyl]pyrimidine-5-carboxamide|Citarinostat (USAN/INN)|CITARINOSTAT [INN]|C24H26ClN5O3|CITARINOSTAT [WHO-DD]|GTPL9426|orb1303944|SCHEMBL2225863|CHEMBL3693786|SCHEMBL29882816|UNII-441P620G3P|EX-A379|BDBM110036|BCP09545|RCC21512|s8464|AKOS024464693|CCG-269430|CS-5140|DB15449|SB18732|Compound (I) [WO2016200919]|AC-33086|AS-74355|HY-15994|DB-239604|D10918|Q27258687|2-(N-(2-chlorophenyl)anilino)-N-[7-(hydroxyamino)-7-oxo-heptyl]pyrimidine-5-carboxamide|2-[(2-Chlorophenyl)phenylamino]-N-[7-(hydroxyamino)-7-oxoheptyl]pyrimidine-5-carboxamide|US8609678, 2-((2-chlorophenyl)(phenyl)amino)-N-(7-(hydroxyamino)-7-oxoheptyl)pyrimidine-5-carboxamide [89]"
ROPINIROLE,5095,,"InChI=1S/C16H24N2O/c1-3-9-18(10-4-2)11-8-13-6-5-7-15-14(13)12-16(19)17-15/h5-7H,3-4,8-12H2,1-2H3,(H,17,19)",UHSKFQJFRQCDBE-UHFFFAOYSA-N,C16H24N2O,260.37,"4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one","ropinirole|91374-21-9|ropinirol|Ropinirolum|Ropitor|SKF 101468|SK&F 101468|Narapin|4-[2-(dipropylamino)ethyl]-1,3-dihydro-2H-indol-2-one|NSC-758917|CHEBI:8888|DTXSID8045195|030PYR8953|DTXCID6025195|Adartrel|SK&F-101468|2H-Indol-2-one, 4-(2-(dipropylamino)ethyl)-1,3-dihydro-|SK&F-101468A|4-(2-(Dipropylamino)ethyl)-1,3-dihydro-2H-indol-2-one|4-[2-(dipropylamino)ethyl]-2,3-dihydro-1h-indol-2-one|4-(2-(dipropylamino)ethyl)-3H-indol-2-ol|4-[2-(dipropylamino)ethyl]-3H-indol-2-ol|4-(2-(dipropylamino)ethyl)-2,3-dihydro-1H-indol-2-one|SK&F-101,468|CLEVOR|RefChem:57482|N04BC04|4-(2-(di-n-propylamino)ethyl)-2(3H)-indolone|Ropinirolum [INN-Latin]|Ropinirol [INN-Spanish]|4-(2-(dipropylamino)ethyl)indolin-2-one|4-[2-(dipropylamino)ethyl]-1,3-dihydroindol-2-one|CHEMBL589|NCGC00015893-02|4-[2-(dipropylamino)ethyl]indolin-2-one|Ropitor (TN)|CAS-91374-21-9|Ropinirole [USAN:INN:BAN]|UNII-030PYR8953|ROPINIROLE [MI]|ROPINIROLE [INN]|Ropinirole (USAN/INN)|Lopac-R-4152|ROPINIROLE [USAN]|ROPINIROLE [VANDF]|ROPINIROLE [WHO-DD]|Lopac0_001101|SCHEMBL35212|BIDD:GT0826|SPECTRUM1505178|GTPL7295|orb1689604|SCHEMBL27885263|SCHEMBL29374522|HSDB 8252|HMS2093K04|Pharmakon1600-01505178|BCP09383|HY-B0623|Tox21_110256|BDBM50020680|MFCD00864147|NSC758917|STL454344|AKOS015843123|Tox21_110256_1|CCG-205177|DB00268|FR32034|NSC 758917|SB65618|SDCCGSBI-0051070.P002|SKF-101468|4-[2-(Dipropylamino)ethyl]2-indolinone|NCGC00015893-01|NCGC00015893-03|NCGC00015893-04|NCGC00015893-06|NCGC00094373-12|NCGC00096064-01|NCGC00096064-02|CS-0009561|NS00008049|C07564|D08489|EN300-708794|G78293|AB01563044_01|AB01563044_02|374R219|4-(2-dipropylaminoethyl)-1,3-dihydroindol-2-one|L000520|Q420590|SR-01000076215-3|BRD-K15933101-003-01-2|BRD-K15933101-003-06-1|BRD-K15933101-003-07-9|4-[2-(dipropylamino)ethyl]-1.3-dihydro-2H-indol-2-one"
PRAMIPEXOLE,119570,,"InChI=1S/C10H17N3S/c1-2-5-12-7-3-4-8-9(6-7)14-10(11)13-8/h7,12H,2-6H2,1H3,(H2,11,13)/t7-/m0/s1",FASDKYOPVNHBLU-ZETCQYMHSA-N,C10H17N3S,211.33,"(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine","pramipexole|104632-26-0|Pramipexol|(-)-Pramipexole|Mirapexin|Sifrol|Pramipexolum|SUD919CL2Y|Mirapex|U-98528E|(6S)-6-N-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexolum [Latin]|SUD-919CL2Y|CHEBI:8356|DTXSID6023496|(6S)-N6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|CTC-501|83619PEU5T|NSC-760426|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N(sup 6)-propyl-, (S)-|DTXCID203496|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (S)-|Pramipexolum (Latin)|(6S)-N'-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Neliprax|Pipexus|2-amino-4,5,6,7-tetrahydro-6-propylaminobenzothiazole|RefChem:56732|4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine|N04BC05|2 Amino 6 propylaminotetrahydrobenzothiazole|(S)-N 6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|(S)-Pramipexole|(S)-N6-Propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine|Oprymea|MFCD00869076|(S)-2-Amino-4,5,6,7-tetrahydro-6-(propylamino)benzothiazole|SND-919|PRAMIPEXOLE HCl|CHEMBL301265|PRAMIPEXOLE HYDROCHLORIDE|NCGC00167441-01|SND 919|(S)-N6-Propyl-4,5,6,7-tetrahydrobenzothiazole-2,6-diamine|(6S)-N(6)-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine|Pramipexol [Spanish]|556801-24-2|SMR000449298|CAS-104632-26-0|SR-01000763219|Pramipexole (USAN/INN)|SUD 919CL2Y|UNII-83619PEU5T|Pramipexole [USAN:INN:BAN]|(-) Pramipexole|Pramipexole (Mirapex)|Pramipexole (Standard)|Spectrum_001838|111GE001|SpecPlus_000820|PRAMIPEXOLE [MI]|2,6-Benzothiazolediamine, 4,5,6,7-tetrahydro-N6-propyl-, (6S)-|Spectrum5_001453|PRAMIPEXOLE [INN]|PRAMIPEXOLE [USAN]|EC 600-593-1|PRAMIPEXOLE [VANDF]|SCHEMBL35376|GTPL953|KBioSS_002343|PRAMIPEXOLE [WHO-DD]|MLS000758250|MLS001423952|BIDD:GT0250|DivK1c_006916|orb1308531|HSDB 8253|HY-B0410R|KBio1_001860|KBio2_002340|KBio2_004908|KBio2_007476|(s)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzothiazole|(s)-4,5,6,7-tetrahydro-n6-propyl-2,6-benzothiazolediamine|HMS2051A21|HMS2090C15|HMS2232B03|HMS3884L19|(S)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole;(S)-2-amino-6-propylamino-4,5,6,7-tetrahydrobenzthiazole|HY-B0410|MSK11202|Tox21_112445|BDBM50116766|CX1349|s2460|AKOS016843188|Tox21_112445_1|CCG-100823|DB00413|FP45322|NC00073|NSC 760426|NCGC00167441-02|NCGC00167441-03|NCGC00167441-10|DS-14807|SY009549|DB-038042|B1488|NS00098767|P2879|SW197453-4|D05575|EN300-150086|AB00053772-12|AB00053772-13|AB00053772_14|AB00053772_16|632P260|A901248|F225637|Q421304|SR-01000763219-5|SR-01000763219-6|BRD-K06388322-001-07-4|BRD-K06388322-312-02-6|(6S)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine|(s)-(-)-2-amino-6-n-propylamino-4,5,6,7-tetrahydrobenzothiazole|(S)-N  6-propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine"
CILOMILAST,151170,,"InChI=1S/C20H25NO4/c1-24-17-7-6-15(12-18(17)25-16-4-2-3-5-16)20(13-21)10-8-14(9-11-20)19(22)23/h6-7,12,14,16H,2-5,8-11H2,1H3,(H,22,23)",CFBUZOUXXHZCFB-UHFFFAOYSA-N,C20H25NO4,343.4,4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexane-1-carboxylic acid,"Cilomilast|153259-65-5|Ariflo|SB-207499|SB 207499|153259-69-9|SB207499|trans-4-Cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylic acid|CIS-4-CYANO-4-[3-(CYCLOPENTYLOXY)-4-METHOXYPHENYL]CYCLOHEXANECARBOXYLIC ACID|Cilomilast-d9|4-cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexane-1-carboxylic acid|164414-71-5|8ATB1C1R6X|CHEMBL27220|cis-4-Cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylic acid|CHEMBL511115|DTXSID6046686|NCGC00167520-01|Cilomilast [USAN:INN]|Cyclohexanecarboxylic acid,4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]-, trans-|CIO|1794779-92-2|4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexane-1-carboxylic acid|4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexane-1-carboxylic acid|Ariflo (TN)|UNII-8ATB1C1R6X|Cilomilast (JAN/USAN/INN)|1xlx|1xom|cis-4-Cyano-4-(3-cyclopentyloxy-4-methoxyphenyl)cyclohexanecarboxylic acid|cis-4-(3-(Cyclopentyloxy)-4-methoxyphenyl)-4-cyanocyclohexane-1-carboxylic acid|CILOMILAST [MI]|CILOMILAST [INN]|CILOMILAST [JAN]|CILOMILAST [USAN]|CILOMILAST [VANDF]|CILOMILAST [MART.]|CILOMILAST [WHO-DD]|SCHEMBL26372|SCHEMBL27515|SCHEMBL27516|CHEMBL32854|Cilomilast (SB-207499)|GTPL7407|orb1300763|DTXCID4026686|SCHEMBL13777301|BDBM14773|CHEBI:94683|DTXSID40861410|BCPP000280|GLXC-06848|GLXC-25763|HMS3654F10|HMS3884K17|BCP02394|Cilomilast, SB 207499, Ariflo|CS-B1491|EX-A1554|UWC77992|Tox21_112517|BDBM50346088|BDBM50407414|MFCD28044030|PDSP1_001287|PDSP2_001271|s1455|4-cyano-4-(3-cyclopentyloxy-4-methoxy-phenyl)cyclohexane-1-carboxylic acid|AKOS015967197|AKOS030526103|AKOS040759016|AT10133|BCP9000529|CCG-267954|CS-0470|DB03849|SB19573|Cyclohexanecarboxylic acid, 4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)-, cis-|NCGC00167520-03|NCGC00167520-06|NCGC00390705-01|NCGC00485415-01|CS-15164|DA-51903|HY-10790|MS-25260|CAS-153259-65-5|NS00073272|SW219280-1|C13118|D01704|SBI-0654063.0001|F788153|Q5120034|BRD-K38473998-001-02-0|BRD-K62982419-001-01-2|6-(3,4-Dimethoxy-phenyl)-5-methyl-4,5-dihydro-2H-pyridazin-3-one|4-Cyano-3-cyclopentyloxy-4-(4-methoxy-phenyl)-cyclohexanecarboxylic acid|4-Cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylic acid|4-Cyano-4-(3-cyclopentyloxy-4-methoxy-phenyl)-cyclohexanecarboxylic acid|4-cyano-4-[3-(cyclopentoxy)-4-methoxy-phenyl]cyclohexanecarboxylic acid|(1r,4r)-4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexane-1-carboxylic acid|(1r,4r)-4-cyano-4-(3-(cyclopentyloxy)-4-methoxyphenyl)cyclohexanecarboxylic acid|(1s,4s)-4-cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexane-1-carboxylic acid|4-Cyano-4-(3-cyclopentyloxy-4-methoxy-phenyl)-cyclohexanecarboxylic acid (Ariflo)|4-Cyano-4-(3-cyclopentyloxy-4-methoxy-phenyl)-cyclohexanecarboxylic acid methyl ester|4-Cyano-4-(3-cyclopentyloxy-4-methoxy-phenyl)-cyclohexanecarboxylic acid(Ariflo)|trans-4-Cyano-4-[3-(cyclopentyloxy)-4-methoxyphenyl]cyclohexanecarboxylicacid"
PICLAMILAST,154575,,"InChI=1S/C18H18Cl2N2O3/c1-24-15-7-6-11(8-16(15)25-12-4-2-3-5-12)18(23)22-17-13(19)9-21-10-14(17)20/h6-10,12H,2-5H2,1H3,(H,21,22,23)",RRRUXBQSQLKHEL-UHFFFAOYSA-N,C18H18Cl2N2O3,381.2,"3-cyclopentyloxy-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide","Piclamilast|144035-83-6|3-(Cyclopentyloxy)-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide|RP 73401|3-(Cyclopentyloxy)-N-(3,5-dichloro-4-pyridyl)-4-methoxybenzamide|RP-73401|RP 73-401|RP-73-401|piclamilastum|RPR-73401|RP73401|Benzamide, 3-(cyclopentyloxy)-N-(3,5-dichloro-4-pyridinyl)-4-methoxy-|3-cyclopentyloxy-N-(3,5-dichloropyridin-4-yl)-4-methoxybenzamide|3-(Cyclopentyloxy)-N-(3,5-dichloro-4-pyridinyl)-4-methoxybenzamide|WM58D7C3ZT|3-(Cyclopentyloxy)-N-(3,5-dichloro-4-pyridyl)-p-anisamide|CHEBI:47619|DTXSID3040227|RefChem:863110|DTXCID1020227|3-cyclopentyloxy-N-(3,5-dichloro-4-pyridyl)-4-methoxybenzamide|PPR 73401|Cpodpmb|CHEMBL42126|RP 73401; RPR 73401|PIL|Piclamilast [INN]|SR-01000945166|RPR 73401|Piclamilast [USAN:INN]|UNII-WM58D7C3ZT|CCRIS 8304|1xon|Piclamilast (Standard)|1xm4|Piclamilast (USAN/INN)|PICLAMILAST [USAN]|SCHEMBL26573|PICLAMILAST [WHO-DD]|MLS006011544|orb1305711|BDBM14775|GTPL11627|GLXC-06857|HMS3604D06|UFA03583|EX-A11875|HY-12887R|MFCD00864786|PDSP1_001283|PDSP2_001267|AKOS024458202|DB01791|NCGC00371037-01|HY-12887|MS-26240|RP-73041|SMR004703311|DB-112325|CS-0012751|NS00068349|D05474|EN300-133366|Q7190965|SR-01000945166-1|SR-01000945166-2|BRD-K47642186-001-01-3|N-(3,5-dichloropyrid-4yl)-3-cyclopentyloxy-4-methoxybenzamide|3-(cyclopentoxy)-N-(3,5-dichloro-4-pyridyl)-4-methoxy-benzamide|3-cyclopentyloxy-N-(3,5-dichloropyridin-4-yl)-4-methoxy-benzamide|N-(3,5-dichloro-pyrid-4-yl)-3-cyclopentyloxy-4-methoxybenzamide|N-(3,5-dichloropyrid-4-yl)-3-cyclopentyloxy-4-methoxy-benzamide|N-(3,5-dichloropyrid-4-yl)-3-cyclopentyloxy-4-methoxybenzamide|3-(Cyclopentyloxy)-N-(3,5-di-chloro-4-pyridyl)-4-methoxy-benzamide|3-(Cyclopentyloxy)-N-(3,5-dichloro-4-pyridinyl)-4-methoxybenzamide #|3-(CYCLOPENTYLOXY)-N-(3,5-DICHLORO-4-PYRIDY)-4-METHOXYBENZAMIDE"
ROFLUMILAST,449193,,"InChI=1S/C17H14Cl2F2N2O3/c18-11-6-22-7-12(19)15(11)23-16(24)10-3-4-13(26-17(20)21)14(5-10)25-8-9-1-2-9/h3-7,9,17H,1-2,8H2,(H,22,23,24)",MNDBXUUTURYVHR-UHFFFAOYSA-N,C17H14Cl2F2N2O3,403.2,"3-(cyclopropylmethoxy)-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide","Roflumilast|162401-32-3|DAXAS|3-(CYCLOPROPYLMETHOXY)-N-(3,5-DICHLOROPYRIDIN-4-YL)-4-(DIFLUOROMETHOXY)BENZAMIDE|Daliresp|BY217|BYK20869|Benzamide, 3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)-|BY-217|ZORYVE|roflumilastum|B9302-107|0P6C6ZOP5U|BYK-20869|CHEBI:47657|ARQ-151|ARQ-154 (Roflumilast foam)|DTXSID8044123|3-cyclopropylmethoxy-4-difluoromethoxy-N-(3,5-di-chloropyrid-4-yl)benzamide|3-Cyclopropylmethoxy-N-(3,5-dichloropyridin-4-yl)-4-(difluoromethoxy)benzamide|B-9302-107|RefChem:57566|DTXCID6024123|R03DX07|685-382-2|C17H14Cl2F2N2O3|MFCD00938270|3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide|Roflumilast (Daxas)|BY 217|CHEMBL193240|B 9302-107|ROF|Libertek|Roflumilast [USAN]|Roflumilast [USAN:INN]|UNII-0P6C6ZOP5U|Roflumilast (JAN/USAN/INN)|Roflumilast?|APTA-2217|1xmu|1xoq|Daliresp (TN)|3-(Cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide;B 9302-107;BY 217|Zoryve (TN)|Roflumilast (Standard)|3g4l|ROFLUMILAST [MI]|ROFLUMILAST [INN]|ROFLUMILAST [JAN]|ROFLUMILAST [VANDF]|ROFLUMILAST [MART.]|SCHEMBL19158|ROFLUMILAST [WHO-DD]|MLS006010074|ROFLUMILAST [EMA EPAR]|GTPL6962|orb1310022|Roflumilast - Bio-X trade mark|SCHEMBL27891482|SCHEMBL29349467|BDBM14774|Roflumilast, >=98% (HPLC)|EX-A059|ROFLUMILAST [ORANGE BOOK]|HMS3655P21|HMS3748C19|HMS3884F09|HMS5080C16|BCP03736|YFC06569|BYK 20869|HY-15455R|MSK169323|s2131|ARQ-151/Zoryve (roflumilast cream)|AKOS005146309|CCG-268678|CS-0963|DB01656|FR27749|PB29130|3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridyl)-4-(difluoromethoxy)benzamide|NCGC00346566-01|NCGC00346566-09|AC-23383|AS-14120|BR164364|HY-15455|SMR002530074|SY008710|BCP0726000146|NS00040687|R0193|SW220196-1|D05744|AB01565852_02|EN300-7365610|401R323|F050816|Q693482|BRD-K03194791-001-02-2|BRD-K03194791-001-04-8|Benzamide,  3-(cyclopropylmethoxy)-N-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)-|n-(3,5-dichloropyridin-4-yl)-4-difluoromethoxy-3-cyclopropylmethoxybenzamide"
ROLIPRAM,5092,,"InChI=1S/C16H21NO3/c1-19-14-7-6-11(12-9-16(18)17-10-12)8-15(14)20-13-4-2-3-5-13/h6-8,12-13H,2-5,9-10H2,1H3,(H,17,18)",HJORMJIFDVBMOB-UHFFFAOYSA-N,C16H21NO3,275.34,4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one,"rolipram|61413-54-5|(R,S)-rolipram|ZK 62711|4-(3-(cyclopentyloxy)-4-methoxyphenyl)pyrrolidin-2-one|Rolipramum|4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-2-pyrrolidinone|4-[3-(cyclopentyloxy)-4-methoxyphenyl]pyrrolidin-2-one|ZK-62711|4-(3-(Cyclopentyloxy)-4-methoxyphenyl)-2-pyrrolidinone|NSC-760125|ZK 62 711|CHEBI:104872|K676NL63N7|SB-95952|ZK-62771|(+-)-rolipram|Pyrrolidone, 4-(3-cyclopentyloxy-4-methoxyphenyl)-2-|ZK62711|RefChem:389268|262-771-1|(+/-)-Rolipram|Rolipramum [Latin]|Adeo|4-(3-cyclopentyloxy-4-methoxyphenyl)pyrrolidin-2-one|MFCD00270906|DTXSID3044124|4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone|CHEMBL63|SB 95952|MLS000069691|2-Pyrrolidinone, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]-|4-[3-(cyclopentoxy)-4-methoxy-phenyl]pyrrolidin-2-one|SMR000058510|(R,S)-Rolipram;SB 95952;ZK 62711|4-(3-(cyclopentyloxy)-4-methoxyphenyl)-2-pyrrolidinon|4-(3-Cyclopentyloxy-4-methoxy-phenyl)-pyrrolidin-2-one|DTXCID1024124|2-Pyrrolidinone, 4-(3-(cyclopentyloxy)-4-methoxyphenyl)-|(4R)-4-[3-(Cyclopentyloxy)-4 Methoxyphenyl)pyrrolidin-2-one|(4S)-4-[3-(Cyclopentyloxy)-4-methoxyphenyl]-pyrrolidin-2-one|Rolipram [USAN:INN]|R-(-)-Rolipram|[3H]rolipram|[3H]-rolipram|SR-01000000162|EINECS 262-771-1|BRN 1588548|UNII-K676NL63N7|Rolipram?|(plusmn)-rolipram|NCGC00016899-01|CAS-61413-54-5|Rolipram (Standard)|ME-3167|ROLIPRAM [USAN]|ROLIPRAM [INN]|ROLIPRAM [JAN]|ROLIPRAM [MI]|Opera_ID_1749|Prestwick0_000924|Prestwick1_000924|Prestwick2_000924|Prestwick3_000924|ROLIPRAM [MART.]|ROLIPRAM [WHO-DD]|UPCMLD-DP110|Lopac0_001072|SCHEMBL27930|BSPBio_000828|BSPBio_001356|KBioGR_000076|KBioSS_000076|Rolipram (JAN/USAN/INN)|MLS000758273|MLS000759531|MLS001146912|MLS001424084|MLS006010272|SPBio_003007|(+)-Rolipram; (S)-Rolipram|BPBio1_000912|GTPL5260|GTPL5313|orb1300590|SCHEMBL29360376|UPCMLD-DP110:001|UPCMLD-DP110:002|BDBM14361|KBio2_000076|KBio2_002644|KBio2_005212|KBio3_000151|KBio3_000152|Bio2_000076|Bio2_000556|GLXC-06145|HMS1361D18|HMS1570J10|HMS1791D18|HMS1989D18|HMS2051N15|HMS2090J16|HMS2097J10|HMS2232F06|HMS3263G06|HMS3267A05|HMS3369J08|HMS3393N15|HMS3402D18|HMS3411F08|HMS3654P06|HMS3655J21|HMS3675F08|HMS3714J10|HMS5079G04|HMS5080M14|Pharmakon1600-01505683|BCP21910|BCP23388|Tox21_110672|Tox21_501072|EX-A10913|HB2896|HY-16900R|MSK169324|NSC760125|Rolipram, solid, >=98% (HPLC)|s1430|Rolipram - CAS 61413-54-5|AKOS015959793|Tox21_110672_1|( inverted exclamation markA)-Rolipram|CCG-100965|CCG-205149|CS-1754|DB01954|FR01270|KS-1400|LP01072|NC00215|NSC 760125|SB12922|SDCCGSBI-0051042.P003|IDI1_033826|NCGC00015898-03|NCGC00015898-04|NCGC00015898-05|NCGC00015898-06|NCGC00015898-07|NCGC00015898-08|NCGC00015898-09|NCGC00015898-11|NCGC00015898-12|NCGC00015898-15|NCGC00015898-31|NCGC00089796-02|NCGC00089796-04|NCGC00089796-05|NCGC00089796-06|NCGC00089796-07|NCGC00089796-08|NCGC00261757-01|AC-32927|HY-16900|SY012737|SBI-0051042.P002|DB-080675|AB00513966|EU-0101072|NS00034678|R0110|ST50405218|SW196583-4|D01783|R 6520|AB00384360-17|AB00384360_19|Q410285|4-[3-(cyclopentyloxy)-4-methoxyphenyl]pyrrolidinone|SR-01000000162-3|SR-01000000162-4|SR-01000000162-5|SR-01000000162-9|4-[3-Cyclopentyloxy-4-methoxyphenyl]-2-pyrrolidinone|BRD-A34255068-001-04-8|BRD-A34255068-001-26-1|BRD-A34255068-001-32-9|BRD-A34255068-001-33-7|BRD-A34255068-001-34-5|SR-01000000162-12|4-(3-cyclopentyloxy-4-methoxy-phenyl)pyrrolidin-2-one|4-(3-cyclopentyloxy-4-methoxyphenyl)-pyrrolidin-2-one|4-(3-CYCLOPENTYLOXY-4-METHOXYPHENYL)PYRROLIDONE|4-[4-Methoxy-3-(cyclopentyloxy)phenyl]-2-pyrrolidinone|2-Pyrrolidinone, 4-[3-(cyclopentyloxy)-4-methoxyphenyl]- (9CI)"
ZARDAVERINE,5723,,"InChI=1S/C12H10F2N2O3/c1-18-10-6-7(2-4-9(10)19-12(13)14)8-3-5-11(17)16-15-8/h2-6,12H,1H3,(H,16,17)",HJMQDJPMQIHLPB-UHFFFAOYSA-N,C12H10F2N2O3,268.22,3-[4-(difluoromethoxy)-3-methoxyphenyl]-1H-pyridazin-6-one,"zardaverine|101975-10-4|Zardaverina|Zardaverinum|6-(4-(Difluoromethoxy)-3-methoxyphenyl)-3(2H)-pyridazinone|DTXSID8042559|TQ358GWH6Y|CHEBI:46548|DTXCID6022559|6-(4-(difluoromethoxy)-3-methoxyphenyl)pyridazin-3(2H)-one|6-[4-(difluoromethoxy)-3-methoxyphenyl]pyridazin-3(2H)-one|6-[4-(Difluoromethoxy)-3-methoxyphenyl]-3(2H)-pyridazinone|6-(4-difluoromethoxy-3-methoxyphenyl)-3(2H)pyridazinone|RefChem:904808|Zardaverine [INN]|6-(4-DIFLUOROMETHOXY-3-METHOXY-PHENYL)-2H-PYRIDAZIN-3-ONE|MFCD00867059|6-(4-Difluoromethoxy-3-methoxyphenyl)-3(2H)-pyridazinone|CHEMBL313842|3(2H)-Pyridazinone, 6-[4-(difluoromethoxy)-3-methoxyphenyl]-|NCGC00016106-04|3-[4-(difluoromethoxy)-3-methoxyphenyl]-1H-pyridazin-6-one|CAS-101975-10-4|3(2H)-Pyridazinone, 6-[4-(difluoromethoxy)-3-methoxyphenyl]- [CAS]|Zardaverinum [INN-Latin]|Zardaverina [INN-Spanish]|SMR000449313|SR-01000076204|UNII-TQ358GWH6Y|Zaradaverine|1mkd|1xor|Tocris-1046|Prestwick0_000977|Prestwick1_000977|Prestwick2_000977|Prestwick3_000977|Lopac-Z-3003|UPCMLD-DP159|Lopac0_001260|SCHEMBL13334|BSPBio_001013|BSPBio_001346|KBioGR_000066|KBioSS_000066|MLS000758207|MLS001401422|SPBio_002924|BPBio1_001115|orb1706448|SCHEMBL14810549|SCHEMBL29388700|UPCMLD-DP159:001|UPCMLD-DP159:002|BDBM14769|KBio2_000066|KBio2_002634|KBio2_005202|KBio3_000131|KBio3_000132|YQF0753|Bio2_000066|Bio2_000546|HMS1361D08|HMS1571C15|HMS1791D08|HMS1989D08|HMS2051O09|HMS2090L06|HMS2098C15|HMS2235H08|HMS3267C08|HMS3370L18|HMS3393O09|HMS3402D08|HMS3412C09|HMS3676C09|HMS3715C15|BCP06509|Tox21_110307|EX-A11924|AKOS024456348|Tox21_110307_1|Zardaverine phosphodiesterase inhibitor|CCG-100782|CCG-205334|DB02918|NC00032|Zardaverine, phosphodiesterase inhibitor|IDI1_033816|NCGC00016106-01|NCGC00016106-02|NCGC00016106-03|NCGC00016106-05|NCGC00016106-06|NCGC00016106-07|NCGC00016106-08|NCGC00016106-09|NCGC00016106-10|NCGC00016106-11|NCGC00016106-13|NCGC00024963-01|NCGC00024963-02|NCGC00024963-03|NCGC00024963-04|NCGC00024963-05|BZ161227|HY-15485|MS-23783|SBI-0051227.P002|AB00513983|EU-0101260|NS00070483|E98661|Z 3003|AB00513983-03|SR-01000076204-1|SR-01000076204-3|SR-01000076204-5|BRD-K37561857-001-04-9|BRD-K37561857-001-06-4|BRD-K37561857-001-13-0|BRD-K37561857-001-15-5|BRD-K37561857-001-17-1|Q15634082|6-(4-difluoromethoxy-3-methoxy-phenyl)-3[2h]-pyridazinone|3-[4-(difluoromethoxy)-3-methoxy-phenyl]-1H-pyridazin-6-one|6-[4-(difluoromethoxy)-3-methoxyphenyl]-2,3-dihydropyridazin-3-one|3- [4- (Difluoromethoxy) - 3- methoxyphenyl] - 1H- pyridazin- 6- one|6-(3,4-Dimethoxy-phenyl)-4,5-dimethyl-4,5-dihydro-2H-pyridazin-3-one"
DAXALIPRAM,449190,,"InChI=1S/C14H19NO4/c1-4-7-18-12-8-10(5-6-11(12)17-3)14(2)9-15-13(16)19-14/h5-6,8H,4,7,9H2,1-3H3,(H,15,16)/t14-/m0/s1",PCCPERGCFKIYIS-AWEZNQCLSA-N,C14H19NO4,265.30,"(5R)-5-(4-methoxy-3-propoxyphenyl)-5-methyl-1,3-oxazolidin-2-one","Mesopram|Daxalipram|189940-24-7|(5R)-5-(4-Methoxy-3-propoxyphenyl)-5-methyl-1,3-oxazolidin-2-one|0RB5T277IY|SH636|SH-636|ZK117137|ZK-117137|DTXSID001319171|RefChem:131031|DTXCID401748598|5-(methoxy-3-propoxyphenyl)-5-methyl-2-oxazolidinone|(R)-MESOPRAM|[R]-Mesopram|Daxalipram [INN]|CHEMBL603830|Daxalipram; SH 636; ZK 117137|2-Oxazolidinone, 5-(4-methoxy-3-propoxyphenyl)-5-methyl-, (5R)-|(R)-5-(4-Methoxy-3-propoxyphenyl)-5-methyl-2-oxazolidinone|1xm6|DAXALIPRAM [WHO-DD]|UNII-0RB5T277IY|SCHEMBL450823|orb1704376|PCCPERGCFKIYIS-AWEZNQCLSA-N|BDBM50308512|SH 636|AKOS024457404|DB01647|5RM|HY-108622|ZK 117137|CS-0029330|NS00069202"
APREMILAST,11561674,,"InChI=1S/C22H24N2O7S/c1-5-31-19-11-14(9-10-18(19)30-3)17(12-32(4,28)29)24-21(26)15-7-6-8-16(23-13(2)25)20(15)22(24)27/h6-11,17H,5,12H2,1-4H3,(H,23,25)/t17-/m1/s1",IMOZEMNVLZVGJZ-QGZVFWFLSA-N,C22H24N2O7S,460.5,"N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide","Apremilast|608141-41-9|OTEZLA|CC-10004|CC 10004|CC10004|CHEBI:78540|apremilastum|UP7QBP99PN|N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|N-{2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide|DTXSID30976289|Acetamide, N-(2-((1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl)-|Acetamide, N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-|N-(2-((1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl)acetamide|N-(2-((1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methanesulfonylethyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl)acetamide|RefChem:56446|L04AA32|DTXCID101478388|(+)-N-(2-((1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl)acetamide|Apremilast (CC-10004)|(S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione|C22H24N2O7S|MFCD18782607|(S)-N-(2-(1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide|CHEMBL514800|N-[2-[(1S)-1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-1,3-dioxoisoindol-4-yl]acetamide|(+)-N-(2-((1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxo- 2,3-dihydro-1H-isoindol-4-yl)acetamide|Apremilast [USAN]|Apremilast [USAN:INN]|UNII-UP7QBP99PN|Apremilast?|HSDB 8221|(S)-Apremilast|Otezla (TN)|Apremilast (Standard)|APREMILAST [MI]|APREMILAST [INN]|APREMILAST [JAN]|Apremilast (JAN/USAN)|APREMILAST [VANDF]|APREMILAST [WHO-DD]|SCHEMBL302992|Apremilast - Bio-X trade mark|GTPL7372|orb1304839|APREMILAST [ORANGE BOOK]|SCHEMBL29350625|SCHEMBL29446192|EX-A336|IMOZEMNVLZVGJZ-QGZVFWFLSA-N|cas:608141-41-9;Apremilast|ARD15152|BCP03783|BCP25283|BDBM50248919|HY-12085R|s8034|AKOS016339660|BCP9000311|CCG-269336|CS-0671|DB05676|FA29510|FK-0727|AC-27650|BA164215|DA-61173|HY-12085|SY046906|BCP0726000109|SW219856-1|D08860|EN300-7423712|Q2858961|BRD-K93208532-001-02-5|Z1837762189|(S)-4-Acetylamino-2-[1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]isoindoline-1,3-dione|(S)-N-{2-[1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}-acetamide|4-[[5 pound not7-dihydroxy-2 pound not2-dimethyl-8-(2-methylpropanoyl)chromen-6-yl]methy l]-3 pound not5-dihydroxy-6 pound not6-dimethyl-2-(2-methylpropanoyl)cyclohexa-2 pound not4-dien- 1-one|A9L|Acetamide, N-(2-((1S)-1-(3-ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)- 2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl)-|N-[2-[(1S)-1-(3-ethoxy-4-methoxy-phenyl)-2-methylsulfonyl-ethyl]-1,3-dioxo-isoindolin-4-yl]acetamide|N-[2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]acetamide"
CARBACHOL,5831,,"InChI=1S/C6H14N2O2.ClH/c1-8(2,3)4-5-10-6(7)9;/h4-5H2,1-3H3,(H-,7,9);1H",AIXAANGOTKPUOY-UHFFFAOYSA-N,C6H15ClN2O2,182.65,2-carbamoyloxyethyl(trimethyl)azanium;chloride,"carbachol|51-83-2|Carbamylcholine chloride|Miostat|CARBACHOL CHLORIDE|Carbastat|Carbacholine chloride|Carbacholin|Carbacholine|Carbacolina|Carbamiotin|Carbochol|Carbocholin|Carbocholine|Carcholin|Vasoperif|Coletyl|Lentin|Doryl|Moryl|Isopto Carbachol|Choline carbamate chloride|Carbacholum|Carbacol|Karbachol|Choline chlorine carbamate|Mistura C|Choline chloride, carbamate|Doryl (pharmaceutical)|Carbacholinum|Carbaminocholine chloride|Carbach|Lentine|Carbaminoylcholine chloride|Karbamoylcholin chlorid|(2-Carbamoyloxyethyl)trimethylammonium chloride|Carbamoylcholine-hydrochloride|Carbacholum chloratum|Carbacolo|(2-Hydroxyethyl)trimethylammonium chloride carbamate|Choline chloride, carbamoyl-|(2-Hydroxyethyl)trimethyl ammonium chloride carbamate|Choline, chloride carbamate(ester)|gamma-Carbamoyl choline chloride|Carbamic acid, ester with choline chloride|Choline, chloride, carbamate|NSC-32865|TL 457|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminum chloride|2-((Aminocarbonyl)oxy)-N,N,N-trimethylethanaminium chloride|CHEBI:3385|DTXSID9022730|8Y164V895Y|Ethanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-, chloride|DTXCID502730|NSC32865|2-(carbamoyloxy)-N,N,N-trimethylethanaminium chloride|2-carbamoyloxyethyl-trimethylazanium|2-[(aminocarbonyl)oxy]-N,N,N-trimethylethanaminium chloride|Carbachol, Isopto|RefChem:5645|N07AB01|S01EB02|200-127-3|Carboptic|Carbamoylcholine chloride|Jestryl|Carbyl|Rilentol|P. V. Carbachol|Carbachol hydrochloride|Carbamoylcholine (chloride)|2-carbamoyloxyethyl(trimethyl)azanium;chloride|Choline chloride carbamate|MFCD00012011|Lentine [French]|Karbachol [Czech]|Carbacolo [DCIT]|Carbacholini chloridum|CHEMBL14|Doryl (VAN)|Carbacholinium chloratum|Carbacol [INN-Spanish]|Carbacholum [INN-Latin]|2-(trimethylamino)ethyl aminooate, chloride|Karbamoylcholin chlorid [Czech]|HSDB 6373|CAS-51-83-2|SR-01000075312|NCGC00163219-01|(2-Carbamoyloxy-ethyl)-trimethyl-ammonium|EINECS 200-127-3|NSC 32865|Choline, chloride, carbamate, hydrochloride|(carbachol)(2-Carbamoyloxy-ethyl)-trimethyl-ammonium|UNII-8Y164V895Y|2-(trimethylazaniumyl)ethyl carbamate chloride|Carbachol [USP:INN:BAN:JAN]|Choline, carbamate|Miostat (TN)|Prestwick_1036|CARBACHOL [INN]|CARBACHOL [JAN]|CARBACHOL [MI]|Ethanaminium, 2-(aminocarbonyl)oxy-N,N,N-trimethyl-, chloride|CARBACHOL [HSDB]|CARBACHOL [VANDF]|CARBACHOL [MART.]|2-carbamoyloxyethyl(trimethyl)ammonium chloride|CARBACHOL [USP-RS]|CARBACHOL [WHO-DD]|SCHEMBL2791|Carbachol (JAN/USP/INN)|MLS002153502|SPECTRUM1500158|orb2893748|CARBACHOL [EP IMPURITY]|CARBACHOL [ORANGE BOOK]|Carbamoylcholine chloride, 99%|CARBACHOL [EP MONOGRAPH]|HMS502E07|CARBACHOL [USP MONOGRAPH]|Carbachol;Carbamylcholine chloride|Choline, carbamate, hydrochloride|.gamma.-Carbamoyl choline chloride|HMS1570P21|HMS1920I15|HMS2091O17|HMS2097P21|HMS2236L04|HMS3260B08|HMS3372G03|HMS3714P21|Pharmakon1600-01500158|HY-B1208|Tox21_112029|Tox21_500243|CCG-38913|NSC755919|SBB057998|AKOS015909565|AKOS025149486|Tox21_112029_1|CS-4836|FC35133|LP00243|NSC-755919|WLN: ZVO2K1&1&1 &Q &G|NCGC00015237-07|NCGC00093705-01|NCGC00093705-02|NCGC00093705-03|NCGC00093705-04|NCGC00093705-05|NCGC00260928-01|DA-62053|SMR000058584|C0596|EU-0100243|NS00078343|ST51007309|SW197107-3|C 4382|D00524|D89274|EN300-122286|2-aminocarbonyloxyethyl(trimethyl)azanium chloride|A828807|Q419401|SR-01000075312-1|SR-01000075312-3|SR-01000075312-6|(2-Carbamoyloxy-ethyl)-trimethyl-ammonium(Carbachol)|Z1255415481|Carbachol, European Pharmacopoeia (EP) Reference Standard|Carbamoylcholine chloride, >=98% (titration), crystalline|Carbachol, United States Pharmacopeia (USP) Reference Standard|Carbachol, Pharmaceutical Secondary Standard; Certified Reference Material|Ethanaminium, 2-((aminocarbonyl)oxy)-N,N,N-trimethyl-, chloride (1:1)"
ARECOLINE,2230,,"InChI=1S/C8H13NO2/c1-9-5-3-4-7(6-9)8(10)11-2/h4H,3,5-6H2,1-2H3",HJJPJSXJAXAIPN-UHFFFAOYSA-N,C8H13NO2,155.19,"methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate","arecoline|63-75-2|Arecolin|Arecaline|Arecholine|Methylarecaiden|Methylarecaidin|Arekolin|Arecoline base|Arecaidine methyl ester|3-Pyridinecarboxylic acid, 1,2,5,6-tetrahydro-1-methyl-, methyl ester|Arecholin|methyl 1-methyl-1,2,5,6-tetrahydropyridine-3-carboxylate|methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate|Methyl N-methyltetrahydronicotinate|N-Methyltetrahydronicotinic acid, methyl ester|Methyl 1,2,5,6-tetrahydro-1-methylnicotinate|Methyl N-methyl-1,2,5,6-tetrahydronicotinate|DTXSID3022617|NSC-56321|1,2,5,6-Tetrahydro-1-methylnicotinic acid, methyl ester|4ALN5933BH|CHEBI:2814|NICOTINIC ACID, 1,2,5,6-TETRAHYDRO-1-METHYL-, METHYL ESTER|DTXCID502617|methyl 1-methyl-5,6-dihydro-2H-pyridine-3-carboxylate|RefChem:559924|200-565-5|Taeniolin|C8H13NO2|NSC 56321|MFCD00059167|1-Methyl-delta(sup 3,4)tetrahydro-3-pyridinecarboxylate|63-75-2 (free)|1,2,5,6-Tetrahydro-1-methyl-3-pyridinecarboxylic acid methyl ester|1-Methyl-1,2,5,6-tetrahydro-pyridine-3-carboxylic acid methyl ester|NCGC00015075-04|N-Methyl-.delta.-tetrahydronicotinic acid methyl ester|N-Methyltetrahydropyridine-.beta.-carboxylic acid methyl ester|MLS000028840|Arecaidine methyl ester;Arecoline base;Methyl arecaidin; Methylarecaidine; NSC56321|CAS-63-75-2|CCRIS 7688|SMR000058258|EINECS 200-565-5|BRN 0123045|UNII-4ALN5933BH|Arecoline_major|Methylarecaidine|arecoline;hydrobromide|methyl 1-methyl-3,6-dihydro-2H-pyridine-5-carboxylate;hydrobromide|Spectrum_000055|N-Methyltetrahydropyridine-beta-carboxylic acid methyl ester|ARECOLINE [MI]|Prestwick0_000402|Prestwick1_000402|Prestwick2_000402|Prestwick3_000402|Spectrum2_000051|Spectrum3_001387|Spectrum4_000810|Spectrum5_001316|Lopac-A-6134|cid_9301|CHEMBL7303|Lopac0_000049|SCHEMBL44065|BSPBio_000324|BSPBio_002974|GTPL296|KBioGR_001299|KBioSS_000435|DivK1c_000810|SPBio_000201|SPBio_002263|BPBio1_000358|MEGxp0_001891|orb1740527|ACon1_002372|BDBM46858|KBio1_000810|KBio2_000435|KBio2_003003|KBio2_005571|KBio3_002194|pyranosyl)-?-D-galactopyranoside|NINDS_000810|WLN: T6N CUTJ A1 CVO1|ALBB-035732|NSC56321|Tox21_110079|BBL036229|MSK170173|AKOS000520752|Tox21_110079_1|CCG-204145|DB04365|SB54186|SDCCGMLS-0066647.P001|SDCCGSBI-0050038.P004|IDI1_000810|NCGC00015075-01|NCGC00015075-02|NCGC00015075-03|NCGC00015075-05|NCGC00015075-06|NCGC00015075-07|NCGC00015075-10|NCGC00015075-19|NCGC00162053-01|NCGC00162053-02|NCGC00162053-03|AC-34025|CAS-300-08-3|ST095172|SBI-0050038.P003|Methyl N-methyl-1,5,6-tetrahydronicotinate|N-Methyl-beta -carboxylic acid methyl ester|CS-0022545|Methyl 1,5,6-tetrahydro-1-methylnicotinate|NS00002617|EN300-40737|AB00053580_08|AB00053580_09|Methyl 1,2,5, 6-tetrahydro-1-methylnicotinate|Methyl N-methyl-1,2,5, 6-tetrahydronicotinate|L000795|Q423515|SR-01000075307-9|BRD-K88646909-004-05-5|BRD-K88646909-004-06-3|BRD-K88646909-004-10-5|BRD-K88646909-004-15-4|BRD-K88646909-004-16-2|1,5,6-Tetrahydro-1-methylnicotinic acid, methyl ester|Methyl 1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylate|Nicotinic acid,2,5,6-tetrahydro-1-methyl-, methyl ester|Methyl 1-methyl-1,2,5,6-tetrahydro-3-pyridinecarboxylate #|3-Pyridinecarboxylic acid,2,5,6-tetrahydro-1-methyl-, methyl ester|1,2,5,6-Tetrahydro-1-methyl-3-pyridinecarboxylic acid, methyl ester|4-Nitrophenyl 2-Acetamido-2-deoxy-(6-O-2-acetamido-2-deoxy-?-D-gluco-|1-methyl-3,6-dihydro-2H-pyridine-5-carboxylic acid methyl ester;hydrobromide|InChI=1/C8H13NO2/c1-9-5-3-4-7(6-9)8(10)11-2/h4H,3,5-6H2,1-2H"
XANOMELINE,60809,,"InChI=1S/C14H23N3OS/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3",JOLJIIDDOBNFHW-UHFFFAOYSA-N,C14H23N3OS,281.42,"3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole","XANOMELINE|131986-45-3|LY-246708|LY 246708|LY246708|xanomelina|9ORI6L73CJ|CHEBI:10056|LY-246708 FREE BASE|DTXSID60157286|5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine|3-(4-hexoxy-1,2,5-thiadiazol-3-yl)-1-methyl-5,6-dihydro-2H-pyridine|xanomelinum|5-(4-(hexyloxy)-1,2,5-thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydropyridine|RefChem:195101|DTXCID9079777|3-(3-O-hexyl-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine|683-413-4|(3-O-hexyloxy)-TZTP|3-(Hexyloxy)-4-(1-methyl-1,2,5,6-tetrahydropyridin-3-yl)-1,2,5-thiadiazole|C14H23N3OS|MFCD00867179|3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole|Pyridine, 3-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1,2,5,6-tetrahydro-1-methyl-|CHEMBL21536|Xanomeline (USAN)|XANOMELINE [USAN]|Pyridine, 3-(4-(hexyloxy)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methyl-|Xanomeline [USAN:INN]|UNII-9ORI6L73CJ|Cobenfy|Lumeron|Memcor|Hexyloxy-TZTP|KarXT|XANOMELINE [MI]|XANOMELINE [INN]|GTPL57|3-(4-(Hexyloxy)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methylpyridine|XANOMELINE [MART.]|XANOMELINE [WHO-DD]|SCHEMBL121046|orb1693565|JOLJIIDDOBNFHW-UHFFFAOYSA-N|BCP31492|EX-A6592|BDBM50003359|XH1457|AKOS016007489|DB15357|SB18821|NNC-11-0232|DA-78997|DS-15663|SY111357|HY-105182|CS-0025224|NS00122598|C72296|D06330|L000694|Q8042940|BRD-K72815923-034-01-2|LY-246708; LY246708; LY 246708|3-hexoxy-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazoleE|(5M)-5-[4-(hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine|3-(4-hexyloxy-1 ,2,5-thiadiazol-3-yl)-1 ,2,5,6-tetrahydro-1-methyl-pyridine|3-(Hexyloxy)-4-(1-methyl-1,2,5,6-tetrahydro-3-pyridyl)-1,2,5-thiadiazole|5-(4-Hexyloxy-[1,2,5]thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine; oxalic acid|5-[4-(Hexyloxy)-1,2,5-thiadiazol-3-yl]-1-methyl-1,2,3,6-tetrahydropyridine, AldrichCPR|1018845-70-9|XNO"
ACETYLCHOLINE,187,,"InChI=1S/C7H16NO2/c1-7(9)10-6-5-8(2,3)4/h5-6H2,1-4H3/q+1",OIPILFWXSMYKGL-UHFFFAOYSA-N,C7H16NO2+,146.21,2-acetyloxyethyl(trimethyl)azanium,"acetylcholine|O-Acetylcholine|51-84-3|Choline acetate (ester)|2-acetyloxyethyl(trimethyl)azanium|2-(Acetyloxy)-N,N,N-trimethylethanaminium|ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-|CHEBI:15355|N9YNS0M02X|2-acetyloxyethyl-trimethylazanium|DTXSID8075334|[2-(acetyloxy)ethyl]trimethylazanium|(2-(acetyloxy)ethyl)trimethylazanium|Cusi, Acetilcolina|Fluoride, Acetylcholine|RefChem:5512|Hydroxide, Acetylcholine|Acetylcholine L Tartrate|L-Tartrate, Acetylcholine|DTXCID6040951|200-128-9|Acetylcholine Picrate|Choline acetate|(2-Acetoxyethyl)trimethylammonium|Acetyl choline ion|Acetylcholinum|Acetyl choline cation|Ach|Azetylcholin|COL Acetate|Acetylcholine cation|BRN 1764436|(2-Acetoxyethyl)trimetilammonium|CHEMBL667|[3H]acetylcholine|14047-05-3|2-acetoxyethyl(trimethyl)ammonium;bromide|NCGC00018123-05|EINECS 200-128-9|UNII-N9YNS0M02X|2rin|3rqw|(14C)Acetylcholine|(14C)-Acetylcholine|Spectrum_000022|2ha4|2xz5|starbld0009701|Spectrum2_001258|Spectrum3_000286|Spectrum4_000136|Spectrum5_000762|Epitope ID:176773|cid_6060|SCHEMBL3216|ACETYLCHOLINE [VANDF]|BSPBio_001792|GTPL294|KBioGR_000552|KBioSS_000382|4-04-00-01446 (Beilstein Handbook Reference)|DivK1c_000686|SPBio_001196|ACETYLCHOLINE [WHO-DD]|Acetylcholinium: acetyl-Choline|GTPL8593|orb1991950|orb2279699|BDBM10759|KBio1_000686|KBio2_000382|KBio2_002950|KBio2_005518|KBio3_001292|NINDS_000686|HMS2089A14|ACETYLCHOLINE [USP IMPURITY]|NSC800293|AKOS040734806|DB03128|NSC-800293|2-acetyloxy-N,N,N-trimethylethanaminium|IDI1_000686|NCGC00018123-01|NCGC00018123-02|NCGC00018123-03|NCGC00018123-04|NCGC00021161-03|NCGC00021161-04|NCGC00163215-01|2-Acetoxy-N,N,N-trimethylethan-1-aminium|SBI-0051271.P003|CS-0453239|NS00002053|ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl|C01996|AB00053790-25|AB00053790_26|AB00053790_27|L000783|Q180623|BRD-K82381502-003-23-1|BRD-K82381502-003-24-9|Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl- (9CI)|2-(Acetyloxy)-N,N,N-trimethylethanaminium labeled with carbon-14|Ethanaminium, 2-(acetyloxy)-N,N,N-trimethyl-, labeled with carbon-14|InChI=1/C7H16NO2/c1-7(9)10-6-5-8(2,3)4/h5-6H2,1-4H3/q+"
ATROPINE,174174,,"InChI=1S/C17H23NO3/c1-18-13-7-8-14(18)10-15(9-13)21-17(20)16(11-19)12-5-3-2-4-6-12/h2-6,13-16,19H,7-11H2,1H3/t13-,14+,15?,16?",RKUNBYITZUJHSG-PJPHBNEVSA-N,C17H23NO3,289.4,"[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate","ATROPINE|51-55-8|dl-Hyoscyamine|Tropine tropate|Atropen|Atropin|dl-Tropyltropate|Atropinol|Eyesules|Isopto-atropine|Troyl tropate|hyoscyamine|Atropina|Atropin-flexiolen|(+,-)-Tropyl tropate|Atropin [German]|Atropina [Italian]|(+-)-hyoscyamine|Tropine, tropate (ester)|(+-)-atropine|Tropic acid, ester with tropine|(+/-)-Atropine|(+/-)-Hyoscyamine|CCRIS 3080|Atropine (USP)|Tropic acid, 3-alpha-tropanyl ester|Atropinum|Atropine sulfate|HSDB 2199|DL-Tropanyl 2-hydroxy-1-phenylpropionate|2-Phenylhydracrylic acid 3-alpha-tropanyl ester|L-Hyoscyamine|AI3-60219|beta-Phenyl-gamma-oxypropionsaure-tropyl-ester [German]|DL-Tropyl tropate|(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|1alphaH,5alphaH-Tropan-3alpha-ol (+-)-tropate (ester)|beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester [German]|(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate|MFCD00022622|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl tropate|MLS000069795|Tropine tropate;DL-Hyoscyamine|DTXSID4020113|CHEBI:16684|7C0697DR9I|8-Methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenylpropanoate|[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl] 3-hydroxy-2-phenyl-propanoate|endo-(+/-)-alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo(3,2,1)oct-3-yl ester, endo-(+-)-|NCGC00017333-03|SMR000058248|alpha-(Hydroxymethyl)benzeneacetic acid 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester|Atropine Sulfate Ansyr Plastic Syringe|AB00694549-11|Benzeneacetic acid, alpha-(hydroxymethyl)-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+-)-|DTXCID20113|[(1R,5S)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate|CAS-51-55-8|16175-85-2|Atropen (TN)|Protamine & Atropine|Atropine [USP:BAN]|EINECS 200-104-8|Tropine (+/-)-tropate|Pseudoatropine|ropine tropate|UNII-7C0697DR9I|(3-ENDO)-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL TROPATE|(1S,5R)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|NCGC00159345-02|3-tropoyloxytropane|Atropine (Standard)|1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester)|ATROPINE [MI]|ATROPINE [VANDF]|ATROPINUM [HPUS]|Opera_ID_1088|ATROPINE [MART.]|HA7DL7YA9K|RefChem:1092872|beta-Phenyl-gamma-oxypropionsaure-tropyl-ester|ATROPINE [USP-RS]|ATROPINE [WHO-DD]|bmse000649|beta-Phenyl-gamma-oxypropionsaeure-tropyl-ester|SCHEMBL2812|Atropine, analytical standard|GTPL320|Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester|MLS001148094|MLS002695888|ATROPINE [GREEN BOOK]|ATNAA COMPONENT ATROPINE|ATROPINE [EP IMPURITY]|ATROPINE [ORANGE BOOK]|CHEMBL254656|CHEMBL475124|CHEMBL517712|cid_174174|MEGxp0_001878|Atropine ((+/-)-Hyoscyamin)|ATROPINE [EP MONOGRAPH]|Npc209773|(+/-)-Tropoyltropan-3beta-ol|ATROPINE [USP MONOGRAPH]|ATROPINE, (+/-)-|SCHEMBL26698079|ACon1_000046|CHEBI:78734|DUODOTE COMPONENT ATROPINE|HY-B1205R|ATROPINE ((+/-)-)|Atropine, >=95.0% (NT)|RKUNBYITZUJHSG-PJPHBNEVSA-N|BDBM200229|DTXSID601141720|HMS2089A16|HMS2231G17|HMS3259M13|BCP15060|HY-B1205|MSK10189|Atropine, >=99% (TLC), powder|Tox21_110816|Tox21_111590|Tox21_200487|1-alpha-H,5-alpha-H-Tropan-3-alpha-ol (+-)-tropate (ester) (8CI)|BDBM50403547|s4713|SBB005985|AKOS015955538|CS-4834|DB00572|FA32433|NC00493|NCGC00017333-02|NCGC00017333-04|NCGC00017333-05|NCGC00017333-06|NCGC00142514-01|NCGC00142514-03|NCGC00258041-01|NCGC00385525-01|AS-56020|Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+-)-|ST057178|Atropine, meets USP testing specifications|C1504|C01479|D00113|Q26272|AB00694549-12|AB00694549_14|rac-tropan-3alpha-yl 3-hydroxy-2-phenylpropanoate|BRD-A27290375-001-01-8|BRD-A27290375-065-01-3|BRD-A27290375-330-01-1|Atropine, European Pharmacopoeia (EP) Reference Standard|HOMATROPINE HYDROBROMIDE IMPURITY D [EP IMPURITY]|1.ALPHA.H,5.ALPHA.H-TROPAN-3.ALPHA.-OL (+/-)-TROPATE (ESTER)|(3-endo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl alpha-(hydroxymethyl)benzeneacetate|(3-exo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl alpha-(hydroxymethyl)benzeneacetate|(3-exo)-8-Methyl-8-azabicyclo[3.2.1]oct-3-yl I+/--(hydroxymethyl)benzeneacetate|[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3-hydroxy-2-phenyl-propanoate|Atropine for peak identification, European Pharmacopoeia (EP) Reference Standard|rac-(3-endo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3-hydroxy-2-phenylpropanoate|BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-(3-ENDO)-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER|BENZENEACETIC ACID, .ALPHA.-(HYDROXYMETHYL)-8-METHYL-8-AZABICYCLO(3.2.1)OCT-3-YL ESTER, ENDO-(+/-)-|Benzeneacetic acid, alpha-(hydroxymethyl)- (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester|Benzeneacetic acid, alpha-(hydroxymethyl)-, (3-exo)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl ester|Benzeneacetic acid, alpha-(hydroxymethyl)-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-(+/-)-|Benzeneacetic acid, alpha-(hydroxymethyl)-8-methyl-8-azabicyclo [3.2.1]oct-3-yl ester, endo-(+/-)-"
METHSCOPOLAMINE,71183,,"InChI=1S/C18H24NO4/c1-19(2)14-8-12(9-15(19)17-16(14)23-17)22-18(21)13(10-20)11-6-4-3-5-7-11/h3-7,12-17,20H,8-10H2,1-2H3/q+1/t12?,13-,14-,15+,16-,17+/m1/s1",LZCOQTDXKCNBEE-XJMZPCNVSA-N,C18H24NO4+,318.4,"[(1R,2R,4S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate","N-Methylscopolamine|N-methyl scopolamine|Bromide, N-Methylscopolamine|Hyoscine Methiodide|N Methylscopolamine|(1R,2R,4S,5S)-7-(((2S)-3-hydroxy-2-phenylpropanoyl)oxy)-9,9-dimethyl-3-oxa-9-azatricyclo(3.3.1.0^(2,4))nonan-9-ium|(1R,2R,4S,5S)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium|Methiodide, Hyoscine|Methobromide, Hyoscine|RefChem:56667|Methylbromide, Scopolamine|Nitrate, Methylscopolamine|N Methylscopolamine Iodide|N Methylscine Methylsulfate|N Methylscopolamine Bromide|N Methylscopolamine Nitrate|Iodide, N-Methylscopolamine|Methylsulfate, N-Methylscine|Nitrate, N-Methylscopolamine|N Methylscopolamine Methylchloride|DD234|Methylchloride, N-Methylscopolamine|methscopolamine|Methylscopolamine|13265-10-6|N-Methylhyoscine|Methscopolamine ion|Methscopolamine cation|(-)-n-methylscopolamine|VDR09VTQ8U|CHEMBL376897|CHEMBL3140030|[(1S,2S,4R,5R)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] (2S)-3-hydroxy-2-phenylpropanoate|Metylskopolamin|Pamine|CHEMBL3091667|3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9,9-dimethyl-, (1a,2b,4b,5a,7b)|[3H]N-methylscopolamine|UNII-VDR09VTQ8U|[3H]N-methyl scopolamine|[3H]NMS|HSDB 5420|Methyl scopolamine|3C0|N-methylscopolamine (NMS)|SCHEMBL65398|GTPL316|GTPL317|METHSCOPOLAMINE [VANDF]|cid_657297|DTXSID0046931|SCHEMBL29398023|BDBM37635|CHEBI:135361|LZCOQTDXKCNBEE-XJMZPCNVSA-N|BDBM214800|METHYLSCOPOLAMINE [WHO-DD]|NMS|BDBM50241132|BDBM50494458|BDBM50538323|PDSP2_000640|DB11315|PD062645|NS00098775|AB00385828_19|BRD-K05224916-004-01-1|BRD-K48619321-004-16-8|Q27087955|(1R,2R,4S,5S,7s)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0~2,4~]nonane|3-Oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane, 7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-|3-OXA-9-AZONIATRICYCLO(3.3.1.02,4)NONANE, 7-((2S)-3-HYDROXY-1-OXO-2-PHENYLPROPOXY)-9,9-DIMETHYL-, (1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-|3-OXA-9-AZONIATRICYCLO(3.3.1.02,4)NONANE, 7-(3-HYDROXY-1-OXO-2-PHENYLPROPOXY)-9,9-DIMETHYL-, (7(S)-(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.))-|7-(3-Hydroxy-2-phenyl-propionyloxy)-9,9-dimethyl-3-oxa-9-azonia-tricyclo[3.3.1.0*2,4*]nonane"
CIPRALISANT,6450823,,"InChI=1S/C14H20N2/c1-14(2,3)7-5-4-6-11-8-12(11)13-9-15-10-16-13/h9-12H,5,7-8H2,1-3H3,(H,15,16)/t11-,12-/m1/s1",CVKJAXCQPFOAIN-VXGBXAGGSA-N,C14H20N2,216.32,"5-[(1R,2R)-2-(5,5-dimethylhex-1-ynyl)cyclopropyl]-1H-imidazole","CIPRALISANT|Cipralisant [INN]|213027-19-1|Cipralisant, (-)-|309713XSKW|UNII-309713XSKW|(-)-GT-2331|4-[(1R,2R)-2-(5,5-dimethylhex-1-ynyl)cyclopropyl]-3H-imidazole|5-((1R,2R)-2-(5,5-DIMETHYL-1-HEXYN-1-YL)CYCLOPROPYL)-1H-IMIDAZOLE|1H-IMIDAZOLE, 5-((1R,2R)-2-(5,5-DIMETHYL-1-HEXYN-1-YL)CYCLOPROPYL)-|cipralisantum|4-((1R,2R)-2-(5,5-dimethylhex-1-ynyl)cyclopropyl)-3H-imidazole|RefChem:126320|GT-2331|5-[(1R,2R)-2-(5,5-dimethylhex-1-ynyl)cyclopropyl]-1H-imidazole|CHEMBL278462|4-((1R,2R)-2-(5,5-Dimethylhex-1-ynyl)cyclopropyl)-1H-imidazole|GTPL1244|orb1707444|SCHEMBL7069804|CVKJAXCQPFOAIN-VXGBXAGGSA-N|DTXSID501318142|BDBM50074629|BDBM50222968|AKOS040741554|DA-72233|MS-23190|HY-106993|CS-0027076|G13506|Q909387|(1R,2R)-4-(2-(5,5-dimethylhex-1-inyl)-cyclopropyl)imidazol|(1R,2R)-4-(2-(5,5-Dimethylhex-1-ynyl)cyclopropyl)imidazole|4-[(1R,2R)-2-(5,5-Dimethyl-hex-1-ynyl)-cyclopropyl]-1H-imidazole"
CONESSINE,441082,,"InChI=1S/C24H40N2/c1-16-20-8-9-22-19-7-6-17-14-18(25(3)4)10-12-23(17,2)21(19)11-13-24(20,22)15-26(16)5/h6,16,18-22H,7-15H2,1-5H3/t16-,18-,19+,20+,21-,22-,23-,24-/m0/s1",GPLGAQQQNWMVMM-MYAJQUOBSA-N,C24H40N2,356.6,"(1R,2S,5S,6S,9R,12S,13R,16S)-N,N,6,7,13-pentamethyl-7-azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-en-16-amine","conessine|546-06-5|Roquessine|Neriine|Conessin|Wrightine|Conessinum|Conesina|EZ38J9BBDF|Konessin|DTXSID6046000|CHEBI:27965|N,N-dimethylcon-5-enin-3beta-amine|NSC-119994|(3-beta)-N,N-Dimethylcon-5-enin-3-amine|DTXCID4026000|(1R,2S,5S,6S,9R,12S,13R,16S)-N,N,6,7,13-pentamethyl-7-azapentacyclo[10.8.0.02,9.05,9.013,18]icos-18-en-16-amine|(1R,2S,5S,6S,9R,12S,13R,16S)-N,N,6,7,13-pentamethyl-7-azapentacyclo(10.8.0.02,9.05,9.013,18)icos-18-en-16-amine|(+)-Conessine|RefChem:578638|3 beta-(dimethylamino)con-5-enine|conessine dihydrobromide, (3beta)-|(3-beta)-N,N-dimethyl-on-5-enin-3-amine dihydrobromide|208-897-2|N,N,6,7,13-pentamethyl-7-azapentacyclo(10.8.0.02,9.05,9.013,18)icos-18-en-16-amine|Conessine [INN]|MFCD00016752|NSC 119994|ST066907|Con-5-enine, 3.beta.-(dimethylamino)-|((2S,5S,12S,16S,1R,9R,13R)-6,7,13-trimethyl-7-azapentacyclo[10.8.0.0<2,9>.0<5, 9>.0<13,18>]icos-18-en-16-yl)dimethylamine|Conesina [INN-Spanish]|Conessinum [INN-Latin]|UNII-EZ38J9BBDF|Conkurchine, N,18-dihydrotrimethyl-|3beta-(Dimethylamino)con-5-ene|NCGC00095844-01|C24H40N2|CAS-546-06-5|Prestwick_692|EINECS 208-897-2|BRN 4702160|CONESSINE [MI]|Prestwick0_000638|Prestwick1_000638|Prestwick2_000638|Prestwick3_000638|ConessineWrightine; Conessine|BSPBio_000636|BIDD:ER0525|SCHEMBL791146|SPBio_002855|BPBio1_000700|CHEMBL191703|GTPL8981|orb1306560|Conessine, >=97% (HPLC)|BDBM27193|3beta-(Dimethylamino)con-5-enine|GLXC-26648|HMS1569P18|HMS2096P18|Tox21_111531|MSK164242|SBB012585|AKOS024283367|Con-5-enine, 3beta-(dimethylamino)-|Tox21_111531_1|FC57645|(3?)-N,N-Dimethylcon-5-enin-3-amine|NCGC00092388-01|NCGC00092388-03|NCGC00092388-05|NCGC00092388-15|MS-25590|(3beta)-N,N-dimethyl-con-5-enin-3-amine|HY-107566|NS00033145|C06545|F82154|Con-5-enin-3-amine, N,N-dimethyl-, (3beta)-|A1-00780|Q5159518|(1R,2S,5S,6S,9R,12S,13R,16S)-N,N,6,7,13-pentamethyl-7-azapentacyclo[10.8.0.0^{2,9}.0^{5,9}.0^{13,18}]icos-18-en-16-amine"
GSK189254,9798547,,"InChI=1S/C21H25N3O2/c1-22-21(25)17-6-8-20(23-14-17)26-19-7-5-15-9-11-24(18-3-2-4-18)12-10-16(15)13-19/h5-8,13-14,18H,2-4,9-12H2,1H3,(H,22,25)",WROHEWWOCPRMIA-UHFFFAOYSA-N,C21H25N3O2,351.4,"6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)oxy]-N-methylpyridine-3-carboxamide","GSK189254|GSK-189254|GSK-189254 free base|6-((3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-8-yl)oxy)-N-methylpyridine-3-carboxamide|6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-8-yl)oxy]-N-methylpyridine-3-carboxamide|RefChem:922531|GSK 189254|720690-73-3|GSK189254A|GSK 189254A|GSK-189254A|6-((3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-pyridinecarboxamide|MFCD16987635|6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)oxy)-N-methylnicotinamide|6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)oxy]-N-methylpyridine-3-carboxamide|5T4TX6CO53|CHEMBL517140|720690-73-3 (free base)|UNII-5T4TX6CO53|6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yl)oxy]-N-methylnicotinamide|WROHEWWOCPRMIA-UHFFFAOYSA-N|GSK-189,254|6-[(3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-N-methylpyridine-3-carboxamide|SCHEMBL169579|orb1296230|SCHEMBL29769888|GTPL10736|DTXSID801005982|HMS3748C15|BCP29549|EX-A1905|GSK189254A?|VDB69073|BDBM50247054|AKOS032944981|BCP9000737|CS-6206|AC-36239|DA-73901|HY-14111|MS-25443|SY389281|EN300-36038|E77309|Q5514566|Z281777806|6-(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methyl-nicotinamide|6-(3-cyclobutyl-2,3,4,5-tetrahydro-1H-benzo[d]azepin-7-yloxy)-N-methylnicotinamide|GSK 189254A; GSK-189254A;GSK189254;GSK-189254;GSK 189254|3-Pyridinecarboxamide, 6-((3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-|6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)oxy]-N-methyl-pyridine-3-carboxamide|854485-15-7"
GSK-1004723,17747460,,"InChI=1S/C39H49ClN4O2/c40-33-19-15-32(16-20-33)29-38-36-13-3-4-14-37(36)39(45)44(41-38)30-34-12-9-27-43(34)26-8-5-11-31-17-21-35(22-18-31)46-28-10-25-42-23-6-1-2-7-24-42/h3-4,13-22,34H,1-2,5-12,23-30H2/t34-/m1/s1",YANGEESWIGIKOP-UUWRZZSWSA-N,C39H49ClN4O2,641.3,2-[[(2R)-1-[4-[4-[3-(azepan-1-yl)propoxy]phenyl]butyl]pyrrolidin-2-yl]methyl]-4-[(4-chlorophenyl)methyl]phthalazin-1-one,"GSK-1004723|955359-72-5|GSK1004723|GSK 1004723|S08212J4ZR|1(2H)-Phthalazinone, 4-((4-chlorophenyl)methyl)-2-(((2R)-1-(4-(4-(3-(hexahydro-1H-azepin-1-yl)propoxy)phenyl)butyl)-2-pyrrolidinyl)methyl)-|RefChem:144500|2-(((2R)-1-(4-(4-(3-(azepan-1-yl)propoxy)phenyl)butyl)pyrrolidin-2-yl)methyl)-4-((4-chlorophenyl)methyl)-1,2-dihydrophthalazin-1-one|UNII-S08212J4ZR|CHEMBL1767164|(R)-2-((1-(4-(4-(3-(azepan-1-yl)propoxy)phenyl)butyl)pyrrolidin-2-yl)methyl)-4-(4-chlorobenzyl)phthalazin-1(2H)-one|2-[[(2R)-1-[4-[4-[3-(azepan-1-yl)propoxy]phenyl]butyl]pyrrolidin-2-yl]methyl]-4-[(4-chlorophenyl)methyl]phthalazin-1-one|4-[(4-chlorophenyl)methyl]-2-({(2r)-1-[4-(4-{[3-(hexahydro-1h-azepin-1-yl)propyl]oxy}phenyl)butyl]-2-pyrrolidinyl}methyl)-1(2h)-phthalazinone|YANGEESWIGIKOP-UUWRZZSWSA-N|SCHEMBL986140|orb1700488|932373-87-0(free base)|BDBM50341447|AKOS040748453|DB12806|CS-0021741|NS00072523|Q27288388"
HISTAMINE DIHYDROCHLORIDE,5818,,"InChI=1S/C5H9N3.2ClH/c6-2-1-5-3-7-4-8-5;;/h3-4H,1-2,6H2,(H,7,8);2*1H",PPZMYIBUHIPZOS-UHFFFAOYSA-N,C5H11Cl2N3,184.06,2-(1H-imidazol-5-yl)ethanamine;dihydrochloride,"Histamine dihydrochloride|56-92-8|Ceplene|peremin|1H-Imidazole-4-ethanamine, dihydrochloride|histaminum hydrochloricum|3POA0Q644U|NSC-257873|DTXSID1058767|1H-Imidazole-5-ethanamine, hydrochloride (1:2)|NSC257873|Maxamine|Histamine 6X|Histamine Phenolic|Histamine 1522|RefChem:55301|Pain Relieving Arthritis|Australian Dream Back Pain|CVS Arthritis Pain Relief|Hand and Wrist Pain Cream|ROPANA Pain Relief Cream|Arthritis Pain Relief Cream|Histaminum Hydrochloricum 30X|Histaminum 30C Allergy Relief|DTXCID2042014|Histaminum Hydrochloricum 200ck|Histamine Dihydrochloride .025%|Minted Leaf Odorless Pain Relief|Bakers Best Arthritis Pain Relief|Glucosamine Cream EXTRA STRENGTH|2nd CHANCE MOBILITY Pain Relief|Walgreens Arthritis Pain Relief Cream|AMINO ACTIVE Topical Analgesic Cream|Bakers Best Arthritis Pain Relief with Hemp Seed|2-(1-H-imidazol-4-yl) Ethylamine Dihydrochloride|BAKERS BEST Arthritis Pain Relief Cream with Hemp and Lavender|ALLERGEN SCRATCH EXTRACT POSITIVE CONTROL'TORII' HISTAMINE DIHYDROCHLORIDE|200-298-4|Histamine 2HCl|2-(1H-Imidazol-4-yl)ethanamine dihydrochloride|1H-Imidazole-4-ethanamine dihydrochloride|2-(1H-Imidazol-4-yl)ethylamine dihydrochloride|2-(4-Imidazolyl)ethylamine dihydrochloride|MFCD00012703|Histaminedihydrochloride|Histamine chloride|Histamine dichloride|Histamine dihydrochloride [USAN]|2-(1H-imidazol-4-yl)ethan-1-amine dihydrochloride|Histamine (dihydrochloride)|Histaminedium dichloride|2-Imidazol-4-ylethylamine dihydrochloride|Histamine HCl|4-(2-Aminoethyl)imidazole dihydrochloride|histamine dichlorhydrate|HISTAMINE, DIHYDROCHLORIDE|2-(1H-imidazol-5-yl)ethanamine;dihydrochloride|2-(1H-imidazol-5-yl)ethanamine dihydrochloride|2-(1H-imidazol-5-yl)ethan-1-amine dihydrochloride|Histamine dihydrochloride (USAN)|2-[4-Imidazolyl]ethylamine dihydrochloride|2-imidazol-4-ylethylamine, chloride, chloride|SR-01000075270|Bichlorhydrate d'histamine [French]|EINECS 200-298-4|Bichlorhydrate D'histamine|NSC 257873|UNII-3POA0Q644U|histamine dihcl|AI3-24394|Histamine dihydrochloride; 2-(1H-imidazol-4-yl)ethanamine dihydrochloride|Ceplene (TN)|MFCD08060928|Histamine dihydrocloride|Bichlorhydrated'Histamine|SCHEMBL58710|histamine dihydrochloride salt|SPECTRUM1500331|orb1300684|CHEMBL1533310|SCHEMBL16778301|HY-B0722R|TIMTEC-BB SBB003722|1H-Imidazole-4-ethanamine 2HCl|MSK9098|HMS1920D11|HMS5082I16|BCP16313|HY-B0722|STR02021|Tox21_500595|CCG-38567|HB2803|s4118|SBB003722|HISTAMINE DIHYDROCHLORIDE [MI]|AKOS015894236|AKOS016353223|AC-7507|BS-3141|CS-W020699|FH10867|Histamine (dihydrochloride) (Standard)|HISTAMINE HYDROCHLORIDE [MART.]|KS-5310|LP00595|HISTAMINE HYDROCHLORIDE [WHO-DD]|HISTAMINUM HYDROCHLORICUM [HPUS]|NCGC00093973-01|NCGC00093973-02|NCGC00093973-03|NCGC00261280-01|2-(4-Imidazolyl)ethylaminedihydrochloride|4-(2-aminoethyl)imidazole dihydorchloride|BP-12001|HISTAMINE DIHYDROCHLORIDE [USP-RS]|SY012860|DB-019204|HISTAMINE DIHYDROCHLORIDE [EMA EPAR]|Histamine dihydrochloride, >=99.0% (AT)|EU-0100595|H0146|NS00078856|ST50308016|SW219552-1|EN300-75558|4-(2-Aminoethyl)-1H-imidazole dihydrochloride|D04444|EDIHYDROCHLORIDEAVAILABLEFROM1KGTO100KG.|H 7250|H-2250|HISTAMINE DIHYDROCHLORIDE [EP MONOGRAPH]|012H703|F068673|Histamine dihydrochloride, >=99% (TLC), powder|1H-IMIDAZOLE-4-ETHANAMINE, CHLORIDE (1:1)|Q5772985|SR-01000075270-1|SR-01000075270-7|Histamine dihydrochloride, tested according to Ph Eur|F2191-0277|Histamine dihydrochloride, SAJ special grade, >=98.0%|Histamine dihydrochloride, Vetec(TM) reagent grade, 98%|Z1267773750|2-(1H-IMIDAZOL-5-YL)ETHANAMINE HYDROCHLORIDE (1:1)|Histamine dihydrochloride 100 microg/mL in Acetonitrile/Water|Histamine dihydrochloride, European Pharmacopoeia (EP) Reference Standard|Histamine dihydrochloride, United States Pharmacopeia (USP) Reference Standard|2-(4-Imidazolyl)ethylamine dihydrochloride;2-(1H-Imidazol-4-yl)ethylamine dihydrochloride, Histamine dihydrochloride"
FENTANYL,3345,,"InChI=1S/C22H28N2O/c1-2-22(25)24(20-11-7-4-8-12-20)21-14-17-23(18-15-21)16-13-19-9-5-3-6-10-19/h3-12,21H,2,13-18H2,1H3",PJMPHNIQZUBGLI-UHFFFAOYSA-N,C22H28N2O,336.5,N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide,"fentanyl|Fentanil|Phentanyl|Fentanest|437-38-7|Duragesic|Fentanila|Fentanylum|Sublimase|Durogesic|Matrifen|Duragesic-100|N-(1-Phenethylpiperidin-4-yl)-N-phenylpropionamide|Duragesic-12|Duragesic-25|Duragesic-50|Duragesic-75|Fentanyl-12|Fentanyl-25|Fentanyl-50|Fentanyl-75|Recuvyra|Subsys|Fentanyl-100|PecFent|Fentanyl CII|1-Phenethyl-4-N-propionylanilinopiperidine|effentora|N-(1-Phenethyl-4-piperidyl)propionanilide|Fendrop|N-Phenethyl-4-(N-propionylanilino)piperidine|1-Phenethyl-4-(N-phenylpropionamido)piperidine|Durogesic d-trans|N-(1-Phenethyl-4-piperidinyl)-N-phenylpropionamide|Fentanilo|Rapinyl|R 4263|N-Phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)propanamide|CHEBI:119915|Fentanyl Transdermal System|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide|N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]propanamide|Propionanilide, N-(1-phenethyl-4-piperidyl)-|IDS-NF-001|DTXSID9023049|En3267|N02AB03|UF599785JZ|AD-923|EN-3267|DTXCID103049|R4263|Propanamide, N-phenyl-N-(1-(2-phenylethyl)-4-piperidinyl)-|Propanamide, N-phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]-|Fentanyl-37|Fentanyl-62|Fentanyl-87|N-phenyl-N-(1-(2-phenylethyl)piperidin-4-yl)propanamide|Breakyl|Fencino|Mylafent|Opiodur|Osmanil|Recivit|Tilofyl|Victanyl|Osmach|Yemex|Mezolar matrix|Fentanyl System|Durogesic dtrans|Fentalis reservoir|RefChem:6639|DURAGESIC-37|N01AH01|207-113-6|Fentora|Sentonil|Sublimaze|Fentanylum [INN-Latin]|Fentanila [INN-Spanish]|CHEMBL596|NCGC00168252-01|Fentanil [DCIT]|Durotep MT|HSDB 3329|EINECS 207-113-6|JNS020QD|BRN 0494484|UNII-UF599785JZ|Abstral-|Fentanyl [USAN:USP:INN:BAN]|N-Phenyl-N-{1-[2-(~2~H_5_)phenylethyl]piperidin-4-yl}propanamide|Duragesic (TN)|7V7|Subsys (TN)|FENTANYL-HCl|201415-26-1|Tranq component fentanyl|FENTANYL [HSDB]|FENTANYL [USAN]|FENTANYL [INN]|FENTANYL [JAN]|FENTANYL [MI]|FENTANYL [VANDF]|FENTANYL [MART.]|Epitope ID:153507|FENTANYL [WHO-DD]|SCHEMBL8804|Fentanyl (JAN/USP/INN)|FENTANYL [EMA EPAR]|Oprea1_152073|Oprea1_207148|5-22-08-00049 (Beilstein Handbook Reference)|BIDD:GT0555|FENTANYL [GREEN BOOK]|Fentanyl, 1mg/ml in Methanol|FENTANYL [EP IMPURITY]|FENTANYL [ORANGE BOOK]|FENTANYL CII [USP-RS]|GTPL1626|FENTANYL [EP MONOGRAPH]|FENTANYL [USP MONOGRAPH]|Fentanyl 0.1 mg/ml in Methanol|Fentanyl 1.0 mg/ml in Methanol|Fentanyl, 0.1mg/ml in Methanol|N-(1-(2-phenylethyl)-4-piperidinyl)-N-phenylpropanamide|Fentanyl (1.0 mg/mL in Methanol)|Tox21_112611|AD 923|BDBM50008984|HY-U00158|PDSP1_000860|PDSP2_000846|FENTANYL [EMA EPAR VETERINARY]|CS-7211|DB00813|CAS-437-38-7|NS00000044|N-(1-Phenylethyl-4-piperidinyl)propionanilide|D00320|1-(2-Phenylethyl)-4-(N-propananilido)piperidine|L001275|Q407541|N-Phenyl-N-[1-(2-phenylethyl)-4-piperidinyl]propanamide #|N-(1-Phenethyl-piperidin-4-yl)-N-phenyl-propionamide(Fentanyl)|PROPANAMIDE, N-PHENYL-N-(1-(2-PHENYLETHYL)-4-PIPERIDINYL)"
LOPERAMIDE,3955,,"InChI=1S/C29H33ClN2O2/c1-31(2)27(33)29(24-9-5-3-6-10-24,25-11-7-4-8-12-25)19-22-32-20-17-28(34,18-21-32)23-13-15-26(30)16-14-23/h3-16,34H,17-22H2,1-2H3",RDOIQAHITMMDAJ-UHFFFAOYSA-N,C29H33ClN2O2,477.0,"4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide","loperamide|53179-11-6|Loperamida|Loperamidum|4-[4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl]-N,N-dimethyl-2,2-diphenylbutanamide|Fortasec|6X9OC3H4II|CHEBI:6532|DTXSID6045165|4-(4-(4-chlorophenyl)-4-hydroxypiperidin-1-yl)-N,N-dimethyl-2,2-diphenylbutanamide|4-(4-Chlorophenyl)-N,N-dimethyl-alpha,alpha-diphenyl-4-hydroxy-1-piperidinebutanamide|DTXCID4025165|1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-alpha,alpha-diphenyl-|NSC696356|RefChem:5959|258-416-5|Imodium|Maalox Anti-Diarrheal|Loperamide (INN)|Ioperamide|CHEMBL841|Loperamidum [INN-Latin]|Loperamida [INN-Spanish]|NCGC00015608-04|Loperacap|LOPERAMIDE [INN]|Apo-Loperamide|Nu-Loperamide|Rho-Loperamide|Kaopectate II|PMS-Loperamide|Loperamide [INN:BAN]|1-Piperidinebutanamide, 4-(4-chlorophenyl)-4-hydroxy-N,N-dimethyl-.alpha.,.alpha.-diphenyl-|2-methoxyethyl1-methylethyl2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Imodium A-D Caplets|4-(p-Chlorophenyl)-4-hydroxy-N,N-dimethyl-.alpha.,.alpha.-diphenyl-1-piperidinebutyramide|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-N,N-dimethyl-2,2-diphenylbutanamide|Diamide (TN)|CAS-53179-11-6|EINECS 258-416-5|UNII-6X9OC3H4II|BRN 1558273|Immodium|LoperamideHCl|Spectrum_000374|Tocris-0840|LOPERAMIDE [MI]|LOPERAMIDE [JAN]|Prestwick0_000144|Prestwick1_000144|Prestwick2_000144|Prestwick3_000144|Spectrum2_001738|Spectrum3_001015|Spectrum4_001143|Spectrum5_001374|Lopac-L-4762|LOPERAMIDE [VANDF]|EC 258-416-5|LOPERAMIDE [WHO-DD]|CBiol_001796|Lopac0_000708|Oprea1_109220|SCHEMBL28530|BSPBio_000248|BSPBio_001381|BSPBio_002769|KBioGR_000101|KBioGR_001685|KBioSS_000101|KBioSS_000854|5-21-02-00379 (Beilstein Handbook Reference)|cid_71420|DivK1c_000215|SPBio_001816|SPBio_002187|BPBio1_000274|GTPL7215|HSDB 8344|KBio1_000215|KBio2_000101|KBio2_000854|KBio2_002669|KBio2_003422|KBio2_005237|KBio2_005990|KBio3_000201|KBio3_000202|KBio3_001989|NINDS_000215|Bio1_000082|Bio1_000571|Bio1_001060|Bio2_000101|Bio2_000581|HMS1791F03|HMS1989F03|HMS2089C13|Tox21_110180|BDBM50017698|EX-A12370|STK042086|AKOS000573892|Tox21_110180_1|CCG-204793|DB00836|SDCCGSBI-0050686.P004|4-(4-Chlorophenyl)-N,N-dimethyl-.alpha.,.alpha.-diphenyl-4-hydroxy-1-piperidinebutanamide|IDI1_000215|IDI1_033851|NCGC00015608-01|NCGC00015608-02|NCGC00015608-03|NCGC00015608-05|NCGC00015608-06|NCGC00015608-07|NCGC00015608-08|NCGC00015608-09|NCGC00015608-11|NCGC00015608-15|NCGC00015608-24|NCGC00016828-01|NCGC00024818-01|NCGC00024818-02|NCGC00024818-03|NCGC00024818-04|NCGC00024818-05|DA-75076|ST095179|SBI-0050686.P003|CAS-34552-83-5|AB00053697|CS-0892719|NS00002516|C07080|D08144|EN300-708764|AB00053697-12|AB00053697-13|AB00053697_14|AB00053697_15|179L116|A829430|L000709|Q423751|BRD-K61250553-001-02-9|BRD-K61250553-003-05-8|BRD-K61250553-003-16-5|BRD-K61250553-003-29-8|BRD-K61250553-003-30-6|BRD-K61250553-003-32-2|LOPERAMIDE OXIDE MONOHYDRATE IMPURITY A [EP IMPURITY]|4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-N,N-dimethyl-2,2-diphenyl-butyramide|4-[4-(4-Chlorophenyl)-4-hydroxy-1-piperidinyl]-N,N-dimethyl-2,2-diphenylbutanamide #|4-[4-(4-chlorophenyl)-4-hydroxypiperidyl]-N,N-dimethyl-2,2-diphenylbutanamide|4-[4-(4-Chloro-phenyl)-4-hydroxy-piperidin-1-yl]-N,N-dimethyl-2,2-diphenyl-butyramide(loperamide)"
APREPITANT,135413536,,"InChI=1S/C23H21F7N4O3/c1-12(14-8-15(22(25,26)27)10-16(9-14)23(28,29)30)37-20-19(13-2-4-17(24)5-3-13)34(6-7-36-20)11-18-31-21(35)33-32-18/h2-5,8-10,12,19-20H,6-7,11H2,1H3,(H2,31,32,33,35)/t12-,19+,20-/m1/s1",ATALOFNDEOCMKK-OITMNORJSA-N,C23H21F7N4O3,534.4,"3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one","Aprepitant|170729-80-3|MK-869|MK-0869|Aponvie|Cinvanti|L-754030|aprepitantum|ONO-7436|1NF15YR6UY|NSC-748825|5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,2-dihydro-1,2,4-triazol-3-one|DTXSID3049047|L-754,030|CHEBI:499361|DTXCID801021794|5-[[(2R,3S)-2-[(1R)-1-[3,5-BIS(Trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one|3H-1,2,4-Triazol-3-one, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-|3H-1,2,4-Triazol-3-one, 5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-2,4-dihydro-|3-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-4,5-dihydro-1H-1,2,4-triazol-5-one|3-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-4,5-dihydro-1H-1,2,4-triazol-5-one|5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-3H-1,2,4-Triazol-3-one|5-(((2R,3S)-2-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholin-4-yl)methyl)-1,2-dihydro-1,2,4-triazol-3-one|MK0517|RefChem:57104|L 754,030|A04AD12|MK869|L754030|L754,030|677-636-6|Emend|MFCD08277635|CHEMBL1471|C23H21F7N4O3|5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-3(2H)-one|5-[2(R)-[1(R)-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY]-3(S)-(4-FLUOROPHENYL)MORPHOLIN-4-YLMETHYL]-3,4-DIHYDRO-2H-1,2,4-TRIAZOL-3-ONE|3-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl]-1,4-dihydro-1,2,4-triazol-5-one|321125-94-4|5-{[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,3-dihydro-1H-1,2,4-triazol-3-one|Aprepitant [USAN]|MK0869|MK 869|3-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-1H-1,2,4-triazol-5(4H)-one|5-[(2R,3S)-2-[(R)-1-(3,5-Bis-trifluoromethyl-phenyl)-ethoxy]-3-(4-fluoro-phenyl)-morpholin-4-ylmethyl]-2,4-dihydro-[1,2,4]triazol-3-one|MK 0869|CAS-170729-80-3|Emend (TN)|Aprepitant (MK-0869)|UNII-1NF15YR6UY|L 754030|eMende|Aprepitant [USAN:INN:JAN]|NCGC00181785-01|Cinvanti (TN)|5-[[(2R,3S)-2-[(R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)morpholino]methyl]-1H-1,2,4-triazol-3(2H)-one|aprepitant, form I|Aponvie (TN)|aprepitant, form II|Aprepitant (Standard)|APREPITANT [MI]|APREPITANT [INN]|APREPITANT [JAN]|APREPITANT [VANDF]|APREPITANT [MART.]|APREPITANT [USP-RS]|APREPITANT [WHO-DD]|Aprepitant (JAN/USP/INN)|MLS006011068|APREPITANT [EMA EPAR]|SCHEMBL264924|SCHEMBL280611|Aprepitant - Bio-X trade mark|GTPL3490|orb1307556|SCHEMBL7117513|APREPITANT [ORANGE BOOK]|APREPITANT [EP MONOGRAPH]|EX-A212|APREPITANT [USP MONOGRAPH]|GLXC-05008|HMS2090N12|HMS3714E16|HMS3884G05|ONO 7436|Tox21_113595|BDBM50220136|HY-10052R|NSC748825|s1189|AKOS015895498|AKOS015969344|Tox21_113595_1|BCP9000312|CCG-220747|CCG-264854|CS-0487|DB00673|FA17962|NSC 748825|NCGC00181785-03|NCGC00181785-11|NCGC00181785-12|NCGC00344566-01|3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-Delta(2)-1,2,4-triazolin-5-one|3-(((2R,3S)-3-(p-Fluorophenyl)-2-(((alphaR)-alpha-methyl-3,5-bis(trifluoromethyl)benzyl)oxy)morpholino)methyl)-delta(sup 2)-1,2,4-triazolin-5-one|5-{[(2R,3S)-2-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)morpholin-4-yl]methyl}-2,4-dihydro-3H-1,2,4-triazol-3-one|AS-14638|BA164216|HY-10052|SMR002530053|SY027654|Aprepitant (MK-0869, L-754030)?|A3135|Aprepitant,MK-0869, L-754030, Emend|C21555|D02968|EN300-761455|SBI-0654102.0001|AB01274775-01|AB01274775_02|AB01275535-01|729A803|SR-05000001531|SR-05000001531-1|BRD-K52827117-001-01-6|Z2937147473|Aprepitant, United States Pharmacopeia (USP) Reference Standard|3-(((2R,3S)-3-(P-FLUOROPHENYL)-2-(((.ALPHA.R)-.ALPHA.-METHYL-3,5-BIS(TRIFLUOROMETHYL)BENZYL)OXY)MORPHOLINO)METHYL)-.DELTA.(SUP 2)-1,2,4-TRIAZOLIN-5-ONE.|3-[((2R,5-bis(trifluoromethyl)benzyl]oxy}morpholino)methyl]-.delta.2-1,2,4-triazolin-5-one|3-[2-{1-[3,5-di(trifluoromethyl)phenyl]ethoxy}-3-(4-fluorophenyl)-1,4-oxazinan-4-ylmethyl]-4,5-dihydro-1H-1,2,4-triazol-5-one|3H-1,2,4-Triazol-3-one, 5-((2-(1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)-4-morpholinyl)methyl)-1,2-dihydro-, (2R-(2alpha(R*),3alpha))-|3H-1,2,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-, rel-|3H-1,2,4-Triazol-3-one,5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-,rel-|3H-1,4-Triazol-3-one, 5-[[(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-|5-(((2R,3S)-2-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-3-(4-fluorophenyl)morpholino)methyl)-2H-1,2,4-triazol-3(4H)-one|5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4 -fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-3-one; MK-0869; MK 0869; MK 869; L-754030; L 754030|5-[[(2R,3S)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-3H-1,2,4-triazol-  3-one;Emend;L 754030"
BAZEDOXIFENE,154257,,"InChI=1S/C30H34N2O3/c1-22-28-20-26(34)12-15-29(28)32(30(22)24-8-10-25(33)11-9-24)21-23-6-13-27(14-7-23)35-19-18-31-16-4-2-3-5-17-31/h6-15,20,33-34H,2-5,16-19,21H2,1H3",UCJGJABZCDBEDK-UHFFFAOYSA-N,C30H34N2O3,470.6,1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol,"Bazedoxifene|198481-32-2|Conbriza|Bazedoxifeno|TSE-424|1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-|Q16TT9C5BK|WAY 140424|1-[[4-[2-(azepan-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methylindol-5-ol|DTXSID70173593|TSE424|1H-Indol-5-ol, 1-((4-(2-(hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-|bazedoxifenum|1-((4-(2-(azepan-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol|1-((4-(2-(azepan-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methylindol-5-ol|1-({4-[2-(azepan-1-yl)ethoxy]phenyl}methyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol|RefChem:116748|DTXCID3096084|G03XC02|Viviant|Bazedoxifene [INN]|Bazedoxifene free base|C30H34N2O3|CHEMBL46740|1-[[4-[2-(AZEPAN-1-YL)ETHOXY]PHENYL]METHYL]-2-(4-HYDROXYPHENYL)-3-METHYL-INDOL-5-OL|198481-32-2 (free base)|1-(4-(2-(azepan-1-yl)ethoxy)benzyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol|1-[4-(2-Azepan-1-yl-ethoxy)-benzyl]-2-(4-hydroxy-phenyl)-3-methyl-1H-indol-5-ol|UNII-Q16TT9C5BK|Bazedoxifeno [INN-Spanish]|Bazedoxifene?|1-{4-[2-(azepan-1-yl)ethoxy]benzyl}-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol|1H-Indol-5-ol, 1-[[4-[2-(hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-; 1-[[4-[2-(Hexahydro-1H-azepin-1-yl)ethoxy]phenyl]methyl]-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol; Bazedoxifene; WAY 140424|MFCD05148441|Bazedoxifene (Standard)|BAZEDOXIFENE [MI]|BAZEDOXIFENE [VANDF]|SCHEMBL41935|orb341885|BAZEDOXIFENE [WHO-DD]|GTPL7355|BAZEDOXIFENE [EMA EPAR]|SCHEMBL29370682|HY-A0031R|CHEBI:135947|UCJGJABZCDBEDK-UHFFFAOYSA-N|EX-A5409|HY-A0031|MSK11395|BDBM50099585|NSC823462|AKOS030255808|AK R215 COMPONENT BAZEDOXIFENE|AK-R215 COMPONENT BAZEDOXIFENE|CS-0932|DB06401|NSC-823462|SB19326|1-((4-(2-Hexahydro-1H-azepin-1-yl)ethoxy)phenyl)methyl)-2-(4-hydroxyphenyl)-3-methyl-1H-indol-5-ol|AS-78494|US8815934, No. 98|DB-345621|NS00007594|D94589|AB01566901_01|EN300-20600169|Q4875166|BRD-K90195324-003-02-5|BRD-K90195324-003-03-3|1-(P-(2-(HEXAHYDRO-1H-AZEPIN-1-YL)ETHOXY)BENZYL)-2-(P-HYDROXYPHENYL)-3-METHYLINDOL-5-OL"
OSANETANT,219077,,"InChI=1S/C35H41Cl2N3O2/c1-27(41)38(2)35(29-13-7-4-8-14-29)19-23-39(24-20-35)21-9-17-34(30-15-16-31(36)32(37)25-30)18-10-22-40(26-34)33(42)28-11-5-3-6-12-28/h3-8,11-16,25H,9-10,17-24,26H2,1-2H3/t34-/m0/s1",DZOJBGLFWINFBF-UMSFTDKQSA-N,C35H41Cl2N3O2,606.6,"N-[1-[3-[(3R)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl]-4-phenylpiperidin-4-yl]-N-methylacetamide","Osanetant|160492-56-8|SR-142801|SR142801|SB-236984|SR-14280|K7G81N94DT|n-(1-{3-[(3r)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl}-4-phenylpiperidin-4-yl)-n-methylacetamide|N-[1-[3-[(3R)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl]-4-phenylpiperidin-4-yl]-N-methylacetamide|SR 142801|SR-142,801|osanetantum|N-(1-(3-((3R)-1-(benzoyl)-3-(3,4-dichlorophenyl)piperidin-3-yl)propyl)-4-phenylpiperidin-4-yl)-N-methylacetamide|N-(1-(3-((3R)-1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl)propyl)-4-phenylpiperidin-4-yl)-N-methylacetamide|N-[1-[3-[(3R)-1-(benzoyl)-3-(3,4-dichlorophenyl)piperidin-3-yl]propyl]-4-phenylpiperidin-4-yl]-N-methylacetamide|RefChem:856963|ACER801|ACER 801|ACER-801|SR14280|SR 14280|Osanetant [INN]|SR-142806|CHEMBL346178|Acetamide, N-[1-[3-[(3R)-1-benzoyl-3-(3,4-dichlorophenyl)-3-piperidinyl]propyl]-4-phenyl-4-piperidinyl]-N-methyl-|N-(1-(3-((R)-1-Benzoyl-3-(3,4-dichlorophenyl)-3-piperidyl)propyl)-4-phenyl-4-piperidyl)-N-methylacetamide|N-(1-(3-((3R)-1-benzoyl-3-(3,4-dichlorophenyl)-3-piperidinyl)propyl)-4-phenyl-4-piperidinyl)-N-methylacetamide|[3H]osanetant|(R)-N-(1-(3-(1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl)propyl)-4-phenylpiperidin-4-yl)-N-methylacetamide|N-(1-{3-[(R)-1-Benzoyl-3-(3,4-dichloro-phenyl)-piperidin-3-yl]-propyl}-4-phenyl-piperidin-4-yl)-N-methyl-acetamide|SR 142806|UNII-K7G81N94DT|C35H41Cl2N3O2|N-[1-[3-[(3R)-1-Benzoyl-3-(3,4-dichlorophenyl)-3-piperidinyl]propyl]-4-phenyl-4-piperidinyl]-N-methylacetamide|[3H]SR142801|[3H]SR142,801|MLS006010325|SCHEMBL119440|GTPL2110|GTPL3480|orb1706862|SCHEMBL29371450|DTXSID901027521|GLXC-03645|HMS3754M21|BDBM50291261|MFCD00938554|PDSP1_001495|PDSP2_001479|AKOS015895948|BCP9001032|DB04872|NCGC00263110-01|NCGC00263110-02|(S)-(N)-(1-(3-(1-benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl)propyl)-4-phenylpiperidin-4-yl)-N-methylacetamide|Acetamide, N-(1-(3-(1-benzoyl-3-(3,4-dichlorophenyl)-3-piperidinyl)propyl)-4-phenyl-4-piperidinyl)-N-methyl-, (R)-|DA-66379|HY-14551|MS-30672|N-[1-[3-[(3R)-1-benzoyl-3-(3,4-dichlorophenyl)-3-piperidyl]propyl]-4-phenyl-4-piperidyl]-N-methyl-acetamide|SMR004701389|CS-0003438|NS00069603|SR 142,806|E98685|Q7105703|BRD-K15646852-001-01-5|(S)-(+)-N-((3-[1-Benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]prop-1-yl)-4-phenylpiperidin-4-yl)-N-methylacetamine"
ESTRADIOL,5757,,"InChI=1S/C18H24O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t14-,15-,16+,17+,18+/m1/s1",VOXZDWNPVJITMN-ZBRFXRBCSA-N,C18H24O2,272.4,"(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","estradiol|beta-Estradiol|50-28-2|17beta-Estradiol|Oestradiol|Dihydrofolliculin|Estrace|Vivelle|Dihydrotheelin|Dihydroxyestrin|Diogynets|Gynoestryl|Aquadiol|Climara|Diogyn|Divigel|Gynergon|Vagifem|Dimenformon|Aerodiol|Estraderm|Estrogel|Femestral|Evorel|cis-Estradiol|Estraldine|Estring|Systen|Zumenon|estradiol-17beta|Compudose|Innofem|Alora|17beta-Oestradiol|Fempatch|Gynodiol|Ovocylin|Esclim|Elestrin|Evamist|Menostar|17-beta-estradiol|17 beta-Estradiol|3,17-Epidihydroxyestratriene|Estraderm TTS 50|Estraderm MX|VIVELLE-DOT|NSC-9895|17beta oestradiol|Oestradiol-17beta|Estra-1,3,5(10)-triene-3,17beta-diol|(17beta)-Estra-1,3,5(10)-triene-3,17-diol|Estradiol-17 beta|Elestrim|Minivelle|Estradiol Anhydrous|Estradiol 17-beta|17-beta-oestradiol|(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol|Estraderm TTS 100|CHEBI:16469|NSC-20293|17beta-Estra-1,3,5(10)-triene-3,17-diol|IMVEXXY|DTXSID0020573|Estradiol valerate metabolite e2|Estra-1,3,5(10)-triene-3,17-diol (17beta)-|4TI98Z838E|WC3011|WC-3011|DTXCID80573|3,17beta-Dihydroxyestra-1,3,5(10)-triene|S21400 (INTRANASAL)|NSC9895|ORIAHNN COMPONENT ESTRADIOL|s21400|S 21400|Aquagen|Gvnodiol|Gynogen|Sandrena|Yuvafem|Bedol|NSC20293|Adgyn estro|Elleste solo|Progynova ts|Estradiol Gel|Estradiol pellet|Estradiol,|E-Cypionate|Vivelle Dot|Estradiol Vaginal|Estrogen 4X|Dermestril 25|Dermestril 50|Estradiol 17beta|Vagifem 8|Estraderm mx 25|Estraderm mx 50|Estraderm mx 75|Fematrix 40|Fematrix 80|Femseven 50|Femseven 75|Menorest 50|Menorest 75|Menoring 50|Dermestril 100|Estraderm tts 25|estradiol valeriante|(8R,9S,13S,14S,17S)-13-methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta(a)phenanthrene-3,17-diol|Vagifem 18|17 beta Estradiol|Estradiol 17 beta|Femseven 100|17 beta Oestradiol|17 beta-Oestradiol|Estraderm mx 100|Estradiol 1557|Estradiol 17 alpha|Estradiol Transdermal|Evorel 25|Evorel 50|Evorel 75|Therapeutic Estradiol|DOTTI|LYLLANA|Menorest 37.5|Elleste solo mx 40|Elleste solo mx 80|Estra-25|Estra-50|Dermestril septem 25|Dermestril septem 50|Dermestril septem 75|Evorel 100|Estradiol Gel 0.1%|Estradiol Vaginal Cream|RefChem:6428|ESTROGEN PHENOLIC|Estradiol, (17-alpha)-|Estradiol Transdermal System|ESTRADIOL VAGINAL INSERTS|(1S,10R,11S,14S,15S)-15-methyltetracyclo(8.7.0.02,7.011,15)heptadeca-2(7),3,5-triene-5,14-diol|200-023-8|Benzhormovarine|CHEBI:23965|progynon|Ovocyclin|Oestroglandol|Corpagen|Estrovite|Follicyclin|Ginosedol|Macrodiol|Oestergon|Ovahormon|Ovasterol|Ovastevol|Perlatanol|Primofol|Profoliol|Altrad|Bardiol|Femogen|Lamdiol|Syndiol|Dihydromenformon|Estroclim|Trocosone|Menorest|Nordicol|D-Oestradiol|D-Estradiol|Estraderm TTS|Progynon DH|Climaderm|Dermestril|Ovocycline|Encore|Menest|Oesclim|Dihydroxyoestrin|SK-Estrogens|Progynon-DH|Gynestrel|Microdiol|Oestrogynal|Ovociclina|Tradelia|Estroclim 50|Macrol|Zerella|Oestradiol R|Estring vaginal ring|Trial SAT|Theelin, dihydro-|Oestrogel|Compudose 200|Compudose 365|Profoliol B|Estradiol-17-beta|Estradot|Estrogen|Gelestra|Zesteem|Dihydroxyesterin|cis-Oestradiol|Estrogens, esterified|17.beta.-Estradiol|B-Estradiol|17b-Oestradiol|Epiestriol 50|Amnestrogen|Femanest|3,17-Epidihydroxyoestratriene|Sandrena 1|17b-Estradiol|Estraderm (TN)|[3H]-estradiol|17|A-Oestradiol|Estrogel (TN)|Climara (TN)|Divigel (TN)|Estrace (TN)|Estring (TN)|Innofem (TN)|Vagifem (TN)|Vivelle (TN)|17.beta.-Oestradiol|3,17.beta.-Estradiol|.beta.-Estradiol|.beta.-Oestradiol|[3H]]estradiol|MFCD00003693|(17beta)-estra-1(10),2,4-triene-3,17-diol|Estradiol (Standard)|Estradiol, .beta.-|Estradiol-17.beta.|Oestradiol-17.beta.|17-.beta.-oestradiol|Oestra-1,3,5(10)-triene-3,17beta-diol|17|A-estradiol|Estrasorb (TN)|17.beta.-OH-estradiol|17.beta.-OH-oestradiol|17beta estradiol (E2)|Extrasorb|Estreva|Estrifam|Femtran|Ginedisc|CHEMBL135|GynPolar|Sandrena Gel|D-3,17.beta.-Estradiol|D-3,17.beta.-Oestradiol|Sisare Gel|Estra-1,3,5(10)-triene-3,17-diol, (17beta)-|Estrofem 2|MLS000069494|3,17b-Dihydroxyestra-1,3,5(10)-triene|(+)-3,17.beta.-Estradiol|Oestradiolum|Climara Forte|Oestradiol Berco|1,3,5-Estratriene-3,17beta-diol|[3H]E2|17 ?-Estradiol|Estrapak 50|(1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2(7),3,5-triene-5,14-diol|Estradiolum [INN]|Estradiolo [DCIT]|NCGC00091544-04|Oestradiol-17-beta|Estradiolum|Estrodiolum|Estradiolo|Femestrol|SMR000059126|Estradiol-3,17beta|17-beta-OH-estradiol|3,17-beta-Estradiol|141290-02-0|3,17beta-Dihydroxy-1,3,5(10)-estratriene|3,17-beta-Oestradiol|D-3,17beta-Estradiol|3,17.beta.-Dihydroxyestra-1,3,5(10)-triene|E(sub 2)|Methyl 1-cyclopropyl-6,7-difluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylate.|Benzogynestry|Estropause|Estasorb|(8R,9S,13S,14S,17S)-13-Methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol|[2,4,6,7-3H]-E2|E 2|E2|Destradiol|Yuvvexy|Zesteen|.alpha.-Estradiol|17-beta-OH-oestradiol|D-3,17beta-Oestradiol|D-3,17-beta-Estradiol|Estrodiolum [INN-Latin]|Estra-1,3,5(10)-triene-3,17-diol (17.beta.)-|D-3,17-beta-Oestradiol|Activella (Salt/Mix)|Combipatch (Salt/Mix)|(1S,10R,11S,14S,15S)-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-triene-5,14-diol|CCRIS 280|component of Menrium|Climara Pro (Salt/Mix)|3,17beta-Estradiol|3,17-.beta.-Oestradiol|HSDB 3589|3,3,5(10)-triene|rec IFN-gamma (human)|SR-01000075866|17-.BETA.-Estradiol|EINECS 200-023-8|1,3,5-Estratriene-3,17-beta-diol|oestrodiol|Estradiol [USP:INN:BAN]|3,17beta-Dihydroxyestra-1,3,5-triene|Estradurin|3,17beta-Dihydroxyoestra-1,3,5-triene|delta-Estradiol|dihydro-Theelin|dl-estradiol|3,17-beta-Dihydroxyoestra-1,3,5-triene|UNII-4TI98Z838E|beta -estradiol|delta-Oestradiol|TX-004HR|Estra-1,3,5(10)-triene-3,17-beta-diol|Estrogel HBF|Oestra-1,3,5(10)-triene-3,17-beta-diol|1jgl|1lhu|1qkt|1qku|3,17-beta-Dihydroxyestra-1,3,5(10)-triene|[3H]estradiol|1,3,5-Estratriene-3,17.beta.-diol|3,17-beta-Dihydroxy-1,3,5(10)-oestratriene|CAS-50-28-2|17-beta-Estra-1,3,5(10)-triene-3,17-diol|17beta-Oestra-1,3,5(10)-triene-3,17-diol|.alpha.-Oestradiol|17-beta-Oestra-1,3,5(10)-triene-3,17-diol|Prestwick_207|3,17b-Estradiol|Bio-E-Gel|Fem7|[3H]-Estrogen|3,17.beta.-Dihydroxyestra-1,3,5-triene|3,17.beta.-Dihydroxyoestra-1,3,5-triene|CMC_11154|Estradiol-17 alpha|1,3,5,(10)-Estratrien-3,17.beta.-diol|SL-1100|Beta-estradiol (E2)|Estra-1,3,5(10)-triene-3,17.beta.-diol|Oestra-1,3,5(10)-triene-3,17.beta.-diol|2j7x|3,17.beta.-Dihydroxy-1,3,5(10)-estratriene|3,17.beta.-Dihydroxy-1,3,5(10)-oestratriene|3,3,5-triene|[3H]17beta-estradiol|ESTRADIOL [INN]|ESTRADIOL [JAN]|17.beta.-Estra-1,3,5(10)-triene-3,17-diol|ESTRADIOL [MI]|ESTRADIOL [HSDB]|17.beta.-Oestra-1,3,5(10)-triene-3,17-diol|Opera_ID_1688|Prestwick0_000441|Prestwick1_000441|Prestwick2_000441|Prestwick3_000441|Spectrum5_002055|17beta-estradiol (E2)|ESTRADIOL [VANDF]|alpha-estradiol (obsolete)|beta-Estradiol, >=98%|bmse000642|Epitope ID:136018|(+)-3,17b-Estradiol|E 8875|EC 200-023-8|ESTRADIOL [USP-RS]|ESTRADIOL [WHO-DD]|SCHEMBL8049|(+)-3,17beta-Estradiol|Estradiol (JAN/USP/INN)|Tritiated estradiol-17-beta|BIDD:PXR0065|Lopac0_000503|S-21400|BSPBio_000482|BSPBio_001065|KBioGR_000405|KBioGR_002269|KBioSS_000405|KBioSS_002270|82115-62-6|MLS000758312|MLS001076331|MLS001424022|BIDD:ER0125|SPBio_002421|ESTRADIOL [GREEN BOOK]|BPBio1_000532|GTPL1012|GTPL1013|SCHEMBL7525926|ESTRADIOL [ORANGE BOOK]|NIOSH/KG7030000|SCHEMBL11037492|SCHEMBL29350151|BDBM17292|BIJUVA COMPONENT ESTRADIOL|HY-B0141R|KBio2_000405|KBio2_002269|KBio2_002973|KBio2_004837|KBio2_005541|KBio2_007405|KBio3_000769|KBio3_000770|KBio3_002749|ESTRADIOL [USP MONOGRAPH]|MSK2212|1a52|1g50|2d06|ANGELIQ COMPONENT ESTRADIOL|cMAP_000005|ESTRADIOL IMPURITY A [IP]|PREFEST COMPONENT ESTRADIOL|Bio1_000403|Bio1_000892|Bio1_001381|Bio2_000363|Bio2_000843|CS336|GLXC-06851|HMS1362E07|HMS1569I04|HMS1792E07|HMS1990E07|HMS2051C17|HMS2090E18|HMS2096I04|HMS2236H04|HMS3261F07|HMS3403E07|HMS3713I04|HMS3884A08|beta-Estradiol, analytical standard|(8S,9S,13S,14S,17S)-13-Methyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol|17916-67-5|ACTIVELLA COMPONENT ESTRADIOL|BCP08579|ESTRADIOL 17-BETA [VANDF]|HY-B0141|Tox21_111148|Tox21_202057|Tox21_300288|Tox21_500503|1,5-Estratriene-3,17.beta.-diol|COMBIPATCH COMPONENT ESTRADIOL|HB2494|LMST02010001|s1709|Estradiol-17-beta-6,7-(sup 3)H|[2,4,6,7-3H]-17beta-estradiol|AKOS015896570|CLIMARA PRO COMPONENT ESTRADIOL|CCG-100808|CS-1938|DB00783|FE10880|LP00503|NC00058|SDCCGSBI-0050487.P002|IDI1_002118|SMP1_000121|NCGC00091544-00|NCGC00091544-01|NCGC00091544-02|NCGC00091544-05|NCGC00091544-06|NCGC00091544-07|NCGC00091544-09|NCGC00091544-10|NCGC00091544-11|NCGC00091544-12|NCGC00091544-13|NCGC00091544-14|NCGC00091544-15|NCGC00091544-16|NCGC00091544-18|NCGC00091544-27|NCGC00179321-01|NCGC00179321-02|NCGC00254177-01|NCGC00259606-01|NCGC00261188-01|17-E|AC-22346|AS-13729|CPD000059126|FR108523|SY017569|Estra-1,3,5(10)-triene-3,17b-diol|Oestra-1,3,5(10)-triene-3,17b-diol|US9034854, E2|US9040509, E2|US9422324, E2|US9561238, E2|WLN: L E5 B666TTT&J E1 FQ OQ|17 beta-Estradiol, 1mg/ml in Acetonitrile|DB-246618|Estra-1,5(10)-triene-3,17.beta.-diol|Estradiol, meets USP testing specifications|3,17beta-dihydroxyestra-1,3,5(10)-trien|CS-0694760|Estra-1,3,5(10)-triene-3,17beta-diol-|EU-0100503|KG70300000|NS00008517|NS00115904|Oestra-1,5(10)-triene-3,17.beta.-diol|C00951|D00105|EN300-119518|(17b)-Estra-1,3,5(10)-triene-3,17-diol|1,3,5-Estratriene-3,17b-diol;Dihydrofolliculin|13b-Methyl-1,3,5(10)-gonatriene-3,17b-ol|17.beta.-Estra-1,5(10)-triene-3,17-diol|17.beta.-Oestra-1,5(10)-triene-3,17-diol|ETHINYLESTRADIOL IMPURITY D [EP IMPURITY]|003E693|17-beta-Estradiol 100 microg/mL in Acetonitrile|F358087|Q422416|SR-01000721892|(17|A)-Estra-1,3,5(10)-triene-3,17-diol|13beta-Methyl-1,3,5(10)-gonatriene-3,17beta-ol|Estra-1,5(10)-triene-3,17-diol (17.beta.)-|ESTRADIOL BENZOATE IMPURITY A [EP IMPURITY]|ESTRADIOL VALERATE IMPURITY A [EP IMPURITY]|SR-01000075866-1|SR-01000075866-4|SR-01000721892-3|BRD-K18910433-001-04-4|BRD-K18910433-001-36-6|BRD-K18910433-001-43-2|estra-1(10),2,4-triene-3,17-diol, (17beta)-|Estra-1,5(10)-triene-3,17-diol, (17.beta.)-|Z1521553843|B8B5AEF5-4957-49EB-A14F-444A8212C482|beta-Estradiol, BioReagent, powder, suitable for cell culture|Estradiol, United States Pharmacopeia (USP) Reference Standard|13.BETA.-METHYL-1,3,5(10)-GONATRIENE-3,17.BETA.-OL|beta-Estradiol, powder, gamma-irradiated, suitable for cell culture|Estra-1,3,5(10)-triene-3,17-diol, (6,7-(sup 3)H,17-beta)-|(9beta,13alpha,14beta,17alpha)-estra-1,3,5(10)-triene-3,17-diol|Estradiol, Pharmaceutical Secondary Standard; Certified Reference Material|(13S,17S)-13-methyl-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-beta-diol"
FULVESTRANT,104741,,"InChI=1S/C32H47F5O3S/c1-30-17-15-26-25-12-11-24(38)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-41(40)19-9-16-31(33,34)32(35,36)37/h11-12,21-22,26-29,38-39H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,41?/m1/s1",VWUXBMIQPBEWFH-WCCTWKNTSA-N,C32H47F5O3S,606.8,"(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol","Fulvestrant|129453-61-8|Faslodex|ICI 182,780|Ici 182780|ICI-182780|ZD-9238|fulvestrantum|ZD9238|DTXSID4022369|(7R,8R,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol|ICI182780|Faslodex(ICI 182,780)|Estra-1,3,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-, (7alpha,17beta)-|CHEBI:31638|22X328QOC4|NSC-759879|7alpha-(9-((4,4,5,5,5-Pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-triene-3,17beta-diol|DTXCID202369|NSC719276|Estra-1,3,5(10)-triene-3,17-diol, 7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-, (7alpha,17beta)-|(7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17-diol|(1S,3aS,3bR,4R,9bS,11aS)-11a-methyl-4-(9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl)-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta(a)phenanthrene-1,7-diol|(1S,3aS,3bR,4R,9bS,11aS)-11a-methyl-4-[9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl]-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1,7-diol|(7alpha,17beta)-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)estra-1(10),2,4-triene-3,17-diol|(7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta(a)phenanthrene-3,17-diol|ZM182780|RefChem:57293|7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)estra-1,3,5(10)-triene-3,17-diol|L02BA03|(1S,9R,11S,14S,15S)-15-methyl-9-(9-(4,4,5,5,5-pentafluoropentanesulfinyl)nonyl)tetracyclo(8.7.0.02,7.011,15)heptadeca-2,4,6-triene-5,14-diol|642-998-6|7a-(9-((4,4,5,5,5,-Pentafluoropentyl)sulphinyl)nonyl)-estra-1,3,5(10)-triene-3,17b-diol|ZM 182780|ZM-182780|Fulvestrant (Faslodex)|Fulvestrant (Standard)|C32H47F5O3S|CHEMBL1358|Fulvestrant S enantiomer|(7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol|Fulvestrant [USAN]|Fulvestrant R enantiomer|MFCD00903953|(7R,13S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol|Faslodex (TN)|(7alpha,17beta)-7-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1,3,5(10)-triene-3,17-diol|7alpha-[9[(4,4,5,5,5-Pentafluropentyl)sulfinyl]nonyl]-estra-1,3,5(10)-triene-3, 17 beta diol|CAS-129453-61-8|ZD 182780|1316849-17-8|Fluvestrant|UNII-22X328QOC4|Fulvestrant?|CCRIS 8741|HSDB 7658|NCGC00024964-02|1807900-80-6|Fulvestrant [USAN:USP:INN:BAN]|ZD-182780|FULVESTRANT [MI]|FULVESTRANT [INN]|FULVESTRANT [JAN]|FULVESTRANT [VANDF]|SCHEMBL8209|FULVESTRANT [MART.]|BIDD:PXR0136|FULVESTRANT [USP-RS]|FULVESTRANT [WHO-DD]|MLS006010187|BIDD:ER0348|Fulvestrant (JAN/USP/INN)|FULVESTRANT [EMA EPAR]|Fulvestrant, >98% (HPLC)|GTPL1015|orb1306347|Fulvestrant - Bio-X trade mark|SCHEMBL29353866|EX-A959|FULVESTRANT [ORANGE BOOK]|ICI 182,780 (Fulvestrant)|MSK8055|FULVESTRANT [EP MONOGRAPH]|FULVESTRANT [USP IMPURITY]|GLXC-03001|HMS2090N22|HMS3260G10|HMS3712A06|FULVESTRANT [USP MONOGRAPH]|(7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol|Tox21_110939|Tox21_202604|Tox21_303656|Tox21_500114|BDBM50169743|HB2501|HY-13636R|AKOS015895669|Tox21_110939_1|AC-4693|BCP9000707|CCG-220082|CCG-221418|CS-1267|DB00947|FF23615|LP00114|NSC 759879|NSC-719276|SDCCGSBI-0633685.P001|ZD 9238|ICI 182 780|ICI 182,789|NCGC00164789-02|NCGC00164789-04|NCGC00257357-01|NCGC00260152-01|NCGC00260799-01|NCGC00386134-10|(7R,8S,9S,13S,14S,17S)-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl) nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol|AS-13024|BI167222|DA-63628|HY-13636|SMR001456109|BCP0726000227|CS-0694849|F1144|NS00004276|S1191|Fulvestrant, Vetec(TM) reagent grade, >98%|D01161|EN300-120628|AB01273957-01|AB01273957-02|AB01273957-03|AB01273957_04|453F618|Q5508491|BRD-A85667082-001-12-7|Fulvestrant, European Pharmacopoeia (EP) Reference Standard|Fulvestrant, United States Pharmacopeia (USP) Reference Standard|Fulvestrant for system suitability, European Pharmacopoeia (EP) Reference Standard|(13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol|(7a,17b)-7-[9-[(4,4,5,5,5pentafluoropentyl)Sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol|(7a,17b)-7-[9-[4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;Faslodex;Fulvestrant;ZD 182780|(7a,17b)-7-[9-[4,4,5,5,5-Pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-triene-3,17-diol;Faslodex;Fulvestrant;ZD 182780;ICI 182780|(7R,13S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol|(7R,8R,9S,13S,14S,17S)-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentyldihydrosulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol|(7R,8R,9S,13S,14S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol|(7R,9S,13S,14S,17S)-13-Methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthrene-3,17-diol|13-Methyl-7-[9-(4,4,5,5,5-pentafluoro-pentane-1-sulfinyl)-nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol|13-Methyl-7-[9-(4,5,5,5-pentafluoropentylsulfinyl)nonyl]-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthrene-3,17-diol|7.ALPHA.-(9-(4,4,5,5,5-PENTAFLUOROPENTYLSULPHINYL)NONYL)ESTRA-1,3,5(10)-TRIENE-3,17.BETA.-DIOL|7alpha-[9-(4,4,5,5,5-pentafluoro-pentylsulfinyl)nonyl]estra-1,3,5(10)-triene-3,17beta-diol|7alpha-{9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl}estra-1(10),2,4-triene-3,17beta-diol|ESTRA-1,3,5(10)-TRIENE-3,17-DIOL, 7-(9-((4,4,5,5,5-PENTAFLUOROPENTYL)SULFINYL)NONYL)-, (7.ALPHA.,17.BETA.)-|Estra-1,5(10)-triene-3,17-diol, 7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]-, (7.alpha.,17.beta.)-"
LASOFOXIFENE,216416,,"InChI=1S/C28H31NO2/c30-24-11-15-27-23(20-24)10-14-26(21-6-2-1-3-7-21)28(27)22-8-12-25(13-9-22)31-19-18-29-16-4-5-17-29/h1-3,6-9,11-13,15,20,26,28,30H,4-5,10,14,16-19H2/t26-,28+/m1/s1",GXESHMAMLJKROZ-IAPPQJPRSA-N,C28H31NO2,413.5,"(5R,6S)-6-phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol","Lasofoxifene|180916-16-9|Oporia|lasofoxifeno|CP 336156|lasofoxifenum|CP-336,156|(-)-cis-5,6,7,8-Tetrahydro-6-phenyl-5-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-naphthol|337G83N988|CHEBI:135938|DTXSID50171037|(5R,6S)-6-phenyl-5-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,6,7,8-tetrahydronaphthalen-2-ol|(5R,6S)-6-phenyl-5-{4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}-5,6,7,8-tetrahydronaphthalen-2-ol|RefChem:924541|DTXCID8093528|G03XC03|rac-Lasofoxifene|180915-78-0|(5R,6S)-6-phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol|2-Naphthalenol, 5,6,7,8-tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-, (5R,6S)-|CHEMBL328190|Rel-(5R,6S)-6-phenyl-5-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,6,7,8-tetrahydronaphthalen-2-ol|CP-336156|Lasofoxifene [INN]|(5R,6S)-6-phenyl-5-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)-5,6,7,8-tetrahydronaphthalen-2-ol.|Lasofoxifene [INN:BAN]|UNII-337G83N988|(5R,6S)-rel-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol; cis-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol;|2-Naphthalenol, 5,6,7,8-tetrahydro-6-phenyl-5-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-, (5R,6S)-|C3D|LASOFOXIFENE [MI]|(5R,6S)-5,6,7,8-Tetrahydro-6-phenyl-5-[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]-2-naphthalenol|SCHEMBL26815|LASOFOXIFENE [MART.]|LASOFOXIFENE [WHO-DD]|GTPL7542|orb1687919|LASOFOXIFENE [EMA EPAR]|SCHEMBL29454456|BDBM20606|GXESHMAMLJKROZ-IAPPQJPRSA-N|GLXC-15757|BCP03626|HY-A0037|MFCD09475650|(1R,2S)-2-phenyl-1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]tetralin-6-ol|AKOS030241621|BCP9000842|DB06202|NCGC00487269-02|DA-64874|BCP0726000177|CS-0006740|NS00007417|G92050|916L169|EN300-18161169|Q644675|(-)-cis-5,6,7,8-Tetrahydro-6-phenyl-5-(p-(2-(1-pyrrolidinyl)ethoxy)phenyl)-2-naphthol.|cis-6-Phenvl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalene-2-ol|cis-6-phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol|cis-6-Phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalene-2-ol|cis-6Phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalene-2-ol|(-)-cis-(5r,6s)-6-phenyl-5-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol|2-Naphthalenol, 5,6,7,8-tetrahydro-6-phenyl-5-(4-(2-(1-pyrrolidinyl)ethoxy)phenyl)-, (5R-cis)-"
ARZOXIFENE,179337,,"InChI=1S/C28H29NO4S/c1-31-22-8-5-20(6-9-22)28-27(25-14-7-21(30)19-26(25)34-28)33-24-12-10-23(11-13-24)32-18-17-29-15-3-2-4-16-29/h5-14,19,30H,2-4,15-18H2,1H3",MCGDSOGUHLTADD-UHFFFAOYSA-N,C28H29NO4S,475.6,2-(4-methoxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)phenoxy]-1-benzothiophen-6-ol,"Arzoxifene|182133-25-1|LY 353381|Arzoxifeno|LY353381|LY-353381|E569WG6E60|DTXSID10171255|2-(4-methoxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]phenoxy}-1-benzothiophen-6-ol|arzoxifenum|2-(4-methoxyphenyl)-3-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)-1-benzothiophen-6-ol|RefChem:560146|DTXCID2093746|Arzoxifene [INN]|2-(4-methoxyphenyl)-3-[4-(2-piperidin-1-ylethoxy)phenoxy]-1-benzothiophen-6-ol|2-(4-methoxyphenyl)-3-(4-(2-(piperidin-1-yl)ethoxy)phenoxy)benzo[b]thiophen-6-ol|Benzo[b]thiophene-6-ol, 2-(4-methoxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-|UNII-E569WG6E60|Benzo(b)thiophene-6-ol, 2-(4-methoxyphenyl)-3-(4-(2-(1-piperidinyl)ethoxy)phenoxy)-|ARZOXIFENE [MI]|ARZOXIFENE [MART.]|ARZOXIFENE [WHO-DD]|SCHEMBL285277|CHEMBL226267|orb1691451|SCHEMBL29354336|BDBM19442|EX-A10187|AKOS030631785|DB06249|SB19713|DA-09024|HY-13556|CS-0007165|NS00068622|EN300-19634484|Q4802769|2-(4-METHOXYPHENYL)-3-(4-(2-(1-PIPERIDINYL)ETHOXY)PHENOXY)BENZO(B)THIOPHENE-6-OL|2-(p-Methoxyphenyl)-3-(p-(2-piperidinoethoxy)phenoxy)benzo(b)thiophene-6-ol|Arzoxifene; Benzo[b]thiophene-6-ol, 2-(4-methoxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]-; 2-(4-Methoxyphenyl)-3-[4-[2-(1-piperidinyl)ethoxy]phenoxy]benzo[b]thiophene-6-ol; Arzoxifene; LY 353381"
6-O-BENZYLGUANINE,4578,,"InChI=1S/C12H11N5O/c13-12-16-10-9(14-7-15-10)11(17-12)18-6-8-4-2-1-3-5-8/h1-5,7H,6H2,(H3,13,14,15,16,17)",KRWMERLEINMZFT-UHFFFAOYSA-N,C12H11N5O,241.25,6-phenylmethoxy-7H-purin-2-amine,"o6-benzylguanine|19916-73-5|6-O-Benzylguanine|O(6)-Benzylguanine|2-Amino-6-(benzyloxy)purine|O(6)-Bgua|2-Amino-6-(phenylmethoxy)-9H-purine|NSC-637037|01KC87F8FE|DTXSID20173700|RefChem:854998|DTXCID5096191|6-(Phenylmethoxy)-9H-purin-2-amine|633-744-5|6-(Benzyloxy)-7H-purin-2-amine|6-(benzyloxy)-9H-purin-2-amine|2-amino-6-benzyloxypurine|6-Benzyloxyguanine|6-phenylmethoxy-7H-purin-2-amine|1000874-21-4|9H-Purin-2-amine, 6-(phenylmethoxy)-|KRX-0402|O-6-Benzylguanine|MFCD00269931|1H-Purin-2-amine, 6-(phenylmethoxy)-|6-benzyloxy-7H-purin-2-amine|CHEMBL407874|6-(benzyloxy)-1H-purin-2-amine|NSC637037|6-(Benzyloxy)guanine|6-(Phenylmethoxy)-1H-purin-2-amine|O6-BG|SMR000326791|6-BENZYLGUANINE|Purine, 2-amino-6-(benzyloxy)-|916B735|NSC 637037|UNII-01KC87F8FE|CCRIS 9383|o6-benzyl-guanine|O6 -benzylguanine|KRX 0402|Purine, 8CI)|O(6)-Benzylguanine?|O6BG|Lopac-B-2292|6-benzyloxy-2-amino-purine|Lopac0_000181|SCHEMBL61740|MLS000859930|MLS001074887|MLS006010145|SCHEMBL600698|6-benzyloxy-9H-purin-2-amine|BDBM5491|orb1299728|SCHEMBL7458810|SCHEMBL7458817|2-Amino-6-benzyloxy-9H-purine|SCHEMBL27986026|SCHEMBL28998305|SCHEMBL29405347|SCHEMBL31517079|0.4 CH3OH|6-(phenylmethoxy)purine-2-ylamine|GLXC-25126|HMS2234P23|HMS3260F03|HMS3369A16|HMS3753G17|O6-BENZYLGUANINE [WHO-DD]|AQB87421|BCP08777|O6-Substituted Guanine Deriv. 31|6-(Benzyloxy)-7H-purin-2-ylamine|Tox21_500181|MFCD11519304|s3658|SBB069180|O6-Benzylguanine - Bio-X trade mark|AKOS015919415|AKOS015963409|AC-1076|CCG-204276|CS-W002585|DB11919|FB04529|HY-W002585|KS-5281|LP00181|SB17232|SDCCGSBI-0050169.P002|NCGC00015144-01|NCGC00015144-02|NCGC00015144-03|NCGC00015144-04|NCGC00015144-08|NCGC00093660-01|NCGC00093660-02|NCGC00260866-01|BB164163|DA-56359|NCI60_012280|Purine, 2-amino-6-(benzyloxy)- (, )|SY008080|O6-Benzylguanine, >=98% (TLC), solid|EU-0100181|NS00069977|B 2292|F047770|SR-01000075709|Q7072275|SR-01000075709-1|BRD-K92041145-001-09-5|OBG"
LOMEGUATRIB,3025944,,"InChI=1S/C10H8BrN5OS/c11-5-1-6(18-3-5)2-17-9-7-8(14-4-13-7)15-10(12)16-9/h1,3-4H,2H2,(H3,12,13,14,15,16)",JUJPKFNFCWJBCX-UHFFFAOYSA-N,C10H8BrN5OS,326.17,6-[(4-bromothiophen-2-yl)methoxy]-7H-purin-2-amine,"Lomeguatrib|192441-08-0|DTXSID60172838|o6-(4-bromothenyl)guanine|S79265T71M|lomeguatribum|RefChem:153986|DTXCID1095329|PaTrin-2|PaTrin 2|6-[(4-bromothiophen-2-yl)methoxy]-7H-purin-2-amine|6-((4-bromothiophen-2-yl)methoxy)-9H-purin-2-amine|MFCD23703756|9H-Purin-2-amine, 6-[(4-bromo-2-thienyl)methoxy]-|CHEMBL339133|6-((4-Bromo-2-thienyl)methoxyl)purin-2-amine|2-Amino-6-[(4-bromo-2-thienyl)methoxy]-9H-purine|Lomeguatrib [INN]|6-((4-bromothiophen-2-yl)methoxy)-7H-purin-2-amine|C10H8BrN5OS|Lomeguatrib [INN:BAN]|Lomeguqtrib|6-(4-Bromothenyloxy)-7H-purin-2-amine|O(6)-(4-bromothenyl)guanine|UNII-S79265T71M|1H-Purin-2-amine, 6-[(4-bromo-2-thienyl)methoxy]-|Lomeguatrib(PaTrin-2)?|6-((4-bromo-2-thienyl)methoxy)purin-2-amine|C521206|LOMEGUATRIB [WHO-DD]|MLS006010267|6-[(4-bromo-2-thienyl)methoxy]-7H-purin-2-amine|orb1305396|SCHEMBL4621691|SCHEMBL19549802|SCHEMBL29406067|Lomeguatrib, >=98% (HPLC)|EX-A661|GLXC-06815|HMS3653P06|HMS3740E17|BCP07818|BDBM50106517|HB1376|NSC787251|s8056|AKOS024458115|AKOS027250766|AKOS028109340|CCG-265033|CS-1385|FL65065|GS-1303|NSC-787251|SB19180|NCGC00345496-02|NCGC00345496-08|NCGC00345496-13|AC-30287|HY-13668|SMR004701339|DB-065785|NS00122673|SW218182-2|441L080|SR-01000945001|SR-01000945001-1|6-(4-Bromo-thiophen-2-ylmethoxy)-9H-purin-2-ylamine|BRD-K27955832-001-02-9|Q27288769"
LIDORESTAT,157839,,"InChI=1S/C18H11F3N2O2S/c19-11-6-12(20)18-17(16(11)21)22-14(26-18)5-9-7-23(8-15(24)25)13-4-2-1-3-10(9)13/h1-4,6-7H,5,8H2,(H,24,25)",KYHVTMFADJNSGS-UHFFFAOYSA-N,C18H11F3N2O2S,376.4,"2-[3-[(4,5,7-trifluoro-1,3-benzothiazol-2-yl)methyl]indol-1-yl]acetic acid","Lidorestat|245116-90-9|IDD-676|Lidorestat anhydrous|Lindolrestat|Lindorestat|EML 676|IDD 676|IDD-000676-01|R3734K0M7L|2-[3-[(4,5,7-trifluoro-1,3-benzothiazol-2-yl)methyl]indol-1-yl]acetic acid|IDD-000676|DTXSID40179264|EML-676|3-[(4,5,7-TRIFLUOROBENZOTHIAZOL-2-YL)METHYL]INDOLE-N-ACETIC ACID|3-((4,5,7-trifluorobenzothiazol-2-yl)methyl)indole-N-acetic acid|2-(3-((4,5,7-trifluoro-1,3-benzothiazol-2-yl)methyl)indol-1-yl)acetic acid|LIDORESTATUM|RefChem:799107|DTXCID70101755|3-((4,5,7-Triflurobenzothiazol-2-yl)methyl)-1H-indol-1-yl-acetic Acid|1H-Indole-1-acetic acid, 3-((4,5,7-trifluoro-2-benzothiazolyl)methyl)-, monohydrate|9Z74BD3QPP|1H-Indole-1-acetic acid, 3-[(4,5,7-trifluoro-2-benzothiazolyl)methyl]-|2-(3-((4,5,7-trifluorobenzo[d]thiazol-2-yl)methyl)-1H-indol-1-yl)acetic acid|MFCD08067733|CHEMBL363387|C18H11F3N2O2S|{3-[(4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL]-1H-INDOL-1-YL}ACETIC ACID|2-{3-[(4,5,7-trifluoro-1,3-benzothiazol-2-yl)methyl]-1H-indol-1-yl}acetic acid|1H-Indole-1-acetic acid, 3-((4,5,7-trifluoro-2-benzothiazolyl)methyl)-|UNII-R3734K0M7L|(3-((4,5,7-TRIFLUORO-1,3-BENZOTHIAZOL-2-YL)METHYL)-1H-INDOL-1-YL)ACETIC ACID|LIDORESTAT [INN]|3NA|Indoleacetic Acid Inhibitor 9|SCHEMBL419032|GTPL7411|orb1707066|SCHEMBL29387869|BDBM16469|KYHVTMFADJNSGS-UHFFFAOYSA-N|HMS3751O07|AKOS028111328|DB07063|FD10676|AS-72624|DA-64967|FL103933|HY-106198|CS-0025212|NS00068310|Q27080524|3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic acid|1H-Indole-1-aceticacid, 3-[(4,5,7-trifluoro-2-benzothiazolyl)methyl]|3-((4,5,7-Triflurobenzothiazol-2-yl)methyl)-1H-indol-1-yl)acetic acid"
IPSAPIRONE,56971,,"InChI=1S/C19H23N5O3S/c25-18-16-6-1-2-7-17(16)28(26,27)24(18)11-4-3-10-22-12-14-23(15-13-22)19-20-8-5-9-21-19/h1-2,5-9H,3-4,10-15H2",TZJUVVIWVWFLCD-UHFFFAOYSA-N,C19H23N5O3S,401.5,"1,1-dioxo-2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,2-benzothiazol-3-one","IPSAPIRONE|95847-70-4|Ipsapirona|Ipsapironum|1,1-dioxo-2-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]-1,2-benzothiazol-3-one|6J9B11MN0K|DTXSID4045688|DTXCID2025688|TVX-Q-7821|1,2-Benzisothiazol-3(2H)-one, 2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-, 1,1-dioxide|isapirone|1,1-dioxo-2-(4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl)-1,2-benzothiazol-3-one|1,1-Dioxo-2-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-butyl)-1,2-dihydro-1lambda*6*-benzo(d)isothiazol-3-one|1,1-Dioxo-2-[4-(4-pyrimidin-2-yl-piperazin-1-yl)-butyl]-1,2-dihydro-1lambda*6*-benzo[d]isothiazol-3-one|RefChem:148673|TVX Q 7821|2-[4-[4-(2-PYRIMIDINYL)-1-PIPERAZINYL]BUTYL]-1,2-BENZISOTHIAZOL-3(2H)-ONE-1,1-DIOXIDE|CHEMBL8412|2-(4-(4-(Pyrimidin-2-yl)piperazin-1-yl)butyl)benzo[d]isothiazol-3(2H)-one 1,1-dioxide|NCGC00025315-01|Ipsapironum [Latin]|Ipsapirona [Spanish]|Ipsapirone [INN:BAN]|C19H23N5O3S|CAS-95847-70-4|SR-01000597547|BRN 5486134|UNII-6J9B11MN0K|Tocris-1869|IPSAPIRONE [MI]|IPSAPIRONE [INN]|GTPL42|2-(4-(4-(2-Pyrimidinyl)-1-piperazinyl)butyl)-1,2-benzisothiazol-3(2H)-one 1,1-dioxide|SCHEMBL79574|orb1704459|SCHEMBL29356316|CHEBI:93578|TZJUVVIWVWFLCD-UHFFFAOYSA-N|GLXC-06128|HMS3268M06|HMS3414N19|HMS3678N17|HMS3713J20|BCP14089|Tox21_110962|BDBM50005127|HB1699|MFCD00866976|PDSP1_000744|PDSP2_000732|AKOS000278833|Tox21_110962_1|CCG-220609|NCGC00025315-02|AS-16846|HY-19686|DB-020290|CS-0016206|NS00125565|G12743|AU-059/43515096|L000682|Q6065448|SR-01000597547-1|SR-01000597547-2|BRD-K90574421-001-01-9|BRD-K90574421-001-03-5|2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)-butyl)-1,2-benzoisothiazol-3(2H)-one-1,1-dioxide|2-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-1,2-benzoisothiazol-3(2H)one 1,1-dioxide|2-(4-(4-(Pyrimidin-2-yl)piperazin-1-yl)butyl)benzo[d]isothiazol-3(2H)-one1,1-dioxide|1,1-Dioxo-2-[4-(4-pyrimidin-2-yl-piperazin-1-yl)-butyl]-1,2-dihydro-1lambda*6*-benzo[d]isothiazol-3-one (Ipsapirone)|1,1-Dioxo-2-[4-(4-pyrimidin-2-yl-piperazin-1-yl)-butyl]-1,2-dihydro-1lambda*6*-benzo[d]isothiazol-3-one(Ipsapirone)|2-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)BUTYL)-1,2-BENZISOTHIAZOLIN-3-ONE 1,1-DIOXIDE|2-{4-[4-(pyrimidin-2-yl)piperazin-1-yl]butyl}-2,3-dihydro-1|E?,2-benzothiazole-1,1,3-trione"
GEPIRONE,55191,,"InChI=1S/C19H29N5O2/c1-19(2)14-16(25)24(17(26)15-19)9-4-3-8-22-10-12-23(13-11-22)18-20-6-5-7-21-18/h5-7H,3-4,8-15H2,1-2H3",QOIGKGMMAGJZNZ-UHFFFAOYSA-N,C19H29N5O2,359.5,"4,4-dimethyl-1-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione","Gepirone|83928-76-1|Gepirona|Gepironum|BMY-13805|4,4-dimethyl-1-[4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl]piperidine-2,6-dione|Ariza|MJ-13805|JW5Y7B8Z18|Org-33062 free base|BMY 13805|DTXSID90232813|MJ 13805|2,6-Piperidinedione, 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-|4,4-Dimethyl-1-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-butyl)-piperidine-2,6-dione|4,4-dimethyl-1-(4-(4-pyrimidin-2-ylpiperazin-1-yl)butyl)piperidine-2,6-dione|4,4-Dimethyl-1-[4-(4-pyrimidin-2-yl-piperazin-1-yl)-butyl]-piperidine-2,6-dione|RefChem:142961|4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-2,6-piperidinedione|DTXCID20155304|N06AX19|ORG 13011|1-(4-(4-(4-(trifluoromethyl)-2-pyridinyl)-1-piperazinyl)butyl)-2-pyrrolidinone(E)-2-butenedioate|4,4-Dimethyl-1-(4-(4-(pyrimidin-2-yl)piperazin-1-yl)butyl)piperidine-2,6-dione|Gepirone [INN]|Gepirone HCl|C19H29N5O2|MFCD00868196|CHEMBL284092|Variza|Gepironum [Latin]|Gepirona [Spanish]|UNII-JW5Y7B8Z18|gepiron ER|2,6-Piperidinedione, 4,4-dimethyl-1-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-; 4,4-Dimethyl-1-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,6-piperidinedione; Gepirone|Gepirone (Standard)|GEPIRONE [WHO-DD]|SCHEMBL79040|orb1306818|GTPL12930|CHEBI:135990|BCP28729|BMY13805|Travivo (gepirone extended-release)|BDBM50005132|AKOS015924526|DB12184|DS-4359|FO65115|HY-122422R|MJ13805|SB19632|NCGC00408912-01|AC-38202|DB-106225|HY-122422|CS-0085425|NS00068813|L001135|Q2650256|F9995-2711|3,3-DIMETHYL-1-(4-(4-(2-PYRIMIDINYL)-1-PIPERAZINYL)BUTYL)GLUTARIMIDE|4,4-Dimethyl-1-[4-(4-pyrimidin-2-yl-piperazin-1-yl)-butyl]-piperidine-2,6-dione (Gepirone)"
DIHYDREXIDINE,5311070,,"InChI=1S/C17H17NO2/c19-15-7-10-5-6-14-17(13(10)8-16(15)20)12-4-2-1-3-11(12)9-18-14/h1-4,7-8,14,17-20H,5-6,9H2/t14-,17-/m0/s1",BGOQGUHWXBGXJW-YOEHRIQHSA-N,C17H17NO2,267.32,"(6aS,12bR)-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine-10,11-diol","DIHYDREXIDINE|DAR0100A|123039-93-0|10,11-Dihydroxyhexahydrobenzo(a)phenanthridine|32D64VH037|DTXSID00894188|Benzo(a)phenanthridine-10,11-diol, 5,6,6a,7,8,12b-hexahydro-, trans-|RefChem:587654|DTXCID101324232|(1R,10S)-9-azatetracyclo(8.8.0.0^(2,7).0^(13,18))octadeca-2,4,6,13,15,17-hexaene-15,16-diol|(-)-Dihydrexidine|Dihydrexidine, (-)-|U4MPC92UC2|(6aS,12bR)-5,6,6a,7,8,12b-hexahydrobenzo[a]phenanthridine-10,11-diol|UNII-U4MPC92UC2|(6aS,12bR)-5,6,6a,7,8,12b-Hexahydrobenzo(a)phenanthridine-10,11-diol|Benzo(a)phenanthridine-10,11-diol, 5,6,6a,7,8,12b-hexahydro-, (6aS,12bR)-|Benzo(a)phenanthridine-10,11-diol, 5,6,6a,7,8,12b-hexahydro-, (6as-trans)-|757161-85-6|DAR-0100|UNII-32D64VH037|GTPL9267|CHEMBL4280145|SCHEMBL14495053|SCHEMBL29595511|GLXC-25864|DB12890|DA-62871|NS00071792|Q5276413|REL-(6AR,12BS)-5,6,6A,7,8,12B-HEXAHYDROBENZO(A)PHENANTHRIDINE-10,11-DIOL|BENZO(A)PHENANTHRIDINE-10,11-DIOL, 5,6,6A,7,8,12B-HEXAHYDRO-, HYDROCHLORIDE (1:1), (6AR,12BS)-REL-|BENZO(A)PHENANTHRIDINE-10,11-DIOL, 5,6,6A,7,8,12B-HEXAHYDRO-, HYDROCHLORIDE (1:1), (6ARS,12BSR)-, (+/-)-|DHX"
ANDROSTENEDIOL,10634,,"InChI=1S/C19H30O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-17,20-21H,4-11H2,1-2H3/t13-,14-,15-,16-,17-,18-,19-/m0/s1",QADHLRWLCPCEKT-LOVVWNRFSA-N,C19H30O2,290.4,"(3S,8R,9S,10R,13S,14S,17S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol","Androstenediol|Hermaphrodiol|5-Androstenediol|521-17-5|Neumune|Androst-5-ene-3beta,17beta-diol|3beta,17beta-Dihydroxyandrost-5-ene|5-andendiol|HE2100|5-AED|(3beta,17beta)-androst-5-ene-3,17-diol|3beta,17beta-Dihydroxy-5-androstene|95PS51EMXY|CHEBI:2710|DTXSID9022609|NSC-12163|(3S,8R,9S,10R,13S,14S,17S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol|HE-2100|DTXCID002609|Androst-5-ene-3,17-diol, (3beta,17beta)-|5 Androstene 3,17 diol|Delta 5-Androstenediol|5-Androstene-3,17-diol|NSC12163|5-Androstene-3beta-17beta-Diol|(3S,8R,9S,10R,13S,14S,17S)-10,13-dimethyl-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H-cyclopenta(a)phenanthrene-3,17-diol|Androst-5-ene-3 beta,17 beta-diol|Delta 5 Androstenediol|delta 5-Androstene-3 beta,17 beta-diol|RefChem:558049|Androst 5 ene 3,17 diol|5 Androstene 3beta 17beta Diol|Androst 5 ene 3 beta,17 beta Diol|delta 5 Androstene 3 beta,17 beta Diol|208-306-8|Androst-5-enediol|Androstenediol [JAN]|delta(sup 5)-Androstenediol|Adiol|5-Androstene-3beta,17beta-diol|androst-5-en-3beta,17beta-diol|CHEMBL440283|Androstenediol (JAN)|NCGC00167494-01|(3alpha,8alpha,17beta)-androst-5-ene-3,17-diol|3Beta,17Beta-Androst-5-enediol|Androst-5-enediol (VAN)|CAS-521-17-5|EINECS 208-306-8|NSC 12163|UNII-95PS51EMXY|3b,17b-Androst-5-enediol (1.0mg/ml in Acetonitrile)|ANDROST-5-ENE-3-beta,17-beta-DIOL|Tetrabol|Androst-5-ene-3,17-diol, (3b,17b)-|(3-beta,17-beta)-Androst-5-ene-3,17-diol|5-Androstene-3.beta.,17.beta.-diol|delta(sup 5)-Androstene-3-beta,17-beta-diol|beta-AED|Tetrabol (TN)|b,17b-diol|delta5-Androstenediol|delta-5-Androstenediol|(3.beta.,17.beta.)-Androst-5-ene-3,17-diol|ANDROSTENEDIOL [MI]|3b,17b-Androst-5-enediol|BIDD:PXR0074|SCHEMBL27485|Androst-5-ene-3b,17b-diol|ANDROSTENEDIOL [MART.]|ANDROSTENEDIOL, (-)-|ANDROSTENEDIOL [WHO-DD]|Androst-5-ene-3,17-diol #|Tox21_112495|BDBM50223237|LMST02020005|3beta,17beta-dihydroxy-androst-5-en|AKOS015955537|Tox21_112495_1|DB01524|NCGC00263558-01|AC-12166|Androst-5-ene, 3beta,17beta-dihydroxy-|NS00000086|13-Iso-androst-5-en-3.beta.,17.beta.-diol|5-ANDROSTENE-3.BETA.O,17.BETA.-DIOL|C04295|D00179|521A175|Q2817108|W-105849|017E86D6-684F-4DB1-90E0-55C1467FF85B|(3S,8R,10R,13S,17S)-10,13-Dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,17-diol|B81|Hermaphrodiol; (3S,8R,9S,10R,13S,14S,17S)-10,13-Dimethyl-2,3,4,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanth rene-3,17-diol"
RALOXIFENE HYDROCHLORIDE,54900,,"InChI=1S/C28H27NO4S.ClH/c30-21-8-4-20(5-9-21)28-26(24-13-10-22(31)18-25(24)34-28)27(32)19-6-11-23(12-7-19)33-17-16-29-14-2-1-3-15-29;/h4-13,18,30-31H,1-3,14-17H2;1H",BKXVVCILCIUCLG-UHFFFAOYSA-N,C28H28ClNO4S,510.0,[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]-[4-(2-piperidin-1-ylethoxy)phenyl]methanone;hydrochloride,"RALOXIFENE HYDROCHLORIDE|82640-04-8|Raloxifene Hcl|Evista|Keoxifene hydrochloride|Optruma|Raloxifene Teva|LY 156758|LY156758|NSC-706725|DTXSID1034181|CHEBI:50740|LY-156758|4F86W47BR6|DTXCID9014181|NSC706725|[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride|Ostiral|Razylan|Evirex|raloxifene.hcl|(6-Hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)methanone Hydrochloride|RefChem:56954|LY139481|(6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride|Raloxifene (hydrochloride)|C28H28ClNO4S|MFCD01938233|2-(4-hydroxyphenyl)-3-({4-[2-(piperidin-1-yl)ethoxy]phenyl}carbonyl)-1-benzothiophen-6-ol hydrochloride|Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-,hydrochloride (1:1)|Evista (Raloxifene Hydrochloride)|6-Hydroxy-2-(p-hydroxyphenyl)benzo(b)thien-3-yl-p-(2-piperidinoethoxy)phenyl ketone, hydrochloride|SMR000058508|Raloxifene hydrochloride [USAN]|NCGC00015889-05|CAS-82640-04-8|Loxifen|UNII-4F86W47BR6|SR-01000076102|CDT-Raloxifene|Raloxifene cloridrato|Evista (TN)|Prestwick_1035|Raloxifene hydrochloride [USAN:USP]|raloxifen hydrochloride|Methanone, hydrochloride|Cloridrato de Raloxifeno|Clorhidrato de raloxifeno|Chlorhydrate de raloxifene|CHEMBL1116|SCHEMBL19077|MLS000859902|MLS001332533|MLS001332534|MLS002222293|Raloxifene hydrochloride, solid|orb1308226|SCHEMBL1665291|Evista, Raloxifene hydrochloride|LY-139481 HCl|BKXVVCILCIUCLG-UHFFFAOYSA-N|HMS1570N05|HMS5079G19|HY-13738AR|Pharmakon1600-01505622|BCP05713|Raloxifene HCl - Bio-X trade mark|Raloxifene hydrochloride (JAN/USP)|Tox21_110255|Tox21_302369|Tox21_501051|HB2509|HY-13738A|NSC759285|RALOXIFENE HYDROCHLORIDE [MI]|s1227|RALOXIFENE HYDROCHLORIDE [JAN]|AKOS008131940|Raloxifene (hydrochloride) (Standard)|Tox21_110255_1|AC-8390|CCG-213497|CS-1775|DS-2162|FR27668|KS-1102|LP01051|NC00665|NSC 706725|NSC 759285|NSC-759285|RALOXIFENE HYDROCHLORIDE [MART.]|RALOXIFENE HYDROCHLORIDE [VANDF]|NCGC00015889-03|NCGC00015889-11|NCGC00092353-01|NCGC00092353-03|NCGC00094334-01|NCGC00094334-02|NCGC00255153-01|NCGC00261736-01|RALOXIFENE HYDROCHLORIDE [USP-RS]|RALOXIFENE HYDROCHLORIDE [WHO-DD]|2-(4-hydroxyphenyl)-3-{4-[2-(piperidin-1-yl)ethoxy]benzoyl}-1-benzothiophen-6-ol hydrochloride|BR164310|Methanone, (6-hydroxy-2-(4-hydroxyphenyl)benzo(b)thien-3-yl)(4-(2-(1-piperidinyl)ethoxy)phenyl)-, hydrochloride|RALOXIFENE HYDROCHLORIDE [EMA EPAR]|EU-0101051|NS00076186|R0109|SW197106-5|EN300-52517|RALOXIFENE HYDROCHLORIDE [ORANGE BOOK]|D02217|R 1402|RALOXIFENE HYDROCHLORIDE [EP MONOGRAPH]|RALOXIFENE HYDROCHLORIDE [USP IMPURITY]|RALOXIFENE HYDROCHLORIDE [USP MONOGRAPH]|640R048|SR-01000076102-2|SR-01000076102-9|Q27122215|Z754931262|Raloxifene hydrochloride, European Pharmacopoeia (EP) Reference Standard|Raloxifene Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material|Raloxifene hydrochloride, United States Pharmacopeia (USP) Reference Standard|(6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl)-(4-(2-(piperidin-1-yl)ethoxy)phenyl)methanone hydrochloride|(6-OH-2-(4-OH-Ph)benzo[b]thiophen-3-yl)(4-(2-(piperidin-1-yl)ethoxy)Ph)methanone hydrochloride|[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothien-3-yl][4-(2-piperidin-1-ylethoxy)phenyl]methanone hydrochloride|[6-hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-methanone hydrochloride|[6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride;Keoxifene hydrochloride ;LY 156758|[6-Hydroxy-2-(4-hydroxyphenyl)-benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride;Keoxifene;LY-139481|[6-Hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone Hydrochloride|[6-hydroxy-2-(4-hydroxyphenyl)benzothiophen-3-yl]-[4-[2-(1-piperidyl)ethoxy]phenyl]methanone;hydrochloride|[6-hydroxy-2[4-hydroxyphenyl)benzo [b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride|[6-hydroxy-2[4-hydroxyphenyl)benzo [b]thien3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride|[6-hydroxy-2[4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]methanone hydrochloride|1-[2-(4-{[6-hydroxy-2-(4-hydroxyphenyl)-1-benzothiophen-3-yl]carbonyl}phenoxy)ethyl]piperidinium chloride|6-hydroxy-2-(4-hydroxyphenyl)-3-[ 4-(2-piperidinoethoxy)benzoyl]benzo[b]thiophene, hydrochloride|6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]-benzo[b]-thiophene hydrochloride|6-hydroxy-2-(4-hydroxyphenyl)-3-[4-(2-piperidinoethoxy)benzoyl]-benzo[b]thiophene hydrochloride|6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl 4-[2-(1-piperidinyl)ethoxy]phenyl methanone hydrochloride|6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thiophen-3-yl 4-[2-(1-piperidinyl)ethoxy]phenyl ketone hydrochloride|6-HYDROXY-2-(P-HYDROXYPHENYL)BENZO(.BETA.)THIEN-3-YL-P-(2-PIPERIDINOETHOXY)PHENYL KETONE, HYDROCHLORIDE|METHANONE, (6-HYDROXY-2-(4-HYDROXYPHENYL)BENZO(.BETA.)THIEN-3-YL)(4-(2-(1-PIPERIDINYL)ETHOXY)PHENYL)-, HYDROCHLORIDE|Methanone, [6-hydroxy-2-(4-hydroxyphenyl)benzo[b]thien-3-yl][4-[2-(1-piperidinyl)ethoxy]phenyl]-, hydrochloride (1:1)|Raloxifene hydrochloride for peak identification, European Pharmacopoeia (EP) Reference Standard"
ALPIDEM,54897,,"InChI=1S/C21H23Cl2N3O/c1-3-11-25(12-4-2)20(27)13-18-21(15-5-7-16(22)8-6-15)24-19-10-9-17(23)14-26(18)19/h5-10,14H,3-4,11-13H2,1-2H3",JRTIDHTUMYMPRU-UHFFFAOYSA-N,C21H23Cl2N3O,404.3,"2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide","ALPIDEM|82626-01-5|Alpidemum|SL 80.0342-00|DTXSID8049046|I93SC245QZ|SL-80.0342-00|DTXCID3028972|SL 80-0342|RefChem:555982|Ananxyl|C21H23Cl2N3O|2-(6-Chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl)-N,N-dipropylacetamide|6-Chloro-2-(p-chlorophenyl)-N,N-dipropylimidazo(1,2-a)pyridine-3-acetamide|2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropylacetamide|CHEMBL54349|MFCD00866978|NCGC00182850-01|Imidazo(1,2-a)pyridine-3-acetamide, 6-chloro-2-(4-chlorophenyl)-N,N-dipropyl-|Alpidemum [Latin]|CAS-82626-01-5|Alpidem [USAN:INN:BAN]|UNII-I93SC245QZ|S-800342|Alpidem (USAN/INN)|ALPIDEM [USAN]|ALPIDEM [INN]|ALPIDEM [MI]|ALPIDEM [MART.]|ALPIDEM [WHO-DD]|6-Chlor-2-(4-chlorphenyl)-N,N-dipropylimidazol(1,2-a)pyridin-3-acetamid|SCHEMBL122619|orb1305206|BDBM22041|CHEBI:135649|GLXC-03641|PXB96223|Tox21_113593|Alpidem, >=98% (HPLC), powder|PDSP1_000633|PDSP2_000628|6-Chloro-2-(4-chlorophenyl)-N,N-dipropyl-imidazo[1,2-a]pyridine-3-acetamide|AKOS016014168|Tox21_113593_1|CS-W013866|FA17325|HY-W013150|NCGC00182850-02|NS00122639|D02833|SR-01000944944|Q4735440|SR-01000944944-1|BRD-K66896751-001-02-4|2-(6-chloro-2-(4-chlorophenyl)H-imidazo[1,2-a]pyridin-3-yl)-N,N-dipropylacetamide|2-[6-chloro-2-(4-chlorophenyl)imidazo[1,2-a]pyridin-3-yl]-N,N-dipropyl-acetamide|6-Chloro-2-(4-chlorophenyl)-N,N-dipropylimidazo[1,2-a]pyridine-3-acetamide|6-Chloro-2-(4-chlorophenyl)-N,N-dipropyl-imidazo[1,2-a]pyridine-3-acetamide;SL 80.0342-00"
[18F]D,24895172,,"InChI=1S/C22H27FN4O2/c1-5-26(6-2)20(28)14-19-21(17-7-9-18(10-8-17)29-12-11-23)25-27-16(4)13-15(3)24-22(19)27/h7-10,13H,5-6,11-12,14H2,1-4H3",FLZZFWBNYJNHMY-UHFFFAOYSA-N,C22H27FN4O2,398.5,"N,N-diethyl-2-[2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl]acetamide","N,N-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)acetamide|N,N-diethyl-2-[2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl]acetamide|n,n-diethyl-2-(2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidin-3-yl)acetamide|N,N-diethyl-2-{2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl}acetamide|RefChem:926466|DPA-714|958233-07-3|Y1H4D2VKZD|2-(2-(4-(2-Fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidin-3-yl)-N,N-diethylacetamide|Pyrazolo[1,5-a]pyrimidine-3-acetamide, N,N-diethyl-2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethyl-|CHEMBL512306|DPA 714|[18F]D|J2.865.885K|N,N-Diethyl-2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethylpyrazolo(1,5-a)pyrimidine-3-acetamide|Pyrazolo(1,5-a)pyrimidine-3-acetamide, N,N-diethyl-2-(4-(2-fluoroethoxy)phenyl)-5,7-dimethyl-|2-(2-(4-(2-Fluoroethoxy)phenyl)-5,7-dimethylpyrazolo[1,5-a]pyrimidin-3-yl)-N,N-diethylacetamide|UNII-Y1H4D2VKZD|orb1308368|SCHEMBL2513934|FLZZFWBNYJNHMY-UHFFFAOYSA-N|DTXSID801121798|EX-A3761|INB23307|BDBM50243007|AKOS040741666|DA-63007|MS-26740|HY-122607|CS-0087451|G16403|N,N-diethyl-2-[2-[4-(2-fluoroethoxy)phenyl]-5,7-dimethyl-pyrazolo[1,5-a]pyrimidin-3-yl]acetamide|n,n-diethyl-2-{2-[4-(2-fluoro-ethoxy)-phenyl]-5,7-dimethyl-pyrazolo[1,5-a]pyrimidin-3-yl}-acetamide"
ELVITEGRAVIR,5277135,,"InChI=1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1",JUZYLCPPVHEVSV-LJQANCHMSA-N,C23H23ClFNO5,447.9,6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid,"Elvitegravir|697761-98-1|GS-9137|JTK-303|Vitekta|GS 9137|CHEBI:72289|JTK 303|elvitegravirum|JTK303|GS9137|4GDQ854U53|VITEKTA COMPONENT ELVITEGRAVIR|STRIBILD COMPONENT ELVITEGRAVIR|6-(3-chloro-2-fluorobenzyl)-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|3-Quinolinecarboxylic acid, 6-((3-chloro-2-fluorophenyl)methyl)-1,4-dihydro-1-((1S)-1-(hydroxymethyl)-2-methylpropyl)-7-methoxy-4-oxo-|6-(3-Chloro-2-fluorobenzyl)-1-((2S)-1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|DTXSID101021650|RefChem:58903|J05AX11|DTXCID101506658|691-248-4|Elvitegravir (GS-9137)|(S)-6-(3-chloro-2-fluorobenzyl)-1-(1-hydroxy-3-methylbutan-2-yl)-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|UNII-4GDQ854U53|6-(3-Chloro-2-fluorobenzyl)-1-[1(S)-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|EVG|MFCD11846134|6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxoquinoline-3-carboxylic acid|Elvitegravir (GS-9137, JTK-303)|CHEMBL204656|C23H23CLFNO5|6-(3-chloro-2-fluorobenzyl)-1-[(1S)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|6-[(3-chloro-2-fluoro-phenyl)methyl]-1-[(1S)-1-(hydroxymethyl)-2-methyl-propyl]-7-methoxy-4-oxo-quinoline-3-carboxylic acid|Elvitegravir [USAN]|Elvitegravir [USAN:INN]|6-(3-CHLORO-2-FLUOROBENZYL)-1-((1S)-1-(HYDROXYMETHYL)-2-METHYLPROPYL)-7-METHOXY-4-OXO-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID|ELV|Vitekta (TN)|Elvitegravir (Standard)|ELVITEGRAVIR [MI]|Elvitegravir (JAN/USAN)|ELVITEGRAVIR [INN]|ELVITEGRAVIR [JAN]|Elvitegravir (JTK-303)|ELVITEGRAVIR [VANDF]|ELVITEGRAVIR [MART.]|MLS006011136|ELVITEGRAVIR [WHO-DD]|SCHEMBL726252|SCHEMBL29623981|GTPL11574|JUZYLCPPVHEVSV-LJQANCHMSA-N|BCPP000242|ELVITEGRAVIR [ORANGE BOOK]|GLXC-05860|6-[(3-chloro-2-fluorophenyl)methyl]-1-[(2S)-1-hydroxy-3-methylbutan-2-yl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|EX-A1542|BDBM50183273|HY-14740R|MSK159130|s2001|Elvitegravir; GS9137; JTK 303|AKOS025396642|BCP9000642|CCG-269208|compound 2 [PMID: 18281931]|CS-0439|DB09101|NCGC00346565-01|NCGC00346565-04|NCGC00346565-08|AC-29947|AS-16986|HY-14740|SMR004702914|NS00040665|SW219721-1|D06677|AB01274749-01|AB01274749_02|EN300-19771136|F547237|Q2740966|BRD-K54472332-001-01-8|BRD-K54472332-001-03-4|3-Quinolinecarboxylic acid, 6-[(3-chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1S)-1-isopropyl-2-hydroxyethyl]-7-methoxy-4-oxo-|6-(3-chloro-2-fluorobenzyl)-1-[(S)-1-hydroxymethyl-2-methylpropyl]-7-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid"
RALTEGRAVIR,54671008,,"InChI=1S/C20H21FN6O5/c1-10-25-26-17(32-10)16(30)24-20(2,3)19-23-13(14(28)18(31)27(19)4)15(29)22-9-11-5-7-12(21)8-6-11/h5-8,28H,9H2,1-4H3,(H,22,29)(H,24,30)",CZFFBEXEKNGXKS-UHFFFAOYSA-N,C20H21FN6O5,444.4,"N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide","Raltegravir|518048-05-0|MK-0518|MK0518|raltegravirum|MK 0518|DTXSID2048660|22VKV8053U|N-[2-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl]propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide|4-Pyrimidinecarboxamide, N-((4-fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-|DTXCID5028586|CHEBI:82960|N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide|L000900612|L-000900612|N-(2-(4-((4-fluorophenyl)methylcarbamoyl)-5-hydroxy-1-methyl-6-oxopyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide|RefChem:55964|J05AX08|0518, MK|Raltegravir (MK-0518)|N-(2-(4-((4-fluorobenzyl)carbamoyl)-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl)-5-methyl-1,3,4-oxadiazole-2-carboxamide|Raltegravir (INN)|MFCD10698872|C20H21FN6O5|518048-05-0 (free)|N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-{2-[(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-yl}-6-oxo-1,6-dihydropyrimidine-4-carboxamide|NCGC00184997-01|RALTEGRAVIR [INN]|N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo-4-pyrimidinecarboxamide|Isentress(TM)|N-[1-[4-[(4-fluorophenyl)methylcarbamoyl]-5-hydroxy-1-methyl-6-oxo-pyrimidin-2-yl]-1-methyl-ethyl]-5-methyl-1,3,4-oxadiazole-2-carboxamide|CAS-518048-05-0|Raltegravir [USAN:INN]|UNII-22VKV8053U|Raltegravir?|HSDB 8124|N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-di hydropyrimidine-4-carboxamide|RLT|RALTEGRAVIR [MI]|Raltegravir(MK-0518)|Raltegravir; MK-0518|K-0518|RALTEGRAVIR [VANDF]|RALTEGRAVIR [MART.]|hydropyrimidine-4-carboxamide|SCHEMBL51817|RALTEGRAVIR [WHO-DD]|MLS006011985|SCHEMBL996804|RALTEGRAVIR [EMA EPAR]|CHEMBL254316|orb1305950|SCHEMBL2112870|Raltegravir - Bio-X trade mark|BDBM25351|GTPL11571|CZFFBEXEKNGXKS-UHFFFAOYSA-N|BCPP000093|HMS3655B09|HMS5080N13|BCP01394|EX-A2147|Tox21_113019|NSC762522|s2005|AKOS015902444|AKOS025149884|AKOS032960305|Tox21_113019_1|AC-5261|CCG-269170|DB06817|FR29048|NSC-762522|PB13312|SB20935|NCGC00274066-01|NCGC00274066-05|AS-16992|BR164312|HY-10353|SMR003601806|NS00015450|SW220138-1|D06676|EN300-120882|yl}-6-oxo-1,6-dihydropyrimidine-4-carboxamide|AB01566833_01|038R721|048R050|Q421552|BRD-K05658747-001-02-9|BRD-K05658747-001-03-7|BRD-K05658747-237-01-1|[(5-methyl-1,3,4-oxadiazol-2-yl)formamido]propan-2-|N-[(4-fluorophenyl)methyl]-5-hydroxy-1-methyl-2-{2-|Z1532717445|N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo  -4-pyrimidinecarboxamide|N-((4-Fluorophenyl)methyl)-1,6-dihydro-5-hydroxy-1-methyl-2-(1-methyl-1-(((5-methyl-1,3,4-oxadiazol-2-yl)carbonyl)amino)ethyl)-6-oxo -4-pyrimidinecarboxamide|N-(2-(4-(4-fluorobenzylcarbamoyl)-5-hydroxy-1-methyl-6-oxo-1, 6-dihydropyrimidin-2-yl)propan-2-yl) -5-methyl-1,3,4-oxadiazole-2- carboxamide|N-(2-(4-(4-FLUOROBENZYLCARBAMOYL)-5-HYDROXY-1-METHYL-6-OXO-1,6- DIHYDROPYRIMIDIN-2-YL)PROPAN-2-YL)-5-METHYL-1,3,4-OXADIAZOLE-2-CARBOXAMIDE|N-(2-(4-(4-Fluorobenzylcarbamoyl)-5-OH-1-Me-6-oxo-pyrimidin-2-yl)propan-2-yl)-5-Me-1,3,4-oxadiazole-2-carboxamide|N-(4-FLUOROBENZYL)-5-HYDROXY-1-METHYL-2-(1-METHYL-1-(((5-METHYL-1,3,4-OXADIAZOL-2-YL)CARBONYL)AMINO)ETHYL)-6-OXO-1,6-DIHYDROPYRIMIDINE-4-CARBOXAMIDE|N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(1-methyl-1-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}ethyl)-6-oxo-1,6-di|N-(4-fluorobenzyl)-5-hydroxy-1-methyl-2-(2-{[(5-methyl-1,3,4-oxadiazol-2-yl)carbonyl]amino}propan-2-yl)-6-oxo-1,6-dihydropyrimidine-4-carboxamide|N-[2-(4-{[(4-fluorophenyl)methyl]carbamoyl}-5-hydroxy-1-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)propan-2-yl]-5-methyl-1,3,4-oxadiazole-2-carboxamide"
ROGLETIMIDE,56487,,"InChI=1S/C12H14N2O2/c1-2-12(9-4-7-13-8-5-9)6-3-10(15)14-11(12)16/h4-5,7-8H,2-3,6H2,1H3,(H,14,15,16)",QXKJWHWUDVQATH-UHFFFAOYSA-N,C12H14N2O2,218.25,"3-ethyl-3-pyridin-4-ylpiperidine-2,6-dione","ROGLETIMIDE|Pyridoglutethimide|92788-10-8|Rogletimida|3-PYG|2-Ethyl-2-(4-pyridyl)glutarimide|2,6-Piperidinedione, 3-ethyl-3-(4-pyridinyl)-|3-Ethyl-3-(4-pyridyl)piperidine-2,6-dione|14P4QR28QF|DTXSID60869670|NSC619778|Rogletimidum|RefChem:930862|DTXCID80817618|3-ethyl-3-pyridin-4-ylpiperidine-2,6-dione|121840-95-7|3-ethyl-3-(pyridin-4-yl)piperidine-2,6-dione|CHEMBL289116|Pyridoglutethimide; Racemic pyridoglutethimide|(+-)-Pyridoglutethimide|Racemic-pyridoglutethimide|UNII-14P4QR28QF|Rogletimide [USAN:INN:BAN]|ROGLETIMIDE [INN]|Rogletimide (USAN/INN)|ROGLETIMIDE [USAN]|SCHEMBL4281|3-Ethyl-4,5-dihydro-3H-[3,4'']bipyridinyl-2,6-dione|ROGLETIMIDE [MART.]|ROGLETIMIDE [WHO-DD]|(+/-)-PYRIDOGLUTETHIMIDE|(+/-)3-ETHYL-3-(4-PYRIDINYL)-2,6-PIPERIDINEDIONE|SDA78810|BDBM50015985|AKOS015904738|NSC-619778|DA-00724|NCI60_005808|3-ethyl-3-(4-pyridyl)-2,6-piperidinedione|NS00124853|3-ethyl-3-(4-pyridinyl)-2,6-piperidinedione|D05746|(+/-)-2-ETHYL-2-(4-PYRIDYL)GLUTARIMIDE|Q7359418|2,6-PIPERIDINEDIONE, 3-ETHYL-3-(4-PYRIDINYL)-, (+/-)-"
DEXFADROSTAT,9815923,,"InChI=1S/C14H13N3/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14/h4-7,9-10,14H,1-3H2/t14-/m1/s1",CLPFFLWZZBQMAO-CQSZACIVSA-N,C14H13N3,223.27,"4-[(5R)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl]benzonitrile","Dexfadrostat|(R)-Fadrozole|102676-87-9|(+)-Fadrozole|Fadrozole, (R)-|Dexfadrostat [INN]|4-[(5r)-5,6,7,8-Tetrahydroimidazo[1,5-A]pyridin-5-Yl]benzonitrile|IC1B8751F6|R-FADROZOLE|UNII-IC1B8751F6|CHEMBL287677|(R)-4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile|4-((5R)-5,6,7,8-Tetrahydroimidazo(1,5-a)pyridin-5-yl)benzonitrile|Benzonitrile, 4-((5R)-5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-|Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-, (R)-|CGS 020286A|SCHEMBL685516|DP13|orb1692018|GTPL13884|CLPFFLWZZBQMAO-CQSZACIVSA-N|DP-13|GLXC-26833|BDBM50047262|AKOS040756426|DA-59606|HY-113986|CS-0064819|EN300-27037804|Q27451399|4-(5,6,7,8-Tetrahydro-imidazo[1,5-a]pyridin-5-yl)-benzonitrile|4-[(5R)-5H,6H,7H,8H-imidazo[1,5-a]pyridin-5-yl]benzonitrile"
ANASTROZOLE,2187,,"InChI=1S/C17H19N5/c1-16(2,9-18)14-5-13(8-22-12-20-11-21-22)6-15(7-14)17(3,4)10-19/h5-7,11-12H,8H2,1-4H3",YBBLVLTVTVSKRW-UHFFFAOYSA-N,C17H19N5,293.4,"2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile","anastrozole|120511-73-1|Arimidex|anastrazole|Anastrozol|ZD1033|ICI D1033|ZD-1033|ICI-D1033|ZD 1033|DTXSID9022607|2Z07MYW1AZ|NSC-719344|NSC-759855|CHEBI:2704|alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|Rvg-106400|NSC719344|DTXCID202607|1,3-Benzenediacetonitrile, alpha,alpha,alpha',alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-|Zeneca ZD 1033|2-[3-(1-cyano-1-methylethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile|anastrozolum|Nastrosa|Anastrozole Tablets|2-(3-(1-Cyano-1-methylethyl)-5-(1H-1,2,4-triazol-1-ylmethyl)phenyl)-2-methylpropanenitrile|2,2'-(5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene)bis(2-methylpropionitrile)|RefChem:54202|L02BG03|2,2'-(5-(1H-1,2,4-Triazol-1-ylmethyl)-1,3-phenylene)di(2-methylpropionitrile)|Alpha,alpha,alpha', alpha'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile|2,2'-(5-((1H-1,2,4-triazol-1-yl)methyl)-1,3-phenylene)bis(2-methylpropanenitrile)|CHEMBL1399|MFCD00866298|2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)|NCGC00164619-01|Asiolex|alpha1,alpha1,alpha3,alpha3-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile|Arimidex (TN)|SMR000466301|CAS-120511-73-1|HSDB 7462|ICI-D 1033|SR-01000759390|UNII-2Z07MYW1AZ|Anastrozole?|2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropanenitrile|CCRIS 9352|Anastrozole [USAN:USP:INN:BAN]|Anastrozole; 2,2'-[5-(1H-1,2,4-Triazol-1-ylmethyl)benzene-1,3-diyl]bis(2-methylpropanenitrile)|Anastrozole (Standard)|Arimidex (AstraZeneca)|ANASTROZOLE [MI]|ANASTROZOLE [INN]|ANASTROZOLE [JAN]|ANASTROZOLE [HSDB]|ANASTROZOLE [USAN]|SCHEMBL9726|ANASTROZOLE [MART.]|ANASTROZOLE [USP-RS]|ANASTROZOLE [WHO-DD]|MLS000759396|MLS001424217|MLS006011961|GTPL5137|orb1310655|Anastrozole (JP18/USP/INN)|Anastrozole - Bio-X trade mark|BDBM10015|ANASTROZOLE [ORANGE BOOK]|ANASTROZOLE [EP MONOGRAPH]|ANASTROZOLE [USP IMPURITY]|BCPP000401|GLXC-03925|HMS2052M11|HMS2089N10|HMS2235M06|HMS3369K05|HMS3394M11|HMS3654I18|HMS3715B05|HMS3742O21|HMS3866K03|HMS5079E13|Pharmakon1600-01502278|ANASTROZOLE [USP MONOGRAPH]|ALBB-037397|BCP02090|VEA51232|Tox21_112238|Tox21_303568|HY-14274R|NSC759855|s1188|STL451008|AKOS015894980|tetramethyl-5-(1h-1,2,4-triazol-1ylmethyl) 1,3-benzenediacetionitrile|Tox21_112238_1|AC-4234|BCP9000301|CCG-101109|CS-0716|DB01217|FT10600|KS-5052|NC00359|NSC 719344|NSC 759855|SB17304|2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]bis(2-methylpropanenitrile)|2-[3-(1-cyano-1-methyl-ethyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile|3-Phenylene]bis(2-methyl-propiononitrile|NCGC00164619-02|NCGC00164619-04|NCGC00257356-01|BT164176|HY-14274|A2370|NS00005588|SW197739-4|11A731|C08159|D00960|EN300-118709|AB00639929-06|AB00639929-08|AB00639929-09|AB00639929-10|AB00639929_11|AB00639929_13|A804526|Q419143|2;2""-[5-(1H-1;2;4-Triazol-1-ylmethyl)-1|SR-01000759390-4|SR-01000759390-5|BRD-K52172416-001-10-6|BRD-K52172416-001-11-4|Z1515385077|1,.alpha.,alpha.,alpha.',.alpha.'-tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-|2,2'-[5-(1H-1,2,4-triazol-1-yl-methyl)-1,3-phenylene]-di(2-methyl propionitrile)|2,2'-[5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-phenylene]di(2-methylpropiononitrile)|2,2'-[5-(1H-1,2,4-triazole-1-yl-methyl)-1,3-phenylene]di(2-methyl propionitrile)|2-[3-(2-cyano-2-propyl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methylpropiononitrile|2-[3-(2-cyanopropan-2-yl)-5-(1,2,4-triazol-1-ylmethyl)phenyl]-2-methyl-propanenitrile|a,a,a',a'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile|.alpha.,.alpha.',.alpha.'-tetramethyl-5(1H-1,2,4-triazol-1-ylmethyl)-m-benzenediacetonitrile|.ALPHA.,.ALPHA.,.ALPHA.',.ALPHA.'-TETRAMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-M-BENZENEDIACETONITRILE|1,3-BENZENEDIACETONITRILE,.ALPHA.,.ALPHA.,.ALPHA.',.ALPHA.'-TETRAMETHYL-5-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-|2-[3-(1-cyano-1-methylethyl)-5-[(1H-1,2,4-triazol-1-yl)methyl]phenyl]-2-methylpropanenitrile|alpha,alpha,alpha',alpha'-Tetramethyl-5-(1H-1,2,4-triazol-1-ylmethyl)-1,3-benzenediacetonitrile"
LETROZOLE,3902,,"InChI=1S/C17H11N5/c18-9-13-1-5-15(6-2-13)17(22-12-20-11-21-22)16-7-3-14(10-19)4-8-16/h1-8,11-12,17H",HPJKCIUCZWXJDR-UHFFFAOYSA-N,C17H11N5,285.30,"4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile","letrozole|112809-51-5|Femara|Letrozol|CGS 20267|CGS-20267|Benzonitrile, 4,4'-(1H-1,2,4-triazol-1-ylmethylene)bis-|4-[(4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl]benzonitrile|4,4'-(1H-1,2,4-Triazol-1-ylmethylene)dibenzonitrile|DTXSID4023202|CGS20267|NSC-759652|7LKK855W8I|CHEBI:6413|4-[(4-CYANOPHENYL)(1H-1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE|DTXCID503202|NSC719345|KISQALI FEMARA CO-PACK COMPONENT LETROZOLE|letrozolum|4-((4-cyanophenyl)-(1,2,4-triazol-1-yl)methyl)benzonitrile|4-((4-cyanophenyl)(1H-1,2,4-triazol-1-yl)methyl)benzonitrile|Letrozole Tablets|4,4'-(1H-1,2,4-triazol-1-yl-methylene)-bis(benzonitrile)|RefChem:55460|L02BG04|4,4'-(1H-1,2,4triazol-1-ylmethylene)dibenzonitrile|675-034-8|4,4'-((1h-1,2,4-triazol-1-yl)methylene)dibenzonitrile|C17H11N5|Femera|4,4'-(1h-1,2,4-triazol-1-ylmethylene)bisbenzonitrile|4,4'-(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile|1-[bis(4-cyanophenyl)methyl]-1,2,4-triazole|CHEMBL1444|MFCD00866241|4,4'-(1h-1,2,4-triazol-1-ylmethylene) bis-benzonitrile|NCGC00016973-01|Letoval|CAS-112809-51-5|SMR000466343|Femara (TN)|LETRAZOLE|HSDB 7461|SR-01000759382|Letrozole (JAN/USP/INN)|UNII-7LKK855W8I|4,4'-(1h-1,2,4-triazol-1-ylmethylene)bis-benzonitrile|CCRIS 8822|Letrozole?|FEM-345|Femara, Letrozole|Letrozole [USAN:USP:INN:BAN]|Letrozole (Standard)|LETROZOLE [INN]|LETROZOLE [JAN]|LETROZOLE [MI]|LETROZOLE [HSDB]|LETROZOLE [USAN]|Prestwick0_001025|Prestwick1_001025|Prestwick2_001025|Prestwick3_001025|Femara (TN) (Novartis)|LETROZOLE [MART.]|LETROZOLE [USP-RS]|LETROZOLE [WHO-DD]|SCHEMBL4331|1-[Bis-(4-cyanophenyl)methyl]-1,2,4-triazole|BIDD:PXR0130|BSPBio_001209|MLS000759455|MLS001424038|MLS002584991|MLS006010040|BIDD:GT0015|Letrozole - Bio-X trade mark|SPBio_003070|BPBio1_001331|GTPL5209|orb1308084|LETROZOLE [EP IMPURITY]|LETROZOLE [ORANGE BOOK]|LETROZOLE [EP MONOGRAPH]|Letrozole, >=98% (HPLC)|BDBM13061|EX-A965|LETROZOLE [USP MONOGRAPH]|GLXC-05072|HMS1571M11|HMS2051E08|HMS2089L22|HMS2098M11|HMS2233C23|HMS3369E11|HMS3393E08|HMS3651K05|HMS3715M11|HMS5079O19|Pharmakon1600-01502354|BCP23354|IVB71296|MSK10362|Tox21_110719|Tox21_303572|HY-14248R|NSC759652|s1235|STL451047|AKOS005145822|AB07525|AC-1193|BCP9000848|CCG-100849|CS-1776|DB01006|FL24873|KS-1269|NC00099|NSC 759652|NSC-719345|NCGC00016973-02|NCGC00016973-03|NCGC00016973-06|NCGC00257460-01|BL164620|HY-14248|BCP0726000213|1-Bis(4-cyanophenyl)methyl-1,2,4-triazole|4,2,4-Triazol-1-ylmethylene)dibenzonitrile|AB00514009|L0248|NS00000663|SW197294-4|A25380|C08163|D00964|EN300-264820|AB00514009-05|AB00514009-07|AB00514009-08|AB00514009-09|AB00514009_10|AB00514009_11|809L515|F036495|Q194974|W-60273|4,4'-(1,2,4-Triazol-1-ylmethylene)dibenzonitrile|SR-01000759382-4|SR-01000759382-5|BRD-K88789588-001-03-2|BRD-K88789588-001-14-9|4,4 -(1H-1,2,4-triazol-1-ylmethanediyl)dibenzonitrile|F2173-0288|Z1741968261|4,4'-((1H-1,2,4-Triazol-1-yl)-methylene)dibenzonitrile|4,4'-(1H-1,2,4-Triazol-1-ylmethylene)bis[benzonitrile]|Letrozole, European Pharmacopoeia (EP) Reference Standard|Letrozole, United States Pharmacopeia (USP) Reference Standard|4-[1-(4-CYANOPHENYL)-1-(1,2,4-TRIAZOL-1-YL)METHYL]BENZONITRILE|Letrozole, Pharmaceutical Secondary Standard; Certified Reference Material"
FADROZOLE HYDROCHLORIDE,59694,,"InChI=1S/C14H13N3.ClH/c15-8-11-4-6-12(7-5-11)14-3-1-2-13-9-16-10-17(13)14;/h4-7,9-10,14H,1-3H2;1H",UKCVAQGKEOJTSR-UHFFFAOYSA-N,C14H14ClN3,259.73,"4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile;hydrochloride","FADROZOLE HYDROCHLORIDE|102676-31-3|Afema|Fadrozole HCl|4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile hydrochloride|Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-, hydrochloride (1:1)|Arensin|Fadrozole monohydrochloride|H0Q44H4ECQ|4-(5,6,7,8-Tetrahydroimidazo(1,5-a)pyridin-5-yl)benzonitrile Hydrochloride|Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-, hydrochloride (1:1)|Hydrochloride, Fadrozole|RefChem:597145|Monohydrochloride, Fadrozole|631-311-5|CGS 16949A|Fadrozole.HCl|Fadrozole hydrochloride [USAN]|Fadrozole (hydrochloride)|MFCD00866239|4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile;hydrochloride|CHEMBL468419|102676-96-0|DTXSID4020618|4-(5,6,7,8-Tetrahydroimidazo(1,5-a)pyridin-5-yl)benzonitrile monohydrochloride|4-(1,8-diazabicyclo[4.3.0]nona-6,8-dien-2-yl)benzonitrile hydrochloride|Fadrozole hydrochloride (USAN)|4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)-Benzonitrile|CCRIS 4597|CGS 16949|UNII-H0Q44H4ECQ|Imidazo[1,5-a]pyridine, benzonitrile deriv.; Afema; CGS 16949; CGS 16949A; 4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzonitrile|Fadrozaole hydrochloride|Fadrozole (hydrochloride)?|FADROZOLEHYDROCHLORIDE|SCHEMBL4143|DTXCID20618|orb1299712|CHEBI:31589|EX-A2624A|GLXC-05489|BCP18654|FADROZOLE HYDROCHLORIDE [MI]|Tox21_303613|AKOS025311475|AT20805|FADROZOLE HYDROCHLORIDE [MART.]|Benzonitrile, 4-(5,6,7,8-tetrahydroimidazo(1,5-a)pyridin-5-yl)-, monohydrochloride|FADROZOLE HYDROCHLORIDE [WHO-DD]|NCGC00257411-01|AC-37994|AS-76078|DA-73298|Fadrozole hydrochloride, >=98% (HPLC)|FF167207|HY-14247|CAS-102676-31-3|CS-0002958|F1301|D02451|EN300-18567338|4-{5H,6H,7H,8H-imidazo[1,5-a]pyridin-5-yl}benzonitrile hydrochloride|5-(p-Cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]-pyridine hydrochloride|5-(p-Cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine hydrochloride|5-p-Cyanophenyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine hydrochloride|5-p-Cyanophenyl-5,6,7,8-tetrahydroimidazo[1,5-a]pyridinehydrochloride|4-(5,6,7,8-tetrahydroimidazo[1,5-a]pyridin-5-yl)benzene-1-carbonitrile hydrochloride|Racemic 5-(p-cyanophenyl)-5,6,7,8-tetrahydroimidazo[1,5-a]pyridine hydrochloride|(+/-)-P-(5,6,7,8-TETRAHYDROIMIDAZO(1,5-A)PYRIDIN-5-YL)BENZONITRILE MONOHYDROCHLORIDE|BENZONITRILE, 4-(5,6,7,8-TETRAHYDROIMIDAZO(1,5-A)PYRIDIN-5-YL)-, MONOHYDROCHLORIDE, (+/-)-"
EXEMESTANE,60198,,"InChI=1S/C20H24O2/c1-12-10-14-15-4-5-18(22)20(15,3)9-7-16(14)19(2)8-6-13(21)11-17(12)19/h6,8,11,14-16H,1,4-5,7,9-10H2,2-3H3/t14-,15-,16-,19+,20-/m0/s1",BFYIZQONLCFLEV-DAELLWKTSA-N,C20H24O2,296.4,"(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione","EXEMESTANE|107868-30-4|Aromasin|6-Methyleneandrosta-1,4-diene-3,17-dione|Exemestano|Exemestanum|FCE-24304|Androsta-1,4-diene-3,17-dione, 6-methylene-|FCE24304|PNU-155971|DTXSID5023037|NY22HMQ4BX|CHEBI:4953|NSC713563|NSC-758907|DTXCID003037|(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione|examestane|(1S,2R,10R,11S,15S)-2,15-dimethyl-8-methylidenetetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,6-diene-5,14-dione|(1S,2R,10R,11S,15S)-2,15-dimethyl-8-methylidenetetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-diene-5,14-dione|(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylidene-7,8,9,11,12,14,15,16-octahydrocyclopenta(a)phenanthrene-3,17-dione|RefChem:57964|L02BG06|Fce 24304|Exemestanum [INN-Latin]|Exemestano [INN-Spanish]|6-Methylene-androsta-1,4-diene-3,17-dione|C20H24O2|(8R,9S,10R,13S,14S)-10,13-Dimethyl-6-methylene-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthrene-3,17(10H,14H)-dione|Exemestane (Standard)|Aromasine|Aromasil|MFCD00866994|(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,10,11,12,13,14,15,16-decahydro-3H-cyclopenta[a]phenanthrene-3,17(6H)-dione|Exemestane [USAN:INN:BAN]|Nikidess|(8alpha,10alpha,13alpha)-6-Methylideneandrosta-1,4-Diene-3,17-Dione|Aromasin (TN)|SMR000466314|CAS-107868-30-4|HSDB 7463|Curator_000009|UNII-NY22HMQ4BX|Exemestane (JAN/USP/INN)|CCRIS 9351|NCGC00095289-01|Androsta-1,4-diene-3,17-dione, 6-methylene-; 6-Methyleneandrosta-1,4-diene-3,17-dione; Aromasil; Aromasin; Exemestane; FCE 24304|Exemestane [INN]|Exemestane; aromasin|Exemestane, Aromasin|PNU 155971|EXEMESTANE [MI]|EXEMESTANE [JAN]|EXEMESTANE [HSDB]|EXEMESTANE [USAN]|EXEMESTANE [VANDF]|EXEMESTANE [MART.]|SCHEMBL6215|Aromasin (Pharmacia Upjohn)|EXEMESTANE [USP-RS]|EXEMESTANE [WHO-DD]|Exemestane(FCE 24304)|MLS000759419|MLS001424062|orb315348|Exemestane(FCE 24304)?|GTPL7073|6-Methylenandrosta-1,17-dione|CHEMBL1200374|EXEMESTANE [ORANGE BOOK]|Exemestane, >=98% (HPLC)|EXEMESTANE [EP MONOGRAPH]|BCPP000235|EXEMESTANE [USP MONOGRAPH]|GLXC-06573|HMS2051J04|HMS3713H12|BCP23353|MSK10960|Tox21_111499|BDBM50398447|HY-13632R|s1196|AKOS015840113|AKOS015895161|Tox21_111499_1|AC-2171|BCP9000676|CCG-100995|CS-1766|DB00990|FM23211|KS-5136|NC00245|NSC 758907|NSC-713563|NCGC00271596-03|(8R,9S,10R,13S,14S)-10,13-dimethyl-6-methylene-7,8,9,11,12,14,15,16-octahydrocyclopenta[a]phenanthrene-3,17-dione|6-methylenandrost-1,4-dien-3,17-dione|AS-31053|CPD000466314|HY-13632|BCP0726000226|6-Methylen-androst-1,4-diene-3,17-dione|CS-0694867|E0941|NS00000304|C08162|D00963|AB00639936-06|AB00639936-08|AB00639936-09|AB00639936-10|AB00639936_11|868E304|Q418819|SR-01000759393|6-Methylenandrosta-1,4-diene-3,17-dione;Aromasin|SR-01000759393-4|BRD-K33425534-001-12-5|Exemestane, European Pharmacopoeia (EP) Reference Standard|Exemestane, United States Pharmacopeia (USP) Reference Standard|Exemestane, Pharmaceutical Secondary Standard; Certified Reference Material|Exemestane for system suitability, European Pharmacopoeia (EP) Reference Standard|EXM"
MENADIONE,4055,,"InChI=1S/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H3",MJVAVZPDRWSRRC-UHFFFAOYSA-N,C11H8O2,172.18,"2-methylnaphthalene-1,4-dione","menadione|58-27-5|Vitamin K3|2-Methyl-1,4-naphthoquinone|2-methylnaphthalene-1,4-dione|Menaphthone|Kayquinone|Thyloquinone|Kappaxin|Kayklot|Klottone|Kolklot|Panosine|2-Methylnaphthoquinone|Kanone|2-Methyl-1,4-naphthalenedione|Menadion|Menaphthon|Kipca|Prokayvit|Aquakay|Aquinone|Hemodal|Kaergona|Mitenon|Mitenone|Karcon|Kareon|Kativ-G|Kaykot|Koaxin|Synkay|K-Thrombyl|K-Vitan|Kappaxan|Juva-K|Vitamin K 3|Vitamin K0|Vitamin K2(0)|Menaquinone 0|2-Methyl-1,4-naphthochinon|Memodol|Usaf ek-5185|3-Methyl-1,4-naphthoquinone|Menaphthene|1,4-Naphthalenedione, 2-methyl-|2-methyl-1,4-dihydronaphthalene-1,4-dione|2-Methyl-1,4-naftochinon|1,4-Naphthoquinone, 2-methyl-|NSC-4170|723JX6CXY5|DTXSID4021715|1,4-naphthalenedione, 2-methyl|CHEBI:28869|DTXCID801715|Menadione Phenolic|Bisulfite, Menadione|Menadione 1528|RefChem:5996|Bisulfite, Menadione Sodium|Sodium Bisulfite, Menadione|200-372-6|Menaphtone|Menadione (Vitamin K3)|MFCD00001681|Kaynone|Menaquinone O|Methyl-1,4-naphthoquinone|NSC 4170|NSC4170|MNQ|CHEMBL590|2-Methyl-1,4-naphthalendione|MLS000069420|Menadionum|Menadione (Vitamin K3) 10 microg/mL in Acetonitrile|34524-96-4|Kappaxan (VAN)|VK3|CAS-58-27-5|Menadione semiquinone|NCGC00016258-02|SMR000059102|2-Methyl-1,4-naftochinon [Czech]|Menadione (USP)|Kappaxin (TN)|2-Methyl-1,4-naphthochinon [German]|CCRIS 6672|HSDB 3354|Menadione [USP:BAN]|SR-01000712386|EINECS 200-372-6|2-Methyl-1,4-naphthodione|Methyl-1,4-naphthalenedione|UNII-723JX6CXY5|Mendione|AI3-14700|1,4-Dihydro-2-methylnaphthalene-1,4-dione|2-methyl-1,4-naphthoquinone, 5|Menadione, 9|Phytomenadione Imp. A (EP); Menadione; 2-methylnaphthalene-1,4-dione; Phytomenadione Impurity A|Prestwick_313|Menadione, 98%|Menadione (Standard)|Menadione, crystalline|Spectrum_001228|SpecPlus_000191|MENADIONE [MI]|MENADIONE [HSDB]|Opera_ID_1802|Prestwick0_000459|Prestwick1_000459|Prestwick2_000459|Prestwick3_000459|Spectrum2_001194|Spectrum4_000722|Spectrum5_001764|MENADIONE [VANDF]|M0373|MENADIONE [MART.]|NCIMech_000105|cid_4055|MENADIONE [USP-RS]|MENADIONE [WHO-DD]|2-methyl-1,4-napthoquinone|SCHEMBL25970|BSPBio_000538|KBioGR_000984|KBioGR_002527|KBioSS_001708|KBioSS_002535|2-methyl-1,4 naphthoquinone|MLS001148443|BIDD:ER0556|DivK1c_000080|DivK1c_006287|SPECTRUM1502254|SPBio_001267|SPBio_002477|3-methyl-1,4-naphthalenedione|BPBio1_000592|orb1310604|SCHEMBL6152803|SCHEMBL6742148|MENADIONE [ORANGE BOOK]|MENADIONE [EP MONOGRAPH]|SCHEMBL11024467|SCHEMBL21046658|SCHEMBL25358615|SCHEMBL29351164|2-Methyl-[1,4]-naphthoquinone|BDBM24778|HMS500D22|HY-B0332R|KBio1_000080|KBio1_001231|KBio2_001708|KBio2_002527|KBio2_004276|KBio2_005095|KBio2_006844|KBio2_007663|KBio3_003005|WLN: L66 BV EVJ C1|MENADIONE [USP MONOGRAPH]|MSK1511|cMAP_000077|NINDS_000080|Bio1_000471|Bio1_000960|Bio1_001449|HMS1569K20|HMS1921P06|HMS2092F12|HMS2096K20|HMS2232A09|HMS2234J16|HMS3371M08|HMS3373A12|HMS3655P03|HMS3869N03|HMS5080H07|Pharmakon1600-01502254|BCP25699|HY-B0332|STR01143|Tox21_110334|Tox21_301367|BBL027351|CCG-35354|Menadione (K3), analytical standard|NSC758200|s1949|SBB012369|STL377874|AKOS004910447|AKOS025244105|Tox21_110334_1|DB00170|FM11258|FS-2556|NSC-758200|SB17255|IDI1_000080|QTL1_000056|NCGC00016258-01|NCGC00016258-03|NCGC00016258-04|NCGC00016258-06|NCGC00016258-07|NCGC00016258-08|NCGC00016258-11|NCGC00094978-01|NCGC00094978-02|NCGC00255225-01|2-Methyl-1,4-naphthoquinone;Vitamin K3|AC-34841|NCI60_003945|SMR000653532|ST066885|SY018303|SBI-0051776.P002|Menadione, meets USP testing specifications|NS00010106|SW219798-1|C05377|D02335|EN300-125382|PHYTOMENADIONE IMPURITY A [EP IMPURITY]|001M681|F049845|Q192471|1,4-Naphthalenedione, 2-methyl-, radical ion(1-)|SR-01000712386-2|SR-01000712386-5|SR-01000712386-6|VITAMIN K3; 2-METHYL-1,4-NAPHTHALENEDIONE|BRD-K78126613-001-16-0|BRD-K78126613-001-27-7|BRD-K78126613-001-28-5|BRD-K78126613-001-29-3|Vitamin K3; 2-Methyl-1,4-naphthoquinone; Menaphthone|Vitamin K3: 1,4-Dihydro-1,4-dioxo-2-methylnaphthalene|Z1255430959|Menadione, European Pharmacopoeia (EP) Reference Standard|03AAE1E9-B215-45AF-976C-91E61894A467|Menadione, United States Pharmacopeia (USP) Reference Standard|Menadione, Pharmaceutical Secondary Standard; Certified Reference Material|InChI=1/C11H8O2/c1-7-6-10(12)8-4-2-3-5-9(8)11(7)13/h2-6H,1H|2-Methyl-1,4-naphthoquinone; Vitamin K2(0); Vitamin K3; 2-Methyl-1,4-dihydronaphthalene-1,4-dione"
PLUMBAGIN,10205,,"InChI=1S/C11H8O3/c1-6-5-9(13)10-7(11(6)14)3-2-4-8(10)12/h2-5,12H,1H3",VCMMXZQDRFWYSE-UHFFFAOYSA-N,C11H8O3,188.18,"5-hydroxy-2-methylnaphthalene-1,4-dione","Plumbagin|481-42-5|5-hydroxy-2-methylnaphthalene-1,4-dione|Plumbagine|5-Hydroxy-2-methyl-1,4-naphthoquinone|2-Methyljuglone|Plumbaein|Plumbagone|5-Hydroxy-2-methyl-1,4-naphthalenedione|2-Methyl-5-hydroxy-1,4-naphthoquinone|YAS4TBQ4OQ|5-hydroxy-2-methyl-1,4-dihydronaphthalene-1,4-dione|NSC-236613|NSC-688284|CHEBI:8273|PCUR-101|RefChem:863847|PCUR101|PCUR 101|Synthetic Plumbagin PCUR-101|207-569-6|1,4-Naphthalenedione, 5-hydroxy-2-methyl-|5-Hydroxy-2-methyl-[1,4]naphthoquinone|MFCD00001682|NSC 236613|NSC 688284|5-Hydroxy-2-methyl-naphthalene-1,4-dione|CHEMBL295316|1,4-NAPHTHOQUINONE, 5-HYDROXY-2-METHYL-|NSC236613|NSC688284|ST069355|CCRIS 6671|SR-05000002263|UNII-YAS4TBQ4OQ|EINECS 207-569-6|BRN 1870475|Pumbagin|AI3-38055|DTXSID8075413|5-Hydroxy-2-methylnaphthoquinone|Plumbagin (Standard)|Plumbagin [WHO-DD]|PLUMBAGIN [MI]|RTK1|1, 5-hydroxy-2-methyl-|SCHEMBL34186|BSPBio_002546|4-08-00-02376 (Beilstein Handbook Reference)|Plumbagin from Plumbago indica|SPECTRUM1505129|GTPL7003|orb1304950|SCHEMBL29386213|ACon1_001611|HY-N1497R|GLXC-07459|HMS3870L13|WLN: L66 BV EVJ C1 GQ|HY-N1497|BDBM50012070|MSK177647|s4777|SBB012388|STL564479|AKOS015969699|CCG-208032|CCG-208410|FP13778|NCGC00094567-01|NCGC00094567-02|NCGC00094567-03|NCGC00094567-04|NCGC00094567-05|NCGC00094567-06|BP-25404|NCI60_001904|PS-11338|SY050738|DB-051524|CS-0017042|NS00031768|P1139|5- HYDROXY,2-METHYL-1,4-NAPHTOQUINONE|AP-782/41885488|A1-00788|Q2550553|SR-05000002263-2|SR-05000002263-3|BRD-K36137799-001-02-4|BRD-K36137799-001-03-2|InChI=1/C11H8O3/c1-6-5-9(13)10-7(11(6)14)3-2-4-8(10)12/h2-5,12H,1H|Plumbagin2-Methyljuglone; 5-hydroxy-2-methylnaphthalene-1,4-dione; 5-Hydroxy-2-methyl-1,4-naphthoquinone"
TESTOSTERONE,6013,,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-17,21H,3-10H2,1-2H3/t14-,15-,16-,17-,18-,19-/m0/s1",MUMGGOZAMZWBJJ-DYKIIFRCSA-N,C19H28O2,288.4,"(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one","testosterone|58-22-0|Testosteron|Virosterone|Androderm|Testim|Homosterone|Mertestate|Testiculosterone|Androlin|Sustanon|Testoderm|Synandrol F|Testosteroid|Andronaq|Andrusol|Homosteron|Orquisteron|Primotest|Primoteston|Sustanone|Testandrone|Testobase|Testogel|Testopropon|Testrone|Relibra|Teslen|Testryl|Cristerona T|Testoviron T|Andropatch|Neotestis|trans-Testosterone|Testoviron Schering|Geno-cristaux gremy|Testosterona|Testostosterone|17beta-Hydroxyandrost-4-en-3-one|Sustason 250|Percutacrine androgenique|Testosteronum|Intrinsa|Testolin|Striant|Testoject-50|Testoderm Tts|Testosterone hydrate|Testro AQ|Malestrone (amps)|Livensa|Vogelxo|Fortesta|Axiron|Androst-4-en-17beta-ol-3-one|17beta-Hydroxy-4-androsten-3-one|delta4-Androsten-17beta-ol-3-one|Testosterone ciii|17beta-Hydroxyandrost-4-ene-3-one|17-beta-Hydroxyandrost-4-en-3-one|4-Androsten-17beta-ol-3-one|Androgel 1%|Bio-T-Gel|ANDROLAN|ANDROID-T|delta(sup 4)-Androsten-17(beta)-ol-3-one|17-Hydroxy-(17-beta)-androst-4-en-3-one|17-beta-Hydroxy-delta(sup 4)-androsten-3-one|CHEBI:17347|Androst-4-en-3-one, 17-beta-hydroxy-|Androst-4-en-3-one, 17-hydroxy-, (17beta)-|3XMK78S47O|(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one|DTXSID8022371|(17beta)-17-Hydroxyandrost-4-en-3-one|NSC-9700|D4-Androsten-17b-ol-3-one|DTXCID302371|NSC9700|Testopatch|Testopel|Tostran|testosterone,|Striant sr|Testostroval-PA|17 beta Hydroxy 4 Androsten 3 one|Testosterone,USP|8 Isotestosterone|Natesto nasal gel|(8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta(a)phenanthren-3-one|Testim 1%|RefChem:6503|Testo-100|Testosterone Gel, 1%|Therapeutic Testosterone|17-beta-Hydroxy-4-Androsten-3-one|17 beta Hydroxy 8 alpha 4 Androsten 3 one|17-beta-Hydroxy-8 alpha-4-Androsten-3-one|(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadec-6-en-5-one|200-370-5|Testostroval|Oreton|AndroGel|Perandren|Malerone|Testoviron|Cristerone T|LibiGel|Oreton-F|Andro 100|beta testosterone|Malogen, aquaspension injection|Testosteronum [INN-Latin]|Testosterona [INN-Spanish]|Natesto|Neo-Hombreol F|7-beta-Hydroxyandrost-4-en-3-one|COL 1621|17-Hydroxy-(17beta)-androst-4-en-3-one|17beta-Hydroxy-delta(sup4)-androsten-3-one|(+)-testosterone|Androst-4-en-3-one, 17beta-hydroxy-|Neo-testis|Testopel Pellets|CDB 111C|Halotensin|Nasobol|Tefina|Androst-4-en-3-one, 17-hydroxy-, (17.beta.)-|CompleoTRT|CP 601B|(8alpha,10alpha,13alpha,14beta,17alpha)-17-hydroxyandrost-4-en-3-one|Androderm (TN)|17.beta.-Testosterone|Androgel (TN)|SMR000058344|Testosterone (1.0mg/mL in Acetonitrile)|CCRIS 574|Striant (TN)|AA 2500|Testim (TN)|Androgel 1.62%|HSDB 3398|NSC 9700|EINECS 200-370-5|Testosterone (JAN/USP)|Androst-4-en-3-on-17B-ol|CHEMBL386630|component of Duogen (Salt/Mix)|component of Tostrex (Salt/Mix)|component of Di-Met (Salt/Mix)|UNII-3XMK78S47O|component of Intrinsa (Salt/Mix)|Epitestosteron|Lumitestosteron|4-Androsten-17.beta.-ol-3-one|4-Androsten-3-one-17.beta.-ol|Tostrelle|Tostrex|Viatrel|component of Di-Genik (Salt/Mix)|4-Androsten-3-one, 17b-hydroxy-|Testosterone [USP:INN:BAN]|9b-testosterone|component of Mal-O-Fem (Salt/Mix)|4-androstene-17beta-ol-3-one|17b-hydroxy-4-androsten-3-one|delta4-androsten-17b-ol-3-one|LPCN 1021|Testosterone, 1|3kdm|Androst-4-en-3-one, 17-hydroxy-, (17b)-|17b-Testosterone|17-.beta.-Hydroxyandrost-4-en-3-one|NCGC00091018-01|8-iso-testosterone|Androst-4-en-3-one, 17-hydroxy-, (17-beta)-|(+-)-testosterone|Axiron (TN)|CMC_13449|13-iso-testosterone|mpp10|TESTSTERONE|9b,10a-testosterone|17.beta.-Hydroxy-.DELTA.4-androsten-3-one|17-Hydroxyandrost-4-en-3-one, (17.beta.)-|(+-)-retrotestosterone|Testosterone, >=98%|TESTOSTERONE [MI]|TESTOSTERONE [INN]|TESTOSTERONE [JAN]|Epitope ID:135865|EC 200-370-5|TESTOSTERONE [HSDB]|(+-)-8-iso-testosterone|SCHEMBL8452|4-Androsten-17beta-ol-one|TESTOSTERONE [VANDF]|TESTOSTERONE [MART.]|4-Androsten-3-one-17b-ol|MLS000563091|MLS001032098|MLS001306401|MLS001424262|MLS002174283|BIDD:ER0555|TESTOSTERONE [WHO-DD]|US9682960, Testosterone|Androst-4-en-17b-ol-3-one|BDBM8885|GTPL2858|SCHEMBL5433252|SCHEMBL5433257|Androst-4-ene-17b-ol-3-one|TESTOSTERONE [EMA EPAR]|SCHEMBL11036482|17-hydroxy-D4-androsten-3-one|17-hydroxy-androst-4-en-3-one|17beta-hydroxy-4-androsten-3one|MSK2220|TESTOSTERONE [GREEN BOOK]|Testosterone, cell culture tested|17b-Hydroxy-androst-4-en-3-on|17b-Hydroxy-D4-androsten-3-one|17b-Hydroxyandrost-4-ene-3-one|1i37|Testosterone, 1mg/ml in Methanol|17a-hydroxy-androst-4-en-3-one|17b-hydroxy-androst-4-en-3-one|HMS2052N11|HMS2272B03|HMS2272P03|TESTOSTERONE [EP IMPURITY]|TESTOSTERONE [ORANGE BOOK]|TESTOSTERONE [EP MONOGRAPH]|(8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one|17-Hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-cyclopenta[a]phenanthren-3-one|TESTOSTERONE [USP MONOGRAPH]|Tox21_200689|HY-15554A|LMST02020002|RB3046|17b-hydroxy-8a-androst-4-en-3-one|rac-17b-hydroxy-androst-4-en-3-one|AKOS015894897|17a-hydroxy-13a-androst-4-en-3-one|17a-hydroxy-14b-androst-4-en-3-one|17b-hydroxy-13a-androst-4-en-3-one|CCG-101189|CS-1415|DB00624|Human Serum - Testosterone, low level|NC00439|CAS-58-22-0|Human Serum - Testosterone, high level|Testosterone 1.0 mg/ml in Acetonitrile|17b-hydroxy-(8a)-androst-4-en-3-one|17b-hydroxy-(9b)-androst-4-en-3-one|NCGC00258243-01|(17b)-17-hydroxy-androst-4-en-3-one|17a-hydroxy-(13a)-androst-4-en-3-one|17b-hydroxy-(10a)-androst-4-en-3-one|17b-hydroxy-(13a)-androst-4-en-3-one|AC-14899|CPD000058344|FH156772|SMR001261453|Testosterone, purum, >=99.0% (HPLC)|Testosterone 100 microg/mL in Acetonitrile|NS00067928|rac-17b-hydroxy-(13a)androst-4-en-3-one|rac-17b-hydroxy-(8a)-androst-4-en-3-one|T0027|Testosterone(Discontinued,See C4X-132633)|17b-hydroxy-(8a,10a)-androst-4-en-3-one|17b-hydroxy-(9b,10a)-androst-4-en-3-one|BIM-0061761.0001|C00535|D00075|rac-17b-hydroxy-(9b,10a)androst-4-en-3-one|S00309|AB00973630-03|Testosterone, VETRANAL(TM), analytical standard|003T654|Androst-4-en-3-one, 17-hydroxy, (17.beta.)-|Q1318776|B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E|TESTOSTERONE ENANTATE IMPURITY D [EP IMPURITY]|TESTOSTERONE PROPIONATE IMPURITY C [EP IMPURITY]|Testosterone, European Pharmacopoeia (EP) Reference Standard|Testosterone;  4-Androsten-17?-ol-3-one;  17?-Hydroxy-4-androsten-3-one|Testosterone for system suitability, European Pharmacopoeia (EP) Reference Standard|(1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one|1050678-68-6"
DEXAMETHASONE,5743,,"InChI=1S/C22H29FO5/c1-12-8-16-15-5-4-13-9-14(25)6-7-19(13,2)21(15,23)17(26)10-20(16,3)22(12,28)18(27)11-24/h6-7,9,12,15-17,24,26,28H,4-5,8,10-11H2,1-3H3/t12-,15+,16+,17+,19+,20+,21+,22+/m1/s1",UREBDLICKHMUKA-CXSFZGCWSA-N,C22H29FO5,392.5,"(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one","dexamethasone|50-02-2|Decadron|Prednisolone F|Aeroseb-Dex|Fluormethylprednisolone|Hexadecadrol|Superprednol|Visumetazone|Cortisumman|Decaderm|Decaspray|Dexacortal|Dexacortin|Fortecortin|Gammacorten|Millicorten|Auxiron|Calonat|Dexason|Dexone|Aphtasolon|Deltafluorene|Dergramin|Desadrene|Desamethasone|Desameton|Dexadeltone|Dexapolcort|Mediamethasone|Mymethasone|Corsone|Decalix|Decasone|Dekacort|Dexalona|Dexameth|Dextelan|Dinormon|Loverine|Luxazone|Dexa-Cortidelt|Dexa-Scheroson|Dexa-Cortisyl|Prednisolon F|Dexa-sine|Isopto-Dex|Aeroseb-D|Anaflogistico|Decacortin|Deseronil|Dexafarma|Dexinolon|Dexinoral|Policort|Spoloven|Deronil|Dexapos|Sunia Sol D|Bisu DS|Dexa Mamallet|Lokalison F|Ocu-trol|Dex-ide|Dexamethasonum|Dexametasona|Fluormone|Corson|Dexone 4|Pet Derm III|Dexamethasone alcohol|Dexamethasone Intensol|Dexone 0.5|Dexone 1.5|Decameth|Ozurdex|Dexone 0.75|Methylfluorprednisolone|Aphthasolone|Decacort|Dexamonozon|Dextenza|9alpha-Fluoro-16alpha-methylprednisolone|OTO-104|Dexametasone|Adexone|Dexycu|DexaSite|Dexa-Mamallet|(11beta,16alpha)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|16alpha-Methyl-9alpha-fluoro-1-dehydrocortisol|16alpha-Methyl-9alpha-fluoroprednisolone|delta1-9alpha-Fluoro-16alpha-methylcortisol|NSC 34521|1-Dehydro-16alpha-methyl-9alpha-fluorohydrocortisone|ISV-305|16-alpha-Methyl-9-alpha-fluoro-delta1-hydrocortisone|7S5I7G3JQL|NSC-34521|HEMADY|DTXSID3020384|CHEBI:41879|9-Fluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione|DTXCID10384|NSC34521|4-alpha-Fluoro-16-alpha-methyl-11-beta,17,21-trihydroxypregna-1,4-diene-3,20-dione|9-alpha-Fluoro-16-alpha-methyl-1,4-pregnadiene-11-beta,17-alpha,21-triol-3,20-dione|Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11beta,16alpha)-|CIPRODEX COMPONENT DEXAMETHASONE|MAXITROL COMPONENT DEXAMETHASONE|TOBRADEX COMPONENT DEXAMETHASONE|(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-3-one|DEXACIDIN COMPONENT DEXAMETHASONE|DEXASPORIN COMPONENT DEXAMETHASONE|TOBRADEX ST COMPONENT DEXAMETHASONE|Decaject L.A.|Amplidermis|Auricularum|Cortidexason|Dexacortisyl|Dexafluorene|Dexamecortin|Fluorodelta|Aacidexam|Baycadron|Decadrol|Dexabliss|Dexachel|Dexafree|Dexalocal|Dropodex|Martapan|Spersadex|Dxevo|Spersadex comp|TaperDex|Aknichthol Dexa|Alin Oftalmico|Anemul mono|Azium Solution|Dexium Tablets|Azium Powder|Dexa-Rhinosan|ZoDex|Alin Depot|Baycuten N|Lokalison-F|Decadron DP|Gppe ear spy|Alba-Dex|Kortico Injection|Zonometh Solution|Dexameth-A-Vet|TaperDex 6-day|TaperDex 7-day|Decasone R.p.|Decadron-75|TaperDex 12-day|(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-3-one|HiDex 6-day|Dexamethasone Ointment|Dexamethasone Solution|Dexamethasone Injection|DEXYCU KIT|Azium Boluses 10 mg|Dexamethasone 1.5 mg|Pet Derm III Tablets|RefChem:6416|Dexameth-A-Vet Injection|Azium Tablets 0.25 mg|DEXAMETHASONE 6-Day|Azium Oral Solution 2 mg|Dexamethasone Sterile Solution|Seacall Dexamethasone Ointment.|Azium Aqueous Suspension Veterinary|Fluoro-9alpha Methyl-16alpha Prednisolone|16Alpha-methyl-9alpha-fluoro-delta1-hydrocortisone|16Alpha-methyl-9alpha-fluoro-1,4-pregnadiene-11beta,17alpha,21-triol-3,20-dione|9Alpha-fluoro-11beta,17alpha,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione|(1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo(8.7.0.02,7.011,15)heptadeca-3,6-dien-5-one|200-003-9|Auxiloson|Maxidex|Dexamethazone|Dexasone|Hexadrol|Desametasone|Dexacort|Oradexon|Dectancyl|Turbinaire|Mexidex|SK-Dexamethasone|Dexaprol|Decagel|Dezone|Hexadrol Elixir|Hl-dex|Fluorocort|Dxms|Hexadrol Tablets|Desametasone [DCIT]|Dexpak|Dexametasona [INN-Spanish]|Dexamethasonum [INN-Latin]|Decadron Tablets, Elixir|Azium (Veterinary)|Dexamethansone|Posurdex|MFCD00064136|Dexamethasone Base|(3H)-Dexamethasone|Azimycin (Veterinary)|MK 125|Naquasone (Veterinary)|Tresaderm (Veterinary)|16-alpha-Methyl-9-alpha-fluoroprednisolone|9-alpha-Fluoro-16-alpha-methylprednisolone|16-alpha-Methyl-9-alpha-fluoro-1-dehydrocortisol|Dexamethasone (GMP)|delta(sup 1)-9-alpha-Fluoro-16-alpha-methylcortisol|9A-FLUORO-16BETA-METHYLPREDNISOLONE|16alpha-Methyl-9alpha-fluoro-delta(sup 1)-hydrocortisone|C22H29FO5|16-alpha-Methyl-9-alpha-fluoro-delta(sup 1)-hydrocortisone|MLS001332507|(1R,2S,10S,11S,13R,14R,15S,17S)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one|16.alpha.-Methyl-9.alpha.-fluoroprednisolone|[3H]-dexamethasone|DEXA|[3H]dexamethasone|9.alpha.-Fluoro-16.alpha.-methylprednisolone|Decaject-L.A.|16.alpha.-Methyl-9.alpha.-fluoro-1-dehydrocortisol|1-Dehydro-16.alpha.-methyl-9.alpha.-fluorohydrocortisone|Osurdex|Decadron (TN)|(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one|SMR000857119|DXM [Steroid]|CCRIS 7067|HSDB 3053|dexamethasone (tetramethyl-rhodamine conjugated )|Prednisolone, 9.alpha.-fluoro-16.alpha.-methyl-|EINECS 200-003-9|UNII-7S5I7G3JQL|.delta.(sup 1)-9-.alpha.-Fluoro-16-.alpha.-methylcortisol|16.alpha.-Methyl-9.alpha.-fluoro-.delta.(sup1)-hydrocortisone|Diodex|AI3-50934|.gamma.corten|9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|Apo-dexamethasone|Prednisolone, 9alpha-fluoro-16alpha-methyl-|Dexasone 4mg|Zema-Pak|PHL-dexamethasone|PMS-dexamethasone|Dexamethasone-omega|NCGC00091019-08|Dexasone 0.5mg|Dexamethasone [USP:INN:BAN:JAN]|Dexasone 0.75mg|Sandoz Dexamethasone|Dexamethasone, topical|Maxidex Ont 0.1%|Maxidex Sus 0.1%|Dexamethasone (Standard)|Spectrum5_002019|DEXAMETHASONE [MI]|MolMap_000018|(9R,14S)-Dexamethasone|DEXAMETHASONE [INN]|DEXAMETHASONE [JAN]|SCHEMBL3774|16-alpha-Methyl-9-alpha-fluoro-1,4-pregnadiene-11-beta,17-alpha,21-triol-3,20-dione|16-alpha-Methyl-9-alpha-fluoro-11-beta,17-alpha,21-trihydroxypregna-1,4-diene-3,20-dione|DEXAMETHASONE [HSDB]|BIDD:PXR0060|BSPBio_000995|DEXAMETHASONE [VANDF]|MLS001055412|MLS001332508|BIDD:ER0494|DEXAMETHASONE [MART.]|sustained-release dexamethasone|DEXAMETHASONE [USP-RS]|DEXAMETHASONE [WHO-DD]|DEXAMETHASONE [WHO-IP]|CHEMBL384467|GTPL2768|GTPL3447|orb1309846|SGCUT00126|9-Fluoro-16-methylprednisolone|Ak Dex Oph Otic Soln 0.1%|DEXAMETHASONE [EMA EPAR]|SCHEMBL11039025|BDBM18207|Dexamethasone (anti-inflammatory)|Dexamethasone (JP18/USP/INN)|MSK2218|1p93|DEXAMETHASONE [GREEN BOOK]|GLXC-06963|HMS1792A17|HMS1990A17|HMS2089N13|HMS2235F08|HMS3039L11|HMS3259N11|HMS3403A17|HMS6018M15|DEXAMETHASONE [ORANGE BOOK]|to_000038|DEXAMETHASONE [EP MONOGRAPH]|Tox21_200122|DEXAMETHASONE [USP MONOGRAPH]|Dexamethasone, >=97.0% (HPLC)|HB2521|HY-14648G|HY-14648R|IBI-10090|MK-125|s1322|Dexamethasone 1.0 mg/ml in Methanol|DEXAMETHASONUM [WHO-IP LATIN]|PMS Dexamethasone Elixir 0.5mg/5ml|AKOS005259009|AKOS015895509|CCG-264887|CS-1505|DB01234|FD15640|KS-1451|NC00645|US10869929, Compound Dexamethasone|US11554172, Compound Dexamethasone|alpha -Fluoro-16-alpha -methylcortisol|CAS-50-02-2|Pregna-1,4-diene-3,20-dione, 9-fluoro-11beta,17,21-trihydroxy-16alpha-methyl-|SMP1_000092|Dexamethasone, >=98% (HPLC), powder|NCGC00091019-01|NCGC00091019-02|NCGC00091019-03|NCGC00091019-04|NCGC00091019-05|NCGC00091019-06|NCGC00091019-07|NCGC00091019-23|NCGC00257676-01|(11beta,16alpha)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione labeled with tritium|(8S,9R,10S,11S,13S,14S,16R,17R)-9-Fluoro-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]ph|23495-06-9|9alpha-fluoro-16alpha-methyl-Prednisolone|AC-11056|HY-14648|NCI60_003067|Pregna-1,4-diene-3,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, labeled with tritium, (11beta,16alpha)-|SMR001227192|16alpha -Methyl-9alpha -fluoroprednisolone|9alpha -Fluoro-16alpha -methylprednisolone|Dexamethasone, tested according to Ph.Eur.|CS-0626118|NS00000344|ST50307091|BETAMETHASONE IMPURITY A [EP IMPURITY]|EN300-52607|D00292|Dexamethasone, meets USP testing specifications|Prednisolone, 9alpha -fluoro-16alpha -methyl-|9.alpha.-Fluoro-16.alpha.-methyl-1,20-dione|AB00918428-05|AB00918428-08|AB00918428-09|AB00918428_10|064D136|16alpha -Methyl-9alpha -fluoro-1-dehydrocortisol|Dexamethasone, VETRANAL(TM), analytical standard|Q422252|BRD-K38775274-001-02-3|BRD-K38775274-001-06-4|DEXAMETHASONE ACETATE IMPURITY A [EP IMPURITY]|1-Dehydro-16alpha -methyl-9alpha -fluorohydrocortisone|9-Fluoro-11alpha -methylpregna-1,4-diene-3,20-dione|Dexamethasone, British Pharmacopoeia (BP) Assay Standard|Z756391748|Pregna-1,4-diene-3,20-dione, 9-fluoro-11alpha -methyl-|Dexamethasone, European Pharmacopoeia (EP) Reference Standard|WLN: L E5 B666 OV KU MUTJ A1 BF CQ E1 FV1Q FQ G1|Dexamethasone, powder, BioReagent, suitable for cell culture, >=97%|Dexamethasone, United States Pharmacopeia (USP) Reference Standard|16-.alpha.-Methyl-9-.alpha.-fluoro-1,17-.alpha.,21-triol-3,20-dione|4.alpha.-Fluoro-16.alpha.-methyl-11.beta.-17,4-diene-3,20-dione|Pregna-1,20-dione, 9-fluoro-11.beta.,17,21-trihydroxy-16.alpha.-methyl-|16.alpha.-Methyl-9.alpha.-fluoro-11.beta.-17.alpha.-21-trihydroxypregna-1,20-dione|9-Fluoro-11.beta.,21-trihydroxy-16.alpha.-methylpregna-1,4-diene-3,20-dione|9-fluoro-16alpha-methyl-11beta,17,21-trihydroxypregna-1,4-diene-3,20-dione|9.alpha.-Fluoro-11.beta.-17.alpha.- 21-trihydroxy-16.alpha.-methylpregna-1,20-dione|9alpha-Fluoro-16alpha-methyl-11beta,17alpha,21-trihydroxy-1,4-pregnadiene-3,20-dione|Dexamethasone for peak identification, European Pharmacopoeia (EP) Reference Standard|Dexamethasone for system suitability, European Pharmacopoeia (EP) Reference Standard|Dexamethasone, Pharmaceutical Secondary Standard; Certified Reference Material|Dexamethasone, powder, gamma-irradiated, BioXtra, suitable for cell culture, >=80% (HPLC)|Pregna-1,20-dione, 9-fluoro-11,17,21-trihydroxy-16-methyl-, (11.beta.,16.alpha.)-|(11.BETA.,16.ALPHA.)-9-FLUORO-11,17,21-TRIHYDROXY-16-METHYLPREGNA-1,4-DIENE-3,20-DIONE|(11alpha,14beta,16alpha,17alpha)-9-fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,20-dione|(1R,2R,3aS,3bS,9aS,9bR,10S,11aS)-9b-fluoro-1,10-dihydroxy-1-(2-hydroxyacetyl)-2,9a,11a-trimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one|(2S,10S,11S,15S,17S,1R,13R,14R)-1-fluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)- 2,13,15-trimethyltetracyclo[8.7.0.0<2,7>.0<11,15>]heptadeca-3,6-dien-5-one|1050677-47-8|9.alpha.-Fluoro-16.alpha.-methyl-11.beta.,21.beta.-trihydroxy-pregna-1,4-diene-3,20-dione|Prednisolone F; 9alpha-Fluoro-16alpha-methylprednisolone; (11beta,16alpha)-9-Fluoro-11,17,21-trihydroxy-16-methylpregna-1,4-diene-3,|PREGNA-1,4-DIENE-3,20-DIONE, 9-FLUORO-11,17,21-TRIHYDROXY-16-METHYL-,(11.BETA.,16.ALPHA.)-9-FLUORO-11.BETA.,17,21-TRIHYDROXY-16.ALPHA.-METHYLPREGNA-1,4-DIENE-3,20-DIONE"
PREDNISOLONE,5755,,"InChI=1S/C21H28O5/c1-19-7-5-13(23)9-12(19)3-4-14-15-6-8-21(26,17(25)11-22)20(15,2)10-16(24)18(14)19/h5,7,9,14-16,18,22,24,26H,3-4,6,8,10-11H2,1-2H3/t14-,15-,16-,18+,19-,20-,21-/m0/s1",OIGNJSKKLXVSLS-VWUMJDOOSA-N,C21H28O5,360.4,"(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one","prednisolone|50-24-8|Metacortandralone|Hydroretrocortine|Delta-Cortef|Deltacortril|Deltahydrocortisone|Codelcortone|Cortalone|Prenolone|Sterane|Hydroretrocortin|Meti-Derm|Deltacortenol|Hydrodeltalone|Hydrodeltisone|Precortancyl|Predniliderm|Decaprednil|Deltisilone|Dicortol|Donisolone|Estilsona|Fernisolone|Hydeltra|Hydeltrone|Paracortol|PRDL|Precortilon|Precortisyl|Prednelan|Prednicen|Scherisolon|Sterolone|Prelone|Steran|Ulacort|Delta-stab|Hostacortin H|Ultracorten H|Ultracortene-H|Predne-Dome|Decortin H|CO-Hydeltra|Eazolin D|Di-adreson F|Delta F|Solone|1-Dehydrohydrocortisone|Fernisolone-P|delta(1)-Hydrocortisone|delta(1)-Dehydrocortisol|Delta-Ef-Cortelan|Predniretard|Panafcortelone|Prednisolonum|1,2-Dehydrohydrocortisone|delta(1)-Cortisol|Deltasolone|Klismacort|1,4-Pregnadiene-11beta,17alpha,21-triol-3,20-dione|Delta(1)-dehydrohydrocortisone|11beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione|(11beta)-11,17,21-Trihydroxypregna-1,4-diene-3,20-dione|1,4-Pregnadiene-3,20-dione-11beta,17alpha,21-triol|3,20-Dioxo-11beta,17alpha,21-trihydroxy-1,4-pregnadiene|9PHQ9Y1OLM|NSC-9120|NSC-9900|APREDNISLON|EQUISOLON|CHEBI:8378|(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one|DTXSID9021184|DTXCID301184|Pregna-1,4-diene-3,20-dione, 11beta,17,21-trihydroxy-|NSC9120|Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11beta)-|delta1-Hydrocortisone|Adnisolone|Deltidrosol|Kuhlprednon|Lenisolone|Longiprednil|Predeltilone|Prednicortelone|Scheriproct|Capsoid|Dekotil|Dhasolone|Dilacort|Fisopred|Frisolona|Gupisone|Opredsone|Pevanti|Prenilone|Precortisyl fte|PrednisTab|Delta-Phoricol|DiAdresonF|Lepi-Cortinolo|Dontisolon D|Predni-Coelin|Dacortin H|Delta-Diona|Pred-Clysma|Predni-Helvacort|Prednisolone oral|Meti Derm|Delta-F|Di Adreson F|Linola-H-Fett N|Linola-H N|(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta(a)phenanthren-3-one|Delta(1)Hydrocortisone|RefChem:6161|prednisolone oral solution|Delta1-dehydro-hydrocortisone|Prednisolone anhydrous Micronized|200-021-7|Cortisolone|Deltalone|Predonine|Cotogesic|Delcortol|Dydeltrone|Erbacort|Erbasona|Lentosone|Paracotol|Predonin|Rolisone|Cordrol|Prednis|Fernisolone P|Derpo PD|Prednisolona|Dexa-Cortidelt hostacortin H|Prednisolonum [INN-Latin]|Prednisolona [INN-Spanish]|Ultracortene-hydrogen|MFCD00003649|K 1557|11beta,17alpha,21-Trihydroxypregna-1,4-diene-3,20-dione|.DELTA.1-Cortisol|Prednisolone (Standard)|.DELTA.1-Hydrocortisone|.DELTA.1-Dehydrocortisol|CHEMBL131|.DELTA.1-Dehydrohydrocortisone|.delta.-Cortef|1-Dehydrocortisol|Neo-Delta-Cortef|.delta.-Stab|component of Ataraxoid|Cotolone|component of K-Predne-Dome|Supercortisol|delta(sup 1)-Cortisol|Bubbli-Pred|Prednisolone (1.0 mg/mL in Methanol)|delta(sup 1)-Hydrocortisone|delta(sup 1)-Dehydrocortisol|SMR000718761|CCRIS 980|Prednisolone [INN:BAN:JAN]|HSDB 3385|delta(sup 1)-Dehydrohydrocortisone|MLS002638110|NSC 9120|Pregna-1,20-dione, 11.beta.,17,21-trihydroxy-|EINECS 200-021-7|UNII-9PHQ9Y1OLM|Predisolone Sodium Phosphate|BRN 1354103|prednisolon|Hydrocortisone EP Impurity A|Preflam|Pregna-1,20-dione, 11,17,21-trihydroxy-, (11.beta.)-|CAS-50-24-8|NCGC00094764-01|Prednisolone Powder|delta-hydrocortisone|TUA|Prestwick_404|delta-dehydrocortisol|DELTA.1-Cortisol|VETSOLONE|Delta-Cortef (TN)|11-beta,17,21-Trihydroxypregna-1,4-diene-3,20-dione|T-Pred (Salt/Mix)|1,4-Pregnadien-11-beta,17-alpha,21-triol-3,20-dione|1,4-Pregnadiene-11-beta,17-alpha,21-triol-3,20-dione|1,4-Pregnadiene-3,20-dione-11-beta,17-alpha,21-triol|Prednisolone, >=99%|Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11b)-|Prestwick0_000274|Prestwick1_000274|Prestwick2_000274|Prestwick3_000274|delta-dehydrohydrocortisone|PREDNISOLONE [EP]|PREDNISOLONE [MI]|(+)-PREDNISOLONE|PREDNISOLONE [INN]|PREDNISOLONE [JAN]|EC 200-021-7|PREDNISOLONE [HSDB]|SCHEMBL3233|K-Predne-Dome (Salt/Mix)|PREDNISOLONE [VANDF]|PREDNISOLONE ANHYDROUS|.DELTA.(sup 1)-Cortisol|BSPBio_000148|PREDNISOLONE [MART.]|(1S,2R,10S,11S,14R,15S,17S)-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-5-one|4-08-00-03467 (Beilstein Handbook Reference)|MLS001304083|MLS002154250|MLS002207037|MLS002548883|PREDNISOLONE [USP-RS]|PREDNISOLONE [WHO-DD]|PREDNISOLONE [WHO-IP]|SPBio_002367|BPBio1_000164|GTPL2866|US10196374, Prednisolone|SCHEMBL11040337|.DELTA.(sup 1)-Hydrocortisone|BDBM19190|Prednisolone (JP17/USP/INN)|MSK2225|NSC9900|PREDNISOLONE [GREEN BOOK]|.DELTA.(sup 1)-Dehydrocortisol|HMS1568H10|HMS2090J05|HMS2095H10|HMS2230P10|HMS3259E09|HMS3712H10|PREDNISOLONE [ORANGE BOOK]|PREDNISOLONE [EP MONOGRAPH]|PREDNISONE IMPURITY B [EP]|BCP09053|PREDNISOLONE [USP MONOGRAPH]|Tox21_111327|Tox21_201673|Tox21_302987|HY-17463R|LMST02030179|PREDNISOLONUM [WHO-IP LATIN]|Pregna-1,4-diene-3,20-dione, 11,17,21-trihydroxy-, (11.beta.)-|s1737|.DELTA.(sup 1)-Dehydrohydrocortisone|AKOS015894935|Tox21_111327_1|AC-1773|CCG-220274|DB00860|FP27131|NC00473|NCGC00179649-01|NCGC00179649-02|NCGC00179649-03|NCGC00179649-04|NCGC00179649-06|NCGC00256577-01|NCGC00259222-01|(8S,9S,10R,11S,13S,14S,17R)-11,17-dihydroxy-17-(2-hydroxyacetyl)-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-3-one|AS-13665|HY-17463|PREDNISOLONE (EMA EPAR: VETERINARY)|CS-0695025|NS00000394|P0637|EN300-53017|PREDNICARBATE IMPURITY A [EP IMPURITY]|C07369|D00472|D91990|HYDROCORTISONE IMPURITY A [EP IMPURITY]|Prednisolone, VETRANAL(TM), analytical standard|003P649|CHLOROPTIC-P S.O.P. COMPONENT PREDNISOLONE|METHYLPREDNISOLONE IMPURITY K [EP IMPURITY]|SR-01000837502|SR-01000837502-2|BRD-K98039984-001-03-0|BRD-K98039984-001-06-3|PREDNISOLONE ACETATE IMPURITY B [EP IMPURITY]|Q11426176|11beta,17,21-trihydroxy-1,4-pregnadiene-3,20-dione|Prednisolone, British Pharmacopoeia (BP) Assay Standard|Z778141968|11-.beta.,17,21-Trihydroxypregna-1,4-diene-3,20-dione|11beta,17alpha,21-Trihydroxy-1,4-pregnadiene-3,20-dione|1,4-Pregnadien-11-.beta.,17-.alpha.,21-triol-3,20-dione|1,4-Pregnadiene-11-.beta.,17-.alpha.,21-triol-3,20-dione|1,4-Pregnadiene-3,20-dione-11-.beta.,17-.alpha.,21-triol|Prednisolone, European Pharmacopoeia (EP) Reference Standard|Pregna-1,4-diene-3,20-dione, 11.beta.,17,21-trihydroxy-|11,17,21-Trihydroxypregna-1,4-diene-3,20-dione, (11.beta.)-|11-.beta.,17-.alpha.,21-Trihydroxy-1,4-pregnadiene-3,20-dione|11-.beta.,17-.alpha.,21-Trihydroxypregna-1,4-diene-3,20-dione|11.BETA.,17,21-TRIHYDROXYPREGNA-1,4-DIENE-3,20-DIONE.|11.beta.,17.alpha.,21-Trihydroxypregna-1,4-diene-3,20-dione|Prednisolone, United States Pharmacopeia (USP) Reference Standard|(11?)-11,17,21-Trihydroxy-pregna-1,4-diene-3,20-dione;Metacortandralone;Delta F|Prednisolone for peak identification, European Pharmacopoeia (EP) Reference Standard|Prednisolone for system suitability, European Pharmacopoeia (EP) Reference Standard|Prednisolone, Pharmaceutical Secondary Standard; Certified Reference Material|PREGNA-1,4-DIENE-3,20-DIONE, 11,17,21-TRIHYDROXY-, (11.BETA)-|(1R,3aS,3bS,9aR,9bS,10S,11aS)-1,10-dihydroxy-1-(2-hydroxyacetyl)-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-7-one|(8S,9S,10R,11S,13S,14S,17R)-10,13-dimethyl-11,17-bis(oxidanyl)-17-(2-oxidanylethanoyl)-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one|8056-11-9"
CORT 108297,44454750,,"InChI=1S/C26H25F4N3O3S/c1-2-36-17-25-14-18-15-31-33(22-7-5-21(27)6-8-22)24(18)13-20(25)11-12-32(16-25)37(34,35)23-9-3-19(4-10-23)26(28,29)30/h3-10,13,15H,2,11-12,14,16-17H2,1H3/t25-/m1/s1",SLKURXRZHJOZOD-RUZDIDTESA-N,C26H25F4N3O3S,535.6,"(4aR)-4a-(ethoxymethyl)-1-(4-fluorophenyl)-6-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinoline","CORT-108297|1018679-79-2|Cort108297|CORT 108297|ADS-108297|A17W0640NB|(R)-4A-(ethoxymethyl)-1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinoline|DTXSID70144304|(R)-4a-(Ethoxymethyl)-1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo(3,4-g)isoquinoline|1H-Pyrazolo(3,4-g)isoquinoline, 4a-(ethoxymethyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-6-((4-(trifluoromethyl)phenyl)sulfonyl)-, (4aR)-|4A-(Ethoxymethyl)-1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo(3,4-g)isoquinoline, (R)-|1H-Pyrazolo[3,4-g]isoquinoline, 4a-(ethoxymethyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-6-[[4-(trifluoromethyl)phenyl]sulfonyl]-, (4aR)-|RefChem:128069|DTXCID0066795|MFCD28044284|CHEMBL271220|(4aR)-4a-(ethoxymethyl)-1-(4-fluorophenyl)-6-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinoline|1H-Pyrazolo[3,4-g]isoquinoline, 4a-(ethoxymethyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-6-[[4-(trifluoromethyl)phenyl]sulfonyl]-, (4aR)-;1H-Pyrazolo[3,4-g]isoquinoline, 4a-(ethoxymethyl)-1-(4-fluorophenyl)-4,4a,5,6,7,8-hexahydro-6-[[4-(trifluoromethyl)phenyl]sulfonyl]-, (4aR)-|UNII-A17W0640NB|C26H25F4N3O3S|SLKURXRZHJOZOD-RUZDIDTESA-N|SCHEMBL755070|orb1707433|GLXC-05378|BCP16798|TQB67979|BDBM50372968|EX-A10713|AKOS027338706|SB17316|AS-35226|DA-72345|HY-15710|CS-0008503|Q27273492"
DAZUCORILANT,72192163,,"InChI=1S/C29H22F4N4O3S/c30-22-6-8-23(9-7-22)37-26-15-21-12-14-36(41(39,40)24-10-4-20(5-11-24)29(31,32)33)18-28(21,16-19(26)17-35-37)27(38)25-3-1-2-13-34-25/h1-11,13,15,17H,12,14,16,18H2/t28-/m0/s1",VXOBXKQLNWYQPQ-NDEPHWFRSA-N,C29H22F4N4O3S,582.6,"[(4aR)-1-(4-fluorophenyl)-6-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinolin-4a-yl]-pyridin-2-ylmethanone","Dazucorilant|1496508-34-9|CORT-113176|HR4RD5RBJ6|CORT113176|Methanone, ((4aR)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-((4-(trifluoromethyl)phenyl)sulfonyl)-4ah-pyrazolo(3,4-g)isoquinolin-4a-yl)-2-pyridinyl-|[(4aR)-1-(4-fluorophenyl)-6-[4-(trifluoromethyl)phenyl]sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinolin-4a-yl]-pyridin-2-ylmethanone|((4aR)-1-(4-fluorophenyl)-6-(4-(trifluoromethyl)phenyl)sulfonyl-4,5,7,8-tetrahydropyrazolo(3,4-g)isoquinolin-4a-yl)-pyridin-2-ylmethanone|Methanone, [(4aR)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-[[4-(trifluoromethyl)phenyl]sulfonyl]-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl]-2-pyridinyl-|RefChem:919688|Dazucorilant [INN]|UNII-HR4RD5RBJ6|CHEMBL3734774|Dazucorilant (USAN/INN)|DAZUCORILANT [USAN]|orb1691649|SCHEMBL15455041|SCHEMBL29886657|GTPL13264|BDBM50265674|AKOS040756862|compound 1 [PMID: 28368581]|DA-52326|MS-30438|HY-132811|CS-0204060|D12638|G18371|(R)-(1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(pyridin-2-yl)methanone|{(4aR)-1-(4-fluorophenyl)-6-[4-(trifluoromethyl)benzene-1-sulfonyl]-1,4,5,6,7,8-hexahydro-4aH-pyrazolo[3,4-g]isoquinolin-4a- yl}(pyridin-2-yl)methanone"
CLONIDINE,2803,,"InChI=1S/C9H9Cl2N3/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9/h1-3H,4-5H2,(H2,12,13,14)",GJSURZIOUXUGAL-UHFFFAOYSA-N,C9H9Cl2N3,230.09,"N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine","clonidine|4205-90-7|Clonidin|N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine|Chlornidinum|Catapres-TTS|ST-155-BS|Catapresan|Catapressan|Clonidina|ST 155BS|CATAPRES-TTS-1|CATAPRES-TTS-2|CATAPRES-TTS-3|Clonidinum|Catarpres-TTS|Nexiclon XR|2-((2,6-Dichlorophenyl)imino)imidazolidine|2,6-Dichloro-N-2-imidazolidinylidenebenzenamine|734571A|Chlofazoline|CHEBI:3757|Clonidine extended release|Benzenamine, 2,6-dichloro-N-2-imidazolidinylidene-|MN3L5RMN02|M 5041T|DTXSID6022846|2-[(2,6-Dichlorophenyl)imino]imidazoline|DTXCID402846|CHEBI:46632|Clofenil|Clopheline|Klofenil|2-[(2,6-Dichlorophenyl)imino]imidazolidine|2-((2,6-Dichlorophenyl)imino)imidazoline|RefChem:5698|Hydrochloride, Clonidine|Dihydrochloride, Clonidine|Monohydrobromide, Clonidine|Monohydrochloride, Clonidine|Clonidine Transdermal System|CHEBI:46631|C02AC01|N02CX02|S01EA04|ST155|M5041T|Clonidine Transdermal System USP, 0.1 mg/day|Clonidine Transdermal System USP, 0.2 mg/day|Clonidine Transdermal System USP, 0.3 mg/day|224-119-4|ST 155|Catapres|Adesipress|Catarpres|Catarpresan|Clonidinum [INN-Latin]|2-(2,6-Dichloroanilino)-2-imidazoline|clonidine (amino form)|Clonidinhydrochlorid|SKF 34427|Dixarit|Isoglaucon|CLORPRES|2-(2,6-Dichloroanilino)-1,3-diazacyclopentene-(2)|CCRIS 7787|M-5041T|HSDB 3040|1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-|[3H]clonidine|2-(2,6-Dichlorophenylamino)-2-imidazoline|CLONIDINE(200MG)|2,6-dichloro-N-imidazolidin-2-ylideneaniline|ST-155BS|2-Imidazoline, 2-(2,6-dichloroanilino)-|4205-90-7 (free base)|NCGC00015268-05|Catapres- TTS|Clonidina [INN-Spanish]|DICHLORANILINO IMIDAZOLIN|CAS-4205-90-7|Catarpres-TTS (TN)|EINECS 224-119-4|CAS-4205-91-8|UNII-MN3L5RMN02|Kapvay&reg|SR-01000759380|3h-clonidine|Clonidine [USAN:USP:INN:BAN]|MFCD00055059|Clonidine (Standard)|Clonidine(200 mg)|clonidine (imino form)|Spectrum_001341|Tocris-0690|2-(2,6-Dichlorophenylimino)imidazolidine|starbld0009556|CLONIDINE [INN]|CLONIDINE [JAN]|CLONIDINE [MI]|CLONIDINE [HSDB]|CLONIDINE [USAN]|Prestwick0_000248|Prestwick1_000248|Prestwick2_000248|Prestwick3_000248|Spectrum2_001187|Spectrum3_000358|Spectrum4_000956|Spectrum5_000759|CLONIDINE [VANDF]|Lopac-C-7897|2-[(2,6-dichlorophenyl)imino]-2-imidazoline|CHEMBL134|CLONIDINE [MART.]|D00281|CLONIDINE [USP-RS]|CLONIDINE [WHO-DD]|SCHEMBL5982|SCHEMBL5983|2,6-dichloro-N-2-imidazolidinylidenebenzenamide|Clonidine (JAN/USP/INN)|Lopac0_000268|BSPBio_000036|BSPBio_001588|BSPBio_002055|GTPL516|KBioGR_000308|KBioGR_001572|KBioSS_000308|KBioSS_001821|MLS006011925|BIDD:GT0547|DivK1c_000774|SPBio_001233|SPBio_002255|BPBio1_000040|orb1300116|SCHEMBL2457114|SCHEMBL2457117|CLONIDINE [ORANGE BOOK]|BDBM14062|GTPL13162|KBio1_000774|KBio2_000308|KBio2_001821|KBio2_002876|KBio2_004389|KBio2_005444|KBio2_006957|KBio3_000615|KBio3_000616|KBio3_001275|CLONIDINE [USP MONOGRAPH]|NINDS_000774|Bio1_000470|Bio1_000959|Bio1_001448|Bio2_000308|Bio2_000788|GLXC-07073|HMS1361P10|HMS1791P10|HMS1989P10|HMS2089G11|HMS3402P10|BCP07223|CLONIDINE, Clonidine hydrochloride|Tox21_110118|BBL025137|BDBM50016897|BDBM50020341|BDBM50225285|HY-12721R|STL355995|AKOS001595470|AKOS015960367|Tox21_110118_1|CCG-204363|DB00575|SDCCGSBI-0050256.P005|IDI1_000774|IDI1_034058|MRF-0000018|NCGC00015268-01|NCGC00015268-02|NCGC00015268-03|NCGC00015268-04|NCGC00015268-06|NCGC00015268-07|NCGC00015268-08|NCGC00015268-12|NCGC00024734-01|NCGC00024734-02|NCGC00024734-03|NCGC00024734-04|NCGC00024734-05|NCGC00179680-01|NCGC00179680-02|NCGC00179680-03|NCGC00179680-05|HY-12721|SMR001550184|SY267931|2-(2,6-dichlorophenylimino)-imidazolidine|SBI-0050256.P004|2-(2,6-dichlorophenyl-imino)-imidazolidine|AB00514634|CS-0012297|N-(2,6-dichlorophenyl)imidazolidin-2-imine|NS00010455|2-(2',6'-dichlorophenylamino)-2-imidazoline|2-[(2,6-dichlorophenyl)imino]-imidazolidine|F74813|AB00053441_03|AB00514634-07|AB00514634-08|AB00514634_09|EN300-8686697|(2,6-Dichlorophenyl)imidazolidin-2-ylidene amine|F869752|L000193|Q412221|(2,6-dichloro-phenyl)-imidazolidin-2-ylidene-amine|SR-01000759380-4|2-IMIDAZOLINE, 2-(2,6-DICHLOROPHENYLAMINO)-|BRD-K98530306-001-02-1|BRD-K98530306-003-05-0|BRD-K98530306-003-07-6|BRD-K98530306-003-16-7|BRD-K98530306-003-17-5|BRD-K98530306-003-18-3|2-Imidazoline, 2-(2,6-dichloroanilino)- (7CI,8CI)|N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine #|1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- (9CI)|CLD"
BI 653048,44543970,,"InChI=1S/C23H25F4N3O4S/c1-4-35(33,34)19-8-13-7-15(30-18(13)11-29-19)10-22(32,23(25,26)27)12-21(2,3)17-6-5-14(24)9-16(17)20(28)31/h5-9,11,30,32H,4,10,12H2,1-3H3,(H2,28,31)/t22-/m0/s1",AUIFRJWXYUNPPV-QFIPXVFZSA-N,C23H25F4N3O4S,515.5,"2-[(4R)-4-[(5-ethylsulfonyl-1H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5,5,5-trifluoro-4-hydroxy-2-methylpentan-2-yl]-5-fluorobenzamide","1198784-72-3|UNII-KQ33EVH4KU|BI 653048|KQ33EVH4KU|BI-653048 free base|CHEMBL3358954|(R)-2-(4-((5-(Ethylsulfonyl)-1H-pyrrolo[2,3-c]pyridin-2-yl)methyl)-5,5,5-trifluoro-4-hydroxy-2-methylpentan-2-yl)-5-fluorobenzamide|2-[(4R)-4-[(5-ethylsulfonyl-1H-pyrrolo[2,3-c]pyridin-2-yl)methyl]-5,5,5-trifluoro-4-hydroxy-2-methylpentan-2-yl]-5-fluorobenzamide|2-((3R)-3-((5-(Ethylsulfonyl)-1H-pyrrolo(2,3-C)pyridin-2-yl)methyl)-4,4,4-trifluoro-3-hydroxy-1,1-dimethylbutyl)-5-fluorobenzamide|2-((4R)-4-((5-Ethylsulfonyl-1H-pyrrolo(2,3-C)pyridin-2-yl)methyl)-5,5,5-trifluoro-4-hydroxy-2-methylpentan-2-yl)-5-fluorobenzamide|Benzamide, 2-((3R)-3-((5-(ethylsulfonyl)-1H-pyrrolo(2,3-C)pyridin-2-yl)methyl)-4,4,4-trifluoro-3-hydroxy-1,1-dimethylbutyl)-5-fluoro-|BI-653048|GTPL9715|orb1710262|SCHEMBL1493900|SCHEMBL30874754|AUIFRJWXYUNPPV-QFIPXVFZSA-N|EX-A8658|BDBM50041896|BI 653048 BS H3PO4|AKOS040732594|BI653048|DA-71461|HY-12946|CS-0012809|(R)-39"
YOHIMBINE,8969,,"InChI=1S/C21H26N2O3/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24/h2-5,12,15,17-19,22,24H,6-11H2,1H3/t12-,15-,17-,18-,19+/m0/s1",BLGXFZZNTVWLAY-SCYLSFHTSA-N,C21H26N2O3,354.4,"methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate","Yohimbine|146-48-5|Yohimbin|Quebrachin|Corynine|Quebrachine|APHRODINE|Yohimbic acid methyl ester|(+)-Yohimbine|Yohimbinum|Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)-|2Y49VWD90Q|DTXSID9040130|CHEBI:10093|17alpha-hydroxyyohimban-16alpha-carboxylic acid methyl ester|methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate|(16alpha,17alpha)-17-hydroxyyohimban-16-carboxylic acid methyl ester|DTXCID7020130|methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate|methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo(11.8.0.0^(2,10).0^(4,9).0^(15,20))henicosa-2(10),4,6,8-tetraene-19-carboxylate|Tartrate, Corynanthine|RefChem:56477|205-672-0|Aphrosol|Johimbin|Yocon|Yohimbe bark|17-Hydroxyyohimban-16-carboxylic acid methyl ester|MFCD00005093|CHEMBL15245|methyl 17alpha-hydroxyyohimban-16alpha-carboxylate|Actibine|Yohimex|YOHIMBINE CHLORIDE|Aphrodyne|CHEMBL537669|Yohimbine (DCF)|CAS-146-48-5|methyl hydroxy[?]carboxylate|EINECS 205-672-0|17?-Hydroxy-yohimban-16?-carboxylic Acid Methyl Ester|BRN 0097276|trans-Quinolizidine yohimbine|UNII-2Y49VWD90Q|CCRIS 9415|SR-01000075297|Benz[g]indolo[2,3-a]quinolizine, yohimban-16-carboxylic acid deriv.|NSC19509|YOHIMBINE [MI]|Prestwick0_000584|Prestwick1_000584|Prestwick2_000584|Prestwick3_000584|Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester|YOHIMBINE [VANDF]|YOHIMBINUM [HPUS]|cid_6169|cid_8969|YOHIMBE HYDROCHLORIDE|YOHIMBINE [WHO-DD]|Lopac0_001210|SCHEMBL33954|BSPBio_000428|BSPBio_001236|GTPL102|KBioGR_000576|KBioSS_000576|17alpha-hydroxy-yohimban-16alpha-carboxylic acid methyl ester|4-25-00-01237 (Beilstein Handbook Reference)|MLS000728591|SPBio_002647|BPBio1_000472|orb1685173|Yohimbol-16alpha-carboxylic acid, methyl ester (6CI)|SCHEMBL29385789|BCBcMAP01_000032|KBio2_000576|KBio2_003144|KBio2_005712|KBio3_001031|KBio3_001032|Bio1_000455|Bio1_000944|Bio1_001433|Bio2_000458|Bio2_000938|HMS1362N17|HMS1792N17|HMS1990N17|HMS2089G19|HMS2234C18|Tox21_110019|BDBM50013515|BDBM50203564|AKOS015902024|Tox21_110019_1|Yohimban-16-.alpha.-carboxylic acid, 17-.alpha.-hydroxy-, methyl ester|Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester (8CI)|CCG-205284|CS-5173|DB01392|FY01219|GS-5751|SDCCGSBI-0051177.P002|IDI1_002213|MRF-0000020|SMP1_000320|NCGC00013260-01|NCGC00025018-05|NCGC00025018-06|NCGC00025018-07|NCGC00025018-10|NCGC00025018-11|NCGC00025018-16|NCGC00025018-17|NCGC00025018-24|NCGC00025018-29|HY-12715|SMR000470778|17a-hydroxy-16a-methoxycarbonyl-yohimbane|NS00003970|65Y190|C09256|D08685|H10057|EN300-19731915|Q412226|SR-01000075297-5|BRD-K35586044-001-02-6|BRD-K35586044-003-03-0|BRD-K35586044-003-11-3|BRD-K35586044-003-14-7|BRD-K35586044-003-15-4|Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16|A,17|A)-|17.ALPHA.-HYDROXY-20-.ALPHA.-YOHIMBAN-16-.BETA.-CARBOXYLIC ACID, METHYL ESTER|Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, (16alpha,17alpha)- (9CI)|(1R,2S,4aR,13bS,14aS)-2-hydroxy-1,2,3,4,4a,5,7,8,13,13b,14,14a-dodecahydro-indolo[2'',3'':3,4]pyrido[1,2-b]isoquinoline-1-carboxylic acid methyl ester hydrochloride|103834-06-6|methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4(9),5,7-tetraene-19-carboxylate"
DOXAZOSIN,3157,,"InChI=1S/C23H25N5O5/c1-30-18-11-14-15(12-19(18)31-2)25-23(26-21(14)24)28-9-7-27(8-10-28)22(29)20-13-32-16-5-3-4-6-17(16)33-20/h3-6,11-12,20H,7-10,13H2,1-2H3,(H2,24,25,26)",RUZYUOTYCVRMRZ-UHFFFAOYSA-N,C23H25N5O5,451.5,"[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone","doxazosin|74191-85-8|Doxazosine|Doxazosina|Doxazosinum|UK-33274|UK 33274|1-(4-Amino-6,7-Dimethoxy-2-quinazolinyl)-4-(1,4-benzodioxan-2-ylcarbonyl)piperazin|CHEBI:4708|1-(4-Amino-6,7-dimethoxy-2-chinazolinyl)-4-(2,3-dihydro-1,4-benzodioxixin-2-ylcarbonyl)piperazin|C02CA04|NW1291F1W8|DTXSID7022964|Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)-|2-{4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine|(4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-1-PIPERAZINYL)(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)METHANONE|(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydro-1,4-benzodioxin-2-yl)methanone|ratio Doxazosin|ratio-Doxazosin|DoxaUro|Doxazosin Wolff|Novo Doxazosin|Apo Doxazosin|Gen Doxazosin|Doxa Puren|MTW Doxazosin|Neo, Carduran|2-(4-((2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl)piperazin-1-yl)-6,7-dimethoxyquinazolin-4-amine|2-(4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazin-1-yl)-6,7-dimethoxy-3,4-dihydroquinazolin-4-imine|2-[4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazin-1-yl]-6,7-dimethoxy-3,4-dihydroquinazolin-4-imine|Doxazosin ratiopharm|Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]-|Ct, Doxazosin Von|Von Ct, Doxazosin|Doxazosina Ratiopharm|Ratiopharm, Doxazosina|RefChem:5778|GlyTouCan:G08967HX|Monohydrochloride, Doxazosin|DTXCID402964|G08967HX|UK33274|616-059-6|(RS)-2-{4-[(2,3-Dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine|Doxazosin (INN)|C23H25N5O5|[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone|Diblocin|Doxazosine [French]|Doxazosinum [Latin]|DOXAZOSIN [INN]|Doxazosina [Spanish]|Doxazosin [INN:BAN]|(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)(2,3-dihydrobenzo[b][1,4]dioxin-2-yl)methanone|2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-bis(methyloxy)quinazolin-4-amine|Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl](2,3-dihydro-1,4-benzodioxin-2-yl)-|Cardura XL (TN)|supress|UNII-NW1291F1W8|METHANONE, (4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-1-PIPERAZINYL)(2,3-DIHYDRO-1,4-BENZODIOXIN-2-YL)-|2-[4-(2,3-dihydro-1,4-benzodioxin-2-ylcarbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine|CPD000097306|DOXAZOSIN [MI]|Prestwick0_000858|Prestwick1_000858|Prestwick2_000858|Prestwick3_000858|DOXAZOSIN [VANDF]|ChemDiv2_005017|CHEMBL707|EC 616-059-6|DOXAZOSIN [WHO-DD]|(+/-)-DOXAZOSIN|Lopac0_000474|Oprea1_259518|SCHEMBL34111|BSPBio_000875|SPBio_002796|BPBio1_000963|GTPL7170|orb1306007|SCHEMBL29641831|SCHEMBL29688095|BDBM86731|HMS1383E01|HMS2090C20|HMS3259N21|HMS3372L09|HMS3886J03|HMS5085L07|BCP12228|HY-B0098|ZCA19185|MFCD00800482|NSC768144|NSC768145|s5782|AKOS001681453|AKOS017343634|CCG-118218|CS-1831|DB00590|NC00685|NSC-768144|NSC-768145|SDCCGSBI-0050459.P003|IDI1_003732|NCGC00018158-02|NCGC00018158-03|NCGC00018158-05|NCGC00018158-06|NCGC00018158-08|NCGC00018158-11|NCGC00018158-20|NCGC00089775-02|[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2,3-dihydro-1,4-benzodioxin-3-yl)methanone|2-[4-(2,3-dihydro-1,4-benzodioxine-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine|AC-11062|AC-37660|AS-77104|SBI-0050459.P002|CAS_74191-85-8|DB-055848|UK 33,274|NS00000605|UK-3327427|EN300-53055|C06970|D07874|191D858|L000738|Q419939|BRD-A13188892-066-03-3|BRD-A13188892-066-13-2|BRD-A13188892-066-21-5|BRD-A13188892-066-22-3|1-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)-4-(1,4-BENZODIOXAN-2-YLCARBONYL)PIPERAZINE|1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-[(2,3-dihydro-1,4-benzodioxin-2-yl)carbonyl]piperazine|137888-77-8"
RILMENIDINE,68712,,"InChI=1S/C10H16N2O/c1-2-7(1)9(8-3-4-8)12-10-11-5-6-13-10/h7-9H,1-6H2,(H,11,12)",CQXADFVORZEARL-UHFFFAOYSA-N,C10H16N2O,180.25,"N-(dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine","Rilmenidine|54187-04-1|Oxaminozoline|Hyperium|Rilmenidinum|2-Oxazolamine, N-(dicyclopropylmethyl)-4,5-dihydro-|rilmenidina|S 3341|P67IM25ID8|DTXSID3045194|DTXCID1025194|S-3341|RefChem:179457|C02AC06|s33413|S 3341 3|259-021-0|2-(N-(Dicyclopropylmethyl)amino)oxazoline|N-(Dicyclopropylmethyl)-4,5-dihydrooxazol-2-amine|Rilmenidine [INN]|N-(Dicyclopropylmethyl)-4,5-dihydro-1,3-oxazol-2-amine|Rilmenidia [Spanish]|Rilmenidinum [Latin]|CHEBI:8862|Oxazolidine, 2-((dicyclopropylmethyl)imino)-|MFCD00865924|Rilmenidine (INN)|NSC664312|NCGC00015884-09|CAS-54187-04-1|S-3341-3|NSC 664312; Oxaminozoline; Rilmenidene;S 3341|SR-01000002992|EINECS 259-021-0|BRN 1211287|UNII-P67IM25ID8|Albarel|Hyperium (TN)|Methylamine, 1,1-dicyclopropyl-N-(2-oxazolinyl)-|2-Oxazolamine, 4,5-dihydro-N-(dicyclopropylmethyl)-|Tocris-0790|Lopac-R-134|RILMENIDINE [MI]|Prestwick0_000982|Prestwick1_000982|Prestwick2_000982|Prestwick3_000982|Lopac0_001104|BSPBio_001043|RILMENIDINE [WHO-DD]|SCHEMBL114420|SPBio_002944|BPBio1_001149|CHEMBL289480|GTPL13356|HMS2089G15|HMS3263M10|Tox21_110254|Tox21_501104|BDBM50070328|2-(dicyclopropylmethylamino) oxazoline|AKOS006273431|Tox21_110254_1|AB07513|CCG-205180|DB11738|FR59491|LP01104|NSC-664312|SDCCGSBI-0051073.P002|NCGC00015884-01|NCGC00015884-02|NCGC00015884-03|NCGC00015884-04|NCGC00015884-05|NCGC00015884-06|NCGC00015884-07|NCGC00015884-08|NCGC00015884-10|NCGC00015884-11|NCGC00015884-13|NCGC00015884-19|NCGC00021689-02|NCGC00021689-04|NCGC00021689-05|NCGC00021689-06|NCGC00261789-01|(N-dicyclopropylmethyl)-amino-2-oxazoline|NCI60_022181|SY267932|DB-052512|HY-100490|AB00514648|CS-0019423|EU-0101104|NS00017270|R-134|D08482|G78307|AB00513728-09|EN300-8092697|187R041|A830020|L001230|Q967973|N-(Dicyclopropylmethyl)-4,5-dihydro-2-oxazolamine;|SR-01000002992-3|SR-01000002992-4|BRD-K01638814-011-01-4|BRD-K01638814-051-16-8|N-(dicyclopropylmethyl)-4,5-dihydrooxazol-3-ium-2-amine|N-(Dicyclopropylmethyl)-N-(4,5-dihydro-1,3-oxazol-2-yl)amine"
PRAZOSIN,4893,,"InChI=1S/C19H21N5O4/c1-26-15-10-12-13(11-16(15)27-2)21-19(22-17(12)20)24-7-5-23(6-8-24)18(25)14-4-3-9-28-14/h3-4,9-11H,5-8H2,1-2H3,(H2,20,21,22)",IENZQIKPVFGBNW-UHFFFAOYSA-N,C19H21N5O4,383.4,"[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone","prazosin|19216-56-9|Furazosin|Prazosine|Prazosina|Prazosinum|2-(4-(2-Furoyl)piperazin-1-yl)-4-amino-6,7-dimethoxyquinazoline|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)piperazine|Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)-|CHEBI:8364|XM03YJ541D|DTXSID4049082|CP-122991|DTXCID0029008|Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)-|2-{4-[(furan-2-yl)carbonyl]piperazin-1-yl}-6,7-dimethoxyquinazolin-4-amine|2-[4-(2-Furoyl)piperazin-1-yl]-4-amino-6,7-dimethoxyquinazoline|(4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl)-furan-2-ylmethanone|[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-furan-2-ylmethanone|2-(4-((furan-2-yl)carbonyl)piperazin-1-yl)-6,7-dimethoxyquinazolin-4-amine|RefChem:55909|C02CA01|242-885-8|Prazocin|Prazosine [INN-French]|Prazosinum [INN-Latin]|Prazosina [INN-Spanish]|Methanone, [4-(4-amino-6,7-dimethoxy-2-quinazolinyl)-1-piperazinyl]-2-furanyl-|[3H]-Prazosin|Prazosin (INN)|[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl]-(furan-2-yl)methanone|CHEMBL2|Minipress (TN)|4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)piperazinyl 2-furyl ketone|Quinazoline, 4-amino-6,7-dimethoxy-2-(4-(2-furoyl)piperazin-1-yl)-|HSDB 3298|[4-(4-amino-6,7-dimethoxy-quinazolin-2-yl)piperazin-1-yl]-(2-furyl)methanone|2-[4-(2-furoyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine|[3H]prazosin|NCGC00016740-13|Lentopres|PRAZOSIN [INN]|Prazosin [INN:BAN]|[4-(4-amino-6,7-dimethoxyquinazolin-2-yl)piperazin-1-yl](furan-2-yl)methanone|2-[4-(Furan-2-Ylcarbonyl)piperazin-1-Yl]-6,7-Dimethoxyquinazolin-4-Amine|CAS-19216-56-9|EINECS 242-885-8|BRN 0768345|UNII-XM03YJ541D|TNP00312|[3H]-Furazosin|[3H]-Minipress|[3H]-Pratsiol|Prazosin (Standard)|Spectrum_000822|Tocris-0623|CP-12299|PRAZOSIN [MI]|Terazosin EP Impurity K|PRAZOSIN [VANDF]|Prestwick0_000947|Prestwick1_000947|Prestwick2_000947|Prestwick3_000947|Spectrum2_001289|Spectrum3_000551|Spectrum4_000483|Spectrum5_001365|PRAZOSIN [WHO-DD]|Oprea1_314778|SCHEMBL26524|BSPBio_000914|BSPBio_001036|BSPBio_002221|GTPL503|KBioGR_000376|KBioGR_000965|KBioSS_000376|KBioSS_001302|5-25-13-00365 (Beilstein Handbook Reference)|MLS006011888|DivK1c_000375|SPBio_001297|SPBio_003073|BPBio1_001006|GTPL5385|orb1305946|TERAZOSIN HCL IMPURITY K|SCHEMBL29376126|BCBcMAP01_000227|BDBM29568|HY-B0193R|KBio1_000375|KBio2_000376|KBio2_001302|KBio2_002944|KBio2_003870|KBio2_005512|KBio2_006438|KBio3_000731|KBio3_000732|KBio3_001721|NINDS_000375|PRAZOSIN, Prazosin Hydrochloride|Bio1_000365|Bio1_000854|Bio1_001343|Bio2_000358|Bio2_000838|HMS1362D17|HMS1792D17|HMS1990D17|HMS2089G09|HMS3403D17|HMS3886H03|HMS5085H07|BCP14556|HY-B0193|Tox21_113646|ARD160270|BBL028799|s5780|SBB032268|STK301545|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl) piperazine|2-[4-(furan-2-carbonyl)piperazin-1-yl]-6,7-dimethoxyquinazolin-4-amine|AKOS000310009|Tox21_113646_1|AF-0052|DB00457|SB17351|SDCCGSBI-0051487.P004|(4-(4-Amino-6,7-dimethoxyquinazolin-2-yl)-piperazin-1-yl)(furan-2-yl)methanone|IDI1_000375|IDI1_002113|SMP1_000063|NCGC00016740-01|NCGC00016740-02|NCGC00016740-03|NCGC00016740-04|NCGC00016740-05|NCGC00016740-06|NCGC00016740-07|NCGC00016740-08|NCGC00016740-09|NCGC00016740-10|NCGC00016740-11|NCGC00016740-12|NCGC00016740-14|NCGC00016740-15|NCGC00016740-18|NCGC00016740-19|NCGC00016740-33|NCGC00024324-02|NCGC00024324-04|NCGC00024324-05|NCGC00024324-06|NCGC00024324-07|NCGC00024324-08|NCGC00024324-09|NCGC00024324-10|AC-37644|NCI60_002417|SMR001550197|ST075549|SBI-0051487.P003|CAS-19237-84-4|DB-044783|AB00053528|NS00006462|C07368|D08411|EN300-229477|AB00053528-19|AB00053528_20|AB00053528_21|237P844|F787576|L000666|Q425296|BRD-K49111258-001-02-8|BRD-K49111258-003-05-7|BRD-K49111258-003-16-4|BRD-K49111258-003-27-1|BRD-K49111258-003-28-9|BRD-K49111258-003-29-7|Z275127478|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)piperazine|1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)4-(2-furoyl)piperazine|2-[4-(2-Furoyl)-1-piperazinyl]-6,7-dimethoxy-4-quinazolinamine #|6,7-dimethoxy-4-amino-2-[4-(2-furoyl)piperazin-1-yl]quinazoline|TERAZOSIN HYDROCHLORIDE DIHYDRATE IMPURITY K [EP IMPURITY]|2-(4-(2-FUROYL)-1-PIPERAZINYL)-6,7-DIMETHOXY-4-QUINAZOLINAMINE|[4-(4-AMINO-6,7-DIMETHOXY-2-QUINAZOLINYL)PIPERAZINO](2-FURYL)METHANONE|1-(4-AMINO-6,7-DIMETHOXYQUINAZOLIN-2-YL)-4-(FURAN-2-YLCARBONYL)PIPERAZINE|Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furanylcarbonyl)- (9CI)|Piperazine, 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-furoyl)- (8CI)|XRA"
ETOMIDATE,667484,,"InChI=1S/C14H16N2O2/c1-3-18-14(17)13-9-15-10-16(13)11(2)12-7-5-4-6-8-12/h4-11H,3H2,1-2H3/t11-/m1/s1",NPUKDXXFDDZOKR-LLVKDONJSA-N,C14H16N2O2,244.29,ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate,"Etomidate|33125-97-2|Hypnomidate|(+)-Etomidate|Amidate|D-Etomidate|Etomidato|Etomidatum|ethyl 1-[(1R)-1-phenylethyl]-1H-imidazole-5-carboxylate|(+)-Ethyl 1-(alpha-methylbenzyl)imidazole-5-carboxylate|R-(+)-Ethyl 1-(1-phenylethyl)-1H-imidazole-5-carboxylate|CHEBI:4910|R 16659|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|(R)-(+)-1-(alpha-Methylbenzyl)imidazole-5-carboxylic acid ethyl ester|NSC-759160|ethyl 3-[(1R)-1-phenylethyl]imidazole-4-carboxylate|1H-Imidazole-5-carboxylic acid, 1-[(1R)-1-phenylethyl]-, ethyl ester|DTXSID5023033|Z22628B598|3-((R)-1-Phenyl-ethyl)-3H-imidazole-4-carboxylic acid ethyl ester|1H-Imidazole-5-carboxylic acid, 1-((1R)-1-phenylethyl)-, ethyl ester|Ethomidate|Imidazole-5-carboxylic acid, 1-(alpha-methylbenzyl)-, ethyl ester, (R)-(+)-|ethyl 3-((1R)-1-phenylethyl)imidazole-4-carboxylate|ethyl 1-((1R)-1-phenylethyl)-1H-imidazole-5-carboxylate|Etomidate Injection|RefChem:56431|R26490|AMIDATE(TM) ETOMIDATE|ETOMIDATE injection, solution|N01AX07|DTXCID401765734|251-385-9|(R)-ETHYL 1-(1-PHENYLETHYL)-1H-IMIDAZOLE-5-CARBOXYLATE|Radenarcon|CHEMBL681|Amidate (pharmaceutical)|1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (R)- [CAS]|(d)-Etomidate|Etomidic acid|Etomidatum [INN-Latin]|Etomidato [INN-Spanish]|MFCD00869295|(R)-(+)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylic Acid Ethyl Ester|1H-Imidazole-5-carboxylic acid, 1-(1-phenylethyl)-, ethyl ester, (+)-|ethyl (R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylate|SMR000466277|Amidate (TN)|1-(1-Phenylethyl)-1H-imidazole-5-carboxylic acid ethyl ester|Etomidate [USAN:USP:INN:BAN]|UNII-Z22628B598|R(+)-etomidate|V8D|EINECS 251-385-9|R-ETOMIDATE|BRN 0665833|Etomidate (USP/INN)|ETOMIDATE [INN]|ETOMIDATE [MI]|ETOMIDATE [USAN]|1-(alpha-Methylbenzyl)-1H-imidazole-5-carboxylic acid ethyl ester|ETOMIDATE [VANDF]|ETOMIDATE [MART.]|ETOMIDATE [USP-RS]|ETOMIDATE [WHO-DD]|(+)-Ethyl 1-(.alpha.-methylbenzyl)imidazole-5-carboxylate|SCHEMBL39487|MLS000758268|MLS001424163|GTPL5463|ETOMIDATE [ORANGE BOOK]|ETOMIDATE [EP MONOGRAPH]|ETOMIDATE [USP MONOGRAPH]|Etomidate 0.1 mg/ml in Methanol|Etomidate 1.0 mg/ml in Methanol|Imidazole-5-carboxylic acid, 1-(.alpha.-methylbenzyl)-, ethyl ester, (R)-(+)-|1-(1-Phenylethyl)-imidazole-5-carboxylic acid, ethyl ester|HMS2051P18|HMS2232A08|HMS3267N06|HMS3412D11|HMS3676D11|HY-B0100|Etomidate, >98% (HPLC), powder|BDBM50125935|MSK163688|AKOS015920052|CCG-101054|CS-1833|DB00292|FE23198|GS-3208|NC00304|NSC 759160|NCGC00025176-01|E0897|C07522|D00548|AB00639951_06|EN300-1074318|125E972|F079091|Q418445|R-16659|SR-01000597569|SR-01000597569-1|BRD-K55055802-001-08-6|BRD-K55055802-001-09-4|BRD-K55055802-001-10-2|Z1741976844|Etomidate, European Pharmacopoeia (EP) Reference Standard|r-(+)-ethyl-1-(1-phenylethyl)-1h-imidazole-5-carboxylate|Ethyl (R)-(+)-1-(1-Phenylethyl)-1H-imidazole-5-carboxylate|Etomidate, United States Pharmacopeia (USP) Reference Standard|(R)-1-(1-phenylethyl)-1H-imidazole-5-carboxylicacid ethyl ester|Amidate;Hypnomidate;1-(1-Phenylethyl)imidazole-5-carboxylic acid ethyl ester"
METYRAPONE,4174,,"InChI=1S/C14H14N2O/c1-14(2,12-6-4-8-16-10-12)13(17)11-5-3-7-15-9-11/h3-10H,1-2H3",FJLBFSROUSIWMA-UHFFFAOYSA-N,C14H14N2O,226.27,"2-methyl-1,2-dipyridin-3-ylpropan-1-one","metyrapone|54-36-4|Metopirone|Methopyrapone|Metopiron|Methapyrapone|Methopirapone|Methopyrinine|Methopyrone|Metopyrone|Metyrapon|Methbipyranone|Mepyrapone|Metirapona|Metyraponum|1-Propanone, 2-methyl-1,2-di-3-pyridinyl-|2-methyl-1,2-di(pyridin-3-yl)propan-1-one|2-Methyl-1,2-di-3-pyridinyl-1-propanone|2-Methyl-1,2-bis(3-pyridyl)-1-propanone|DTXSID1023314|1-Propanone, 2-methyl-1,2-di-3-pyridyl-|ZS9KD92H6V|NSC-25265|2-methyl-1,2-bis(pyridin-3-yl)propan-1-one|CHEBI:44241|1-Propanone, 1,2-di-3-pyridyl-2-methyl-|DTXCID803314|NSC25265|RefChem:57627|V04CD01|200-206-2|2-Methyl-1,2-di-3-pyridyl-1-propanone|Metroprione|2-methyl-1,2-dipyridin-3-ylpropan-1-one|Metapirone|Metapyron|Su 4885|MFCD00006397|NSC 25265|CHEMBL934|CAS-54-36-4|NCGC00016242-01|Metyraponum [INN-Latin]|Metirapona [INN-Spanish]|MYT|SMR000059134|1,2-Di-3-pyridyl-2-methyl-1-propanone|HSDB 2500|METOPIRONE (TN)|EINECS 200-206-2|UNII-ZS9KD92H6V|Metyrapone [USAN:USP:INN:BAN:JAN]|Metyrapone (Standard)|METYRAPONE [MI]|METYRAPONE [INN]|METYRAPONE [JAN]|2-methyl-1,2-bis(3-pyridyl)propan-1-one|Prestwick0_000904|Prestwick1_000904|Prestwick2_000904|Prestwick3_000904|METYRAPONE [HSDB]|METYRAPONE [USAN]|2-methyl-1,2-dipyridin-3-yl-propan-1-one|METYRAPONE [VANDF]|METYRAPONE [MART.]|METYRAPONE [USP-RS]|METYRAPONE [WHO-DD]|BIDD:PXR0082|BSPBio_000748|MLS001066377|MLS001335881|MLS001335882|SCHEMBL637432|SPBio_002947|1-Propanone,2-di-3-pyridyl-|BPBio1_000824|GTPL5224|Metyrapone (JP18/USP/INN)|orb1310750|METYRAPONE [ORANGE BOOK]|SCHEMBL29462551|SCHEMBL29917903|1-Propanone,2-di-3-pyridinyl-|HY-B1232R|HMS1570F10|HMS2094I07|HMS2097F10|HMS2235E16|HMS3259O05|HMS3371B16|HMS3714F10|HMS3742E21|HMS3869K13|HMS5084O20|METYRAPONE [USP MONOGRAPH]|Pharmakon1600-01506014|BCP19099|EX-A1403|HY-B1232|Tox21_110323|BDBM50028166|NSC760076|s5416|AKOS015919707|Metyrapone, >=98% (HPLC), solid|Tox21_110323_1|CCG-213598|CS-4879|DB01011|NC00462|NSC-760076|NCGC00016242-02|NCGC00016242-03|NCGC00016242-05|NCGC00161837-01|AS-56195|2-methyl-1,2-di(3-pyridyl)propan-1-one|DB-052546|AB00513955|EU-0009322|NS00010555|ST51006925|Su-4885; Su 4885; Su4885|2-Methyl-1,2-di(3-pyridinyl)-1-propanone #|C07205|D00410|D70339|2-Methyl-1,2-di-3-pyridyl-1-propanone, 96%|AB00513955_07|054M364|EN300-18532278|Q821641|SR-01000765398|SR-01000765398-2|BRD-K46862739-001-03-6|BRD-K46862739-001-13-5|BRD-K46862739-001-14-3|Z2289798161|Metyrapone, United States Pharmacopeia (USP) Reference Standard"
OSILODROSTAT,44139752,,"InChI=1S/C13H10FN3/c14-12-5-9(6-15)1-3-11(12)13-4-2-10-7-16-8-17(10)13/h1,3,5,7-8,13H,2,4H2/t13-/m1/s1",USUZGMWDZDXMDG-CYBMUJFWSA-N,C13H10FN3,227.24,"4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile","osilodrostat|LCI699|928134-65-0|LCI-699|(+)-Osilodrostat|LCI699-NX|LCI 699|4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile|LCI-699-NX|5YL4IQ1078|(R)-4-(6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluorobenzonitrile|DTXSID40156570|4-((5R)-6,7-Dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluoro-benzonitrile|Benzonitrile, 4-((5R)-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluoro-|3-FLUORO-4-[(5R)-5H,6H,7H-PYRROLO[1,2-C]IMIDAZOL-5-YL]BENZONITRILE|osilodrostatum|(R)-4-(6,7-Dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluorobenzonitrile|3-fluoro-4-((5R)-5H,6H,7H-pyrrolo(1,2-c)imidazol-5-yl)benzonitrile|4-((5R)-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluorobenzonitrile|4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluoro-benzonitrile|RefChem:56448|DTXCID4079061|H02CA02|4-(R)-(6,7-Dihydro-5H-pyrrolo(1,2-c)imidazol-5-yl)-3-fluorobenzonitrile|Osilodrostat free base|Osilodrostat (LCI699)|CHEMBL3099695|4-[(4R,5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile|Osilodrostat [USAN:INN]|4-[(5R)-6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile;4-(R)-(6,7-Dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl)-3-fluorobenzonitrile;Isturisa; LCI 699; LCI 699NX|MFCD25976825|Isturisa (Osilodrostat)|OSILODROSTAT [MI]|Osilodrostat (USAN/INN)|OSILODROSTAT [INN]|OSILODROSTAT [USAN]|NVP-LCI699|OSILODROSTAT [WHO-DD]|UNII-5YL4IQ1078|GTPL8310|orb1302995|SCHEMBL12460772|SCHEMBL30395982|Osilodrostat;4-[(5R)-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-5-yl]-3-fluorobenzonitrile|GLXC-10225|EX-A1397|BDBM50444549|MSK165203|s7456|AKOS027323750|CCG-266774|CS-6896|DB11837|AC-32907|BS-17881|DA-56496|HY-16276|SY338302|NS00072969|D11061|EN300-14284797|Q27088216|1304733-26-3"
TADALAFIL,110635,,"InChI=1S/C22H19N3O4/c1-24-10-19(26)25-16(22(24)27)9-14-13-4-2-3-5-15(13)23-20(14)21(25)12-6-7-17-18(8-12)29-11-28-17/h2-8,16,21,23H,9-11H2,1H3/t16-,21-/m1/s1",WOXKDUGGOYFFRN-IIBYNOLFSA-N,C22H19N3O4,389.4,"(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione","Tadalafil|Cialis|171596-29-5|Ic351|ADCIRCA|IC 351|IC-351|Tadalafilo|Tadalafil mylan|Trans-tadalafil|742SXX0ICT|NSC-750236|NSC-759172|CHEWTADZY|DTXSID9046786|CHEBI:71940|LY-450190|(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-(methylenedioxy)phenyl) pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|(6R-trans)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|LY450190|(6R,12aR)-2,3,6,7,12,12a-Hexahydro-2-methyl-6-(3,4-methylenedioxyphenyl)pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione|DTXCID7026786|ENTADFI COMPONENT TADALAFIL|OPSYNVI COMPONENT TADALAFIL|Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-|Pyrazino(1',2':1,6)pyrido(3,4-b)indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R-trans)-|Pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R,12aR)-|tadalafilum|(2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo(8.7.0.0^(3,8).0^(11,16))heptadeca-1(10),11,13,15-tetraene-4,7-dione|(2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11,13,15-tetraene-4,7-dione|Pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-, (6R-trans)-|ALYQ|TADLIQ|RefChem:6280|G04BE08|Tadanafil|ICOS 351|(6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione|GF 196960|Tadalafil(Cialis)|MFCD07771966|CHEMBL779|GF-196960|(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|(6R,12aR)-6-(benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|Tadalafil [USAN]|C22H19N3O4|(2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione|6-BENZO[1,3]DIOXOL-5-YL-2-METHYL-2,3,6,7,12,12A-HEXAHYDRO-PYRAZINO[1',2':1,6]PYRIDO[3,4-B]INDOLE-1,4-DIONE|Tadalafil Lilly|(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|CIA|SMR000466321|Cialis (TN)|CAS-171596-29-5|HSDB 7303|UNII-742SXX0ICT|Tadalafila|Tadalafil [USAN:INN:BAN]|Tadalafil?|1xoz|Cialis, Tadalafil|NCGC00168781-01|Adcirca (TN)|Tadalafil (Cialis)|Zalutia (TN)|Tadalafil (Standard)|KS-1117|TADALAFIL [INN]|TADALAFIL [JAN]|TADALAFIL [MI]|TADALAFIL; CIALIS|TADALAFIL [HSDB]|TADALAFIL [VANDF]|(-)-Tadalafil (6R)|TADALAFIL [MART.]|TADALAFIL [USP-RS]|TADALAFIL [WHO-DD]|Tadalafil (JAN/USP/INN)|SCHEMBL33333|TADALAFIL [EMA EPAR]|MLS000759426|MLS001165782|MLS001195644|MLS001424132|MLS006010126|Tadalafil - Bio-X trade mark|GTPL7299|orb1308738|TADALAFIL [ORANGE BOOK]|SCHEMBL29358190|SCHEMBL29427554|TADALAFIL [EP MONOGRAPH]|BDBM14777|TADALAFIL [USP MONOGRAPH]|GLXC-07318|HMS2051N17|HMS2235L21|HMS3884G19|HY-90009AR|Pharmakon1600-01505639|EX-A2644|MSK10246|Tox21_112642|HY-90009A|NSC750236|NSC759172|s1512|Tadalafil 1.0 mg/ml in Acetonitrile|AKOS015892559|Tox21_112642_1|AB42193|CCG-100973|CS-1414|DB00820|FB02802|NC00223|NSC 750236|NSC 759172|1,3-benzodioxol-5-yl(methyl)[?]dione|NCGC00263909-02|Tadalafil 100 microg/mL in Acetonitrile|BT164435|NS00006532|SW197603-2|A23556|D02008|AB00639969-08|AB00639969_09|AB00639969_10|596T295|AR-270/43507798|Q424156|SR-05000001940|SR-05000001940-1|BRD-K93645900-001-04-8|BRD-K93645900-001-11-3|BRD-K93645900-001-12-1|Z1501485354|(2R,8R)-2-(2H-1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.0^{3,8}.0^{11,16}]heptadeca-1(10),11(16),12,14-tetraene-4,7-dione|(6R,12 aR)-6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|(6R,12?R)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12?-tetrahydropyrazino[1',2':1,6]pyrido[3,4-?]indole-1,4(6H,7H)-dione|(6R,12aR) 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino [1',2':1,6] pyrido[3,4-b]indole-1,4-dione|(6R,12aR) 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methyl-pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|(6R,12aR)-6-(1,3-Benzodioxol-5-yl)-2,3,6,7,12,12a-hexahydro-2-methylpyrazino[1,2:1,6]pyrido[3,4-b]indole-1,4-dione|(6R,12aR)-6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[1,2,1,6]pyrido[3,4-b]indole-1,4-dione|(6R,3,6,7,12,12a-Hexahydro-2-methyl-6-[3,4-(methylenedioxy)phenyl]pyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione|1242099-07-5|171488-03-2|6-(1,3-benzodioxol-5-yl)-2-methyl-2,3,6,7,12,12a-hexahydropyrazino[2',1':6,1]pyrido[3,4-b]indole-1,4-dione|Pyrazino[1',6]pyrido[3,4-b]indole-1,4-dione, 6-(1,3-benzodioxol-5-yl)-2,3,6,7,12,12ahexahydro-2-methyl-, (6R,12aR)-|rel-(6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-2,3,12,12a-tetrahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4(6H,7H)-dione"
SILDENAFIL,135398744,,"InChI=1S/C22H30N6O4S/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29)",BNRNXUUZRGQAQC-UHFFFAOYSA-N,C22H30N6O4S,474.6,"5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one","sildenafil|139755-83-2|Aphrodil|Vizarsin|Patrex|Sildenafil teva|Sildenafil actavis|Sildenafil ratiopharm|Sildenafilo|3M7OB98Y7H|CHEBI:9139|1-((3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine|HIP0908|HIP-0908|DTXSID6023579|Piperazine, 1-((3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methyl-|sildenafilum|Nipatra|1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine|5-(2-ethoxy-5-(4-methylpiperazine-1-sulfonyl)phenyl)-1-methyl-3-propyl-1H,4H,7H-pyrazolo(4,3-d)pyrimidin-7-one|5-[2-ethoxy-5-(4-methylpiperazine-1-sulfonyl)phenyl]-1-methyl-3-propyl-1H,4H,7H-pyrazolo[4,3-d]pyrimidin-7-one|RefChem:6218|DTXCID003579|G04BE03|C22H30N6O4S|Sildenafil (INN)|UK-92480|CHEMBL192|UK 92480-10|5-(2-Ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one|7H-Pyrazolo[4,3-d]pyrimidin-7-one, 5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-|5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one|SILDENAFIL [INN]|Sildenafil [INN:BAN]|Aphrodil (TN)|5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one|5-{2-(ethyloxy)-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one|5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,4-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one|5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1H,4H,7H-pyrazolo[4,3-d]pyrimidin-7-one|5-{2-ETHOXY-5-[(4-METHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-1-METHYL-3-PROPYL-1H,6H,7H-PYRAZOLO[4,3-D]PYRIMIDIN-7-ONE|SMR000752512|HSDB 7305|SR-05000001934|NCGC00159496-02|5-[2-ethoxy-5-(4-methyl-1-piperazinylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one|UNII-3M7OB98Y7H|Sildenafil#|1udt|1xos|5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one|5-(2-Ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl)-1-methyl-3-propyl-1h,4h,7h-pyrazolo[4,3-d]pyrimidin-7-one|5-[2-ethoxy-5-(4-methylpiperazinylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo(4,3-d]pyrimidin-7-one|5-[2-ethoxy-5-(4-methylpiperazinylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one|Spectrum_001555|SILDENAFIL [MI]|SpecPlus_000798|Spectrum2_001648|Spectrum3_001892|Spectrum4_000586|Spectrum5_001508|SILDENAFIL [HSDB]|SILDENAFIL; VIAGRA|SILDENAFIL [VANDF]|Cambridge id 7030299|SCHEMBL1895|SILDENAFIL [WHO-DD]|BSPBio_003424|KBioGR_001052|KBioSS_002035|MLS001240224|MLS001304737|MLS006011565|orb401930|BIDD:GT0352|DivK1c_006894|SCHEMBL492566|SILDENAFIL [EMA EPAR]|SPECTRUM1504099|SPBio_001775|GTPL4743|SCHEMBL5795456|SCHEMBL8100377|Sildenafil - Bio-X trade mark|SCHEMBL29361663|BDBM14390|KBio1_001838|KBio2_002035|KBio2_004603|KBio2_007171|KBio3_002927|MSK2278|2h42|HMS1684K08|HMS1922B19|HMS2089M12|HMS2093O17|HMS2233L22|HMS3372N07|HMS3715P17|HMS3740G19|Sildenafil 1.0 mg/ml in Methanol|BCP05337|AC-938|BDBM50238854|CCG-21806|CCG-39076|s4684|STL483201|STL483720|STL565123|AKOS008901403|AKOS025397193|AKOS037623334|CS-1577|DB00203|FD12062|FS27828|SB17345|NCGC00095099-01|NCGC00095099-02|NCGC00095099-03|NCGC00095099-04|NCGC00370976-03|5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one|AS-48884|BS164403|HY-15025|SMR004703325|SBI-0051920.P002|NS00010359|UK-9248010|C07259|D08514|EN300-117245|AB00052444-02|AB00052444-03|AB00052444_04|AB00052444_05|755S832|F979721|Q191521|SR-01000504734|SR-01000504734-1|SR-05000001934-1|SR-05000001934-2|BRD-K50128260-001-01-6|BRD-K79759585-001-02-1|BRD-K79759585-048-01-4|BRD-K79759585-048-03-0|BRD-K79759585-048-04-8|Z1522567175|1-((3-(6,7-DIHYDRO-1-METHYL-7-OXO-3-PROPYL-1H-PYRAZOLO(4,3-D)PYRIMIDIN-5-YL)-4-ETHOXYPHENYL)SULFONYL)-4-METHYLPIPERAZINE|1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine;5-[2-Ethoxy  -5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one|5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one|5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propylpyrazolo[4,3-d]pyrimidin-7-ol|5-[2-Ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one|5-[2-Ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl]-1-methyl-3-n-propyl-1.6-dihydro-7H-pyrazolo[4,3-d]Pyrimidin-7-one|5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7-ol|5-{2-ethoxy-5-[(4-methylpiperazine-1-)sulfonyl]phenyl}-1-methyl-3-propyl-1H,6H,7H-pyrazolo[4,3-d]pyrimidin-7-one|PIPERAZINE, 1-((3-(6,7-DIHYDRO-1-METHYL-7-OXO-3-PROPYL-1H-PYRAZOLO(4,3-D)PYRIMIDIN-5-YL)-4-ETHOXYPHENYL)SULFONYL)-4-METHYL-"
VARDENAFIL,135400189,,"InChI=1S/C23H32N6O4S/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30)",SECKRCOLJRRGGV-UHFFFAOYSA-N,C23H32N6O4S,488.6,"2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one","Vardenafil|224785-90-4|Vivanza|BAY38-9456|UCE6F4125H|CHEBI:46295|BAY-389456|DTXSID3048318|Piperazine, 1-((3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo(5,1-f)(1,2,4)triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethyl-|Vardenafilum|2-(2-ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propyl-1H,4H-imidazo(4,3-f)(1,2,4)triazin-4-one|2-(2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl)phenyl)-5-methyl-7-propyl-1H,4H-imidazo(4,3-f)(1,2,4)triazin-4-one|2-[2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl)phenyl]-5-methyl-7-propyl-1H,4H-imidazo[4,3-f][1,2,4]triazin-4-one|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propyl-1H,4H-imidazo[4,3-f][1,2,4]triazin-4-one|RefChem:57722|DTXCID5028293|G04BE09|1-(((3-(3,4-dihydro-5-methyl)-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine|Levitra|Levitra (TN)|CHEMBL1520|2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(3H)-one|2-{2-ETHOXY-5-[(4-ETHYLPIPERAZIN-1-YL)SULFONYL]PHENYL}-5-METHYL-7-PROPYLIMIDAZO[5,1-F][1,2,4]TRIAZIN-4(1H)-ONE|VDN|1-((3-(3,4-Dihydro-5-methyl-4-oxo-7-propylimidazo(5,1-f)-as-triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethylpiperazine|2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one|Vardenafil ODT|2-(2-ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one|2-{2-ethoxy-5-[(4-ethylpiperazin-1-yl)sulfonyl]phenyl}-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4-ol|HSDB 7304|SR-05000001442|NCGC00167533-01|UNII-UCE6F4125H|Vardenafil [USAN:INN:BAN]|2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4-ol|Vardenafil (Vivanza)|2-(2-Ethoxy-5-(4-ethylpiperazin-1-yl-1-sulfonyl)phenyl)-5-methyl-7-propyl-3H-imidazo(5,1-f)(1,2,4)triazin-4-one|Vardenafil (Standard)|VARDENAFIL [MI]|VARDENAFIL [INN]|Vardenafil (USAN/INN)|VARDENAFIL [HSDB]|VARDENAFIL [USAN]|VARDENAFIL [VANDF]|EC 607-088-5|SCHEMBL5772|VARDENAFIL [MART.]|VARDENAFIL [WHO-DD]|SCHEMBL35902|BSPBio_002392|VARDENAFIL [EMA EPAR]|GTPL7320|orb1710756|SCHEMBL29390262|SCHEMBL29491016|BDBM14776|HY-B0442R|MSK8580|GLXC-07317|HMS2089K04|HMS3715F19|BCP02961|EX-A2806|HY-B0442|STK642629|AKOS005574038|AKOS015994765|AKOS022186043|CCG-221149|DB00862|GS-6519|KS-5073|SB17349|NCGC00167533-03|2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one|BCP0726000254|SBI-0206836.P001|NS00004123|85V904|D08668|H50902|AB00698215-08|AB01274740-01|AB01274740_02|AB01274740_03|AB01275440-01|Q424161|SR-05000001442-1|SR-05000001442-2|BRD-K13926615-003-01-7|BRD-K13926615-003-02-5|BRD-K13926615-003-03-3|BRD-K13926615-394-02-8|Z2588038957|2-(2-Ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo(5,1-f)triazin-4(3H)-one|2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one|2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazine-4-one|2-[2-ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]phenyl]-5-methyl-7-propyl-imidazo[5,1-f][1,2,4]triazin-4-one|2-{2-ethoxy-5-[(4-ethylpiperazine-1-)sulfonyl]phenyl}-5-methyl-7-propyl-3H,4H-imidazo[1,5-a][1,2,4]triazin-4-one|citric acid;2-[2-ethoxy-5-(4-ethylpiperazino)sulfonyl-phenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one"
VARDENAFIL HYDROCHLORIDE,135438569,,"InChI=1S/C23H32N6O4S.ClH/c1-5-8-20-24-16(4)21-23(30)25-22(26-29(20)21)18-15-17(9-10-19(18)33-7-3)34(31,32)28-13-11-27(6-2)12-14-28;/h9-10,15H,5-8,11-14H2,1-4H3,(H,25,26,30);1H",XCMULUAPJXCOHI-UHFFFAOYSA-N,C23H33ClN6O4S,525.1,"2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one;hydrochloride","Vardenafil hydrochloride|224785-91-5|Vardenafil HCL|VARDENAFIL MONOHYDROCHLORIDE|Nuviva|IF61NL91H3|vardenafil hydrochloride anhydrous|BAY 38-9456|BAY-38-9456|Piperazine, 1-((3-(1,4-dihydro-5-methyl-4-oxo-7-propylimidazo(5,1-f)(1,2,4)triazin-2-yl)-4-ethoxyphenyl)sulfonyl)-4-ethyl-, monohydrochloride|Hydrochloride, Vardenafil|RefChem:933934|Anhydrous, Vardenafil Hydrochloride|Hydrochloride Anhydrous, Vardenafil|Staxyn|Vardenafilhydrochloride|Vardenafil (hydrochloride)|Vardenafil hydrochloride [USAN]|2-(2-ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one hydrochloride|2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one|MFCD07369690|CHEMBL1339|2-(2-Ethoxy-5-(4-ethyl-piperazine-1-sulfonyl)-phenyl)-5-methyl-7-propyl-3H-imidazo(5,1-f)(1,2,4)triazin-4-one, hydrochloride|2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one;hydrochloride|2-[2-ethoxy-5-(4-ethylpiperazine-1-sulfonyl)phenyl]-5-methyl-7-propyl-1H,4H-imidazo[4,3-f][1,2,4]triazin-4-one hydrochloride|C23H33ClN6O4S|UNII-IF61NL91H3|Vardenafil, Hydrochloride Salt|Vardenafil Hydrochloride Salt|MLS006011996|SCHEMBL973820|MSK2277A|orb1685387|Vardenafil hydrochloride (USP)|SCHEMBL29369568|HY-B0442A|DTXSID30945152|XCMULUAPJXCOHI-UHFFFAOYSA-N|HMS5087I09|Pharmakon1600-01505374|BCP21908|Vardenafil HCl - Bio-X trade mark|NSC759103|s5957|224785-90-4 (base)|AKOS025312515|AKOS032400217|224789-15-5 (di-hcl)|CCG-213406|FV15180|FV28670|2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one;hydrochloride|AC-30725|AS-12621|SMR004703549|D09989|F85016|VARDENAFIL HYDROCHLORIDE ANHYDROUS [MI]|785V915|Vardenafil hydrochloride trihydrate, >=98% (HPLC)|Q27280699|Vardenafil for system suitability, European Pharmacopoeia (EP) Reference Standard|Vardenafil hydrochloride trihydrate, European Pharmacopoeia (EP) Reference Standard|Vardenafil hydrochloride, United States Pharmacopeia (USP) Reference Standard|1-[[3-(1,4-Dihydro-5-methyl-4-oxo-7-propylimidazo[5,1-f][1,2,4]triazin-2 -yl)-4-ethoxyphenyl]sulfonyl]-4-ethyl-piperazine;Levitra;Nuviva|2-(2-ethoxy-5-((4-ethylpiperazin-1-yl)sulfonyl)phenyl)-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-onehydrochloride|2-[2-ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3H-imidazo[5,1-f][1,2,4]triazin-4-one hydrochloride|2-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonyl-phenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one;hydrochloride|2-[2-Ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylphenyl]-5-methyl-7-propyl-1H-imidazo[5,1-f][1,2,4]triazin-4-one hydrochloride|2-[2-Ethoxy-5-(4-ethylpiperazine-1-sulfonyl)phenyl]-5-methyl-7-propylimidazo[5,1-f][1,2,4]triazin-4(1H)-one--hydrogen chloride (1/1)|2-[2ethoxy-5-(4-ethyl-piperazine-1-sulphonyl)-phenyl]-5-methyl-7-propyl-3h-imidazo[5,1-f][1,2,4]triazin-4-one hydrochloride|Vardenafil, Hydrochloride Salt is known as a phosphodiesterase type 5 (PDE 5) enzyme inhibitor."
ZAPRINAST,135399235,,"InChI=1S/C13H13N5O2/c1-2-7-20-9-6-4-3-5-8(9)11-14-12-10(13(19)15-11)16-18-17-12/h3-6H,2,7H2,1H3,(H2,14,15,16,17,18,19)",REZGGXNDEMKIQB-UHFFFAOYSA-N,C13H13N5O2,271.27,"5-(2-propoxyphenyl)-2,6-dihydrotriazolo[4,5-d]pyrimidin-7-one","zaprinast|37762-06-4|Zaprinastum|M&B 22948|NSC-757885|DTXSID8045224|GXT25D5DS0|2-o-Propoxyphenyl-8-azapurine-6-one|M&B-22948|DTXCID6025224|2-(2-propoxyphenyl)-8-azapurin-6-one|5-(2-propoxyphenyl)-2,3-dihydrotriazolo(4,5-e)pyrimidin-7-one|5-(2-propoxyphenyl)-2,3-dihydrotriazolo[4,5-e]pyrimidin-7-one|RefChem:904807|253-655-1|M&B 22,948|2-(o-Propoxyphenyl)-8-azapurin-6-one|5-(2-Propoxyphenyl)-1H-[1,2,3]triazolo[4,5-d]pyrimidin-7(4H)-one|Tocris-0947|MFCD00214073|1,4-Dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo(4,5-d)pyrimidin-7-one|NCGC00016105-03|CAS-37762-06-4|3,6-dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one|1110670-37-5|5-(2-propoxyphenyl)-2H-triazolo[4,5-d]pyrimidin-7-ol|5-(2-propoxyphenyl)-2,6-dihydrotriazolo[4,5-d]pyrimidin-7-one|Zaprinastum [INN-Latin]|M and B 22948|8-Aza-2-(2-propoxyphenyl)-6-purinone|Zaprinast [INN:BAN]|SR-01000075536|EINECS 253-655-1|UNII-GXT25D5DS0|Zaprinast?|Zaprinast, solid|1,4-Dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo[4,5-d]pyrimidin-7-one|Prestwick_655|2-o-Propoxyphenyl-8-azapurin-6-on|Spectrum_001265|ZAPRINAST [INN]|Prestwick0_000335|Prestwick1_000335|Prestwick2_000335|Prestwick3_000335|Spectrum2_001447|Spectrum3_000933|Spectrum4_001032|Spectrum5_001023|Lopac-Z-0878|3,6-Dihydro-5-(o-propoxyphenyl)-7H-v-triazolo(4,5-d)pyrimidin-7-one|ZAPRINAST [MART.]|1,4-Dihydro-5-(2-propoxyphenyl)-7H-1,2,3-triazolo[4,5-d]pyrimidine-7-one|3,6-Dihydro-5-(2-propoxyphenyl)-7H-(1,2,3)truaziki(4,5-d)pyrimidin-7-on|A1IL3|Lopac0_001240|SCHEMBL50328|SCHEMBL50329|SCHEMBL50330|BSPBio_000369|BSPBio_001348|KBioGR_001583|KBioSS_001745|MLS000859963|CHEMBL28079|DivK1c_000584|SPECTRUM1501199|SPBio_001313|SPBio_002290|Zaprinast (M B 22948)|BPBio1_000407|GTPL2919|orb1306414|SCHEMBL6374345|SCHEMBL6913739|SCHEMBL30276335|SCHEMBL30713719|BCBcMAP01_000103|BDBM14363|CHEBI:92215|HMS501N06|KBio1_000584|KBio2_001745|KBio2_004313|KBio2_006881|KBio3_001966|NINDS_000584|GLXC-06862|HMS1569C11|HMS1791D10|HMS1921P15|HMS1989D10|HMS2090L04|HMS2096C11|HMS2235N23|HMS3263H22|HMS3267G07|HMS3370J04|HMS3402D10|HMS3411J20|HMS3675J20|HMS3713C11|Pharmakon1600-01501199|5-(2-propoxyphenyl)-2,3-dihydrotriazolo[4,5-d]pyrimidin-7-one|HY-B1816|Tox21_110306|Tox21_501240|6,7-Dihydro-5-(2-propoxyphenyl)-1H-triazolo(4,5-d)pyrimidin-7-on|BDBM50612246|CCG-39177|NSC757885|1,4-Dihydro-5-(2-propoxyphenyl)-1,2,3-triazolo(4,5-d)pyrimidin-7-one|6,7-Dihydro-5-(2-propoxyphenyl)-1H-triazolo(4,5-d)pyrimidin-7-on [IUPAC]|AKOS024458708|AKOS027446368|Tox21_110306_1|2-(2-propoxyphenyl)-8-azahypoxanthine|CCG-205314|CCG-220335|CCG-222544|FZ28754|LP01240|NSC 757885|SDCCGSBI-0051207.P004|7H-1,2,3-Triazolo(4,5-d)pyrimidin-7-one, 1,4-dihydro-5-(2-propoxyphenyl)-|IDI1_000584|SMP1_000321|NCGC00016105-01|NCGC00016105-02|NCGC00016105-04|NCGC00016105-05|NCGC00016105-08|NCGC00024894-01|NCGC00024894-02|NCGC00024894-03|NCGC00024894-04|NCGC00024894-08|NCGC00094481-01|NCGC00094481-02|NCGC00261925-01|DA-79072|MS-23838|SMR000326822|SBI-0051207.P002|CS-0013862|EU-0101240|NS00015865|M02689|Z 0878|AB00052245_02|SR-01000597480|Q6592076|SR-01000075536-1|SR-01000075536-4|SR-01000075536-5|SR-01000597480-1|BRD-K12516989-001-01-9|BRD-K16542329-001-05-1|BRD-K16542329-001-08-5|BRD-K16542329-001-13-5|BRD-K16542329-001-14-3|5-(2-propoxyphenyl)-3,6-dihydrotriazolo[4,5-d]pyrimidin-7-one|5-(2-Propoxy-phenyl)-3,6-dihydro-[1,2,3]triazolo[4,5-d]pyrimidin-7-one|5-(2-propoxyphenyl)-2H,3H,7H-[1,2,3]triazolo[4,5-d]pyrimidin-7-one|3-(2-propoxyphenyl)-2,4,7,8,9-pentazabicyclo[4.3.0]nona-1,3,6-trien-5-one|7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one, 2,3-dihydro-5-(2-propoxyphenyl)-|7H-1,2,3-Triazolo[4,5-d]pyrimidin-7-one,2,3-dihydro-5-(2-propoxyphenyl)-"
LIXIVAPTAN,172997,,"InChI=1S/C27H21ClFN3O2/c1-17-8-9-19(29)13-23(17)26(33)30-20-10-11-22(24(28)14-20)27(34)32-16-21-6-4-12-31(21)15-18-5-2-3-7-25(18)32/h2-14H,15-16H2,1H3,(H,30,33)",PPHTXRNHTVLQED-UHFFFAOYSA-N,C27H21ClFN3O2,473.9,"N-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methylbenzamide","Lixivaptan|168079-32-1|VPA-985|Lixar|WAY-VPA-985|VPA985|CRTX-080|N-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methylbenzamide|CRTX080|WAY VPA-985|8F5X4B082E|CRTX 080|Benzamide, N-[3-chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methyl-|DTXSID00168472|Benzamide, N-(3-chloro-4-(5H-pyrrolo(2,1-c)(1,4)benzodiazepin-10(11H)-ylcarbonyl)phenyl)-5-fluoro-2-methyl-|5-fluoro-2-methyl-N-(4-(5H-pyrrolo(2,1-c)-(1,4)benzodiazepin-10-(11H)-ylcarbonyl)-3-chlorophenyl)benzamide|N-4-(3-chloro-4-(5H-pyrrolo(2,1-C)(1,4)benzodiazepin-10(11H)-ylcarbonyl)phenyl)-5-fluoro-2-methylbenzamide|lixivaptanum|N-(3-chloro-4-(6,11-dihydropyrrolo(2,1-c)(1,4)benzodiazepine-5-carbonyl)phenyl)-5-fluoro-2-methylbenzamide|RefChem:800001|DTXCID5090963|605-500-8|N-(3-chloro-4-(3,9-diazatricyclo(8.4.0.0^(3,7))tetradeca-1(10),4,6,11,13-pentaene-9-carbonyl)phenyl)-5-fluoro-2-methylbenzamide|VPA 985|MFCD00937905|N-(3-Chloro-4-(10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10-carbonyl)phenyl)-5-fluoro-2-methylbenzamide|CHEMBL49429|N-[3-chloro-4-(6,11-dihydropyrrolo[2,1-c][1,4]benzodiazepine-5-carbonyl)phenyl]-5-fluoro-2-methyl-benzamide|Lixivaptan [USAN:INN]|3'-Chloro-5-fluoro-4'-(5H-pyrrolo(2,1-c)(1,4)benzodiazepin-10(11H)-ylcarbonyl)-o-toluanilide|Lixivaptan (USAN/INN)|C27H21ClFN3O2|UNII-8F5X4B082E|N-[3-Chloro-4-[10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepine-10-carbonyl]phenyl]-5-fluoro-2-methylbenzamide|Lixivaptan [USAN]|LIXIVAPTAN [MI]|LIXIVAPTAN [INN]|LIXIVAPTAN [VANDF]|LIXIVAPTAN [MART.]|LIXIVAPTAN [WHO-DD]|GTPL2238|orb1299938|SCHEMBL1649340|SCHEMBL29373157|SCHEMBL29377065|SCHEMBL29387791|PPHTXRNHTVLQED-UHFFFAOYSA-N|GLXC-05111|HMS3747A19|BCP09167|EX-A1129|VPA-985;WAY-VPA 985|BDBM50065115|AKOS022181388|CS-7512|DB06666|FL24915|NCGC00485402-01|AC-26832|BS-15602|HY-14185|SY225929|DB-064673|NS00068352|D04752|L001508|Q6659958|BRD-K59391348-001-01-7|3-chloro-4-(10,11-dihydro-5H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-10-ylcarbonyl)-1-(5-fluoro-2-methylphenylcarboxamido)benzene|Benzamide, N-(3-chloro-4-(5H-pyrrolo(2,1-c)(1,4)benzodiazepin-10(11H)-ylcarbonyl)phenyl)-5-fluoro-2-methyl-;|N-[3-Chloro-4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)phenyl]-5-fluoro-2-methyl-benzamide;VPA 985;WAY-VPA 985|N-[4-(5H,11H-Benzo[e]pyrrolo[1,2-a][1,4]diazepine-10-carbonyl)-3-chloro-phenyl]-5-fluoro-2-methyl-benzamide|N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbony)-3-chlorophenyl]-5-fluoro-2-methylbenzamide|N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methyl-benzamide|N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)-ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide|N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin-10(11H)ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide|N-[4-(5H-pyrrolo[2,1-c][1,4]benzodiazepin10(11H)-ylcarbonyl)-3-chlorophenyl]-5-fluoro-2-methylbenzamide"
FIDEXABAN,4322,,"InChI=1S/C25H24F2N6O5/c1-32-9-8-30-23(32)14-4-3-5-15(10-14)37-24-19(26)21(33(2)12-18(35)36)20(27)25(31-24)38-17-11-13(22(28)29)6-7-16(17)34/h3-7,10-11,34H,8-9,12H2,1-2H3,(H3,28,29)(H,35,36)",NPNSVNGQJGRSNR-UHFFFAOYSA-N,C25H24F2N6O5,526.5,"2-[[2-(5-carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-[3-(1-methyl-4,5-dihydroimidazol-2-yl)phenoxy]pyridin-4-yl]-methylamino]acetic acid","Fidexaban|183305-24-0|CI-1031|ZK-807834|10NHF3008V|ZK807834|N-(2-(5-(amino(imino)methyl)-2-hydroxyphenoxy)-3,5-difluoro-6-(3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy)pyridin-4-yl)-N-methylglycine|n-[2-[5-[amino(imino)methyl]-2-hydroxyphenoxy]-3,5-difluoro-6-[3-(4,5-dihydro-1-methyl-1h-imidazol-2-yl)phenoxy]pyridin-4-yl]-n-methylglycine|fidexabanum|RefChem:921606|XK-807834|N-[2-[5-(aminoiminomethyl)-2-hydroxyphenoxy]-6-[3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy]-3,5-difluoro-4-pyridinyl]-N-methylglycine|ZK 807834|CHEMBL73193|Glycine, N-(2-(5-(aminoiminomethyl)-2-hydroxyphenoxy)-6-(3-(4,5-dihydro-1-methyl-1H-imidazol-2-yl)phenoxy)-3,5-difluoro-4-pyridinyl)-N-methyl-|ZK-807191|2-[[2-(5-carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-[3-(1-methyl-4,5-dihydroimidazol-2-yl)phenoxy]pyridin-4-yl]-methylamino]acetic acid|Fidexaban [USAN]|Fidexaban [USAN:INN]|UNII-10NHF3008V|1fjs|((2-(5-Carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-(3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy)pyridin-4-yl)methylamino)acetic acid|[[2-(5-Carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-[3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridin-4-yl]methylamino]acetic acid|N-(2-(5-Carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-(3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy)pyridin-4-yl)-N-methylglycine|N-{2-(5-carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-[3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridin-4-yl}-N-methylglycine|FIDEXABAN [INN]|Fidexaban (USAN/INN)|orb1700607|SCHEMBL4354301|SCHEMBL29371695|SCHEMBL29381445|BDBM17284|AKOS040748351|HY-10724|TS-08520|BX-807834|PD-200022|D04183|Q27251148|2-{[2-(5-carbamimidoyl-2-hydroxyphenoxy)-3,5-difluoro-6-[3-(1-methyl-4,5-dihydro-1H-imidazol-2-yl)phenoxy]pyridin-4-yl](methyl)amino}acetic acid"
LYSERGIDE,5761,,"InChI=1S/C20H25N3O/c1-4-23(5-2)20(24)14-9-16-15-7-6-8-17-19(15)13(11-21-17)10-18(16)22(3)12-14/h6-9,11,14,18,21H,4-5,10,12H2,1-3H3/t14-,18-/m1/s1",VAYOSLLFUXYJDT-RDTXWAMCSA-N,C20H25N3O,323.4,"(6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","Lysergide|LYSERGIC ACID DIETHYLAMIDE|D-Lsd|N,N-Diethyllysergamide|50-37-3|Lysergsaeurediaethylamid|N,N-Diethyl-D-lysergamide|Lysergaure diethylamid|LSD-25|LSD 25|Lisergide|Lysergidum|N,N-Diethyl-(+)-Lysergamide|(+)-Lysergic acid diethylamide|Dextrolysergic Acid diethylamide|lisergida|8NA5SWF92O|(+)-Lysergide|Diethylamid kyseliny lysergove|CHEBI:6605|DTXSID1023231|DTXCID003231|Ergoline-8-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-, (8beta)-|(8R)-9,10-didehydro-N,N-diethyl-6-methylergoline-8-carboxamide|(6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide|(4R,7R)-N,N-diethyl-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide|(4R,7R)-N,N-diethyl-6-methyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide|(6aR,9R)-N,N-diethyl-7-methyl-6,6a,8,9-tetrahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide|RefChem:5968|Acid Diethylamide, Lysergic|Diethylamide, Lysergic Acid|(4R,7R)-N,N-diethyl-6-methyl-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide|200-033-2|D-Lysergic acid diethylamide|Delysid|LSD|Lysergamid|LSD (alkaloid)|Lysergsauerediaethylamid|Lysergic acid diethylamide-25|Lysergamide, N,N-diethyl-|HSDB 3920|Lysergsaeurediethylamid|(+)-LSD|[3H]-LSD|CHEMBL263881|Cubes|Pearly gates|Heavenly Blue|Royal blue|Acid [Street Name]|Cubes [Street Name]|NCGC00168265-01|NCGC00168265-02|Royal Blue [Street Name]|Lysergidum [INN-Latin]|Pearly gates [Street Name]|Wedding bells [Street Name]|Heavenly Blue [Street Name]|Lisergide [DCIT]|Clearlight|Ubergluben|Barrels|Bartman|Cupcakes|Greenies|Lisergido|Microdots|Spoonies|Sunshine|Trippers|Yellows|Beast|CHEMBL463207|Chief|Domes|Fifty|Flats|Owsley|Scapes|Wedges|Chocolate Chips|Orange Mushroom|Orange Sunshine|Purple Microdot|Gelatin Chips|Mellow Yellow|Orange Wedges|Bart Simpson|Blotter Acid|Contact Lens|(8alpha)-N,N-Diethyl-6-Methyl-9,10-Didehydroergoline-8-Carboxamide|Purple Haze|White Light|Window Pane|Blue Cheer|Brown Dots|Cherry Top|Lisergido [INN-Spanish]|Mean Green|Paper Acid|Sugar Lump|Blue Acid|Blue Mist|Blue Star|Strawberry Fields|The Hawk|CAS-50-37-3|California Sunshine|LSD (d-Lysergic acid N,N-diethylamide)|Lysergide [INN:BAN:DCF]|Diethylamid kyseliny lysergove [Czech]|Big F|(+)-Lysergide (1.0 mg/mL in Acetonitrile)|(+)-Lysergide (100 microg/mL in Methanol)|EINECS 200-033-2|UNII-8NA5SWF92O|BRN 0094179|Hawk|Haze|Lucy in the Sky with Diamonds|Instant Zen|DEA No. 7315|Lysergide (LSD)|Wedding Bells Acid|7LD|[N-methyl-3H]LSD|LYSERGIDE [INN]|LYSERGIDE [MI]|LSD,l-|LYSERGIDE [HSDB]|9,10-Didehydro-N,N-diethyl-6-methyl-ergoline-8-beta-carboxamide|Ergoline-8beta-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-|GTPL17|Indolo[4,3-fg]quinoline, ergoline-8-carboxamide deriv.|LYSERGIDE [WHO-DD]|4-25-00-00939 (Beilstein Handbook Reference)|SCHEMBL113755|NIOSH/KE4200000|SCHEMBL29349465|BDBM21342|LSD,(+)|9,10-Didehydro-N,N-diethyl-6-methylergoline-8b-carboxamide|Lysergic acid diethylamide, l-isomer|Tox21_112872|Tox21_113508|BDBM50241702|Ergoline-8-beta-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-|Ergoline-8-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-, (8b)-|PDSP1_001431|PDSP1_001540|PDSP2_001415|PDSP2_001524|Lysergic acid diethylamide tartrate ci|DB04829|US20240166618, Compound LSD|(+)-LYSERGIDE (INCB:GREEN LIST)|LSD (Lysergic Acid Diethylamide;Lysergide)|KE42000000|NS00000052|C07542|Q23118|LSD (Lysergic Acid Diethylamide) 0.025 mg/ml in Acetonitrile|LSD (Lysergic Acid Diethylamide) 1.0 mg/ml in Acetonitrile|(8beta)-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide|9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYL-ERGOLINE-8B-CARBOXAMIDE|LSD (d-Lysergic acid N,N-diethylamide), 0.1mg/ml in Acetonitrile|LSD (d-Lysergic acid N,N-diethylamide), 1mg/ml in Acetonitrile|Ergoline-8-beta-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl-, (-)-|Ergoline-8b-carboxamide, 9,10-didehydro-N,N-diethyl-6-methyl- (8CI)|(8.BETA.)-9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYLERGOLINE-8-CARBOXAMIDE|ERGOLINE-8-CARBOXAMIDE, 9,10-DIDEHYDRO-N,N-DIETHYL-6-METHYL-, (5.BETA., 8.BETA.)-|(6aR,9R)-N,N-diethyl-7-methyl-4,6,6a,7,8,9-hexahydroindolo[4,3-fg]quinoline-9-carboxamide"
ATIPAMEZOLE,71310,,"InChI=1S/C14H16N2/c1-2-14(13-9-15-10-16-13)7-11-5-3-4-6-12(11)8-14/h3-6,9-10H,2,7-8H2,1H3,(H,15,16)",HSWPZIDYAHLZDD-UHFFFAOYSA-N,C14H16N2,212.29,"5-(2-ethyl-1,3-dihydroinden-2-yl)-1H-imidazole","Atipamezole|104054-27-5|Antisedan|MPV 1248|MPV-1248|Atipamezol|1H-Imidazole, 4-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-|Atipamezolum|5-(2-ethyl-1,3-dihydroinden-2-yl)-1H-imidazole|4-(2-Ethyl-2-indanyl)imidazole|5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole|03N9U5JAF6|DTXSID2049135|4-(2-ethyl-2-indanyl)imidazole.|DTXCID9029061|antipamezole|Atipamezole Base|RefChem:57488|4-(2-ethyl-2,3-dihydro-1h-inden-2-yl)-1h-imidazole|MFCD00864502|308081-08-5|ZEOLITE, TYPE|NCGC00182707-01|Atipamezolum [Latin]|Atipamezol [Spanish]|CAS-104054-27-5|NCGC00182707-02|UNII-03N9U5JAF6|Atipamezole [USAN:INN:BAN]|Atipamezole?|4-(2-Ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole; MPV 1248|Antisedan (TN)|Zeolite ZSM-5|5-(2-ethylindan-2-yl)-1H-imidazole|ATIPAMEZOLE [MI]|ATIPAMEZOLE [INN]|Atipamezole (USAN/INN)|ATIPAMEZOLE [USAN]|ATIPAMEZOLE [MART.]|SCHEMBL304971|SCHEMBL881064|CHEMBL353972|orb1685616|SCHEMBL29357620|Atipamezole, >=98% (HPLC)|BDBM81807|GTPL12576|MPV1248|CHEBI:230832|GLXC-25083|HMS3885F14|HMS5083K08|BCP02215|IMA08108|Tox21_113005|HY-12380A|NSC_71310|PDSP1_001582|PDSP2_001566|s4650|AKOS015900246|AKOS032960366|Tox21_113005_1|5-(2-Ethyl-2-indanyl)-1H-imidazole|AC-1614|CCG-266667|CS-3390|DB11481|NCGC00182707-03|AS-56282|4719B|A3259|CAS_104054-27-5|NS00069974|NS00134266|A11849|D03002|054A275|L000823|Q413894|SR-01000944943|SR-01000944943-1|BRD-K39252998-003-01-5|1H-imidazole, 5-(2-ethyl-2,3-dihydro-1H-inden-2-yl)-; 4-(2-Ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole; 5-(2-Ethyl-2,3-dihydro-1H-inden-2-yl)-1H-imidazole"
BROLAMFETAMINE,62065,,"InChI=1S/C11H16BrNO2/c1-7(13)4-8-5-11(15-3)9(12)6-10(8)14-2/h5-7H,4,13H2,1-3H3",FXMWUTGUCAKGQL-UHFFFAOYSA-N,C11H16BrNO2,274.15,"1-(4-bromo-2,5-dimethoxyphenyl)propan-2-amine","2,5-Dimethoxy-4-bromoamphetamine|DOB-4|4-Bromo-2,5-dimethoxyphenylisopropylamine|32156-26-6|1-(2,5-Dimethoxyphenyl-4-bromo)-2-aminopropane|4-DOB|2,5-Dimethoxy-(4-bromo)phenylisopropylamine|1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane|4-Bromo-2,5-dimethoxy-alpha-methylbenzeneethanamine|RefChem:444455|Brolamfetamine|64638-07-9|4-Bromo-2,5-dimethoxyamphetamine|Brolanfetamina|1-(4-bromo-2,5-dimethoxyphenyl)propan-2-amine|Brolamfetamine [INN]|bromoamphetamine|dl-2,5-Dimethoxy-4-bromoamphetamine|DOB|BROMO-DMA|67WJC4Y2QY|CHEMBL6607|Brolamfetamine (INN)|J275.083J|Brolamfetaminum|4-Bromo-DMA|Brolamfetaminum [Latin]|Brolanfetamina [Spanish]|NCGC00168267-01|UNII-67WJC4Y2QY|DEA No. 7391|DTXSID5050428|Racemic DOB|4-Bromo-2,5-dimethoxy-amphetamine|(RS)-brolamfetamine|Benzeneethanamine, 4-bromo-2,5-dimethoxy-alpha-methyl-|2,5-DIMETHOXY-4-BROMAMPHETAMIN|(+-)-2,5-Dimethoxy-4-bromoamphetamine|NCGC00168267-02|GTPL155|GTPL163|SCHEMBL714339|BROLAMFETAMINE [MART.]|(+-)-1-(4-Bromo-2,5-dimethoxyphenyl)-2-aminopropane|SCHEMBL29543691|Benzeneethanamine, 4-bromo-2,5-dimethoxy-.alpha.-methyl-|[3H](+)DOB|WQB68464|BDBM50005257|PDSP1_001355|PDSP2_001339|DB01484|(+-)2,5-Dimethoxy-4-bromoamphetamine|BROLAMFETAMINE [INCB GREEN LIST]|NS00002917|D12707|L000010|Q209241|(+-)-4-Bromo-2,5-dimethoxy-alpha-methylphenethylamine|2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine|(+)2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine|(-)2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine|(+)-2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine|(+/-)2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine|(-)-2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine|2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine(DOB)|(+/-)-4-BROMO-2,5-DIMETHOXY-.ALPHA.-METHYLPHENETHYLAMINE|2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine((-)-DOB)|2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine[R(-)DOB]|Benzeneethanamine, 4-bromo-2,5-dimethoxy-alpha-methyl-, (+-)-|Benzeneethanamine,4-bromo-2,5-dimethoxy-.alpha.-methyl-(.+/-.)-|2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine((R)-(-)-DOB)|2-(4-Bromo-2,5-dimethoxy-phenyl)-1-methyl-ethylamine((S)-(+)-DOB)"
PIRENZEPINE,4848,,"InChI=1S/C19H21N5O2/c1-22-9-11-23(12-10-22)13-17(25)24-16-7-3-2-5-14(16)19(26)21-15-6-4-8-20-18(15)24/h2-8H,9-13H2,1H3,(H,21,26)",RMHMFHUVIITRHF-UHFFFAOYSA-N,C19H21N5O2,351.4,"11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one","pirenzepine|28797-61-7|Pirenzepin|Pirenzepina|Pirenzepinum|11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one|ACI-91|CHEBI:8247|11-((4-Methyl-1-piperazinyl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one|DTXSID7023487|11-[(4-methylpiperazin-1-yl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one|LS-519|3G0285N20N|DTXCID303487|WST-057|6H-Pyrido(2,3-b)(1,4)benzodiazepin-6-one, 5,11-dihydro-11-((4-methyl-1-piperazinyl)acetyl)-|Pyrenzepine|6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-|LS 519|Piren basan|Gastri p|11-(2-(4-methylpiperazin-1-yl)acetyl)-5H-pyrido(2,3-b)(1,4)benzodiazepin-6-one|11-((4-methylpiperazin-1-yl)acetyl)-5,11-dihydro-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one|2-(2-(4-methylpiperazin-1-yl)acetyl)-2,4,9-triazatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3,5,7,12,14-hexaen-10-one|2-[2-(4-methylpiperazin-1-yl)acetyl]-2,4,9-triazatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaen-10-one|Pirenzepin ratiopharm|Von Ct, Pirenzepin|RefChem:174513|A02BX03|249-228-4|LS519|Gastrozepin|CHEMBL9967|6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[2-(4-methyl-1-piperazinyl)acetyl]-|5,11-Dihydro-11-((4-methyl-1-piperazinyl)acetyl)-6H-pyrido(2,3-b)(1,4)benzodiazepin-6-one|NCGC00015836-08|Pirenzepinum [INN-Latin]|Pirenzepina [INN-Spanish]|Pirenzepine [INN:BAN]|MLS000069702|5,11-Dihydro-11-[(4-methyl-1-piperazinyl)acetyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one|11-(2-(4-Methylpiperazin-1-yl)acetyl)-5,11-dihydro-6H-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one|6H-Pyrido[2,3-b][1,4]benzodiazepin-6-one, 5,11-dihydro-11-[(4-methyl-1-piperazinyl)acetyl]- (8CI,9CI)|CAS-28797-61-7|SMR000058502|EINECS 249-228-4|BRN 0628987|UNII-3G0285N20N|PirenzepineDihydrochlorideMonohydrate|Spectrum_001378|Tocris-1071|starbld0016668|PIRENZEPINE [MI]|Prestwick0_000129|Prestwick1_000129|Prestwick2_000129|Prestwick3_000129|Spectrum2_001417|Spectrum3_001453|Spectrum4_000437|Spectrum5_001344|Lopac-P-7412|PIRENZEPINE [INN]|Pirenzepine (USAN/INN)|PIRENZEPINE [USAN]|PIRENZEPINE [VANDF]|Lopac0_000962|SCHEMBL41705|BSPBio_000178|BSPBio_002945|GTPL328|KBioGR_000794|KBioSS_001858|PIRENZEPINE [WHO-DD]|DivK1c_000127|SPBio_001494|SPBio_002117|BPBio1_000196|cid_185248|orb1688810|SCHEMBL29793172|SCHEMBL30553045|BDBM39341|KBio1_000127|KBio2_001858|KBio2_004426|KBio2_006994|KBio3_002445|NINDS_000127|HMS2089K21|HMS3742E07|HMS3742G13|BCP12188|Tox21_110239|HY-17037A|PDSP1_000965|PDSP2_000949|AKOS015969751|Tox21_110239_1|CCG-205042|DB00670|SDCCGSBI-0050935.P004|IDI1_000127|NCGC00015836-01|NCGC00015836-02|NCGC00015836-03|NCGC00015836-04|NCGC00015836-05|NCGC00015836-06|NCGC00015836-07|NCGC00015836-09|NCGC00015836-10|NCGC00015836-12|NCGC00015836-19|NCGC00024297-02|NCGC00024297-04|NCGC00024297-05|SBI-0050935.P003|CAS-29868-97-1|AB00053603|CS-0013749|NS00006691|97P617|C07508|D08389|AB00053603-08|AB00053603_09|L000485|Q419550|BRD-K89375097-300-05-4|BRD-K89375097-300-06-2|BRD-K89375097-300-08-8|11-[2-(4-methylpiperazino)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride|11-[(4-Methyl-1-piperazinyl)acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one #|11-[2-(4-methyl-1-piperazinyl)-1-oxoethyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride|11-[2-(4-Methyl-piperazin-1-yl)-acetyl]-5,11-dihydro-benzo[e]pyrido[3,2-b][1,4]diazepin-6-one|11-[2-(4-methylpiperazin-1-yl)-acetyl]-5,11-dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one|11-[2-(4-methylpiperazin-1-yl)acetyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride|11-[2-(4-methylpiperazin-1-yl)ethanoyl]-5H-pyrido[2,3-b][1,4]benzodiazepin-6-one;hydrochloride|5,11-Dihydro-11-[2-(4-methyl-1-piperazinyl)acetyl]-6H-pyrido[2,3-b][1,4]benzodiazepin-6-one"
DARIFENACIN,444031,,"InChI=1S/C28H30N2O2/c29-27(31)28(23-7-3-1-4-8-23,24-9-5-2-6-10-24)25-14-17-30(20-25)16-13-21-11-12-26-22(19-21)15-18-32-26/h1-12,19,25H,13-18,20H2,(H2,29,31)/t25-/m1/s1",HXGBXQDTNZMWGS-RUZDIDTESA-N,C28H30N2O2,426.5,"2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide","Darifenacin|133099-04-4|UK-88525|darifenacine|Darifenacina|2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-diphenylacetamide|Darifenacin extended release|APG9819VLM|CHEBI:391960|(S)-1-(2-(2,3-Dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-3-pyrrolidineacetamide|DTXSID2048290|UK88525|2-{(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl}-2,2-diphenylacetamide|3-Pyrrolidineacetamide, 1-(2-(2,3-dihydro-5-benzofuranyl)ethyl)-alpha,alpha-diphenyl-, (3S)-|darifenicin|Darifenacinum|2-((3S)-1-(2-(2,3-dihydro-1-benzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide|2-((3S)-1-(2-(2,3-dihydro-1-benzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-di(phenyl)acetamide|2-[(3S)-1-[2-(2,3-dihydro-1-benzofuran-5-yl)ethyl]pyrrolidin-3-yl]-2,2-di(phenyl)acetamide|RefChem:57150|DTXCID3028265|G04BD10|603-704-1|Emselex|CHEMBL1346|[3H]darifenacin|NCGC00168775-01|UK-88525 (hydrobromide)|Darifenacin (USAN/INN)|UNII-APG9819VLM|Darifenacin [USAN:INN:BAN]|Darifenacin [USAN]|DARIFENACIN [MI]|DARIFENACIN [INN]|DARIFENACIN [VANDF]|DARIFENACIN [MART.]|SCHEMBL56574|DARIFENACIN [WHO-DD]|GTPL319|GTPL321|MLS003876823|orb1687722|SCHEMBL31257801|GLXC-05233|HY-A0033|AC-302|BDBM50109647|EX-A10864|AKOS015907962|CS-1168|DB00496|(S)-2-(1-(2-(2,3-dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide|NCGC00168775-07|3-(S)-(-)-(1-carbamoyl-1,1-diphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]pyrrolidine|SMR002533186|NS00007299|D03654|AB01566824_01|099D044|EN300-19768793|Q166476|BRD-K95773607-004-03-8|(s)-1-[2-(2,3-dihydro-5-benzofuranyl) ethyl]-alpha,alpha-diphenyl-3-pyrrolidine acetamide|(S)-2-{1-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-pyrrolidin-3-yl}-2,2-diphenyl-acetamide|(S)-2-{1-[2-(2,3-dihydrobenzofuran-5-yl)ethyl]-3-pyrrolidinyl}-2,2-diphenylacetamide|2-((3S)-1-(2-(2,3-Dihydrobenzofuran-5-yl)ethyl)pyrrolidin-3-yl)-2,2-diphenylacetamide|2-((3S)-1-(2-(2,3-DIHYDROBENZOFURAN-5-YL)ETHYL)PYRROLIDIN-3-YL)-2,2-DIPHENYLACETAMIDE.|2-{1-[2-(2,3-Dihydro-benzofuran-5-yl)-ethyl]-pyrrolidin-3-yl}-2,2-diphenyl-acetamide (Darifenacin)|3-(S)-(-)-(1-carbamoyl-1,1-diphenylmethyl)-1-[2-(2,3-dihydrobenzofuran-5-y l)ethyl]pyrrolidine|3-PYRROLIDINEACETAMIDE, 1-(2-(2,3-DIHYDRO-5-BENZOFURANYL)ETHYL)-.ALPHA.,.ALPHA.-DIPHENYL-, (3S)-|Darifenacin; 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-a,a-diphenyl-, (3S)-; 3-Pyrrolidineacetamide, 1-[2-(2,3-dihydro-5-benzofuranyl)ethyl]-a,a-diphenyl-, (S)-; (3S)-1-[2-(2,3-Dihydro-5-benzofuranyl)ethyl]-a,a-diphenyl-3-pyrrolidineacetamide; (3"
RAZAXABAN HYDROCHLORIDE,204101,,"InChI=1S/C24H20F4N8O2.ClH/c1-34(2)12-21-30-7-8-35(21)13-3-5-17(16(25)10-13)31-23(37)18-11-20(24(26,27)28)32-36(18)14-4-6-19-15(9-14)22(29)33-38-19;/h3-11H,12H2,1-2H3,(H2,29,33)(H,31,37);1H",CASCTHHMARGRLB-UHFFFAOYSA-N,C24H21ClF4N8O2,564.9,"2-(3-amino-1,2-benzoxazol-5-yl)-N-[4-[2-[(dimethylamino)methyl]imidazol-1-yl]-2-fluorophenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide;hydrochloride","Razaxaban Hydrochloride|405940-76-3|Razaxaban HCl|BMS-561389|7CLJ1MEZ8V|1H-Pyrazole-5-carboxamide, 1-(3-amino-1,2-benzisoxazol-5-yl)-N-(4-(2-((dimethylamino)methyl)-1H-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-, monohydrochloride|DTXSID10193598|RefChem:178672|DTXCID50116089|Razaxaban Hydrochloride [USAN]|405940-76-3 (HCl)|DPC 906|1-(3-aminobenzo[d]isoxazol-5-yl)-N-(4-(2-((dimethylamino)methyl)-1H-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide hydrochloride|2-(3-amino-1,2-benzoxazol-5-yl)-N-[4-[2-[(dimethylamino)methyl]imidazol-1-yl]-2-fluorophenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide;hydrochloride|CHEMBL558198|Razaxaban hydrochloride (USAN)|UNII-7CLJ1MEZ8V|DPC-906|1-(3-Amino-1,2-benzisoxazol-5-yl)-N-(4-(2-((dimethylamino)methyl)-1H-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide monohydrochloride|1-(3-Amino-1,2-benzisoxazol-5-yl)-N-[4-[2-[(dimethylamino)methyl]-1H-imidazol-1-yl]-2-fluorophenyl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide monohydrochloride|BMS 561389|orb1708696|SCHEMBL6885838|SCHEMBL29456625|CASCTHHMARGRLB-UHFFFAOYSA-N|AKOS040736566|DA-77358|HY-11091|Razaxaban hydrochloride, >=98% (HPLC)|CS-0003049|D04029|Q27268081|1H-Pyrazole-5-carboxamide, 1-(3-amino-1,2-benzisoxazol-5-yl)-N-(4-(2-((dimethylamino)methyl)-1H-imidazol-1-yl)-2-fluorophenyl)-3-(trifluoromethyl)-,  monohydrochloride"
DRONABINOL,16078,,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h11-13,16-17,22H,5-10H2,1-4H3/t16-,17-/m1/s1",CYQFCXCEBYINGO-IAGOWNOFSA-N,C21H30O2,314.5,"(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol","Dronabinol|TETRAHYDROCANNABINOL|Marinol|delta9-Tetrahydrocannabinol|delta9-THC|delta-9-tetrahydrocannabinol|Abbott 40566|1972-08-3|delta-9-THC|delta(9)-THC|Dronabinolum|delta1-THC|delta(1)-Tetrahydrocannabinol|1-trans-delta-9-Tetrahydrocannabinol|QCD 84924|SP 104|delta(9)-Tetrahydrocannabinol|delta1-Tetrahydrocannabinol|QCD-84924|Syndros|delta(9)-Tetrahydrocannibinol|CHEBI:66964|3-Pentyl-6,6,9-trimethyl-6a,7,8,10a-tetrahydro-6H-dibenzo(b,d)pyran-1-ol|NSC-134454|ABBOTT-40566|DTXSID6021327|(-)-delta9-Tetrahydrocannabinol|J882F|SP-104|7J8897W37S|6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-|SCI-110 component dronabinol|DTXCID101327|NSC134454|6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-|Hashish|delta(1)-THC|Ganja|9-ene-Tetrahydrocannabinol|6H-dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-|9 ene Tetrahydrocannabinol|(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6H,6aH,7H,8H,10aH-benzo(c)isochromen-1-ol|(6AR,10AR)-6,6,9-TRIMETHYL-3-PENTYL-6H,6AH,7H,8H,10AH-BENZO[C]ISOCHROMEN-1-OL|6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-|RefChem:5782|Delta9tetrahydrocannabinol|Tetrahydrocannabinol, Trans|delta 1-Tetrahydrocannabinol|A04AD10|(-)-delta 9-trans-Tetrahydrocannabinol|Tetrahydrocannabinols (-)-trans-delta9-|(-)-delta1-3,4-trans-Tetrahydrocannabinol|Deltanyne|THC|delta(sup 1)-Thc|delta(sup 9)-Thc|Namisol|(-)-delta9-trans-Tetrahydrocannabinol|9-tetrahydrocannabinol|1-trans-delta9-Tetrahydrocannabinol|.DELTA.9-Tetrahydrocannabinol|delta(sup 1)-Tetrahydrocannabinol|delta(sup 9)-Tetrahydrocannabinol|.DELTA.1-THC|.DELTA.9-THC|L-delta1-trans-Tetrahydrocannabinol|Cannabinol, delta1-tetrahydro-|CCRIS 4726|(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol|(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|6465-30-1|CHEMBL465|Tetrahydrocannabinols (-)-delta1-3,4-trans-form|.delta.-9-tetrahydrocannabinol|Cannabinol, 1-trans-delta(sup 9)-tetrahydro-|trans-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol|Dronabinolum [Latin]|Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol|6,6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo(b,d)pyran-1-ol|Tetrahydrocannabinols (-)-trans-.delta.9-form|6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-|(-)-.DELTA.9-THC|Compassia|Relivar|(L)-.delta.1-Tetrahydrocannabinol|(-)-.DELTA.1-Tetrahydrocannabinol|(-)-.DELTA.9-Tetrahydrocannabinol|6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|L-.delta.1-trans-Tetrahydrocannabinol|L-trans-.delta.9-Tetrahydrocannabinol|Delta 9-THC|(6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol|(6aR,10aR)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol|(6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo(b,d)pyran-1-ol|(-)-.DELTA.9-trans-Tetrahydrocannabinol|(-)-trans-.DELTA.9-Tetrahydrocannabinol|Marinol (TN)|DEA No. 7369|delta1-Tetrahydrocannabinol (VAN)|delta9-Tetrahydrocannabinol (VAN)|Dronabinol (USP/INN)|.DELTA.1-Tetrahydrocannabinol|Tetrahydrocannabinol delta9|(-)-trans-Delta9-THC|(l)-delta(sup 1)-Tetrahydrocannabinol|Cannabinol, .DELTA.1-tetrahydro-|1-trans-delta(sup 9)-Tetrahydrocannabinol|.DELTA.9-trans-Tetrahydrocannabinol|(l)-delta1-Tetrahydrocannabinol|L-.delta.1-Tetrahydrocannabinol|(-)-delta1-Tetrahydrocannabinol|delta9-trans-Tetrahydrocannabinol|HSDB 6471|trans-delta9-Tetrahydrocannabinol|(6aR-trans)-6a,7,8,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol|CAT-310|L-trans-delta9-Tetrahydrocannabinol|(-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol|DRG-0138|TCI|14C-.DELTA.1-Tetrahydrocannabinol|trans-.DELTA.9-Tetrahydrocannabinol|(-)-trans-Delta1-Tetrahydrocannabinol|(-)-trans-delta9-Tetrahydrocannabinol|NSC 134454|.delta.-9-THC|1-trans-delta(sup9)-tetrahydrocannabinol|Dronabinol (Synthetic)|.delta.(sup9)-THC|3ls4|DRONABINOL [INN]|(-)-3,4-trans-Delta1-Tetrahydrocannabinol|1-trans-.delta.(sup9)-tetrahydrocannabinol|DRONABINOL [HSDB]|DRONABINOL [USAN]|(-)-.delta.(sup9)-trans-Tetrahydrocannabinol|DRONABINOL [VANDF]|Epitope ID:224552|DRONABINOL [MART.]|SCHEMBL4609|AD313 component dronabinol|delta 9-Tetrahydrocannabinol|delta-9 Tetrahydrocannabinol|DRONABINOL [WHO-DD]|AD-313 component dronabinol|BIDD:GT0427|Dronabinol [USAN:USP:INN]|GTPL2424|Cannabinol, tetrahydro- (6CI)|DRONABINOL [ORANGE BOOK]|SCHEMBL29390424|UNII-7J8897W37S|BDBM60994|delta-Tetrahydrocannabinol (THC)|DRONABINOL [USP MONOGRAPH]|DTXSID001038830|US9416103, Delta9-THC|INT-0010|(A+/-)-delta9-Tetrahydrocannabinol|Tox21_112616|BDBM50007391|PDSP2_000714|Cannabinol, Delta1-tetrahydro- (7CI)|DB00470|FT28083|INT-0010/06|(-)-Delta-9-THC, 1mg/ml in Methanol|CAS-1972-08-3|TETRAHYDROCANNABINOL, DELTA-9 TRANS|NS00000050|C06972|Cannabinol, 1-trans-.delta.(sup9)-tetrahydro-|D00306|Q190067|(-)-.DELTA.1-3,4-TRANS-TETRAHYDROCANNABINOL|(-)-Delta9-THC (Dronabinol) 0.1 mg/ml in Methanol|(-)-Delta9-THC (Dronabinol) 1.0 mg/ml in Methanol|(-)-Delta-9-THC (Dronabinol) 5.0 mg/ml in Methanol|(-)-trans-Delta-9-THC (Dronabinol), 100mg/ml in Ethanol|(-)-trans-Delta-9-THC (Dronabinol), 10mg/ml in Ethanol|(-)-trans-Delta-9-THC (Dronabinol), 1mg/ml in Ethanol|(-)-trans-Delta-9-THC (Dronabinol), 50mg/ml in Ethanol|Delta9-Tetrahydrocannabinol 250 microg/mL in Acetonitrile|TETRAHYDROCANNABINOLS (-)-TRANS-.DELTA.9-FORM [MI]|Delta-9-Tetrahydrocannabinol - 50 mg/ml solution in ethanol|6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-|(-)-delta 9-Tetrahydrocannabinol (delta9-THC) 1000 microg/mL in Methanol|(-)-Delta9-Tetrahydrocannabinol (Delta9-THC) 100 microg/mL in Methanol|6,9-Trimethyl-3-pentyl-7,8,9,10-tetrahydro-6H-dibenzo[b,d]pyran-1-ol|6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, trans-|(-)-(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|(-)-delta(sup 1)-3,4-trans-Tetrahydrocannabinol(l)-delta(sup 1)-Tetrahydrocannabinol|(10R,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|(S)-6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol(DeltaE-9-THC)|6H-Dibenzo[b, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-|Delta-9-Tetrahydrocannabinol, United States Pharmacopeia (USP) Reference Standard|(6AR,10AR)-6,6,9-TRIMETHYL-3-PENTYL-6A,7,8,10A-TETRAHYDRO-6H-DIBENZO(B,D)PYRAN-1-OL|6,6,9-Trimethyl-3-pentyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol(delta9-THC(delta9-tetrahydrocannabinol))|8,8-Dimethyl-11-methylene-5-pentyl-3,4,8a,9,10,11,12,12a-octahydro-2H,8H-1,7-dioxa-benzo[c]phenanthrene"
DELTA 8-TETRAHYDROCANNOBINOL,638026,,"InChI=1S/C21H30O2/c1-5-6-7-8-15-12-18(22)20-16-11-14(2)9-10-17(16)21(3,4)23-19(20)13-15/h9,12-13,16-17,22H,5-8,10-11H2,1-4H3/t16-,17-/m1/s1",HCAWPGARWVBULJ-IAGOWNOFSA-N,C21H30O2,314.5,"(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol","5957-75-5|DELTA8-Tetrahydrocannabinol|delta8-THC|delta-6-THC|DELTA-8-THC|delta-8-tetrahydrocannabinol|DTXSID20878586|trans-DELTA8-Tetrahydrocannabinol|B49D0HH807|NSC-134453|NSC134453|delta6-THC|RefChem:919820|DTXCID601016630|DELTA 8-TETRAHYDROCANNOBINOL|CHEMBL267227|(6aR,10aR)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol|NSC 134453|8-Tetrahydrocannabinol|(6aR-trans)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol|delta(sup 6)-Thc|delta(sup 8)-Thc|delta-(sup6)-THC|delta-(sup8)-THC|delta6-Tetrahydrocannabinol|UNII-B49D0HH807|trans-.DELTA.8-Tetrahydrocannabinol|(-)-delta8-Tetrahydrocannabinol|6H-Dibenzo(b,d)pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR-trans)-|Cannabinol, delta1(6)-tetrahydro-|delta1(6)-trans-Tetrahydrocannabinol|BRN 0023921|(-)-.DELTA.6-3,4-trans-Tetrahydrocannabinol|1-trans-delta(sup 8)-Tetrahydrocannabinol|1-trans-delta-(sup8)-Tetrahydrocannabinol|?8-Tetrahydro Cannabinol|(-)-delta(sup 8)-trans-Tetrahydrocannabinol|(-)-delta-(sup8)-trans-Tetrahydrocannabinol|Cannabinol, 1-trans-delta(sup 8)-tetrahydro-|Cannabinol, 1-trans-delta-(sup8)-tetrahydro-|Tetrahydrocannabinols (-)-delta6-3,4-trans-form|(-)-delta(sup 6)-3,4-trans-Tetrahydrocannabinol|5-17-04-00421 (Beilstein Handbook Reference)|SCHEMBL2762327|SCHEMBL29361531|CHEBI:183415|6H-Dibenzo(b,d)pyran-1-ol, 6a,7,10,10a-tetrahydro-6,6,9-trimethyl-3-pentyl-, (6aR,10aR)-|BDBM50067734|PDSP2_000219|.DELTA.-8-TETRAHYDROCANNABINOL|FT28082|(6aR,10aR)-6a,7,10,10a-Tetrahydro-6,6,9-trimethyl-3-pentyl-6H-dibenzo[b,d]pyran-1-ol|8-TETRAHYDROCANNABINOL [WHO-DD]|(-)-Delta-8-THC, 1mg/ml in Ethanol|(-)-Delta-8-THC, 10mg/ml in Ethanol|(-)-Delta-8-THC, 50mg/ml in Ethanol|DELTA(8)-TRANS-TETRAHYDROCANNABINOL|(-)-Delta-8-THC, 100mg/ml in Ethanol|C22741|DELTA-8-TETRAHYDROCANNABINOL [NFLIS-DRUG]|DELTA-8-TETRAHYDROCANNABINOL- [NFLIS-DRUG]|Q27274350|TETRAHYDROCANNABINOLS (-)-TRANS-.DELTA.8-FORM|Delta8-Tetrahydrocannabinol 250 microg/mL in Acetonitrile|TETRAHYDROCANNABINOLS (-)-TRANS-.DELTA.8-FORM [MI]|Cannabinoids Mixture 258 Kit 250 microg/mL in Acetonitrile|delta-8-Tetrahydrocannabinol - 20 mg/ml solution in methanol|(-)-delta 8-Tetrahydrocannabinol (delta8-THC) 100 microg/mL in Methanol|(-)-delta 8-Tetrahydrocannabinol (delta8-THC) 1000 microg/mL in Methanol|6,6,9-Trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol|Cannabinoids Acid/Neutrals Mixture 205 Kit 250 microg/mL in Acetonitrile|Cannabinoids Acid/Neutrals Mixture 206 Kit 500 microg/mL in Acetonitrile|Cannabinoids Acid/Neutrals Mixture 214 Kit 250 microg/mL in Acetonitrile|Cannabinoids Acid/Neutrals Mixture 215 Kit 500 microg/mL in Acetonitrile|Cannabinoids Acid/Neutrals Mixture 216 Kit 1000 microg/mL in Acetonitrile|(-)-(6aR-trans)-6,6,9-trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol|(-)-delta8-THC6,6,9-Trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol|(6aR,10aR)-6,6,9-Trimethyl-3-pentyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol|6,6,9-TRIMETHYL-3-PENTYL-6H,6AH,7H,10H,10AH-BENZO(C)ISOCHROMEN-1-OL|6H-Dibenzo(b,d)pyran-1-ol, 6a,7,10,10a-tetrahydro-3-pentyl-6,6,9-trimethyl-, trans(-)-"
ENZASTAURIN,176167,,"InChI=1S/C32H29N5O2/c1-35-19-25(23-9-2-4-11-27(23)35)29-30(32(39)34-31(29)38)26-20-37(28-12-5-3-10-24(26)28)22-13-16-36(17-14-22)18-21-8-6-7-15-33-21/h2-12,15,19-20,22H,13-14,16-18H2,1H3,(H,34,38,39)",AXRCEOKUDYDWLF-UHFFFAOYSA-N,C32H29N5O2,515.6,"3-(1-methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione","Enzastaurin|170364-57-5|LY317615|LY-317615|enzastaurina|DB102|UC96G28EQF|ENZASTAURINE|DTXSID5044029|DB-102|DTXCID3024029|1H-Pyrrole-2,5-dione, 3-(1-methyl-1H-indol-3-yl)-4-(1-(1-(2-pyridinylmethyl)-4-piperidinyl)-1H-indol-3-yl)-|enzastaurinum|Kinenza|3-(1-methyl-1H-indol-3-yl)-4-(1-(1-(pyridin-2-ylmethyl)piperidin-4-yl)-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione|3-(1-methyl-1H-indol-3-yl)-4-{1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl}-2,5-dihydro-1H-pyrrole-2,5-dione|RefChem:137067|3-(1-methyl-1H-indol-3-yl)-4-(1-(1-((pyridin-2-yl)methyl)piperidin-4-yl)-1H-indol-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione|Enzastaurin (LY317615)|3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(pyridin-2-ylmethyl)piperidin-4-yl)-1H-indol-3-yl)-1H-pyrrole-2,5-dione|MFCD11040980|3-(1-methylindol-3-yl)-4-[1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]indol-3-yl]pyrrole-2,5-dione|LY 317615|CHEMBL300138|3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(pyridin-2-ylmethyl)-piperidin-4-yl)-1H-indol-3-yl)-1H-pyrrole-2,5-dione|3-(1-Methyl-1H-indol-3-yl)-4-(1-(1-(2-pyridinylmethyl)-4-piperidinyl)-1H-indol-3-yl)-1H-pyrrole-2,5-dione|3-(1-Methyl-1H-indol-3-yl)-4-[1-[1-(2-pyridinylmethyl)-4-piperidinyl]-1H-indol-3-yl]-1H-pyrrole-2,5-dione|3-(1-methyl-1H-indol-3-yl)-4-{1-[1-(pyridin-2-ylmethyl)piperidin-4-yl]-1H-indol-3-yl}-1H-pyrrole-2,5-dione|Enzastaurin [INN]|CAS-170364-57-5|UNII-UC96G28EQF|C32H29N5O2|LE-0014|ENZASTAURIN [MI]|Enzastaurin (USAN/INN)|Enzastaurin [USAN:INN]|Enzastaurin,LY317615|ENZASTAURIN [USAN]|Enzastaurin; LY317615|ENZASTAURIN [WHO-DD]|SCHEMBL678748|Enzastaurin (LY317615)?|GTPL5693|orb1300907|SCHEMBL29356867|SCHEMBL29371538|CHEBI:91368|BCPP000241|GLXC-03501|HMS3265M05|HMS3265M06|HMS3265N05|HMS3265N06|HMS3654A13|HMS3748E03|HMS5079M07|BCP02703|EX-A1055|WHO 8426|Tox21_113367|BDBM50128285|NSC767124|NSC800096|s1055|AKOS015994764|Tox21_113367_1|AC-5900|BCP9000648|CCG-264797|CS-0132|DB06486|FE22698|NSC-767124|NSC-800096|SB16481|SDCCGSBI-0654101.P001|3-(1-methylindol-3-yl)-4-[1-[1-(2-pyridylmethyl)-4-piperidyl]indol-3-yl]pyrrole-2,5-dione|NCGC00238452-01|NCGC00238452-02|NCGC00238452-03|NCGC00238452-11|HY-10342|DB-064781|NS00068507|SW219797-1|D11935|SBI-0654101.0001|364E575|Q5381479|BRD-K79404599-001-01-0|BRD-K79404599-001-09-3|1H-Pyrrole-2,5-dione, 3-(1-methyl-1H-indol-3-yl)-4-(1-(1-(2-pyridinylmethyl)-4-piperidinyl)-1H-indol-3-yl)|3-(1-Methyl-1H-indol-3-yl)-4-[1-(1-pyridin-2-ylmethyl-piperidin-4-yl)-1H-indol-3-yl]-pyrrole-2,5-dione"
RUBOXISTAURIN,153999,,"InChI=1S/C28H28N4O3/c1-30(2)15-18-11-12-31-16-21(19-7-3-5-9-23(19)31)25-26(28(34)29-27(25)33)22-17-32(13-14-35-18)24-10-6-4-8-20(22)24/h3-10,16-18H,11-15H2,1-2H3,(H,29,33,34)/t18-/m0/s1",ZCBUQCWBWNUWSU-SFHVURJKSA-N,C28H28N4O3,468.5,"(18S)-18-[(dimethylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione","Ruboxistaurin|169939-94-0|LY-333531|Ruboxistaurina|Ruboxistaurine|721809WQCP|13-((Dimethylamino)methyl)-10,11,14,15-tetrahydro-4,9:16,21-dimetheno-1H,13H-dibenzo(e,k)pyrrolo(3,4-h)(1,4,13)oxadiazacyclohexadecene-1,3(2H)-dione|DTXSID00168775|ruboxistaurinum|RefChem:930973|DTXCID1091266|Ruboxistaurin [INN]|LY 333531|LY333531|K00587a|(18S)-18-[(dimethylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8,10,12,22,24,26-nonaene-3,5-dione|CHEMBL432130|(7S)-7-((Dimethylamino)methyl)-22,25-dihydro-11H,21H,31H-6-oxa-1,3(3,1)-diindola-2(3,4)-pyrrolacyclononaphane-22,25-dione|(9S)-9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-9H,18H-5,21:12,17-di(metheno)dibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione|9H,18H-5,21:12,17-Dimethenodibenzo(e,k)pyrrolo(3,4-h)(1,4,13)oxadiazacyclohexadecine-18,20(19H)-dione, 9-((dimethylamino)methyl)-6,7,10,11-tetrahydro-, (9S)-|UNII-721809WQCP|(9R)-9-[(DIMETHYLAMINO)METHYL]-6,7,10,11-TETRAHYDRO-9H,18H-5,21:12,17-DIMETHENODIBENZO[E,K]PYRROLO[3,4-H][1,4,13]OXADIA ZACYCLOHEXADECINE-18,20-DIONE|9H,18H-5,21:12,17-Dimethenodibenzo[e,k]pyrrolo[3,4-h][1,4,13]oxadiazacyclohexadecine-18,20(19H)-dione, 9-[(dimethylamino)methyl]-6,7,10,11-tetrahydro-, (9S)-|LY4|1uu3|RUBOXISTAURIN [MI]|LY333531;LY-333531;LY 333531|Ruboxistaurin; LY333531|RUBOXISTAURIN [VANDF]|CHEMBL91829|RUBOXISTAURIN [MART.]|RUBOXISTAURIN [WHO-DD]|cid_153999|GTPL5263|orb1687029|SCHEMBL2496701|BDBM17055|EX-A2313|BDBM50128281|NSC800873|DB11829|FR61574|NSC-800873|ZACYCLOHEXADECINE-18,20-DIONE|(9S)-9-((Dimethylamino)methyl)-6,7,10,11-tetrahydro-9H,19H-5,21:12,17-dimethenodibenzo(e,k)pyrrolo(3,4-h)(1,4,13)oxadiazacyclohexadecene-18,20-dione|AC-35844|DA-77580|HY-10195|MS-28648|CS-0002500|LY-333,531|NS00069260|G13598|Q7376181|(18S)-18-[(dimethylamino)methyl]-17-oxa-4,14,21-triazahexacyclo[19.6.1.1;{7,14}.0;{2,6}.0;{8,13}.0;{22,27}]nonacosa-1(28),2(6),7(29),8(13),9,11,22(27),23,25-nonaene-3,5-dione|(9R)-9-[(DIMETHYLAMINO)METHYL]-6,7,10,11-TETRAHYDRO-9H,18H-5,21:12,17-DIMETHENODIBENZO[E,K]PYRROLO[3,4-H][1,4,13]OXADIA|18-dimethylaminomethyl-(18S)-17-oxa-4,14,21-triazahexacyclo[19.6.1.17,14.02,6.08,13.022,27]nonacosa-1(28),2(6),7(29),8(13),9,11,22(27),23,25-nonaene-3,5-dione; methane sulphonic acid salt"
LY-2090314,10029385,,"InChI=1S/C28H25FN6O3/c29-18-12-17-15-34(28(38)32-7-3-1-4-8-32)11-10-33-16-20(19(13-18)25(17)33)23-24(27(37)31-26(23)36)21-14-30-22-6-2-5-9-35(21)22/h2,5-6,9,12-14,16H,1,3-4,7-8,10-11,15H2,(H,31,36,37)",HRJWTAWVFDCTGO-UHFFFAOYSA-N,C28H25FN6O3,512.5,"3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-ylpyrrole-2,5-dione","LY2090314|603288-22-8|LY-2090314|LY 2090314|3-(9-Fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl)-4-(imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione|822M3GYM67|CHEBI:167661|DTXSID90209085|3-(9-Fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-(imidazo(1,2-a)pyridin-3-yl)-1H-pyrrole-2,5-dione|RefChem:154536|DTXCID10131576|GSK-3 Inhibitor LY2090314|110-218-9|3-(6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo(6.4.1.0^(4,13))trideca-2,4,6,8(13)-tetraen-3-yl)-4-(imidazo(1,2-a)pyridin-3-yl)-2,5-dihydro-1H-pyrrole-2,5-dione|MFCD20526532|CHEMBL362558|3-[6-Fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-ylpyrrole-2,5-dione|Kinome_3681|3-[9-fluoro-1,2,3,4-tetrahydro-2-(1-piperidinylcarbonyl)pyrrolo[3,2,1-jk][1,4]benzodiazepin-7-yl]-4-imidazo[1,2-a]pyridin-3-yl-1H-pyrrole-2,5-dione|UNII-822M3GYM67|SCHEMBL633455|GTPL7958|orb1307529|SCHEMBL29533963|C28H25FN6O3|GLXC-06318|HMS3673E17|HMS3747E07|BCP07855|EX-A2214|BDBM50150699|NSC772198|NSC801005|s7063|AKOS026750195|AKOS032950045|CCG-269790|CS-1633|DB11913|NSC-772198|NSC-801005|SB16558|LY 2090314 [WHO-DD]|NCGC00378942-02|NCGC00378942-05|AC-32724|AS-56097|DA-55098|FL104294|HY-16294|LY2090314?|NS00069302|LY2090314, >=98% (HPLC)|BRD-K78055238-001-01-8|Q27082598|1H-PYRROLE-2,5-DIONE, 3-(9-FLUORO-1,2,3,4-TETRAHYDRO-2-(1-PIPERIDINYLCARBONYL)PYRROLO(3,2,1-JK)(1,4)BENZODIAZEPIN-7-YL)-4-IMIDAZO(1,2-A)PYRIDIN-3-YL-|3-(9-Fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro(1,4)diazepino(6,7,1-hi)indol-7-yl)-4-imidazo(1,2-a)pyridin-3-yl-1H-pyrrole-2,5-dione|3-(9-fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl)-4-(H-imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione|3-[6-fluoro-10-(piperidine-1-carbonyl)-1,10-diazatricyclo[6.4.1.04,13]trideca-2,4,6,8(13)-tetraen-3-yl]-4-imidazo[1,2-a]pyridin-3-yl-pyrrole-2,5-dione|3-[9-fluoro-2-(piperidin-1-ylcarbonyl)-1,2,3,4-tetrahydro[1,4]diazepino[6,7,1-hi]indol-7-yl]-4-(imidazo[1,2-a]pyridin-3-yl)-1H-pyrrole-2,5-dione|3-[9-Fluoro-2-(piperidine-1-carbonyl)-1,2,3,4-tetrahydro-[1,4]diazepino[6,7,1-hi]indol-7-yl]-4-imidazo[1,2-a]pyridin-3-yl-pyrrole-2,5-dione|PYRROLO(3,2,1-JK)(1,4)BENZODIAZEPINE, 7-(2,5-DIHYDRO-4-IMIDAZO(1,2-A)PYRIDIN-3-YL-2,5-DIOXO-1H-PYRROL-3-YL)-9-FLUORO-1,2,3,4-TETRAHYDRO-2-(1-PIPERIDINYLCARBONYL)-"
AZD-1152-HQPA,16007391,,"InChI=1S/C26H30FN7O3/c1-2-34(10-11-35)9-4-12-37-21-7-8-22-23(16-21)28-17-29-26(22)31-24-14-20(32-33-24)15-25(36)30-19-6-3-5-18(27)13-19/h3,5-8,13-14,16-17,35H,2,4,9-12,15H2,1H3,(H,30,36)(H2,28,29,31,32,33)",QYZOGCMHVIGURT-UHFFFAOYSA-N,C26H30FN7O3,507.6,2-[3-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]quinazolin-4-yl]amino]-1H-pyrazol-5-yl]-N-(3-fluorophenyl)acetamide,"722544-51-6|AZD1152-HQPA|barasertib-hQPA|AZD-1152HQPA|defosbarasertib|2-(5-((7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-yl)amino)-1H-pyrazol-3-yl)-N-(3-fluorophenyl)acetamide|INH-34|2-(3-((7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-yl)amino)-1H-pyrazol-5-yl)-N-(3-fluorophenyl)acetamide|AZD-1152 hqpa|29P8LWS24N|AZD2811|AZD-2811|2-[3-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]quinazolin-4-yl]amino]-1H-pyrazol-5-yl]-N-(3-fluorophenyl)acetamide|DTXSID60222584|AZD 2811|2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide|1H-Pyrazole-3-acetamide, 5-((7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)-4-quinazolinyl)amino)-N-(3-fluorophenyl)-|1H-Pyrazole-5-acetamide, 3-((7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)-4-quinazolinyl)amino)-N-(3-fluorophenyl)-|2-{5-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}quinazolin-4-yl)amino]-1H-pyrazol-3-yl}-N-(3-fluorophenyl)acetamide|1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-|RefChem:919762|DTXCID90145075|Barasertib (AZD1152-HQPA)|AZD-1152-HQPA|INH 34|UNII-29P8LWS24N|2-[5-(7-{3-[Ethyl-(2-hydroxy-ethyl)-amino]-propoxy}-quinazolin-4-ylamino)-2H-pyrazol-3-yl]-N-(3-fluoro-phenyl)-acetamide|CHEMBL215152|AZD 2811 [WHO-DD]|1218904-24-5|2-[5-[[7-[3-[ethyl(2-Hydroxyethyl)amino]propoxy]quinazolin-4-Yl]amino]-1h-Pyrazol-3-Yl]-N-(3-Fluorophenyl)ethanamide|AZD1152 HPQA|Barasertib_HQPA|C26H30FN7O3|MFCD10687152|Kinome_3323|AZD1152-HQPA,Barasertib|DEFOSBARASERTIB [INN]|2-(5-(7-(3-(ethyl(2-hydroxyethyl)amino)propoxy)quinazolin-4-ylamino)-1H-pyrazol-3-yl)-N-(3-fluorophenyl)acetamide|MLS006010643|AZD-1152-HPQA?|GTPL5663|orb1305276|pyrazoloquinazoline deriv., 34|SCHEMBL1343965|SCHEMBL10102580|SCHEMBL29399814|SCHEMBL29422988|SCHEMBL29805611|BDBM26300|CHEBI:91367|cid_16007391|QYZOGCMHVIGURT-UHFFFAOYSA-N|BCPP000363|HMS3265M01|HMS3265M02|HMS3265N01|HMS3265N02|HMS3654I10|HMS3740I17|BCP01736|EX-A1803|BDBM50466808|NSC757444|NSC799356|s1147|AKOS025404840|AKOS026750558|BCP9000359|CCG-264836|CS-0163|FB32080|NSC-757444|NSC-799356|SDCCGSBI-0654349.P001|NCGC00263089-02|NCGC00263089-07|1H-Pyrazole-3-acetamide, 5-[[7-[3-[ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fl|AC-30235|BS-17404|HY-10126|SMR004701644|AZD1152-HQPA, >=98% (HPLC)|SW219431-1|EN300-25886121|BRD-K63923597-001-05-0|BRD-K63923597-001-10-0|BRD-K63923597-001-11-8|Q27074868|Z2037280547|2-(5-((7-(3-(ETHYL(2- HYDROXYETHYL)AMINO)PROPOXY)QUINAZOLIN-4-YL)AMINO)- 1H-PYRAZOL-3-YL)-N-(3-FLUOROPHENYL)ACETAMIDE|2-[5-(7-{3-[Ethyl-(2-hydroxy-ethyl)-amino]-propoxy}-quinazolin-4-ylamino)-1H-pyrazol-3-yl]-N-(3-fluoro-phenyl)-acetamide|2-[5-(7-{3-[Ethyl-(2-hydroxy-ethyl)-amino]-propoxy}-quinazolin-4-ylamino)-2H-pyrazol-3-yl]-N-(3-fluoro-phenyl)-acetamide;AZD1152 HQPA|2-{3-[(7-{3-[ethyl(2-hydroxyethyl)amino]propoxy}-quinazolin-4-yl)amino]-1H-pyrazol-5-yl}-N-(3-fluorophenyl)acetamide|AZD1152-HQPA;5-[[7-[3-[Ethyl(2-hydroxyethyl)amino]propoxy]-4-quinazolinyl]amino]-N-(3-fluorophenyl)-1H-pyrazole-3-acetamide;INH 34;A  ZD 1152HQPA|YJA"
BMS-777607,24794418,,"InChI=1S/C25H19ClF2N4O4/c1-2-35-19-10-12-32(16-6-3-14(27)4-7-16)25(34)21(19)24(33)31-15-5-8-18(17(28)13-15)36-20-9-11-30-23(29)22(20)26/h3-13H,2H2,1H3,(H2,29,30)(H,31,33)",VNBRGSXVFBYQNN-UHFFFAOYSA-N,C25H19ClF2N4O4,512.9,N-[4-(2-amino-3-chloropyridin-4-yl)oxy-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide,"BMS-777607|1025720-94-8|BMS 777607|BMS777607|ASLAN-002|N-(4-((2-amino-3-chloropyridin-4-yl)oxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide|ASLAN002|N-[4-(2-amino-3-chloropyridin-4-yl)oxy-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide|A3MMS6HDO1|DTXSID50145278|N-{4-[(2-amino-3-chloropyridin-4-yl)oxy]-3-fluorophenyl}-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide|N-(4-(2-amino-3-chloropyridin-4-yl)oxy-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxopyridine-3-carboxamide|N-[4-[(2-Amino-3-chloropyridin-4-yl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide|RefChem:120741|DTXCID0067769|MET Tyrosine Kinase Inhibitor BMS-777607|110-725-5|1196681-44-3|N-(4-(2-Amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide|3-Pyridinecarboxamide, N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-1,2-dihydro-2-oxo-|MFCD16495773|BMS 817378|3-Pyridinecarboxamide, N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-1,2-dihydro-2-oxo-;3-Pyridinecarboxamide, N-[4-[(2-amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl]-4-ethoxy-1-(4-fluorophenyl)-1,2-dihydro-2-oxo-|N-(4-((2-amino-3-chloropyridin-4-yl)oxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide.|UNII-A3MMS6HDO1|C25H19ClF2N4O4|VNBRGSXVFBYQNN-UHFFFAOYSA-N|3-PYRIDINECARBOXAMIDE, N-(4-((2-AMINO-3-CHLORO-4-PYRIDINYL)OXY)-3-FLUOROPHENYL)-4-ETHOXY-1-(4-FLUOROPHENYL)-1,2-DIHYDRO-2-OXO-|MLS006010958|N-[4-[(2-amino-3-chloro-4-pyridyl)oxy]-3-fluoro-phenyl]-4-ethoxy-1-(4-fluorophenyl)-2-oxo-pyridine-3-carboxamide|N-{4-[(2-Amino-3-chloro-4-pyridinyl)oxy]-3-fluorophenyl}-4-ethoxy -1-(4-fluorophenyl)-2-oxo-1,2-dihydro-3-pyridinecarboxamide|orb322920|CHEMBL460702|GTPL7953|orb1305149|SCHEMBL2588311|SCHEMBL29391695|SCHEMBL29428132|BDBM28031|CHEBI:91409|EX-A004|3f82|HMS3295I07|HMS3655C05|BCP02303|BCP13190|NSC764090|NSC799365|s1561|AKOS026750587|BCP9000432|BMS777607?|CCG-264913|CS-0227|DB12064|EX-7213|FB64961|NSC-764090|NSC-799365|SB16607|SDCCGSBI-0654386.P001|NCGC00263157-01|NCGC00263157-09|AC-30912|AC-31421|AS-17034|DA-35016|HY-12076|SMR004702762|BMS-777607;BMS777607|NS00072431|SW219298-1|BMS-777607, >=98% (HPLC)|BRD-K40738845-001-01-9|BRD-K40738845-001-05-0|Q27075371|N-(4-(2-amino-3-chloropyridin-4-yloxy )-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide"
SGX-523,24779724,,"InChI=1S/C18H13N7S/c1-24-11-13(10-20-24)16-6-7-17-21-22-18(25(17)23-16)26-14-4-5-15-12(9-14)3-2-8-19-15/h2-11H,1H3",BCZUAADEACICHN-UHFFFAOYSA-N,C18H13N7S,359.4,"6-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl]quinoline","SGX-523|1022150-57-7|SGX523|WH8SQN09KJ|CHEBI:90624|6-{[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline|Quinoline, 6-((6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazin-3-yl)thio)-|6-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[5,4-f]pyridazin-3-yl]sulfanyl]quinoline|6-((6-(1-methyl-1H-pyrazol-4-yl)(1,2,4)triazolo(4,3-b)pyridazin-3-yl)sulfanyl)quinoline|6-((6-(1-methylpyrazol-4-yl)-(1,2,4)triazolo(5,4-f)pyridazin-3-yl)sulfanyl)quinoline|6-((6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)sulfanyl)quinoline|6-{[6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline|RefChem:884969|MET TYROSINE KINASE INHIBITOR SGX523|SGX 523|6-(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylthio)quinoline|6-((6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)thio)quinoline|6-[[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl]quinoline|CHEMBL1236107|BDBM50355498|Quinoline, 6-[[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]thio]-;Quinoline, 6-[[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]thio]-|UNII-WH8SQN09KJ|C18H13N7S|3dkf|3dkg|MFCD16660190|1072116-01-8|MLS006010279|GTPL5709|orb1305777|SCHEMBL4496422|SCHEMBL29354539|SCHEMBL30222396|BDBM60589|DTXSID70647300|BCZUAADEACICHN-UHFFFAOYSA-N|GLXC-21110|HMS3295E13|HMS3654I04|BCP01772|EX-A1482|SGX-523?|NSC758591|NSC800884|s1112|AKOS025117577|CCG-264717|CS-0154|DB06314|DB08584|FM32803|NSC-758591|NSC-800884|SB19371|SDCCGSBI-0654344.P001|NCGC00263163-01|NCGC00263163-02|AC-28431|AS-16292|HY-12019|SMR004701349|NS00072376|SW219713-1|BRD-K19477839-001-01-9|BRD-K19477839-001-07-6|Q27088796|Met Kinase Inhibitor VI, SGX523 - CAS 1022150-57-7|6-(6-(1-Methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylthio) quinoline|6-[6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-ylsulfanyl]-quinoline|6-{[6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]sulfanyl}quinoline (4)"
RUXOLITINIB,25126798,,"InChI=1S/C17H18N6/c18-7-5-15(12-3-1-2-4-12)23-10-13(9-22-23)16-14-6-8-19-17(14)21-11-20-16/h6,8-12,15H,1-5H2,(H,19,20,21)/t15-/m1/s1",HFNKQEVNSGCOJV-OAHLLOKOSA-N,C17H18N6,306.4,"(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile","Ruxolitinib|941678-49-5|INCB018424|INCB-018424|INC424|82S8X8XX8H|CHEBI:66919|INCB18424|INC-424|INCB-18424|(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile|DTXSID10240930|(3R)-3-cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile|(3R)-3-cyclopentyl-3-(4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1H-pyrazol-1-yl)propanenitrile|(3R)-3-CYCLOPENTYL-3-(4-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PYRAZOL-1-YL)PROPANENITRILE|1H-Pyrazole-1-propanenitrile, beta-cyclopentyl-4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-,(betaR)-|ruxolitinibum|(3R)-3-cyclopentyl-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)propanenitrile|(3R)-3-cyclopentyl-3-(4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}pyrazol-1-yl)propanenitrile|RefChem:6207|INCA24|DTXCID40163421|L01XE18|Oral JAK Inhibitor INCB18424|3R)-3-cyclopentyl-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)pyrazol-1-yl)propanenitrile|107-728-9|Ruxolitinib (INCB018424)|(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile|MFCD12031592|(R)-3-(4-(7H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-3-cyclopentylpropanenitrile (Synonyms:Ruxolitinib)|C17H18N6|(R)-Ruxolitinib (>90%)|R-Ruxolitinib|(betaR)-beta-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile|Ruxolitinib [INN]|Ruxolitinib [USAN:INN]|UNII-82S8X8XX8H|INC 424|(ssR)-ss-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile; (3R)-3-Cyclopentyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]propanenitrile; (ssR)-ss-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile; INC 424; INCB 018424; Ruxolitinib|RXT|Ruxolitinib (Standard)|RUXOLITINIB [MI]|Ruxolitinib (USAN/INN)|INCB18424,Ruxolitinib|RUXOLITINIB [USAN]|RUXOLITINIB [VANDF]|RUXOLITINIB [WHO-DD]|SCHEMBL171319|GTPL5688|orb1307364|CHEMBL1789941|SCHEMBL16546708|SCHEMBL29349794|HSDB 8259|HFNKQEVNSGCOJV-OAHLLOKOSA-N|HMS6018A14|EX-A1670|BDBM50355501|HY-50856R|NSC763371|NSC800874|s1378|AKOS016842401|BCP9000784|CCG-264889|CS-0864|DB08877|FR27771|NSC-763371|NSC-800874|SDCCGSBI-0654261.P002|NCGC00244253-01|NCGC00244253-02|NCGC00244253-11|NCGC00244253-12|NCGC00244253-23|AC-24280|AC-38227|AS-18619|BP-44052|HY-50856|D09959|AB01565782_02|EN300-18772174|Q7383611|BRD-K53972329-001-02-1|BRD-K53972329-001-03-9|BRD-K53972329-001-07-0|(3R)-3-cyclopentyl-3-[4-(1H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]propanenitrile|(R)-3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H -pyrazol-1-yl)-3-cyclopentylpropanenitrile|3-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(beta-R)-1H-pyrazole-1-propanenitrile|A-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-(AR)-1H-pyrazole-1-propanenitrile|(?-R)-?-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile;INCB 018424|1H-PYRAZOLE-1-PROPANENITRILE, .BETA.-CYCLOPENTYL-4-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)-, (.BETA.R)-"
SGI-1776,24795070,,"InChI=1S/C20H22F3N5O/c1-27-9-7-14(8-10-27)12-24-18-5-6-19-25-13-17(28(19)26-18)15-3-2-4-16(11-15)29-20(21,22)23/h2-6,11,13-14H,7-10,12H2,1H3,(H,24,26)",MHXGEROHKGDZGO-UHFFFAOYSA-N,C20H22F3N5O,405.4,"N-[(1-methylpiperidin-4-yl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine","SGI-1776|1025065-69-3|SGI-1776 free base|N-[(1-methylpiperidin-4-yl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine|N-((1-methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo[1,2-b]pyridazin-6-amine|MFCD16659064|Imidazo[1,2-b]pyridazin-6-amine, N-[(1-methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]-|CHEMBL1952329|72AUA0603W|N-[(1-Methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]-imidazo[1,2-b]pyridazin-6-amine|N-[(1-methyl-4-piperidyl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine|CHEMBL1952141|Imidazo(1,2-b)pyridazin-6-amine, N-((1-methyl-4-piperidinyl)methyl)-3-(3-(trifluoromethoxy)phenyl)-|Imidazo[1,2-b]pyridazin-6-amine, N-[(1-methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]-;Imidazo[1,2-b]pyridazin-6-amine, N-[(1-methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]-|N-((1-Methylpiperidin-4-yl)methyl)-3-(3-(trifluoromethoxy)phenyl)imidazo(1,2-b)pyridazin-6-amine|C20H22F3N5O|MHXGEROHKGDZGO-UHFFFAOYSA-N|SGI 1776 free base|MLS006011076|SCHEMBL102498|UNII-72AUA0603W|GTPL8784|orb1304563|SCHEMBL29353896|CHEBI:95061|DTXSID10647329|GLXC-04468|HMS3655P08|HMS3672I15|HMS3747C17|BCP02279|EX-A1373|SGI 1776;SGI1776|BDBM50364776|NSC757333|NSC800883|s2198|SGI-1776?|AKOS026750649|CCG-264941|CS-0513|DB12494|FM43363|NSC-757333|NSC-800883|SB19298|NCGC00263186-01|NCGC00263186-02|NCGC00263186-11|AC-28432|AS-16326|HY-13287|N-[(1-Methyl-4-piperidinyl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[1,2-b]pyridazin-6-amine|SMR004702864|SY387356|DB-058820|NS00072905|SW218133-2|BRD-K80700417-001-04-2|Q27088795|N-[(1-methylpiperidin-4-yl)methyl]-3-[3-(trifluoromethoxy)phenyl]imidazo[2,1-f]pyridazin-6-amine"
PF-03758309,25227462,,"InChI=1S/C25H30N8OS/c1-15-26-18-11-12-35-20(18)23(27-15)29-22-17-13-33(25(2,3)21(17)30-31-22)24(34)28-19(14-32(4)5)16-9-7-6-8-10-16/h6-12,19H,13-14H2,1-5H3,(H,28,34)(H2,26,27,29,30,31)/t19-/m1/s1",AYCPARAPKDAOEN-LJQANCHMSA-N,C25H30N8OS,490.6,"N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide","PF-3758309|898044-15-0|PF-03758309|PK459EA5I2|example 114 [US8530652]|N-((1S)-2-(Dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno(3,2-d)pyrimidin-4-yl)amino)-4,6-dihydropyrrolo(3,4-C)pyrazole-5(1H)-carboxamide|PF3758309|N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide|compound 1 [PMID: 24432870]|example 114 (US8530652)|compound 1 (PMID: 24432870)|PF 3758309|N-((1S)-2-(dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno(3,2-d)pyrimidin-4-yl)amino)-1,4-dihydropyrrolo(3,4-c)pyrazole-5-carboxamide|n-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1h)-carboxamide|RefChem:860475|N-((1S)-2-(dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno(3,2-d)pyrimidin-4-yl)amino)-1H,4H,5H,6H-pyrrolo(3,4-c)pyrazole-5-carboxamide|N-[(1S)-2-(dimethylamino)-1-phenylethyl]-6,6-dimethyl-3-({2-methylthieno[3,2-d]pyrimidin-4-yl}amino)-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazole-5-carboxamide|(S)-N-(2-(dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno[3,2-d]pyrimidin-4-yl)amino)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxamide|MFCD18633226|CHEMBL3128043|898044-15-0 (free base)|(S)-N-(2-(DIMETHYLAMINO)-1-PHENYLETHYL)-6,6-DIMETHYL-3-((2-METHYLTHIENO[3,2-D]PYRIMIDIN-4-YL)AMINO)-4,6-DIHYDROPYRROLO[3,4-C]PYRAZOLE-5(1H)-CARBOXAMIDE.|US8530652, 114|UNII-PK459EA5I2|C25H30N8OS|7KC|GTPL8937|orb1300605|SCHEMBL1369342|CHEBI:93751|DTXSID70649389|EX-A849|BDBM101536|BDBM101618|BCP08233|Pyrrolo[3,4-c]pyrazole-5(1H)-carboxaMide, N-[(1S)-2-(diMethylaMino)-1-phenylethyl]-4,6-dihydro-6,6-diMethyl-3-[(2-Methylthieno[3,2-d]pyriMidin-4-yl)aMino]-|YKB04415|NSC781470|NSC800847|s7094|AKOS027422746|CCG-269617|CS-0773|DB11775|NSC-781470|NSC-800847|NCGC00345784-01|NCGC00345784-03|NCGC00345784-05|(S)-N-(2-(Dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno[3,2-d]pyrimidin-4-yl)amino)-|AC-33020|AS-56208|HY-13007|NS00072558|SW219931-1|PF03758309 pound>>PF 03758309|PF 3758309; PF3758309|PF-3758309;cas:898044-15-0|BRD-K37764012-001-04-1|Q27088331|(S)-N-(2-(Dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-((2-methylthieno[3,2-d]pyrimidin-4-yl)amino)-2,6-dihydropyrrolo[3,4-c]pyrazole-5(4H)-carboxamide|(S)-N-(2-(Dimethylamino)-1-phenylethyl)-6,6-dimethyl-3-(2-methylthieno[3,2-d]pyrimidin-4-ylamino)-4,6-dihydropyrrolo[3,4-c]pyrazole-5(1H)-carboxamide|1279200-38-2|N-[(1S)-2-(dimethylamino)-1-phenyl-ethyl]-6,6-dimethyl-3-[(2-methylthieno[3,2-d]pyrimidin-4-yl)amino]-1,4-dihydropyrrolo[3,4-c]pyrazole-5-carboxamide"
BI-2536,11364421,,"InChI=1S/C28H39N7O3/c1-5-22-27(37)34(3)23-17-29-28(32-25(23)35(22)20-8-6-7-9-20)31-21-11-10-18(16-24(21)38-4)26(36)30-19-12-14-33(2)15-13-19/h10-11,16-17,19-20,22H,5-9,12-15H2,1-4H3,(H,30,36)(H,29,31,32)/t22-/m1/s1",XQVVPGYIWAGRNI-JOCHJYFZSA-N,C28H39N7O3,521.7,4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide,"BI 2536|755038-02-9|BI-2536|BI2536|4LJG22T9C6|DTXSID20226442|Benzamide, 4-(((7R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl)amino)-3-methoxy-N-(1-methyl-4-piperidinyl)-|RefChem:568032|Plk1 Inhibitor BI 2536|DTXCID20148933|(R)-4-((8-cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide|MFCD10565924|UNII-4LJG22T9C6|4-{[(7r)-8-Cyclopentyl-7-Ethyl-5-Methyl-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxy-N-(1-Methylpiperidin-4-Yl)benzamide|(R)-BI-2536|CHEMBL513909|4-{[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino}-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide|4-[[(7R)-8-CYCLOPENTYL-7-ETHYL-5,6,7,8-TETRAHYDRO-5-METHYL-6-OXO-2-PTERIDINYL]AMINO]-3-METHOXY-N-(1-METHYL-4-PIPERIDINYL)BENZAMIDE|4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methyl-4-piperidyl)benzamide|4-[[(7R)-8-cyclopentyl-7-ethyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide|US8598172, 5|XQVVPGYIWAGRNI-JOCHJYFZSA-N|C28H39N7O3|(R)-4-((8-CYCLOPENTYL-7-ETHYL-5,6,7,8-TETRAHYDRO-5-METHYL-6-OXO-2-PTERIDINYL)AMINO)-3-METHOXY-N-(1-METHYL-4-PIPERIDINYL)BENZAMIDE|(R)-4-[(8-Cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxo-2-pteridinyl)amino]-3-methoxy-N-(1-methyl-4-piperidinyl)benzamide|R78|MLS006011060|SCHEMBL372489|GTPL5666|orb1301011|SCHEMBL29395966|BDBM25121|CHEBI:49868|BI 2536 [WHO-DD]|BCPP000342|EX-A2350|FFB03802|NSC755983|NSC799359|s1109|AKOS022179331|BCP9000402|CCG-264824|CS-0071|EX-8611|NSC-755983|NSC-799359|SDCCGSBI-0654342.P001|NCGC00253438-01|AC-32625|AS-16191|BP-23384|HY-50698|SMR004702852|SY105304|SW218289-2|038B029|EN300-18167228|BRD-K64890080-001-01-3|BRD-K64890080-001-13-8|Q27075215|((R)-4-[(8-Cyclopentyl-7-Et-5,6,7,8-tetrahydro-5-Me-6-oxo-2-pteridinyl)amino]-3-methoxy-N-(1-Me-4-piperidinyl)benzamide|(R)-4-[(8-Cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydro-2-pteridinyl)amino]-3-methoxy-N-(1-methyl-4-piperidyl)benzamide|4-((R)-8-cyclopentyl-7-ethyl-5,6,7,8-tetrahydro-5-methyl-6-oxopteridin-2-ylamino)-3-methoxy-N-(1-methylpiperidin-4-yl)benzamide|4-((R)-8-Cyclopentyl-7-ethyl-5-methyl-6-oxo-5,6,7,8-tetrahydro-pteridin-2-ylamino)-3-methoxy-N-(1-methyl-piperidin-4-yl)-benzamide"
CABOZANTINIB,25102847,,"InChI=1S/C28H24FN3O5/c1-35-24-15-21-22(16-25(24)36-2)30-14-11-23(21)37-20-9-7-19(8-10-20)32-27(34)28(12-13-28)26(33)31-18-5-3-17(29)4-6-18/h3-11,14-16H,12-13H2,1-2H3,(H,31,33)(H,32,34)",ONIQOQHATWINJY-UHFFFAOYSA-N,C28H24FN3O5,501.5,"1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide","Cabozantinib|849217-68-1|XL-184|XL 184|BMS-907351|XL-184 free base|BMS 907351|CHEBI:72317|XL184 cpd|BMS907351|N-(4-((6,7-Dimethoxyquinolin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|1C39JW444G|BMS-907351 FREE BASE|DTXSID10233968|1,1-Cyclopropanedicarboxamide, N'-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-|N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|cabozantinibum|1,1-CYCLOPROPANEDICARBOXAMIDE, N'-(4-((6,7-DIMETHOXY-4-QUINOLINYL)OXY)PHENYL)-N-(4-FLUOROPHENYL)-|N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|N-[4-[(6,7-Dimethoxyquinolin-4-yl)oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|RefChem:57604|DTXCID40156459|L01XE26|XL184|Cometriq|Cabozantinib (XL184, BMS-907351)|MFCD20926324|Cabozantinib [USAN]|N'-[4-[(6,7-DIMETHOXY-4-QUINOLINYL)OXY]PHENYL]-N-(4-FLUOROPHENYL)-1,1-CYCLOPROPANEDICARBOXAMIDE|1-N-[4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-1-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|Cabozantinib (USAN)|Cabometyx (TN)|Cometriq (TN)|n-(4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-n'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide|N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide|N1-[4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-N1'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|Cabozantinib [USAN:INN]|Carbozantinib|UNII-1C39JW444G|Cabozantinib; N'-?[4-?[(6,?7-?Dimethoxy-?4-?quinolinyl)?oxy]?phenyl]?-?N-?(4-?fluorophenyl)?-1,?1-cyclopropanedicarbox?amide; N'-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; BMS 907351; N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide|Cabozantinib (Standard)|Cabozantinib (free base)|CABOZANTINIB [MI]|Cabozantinib (XL-184)|CABOZANTINIB [INN]|CABOZANTINIB [VANDF]|CABOZANTINIB [WHO-DD]|SCHEMBL360795|GTPL5887|orb1305297|Cabozantinib (BMS-907351)|CHEMBL2105717|SCHEMBL29351408|EX-A075|BCPP000308|HMS3654G06|HMS5079K09|XL-184 free base (Cabozantinib)|BCP02591|849217-68-1 (free base)|BDBM50021574|HY-13016R|NSC761068|NSC800066|s1119|AKOS025142112|BCP9000470|CCG-264678|CS-0278|DB08875|FD59688|NSC-761068|NSC-800066|SB20062|SDCCGSBI-0646928.P001|XL-184 (Cabozantinib,BMS907351)|XL-184,Cabozantinib, BMS-907351|NCGC00263164-01|NCGC00263164-14|NCGC00263164-17|AC-25082|AS-16277|BP-43629|HY-13016|N-{4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1- dicarboxamide|SY097158|XL-184 (Cabozantinib,BMS907351)?|DB-023624|NS00020240|SW218093-3|D10062|AB01565831_02|Q795057|SR-01000941569|SR-01000941569-1|BRD-K51544265-001-01-8|BRD-K51544265-001-04-2|BRD-K51544265-001-06-7|1,1-Cyclopropanedicarboxamide, N'-(4-((6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N-(4- fluorophenyl)-|1,1-Cyclopropanedicarboxamide, N-[4-[(6,7-dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-|cyclopropane-1,1-dicarboxylic acid [4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide(4-fluoro-phenyl)-amide|cyclopropane-1,1-dicarboxylic acid[4-(6,7-dimethoxy-quinoline-4-yloxy)-phenyl]-amide (4-fluoro-phenyl)-amide|N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4 fluorophenyl)cyclopropane-1,1-dicarboxamide|N-(4-{[6,7-bis(methyloxy)quinolin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|N-[4-[(6,7-Dimethoxy-4-quinolinyl)oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide;Cabozantinib"
CETIRIZINE,2678,,"InChI=1S/C21H25ClN2O3/c22-19-8-6-18(7-9-19)21(17-4-2-1-3-5-17)24-12-10-23(11-13-24)14-15-27-16-20(25)26/h1-9,21H,10-16H2,(H,25,26)",ZKLPARSLTMPFCP-UHFFFAOYSA-N,C21H25ClN2O3,388.9,2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid,"cetirizine|83881-51-0|Virlix|Cetirizina|Cetryn|Ziptek|Setir|Cetirizinum|Cetirizin|Hitrizin Film Tablet|Cetiderm|Reactine|2-(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid|CHEBI:3561|YO7261ME24|2-[2-[4-[(4-chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid|(2-(4-((4-Chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)acetic acid|DTXSID4022787|2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)acetic acid|Acetic acid, (2-(4-((4-chlorophenyl)phenylmethyl)-1-piperazinyl)ethoxy)-|Acetic acid, [2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-|[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid|2-(2-(4-((4-chlorophenyl)-phenylmethyl)piperazin-1-yl)ethoxy)acetic acid|RefChem:5658|DTXCID802787|R06AE07|Zirtek|2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid dihydrichloride|Cetirizine (INN)|AC-170|CHEMBL1000|Cetirizinum [Latin]|Cetirizina [Spanish]|Alerlisin|Zyrlex|CETIRIZINE [INN]|(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethoxy)acetic acid|Cetirizine [INN:BAN]|Xarlin|Cetiderm (TN)|irizine|(R)-Cetirizine (dihydrochloride)|Benaday|Cetrizine|Humex|UNII-YO7261ME24|HSDB 7739|MFCD00800721|1219803-84-5|774596-22-4|Cetirizine (Standard)|CETIRIZINE [MI]|Prestwick0_000503|Prestwick1_000503|Prestwick2_000503|Prestwick3_000503|CETIRIZINE [HSDB]|CETIRIZINE [VANDF]|SCHEMBL4176|TimTec1_002075|CETIRIZINE [WHO-DD]|BSPBio_000425|BSPBio_002302|orb611889|SPBio_002346|BPBio1_000469|GTPL1222|BDBM22890|HMS1539O07|HMS3259D06|HMS3370I19|HMS3393N10|HMS5087A07|BCP08787|BCP28477|IDA88151|IVB21023|BBL009968|Cet83881-51-0|HY-17042R|STK711108|[(2-{4-[(4-chlorophenyl)(phenyl)methyl]piperazin-1-yl}ethyl)oxy]acetic acid|2-[2-[4-[(4-chlorophenyl)-phenyl-methyl]piperazin-1-yl]ethoxy]acetic acid|2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]acetic acid|Acetic acid, 2-[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]ethoxy]-|AKOS003589059|AKOS021729457|AC-5545|CS-0886|DB00341|NC00696|SDCCGSBI-0206838.P002|NCGC00167781-01|NCGC00167781-02|NCGC00167781-03|NCGC00167781-04|NCGC00167781-07|NCGC00167781-12|NCGC00167781-18|AS-77105|HY-17042|ST024755|SBI-0206838.P001|DB-049948|NS00000386|EN300-52521|81C510|C07778|D07662|E75781|L000655|Q423075|BRD-A42571354-300-05-4|BRD-A42571354-300-07-0|BRD-A42571354-300-11-2|BRD-A42571354-300-12-0|BRD-A42571354-300-13-8|Z754931270|[2-[4-[(4-Chlorophenyl)-phenyl methyl]-1-piperazinyl] ethoxy] acetic acid|[2-[4-[(4-chlorophenyl)phenylmethyl] 1-piperazinyl]-ethoxy] acetic acid|[2-[4-[(4-chlorophenyl)phenylmethyl]-1-piperazinyl]-ethoxy]acetic acid|2-(2-(4-((4-Chlorophenyl)(phenyl)methyl)piperazin-1-yl)ethoxy)aceticacid|2-(2-{4-[(4-chlorophenyl)phenylmethyl]piperazinyl}ethoxy)acetic acid|(+/-)-(2-(4-(P-CHLORO-A-PHENYLBENZYL)-1-PIPERAZINYL)ETHOXY)ACETIC ACID|ACETIC ACID, (2-(4-((4-CHLOROPHENYL)PHENYLMETHYL)-1-PIPERAZINYL)ETHOXY)-, (+/-)-"
ADRIFORANT,24745335,,"InChI=1S/C13H22N6/c1-15-10-4-5-19(8-10)12-6-11(17-13(14)18-12)16-7-9-2-3-9/h6,9-10,15H,2-5,7-8H2,1H3,(H3,14,16,17,18)/t10-/m1/s1",ISBHYKVAFKTATD-SNVBAGLBSA-N,C13H22N6,262.35,"4-N-(cyclopropylmethyl)-6-[(3R)-3-(methylamino)pyrrolidin-1-yl]pyrimidine-2,4-diamine","Adriforant|PF-3893787|943057-12-3|ZPL-389|NVP-ZPL389-NX|ZPL-3893787|ZPL389-NX|D65H9YE9VU|PF-03893787|ZPL-389-NX|2,4-Pyrimidinediamine, N4-(cyclopropylmethyl)-6-((3R)-3-(methylamino)-1-pyrrolidinyl)-|adriforantum|N'-(cyclopropylmethyl)-6-((3R)-3-methylaminopyrrolidin-1-yl)pyrimidine-2,4-diamine|N'-(cyclopropylmethyl)-6-[(3R)-3-methylaminopyrrolidin-1-yl]pyrimidine-2,4-diamine|n4-(cyclopropylmethyl)-6-[(3r)-3-(methylamino)pyrrolidin-1-yl]pyrimidine-2,4-diamine|N4-(CYCLOPROPYLMETHYL)-6-((3R)-3-(METHYLAMINO)PYRROLIDIN-1-YL)PYRIMIDINE-2,4-DIAMINE|RefChem:109842|Adriforant [USAN]|UNII-D65H9YE9VU|CHEMBL1915540|WHO 10855|4-N-(cyclopropylmethyl)-6-[(3R)-3-(methylamino)pyrrolidin-1-yl]pyrimidine-2,4-diamine|(R)-N4-(cyclopropylmethyl)-6-(3-(methylamino)pyrrolidin-1-yl)pyrimidine-2,4-diamine|ADRIFORANT [INN]|ADRIFORANT [WHO-DD]|GTPL8985|orb1741200|ZPL389|SCHEMBL12604990|GLXC-15701|BCP23584|EX-A7358|BDBM50356884|DB15027|ZPL-389378|ZPL3893787|PF 3893787|Q27089302"
CERONAPRIL,189729,,"InChI=1S/C21H33N2O6P/c22-14-6-4-13-19(20(24)23-15-8-12-18(23)21(25)26)29-30(27,28)16-7-5-11-17-9-2-1-3-10-17/h1-3,9-10,18-19H,4-8,11-16,22H2,(H,25,26)(H,27,28)/t18-,19-/m0/s1",IFYLTXNCFVRALQ-OALUTQOASA-N,C21H33N2O6P,440.5,(2S)-1-[(2S)-6-amino-2-[hydroxy(4-phenylbutyl)phosphoryl]oxyhexanoyl]pyrrolidine-2-carboxylic acid,"CERONAPRIL|111223-26-8|SQ-29852|Ceronaprilum|Ceranapril|X3MM60SOVP|SQ 29,852|DTXSID80891418|1-(6-amino-2-((hydroxy(4-phenylbutyl)phosphinyl)oxy)-1-oxohexyl)proline|L-Proline, 1-(6-amino-2-((hydroxy(4-phenylbutyl)phosphinyl)oxy)-1-oxohexyl)-, (S)-|SQ-29,852|RefChem:918270|DTXCID801030535|120122-26-1|(2S)-1-[(2S)-6-amino-2-[hydroxy(4-phenylbutyl)phosphoryl]oxyhexanoyl]pyrrolidine-2-carboxylic acid|CHEMBL36503|Novopril|((2S)-6-amino-2-((hydroxy(4-phenylbutyl)phosphoryl)oxy)hexanoyl)-L-proline|Ceronapril; SQ 29852|Ceronapril [USAN:INN]|UNII-X3MM60SOVP|428863-50-7|Ceronaprilum [INN-Latin]|SQ 29852|1-[(2s)-6-amino-2-{[hydroxy(4-phenylbutyl)phosphoryl]oxy}hexanoyl]-l-proline|BRN 3635091|SQ29,852|CERONAPRIL [MI]|CERONAPRIL [INN]|CERONAPRIL [JAN]|Ceronapril (USAN/INN)|CERONAPRIL [USAN]|CERONAPRIL [MART.]|CERONAPRIL [WHO-DD]|SCHEMBL121163|SCHEMBL121164|CHEBI:177391|BDBM50405594|AKOS040746686|(S)-1-(6-Amino-2-((hydroxy(4-phenylbutyl)phosphinyl)oxy)-1-oxohexyl)-L-proline|1-((2S)-6-Amino-2-hydroxyhexanoyl)-L-proline, hydrogen (4-phenylbutyl)phosphonate (ester)|DA-72097|DB-344620|HY-106816|CS-0026611|D03440|Q27293516|(2S)-1-((2s)-6-amino-2-((hydroxy(4-phenylbutyl)phosphoryl)oxy)hexanoyl)pyrrolidine-2-carboxylic acid"
ENALAPRILAT ANHYDROUS,5462501,,"InChI=1S/C18H24N2O5/c1-12(16(21)20-11-5-8-15(20)18(24)25)19-14(17(22)23)10-9-13-6-3-2-4-7-13/h2-4,6-7,12,14-15,19H,5,8-11H2,1H3,(H,22,23)(H,24,25)/t12-,14-,15-/m0/s1",LZFZMUMEGBBDTC-QEJZJMRPSA-N,C18H24N2O5,348.4,(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid,"Enalaprilat|76420-72-9|Enalaprilate|Enalaprilatum|Enalaprilat anhydrous|Enalapril diacid|enalaprilat (anhydrous)|N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-L-proline|CHEBI:4786|Q508Q118JM|MK 422|N-(1(S)-Carboxy-3-phenylpropyl)-L-alanyl-L-proline|NSC-760053|(2S)-1-[(2S)-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid|L-Proline, N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl-|L-Proline, N-[(1S)-1-carboxy-3-phenylpropyl]-L-alanyl-|CHEBI:59877|Enalapril diacid dihydrate anhydrous|N-((1S)-1-carboxy-3-phenylpropyl)-L-alanyl-L-proline|(2S)-1-((2S)-2-(((2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid|RefChem:136738|MK422|278-459-3|Enalapril diacid dihydrate|GV0O7ES0R3|Vasotec i.v.|Enalapril acid|Enalaprilic acid|(S)-1-((S)-2-(((S)-1-Carboxy-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylic acid|MFCD00865786|Enalaprilat [INN]|DTXSID0048975|MK-422|Enalaprilat hydrate|1-((2S)-2-{[(1S)-1-CARBOXY-3-PHENYLPROPYL]AMINO}PROPANOYL)-L-PROLINE|((S)-1-carboxy-3-phenylpropyl)-L-alanyl-L-proline|EAL|DTXCID301265905|ENALAPRILAT INHIBITOR|(2S)-1-[(2S)-2-[[(1S)-1-CARBOXY-3-PHENYL-PROPYL]AMINO]PROPANOYL]PYRROLIDINE-2-CARBOXYLIC ACID|(2S)-1-[(2S)-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}propanoyl]pyrrolidine-2-carboxylic acid|SMR000466359|CAS-76420-72-9|enalaprilat [Spanish]|MK 421 diacid|CHEMBL577|Enalaprilate [French]|Enalaprilatum [Latin]|UNII-Q508Q118JM|NCGC00183129-01|(2S)-1-((2S)-2-(((1S)-1-CARBOXY-3-PHENYLPROPYL)AMINO)PROPANOYL)PYRROLIDINE-2-CARBOXYLIC ACID|(2S)-1-[(2S)-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic acid|EINECS 278-459-3|Enalaprilate; Enalaprilic acid; MK 421 diacid|SCHEMBL37289|MLS000759476|MLS001424138|BIDD:GT0752|GTPL6332|orb1908989|Enalaprilat, analytical standard|HY-B0231A|HMS2051H16|HMS2089P04|HMS2232B19|HMS3263O13|Pharmakon1600-01503833|Tox21_113430|Tox21_501036|BDBM50367254|NSC760053|AKOS015840130|AKOS015892570|Tox21_113430_1|CCG-101042|DB09477|LP01036|NC00292|SDCCGSBI-0633781.P001|NCGC00164593-01|NCGC00164593-02|NCGC00164593-11|NCGC00261721-01|(2S)-1-[(2S)-2-[[(1S)-1-Carboxy-3-phenylpropyl]amino]propanoyl]pyrrolidine-2-carboxylic Acid (Enalaprilat)|AS-13013|BP-41163|CS-0012359|E1302|NS00015409|EN300-123964|AB00698268-05|AB00698268-07|AB00698268-08|AB00698268_09|AB00698268_10|ENALAPRIL DIACID DIHYDRATE ANHYDROUS [MI]|420E729|ENALAPRIL MALEATE IMPURITY C [EP IMPURITY]|SR-01000763426|Q5375179|SR-01000763426-3|BRD-K99447003-335-02-5|BRD-K99447003-335-03-3|BRD-K99447003-335-04-1|BRD-K99447003-335-05-8|N-[(s)-1-carboxy-3-phenyl-propyl]-l-alanyl-l-proline|1-(N-((S)-1-CARBOXY-3-PHENYLPROPYL)-L-ALANYL)-L-PROLINE|L-Proline, 1-(N-(1-carboxt-3-phenylpropyl)-L-alanyl)-, (S)-|L-PROLINE, 1-(N-(1-CARBOXY-3-PHENYLPROPYL)-L-ALANYL)-, (S)-|(S)-1-((S)-2-(((S)-1-Carboxy-3-phenylpropyl)amino)propanoyl)pyrrolidine-2-carboxylicacid"
CAPTOPRIL,44093,,"InChI=1S/C9H15NO3S/c1-6(5-14)8(11)10-4-2-3-7(10)9(12)13/h6-7,14H,2-5H2,1H3,(H,12,13)/t6-,7+/m1/s1",FAKRSMQSSFJEIM-RQJHMYQMSA-N,C9H15NO3S,217.29,(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid,"captopril|62571-86-2|Capoten|L-Captopril|Captopryl|Cesplon|Garranil|Acepress|Captolane|Captoril|Tensoprel|Dilabar|Hypertil|Tenosbon|Alopresin|Captoprilum|Acepril|Apopril|Lopril|Acediur|Aceplus|Farcopril|Hypopress|Tensiomin|Tensobon|Zapto|(2S)-1-[(2S)-2-methyl-3-sulfanylpropanoyl]pyrrolidine-2-carboxylic acid|SQ-14225|D-2-Methyl-3-mercaptopropanoyl-L-proline|SQ 14225|D-3-Mercapto-2-methylpropanoyl-L-proline|SQ 14,225|Captomax|Mepha|1-((2S)-3-Mercapto-2-methylpropionyl)-L-proline|Lopirin [Switzerland]|D-3-Mercapto-2-methylpropionylproline|(2S)-1-(3-Mercapto-2-methylpropionyl)-L-proline|3-Mercapto-2-methylpropionyl-proline|CHEBI:3380|DTXSID1037197|L-Proline, 1-[(2S)-3-mercapto-2-methyl-1-oxopropyl]-|1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline|9G64RSX1XD|NSC-757419|C09AA01|1-(D-3-Mercapto-2-methyl-1-oxopropyl)-L-proline (S,S)|SA-333|SQ14534|L-Proline, 1-((2S)-3-mercapto-2-methyl-1-oxopropyl)-|DTXCID9017197|(S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline|[2S]-1-[3-Mercapto-2-methylpropionyl]-L-proline|1-Pyrrolidinecarboxylic acid, 1-(D-3-mercapto-2-methyl-1-propionyl)-, L-(S,S)-|Lopirin (Switzerland)|(2S)-1-((2S)-2-methyl-3-sulfanylpropanoyl)pyrrolidine-2-carboxylic acid|1-[(2s)-3-mercapto-2-methylpropionyl]-l-proline|SQ14225|Captomex|Ecopace|Kaplon|Noyada|Hyteneze 25|Hyteneze 50|CAPTORPIL|Hyteneze 12.5|RefChem:5644|SQ14,225|SQ14,534|SQ 14,534|NSC719847|263-607-1|Lopirin|Captoprilum [INN-Latin]|SA 333|MFCD00168073|Hipertil|1-[(2S)-2-methyl-3-sulfanylpropanoyl]-L-proline|(S)-1-((S)-3-mercapto-2-methylpropanoyl)pyrrolidine-2-carboxylic acid|L-Proline, 1-(3-mercapto-2-methyl-1-oxopropyl)-, (S)-|CHEMBL1560|1-[(2S)-3-Mercapto-2-methyl-1-oxopropyl]-L-proline|MLS000069484|Asisten|Isopresol|(-)-Captopril|NCGC00023654-04|SMR000059061|SQ -14225|Novocaptopril|Captril|Captopril (Capoten)|Capozide (Salt/Mix)|X8Z|Apopril (TN)|Capoten (TN)|HSDB 6527|SR-01000075603|EINECS 263-607-1|UNII-9G64RSX1XD|component of Captea (Salt/Mix)|component of Acezide (Salt/Mix)|component of Ecazide (Salt/Mix)|Prestwick_103|Capoten;L-Captopril|Captopril (Standard)|Captopril [USAN:USP:INN:BAN:JAN]|SCHEMBL4|Spectrum_000688|CAPTOPRIL [INN]|CAPTOPRIL [JAN]|CAPTOPRIL [MI]|CAPTOPRIL [HSDB]|CAPTOPRIL [USAN]|Opera_ID_1041|Prestwick3_000019|Spectrum2_001211|Spectrum3_001388|Spectrum4_000811|Spectrum5_001587|CAPTOPRIL [VANDF]|Lopac-C-4042|1-((2S)-2-Methyl-3-sulfanylpropanoyl)-L-proline #|CAPTOPRIL [MART.]|Epitope ID:114065|UPCMLD-DP003|C 4042|CAPTOPRIL [USP-RS]|CAPTOPRIL [WHO-DD]|CAPTOPRIL [WHO-IP]|Lopac0_000302|N-[(S)-3-Mercapto-2-methylpropionyl]-L-proline|BSPBio_000057|BSPBio_002976|KBioGR_001321|KBioSS_001168|MLS001076488|DivK1c_000208|SPECTRUM1500682|SPBio_001022|Captopril (JP18/USP/INN)|(S)-1-(3-Mercapto-2-methyl-1-oxo-propyl)-L-proline|BPBio1_000063|GTPL5158|orb1308556|CAPTOPRIL [ORANGE BOOK]|Captopril for system suitability|CAPTOPRIL [EP MONOGRAPH]|CAPTOPRIL [USP IMPURITY]|UPCMLD-DP003:001|BDBM21642|HMS500K10|HY-B0368R|KBio1_000208|KBio2_001168|KBio2_003736|KBio2_006304|KBio3_002196|CAPTOPRIL [USP MONOGRAPH]|1j37|NINDS_000208|HMS1921C12|HMS2089P19|HMS2092I12|HMS2095C19|HMS2233I04|HMS3259G10|HMS3260N06|HMS3712C19|Pharmakon1600-01500682|CAPTOPRILUM [WHO-IP LATIN]|ALBB-038657|HY-B0368|MSK10103|Tox21_110890|Tox21_500302|BBL033600|CCG-39104|EI-213|HB3636|NSC757419|s2051|SBB017523|STK802012|AKOS005622581|Captopril, >=98% (HPLC), powder|Tox21_110890_1|BCP9000485|CS-2425|DB01197|FC19675|KS-5025|LP00302|NC00554|NSC 757419|SDCCGSBI-0050290.P006|IDI1_000208|SMP1_000056|NCGC00015235-01|NCGC00015235-02|NCGC00023654-03|NCGC00023654-05|NCGC00023654-06|NCGC00023654-07|NCGC00023654-08|NCGC00023654-09|NCGC00023654-10|NCGC00023654-11|NCGC00023654-13|NCGC00023654-25|NCGC00023654-26|NCGC00260987-01|AC-12047|AC-32120|ST079562|SY057979|SBI-0050290.P004|Captopril, meets USP testing specifications|EU-0100302|NS00008201|BIM-0050290.0001|C06867|D00251|EN300-118718|AB00052156-16|AB00052156_17|AB00052156_18|571C862|F358072|Q421119|SR-01000000039|SR-01000000039-2|SR-01000075603-1|SR-01000075603-3|1-[(S)-3-mercapto-2-methyl-1-oxopropyl]-L-proline|BRD-K54529596-001-04-0|BRD-K54529596-001-15-6|BRD-K54529596-001-25-5|BRD-K54529596-001-26-3|1-[(2S)-2-Methyl-3-mercapto-1-oxopropyl]-L-proline|Captopril, British Pharmacopoeia (BP) Reference Standard|Z1269124804|Captopril, European Pharmacopoeia (EP) Reference Standard|([2S]-N-[3-Mercapto-2-methylpropionyl]-L-proline;SQ-14225|Captopril, United States Pharmacopeia (USP) Reference Standard|(2S)-1-[(2S)-2-methyl-3-sulfanyl-propanoyl]pyrrolidine-2-carboxylic acid|(S)-1-((S)-3-mercapto-2-methylpropanoyl)pyrrolidine-2-carboxylicacid|Captopril, Pharmaceutical Secondary Standard; Certified Reference Material|Captopril for system suitability, European Pharmacopoeia (EP) Reference Standard"
FINASTERIDE,57363,,"InChI=1S/C23H36N2O2/c1-21(2,3)25-20(27)17-8-7-15-14-6-9-18-23(5,13-11-19(26)24-18)16(14)10-12-22(15,17)4/h11,13-18H,6-10,12H2,1-5H3,(H,24,26)(H,25,27)/t14-,15-,16-,17+,18+,22-,23+/m0/s1",DBEPLOCGEIEOCV-WSBQPABSSA-N,C23H36N2O2,372.5,"(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide","finasteride|98319-26-7|Proscar|Propecia|Finastid|Prostide|Chibro-Proscar|MK-906|Finasterida|Finpecia|Finasteridum|MK 906|DTXSID3020625|MK906|N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide|(5alpha,17beta)-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|NSC-741485|57GNO57U7G|CHEBI:5062|NSC-759318|DTXCID50625|N-(2-Methyl-2-propyl)-3-oxo-4-aza-5-alpha-androst-1-ene-17-beta-carboxamide|4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5alpha,17beta)-|ENTADFI COMPONENT FINASTERIDE|Propeshia|Chibro Proscar|Aindeem|Urprosan|Pro-Cure|(1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo(8.7.0.0^(2,7).0^(11,15))heptadec-3-ene-14-carboxamide|(1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-3-ene-14-carboxamide|RefChem:57216|D11AX10|G04CB01|(5ALPHA,17BETA)-N-(1,1-DIMETHYLETHYL)-3-OXO-4-AZAANDROST-1-ENE-17-CARBOXAMIDE|(1S,2R,7R,10S,11S,14S,15S)-N-tert-butyl-2,15-dimethyl-5-oxo-6-azatetracyclo(8.7.0.02,7.011,15)heptadec-3-ene-14-carboxamide|MFCD00869737|C23H36N2O2|(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-tert-butyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide|N-tert-Butyl-3-oxo-4-aza-5alpha-androst-1-en-17beta-carboxamide|CHEMBL710|(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-tert-butyl-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide|Finasteridum [INN-Latin]|Finasterida [INN-Spanish]|(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(1,1-dimethylethyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide|Andozac|(4aR,4bS,6aS,7S,9aS,9bS,11aR)-N-(tert-butyl)-4a,6a-dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxamide|Propecia (TN)|SMR000466304|Proscar (TN)|MK 0906|MK-0906|CCRIS 7438|HSDB 6793|SR-01000759414|BRN 4269024|UNII-57GNO57U7G|L-652,931|17beta-(N-tert-butylcarbamoyl)-4-aza-5 alpha-androst-1-en-3-one|NCGC00016965-01|140375-21-9|Finasteride [USAN:USP:INN:BAN]|CAS-98319-26-7|YM-152|KS-1058|Finasteride (Proscar)|Finasteride (Standard)|FINASTERIDE [MI]|Prestwick0_000717|Prestwick1_000717|Prestwick2_000717|Prestwick3_000717|FINASTERIDE [INN]|FINASTERIDE [JAN]|FINASTERIDE [USAN]|FINASTERIDE [VANDF]|N-(2-methyl-2-propyl)-3-oxo-4-aza-5alpha-androst-1-ene-17beta-carboxamide|SCHEMBL5509|FINASTERIDE [MART.]|BSPBio_000933|FINASTERIDE [WHO-DD]|MLS000759404|MLS001165768|MLS001424046|Finasteride (JAN/USP/INN)|SPBio_002854|BPBio1_001027|GTPL6818|orb1310564|Finasteride - Bio-X trade mark|FINASTERIDE [EP IMPURITY]|FINASTERIDE [ORANGE BOOK]|4-Azaandrost-1-ene-17-carboxamide, N-(1,1-dimethylethyl)-3-oxo-, (5.alpha.,17.beta.)-|BCPP000229|FINASTERIDE [EP MONOGRAPH]|FINASTERIDE [USP IMPURITY]|HMS1570O15|HMS2051F09|HMS2090G22|HMS2097O15|HMS2235L23|HMS3714O15|FINASTERIDE [USP MONOGRAPH]|EX-A1951|Tox21_110717|Tox21_201506|Tox21_302744|BDBM50334788|HY-13635R|MSK011113|NSC741485|NSC757443|s1197|(5?,17?)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|AKOS015894916|Tox21_110717_1|BCP9000685|CCG-100937|CS-1767|DB01216|FF23286|Finasteride, >=98% (HPLC), powder|NC00187|NSC 741485|NSC 759318|NSC-757443|NCGC00093560-05|NCGC00256334-01|NCGC00259057-01|BF164456|CPD000466304|HY-13635|SY058000|BCP0726000222|AB00513901|NS00010893|D00321|AB00513901-07|AB00513901-08|AB00513901_09|Finasteride, VETRANAL(TM), analytical standard|319F267|A845840|Q424167|SR-01000759414-4|SR-01000759414-6|BRD-K01095011-001-03-5|BRD-K01095011-001-15-9|Z1501475008|Finasteride, British Pharmacopoeia (BP) Reference Standard|Finasteride, European Pharmacopoeia (EP) Reference Standard|(17beta-(N-tert-butylcarbamoyl)-4-aza-5alpha-androst-1-en-3-one|Finasteride, United States Pharmacopeia (USP) Reference Standard|(5a,17b)-N-(1,1-Dimethylethyl)-3-oxo-4-azaandrost-1-ene-17-carboxamide|4-Azaandrost-1-ene-17-carboxamide,1-dimethylethyl)-3-oxo-, (5.alpha., 17.beta.)-|Finasteride for peak identification, European Pharmacopoeia (EP) Reference Standard|(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide|(1S,3aS,3bS,5aR,9aR,9bS,11aS)-N-isobutyl-9a,11a-dimethyl-7-oxo-1,2,3,3a,3b,4,5,5a,6,9b,10,11-dodecahydroindeno[5,4-f]quinoline-1-carboxamide;Finasteride|(4AR,4BS,6AS,7S,9AS,9BS,11AR)-4A,6A-DIMETHYL-2-OXO-2,4A,4B,5,6,6A,7,8,9,9A,9B,10,11,11A-TETRADECAHYDRO-1H-INDENO[5,4-F]QUINOLINE-7-CARBOXYLIC ACID TERT-BUTYLAMIDE|(4aR,4bS,6aS,9aS,9bS,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide|(4aR,6aS)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide|(4aR,6aS,11aR)-4a,6a-Dimethyl-2-oxo-hexadecahydro-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide|(4aR,6aS,7S)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide|(4aR,6aS,7S,11aR)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide|(R)-4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide|1H-Indeno[5,4-f]quinoline-7-carboxamide, N-(1,1-dimethylethyl)-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-4a,6a-dimethyl-2-oxo-, (4aR,4bS,6aS,7S,9aS,9bS,11aR)-|4a,6a,9a-Trimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid (Finasteride)|4a,6a-Dimethyl-2-oxo-2,4a,4b,5,6,6a,7,8,9,9a,9b,10,11,11a-tetradecahydro-1H-indeno[5,4-f]quinoline-7-carboxylic acid tert-butylamide(Finasteride)"
ZB-716,126480615,,"InChI=1S/C32H48BF5O4S/c1-30-17-15-26-25-12-11-24(33(40)41)21-23(25)20-22(29(26)27(30)13-14-28(30)39)10-7-5-3-2-4-6-8-18-43(42)19-9-16-31(34,35)32(36,37)38/h11-12,21-22,26-29,39-41H,2-10,13-20H2,1H3/t22-,26-,27+,28+,29-,30+,43?/m1/s1",FIAYIYKWRBIBQG-GDWZZRAASA-N,C32H48BF5O4S,634.6,"[(7R,8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]boronic acid","ZB716|Fulvestrant-3-boronic acid|1853279-29-4|ZB-716|Borestrant|UNII-E35ZN95LMT|B-((7alpha,17beta)-17-Hydroxy-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-trien-3-yl)boronic acid|Boronic acid, B-((7alpha,17beta)-17-hydroxy-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)estra-1,3,5(10)-trien-3-yl)-|B-((7.ALPHA.,17.BETA.)-17-HYDROXY-7-(9-((4,4,5,5,5-PENTAFLUOROPENTYL)SULFINYL)NONYL)ESTRA-1,3,5(10)-TRIEN-3-YL)BORONIC ACID|BORONIC ACID, B-((7.ALPHA.,17.BETA.)-17-HYDROXY-7-(9-((4,4,5,5,5-PENTAFLUOROPENTYL)SULFINYL)NONYL)ESTRA-1,3,5(10)-TRIEN-3-YL)-|B-[(7alpha,17beta)-17-Hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl]boronic acid|RefChem:195878|SERD ZB-716|ZB 716|Selective Estrogen Receptor Degrader ZB716|Selective Estrogen Receptor Alpha Degrader ZB716|E35ZN95LMT|[(7R,8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7-[9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl]-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl]boronic acid|CHEMBL4526356|SCHEMBL19578939|SCHEMBL29355892|FIAYIYKWRBIBQG-GDWZZRAASA-N|DTXSID601107524|GLXC-20536|BDBM50516760|ZB716(Fulvestrant-3 Boronic Acid)?|HY-137144|((7R,8R,9S,13S,14S,17S)-17-Hydroxy-13-methyl-7-(9-((4,4,5,5,5-pentafluoropentyl)sulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl)boronic acid|(7R,8R,9S,13S,14S,17S)-17-hydroxy-13-methyl-7-(9-(4,4,5,5,5-pentafluoropentylsulfinyl)nonyl)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-ylboronic acid"
FORMESTANE,11273,,"InChI=1S/C19H26O3/c1-18-10-8-15(20)17(22)14(18)4-3-11-12-5-6-16(21)19(12,2)9-7-13(11)18/h11-13,22H,3-10H2,1-2H3/t11-,12-,13-,18+,19-/m0/s1",OSVMTWJCGUFAOD-KZQROQTASA-N,C19H26O3,302.4,"(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione","formestane|566-48-3|4-Hydroxyandrost-4-ene-3,17-dione|4-Hydroxyandrostenedione|Lentaron|CGP-32349|4-OH-A|CGP 32349|formestano|4-Hydroxy-4-androstene-3,17-dione|4-OHA|formestanum|DTXSID3034113|4-OHAD|NSC-282175|4-oh-androstene-3,17-dione|PUB9T8T355|CHEBI:75172|4-hydroxy-Delta(4)-androstenedione|DTXCID1014113|4-hydroxyandrostene-3,17-dione|CGP 32 349|(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta(a)phenanthrene-3,17-quinone|(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-quinone|RefChem:921765|L02BG02|Lentaron(R)|ANDROST-4-ENE-3,17-DIONE, 4-HYDROXY-|NSC 282175|B, Aromatase inhibitor|(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione|MLS000028826|MLS002153359|Formestane (INN)|MFCD00057814|SMR000058722|FORMESTANE [INN]|17-dione|Formestane [INN:BAN]|(8R,9S,10R,13S,14S)-4-hydroxy-10,13-dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,6H)-dione|CAS-566-48-3|CCRIS 7483|4-Hydroxy-delta(sub 4)-androstenedione|BRN 1889793|UNII-PUB9T8T355|SaveCream|Lentaron Depot|Formestane, solid|NCGC00015070-04|NCGC00164380-02|Lentaron (TN)|Lentaron(R)17-dione|FORMESTANE [MI]|Opera_ID_865|FORMESTANE [MART.]|FORMESTANE [WHO-DD]|SCHEMBL25717|MLS001148070|Androst-4-ene-3, 4-hydroxy-|4-hydroxy-Delta4-androstenedione|BDBM225704|CS333|HMS2090I22|HMS2234J06|HMS3715G16|BCP03066|HY-B0697|Tox21_112111|Tox21_113509|Tox21_302286|NSC282175|s2208|4-hydroxy-androst-4-ene-3,17-dione|AKOS015895451|Tox21_112111_1|CCG-221077|DB08905|FF23546|NCGC00164380-01|NCGC00255321-01|NCGC00344560-01|AS-75658|NCI60_002316|NS00009015|D07260|AB00572625-07|566F483|A831133|SR-01000721948|Q3077501|SR-01000721948-2|4-Hydroxyandrost-4-ene-3,17-dione, 4-OHA, CGP-32349, lentaron;NSC 282175|(10R,13S)-4,10,13-trimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione|(8R,9S,10R,13S,14S)-10,13-dimethyl-4-oxidanyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione"
PLOMESTANE,9904788,,"InChI=1S/C21H26O2/c1-3-10-21-12-8-15(22)13-14(21)4-5-16-17-6-7-19(23)20(17,2)11-9-18(16)21/h1,13,16-18H,4-12H2,2H3/t16-,17-,18-,20-,21-/m0/s1",JKPDEYAOCSQBSZ-OEUJLIAZSA-N,C21H26O2,310.4,"(8R,9S,10S,13S,14S)-13-methyl-10-prop-2-ynyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione","Plomestane|77016-85-4|MDL-18962|Plomestano|MDL 18,962|FL3VS913TW|10-(2-Propynyl)estr-4-ene-3,17-dione|10-PED|Estr-4-ene-3,17-dione, 10-(2-propynyl)-|DTXSID601318490|10-propargylestr-4-ene-3,17-dione|plomestanum|RefChem:929444|19-acetylenic androstenedione|DTXCID901748298|MDL 18962|MDL-18,962|10-propargylandrost-4-ene-3,17-dione|(8R,9S,10S,13S,14S)-13-methyl-10-prop-2-ynyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione|Plomestane [USAN:INN]|UNII-FL3VS913TW|PLOMESTANE [INN]|Plomestane (USAN/INN)|PLOMESTANE [USAN]|SCHEMBL3434|orb1740760|CHEMBL2105261|JKPDEYAOCSQBSZ-OEUJLIAZSA-N|BDBM50421840|10beta-propargyl-estra-4-ene-3,17-dione|10-(2-propynyl)-estr-4-ene-3,17-dione|D03749|10-(2-PROPYNL)-ESTR-4-ENE-3,17-DIONE|Q7205081"
MIBOLERONE,251636,,"InChI=1S/C20H30O2/c1-12-10-13-11-14(21)4-5-15(13)16-6-8-19(2)17(18(12)16)7-9-20(19,3)22/h11-12,15-18,22H,4-10H2,1-3H3/t12-,15+,16-,17+,18-,19+,20+/m1/s1",PTQMMNYJKCSPET-OMHQDGTGSA-N,C20H30O2,302.5,"(7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,13,17-trimethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one","MIBOLERONE|3704-09-4|Mibolerona|Cheque|Cheque Drops|Dihydrolone|Miboleronum|Mibolerone ciii|Matenon|U-10,997|17-beta-Hydroxy-7-alpha,17-dimethylestr-4-en-3-one|9OGY4BOR8D|NSC 72260|NSC-72260|U 10997|U-10997|17beta-Hydroxy-7alpha,17-dimethylestr-4-en-3-one|DTXSID4036489|CHEBI:34849|7alpha-17alpha-dimethyl-19-nortestosterone|(7alpha,17beta)-17-hydroxy-7,17-dimethylestr-4-en-3-one|17,17-dimethyl-19-nortestosterone|(7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,13,17-trimethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-3-one|DTXCID2016489|U-10-997|Estr-4-en-3-one, 17-beta-hydroxy-7-alpha,17-dimethyl-|mobilerone|Estr-4-en-3-one, 17-hydroxy-7,17-dimethyl-, (7alpha,17beta)-|(7R,8R,9S,10R,13S,14S,17S)-17-hydroxy-7,13,17-trimethyl-1,2,6,7,8,9,10,11,12,14,15,16-dodecahydrocyclopenta(a)phenanthren-3-one|RefChem:57292|Cheque Medicated Dog Food|223-046-5|[3H]mibolerone|Miboleron|CDB 904|Mibolerone (1.0 mg/mL in Acetonitrile)|7.alpha.,17-Dimethyl-19-nortestosterone|Cheque (Veterinary)|7.alpha.,17.alpha.-Dimethyl-19-nortestosterone|MIBOLERONE [MI]|Mibolerone (USP/INN)|MIBOLERONE [INN]|17-.beta.-hydroxy-7,17-dimethylestr-4-en-3-one|UNII-9OGY4BOR8D|MIBOLERONE [USAN]|Miboleronum [INN-Latin]|Mibolerona [INN-Spanish]|17.beta.-Hydroxy-7.alpha.,17-dimethylestr-4-en-3-one|MIBOLERONE [MART.]|[3H]MIB|SCHEMBL565277|CHEMBL425863|GTPL2859|GTPL3456|MIBOLERONE [GREEN BOOK]|Estr-4-en-3-one, 17-hydroxy-7,17-dimethyl-, (7.alpha.,17.beta.)-|BDBM26258|MIBOLERONE CIII [USP-RS]|PTQMMNYJKCSPET-OMHQDGTGSA-N|MIBOLERONE [USP MONOGRAPH]|Mibolerone [USAN:USP:INN:BAN]|NSC72260|EINECS 223-046-5|Tox21_113738|7alpha,17-Dimethyl-19-nortestosterone|DB11429|BRN 5565683|NCGC00253603-01|19-Nortestosterone, 7alpha,17-dimethyl-|CAS-3704-09-4|7alpha,17alpha-Dimethyl-19-nortestosterone|NS00030147|7-alpha-17-alpha-Dimethyl-19-nortestosterone|D05025|17-beta-hydroxy-7,17-dimethylestr-4-en-3-one|704M094|7-.alpha.-17-.alpha.-Dimethyl-19-nortestosterone|Q6827784|7alpha,17alpha-Dimethyl-17beta-hydroxyestr-4-en-3-one|Estr-4-en-3-one, 17beta-hydroxy-7alpha,17-dimethyl-|Estr-4-en-3-one,17-dimethyl-, (7.alpha.,17.beta.)-|Estr-4-en-3-one, 17-hydroxy-7,17-dimethyl-, (7-alpha,17-beta)-|(1S,2R,9R,10R,11S,14S,15S)-14-hydroxy-9,14,15-trimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-en-5-one|Estr-4-en-3-one, 17-hydroxy-7,17-dimethyl-, (7.beta.,8.epsilon.,9.beta.,10.alpha.,13.alpha.,14.beta.,17.alpha.)-"
BICALUTAMIDE,2375,,"InChI=1S/C18H14F4N2O4S/c1-17(26,10-29(27,28)14-6-3-12(19)4-7-14)16(25)24-13-5-2-11(9-23)15(8-13)18(20,21)22/h2-8,26H,10H2,1H3,(H,24,25)",LKJPYSCBVHEWIU-UHFFFAOYSA-N,C18H14F4N2O4S,430.4,N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide,"bicalutamide|90357-06-5|Casodex|Cosudex|Calutide|ICI 176334|Kalumid|ICI-176334|bicalutamida|N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide|ICI 176,334|A0Z3NAU9DP|NSC-759816|DTXSID2022678|ICI176,334-1|DTXCID00209197|NSC722665|Propanamide, N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methyl-, (+-)-|CHEBI:3090|bicalutamidum|4-cyano-3-trifluoromethyl-N-(3-p-fluorophenylsulfonyl-2-hydroxy-2-methylpropionyl)aniline|N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-fluorobenzenesulfonyl)-2-hydroxy-2-methylpropanamide|N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methylpropanamide|N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorobenzenesulfonyl)-2-hydroxy-2-methylpropanamide|RefChem:54538|4'-cyano-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methyl-3'-(trifluoromethyl)propionanilide|L02BB03|4'-Cyano-alpha,alpha,alpha-trifuloro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide|(+-)-N-(4-Cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methylpropanamide|N-(4-Cyano-3-(trifluoromethyl)phenyl)3-3((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methyl-propanamide|Bicalutamide (CDX)|N-(4-cyano-3-(trifluoromethyl)phenyl)-3-((4-fluorophenyl)sulfonyl)-2-hydroxy-2-methylpropanamide|MFCD00869971|C18H14F4N2O4S|CHEMBL409|N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide|Propanamide, N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-|Bicalutamide Crystalline Form II|Raffolutil|N-[4-cyano-3-(trifluoromethyl)phenyl]-3-(4-fluorophenyl)sulfonyl-2-hydroxy-2-methyl-propanamide|SMR000466329|Casodex (TN)|CAS-90357-06-5|SR-01000759410|UNII-A0Z3NAU9DP|BRN 5364666|Propanamide,|CCRIS 8728|HSDB 7655|NCGC00167487-01|Bicalutamide [USAN:USP:INN:BAN]|(+-)-4'-Cyano-alpha,alpha,alpha-trifluoro-3-((p-fluorophenyl)sulfonyl)-2-methyl-m-lactotoluidide|KS-1161|Bicalutamide (Casodex)|CPD000466329|Bicalutamide (Standard)|BICALUTAMIDE [MI]|BICALUTAMIDE [INN]|BICALUTAMIDE [JAN]|BICALUTAMIDE [HSDB]|BICALUTAMIDE [USAN]|SCHEMBL3611|BICALUTAMIDE [VANDF]|BICALUTAMIDE [MART.]|MLS000759437|MLS001424047|BICALUTAMIDE [USP-RS]|BICALUTAMIDE [WHO-DD]|GTPL2863|orb1310668|SCHEMBL29353850|BDBM18525|Bicalutamide (JP18/USP/INN)|CHEBI:91617|EX-A962|CHEBI:144093|BCPP000337|BICALUTAMIDE [ORANGE BOOK]|GLXC-06685|HMS2051B13|HMS2089N12|HMS2232H03|HMS3263M13|HMS3372K05|HMS3393B13|HMS3654K18|HMS3714P13|HMS5079I13|Pharmakon1600-01504827|BICALUTAMIDE [EP MONOGRAPH]|BICALUTAMIDE [USP IMPURITY]|BCP02110|MSK11156|SYB76979|BICALUTAMIDE [USP MONOGRAPH]|Tox21_112488|Tox21_303560|Tox21_501026|HY-14249R|NSC759816|s1190|AKOS015895073|AC-4232|BCP9000408|CCG-100951|CCG-220876|CCG-222330|CS-1296|DB01128|IC58278|LP01026|NC00201|NSC 759816|NSC-722665|SB17301|SDCCGSBI-0633779.P001|NCGC00167977-01|NCGC00167977-02|NCGC00167977-03|NCGC00167977-09|NCGC00167977-20|NCGC00257459-01|NCGC00261711-01|HY-14249|SY057461|DB-041165|B3206|NS00000400|SW197581-4|Bicalutamide (CDX), >=98% (HPLC), powder|C08160|D00961|AB00639963-06|AB00639963-08|AB00639963-09|AB00639963_10|EN300-1715981|357B065|Q1988832|SR-01000759410-4|SR-01000759410-5|BRD-A29485665-001-03-7|BRD-A29485665-001-11-0|BRD-A29485665-001-12-8|Z2108698963|Bicalutamide, British Pharmacopoeia (BP) Reference Standard|Bicalutamide, European Pharmacopoeia (EP) Reference Standard|Bicalutamide, United States Pharmacopeia (USP) Reference Standard|4'-cyano-3-[(4- fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3'-trifluoromethylpropionanilide|4'-cyano-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methyl-3'-trifluoromethylpropionanilide|Bicalutamide for system suitability, European Pharmacopoeia (EP) Reference Standard|Bicalutamide, Pharmaceutical Secondary Standard; Certified Reference Material|(+/-)-4'-CYANO-.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-3-((P-FLUOROPHENYL)SULFONYL)-2-METHYL-M-LACTOTOLUIDIDE|N-(4-cyano-3-(trifluoromethyl)phenyl)-3-(4-fluorophenylsulfonyl)-2-hydroxy-2-methylpropanamide|N-[(4-CYANO-3-TRIFLUOROMETHYL)PHENYL]-3-[(4-FLUOROPHENYL)SULFONYL]-2-HYDROXY-2-METHYLPROPANAMIDE|N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorobenzene)sulfonyl]-2-hydroxy-2-methylpropanamide|N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfinyl]-2-hydroxy-2-methylpropanamide;ICI-176334;Casodex|N-[4-Cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropionamide|N-[4-cyano-3-trifluoromethyl-phenyl]-3-[4-fluorophenyl-sulfonyl]-2-hydroxy-2-methyl-propionamide|PROPANAMIDE, N-(4-CYANO-3-(TRIFLUOROMETHYL)PHENYL)-3-((4-FLUOROPHENYL)SULFONYL)-2-HYDROXY-2-METHYL-, (+/-)-"
VOROZOLE,6918191,,"InChI=1S/C16H13ClN6/c1-22-15-8-12(4-7-14(15)20-21-22)16(23-10-18-9-19-23)11-2-5-13(17)6-3-11/h2-10,16H,1H3/t16-/m0/s1",XLMPPFTZALNBFS-INIZCTEOSA-N,C16H13ClN6,324.77,"6-[(S)-(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole","Vorozole|129731-10-8|Vorozolum|Vorozol|R-83842|(+)-Vorozole|1E2S9YXV2A|DTXSID20156230|RefChem:902055|R83842|DTXCID7078721|L02BG05|R 83 842|(+)-6-((4-Chlorophenyl)-1H-1,2,4-triazol-1-ylmethyl)-1-methyl-1H-benzotriazole|6-((S)-(4-chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl)-1-methyl-1H-1,2,3-benzotriazole|1H-Benzotriazole, 6-((4-chlorophenyl)-1H-1,2,4-triazol-1-ylmethyl)-1-methyl-|6-((4-chlorophenyl)-(1H-1,2,4-triazol-1-yl)methyl)-1-methyl-1H-benzotriazole|7331QX0ML8|R-76713|Rivizor|6-[(S)-(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole|R 83842|(S)-6-((4-chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl)-1-methyl-1H-benzo[d][1,2,3]triazole|(N-methyl-(11C))vorozole|1H-Benzotriazole, 6-((4-chlorophenyl)-1H-1,2,4-triazol-1-ylmethyl)-1-methyl-, (S)-|1H-Benzotriazole,6-[(S)-(4-chlorophenyl)-1H-1,2,4-triazol-1-ylmethyl]-1-methyl-|Vorozol [INN-Spanish]|Vorozolum [INN-Latin]|UNII-1E2S9YXV2A|Vorozole [USAN:INN:BAN]|CCRIS 7482|Rivizor (TN)|VOROZOLE [USAN]|Vorozole (USAN/INN)|VOROZOLE [INN]|VOROZOLE [MI]|(S)-VOROZOLE|VOROZOLE [MART.]|VOROZOLE [WHO-DD]|SCHEMBL4554|CHEMBL224060|orb1701481|SCHEMBL29363602|CHEBI:135387|BCP04202|BDBM50378780|DB13767|(+)-(S)-6-(p-Chloro-alpha-1H-1,2,4-triazol-1-ylbenzyl)-1-methyl-1H-benzotriazole|r76713|DA-68630|HY-19599|TS-08462|BCP0726000088|CS-0015881|D03786|R-83942|Q7941876|(+)-(S)-6-(P-CHLORO-A-1H-1,2,4-TRIAZOL-1-YLBENZYL)-1-METHYL-1H-BENZOTRIAZOLE|(+)-6-[(4-chlorophenyl)(1H-1,2,4-triazol-1-yl)methyl]-1-methyl-1H- benzotriazole|(S)-6-[(4-chlorophenyl)-(1,2,4-triazol-1-yl)methyl]-1-methylbenzotriazole"
NAFTOPIDIL,4418,,"InChI=1S/C24H28N2O3/c1-28-24-11-5-4-10-22(24)26-15-13-25(14-16-26)17-20(27)18-29-23-12-6-8-19-7-2-3-9-21(19)23/h2-12,20,27H,13-18H2,1H3",HRRBJVNMSRJFHQ-UHFFFAOYSA-N,C24H28N2O3,392.5,1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol,"naftopidil|57149-07-2|Flivas|Naftopidilum|DTXSID5045176|1-(4-(2-methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol|R9PHW59SFN|NSC-759293|1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(naphthalen-1-yloxy)propan-2-ol|DTXCID3025176|1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol|1-[4-(2-Methoxyphenyl)-1-piperazinyl]-3-(1-naphthyloxy)-2-propanol|RefChem:831691|GlyTouCan:G63311LY|G63311LY|(2RS)-1-(4-(2-Methoxyphenyl)piperazin-1-yl)-3-(naphthalen-1-yloxy)propan-2-ol|KT-611|Naftopidil [INN]|Avishot|BM-15275|4-(2-methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol|MFCD00242741|CHEMBL142635|MFCD11046013|NCGC00015718-06|1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol|Naftopidilum [Latin]|Naftopidil hydrochloride hydrate|SMR000466346|CAS-57149-07-2|UNII-R9PHW59SFN|BRN 0629965|Flivas (TN)|Naftopidil (Flivas)|(+/-)-Naftopidil|Naftopidil (Standard)|NAFTOPIDIL [MI]|NAFTOPIDIL [JAN]|Prestwick0_000975|Prestwick1_000975|Prestwick2_000975|Prestwick3_000975|(+-)-1-(4-(2-Methoxyphenyl)piperazinyl)-3-(1-naphthyloxy)propan-2-ol|Naftopidil (JP17/INN)|(RS)-1-(4-(2-methoxyphenyl)-1-piperazinyl)-3-(1-naphthyloxy)-2-propanol|4-(2-Methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-1-pioerazineethanol|cid_4418|NAFTOPIDIL [MART.]|NAFTOPIDIL [WHO-DD]|Lopac0_000941|REGID_for_CID_4418|BSPBio_001009|MLS000759459|MLS001424117|SCHEMBL113215|SPBio_002920|BPBio1_001111|Naftopidil - Bio-X trade mark|orb1310376|SCHEMBL29449978|BDBM50773|CHEBI:31891|cid_6603044|HY-B0391R|HMS2051B09|HMS2089G07|HMS3393B09|HMS3655H21|HMS3884P07|HMS5080K14|Pharmakon1600-01506024|BCP21786|HY-B0391|Tox21_110205|1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-(1-naphthyloxy)propan-2-ol|BBL028454|MSK163437|NSC759293|s2126|STL372645|(+-)-4-(o-Methoxyphenyl)-alpha-((1-naphthyloxy)methyl)-1-piperazineethanol|1-Pioerazineethanol, 4-(2-methoxyphenyl)-alpha-((1-naphthalenyloxy)methyl)-|AKOS002279617|AKOS016328058|Tox21_110205_1|BCP9000976|CCG-100935|CCG-205022|DB12092|FE-0209|FN26123|NC00185|NSC 759293|SB19321|SDCCGSBI-0050915.P003|NCGC00015718-04|NCGC00015718-05|NCGC00015718-08|NCGC00015718-09|NCGC00015718-10|NCGC00015718-12|NCGC00015718-25|NCGC00024672-03|NCGC00024672-04|BN164631|SY053735|SBI-0050915.P002|AB00514643|N0832|ST50794017|SW196570-4|49N072|D01674|AB00489961-18|AB00489961-19|AB00489961_20|AB00489961_21|EN300-6492981|F463444|Q6958243|BRD-A01787639-001-06-4|BRD-A01787639-001-07-2|BRD-A01787639-001-08-0|BRD-A01787639-003-16-9|BRD-A01787639-300-03-7|BRD-A01787639-300-04-5|BRD-A01787639-300-08-6|BRD-A01787639-300-09-4|Z31369389|1-[4-(2-methoxyphenyl)piperazinyl]-3-naphthyloxypropan-2-ol|1-[4-(2-Methoxyphenyl)piperazinyl]-3-(1-naphthyloxy)propan-2-ol|1-[4-(2-methoxyphenyl)piperazino]-3-(1-naphthoxy)propan-2-ol;hydrochloride|BM-15275; KT-611; BM 15275; KT 611; BM15275; KT611|(+/-)-4-(O-METHOXYPHENYL)-.ALPHA.-((1-NAPHTHYLOXY)METHYL)-1-PIPERAZINEETHANOL|1-[4-(2-methoxyphenyl)-1-piperazinyl]-3-(1-naphthalenyloxy)-2-propanol;hydrochloride|1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxy-propan-2-ol;hydrochloride|1-[4-(2-methoxyphenyl)piperazin-1-yl]-3-naphthalen-1-yloxypropan-2-ol;hydrochloride|4-(2-Methoxyphenyl)-?-[(1-naphthalenyloxy)methyl]-1-piperazineethanol;(+/-)-Naftopidil|4-(2-Methoxyphenyl)-a-(1-naphthalenyloxy)methyl-1-piperazineethanol;Naftopil;(+/-)-Naftopidil|4-(2-Methoxyphenyl)-alpha-[(1-naphthalenyloxy)methyl]-1-piperazineethanol hydrochloride hydrate"
PHENTOLAMINE,5775,,"InChI=1S/C17H19N3O/c1-13-5-7-14(8-6-13)20(12-17-18-9-10-19-17)15-3-2-4-16(21)11-15/h2-8,11,21H,9-10,12H2,1H3,(H,18,19)",MRBDMNSDAVCSSF-UHFFFAOYSA-N,C17H19N3O,281.35,"3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol","phentolamine|50-60-2|Regitin|Fentolamin|Dibasin|Fentolamina|Phentolaminum|Rogitine|C 7337 Ciba|Phentolamin|C 7337|2-(m-Hydroxy-N-p-tolylanilinomethyl)-2-imidazoline|3-[(4,5-dihydro-1H-imidazol-2-ylmethyl)(4-methylphenyl)amino]phenol|2-(N-(m-Hydroxyphenyl)-p-toluidinomethyl)imidazoline|2-((N-(m-Hydroxyphenyl)-p-toluidino)methyl)-2-imidazoline|2-(N'-p-Tolyl-N'-m-hydroxyphenylaminomethyl)-2-imidazoline|CHEBI:8081|DTXSID4023462|Z468598HBV|Phenol, m-(N-(2-imidazolin-2-ylmethyl)-p-toluidino)-|DTXCID703462|Phenol, 3-(((4,5-dihydro-1H-imidazol-2-yl)methyl)(4-methylphenyl)amino)-|Phenol, 3-[[(4,5-dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino]-|Regityn|3-((4,5-DIHYDRO-1H-IMIDAZOL-2-YLMETHYL)(4-METHYLPHENYL)AMINO)PHENOL|3-(4,5-dihydro-1H-imidazol-2-ylmethyl-(4-methylphenyl)amino)phenol|3-[4,5-dihydro-1H-imidazol-2-ylmethyl-(4-methylphenyl)amino]phenol|RefChem:55850|Phentolamine Mono hydrochloride|Mono-hydrochloride, Phentolamine|C04AB01|V03AB36|2-(N-p'-Tolyl-N-(m'-hydroxyphenyl)aminomethyl)imidazoline|200-053-1|Regitine|3-{[(4,5-Dihydro-1H-imidazol-2-yl)methyl](4-methylphenyl)amino}phenol|Phentolamine (INN)|MLS000040874|2-Imidazoline, 2-((N-(m-hydroxyphenyl)-p-toluidino)methyl)-|NCGC00016311-10|Phenotolamine|Phentalamine|Regitipe|SMR000058051|3-[[(4,5-dihydro-1h-imidazol-2-yl)methyl](4-methylphenyl)amino]phenol|PHENTOLAMINE [INN]|Phentolamine [INN:BAN]|Fentolamina [INN-Spanish]|Phentolaminum [INN-Latin]|Fentolamine|3-(((4,5-Dihydro-1H-imidazol-2-yl)methyl)(p-tolyl)amino)phenol|CAS-50-60-2|Phentolamine mesylas|HSDB 3382|EINECS 200-053-1|BRN 0272944|Regitina|phentol amine|UNII-Z468598HBV|Rogitine (Salt/Mix)|Spectrum_000077|Phentolamine (Standard)|Opera_ID_116|Prestwick0_000230|Prestwick1_000230|Prestwick2_000230|Prestwick3_000230|Spectrum3_000788|Spectrum4_000899|Spectrum5_001704|PHENTOLAMINE [MI]|CHEMBL597|PHENTOLAMINE [HSDB]|cid_5775|SCHEMBL5653|PHENTOLAMINE [VANDF]|Lopac0_000982|Ryzumvi (opthalmic solution)|BSPBio_000279|BSPBio_001435|BSPBio_002496|GTPL502|KBioGR_001338|KBioSS_000477|5-25-09-00365 (Beilstein Handbook Reference)|cid_91430|MLS001201741|DivK1c_000807|PHENTOLAMINE [WHO-DD]|Phentolamine Mono-hydrochloride|SPBio_002200|BPBio1_000307|orb1299012|SCHEMBL29395338|BCBcMAP01_000014|BDBM31046|KBio1_000807|KBio2_000477|KBio2_003045|KBio2_005613|KBio3_001716|NINDS_000807|HMS1791H17|HMS1989H17|HMS2089E03|HMS2235D17|HMS3372H21|HMS3402H17|Tox21_110364|3-[N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-4-methyl-anilino]phenol|BBL010978|HY-12717R|STK802099|AKOS004119917|Tox21_110364_1|CCG-205062|DB00692|FP37047|SDCCGSBI-0050955.P005|CAS-73-05-2|IDI1_000807|SMP1_000236|NCGC00016311-01|NCGC00016311-02|NCGC00016311-03|NCGC00016311-04|NCGC00016311-05|NCGC00016311-06|NCGC00016311-07|NCGC00016311-08|NCGC00016311-09|NCGC00016311-11|NCGC00016311-12|NCGC00016311-13|NCGC00016311-14|NCGC00016311-15|NCGC00016311-16|NCGC00016311-17|NCGC00016311-19|NCGC00016311-33|NCGC00021804-06|NCGC00021804-07|NCGC00021804-08|NCGC00021804-09|NCGC00021804-10|HY-12717|SBI-0050955.P004|DB-050268|CS-0012293|NS00007720|EN300-51916|D08362|G78138|AB00053768-28|AB00053768_29|AB00053768_30|242P985|L001116|Q420360|m-[N-(2-Imidazolin-2-ylmethyl)-p-toluidino]phenol|BRD-K90333595-001-02-8|BRD-K90333595-003-04-0|BRD-K90333595-003-21-4|BRD-K90333595-003-22-2|BRD-K90333595-066-16-1|BRD-K90333595-066-17-9|Z732246520|3-(((4,5-Dihydro-1H-Imidazol-2-Yl)Methyl)(P-Tolyl)Amino)Pheno|3-[(4,5-Dihydro-1H-imidazol-2-ylmethyl)-4-methylanilino]phenol #|3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl-(4-methylphenyl)-amino]phenol|3-[N-(2-imidazolin-2-ylmethyl)-4-methyl-anilino]phenol;hydrochloride|3-[N-(2-imidazolin-2-ylmethyl)-4-methyl-anilino]phenol;mesylic acid|3-[4,5-dihydro-1H-imidazol-2-ylmethyl-(4-methylphenyl)amino]phenol;methanesulfonic acid"
TETRODOTOXIN,11174599,,"InChI=1S/C11H17N3O8/c12-8-13-6(17)2-4-9(19,1-15)5-3(16)10(2,14-8)7(18)11(20,21-4)22-5/h2-7,15-20H,1H2,(H3,12,13,14)/t2-,3-,4-,5+,6-,7+,9+,10-,11+/m1/s1",CFMYXEVWODSLAX-QOZOJKKESA-N,C11H17N3O8,319.27,"(1R,5R,6R,7R,9S,11S,12S,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.17,11.01,6]tetradec-3-ene-5,9,12,13,14-pentol","TETRODOTOXIN|Spheroidine|Tetrodotoxine|4368-28-9|Tarichatoxin|Babylonia japonica toxin 1|Tetrodoxin|Tectin|BJT 1|Maculotoxin|Pft-1 toxin|tetrodotoxina|Tetrodontoxin|Fugu poison|3KUM2721U9|(4R-(4alpha,4aalpha,5alpha,7alpha,9alpha,10alpha,10abeta,11S*,12S*))-Octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10aH-(1,3)dioxocino(6,5-d) pyrimidine-4,7,10,11,12-pentol|DTXSID10881342|Tetradotoxin|Toxin, Fugu|5,9:7,10A-DIMETHANO-10AH-(1,3)DIOXOCINO(6,5-D)PYRIMIDINE-4,7,10,11,12-PENTOL, 2-AMINO-1,4,4A,5,9,10-HEXAHYDRO-12-(HYDROXYMETHYL)-, (4R,4AR,5R,7S,9S,10S,10AR,11S,12S)-|5,9:7,10a-Dimethano-10aH-(1,3)dioxocino(6,5-d)pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-|Octahydro-12-(hydroxymethyl)-2-imino-5,9:7,10a-dimethano-10aH-(1,3)dioxocino(6,5-d)pyrimidine-4,7,10,11,12-pentol|CHEBI:9506|tetrodotoxinum|(1R,5R,6R,7R,9S,11S,12S,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo(7.3.1.17,11.01,6)tetradec-3-ene-5,9,12,13,14-pentol|(1R,5R,6R,7R,9S,11S,12S,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.17,11.01,6]tetradec-3-ene-5,9,12,13,14-pentol|RefChem:6297|DTXCID101022591|(11S,13S)-3-amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo(7.3.1.17,11.01,6)tetradec-3-en-4-ium-9-olate|(13S)-3-amino-5,12,13,14-tetrahydroxy-14-(hydroxymethyl)-8,10-dioxa-2-aza-4-azoniatetracyclo(7.3.1.17,11.01,6)tetradec-3-en-9-olate|(1R,5R,6R,7R,9S,11S,12R,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo(7.3.1.17,11.01,6)tetradec-3-ene-5,9,12,13,14-pentol|224-458-8|Fugu Toxin|CHEMBL507974|TTX|(1R,5R,6R,7R,9S,11S,12S,13S,14S)-3-amino-14-(hydroxymethyl)-8,10-dioxa-2,4-diazatetracyclo[7.3.1.1~7,11~.0~1,6~]tetradec-3-ene-5,9,12,13,14-pentol (non-preferred name)|tettrodotoxin|UNII-3KUM2721U9|CCRIS 9328|HSDB 3543|9SR|EINECS 224-458-8|BRN 0049176|TETRODOTOXIN [MI]|TETRODOTOXIN [INN]|Tetrodotoxin - citrate free|4-27-00-08206 (Beilstein Handbook Reference)|TETRODOTOXIN [WHO-DD]|SCHEMBL6406675|SCHEMBL29352502|MSK9101|CFMYXEVWODSLAX-QOZOJKKESA-N|BDBM50344821|FT29063|5,9:7,10a-Dimethano-10ah-(1,3)dioxocino(6,5-d)pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-, (4R-(4alpha,4aalpha,5alpha,7alpha,9alpha,10alpha,10abeta,11S*,12S*))-|10-hydroxymethyl-5-imino-(2S)-12,13-dioxa-4,6-diazatetracyclo[7.3.1.13,11.03,8]tetradecane-1,2,7,10,14-pentaol|10-hydroxymethyl-5-imino-(2S)-12,13-dioxa-4,6-diazatetracyclo[7.3.1.13,11.03,8]tetradecane-1,2,7,10,14-pentaolCitrate|5,9:7,10a-Dimethano-10aH-(1,3)dioxocino(6,5-d)pyrimidine-4,7,10,11,12-pentol, octahydro-12-(hydroxymethyl)-2-imino-, (4R,4aR,5R,7S,9S,10S,10aR,11S,12S)-"
ELACRIDAR,119373,,"InChI=1S/C34H33N3O5/c1-40-28-9-5-7-26-32(28)36-31-25(33(26)38)6-4-8-27(31)34(39)35-24-12-10-21(11-13-24)14-16-37-17-15-22-18-29(41-2)30(42-3)19-23(22)20-37/h4-13,18-19H,14-17,20H2,1-3H3,(H,35,39)(H,36,38)",OSFCMRGOZNQUSW-UHFFFAOYSA-N,C34H33N3O5,563.6,"N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-5-methoxy-9-oxo-10H-acridine-4-carboxamide","Elacridar|143664-11-3|GF120918|GF-120918|GF 120918|GG 918|DTXSID90162489|N488540F94|GW120918|4-Acridinecarboxamide, N-(4-(2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)-9,10-dihydro-5-methoxy-9-oxo-|elacridarum|RefChem:136419|DTXCID5084980|878-621-9|N-(4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)-5-methoxy-9-oxo-9,10-dihydroacridine-4-carboxamide|LY-335979|Elacridar [INN]|N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-5-methoxy-9-oxo-10H-acridine-4-carboxamide|MFCD00912604|GG918|Elacridar (GF120918)|N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-5-methoxy-9-oxo-9,10-dihydroacridine-4-carboxamide|CHEMBL396298|Elacridar-d4|GW-120918|N-(4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)-phenyl)-5-methoxy-9-oxo-9,10-dihydroacridine-4-carboxamide|N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide|N-(4-(2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl)phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide|C34H33N3O5|Elacridar?|UNII-N488540F94|R0Z|Elacridar; GF120918|ELACRIDAR [WHO-DD]|MLS006010053|N-(4-(2-(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl)phenyl)-9,10-dihydro-5-methoxy-9-oxo-4-acridine carboxamide|SCHEMBL536983|Elacridar - Bio-X trade mark|orb1305209|Elacridar, >=98% (HPLC)|SCHEMBL29357341|SCHEMBL29368308|GTPL13578|BCP05709|EX-A2228|PXB48151|BDBM50206310|GG-918|GW-918|s7772|AKOS016842744|BCP9000638|CCG-270068|CS-1112|DB04881|FE22653|NCGC00263219-01|NCGC00263219-08|AC-30265|AS-18773|BE300074|HY-50879|SMR002529556|DB-015026|E1371|NS00069563|664E113|BRD-K88807631-001-01-3|Q27095554|4'-(2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLYL)ETHYL)-5-METHOXY-9-OXO-4-ACRIDANCARBOXANILIDE|5-Methoxy-9-oxo-9,10-dihydro-acridine-4-carboxylic acid {4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-amide|N-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-5-methoxy-9-oxo-9,10-dihydroacridine-2-carboxamide|N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide;GF 12091|N-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-9,10-dihydro-5-methoxy-9-oxo-4-acridinecarboxamide;GF 120918;GG   918|N-4-[2-(1,2,3,4-Tetrahydro-6,7-dimethoxy-2-isoquinolinyl)ethyl]phenyl}-9,10-dihydro-5-methoxy-9-oxo-4-acridone carboxamide"
DOXORUBICIN HYDROCHLORIDE,443939,,"InChI=1S/C27H29NO11.ClH/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34;/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3;1H/t10-,13-,15-,17-,22+,27-;/m0./s1",MWWSFMDVAYGXBV-RUELKSSGSA-N,C27H30ClNO11,580.0,"(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride","Doxorubicin Hydrochloride|25316-40-9|Doxorubicin HCl|Adriacin|ADRIAMYCIN HYDROCHLORIDE|Adriamycin PFS|Adriamycin RDF|ADRIAMYCIN, HYDROCHLORIDE|Adriablastina cs|doxorubicin.HCl|hydroxydaunomycin hydrochloride|82F2G7BL4E|DTXSID3030636|Doxorubicini hydrochloridum|Doxorubicin citric acid salt|DTXCID1010636|Liposomal doxorubicin hydrochloride|DOXORUBICIN HYDROCHLORIDE LIPOSOME|5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S,10S)-|FI 106|adriamycine|Farmiblastina|Adrimedac|Doxolem|Doxorubin|Urokit Doxo cell|Urokit Doxo-cell|DOXO cell|DOXO-cell|FI-106|NSC123127|RefChem:5781|DOXIL (LIPOSOMAL)|Hydrochloride, Doxorubicin|Chloridrato de Doxorrubicina|doxorubicin hydrochloride, Liposomal|14-Hydroxydaunorubicin Hydrochloride|Doxorubicin hydrochloride (liposomal)|F.I 106|3-Hydroxyacetyldaunorubicin Hydrochloride|(2S,4S)-4-(3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyloxy)-2,5,12-trihydroxy-2-hydroxyacetyl-7-methoxy-1,2,3,4-tetrahydrotetracene-6,11-dione monohydrochloride|5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8, 9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-|5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-,hydrochloride, (8S-cis)-|L-Lyxo-hexopyranoside, 3b-glycol-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1a-naphthacenyl 3-amino-2,3,6-trideoxy-alpha-, hydrochloride|Rubex|Hydroxydaunorubicin hydrochloride|Adriblastina|Doxil|Doxorubicin (hydrochloride)|Caelyx|MFCD00077757|Adriblastin|Doxorubicin (Adriamycin) HCl|MLS001401460|ADM hydrochloride|(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride|Hydroxydaunorubicin|SMR000058570|DSSTox_CID_10636|DSSTox_RID_80678|DSSTox_GSID_45111|Adrosal|Duxocin|Lipodox|MLS000028393|Lipo-Dox|FI 6804|(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride|(8S,10S)-10-{[(2R,4S,5S,6S)-4-AMINO-5-HYDROXY-6-METHYLOXAN-2-YL]OXY}-6,8,11-TRIHYDROXY-8-(2-HYDROXYACETYL)-1-METHOXY-5,7,8,9,10,12-HEXAHYDROTETRACENE-5,12-DIONE HYDROCHLORIDE|SR-01000003049|C27H30ClNO11|UNII-82F2G7BL4E|Resmycin|CCRIS 740|Doxorubicin hydrochloride [JAN]|icin Hydrochloride|Adriamycin (TN)|DOX base|Adriacin (TN)|(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-a-L-lyxo-hexopyranoside hydrochloride|Prestwick_188|EINECS 246-818-3|Doxorubicin hydrochloride [USP:JAN]|Doxil (TN)|Rubex (TN)|Doxorubicin, free base|CPD000058570|Adriblastina hydrochloride|Doxorubicine hydrochloride|ADRIAMYCIN [IARC]|Doxorubicin hydrochloride?|NCGC00163543-01|SCHEMBL3242|CAS-25316-40-9|MLS000049969|MLS000049970|MLS000049971|MLS000070047|MLS000392861|MLS000392871|MLS000392881|MLS000392891|MLS000392901|MLS000759533|MLS001055359|CHEMBL359744|orb1310036|SCHEMBL29349501|SCHEMBL29567127|CHEBI:31522|BCPP000429|GLXC-06425|HMS1569G18|HMS6018M19|KUC110341C|MSK001346A|EX-A1337|Tox21_110050|Tox21_112061|Tox21_202483|Adriamycin (Doxorubicin Hydrochloride|HB4183|HY-15142R|s1208|AKOS007930231|AKOS015920241|Doxorubicin hydrochloride (JP18/USP)|Tox21_110050_1|AD15377|BCP9000237|CCG-100975|CS-1239|Doxorubicin (hydrochloride) (Standard)|NC00225|DOXORUBICIN HYDROCHLORIDE [MART.]|DOXORUBICIN HYDROCHLORIDE [VANDF]|NCGC00014486-01|NCGC00024415-33|NCGC00024415-36|NCGC00260032-01|NCGC00263918-03|(8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione hydrochloride|AD184265|AS-31687|BD164391|DOXORUBICIN HYDROCHLORIDE [USP-RS]|DOXORUBICIN HYDROCHLORIDE [WHO-DD]|DOXORUBICIN HYDROCHLORIDE [WHO-IP]|HY-15142|SY059508|KSC-230-184-1|DOXORUBICIN HYDROCHLORIDE [EMA EPAR]|Adriamycin;14-Hydroxydaunomycin hydrochloride|Doxorubicin hydrochloride - Bio-X trade mark|NS00093622|D01275|DOXORUBICIN HYDROCHLORIDE [EP MONOGRAPH]|DOXORUBICIN HYDROCHLORIDE [ORANGE BOOK]|EN300-123444|DOXORUBICIN HYDROCHLORIDE [USP MONOGRAPH]|316D409|DOXORUBICIN HYDROCHLORIDE LIPOSOME [VANDF]|DOXORUBICINI HYDROCHLORIDUM [WHO-IP LATIN]|F021790|Doxorubicin hydrochloride, 10 mg/ml aqueous solution|Doxorubicin hydrochloride, 98.0-102.0% (HPLC)|IMX-110 COMPONENT DOXORUBICIN HYDROCHLORIDE|LIPOSOMAL DOXORUBICIN HYDROCHLORIDE [WHO-DD]|SR-01000003049-5|Q27032359|SR-01000003049-10|Z1557399790|Doxorubicin hydrochloride, European Pharmacopoeia (EP) Reference Standard|Doxorubicin hydrochloride, suitable for fluorescence, 98.0-102.0% (HPLC)|Doxorubicin Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material|Doxorubicin hydrochloride, United States Pharmacopeia (USP) Reference Standard|(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride|(8S,10S)-10-(((2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracen|(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dionehydrochloride|(8S,10S)-10-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yloxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione hydrochloride|(8S,10S)-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-GLYCOLOYL-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-5,12-NAPHTHACENEDIONE HYDROCHLORIDE|(8S,10S)-10-[[(2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione Hydrochloride|5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYLACETYL)-1-METHOXY-, HYDROCHLORIDE (8S-CIS)-|5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, hydrochloride, (8S-cis)-|5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxylacetyl)-1-methoxy-, hydrochloride (8S-cis)-|Adriamycin; ADR; Doxorubicin; DOX; Caelyx; (8S,10S)-10-[(3-Amino-2,3 ,6-trideoxy-?-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8, 11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione hydrochloride"
ZOSUQUIDAR,3036703,,"InChI=1S/C32H31F2N3O2/c33-32(34)29-22-7-1-3-9-24(22)31(25-10-4-2-8-23(25)30(29)32)37-17-15-36(16-18-37)19-21(38)20-39-28-13-5-12-27-26(28)11-6-14-35-27/h1-14,21,29-31,38H,15-20H2/t21-,29-,30+,31?/m1/s1",IHOVFYSQUDPMCN-XAKVHENESA-N,C32H31F2N3O2,527.6,"(2R)-1-[4-[(2R,4S)-3,3-difluoro-11-tetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaenyl]piperazin-1-yl]-3-quinolin-5-yloxypropan-2-ol","RefChem:905391|GlyTouCan:G06891UD|G06891UD|Zosuquidar|167354-41-8|Zosuquidar [INN]|Ly335979|AB5K82X98Y|NCGC00274062-01|UNII-AB5K82X98Y|ZQU|ZOSUQUIDAR [MI]|ZOSUQUIDAR [WHO-DD]|CHEMBL444172|orb1689786|CHEMBL3907347|DTXSID9057894|SCHEMBL12432743|SCHEMBL29774029|SCHEMBL29774070|CHEBI:94717|GTPL11788|IHOVFYSQUDPMCN-CPESPADLSA-N|IHOVFYSQUDPMCN-DBEBIPAYSA-O|IHOVFYSQUDPMCN-XAKVHENESA-N|LSM-5782|BDBM50420186|EX-A10900|AKOS027325798|CS-0921|DB06191|NCGC00274062-09|NCGC00386147-04|NCGC00389568-01|HY-15255|NS00073202|NS00073659|RS 33295-198|Q8074586|BRD-K70557564-305-01-0|BRD-K70557564-305-03-6|Q27166515|(2R)-1-[4-[(2R,4S)-3,3-difluoro-11-tetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaenyl]piperazin-1-yl]-3-quinolin-5-yloxypropan-2-ol|(2R)-1-[4-[(2S,4R)-3,3-difluoro-11-tetracyclo[10.4.0.02,4.05,10]hexadeca-1(16),5,7,9,12,14-hexaenyl]piperazin-1-yl]-3-quinolin-5-yloxypropan-2-ol|1-Piperazineethanol, 4-((1aalpha,6alpha,10balpha)-1,1-difluoro-1,1a,6,10b-tetrahydrodibenzo(a,e)cyclopropa(c)cycloheptan-6-yl)-alpha-1((5-quinolinyloxy)methyl-, (alphaR)-"
DOXORUBICIN,31703,,"InChI=1S/C27H29NO11/c1-10-22(31)13(28)6-17(38-10)39-15-8-27(36,16(30)9-29)7-12-19(15)26(35)21-20(24(12)33)23(32)11-4-3-5-14(37-2)18(11)25(21)34/h3-5,10,13,15,17,22,29,31,33,35-36H,6-9,28H2,1-2H3/t10-,13-,15-,17-,22+,27-/m0/s1",AOJJSUZBOXZQNB-TZSSRYMLSA-N,C27H29NO11,543.5,"(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione","doxorubicin|Adriamycin|23214-92-8|Adriablastin|Doxorubicine|Doxorubicinum|Doxorubicina|14-Hydroxydaunomycin|14-Hydroxydaunorubicine|NDC 38242-874|CHEBI:28748|NSC 123127|(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione|NSC-759155|80168379AG|DTXSID8021480|NSC-123127|(1S,3S)-3-glycoloyl-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)-|(8S,10S)-10-{[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy}-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione|(8S-cis)-10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|hydroxydaunomycin|doxorrubicina|Adriablastine|Hydroxyldaunorubicin|(7S,9S)-7-((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl)oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione|(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-5,7,8,9,10,12-hexahydrotetracene-5,12-dione|Hydroxyl Daunorubicin|RefChem:5780|DTXCID301480|L01DB01|(8S-cis)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroacetyl)-1-methoxy-5,12-naphthacenedione|245-495-6|KW-125|Doxil|Adriblastina|Doxorubicine [INN-French]|Doxorubicinum [INN-Latin]|Doxorubicina [INN-Spanish]|Hydroxydaunorubicin|Adriamycin semiquinone|Caelyx|MFCD00869292|CHEMBL53463|NCI-C01514|ADM|(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione|(8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione|5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-|Doxorubicin [USAN:INN:BAN]|ThermoDox|MLS000028393|C27H29NO11|Doxorubicin-hLL1|(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-(methyloxy)-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|(1S,3S)-3,5,12-trihydroxy-3-(hydroxyacetyl)-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydrotetracen-1-yl 3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranoside|Adriblastina (TN)|CCRIS 739|Doxorubicin-P4/D10|HSDB 3070|EINECS 245-495-6|Doxorubicin (USAN/INN)|Doxorubicin-hLL1 conjugate|Doxorubicin-P4/D10 conjugate|Doxorubicin?|UNII-80168379AG|DOXORUBICIN [MI]|Prestwick0_000438|Prestwick1_000438|Prestwick2_000438|Prestwick3_000438|DOXORUBICIN [INN]|ADR|DOXORUBICIN [HSDB]|DOXORUBICIN [USAN]|Probes1_000151|Probes2_000129|DOXORUBICIN [VANDF]|SCHEMBL3243|DOXORUBICIN [MART.]|BSPBio_000456|BSPBio_001031|DOXORUBICIN [WHO-DD]|(1S,3S)-3-Glycoloyl-1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-10-methoxy-6,11-dioxo-1-naphthacenyl-(3-amino-2,3,6-tridesoxy-alpha-L-lyxo-hexopyranosid)|(8S,10S)-10-((3-Amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-8-glycoloyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione|1,2,3,4,6,11-Hexahydro-4beta,5,12-trihydroxy-4-(hydroxyacetyl)-10-methoxy-6,11-dioxonaphthacen-1beta-yl-3-amino-2,3,6-trideoxy-alpha-L-lyxohexopyranoside|10-((3-Amino-2,3,6-trideoxy-D-lyxohexopyranosyl)oxy)-8-glycolcyl-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione|Caelyx (liposomal doxorubicin)|SPBio_002395|BPBio1_000502|cid_443939|GTPL7069|orb1308571|orb2279710|Valrubicin impurity, doxorubicin|SCHEMBL29459849|BDBM22984|BDBM32022|HMS2089H06|(8S,10S)-10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-8-GLYCOLOYL-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-1-METHOXY-5,12-NAPHTHACENEDIONE|5,12-NAPHTHACENEDIONE, 10-((3-AMINO-2,3,6-TRIDEOXY-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-7,8,9,10-TETRAHYDRO-6,8,11-TRIHYDROXY-8-(HYDROXYACETYL)-1-METHOXY-, (8S-CIS)-|GR-319|HY-15142A|LMPK13050001|AKOS015951330|Conjugate of doxorubicin with humanized monoclonal antibody LL1 against CD74|Conjugate of doxorubicin with monoclonal antibody P4/D10 against GP120|DB00997|SMP1_000106|NCGC00024415-35|NCGC00024415-37|NCGC00024415-38|NCGC00024415-40|NCGC00024415-41|NCGC00024415-42|NCGC00024415-61|AC-37453|BP-23114|SY224845|NS00002473|14D928|C01661|D03899|EN300-120698|Epirubicin hydrochloride impurity, doxorubicin-|H11954|Q18936|BRD-K92093830-003-04-3|BRD-K92093830-003-25-8|BRD-K92093830-003-30-8|BRD-K92093830-003-31-6|BRD-K92093830-003-33-2|VALRUBICIN IMPURITY, DOXORUBICIN [USP IMPURITY]|EPIRUBICIN HYDROCHLORIDE IMPURITY C [EP IMPURITY]|DAUNORUBICIN HYDROCHLORIDE IMPURITY D [EP IMPURITY]|EPIRUBICIN HYDROCHLORIDE IMPURITY, DOXORUBICIN- [USP IMPURITY]|(7S,9R)-7-[(2S,4S,5S,6S)-4-Amino-5-hydroxy-6-methyl-oxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione|(7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-9-glycoloyl-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-quinone;hydrochloride|(7S,9S)-7-[(2R,4S,5S,6S)-4-azanyl-6-methyl-5-oxidanyl-oxan-2-yl]oxy-4-methoxy-6,9,11-tris(oxidanyl)-9-(2-oxidanylethanoyl)-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride|(7S,9S)-7-[(4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-6,9,11-trihydroxy-9-(2-hydroxyacetyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione|(7S,9S)-7-[[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyl-2-oxanyl]oxy]-6,9,11-trihydroxy-9-(2-hydroxy-1-oxoethyl)-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione;hydrochloride|(8S,10S)-10-[[(2R,4S,5S,6S)-4-Amino-5-hydroxy-6-methyl-2-tetrahydropyranyl]oxy]-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione|(8S-cis)-10-[(3-Amino-2,3,6-trideoxy-.alpha.-L-lyxo-hexopyranosyl]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-5,12-naphthacenedione|1392315-46-6|5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-alpha-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S,10S)-|5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-|A-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(2-hydroxyacetyl)-1-methoxy-, (8S,10S)-"
GLYBURIDE,3488,,"InChI=1S/C23H28ClN3O5S/c1-32-21-12-9-17(24)15-20(21)22(28)25-14-13-16-7-10-19(11-8-16)33(30,31)27-23(29)26-18-5-3-2-4-6-18/h7-12,15,18H,2-6,13-14H2,1H3,(H,25,28)(H2,26,27,29)",ZNNLBTZKUZBEKO-UHFFFAOYSA-N,C23H28ClN3O5S,494.0,5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide,"glyburide|Glibenclamide|10238-21-8|Glynase|Euglucon|Semi-daonil|Libanil|Glibenclamida|Glibenclamidum|Calabren|Lederglib|HB 419|Glyburide (micronized)|1-(p-(2-(5-Chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexylurea|SX6K58TVWC|5-Chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|NSC-759618|CHEBI:5441|5-chloro-N-[2-(4-{[(cyclohexylcarbamoyl)amino]sulfonyl}phenyl)ethyl]-2-methoxybenzamide|5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxybenzamide|U-26452|U-26,452|U-26,45|N-(4-(beta-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff|HB419|HB420|HB 420|Gliken|Glynase Prestab|Diabetamide 5|5-chloro-N-(2-(4-(((cyclohexylcarbamoyl)amino)sulfonyl)phenyl)ethyl)-2-methoxybenzamide|5-chloro-N-(2-(4-(cyclohexylcarbamoylsulfamoyl)phenyl)ethyl)-2-methoxybenzamide|Diabetamide 2.5|RefChem:5865|A10BB01|4-(2-(5-Chloro-2-methoxybenzoylamino)ethyl)-N-(cyclohexylcarbamoyl)benzenesulfonamide|233-570-6|Glybenclamide|Diabeta|Micronase|Daonil|Maninil|Glybenzcyclamide|Apo-Glibenclamide|Euglucon 5|Azuglucon|Bastiverit|Benclamin|Betanase|Duraglucon|Euglucan|Euglykon|Glibenil|Glucolon|Neogluconin|Orabetic|Prodiabet|Renabetic|Yuglucon|Dibelet|Gilemal|Glibens|Glibil|Glimel|Glimide|Humedia|Suraben|Tiabet|Adiab|Melix|Pira|Med-Glionil|5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)phenethyl)-2-methoxybenzamide|Glibenclamidum [INN-Latin]|C23H28ClN3O5S|Glibenclamida [INN-Spanish]|MFCD00056625|glyburide (glibenclamide)|HB-419|UR 606|Cirara|1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexylurea|Glibenclamide [INN]|U 26452|DTXSID0037237|5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]-amino]sulfonyl]phenyl]-ethyl]-2-methoxybenzamide|Gewaglucon|Glibenbeta|Glidiabet|Glucobene|Glucohexal|Glucoremed|Hexaglucon|Lisaglucon|Normoglucon|Praeciglucon|Cytagon|Euclamin|Glamide|Glibesyn|Glibetic|Gliboral|Glisulin|Glitisol|Glubate|Glucomid|Glucoven|Glycomin|Miglucan|Debtan|Gliban|Gliben|Glibet|Glicem|Gluben|Glyben|Nadib|Sugril|CHEMBL472|Novo-Glyburide|Glibenclamid AL|Gen-Glybe|Norglicem 5|Betanese 5|N-(4-(2-(5-Chloro-2-methoxybenzamido)ethyl)phenylsulfonyl)-N'-cyclohexylurea|Glibenclamid Fabra|Benzamide, 5-chloro-N-(2-(4-((((cyclohexylamino)carbonyl)amino)sulfonyl)phenyl)ethyl)-2-methoxy-|MLS000069721|Glibenclamid Basics|Glibenclamid-Cophar|Glibenclamid Heumann|Semi-Euglucon|Glibenclamid Genericon|5-Chloro-N-[4-(cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide|Hemi-Daonil|Glibenclamid-Ratiopharm|Urea, 1-(p-(2-(5-chloro-2-methoxybenzamido)ethyl)benzenesulfonyl)-3-cyclohexyl-|Benzamide, 5-chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxy-|Glyburide [USAN]|NCGC00015467-11|Abbenclamide|Diabiphage|Glibadone|SMR000058229|Semi-Gliben-Puren N|GBN 5|CAS-10238-21-8|Glibenclamid Riker M.|N-p-[2-(5-Chloro-2-methoxybenzamido)ethyl]benzenesulfonyl-N'-cyclohexylurea|Urea, 1-((p-(2-(chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl-|5-chloro-N-(2-{4-[(cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide|Micronized glyburide|DTXCID8017237|Glycron|1-[[p-[2-(5-Chloro-o-anisamido)ethyl]phenyl]sulfonyl]-3-cyclohexylurea|5-chloro-N-(2-{4-[N-(N-cyclohexylcarbamoyl)sulfamoyl]phenyl}ethyl)-2-methoxybenzamide|Glyburide (USP)|Micronase (TN)|1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea;1-{4-[2-(5-chloro-2-methoxybenzamido)ethyl]benzenesulfonyl}-3-cyclohexylurea|Diabeta (TN)|Glynase (TN)|SR-01000000196|Glyburide [USAN:USP]|EINECS 233-570-6|UNII-SX6K58TVWC|BRN 2230085|Glibenclamid|Amglidia|Delmide|5-chloro-N-(4-[N-(cyclohexylcarbamoyl)sulfamoyl]phenethyl)-2-methoxybenzamide|GBM|Glyburide;5-Chloro-N-[2-[4-[[[(cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-2-methoxybenzamide|Prestwick_569|RP-1127|Spectrum_000250|Tocris-0911|Glybenzcyclamide, 99%|Glibenclamide; Glyburide|Opera_ID_801|GLYBURIDE [MI]|Glibenclamide (Standard)|Prestwick0_000316|Prestwick1_000316|Prestwick2_000316|Prestwick3_000316|Spectrum2_001816|Spectrum3_001327|Spectrum4_001199|Spectrum5_001631|GLYBURIDE [VANDF]|Lopac-G-0639|Probes1_000431|Probes2_000378|UPCMLD-DP006|G 0639|GLIBENCLAMIDE [JAN]|GLYBURIDE [USP-RS]|GLYBURIDE [WHO-IP]|Glibenclamide (JP18/INN)|CBiol_001790|Lopac0_000499|Oprea1_764617|SCHEMBL22009|BSPBio_000312|BSPBio_001351|BSPBio_003053|KBioGR_000071|KBioGR_001897|KBioSS_000071|KBioSS_000730|MLS001077262|BIDD:GT0239|DivK1c_000481|GLIBENCLAMIDE [MART.]|SPECTRUM2300229|SPBio_001831|SPBio_002531|GLIBENCLAMIDE [WHO-DD]|GLIBENCLAMIDE [WHO-IP]|BPBio1_000344|GTPL2414|orb1307954|GLYBURIDE [ORANGE BOOK]|SCHEMBL29355447|UPCMLD-DP006:001|HMS501I03|KBio1_000481|KBio2_000071|KBio2_000730|KBio2_002639|KBio2_003298|KBio2_005207|KBio2_005866|KBio3_000141|KBio3_000142|KBio3_002273|GLYBURIDE [USP MONOGRAPH]|MSK7191|Glibenclamide - Bio-X trade mark|Glybenclamide, >=99% (HPLC)|NINDS_000481|Bio1_000076|Bio1_000565|Bio1_001054|Bio2_000071|Bio2_000551|GLXC-05423|HMS1361D13|HMS1568P14|HMS1791D13|HMS1922L08|HMS1989D13|HMS2089L06|HMS2093P04|HMS2095P14|HMS3259O12|HMS3261D19|HMS3267A15|HMS3402D13|HMS3411F16|HMS3428D15|HMS3651E17|HMS3675F16|HMS3712P14|HMS5079L16|HMS6018I15|Pharmakon1600-02300229|BCP05327|PXB98502|GLIBENCLAMIDE [EP MONOGRAPH]|Glibenclamide for peak identification|Tox21_110158|Tox21_300758|Tox21_500499|BDBM50012957|CCG-39618|GLUCOVANCE COMPONENT GLYBURIDE|HD 419|HY-15206R|NSC759618|NSC813214|SBB057426|STK362992|GLIBENCLAMIDUM [WHO-IP LATIN]|Glyburide - CAS 10238-21-8|AKOS001487495|Tox21_110158_1|BCP9000729|DB01016|FC23675|KS-5326|LP00499|NC00566|NSC 759618|NSC-813214|SB17414|SDCCGSBI-0050483.P004|5-Chloro-N-(4-(N-(cyclohexylcarbamoyl)sulfamoyl)-phenethyl)-2-methoxybenzamide|5-chloro-N-[2-[4-(cyclohexylcarbamoylsulfamoyl)phenyl]ethyl]-2-methoxy-benzamide|IDI1_000481|IDI1_033821|Glibenclamide 1.0 mg/ml in Acetonitrile|NCGC00015467-01|NCGC00015467-02|NCGC00015467-03|NCGC00015467-04|NCGC00015467-05|NCGC00015467-06|NCGC00015467-07|NCGC00015467-08|NCGC00015467-09|NCGC00015467-10|NCGC00015467-12|NCGC00015467-13|NCGC00015467-14|NCGC00015467-15|NCGC00015467-16|NCGC00015467-17|NCGC00015467-18|NCGC00015467-20|NCGC00015467-21|NCGC00015467-36|NCGC00015467-37|NCGC00016689-01|NCGC00023447-02|NCGC00023447-04|NCGC00023447-05|NCGC00023447-06|NCGC00023447-07|NCGC00023447-08|NCGC00023447-09|NCGC00023447-10|NCGC00023447-11|NCGC00023447-12|NCGC00254662-01|NCGC00261184-01|BG166164|HY-15206|ST024780|SY057080|SBI-0050483.P003|Glyburide, meets USP testing specifications|AB00051949|EU-0100499|G0382|NS00001144|S1716|SW195828-5|C07022|D00336|D81733|EN300-117270|M01823|AB00051949-16|AB00051949-17|AB00051949_18|AB00051949_19|Q420626|SR-01000000196-2|SR-01000000196-4|SR-01000000196-5|SR-01000000196-6|SR-01000000196-8|BRD-K36927236-001-06-0|BRD-K36927236-001-17-7|BRD-K36927236-001-30-0|BRD-K36927236-001-31-8|BRD-K36927236-001-32-6|Z277540138|Glybenclamide, European Pharmacopoeia (EP) Reference Standard|Glyburide, United States Pharmacopeia (USP) Reference Standard|1-((p-(2-(5-Chloro-o-anisamido)ethyl)phenyl)sulfonyl)-3-cyclohexyl urea|5-Chloro-N-[4-(3-cyclohexylureidosulfonyl)phenethyl]-2-methoxybenzamide|Glibenclamide for peak identification, European Pharmacopoeia (EP) Reference Standard|Glyburide (Glibenclamide), Pharmaceutical Secondary Standard; Certified Reference Material|N-(4-(.beta.-(2-Methoxy-5-chlorbenzamido)-aethyl)-benzolsulfonyl)-N'-cyclohexyl-harnstoff|N1-[4-({[(cyclohexylamino)carbonyl]amino}sulfonyl)phenethyl]-5-chloro-2-methoxybenzamide|(5-chloro-2-methoxyphenyl)-N-[2-(4-{[(cyclohexylamino)carbonylamino]sulfonyl}p henyl)ethyl]carboxamide|5-Chloro-N-(2-[4-(([(cyclohexylamino)carbonyl]amino)sulfonyl)phenyl]ethyl)-2-methoxybenzamide #|N-[(4-{2-[(5-chloro-2-methoxyphenyl)carbonylamino]ethyl}phenyl)sulfonyl](cyclo hexylamino)carboxamide"
MOSAPRIDE,119584,,"InChI=1S/C21H25ClFN3O3/c1-2-28-20-10-19(24)18(22)9-17(20)21(27)25-11-16-13-26(7-8-29-16)12-14-3-5-15(23)6-4-14/h3-6,9-10,16H,2,7-8,11-13,24H2,1H3,(H,25,27)",YPELFRMCRYSPKZ-UHFFFAOYSA-N,C21H25ClFN3O3,421.9,4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide,"Mosapride|112885-41-3|4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)-2-morpholinyl)methyl)benzamide|Mosart|4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide|mosaprida|I8MFJ1C0BY|4-amino-5-chloro-2-ethoxy-N-({4-[(4-fluorophenyl)methyl]morpholin-2-yl}methyl)benzamide|DTXSID2048408|CHEBI:94373|CHEBI:167204|mosapridum|4-amino-5-chloro-2-ethoxy-N-((4-((4-fluorophenyl)methyl)morpholin-2-yl)methyl)benzamide|4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)-2-morpholinyl]methyl]benzamide|RefChem:159818|DTXCID4028381|A03FA09|Benzamide, 4-amino-5-chloro-2-ethoxy-N-((4-((4-fluorophenyl)methyl)-2-morpholinyl)methyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)|Mosapride [INN]|C21H25ClFN3O3|4-amino-5-chloro-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide|MFCD00867430|CHEMBL60889|Mosapride (INN)|4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide|Mosapride 100 microg/mL in Acetonitrile|UNII-I8MFJ1C0BY|Moza|4-amino-5-chloro-2-ethoxy-N-{[4-(4-fluorobenzyl)morpholin-2-yl]methyl}benzamide|Mosart (TN)|MOSAPRIDE [MI]|MOSAPRIDE [WHO-DD]|SCHEMBL16417|GTPL242|MLS004774042|cid_119583|orb1299196|SCHEMBL29400580|BDBM94630|YPELFRMCRYSPKZ-UHFFFAOYSA-N|HMS3886A05|HMS5083H12|BCP06695|HY-B0189|BBL010131|MSK158555|PDSP1_001757|PDSP2_001740|s4839|STK711184|AKOS005530698|AC-4523|CCG-268905|DB11675|DS-1071|FM26090|(+-)-4-Amino-5-chloro-2-ethoxy-N-((4-(p-fluorobenzyl)-2-morpholinyl)methyl)benzamide|NCGC00160527-02|NCGC00160527-05|SMR003500712|SY102307|DB-041129|D08236|Q68566|AB00698266-07|AB00698266_11|885M413|A802685|F078494|L000932|SR-01000763405|W-60401|SR-01000763405-4|BRD-A39052811-048-11-0|(- )-4-Amino-5-chloro-2-ethoxy-N-((4-(p-fluorobenzyl)-2-morpholinyl)methyl)-benzamide.|4-Amino-5-chloro-2-ethoxy-N-[[4-(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide|4-amino-5-chloro-2-ethoxy-N-[[4-(4-fluorobenzyl)morpholin-2-yl]methyl]benzamide;citric acid|4-Amino-5-chloro-2-ethoxy-N-[[4-(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide;Mosapid;Mosid-MT|4-amino-5-chloro-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]-2-morpholinyl]methyl]benzamide;2-hydroxypropane-1,2,3-tricarboxylic acid|4-Amino-5-chloro-2-ethoxy-N-[4-(4-fluoro-benzyl)-morpholin-2-ylmethyl]-benzamide; citrate(AS-4370)|4-azanyl-5-chloranyl-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide|4-azanyl-5-chloranyl-2-ethoxy-N-[[4-[(4-fluorophenyl)methyl]morpholin-2-yl]methyl]benzamide;2-oxidanylpropane-1,2,3-tricarboxylic acid"
KETOTIFEN,3827,,"InChI=1S/C19H19NOS/c1-20-9-6-13(7-10-20)18-15-5-3-2-4-14(15)12-17(21)19-16(18)8-11-22-19/h2-5,8,11H,6-7,9-10,12H2,1H3",ZCVMWBYGMWKGHF-UHFFFAOYSA-N,C19H19NOS,309.4,"2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one","ketotifen|34580-13-7|Ketotifene|Ketotifeno|Ketotifenum|HC 20-511|4,9-Dihydro-4-(1-methyl-4-piperidinylidene)-10H-benzo(4,5)cyclohepta(1,2-b)thiophen-10-one|DTXSID7023190|X49220T18G|DTXCID203190|CHEBI:92511|10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-|Ketotiphene|Ketotiphen|10-(1-methylpiperidin-4-ylidene)-5H-benzo[1,2]cyclohepta[3,4-b]thiophen-4-one|10H-Benzo(4,5)cyclohepta(1,2-b)thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-|4,9-dihydro-4-(1-methyl-4-piperidinylidene)-10h-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one|10-(1-methylpiperidin-4-ylidene)-5H-benzo(1,2)cyclohepta(3,4-b)thiophen-4-one|2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo(8.4.0.0^(3,7))tetradeca-1(10),3(7),4,11,13-pentaen-8-one|2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.0^{3,7}]tetradeca-1(10),3(7),4,11,13-pentaen-8-one|RefChem:57862|4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo(4,5)-cyclohepta(1,2-b)thiophen-10-one|R06AX17|S01GX08|252-099-7|Ketotifene [INN-French]|Ketotifenum [INN-Latin]|Ketotifeno [INN-Spanish]|Ketotifen (INN)|HC 20511 fumarate|4-(1-methylpiperidin-4-ylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one|2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one|CHEMBL534|MFCD00599548|NCGC00015580-08|KETOTIFEN [INN]|Ketotifen [INN:BAN]|4-(1-Methyl-4-piperidylidene)-9-hydrobenzo[a]thiopheno[3,2-d][7]annulen-10-one|Ketotifene fumarate|Ketotifin|MLS002222254|Alaway (TN)|CAS-34580-13-7|HSDB 7283|SMR001307257|EINECS 252-099-7|BRN 3983897|UNII-X49220T18G|(R)-Ketotifen|Spectrum_000426|Tocris-0784|KETOTIFEN [MI]|KETOTIFEN [HSDB]|Prestwick0_000371|Prestwick1_000371|Prestwick2_000371|Prestwick3_000371|Spectrum2_001198|Spectrum3_001382|Spectrum4_000805|Spectrum5_001395|KETOTIFEN [VANDF]|Lopac-K-2628|4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one|KETOTIFEN [WHO-DD]|SCHEMBL4436|Lopac0_000706|Oprea1_335550|Oprea1_553550|BSPBio_000521|BSPBio_002964|KBioGR_001289|KBioSS_000906|BIDD:GT0509|DivK1c_000111|SPBio_001275|SPBio_002442|BPBio1_000575|GTPL7206|orb1744252|SCHEMBL29356083|BDBM94597|cid_5282408|KBio1_000111|KBio2_000906|KBio2_003474|KBio2_006042|KBio3_002184|cid_45479747|NINDS_000111|GLXC-25233|HMS2090F16|US9138431, KETOTIFEN|US9333199, KETOTIFEN|ALBB-038658|HY-B0157|Tox21_110176|BDBM50002087|STK048448|AKOS000541268|Tox21_110176_1|CCG-204791|DB00920|SDCCGSBI-0050684.P005|IDI1_000111|NCGC00015580-01|NCGC00015580-02|NCGC00015580-03|NCGC00015580-04|NCGC00015580-05|NCGC00015580-06|NCGC00015580-07|NCGC00015580-09|NCGC00015580-10|NCGC00015580-11|NCGC00015580-13|NCGC00015580-23|NCGC00022572-02|NCGC00022572-04|NCGC00022572-05|10H-Benzo[4,5]cyclohepta[1,2-b]thiophen-10-one, 4,9-dihydro-4-(1-methyl-4-piperidinylidene)-, (2E)-2-butenedioate (1:1)|AC-15945|DA-54624|HC-20511|SY420976|SBI-0050684.P004|CAS-34580-14-8|AB00053575|CS-0013637|NS00009685|ST50002662|D08105|F97963|AB00053575-21|AB00053575_22|AB00053575_23|EN300-18530986|L000753|SR-01000000175|Q2458673|SR-01000000175-7|BRD-K28936863-051-05-8|BRD-K28936863-051-18-1|BRD-K28936863-051-31-4|BRD-K28936863-051-32-2|BRD-K28936863-051-33-0|KETOTIFEN HYDROGEN FUMARATE IMPURITY E [EP IMPURITY]|10-(1-methyl-4-piperidinylidene)-5H-benzo[1,2]cyclohepta[3,4-b]thiophen-4-one|10-(1-methyl-4-piperidylidene)-5H-benzo[[?]:[?]]cyclohepta[[?]]thiophen-4-one|10-(1-methyl-4-piperidylidene)-5H-benzo[1,2]cyclohepta[3,4-b]thiophen-4-one;maleate|4,9-Dihydro-4-(1-methyl-4-piperidylidene)-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one|4-(1-methyl-4-piperidylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one|4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one(Ketotifen)|4-(1-Methylpiperidin-4-ylidene)-4H-benzo[4,5]cyclohepta[1,2-b]thiophen-10(9H)-one|(Z)-2-butenedioate;10-(1-methyl-4-piperidinylidene)-5H-benzo[1,2]cyclohepta[3,4-b]thiophen-4-one|(Z)-but-2-enedioate;10-(1-methylpiperidin-4-ylidene)-5H-benzo[1,2]cyclohepta[3,4-b]thiophen-4-one|116655-76-6|2-(1-methyl-4-piperidylidene)-6-thiatricyclo[8.4.0.03,7]tetradeca-1(14),3(7),4,10,12-pentaen-8-one|2-(1-methylpiperidin-4-ylidene)-6-thiatricyclo[8.4.0.0,3,7]tetradeca-1(10),3(7),4,11,13-pentaen-8-one|4-(1-Methyl-4-piperidinylidene)-4,9-dihydro-10H-benzo[4,5]cyclohepta[1,2-b]thiophen-10-one #|4-(1-Methyl-piperidin-4-ylidene)-4,9-dihydro-1-thia-benzo[f]azulen-10-one(Ketotifen hydrogen malate)"
ASPIRIN,2244,,"InChI=1S/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12)",BSYNRYMUTXBXSQ-UHFFFAOYSA-N,C9H8O4,180.16,2-acetyloxybenzoic acid,"aspirin|ACETYLSALICYLIC ACID|50-78-2|2-Acetoxybenzoic acid|2-(Acetyloxy)benzoic acid|O-Acetylsalicylic acid|o-Acetoxybenzoic acid|Acylpyrin|Ecotrin|Salicylic acid acetate|Acenterine|Acetophen|Polopiryna|Acetosalin|Aspirdrops|o-Carboxyphenyl acetate|Pharmacin|Premaspin|Salcetogen|Aceticyl|Acetonyl|Acidum acetylsalicylicum|Benaspir|Empirin|Endydol|Measurin|Rhodine|Saletin|Temperal|Ecolen|Rheumintabletten|Solprin acid|2-acetyloxybenzoic acid|Enterosarine|Acetisal|Acetylsal|Aspirine|Bialpirina|Bialpirinia|Entericin|Enterophen|Globentyl|Salacetin|Solpyron|Acesal|Acisal|Asagran|Asteric|Caprin|Cemirit|Duramax|Extren|Globoid|Helicon|Idragin|Levius|Rhonal|Adiro|Aspro|Novid|Yasta|Acetosalic acid|Benzoic acid, 2-(acetyloxy)-|Acimetten|Delgesic|Entrophen|Acetilum acidulatum|Acetilsalicilico|2-Carboxyphenyl acetate|Dolean pH 8|Contrheuma retard|XAXA|Acido acetilsalicilico|Acide acetylsalicylique|Bayer|8-hour Bayer|Asatard|Durlaza|Ronal|Rheumin tabletten|2-Acetoxybenzenecarboxylic acid|acetyl salicylate|Acetylsalicylsaeure|Azetylsalizylsaeure|SP 189|AC 5230|Acetylsalicyclic acid|Acetylsalicylicum acidum|DTXSID5020108|CHEBI:15365|o-(Acetyloxy)benzoic acid|NSC-27223|acide 2-(acetyloxy)benzoique|Bayer Extra Strength Aspirin for Migraine Pain|NSC-406186|R16CO5Y76E|BAY1019036|DTXCID50108|DUOCOVER COMPONENT ASPIRIN|YOSPRALA COMPONENT ASPIRIN|DUOPLAVIN COMPONENT ASPIRIN|NSC406186|CLOPIDOGREL/ACETYLSALICYLIC ACID COMPONENT ASPIRIN|Acid, Acetylsalicylic|vetality|Ascurin|Danamep|Fasprin|Gencardia|Medpurine|Paynocil|Enprin|Platet|Disprin direct|Micropirin ec|Solves-aspirin|Aramark Aspirin|Aspirin Powder|Aspirin Regimen|Canine Aspirin|Clopidogrel Kit|Coated Aspirin|Enteric Aspirin|Equate Aspirin|Leader Aspirin|Medique Aspirin|Rapidol Aspirin|Sunmark Aspirin|Topcare Aspirin|Acetylsalic acid|Alka rapid|Aspirin Bolus|Aspirin Nsaid|Aspirin Packs|AspirinLow Dose|Bayer Aspirin|Disprin cv|Pain Reliever|Rugby Aspirin|Value Pharma|Aspro clr|Aspi-cor|Aspirin Chewable|Buffered Aspirin|Chewable Aspirin|Geritrex Aspirin|Plus Pharma|Regular Strength|Thompson Aspirin|McKesson Aspirin|Anadin all night|Aspir Low|Equi-Prin|Aspirin EC|Childrens Aspirin|Unishield Aspirin|Adult Low Dose|Bayer Low Dose|Aspirin 5 Grain|Aspirin Low Dose|Low Dose Aspirin|Bufferin Arthritis|ULINE Aspirin|CAREALL Aspirin|Aspica (Aspirin)|Aspirin 81mg|Dg Health Aspirin|Low Dose Miniprin|Angettes 75|Medi-first Aspirin|aspirin pain relief|Basic Care Aspirin|Good Sense Aspirin|Aspirin 325mg|Aspirin 81|Aspirin 81 mg|Health Mart Aspirin|MBR Aspirin Powder|Pain Relief Aspirin|Max strgh aspro clr|AsCurin Fast Action|Aspirin 325 mg|Aspirin Pain reliver|Postmi 75|RefChem:17|Tri-buffered Aspirin|Aspirin 325|Aspirin 50 CT|Aspirin Low Strength|ASPIRN|ASPRISOL|Crane Safety Aspirin|Henry Schein Aspirin|Nu-seals 75|Travel Savvy Aspirin|VAZALORE|Solves-aspirin Cherry|Adult Aspirin Regimen|Aspirin Bolus-240|Bayer Aspirin Regimen|Bayer Genuine Aspirin|Direct Safety Aspirin|Nu-seals cardio 75|Rapid Comfort Aspirin|MEDIQUE ASPIRN|Platet 300|Postmi 300|Nu-seals 300|Nu-seals 600|Adult Chewable Aspirin|Aspirin Enteric Coated|Aspirin Extra Strength|Enteric Coated Aspirin|Extra Strength Aspirin|ADVANCED ASPIRIN|VALUMEDS ASPIRIN|Aspirin Delayed Release|Aspirin tablet 325mg|Chewable Aspirin 81mg|Dye-Free Aspirin 81|Equate Aspirin Chewable|Physicians Care Aspirin|Adult Low Dose Aspirin|Aspirin Adult Low Dose|Low dose aspirin 81mg|Medique at Home Aspirin|Aspirin 81mg Dye-Free|Aspirin Regular Strength|Ecotrin Regular Strength|Leader Low Dose Aspirin|Medi-First Plus Aspirin|Medique Products Aspirin|Regular Strength Aspirin|Circle K Aspirin 325|Pharbest Aspirin 325mg|foster and thrive aspirin|AquaSource Aspirin Powder|AspirinLow Dose Low Dose|Value PharmaPain Reliever|meijer LOW DOSE Aspirin|Aspirin Chewable Low Dose|Aspirin Liquid Concentrate|Aspirin Low Dose Chewable|BAYER 500 mg|Chewable Aspirin Low Dose|Chewable Low Dose Aspirin|Chronic Pain/Fever Relief|Low Dose Chewable Aspirin|Aspirin 81 Mg Low Dose|aspirin chewable, low dose|CARDIASPIRIN PROTECT|NobleAid PAIN RELIEVER|Acetylsalicylic Acid Coated|Adult Low Strength Aspirin|ASPIRIN 480|Up and Up Chewable Aspirin|ASPIRIN BOLUS-480|Regular Strength Aspirin EC|Plus Pharma Nsaid 325 mg|Alka-Seltzer Original Flavor|Aspirin 81mg Enteric coated|Critical Care Aspirin To Go|ASPIRIN 325 MG EC|HEB Effervescent Pain Relief|Adult Low Dose Pain Reliever|Aspirin Enteric Safety Coated|Aspirin Enteric Safety-coated|Dr. Waynes Aspirin Low Dose|Family Wellness Pain Reliever|Low Strength Chewable Aspirin|Pain Relief Aspirin Low Dose|St. Joseph Low Dose Aspirin|Aspirin 81mg Adult Low Dose|BAYER Aspirin Extra Strength|Lil Drug Store Aspirin 325|Aspirin 81 mg Enteric Coated|Aspirin Low Strength, Enteric|Bayer Aspirin Regimen Chewable|Bayer Chewable-Aspirin Regimen|Good Neighbor Pharmacy Aspirin|Rapidol Aspirin Display 2x25|CVS Effervescent Pain Reliever|Adult Aspirin Regimen Low Dose|Aspirin Low Dose Safety Coated|Meijer Effervescent Pain Relief|Chewable Aspirin Adult low dose|Aspen Aspirin Liquid Concentrate|Aspirin Enteric Coated Low Dose|Aspirin Low Dose Enteric Coated|Buffered Aspirin For Small Dogs|Chewable Adult Low Dose Aspirin|MBR Aspirin Bolus 240 Grains|TopCare Effervescent Pain Relief|Aspirin Low Dose Chewable Orange|Pharbest Regular Strength Aspirin|First Aid Direct Chewable Aspirin|Regular Strength Aspirin 325 mg|Pain Reliever / Low Dose Aspirin|Drug Mart Effervescent Pain Relief|Equaline Effervescent Pain Reliever|Sunmark Aspirin Adult Low Strength|Value Pharma Aspirin Pain Reliever|Good Sense Effervescent Pain Relief|AquaPrime Aspirin Liquid Concentrate|Bayer Aspirin Regimen enteric coated|Green Guard Chewable Aspirin 81 mg|AquaSource Aspirin Liquid Concentrate|Bayer Aspirin Extra Strength Caplets|Buffered aspirin, effervescent tablet|Winco Foods Effervescent Pain Relief|Bufferin Regular Strength Pain Relief|Adult Low Dose Aspirin Enteric Coated|Adult Low Dose Enteric Coated Aspirin|Aspirin Enteric Coated Tablets 81 mg|BAYER Aspirin Original, CVP HEALTH|Market Basket Effervescent Pain Relief|St. Joseph Chewable Low Dose Aspirin|Aspirin 81 mg Delayed Release Tablets|Low Dose Aspirin Enteric Safety Coated|Low Dose Aspirin Enteric Safety-Coated|Safety Coated Aspirin 81 mg Low Dose|Acido Acetilsalicilico With enteric coat|BAYER Aspirin Original, TRAVEL BASIX|Enteric Coated Aspirin Regular Strength|Low Dose Miniprin Enteric Safety Coated|Pain Relief Aspirin Chewable, Low Dose|Quality Choice Effervescent Pain Relief|Regular Strength Enteric Coated Aspirin|Right Remedies Aspirin Low Dose 81 mg|Aspirin Delayed Release Tablets, 81 mg|Aspirin Enteric Coated, Regular Strength|Coraspirin 81 mg Enteric Coasted Tablet|FIRST CHOICE ASPIRIN BOLUS-480grs|Value Pharmapain Reliever Extra Strength|Dollar General Effervescent Pain Reliever|Best Choice Effervescent Pain Reliever 36|Buffered Aspirin For Medium to Large Dogs|Cardioaspirin 81 mg Enteric Coated Tablet|Medique Products Chewable Low Dose Aspirin|FIRST CHOICE dairy supply ASPIRIN BOLUS|Aspirin 81mg Enteric coated Delayed Release|Adult Low Dose Aspirin Enteric Safety Coated|Publix Fast Relief Effervescent-Original Flavor|Safety Coated Aspirin 325 mg Regular Strength|Coraspirina 81 mg Tabletas con cubierta enterica|Gencare-Aspirin Low Dose Pain reliever (NSAID)|Cardiospirina 81 mg Tabletas con cubierta enterica|Natural Aspirin plus Tart Cherry Dietary Supplement|ASPIRIN LOW DOSE CHEWABLE ORANGE PAIN RELIEVER|Bayer Aspirin Regimen Chewable Low Dose Aspirin Orange|Aspirin 81mg Enteric coated Low Strength Aspirin Regimen|Natural Aspirin plus Immune Supporting Dietary Supplement|Natural Aspirin plus Lemon and Honey Dietary Supplement|Bayer Chewable-Aspirin Regimen Low Dose Aspirin Cherry Flavored|200-064-1|Acetosal|Easprin|Colfarit|Enterosarein|Acetylin|Micristin|Claradin|Clariprin|Neuronika|Decaten|Pirseal|Solfrin|Aspec|Triple-sal|Spira-Dine|ZORprin|Bi-prin|Persistin|A.S.A. empirin|ASA|Endosprin|Kapsazal|Solprin|Acetylsalicylsaure|acetyl salicylic acid|Tasprin|Nu-seals aspirin|Salicylic acid, acetate|Acido O-acetil-benzoico|Kyselina acetylsalicylova|St. Joseph Aspirin for Adults|A.S.A.|St. Joseph|Kyselina 2-acetoxybenzoova|Acetard|S-211|MFCD00002430|Aspirin (Standard)|ECM|2-(acetyloxy)benzoate|benzoic acid, 2-acetoxy-|Acetylsalicylic acid (who-ip)|Aspirin form II|component of Midol|NSC27223|component of Synirin|component of Zactirin|component of Coricidin|component of Persistin|component of Robaxisal|o-Acetoxybenzoate|NCGC00015067-04|Acetysal|ACIDUM ACETYLSALICYLICUM (WHO-IP)|Istopirin|Magnecyl|Medisyl|Polopirin|Bayer Buffered|Aspro Clear|component of Ascodeen-30|Bayer Plus|WLN: QVR BOV1|aspirin (acetylsalicylic acid)|Aspirina 03|Acetylsalycilic acid|component of Darvon with A.S.A|Bayer Aspirin 8 Hour|Asaphen|Aspalon|Asprin|Bayer Children's Aspirin|Nu-seals|component of St. Joseph Cold Tablets|Aspir-Mox|Durlaza ER|Acetylsalicylsaure [German]|CAS-50-78-2|Acetoxybenzoic acid|Acetysalicylic acid|AIN|SMR000059138|Ascoden-30|CCRIS 3243|HSDB 652|Acide acetylsalicylique [French]|Acido acetilsalicilico [Italian]|Kyselina acetylsalicylova [Czech]|Acido O-acetil-benzoico [Italian]|SR-01000075668|Kyselina 2-acetoxybenzoova [Czech]|EINECS 200-064-1|NSC 27223|Aspirin [USP:BAN:JAN]|Bayer Enteric 325 mg Regular Strength|BRN 0779271|Bay E4465|UNII-R16CO5Y76E|Aspropharm|Bayer Enteric 81 mg Adult Low Strength|Cardioaspirin|Cardioaspirina|Acetyonyl|Asacard|Ascolong|Bayer Enteric 500 mg Arthritis Strength|Colsprin|Miniasal|Salospir|Acesan|Toldex|AI3-02956|1oxr|2-Acetoxybenzoate|Aspalon (JAN)|Durlaza (TN)|Easprin (TN)|acetyl-salicylic acid|acetyl salicyclic acid|o-(Acetyloxy)benzoate|Percodan (Salt/Mix)|Ascriptin (Salt/Mix)|Micrainin (Salt/Mix)|2-acetoxy benzoic acid|Acetylsalicylic acidASA|Spectrum_001245|2-Acetylsalicyclic acid|ASPIRIN [VANDF]|ASPIRIN [HSDB]|Salicylic acid, acetyl-|ASPIRIN [JAN]|ASPIRIN [MI]|CHEMBL25|ASPIRIN [MART.]|Spectrum2_001899|Spectrum3_001295|Spectrum4_000099|Spectrum5_000740|Aspirin (JP18/USP)|Lopac-A-5376|Salycylacetylsalicylic acid|ASPIRIN [USP-RS]|Epitope ID:114151|Percodan Demi (Salt/Mix)|Soma Compound (Salt/Mix)|EC 200-064-1|PL2200 component aspirin|Acetylsalicylic acid, 99%|cid_2244|Pravigard PAC (Salt/Mix)|SCHEMBL1353|2-(Acetyloxy)-benzoic acid|Aspirin-PC component aspirin|Bay-e-4465|Lopac0_000038|KBioGR_000398|KBioGR_002271|KBioSS_001725|KBioSS_002272|4-10-00-00138 (Beilstein Handbook Reference)|MLS001055329|MLS001066332|MLS001336045|MLS001336046|ASPIRIN [ORANGE BOOK]|BIDD:GT0118|DivK1c_000555|SPECTRUM1500130|PA-32540 component aspirin|SPBio_001838|Acetylsalicylic acid, >=99%|AXOTAL COMPONENT ASPIRIN|AZDONE COMPONENT ASPIRIN|CODOXY COMPONENT ASPIRIN|GTPL4139|orb1311035|SCHEMBL1369714|SCHEMBL6200251|ASPIRIN [USP MONOGRAPH]|O-Acetylsalicylic acid; Aspirin|SCHEMBL29350479|Acetylsalicylic acid-carboxy-14c|AGGRENOX COMPONENT ASPIRIN|BDBM22360|EXCEDRIN COMPONENT ASPIRIN|FIORINAL COMPONENT ASPIRIN|HMS501L17|KBio1_000555|KBio2_001725|KBio2_002271|KBio2_004293|KBio2_004839|KBio2_006861|KBio2_007407|KBio3_002149|KBio3_002751|NORGESIC COMPONENT ASPIRIN|PERCODAN COMPONENT ASPIRIN|Q-GESIC COMPONENT ASPIRIN|ROXIPRIN COMPONENT ASPIRIN|VICOPRIN COMPONENT ASPIRIN|Empirin with Codeine (Salt/Mix)|MSK9019|Acetylsalicylic acid, >=99.0%|cMAP_000006|component of Zactirin (Salt/Mix)|EQUAGESIC COMPONENT ASPIRIN|INVAGESIC COMPONENT ASPIRIN|LANORINAL COMPONENT ASPIRIN|MICRAININ COMPONENT ASPIRIN|NINDS_000555|ROBAXISAL COMPONENT ASPIRIN|HMS1920E13|HMS2090G03|HMS2091K13|HMS2233L18|HMS3260G17|HMS3372N15|HMS3656N14|HMS3715P19|HMS3866L03|HMS3885G03|HMS5081M04|HMS6018L04|Pharmakon1600-01500130|BCP21790|ORPHENGESIC COMPONENT ASPIRIN|STR01551|ACETYLSALICYLIC ACID; ASPIRIN|SYNALGOS-DC COMPONENT ASPIRIN|Tox21_110076|Tox21_202117|Tox21_300146|Tox21_500038|CCG-39490|HY-14654R|NSC755899|s3017|SBB015069|STL137674|ACETYLSALICYLIC ACID [WHO-DD]|AKOS000118884|component of Ascodeen-30 (Salt/Mix)|MEPRO-ASPIRIN COMPONENT ASPIRIN|PERCODAN-DEMI COMPONENT ASPIRIN|PRAVIGARD PAC COMPONENT ASPIRIN|SOMA COMPOUND COMPONENT ASPIRIN|Tox21_110076_1|ACETYLSALICYLIC ACID [EMA EPAR]|ACETYLSALICYLICUM ACIDUM [HPUS]|CS-2001|DB00945|FA17179|LP00038|NSC-755899|PL-2200|SDCCGSBI-0050027.P005|BAY-1019036|DARVON COMPOUND COMPONENT ASPIRIN|IDI1_000555|INVAGESIC FORTE COMPONENT ASPIRIN|TALWIN COMPOUND COMPONENT ASPIRIN|ACETYLSALICYLIC ACID [GREEN BOOK]|Acetylsalicylic acid, analytical standard|NCGC00015067-01|NCGC00015067-02|NCGC00015067-03|NCGC00015067-05|NCGC00015067-06|NCGC00015067-07|NCGC00015067-08|NCGC00015067-09|NCGC00015067-10|NCGC00015067-11|NCGC00015067-12|NCGC00015067-13|NCGC00015067-14|NCGC00015067-24|NCGC00015067-26|NCGC00090977-01|NCGC00090977-02|NCGC00090977-03|NCGC00090977-04|NCGC00090977-05|NCGC00090977-06|NCGC00090977-07|NCGC00254034-01|NCGC00259666-01|NCGC00260723-01|AC-37704|Aspirin, meets USP testing specifications|DA-61272|HY-14654|NCI60_002222|ORPHENGESIC FORTE COMPONENT ASPIRIN|ST075414|ACETYLSALICYLIC ACID [EP MONOGRAPH]|SBI-0050027.P004|DS-017139|UNM-0000306102|A2262|component of Darvon with A.S.A (Salt/Mix)|CS-0694916|EU-0100038|NS00000658|SW199665-2|CARISOPRODOL COMPOUND COMPONENT ASPIRIN|EN300-19606|A 5376|Acetylsalicylic Acid 1.0 mg/ml in Acetonitrile|C01405|D00109|E80792|Q18216|AB00051918-08|AB00051918_09|AB00051918_10|F358239|Arthritis Pain Formula Maximum Strength (Salt/Mix)|SR-01000075668-1|SR-01000075668-4|SR-01000075668-6|BRD-K11433652-001-16-2|BRD-K11433652-001-17-0|BRD-K11433652-001-18-8|Acetylsalicylic acid, Vetec(TM) reagent grade, >=99%|Aspirin, British Pharmacopoeia (BP) Reference Standard|F2191-0068|Z104474430|Aspirin, United States Pharmacopeia (USP) Reference Standard|D41527A7-A9EB-472D-A7FC-312821130549|Acetylsalicylic acid, European Pharmacopoeia (EP) Reference Standard|Acetylsalicylic acid, BioReagent, plant cell culture tested, >=99.0%|2-Acetoxybenzoic acid;2-(Acetyloxy)benzoic acid;Acylpyrin;Aspirin;Aspirin granular|Acetylsalicylic acid for peak identification, European Pharmacopoeia (EP) Reference Standard|InChI=1/C9H8O4/c1-6(10)13-8-5-3-2-4-7(8)9(11)12/h2-5H,1H3,(H,11,12|11126-35-5|Aspirin (Acetyl Salicylic Acid), Pharmaceutical Secondary Standard; Certified Reference Material"
IBUPROFEN,3672,,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)",HEFNNWSXXWATRW-UHFFFAOYSA-N,C13H18O2,206.28,2-[4-(2-methylpropyl)phenyl]propanoic acid,"58560-75-1|RefChem:6648|IBUPROFEN, (+-)-|ibuprofen|15687-27-1|2-(4-Isobutylphenyl)propanoic acid|Motrin|Brufen|Advil|Nurofen|Medipren|Dolgit|Liptan|Nuprin|Anflagen|Buburone|Butylenin|Ibuprocin|Ebufac|Lamidon|2-[4-(2-methylpropyl)phenyl]propanoic acid|Mynosedin|Apsifen|Epobron|Haltran|Ibumetin|Roidenin|Trendar|Adran|Andran|Bluton|Nobfen|Nobgen|PediaProfen|Rufen|Ibuprohm|Nobfelon|Brufort|Burana|Inabrin|Pantrop|Rebugen|Suspren|Tabalon|(RS)-Ibuprofen|Anco|Urem|Ibu-slo|Brufanic|Napacetin|Ibufen|Ibuprin|Profen|Midol|4-Isobutylhydratropic acid|Cap-Profen|Tab-Profen|(+/-)-Ibuprofen|Ibu-Tab|p-Isobutylhydratropic acid|Ibuprofeno|Proartinal|Dibufen|Optifen|Ostofen|Panafen|Proflex|Quadrax|Uprofen|Carol|Dolgin|Cobo|(+-)-Ibuprofen|Artril 300|4-Isobutyl-alpha-methylphenylacetic acid|Midol 200|duralbuprofen|Butacortelone|Amibufen|Caldolor|Dolgirid|Ibuprofene|Ibuprofenum|Lebrufen|Seclodin|Amelior|Femadon|Ibutid|Inoven|alpha-(4-Isobutylphenyl)propionic acid|Brufen Retard|Ibu-Attritin|Dolo-Dolgit|ACHES-N-PAIN|IP-82|Esprenit|(+-)-p-Isobutylhydratropic acid|Pedea|RD 13621|Hydratropic acid, p-isobutyl-|IB-100|(4-Isobutylphenyl)-alpha-methylacetic acid|U-18,573|p-Isobutyl-2-phenylpropionic acid|(+-)-2-(p-Isobutylphenyl)propionic acid|alpha-(p-isobutylphenyl)propionic acid|rac Ibuprofen|Racemic ibuprofen|alpha-p-Isobutylphenylpropionic acid|MFCD00010393|(+-)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Benzeneacetic acid, .alpha.-methyl-4-(2-methylpropyl)-|CHEBI:5855|Ibren|2-(4-ISOBUTYLPHENYL)PROPIONIC ACID|Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-|(+/-)-p-Isobutylhydratropic acid|2-(p-Isobutylphenyl)propionic acid|Novoprofen|Amersol|Dolocyl|Lidifen|Paxofen|Rafen|WK2XYI10QM|Ibu|alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|CHEMBL521|Ifen|U-18573|2-(4-Isobutyl-phenyl)-propionic acid|NSC-256857|alpha-Methyl-4-(isobutyl)phenylacetic acid|MLS000069733|(+/-)-2-(4-Isobutylphenyl)Propanoic Acid|Balkaprofen|Betaprofen|Daiprophen|Jenaprofen|Antagil|Antalfene|Antarene|Antiflam|Artofen|Bruflam|Bufigen|Bukrefen|Buracaps|Citalgan|Combiflam|Dansida|Dentigoa|Dignoflex|Dolmaral|Dolofen|Dolofort|Dologel|Dolomax|Doloren|Doltibil|Dorival|DTXSID5020732|Duobrus|Dysdolen|Easifon|Exneural|Femafen|Femapirin|Femidol|Fenspan|Fibraflex|Gelufene|Gynofug|Ibubest|Ibubeta|Ibucasen|Ibudolor|Ibuflamar|Ibugesic|Ibuhexal|Ibulagic|Ibuleve|Ibulgan|Ibumerck|Ibupirac|Junifen|Kratalgin|Librofem|Malafene|Manypren|Mensoton|Neobrufen|Nerofen|Noalgil|Nobafon|Noritis|Novadol|Novogent|Nuprilan|Opturem|Oralfene|Ostarin|Paduden|Perofen|R.D. 13621|Ranofen|Relcofen|Rhinadvil|Sadefen|Salivia|Sednafen|Seklodin|Seskafen|Siyafen|Solpaflex|Sugafen|Suprafen|Syntofene|Tatanal|Unipron|Alaxan|Anafen|Artril|Brofen|Bufeno|Bupron|Dolibu|Dolven|Duafen|Emflam|Eputex|Faspic|Fenbid|Fendol|Grefen|Ibudol|Ibufug|Ibugel|Ibugen|Ibular|Ibulav|Ibumed|Ibusal|Inflam|Isodol|Lopane|Melfen|Moment|Narfen|Ozonol|Provon|Stelar|Tempil|Bloom|Cesra|Cunil|Dalsy|Ergix|Gofen|Ipren|Irfen|Kesan|Rofen|Rufin|Rupan|Tofen|Tonal|Upfen|Zafen|Zofen|Drin|Ibol|M01AE01|Pediatric Advil|Apo-Ibuprofen|Neo-Helvagit|Deep Relief|Ibu-slow|Novo-Profen|Neo-Mindol|Dolofen-F|Donjust B|Nagifen-D|Dura-Ibu|Children's Advil|Motrin IB|Togal N|Children's Motrin|NSC256857|Ibu-Tab 200|.alpha.-(p-isobutylphenyl)propionic acid|Children's Ibuprofen|NCGC00015529-09|Dularbuprofen|.alpha.-(4-Isobutylphenyl)propionic acid|Acide (isobutyl-4 phenyl)-2 propionique|Ibuprophen|SMR000058184|Tabalon 400|Junior Strength Advil|(+/-)-2-(p-isobutylphenyl)propionic acid|4-Isobutyl-.alpha.-methylphenylacetic acid|Brufen 400|Emflam-200|Kontagripp Mono|DOLO PUREN|Junior Strength Motrin|Novo Dioxadol|Schmerz-Dolgit|Act-3|Ak+C2278tren|Hemagene Tailleur|Advil Liqui-Gels|Adex 200|Junior Strength Ibuprofen|Advil, Children's|Am-Fam 400|Codral Period Pain|Children's Elixsure|(+-)-Ibuprophen|DTXCID90732|.alpha.-Methyl-4-(2-methylpropyl)benzeneacetic acid|Midol IB Cramp Relief|Alivium|Advil migraine|Bayer Select Pain Relief|Ibuprofene [INN-French]|Ibuprofenum [INN-Latin]|Perrigo ibuprofen|Ibuprofeno [INN-Spanish]|MOTRIN MIGRAINE PAIN|Motrin IB Gelcaps|rac Ibuprofen (1.0 mg/mL in Methanol)|UCB 79171|alpha-(4-Isobutylphenyl)propionate|CAS-15687-27-1|Motrin (TN)|CCRIS 3223|Advil (TN)|CHILDREN'S ADVIL-FLAVORED|HSDB 3099|Children's Elixsure IB|SR-01000000214|EINECS 239-784-6|UNII-WK2XYI10QM|Advil Migraine Liqui-Gels|U 18573|NSC 256857|BRN 2049713|Ibupril|Ibuprox|Aktren|Ibux|CDT-ibuprofen|Nurofen Meltlets|(y)-Ibuprofen|Midol Liquid Gels|(+) ibuprofen|Ibuprofen (Advil)|Acide (isobutyl-4-phenyl)-2 propionique [French]|Isobutylpropanoicphenolic acid;(RS)-2-(4-(2-Methylpropyl)phenyl)propanoic acid;Racemic ibuprofen|(?)-Ibuprofen|Ibuprofen [USAN]|Ibuprofen (Standard)|p-Isobutylhydratropate|Ibuprofen [USAN:USP:INN:BAN:JAN]|Combunox (Salt/Mix)|(A+/-)-Ibuprofen|Spectrum_000849|Acide (isobutyl-4-phenyl)-2 propionique|IBUPROFEN [INN]|IBUPROFEN [JAN]|Opera_ID_554|IBUPROFEN [MI]|IBUPROFEN [HSDB]|Spectrum2_000129|Spectrum3_000465|Spectrum4_000015|Spectrum5_000862|IBUPROFEN [VANDF]|WLN: QVY&R DIY|CBMicro_005634|Epitope ID:139973|IBUPROFEN [MART.]|p-isobutyl-hydratropic acid|EC 239-784-6|I 4883|Cambridge id 5152402|IBUPROFEN [USP-RS]|IBUPROFEN [WHO-DD]|IBUPROFEN [WHO-IP]|SCHEMBL3001|Isobutylpropanoicphenolic acid|Lopac0_000691|BSPBio_002170|IBUPROFEN [EMA EPAR]|KBioGR_000389|KBioSS_001329|MLS001146965|p-Isobutyl-2-phenylpropionate|BIDD:GT0050|DivK1c_000887|SPECTRUM1500347|Ibuprofen - Bio-X trade mark|Ibuprofen, >=98% (GC)|SPBio_000178|Ibuprofen (JP17/USP/INN)|Ibuprofen, 1mg/ml in Methanol|alpha-p-Isobutylphenylpropionate|GTPL2713|Motrin IB Gelcaps (Salt/Mix)|IBUPROFEN [ORANGE BOOK]|2-p-isobutylphenylpropionic acid|IBUPROFEN [EP MONOGRAPH]|IBUPROFEN [USP IMPURITY]|HEFNNWSXXWATRW-UHFFFAOYSA-|HMS502M09|KBio1_000887|KBio2_001329|KBio2_003897|KBio2_006465|KBio3_001390|Advil Cold & Sinus (Salt/Mix)|IBUPROFEN [USP MONOGRAPH]|MSK7157|Ibuprofen 1.0 mg/ml in Methanol|NINDS_000887|Sine-Aid IB Caplets (Salt/Mix)|Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl), (+-)-|HMS1920F15|HMS2089P05|HMS2091N03|HMS2230N04|HMS3259G05|HMS3262K03|HMS3372M09|HMS3649M11|HMS3651A15|HMS3884I04|HMS5079J04|HMS5087B05|Pharmakon1600-01500347|COMBUNOX COMPONENT IBUPROFEN|IBUPROFENUM [WHO-IP LATIN]|ALBB-025647|BCP10423|BCP20325|BCP25225|EDC64344|REPREXAIN COMPONENT IBUPROFEN|ZAG-1701|( inverted question mark)-Ibuprofen|(.+-.)-p-Isobutylhydratropic acid|Children's Elixsure IB (Salt/Mix)|Tox21_110170|Tox21_201384|Tox21_302829|Tox21_500691|1189866-35-0 (unlabeled)|2-(4'-isobutylphenyl)propionic acid|2-(4-isobutylphenyl) propanoic acid|2-(4-isobutylphenyl) propionic acid|2-(4-isobutylphenyl)-propionic acid|BBL010660|BDBM50009859|CCG-38947|COMBOGESIC COMPONENT IBUPROFEN|HY-78131R|NSC757073|s1638|SBB064160|STK177358|VICOPROFEN COMPONENT IBUPROFEN|(.+/-.)-p-Isobutylhydratropic acid|2-(4-isobutylphenyl)-propionoic acid|2-(4'-isobutylphenyl)-propionic acid|AKOS003237488|AKOS016340658|Propanoic acid, 2-(4-isobutylphenyl)|Tox21_110170_1|CS-1931|DB01050|FI15848|KS-5029|LP00691|NC00458|NSC-757073|SB19113|SDCCGSBI-0050669.P005|SINE-AID IB COMPONENT IBUPROFEN|ST-1482|alpha-(4-isobutylphenyl)-propionic acid|alpha-(p-isobutylphenyl)-propionic acid|IDI1_000887|2-(4-Isobutylphenyl)propionic Acid-d3;|NCGC00015529-04|NCGC00015529-05|NCGC00015529-06|NCGC00015529-07|NCGC00015529-08|NCGC00015529-10|NCGC00015529-12|NCGC00015529-13|NCGC00015529-14|NCGC00015529-15|NCGC00015529-18|NCGC00015529-32|NCGC00089819-02|NCGC00089819-03|NCGC00089819-04|NCGC00089819-05|NCGC00089819-06|NCGC00089819-07|NCGC00256416-01|NCGC00258935-01|NCGC00261376-01|AC-11312|BI166241|HY-78131|NCI60_002065|ST024750|Ibuprofen, Vetec(TM) reagent grade, 97%|SBI-0050669.P004|.alpha.-2-(p-Isobutylphenyl)propionic acid|DB-043333|DB-071312|Ibuprofen, meets USP testing specifications|(.+-.)-2-(p-Isobutylphenyl)propionic acid|4-Isobutylphenyl)-.alpha.-methylacetic acid|EU-0100691|I0415|NS00000214|SW203738-2|(.+/-.)-2-(p-Isobutylphenyl)propionic acid|ADVIL ALLERGY SINUS COMPONENT IBUPROFEN|Ibuprofen, VETRANAL(TM), analytical standard|(r/s)-alpha-methyl-4-isobutylphenylacetic acid|C01588|D00126|EN300-120638|AB00052020-16|AB00052020-17|AB00052020_18|AB00052020_19|CHILDREN'S ADVIL COLD COMPONENT IBUPROFEN|(RS)-2-(4-(2-Methylpropyl)phenyl)propanoic acid|687I271|ADVIL CONGESTION RELIEF COMPONENT IBUPROFEN|CHILDREN'S MOTRIN COLD COMPONENT IBUPROFEN|F078863|Q186969|SR-01000000214-2|SR-01000000214-4|BRD-A17655518-001-02-0|BRD-A17655518-001-12-9|BRD-A17655518-001-23-6|BRD-A17655518-001-24-4|SR-01000000214-13|F2173-0233|Ibuprofen, British Pharmacopoeia (BP) Reference Standard|Z1695709473|(+/-)-alpha-methyl-4-(2-methylpropyl)benzeneacetic acid|Ibuprofen, European Pharmacopoeia (EP) Reference Standard|Benzeneacetic acid, a-methyl-4-(2-methylpropyl)-, (+/-)-|Benzeneacetic acid, a-methyl-4-(2-methylpropyl)-, (A+/-)-|Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl), (+/-)-|Ibuprofen, United States Pharmacopeia (USP) Reference Standard|Benzeneacetic acid, .alpha.-methyl-4-(2-methylpropyl), (.+/-.)-|BENZENEACETIC ACID, .ALPHA.-METHYL-4-(2-METHYLPROPYL), (+/-)-|Dexibuprofen;(S)-Ibuprofen; L 669455; L-669,455, MK 233; MK-233|Ibuprofen, Pharmaceutical Secondary Standard; Certified Reference Material|Ibuprofen for peak identification, European Pharmacopoeia (EP) Reference Standard|2-(4-Isobutylphenyl)-propionic acid ; alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid ;  p-Isobutylhydratropic acid|2-(4-Isobutylphenyl)-propionic acid;alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid; p-Isobutylhydratropic acid|InChI=1/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)"
CARPROFEN,2581,,"InChI=1S/C15H12ClNO2/c1-8(15(18)19)9-2-4-11-12-7-10(16)3-5-13(12)17-14(11)6-9/h2-8,17H,1H3,(H,18,19)",PUXBGTOOZJQSKH-UHFFFAOYSA-N,C15H12ClNO2,273.71,2-(6-chloro-9H-carbazol-2-yl)propanoic acid,"carprofen|53716-49-7|2-(6-Chloro-9H-carbazol-2-yl)propanoic acid|Rimadyl|Carprofeno|Carprofene|Carprofenum|6-Chloro-alpha-methyl-9H-carbazole-2-acetic acid|Carprodyl|6-Chloro-alpha-methylcarbazole-2-acetic acid|Ro 20-5720/000|DTXSID1045871|(+-)-6-Chloro-alpha-methylcarbazole-2-acetic acid|Carprofen for veterinary use|FFL0D546HO|NSC-297935|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid|CHEBI:364453|Ro-20-5720/000|Ro-205720000|DTXCID9025871|(+-)-isomer of carprofen|Carofenvet|Belprofen|Carprieve|Carprovet|Levafen|Quellin|Vetprofen|Rovera|OstiFen|Novox Chewable|Rimadyl Caplets|Rimadyl Sterile|carprofen flavored|Carprofen Tablets|Carprovet Flavored|Carprieve Injection|Carprofen Injection|FLEXPROFEN|MOVODYL|Carprofen Soft Chewable|RefChem:54725|Rimadyl Chewable Tablets|Carprieve Chewable Tablets|Carprofen Chewable Tablets|Carprofen Flavored Tablets|Carprofen Sterile Injectable|Carprovet Sterile Injectable|TRUPROFEN FLAVORED TAB|Carprofen Caplets, Novox Caplets|Rimadyl Sterile Injectable Solution|Carprofen Sterile Injectable Solution|(RS)-2-(6-Chloro-9H-carbazol-2-yl)propanoic acid|(+-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid|258-712-4|Imadyl|Ridamyl|Carprofene [INN-French]|Carprofenum [INN-Latin]|Carprofeno [INN-Spanish]|MFCD00079028|52263-47-5|rac Carprofen|CHEMBL1316|(+/-)-2-(3-chloro-9H-carbazol-7-yl)propanoic acid|2-(6-chloro-9H-carbazol-2-yl)-3,3,3-trideuteriopropanoic acid|NSC297935|9H-Carbazole-2-acetic acid, 6-chloro-.alpha.-methyl-|NCGC00094937-01|Carprofeno [Spanish]|(+/-)-6-Chloro-alpha-methylcarbazole-2-acetic acid|(.+-.)-6-Chloro-.alpha.-methylcarbazole-2-acetic acid|Carpaquin|Norocarp|Ro 20-5720|SMR000718633|Rimadyl (TN)|C 5720|CAS-53716-49-7|CCRIS 3507|SR-01000837515|EINECS 258-712-4|UNII-FFL0D546HO|NSC 297935|BRN 0487098|Carprofen; (2RS)-2-(6-Chloro-9H-carbazol-2-yl)propanoic acid|Carprofen [USAN:USP:INN:BAN]|Carprofen (Standard)|Ro-20-5720|Carprofen (USP/INN)|CARPROFEN [INN]|CARPROFEN [MI]|CARPROFEN [USAN]|Spectrum2_001236|Spectrum3_000939|Spectrum4_001038|Spectrum5_001802|CARPROFEN [VANDF]|CARPROFEN [MART.]|(R)-alpha-Methyl-6-chloro-9H-carbazole-2-acetic acid|(S)-alpha-Methyl-6-chloro-9H-carbazole-2-acetic acid|C-5720|CARPROFEN [USP-RS]|CARPROFEN [WHO-DD]|SCHEMBL3909|(+-)-6-Chlor-alpha-methyl-2-carbazolessigsaeure|KBioGR_001595|5-22-03-00391 (Beilstein Handbook Reference)|MLS001201778|MLS001306441|SPECTRUM1502006|SPBio_001112|CARPROFEN [GREEN BOOK]|GTPL7141|orb1308975|CARPROFEN [ORANGE BOOK]|(+/-)-6-Chloro-.alpha.-methylcarbazole-2-acetic acid|CARPROFEN [USP IMPURITY]|Carprofen, >=97% (HPLC)|SCHEMBL29377449|SCHEMBL29743273|HY-B1227R|KBio3_001978|CARPROFEN [USP MONOGRAPH]|MSK7152|GLXC-20198|HMS1921D04|HMS2092B16|HMS2234P15|HMS3652E20|HMS3715F09|HMS3748C07|HMS3885F07|HMS5082M18|Pharmakon1600-01502006|HY-B1227|Tox21_111363|9H-Carbazole-2-acetic acid, 6-chloro-.alpha.-methyl-, (.+-.)-|9H-CARBAZOLE-2-ACETIC ACID, 6-CHLORO-alpha-METHYL-, (+-)-|BBL009935|BDBM50097346|CCG-39146|NSC758154|STK711093|9H-Carbazole-2-acetic acid, (-)-|AKOS005530663|Tox21_111363_1|AC-1266|CS-4875|DB00821|FC31969|KS-1163|NSC-758154|NCGC00094937-02|NCGC00094937-04|NCGC00094937-05|9H-Carbazole-2-acetic acid, (.+-.)-|SY052509|Carprofen 1000 microg/mL in Acetonitrile|SBI-0052885.P002|C2701|NS00008183|S4136|SW199610-3|6-chloro-alpha-methyl-carbazole-2-acetic acid|Carprofen, VETRANAL(TM), analytical standard|6-Chloro-?-methyl-9H-carbazole-2-acetic acid|C18364|D03410|D70911|EN300-120629|2-(6-chloranyl-9H-carbazol-2-yl)propanoic acid|AB00876263_06|AB00876263_07|716C497|A829748|F358099|Q905755|CARPROFEN FOR VETERINARY USE [EP MONOGRAPH]|SR-01000837515-2|SR-01000837515-3|BRD-A17411484-001-05-1|BRD-A17411484-001-10-1|BRD-A17411484-001-11-9|Z1530425063|2-(6-Chloro-9H-carbazol-2-yl)-propionic acid(carprofen)|Carprofen, European Pharmacopoeia (EP) Reference Standard|9H-Carbazole-2-acetic acid, 6-chloro-.alpha.-methyl-, (-)-|Carprofen, United States Pharmacopeia (USP) Reference Standard|9H-CARBAZOLE-2-ACETIC ACID, 6-CHLORO-.ALPHA.-METHYL, (+/-)-|Carprofen, Pharmaceutical Secondary Standard; Certified Reference Material|Carprofen for system suitability, European Pharmacopoeia (EP) Reference Standard|6-Chloro-a-methyl-9H-carbazole-2-acetic acid;(dl)-6-Chloro-a-methylcarbazole-2-acetic acid;RS-Carprofen"
NAPROXEN,156391,,"InChI=1S/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1",CMWTZPSULFXXJA-VIFPVBQESA-N,C14H14O3,230.26,(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid,"NAPROXEN|22204-53-1|(S)-Naproxen|Naproxene|(+)-Naproxen|Naprosyn|Equiproxen|Naproxeno|(S)-(+)-Naproxen|d-Naproxen|Ec-Naprosyn|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-(S)-Naproxen|Laraflex|Naprosyne|Naproxenum|Nycopren|Calosen|Naixan|Reuxen|Bonyl|Axer|(2S)-2-(6-methoxynaphthalen-2-yl)propanoic acid|Naprius|Veradol|Naxen|Xenar|Dysmenalgit N|Napren E|RS-3540|(S)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionic acid|(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(S)-2-(6-Methoxy-2-naphthyl)propanoic acid|d-2-(6-Methoxy-2-naphthyl)propionic acid|(+)-2-(Methoxy-2-naphthyl)-propionsaeure|CHEBI:7476|CG 3117|(+)-(S)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|NSC-750183|NSC-757239|57Y76R9ATQ|DTXSID4040686|PN400 COMPONENT NAPROXEN|(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (+)-|DTXCID2020686|Apranax|Numidan|2-Naphthaleneacetic acid, 6-methoxy-alpha-methyl-, (S)-|Methoxypropiocin|Stirlescent|Condrotec|Grenoxal|Kenosyn|Naprotin|Prosaid|Rimoxyn|Timpron|Naproxen oral|Napratec op|Feminax Ultra|Pranoxen continus|Naprosyn EC|Equiproxen Granules|Arthrosin 250|Arthrosin 500|Naproxen, Capsaicin|Naprosyn 375|Rheuflex 250|Rheuflex 500|Trepoxen-250|Arthrosin 250 ec|Arthrosin 500 ec|Timpron 250 ec|Timpron 500 ec|VALROX|EC-NAPROXEN|6-methoxy-alpha-methyl-2-naphthaleneacetic acid|RefChem:6469|Naproxen Delayed Release|Naproxen Oral Suspension|NAPROXEN,HISTIDINE|Equiproxen 10% Solution|G02CC02|M01AE02|M02AA12|Sallus Pain Relief Collection With Naproxen|244-838-7|(2S)-2-(6-methoxynaphthalen-2-yl)propanoate|(S)-2-(6-methoxynaphthalen-2-yl)propanoic acid|Aleve|naproxen(+)|Acusprain|Anexopen|Arthrisil|Artrixen|Artroxen|Bipronyl|Clinosyn|Danaprox|Flexipen|Leniartil|Novonaprox|Apronax|Artagen|Atiflan|Congex|Daprox|Genoxen|Lefaine|Nafasol|Nalyxan|Napflam|Napmel|Naposin|Napren|Fuxen|Naxyn|Apo-Naproxen|Anaprox|Floginax|MFCD00010500|Dysmenalgit|Apo-Napro-NA|(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid|(alphas)-6-methoxy-alpha-methyl-2-naphthaleneacetic acid|(2S)-2-(6-methoxy-2-naphthyl)propanoic acid|CHEMBL154|d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure|Proxen|Propionic acid, 2-(6-methoxy-2-naphthyl)-, (+)-|Duk|2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (S)-|Headlon|Napratec|Naprontag|Narocin|Naxopren|Prafena|Priaxen|Pronaxen|Rheumaflex|Saritilron|Sinartrin|Soproxen|Sutolin|Tohexen|Traumox|Flexen|Napxen|Noflam|Patxen|Rahsen|Sinton|Sutony|Velsay|Vinsen|Narma|Roxen|Anax|2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (.alpha.S)-|CAS-22204-53-1|Flanax Forte|Naprosyn LLE|Proxen LE|Naxen F|Proxen LLE|U-Ritis|Naprosyn LLE Forte|(S)-2-(6-Methoxy-naphthalen-2-yl)-propionic acid|Naproxi 250|Naproxi 500|(S)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid|Naxyn 250|Naxyn 500|Equiproxen (Veterinary)|Naproxene [INN-French]|Naproxenum [INN-Latin]|Naproxeno [INN-Spanish]|Xenar-CR|CCRIS 5265|HSDB 3369|EINECS 244-838-7|RS 3540|UNII-57Y76R9ATQ|Naprolag|Naprosine|Naprosy|Panoxen|Proxine|Mnpa|SR-01000075977|DL Naproxen|Naprosyn (TN)|NPS|Prestwick_349|(+)-2-(Methoxy-2-naphthyl)-propionsaeure [German]|Naproxen (Standard)|Naproxen [USAN:USP:INN:BAN:JAN]|d-2-(6'-Methoxy-2'-naphthyl)-propionsaeure [German]|S-NAPROXEN|Spectrum_000977|4or0|4po0|NAPROXEN [HSDB]|NAPROXEN [USAN]|(S)-(+)-Naproxene|NAPROXEN [INN]|NAPROXEN [JAN]|NAPROXEN [MI]|NAPROXEN [VANDF]|Prestwick0_000791|Prestwick1_000791|Prestwick2_000791|Spectrum2_001043|Spectrum3_000514|Spectrum4_000069|Spectrum5_001327|(+)NAPROXEN|NAPROXEN [MART.]|Naproxen2-(6-Methoxy-naphthalen-2-yl)-propionic acid|Epitope ID:139974|NAPROXEN [USP-RS]|NAPROXEN [WHO-DD]|UPCMLD-DP001|2-(6-Methoxy-naphthalen-2-yl)-propionic acid(Naproxen)|EC 244-838-7|SCHEMBL3046|Lopac0_000792|BSPBio_002067|KBioGR_000597|KBioSS_001457|BIDD:GT0062|DivK1c_000242|NAPROXEN [GREEN BOOK]|SPECTRUM1500425|Naproxen (JP17/USP/INN)|Naproxen, 1mg/ml in Methanol|SPBio_000966|SPBio_002861|NAPROXEN [ORANGE BOOK]|GTPL5230|orb1308096|NAPROXEN [EP MONOGRAPH]|VIMOVO COMPONENT NAPROXEN|NAPROXEN [USP MONOGRAPH]|SCHEMBL29350704|SCHEMBL29360045|UPCMLD-DP001:001|CMWTZPSULFXXJA-VIFPVBQESA-|HMS500M04|KBio1_000242|KBio2_001457|KBio2_004025|KBio2_006593|KBio3_001567|MSK7160|Naproxen 1.0 mg/ml in Methanol|NINDS_000242|HMS1920P13|HMS2089N21|HMS2091H12|HMS3649M13|HMS3886C15|Pharmakon1600-01500425|Tox21_301953|BDBM50339185|CCG-40130|HY-15030R|NSC750183|NSC757239|AKOS005267223|AC-1363|DB00788|FN26157|ME-0100|NSC 750183|NSC 757239|SDCCGSBI-0050769.P005|IDI1_000242|Naproxen 100 microg/mL in Acetonitrile|NCGC00016759-01|NCGC00016759-02|NCGC00016759-03|NCGC00016759-29|NCGC00016759-38|NCGC00021127-01|NCGC00161591-01|NCGC00255562-01|HY-15030|SY015060|Naproxen, meets USP testing specifications|SBI-0050769.P004|M1021|NS00098611|S5177|Naproxen, VETRANAL(TM), analytical standard|(S)-2-(6-methoxy-2-naphthyl)-propionic acid|(S)-2-(6-methoxynaphthalen-2-yl)propanoicacid|04N531|C01517|D00118|EN300-139795|O10203|(2S)-2-(6-methoxy(2-naphthyl))propanoic acid|(R)-6-Methoxy-a-methyl-2-naphthaleneacetic acid|AB00052049-04|AB00052049_05|(+)(S)2-(6-methoxy-2-naphthyl)-propionic acid|2-(6-Methoxy-2-naphthyl)propanoic acid , (+)-|F079426|SR-01000003110|Q1215575|SR-01000003110-5|SR-01000075977-3|SR-01000075977-4|(+)-6-Methoxy-.alpha.-methyl-2-napthaleneacetic acid|(|AS)-6-Methoxy-|A-methyl-2-naphthaleneacetic acid|BRD-K59197931-001-02-9|BRD-K59197931-001-03-7|BRD-K59197931-001-04-5|BRD-K59197931-236-09-6|BRD-K59197931-236-20-3|BRD-K59197931-236-21-1|BRD-K59197931-236-22-9|SR-01000075977-10|(+)-6-Methoxy-.alpha.-methyl-2-naphthaleneacetic acid|(S)-(+)-2-(6-methoxy-naphthalen-2-yl)-propionic acid|(S)-6-Methoxy-.alpha.-methyl-2-naphthalene acetic acid|(S)-6-Methoxy-?-methyl-2-naphthaleneacetic acid;Aproxen|Naproxen, British Pharmacopoeia (BP) Reference Standard|Naproxen, European Pharmacopoeia (EP) Reference Standard|Z1695772815|(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic acid, 98%|2-Naphthaleneacetic acid, 6-methoxy-.alpha.-methyl-, (+)-|Naproxen, United States Pharmacopeia (USP) Reference Standard|(+)-(S)-6-METHOXY-.ALPHA.-METHYL-2-NAPHTHALENEACETIC ACID|Naproxen, Pharmaceutical Secondary Standard; Certified Reference Material|(S)-(+)-2-(6-Methoxy-2-naphthyl)propionic Acid;(S)-(+)-6-Methoxy-alpha-methyl-2-naphthaleneacetic Acid|131991-52-1|InChI=1/C14H14O3/c1-9(14(15)16)10-3-4-12-8-13(17-2)6-5-11(12)7-10/h3-9H,1-2H3,(H,15,16)/t9-/m0/s1"
KETOPROFEN,3825,,"InChI=1S/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)",DKYWVDODHFEZIM-UHFFFAOYSA-N,C16H14O3,254.28,2-(3-benzoylphenyl)propanoic acid,"ketoprofen|22071-15-4|2-(3-Benzoylphenyl)propanoic acid|2-(3-Benzoylphenyl)propionic acid|Orudis|Actron|Ketoprofene|Capisten|Oruvail|m-Benzoylhydratropic acid|Alrheumat|Aneol|3-Benzoylhydratropic acid|Ketoprofeno|Iso-K|Orudis KT|RP-19583|Ketoprofenum|Ketorin|Sector|(rs)-ketoprofen|Actron ketoprofen|CHEBI:6128|3-BENZOYL-ALPHA-METHYLBENZENEACETIC ACID|DTXSID6020771|Benzeneacetic acid, 3-benzoyl-alpha-methyl-|Hydratropic acid, m-benzoyl-|NSC-758144|NEXCEDE|IDEA-033|90Y4QC304K|2-[3-Benzoylphenyl]propionic acid|R.P. 19,583|19583RP|RU-4733|DTXCID40771|R.P. 19583|Benzoylhydratropic Acid|ketonal|Ketofen|Ketovail|Kiprofen|Larafen|Powergel|Tiloket|Axorid|KetoMed|Jomethid xl|Larafen cr|Oruvail im|Tiloket cr|RP, 19,583|Ketotard 200 xl|Ketozip 200 xl|Fenoket 200|Ketocid 200|KETOPHENE|Oruvail 100|Oruvail 150|Oruvail 200|Valket 200 retard|Orudis 100|RefChem:5933|M01AE03|M02AA10|(2RS)-2-(3-Benzoylphenyl)propanoic acid|244-759-8|RP19583|Profenid|Alrheumun|Epatec|Orudis (TN)|Ketoprophene|rac Ketoprofen|2-(m-Benzoylphenyl)propionic acid|Racemic ketoprofen|2-[3-(phenylcarbonyl)phenyl]propanoic acid|MFCD00055790|Benzeneacetic acid, 3-benzoyl-.alpha.-methyl-|RU 4733|Ketoprofen (Actron)|CHEMBL571|Propionic acid, 2-(3-benzoylphenyl)-|19583 RP|1189508-77-7|L'Acide (benzoyl-3-phenyl)-2-propionique|MLS000079024|(+/-)-m-Benzoylhydratropic acid|Kefenid|Ketopron|Menamin|Meprofen|Orugesic|Oscorel|SMR000040181|Fastum|Ketoprofen 100 microg/mL in Acetonitrile|Lertus|Toprec|Toprek|Dexal|racemic-Ketoprofen|RP 19583|Ketoprofene [INN-French]|Ketoprofenum [INN-Latin]|Ketoprofeno [INN-Spanish]|Ketoprofen (+-)|(+-)-m-Benzoylhydratropic acid|(S)-Ketoprofen;Dexketoprofen|SR-01000075949|CCRIS 4508|(+-)-3-Benzoyl-alpha-methylbenzeneacetic acid|(+) ketoprofen|NCGC00016757-01|Acide (benzoyl-3-phenyl)-2-propionique [French]|Prestwick_617|EINECS 244-759-8|2-[3-(benzoyl)phenyl]propanoic acid|CAS-22071-15-4|Ketoprofen (Standard)|2-(3-benzoylphenyl)-propionic acid|Hydratropic acid, m-benzoyl-, (+-)-|Acide (benzoyl-3-phenyl)-2-propionique|Spectrum_001309|KETOPROFEN [MI]|Opera_ID_509|KETOPROFEN [INN]|KETOPROFEN [JAN]|Prestwick0_000219|Prestwick1_000219|Prestwick2_000219|Prestwick3_000219|Spectrum2_000956|Spectrum3_001479|Spectrum4_000028|Spectrum5_001254|KETOPROFEN [USAN]|m-benzoyl-hydratropic acid|KETOPROFEN [VANDF]|Epitope ID:131783|K 1751|KETOPROFEN [MART.]|SCHEMBL2896|KETOPROFEN [WHO-DD]|(+/-)-KETOPROFEN|Lopac0_000686|Oprea1_117113|BSPBio_000237|BSPBio_003037|KBioGR_000435|KBioSS_001789|22161-86-0|MLS000028446|MLS001201752|MLS001306444|MLS002548889|MLS006011967|BIDD:GT0443|DivK1c_000598|SCHEMBL679920|SPECTRUM1501215|UNII-90Y4QC304K|SPBio_000952|SPBio_002158|Benzeneacetic acid, 3-benzoyl-alpha-methyl-, (+-)-|BPBio1_000261|GTPL4795|Ketoprofen (JP18/USP/INN)|Ketoprofen - Bio-X trade mark|orb1310246|KETOPROFEN [GREEN BOOK]|Ketoprofen, >=98% (TLC)|(2S)-2-(3-Benzoylphenyl)(3-~13~C,3,3,3-~2~H_3_)propanoic acid|KETOPROFEN [EP IMPURITY]|KETOPROFEN [ORANGE BOOK]|DKYWVDODHFEZIM-UHFFFAOYSA-|HMS501N20|HY-B0227R|KBio1_000598|KBio2_001789|KBio2_004357|KBio2_006925|KBio3_002537|2-(3-Benzoylphenyl)propanoicacid|KETOPROFEN [EP MONOGRAPH]|KETOPROFEN [USP IMPURITY]|MSK7153|NINDS_000598|HMS1568L19|HMS1921B12|HMS2089B16|HMS2092L19|HMS2095L19|HMS2234H16|HMS3259I05|HMS3262I13|HMS3372M08|HMS3373G09|HMS3649N10|HMS3655C15|HMS3712L19|HMS3884K04|HMS5079F06|HMS5086B22|KETOPROFEN [USP MONOGRAPH]|Pharmakon1600-01501215|BCP23428|HY-B0227|2-(3'-benzoylphenyl)propionic acid|2-(3-benzoylphenyl) propionic acid|alpha(3-benzoylphenyl)propionic acid|Tox21_110594|Tox21_200847|Tox21_500686|(.+/-.)-m-Benzoylhydratropic acid|2-(3-benzoylphenyl) propionoic acid|alpha-(m-benzoylphenyl)propionic acid|BDBM50022271|CCG-39685|NSC758144|s1645|SBB063946|STL450995|2-(3-Benzoylphenyl)propanoic acid #|alpha-(3-benzoylphenyl)propionic acid|AKOS007930512|alpha-(m-benzoylphenyl) propionic acid|Tox21_110594_1|AC-1486|BCP9000810|DB01009|FK15499|Ketoprofen [USAN:USP:INN:BAN:JAN]|KS-5031|LP00686|NC00459|NSC 758144|SDCCGSBI-0050664.P004|IDI1_000598|NCGC00015578-02|NCGC00015578-03|NCGC00015578-04|NCGC00015578-05|NCGC00015578-07|NCGC00015578-08|NCGC00015578-10|NCGC00015578-12|NCGC00015578-23|NCGC00094043-01|NCGC00094043-02|NCGC00094043-03|NCGC00094043-04|NCGC00258401-01|NCGC00261371-01|BK166172|3-Benzoyl-.alpha.-methylbenzeneacetic acid|BCP0726000302|SBI-0050664.P003|(+/-)-2-(3-Benzoylphenyl)propionic acid|Ketoprofen 1000 microg/mL in Acetonitrile|L''Acide (benzoyl-3-phenyl)-2-propionique|UNM-0000306100|AB00052249|EU-0100686|K0038|Ketoprofen, meets USP testing specifications|NS00000216|SW196784-3|BIM-0050664.0001|C01716|D00132|D78110|EN300-120644|Ketoprofen, VETRANAL(TM), analytical standard|AB00052249-17|AB00052249-19|AB00052249-20|AB00052249_21|AB00052249_22|071K154|F078938|Q409192|SR-01000075949-1|SR-01000075949-6|SR-01000075949-9|(.+/-.)-3-Benzoyl-.alpha.-methylbenzeneacetic acid|Benzeneacetic acid, 3-benzoyl-alpha-methyl-, (+/-)|BRD-A97739905-001-05-9|BRD-A97739905-001-15-8|BRD-A97739905-001-25-7|BRD-A97739905-001-26-5|SR-01000075949-18|F2173-0960|Z1530532758|(+/-)-3-BENZOYL-.ALPHA.-METHYLBENZENEACETIC ACID|Ketoprofen, British Pharmacopoeia (BP) Reference Standard|Ketoprofen, European Pharmacopoeia (EP) Reference Standard|Ketoprofen, United States Pharmacopeia (USP) Reference Standard|Ketoprofen, Pharmaceutical Secondary Standard; Certified Reference Material|154907-35-4|2-(3-Benzoylphenyl)propionic acid;3-Benzoyl-?-methyl-benzeneacetic acid;3-Benzoylhydratropic acid;Oruvail|2-(3-Benzoylphenyl)propionic acid;3-Benzoyl-a-methyl-benzeneacetic acid;3-Benzoylhydratropic acid;Oruvail|InChI=1/C16H14O3/c1-11(16(18)19)13-8-5-9-14(10-13)15(17)12-6-3-2-4-7-12/h2-11H,1H3,(H,18,19)"
ROFECOXIB,5090,,"InChI=1S/C17H14O4S/c1-22(19,20)14-9-7-12(8-10-14)15-11-21-17(18)16(15)13-5-3-2-4-6-13/h2-10H,11H2,1H3",RZJQGNCSTQAWON-UHFFFAOYSA-N,C17H14O4S,314.4,3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one,"rofecoxib|162011-90-7|Vioxx|Ceoxx|MK 966|4-(4-(Methylsulfonyl)phenyl)-3-phenylfuran-2(5H)-one|Vioxx Dolor|MK-966|4-[4-(methylsulfonyl)phenyl]-3-phenyl-2(5H)-furanone|4-[4-(methylsulfonyl)phenyl]-3-phenylfuran-2(5H)-one|MK0966|MK-0966|rofecoxibum|TRM-201|0QTW8Z7MCR|NSC-720256|NSC-758705|CHEBI:8887|TRM201|DTXSID2023567|M01AH02|3-phenyl-4-[4-(methylsulfonyl)phenyl]-2(5H)-furanone|4-(4-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone|4-(4-methylsulfonylphenyl)-3-phenyl-5H-furan-2-one|DTXCID903567|NSC720256|3-phenyl-4-(4-(methylsulfonyl)phenyl)-2(5H)-furanone|RefChem:55985|4-(4'-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone|803-260-0|MK 0966|3-(4-methylsulfonylphenyl)-4-phenyl-2H-furan-5-one|2(5H)-Furanone, 4-[4-(methylsulfonyl)phenyl]-3-phenyl-|C17H14O4S|MK966|4-(4-methanesulfonylphenyl)-3-phenyl-2,5-dihydrofuran-2-one|MFCD00935806|CHEMBL122|4-(p-(Methylsulfonyl)phenyl)-3-phenyl-2(5H)-furanone|refecoxib|NCGC00095118-01|Vioxx-d5 (Major)|2(5H)-Furanone, 4-(4-(methylsulfonyl)phenyl)-3-phenyl-|Vioxx (trademark)|SMR000466331|CCRIS 8967|Vioxx (TN)|HSDB 7262|SR-01000762904|UNII-0QTW8Z7MCR|Rofecoxib (JAN/USAN/INN)|Rofecoxib [USAN:INN:BAN]|3-Phenyl-4-(4-(methylsulfonyl)phenyl))-2(5H)-furanone|Rofecoxib (Vioxx)|Rofecoxib [USAN]|Rofecoxib (Standard)|KS-1107|MK 0996|Spectrum_000119|ROFECOXIB [INN]|ROFECOXIB [JAN]|SpecPlus_000669|ROFECOXIB [MI]|ROFECOXIB [HSDB]|Spectrum2_000446|Spectrum3_001153|Spectrum4_000631|Spectrum5_001598|ROFECOXIB [VANDF]|ROFECOXIB [MART.]|ROFECOXIB [WHO-DD]|SCHEMBL3050|BSPBio_002705|KBioGR_001242|KBioGR_002345|KBioSS_000559|KBioSS_002348|MLS000759440|MLS001165770|MLS001195623|MLS001424113|MLS006010091|BIDD:GT0399|DivK1c_006765|SPECTRUM1504235|Rofecoxib - Bio-X trade mark|SPBio_000492|3-(4-methanesulfonylphenyl)-2-phenyl-2-buten-4-olide|GTPL2893|orb1309482|ROFECOXIB [ORANGE BOOK]|BDBM22369|KBio1_001709|KBio2_000559|KBio2_002345|KBio2_003127|KBio2_004913|KBio2_005695|KBio2_007481|KBio3_002205|KBio3_002825|EX-A708|cMAP_000024|GLXC-05865|HMS1922H11|HMS2051G16|HMS2089H20|HMS2093E04|HMS2232G21|HMS3371P11|HMS3393G16|HMS3651F16|HMS3713B07|HMS3750I17|HMS3885E05|HMS5081K08|Pharmakon1600-01504235|BCP03619|MSK10084|UWA68493|Tox21_111430|CCG-40253|HY-17372R|NSC758705|s3043|STK635144|AKOS000280931|AB07701|CS-0997|DB00533|FV28711|NC00132|NSC 720256|NSC 758705|SB19518|NCGC00095118-02|NCGC00095118-03|NCGC00095118-04|NCGC00095118-05|NCGC00095118-08|NCGC00095118-17|NCGC00095118-18|AC-28318|BR164362|HY-17372|NCI60_041175|SBI-0206774.P001|CAS-162011-90-7|NS00003940|R0206|SW219668-1|C07590|D00568|AB00052090-06|AB00052090-08|AB00052090_09|AB00052090_10|EN300-7364304|011R907|L000912|Q411412|SR-01000762904-3|SR-01000762904-5|BRD-K21733600-001-02-6|BRD-K21733600-001-06-7|BRD-K21733600-001-14-1|BRD-K21733600-001-15-8|BRD-K21733600-001-19-0|BRD-K21733600-001-23-2|BRD-K21733600-001-24-0|3-(4-methanesulfonyl-phenyl)-2-phenyl-2-buten-4-olide|Z2037279770|2(5H)-Furanone, 4-[4-(methyl-sulfonyl)phenyl]-3-phenyl-|3-(Phenyl)-4-(4-(methylsulfonyl)phenyl)-2-(5H)-furanone|3-Phenyl-4-(4-(Methylsulfonyl)Phenyl)-2-(5H)-Furanone|4-(4-METHANESULFONYL-PHENYL)-3-PHENYL-5H-FURAN-2-ONE|4-(4-methylsulfonylphenyl)-3-phenyl-2,5-dihydro-2-furanone|4-4-(Methylsulfonyl)phenyl-3-phenyl-2(5H)-furanone;Rofecoxib"
DICLOFENAC,3033,,"InChI=1S/C14H11Cl2NO2/c15-10-5-3-6-11(16)14(10)17-12-7-2-1-4-9(12)8-13(18)19/h1-7,17H,8H2,(H,18,19)",DCOPUUMXTXDBNB-UHFFFAOYSA-N,C14H11Cl2NO2,296.1,"2-[2-(2,6-dichloroanilino)phenyl]acetic acid","diclofenac|15307-86-5|Diclofenac acid|Diclofenaco|2-(2-((2,6-Dichlorophenyl)amino)phenyl)acetic acid|Diclofenacum|Diclophenac|Diclofenac free acid|Zorvolex|2-{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid|Benzeneacetic acid, 2-[(2,6-dichlorophenyl)amino]-|Allvoran|CHEBI:47381|Voltaren ophthalmic|Benzeneacetic acid, 2-((2,6-dichlorophenyl)amino)-|144O8QL0L1|LAS41007|LAS-41007|{2-[(2,6-dichlorophenyl)amino]phenyl}acetic acid|[2-(2,6-Dichloroanilino)phenyl]acetic acid|DTXSID6022923|(2-((2,6-DICHLOROPHENYL)AMINO)PHENYL)ACETIC ACID|Dicrofenac|(2-(2,6-dichloroanilino)phenyl)acetic acid|2-[2-[(2,6-dichlorophenyl)amino]phenyl]acetic acid|Xiclo|Zorvolex capsules|Voltaren XR|RefChem:6419|DTXCID802923|SR38|M01AB05|M02AA15|S01BC03|GP45,840|GP 45,840|239-348-5|Dichlofenal|dichlofenac|2-(2,6-Dichloroanilino)phenylacetic Acid|2-[2-(2,6-dichloroanilino)phenyl]acetic acid|Voltarol|2-[2-(2,6-dichlorophenyl)aminophenyl]ethanoic acid|2-((2,6-Dichlorophenyl)amino)benzeneacetic acid|MFCD00056694|2-[(2,6-Dichlorophenyl)amino]benzeneacetic acid|CHEMBL139|2-[2,6-DICHLOROPHENYL)AMINO]BENZENEACETIC ACID|ACETIC ACID, (o-(2,6-DICHLOROANILINO)PHENYL)-|15307-86-5 (free)|ProSorb-D|Olfen|Solaraze (TN)|Diclofenac resinate|Enfenamic acid; N-Phenethylanthranilic acid; RH 8|Zorovolex|2-[2-[(2,6-Dichlorophenyl)amino]phenyl]acetic Acid (Diclofenac)|Diclofenamic acid|Diclofenacum [INN-Latin]|Diclofenaco [INN-Spanish]|DIF|HSDB 7234|EINECS 239-348-5|(2-((2,6-Dichlorophenyl)amino-phenyl)acetic acid (HD)|BRN 2146636|Diclofenac [USAN:INN:BAN]|UNII-144O8QL0L1|ISV-205|Zorvolex (TN)|57 - Pharmaceuticals|Spectrum_000930|DICLOFENAC [MI]|S17 - Pharmaceuticals|DICLOFENAC [INN]|128402-48-2|Diclofenac (USAN/INN)|Prestwick0_000594|Prestwick1_000594|Prestwick2_000594|Prestwick3_000594|Spectrum2_000991|Spectrum3_000385|Spectrum4_000506|Spectrum5_000867|DICLOFENAC [HSDB]|DICLOFENAC [USAN]|DICLOFENAC [VANDF]|Epitope ID:116873|EC 239-348-5|AM01 - Analgesic mixture|DICLOFENAC [MART.]|SCHEMBL2799|DICLOFENAC [WHO-DD]|Lopac0_000441|Oprea1_011155|BSPBio_000468|BSPBio_002169|KBioGR_001051|KBioGR_002306|KBioSS_001410|KBioSS_002308|MLS006011795|BIDD:GT0380|DivK1c_000272|DivK1c_000402|SPBio_001081|SPBio_002687|BPBio1_000516|GTPL2714|orb1310846|SCHEMBL4960317|DICLOFENAC [ORANGE BOOK]|SCHEMBL29354260|BDBM13066|HMS501E04|KBio1_000272|KBio1_000402|KBio2_001410|KBio2_002306|KBio2_003978|KBio2_004874|KBio2_006546|KBio2_007442|KBio3_001389|KBio3_002786|MSK7161|2b17|cMAP_000014|NINDS_000272|NINDS_000402|HMS2090C10|HMS3886F09|HMS5085I06|BCP09087|BCP13860|s6073|STK984493|AKOS001579542|DB00586|FD30611|KS-1258|IDI1_000272|IDI1_000402|NCGC00021125-01|NCGC00021125-02|NCGC00021125-11|AC-27673|DA-72738|HY-15036|o-(2,6-dichloroanilino)phenylacetic acid|SMR001550371|SY038623|SBI-0051341.P003|Diclofenac 1000 microg/mL in Acetonitrile|ACECLOFENAC IMPURITY A [EP IMPURITY]|D3748|NS00000212|ST51039044|UNM000001216103|[2-(2,6-Dichloroanilino)phenyl]acetic acid #|C01690|D07816|EN300-119509|H10425|[o-(2,6-dichloro-anilino)-phenyl]-acetic acid|2-[(2,6-dichlorophenyl)amino]phenylacetic acid|AB01275502-01|AB01275502_02|056D694|2-[(2,6-dichlorophenyl)amino]-benzeneacetic acid|2-[(2,6-dichlorophenyl)amino]-phenyl-acetic acid|F224122|Q244408|(O-(2,6-DICHLOROANILINO)PHENYL)ACETIC ACID|[2-(2,6-dichloro-phenylamino)-phenyl]-acetic acid|2-[(2,6-dichlorophenyl)-amino]-benzeneacetic acid|2-[(2,6-dichlorophenyl)-amino]-phenyl-acetic acid|2-[2-(2,6-dichlorophenylamino)phenyl]-acetic acid|SR-01000003041-3|2-[2-(2,6-dichlorophenylamino)-phenyl]-acetic acid|BRD-K08252256-224-02-9|BRD-K08252256-236-05-6|BRD-K08252256-236-17-1|BRD-K08252256-236-32-0|BRD-K08252256-236-33-8|BRD-K08252256-237-02-1|Z57664869|F0722-0745"
NIMESULIDE,4495,,"InChI=1S/C13H12N2O5S/c1-21(18,19)14-12-8-7-10(15(16)17)9-13(12)20-11-5-3-2-4-6-11/h2-9,14H,1H3",HYWYRSMBCFDLJT-UHFFFAOYSA-N,C13H12N2O5S,308.31,N-(4-nitro-2-phenoxyphenyl)methanesulfonamide,"nimesulide|51803-78-2|N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide|Methanesulfonamide, N-(4-nitro-2-phenoxyphenyl)-|Nimesulida|4-NITRO-2-PHENOXYMETHANESULFONANILIDE|R-805|Nimesulidum|R 805|4'-Nitro-2'-phenoxymethanesulfonanilide|DTXSID3037250|NSC-758412|V4TKW1454M|CHEBI:44445|DTXCID1017250|N-(4-nitro-2-(phenoxy)phenyl)methanesulfonamide|N-[4-nitro-2-(phenoxy)phenyl]methanesulfonamide|RefChem:6063|M01AX17|257-431-4|Aulin|Mesulid|Flogovital|Sulidene|Nimed|Nisulid|MFCD00079470|4-Nitro-2-phenoxy-methanesulfonanilide|CHEMBL56367|MLS000069680|Methanesulfonanilide, 4'-nitro-2'-phenoxy-|NCGC00015725-02|SMR000058484|CAS-51803-78-2|M02164|Antifloxil|Guaxan|Nimesulidum [INN-Latin]|Nimesulida [INN-Spanish]|NIM|Nimesulide [INN:BAN]|SR-01000000218|EINECS 257-431-4|4'-Nitro-2'-phenoxymethansulfonanilid|BRN 2421175|UNII-V4TKW1454M|Aldoron|Nimedex|Orthobid|CCRIS 8225|Nise Gel|N-(4-Nitro-2-phenoxyphenyl)methanesulfonamide;4-Nitro-2-phenoxymethane-sulfonamide;4'-Nitro-2'-phenoxymethanesulfonanilide|Prestwick_618|Nimesulide (Standard)|Spectrum_001577|NIMESULIDE [MI]|Nimesulide (JAN/INN)|NIMESULIDE [INN]|NIMESULIDE [JAN]|Opera_ID_1247|Prestwick0_000194|Prestwick1_000194|Prestwick2_000194|Prestwick3_000194|Spectrum2_001541|Spectrum3_001576|Spectrum4_000178|Spectrum5_000964|Lopac-N-1016|N-(4-nitro-2-phenoxy-phenyl)methanesulfonamide|NIMESULIDE [MART.]|NIMESULIDE [WHO-DD]|Lopac0_000855|SCHEMBL24882|BSPBio_000147|BSPBio_001103|BSPBio_003112|KBioGR_000443|KBioGR_000695|KBioSS_000443|KBioSS_002057|MLS001148268|DivK1c_000693|SPECTRUM1503231|SPBio_001382|SPBio_002068|BPBio1_000163|GTPL7401|NIM-03|Nimesulide - Bio-X trade mark|orb1309658|NIMESULIDE [EP IMPURITY]|SCHEMBL29393272|BCBcMAP01_000034|HMS502C15|HY-B0363R|KBio1_000693|KBio2_000443|KBio2_002057|KBio2_003011|KBio2_004625|KBio2_005579|KBio2_007193|KBio3_000825|KBio3_000826|KBio3_002612|NIMESULIDE [EP MONOGRAPH]|Nimesulide for peak identification|NINDS_000693|Bio2_000382|Bio2_000862|HMS1362G05|HMS1568H09|HMS1792G05|HMS1922K17|HMS1990G05|HMS2089B14|HMS2095H09|HMS2234K19|HMS3262L11|HMS3269G17|HMS3371J19|HMS3403G05|HMS3414P09|HMS3649A04|HMS3655D13|HMS3678P07|HMS3712H09|HMS3884C22|HMS5080D19|Pharmakon1600-01503231|BCP10076|FDC18022|HY-B0363|MSK10036|Tox21_110207|Tox21_301850|Tox21_500855|BDBM50056999|CCG-39319|EI-287|NSC758412|s2040|STL018679|AKOS015897356|Tox21_110207_1|AC-4524|DB04743|FN26223|KS-1277|LP00855|NSC 758412|SDCCGSBI-0050831.P004|IDI1_000693|IDI1_002137|NCGC00015725-01|NCGC00015725-03|NCGC00015725-04|NCGC00015725-05|NCGC00015725-06|NCGC00015725-07|NCGC00015725-08|NCGC00015725-09|NCGC00015725-10|NCGC00015725-11|NCGC00015725-12|NCGC00015725-13|NCGC00015725-15|NCGC00015725-16|NCGC00015725-29|NCGC00021842-03|NCGC00021842-04|NCGC00021842-05|NCGC00021842-06|NCGC00021842-07|NCGC00021842-08|NCGC00255661-01|NCGC00261540-01|BN166246|Nimesulide 100 microg/mL in Acetonitrile|R805|N-(4-Nitro-2-Phenoxy)Methanesulfonanilide|SBI-0050831.P003|DB-052029|AB00052332|EU-0100855|N0984|NS00006725|ST51015069|SW196785-3|(methylsulfonyl)(4-nitro-2-phenoxyphenyl)amine|D01049|D70376|N 1016|Q20994|AB00052332-16|AB00052332_17|AB00052332_18|EN300-7388636|803N782|SR-01000000218-2|SR-01000000218-6|SR-01000000218-7|BRD-K76775527-001-06-2|BRD-K76775527-001-18-7|BRD-K76775527-001-28-6|BRD-K76775527-001-29-4|BRD-K76775527-001-30-2|SR-01000000218-11|Nimesulide, European Pharmacopoeia (EP) Reference Standard|Nimesulide, Pharmaceutical Secondary Standard; Certified Reference Material|Nimesulide for peak identification, European Pharmacopoeia (EP) Reference Standard|1364966-82-4"
PONATINIB,24826799,,"InChI=1S/C29H27F3N6O/c1-20-5-6-22(16-21(20)8-10-25-18-33-27-4-3-11-34-38(25)27)28(39)35-24-9-7-23(26(17-24)29(30,31)32)19-37-14-12-36(2)13-15-37/h3-7,9,11,16-18H,12-15,19H2,1-2H3,(H,35,39)",PHXJVRSECIGDHY-UHFFFAOYSA-N,C29H27F3N6O,532.6,"3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide","PONATINIB|943319-70-8|AP24534|AP 24534|ponatinibum|AP-24534|CHEBI:78543|4340891KFS|DTXSID50241426|3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]benzamide|3-(2-(IMIDAZO(1,2-B)PYRIDAZIN-3-YL)ETHYNYL)-4-METHYL-N-(4-((4-METHYLPIPERAZIN-1-YL)METHYL)-3-(TRIFLUOROMETHYL)PHENYL)BENZAMIDE|3-(2-(Imidazo[1,2-b]pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide|3-(2-{imidazo[1,2-b]pyridazin-3-yl}ethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide|3-(2-imidazo(1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide|3-[2-(imidazo[1,2-b]pyridazin-3-yl)ethynyl]-4-methyl-n-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzamide|RefChem:58011|DTXCID50163917|L01XE24|3-(2-(imidazo(1,2-b)pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-y-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide|851-222-7|Benzamide, 3-(2-Imidazo(1,2-B)Pyridazin-3-Ylethynyl)-4-Methyl-N-(4-((4-Methyl-1-Piperazinyl)Methyl)-3-(Trifluoromethyl)Phenyl)|Ponatinib (AP24534)|3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide|3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzamide|MFCD17215203|CHEMBL1171837|C29H27F3N6O|943319-70-8 (free base)|3-(Imidazo[1,2-B]pyridazin-3-Ylethynyl)-4-Methyl-N-{4-[(4-Methylpiperazin-1-Yl)methyl]-3-(Trifluoromethyl)phenyl}benzamide|Benzamide, 3-(2-imidazo(1,2-b)pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methyl-1- piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-|3-(2-(Imidazo(1,2-b)pyridazin-3-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1- yl)methyl)-3-(trifluoromethyl)phenyl)benzamide|3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide.|Ponatinib [USAN]|Ponatinib [USAN:INN]|UNII-4340891KFS|HSDB 8184|0LI|3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzam ide|Benzamide, 3-(2-imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-; 3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzamide; AP 24534; Iclusig; Ponatinib|Ponatinib (Standard)|AP24534,Ponatinib|PONATINIB [INN]|PONATINIB [MI]|Ponatinib (USAN/INN)|PONATINIB [VANDF]|AP24534 (Ponatinib)|PONATINIB [WHO-DD]|Ponatinib (AP24534)?|MLS006010166|SCHEMBL589260|GTPL5890|orb1305580|SCHEMBL29353054|SCHEMBL29373892|SCHEMBL29889039|EX-A067|BCPP000397|HMS3295I23|HMS3654H16|HMS5079I10|BCP02037|BDBM50322535|HY-12047R|NSC758487|NSC800855|AKOS015995214|BCP9000307|CCG-264900|CS-0204|DB08901|FP27104|NSC-758487|NSC-800855|PB34916|SDCCGSBI-0654374.P001|NCGC00263152-01|NCGC00263152-02|NCGC00263152-12|NCGC00263152-14|AC-26973|AS-19133|HY-12047|SMR004701274|NS00072196|S1490|SW218091-2|D09950|AB01565847_03|EN300-6733072|Q198728|BRD-K44227013-001-02-3|BRD-K44227013-001-06-4|BRD-K44227013-001-08-0|Z1828098700|3-(2-Imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzamide;AP 2453 4|3-(imidazo[1,2-b]pyridazin-3-ylethynyl)-4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}benzam"
LENVATINIB,9823820,,"InChI=1S/C21H19ClN4O4/c1-29-19-10-17-13(9-14(19)20(23)27)18(6-7-24-17)30-12-4-5-16(15(22)8-12)26-21(28)25-11-2-3-11/h4-11H,2-3H2,1H3,(H2,23,27)(H2,25,26,28)",WOSKHXYHFSIKNG-UHFFFAOYSA-N,C21H19ClN4O4,426.9,4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide,"Lenvatinib|417716-92-8|E7080|E-7080|E 7080|ER-203492-00|Kisplyx|4-{3-Chloro-4-[(Cyclopropylcarbamoyl)amino]phenoxy}-7-Methoxyquinoline-6-Carboxamide|CHEBI:85994|4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxyquinoline-6-carboxamide|EE083865G2|DTXSID50194605|4-(3-chloro-4-(N'-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide|4-(3-chloro-4-((cyclopropylaminocarbonyl)amino)phenoxy)-7-methoxy-6-quinolinecarboxamide|4-(3-CHLORO-4-((CYCLOPROPYLCARBAMOYL)AMINO)PHENOXY)-7-METHOXYQUINOLINE-6-CARBOXAMIDE|6-QUINOLINECARBOXAMIDE, 4-(3-CHLORO-4-(((CYCLOPROPYLAMINO)CARBONYL)AMINO)PHENOXY)-7-METHOXY-|lenvatinibum|4-(3-chloro-4-(cyclopropylcarbamoylamino)phenoxy)-7-methoxyquinoline-6-carboxamide|RefChem:58936|Multi-Kinase Inhibitor E7080|DTXCID50117096|L01XE29|970-217-1|4-(3-chloro-4-(3-cyclopropylureido)phenoxy)-7-methoxyquinoline-6-carboxamide|E7080 (Lenvatinib)|Lenvatinib (E7080)|Lenvatinib free base|C21H19ClN4O4|4-[3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy]-7-methoxy-6-quinolinecarboxamide|UNII-EE083865G2|4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide|MFCD16038644|4-[3-chloro-4-(cyclopropylcarbamoylamino)phenoxy]-7-methoxy-quinoline-6-carboxamide|CHEMBL1289601|417716-92-8 (free base)|Lenvatinib [USAN]|Lenvatinib [USAN:INN]|Lenvatini|Lenvatinib base|4-(3-Chloro-4-(cyclopropylaminocarbonyl)aminophenoxy)-7-methoxy-6-quinolinecarboxamide|6-Quinolinecarboxamide, 4-[3-chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-; 4-[3-Chloro-4-[[(cyclopropylamino)carbonyl]amino]phenoxy]-7-methoxy-6-quinolinecarboxamide; E 7080; ER 203492-00; Lenvatinib; Lenvima|LEV|Lenvatinib (Standard)|LENVATINIB [MI]|LENVATINIB [INN]|Lenvatinib (USAN/INN)|E7080 (Lenvatinib)?|LENVATINIB [WHO-DD]|MLS006011239|SCHEMBL864638|GTPL7426|orb1310532|SCHEMBL29349806|SCHEMBL29372021|EX-A249|WOSKHXYHFSIKNG-UHFFFAOYSA-N|BCPP000247|HMS3244A07|HMS3244A08|HMS3244B07|HMS3654A14|HMS5079K11|BCP01799|Lenvatinib base - Bio-X trade mark|BDBM50331094|HY-10981R|NSC755980|NSC800781|s1164|AKOS025401742|BCP9000633|CCG-264842|CS-0109|DB09078|FC75063|NSC-755980|NSC-800781|SB16580|SDCCGSBI-0654449.P001|NCGC00263198-01|NCGC00263198-04|NCGC00263198-07|AC-25047|AS-16203|BL164616|BP-43663|HY-10981|SMR004702999|DB-070219|NS00069283|SW219259-1|D09919|EN300-7418350|716C928|Q6523413|BRD-K39974922-001-02-7|BRD-K39974922-001-04-3|Z2235801899|N-(4-((6-CARBAMOYL-7-METHOXYQUINOLIN-4-YL)OXY)-2-CHLOROPHENYL)-N'-CYCLOPROPYLUREA|6-Quinolinecarboxamide, 4-(3-chloro-4-     (((cyclopropylamino)carbonyl)amino)phenoxy)-7-methoxy-|6-QUINOLINECARBOXAMIDE, 4-(3-CHLORO-4-(((CYCLOPROPYLAMINO)CARBONYL)AMINO)PHENOXY)- 7-METHOXY-"
CEDIRANIB,9933475,,"InChI=1S/C25H27FN4O3/c1-16-12-17-19(29-16)6-7-21(24(17)26)33-25-18-13-22(31-2)23(14-20(18)27-15-28-25)32-11-5-10-30-8-3-4-9-30/h6-7,12-15,29H,3-5,8-11H2,1-2H3",XXJWYDDUDKYVKI-UHFFFAOYSA-N,C25H27FN4O3,450.5,4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline,"Cediranib|288383-20-0|AZD-2171|4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline|AZD 2171|NQU9IPY4K9|4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline|DTXSID10183035|cediranibum|4-((4-Fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline (2Z)-but-2-enedioate|RefChem:574948|DTXCID20105526|L01XE32|4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline (2Z)-but-2-enedioate (1:1)|AZD2171|Cediranib (AZD2171)|4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-(3-pyrrolidin-1-ylpropoxy)quinazoline|Cediranib free base|MFCD09954115|4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline|C25H27FN4O3|Cedirannib|ZD-2171|Quinazoline,4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-|CHEMBL491473|288383-20-0 (free base)|4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline|Cediranib [INN]|Kinome_3318|NSC-732208|Cediranib (USAN/INN)|UNII-NQU9IPY4K9|Cediranib [USAN:INN:BAN]|Cediranib?|4-(4-fluoro-2-methylindol-5-yloxy)-6-methoxy-7-(3-(pyrrolidin-1-yl)propoxy)quinazoline|4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-6-METHOXY-7-(3-PYRROLIDIN-1-YLPROPOXY)QUINAZOLINE|4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline; 4-[(4-Fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]quinazoline; 4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline; ZD 2171; AZD 2171|Quinazoline, 4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-6-methoxy-7-(3-(1-pyrrolidinyl)propoxy)-|Quinazoline, 4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-6-methoxy-7-[3-(1-pyrrolidinyl)propoxy]-|Cediranib (Standard)|Cediranib,AZD2171|AZD2171, Cediranib|CEDIRANIB [USAN]|CEDIRANIB [MART.]|CEDIRANIB [WHO-DD]|SCHEMBL63147|MLS006010063|GTPL5664|orb1305389|SCHEMBL29351458|SCHEMBL29368143|SCHEMBL29383181|CHEBI:94782|XXJWYDDUDKYVKI-UHFFFAOYSA-N|BCPP000295|GLXC-02838|HMS3654G05|HMS3674G17|HMS3744O21|BCP01378|EX-A2039|BDBM50331096|HY-10205R|NSC755606|NSC800069|s1017|AKOS005145767|BCP9000500|CCG-264679|CS-0119|DB04849|ES-0052|FC32854|NSC-755606|NSC-800069|SB16536|SDCCGSBI-0654326.P001|ZD 2171|NCGC00263097-01|NCGC00263097-09|NCGC00263097-11|AC-25033|HY-10205|SMR004701223|SY102459|NS00069640|SW219261-1|D08881|Q5057052|BRD-K86930074-001-01-9|BRD-K86930074-001-05-0|4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-6-methoxy-7-(3-pyrrolidin-1-yl-propoxy)-quinazoline|AV3|Recentin;4-(4-Fluoro-2-methylindol-5-yloxy)-6-methoxy-7-[3-(pyrrolidin-1-yl)propoxy]quinazoline"
MOTESANIB,11667893,,"InChI=1S/C22H23N5O/c1-22(2)14-26-19-12-16(5-6-18(19)22)27-21(28)17-4-3-9-24-20(17)25-13-15-7-10-23-11-8-15/h3-12,26H,13-14H2,1-2H3,(H,24,25)(H,27,28)",RAHBGWKEPAQNFF-UHFFFAOYSA-N,C22H23N5O,373.5,"N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide","Motesanib|453562-69-1|AMG 706|AMG-706|N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4-ylmethyl)amino]pyridine-3-carboxamide|U1JK633AYI|CHEBI:51098|DTXSID10196488|N-(3,3-Dimethyl-2,3-dihydro-1H-indol-6-yl)-2-((pyridin-4-ylmethyl)amino)pyridine-3-carboxamide|motesanibum|RefChem:159829|DTXCID20118979|113-839-3|N-(3,3-dimethylindolin-6-yl)-2-(pyridin-4-ylmethylamino)nicotinamide|Motesanib [USAN]|N-(2,3-Dihydro-3,3-dimethyl-1H-indol-6-yl)-2-[(4-pyridinylmethyl)amino]-3-pyridinecarboxamide|MFCD10567689|N-(3,3-dimethylindolin-6-yl)-2-((pyridin-4-ylmethyl)amino)nicotinamide|Motesanib (USAN)|453562-69-1 (free base)|N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)pyridine-3-carboxamide|N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-3-pyridinecarboxamide|N-(3,3-dimethyl-2,3-dihydro-1H-indol-6-yl)-2-[(pyridin-4- ylmethyl)amino]pyridine-3-carboxamide|3-Pyridinecarboxamide, N-(2,3-dihydro-3,3-dimethyl-1H-indol-6-yl)-2-((4-pyridinylmethyl)amino)-|Motesanib [USAN:INN]|UNII-U1JK633AYI|Motesanib?|C22H23N5O|MOTESANIB [INN]|MOTESANIB [MI]|Motesanib (AMG-706)|MOTESANIB [MART.]|MOTESANIB [WHO-DD]|SCHEMBL187470|CHEMBL572881|GTPL5660|orb1305790|SCHEMBL29354461|BDBM24773|EX-A487|cid_11667893|BCPP000407|HMS3244A09|HMS3244A10|HMS3244B09|HMS3265G19|HMS3265G20|HMS3265H19|HMS3265H20|BCP01982|NSC760843|NSC800801|s5793|AKOS005146333|N-(3,3-dimethylindolin-6-yl)-2-(4-pyridylmethylamino)pyridine-3-carboxamide|BCP9000289|DB05575|EX-8571|FM65094|NSC-760843|NSC-800801|SB14621|SDCCGSBI-0654329.P001|NCGC00263205-01|NCGC00263205-06|AC-32664|AS-16212|HY-10228|NS00071589|PA-11667893|D06678|562M691|Q6917202|BRD-K99616396-001-05-1|BRD-K99616396-316-01-2|BRD-K99616396-316-04-6|BRD-K99616396-316-05-3|BRD-K99616396-316-06-1|N-(3,3-dimethylindolin-6-yl)-2-(4-pyridylmethylamino)nicotinamide|N-(3,3-dimethyl-1,2-dihydroindol-6-yl)-2-(pyridin-4-ylmethylamino)-3-pyridinecarboxamide|N-(3,3-DIMETHYL-2,3-DIHYDRO-1H-INDOL-6-YL)-2-((PYRIDIN-4-YLMETHYL)AMINO)NICOTINAMIDE"
REGORAFENIB,11167602,,"InChI=1S/C21H15ClF4N4O3/c1-27-19(31)18-10-13(6-7-28-18)33-12-3-5-17(16(23)9-12)30-20(32)29-11-2-4-15(22)14(8-11)21(24,25)26/h2-10H,1H3,(H,27,31)(H2,29,30,32)",FNHKPVJBJVTLMP-UHFFFAOYSA-N,C21H15ClF4N4O3,482.8,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide,"Regorafenib|755037-03-7|BAY 73-4506|Stivarga|Regorafenibum|BAY73-4506|BAY-73-4506|4-[4-({[4-Chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)-3-fluorophenoxy]-N-methylpyridine-2-carboxamide|REGORAFENIB ANHYDROUS|24T2A1DOYB|CHEBI:68647|Bay-734506|4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide|DTXSID60226441|4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl)amino)-3-fluorophenoxy)-n-methylpyridine-2-carboxamide|BAY-734506 monohydrate|BAY-73-4506 MONOHYDRATE|4-(4-(((4-chloro-3-(trifluoromethyl)phenyl)carbamoyl}amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide|4-(4-((4-chloro-3-(trifluoromethyl)phenyl)carbamoylamino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide|RefChem:57911|DTXCID60148932|L01XE21|2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)-3-fluorophenoxy)-N-methyl-, hydrate (1:1)|BAY 73-4506 Monohydrate|MGN125FS9D|4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)-3-fluorophenoxy)-N-methylpicolinamide|Regorafenib (BAY 73-4506)|C21H15ClF4N4O3|MFCD16038047|2-Pyridinecarboxamide,4-[4-[[[[4-chloro-3-(trifluoromethyl)phenyl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-|CHEMBL1946170|Stivarga (TN)|4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]-3-fluoro-phenoxy]-N-methyl-pyridine-2-carboxamide|Regorafenib [INN]|Regorafenib [USAN:INN]|UNII-24T2A1DOYB|Regorafenib (Standard)|REGORAFENIB [MI]|Regorafenib (USAN/INN)|REGORAFENIB [VANDF]|BAY73-4506 hydrochloride|REGORAFENIB [WHO-DD]|MLS006010303|Regorafenib crystalline form I|SCHEMBL432230|Regorafenib,BAY 73-4506|GTPL5891|orb1307437|SCHEMBL29349808|SCHEMBL29351376|EX-A058|BCPP000352|HMS3654K16|HMS3672E15|HMS5079O11|BCP02105|BDBM50363397|HY-10331R|NSC763932|NSC800865|s1178|AKOS015951107|BCP9000384|CCG-269571|CS-0170|DB08896|FR16116|NSC-763932|NSC-800865|SB16819|SDCCGSBI-0654355.P001|NCGC00263138-01|NCGC00263138-13|NCGC00263138-19|AC-25075|AC-31116|AS-16304|BP-44042|HY-10331|SMR004701370|NS00040710|R0142|SW218097-2|cas:835621-07-3;Regorafenib hydrochloride|Regorafenib (BAY73-4506,Fluoro-Sorafenib)|D10138|Regorafenib (BAY73-4506,Fluoro-Sorafenib)?|AB01565826_02|SR-01000941571|Q3891664|SR-01000941571-1|BRD-K16730910-001-02-4|BRD-K16730910-001-07-3|Z2235801830|4-[4-({[4-Chloro-3-(trifluoromethy)phenyl]carbamoyl}amino)-3-fluorophenoxy]-1-methylpyridine-2-carboxamide|4{4-[3-(4-chloro-3-trifluoromethylphenyl)-ureido]-3-fluorophenoxy}-pyridine-2-carboxylic acid methylamide"
LUCITANIB,25031915,,"InChI=1S/C26H25N3O4/c1-28-25(30)19-5-3-4-16-12-17(6-7-18(16)19)33-22-8-11-29-21-14-24(23(31-2)13-20(21)22)32-15-26(27)9-10-26/h3-8,11-14H,9-10,15,27H2,1-2H3,(H,28,30)",CUDVHEFYRIWYQD-UHFFFAOYSA-N,C26H25N3O4,443.5,6-[7-[(1-aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl]oxy-N-methylnaphthalene-1-carboxamide,"Lucitanib|1058137-23-7|E-3810|E-3810 amine|PP449XA4BH|AL-3810|CO-3810|6-[7-[(1-aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl]oxy-N-methylnaphthalene-1-carboxamide|DTXSID30147356|S-80881|1-Naphthalenecarboxamide, 6-((7-((1-aminocyclopropyl)methoxy)-6-methoxy-4-quinolinyl)oxy)-n-methyl-|6-({7-[(1-Aminocyclopropyl)methoxy]-6-Methoxyquinolin-4-Yl}oxy)-N-Methylnaphthalene-1-Carboxamide|S80881|6-((7-((1-Aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yl)oxy)-n-methylnaphthalene-1-carboxamide|AL3810|lucitanibum|6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yl)oxy-N-methylnaphthalene-1-carboxamide|RefChem:924964|DTXCID9069847|CHEBI:65138|6-((7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yl)oxy)-N-methyl-1-naphthamide|E-3810 free base|CHEBI:65209|6-({7-[(1-aminocyclopropyl)methoxy]-6-methoxyquinolin-4-yl}oxy)-N-methyl-1-naphthamide|CHEMBL2180605|Lucitanib [INN]|Lucitanib [USAN:INN]|UNII-PP449XA4BH|Lucitanib(E3810)|E-3810; Lucitanib|Lucitanib (USAN/INN)|LUCITANIB [USAN]|LUCITANIB [WHO-DD]|SCHEMBL381394|GTPL7649|orb1308358|CHEMBL2220486|SCHEMBL29363689|SCHEMBL29365836|SCHEMBL29375046|CUDVHEFYRIWYQD-UHFFFAOYSA-N|BCP05747|EX-A2052|BDBM50399539|MFCD09607817|NSC782762|NSC800786|AKOS030526232|BCP9000632|CS-0782|DB11845|NSC-782762|NSC-800786|SB16928|6-(7-((1-aminocyclopropyl)methoxy)-6-methoxyquinolin-4-yloxy)-N-methyl-1-naphthamide|NCGC00378878-02|NCGC00378878-03|AC-35833|AS-82279|DA-33429|HY-15391|NS00072983|D11762|F84836|EN300-23251017|S 80881|BRD-K31309378-001-01-5|Q27082198|6-(7-((1-aminocyclopropyl)methoxy)-6-methoxy-quinolin-4-yloxy)-N-methyl-1-naphthamide|3ZC|6-[[7-[(1-aminocyclopropyl)methoxy]-6-methoxy-4-quinolyl]oxy]-N-methyl-naphthalene-1-carboxamide"
DOPAMINE HYDROCHLORIDE,65340,,"InChI=1S/C8H11NO2.ClH/c9-4-3-6-1-2-7(10)8(11)5-6;/h1-2,5,10-11H,3-4,9H2;1H",CTENFNNZBMHDDG-UHFFFAOYSA-N,C8H12ClNO2,189.64,"4-(2-aminoethyl)benzene-1,2-diol;hydrochloride","Dopamine hydrochloride|62-31-7|Dopamine HCl|Cardiosteril|1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride|Inotropin|Tensamin|4-(2-Aminoethyl)pyrocatechol hydrochloride|ASL-279|NSC-169105|DTXSID7020550|Dopamini hydrochloridum|7L3E358N9L|Dopamine hydrochloride in dextrose 5%|Dopamine hydrochloride and dextrose 5%|DTXCID50550|Dopamine hydrochloride in dextrose 5% in plastic container|Dopamine hydrochloride and dextrose 5% in plastic container|NSC173182|Dopaminergic|Selectajet|Dopmin|Sabax Dopamin|Dopamin-Natterman|DOPAMINE HCI|Hydrochloride, Dopamine|DOPAMINE PHENOLIC|RefChem:55066|Dopamine Hydrochloride in Dextrose|Dopamine Hydrochloride and Dextrose|DOPAMINE HCI IN 5% DEXTROSE|4-(2-Aminoethyl)benzene-1,2-diol monohydrochloride|200-527-8|3-Hydroxytyramine hydrochloride|intropin|4-(2-aminoethyl)benzene-1,2-diol hydrochloride|Dopastat|Dopamine.HCl|3,4-Dihydroxyphenethylamine hydrochloride|Dynatra|2-(3,4-Dihydroxyphenyl)ethylamine hydrochloride|m-Hydroxytyramine hydrochloride|Dopamine (hydrochloride)|3-Hydroxytyramine, Hydrochloride|3-Hydroxytyramine, HCl|P 498|MFCD00012898|4-(2-aminoethyl)benzene-1,2-diol;hydrochloride|MLS000069419|SMR000059081|4-(2-Aminoethyl)-1,2-benzenediol hydrochloride|Dopamine chloride|Dopamine Fresenius|(Dopamine HCl)|62-31-7 (HCl); 51-61-6 (free base)|3-hydroxytyraminium chloride|Abbodop|Rascordin|Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride|NSC169105|EINECS 200-527-8|NSC 169105|4-(2-aminoethyl)benzene-1,2-diol, chloride|UNII-7L3E358N9L|SR-01000075366|.beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride|3-Hydroxytyramine hydrochloride;2-(3,4-Dihydroxyphenyl)ethylamine hydrochloride|Actopamin (TN)|Dopamine HCl salt|1,2-Benzenediol, 4-(2-aminoethyl)-, hydrochloride (1:1)|Intropin (TN)|beta-(3,4-Dihydroxyphenyl)ethylamine hydrochloride|Dopamine hydrochloride [USAN:USP:JAN]|Opera_ID_218|3,4-dihydroxyphenyl-ethylamine hydrochloride|dopamine hydrogen chloride|Intropin [as hydrochloride]|CHEMBL1557|SCHEMBL40951|SCHEMBL40952|MLS001074180|SPECTRUM1500263|CHEBI:4698|MSK1322A|orb1819288|SGCUT00110|HY-B0451A|Dopamine HCl - Bio-X trade mark|Dopamine hydrochloride (Inotropin)|HMS1920I18|HMS5081C19|KUC104380C|Pharmakon1600-01500263|DOPAMINE HYDROCHLORIDE [MI]|BCP06611|to_000060|Dopamine hydrochloride (JP18/USP)|DOPAMINE HYDROCHLORIDE [JAN]|Tox21_201018|Tox21_500586|CCG-40211|DOPAMINE HYDROCHLORIDE [USAN]|NSC756749|s2529|SBB003668|DOPAMINE HYDROCHLORIDE [VANDF]|AKOS008056421|DOPAMINE HYDROCHLORIDE [MART.]|1, 4-(2-aminoethyl)-, hydrochloride|DOPAMINE HYDROCHLORIDE [USP-RS]|DOPAMINE HYDROCHLORIDE [WHO-DD]|DOPAMINE HYDROCHLORIDE [WHO-IP]|FD31938|KS-5304|KSC-10-159|LP00586|NC00545|NSC-756749|3,4-dihydoxyphenethylamine hydrochloride|CAS-62-31-7|NCGC00093965-01|NCGC00093965-02|NCGC00093965-03|NCGC00093965-04|NCGC00258571-01|NCGC00261271-01|3,4-dihydroxyphenylethylaminehydrochloride|AC-12190|BD166234|DB-023081|DOPAMINE HYDROCHLORIDE [ORANGE BOOK]|A0305|DOPAMINE HYDROCHLORIDE [EP MONOGRAPH]|EU-0100586|NS00078923|SW199608-2|DOPAMINE HYDROCHLORIDE [USP MONOGRAPH]|DOPAMINI HYDROCHLORIDUM [WHO-IP LATIN]|EN300-19500|D00633|F10519|H 8502|2-(3,4-dihydroxyphenyl)-ethylamine hydrochloride|A937196|Dopamine hydrochloride, puriss., >=98.5% (AT)|F008896|SR-01000075366-1|SR-01000075366-8|Q27268491|F0001-1648|Z104474032|3,4-Dihydroxyphenethylamine hydrochloride;Dopamine hydrochloride|963AD780-3E96-47B5-9044-7E59F6C84D67|Norepinephrine EP Impurity C HCl(Dobutamine EP Impurity A HCl)|Dopamine hydrochloride, certified reference material, TraceCERT(R)|Dopamine hydrochloride, British Pharmacopoeia (BP) Reference Standard|Dopamine hydrochloride, European Pharmacopoeia (EP) Reference Standard|Dopamine hydrochloride, United States Pharmacopeia (USP) Reference Standard|Dopamine hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material|1200398-97-5"
NAXAGOLIDE HYDROCHLORIDE,57532,,"InChI=1S/C15H21NO2.ClH/c1-2-7-16-8-9-18-15-13-10-12(17)5-3-11(13)4-6-14(15)16;/h3,5,10,14-15,17H,2,4,6-9H2,1H3;1H/t14-,15-;/m1./s1",NNEACMQMRLNNIL-CTHHTMFSSA-N,C15H22ClNO2,283.79,"(4aR,10bR)-4-propyl-2,3,4a,5,6,10b-hexahydrobenzo[h][1,4]benzoxazin-9-ol;hydrochloride","NAXAGOLIDE HYDROCHLORIDE|99705-65-4|Naxagolide HCl|MK-458|MK 458|E5KFJ9796W|L-647,339|L-647339|CHEBI:177381|DTXSID60244221|2H-Naphth(1,2-b)-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, hydrochloride, (4aR-trans)-|RefChem:164888|DTXCID60166712|100935-99-7|ent Naxagolide Hydrochloride|(+)-PHNO Hydrochloride|Naxagolide hydrochloride [USAN]|Naxagolide (hydrochloride)|2H-Naphth[1,2-b]-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, hydrochloride, trans- (9CI)|(4aR,10bR)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol hydrochloride|L 647,339|(4aR,10bR)-4-propyl-2,3,4a,5,6,10b-hexahydrobenzo[h][1,4]benzoxazin-9-ol;hydrochloride|(4aR-trans)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol Hydrochloride|99705-65-4 (HCl)|(+)-(4aR,10bR)-3,4,4a,5,6,10b-Hexahydro-4-propyl-2H-naphth(1,2-b)-1,4-oxazin-9-ol hydrochloride|Naxagolide hydrochloride (USAN)|trans-4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol hydrochloride|UNII-E5KFJ9796W|(4aR,10bR)-4-propyl-2H,3H,4H,4aH,5H,6H,10bH-naphtho[1,2-b][1,4]oxazin-9-ol hydrochloride|L 647339; MK 458|entNaxagolideHydrochloride|naxagolide monohydrochloride|(+)-Propyl-9-hydroxynaphthoxazine Hydrochloride|(+/-)-PHNO hydrochloride|NAXAGOLIDEHYDROCHLORIDE|MLS006010256|SCHEMBL122853|L 647339|PHNO-(+)|CHEMBL2106804|SCHEMBL30137727|GLXC-01792|GLXC-07141|EX-A10986|MFCD10565901|AKOS030254483|NAXAGOLIDE HYDROCHLORIDE [MART.]|SMR004701331|HY-108236|CS-0027623|D05124|E98816|Q27276897|N-0500-(+)|(4aR,10bR)-9-hydroxy-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-4-ium chloride|trans-(+/-)-4-Propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol hydrochloride"
IBUDILAST,3671,,"InChI=1S/C14H18N2O/c1-9(2)13-12(14(17)10(3)4)11-7-5-6-8-16(11)15-13/h5-10H,1-4H3",ZJVFLBOZORBYFE-UHFFFAOYSA-N,C14H18N2O,230.31,"2-methyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one","ibudilast|50847-11-5|Ketas|KC-404|Ibudilastum|MN-166|AV-411|AV411|3-Isobutyryl-2-isopropylpyrazolo(1,5-a)pyridine|3-Isobutyryl-2-isopropylpyrazolo[1,5-a]pyridine|2-methyl-1-(2-propan-2-ylpyrazolo[1,5-a]pyridin-3-yl)propan-1-one|AV 411|DTXSID7049007|M0TTH61XC5|1-(2-Isopropylpyrazolo(1,5-a)pyridin-3-yl)-2-methyl-1-propanone|DTXCID2028933|2-methyl-1-(2-propan-2-ylpyrazolo(1,5-a)pyridin-3-yl)propan-1-one|MN166|RefChem:789642|R03DC04|1-(2-isopropylpyrazolo(1,5-alpha)pyridin-3-yl)-2-methyl-1-propanone|1-(2-(1-Methylethyl)pyrazolo(1,5-a)pyridin-3-yl)-2-methylpropan-1-one|Ke Tas|Ibudilastum [Latin]|Ibudilast [INN:JAN]|Eyevinal|1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)-2-methylpropan-1-one|Ketas (TN)|1-Propanone, 2-methyl-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]-|MFCD00864808|UNII-M0TTH61XC5|Tocris-1694|Lopac-I-0157|2-Isopropyl-3-isobutyrylpyrazolo(1,5-a)pyridine|CHEMBL19449|KC-404;AV-411;MN-166|2-Methyl-1-[2-(Propan-2-Yl)pyrazolo[1,5-A]pyridin-3-Yl]propan-1-One|NCGC00015542-05|1-Propanone, 2-methyl-1-(2-(1-methylethyl)pyrazolo(1,5-a)pyridin-3-yl)-|2-isopropyl-3-isobutyrylpyrazolo[1,5-a]pyridine|Ibudilast (JAN/INN)|CAS-50847-11-5|SR-01000075927|BRN 0656579|Pinatos|I0157_SIGMA|Ibudilast?|Pyrazolo(1,5-a)pyridine, 3-isobutyryl-2-isopropyl-|Ibudilast (Standard)|IBUDILAST [INN]|IBUDILAST [JAN]|IBUDILAST [MI]|Ibudilast (JP17/INN)|IBUDILAST [MART.]|I 0157|IBUDILAST [WHO-DD]|Lopac0_000599|SCHEMBL30390|5-24-03-00396 (Beilstein Handbook Reference)|MLS000862198|GTPL7399|orb1306386|CHEBI:31684|HY-B0763R|BCPP000209|HMS2089B21|HMS2233H08|HMS3261H20|HMS3268O11|HMS3374P02|HMS3412B20|HMS3676B20|HMS3715L09|HMS3886M03|HMS5083D12|BCP02335|CEA06445|HY-B0763|MSK10258|Tox21_113503|Tox21_500599|1-(2-isopropylpyrazolo[1,5-a]pyridin-3-yl)-2-methyl-propan-1-one|BDBM50240404|s4837|SBB056343|Ibudilast, >=99% (HPLC), solid|2-Methyl-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl] 1-propanone|AKOS015895123|Tox21_113503_1|AC-1044|BCP9000768|CCG-204688|DB05266|FI24525|LP00599|SB19092|SDCCGSBI-0050581.P002|NCGC00015542-01|NCGC00015542-02|NCGC00015542-03|NCGC00015542-04|NCGC00015542-06|NCGC00015542-07|NCGC00015542-17|NCGC00025261-01|NCGC00025261-02|NCGC00025261-03|NCGC00025261-04|NCGC00261284-01|SMR000326961|SY051343|EU-0100599|I0740|NS00068102|D01385|F20666|AB00698306-06|3-Isobutyryl-2-isopropyl-Pyrazolo(1,5-a)pyridine|847I115|EN300-18563279|F069148|H-20256|L003042|Q261167|SR-01000075927-1|SR-01000075927-3|SR-01000075927-6|BRD-K16444452-001-03-4|BRD-K16444452-001-09-1|Z2588063484|1-(2-isopropylH-pyrazolo[1,5-a]pyridin-3-yl)-2-methylpropan-1-one|1-(2-Isopropyl-pyrazolo[1,5-a]pyridin-3-yl)-2-methyl-propan-1-one|1-(2-Isopropyl-pyrazolo[1,5-alpha]pyridin-3-yl)-2-methyl-propan-1-one|1-(2-isopropylpyrazolo[1,5-alpha]pyridin-3-yl)-2-methylpropan-1-one|(Ibudilast)1-(2-Isopropyl-pyrazolo[1,5-a]pyridin-3-yl)-2-methyl-propan-1-one|1-(2-ISOPROPYLPYRAZOLO(1,5-.ALPHA.)PYRIDIN-3-YL)-2-METHYL-1-PROPANONE|1-(2-Isopropylpyrazolo[1,5-a]pyridin-3-yl)-2-methylpropan-1-one (Ibudilast)|2-methyl-1-[2-(methylethyl)(8-hydropyrazolo[1,5-a]pyridin-3-yl)]propan-1-one|2-Methyl-1-[2-(1-methylethyl)pyrazolo[1,5-a]pyridin-3-yl]-1-propanone;1-(2-Isopropylpyrazolo[1,5-a]pyridin-3-yl)-2-methylpropan-1-on  e;2-Isopropyl-3-isobutyrylpyrazolo[1,5-a]pyridine|AVL"
ENALAPRIL,5388962,,"InChI=1S/C20H28N2O5/c1-3-27-20(26)16(12-11-15-8-5-4-6-9-15)21-14(2)18(23)22-13-7-10-17(22)19(24)25/h4-6,8-9,14,16-17,21H,3,7,10-13H2,1-2H3,(H,24,25)/t14-,16-,17-/m0/s1",GBXSMTUPTTWBMN-XIRDDKMYSA-N,C20H28N2O5,376.4,(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid,"enalapril|75847-73-3|Enalaprila|Enalaprilum|Olinapril|Bonuten|69PN84IO1A|CHEBI:4784|DTXSID5022982|C09AA02|(S)-1-(N-(1-(Ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-L-proline|1-(N-((S)-1-Carboxy-3-phenylpropyl)-L-alanyl)-L-proline 1'-ethyl ester|DTXCID202982|(2S)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]pyrrolidine-2-carboxylic acid|L-Proline, N-[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]-L-alanyl-|(2S)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]pyrrolidine-2-carboxylic acid|(S)-1-{(S)-2-[1-((S)-Ethoxycarbonyl)-3-phenyl-propylamino]-propionyl}-pyrrolidine-2-carboxylic acid|L-Proline, N-((1S)-1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl-|Renitek|L-Proline, 1-(N-(1-(ethoxycarbonyl)-3-phenylpropyl)-L-alanyl)-, (S)-|(2S)-1-((2S)-2-(((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid|(S)-1-((S)-2-(1-((S)-Ethoxycarbonyl)-3-phenyl-propylamino)-propionyl)-pyrrolidine-2-carboxylic acid|RefChem:6425|616-271-9|Kinfil|Enalaprilum [INN-Latin]|Enalaprila [INN-Spanish]|Enalapril (INN)|CHEMBL578|NCGC00021569-04|ENALAPRIL [INN]|Enalapril Richet|MFCD00865774|((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl-L-proline|Gadopril|HSDB 6529|Enalapril (TN)|CAS-75847-73-3|Enalapril [INN:BAN]|analapril|UNII-69PN84IO1A|Enaladex|Enalapril, AldrichCPR|Spectrum_001307|ENALAPRIL [MI]|SCHEMBL18|Prestwick3_000314|Spectrum2_001455|Spectrum3_001478|Spectrum4_000008|Spectrum5_001107|ENALAPRIL [VANDF]|ENALAPRIL [MART.]|ENALAPRIL [WHO-DD]|BSPBio_000308|BSPBio_003035|KBioGR_000355|KBioSS_001787|BIDD:GT0751|DivK1c_000408|SPBio_001349|BPBio1_000340|GTPL6322|orb1308046|KBio1_000408|KBio2_001787|KBio2_004355|KBio2_006923|KBio3_002535|NINDS_000408|HMS2090E08|HY-B0331|N-[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]-L-alanyl-L-proline|Tox21_110872|BDBM50017129|N-{(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}-L-alanyl-L-proline|AKOS025310615|Tox21_110872_1|DB00584|IDI1_000408|NCGC00016932-01|NCGC00021569-05|NCGC00021569-06|NCGC00021569-09|SBI-0051691.P002|CAS-76095-16-4|NS00008385|C06977|D07892|H10947|AB00053615-17|AB00053615-18|AB00053615_19|AB00053615_20|EN300-7481394|847E733|F808738|Q422185|BRD-K57545991-050-16-5|BRD-K57545991-050-23-1|BRD-K57545991-050-24-9|N-(1(S)-Ethoxycarbonyl-3-phenylpropyl)-L-alanyl-L-proline|N-[1-(S)-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline|N-[(2S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]-L-alanyl-L-proline|Nalpha -[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl-L-proline|(S)-1-[N-[1-(ethoxycarbonyl)-3- phenylpropyl]-L-alanyl]-L-proline|(SSS)1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid|1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid|(2S)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]pyrrolidine-2-carboxylic acid|(S)-1-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylic acid|(S)-1-((S)-2-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)pyrrolidine-2-carboxylicacid|(S)-1-((S)-2-((R)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl)pyrrolidine-2-carboxylic acid|(S)-1-[(R)-2-((R)-1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid|(S,S,S)-1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid|1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid (Enalapril)|1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-pyrrolidine-2-carboxylic acid(enalapril)|2-[2-(1-Carboxy-3-phenyl-propylamino)-propionyl]-1,2,3,4-tetrahydro-isoquinoline-3-carboxylic acid(enalapril)"
TIOPRONIN,5483,,"InChI=1S/C5H9NO3S/c1-3(10)5(9)6-2-4(7)8/h3,10H,2H2,1H3,(H,6,9)(H,7,8)",YTGJWQPHMWSCST-UHFFFAOYSA-N,C5H9NO3S,163.20,2-(2-sulfanylpropanoylamino)acetic acid,"tiopronin|1953-02-2|N-(2-Mercaptopropionyl)glycine|Thiopronine|Thiola|Tiopronine|2-(2-sulfanylpropanoylamino)acetic acid|Glycine, N-(2-mercapto-1-oxopropyl)-|Thiolpropionamidoacetic acid|tiopronina|Tioproninum|DTXSID4023678|(2-Mercaptopropionyl)glycine|NSC-760416|C5W04GO61S|THIOLA EC|DTXCID803678|alpha-Mercaptopropionylglycine|2 Mercaptopropionylglycine|2-Mercaptopropionylglycine|alpha Mercaptopropionylglycine|2 Thiolpropionamidoacetic Acid|2-Thiolpropionamidoacetic Acid|Tiopronin Base|Acid, 2-Thiolpropionamidoacetic|2 Thiol propionamido acetic Acid|2-Thiol-propionamido-acetic Acid|Acid, 2-Thiol-propionamido-acetic|VENXXIVA|RefChem:56132|G04BX16|217-778-4|Mercaptopropionylglycine|Acadione|Captimer|Mucolysin|Capen|Epatiol|Thiosol|Tiopronin (Thiola)|2-(2-Mercaptopropanamido)acetic acid|MFCD00004861|2-(2-sulfanylpropanamido)acetic acid|CHEMBL1314|alpha-mercaptopropionyl glycine|N-(2-mercaptopropanoyl)glycine|Thiopronin|CHEBI:32229|NCGC00159422-02|NCGC00159422-04|Sutilan|Glycine, N-(2-mercapto-1-oxopropyl)- (9CI)|Tioglis|Vincol|N-(2-Mercapto-1-oxopropyl)glycine|CAS-1953-02-2|Meprin (detoxicant)|A-MERCAPTOPROPIONYL GLYCINE|Tiopronine [INN-French]|Tioproninum [INN-Latin]|Tiopronino [INN-Spanish]|Tiopronin [INN:DCF:JAN]|Tiopronino|CCRIS 1935|MFCD30157366|EINECS 217-778-4|Thiola (TN)|BRN 1859822|Tiopronin (JAN/INN)|TIOPRONIN [INN]|TIOPRONIN [JAN]|TIOPRONIN [MI]|GLYCINE, N-(2-MERCAPTOPROPIONYL)-|TIOPRONIN [VANDF]|2-mercapto-propionylglycine|TIOPRONIN [MART.]|TIOPRONIN [WHO-DD]|(2-mercaptopropanoyl)glycine|UNII-C5W04GO61S|SCHEMBL19989|MLS006010632|MERCAPTOPROPIONYLGLYCINE-|N-(2-Sulfanylpropanoyl)glycine|orb1307968|TIOPRONIN [ORANGE BOOK]|n-(2-mercaptopropionyl) glycine|N-(2-mercaptopropanoyl) glycine|Acadione; Capen; Epatiol; Vincol|(+)-(2-Mercaptopropanoyl)glycine|(-)-(2-Mercaptopropanoyl)glycine|GLXC-22196|HMS3264B11|HMS3655L15|HMS5080E04|Pharmakon1600-01506190|BCP13354|HY-B0373|MSK10365|2-(2-Mercaptopropanamido)aceticacid|Tox21_111654|BDBM50020805|NSC760416|s2062|SBB057668|(2-Mercaptopropionylamino)acetic acid|AKOS015895408|N-(2-Mercaptopropionyl)glycine, 99%|Tox21_111654_1|AC-2087|CCG-214007|DB06823|FM28287|NSC 760416|(2-Mercapto-propionylamino)-acetic acid|NCGC00159422-03|1939-02-2|AS-12522|SMR001550282|SY107319|DB-352240|NS00005173|ST51006782|SW219206-1|T2614|Tiopronin, VETRANAL(TM), analytical standard|C73708|D01430|SBI-0653504.0001|AB00376096_02|EN300-7408657|953T022|F099155|Q414456|SR-01000942263|SR-01000942263-1|BRD-A85295731-001-02-3|BRD-A85295731-001-03-1|BRD-A85295731-001-04-9|BRD-A85295731-001-05-6|BRD-A85295731-001-06-4|Z2681891170|N-(2-Mercaptopropionyl)glycine;alpha-Mercaptopropionyl glycine|TIOPRONIN, Dextiopronin, Tiopronin (n-2-mercaptopropionyl glycine)|2254742-22-6|2254742-23-7"
PIVOPRIL,6917956,,"InChI=1S/C16H27NO4S/c1-11(10-22-15(21)16(2,3)4)14(20)17(9-13(18)19)12-7-5-6-8-12/h11-12H,5-10H2,1-4H3,(H,18,19)/t11-/m1/s1",XRKXJJYSKUIIEN-LLVKDONJSA-N,C16H27NO4S,329.5,"2-[cyclopentyl-[(2S)-3-(2,2-dimethylpropanoylsulfanyl)-2-methylpropanoyl]amino]acetic acid","PIVOPRIL|81045-50-3|REV 3659-(S)|REV-3659 (S)|RHC 3659-(S)|RHC-3659 (S)|USV 3659-(S)|USV-3659 (S)|3V6I5962EM|REV 3569-(S)|REV-3659-(S)|RHC-3659-(S)|USV-3659-(S)|DTXSID501319138|2-[cyclopentyl-[(2S)-3-(2,2-dimethylpropanoylsulfanyl)-2-methylpropanoyl]amino]acetic acid|(S)-N-cyclopentyl-N-(2-methyl-3-(pivaloylthio)propanoyl)glycine|Pivopril [USAN:INN]|Pivopril; RHC 3659(S)|pivoprilum|UNII-3V6I5962EM|PIVOPRIL [USAN]|Pivopril (USAN/INN)|PIVOPRIL [INN]|PIVOPRIL [MART.]|RefChem:1096358|SCHEMBL120071|orb1706787|CHEMBL2051970|CHEBI:188840|DTXCID901748567|REV 3659(S)|RHC 3659(S)|USV 3659(S)|BDBM50421708|HY-U00041|AKOS040742424|CS-6664|DA-66757|MS-24947|D03763|G12720|Q27258071|2-[cyclopentyl-[(2S)-3-(2,2-dimethylpropanoylsulanyl)-2-methylpropanoyl]amino]acetic acid|2,2-Dimethylthiopropionic acid, S-ester with (-)-(S)-N-cyclopentyl-N-(3-mercapto-2-methylpropionyl)glycine|Glycine, N-cyclopentyl-N-(3-((2,2-dimethyl-1-oxopropyl)thio)-2-methyl-1-oxopropyl)-, (S)-(-)-"
UBENIMEX,72172,,"InChI=1S/C16H24N2O4/c1-10(2)8-13(16(21)22)18-15(20)14(19)12(17)9-11-6-4-3-5-7-11/h3-7,10,12-14,19H,8-9,17H2,1-2H3,(H,18,20)(H,21,22)/t12-,13+,14+/m1/s1",VGGGPCQERPFHOB-RDBSUJKOSA-N,C16H24N2O4,308.37,"(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid","Bestatin|Ubenimex|58970-76-6|Ubenimexum|NK-421|NK 421|I0J33N5627|NSC-265489|(3-Amino-2-hydroxy-4-phenylbutanoyl)-L-leucine|((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)-L-leucine|[(2s,3r)-3-amino-2-hydroxy-4-phenylbutanoyl]-l-leucine|(S-(R*,S*))-N-(3-Amino-2-hydroxy-4-phenylbutyroyl)-L-leucine|L-Leucine, N-(3-amino-2-hydroxy-1-oxo-4-phenylbutyl)-, (S-(R*,S*))-|(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]amino]-4-methylpentanoic acid|([2S,3R]-3-Amino-2-hydroxy-4-phenylbutanoyl)-L-leucine|NSC265489|DTXSID4048430|(2S)-2-(((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl)amino)-4-methylpentanoic acid|RefChem:900961|3-amino-2-hydroxy-4-phenylbutyryl-L-leucine|DTXCID0028404|(2R)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid|N-((2S,3R)-4-phenyl-3-amino-2-hydroxybutyryl)-L-leucine|(S-(R*,S*))-N-(3-amino-2-hydroxy-1-oxo-4-phenylbutyl)-L-leucine|(2S)-2-(((2S,3R)-3-azaniumyl-2-hydroxy-4-phenylbutanoyl)amino)-4-methylpentanoate|(2S)-2-((2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoylamino)-4-methylpentanoic acid|261-529-2|2-((3-amino-2-hydroxy-4-phenylbutanoyl)amino)-4-methylpentanoic acid|(S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoic acid|MFCD00083262|N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine|N-[(2S,3R)-3-Amino-2-hydroxy-1-oxo-4-phenylbutyl]-L-leucine|(-)-bestatin|(2S)-2-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido]-4-methylpentanoic acid|CHEMBL29292|Bestatin;Ubenimex|58970-76-6 (free base)|L-Leucine, N-[(2S,3R)-3-amino-2-hydroxy-1-oxo-4-phenylbutyl]-|2-(3-AMINO-2-HYDROXY-4-PHENYL-BUTYRYLAMINO)-4-METHYL-PENTANOIC ACID|Ubenimexum [Latin]|Ubenimex [INN:JAN]|(2S)-2-[[(2S,3R)-3-amino-2-hydroxy-4-phenyl-butanoyl]amino]-4-methyl-pentanoic acid|SMR000059165|EINECS 261-529-2|NSC 265489|[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine|BRN 4704312|Ubestatin|N-((2S,3R)-3-AMINO-2-HYDROXY-4-PHENYLBUTYRYL)-L-LEUCINE|Ubenimex, solid|L-LEUCINE, N-((2S,3R)-3-AMINO-2-HYDROXY-1-OXO-4-PHENYLBUTYL)-|UNII-I0J33N5627|1txr|Ubenimex(Bestatin)|Ubenimex, Bestatin|[S-(R*,S*)]-N-(3-amino-2-hydroxy-1-oxo-4-phenylbutyl)-L-leucine; (-)-Bestatin; NK 421; NSC 265489; Ubenimex;|Bestatin (Standard)|Ubenimex (Bestatin)|Ubenimex (Bestatin)?|3-(R)-Amino-2-(S)-hydroxy-4-phenylbutanoyl-(S)-leucine|UBENIMEX [INN]|UBENIMEX [JAN]|UBENIMEX [MI]|UBENIMEX [MART.]|UBENIMEX [WHO-DD]|SCHEMBL7944|Lopac0_000214|BSPBio_001553|KBioGR_000273|KBioSS_000273|MLS000028649|MLS001424177|MLS006010137|Ubenimex - Bio-X trade mark|orb1708791|BCBcMAP01_000178|BDBM23971|HY-B0134R|KBio2_000273|KBio2_002841|KBio2_005409|KBio3_000545|KBio3_000546|Bio2_000273|Bio2_000753|GLXC-04737|HMS1361N15|HMS1791N15|HMS1989N15|HMS2052A03|HMS2232H13|HMS3268O06|HMS3402N15|HMS3412N16|HMS3676N16|HMS3715B20|(-)-N-((2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl)-L-leucine|EX-A1292|HY-B0134|BDBM50367209|MSK163434|NSC779839|s1591|AKOS016339610|CCG-101071|CS-1910|DB03424|FU65199|KS-5207|NC00321|NSC-779839|SDCCGSBI-0050202.P003|IDI1_034023|SMP1_000030|NCGC00025323-01|NCGC00025323-02|NCGC00025323-03|NCGC00025323-04|NCGC00025323-05|NCGC00025323-06|NCGC00025323-08|NCGC00025323-14|BU164499|SY107271|BCP0726000308|NS00011810|ST50405897|U0111|AB00698345_05|EN300-7388593|970B766|SR-01000075724-3|[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutanoyl]-Leu|BRD-K59574735-001-02-7|BRD-K59574735-001-05-0|BRD-K59574735-001-11-8|BRD-K59574735-001-12-6|Q10909912|Z2242062173|N-[(2S,3R)-3-amino-2-hydroxy-4-phenylbutanoyl]-L-leucine|N-((2S,3R)-3-AMINO-2-HYDROXY-4-PHENYLBUTANOYL)-LEUCINE|N-[(2S,3R)-3-Amino-2-hydroxy-4-phenylbutyryl]-L-leucine, 97%|(2S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanoylamino)-4-methylpentanoic aci d|(S)-2-((2S,3R)-3-amino-2-hydroxy-4-phenylbutanamido)-4-methylpentanoicacid"
DIPYRIDAMOLE,3108,,"InChI=1S/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2",IZEKFCXSFNUWAM-UHFFFAOYSA-N,C24H40N8O4,504.6,"2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol","dipyridamole|58-32-2|Persantin|Dipyridamine|Persantine|Dipyudamine|Curantyl|Dipiridamol|Cleridium 150|Dypyridamol|Iv Persantine|Dipyridamolum|NSC-515776|DTXSID6040668|64ALC7F90C|CHEBI:4653|2-({6-[bis(2-hydroxyethyl)amino]-4,8-bis(piperidin-1-yl)pyrimido[5,4-d][1,3]diazin-2-yl}(2-hydroxyethyl)amino)ethan-1-ol|B01AC07|NSC515776|2-[[2-[bis(2-hydroxyethyl)amino]-4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol|Dipyramidole|DTXCID4020668|2,2',2'',2'''-{[4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilo}tetraethanol|Novo Dipiradol|Apo Dipyridamole|dipiridamolo|Dipridamole|Pyridantin|Modaplate|Vasyrol|Attia|Persantin ret|Ofcram pr|Cerebrovase 25|Cerebrovase 100|2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetraethanol|2-((2-(bis(2-hydroxyethyl)amino)-4,8-di(piperidin-1-yl)pyrimido(5,4-d)pyrimidin-6-yl)-(2-hydroxyethyl)amino)ethanol|2-((6-(bis(2-hydroxyethyl)amino)-4,8-bis(piperidin-1-yl)pyrimido(5,4-d)(1,3)diazin-2-yl)(2-hydroxyethyl)amino)ethan-1-ol|RefChem:55053|2,2',2'',2''''-((4,8-Dipiperidinopyrimido-(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetraethanol|200-374-7|Dipyridamol|Stimolcardio|Kurantil|Stenocardil|Cardioflux|Dipyridan|Peridamol|Anginal|Apricor|Coribon|Corosan|Coroxin|Stenocardiol|Agilease|Chilcolan|Justpertin|Permiltin|Piroan|Coronarine|Gulliostin|Prandiol|Natyl|Prandiol 75|Usaf Ge-12|Cleridium|2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol|RA 8|RA-8|C24H40N8O4|MFCD00010555|NSC 515776|MLS000028420|Dipyridamole (Persantine)|Dypyridamole|CHEMBL932|2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido(5,4-d)pyrimidine|SMR000058382|2,2',2'',2'''-((4,8-di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl)bis(azanetriyl))tetrakis(ethan-1-ol)|Ethanol,2,2',2'',2'''-[(4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakis-|Cardoxil|Pyrimido(5,4-d)pyrimidine, 2,6-bis(bis(2-hydroxyethyl)amino)-4,8-dipiperidino-|Ethanol, 2,2',2'',2'''-[(4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakis-|CAS-58-32-2|NCGC00015385-12|Coridil|Protangix|2,6-Bis(diethanolamino)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine|Novo-Dipiradol|2-[[2-[bis(2-hydroxyethyl)amino]-4,8-bis(1-piperidyl)pyrimido[5,4-d]pyrimidin-6-yl]-(2-hydroxyethyl)amino]ethanol|Ethanol, 2,2',2'',2'''-((4,8-di-1-piperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-|Dipiridamol [INN-Spanish]|Dipyridamolum [INN-Latin]|Permole|Persantine (TN)|(3E)-3-[[(1S,4aS,8aS)-Decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]methylene]dihydro-5-methoxy-2(3H)3-[(1E)-2-[(1S,4aS,8aS)-Decahydro-5,5,8a-trimethyl-2-methylene-1-naphthalenyl]ethenyl]furan; (+)-Coronarin E-furanone; Coronarin D methyl ethe|SR-01000003065|EINECS 200-374-7|BRN 0068373|UNII-64ALC7F90C|Dipridacot|Curanty|Dipyridamole; 2,2',2'',2'''-[[4,8-Di(piperidin-1-yl)pyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilo]tetraethanol|H9F|Prestwick_145|Dipyridamole [USAN:USP:INN:BAN:JAN]|Spectrum_001004|Tocris-0691|Dipyridamole (Standard)|Opera_ID_494|Prestwick0_000142|Prestwick1_000142|Prestwick2_000142|Prestwick3_000142|Spectrum2_000972|Spectrum3_000402|Spectrum4_000522|Spectrum5_000839|DIPYRIDAMOLE [MI]|Lopac-D-9766|DIPYRIDAMOLE [INN]|DIPYRIDAMOLE [JAN]|UPCMLD-DP072|D 9766|DIPYRIDAMOLE [USAN]|cid_3108|2,2',2'',2'''-((4,8-Dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetraethanol|DIPYRIDAMOLE [VANDF]|Lopac0_000464|SCHEMBL16119|BSPBio_000244|BSPBio_001554|BSPBio_001924|DIPYRIDAMOLE [MART.]|KBioGR_001123|KBioSS_001484|4-26-00-03840 (Beilstein Handbook Reference)|MLS001076306|MLS001333724|MLS002548866|DIPYRIDAMOLE [USP-RS]|DIPYRIDAMOLE [WHO-DD]|DivK1c_000696|SPECTRUM1500259|SPBio_001003|SPBio_002183|BPBio1_000270|GTPL4807|orb1307994|SCHEMBL29381078|Thymidine,6-dihydro-6-methoxy-|UPCMLD-DP072:001|BDBM23620|Dipyridamole (JP18/USP/INN)|HMS502C18|HY-B0312R|IZEKFCXSFNUWAM-UHFFFAOYSA-|KBio1_000696|KBio2_001484|KBio2_004052|KBio2_006620|KBio3_001144|NINDS_000696|BCPP000256|DIPYRIDAMOLE [ORANGE BOOK]|HMS1568M06|HMS1791N16|HMS1920I10|HMS1989N16|HMS2089N15|HMS2091O18|HMS2095M06|HMS2232E19|HMS3259C03|HMS3261M10|HMS3266J17|HMS3371J03|HMS3402N16|HMS3411B03|HMS3655I20|HMS3675B03|HMS3712M06|HMS3742O03|HMS3867F13|HMS5080C21|Pharmakon1600-01500259|DIPYRIDAMOLE [EP MONOGRAPH]|BCP26947|HY-B0312|MSK14886|PXB98352|DIPYRIDAMOLE [USP MONOGRAPH]|Tox21_110133|Tox21_500464|2,6-Bis(diethanolamine)-4,8-dipiperidinopyrimido[5,4-d]pyrimidine|BBL027781|CCG-40190|NSC756743|s1895|STL377790|AGGRENOX COMPONENT DIPYRIDAMOLE|AKOS000509426|Tox21_110133_1|BCP9000613|DB00975|Dipyridamole, >=98% (TLC), powder|FD22534|HS-0041|LP00464|NC00448|NSC-619103|NSC-756743|SDCCGSBI-0050449.P005|IDI1_000696|SMP2_000208|NCGC00015385-01|NCGC00015385-02|NCGC00015385-03|NCGC00015385-04|NCGC00015385-05|NCGC00015385-06|NCGC00015385-07|NCGC00015385-08|NCGC00015385-09|NCGC00015385-10|NCGC00015385-11|NCGC00015385-13|NCGC00015385-14|NCGC00015385-15|NCGC00015385-16|NCGC00015385-17|NCGC00015385-18|NCGC00015385-29|NCGC00023914-02|NCGC00023914-04|NCGC00023914-05|NCGC00023914-06|NCGC00023914-07|NCGC00023914-08|NCGC00023914-09|NCGC00023914-10|NCGC00023914-11|NCGC00261149-01|2,2',2'',2'''-((4,8-Di(piperidin-1-yl)pyrimido[5,4-d]-pyrimidine-2,6-diyl)bis(azanetriyl))tetraethanol|2-({6-[bis(2-hydroxyethyl)amino]-4,8-bis(piperidin-1-yl)-[1,3]diazino[5,4-d]pyrimidin-2-yl}(2-hydroxyethyl)amino)ethan-1-ol|AC-18100|AC-30804|Ethanol, 2,2',2'',2'''-((4,8-dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetra-|NCI60_005689|ST078856|SBI-0050449.P004|2,8-dipiperidinopyrimido[5,4-d]pyrimidine|AB00051974|B1933|EU-0100464|NS00010369|SW196456-3|EN300-70723|BIM-0050449.0001|D00302|O10551|AB00051974-18|AB00051974-19|AB00051974_20|AB00051974_21|F079856|Q419374|SR-01000003065-2|SR-01000003065-4|SR-01000003065-5|SR-01000003065-7|BRD-K86301799-001-04-1|BRD-K86301799-001-19-9|BRD-K86301799-001-24-9|BRD-K86301799-001-34-8|BRD-K86301799-001-35-5|BRD-K86301799-001-36-3|BRD-K86301799-001-37-1|Z1137167676|Dipyridamole, British Pharmacopoeia (BP) Reference Standard|Dipyridamole, European Pharmacopoeia (EP) Reference Standard|Dipyridamole, United States Pharmacopeia (USP) Reference Standard|Pyrimido(5, 2,6-bis[bis(2-hydroxyethyl)amino]-4,8-diperidino-|2,2'',2'''-[4,8-Dipiperidinopyrimido[5,4-d]pyrimidine-2,6-diyl]dinitrilotetraethanol|2,2',2'',2'''-(4,8-Dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilotetraethanol|2-[[2-(bis(2-hydroxyethyl)amino)-4,8-di(piperidin-1-yl)pyrimido[6,5-e]pyrimidin-|Dipyridamole for peak identification, European Pharmacopoeia (EP) Reference Standard|Ethanol,2',2'',2'''-(4,8-dipiperidinopyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetra-|WLN: T66 BN DN GN INJ CCN HCN E- AT6NTJ B2Q F2Q& J- AT6NTJ B2Q F2Q|2,2',2'',2'''-[(4,8-Di-1-piperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakis-ethanol;2,6-Bis(diethanolamino)-4,8-dipipe  ridinopyrimido[5,4-d]pyrimidine|2,2',2'',2'''-[(4,8-dipiperidin-1-ylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol|2,2',2'',2'''-[(4,8-Dipiperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetraethanol|2,2',2'',2'''-[(4,8-Dipiperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakisethanol|2-({6-[bis(2-hydroxyethyl)amino]-4,8-dipiperidylpyrimidino[5,4-d]pyrimidin-2-y l}(2-hydroxyethyl)amino)ethan-1-ol|Ethanol, 2,2',2'',2'''-(4,8-dipiperidinopyrimido(5,4-d)pyrimidine-2,6-diyldinitrilo)tetra-|Ethanol, 2,2',2',2'''-((4,8-di-1-iperidinylpyrimido(5,4-d)pyrimidine-2,6-diyl)dinitrilo)tetrakis-|Ethanol,2',2'',2'''-[(4,8-di-1-piperidinylpyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetrakis-|Ethanol,2',2'',2'''-[(4,8-dipiperidinopyrimido[5,4-d]pyrimidine-2,6-diyl)dinitrilo]tetra-|InChI=1/C24H40N8O4/c33-15-11-31(12-16-34)23-26-20-19(21(27-23)29-7-3-1-4-8-29)25-24(32(13-17-35)14-18-36)28-22(20)30-9-5-2-6-10-30/h33-36H,1-18H2"
ZILEUTON,60490,,"InChI=1S/C11H12N2O2S/c1-7(13(15)11(12)14)10-6-8-4-2-3-5-9(8)16-10/h2-7,15H,1H3,(H2,12,14)",MWLSOWXNZPKENC-UHFFFAOYSA-N,C11H12N2O2S,236.29,1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea,"ZILEUTON|111406-87-2|Zyflo|Leutrol|Zyflo CR|Zileutonum|A-64077|1-[1-(1-benzothiophen-2-yl)ethyl]-1-hydroxyurea|N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|ABBOTT-64077|V1L22WVE2S|NSC-730712|NSC-759277|DTXSID9023752|CHEBI:10112|(+-)-1-(1-Benzo(b)thien-2-ylethyl)-1-hydroxyurea|N-[1-(benzo[b]thiophen-2-yl)ethyl]-N-hydroxyurea|DTXCID003752|(+-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea|NSC730712|n-(1-benzo[b]thien-2-ylethyl)-n-hydroxyurea|Abbot 64077|1-(1-(1-benzothiophen-2-yl)ethyl)-1-hydroxyurea|N-(1-(benzo(b)thiophen-2-yl)ethyl)-N-hydroxyurea|RefChem:56486|(+-)-N-Hydroxy-N-(1-benzo(b)thien-2-ylethyl)-urea|1-(1-(Benzo[b]thiophen-2-yl)ethyl)-1-hydroxyurea|Zileutonum [INN-Latin]|Abbott 64077|MFCD00866097|Urea, N-(1-benzo[b]thien-2-ylethyl)-N-hydroxy-|A 64077|Zyflo (TN)|CHEMBL93|1-[1-(1-benzothien-2-yl)ethyl]-1-hydroxyurea|(+/-)-1-(1-Benzo[b]thien-2-ylethyl)-1-hydroxyurea|N-(1-BENZO(B)THIEN-2-YL-ETHYL)-N-HYDROXYUREA|NCGC00159453-02|Urea, N-(1-benzo(b)thien-2-ylethyl)-N-hydroxy-|Ziluton|Zyflo Filmtab|SMR000466377|CAS-111406-87-2|Zileuton (USP/INN)|SR-01000759349|(+/-)-1-(1-benzo(b)thien-2-ylethyl)-1-hydroxyurea|UNII-V1L22WVE2S|CTI-02|( inverted exclamation markA)-1(1-Benzo[b]thien-2-ylethyl)-1-hydroxyure|ABT-077|Zileuton [USAN:USP:INN:BAN]|Zileuton (Standard)|starbld0016861|ZILEUTON [USAN]|ZILEUTON [INN]|ZILEUTON [MI]|ZILEUTON [VANDF]|Prestwick0_001090|ZILEUTON [MART.]|ZILEUTON [USP-RS]|ZILEUTON [WHO-DD]|SCHEMBL4209|Zileuton- Bio-X trade mark|1-[1-(benzothiophen-2-yl)ethyl]-1-hydroxy-urea|MLS000759510|MLS001424079|MLS006011971|ZILEUTON [ORANGE BOOK]|GTPL5297|orb1310574|Zileuton, >=98% (HPLC)|SCHEMBL18251470|ZILEUTON [USP MONOGRAPH]|Urea, N-(1-benzo(b)thien-2-ylethyl)-N-hydroxy-, (+-)-|HMS2051M20|HMS2089J12|HMS2093H06|HMS2235O04|HMS3369I17|HMS3393M20|HMS3654J08|HMS3714E07|HMS3872F13|HMS5079K06|Pharmakon1600-01505906|BCP16199|Tox21_111680|Tox21_301148|BBL029070|BDBM50000541|HY-14164R|NSC759277|s1443|STL373010|AKOS000280127|AKOS016340558|Tox21_111680_1|CCG-100901|CCG-213571|CS-1563|DB00744|FZ28760|KS-1195|NC00151|NSC 730712|NSC 759277|SB19083|MRF-0000030|NCGC00159453-03|NCGC00159453-04|NCGC00159453-05|NCGC00159453-06|NCGC00255046-01|AC-13198|AC-31490|BZ164573|HY-14164|SY102131|SBI-0206869.P001|DB-015071|DB-335363|1-[1-(2-Benzothienyl)ethyl]-1-hydroxyurea|NS00023571|SW197531-3|D00414|EN300-123022|N-(1-benzo[b]thien-2-ylethyl)-N-hydroxy-urea|()-1(1-Benzo[b]thien-2-ylethyl)-1-hydroxyure|AB00639921-06|AB00639921-08|AB00639921-09|AB00639921_10|AB00639921_11|406Z872|F223894|Q202998|SR-01000759349-4|SR-01000759349-5|SR-01000759349-6|Zileuton, commercially available as 600 mg tablets|(+/-)-N-hydroxy-N-(1-benzo[b]thien-2-ylethyl)urea|1-(1-(Benzo[b]thiophen-2-yl)ethyl)-1-hydroxyureaE|BRD-A56359832-001-04-6|BRD-A56359832-001-11-1|BRD-A56359832-001-12-9|BRD-A56359832-001-13-7|Leutrol; N-(1-Benzo(b)thien-2-ylethyl)-N-hydroxyurea|N-HYDROXY-N-{1-(BENZO[B]THIEN-2-YL)ETHYL}UREA|Z1546610483|Zileuton, United States Pharmacopeia (USP) Reference Standard|UREA, N-(1-BENZO(B)THIEN-2-YLETHYL)-N-HYDROXY-, (+/-)-|N-(1-Benzo[b]thien-2-yl-ethyl)-N-hydroxyurea;A-64077;Abbott 64077"
QUIFLAPON,60923,,"InChI=1S/C34H35ClN2O3S/c1-33(2,3)41-31-27-18-26(40-21-25-15-12-23-8-6-7-9-28(23)36-25)16-17-29(27)37(20-22-10-13-24(35)14-11-22)30(31)19-34(4,5)32(38)39/h6-18H,19-21H2,1-5H3,(H,38,39)",NZOONKHCNQFYCI-UHFFFAOYSA-N,C34H35ClN2O3S,587.2,"3-[3-tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-(quinolin-2-ylmethoxy)indol-2-yl]-2,2-dimethylpropanoic acid","Quiflapon|136668-42-3|MK-0591|MK 0591|MK 591|L-686,708|1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-alpha,alpha-dimethyl-5-(2-quinolinylmethoxy)-|9295C885I4|DTXSID20159882|1H-Indole-2-propanoic acid, 1-((4-chlorophenyl)methyl)-3-((1,1-dimethylethyl)thio)-alpha,alpha-dimethyl-5-(2-quinolinylmethoxy)-|quiflaponum|MK591 compound|RefChem:178139|DTXCID4082373|3-(TERT-BUTYLTHIO)-1-(P-CHLOROBENZYL)-ALPHA,ALPHA-DIMETHYL-5-(2-QUINOLYLMETHOXY)INDOLE-2-PROPIONATE|Quiflapon [INN]|Quiflapon free acid|3-(3-(tert-butylthio)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylpropanoic acid|3-[3-tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-(quinolin-2-ylmethoxy)indol-2-yl]-2,2-dimethylpropanoic acid|CHEMBL16596|L-686708|3-[3-(Tert-Butylthio)-1-(4-Chlorobenzyl)-5-(Quinolin-2-Ylmethoxy)-1h-Indol-2-Yl]-2,2-Dimethylpropanoic Acid|C34H35ClN2O3S|L 686708|UNII-9295C885I4|MFCD00900782|MK591 free acid|2q7m|3-[3-tert-Butylsulfanyl-1-(4-chloro-benzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid|MK-0591Quiflapon ?|3-(tert-Butylthio)-1-(p-chlorobenzyl)-alpha,alpha-dimethyl-5-(2-quinolylmethoxy)indole-2-propionic acid|SCHEMBL502947|orb1308037|SCHEMBL29370879|SCHEMBL29372303|SCHEMBL30505315|GLXC-02801|HMS3747O19|BCP06574|EX-A5139|LFA66842|BDBM50029559|MK0591|AKOS027420455|CS-0953|SB19076|NCGC00379068-01|AC-36773|HY-10037|MS-30490|DB-063158|NS00123942|F84868|BRD-K39503511-001-01-3|BRD-K39503511-001-03-9|Q27271487|1H-INDOLE-2-PROPANOIC ACID, 1-((4-CHLOROPHENYL)METHYL)-3-((1,1-DIMETHYLETHYL)THIO)-.ALPHA.,.ALPHA.-DIMETHYL-5-(2-QUINOLINYLMETHOXY)-|1H-Indole-2-propanoic acid, 1-[(4-chlorophenyl)methyl]-3-[(1,1-dimethylethyl)thio]-|A,|A-dimethyl-5-(2-quinolinylmethoxy)-|2-[3-tert-Butylsulfanyl-1-(4-chloro-benzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl]-2-methyl-propionic acid|2CS|3-(1-(4-chlorobenzyl)-3-(tert-butylthio)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl)-2,2-dimethylpropanoic acid|3-(TERT-BUTYLTHIO)-1-(P-CHLOROBENZYL)-.ALPHA.,.ALPHA.-DIMETHYL-5-(2-QUINOLYLMETHOXY)INDOLE-2-PROPIONATE|3-[3-(1,1-dimethylethylthio)-5-(quinolin-2-ylmethoxy)-1-(4-chlorophenylmethyl)indol-2-yl]-2,2-dimethylpropionic acid|3-[3-(tert-butylsulfanyl)-1-(4-chlorobenzyl)-5-(quinolin-2-ylmethoxy)-1H-indol-2-yl]-2,2-dimethylpropanoic acid|3-[3-tert-butylsulfanyl-1-[(4-chlorophenyl)methyl]-5-(2-quinolylmethoxy)indol-2-yl]-2,2-dimethyl-propanoic acid|3-[N-(p-Chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-ylmethoxy)indol-2-yl]-2, 2-dimethylpropanoic acid|3-[n-(p-chlorobenzyl)-3-(t-butylthio)-5-(quinolin-2-ylmethoxy)indol-2-yl]-2,2-dimethylpropanoic acid"
LICOFELONE,133021,,"InChI=1S/C23H22ClNO2/c1-23(2)13-19-22(15-6-4-3-5-7-15)21(16-8-10-17(24)11-9-16)18(12-20(26)27)25(19)14-23/h3-11H,12-14H2,1-2H3,(H,26,27)",UAWXGRJVZSAUSZ-UHFFFAOYSA-N,C23H22ClNO2,379.9,"2-[2-(4-chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetic acid","Licofelone|156897-06-2|ML 3000|licofelona|licofelonum|P5T6BYS22Y|6-(4-Chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-phenyl-1H-pyrrolizine-5-acetic acid|2,2-Dimethyl-6-(4-chlorophenyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl)acetic acid|2,3-Dihydro-6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-1H-pyrrolizine-5-acetic acid|DTXSID40166154|(6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl)-acetic acid|(2-(4-Chloro-phenyl)-6,6-dimethyl-1-phenyl-6,7-dihydro-5H-pyrrolizin-3-yl)-acetic acid|[2-(4-Chloro-phenyl)-6,6-dimethyl-1-phenyl-6,7-dihydro-5H-pyrrolizin-3-yl]-acetic acid|(2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizine-5-yl)acetic acid|RefChem:153386|DTXCID3088645|ML-3000|Licofelone [INN]|2-[2-(4-chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetic acid|[6-(4-CHLOROPHENYL)-2,2-DIMETHYL-7-PHENYL-2,3-DIHYDRO-1H-PYRROLIZIN-5-YL]ACETIC ACID|(6-(4-Chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl)acetic acid|2-(6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1h-pyrrolizin-5-yl)acetic acid|CHEMBL300982|ML3000|1H-Pyrrolizine-5-acetic acid, 6-(4-chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-phenyl-|2-[6-(4-Chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetic acid|LCF|C23H22ClNO2|UNII-P5T6BYS22Y|BRN 6823674|1H-Pyrrolizine-5-acetic acid, 6-(4-chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-phenyl-; Licofelone; ML 3000; [2,2-Dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetic acid|MFCD00929900|LICOFELONE [MI]|LICOFELONE [MART.]|MLS006011224|SCHEMBL237833|orb1300651|CHEBI:47532|UAWXGRJVZSAUSZ-UHFFFAOYSA-N|HMS3655D21|BCP06598|HY-B1452|PXB42704|BDBM50038649|s2121|AKOS027250758|DB04725|FC24890|SB19520|1H-Pyrrolizine-5-acetic acid, 2,3-dihydro-6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-|NCGC00250374-01|NCGC00250374-02|AC-33111|AS-73938|SMR004702985|CS-0013159|NS00069236|SW219543-1|AB01566204_02|897L062|Q3832015|BRD-K08439945-001-01-3|BRD-K08439945-001-02-1|BRD-K08439945-001-03-9|[2,2-dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acetic acid|6-(4-chlorophenyl)-2,2-dimethyl-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-ylacetic acid|2-[2-(4-Chlorophenyl)-6,6-dimethyl-1-phenyl-5,7-dihydropyrrolizin-3-yl]acetic acid;6-(4-Chlorophenyl)-2,3-dihydro-2,2-dimethyl-7-phe  nyl-1H-pyrrolizine-5-acetic acid;ML-3000;[2,2-Dimethyl-6-(4-chlorophenyl)-7-phenyl-2,3-dihydro-1H-pyrrolizin-5-yl]acet"
U-50488 METHANE SULFONATE,135349,,"InChI=1S/C19H26Cl2N2O.CH4O3S/c1-22(19(24)13-14-8-9-15(20)16(21)12-14)17-6-2-3-7-18(17)23-10-4-5-11-23;1-5(2,3)4/h8-9,12,17-18H,2-7,10-11,13H2,1H3;1H3,(H,2,3,4)/t17-,18-;/m1./s1",OJPHNZCUXUUVKU-JAXOOIEVSA-N,C20H30Cl2N2O4S,465.4,"2-(3,4-dichlorophenyl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide;methanesulfonic acid","(+/-)-trans-U-50488 methanesulfonate salt|83913-06-8|U-50488 methane sulfonate|83913-05-7|MLS000069740|CHEMBL482811|SMR000058892|2-(3,4-dichlorophenyl)-N-methyl-N-[(1R,2R)-2-pyrrolidin-1-ylcyclohexyl]acetamide;methanesulfonic acid|U50,488H|U 50488H|Opera_ID_588|Lopac-D-8040|MLS001076340|SCHEMBL548872|SCHEMBL29412563|DTXSID301004058|HMS2232L15|MFCD00133867|NCGC00016144-01|2-(3,4-Dichlorophenyl)-N-methyl-N-[trans-2-(1-pyrrolidinyl)cyclohexyl]acetamide Methanesulfonate|Benzeneacetamide, 3,4-dichloro-N-methyl-N-(2-(1-pyrrolidinyl)cyclohexyl)-, trans-(+-)-, monomethanesulfonate|SY395728|NCG-C00093883-01|Benzeneacetamide, 3,4-dichloro-N-methyl-N-[(1R,2R)-2-(1-pyrrolidinyl)cyclohexyl]-, methanesulfonate (1:1)|trans-(+/-)-3,4-Dichloro-N-methyl-N-[2-(1-pyrrolidinyl)cyclohexyl]benzeneacetamide hydrochloride"
LEVOMILNACIPRAN,6917779,,"InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m0/s1",GJJFMKBJSRMPLA-DZGCQCFKSA-N,C15H22N2O,246.35,"(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide","Levomilnacipran|96847-54-0|(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide|(1S,2R)-milnacipran|Milnacipran, (1s,2r)-|UGM0326TXX|Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, (1S,2R)-|F2695|F 2695|F-2695|DTXSID701025167|levomilnacipranum|RefChem:56888|DTXCID901509399|CHEMBL99946|(+)-(1S,2R)-MILNACIPRAN|96847-55-1|(1S,2R)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide|UNII-UGM0326TXX|Levomilnacipran [USAN:INN]|Milnacipram|starbld0000863|Levomilnacipran (USAN/INN)|LEVOMILNACIPRAN [INN]|LEVOMILNACIPRAN [USAN]|LEVOMILNACIPRAN [VANDF]|GTPL7435|SCHEMBL1414867|LEVOMILNACIPRAN [WHO-DD]|CHEBI:136040|GJJFMKBJSRMPLA-DZGCQCFKSA-N|GLXC-06018|BDBM50032379|HY-14794A|DB08918|f2-695|DA-64940|CS-0063121|NS00068053|D10072|EN300-19809925|Q6535779|(1S,2R)-2-Aminomethyl-1-phenyl-cyclopropanecarboxylic acid diethylamide"
MILNACIPRAN,65833,,"InChI=1S/C15H22N2O/c1-3-17(4-2)14(18)15(10-13(15)11-16)12-8-6-5-7-9-12/h5-9,13H,3-4,10-11,16H2,1-2H3/t13-,15+/m1/s1",GJJFMKBJSRMPLA-HIFRSBDPSA-N,C15H22N2O,246.35,"(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide","Milnacipran|92623-85-3|Milnacipranum|Impulsor|(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropane-1-carboxamide|F 2207|G56VK1HF36|DTXSID3048287|MILNACIPRAN PIERRE FABRE MEDICAMENT|F2207|RefChem:56579|N06AX17|DTXCID401509394|F-2207|Midalcipran|Dextromilnacipran|Milnacipranum [Latin]|96847-55-1|(-)-milnacipran|Milnacipran [INN]|ES1O38J3C4|F2696|Milnacipran (INN)|(+-)-Milnacipran|Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-,(1R,2S)-rel-|Milnace|(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide|(1R,2S)-2-(aminomethyl)-N,N-diethyl-1-phenyl-cyclopropane-1-carboxamide|Milnacipran [INN:BAN]|UNII-ES1O38J3C4|UNII-G56VK1HF36|MILNACIPRAN [MI]|Cyclopropanecarboxamide, 2-(aminomethyl)-N,N-diethyl-1-phenyl-, cis-(+-)-|MILNACIPRAN [VANDF]|SCHEMBL8099|MILNACIPRAN [WHO-DD]|(1R,2S)-MILNACIPRAN|MILNACIPRAN [EMA EPAR]|CHEMBL252923|orb1305287|orb1685522|SCHEMBL30083111|BDBM86420|CHEBI:94468|DTXSID601025164|HY-B0168|(+-)-cis-2-(Aminomethyl)-N,N-diethyl-1-phenylcyclopropanecarboxamide|EX-A10208|NCGC00165825-01|DA-59410|HY-14794|CAS_92623-85-3|CS-0003566|NS00005402|C16729|D08222|F-2696|AB00640027_06|623M853|EN300-18531191|Q421058|BRD-K02227374-003-07-1|(1RS,2SR)-2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYLCYCLOPROPANECARBOXAMIDE|CYCLOPROPANECARBOXAMIDE, 2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYL-, (1R,2S)-|CYCLOPROPANECARBOXAMIDE, 2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYL-, (1R,2S)-REL-|CYCLOPROPANECARBOXAMIDE, 2-(AMINOMETHYL)-N,N-DIETHYL-1-PHENYL-, (1R-CIS)-|F0F"
PEPSTATIN,5478883,,"InChI=1S/C34H63N5O9/c1-17(2)12-23(37-33(47)31(21(9)10)39-34(48)30(20(7)8)38-27(42)14-19(5)6)25(40)15-28(43)35-22(11)32(46)36-24(13-18(3)4)26(41)16-29(44)45/h17-26,30-31,40-41H,12-16H2,1-11H3,(H,35,43)(H,36,46)(H,37,47)(H,38,42)(H,39,48)(H,44,45)/t22-,23-,24-,25-,26-,30-,31-/m0/s1",FAXGPCHRFPCXOO-LXTPJMTPSA-N,C34H63N5O9,685.9,"(3S,4S)-3-hydroxy-4-[[(2S)-2-[[(3S,4S)-3-hydroxy-6-methyl-4-[[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(3-methylbutanoylamino)butanoyl]amino]butanoyl]amino]heptanoyl]amino]propanoyl]amino]-6-methylheptanoic acid","Pepstatin A|pepstatin|26305-03-3|Pepstatine|Pepstatina|Ahpatinin C|Pepstatinum|Procidin S 735A|Pepsin inhibitor S 735A|V6Y2T27Q1U|DTXSID7046095|NSC-272671|CHEBI:7989|(3S,4S)-3-hydroxy-4-[[(2S)-2-[[(3S,4S)-3-hydroxy-6-methyl-4-[[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(3-methylbutanoylamino)butanoyl]amino]butanoyl]amino]heptanoyl]amino]propanoyl]amino]-6-methylheptanoic acid|DTXCID5026095|N-Isovaleryl-L-valyl-L-valyl-3-hydroxy-6-methyl-gamma-aminoheptanoyl-L-alanyl-3-hydroxy-6-methyl-gamma-aminoheptanoic acid|NSC272671|(3S,4S)-3-hydroxy-4-(((2S)-2-(((3S,4S)-3-hydroxy-6-methyl-4-(((2S)-3-methyl-2-(((2S)-3-methyl-2-(3-methylbutanoylamino)butanoyl)amino)butanoyl)amino)heptanoyl)amino)propanoyl)amino)-6-methylheptanoic acid|RefChem:860129|247-600-0|MFCD00060740|Pepstatin (nonspecific)|39324-30-6|Pepstatin (VAN)|CCRIS 3603|Iva-Val-Val-Sta-Ala-Sta-OH|MLS002222329|CHEMBL296588|(6S,9S,12S,13S,17S,20S,21S)-13,21-dihydroxy-12,20-diisobutyl-6,9-diisopropyl-2,17-dimethyl-4,7,10,15,18-pentaoxo-5,8,11,16,19-pentaazatricosan-23-oic acid|L-Alaninamide,N-(3-methyl-1-oxobutyl)-L-valyl-L-valyl-(3S,4S)-4-amino-3-hydroxy-6-methylheptanoyl-N-[(1S)-1-[(1S)-2-carboxy-1-hydroxyethyl]-3-methylbutyl]-|NCGC00161670-06|C34H63N5O9|3-hydroxy-4-[2-[[3-hydroxy-6-methyl-4-[[3-methyl-2-[[3-methyl-2-(3-methylbutanoylamino)butanoyl]amino]butanoyl]amino]heptanoyl]amino]propanoylamino]-6-methylheptanoic acid|(3S,4S)-3-hydroxy-4-[(2S)-2-[(3S,4S)-3-hydroxy-6-methyl-4-[(2S)-3-methyl-2-[(2S)-3-methyl-2-(3-methylbutanamido)butanamido]butanamido]heptanamido]propanamido]-6-methylheptanoic acid|N-[(3-Methyl-1-oxobutyl)-L-valyl-L-valyl-4-amino-3-hydroxy-6-methylheptanoyl-L-alanyl]-4-amino-3-hydroxy-6-methylheptanoic acid|SMR000059191|Pepstatin [USAN:INN]|Pepstatine [INN-French]|Pepstatinum [INN-Latin]|Pepstatina [INN-Spanish]|UNII-V6Y2T27Q1U|1lyb|1sme|6apr|N-(3-Methyl-1-oxobutyl)-L-valyl-L-valyl-4-amino-3-hydroxy-6-methylheptanoyl-L-alanyl-4-amino-3-hydroxy-6-methylheptanoic acid|EINECS 247-600-0|CAS-26305-03-3|NSC 272671|BRN 2201362|4er2|PEPSTATIN [INN]|PEPSTATIN [MI]|Pepstatin (USAN/INN)|PEPSTATIN [USAN]|Prestwick3_000405|Iva-Val-Val-Sta-Ala-Sta|UPCMLD-DP141|PEPSTATIN [WHO-DD]|SCHEMBL50324|BDBM912|BSPBio_000330|BSPBio_001000|KBioGR_000340|KBioSS_000340|MLS000069747|MLS002207302|MLS006010748|BPBio1_000364|orb1303884|UPCMLD-DP141:001|UPCMLD-DP141:002|KBio2_000340|KBio2_002908|KBio2_005476|KBio3_000679|KBio3_000680|Bio1_000404|Bio1_000893|Bio1_001382|Bio2_000340|Bio2_000820|GLXC-23556|HMS1362B21|HMS1792B21|HMS1990B21|HMS2096A12|HMS2233I07|HMS3403B21|HMS3713A12|BCP15859|EX-A4027|HY-P0018|Pepstatin, from Streptomyces species|Tox21_111747|HB3359|s7381|Pepstatin A, >=100,000 U/mg|AKOS024456453|Tox21_111747_1|AC-8820|CCG-207852|CS-4202|FP29630|IDI1_002095|NCGC00160128-02|NCGC00161670-01|NCGC00161670-02|NCGC00161670-03|NCGC00161670-04|BS-16753|DA-76723|Heptanoic acid, N-(3-methyl-1-oxobutyl)-L-valyl-L-valyl-(3S,4S)-3-hydroxy-6-methyl-4-aminoheptanoyl-L-alanyl-(3S,4S)-3-hydroxy-6-methyl-4-amino-|L-Alaninamide, N-(3-methyl-1-oxobutyl)-L-valyl-L-valyl-(3S,4S)-4-amino-3-hydroxy-6-methylheptanoyl-N-[(1S)-1-[(1S)-2-carboxy-1-hydroxyethyl]-3-methylbutyl]-|SMR001307268|SY067712|Pepstatin A, microbial, >=75% (HPLC)|Pepstatin A, microbial, >=90% (HPLC)|AB00513830|Isovaleryl-L-val-L-val-statinyl-L-alastatine|NS00051237|C74361|D03818|Pepstatin A; Isovaleryl-Val-Val-Sta-Ala-Sta-OH|324P306|SR-01000721876|Q7166509|SR-01000721876-3|BRD-K13571841-001-03-7|BRD-K13571841-001-14-4|(3S,4S)-3-hydroxy-4-[[(2S)-2-[[(3S,4S)-3-hydroxy-6-methyl-4-[[(2S)-3-methyl-2-[[(2S)-3-methyl-2-(3-methylbutanoylamino)butanoyl]amino]butanoyl]amino]heptanoyl]amino]propanoyl]amino]-6-methyl-heptanoic acid|Isovaleryl-Val-Val-4-amino-3-hydroxy-6-methylheptanoyl-Ala-4-amino-3-hydroxy-6-methylheptanoic Acid|L-Alaninamide, N-(3-methyl-1-oxobutyl)-L-valyl-(3S,4S)-4-amino-3-hydroxy-6-methylheptanoyl-N-((1S)-1-((1S)-2-carboxy-1-hydroxyethyl)-3-methylbutyl)-|L-Valinamide, N-(3-methyl-1-oxobutyl)-L-valyl-N-(4-((2-((1-(2-carboxy-1-hydroxyethyl)-3-methylbutyl)amino)-1-methyl-2-oxoethyl)amino)-2-hydroxy-1-(2-methylpropyl)-4-oxobutyl)-, (1S-(1R*,2R*,4(R*(R*(R*)))))-|N-(3-Methylbutanoyl)-L-valyl-N-[(3S,4S)-1-{[(2S)-1-{[(2S,3S)-1-carboxy-2-hydroxy-5-methyl-3-hexanyl]amino}-1-oxo-2-propanyl]amino}-3-hydroxy-6-methyl-1-oxo-4-heptanyl]-L-valinamide|N-(3-methylbutanoyl)-L-valyl-N-[(3S,4S)-1-{[(2S)-1-{[(2S,3S)-1-carboxy-2-hydroxy-5-methylhexan-3-yl]amino}-1-oxopropan-2-yl]amino}-3-hydroxy-6-methyl-1-oxoheptan-4-yl]-L-valinamide"
SIRAMESINE,9829526,,"InChI=1S/C30H31FN2O/c31-25-12-14-26(15-13-25)33-21-23(27-9-2-4-11-29(27)33)7-5-6-18-32-19-16-30(17-20-32)28-10-3-1-8-24(28)22-34-30/h1-4,8-15,21H,5-7,16-20,22H2",XWAONOGAGZNUSF-UHFFFAOYSA-N,C30H31FN2O,454.6,"1'-[4-[1-(4-fluorophenyl)indol-3-yl]butyl]spiro[1H-2-benzofuran-3,4'-piperidine]","Siramesine|147817-50-3|siramesina|3IX8CWR24V|DTXSID90163810|SIRAMESINUM|RefChem:183231|DTXCID4086301|1'-(4-(1-(4-fluorophenyl)-1H-indol-3-yl)butyl)-3H-spiro(2-benzofuran-1,4'-piperidine)|Siramesine [INN]|1'-(4-(1-(4-fluorophenyl)-1H-indol-3-yl)butyl)-3H-spiro[isobenzofuran-1,4'-piperidine]|Spiro[isobenzofuran-1(3H),4'-piperidine], 1'-[4-[1-(4-fluorophenyl)-1H-indol-3-yl]butyl]-|CHEMBL61479|1'-[4-[1-(4-fluorophenyl)indol-3-yl]butyl]spiro[1H-2-benzofuran-3,4'-piperidine]|Lu-28-179|UNII-3IX8CWR24V|Siramesine(Lu 28-179)|Siramesine?|C30H31FN2O|Siramesine free base|MFCD00912182|orb1689964|SCHEMBL2090079|SCHEMBL29358736|EX-A355|XWAONOGAGZNUSF-UHFFFAOYSA-N|BCP08745|BDBM50035105|AKOS027251054|CS-1920|DB06555|1'-[4-[1-(4-fluorophenyl)indol-3-yl]butyl]spiro[1H-isobenzofuran-3,4'-piperidine]|NCGC00370727-06|DA-67599|HY-14221|NS00068590|Q7529961|BRD-K51333959-003-01-3|1'-(4-(1-(p-Fluorophenyl)indol-3-yl)butyl)spiro(phthalan-1,4'-piperidine)|Lu-28-179; Lu 28-179; Lu28-179; Lu-28179; Lu 28179; Lu28179|1''-{4-[1-(4-fluorophenyl)-1H-3-indolyl]butyl}spiro[1,3-dihydroisobenzofuran-1,4''-(hexahydropyridine)]|1''-{4-[1-(4-fluorophenyl)-1H-3-indolyl]butyl}spiro[1,3-dihydroisobenzofuran-1,4''-(hexahydropyridine)](Lu 28-179)|1'-[4-[1-(4-fluorophenyl)-1H-indole-3-yl]-1-butyl]-spiro[isobenzofuran-1(3H),4'-piperidine]"
BEXAROTENE,82146,,"InChI=1S/C24H28O2/c1-15-13-20-21(24(5,6)12-11-23(20,3)4)14-19(15)16(2)17-7-9-18(10-8-17)22(25)26/h7-10,13-14H,2,11-12H2,1,3-6H3,(H,25,26)",NAVMQTYZDKMPEU-UHFFFAOYSA-N,C24H28O2,348.5,"4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid","Bexarotene|153559-49-0|Targretin|Targrexin|LGD1069|bexaroteno|LGD-1069|bexarotenum|LG100069|DTXSID1040619|p-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthyl)vinyl)benzoic acid|LG-100069|NSC-747528|4-[1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid|CHEBI:50859|A61RXM4375|4-(1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)benzoic acid|4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl]benzoic acid|DTXCID9020619|4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl)benzoic acid|Benzoic acid, 4-(1-(5,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)-|3-methyl-TTNEB|Targretine|4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)ethenyl)benzoic acid|4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl]benzoic acid|4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)benzoic Acid|3-methyl TTNEB|RefChem:54537|L01XX25|LGD 1069|166175-31-1|4-[1-(3,5,5,8,8-pentamethyl-6,7-dihydronaphthalen-2-yl)ethenyl]benzoic acid|4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl)benzoic acid|MFCD00932428|Targretyn|LG 100069|4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)-vinyl]-benzoic acid|CHEMBL1023|Targret|Bexarotene [USAN]|NCGC00181016-01|4-[1-(1,1,4,4,7-pentamethyltetralin-6-yl)vinyl]benzoic acid|4-[1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydronaphthalen-2-yl)vinyl]benzoic acid|Targretin (TN)|LG 1069|CAS-153559-49-0|HSDB 7453|SR-05000001480|Bexarotene [USAN:INN:BAN]|UNII-A61RXM4375|LG 69|4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl)benzoic acid;LG 100069;LG 1069|Bexarotene (Standard)|Bexarotene, Free Acid|4k6i|SR 11247|BEXAROTENE [MI]|BEXAROTENE [INN]|BEXAROTENE [JAN]|BEXAROTENE [HSDB]|Bexarotene oral(targretin)|BEXAROTENE [VANDF]|BEXAROTENE [MART.]|SCHEMBL9025|BEXAROTENE [WHO-DD]|BIDD:PXR0021|MLS006010146|Bexarotene (JAN/USAN/INN)|BEXAROTENE [EMA EPAR]|Bexarotene - Bio-X trade mark|GTPL2807|orb1300792|BEXAROTENE [ORANGE BOOK]|Bexarotene, >=98% (HPLC)|SCHEMBL29412584|HMS2089L14|HMS3655D19|HMS3747C21|HMS3884B07|HMS5080E10|BCP04099|Tox21_112666|Tox21_302407|ARD169774|BDBM50032675|DL-298|HY-14171R|NSC747528|NSC783322|s2098|AKOS015902814|Tox21_112666_1|BCP9000396|CCG-221823|CS-0626|DB00307|FB18579|NSC 741061|NSC 747528|NSC-783322|SB17341|SS-4628|NCGC00181016-02|NCGC00181016-03|NCGC00181016-04|NCGC00181016-06|NCGC00181016-08|NCGC00181016-20|NCGC00255426-01|AC-24569|BB164246|HY-14171|SMR001614557|BCP0726000106|B4798|NS00000606|SW203810-3|D03106|SBI-0654103.0001|AB01275475-01|AB01275475_02|559B490|EN300-19769221|F050667|Q418192|SR-05000001480-1|SR-05000001480-2|BRD-K92441787-001-02-5|BRD-K92441787-001-04-1|4-[1-(3,5,5,8,8-pentamethyltetralin-2-yl)ethenyl]benzoic acid|4-[1-(3,5,5,8,8-Pentamethyl-2-5,8-dihydronaphthyl)vinyl]benzoic acid|4-(1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahydro-naphthalen-2-yl)vinyl)benzoic acid|4-[1-(5,6,7,8,-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphtalenyl)ethenyl]benzoic acid|4-[1-(5,6,7,8-Tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)-1-ethenyl]benzoic acid|Benzoic acid,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]-"
MELOXICAM,54677470,,"InChI=1S/C14H13N3O4S2/c1-8-7-15-14(22-8)16-13(19)11-12(18)9-5-3-4-6-10(9)23(20,21)17(11)2/h3-7,18H,1-2H3,(H,15,16,19)",ZRVUJXDFFKFLMG-UHFFFAOYSA-N,C14H13N3O4S2,351.4,"4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide","meloxicam|71125-38-7|Mobic|Metacam|Movalis|Movatec|Mobec|Mobicox|Coxicam|Meloxivet|Melfax|UH-AC 62XX|Meloxicamum|Meloxidolor|Meloxoral|Rheumocam|Vivlodex|Melosus|RevitaCAM|Acticam|Contacera|Emdocam|Flexicam|Inflacam|Loxicom|Melovem|Meloxidyl|Recocam|UHAC-62XX|DTXSID1020803|VG2QF83CGL|UH-AC-62 XX|ANJESO|CHEBI:6741|QMIIZ ODT|4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide|N-1539|DTXCID70803|miloxicam|N1539|ZELERIS COMPONENT MELOXICAM|SYMBRAVO COMPONENT MELOXICAM|ZYNRELEF COMPONENT MELOXICAM|2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methylthiazolyl)-, 1,1-dioxide|4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide|4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1$l^{6},2-benzothiazine-3-carboxamide|Masflex|Movicox|Alloxate|Ostilox|Meloxicam Injection|4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1$l^(6),2-benzothiazine-3-carboxamide|4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-1$l^{6},2-benzothiazine-3-carboxamide|4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1$l^(6),2-benzothiazine-3-carboxamide|Metacam Oral Suspension|RefChem:5991|OroCAM Transmucosal Oral Spray|Meloxicam Solution for Injection|M01AC06|Metacam 5 mg/mL Solution for Injection|2H-1,2-Benzothiazine-3-carboximidic acid, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide|4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-1,1-dioxo-2H-1lambda6,2-benzothiazine-3-carboxamide|615-253-8|Meloxicam (Mobic)|Parocin|Meloxicamum [Latin]|4-Hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide 1,1-dioxide|4-hydroxy-2-methyl-N-(5-methyl-1,3-thiazol-2-yl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide|C14H13N3O4S2|UNII-VG2QF83CGL|MFCD00868752|CHEMBL599|MLS000028587|4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide-1,1-dioxide|NCGC00018248-04|Meloxicam 100 microg/mL in Acetonitrile|SMR000058994|2H-1,2-Benzothiazine-3-carboxamide, 4-hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-, 1,1-dioxide|Revmoksikam|Coxflam|Melonex|Tenaron|(3E)-3-[hydroxy-[(5-methyl-1,3-thiazol-2-yl)amino]methylidene]-2-methyl-1,1-dioxo-1lambda6,2-benzothiazin-4-one|CAS-71125-38-7|CCRIS 9139|HSDB 7741|Meloxicam [USAN:USP:INN:BAN]|4-Hydroxy-2-methyl-N-(5-methyl-2-thiazolyl)-2H-1,2-benzothiazine-3-carboxamide 1,1-dioxide;Metacam;Mobic|QAMZOVA|XIFYRM|Meloxicam (Standard)|Mobic (TN)|Opera_ID_2|Spectrum_001633|MELOXICAM [INN]|MELOXICAM [JAN]|MELOXICAM [MI]|MELOXICAM [HSDB]|MELOXICAM [USAN]|Spectrum2_000941|Spectrum3_000649|Spectrum4_000787|Spectrum5_001813|MELOXICAM [VANDF]|Meloxicam impurity standard|MELOXICAM [MART.]|MELOXICAM [USP-RS]|MELOXICAM [WHO-DD]|SCHEMBL3576|Meloxicam (JAN/USP/INN)|Lopac0_000766|SCHEMBL33369|BSPBio_002257|KBioGR_001234|KBioSS_002113|MLS001304725|MLS001306413|MLS006011422|BIDD:GT0726|SCHEMBL713100|SPECTRUM1504150|Meloxicam - Bio-X trade mark|SPBio_000902|MELOXICAM [GREEN BOOK]|GTPL7220|orb1310257|MELOXICAM [ORANGE BOOK]|CHEMBL1741042|MELOXICAM [EP MONOGRAPH]|SCHEMBL23589638|HY-B0261R|KBio2_002113|KBio2_004681|KBio2_007249|KBio3_001477|ETI-511|MELOXICAM [USP MONOGRAPH]|MSK7155|HMS1922D19|HMS2089B18|HMS2096I19|HMS2234P07|HMS2236C09|HMS3259H06|HMS3372C13|HMS3372P18|HMS3655K06|HMS3713I19|HMS3744K09|HMS3884G08|HMS5079D20|ALBB-027268|BCP11928|HY-B0261|Tox21_111734|Tox21_113192|Tox21_201689|Tox21_302756|BBL029076|BDBM50056998|CCG-39098|HSCI1_000045|s1734|STK620505|Meloxicam - CAS 71125-38-7|AKOS000279442|AKOS026749959|Tox21_111734_1|AC-1325|DB00814|FH25045|KS-1084|MELOXICAM [EMA EPAR VETERINARY]|NC00698|SMP2_000133|NCGC00018248-01|NCGC00018248-02|NCGC00018248-03|NCGC00018248-05|NCGC00018248-06|NCGC00018248-07|NCGC00018248-08|NCGC00018248-10|NCGC00018248-23|NCGC00018248-24|NCGC00018248-25|NCGC00018248-26|NCGC00022924-03|NCGC00022924-04|NCGC00256316-01|NCGC00259238-01|NCGC00263878-02|BH164661|SMR000718800|Meloxicam 1000 microg/mL in Acetonitrile|DB-055490|Meloxicam 1.0 mg/ml in Dimethyl Sulfoxide|M1959|NS00000018|SW219562-1|EN300-52507|C08169|D00969|F20356|M02128|AB00383033-17|AB00383033-18|AB00383033_20|125M387|AN-668/13244001|Q414028|SR-01000003132-10|F2173-0387|Z1695493323|4-hydroxy-2-methyl-N-(5-methy-2-thiazolyl)-2H-1,2-benzothiazine-3-caboxamide-1,1-dioxide|133687-22-6|3-{hydroxy[(5-methyl-1,3-thiazol-2-yl)amino]methylidene}-2-methyl-3,4-dihydro-2H-1lambda6,2-benzothiazine-1,1,4-trione|4-Hydroxy-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[e][1,2]thiazine-3-carboxylic acid (5-methyl-thiazol-2-yl)-amide|4-Hydroxy-2-methyl-1,1-dioxo-1,2-dihydro-1lambda*6*-benzo[e][1,2]thiazine-3-carboxylic acid (5-methyl-thiazol-2-yl)-amide|4-hydroxy-2-methyl-N-(5-methyl-2-thiazole)-2H-1,2-benzothiazine-3 -carboxamide 1,1-dioxide|4-hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-1,1-dioxo-1lambda6,2-benzothiazine-3-carboxamide|4-Hydroxy-2-methyl-N-(5-methylthiazol-2-yl)-2H-benzo[e][1,2]thiazine-3-carboxamide1,1-dioxide"
MECLOFENAMIC ACID,4037,,"InChI=1S/C14H11Cl2NO2/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19/h2-7,17H,1H3,(H,18,19)",SBDNJUWAMKYJOX-UHFFFAOYSA-N,C14H11Cl2NO2,296.1,"2-(2,6-dichloro-3-methylanilino)benzoic acid","meclofenamic acid|meclofenamate|644-62-2|Arquel|2-[(2,6-dichloro-3-methylphenyl)amino]benzoic acid|Acido meclofenamico|Acide meclofenamique|INF 4668|Meclomen|Acidum meclofenamicum|CI-583|N-(2,6-Dichloro-m-tolyl)anthranilic acid|INF-4668|N-(3-Methyl-2,6-dichlorophenyl)anthranilic acid|N-(2,6-Dichloro-3-methylphenyl)anthranilic acid|2-((2,6-Dichloro-3-methylphenyl)amino)benzoic acid|48I5LU4ZWD|CL-583|NSC-95309|CHEBI:6710|Benzoic acid, 2-((2,6-dichloro-3-methylphenyl)amino)-|benzoic acid, 2-[(2,6-dichloro-3-methylphenyl)amino]-|DTXSID0048559|Arquel Granules|Arquel Tablets|Meclofenamate, Sodium|RefChem:58589|DTXCID3028188|M01AG04|M02AA18|211-419-5|Meclophenamic acid|Meclomen (free acid)|2-(2,6-dichloro-3-methylanilino)benzoic acid|Acide meclofenamique [INN-French]|Acido meclofenamico [INN-Spanish]|Acidum meclofenamicum [INN-Latin]|CHEMBL509|644-62-2 (free acid)|2-[(2,6-dichloro-3-methyl-phenyl)amino]benzoic acid|Meclofenamic acid [USAN:INN:BAN]|CCRIS 5532|EINECS 211-419-5|NSC 95309|UNII-48I5LU4ZWD|BRN 2221428|Meclofenamic acid (USAN/INN)|meclofenamic-acid|Anthranilic acid, N-(2,6-dichloro-m-tolyl)-|JMS|CL 583|Spectrum_000893|Prestwick0_000206|Prestwick1_000206|Prestwick2_000206|Prestwick3_000206|Spectrum2_001045|Spectrum3_000486|Spectrum4_000038|Spectrum5_000942|SCHEMBL106|2-(2,6-dichloro-3-methyl-anilino)benzoic acid|Lopac0_000727|BSPBio_000191|BSPBio_001951|KBioGR_000475|KBioSS_001373|MECLOFENAMATE [VANDF]|2-(2,6-Dichloro-3-methylphenyl)aminobenzoic acid|DivK1c_000504|SPBio_000970|SPBio_002112|MECLOFENAMIC ACID [MI]|BPBio1_000211|GTPL7219|orb1709159|MECLOFENAMIC ACID [INN]|MECLOFENAMIC ACID [USAN]|SCHEMBL29373906|SCHEMBL29379636|BDBM22971|KBio1_000504|KBio2_001373|KBio2_003941|KBio2_006509|KBio3_001451|MECLOFENAMIC ACID [VANDF]|MSK8010|MECLOFENAMIC ACID [MART.]|NINDS_000504|GLXC-23164|MECLOFENAMIC ACID [WHO-DD]|NSC95309|AKOS012836983|MECLOFENAMIC ACID [GREEN BOOK]|Anthranilic acid,6-dichloro-m-tolyl)-|DB00939|FM25028|SDCCGSBI-0050705.P005|IDI1_000504|NCGC00021132-01|SBI-0050705.P004|HY-117275|CS-0064844|NS00000697|UNM000001246303|Benzoic acid,6-dichloro-3-methylphenyl)amino]-|C07117|D02341|EN300-708777|G12198|644M622|2-((2,6-Dichloro-3-methylphenyl)amino)benzoicacid|Q2823284|2-[(2,6-dichloro-3-methylphenyl)amino]-benzoic acid|BRD-K50398167-236-02-9|BRD-K50398167-236-22-7|BRD-K50398167-323-03-3|2-[(2,6-Dichloro-3-methylphenyl)amino]benzoic acid;N-(2,6-Dichloro-m-tolyl)anthranilic acid|InChI=1/C14H11Cl2NO2/c1-8-6-7-10(15)13(12(8)16)17-11-5-3-2-4-9(11)14(18)19/h2-7,17H,1H3,(H,18,19"
FLUFENAMIC ACID,3371,,"InChI=1S/C14H10F3NO2/c15-14(16,17)9-4-3-5-10(8-9)18-12-7-2-1-6-11(12)13(19)20/h1-8,18H,(H,19,20)",LPEPZBJOKDYZAD-UHFFFAOYSA-N,C14H10F3NO2,281.23,2-[3-(trifluoromethyl)anilino]benzoic acid,"flufenamic acid|530-78-9|Arlef|Fluphenamic acid|Achless|2-((3-(Trifluoromethyl)phenyl)amino)benzoic acid|Acido flufenamico|N-(3-Trifluoromethylphenyl)anthranilic acid|Flufenaminsaeure|Meralen|2-{[3-(trifluoromethyl)phenyl]amino}benzoic acid|Acide flufenamique|CI 440|NSC-82699|Acidum flufenamicum|CN-27,554|3'-Trifluoromethyldiphenylamine-2-carboxylic acid|2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid|Benzoic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-|INF-1837|DTXSID7023063|2-[3-(Trifluoromethyl)anilino]benzoic acid|Benzoic acid, 2-((3-(trifluoromethyl)phenyl)amino)-|60GCX7Y6BH|N-(alpha,alpha,alpha-Trifluoro-m-tolyl)anthranilic acid|NSC-219007|CHEBI:42638|CI-440|CN-27554|DTXCID303063|Acid, Flufenamic|2-(3-(trifluoromethyl)anilino)benzoic acid|flufenamic acid aluminium|RefChem:388982|M01AG03|208-494-1|Nichisedan|Flufacid|Fullsafe|Lanceat|Paraflu|Plostene|Tecramine|Parlef|Parlif|Surika|Reumajust A|Ristogen|Sastridex|Ansatin|Fluore-200|ANT-1|TVX 916|INF 1837|MFCD00002422|C.I. 440|NSC 219007|N-[3-(Trifluoromethyl)phenyl]anthranilic acid|2-((3-Trifluromethyl)phenyl)aminobenzoic acid|2-[[3-(TRIFLUOROMETHYL)PHENYL]AMINO] BENZOIC ACID|N-(m-Trifluoromethylphenyl)-2-aminobenzoic acid|2-(3-Trifluoromethylanilino)benzoic Acid|CHEMBL23588|MLS000028563|Saal-F|NCGC00016490-06|CAS-530-78-9|SMR000059027|N-(3-Trifluoromethylphenyl)-anthranilic acid|WLN: QVR BMR CXFFF|FFA|F0909-0007|Flufenamicacid|N-(.alpha.,.alpha.,.alpha.-Trifluoro-m-tolyl)anthranilic acid|Flufenaminsaeure [German]|Acido flufenamico [Italian]|FLF|CCRIS 5266|2-[(3-Trifluromethyl)phenyl]aminobenzoic acid|N-[(3-Trifluoromethyl)phenyl]anthranilic acid|Acide flufenamique [INN-French]|Acido flufenamico [INN-Spanish]|Acidum flufenamicum [INN-Latin]|N-((m-Trifluoromethyl)phenyl)-2-aminobenzoic acid|N-[(m-Trifluoromethyl)phenyl]-2-aminobenzoic acid|N-[m-(Trifluoromethyl)phenyl]-2-aminobenzoic acid|SR-01000000241|EINECS 208-494-1|Anthranilic acid,.alpha.,.alpha.-trifluoro-m-tolyl)-|N-(.alpha.,.alpha.-Trifluoro-m-tolyl)anthranilic acid|UNII-60GCX7Y6BH|Flufenamic acid [USAN:INN:BAN:JAN]|BRN 1996069|flufenamic-acid|Prestwick_220|Arlef (TN)|Spectrum_001257|1bm7|Opera_ID_578|Prestwick0_000203|Prestwick1_000203|Prestwick2_000203|Prestwick3_000203|Spectrum2_000789|Spectrum3_001273|Spectrum4_000102|Spectrum5_000686|EC 208-494-1|Flufenamic acid (Standard)|CBiol_001756|SCHEMBL17497|BSPBio_000185|BSPBio_001319|BSPBio_002866|CBDivE_012649|FLUFENAMIC ACID [MI]|KBioGR_000039|KBioGR_000424|KBioGR_002267|KBioSS_000039|KBioSS_001737|KBioSS_002268|3-14-00-00905 (Beilstein Handbook Reference)|MLS001148610|DivK1c_000581|FLUFENAMIC ACID [INN]|FLUFENAMIC ACID [JAN]|SPECTRUM1501015|SPBio_000898|SPBio_002106|FLUFENAMIC ACID [USAN]|BPBio1_000205|GTPL2447|orb1310228|FLUFENAMIC ACID [MART.]|SCHEMBL29356958|BCBcMAP01_000039|BDBM17636|HMS501N03|HY-B1221R|KBio1_000581|KBio2_000039|KBio2_001737|KBio2_002267|KBio2_002607|KBio2_004305|KBio2_004835|KBio2_005175|KBio2_006873|KBio2_007403|KBio3_000077|KBio3_000078|KBio3_002366|KBio3_002747|Anthranilic acid, N-(alpha,alpha,alpha-trifluoro-m-tolyl)-|FLUFENAMIC ACID [WHO-DD]|MSK8002|cMAP_000004|NINDS_000581|Bio1_000042|Bio1_000531|Bio1_001020|Bio2_000039|Bio2_000519|Flufenamic acid (JAN/USAN/INN)|GLXC-27023|HMS1361B21|HMS1568J07|HMS1791B21|HMS1921B21|HMS1989B21|HMS2089E07|HMS2092B09|HMS2095J07|HMS2232G24|HMS3371F01|HMS3402B21|HMS3652F06|HMS3712J07|HMS3885P15|HMS5082J22|Pharmakon1600-01501015|SMSSF-0062312|HY-B1221|NSC82699|Tox21_110452|Tox21_302111|CCG-40167|NSC219007|NSC757823|s4268|SBB001140|STK985630|AKOS000265536|Tox21_110452_1|CS-4811|DB02266|FF23323|KS-1143|NSC-757823|IDI1_000581|IDI1_033789|NCGC00016490-01|NCGC00016490-02|NCGC00016490-03|NCGC00016490-04|NCGC00016490-05|NCGC00016490-07|NCGC00016490-08|NCGC00016490-09|NCGC00016490-10|NCGC00016490-12|NCGC00023200-03|NCGC00023200-04|NCGC00023200-05|NCGC00023200-06|NCGC00023200-07|NCGC00255175-01|CN-27544|ST026563|SY014664|SBI-0051633.P002|DB-052254|2-[3-(trifluoromethyl)anilino]-benzoic acid|AB00052198|ETOFENAMATE IMPURITY A [EP IMPURITY]|n-(a,a,a-trifluoro-m-tolyl)anthranilic acid|NS00000475|SW196528-3|T2354|UNM000001246003|2-[3-(Trifluoromethyl)anilino]benzoic acid #|EN300-16858|o-[m-(trifluoromethyl)phenylamino]benzoic acid|2-[(3-Trifluoromethylphenyl)amino]benzoic Acid|D01581|D97458|AB00052198-14|AB00052198_15|530F789|F358173|Q416341|SR-01000000241-2|SR-01000000241-3|BRD-K44067360-001-06-3|BRD-K44067360-001-16-2|BRD-K44067360-001-29-5|BRD-K44067360-001-30-3|Z56797275|Flufenamic acid, analytical standard, for drug analysis|Anthranilic acid, N-(.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-|2-[[3-(Trifluoromethyl)phenyl]amino]benzoic acid;2-[3-(Trifluoromethyl)anilino]benzoic acid;3'-Trifluoromethyldiphenylamine-2-carbox  ylic acid|FFA, Flufenamic acid, 3-[(2-Carboxyphenyl)amino]benzotrifluoride, 2-Carboxy-3'-(trifluoromethyl)diphenylamine"
ABLUKAST,57109,,"InChI=1S/C28H34O8/c1-4-8-21-23(12-10-20(17(2)29)27(21)31)34-13-6-5-7-14-35-26-16-25-19(15-22(26)18(3)30)9-11-24(36-25)28(32)33/h10,12,15-16,24,31H,4-9,11,13-14H2,1-3H3,(H,32,33)",FGGYJWZYDAROFF-UHFFFAOYSA-N,C28H34O8,498.6,"6-acetyl-7-[5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentoxy]-3,4-dihydro-2H-chromene-2-carboxylic acid","Ablukast|96566-25-5|Ro-23-3544|Ablukastum|000TKM5BBQ|Ro 23-3544/000|RO 23 3544/000|RO-23-3544/000|6-acetyl-7-(5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyloxy)-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid|RefChem:914901|Ro 23-3544|131147-29-0|6-acetyl-7-[5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentoxy]-3,4-dihydro-2H-chromene-2-carboxylic acid|CHEMBL22016|2H-1-Benzopyran-2-carboxylic acid, 6-acetyl-7-[[5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl]oxy]-3,4-dihydro-|6-Acetyl-7-(5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyloxy)-3,4-dihydro-2H-1-be nzopyran-2-carboxylic acid|2H-1-Benzopyran-2-carboxylic acid, 6-acetyl-7-((5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl)oxy)-3,4-dihydro-, (+-)-|6-Acetyl-7-((5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl)oxy)chromane-2-carboxylic acid|Ablukast [USAN:INN]|Ablukastum [INN-Latin]|UNII-000TKM5BBQ|ABLUKAST [USAN]|Ablukast (USAN/INN)|ABLUKAST [INN]|SCHEMBL37501|orb1305216|DTXSID20869277|6-Acetyl-7-[5-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-pentyloxy]-chroman-2-carboxylic acid|CHEBI:229915|BDBM50009071|AKOS000278590|AKOS040747736|(+-)-6-Acetyl-7-((5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl)oxy)-2-chromancarboxylic acid|DA-50093|MS-29252|HY-118958|CS-0078139|NS00121301|D02739|H39142|Q4668103|6-acetyl-7-[5-(4-acetyl-3-hydroxy-2-propyl-phenoxy)pentoxy]chromane-2-carboxylic acid|(+/-)-6-ACETYL-7-((5-(4-ACETYL-3-HYDROXY-2-PROPYLPHENOXY)PENTYL)OXY)-2-CHROMANCARBOXYLIC ACID|122444-22-8|2H-1-BENZOPYRAN-2-CARBOXYLIC ACID, 6-ACETYL-7-((5-(4-ACETYL-3-HYDROXY-2-PROPYLPHENOXY)PENTYL)OXY)-3,4-DIHYDRO-, (+/-)-|6-Acetyl-7-[5-(4-acetyl-3-hydroxy-2-propyl-phenoxy)-pentyloxy]-chroman-2-carboxylic acid(Ro 23-3544)|6-Acetyl-7-{[5-(4-acetyl-3-hydroxy-2-propylphenoxy)pentyl]oxy}-3,4-dihydro-2H-1-benzopyran-2-carboxylic acid"
APALUTAMIDE,24872560,,"InChI=1S/C21H15F4N5O2S/c1-27-17(31)13-4-3-11(8-15(13)22)30-19(33)29(18(32)20(30)5-2-6-20)12-7-14(21(23,24)25)16(9-26)28-10-12/h3-4,7-8,10H,2,5-6H2,1H3,(H,27,31)",HJBWBFZLDZWPHF-UHFFFAOYSA-N,C21H15F4N5O2S,477.4,"4-[7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide","apalutamide|ARN-509|956104-40-8|ARN 509|Erleada|JNJ-56021927|ARN509|apalutamida|4-(7-(6-CYANO-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)-8-OXO-6-THIOXO-5,7-DIAZASPIRO[3.4]OCTAN-5-YL)-2-FLUORO-N-METHYLBENZAMIDE|4T36H88UA7|JNJ 56021927|DTXSID40241899|4-(7-(6-Cyano-5-(trifluoromethyl)pyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro(3.4)octan-5-yl)-2-fluoro-N-methylbenzamide|apalutamidum|4-[7-[6-Cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide|RefChem:58966|DTXCID20164390|L02BB05|Apalutamide [INN]|Apalutamide (ARN-509)|UNII-4T36H88UA7|MFCD22380626|C21H15F4N5O2S|956104-40-8 (free base)|4-[7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide|4-{7-[6-cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-sulfanylidene-5,7-diazaspiro[3.4]octan-5-yl}-2-fluoro-N-methylbenzamide|Erleada (TN)|ApalutamideARN509?|Apalutamide (Standard)|Apalutamide (JAN/INN)|APALUTAMIDE [MI]|APALUTAMIDE [JAN]|APALUTAMIDE [WHO-DD]|MLS006011109|SCHEMBL909297|GTPL9043|orb1305642|CHEMBL3183409|SCHEMBL29351392|SCHEMBL29396285|APALUTAMIDE [ORANGE BOOK]|EX-A089|HMS3656N12|HMS5081D19|Apalutamide (Amorphous & Form B)|BCP05829|AR509/AR-509|BDBM50094975|HY-16060R|NSC771649|NSC794776|s2840|AKOS025401932|CCG-264760|CS-0885|DB11901|FA64943|NSC-771649|NSC-794776|PB27306|NCGC00346725-01|NCGC00346725-02|NCGC00346725-06|AC-27403|AS-35181|Benzamide, 4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methyl-|BP-43625|DA-71039|HY-16060|SMR004702891|NS00072522|SW220300-1|24872560, Erleada, C21H15F4N5O2S|D11040|EN300-18167004|F857109|BRD-K91308639-001-02-7|Q21098975|Z2037280438|4-[7-[6-Cyano-5-(trifluoromethyl)-3-pyridinyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]oct-5-yl]-2-fluoro-N-methylbenzamide|4-[7-[6-cyano-5-(trifluoromethyl)-3-pyridyl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methyl-benzamide|Apalutamide;4-[7-[6-Cyano-5-(trifluoromethyl)pyridin-3-yl]-8-oxo-6-thioxo-5,7-diazaspiro[3.4]octan-5-yl]-2-fluoro-N-methylbenzamide;   Erleada"
AMIGLUMIDE,10478431,,"InChI=1S/C26H36N2O4/c1-3-5-9-17-28(18-10-6-4-2)26(32)23(15-16-24(29)30)27-25(31)22-14-13-20-11-7-8-12-21(20)19-22/h7-8,11-14,19,23H,3-6,9-10,15-18H2,1-2H3,(H,27,31)(H,29,30)/t23-/m1/s1",LFMMKOQRKPJBIG-HSZRJFAPSA-N,C26H36N2O4,440.6,(4R)-5-(dipentylamino)-4-(naphthalene-2-carbonylamino)-5-oxopentanoic acid,"Amiglumide|Amiglumide [INN]|119363-62-1|amiglumida|UNII-H48W1A97VB|H48W1A97VB|(R)-4-(2-Naphthamido)-N,N-dipentylglutaramic acid|amiglumidum|RefChem:111983|CR-1795|CHEMBL114325|CR1795|(4R)-5-(dipentylamino)-4-(naphthalene-2-carbonylamino)-5-oxopentanoic acid|4-Dipentylcarbamoyl-4-[(naphthalene-2-carbonyl)-amino]-butyric acid|orb1738203|SCHEMBL1056352|SCHEMBL29387700|BDBM50008667|Q27279626"
CLEBOPRIDE,2780,,"InChI=1S/C20H24ClN3O2/c1-26-19-12-18(22)17(21)11-16(19)20(25)23-15-7-9-24(10-8-15)13-14-5-3-2-4-6-14/h2-6,11-12,15H,7-10,13,22H2,1H3,(H,23,25)",BVPWJMCABCPUQY-UHFFFAOYSA-N,C20H24ClN3O2,373.9,4-amino-N-(1-benzylpiperidin-4-yl)-5-chloro-2-methoxybenzamide,"Clebopride|55905-53-8|Cleboprida|Clebopridum|4-amino-N-(1-benzylpiperidin-4-yl)-5-chloro-2-methoxybenzamide|LAS 9273|N-(1'-Benzyl-4'-piperidyl)-2-methoxy-4-amino-5-chlorobenzamide|LAS-9273|I0A84520Y9|DTXSID7022831|BENZAMIDE, 4-AMINO-5-CHLORO-2-METHOXY-N-(1-(PHENYLMETHYL)-4-PIPERIDINYL)-|Clanzoflat|RefChem:126893|DTXCID102831|A03FA06|N-1-benzyl-4 piperidil-3-methoxy-4-amino-5-chlorobenzamide|259-885-9|Cleboril|EINECS 259-885-9|4-Amino-N-(1-benzyl-4-piperidyl)-5-chloro-o-anisamide|CHEMBL325109|Clebopride (USAN)|clebopride malate|CLEBOPRIDE [USAN]|Clebopride hydrogen malate|Clebopridum [INN-Latin]|4-Amino-5-chloro-2-methoxy-N-[1-(phenylmethyl)-4-piperidinyl]benzamide|Cleboprida [INN-Spanish]|NCGC00016951-01|CAS-84370-95-6|BRN 0493934|Clebopride [USAN:INN:BAN]|UNII-I0A84520Y9|4-AMINO-5-CHLORO-2-METHOXY-N-(1-(PHENYLMETHYL)-4-PIPERIDINYL)BENZAMIDE|Cleboril (TN)|Spectrum_001692|CLEBOPRIDE [MI]|SpecPlus_000752|4-Amino-5-chloro-2-methoxy-N-(1-benzyl-4-piperidyl)benzamide|CLEBOPRIDE [INN]|Prestwick0_000380|Prestwick1_000380|Prestwick2_000380|Prestwick3_000380|Spectrum2_000767|Spectrum3_001997|Spectrum4_000083|Spectrum5_001571|CLEBOPRIDE [MART.]|CLEBOPRIDE [WHO-DD]|SCHEMBL25710|BSPBio_000539|BSPBio_003597|KBioGR_000346|KBioSS_002172|5-22-08-00086 (Beilstein Handbook Reference)|DivK1c_006848|SPBio_000814|SPBio_002460|BPBio1_000593|orb1685475|SCHEMBL25259199|CHEBI:92309|KBio1_001792|KBio2_002172|KBio2_004740|KBio2_007308|KBio3_003039|BDBM50132693|AKOS027420458|DB13511|NCGC00016951-02|NCGC00016951-03|NCGC00177974-01|NCGC00177974-02|AB00053707|NS00033420|D03534|905C538|L000785|Q5131021|BRD-K17294426-050-05-7|BRD-K17294426-050-12-3|4-amino-N-(1-benzyl-4-piperidinyl)-5-chloro-2-methoxybenzamide|4-Amino-N-(1-benzyl-piperidin-4-yl)-5-chloro-2-methoxy-benzamide|4-amino-5-chloro-2-(methyloxy)-N-[1-(phenylmethyl)piperidin-4-yl]benzamide|4-Amino-N-(1-benzyl-piperidin-4-yl)-5-chloro-2-methoxy-benzamide(Clebopride)"
MIANSERIN HYDROCHLORIDE,68551,,"InChI=1S/C18H20N2.ClH/c1-19-10-11-20-17-9-5-3-7-15(17)12-14-6-2-4-8-16(14)18(20)13-19;/h2-9,18H,10-13H2,1H3;1H",YNPFMWCWRVTGKJ-UHFFFAOYSA-N,C18H21ClN2,300.8,"5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene;hydrochloride","Mianserin hydrochloride|21535-47-7|Mianserin HCl|Mianserine hydrochloride|Bolvidon|ORG GB 94|Tetramide|1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine hydrochloride|ORG-GB 94|NSC-759590|2X03TN217S|CHEBI:31843|DTXSID30944145|Dibenzo(c,f)pyrazino(1,2-a)azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, monohydrochloride|1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)-pyrazino(1,2-a)azepine monohydrochloride|1,2,3,4,10,14b-Hexahydro-2-methyldibenzo(c,f)pyrazino(1,2-a)azepine hydrochloride|1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]-pyrazino[1,2-a]azepine monohydrochloride|Hydrochloride, Mianserin|RefChem:925840|Mianserin Monohydrochloride|Monohydrochloride, Mianserin|DTXCID601372498|244-426-7|Athymil|Mianserin (hydrochloride)|MFCD00055072|MLS000069681|Mianserin.HCl|2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine hydrochloride|Lerivon|5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene;hydrochloride|SMR000058472|Tolvin|mianserine HCl|78644-54-9|Mianserin Hydrocloride|SR-01000000185|ORG GB-94 HCl|GB 94|Tetramide (TN)|1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyrazino[1,2-a]azepine hydrochloride;Athymil;Bolvidon|Prestwick_514|EINECS 244-426-7|Mianserin hydrochloride [USAN:JAN]|Mianserin hydrochloride?|(.+-.)-Athymil|Opera_ID_1505|(.+-.)-Norval|MLS001148213|MLS002222220|SCHEMBL340474|SPECTRUM2300292|UNII-2X03TN217S|CHEMBL544428|HY-B0188AR|orb1310297|Mianserin for system suitability|SCHEMBL29366576|HY-B0188A|MSK10904A|YNPFMWCWRVTGKJ-UHFFFAOYSA-N|HMS1568C20|HMS5079J17|Pharmakon1600-02300292|Mianserin HCl - Bio-X trade mark|BCP09259|Mianserin hydrochloride (JAN/USAN)|MIANSERIN HYDROCHLORIDE [MI]|Tox21_500744|CCG-39108|HB1658|Mianserin (hydrochloride) (Standard)|MIANSERIN HYDROCHLORIDE [JAN]|NSC292267|NSC759590|s1382|MIANSERIN HYDROCHLORIDE [USAN]|AKOS015902308|CS-2079|FM25996|KS-5096|LP00744|MIANSERIN HYDROCHLORIDE [MART.]|NSC 759590|NSC-292267|MIANSERIN HYDROCHLORIDE [WHO-DD]|NCGC00094086-01|NCGC00094086-02|NCGC00094086-03|NCGC00094086-04|NCGC00261429-01|AC-25005|BM166416|SY107357|DB-045611|EU-0100744|M2623|NS00084235|SW196707-3|MIANSERIN HYDROCHLORIDE [EP MONOGRAPH]|C74052|D01358|M 2525|535M477|Mianserin.HCl, 1mg/ml in Methanol (as free base)|SR-01000000185-2|SR-01000000185-4|SR-01000000185-8|Q27114695|Mianserin Hydrochloride 1.0 mg/ml in Methanol (as free base)|Mianserin hydrochloride, analytical standard, for drug analysis|Mianserin hydrochloride, European Pharmacopoeia (EP) Reference Standard|1,2,3,4,10,14b-Hexahydro-2-methyl-dibenzo[c,f]pyrazino[1,2-a]azepine hydrochloride|1,2,3,4,10,14b-Hexahydro-2-methyldibenzo[c,f]pyryzino[1,2-a]azepine hydrochloride|2-methyl-1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepinehydrochloride|Mianserin for system suitability, European Pharmacopoeia (EP) Reference Standard|Dibenzo[c,f]pyrazino[1,2-a]azepine, 1,2,3,4,10,14b-hexahydro-2-methyl-, hydrochloride (1:1)|Hydron;5-methyl-2,5-diazatetracyclo[13.4.0.02,7.08,13]nonadeca-1(19),8,10,12,15,17-hexaene;chloride"
LECIMIBIDE,71355,,"InChI=1S/C34H40F2N4OS/c1-2-3-4-5-13-22-40(34(41)37-30-21-20-28(35)25-29(30)36)23-14-8-15-24-42-33-38-31(26-16-9-6-10-17-26)32(39-33)27-18-11-7-12-19-27/h6-7,9-12,16-21,25H,2-5,8,13-15,22-24H2,1H3,(H,37,41)(H,38,39)",TVXOXGBTADZYCZ-UHFFFAOYSA-N,C34H40F2N4OS,590.8,"3-(2,4-difluorophenyl)-1-[5-[(4,5-diphenyl-1H-imidazol-2-yl)sulfanyl]pentyl]-1-heptylurea","Lecimibide|130804-35-2|DuP 128|dup128|DuP-128|lecimibida|A7T248B302|DTXSID80156751|N'-(2,4-DIFLUOROPHENYL)-N-(5-(4,5-DIPHENYL-1H-IMIDAZOL-2-YLTHIO)PENTYL)-N-HEPTYLUREA|lecimibidum|N'-(2,4-difluorophenyl)-N-[5-(4,5-diphenyl-1H-imidazol-2-ylthio)pentyl]-N-heptylurea|RefChem:152691|DTXCID7079242|3-(2,4-difluorophenyl)-1-[5-[(4,5-diphenyl-1H-imidazol-2-yl)sulfanyl]pentyl]-1-heptylurea|CHEMBL274185|Lecimibide (USAN)|LECIMIBIDE [USAN]|3-(2,4-difluorophenyl)-1-[5-[[4,5-di(phenyl)-1H-imidazol-2-yl]sulfanyl]pentyl]-1-heptylurea|3-(2,4-difluorophenyl)-1-(5-((4,5-diphenyl-1H-imidazol-2-yl)thio)pentyl)-1-heptylurea|3-(2,4-Difluorophenyl)-1-(5-((4,5-diphenylimidazol-2-yl)thio)pentyl)-1-heptylurea|Urea, N'-(2,4-difluorophenyl)-N-(5-((4,5-diphenyl-1H-imidazol-2-yl)thio)pentyl)-N-heptyl-|Lecimibide [USAN:INN]|UNII-A7T248B302|3-(2,4-Difluorophenyl)-1-[5-[(4,5-diphenylimidazol-2-yl)thio]pentyl]-1-heptylurea|3-(2,4-Difluorophenyl)-1-{5-[(4,5-diphenyl-1H-imidazol-2-yl)sulfanyl]pentyl}-1-heptylurea|LECIMIBIDE [INN]|LECIMIBIDE [WHO-DD]|SCHEMBL49619|orb1702075|SCHEMBL30548840|TVXOXGBTADZYCZ-UHFFFAOYSA-N|GLXC-26601|BDBM50033969|AKOS040747027|BP-43193|HY-16281|TS-08432|NS00125525|D03735|Q1303494|N'-(2,4-difluorophenyl)-N-[5-(4,5 -diphenyl-1H-imidazol-2-ylthio)pentyl]-N-heptylurea|3-(2,4-Difluoro-phenyl)-1-[5-(4,5-diphenyl-1H-imidazol-2-ylsulfanyl)-pentyl]-1-heptyl-urea"
DORAMAPIMOD,156422,,"InChI=1S/C31H37N5O3/c1-22-9-11-23(12-10-22)36-29(21-28(34-36)31(2,3)4)33-30(37)32-26-13-14-27(25-8-6-5-7-24(25)26)39-20-17-35-15-18-38-19-16-35/h5-14,21H,15-20H2,1-4H3,(H2,32,33,37)",MVCOAUNKQVWQHZ-UHFFFAOYSA-N,C31H37N5O3,527.7,1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea,"Doramapimod|285983-48-4|BIRB-796|BIRB 796|BIRB796|BIRB-796 BS|BIRB 796 BS|3-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-1-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea|HO1A8B3YVV|DTXSID2048957|CHEBI:40953|Urea, N-[3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-|1-(3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)-3-(4-(2-(morpholin-4-yl)ethoxy)naphthalen-1-yl)urea|DTXCID9028883|Urea, N-(3-(1,1-dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl)-N'-(4-(2-(4-morpholinyl)ethoxy)-1-naphthalenyl)-|doramapimodum|1-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl]urea|3-(3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl)-1-(4-(2-(morpholin-4-yl)ethoxy)naphthalen-1-yl)urea|RefChem:590371|1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3(4-(2-morpholin-4-yl-ethoxy)naph-thalen-1-yl)urea|BIRB 796 (Doramapimod)|MFCD09752957|1-[5-tert-butyl-2-(4-methylphenyl)pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea|1-(5-TERT-BUTYL-2-P-TOLYL-2H-PYRAZOL-3-YL)-3-[4-(2-MORPHOLIN-4-YL-ETHOXY)-NAPHTHALEN-1-YL]-UREA|1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea|1-(3-tert-butyl-1-p-tolyl-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea|CHEMBL103667|1-[2-(4-methylphenyl)-5-tert-butyl-pyrazol-3-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea|NCGC00241104-01|1-[5-tert-butyl-2-(p-tolyl)pyrazol-3-yl]-3-[4-(2-morpholinoethoxy)-1-naphthyl]urea|1-(3-(tert-butyl)-1-(p-tolyl)-1H-pyrazol-5-yl)-3-(4-(2-morpholinoethoxy)naphthalen-1-yl)urea.|1-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-3-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea|B96|CAS-285983-48-4|C31H37N5O3|UNII-HO1A8B3YVV|Doramapimod (USAN/INN)|Doramapimod [USAN:INN]|Doramapimod (GMP)|Kinome_2137|1kv2|BIRB 796,Doramapimod|diaryl urea compound 10|DORAMAPIMOD [INN]|DORAMAPIMOD [USAN]|Doramapimod (BIRB 796)|Doramapimod (BIRB-796)|1-(5-tert-butyl-2-p-tolyl-2H-pyrazol-3-yl)-3(4-(2-morpholin-4-yl-ethoxy)naphthalen-1-yl)urea|BIRB 796BS|DORAMAPIMOD [WHO-DD]|Doramapimod (BIRB-796)?|MLS006010153|SCHEMBL129721|BIBR-796|cid_156422|GTPL5668|orb1300911|SCHEMBL29353023|BDBM13533|BIRB 0796|BIRB-0796|BCPP000333|GLXC-02504|HMS3295M15|HMS3655C07|HMS3747G11|ALBB-035131|BCP01896|BIRB-796, 3|EX-A4530|Tox21_113386|HY-10320G|NSC785337|s1574|AKOS005256489|Tox21_113386_1|BCP9000416|CCG-264915|CS-0219|DB03044|FD32902|NSC-785337|SB16634|SDCCGSBI-0654251.P002|NCGC00241104-02|NCGC00241104-07|AC-24379|AS-19375|HY-10320|SMR004458704|SY046842|US8933228, BIRB 796|NS00071680|SW219700-1|D03736|SR-00000002531|SR-00000002531-1|BRD-K74065929-001-01-5|BRD-K74065929-001-07-2|BRD-K74065929-001-08-0|Q27077098|p38 MAP Kinase Inhibitor X, BIRB 796 - CAS 285983-48-4|1-[3-(tert-Butyl)-1-(p-tolyl)-5-pyrazolyl]-3-[4-(2-morpholinoethoxy)-1-naphthyl]urea|CC1=CC=C(C=C1)N1N=C(C=C1NC(=O)NC1=C2C=CC=CC2=C(OCCN2CCOCC2)C=C1)C(C)(C)C|1-[5-tert-butyl-2-(4-methylphenyl)-3-pyrazolyl]-3-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea|3-[2-(4-methylphenyl)-5-tert-butyl-pyrazol-3-yl]-1-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]urea|N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]- N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]-urea|N-[3-(1,1-Dimethylethyl)-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-[4-[2-(4-morpholinyl)ethoxy]-1-naphthalenyl]urea; BIRB 796BS; Birb 796;|N-[3-tert-butyl-1-(4-methylphenyl)-1H-pyrazol-5-yl]-N'-{4-[2-(morpholin-4-yl)ethoxy]naphthalen-1-yl}urea"
NEFLAMAPIMOD,3038525,,InChI=1S/C19H9Cl2F2N3OS/c20-11-2-1-3-12(21)17(11)18-14-5-7-16(25-26(14)9-24-19(18)27)28-15-6-4-10(22)8-13(15)23/h1-9H,VEPKQEUBKLEPRA-UHFFFAOYSA-N,C19H9Cl2F2N3OS,436.3,"5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyrimido[1,6-b]pyridazin-6-one","209410-46-8|Neflamapimod|VX-745|5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido[1,6-b]pyridazin-6-one|VRT-031745|TYL52QM320|VD-31745|CHEBI:90528|VD-31,745|6H-Pyrimido[1,6-b]pyridazin-6-one, 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]-|5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido(1,6-b)pyridazin-6-one|5-(2,6-Dichlorophenyl)-2-[(2,4-Difluorophenyl)sulfanyl]-6h-Pyrimido[1,6-B]pyridazin-6-One|6H-Pyrimido(1,6-b)pyridazin-6-one, 5-(2,6-dichlorophenyl)-2-((2,4-difluorophenyl)thio)-|5-(2,6-Dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyridazino[6,1-f]pyrimidin-6-one|neflamapimodum|5-(2,6-dichlorophenyl)-2-((2,4-difluorophenyl)sulfanyl)-6H-pyrimido(1,6-b)pyridazin-6-one|5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyridazino(6,1-f)pyrimidin-6-one|RefChem:832136|6H-pyrimido(1,6-b)pyridazin-6-one,5-(2,6-dichlorophenyl)-2-(phenylthio)-|VX 745|VX745|5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanylpyrimido[1,6-b]pyridazin-6-one|C19H9Cl2F2N3OS|Neflamapimod [USAN]|5-(2,6-dichlorophenyl)-2-(2,4-difluorophenylthio)-6H-pyrimido[1,6-b]pyridazin-6-one|5-(2,6-Dichlorophenyl)-2-[2,4-difluorophenyl)thio]-6H-pyrimido[1,6-b]pyridazin-6-one|5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)-thio)-6H-pyrimido[1,6-b]pyridazin-6-one|5-(2,6-dichlorophenyl)-2-(2,4-difluorophenyl)sulfanyl-pyrimido[1,6-b]pyridazin-6-one|5-(2,6-dichlorophenyl)-2-(2,4-difluorophenylsulfanyl)-6h-pyrimido[3,4-b]pyridazin-6-one|5-(2,6-Dichlorophenyl)-2-((2,4-difluorophenyl)thio)-6H-pyrimido[1,6-B]pyridazine-6-one|5-(2,6-DICHLOROPHENYL)-2-((2,4-DIFLUOROPHENYL)THIO)-6H-PYRIMIDO(1,6-B)PYRIDAZINE-6-ONE|MFCD09834070|Kinome_3767|Neflamapimod (USAN/INN)|NEFLAMAPIMOD [INN]|UNII-TYL52QM320|MLS006010281|NEFLAMAPIMOD [WHO-DD]|SCHEMBL156367|CHEMBL119385|GTPL5719|orb1301083|SCHEMBL29396525|BDBM15244|cid_3038525|DTXSID90175115|EX-A854|BCPP000015|GLXC-05950|HMS3295M13|HMS3654L10|HMS3884M17|HMS5079E08|VD-31|BCP01837|AC-707|HB1309|NSC785334|s1458|AKOS005766014|CCG-269082|CS-0195|DB07138|EX-8451|NSC-785334|SB19425|VX-745?|NCGC00241111-01|NCGC00241111-02|NCGC00241111-12|FD139233|HY-10328|SMR004701351|DB-000564|VX-745, >=98% (HPLC)|NS00070857|SW219693-1|D10959|410V468|5T-0205|BRD-K91900765-001-01-9|BRD-K91900765-001-05-0|BRD-K91900765-001-06-8|BRD-K91900765-001-07-6|Q27089208|5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)sulfanyl]-6H-pyrimido[1,6-a]pyridazin-6-one|5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]-6-pyrimido[1,6-b]pyridazinone|5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]pyrimido[1,6-b]pyridazin-6-one|5-(2,6-dichlorophenyl)-9-(2,4-difluorophenyl)sulfanyl-1,3,10-triazabicyclo[4.4.0]deca-2,5,7,9-tetraen-4-one|5-[2,6-bis(chloranyl)phenyl]-2-[2,4-bis(fluoranyl)phenyl]sulfanyl-pyrimido[1,6-b]pyridazin-6-one|6H-Pyrimido[1,6-b]pyridazin-6-one, 5-(2,6-dichlorophenyl)-2-[(2,4-difluorophenyl)thio]- (9CI)"
TAK-715,9952773,,"InChI=1S/C24H21N3OS/c1-3-21-27-22(18-11-7-8-16(2)14-18)23(29-21)19-12-13-25-20(15-19)26-24(28)17-9-5-4-6-10-17/h4-15H,3H2,1-2H3,(H,25,26,28)",HEKAIDKUDLCBRU-UHFFFAOYSA-N,C24H21N3OS,399.5,"N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]pyridin-2-yl]benzamide","TAK-715|303162-79-0|TAK 715|Benzamide, N-[4-[2-ethyl-4-(3-methylphenyl)-5-thiazolyl]-2-pyridinyl]-|WE92U03C5Z|N-[4-[2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl]pyridin-2-yl]benzamide|DTXSID20184412|Benzamide, N-(4-(2-ethyl-4-(3-methylphenyl)-5-thiazolyl)-2-pyridinyl)-|N-{4-[2-ETHYL-4-(3-METHYLPHENYL)-1,3-THIAZOL-5-YL]PYRIDIN-2-YL}BENZAMIDE|N-(4-(2-ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl)pyridin-2-yl)benzamide|RefChem:187198|DTXCID30106903|N-(4-(2-ethyl-4-(m-tolyl)thiazol-5-yl)pyridin-2-yl)benzamide|TAK715|MFCD17012805|CHEMBL363648|N-[4-[2-ethyl-4-(m-tolyl)thiazol-5-yl]-2-pyridyl]benzamide|UNII-WE92U03C5Z|C24H21N3OS|T75|N-(4-(2-Ethyl-4-(3-methylphenyl)-1,3-thiazol-5-yl)-2-pyridyl)benzamide|Kinome_2655|MLS006011241|SCHEMBL297487|GTPL9328|orb1301032|SCHEMBL29350215|SCHEMBL29435089|CHEBI:91360|TAK0715|BCPP000054|HMS3244J06|HMS3244J10|HMS3244J14|HMS3265K09|HMS3265K10|HMS3265L09|HMS3265L10|HMS3651N12|BCP01965|EX-A2443|BDBM50173609|HB0599|NSC785339|s2928|AKOS015904193|CCG-268646|CS-0073|NSC-785339|SB19426|compound 8h [PMID: 16162000]|NCGC00345834-01|NCGC00345834-05|AC-36073|AS-16239|HY-10456|SMR004703001|SY308217|TAK-715, >=98% (HPLC)|SW219195-1|D70787|BRD-K52751261-001-01-2|BRD-K52751261-001-06-1|BRD-K52751261-001-08-7|Q27163230|N-[4-[2-Ethyl-4-(m-tolyl)-5-thiazolyl]-2-pyridyl]benzamide|N-[4-(2-Ethyl-4-m-tolyl-thiazol-5-yl)-pyridin-2-yl]-benzamide"
ALTANSERIN,3033677,,"InChI=1S/C22H22FN3O2S/c23-17-7-5-15(6-8-17)20(27)16-9-11-25(12-10-16)13-14-26-21(28)18-3-1-2-4-19(18)24-22(26)29/h1-8,16H,9-14H2,(H,24,29)",SMYALUSCZJXWHG-UHFFFAOYSA-N,C22H22FN3O2S,411.5,3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-2-sulfanylidene-1H-quinazolin-4-one,"Altanserin|76330-71-7|Altanserina|Altanserine|Altanserinum|4(1H)-Quinazolinone, 3-(2-(4-(4-fluorobenzoyl)-1-piperidinyl)ethyl)-2,3-dihydro-2-thioxo-|5015H744JQ|DTXSID5043891|R 53200|3-(2-(4-(p-Fluorobenzoyl)piperidino)ethyl)-2-thio-2,4(1H,3H)-quinazolinedione|3-[2-[4-(4-fluorobenzoyl)-1-piperidyl]ethyl]-2-thioxo-1H-quinazolin-4-one|3-(2-(4-(4-fluorobenzoyl)-1-piperidyl)ethyl)-2-thioxo-1H-quinazolin-4-one|RefChem:111472|DTXCID3023891|278-422-1|Altanserin [INN]|3-(2-(4-(4-fluorobenzoyl)piperidin-1-yl)ethyl)-2-thioxo-2,3-dihydroquinazolin-4(1H)-one|CHEMBL62919|Altanserin hydrochloride hydrate|CHEBI:2613|NCGC00025302-01|Altanserine [French]|Altanserinum [Latin]|Altanserina [Spanish]|3-[2-[4-(4-fluorobenzoyl)piperidin-1-yl]ethyl]-2-sulfanylidene-1H-quinazolin-4-one|UNII-5015H744JQ|EINECS 278-422-1|Tocris-1809|ALTANSERIN [WHO-DD]|SCHEMBL404849|orb1698522|SCHEMBL23326249|SCHEMBL30136524|SCHEMBL30136526|BCP12678|BDBM50113332|MFCD11045280|PDSP1_001703|PDSP2_001686|AKOS027380286|FA41790|3-(2-(4-(4-Fluorbenzoyl)piperidino)ethyl)-1,2,3,4-tetrahydro-2-thioxo-4-chinazolinon|MS-27104|HY-119156|CS-0069101|NS00089942|G12765|330A717|L000856|Q4736154|BRD-K00610438-003-01-7|BRD-K00610438-003-02-5|3-[2-[4-(4-Fluorobenzoyl)-1-piperidinyl]ethyl]-2,3-dihydro-2-thioxo-4(1H)-quinazolinone hydrochloride hydrate|3-{2-[4-(4-Fluoro-benzoyl)-piperidin-1-yl]-ethyl}-2-thioxo-2,3-dihydro-1H-quinazolin-4-one"
SOTALOL,5253,,"InChI=1S/C12H20N2O3S/c1-9(2)13-8-12(15)10-4-6-11(7-5-10)14-18(3,16)17/h4-7,9,12-15H,8H2,1-3H3",ZBMZVLHSJCTVON-UHFFFAOYSA-N,C12H20N2O3S,272.37,N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide,"sotalol|3930-20-9|beta-Cardone|DL-Sotalol|Sotalolum|Darob mite|4'-(1-Hydroxy-2-(isopropylamino)ethyl)methane sulfonanilide|Methanesulfonanilide, 4'-(1-hydroxy-2-(isopropylamino)ethyl)-|DTXSID0023589|CHEBI:63622|C07AA07|A6D97U294I|Methanesulfonamide, N-(4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)phenyl)-|DTXCID303589|N-(4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}phenyl)methanesulfonamide|Methanesulfonamide, N-[4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]phenyl]-|Sotalolo|N-(4-(1-hydroxy-2-((propan-2-yl)amino)ethyl)phenyl)methanesulfonamide|RefChem:56607|MJ1999|N-(4-(1-Hydroxy-2-(isopropylamino)ethyl)phenyl)methanesulfonamide|.beta.-Cardone|N-[4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl]methanesulfonamide|Sotalol (INN)|MJ-1999|CHEMBL471|N-{4-[1-hydroxy-2-(propan-2-ylamino)ethyl]phenyl}methanesulfonamide|NCGC00015919-04|SOTALOL [INN]|Sotalol [INN:BAN]|Sotalolum [INN-Latin]|N-[4-[1-Hydroxy-2-(isopropylamino)ethyl]phenyl]methanesulfonamide|N-{4-[1-hydroxy-2-(isopropylamino)ethyl]phenyl}methanesulfonamide|N-(4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}phenyl)methanesulfonamide|Darob mite (TN)|CCRIS 4204|(+-)-Sotalol|4'-[1-Hydroxy-2-(isopropylamino)ethyl]methanesulfonanilide|4'-(1-Hydroxy-2-isopropylaminoethyl)methanesulfonanilid|UNII-A6D97U294I|4'-(1-HYDROXY-2-(ISOPROPYLAMINO)ETHYL)METHANESULFONANILIDE|N-(4-(1-HYDROXY-2-((1-METHYLETHYL)AMINO)ETHYL)PHENYL)METHANESULFONAMIDE|Sotalol,(+)|Sotalol,(-)|SOTALOL [VANDF]|SOTALOL [MI]|Prestwick0_000966|Prestwick1_000966|Prestwick2_000966|Prestwick3_000966|SOTALOL [WHO-DD]|Lopac0_001055|SCHEMBL16407|BSPBio_000971|cid_66245|(+/-)-SOTALOL|SPBio_002892|BPBio1_001069|GTPL7297|SCHEMBL7452691|BDBM25762|HMS2089K09|ALBB-022454|MSK10119|Tox21_110261|MFCD00242936|AKOS015897340|CCG-205132|DB00489|SDCCGSBI-0051025.P003|NCGC00015919-03|NCGC00015919-05|NCGC00015919-06|NCGC00015919-07|NCGC00015919-14|NCGC00015919-18|NCGC00024899-02|NCGC00024899-03|AC-19021|CAS-3930-20-9|SBI-0051025.P002|DB-049399|AB00514715|CS-0025287|NS00000195|C07309|D08525|AB00514715-09|AB00514715-10|AB00514715_11|AB00514715_12|EN300-7382649|930S209|L013427|Q413591|BRD-A33168282-003-03-2|BRD-A33168282-003-06-5|BRD-A33168282-003-16-4|BRD-A33168282-003-17-2|BRD-A33168282-003-18-0|4'-[1-Hhydroxy-2-(isopropylamino)ethyl]methanesulfonanilide|4'-[1-Hydroxy-2-(isopropylamino)ethyl]metahnesulfonanilide|aniline, 4-(1-hydroxy-2-isopropylamino)ethyl-N-methylsulphonyl-|DL-4-(2-ISOPROPYLAMINO-1-HYDROXYETHYL)METHANESULFONANILIDE|N-(4-[1-Hydroxy-2-(isopropylamino)ethyl]phenyl)methanesulfonamide #"
THIORPHAN,3132,,"InChI=1S/C12H15NO3S/c14-11(15)7-13-12(16)10(8-17)6-9-4-2-1-3-5-9/h1-5,10,17H,6-8H2,(H,13,16)(H,14,15)",LJJKNPQAGWVLDQ-UHFFFAOYSA-N,C12H15NO3S,253.32,2-[(2-benzyl-3-sulfanylpropanoyl)amino]acetic acid,"THIORPHAN|dl-thiorphan|76721-89-6|NSC-727676|B79L7B5X3Z|Glycine, N-(2-(mercaptomethyl)-1-oxo-3-phenylpropyl)-, (+-)-|Tiorphan|XJ8Z52GK3X|(3-Mercapto-2-benzylpropionyl)glycine|RefChem:897915|2-[(2-benzyl-3-sulfanylpropanoyl)amino]acetic acid|2-(2-Benzyl-3-mercaptopropanamido)acetic acid|MFCD00058435|DL-3-Mercapto-2-benzylpropanoylglycine|(+/-)-Thiorphan|CHEMBL10247|(DL-3-Mercapto-2-benzylpropanoyl)-Gly-OH|CHEBI:9568|(+/-)-N-(3-Mercapto-2-benzylpropionyl)glycine|2-[(2-benzyl-3-sulfanyl-propanoyl)amino]acetic acid|SR-01000076164|Racecadotril EP impurity B|UNII-B79L7B5X3Z|n-(2-benzyl-3-sulfanylpropanoyl)glycine|DTXSID70868412|Thiorphan (DL)|Glycine, N-[2-(mercaptomethyl)-1-oxo-3-phenylpropyl]-, (+/-)-; (+/-)-Thiorphan; DL-Thiorphan; N-[2-(Mercaptomethyl)-1-oxo-3-phenylpropyl]glycine; Thiorphan|Prestwick_694|Prestwick0_000633|Prestwick1_000633|Prestwick2_000633|Prestwick3_000633|Lopac0_001139|BSPBio_000626|BSPBio_001543|KBioGR_000263|KBioSS_000263|MLS002153923|SCHEMBL401174|SPBio_002845|BPBio1_000690|orb1299587|BDBM21641|KBio2_000263|KBio2_002831|KBio2_005399|KBio3_000525|KBio3_000526|Bio2_000263|Bio2_000743|DL-Thiorphan, >=98% (TLC)|HMS1361N05|HMS1569P08|HMS1791N05|HMS1989N05|HMS2096P08|HMS2230G03|HMS3263D19|HMS3373F16|HMS3402N05|HMS3713P08|BBC29768|Tox21_501139|NSC727676|AKOS024257670|CCG-205213|CS-W014091|FD21637|FT28239|HY-W013375|LP01139|NSC 727676|SDCCGSBI-0051106.P003|IDI1_034013|SMP2_000064|DL-3-Mercapto-2-benzylpropanoyl)glycine|DL-Thiorphan - CAS 76721-89-6|NCGC00016033-02|NCGC00016033-03|NCGC00016033-04|NCGC00016033-05|NCGC00016033-06|NCGC00016033-11|NCGC00094405-01|NCGC00094405-02|NCGC00094405-03|NCGC00094405-04|NCGC00261824-01|AS-79321|DA-68161|Neprilysin/neutral endopeptidase inhibitor|SMR001233267|SY066996|EU-0101139|RACECADOTRIL IMPURITY B [EP IMPURITY]|2-(2-benzyl-3-sulfanylpropanamido)acetic acid|C01619|T 6031|F475389|Q7784695|SR-01000076164-1|SR-01000076164-5|BRD-A56012032-001-06-4|BRD-A56012032-001-14-8|BRD-A56012032-001-15-5|N-((RS)-2-BENZYL-3-MERCAPTOPROPANOYL)-GLYCINE|(((2RS)-2-BENZYL-3-SULFANYLPROPANOYL)AMINO)ACETIC ACID|GLYCINE, N-(2-(MERCAPTOMETHYL)-1-OXO-3-PHENYLPROPYL)-|N-[2-(Mercaptomethyl)-1-oxo-3-phenylpropyl]glycine;2-Mercaptomethyl-3-phenylpropionylaminoacetic acid;D,L-3-Mercapto-2-benzylpropano ylglycine"
ERSENTILIDE,208932,,"InChI=1S/C21H26N4O5S/c1-31(27,28)24-17-2-6-21(7-3-17)30-15-19(26)14-22-11-13-29-20-8-4-18(5-9-20)25-12-10-23-16-25/h2-10,12,16,19,22,24,26H,11,13-15H2,1H3/t19-/m0/s1",QZWUQVSQIFFFKY-IBGZPJMESA-N,C21H26N4O5S,446.5,N-[4-[(2S)-2-hydroxy-3-[2-(4-imidazol-1-ylphenoxy)ethylamino]propoxy]phenyl]methanesulfonamide,Ersentilide|125279-79-0|ersentilida|L2JY6Z298S|HE93|4-HIPPM|ck-3579|DTXSID70154721|HE-93|CK3579|ersentilidum|RefChem:137659|DTXCID1077212|CK-4000|CK-4001|Ersentilide [INN]|UNII-L2JY6Z298S|CHEMBL1193886|N-[4-[(2S)-2-hydroxy-3-[2-(4-imidazol-1-ylphenoxy)ethylamino]propoxy]phenyl]methanesulfonamide|CHEMBL545363|4'-((2S)-2-Hydroxy-3-((2-(p-imidazol-1-ylphenoxy)ethyl)amino)propoxy)methanesulfonanilide|SCHEMBL221142|orb2802429|N-(4-{2-Hydroxy-3-[2-(4-imidazol-1-yl-phenoxy)-ethylamino]-propoxy}-phenyl)-methanesulfonamide; hydrochloride|BDBM50015195|BDBM50367951|NS00124884|4'-((2S)-2-Hydroxy-3-((2-(p-imidazol-1-ylphenoxy)ethyl)amino)propoxy)methane-sulfonanilide.
L-NAME,39836,,"InChI=1S/C7H15N5O4/c1-16-6(13)5(8)3-2-4-10-7(9)11-12(14)15/h5H,2-4,8H2,1H3,(H3,9,10,11)/t5-/m0/s1",KCWZGJVSDFYRIX-YFKPBYRVSA-N,C7H15N5O4,233.23,methyl (2S)-2-amino-5-[[amino(nitramido)methylidene]amino]pentanoate,"L-NAME|NG-NITROARGININE METHYL ESTER|50903-99-6|N(G)-Nitro-L-arginine methyl ester|N-Nitroarginine methyl ester|N(G)-Nitroarginine methyl ester|Ng-nitro-L-arginine methyl ester|V55S2QJN2X|n-nitro-arginine methyl ester|N(5)-(Imino(nitroamino)methyl)-L-ornithine methyl ester|methyl (2S)-2-amino-5-(1-nitrocarbamimidamido)pentanoate|NG Nitroarginine Methyl Ester|methyl (2S)-2-amino-5-((amino(nitramido)methylene)amino)pentanoate|methyl (2S)-2-amino-5-[[amino(nitramido)methylene]amino]pentanoate|Methyl Ester, NG-Nitroarginine|NG Nitro L Arginine Methyl Ester|Methyl Ester, NG-Nitro-L-Arginine|N omega Nitro L arginine Methyl Ester|N omega-Nitro-L-arginine Methyl Ester|RefChem:389146|NG Nitroarginine Methyl Ester, D Orn|N-Nitro-L-arginine methylester|methyl (2S)-2-amino-5-[[amino(nitramido)methylidene]amino]pentanoate|CHEMBL7890|methyl Nw-nitro-L-argininate|CHEBI:7549|L-Ornithine, N(5)-(imino(nitroamino)methyl)-, methyl ester|N-omega-NITRO-L-ARGININE METHYL ESTER|N-omega-Nitro-O-arginine methyl ester|UNII-V55S2QJN2X|N(sup G)-Nitro-L-arginine methyl ester|Ngamma-Nitro-L-arginine methyl ester|AmbotzHAA5810|N(omega)-Nitro-L-arginine methyl ester|Tocris-0665|Arg(NO2)-OMe|Argatroban Impurity 87|Lopac0_000848|BSPBio_001221|KBioGR_000561|KBioSS_000561|GTPL5213|orb1305296|SCHEMBL3034749|L-NG-nitroarginine methyl ester|SCHEMBL29361066|KBio2_000561|KBio2_003129|KBio2_005697|KBio3_001001|KBio3_001002|Bio1_000442|Bio1_000931|Bio1_001420|Bio2_000441|Bio2_000921|HMS1362M03|HMS1792M03|HMS1990M03|methyl N(gamma)-nitro-L-argininate|omega-nitro-l-arginine methyl ester|nomega-nitro-l-arginine methyl ester|HSCI1_000257|Methyl (2S)-2-amino-5-[(amino-nitramido-methylidene)amino]pentanoate|AKOS030213027|AKOS040747206|CCG-204931|DB12750|SDCCGSBI-0050824.P002|IDI1_002196|NCGC00024717-01|NCGC00024717-02|NCGC00024717-03|NCGC00024717-04|NCGC00024717-05|NCGC00024717-07|NCGC00024717-12|TS-08439|N(G)-NITRO-L-ARGININE-METHYL ESTER|C04337|EN300-204407|N.OMEGA.-NITRO-L-ARGININE METHYL ESTER|methyl N(5)-(N-nitrocarbamimidoyl)-L-ornithinate|BRD-K33141550-003-05-7|Q27081090|N5-[Imino(nitroamino)methyl]-L-ornithine, methyl ester|L-Ornithine, N^5-[imino(nitroamino)methyl]-, methyl ester|methyl (2S)-2-amino-5-(N'-nitrocarbamimidamido)pentanoate|methyl (2S)-2-amino-5-[(N-nitrocarbamimidoyl)amino]pentanoate"
TILARGININE,132862,,"InChI=1S/C7H16N4O2/c1-10-7(9)11-4-2-3-5(8)6(12)13/h5H,2-4,8H2,1H3,(H,12,13)(H3,9,10,11)/t5-/m0/s1",NTNWOCRCBQPEKQ-YFKPBYRVSA-N,C7H16N4O2,188.23,(2S)-2-amino-5-[(N'-methylcarbamimidoyl)amino]pentanoic acid,"Tilarginine|Targinine|L-NMMA|17035-90-4|L-Monomethylarginine|NG-Monomethyl-L-arginine|N-Monomethyl-L-arginine|N-Methylarginine|omega-N-METHYLARGININE|tilarginina|N(G)-Monomethyl-L-arginine|omega-N-Monomethylarginine|N(G)-Methylarginine|NG-Methylarginine|L-NG-Monomethyl Arginine|Nomega-Monomethyl-L-arginine Acetate|tilargininum|Tilarginine [INN]|NG-monomethyl-L-argine|N5-(Methylamidino)-L-ornithine|L-Targinine|(2S)-2-amino-5-[(N'-methylcarbamimidoyl)amino]pentanoic acid|N(omega)-methyl-L-arginine|Ngamma-Monomethyl-L-arginine|N-omega-monomethyl-L-arginine|27JT06E6GR|(S)-2-Amino-5-(3-methylguanidino)pentanoic acid|NG-Monomethyl-L-arginine acetate|Nw-methyl-L-arginine|N(5)-(methylamidino)-L-ornithine|.omega.-n-methylarginine|N5-(N-methylcarbamimidoyl)-L-ornithine|N(5)-(N-methylcarbamimidoyl)-L-ornithine|CHEMBL256147|N(5)-[imino(methylamino)methyl]-L-ornithine|CHEBI:28229|L-Arginine, 2|(2S)-2-amino-5-(N'-methylcarbamimidamido)pentanoic acid|(2S)-2-amino-5-[(N-methylcarbamimidoyl)amino]pentanoic acid|H-Arg(me)-OH|Arginine, L-NG-Monomethyl|targinina|targininum|CHEMBL1835117|Targinine [BAN]|H-Arg(Me)-OH acetate salt|L-NMMA;Tilarginine;Targinine|NCGC00024780-01|NCGC00024780-04|UNII-27JT06E6GR|(2S)-2-amino-5-((N'-methylcarbamimidoyl)amino)pentanoic acid|DTXSID3040560|N(sup G)-Monomethyl-L-arginine|N(5)-(metilamidino)-L-ornitina|Tocris-0771|L-NG-Monomethylarginine|8-monomethyl l-arginine|L-NMA|2-Amino-5-(N''-methyl-guanidino)-pentanoic acid|N5-[Imino(methylamino)methyl]-L-ornithine|Spectrum3_001937|Spectrum3_001957|Lopac-M-7033|n-omega-methyl-l-arginine|N omega-methyl-L-arginine|RefChem:1092346|targinine (deprecated INN)|N(G)-monomethyl L-arginine|TILARGININE [MART.]|Lopac0_000750|BSPBio_003537|BSPBio_003557|NMMA, 2|N(G)-mono-methyl-L-arginine|L-N.gamma.-Monomethylarginine|N-gamma-monomethyl-L-arginine|SCHEMBL315843|SCHEMBL349879|NG-METHYLARGININE [MI]|acide (2S)-2-amino-5-(3-methylguanidino)pentanoique|orb1701519|SCHEMBL1736031|BDBM92900|GTPL11467|KBio3_002795|KBio3_002876|CHEBI:124959|(2S)-2-amino-5-{[imino(methylamino)methyl]amino}pentanoic acid|BDBM50230993|BDBM50441055|AKOS022181072|Ornithine, N5-(methylamidino)-, L-|CCG-204835|DB11815|N(sup 6)-(Methylamidino)-L-ornithine|SDCCGSBI-0050728.P002|NCGC00015698-01|NCGC00024780-02|NCGC00024780-03|NCGC00024780-08|NCGC00178003-01|HY-18732|N~5~-(N-methylcarbamimidoyl)-L-ornithine|CS-0014212|NS00068533|L-Ornithine, N5-(imino(methylamino)methyl)-|C03884|G78334|(S)-2-Amino-5-(3-methylguanidino)pentanoicacid|EN300-8092850|(S)-2-amino-5-(2-methylguanidino)pentanoic acid|BRD-K59506194-015-04-9|(2S)-2-amino-5-(3-methylcarbamimidamido)pentanoic acid|(R)-2-Amino-5-(N''-methyl-guanidino)-pentanoic acid|(S)-2-Amino-5-(N''-methyl-guanidino)-pentanoic acid|L-ORNITHINE, N(SUP 5)-(IMINO(METHYLAMINO)METHYL)-|(2S)-2-azaniumyl-5-((N'-methylcarbamimidoyl)amino)pentanoate|(2S)-2-AMINO-5-((METHYLCARBAMIMIDOYL)AMINO)PENTANOIC ACID"
ILOMASTAT,132519,,"InChI=1S/C20H28N4O4/c1-12(2)8-13(10-18(25)24-28)19(26)23-17(20(27)21-3)9-14-11-22-16-7-5-4-6-15(14)16/h4-7,11-13,17,22,28H,8-10H2,1-3H3,(H,21,27)(H,23,26)(H,24,25)/t13-,17+/m1/s1",NITYDPDXAAFEIT-DYVFJYSZSA-N,C20H28N4O4,388.5,(2R)-N'-hydroxy-N-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide,"Ilomastat|142880-36-2|Galardin|GM6001|GM 6001|CS 610|GM-6001|DTXSID0046353|CS-610|I0403ML141|(R)-N(sup 1)-Hydroxy-N-((S)-2-indol-3-yl-1-(methylcarbamoyl)ethyl)-2-isobutylsuccinamide|(S-(R*,S*))-N(sup 4)-Hydroxy-N(sup 1)-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylopropyl)butanediamide|DTXCID8026353|CHEBI:137236|ilomastatum|(2R)-N'-hydroxy-N-((2S)-3-(1H-indol-3-yl)-1-methylamino-1-oxopropan-2-yl)-2-(2-methylpropyl)butanediamide|(2R)-N'-hydroxy-N-[(2S)-3-(1H-indol-3-yl)-1-methylamino-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide|RefChem:790596|N'-hydroxy-N-((S)-2-indol-3-yl-1-(methylcarbamoyl)ethyl)-2-isobutylsuccinamide|(2R)-N'-hydroxy-N-((1S)-2-(1H-indol-3-yl)-1-(methylcarbamoyl)ethyl)-2-(2-methylpropyl)butanediamide|Butanediamide, N4-hydroxy-N1-((1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylpropyl)-,(2R)-|Illomastat|(R)-N1-((S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutylsuccinamide|Ilomastat (GM6001, Galardin)|MFCD00917040|CHEMBL19611|MFCD03453614|(2R)-N'-hydroxy-N-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide|Ilomastat [USAN]|NCGC00163450-02|3-(N-HYDROXYCARBOXAMIDO)-2-ISOBUTYLPROPANOYL-TRP-METHYLAMIDE|(R)-N4-Hydroxy-N1-[(S)-2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl]-2-isobutyl-succinamide|Galardin MPI|(2R)-2-[2-(hydroxyamino)-2-oxo-ethyl]-N-[(1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxo-ethyl]-4-methyl-pentanamide|Ilomastat (USAN/INN)|Ilomastat [USAN:INN]|UNII-I0403ML141|4pkw|GM6|ILOMASTAT [INN]|Ilomastat; GM-6001|GM6001;Galardin;Ilomastat|CBiol_001883|SCHEMBL35303|BSPBio_001079|KBioGR_000419|KBioSS_000419|GTPL7409|orb1305084|SCHEMBL29412562|BCBcMAP01_000057|KBio2_000419|KBio2_002987|KBio2_005555|KBio3_000797|KBio3_000798|EX-A765|GM6001 (galardin, ilomastat)?|BDBM234334|Bio1_000169|Bio1_000658|Bio1_001147|Bio2_000370|Bio2_000850|HMS1362E21|HMS1792E21|HMS1990E21|HMS3403E21|SFA88036|Tox21_112055|BDBM50062351|NSC727632|s7157|AKOS016355429|CCG-207857|CS-1701|DB02255|NSC-727632|IDI1_002125|SMP2_000212|NCGC00163450-01|NCGC00163450-03|NCGC00163450-04|AS-56152|Butanediamide, N4-hydroxy-N1-((1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylpropyl)-, (2R)-|Butanediamide, N4-hydroxy-N1-(1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl)-2-(2-methylpropyl)-, (S-(R*,S*))-|DA-73817|HY-15768|CAS-142880-36-2|NS00069181|SW218170-2|A11456|D03793|BRD-K51662849-001-02-1|BRD-K51662849-001-05-4|BRD-K51662849-001-08-8|GM 6001 - CAS 142880-36-2|(R)-N*4*-Hydroxy-N*1*-[2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl]-2-isobutyl-succinamide|(2R)-N(4)-hydroxy-N(1)-[(2S)-3-(1H-indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl]-2-(2-methylpropyl)butanediamide|(2R)-N~4~-hydroxy-N~1~-[(1S)-1-(1H-indol-3-ylmethyl)-2-(methylamino)-2-oxoethyl]-2-(2-methylpropyl)butanediamide|(R)-N*4*-Hydroxy-N*1*-[(S)-2-(1H-indol-3-yl)-1-methylcarbamoyl-ethyl]-2-isobutyl-succinamide|(R)-N1-((S)-3-(1H-Indol-3-yl)-1-(methylamino)-1-oxopropan-2-yl)-N4-hydroxy-2-isobutyl succinamide"
ALLOPURINOL,135401907,,"InChI=1S/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10)",OFCNXPDARWKPPY-UHFFFAOYSA-N,C5H4N4O,136.11,"1,5-dihydropyrazolo[3,4-d]pyrimidin-4-one","allopurinol|315-30-0|1H-Pyrazolo[3,4-d]pyrimidin-4-ol|Zyloric|Takanarumin|Suspendol|Bloxanth|Xanturat|Allopur|Uriprim|Urbol|Ketobun-A|Nektrohan|Adenock|Aluline|Dabrosin|Urobenyl|4-Hydroxypyrazolo[3,4-d]pyrimidine|Allopurinol(I)|Allopurinolum|4-HPP|Alopurinol|1H-Pyrazolo(3,4-d)pyrimidin-4-ol|4-Hydroxypyrazolopyrimidine|4-Hydroxy-1H-pyrazolo(3,4-d)pyrimidine|1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one|4-Hydroxy-3,4-pyrazolopyrimidine|NSC-1390|4-Hydroxypyrazolo(3,4-d)pyrimidine|Sigapurol|4-Hydroxypyrazolyl(3,4-d)pyrimidine|4H-Pyrazolo(3,4-d)pyrimidin-4-one|4'-Hydroxypyrazolol(3,4-d)pyrimidine|BW 56-158|AL-100|1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one|BW-56-158|1,5-Dihydro-4H-pyrazolo(3,4-d)pyrimidine-4-one|1,5-Dihydropyrazolo[3,4-d]pyrimidin-4-one|Uricto|CHEBI:40279|4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-|4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-|63CZ7GJN5I|Xanthomax-100|Xanthomax-300|NSC-101655|Aluline 100|Aluline 300|Hamarin 100|Hamarin 300|Zyloric-300|DTXSID4022573|NSC1390|1,2-dihydropyrazolo[3,4-d]pyrimidin-4-one|1H,2H,4H-pyrazolo[3,4-d]pyrimidin-4-one|NSC101655|BW-56158|4-Hydroxy-1H-pyrazolo[3,4-d]pyrimidine|DTXCID502573|DUZALLO COMPONENT ALLOPURINOL|Milurite|Allohexan|4-Hydroxypyrazolyl[3,4-d]pyrimidine|Pan Quimica|4'-Hydroxypyrazolol[3,4-d]pyrimidine|1,2-dihydropyrazolo(3,4-d)pyrimidin-4-one|1,5-dihydropyrazolo(3,4-d)pyrimidin-4-one|1H,2H,4H-pyrazolo(3,4-d)pyrimidin-4-one|allopurinolo|Zurinol|RefChem:54100|4'-HPP|M04AA01|1,5-Dihydro-4H-pyrazolo(3,4-d)pryimidin-4-one|206-250-9|Zyloprim|Lopurin|Anoprolin|Epidropal|Ailural|Alositol|Atisuril|Cosuric|Ledopur|Progout|Uricemil|Aloral|Anzief|Apurol|Urolit|Urosin|1H-Pyrazolo[3,4-d]pyrimidin-4(5H)-one|Ketanrift|Miniplanor|Allozym|Gichtex|Monarch|Riball|Hexanuret|Epuric|Xanthine oxidase|73334-58-4|Dura Al|180749-06-8|180749-08-0|Urtias 100|1H-pyrazolo[3,4-d]pyrimidin-4(7H)-one|2H-Pyrazolo[3,4-d]pyrimidin-4-ol|Alopurinol [INN-Spanish]|Allopurinolum [INN-Latin]|1H-pyrazolo[3,4-d]pyrimidin-4(2H)-one|MFCD00599413|180749-09-1|9002-17-9|Zyloprim (TN)|916980-04-6|1H,4H,7H-pyrazolo[3,4-d]pyrimidin-4-one|B. W. 56-158|4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,2-dihydro-|180749-07-9|184789-03-5|MLS000069453|SMR000059083|1H-Pyrazolo[3,4-d]pyrimidin-4-ol (9CI)|291279-53-3|4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,7-dihydro- (9CI)|NCGC00015094-02|NCGC00094580-04|4H-Pyrazolo[3,4-d]pyrimidin-4-one, 2,5-dihydro- (9CI)|4H-Pyrazolo[3,4-d]pyrimidin-4-one, 2,7-dihydro- (9CI)|Uritas|1H,4H,5H-pyrazolo[3,4-d]pyrimidin-4-one|1,5-Dihydro-pyrazolo[3,4-d]pyrimidin-4-one|4H-pyrazolo[3,4-d]pyrimidin-4-one, 1,7-dihydro-|F3329-0375|pyrazolo[5,4-d]pyrimidin-4-ol|4H-Pyrazolo[3, 1,5-dihydro-|Ailurial|Allohexal|WLN: T56 BMN GN INJ FQ|NSC 1390|CAS-315-30-0|CCRIS 626|NSC 101655|HSDB 3004|SR-05000001983|EINECS 206-250-9|UNII-63CZ7GJN5I|ATH008|Xanthione oxidase|4-Hydroxypyrazol[3,4-D]pyrimidine|Prestwick_511|Allopurinol [USAN:USP:INN:BAN:JAN]|Allopurinol (Standard)|Allopurinol (Zyloprim)|Spectrum_000026|Allopurinol - EP grade|ALLOPURINOL [MI]|Opera_ID_1680|Spectrum2_000098|Spectrum3_000289|Spectrum4_000135|Spectrum5_000768|ALLOPURINOL [INN]|ALLOPURINOL [JAN]|Lopac-A-8003|1,4-d]pyrimidin-4-one|ALLOPURINOL [HSDB]|ALLOPURINOL [USAN]|A 8003|cid_2094|SCHEMBL4627|SCHEMBL4628|A1BD4|ALLOPURINOL [MART.]|CHEMBL1467|NCIOpen2_001825|Lopac0_000102|SCHEMBL25803|ALLOPURINOL [USP-RS]|ALLOPURINOL [WHO-DD]|ALLOPURINOL [WHO-IP]|BSPBio_001798|KBioGR_000550|KBioSS_000386|MLS001148183|US9138393, Allopurinol|US9144538, Allopurinol|DivK1c_000685|SCHEMBL167561|SCHEMBL626453|SPECTRUM1500108|SPBio_000056|ALLOPURINOLUM [WHO-IP]|GTPL6795|orb1310380|SCHEMBL1128219|SCHEMBL3739112|SCHEMBL5550199|SCHEMBL6034419|SCHEMBL7400319|SCHEMBL7400321|SCHEMBL7403740|Allopurinol (JP18/USP/INN)|SCHEMBL28672687|SCHEMBL29693720|BDBM35440|HMS502C07|HY-B0219R|KBio1_000685|KBio2_000386|KBio2_002954|KBio2_005522|KBio3_001298|ALLOPURINOL [EP IMPURITY]|ALLOPURINOL [ORANGE BOOK]|NINDS_000685|ALLOPURINOL [EP MONOGRAPH]|BDBM181133|HMS1920A15|HMS2091G15|HMS2234M09|HMS3259K13|HMS3260E06|HMS3371I11|HMS3651O13|HMS3714L22|HMS5079O22|Pharmakon1600-01500108|ALLOPURINOL [USP MONOGRAPH]|SMSSF-0109038|BCP26973|HY-B0219|MSK10865|STR05189|Tox21_110082|Tox21_200922|Tox21_500102|4-Hydroxy-pyrazolo[3,4-d]pyrimidin|AC-019|BBL009959|BDBM50016784|BDBM50140241|CCG-38916|MFCD08276167|NSC755858|s1630|SBB004202|SC1118|SC2251|STK378584|STK711106|1,2,5,7-tetraaza-5H-inden-4-ol|AKOS000267490|AKOS000269759|AKOS024255717|Tox21_110082_1|Allopurinol, xanthine oxidase inhibitor|CCG-204197|CCG-221406|CCG-266128|DB00437|FA17288|LP00102|NC00492|NSC-755858|SB10164|SDCCGSBI-0050090.P005|IDI1_000685|NCGC00015094-01|NCGC00015094-03|NCGC00015094-04|NCGC00015094-05|NCGC00015094-06|NCGC00015094-07|NCGC00015094-08|NCGC00015094-18|NCGC00015094-22|NCGC00091134-01|NCGC00091134-02|NCGC00091134-03|NCGC00094580-01|NCGC00094580-02|NCGC00094580-05|NCGC00188948-01|NCGC00258476-01|NCGC00260787-01|FA160361|FA162226|TS-00028|SBI-0050090.P004|DB-065332|DB-261136|DB-272461|DB-272465|DB-272466|DB-272469|2H-Pyrazolo[3,4-d]pyrimidin-4-ol (9CI)|A0907|EU-0100102|NS00000618|ST45179105|SW199406-4|1,5-dihydropyrazolo[3,4-d]-pyrimidin-4-one|EN300-34144|VU0611037-1|BIM-0061756.0001|D00224|F18007|AB00173448-03|AB00173448-04|AB00173448_05|AB01274719-01|AB01274719_02|AB-323/25048497|Allopurinol (4-Hydroxypyrazolo[3,4-d]pyrimidine)|F069190|Q412486|SR-01000075595|4H-Pyrazolo[3,4-d]pyrimidin-4-one, 2,5-dihydro-|SR-01000075595-1|SR-05000001983-1|SR-05000001983-2|BRD-K86307448-001-16-7|BRD-K86307448-001-17-5|BRD-K86307448-001-19-1|F2173-0394|Z104486670|4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,2-dihydro- (9CI)|4H-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONE, 2,7-DIHYDRO-|Allopurinol, British Pharmacopoeia (BP) Reference Standard|Allopurinol, European Pharmacopoeia (EP) Reference Standard|Allopurinol, United States Pharmacopeia (USP) Reference Standard|1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one Synonym:  Allopurinol|Allopurinol, Pharmaceutical Secondary Standard; Certified Reference Material|InChI=1/C5H4N4O/c10-5-3-1-8-9-4(3)6-2-7-5/h1-2H,(H2,6,7,8,9,10|1,5-Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one;4-Hydroxypyrazolo[3,4-d]pyrimidine;4-Oxopyrazolo[3,4-d]pyrimidine|1,5Dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one;4-Hydroxypyrazolo[3,4-d]pyrimidine;4-Oxopyrazolo[3,4-d]pyrimidine"
TOPIROXOSTAT,5288320,,"InChI=1S/C13H8N6/c14-8-11-7-10(3-6-16-11)13-17-12(18-19-13)9-1-4-15-5-2-9/h1-7H,(H,17,18,19)",UBVZQGOVTLIHLH-UHFFFAOYSA-N,C13H8N6,248.24,"4-(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)pyridine-2-carbonitrile","Topiroxostat|577778-58-6|FYX-051|4-(5-PYRIDIN-4-YL-1H-1,2,4-TRIAZOL-3-YL)PYRIDINE-2-CARBONITRILE|uriadec|0J877412JV|4-(5-(Pyridin-4-yl)-1h-1,2,4-triazol-3-yl)pyridine-2-carbonitrile|DTXSID80206462|4-(5-pyridin-4-yl-1H-(1,2,4) triazol-3-yl)pyridine-2-carbonitrile|4-[5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile|topiroxostatum|RefChem:898615|DTXCID80128953|FYX 051|topiloric|Topiroxostat [INN]|MFCD17167057|4-(3-(Pyridin-4-yl)-1H-1,2,4-triazol-5-yl)picolinonitrile|5-(2-cyano-4-pyridyl)-3-(4-pyridyl)-1,2,4-triazole|CHEMBL1078685|4-(5-(pyridin-4-yl)-1H-1,2,4-triazol-3-yl)picolinonitrile|4-[5-(4-Pyridyl)-1H-1,2,4-triazol-3-yl]pyridine-2-carbonitrile|2-Pyridinecarbonitrile, 4-[5-(4-pyridinyl)-1H-1,2,4-triazol-3-yl]-|UNII-0J877412JV|Uriadec (TN)|Topiroxostat (Standard)|Topiroxostat (JAN/INN)|TOPIROXOSTAT [MI]|TOPIROXOSTAT [JAN]|Topiroxostat(FYX-051)?|SCHEMBL860420|TOPIROXOSTAT [WHO-DD]|orb1305544|SCHEMBL4680577|SCHEMBL18056618|SCHEMBL29403929|GTPL10592|C13H8N6|UBVZQGOVTLIHLH-UHFFFAOYSA-N|GLXC-06067|HMS5082G03|BCP09957|EX-A1197|BDBM50267750|BDBM50311275|HY-14874R|MSK160033|s3719|4-[5-PYRIDIN-4-YL-1H-[1,2,4]TRIAZOL-3-YL]-PYRIDINE-2-CARBONITRILE|AKOS026750465|AKOS026751485|CCG-266938|CS-2033|DB01685|NCGC00378610-01|NCGC00378610-02|AC-30740|AS-56359|HY-14874|SY116097|NS00070900|A11261|D09786|F511535|BRD-K77561571-001-01-1|Q15725832"
FEBUXOSTAT,134018,,"InChI=1S/C16H16N2O3S/c1-9(2)8-21-13-5-4-11(6-12(13)7-17)15-18-10(3)14(22-15)16(19)20/h4-6,9H,8H2,1-3H3,(H,19,20)",BQSJTQLCZDPROO-UHFFFAOYSA-N,C16H16N2O3S,316.4,"2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid","Febuxostat|144060-53-7|Adenuric|Uloric|Tei 6720|TMX-67|Tei-6720|TMX 67|2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-1,3-thiazole-5-carboxylic acid|Zurig|Febuxostatum|NSC-758874|DTXSID8048650|101V0R1N2E|5-Thiazolecarboxylic acid, 2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-|DTXCID1028576|CHEBI:31596|2-(3-Cyano-4-(2-methylpropoxy)phenyl)-4-methylthiazole-5-carboxylic acid|2-(3-CYANO-4-ISOBUTOXYPHENYL)-4-METHYL-1,3-THIAZOLE-5-CARBOXYLIC ACID|2-(3-cyano-4-(2-methylpropoxy)phenyl)-4-methyl-1,3-thiazole-5-carboxylic acid|5-Thiazolecarboxylic acid, 2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-|TEI6720|6720, TEI|RefChem:57913|Febuxostat tablets 40 mg|Febuxostat tablets 80 mg|M04AA03|682-158-6|2-(3-cyano-4-isobutoxyphenyl)-4-methylthiazole-5-carboxylic acid|Feburic|MFCD00871598|Febuxostat (Uloric)|2-(3-CYANO-4-ISOBUTOXY-PHENYL)-4-METHYL-5-THIAZOLE-CARBOXYLIC ACID|CHEMBL1164729|Febuxostat [USAN]|NCGC00182059-02|2-(3-cyano-4-isobutoxy-phenyl)-4-methyl-thiazole-5-carboxylic acid|TEI|2-[3-cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid|SMR002529566|Uloric (TN)|CAS-144060-53-7|2-(3-Cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylic acid|Donifoxate|Febuday|Goturic|Febric|Goutex|Febuxostat [USAN:INN:BAN]|UNII-101V0R1N2E|2-[3-Cyano-4-isobutoxyphenyl]-4-methylthiazole-5-carboxylic acid|Feburic (TN)|Febuxostat (Standard)|FEBUXOSTAT?|111GE013|FEBUXOSTAT [MI]|FEBUXOSTAT [INN]|FEBUXOSTAT [JAN]|S1547|FEBUXOSTAT [VANDF]|FEBUXOSTAT [MART.]|FEBUXOSTAT [WHO-DD]|Febuxostat,Uloric, TMX-67|MLS004774136|MLS006011568|FEBUXOSTAT [EMA EPAR]|SCHEMBL249339|Febuxostat - Bio-X trade mark|GTPL6817|orb1310305|Febuxostat (JP18/USAN/INN)|FEBUXOSTAT [ORANGE BOOK]|Febuxostat, >=98% (HPLC)|SCHEMBL29398803|BCPP000233|GLXC-05201|HMS3264C20|HMS3655C03|HMS3673M21|HMS3743I09|HMS3868J03|HMS5079I14|MX-67|Pharmakon1600-01504286|BCP02342|KBC53974|MSK10866|Tox21_113004|AC-425|BBL036503|BDBM50320491|FD7322|HY-14268R|NSC758874|STL559020|AKOS015841695|Tox21_113004_1|BCP9000679|BS-1018|CCG-213303|CS-0403|DB04854|FC10814|NSC 758874|PB33929|NCGC00182059-03|BC164443|HY-14268|SY053100|F0847|NS00004138|SW219283-1|D01206|EN300-122360|SBI-0653454.0001|AB01274796-01|AB01274796_02|AB01274796_03|060F537|F213321|Q417296|SR-01000940023|SR-01000940023-2|BRD-K48367671-001-01-8|BRD-K48367671-001-05-9|BRD-K48367671-001-06-7|Z1541759499|2-(3-cyano-4-isobutyloxy)-phenyl-4-methyl-5-thiazolecarboxylic acid|2-(3-cyano-4-isobutoxyphenyl)-4-methyl- 1,3-thiazole-5-carboxylic acid|2-[3-Cyano-4-(2-methylpropoxy)phenyl]-4-methyl-5-thiazolecarboxylic acid; Adenuric; Uloric"
BOSUTINIB,5328940,,"InChI=1S/C26H29Cl2N5O3/c1-32-6-8-33(9-7-32)5-4-10-36-25-13-21-18(11-24(25)35-3)26(17(15-29)16-30-21)31-22-14-23(34-2)20(28)12-19(22)27/h11-14,16H,4-10H2,1-3H3,(H,30,31)",UBPYILGKFZZVDX-UHFFFAOYSA-N,C26H29Cl2N5O3,530.4,"4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile","Bosutinib|380843-75-4|SKI-606|SKI 606|4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile|4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile|4-[(2,4-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile|SK-606|4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-3-quinolinecarbonitrile|CHEBI:39112|5018V4AEZ0|DTXSID10861568|3-Quinolinecarbonitrile, 4-((2,4-dichloro-5-methoxyphenyl)amino)-6-methoxy-7-(3-(4-methyl-1-piperazinyl)propoxy)-|bosutinibum|uglysycpd2|RefChem:58901|DTXCID40207910|L01XE14|4-Anilinobenzo(g)quinoline-3-carbonitrile|700-455-1|943-866-3|4-Anilino-3-quinolinecarbonitrile|Bosutinib (SKI-606)|BOSULIF|SKI606|MFCD07367846|Bosutinib (USAN)|Bosutinib [USAN]|4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile|BOSUTINIB ISOMER 1|CHEMBL288441|4-(2,4-dichloro-5-methoxyphenylamino)-6-methoxy-7-(3-(4-methylpiperazin-1-yl)propoxy)quinoline-3-carbonitrile|C26H29Cl2N5O3|SKI-606)|4-(2,4-dichloro-5-methoxy-anilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile|Bosutinib [USAN:INN]|NCGC00241107-01|UNII-5018V4AEZ0|Bosutinib (Standard)|WAY-173606|Bosutinib,SKI-606|BOSUTINIB [INN]|BOSUTINIB [MI]|BOSUTINIB [VANDF]|PF-5208763|BOSUTINIB [MART.]|EC 700-455-1|BOSUTINIB [WHO-DD]|Bosutinib (SKI-606)?|MLS006011212|SCHEMBL158390|BDBM4552|GTPL5710|orb1310890|Bosutinib Isomer 1, Free Base|Bosutinib, >=98% (HPLC)|SCHEMBL29350234|SCHEMBL29428159|EX-A391|UBPYILGKFZZVDX-UHFFFAOYSA-N|BCPP000318|HMS2043A22|HMS3244A03|HMS3244A04|HMS3244B03|HMS3651C03|HMS3672K11|HMS3743E09|HMS5079M03|K00615a|BCP01782|HB1323|HY-10158R|NSC765694|NSC799367|SK 606|AKOS015902521|AC-2413|BCP9000446|CCG-208129|CS-0118|DB06616|FB19002|NSC-765694|NSC-799367|PB30881|SDCCGSBI-0646926.P001|NCGC00241107-03|NCGC00241107-05|AS-11064|HY-10158|SMR002530350|NS00002757|S1014|SKI606; SKI 606; SK-I606|SW220197-1|D03252|AB01565836_03|EN300-7565041|843B754|Q894611|SR-01000941572|SR-01000941572-1|BRD-K99964838-001-01-0|BRD-K99964838-001-06-9|BRD-K99964838-001-11-9|BRD-K99964838-001-12-7|Z2216885221|3-QUINOLINECARBONITRILE, 4-((2,4-DICHLORO-5-METHOXYPHENYL)AMINO)-6-METHYL-1-PIPERAZINYL)PROPOXY)-|4-(2,4-Dichloro-5-methoxy-phenylamino)-6-methoxy-7-[3-(4-methyl-piperazin-1-yl)propoxy]quinoline-3-carbonitrile|4-[(2,4-Dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methyl-1-piperazinyl)propoxy]-3-quinolinecarbonitrile;SKI 606"
PD-0166285,5311382,,"InChI=1S/C26H27Cl2N5O2/c1-4-33(5-2)13-14-35-19-11-9-18(10-12-19)30-26-29-16-17-15-20(25(34)32(3)24(17)31-26)23-21(27)7-6-8-22(23)28/h6-12,15-16H,4-5,13-14H2,1-3H3,(H,29,30,31)",IFPPYSWJNWHOLQ-UHFFFAOYSA-N,C26H27Cl2N5O2,512.4,"6-(2,6-dichlorophenyl)-2-[4-[2-(diethylamino)ethoxy]anilino]-8-methylpyrido[2,3-d]pyrimidin-7-one","185039-89-8|PD0166285|PD166285|PD-166285|TCMDC-140940|PD-0166285|6-(2,6-dichlorophenyl)-2-((4-(2-(diethylamino)ethoxy)phenyl)amino)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one|6-(2,6-dichlorophenyl)-2-[4-[2-(diethylamino)ethoxy]anilino]-8-methylpyrido[2,3-d]pyrimidin-7-one|6-(2,6-Dichloro-phenyl)-2-[4-(2-diethylamino-ethoxy)-phenylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one|F2UH9R2JT6|CHEMBL49120|C26H27Cl2N5O2|6-(2,6-dichlorophenyl)-2-({4-[2-(diethylamino)ethoxy]phenyl}amino)-8-methyl-7H,8H-pyrido[2,3-d]pyrimidin-7-one|6-(2,6-Dichlorophenyl)-2-({4-[2-(Diethylamino)ethoxy]phenyl}amino)-8-Methylpyrido[2,3-D]pyrimidin-7(8h)-One|IFPPYSWJNWHOLQ-UHFFFAOYSA-N|6-(2,6-Dichlorophenyl)-2-((4-(2-(diethylamino)ethoxy)phenyl)amino)-8-methylpyrido(2,3-d)pyrimidin-7(8H)-one|6-(2,6-dichlorophenyl)-2-((4-(2-diethylaminoethoxy)phenyl)amino)-8-methylpyrido(6,5-d)pyrimidin-7-one|6-(2,6-dichlorophenyl)-2-[[4-(2-diethylaminoethoxy)phenyl]amino]-8-methylpyrido[6,5-d]pyrimidin-7-one|6-(2,6-Dichlorophenyl)-2-[[4-[2-(diethylaMino)ethoxy]phenyl]aMino]-8-Methylpyrido[2,3-d]pyriMidin-7(8H)-one|Kinome_3263|PD 0166285|RefChem:1073669|SCHEMBL133914|BDBM3096|GTPL8183|orb1300335|SCHEMBL30250248|DTXSID501019043|BCP20228|EX-A4179|KHA03989|WZB81459|s8148|AKOS032945173|CCG-269785|NCGC00242490-01|NCGC00242490-02|AC-35457|BS-16163|DA-76653|HY-13925|CS-0008610|PD0166285?|C73566|2-aminopyrido[2,3-d]pyrimidin-7(8H)-one deriv.|Q27088273|6-(2,6-Dichlorophenyl)-2-[4-(2-diethylaminoethoxy)-phenylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one|6-(2,6-Dichlorophenyl)-2-[4-(2-diethylaminoethoxy)phenylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one, Dihydrochloride|6-(2,6-dichlorophenyl)-2-[4-[2-(diethylamino)ethoxy]anilino]-8-methyl-pyrido[2,3-d]pyrimidin-7-one|96M|Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-(2,6-dichlorophenyl)-2-[[4-[2-(diethylamino)ethoxy]phenyl]amino]-8-methyl-"
OLICERIDINE,66553195,,"InChI=1S/C22H30N2O2S/c1-25-18-7-15-27-19(18)16-23-13-10-21(20-6-2-5-12-24-20)11-14-26-22(17-21)8-3-4-9-22/h2,5-7,12,15,23H,3-4,8-11,13-14,16-17H2,1H3/t21-/m1/s1",DMNOVGJWPASQDL-OAQYLSRUSA-N,C22H30N2O2S,386.6,N-[(3-methoxythiophen-2-yl)methyl]-2-[(9R)-9-pyridin-2-yl-6-oxaspiro[4.5]decan-9-yl]ethanamine,"Oliceridine|TRV130|1401028-24-7|TRV-130|Olinvyk|oliceridina|MCN858TCP0|[(3-methoxythiophen-2-yl)methyl]({2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine|DTXSID201031292|oliceridinum|Olynvik|((3-methoxythiophen-2-yl)methyl)((2-((9R)-9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethyl))amine|RefChem:57313|DTXCID801516298|(9R)-N-((3-Methoxy-2-thienyl)methyl)-9-(2-pyridinyl)-6-oxaspiro(4.5)decane-9-ethanamine|Oliceridine [USAN]|N-[(3-methoxythiophen-2-yl)methyl]-2-[(9R)-9-pyridin-2-yl-6-oxaspiro[4.5]decan-9-yl]ethanamine|TRV 130|6-Oxaspiro[4.5]decane-9-ethanamine, N-[(3-methoxy-2-thienyl)methyl]-9-(2-pyridinyl)-, (9R)-|Olinvo|6-Oxaspiro(4.5)decane-9-ethanamine, N-((3-methoxy-2-thienyl)methyl)-9-(2-pyridinyl)-, (9R)-|N-[(3-methoxythiophen-2-yl)methyl]-2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethan-1-amine|UNII-MCN858TCP0|TRV130A|Oliceridine;Olinvo|N-((3-methoxythiophen-2-yl)methyl)-2-((9R)-9-(pyridin-2-yl)-6-oxaspiro(4.5)decan-9-yl)ethanamine|N-[(3-Methoxythiophen-2-yl)methyl]-2-[(9R)-9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethanamine|Olinvyk (TN)|OLICERIDINE [MI]|Oliceridine; TRV-130|OLICERIDINE [INN]|Oliceridine (USAN/INN)|OLICERIDINE [WHO-DD]|GTPL7334|CHEMBL2443262|SCHEMBL12542370|SCHEMBL29360907|OLICERIDINE [ORANGE BOOK]|DEA NO. 9245|BCP14196|EX-A2170|BDBM50493818|AKOS030526482|Oliceridine;Olinvo;TRV 130;TRV130|CS-3571|DB14881|NCGC00390659-01|AC-35966|DA-68381|FO180059|HY-16655|D11214|EN300-20351935|BRD-K35626314-003-01-1|Q17142898|(R)-N-((3-methoxythiophen-2-yl)methyl)-2-(9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9-yl)ethanamine|[(3-methoxythiophen-2-yl)methyl]({2-[(9r)-9-(pyridine-2-yl)-6-oxaspiro[4.5]decan-9-yl]ethyl})amine|WH2"
ANDROSTENEDIONE,6128,,"InChI=1S/C19H26O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h11,14-16H,3-10H2,1-2H3/t14-,15-,16-,18-,19-/m0/s1",AEMFNILZOJDQLW-QAGGRKNESA-N,C19H26O2,286.4,"(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione","androstenedione|4-Androstene-3,17-dione|Androst-4-ene-3,17-dione|63-05-8|4-Androstenedione|Androtex|delta-4-Androstenedione|3,17-Dioxoandrost-4-ene|SKF 2170|delta-4-Androsten-3,17-dione|NSC 9563|delta(sup 4)-Androstene-3,17-dione|DTXSID8024523|CHEBI:16422|(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17-dione|DELTA4-Androstene-3,17-dione|NSC9563|409J2J96VR|NSC-9563|DTXCID204523|delta 4 Androstenedione|4 Androstene 3,17 dione|(8R,9S,10R,13S,14S)-10,13-dimethyl-2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta(a)phenanthrene-3,17-dione|RefChem:388799|Therapeutic Androstenedione|(1S,2R,10R,11S,15S)-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadec-6-ene-5,14-dione|200-554-5|Andro|Androstendione|Fecundin|4-ANDROSTENE-3-17-DIONE|Androstenedione [JAN]|delta-(sup4)-Androsten-3,17-dione|17-Ketotestosterone|4-Androsten-3,17-dione|MLS000028510|Delta(4)-androsten-3,17-dione|Delta(4)-androstene-3,17-dione|.DELTA.4-Androstene-3,17-dione|Androstenedione (JAN)|NCGC00023902-06|SMR000058281|delta-4-Androstene-3,17-dione|CAS-63-05-8|ASD|androst-4-ene-3,17-dione (androstenedione)|Androstenedione (1.0 mg/mL in Acetonitrile)|HSDB 7335|EINECS 200-554-5|CHEMBL274826|adione|UNII-409J2J96VR|MFCD00003615|delta4-androstenedione|4-ANDENDION|Androsten-3,17-dione|Opera_ID_1694|Spectrum5_002059|[4-14C]-androstenedione|Epitope ID:135869|EC 200-554-5|androst-4-en-3,17-dione|ANDROSTENEDIONE [MI]|BIDD:PXR0101|D4-Androstene-3,17-dione|Lopac0_000114|SCHEMBL23272|MLS000563086|MLS002152886|ANDROSTENEDIONE [HSDB]|(4)-Androsten-3,17-dione|ANDROSTENEDIONE [VANDF]|GTPL2860|ANDROSTENEDIONE [MART.]|ANDROSTENEDIONE [WHO-DD]|SCHEMBL20483050|BDBM91713|.delta.4-Androsten-3,17-dione|Androst-4-en-3,17-dione, 2|HMS2231F18|(8R,9S,10R,13S,14S)-10,13-dimethyl-7,8,9,10,11,12,13,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-3,17(2H,6H)-dione|Androstenedione, 1mg/ml in Methanol|Tox21_110893|Tox21_202269|Tox21_300579|BBL033517|c1015|LMST02020007|MSK2287-100A|STK801871|AKOS005622710|Tox21_110893_1|[4-14C]androst-4-ene-3,17-dione|CCG-204209|DB01536|.delta.-(sup4)-Androsten-3,17-dione|Estr-5-ene-3,17-diol,(3b,17b)-|NCGC00023902-03|NCGC00023902-04|NCGC00023902-05|NCGC00023902-07|NCGC00023902-08|NCGC00023902-09|NCGC00254238-01|NCGC00259818-01|AC-11042|AC-33197|Androstenedione; 3,17-Dioxo-4-andostene|FA156791|VS-12118|A0845|EU-0100114|NS00010905|TESTOSTERONE IMPURITY A [EP IMPURITY]|WLN: L E5 B666 FV OV MUTJ A1 E1|A 9630|C00280|D00051|Q411064|SR-01000003096|SR-01000075697|Androstenedione Solution in Acetonitrile, 100ug/mL|SR-01000003096-4|SR-01000075697-1|8F5F4DCB-1164-4F2C-B4E3-3B74F684B189|4-Androstene-3,17-dione, VETRANAL(TM), analytical standard|Androstenedione (Androst-4-ene-3,17-dione) 1.0 mg/ml in Acetonitrile|(3aS,3bR,9aR,9bS,11aS)-9a,11a-dimethyl-1H,2H,3H,3aH,3bH,4H,5H,7H,8H,9H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthrene-1,7-dione|(8R,10R,13S)-10,13-Dimethyl-1,6,7,8,9,10,11,12,13,14,15,16-dodecahydro-2H-cyclopenta[a]phenanthrene-3,17-dione|117598-81-9"
FOSCARNET,3415,,"InChI=1S/CH3O5P/c2-1(3)7(4,5)6/h(H,2,3)(H2,4,5,6)",ZJAOAACCNHFJAH-UHFFFAOYSA-N,CH3O5P,126.01,phosphonoformic acid,"foscarnet|Phosphonoformic acid|Phosphonoformate|Carboxyphosphonic acid|4428-95-9|Foscarmet|phosphonocarboxylic acid|phosphonomethanoic acid|364P9RVW4X|J05AD01|CHEBI:127780|Phosphinecarboxylic acid, dihydroxy-, oxide|DTXSID0048478|RefChem:55232|DTXCID0028452|112-287-0|Dihydroxyphosphinecarboxylic acid oxide|CHEMBL666|dihydroxyphosphanecarboxylic acid oxide|Phgosphonocarboxylic acid|Formic acid, phosphono-|UNII-364P9RVW4X|Forscarnet|HSDB 8122|1nki|Foscarnet (PFA)|Spectrum_001359|PFA & rIFN.alpha.A|Spectrum2_000668|Spectrum3_001484|Spectrum4_000840|Spectrum5_000932|FOSCARNET [VANDF]|phosphonoformic acid(PFA)|MSL & PFA|FOSCARNET [WHO-DD]|Phosphono-formic acid(PFA)|hydroxycarbonylphosphonic acid|SCHEMBL23633|BSPBio_003067|Foscarnet & IFN-.ALPHA.|KBioGR_001419|KBioSS_001839|DivK1c_000915|SPBio_000735|GTPL5497|orb1298211|KBio1_000915|KBio2_001839|KBio2_004407|KBio2_006975|KBio3_002567|NINDS_000915|BDBM50011181|Phosphonoformic acid & IFN-.ALPHA.|AKOS006281397|DB00529|IDI1_000915|(PFA)dihydroxyphosphinecarboxylic acid oxide|dihydroxyphosphinecarboxylic acid oxide(PFA)|NS00005428|C06456|EN300-708767|Q420387|BRD-K85146014-314-05-4|BRD-K85146014-314-06-2|BRD-K85146014-314-07-0|Phosphonoformate(trisodium) & Recombinant Alpha-A Interferon|Dihydroxyphosphinecarboxylic acid oxide and MSL, neutralizing monoclonal antibody"
HALOFANTRINE,37393,,"InChI=1S/C26H30Cl2F3NO/c1-3-5-10-32(11-6-4-2)12-9-25(33)23-16-22-21(14-18(27)15-24(22)28)20-13-17(26(29,30)31)7-8-19(20)23/h7-8,13-16,25,33H,3-6,9-12H2,1-2H3",FOHHNHSLJDZUGQ-UHFFFAOYSA-N,C26H30Cl2F3NO,500.4,"3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol","Halofantrine|69756-53-2|Halofantrinum|3-(Dibutylamino)-1-(1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl)propan-1-ol|3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)phenanthren-9-yl]propan-1-ol|Q2OS4303HZ|DL-WR-171669|DTXSID0023119|WR-171699|RefChem:783364|DTXCID403119|P01BX01|274-104-1|Halofantrine, (-)-|Halofantrinum [INN-Latin]|Halofantrina [INN-Spanish]|66051-76-1|dl-WR 171669|(+)-Halofantrine|Halofantrine (INN)|Halofantrine [USAN]|HALOFANTRINE [INN]|3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthryl]propan-1-ol|66051-74-9|(-)-Halofantrine|EINECS 274-104-1|MLS002154111|Halofantrine, (R)-|Halofantrine, (+)-|(1)-Halofantrine|R7ADS21FSN|SMR001233418|C26H30Cl2F3NO|UNII-Q2OS4303HZ|Halofantrine [USAN:INN:BAN]|9-Phenanthrenemethanol, 1,3-dichloro-.alpha.-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-|D-WR-171669|L-WR-171669|9-PHENANTHRENEMETHANOL, 1,3-DICHLORO-.ALPHA.-(2-(DIBUTYLAMINO)ETHYL)-6-(TRIFLUOROMETHYL)-|4646B297U7|3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthryl]propan-1-ol;hydrochloride|Prestwick0_001031|Prestwick1_001031|Prestwick2_001031|Prestwick3_001031|UNII-R7ADS21FSN|HALOFANTRINE [MI]|3-(Dibutylamino)-1-(1,3-dichlor-6-(trifluormethyl)-9-phenanthryl)propanol|CHEMBL1107|HALOFANTRINE [VANDF]|SCHEMBL43795|BSPBio_001241|cid_37392|MLS006010152|(+/-)-HALOFANTRINE|HALOFANTRINE [WHO-DD]|SPBio_003092|BPBio1_001366|orb1686650|orb1702213|SCHEMBL29430180|SCHEMBL29500273|BDBM79214|CHEBI:94392|GTPL10019|UNII-4646B297U7|BCP13777|HY-A0148|AC-481|AKOS015907678|DB01218|1,3-Dichloro-.alpha.-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-9-phenanthrene-methanol|1,3-Dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-9-phenanthrenemetnaol|9-Phenanthrenemethanol, 1,3-dichloro-.alpha.-[2-(dibutylamino)ethyl]-6-(trifluoromethyl)-(1)|NCGC00179250-01|NCGC00179250-04|AS-14162|NCI60_002593|SMR004701269|AB00514703|CS-0017473|NS00003472|C07634|D08033|EN300-226522|AS-839/43469859|Q947595|BRD-A51964809-003-12-6|1,3-Dichloro-.alpha.-[2-(dibutylamino)ethyl]-6- (trifluoromethyl)-9-phenathrenemethanol|1-[-1,3-dichloro-6-trifluoromethyl-9-phenanthryl]-3-di(n-butyl)aminopropanol|3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthrenyl]-1-propanol|3-(Dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthryl]-1-propanol|3-(Dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthryl]-1-propanol #|9-Phenanthrenemethanol, 1,3-dihydro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-|1,3-DICHLORO-.ALPHA.-(2-(DIBUTYLAMINO)ETHYL)-6-(TRIFLUOROMETHYL)-9-PHENANTHRENEMETHANOL|1-[1,3-bis(chloranyl)-6-(trifluoromethyl)phenanthren-9-yl]-3-(dibutylamino)propan-1-ol;hydrochloride|3-(dibutylamino)-1-[1,3-dichloro-6-(trifluoromethyl)-9-phenanthrenyl]-1-propanol;hydrochloride|9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, (+)-|9-Phenanthrenemethanol, 1,3-dichloro-alpha-(2-(dibutylamino)ethyl)-6-(trifluoromethyl)-, (-)-"
NAFAZATROM,42923,,"InChI=1S/C16H16N2O2/c1-12-10-16(19)18(17-12)8-9-20-15-7-6-13-4-2-3-5-14(13)11-15/h2-7,11H,8-10H2,1H3",ISBUYSPRIJRBKX-UHFFFAOYSA-N,C16H16N2O2,268.31,5-methyl-2-(2-naphthalen-2-yloxyethyl)-4H-pyrazol-3-one,"NAFAZATROM|59040-30-1|Bay-g 6575|Bay-g-6575|BAY g 6575|DTXSID00207794|2,4-Dihydro-5-methyl-2-(2-(2-naphthalenyloxy)ethyl)-3H-pyrazol-3-one|3H-Pyrazol-3-one, 2,4-dihydro-5-methyl-2-(2-(2-naphthalenyloxy)ethyl)-|K94216221B|RefChem:927431|DTXCID50130285|1-(2-(beta-naphthyloxy)ethyl)-3-methyl-2-pyrazolin-5-one|3H-pyrazol-3-one,2,4-dihydro-5-methyl-2-(2-(2-naphthalenyloxy)ethyl)|261-571-1|5-methyl-2-(2-naphthalen-2-yloxyethyl)-4H-pyrazol-3-one|3-methyl-1-(2-(naphthalen-2-yloxy)ethyl)-1H-pyrazol-5(4H)-one|Nafazatromum|Nafazatromum [INN-Latin]|Nafazatrom [INN:BAN]|EINECS 261-571-1|BRN 0665222|UNII-K94216221B|1-(2-(beta-naphthyloxy)ethyl)-3-methyl-2- pyrazolin-5-one|Oprea1_097893|SCHEMBL93681|orb1695972|ISBUYSPRIJRBKX-UHFFFAOYSA-N|AKOS040753204|HY-121586|NS00034068|Q27282112"
DIGOXIN,2724385,,"InChI=1S/C41H64O14/c1-19-36(47)28(42)15-34(50-19)54-38-21(3)52-35(17-30(38)44)55-37-20(2)51-33(16-29(37)43)53-24-8-10-39(4)23(13-24)6-7-26-27(39)14-31(45)40(5)25(9-11-41(26,40)48)22-12-32(46)49-18-22/h12,19-21,23-31,33-38,42-45,47-48H,6-11,13-18H2,1-5H3/t19-,20-,21-,23-,24+,25-,26-,27+,28+,29+,30+,31-,33+,34+,35+,36-,37-,38-,39+,40+,41+/m1/s1",LTMHDMANZUZIPE-PUGKRICDSA-N,C41H64O14,780.9,"3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one","digoxin|20830-75-5|Lanoxin|Rougoxin|12beta-Hydroxydigitoxin|Digacin|Dilanacin|Dynamos|Vanoxin|Digoxine|Fargoxin|Lanoxicaps|Mapluxin|Natigoxin|Digosin|Cardiogoxin|Cordioxil|Digoxina|Digoxinum|Lanocardin|Toloxin|Stillacor-|Digoxin Pediatric|Davoxin|Acygoxin|Cardioxin|CHEBI:4551|Digoksyna|Digonix|Digossina|Saroxin|Lanoxin PG|Cardoxin|Eudigox|Lanacrist|Chloroformic digitalin|Neo-Lanicor|DTXSID5022934|SK-Digoxin|LANOXIN PEDIATRIC|Homolle's digitalin|Digoxigenin-tridigitoxosid|NSC-95100|Lanacordin|Lenoxin|Dixina|DTXCID502934|73K4184T59|Digitalis glycoside|3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one|3beta,12beta,14-Trihydroxy-5beta,14beta-card-20(22)-enolid-3-tridigitoxosid|(3beta,5beta,12beta)-3-((O-2,6-Dideoxy-beta-D-ribo-hexapyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxycard-20(22)-enolide|4-[(1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-14-yl]-2,5-dihydrofuran-2-one|Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-|Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1.fwdarw.4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1.fwdarw.4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-|Digamex|Digox|NSC95100|Lanoxin-PG|3-((3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-((2R,4S,5S,6R)-5-((2S,4S,5S,6R)-5-((2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl)oxy-4-hydroxy-6-methyloxan-2-yl)oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta(a)phenanthren-17-yl)-2H-furan-5-one|4-((1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-(((2R,4S,5S,6R)-5-(((2S,4S,5S,6R)-5-(((2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl)oxy)-4-hydroxy-6-methyloxan-2-yl)oxy)-4-hydroxy-6-methyloxan-2-yl)oxy)-11,16-dihydroxy-2,15-dimethyltetracyclo(8.7.0.0^(2,7).0^(11,15))heptadecan-14-yl)-2,5-dihydrofuran-2-one|Nativelle, Digoxine|Boehringer, Digoxina|Lanoxin-125|Nativelle, Hemigoxine|RefChem:5754|C01AA05|244-068-1|3beta-(2,6-Dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyloxy)-12beta,14-dihydroxy-5beta,14beta-card-20(22)-enolide|4-((1S,2S,5S,7R,10R,11S,14R,15S,16R)-5-(((2R,4S,5S,6R)-5-(((2S,4S,5S,6R)-5-(((2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl)oxy)-4-hydroxy-6-methyloxan-2-yl)oxy)-4-hydroxy-6-methyloxan-2-yl)oxy)-11,16-dihydroxy-2,15-dimethyltetracyclo(8.7.0.02,7.011,15)heptadecan-14-yl)-2,5-dihydrofuran-2-one|MFCD00003674|MLS000069819|SMR000059217|Digoxin Nativelle|(3beta,5beta,12beta)-3-{[2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl]oxy}-12,14-dihydroxycard-20(22)-enolide|NCGC00090797-03|Digoxin, analytical standard|Coragoxine|Lenoxicaps|Neodioxanin|Cardigox|Digomal|Lanikor|Lanorale|Purgoxin|Grexin|Digon|Dokim|Lanoxicaps (TN)|[3H]digoxin|3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-4-hydroxy-6-methyl-tetrahydropyran-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one|SMR000653537|Lanoxin (TN)|[3H]-digoxin|Digitek|Dimecip|Lifusin|Digos|Digoxin-Sandoz|Digoxina-Sandoz|Digoxin-Zori|NSC 95100|Digoxine Navtivelle|Novodigal [inj.]|Prestwick_170|Digoksyna [Polish]|Digossina [DCIT]|Hemigoxine Nativelle|CAS-20830-75-5|12A-Hydroxydigitoxin|3b0w|DIGOXIN [VANDF]|Digoxinum [INN-Latin]|DIGOXIN [HSDB]|DIGOXIN [IARC]|DIGOXIN [INN]|DIGOXIN [JAN]|DIGOXIN [MI]|Digoxina [INN-Spanish]|DIGOXIN [MART.]|Opera_ID_1134|Prestwick0_000437|Prestwick1_000437|Prestwick2_000437|Prestwick3_000437|Digoxin (JP17/USP)|DIGOXIN [USP-RS]|DIGOXIN [WHO-DD]|DIGOXIN [WHO-IP]|12 beta -Hydroxydigitoxin|Epitope ID:122964|CHEMBL1751|BIDD:PXR0148|SCHEMBL20506|BSPBio_000454|Digoxin, 1mg/ml in Methanol|MLS001055371|MLS001076495|orb104782|DIGOXIN [ORANGE BOOK]|12b-Hydroxydigitoxin; Lanicor|digoxin for peak identification|SPBio_002393|DIGOXIN [EP MONOGRAPH]|BPBio1_000500|GTPL4725|GTPL4726|HSDB 214|DIGOXIN [USP MONOGRAPH]|Digoxin [USP:INN:BAN:JAN]|Digoxin 1.0 mg/ml in Methanol|BDBM46355|cid_2724385|DIGOXINUM [WHO-IP LATIN]|REGID_for_CID_2724385|HMS1569G16|HMS2096G16|HMS2232G20|HMS3713G16|Human Serum - Digoxin, low level|UNII-73K4184T59|Digoxigenin-tridigitoxosid [German]|Human Serum - Digoxin, high level|HY-B1049|MSK10026|EINECS 244-068-1|Tox21_111025|Tox21_201678|Tox21_303050|20830-75-5 (free)|HB1138|s4290|AKOS015895113|AKOS024283494|CCG-220437|CS-4571|DB00390|OD01513|BRN 0077011|NCGC00090797-01|NCGC00090797-02|NCGC00090797-04|NCGC00090797-05|NCGC00090797-06|NCGC00090797-07|NCGC00090797-09|NCGC00090797-12|NCGC00090797-15|NCGC00257022-01|NCGC00259227-01|AS-13281|ST069334|D1828|NS00008620|C06956|D00298|EN300-6492954|5-18-04-00381 (Beilstein Handbook Reference)|830D755|A814956|Q422222|SR-01000721866|Digoxin, certified reference material, TraceCERT(R)|SR-01000721866-3|SR-01000721866-4|BRD-K23478508-001-03-7|Digoxin, European Pharmacopoeia (EP) Reference Standard|Z2108699066|0B9662A7-264E-4ACD-94B2-9E1138C0CA5A|Digoxin, United States Pharmacopeia (USP) Reference Standard|Digoxin, Pharmaceutical Secondary Standard; Certified Reference Material|Digoxin for peak identification, European Pharmacopoeia (EP) Reference Standard|3-[(3S,5R,10S,12R,13S,14S,17R)-3-[(2R,4S,5S,6R)-5-[(2S,4S,5S,6R)-5-[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-4-hydroxy-6-methyloxan-2-yl]oxy-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one|3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-10,13-dimethyl-3-[(2R,4S,5S,6R)-6-methyl-5-[(2S,4S,5S,6R)-6-methyl-5-[(2S,4S,5S,6R)-6-methyl-4,5-bis(oxidanyl)oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxy-4-oxidanyl-oxan-2-yl]oxy-12,14-bis(oxidanyl)-1,2,3,4,5,6,7,8,9,11,12,|3-[(3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-[[(2R,4S,5S,6R)-5-[[(2S,4S,5S,6R)-5-[[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyl-2-oxanyl]oxy]-4-hydroxy-6-methyl-2-oxanyl]oxy]-4-hydroxy-6-methyl-2-oxanyl]oxy]-12,14-dihydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,|3.BETA.-((O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL)OXY)-12.BETA.,14-DIHYDROXY-5.BETA.-CARD-20(22)-ENOLIDE|3beta-((O-2,6-Dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1-4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12beta,14-dihydroxy-5beta-card-20(22)-enolide|4-((1S,2S,5S,11S,15S,7R,10R,14R,16R)-5-{5-[5-((2S,4S,5S,6R)-4,5-dihydroxy-6-me thyl(2H-3,4,5,6-tetrahydropyran-2-yloxy))(4S,5S,2R,6R)-4-hydroxy-6-methyl(2H-3 ,4,5,6-tetrahydropyran-2-yloxy)](4S,5S,2R,|4-((1S,2S,5S,11S,15S,7R,10R,14R,16R)-5-{5-[5-((2S,4S,5S,6R)-4,5-dihydroxy-6-me thyl(2H-3,4,5,6-tetrahydropyran-2-yloxy))(4S,5S,2R,6R)-4-hydroxy-6-methyl(2H-3 ,4,5,6-tetrahydropyran-2-yloxy)](4S,5S,2R,6R)-4-hydroxy-6-methyl(2H-3,4,5,6-te trahydropyran-2-yl|4-((3S,5R,8R,9S,10S,12R,13S,14S,17R)-3-(((2R,4S,5S,6R)-5-(((2S,4S,5S,6R)-5-(((2S,4S,5S,6R)-4,5-dihydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-4-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-12,14-dihydroxy-10,13-dimethylhexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)furan-2(5H)-one|4-[(1R,3aS,3bR,5aR,7S,9aS,9bS,11R,11aS)-7-{[(2R,4S,5S,6R)-5-{[(2S,4S,5S,6R)-5-{[(2S,4S,5S,6R)-4,5-dihydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-4-hydroxy-6-methyloxan-2-yl]oxy}-3a,11-dihydroxy-9a,11a-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-1-yl]-2,5-dihydrofuran-2-one|6R)-4-hydroxy-6-methyl(2H-3,4,5,6-te trahydropyran-2-yloxy)}-11,16-dihydroxy-2,15-dimethyltetracyclo[8.7.0.0<2,7>.0 <11,15>]heptadec-14-yl)-5-hydrofuran-2-one|CARD-20(22)-ENOLIDE, 3-((O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-O-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL-(1->4)-2,6-DIDEOXY-.BETA.-D-RIBO-HEXOPYRANOSYL)OXY)-12,14-DIHYDROXY-,(3.BETA.,5.BETA.,12.BETA.)-|Card-20(22)-enolide, 3-((O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-O-2,6-dideoxy-beta-D-ribo-hexopyranosyl-(1->4)-2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-12,14-dihydroxy-, (3beta,5beta,12beta)-|Card-20(22)-enolide, 3-[[O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1-->4)-O-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl-(1-->4)-2,6-dideoxy-.beta.-D-ribo-hexopyranosyl]oxy]-12,14-dihydroxy-, (3.beta.,5.beta.,12.beta.)-"
ETORICOXIB,123619,,"InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3",MNJVRJDLRVPLFE-UHFFFAOYSA-N,C18H15ClN2O2S,358.8,5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine,"Etoricoxib|202409-33-4|Arcoxia|MK-0663|5-Chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-2,3'-bipyridine|L-791456|2,3'-Bipyridine, 5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-|5-chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine|etoricoxibum|MK0663|5-chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine|DTXSID3046457|WRX4NFY03R|CHEBI:6339|L791456|5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine|2,3'-Bipyridine, 5-chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)-|DTXCID1026457|5-chloro-2-(6-methylpyridin-3-yl)-3-(4-(methylsulfonyl)phenyl)pyridine|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-[2,3']bipyridinyl|5-chloro-3-(4-methanesulfonylphenyl)-2-(6-methylpyridin-3-yl)pyridine|5-Chloro-3-(4-methanesulfonyl-phenyl)-6'-methyl-(2,3')bipyridinyl|RefChem:388965|L 791456|M01AH05|5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl) Pyridine|Tauxib|Nucoxia|Algix|MK-663|MK 0663|MFCD06797512|CHEMBL416146|C18H15ClN2O2S|NCGC00164578-01|Etoricoxibe|Etropain|Torcoxia|Etoxib|MK-0663;L-791456|Etoricoxib [USAN:INN:BAN]|Kingcox|MK 663|Etoricoxib [USAN]|CAS-202409-33-4|SR-05000001486|Etoricoxib (USAN/INN)|UNII-WRX4NFY03R|Etoricoxib?|Etoricoxib (Standard)|ETORICOXIB [MI]|ETORICOXIB [INN]|ETORICOXIB [MART.]|SCHEMBL4680|ETORICOXIB [WHO-DD]|Etoricoxib - Bio-X trade mark|GTPL2896|orb1308128|SCHEMBL29366203|SCHEMBL29402456|SCHEMBL30988052|MSK8006|HMS2090A05|HMS3713P20|HMS3885H14|HMS5083M08|BCP06428|EX-A2642|Tox21 112206|Tox21_112206|5-chloro-2-(6-methyl-3-pyridyl)-3-(4-methylsulfonylphenyl)pyridine|5-Chloro-6'-methyl-3-(4-(methylsulfonyl)-phenyl)-2,3'-bipyridine|BDBM50072064|Etoricoxib; MK-663; MK-0663|HY-15321R|s4651|AKOS016010125|Tox21_112206_1|CCG-220639|DB01628|FC23204|SB18988|NCGC00164578-02|5CH|AC-29052|AS-17761|BC164436|HY-15321|SY111379|DB-045133|NS00005633|D03710|Etoricoxib, VETRANAL(TM), analytical standard|AB01275483-01|409E334|EN300-18530864|L001141|Q631202|SR-05000001486-1|SR-05000001486-2|BRD-K54770957-001-01-9|BRD-K54770957-001-02-7|BRD-K54770957-001-04-3|F2173-0490|Z2216907255|Etoricoxib, United States Pharmacopeia (USP) Reference Standard|5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-2,3'-bipyridine|5-Chloro-3-(4-methanesulfonyl-phenyl)-6''''-methyl-[2,3'''']bipyridinyl|5-Chloro-3-(4-methanesulfonyl-phenyl)-6''-methyl-[2,3'']bipyridinyl|5-chloro-6''-methyl-3-[4-(methylsulfonyl)phenyl]-2,3''-bipyridine|5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine;Arcoxia|5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine;Etoricoxib;Arcoxia|5-Chloro-6 inverted exclamation mark -methyl-3-[4-(methylsulfonyl)phenyl]-2,3 inverted exclamation mark -bipyridine"
FLURBIPROFEN,3394,,"InChI=1S/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)",SYTBZMRGLBWNTM-UHFFFAOYSA-N,C15H13FO2,244.26,2-(3-fluoro-4-phenylphenyl)propanoic acid,"flurbiprofen|5104-49-4|Ansaid|Froben|Antadys|2-(3-fluoro-4-phenylphenyl)propanoic acid|2-(2-fluorobiphenyl-4-yl)propanoic acid|Flurbiprofene|Flurbiprofeno|3-Fluoro-4-phenylhydratropic acid|Cebutid|Flurbiprofenum|Flubiprofen|Zepolas|Froben Sr|BTS 18322|BTS-18322|U-27182|(+-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-Fluoro-alpha-methyl-(1,1'-biphenyl)-4-acetic acid|5GRO578KLP|BTS 18,322|NSC-757037|CHEBI:5130|DTXSID0037231|U-27,182|DTXCID8017231|NSC685701|Fluriproben|(1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, (+-)-|Strefen|2-FLUORO-ALPHA-METHYL-[1,1'-BIPHENYL]-4-ACETIC ACID|Novo Flurprofen|Nu Flurbiprofen|Apo Flurbiprofen|Rinol-STroche|ratio Flurbiprofen|RefChem:55218|2-Fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic acid|Antiphlamine Pain Relieving|M01AE09|M02AA19|R02AX01|S01BC04|BTS18322|(2RS)-2-(2-Fluorobiphenyl-4-yl)propanoic acid|225-827-6|Flurofen|MFCD00079303|Flurbiprofene [INN-French]|Flurbiprofenum [INN-Latin]|Flurbiprofeno [INN-Spanish]|Ocufen|FP 70|2-(2-FLUORO-[1,1'-BIPHENYL]-4-YL)PROPANOIC ACID|51543-38-5|Stayban|Adfeed|U 27182|CHEMBL563|(+/-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|2-(2-Fluoro-4-biphenylyl)propionic acid|MLS000040873|2-(3-fluoro-4-phenyl-phenyl)propanoic acid|2-Fluoro-alpha-methyl-4-biphenylacetic acid|Flugalin|SMR000042823|Anmetarin|Ocuflur|Yakuban|Novo-Flurprofen|Nu-Flurbiprofen|Apo-Flurbiprofen|2-(2-Fluorobiphenyl-4-yl)propionic Acid|Flurbiprofen (Ansaid)|Ansaid (TN)|CCRIS 3708|SR-01000003043|FLP|(R)-Flurbiprofen;MPC7869|EINECS 225-827-6|(+-)-2-(2-Fluoro-4-biphenylyl)propionic acid|UNII-5GRO578KLP|U 27,182|Flurbiprofen; (2RS)-2-(2-Fluorobiphenyl-4-yl)propanoic acid|Flurbiprofen O|MKS-11|rac-Flurbiprofen|NCGC00016654-01|(+-)Flurbiprofen|CAS-5104-49-4|EINECS 257-262-6|L-790,330|Ocufen (Salt/Mix)|[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-?-methyl-|(1)-2-Fluoro-alpha-methyl(1,1'-biphenyl)-4-acetic acid|Flurbiprofen (NSAID)|Flurbiprofen [USAN:USP:INN:BAN:JAN]|Spectrum_001096|Flurbiprofen (Standard)|Opera_ID_777|Prestwick0_000917|Prestwick1_000917|Prestwick2_000917|Prestwick3_000917|Spectrum2_001025|Spectrum3_000435|Spectrum4_000558|Spectrum5_000720|FLURBIPROFEN [MI]|F0371|(.+/-.)-Flurbiprofen|FLURBIPROFEN [INN]|FLURBIPROFEN [JAN]|4-Biphenylacetic acid, 2-fluoro-alpha-methyl-|FLURBIPROFEN [USAN]|SCHEMBL2248|FLURBIPROFEN [VANDF]|4-Biphenylacetic acid, 2-fluoro-.alpha.-methyl-|BSPBio_000794|BSPBio_002050|FLURBIPROFEN [MART.]|KBioGR_001255|KBioSS_001576|MLS000028441|MLS000758198|MLS001201729|MLS001401361|MLS006011431|MLS006011931|DivK1c_000804|FLURBIPROFEN [USP-RS]|FLURBIPROFEN [WHO-DD]|SPECTRUM1500308|2-(2-fluoro-[1,1'-biphenyl-4-yl])propanoic acid|SPBio_001209|SPBio_002983|BPBio1_000874|GTPL4194|orb1310752|SCHEMBL10029029|Flurbiprofen (JP18/USP/INN)|HMS502I06|KBio1_000804|KBio2_001576|KBio2_004144|KBio2_006712|KBio3_001270|SYTBZMRGLBWNTM-UHFFFAOYSA-|[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-.alpha.-methyl-|MSK7164|NINDS_000804|FLURBIPROFEN [ORANGE BOOK]|HMS1570H16|HMS1920O20|HMS2051A05|HMS2090I06|HMS2091F21|HMS2097H16|HMS2232I08|HMS3259I12|HMS3268E10|HMS3370N14|HMS3371I05|HMS3393A05|HMS3414N17|HMS3649K11|HMS3655G19|HMS3678N15|HMS3714H16|HMS5079N10|Pharmakon1600-01500308|FLURBIPROFEN [EP MONOGRAPH]|2-FLUORO-[1,1'-BIPHENYL]-4-(ALPHA-METHYL)ACETIC ACID|BCP09086|BCP13426|FLURBIPROFEN [USP MONOGRAPH]|Tox21_110547|Tox21_302353|BBL010980|BDBM50074922|CCG-40243|Flurbiprofen - CAS 5104-49-4|HB3049|HY-10582R|NSC755404|NSC757037|SBB067242|STK802101|Flurbiprofen, cyclooxygenase inhibitor|AKOS004119934|AKOS016340701|AC-8106|CCG-100759|DB00712|FF23507|KS-5035|NC00009|NC00563|NSC 757037|NSC-685701|NSC-755404|2(2-Fluoro-4-biphenylyl)propionic acid|IDI1_000804|NCGC00018157-03|NCGC00018157-04|NCGC00018157-05|NCGC00018157-08|NCGC00018157-11|NCGC00018157-13|NCGC00025287-03|NCGC00025287-04|NCGC00255457-01|HY-10582|NCI60_030812|SY057091|2 -(2-fluoro-4-biphenylyl)propionic acid|2-(2-fluoro-4-biphenylyl)-propionic acid|2-(2-fluoro-biphenyl-4-yl)propionic acid|SBI-0051387.P003|DB-051888|2-(2-fluoro-biphenyl-4-yl)-propionic acid|AB00051999|NS00003058|ST50825909|alpha-methyl-2-fluoro-4-biphenylylacetic acid|(RS)-2-(2-fluorobiphenyl-4-yl)propionic acid|2-Fluoro-.alpha.-methyl-4-biphenylacetic acid|BIM-0051387.0001|C07013|D00330|AB00051999-17|AB00051999_18|EN300-7479231|104F494|2-(2-Fluoro-1,1'-biphenyl-4-yl)propanoic acid|2-(2-Fluoro[1,1'-biphenyl]-4-yl)propanoic acid|2-fluoro--methyl-(1,1'-biphenyl)-4-acetic acid|AO-295/42284050|F463477|Q419890|(.+/-.)-2-(2-Fluoro-4-biphenylyl)propionic acid|(r/s)-2-fluoro-alpha-methyl-4-biphenylacetic acid|SR-01000003043-2|SR-01000003043-5|SR-01000003043-6|2-(2-fluoro-[1,1''-biphenyl-4-yl])propanoic acid|2-(2-Fluoro[1,1'-biphenyl]-4-yl)propanoic acid #|BRD-A86044036-001-05-9|BRD-A86044036-001-26-5|BRD-A86044036-001-27-3|SR-01000003043-14|(+/-)-2-(2-FLUORO-4-BIPHENYLYL)PROPIONIC ACID|(.+/-.)-2-Fluoro-.alpha.-methyl-4-biphenylacetic acid|[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-alpha-methyl-|2-Fluoro-.alpha.-methyl(1,1'-biphenyl)-4-acetic acid|2-fluoro-alpha-methyl-(1,1''-biphenyl)-4-acetic acid|Z2216885233|(+/-)-2-FLUORO-.ALPHA.-METHYL-4-BIPHENYLACETIC ACID|[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-a-methyl-, (+/-)-|Flurbiprofen, European Pharmacopoeia (EP) Reference Standard|(1,1'-Biphenyl)-4-acetic acid, 2-fluoro-alpha-methyl-, (+/-)-|[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-a-methyl-, (A+/-)-|Flurbiprofen, United States Pharmacopeia (USP) Reference Standard|[1,1'-Biphenyl]-4-acetic acid, 2-fluoro-.alpha.-methyl-, (.+/-.)-|2-[2-Fluoro-[1,1 inverted exclamation mark -biphenyl]-4-yl]propanoic Acid|(1,1'-BIPHENYL)-4-ACETIC ACID, 2-FLUORO-.ALPHA.-METHYL-, (+/-)-|2-(2-Fluoro-4-biphenylyl)propanoic acid; (+/-)-2-Fluoro-alpha-methyl-4-biphenylacetic acid|Flurbiprofen, 2-(2-Fluorobiphenyl-4-yl)propionic acid, 3-Fluoro-4-phenylhydratropic acid|Flurbiprofen, Pharmaceutical Secondary Standard; Certified Reference Material|InChI=1/C15H13FO2/c1-10(15(17)18)12-7-8-13(14(16)9-12)11-5-3-2-4-6-11/h2-10H,1H3,(H,17,18)"
IDAZOXAN,54459,,"InChI=1S/C11H12N2O2/c1-2-4-9-8(3-1)14-7-10(15-9)11-12-5-6-13-11/h1-4,10H,5-7H2,(H,12,13)",HPMRFMKYPGXPEP-UHFFFAOYSA-N,C11H12N2O2,204.22,"2-(2,3-dihydro-1,4-benzodioxin-3-yl)-4,5-dihydro-1H-imidazole","IDAZOXAN|79944-58-4|Idazoxano|Idazoxane|Idazoxanum|2-(2,3-Dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-1H-imidazole|Dl-idazoxan|Racemic idazoxan|CHEBI:5862|DTXSID6045161|Y310PA316B|NSC-759867|DTXCID4025161|RefChem:147691|2-(2,3-dihydro-1,4-benzodioxin-3-yl)-4,5-dihydro-1H-imidazole|CHEMBL10316|NCGC00015560-06|1H-Imidazole, 2-(2,3-dihydro-1,4-benzodioxin-2-yl)-4,5-dihydro-|Idazoxane [French]|Idazoxanum [Latin]|Idazoxano [Spanish]|4,5-dihydro-2-(2,3-dihydro-1,4-benzodioxin-2-yl)-1H-imidazole|2-(2,3-Dihydrobenzo[b][1,4]dioxin-2-yl)-4,5-dihydro-1H-imidazole|CAS-79944-58-4|Idazoxan [INN:BAN]|idasoxan|UNII-Y310PA316B|IDAZOXAN [INN]|IDAZOXAN [MI]|Prestwick0_000926|Prestwick1_000926|Prestwick2_000926|Prestwick3_000926|(+-)-2-(1,4-Benzodioxan-2-yl)-2-imidazoline|Lopac0_000652|US8633208, Idazoxan|(+/-)-IDAZOXAN|BSPBio_000832|TR-01-XRR|SCHEMBL114731|SPBio_003011|BPBio1_000916|orb2815651|SCHEMBL29368292|GTPL12575|HMS2089E14|Tox21 110173|Tox21_110173|1H-Imidazole, 4,5-dihydro-2-(2,3-dihydro-1,4-benzodioxin-2-yl)-|BDBM50019848|2-(1,4-benzodioxan-2-yl)imidazoline|AKOS015915004|Tox21_110173_1|CCG-204739|DB12551|NSC 759867|SDCCGSBI-0050632.P003|NCGC00015560-04|NCGC00015560-05|NCGC00015560-08|NCGC00015560-09|NCGC00015560-10|NCGC00015560-12|NCGC00015560-17|NCGC00024794-03|NCGC00024794-04|HY-14561|SBI-0050632.P002|AB00514632|CS-0003445|AB00489883-09|AB00489883_10|L000808|Q5987770|2-IMIDAZOLINE, 2-(1,4-BENZODIOXAN-2-YL)-|BRD-A18696154-003-03-6|BRD-A18696154-003-14-3|BRD-A18696154-003-21-8|BRD-A18696154-003-22-6|(+/-)-2-(1,4-BENZODIOXAN-2-YL)-2-IMIDAZOLINE"
NIGULDIPINE,60602,,"InChI=1S/C36H39N3O6/c1-25-31(34(40)44-3)33(27-12-10-17-30(24-27)39(42)43)32(26(2)37-25)35(41)45-23-11-20-38-21-18-36(19-22-38,28-13-6-4-7-14-28)29-15-8-5-9-16-29/h4-10,12-17,24,33,37H,11,18-23H2,1-3H3/t33-/m0/s1",SVJMLYUFVDMUHP-XIFFEERXSA-N,C36H39N3O6,609.7,"5-O-[3-(4,4-diphenylpiperidin-1-yl)propyl] 3-O-methyl (4S)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","113165-32-5|NIGULDIPINE|Z81N45O25Z|DNIG|3-((4,4-Diphenyl-1-piperidinyl)propyl)-5-methyl-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate hydrochloride|B859-35|RefChem:854146|3-Methyl-5-(3-(4,4-diphenyl-1-piperidinyl)propyl)-1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)pyridine-3,5-dicarboxylate|3-(3-(4,4-diphenylpiperidin-1-yl)propyl) 5-methyl (4S)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|6Q39TPF0GL|Niguldipino|Niguldipinum|S(+)-Niguldipine hydrochloride|(S)-Niguldipine|Niguldipine [INN]|S(+)-niguldipine|5-O-[3-(4,4-diphenylpiperidin-1-yl)propyl] 3-O-methyl (4S)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|(-)-(S)-3-(4,4-Diphenylpiperidino)propyl methyl 1,4-dihydro-2,6-dimethyl-4-(m-nitrophenyl)-3,5-pyridinedicarboxylate|UNII-Z81N45O25Z|Tocris-1123|Tocris-1124|niguldipine-(S)-(+)|S(+)-1,4-Dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridinedicarboxylic acid 3-(4,4-diphenyl-1-piperidinyl)-propyl methyl ester hydrochloride|GTPL487|NIGULDIPINE [WHO-DD]|CHEMBL41929|SCHEMBL245992|CHEMBL405355|SCHEMBL29385244|DTXSID60274008|CHEBI:103931|BDBM50034683|BDBM50453799|MFCD00873564|DB09239|NCGC00025014-01|NCGC00025015-01|NS00073175|BRD-K59333713-003-01-2|BRD-K59333713-003-02-0|Q27088835|(S)-2,6-Dimethyl-4-(3-nitro-phenyl)-1,4-dihydro-pyridine-3,5-dicarboxylic acid 3-[3-(4,4-diphenyl-piperidin-1-yl)-propyl] ester 5-methyl ester|O3-[3-[4,4-di(phenyl)piperidin-1-yl]propyl] O5-methyl (4S)-2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate"
TAMSULOSIN,129211,,"InChI=1S/C20H28N2O5S/c1-4-26-17-7-5-6-8-18(17)27-12-11-22-15(2)13-16-9-10-19(25-3)20(14-16)28(21,23)24/h5-10,14-15,22H,4,11-13H2,1-3H3,(H2,21,23,24)/t15-/m1/s1",DRHKJLXJIQTDTD-OAHLLOKOSA-N,C20H28N2O5S,408.5,5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide,"TAMSULOSIN|106133-20-4|(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzenesulfonamide|Tamsulosine|Tamsulosina|Tamsulosinum|(-)-Tamsulosin|Tamsulon|(r)-(-)-tamsulosin|G3P28OML5I|CHEBI:9398|HIP1402|5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxybenzenesulfonamide|HGP-0412|HIP-1402|DTXSID3023631|Benzenesulfonamide, 5-(2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxy-, (R)-|5-[(2R)-2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|5-((2R)-2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxy-benzenesulfonamide|5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzene-1-sulfonamide|LY-253352|5-((2R)-2-((2-(2-ethoxyphenoxy)ethyl)amino)propyl)-2-methoxybenzene-1-sulfonamide|5-((2R)-2-(2-(2-ethoxyphenoxy)ethylamino)propyl)-2-methoxybenzenesulfonamide|RefChem:56609|DTXCID803631|G04CA02|Alna|Josir|Omnic|Flomax|Tamsulosin (INN)|C20H28N2O5S|MFCD00871531|Flomax (TN)|CHEMBL836|(R)-5-(2-((2-(2-Ethoxyphenoxy)ethyl)amino)-propyl)-2-methoxybenzenesulfonamide|5-[(2R)-2-{[2-(2-ethoxyphenoxy)ethyl]amino}propyl]-2-methoxybenzenesulfonamide|Tamsulosine [INN-French]|Tamsulosinum [INN-Latin]|Flowmax|Tamsulosina [INN-Spanish]|TAMSULOSIN [INN]|Tamsulosin [INN:BAN]|Amsulosin|Harnal-D|HSDB-7744|Contiflo OD|Tamsulon (TN)|NCGC00167442-01|UNII-G3P28OML5I|HSDB 7744|JGX|Tamsulosin (Standard)|TAMSULOSIN [MI]|TAMSULOSIN [HSDB]|TAMSULOSIN [VANDF]|5-[2-[2-(2-ethoxyphenoxy)ethylamino]propyl]-2-methoxy-benzenesulfonamide|TAMSULOSIN [WHO-DD]|SCHEMBL34378|GTPL488|MLS006011810|BIDD:GT0261|orb1710739|SCHEMBL29363851|SCHEMBL29566149|SCHEMBL29588704|HY-B0661R|HMS2090P15|HMS3884M15|HY-B0661|BDBM50060964|s1435|STK626950|AKOS005266643|CCG-268745|DB00706|5-{(2R)-2-[(2-{[2-(ethyloxy)phenyl]oxy}ethyl)amino]propyl}-2-(methyloxy)benzenesulfonamide|NCGC00167442-02|NCGC00167442-08|AS-82157|SMR004703489|(-)-YM617|NS00001206|C07124|D08560|F15143|SBI-0653937.0001|AB01275521-01|EN300-7417041|133T204|A835382|Q418480|SR-05000001519|SR-05000001519-1|BRD-K74339692-001-01-9|(-)-(R)-5-(2-((2-(O-ETHOXYPHENOXY)ETHYL)AMINO)PROPYL)-2-METHOXYBENZENESULFONAMIDE|(r)-5-[2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxy-benzenesulfonamide|5-[(2R)-2-[[2-(2-ethoxyphenoxy)ethyl]amino]propyl]-2-methoxybenzene-sulfonamide"
BENAZEPRIL,5362124,,"InChI=1S/C24H28N2O5/c1-2-31-24(30)20(14-12-17-8-4-3-5-9-17)25-19-15-13-18-10-6-7-11-21(18)26(23(19)29)16-22(27)28/h3-11,19-20,25H,2,12-16H2,1H3,(H,27,28)/t19-,20-/m0/s1",XPCFTKFZXHTYIP-PMACEKPBSA-N,C24H28N2O5,424.5,"2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid","benazepril|86541-75-5|Benazeprilum|Benazeprilum [Latin]|Benazepril Sandoz|Briem|Forteekor|Cibacen ws|CGS-14824A|UDM7Q7QWP8|2-[(3S)-3-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid|CHEBI:3011|C09AA07|1H-1-Benzazepine-1-acetic acid, 3-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (S-(R*,R*))-|DTXSID5022645|Benazeprilum (Latin)|benazapril|benzazepril|2-[(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid|2-((3S)-3-(((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)acetic acid|2-((3S)-3-(((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl)acetic acid|RefChem:54434|DTXCID602645|Cibacene|Benazepril (INN)|Benazepril Free base|MFCD00864466|CHEMBL838|109010-10-8|2-((S)-3-(((S)-1-Ethoxy-1-oxo-4-phenylbutan-2-yl)amino)-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)acetic acid|BENAZEPRIL [INN]|Benazepril, (+/-)-|Benazepril [INN:BAN]|[(3S)-3-{[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid|1H-1-Benzazepine-1-acetic acid, 3-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (3S)-|CGS-14824-A|[(3S)-3-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid|PX47FSF9B3|Benazepril impurity A|Benazepril Sandoz (TN)|UNII-UDM7Q7QWP8|Forteekor [veterinary] (TN)|Benazepril (Standard)|Spectrum_001922|BENAZEPRIL [MI]|Spectrum2_000482|Spectrum3_001674|Spectrum4_000286|Spectrum5_001546|BENAZEPRIL [VANDF]|BENAZEPRIL [WHO-DD]|SCHEMBL16396|BSPBio_003487|KBioGR_000812|KBioSS_002464|MLS006011854|BIDD:GT0800|SPBio_000343|GTPL6374|orb1705329|SCHEMBL29382644|HSDB 7081|HY-B0093R|KBio2_002457|KBio2_005025|KBio2_007593|KBio3_002707|(3S)-3-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic Acid|BCP12672|HY-B0093|BBL034011|BDBM50021153|s5938|STK627447|AKOS005560204|CS-1795|DB00542|BENAZEPRIL [EMA EPAR VETERINARY]|NCGC00165740-01|NCGC00165740-02|NCGC00165740-03|NCGC00165740-04|[(3S)-3-({(1S)-1-[(ethyloxy)carbonyl]-3-phenylpropyl}amino)-2-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl]acetic acid|2-[(3S)-3-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]-2-oxo-4,5-dihydro-3H-1-benzazepin-1-yl]acetic acid|86499-21-0|FB171048|SMR000857173|SY028603|SBI-0206744.P001|NS00010378|C06843|D07499|AB00698518-07|AB00698518_08|AB00698518_09|EN300-6481298|541B744|Q592802|BRD-K49807096-003-02-3|BRD-K49807096-003-14-8|BRD-K49807096-003-15-5|BRD-K49807096-003-16-3|Tert butyl-3-(3S)amino-2,3,4,5-tetrahydro-1h(1)benzazepin-2-one-1-acetate|1H-1-Benzazepine-1-acetic acid, 3-[[(1R)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (3R)-rel-|1H-1-Benzazepine-1-acetic acid, 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (R*,R*)-|1H-1-Benzazepine-1-acetic acid, 3-[[1-(ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-, (R*,R*)-(+/-)-|2-[(S)-3-[[(S)-1-Ethoxy-1-oxo-4-phenyl-2-butanyl]amino]-2-oxo-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl]acetic Acid|rel-(3R)-3-[[(1R)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-2,3,4,5-tetrahydro-2-oxo-1H-1-benzazepine-1-acetic acid"
RAMIPRIL,5362129,,"InChI=1S/C23H32N2O5/c1-3-30-23(29)18(13-12-16-8-5-4-6-9-16)24-15(2)21(26)25-19-11-7-10-17(19)14-20(25)22(27)28/h4-6,8-9,15,17-20,24H,3,7,10-14H2,1-2H3,(H,27,28)/t15-,17-,18-,19-,20-/m0/s1",HDACQVRGBOVJII-JBDAPHQKSA-N,C23H32N2O5,416.5,"(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid","ramipril|87333-19-5|Tritace|Altace|Triatec|Ramace|Delix|Vesdil|Cardace|Acovil|Pramace|Hoe-498|Ramiprilum|Unipril|Ramiprilum [Latin]|HOE 498|Corpril|Ramipres|Ecator|Hopace|HOE498|DTXSID8023551|L35JN3I7SJ|NSC-758933|CHEBI:8774|C09AA05|DTXCID203551|(2S,3aS,6aS)-1-((S)-N-((S)-1-Carboxy-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid, 1-ethyl ester|(2S,3aS,6aS)-1-((S)-N-((S)-1-Ethoxycarbonyl-3-phenylpropyl)alanyl)octahydrocyclopenta(b)pyrrol-2-carbonsaeure|Ramiprilum (Latin)|(2S-(1(R*(R*)),2alpha,3abeta,6abeta))-1-(2-((1-(Ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydrocyclopenta(b)pyrrole-2-carboxylic acid|Cyclopenta(b)pyrrole-2-carboxylic acid, 1-(2-((1-(ethoxycarbonyl)-3-phenylpropyl)amino)-1-oxopropyl)octahydro-, (2S-(1(R*(R*)),2alpha,3abeta,6abeta))-|Zabien|(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]-octahydrocyclopenta[b]pyrrole-2-carboxylic acid|CYCLOPENTA(B)PYRROLE-2-CARBOXYLIC ACID, 1-((2S)-2-(((1S)-1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)AMINO)-1-OXOPROPYL)OCTAHYDRO-, (2S,3AS,6AS)-|Cyclopenta[b]pyrrole-2-carboxylic acid, 1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-, (2S,3aS,6aS)-|Lopace|Ranace|(2S,3aS,6aS)-1-((2S)-2-(((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta(d)pyrrole-2-carboxylic acid|(2S,3aS,6aS)-1-((2S)-2-(((2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)-octahydrocyclopenta(b)pyrrole-2-carboxylic acid|(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[d]pyrrole-2-carboxylic acid|(2S,3aS,6aS)-1-[(S)-N-[(S)-1-Carboxy-3-phenylpropyl]alanyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid, 1-ethyl ester|RefChem:56358|642-904-3|Carasel|Quark|MFCD00865775|Altace (TN)|Lostapres|Hytren|(2S,3aS,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid|CHEMBL1168|C23H32N2O5|(2S,3aS,6aS)-1-((S)-2-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)amino)propanoyl)octahydrocyclopenta[b]pyrrole-2-carboxylic acid|Ramipro|Naprix|(2S,3As,6aS)-1-[(2S)-2-[[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]azaniumyl]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylate|Ramipril (Altace)|Ramipril (1.0 mg/mL in Methanol)|(2S,3AS,6AS)-1((S)-N-((S)-1-CARBOXY-3-PHENYLPROPYL)ALANYL)OCTAHYDROCYCLOPENTA(B)PYRROLE-2-CARBOXYLIC ACID 1-ETHYL ESTER|(2S,3aS,6aS)-1-[(2S)-2-{[(2S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid (non-preferred name)|SMR000466386|Ramipril (USP/INN)|SR-05000001908|UNII-L35JN3I7SJ|Ramipril [USAN:USP:INN:BAN]|NCGC00016955-01|CAS-87333-19-5|Ramipril (Standard)|VOSTALLY|Spectrum_001958|RAMIPRIL [USAN]|RAMIPRIL [INN]|RAMIPRIL [JAN]|RAMIPRIL [MI]|RAMIPRIL [VANDF]|Spectrum3_001794|Spectrum4_001269|Spectrum5_001721|RAMIPRIL [MART.]|RAMIPRIL [USP-RS]|RAMIPRIL [WHO-DD]|SCHEMBL16059|BSPBio_003347|KBioGR_001858|KBioSS_002512|RAMIPRIL, (+)-|MLS000759523|MLS001216547|MLS001423965|N-(1S-carboethoxy-3-phenylpropyl)-S-alanyl-cis,endo-2-azabicyclo[3.3.0]octane-3S-carboxylic Acid|Ramipril - Bio-X trade mark|BIDD:GT0803|SPECTRUM1505214|RAMIPRIL [ORANGE BOOK]|GTPL6339|orb1307911|RAMIPRIL [EP MONOGRAPH]|Ramipril, >=98% (HPLC)|RAMIPRIL [USP MONOGRAPH]|HSDB 8393|HY-B0279R|KBio2_002504|KBio2_005072|KBio2_007640|KBio3_002849|NPD2431|HMS2051E04|HMS2090L11|HMS2093M10|HMS2231M05|HMS3259J07|HMS3715M16|Pharmakon1600-01505214|ALBB-038665|CYCLOPENTA(B)PYRROLE-2-CARBOXYLIC ACID, 1-(2-((1-(ETHOXYCARBONYL)-3-PHENYLPROPYL)AMINO)-1-OXOPROPYL)OCTAHYDRO-, (2S-(1(R*(R*)),2.ALPHA.,3A.BETA.,6A.BETA.))-|HY-B0279|MSK11236|Tox21_110708|BBL033964|BDBM50084681|NSC758933|s1793|STK801937|AKOS005622534|Tox21_110708_1|AC-1347|CCG-100833|DB00178|FC27676|KS-1103|NC00083|NC00627|NSC 758933|NCGC00178127-01|NCGC00178127-02|(2S,3aS,6aS)-1-(((S)-1-ethoxy-1-oxo-4-phenylbutan-2-yl)-L-alanyl)octahydrocyclopenta[b]pyrrole-2-carboxylic acid|(2S,3aS,6aS)-1-((S)-2-((S)-1-ethoxy-1-oxo-4-phenylbutan-2-ylamino)propanoyl) octahydrocyclopenta[b]pyrrole-2-carboxylic acid|(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-(ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydro-cyclopenta[b]pyrrole-2-carboxylic acid|(2S,3aS,6aS)-1-[(2S)-2-[[(1S)-1-ethoxycarbonyl-3-phenyl-propyl]amino]propanoyl]-3,3a,4,5,6,6a-hexahydro-2H-cyclopenta[b]pyrrole-2-carboxylic acid|(2S,3aS,6aS)-1-[(2S)-2-{[(1S)-1-ethoxycarbonyl-3-phenylpropyl]amino}propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid|[2S,3aS,6aS]-1-[(2S)-2-[[(1S)-1-(Ethoxycarbonyl)-3-phenylpropyl]amino]-1-oxopropyl]octahydrocyclopenta[b]pyrrole-2-carboxylic acid|BR164319|SY031735|SBI-0206728.P001|B2208|NS00004700|R0219|D00421|EN300-118695|AB00698339-07|AB00698339-08|AB00698339_09|AB00698339_10|333R195|Q412666|SR-05000001908-1|SR-05000001908-2|BRD-K89348303-001-14-7|Ramipril, British Pharmacopoeia (BP) Reference Standard|Ramipril, European Pharmacopoeia (EP) Reference Standard|Z1515381509|Ramipril, United States Pharmacopeia (USP) Reference Standard|Ramipril, Pharmaceutical Secondary Standard; Certified Reference Material|(2S,3aS,6aS)-1-[(S)-2-[[(S)-1-Ethoxy-1-oxo-4-phenyl-2-butyl]amino]propanoyl]octahydrocyclopenta[b]pyrrole-2-carboxylic Acid|1-[2-(1-Ethoxycarbonyl-3-phenyl-propylamino)-propionyl]-octahydro-cyclopenta[b]pyrrole-2-carboxylic acid(Ramipril)|1-[2-(1-ethoxycarbonyl-3-phenylpropylamino)propionyl]octahydrocyclopenta[b]- pyrrole-2-carboxylic acid|1028843-43-7"
LISINOPRIL ANHYDROUS,5362119,,"InChI=1S/C21H31N3O5/c22-13-5-4-9-16(19(25)24-14-6-10-18(24)21(28)29)23-17(20(26)27)12-11-15-7-2-1-3-8-15/h1-3,7-8,16-18,23H,4-6,9-14,22H2,(H,26,27)(H,28,29)/t16-,17-,18-/m0/s1",RLAWWYSOJDYHDC-BZSNNMDCSA-N,C21H31N3O5,405.5,(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid,"lisinopril|76547-98-3|Prinivil|Zestril|Lisinopril anhydrous|Lysinopril|Carace|Novatec|Lisinoprilum|Lisinoprilum [Latin]|Qbrelis|7Q3P4BS2FD|MK-521|[N2-[(S)-1-CARBOXY-3-PHENYLPROPYL]-L-LYSYL-L-PROLINE|CHEBI:43755|N-(1(S)-Carboxy-3-phenylpropyl)-L-lysyl-L-proline|N2-((S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline|(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid|L-Proline, N2-((1S)-1-carboxy-3-phenylpropyl)-L-lysyl-|DTXSID6040537|(S)-1-(N(2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Lisinoprilum (Latin)|L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)-|NSC-751176|NSC-758151|(2S)-1-[(2S)-6-amino-2-[[(2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid|L-PROLINE, 1-(N(SUP 2)-(1-CARBOXY-3-PHENYLPROPYL)-L-LYSYL)-|1-(N(SUP 2)-((S)-1-CARBOXY-3-PHENYLPROPYL)-L-LYSYL)-L-PROLINE|(N2-((S)-1-carboxy-3-phenylpropyl)-L-lysyl-L-proline|L-Proline, N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-|Lisinoril|Lisopress|(2S)-1-((2S)-6-amino-2-(((1S)-1-carboxy-3-phenylpropyl)amino)hexanoyl)pyrrolidine-2-carboxylic acid|(2S)-1-((2S)-6-amino-2-(((2S)-1-hydroxy-1-oxo-4-phenylbutan-2-yl)amino)hexanoyl)pyrrolidine-2-carboxylic acid|(2S)-1-[(2S)-6-amino-2-{[(1S)-1-carboxy-3-phenylpropyl]amino}hexanoyl]pyrrolidine-2-carboxylic acid|L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-|RefChem:5952|L-Proline, 1-(N(sup 2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-, dihydrate, (S)-|DTXCID4020537|C09AA03|N2-((1S)-1-Carboxy-3-phenylpropyl)-L-lysyl-L-proline, Dihydrate|278-488-1|E7199S1YWR|Ranolip|Linopril|Tensopril|Acercomp|Inhibril|Lisipril|Noperten|Presiten|Sinopril|Acerbon|Vivatec|83915-83-7|Coric|Alapril|Inopril|Lisinal|Lisoril|Lispril|Sinopryl|Cipral|Linvas|Lipril|Loril|Prinil|Tensyn|Tersif|Longes|Hipril|Lisinopril (INN)|Lisinopril [INN]|N2-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline|(S)-1-((S)-6-Amino-2-(((S)-1-carboxy-3-phenylpropyl)amino)hexanoyl)pyrrolidine-2-carboxylic acid|Zestril (TN)|C21H31N3O5|LPR|(S)-1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Nanopril|CHEMBL1237|(S)-Lisinopril Dihydrate|Lizinopril|Diroton|Lisitec|Lisopril|Listril|Lizonoton|Optimon|Prinvil|Skopryl|Vitopril|Amicor|Doneka|Irumed|Laaven|MLS002154258|MK 521|MK 522|SMR000544473|CCRIS 3568|SMR001233519|EINECS 278-488-1|UNII-7Q3P4BS2FD|BRN 4276619|L-Proline, 1-(N2-(1-carboxy-3-phenylpropyl)-L-lysyl)-|lysinopryl|(S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline|HSDB 6852|(S)-1-(N(sup 2)-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|MFCD00214086|(S)-1-[N2-(1-carboxy-3-phenylpropyl)-L-lysyl]-L-proline dihydrate|Lisinopril (Zestril)|1-(N2-(1-Carboxy-3-phenylpropyl)-L-lysyl)-L-proline|Spectrum_000497|LISINOPRIL [MI]|1-[Nalpha-[(S)-1-Carboxy-3-phenylpropyl]-L-lysyl]-L-proline|(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;hydrate|Prestwick0_000301|Prestwick1_000301|Prestwick2_000301|Prestwick3_000301|Spectrum2_001456|Spectrum3_000941|Spectrum4_001040|Spectrum5_000995|LISINOPRIL [WHO-DD]|SCHEMBL15680|BSPBio_000262|KBioGR_001599|KBioSS_000977|MLS001306436|MLS001306481|BIDD:GT0755|DivK1c_001037|SPECTRUM1501217|SPBio_001351|SPBio_002481|BPBio1_000290|GTPL6360|ICI-209K|orb1306371|BDBM66979|HMS503O15|KBio1_001037|KBio2_000977|KBio2_003545|KBio2_006113|KBio3_002002|N(2)-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline|cid_22887897|NINDS_001037|HMS1921B14|HMS2090O14|HMS2092L21|HMS2850N20|Pharmakon1600-01501217|BDBM50367879|CCG-39190|DL-434|NSC751176|NSC758151|s2076|AKOS015836369|AKOS015894970|L-Proline, 1-(N(sup 2)-(1-carboxy-3-phenylpropyl)-L-lysyl)-, (S)-|BCP9000856|DB00722|IDI1_001037|NCGC00179623-01|NCGC00179623-07|(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]pyrrolidine-2-carboxylic acid|HY-18206|SBI-0051692.P002|L0220|NS00009977|C76449|D08131|AB00052250-13|AB00052250_14|AB00052250_15|547L983|Q412208|SR-05000001786|SR-05000001786-1|BRD-K67966701-001-10-8|BRD-K67966701-001-11-6|BRD-K67966701-001-12-4|BRD-K67966701-335-03-5|Z1515376765|N-[N2 (1(S)-carboxy-3-phenylpropyl)-L-lysyl]-L-proline|N-[N2 -(1(S)-carboxy-3-phenylpropyl)-L-lysyl]-L-proline|N~2~-[(1S)-1-carboxy-3-phenylpropyl]-L-lysyl-L-proline|(S)-1-[N2-(1-Carboxy-3-phenylpropyl)-lysyl-proline dihydrate|(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenyl-propyl]amino]hexanoyl]proline;hydrate|(2S)-1-[(2S)-6-amino-2-[[(1S)-1-carboxy-3-phenylpropyl]amino]-1-oxohexyl]-2-pyrrolidinecarboxylic acid;hydrate|(2S)-1-[(2S)-6-azanyl-2-[[(2S)-1-oxidanyl-1-oxidanylidene-4-phenyl-butan-2-yl]amino]hexanoyl]pyrrolidine-2-carboxylic acid;hydrate"
DASATINIB,3062316,,"InChI=1S/C22H26ClN7O2S/c1-14-4-3-5-16(23)20(14)28-21(32)17-13-24-22(33-17)27-18-12-19(26-15(2)25-18)30-8-6-29(7-9-30)10-11-31/h3-5,12-13,31H,6-11H2,1-2H3,(H,28,32)(H,24,25,26,27)",ZBNZXTGUTAYRHI-UHFFFAOYSA-N,C22H26ClN7O2S,488.0,"N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide","Dasatinib|302962-49-8|Sprycel|BMS-354825|Dasatinib anhydrous|BMS 354825|BMS354825|Dasatinib (anhydrous)|dasatinibum|N-(2-CHLORO-6-METHYLPHENYL)-2-({6-[4-(2-HYDROXYETHYL)PIPERAZIN-1-YL]-2-METHYLPYRIMIDIN-4-YL}AMINO)-1,3-THIAZOLE-5-CARBOXAMIDE|anh. dasatinib|anhydrous dasatinib|dasatinib (anh.)|N-(2-chloro-6-methylphenyl)-2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)thiazole-5-carboxamide|N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methylpyrimidin-4-yl]amino]-1,3-thiazole-5-carboxamide|BMS Dasatinib|X78UG0A0RN|DTXSID4040979|CHEBI:49375|NSC732517|NSC-759877|5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-|DTXCID2020979|BMS-354825 HYDRATE|5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-|BMS-354825-03|n-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)-1,3-thiazole-5-carboxamide|JLTN compound|PHYRAGO|354825, BMS|RefChem:5732|L01XE06|801-607-0|5-Thiazolecarboxamide, N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)-1-piperazinyl)-2-methyl-4-pyrimidinyl)amino)-, Monohydrate|N-(2-Chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide hydrate|RBZ1571X5H|Dasatinib (BMS-354825)|N-(2-chloro-6-methylphenyl)-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-yl)amino)thiazole-5-carboxamide|C22H26ClN7O2S|MFCD11046566|CHEMBL1421|NSC-732517|NCGC00181129-01|N-(2-chloro-6-methyl-phenyl)-2-[[6-[4-(2-hydroxyethyl)piperazin-1-yl]-2-methyl-pyrimidin-4-yl]amino]thiazole-5-carboxamide|SMR002529551|CAS-302962-49-8|302962-49-8 pound not863127-77-9|Dasatinib [USAN:INN]|UNII-X78UG0A0RN|1N1|Dasatinib (Standard)|Kinome_3650|Dasatinib (JAN/INN)|DASATINIB [INN]|DASATINIB [MI]|Sprycel (Bristol Meyers)|DASATINIB [WHO-DD]|SCHEMBL8226|Dasatinib,BMS-354825|MLS003915609|MLS004774145|MLS006010904|Dasatinib - Bio-X trade mark|GTPL5678|orb1308592|SCHEMBL3301361|SCHEMBL29381185|BDBM13216|cid_3062316|Dasatinib (BMS-354825)?|EX-A401|5-Thiazolecarboxamide, monohydrate|BCPP000263|HMS2043N05|HMS3244A05|HMS3244A06|HMS3244B05|HMS3265C19|HMS3265C20|HMS3265D19|HMS3265D20|HMS3654K05|HMS3744C11|HMS5079O03|Pharmakon1600-01502275|BCP01797|Tox21_112736|HY-10181R|NSC759877|NSC800087|s1021|AKOS015902363|Tox21_112736_1|BCP9000589|BMS 345825|CCG-264779|CS-0100|DB01254|FC36515|GS-6548|NSC-800087|SB17284|SDCCGSBI-0061713.P004|NCGC00181129-02|NCGC00181129-03|NCGC00181129-05|NCGC00181129-06|NCGC00181129-07|NCGC00181129-12|NCGC00181129-14|NCGC00181129-22|NCGC00481571-01|2-(6-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-4-ylamino)-N-(2-chloro-6-methylphenyl)thiazole-5-carboxamide|AC-22749|BCB03_000715|BD300052|BMS 35482513|HY-10181|D5949|NS00001968|PA-3062316|SW208076-5|D-3307|D03658|EN300-123025|AB01273956-01|AB01273956-02|AB01273956_03|AR-270/43507994|F050286|Q419940|SR-00000000554|SR-00000000554-5|BRD-K49328571-001-05-1|BRD-K49328571-001-07-7|BRD-K49328571-001-15-0|BRD-K49328571-001-19-2|Z1546610486|2-{6-[4-(2-Hydroxy-ethyl)-piperazin-1-yl]-2-methyl-pyrimidin-4-ylamino}-thiazole|N-(2-chloro-6-methylphenyl)-2-({6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl}amino)-1,3-thiazole-5-carboxamide|N-(2-Chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl)]-2-methyl-4-pyrimidinyl]amino)]-1,3-thiazole-5-carboxamide"
ESREBOXETINE,65856,,"InChI=1S/C19H23NO3/c1-2-21-16-10-6-7-11-17(16)23-19(15-8-4-3-5-9-15)18-14-20-12-13-22-18/h3-11,18-20H,2,12-14H2,1H3/t18-,19-/m0/s1",CBQGYUDMJHNJBX-OALUTQOASA-N,C19H23NO3,313.4,(2S)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine,"Esreboxetine|(S,S)-reboxetine|98819-76-2|S,S-reboxetine|Esreboxetina|L8S50ZY490|(S,S)-(+)-Reboxetine|(+)-(2S)-2-((S)-(2-Ethoxyphenoxy)phenylmethyl)morpholine|DTXSID601009938|(S,S)-RBX|[S,S]-RBX|esreboxetinum|RefChem:591145|DTXCID601436369|Esreboxetine [USAN:INN]|(2S)-2-[(S)-(2-ethoxyphenoxy)-phenylmethyl]morpholine|UNII-L8S50ZY490|PNU 165442g|Morpholine, 2-((S)-(2-ethoxyphenoxy)phenylmethyl)-, (2S)-|S-Reboxetine|(S)-2-((S)-(2-ethoxyphenoxy)(phenyl)methyl)morpholine|Esreboxetine [USAN]|98769-81-4|Esreboxetine (USAN/INN)|Tocris-1982|SS-RBX|NCGC00025335-01|ESREBOXETINE [INN]|A1D9Y|SCHEMBL34534|ESREBOXETINE [WHO-DD]|CHEMBL180101|GTPL4808|orb1697285|SCHEMBL29360893|BDBM35226|(2S)-2-[(S)-(2-ethoxyphenoxy)-phenyl-methyl]morpholine|CHEBI:125535|AKOS027393802|DB12395|CS-0003563|NS00009174|D09340|819S762|Q5399299|BRD-K32814891-001-01-1"
ESCITALOPRAM,146570,,"InChI=1S/C20H21FN2O/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20/h4-9,12H,3,10-11,14H2,1-2H3/t20-/m0/s1",WSEQXVZVJXJVFP-FQEVSTJZSA-N,C20H21FN2O,324.4,(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile,"Escitalopram|128196-01-0|(S)-Citalopram|S(+)-Citalopram|S-(+)-Citalopram|(+)-Citalopram|Esertia|Seroplex|Cipralex|Esitol|escitalopramum|(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile|4O4S742ANY|5-Isobenzofurancarbonitrile, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-|CHEBI:36791|(+)-(S)-1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile|LU-26-054|DTXSID8048440|5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-|(1S)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile|RefChem:5803|DTXCID4028414|N06AB10|Escitalopram [INN]|Escitalopram (INN)|CHEMBL1508|(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile|(s)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile|(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile|Esertia (TN)|Escitalopram [INN:BAN]|UNII-4O4S742ANY|68P|PS28 - Escitalopram|Spectrum_001401|Tocris-1427|Spectrum2_000551|Spectrum3_001062|Spectrum4_001212|Spectrum5_001693|ESCITALOPRAM [MI]|Lopac-C-7861|ESCITALOPRAM [VANDF]|BIDD:PXR0135|SCHEMBL34948|BSPBio_002644|KBioGR_001644|KBioSS_001881|ESCITALOPRAM [WHO-DD]|SPBio_000621|(S)-(+)-CITALOPRAM|GTPL7177|orb1745294|SCHEMBL29358316|HSDB 8410|KBio2_001881|KBio2_004449|KBio2_007017|KBio3_001864|WSEQXVZVJXJVFP-FQEVSTJZSA-N|HMS2089O08|ESCITALOPRAM [EP MONOGRAPH]|(S)-Citalopram;S-(+)-Citalopram|BCP12154|BDBM50302225|MFCD09817397|AKOS017343470|MSK11176-100A|AC-1594|AC-4508|CS-2053|DB01175|SB17453|MRF-0000226|NCGC00015267-01|NCGC00015267-02|NCGC00015267-03|NCGC00015267-06|NCGC00025160-01|NCGC00178555-01|NCGC00178555-07|NCGC00178555-14|DA-63281|FE102240|HY-14258|B1183|NS00068032|D07913|I10299|AB00698374-07|AB00698374-09|AB00698374_10|Escitalopram Solution in Acetonitrile, 100ug/mL|EN300-18530974|Q423757|BRD-K70301876-034-02-0|BRD-K70301876-034-13-7|BRD-K70301876-034-14-5|(s)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5 carbonitrile|S-(+)-1-(3-(DIMETHYLAMINO)PROPYL)-1-(P-FLUOROPHENYL)-5-PHTHALANCARBONITRILE|(S)-(+)-1-[3-(dimethylamino) propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile|(S)-(+)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofuran carbonitrile|S-(+)-5-ISOBENZOFURANCARBONITRILE, 1-(3-(DIMETHYLAMINO)PROPYL)-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-"
FRESELESTAT,216294,,"InChI=1S/C23H28N6O4/c1-13(2)17(18(31)20-27-28-22(33-20)23(3,4)5)26-16(30)12-29-19(14-9-7-6-8-10-14)25-11-15(24)21(29)32/h6-11,13,17H,12,24H2,1-5H3,(H,26,30)",YSIHYROEMJSOAS-UHFFFAOYSA-N,C23H28N6O4,452.5,"2-(5-amino-6-oxo-2-phenylpyrimidin-1-yl)-N-[1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-3-methyl-1-oxobutan-2-yl]acetamide","Freselestat|208848-19-5|Freselestat [INN]|1CW4RL23VP|UNII-1CW4RL23VP|ONO-PO 736|1(6H)-Pyrimidineacetamide, 5-amino-N-[1-[[5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2-yl]carbonyl]-2-methylpropyl]-6-oxo-2-phenyl-|2-(5-Amino-6-oxo-2-phenylpyrimidin-1(6H)-yl)-N-((1RS)-1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-3-methyl-1-oxobutan-2-yl)acetamide|1(6H)-Pyrimidineacetamide, 5-amino-N-(1-((5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2-yl)carbonyl)-2-methylpropyl)-6-oxo-2-phenyl-|freselestatum|2-(5-amino-6-oxo-2-phenyl-1,6-dihydropyrimidin-1-yl)-N-((1R,2R)-1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-1-hydroxy-3-methylbutan-2-yl)acetamide|2-(5-amino-6-oxo-2-phenyl-1,6-dihydropyrimidin-1-yl)-N-[(1R,2R)-1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-1-hydroxy-3-methylbutan-2-yl]acetamide|RefChem:141534|ONO-6818|Ono 6818|2-(5-amino-6-oxo-2-phenylpyrimidin-1-yl)-N-[1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-3-methyl-1-oxobutan-2-yl]acetamide|CHEMBL25892|ONO-6818;ONO-PO-736;ONO6818;ONO 6818|2-(5-Amino-6-oxo-2-phenylpyrimidin-1(6H)-yl)-N-(1-(5-(tert-butyl)-1,3,4-oxadiazol-2-yl)-3-methyl-1-oxobutan-2-yl)acetamide|5-Amino-N-[1-[[5-(1,1-dimethylethyl)-1,3,4-oxadiazol-2-yl]carbonyl]-2-methylpropyl]-6-oxo-2-phenyl-1(6H)-pyrimidineacetamide; ONO 6818; ONO-PO 736|Ono6818|orb1697142|SCHEMBL6748609|DTXSID50943150|YSIHYROEMJSOAS-UHFFFAOYSA-N|GLXC-07195|2-(5-Amino-6-oxo-2-phenyl-6H-pyrimidin-1-yl)-N-[1-(5-tert-butyl-[1,3,4]oxadiazole-2-carbonyl)-2-methyl-propyl]-acetamide|BDBM50095522|AKOS027338660|DA-76432|HY-15652|CS-0007925|(RS)-N-[1-(5-tert-Butyl-1,3,4-oxadiazol-2-ylcarbonyl)-2-methylpropyl]-2-(6-oxo-2-phenyl-5-amino-1,6-dihydropyrimidin-1-yl)acetamide|2-(5-amino-6-oxo-2-phenyl-1,6-dihydropyrimidin-1-yl)-N-[1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-3-methyl-1-oxobutan-2-yl]acetamide|2-(5-amino-6-oxo-2-phenylpyrimidin-1(6H)-yl)-N-(1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-3-methyl-1-oxobutan-2-yl)acetamide|2-(5-Amino-6-oxo-2-phenylpyrimidin-1(6H)-yl)-N-[1-(5-tert-butyl-1,3,4-oxadiazol-2-yl)-3-methyl-1-oxobutan-2-yl]ethanimidic acid"
RETOSIBAN,11340891,,"InChI=1S/C27H34N4O5/c1-4-16(2)23-25(32)29-22(20-13-18-7-5-6-8-19(18)14-20)26(33)31(23)24(21-15-36-17(3)28-21)27(34)30-9-11-35-12-10-30/h5-8,15-16,20,22-24H,4,9-14H2,1-3H3,(H,29,32)/t16-,22+,23+,24+/m0/s1",PLVGDGRBPMVYPB-FDUHJNRSSA-N,C27H34N4O5,494.6,"(3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxoethyl]piperazine-2,5-dione","Retosiban|820957-38-8|GSK221149A|GSK-221149A|GSK221149|GIE06H28OX|GSK 221149A|GSK-221149|(3R,6R)-6-[(2S)-butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxoethyl]piperazine-2,5-dione|DTXSID00231559|retosibanum|(3R,6R)-6-((2S)-BUTAN-2-YL)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-1-((1R)-1-(2-METHYL-1,3-OXAZOL-4-YL)-2-(MORPHOLIN-4-YL)-2-OXOETHYL)PIPERAZINE-2,5-DIONE|(3R,6R)-6-((2S)-butan-2-yl)-3-(2,3-dihydro-1H-inden-2-yl)-1-((1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-morpholin-4-yl-2-oxoethyl)piperazine-2,5-dione|(3R,6R)-6-[(2S)-Butan-2-yl]-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl]piperazine-2,5-dione|RefChem:879490|DTXCID80154050|(3R,6R)-3-(2,3-Dihydro-1H-inden-2-yl)-1-((1R)-1-(2-methyl-4-oxazolyl)-2-(4-morpholinyl)-2-oxoethyl)-6-((1S)-1-methylpropyl)-2,5-piperazinedione|Retosiban [USAN:INN]|UNII-GIE06H28OX|Retosiban [USAN]|CHEMBL429736|Retosiban (USAN)|(3R,6R)-6-((2S)-Butan-2-yl)-3-(2,3-dihydro-1H-inden-2-yl)-1-((1R)-1-(2-methyl- 1,3-oxazol-4-yl)-2-(morpholin-4-yl)-2-oxoethyl)piperazine-2,5-dione|Morpholine, 4-((2R)-((3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-6-((1S)-1- methylpropyl)-2,5-dioxo-1-piperazinyl)(2-methyl-4-oxazolyl)acetyl)-|GSK 221149; GSK 221149A|RETOSIBAN [INN]|SCHEMBL230301|GTPL8403|orb1706726|SCHEMBL29376892|CHEBI:188651|PLVGDGRBPMVYPB-FDUHJNRSSA-N|BDBM50372608|EX-A12369|MFCD19443707|AKOS040742542|GSK-221,149-A|DB11818|DA-67173|HY-14778|MS-29186|CS-0003555|NS00070346|D08986|G14036|Q7316883|(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2,5-piperazinedione|(3R,6R)-3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-1,3-oxazol-4-yl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-2.5-piperazinedione|(3R,6R)-3-indan-2-yl-1-[(1R)-1-(2-methyloxazol-4-yl)-2-morpholino-2-oxo-ethyl]-6-[(1S)-1-methylpropyl]piperazine-2,5-dione|2,5-Piperazinedione, 3-(2,3-dihydro-1H-inden-2-yl)-1-[(1R)-1-(2-methyl-4-oxazolyl)-2-(4-morpholinyl)-2-oxoethyl]-6-[(1S)-1-methylpropyl]-, (3R,6R)-|MORPHOLINE, 4-((2R)-2-((3R,6R)-3-(2,3-DIHYDRO-1H-INDEN-2-YL)-6-((1S)-1-METHYLPROPYL)-2,5-DIOXO-1-PIPERAZINYL)-2-(2-METHYL-4-OXAZOLYL)ACETYL)-"
LAMOTRIGINE,3878,,"InChI=1S/C9H7Cl2N5/c10-5-3-1-2-4(6(5)11)7-8(12)14-9(13)16-15-7/h1-3H,(H4,12,13,14,16)",PYZRQGJRPPTADH-UHFFFAOYSA-N,C9H7Cl2N5,256.09,"6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine","lamotrigine|84057-84-1|6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine|Lamictal|Lamictal Cd|Lamotrigina|Lamictal XR|Lamotriginum|BW 430C|BW-430C|Lamictal ODT|3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine|1,2,4-Triazine-3,5-diamine, 6-(2,3-dichlorophenyl)-|3,5-Diamino-6-(2,3-dichlorophenyl)-as-triazine|BW430C|DTXSID2023195|NSC-759171|CHEBI:6367|GW 273293|U3H27498KS|DTXCID203195|Lamotirigine|Lamotrigine ER|LAMOTRIGINE Kit|SUBVENITE|RefChem:5936|lamotrigine extended-release|Lamotrigine Extended Release|lamotrigine chewable dispersible|N03AX09|281-901-8|658-035-8|Lamotriginum [Latin]|Lamotrigina [Spanish]|Labileno|Lamitor|MFCD00865333|C9H7Cl2N5|LTG;BW430C|CHEMBL741|MLS000069685|NCGC00015605-06|SMR000058464|6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine|(6M)-6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine|Lamictal (TN)|CAS-84057-84-1|SR-01000000187|EINECS 281-901-8|Epilepax|UNII-U3H27498KS|HSDB 7526|EUR-1048|IYJ|Lamotrigine [USAN:USP:INN:BAN]|GI 267119X|Opera_ID_12|Lamotrigine (Standard)|Tocris-1611|LAMOTRIGINE [MI]|LAMOTRIGINE [INN]|LAMOTRIGINE [JAN]|Lopac-L-3791|LAMOTRIGINE [HSDB]|LAMOTRIGINE [USAN]|L 3791|LAMOTRIGINE [MART.]|Lopac0_000688|SCHEMBL35439|LAMOTRIGINE [USP-RS]|LAMOTRIGINE [WHO-DD]|MLS000759486|MLS001077325|MLS001423991|BIDD:GT0794|Lamotrigine (JAN/USP/INN)|Lamotrigine, >=98%, powder|GTPL2622|orb1310392|Lamotrigine, 1mg/ml in Ethanol|Lamotrigine - Bio-X trade mark|SCHEMBL29360953|SCHEMBL29801510|HY-B0495R|LAMOTRIGINE [EP IMPURITY]|LAMOTRIGINE [ORANGE BOOK]|GLXC-07355|HMS2051C10|HMS2089M08|HMS2093P21|HMS2230L04|HMS3262I17|HMS3268G17|HMS3371O16|HMS3393C10|HMS3657A17|HMS3715H21|HMS3885M03|HMS5081I06|LAMOTRIGINE [EP MONOGRAPH]|LAMOTRIGINE [USP IMPURITY]|Pharmakon1600-01505610|LAMOTRIGINE [USP MONOGRAPH]|BCP12156|HY-B0495|Lamotrigine 1.0 mg/ml in Methanol|MSK10267|Tox21_110179|Tox21_500688|BDBM50031299|HB0368|NSC746307|NSC759171|s3024|STK628377|AKOS005561147|Tox21_110179_1|6-(2,2,4-triazine-3,5-diyldiamine|CCG-100856|DB00555|ID58057|KS-1074|LP00688|NC00106|NSC 746307|NSC 759171|NSC-746307|SDCCGSBI-0050666.P003|SMP2_000303|NCGC00015605-01|NCGC00015605-02|NCGC00015605-03|NCGC00015605-04|NCGC00015605-05|NCGC00015605-07|NCGC00015605-08|NCGC00015605-09|NCGC00015605-10|NCGC00015605-23|NCGC00015605-24|NCGC00022936-02|NCGC00022936-04|NCGC00022936-05|NCGC00261373-01|AC-10298|AC-32483|BL166799|Lamotrigine 100 microg/mL in Acetonitrile|SBI-0050666.P002|DB-014839|B2249|EU-0100688|L0241|NS00000354|SW197486-3|57L841|D00354|EN300-120680|W13018|AB00384359-16|AB00384359_17|AB00384359_18|F093440|Q410346|3,5-diamino-(2,3-dichlorophenyl)-1,2,4-triazine|SR-01000000187-2|SR-01000000187-4|SR-01000000187-7|BRD-K93460210-001-22-9|BRD-K93460210-001-23-7|BRD-K93460210-071-01-6|SR-01000000187-10|3,5-diamino-6-(2,3,-dichlorophenyl)-1,2,4-triazine|F2173-0540|Z1532338577|Lamotrigine, British Pharmacopoeia (BP) Reference Standard|Lamotrigine, European Pharmacopoeia (EP) Reference Standard|1,2,4-TRIAZINE-3,5-DIAMINE, 6-(2,3-DICHLOROPHENYL)|6-(2,3-Dichloro-phenyl)-[1,2,4]triazine-3,5-diamine(lamotrigine)|GI 267119X; 6-(2,3-dichlorophenyl)-1,2,4-triazine-3,5-diamine|Lamotrigine, United States Pharmacopeia (USP) Reference Standard|Lamotrigine, Pharmaceutical Secondary Standard; Certified Reference Material|Lamotrigine for peak identification, European Pharmacopoeia (EP) Reference Standard|Lamotrigine for system suitability, European Pharmacopoeia (EP) Reference Standard|6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diamine;3,5-Diamino-6-(2,3-dichlorophenyl)-1,2,4-triazine"
PHENYTOIN,1775,,"InChI=1S/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19)",CXOFVDLJLONNDW-UHFFFAOYSA-N,C15H12N2O2,252.27,"5,5-diphenylimidazolidine-2,4-dione","phenytoin|5,5-DIPHENYLHYDANTOIN|57-41-0|Diphenylhydantoin|5,5-diphenylimidazolidine-2,4-dione|Phenytoine|Zentropil|Lepitoin|Epamin|Dihydantoin|Diphantoin|Diphenylan|Dilabid|Dihycon|Diphedan|Fenitoina|Fenylepsin|Lehydan|Phentytoin|Sodanton|Diphenylhydatanoin|Auranile|Dantinal|Dantoinal|Dantoine|Difetoin|Difhydan|Dilantine|Dillantin|Dintoina|Diphedal|Diphenin|Diphenine|Diphentyn|Ditoinate|Elepsindon|Enkelfel|Epifenyl|Epihydan|Epilantin|Fenytoine|Hidantal|Hidantilo|Hidantina|Hidantomin|Hydantal|Idantoil|Idantoin|Kessodanten|Phanantin|Phanatine|Phenatoine|Phentoin|Ritmenal|Silantin|Sodantoin|Solantin|Sylantoic|Thilophenyl|Zentronal|Danten|Di-Hydan|Dintoin|Epelin|Epinat|Epised|Fentoin|Lepsin|Saceril|Sanepil|Denyl|Eptal|Hidan|Ekko|Ictalis simple|Toin unicelles|Om-Hydantoine|Dantoinal klinos|Di-Phetine|Epdantoine simple|Gerot-epilan-D|Hidantina vitoria|Comitoina|Epilan-D|Neosidantoina|Novantoina|Causoin|Hidantina senosian|Minetoin|Convul|Ekko capsules|Di-Lan|Neos-Hidantoina|Om hidantoina simple|Hydantol|Phenytoinum|TOIN|2,4-Imidazolidinedione, 5,5-diphenyl-|Dilantin-125|5,5-Diphenyl-2,4-imidazolidinedione|Epanutin|Hydantin|Diphentoin|Comital|Solantoin|Solantyl|Eptoin|5,5-Dwufenylohydantoina|Citrullamon|DILANTIN-30|5,5-Diphenylimidazolidin-2,4-dione|5,5-Diphenyl-imidazolidine-2,4-dione|Hydantoin, 5,5-diphenyl-|CHEBI:8107|NCI-C55765|NSC-8722|DTXSID8020541|6158TKW0C5|SM-88 COMPONENT PHENYTOIN|5,5-diphenyltetrahydro-1H-2,4-imidazoledione|DTXCID60541|Fenitoin|Dilantin Infatabs|5,5-di(phenyl)imidazolidine-2,4-dione|Phenytoin Infatabs|RefChem:861853|N03AB02|200-328-6|Epilan|Fenantoin|Dilantin|Aleviatin|Hydantoinal|Difenin|Labopal|Oxylan|Dilantin acid|Phenhydanin|Sinergina|Sodanthon|Iphenylhydantoin|Phenytoin-Gerot|Difenilhidantoina|Fenytoin Dak|Didan TDC 250|Epdantoin Simple|Phenytoin AWD|Epilan D|Diphenat|Hindatal|Fenitoina [INN-Spanish]|Phenytoine [INN-French]|Phenytoinum [INN-Latin]|Difenilhidantoina [Spanish]|Diphenylhydantoine [French]|Fenantoin Mn Pharma|Diphenylhydantoine|Di-Lan (VAN)|Diphenylhydantoin (VAN)|DPH (VAN)|5,5-diphenyl hydantoin|5,5-Diphenylhydantoin (IUPAC)|Phenhydan|5,5-Dwufenylohydantoina [Polish]|CCRIS 515|MFCD00005264|5,5-Diphenylhydantoin (phenytoin)|AI3-52498|Dilantin (TN)|Novophenytoin|MLS000069789|Citrulliamon|Phenitoin|Fenidantoin s|Epasmir 5|NCGC00021139-03|SMR000059026|Fenidantoin ""s""|5,5-DIPHENYLHYDANTOIN-D5 98 ATOM % D|Epasmir ""5""|Didan-tdc-250|CAS-57-41-0|phenytoin (PHN)|5,5-diphenyl-1,3-diazolidine-2,4-dione|component of Mebroin|fenidantoin ''s''|epasmir ''5''|NSC 8722|EINECS 200-328-6|UNII-6158TKW0C5|SR-01000075211|IFLab1_000214|Fenidantoin 's'|HSDB 3160|Episar (Salt/Mix)|Epasmir '5'|Aladdin (Salt/Mix)|Alepsin (Salt/Mix)|Epsolin (Salt/Mix)|Phenytoin (Lepitoin)|Phenytoin (Standard)|Tacosal (Salt/Mix)|Phenytoin [USAN:USP:INN:BAN:JAN]|Antisacer (Salt/Mix)|Epdantoin (Salt/Mix)|Epileptin (Salt/Mix)|Hydantoin,5-diphenyl-|Spectrum_001105|Fenigramon (Salt/Mix)|Citrullamon (Salt/Mix)|Opera_ID_394|PHENYTOIN [INN]|PHENYTOIN [JAN]|2, 5,5-diphenyl-|PHENYTOIN [MI]|CHEMBL16|PHENYTOIN [HSDB]|PHENYTOIN [IARC]|PHENYTOIN [USAN]|Spectrum2_001281|Spectrum3_000890|Spectrum4_000984|Spectrum5_001369|Lopac-D-4007|PHENYTOIN [VANDF]|Epitope ID:117723|PHENYTOIN [MART.]|D 4007|PHENYTOIN [USP-RS]|PHENYTOIN [WHO-DD]|PHENYTOIN [WHO-IP]|SCHEMBL3440|BIDD:PXR0090|Lopac0_000329|Lopac0_000378|Oprea1_373280|BSPBio_001437|KBioGR_001387|KBioSS_001585|MLS001074087|MLS002454401|BIDD:GT0625|DivK1c_000507|Soluble phenytoin (Salt/Mix)|SPBio_001281|Phenytoin (JP18/USP/INN)|Phenytoin, 1mg/ml in Methanol|GTPL2624|orb1310151|PHENYTOIN [ORANGE BOOK]|2-hydroxy-5,5-diphenyl-3,5-dihydro-4H-imidazol-4-one|PHENYTOIN [EP MONOGRAPH]|PHENYTOIN [USP IMPURITY]|SCHEMBL11836878|HY-B0448R|KBio1_000507|KBio2_001585|KBio2_004153|KBio2_006721|KBio3_001780|PHENYTOIN [USP MONOGRAPH]|WLN: T5MVMV EHJ ER& ER|5,5-Diphenylhydantoin, >=99%|NINDS_000507|Phenytoin 1.0 mg/ml in Methanol|HMS1412J16|HMS1694O05|HMS1791H19|HMS1989H19|HMS2089E11|HMS2236J06|HMS3261K17|HMS3402H19|HMS3657O03|HMS5081O17|PHENYTOINUM [WHO-IP LATIN]|SMSSF-0000406|BCP05960|HY-B0448|Hydantoin, 5,5-diphenyl- (8CI)|MSK10317|Tox21_110861|Tox21_202299|Tox21_300281|Tox21_500378|AC-376|BDBM50003655|BDBM50101816|s2525|SBB057224|STK058029|STK182871|STL454130|AKOS000416887|AKOS003245432|Tox21_110861_1|CCG-104011|CCG-221682|DB00252|FD22484|LP00378|Phenytoin 1000 microg/mL in Methanol|IDI1_000507|IDI1_008433|NCGC00015342-01|NCGC00015342-02|NCGC00015342-03|NCGC00015342-04|NCGC00015342-05|NCGC00015342-06|NCGC00015342-07|NCGC00015342-08|NCGC00015342-09|NCGC00015342-10|NCGC00015342-11|NCGC00015342-12|NCGC00021139-01|NCGC00021139-02|NCGC00021139-04|NCGC00021139-05|NCGC00021139-06|NCGC00021139-07|NCGC00021139-08|NCGC00021139-09|NCGC00021139-10|NCGC00021139-11|NCGC00091492-01|NCGC00091492-02|NCGC00091492-03|NCGC00091492-04|NCGC00091492-05|NCGC00093810-01|NCGC00093810-02|NCGC00254135-01|NCGC00259848-01|NCGC00261063-01|5,5-?Diphenyl-?2,4-?imidazolidinedione|DA-56808|imidazolidine-2,4-dione, 5,5-diphenyl-|5,5-Diphenyl-1H-imidazolidine-2,4-dione|D0894|EU-0100378|NS00010290|ST45024762|SW203757-2|EN300-16818|5,5-Diphenyl-2,4-imidazolidinedione;Phenytoin|C07443|D00512|E76094|2,4-Imidazolidinedione, 5,5-diphenyl- (9CI)|AB00374253-10|AB00374253-11|AB00374253_13|F358172|Q410400|SR-01000003141|SR-01000003141-8|SR-01000075211-2|BRD-K55930204-001-02-7|BRD-K55930204-001-20-9|BRD-K55930204-236-11-0|BRD-K55930204-236-23-5|BRD-K55930204-236-24-3|Z56786458|4-hydroxy-5,5-diphenyl-1,5-dihydro-2H-imidazol-2-one|F0020-1370|F0081-0306|Phenytoin, European Pharmacopoeia (EP) Reference Standard|Phenytoin, United States Pharmacopeia (USP) Reference Standard|Phenytoin, Pharmaceutical Secondary Standard; Certified Reference Material|Phenytoin for system suitability, European Pharmacopoeia (EP) Reference Standard|InChI=1/C15H12N2O2/c18-13-15(17-14(19)16-13,11-7-3-1-4-8-11)12-9-5-2-6-10-12/h1-10H,(H2,16,17,18,19"
IBUTAMOREN,178024,,"InChI=1S/C27H36N4O5S/c1-26(2,28)25(33)29-22(18-36-17-20-9-5-4-6-10-20)24(32)30-15-13-27(14-16-30)19-31(37(3,34)35)23-12-8-7-11-21(23)27/h4-12,22H,13-19,28H2,1-3H3,(H,29,33)/t22-/m1/s1",UMUPQWIGCOZEOY-JOCHJYFZSA-N,C27H36N4O5S,528.7,"2-amino-2-methyl-N-[(2R)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propanamide","Ibutamoren|159634-47-6|ibutamoreno|GJ0EGN38UL|L 163191|2-amino-2-methyl-N-[(2R)-1-(1-methylsulfonylspiro[2H-indole-3,4'-piperidine]-1'-yl)-1-oxo-3-phenylmethoxypropan-2-yl]propanamide|L-163,191|DTXSID90166700|2-AMINO-N-((R)-2-(BENZYLOXY)-1-((1-(METHYLSULFONYL)SPIRO(INDOLINE-3,4'-PIPERIDIN)-1'-YL)CARBONYL)ETHYL)-2-METHYLPROPIONAMIDE|2-AMINO-N-(3-(BENZYLOXY)-1-(1-METHANESULFONYL-1,2-DIHYDROSPIRO(INDOLE-3,4'-PIPERIDIN)-1'-YL)-1-OXOPROPAN-2-YL)-2-METHYLPROPANAMIDE|ibutamorenum|2-amino-2-methyl-N-((2R)-1-(1-methylsulfonylspiro(2H-indole-3,4'-piperidine)-1'-yl)-1-oxo-3-phenylmethoxypropan-2-yl)propanamide|RefChem:55388|DTXCID0089191|Ibutamoren [INN]|CHEMBL13817|(R)-2-amino-N-(3-(benzyloxy)-1-(1-(methylsulfonyl)spiro[indoline-3,4'-piperidin]-1'-yl)-1-oxopropan-2-yl)-2-methylpropanamide|159634-47-6 (free base)|192511-65-2|MK-677, (HCl salt)|CHEMBL542653|1-(methanesulfonyl)-1'-(2-methyl-L-alanyl-O-benzyl-D-seryl)-1,2-dihydrospiro[indole-3,4'-piperidine]|159633-92-8|UNII-GJ0EGN38UL|MK677|MK-677;Crescendo;MK 0677;MK-0677;MK0677|IBUTAMOREN [WHO-DD]|SCHEMBL739398|GTPL5867|IBUTAMOREN (MK-677)|IBUTAMOREN [NFLIS-DRUG]|SCHEMBL29369919|BDBM50049478|BDBM50403624|HY-10199A|AKOS025401779|NCGC00263115-01|NCGC00263115-05|NCGC00263115-10|AC-25509|CS-0002502|NS00125727|Q5984942|BRD-K44771174-066-01-0|1-{[(2R)-3-(benzyloxy)-1-{1-methanesulfonyl-1,2-dihydrospiro[indole-3,4''-piperidine]-1''-yl}-1-oxopropan-2-yl]carbamoyl}-1-methylethan-1-aminium|1KD|1N-[1-benzyloxymethyl-2-[1-methylsulfonylspiro[2,3-dihydro-1H-indole-3,4''-(hexahydropyridine)]-1-yl]-2-oxo-(1R)-ethyl]-2-amino-2-methylpropanamide|1N-[1-benzyloxymethyl-2-[1-methylsulfonylspiro[2,3-dihydro-1H-indole-3,4''-(hexahydropyridine)]-1-yl]-2-oxo-(1R)-ethyl]-2-amino-2-methylpropanamide [3a(MK-0677)]|1N-[1-benzyloxymethyl-2-[1-methylsulfonylspiro[2,3-dihydro-1H-indole-3,4''-(hexahydropyridine)]-1-yl]-2-oxo-(1R)-ethyl]-2-amino-2-methylpropanamide(MK-0677)|Propanamide, 2-amino-N-((1R)-2-(1,2-dihydro-1-(methylsulfonyl)spiro(3H-indole-3,4'-piperidin)-1'-yl)-2-oxo-1-((phenylmethoxy)methyl)ethyl)-2-methyl-|Propanamide, 2-amino-N-(2-(1,2-dihydro-1-(methylsulfonyl)spiro(3H-indole-3,4'-piperidin)-1'-yl)-2-oxo-1-((phenylmethoxy)methyl)ethyl)-2-methyl-, (R)-"
CAPROMORELIN,216208,,"InChI=1S/C28H35N5O4/c1-27(2,29)25(35)30-22(18-37-17-21-12-8-5-9-13-21)24(34)33-15-14-23-28(19-33,26(36)32(3)31-23)16-20-10-6-4-7-11-20/h4-13,22H,14-19,29H2,1-3H3,(H,30,35)/t22-,28-/m1/s1",KVLLHLWBPNCVNR-SKCUWOTOSA-N,C28H35N5O4,505.6,"N-[(2R)-1-[(3aR)-3a-benzyl-2-methyl-3-oxo-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]-1-oxo-3-phenylmethoxypropan-2-yl]-2-amino-2-methylpropanamide","Capromorelin|193273-66-4|Capimorelin|CP-424391|capromorelina|capromoreline|CP-424,391|0MQ44VUN84|N-[(2R)-1-[(3aR)-3a-benzyl-2-methyl-3-oxo-6,7-dihydro-4H-pyrazolo[4,3-c]pyridin-5-yl]-1-oxo-3-phenylmethoxypropan-2-yl]-2-amino-2-methylpropanamide|DTXSID5057886|Elura|N-((2R)-1-((3aR)-3a-benzyl-2-methyl-3-oxo-6,7-dihydro-4H-pyrazolo(4,3-c)pyridin-5-yl)-1-oxo-3-phenylmethoxypropan-2-yl)-2-amino-2-methylpropanamide|CAPROMORELINUM|RefChem:57558|DTXCID6031673|Capromorelin [INN]|CHEMBL113313|Cp 424391|UNII-0MQ44VUN84|CAPROMORELIN [MI]|CP 424,391|SCHEMBL1147592|CAPROMORELIN [GREEN BOOK]|GLXC-10731|EX-A2367|BDBM50083974|AKOS027326852|DB15205|AC-35748|HY-15242|CS-0003826|NS00123001|Q5036299|2-AMINO-N-((1R)-1-(((3AR)-3A-BENZYL-2,3,3A,4,6,7-HEXAHYDRO-2-METHYL-3-OXO-5H-PYRAZOLO(4,3-C)PYRIDIN-5-YL)CARBONYL)-2-(BENZYLOXY)ETHYL)-2-METHYLPROPIONAMIDE|2-amino-N-((R)-1-((R)-3a-benzyl-2-methyl-3-oxo-3a,4,6,7-tetrahydro-2H-pyrazolo[4,3-c]pyridin-5(3H)-yl)-3-(benzyloxy)-1-oxopropan-2-yl)-2-methylpropanamide|2-Amino-N-[(R)-2-((R)-3a-benzyl-2-methyl-3-oxo-2,3,3a,4,6,7-hexahydro-pyrazolo[4,3-c]pyridin-5-yl)-1-benzyloxymethyl-2-oxo-ethyl]-2-methyl-propionamide|PROPANAMIDE, 2-AMINO-N-(2-(2,3,3A,4,6,7-HEXAHYDRO-2-METHYL-3-OXO-3A-(PHENYLMETHYL)-5H-PYRAZOLO(4,3-C)PYRIDIN-5-YL)-2-OXO-1-((PHENYLMETHOXY)METHYL)ETHYL)-2-METHYL-, (R-(R*,R*))-"
LADUVIGLUSIB,9956119,,"InChI=1S/C22H18Cl2N8/c1-13-10-29-21(31-13)17-12-30-22(32-20(17)16-4-3-15(23)8-18(16)24)27-7-6-26-19-5-2-14(9-25)11-28-19/h2-5,8,10-12H,6-7H2,1H3,(H,26,28)(H,29,31)(H,27,30,32)",AQGNHMOJWBZFQQ-UHFFFAOYSA-N,C22H18Cl2N8,465.3,"6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile","252917-06-9|CHIR-99021|laduviglusib|CHIR 99021|CT99021|CT-99021|6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile|CHIR-911|CT 99021|Laduviglusib [USAN]|CHR00921|6-[2-[[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile|234CMT4GK4|CHIR 911|CHR-00921|6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile|LADUVIGLUSIB [INN]|CHEBI:91091|DTXSID90179931|3-Pyridinecarbonitrile, 6-((2-((4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl)amino)ethyl)amino)-|Laduviglusib (USAN)|6-[(2-{[4-[2,4-Dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]NH}ethyl)NH]pyridine-3-CN|6-((2-((4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)pyridine-3-carbonitrile|6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl)NH)ethyl)NH)pyridine-3-CN|6-(2-((4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethylamino)pyridine-3-carbonitrile|RefChem:798393|DTXCID50102422|809-015-4|CHIR99021|6-[2-[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino]ethylamino]pyridine-3-carbonitrile|Laduviglusib (GMP)|FX03|MFCD11846251|6-((2-((4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile|CHIR-99021 (CT99021)|CHEMBL412142|[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile|252917-06-9 (free base)|CHIR 99021 Hydrochloride Salt|GSK-3 Inhibitor XVI|6-(2-(4-(2,4-dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-ylamino)ethylamino)nicotinonitrile|UNII-234CMT4GK4|C22H18Cl2N8|6-[(2-([4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile|6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino)ethyl)amino]pyridine-3-carbonitrile|6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile|65C|Kinome_3785|Laduviglusib (Standard)|SCHEMBL151139|SCHEMBL240280|GTPL8014|orb1305728|SCHEMBL29351682|SCHEMBL29353709|SCHEMBL29359162|SCHEMBL29381114|SCHEMBL29838591|EX-A535|BCPP000285|HMS3295O15|BCP01901|BDBM50325983|HB1261|HY-10182G|HY-10182R|MFCD12546133|s1263|WHO 11473|AKOS015904410|AKOS026750421|BCP9000520|CCG-269402|CS-0181|FD43329|SB19266|SDCCGSBI-0654265.P001|CHIR-99021,CT99021|NCGC00250379-01|NCGC00250379-03|NCGC00250379-09|NCGC00250379-21|6-[[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino]ethyl]amino]-3-pyridinecarbonitrile|6-[2-[[4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino]ethylamino]pyridine-3-carbonitrile|AC-25532|AS-16523|HY-10182|SY016322|C2943|CHIR99021, >=98% (HPLC)|CS-0615620|CHIR-99021 (CT99021)?|D12196|EN300-18520201|GSK-3 Inhibitor XVI - CAS 252917-06-9|BRD-K16189898-001-02-9|BRD-K16189898-001-04-5|BRD-K16189898-001-09-4|BRD-K16189898-001-10-2|BRD-K16189898-001-11-0|BRD-K16189898-001-15-1|BRD-K16189898-003-03-3|Q27075965|6-[(2-{[4-(2,4-dichlorophenyl) -5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile|6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol -2-yl)-pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile|6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)-pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile|6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino }ethyl)amino]pyridine-3-carbonitrile|6-[(2-{[4-(2,4-dichlorophenyl)-5-(4-methylimidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3 -carbonitrile|6-[(2-{[4-(2,4-Dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)-2-pyrimidinyl]amino}ethyl)amino]nicotinonitrile|6-[(2-{[4-(2,4-dichlorophenyl)-5-(5-methyl-1H-imidazol-2-yl)pyrimidin-2-yl]amino}ethyl)amino]pyridine-3-carbonitrile|6-[2-[[4-(2,4-Dichlorophenyl)-5-(5-methyl-2-imidazolyl)-2-pyrimidinyl]amino]ethylamino]-3-pyridinecarbonitrile|6-{2-[4-(2,4-dichloro-phenyl)-5-(4-methyl-1h-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile|6-{2-[4-(2,4-dichloro-phenyl)-5-(5-methyl-1h-imidazol-2-yl)-pyrimidin-2-ylamino]-ethylamino}-nicotinonitrile"
TIDEGLUSIB,11313622,,"InChI=1S/C19H14N2O2S/c22-18-20(13-14-7-2-1-3-8-14)19(23)24-21(18)17-12-6-10-15-9-4-5-11-16(15)17/h1-12H,13H2",PMJIHLSCWIDGMD-UHFFFAOYSA-N,C19H14N2O2S,334.4,"4-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione","Tideglusib|865854-05-3|NP-12|NP031112|4-Benzyl-2-(naphthalen-1-yl)-1,2,4-thiadiazolidine-3,5-dione|NP-031112|tideglusibum|Zentylor|Nypta|Q747Y6TT42|CHEBI:147398|DTXSID90235682|4-benzyl-2-(a-naphtyl)-1,2,4-thiadiazolidine-3,5-dione|NP12 compound|NP-12 compound|Zentylor nypta|RefChem:189971|DTXCID20158173|4-benzyl-2-(naphthalene-1-yl)-1,2,4-thiadiazolidine-3,5-dione|Tideglusib [INN]|MFCD18633296|NP 031112|4-benzyl-2-(1-naphthyl)-1,2,4-thiadiazolidine-3,5-dione|2-(1-naphthalenyl)-4-(phenylmethyl)-1,2,4-thiadiazolidine-3,5-dione|4-benzyl-2-naphthalen-1-yl-1,2,4-thiadiazolidine-3,5-dione|UNII-Q747Y6TT42|1,2,4-Thiadiazolidine-3,5-dione, 2-(1-naphthalenyl)-4-(phenylmethyl)-|TIDEGLUSIB [WHO-DD]|Tideglusib(NP-031112)|1353564-66-5|SCHEMBL676929|Tideglusib(NP-031112)?|GTPL6929|orb1304574|CHEMBL3545157|SCHEMBL29357303|Tideglusib, >=98% (HPLC)|EX-A600|GLXC-06654|HMS3673G17|HMS3744E05|HMS3884J18|4-Benzyl-2-(naphthalen-1-yl)-[1,2,4]thiadiazolidine-3,5-dione|BCP06016|Tideglusib,CAS:865854-05-3|BDBM50166940|NSC800950|s2823|AKOS025149085|CCG-267855|CS-0613|DB12129|FT30356|NSC-800950|SB19268|SDCCGSBI-0654483.P001|Tideglusib (NP031112, NP-12)|Tideglusib (NP-031112, NP-12)|NCGC00386380-06|AC-31056|AS-56156|DA-41071|DA-56282|HY-14872|SY122311|NS00071037|F547235|BRD-K81330143-001-02-2|BRD-K81330143-001-04-8|Q10382411|4-BENZYL-2-(A-NAPHTHYL)-1,2,4-THIADIAZOLIDINE-3,5-DIONE"
DESVENLAFAXINE,125017,,"InChI=1S/C16H25NO2/c1-17(2)12-15(13-6-8-14(18)9-7-13)16(19)10-4-3-5-11-16/h6-9,15,18-19H,3-5,10-12H2,1-2H3",KYYIDSXMWOZKMP-UHFFFAOYSA-N,C16H25NO2,263.37,4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol,"Desvenlafaxine|93413-62-8|O-Desmethylvenlafaxine|4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenol|4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol|Khedezla|Newven|Mdd-xr|Desvenlafaxina|NG99554ANW|CHEBI:83527|Phenol, 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)-|DTXSID40869118|Phenol, 4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]-|desvenlafaxinum|O desmethylvenlafaxine|RefChem:57728|DTXCID00216346|N06AX23|700-516-2|O-desmethyl venlafaxine|D,L-O-Desmethyl Venlafaxine|DVS 233|O-Desvenlafaxine|D-veniz|Desvenlafaxine (INN)|Desvenlafaxine [INN]|MFCD00871934|93413-62-8 (free base)|1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol|Desvenlafaxine [INN:BAN]|ODV|Venlafaxine O-Desmethyl|D,L-O-Desmethyl Venlafaxine (100 ug/mL in Methanol)|UNII-NG99554ANW|HSDB 7993|Khedezla (TN)|O-Desmethylvenlafaxine; 4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol; D-VENIZ; DVS 233; Desvenlafaxine; Pristiq|O-DESMETHYLVENLAFAXINE (ODV)|O-desmethyl-venlafaxine|DESVENLAFAXINE [MI]|EC 700-516-2|CHEMBL1118|D,L O-Desmethyl Venlafaxine|SCHEMBL34864|MLS006010042|DESVENLAFAXINE [VANDF]|GTPL7158|orb1308104|SCHEMBL1133549|DESVENLAFAXINE [USP-RS]|DESVENLAFAXINE [WHO-DD]|BDBM86748|HMS3652K16|HMS3885F05|HMS5082E16|BCP28517|HY-B0602|MSK10512|DESVENLAFAXINE [ORANGE BOOK]|PDSP1_001804|PDSP2_001787|s4113|DESVENLAFAXINE [USP MONOGRAPH]|AKOS015896311|CCG-267081|DB06700|DS-1282|SB17444|NSC_6918664|NCGC00345883-04|NCGC00345883-07|DA-76384|SMR004701214|O-Desmethylvenlafaxine, analytical standard|O-Desmethylvenlafaxine, 1mg/ml in Methanol|CAS_386750-22-7|D5598|NS00000330|SW219514-2|O-Desmethylvenlafaxine 0.1 mg/ml in Methanol|D07793|AB01563022_01|EN300-7353726|413D628|A844583|F079439|Q2419445|BRD-A98845662-001-02-3|BRD-A98845662-001-03-1|BRD-A98845662-036-02-9|BRD-A98845662-036-03-7|BRD-A98845662-036-04-5|Venlafaxine O-desmethyl 100 microg/mL in Acetonitrile|Z1741977125|1-[2-dimethylamino-1-(4-hydroxyphenyl)ethyl]cyclohexanol|4-(2-(Dimethylamino)-1-(1-hydroxycyclohexyl)-ethyl)phenol|4-[2-(dimethylamino)-1-(1-oxidanylcyclohexyl)ethyl]phenol|4-[2-(Dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenol #|(RS)-1-[2-(dimethylamino)-1-(4-hydroxyphenyl)ethyl]cyclohexanol|4-[2-(Dimethylamino)-1-(1-hydroxycyclo-hexyl)ethyl]phenol;DVS 233;Desvenlafaxine"
GW-406381,9832687,,"InChI=1S/C21H19N3O3S/c1-3-27-17-10-6-16(7-11-17)21-20(19-5-4-14-22-24(19)23-21)15-8-12-18(13-9-15)28(2,25)26/h4-14H,3H2,1-2H3",NXMZBNYLCVTRGB-UHFFFAOYSA-N,C21H19N3O3S,393.5,"2-(4-ethoxyphenyl)-3-(4-methylsulfonylphenyl)pyrazolo[1,5-b]pyridazine","221148-46-5|GW-406381|2-(4-ethoxyphenyl)-3-[4-(methylsulfonyl)phenyl]pyrazolo[1,5-b]pyridazine|5Y869C2THE|DTXSID60202043|2-(4-ethoxyphenyl)-3-(4-(methylsulfonyl)phenyl)pyrazolo[1,5-b]pyridazine|Pyrazolo(1,5-b)pyridazine, 2-(4-ethoxyphenyl)-3-(4-(methylsulfonyl)phenyl)-|2-(4-ETHOXYPHENYL)-3-(4-(METHYLSULFONYL)PHENYL)PYRAZOLO(1,5-B)PYRIDAZINE|RefChem:909327|DTXCID60124534|2-(4-ethoxyphenyl)-3-(4-methanesulfonylphenyl)pyrazolo(1,5-b)pyridazine|GW406381|GW 406381|GW 406381X|GW406381X|2-(4-ETHOXYFENYL)-3-(4-MESYLFENYL)PYRAZOLO[1,5-B]PYRIDAZINE|CHEMBL364804|2-(4-ethoxyphenyl)-3-(4-methylsulfonylphenyl)pyrazolo[1,5-b]pyridazine|537697-89-5|2-(4-Ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo[1,5-b]pyridazine|UNII-5Y869C2THE|SCHEMBL309320|GTPL9850|orb1707232|NXMZBNYLCVTRGB-UHFFFAOYSA-N|WIA14846|BDBM50153982|MFCD09475687|GW 406381 [WHO-DD]|AKOS040741824|compound 8 [PMID: 15454242]|DB12009|NCGC00386669-01|MS-26597|DB-216431|HY-119304|CS-0066982|NS00068319|E98787|Q27263044|2-(4-Ethoxyphenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo[1,5-b]pyridazine|2-(4-ethoxyphenyl)-3-(4-methylsulfonylphenyl)pyrazolo[5,1-f]pyridazine|2-(4-Ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl )-pyrazolo[1,5-b]pyridazine|2-(4-ethoxy-phenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo[1 ,5-b]pyridazine|2-(4-Ethoxyphenyl)-3-(4-methanesulfonyl-phenyl)-pyrazolo[1, 5-b]pyridazine"
CIMICOXIB,213053,,"InChI=1S/C16H13ClFN3O3S/c1-24-14-7-2-10(8-13(14)18)15-16(17)20-9-21(15)11-3-5-12(6-4-11)25(19,22)23/h2-9H,1H3,(H2,19,22,23)",KYXDNECMRLFQMZ-UHFFFAOYSA-N,C16H13ClFN3O3S,381.8,4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]benzenesulfonamide,"Cimicoxib|265114-23-6|Cimalgex|UR-8880|W7FHJ107MC|4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)-1H-imidazol-1-yl]benzenesulfonamide|CHEBI:76127|Cimicoxib (ema epar: veterinary)|4-(4-Chloro-5-(3-fluoro-4-methoxyphenyl)-1H-imidazol-1-yl)benzenesulfonamide|DTXSID30181093|cimicoxibum|RefChem:126164|DTXCID40103584|4-(4-chloro-5-(3-fluoro-4-methoxyphenyl)-1H-imidazol-1-yl)benzene-1-sulfonamide|Cimicoxib [INN]|Benzenesulfonamide, 4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)-1H-imidazol-1-yl]-|4-[4-chloro-5-(3-fluoro-4-methoxyphenyl)imidazol-1-yl]benzenesulfonamide|CHEMBL435381|UR 8880;UR-8880;UR8880|UNII-W7FHJ107MC|CIMICOXIB [MI]|UR-8880 (Cimicoxib)?|orb1304548|SCHEMBL3123310|SCHEMBL29386198|KYXDNECMRLFQMZ-UHFFFAOYSA-N|BCP24933|BDBM50131593|AKOS030586367|DB05095|NCGC00531794-01|TS-08697|DB-218661|HY-100516|CS-0019655|NS00068504|Q5120133|4-[4-Chloro-5-(3-fluoro-4-methoxy-phenyl)-imidazol-1-yl]-benzenesulfonamide|4-[4-CHLORO-5-(3-FLUORO-4-METHOXY-PHENYL)IMIDAZOL-1-YL]BENZENESULFONAM IDE|Cimicoxib;4-(4-chloro-5-(3-fluoro-4-Methoxyphenyl)-1H-iMidazol-1-yl)benzene sulfonaMide"
LY-3031207,57382526,,"InChI=1S/C16H19ClN4O2/c1-16(2,3)14(23)20-9-10-4-5-12(17)11(8-10)13(22)21-15-18-6-7-19-15/h4-8H,9H2,1-3H3,(H,20,23)(H2,18,19,21,22)",MBAHGUNQNAJTLD-UHFFFAOYSA-N,C16H19ClN4O2,334.80,"2-chloro-5-[(2,2-dimethylpropanoylamino)methyl]-N-(1H-imidazol-2-yl)benzamide","1381846-21-4|NQ7VQ61PBC|LY-3031207|LY3031207|2-Chloro-5-(((2,2-dimethyl-1-oxopropyl)amino)methyl)-N-1H-imidazol-2-ylbenzamide|Benzamide, 2-chloro-5-(((2,2-dimethyl-1-oxopropyl)amino)methyl)-N-1H-imidazol-2-yl|RefChem:154552|mPGES-1 Inhibitor-1|2-chloro-5-[(2,2-dimethylpropanoylamino)methyl]-N-(1H-imidazol-2-yl)benzamide|UNII-NQ7VQ61PBC|mPGES1-IN-8|2-chloro-5-[[(2,2-dimethyl-1-oxopropyl)amino]methyl]-N-1H-imidazol-2-yl-benzamide|CHEMBL2152712|BenzaMide, 2-chloro-5-[[(2,2-diMethyl-1-oxopropyl)aMino]Methyl]-N-1H-iMidazol-2-yl-|2-Chloro-5-[(2,2-dimethyl-propionylamino)-methyl]-N-(1H-imidazol-2-yl)-benzamide|2-Chloro-5-{[(2,2-Dimethylpropanoyl)amino]methyl}-N-(1h-Imidazol-2-Yl)benzamide|MBAHGUNQNAJTLD-UHFFFAOYSA-N|orb1699909|SCHEMBL9931208|2-chloro-N-(1H-imidazol-2-yl)-5-(pivalamidomethyl)benzamide|BDBM50393042|MFCD25976583|AKOS040748956|HY-13475|CS-0007052"
LUMIRACOXIB,151166,,"InChI=1S/C15H13ClFNO2/c1-9-5-6-13(10(7-9)8-14(19)20)18-15-11(16)3-2-4-12(15)17/h2-7,18H,8H2,1H3,(H,19,20)",KHPKQFYUPIUARC-UHFFFAOYSA-N,C15H13ClFNO2,293.72,2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid,"Lumiracoxib|220991-20-8|Prexige|COX-189|COX189|2-(2-((2-chloro-6-fluorophenyl)amino)-5-methylphenyl)acetic acid|lumiracoxibum|DTXSID9049035|CHEBI:73044|V91T9204HU|DTXCID4028961|Benzeneacetic acid, 2-((2-chloro-6-fluorophenyl)amino)-5-methyl-|2-{2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid|Benzeneacetic acid, 2-[(2-chloro-6-fluorophenyl)amino]-5-methyl-|2-[2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl]acetic acid|RefChem:800128|2-(2-((2-chloro-6-fluoro-phenyl)amino)-5-methyl-phenyl)acetic acid|M01AH06|COX 189|CGS-35189|Prexige;COX 189|2-[2-(2-chloro-6-fluoroanilino)-5-methylphenyl]acetic acid|2-((2-Chloro-6-fluorophenyl)amino)-5-methylbenzeneacetic acid|CHEMBL404108|{2-[(2-chloro-6-fluorophenyl)amino]-5-methylphenyl}acetic acid|NCGC00181795-01|Lumaricoxib|Joicela|2-((2-Chloro-6-fluorophenyl)amino)-5-methylphenyl)acetic acid|CAS-220991-20-8|Lumiracoxib (USAN/INN)|2-[(2-Chloro-6-fluorophenyl)amino]-5-methylphenyl]acetic acid|4llz|4oty|LUR|MFCD07186254|Prexige, Lumiracoxib|Lumiracoxib (Standard)|2-(2-(2-chloro-6-fluorophenylamino)-5-methylphenyl)aceticacid|LUMIRACOXIB [MI]|LUMIRACOXIB [INN]|LUMIRACOXIB [USAN]|Lumiracoxib (COX-189)|SCHEMBL4479|LUMIRACOXIB [MART.]|LUMIRACOXIB [WHO-DD]|MLS003882594|UNII-V91T9204HU|Lumiracoxib [USAN:INN:BAN]|GTPL2897|orb1300646|Lumiracoxib - Bio-X trade mark|SCHEMBL29377334|SCHEMBL29475008|GLXC-23308|HMS3264F19|HMS3651H08|HMS3884J22|HMS5081H21|2-[2-(2-chloro-6-fluoro-anilino)-5-methyl-phenyl]acetic acid|BCP06134|EX-A8012|Tox21_113566|BDBM50207446|HY-13507R|s2903|STL239146|AKOS015895138|Tox21_113566_1|AC-1738|CCG-213068|DB01283|FL24957|KS-1302|SB19319|NCGC00181795-02|NCGC00181795-03|BL164650|HY-13507|SMR002529582|CS-0007130|NS00007961|SW219769-1|D03714|D71097|SBI-0653382.0001|AB01563279_01|991L208|EN300-24116087|Q413744|SR-01000930684|SR-01000930684-2|BRD-K26901728-001-05-4|BRD-K26901728-001-06-2|2-(2-((2-chloro-6-fluorophenyl)amino)-5-methylphenyl)aceticacid|2-(2-(2-chloro-6-fluorophenylamino)-5-methylphenyl)acetic acid|2-[(2-Chloro-6-fluorophenyl)amino]-5-methylbenzeneacetic acid;2-[2-(2-Chloro-6-fluorophenylamino)-5-methylphenyl]acetic acid;CGS 351    89|2-[(2-Chloro-6-fluorophenyl)amino]-5-methylbenzeneacetic acid;2-[2-(2-Chloro-6-fluorophenylamino)-5-methylphenyl]acetic acid;CGS 351 89"
ELIPRODIL,60703,,"InChI=1S/C20H23ClFNO/c21-18-5-3-17(4-6-18)20(24)14-23-11-9-16(10-12-23)13-15-1-7-19(22)8-2-15/h1-8,16,20,24H,9-14H2",GGUSQTSTQSHJAH-UHFFFAOYSA-N,C20H23ClFNO,347.9,1-(4-chlorophenyl)-2-[4-[(4-fluorophenyl)methyl]piperidin-1-yl]ethanol,"Eliprodil|119431-25-3|DTXSID1045744|SL-820715|YW62A6TW29|DTXCID9025744|CHEBI:91784|1-Piperidineethanol, alpha-(4-chlorophenyl)-4-(4-fluorophenyl)-, (+-)-|1-(4-chlorophenyl)-2-{4-[(4-fluorophenyl)methyl]piperidin-1-yl}ethan-1-ol|eliprodilum|SL 82.0715|1-(4-chlorophenyl)-2-(4-((4-fluorophenyl)methyl)piperidin-1-yl)ethan-1-ol|1-(4-chlorophenyl)-2-[4-[(4-fluorophenyl)methyl]piperidin-1-yl]ethan-1-ol|(4-chlorophenyl)-4-((4-fluorophenyl)methyl)-1-piperidineethanol|RefChem:590714|Eliprodil [INN]|C20H23ClFNO|MFCD00866651|1-(4-chlorophenyl)-2-[4-[(4-fluorophenyl)methyl]piperidin-1-yl]ethanol|1-(4-chlorophenyl)-2-(4-(4-fluorobenzyl)piperidin-1-yl)ethan-1-ol|alpha-(4-Chlorophenyl)-4-[(4-fluorophenyl)methyl]-1-piperidineethanol|1-Piperidineethanol, alpha-(4-chlorophenyl)-4-[(4-fluorophenyl)methyl]-|SL 82-0715|CHEMBL28564|SL 820715|NCGC00092329-02|1-(4-Chloro-phenyl)-2-[4-(4-fluoro-benzyl)-piperidin-1-yl]-ethanol|1-(4-chlorophenyl)-2-[4-[(4-fluorophenyl)methyl]-1-piperidyl]ethanol|CAS-119431-25-3|UNII-YW62A6TW29|1-(4-Chlorophenyl)-2-(4-(4-fluorobenzyl)piperidin-1-yl)ethanol|1-(4-chlorophenyl)-2-[4-(4-fluorobenzyl)piperidin-1-yl]ethanol|Eliprodil?|MLS006010706|SCHEMBL154047|orb1307538|EX-A878|CHEBI:180651|HMS3261M16|HMS3268B06|HMS3413M03|HMS3677M03|BCP23813|Tox21_111194|Tox21_500467|(+-)-alpha-(p-Chlorophenyl)-4-(p-fluorobenzyl)-1-piperidineethanol|BDBM50079387|HB0274|PDSP1_000365|PDSP2_000363|AKOS015850327|Eliprodil, >=98% (HPLC), powder|Tox21_111194_1|CCG-221771|DB12869|LP00467|SDCCGSBI-0633716.P001|1-Piperidineethanol, alpha-(4-chlorophenyl)-4-((4-fluorophenyl)methyl)-, (+-)-|NCGC00092329-01|NCGC00092329-03|NCGC00092329-04|NCGC00092329-06|NCGC00092329-08|NCGC00261152-01|AC-36819|AS-72184|DA-63155|HY-12881|SMR001456245|EU-0100467|SR-01000597358|Q5361298|SR-01000597358-1|BRD-A61392169-001-01-9|BRD-A61392169-001-02-7|1-Piperidineethanol, |A-(4-chlorophenyl)-4-[(4-fluorophenyl)methyl]-|(+/-)-.ALPHA.-(P-CHLOROPHENYL)-4-(P-FLUOROBENZYL)-1-PIPERIDINEETHANOL|SL-82,0715; SL82,0715; SL 82,0715; SL-820715; SL820715; SL 820715"
FLUTICASONE PROPIONATE,444036,,"InChI=1S/C25H31F3O5S/c1-5-20(31)33-25(21(32)34-12-26)13(2)8-15-16-10-18(27)17-9-14(29)6-7-22(17,3)24(16,28)19(30)11-23(15,25)4/h6-7,9,13,15-16,18-19,30H,5,8,10-12H2,1-4H3/t13-,15+,16+,18+,19+,22+,23+,24+,25+/m1/s1",WMWTYOKRWGGJOA-CENSZEJFSA-N,C25H31F3O5S,500.6,"[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate","FLUTICASONE PROPIONATE|80474-14-2|Flovent|Cutivate|Flixotide|Flonase|Flovent HFA|Flovent Diskus|Flovent Diskus 50|Flovent Diskus 100|Flovent Diskus 250|Xhance|CCI-18781|ArmonAir RespiClick|CCI 18781|Fluticasone-17-propionate|O2GMZ0LF5W|cci18781|DTXSID8045511|CHEBI:31441|Flonase Allergy Relief|NSC-759889|[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate|PF-00241939|DTXCID801476602|ADVAIR COMPONENT FLUTICASONE PROPIONATE|Androsta-1,4-diene-17-carbothioic acid, 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-, (6alpha,11beta,16alpha,17alpha)-S-(fluoromethyl) ester|AIRDUO RESPICLICK COMPONENT FLUTICASONE PROPIONATE|Nasofan|Pirinase|Sereflo|Sirdupla|childrens nasal|FlutiCare|Aerivio Spiromax|Childrens Nasopro|Welby Fluticasone|Airflusal forspiro|Seretide 50|((6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-17-yl) propanoate|(1R,2S,8S,10S,11S,13R,14R,15S,17S)-1,8-difluoro-14-(((fluoromethyl)sulfanyl)carbonyl)-17-hydroxy-2,13,15-trimethyl-5-oxotetracyclo(8.7.0.0^(2,7).0^(11,15))heptadeca-3,6-dien-14-yl propanoate|(1R,2S,8S,10S,11S,13R,14R,15S,17S)-1,8-difluoro-14-{[(fluoromethyl)sulfanyl]carbonyl}-17-hydroxy-2,13,15-trimethyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-3,6-dien-14-yl propanoate|Nasopro 24|allergy relief nasal|Seretide 100|Seretide 125|Seretide 250|Seretide 500|HEB Nasopro 24|childrens allergy nasal|Walgreens allergy nasal|RefChem:5840|CHILDRENS FLONASE|24 Hour Allergy Nasal|ARMONAIR DIGIHALER|Fluticasone Propionate HFA|leader allergy relief nasal|Fluticasone Propionate Nasal|leader fluticasone propionate|Kirkland Signature Aller Flo|Topcare Allergy Relief Nasal|Equaline Fluticasone Propionate|basic care allergy relief nasal|DG Health Allergy Relief Nasal|caring mill allergy relief nasal|Up and Up Allergy Relief Nasal|Good Sense 24 hour allergy nasal|Harris Teeter Allergy Relief Nasal|FLUTICASONE PROPIONATE DISKUS|topcare fluticasone propionate nasal|SunMark allergy relief nasal 24 hr|Fluticasone Propionate spray, metered|CHILDRENS FLUTICASONE PROPIONATE|CHILDRENS FLONASE ALLERGY RELIEF|basic care childrens allergy relief nasal|DG Health childrens allergy relief nasal|RUGBY FLUTICASONE PROPIONATE NASAL|caring mill childrens allergy relief nasal|good neighbor pharmacy fluticasone propionate|TopCare Childrens Allergy Relief Nasal 24 Hour|Good Neighbor Pharmacy Childrens Fluticasone Propionate|(6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic Acid, S-(Fluoromethyl) Ester|Flixonase|Flusonal|Fluspiral|Flutide|Flutivate|Asmatil|Axotide|Brethal|Fluinol|Flixotide Disks|Flixotide Disk|Flixotide Inhaler|Cultivate|Flixonase Nasal Spray|Fluticasonpropionat Allen|Fluticasone (propionate)|MFCD00866007|Fluticasone propionate (Flonase, Veramyst)|C25H31F3O5S|atemur|Inalacor|Rinosone|Trialona|Ubizol|Zoflut|Flonase Aq|Flovent-hfa|Fluticasone propionate [USAN]|UNII-O2GMZ0LF5W|Fluxonal|Skyron|Flovent Rotadisk|NCGC00016943-01|Cutivate (TN)|Fluticasone propionate [USAN:USP]|(6a,11b,16a,17a)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic acid S-(fluoromethyl) es ter|Flonase (TN)|Flovent (TN)|CAS-80474-14-2|fluticasone-propionate|ArmonAir RespiClickTM|Prestwick0_000997|Prestwick1_000997|Prestwick2_000997|Prestwick3_000997|SCHEMBL4068|CHEMBL1473|BSPBio_001093|MLS001424085|S-(Fluoromethyl) 6alpha,9-difluoro-11beta,17-dihydroxy-16alpha-methyl-3-oxoandrosta-1,4-diene-17beta-carbothioate, 17-propionate|SPBio_002984|BPBio1_001203|GTPL7080|orb1310855|HY-B0154R|MSK2239|Fluticasone propionate (JAN/USP)|FN-25|HMS1571G15|HMS2051N19|HMS2098G15|HMS3413A19|HMS3677A19|HMS3715G15|FLUTICASONE PROPIONATE [MI]|HY-B0154|YMB56612|Fluticasone (propionate) (Standard)|FLUTICASONE PROPIONATE [JAN]|Tox21_110698|AC-457|BDBM50354849|HB1091|s1992|FLUTICASONE PROPIONATE [VANDF]|AKOS015895220|FLUTICASONE PROPIONATE [MART.]|Tox21_110698_1|CCG-100981|CS-1986|DB00588|FF23515|FLUTICASONE PROPIONATE [USP-RS]|FLUTICASONE PROPIONATE [WHO-DD]|KS-1173|NC00231|NSC 759889|NCGC00179308-01|NCGC00179308-04|NCGC00179308-05|BF160362|BF161262|SMR000469159|SY028612|Fluticasone propionate - Bio-X trade mark|FLUTICASONE PROPIONATE [ORANGE BOOK]|AB00513992|FLUTICASONE PROPIONATE [EP MONOGRAPH]|NS00069576|FLUTICASONE PROPIONATE [USP MONOGRAPH]|A51110|D01708|DYMISTA COMPONENT FLUTICASONE PROPIONATE|AB00513992-06|AB00513992_08|EN300-7480904|Fluticasone propionate - micronised pharma grade|Fluticasone propionate, >=98% (HPLC), powder|474F142|ADVAIR HFA COMPONENT FLUTICASONE PROPIONATE|AN-584/43505443|LIPO-102 COMPONENT FLUTICASONE PROPIONATE|SR-01000763355|Q8564098|SR-01000763355-3|BRD-K62310379-001-03-0|BRD-K62310379-001-10-5|Fluticasone propionate 100 microg/mL in Acetonitrile|Fluticasone 17(2)-Carbonylsulfenic Acid 17-Propionate|Fluticasone propionate, European Pharmacopoeia (EP) Reference Standard|Fluticasone propionate, United States Pharmacopeia (USP) Reference Standard|Fluticasone Propionate, Pharmaceutical Secondary Standard; Certified Reference Material|(1R,2R,3aS,3bS,5S,9aS,9bR,10S,11aS)-5,9b-difluoro-1-{[(fluoromethyl)sulfanyl]carbonyl}-10-hydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl propanoate|(6?,11?,16?,17?)-6 ,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1 ,4-diene-17-carbothioic acid S-(fluoromethyl) ester; Cutivate; Flixonase; Fluticasone; Fluticasone propionate|(6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)androsta-1,4-diene-17-carbothioic acid S-(fluoromethyl) ester|6,9-difluoro-17-{[(fluoromethyl)sulfanyl]carbonyl}-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl propionate|6alpha,9-difluoro-17beta-{[(fluoromethyl)sulfanyl]carbonyl}-11beta-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17alpha-yl propanoate|ANDROSTA-1,4-DIENE-17-CARBOTHIOIC ACID, 6,9-DIFLUORO-11-HYDROXY-16-METHYL-3-OXO-17-(1-OXOPROPOXY)-, (6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-S-(FLUOROMETHYL) ESTER|Androsta-1,4-diene-17-carbothioic acid, 6,9-difluoro-11-hydroxy-16-methyl-3-oxo-17-(1-oxopropoxy)-,S-(fluoromethyl) ester, (6.alpha.,11.beta.,16.alpha.,17.alpha.)-|Fluticasone propionate for impurity C identification, EuropePharmacopoeia (EP) Reference Standard|Fluticasone propionate for impurity G identification, EuropePharmacopoeia (EP) Reference Standard|S-FLUOROMETHYL 6.ALPHA., 9.ALPHA.-DIFLUORO-11.BETA.-HYDROXY-16.ALPHA.-METHYL-3-OXO-17.ALPHA.-PROPIONYLOXYANDROSTA-1,4-DIENE-17.BETA-. CARBOTHIOATE"
FLUTICASONE FUROATE,9854489,,"InChI=1S/C27H29F3O6S/c1-14-9-16-17-11-19(29)18-10-15(31)6-7-24(18,2)26(17,30)21(32)12-25(16,3)27(14,23(34)37-13-28)36-22(33)20-5-4-8-35-20/h4-8,10,14,16-17,19,21,32H,9,11-13H2,1-3H3/t14-,16+,17+,19+,21+,24+,25+,26+,27+/m1/s1",XTULMSXFIHGYFS-VLSRWLAYSA-N,C27H29F3O6S,538.6,"[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate","Fluticasone furoate|397864-44-7|Veramyst|Avamys|Allermist|Furamist|Arnuity Ellipta|Ennhale|Flonase Sensimist|GSK 685 698|furoate de fluticasone|furoato de fluticasona|fluticasonum furoas|GW685698X|GSK 685698|GW-685698X|JS86977WNV|CHEBI:74899|GSK685968|GSK-685968|Flonase Sensimist Allergy Relief|DTXSID401024827|[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] furan-2-carboxylate|BREO ELLIPTA COMPONENT FLUTICASONE FUROATE|ARNUITY ELLIPTA COMPONENT FLUTICASONE FUROATE|TRELEGY ELLIPTA COMPONENT FLUTICASONE FUROATE|Relvar ellipta|((6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(fluoromethylsulfanylcarbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-17-yl) furan-2-carboxylate|RefChem:55222|DTXCID10151077|(1R,2S,8S,10S,11S,13R,14R,15S,17S)-1,8-difluoro-14-(((fluoromethyl)sulfanyl)carbonyl)-17-hydroxy-2,13,15-trimethyl-5-oxotetracyclo(8.7.0.02,?.011,1?)heptadeca-3,6-dien-14-yl furan-2-carboxylate|(6alpha,11beta,16alpha,17alpha)-6,9-DIFLUORO-17-(((FLUORO-METHYL)THIO)CARBONYL)-11-HYDROXY-16-METHYL-3-OXOANDROSTA-1,4-DIEN-17-YL 2-FURANCARBOXYLATE|629-894-6|Androsta-1,4-diene-17-carbothioic acid, 6,9-difluoro-17-((2-furanylcarbonyl)oxy)-11-hydroxy-16-methyl-3-oxo-, S-(fluoromethyl) ester, (6alpha,11beta,16alpha,17alpha)-|GW 685698X|Alisade|(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-17-(((fluoromethyl)thio)carbonyl)-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl furan-2-carboxylate|UNII-JS86977WNV|Fluticasone furoate [USAN:INN]|Fluticasone fuorate|Veramyst (TN)|(6alpha,11alpha,14beta,16alpha,17alpha)-6,9-difluoro-17-{[(fluoromethyl)sulfanyl]carbonyl}-11-hydroxy-16-methyl-3-oxoan drosta-1,4-dien-17-yl furan-2-carboxylate|(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-Difluoro-17-[[(fluoromethyl)thio]carbonyl]-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-3H-cyclopenta[a]phenanthren-17-yl Furan-2-carboxylate|6alpha,9-Difluoro-17-(((fluoromethyl)sulfanyl)carbonyl)-11beta-hydroxy-16alpha-methyl-3-oxoandrosta-1,4-dien-17alpha-yl furan-2-carboxylate|6alpha,9-Difluoro-17-[[(fluoromethyl)sulfanyl]carbonyl]-11beta-hydroxy-16alpha-methyl-3-oxoandrosta-1,4-dien-17alpha-yl furan-2-carboxylate|GW6|Fluticasone furoate?|MFCD09954122|CHEMBL1676|SCHEMBL140504|Fluticasone furoate (Standard)|orb1306375|FLUTICASONE FUROATE [MI]|C27H29F3O6S|GTPL10892|FLUTICASONE FUROATE [INN]|FLUTICASONE FUROATE [JAN]|gw685698|FLUTICASONE FUROATE [USAN]|FLUTICASONE FUROATE [VANDF]|BCP18136|FLUTICASONE FUROATE [MART.]|BDBM50354851|FLUTICASONE FUROATE [WHO-DD]|HY-15234R|s6487|Fluticasone furoate (JAN/USAN/INN)|AKOS040744839|FLUTICASONE FUROATE [EMA EPAR]|DB08906|FF23514|FLUTICASONE FUROATE [ORANGE BOOK]|DA-63499|HY-15234|MS-29934|SY372804|Avamys pound>> Veramyst pound>> Allermist|GW-685698|CS-0003822|drosta-1,4-dien-17-yl furan-2-carboxylate|NS00006583|D06315|E86983|EN300-19659651|Q2166700|(1R,2R,3aS,3bS,5S,9aS,9bR,10S,11aS)-5,9b-difluoro-1-{[(fluoromethyl)sulfanyl]carbonyl}-10-hydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl furan-2-carboxylate|(6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-6,9-DIFLUORO-17-(((FLUORO-METHYL)THIO)CARBONYL)-11-HYDROXY-16-METHYL-3-OXOANDROSTA-1,4-DIEN-17-YL 2-FURANCARBOXYLATE|(6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-6,9-DIFLUORO-17-(((FLUOROMETHYL)THIO)CARBONYL)-11-HYDROXY-16-METHYL-3-OXOANDROSTA-1,4-DIEN-17-YL 2-FUROATE|(6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-6,9-DIFLUORO-17-(((FLUOROMETHYL)THIO)CARBONYL)-11-HYDROXY-16-METHYL-3-OXOANDROSTA-1,4-DIEN-17-YL-2-FURANCARBOXYLATE|(6a,11b,16a,17a)-6,9-Difluoro-17-[(2-furanylcarbonyl)oxy]-11-hydroxy-16- methyl-3-oxoandrosta-1,4-diene-17-carbothioic acid S-(fluoromethyl) ester|(6alpha,11alpha,14beta,16alpha,17alpha)-6,9-difluoro-17-{[(fluoromethyl)sulfanyl]carbonyl}-11-hydroxy-16-methyl-3-oxoan|(6alpha,11alpha,14beta,16alpha,17alpha)-6,9-Difluoro-17-{[(Fluoromethyl)sulfanyl]carbonyl}-11-Hydroxy-16-Methyl-3-Oxoandrosta-1,4-Dien-17-Yl Furan-2-Carboxylate|(6alpha,11beta,16alpha,17alpha)-6,9-Difluoro-17-(((fluoromethyl)thio)carbonyl)-11-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17-yl-2-furancarboxylate|6alpha,9-difluoro-17beta-{[(fluoromethyl)sulfanyl]carbonyl}-11beta-hydroxy-16-methyl-3-oxoandrosta-1,4-dien-17alpha-yl 2-furoate|Androsta-1,4-diene-17-carbothioic acid, 6,9-difluoro-17-((2-     furanylcarbonyl)oxy)-11-hydroxy-16-methyl-3-oxo-, S-(fluoromethyl) ester, (6alpha,11beta,16alpha,17alpha)-|ANDROSTA-1,4-DIENE-17-CARBOTHIOIC ACID, 6,9-DIFLUORO-17-((2-FURANYLCARBONYL)OXY)-11-HYDROXY-16-METHYL-3-OXO-, S-(FLUOROMETHYL) ESTER, (6.ALPHA.,11.BETA.,16.ALPHA.,17.ALPHA.)-"
L-21649,5329450,,"InChI=1S/C23H24N4OS/c1-2-9-26(10-3-1)11-12-28-21-6-4-18(5-7-21)20-14-24-23-22(15-25-27(23)16-20)19-8-13-29-17-19/h4-8,13-17H,1-3,9-12H2",VOYMOBPSYVKQGF-UHFFFAOYSA-N,C23H24N4OS,404.5,"6-[4-(2-piperidin-1-ylethoxy)phenyl]-3-thiophen-3-ylpyrazolo[1,5-a]pyrimidine","L-21649|pyrazolo[1,5-a]pyrimidine 4e|BDBM5413|CHEMBL333021|SCHEMBL7622425|VOYMOBPSYVKQGF-UHFFFAOYSA-N|1-(2-{4-[3-(thiophen-3-yl)pyrazolo[1,5-a]pyrimidin-6-yl]phenoxy}ethyl)piperidine|6-(4-(2-(Piperidin-1-yl)ethoxy)phenyl)-3-(thiophen-3-yl)pyrazolo[1,5-a]pyrimidine|6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl]-3-thiophen-3-yl-pyrazolo[1,5-a]pyrimidine"
DEXIBUPROFEN,39912,,"InChI=1S/C13H18O2/c1-9(2)8-11-4-6-12(7-5-11)10(3)13(14)15/h4-7,9-10H,8H2,1-3H3,(H,14,15)/t10-/m0/s1",HEFNNWSXXWATRW-JTQLQIEISA-N,C13H18O2,206.28,(2S)-2-[4-(2-methylpropyl)phenyl]propanoic acid,"51146-56-6|DEXIBUPROFEN|Dexibuprofene|Dexibuprofeno|Seractil|s-ibuprofen|d-Ibuproten|(+)-(S)-p-Isobutylhydratropic acid|Dexibuprofenum|(2S)-2-(4-isobutylphenyl)propanoic acid|NSC-759814|671DKG7P5S|(2S)-2-[4-(2-methylpropyl)phenyl]propanoic acid|DTXSID9048724|CHEBI:43415|(+)-Ibuprofen|(S)-alpha-methyl-4-(2-methylpropyl)benzeneacetic acid|DTXCID6028650|Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, (S)-|(2S)-2-(4-(2-methylpropyl)phenyl)propanoic acid|RefChem:585862|M01AE14|(S)-(+)-Ibuprofen|(S)-2-(4-Isobutylphenyl)propanoic acid|S(+)-Ibuprofen|(S)-(+)-2-(4-Isobutylphenyl)propionic acid|MFCD00069289|(S)-(+)-4-Isobutyl-alpha-methylphenylacetic acid|Dexibuprofen (free acid)|S-(+)-ibuprofen|CHEMBL175|(S)-2-(4-Isobutylphenyl)propionic acid|51146-56-6 (free acid)|NCGC00016861-05|(S)-2-(4-isobutyl-phenyl)-propionic acid|CAS-51146-56-6|S-(+)-2-(4-Isobutylphenyl)propionic acid|(s)-(+)-4-isobutyl-a-methylphenylacetic acid|SMR000326688|Dexibuprofene [INN-French]|Dexibuprofenum [INN-Latin]|UNII-671DKG7P5S|Dexibuprofeno [INN-Spanish]|Atriscal|Dolomin|DexOptifen|d-Ibuprofen|Maxibufen Syr|Dexibuprofen [USAN:INN:BAN]|Maxibufen ER|ibuprofen-(S)|(+)-Ibuprophen|(2S)-2-[4-(2-Methylpropyl)phenyl]propionic acid; (S)-(+)-4-Isobutyl-alpha-methylphenylacetic acid; (S)-(+)-2-(4-Isobutylphenyl)propionic acid|(s)(+)ibuprofen|S (+) Ibuprofen|(s)(+) ibuprofen|Ibuprofen Impurity 78|(+)-(S)-Ibuprofen|(S)-(-)-Ibuprofen|Lopac-I-106|Prestwick0_000907|Prestwick1_000907|Prestwick2_000907|Prestwick3_000907|Lopac-I-4883|Dexibuprofen (USAN/INN)|DEXIBUPROFEN [INN]|DEXIBUPROFEN [USAN]|Lopac0_000654|SCHEMBL43531|BSPBio_000754|DEXIBUPROFEN [MART.]|MLS001066327|MLS001335879|MLS001335880|DEXIBUPROFEN [WHO-DD]|SPBio_002953|BPBio1_000830|orb1310605|SCHEMBL30091137|(S)-(+)-Ibuprofen (Standard)|HMS1570F16|HMS2097F16|HMS2231C07|HMS3262C09|HMS3714F16|HY-78131AR|Pharmakon1600-01502363|Tox21_113141|Tox21_500654|BDBM50169047|HY-78131A|NSC759814|AKOS015890528|AKOS015994628|CCG-204740|CS-1393|DB09213|FI24528|HS-0088|LP00654|NSC 759814|SDCCGSBI-0050633.P002|(S)-2-(p-Isobutylphenyl)propionic acid|NCGC00015529-01|NCGC00015529-02|NCGC00015529-03|NCGC00015529-11|NCGC00016861-01|NCGC00016861-02|NCGC00016861-03|NCGC00016861-06|NCGC00016861-13|NCGC00094017-01|NCGC00094017-02|NCGC00094017-04|NCGC00261339-01|SY046826|UNM-0000306099|AB00513957|EU-0100654|I-106|I0549|NS00098758|(S)-(+)-Ibuprofen, ReagentPlus(R), 99%|(s)-(+)-2-(4-isobutylphenyl) propionic acid|D03715|EN300-180104|O10202|AB00513957_07|146I566|A849905|F079519|Q420051|SR-01000075945|SR-01000761395|SR-01000075945-1|SR-01000761395-2|BRD-K14965640-001-03-3|BRD-K14965640-001-12-4|(+)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|Z1508914616|(alphaS)-alpha-Methyl-4-(2-methylpropyl)benzeneacetic acid|benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, (alphaS)-|BENZENEACETIC ACID, .ALPHA.-METHYL-4-(2-METHYLPROPYL)-, (S)-|Benzeneacetic acid, alpha-methyl-4-(2-methylpropyl)-, (alphaS)- (9CI)|(S)-(+)-Ibuprofen;(2S)-2-[4-(2-Methylpropyl)phenyl]propionic acid;DEXIBUPROFEN"
NICOTINE,89594,,"InChI=1S/C10H14N2/c1-12-7-3-5-10(12)9-4-2-6-11-8-9/h2,4,6,8,10H,3,5,7H2,1H3/t10-/m0/s1",SNICXCGAKADSCV-JTQLQIEISA-N,C10H14N2,162.23,3-[(2S)-1-methylpyrrolidin-2-yl]pyridine,"nicotine|L-Nicotine|54-11-5|(-)-Nicotine|(S)-Nicotine|(S)-3-(1-methylpyrrolidin-2-yl)pyridine|(S)-(-)-Nicotine|Habitrol|Nicotrol|3-[(2S)-1-methylpyrrolidin-2-yl]pyridine|Nicoderm|Nicoderm Cq|Fumetobac|Prostep|1-Methyl-2-(3-pyridyl)pyrrolidine|Flux MAAG|Nicotina|Nikotyna|Ortho N-4 dust|Ortho N-5 dust|XL All Insecticide|Niagara P.A. dust|Destruxol orchid spray|L(-)-nicotine|3-(N-Methylpyrollidino)pyridine|3-(N-Methylpyrrolidino)pyridine|Nicabate|Nicotinum|Niquitin|Tabazur|L-3-(1-Methyl-2-pyrrolidyl)pyridine|Ortho N-4 and N-5 dusts|Nicocide|Nicotin|Tendust|(-)-3-(1-Methyl-2-pyrrolidyl)pyridine|Black leaf|(S)-3-(1-Methyl-2-pyrrolidinyl)pyridine|Nico-dust|Nicotine alkaloid|Emo-nik|Nico-Fume|Mach-Nic|RCRA waste number P075|Nic-Sal|ENT 3,424|beta-Pyridyl-alpha-N-methylpyrrolidine|3-(2-(N-methylpyrrolidinyl))pyridine|3-((2S)-1-methylpyrrolidin-2-yl)pyridine|Pyridine, 3-(1-methyl-2-pyrrolidinyl)-, (S)-|6M3C89ZY6R|Pyrrolidine, 1-methyl-2-(3-pyridal)-|DTXSID1020930|CHEBI:17688|(S)-3-(N-methylpyrrolidin-2-yl)pyridine|3-(1-Methyl-2-pyrrolidinyl)pyridine|Pyridine, 3-(tetrahydro-1-methylpyrrol-2-yl)|Pyridine, 3-((2S)-1-methyl-2-pyrrolidinyl)-|DTXCID50930|NSC-5065|Pyridine, 3-[(2S)-1-methyl-2-pyrrolidinyl]-|CHEBI:18723|blip|Nicorelief|Nicopass|Nicopatch|Stoppers|bjwc nicotine|euqate nicotine|Stubit|nictoine gum|Lucy nicotine|Niquitin mint|Equate Nicotine|Leader Nicotine|NicFix|Nicorette Mint|Niquitin clr|quitine nicotine|Rexall Nicotine|Maxi Nicotine|Mini Nicotine|Nicorette invisi|Nicotine Mini|Nicotinum,|Careone Nicotine|Good Sense|Habitrol Lozenge|Sunmark Nicotine|Topcare Nicotine|NicFix Plus|HEB Nicotine|Nicotine polarilex|Nicotinell classic|Nicotinell support|Habitrol Step 1|Habitrol Step 2|Habitrol Step 3|Niquitin pre-quit|Stop Smoking Aid|Nicorette Original|Care One Nicotine|Nicoitne Polacrilex|DG Health nicotine|Nicotine transdermal|Niquitin minis mint|3-(1-Methyl-2-pyrrolidyl)pyridine|Basic Care Nicotine|Good Sense Nicotine|Nicotine Sugar Free|Nicotinell tts 10|Nicotinell tts 20|Nicotinell tts 30|Niquitin strips mint|Up and Up Nicotine|Health Mart Nicotine|Nicotine Mint Flavor|Topcare Nicotine Gum|Niquitin minis cherry|Niquitin minis orange|Members Mark Nicotine|Nicorette Fruit Chill|Harris Teeter Nicotine|Habitrol Lozenge Cherry|Nicotine Polacrilex Gum|RefChem:6661|Signature Care Nicotine|exchange select nicotine|up and up mini nicotine|Nicorette Cinnamon Surge|Good Sense Nicotine Mint|Nicorette Spearmint Burst|Nicorette White Ice Mint|Nicotine Polacrilex MINT|Up and Up Mint Nicotine|up and up cherry nicotine|foster and thrive nicotine|Nicotine COATED ice mint|Kirkland Signature Quit 2|Kirkland Signature Quit 4|foster and thrive STEP 1|foster and thrive STEP 2|foster and thrive STEP 3|Kirkland Signature Nicotine|Members Mark Mini Nicotine|Nicotine Transdermal System|Topcare Nicotine Polacrilex|Berkley and Jensen Nicotine|up and up uncoated nicotine|Nicotine Polacrilex Original|Nicotine Coated Fruit Flavor|Nicorette 4mg Cinnamon Surge|up and up mint mini nicotine|up and up nicotine mini mint|Nicotine Polacrilex, Original|up and up cherry ice nicotine|Up and Up Nicotine Polacrilex|NICOTINE POLACRILEX MINI|up and up citrus mini nicotine|Good Neighbor Pharmacy Nicotine|Health Mart Nicotine Polacrilex|Nicotine Polacrilex Coated Mint|Careone Mini Nicotine Polacrilex|Habitrol Lozenge Original Flavor|Nicotine Polacrilex Coated Fruit|Nicotine Polacrilex Lozenge Mint|up and up uncoated mint nicotine|Nicotine Polacrilex Lozenge 2 mg|Nicotine Polacrilex Lozenge 4 mg|Nicotine Transdermal System Patch|up and up coated cinnamon nicotine|up and up mini nicotine polacrilex|Nicotine Polacrilex coated cinnamon|Nicotine Polacrilex Origianl Flavor|Nicotine Polacrilex Original Flavor|Nicotine Transdermal System Step 1|Nicotine Transdermal System Step 2|Nicotine Transdermal System Step 3|good neighbor pharmacy nicotine mini|Nicotine Polacrilex Coated Ice Mint|NiEnjoy Nicotine Transdermal System|up and up coated cool mint nicotine|up and up uncoated original nicotine|up and up coated mint freeze nicotine|Berkley and Jensen Nicotine Polacrilex|UP AND UP COATED FRUIT NICOTINE|Clear Nicotine Transdermal System Patch|Nicorette White Mint nicotine polacrilex|LEADER NICOTINE TRANSDERMAL SYSTEM|Nicorette Fruit Chill nicotine polacrilex|Habitrol Nicotine Polacrilex Lozenge Mint|NiEnjoy Nicotine Transdermal System Patch|Leader Nicotine Transdermal System Step 1|Leader Nicotine Transdermal System Step 2|Leader Nicotine Transdermal System Step 3|Sielkin QUIT SMOKING NICOTINE PATCHES|Rugby Nicotine Polacrilex Gum, Mint Flavor|AMAZON BASIC CARE NICOTINE POLACRILEX|SEFUDUN QUIT SMOKING NICOTINE PATCHES|Nicorette 4mg Fruit Chill Gum, Lil Drug Store|Rugby Nicotine Polacrilex Gum, Original Flavor|Sielkin QUIT SMOKING NICOTINE PATCHES 14mg|Sielkin QUIT SMOKING NICOTINE PATCHES 21mg|Nicorette 4mg White Ice Mint Gum, Lil Drug Store|Rugby Nicotine Polacrilex Gum, Coated Mint Flavor|Rugby Nicotine Polacrilex Gum, Coated Fruit Flavor|200-193-3|686-240-2|Black Leaf 40|Nikotin|NSC5065|Pyridine, 3-(1-methyl-2-pyrrolidinyl)-|Nicotine polacrilex|Nicorette|S-(-)-Nicotine|MFCD00006369|NSC 5065|beta-Pyridyl-alpha-N-methyl pyrrolidine|3-(1-Methyl-2-pyrollidinyl)pyridine|(-)-3-(N-Methylpyrrolidino)pyridine|Micotine|1-Methyl-2-(3-pyridiyl)pyrrolidine|Nikotin [German]|Nikotyna [Polish]|104062-50-2|Nicotina [Italian]|Pyrrolidine, 1-methyl-2-(3-pyridyl)-|Nicotrol Inhaler|Nicotrol NS|Nicotine [for single use]|NICOTINE-L (BASE)|destruxol|(-)-1-Methyl-2-(3-pyridyl)pyrrolidine|fumeto bac|Caswell No. 597|Nicotine [BSI:ISO]|Nicotine-D salicylate|CAS-54-11-5|DL-tetrahydronicotyrine|Habitrol (TN)|Nicotine (USP)|Nicotine [ISO]|SMR000059074|CCRIS 1637|HSDB 1107|(S)-(-)-Nicotine (1.0 mg/mL in Methanol)|Nicotine [USP:BAN]|EINECS 200-193-3|methyl-2-pyrrolidinyl)pyridine|UN1654|RCRA waste no. P075|EPA Pesticide Chemical Code 056702|UNII-6M3C89ZY6R|delta-Nicotine|AI3-03424|Nicotine betadex|1-methyl-2-(3-pyridal)-pyrrolidene|nicotine s(-)|a-N-methylpyrrolidine|Campbell's nico-soap|3-N-methylpyrrolidine|R)-(+)-nicotine|a -N-methylpyrrolidine|CHEMBL3|1uw6|NICOTINE [HSDB]|NICOTINE (TPD)|alpha-N-methylpyrrolidine|NICOTINE [MI]|Nicotine [UN1654]|NICOTINE [VANDF]|NICOTINUM [HPUS]|(S)-(-)--nicotine|NICOTINE [MART.]|bmse000105|NICOTINE [WHO-DD]|(2S) 3-(1-Methyl-pyrrolidin-2-yl)-pyridine|EC 200-193-3|Nicotine polacrilex [USAN]|S-()-Nicotine-pyridine-d4|SCHEMBL20192|MLS001055457|MLS001335905|BIDD:GT0599|NICOTINE [ORANGE BOOK]|GTPL2585|SCHEMBL6810286|SCHEMBL7957968|NICOTINE [EP MONOGRAPH]|NICOTINE [USP MONOGRAPH]|SCHEMBL11568397|SCHEMBL29350932|BDBM82070|l-Nicotine, 1mg/ml in Methanol|l-Nicotine, 5mg/ml in Methanol|l-Nicotine, 10mg/ml in Methanol|l-Nicotine, 50mg/ml in Methanol|HMS2230H17|HMS3259E16|Nicotine [UN1654]  [Poison]|HY-B0638|l-Nicotine, 100mg/ml in Methanol|MSK20302|Nicotine 10 microg/mL in Methanol|Tox21_201814|Tox21_300174|Nicotine 100 microg/mL in Methanol|PDSP1_000113|PDSP1_000465|PDSP2_000463|PDSP2_000555|SBB012359|1-methyl-2-(3-pyridal)-Pyrrolidine|AKOS016843798|Nicotine 1000 microg/mL in Methanol|3-(1-methyl-2-pyrrolidinyl)-Pyridine|CCG-204892|CS-3999|DB00184|NC00577|SB12751|SDCCGMLS-0066911.P001|SDCCGSBI-0050785.P004|NCGC00090693-01|NCGC00090693-02|NCGC00090693-03|NCGC00090693-04|NCGC00090693-05|NCGC00090693-06|NCGC00090693-07|NCGC00090693-08|NCGC00090693-09|NCGC00254095-01|NCGC00259363-01|(-)-Nicotine, >=99% (GC), liquid|ST069320|3-[(S)-1-Methylpyrrolidin-2-yl]pyridine|SBI-0050785.P003|CAS_29790-52-1|N0079|NS00010445|C00745|D03365|EN300-304948|P10017|(-)-.beta.-Pyridyl-.alpha.-N-methylpyrrolidine|AB00694322_12|(-)-Nicotine, PESTANAL(R), analytical standard|006N369|3-((2S)-1-METHYL-2-PYRROLIDINYL)PYRIDINE|SR-05000001762-5|BRD-K05395900-322-02-1|BRD-K05395900-322-04-7|BRD-K05395900-322-05-4|Pyridine, 3-(tetrahydro-1-methylpyrrol-2-yl), (S)-|Q28086552|Z1198150037|434F7990-3240-4A43-ACEC-E6CC1E495FA0|(S)-(-)-NICOTINE; 3-[(2S)-1-METHYL-2-PYRROLIDINYL] PYRIDINE"
OMAPATRILAT,656629,,"InChI=1S/C19H24N2O4S2/c22-17(15(26)11-12-5-2-1-3-6-12)20-13-9-10-27-16-8-4-7-14(19(24)25)21(16)18(13)23/h1-3,5-6,13-16,26H,4,7-11H2,(H,20,22)(H,24,25)/t13-,14-,15-,16-/m0/s1",LVRLSYPNFFBYCZ-VGWMRTNUSA-N,C19H24N2O4S2,408.5,"(4S,7S,10aS)-5-oxo-4-[[(2S)-3-phenyl-2-sulfanylpropanoyl]amino]-2,3,4,7,8,9,10,10a-octahydropyrido[2,1-b][1,3]thiazepine-7-carboxylic acid","Omapatrilat|167305-00-2|BMS-186716|Vanlev|Omapatrilate|BMS-186716-01|36NLI90E7T|DTXSID80168273|(4S,7S,10aS)-Octahydro-4-((S)-alpha-mercaptohydrocinnamamido)-5-oxo-7H-pyrido(2,1-b)(1,3)thiazepine-7-carboxylic acid|octahydro-4-((2-mercapto-1-oxo-3-phenylpropyl)amino)-5-oxo-7H-pyrido(2,1-b)(1,3)thiazepine-7-carboxylic acid|omapatrilatum|(4S,7S,10aS)-Octahydro-4-[(S)-alpha-mercaptohydrocinnamamido]-5-oxo-7H-pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid|RefChem:856761|DTXCID4090764|(4S,7S,10aS)-5-oxo-4-((2S)-3-phenyl-2-sulfanylpropanamido)-octahydro-2H-pyrido(2,1-b)(1,3)thiazepine-7-carboxylic acid|Bms 186716|CHEMBL289556|(4S,7S,10aS)-5-oxo-4-[[(2S)-3-phenyl-2-sulfanylpropanoyl]amino]-2,3,4,7,8,9,10,10a-octahydropyrido[2,1-b][1,3]thiazepine-7-carboxylic acid|(4S,7S,10aS)-4-((S)-2-mercapto-3-phenylpropanamido)-5-oxooctahydro-2H-pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid|(4S,7S,10aS)-4-((S)-2-Mercapto-3-phenylpropanamido)-5-oxooctahydro-7H-pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid|Omapatrilat [USAN]|omapatrylate|UNII-36NLI90E7T|Omapatrilat (JAN/USAN/INN)|Omapatrilat [USAN:INN:BAN]|FT8|OMAPATRILAT [MI]|OMAPATRILAT [INN]|OMAPATRILAT [JAN]|OMAPATRILAT [VANDF]|OMAPATRILAT [MART.]|OMAPATRILAT [WHO-DD]|SCHEMBL130098|orb1706879|Omapatrilat, >=98% (HPLC)|CHEBI:135660|GLXC-22404|SGA30500|BDBM50073120|AKOS040742333|CS-6369|DB00886|NCGC00509984-01|DA-66337|HY-18208|MS-27025|NS00069248|D01970|G12899|Q7089596|(4S,6S,9aS)-6-((S)-2-Mercapto-3-phenyl-propionylamino)-5-oxo-octahydro-9-thia-4a-aza-benzocycloheptene-4-carboxylic acid|(4S,7S,10aS)-4-((S)-2-mercapto-3-phenylpropanamido)-5-oxo-octahydro-2H-pyrido[2,1-b][1,3]thiazepine-7-carboxylic acid|(4S,7S,10aS)-5-oxo-4-[[(2S)-3-phenyl-2-sulfanyl-propanoyl]amino]-2,3,4,7,8,9,10,10a-octahydropyrido[2,1-b][1,3]thiazepine-7-carboxylic acid|(4S-(4.ALPHA.(R*),7.ALPHA.,10A.BETA.))-OCTAHYDRO-4-((2-MERCAPTO-1-OXO-3-PHENYLPROPYL)AMINO)-5-OXO-7H-PYRIDO(2,1-B)(1,3)THIAZEPINE-7-CARBOXYLIC ACID|(4S-(4alpha(R*),7alpha,10abeta))-Octahydro-4-((2-mercapto-1-oxo-3-phenylpropyl)amino)-5-oxo-7H-pyrido(2,1-b)(1,3)thiazepine-7-carboxylic acid|159317-63-2|7H-Pyrido(2,1-b)(1,3)thiazepine-7-carboxylic acid, octahydro-4-(((2S)-2-mercapto-1-oxo-3-phenylpropyl)amino)-5-oxo-, (4S,7S,10aS)-|7H-Pyrido(2,1-b)(1,3)thiazepine-7-carboxylic acid, octahydro-4-((2-mercapto-1-oxo-3-phenylpropyl)amino)-5-oxo-, (4S-(4alpha(R*),7alpha,10abeta))-"
CYTISINICLINE,10235,,"InChI=1S/C11H14N2O/c14-11-3-1-2-10-9-4-8(5-12-6-9)7-13(10)11/h1-3,8-9,12H,4-7H2/t8-,9+/m0/s1",ANJTVLIZGCUXLD-DTWKUNHWSA-N,C11H14N2O,190.24,"(1R,9S)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one","CYTISINE|485-35-8|Baptitoxine|Sophorine|Cytisinicline|Baptitoxin|Laburnin|Cytiton|Ulexine|Ulexin|Cytitone|Citizin|Cystisine|Cytizin|6039 Sopharma|(1r,5s)-1,2,3,4,5,6-Hexahydro-8h-1,5-Methanopyrido[1,2-A][1,5]diazocin-8-One|citisiniclina|NSC-407282|CHEBI:4055|53S5U404NU|DTXSID00883395|(1R,9S)-7,11-diazatricyclo[7.3.1.02,7]trideca-2,4-dien-6-one|1,5-Methano-8H-pyrido(1,2-a)(1,5)diazocin-8-one, 1,2,3,4,5,6-hexahydro-|(1R,9S)-7,11-diazatricyclo[7.3.1.0^{2,7}]trideca-2,4-dien-6-one|citizine|cystisin|cytisiniclinum|(1R,9S)-7,11-diazatricyclo(7.3.1.02,7)trideca-2,4-dien-6-one|(1R,9S)-7,11-diazatricyclo(7.3.1.0^(2,7))trideca-2,4-dien-6-one|(1R,5S)-1,2,3,4,5,6-hexahydro-8H-1,5-methanopyrido(1,2-a)(1,5)diazocin-8-one|TBX-Free|RefChem:54921|DTXCID501022929|207-616-0|Tabex|(-)-Cytisine|Tsitizin|Cytisin|Tabax|(1R,5S)-3,4,5,6-Tetrahydro-1H-1,5-methanopyrido[1,2-a][1,5]diazocin-8(2H)-one|MFCD00136048|Cytisine (-)|1,5-Methano-8H-pyrido[1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R,5S)-|Cytisinicline [USAN]|CHEMBL497939|1,5-Methano-8H-pyrido(1,2-a)(1,5)diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R,5S)-|Baphitoxine|SMR001233264|HSDB 3560|MLS003171607|EINECS 207-616-0|NSC 407282|BRN 0083882|UNII-53S5U404NU|NSC407282|1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido(1,2-a)(1,5)diazocin-8-one|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-8H-pyrido[1,2a][1,5]diazocin-8-one|C5E|Prestwick_140|Cytisine ((+)-)|Tocris-1390|CYTISINE [HSDB]|CYTISINE [MI]|Cytisinicline (Standard)|115051-74-6|Prestwick3_000624|Baptitoxine;(?)-Cytisine|CYTISINE [MART.]|CYTISINICLINE [INN]|BSPBio_000588|Cytisine, >=99%, powder|5-24-02-00535 (Beilstein Handbook Reference)|MLS002153916|MLS002222174|SCHEMBL161398|CYTISINICLINE [WHO-DD]|BPBio1_000648|GTPL5347|orb1310572|(1R,9R)-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-6-one|(1S,9R)-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-6-one|HY-N0175R|1,2,3,4,5,6-Hexahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-8-one (cytisine)|Cytisine1,2,3,4,5,6-Hexahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-8-one|HMS2096N10|HMS2235L06|HMS3267D20|HMS3414N03|HMS3678L21|HMS3884L11|HY-N0175|MSK40318|TNP00030|BDBM50143282|HB2033|PDSP1_000461|s2287|WLN: T C666 A GVN LM&TTJ|AKOS000276818|AKOS015833102|CCG-208621|DB09028|FC09851|NCGC00016463-01|NCGC00016463-02|NCGC00016463-03|NCGC00016463-04|NCGC00017171-01|NCGC00025138-01|NCGC00025138-02|NCGC00179513-01|AC-34317|AS-19539|CAS-485-35-8|SY057153|CS-0007888|NS00067015|SW219952-1|Cytisine, >=99.0% (HPLC), >=99%|EN300-224852|485C358|F049425|Q417343|BRD-K74186897-001-02-5|BRD-K74186897-001-04-1|BRD-K74186897-001-10-8|BRD-K74186897-001-11-6|BRD-K74186897-001-12-4|BRD-K74186897-001-13-2|F9994-5373|Z1203159860|1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-|1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R)-|(1R,9S)-7,11-diazatricyclo[7.3.1.0,2,7]trideca-2,4-dien-6-one|(1R,9S)-7,11-diazatricyclo[7.3.1.0~2,7~]trideca-2,4-dien-6-one|1,2-a][1,5]diazocin-8-one, 1,2,3,4,5,6-hexahydro-, (1R-cis)-|(1R,5S)-1,2,3,4,5,6-Hexahydro-1,5-methano-pyrido[1,2-a][1,5]diazocin-8-one|(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-1,5-METHANO-8H-PYRIDO-(1,2-A)(1,5)DIAZOCIN-8-ONE|(1R,5S)-1,2,3,4,5,6-HEXAHYDRO-8H-1,5-METHANOPYRIDO(1,2-A)(1,5)DIAZOCIN-8-ONE (CYTISINE)"
NAXAGOLIDE,57533,,"InChI=1S/C15H21NO2/c1-2-7-16-8-9-18-15-13-10-12(17)5-3-11(13)4-6-14(15)16/h3,5,10,14-15,17H,2,4,6-9H2,1H3/t14-,15-/m1/s1",JCSREICEMHWFAY-HUUCEWRRSA-N,C15H21NO2,247.33,"(4aR,10bR)-4-propyl-2,3,4a,5,6,10b-hexahydrobenzo[h][1,4]benzoxazin-9-ol","NAXAGOLIDE|dopazinol|88058-88-2|Nazagolide|Naxagolida|Naxagolidum|(+)-PHNO|(+)-4-Propyl-9-hydroxynaphthoxazine|(r,r)-phno|22Z7E0X6OF|DTXSID60236782|2H-Naphth(1,2-b)-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-propyl-, (4aR-trans)-|4-Propyl-9-hydroxy-1,2,3,4a,5,6-hexahydronaphthoxazine|CHEBI:177372|(11C)(+)-PHNO|4-propyl-9-hydroxynaphthoxazine|N-0500|(11C)-(+)-PHNO|(11C)-(+)-propyl-hexahydro-naphtho-oxazin|RefChem:164887|1,2,3,4a,5,6-hexahydro-9-hydroxy-4-n-propyl-4H-naphth(1,2-b)(1,4)oxazine|3,4,4A,5,6,10B-hexahydro-4-propyl-2H-naphth(1,2-B)(1,4)oxozin-9-ol|DTXCID90159273|(10bR)-4-((1-11C)Propyl)-3,4,4a,5,6,10b-hexahydro-2H-naphtho(1,2-b)(1,4)oxazin-9-ol|(11C)-(+)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho(1,2-b)(1,4)oxazin-9-ol|2H-Naphth(1,2-b)-1,4-oxazin-9-ol, 3,4,4a,5,6,10b-hexahydro-4-(propyl-1-11C)-, (10bR)-|PHNO|Naxagolide [INN]|(4aR,10bR)-4-propyl-2,3,4a,5,6,10b-hexahydrobenzo[h][1,4]benzoxazin-9-ol|CHEMBL69271|(4aR,10bR)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol|CHEMBL1288585|Naxagolidum [INN-Latin]|Naxagolida [INN-Spanish]|UNII-22Z7E0X6OF|(+)-PHNO; (R,R)-PHNO; Dopazinol; Nazagolide|SCHEMBL221758|orb1705793|PHNO,(+)|GLXC-04938|BCP02364|BDBM50020217|BDBM50331552|EX-A10985|AKOS005146337|BCP9000980|MS-23506|HY-108237|CS-0027625|NS00122463|Q27253689|(4aR,10bR)-4-propyl-2H,3H,4H,4aH,5H,6H,10bH-naphtho[1,2-b][1,4]oxazin-9-ol|(4aR-trans)-3,4,4a,5,6,10b-hexahydro-4-propyl-2H-naphth[1,2-b]-1,4-oxazin-9-ol|(+)-(4AR,10BR)-3,4,4A,5,6,10B-HEXAHYDRO-4-PROPYL-2H-NAPHTH(1,2-B)-1,4-OXAZIN-9-OL|[11C]-(+)-(4aR,10bR)-4-propyl-3,4,4a,5,6,10b-hexahydro-2H-naphtho[1,2-b][1,4]oxazin-9-ol"
TAZOBACTAM,123630,,"InChI=1S/C10H12N4O5S/c1-10(5-13-3-2-11-12-13)8(9(16)17)14-6(15)4-7(14)20(10,18)19/h2-3,7-8H,4-5H2,1H3,(H,16,17)/t7-,8+,10+/m1/s1",LPQZKKCYTLCDGQ-WEDXCCLWSA-N,C10H12N4O5S,300.29,"(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid","Tazobactam|89786-04-9|Tazobactamum|YTR-830H|CL 298,741|CHEBI:9421|SE10G96M8W|NSC-759887|CXA201|YTR830|DTXSID8023634|(2S,3S,5R)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 4,4-dioxide|4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S,3S,5R)-|(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4$l^(6)-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid|(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S,3S,5R)-|RefChem:891206|DTXCID003634|J01CG02|YTR-830|Tazobactam acid|MFCD00867002|YTR 830H|(2S,3S,5R)-3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide|(2S,3S,5R)-3-METHYL-4,4,7-TRIOXO-3-(1H-1,2,3-TRIAZOL-1-YLMETHYL)-4-THIA-1-AZABICYCLO[3.2.0]HEPTANE-2-CARBOXYLIC ACID|CHEMBL404|YTR 830|(2S,3S,5R)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide|YTR 830 H|89786-04-9 (free acid)|CL-298741|CL-298741;YTR-830H|(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4lambda6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|C10H12N4O5S|(2S,3S,5R)-3-Methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid 4,4-dioxide|SR-01000872598|Tazobactamum [INN-Latin]|UNII-SE10G96M8W|YTR830H|CCRIS 2203|Tazobactam [USAN:USP:INN:BAN]|(2S,3S,5R)-3-[(1H-1,2,3-Triazol-1-yl)methyl]-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic Acid 4,4-Dioxide|1246733-29-8|Cl 298741|Tazobactam (Standard)|Tazobactam, Free acid|BRN 4787943|CL298741|TAZOBACTAM [MI]|TAZOBACTAM [INN]|TAZOBACTAM [JAN]|TAZOBACTAM [USAN]|EC 618-303-7|TAZOBACTAM [USP-RS]|TAZOBACTAM [WHO-DD]|BIDD:GT0212|SCHEMBL122302|orb1309188|Tazobactam (JP18/USP/INN)|GTPL10789|HY-B1418R|TAZOBACTAM [USP IMPURITY]|LPQZKKCYTLCDGQ-WEDXCCLWSA-N|A1H57|HMS3714G17|TAZOBACTAM [USP MONOGRAPH]|(2S,3S,5S)-3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid 4,4-dioxide|BCP09757|EX-A1377|HY-B1418|BDBM50053173|MSK158460|s3077|AKOS015960801|AC-7620|CCG-207890|CS-4914|DB01606|DS-8301|NSC 759887|(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4$l^{6}-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|AT111973|SY104963|NS00006778|T3732|C07771|D00660|D78146|786T049|Q423376|SR-01000872598-1|SR-01000872598-2|89786-04-9, 89785-84-2 (sodium salt)|BRD-K14312455-001-01-6|(2S,3S,5R)-3-((1H-1,2,3-triazol-1-yl)methyl)-3-methyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylicacid4,4-dioxide|(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-(triazol-1-ylmethyl)-4|E6-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-[(1H-1,2,3-triazol-1-yl)methyl]-4lambda(6)-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|(2S,3S,5R)-3-Methyl-4,4,7-trioxo-3-[1,2,3]triazol-1-ylmethyl-4-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid|(2S,3S,5R)-3-Methyl-4,4,7-trioxo-3-[1,2,3]triazol-1-ylmethyl-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid|(2S,3S,5R)-3-Methyl-4,4,7-trioxo-3-[1,2,3]triazol-1-ylmethyl-4lambda 6-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid|(2S,3S,5R)-3-methyl-4,4,7-trioxo-3-[1,2,3]triazol-1-ylmethyl-4lambda6-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid|3-Methyl-4,4,7-trioxo-3-[1,2,3]triazol-1-ylmethyl-4lambda*6*-thia-1-aza-bicyclo[3.2.0]heptane-2-carboxylic acid|4-Thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 3-methyl-7-oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, (2S-(2alpha,3beta,5alpha))-|4-Thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid, 3-methyl-7- oxo-3-(1H-1,2,3-triazol-1-ylmethyl)-, 4,4-dioxide, [2S- (2alpha,3beta,5alpha)]-"
PHENCYCLIDINE,6468,,"InChI=1S/C17H25N/c1-4-10-16(11-5-1)17(12-6-2-7-13-17)18-14-8-3-9-15-18/h1,4-5,10-11H,2-3,6-9,12-15H2",JTJMJGYZQZDUJJ-UHFFFAOYSA-N,C17H25N,243.4,1-(1-phenylcyclohexyl)piperidine,"PHENCYCLIDINE|1-(1-Phenylcyclohexyl)piperidine|Angel dust|Fenciclidina|Phencyclidinum|77-10-1|Piperidine, 1-(1-phenylcyclohexyl)-|Phencycline|Phenylcyclidine|Cl-395|CHEBI:8058|J1DOI7UV76|CL 395|J4.441E|DTXSID6023446|GP 121|Dust, Angel|RefChem:6117|DTXCID703446|CL395|PCP (Anesthetic)|Elephant tranquilizer|Peace pill|Tic Tac|Killer weed|1-(PHENYL-1-CYCLOHEXYL)PIPERIDINE|Supergrass|Cadillac|Crystal|Stardust|Surfer|Tranks|HOG|Whack|Magic mist|Zombie dust|Busy bee|DEA No. 7471|Cycline|Cyclones|Scuffle|Sherman|Superjoint|Superweed|Sheets|Snorts|Aurora borealis|Peace|Selma|Crystal joints|Goon|Pits|Horse tracks|Monkey dust|Whacky weed|Wobble weed|Angel hair|Angel mist|Peace weed|Gorilla biscuits|Mint weed|Mint dew|Super Kool|Green tea leaves|Hog Dust|Horse tranquilizer|Kay Jay|Animal tranquilizer|Monkey tranquilizer|Fenciclidina [INN-Spanish]|Phencyclidinum [INN-Latin]|MLS002320664|Phencyclidine [INN:BAN]|Phencyclidine-d5 Hydrochloride|Good [Street Name]|HSDB 6472|SMR001338811|UNII-J1DOI7UV76|Rocket fuel [Street Name]|BRN 1287039|Phencylidine|2pcp|Sernyl (Salt/Mix)|Elysion (Salt/Mix)|CJs|Sernylan (Salt/Mix)|PHENCYCLIDINE [MI]|Epitope ID:180852|PHENCYCLIDINE [INN]|PHENCYCLIDINE [HSDB]|Oprea1_593450|SCHEMBL42022|PHENCYCLIDINE [VANDF]|101887-87-0|5-20-02-00078 (Beilstein Handbook Reference)|PHENCYCLIDINE [WHO-DD]|CHEMBL275528|GTPL4282|BDBM83449|cid_9795678|KCA12479|PDSP1_001675|PDSP2_001658|AKOS015902745|Phencyclidine hydrochloride (Salt/Mix)|DB03575|NCGC00247332-01|NS00008732|Phencyclidine (PCP) 1.0 mg/ml in Methanol|1-(1-phenylcyclohexyl)piperidine;hydrochloride|C07575|Q407324"
URB-597,1383884,,"InChI=1S/C20H22N2O3/c21-19(23)16-8-4-6-14(12-16)15-7-5-11-18(13-15)25-20(24)22-17-9-2-1-3-10-17/h4-8,11-13,17H,1-3,9-10H2,(H2,21,23)(H,22,24)",ROFVXGGUISEHAM-UHFFFAOYSA-N,C20H22N2O3,338.4,[3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate,"cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester|RefChem:901194|546141-08-6|URB597|URB-597|3'-Carbamoyl-[1,1'-biphenyl]-3-yl cyclohexylcarbamate|URB 597|FAAH Inhibitor II|[3-(3-carbamoylphenyl)phenyl] N-cyclohexylcarbamate|KDS-4103|C20H22N2O3|MFCD05863934|Org-231295|3'-Carbamoylbiphenyl-3-yl cyclohexylcarbamate|3-(3-carbamoylphenyl)phenyl N-cyclohexylcarbamate|URB597 (KDS-4103)|PX47LB88FO|CHEMBL184238|Carbamic acid, N-cyclohexyl-, 3'-(aminocarbonyl)[1,1'-biphenyl]-3-yl ester|Cyclohexyl-carbamic acid 3'-carbamoyl-biphenyl-3-yl ester|SMR000524783|SR-01000342602|UNII-PX47LB88FO|CARBAMIC ACID, N-CYCLOHEXYL-, 3'-(AMINOCARBONYL)(1,1'-BIPHENYL)-3-YL ESTER|CARBAMIC ACID, CYCLOHEXYL-, 3'-(AMINOCARBONYL)[1,1'-BIPHENYL]-3-YL ESTER|SCHEMBL93842|MLS001210199|MLS006012031|GTPL4339|orb1300530|SCHEMBL29371698|BDBM26739|DTXSID70203046|EX-A769|KDS4103|CHEBI:188061|ROFVXGGUISEHAM-UHFFFAOYSA-N|GLXC-06710|HMS2844K18|HMS3648C09|HMS3656B07|HMS3884N12|HMS6018P08|BCP27727|HB2365|s2631|ZINC01238258|AKOS000674060|CCG-207886|CS-0266|NCGC00165915-01|NCGC00165915-03|URB597, >=98% (HPLC), powder|AC-26873|AS-18410|BU140504|HY-10864|ST080941|DB-366359|NS00017274|SW219633-1|3-Carbamoyl-Biphenyl-3-yl-Cyclohexylcarbamate|FAAH Inhibitor II - CAS 546141-08-6|3-[3-(N-cyclohexylcarbamoyloxy)phenyl]benzamide|Q7865591|SR-01000342602-1|SR-01000342602-3|BRD-K92169341-001-10-4|BRD-K92169341-001-11-2|Cyclohexylcarbamic acid 3 -carbamoyl-biphenyl-3-yl ester|3\'-Carbamoyl-[1,1\'-biphenyl]-3-yl cyclohexylcarbamate|3'-(3-aminocarbonyl)[1,1'-biphenyl]-3-yl)-cyclohexylcarbamat|3'-(aminocarbonyl)-[1,1'-biphenyl]-3-yl cyclohexylcarbamate|3'-(AMINOCARBONYL)(1,1'-BIPHENYL)-3-YL N-CYCLOHEXYLCARBAMATE"
NILOTINIB,644241,,"InChI=1S/C28H22F3N7O/c1-17-5-6-19(10-25(17)37-27-33-9-7-24(36-27)20-4-3-8-32-14-20)26(39)35-22-11-21(28(29,30)31)12-23(13-22)38-15-18(2)34-16-38/h3-16H,1-2H3,(H,35,39)(H,33,36,37)",HHZIURLSWUIHRB-UHFFFAOYSA-N,C28H22F3N7O,529.5,4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide,"Nilotinib|641571-10-0|AMN 107|AMN-107|nilotinibum|4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide|Danziten|NSC-747599|CHEBI:52172|4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide|DTXSID5042663|F41401512X|4-Methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide|4-Methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide|Benzamide, 4-methyl-N-((3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-|RefChem:58968|AMN 107 Base|DTXCID3022663|L01XE08|benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-, hydrochloride, hydrate|Tasigna|AMN107|MFCD09833716|Nilotinib (AMN-107)|Nilotinib free base|C28H22F3N7O|4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide|4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}benzamide|4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]benzamide|CHEMBL255863|641571-10-0 (free base)|NSC747599|4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)benzamide|4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-{(4-(pyridin-3-yl)pyrimidin-2-yl)amino}benzamide|benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-|4-Methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]benzamide|Nilotinib,AMN107,Tasigna;4-methyl-N-(3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-((4-pyridin-3-ylpyrimidin-2-yl)amino)benzamide|SMR002544680|Nilotinib [USAN]|Nilotinib [USAN:INN:BAN]|Nilotinib?|HSDB 7842|UNII-F41401512X|Nilotinib (Standard)|3gp0|NILOTINIB [INN]|NILOTINIB [MI]|Nilotinib (USAN/INN)|NILOTINIB [HSDB]|1353151-22-0|NILOTINIB [VANDF]|NILOTINIB [MART.]|EC 700-544-5|NILOTINIB [USP-RS]|NILOTINIB [WHO-DD]|SCHEMBL7901|NILOTINIB [EMA EPAR]|MLS003915611|MLS006010160|Nilotinib - Bio-X trade mark|GTPL5697|orb1308331|SCHEMBL29366964|SCHEMBL29580067|BCPP000149|HMS3244A13|HMS3244A14|HMS3244B13|HMS3295A23|HMS3654M07|HMS3748E11|HMS5079M05|BCP01367|EX-A8380|TAC35617|AC-647|BDBM50237710|HY-10159R|MSK159953|NSC800804|s1033|AKOS005063561|BCP9000989|CCG-264784|CS-0102|DB04868|FM10831|NSC 747599|NSC-800804|SB17315|SDCCGSBI-0634418.P004|NCGC00183285-01|NCGC00183285-03|NCGC00183285-04|NCGC00183285-09|NCGC00183285-15|4-Methyl-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-[5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl]benzamide|4-Methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)-phenyl)-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)benzamide|4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-benzamide|4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]benzamide|AS-16214|BN164654|HY-10159|N-(3-(3-(1H-Imidazolyl)propoxy)phenyl)-4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)benzamide|SY024415|NS00000665|SW218083-2|D08953|N-8207|AB01273978-01|AB01273978-02|AB01273978_03|EN300-7381984|571N100|F079266|Q412327|SR-01000931150|SR-01000931150-2|BRD-K81528515-001-04-7|BRD-K81528515-001-13-8|Z1741976994|4-Methyl-N-[3-(4-methyl-1-imidazolyl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridyl)-2-pyrimidyl]amino]benzamide|4-methyl-N-[3-(4-methyl-imidazol-1-yl)-5-trifluoromethyl-phenyl]-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)-benzamide|4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4 -pyridin-3-ylpyrimidin-2-yl)amino]benzamide|4-methyl-N-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino] benzamide|Benzamide, 4-methyl-N-(3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl)-3-(4-(3-pyridinyl)-2-pyrimidinyl)amino)-|Benzamide, 4-methyl-N-[3-(4-methyl-1H-imidazol-1-yl)-5-(trifluoromethyl)phenyl]-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]- (9CI)"
FORODESINE,135409409,,"InChI=1S/C11H14N4O4/c16-2-5-9(17)10(18)7(15-5)4-1-12-8-6(4)13-3-14-11(8)19/h1,3,5,7,9-10,12,15-18H,2H2,(H,13,14,19)/t5-,7+,9-,10+/m1/s1",IWKXDMQDITUYRK-KUBHLMPHSA-N,C11H14N4O4,266.25,"7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one","Forodesine|209799-67-7|Immucillin H|Fodosine|Immucillin-H|mundesine|BCX-1777|ImmH cpd|1,4-dideoxy-4-aza-1-(s)-(9-deazahypoxanthin-9-yl)-d-ribitol|Forodesina|CHEBI:43362|426X066ELK|(1S)-1,4-dideoxy-4-imino-(9-deazahypoxanthin-9-yl)-D-ribitol|NSC-717904|1-(9-deazahypoxanthin-9-yl)-1,4-dideoxy-1,4-iminoribitol|DTXSID50943276|4H-Pyrrolo(3,2-d)pyrimidin-4-one, 7-((2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl)-1,5-dihydro-|7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one|forodesinum|7-((2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-1,5-dihydro-4H-pyrrolo(3,2-d)pyrimidin-4-one|7-((2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-1,5-dihydropyrrolo(2,3-e)pyrimidin-4-one|7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydropyrrolo[2,3-e]pyrimidin-4-one|RefChem:600335|DTXCID101478471|BCX1777|MFCD09837827|7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one|CHEMBL218291|4H-Pyrrolo[3,2-d]pyrimidin-4-one, 7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)-2-pyrrolidinyl]-3,5-dihydro-|5(S),12(S)-diHETE|IMH|2-Furoyl Ecgonine Methyl Ester|Fodosine (TN)|188948-53-0|7-((2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-3H-pyrrolo[3,2-d]pyrimidin-4(5H)-one|7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one|Forodesine (USAN/INN)|(-)-7-((2S,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-1,5-dihydro-4H-pyrrolo(3,2-d)pyrimidin-4-one|(-)-7-[(2S,3S,4R,5R)-3,4-Dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one|(1R,2R,3S,5S)-Methyl 3-((furan-2-carbonyl)oxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate|7-((2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl)-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one|7-[(2S,3S,4R,5R)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-3,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one|1b8o|1g2o|1nw4|2ff1|2ff2|FORODESINE [MI]|FORODESINE [INN]|Forodesine; Immucillin H|Forodesine [USAN:INN]|FORODESINE [USAN]|FORODESINE [WHO-DD]|SCHEMBL506383|UNII-426X066ELK|Fodosine (proposed trade name)|GTPL8272|orb1707303|SCHEMBL3896676|SCHEMBL16321929|SCHEMBL30989336|EX-A7842M|TXFGPFIDYBMMJY-KUBHLMPHSA-N|BCX 1777|BDBM50195587|AKOS027326672|AKOS040741759|CS-3781|DB06185|MD11591|NSC 717904|NCGC00485883-01|(2R,3R,4S,5S)-2-(hydroxymethyl)-5-(4-hydroxy-5H-pyrrolo[3,2-d]pyrimidin-7-yl)pyrrolidine-3,4-diol|AS-35282|DA-53379|HY-16210|NS00070855|D06596|799F677|Q410040|BRD-K16505263-003-01-1|BRD-K16505263-003-02-9|(1S)-1,4-dideoxy-1-c-(4-hydroxypyrrolo[3,2-d]pyrimidin-7-yl)-1,4-imino-d-ribitol|7-[(2s,3s,4r,5r)-3,4-dihydroxy-5-hydroxymethyl-2-pyrrolidinyl]-1,5-dihydro-4h-pyrrolo-[3,2-d]-pyrimidin-4-one"
ULODESINE,135449518,,"InChI=1S/C12H16N4O3/c17-5-8-3-16(4-9(8)18)2-7-1-13-11-10(7)14-6-15-12(11)19/h1,6,8-9,13,17-18H,2-5H2,(H,14,15,19)/t8-,9+/m1/s1",AFNHHLILYQEHKK-BDAKNGLRSA-N,C12H16N4O3,264.28,"7-[[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]methyl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one","ULODESINE|548486-59-5|DADMe-immucillin H|BCX4208|Ulodesina|JNG8L9460Y|BCX-4208|R-3421|DTXSID00203332|LR-09|4H-PYRROLO(3,2-D)PYRIMIDIN-4-ONE, 1,5-DIHYDRO-7-(((3R,4R)-3-HYDROXY-4-(HYDROXYMETHYL)-1-PYRROLIDINYL)METHYL)-|7-(((3R,4R)-3-HYDROXY-4-(HYDROXYMETHYL)PYRROLIDIN-1-YL)METHYL(-1,5-DIHYDRO-4H-PYRROLO(3,2-D)PYRIMIDIN-4-ONE|7-(((3R,4R)-3-HYDROXY-4-(HYDROXYMETHYL)PYRROLIDIN-1-YL)METHYL)-3,5-DIHYDRO-4H-PYRROLO(3,2-D)PYRIMIDIN-4-ONE|ulodesinum|DADMe-immucillin-H|RefChem:933784|DTXCID00125823|7-(((3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl)methyl)-3H,4H,5H-pyrrolo(3,2-d)pyrimidin-4-one|CHEMBL269864|7-(((3R,4R)-3-Hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl)methyl)-1H-pyrrolo[3,2-d]pyrimidin-4(5H)-one|7-[[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]methyl]-1,5-dihydropyrrolo[3,2-d]pyrimidin-4-one|7-[[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]methyl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one|Ulodesine [USAN]|DADMe-ImmH,7|Ulodesine [USAN:INN]|UNII-JNG8L9460Y|BCX-3408|1n3i|ULODESINE [INN]|Ulodesine (USAN/INN)|7-[[(3R,4R)-3-(hydroxymethyl)-4-oxidanyl-pyrrolidin-1-ium-1-yl]methyl]-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one|ULODESINE [WHO-DD]|SCHEMBL474735|orb1741404|SCHEMBL16320802|BDBM22109|EX-A12265|DB12353|HY-19480|MS-23730|CS-0015580|NS00070138|D10431|F82076|Q27281592|BCX4208, BCX 4208, BCX-4208, Ulodesine, DADMe-immucillin H|7-{[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]methyl}-1,5-dihydro-4H-pyrrolo[3,2-d]pyrimidin-4-one|7-{[(3R,4R)-3-hydroxy-4-(hydroxymethyl)pyrrolidin-1-yl]methyl}-1H,4H,5H-pyrrolo[3,2-d]pyrimidin-4-one|7-{[(3R,4R)-3-HYDROXY-4-(HYDROXYMETHYL)PYRROLIDIN-1-YL]METHYL}-3H,5H-PYRROLO[3,2-D]PYRIMIDIN-4-ONE"
FENOFIBRIC ACID,64929,,"InChI=1S/C17H15ClO4/c1-17(2,16(20)21)22-14-9-5-12(6-10-14)15(19)11-3-7-13(18)8-4-11/h3-10H,1-2H3,(H,20,21)",MQOBSOSZFYZQOK-UHFFFAOYSA-N,C17H15ClO4,318.7,2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid,"Fenofibric acid|42017-89-0|Procetofenic acid|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropanoic acid|2-[4-(4-chlorobenzoyl)phenoxy]-2-methylpropanoic acid|BGF9MN2HU1|Fibricor|NSC-281318|Fenofibrate free acid|CHEBI:83469|Propanoic acid, 2-(4-(4-chlorobenzoyl)phenoxy)-2-methyl-|LF-153|DTXSID8041030|Propanoic acid, 2-[4-(4-chlorobenzoyl)phenoxy]-2-methyl-|Fenocor-67|RefChem:55183|2-(4-(4'-chlorophenoxy)phenoxy)propionic acid|ABT335|DTXCID6021030|2-methyl-((4'-4-chlorobenxoly)-2-phenoxy)propionic acid|2-methyl-((4'-p-chlorobenzoyl)-2-phenoxy)propionic acid|FENOFIBRIC ACID DELAYED-RELEASE|255-626-9|447-850-2|Trilipix|NSC 281318|2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic Acid|LF 153|MFCD00792461|CHEMBL981|Fenofibric acid (Standard)|2-{4-[(4-chlorophenyl)carbonyl]phenoxy}-2-methylpropanoic acid|2-(4-(4-Chlorobenzoyl)phenoxy)-2-methylpropionic acid|Fenofibricacid|alpha 1081|2-[4-(4-chlorobenzene-1-carbonyl)phenoxy]-2-methylpropanoic acid|LF 178 acid|ABT 335|FNF Acid|CCRIS 7302|EINECS 255-626-9|UNII-BGF9MN2HU1|Fenofibrate EP Impurity B|BRN 2058973|fenofibric-acid|feno-fibric acid|2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropanoic Acid (Fenofibric Acid)|Fibricor (TN)|F5A|2-[4-(4-Chlorobenzoyl)phenoxy]-2-methyl-propanoic Acid|SCHEMBL16377|GTPL2662|orb1308727|FENOFIBRIC ACID [VANDF]|BDBM28700|HY-B0760R|FENOFIBRIC ACID [USP-RS]|FENOFIBRIC ACID [WHO-DD]|Choline Fenofibrate EP Impurity B|HMS5083D07|FENOFIBRATE FREE ACID [MI]|BCP22437|HY-B0760|Fenofibric acid, analytical standard|MSK163699|NSC281318|s4527|FENOFIBRIC ACID [ORANGE BOOK]|AKOS015889489|CCG-213311|DB13873|FF23254|KS-1234|AC-22277|SY052754|CS-0694864|F1011|NS00000286|ST50998899|D11579|D83849|Fenofibric acid 100 microg/mL in Acetonitrile|AB01563028_01|EN300-1697940|017F890|F242950|BRD-K30213273-001-01-6|Q27077290|2-[4-(4-Chlorobenzoyl)-phenoxy]-2-methylpropionic acid|2-[4-(4-Chlorobenzoyl)phenoxy]-2-methylpropionic acid, 95%|Fenofibrate impurity B, European Pharmacopoeia (EP) Reference Standard|2-[4-(4-Chlorobenzoyl)phenoxy]-2-methyl-propanoic acid;FNF acid;NSC 281318"
LOMOFUNGIN,multiply,multiply,multiply,multiply,multiply,multiply,multiply,multiply
CHLORPHENIRAMINE,2725,,"InChI=1S/C16H19ClN2/c1-19(2)12-10-15(16-5-3-4-11-18-16)13-6-8-14(17)9-7-13/h3-9,11,15H,10,12H2,1-2H3",SOYKEARSMXGVTM-UHFFFAOYSA-N,C16H19ClN2,274.79,"3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine","chlorpheniramine|Chlorphenamine|132-22-9|Chlorophenylpyridamine|Clorfeniramina|Clorfenamina|Haynon|Chloropheniramine|Allergican|Allergisan|Histadur|Chlorpheniraminum|Chlorprophenpyridamine|Chloroprophenpyridamine|Chlorphenaminum|4-Chloropheniramine|Clofeniramina|Chlorphenamin|1-(p-Chlorophenyl)-1-(2-pyridyl)-3-dimethylaminopropane|3-(p-Chlorophenyl)-3-(2-pyridyl)-N,N-dimethylpropylamine|gamma-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|gamma-(4-Chlorophenyl)-gamma-(2-pyridyl)propyldimethylamine|1-(p-Chlorophenyl)-1-(2-pyridyl)-3-N,N-dimethylpropylamine|3-(4-chlorophenyl)-N,N-dimethyl-3-pyridin-2-ylpropan-1-amine|CHEBI:52010|3U6IO1965U|3-(4-chlorophenyl)-N,N-dimethyl-3-(2-pyridyl)propan-1-amine|2-(p-Chloro-alpha-(2-(dimethylamino)ethyl)benzyl)pyridine|DTXSID0022804|Pyridine, 2-(p-chloro-alpha-(2-(dimethylamino)ethyl)benzyl)-|Hayon|TUZISTRA COMPONENET OF CHLORPHENIRAMINE|2-[p-chloro-alpha-[2-(dimethylamino)ethyl]benzyl]pyridine|(3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl)dimethylamine|[3-(4-chlorophenyl)-3-(pyridin-2-yl)propyl]dimethylamine|Cloro-Trimeton|(+-)-Chlorpheniramine|Tannate, Chlorpheniramine|RefChem:390707|DTXCID402804|R06AB04|205-054-0|Chloropheniramine-d4|Teldrin|Chlor-trimeton|Polaronil|Chlorpheniramine polistirex|3-(4-chlorophenyl)-N,N-dimethyl-3-(pyridin-2-yl)propan-1-amine|Aller-Chlor|Chlor-tripolon|Chlorphenamine [INN]|2-Pyridinepropanamine, gamma-(4-chlorophenyl)-N,N-dimethyl-|CHEMBL505|Chlorphenamine Maleate|Dexchlorpheniramine free base|Chloropiril|25523-97-1 (free base)|Chlorphenamine (INN)|Chloropheniramine maleate|Telachlor|Clorfeniramina [Italian]|(R)-Chloropheniramine|Clorfenamina [INN-Spanish]|Chlorphenaminum [INN-Latin]|HSDB 3032|EINECS 205-054-0|Chlorphenamine [INN:BAN]|[3-(4-Chlorophenyl)-3-(2-pyridyl)propyl]dimethylamine|PiriIton|UNII-3U6IO1965U|Chlor-Pro|[3H]Chlorphenamine|Clofeniramina (TN)|[3H]Chlorpheniramine|chlorpheniaramine maleate|S-(+)-Chlorpheniramine|Prestwick0_000117|Prestwick1_000117|Prestwick2_000117|Prestwick3_000117|NCGC00015227-04|5-HT,N-ACETYL|SCHEMBL4219|Lopac0_000261|Oprea1_779072|BSPBio_000134|CHLORPHENIRAMINE [MI]|DivK1c_000596|SPBio_002073|CHLORPHENIRAMINE [HSDB]|BPBio1_000148|GTPL6976|orb1689526|CHLORPHENAMINE [WHO-DD]|CHLORPHENIRAMINE [VANDF]|SCHEMBL29687335|BDBM35938|KBio1_000596|Chlorpheniramine-d6see c424303|NINDS_000596|783AHI015X|HMS2090M21|HMS3428J07|Chlorpheniramine polistirex [USAN]|2-Pyridinepropanamine, .gamma.-(4-chlorophenyl)-N,N-dimethyl-|HBA18809|HY-B0286|BBL012285|MFCD00053581|SBB017260|STK736174|AKOS001650136|AKOS022060794|CCG-108982|DB01114|SB19135|SDCCGSBI-0050249.P002|IDI1_000596|NCGC00015227-03|NCGC00015227-05|NCGC00015227-06|NCGC00015227-09|NCGC00015227-19|NCGC00162108-01|NCGC00162108-02|DA-62286|ST076791|CS-0009285|NS00010179|C06905|D07398|EN300-708772|G77687|L000003|Q420133|BRD-A04553218-050-03-0|BRD-A04553218-050-08-9|BRD-A04553218-050-16-2|pyridine, 2-[p-chloro-alpha-(2-dimethylaminoethyl)benzyl]-|.gamma.-(4-Chlorophenyl)-N,N-dimethyl-2-pyridinepropanamine|2-(P-CHLORO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)BENZYL)PYRIDINE|N-[3-(4-Chlorophenyl)-3-(2-pyridinyl)propyl]-N,N-dimethylamine #|n.-Propanamine, 3-(4-chlorophenyl)-3-(2-pyridyl)-N,N-dimethyl-|2-Pyridinepropanamine, .gamma.-(4-chlorophenyl)-N,N-dimethyl-, (S)-|Pyridine, 2-[p-chloro-.alpha.-[2-(dimethylamino)ethyl]benzyl]-, (S)-(+)-"
HOMIDIUM BROMIDE,14710,,"InChI=1S/C21H19N3.BrH/c1-2-24-20-13-16(23)9-11-18(20)17-10-8-15(22)12-19(17)21(24)14-6-4-3-5-7-14;/h3-13,23H,2,22H2,1H3;1H",ZMMJGEGLRURXTF-UHFFFAOYSA-N,C21H20BrN3,394.3,"5-ethyl-6-phenylphenanthridin-5-ium-3,8-diamine;bromide","ETHIDIUM BROMIDE|1239-45-8|Homidium bromide|Dromilac|EtBr|3,8-Diamino-5-ethyl-6-phenylphenanthridinium bromide|Ethydium bromide|Bromure d'homidium|Bromuro de homidio|Homidii bromidum|2,7-Diamino-10-ethyl-9-phenylphenanthridinium bromide|2,7-Diamino-9-phenyl-10-ethylphenanthridinium bromide|2,7-Diamino-9-phenylphenanthridine ethobromide|NSC-268986|RD 1572|059NUO2Z1L|CHEBI:4883|DTXSID8025258|DTXCID605258|Bromide, Ethidium|Bromide, Homidium|RefChem:138396|214-984-6|3,8-Diamino-5-ethyl-6-phenylphenanthridin-5-ium bromide|Phenanthridinium, 3,8-diamino-5-ethyl-6-phenyl-, bromide (1:1)|MFCD00011724|Phenanthridinium, 3,8-diamino-5-ethyl-6-phenyl-, bromide|Ethidium (bromide)|Ethidium bromide(EB)|5-ethyl-6-phenylphenanthridin-5-ium-3,8-diamine;bromide|MLS002702536|NSC268986|NCGC00091387-01|NCGC00095070-01|CHEMBL284328|Homidium bromide [INN:BAN]|CAS-1239-45-8|Homidii bromidum [INN-Latin]|CCRIS 1017|HSDB 7297|Bromure d'homidium [INN-French]|Bromuro de homidio [INN-Spanish]|EINECS 214-984-6|NSC 268986|ethidiumbromide|UNII-059NUO2Z1L|3,8-Diamino-1-ethyl-6-phenylphenantridinium bromide|AI3-62997|5-ethyl-6-phenylphenanthridine-3,8-diamine, bromide|Ethidium bromide, 98%|SCHEMBL20520|HOMIDIUM BROMIDE [MI]|SPECTRUM1503806|HOMIDIUM BROMIDE [INN]|Ethidium bromide, >=95.0%|orb1309347|HOMIDIUM BROMIDE [HSDB]|SCHEMBL29376492|SCHEMBL29498260|HMS502O22|HOMIDIUM BROMIDE [MART.]|HMS1922I08|HMS3868D03|HMS5081D20|Pharmakon1600-01503806|Ethidium bromide, ~95% (HPLC)|HY-D0021|Tox21_111123|Tox21_111410|Tox21_202511|CCG-39365|HB9326|NSC758630|AKOS015904050|Tox21_111410_1|Ethidium bromide solution, 1% in H2O|Ethidium bromide, electrophoresis grade|FE10537|NSC-758630|NCGC00091387-08|NCGC00095070-02|NCGC00260060-01|AS-79030|SMR001566146|DB-062201|CS-0009917|E0370|E1363|Ethidium Bromide solution, 10mg/mL in H2O|NS00081473|ST50308645|F16485|SR-01000872761|SR-01000872761-1|Ethidium bromide, for fluorescence, >=95.0% (HPLC)|Phenanthridinium,8-diamino-5-ethyl-6-phenyl-, bromide|WLN: T B666 HKJ EJ H2 IR& LZ &E &9/26|Ethidium bromide, ~10 mg/tablet ethidium bromide, tablet|Ethidium bromide, BioReagent, for molecular biology, powder|J Mol Biol 13: 269 (1965); 27: 87 (1967)|2,7-Diamino-10-ethyl-9-phenylphenanthridinium bromide, 1% aqueous solution|Ethidium Bromide (0.5mg/mL in Water) (in Dropper Bottle) [for Electrophoresis]"
TALMAPIMOD,9871074,,"InChI=1S/C27H30ClFN4O3/c1-16-13-33(17(2)12-32(16)14-18-6-8-19(29)9-7-18)26(35)21-10-20-22(25(34)27(36)30(3)4)15-31(5)24(20)11-23(21)28/h6-11,15-17H,12-14H2,1-5H3/t16-,17+/m0/s1",ZMELOYOKMZBMRB-DLBZAZTESA-N,C27H30ClFN4O3,513.0,"2-[6-chloro-5-[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethylpiperazine-1-carbonyl]-1-methylindol-3-yl]-N,N-dimethyl-2-oxoacetamide","Talmapimod|309913-83-5|SCIO-469|SCIO 469|Scios 469|B1E00KQ6NT|CHEBI:90683|1H-Indole-3-acetamide, 6-chloro-5-[[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-N,N,1-trimethyl-alpha-oxo-|2-(6-Chloro-5-{[(2r,5s)-4-(4-Fluorobenzyl)-2,5-Dimethylpiperazin-1-Yl]carbonyl}-1-Methyl-1h-Indol-3-Yl)-N,N-Dimethyl-2-Oxoacetamide|2-[6-chloro-5-[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethylpiperazine-1-carbonyl]-1-methylindol-3-yl]-N,N-dimethyl-2-oxoacetamide|1H-Indole-3-acetamide, 6-chloro-5-(((2R,5S)-4-((4-fluorophenyl)methyl)-2,5-dimethyl-1-piperazinyl)carbonyl)-N,N,1-trimethyl-alpha-oxo-|2-(6-chloro-5-(((2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl)carbonyl)-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide|talmapimodum|2-(6-chloro-5-((2R,5S)-4-((4-fluorophenyl)methyl)-2,5-dimethylpiperazine-1-carbonyl)-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide|2-(6-chloro-5-((2R,5S)-4-((4-fluorophenyl)methyl)-2,5-dimethylpiperazine-1-carbonyl)-1-methylindol-3-yl)-N,N-dimethyl-2-oxoacetamide|2-(6-chloro-5-{(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethylpiperazine-1-carbonyl}-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide|2-[6-Chloro-5-[[(2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazin-1-yl]carbonyl]-1-methyl-1H-indol-3-yl]-N,N-dimethyl-2-oxoacetamide|RefChem:890880|rac-Talmapimod|CHEMBL514201|309913-83-5 (free base)|2-(6-chloro-5-((2R,5S)-4-(4-fluorobenzyl)-2,5-dimethylpiperazine-1-carbonyl)-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide|309915-13-7|Talmapimod [USAN]|Talmapimod [USAN:INN]|UNII-B1E00KQ6NT|TALMAPIMOD [INN]|Talmapimod (USAN/INN)|TALMAPIMOD [WHO-DD]|C27H30ClFN4O3|SCIO469|MLS006010308|GTPL7817|orb1309113|SCHEMBL4779242|SCHEMBL29394770|SCHEMBL29437775|DTXSID10953119|GLXC-27441|BDBM50266947|EX-A11087|NSC777446|NSC800941|AKOS030526777|CS-5645|DB05412|NSC-777446|NSC-800941|NCGC00263140-01|NCGC00263140-03|2-[6-chloro-5-[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-piperazine-1-carbonyl]-1-methyl-indol-3-yl]-N,N-dimethyl-2-oxo-acetamide|HY-10406|MS-29524|SMR004701374|NS00072037|D09386|E98853|913T835|BRD-K17555800-001-01-9|BRD-K17555800-003-01-5|Q27088933|1H-INDOLE-3-ACETAMIDE, 6-CHLORO-5-(((2R,5S)-4-((4-FLUOROPHENYL)METHYL)-2,5-DIMETHYL-1-PIPERAZINYL)CARBONYL)-N,N,1-TRIMETHYL-.ALPHA.-OXO-|2-(6-Chloro-5-{4-[(4-fluorophenyl)methyl]-2,5-dimethylpiperazine-1-carbonyl}-1-methyl-1H-indol-3-yl)-N,N-dimethyl-2-oxoacetamide|rel-6-Chloro-5-[[(2R,5S)-4-[(4-fluorophenyl)methyl]-2,5-dimethyl-1-piperazinyl]carbonyl]-N,N,1-trimethyl-a-oxo-1H-indole-3-acetamide; SCIO 282; SD 282"
TROGLITAZONE,5591,,"InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28)",GXPHKUHSUJUWKP-UHFFFAOYSA-N,C24H27NO5S,441.5,"5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","troglitazone|97322-87-7|Rezulin|Romglizone|Prelay|CS-045|Romozin|Noscal|troglitazona|troglitazonum|CI-991|GR92132X|GR-92132X|CHEBI:9753|DTXSID8023719|5-(4-(6-Hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl)thiazolidine-2,4-dione|CS045|I66ZZ0ZN0E|DTXCID603719|2,4-Thiazolidinedione, 5-((4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy)phenyl)methyl)-|5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-2,4-thiazolidinedione|5-{4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methoxy]benzyl}-1,3-thiazolidine-2,4-dione|5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]thiazolidine-2,4-dione|2,4-thiazolidinedione, 5-[[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-|5-((4-((3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy)phenyl)methyl)-2,4-Thiazolidinedione|5-((4-((6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy)phenyl)methyl)-1,3-thiazolidine-2,4-dione|5-(4-((6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methoxy)benzyl)-1,3-thiazolidine-2,4-dione|5-[[4-[(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione|RefChem:56538|GlyTouCan:G22199FT|A10BG01|G22199FT|5-(4-((6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy)benzyl)-2,4-thiazolidinedione|5-((4-((6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-1-benzopyran-2-yl)methoxy)phenyl)methyl)-1,3-thiazolidine-2,4-dione|5-(4-((6-Hydroxy-2,5,7,8-tetramethylchroman-2-yl-methoxy)benzyl)-2,4-thiazolidinedione)-T|Rezulin (TN)|CS 045|GR 92132X|CCRIS 8969|CI 991|(+-)-all-rac-5-(p-((6-Hydroxy-2,5,7,8-tetramethyl-2-chromanyl)methoxy)benzyl)-2,4-thiazolidinedione|5-(4-((6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy)benzyl)thiazolidine-2,4-dione|MFCD00878416|Troglitazone (CS-045)|5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione|NCGC00164445-01|BDBM50101974|5-[(4-{[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2H-chromen-2-yl)methyl]oxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione|CAS-97322-87-7|SR-05000000454|UNII-I66ZZ0ZN0E|BRN 4338399|Troglitazone (JAN/USAN/INN)|Troglitazone [USAN:INN:BAN]|Troglitazone (Standard)|Spectrum5_001973|UPCMLD-DP017|SCHEMBL4959|(+/-)-5-[4-[(6-hydroxy-2,5,7,8-tetramethylchroman-2-yl)methoxy]benzyl]-2,4-thiazolidinedione|MLS006010817|GTPL2693|orb1304465|CHEMBL3542292|SCHEMBL29349864|UPCMLD-DP017:001|UPCMLD-DP017:002|Troglitazone, >=98% (HPLC)|GLXC-03930|HMS2089D22|HMS2093D04|HMS3649G12|HMS3713D08|HMS5086A11|BCP06753|EX-A3782|MSK10690|Tox21_112119|Tox21_300470|BDBM50088494|HB2559|HSCI1_000037|HY-50935R|s8432|AKOS000281116|AKOS024457434|Tox21_112119_1|Troglitazone - CAS 97322-87-7|CCG-208125|CS-1634|DB00197|FT28613|SMP2_000224|NCGC00161599-01|NCGC00161599-02|NCGC00161599-03|NCGC00161599-04|NCGC00161599-05|NCGC00161599-06|NCGC00161599-07|NCGC00161599-08|NCGC00161599-09|NCGC00161599-11|NCGC00254440-01|5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl)methoxy]phenyl]methyl]thiazolidine-2,4-dione|AC-31453|AS-56378|HY-50935|SMR001550129|DB-057670|NS00015646|T3920|D00395|H12073|AB00643330-02|322T877|Q7844989|SR-05000000454-2|SR-05000000454-3|SR-05000000454-5|BRD-A13084692-001-02-5|BRD-A13084692-001-17-3|5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]-2,4-dioxothiazolidine|5-[4-(6-hydroxy-2,5,7,8-tetramethylchroman-2-ylmethoxy)benzyl]thiazolidine -2,4-dione|(5R)-5-[[4-[[(2S)-6-hydroxy-2,5,7,8-tetramethyl-chroman-2-yl]methoxy]phenyl]methyl]thiazolidine-2,4-dione|2,4-Thiazolidinedione, 5-[[4-[(3,4-dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]- (9CI)|5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1- benzopyran-2-yl)methoxy]phenyl]methyl]-2,4-thiazlidinedione|5-[[4-[(3,4-Dihydro-6-hydroxy-2,5,7,8-tetramethyl-2H-1-benzopyran-2-yl)methoxy]phenyl]methyl]-2,4-thiazolidinedione;CI 991;CS 045|5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dioneE|5-{4-(6-hydroxy-2, 5, 7, 8-tetramethylchroman-2-yl-methoxy) benzyl) thiazolidine-2,4-dione"
PIOGLITAZONE,4829,,"InChI=1S/C19H20N2O3S/c1-2-13-3-6-15(20-12-13)9-10-24-16-7-4-14(5-8-16)11-17-18(22)21-19(23)25-17/h3-8,12,17H,2,9-11H2,1H3,(H,21,22,23)",HYAFETHFCAUJAY-UHFFFAOYSA-N,C19H20N2O3S,356.4,"5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","Pioglitazone|111025-46-8|Glustin|Zactos|Pioglitazona|Pioglitazonum|AD-4833|5-[[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione|CHEBI:8228|5-[[4-[2-(5-Ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-2,4-thiazolidinedione|X4OV71U42S|U-72107|5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-1,3-thiazolidine-2,4-dione|5-[4-[2-(5-ETHYL-2-PYRIDYL)ETHOXY]BENZYL]-2,4-THIAZOLIDINEDIONE|DTXSID3037129|5-(4-(2-(5-ethyl-2-pyridyl)ethoxy)benzyl)-2,4-thiazolidinedione|5-((4-(2-(5-Ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|5-({4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl}methyl)-1,3-thiazolidine-2,4-dione|(+-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-, (+-)-|U72,107A|5-{4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl}-2,4-thiazolidinedione|5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-1,3-thiazolidine-2,4-dione|5-((4-(2-(5-ethylpyridin-2-yl)ethoxy)phenyl)methyl)-1,3-thiazolidine-2,4-dione|RefChem:56525|DTXCID1017129|A10BG03|AD4833|U72107A|601-029-7|921-004-7|Actos|105355-27-9|Pioglitazonum [INN-Latin]|Pioglitazona [INN-Spanish]|5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)thiazolidine-2,4-dione|Pioglitazone (Actos)|U 72107|MFCD00865504|C19H20N2O3S|pioglitazone (INN)|105390-47-4|Actos (TN)|2,4-thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-|5-[4-[2-(5-Ethyl-2-pyridyl)ethoxy]benzyl]thiazolidine-2,4-dione|PIOGLITAZONE [INN]|Pioglitazone [BAN:INN]|Pioglitazone [INN:BAN]|Piozone|Pioglu|2,4-Thiazolidinedione, 5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-|HSDB 7322|U-72107E|UNII-X4OV71U42S|Pioglitazone?|SR-01000763737|Pioglitazone base|5-(4-(2-(5-ETHYL-2-PYRIDYL)ETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE|2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]-, (+/-)-|[( inverted exclamation markA)-5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2,4-] thiazolidinedione monohydrochlorid|2,4-THIAZOLIDINEDIONE, 5-((4-(2-(5-ETHYL-2-PYRIDINYL)ETHOXY)PHENYL)METHYL)-, (+/-)-|Pioglitazone-[d4]|HS-0047|Spectrum_001623|Pioglitazone (Standard)|Spectrum2_001679|Spectrum3_001002|Spectrum4_001130|Spectrum5_001480|Spectrum5_002067|PIOGLITAZONE [MI]|PIOGLITAZONE [HSDB]|PIOGLITAZONE [IARC]|SCHEMBL4121|PIOGLITAZONE [VANDF]|BSPBio_002723|KBioGR_001619|KBioSS_002103|MLS006011848|PIOGLITAZONE [WHO-DD]|SPBio_001897|GTPL2694|orb1310828|PIOGLITAZONE [EMA EPAR]|SCHEMBL29364546|KBio2_002103|KBio2_004671|KBio2_007239|KBio3_001943|Pioglitazone - Bio-X trade mark|BDBM724000|GLXC-05211|HMS2089H14|HMS3651D09|HMS3712E16|HMS3884L10|HMS5081P07|Pharmakon1600-01504401|BCP26474|MSK11071|BBL029068|BDBM50103521|HB4139|HY-13956R|NSC758876|s2590|STL309607|STL373406|(+/-)-5-[p-[2-(ethyl-2-pyridyl)ethoxy]benzyl]-2,4-thiazolidinedione|5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy]phenyl]methyl]thiazolidine-2,4-dione|AKOS015894953|AKOS022109420|AC-1021|CCG-220107|CS-1700|DB01132|FP39372|SB17323|(+/-)-5-[[4-[2-(5-Ethyl-2-pyridinyl)-ethoxy]phenyl]methyl]-2,4-thiazolidinedione|NCGC00163128-01|NCGC00163128-02|NCGC00163128-03|NCGC00163128-04|NCGC00163128-05|NCGC00163128-06|NCGC00163128-07|BP164273|HY-13956|SMR002204015|SY017473|SBI-0206791.P001|US20250064791, Compound Pioglitazone|DB-027350|NS00000599|SW197561-3|C07675|D08378|EN300-117258|AB00698454-10|AB00698454_11|AB00698454_12|AB00698454_13|355P279|F386732|Q417765|SR-01000763737-5|BRD-A48430263-001-07-7|BRD-A48430263-003-02-4|BRD-A48430263-003-06-5|BRD-A48430263-003-16-4|BRD-A48430263-003-17-2|Z1501480426|5-[4-[2-(5-ethyl-2-pyridyl) ethoxy]benzyl]-2,4-thiazolidinedione|5-[4-[2-(5-ethyl-2-pyridyl)eth-oxy]benzyl]-2,4-thiazolidinedione|5-{4-[2-(5-ethyl-2-pyridyl)ethoxy]benzyl}-2,4thiazolidinedione|5-(4-(2-(5-ethylpyridin-2-yl)ethoxy)benzyl)-thiazolidine-2,4-dione|5-[[4-[2-(5-ethyl-2-pyridyl)ethoxy] phenyl]methyl]-2,4-thiazolidinedione|(+/-)-5-((4-(2-(5-ethyl-2-pyridinyl)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|(+/-)-5-(P-(2-(5-ETHYL-2-PYRIDYL)ETHOXY)BENZYL)-2,4-THIAZOLIDINEDIONE|(RS)-5-(4-(2-(5-ETHYLPYRIDIN-2-YL)ETHOXY)BENZYL)THIAZOLIDINE-2,4-DIONE|2,4-Thiazolidinedione, 5-[[4-[2-(5-ethyl-2-pyridinyl)ethoxy]phenyl]methyl]- (9CI)|5-[[4-[2-[(5-ethyl-2-pyridyl)]ethoxy]phenyl]methyl]thiazolidine- 2,4-dione|5-{4-[2-(5-ethylpyridin-2-yl)ethoxy]benzyl}-4-hydroxy-1,3-thiazol-2(5H)-one|[()-5-[[4-[2-(5-ethyl-2-pyridinyl) ethoxy] phenyl] methyl]-2,4-] thiazolidinedione monohydrochlorid|198077-89-3"
ROSIGLITAZONE,77999,,"InChI=1S/C18H19N3O3S/c1-21(16-4-2-3-9-19-16)10-11-24-14-7-5-13(6-8-14)12-15-17(22)20-18(23)25-15/h2-9,15H,10-12H2,1H3,(H,20,22,23)",YASAKCUCGLMORW-UHFFFAOYSA-N,C18H19N3O3S,357.4,"5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione","rosiglitazone|122320-73-4|Rosiglizole|Brl-49653|Rezult|BRL49653|rosiglitazona|Gaudil|Rosvel|rosiglitazonum|CHEBI:50122|NSC-758698|2,4-thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-|5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]-2,4-thiazolidinedione|05V02F2KDG|TDZ-01|DTXSID7037131|5-((4-(2-Methyl-2-(pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione-2-butenedioate|2,4-Thiazolidinedione, 5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-|DTXCID5017131|5-((4-(2-(methyl-2-pyridinylamino)ethoxy)phenyl)methyl)-2,4-thiazolidinedione|5-((4-(2-(methyl-pyridin-2-ylamino)ethoxy)phenyl)methyl)-1,3-thiazolidine-2,4-dione|5-[[4-[2-(methyl-pyridin-2-ylamino)ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione|RefChem:56529|A10BG02|Avandia|5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)benzyl)thiazolidine-2,4-dione|Brl 49653|Avandamet|MFCD00871760|Avandaryl|TDZ 01|rosiglitazone (Avandia)|Rosiglitazone base|Rosigilitazone|5-[[4-[2-[methyl(pyridin-2-yl)amino]ethoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione|Rosiglitazone (INN)|NCGC00095124-01|5-(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}benzyl)-1,3-thiazolidine-2,4-dione|ROSIGLITAZONE [INN]|5-[(4-{2-[methyl(pyridin-2-yl)amino]ethoxy}phenyl)methyl]-1,3-thiazolidine-2,4-dione|Rosiglitazone [INN:BAN]|5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione|CAS-122320-73-4|SR-01000763023|UNII-05V02F2KDG|Rosigltazone|Rosi|HSDB 7555|5-[4-[2-[N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione|RGZ|Gaudil (TN)|Spectrum_001703|Rosiglitazone (Standard)|1217260-35-9|Spectrum2_001241|Spectrum3_000997|Spectrum4_001125|Spectrum5_001464|ROSIGLITAZONE [MI]|SCHEMBL5169|ROSIGLITAZONE [HSDB]|ROSIGLITAZONE [IARC]|BSPBio_002693|KBioGR_001609|KBioSS_002183|ROSIGLITAZONE [VANDF]|ROSIGLITAZONE [MART.]|SPECTRUM1504263|SPBio_001142|ROSIGLITAZONE [WHO-DD]|GTPL1056|orb1310711|ROSIGLITAZONE [EMA EPAR]|SCHEMBL14383595|SCHEMBL14383596|SCHEMBL29530259|KBio2_002183|KBio2_004751|KBio2_007319|KBio3_001913|Rosiglitazone - Bio-X trade mark|Rosiglitazone, >=98% (HPLC)|BDBM723998|GLXC-06376|HMS1922J11|HMS2094O13|HMS3649G08|HMS3656K16|HMS3744M11|HMS3871L03|HMS3884N08|HMS5081F03|Pharmakon1600-01504263|BCP03047|MSK11057|Tox21_111434|BDBM50030474|CCG-39102|HB2556|HY-17386R|NSC758698|STL350047|5-[[4-[2-[methyl(2-pyridyl)amino]ethoxy]phenyl]methyl]thiazolidine-2,4-dione|AKOS015894872|O-De-Me, 2-O-B-D-galactopyranoside|Tox21_111434_1|AC-3459|BCP9000017|DB00412|FR39350|NSC 758698|SB17326|NCGC00095124-02|NCGC00095124-03|NCGC00095124-04|NCGC00095124-05|NCGC00095124-06|NCGC00095124-08|BR164372|HY-17386|SY031184|BCP0726000232|US20250064791, Compound Rosiglitazone|NS00008920|R0106|S2556|SW197573-6|20R734|6P-065|D08491|S00306|AB00698473-15|AB00698473-17|AB00698473-18|AB00698473-19|AB00698473_20|AB00698473_21|AB00698473_22|AB00698473_23|F093413|Q424771|SR-01000763023-5|SR-01000763023-6|BRD-A97437073-001-02-3|BRD-A97437073-001-03-1|BRD-A97437073-001-04-9|BRD-A97437073-001-08-0|BRD-A97437073-003-14-4|BRD-A97437073-050-13-7|BRD-A97437073-050-14-5|SR-01000763023-12|(RS)-5-{4-[2-(Methyl-2-pyridylamino)ethoxy]benzyl}-2,4-thiazolidinedion|5-(4-(2-(Methyl(pyridin-2-yl)amino)ethoxy)-benzyl)thiazolidine-2,4-dione|5-[4-[2-(N-Methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4dione|5-[4-[2-[Methyl(2-pyridyl)amino]ethoxy]benzyl]thiazolidine-2,4-dione|IDMB (1uM BRL49653, 1uM Dexamethasone, 0.5uM IBMX, 10ug/mL Insulin)|(+/-)-5-[p-[2-(methyl-2-pyridylamino)ethoxy]benzyl]-2,4-thiazolidinedione|2,4-Thiazolidinedione, 5-[[4-[2-(methyl-2-pyridinylamino)ethoxy]phenyl]methyl]- (9CI)|5-(4-(2-(N-METHYL-N-(2-PYRIDINYL)AMINO)ETHOXY)BENZYL)-2,4-THIAZOLIDINEDIONE|5-[[4-[2-(methyl-(2-pyridyl)amino)ethoxy]phenyl]methyl] thiazolidine-2,4-dione|5-[[4-[2-(methyl-2-pyridinylamino) ethoxy]phenyl]methyl]-2,4-thiazolidinedione|5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione|5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]phenyl methyl]thiazolidine-2,4-dione"
MURAGLITAZAR,206044,,"InChI=1S/C29H28N2O7/c1-20-26(30-28(37-20)22-6-4-3-5-7-22)16-17-36-24-10-8-21(9-11-24)18-31(19-27(32)33)29(34)38-25-14-12-23(35-2)13-15-25/h3-15H,16-19H2,1-2H3,(H,32,33)",IRLWJILLXJGJTD-UHFFFAOYSA-N,C29H28N2O7,516.5,"2-[(4-methoxyphenoxy)carbonyl-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]amino]acetic acid","Muraglitazar|331741-94-7|BMS-298585|W1MKM70WQI|BMS298585|DTXSID9057719|MK0478|MK-0478|BMS-298585-01|2-[(4-methoxyphenoxy)carbonyl-[[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]methyl]amino]acetic acid|DTXCID0031508|N-((4-methoxyphenoxy)carbonyl)-N-((4-(2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy)phenyl)methyl)glycine|N-[(4-Methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]glycine|2-((4-methoxyphenoxy)carbonyl-((4-(2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy)phenyl)methyl)amino)acetic acid|muraglitazarum|RefChem:819616|2-(((4-methoxyphenoxy)carbonyl)((4-(2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy)phenyl)methyl)amino)acetic acid|Pargluva|BMS 298585;Pargluva|CHEMBL186179|2-(((4-methoxyphenoxy)carbonyl)(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)amino)acetic acid|Glycine, N-((4-methoxyphenoxy)carbonyl)-N-((4-(2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy)phenyl)methyl)-|BMS 298585|Muraglitazar [USAN]|UNII-W1MKM70WQI|Muraglitazar [USAN:INN]|CCRIS 9258|(((4-Methoxyphenoxy)carbonyl)(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)amino)acetic acid|[[(4-Methoxyphenoxy)carbonyl][4-[2-(5-methyl-2-phenyloxazol-4-yl)ethoxy]benzyl]amino]acetic acid|Glycine, N-[(4-methoxyphenoxy)carbonyl]-N-[[4-[2-(5-methyl-2-phenyl-4-oxazolyl)ethoxy]phenyl]methyl]-|MURAGLITAZAR [MI]|Muraglitazar (USAN/INN)|MURAGLITAZAR [INN]|MURAGLITAZAR [MART.]|MURAGLITAZAR [WHO-DD]|SCHEMBL676469|orb1705016|CHEBI:188851|IRLWJILLXJGJTD-UHFFFAOYSA-N|C29H28N2O7|GLXC-15805|MSK11070|Tox21_113946|BDBM50150998|EX-A10674|MFCD20270627|AKOS030255656|DB06510|NCGC00262954-01|2-[(4-methoxyphenoxy)carbonyl-[[4-[2-(5-methyl-2-phenyl-oxazol-4-yl)ethoxy]phenyl]methyl]amino]acetic acid|HY-17445|TS-08171|CAS-331741-94-7|CS-0008241|NS00072609|D05091|H39694|[C14]-2-((4-methoxyphenoxy)carbonyl)acetic acid|Q6937233|((4-Methoxy-phenoxycarbonyl)-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-benzyl}-amino)-acetic acid|2-[(4-methoxyphenoxycarbonyl)({3-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl}methyl)amino]acetic acid|2-[(4-methoxyphenoxycarbonyl)({4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl}methyl)amino]acetic acid|N-((4-METHOXYPHENOXY)CARBONYL)-N-((4-(2-(5-METHYL-2-PHENYL-4-OXAZOLYL)ETHOXY)PHENYL)-METHYL)GLYCINE|N-((4-Methoxyphenoxy)carbonyl)-N-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)benzyl)glycine|N-[[4-methoxyphenoxy)carbonyl]-N-[(4-[2-(5-methyl-2-phenyl-4-oxazolyl)-ethoxy]phenyl]methyl]glycine"
FARGLITAZAR,170364,,"InChI=1S/C34H30N2O5/c1-23-29(36-33(41-23)26-12-6-3-7-13-26)20-21-40-27-18-16-24(17-19-27)22-31(34(38)39)35-30-15-9-8-14-28(30)32(37)25-10-4-2-5-11-25/h2-19,31,35H,20-22H2,1H3,(H,38,39)/t31-/m0/s1",ZZCHHVUQYRMYLW-HKBQPEDESA-N,C34H30N2O5,546.6,"(2S)-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoic acid","Farglitazar|196808-45-4|GI-262570|GI262570|GI262570X|GI-262570X|DTXSID1047310|GI2570|GI-2570|3433GY7132|DTXCID9027310|G1-262570|(2S)-2-((2-(benzoyl)phenyl)amino)-3-(4-(2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy)phenyl)propanoic acid|(2S)-2-[[2-(benzoyl)phenyl]amino]-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoic acid|FARGLITAZARUM|RefChem:921467|GI 262570|CHEMBL107367|(2S)-2-(2-benzoylanilino)-3-[4-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethoxy]phenyl]propanoic acid|(S)-2-((2-Benzoylphenyl)amino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid|2-(2-BENZOYL-PHENYLAMINO)-3-{4-[2-(5-METHYL-2-PHENYL-OXAZOL-4-YL)-ETHOXY]-PHENYL}-PROPIONIC ACID|L-Tyrosine, N-(2-benzoylphenyl)-o-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)-|N-(o-Benzoylphenyl)-O-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)-L-tyrosine|Farglitazar [USAN]|Farglitazar [USAN:INN]|N-(2-Benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-L-tyrosine|L-tyrosine, N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]-|UNII-3433GY7132|GI 2570|1fm9|FARGLITAZAR [INN]|Farglitazar (USAN/INN)|GI262570; Farglitazar|FARGLITAZAR [WHO-DD]|KBioGR_002347|KBioSS_002350|G1 262570; GI 262570; GI 262570X|SCHEMBL501024|GTPL2672|orb1700621|KBio2_002347|KBio2_004915|KBio2_007483|CHEBI:229920|cMAP_000025|ZZCHHVUQYRMYLW-HKBQPEDESA-N|GLXC-07306|Tox21_300218|BDBM50085044|AKOS027326860|L-Tyrosine, N-(2-benzoylphenyl)-o-(2-(5-methyl-2-phenyl-4-oxazolyl)ethyl)|GI 262570X|NCGC00247940-01|NCGC00254050-01|DA-63375|HY-105074|CAS-196808-45-4|CS-0024894|NS00127403|D04132|Q5435087|L-Tyrosine, N-(2-benzoylphenyl)-O-[2-(5-methyl-2-phenyl-4-oxazolyl)ethyl]- (9CI)|O-[2-(5-methyl-2-phenyl-1,3-oxazol-4-yl)ethyl]-N-[2-(phenylcarbonyl)phenyl]-L-tyrosine|(S)-2-((2-Benzoylphenyl)amino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoicacid|(S)-2-(2-Benzoyl-phenylamino)-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid|(S)-2-(2-benzoylphenylamino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid|2-(2-Benzoyl-phenylamino)-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid(GI 262570)"
SAFINAMIDE,131682,,"InChI=1S/C17H19FN2O2/c1-12(17(19)21)20-10-13-5-7-16(8-6-13)22-11-14-3-2-4-15(18)9-14/h2-9,12,20H,10-11H2,1H3,(H2,19,21)/t12-/m0/s1",NEMGRZFTLSKBAP-LBPRGKRZSA-N,C17H19FN2O2,302.34,(2S)-2-[[4-[(3-fluorophenyl)methoxy]phenyl]methylamino]propanamide,"Safinamide|133865-89-1|(2S)-2-[[4-[(3-Fluorophenyl)methoxy]phenyl]methylamino]propanamide|Fce-26743|EMD 1195686|Safinamida|EMD-1195686|90ENL74SIG|2-(4-(3-Fluorobenzyloxy)benzylamino)propionamide|DTXSID601010282|safinamidum|(2S)-2-((4-((3-fluorophenyl)methoxy)phenyl)methylamino)propanamide|fbap methanesulfonate|RefChem:57040|N04BD03|DTXCID701436700|(S)-2-((4-(3-fluorobenzoxy)benzyl)amino)propanamide|603-772-2|(S)-2-((4-((3-Fluorobenzyl)oxy)benzyl)amino)propanamide|Xadago|MFCD00897036|(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propanamide|CHEMBL396778|(2S)-2-[({4-[(3-fluorophenyl)methoxy]phenyl}methyl)amino]propanamide|CHEMBL48582|Safinamide [USAN:INN]|UNII-90ENL74SIG|Safinamide (Standard)|SAFINAMIDE [MI]|SAFINAMIDE [INN]|Safinamide (USAN/INN)|SAFINAMIDE [USAN]|(S)-2-(((4-((3-Fluorophenyl)methoxy)phenyl)methyl)amino)propanamide|EC 603-772-2|SAFINAMIDE [WHO-DD]|N2-(4-((3-Fluorbenzyl)oxy)benzyl)-L-alaninamid|SCHEMBL69350|GTPL8291|orb1685635|SCHEMBL29358109|BDBM19187|CHEBI:134718|HMS3886M21|HMS6018J03|BCP12082|EX-A2759|BDBM50078694|HY-70057R|s5357|AKOS016002015|CCG-267489|CS-0556|DB06654|ER-0076|NCGC00346529-01|NCGC00346529-03|NCGC00346529-05|AC-26829|DA-67371|HY-70057|5139B|NS00001226|S0935|D10158|EN300-18567503|F222585|(S)-2[4-(3-fluorobenzyloxy)benzylamino]propanamide|Q2211523|(5)-2-[4-(3-fluorobenzyloxy)benzylamino]propanamide|(S)-2-[4-(3-fluorobenzyloxy)benzylamino]propanamide|(S)-2[4-(3-fluorobenzyloxy)benzylamino] propanamide|BRD-K92613113-066-02-7|(2S)-2-[4-(3-fluorobenzyloxy)benzylamino]propionamide|2(S)-[4-(3-Fluorobenzyloxy) benzylamino] propionamide|(S)-2-[[4-[(3-Fluorobenzyl)oxy]benzyl]amino]propionamide|(+-)-(S)-2-((p-((m-Fluorobenzyl)oxy)benzyl)amino)propionamide|Propanamide, 2-(((4-((3-fluorophenyl)methoxy)phenyl)methyl)amino)-, (S)-|(S)-2-[4-(3-Fluoro-benzyloxy)-benzylamino]-propionamide; compound with methanesulfonic acid|EMD 1195686;FCE 26743;EMD-1195686;EMD1195686;FCE-26743"
PHENELZINE,3675,,"InChI=1S/C8H12N2/c9-10-7-6-8-4-2-1-3-5-8/h1-5,10H,6-7,9H2",RMUCZJUITONUFY-UHFFFAOYSA-N,C8H12N2,136.19,2-phenylethylhydrazine,"Phenelzine|51-71-8|2-Phenylethylhydrazine|Phenethylhydrazine|Hydrazine, (2-phenylethyl)-|Fenelzyne|Fenelzyna|beta-Phenylethylhydrazine|Phenelzinum|Fenelzina|1-Hydrazino-2-phenylethane|Fenelzin|(2-phenylethyl)hydrazine|2-Phenethylhydrazine|O408N561GF|DTXSID2041094|4-15-00-01269 (Beilstein Handbook Reference)|2 Phenethylhydrazine|beta Phenylethylhydrazine|RefChem:55842|DTXCID0021094|200-117-9|Monofen|Nardelzine|Nardil|Phenethyl-hydrazine|HYDRAZINE, PHENETHYL-|W 1544-A|phenethyl hydrazine|(2-Phenyl-ethyl)-hydrazine|CHEMBL1089|CHEBI:8060|MFCD00047825|Fenelzina [INN-Spanish]|Fenelzyna [Polish]|Fenelzyne [Polish]|Phenelzinum [INN-Latin]|Phenelzine [INN:BAN]|Phenylethylhydrazine|Phenelzine (BAN)|W1544|EINECS 200-117-9|BRN 0742354|UNII-O408N561GF|HSDB 8127|Nardil (Salt/Mix)|Phenelzine Free Base|Spectrum_000851|PHENELZINE [MI]|PHENELZINE [INN]|Prestwick0_000170|Prestwick1_000170|Prestwick2_000170|Prestwick3_000170|Spectrum2_001009|Spectrum3_000677|Spectrum4_000475|Spectrum5_000990|Lopac-P-6777|1-(2-phenethyl)hydrazine|PHENELZINE [VANDF]|CBChromo1_000176|.beta.-Phenylethylhydrazine|1-(2-Phenylethyl)hydrazine|PHENELZINE [WHO-DD]|Lopac0_000971|SCHEMBL34335|BSPBio_000039|BSPBio_002373|KBioGR_000950|KBioGR_002265|KBioSS_001331|KBioSS_002266|DivK1c_000062|SPBio_001137|SPBio_001960|1-(2-Phenylethyl)hydrazine #|BPBio1_000043|GTPL7266|orb1685281|SCHEMBL3948588|SCHEMBL6257792|SCHEMBL10754359|KBio1_000062|KBio2_001331|KBio2_002265|KBio2_003899|KBio2_004833|KBio2_006467|KBio2_007401|KBio3_001593|KBio3_002745|cMAP_000003|NINDS_000062|HMS3259L04|HY-B1018|BDBM50105417|AKOS000131105|CCG-205051|CS-4532|DB00780|FP13942|NC00692|SDCCGSBI-0050944.P005|IDI1_000062|NCGC00015830-01|NCGC00015830-03|NCGC00015830-04|NCGC00015830-05|NCGC00015830-07|NCGC00015830-13|NCGC00162301-01|AS-77074|SBI-0050944.P004|DB-052010|AB00053520|NS00098766|EN300-58071|C07430|D08349|F74244|W-1544|AB00053520_12|047P825|Q1747559|BRD-K87024524-065-05-2|BRD-K87024524-065-17-7|BRD-K87024524-065-18-5|14847-47-3"
DETROTHYRONINE,71212,,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m1/s1",AUYYCJSJGJYCDS-GFCCVEGCSA-N,C15H12I3NO4,650.97,"(2R)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid","Detrothyronine|5714-08-9|3,5,3'-Triiodo-D-thyronine|Detrotironina|DEXTROTHYRONINE|Rathyronine, (r)-|(+)-Triiodothyronine|Detrothyroninum|DT-3|3,3',5-Triiodo-D-thyronine|46XII7C16X|Detrothyronine [INN]|(2R)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid|NSC-46046|CHEMBL557|DTXSID501016651|D-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-|Alanine, 3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, D-|(R)-2-amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoic acid|Detrothyronin|D-Triiodothyronine|D-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-alanine|327-86-6|Dextro-3:5:3'-triiodothyronine|D-Trijodthyronin|Triiodothyronine, D-|liothyronine-(isomer)|RefChem:1082933|SCHEMBL8301|UNII-46XII7C16X|Detrothyroninum [INN-Latin]|Detrotironina [INN-Spanish]|D-3,5,3'-Triiodothyronine|DT3 (VAN)|DETROTHYRONINE [MART.]|orb1986141|SCHEMBL29383803|AUYYCJSJGJYCDS-GFCCVEGCSA-N|DTXCID501474845|HMS2092K14|Pharmakon1600-01500778|SKF D 2623|EINECS 227-203-9|BDBM50178971|NSC 46046|NSC757435|AKOS027383789|CCG-212884|NSC-757435|CAS-1823692|NCGC00016993-01|NCGC00021140-01|SBI-0206705.P001|HY-116325|CS-0065055|NS00082292|H52644|AB01562945_01|BRD-K46428823-001-01-7|BRD-K46428823-001-02-5|Q27258967|D-3-(4-(-Hydroxy-3-iodphenoxy)-3,5-diiodphenyl)alanin|D-Alanine, 3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-|(R)-2-Amino-3-(4-(4-hydroxy-3-iodphenoxy)-3,5-diiodphenyl)propionsaeure|(R)-2-Amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]-propionic acid|2-Amino-3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]-propionic acid|227-203-9"
TIRATRICOL,5803,,"InChI=1S/C14H9I3O4/c15-9-6-8(1-2-12(9)18)21-14-10(16)3-7(4-11(14)17)5-13(19)20/h1-4,6,18H,5H2,(H,19,20)",UOWZUVNAGUAEQC-UHFFFAOYSA-N,C14H9I3O4,621.93,"2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid","Tiratricol|51-24-1|3,3',5-TRIIODOTHYROACETIC ACID|Triac|Triiodothyroacetic acid|Tiratricolum|Tiracana|2-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid|T3-acetic acid|DTXSID2045232|3',3,5-Triiodothyroacetic acid|2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)acetic acid|3,5,3'-triiodothyroacetate|NSC-759294|29OQ9EU4R1|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodobenzeneacetic acid|DTXCID0025232|3,5,3'-triiodothyroacetic acid|RefChem:190125|D11AX08|H03AA04|200-086-1|Teatrois|Tiratricol [INN]|MFCD00055931|Emcitate|3,3',5-Triiodo Thyroacetic Acid|Benzeneacetic acid, 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-|CHEMBL41632|Triacana|2-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]acetic acid|CAS-51-24-1|NCGC00016227-01|[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic acid|Tiratricol, 3,3',5-triiodothyroacetic acid|[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]-ACETIC ACID|3,3 inverted exclamation marka,5-Triiodothyroacetic acid|(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)acetic acid|C14H9I3O4|[4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl]acetic Acid (Triiodothyroacetic Acid)|4HY|SMR000058684|SR-01000003135|Tiratricolum [INN-Latin]|Levothyroxine EP Impurity C|UNII-29OQ9EU4R1|Nidolin|Triax|Emcitate (TN)|Tiracana (TN)|Prestwick_439|EINECS 200-086-1|Tiratricol (Standard)|1nq0|TIRATRICOL [MI]|Prestwick0_000202|Prestwick1_000202|Prestwick2_000202|Prestwick3_000202|Tiratricol (USAN/INN)|TIRATRICOL [USAN]|Triiodothyroacetic acid, 3|DES32736 (Dottikon)|TIRATRICOL [MART.]|DIV08177 (DiverChim)|TIRATRICOL [WHO-DD]|REGID_for_CID_5803|SCHEMBL25149|BSPBio_000183|MLS000028613|MLS006010657|SPBio_002104|3,3,5-triiodothyroacetic acid|BPBio1_000203|GTPL2637|orb1308050|SCHEMBL30161572|BDBM18862|CHEBI:40021|HY-B1201R|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylacetic acid|GLXC-22117|HMS1568J05|HMS2095J05|HMS3264A05|HMS3652J07|HMS3712J05|HMS5082P06|MR-49|Pharmakon1600-01506047|BCP07182|HY-B1201|Tox21_110317|Tox21_303544|NSC759294|s4185|AKOS015951178|CCG-213970|CS-4829|DB03604|FT28502|NSC 759294|T3-ACETIC ACID [USP IMPURITY]|NCGC00016227-02|NCGC00016227-03|NCGC00016227-04|NCGC00016227-05|NCGC00016227-06|NCGC00016227-07|NCGC00016227-08|NCGC00257371-01|AS-15930|DA-58599|SY111973|3,3',5-Triiodothyroacetic acid, >=90%|SBI-0207015.P001|3,3',5-Triiodothyroacetic acid, free acid|NS00015686|SW196661-4|T3878|TRIIODOTHYROACETIC ACID [USP IMPURITY]|D07214|055T931|F787612|LEVOTHYROXINE SODIUM IMPURITY [USP IMPURITY]|LIOTHYRONINE SODIUM IMPURITY C [EP IMPURITY]|Q7809151|SR-01000003135-2|SR-01000003135-3|BRD-K61236135-001-03-3|BRD-K61236135-001-08-2|BRD-K61236135-001-09-0|LEVOTHYROXINE SODIUM IMPURITY C [EP IMPURITY]|[(4-hydroxy-3-iodo-4-phenoxy)-3,5-diiodophenyl]acetic acid|2-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)aceticacid|Levothyroxine sodium impurity, triiodothyroacetic acid, or t3-acetic acid-|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodobenzeneacetic acid;Nidolin;T3A;Tiratricol"
THYROPROPIC ACID,5804,,"InChI=1S/C15H11I3O4/c16-10-7-9(2-3-13(10)19)22-15-11(17)5-8(6-12(15)18)1-4-14(20)21/h2-3,5-7,19H,1,4H2,(H,20,21)",VRORTNGXAKZJML-UHFFFAOYSA-N,C15H11I3O4,635.96,"3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid","3,3',5-Triiodothyropropionic acid|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodobenzenepropanoic acid|RefChem:910529|THYROPROPIC ACID|51-26-3|3,3',5-Triiodo Thyropropionic Acid|Acido tiropropico|Triopron; Triprop|Acide thyropropique|Thyropropic acid [INN]|3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid|3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoic acid|OK7481S22O|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodohydrocinnamic acid|3-[4-(4-hydroxy-3-iodo-phenoxy)-3,5-diiodo-phenyl]propanoic acid|Acidum thyropropicum|UNII-OK7481S22O|Acido tiropropico [INN-Spanish]|Acide thyropropique [INN-French]|Acidum thyropropicum [INN-Latin]|Benzenepropanoic acid, 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-|C15H11I3O4|Levothyroxine Impurity 17|cid_5804|triiodothyropropionic acid, 5|MLS000028680|SCHEMBL310201|THYROPROPIC ACID [MI]|CHEMBL291053|BDBM18864|DTXSID20198998|CHEBI:135860|HY-B1797|MSK157728|AKOS027380181|FT28503|NCGC00018303-01|NCGC00018303-02|NCGC00018303-03|SMR000058682|NS00126101|G79743|SR-01000003172|SR-01000003172-2|Q27285698|3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoicacid|Hydrocinnamic acid, 4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-|3,3',5-Triiodothyropropionic acid 100 microg/mL in Acetonitrile|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-benzenepropanoic acid;4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodo-hydrocinnamic acid"
LIOTHYRONINE,5920,,"InChI=1S/C15H12I3NO4/c16-9-6-8(1-2-13(9)20)23-14-10(17)3-7(4-11(14)18)5-12(19)15(21)22/h1-4,6,12,20H,5,19H2,(H,21,22)/t12-/m0/s1",AUYYCJSJGJYCDS-LBPRGKRZSA-N,C15H12I3NO4,650.97,"(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid","liothyronine|3,3',5-Triiodo-L-thyronine|triiodothyronine|6893-02-3|Liothyronin|Tresitope|3,5,3'-triiodothyronine|Liotironina|L-Liothyronine|O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine|triothyrone|Liothyroninum|3,5,3'-Triiodo-L-thyronine|Lyothyronine|Cyronine|Triiodo-L-thyronine|L-triiodothyronine|L-3,3',5-TriioDOThyronine|3,3',5-Triiodothyronine|3,5,3'TRIIODOTHYRONINE|L-3,5,3'-Triiodothyronine|(2S)-2-amino-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]propanoic acid|Rathyronine, (s)-|CHEBI:18258|L-Tyrosine, O-(4-hydroxy-3-iodophenyl)-3,5-diiodo-|Thyronine, 3,3',5-triiodo-, L-|06LU7C9H1V|3,5,3'-triiodothyronine, l-|DTXSID8023216|4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenylalanine|4-(4-hydroxy-3-iodophenoxy)-3,5-diiodo-L-phenylalanine|NSC-80203|4-(3-Iodo-4-hydroxyphenoxy)-3,5-diiodophenylalanine|DTXCID403216|Alanine, 3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)-, L-|(2S)-2-AMINO-3-(4-(4-HYDROXY-3-IODOPHENOXY)-3,5-DIIODOPHENYL)PROPANOIC ACID|NSC80203|Therapeutic T3|(2S)-2-azaniumyl-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoate|RefChem:55511|H03AA02|229-999-3|CHEBI:11684|NSC46046|Tertroxin|T3|L-T3|MFCD00002593|(S)-2-amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoic acid|Liothyronine (GMP)|Liothyronine (INN)|CHEMBL1544|LIOTHYRONINE [INN]|T3 (amino acid)|T3 (Triiodothyronine)|Liothyronine [INN:BAN]|Euthroid-1|Euthroid-2|Euthroid-3|Thyrolar-1|Thyrolar-2|Thyrolar-3|Liotironina [INN-Spanish]|CAS-6893-02-3|Euthroid-0.5|Thyrolar-0.5|T3 (VAN)|Thyrolar-0.25|Triiodothyronine, l-|3,5,3'-Tri-iodo-L-thyronine|Triiodothyronine (T3)|SR-05000000455|T-3|Liothyroninum [INN-Latin]|Levothyroxine EP Impurity A|3,3',5-Triiodothyronine, L-|HSDB 3110|1xzx|Thyrolar (TN)|Prestwick_135|EINECS 229-999-3|NSC 80203|BRN 2710227|Spectrum_001445|L-3-(4-(4-Hydroxy-3-iodophenoxy)-3,5-diiodophenyl)alanine|Triiodothyronine;3,3',5-Triiodo-L-thyronine;T3|Liothyronine (Standard)|THYROLAR-5|Prestwick0_000853|Prestwick1_000853|Prestwick2_000853|Prestwick3_000853|Spectrum2_001984|Spectrum3_001887|Spectrum4_000326|Spectrum5_001793|LIOTHYRONINE [MI]|Epitope ID:131324|LIOTHYRONINE [HSDB]|SCHEMBL8300|NCIStruc1_000449|LIOTHYRONINE [VANDF]|UNII-06LU7C9H1V|REGID_for_CID_5920|BSPBio_000865|BSPBio_003394|KBioGR_000671|KBioGR_002568|KBioSS_001925|KBioSS_002577|MLS000028458|3,5,3'-triodo-L-thyronine|LIOTHYRONINE [USP-RS]|LIOTHYRONINE [WHO-DD]|SPBio_002167|SPBio_002786|BPBio1_000953|GTPL2634|HY-A0070AG|HY-A0070AR|L-3,3',5-triiodo-Thyronine|orb1307879|SCHEMBL29390909|BCBcMAP01_000192|BDBM18860|HY-A0070A|KBio2_001925|KBio2_002568|KBio2_004493|KBio2_005136|KBio2_007061|KBio2_007704|KBio3_002897|KBio3_003046|cMAP_000088|HMS1570L07|HMS2097L07|HMS2235A22|HMS3714L07|LIOTHYRONINE [USP IMPURITY]|MSK10002|TRIIODOTHYRONINE (T3 OR LIOTHYRONINE, ACTIVE) (6-11%)|Tox21_110029|Tox21_301943|HB7470|NCGC00013556|s5726|3,5,3'-triiodo-L-thyronine (T3)|(S)-2-Amino-3-(4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl)propanoicacid|AKOS016003266|Thyroid hormone triiodothyronine (T3)|3,3',5-Triiodo-L-thyronine, 95%|CCG-220853|CS-4141|DB00279|FT28506|(2S)-2-AMINO-3-[4-(4-HYDROXY-3-IODO-PHENOXY)-3,5-DIIODO-PHENYL]PROPANOIC ACID|L-3,3',5-Triiodothyronine, free acid|SMP1_000179|NCGC00013556-01|NCGC00013556-02|NCGC00013556-03|NCGC00013556-04|NCGC00013556-05|NCGC00013556-12|NCGC00013556-15|NCGC00096669-01|NCGC00096669-02|NCGC00255336-01|[125I]T3|AC-31935|AS-17446|SMR000058402|SBI-0206718.P001|DB-021796|CS-0622788|NS00076841|T0453|A11632|C02465|D08128|EN300-123970|893T023|F787598|Q327362|SR-01000003143|SR-01000003143-4|SR-05000000455-2|SR-05000000455-3|BRD-K89152108-001-03-3|BRD-K89152108-236-05-0|BRD-K89152108-236-06-8|BRD-K89152108-236-07-6|LEVOTHYROXINE SODIUM IMPURITY A [EP IMPURITY]|3,3',5-Triiodo-L-thyronine, >=95% (HPLC), powder|Z1557400301|D-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]alanine|L-3-[4-(4-hydroxy-3-iodophenoxy)-3,5-diiodophenyl]-Alanine|O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine;Liothyronine|Liothyronine, United States Pharmacopeia (USP) Reference Standard|3,3',5 Triiodothyronine (T3), IRMM(R) certified Reference Material|O-(4-Hydroxy-3-iodophenyl)-3,5-diiodo-L-tyrosine,labeled with(125i)iodine|Liothyronine, Pharmaceutical Secondary Standard; Certified Reference Material"
SAFOTIBANT,11953367,,"InChI=1S/C25H34N4O5S/c1-18-14-22(33-5)15-19(2)24(18)35(31,32)29(4)12-13-34-17-23(30)28(3)16-20-6-8-21(9-7-20)25-26-10-11-27-25/h6-9,14-15H,10-13,16-17H2,1-5H3,(H,26,27)",AMTQCENHQIDBHQ-UHFFFAOYSA-N,C25H34N4O5S,502.6,"N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[(4-methoxy-2,6-dimethylphenyl)sulfonyl-methylamino]ethoxy]-N-methylacetamide","Safotibant|Safotibant [INN]|Lf 22-0542|LF22-0542|UNII-02HU8HWP7U|LF-22-0542|02HU8HWP7U|FOV2304 FREE BASE|SAFOTIBANT [WHO-DD]|FOV-2304 FREE BASE|Acetamide, N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]-N-methyl-|DTXSID20212769|Acetamide, N-((4-(4,5-dihydro-1H-imidazol-2-yl)phenyl)methyl)-2-(2-(((4-methoxy-2,6-dimethylphenyl)sulfonyl)methylamino)ethoxy)-N-methyl-|N-((4-(4,5-Dihydro-1H-imidazol-2-yl)phenyl)methyl)-2-(2-(((4-methoxy-2,6-dimethylphenyl)sulfonyl)methylamino)ethoxy)-N-methylacetamide|N-((4-(4,5-Dihydro-1H-imidazol-2-yl)phenyl]methyl)-2-(2-((4-methoxy-2,6-dimethylbenzenesulfonyl)(methyl)amino]ethoxy)-N-methylacetamide|N-((4-(4,5-DIHYDRO-1H-IMIDAZOL-2-YL)PHENYL)METHYL)-2-(2-((4-METHOXY-2,6-DIMETHYLBENZENESULFONYL)(METHYL)AMINO)ETHOXY)-N-METHYLACETAMIDE|safotibantum|N-[[4-(4,5-Dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[[(4-methoxy-2,6-dimethylphenyl)sulfonyl]methylamino]ethoxy]-N-methylacetamide|RefChem:180808|DTXCID00135260|633698-99-4|CHEMBL1254771|N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[(4-methoxy-2,6-dimethylphenyl)sulfonyl-methylamino]ethoxy]-N-methylacetamide|N-(4-(4,5-dihydro-1H-imidazol-2-yl)benzyl)-2-(2-(4-methoxy-N,2,6-trimethylphenylsulfonamido)ethoxy)-N-methylacetamide|N-(4-(4,5-dihydro-1H-imidazol-2-yl)benzyl)-2-(2-((4-methoxy-N,2,6-trimethylphenyl)sulfonamido)ethoxy)-N-methylacetamide|orb1695332|SCHEMBL1723565|CHEBI:230949|BDBM50326708|AKOS040753898|TS-08789|HY-100827|CS-0020470|L022637|Q6457712|N-[[4-(4,5-dihydro-1H-imidazol-2-yl)phenyl]methyl]-2-[2-[(4-methoxy-2,6-dimethylphenyl)sulonyl-methylamino]ethoxy]-N-methylacetamide"
TOLOXATONE,34521,,"InChI=1S/C11H13NO3/c1-8-3-2-4-9(5-8)12-6-10(7-13)15-11(12)14/h2-5,10,13H,6-7H2,1H3",MXUNKHLAEDCYJL-UHFFFAOYSA-N,C11H13NO3,207.23,"5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one","Toloxatone|29218-27-7|Humoryl|Perenum|Toloxatona|Toloxatonum|Taloxotone|Delalande 69276|5-(Hydroxymethyl)-3-(3-methylphenyl)-2-oxazolidinone|5-Hydroxymethyl-3-(m-tolyl)-2-oxazolidinone|DTXSID40865478|5T206015T5|MD-69276|(3-methyl)-3-phenyl-5-hydroxymethyl-2-oxazolidinone|RefChem:898548|DTXCID10813880|N06AG03|CHEBI:134870|249-522-2|5-(Hydroxymethyl)-3-(m-tolyl)oxazolidin-2-one|Toloxatone [INN]|5-(hydroxymethyl)-3-(3-methylphenyl)-1,3-oxazolidin-2-one|5-(Hydroxymethyl)-3-m-tolyl-2-oxazolidinone|MFCD00865391|MD 69276|CHEMBL18116|Toloxatone (INN)|Toloxatonum [INN-Latin]|Toloxatona [INN-Spanish]|EINECS 249-522-2|BRN 0527506|69276 MD|Umoril|2-oxazolidinone, 5-(hydroxymethyl)-3-(3-methylphenyl)-|UNII-5T206015T5|Humoryl (TN)|TOLOXATONE [MI]|5-(hydroxymethyl)-3-m-tolyloxazolidin-2-one|TOLOXATONE [MART.]|2-Oxazolidinone, 5-hydroxymethyl-3-(m-tolyl)-|TOLOXATONE [WHO-DD]|SCHEMBL49437|Toloxatone (MD 69276)?|orb1301889|SCHEMBL29394786|CHEBI:156575|GLXC-06144|HMS6018I14|BCP32681|BDBM50110725|AKOS016014000|Toloxatone, >=98% (HPLC), solid|DB09245|AS-16848|HY-14196|DB-047546|5-Hydroxymethyl-3-m-tolyl-oxazolidin-2-one|CS-0002916|NS00002087|S0160|D02559|D84133|EN300-6745454|SR-01000944934|Q3530618|SR-01000944934-1|BRD-A67182178-001-01-7|5-(hydroxymethyl)-3-(3-methylphenyl)-oxazolidin-2-one|MD 69276; MD-69276; MD69276|Z1509617301|(+/-)-5-(HYDROXYMETHYL)-3-M-TOLYL-2-OXAZOLIDINONE"
MOCLOBEMIDE,4235,,"InChI=1S/C13H17ClN2O2/c14-12-3-1-11(2-4-12)13(17)15-5-6-16-7-9-18-10-8-16/h1-4H,5-10H2,(H,15,17)",YHXISWVBGDMDLQ-UHFFFAOYSA-N,C13H17ClN2O2,268.74,4-chloro-N-(2-morpholin-4-ylethyl)benzamide,"moclobemide|71320-77-9|Aurorix|Moclobemid|Manerix|Moclamine|Moclobemida|Moclobemidum|p-Chloro-N-(2-morpholinoethyl)benzamide|4-Chlor-N-(2-morpholinoethyl)benzamid|GNF-PF-695|4-Chloro-N-(2-(4-morpholinyl)ethyl)benzamide|4-chloro-N-[2-(morpholin-4-yl)ethyl]benzamide|Ro 11-1163/000|4-chloro-N-[2-(4-morpholinyl)ethyl]benzamide|Benzamide, 4-chloro-N-[2-(4-morpholinyl)ethyl]-|PJ0Y7AZB63|BENZAMIDE, 4-CHLORO-N-(2-(4-MORPHOLINYL)ETHYL)-|Ro-11-1163|DTXSID9040554|CHEBI:83531|Ro-111163000|Moclobamide|DTXCID7020554|Ro-11-1163/000|Aurorex|NovoMoclobemide|NuMoclobemide|Apo Moclobemide|Nu Moclobemide|Moclobemid Puren|Novo Moclobemide|PMS Moclobemide|AZU, Moclobemid|Stada, Moclobemid|Moclobemide, DBL|von ct, Moclobemid|Moclobemide, GenRX|Moclobemid ratiopharm|Moclobemid1A Pharma|Moclobemid 1A Pharma|Moclobemide, Chem mart|4-chloro-N-(2-(morpholin-4-yl)ethyl)benzamide|Moclobemide, Healthsense|Ro 11 1163|RefChem:389127|N06AG02|4-chloro-N-(2-morpholinoethyl)benzamide|Moclaime|Moclamide|Moclobemidum [INN-Latin]|Moclobemida [INN-Spanish]|4-Chloro-N-(2-morpholin-4-yl-ethyl)-benzamide|Moclobemide (Ro 111163)|4-chloro-N-(2-morpholin-4-ylethyl)benzamide|Ro 11-1163|MFCD00865388|Ro111163|CHEMBL86304|MLS000070549|NCGC00027930-02|NCGC00027930-04|SMR000012114|Moclobemide [USAN:BAN:INN]|Moclobemide [USAN:INN:BAN]|Auromid|Aurorix (TN)|CAS-71320-77-9|HSDB 7180|SR-01000357772|CBMicro_048319|Moclobemide (USAN/INN)|UNII-PJ0Y7AZB63|BRN 0530974|Moclobemide?|Ro-11-1163, Aurorix, Manerix, Moclamine, p-Chloro-N-(2-morpholinoethyl)benzamide|Moclamine (Salt/Mix)|Moclobemide (Standard)|Opera_ID_225|MOCLOBEMIDE [MI]|MOCLOBEMIDE [INN]|MOCLOBEMIDE [HSDB]|MOCLOBEMIDE [USAN]|MOCLOBEMIDE [MART.]|Oprea1_256739|Oprea1_270122|SCHEMBL49708|MOCLOBEMIDE [WHO-DD]|MLS000759438|MLS001240195|MLS001424077|GTPL7428|orb1310956|BENZAMIDE,4-CHLORO-N-[2-(4-MORPHOLINYL)ETHYL]-|Moclobemide - Bio-X trade mark|BDBM15613|HY-B0534R|GLXC-06724|HMS2051A16|HMS2096G07|HMS2232B20|HMS3262F09|HMS3371A01|HMS3393A16|HMS3657K05|HMS3713G07|HMS3885A15|HMS5081J08|HMS6018E20|BCP15783|HY-B0534|Moclobemide 1.0 mg/ml in Methanol|MSK11178|Tox21_110971|Tox21_113614|Tox21_500824|HB1791|s3212|STK222240|AKOS003270184|Moclobemide, >=98% (HPLC), solid|Tox21_110971_1|CCG-100879|DB01171|FM26030|LP00824|NC00129|SDCCGSBI-0048213.P003|NCGC00027930-03|NCGC00027930-05|NCGC00027930-07|NCGC00027930-16|NCGC00261509-01|AC-12467|AC-35244|BM164599|p-chloro-N-(2-morpholinoethyl)-benzamide|BIM-0048213.P001|M2733|NS00009131|ST45245423|SW197509-3|D02561|EN300-761488|AB00400932_12|320M779|Q421934|SR-01000357772-1|SR-01000357772-4|BRD-K07237224-001-19-6|Z32409934|(4-chlorophenyl)-N-(2-morpholin-4-ylethyl)carboxamide|4-Chloro-N-[2-(4-morpholinyl)ethyl]benzamide; Aurorix; Moclamine|Ro11-1163; Ro 11-1163; Ro111163; Ro-111163; Ro 111163|108375-13-9"
PARGYLINE,4688,,"InChI=1S/C11H13N/c1-3-9-12(2)10-11-7-5-4-6-8-11/h1,4-8H,9-10H2,2H3",DPWPWRLQFGFJFI-UHFFFAOYSA-N,C11H13N,159.23,N-benzyl-N-methylprop-2-yn-1-amine,"pargyline|555-57-7|N-Methyl-N-propargylbenzylamine|Pargylamine|Paragyline|Supirdyl|Eudatin|N-Methyl-N-2-propynylbenzylamine|Pargilina|Pargylinum|Benzenemethanamine, N-methyl-N-2-propynyl-|benzyl(methyl)(prop-2-yn-1-yl)amine|9MV14S8G3E|DTXSID3023423|Hydrochloride, Pargyline|RefChem:65904|DTXCID903423|C02KC01|209-101-6|N-benzyl-N-methylprop-2-yn-1-amine|Pargylin|Benzyl-methyl-2-propinylamin|Benzylmethylpropargylamine|N-Benzyl-N-methyl-2-propynylamine|N-Methyl-N-benzylpropynylamine|Eutron|Methylbenzylpropynylamine|MO 911|N-Benzyl-N-methyl-2-propyn-1-amine|Pargyline chloride|BENZYLAMINE, N-METHYL-N-2-PROPYNYL-|Pargyline (INN)|Pargyline [INN]|A 19120|MFCD00008576|CHEMBL673|CHEBI:7930|N-methyl-N-(phenylmethyl)prop-2-yn-1-amine|Benzyl-methyl-prop-2-ynyl-amine|N-benzyl-N-methyl-prop-2-yn-1-amine|Pargyline [INN:BAN]|methylbenzylprop-2-ynylamine|Pargylinum [INN-Latin]|Pargilina [INN-Spanish]|Benzyl-methyl-2-propinylamin [Czech]|CCRIS 6740|Benzylmethylpropynylamine|NCGC00015841-02|CAS-306-07-0|EINECS 209-101-6|Lopac-P-8013|BRN 1938132|UNII-9MV14S8G3E|AI3-62058|Eutonyl (Salt/Mix)|Pargyline (Standard)|Spectrum_000641|PARGYLINE [MI]|Prestwick0_000183|Prestwick1_000183|Prestwick2_000183|Prestwick3_000183|Spectrum2_001039|Spectrum3_000540|Spectrum4_000469|Spectrum5_001030|PARGYLINE [VANDF]|CBChromo1_000308|PARGYLINE [WHO-DD]|SCHEMBL2045|Lopac0_001022|BSPBio_000105|BSPBio_002159|KBioGR_000918|KBioSS_001121|2-12-00-00548 (Beilstein Handbook Reference)|DivK1c_000053|SPBio_001257|SPBio_002026|BPBio1_000117|GTPL7262|HY-A0091AR|orb1310744|SCHEMBL14661612|DPWPWRLQFGFJFI-UHFFFAOYSA-|HY-A0091A|KBio1_000053|KBio2_001121|KBio2_003689|KBio2_006257|KBio3_001659|NINDS_000053|HMS3604I04|HMS6018A09|N-benzyl-N-methyl-2-propinylamine|Pargyline hydrochloride (Salt/Mix)|AAA55557|BDBM50172756|MSK169387|SBB037855|2-Propynylamine, N-benzyl-N-methyl-|N-Methyl-N-(2-propynyl)benzylamine-|AKOS009027469|N-Methyl-N-propargylbenzylamine, 97%|CCG-205102|CS-4685|DB01626|SDCCGSBI-0050995.P005|IDI1_000053|N-Benzyl-N-methyl-2-propyn-1-amine #|N-Methyl-N-(2-propyn-1-yl)benzylamine|NCGC00015841-01|NCGC00015841-03|NCGC00015841-04|NCGC00015841-05|NCGC00015841-06|NCGC00015841-07|NCGC00015841-18|NCGC00024240-03|AS-75650|ST079278|SY056647|SBI-0050995.P004|DB-072009|AB00053516|M2618|NS00000467|C07414|D08453|EN300-120295|T72610|AB00053516_13|N-benzyl-N-methylprop-2-yn-1-amine,hydrochloride|Q781329|BRD-K83597974-003-05-7|BRD-K83597974-003-22-2|Z103710848|InChI=1/C11H13N/c1-3-9-12(2)10-11-7-5-4-6-8-11/h1,4-8H,9-10H2,2H3"
PINDOLOL,4828,,"InChI=1S/C14H20N2O2/c1-10(2)16-8-11(17)9-18-14-5-3-4-13-12(14)6-7-15-13/h3-7,10-11,15-17H,8-9H2,1-2H3",JZQKKSLKJUAGIC-UHFFFAOYSA-N,C14H20N2O2,248.32,1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol,"pindolol|13523-86-9|Visken|Prinodolol|Betapindol|Carvisken|Durapindol|Pinbetol|Calvisken|Decreten|Pectobloc|Pynastin|Blocklin L|Glauco-visken|LB-46|Pindololum|Blocklin-L|DL-Pindolol|LB 46|(rs)-pindolol|Apo-pindol|4-(2-Hydroxy-3-isopropylaminopropoxy)-indole|1-(1H-Indol-4-yloxy)-3-[(1-methylethyl)amino]-2-propanol|1-(Indol-4-yloxy)-3-(isopropylamino)-2-propanol|1-(1H-indol-4-yloxy)-3-(isopropylamino)propan-2-ol|1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol|1-((1-Methylethyl)amino)-3-(4-indolyloxy)-2-propanol|DTXSID8023476|Dl-lb-46|BJ4HF6IU1D|NSC-757276|1-(1H-Indol-4-yloxy)-3-((1-methylethyl)amino)-2-propanol|CHEBI:8214|2-Propanol, 1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]-|2-Propanol, 1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)-|1-(1H-indol-4-yloxy)-3-(propan-2-ylamino)-propan-2-ol|DTXCID603476|1-(1H-indol-4-yloxy)-3-[(1-methylethyl)amino]propan-2-ol|Prindolol|1-(1H-indol-4-yloxy)-3-[(propan-2-yl)amino]propan-2-ol|2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-, (+-)-|LB46|pindololo|1-(1H-indol-4-yloxy)-3-((propan-2-yl)amino)propan-2-ol|1-(1H-indol-4-yloxy)-3-((1-methylethyl)amino)propan-2-ol|RefChem:55861|C07AA03|(A+-)-LB-46|(2RS)-1-(1H-Indol-4-yloxy)-3-(1-methylethyl)aminopropan-2-ol|236-867-9|Blockin L|4-(3-(Isopropylamino)-2-hydroxypropoxy)indole|2-Propanol, 1-(4-indolyloxy)-3-(isopropylamino)-|Glauco-Viskin|MFCD00010530|NCGC00015786-11|2-Propanol, 1-(1H-indol-4-yloxy)-3-(1-methylethyl)amino-|(+-)-Pindolol|Pindololum [INN-Latin]|DL-4-[2-Hydroxy-3-(isopropylamino)propoxy]indole|Blocklin|Carvisken (TN)|SMR000059120|Blocklin-L (TN)|Visken (TN)|CCRIS 9215|HSDB 6539|SR-01000000027|EINECS 236-867-9|EINECS 244-623-8|UNII-BJ4HF6IU1D|BRN 1536506|DL-4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)INDOLE|DL-LB 46|Prestwick_397|CAS-13523-86-9|Pindolol (Standard)|Pindolol [USAN:USP:INN:BAN:JAN]|1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol|Spectrum_001109|(-)-Pindolol; (S)-(-)-Pindolol; S-Pindolol|(1)-1-(1H-Indol-4-yloxy)-3-(isopropylamino)propan-2-ol|PINDOLOL [HSDB]|PINDOLOL [USAN]|PINDOLOL [INN]|PINDOLOL [JAN]|PINDOLOL [MI]|PINDOLOL [VANDF]|(.+/-.)-Pindolol|Prestwick0_000090|Prestwick1_000090|Prestwick2_000090|Prestwick3_000090|Spectrum2_001285|Spectrum3_000547|Spectrum4_000479|Spectrum5_001266|PINDOLOL [MART.]|CHEMBL500|GTPL91|PINDOLOL [USP-RS]|PINDOLOL [WHO-DD]|PINDOLOL,(-)|P 0778|SCHEMBL5219|Lopac0_000955|Oprea1_770884|(+/-)-PINDOLOL|BSPBio_000020|BSPBio_002193|KBioGR_000958|KBioSS_001589|5-21-03-00017 (Beilstein Handbook Reference)|MLS000069496|MLS002548891|DivK1c_000837|SPECTRUM1500488|Pindolol (JP18/USP/INN)|SPBio_001289|SPBio_001959|PINDOLOL [ORANGE BOOK]|2-Propanol, 1-(indol-4-yloxy)-3-(isopropylamino)-|BPBio1_000022|orb2703260|PINDOLOL [EP MONOGRAPH]|1-((1H-indol-4-yl)oxy)-3-(isopropylamino)propan-2-ol|PINDOLOL [USP MONOGRAPH]|SCHEMBL29908300|HMS502J19|HY-B0982R|KBio1_000837|KBio2_001589|KBio2_004157|KBio2_006725|KBio3_001693|NINDS_000837|HMS1568A22|HMS1920H16|HMS2089I21|HMS2091P20|HMS2095A22|HMS3259I07|HMS3262P12|HMS3267K17|HMS3369E14|HMS3414J03|HMS3678H21|HMS3712A22|HMS3742C07|HMS3885N04|HMS5083C21|Pharmakon1600-01500488|VISKAZIDE COMPONENT PINDOLOL|HY-B0982|MSK10061|Pindolol, >=98% (TLC), powder|Tox21_110221|Tox21_500955|BDBM50019443|CCG-39223|NSC757276|PDSP1_000771|PDSP1_000772|PDSP2_000759|PDSP2_000760|AKOS015969756|Tox21_110221_1|CS-4473|DB00960|LP00955|NC00467|NSC 757276|SB17015|SDCCGSBI-0050929.P005|IDI1_000837|NCGC00015786-06|NCGC00015786-07|NCGC00015786-08|NCGC00015786-09|NCGC00015786-10|NCGC00015786-13|NCGC00015786-14|NCGC00015786-16|NCGC00015786-20|NCGC00015786-22|NCGC00024925-03|NCGC00024925-04|NCGC00024925-05|NCGC00024925-06|NCGC00024925-07|NCGC00261640-01|BS-42390|DA-66729|SBI-0050929.P004|4-(3-Isopropylamino-2-hydroxypropoxy)indole|AB00052072|EU-0100955|NS00007947|ST50319990|SW196641-3|(+/-)-LB-46|C07445|C90604|D00513|AB00052072-11|AB00052072_12|AB00052072_13|1-(4-Indolyloxy)-3-(isopropylamino)-2-propanol|523P869|EN300-18518413|L000006|Q418101|3-indol-4-yloxy-1-[(methylethyl)amino]propan-2-ol|4-(2-HYDROXY-3-ISOPROPYLAMINOPROPOXY)INDOLE|SR-01000000027-2|SR-01000000027-4|SR-01000000027-5|SR-01000000027-7|1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol|BRD-A97701745-001-05-3|BRD-A97701745-001-09-5|BRD-A97701745-001-14-5|BRD-A97701745-001-15-2|BRD-A97701745-001-16-0|1-(1H-Indol-4-yloxy)-3-(isopropylamino)-2-propanol #|Pindolol, European Pharmacopoeia (EP) Reference Standard|(+/-)-4-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)INDOLE|1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol(pindolol)|Pindolol, United States Pharmacopeia (USP) Reference Standard|1-(1H-Indol-4-yloxy)-3-isopropylamino-propan-2-ol((-)-Pindolol)|N-(2-HYDROXY-3-(1H-INDOL-4-YLOXY)PROPYL)-N-ISOPROPYLAMINE"
TENOFOVIR,464205,,"InChI=1S/C9H14N5O4P/c1-6(18-5-19(15,16)17)2-14-4-13-7-8(10)11-3-12-9(7)14/h3-4,6H,2,5H2,1H3,(H2,10,11,12)(H2,15,16,17)/t6-/m1/s1",SGOIRFVFHAKUTI-ZCFIWIBFSA-N,C9H14N5O4P,287.21,[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid,"Tenofovir|147127-20-6|(R)-9-(2-Phosphonomethoxypropyl)adenine|(R)-PMPA|tenofovir (anhydrous)|anhydrous tenofovir|Tenofovir anhydrous|tenofovir (anh.)|GS-1275|PMP-A|CHEBI:63625|GS-1278|W4HFE001U5|(R)-9-(2-Phosphonylmethoxypropyl)adenine|(R)-9-(Phosphonomethoxypropyl)adenine|[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethylphosphonic acid|({[(2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl]oxy}methyl)phosphonic acid|DTXSID9040132|(((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonic acid|{[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl}phosphonic acid|Phosphonic acid, (((1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-|CHEBI:63716|9-PMPA (tenofovir)|tenofovirum|((2R)-1-(6-aminopurin-9-yl)propan-2-yl)oxymethylphosphonic acid|((((2R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)phosphonic acid|Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-|9-(2-Phosphonylmethoxypropyl)adenine|Disoproxil, Tenofovir|RefChem:6288|Phosphonic acid, ((2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-, monohydrate, (R)-|Disoproxil Fumarate, Tenofovir|Fumarate, Tenofovir Disoproxil|DTXCID7020132|J05AF07|(R)-9-(Phosphonomethoxypropyl)adenine Hydrate|(R)-9-(2-Phosphonomethoxypropyl)adenine Hydrate|(((1R)-2-(6-Amino-9H-purin-9-yl)-1-methylethoxy)methyl)phosphonic Acid, Monohydrate|9-(2-Phosphonomethoxypropyl)adenine|99YXE507IL|PMPA|tenofovir monohydrate|(R)-(((1-(6-AMINO-9H-PURIN-9-YL)PROPAN-2-YL)OXY)METHYL)PHOSPHONIC ACID|PMPA gel|Phosphonic acid, P-[[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]-|MFCD00943794|C9H14N5O4P|147127-20-6 (Tenofovir)|[(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methylphosphonic acid|9-[(R)-2-(phosphonomethoxy)propyl]adenine|(R)-(1-(6-amino-9H-purin-9-yl)propan-2-yloxy)methylphosphonic acid|D,L-Tenofovir|(R)-9-[2-(Phosphonomethoxy)propyl]adenine|Tenofovir (1.0 mg/mL in Water)|Tenofovir gel|[2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYLPHOSPHONIC ACID|GNA & Tenofovir|HHA & Tenofovir|TFV gel|TFV|GS 1275|PMPA-(R)|UNII-W4HFE001U5|Tenofovir [USAN:INN:BAN]|Rac tenofovir|anh. tenofovir|Viread (prodrug for Tenofovir)|[[(1R)-2(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic Acid;|(R)-[[2-(6-Amino-9H-purin-9-yl)-1-methylethoxy]methyl]phosphonic acid|PHOSPHONIC ACID, P-(((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)-|Tenofovir (Viread)|KS-5021|TENOFOVIR [INN]|TENOFOVIR [MI]|9-PMPA|CHEMBL483|EC 604-571-2|TENOFOVIR [WHO-DD]|SCHEMBL39724|orb533302|Tenofovir gel (GS-1278)|Tenofovir - Bio-X trade mark|orb1307900|SCHEMBL29355255|Tenofovir, >=98% (HPLC)|GTPL10948|SGOIRFVFHAKUTI-ZCFIWIBFSA-N|BCPP000049|HMS3264H05|MSK10872|AC-760|BDBM50450813|MFCD07357269|AKOS015856701|AKOS015894941|CCG-267345|CS-1609|DB14126|FT10480|Phosphonic acid, ((2-(6-amino-9H-purin-9-yl)-1-methylethoxy)methyl)-, (R)-|NCGC00167535-16|BT164455|HY-13910|SY046605|NS00000521|T3006|(R)-9-[2-(phosphonomethoxy) propyl] adenine|C17407|EN300-123033|AB01274787-01|AB01274787_02|AB01274787_03|127T206|F077792|Q155954|SR-01000883934|SR-01000883934-1|BRD-K15891719-001-02-8|BRD-K15891719-001-04-4|BRD-K15891719-001-05-1|BRD-K15891719-213-01-1|Z1546616194|(R)-[[(1-(6-Amino-9-purinyl)-2-propyl)oxy]methyl]phosphonic Acid|[[(1R)-2(6-Amino-9H-Purin-9-Yl)-1-Methylethoxy]Methyl]Phosphonic Acid|(R)-9-(2-Phosphonoylmethoxypropyl)adenine; 1-(6-aminopurin-9-yl)propan-2-yloxymethylphosphonic acid; 9-PMPA; Disoproxil|(R)-9-(2-Phosphonoylmethoxypropyl)adenine;1-(6-aminopurin-9-yl)propan-2- yloxymethylphosphonic acid;(R)-[[2-(6-Amino-9H-purin-9-|Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Galanthus nivalis agglutinin (GNA)|Phosphonic acid, [[(1R)-2-(6-amino-9H-purin-9-yl)-1-methylethoxy]methyl]- & Hippeastrum hybrid agglutinin( HHA)|TFO"
STAVUDINE TRIPHOSPHATE,65355,,"InChI=1S/C10H15N2O13P3/c1-6-4-12(10(14)11-9(6)13)8-3-2-7(23-8)5-22-27(18,19)25-28(20,21)24-26(15,16)17/h2-4,7-8H,5H2,1H3,(H,18,19)(H,20,21)(H,11,13,14)(H2,15,16,17)/t7-,8+/m0/s1",ODSQODTUNULBHF-JGVFFNPUSA-N,C10H15N2O13P3,464.15,"[hydroxy-[[(2S,5R)-5-(5-methyl-2,4-dioxopyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate","Stavudine triphosphate|D4TTP|26194-89-8|2,3-Ddddttp|2',3'-Dideoxy-2',3'-dehydrothymidine 5'-triphosphate|1ZP0VJ751G|DTXSID10180822|2',3'-Dedehydro-2',3'-dideoxythymidine triphosphate|Thymidine 5'-(tetrahydrogen triphosphate), 2',3'-didehydro-3'-deoxy-|RefChem:185389|DTXCID50103313|((hydroxy(((hydroxy((((2S,5R)-5-(5-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)-2,5-dihydrofuran-2-yl)methoxy))phosphoryl)oxy))phosphoryl)oxy)phosphonic acid|CHEMBL485652|2',3'-Didehydro-3'-deoxythymidine 5'-triphosphate|Dddttp|Thymine, 1-(2,3-dideoxy-.beta.-D-glycero-pent-2-enofuranosyl)-, 5'-(tetrahydrogen triphosphate)|d4T-TP|ddeTTP|[hydroxy-[[(2S,5R)-5-(5-methyl-2,4-dioxo-pyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methoxy]phosphoryl] phosphono hydrogen phosphate|orb63245|UNII-1ZP0VJ751G|SCHEMBL987898|orb1734034|orb2646545|BDBM50370655|DB02887|CAS 26194-89-8|NS00070643|3'-Deoxy-2',3'-didehydrothymidine-5'-triphosphate|Q27093852|HYMIDINE 5'-(TETRAHYDROGEN TRIPHOSPHATE), 2',3'-DIDEHYDRO-3'-DEOXY-|((2S,5R)-5-(5-Methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)-2,5-dihydrofuran-2-yl)methyl tetrahydrogen triphosphate"
GW501516,9803963,,"InChI=1S/C21H18F3NO3S2/c1-12-9-16(7-8-17(12)28-10-19(26)27)29-11-18-13(2)25-20(30-18)14-3-5-15(6-4-14)21(22,23)24/h3-9H,10-11H2,1-2H3,(H,26,27)",YDBLKRPLXZNVNB-UHFFFAOYSA-N,C21H18F3NO3S2,453.5,"2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid","317318-70-0|Endurobol|GW 501516|GW501516|GW-501516|GSK-516|GW1516|GW-1516|7I2HA1NU22|2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid|CHEBI:73726|{2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acid|DTXSID3041037|(2-methyl-4-(((4-methyl-2-(4-(trifluoromethyl)phenyl)-1,3-thiazol-5-yl)methyl)sulfanyl)phenoxy)acetic acid|2-(2-methyl-4-((4-methyl-2-(4-(trifluoromethyl)phenyl)-1,3-thiazol-5-yl)methylsulfanyl)phenoxy)acetic acid|RefChem:574663|DTXCID1021037|Cardarine|UNII-7I2HA1NU22|GW 1516|2-(4-((2-(4-(Trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methylthio)-2-methylphenoxy)acetic acid|GW-516|CHEMBL38943|2-{2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]phenoxy}acetic acid|MFCD09033000|GW501,516|GW 501,516|GW-501,516|2-(2-Methyl-4-(((4-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-5-yl)methyl)thio)phenoxy)acetic acid|C21H18F3NO3S2|GSK 516|GW501516 (Endurobol)|SCHEMBL68714|MLS006010753|GW 501516 (Standard)|ENDUROBOL;GW501516|GTPL2687|orb1301031|SCHEMBL29356729|BDBM28661|EX-A723|GLXC-03110|HMS3674C03|HMS3744O09|BCP21491|MSK10566|GW 501516 - Bio-X trade mark|HY-10838R|PDSP1_000255|PDSP2_000254|s5615|AKOS015965103|CCG-269268|CS-0438|DB05416|EX-3881|FM23721|SB19569|GW501516(G)|GW501516(GSK-516)|NCGC00241455-01|NCGC00241455-02|NCGC00241455-08|2-[2-methyl-4-[[4-methyl-2-[4-(trifluoromethyl)phenyl]thiazol-5-yl]methylsulfanyl]phenoxy]acetic acid|AC-23001|BG300099|HY-10838|SMR004701706|GW501516?|NS00068648|A26949|GW501516, >=98% (HPLC)|318G700|6T-0058|Q5515069|BRD-K14880289-001-01-4|BRD-K14880289-001-02-2|BRD-K14880289-001-03-0|(2-METHYL-4-(((4-METHYL-2-(4-(TRIFLUOROMETHYL)PHENYL)-1,3-THIAZOL-5-YL)METHYL)THIO)PHENOXY)ACETIC ACID|{2-Methyl-4-{{4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl}methylthio}phenoxy}acetic acid, analytical standard|{4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazol-5-yl}methyl)sulfanyl]-2-methylphenoxy}acetic acid|2-(2-methyl-4-((5-methyl-2-(4-(trifluoromethyl)phenyl)thiazol-4-yl)methylthio)phenoxy)acetic acid;GW 501516|2-(4-((2-(4-(trifluoromethyl)phenyl)-4-methylthiazol-5-yl)methylthio)-2-methylphenoxy)acetic acid,GW501516|2-{2-methyl-4-[({4-methyl-2-[4-(trifluoromethyl)phenyl]-1,3-thiazole-5-yl}methyl)sulfanyl]phenoxy}acetic acid|7T1|Acetic acid, (2-methyl-4-(((4-methyl-2-(4-(trifluoromethyl)phenyl)-5-thiazolyl)methyl)thio)phenoxy)-|GW 501516;2-[2-Methyl-4-[[[4-methyl-2-[4-(trifluoromethyl)phenyl]-5-thiazolyl]methyl]thio]phenoxy]acetic acid"
OXYBUTYNIN,4634,,"InChI=1S/C22H31NO3/c1-3-23(4-2)17-11-12-18-26-21(24)22(25,19-13-7-5-8-14-19)20-15-9-6-10-16-20/h5,7-8,13-14,20,25H,3-4,6,9-10,15-18H2,1-2H3",XIQVNETUBQGFHX-UHFFFAOYSA-N,C22H31NO3,357.5,4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate,"oxybutynin|5633-20-5|Oxytrol|Oxybutynine|kentera|Oxibutinina|Oxybutyninum|Anturol|Cystrin|Lyrinel XL|Oxytrol for Women|4-Diethylamino-2-butinyl alpha-cyclohexylmandelat|4-Diethylamino-2-butynyl alpha-phenylcyclohexaneglycolate|CHEBI:7856|K9P6MC7092|Cyclohexaneglycolic acid, alpha-phenyl-, 4-(diethylamino)-2-butynyl ester|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butynyl ester|DTXSID0023406|Dridase|4-diethylaminobut-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate|Promictuline|Urimin|Contimin 5|Contimin 2.5|RefChem:58311|GELNIQUE 3%|DTXCID503406|4-(diethylamino)-2-butynyl-alpha-phenylcyclohexaneglycolate|G04BD04|4-(diethylamino)-2-butynyl-alpha-cyclohexyl-alpha-hydroxybenzeneacetate|Ditropan|Oxibutyninum|Oxybutinin|Oxybutynine [INN-French]|Oxybutyninum [INN-Latin]|Oxibutinina [INN-Spanish]|4-(diethylamino)but-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate|4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenylacetate|Oxybutynin (Ditropan)|MFCD00865252|CHEMBL1231|4-(Diethylamino)-2-butynyl alpha-phenylcyclohexaneglycolic acid ester|5633-20-5 (free)|Benzeneacetic acid, a-cyclohexyl-a-hydroxy-,4-(diethylamino)-2-butynyl ester|Oxybutynin Base|4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate|transdermal patch|(R)-4-(Diethylamino)but-2-yn-1-yl 2-cyclohexyl-2-hydroxy-2-phenylacetate|Oxybutynin [USAN:INN:BAN]|CCRIS 1923|Oxybutynin transdermal|oxybutynin topical gel|HSDB 3270|Oxybutynin transdermal patch|Oxybutinyn|UNII-K9P6MC7092|(RS)-oxybutynin|Anturol (TN)|Oxytrol (TN)|Oxybutynin (Standard)|OXYBUTYNIN [MI]|OXYBUTYNIN [INN]|Oxybutynin (USAN/INN)|Prestwick0_000287|Prestwick1_000287|Prestwick2_000287|Prestwick3_000287|OXYBUTYNIN [HSDB]|OXYBUTYNIN [USAN]|OXYBUTYNIN [VANDF]|OXYBUTYNIN [MART.]|SCHEMBL2992|OXYBUTYNIN [WHO-DD]|Lopac0_000923|BSPBio_000194|GTPL359|MLS006010052|OXYBUTYNIN [EMA EPAR]|SPBio_002413|BPBio1_000214|orb1309936|OXYBUTYNIN [ORANGE BOOK]|HY-B0267R|OXYBUTYNIN, Oxybutynin chloride|CHEBI:144551|HMS3884K08|HMS5079P22|BCP12179|HY-B0267|MSK15451|4-(diethylamino)but-2-ynyl 2-cyclohexyl-2-hydroxy-2-phenyl-acetate|AB7701|BDBM50165019|s1754|AKOS015896242|Cyclohexaneglycolic acid, .alpha.-phenyl-, 4-(diethylamino)-2-butynyl ester|AC-2153|CCG-205005|DB01062|KS-5221|SDCCGSBI-0050898.P003|MRF-0000601|NCGC00015767-03|NCGC00015767-04|NCGC00015767-06|NCGC00015767-07|NCGC00015767-09|NCGC00015767-10|NCGC00015767-21|NCGC00089795-02|FO147213|SMR001550466|SBI-0050898.P002|NS00010348|SW196787-3|C07360|D00465|EN300-6478839|633O205|L000923|Q1060922|BRD-A65013509-001-02-4|BRD-A65013509-003-03-8|BRD-A65013509-003-13-7|BRD-A65013509-003-23-6|BRD-A65013509-003-24-4|Z2588038990|4-(Diethylamino)-2-butynyl .alpha.-phenylcyclohexaneglycolate|4-(Diethylamino)-2-butynyl cyclohexyl(hydroxy)phenylacetate #|4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)(phenyl)acetate|rac-4-(diethylamino)but-2-yn-1-yl cyclohexyl(hydroxy)phenylacetate|alpha-cyclohexyl-alpha-hydroxybenzeneacetic acid 4-(diethylamino)-2-butynyl ester|Benzeneacetic acid, alpha-cyclohexyl-alpha-hydroxy-, 4-(diethylamino)-2-butyn-1-yl ester|119579-36-1"
TOLTERODINE,443879,,"InChI=1S/C22H31NO/c1-16(2)23(17(3)4)14-13-20(19-9-7-6-8-10-19)21-15-18(5)11-12-22(21)24/h6-12,15-17,20,24H,13-14H2,1-5H3/t20-/m1/s1",OOGJQPCLVADCPB-HXUWFJFHSA-N,C22H31NO,325.5,2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol,"tolterodine|124937-51-5|(+)-Tolterodine|Tolterodinum|Kabi 2234|Tolterodina|Kabi-2234|WHE7A56U7K|CHEBI:9622|2-[(1R)-3-[di(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol|(+)-(R)-2-(alpha-(2-(Diisopropylamino)ethyl)benzyl)-p-cresol|2-[(1R)-3-[bis(propan-2-yl)amino]-1-phenylpropyl]-4-methylphenol|Detrusitol xl|Efflosomyl xl|Mariosea xl|Preblacon xl|Santizor xl|2-((1R)-3-(bis(propan-2-yl)amino)-1-phenylpropyl)-4-methylphenol|2-((1R)-3-(di(propan-2-yl)amino)-1-phenylpropyl)-4-methylphenol|2-[(1R)-3-(di(propan-2-yl)amino)-1-phenylpropyl]-4-methylphenol|Blerone xl|Inconex xl|Neditol xl|RefChem:56377|G04BD07|R-(+)-Tolterodine|Urotrol|Tolterodine [INN]|Phenol, 2-[(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methyl-|Tolterodinum [INN-Latin]|Tolterodina [INN-Spanish]|2-[(1R)-3-(diisopropylamino)-1-phenylpropyl]-4-methylphenol|S-(-)-Tolterodine|CHEMBL1382|DTXSID3023687|(R)-(+)-Tolterodine|NCGC00159519-02|Unidet|tolterodin|DTXCID703687|2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol|2-{(1R)-3-[bis(1-methylethyl)amino]-1-phenylpropyl}-4-methylphenol|Tolterodine (racemate)|SMR000596518|CAS-124937-51-5|PHA-686464B|C22H31NO|UNII-WHE7A56U7K|PNU 200583|Tolterodine [USAN:INN:BAN]|Phenol, 2-((1R)-3-(bis(1-methylethyl)amino)-1-phenylpropyl)-4-methyl-|2-[(1R)-3-[Bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol; (R)-(+)-N,N-Diisopropyl-3-(2-hydroxy-5-methylphenyl)-3-phenylpropylamine;|Tolterondine Tartrate|TOLTERODINE [MI]|Tolterodine (USAN/INN)|TOLTERODINE [USAN]|TOLTERODINE [VANDF]|SCHEMBL3064|GTPL360|TOLTERODINE [WHO-DD]|MLS001195620|MLS001304745|BIDD:GT0318|orb1704166|SCHEMBL29379290|(r)-2-(3-(diisopropylamino)-1-phenylpropyl)-4-methylphenol|HMS2230E24|HY-A0024|tolterodine extended release capsules|Tox21_111737|BDBM50165008|AKOS015841711|AKOS015895578|Tox21_111737_1|AC-3472|CS-1799|DB01036|KS-5165|NCGC00159519-01|NCGC00159519-04|NCGC00159519-14|NCGC00263557-01|2-[3-[Bis(1-Methylethyl)Amino]-1-Phenylpropyl]-4-Methyl Phenol Monohydrobromide|DB-260460|C07750|D00646|H10328|AB00698547-12|AB00698547_13|EN300-1709733|937T515|Q424312|BRD-K54316499-046-04-5|BRD-K54316499-046-05-2|2-[(1R)-3-(diisopropylamino)-1-phenyl-propyl]-4-methyl-phenol|2-[(1r)3-[bis(1-methylethyl)amino]-1-phenylpropyl]-4-methylphenol|(+)-(R)-3-(2-hydroxy-5-methylphenyl)-N,N-diisopropyl-3-phenylpropylamine|2-[(1R)-3-[BIS(1-METHYLETHYL)AMINO]-1-PHENYLPROPYL]-4-METHYL-PHENOL TARTRATE|PNU-200583 racemate; PNU 200583 racemate; PNU200583 racemate; ()-Tolterodine; Racemic tolterodine"
SALMETEROL,5152,,"InChI=1S/C25H37NO4/c27-20-23-18-22(13-14-24(23)28)25(29)19-26-15-7-1-2-8-16-30-17-9-6-12-21-10-4-3-5-11-21/h3-5,10-11,13-14,18,25-29H,1-2,6-9,12,15-17,19-20H2",GIIZNNXWQWCKIB-UHFFFAOYSA-N,C25H37NO4,415.6,2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol,"Salmeterol|89365-50-4|Salmeterolum|2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]phenol|GR 33343X|SALMATEROL|SN408D|GR 33343 X|2I4BC502BT|DTXSID6023571|GR-33343-X|DTXCID803571|4-(1-hydroxy-2-((6-(4-phenylbutoxy)hexyl)amino)ethyl)-2-(hydroxymethyl)phenol|4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)-2-(hydroxymethyl)phenol|Neovent|Soltel|2-(hydroxymethyl)-4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)phenol|RefChem:56523|CHEBI:9011|R03AC12|Arial|Beglan|GR-33343X|NSC-272693|Salmetedur|salmeterolo|Serevent|Astmerole|Aeromax|Salmeterolum [Latin]|2-(hydroxymethyl)-4-(1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]amino}ethyl)phenol|CHEBI:64064|MFCD00867037|4-(1-hydroxy-2-(6-(4-phenylbutoxy)hexylamino)ethyl)-2-(hydroxymethyl)phenol|2-(hydroxymethyl)-4-[1-hydroxy-2-({6-[(4-phenylbutyl)oxy]hexyl}amino)ethyl]phenol|SMR000466295|HSDB 7315|SR-01000076139|Salmeterol (USAN/INN)|UNII-2I4BC502BT|Salmeterol [USAN:INN:BAN]|Salmeterol?|Salmeterolxinafoate|NCGC00025247-01|3-Benzenedimethanol, 4-hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-; 1,3-Benzenedimethanol, 4-hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-, (+/-)-; GR 33343X; Salmeterol; GR 33343X|(+-)-4-Hydroxy-alpha'-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-m-xylene-alpha,alpha'-diol|(+-)-4-Hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-1,3-benzenedimethanol|CPD000466295|SALMETEROL [MI]|SALMETEROL [INN]|Prestwick3_000945|SALMETEROL [HSDB]|SALMETEROL [USAN]|SALMETEROL [VANDF]|S 2692|SCHEMBL4767|CHEMBL1263|SALMETEROL [WHO-DD]|Lopac0_001100|BSPBio_000910|GTPL559|MLS000759000|MLS001424322|BPBio1_001002|orb1309132|Salmeterol Xinafoate Impurity 1|SCHEMBL29393289|BDBM25771|MSK1377|GLXC-07244|HMS2052H13|HMS2090E17|HMS2097N12|HMS3268K19|HMS3394H13|HMS3412P13|HMS3714N12|HMS3886G10|HMS5084P12|BCP04199|EX-A4409|Tox21_113584|s5527|STK629186|AKOS005561914|CCG-101194|CCG-205176|DB00938|FS46783|NC00444|SDCCGSBI-0633788.P001|1,3-Benzenedimethanol, 4-hydroxy-.alpha.1-[[[6-(4-phenylbutoxy)hexyl]amino]methyl]-|1,3-Benzenedimethanol, 4-hydroxy-alpha1-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-|MRF-0000468|NCGC00015938-03|NCGC00025247-02|1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl)-, (+-)-|1,3-Benzenedimethanol, 4-hydroxy-alpha(sup 1)-(((6-(4-phenylbutoxy)hexyl)amino)methyl-, (+-)-|AS-56157|HY-14302|Salmeterol 100 microg/mL in Acetonitrile|CAS-89365-50-4|DB-226688|AB00513972|NS00010340|C07241|C77008|D05792|AB00513972-07|365S504|EN300-18530979|L000532|Q424333|SR-01000076139-2|SR-01000076139-6|BRD-A01320529-001-05-9|BRD-A01320529-104-10-1|BRD-A01320529-104-11-9|BRD-A01320529-104-12-7|2-hydroxymethyl-4-{1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl}phenol|(RS)-2-(Hydroxymethyl)-4-{1-hydroxy-2-[6-(4-phenylbutoxy) hexylamino]ethyl}phenol|2-(Hydroxymethyl)-4-[(1R)-1-hydroxy-2-{[6-(4-phenylbutoxy)hexyl]a mino}ethyl]phenol|2-(hydroxymethyl)-4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]-phenol|( inverted question mark) 4-Hydroxy-a1-[[[6-(4-phenylbutoxy)hexyl]amino]m-ethyl]-1,3-benzenedimethanol; GR 33343X|1-hydroxy-2-naphthoic acid;4-[1-hydroxy-2-[6-(4-phenylbutoxy)hexylamino]ethyl]-2-methylol-phenol"
FORMOTEROL,3410,,"InChI=1S/C19H24N2O4/c1-13(9-14-3-6-16(25-2)7-4-14)20-11-19(24)15-5-8-18(23)17(10-15)21-12-22/h3-8,10,12-13,19-20,23-24H,9,11H2,1-2H3,(H,21,22)",BPZSYCZIITTYBL-UHFFFAOYSA-N,C19H24N2O4,344.4,N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide,"formoterol|73573-87-2|Oxis|Formoterolum|N-[2-hydroxy-5-[1-hydroxy-2-[1-(4-methoxyphenyl)propan-2-ylamino]ethyl]phenyl]formamide|(+-)-Formoterol|2'-hydroxy-5'-(1-hydroxy-2-((p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|2'-hydroxy-5'-{1-hydroxy-2-[(p-methoxy-alpha-methylphenethyl)amino]ethyl}formanilide|DTXSID1023077|N-(2-hydroxy-5-(1-hydroxy-2-(1-(4-methoxyphenyl)propan-2-ylamino)ethyl)phenyl)formamide|(+-)-2'-Hydroxy-5'-((RS)-1-hydroxy-2-(((RS)-p-methoxy-alpha-methylphenethyl)amino)ethyl)formanilide|RefChem:5843|CHEBI:5147|DTXCID4065311|R03AC13|5ZZ84GCW8B|Eformoterol|128954-45-0|n-[2-hydroxy-5-(1-hydroxy-2-{[1-(4-methoxyphenyl)propan-2-yl]amino}ethyl)phenyl]formamide|Formoterolum [INN-Latin]|CHEBI:63082|Formoterol (INN)|N-[2-hydroxy-5-(1-hydroxy-2-{[2-(4-methoxyphenyl)-1-methylethyl]amino}ethyl)phenyl]formamide|Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-, [R-(R*,S*)]-|Oxis (TN)|Oxeze/Oxis|Formamide, N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]-; N-[2-Hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide|n-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide|NCGC00181126-01|SCHEMBL349579|GTPL3465|CHEMBL1256786|SCHEMBL15856256|BDBM86453|DTXSID20860603|MSK1310|BPZSYCZIITTYBL-UHFFFAOYSA-N|HWA41436|AC-459|STL450992|AKOS015961179|AT22502|DB00983|SB17482|NSC_3083544|AS-14186|N-[2-hydroxy-5-[1-hydroxy-2-[[2-(4-methoxyphenyl)-1-methyl-ethyl]amino]ethyl]phenyl]formamide|CAS_73573-87-2|NS00008796|C07805|D07990|EN300-7480042|L000259|Q637247|126587-85-7|N-[2-hydroxy-5-[(1rs)-1-hydroxy-2-[[(1rs)-2(4methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl] formamide"
TALNETANT,5311424,,"InChI=1S/C25H22N2O2/c1-2-20(17-11-5-3-6-12-17)27-25(29)22-19-15-9-10-16-21(19)26-23(24(22)28)18-13-7-4-8-14-18/h3-16,20,28H,2H2,1H3,(H,27,29)/t20-/m0/s1",BIAVGWDGIJKWRM-FQEVSTJZSA-N,C25H22N2O2,382.5,3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide,"Talnetant|174636-32-9|SB 223412|SB-223412|3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]quinoline-4-carboxamide|CZ3T9T146K|DTXSID00870124|talnetantum|3-hydroxy-2-phenyl-N-((1S)-1-phenylpropyl)quinoline-4-carboxamide|RefChem:187318|DTXCID701509648|Talnetant [INN]|4-Quinolinecarboxamide, 3-hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]-|MFCD00944075|CHEMBL10188|3-hydroxy-2-phenyl-n-[(1S)-1-phenylpropyl]-4-quinolinecarboxamide|SB-2234|SB223412|(S)-3-Hydroxy-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide|(-)-(S)-N-(alpha-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide|UNII-CZ3T9T146K|3-Hydroxy-2-phenyl-N-[(1S)-1-phenylpropyl]-4-quinolinecarboxamide; SB 223412;|TALNETANT [WHO-DD]|SCHEMBL74220|GTPL2132|orb1299718|3-Hydroxy-2-phenyl-quinoline-4-carboxylic acid (1-phenyl-propyl)-amide|SCHEMBL29390363|Talnetant (SB 223412)?|Talnetant, >=98% (HPLC)|EX-A894|GLXC-02536|N-((S)-alpha-Ethylbenzyl)-3-hydroxy-2-phenylcinchoninamide|BDBM50051293|AKOS024458283|CS-1638|NCGC00370774-02|NCGC00370774-05|AC-36821|AS-72166|HY-14552|DB-335820|NS00068616|SB-223,412|BRD-K47095176-001-01-6|(s)-3-hydroxy-2-phenyl-n-(1-phenylpropyl)-4-quinolinecarboxamide|(S)-N-(alpha-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide|(-)-(S)-N-(alpha-ethylbenzyl)-3-hydroxy-2-phenylquinoline4-carboxamide|(S)-(-)-N-(alpha-ethylbenzyl)-3-hydroxy-2-phenyl-4-quinoline carboxamide|(S)-(-)-N-(alpha-ethylbenzyl)-3-hydroxy-2phenyl-4-quinoline carboxamide|(S)-(-)-N-(R-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide|3-Hydroxy-2-phenyl-quinoline-4-carboxylic acid ((S)-1-phenyl-propyl)-amide|4-Quinolinecaeboxamide, 3-hydroxy-2-phenyl-N-((1S)-1-phenylpropyl)-|4-Quinolinecarboxamide, 3-hydroxy-2-phenyl-N-(1-phenylpropyl)-, (S)-|N-((S)-.ALPHA.-ETHYLBENZYL)-3-HYDROXY-2-PHENYLCINCHONINAMIDE"
MELAGATRAN,183797,,"InChI=1S/C22H31N5O4/c23-20(24)16-8-6-14(7-9-16)12-26-21(30)17-10-11-27(17)22(31)19(25-13-18(28)29)15-4-2-1-3-5-15/h6-9,15,17,19,25H,1-5,10-13H2,(H3,23,24)(H,26,30)(H,28,29)/t17-,19+/m0/s1",DKWNMCUOEDMMIN-PKOBYXMFSA-N,C22H31N5O4,429.5,2-[[(1R)-2-[(2S)-2-[(4-carbamimidoylphenyl)methylcarbamoyl]azetidin-1-yl]-1-cyclohexyl-2-oxoethyl]amino]acetic acid,"Melagatran|159776-70-2|2A9QP32MD4|CHEBI:43966|DTXSID30166724|N-((R)-(((2S)-2-((-p-Amidobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine|2-[[(1R)-2-[(2S)-2-[(4-carbamimidoylphenyl)methylcarbamoyl]azetidin-1-yl]-1-cyclohexyl-2-oxoethyl]amino]acetic acid|Glycine, N-[(1R)-2-[(2S)-2-[[[[4-(aminoiminomethyl)phenyl]methyl]amino]carbonyl]-1-azetidinyl]-1-cyclohexyl-2-oxoethyl]-|Glycine, N-((1R)-2-((2S)-2-((((4-(aminoiminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-1-cyclohexyl-2-oxoethyl)-|melagatranum|2-(((1R)-2-((2S)-2-((4-carbamimidoylphenyl)methylcarbamoyl)azetidin-1-yl)-1-cyclohexyl-2-oxoethyl)amino)acetic acid|RefChem:156293|DTXCID1089215|B01AE04|Melagatran [INN]|Melagatran (INN)|H-319/68|159776-70-2 (free base)|[((1R)-2-{(2S)-2-[({4-[AMINO(IMINO)METHYL]BENZYL}AMINO)CARBONYL]AZETIDINYL}-1-CYCLOHEXYL-2-OXOETHYL)AMINO]ACETIC ACID|2-(((R)-2-((S)-2-((4-Carbamimidoylbenzyl)carbamoyl)azetidin-1-yl)-1-cyclohexyl-2-oxoethyl)amino)acetic acid|((R)-2-((S)-2-((4-carbamimidoylbenzyl)carbamoyl)azetidin-1-yl)-1-cyclohexyl-2-oxoethyl)glycine|N-[(1R)-2-{(2S)-2-[(4-carbamimidoylbenzyl)carbamoyl]azetidin-1-yl}-1-cyclohexyl-2-oxoethyl]glycine|UNII-2A9QP32MD4|MELAGATRAN (ASTRA-ZENECA)|Melagatran AstraZeneca|MELAGATRAN [MI]|MELAGATRAN [MART.]|MELAGATRAN [WHO-DD]|SCHEMBL27652|N-[(1R)-2-[(2S)-2-[[[[4-(Aminoiminomethyl)phenyl]methyl]amino]carbonyl]-1-azetidinyl]-1-cyclohexyl-2-oxoethyl]glycine|CHEMBL266349|GTPL6382|orb1709156|BDBM29388|1k22|EX-A11153|AKOS022181213|DB13616|N-((R)-(((2S)-2-((p-Amidinobenzyl)carbamoyl)-1-azetidinyl)carbonyl)cyclohexylmethyl)glycine|DA-65325|Glycine, N-(2-(2-((((4-(aminoiminomethyl)phenyl)methyl)amino)carbonyl)-1-azetidinyl)-1-cyclohexyl-2-oxoethyl)-, (S-(R*,S*))-|TS-07835|HY-129056|CS-0103405|NS00009077|C21551|D07143|G12919|H-319-68|Q27084209"
DABIGATRAN,216210,,"InChI=1S/C25H25N7O3/c1-31-20-10-7-17(25(35)32(13-11-23(33)34)21-4-2-3-12-28-21)14-19(20)30-22(31)15-29-18-8-5-16(6-9-18)24(26)27/h2-10,12,14,29H,11,13,15H2,1H3,(H3,26,27)(H,33,34)",YBSJFWOBGCMAKL-UHFFFAOYSA-N,C25H25N7O3,471.5,3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid,"Dabigatran|211914-51-1|BIBR-953|Pradaxa (dabigatran)|BIBR 953 ZW|CHEBI:70752|I0VM4M70GC|BIBR-953-ZW|3-[[2-[(4-carbamimidoylanilino)methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid|DTXSID50175419|N-((2-((p-Amidinoanilino)methyl)-1-methyl-5-benzimidazolyl)carbonyl)-N-2-pyridyl-beta-alanine|beta-Alanine, N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-|3-((2-(((4-carbamimidoylphenyl)amino)methyl)-1-methylbenzimidazole-5-carbonyl)-pyridin-2-ylamino)propanoic acid|3-((2-((4-carbamimidoylanilino)methyl)-1-methylbenzimidazole-5-carbonyl)-pyridin-2-ylamino)propanoic acid|3-[[2-[[(4-carbamimidoylphenyl)amino]methyl]-1-methylbenzimidazole-5-carbonyl]-pyridin-2-ylamino]propanoic acid|RefChem:54923|Etexilate Mesylate, Dabigatran|Mesylate, Dabigatran Etexilate|DTXCID4097910|N-((2-(((4-(aminoiminomethyl)phenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)-N-2-pyridinyl-beta-alanine|859-177-5|BIBR 953|3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoic acid|MFCD09837830|3-[1-(2-{[(4-carbamimidoylphenyl)amino]methyl}-1-methyl-1H-1,3-benzodiazol-5-yl)-N-(pyridin-2-yl)formamido]propanoic acid|CHEMBL48361|C25H25N7O3|b-Alanine,N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-|N-[(2-{[(4-Carbamimidoylphenyl)amino]methyl}-1-Methyl-1h-Benzimidazol-5-Yl)carbonyl]-N-Pyridin-2-Yl-Beta-Alanine|1-Methyl-2-[(4-amidinophenyl)aminomethyl]benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-hydroxycarbonylethyl)amide|3-[[2-[[(4-CARBAMIMIDOYLPHENYL)AMINO]METHYL]-1-METHYL-BENZOIMIDAZOLE-5-CARBONYL]-PYRIDIN-2-YL-AMINO]PROPANOIC ACID|Dabigatran Standard|3-(((2-(((4-Carbamimidoylphenyl)amino)methyl)-1-methyl-1H-benzimidazol-5-yl)carbonyl)(pyridin-2-yl)amino)propanoic acid|3-{[(2-{[(4-Carbamimidoylphenyl)amino]methyl}-1-methyl-1H-benzimidazol-5-yl)carbonyl](pyridin-2-yl)amino}propanoic acid|BIBR 953; BIBR 953ZW; Dabigatran; N-[[2-[[[4-(aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-Alanine; N-[[2-[[[4-(Aminoiminomethyl)phenyl]amino]methyl]-1-methyl-1H-benzimidazol-5-yl]carbonyl]-N-2-pyridinyl-beta-alanine|Dabigatran [INN]|DABIGATRAN [MI]|Dabigatran (USAN/INN)|DABIGATRAN [USAN]|DABIGATRAN [VANDF]|Epitope ID:186729|UNII-I0VM4M70GC|BIBR 953(Dabigatran)?|Dabigatran (BIBR 953)|DABIGATRAN [MART.]|SCHEMBL3573|BIBR-953ZW|DABIGATRAN [WHO-DD]|Dabigatran [USAN:INN:BAN]|GTPL6380|orb1300894|BIBR 953,Dabigatran, Pradaxa|SCHEMBL29582891|SCHEMBL30038681|HSDB 8062|YBSJFWOBGCMAKL-UHFFFAOYSA-N|GLXC-06454|BCP06664|WZB81744|BDBM50112086|MSK159566|s2196|STL450902|AKOS005266720|CS-1399|DB14726|FD32710|PB38204|SB20292|NCGC00346575-01|NCGC00346575-06|3-[[2-[(4-carbamimidoylanilino)methyl]-1-methyl-benzimidazole-5-carbonyl]-(2-pyridyl)amino]propanoic acid|AC-25299|AS-11488|HY-10163|SY030371|BIBR 953 (Dabigatran etexilate, Pradaxa)|D5902|NS00076319|C21556|D09707|AB01274802-01|AB01274802_02|EN300-7418742|A815190|Q419345|BRD-K38168441-001-02-9|BRD-K38168441-001-03-7|BRD-K38168441-001-04-5|Z2681891234|.BETA.-ALANINE, N-((2-(((4-(AMINOIMINOMETHYL)PHENYL)AMINO)METHYL)-1-METHYL-1H-BENZIMIDAZOL-5-YL)CARBONYL)-N-2-PYRIDINYL-|1-Methyl-2-[N-(4-amidinophenyl)-aminomethyl]-benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-hydroxycarbonylethyl)-amide|1-Methyl-2-[N-(4-amidinophenyl)aminomethyl]benzimidazol-5-yl-carboxylic acid-N-(2-pyridyl)-N-(2-hydroxycarbonylethyl)amide|3-({2-[(4-Carbamimidoyl-phenylamino)-methyl]-1-methyl-1H-benzoimidazole-5-carbonyl}-pyridin-2-yl-amino)-propionic acid|3-(2-(((4-carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoicacid|3-[[[2-[(4-carbamimidoylanilino)methyl]-1-methyl-5-benzimidazolyl]-oxomethyl]-(2-pyridinyl)amino]propanoic acid|3-[[2-[[(4-carbamimidoylphenyl)amino]methyl]-1-methyl-benzimidazol-5-yl]carbonyl-pyridin-2-yl-amino]propanoic acid|3-[2-[[(4-Carbamimidoylphenyl)amino]methyl]-1-methyl-N-(2-pyridyl)benzimidazole-5-carboxamido]propanoic Acid|N-((2-((P-AMIDINOANILINO)METHYL)-1-METHYL-5-BENZIMIDAZOLYL)CARBONYL)-N-2-PYRIDYL-.BETA.-ALANINE"
ARGATROBAN,92722,,"InChI=1S/C23H36N6O5S/c1-14-8-10-29(18(12-14)22(31)32)21(30)17(6-4-9-26-23(24)25)28-35(33,34)19-7-3-5-16-11-15(2)13-27-20(16)19/h3,5,7,14-15,17-18,27-28H,4,6,8-13H2,1-2H3,(H,31,32)(H4,24,25,26)/t14-,15?,17+,18-/m1/s1",KXNPVXPOPUZYGB-IOVMHBDKSA-N,C23H36N6O5S,508.6,"(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid","argatroban|74863-84-6|Argatroban anhydrous|Novastan|Acova|Argatrobanum|MCI-9038|Argatrobanum [Latin]|MD-805|Argipidine|GN-1600|Argatroban In Sodium Chloride|OCY3U280Y3|(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methylpiperidine-2-carboxylic acid|DK-7419|DTXSID7046467|GN1600|Argatrobanum (Latin)|2-Piperidinecarboxylic acid, 1-(5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-|MMTQAP|MPQA|2-Piperidinecarboxylic acid, 1-((2S)-5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-, (2R,4R)-|MD805|(2R,4R)-1-[(2S)-5-carbamimidamido-2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido)pentanoyl]-4-methylpiperidine-2-carboxylic acid|(2R,4R)-1-((2S)-5-((aminoiminomethyl)amino)-1-oxo-2-((((3R)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-2-piperidinecarboxylic acid|(2R,4R)-1-((2S)-5-(diaminomethylideneamino)-2-((3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino)pentanoyl)-4-methylpiperidine-2-carboxylic acid|(2R,4R)-1-((2S)-5-carbamimidamido-2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido)pentanoyl)-4-methylpiperidine-2-carboxylic acid|2-Piperidinecarboxylic acid, 1-(5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)methyl-, monohydrate, (2R-((2S*),2-alpha,4-beta))-|RefChem:559934|ARGATROBAN IN DEXTROSE|CHEBI:48720|B01AE03|DTXCID901508458|(2R,4R)-1-(5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-2-piperidinecarboxylic acid|(2R,4R)-1-(5-((aminoiminomethyl)amino)-1-oxo-2-(((1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-2-piperidinecarboxylic acid monohydrate|ARGATROBAN IN 0.9% SODIUM CHLORIDE|(2R,4R)-1-((2S)-5-((aminoiminomethyl)amino)-1-oxo-2-((((3S)-1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl)amino)pentyl)-4-methyl-2-piperidinecarboxylic acid|1-(5-guanidino-2-((3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino)pentanoyl)-4-methyl-piperidine-2-carboxylic acid|IY90U61Z3S|(2R,4R)-1-((2S)-5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido)pentanoyl)-4-methylpiperidine-2-carboxylic acid|Argatroban Injection|CHEMBL1166|C23H36N6O5S|74863-84-6 (anhydrous)|Argatroban [INN:JAN]|(2R,4R)-1-[(2S)-5-guanidino-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]pentanoyl]-4-methyl-piperidine-2-carboxylic acid|(2R,4R)-4-methyl-1-(((3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonyl)-L-arginyl)piperidine-2-carboxylic acid|SMR000466348|SR-05000001529|UNII-OCY3U280Y3|Argatroban?|(2R,4R)-1-[(2S)-5-[(diaminomethylidene)amino]-2-[(3R)-3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido]pentanoyl]-4-methylpiperidine-2-carboxylic acid|MFCD00866789|(2R,4R)-1-((2S)-5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido)pentanoyl)-4-methy|ARGATROBAN [MI]|ARGATROBAN [INN]|ARGATROBAN [WHO-DD]|(2R,4R)-4-Methyl-1-((S)-N(sup 2)-(((RS)-1,2,3,4-tetrahydro-3-methyl-8-quinolyl)sulfonyl)arginyl)pipecolic acid|MLS000759461|MLS001424093|MLS006010033|GTPL6385|orb1710747|SCHEMBL1145308|SCHEMBL20567702|CHEBI:94385|HSDB 8488|KXNPVXPOPUZYGB-IOVMHBDKSA-N|HMS2051N07|HMS2090L12|HMS3713D22|BCP06831|EX-A4276|HY-B0375|BDBM50038001|s2069|AKOS015919612|CCG-100933|CCG-207885|DB00278|FA17976|NC00183|NCGC00166413-01|NCGC00166413-03|AS-14191|SMR004624627|SY274207|A2705|AB00639932-04|AB01275532-01|AB01275532_02|863A846|EN300-19767223|SR-01000759392|SR-01000759392-4|SR-05000001529-1|SR-05000001529-2|BRD-A48261811-001-08-1|Q27074501|(2R,4R)-1-((S)-5-(diaminomethyleneamino)-2-(3-methyl-1,2,3,4-tetrahydroquinoline-8-sulfonamido)pentanoyl)-4-methylpiperidine-2-carboxylic acid|(2R,4R)-1-[(2S)-5-(diaminomethylideneamino)-2-[(3-methyl-1,2,3,4-tetrahydroquinolin-8-yl)sulfonylamino]-1-oxopentyl]-4-methyl-2-piperidinecarboxylic acid|(2R,4R)-1-[(2S)-5-(DIAMINOMETHYLIDENEAMINO)-2-[[(3R)-3-METHYL-1,2,3,4-TETRAHYDROQUINOLIN-8-YL]SULFONYLAMINO]PENTANOYL]-4-METHYL-PIPERIDINE-2-CARBOXYLIC ACID|(2R,4R)-1-[(2S)-5-[(Aminoiminomethyl)amino]-1-oxo-2-[[(1,2,3,4-tetrahydro-3-methyl-8-quinolinyl)sulfonyl]amino]pentyl]-4-methyl-2-pi peridinecarboxylic acid;Argipidine;DK 7419|(2R,4R)-1-[(S)-5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydro-quinoline-8-sulfonylamino)-pentanoyl]-4-methyl-piperidine-2-carboxylic acid|(2R,4R)-4-METHYL-1-(N (SUP 2)-((1,2,3,4-TETRAHYDRO-3-METHYL-8-QUINOLYL)SULFONYL)-L-ARGINYL)PIPECOLIC ACID|(2R,4S)-1-[5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydro-quinoline-8-sulfonylamino)-pentanoyl]-4-methyl-piperidine-2-carboxylic acid|(2S,4S)-1-[5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydro-quinoline-8-sulfonylamino)-pentanoyl]-4-methyl-piperidine-2-carboxylic acid|(S)-1-[5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydro-quinoline-8-sulfonylamino)-pentanoyl]-4-methyl-piperidine-2-carboxylic acid|1-[(2R,3S)-5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydro-quinoline-8-sulfonylamino)-pentanoyl]-4-methyl-piperidine-2-carboxylic acid|1-[5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydro-quinoline-8-sulfonylamino)-pentanoyl]-4-methyl-piperidine-2-carboxylic acid|1-[5-Guanidino-2-(3-methyl-1,2,3,4-tetrahydro-quinoline-8-sulfonylamino)-pentanoyl]-4-methyl-piperidine-2-carboxylic acid (Argatroban)|2-PIPERIDINECARBOXYLIC ACID, 1-((2S)-5-((AMINOIMINOMETHYL)AMINO)-1-OXO-2-(((1,2,3,4-TETRAHYDRO-3-METHYL-8-QUINOLINYL)SULFONYL)AMINO)PENTYL)-4-METHYL-, (2R,4R)- ANHYDROUS"
PYRILAMINE,4992,,"InChI=1S/C17H23N3O/c1-19(2)12-13-20(17-6-4-5-11-18-17)14-15-7-9-16(21-3)10-8-15/h4-11H,12-14H2,1-3H3",YECBIJXISLIIDS-UHFFFAOYSA-N,C17H23N3O,285.4,"N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine","Mepyramine|pyrilamine|91-84-9|Pyranisamine|Dorantamin|Mepiramine|Anhistabs|Anhistol|Antalergan|Antallergan|Antamine|Copsamine|Harvamine|Histacap|Histalon|Histapyran|Histasan|Maranhist|Neoantergan|Paraminyl|Statomin|Coradon|Dipane|Isamin|Kriptin|Mepyren|Nyscaps|Pyramal|Stamine|Neo-Bridal|Afko-Hist|Mepyramin|Thylogen|Parmal|Stangen|PYRA|Mepiramina|Mepyraminum|Wait's green mountain antihistamine|RP 2786|NCI-C60651|N',N'-Dimethyl-N-(p-methoxybenzyl)-N-(2-pyridyl)ethylenediamine|HPE317O9TL|NSC-13136|1,2-Ethanediamine, N-((4-methoxyphenyl)methyl)-N',N'-dimethyl-N-2-pyridinyl-|CHEBI:6762|DTXSID9023542|DTXCID303542|N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridylethylenediamine|Pyridine, 2-((2-(dimethylamino)ethyl)(p-methoxybenzyl)amino)-|N-(para-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridylethylenediamine|N-para-Methoxybenzyl-N',N'-dimethyl-N-alpha-pyridylethylenediamine|N-(4-methoxybenzyl)-N',N'-dimethyl-N-pyridin-2-ylethane-1,2-diamine|N-[2-(dimethylamino)ethyl]-N-[(4-methoxyphenyl)methyl]pyridin-2-amine|N-((4-Methoxyphenyl)methyl)-N',N'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|N-(p-Methoxybenzyl)-N',N'-dimethyl-N-(alpha-pyridyl)ethylenediamine|1,2-Ethanediamine, N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-|2-[(2-Dimethylaminoethyl)(p-methoxybenzyl)amino]pyridine|2-[[2-(Dimethylamino)ethyl](p-methoxybenzyl)amino]pyridine|Pyridine, 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]-|2-((2-(DIMETHYLAMINO)ETHYL)(P-METHOXYBENZYL)AMINO)PYRIDINE|N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-1,2-ethanediamine|2-((2-DIMETHYLAMINOETHYL)(P-METHOXYBENZYL)AMINO)PYRIDINE|N-(2-(dimethylamino)ethyl)-N-((4-methoxyphenyl)methyl)pyridin-2-amine|N-((4-methoxyphenyl)methyl)-N',N'-dimethyl-N-pyridin-2-ylethane-1,2-diamine|N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-pyridin-2-ylethane-1,2-diamine|RefChem:55948|D04AA02|R06AC01|202-102-2|Anthisan|Pyrilamide|NSC13136|CHEMBL511|102206-59-7|2-((p-Methoxybenzyl)(2-(dimethylamino)ethyl)amino)pyridine|Pyridine, 2-((p-methoxybenzyl)(2-(dimethylamino)ethyl)amino)-|N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-pyridyl-1,2-ethanediamine|Mepyramine (INN)|[3H]mepyramine|N1-(4-Methoxybenzyl)-N2,N2-dimethyl-N1-(pyridin-2-yl)ethane-1,2-diamine|NCGC00015822-09|2-((2-(Dimethylamino)ethyl)-(p-methoxybenzyl)amino)pyridine|MEPYRAMINE [INN]|Mepyramin [German]|p-Methoxy-benzyl-.alpha.-pyridyl-dimethyl-aethylendiamin|Mepyramine [INN:BAN]|N-(p-Methoxybenzyl)-N',N'-dimethyl-N-(.alpha.-pyridyl)ethylenediamine|Mepyraminum [INN-Latin]|Mepiramina [INN-Spanish]|CAS-91-84-9|[11C]pyrilamine|[11C]-pyrilamine|[11C]-Mepyramine|CCRIS 4865|HSDB 5187|CAS-59-33-6|EINECS 202-102-2|NSC 13136|UNII-HPE317O9TL|BRN 0269019|2-[(p-Methoxybenzyl)[2-(dimethylamino)ethyl]amino]pyridine|Pyriliamine|Neobridal|2-[[2-(Dimethylamino)ethyl]-(p-methoxybenzyl)amino]pyridine|Pyridine, 2-[(p-methoxybenzyl)[2-(dimethylamino)ethyl]amino]-|Pyrlex|Pyrilamine salt with fine resin|3H]pyrilamine|N,N-dimethyl-N'-{[4-(methyloxy)phenyl]methyl}-N'-pyridin-2-ylethane-1,2-diamine|Histan (Salt/Mix)|Pymafed (Salt/Mix)|Antihist (Salt/Mix)|Minihist (Salt/Mix)|Spectrum_000904|Tocris-0660|Prefrin A (Salt/Mix)|PYRILAMINE [MI]|N-p-Methoxybenzyl-N',N'-dimethyl-N-alpha-pyridylethylenediamine|p-Methoxybenzyl-alpha-pyridyl-dimethyl-aethylendiamin [German]|Prestwick0_000289|Prestwick1_000289|Prestwick2_000289|Prestwick3_000289|Spectrum2_001306|Spectrum3_000605|Spectrum4_000493|Spectrum5_001264|Lopac-P-5514|MEPYRAMINE [HSDB]|PYRILAMINE [VANDF]|MEPYRAMINE [MART.]|MEPYRAMINE [WHO-DD]|Lopac0_000890|Oprea1_317349|SCHEMBL19114|BSPBio_000198|BSPBio_002110|KBioGR_001005|KBioSS_001384|5-22-08-00381 (Beilstein Handbook Reference)|BIDD:GT0215|DivK1c_000175|p-Methoxybenzyl-alpha-pyridyl-dimethyl-aethylendiamin|SPBio_001371|SPBio_002417|BPBio1_000218|CCRIS 1330 (Salt/Mix)|GTPL1227|GTPL3957|orb1305474|SCHEMBL29444024|BDBM22567|KBio1_000175|KBio2_001384|KBio2_003952|KBio2_006520|KBio3_001610|NINDS_000175|HMS2089M19|Tox21_110230|Tox21_200978|MFCD00023451|AKOS001637059|N'-[(4-methoxyphenyl)methyl]-N,N-dimethyl-N'-pyridin-2-ylethane-1,2-diamine|Tox21_110230_1|CCG-204972|DB06691|R.d. 2786|SDCCGSBI-0050865.P005|IDI1_000175|WLN: T6NJ BN2N1&1&1R DO1|WLN: T6NJ DN1R DO1&2N1&1|N-(p-Methoxybenzyl)-N',2-ethanediamine|NCGC00015822-01|NCGC00015822-02|NCGC00015822-03|NCGC00015822-04|NCGC00015822-05|NCGC00015822-06|NCGC00015822-07|NCGC00015822-08|NCGC00015822-10|NCGC00015822-11|NCGC00015822-12|NCGC00015822-13|NCGC00015822-15|NCGC00015822-17|NCGC00015822-21|NCGC00023513-02|NCGC00023513-04|NCGC00023513-05|NCGC00023513-06|NCGC00258531-01|TS-08382|SBI-0050865.P004|AB00053539|NS00008274|D08183|AB00053539-19|AB00053539_20|AB00053539_21|EN300-18535450|L000391|Q3800087|BRD-K97564742-050-04-6|BRD-K97564742-050-05-3|BRD-K97564742-050-31-9|BRD-K97564742-050-32-7|BRD-K97564742-051-02-8|BRD-K97564742-103-01-9|pyridine, 2-((2-dimethylaminoethyl)(p-methoxybenzyl)amino)-|pyridine, 2-[(2-dimethylaminoethyl) (p-methoxybenzyl) amino]-|1, N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl-|Ethylenediamine, N',N'-dimethyl-N-(p-methoxybenzyl)-N-(2-pyridyl)-|Ethylenediamine,N'-dimethyl-N-(p-methoxybenzyl)-N-(2-pyridyl)-|n,n-dimethyl-n'-(4-methoxybenzyl)-n'-(2-pyridyl)ethylenediamine|N,N-Dimethyl-N'-(p-methoxybenzyl)-N'-(2 -Pyridyl)ethylenediamine|N-(p-Methoxybenzyl)-N',N'-dimethyl-N-2-(pyridylethylene)diamine|N-p-Methoxybenzyl-N',N'-dimethyl-N-.alpha.-pyridylethylenediamine|Pyridine, 2-[[2-(dimethylamino)ethyl][p-methoxybenzyl)amino]]-|N,N-Dimethyl-N'-(4-methoxybenzyl)-N'-(.alpha.-pyridyl)-ethylenediaminene|N-(4-methoxybenzyl)-N ,N -dimethyl-N-pyridin-2-ylethane-1,2-diamine|N-Dimethylamino-aethyl-N-p-methoxy-benzyl-.alpha.-amino-pyridin-maleat|1,2-Ethanediamine, N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridyl-|1,2-Ethanediamine, N1-[(4-methoxyphenyl)methyl]-N2,N2-dimethyl-N1-2-pyridinyl-; 1,2-Ethanediamine, N-[(4-methoxyphenyl)methyl]-N',N'-dimethyl-N-2-pyridinyl- (9CI); Pyridine, 2-[[2-(dimethylamino)ethyl](p-methoxybenzyl)amino]- (7CI,8CI); N1-[(4-Methoxyphen|Y5E"
RIMONABANT,104850,,"InChI=1S/C22H21Cl3N4O/c1-14-20(22(30)27-28-11-3-2-4-12-28)26-29(19-10-9-17(24)13-18(19)25)21(14)15-5-7-16(23)8-6-15/h5-10,13H,2-4,11-12H2,1H3,(H,27,30)",JZCPYUJPEARBJL-UHFFFAOYSA-N,C22H21Cl3N4O,463.8,"5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide","Rimonabant|168273-06-1|Acomplia|Zimulti|5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(piperidin-1-yl)-1H-pyrazole-3-carboxamide|SR141716|SR 141716|SR-141716A|A 281|5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidin-1-ylpyrazole-3-carboxamide|RML78EN3XE|SR-141716|DTXSID3046453|CHEBI:34967|SR-14171|5-(4-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide|DTXCID1026453|1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-|rimonabantum|RefChem:389265|A08AX01|Rimoslim|SR141716A|Rimonabant free base|5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-n-piperidinopyrazole-3-carboxamide|MFCD04034714|CHEMBL111|Rimonabant (SR141716)|C22H21Cl3N4O|5-(4-CHLOROPHENYL)-1-(2,4-DICHLOROPHENYL)-4-METHYL-1H-PYRAZOLE-3-CARBOXYLIC ACID PIPERIDIN-1-YLAMIDE|NCGC00164572-01|[3H]SR141716A|158681-13-1 (HCl)|5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-(1-piperidyl)pyrazole-3-carboxamide|5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidino-1H-pyrazole-3-carboxamide|Acomplia (TN)|Rimonabant [INN]|SMR003500713|CAS-168273-06-1|UNII-RML78EN3XE|Rimonabant (JAN/USAN/INN)|Rimonabant [USAN:INN:JAN]|SR141,716A|RIMONABANT [MI]|RIMONABANT [JAN]|1H-Pyrazole-3-carboxamide, 5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-1-piperidinyl-, monohydrochloride|Rimonabant - from sample|RIMONABANT [USAN]|Rimonabant(SR141716)|RIMONABANT [MART.]|5-(p-Chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-N-piperidinopyrazole-3-carboxamide|RIMONABANT [WHO-DD]|SCHEMBL38637|GTPL743|Rimonabant(SR141716)?|MLS004774043|MLS006011772|RIMONABANT [EMA EPAR]|orb1308349|Rimonabant - Bio-X trade mark|SCHEMBL29373177|BDBM21278|EX-A688|HMS3604M05|HMS3657O15|HMS5081C06|BCP07803|EMB22188|Tox21_112200|AC-731|BBL030198|NSC791533|s3021|STK642500|AKOS005266728|Tox21_112200_1|CCG-269385|CS-0645|DB06155|FC61502|NSC-791533|SB19549|NCGC00164572-02|AS-37280|BR164345|HY-14136|AC-163720|DB-011649|B1429|NS00004141|R0205|SW220167-1|81R131|D05731|AB01566860_01|EN300-7382474|L000572|Q412529|SR-01000884001|SR-01000884001-1|BRD-K13296708-001-05-8|(N-(Piperidin-1-yl)-5-(4-chlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide|N-piperidino-5-(4-chlorophenyl)-1(2,4-dichlorophenyl)-4-methyl-pyrazole-3-carboxamide|N-piperidino-5-(4-chlorophenyl)-1-(2,4-dichlorophenyl)-4-methyl-3-pyrazolecarboxamide|5-(4-Chlorophenyl)-1-(2,4-dichloro-phenyl)-4-methyl-1H-pyrazole-3-carboxylic acid piperidin-1-ylamide|AY6"
DOXEPIN,3158,,"InChI=1S/C19H21NO/c1-20(2)13-7-11-17-16-9-4-3-8-15(16)14-21-19-12-6-5-10-18(17)19/h3-6,8-12H,7,13-14H2,1-2H3",ODQWQRRAPPTVAG-UHFFFAOYSA-N,C19H21NO,279.4,"3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine","doxepin|1668-19-5|Doxepina|Sinepin|Doxepine|CHEBI:4710|Doxepinum|DTXSID7022966|1-Propanamine, 3-dibenz[b,e]oxepin-11(6H)-ylidene-N,N-dimethyl-|1-Propanamine, 3-dibenz(b,e)oxepin-11(6H)-ylidene-N,N-dimethyl-|5ASJ6HUZ7D|Sinquan|ApoDoxepin|11-(3-Dimethylamino-propyliden)-6,11-dihydro-dibenz(b,e)oxipin|N,N-Dimethyldibenz(b,e)oxepin-delta(11(6H),gamma)-propylamine|Novo Doxepin|Apo Doxepin|Doxepin RPh|RefChem:57847|3-DIBENZO(B,E)OXEPIN-11(6H)-YLIDENE-N,N-DIMETHYLPROPAN-1-AMINE|Dibenz(b,e)oxepin-delta(sup 11(6H)),gamma-propylamine, N,N-dimethyl-|D04AX01|DTXCID90809786|N06AA12|dimethyl(3-(9-oxatricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,11,13-hexaen-2-ylidene)propyl)amine|Zonalon|Sinequan|(E)-Doxepin-d3|NSC 108160|Cidoxepin (free base)|Spectrum_000805|Prestwick0_000263|Prestwick1_000263|Spectrum2_000133|Spectrum3_000407|Spectrum4_000526|Oprea1_473232|SCHEMBL28054|KBioGR_001131|KBioSS_001285|DivK1c_000431|SPBio_000206|SPBio_002325|orb1689503|(E)-3-(Dibenzo[b,e]oxepin-11(6H)-ylidene)-N,N-dimethylpropan-1-amine|CHEMBL1628227|SCHEMBL16685227|SCHEMBL31349647|KBio1_000431|KBio2_001285|KBio2_003853|KBio2_006421|KBio3_001154|NINDS_000431|DAA60734|3-(6H-benzo[c][1]benzoxepin-11-ylidene)-N,N-dimethylpropan-1-amine|BDBM50225488|AKOS028110197|NCGC00015344-05|G78292|11-(3-dimethylamino-propylidene)-6,11-dihydrodibenzo-[b,e]-oxepine|3-(6,11-Dihydrodibenz[b,e]oxepin-11-yliden)-N,N-dimethylpropylamin|(3Z)-3-(Dibenzo[b,e]Oxepin-11(6H)-Ylidene)-N,N-Dimethyl-1-Propanamine|11-(3-dimethylamino-propylidene)- 6,11-dihydrodibenzo- [b,e]-oxepine"
DEXANABINOL,107778,,"InChI=1S/C25H38O3/c1-6-7-8-9-12-24(2,3)18-14-21(27)23-19-13-17(16-26)10-11-20(19)25(4,5)28-22(23)15-18/h10,14-15,19-20,26-27H,6-9,11-13,16H2,1-5H3/t19-,20-/m0/s1",SSQJFGMEZBFMNV-PMACEKPBSA-N,C25H38O3,386.6,"(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol","Dexanabinol|112924-45-5|HU-211|HU 211|Sinnabidol|11-OH-delta(8)-Thc-dmh|11-Hydroxy-delta-8-dmh-thc|1,1-Dimethylheptyl-11-hydroxytetrahydrocannabinol|5'(1,1-Dimethylheptyl)-7-hydroxyhexahydrocannabinol|7-Hydroxy-delta-6-tetrahydrocannabinoldimethylheptyl|R6VT8U5372|11-Hydroxy-delta(8)-tetrahydrocannabinol-dimethylheptyl|1,1-Dimethylheptyl-7-hydroxy-delta(6)-tetrahydrocannabinol|11-Hydroxymethyl-delta(8)-tetrahydrocannabinol-dimethylheptyl|PRS-211007|PA-50211|PRS-211007-000|DTXSID40150235|(+)-HU-210|6H-Dibenzo(b,d)pyran-9-methanol, 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-, (6aS-trans)-|RefChem:132380|DTXCID0072726|(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H,6aH,7H,10H,10aH-benzo(c)isochromen-1-ol|11-oh-thc|Sinnabidiol|(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromen-1-ol|CHEMBL334533|PRS 211007-000|UNII-R6VT8U5372|6H-DIBENZO(B,D)PYRAN-9-METHANOL, 3-(1,1-DIMETHYLHEPTYL)-6A,7,10,10A-TETRAHYDRO-1-HYDROXY-6,6-DIMETHYL-, (6AS,10AS)-|6H-Dibenzo[b,d]pyran-9-methanol, 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-, (6aS,10aS)-|DEXANABINOL [MI]|SINNABIDOL [WHO-DD]|(6aS,10aS)-9-(hydroxymethyl)-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol|SCHEMBL1649687|SCHEMBL29358335|CHEBI:230837|GLXC-05794|MEA92445|BDBM50067498|PDSP2_000937|AKOS015967265|DB06444|DA-62805|HY-106387|CS-0025698|NS00069217|924D455|Q962504|(6aS,10aS)-3-(1,1-Dimethyl-heptyl)-9-hydroxymethyl-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol|(6AS,10AS)-9-(HYDROXYMETHYL)-6,6-DIMETHYL-3-(2-METHYLOCTAN-2-YL)- 6A,7,10,10A-TETRAHYDROBENZO(C)CHROMEN-1-OL|(6aS,7S)-3-(1,1-Dimethyl-heptyl)-9-hydroxymethyl-6,6-dimethyl-6a,7,10,10a-tetrahydro-6H-benzo[c]chromen-1-ol"
TARANABANT,11226090,,"InChI=1S/C27H25ClF3N3O2/c1-17(34-25(35)26(2,3)36-24-12-9-21(16-33-24)27(29,30)31)23(14-18-7-10-22(28)11-8-18)20-6-4-5-19(13-20)15-32/h4-13,16-17,23H,14H2,1-3H3,(H,34,35)/t17-,23+/m0/s1",QLYKJCMUNUWAGO-GAJHUEQPSA-N,C27H25ClF3N3O2,516.0,"N-[(2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl]-2-methyl-2-[5-(trifluoromethyl)pyridin-2-yl]oxypropanamide","Taranabant|701977-09-5|MK-0364|MK0364|X9U622S114|DTXSID60220464|N-((2S,3S)-4-(4-Chlorophenyl)-3-(3-cyanophenyl)butan-2-yl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|N-(3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|N-[(2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl]-2-methyl-2-[5-(trifluoromethyl)pyridin-2-yl]oxypropanamide|Propanamide, N-((1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)-2-pyridinyl)oxy)-|N-((1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl)-2-methyl-2-((5-(trifluoromethyl)pyridin-2-yl)oxy)propanamide|N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[[5-(trifluoromethyl)pyridin-2-yl]oxy]propanamide|N-[(2s,3s)-4-(4-Chlorophenyl)-3-(3-Cyanophenyl)butan-2-Yl]-2-Methyl-2-{[5-(Trifluoromethyl)pyridin-2-Yl]oxy}propanamide|taranabantum|N-((2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl)-2-methyl-2-(5-(trifluoromethyl)pyridin-2-yl)oxypropanamide|n-[(1s,2s)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-{[5-(trifluoromethyl)pyridin-2-yl]oxy}propanamide|RefChem:891166|DTXCID60142955|MK 0364|Taranabant (MK-0364)|N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[(5-(trifluoromethyl)pyridin-2-yl)oxy]propanamide( MK 0364)|Tranabant (MK-0364)|MK-0634|CHEMBL220360|1204240-86-7|C27H25ClF3N3O2|Taranabant [USAN]|MK-0364 racemate|Taranabant [USAN:INN]|Taranbant|UNII-X9U622S114|701977-00-6|N-((2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl)-2-methyl-2-(5-(trifluoromethyl)pyridin-2-yloxy)propanamide|TARANABANT [INN]|Taranabant (USAN/INN)|TARANABANT [WHO-DD]|SCHEMBL304925|GTPL9231|orb1708415|SCHEMBL29434856|CHEBI:177607|QLYKJCMUNUWAGO-GAJHUEQPSA-N|GLXC-01648|BCP21059|BDBM50200841|EX-A10981|AKOS005145560|CS-0289|DB06624|NCGC00378803-02|DA-78197|FT103970|HY-10013|MS-29577|N-[(1S,2S)-3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methyl-propyl]-2-methyl-2-[[5-(trifluoromethyl)-2-pyridyl]oxy]propanamide|NS00071837|D09009|E98795|977T095|Q7685387|BRD-K35169477-001-01-9|N- [(1S, 2S) - 3- (4- Chlorophenyl) - 2- (3- cyanophenyl) - 1- methylpropyl] - 2- methyl- 2- [(5- (trifluoromethyl) pyridin- 2- yl) oxy] propanamide;MK 0364|N-[(1S,2S)-3-(4-Chloro-phenyl)-2-(3-cyano-phenyl)-1-methyl-propyl]-2-methyl-2-(5-trifluoromethyl-pyridin-2-yloxy)-propionamide|N-[(1S,2S)-3-(4-Chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-methyl-2-[(5-(trifluoromethyl)pyridin-2-yl)oxy]propanamide(mk 0364)|N-[(2S,3S)-4-(4-chlorophenyl)-3-(3-cyanophenyl)butan-2-yl]-2-methyl-2-[5-(triluoromethyl)pyridin-2-yl]oxypropanamide"
OTENABANT,10052040,,"InChI=1S/C25H25Cl2N7O/c1-2-31-25(24(28)35)11-13-33(14-12-25)22-20-23(30-15-29-22)34(17-9-7-16(26)8-10-17)21(32-20)18-5-3-4-6-19(18)27/h3-10,15,31H,2,11-14H2,1H3,(H2,28,35)",UNAZAADNBYXMIV-UHFFFAOYSA-N,C25H25Cl2N7O,510.4,1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)purin-6-yl]-4-(ethylamino)piperidine-4-carboxamide,"1-(9-(4-chlorophenyl)-8-(2-chlorophenyl)-9h-purin-6-yl)-4-ethylaminopiperidine-4-carboxylic acid amide|1-[9-(4-Chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]-4-ethylaminopiperidine-4-carboxylic Acid Amide|RefChem:856989|otenabant|686344-29-6|CP-945598|CP-945,598|Otenabant free base|CP945598|1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)purin-6-yl]-4-(ethylamino)piperidine-4-carboxamide|CP 945598|MFCD11973672|1-(8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl)-4-(ethylamino)piperidine-4-carboxamide|J8211Y53EF|686344-29-6 (free base)|Otenabant (CP-945598 free base)|1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)-4-piperidinecarboxamide|Otenabant [USAN]|Otenabant [USAN:INN]|C25H25Cl2N7O|UNII-J8211Y53EF|1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl]-4-(ethylamino)piperidine-4-carboxamide|OTENABANT [INN]|Otenabant (USAN/INN)|OTENABANT [WHO-DD]|CHEMBL562668|GTPL9232|orb1304116|SCHEMBL1622757|BDBM27337|DTXSID20988316|EX-A466|UNAZAADNBYXMIV-UHFFFAOYSA-N|GLXC-04079|BCP07507|AKOS030526880|CS-1279|DB11745|SB22996|NCGC00351601-07|AS-56103|DA-41692|HY-10871|NS00069643|CP-945598-01|D09362|344O296|Q7108517|BRD-K09090949-001-01-9|1-[8-(2-chlorophenyl)-9-(4-chlorophenyl)purin-6-yl]-4-ethylaminopiperidine-4-carboxamide|1-(8-(2-CHLOROPHENYL)-9-(4-CHLOROPHENYL)-9H-PURIN-6-YL)-4-(ETHYLAMINO)PIPERIDINE-4- CARBOXAMIDE|1-[9-(4-chloro-phenyl)-8-(2-chloro-phenyl)-9H-purin-6-yl]-4-ethylamino-piperidine-4-carboxylic acid amide|1-[9-(4-Chlorophenyl)-8-(2-chlorophenyl)-9H-purin-6-yl]- 4-ethylaminopiperidine-4-carboxylic Acid Amide|4-PIPERIDINECARBOXAMIDE, 1-(8-(2-CHLOROPHENYL)-9-(4-CHLOROPHENYL)-9H-PURIN-6-YL)-4- (ETHYLAMINO)-|4-Piperidinecarboxamide, 1-(8-(2-chlorophenyl)-9-(4-chlorophenyl)-9H-purin-6-yl)-4-(ethylamino)-"
DUVOGLUSTAT,29435,,"InChI=1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5-,6-/m1/s1",LXBIFEVIBLOUGU-JGWLITMVSA-N,C6H13NO4,163.17,"(2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol","19130-96-2|DUVOGLUSTAT|deoxynojirimycin|Moranolin|D-1-deoxynojirimycin|1 Deoxynojirimycin|1,5-Dideoxy-1,5-imino-D-glucitol|Nojirimycin, 1-deoxy-|BAY-h-5595|5-Amino-1,5-dideoxy-D-glucopyranose|1,5-dideoxy-1,5-imino-|FZ56898FLE|CHEBI:44369|DTXSID70172647|3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-|duvoglustatum|RefChem:388743|GlyTouCan:G62915MH|DTXCID4095138|G62915MH|606-239-2|1-DEOXYNOJIRIMYCIN|(2R,3R,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol|Moranoline|1,5-Deoxy-1,5-imino-D-mannitol|MFCD00063474|(2R,3R,4R,5S)-2-Hydroxymethyl-piperidine-3,4,5-triol|(+)-1-DEOXYNOJIRIMYCIN|1-deoxynojirimycin (DNJ)|3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R,3R,4R,5S)-|CHEMBL307429|DNJ|1-Deoxy-Nojirimycin|S-GI|1oim|DNM|Duvoglustat (hydrochloride)|Duvoglustat [USAN:INN]|UNII-FZ56898FLE|BAY-h 5595|NOJ|DUVOGLUSTAT [INN]|Duvoglustat (USAN/INN)|DUVOGLUSTAT [USAN]|EC 606-239-2|SCHEMBL2969|1-DNJ|BSPBio_000993|1-Deoxynojirimycin (Standard)|GTPL4642|orb1303921|1-DEOXYNOJIRIMYCIN [MI]|BDBM18351|2j77|Bio1_000415|Bio1_000904|Bio1_001393|HMS1792A15|HMS1990A15|HMS3267J09|HMS3403A15|MSK10764|HB4599|HY-14860R|s3839|1,5-didesoxy-1,5-imino-D-glucitol|1, 5-dideoxy-1,5-imino-D-glucitol|AKOS006275143|1-Deoxynojirimycin, analytical standard|AC-1386|CCG-266301|CS-5594|DB03206|MD05255|SMP2_000333|NCGC00025085-02|NCGC00025085-03|BS-15755|HY-14860|SY032317|D5612|NS00009621|30D962|D09605|M01692|EN300-7411893|GLUCOPYRANOSE, 5-AMINO-1,5-DIDEOXY-, D-|SR-01000597392|SR-01000597392-1|Q15274561|(2R,3R,4R,5S)-2-(Hydroxymethyl)piperidine-3,4,5-triol, 10|1,5-Dideoxy-1,5-imino-D-glucitol;Moranoline;1,5-Dideoxy-1,5-imino-D-sorbitol;DNJ;2R- (hydroxymethyl)- 3R, 4R, 5S- piperidinetriol|3,4,5-PIPERIDINETRIOL, 2-(HYDROXYMETHYL)-, (2R-(2.ALPHA.,3.BETA.,4.ALPHA.,5.BETA.))-"
MIGLITOL,441314,,"InChI=1S/C8H17NO5/c10-2-1-9-3-6(12)8(14)7(13)5(9)4-11/h5-8,10-14H,1-4H2/t5-,6+,7-,8-/m1/s1",IBAQFPQHRJAVAV-ULAWRXDQSA-N,C8H17NO5,207.22,"(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol","MIGLITOL|72432-03-2|Glyset|(2R,3R,4R,5S)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol|Bay-m-1099|Bay m 1099|0V5436JAQW|DTXSID0023323|NSC-758702|(2R,3R,4R,5S)-1-(2-Hydroxyethyl)-2-(hydroxymethyl)-3,4,5-piperidinetriol|DTXCID703323|BAY-m 1099|3,4,5-Piperidinetriol, 1-(2-hydroxyethyl)-2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-|N-hydroxyethyl-1-desoxynojirimycin|N-hydroxyethyl-1-desoxy-nojirimycin|RefChem:57016|GlyTouCan:G25287AB|G25287AB|MFCD00867240|Miglitol (Glyset)|Seibule|CHEMBL1561|CHEBI:6935|Diastabol|3,4,5-Piperidinetriol, 1-(2-hydroxyethyl)-2-(hydroxymethyl)-,(2R,3R,4R,5S)-|N-(b-Hydroxyethyl)-1-deoxynojirimycin|Plumarol|Miglitolum|N-(2-Hydroxyethyl)-1-deoxynojirimycin|SMR000466381|Miglitolum [Latin]|CAS-72432-03-2|Glyset (TN)|UNII-0V5436JAQW|Miglitol [USAN:INN:BAN]|BAY1099;BAY-m1099|Bay 1099|HSDB 8022|NCGC00095127-01|EINECS 276-661-6|SK-983|baym1099|MIGLITOL [USAN]|MIGLITOL [INN]|MIGLITOL [JAN]|MIGLITOL [MI]|MIGLITOL [VANDF]|MIGLITOL [MART.]|MIGLITOL [WHO-DD]|SCHEMBL22593|MLS000759514|MLS001424128|MLS006011963|BIDD:GT0732|Miglitol;Glyset;Bay m 1099|MIGLITOL [ORANGE BOOK]|cid_441314|GTPL4842|Miglitol (JP18/USAN/INN)|orb1308301|IBAQFPQHRJAVAV-ULAWRXDQSA-N|GLXC-06668|HMS2051D05|HMS3713J07|N-hydroxylethyl-1-deoxynojirimycin|HY-B0481|MSK10671|Tox21_111436|BDBM50242271|AKOS015969689|Tox21_111436_1|CCG-100920|DB00491|KS-1242|MH07215|NC00170|NSC 758702|NCGC00270540-02|SY068958|M2302|NS00004693|S2589|C07708|C76308|D00625|EN300-119541|AB00639982-06|AB00639982_08|432M032|F825537|Q772735|SR-01000759413|SR-01000759413-4|BRD-K44779798-001-06-5|Z1269163651|(2R,3R,4R,5S)-1-ethoxy-2-(hydroxymethyl)piperidine-3,4,5-triol|(4R,5R)-1-(2-hydroxyethyl)-2-(hydroxymethyl)piperidine-3,4,5-triol|1204250-58-7|3,4,5-PIPERIDINETRIOL, 1-(2-HYDROXYETHYL)-2-(HYDROXYMETHYL)-, (2R-(2.ALPHA.,3.BETA.,4.ALPHA.,5.BETA.))-"
VOGLIBOSE,444020,,"InChI=1S/C10H21NO7/c12-2-5(3-13)11-6-1-10(18,4-14)9(17)8(16)7(6)15/h5-9,11-18H,1-4H2/t6-,7-,8+,9-,10-/m0/s1",FZNCGRZWXLXZSZ-CIQUZCHMSA-N,C10H21NO7,267.28,"(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol","voglibose|83480-29-9|Basen|Glustat|Voglibosa|AO-128|Voglibosum|A-71100|N-(1,3-Dihydroxy-2-propyl)valiolamine|DTXSID2021442|S77P977AG8|DTXCID901442|(1S,2S,3R,4S,5S)-5-[(1,3-dihydroxypropan-2-yl)amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol|(1S,2S,3R,4S,5S)-5-((1,3-dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol|RefChem:902044|GlyTouCan:G23864GM|A10BF03|G23864GM|3,4-Dideoxy-4-(2-hydroxy-1-(hydroxymethyl)ethylamino)-2-C-(hydroxymethyl)-D-epi-inositol|(1S,2S,3R,4S,5S)-5-((1,3-dihydroxypropan-2-yl)amino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol|(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol|CHEMBL476960|3,4-Dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-D-epi-inositol|AO 128|MFCD00865496|(1S,2S,3R,4S,5S)-5-(1,3-dihydroxypropan-2-ylamino)-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetraol|C10H21NO7|Basen OD|Voglibose [INN]|(1S,2S,3R,4S,5S)-5-{[2-hydroxy-1-(hydroxymethyl)ethyl]amino}-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol|CAS-83480-29-9|Basen (TN)|Voglibose [USAN:INN]|Voglibosum [INN-Latin]|Voglibosa [INN-Spanish]|UNII-S77P977AG8|CCRIS 4540|NCGC00164595-01|(1S,2S,3R,4S,5S)-5-[[2-hydroxy-1-(hydroxymethyl)ethyl]amino]-1-(hydroxymethyl)cyclohexane-1,2,3,4-tetrol|VOG|VOGLIBOSE [JAN]|VOGLIBOSE [MI]|VOGLIBOSE [USAN]|VOGLIBOSE [MART.]|SCHEMBL5882|VOGLIBOSE [WHO-DD]|A 71100|MLS003882582|Voglibose - Bio-X trade mark|orb1300524|Voglibose (JP18/USAN/INN)|CHEBI:32300|AO128|BCPP000020|DTXSID501031239|GLXC-06681|HMS3414A17|HMS3678A17|Voglibose, >=97.0% (TLC)|112653-29-9|HY-B0025|MSK10642|Tox21_112220|BDBM50263044|s4101|AKOS015950839|Tox21_112220_1|CCG-267119|DB04878|MV06910|NCGC00164595-02|3,4-DIDEOXY-4-[[2-HYDROXY-1-(HYDROXYMETHYL)ETHYL]AMINO]-2-C-(HYDROXYMETHYL)-D-EPINOSITOL|BV164530|SMR002530327|SY108971|NS00069197|D01665|AB01566929_01|480V299|F818267|SR-01000883931|Q7939403|SR-01000883931-1|BRD-K66850609-001-01-7|BRD-K66850609-001-05-8|BRD-K66850609-001-07-4|3,4-Dideoxy-[2-hydroxy-1-(hydroxyethyl)ethyl] amino-1-C-(hydroxymethyl)-1,2,3,4-cyclohexaneterol; 3,4-Dideoxy-4-[[2-hy droxy-1-(hydr oxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epiinositol|3,4-Dideoxy-[2-hydroxy-1-(hydroxyethyl)ethyl] amino-1-C-(hydroxynethyl)-1,2,3,4-cyclohexaneterol;3,4-Dideoxy-4-[[2-hyd roxy-1-(hydroxymethyl)ethyl]amino]-2-C-(hydroxymethyl)-D-epiinositol|D-epi-Inositol, 3,4-dideoxy-4-((2-hydroxy-1-(hydroxymethyl)ethyl)amino)-2-C-(hydroxymethyl)-"
MIGLUSTAT,51634,,"InChI=1S/C10H21NO4/c1-2-3-4-11-5-8(13)10(15)9(14)7(11)6-12/h7-10,12-15H,2-6H2,1H3/t7-,8+,9-,10-/m1/s1",UQRORFVVSGFNRO-UTINFBMNSA-N,C10H21NO4,219.28,"(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol","Miglustat|72599-27-0|Zavesca|N-Butyldeoxynojirimycin|Butyldeoxynojirimycin|(2R,3R,4R,5S)-1-butyl-2-(hydroxymethyl)piperidine-3,4,5-triol|N-Butylmoranoline|NB-DNJ|N-butyl-1-deoxynojirimycin|BuDNJ|n-Butyl deoxynojirimycin|N-(n-Butyl)deoxynojirimycin|SC-48334|OGT-918|miglustatum|SC 48334|3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2R,3r,4R,5S)-|ADN3S497AZ|N-(n-butyl)deoxy-nojirimycin|OPFOLDA|DTXSID6045618|CHEBI:50381|DTXCID4025618|1,5-(BUTYLIMINO)-1,5-DIDEOXY-D-GLUCITOL|Yargesa|RefChem:57017|GlyTouCan:G94744IV|A16AX06|G94744IV|3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-,(2R-(2alpha,3beta,4alpha,5beta))-|689-232-7|OGT 918|N-Butyl-DNJ|MFCD00272581|CHEMBL1029|72599-27-0 (free base)|n-Butyl dnj|Miglustat [USAN]|Vevesca|N-Butyldeoxynojirimycin;NB-DNJ;OGT918|Zavesca (TN)|CAS-72599-27-0|N-Bu-DNJ|N-Butyl-deoxynojirimycin|NBV|UNII-ADN3S497AZ|SC48334|Brazaves|Miglustat [USAN:INN:BAN]|D-Glucitol, 1,5-(butylimino)-1,5-dideoxy-|NCGC00018140-02|Brazaves (TN)|Opfolda (TN)|MIGLUSTAT [INN]|MIGLUSTAT [JAN]|MIGLUSTAT [MI]|1,5-Dideoxy-1,5-N-butylimino-D-glucitol|MIGLUSTAT [VANDF]|MIGLUSTAT [MART.]|MIGLUSTAT [WHO-DD]|N-(n-butyl)-1,5-dideoxy-1,5-imino-D-glucitol|MIGLUSTAT [EMA EPAR]|Miglustat (JAN/USAN/INN)|SCHEMBL246893|GTPL4841|MIGLUSTAT [ORANGE BOOK]|BDBM18355|N-(n-Butyl)-1-deoxynojirimycin|UQRORFVVSGFNRO-UTINFBMNSA-N|GLXC-15328|HMS2090N20|Tox21_110830|(2R,3R,4R,5S)-1-Butyl-2-(hydroxymethyl)-3,4,5-piperidinetriol|Zavesca;Miglustat;OGT 918;NB-DNJ|AKOS028109118|Tox21_110830_1|DB00419|MB06729|3,4,5-Piperidinetriol, 1-butyl-2-(hydroxymethyl)-, (2R-(2alpha,3beta,4alpha,5beta))-|NCGC00024452-03|NCGC00024452-04|DA-65462|HY-17020|N-(n-Butyl)-1-deoxynojirimycin min. 99%|NS00003211|N-Butyldeoxynojirimycin, film (dried in situ)|D05032|P16976|AB00489939-10|Q425911|SR-01000000043|SR-01000000043-2|BRD-K33251802-001-01-3|Z2379810058|134282-77-2"
REDAFAMDASTAT,24771824,,"InChI=1S/C23H20F3N5O2/c24-23(25,26)18-6-7-21(27-15-18)33-19-4-1-3-17(14-19)13-16-8-11-31(12-9-16)22(32)29-20-5-2-10-28-30-20/h1-7,10,13-15H,8-9,11-12H2,(H,29,30,32)",BATCTBJIJJEPHM-UHFFFAOYSA-N,C23H20F3N5O2,455.4,N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide,"PF-04457845|1020315-31-4|1-Piperidinecarboxamide, N-3-pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-|H4C81M8YYW|PF 04457845|N-pyridazin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methylidene]piperidine-1-carboxamide|PF-4457845|PF04457845|DTXSID00144539|1-Piperidinecarboxamide, N-3-pyridazinyl-4-((3-((5-(trifluoromethyl)-2-pyridinyl)oxy)phenyl)methylene)-|N-(pyridazin-3-yl)-4-[(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}phenyl)methylidene]piperidine-1-carboxamide|N-Pyridazin-3-yl-4-((3-(5-(trifluoromethyl)pyridin-2-yl)oxyphenyl)methylidene)piperidine-1-carboxamide|N-Pyridazin-3-yl-4-[(3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl)methylidene]piperidine-1-carboxamide|N-(pyridazin-3-yl)-4-((3-((5-(trifluoromethyl)pyridin-2-yl)oxy)phenyl)methylidene)piperidine-1-carboxamide|RefChem:928916|DTXCID2067030|Redafamdastat|MFCD18782721|CHEMBL1651534|N-(Pyridazin-3-yl)-4-(3-((5-(trifluoromethyl)pyridin-2-yl)oxy)benzylidene)piperidine-1-carboxamide|N-3-Pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-1-piperidinecarboxamide|1-Piperidinecarboxamide, N-3-pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-;1-Piperidinecarboxamide, N-3-pyridazinyl-4-[[3-[[5-(trifluoromethyl)-2-pyridinyl]oxy]phenyl]methylene]-|N-pyridazin-3-yl-4-(3-{[5-(trifluoromethyl)pyridin-2-yl]oxy}benzylidene)piperidine-1-carboxamide|C23H20F3N5O2|UNII-H4C81M8YYW|redafamdastat [INN]|compound 23 [PMID: 21666860]|GTPL6694|orb1302952|SCHEMBL1010408|SCHEMBL29390562|SCHEMBL30178141|SCHEMBL30321431|BCP05805|EX-A2309|BDBM50335377|s2421|AKOS027338651|CS-0868|DB12012|SB17493|NCGC00378983-01|NCGC00378983-03|AC-36022|AS-74797|DA-66617|FP103118|HY-14376|NS00072877|PF-04457845?|PF-04457845, >=98% (HPLC)|Q7119045|BRD-K86816506-001-01-8|N-pyridazin-3-yl-4-[[3-[[5-(trifluoromethyl)-2-pyridyl]oxy]phenyl]methylene]piperidine-1-carboxamide"
RAZAXABAN,204102,,"InChI=1S/C24H20F4N8O2/c1-34(2)12-21-30-7-8-35(21)13-3-5-17(16(25)10-13)31-23(37)18-11-20(24(26,27)28)32-36(18)14-4-6-19-15(9-14)22(29)33-38-19/h3-11H,12H2,1-2H3,(H2,29,33)(H,31,37)",OFJRNBWSFXEHSA-UHFFFAOYSA-N,C24H20F4N8O2,528.5,"2-(3-amino-1,2-benzoxazol-5-yl)-N-[4-[2-[(dimethylamino)methyl]imidazol-1-yl]-2-fluorophenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide","Razaxaban|218298-21-6|3K2509846L|razaxabanum|1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-(2-fluoro-4-((2'-dimethylaminomethyl)imidazol-1-yl)phenyl)-1H-pyrazole-5-carboxamide|RefChem:930574|DPC906|BMS561389|1-(3'-aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-(2-fluoro-4-((2'-dimethylaminomethyl)imidazol-1-yl)phenyl)-1H-pyrazole-5-carboxamide hydrochloride|Razaxaban [INN]|2-(3-amino-1,2-benzoxazol-5-yl)-N-[4-[2-[(dimethylamino)methyl]imidazol-1-yl]-2-fluorophenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide|CHEMBL206335|BMS 561389;DPC 906|1-(3-amino-1,2-benzoxazol-5-yl)-N-(4-{2-[(dimethylamino)methyl]-1H-imidazol-1-yl}-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide|DPC 906|1z6e|IK8|SCHEMBL677372|orb2815238|SCHEMBL29376499|BDBM12676|DTXSID40870249|OFJRNBWSFXEHSA-UHFFFAOYSA-N|UNII-3K2509846L|-1H-PYRAZOLE-5-CARBOXAMIDE|BCP24153|BMS-5613|TIA29821|AKOS016008770|HY-10278|CS-0002526|Q27257381|1-(3'-Aminobenzisoxazol-5'-yl)-3-trifluoromethyl-N-(2-fluoro-4-((2'-dimethylaminomethyl)imidazol-1-yl)phenyl)-1H-pyrazole-5-carboxyamide hydrochloride|1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-N-(4-(2-((DIMETHYLAMINO)METHYL)-1H-IMIDAZOL-1-YL)-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-1H-PYRAZOLE-5-CARBOXAMIDE|1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-N-(4-{2-[(DIMETHYLAMINO)METHYL]-1H-IMIDAZOL-1-YL}-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)|1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-N-(4-{2-[(DIMETHYLAMINO)METHYL]-1H-IMIDAZOL-1-YL}-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL) -1H-PYRAZOLE-5-CARBOXAMIDE|1-(3-Aminobenzisoxazol-5-yl)-3-trifluoromethyl-N-[2-fluoro-4-[(2-dimethylaminomethyl)imidazol-1-yl]phenyl]-1H-pyrazole-5-carboxyamide Hydrochloride Salt|1H-PYRAZOLE-5-CARBOXAMIDE, 1-(3-AMINO-1,2-BENZISOXAZOL-5-YL)-N-(4-(2-((DIMETHYLAMINO)METHYL)-1H-IMIDAZOL-1-YL)-2-FLUOROPHENYL)-3-(TRIFLUOROMETHYL)-"
APIXABAN,10182969,,"InChI=1S/C25H25N5O4/c1-34-19-11-9-18(10-12-19)30-23-20(22(27-30)24(26)32)13-15-29(25(23)33)17-7-5-16(6-8-17)28-14-3-2-4-21(28)31/h5-12H,2-4,13-15H2,1H3,(H2,26,32)",QNZCBYKSOIHPEH-UHFFFAOYSA-N,C25H25N5O4,459.5,"1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide","Apixaban|503612-47-3|Eliquis|BMS-562247|BMS-562247-01|BMS 562247-01|1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide|apixabanum|1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide|3Z9Y7UWC1J|CHEBI:72296|DTXSID80436500|BMS562247|1H-Pyrazolo[3,4-c]pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-|1H-Pyrazolo(3,4-c)pyridine-3-carboxamide,4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1-piperidinyl)phenyl)-|1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo(3,4-c)pyridine-3-carboxamide|1H-Pyrazolo(3,4-c)pyridine-3-carboxamide, 4,5,6,7-tetrahydro-1-(4-methoxyphenyl)-7-oxo-6-(4-(2-oxo-1-piperidinyl)phenyl)-|RefChem:5558|ELIQUIS 30-Day Starter Pack|B01AF02|DTXCID60387324|MFCD11977295|1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide|Apixaban 13CD3|C25H25N5O4|CHEMBL231779|1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-1H,4H,5H,6H,7H-pyrazolo[3,4-c]pyridine-3-carboxamide|1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[5,4-c]pyridine-3-carboxamide|Apixaban [USAN]|GG2|Eliquis (TN)|UNII-3Z9Y7UWC1J|Apixaban (JAN/USAN/INN)|Apixaban [USAN:INN:JAN]|HSDB 8223|Apixaban (Standard)|BMS 562247|BMS562247-01|APIXABAN [INN]|APIXABAN [JAN]|APIXABAN [MI]|APIXABAN [VANDF]|APIXABAN [MART.]|APIXABAN [WHO-DD]|APIXABAN [EMA EPAR]|Apixaban - Bio-X trade mark|MLS006010026|SCHEMBL118023|APIXABAN [ORANGE BOOK]|GTPL6390|orb1307573|Apixaban,BMS-562247-01|BDBM19023|EX-A048|2p16|QNZCBYKSOIHPEH-UHFFFAOYSA-N|BCPP000396|HMS3655O07|HMS5079A18|BCP02451|503612-47-3, Eliquis,|Apixaban (BMS 562247-01)|HY-50667R|MSK159567|NSC784102|s1593|Apixaban (BMS 562247-01)?|AKOS005146204|BCP9000310|CCG-229675|CS-0401|DB06605|FM61539|ME-0152|NSC-784102|PB10976|NCGC00346555-01|NCGC00346555-02|NCGC00346555-05|NCGC00346555-08|1-(4-Methoxy-phenyl)-7-oxo-6-[4-(2-oxo-piperidin-1-yl)-phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxylic acid amide|1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidyl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide|AC-26301|BM164185|HY-50667|SMR004676529|SY097159|NS00014946|SW220177-1|D03213|AB01565766_02|612A473|AR-270/43507990|Q414462|BRD-K67121414-001-02-5|BRD-K67121414-001-03-3|Z195110238|1-(4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXOPIPERIDIN-1-YL)PHENYI)-4,5,6,7-TETRAHYDRO-1H-PYRAZOLO(3,4-C)PYRIDINE-3-CARBOXAMIDE|1-(4-Methoxyphenyl)-7-oxo-6-(4-(2-oxopiperidin-1-yl)phenyl)-4,5,6,7-tetrahydro-1H-pyrazolo(3,4c)pyridine-3-carboxamide|1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo piperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide|1-(4-methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidinyl)phenyl]-4,5,6,7-tetrahydro-1h-pyrazolo[3,4-c]pyridine-3-carboxamide|1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxo-1-piperidyl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide|1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridine-3-carboxamide?BMS-562247; BMS-562247-01|1-(4-Methoxyphenyl)-7-oxo-6-[4-(2-oxopiperidin-1-yl)phenyl]-4,5-dihydropyrazolo[3,4-c]pyridine-3-carboxamide;BMS 562247-01|1H-PYRAZOLO(3,4-C)PYRIDINE-3-CARBOXAMIDE, 4,5,6,7-TETRAHYDRO-1-( 4-METHOXYPHENYL)-7-OXO-6-(4-(2-OXO-1-PIPERIDINYL)PHENYL)-"
ALVOCIDIB,5287969,,"InChI=1S/C21H20ClNO5/c1-23-7-6-12(17(27)10-23)19-14(24)8-15(25)20-16(26)9-18(28-21(19)20)11-4-2-3-5-13(11)22/h2-5,8-9,12,17,24-25,27H,6-7,10H2,1H3/t12-,17+/m0/s1",BIIVYFLTOXDAOV-YVEFUNNKSA-N,C21H20ClNO5,401.8,"2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one","Flavopiridol|Alvocidib|146426-40-6|Alvocidib freebase|L86-8275|L 868275|L-868275|alvocidibum|HMR 1274|2-(2-chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)-4H-chromen-4-one|L 86-8275|45AD6X575G|2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]-4H-chromen-4-one|2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methylpiperidin-4-yl]chromen-4-one|(-)cis-5,7-Dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one|CHEBI:47344|DTXSID20904970|(-)-cis-5,7-dihydroxy-2-(2-chlorophenyl)-8-(4-(3-hydroxy-1-methyl)piperidinyl)-4H-1-benzopyran-4-one|NSC-649890|2-(2-chlorophenyl)-5,7-dihydroxy-8-((3S,4R)-3-hydroxy-1-methylpiperidin-4-yl)chromen-4-one|RefChem:915621|DTXCID701334093|Flavopiridol (Alvocidib)|HMR-1275|MFCD20501884|4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidinyl]-|CHEMBL428690|2-(2-chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidyl]chromen-4-one|2-(2-CHLORO-PHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYL-PIPERIDIN-4-YL)-4H-BENZOPYRAN-4-ONE|MDL-107826A|Alvocidib [INN]|FLAVO|Flavoperidol|Alvocidib [USAN]|Alvocidib [USAN:INN]|UNII-45AD6X575G|CCRIS 9399|NSC 649890 HCl|4H-1-BENZOPYRAN-4-ONE, 2-(2-CHLOROPHENYL)-5,7-DIHYDROXY-8-((3S,4R)-3-HYDROXY-1-METHYL-4-PIPERIDINYL)-|NSC649890|1c8k|1e1y|Alvocidib (USAN/INN)|FLAVOPIRIDOL [MI]|ALVOCIDIB [MART.]|ALVOCIDIB [WHO-DD]|SCHEMBL3652|Flavopiridol HCl; Alvocidib|BDBM5655|GTPL5680|orb1685546|SCHEMBL29351027|SCHEMBL29388553|SCHEMBL29577824|EX-A1901|Flavopiridol,Alvocidib, HMR-1275|HMR-1274|NSC799330|s1230|AKOS022182942|CCG-268666|DB03496|FF65024|NSC-799330|SDCCGSBI-0646527.P001|4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5,7-dihydroxy-8-((3R,4S)-3-hydroxy-1-methyl-4-piperidinyl)-, rel-(-)-|4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-5,7-dihydroxy-8-(3-hydroxy-1-methyl-4-piperidinyl)-, cis-(-)-|AS-74761|HY-10005|SY271430|NS00071644|D09868|EN300-22867972|Q4063441|BRD-K87909389-001-01-2|BRD-K87909389-003-03-4|BRD-K87909389-003-04-2|(-)-CIS-2-(2-CHLOROPHENYL)-5,7-DIHYDROXY-8-(3-HYDROXY-1-METHYLPIPERIDIN-4-YL)-4H-1-BENZOPYRAN-4-ONE|2-(2-Chlorophenyl)-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidyl]-4H-chromen-4-one|4H-1-Benzopyran-4-one, 2-(2-chlorophenyl)-2,3-dihydro-5,7-dihydroxy-8-[(3S,4R)-3-hydroxy-1-methyl-4-piperidinyl]-"
PALBOCICLIB,5330286,,"InChI=1S/C24H29N7O2/c1-15-19-14-27-24(28-20-8-7-18(13-26-20)30-11-9-25-10-12-30)29-22(19)31(17-5-3-4-6-17)23(33)21(15)16(2)32/h7-8,13-14,17,25H,3-6,9-12H2,1-2H3,(H,26,27,28,29)",AHJRHEGDXFFMBM-UHFFFAOYSA-N,C24H29N7O2,447.5,"6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one","Palbociclib|571190-30-2|PD-0332991|Ibrance|PD0332991|PD 0332991|6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido[2,3-d]pyrimidin-7(8H)-one|G9ZF61LE7G|CHEBI:85993|PD 332991|6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-ylpyridin-2-ylamino)-8H-pyrido(2,3-d)pyrimidin-7-one|6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one|DTXSID40972590|6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one|Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-((5-(1-piperazinyl)-2-pyridinyl)amino)-|Pyrido[2,3-d]pyrimidin-7(8H)-one, 6-acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-|palbociclibum|6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-((5-(PIPERAZIN-1-YL)PYRIDIN-2-YL)AMINO)-8H-PYRIDO(2,3-D)PYRIMIDIN-7-ONE|6-acetyl-8-cyclopentyl-5-methyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)pyrido(2,3-d)pyrimidin-7(8H)-one|6-acetyl-8-cyclopentyl-5-methyl-2-((5-piperazin-1-ylpyridin-2-yl)amino)pyrido(6,5-d)pyrimidin-7-one|6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[6,5-d]pyrimidin-7-one|RefChem:6097|DTXCID80207212|L01XE33|PD 991|Palbociclib free base|UNII-G9ZF61LE7G|MFCD11840850|571190-30-2 (free base)|6-ACETYL-8-CYCLOPENTYL-5-METHYL-2-[(5-PIPERAZIN-1-YLPYRIDIN-2-YL)AMINO]PYRIDO[2,3-D]PYRIMIDIN-7(8H)-ONE|Palbociclib(PD0332991)|C24H29N7O2|LQQ|2euf|Palbociclib [USAN]|PD-332991|571190-30-2 pound not827022-32-2|Palbociclib [USAN:INN]|Palbociclib?|[d8]-Palbociclib|Ibrance (TN)|Kinome_3823|Kinome_3824|Palbociclib (Standard)|PALBOCICLIB [MI]|6-acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8h-pyrido[2,3-d]pyrimidin-7-one hydrochloride|PALBOCICLIB [INN]|PALBOCICLIB [JAN]|Palbociclib (JAN/USAN)|PALBOCICLIB [WHO-DD]|6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrido[2,3-d]pyrimidin-7-one|SCHEMBL462630|BDBM6309|CHEMBL189963|GTPL7380|orb1307454|Palbociclib - Bio-X trade mark|SCHEMBL29362383|SCHEMBL29379411|SCHEMBL30584526|EX-A408|PALBOCICLIB [ORANGE BOOK]|2euf; PD 0332991|AHJRHEGDXFFMBM-UHFFFAOYSA-N|OTAVA-BB 1115529|BCPP000125|HMS3265M09|HMS3265M10|HMS3265N09|HMS3265N10|HMS3744G13|HMS5087D18|BCP09274|BCP18381|HY-50767R|NSC758247|NSC772256|NSC800815|s4482|AKOS022205241|BCP9001058|DB09073|FA65120|NSC-758247|NSC-772256|NSC-800815|SB40426|SDCCGSBI-0646936.P001|Pyrido-[2,3-d]-pyrimidin-7-one 43|NCGC00263129-01|NCGC00263129-08|NCGC00263129-21|NCGC00263129-22|6-acetyl-8-cyclopentyl-5-methyl-2-[(5-piperazin-1-yl-2-pyridyl)amino]pyrido[2,3-d]pyrimidin-7-one|6-acetyl-8-cyclopentyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H,8H-pyrido[2,3-d]pyrimidin-7-one|AC-25485|AS-17016|BP-43645|BP-44037|BP166224|HY-50767|SY026143|571190-30-2(DMSO)|A8153|NS00069617|D10372|190P302|EN300-18531248|F794410|PD 0332991,PD0332991|BRD-K51313569-001-01-1|BRD-K51313569-001-07-8|BRD-K51313569-003-03-3|P-0332991|Q15269707|Z2216894329|6-acetyl-8-cyclopentyl-5-methyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one|6-Acetyl-8-cyclopentyl-5-methyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-8H-pyrido[2,3-d]pyrimidin-7-one|6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one|6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(1-piperazinyl)-2-pyridyl]amino]pyrido[2,3-d]pyrimidin-7(8H)-one|6-Acetyl-8-cyclopentyl-5-methyl-2-[[5-(piperazin-1-yl)-pyridin-2-yl]amino]-8H-pyrido[2,3-d]pyrimidin-7-one|6-Acetyl-8-cyclopentyl-5-methyl-2-{[5-(1-piperazinyl)-2-pyridinyl]amino}pyrido[2,3-d]pyrimidin-7(8H)-one;PD 0332991;Ibrance|8-cyclopentyl-6-acetyl-5-methyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H,8H-pyrido[2,3-d]pyrimidin-7-one"
ABEMACICLIB,46220502,,"InChI=1S/C27H32F2N8/c1-5-35-8-10-36(11-9-35)16-19-6-7-24(30-14-19)33-27-31-15-22(29)25(34-27)20-12-21(28)26-23(13-20)37(17(2)3)18(4)32-26/h6-7,12-15,17H,5,8-11,16H2,1-4H3,(H,30,31,33,34)",UZWDCWONPYILKI-UHFFFAOYSA-N,C27H32F2N8,506.6,N-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine,"Abemaciclib|1231929-97-7|LY2835219|Verzenio|LY-2835219|N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo[d]imidazol-6-yl)pyrimidin-2-amine|Verzenios|60UAB198HK|N-[5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl]-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine|LY 2835219|LY2835210|LY-2835210|2-Pyrimidinamine, N-(5-((4-ethyl-1-piperazinyl)methyl)-2-pyridinyl)-5-fluoro-4-(4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl)|5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzimidazol-5-yl)pyrimidin-2-yl)amine|5-(4-ethylpiperazin-1-ylmethyl)pyridin-2-yl)-(5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)pyrimidin-2-yl)amine|abemaciclibum|N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-1-isopropyl-2-methyl-1H-benzo(d)imidazol-6-yl)pyrimidin-2-amine|N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(4-fluoro-2-methyl-1-(propan-2-yl)-1H-1,3-benzodiazol-6-yl)pyrimidin-2-amine|N-(5-((4-ethylpiperazin-1-yl)methyl)pyridin-2-yl)-5-fluoro-4-(7-fluoro-2-methyl-3-propan-2-ylbenzimidazol-5-yl)pyrimidin-2-amine|N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-1,3-benzodiazol-6-yl]pyrimidin-2-amine|RefChem:58097|L01XE50|LY2385219|806-670-8|LY2835219 free base|UNII-60UAB198HK|MFCD22665744|2-Pyrimidinamine, N-[5-[(4-ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-|C27H32F2N8|HY-16297A|CS-1230|N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-1,3-benzodiazol-5-yl)pyrimidin-2-amine|N-{5-[(4-Ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-benzimidazol-6-yl]pyrimidin-2-amine|Abemaciclib [USAN:INN]|LY2835219 (free base)|rimidin-2-amine|Verzenio (TN)|6ZV|N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-benzimidazol-6-yl]py rimidin-2-amine|Abemaciclib (Standard)|ABEMACICLIB [MI]|ABEMACICLIB [INN]|ABEMACICLIB [JAN]|ABEMACICLIB [USAN]|ABEMACICLIB [WHO-DD]|Abemaciclib (JAN/USAN/INN)|GTPL7382|orb1305567|SCHEMBL2487229|CHEMBL3301610|SCHEMBL29356350|SCHEMBL29423472|SCHEMBL29591527|ABEMACICLIB [ORANGE BOOK]|DTXSID20673119|EX-A521|LY 2835219 (free base)|CHEBI:233362|UZWDCWONPYILKI-UHFFFAOYSA-N|HMS3673I05|HMS5085C17|HY-16297AR|BCP13079|EX-A1588|BDBM50110183|NSC768073|NSC783671|s5716|1231929-97-7, Verzenio,|AKOS025404907|LY2835219 free base (Abemaciclib)|CCG-269750|DB12001|NSC-768073|NSC-783671|SB16476|LY2835219 free base (Abemaciclib)?|NCGC00351599-02|NCGC00351599-06|AC-30666|AS-10230|BP-43621|DA-33422|FE103812|LY2835219 Ms salt, Abemaciclib Ms salt|LY 2835210|NS00072970|D10688|EN300-7406007|F979456|BRD-K33622447-066-01-9|Q23901483|[5-(4-ethyl-piperazin-1-ylmethyl)-pyridin-2-yl]-[5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-3H-benzoimidazol-5-yl)-pyrimidin-2-yl]-amine|Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine|N-[5-[(4-Ethyl-1-piperazinyl)methyl]-2-pyridinyl]-5-fluoro-4-[4-fluoro-2-methyl-1-(1-methylethyl)-1H-benzimidazol-6-yl]-2-pyrimidinamine|N-[5-[(4-ethylpiperazin-1-yl)methyl]-2-pyridyl]-5-fluoro-4-(7-fluoro-3-isopropyl-2-methyl-benzimidazol-5-yl)pyrimidin-2-amine|N-{5-[(4-ethylpiperazin-1-yl)methyl]pyridin-2-yl}-5-fluoro-4-[4-fluoro-2-methyl-1-(propan-2-yl)-1H-benzimidazol-6-yl]py"
RIBOCICLIB,44631912,,"InChI=1S/C23H30N8O/c1-29(2)22(32)19-13-16-14-26-23(28-21(16)31(19)17-5-3-4-6-17)27-20-8-7-18(15-25-20)30-11-9-24-10-12-30/h7-8,13-15,17,24H,3-6,9-12H2,1-2H3,(H,25,26,27,28)",RHXHGRAEPCAFML-UHFFFAOYSA-N,C23H30N8O,434.5,"7-cyclopentyl-N,N-dimethyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide","Ribociclib|1211441-98-3|LEE011|LEE-011|7-cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide|LEE011A|TK8ERE8P56|7-cyclopentyl-N,N-dimethyl-2-{[5-(piperazin-1-yl)pyridin-2-yl]amino}-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide|LEE-011A|DTXSID201021027|ribociclibum|7-Cyclopentyl-N,N-dimethyl-2-((5-(piperazin-1-yl)pyridin-2-yl)amino)-7H-pyrrolo(2,3-d)pyrimidine-6-carboxamide|RefChem:55976|L01XE42|DTXCID701506068|807-111-0|Ribociclib (LEE011)|Kisqali|LEE 011|UNII-TK8ERE8P56|MFCD27976795|7-Cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide|7-cyclopentyl-N,N-dimethyl-2-[(5-piperazin-1-ylpyridin-2-yl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide|C23H30N8O|7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo [2,3-d]pyrimidine-6-carboxylic acid dimethylamide|7-Cyclopentyl-N,N-dimethyl-2-(5-(piperazin-1-yl)pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide|Ribociclib [INN]|Ribociclib, LEE011|Ribociclib [USAN:INN]|6ZZ|7H-Pyrrolo[2,3-d]pyrimidine-6-carboxamide, 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-; 7-Cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-7H-pyrrolo[2,3-d]pyrimidine-6-carboxamide; Kisqali; LEE 011; LEE 011A; Ribociclib|Ribociclib (Standard)|RIBOCICLIB [MI]|Ribociclib (USAN/INN)|RIBOCICLIB [USAN]|Ribociclib (LEE011)?|NVP-LEE011|RIBOCICLIB [WHO-DD]|SCHEMBL302310|GTPL7383|orb1300987|CHEMBL3545110|SCHEMBL29384231|SCHEMBL29385337|SCHEMBL29912679|EX-A304|CHEBI:230905|RHXHGRAEPCAFML-UHFFFAOYSA-N|BDBM148264|HMS3653N03|HMS3673I19|HMS3748M05|HMS5085P14|example 74 [US8962630]|BCP08804|HY-15777R|NSC778909|NSC794613|NSC800867|s7440|AKOS025404915|AKOS032949987|CCG-269070|CS-1750|DB11730|NSC-778909|NSC-794613|NSC-800867|SB18480|NCGC00386317-10|NCGC00386317-11|AC-30029|AS-10159|BP-44045|DA-35904|FR106414|HY-15777|LEE-011; LEE 011;LEE011|NS00072964|SW220101-1|D10883|EN300-7409093|US8962630, 74|BRD-K36788280-001-01-2|BRD-K36788280-001-03-8|BRD-K36788280-001-04-6|Q27088552|7-cyclopentyl-2-(5-piperazin-1-yl-pyridin-2-ylamino)-7H-pyrrolo[2,3-d]pyrimidine-6-carboxylic acid dimethylamide|7-cyclopentyl-N,N-dimethyl-2-[(5-piperazin-1-yl-2-pyridyl)amino]pyrrolo[2,3-d]pyrimidine-6-carboxamide|7H-Pyrrolo[2,3-d]pyrimidine-6-carboxamide, 7-cyclopentyl-N,N-dimethyl-2-[[5-(1-piperazinyl)-2-pyridinyl]amino]-"
BMS-387032,3025986,,"InChI=1S/C17H24N4O2S2/c1-17(2,3)12-8-19-13(23-12)10-24-14-9-20-16(25-14)21-15(22)11-4-6-18-7-5-11/h8-9,11,18H,4-7,10H2,1-3H3,(H,20,21,22)",OUSFTKFNBAZUKL-UHFFFAOYSA-N,C17H24N4O2S2,380.5,"N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide","345627-80-7|SNS-032|SNS 032|BMS 387032|N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-piperidinecarboxamide|BMS387032|N-(5-{[(5-tert-butyl-1,3-oxazol-2-yl)methyl]sulfanyl}-1,3-thiazol-2-yl)piperidine-4-carboxamide|N-[5-[[[5-(1,1-Dimethylethyl)-2-oxazolyl]methyl]thio]-2-thiazolyl]-4-piperidinecarboxamide|CHEBI:91399|DTXSID50188100|4-Piperidinecarboxamide, N-(5-(((5-(1,1-dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-|9979I93686|N-(5-(((5-tert-butyl-1,3-oxazol-2-yl)methyl)sulfanyl)-1,3-thiazol-2-yl)piperidine-4-carboxamide|RefChem:886481|DTXCID40110591|892-362-9|BMS-387032|SNS-032 (BMS-387032)|N-(5-(((5-(tert-Butyl)oxazol-2-yl)methyl)thio)thiazol-2-yl)piperidine-4-carboxamide|N-[5-[(5-tert-butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide|SNS032|N-(5-((5-tert-butyloxazol-2-yl)methylthio)thiazol-2-yl)piperidine-4-carboxamide|MFCD09833875|SNS-032 (hydrochloride)|CHEMBL296468|345627-80-7 (free base)|BMS-387072|OUSFTKFNBAZUKL-UHFFFAOYSA-N|UNII-9979I93686|Kinome_3820|MLS006011029|SCHEMBL187401|BDBM5931|GTPL5670|orb1301119|SNS 032 [WHO-DD]|cid_3025986|EX-A054|BCPP000066|HMS3295G09|HMS3654G10|BCP01951|NSC767048|NSC799362|s1145|AKOS015898717|CCG-264835|DB05969|FS16408|NSC-767048|NSC-799362|SB16651|SDCCGSBI-0654348.P001|N-(5-(((5-(1,1-Dimethylethyl)-2-oxazolyl)methyl)thio)-2-thiazolyl)-4-peridinecarboxamide|N-[5-[(5-tert-butyloxazol-2-yl)methylsulfanyl]thiazol-2-yl]piperidine-4-carboxamide|compound 21 [PMID: 15027863]|NCGC00263167-01|NCGC00263167-02|?BMS-387032?|AC-26846|AS-35116|BP-14149|HY-10008|SMR004702824|SNS-032(BMS-387032)?|NS00069289|SW219478-1|A20554|EN300-7398299|627B807|BRD-K43389698-001-01-6|BRD-K43389698-001-07-3|BRD-K43389698-001-09-9|Q27075347|Z2037281190|N-(5-((5-tert-butyloxazol-2-yl)methylthio)thiazol-2-yl)piperidine-4-carboxamide;SNS-032|56H|N-(5-(((5-(1,1-DIMETHYLETHYL)-2-OXAZOLYL)METHYL)THIO)-2-THIAZOLYL)-4-PERIDINECARBOXAM|N-[5-[(5-tert-Butyl-1,3-oxazol-2-yl)methylsulfanyl]-1,3-thiazol-2-yl]piperidine-4-carboxamide;BMS 387032|n-[5-[[[5-(1,1-dimethylethyl)-2-oxazolyl]methyl]-thio]-2-thiazolyl]-4-piperidinecarboxamide"
AT-7519,11338033,,"InChI=1S/C16H17Cl2N5O2/c17-10-2-1-3-11(18)13(10)15(24)22-12-8-20-23-14(12)16(25)21-9-4-6-19-7-5-9/h1-3,8-9,19H,4-7H2,(H,20,23)(H,21,25)(H,22,24)",OVPNQJVDAFNBDN-UHFFFAOYSA-N,C16H17Cl2N5O2,382.2,"4-[(2,6-dichlorobenzoyl)amino]-N-piperidin-4-yl-1H-pyrazole-5-carboxamide","RefChem:560289|4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide|AT7519|844442-38-2|AT-7519|4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide|AT 7519|AT7519 Hydrochloride|4-[(2,6-dichlorobenzoyl)amino]-N-piperidin-4-yl-1H-pyrazole-5-carboxamide|4-(2,6-Dichloro-benzoylamino)-1H-pyrazole-3-carboxylic acid piperidin-4-ylamide|Cdki at7519|AT-7519 free base|MFCD13184820|X1BF92PW9T|N-(4-Piperidinyl)-4-(2,6-dichlorobenzoylamino)-1H-pyrazole-3-carboxamide|1H-Pyrazole-3-carboxamide, 4-((2,6-dichlorobenzoyl)amino)-n-4-piperidinyl|4-(2,6-Dichlorobenzoylamino)-1H-pyrazole-3-carboxylic acid N-(piperidin-4-yl)amide|844442-38-2 (free base),|4-{[(2,6-dichlorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide|UNII-X1BF92PW9T|LZE|C16H17Cl2N5O2|OVPNQJVDAFNBDN-UHFFFAOYSA-N|pyrazole diamide, 33|MLS006010064|SCHEMBL955568|CHEMBL445813|GTPL5662|JMC514986 Compound 33|orb1300982|SCHEMBL21134171|BDBM24654|CHEBI:91326|DTXSID30233420|EX-A225|BCPP000381|HMS3265A09|HMS3265A10|HMS3265B09|HMS3265B10|HMS3654F20|BCP02166|BDBM50113281|NSC773394|NSC799338|s1524|4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-5-carboxamide|AKOS026674096|AKOS037515688|AT7519?|BCP9000335|CCG-264904|CS-0017|DB08142|NSC-773394|NSC-799338|SB16654|SDCCGSBI-0654378.P001|NCGC00263091-01|NCGC00263091-02|NCGC00263091-03|NCGC00263091-15|NCGC00263091-16|AC-29010|AS-19551|HY-50940|SMR004701224|7288B|NS00071536|SW219609-1|BRD-K13390322-001-01-4|BRD-K13390322-001-06-3|Q27074569|Z2488957173|4-(2,6-dichlorobenzamido)-N-(piperidin-4-yl)-pyrazole-3-carboxamide|4-[(2,6-dichlorobenzoyl)amino]-N-(4-piperidyl)-1H-pyrazole-5-carboxamide|4-N-(2,6-dichlorobenzene)-3-N-(piperidin-4-yl)-1H-pyrazole-3,4-diamido|4-[(2,6-dichlorobenzene)amido]-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide"
DINACICLIB,46926350,,"InChI=1S/C21H28N6O2/c1-2-17-14-23-27-19(22-13-16-6-5-9-25(29)15-16)12-20(24-21(17)27)26-10-4-3-7-18(26)8-11-28/h5-6,9,12,14-15,18,22,28H,2-4,7-8,10-11,13H2,1H3/t18-/m0/s1",PIMQWRZWLQKKBJ-SFHVURJKSA-N,C21H28N6O2,396.5,"2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-2-yl]ethanol","Dinaciclib|779353-01-4|SCH727965|SCH 727965|SCH-727965|MK-7965|4V8ECV0NBQ|2-[(2S)-1-[3-ethyl-7-[(1-oxidopyridin-1-ium-3-yl)methylamino]pyrazolo[1,5-a]pyrimidin-5-yl]piperidin-2-yl]ethanol|dinaciclibum|2-((2S)-1-(3-ethyl-7-((1-oxidopyridin-1-ium-3-yl)methylamino)pyrazolo(1,5-a)pyrimidin-5-yl)piperidin-2-yl)ethanol|3-(((3-ethyl-5-((2S)-2-(2-hydroxyethyl)piperidin-1-yl)pyrazolo(1,5-a)pyrimidin-7-yl)amino)methyl)pyridin-1-ium-1-olate|3-[({3-ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl}amino)methyl]pyridin-1-ium-1-olate|RefChem:588639|CDK Inhibitor SCH 727965|2-Piperidineethanol, 1-(3-ethyl-7-(((1-oxido-3-pyridinyl)methyl)amino)pyrazolo(1,5-a)pyrimidin-5-yl)-, (2S)-|Dinaciclib (SCH727965)|(S)-3-(((3-ethyl-5-(2-(2-hydroxyethyl)piperidin-1-yl)pyrazolo[1,5-a]pyrimidin-7-yl)amino)methyl)pyridine 1-oxide|MFCD16037702|(2S)-1-[3-Ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-2-piperidineethanol|1-[3-Ethyl-7[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-2(s)-piperidineethanol|DINACICLIB [INN]|Dinaciclib (USAN/INN)|DINACICLIB [USAN]|DINACICLIB [WHO-DD]|MLS006011034|GTPL7379|Dinaciclib (SCH727965)?|CHEMBL2103840|SCHEMBL12048446|SCHEMBL30176832|CHEBI:95060|BDBM50139171|NSC747135|NSC764036|NSC800091|s2768|AKOS030526898|CCG-268610|CS-0541|DB12021|NSC-727135|NSC-747135|NSC-764036|NSC-800091|SDCCGSBI-0654457.P001|NCGC00346656-13|AC-32835|AS-17017|FD158760|HY-10492|SMR004702827|SY045420|DB-362421|SCH 727965,SCH727965, Dinaciclib|NS00072125|SW220016-1|D09604|EN300-23218095|BRD-K13662825-001-02-6|BRD-K13662825-001-07-5|Q15723091|(S)-3-((3-ethyl-5-(2-(2-hydroxyethyl)piperidin-1-yl)pyrazolo[1,5-a]pyrimidin-7-ylamino)methyl)pyridine 1-oxide|(S)-3-[[[3-Ethyl-5-[2-(2-hydroxyethyl)-1-piperidyl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]methyl]pyridine 1-Oxide|1-[3-ethyl-7-[[(1-oxido-3-pyridinyl)methyl]amino]pyrazolo[1,5-a]pyrimidin-5-yl]-2S-piperidineethanol|2-PIPERIDINEETHANOL, 1-(3-ETHYL-7-(((1-OXIDO-3-PYRIDINYL)METHYL)AMINO)PYRAZOLO(1,5- A)PYRIMIDIN-5-YL)-, (2S)-|3-[[[3-Ethyl-5-[(2S)-2-(2-hydroxyethyl)piperidin-1-yl]pyrazolo[1,5-a]pyrimidin-7-yl]amino]methyl]pyridine 1-oxide"
CT-7001,91844733,,"InChI=1S/C22H30N6O/c1-15(2)18-13-26-28-21(25-11-16-6-4-3-5-7-16)10-20(27-22(18)28)24-12-17-8-9-23-14-19(17)29/h3-7,10,13,15,17,19,23,25,29H,8-9,11-12,14H2,1-2H3,(H,24,27)/t17-,19+/m1/s1",YCVGLKWJKIKVBI-MJGOQNOKSA-N,C22H30N6O,394.5,"(3R,4R)-4-[[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol","Samuraciclib|ICEC0942|1805833-75-3|CT-7001|46D4HS9ODA|PPDA-001|SAMURACICLIB [INN]|UNII-46D4HS9ODA|SAMURACICLIB [WHO-DD]|RefChem:181111|CDK7 Inhibitor CT7001|CT 7001|CT7001|ICEC-0942|ICEC0942 free base|1805833-75-3 (free base)|(3R,4R)-4-[[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol|CT7001 HCl|(3~{R},4~{R})-4-[[[7-(benzylamino)-3-propan-2-ylpyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]piperidin-3-ol|3-Piperidinol, 4-(((3-(1-methylethyl)-7-((phenylmethyl)amino)pyrazolo(1,5-a)pyrimidin-5-yl)amino)methyl)-, (3R,4R)-|Samuraciclib?|Samuraciclib HCl|(3r,4r)-4-[[[7-[(Phenylmethyl)amino]-3-Propan-2-Yl-Pyrazolo[1,5-A]pyrimidin-5-Yl]amino]methyl]piperidin-3-Ol|3-Piperidinol, 4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-, (3R,4R)-|Samuraciclib di-HCl|CT7001 di-HCl|CT-7001 di-HCl|CT-7001 HCl|GTPL9903|orb1688202|CHEMBL4297488|SCHEMBL17032274|ICEC 0942|GLXC-20490|EX-A3445|BDBM50526797|NSC832261|NSC835588|NSC-832261|NSC-835588|DA-67394|HY-103712|(3R,4R)-4-((7-(benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-ylamino)methyl)piperidin-3-ol dihydrochloride|(3R,4R)-4-({[7-(benzylamino)-3-(propan-2-yl)pyrazolo[1,5-a]pyrimidin-5-yl]amino}methyl)piperidin-3-ol|3-Piperidinol,4-[[[3-(1-methylethyl)-7-[(phenylmethyl)amino]pyrazolo[1,5-a]pyrimidin-5-yl]amino]methyl]-,(3R,4R)-"
SUFUGOLIX,3038517,,"InChI=1S/C36H31F2N5O4S/c1-41(20-23-10-5-3-6-11-23)21-28-31-33(44)43(26-12-7-4-8-13-26)36(46)42(22-27-29(37)14-9-15-30(27)38)34(31)48-32(28)24-16-18-25(19-17-24)39-35(45)40-47-2/h3-19H,20-22H2,1-2H3,(H2,39,40,45)",UCQSBGOFELXYIN-UHFFFAOYSA-N,C36H31F2N5O4S,667.7,"1-[4-[5-[[benzyl(methyl)amino]methyl]-1-[(2,6-difluorophenyl)methyl]-2,4-dioxo-3-phenylthieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea","Sufugolix|308831-61-0|TAK-013|Sufugolix [INN:BAN]|TAK 013|56S17Z6X9M|SUFUGOLIX [INN]|DTXSID40184893|1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(methyl-(phenylmethyl)amino)methyl]-2,4-dioxo-3-phenylthieno[4,5-e]pyrimidin-6-yl]phenyl]-3-methoxyurea|1-[4-(5-{[BENZYL(METHYL)AMINO]METHYL}-1-[(2,6-DIFLUOROPHENYL)METHYL]-2,4-DIOXO-3-PHENYL-1H,2H,3H,4H-THIENO[2,3-D]PYRIMIDIN-6-YL)PHENYL]-3-METHOXYUREA|5-((BENZYL(METHYL)AMINO)METHYL)-1-(2,6-DIFLUOROBENZYL)-6-(4-(3-METHOXYUREIDO)PHENYL)-3-PHENYLTHIENO(2,3-D)PYRIMIDINE-2,4(1H,3H)-DIONE|5-(N-Benzyl-N-methylaminomethyl)-1-(2,6-difluorobenzyl)-6-(4-(3-methoxyureido)phenyl)-3-phenylthieno(2,3-d)pyrimidine-2,4(1H,3H)-dione|Urea, N-(4-(1-((2,6-difluorophenyl)methyl)-1,2,3,4-tetrahydro-5-((methyl(phenylmethyl)amino)methyl)-2,4-dioxo-3-phenylthieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxy-|sufugolixum|1-(4-(1-((2,6-difluorophenyl)methyl)-5-((methyl-(phenylmethyl)amino)methyl)-2,4-dioxo-3-phenylthieno(4,5-e)pyrimidin-6-yl)phenyl)-3-methoxyurea|1-(4-(5-((benzyl(methyl)amino)methyl)-1-((2,6-difluorophenyl)methyl)-2,4-dioxo-3-phenyl-1H,2H,3H,4H-thieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea|5-{(Benzyl(methyl)amino)methyl}-1-(2,6-difluorobenzyl)-6-(4-(3-methoxyureido)phenyl)-3-phenylthieno(2,3-d)pyrimidine-2,4(1H,3H)-dione|RefChem:889481|DTXCID80107384|MFCD09837896|CHEMBL22055|1-(4-(5-((Benzyl(methyl)amino)methyl)-1-(2,6-difluorobenzyl)-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea|UNII-56S17Z6X9M|C36H31F2N5O4S|Sufugolix(TAK-013)|Sufugolix(TAK-013)?|1-[4-[5-[[benzyl(methyl)amino]methyl]-1-[(2,6-difluorophenyl)methyl]-2,4-dioxo-3-phenylthieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea|SCHEMBL209021|GTPL1185|orb1304092|UCQSBGOFELXYIN-UHFFFAOYSA-N|GLXC-04354|EX-A9303|BDBM50122654|AKOS030629545|CS-6434|DB06494|AS-35342|DA-78091|N-(4-(5-((benzyl(methyl)amino)methyl)-1-(2,6-difluorobenzyl)-1,2,3,4-tetrahydro-2,4-dioxo-3-phenylthieno[2,3-d]pyrimidin-6-yl)phenyl)-N'-methoxyurea|HY-100209|NS00069390|L001648|Q21099001|1-(4-(1-(2,6-difluorobenzyl)-5-((benzyl(methyl)amino)methyl)-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea|1-[4-[5-[[benzyl(methyl)amino]methyl]-1-[(2,6-difluorophenyl)methyl]-2,4-dioxo-3-phenyl-thieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxy-urea|1-{4-[5-[(Benzyl-methyl-amino)-methyl]-1-(2,6-difluoro-benzyl)-2,4-dioxo-3-phenyl-1,2,3,4-tetrahydro-thieno[2,3-d]pyrimidin-6-yl]-phenyl}-3-methoxy-urea|5-(n-benzyl-n-methylaminomethyl)-1-(2,6-difluorobenzyl)-6-[4-(3-methoxyureido)phenyl]-3-phenylthieno[2,3-d]pyrimidine-2,4(1h, 3h)-dione|5-(N-benzyl-N-methylaminomethyl)-l-(2,6-difluorobenzyl)-6-[4-(3-methoxyureido)phenyl]-3-phenylthieno[2,3-d]pyrimidine-2,4(1H, 3H)-dione|N-[4-(3-phenyl-5-(N-benzyl-N-methyl-aminomethyl)-1-(2,6-difluorobenzyl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl]-N''-methoxyurea"
ABT-102,11256560,,"InChI=1S/C21H24N4O/c1-21(2,3)14-8-9-15-13(11-14)7-10-18(15)24-20(26)23-17-5-4-6-19-16(17)12-22-25-19/h4-6,8-9,11-12,18H,7,10H2,1-3H3,(H,22,25)(H2,23,24,26)/t18-/m1/s1",TYOYXJNGINZFET-GOSISDBHSA-N,C21H24N4O,348.4,"1-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-3-(1H-indazol-4-yl)urea","ABT-102|808756-71-0|ABT 102|J0YBN3USJN|ABT102|Urea, N-((1R)-5-(1,1-dimethylethyl)-2,3-dihydro-1H-inden-1-yl)-N'-1H-indazol-4-yl-|RefChem:108560|(R)-1-(5-tert-Butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea|CHEMBL398338|1-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-3-(1H-indazol-4-yl)urea|N-[(1R)-5-(1,1-Dimethylethyl)-2,3-dihydro-1H-inden-1-yl]-N'-1H-indazol-4-ylurea|UNII-J0YBN3USJN|orb1304806|SCHEMBL1857275|N-(5-tert-Butylindan-4-yl)-N'-(1H-indazol-4-yl)urea|SCHEMBL29388297|SCHEMBL29857846|TYOYXJNGINZFET-GOSISDBHSA-N|DTXSID801001609|GLXC-04286|BDBM50232114|EX-A12463|AKOS015900672|BCP9000217|NCGC00386568-01|HY-10635|TS-08659|CS-0002691|E98875|(r)-(5-tert-butyl-2,3-dihydro-1h-inden-1-yl)-3-(1h-indazol-4-yl)-urea|(r)-1-(5-t-butyl-2,3-dihydro-1h-inden-1-yl)-3-(1h-indazol-4-yl)urea|(R)-1-(5-TERT-BUTYL-INDAN-1-YL)-3-(1H-INDAZOL-4-YL)-UREA|N-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-N'-1H-indazol-4-ylurea|(R)-1-(5-(tert-Butyl)-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)urea|N'-(5-tert-Butyl-2,3-dihydro-1H-inden-1-yl)-N-1H-indazol-4-ylcarbamimidic acid|N-[(1R)-5-tert-butyl-2,3-dihydro-1H-inden-1-yl]-N''-1H-indazol-4-ylurea"
AMG-517,16007367,,"InChI=1S/C20H13F3N4O2S/c1-11(28)26-19-27-18-15(3-2-4-16(18)30-19)29-17-9-14(24-10-25-17)12-5-7-13(8-6-12)20(21,22)23/h2-10H,1H3,(H,26,27,28)",YUTIXVXZQIQWGY-UHFFFAOYSA-N,C20H13F3N4O2S,430.4,"N-[4-[6-[4-(trifluoromethyl)phenyl]pyrimidin-4-yl]oxy-1,3-benzothiazol-2-yl]acetamide","AMG-517|659730-32-2|AMG 517|AMG517|Acetamide, N-(4-((6-(4-(trifluoromethyl)phenyl)-4-pyrimidinyl)oxy)-2-benzothiazolyl)-|172V4FBZ75|DTXSID90216178|N-[4-({6-[4-(trifluoromethyl)phenyl]pyrimidin-4-yl}oxy)-1,3-benzothiazol-2-yl]acetamide|N-(4-((6-(4-(trifluoromethyl)phenyl)pyrimidin-4-yl)oxy)-1,3-benzothiazol-2-yl)acetamide|RefChem:111927|DTXCID90138669|N-(4-((6-(4-(trifluoromethyl)phenyl)pyrimidin-4-yl)oxy)benzo[d]thiazol-2-yl)acetamide|N-[4-[6-[4-(trifluoromethyl)phenyl]pyrimidin-4-yl]oxy-1,3-benzothiazol-2-yl]acetamide|MFCD14584859|CHEMBL229430|BD-0082|UNII-172V4FBZ75|C20H13F3N4O2S|GTPL4129|JMC503515 Compound 23|orb1300820|SCHEMBL1042780|SCHEMBL29360942|SCHEMBL29389509|BDBM20557|HMS3653C07|HMS3886D11|BCP07380|EX-A2915|s7115|AKOS015994535|CCG-269008|CS-0980|SB19597|N-[4-[[6-[4-(TRIFLUOROMETHYL)PHENYL]-4-PYRIMIDINYL]OXY]-2-BENZOTHIAZOLYL]ACETAMIDE|NCGC00386259-04|AC-30947|HY-10634|SY341710|US8796328, A|US8802711, H|DB-298386|SW219382-1|BRD-K34185671-001-02-8|Q27074438|N-(4-(6-(4-(trifluoromethyl)phenyl)pyrimidin-4-yloxy)benzo[d]thiazol-2-yl)acetamide|N-{4-[6-(4-trifluoromethyl-phenyl)-pyrimidin-4-yloxy]-benzothiazol-2-yl}-acetamide"
RAMATROBAN,123879,,"InChI=1S/C21H21FN2O4S/c22-14-5-8-16(9-6-14)29(27,28)23-15-7-10-20-18(13-15)17-3-1-2-4-19(17)24(20)12-11-21(25)26/h1-6,8-9,15,23H,7,10-13H2,(H,25,26)/t15-/m1/s1",LDXDSHIEDAPSSA-OAHLLOKOSA-N,C21H21FN2O4S,416.5,"3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid","Ramatroban|116649-85-5|Baynas|BAY u3405|Bay u-3405|Bay-u-3405|3-[(3R)-3-[(4-fluorophenyl)sulfonylamino]-1,2,3,4-tetrahydrocarbazol-9-yl]propanoic acid|DTXSID1046685|P1ALI72U6C|EN-137774|3-(4-Fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9-carbazole propanoic acid|DTXCID9026685|9H-Carbazole-9-propanoic acid, 3-(((4-fluorophenyl)sulfonyl)amino)-1,2,3,4-tetrahydro-, (R)-|ramatrobanum|3-((3R)-3-((4-fluorophenyl)sulfonylamino)-1,2,3,4-tetrahydrocarbazol-9-yl)propanoic acid|RefChem:875107|3-((3R)-3-(4-fluorobenzenesulfonamido)-2,3,4,9-tetrahydro-1H-carbazol-9-yl)propanoic acid|631-428-1|Bay u 3405|MFCD00887606|9H-Carbazole-9-propanoic acid, 3-[[(4-fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-, (3R)-|(+)-(3R)-3-(p-Fluorobenzenesulfonamido)-1,2,3,4-tetrahydrocarbazole-9-propionic acid|(R)-3-(3-(4-fluorophenylsulfonamido)-3,4-dihydro-1H-carbazol-9(2H)-yl)propanoic acid|CHEMBL361812|NCGC00167519-01|EN 137774|Bay u 3406|BAY-u 3405|[3H]ramatroban|[3H]baynas|Baynas (TN)|CAS-116649-85-5|Ramatroban (JAN/INN)|Ramatroban [INN:BAN]|UNII-P1ALI72U6C|[3H]Bay u 3405|[3H]BAY u3405|9H-CARBAZOLE-9-PROPANOIC ACID, 3-(((4-FLUOROPHENYL)SULFONYL)AMINO)-1,2,3,4-TETRAHYDRO-, (3R)-|RAMATROBAN [MI]|RAMATROBAN [INN]|RAMATROBAN [JAN]|RAMATROBAN [MART.]|RAMATROBAN [WHO-DD]|Ramatroban (BAY u3405)|SCHEMBL29030|(+)-(3R)-3-[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid|MLS006010637|GTPL1910|GTPL1911|orb1305546|SCHEMBL29503087|CHEBI:32087|(R)-3-[3-(4-Fluorophenylsulphonylamino)-1,2,3,4-tetrahydrocarbazol- 9-yl]propionic acid|GLXC-06615|HMS3648E21|EX-A4208|HY-B0745|Tox21_112516|AC-719|BDBM50161746|s5286|AKOS015966619|Ramatroban, >=98% (HPLC), solid|Tox21_112516_1|CCG-268842|DB13036|FR27672|KS-1310|NCGC00167519-02|NCGC00167519-04|NCGC00167519-07|SMR002530322|NS00069216|R0144|A11926|D01128|SBI-0654089.0001|649F855|SR-01000883932|SR-01000946208|SR-01000883932-1|SR-01000946208-1|BRD-K08586861-001-01-1|Q10357327|(R)-3-(3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydrocarbazol-9-yl)propanoic acid|(R)-3-(3-(4-fluorophenylsulfonamido)-3,4-dihydro-1H-carbazol-9(2H)-yl)propanoicacid|3(r)-[[(4-fluoro-phenyl) sulfonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid|3-[(R)-3-(4-Fluoro-benzenesulfonylamino)-1,2,3,4-tetrahydro-carbazol-9-yl]-propionic acid|(3R)-3-(((4-FLUOROPHENYL)SULFONYL)AMINO)-1,2,3,4-TETRAHYDRO-9H-CARBAZOLE-9-PROPANOIC ACID|(3R)-3-[[(4-Fluorophenyl)sulfonyl]amino]-1,2,3,4-tetrahydro-9H-carbazole-9-propanoic acid;BAY-u 3405;Baynas|A8X"
MK-7246,45268455,,"InChI=1S/C21H21FN2O4S/c1-23(29(27,28)16-9-6-14(22)7-10-16)15-8-11-20-18(12-21(25)26)17-4-2-3-5-19(17)24(20)13-15/h2-7,9-10,15H,8,11-13H2,1H3,(H,25,26)/t15-/m1/s1",JTCAGRAKUAAYDY-OAHLLOKOSA-N,C21H21FN2O4S,416.5,"2-[(7R)-7-[(4-fluorophenyl)sulfonyl-methylamino]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]acetic acid","MK-7246|1218918-62-7|MK7246|X0LHZ71TLK|Pyrido(1,2-a)indole-10-acetic acid, 7-(((4-fluorophenyl)sulfonyl)methylamino)-6,7,8,9-tetrahydro-, (7R)-|RefChem:159212|849-144-3|(R)-2-(7-(4-fluoro-N-methylphenylsulfonamido)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl)acetic acid|MFCD22741619|C21H21FN2O4S|CHEMBL561132|(7R)-7-[[(4-Fluorophenyl)sulfonyl]methylamino]-6,7,8,9-tetrahydropyrido[1,2-a]indole-10-acetic acid|(R)-2-(7-((4-fluoro-N-methylphenyl)sulfonamido)-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl)acetic acid|2-[(7R)-7-[(4-fluorophenyl)sulfonyl-methylamino]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]acetic acid|MK-7246-d3|2-[(7R)-7-(N-methyl4-fluorobenzenesulfonamido)-6H,7H,8H,9H-pyrido[1,2-a]indol-10-yl]acetic acid|UNII-X0LHZ71TLK|CRTH2 antagonist|orb1679063|SCHEMBL2186905|SCHEMBL29486331|GLXC-15109|BCP16217|EX-A1915|TYB91862|BDBM50296980|AKOS027321599|PB37255|[(7R)-7-{[(4-fluorophenyl)sulfonyl](methyl)amino}-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]acetic|AC-36247|AS-74694|HY-15853|CS-0009391|2-[(7R)-7-(N-methyl4-fluorobenzenesulfonamido)-|6H,7H,8H,9H-pyrido[1,2-a]indol-10-yl]acetic acid|Q27293208|(R)-2-(7-(4-Fluoro-N-Methylphenylsulfonamide)-6,7,8,9-Tetrahydropyridine[1,2-A]Indole-10-Yl)Acetic Acid|2-[(7R)-7-[(4-fluorophenyl)sulfonyl-methyl-amino]-6,7,8,9-tetrahydropyrido[1,2-a]indol-10-yl]acetic acid|MK-7246; Pyrido[1,2-a]indole-10-acetic acid, 7-[[(4-fluorophenyl)sulfonyl]methylamino]-6,7,8,9-tetrahydro-, (7R)-; (7R)-7-[[(4-Fluorophenyl)sulfonyl]methylamino]-6,7,8,9-tetrahydropyrido[1,2-a]indole-10-acetic acid; MK 7246; (R)-2-(7-(4-Fluoro-N-methylphenylsulfon"
TIMAPIPRANT,11462174,,"InChI=1S/C21H17FN2O2/c1-13-17(11-16-8-6-14-4-2-3-5-19(14)23-16)18-10-15(22)7-9-20(18)24(13)12-21(25)26/h2-10H,11-12H2,1H3,(H,25,26)",FATGTHLOZSXOBC-UHFFFAOYSA-N,C21H17FN2O2,348.4,2-[5-fluoro-2-methyl-3-(quinolin-2-ylmethyl)indol-1-yl]acetic acid,"851723-84-7|OC000459|timapiprant|OC-000459|OC459|ODC-9101|04XB9TB8OL|2-[5-fluoro-2-methyl-3-(quinolin-2-ylmethyl)indol-1-yl]acetic Acid|CHF-6532|(5-Fluoro-2-methyl-3-quinolin-2-ylmethylindo-1-yl)-acetic acid|DTXSID00234343|timapiprantum|2-(5-fluoro-2-methyl-3-(quinolin-2-ylmethyl)indol-1-yl)acetic acid|RefChem:190026|DTXCID00156834|2-(5-fluoro-2-methyl-3-(quinolin-2-ylmethyl)-1H-indol-1-yl)acetic acid|OC-459|MFCD18633254|C21H17FN2O2|CHEMBL560993|1H-Indole-1-acetic acid, 5-fluoro-2-methyl-3-(2-quinolinylmethyl)-|851723-84-7 (free acid)|[5-Fluoro-2-methyl-3-(2-quinolinylmethyl)-1H-indol-1-yl]acetic acid|UNII-04XB9TB8OL|2-[5-Fluoro-2-methyl-3-(quinolin-2-ylmethyl)-1H-indol-1-yl]acetic acid|Timapiprant; OC-459|TIMAPIPRANT [INN]|Racemic A-278637|OC000459(Timapiprant)|TIMAPIPRANT [WHO-DD]|OC000459(Timapiprant)?|GTPL9277|orb1305198|SCHEMBL1782956|851723-84-7, 950688-14-9 (sodium salt)|SCHEMBL29379400|SCHEMBL29648518|EX-A090|GLXC-02509|HMS3651F15|HMS3748O11|ANB68814|BCP04237|5-fluoro-2-methyl-3-(2-quinolinylmethyl)-1H-Indole-1-acetic acid|BDBM50296977|s2822|AKOS016007630|BCP9001018|CCG-268010|CS-1285|DB11900|FF32729|SB16523|NCGC00386286-04|AC-33103|AS-56024|DA-18057|HY-15342|BCP0726000084|NS00072499|SW219412-1|BRD-K36463073-001-01-3|BRD-K36463073-001-02-1|BRD-K36463073-001-03-9|Q27247701|(+/-)-A-278637|2-[5-fluoro-2-methyl-3-(2-quinolylmethyl)indol-1-yl]acetic acid|227609-25-8"
BI-671800,45270144,,"InChI=1S/C25H26F3N5O3/c1-32(2)22-19(14-21(34)35)23(33(3)4)31-20(30-22)13-15-5-11-18(12-6-15)29-24(36)16-7-9-17(10-8-16)25(26,27)28/h5-12H,13-14H2,1-4H3,(H,29,36)(H,34,35)",XEOSTBFUCNZKGS-UHFFFAOYSA-N,C25H26F3N5O3,501.5,"2-[4,6-bis(dimethylamino)-2-[[4-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methyl]pyrimidin-5-yl]acetic acid","BI-671800|1093108-50-9|5-Pyrimidineacetic acid, 4,6-bis(dimethylamino)-2-((4-((4-(trifluoromethyl)benzoyl)amino)phenyl)methyl)-|BI 671800|BI671800|721F767LHB|5-Pyrimidineacetic acid, 4,6-bis(dimethylamino)-2-[[4-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methyl]-|RefChem:917138|2-(4,6-bis(dimethylamino)-2-((4-(4-(trifluoromethyl)benzamido)phenyl)methyl)pyrimidin-5-yl)acetic acid|AP-761|2-[4,6-bis(dimethylamino)-2-[[4-[[4-(trifluoromethyl)benzoyl]amino]phenyl]methyl]pyrimidin-5-yl]acetic acid|CHEMBL551813|2-(4,6-bis(dimethylamino)-2-(4-(4-(trifluoromethyl)benzamido)benzyl)pyrimidin-5-yl)acetic acid|Actimis|UNII-721F767LHB|MFCD28144681|SCHEMBL525024|orb1308569|BCP30656|TTB10850|BDBM50296978|AKOS040741332|DB12524|NCGC00345797-01|NCGC00345797-02|AC-30903|DA-51094|MS-29308|HY-114141|BI 671800?|CS-0070031|NS00070339|F82291|Q27266004|AP-761;AP761; AP 761;BI 671800; BI671800|[4,6-bis(dimethylamino)-2-(4-{[4-(trifluoromethyl)benzoyl]amino}benzyl)pyrimidin-5-yl]acetic acid|[4,6-bis-dimethylamino-2-[4-(4-trifluoromethyl-benzoyl-amino)benzyl]pyrimidin-5-yl]acetic acid"
LADOSTIGIL,208907,,"InChI=1S/C16H20N2O2/c1-4-10-17-15-9-7-12-6-8-13(11-14(12)15)20-16(19)18(3)5-2/h1,6,8,11,15,17H,5,7,9-10H2,2-3H3/t15-/m1/s1",LHXOCOHMBFOVJS-OAHLLOKOSA-N,C16H20N2O2,272.34,"[(3R)-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-5-yl] N-ethyl-N-methylcarbamate","Ladostigil|209394-27-4|Ladostigilo|SW3H1USR4Q|TV-3326 FREE BASE|DTXSID101045854|ladostigilum|RefChem:924477|DTXCID301527785|Ladostigil free base|Ladostigil [INN]|[(3R)-3-(prop-2-ynylamino)-2,3-dihydro-1H-inden-5-yl] N-ethyl-N-methylcarbamate|TV3326|209349-27-4 (free base)|Carbamic acid, N-ethyl-N-methyl-, (3R)-2,3-dihydro-3-(2-propyn-1-ylamino)-1H-inden-5-yl ester|R-CPAI|(R)-3-(Prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-5-yl ethyl(methyl)carbamate|(N-propargyl-(3R) aminoindan-5-yl)-ethyl methyl carbamate|(3R)-3-(Prop-2-ynylamino)indan-5-yl ethyl(methyl)carbamate|UNII-SW3H1USR4Q|Aminoindan deriv. (R)18b|SCHEMBL678895|CHEMBL255231|orb1696638|Aminoindan deriv. (R)18b.HCl|BDBM10750|CHEBI:177484|LHXOCOHMBFOVJS-OAHLLOKOSA-N|N-propargylaminoindan (R)18b.HCl|EX-A10721|AKOS030531889|DA-54769|HY-10399|TS-08743|CS-0002592|NS00123142|Q374426|N-Propargyl-(3R)-aminoindan-5-yl) ethyl methyl carbamate|Ethyl-methyl-carbamic acid (R)-3-prop-2-ynylamino-indan-5-yl ester|(3R)-3-(PROP-2-YN-1-YLAMINO)-2,3-DIHYDRO-1H-INDEN-5-YL ETHYL(METHYL)CARBAMATE|(3R)-3-(prop-2-yn-1-ylamino)-2,3-dihydro-1H-inden-5-yl N-ethyl-N-methylcarbamate hydrochloride|CARBAMIC ACID, ETHYL(METHYL)-, (3R)-2,3-DIHYDRO-3-(2-PROPYNYLAMINO)-1H-INDEN-5-YL ESTER"
SORAFENIB TOSYLATE,406563,,"InChI=1S/C21H16ClF3N4O3.C7H8O3S/c1-26-19(30)18-11-15(8-9-27-18)32-14-5-2-12(3-6-14)28-20(31)29-13-4-7-17(22)16(10-13)21(23,24)25;1-6-2-4-7(5-3-6)11(8,9)10/h2-11H,1H3,(H,26,30)(H2,28,29,31);2-5H,1H3,(H,8,9,10)",IVDHYUQIDRJSTI-UHFFFAOYSA-N,C28H24ClF3N4O6S,637.0,4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid,"Sorafenib tosylate|475207-59-1|Nexavar|Sorafenib tosilate|BAY 54-9085|DTXSID9047839|CHEBI:50928|5T62Q3B36J|NSC724772|BAY-54-9085|BAY 43-9006 tosylate|DTXCID9027817|1-(4-Chloro-3-(trifluoromethyl)phenyl)-3-(4-((2-(methylcarbamoyl)pyridin-4-yl)oxy)phenyl)urea mono(4-methylbenzenesulfonate)|4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULFONATE|1-[4-Chloro-3-(trifluoromethyl)phenyl]-3-[4-[[2-(methylcarbamoyl)pyridin-4-yl]oxy]phenyl]urea mono(4-methylbenzenesulfonate)|4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide 4-methylbenzenesulfonate|RefChem:57444|4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxyllic Acid Methyamide-4-methylbenzenesulfonate Tosylate|641-758-8|4-(4-(3-(4-Chloro-3-trifluoromethylphenyl)ureido)phenoxy)pyridine-2-carboxylic acid methyamide-4-methylbenzenesulfonate|Sorafenib tosylate [USAN]|Sorafenib (Tosylate)|MFCD08235032|Sorafenib Hemitosylate|475207-59-1 (tosylate)|4-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate)|4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide 4-methylbenzenesulfonate|Sorafenib tosilate (JAN)|Sorafenib (Nexavar)|Sorafenib tosylate (USAN)|Nexavar(R)|2056030-06-7|4-[4-({[4-chloro-3-(trifluoromethyl)phenyl]carbamoyl}amino)phenoxy]-N-methylpyridine-2-carboxamide; 4-methylbenzene-1-sulfonic acid|SORAFENIB TOSILATE [JAN]|4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide 4-methylbenzenesulfonate.|CAS-475207-59-1|NSC-724772|NCGC00167488-01|C28H24ClF3N4O6S|UNII-5T62Q3B36J|SR-00000000529|orafenib tosylate|BAY43-9006 mono-p-tosylate|BAY 43-9006 mono-p-tosylate|Nexavar (TN)|MLS002415564|SCHEMBL162935|orb1310945|SORAFENIB TOSYLATE [MI]|CHEMBL1200485|SCHEMBL29919725|Sorafenib (Tosylate) (Standard)|HMS2219E08|HMS3654I09|HMS5079C07|HY-10201AR|Sorafenib (BAY-43-9006)?|Sorafenib, p-Toluenesulfonate salt|SORAFENIB TOSILATE [MART.]|SORAFENIB TOSILATE [WHO-DD]|SORAFENIB TOSYLATE [USP-RS]|Tox21_112489|HY-10201A|s1040|AKOS015924650|AKOS027469919|Tox21_112489_1|AC-6799|CCG-208000|CS-0164|FS10808|ND-0228|Sorafenib tosylate - Bio-X trade mark|SORAFENIB TOSYLATE [ORANGE BOOK]|NCGC00167488-08|SORAFENIB TOSILATE [EP MONOGRAPH]|2-Pyridinecarboxamide, 4-(4-((((4-chloro-3-(trifluoromethyl)phenyl)amino)carbonyl)amino)phenoxy)-N-methyl-, mono(4-methylbenzenesulfonate)|4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid|BS164414|SMR001339079|SORAFENIB TOSYLATE [USP MONOGRAPH]|SY012324|BCP0726000112|SW202562-3|D06272|S-8502|207S591|SR-00000000529-5|Q27122250|4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide tosylate|-(4-(3-(4-Chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N2-methylpyridine-2-carboxamide mono (4-methylbenzenesulfonate)|4-(4-(((4-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)CARBAMOYL)AMINO)PHENOXY)-N-METHYLPYRIDINE-2-CARBOXAMIDE 4-METHYLBENZENESULPHONATE|4-(4-(3-(4-chloro-3-(trifluoromethyl)phenyl)ureido)phenoxy)-N-methylpicolinamide4-methylbenzenesulfonate|4-[4-[[4-Chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-2-pyridinecarboxamide Tosylate|4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methyl-pyridine-2-carboxamide;4-methylbenzenesulfonic acid|4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;hydron;4-methylbenzenesulfonate|4-{4-[({[4-chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)-amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate|4-{4-[({[4-Chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N -methylpyridine-2-carboxamide tosylate|4-{4-[({[4-Chloro-3-(trifluoromethyl)phenyl]amino}carbonyl)amino]phenoxy}-N-methylpyridine-2-carboxamide tosylate|4-{4-[3-(4-Chloro-3-trifluoromethyl-phenyl)-ureido]-phenoxy} -pyridine-2-carboxylic acid methylamide-4-methylbenzenesulfonate|4-{4-[3-(4-Cl-3-trifluoromethyl-phenyl)-ureido]-phenoxy}-pyridine-2-carboxylic acid methylamide 4-methylbenzenesulfonate|4-Methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)-N-(5-(4-methyl-1H-imidazol-1-yl)-3-(trifluoromethyl)phenyl)benzamide monomethanesulfonate"
IRDABISANT,25070031,,"InChI=1S/C18H23N3O2/c1-14-4-2-11-21(14)12-3-13-23-16-7-5-15(6-8-16)17-9-10-18(22)20-19-17/h5-10,14H,2-4,11-13H2,1H3,(H,20,22)/t14-/m1/s1",XUKROCVZGZNGSI-CQSZACIVSA-N,C18H23N3O2,313.4,3-[4-[3-[(2R)-2-methylpyrrolidin-1-yl]propoxy]phenyl]-1H-pyridazin-6-one,"Irdabisant|1005402-19-6|CEP-26401|Irdabisant [USAN:INN]|UNII-WH7ISP34KA|Irdabisant (USAN)|IRDABISANT [INN]|IRDABISANT [USAN]|IRDABISANT [WHO-DD]|DTXSID50143375|6-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)-2H-pyridazin-3-one|irdabisantum|6-(4-(3-((2R)-2-methylpyrrolidin-1-yl)propoxy)phenyl)-2,3-dihydropyridazin-3-one|6-(4-{3-[(2R)-2-methylpyrrolidin-1-yl]propoxy}phenyl)-2,3-dihydropyridazin-3-one|RefChem:148699|DTXCID4065866|CEP26401|CEP 26401|WH7ISP34KA|3-[4-[3-[(2R)-2-methylpyrrolidin-1-yl]propoxy]phenyl]-1H-pyridazin-6-one|(R)-6-(4-(3-(2-methylpyrrolidin-1-yl)propoxy)phenyl)pyridazin-3(2H)-one|SCHEMBL118744|orb1696917|CHEMBL1813052|CHEMBL1829335|CHEBI:177564|XUKROCVZGZNGSI-CQSZACIVSA-N|BDBM50350021|MFCD28502107|(R)-6-[4-[3-(2-Methyl-1-pyrrolidinyl)propoxy]phenyl]pyridazin-3(2H)-one|AKOS040752101|AT38262|DB12900|BI184163|DA-64495|SY345378|TS-08733|HY-109968|CS-0034318|NS00072924|D10128|Q27292641|6-[4-[3-[(2R)-2-Methyl-1-pyrrolidinyl]propoxy]phenyl]-3(2H)-pyridazinone;CEP 26401|6-{4-[3-((R)-2-methyl-pyrrolidin-1-yl)-propoxy]-phenyl}-2H-pyridazin-3-one"
MK-0249,11697697,,"InChI=1S/C23H24F3N3O2/c1-16-27-20-7-4-6-19(23(24,25)26)21(20)22(30)29(16)17-8-10-18(11-9-17)31-15-5-14-28-12-2-3-13-28/h4,6-11H,2-3,5,12-15H2,1H3",DDDZBLNULGDPGA-UHFFFAOYSA-N,C23H24F3N3O2,431.4,2-methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-(trifluoromethyl)quinazolin-4-one,"MK-0249|1167574-41-5|MK0249|MK 0249|KF50235Q04|2-methyl-3-[4-(3-pyrrolidin-1-ylpropoxy)phenyl]-5-(trifluoromethyl)quinazolin-4-one|DTXSID70151492|2-METHYL-3-(4-(3-PYRROLIDIN-1-YLPROPOXY)PHENYL)-5-(TRIFLUOROMETHYL)QUINAZOLIN-4-ONE|RefChem:159169|DTXCID7073983|2-methyl-3-(4-(3-(pyrrolidin-1-yl)propoxy)phenyl)-5-(trifluoromethyl)-3,4-dihydroquinazolin-4-one|862309-06-6|UNII-KF50235Q04|CHEMBL476323|2-methyl-3-(4-(3-(pyrrolidin-1-yl)propoxy)phenyl)-5-(trifluoromethyl)quinazolin-4(3h)-one|MK-0249 free base|SCHEMBL119607|GTPL7346|orb1709121|SCHEMBL29378542|BCP30795|MJB30906|BDBM50262939|HY-U00076|MFCD31382164|AKOS040733747|CS-6803|DB11910|MK0249; MK 0249|DA-75577|MS-27674|NS00072237|G16077|Q6716391|2-methyl-3-{4-[3-(1-pyrrolidinyl)propoxy]phenyl}-5-trifluoromethyl-4(3H)-quinazolinone|2-Methyl-3-(4-{[3-(1-pyrrolidinyl)propyl]oxy}phenyl)-5-(trifluoromethyl)-4(3H)-quinazolinone"
VARESPLADIB,155815,,"InChI=1S/C21H20N2O5/c1-2-14-19(20(26)21(22)27)18-15(9-6-10-16(18)28-12-17(24)25)23(14)11-13-7-4-3-5-8-13/h3-10H,2,11-12H2,1H3,(H2,22,27)(H,24,25)",BHLXTPHDSZUFHR-UHFFFAOYSA-N,C21H20N2O5,380.4,2-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetic acid,"Varespladib|172732-68-2|LY315920|LY-315920|VAREPLADIB|varespladibum|2Q3P98DATH|S-5920|2-(1-benzyl-2-ethyl-3-oxamoylindol-4-yl)oxyacetic acid|({3-[amino(oxo)acetyl]-1-benzyl-2-ethyl-1H-indol-4-yl}oxy)acetic acid|CHEBI:189668|DTXSID50169378|A-001|((3-(aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl)oxy)acetate|((3-(AMINO(OXO)ACETYL)-1-BENZYL-2-ETHYL-1H-INDOL-4-YL)OXY)ACETIC ACID|2-((1-benzyl-3-(carbamoylcarbonyl)-2-ethyl-1H-indol-4-yl)oxy)acetic acid|2-{[1-benzyl-3-(carbamoylcarbonyl)-2-ethyl-1H-indol-4-yl]oxy}acetic acid|RefChem:933936|DTXCID4091869|Varespladib (LY315920)|MFCD00944812|CHEMBL148674|2-((3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yl)oxy)acetic acid|LY 315920|S 5920|2-[[3-(2-Amino-2-oxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetic acid|2-(3-(2-amino-2-oxoacetyl)-1-benzyl-2-ethyl-1H-indol-4-yloxy)acetic acid|SMR004701444|Varespladib [INN]|Varespladib [USAN]|Varespladib [USAN:INN]|UNII-2Q3P98DATH|Varespladib?|[[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetic Acid LY 315920; Varespladib; [[3-(2-Amino-1,2-dioxoethyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetic Acid;|VRD|VARESPLADIB [MI]|Varespladib (USAN/INN)|SCHEMBL26726|VARESPLADIB [WHO-DD]|MLS006010414|MLS006010980|varespladib methyl (A-002)|varespladib sodium (A-001)|LY 315920 (Varespladib)|GTPL9657|orb1306656|SCHEMBL29358982|2-(1-benzyl-2-ethyl-3-oxamoyl-indol-4-yl)oxyacetic acid|EX-A153|BCPP000175|GLXC-05612|HMS3654E04|HMS3744O03|BCP01854|BDBM50055366|s1110|[[3-(Aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl]oxy]acetic acid|AKOS015842901|compound 6m [PMID: 8978844]|BCP9000883|CCG-268404|DB11909|EX-8676|FV65203|SB16690|NCGC00346491-01|NCGC00346491-02|NCGC00346491-08|NCGC00346491-12|AC-32931|AS-16956|HY-13402|NS00068617|SW219559-1|D08107|EN300-144829|Q7915613|BRD-K09711437-001-01-9|BRD-K09711437-001-04-3|Z1721255146|(3-Aminooxalyl-1-benzyl-2-ethyl-1H-indol-4-yloxy)-acetic acid|2-[2-ethyl-3-oxamoyl-1-(phenylmethyl)indol-4-yl]oxyethanoic acid|(3-Aminooxalyl-1-benzyl-2-ethyl-2,3-dihydro-1H-indol-4-yloxy)-acetic acid|ACETIC ACID, ((3-(AMINOOXOACETYL)-2-ETHYL-1-(PHENYLMETHYL)-1H-INDOL-4-YL)OXY)-|Acetic acid, ((3-(aminooxoacetyl)-2-ethyl-1-(phenylmethyl)-1H-indol-4-yl)oxy)-,"
MEPERIDINE HYDROCHLORIDE,5750,,"InChI=1S/C15H21NO2.ClH/c1-3-18-14(17)15(9-11-16(2)12-10-15)13-7-5-4-6-8-13;/h4-8H,3,9-12H2,1-2H3;1H",WCNLCIJMFAJCPX-UHFFFAOYSA-N,C15H22ClNO2,283.79,ethyl 1-methyl-4-phenylpiperidine-4-carboxylate;hydrochloride,"MEPERIDINE HYDROCHLORIDE|Pethidine hydrochloride|50-13-5|Antiduol|Centralgin|Dispadol|Dolantal|Dolestine|Dolaren|Algil|Meperidine Hcl|Antidurol|Doloneurine|Petantin|Piridosal|Dolenal|Dolenol|Mepadin|Petidin|Demerol hydrochloride|Pethidine chloride|Chlorbicyclene|Dolopethin|Pantalgine|Sauteralgyl|Spasmodolin|Endolat|Mephedine|Spasmedal|Petantin hydrochloride|Meperitab|Isonipecaine hydrochloride|NIH 10522|Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate hydrochloride|Ethyl 1-methyl-4-phenylisonipecotate hydrochloride|Ethyl-1-methyl-4-phenylisonipecotate hydrochloride|Meperidine hydrochloride cii|1-Methyl-4-carbethoxy-4-phenylpiperidine hydrochloride|N-Methyl-4-phenyl-4-carbethoxypiperidine hydrochloride|1-Methyl-4-phenyl-4-carboethoxypiperidine hydrochloride|4-Piperidinecarboxylic acid, 1-methyl-4-phenyl-, ethyl ester, hydrochloride|NSC-400479|1-Methyl-4-phenylisonipecotic acid ethyl ester hydrochloride|Ethyl 1-methyl-4-phenylpiperidyl-4-carboxylate hydrochloride|Pethidini hydrochloridum|N8E7F7Q170|Meperidine hydrochloride preservative free|CHEBI:31984|DTXSID30950620|NSC400479|Spasmodlin|Pamergan|RefChem:55578|DTXCID701378770|Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate monohydrochloride|200-013-3|Chlorbycyclen|Dolantin|Dolargan|Dolin|Lidol|Operidine|Synelaudine|Alodan (gerot)|WY 554|S 140|ethyl 1-methyl-4-phenylpiperidine-4-carboxylate;hydrochloride|Pethidine hydrochloride [JAN]|Mefedina|meperidina|50-13-5 (HCl)|Meperidine-d5 Hydrochloride|Meperidine.HCl (Pethidine.HCl)|Chlorbicyclene [French]|(+-)-Pethidine hydrochloride|Pethidine Hydrochloride (1mg/ml in Methanol)|EINECS 200-013-3|NSC 400479|Clopedin|Dolantina|Dolantol|Doloblok|Meperdol|Meperidin|Opystan|Petholan|Petisel|Cluyer|UNII-N8E7F7Q170|G-Pethidine|Pethidine HCl|Petidin Dak|55989-09-8|Demerol (TN)|Meperidine hydrochloride [USAN:USP]|Dolantin hydrochloride|Ethyl 1-methyl-4-phenylpiperidine-4-carboxylate,hydrochloride|CHEMBL1701|SCHEMBL41046|Meperidine hydrochloride (USP)|Pethidine hydrochloride (JP18)|FDC18005|Ethyl 1-methyl-4-phenyl-4-piperidinecarboxylate hydrochloride (1: 1)|Isonipecotic acid, 1-methyl-4-phenyl-, ethyl ester, hydrochloride|MEPERIDINE HYDROCHLORIDE [MI]|MFCD00058210|1-Methyl-4-phenylpiperidine-4-carboxylic acid ethyl ester hydrochloride|WLN: T6NTJ A1 DVO2 DR &GH|FM25061|MEPERIDINE HYDROCHLORIDE [USAN]|PETHIDINE HYDROCHLORIDE [MART.]|MEPERIDINE HYDROCHLORIDE [VANDF]|PETHIDINE HYDROCHLORIDE [WHO-DD]|PETHIDINE HYDROCHLORIDE [WHO-IP]|DB-051733|Isonipecotic acid, ethyl ester, hydrochloride|MEPERIDINE HYDROCHLORIDE CII [USP-RS]|NS00078332|PETHIDINE HYDROCHLORIDE [EP IMPURITY]|MEPERIDINE HYDROCHLORIDE [ORANGE BOOK]|PETHIDINE HYDROCHLORIDE [EP MONOGRAPH]|D01383|MEPERIDINE HYDROCHLORIDE [USP MONOGRAPH]|PETHIDINI HYDROCHLORIDUM [WHO-IP LATIN]|MEPERGAN COMPONENT MEPERIDINE HYDROCHLORIDE|Pethidine Hydrochloride (Meperidine Hydrochloride)|Q27284706|4-(ethoxycarbonyl)-1-methyl-4-phenylpiperidinium chloride|Piperidine, N-methyl-4-phenyl-4-carbethoxy-, hydrochloride|Meperidine.HCl (Pethidine.HCl), 1mg/ml in Methanol (as free base)|1-Methyl-4-phenyl-piperidine-4-carboxylic acid ethyl ester hydrochloride|Dolvanolendolatethyl 1-methyl-4-phenylpiperidine-4-carboxylate hydrochloride|1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester hydrochloride (1:1)|Meperidine hydrochloride, United States Pharmacopeia (USP) Reference Standard|1-Methyl-4-phenyl-4-piperidinecarboxylic acid ethyl ester hydrochloride;1-Methyl-4-phenyl-isonipecotic acid ethyl ester hydrochlorid e;(+/-)-Pethidine hydrochloride"
LORATADINE,3957,,"InChI=1S/C22H23ClN2O2/c1-2-27-22(26)25-12-9-15(10-13-25)20-19-8-7-18(23)14-17(19)6-5-16-4-3-11-24-21(16)20/h3-4,7-8,11,14H,2,5-6,9-10,12-13H2,1H3",JCCNYMKQOSZNPW-UHFFFAOYSA-N,C22H23ClN2O2,382.9,"ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate","loratadine|79794-75-5|Claritin|Alavert|Clarityn|Lisino|Clarityne|Loracert|Loradex|Bonalerg|Claritine|Fristamin|Histaloran|Lertamine|Lorastine|Loratyne|Civeran|Loranox|Aerotina|Alerpriv|Anhissen|Claratyne|Loritine|Restamine|Sch 29851|Sensibit|Biloina|Nularef|Claritin Reditabs|Loratadina|Sch-29851|Children's Claritin|Loratadinum|Loratadine Redidose|Roletra|Claritin Hives Relief|Claritin Hives Relief Reditab|DTXSID2023224|7AJO3BO7QN|NSC-758628|Topcare childrens allergy relief|Ethyl 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylate|BAY76-2211|CHEBI:6538|DTXCID903224|ethyl 4-(13-chloro-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate|ethyl 4-{13-chloro-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene}piperidine-1-carboxylate|NSC721075|4-(8-Chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-1-piperidinecarboxylic Acid Ethyl Ester|Ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylate|ethyl 4-(8-chloro-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridin-11-ylidene)piperidine-1-carboxylate|Sch29851|Allervarx|Clarityn rapide|HealthMart|Alavert Allergy|Loratadine Oral|Claritin Allergy|Hay-rite|Loratadine OD|loratadine tablet|Wal-itin|Loratadine ODT|Children Claritin|Childrens Allergy|Childrens Walitin|Claritin Chewable|Leader Loratadine|Loratadine 10mg|Medique Loradamed|Wal Itin|AlloPAX|Counteract Allergy|Loratadine Tablets|Claritin, BSX|Claritin, CVP|Hy-Vee|Childrens Wal-itin|Guardian Loratadine|Loratadine 10 mg|McKesson Loratadine|4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester|ethyl 4-(13-chloro-4-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate|ethyl 4-(13-chloro-4-azatricyclo(9.4.0.03,8)pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene)piperidine-1-carboxylate|ethyl 4-(8-chloro-5,6-dihydrobenzo(1,2)cyclohepta(2,4-b)pyridin-11-ylidene)piperidine-1-carboxylate|Claritin Liqui-gels|Childrens Loratadine|XL-3 Allergy|CAREALL Loratadine|Childrens Non-Drowsy|Loratadine Non drowsy|Curist Allergy Relief|Equate Allergy Relief|Leader Allergy Relief|Loratadineantihistamine|Rexall Allergy Relief|Careone Allergy Relief|Health Mart Loratadine|Live Better Loratadine|Topcare Allergy Relief|Help I Have Allergies|Equaline Allergy Relief|Loratadine Antihistamine|RefChem:5961|Sunmark Loratadine ODT|All Day Allergy Relief|equate childrens allergy|Members Mark Aller-itin|Wal-itin Allergy Relief|Allergy Relief Childrens|Childrens Allergy Relief|Lil Drug Store Claritin|CAREALL Allergy Relief|non drowsy allergy relief|Children Claritin Allergy|Childrens Loratadine Oral|Dg Health Allergy Relief|Loratadine Allergy Relief|Topcare Childrens Allergy|Healthmart Loratadine ODT|LORATADINE SOFTGELS|caring mill allergy relief|Allergy Relief Non Drowsy|Basic Care Allergy Relief|Good Sense Allergy Relief|Non-Drowsy Allergy Relief|Sound Body Allergy Relief|Up and Up Allergy Relief|ALLERGY RELIEF 10mg|dg health childrens allergy|Hy-vee Childrens Loratadine|up and up childrens allergy|Members Mark Allergy Relief|Sunmark Childrens Loratadine|Topcare Childrens Loratadine|childrens allergy Sugar Free|welby all day allergy relief|ALLERGY RELIEF 10 mg|Equaline Childrens Loratadine|Kirkland Signature Allerclear|Care One Childrens Loratadine|Dye-Free Childrens Loratadine|Indoor Outdoor Allergy Relief|Signature Care Allergy Relief|Exchange Select Allergy Relief|Medi-First Plus Allery Relief|Welby Childrens Allergy Relief|CHILDRENS LORATADINE ODT|Healthmart Childrens Loratadine|Childrens Loratadine Sugar Free|Curist Childrens Allergy Relief|Equate Childrens Allergy Relief|Good Sense Childrens Loratadine|Leader Childrens Allergy Relief|Medi First Plus Allergy Relief|Best Choice Childrens Loratadine|Careone Allergy Relief 24 Hour|First Aid Direct Allergy Relief|Topcare Allergy Relief 24 Hour|CareOne Childrens Allergy Relief|Foster and Thrive Allergy Relief|loratadine 5 mg chewable tablets|Loratadine Tablets USP, 10 mg|Equaline Childrens Allergy Relief|Good Neighbor Pharmacy Loratadine|Handy Solutions 24 Hour Allergy|R06AX13|Rexall Allergy Relief Non Drowsy|Berkley and Jensen Allergy Relief|dg health childrens allergy relief|Meijer Childrens 24 Hour Allergy|Premier Value Childrens Loratadine|Claritin Chewable Cool Mint Flavor|Good Sense childrens allergy relief|Basic Care Childrens Allergy Relief|Loratadineantihistamine Antihistamine|Up and Up Childrens Allergy Relief|Claritin Chewable Grape and Bubblegum|Claritin, BSX Non-Drowsy, 24 Hour|Claritin, CVP Non-Drowsy, 24 Hour|LORATADINE ALLERGY RELIEF 10mg|AMAZON BASIC CARE ALLERGY RELIEF|Non-Drowsy Allergy Relief, 24-7 Life|Quality Choice Childrens Allergy Relief|Western Family Childrens Allergy Relief|24 / 7 Life Non-Drowsy Allergy Relief|Medicine Shoppe Loratadine Allergy Relief|Foster and Thrive Childrens Allergy Relief|Berkley and Jensen Childrens Allergy Relief|Best Choice Childrens Loratadine Sugar Free|Good Neighbor Pharmacy Childrens Loratadine|Childrens Non-drowsy 24-hour Allergy Relief|Childrens Non-drowsy Allergy Relief 24-hour|Lil Drug Store Claritin Non-Drowsy, 24 Hour|Levocetirizine dihydrochloride 5%, Loratadine 5%|SUNMARK CHILDRENS LORATADINE SRP SF GRAPE|616-734-5|Lomilan|Loratidine|Versal|MFCD00672869|ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylate|Loratadine-d4|Allertidin|Polaratyne|Lesidas|Loradif|Lorantis|Loraver|Lorfast|Lowadina|Optimin|Sanelor|Sohotin|Velodan|Lergy|Pylor|Tadine|CHEMBL998|Zeos|Sinhistan Dy|Bedix Loratadina|Talorat Dy|Clarinase Reperabs|MLS000069647|1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo(5,6)cyclohepta(1,2-b)pyridin-11-ylidene)-, ethyl ester|1-Piperidinecarboxylic acid,4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-, ethyl ester|Loratadinum [Latin]|Claritin reditab|Loratadina [Spanish]|Clarityne-D|1-Piperidinecarboxylic acid, 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-, ethyl ester|NCGC00015619-09|SMR000058255|Clarityne Dy Repetabs|Bactimicina allergy|Claritin (TN)|CAS-79794-75-5|HSDB 3578|SR-01000075968|UNII-7AJO3BO7QN|Cronopen|Flonidan|Klaritin|loratadine-form1|LoratadineI-p25|Loratadine [USAN:USP:INN:BAN]|loratadine-form2-He|Loratadine (Standard)|Spectrum_001496|Tocris-1944|LORATADINE [MI]|LORATADINE [INN]|LORATADINE [JAN]|LoratadineI-0deg(L13)|Opera_ID_1868|Spectrum2_001584|Spectrum3_000740|Spectrum4_000177|Spectrum5_001650|Lopac-L-9664|LORATADINE [HSDB]|LORATADINE [USAN]|LoratadineI-p80(L13)|LORATADINE [VANDF]|L 9664|LORATADINE [MART.]|LoratadineI-m100(L13)|LoratadineI-m173(L13)|SCHEMBL4596|LORATADINE [USP-RS]|LORATADINE [WHO-DD]|Lopac0_000680|Oprea1_027965|REGID_for_CID_3957|BSPBio_002300|KBioGR_000693|KBioSS_001976|Loratadine (JAN/USP/INN)|MLS000758260|MLS001148466|MLS001423984|BIDD:GT0198|DivK1c_000792|SPECTRUM1503712|SPBio_001548|GTPL7216|Loratadine - Bio-X trade mark|orb1309786|LORATADINE [EP IMPURITY]|LORATADINE [ORANGE BOOK]|SCHEMBL29380223|SCHEMBL29441811|BDBM22876|HMS502H14|KBio1_000792|KBio2_001976|KBio2_004544|KBio2_007112|KBio3_001520|LORATADINE [EP MONOGRAPH]|NINDS_000792|HMS2051G11|HMS2090O18|HMS2093I15|HMS2235G23|HMS3262G21|HMS3268M16|HMS3371D13|HMS3393G11|HMS3412N06|HMS3654L17|HMS3676N06|HMS3714E09|HMS5079B15|LORATADINE [USP MONOGRAPH]|Pharmakon1600-01503712|Loratadine 0.1 mg/ml in Methanol|BCP22338|GQA72727|MSK10120|Tox21_110185|Tox21_301532|Tox21_500680|BBL010757|CCG-39362|DL-436|HY-17043R|NSC758628|s1358|STK574925|AKOS005499513|CLARITIN-D COMPONENT LORATADINE|Loratadine, >=98% (HPLC), powder|Tox21_110185_1|AB06849|AC-2086|BCP9000858|CCG-100786|CS-0887|DB00455|FL24933|KS-1079|LP00680|NC00036|NSC 721075|NSC 758628|NSC-721075|SDCCGSBI-0050659.P004|IDI1_000792|NCGC00015619-01|NCGC00015619-02|NCGC00015619-03|NCGC00015619-04|NCGC00015619-05|NCGC00015619-06|NCGC00015619-07|NCGC00015619-08|NCGC00015619-10|NCGC00015619-11|NCGC00015619-12|NCGC00015619-13|NCGC00015619-26|NCGC00023125-02|NCGC00023125-04|NCGC00023125-05|NCGC00023125-06|NCGC00023125-07|NCGC00255171-01|NCGC00261365-01|4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cycloheptal[1,2-b]pyridin-11-ylidene-1-piperidinecarboxylic acid ethyl ester|BL164637|HY-17043|NCI60_041473|SY052751|BCP0726000007|SBI-0050659.P003|EU-0100680|L0223|NS00002063|SW197416-3|D00364|EN300-119520|AB00053224-15|AB00053224-16|AB00053224_17|AB00053224_18|794L755|F793544|L000667|Q424049|SR-01000075968-1|SR-01000075968-3|SR-01000075968-4|SR-01000075968-6|BRD-K82795137-001-02-3|BRD-K82795137-001-10-6|BRD-K82795137-001-24-7|BRD-K82795137-001-25-4|BRD-K82795137-001-26-2|F2173-0505|Z1521553845|Loratadine, British Pharmacopoeia (BP) Reference Standard|Loratadine, European Pharmacopoeia (EP) Reference Standard|Loratadine, United States Pharmacopeia (USP) Reference Standard|Loratadine, Pharmaceutical Secondary Standard; Certified Reference Material|Loratadine for system suitability, European Pharmacopoeia (EP) Reference Standard|1-Piperidenecarboxylic acid,6-duhydro-11H-benzo [5,6]cyclohepta[1,2-b]-pyridin-11-ylidene)-, ethyl ester|11-[N-(ethoxycarbonyl)-4-piperidylidene]-8-chloro-6,11-dihydro-5H-benzo-[5,6]cyclohepta[1,2-b]pyridine|4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester;Claritin;Sch-2985 1|4-(8-Chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene-1-piperidinecarboxylic acid ethyl ester|4-(8-Chloro-5,6-dihydro-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-piperidine-1-carboxylic acid ethyl ester|4-(8-chloro-5,6-dihydrobenzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine-1-carboxylic acid ethyl ester|8-chloro-11-(1-ethoxycarbonyl-4-piperidylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|8-chloro-6,11-dihydro-11-(1- ethoxycarbonyl-4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|8-Chloro-6,11-dihydro-11-(1-ethoxycarbonyl-4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|Ethyl 4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidine)-1-piperidinecarboxylate|ethyl 4-(8-chloro-5,6-dihydrobenzo[1,2]cyclohepta[3,4-b]pyridin-11-ylidene)piperidine-1-carboxylate|ethyl 4-{13-chloro-4-azatricyclo[9.4.0.0(3),]pentadeca-1(11),3,5,7,12,14-hexaen-2-ylidene}piperidine-1-carboxylate|ethyl 4-{13-chloro-4-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-ylidene}piperidine-1-carboxylate"
DESLORATADINE,124087,,"InChI=1S/C19H19ClN2/c20-16-5-6-17-15(12-16)4-3-14-2-1-9-22-19(14)18(17)13-7-10-21-11-8-13/h1-2,5-6,9,12,21H,3-4,7-8,10-11H2",JAUOIFJMECXRGI-UHFFFAOYSA-N,C19H19ClN2,310.8,"13-chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene","Desloratadine|100643-71-8|Clarinex|Descarboethoxyloratadine|Desloratidine|Neoclarityn|Aerius|Azomyr|Denosin|Sch-34117|Opulis|Allex|Sch 34117|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|Desloratadine Actavis|Dasselta|5H-Benzo[5,6]cyclohepta[1,2-b]pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-|Desloratadine teva|Desloratadina|8-chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|NSC-759824|DTXSID1044196|CHEBI:291342|FVF865388R|8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|DESLORATADINE RATIOPHARM|DTXCID9024196|13-chloro-2-piperidin-4-ylidene-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene|5H-Benzo(5,6)cyclohepta(1,2-b)pyridine, 8-chloro-6,11-dihydro-11-(4-piperidinylidene)-|8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|DESLORATADINE TEVA (AUTHORIZED: RHINITIS, URTICARIA)|DESLORATADINE ACTAVIS (AUTHORIZED: RHINITIS, URTICARIA)|DESLORATADINE RATIOPHARM (AUTHORIZED: RHINITIS, URTICARIA)|desloratadinum|Midetorin|8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|8-chloro-11-piperidin-4-ylidene-5,6-dihydrobenzo(1,2)cyclohepta(2,4-b)pyridine|8-chloro-11-piperidin-4-ylidene-5,6-dihydrobenzo[1,2]cyclohepta[2,4-b]pyridine|8-Chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo(5,6)cyclohepta(1,2-b)pyridine|13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3,5,7,12,14-hexaene|13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,12,14-hexaene|13-chloro-2-piperidin-4-ylidene-4-azatricyclo(9.4.0.03,8)pentadeca-1(11),3(8),4,6,12,14-hexaene|RefChem:57884|R06AX27|13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo(9.4.0.03,8)pentadeca-1(11),3(8),4,6,12,14-hexaene|MFCD00871949|Descarboethoxyoratidine|CHEMBL1172|MLS000559042|NSC675447|NCGC00159325-02|SMR000149358|Desloratadine [USAN]|Clarinex RediTabs|13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaene|Desalex|8-chloro-6,11-dihydro-11-(4-piperdinylidene)- 5H-benzo[5,6]cyclohepta[1,2-b]pyridine|Clarinex (TN)|8-Chloro-11-(piperidin-4-ylidene)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine (Descarboethoxyloratadine; Desloratadine)|8-CHLORO-6,11-DIHYDRO-11-(4-PIPERIDINYLIDENE)-5H-BENZO[5,6]CYCLOHEPTA[1,2-B]PYRIDINE-D5|CAS-100643-71-8|SR-01000668962|Loratadine EP Impurity D|UNII-FVF865388R|Desloratadine [USAN:INN:BAN]|Desloratadine-d7|Clarinex(R)|4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta(1,2-b]pyridin-11-ylidene)-piperidine|4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine|4-{8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene}-piperidine|4-{8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene}piperidine|Loratadine metabolite|MK-4117|CPD000149358|Desloratadine (Standard)|Opera_ID_1891|DESLORATADINE [MI]|DESLORATADINE [INN]|DESLORATADINE [JAN]|SCHEMBL4425|DESLORATADINE [VANDF]|MLS000759406|MLS001201801|MLS001424247|DESLORATADINE [MART.]|DESLORATADINE [USP-RS]|DESLORATADINE [WHO-DD]|Desloratadine (JAN/USP/INN)|GTPL7157|orb1305363|DESLORATADINE [EMA EPAR]|SCHEMBL29371361|SCHEMBL29390260|HY-B0539R|Desloratadine - Bio-X trade mark|GLXC-03578|HMS2052H05|HMS2090C06|HMS2093F19|HMS3394H05|HMS3652O15|HMS3715J15|HMS3885C18|HMS5082N15|Pharmakon1600-01505393|DESLORATADINE [ORANGE BOOK]|ALBB-027276|ARD10141|BCP02340|Desloratadine for system suitability|HY-B0539|MSK10141|VQB71934|VWC02482|DESLORATADINE [EP MONOGRAPH]|Tox21_111574|BBL010777|BDBM50073179|DESLORATADINE [USP MONOGRAPH]|NSC759824|s4012|STK586537|AKOS000280921|Tox21_111574_1|AC-1279|CCG-101162|DB00967|KS-1048|NC00412|NSC 759824|NSC-675447|SB17503|CLARINEX-D COMPONENT DESLORATADINE|Desloratadine, powder, >=98% (HPLC)|NCGC00159325-03|NCGC00159325-04|NCGC00159325-05|BD164361|SY053082|SBI-0206828.P001|LORATADINE IMPURITY D [EP IMPURITY]|D3787|NS00008826|SW197792-3|D03693|H11943|AB00456701-11|AB00456701-13|AB00456701_14|AB00456701_15|EN300-1589139|643D718|F375848|L001025|Q418060|RUPATADINE FUMARATE IMPURITY B [EP IMPURITY]|SR-01000668962-4|SR-01000668962-5|SR-01000668962-8|BRD-K82357231-001-13-4|BRD-K82357231-001-17-5|BRD-K82357231-001-18-3|BRD-K82357231-001-19-1|Z2235801903|Desloratadine, European Pharmacopoeia (EP) Reference Standard|Desloratadine, United States Pharmacopeia (USP) Reference Standard|4-(8-chloro-5,6-dihydro-11 H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)piperidine|4-(8-chloro-5,6-dihydro-11H-benzo-[5,6]cyclohepta(1,2-b]pyridin-11-ylidene)-piperidine|4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta [1,2-b]pyridin-11-ylidene) piperidine|4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene) piperidine|8-chloro-11-(4-piperidinylidene)-6,11-dihydro-5H- benzo[4,5]cyclohepta[2,1-b]pyridine|8-chloro-11-(4-piperidyliden)-6,11-dihydro-5H-benzo[5,6]cyclohepta [1,2-b]pyridine|8-chloro-11-(4-piperidyliden)-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|8-chloro-11-(4-piperidylidene)-6,11-dihydro-5h-benzo[5.6]cyclohepta[1,2-b]pyridine|8-Chloro-5,6-dihydro-11-(piperidin-4-ylidene)-11H-benzo[5,6]cyclohepta[1,2-b]pyridine)|8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H- benzo[5,6]cyclohepta[1,2,b]pyridine|8-chloro-6,11-dihydro-11-(4-piperidylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine|Desloratadine for system suitability, European Pharmacopoeia (EP) Reference Standard|Desloratidine, Pharmaceutical Secondary Standard; Certified Reference Material|13-chloro-2-(4-piperidylidene)-4-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,12,14-hexaene|13-chloro-2-(piperidin-4-ylidene)-4-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaene|8-CHLORO-11-(4-PIPERIDYLIDENE)-6,11-DIHYDRO-5H-BENZO[5,6]CYCLOHEPTA[1,2-b]PYRIDINE|8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-?]pyridine;Aerius;Allex|8-Chloro-6,11-dihydro-11-(4-piperidinylidene)-5H-benzo[5,6]cyclohepta[1,2-b]pyridine;Aerius;Allex"
DDA-TRIPHOSPHATE,65304,,"InChI=1S/C10H16N5O11P3/c11-9-8-10(13-4-12-9)15(5-14-8)7-2-1-6(24-7)3-23-28(19,20)26-29(21,22)25-27(16,17)18/h4-7H,1-3H2,(H,19,20)(H,21,22)(H2,11,12,13)(H2,16,17,18)/t6-,7+/m0/s1",OAKPWEUQDVLTCN-NKWVEPMBSA-N,C10H16N5O11P3,475.18,"[[(2S,5R)-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate","ddATP|24027-80-3|2',3'-Dideoxyadenosine triphosphate|2',3'-Dideoxy-ATP|2',3'-DIDEOXYADENOSINE 5'-TRIPHOSPHATE|9MCI2H1EJ6|Adenosine 5'-(tetrahydrogen triphosphate), 2',3'-dideoxy-|DTXSID90178767|RefChem:439358|DTXCID50101258|(((((((2S,5R)-5-(6-amino-9H-purin-9-yl)oxolan-2-yl)methoxy)(hydroxy)phosphoryl)oxy)(hydroxy)phosphoryl)oxy)phosphonic acid|2',3'-ddATP|Dda-triphosphate|[[(2S,5R)-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate|dideoxyadenosine 5'-triphosphate|CHEMBL1383|2',3'-dideoxyadenosine-5'-triphosphate|2',3'-Dideoxyadenosine-5-triphosphate|(((2S,5R)-5-(6-Amino-9H-purin-9-yl)tetrahydrofuran-2-yl)methyl)triphosphoric acid|UNII-9MCI2H1EJ6|ddA-TP|ATP,2',3'-dideoxy|dideoxyadenosine triphosphate|orb65197|SCHEMBL79815|GTPL1709|orb1709912|orb1734211|orb2702620|orb2702621|SCHEMBL30301198|EX-A9032N|CHEBI:172701|BDBM50164644|AKOS030589611|2'',3''-dideoxyadenosine triphosphate|DB02189|DB-227048|HY-128036|CS-0095043|NS00070603|DIDEOXYADENOSINE 5'-TRIPHOSPHATE [MI]|H49714|2'',3''-Dideoxyadenosine Triphosphate (Ddatp)|Q27071868|[(2S,5R)-5-(6-aminopurin-9-yl)oxolan-2-yl]methyl (hydroxy-phosphonooxyphosphoryl) hydrogen phosphate|[[(2S,5R)-5-(6-aminopurin-9-yl)tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate|[[[5-(6-amino-9H-purin-9-yl)tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxyphosphonic acid"
TENOFOVIR DIPHOSPHATE,5481180,,"InChI=1S/C9H16N5O10P3/c1-6(2-14-4-13-7-8(10)11-3-12-9(7)14)22-5-25(15,16)23-27(20,21)24-26(17,18)19/h3-4,6H,2,5H2,1H3,(H,15,16)(H,20,21)(H2,10,11,12)(H2,17,18,19)/t6-/m1/s1",IACQCQDWSIQSRP-ZCFIWIBFSA-N,C9H16N5O10P3,447.17,[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-[hydroxy(phosphonooxy)phosphoryl]oxyphosphinic acid,"tenofovir diphosphate|166403-66-3|TL2NJ3X9HC|RefChem:187851|PMPApp|[2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY]METHYL-TRIPHOSPHATE|TENOFOVIR-DIPHOSPHATE|[(2R)-1-(6-aminopurin-9-yl)propan-2-yl]oxymethyl-[hydroxy(phosphonooxy)phosphoryl]oxyphosphinic acid|CHEMBL1236349|TNV|TenofovirDiphosphate|TFVTP|Tenofovir-DP|PMPA diphosphate|[(1R)-2-(6-aminopurin-9-yl)-1-methyl-ethoxy]methyl-[hydroxy(phosphonooxy)phosphoryl]oxy-phosphinic acid|orb533303|orb1692475|SCHEMBL14354588|SCHEMBL29395812|DTXSID70420498|BDBM50483421|AKOS027326734|DA-78314|HY-136548|CS-0130991|Tenofovir diphosphate, PMPA-diphosphate, PMPApp|TENOFOVIR METABOLITE (TENOFOVIR DIPHOSPHATE)|Q27466645|166403-66-3, 2738719-07-6 (Na+ salt), 2122333-63-3 (Et3NH+ salt)|9-[(2R)-2-({[(Phosphonooxy)(hydroxyphosphoryl)oxy](hydroxyphosphoryl)}methoxy)propyl]purine-6-ylamine|DIPHOSPHORIC ACID, ANHYDRIDE WITH (((1R)-2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)PHOSPHONIC ACID (1:1)|DIPHOSPHORIC ACID, MONOANHYDRIDE WITH ((2-(6-AMINO-9H-PURIN-9-YL)-1-METHYLETHOXY)METHYL)PHOSPHONIC ACID, (R)-"
FENOBAM ANHYDROUS,135497698,,"InChI=1S/C11H11ClN4O2/c1-16-6-9(17)14-10(16)15-11(18)13-8-4-2-3-7(12)5-8/h2-5H,6H2,1H3,(H2,13,14,15,17,18)",DWPQODZAOSWNHB-UHFFFAOYSA-N,C11H11ClN4O2,266.68,1-(3-chlorophenyl)-3-(1-methyl-4-oxoimidazolidin-2-ylidene)urea,"Fenobam|57653-26-6|fenobam anhydrous|3-(3-chlorophenyl)-1-(1-methyl-4-oxo-5H-imidazol-2-yl)urea|NPL2009|078RCY7I27|NPL-2009|1-(3-chlorophenyl)-3-(1-methyl-4-oxo-4,5-dihydro-1H-imidazol-2-yl)urea|Urea, N-(3-chlorophenyl)-N'-(4,5-dihydro-1-methyl-4-oxo-1H-imidazol-2-yl)-|RefChem:598884|637-337-3|07O6708M02|63540-28-3|MCN-3377-98|DTXSID5046770|[3H]fenobam|SMR001456387|MLS006011708|SCHEMBL111562|GTPL1433|GTPL1434|orb1308308|SCHEMBL7321308|SCHEMBL15951593|SCHEMBL30601641|DWPQODZAOSWNHB-UHFFFAOYSA-N|HMS3753M03|HB0286|LP00842|NCGC00092384-04|DB-053076|NS00068071|E85733|M03843|Q5443558|1-m-chlorophenyl-3-(1-methyl-4-oxo-2-imidazolidinylidene)urea|(3Z)-1-(3-chlorophenyl)-3-(1-methyl-4-oxoimidazolidin-2-ylidene)urea|1-(3-chlorophenyl)-3-[(2Z)-1-methyl-4-oxoimidazolidin-2-ylidene]urea"
PIBOSEROD,177336,,"InChI=1S/C22H31N3O2/c1-2-3-11-24-13-9-17(10-14-24)16-23-21(26)20-18-7-4-5-8-19(18)25-12-6-15-27-22(20)25/h4-5,7-8,17H,2-3,6,9-16H2,1H3,(H,23,26)",KVCSJPATKXABRQ-UHFFFAOYSA-N,C22H31N3O2,369.5,"N-[(1-butylpiperidin-4-yl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide","Piboserod|152811-62-6|N-[(1-butylpiperidin-4-yl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide|N-((1-butylpiperidin-4-yl)methyl)-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide|SB207256|4UQ3S81B25|DTXSID60165129|N-[(1-BUTYLPIPERIDIN-4-YL)METHYL]-2H,3H,4H-[1,3]OXAZINO[3,2-A]INDOLE-10-CARBOXAMIDE|piboserodum|N-((1-butylpiperidin-4-yl)methyl)-2H,3H,4H-(1,3)oxazino(3,2-a)indole-10-carboxamide|N-((1-butylpiperidin-4-yl)methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide|RefChem:174124|DTXCID8087620|110-127-4|SB-207266|MFCD00923681|PIBOSEROD,2H-(1,3)OXAZINO(3,2-A)INDOLE-10-CARBOXAMIDE, N-((1-BUTYL-4-PIPERIDINYL)METHYL)-3,4-DIHYDRO-|SB 207266|N-[(1-butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2-a]indole-10-carboxamide|Piboserod [INN]|Piboserod [INN:BAN]|Serotonin 5-HT4 Receptor Antagonists|UNII-4UQ3S81B25|Piboserod?|N-[(1-butyl-4-piperidyl)methyl]-3,4-dihydro-2H-[1,3]oxazino[3,2-a]indole-10-carboxamide|N-((1-BUTYL-4-PIPERIDYL)METHYL)-3,4-DIHYDRO-2H-(1,3)OXAZINO(3,2-A)INDOLE-10-CARBOXAMIDE|PIBOSEROD [MI]|PIBOSEROD [WHO-DD]|GTPL225|SCHEMBL467339|CHEMBL356359|orb1305814|SCHEMBL30234609|BDBM85026|KVCSJPATKXABRQ-UHFFFAOYSA-N|BCP15982|EX-A1189|PDSP1_001702|PDSP2_001685|AKOS015909931|DB04873|FD10684|SB 207266-A|NCGC00250378-01|AC-36094|AS-82492|BP166459|HY-15574|SB 207256|NS00068599|Q75884|SB-207266, >=98% (HPLC)|L000973|BRD-K02750403-001-01-4|BRD-K02750403-001-02-2|N-(1-Butylpiperidine-4-ylmethyl)-1,2-(trimethyleneoxy)-1H-indole-3-carboxamide|2H-(1,3)OXAZINO(3,2-A)INDOLE-10-CARBOXAMIDE, N-((1-BUTYL-4-PIPERIDINYL)METHYL)-3,4-DIHYDRO-|N-((1-Butyl-4-piperidyl)-methyl)-3,4-dihydro-2H-(1,3)oxazino(3,2-a)indole-10-carboxamide|N-[(1-Butyl-4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2-alpha]indole-10-carboxamide|N-[(1-Butyl4-piperidinyl)methyl]-3,4-dihydro-2H-[1,3]-oxazino[3,2-a]indole-10-carboxamide"
ORGANON,235905,,"InChI=1S/C21H32O/c1-3-12-21(22)14-11-19-18-9-8-15-6-4-5-7-16(15)17(18)10-13-20(19,21)2/h3,6,16-19,22H,1,4-5,7-14H2,2H3/t16-,17+,18+,19-,20-,21-/m0/s1",ATXHVCQZZJYMCF-XUDSTZEESA-N,C21H32O,300.5,"(8R,9S,10R,13S,14S,17R)-13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol","allylestrenol|432-60-0|Gestanin|Allyloestrenol|Orageston|Organon|Perselin|17alpha-Allylestr-4-en-17beta-ol|Alilestrenol|Allilestrenolo|Allylestrenolum|DTXSID9022574|I47VB5DZ8O|17-(2-Propenyl)estr-4-en-17-ol|17-Hydroxy-17-alpha-allyl-4-estrene|17-alpha-Allyl-17-beta-hydroxy-4-estrene|17-alpha-Allyl-3-deoxy-19-nortestosterone|NSC-37723|19-norpregn-4-ene-20-yn-17beta-ol|DTXCID902574|NSC37723|RefChem:554916|G03DC01|207-082-9|Gestanon|Gestanol|Turinal|Gestanyn|Estrenol, allyl-|17-allylestr-4-en-17-beta-ol|Estr-4-en-17-ol, 17-(2-propenyl)-, (17b)-|17alpha-Allyl-4-estren-17beta-ol|MFCD00198957|(8R,9S,10R,13S,14S,17R)-13-methyl-17-prop-2-enyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol|17.alpha.-Allylestr-4-en-17.beta.-ol|CHEBI:31189|Allyloestrenolum|17-alpha-Allylestr-4-en-17-beta-ol|17alpha-Allylestrenol|Allilestrenolo [DCIT]|Gestanon-r|Alilestrenol [INN-Spanish]|Allylestrenolum [INN-Latin]|Perselin (TN)|17.alpha.-Allylestrenol|17alpha-Allyl-4-destrene-17beta-ol|17alpha-Allyl-4-oestrene-17beta-ol|Allylestrenol (JAN/INN)|17-alpha-Allyl-4-oestrene-17-beta-ol|17alpha-Allyl-17beta-hydroxy-4-estrene|17alpha-Allyl-3-deoxy-19-nortestosterone|Allyl estrenol|CCRIS 9068|17-alpha-Allylhydroxy-19-nor-4-androstene|3-Deoxy-17-alpha-allyl-19-nortestosterone|NCGC00159497-02|21-Methylene-19-nor-17-alpha-preg-4-en-17-ol|EINECS 207-082-9|Estr-4-en-17beta-ol, 17-allyl-|17-alpha-Allyl-17-beta-hydroxy-delta(sup 4)-estren|17alpha-Allyl-19-nor-delta-4-androstene-17beta-ol|NSC 37723|Estr-4-en-17-ol, 17-(2-propenyl)-, (17beta)-|BRN 3148038|17.alpha.-Allyl-4-estren-17.beta.-ol|17.alpha.-Allyl-4-destrene-17.beta.-ol|17.alpha.-Allyl-4-oestrene-17.beta.-ol|ESTR-4-EN-17-beta-OL, 17-ALLYL-|17.alpha.-Allyl-3-deoxy-19-nortestosterone|17.alpha.-Allyl-17.beta.-hydroxy-4-estrene|ALLYLESTRENOL [MI]|UNII-I47VB5DZ8O|ALLYLESTRENOL [INN]|ALLYLESTRENOL [JAN]|(17beta)-17-prop-2-en-1-ylestr-4-en-17-ol|ALLYLESTRENOL [MART.]|SCHEMBL329623|19-Nor-17-alpha-preg-4-en-17-ol, 21-methylene-|ALLYLESTRENOL [WHO-DD]|Allylestrenol [INN:BAN:JAN]|orb1305318|CHEMBL3185133|SCHEMBL17891654|17.alpha.-Allyl-17-.beta.-hydroxy-.delta.(sup 4)-estren|BCP10809|Tox21_111718|LMST02030125|s5219|AKOS015964938|DB01431|DS-8255|Estr-4-en-17-ol, (17.beta.)-|FA55289|Estr-4-en-17.beta.-ol, 17-allyl-|CAS-432-60-0|HY-17375|SY108284|3-deketo-17alpha-allyl-19-nortestosterone|A2570|CS-0006769|NS00031328|WLN: L E5 B666 MUTJ E1 FQ F2U1|D01374|4-06-00-04143 (Beilstein Handbook Reference)|432A600|Q531965|SR-01000883956|SR-01000883956-1|BRD-K12872829-001-01-0|(8R,9S,10R,13S,14S,17R)-17-allyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol|13-Methyl-17-prop-2-enyl-2,3,6,7,8,9,1,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol"
SILODOSIN,5312125,,"InChI=1S/C25H32F3N3O4/c1-17(30-8-12-34-21-5-2-3-6-22(21)35-16-25(26,27)28)13-18-14-19-7-10-31(9-4-11-32)23(19)20(15-18)24(29)33/h2-3,5-6,14-15,17,30,32H,4,7-13,16H2,1H3,(H2,29,33)/t17-/m1/s1",PNCPYILNMDWPEY-QGZVFWFLSA-N,C25H32F3N3O4,495.5,"1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide","Silodosin|160970-54-7|Rapaflo|Urief|Silodyx|Urorec|KMD-3213|Rapilif|Silodal|KAD-3213|silodosine|Silodosina|KSO-0400|CUZ39LUY82|1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]-2,3-dihydroindole-7-carboxamide|DTXSID40167045|1-(3-hydroxypropyl)-5-[(2r)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl}amino)propyl]-2,3-dihydro-1h-indole-7-carboxamide|1-(3-hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxamide|silodosinum|1-(3-Hydroxypropyl)-5-((2R)-2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)-2,3-dihydro-1H-indole-7-carboxamide|1-(3-hydroxypropyl)-5-((2R)-2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)-2,3-dihydroindole-7-carboxamide|1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-dihydro-1H-indole-7-carboxamide|RefChem:56683|DTXCID3089536|G04CA04|KMD 3213|MFCD00930170|1H-Indole-7-carboxamide, 2,3-dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-|CHEMBL24778|C25H32F3N3O4|(-)-1-(3-Hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-2,3-di-hydro-1H-indole-7-carboxamide|2,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carboxamide|(R)-1-(3-hydroxypropyl)-5-(2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)indoline-7-carboxamide|Rapflo|Silodosin [INN]|(-)-1-(3-Hydroxypropyl)-5-((2R)-2-((2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethyl)amino)propyl)-2,3-dihydro-1H-indole-7-carboxamide|Silodosin [INN:BAN]|KAD 3213|UNII-CUZ39LUY82|Urief, Rapaflo|2,3-DIHYDRO-1-(3-HYDROXYPROPYL)-5-((2R)-2-((2-(2-(2,2,2-TRIFLUOROETHOXY)PHENOXY)ETHYL)AMINO)PROPYL)-1H-INDOLE-7-CARBOXAMIDE|Rapaflo (TN)|Silodosin (Rapaflo)|Silodosin (Standard)|Urief (TN)|Silodosin Impurity 13|A1EMV|SILODOSIN [JAN]|SILODOSIN [MI]|SILODOSIN [VANDF]|Silodosin (JP18/INN)|SILODOSIN [MART.]|SILODOSIN [WHO-DD]|GTPL493|SILODOSIN [EMA EPAR]|MLS006010022|SCHEMBL136973|orb1308412|SILODOSIN [ORANGE BOOK]|SCHEMBL29967021|Silodosin, >=98% (HPLC)|KMD3213|CHEBI:135929|GLXC-03240|HMS3715B06|HMS3884O21|BCP02143|BDBM50160154|HY-10122R|s1613|AKOS005145899|KAD 3213;KMD 3213|BS-1011|CCG-221202|CS-0284|DB06207|FS27830|NCGC00345882-03|1-(3-hydroxypropyl)-5-[(2R)-2-[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethylamino]propyl]indoline-7-carboxamide|AC-22605|HY-10122|SMR004701206|I1128|SW219765-1|D01965|SBI-0654161.0001|EN300-6481367|970S649|Q411770|SR-01000944157|SR-01000944157-1|BRD-K10906636-001-01-1|BRD-K10906636-001-02-9|Z2235802137|(r)-1-(3-hydroxypropyl)-5-(2-(2-(2-(2,2,2-trifluoroethoxy)phenoxy)ethylamino)propyl)indoline-7-carboxamide|(R)-5-[2-[[2-[2-(2,2,2-trifluoro-ethoxy)phenoxy]ethyl]amino]propyl]-1-(3-hydroxypropyl)-2,3-dihydro-1H-indole-7-carboxamide|1-(3-Hydroxy-propyl)-5-((R)-2-{2-[2-(2,2,2-trifluoro-ethoxy)-phenoxy]-ethylamino}-propyl)-2,3-dihydro-1H-indole-7-carboxylic acid amide|1-(3-hydroxypropyl)-5-[(2R)-2-({2-[2-(2,2,2-trifluoroethoxy)phenoxy]-ethyl}amino)propyl]-2,3-dihydro-1H-indole-7-carboxamide|2,3-Dihydro-1-(3-hydroxypropyl)-5-[(2R)-2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]-1H-indole-7-carboxamide;(R)-1-(3 -Hydroxypropyl)-5-[2-[[2-[2-(2,2,2-trifluoroethoxy)phenoxy]ethyl]amino]propyl]indoline-7-carboxamide;1-(3-Hydroxypropy"
DEPTROPINE,203911,,"InChI=1S/C23H27NO/c1-24-18-12-13-19(24)15-20(14-18)25-23-21-8-4-2-6-16(21)10-11-17-7-3-5-9-22(17)23/h2-9,18-20,23H,10-15H2,1H3/t18-,19+,20?",ZWPODSUQWXAZNC-YOFSQIOKSA-N,C23H27NO,333.5,"(1R,5S)-8-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyloxy)-8-azabicyclo[3.2.1]octane","Deptropine|Dibenzheptropine|604-51-3|Deptropina|Deptropinum|AY31301GKG|CHEBI:50189|3-(10,11-Dihydro-5H-dibenzo(a,d)cyclohepten-5-yloxy)tropane|(1R,5S)-8-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,11,13-hexaenyloxy)-8-azabicyclo[3.2.1]octane|endo-3-[(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)oxy]-1alphaH,5alphaH-tropane|(3-endo)-3-(10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane|8-Azabicyclo(3.2.1)octane, 3-((10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yl)oxy)-8-methyl-, (3-endo)-|endo-3-[(10,11-Dihydro-5H-dibenzo[a,d]cyclohepten-5-yl)oxy]-8-methyl-8-azabicyclo[3.2.1]octane|DEPTROPINE [INN]|Deptropine [INN:BAN]|8-Azabicyclo(3.2.1)octane, 3-((10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yl)oxy)-8-methyl-, endo-|Deptropinum [INN-Latin]|Deptropina [INN-Spanish]|UNII-AY31301GKG|ENDO-3-((10,11-DIHYDRO-5H-DIBENZO(A,D)CYCLOHEPTEN-5-YL)OXY)-8-METHYL-8-AZABICYCLO(3.2.1)OCTANE|EINECS 210-069-0|DEPTROPINE [MI]|DEPTROPINE [WHO-DD]|SCHEMBL28710|CHEMBL1622878|CHEMBL1946186|DTXSID5048556|SCHEMBL30489355|BDBM79210|CHEBI:94419|cid_6604492|ZWPODSUQWXAZNC-YOFSQIOKSA-N|BDBM50419751|Tropane, 3alpha-((10,11-dihydro-5H-dibenzo(a,d)cyclohepen-5-yl)oxy)-|DB13466|1alphaH,5alphaH-Tropane, 3alpha-((10,11-dihydro-5H-dibenzo(a,d)cyclohepten-5-yl)oxy)-|NS00034356|Q5260984|BRD-A65797496-048-09-3|Q27166277|3.ALPHA.-((10,11-DIHYDRO-5H-DIBENZO(A,D)CYCLOHEPTEN-5-YL)OXY)TROPANE|TROPANE, 3.ALPHA.-((10,11-DIHYDRO-5H-DIBENZO(A,D)CYCLOHEPTEN-5-YL)OXY)-|(1S,5R)-3-(6,11-dihydro-5H-dibenzo[1,2-a:1'',2''-e][7]annulen-11-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane;2-hydroxypropane-1,2,3-tricarboxylic acid|(1S,5R)-3-(6,11-dihydro-5H-dibenzo[1,2-a:1'',2''-e][7]annulen-11-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane;2-oxidanylpropane-1,2,3-tricarboxylic acid|(1S,5R)-3-(6,11-dihydro-5H-dibenzo[1,2-a:1',2'-e][7]annulen-11-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane|1.ALPHA.H,5.ALPHA.H-TROPANE, 3.ALPHA.-((10,11-DIHYDRO-5H-DIBENZO(A,D)CYCLOHEPTEN-5-YL)OXY)-|3.ALPHA.-((10,11-DIHYDRO-5H-DIBENZO(A,D)CYCLOHEPTEN-5-YL)OXY)-1.ALPHA.H,5.ALPHA.H-TROPANE|citric acid;(1S,5R)-3-(6,11-dihydro-5H-dibenzo[1,2-a:1'',2''-e]cyclohepten-11-yloxy)-8-methyl-8-azabicyclo[3.2.1]octane"
TILORONE,5475,,"InChI=1S/C25H34N2O3/c1-5-26(6-2)13-15-29-19-9-11-21-22-12-10-20(30-16-14-27(7-3)8-4)18-24(22)25(28)23(21)17-19/h9-12,17-18H,5-8,13-16H2,1-4H3",MPMFCABZENCRHV-UHFFFAOYSA-N,C25H34N2O3,410.5,"2,7-bis[2-(diethylamino)ethoxy]fluoren-9-one","tilorone|27591-97-5|Tilorona|Bis-DEAE-fluorenone|Tiloronum|9H-Fluoren-9-one, 2,7-bis[2-(diethylamino)ethoxy]-|O6W7VEW6KS|2,7-Bis(2-(diethylamino)ethoxy)-9H-fluoren-9-one|DTXSID1045958|DTXCID9025958|9H-FLUOREN-9-ONE, 2,7-BIS(2-(DIETHYLAMINO)ETHOXY)-|CHEBI:147347|2,7-bis[2-(diethylamino)ethoxy]-9H-fluoren-9-one|Bis DEAE Fluorenone|RefChem:933073|J05AX19|2,7-Bis-(2-diethylamino-ethoxy)-fluoren-9-one|Tilorone [INN]|2,7-Bis-DEAE-fluorenone|2,7-bis[2-(diethylamino)ethoxy]fluoren-9-one|Amixin IC|DEAE-F|RMI 10008DA|NCGC00095196-01|Tiloronum [INN-Latin]|Tilorona [INN-Spanish]|CAS-27591-97-5|NSC143969|UNII-O6W7VEW6KS|BRN 2011558|2,7-Bis(2-diethylaminoethoxy)fluoren-9-one dihydrochloride|MFCD00866953|Spectrum_000231|TILORONE [MI]|Spectrum2_001742|Spectrum3_001055|Spectrum5_001889|ChemDiv1_019101|2,7-bis(2-diethylaminoethyloxy)fluoren-9-one|TILORONE [WHO-DD]|2,7-Bis[2-(diethylamino)ethoxy]-9-fluorenone|Tiloron (*dihydrochloride*)|Oprea1_331997|BSPBio_002610|KBioSS_000711|Tilorone hydrochloride(USAN)|CHEMBL47298|DivK1c_000018|SCHEMBL352401|SPECTRUM2300009|SPBio_001844|SCHEMBL29500271|SCHEMBL30520073|HMS500A20|HMS641E05|HY-B1080A|KBio1_000018|KBio2_000711|KBio2_003279|KBio2_005847|KBio3_001830|CHEBI:109553|NINDS_000018|HMS1922J22|HMS2094I17|Pharmakon1600-02300009|BCP34398|Tox21_111484|BDBM50364890|CCG-39449|NSC759311|RMI 10008DA (*dihydrochloride*)|STL483841|AKOS025310183|Tox21_111484_1|NSC-759311|IDI1_000018|Bis-DEAE-fluorenone (*dihydrochloride*)|NCGC00095196-02|NCGC00095196-03|NCGC00095196-04|NCGC00095196-06|NCGC00178576-01|AC-24571|AS-14877|SBI-0052826.P002|CS-0013836|G78315|AB00053319_02|591T975|SR-05000001961|Q2028068|SR-05000001961-1|BRD-K34568562-001-03-5|BRD-K34568562-001-04-3|BRD-K34568562-300-01-5|2, {7-Bis[2-(diethylamino)ethoxy]fluoren-9-one} dihydrochloride|2,7-Bis[2-(diethylamino)ethoxy]-9-fluorenone; Bis-DEAE-fluorenone|9H-Fluoren-9-one, {2,7-bis[2-(diethylamino)ethoxy]-,} dihydrochloride|Fluoren-9-one, 2, {7-bis[2-(diethylamino)ethoxy]-,} dihydrochloride"
BRADANICLINE,25147644,,"InChI=1S/C22H23N3O2/c26-22(20-13-17-5-1-2-6-19(17)27-20)24-21-16-7-10-25(11-8-16)18(21)12-15-4-3-9-23-14-15/h1-6,9,13-14,16,18,21H,7-8,10-12H2,(H,24,26)/t18-,21+/m0/s1",OXKRFEWMSWPKKV-GHTZIAJQSA-N,C22H23N3O2,361.4,"N-[(2S,3R)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide","Bradanicline|639489-84-2|TC-5619|Bradaniclina|TC 5619|ATA-101|Bradanicline [USAN:INN]|N-[(2S,3R)-2-(pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide|BRADANICLINE [INN]|BRADANICLINE [USAN]|UM3821998K|BRADANICLINE [WHO-DD]|ATA101|DTXSID40213778|2-Benzofurancarboxamide, N-((2S,3R)-2-(3-pyridinylmethyl)-1-azabicyclo(2.2.2)oct-3-yl)-|2-Benzofurancarboxamide, N-[(2S,3R)-2-(3-pyridinylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]-|compound 7a [PMID 23126648]|compound 7a (PMID 23126648)|bradaniclinum|N-((2S,3R)-2-((pyridin-3-yl)methyl)-1-azabicyclo(2.2.2)octan-3-yl)-1-benzofuran-2-carboxamide|N-((2S,3R)-2-(PYRIDIN-3-YLMETHYL)-1-AZABICYCLO(2.2.2)OCT-3-YL)-1-BENZOFURAN-2-CARBOXAMIDE|N-((2S,3R)-2-(pyridin-3-ylmethyl)-1-azabicyclo(2.2.2)octan-3-yl)-1-benzofuran-2-carboxamide|N-[(2S,3R)-2-(Pyridin-3-ylmethyl)-1-azabicyclo[2.2.2]oct-3-yl]-1-benzofuran-2-carboxamide|N-[(2S,3R)-2-[(pyridin-3-yl)methyl]-1-azabicyclo[2.2.2]octan-3-yl]-1-benzofuran-2-carboxamide|RefChem:570182|DTXCID70136269|CHEMBL1258006|Bradanicline (TC-5619)|UNII-UM3821998K|Bradanicline free base|Bradanicline (USAN/INN)|Bradanicline (TC-5619)?|SCHEMBL372929|GTPL3969|orb1688689|OXKRFEWMSWPKKV-GHTZIAJQSA-N|EX-A7201|BDBM50393247|TC5619|DB06090|DA-61857|HY-18060|MS-25725|CS-0007204|NS00072871|TC-5619-238|D10613|(2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]oct-3-yl)benzofuran-2-carboxamide|n-(2-(pyridin-3-ylmethyl)-1-azabicyclo(2.2.2)oct-3-yl)-1-benzofuran-2-carboxamide|(2S,3R)-N-(2-((3-pyridinyl)methyl)-1-azabicyclo[2.2.2]octan-3-yl)benzofuran-2-carboxamide"
AZD1446,120656155,,"InChI=1S/C11H13ClN2O2.ClH/c12-10-2-1-9(16-10)11(15)14-5-7-3-13-4-8(7)6-14;/h1-2,7-8,13H,3-6H2;1H/t7-,8+;",SQQDKOJWFGSPEW-KVZVIFLMSA-N,C11H14Cl2N2O2,277.14,"[(3aR,6aS)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]-(5-chlorofuran-2-yl)methanone;hydrochloride","ANR9OP1V17|AZD1446 HCl|TC6683 HCl|TC6683|AZD-1446|1788894-06-3|(5-Chloro-furan-2-yl)-(hexahydro-pyrrolo(3,4-C)pyrrol-2-yl)-methanone hydrochloride|Methanone, (5-chloro-2-furanyl)((3aR,6aS)-hexahydropyrrolo(3,4-C)pyrrol-2(1H)-yl)-, hydrochloride (1:1)|AZD1446|RefChem:115988|AZD 1446 [WHO-DD]|UNII-ANR9OP1V17|AKOS026461937|AZD-1446 HCl, AZD1446 HCl, TC6683 HCl|[(3aR,6aS)-2,3,3a,4,6,6a-hexahydro-1H-pyrrolo[3,4-c]pyrrol-5-yl]-(5-chlorofuran-2-yl)methanone;hydrochloride"
ANABASEINE,18985,,"InChI=1S/C10H12N2/c1-2-7-12-10(5-1)9-4-3-6-11-8-9/h3-4,6,8H,1-2,5,7H2",AUBPMADJYNSPOA-UHFFFAOYSA-N,C10H12N2,160.22,"3-(2,3,4,5-tetrahydropyridin-6-yl)pyridine","Anabaseine|3471-05-4|3,4,5,6-Tetrahydro-2,3'-bipyridine|3-(2,3,4,5-tetrahydropyridin-6-yl)pyridine|2,3'-BIPYRIDINE, 3,4,5,6-TETRAHYDRO-|DYE103K23I|DTXSID50188266|RefChem:112471|DTXCID80110757|3-(3,4,5,6-tetrahydropyridin-2-yl)pyridine|CHEBI:80787|BRN 0125981|UNII-DYE103K23I|SCHEMBL261062|orb1984497|CHEMBL1230982|SCHEMBL30394330|US8609708, 74 Anabaseine|BDBM109773|AKOS000277414|HY-115766|CS-0255607|NS00010542|C16906|EN300-269722|5-23-06-00507 (Beilstein Handbook Reference)|Q19903288|AN4"
ENCENICLINE,46196517,,"InChI=1S/C16H17ClN2OS/c17-12-3-1-2-11-8-14(21-15(11)12)16(20)18-13-9-19-6-4-10(13)5-7-19/h1-3,8,10,13H,4-7,9H2,(H,18,20)/t13-/m0/s1",SSRDSYXGYPJKRR-ZDUSSCGKSA-N,C16H17ClN2OS,320.8,N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-7-chloro-1-benzothiophene-2-carboxamide,"Encenicline|550999-75-2|EVP 6124|EVP6124|Enceniclina|N-[(3R)-1-azabicyclo[2.2.2]octan-3-yl]-7-chloro-1-benzothiophene-2-carboxamide|5FI5376A0X|MT4666|MT-4666|Benzo(b)thiophene-2-carboxamide, N-(3R)-1-azabicyclo(2.2.2)oct-3-yl-7-chloro-|DTXSID701025836|(r)-7-chloro-n-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide|enceniclinum|(R)-7-CHLORO-N-(QUINUCLIDIN-3-YL)BENZO(B)THIOPHENE-2-CARBOXAMIDE|N-((3R)-1-azabicyclo(2.2.2)octan-3-yl)-7-chloro-1-benzothiophene-2-carboxamide|RefChem:590788|DTXCID801510088|EVP-6124|UNII-5FI5376A0X|Encenicline [USAN:INN]|FRM-6124|MFCD23381267|CHEMBL2151572|7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide|I33|ENCENICLINE [INN]|Encenicline (USAN/INN)|ENCENICLINE [USAN]|Encenicline (Evp-6124)|ENCENICLINE [WHO-DD]|SCHEMBL744767|GTPL6926|CHEMBL5316020|SSRDSYXGYPJKRR-ZDUSSCGKSA-N|EX-A3984|BDBM50393255|AKOS027322165|CS-0933|DB11726|NCGC00378871-01|DA-73269|HY-15430|NS00073068|D10626|BRD-K71603915-003-01-8|Q19904062|(R)-7-Chloro-N-(quinuclidine-3-yl)benzo[b]thiophene-2-carboxamide|7-chloro-N-[(3R)-quinuclidin-3-yl]benzothiophene-2-carboxamide|N-(3R)-1-azabicyclo[2.2.2]oct-3-yl-7-chlorobenzo[b]thiophene-2-carboxamide|n-[(3r)-1-azabicyclo[2.2.2]oct-3-yl]-7-chloro-1-benzothiophene-2-carboxamide|1275596-71-8"
NGD-8243,11247522,,"InChI=1S/C21H12F6N4/c22-20(23,24)13-4-6-14(7-5-13)31-19-15-8-3-12(10-17(15)29-11-30-19)18-16(21(25,26)27)2-1-9-28-18/h1-11H,(H,29,30,31)",VTANGSDRFFLTSQ-UHFFFAOYSA-N,C21H12F6N4,434.3,N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)pyridin-2-yl]quinazolin-4-amine,"NGD-8243|573678-04-3|K3S4K8ACHE|UNII-K3S4K8ACHE|MK-2295-005|(4-(Trifluoromethyl)phenyl)-(7-(3-(trifluoromethyl)pyridin-2-yl)quinazolin-4-yl)amine|4-((4-(Trifluoromethyl)phenyl)amino)-7-(3-(trifluoromethyl)pyridin-2-yl)quinazoline|4-Quinazolinamine, N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)-2-pyridinyl)-|RefChem:165627|N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)-2-pyridinyl]-4-quinazolinamine|N-[4-(trifluoromethyl)phenyl]-7-[3-(trifluoromethyl)pyridin-2-yl]quinazolin-4-amine|CHEMBL214796|N-(4-(trifluoromethyl)phenyl)-7-(3-(trifluoromethyl)pyridin-2-yl)quinazolin-4-amine|orb1297860|SCHEMBL2730820|SCHEMBL29706343|VTANGSDRFFLTSQ-UHFFFAOYSA-N|GLXC-20294|BDBM50191726|AKOS015993894|BC-0200|DB-144092|BRD-K43316319-001-01-8|Q27281913|(4-Trifluoromethylphenyl)-[7-(3-trifluoromethylpyridin-2-yl)-quinazolin-4-yl]amine"
MAVOGLURANT,9926832,,"InChI=1S/C19H23NO3/c1-14-5-3-6-15(13-14)8-11-19(22)10-4-7-17-16(19)9-12-20(17)18(21)23-2/h3,5-6,13,16-17,22H,4,7,9-10,12H2,1-2H3/t16-,17-,19-/m1/s1",ZFPZEYHRWGMJCV-ZHALLVOQSA-N,C19H23NO3,313.4,"methyl (3aR,4S,7aR)-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-3,3a,5,6,7,7a-hexahydro-2H-indole-1-carboxylate","Mavoglurant|543906-09-8|AFQ056|AFQ-056|GT0I9SV4F6|DTXSID30202777|1H-Indole-1-carboxylic acid, octahydro-4-hydroxy-4-(2-(3-methylphenyl)ethynyl)-, methyl ester, (3aR,4S,7aR)-|methyl (3aR,4S,7aR)-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-3,3a,5,6,7,7a-hexahydro-2H-indole-1-carboxylate|mavoglurantum|methyl (3aR,4S,7aR)-4-hydroxy-4-(2-(3-methylphenyl)ethynyl)-3,3a,5,6,7,7a-hexahydro-2H-indole-1-carboxylate|RefChem:155994|DTXCID60125268|methyl (3aR,4S,7aR)-4-hydroxy-4-(2-(3-methylphenyl)ethynyl)-octahydro-1H-indole-1-carboxylate|Mavoglurant racemate|(3ar,4s,7ar)-octahydro-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]-1h-indole-1-carboxylic acid methyl ester|1636881-61-2|(3aR,4S,7aR)-Methyl 4-hydroxy-4-(m-tolylethynyl)octahydro-1H-indole-1-carboxylate|methyl (3aR,4S,7aR)-4-hydroxy-4-(m-tolylethynyl)octahydro-1H-indole-1-carboxylate|(-)-(3aR,4S,7aR)-4-hydroxy-4-m-tolylethynyl-octahydro-indole-1-carboxylic acid methyl ester|Mavoglurant [INN]|Mavoglurant [USAN:INN]|UNII-GT0I9SV4F6|AFQ 056|MFCD18633263|4oo9|Mavoglurant, AFQ056|MAVOGLURANT [USAN]|Mavoglurant (AFQ 056)?|MAVOGLURANT [WHO-DD]|orb198441|SCHEMBL989279|GTPL7586|orb1709192|CHEMBL3087515|SCHEMBL29744485|ZFPZEYHRWGMJCV-ZHALLVOQSA-N|GLXC-15608|BCP20624|EX-A1564|BDBM50443085|AKOS027326541|CS-5245|DB13004|AS-79009|HY-15257|DB-102250|NS00069300|F85319|F85489|Q6589598|BRD-K07790550-001-01-6|Methyl (3ar,4s,7ar)-4-Hydroxy-4-[(3-Methylphenyl)ethynyl]octahydro-1h-Indole-1-Carboxylate|(3aR,4S,7aR)-Octahydro-4-hydroxy-4-[(3-methylphenyl)ethynyl]-1H-indole-1-carboxylic Acid Methyl Ester; AFQ 056|1H-INDOLE-1-CARBOXYLIC ACID, OCTAHYDRO-4-HYDROXY-4-((3-METHYLPHENYL)ETHYNYL)-, METHYL ESTER, (3AR,4S,7AR)-|2U8|Methyl (3aR,4S,7aR)-4-hydroxy-4-[2-(3-methylphenyl)ethynyl]octahydro-1H-indole-1-carboxylate|methyl (3aR,4S,7aR)-4-hydroxy-4-[2-(m-tolyl)ethynyl]-3,3a,5,6,7,7a-hexahydro-2H-indole-1-carboxylate"
MEVASTATIN,64715,,"InChI=1S/C23H34O5/c1-4-14(2)23(26)28-20-7-5-6-16-9-8-15(3)19(22(16)20)11-10-18-12-17(24)13-21(25)27-18/h6,8-9,14-15,17-20,22,24H,4-5,7,10-13H2,1-3H3/t14-,15-,17+,18+,19-,20-,22-/m0/s1",AJLFOPYRIVGYMJ-INTXDZFKSA-N,C23H34O5,390.5,"[(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate","Mevastatin|compactin|73573-88-3|Mevastatina|Mevastatine|Mevastatinum|Antibiotic ML 236B|ML-236B|ML 236 B|CS 500|1UQM1K0W9X|ML236B lactone|ML-236B lactone|DTXSID4040684|CHEBI:34848|CS-500|NSC-759322|[(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate|DTXCID2020684|CS500|L-637312|NSC-281245|7-(1,2,6,7,8,8a-Hexahydro-2-methyl-8-(2-methylbutyryloxy)naphthyl)-3-hydroxyheptan-5-olide|L637312|(1S,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl(2S)-2-methylbutanoate|ML236B|6-demethylmevinolin|((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxooxan-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) (2S)-2-methylbutanoate|RefChem:53384|EC 700-442-0|658-033-7|700-442-0|NSC281245|Mevastatin [INN]|Mevastatinum [INN-Latin]|Compactin;ML236B|MFCD05662341|Butanoic acid, 2-methyl-, (1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-|CHEMBL54440|(1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate|M02108|(1S,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-7-methyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthyl (S)-2-methylbutyrate|Mevastatin (Compactin)|Compactin (penicillium)|Mevastatine [INN-French]|Mevastatina [INN-Spanish]|SMR000336944|CCRIS 4505|Lovastatin EP Impurity A|UNII-1UQM1K0W9X|kompaktin|NCGC00095942-01|(+)-Compactin|Mevastatin (Standard)|MEVASTATIN [MI]|MEVASTATIN [JAN]|MEVASTATIN [MART.]|SCHEMBL1116|MEVASTATIN [USP-RS]|Lopac0_000754|MLS000721804|MLS000759452|MLS001424284|MLS002207227|Compactin, 6-Demethylvevinolin, CS-500, ML-236 B|GTPL3031|Mevastatin - Bio-X trade mark|orb1310389|Mevastatin, >=96% (HPLC)|HMS2052P07|HMS2089D10|HMS2232N09|HMS3262G10|HMS3268A19|HMS3412H15|HMS3676H15|HMS3713B06|[(1S,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate|MSK10322|Compactin, Mevastatinum, Mevastatina|Tox21_111540|Tox21_500754|BDBM50011036|HY-17408R|NSC779705|s4223|AKOS015994712|Mevastatin, >=95% (HPLC), powder|CCG-101174|CS-1234|DB06693|FM25991|KS-1085|LP00754|NC00424|NSC 759322|NSC-779705|SDCCGSBI-0050732.P002|SMP1_000077|NCGC00025202-04|NCGC00261439-01|BM164666|Butanoic acid, 2-methyl-, (1S,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-7-methyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-|Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-7-methyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1-alpha(R*),7-beta,8-beta(2S*,4S*),8a-beta))-|HY-17408|Mevastatin 100 microg/mL in Acetonitrile|SY077144|CAS-73573-88-3|LOVASTATIN IMPURITY A [EP IMPURITY]|B1788|EU-0100754|M2275|H11997|M 2537|AB00588266-06|AB00588266-08|AB00588266_09|573M883|A837861|Compactin;6-Demethylvevinolin;CS-500;ML-236 B|Q414407|SR-01000729493|SR-01000729493-4|BRD-K94441233-001-03-1|BRD-K94441233-001-12-2|BRD-K94441233-001-13-0|BRD-K94441233-001-17-1|(1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate|(1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate|(S)-((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate|(S)-((1S,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-7-methyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate|(S)-2-Methyl-butyric acid (1S,7S,8S,8aR)-8-[2-((2R,4R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester|2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester|2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester((+)-compactin)|2-Methyl-butyric acid 8-[2-(4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-7-methyl-1,2,3,7,8,8a-hexahydro-naphthalen-1-yl ester(compactin)"
SIMVASTATIN,54454,,"InChI=1S/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1",RYMZZMVNJRMUDD-HGQWONQESA-N,C25H38O5,418.6,"[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate","simvastatin|79902-63-9|Zocor|Synvinolin|Sinvacor|Denan|Lipex|MK-733|Simvastatine|Sivastin|Lodales|Cholestat|Simvastatina|Colemin|Medipo|Simovil|Labistatin|Simvastatinum|Velostatin|Nivelipol|Rechol|(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate|MK-0733|Simvastatinum [Latin]|DTXSID0023581|AGG2FN16EV|MK733|2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|MK 733|NSC-758706|CHEBI:9150|C10AA01|(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate|DTXCID103581|Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester|NSC633782|[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate|Butanoic acid, 2,2-dimethyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester|Simvastatinum (Latin)|Butanoic acid, 2,2-dimethyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha,3alpha,7beta,8beta(2S*,4S*),8abeta))-|Lacersa|Ranzolont|Simvador|Zocor heart-pro|((1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2,2-dimethylbutanoate|2,2-Dimethylbutyric acid, 8-ester with (4R,6R)-6-[2-[(1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one|FLOLIPID|RefChem:6225|(1S-(1alpha,3alpha,7beta,8beta(2S*,4S*),8abeta))-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl 2,2-dimethylbutanoate|616-751-8|Pantok|Zocord|Zorced|Simvastatin lactone|Simvastatin (Zocor)|Lipovas|Simcard|Simvacor|Simvoget|Simlup|MFCD00072007|Statin|Coledis|Corolin|Rendapid|Vasotenal|C25H38O5|Simvastatine [French]|Simvastatina [Spanish]|[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] 2,2-dimethylbutanoate|Zosta|Simvast CR|(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate|DRG-0320|SMR000718785|MK 0733|CCRIS 7558|Zocor (TN)|HSDB 7208|Simvastatin & Primycin|SR-05000001894|UNII-AGG2FN16EV|L 644128-000U|BRN 4768037|Kolestevan|Lipinorm|Modutrol|Simvotin|Sinvascor|Valemia|Eucor|Nor-Vastina|simvastatin predrug|(+)-Simvastatin|NCGC00016940-01|inactive simvastatin|8-[2-((2R,4R)-4-hydroxy-6-oxo(2H-3,4,5-trihydropyran-2-yl))ethyl](1S,7S,8S,3R, 8aR)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthyl 2,2-dimethylbutanoate|Simvastatin [USAN:USP:INN:BAN]|TNP00259|Prestwick_171|CAS-79902-63-9|KS-1113|Simvastatin (Zocor)?|Simvastatin (Standard)|Spectrum_001717|SpecPlus_000895|SIMVASTATIN [MI]|Prestwick0_000865|Prestwick1_000865|Prestwick2_000865|Prestwick3_000865|Spectrum2_001671|Spectrum3_000669|Spectrum4_000632|Spectrum5_001428|SIMVASTATIN [INN]|SIMVASTATIN [JAN]|SIMVASTATIN [HSDB]|SIMVASTATIN [USAN]|SIMVASTATIN [VANDF]|SCHEMBL2471|CHEMBL1064|SIMVASTATIN [MART.]|BSPBio_000909|BSPBio_002337|KBioGR_001244|KBioSS_002197|SIMVASTATIN [USP-RS]|SIMVASTATIN [WHO-DD]|MLS001304029|MLS001333077|MLS001333078|MLS002154038|MLS006011866|BIDD:GT0769|DivK1c_006991|SPECTRUM1504236|SPBio_001881|SPBio_002830|BPBio1_001001|GTPL2955|orb1310385|Simvastatin (JP18/USP/INN)|Simvastatin, analytical standard|Simvastatin - Bio-X trade mark|BCBcMAP01_000007|KBio1_001935|KBio2_002197|KBio2_004765|KBio2_007333|KBio3_001557|RYMZZMVNJRMUDD-HGQWONQESA-|SIMVASTATIN [ORANGE BOOK]|GLXC-06021|HMS1570N11|HMS1922H13|HMS2089D12|HMS2093E06|HMS2097N11|HMS2231N22|HMS3259B12|HMS3412P08|HMS3676P08|HMS3714N11|HMS3884G10|Pharmakon1600-01504236|SIMVASTATIN [EP MONOGRAPH]|SIMCOR COMPONENT SIMVASTATIN|SIMVASTATIN [USP MONOGRAPH]|BUTANOIC ACID, 2,2-DIMETHYL-, 1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-(TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER, (1S-(1.ALPHA.,3.ALPHA.,7.BETA.,8.BETA.(2S*,4S*),8A.BETA.))-|MSK10236|VYTORIN COMPONENT SIMVASTATIN|Tox21_110696|Tox21_300400|BBL024390|BDBM50139181|CCG-39069|HY-17502R|NSC758706|s1792|SBB080618|STK801938|AKOS005111006|AKOS015842733|Simvastatin, >=97% (HPLC), solid|Tox21_110696_1|AC-1530|DB00641|FS27832|NC00719|NSC 758706|NSC-633782|MRF-0000729|NCGC00017324-01|NCGC00017324-02|NCGC00017324-03|NCGC00017324-04|NCGC00017324-05|NCGC00017324-07|NCGC00017324-08|NCGC00017324-09|NCGC00254418-01|2,2-Dimethylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester|BS164407|HY-17502|ST057168|SY002874|SBI-0206773.P001|Simvastatin 100 microg/mL in Acetonitrile|NS00008782|S0509|EN300-52503|D00434|M03997|AB00053395-07|AB00053395-08|AB00053395-10|AB00053395_11|AB00053395_13|902S639|Q670131|SR-05000001894-1|SR-05000001894-2|BRD-K22134346-001-05-8|BRD-K22134346-001-11-6|BRD-K22134346-001-15-7|BRD-K22134346-001-21-5|BRD-K22134346-001-22-3|BRD-K22134346-001-24-9|Z754918914|Simvastatin, British Pharmacopoeia (BP) Reference Standard|Simvastatin, European Pharmacopoeia (EP) Reference Standard|Simvastatin, United States Pharmacopeia (USP) Reference Standard|Simvastatin, Pharmaceutical Secondary Standard; Certified Reference Material|Simvastatin for peak identification, European Pharmacopoeia (EP) Reference Standard|(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-Hydroxy-6-oxo-tetrahydro-2H-2-pyranyl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthalenyl 2,2-Dimethylbutanoate|(1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2,2-dimethylbutanoate|[1S-[1?,3?,7?,8?(2S*,4S*),8??]]-2,2-Dimethyl-butanoic acid 1,2,3,7,8,8?-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-p yran-2-yl)ethyl]-1-naphthalenyl ester|InChI=1/C25H38O5/c1-6-25(4,5)24(28)30-21-12-15(2)11-17-8-7-16(3)20(23(17)21)10-9-19-13-18(26)14-22(27)29-19/h7-8,11,15-16,18-21,23,26H,6,9-10,12-14H2,1-5H3/t15-,16-,18+,19+,20-,21-,23-/m0/s1"
ATORVASTATIN,60823,,"InChI=1S/C33H35FN2O5/c1-21(2)31-30(33(41)35-25-11-7-4-8-12-25)29(22-9-5-3-6-10-22)32(23-13-15-24(34)16-14-23)36(31)18-17-26(37)19-27(38)20-28(39)40/h3-16,21,26-27,37-38H,17-20H2,1-2H3,(H,35,41)(H,39,40)/t26-,27-/m1/s1",XUKUURHRXDUEBC-KAYWLYCHSA-N,C33H35FN2O5,558.6,"(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid","atorvastatin|134523-00-5|Cardyl|atorvastatina|atorvastatine|Sortis|(3R,5R)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid|atorvastatinum|A0JWA85V8F|DTXSID8029868|CHEBI:39548|DTXCID509868|(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid|(betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrole-1-heptanoic acid|(R-(R*,R*))-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic acid|Prevencor|1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (R-(R*,R*))-|1H-Pyrrole-1-heptanoic acid, 2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-, (betaR,deltaR)-|Zarator|CI981|atrovastatin calcium|(3R,5R)-7-(2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid|RefChem:6384|GlyTouCan:G14995TG|C10AA05|G14995TG|7-(2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-(propan-2-yl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoate|(betaR,deltaR)-2-(4-Fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-((phenylamino)carbonyl)-1H-pyrrole-1-heptanoic Acid|(betaR,deltaR)-2-(p-Fluorophenyl)-beta,delta-dihydroxy-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-pyrrole-1-heptanoic Acid|Hipolixan|Lipitor|110862-48-1|Atorvastatin (INN)|Lipitor (TN)|Tozalip|Xavator|(3R,5R)-7-[2-(4-fluorophenyl)-3-phenyl-4-(phenylcarbamoyl)-5-propan-2-ylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid|CHEMBL1487|C33H35FN2O5|(3R,5R)-7-[2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoylpyrrol-1-yl]-3,5-dihydroxyheptanoic acid|ATORVASTATIN [INN]|MFCD00899261|Atorvastatin [INN:BAN]|(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid|7-[2-(4-FLUORO-PHENYL)-5-ISOPROPYL-3-PHENYL-4-PHENYLCARBAMOYL-PYRROL-1-YL]- 3,5-DIHYDROXY-HEPTANOIC ACID|Atorvastatin calcium salt|atrovastin|Atofast|Atorcor|Atorlip|Lipilou|Lipinon|Atorin|Ator|Lipitor(TM)|(3R,5R)-7-[2-(4-fluorophenyl)-5-(1-methylethyl)-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid|(3R,5R)-7-[3-(anilinocarbonyl)-5-(4-fluorophenyl)-2-isopropyl-4-phenyl-1H-pyrrol-1-yl]-3,5-dihydroxyheptanoic acid|rel-(3S,5S)-7-(2-(4-Fluorophenyl)-5-isopropyl-3-phenyl-4-(phenylcarbamoyl)-1H-pyrrol-1-yl)-3,5-dihydroxyheptanoic acid|Sortis (TN)|CCRIS 7159|HSDB 7039|NCGC00159458-03|UNII-A0JWA85V8F|rel-Atorvastatin|Atorvastatin & Primycin|Atorvastatin (Standard)|ATORVASTATIN [MI]|ATORVASTATIN [HSDB]|SCHEMBL3831|ATORVASTATIN [VANDF]|ATORVASTATIN [WHO-DD]|BIDD:GT0336|GTPL2949|orb1306540|BDBM22164|HY-B0589R|GLXC-15111|HMS3715L05|HMS3886C20|Lipilou; Tozalip; Torvast; Cardyl|HY-B0589|Tox21_302417|s5715|AKOS000281127|AC-9386|CCG-221172|DB01076|MRF-0000761|NCGC00159458-02|NCGC00159458-20|NCGC00255181-01|AS-35260|FA156586|CAS-134523-00-5|NS00009054|C06834|D07474|523A005|EN300-18527331|F079255|Q668093|SR-01000872702|SR-01000872702-1|BRD-K69726342-001-02-6|BRD-K69726342-001-03-4|BRD-K69726342-238-02-4|Atorvastatin is known as an HMG-CoA reductase inhibitor.|(.BETA.R,.DELTA.R)-2-(P-FLUOROPHENYL)-.BETA.,.DELTA.-DIHYDROXY-5-ISOPROPYL-3-PHENYL-4-(PHENYLCARBAMOYL)PYRROLE-1-HEPTANOIC ACID|(3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4-phenylcarbamoyl-pyrrol-1-yl]-3,5-dihydroxy-heptanoic acid|1H-PYRROLE-1-HEPTANOIC ACID, 2-(4-FLUOROPHENYL)-.BETA.,.DELTA.-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-((PHENYLAMINO)CARBONYL)-, (R-(R*,R*))-"
LOVASTATIN,53232,,"InChI=1S/C24H36O5/c1-5-15(3)24(27)29-21-11-14(2)10-17-7-6-16(4)20(23(17)21)9-8-19-12-18(25)13-22(26)28-19/h6-7,10,14-16,18-21,23,25H,5,8-9,11-13H2,1-4H3/t14-,15-,16-,18+,19+,20-,21-,23-/m0/s1",PCZOHLXUXFIOCF-BXMDZJJMSA-N,C24H36O5,404.5,"[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate","lovastatin|75330-75-5|mevinolin|Mevacor|Monacolin K|Mevinacor|Altoprev|Mevlor|Sivlor|Altocor|MK-803|Lovastatine|6alpha-Methylcompactin|Lovastatina|6-alpha-Methylcompactin|Lovastatinum [Latin]|Lovastatinum|MK 803|DTXSID5020784|9LHU78OQFD|NSC-758662|L-154803|CHEBI:40303|C10AA02|ML-530B|2beta,6alpha-Dimethyl-8alpha-(2-methyl-1-oxobutoxy)-mevinic acid lactone|[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate|DTXCID50784|(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-(2R,4R)-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl (S)-2-methyl-butyrate|(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate|6-Methylcompactin|NSC633781|Lovastatinum (Latin)|(1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-2-Methylbutanoic acid 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester|(S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-(2-((1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl)ethyl)tetrahydro-4-hydroxy-2H-pyran-2-one|1,2,6,7,8,8a-Hexahydro-beta,delta-dihydroxy-2,6-dimethyl-8-(2-methyl-1-oxobutyoxy)-1-naphthaleneheptanoic acid delta-lactone|Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-|1 alpha-Isomer Lovastatin|6 Methylcompactin|(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate|MK803|alpha-Isomer Lovastatin, 1|Mevinacor 10|Mevinacor 40|((1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) (2S)-2-methylbutanoate|(S)-2-Methylbutyric acid, 8-ester with (4R,6R)-6-[2-[(1S,2S,6R,8S,8aR)-1,2,6,7,8,8a-hexahydro-8-hydroxy-2,6-dimethyl-1-naphthyl]ethyl]tetrahydro-4-hydroxy-2H-pyran-2-one|Lovastatin, 1 alpha|RefChem:5964|(8-(2-(4-hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) 2-methylbutanoate|(2S)-2-Methylbutanoic Acid, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl Ester|616-212-7|((1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxooxan-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl) (2R)-2-methylbutanoate|Lovalord|Nergadan|Artein|Lovastatine [French]|Lovastatina [Spanish]|Lovalip|Hipovastin|Lovasterol|Cholestra|Closterol|Colevix|Hipolip|Lestatin|Lipivas|Lipofren|Lovastin|Lozutin|Paschol|Rodatin|Rovacor|Tecnolip|Teroltrat|Belvas|Lipdip|Taucor|butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester, (2S)-|MFCD00072164|Lovastatin [USAN]|MLS000069585|Lovastatin (Standard)|6.alpha.-Methylcompactin|MSD 803|SMR000058779|(1S,3R,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate|C24H36O5|Lovastatin (Mevacor)|HSDB 6534|NCGC00023509-03|(S)-(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl 2-methylbutanoate|Liposcler|6 alpha-Methylcompactin|Rextat|Monakolin K|[(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-tetrahydropyran-2-yl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate|Mevacor (TN)|CHEMBL503|Lovastatin & Primycin|Lovastatin (USP/INN)|SR-05000001880|UNII-9LHU78OQFD|Simvastatin EP Impurity E|BRN 3631989|Mevinolin from Aspergillus sp.|CCRIS 8092|1cqp|Lovastatin [USAN:USP:INN:BAN]|(+)-mevinolin|(2S)-2-METHYLBUTANOIC ACID (1S,3R,7S,8S,8AR)-1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-((2R,4R)-TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER|(2S)-2-Methylbutanoic acid (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-[(2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl]ethyl]-1-naphthalenyl ester|1,2,3,7,8,8a-Hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl 2-methylbutanoate|Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-((2R,4R)-tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-|Prestwick_819|CAS-75330-75-5|Mevinolin (lovastatin)|LOVASTATIN [MI]|LOVASTATIN [INN]|Opera_ID_1578|Prestwick0_000516|Prestwick1_000516|Prestwick2_000516|Prestwick3_000516|Spectrum3_001873|Spectrum5_001294|Lovastatin (MK-803)|LOVASTATIN [HSDB]|LOVASTATIN [VANDF]|EC 616-212-7|LOVASTATIN [MART.]|SCHEMBL3136|LOVASTATIN [USP-RS]|LOVASTATIN [WHO-DD]|US9115116, lovastatin|BIDD:PXR0113|BSPBio_000471|BSPBio_001265|BSPBio_003346|74133-25-8|cid_53232|MLS001055358|MLS006011867|US9353061, Lovastatina|BIDD:GT0749|DivK1c_001032|SPECTRUM1503977|SPBio_002392|BPBio1_000519|GTPL2739|Lovastatin - Bio-X trade mark|MEGxm0_000398|orb1309414|LOVASTATIN [ORANGE BOOK]|ACon0_000534|ACon1_000390|BDBM34168|HMS503O05|HY-N0504R|KBio1_001032|KBio3_002848|LOVASTATIN [EP MONOGRAPH]|Simvastatin impurity, lovastatin-|Lovastatin for peak identification|NINDS_001032|GLXC-06458|HMS1569H13|HMS1792O07|HMS1923O13|HMS1990O07|HMS2089M06|HMS2093O03|HMS2096H13|HMS2236F07|HMS3039N16|HMS3259F10|HMS3268C03|HMS3403O07|HMS3412H19|HMS3676H19|HMS3713H13|HMS3884B03|LOVASTATIN [USP MONOGRAPH]|Pharmakon1600-01503977|ADVICOR COMPONENT LOVASTATIN|2-Methyl-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-[2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl]-1-naphthalenyl ester butanoic acid|ALBB-027272|HY-N0504|MK-803; LOVALIP; MEVACOR|MSK10235|Tox21_110888|Tox21_201475|Tox21_300268|BBL024473|CCG-39627|NSC758662|NSC779704|s2061|SBB080686|STK801953|AKOS005267139|Tox21_110888_1|CS-1990|DB00227|FH24950|KS-1082|Mevinolin from Aspergillus sp., powder|NC00713|NSC 758662|NSC-633781|NSC-779704|IDI1_001032|NCGC00023509-04|NCGC00023509-05|NCGC00023509-06|NCGC00023509-07|NCGC00023509-08|NCGC00023509-09|NCGC00023509-10|NCGC00023509-11|NCGC00023509-13|NCGC00023509-14|NCGC00023509-16|NCGC00254157-01|NCGC00259026-01|AC-13961|BL164644|Butanoic acid, 2-methyl-, (1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (2S)-|G226|SMR000673570|SBI-0051881.P002|CS-0694830|L0214|NS00000544|SIMVASTATIN IMPURITY E [EP IMPURITY]|EN300-52515|C07074|D00359|M02056|AB00052400-17|AB00052400_18|AB00052400_19|Mevinolin from Aspergillus sp., >=98% (HPLC)|330L755|A838030|Q417740|SR-01000000123|SR-01000000123-3|SR-05000001880-1|SR-05000001880-2|BRD-K09416995-001-06-8|BRD-K09416995-001-21-7|BRD-K09416995-001-38-1|BRD-K09416995-001-39-9|BRD-K09416995-001-40-7|Mevacor;Monacolin K;mevinolin;6-alpha-Methylcompactin|SIMVASTATIN IMPURITY, LOVASTATIN- [USP IMPURITY]|Z754931258|(1S,3R,7S,8S,8aR)-1,2,3,7,8,8a-Hexahydro-8-(2-((4R,6R)-4-hydroxy-2-oxo-2H-pyran-6-yl)ethyl)-3,7-dimethylnaphtyl(S)-2-methylbutyrat|(1S,3R,7S,8S,8aR)-8-(2-((2R,4R)-4-hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (S)-2-methylbutanoate|(2S)-2-methylbutanoic acid [(1S,3R,7S,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-2-oxanyl]ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] ester|(S)-2-Methyl-butyric acid (1S,3R,7S,8S,8aR)-8-[2-((3R,5R)-4-hydroxy-6-oxo-tetrahydro-pyran-2-yl)-ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl ester|[(1S,3R,7S,8S,8aR)-3,7-dimethyl-8-[2-[(2R,4R)-4-oxidanyl-6-oxidanylidene-oxan-2-yl]ethyl]-1,2,3,7,8,8a-hexahydronaphthalen-1-yl] (2S)-2-methylbutanoate|1S,7S,8S,8aR)-8-{2-[(2R,4R)-4-hydroxy-6-oxooxan-2-yl]ethyl}-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthalen-1-yl (2S)-2-methylbutanoate|8-[2-((2R,4R)-4-hydroxy-6-oxo(2H-3,4,5-trihydropyran-2-yl))ethyl](1S,7S,8S,3R, 8aR)-3,7-dimethyl-1,2,3,7,8,8a-hexahydronaphthyl (2S)-2-methylbutanoate|8-[2-(4-Hydroxy-6-oxotetrahydro-2H-pyran-2-yl)ethyl]-3,7-dimethyl-1,2,3,7,8,8a-hexahydro-1-naphthale|Butanoic acid, 2-methyl-, 1,2,3,7,8,8a-hexahydro-3,7-dimethyl-8-(2-(tetrahydro-4-hydroxy-6-- oxo-2H-pyran-2-yl)ethyl)-1-naphthalenyl ester, (1S-(1alpha(R*),3alpha,7beta,8beta(2S*,4S*),8abeta))-|BUTANOIC ACID, 2-METHYL-, 1,2,3,7,8,8A-HEXAHYDRO-3,7-DIMETHYL-8-(2-(TETRAHYDRO-4-HYDROXY-6-OXO-2H-PYRAN-2-YL)ETHYL)-1-NAPHTHALENYL ESTER, (1S-(1.ALPHA.(R*),3.ALPHA.,7.BETA.,8.BETA.(2S*,4S*),8.ALPHA..BETA.))-"
PRAVASTATIN,54687,,"InChI=1S/C23H36O7/c1-4-13(2)23(29)30-20-11-17(25)9-15-6-5-14(3)19(22(15)20)8-7-16(24)10-18(26)12-21(27)28/h5-6,9,13-14,16-20,22,24-26H,4,7-8,10-12H2,1-3H3,(H,27,28)/t13-,14-,16+,17+,18+,19-,20-,22-/m0/s1",TUZYXOIXSAXUGO-PZAWKZKUSA-N,C23H36O7,424.5,"(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid","pravastatin|81093-37-0|Pravastatina|Pravastatine|Pravastatinum|Eptastatin|Pravator|Pravastatinum [Latin]|KXO2KT9N0G|(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid|CHEBI:63618|C10AA03|DTXSID6023498|Pravastatinum (Latin)|1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-((2S)-2-methyl-1-oxobutoxy)-, (betaR,deltaR,1S,2S,6S,8S,8aR)-|1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betas*,deltas*),2alpha,6alpha,8beta(R*),8aalpha))-|(+)-(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(S)-2-methylbutyryl]oxy}-1,2,6,7,8,8a-hexahydro-1-naphthyl]heptanoic acid|Apo Pravastatin|Lin Pravastatin|Nu Pravastatin|(+)-(3R,5R)-3,5-dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutyryl)oxy)-1,2,6,7,8,8a-hexahydro-1-naphthyl)heptanoic acid|(3R,5R)-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-((2S)-2-methylbutanoyl)oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)-3,5-dihydroxyheptanoic acid|RefChem:56363|DTXCID003498|RMS431|Pravastatin tert Octylamine Salt|RMS 431|(1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1,2,6,7,8,8a-Hexahydro-beta,!d,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-1-naphthaleneheptanoic Acid|Pravachol|Pravastatin acid|Lipostat|Pravastatin (INN)|Vasten|CHEMBL1144|(3R,5R)-3,5-dihydroxy-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]heptanoic acid|(betaR,deltaR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-beta,delta,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid|Pravastatine [French]|Pravastatina [Spanish]|(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-{[(2S)-2-methylbutanoyl]oxy}-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid|PRAVASTATIN [INN]|Pravastatin [INN:BAN]|Mevalothin|Pravator (TN)|(3R,5R)-3,5-Dihydroxy-7-((1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-(((S)-2-methylbutanoyl)oxy)-1,2,6,7,8,8a-hexahydronaphthalen-1-yl)heptanoic acid|CCRIS 7557|C23H36O7|UNII-KXO2KT9N0G|Pravastatin-3H|3beta-Hydroxycompactin|KS-5015|PRAVASTATIN [VANDF]|SCHEMBL1117|PRAVASTATIN [WHO-DD]|BIDD:GT0773|PRAVASTATIN [EMA EPAR]|GTPL2953|orb1704797|BDBM20688|HSDB 8368|HMS3715P11|HY-B0165|LMFA05000695|MFCD00869375|s5713|AKOS015895229|CCG-221195|DB00175|NCGC00188962-01|NCGC00188962-02|(3R,5R)-7-[(1S,2S,6S,8S,8aR)-6-hydroxy-2-methyl-8-[(2S)-2-methylbutanoyl]oxy-1,2,6,7,8,8a-hexahydronaphthalen-1-yl]-3,5-dihydroxy-heptanoic acid|1,2,6,7,8,8a-hexahydro-beta,delta,6-trihydroxy-2-methyl-8-(2-methyl-1-oxobutoxy)-, (1S-(1alpha(betaS*,deltaS*),2alpha,6alpha,8beta(R*),8aalpha))-1-Naphthaleneheptanoic acid|FP158560|NS00000420|C01844|D08410|H12037|EN300-6481366|093P370|SR-01000781259|Q1240093|SR-01000781259-2|BRD-K60511616-236-01-4|BRD-K60511616-236-02-2|BRD-K60511616-236-06-3|BRD-K60511616-236-08-9|(|AR,|AR,1S,2S,6S,8S,8aR)-1,2,6,7,8,8a-Hexahydro-|A,|A,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-1-naphthaleneheptanoic acid|1-Naphthaleneheptanoic acid, 1,2,6,7,8,8a-hexahydro-.beta.,.delta.,6-trihydroxy-2-methyl-8-[(2S)-2-methyl-1-oxobutoxy]-, (.beta.R,.delta,R,1S,2S,6S,8S,8aR)-"
DAIDZEIN,5281708,,"InChI=1S/C15H10O4/c16-10-3-1-9(2-4-10)13-8-19-14-7-11(17)5-6-12(14)15(13)18/h1-8,16-17H",ZQSIJRDFPHDXIC-UHFFFAOYSA-N,C15H10O4,254.24,7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one,"daidzein|486-66-8|4',7-Dihydroxyisoflavone|Daidzeol|7-hydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one|7,4'-Dihydroxyisoflavone|7-hydroxy-3-(4-hydroxyphenyl)chromen-4-one|7-Hydroxy-3-(4-hydroxyphenyl)-4H-1-benzopyran-4-one|7-Hydroxy-3-(4-hydroxyphenyl)-4-benzopyrone|DTXSID9022310|CHEBI:28197|6287WC5J2L|DTXCID102310|Diadzein|RefChem:5729|207-635-4|4H-1-Benzopyran-4-one, 7-hydroxy-3-(4-hydroxyphenyl)-|MFCD00016954|Daidzein (Standard)|4,7-Dihydroxyisoflavone|7-Hydroxy-3-(4-hydroxy-phenyl)-chromen-4-one|CHEMBL8145|4',7-Dihydroxy-iso-flavone|7-Hydroxy-3-(4-hydroxy-phenyl)-chromone|CAS-486-66-8|SMR000326832|CCRIS 7600|K 251b|SR-01000075492|EINECS 207-635-4|BRN 0231523|UNII-6287WC5J2L|Isoflavone, 4',7-dihydroxy-|NPI 031E|Daidzein (DAI)|Spectrum_000255|Tocris-1417|DAIDZEIN [MI]|BiomolKI_000060|Spectrum2_000053|Spectrum3_000191|Spectrum4_001964|Spectrum5_000857|Lopac-D-7802|DAIDZEIN [MART.]|BiomolKI2_000066|DAIDZEIN [USP-RS]|DAIDZEIN [WHO-DD]|UPCMLD-DP052|4',7-dihydroxy isoflavone|4',7-dihydroxy-Isoflavone|Lopac0_000412|Oprea1_182317|Oprea1_305345|SCHEMBL19814|BSPBio_001741|Daidzein, analytical standard|KBioGR_002432|KBioSS_000735|SPECTRUM200789|5-18-04-00089 (Beilstein Handbook Reference)|MLS000859973|MLS001304056|MLS006011853|BIDD:ER0120|DivK1c_001023|d-(+)-alpha-methylbenzylamine|SPBio_000205|Daidzein, >=98%, synthetic|BMK1-F12|GTPL2828|MEGxm0_000123|NPI-031E|orb1309277|d-(+)-alpha-methylbenzyl amine|SCHEMBL29374778|UPCMLD-DP052:001|ACon0_001477|ACon1_000543|BDBM23420|HMS503M07|HY-N0019R|K-251b|KBio1_001023|KBio2_000735|KBio2_003303|KBio2_005871|KBio3_001241|NINDS_001023|7,4'-Dihydroxy-isoflavone (3a)|GLXC-06643|HMS1922P18|HMS2233H24|HMS3261C06|HMS3267J04|HMS3370C03|HMS3412O12|HMS3468L18|HMS3649B20|HMS3655A18|HMS3676O12|HMS5080K15|ALBB-015933|BCP28286|HY-N0019|MSK40144|Tox21_201444|Tox21_303650|Tox21_500412|BBL010490|CCG-38357|HB2488|LMPK12050038|s1849|SBB066056|STK801626|Daidzein (4',7-Dihydroxyisoflavone)|AKOS002385052|AC-6035|DB13182|KS-5260|LP00412|SDCCGMLS-0066422.P001|SDCCGSBI-0050397.P003|IDI1_001023|SMP1_000089|NCGC00015365-01|NCGC00015365-02|NCGC00015365-03|NCGC00015365-04|NCGC00015365-05|NCGC00015365-06|NCGC00015365-07|NCGC00015365-08|NCGC00015365-09|NCGC00015365-10|NCGC00015365-11|NCGC00015365-12|NCGC00015365-13|NCGC00015365-14|NCGC00015365-15|NCGC00015365-16|NCGC00015365-17|NCGC00015365-18|NCGC00015365-31|NCGC00025156-01|NCGC00025156-02|NCGC00025156-03|NCGC00025156-04|NCGC00025156-05|NCGC00025156-06|NCGC00025156-07|NCGC00025156-08|NCGC00025156-09|NCGC00025156-10|NCGC00168978-01|NCGC00168978-02|NCGC00257367-01|NCGC00258995-01|NCGC00261097-01|ST057515|SY049259|CS-0694988|D2668|EU-0100412|NS00010903|SW218107-2|7-hydroxy-3-(4-hydroxyphenyl)-chromen-4-one|D 7802|EN300-116213|S00273|US8552057, 7|AB00052712-08|AB00052712_10|486D668|DAIDZEIN (CONSTITUENT OF ASTRAGALUS) [DSC]|Daidzein, primary pharmaceutical reference standard|F024979|Q408732|DAIDZEIN (CONSTITUENT OF RED CLOVER) [DSC]|SR-01000075492-1|SR-01000075492-3|SR-01000075492-7|SR-01000075492-8|BRD-K42095107-001-02-3|BRD-K42095107-001-05-6|BRD-K42095107-001-08-0|BRD-K42095107-001-16-3|BRD-K42095107-001-17-1|BRD-K42095107-001-18-9|BRD-K42095107-001-21-3|SR-01000075492-12|80E3ED75-D852-4D97-9BD6-B5ADE7EA25A1|DAIDZEIN (CONSTITUENT OF SOY ISOFLAVONES) [DSC]|Z1494829514|7-Hydroxy-3-(4-hydroxy-phenyl)-4H-1-benzo-pyran-4-one|4',7-Dihydroxyisoflavone;7-Hydroxy-3-(4-hydroxyphenyl)chromone|Daidzein, United States Pharmacopeia (USP) Reference Standard|Daidzein, Pharmaceutical Secondary Standard; Certified Reference Material|ZF1"
ALMOREXANT,23727689,,"InChI=1S/C29H31F3N2O3/c1-33-28(35)27(20-7-5-4-6-8-20)34-16-15-21-17-25(36-2)26(37-3)18-23(21)24(34)14-11-19-9-12-22(13-10-19)29(30,31)32/h4-10,12-13,17-18,24,27H,11,14-16H2,1-3H3,(H,33,35)/t24-,27+/m0/s1",DKMACHNQISHMDN-RPLLCQBOSA-N,C29H31F3N2O3,512.6,"(2R)-2-[(1S)-6,7-dimethoxy-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-3,4-dihydro-1H-isoquinolin-2-yl]-N-methyl-2-phenylacetamide","Almorexant|871224-64-5|ACT-078573|9KCW39P2EI|(2R)-2-((1S)-6,7-dimethoxy-1-{2-(4-(trifluoromethyl)phenyl)ethyl}-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide|(2R)-2-[(1S)-6,7-dimethoxy-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-3,4-dihydro-1H-isoquinolin-2-yl]-N-methyl-2-phenylacetamide|DTXSID801007352|((2r)-2-((1s)-6,7-dimethoxy-1-(2-(4-trifluoromethylphenyl)-ethyl)-3,4-dihydro-1h-isoquinolin-2-yl)-n-methyl-2-phenylacetamide)|(2R)-2-((1S)-6,7-DIMETHOXY-1-(2-(4-(TRIFLUOROMETHYL)PHENYL)ETHYL)-3,4-DIHYDROISOQUINOLIN-2(1H)-YL)-N-METHYL-2-PHENYLACETAMIDE|almorexantum|(2R)-2-((1S)-6,7-dimethoxy-1-(2-(4-(trifluoromethyl)phenyl)ethyl)-3,4-dihydro-1H-isoquinolin-2-yl)-N-methyl-2-phenylacetamide|RefChem:110942|DTXCID601510175|(2R)-2-((1S)-6,7-dimethoxy-1-(2-(4-(trifluoromethyl)phenyl)ethyl)-1,2,3,4-tetrahydroisoquinolin-2-yl)-N-methyl-2-phenylacetamide|Almorexant [INN]|(R)-2-((S)-6,7-Dimethoxy-1-(4-(trifluoromethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide|1266467-63-3|UNII-9KCW39P2EI|(R)-2-((R)-6,7-DIMETHOXY-1-(4-(TRIFLUOROMETHYL)PHENETHYL)-3,4-DIHYDROISOQUINOLIN-2(1H)-YL)-N-METHYL-2-PHENYLACETAMIDE|CHEMBL455136|Almorexant (INN)|MFCD22419385|(R)-2-((S)-6,7-diMethoxy-1-(4-(trifluoroMethyl)phenethyl)-3,4-dihydroisoquinolin-2(1H)-yl)-N-Methyl-|ALMOREXANT [MI]|ALMOREXANT [WHO-DD]|SCHEMBL196577|GTPL2886|orb1305266|SCHEMBL29376949|CHEBI:177401|BCPP000414|BCP02616|BDBM50292929|AKOS016011276|BCP9000275|DB06673|NCGC00378603-03|AC-24400|AS-17049|HY-10805|NS00072173|D09964|Q4355941|BRD-K84810405-003-01-1|(2R)-2-[(1S)-6,7-dimethoxy-1-[2-[4-(trifluoromethyl)phenyl]ethyl]-3,4-dihydro-1H-isoquinolin-2-yl]-N-methyl-2-phenyl-acetamide|(2R)-2-[(1S)-6,7-dimethoxy-1-[2-[4-(triluoromethyl)phenyl]ethyl]-3,4-dihydro-1H-isoquinolin-2-yl]-N-methyl-2-phenylacetamide|(2r)-2-{(1S)-6,7-dimethoxy-1-[2-(4-trifluoromethyl-phenyl)-ethyl]-3,4-dihydro-1h-isoquinolin-2-yl}-n-methyl-2-phenyl-acetamide"
SUVOREXANT,24965990,,"InChI=1S/C23H23ClN6O2/c1-15-3-5-20(30-25-8-9-26-30)18(13-15)22(31)29-12-11-28(10-7-16(29)2)23-27-19-14-17(24)4-6-21(19)32-23/h3-6,8-9,13-14,16H,7,10-12H2,1-2H3/t16-/m1/s1",JYTNQNCOQXFQPK-MRXNPFEDSA-N,C23H23ClN6O2,450.9,"[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone","Suvorexant|1030377-33-3|MK-4305|BELSOMRA|MK 4305|MK4305|CHEBI:82698|[(7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone|081L192FO9|DTXSID90145616|BELSOMRA COMPONENT SUVOREXANT|((7R)-4-(5-Chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone|(4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2h-1,2,3-triazol-2-yl)phenyl)methanone|Methanone, ((7R)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)-|Methanone, [(7R)-4-(5-chloro-2-benzoxazolyl)hexahydro-7-Methyl-1H-1,4-diazepin-1-yl][5-Methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]-|suvorexantum|RefChem:56329|DTXCID0068107|N05CM19|Suvorexant (MK-4305)|MFCD22377755|5-Chloro-2-[(5R)-5-methyl-4-[5-methyl-2-(2H-1,2,3-triazol-2-yl)benzoyl]-1,4-diazepan-1-yl]-1,3-benzoxazole|CHEMBL1083659|C23H23ClN6O2|[(7R)-4-(5-chloro-1,3-benzoxazol-2-yl)-7-methyl-1,4-diazepan-1-yl]-[5-methyl-2-(triazol-2-yl)phenyl]methanone|(R)-(4-(5-chlorobenzo[d]oxazol-2-yl)-7-methyl-1,4-diazepan-1-yl)(5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl)methanone.|Suvorexant [USAN:INN]|UNII-081L192FO9|Belsomra (TN)|SUV|Suvorexant Impurity 19|SUVOREXANT [MI]|SUVOREXANT [INN]|SUVOREXANT [JAN]|Suvorexant (JAN/USAN)|SUVOREXANT [USAN]|Suvorexant; MK 4305|SUVOREXANT [VANDF]|SUVOREXANT [WHO-DD]|orb146219|GTPL2890|SCHEMBL1586289|SCHEMBL13372948|SCHEMBL29357712|SUVOREXANT [ORANGE BOOK]|EX-A211|JYTNQNCOQXFQPK-MRXNPFEDSA-N|BDBM50318701|AKOS022185167|CS-0614|DB09034|FS65089|NCGC00386302-04|AC-30276|AS-74879|HY-10807|BCP0726000197|NS00067952|SW219649-1|D10082|Q7650517|BRD-K94293891-001-01-3|CAS:1030377-33-3;MK-4305|[(7R)-4-(5-Chloro-2-benzoxazolyl)hexahydro-7-methyl-1H-1,4-diazepin-1-yl][5-methyl-2-(2H-1,2,3-triazol-2-yl)phenyl]methanone|[(R)-4-(5-Chloro-benzooxazol-2-yl)-7-methyl-[1,4]diazepan-1-yl]-(5-methyl-2-[1,2,3]triazol-2-yl-phenyl)-methanone|2762965-03-5"
SB-649868,25195495,,"InChI=1S/C26H24FN3O3S/c1-16-29-23(24(34-16)17-8-10-18(27)11-9-17)26(32)30-13-3-2-5-19(30)15-28-25(31)21-6-4-7-22-20(21)12-14-33-22/h4,6-12,14,19H,2-3,5,13,15H2,1H3,(H,28,31)/t19-/m0/s1",ZJXIUGNEAIHSBI-IBGZPJMESA-N,C26H24FN3O3S,477.6,"N-[[(2S)-1-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]piperidin-2-yl]methyl]-1-benzofuran-4-carboxamide","380899-24-1|SB-649868|SB649868|GSK649868|1L1V1K2M4V|SB 649868|N-[[(2S)-1-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]piperidin-2-yl]methyl]-1-benzofuran-4-carboxamide|4-Benzofurancarboxamide, N-(((2S)-1-((5-(4-fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-|N-[[(2S)-1-[[5-(4-Fluorophenyl)-2-methyl-4-thiazolyl]carbonyl]-2-piperidinyl]methyl]-4-benzofurancarboxamide|DTXSID90191491|N-(((2S)-1-((5-(4-Fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide|N-(((2S)-1-(5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl)piperidin-2-yl)methyl)-1-benzofuran-4-carboxamide|N-{[(2S)-1-[5-(4-fluorophenyl)-2-methyl-1,3-thiazole-4-carbonyl]piperidin-2-yl]methyl}-1-benzofuran-4-carboxamide|RefChem:926512|DTXCID00113982|(S)-N-((1-(5-(4-Fluorophenyl)-2-methylthiazole-4-carbonyl)piperidin-2-yl)methyl)benzofuran-4-carboxamide|UNII-1L1V1K2M4V|C26H24FN3O3S|N-((1-((5-(4-Fluorophenyl)-2-methyl-4-thiazolyl)carbonyl)-2-piperidinyl)methyl)-4-benzofurancarboxamide|GTPL4461|MFCD18251524|orb1301739|SCHEMBL8045969|CHEMBL1272307|SCHEMBL29424764|GLXC-03492|EX-A2570|BDBM50417257|AKOS027323765|CS-7584|DB14822|AC-36150|BS-50120|DA-77718|HY-10806|SB-649,868|SB649868; GSK649868|D82888|Q7388914|N-[((2S)-1-{[5-(4-fluorophenyl)-2-methyl-1,3-thiazol-4-yl]carbonyl}-2-piperidinyl)methyl]-1-benzofuran-4-carboxamide|N-[[(2S)-1-[5-(4-fluorophenyl)-2-methyl-thiazole-4-carbonyl]-2-piperidyl]methyl]benzofuran-4-carboxamide"
FILOREXANT,25128145,,"InChI=1S/C24H25FN4O2/c1-16-4-8-20(23-26-10-3-11-27-23)21(12-16)24(30)29-14-18(6-5-17(29)2)15-31-22-9-7-19(25)13-28-22/h3-4,7-13,17-18H,5-6,14-15H2,1-2H3/t17-,18-/m1/s1",NPFDWHQSDBWQLH-QZTJIDSGSA-N,C24H25FN4O2,420.5,"[(2R,5R)-5-[(5-fluoropyridin-2-yl)oxymethyl]-2-methylpiperidin-1-yl]-(5-methyl-2-pyrimidin-2-ylphenyl)methanone","FILOREXANT|1088991-73-4|MK-6096|MK 6096|((2R,5R)-5-(((5-Fluoropyridin-2-yl)oxy)methyl)-2-methylpiperidin-1-yl)(5-methyl-2-(pyrimidin-2-yl)phenyl)methanone|MK6096|E6BTT8VA5Z|DTXSID50148764|[(2R,5R)-5-[(5-fluoropyridin-2-yl)oxymethyl]-2-methylpiperidin-1-yl]-(5-methyl-2-pyrimidin-2-ylphenyl)methanone|Methanone, ((2R,5R)-5-(((5-fluoro-2-pyridinyl)oxy)methyl)-2-methyl-1-piperidinyl)(5-methyl-2-(2-pyrimidinyl)phenyl)-|filorexantum|((2R,5R)-5-((5-fluoropyridin-2-yl)oxymethyl)-2-methylpiperidin-1-yl)-(5-methyl-2-pyrimidin-2-ylphenyl)methanone|[(2R,5R)-5-{[(5-Fluoropyridin-2-yl)oxy]methyl}-2-methylpiperidin-1-yl][5-methyl-2-(pyrimidin-2-yl)phenyl]methanone|Methanone, [(2R,5R)-5-[[(5-fluoro-2-pyridinyl)oxy]methyl]-2-methyl-1-piperidinyl][5-methyl-2-(2-pyrimidinyl)phenyl]-|RefChem:140450|DTXCID0071255|2-(2-((2R,5R)-5-(((5-fluoropyridin-2-yl)oxy)methyl)-2-methylpiperidine-1-carbonyl)-4-methylphenyl)pyrimidine|MFCD28100674|Filorexant [USAN]|[(2~{R},5~{R})-5-[(5-fluoranylpyridin-2-yl)oxymethyl]-2-methyl-piperidin-1-yl]-(5-methyl-2-pyrimidin-2-yl-phenyl)methanone|Filorexant [USAN:INN]|UNII-E6BTT8VA5Z|Filorexant(mk-6096)|FILOREXANT [INN]|Filorexant (USAN/INN)|MK-6096; Filorexant|Filorexant(mk-6096)?|FILOREXANT [WHO-DD]|GTPL4460|orb1308033|SCHEMBL1716633|CHEMBL2107822|BDBM104692|GLXC-10633|EX-A2101|AKOS027323764|CS-4437|DB12158|NCGC00484077-01|AC-35933|AS-82282|HY-15653|US8569311, E-5|NS00072550|D10345|BRD-K03894385-001-01-1|Q18355303|[(2R,5R)-5-[(5-fluoro-2-pyridyl)oxymethyl]-2-methyl-1-piperidyl]-(5-methyl-2-pyrimidin-2-yl-phenyl)methanone|NT5"
BALICATIB,10201696,,"InChI=1S/C23H33N5O2/c1-2-14-27-15-17-28(18-16-27)20-8-6-19(7-9-20)21(29)26-23(10-4-3-5-11-23)22(30)25-13-12-24/h6-9H,2-5,10-11,13-18H2,1H3,(H,25,30)(H,26,29)",LLCRBOWRJOUJAE-UHFFFAOYSA-N,C23H33N5O2,411.5,N-[1-(cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl)benzamide,"Balicatib|354813-19-7|AAE581|AAE-581|N-(1-((cyanomethyl)carbamoyl)cyclohexyl)-4-(4-propylpiperazin-1-yl)benzamide|N-[1-(cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl)benzamide|E00MVC7O57|DTXSID10188989|N-(1-(cyanomethylcarbamoyl)cyclohexyl)-4-(4-propylpiperazin-1-yl)benzamide|balicatibum|N-{1-[(cyanomethyl)carbamoyl]cyclohexyl}-4-(4-propylpiperazin-1-yl)benzamide|RefChem:116378|DTXCID20111480|967-672-3|Balicatib [INN]|AAE 581|MFCD19443790|CHEMBL371064|UNII-E00MVC7O57|Balicatib?|Balicatib (aae-581)|BALICATIB [WHO-DD]|GTPL7861|orb1307327|SCHEMBL1587772|BDBM19855|EX-A362|LLCRBOWRJOUJAE-UHFFFAOYSA-N|C23H33N5O2|GLXC-06343|HMS3740C15|BCP09098|EPA81319|AKOS025149083|DB12239|basic piperazine-containing compound, 10|NCGC00371151-01|NCGC00371151-06|AC-35832|AS-56087|DA-35184|HY-15100|NS00069660|S0194|BRD-K27204852-001-01-9|Q27074857|N-[1-(cyanomethylcarbamoyl)cyclohexyl]-4-(4-propylpiperazin-1-yl)|N-[1-(Cyanomethyl-carbamoyl)-cyclohexyl]-4-[4-(1-propyl)-piperazin-1-yl]-benzamide"
GALUNISERTIB,10090485,,"InChI=1S/C22H19N5O/c1-13-4-2-5-18(25-13)21-20(19-6-3-11-27(19)26-21)15-9-10-24-17-8-7-14(22(23)28)12-16(15)17/h2,4-5,7-10,12H,3,6,11H2,1H3,(H2,23,28)",IVRXNBXKWIJUQB-UHFFFAOYSA-N,C22H19N5O,369.4,"4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide","Galunisertib|700874-72-2|LY2157299|LY 2157299|LY-2157299|4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide|galunisertibum|3OKH1W5LZE|DTXSID00220362|4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide|CHEBI:137064|6-Quinolinecarboxamide, 4-(5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo(1,2-b)pyrazol-3-yl)-|6-Quinolinecarboxamide, 4-[5,6-dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-|4-(2-(6-METHYLPYRIDIN-2-YL)-5,6-DIHYDRO-4H-PYRROLO(1,2-B)PYRAZOL-3-YL)QUINOLINE-6-CARBOXAMIDE|4-(2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo(2,1-e)pyrazol-3-yl)quinoline-6-carboxamide|4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[2,1-e]pyrazol-3-yl]quinoline-6-carboxamide|RefChem:142227|DTXCID00142853|UNII-3OKH1W5LZE|ly2157299(galunisertib)|Galunisertib (LY2157299)|MFCD12923319|4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo-[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide|4-[2-(6-methylpyridin-2-yl)-4H,5H,6H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide|Galunisertib [USAN]|Galunisertib [USAN:INN]|LY2157299; 4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide; 4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide|4-[5,6-Dihydro-2-(6-methyl-2-pyridinyl)-4H-pyrrolo[1,2-b]pyrazol-3-yl]-6-quinolinecarboxamide|Galunisertib (USAN/INN)|GALUNISERTIB [INN]|4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo(1,2-b)pyrazol-3-yl)quinoline-6-carboxylic acid amide|GALUNISERTIB [WHO-DD]|GTPL7797|LY2157299(Galunisertib)?|orb1305376|CHEMBL2364611|SCHEMBL12922153|SCHEMBL29362145|EX-A009|HMS3655D14|BCP02173|BDBM50015640|NSC761216|NSC800103|s2230|AKOS022175280|CCG-264950|CS-0474|DB11911|EX-8675|FM43366|NSC-761216|NSC-800103|SB16483|NCGC00384167-07|AC-31327|AS-42940|HY-13226|inhibitor 15d [PMID: 18314943]|NS00069665|SW219460-1|D10437|BRD-K78118466-001-03-3|Q27077768|2-(6-Methyl-Pyridin-2-Yl)-3-[6-Amido-Quinolin-4-Yl)-5,6-Dihydro-4H-Pyrrolo[1,2-B]Pyrazole|4-[2-(6-methyl-2-pyridyl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide|4-[2-(6-Methyl-pyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]-quinoline-6-carboxylic acid amide|6-QUINOLINECARBOXAMIDE, 4-(5,6-DIHYDRO-2-(6-METHYL-2-PYRIDINYL)-4H-PYRROLO(1,2-B)PYRAZOL-3-YL)-)|Galunisertib;4-(2-(6-Methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl)quinoline-6-carboxamide"
SAXAGLIPTIN ANHYDROUS,11243969,,"InChI=1S/C18H25N3O2/c19-8-13-2-12-3-14(12)21(13)16(22)15(20)17-4-10-1-11(5-17)7-18(23,6-10)9-17/h10-15,23H,1-7,9,20H2/t10?,11?,12-,13+,14+,15-,17?,18?/m1/s1",QGJUIPDUBHWZPV-SGTAVMJGSA-N,C18H25N3O2,315.4,"(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile","Saxagliptin|361442-04-8|BMS-477118|Saxagliptin anhydrous|BMS 477118|Saxagliptine|8I7IO46IVQ|DTXSID7048580|CHEBI:71272|DTXCID3028506|BMS477118|Saxagliptina|NSC760407|(1S,3S,5S)-2-((2S)-2-Amino-2-(3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo[3.1.0]hexane-3-carbonitrile|(1S,3S,5S)-2-((2S)-Amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile|(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile|NSC-760407|(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile|3-hydroxyadamantylglycine-4,5-methanoprolinenitrile hydrate|QTERNMET COMPONENT SAXAGLIPTIN|saxagliptinum|(1S,3S,5S)-2-((2S)-2-amino-2-(3-hydroxy-1-adamantyl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile|(1S,3S,5S)-2-((2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile|RefChem:931331|A10BH03|(1S,3S,5S)-2-((2S)-2-Amino-2-(3-hydroxyadamantan-1-yl) acetyl)-2-azabicyclo(3.1.0)hexane-3-carbonitrile hydrate|9GB927LAJW|BMS-477118-11|Saxagliptin Monohydrate|Onglyza|Saxagliptin [INN]|OPC-262|CHEMBL385517|1073057-20-1|UNII-8I7IO46IVQ|Saxagliptin?|HSDB 8199|OPC 262|NCGC00242597-01|SAXAGLIPTIN [MI]|Saxagliptin (USAN/INN)|SCHEMBL17168|SAXAGLIPTIN [WHO-DD]|MLS006011223|GTPL6316|BDBM11542|QGJUIPDUBHWZPV-SGTAVMJGSA-N|HMS3264P11|Pharmakon1600-01502500|MSK10924|SBMS-477118|Tox21_112908|BDBM50225074|s1540|Saxagliptin (BMS-477118,Onglyza)|AKOS015896547|AC-6008|CCG-213084|CCG-267647|CS-0650|DB06335|EX-7795|FA29598|NCGC00242597-02|NCGC00242597-10|HY-10285|SMR004702984|SY022234|CAS-361442-04-8|D08996|EN300-761487|AB01562984_01|AB01562984_02|Q3121121|BRD-A81513827-001-03-6|Z2235802036|(S)-3-Hydroxyadamantylglycine-L-cis-4,5-methanoprolinenitrile TFA salt|(1S,6S)-2-(2-adamantan-1-yl-2-amino-acetyl)-2-aza-bicyclo[3.1.0]hexane-3-carbonitrile|(1S,3S,5S)-2-((2S)-AMINO(3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)ACETYL)-2-AZABICYCLO(3.1.0)HEXANE-3-CARBONITRILE|(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxyadamantan-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile; 2,2,2-trifluoroacetic acid|(1S,3S,5S)-2-[(2S)-2-Amino-2-(3-hydroxytricyclo[3.3.1.1(3,7)]dec-1-yl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile;Onglyza|(1S,3S,5S)-2-[(2S)-2-amino-2-(3-hydroxytricyclo[3.3.1.13,7]dec-1-yl)-1-oxoethyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile|(1S,3S,5S)-2-[(S)-2-amino-2-(3-hydroxy-adamantan-1-yl)-acetyl]-2-aza-bicyclo[3.1.0]hexane-3-carbonitrile|(1S,3S,5S)-2-[2-Amino-2-(3-hydroxy-1-adamantyl)acetyl]-2-azabicyclo[3.1.0]hexane-3-carbonitrile|2-AZABICYCLO(3.1.0)HEXANE-3-CARBONITRILE, 2-((2S)-AMINO(3-HYDROXYTRICYCLO(3.3.1.1(SUP 3,7))DEC-1-YL)ACETYL), (1S,3S,5S)-|2-Azabicyclo(3.1.0)hexane-3-carbonitrile, 2-((2S)-amino(3-hydroxytricyclo(3.3.1.13,7)dec-1-yl)acetyl) , (1S,3S,5S)-"
ALBUTEROL,2083,,"InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3",NDAUXUAQIAJITI-UHFFFAOYSA-N,C13H21NO3,239.31,4-[2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol,"Salbutamol|albuterol|18559-94-9|Ventoline|Proventil HFA|Salbutamolum|Cobutolin|Salbuvent|Asmaven|Salamol|Asmol|Aerolin|Ventilan|Ventodisks|Asthalin|4-[2-(tert-Butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol|Airomir|Etinoline|Vospire|4-(2-(tert-Butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol|SCH-13949W|2-(tert-Butylamino)-1-(4-hydroxy-3-hydroxymethylphenyl)ethanol|QF8SVZ843E|NSC-757417|CHEBI:2549|DTXSID5021255|SCH 13949W|DTXCID001255|1,3-Benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-|salbutamolo|Salipraneb|Airsalb|Asmavent|Kentamol|Libetist|Rimasal|Salapin|Combivent udvs|Aerolin auto|Ventolin cr|Ventmax sr|Asmasal clickhaler|Asmasal spacehaler|Salbulin novolizer|Ipramol steri-neb|Salamol e-breathe|Steri-neb salamol|Ventolin e-breathe|Aerolin 400|PROAIRHFA|VENTOLINHFA|RefChem:54031|2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol|242-424-0|Proventil|Broncovaleas|dl-Salbutamol|dl-Albuterol|Ventolin Inhaler|Salbulin|Saventol|Spreor|Ventolin|Sultanol N|Proventil Inhaler|Novosalmol|Salbuhexal|Salbutalan|Servitamol|Ventiloboi|Almotex|Anebron|Asmadil|Asmanil|Asmasal|Asmatol|Asmidon|Bronter|Bugonol|Butamol|Butohaler|Butotal|Butovent|Dilatamol|Farcolin|Gerivent|Grafalin|Libretin|Medolin|Parasma|Pneumolat|Respolin|Sabutal|Salbetol|Salbron|Salbupur|Salbusian|Salbutan|Salbutol|Salbuven|Sallbupp|Salmaplon|Salomol|Salvent|Suprasma|Theosal|Tobybron|Vencronyl|Ventamol|Zaperin|Bumol|Mozal|Respax|Suxar|Alti-Salbutamol|Broncho-Spray|Salbu-Fatol|Buto-Asma|Asmol Uni-Dose|Salbu-BASF|Volare easi-breathe|Arubendol-Salbutamol|Volare albuterol HFA|Salbutamol sulfate|ALBUTEROL (+/-)|alpha-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha'-diol|MFCD00148978|AH 3365|rac Albuterol|Proventil (TN)|1-(tert-Butylaminomethyl)-4-hydroxy-m-xylene-alpha1,alpha3-diol|alpha'-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol|4-Hydroxy-3-hydroxymethyl-alpha-((tert-butylamino)methyl)benzyl alcohol|DL-N-tert-Butyl-2-(4-hydroxy-3-hydroxymethylphenyl)-2-hydroxyethylamine|alpha(sup 1)-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol|d,l-Salbutamol|35763-26-9|Ventalin inhaler|Albuterol [USAN]|NCGC00015955-09|Solbutamol|4-[2-(tert-butylamino)-1-hydroxy-ethyl]-2-(hydroxymethyl)phenol|1,3-Benzenedimethanol, .alpha.1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-|4-{2-[(1,1-dimethylethyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol|Salbutamolum [INN-Latin]|Eolene|4-{2-[(tert-butyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol|(l)-albuterol|Salbutamol-(tert-butyl-d9) acetate|Albuterol (USP)|148563-15-9|Salbutamol (hemisulfate)|HSDB 7206|SR-01000075161|Albuterol [USAN:USP]|EINECS 242-424-0|UNII-QF8SVZ843E|BRN 2213614|racemic salbutamol|Salamol EB|Prestwick_665|CAS-18559-94-9|Salbutamol Free Base|(+/-)-salbutamol|(R)-Albuterol;(R)-Salbutamol;Levosalbutamol|Salbutamol,(+/-)|Venetlin (Salt/Mix)|Salbutamol (Standard)|Spectrum_000200|Albuterol (hemisulfate);AH-3365 (hemisulfate)|ALBUTEROL [MI]|Salbutamol [INN:BAN]|ALBUTEROL [HSDB]|SALBUTAMOL [INN]|Prestwick0_000198|Prestwick1_000198|Prestwick2_000198|Prestwick3_000198|Spectrum2_001350|Spectrum4_000887|Spectrum5_001059|ALBUTEROL [VANDF]|m-Xylene-alpha,alpha'-diol, alpha-((tert-butylamino)methyl)-4-hydroxy-|CHEMBL714|EC 242-424-0|S 8260|ALBUTEROL [USP-RS]|SALBUTAMOL [MART.]|SCHEMBL4913|SALBUTAMOL [WHO-DD]|SALBUTAMOL [WHO-IP]|Lopac0_001090|Lopac0_001098|BSPBio_000155|GTPL558|KBioGR_001294|KBioSS_000680|DivK1c_000943|SPECTRUM1500677|Albuterol - Bio-X trade mark|SPBio_001539|SPBio_002076|BPBio1_000171|orb1309633|SGCUT00011|ALBUTEROL [ORANGE BOOK]|SALBUTAMOL [EP IMPURITY]|SCHEMBL10025126|SCHEMBL27674053|BCBcMAP01_000116|BDBM25769|HMS502P05|HY-B1037R|KBio1_000943|KBio2_000680|KBio2_003248|KBio2_005816|ALBUTEROL [USP MONOGRAPH]|MSK1302|SALBUTAMOL [EP MONOGRAPH]|NINDS_000943|Bio1_000446|Bio1_000935|Bio1_001424|HMS1568H17|HMS1921C04|HMS2089I19|HMS2092I08|HMS2095H17|HMS3712H17|HMS3886I08|HMS5084J10|KUC106739N|Pharmakon1600-01500677|ALBB-038670|BCP28423|d,l-Salbutamol, 1mg/ml in Ethanol|HY-B1037|SALBUTAMOLUM [WHO-IP LATIN]|to_000081|Tox21_110266|Tox21_200800|CCG-39288|NSC757417|PDSP1_000623|PDSP2_000620|s5494|SBB066105|1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-|AKOS007930174|m-Xylene-alpha,alpha'-diol, alpha'-((tert-butylamino)methyl)-4-hydroxy-|Tox21_110266_1|CS-4556|DB01001|FA61527|KS-5209|NSC 757417|SB19749|SDCCGSBI-0051060.P006|IDI1_000943|SMP1_000268|NCGC00015955-04|NCGC00015955-05|NCGC00015955-06|NCGC00015955-07|NCGC00015955-08|NCGC00015955-10|NCGC00015955-11|NCGC00015955-12|NCGC00015955-13|NCGC00015955-14|NCGC00015955-16|NCGC00015955-28|NCGC00024698-02|NCGC00024698-03|NCGC00024698-04|NCGC00024698-05|NCGC00024698-06|NCGC00024698-07|NCGC00258354-01|AC-10286|BA164143|KSC-11-222-1|Salbutamol 100 microg/mL in Acetonitrile|ST024764|ST075204|ST077150|SBI-0051060.P005|AB00052154|EU-0101090|NS00000415|VU0243312-5|D02147|EN300-365894|F15026|Salbutamol, VETRANAL(TM), analytical standard|AB00052154-08|AB00052154-09|AB00052154_10|AB00052154_11|559S949|L000531|Q410358|SR-01000075161-3|SR-01000075161-4|SR-01000075161-5|SR-01000075161-8|BRD-A88254928-001-04-6|BRD-A88254928-001-05-3|BRD-A88254928-001-07-9|BRD-A88254928-065-04-1|SR-01000075161-11|Z2301287926|Salbutamol, British Pharmacopoeia (BP) Reference Standard|Salbutamol, European Pharmacopoeia (EP) Reference Standard|Albuterol, United States Pharmacopeia (USP) Reference Standard|2-(tert-Butylamino)-1-[4-hydroxy-3-(hydroxymethyl)phenyl]ethanol|4-[2-(tert-Butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol #|1-(tert-Butylaminomethyl)-4-hydroxy-m-xylene-.alpha.1,.alpha.3-diol|4-[(1S)-2-(butylamino)-1-hydroxy-isopropyl]-2-(hydroxymethyl)phenol|4-Hydroxy-3-hydroxymethyl-.alpha.-((tert-butylamino)methyl)benzyl alcohol|Albuterol; 4-[2-(tert-Butylamino)-1-hydroxy-ethyl]-2-methylol-phenol|alpha-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-alpha,alpha1-diol|.alpha.'-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-.alpha.,.alpha.'-diol|.alpha.1'-[[(1,1-Dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol, hemisulfate|.alpha.1-[(tert-Butylamino)methyl]-4-hydroxy-m-xylene-.alpha.,.alpha.'-diol|?(1)-[[(1,1-Dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol;(+/-)-Salbutamol|1,3-Benzenedimethanol, .alpha.(1)-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-|4-[(1S)-1-hydroxy-2-(propylamino)ethyl]-2-(hydroxymethyl)phenol, oxamethane|m-Xylene-.alpha.,.alpha.'-diol, .alpha.'-((tert-butylamino)methyl)-4-hydroxy-|m-Xylene-.alpha.,.alpha.-diol, .alpha.-1-((tert-butylamino)methyl)-4-hydroxy-|(+/-)-1,3-BENZENEDIMETHANOL, .ALPHA.(SUP 1)-(((1,1-DIMETHYLETHYL)AMINO)METHYL)-4-HYDROXY-|1,3-BENZENEDIMETHANOL, .ALPHA.(SUP 1)-(((1,1-DIMETHYLETHYL)AMINO)METHYL)-4-HYDROXY-|1,3-Benzenedimethanol, a1-[[(1,1-dimethylethyl)amino]methyl]-4-hydroxy-, (S)-, sulfate (2"
INDACATEROL,6918554,,"InChI=1S/C24H28N2O3/c1-3-14-9-16-11-18(12-17(16)10-15(14)4-2)25-13-22(28)19-5-7-21(27)24-20(19)6-8-23(29)26-24/h5-10,18,22,25,27-28H,3-4,11-13H2,1-2H3,(H,26,29)/t22-/m0/s1",QZZUEBNBZAPZLX-QFIPXVFZSA-N,C24H28N2O3,392.5,"5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one","Indacaterol|312753-06-3|Onbrez|QAB-149|QAB149|QAB 149|Indacterol|8OR09251MQ|5-(2-(5,6-Diethylindan-2-ylamino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one|CHEBI:68575|QABI49|5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one|DTXSID90185198|5-[(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxy-1,2-dihydroquinolin-2-one|5-{(1R)-2-[(5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl}-8-hydroxyquinolin-2(1H)-one|indacaterolum|5-((1R)-2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)-8-hydroxy-1,2-dihydroquinolin-2-one|5-((1R)-2-((5,6-diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)-8-hydroxy-1H-quinolin-2-one|5-((1R)-2-((5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one|5-[(1R)-2-[(5,6-DIETHYL-2,3-DIHYDRO-1H-INDEN-2-YL)AMINO]-1-HYDROXYETHYL]-8-HYDROXYQUINOLIN-2(1H)-ONE|5-{(1R)-2-((5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino)-1-hydroxyethyl}-8-hydroxyquinolin-2(1H)-one|RefChem:790882|DTXCID00107689|R03AC18|Arcapta|UNII-8OR09251MQ|Indacaterol [USAN:INN:BAN]|MFCD18782702|753498-25-8|CHEMBL1095777|312753-06-3 (free base)|(R)-5-(2-(5,6-diethyl-2,3-dihydro-1H-inden-2-ylamino)-1-hydroxyethyl)-8-hydroxyquinolin-2(1H)-one|(R)-5-[2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one|Indacaterol [INN]|Indacaterol (USAN/INN)|Indacaterol (Standard)|INDACATEROL [MI]|INDACATEROL [USAN]|INDACATEROL [VANDF]|INDACATEROL [MART.]|SCHEMBL48098|INDACATEROL [WHO-DD]|GTPL7455|orb1305700|SCHEMBL29350045|SCHEMBL29367297|QZZUEBNBZAPZLX-QFIPXVFZSA-N|HMS3886I14|BCP03766|EX-A6067|MSK10570|BDBM50318159|HY-14299R|s5654|AKOS024463516|BCP9000787|CCG-268560|CS-0744|DB05039|5-[(1R)-2-[(5,6-diethylindan-2-yl)amino]-1-hydroxy-ethyl]-8-hydroxy-1H-quinolin-2-one|NCGC00386216-07|AC-27668|AS-56318|HY-14299|BCP0726000140|NS00005616|D09318|AB01565805_02|753I063|EN300-20321622|Q425654|BRD-K89208535-051-01-5|(R)-5-[2-(5,6-diethyl-indan-2-ylamino)-1-hydroxyethyl]-8-hydroxy-1H-quinolin-2-one|5-[(r)-2-(5,6-diethyl-indan-2-ylamino)-1-hydroxy-ethyl]-8-hydroxy-1h-quinolin-2-one|8-Hydroxy-5-[(R)-1-hydroxy-2-(5,6-diethylindan-2-ylamino)-ethyl]-1H-quinolin-2-one|5-[(1R)-2-[(5,6-Diethyl-2,3-dihydro-1H-inden-2-yl)amino]-1-hydroxyethyl]-8-hydroxyquinolin-2(1H)-one; QAB 149"
ISOPROTERENOL,3779,,"InChI=1S/C11H17NO3/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8/h3-5,7,11-15H,6H2,1-2H3",JWZZKOKVBUJMES-UHFFFAOYSA-N,C11H17NO3,211.26,"4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol","isoproterenol|Isoprenaline|7683-59-2|Isopropydrin|Novodrin|Asiprenol|Assiprenol|Bellasthman|Isoprenalin|Respifral|Aludrine|Asmalar|Neodrenal|Proternol|neo-Epinine|Isonorin|Isorenin|Saventrine|Isopropylarterenol|N-Isopropylnoradrenaline|Isopropyladrenaline|N-Isopropylnorepinephrine|Isupren|Isopropylnorepinephrine|Vapo-N-iso|Isopropylnoradrenaline|(+-)-Isoproterenol|Isopropyl noradrenaline|Isoprenalina|Isoprenalinum|Aleudrin|Epinephrine isopropyl homolog|(+-)-Isoprenaline|4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol|1-(3,4-Dihydroxyphenyl)-2-(isopropylamino)ethanol|1-(3,4-Dihydroxyphenyl)-2-isopropylaminoethanol|alpha-(Isopropylaminomethyl)protocatechuyl alcohol|1,2-Benzenediol, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-|N-Isopropyl-beta-dihydroxyphenyl-beta-hydroxyethylamine|NSC-9975|NSC-33791|4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol|1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-|DTXSID4023175|CHEBI:64317|L628TT009W|3,4-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol|DTXCID603175|3,4-dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol|Isadrin|4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,2-diol|4-(1-hydroxy-2-(propan-2-ylamino)ethyl)benzene-1,2-diol|4-(1-hydroxy-2-((propan-2-yl)amino)ethyl)benzene-1,2-diol|Isoproterenol dl-|Noradrenaline, Isopropyl|RefChem:55417|C01CA02|R03AB02|R03CB01|231-687-7|Isonorene|Lomupren|Isadrine|DL-ISOPROTERENOL|Racemic isoprenaline|dl-Isadrine|Racemic isoproterenol|Aleudrine|Dihydroxyphenylethanolisopropylamine|WIN 5162|149-53-1|ICI 46399|Isoprenaline (INN)|Isoprenaline [INN]|4-(1-Hydroxy-2-(isopropylamino)ethyl)benzene-1,2-diol|CHEMBL434|Isoproterenolum|Isopropylaminomethyl(3,4-dihydroxyphenyl)carbinol|7683-59-2 (free)|NSC33791|NCGC00015558-06|3,4-Dihydroxy-.alpha.-(isopropylaminomethyl)-benzyl alcohol|A-21|Isoproterenol [JAN]|Protocatechuyl alcohol,-|DL(+-)-Isoproterenol|Isoprenalinum [INN-Latin]|.alpha.-(Isopropylaminomoethyl)protocatechuyl alcohol|Isoprenalina [INN-Spanish]|Isoproterenol Chloride|WLN: QR BQ DYQ1MY1&1|3,4-Dihydroxy-.alpha.-[(isopropylamino)methyl]benzyl alcohol|4-{1-hydroxy-2-[(1-methylethyl)amino]ethyl}benzene-1,2-diol|CAS-7683-59-2|ISOPROP|CCRIS 3081|NSC 9975|1, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-|EINECS 231-687-7|NSC 33791|Isopropylaminomethyl-3,4-dihydroxyphenyl carbinol|4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol|BRN 2213857|4-{1-hydroxy-2-[(methylethyl)amino]ethyl}benzene-1,2-diol|Benzyl alcohol,4-dihydroxy-.alpha.-[(isopropylamino)methyl]-|Isoproterenol-l|UNII-L628TT009W|3,4-DIHYDROXY-.ALPHA.-((ISOPROPYLAMINO)METHYL)BENZYL ALCOHOL|Isoproterenol (-)|Isoproterenol,(+)|Protocatechuyl alcohol, alpha-(isopropylaminomethyl)-|ISOPROTERONOL|Isoproterenol dl-form|Isuprel (Salt/Mix)|Izadrin (Salt/Mix)|Euspiran (Salt/Mix)|L-Isoproterenol; Levisoprenaline; Proternol L|(+/-)-isoprenaline|(+/-)-isoproterenol|Spectrum_000949|Prestwick0_001097|Prestwick1_001097|Prestwick2_001097|Spectrum2_001061|Spectrum3_000474|Spectrum4_000024|Spectrum5_000880|(.+/-.)-Isoprenaline|ISOPROTERENOL [MI]|(.+/-.)-Isoproterenol|SCHEMBL4165|DL(.+/-.)-Isoproterenol|Lopac0_000711|Oprea1_009434|BSPBio_002208|GTPL536|ISOPRENALINE [MART.]|ISOPROTERENOL [VANDF]|KBioGR_000427|KBioSS_001429|3-13-00-02387 (Beilstein Handbook Reference)|DivK1c_000894|ISOPRENALINE [WHO-DD]|SPBio_001042|SPBio_003057|orb1705072|SGCUT00015|4-(1-Hydroxy-2(isopropylamino)ethyl)-benzene 1,2-diol|SCHEMBL29386243|BDBM25392|KBio1_000894|KBio2_001429|KBio2_003997|KBio2_006565|KBio3_001428|NSC9975|NINDS_000894|HMS2089A12|HMS3742A11|ISOPROTERENOL DL-FORM [MI]|BCP09043|Benzyl alcohol, 3,4-dihydroxy-alpha-((isopropylamino)methyl)-|to_000062|(A+/-)-Isoproterenol hydrochloride|Tox21_110172|PDSP1_001425|PDSP2_001409|SBB005855|STL558077|AKOS015913894|Tox21_110172_1|CCG-204727|CCG-204796|DB01064|SDCCGSBI-0050620.P003|SDCCGSBI-0050689.P005|IDI1_000894|NCGC00015558-04|NCGC00015558-05|NCGC00015558-07|NCGC00015558-08|NCGC00015558-09|NCGC00015558-10|NCGC00015558-11|NCGC00015558-12|NCGC00015558-13|NCGC00015558-14|NCGC00015558-25|NCGC00016665-02|NCGC00025274-03|NCGC00025274-04|NCGC00162220-01|114-45-4|ST077771|TS-08150|SBI-0050689.P004|HY-108353|CS-0028436|NS00001320|C07056|D08090|EN300-148243|AB00053487-09|AB00053487-10|AB00053487_11|AB00053487_12|683I592|AG-219/03618046|L000936|Q415550|.alpha.-(Isopropylaminomethyl)protocatechuyl alcohol|BRD-A04322457-003-15-3|BRD-A04322457-003-16-1|BRD-A04322457-003-17-9|BRD-A04322457-003-18-7|4-[1-Hydroxy-2-(isopropylamino)ethyl]-1,2-benzenediol|Protocatechuyl alcohol,.alpha.-(isopropylamino-methyl),-|4-[1-Hydroxy-2-(isopropylamino)ethyl]-1,2-benzenediol #|N-Isopropyl-.beta.-dihydroxyphenyl-.beta.-hydroxyethylamine|4-[1-hydroxy-2-(isopropylamino)ethyl]pyrocatechol;hydrochloride|4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,2-diol, 2|Benzyl alcohol, 3,4-dihydroxy-.alpha.-((isopropylamino)methyl)-"
CARAZOLOL,71739,,"InChI=1S/C18H22N2O2/c1-12(2)19-10-13(21)11-22-17-9-5-8-16-18(17)14-6-3-4-7-15(14)20-16/h3-9,12-13,19-21H,10-11H2,1-2H3",BQXQGZPYHWWCEB-UHFFFAOYSA-N,C18H22N2O2,298.4,1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol,"Carazolol|57775-29-8|Conducton|Suacron|Carazololum|BM 51052|BM-51052|1-(9H-carbazol-4-yloxy)-3-(propan-2-ylamino)propan-2-ol|29PW75S82A|4-(2-Hydroxy-3-isopropylamino-propoxy)-carbazole|DTXSID00866648|RefChem:123361|DTXCID10814913|260-945-1|1-(Carbazol-4-yloxy)-3-(isopropylamino)-2-propanol|1-((9H-Carbazol-4-yl)oxy)-3-(isopropylamino)propan-2-ol|corazolol|2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[(1-methylethyl)amino]-|1-(9H-carbazol-4-yloxy)-3-(isopropylamino)propan-2-ol|MFCD00864588|CHEMBL324665|Carazolol (INN)|Carazolol 100 microg/mL in Acetonitrile|CARAZOLOL [INN]|Carazolol [INN:BAN]|2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((1-methylethyl)amino)-|Carazololum [INN-Latin]|CCRIS 1047|(R)-Carazolol Hydrochloride|EINECS 260-945-1|BRN 3620576|UNII-29PW75S82A|Conducton (TN)|1-(4-Carbazolyloxy)-3-isopropylamino-2-propanol|Carazolol (Standard)|1-(9H-Carbazol-4-yloxy-3-((1-methylethyl)amino)-2-propanol)|CARAZOLOL [MI]|CARAZOLOL [MART.]|CARAZOLOL [WHO-DD]|Suacron [veterinary] (TN)|SCHEMBL77901|GTPL569|MLS006010892|Carazolol, analytical standard|orb1304347|SCHEMBL29354289|MSK7126|CHEBI:135261|HMS5085I22|DDA85934|YWB02102|BDBM50027663|s6447|AKOS027320502|HY-107327R|SB66991|LS-14657|SMR002529709|SY053155|Carazolol 1000 microg/mL in Acetonitrile|HY-107327|C2578|CS-0028150|NS00008336|75C298|D07608|T71087|F601155|L000159|Q5037818|BRD-A50675490-001-01-0|1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)-2-propanol|1-(9H-Carbazol-4-yloxy)-3-isopropylamino-propan-2-ol|1-(9H-Carbazol-4-yloxy)-3-(isopropylamino)-2-propanol #|1-(9H-Carbazol-4-yloxy)-3-isopropylamino-propan-2-ol(carazolol)"
JNJ-39758979,24994634,,"InChI=1S/C11H19N5/c1-7(2)9-5-10(15-11(13)14-9)16-4-3-8(12)6-16/h5,7-8H,3-4,6,12H2,1-2H3,(H2,13,14,15)/t8-/m1/s1",COOGVHJHSCBOQT-MRVPVSSYSA-N,C11H19N5,221.30,4-[(3R)-3-aminopyrrolidin-1-yl]-6-propan-2-ylpyrimidin-2-amine,"JNJ-39758979|1046447-90-8|jnj39758979|JNJ 39758979|5RV7T5BNMG|4-[(3R)-3-aminopyrrolidin-1-yl]-6-propan-2-ylpyrimidin-2-amine|2-Pyrimidinamine, 4-((3R)-3-amino-1-pyrrolidinyl)-6-(1-methylethyl)-|JNJ-39758979, (-)-|4-((3R)-3-aminopyrrolidin-1-yl)-6-propan-2-ylpyrimidin-2-amine|RefChem:150541|MFCD28502028|CHEMBL3236549|(r)-4-(3-amino-pyrrolidin-1-yl)-6-isopropyl-pyrimidin-2-ylamine|4-[(3R)-3-aminopyrrolidin-1-yl]-6-(propan-2-yl)pyrimidin-2-amine|UNII-5RV7T5BNMG|SCHEMBL604514|GTPL8984|orb1309524|GLXC-04851|WRB44790|BDBM50006789|EX-A11126|AKOS030628488|JNJ 39758979 [WHO-DD]|MS-23237|HY-101189|CS-0020957|Q27888282|4-[(3R)-3-aminopyrrolidin-1-yl]-6-isopropyl-pyrimidin-2-amine"
AZD-6703,11373432,,"InChI=1S/C24H27N5O2/c1-16-3-4-17(23(30)26-18-5-6-18)13-22(16)29-15-25-21-8-7-19(14-20(21)24(29)31)28-11-9-27(2)10-12-28/h3-4,7-8,13-15,18H,5-6,9-12H2,1-2H3,(H,26,30)",ZMAZXHICVRYLQN-UHFFFAOYSA-N,C24H27N5O2,417.5,N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3-yl]benzamide,"AZD6703|AZD-6703|851845-37-9|AZ12012199|8QS8G2Y8E0|AZ-12012199|AZD 6703|N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3-yl]benzamide|Benzamide, N-cyclopropyl-4-methyl-3-(6-(4-methyl-1-piperazinyl)-4-oxo-3(4H)-quinazolinyl)-|N-Cyclopropyl-4-methyl-3-(6-(4-methyl-1-piperazinyl)-4-oxo-3(4H)-quinazolinyl)benzamide|N-cyclopropyl-4-methyl-3-(6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3-yl)benzamide|RefChem:116048|AZD6703 free base|AZD 6703 [WHO-DD]|N-cyclopropyl-4-methyl-3-[6-(4-methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide|UNII-8QS8G2Y8E0|CHEMBL2031465|GTPL7687|orb1701123|SCHEMBL1140074|SCHEMBL29367099|ZMAZXHICVRYLQN-UHFFFAOYSA-N|851845-37-9 (free base)|BDBM50384367|AKOS040747898|DB-343869|CS-0027117|AZ 12012199|Q27074780|N-cyclopropyl-4-methyl-3-[6-(4 methylpiperazin-1-yl)-4-oxoquinazolin-3(4H)-yl]benzamide"
NIRAPARIB,24958200,,"InChI=1S/C19H20N4O/c20-19(24)17-5-1-3-15-12-23(22-18(15)17)16-8-6-13(7-9-16)14-4-2-10-21-11-14/h1,3,5-9,12,14,21H,2,4,10-11H2,(H2,20,24)/t14-/m1/s1",PCHKPVIQAHNQLW-CQSZACIVSA-N,C19H20N4O,320.4,2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide,"Niraparib|1038915-60-4|MK4827|2-[4-[(3S)-piperidin-3-yl]phenyl]indazole-7-carboxamide|HMC2H89N35|2-{4-[(3s)-piperidin-3-yl]phenyl}-2h-indazole-7-carboxamide|ZL-2306|JNJ-64091742|CHEBI:176844|DTXSID50146129|niraparibum|2-(4-((3S)-piperidin-3-yl)phenyl)indazole-7-carboxamide|2-{4-[(3S)-piperidin-3-yl]phenyl}indazole-7-carboxamide|2-(4-((3S)-PIPERIDIN-3-YL)PHENYL)-2H-INDAZOLE-7-CARBOXAMIDE|RefChem:57941|DTXCID8068620|L01XX54|685-112-3|MK-4827|(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide|MFCD17779309|Niraparib [USAN]|C19H20N4O|MK-4827 (Niraparib)|2-[4-(3S)-3-Piperidinylphenyl]-2H-indazole-7-carboxamide|CHEMBL1094636|Niraparib (USAN)|Niraparib [USAN:INN]|2-[4-[(3S)-3-Piperidyl]phenyl]indazole-7-carboxamide|UNII-HMC2H89N35|MK 4827 (Base)|3JD|Niraparib (Standard)|NIRAPARIB [INN]|NIRAPARIB [MI]|MK-4827(Niraparib)|NIRAPARIB [WHO-DD]|GTPL8275|orb1304399|SCHEMBL1421875|(S)-2-(4-(piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide;MK-4827|Niraparib(MK4827) free base?|EX-A290|MK-4827 (PARP-1)|BDBM50316226|HY-10619R|MSK168159|NSC754355|NSC800020|s2741|AKOS016004869|BCP9000940|CCG-267709|compound 56 [PMID 19873981]|CS-0780|DB11793|FP35532|MK-4827/MK4827|NSC-754355|NSC-800020|NCGC00346435-01|NCGC00346435-04|NCGC00346435-12|NCGC00346435-13|AC-28447|AS-35248|BP-44033|HY-10619|Akeega (niraparib and abiraterone acetate)|BCP0726000077|5129B|5142B|NS00072574|D10140|EN300-7364833|F227536|BRD-K54955827-001-01-4|BRD-K54955827-001-02-2|Q25326660|2H-Indazole-7-carboxamide, 2-[4-(3S)-3-piperidinylphenyl]|2H-INDAZOLE-7-CARBOXAMIDE, 2-(4-(3S)-3-PIPERIDINYLPHENYL)-|Niraparib;(S)-2(4-(Piperidin-3-yl)phenyl)-2H-indazole-7-carboxamide"
PEXACERFONT,9884366,,"InChI=1S/C18H24N6O/c1-7-10(2)19-18-22-13(5)21-17-16(12(4)23-24(17)18)14-8-9-15(25-6)20-11(14)3/h8-10H,7H2,1-6H3,(H,19,21,22)/t10-/m1/s1",LBWQSAZEYIZZCE-SNVBAGLBSA-N,C18H24N6O,340.4,"N-[(2R)-butan-2-yl]-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine","PEXACERFONT|459856-18-9|BMS-562086|LF1VBG4ZUK|Dpc-a69448|DTXSID60196675|BMS562086|N-[(2R)-butan-2-yl]-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine|N-((2R)-BUTAN-2-YL)-8-(6-METHOXY-2-METHYLPYRIDIN-3-YL)-2,7-DIMETHYLPYRAZOLO(1,5-A)(1,3,5)TRIAZIN-4-AMINE|pexacerfontum|RefChem:928912|DTXCID00119166|N-((R)-sec-butyl)-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethylpyrazolo[1,5-a][1,3,5]triazin-4-amine|CRF1 ANTAGONIST|8-(6-Methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-((1R)-1-methylpropyl)pyrazolo(1,5-a)-1,3,5-triazin-4-amine|UNII-LF1VBG4ZUK|Pexacerfont [USAN]|Pexacerfont [USAN:INN]|8-(6-Methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-[(1R)-1-methylpropyl]pyrazolo[1,5-a]-1,3,5-triazin-4-amine|BMS 562086|PEXACERFONT [INN]|Pexacerfont (USAN/INN)|CHEMBL482950|orb1706825|SCHEMBL5235999|SCHEMBL29482255|BDBM29490|GTPL10379|CHEBI:177416|GLXC-15296|EX-A3079|ZB1563|AKOS040742389|CS-6630|DB12572|AC-32621|DA-66596|FP170137|HY-12127|MS-25202|NS00072040|D10022|D70085|Pyrazolo[1,5-a]-1,3,5-triazine, 13-15|Q7179563|8-(6-methoxy-2-methyl-3-pyridyl)-2,7-dimethyl-N-[(1R)-1-methylpropyl]pyrazolo[1,5-a][1,3,5]triazin-4-amine|Pyrazolo(1,5-a)-1,3,5-triazin-4-amine, 8-(6-methoxy-2-methyl-3-pyridinyl)-2,7-dimethyl-N-((1R)-1-methylpropyl)-"
FLUOXETINE HYDROCHLORIDE,62857,,"InChI=1S/C17H18F3NO.ClH/c1-21-12-11-16(13-5-3-2-4-6-13)22-15-9-7-14(8-10-15)17(18,19)20;/h2-10,16,21H,11-12H2,1H3;1H",GIYXAJPCNFJEHY-UHFFFAOYSA-N,C17H19ClF3NO,345.8,N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride,"FLUOXETINE HYDROCHLORIDE|56296-78-7|Fluoxetine Hcl|Fluoxeren|Adofen|Fluctin|Lovan|Fontex|Foxetin|Fluox-Puren|Fluneurin|Reconcile|Affectine|Deproxin|Digassim|Fluctine|Margrilan|Modipran|Pragmaten|Rowexetina|Erocap|Fludac|Flufran|Flunil|Fluoxac|Fluoxil|Flutin|Flutine|Fluxen|Fluxil|Lorien|Neupax|Nopres|Oxedep|Prizma|Prodep|Sanzur|Sinzac|Zactin|Nuzak|Zepax|Profluzac|Selfemra|Fluxet|Prozac Weekly|Lilly 110140|LY110140|LY 110140|LY-110140|I9W7N6B1KJ|Fluoxetine (as hydrochloride)|DTXSID7020635|DTXCID70635|3-(p-Trifluoromethylphenoxy)-N-methyl-3-phenylpropylamine hydrochloride|(+-)-Methyl-gamma-(4-(trifluoromethyl)phenoxy)benzenepropanamine hydrochloride|(+-)-N-Methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propylamine hydrochloride|NSC714457|Felicium|Oxactin|Ranflutin|Prozep|Prozit|Olena|Fluoxetine Capsules|Prozac 60|RefChem:5839|CHEBI:5119|260-101-2|Ansilan|Flusol|Prozac|59333-67-4|Sarafem|Fluoxetine (hydrochloride)|Fluoxetine.HCl|MFCD00214288|N-methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine hydrochloride|C17H19ClF3NO|HSDB 6633|methyl({3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl})amine hydrochloride|MLS000069361|LY-110140 (free base)|CHEMBL1201082|N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine hydrochloride|Flunirin|Proctin|SMR000058452|Prozac 20|Fluoxetine hydrochloride 100 microg/mL in Acetonitrile|Alzac 20|FluoxetineHydrochloride|N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]-1-propylamine Hydrochloride|N-methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propan-1-amine;hydrochloride|CCRIS 6150|Fluoxetine hydrochloride [USAN]|SR-01000002988|EINECS 260-101-2|UNII-I9W7N6B1KJ|Framex|Fluoxetin HCl|Fluoxetine  HCl|Prestwick_798|Sarafem (TN)|Fluoxetine hydrochloride [USAN:USP]|Prozac (TN)|CPD000058452|Fluoxetine Hydrochloride?|Opera_ID_1538|SCHEMBL33384|MLS001076338|MLS002222264|LY-110,140 hydrochloride|SPECTRUM1504173|Fluoxetine hydrochloride, solid|orb1310602|HY-B0102A|MSK10030A|CHEBI:145458|HMS1569H03|HMS1922F07|HMS5079N11|Pharmakon1600-01504173|BCP19962|Fluoxetine HCl - Bio-X trade mark|NPL-2008|YWB02043|Fluoxetine hydrochloride (JAN/USP)|Tox21_200182|Tox21_500558|CCG-39084|FLUOXETINE HYDROCHLORIDE [MI]|HB1600|Methyl(3-phenyl-3-(4-(trifluoromethyl)phenoxy)propyl)ammonium chloride|NSC758685|Prozac; LY-110,140 hydrochloride|s1333|FLUOXETINE HYDROCHLORIDE [JAN]|AKOS015894939|Propylamine, N-methyl-3-phenyl-3-(p-trifluoromethylphenoxy)-, hydrochloride|AB04860|AC-1697|CS-1838|FF23496|FLUOXETINE HYDROCHLORIDE [HSDB]|KS-1061|LP00558|NC00715|NSC-714457|Benzenepropanamine, N-methyl-gamma-(4-(trifluoromethyl)phenoxy)-, hydrochloride|FLUOXETINE HYDROCHLORIDE [VANDF]|N-methyl-3-phenyl-3-{[4-(trifluoromethyl)phenyl]oxy}propan-1-amine hydrochloride|FLUOXETINE HYDROCHLORIDE [USP-RS]|FLUOXETINE HYDROCHLORIDE [WHO-DD]|NCGC00093943-01|NCGC00093943-02|NCGC00093943-03|NCGC00093943-04|NCGC00093943-05|NCGC00257736-01|NCGC00261243-01|BF163653|SY035644|CAS-56296-78-7|A8349|EU-0100558|F-132|F0750|FLUOXETINE HYDROCHLORIDE [GREEN BOOK]|NS00076376|SW196934-4|FLUOXETINE HYDROCHLORIDE [ORANGE BOOK]|D00823|EN300-199739|FLUOXETINE HYDROCHLORIDE [EP MONOGRAPH]|FLUOXETINE HYDROCHLORIDE [USP IMPURITY]|FLUOXETINE HYDROCHLORIDE [USP MONOGRAPH]|SYMBYAX COMPONENT FLUOXETINE HYDROCHLORIDE|910F893|F375072|Fluoxetine.HCl, 1mg/ml in Methanol (as free base)|SR-01000002988-2|SR-01000002988-4|SR-01000002988-9|Q27280620|Z1741982921|Fluoxetine hydrochloride, VETRANAL(TM), analytical standard|Fluoxetine Hydrochloride 1.0 mg/ml in Methanol (as free base)|Fluoxetine hydrochloride, British Pharmacopoeia (BP) Reference Standard|Fluoxetine hydrochloride, European Pharmacopoeia (EP) Reference Standard|Methyl-[3-phenyl-3-(4-trifluoromethyl-phenoxy)-propyl]-amine hydrochloride|N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propylamine Hydrochloride|(+/-)-N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride|Fluoxetine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material|Fluoxetine hydrochloride, United States Pharmacopeia (USP) Reference Standard|N-Methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-amine hydrochloride1|N-Methyl-3-phenyl-3-(4-(trifluoromethyl)phenoxy)propan-1-aminehydrochloride1|N-Methyl-gamma-[4-(trifluoromethyl)phenoxy]benzenepropanamine HCl;5-HT reuptake inhibitor|(+/-)-N-METHYL-3-PHENYL-3-((.ALPHA.,.ALPHA.,.ALPHA.-TRIFLUORO-P-TOLYL)OXY)PROPYLAMINE, HYDROCHLORIDE|BENZENEPROPANAMINE, N-METHYL-.GAMMA.-(4-(TRIFLUOROMETHYL)PHENOXY)-, HYDROCHLORIDE (1:1)|BENZENEPROPANAMINE, N-METHYL-.GAMMA.-(4-(TRIFLUOROMETHYL)PHENOXY)-, HYDROCHLORIDE, (+/-)-|N-Methyl-?-[4-(trifluoromethyl)phenoxy]benzenepropanamine hydrochloride;(+/-)-N-Methyl-3-phenyl-3-[4-(trifluoromethyl)phenoxy]propyl amine hydrochloride;Adofen"
VORTIOXETINE,9966051,,"InChI=1S/C18H22N2S/c1-14-7-8-17(15(2)13-14)21-18-6-4-3-5-16(18)20-11-9-19-10-12-20/h3-8,13,19H,9-12H2,1-2H3",YQNWZWMKLDQSAC-UHFFFAOYSA-N,C18H22N2S,298.4,"1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine","VORTIOXETINE|508233-74-7|Lu AA21004|vortioxetina|1-{2-[(2,4-dimethylphenyl)sulfanyl]phenyl}piperazine|vortioxetinum|LuAA21004|Lu-AA21004|3O2K1S3WQV|CHEBI:76016|Piperazine, 1-[2-[(2,4-dimethylphenyl)thio]phenyl]-|DTXSID80965062|Piperazine, 1-(2-((2,4-dimethylphenyl)thio)phenyl)-|1-(2-(2,4-dimethylphenylsulfanyl)phenyl)piperazine|1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine|1-(2-((2,4-Dimethylphenyl)sulfanyl)phenyl}piperazine|1-(2-((2,4-DIMETHYLPHENYL)SULFANYL)PHENYL)PIPERAZINE|RefChem:57757|N06AX26|DTXCID801392739|1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine|Vortioxetine free base|Vortioxetine [USAN]|1-[2-(2,4-dimethylphenyl)sulfanylphenyl]piperazine|C18H22N2S|508233-74-7 (free base)|Vortioxetine (USAN)|Brintellix (TN)|1-[2-(2,4-dimethyl-phenylsulfanyl)-phenyl]-piperazine|CHEMBL2204360|Vortioxetine [USAN:INN]|UNII-3O2K1S3WQV|Piperazine, 1-[2-[(2,4-dimethylphenyl)thio]phenyl]-; 1-[2-(2,4-Dimethylphenylsulfanyl)phenyl]piperazine; Lu AA 21004; Vortioxetine|VTX|MFCD22380814|PS37 - Vortioxetine|Vortioxetine (Standard)|VORTIOXETINE [MI]|VORTIOXETINE [INN]|VORTIOXETINE [VANDF]|Vortioxetine, Lu AA21004|SCHEMBL236115|VORTIOXETINE [WHO-DD]|GTPL7351|orb1305548|Vortioxetine (Lu AA21004)|CHEMBL2104993|SCHEMBL29469584|HSDB 8250|Vortioxetine (Lu AA21004)?|YQNWZWMKLDQSAC-UHFFFAOYSA-N|GLXC-15242|HMS3886M08|HMS5084J12|BCP05996|QKD31662|BDBM50400902|HY-15414R|MSK157139|s5506|STL483777|AKOS016008748|CCG-229998|CS-1471|DB09068|FD58721|GG-0052|SB16506|compound 5m [PMID: 21486038]|NCGC00386237-08|AC-27648|DA-42264|HY-15414|NS00068019|D10184|EN300-746942|AR-270/43507985|Q3563148|1-[2-(2,4-Dimethylphenylsulfanyl)-phenyl]piperazine|BRD-K53963539-001-01-8|BRD-K53963539-004-02-0|1-[2-[(2,4-Dimethylphenyl)thio]phenyl]-piperazine; Vortioxetine; 1-(2-((2,4-Dimethylphenyl)thio)phenyl)piperazine|Lu AA 21004 pound>>LuAA21004 pound>> Lu-AA21004 pound>> Lu AA21004 pound>> AA21004"
MOFEZOLAC,4237,,"InChI=1S/C19H17NO5/c1-23-14-7-3-12(4-8-14)18-16(11-17(21)22)25-20-19(18)13-5-9-15(24-2)10-6-13/h3-10H,11H2,1-2H3,(H,21,22)",DJEIHHYCDCTAAH-UHFFFAOYSA-N,C19H17NO5,339.3,"2-[3,4-bis(4-methoxyphenyl)-1,2-oxazol-5-yl]acetic acid","mofezolac|78967-07-4|Mofezolaco|Mofezolacum|DTXSID1046716|RVJ0BV3H3Y|(3,4-bis(4-methoxyphenyl)-5-isoxazolyl)acetic acid|DTXCID9026716|3,4-DMPIAA|N-22 compound|[3,4-bis(4-methoxyphenyl)-5-isoxazolyl]acetic acid|(3,4-di-(4-methoxyphenyl)-5-isoxazolyl)acetic acid|RefChem:159308|2-(3,4-bis(4-methoxyphenyl)isoxazol-5-yl)acetic acid|Disopain|Mofezolac [INN]|N-22|2-[3,4-bis(4-methoxyphenyl)-1,2-oxazol-5-yl]acetic acid|5-Isoxazoleacetic acid, 3,4-bis(4-methoxyphenyl)-|Mofezolac (TN)|[3,4-Bis-(4-methoxyphenyl)isoxazol-5-yl]-acetic acid|CHEMBL259972|3,4-bis(p-Methoxyphenyl)-5-isoxazoleacetic acid|NCGC00167563-01|2-[3,4-bis(4-methoxyphenyl)isoxazol-5-yl]acetic acid|[3,4-bis(4-methoxyphenyl)-1,2-oxazol-5-yl]acetic acid|Mofezolacum [INN-Latin]|Mofezolaco [INN-Spanish]|CCRIS 4316|UNII-RVJ0BV3H3Y|BRN 5986171|Mofezolac?|3,4-Bis(4-methoxyphenyl)-5-isoxazoleacetic acid|3,4-Bis((4-methoxyphenyl)-5-isooxazolyl)acetic acid|Acetic acid, 3,4-bis(4-methoxyphenyl)-5-isooxazolyl-|Mofezolac (JAN/INN)|MOFEZOLAC [JAN]|MOFEZOLAC [MI]|CBKinase1_012222|CBKinase1_024622|MOFEZOLAC [MART.]|MOFEZOLAC [WHO-DD]|Oprea1_261181|Oprea1_588700|MLS006011640|SCHEMBL151701|IFLab1_003830|orb1301773|CHEBI:31860|HMS1422O02|Tox21_112558|BDBM50376383|EX-A11206|MFCD00712149|STK973280|AKOS000523630|CCG-107450|IDI1_009937|AC-38121|AS-68999|DA-75652|SMR000069874|CAS-78967-07-4|HY-120824|CS-0079262|NS00121011|ST50117184|D01718|N16836|3,4,-Di(p-methoxyphenyl)isoxazol-5-acetic Acid|[3,4-bis(4-methoxyphenyl)isoxazol-5-yl]acetic acid|BRD-K49372556-001-01-7|BRD-K49372556-001-02-5|BRD-K49372556-001-04-1|Q15409378|63X"
ICOPEZIL,172972,,"InChI=1S/C23H25N3O2/c27-23-13-18-12-19-20(25-28-22(19)14-21(18)24-23)7-6-16-8-10-26(11-9-16)15-17-4-2-1-3-5-17/h1-5,12,14,16H,6-11,13,15H2,(H,24,27)",MTCMTKNMZCPKLX-UHFFFAOYSA-N,C23H25N3O2,375.5,"3-[2-(1-benzylpiperidin-4-yl)ethyl]-5,7-dihydropyrrolo[3,2-f][1,2]benzoxazol-6-one","Icopezil|145508-78-7|Icopezil [INN]|UNII-ERZ60E6B7C|ERZ60E6B7C|CP 118954|icopezilo|CP-118954|CP 118,954|ICOPEZIL [WHO-DD]|3-(2-(1-BENZYL-4-PIPERIDYL)ETHYL)-5,7-DIHYDRO-6H-PYRROLO(3,2-F)-1,2-BENZISOXAZOL-6-ONE|icopezilum|RefChem:147665|CID 5490675|CHEMBL359570|CHEMBL329012|3-[2-(1-benzylpiperidin-4-yl)ethyl]-5,7-dihydropyrrolo[3,2-f][1,2]benzoxazol-6-one|SCHEMBL194482|orb1819168|DTXSID70932622|BDBM50032162|TS-09515|HY-105157|CS-0025147|Q27277324|3-[2-(1-Benzylpiperidin-4-yl)ethyl]-2,5-dihydro-6H-[1,2]oxazolo[4,5-f]indol-6-one|3-[2-(1-Benzyl-piperidin-4-yl)-ethyl]-5,7-dihydro-isoxazolo[4,5-f]indol-6-one; compound with (Z)-but-2-enedioic acid"
TIAGABINE,60648,,"InChI=1S/C20H25NO2S2/c1-14-7-11-24-18(14)17(19-15(2)8-12-25-19)6-4-10-21-9-3-5-16(13-21)20(22)23/h6-8,11-12,16H,3-5,9-10,13H2,1-2H3,(H,22,23)/t16-/m1/s1",PBJUNZJWGZTSKL-MRXNPFEDSA-N,C20H25NO2S2,375.6,"(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid","tiagabine|115103-54-3|Tiagabina|(R)-Tiagabine|Tiagabinum|Abbott-70569|Z80I64HMNP|ABT-569 FREE BASE|CHEBI:9586|(-)-(R)-1-(4,4-Bis(3-methyl-2-thienyl)-3-butenyl)nipecotic acid|NO-050328 FREE BASE|ABBOTT-70569 FREE BASE|NNC-050328 FREE BASE|NO-328|ABBOTT-705691 FREE BASE|3-Piperidinecarboxylic acid, 1-[4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl]-, (3R)-|DTXSID5023663|3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-butenyl)-, (R)-|(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxylic acid|NO-329|(-)-(r)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid|3-Piperidinecarboxylic acid, 1-(4,4-bis(3-methyl-2-thienyl)-3-buten-1-yl)-, (3R)-|(3R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic acid|RefChem:56679|DTXCID503663|N03AG06|N-(4,4-di(3-Methylthien-2-yl)but-3-enyl)nipecotic acid|Gabitril|Tiagabinum [INN-Latin]|Tiagabina [INN-Spanish]|Tiagabine [INN]|Tiagabine (INN)|ABBOTT-70569-1|(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-enyl]piperidine-3-carboxylic acid|Gabitril (TN)|CHEMBL1027|A-70569-1|Tiagabine [INN:BAN]|(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]piperidine-3-carboxylic acid|(R)-1-(4,4-Bis(3-methylthiophen-2-yl)but-3-en-1-yl)piperidine-3-carboxylic acid|[3H]tiagabine|1006863-69-9|C20H25NO2S2|NCGC00164626-01|NO 328|UNII-Z80I64HMNP|HSDB 7527|NO328|MFCD00865317|TIAGABINE [MI]|NO 050328|TIAGABINE [HSDB]|TIAGABINE [VANDF]|TIAGABINE [WHO-DD]|SCHEMBL34653|BIDD:GT0018|GTPL4685|GTPL4818|orb1305531|(-)-(R)-1-[4,4-Bis(3-methyl-2-thienyl)-3butenyl]nipecotic acid hydrochloride|HMS3885J16|HY-B0696|MSK14208|BDBM50039251|BDBM50368628|s4675|(3R)-1-[4,4-bis(3-methyl-2-thienyl)but-3-enyl]piperidine-3-carboxylic acid|AKOS016011165|AC-7048|CCG-268358|DB00906|NO050328|TS-08360|NS00001014|C07503|D08588|EN300-222195|H37009|103T543|Q907219|BRD-K60160658-003-08-8|BRD-K60160658-003-11-2|(R)-(-)-1-[4,4-bis(3-methyl-2-thienyl)-3-butenyl]nipecotic acid|(r)-n-[4,4-bis(3-methyl-2-thienyl)but-3-en-1-yl]nipecotic acid|(3R)-1-(4,4-BIS(3-METHYL-2-THIENYL)-3-BUTEN-1-YL)-3-PIPERIDINECARBOXYLIC ACID|(R)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-enyl)piperidine-3-carboxylic acid hydrochloride|(R)-1-[4,4-Bis-(3-methyl-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid|(S)-1-(4,4-bis(3-methylthiophen-2-yl)but-3-enyl)piperidine-3-carboxylic acid|1-[4,4-Bis-(3-methyl-4,5-dihydro-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid|(3R)-1-[4,4-bis(3-methylthiophen-2-yl)but-3-en-1-yl]piperidine-3-carboxylic acid; Gabitril|(R)-1-[4,4-Bis-(3-methyl-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid; hydrochloride|1-[4,4-Bis-(3-methyl-thiophen-2-yl)-but-3-enyl]-piperidine-3-carboxylic acid; hydrochloride"
GAMMA-AMINOBUTYRIC ACID,119,,"InChI=1S/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7)",BTCSSZJGUNDROE-UHFFFAOYSA-N,C4H9NO2,103.12,4-aminobutanoic acid,"gamma-aminobutyric acid|GABA|56-12-2|Piperidic acid|Piperidinic acid|Aminalon|butanoic acid, 4-amino-|Gaballon|Gammalon|Gammalone|Gammasol|Mielomade|Gamarex|Gammar|Butyric acid, 4-amino-|gamma-amino-n-butyric acid|gamma-Aminobutanoic acid|Immu-G|Gammagee|Gamulin|4-aminobutyrate|omega-Aminobutyric acid|Aminalone|4-aminobutanoate|gamma-Aminobuttersaeure|gamma Aminobutyric acid|Factor I|4Abu|2ACZ6IPC6I|Aminobutyric acid, gamma-|NSC-27418|CHEBI:16865|Lithium GABA|Acid, Aminobutyric|GABA, Lithium|4 Aminobutyric Acid|4 Aminobutanoic Acid|Therafeldamine|Theraproxen|GABA Phenolic|Therapentin-60|Theraprofen-60|Theraprofen-90|Theraproxen-90|Theratramadol-60|Theratramadol-90|Theraprofen-800|Theraproxen-500|Theracodeine-300|Therabenzaprine-60|Therabenzaprine-90|Theracodophen-650|Theracodophen-750|Hydrochloride gamma-Aminobutyric Acid|Acid, Hydrochloride gamma-Aminobutyric|gamma Aminobutyric Acid, Hydrochloride|gamma Aminobutyric Acid, Monosodium Salt|RefChem:5851|Therabenzaprine-90-5|gamma Aminobutyric Acid, Monolithium Salt|gamma-amino-butyric acid|gamma.-aminobutyric acid|CARISOPRODOL, GABA|Gaba (Gamma-Aminobutyric Acid)|GABA 1519|TRAMADOL HYDROCHLORIDE, GABA|NAPROXEN, GAMMA-AMINOBUTYRIC ACID|IBUPROFEN, GAMMA-AMINOBUTYRIC ACID|PIROXICAM, GAMMA-AMINOBUTYRIC ACID|GABAPENTIN, GAMMA-AMINOBUTYRIC ACID|TRAMADOL HYDROCHLORIDE, GAMMA-AMINOBUTYRIC ACID|HYDROCODONE, ACETAMINOPHEN, gamma-AMINOBUTYRIC ACID|CYCLOBENZAPRINE HYDROCHLORIDE, GAMMA-AMINOBUTYRIC ACID|ACETAMINOPHEN, CODEINE PHOSPHATE, GAMMA-AMINOBUTYRIC ACID|HYDROCODONE BITARTRATE, ACETAMINOPHEN, GAMMA-AMINOBUTYRIC ACID|200-258-6|4-azaniumylbutanoate|Aminobutyric Acid|4-aminobutyric acid|4-Aminobutanoic acid|Mielogen|Reanal|.gamma.-Aminobutyric acid|Gamastan|gamma-aminobutyrate|gamma-Amino butyric acid|3-Carboxypropylamine|4-amino-butanoic acid|GAMMA-AMINO-BUTANOIC ACID|g-Aminobutyric acid|4-amino butyric acid|4-Amino-butyric acid|DF 468|CCRIS 3721|Gamma-aminobutyric acid [JAN]|4-amino-n-butyric acid|GAMMA(AMINO)-BUTYRIC ACID|Aminobutanoic acid|.gamma.-Amino-butyric acid|20-79-1|NSC 27418|.gamma.-Amino-N-butyric acid|EPA Pesticide Chemical Code 030802|DTXSID6035106|AI3-26812|gamma-Aminobutryic acid|4-NH2-but|4-NH3-but|CHEMBL96|MFCD00008226|.gamma.-Aminobutanoic acid|[3H]GABA|MLS000028505|gamma-Aminobutyric acid (JAN)|Butanoic acid, 4-amino- (9CI)|NSC27418|NSC32044|NSC45460|NSC51295|4-Aminobutylate|Butyric acid, 4-amino- (7CI,8CI)|NCGC00015043-07|SMR000058285|4-AMINO-BUTYRATE|WLN: Z3VQ|4-Aminobutyricacid|BUTANOIC ACID,4-AMINO|Chemical Name: .gamma.-Aminobutanoic acid|gamma-Aminobuttersaeure [German]|4-aminobutanoic acid (gamma-aminobutyric acid)|SR-01000075618|Acide amino-4- butyrique [French]|EINECS 200-258-6|UNII-2ACZ6IPC6I|Vigabatrin EP Impurity D|Acide amino-4- butyrique|aminobutyrate|Immuglobin|Piperidate|Piperidinate|w-Aminobutyrate|Gamma aminobutyrate|omega-Aminobutyrate|Gammalon (TN)|a-Aminobutyric acid|w-Aminobutyric acid|Vigabatrin impurity D|Vigabatrin Impurity 1|gamma-aminobutyric-acid|Spectrum_000049|Tocris-0344|Aminobutyric acid,-4-|4-Amino-n-butanoic acid|Opera_ID_1152|Spectrum2_001208|Spectrum3_001385|Spectrum4_000809|Spectrum5_001425|Lopac-A-2129|.omega.-Aminobutyric acid|cid_119|Biomol-NT_000230|bmse000340|bmse000820|bmse000871|SCHEMBL4878|Lopac0_000005|Oprea1_584567|BSPBio_002970|KBioGR_001297|KBioSS_000429|DivK1c_000616|NH2-(CH2)3-COOH|SCHEMBL442853|SCHEMBL444549|SPECTRUM1500678|SPBio_000996|GTPL1067|GTPL5410|orb1310544|SCHEMBL1498122|SCHEMBL3256936|SCHEMBL5165011|SCHEMBL6609421|SGCUT00121|DTXCID4015106|BDBM24183|HMS501O18|KBio1_000616|KBio2_000429|KBio2_002997|KBio2_005565|KBio3_002190|MSK7512|gamma-Aminobutyric acid, >=99%|NINDS_000616|HMS1921C06|HMS2232P09|HMS3260A11|Pharmakon1600-01500678|4-AMINOBUTYRIC ACID [FHFI]|BCP34675|HY-N0067|STR01523|to_000021|4-amino-n-[2,3-3H]butyric acid|Tox21_110071|Tox21_500005|BBL008590|CCG-38515|HB0882|LMFA01100039|NSC-32044|NSC-45460|NSC-51295|NSC757426|PDSP1_001275|PDSP2_001259|s4700|SBB028179|STK301748|AKOS000119660|CS-W020704|DB02530|FA17705|KS-5273|LP00005|NSC-757426|SDCCGSBI-0049994.P004|.GAMMA.-AMINOBUTYRIC ACID [MI]|CAS-56-12-2|GAMMA-AMINOBUTYRIC ACID [MART.]|IDI1_000616|GAMMA-AMINOBUTYRIC ACID [USP-RS]|GAMMA-AMINOBUTYRIC ACID [WHO-DD]|NCGC00015043-01|NCGC00015043-02|NCGC00015043-03|NCGC00015043-04|NCGC00015043-05|NCGC00015043-06|NCGC00015043-08|NCGC00015043-09|NCGC00015043-10|NCGC00015043-14|NCGC00024546-01|NCGC00024546-02|NCGC00024546-03|NCGC00024546-04|NCGC00024546-05|NCGC00024546-06|NCGC00260690-01|BP-21452|gamma-Aminobutyric acid, BioXtra, >=99%|SBI-0049994.P003|gamma-Aminobutyric acid, analytical standard|VIGABATRIN IMPURITY D [EP IMPURITY]|A0282|EU-0100005|NS00002712|ST45061580|EN300-19823|gamma-Aminobutyric acid (4-Aminobutyric acid)|A 2129|C00334|D00058|D70585|Vigabatrin impurity, .gamma.-aminobutyric acid-|AB00052155_12|F317856|L000262|Q210021|SR-01000075618-1|SR-01000075618-3|SR-01000075618-6|SR-01000075618-7|BRD-K77245796-001-19-2|BRD-K77245796-003-01-6|BUTANOIC ACID,4-AMINO   4-AMINO,BUTYRIC ACID|F2191-0196|Z104475620|C5C3DC27-C105-4D18-8A52-F51978B32D24|SODIUM ALENDRONATE TRIHYDRATE IMPURITY A [EP IMPURITY]|4-Aminobutanoic Acid;3-Carboxypropylamine;4-Aminobutyric acid;GABA|gamma-Aminobutyric acid pound>>(c)(3/4)?Aminobutyric acid (GABA)|gamma-Aminobutyric acid, certified reference material, TraceCERT(R)|InChI=1/C4H9NO2/c5-3-1-2-4(6)7/h1-3,5H2,(H,6,7|Vigabatrin impurity D, European Pharmacopoeia (EP) Reference Standard|VIGABATRIN IMPURITY, .GAMMA.-AMINOBUTYRIC ACID- [USP IMPURITY]|gamma-Aminobutyric acid, United States Pharmacopeia (USP) Reference Standard"
CANNABIDIOL,644019,,"InChI=1S/C21H30O2/c1-5-6-7-8-16-12-19(22)21(20(23)13-16)18-11-15(4)9-10-17(18)14(2)3/h11-13,17-18,22-23H,2,5-10H2,1,3-4H3/t17-,18+/m0/s1",QHMBSVQNZZTUGM-ZWKOTPCHSA-N,C21H30O2,314.5,"2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol","cannabidiol|13956-29-1|(-)-Cannabidiol|(-)-trans-Cannabidiol|Epidiolex|GWP42003-P|CARDIOLRX|delta1(2)-trans-Cannabidiol|cannabidiolum|(-)-trans-2-p-Mentha-1,8-dien-3-yl-5-pentylresorcinol|19GBJ60SN5|CHEBI:69478|DTXSID00871959|BTX-1204|BTX-1503|GWP42003|GWP-42003-P|GWP-42003|(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydrobiphenyl-2,6-diol|1,3-Benzenediol, 2-(3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, (1R-trans)-|1,3-BENZENEDIOL, 2-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)-2-CYCLOHEXEN-1-YL)-5-PENTYL-|2-((1R,6R)-3-METHYL-6-(PROP-1-EN-2-YL)CYCLOHEX-2-EN-1-YL)-5-PENTYLBENZENE-1,3-DIOL|NanoCDB|1,3-benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-|2-((1R,6R)-3-methyl-6-prop-1-en-2-yl-1-cyclohex-2-enyl)-5-pentylbenzene-1,3-diol|2-[(1R,6R)-3-methyl-6-prop-1-en-2-yl-1-cyclohex-2-enyl]-5-pentylbenzene-1,3-diol|Melody Cloverstrip|1,3-Benzenediol, 2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, (1R-trans)-|CBD Oil|Cannabidiol Hemp Oil|RefChem:6403|leafPro CBDmed Oil FS QP 3%|leafPro CBDmed Oil FS QP 5%|N03AX24|leafPro CBDmed Oil FS QP 20%|DTXCID401436151|leafPro CBDmed Oil T-FS QD 3%|leafPro CBDmed Oil T-FS QD 5%|leafPro CBDmed Oil T-FS QD 20%|leafPro CBDmed Softgels FS QP 20|leafPro CBDmed Softgels T-FS QD 20|CBD|(-)-CBD|Cannabidiol [USAN]|3556-78-3|2-[(1R,6R)-3-methyl-6-prop-1-en-2-ylcyclohex-2-en-1-yl]-5-pentylbenzene-1,3-diol|CHEMBL190461|.delta.1(2)-trans-Cannabidiol|Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, (-)-(E)-|2-[1R-3-methyl-6R-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol|Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, (+-)-|(+/-)-Cannabidiol|1,3-Benzenediol, 2-(4-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-, trans-|2-((1R,6R)-6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol|2-(4-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol trans-|(-)-Cannabidiol (CBD)|UNII-19GBJ60SN5|Epidiolex (TN)|Cannabidiol (7CI)|(A+/-)-Cannabidiol|CANNABIDIOL [MI]|P0T|CANNABIDIOL [INN]|Cannabidiol, (+/-)-|D1(2)-trans-Cannabidiol|CANNABIDIOL [MART.]|QJ36T2J3TS|CANNABIDIOL [USP-RS]|CANNABIDIOL [WHO-DD]|(-)-Cannabidiol (Synthetic)|SCHEMBL119679|Cannabidiol (JAN/USAN/INN)|GTPL4150|orb2299258|ZYN002|2-(6-Isopropenyl-3-methyl-2-cyclohexen-1-yl)-5-pentyl-1,3-benzenediol #|2-(6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol|Delta(1(2))-trans-cannabidiol|Cannabidiol, 1mg/ml in Methanol|16 - Cannabidiol in supplements|CANNABIDIOL [ORANGE BOOK]|DTXSID301038839|849 - Cannabidiol (CBD) in food|BDBM50121429|BDBM50318484|HB2785|AKOS032948358|DB09061|FC19666|NCGC00386518-01|(-)-Cannabidiol 1.0 mg/ml in Methanol|AC-34022|FS-10329|DB-093531|Sativex (CBD + THC, fixed-dose oral spray)|C07578|D10915|nabiximols (CBD + THC, fixed-dose oral spray)|Q422917|(-)-Cannabidiol (CBD) 100 microg/mL in Methanol|(-)-Cannabidiol (CBD) 1000 microg/mL in Methanol|(-)-Cannabidiol (CBD) 250 microg/mL in Acetonitrile|(3R,4R)-2-p-mentha-1,8-dien-3-yl-5-pentylresorcinol|Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, (+/-)-|Resorcinol, 2-p-mentha-1,8-dien-3-yl-5-pentyl-, trans-(-)- (8CI)|1,3-Benzenediol, 2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, trans-|2-((1R,6R)-3-METHYL-6-(1-METHYLETHENYL)CYCLOHEX-2-ENYL)-5-PENTYLBENZENE-1,3-DIOL|2-(3-methyl-6-prop-1-en-2-yl-1-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol|2-(6-Isopropenyl-3-methyl-cyclohex-2-enyl)-5-pentyl-benzene-1,3-diol (Cannabidiol)|2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol;CBD|2-[(1R,6R)-6-isopropenyl-3-methyl-cyclohex-2-en-1-yl]-5-pentyl-benzene-1,3-diol|2-[3-Methyl-6-(methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol|rel-2-[(1R,6R)-3-Methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-1,3-benzenediol|(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro-[1,1'-biphenyl]-2,6-diol|(1'R,2'R)-5'-methyl-4-pentyl-2'-(prop-1-en-2-yl)-1',2',3',4'-tetrahydro[1,1'-biphenyl]-2,6-diol|1,3-Benzenediol, 2-[(1R,6R)-3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, rel-|1,3-Benzenediol, 2-[3-methyl-6-(1-methylethenyl)-2-cyclohexen-1-yl]-5-pentyl-, trans-(+/-)-"
LENABASUM,3083542,,"InChI=1S/C25H36O4/c1-6-7-8-9-12-24(2,3)17-14-20(26)22-18-13-16(23(27)28)10-11-19(18)25(4,5)29-21(22)15-17/h10,14-15,18-19,26H,6-9,11-13H2,1-5H3,(H,27,28)/t18-,19-/m1/s1",YCHYFHOSGQABSW-RTBURBONSA-N,C25H36O4,400.5,"(6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene-9-carboxylic acid","Ajulemic acid|Lenabasum|137945-48-3|Resunab|IP-751|CPL-7075|IP 751|CPL7075|JBT-101|HU-239|(6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo[c]chromene-9-carboxylic acid|OGN7X90BT8|DTXSID40900959|6H-Dibenzo(b,d)pyran-9-carboxylic acid, 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-, (6aR,10aR)-|6H-Dibenzo[b,d]pyran-9-carboxylic acid, 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-, (6aR,10aR)-|lenabasumum|(6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6a,7,10,10a-tetrahydrobenzo(c)chromene-9-carboxylic acid|RefChem:798937|DTXCID901329393|(6aR,10aR)-1-hydroxy-6,6-dimethyl-3-(2-methyloctan-2-yl)-6H,6aH,7H,10H,10aH-benzo(c)isochromene-9-carboxylic acid|CT-3|Lenabasum [USAN]|(6ar,10ar)-3-(1,1-Dimethylheptyl)-1-Hydroxy-6,6-Dimethyl-6a,7,10,10a-Tetrahydro-6h-Benzo[c]chromene-9-Carboxylic Acid|UNII-OGN7X90BT8|DMH-THC-11-OIC|AB-III-56|(6AR,10AR)-3-(1,1-DIMETHYLHEPTYL)-1-HYDROXY-6,6-DIMETHYL-6A,7,10,10A-TETRAHYDRO-6H-BENZO(C)CHROMENE-9-CARBOXYLIC ACID|CPL 7075|LENABASUM [INN]|Lenabasum (USAN/INN)|AJULEMIC ACID [MI]|LENABASUM [WHO-DD]|SCHEMBL26441|CHEMBL456341|GTPL9772|SCHEMBL29362927|IP751|BCP15191|EX-A3627|BDBM50005920|AKOS040747784|DB12193|(6aR,10aR)-1-Hydroxy-6,6-dimethyl-3-(2-methyl-2-octanyl)-6a,7,8,10a-tetrahydro-6H-benzo(c)chromene-9-carboxylic acid|6H-Dibenzo(b,d)pyran-9-carboxylic acid, 3-(1,1-dimethylheptyl)-6a,7,10,10a-tetrahydro-1-hydroxy-6,6-dimethyl-, (6aR,10aR)|AJA|HY-106346|CS-0025624|NS00068771|D11312|945A483|Q3604498|(6AR, 10AR)-3-(1,1-DIMETHYLHEPTYL)-DELTA8-TETRAHYDRO-CANNABINOL-9-CARBOXYLIC ACID|(6AR, 10AR)-3-(1',1'-DIMETHYLHEPTYL)-DELTA-8-TETRAHYDRO-CANNABINOL-9-CARBOXYLIC ACID|6H-DIBENZO(B,D)PYRAN-9-CARBOXYLIC ACID, 3-(1,1-DIMETHYLHEPTYL)-6A,7,10,10A-TETRAHYDRO-1-HYDROXY-6,6-DIMETHYL-, (6AR-TRANS)-|AJULEMIC ACID; CT-3; IP-751; 1',1'-DIMETHYLHEPTYL-DELTA8-TETRAHYDROCANNABINOL-11-OIC ACID"
TETRAHYDROCANNABIVARIN,93147,,"InChI=1S/C19H26O2/c1-5-6-13-10-16(20)18-14-9-12(2)7-8-15(14)19(3,4)21-17(18)11-13/h9-11,14-15,20H,5-8H2,1-4H3/t14-,15-/m1/s1",ZROLHBHDLIHEMS-HUUCEWRRSA-N,C19H26O2,286.4,"(6aR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol","TETRAHYDROCANNABIVARIN|31262-37-0|THCV|delta9-Tetrahydrocannabivarin|THC-V|.delta.9-Tetrahydrocannabivarin|(6aR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol|GWP42004|GWP-42004|I5YE3I47D8|O-4394|Cannabivarol, .delta.9-tetrahydro-|(-)-.delta.9-trans-Tetrahydrocannabivarin|(6aR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol|6H-Dibenzo(b,d)pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6aR-trans)-|6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6aR-trans)-|UNII-I5YE3I47D8|6H-DIBENZO(B,D)PYRAN-1-OL, 6A,7,8,10A-TETRAHYDRO-6,6,9-TRIMETHYL-3-PROPYL-, (6AR,10AR)-|6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (6aR,10aR)-|I8E|Delta9-THCV|.delta.9-Tetrahydrocannabivarol|GTPL6418|SCHEMBL6856739|CHEMBL2387541|SCHEMBL29350511|.delta.1-Tetrahydrocannabidivarol|DTXSID10893920|ZROLHBHDLIHEMS-HUUCEWRRSA-N|BDBM50511105|HY-U00342|.delta.9-trans-Tetrahydrocannabivarin|Cannabidivarol, .delta.1-tetrahydro-|AKOS040762420|CS-7377|DB11755|6H-Dibenzo[b,d]pyran-1-ol, 6a,7,8,10a-tetrahydro-6,6,9-trimethyl-3-propyl-, (-)-|FT172555|FT181851|TS-10146|DB-215043|NS00069987|Tetrahydrocannabivarin (THCV), 1mg/ml in Methanol|Tetrahydrocannabivarin - 20 mg/ml solution in methanol|delta9-Tetrahydrocannabivarin 1000 microg/mL in Methanol|Delta9-Tetrahydrocannabivarin (THCV) 10 microg/mL in Methanol|delta 9-Tetrahydrocannabivarin (THCV) 100 microg/mL in Methanol|Delta9-Tetrahydrocannabivarin (THCV) 250 microg/mL in Acetonitrile|(6aR,10aR)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6H-dibenzo[b,d]pyran-1-ol|6,6,9-Trimethyl-3-propyl-6a,7,8,10a-tetrahydro-6H-benzo[c]chromen-1-ol-, (6aR-trans)-"
RADAFAXINE,9795056,,"InChI=1S/C13H18ClNO2/c1-9-13(16,17-8-12(2,3)15-9)10-5-4-6-11(14)7-10/h4-7,9,15-16H,8H2,1-3H3/t9-,13+/m0/s1",RCOBKSKAZMVBHT-TVQRCGJNSA-N,C13H18ClNO2,255.74,"(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethylmorpholin-2-ol","Radafaxine|192374-14-4|(2S,3S)-2-(3-Chlorophenyl)-3,5,5-trimethylmorpholin-2-ol|radafaxina|2-Morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-, (2S,3S)-|GW 353162|Q47741214K|DTXSID501318447|GW-353162|GW-353,162|radafaxinum|RefChem:178519|DTXCID801748257|(S,S)-Hydroxy Bupropion|Radafaxine [INN]|CHEMBL1172928|233600-52-7|(+)-(2S,3S)-2-(3-Chlorophenyl)-3,5,5-trimethyl-2-morpholinol|Hydroxybupropion (as (RS,RS)-cyclic Hemiketal)|(2S,3S)-2-(3-Chlorophenyl)-3,5,5-trimethyl-2-morpholinol|(2s,3s)-hydroxybupropion|UNII-Q47741214K|s,s-hydroxybupropion|SCHEMBL48964|SCHEMBL29465705|RCOBKSKAZMVBHT-TVQRCGJNSA-N|BDBM50322532|MFCD12911693|AKOS030254719|DB11790|FH23926|CS-0136594|Q1485208|BRD-K13394247-003-01-4|(2S,3S)-2-(3-chlorophenyl)-3,5,5-trimethyl-morpholin-2-ol|2-Morpholinol, 2-(3-chlorophenyl)-3,5,5-trimethyl-, (2S-cis)-|(2~{S},3~{S})-2-(3-chlorophenyl)-3,5,5-trimethyl-morpholin-2-ol|(2S,3S)-2-(3-Chlorophenyl)-3,5,5-trimethyl-2-morpholinol;Radafaxine;(2S-cis)-2-(3-Chlorophenyl)-3,5,5-trimethyl-2-morpholinol|YNT"
ALOGLIPTIN,11450633,,"InChI=1S/C18H21N5O2/c1-21-17(24)9-16(22-8-4-7-15(20)12-22)23(18(21)25)11-14-6-3-2-5-13(14)10-19/h2-3,5-6,9,15H,4,7-8,11-12,20H2,1H3/t15-/m1/s1",ZSBOMTDTBDDKMP-OAHLLOKOSA-N,C18H21N5O2,339.4,"2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile","Alogliptin|850649-61-5|alogliptina|alogliptine|vipidia|alogliptinum|JHC049LO86|CHEBI:72323|HSDB 8203|2-({6-[(3r)-3-Aminopiperidin-1-Yl]-3-Methyl-2,4-Dioxo-3,4-Dihydropyrimidin-1(2h)-Yl}methyl)benzonitrile|DTXSID90234130|2-((6-((3R)-3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl) benzonitrile|alogliptin tartrate|2-((6-((3R)-3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile|RefChem:57142|A10BH04|DTXCID90156621|Benzonitrile, 2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl)methyl)-|(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)benzonitrile|Alogliptin [INN]|MFCD09833196|2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]benzonitrile|2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl}methyl)benzonitrile|Benzonitrile,2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-|UNII-JHC049LO86|2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile|1246610-75-2|1347001-80-2|2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile; (R)-2-[6-[3-Aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-ylmethyl]benzonitrile; 2-[[6-[(3R)-3-Amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]benzonitrile; Alogliptin|Alogliptin (Standard)|ALOGLIPTIN [MI]|Trelagliptin Impurity 30|ALOGLIPTIN [VANDF]|ALOGLIPTIN [WHO-DD]|SCHEMBL121028|CHEMBL376359|GTPL6319|HY-A0023AR|orb1300993|SCHEMBL29352995|BDBM16285|HY-A0023A|ZSBOMTDTBDDKMP-OAHLLOKOSA-N|ALBB-038593|EX-A5446|Alogliptin pound SYR-322 pound(c)|MSK177669|s2868|s5365|AKOS025149226|CCG-267914|CCG-267915|CS-1617|DB06203|FA17319|2-[[6-[(3R)-3-amino-1-piperidyl]-3-methyl-2,4-dioxo-pyrimidin-1-yl]methyl]benzonitrile|NCGC00386215-04|NCGC00386215-05|AC-26300|AS-19582|SY077741|NS00071194|SW219186-1|EN300-6482025|F468425|Q4734170|BRD-K83003151-001-02-2|BRD-K83003151-001-03-0|BRD-K83003151-057-02-4|2-{6-[3(R)-Amino-piperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile"
LUMINESPIB,135539077,,"InChI=1S/C26H31N3O5/c1-4-27-26(32)24-23(18-7-5-17(6-8-18)15-29-9-11-33-12-10-29)25(34-28-24)20-13-19(16(2)3)21(30)14-22(20)31/h5-8,13-14,16,30-31H,4,9-12,15H2,1-3H3,(H,27,32)",NDAZATDQFDPQBD-UHFFFAOYSA-N,C26H31N3O5,465.5,"5-(2,4-dihydroxy-5-propan-2-ylphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide","Luminespib|747412-49-3|NVP-AUY922|VER-52296|AUY-922|NVP-AUY 922|C6V1DAR5EB|NVP-AUY922-NX|NVP-AUY-922|CHEBI:83656|DTXSID001336117|luminespibum|RefChem:924982|Hsp90 Inhibitor AUY922|NVP AUY 922|DTXCID701766236|5-(2,4-dihydroxy-5-isopropylphenyl)-N-ethyl-4-(4-(morpholinomethyl)phenyl)isoxazole-3-carboxamide|Luminespib (AUY-922, NVP-AUY922)|Luminespib (NVP-AUY922)|Luminespib (AUY-922 )|MFCD14635361|VER 52296|CHEMBL3900791|AUY922 (NVP-AUY922)|5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide|5-[2,4-Dihydroxy-5-(1-methylethyl)phenyl]-N-ethyl-4-[4-(4-morpholinylmethyl)phenyl]-3-isoxazolecarboxamide|5-[2,4-Dihydroxy-5-(1-Methylethyl)phenyl]-N-Ethyl-4-[4-(Morpholin-4-Ylmethyl)phenyl]isoxazole-3-Carboxamide|Luminespib [USAN:INN]|UNII-C6V1DAR5EB|NVR-AUY 922|Isoxazole, 40f|2GJ|5-[2,4-Dihydroxy-5-(1-methylethyl)phenyl]-N-ethyl-4-[4-(4-morpholinylmethyl)phenyl]-3-isoxazolecarboxamide;VER 52296; NVP-AUY922;|VER-52296/NVP-AUY922|LUMINESPIB [INN]|Luminespib (USAN/INN)|LUMINESPIB [USAN]|Luminespib; NVP-AUY922|LUMINESPIB [WHO-DD]|5-(2,4-dihydroxy-5-propan-2-ylphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide|MLS006011081|SCHEMBL892205|Luminespib (NVP-AUY922)?|CHEMBL252164|GTPL9261|orb1306830|SCHEMBL2682235|SCHEMBL2682238|AUY922,NVP-AUY922|LUMINESPIB(NVP-AUY922)|SCHEMBL29366572|BDBM20926|CHEBI:91422|EX-A611|NDAZATDQFDPQBD-UHFFFAOYSA-N|BCPP000145|HMS3295K23|HMS3654C15|BCP01827|BDBM50274536|NSC755762|s1069|AKOS015966502|AKOS026750297|BCP9001007|CCG-264804|CS-0136|NSC-755762|SB16640|NCGC00247878-01|NCGC00387853-03|AC-33144|AS-17014|FL137696|HY-10215|SMR004702869|SW219319-1|NVP AUY 922;AUY922;VER 52296|CAS:747412-49-3;NVP-AUY922|D10646|412D493|BRD-K41859756-001-01-9|BRD-K41859756-001-06-8|BRD-K41859756-001-08-4|BRD-K41859756-001-09-2|Q10859697|Q27082304|Q27163272|AUY922; VER-52296; AUY 922; VER 52296; AUY-922; VER-52296|5-(2,4-DIHYDROXY-5-(PROPAN-2-YL)PHENYL)-N-ETHYL-4-(4-((MORPHOLIN-4-YL)METHYL)PHENYL(-1,2-OXAZOLE-3-CARBOXAMIDE|5-(2,4-dihydroxy-5-isopropyl-phenyl)-N-ethyl-4-[4-(morpholinomethyl)phenyl]isoxazole-3-carboxamide|5-(2,4-dihydroxy-5-isopropylphenyl)-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide|5-[2,4-dihydroxy-5-(propan-2-yl)phenyl]-N-ethyl-4-[4-(morpholin-4-ylmethyl)phenyl]-1,2-oxazole-3-carboxamide|N-ethyl-5-(4-hydroxy-6-oxo-3-propan-2-yl-1-cyclohexa-2,4-dienylidene)-4-[4-(4-morpholinylmethyl)phenyl]-2H-isoxazole-3-carboxamide"
SNX-2112,24772860,,"InChI=1S/C23H27F3N4O3/c1-22(2)10-17-19(18(32)11-22)20(23(24,25)26)29-30(17)13-5-8-15(21(27)33)16(9-13)28-12-3-6-14(31)7-4-12/h5,8-9,12,14,28,31H,3-4,6-7,10-11H2,1-2H3,(H2,27,33)",ZFVRYNYOPQZKDG-UHFFFAOYSA-N,C23H27F3N4O3,464.5,"4-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]-2-[(4-hydroxycyclohexyl)amino]benzamide","SNX-2112|908112-43-6|4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((1r,4r)-4-hydroxycyclohexylamino)benzamide|PF-04928473|SNX 2112|4-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]-2-[(4-hydroxycyclohexyl)amino]benzamide|SNX2112|MFCD16038907|SNX-2112 (PF-04928473)|10C9P3FFOW|CHEMBL560895|CHEMBL561224|4-(6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-(((1r,4r)-4-hydroxycyclohexyl)amino)benzamide|945626-71-1|4-(6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-((trans-4-hydroxycyclohexyl)amino)benzamide|Benzamide, 2-((trans-4-hydroxycyclohexyl)amino)-4-(4,5,6,7-tetrahydro-6,6-dimethyl-4-oxo-3-(trifluoromethyl)-1H-indazol-1-yl)-|4-(6,6-dimethyl-4-oxo-3-trifluoromethyl-4,5,6,7-tetrahydro-indazol-1-yl)-2-(trans-4-hydroxy-cyclohexylamino)-benzamide|4-[6,6-dimethyl-4-oxidanylidene-3-(trifluoromethyl)-5,7-dihydroindazol-1-yl]-2-[(4-oxidanylcyclohexyl)amino]benzamide|4-[6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-[(cis-4-hydroxycyclohexyl)amino]benzamide|C23H27F3N4O3|UNII-10C9P3FFOW|4-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl]-2-{[(1r,4r)-4-hydroxycyclohexyl]amino}benzamide|E0G|4nh7|MLS006011082|orb1300885|SCHEMBL1219380|SCHEMBL1219382|SCHEMBL1221195|SCHEMBL12685879|SCHEMBL29350240|CHEBI:231695|ZFVRYNYOPQZKDG-XBXGTLAGSA-N|DTXSID601025695|GLXC-04491|HMS3656P07|BCP02907|EX-A2375|BDBM50450704|BDBM50480401|MFCD28978131|s2639|AKOS027270068|AKOS032947229|CCG-269392|CS-0481|SB19446|NCGC00346633-01|NCGC00386182-02|AC-36048|AS-75100|DA-77906|FS103989|HY-10214|SMR004702870|BCP0726000309|SW219742-1|C77089|SNX-2112(PF-04928473)|SNX-2112; PF-04928473|BRD-K71281111-001-01-9|BRD-K71281111-001-04-3|Q27251134|Q27461098|Z2235801955|4-(6,6-Dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-indazol-1-yl)-2-(trans-4-hydroxycyclohexylamino)benzamide|4-[6,6-dimethyl-4-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1h-indazol-1-yl]-2-[(4-hydroxycyclohexyl)amino]benzamide"
PU-H71,9549213,,"InChI=1S/C18H21IN6O2S/c1-10(2)21-4-3-5-25-17-15(16(20)22-8-23-17)24-18(25)28-14-7-13-12(6-11(14)19)26-9-27-13/h6-8,10,21H,3-5,9H2,1-2H3,(H2,20,22,23)",SUPVGFZUWFMATN-UHFFFAOYSA-N,C18H21IN6O2S,512.4,"8-[(6-iodo-1,3-benzodioxol-5-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine","PU-H71|873436-91-0|Zelavespib|PU-H 71|PUH-71|PU-H-71|9H-Purine-9-propanamine, 6-amino-8-((6-iodo-1,3-benzodioxol-5-yl)thio)-N-(1-methylethyl)-|06IVK87M04|PUH71|DTXSID20236288|RefChem:177153|Hsp90 Inhibitor PU-H71|DTXCID20158779|8-((6-iodo-2H-1,3-benzodioxol-5-yl)sulfanyl)-9-(3-((propan-2-yl)amino)propyl)-9H-purin-6-amine|8-((6-Iodobenzo[d][1,3]dioxol-5-yl)thio)-9-(3-(isopropylamino)propyl)-9H-purin-6-amine|6-amino-8-[(6-iodo-1,3-benzodioxol-5-yl)thio]-n-(1-methylethyl)-9h-purine-9-propanamine|CHEMBL200102|CAS#873436-91-0|8-[(6-iodo-1,3-benzodioxol-5-yl)sulfanyl]-9-[3-(propan-2-ylamino)propyl]purin-6-amine|CAS# 873436-91-0|PU H71|8-(6-Iodobenzo[d][1,3]dioxol-5-ylthio)-9-(3-(isopropylamino)propyl)-9H-purin-6-amine|8-[(6-Iodo-1,3-Benzodioxol-5-Yl)thio]-9-[3-(Isopropylamino)propyl]-9h-Purin-6-Amine|H71|UNII-06IVK87M04|2fwz|SUPVGFZUWFMATN-UHFFFAOYSA-N|NSC 750424|ZELAVESPIB [INN]|C18H21IN6O2S|orb1819131|SCHEMBL1857579|PU-H71, d6|SCHEMBL29414148|EX-A315|GLXC-02874|HMS3653N04|BCP03616|NSC 750424-d6|BDBM50180302|NSC752199|s8039|AKOS024457431|CCG-269784|CS-0546|DB12638|FP65141|NSC-752199|SB17115|NCGC00371072-06|AC-33112|BS-17694|DA-41005|HY-11038|BCP0726000178|NS00070975|SW220214-1|BRD-K36529613-001-01-8|BRD-K36529613-001-02-6|Q27236209|8-(6-iodo-benzo[1,3]dioxol-5-ylsulfanyl)-9-(3-isopropylamino-propyl)adenine|8-[(6-iodo-1,3-benzodioxol-5-yl)sulfanyl]-9-[3-(isopropylamino)propyl]purin-6-amine|8-(6-Iodo-benzo[1,3]dioxol-5-ylsulfanyl)-9-(3-isopropyl-aminopropyl-d6)adenine (PU-H71-d6)|8-[(6-iodo-1,3-benzodioxol-5-yl)sulfanyl]-9-{3-[(1-methylethyl)amino]propyl}-9H-purin-6-amine"
BIIB021,16736529,,"InChI=1S/C14H15ClN6O/c1-7-4-17-9(8(2)11(7)22-3)5-21-6-18-10-12(15)19-14(16)20-13(10)21/h4,6H,5H2,1-3H3,(H2,16,19,20)",QULDDKSCVCJTPV-UHFFFAOYSA-N,C14H15ClN6O,318.76,"6-chloro-9-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]purin-2-amine","BIIB021|848695-25-0|6-chloro-9-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)-9H-purin-2-amine|BIIB-021|CNF2024|CNF-2024|851B9FQ7Q0|CHEBI:90687|6-chloro-9-[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]purin-2-amine|(6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9h-purin-2-yl)amine|9H-purin-2-amine, 6-chloro-9-((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)-|6-Chloro-9-[(4-Methoxy-3,5-Dimethylpyridin-2-Yl)methyl]-9h-Purin-2-Amine|[6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9H-purin-2-yl]amine|6-chloro-9-((4-methoxy-3,5-dimethylpyridin-2-yl)methyl)purin-2-amine|RefChem:119789|BIIB 021|UNII-851B9FQ7Q0|CNF 2024|MFCD15528939|CHEMBL467399|848695-25-0 (free base)|6-chloro-9-(4-methoxy-3,5-dimethyl-pyridin-2-ylmethyl)-9H-purin-2-ylamine|94M|C14H15ClN6O|3qdd|QULDDKSCVCJTPV-UHFFFAOYSA-N|BIIB021, Free Base|MLS006011080|GTPL9258|orb1305792|SCHEMBL1791028|BIIB 021 [WHO-DD]|BIIB021,CNF2024|SCHEMBL29351570|SCHEMBL29394202|SCHEMBL29409214|BDBM20800|EX-A681|BIIB021; CNF2024|BCPP000335|DTXSID601025952|GLXC-03674|HMS3654G16|BCP02111|YIB69525|BIIB021(CNF2024)?|CF1983|NSC773265|s1175|AKOS015969048|BCP9000411|CCG-264848|CS-0168|DB12359|NSC-773265|SB16641|NCGC00247877-01|AC-32860|AS-55914|HY-10212|SMR004702868|NS00071234|SW220186-1|F14744|BRD-K51967704-001-01-0|BRD-K51967704-001-03-6|BRD-K51967704-001-04-4|Q27075249|6-chloro-9-[(4-methoxy-3,5-dimethyl-2-pyridyl)methyl]purin-2-amine|(6-Chloro-9-(4-methoxy-3,5-dimethylpyridin-2-ylmethyl)-9h-purin-2-yl)amin"
IPRONIAZID,3748,,"InChI=1S/C9H13N3O/c1-7(2)11-12-9(13)8-3-5-10-6-4-8/h3-7,11H,1-2H3,(H,12,13)",NYMGNSNKLVNMIA-UHFFFAOYSA-N,C9H13N3O,179.22,N'-propan-2-ylpyridine-4-carbohydrazide,"iproniazid|54-92-2|Iprazid|Iproniazide|Euphozid|Rivivol|4-Pyridinecarboxylic acid, 2-(1-methylethyl)hydrazide|N'-isopropylpyridine-4-carbohydrazide|Iproniazida|Iproniazidum|Ro 2-4572|1-Isonicotinoyl-2-isopropylhydrazine|Isonicotinic acid 2-isopropylhydrazide|D892HFI3XA|DTXSID5023168|RefChem:148662|DTXCID503168|200-218-8|N'-Isopropylisonicotinohydrazide|Marsilid|Marsalid|Yatrozide|MFCD00153819|N'-Isopropylisonicotinoylhydrazide|N'-(propan-2-yl)pyridine-4-carbohydrazide|P 887|CHEMBL92401|CHEBI:5958|ISONICOTINIC ACID, 2-ISOPROPYLHYDRAZIDE|Iproniazid (INN)|IPRONIAZID [INN]|N'-(1-methylethyl)pyridine-4-carbohydrazide|Iproniazyd [Polish]|N inverted exclamation mark -Isopropylisonicotinohydrazide|Iproniazyd|Propilniazida|Iprazide|Ipronid|Iproniazide [INN-French]|Iproniazidum [INN-Latin]|Iproniazida [INN-Spanish]|NSC81850|CCRIS 9177|N-[(methylethyl)amino]-4-pyridylcarboxamide|EINECS 200-218-8|UNII-D892HFI3XA|BRN 0142700|Iproniazid [INN:BAN:DCF]|Ipronin|Isonicotinic acid, N'-isopropyl hydrazide|N'-propan-2-ylpyridine-4-carbohydrazide|Spectrum_000268|IPRONIAZID [MI]|Prestwick0_000176|Prestwick1_000176|Prestwick2_000176|Prestwick3_000176|Spectrum2_000468|Spectrum3_000272|Spectrum4_000396|Spectrum5_001437|Lopac-I-7627|SCHEMBL4153|IPRONIAZID [WHO-DD]|Lopac0_000643|BSPBio_000071|BSPBio_001744|KBioGR_000951|KBioSS_000748|4-22-00-00551 (Beilstein Handbook Reference)|DivK1c_000121|N-Isopropyl isonicotinhydrazide|SPBio_000576|SPBio_001992|BPBio1_000079|Iproniazid - Bio-X trade mark|orb1705831|BDBM29136|HY-B0886A|KBio1_000121|KBio2_000748|KBio2_003316|KBio2_005884|KBio3_001244|N'-isopropylisonicotino hydrazide|NINDS_000121|GLXC-02864|HMS2090F08|HMS3886E05|HMS5083D16|HMS6018G13|N'-Isopropylisonicotinohydrazide #|MSK10884|s4856|SBB003758|AKOS006229272|CCG-204730|DB04818|DS-7371|FI63875|Isonicotinic acid N'-isopropylhydrazide|N'-isopropyl-pyridine-4-carbohydrazide|SDCCGSBI-0050623.P004|IDI1_000121|Isonicotinic acid N'-isopropyl-hydrazide|NCGC00015565-01|NCGC00015565-02|NCGC00015565-03|NCGC00015565-04|NCGC00015565-12|NCGC00162210-01|BI164580|CAS-305-33-9|DA-04957|P887|SY025980|SBI-0050623.P003|AB00053568|CS-0013623|NS00008980|ST50825141|D02579|AB00053568-12|AB00053568_13|AN-068/14539031|F386952|Q421368|BRD-K88568253-011-03-3|BRD-K88568253-011-19-9|BRD-K88568253-065-03-9"
LAZABEMIDE,71307,,"InChI=1S/C8H10ClN3O/c9-6-1-2-7(12-5-6)8(13)11-4-3-10/h1-2,5H,3-4,10H2,(H,11,13)",JZXRLKWWVNUZRB-UHFFFAOYSA-N,C8H10ClN3O,199.64,N-(2-aminoethyl)-5-chloropyridine-2-carboxamide,"Lazabemide|103878-84-8|N-(2-aminoethyl)-5-chloropyridine-2-carboxamide|Lazabemida|Ro 19-6327/000|DTXSID2048294|420HD787N9|Ro-196327|Ro-19-6327/000|lazabemidum|RefChem:924579|DTXCID3028269|N-(2-Aminoethyl)-5-chloropicolinamide|Ro-19-6327|Lazabemide hydrate|Ro 19-6327 hydrate|CHEMBL279390|2-Pyridinecarboxamide, N-(2-aminoethyl)-5-chloro-|MFCD20488051|N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide hydrate|N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide;N-(2-Aminoethyl)-5-chloro-2-pyridinecarboxamide|CCRIS 7301|NCGC00167737-01|Lazabemide [USAN:INN:BAN]|UNII-420HD787N9|LAZABEMIDE [MI]|LAZABEMIDE [INN]|Lazabemide (USAN/INN)|LAZABEMIDE [USAN]|LAZABEMIDE [MART.]|LAZABEMIDE [WHO-DD]|SCHEMBL121998|GTPL6640|orb1689882|SCHEMBL29710899|HMS6018P10|BCP21224|BDBM50029816|AKOS006272560|CS-4008|AC-27411|HY-14201|MS-23081|DB-040491|NS00122745|D04681|EN300-267479|N17089|N-(2-aminoethyl)-5-chloro-2-pyridine carboxamide|N-(2-aminoethyl)-5-chloro-pyridine-2-carboxamide|Q6505756|BRD-K51486818-002-01-2|BRD-K51486818-003-02-8|Ro-19-6327;Ro 19-6327;Ro 196327|5-Chloro-pyridine-2-carboxylic acid (2-amino-ethyl)-amide"
RASAGILINE,3052776,,"InChI=1S/C12H13N/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12/h1,3-6,12-13H,7-9H2/t12-/m1/s1",RUOKEQAAGRXIBM-GFCCVEGCSA-N,C12H13N,171.24,"(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine","rasagiline|136236-51-6|(R)-N-2-Propynyl-1-indanamine|TV-1030|Rasagilina|(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine|NSC-759639|(1R)-N-propargylindan-1-amine|CHEBI:63620|003N66TS6T|(R)-Indan-1-yl-prop-2-ynyl-amine|1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (1R)|DTXSID3041112|Agn-1135|rasagilinum|RefChem:875177|DTXCID1021112|N04BD02|TVP-101|851-611-1|N-2-propynyl-1-indanamine|TVP-1022|TVP1022|(R)-N-(2-Propynyl)-2,3-dihydroinden-1-amine|(1R)-N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine|MFCD00866571|1-Indanamine, N-2-propynyl-, (R)-|Azilect (TN)|RAS|CHEMBL887|1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (1R)-|(R)-2,3-dihydro-N-2-propynyl-1H-inden-1-amine|Rasagiline [INN]|(R)-N-(Prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine|Rasagiline [USAN]|(R)-(+)-Rasagiline|(1R)-N-prop-2-ynylindan-1-amine|Rasagiline [USAN:INN]|UNII-003N66TS6T|HSDB 7699|TV 1030|Rasagiline (Standard)|RASAGILINE [MI]|Rasagiline (USAN/INN)|RASAGILINE [HSDB]|RASAGILINE [VANDF]|RASAGILINE [WHO-DD]|SCHEMBL74699|MLS006012042|N-propargyl-1-(R)aminoindan|RASAGILINE [EMA EPAR]|GTPL6641|orb1309706|SCHEMBL6054642|RASAGILINE [ORANGE BOOK]|BDBM10989|RUOKEQAAGRXIBM-GFCCVEGCSA-N|HMS3264K12|HMS3715L12|HMS3886N03|HMS6019L06|HY-14605AR|Pharmakon1600-01502333|AC-723|HY-14605A|NSC759639|NSC789038|s5795|AKOS006271452|AKOS015837675|CCG-213034|DB01367|FS-3130|NSC 759639|NSC-789038|SMR002533187|SY012374|(1R)-N-(prop-2-yn-1-yl)indan-1-amine|DB-001111|NS00002143|D08469|EN300-150047|AB01562963_01|AB01562963_02|F078410|Q420685|SR-00000006359|SR-00000006359-3|(R)-N-(prop-2-ynyl)-2,3-dihydro-1H-inden-1-amine|BRD-K58114536-001-01-6|BRD-K58114536-066-02-7|(1R)-2,3-DIHYDRO-N-2-PROPYN-1-YL-1H-INDEN-1-AMINE|1H-INDEN-1-AMINE, 2,3-DIHYDRO-N-2-PROPYNYL-, (R)-|1H-INDEN-1-AMINE, 2,3-DIHYDRO-N-2-PROPYN-1-YL-, (1R)-|1204184-69-9"
SEMBRAGILINE,10246762,,"InChI=1S/C19H19FN2O3/c1-13(23)21-16-10-19(24)22(11-16)17-5-7-18(8-6-17)25-12-14-3-2-4-15(20)9-14/h2-9,16H,10-12H2,1H3,(H,21,23)/t16-/m0/s1",VMAVCCUQTALHOB-INIZCTEOSA-N,C19H19FN2O3,342.4,N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxopyrrolidin-3-yl]acetamide,Sembragiline|676479-06-4|RG1577|Sembragilina|K3W9672PNJ|RG-1577|sembragilinum|RefChem:931607|Sembragiline [INN]|Sembragiline [USAN:INN]|UNII-K3W9672PNJ|RO4602522|N-[(3S)-1-[4-[(3-fluorophenyl)methoxy]phenyl]-5-oxopyrrolidin-3-yl]acetamide|Sembragiline (USAN/INN)|SEMBRAGILINE [USAN]|SEMBRAGILINE [WHO-DD]|orb1699329|SCHEMBL2440939|CHEMBL3707394|SCHEMBL29361249|VMAVCCUQTALHOB-INIZCTEOSA-N|BDBM50452674|AKOS032954121|HY-16731|CS-0012329|D11224|Q27281921|(S)-N-[1-[4-(3-fluoro-benzyloxy)-phenyl]-5-oxo-pyrrolidin-3-yl-]acetamide|(S)-N-{1-[4-(3-fluoro-benzyloxy)-phenyl]-5-oxo-pyrrolidin-3-yl}-acetamide
BENZOIN,8400,,"InChI=1S/C14H12O2/c15-13(11-7-3-1-4-8-11)14(16)12-9-5-2-6-10-12/h1-10,13,15H",ISAOCJYIOMOJEB-UHFFFAOYSA-N,C14H12O2,212.24,"2-hydroxy-1,2-diphenylethanone","BENZOIN|119-53-9|2-Hydroxy-1,2-diphenylethanone|2-Hydroxy-2-phenylacetophenone|Benzoylphenylcarbinol|Ethanone, 2-hydroxy-1,2-diphenyl-|DL-BENZOIN|(+-)-Benzoin|Phenylbenzoyl carbinol|alpha-Hydroxybenzyl phenyl ketone|alpha-Hydroxy-alpha-phenylacetophenone|Aerozoin|desyl alcohol|Phenyl-alpha-hydroxybenzyl ketone|FEMA No. 2132|NCI-C50011|(RS)-Benzoin|Hydroxy-2-phenyl acetophenone|Wy 42956|NSC-8082|L7J6A1NE81|DTXSID1020144|CHEBI:17682|DTXCID10144|RefChem:578585|BENZOIN, (+-)-|2 hydroxy 1,2 diphenylethanone|204-331-3|209-441-5|579-44-2|2-hydroxy-1,2-diphenylethan-1-one|Acetophenone, 2-hydroxy-2-phenyl-|MFCD00004496|2-hydroxy-1,2-diphenyl-ethanone|NSC 8082|a-Hydroxybenzyl phenyl ketone|CHEMBL190677|Phenyl-.alpha.-hydroxybenzyl ketone|Ketone, .alpha.-hydroxybenzyl phenyl|NCGC00091396-02|.alpha.-Hydroxy-.alpha.-phenylacetophenone|CCRIS 75|CAS-119-53-9|Benzoin (VAN)|HSDB 384|Ketone, alpha-hydroxybenzyl phenyl|EINECS 204-331-3|EINECS 209-441-5|Fenyl-alpha-hydroxybenzylketon [Czech]|benzoine|BRN 0391839|UNII-L7J6A1NE81|Fenyl-alpha-hydroxybenzylketon|WY-42956|AI3-00851|Benzoin absolute|CCRIS 9123|DL-Benzoin; Desyl alcohol;(+/-)-2-Hydroxy-2-phenylacetophenone|2-hydroxy-1,2-diphenyl ethanone|Alpha-hydroxy-a-phenylacetophenone|benzoin resin siam|PhCH(OH)COPh|PhCOCH(OH)Ph|Benzoin, 98%|(+/-)-benzoin|(1)-2-Hydroxy-1,2-diphenylethan-1-one|Benzoin, >=98%|BENZOIN [MI]|(.+/-.)-Benzoin|WLN: QYR&VR|SCHEMBL145|EC 204-331-3|Hyperabsolute benzoin, Siam|Benzoin, analytical standard|Oprea1_687165|4-08-00-01279 (Beilstein Handbook Reference)|MLS002152893|a-Hydroxy-a-phenylacetophenone|FEMA No. 2133|orb1303537|SCHEMBL3275656|SCHEMBL6033766|2-hydroxy-2-phenyl-acetophenone|BENZOIN, (+/-)-|Fenyl-.alpha.-hydroxybenzylketon|SCHEMBL27565550|SCHEMBL27703917|BDBM22728|FEMA 2132|HSDB 1929|NSC8082|alpha -Hydroxybenzyl phenyl ketone|HMS3039I03|Phenyl-alpha -hydroxybenzyl ketone|.alpha.-Hydroxybenzyl phenyl ketone|HY-B1550|Tox21_111126|Tox21_201888|Tox21_302790|MSK159940|SBB012413|STK358785|AKOS000118894|AKOS016038141|Tox21_111126_1|2-Hydroxy-1,2-diphenylethanone, 9CI|Benzoin 100 microg/mL in Acetonitrile|CS-W020562|DB14020|FB34686|alpha -Hydroxy-alpha -phenylacetophenone|NCGC00091396-01|NCGC00091396-03|NCGC00091396-05|NCGC00256433-01|NCGC00259437-01|AC-11139|Benzoin, Vetec(TM) reagent grade, 98%|BS-14748|DA-51025|SMR001224505|ST069353|DB-018065|B0079|B0222|Benzoin Zone Refined (number of passes:40)|Benzoin, purified by sublimation, >=99.5%|NS00001432|EN300-18095|C01408|D77908|Ethanone, 2-hydroxy-1,2-diphenyl-, (+/-)-|SBI-0653864.0001|(+/-)-2-HYDROXY-1,2-DIPHENYLETHANONE|Ethanone, 2-hydroxy-1,2-diphenyl-, (A+/-)-|AE-848/06163047|Ethanone, 2-hydroxy-1,2-diphenyl-, (.+/-.)-|F235660|Q426819|SR-01000854680|SR-01000854680-2|BRD-A55748233-001-08-7|Z57160197|F0001-0307|DL-Benzoin; Desyl alcohol;()-2-Hydroxy-2-phenylacetophenone|Ethanone, 2-hydroxy-1,2-diphenyl-,  mixt. with aloe, storax and Tolu Balsam, tincture|Hydroxy-a-phenylacetophenone;Hydroxybenzyl phenyl ketone;Hydroxy-2-phenylacetophenone"
EGLUMETAD,213056,,"InChI=1S/C8H11NO4/c9-8(7(12)13)2-1-3-4(5(3)8)6(10)11/h3-5H,1-2,9H2,(H,10,11)(H,12,13)/t3-,4-,5-,8-/m0/s1",VTAARTQTOOYTES-RGDLXGNYSA-N,C8H11NO4,185.18,"(1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid","Eglumegad|176199-48-7|Eglumetad|(1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylic acid|LY354740|LY 354740|LY 354740 Hydrate|(rel)-Eglumegad|LY-354740|Eglumetad anhydrous|Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-, (1S,2S,5R,6S)-|(1S,2S,5R,6S)-2-Aminobicyclo(3.1.0)hexane-2,6-dicarboxylic acid|CHEMBL8759|ONU5A67T2S|DTXSID40170094|176027-90-0|MFCD04113018|(+)-2-Aminobicyclo(3.1.0)hexane-2,6-dicarboxylic acid|(1S,2S,5R,6S)-2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid|Bicyclo(3.1.0)hexane-2,6-dicarboxylic acid, 2-amino-, (1S,2S,5R,6S)-|[3H]Eglumegad|LY366563|LY354740;Eglumetad|Eglumetad [USAN:INN]|UNII-ONU5A67T2S|Bicyclo[3.1.0]hexane-2,6-dicarboxylic acid, 2-amino-, (1R,2R,5S,6R)-rel- (9CI)|Eglumegad (INN)|40F|(+)-(1S,2S,5R,6S)-2-aminobicyclo(3.1.0)hexane-2,6-dicarboxylic acid|[3H]LY354740|EGLUMETAD [INN]|RefChem:1048900|SCHEMBL481248|(1S,2S,5R,6S)-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylicacid|GTPL1393|GTPL1396|DTXCID5092585|CHEBI:194387|VTAARTQTOOYTES-RGDLXGNYSA-N|GLXC-02819|BDBM50056272|BDBM50397661|HB0397|HY-18941B|AKOS015900075|AT33389|CS-5052|NCGC00485401-01|BL162676|DA-51108|HY-18941|MS-22995|DB-028800|CS-0881508|NS00126117|EN300-72644|D08908|317A281|Q5348096|2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid|BRD-K65359424-001-01-3|BRD-K65359424-001-02-1|(2S,6S)-2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid|2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid (LY 354740)|2-Amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid(LY354740)"
LOBELINE,101616,,"InChI=1S/C22H27NO2/c1-23-19(15-21(24)17-9-4-2-5-10-17)13-8-14-20(23)16-22(25)18-11-6-3-7-12-18/h2-7,9-12,19-21,24H,8,13-16H2,1H3/t19-,20+,21-/m0/s1",MXYUKLILVYORSK-HBMCJLEFSA-N,C22H27NO2,337.5,"2-[(2R,6S)-6-[(2S)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethanone","lobeline|(-)-Lobeline|alpha-Lobeline|Inflatine|Lobelinum|Lobnico|90-69-7|Lobelina|Lobelin|8,10-Diphenyllobelionol|2-[(2R,6S)-6-[(2S)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl]-1-phenylethanone|DTXSID3023219|CHEBI:48723|D0P25S3P81|2-(6-(2-Hydroxy-2-phenylethyl)-1-methyl-2-piperidinyl)-1-phenylethanone|2-(6-(beta-Hydroxyphenethyl)-1-methyl-2-piperidyl)acetophenone|NSC-757421|2-{(2R,6S)-6-[(2S)-2-hydroxy-2-phenylethyl]-1-methylpiperidin-2-yl}-1-phenylethanone|DTXCID603219|Ethanone, 2-(6-(2-hydroxy-2-phenylethyl)-1-methyl-2-piperidinyl)-1-phenyl-, (2R-(2alpha,6alpha(S*)))-|2-((2R,6S)-6-((2S)-2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl)-1-phenylethanone|RefChem:153874|GlyTouCan:G34337IT|2-(6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl)-1-phenylethanone|2-[6-(2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl]-1-phenylethanone|G34337IT|202-012-3|Lobeline [INN]|Lobron|.alpha.-Lobeline|CHEMBL122270|alpha-Lobeline hydrochloride|Lobeline (INN)|NCGC00024378-05|Alpha-Lobeline HCl|2-((2R,6S)-6-((S)-2-hydroxy-2-phenylethyl)-1-methylpiperidin-2-yl)-1-phenylethan-1-one|Lobeline [INN:BAN]|Lobelinum [INN-Latin]|Lobelina [INN-Spanish]|UNII-D0P25S3P81|SR-01000075960|L0B|EINECS 202-012-3|Lobeline alpha (-)|NSC36866|BRN 0091533|LOBELINE [MI]|LOBELINUM [HPUS]|Prestwick0_000585|Prestwick1_000585|Prestwick2_000585|Prestwick3_000585|LOBELINE [WHO-DD]|Lopac0_000698|BSPBio_000430|5-21-12-00627 (Beilstein Handbook Reference)|SCHEMBL290803|SPBio_002649|BPBio1_000474|orb1685081|GTPL13498|Tox21_110900|BDBM50080818|AKOS024278800|CCG-204783|DB05137|NSC 757421|SDCCGSBI-0050676.P002|CAS-90-69-7|NCGC00024378-06|NCGC00024378-07|NCGC00024378-08|NCGC00024378-09|NCGC00024378-10|NCGC00024378-14|DA-48561|AB00489926|NS00001152|C07475|D02364|Q421905|SR-01000075960-5|BRD-K66206289-003-03-1|BRD-K66206289-003-09-8|BRD-K66206289-003-20-5|BRD-K66206289-003-21-3|2-(6-(.BETA.-HYDROXYPHENETHYL)-1-METHYL-2-PIPERIDYL)ACETOPHENONE|2-[(2R,6S)-6-[(2S)-2-hydroxy-2-phenyl-ethyl]-1-methyl-2-piperidyl]-1-phenyl-ethanone|Ethanone, 2-[(2R,6S)-6-[(2S)-2-hydroxy-2-phenylethyl]-1-methyl-2-piperidinyl]-1-phenyl-|2-((2R,6S)-6-((2S)-2-HYDROXY-2-PHENYLETHYL)-1-METHYL-2-PIPERIDINYL)-1-PHENYLETHANONE"
TETRABENAZINE,6018,,"InChI=1S/C19H27NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16H,5-7,10-11H2,1-4H3",MKJIEFSOBYUXJB-UHFFFAOYSA-N,C19H27NO3,317.4,"9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one","TETRABENAZINE|58-46-8|Nitoman|Xenazine|Tetrabenazina|Tetrabenazinum|Ro 1-9569|Revocon|9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-one|CHEBI:64028|Ro-19569|NSC-169886|2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine|2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-|RO-1-9569|2-oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzoquinolizine|1,2,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-|2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-|1,3,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo(a)quinolizin-2-one|2-Oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11-beta-hexahydro-2H-benzoquinolizine|DTXCID001476353|Tetmodis|1,2,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo(a)quinolizin-2-one|2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo(a)quinolizine|Xenazine 25|9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido(2,1-a)isoquinolin-2-one|(+-)-Tetrabenazine|RefChem:56111|CHEBI:9467|N07XX06|2-Oxo-3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11-beta-hexahydro-|200-383-6|DTXSID0042614|Z9O08YRN8O|718635-93-9|Tetrabenzaine|Rubigen|Tetrabenazine Racemate|Tetrabenzine|Tetrabenazine (Racemate)|tetra Benazin|3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one|Tetrabenazinum [INN-Latin]|9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one|Tetrabenazina [INN-Spanish]|MFCD00042740|Ro 1-9569 Racemate|9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one|MLS003106727|Ro 1-9569/12|CHEMBL117785|MFCD08461052|9,10-dimethoxy-3-isobutyl-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one|NSC 169886|(3S,11bR)-3-isobutyl-9,10-dimethoxy-3,4,6,7-tetrahydro-1H-pyrido[2,1-a]isoquinolin-2(11bH)-one|(-)-tetrabenazine|3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-pyrido[2,1-a]isoquinolin-2-one|Xenazine (TN)|SMR000718664|Nitoman (TN)|WLN: T B666 DV GNTT&J E1Y1&1 LO1 MO1|Tetrabenazin|Tetrabenazine?|2-Oxo-3-isobutyl-9,2,3,4,6,7-hexahydro-11bH-benzo[a]quinolizine|rac-Tetrabenazine|2-Oxo-3-isobutyl-9,3,4,6,7,11.beta.-hexahydro-2H-benzoquinolizine|1,4,6,7,11b-Hexahydro-3-isobutyl-9,10-dimethoxy-2H-benzo[a]quinolizin-2-one|2H-Benzo[a]quinolizin-2-one,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-|2H-Benzo[a]quinolizin-2-one,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-|NCGC00160421-01|2,3-dimethoxy-9-(2-methylpropyl)-5,6,7,11a-tetrahydropiperidino[2,1-a]isoquino lin-10-one|1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-Benzo[a]quinolizin-2-one|Nitoman;Ro 1-9569|Tetrabenazine (JAN/INN)|TimTec1_002217|Oprea1_264344|SCHEMBL62026|MLS001249426|MLS001249497|GTPL4834|orb1304107|SCHEMBL29609598|HY-B0590A|Tetrabenazine - Bio-X trade mark|DTXSID501127442|HMS1540E17|HMS2966E06|HMS3263I14|HMS3430F03|HMS3884E10|HMS5080I07|Tetrabenazine (Nitoman, Xenazine)|BCP15831|BCP24156|EX-A2361|TDB63593|Tox21_501086|BDBM50017701|MSK168092|NSC169886|NSC172187|s1789|SBB018797|STK678061|3-isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one|AKOS001681311|AKOS016347602|CCG-118217|CS-5700|DB04844|FT28060|LP01086|NSC-172187|PB21652|PB25061|PB38735|SB49797|SDCCGSBI-0633786.P001|9,10-Dimethoxy-1,3,4,6,7,11b-hexahydro-3-isobutyl-2H-benzo[a]quinolizin-2-one|NCGC00160421-02|NCGC00160421-06|NCGC00261771-01|AS-35785|BT164463|DA-78345|ST028814|SY333387|NS00008216|D08575|EN300-122639|A856325|F301460|Q413050|SR-01000833864|SR-01000833864-4|BRD-A47564106-001-01-8|Z1544404943|2-Oxo-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7,11b-hexahydro-2H-benzo(a)quinolizine|2H-Benzo[a]quinolizin-2-one, 1,3,4,6,7, 11b-hexahydro-3-isobutyl-9,10-dimethoxy-,|3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one #|3-isobutyl-9-,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-benzo[a]quinolizin-2-one|(3R,11bR)-rel-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one;cis-2-Oxo-3-isobutyl-9,10-di|(3R,11bR)-rel-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-one;cis-2-Oxo-3-isobutyl-9,10-dimeth oxy-1,2,3,4,6,7-hexahydro -11bH-benzo[a]quinolizine;(+/-)-Tetrabenazine|rel-(3R,11bR)-3-Isobutyl-9,10-dimethoxy-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-one|Tetrabenazine (3r,11br)-rel-1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2h-benzo[a]quinolizin-2-one"
METHAMPHETAMINE,10836,,"InChI=1S/C10H15N/c1-9(11-2)8-10-6-4-3-5-7-10/h3-7,9,11H,8H2,1-2H3/t9-/m0/s1",MYWUZJCMWCOHBA-VIFPVBQESA-N,C10H15N,149.23,(2S)-N-methyl-1-phenylpropan-2-amine,"METHAMPHETAMINE|Metamfetamine|d-Deoxyephedrine|d-Desoxyephedrine|Metamphetamine|d-N-Methylamphetamine|d-Methylamphetamine|d-Phenylisopropylmethylamine|Norodin|(S)-Methamphetamine|N-Methylamphetamine|(+)-Methylamphetamine|d-(S)-Methamphetamine|D-1-Phenyl-2-methylaminopropane|(S)-Methylamphetamine|(+)-N-Methylamphetamine|(+)-(S)-Deoxyephedrine|Metamfetamina|Metamfetaminum|Metanfetamina|Methyl-beta-phenylisopropylamine|Stimulex|(S)-(+)-Deoxyephedrine|1-Phenyl-2-methylaminopropane|(+)-methamphetamine|537-46-2|(2S)-N-methyl-1-phenylpropan-2-amine|S-(+)-Methamphetamine|(S)-N,alpha-Dimethylbenzeneethanamine|D-N,alpha-dimethylphenethylamine|Methamphetaminum|(+)-2-(N-Methylamino)-1-phenylpropane|N-Methyl-beta-phenylisopropylamine|(+)-N,alpha-Dimethylphenethylamine|dextromethamphetamine|(+)-N,alpha-Dimethyl-beta-phenylethylamine|(+)-(S)-N-alpha-Dimethylphenethylamine|(alphaS)-N,alpha-dimethylbenzeneethanamine|CHEBI:6809|(s)-phenylmethylaminopropane|NSC-25115|44RAL3456C|Benzeneethanamine, N,alpha-dimethyl-, (S)-|Benzeneethanamine, N,alpha-dimethyl-, (+)-|J6.362B|DTXSID8037128|Phenethylamine, N,alpha-dimethyl-, (S)-(+)-|methyl((2S)-1-phenylpropan-2-yl)amine|methyl[(2S)-1-phenylpropan-2-yl]amine|N Methylamphetamine|metamfetamine racemate|RefChem:6653|DTXCID6017128|N06BA03|208-668-7|Deoxyephedrine|Desoxyephedrine|N-methyl-1-phenylpropan-2-amine|d-Methamphetamine|Methylamphetamine|Desyphed|Meth|Metamfetamine [INN]|Metamfetaminum [INN-Latin]|Metamfetamina [INN-Spanish]|Metanfetamina [INN-Spanish]|Methamphetaminum [INN-Latin]|1-Phenyl-2-methylamino-propan [German]|d-1-Phenyl-2-methylaminopropan [German]|D-1-Phenyl-2-methylaminopropan|2S-(+)-Methamphetamine|(S)-(+)-Methamphetamine|N-Methyl-beta-phenylisopropylamin [German]|NSC 25115|(S)-N,alpha-Dimethylbenzeneethanoamine|(S)-(+)-N,alpha,dimethylphenethylamine|Metamfetamine (INN)|DEA No. 1105|Methyl-.beta.-phenylisopropylamine|d-N,.alpha.-Dimethylphenethylamine|Speed|Benzeneethanamine, N,alpha-dimethyl-, (alphaS)-|1-Phenyl-2-methylamino-propan|Desoxyn|N-Methyl-beta-phenylisopropylamin|Crank|Methamphetaminum [JP]|Crystal Meth|Metamfetaminum [Latin]|Metanfetamina [Spanish]|Meth (Street Name)|ICE [Street Name]|Crank [Street Name]|Speed [Street Name]|Crystal Meth [Street Name]|HSDB 3359|N-Methyl-1-phenyl-2-propanamine|(+ )-Methylamphetamine|EINECS 208-668-7|Phenethylamine, N,alpha-dimethyl-, (+)-|UNII-44RAL3456C|B40|Methamphetamine (MA)|Benzeneethanamine, N,.alpha.-dimethyl-, (S)-|Phenethylamine, N,.alpha.-dimethyl-, (S)-(+)-|Epitope ID:178090|intra-venous methamphetamine|Benzeneethanamine,.alpha.-dimethyl-, (S)-|d-N,a-dimethylphenethylamine|METHAMPHETAMINE [MI]|SCHEMBL42615|Phenethylamine,.alpha.-dimethyl-, (S)-(+)-|METHAMPHETAMINE [HSDB]|METAMFETAMINE [WHO-DD]|METHAMPHETAMINE [VANDF]|CHEMBL1201201|WLN: 1MY1&1R -D|N,I+/--Dimethyl-phenethyl amine|Desyphed hydrochloride (Salt/Mix)|NSC25115|N-Methyl-1-phenyl-2-propanamine #|BDBM50359499|PDSP1_001404|PDSP1_001405|PDSP2_001388|PDSP2_001389|(+)-N,.alpha.-Dimethylphenethylamine|DB01577|Desoxyephedrine hydrochloride (Salt/Mix)|Phenethylamine,.alpha.-dimethyl-, (+)-|(+)-(S)-N-.alpha.-Dimethylphenethylamine|Benzeneethanamine,.alpha.-dimethyl-, (+)-|NS00000412|Phenethylamine, N,.alpha.-dimethyl-, (+)-|Benzeneethanamine, N,.alpha.-dimethyl-, (+)-|C07164|D08187|(+)-N,.alpha.-Dimethyl-.beta.-phenylethylamine|Q191924|Phenethylamine, N,alpha-dimethyl-, (S)-(+)- (8CI)|Benzeneethanamine, N,alpha-dimethyl-, (alphaS)- (9CI)|(+)-N,.alpha.-Dimethylphenethylamine hydrochloride (Salt/Mix)"
CAMPTOTHECIN,24360,,"InChI=1S/C20H16N2O4/c1-2-20(25)14-8-16-17-12(7-11-5-3-4-6-15(11)21-17)9-22(16)18(23)13(14)10-26-19(20)24/h3-8,25H,2,9-10H2,1H3/t20-/m0/s1",VSJKWCGYPAHWDS-FQEVSTJZSA-N,C20H16N2O4,348.4,"(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione","camptothecin|7689-03-4|Camptothecine|(S)-(+)-Camptothecin|d-Camptothecin|(+)-Camptothecine|(+)-Camptothecin|20(S)-Camptothecine|21,22-Secocamptothecin-21-oic acid lactone|NSC94600|NSC-94600|XT3Z54Z28A|DTXSID0030956|CHEBI:27656|(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione|(4S)-4-ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-|(4S)-4-ETHYL-4-HYDROXY-1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE|(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione|1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-|20-(S)-camptothecine|RefChem:388854|DTXCID8010956|21, 22-Secocamptothecin-21-oic acid lactone|(S)-4-ethyl-4-hydroxy-1H-pyrano-(3',4':6,7)indolozino(1,2-b)quinoline-3,14(4H,12H)-dione|1H-Pyrano(3',3'.6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4hydroxy-(S)-|Campathecin|(S)-4-ethyl-4-hydroxy-1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|MFCD00081076|Camptothecine (S,+)|CHEMBL65|MLS000766223|M01564|(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione|(S)-Camptothecin|1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-|1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (4S)-|20(S)-Camptothecin|4-ETHYL-4-HYDROXY-1,12-DIHYDRO-4H-2-OXA-6,12A-DIAZA-DIBENZO[B,H]FLUORENE-3,13-DIONE|SR-01000075798|SR-01000597379|d-camptothecine|(s)-camptothecine|(S)-4-ethyl-4-hydroxy-1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione|(S)-4-Ethyl-4-hydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14-(4H,12H)-dione|Prestwick_102|Camptothecine (8CI)|Spectrum_000299|Tocris-1100|SpecPlus_000712|Prestwick0_000200|Prestwick1_000200|Prestwick2_000200|Prestwick3_000200|Spectrum2_000903|Spectrum3_001203|Spectrum4_000738|Spectrum5_001126|CAMPTOTHECIN [MI]|Lopac-C-9911|SCHEMBL6038|UNII-XT3Z54Z28A|Lopac0_000341|BSPBio_000159|BSPBio_002586|KBioGR_001036|KBioSS_000779|KBioSS_002283|cid_24360|CAMPTOTHECIN [WHO-DD]|DivK1c_000826|DivK1c_006808|SPECTRUM1502232|SPBio_000746|SPBio_002080|BPBio1_000175|CCRIS 8162|orb1309690|SCHEMBL29351099|SCHEMBL29360250|HMS502J08|KBio1_000826|KBio1_001752|KBio2_000779|KBio2_003347|KBio2_005915|KBio3_002086|4-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|NINDS_000826|Bio1_000400|Bio1_000889|Bio1_001378|GLXC-10346|HMS1568H21|HMS1921N08|HMS2089F08|HMS2095H21|HMS3261E03|HMS3414J17|HMS3654D13|HMS3678J15|HMS3712H21|BCP02857|MSK40312|Tox21_500341|AC-202|BBL033963|BDBM50008923|CCG-40255|GR-301|NSC 94600|s1288|STK801886|AKOS004119861|DB04690|FC15450|KS-5235|LP00341|SDCCGMLS-0066688.P001|SDCCGSBI-0050329.P003|BRN 0631069|CAS-2114454|IDI1_000826|NCGC00015290-01|NCGC00016994-01|NCGC00016994-02|NCGC00016994-03|NCGC00016994-04|NCGC00016994-05|NCGC00016994-06|NCGC00016994-07|NCGC00016994-08|NCGC00016994-09|NCGC00016994-10|NCGC00016994-11|NCGC00016994-12|NCGC00016994-16|NCGC00016994-19|NCGC00016994-23|NCGC00016994-29|NCGC00024997-01|NCGC00024997-02|NCGC00024997-03|NCGC00024997-04|NCGC00024997-05|NCGC00024997-06|NCGC00178592-01|NCGC00178592-02|NCGC00261026-01|HY-16560|NCI60_042105|SMR000445686|SY010324|AI3-62475|EU-0100341|NS00011856|SW196414-3|C 9911|C01897|AB00052452-08|AB00052452-09|AB00052452_10|EN300-1725804|(S)-(+)-Camptothecin, >=90% (HPLC), powder|689C034|Q419964|SR-01000075798-1|SR-01000075798-4|SR-01000597379-1|SR-01000597379-3|BRD-K37890730-001-09-4|BRD-K37890730-001-10-2|BRD-K37890730-001-15-1|BRD-K37890730-001-16-9|BRD-K37890730-001-17-7|Z1741982070|(S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]florene-3,13-dione|(S)-4-ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione|4-Ethyl-4-hydroxy-1H-pyrano-[3,4:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|4-Ethyl-4-hydroxy-1H-pyrano-[3[,4[:6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|(19S)-19-ethyl-19-hydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione|(S)-4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione;Camptothecine|1H-Pyrano[3',7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4-ethyl-4-hydroxy-, (S)-|4(S)-Ethyl-4-hydroxy-1H-pyrano-[3',4':6,7]indolizino[1,2-b]quinoline-3,14 (4H,12H)-dione|4-ethyl-4-hydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinoline-3,14-dione|4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (camptothecin or CPT)|4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (Camptothecin)|4-Ethyl-4-hydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (CPT, Camptothecin)"
TOPOTECAN,60700,,"InChI=1S/C23H23N3O5/c1-4-23(30)16-8-18-20-12(9-26(18)21(28)15(16)11-31-22(23)29)7-13-14(10-25(2)3)19(27)6-5-17(13)24-20/h5-8,27,30H,4,9-11H2,1-3H3/t23-/m0/s1",UCFGDBYHRUNTLO-QHCPKHFHSA-N,C23H23N3O5,421.4,"(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione","topotecan|123948-87-8|Hycamptamine|Topotecan lactone|Hycamptin|Topotecane|(S)-Topotecan|Topotecanum|Nogitecan|Topophore C|TopoCED|SKF-104864-A|9-Dimethylaminomethyl-10-hydroxycamptothecin|NSC-641007|7M7YKX2N15|CHEBI:63632|FF-10850 (liposomal topotecan)|NSC609699|NSC-609699|SK&F 104864 A|SKF-104864|(S)-10-((Dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione|DTXSID3042685|NSC641007|9-[(dimethylamino)methyl]-10-hydroxy-(4S)-camptothecin|SK&F-104864|1H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-, (S)-|(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione|(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]-quinoline-3,14(4H,12H)-dione|(S)-10-[(Dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|9-((dimethylamino)methyl)-10-hydroxy-(4S)-camptothecin|(19S)-8-((dimethylamino)methyl)-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.0^(2,11).0^(4,9).0^(15,20))henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione|(s)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)-quinoline-3,14(4H,12H)-dione|1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (S)-|RefChem:57197|DTXCID1022685|SKF104864A|SK&F104864A|SKF 104864 A|9 Dimethylaminomethyl 10 hydroxycamptothecin|9-((dimethylamino)methyl)-10-hydroxy-(20S)-camptothecin|NSC 609699|Topotecane [INN-French]|Topotecanum [INN-Latin]|1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-|CHEMBL84|Hycamtin (TN)|(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione|(S)-10-((dimethylamino)methyl)-4-ethyl-4,9-dihydroxy-1,12-dihydro-14H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H)-dione|(4S)-10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3',4':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE|Hycamtamine|Topotecan [INN:BAN]|CHEMBL1607|Topotecan (BAN)|SK&F-104864-A|SK&F-S-104864A|SR-01000763672|UNII-7M7YKX2N15|CCRIS 8163|MFCD00870670|HSDB 8213|1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 10-((DIMETHYLAMINO)METHYL)-4-ETHYL-4,9-DIHYDROXY-, (4S)-|SKF-S 104864|SKF 104864|TOPOTECAN [INN]|TOPOTECAN [MI]|TOPOTECAN [VANDF]|SCHEMBL3836|TOPOTECAN [WHO-DD]|NCIStruc1_001659|NCIStruc2_001796|BSPBio_002348|TOPOTECAN [EMA EPAR]|cid_60699|GTPL7101|orb1301493|SCHEMBL29350221|SCHEMBL29726458|EX-A834|HMS2090B20|HMS3715L03|BDBM50008935|BDBM50034026|HSCI1_000228|s9321|AKOS015966792|CCG-221171|DB01030|SMP2_000312|SMP2_000327|NCGC00014925-02|NCGC00014925-03|NCGC00014925-04|NCGC00014925-07|NCGC00014925-10|NCGC00014925-24|NCGC00178695-01|AC-11592|AC-34812|AS-75098|BP-29353|HY-13768|NCI60_004771|dimethylaminomethyl-ethyl-dihydroxy-[?]dione|NS00003193|D08618|EN300-117268|AB00641837-09|AB00641837-11|AB00641837-12|AB00641837-13|AB00641837-14|AB00641837_15|AB00641837_16|948T878|Q419953|SR-01000763672-3|SR-01000763672-4|BRD-K55696337-001-03-2|BRD-K55696337-003-08-7|BRD-K55696337-003-20-2|BRD-K55696337-003-21-0|BRD-K55696337-003-22-8|BRD-K55696337-003-23-6|BRD-K55696337-003-24-4|Z1501485359|Topotecan hydrochloride hydrate, >=98% (HPLC and enzymatic)|10-HYDROXY-9-((DIMETHYLAMINO)METHYL)-(20S)-CAMPTOTHECIN|(19S)-8-[(dimethylamino)methyl]-19-ethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0(2),(1)(1).0?,?.0(1)?,(2)?]henicosa-1(21),2,4,6,8,10,15(20)-heptaene-14,18-dione|(20S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione|(4-Ethyl-4,9-dihydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-10-ylmethyl)-dimethyl-ammonium|(S)-10-[(DIMETHYLAMINO)METHYL]-4-ETHYL-4,9-DIHYDROXY-1H-PYRANO[3'''',4'''':6,7]INOLIZINO[1,2-B]-QUINOLINE-3,14(4H,12H)-DIONE|(S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione|(S)-10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride|(S)-11-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione|(S)-11-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride|10-dimethylaminomethyl-4-ethyl-4,9-dihydroxy-(4S)-3,4,12,14-tetrahydro-1H-pyrano[3'''',4'''':6,7]indolizino[1,2-b]quinoline-3,14-dione|10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione|10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione (Topotecan)|10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione(Topotecan)|10-Dimethylaminomethyl-4-ethyl-4,9-dihydroxy-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione; hydrochloride|1H-Pyrano[3',7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 10-[(dimethylamino)methyl]-4-ethyl-4,9-dihydroxy-, (4S)-"
7-ETHYL-10-HYDROXYCAMPTOTHECIN,104842,,"InChI=1S/C22H20N2O5/c1-3-12-13-7-11(25)5-6-17(13)23-19-14(12)9-24-18(19)8-16-15(20(24)26)10-29-21(27)22(16,28)4-2/h5-8,25,28H,3-4,9-10H2,1-2H3/t22-/m0/s1",FJHBVJOVLFPMQE-QFIPXVFZSA-N,C22H20N2O5,392.4,"(19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione","7-Ethyl-10-hydroxycamptothecin|86639-52-3|SN-38|SN 38 lactone|SN 38|10-Hydroxy-7-ethylcamptothecin|7-Ethyl-10-hydroxy-20(S)-camptothecin|NK 012|NK-012|NK012|CHEBI:8988|0H43101T0J|CAMPTOTHECIN, 7-ETHYL-10-HYDROXY-|DTXSID4040399|(4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione|(4S)-4,11-diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|(1S,2S,3R)-1-(3,4-dihydroxy-5-methoxy-phenyl)-2,3,7-trihydroxy-3-(hydroxymethyl)-6-methoxy-tetralin-2-carboxylic acid|1H-PYRANO(3',4':6,7)INDOLIZINO(1,2-B)QUINOLINE-3,14(4H,12H)-DIONE, 4,11-DIETHYL-4,9-DIHYDROXY-, (4S)-|H-Pyrano(3',4':6,7)indolizino(1,2-b)quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (S)-|(19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione|(19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione|1H-Pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (4S)-|RefChem:914300|7 Ethyl 10 hydroxycamptothecin|DTXCID2020399|7-Ethyl-10-hydroxy-camptothecin|(S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione|SN38|MFCD00871873|C22H20N2O5|(19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaene-14,18-dione|113015-38-6|IT-141|NSC673596|7-Ethyl-10-hydroxy campthotecin|7-ethyl-10-hydroxy-20(s)-campthothecin|LE-SN38|Captothecin, 7-ethyl-10-hydroxy-|UNII-0H43101T0J|7-Ethyl-10-hydroxycamptothecin ((S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)-dione)|AvaChem1025|SN-38 (Standard)|(+)-7-ETHYL-10-HYDROXYCAMPTOTHECIN|diethyl(dihydroxy)[?]dione|SCHEMBL34018|GTPL6925|orb1307686|SN 38 [WHO-DD]|SCHEMBL29354078|SCHEMBL29359781|10-hydroxy-7-ethyl camptothecin|10-hydroxy-7-ethyl-camptothecin|EX-A989|HMS3413B12|HMS3652P12|HMS3677B12|HMS3753E15|BCP01386|7-Ethyl-10-hydroxy-20(S)-CPT|BDBM50418088|HY-13704R|MSK162382|s4908|AKOS015920433|AC-1357|BCP9000200|CCG-264764|CS-1579|DB05482|FE29579|NSC-673596|SN-38(NK-012)?|NCGC00167831-01|NCGC00167831-05|110714-48-2|AS-13533|BP-24513|Camptothecin 7-Ethyl-10-Hydroxy Impurity|HY-13704|NCI60_026056|SY013197|7-Ethyl-10-hydroxy-20-(S)-camptothecine|E0748|NS00069821|SW219948-1|S-(+)-7-ETHYL-10-HYDROXYCAMPOTHECIN|EN300-122379|439E812|F046379|Q1750127|BRD-K89561498-001-01-7|BRD-K89561498-001-02-5|7-Ethyl-10-hydroxycamptothecin, >=98% (HPLC), powder|Z1541759909|(19S)-10,19-diethyl-7,19-dihydroxy-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaene-14,18-dione|(4S)-4,11-Diethyl-4,9-dihydroxy-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinoline-3,14(4H,12H)dione, AldrichCPR|(S)-4,11-Diethyl-4,9-di-OH-1,12-dihydro-4H-2-oxa-6,12a-diaza-dibenzo[b,h]fluorene-3,13-dione|1H-Pyrano[3',7]indolizino[1,2-b]quinoline- 3,14(4H,12H)-dione, 4,11-diethyl-4,9-dihydroxy-, (4S)-|RS4"
CARIPORIDE,151172,,"InChI=1S/C12H17N3O3S/c1-7(2)9-5-4-8(11(16)15-12(13)14)6-10(9)19(3,17)18/h4-7H,1-3H3,(H4,13,14,15,16)",IWXNYAIICFKCTM-UHFFFAOYSA-N,C12H17N3O3S,283.35,N-(diaminomethylidene)-3-methylsulfonyl-4-propan-2-ylbenzamide,"Cariporide|159138-80-4|HOE642|Cariporida|7E3392891K|N-carbamimidoyl-3-methanesulfonyl-4-(propan-2-yl)benzamide|cariporidum|RefChem:918079|N-(Diaminomethylene)-4-isopropyl-3-(methylsulfonyl)benzamide|Cariporide [INN]|N-(diaminomethylidene)-3-methylsulfonyl-4-propan-2-ylbenzamide|MFCD00864683|CHEMBL436559|n-[bis(azanyl)methylidene]-3-methylsulfonyl-4-propan-2-yl-benzamide|N-(4-Isopropyl-3-methanesulfonyl-benzoyl)-guanidine|N-(Aminoiminomethyl)-4-(1-methylethyl)-3-(methylsulfonyl)benzamide|UNII-7E3392891K|CARIPORIDE [MI]|4-isopropyl-3-(methylsulfonyl)benzoyl-guanidine methanesulfonate|CARIPORIDE [WHO-DD]|SCHEMBL39639|orb1305960|SCHEMBL1648723|Cariporide, >=98% (HPLC)|DTXSID8047345|SCHEMBL31563713|EX-A886|GLXC-06804|BCP15215|BDBM50058759|BDBM50234609|s5814|AKOS015854493|AKOS025142097|CS-6968|DB06468|NCGC00247951-01|AC-14535|AC-31727|DS-11823|HY-19693|3-methylsulfonyl-4-i-propylbenzoylguanidine|DB-043416|NS00070850|4-isopropyl-3-methylsulphonylbenzoyl-guanidine|Q5039665|BRD-K21670884-001-01-9|N-(diaminomethylene)-4-isopropyl-3-methylsulfonyl-benzamide|N-(4-Isopropyl-3-methanesulfonyl-benzoyl)-guanidine (Cariporide)|N-(4-Isopropyl-3-methanesulfonyl-benzoyl)-guanidine(Cariporide)|N-(diaminomethylidene)-3-(methylsulfonyl)-4-(propan-2-yl)benzamide|BENZAMIDE, N-(DIAMINOMETHYLENE)-4-(1-METHYLETHYL)-3-(METHYLSULFONYL)-|Cariporide; Cariporide; N-(Aminoiminomethyl)-4-(1-methylethyl)-3-(methylsulfonyl)benzamide|159138-73-5"
ESTRONE,5870,,"InChI=1S/C18H22O2/c1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h3,5,10,14-16,19H,2,4,6-9H2,1H3/t14-,15-,16+,18+/m1/s1",DNXHEGUUPJUMQT-CBZIJGRNSA-N,C18H22O2,270.4,"(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one","estrone|53-16-7|folliculin|Theelin|estrovarin|Kestrone|Thelykinin|Ketohydroxyestrin|Estrugenone|Estron|Tokokin|1,3,5(10)-Estratrien-3-ol-17-one|Disynformon|Follicunodis|Glandubolin|Hiestrone|Oestroform|Oestronum|Oestroperos|Femidyn|Folipex|Folisan|Menagen|Oestrin|Kolpon|Cristallovar|Endofolliculina|Aquacrine|Crinovaryl|Crystogen|Destrone|Estrusol|Folikrin|Follestrine|Hormofollin|Hormovarine|Ketodestrin|Menformon|Ovifollin|Perlatan|Solliculin|Thelestrin|Thynestron|Wynestron|3-Hydroxyestra-1,3,5(10)-trien-17-one|Estrona|Femestrone injection|Estrogenic Substance|Estra-1,3,5(10)-trien-17-one, 3-hydroxy-|Estronum|3-Hydroxy-17-keto-estra-1,3,5-triene|Folliculinum|3-Hydroxy-oestra-1,3,5(10)-trien-17-one|1,3,5(10)-Oestratrien-3-ol-17-one|3-Hydroxy-17-keto-oestra-1,3,5-triene|delta-1,3,5-estratrien-3-beta-ol-17-one|delta-1,3,5-oestratrien-3-beta-ol-17-one|3-Hydroxy-1,3,5(10)-estratrien-17-one|Estradiol metabolite e1|(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-17-one|DTXSID4022367|Unden (pharmaceutical)|NATURAL ESTROGENIC SUBSTANCE-ESTRONE|1,3,5-Estratrien-3-ol-17-one|3-hydroxy-estra-1,3,5(10)-trien-17-one|2DI9HA706A|CHEBI:17263|NSC-9699|WAY 164397|DTXCID402367|(8R,9S,13S,14S)-3-hydroxy-13-methyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta(a)phenanthren-17-one|Estrone 1516|RefChem:5805|G03CA07|G03CC04|(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo(8.7.0.02,7.011,15)heptadeca-2(7),3,5-trien-14-one|200-164-5|OESTRONE|Folliculine|Hormestrin|Unden|Estrone-A|Ketohydroxyoestrin|Estrona [Spanish]|Folliculine benzoate|Ovex (tablets)|Estronum [INN-Latin]|estrol|Estrona [INN-Spanish]|Follestrol|Mestronaq|Ketohydroxy-Estratriene|3-Hydroxyestra-1,3,5(10)-triene-17-one|(+)-Estrone|Estrone (E1)|delta-1,3,5-Estratrien-3beta-ol-17-one|Fem-O-Gen|(+/-)-Oestrone|delta-1,3,5-Oestratrien-3beta-ol-17-one|(+/-)-Estrone|Estrone DL-form [MI]|Estrone, (+/-)-|19973-76-3|MFCD00003620|Estrone (Standard)|E(sub 1)|CHEMBL1405|MLS000028475|X9XKA379T9|Estra-1,3,5(10)-trien-17-one, 3-hydroxy-, (+/-)-|SMR000058338|Unigen|(13S)-3-hydroxy-13-methyl-7,8,9,11,12,13,15,16-octahydro-6H-cyclopenta[a]phenanthren-17(14H)-one|[2,4,6,7-3H]-E1|hydroxyestrones|Unden (pharmaceutical) (VAN)|(9beta,13alpha)-3-Hydroxyestra-1,3,5(10)-Trien-17-One|Oestrone [Steroidal oestrogens]|(1S,10R,11S,15S)-5-hydroxy-15-methyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadeca-2,4,6-trien-14-one|CCRIS 285|Estrone (TN)|HSDB 3324|NSC 9699|EINECS 200-164-5|Estrone (JAN/USP/INN)|Estrone [USP:INN:BAN]|BRN 1915077|UNII-2DI9HA706A|UNII-X9XKA379T9|Aquest|CAS-53-16-7|NCGC00015423-03|J3Z|CMC_13458|Estrone, 15|ESTRONE [VANDF]|Opera_ID_330|ESTRONE [HSDB]|Estrone, >=99%|ESTRONE [INN]|ESTRONE [JAN]|ESTRONE [MI]|ESTRONE [MART.]|Prestwick0_000914|Prestwick1_000914|Prestwick2_000914|Prestwick3_000914|Spectrum5_002047|E0026|ESTRONE [USP-RS]|ESTRONE [WHO-DD]|bmse000549|E 9750|EC 200-164-5|FOLLICULINUM [HPUS]|Lopac0_000513|SCHEMBL21702|BSPBio_000788|3-08-00-01171 (Beilstein Handbook Reference)|MLS001077340|MLS002695951|MLS006011890|BIDD:ER0145|ESTRONE [ORANGE BOOK]|SPBio_002977|BPBio1_000868|GTPL2818|MEGxm0_000444|orb1310063|SGCUT00128|ESTRONE [USP MONOGRAPH]|Estrone 1.0 mg/ml in Methanol|SCHEMBL29373834|ACon0_000083|ACon1_000122|BDBM17289|HY-B0234R|[2,4,6,7-3H]-Estrone|MSK2214|Estriol EP Impurity B (Estrone)|HMS1570H10|HMS2090E22|HMS2097H10|HMS2232O15|HMS3261H07|HMS3714H10|BCP13336|HY-B0234|to_000049|Tox21_113567|Tox21_201375|Tox21_303651|Tox21_500513|BBL033470|BL-090|LMST02010004|s1665|STK801833|AKOS005622512|AKOS007930641|Tox21_113567_1|AC-1395|CCG-204604|DB00655|DS-6316|Estrone 100 microg/mL in Acetonitrile|FE22839|LP00513|SDCCGSBI-0050497.P002|SMP1_000123|NCGC00023643-03|NCGC00023643-04|NCGC00023643-05|NCGC00023643-06|NCGC00023643-07|NCGC00023643-08|NCGC00023643-09|NCGC00023643-10|NCGC00023643-11|NCGC00023643-12|NCGC00023643-13|NCGC00023643-15|NCGC00023643-16|NCGC00023643-22|NCGC00179433-01|NCGC00179433-02|NCGC00179433-03|NCGC00257402-01|NCGC00258926-01|NCGC00261198-01|Estrone, meets USP testing specifications|SY036249|D1,3,5(10)-Estratrien-3-ol-17-one|3-hydroxyl-1,3,5(10)-estratien-17-one|3-Hydroxyoestra-1,3,5(10)-trien-17-one|AB00382990|CS-0694877|Estrone, VETRANAL(TM), analytical standard|EU-0100513|NS00010299|3-hydroxy-estra-1,3,5(10)-triene-17-one|C00468|D00067|EN300-120636|AB00382990-16|AB00382990-17|AB00382990_18|estra-1(10),2,4-trien-17-one, 3-hydroxy-|ETHINYLESTRADIOL IMPURITY C [EP IMPURITY]|003E620|3-Hydroxyestra-1,3,5(10)-trien-17-one;Estrone|F301492|Q414986|SR-01000000085|SR-01000075867|SR-01000000085-3|SR-01000075867-1|BRD-K81839095-001-04-6|BRD-K81839095-001-25-1|BRD-K81839095-001-30-1|ESTRADIOL HEMIHYDRATE IMPURITY A [EP IMPURITY]|86C77018-146D-4603-ACEA-CA0D8C4F1E2C|Estrone, European Pharmacopoeia (EP) Reference Standard|Z1530425070|Estrone, United States Pharmacopeia (USP) Reference Standard|Estrone, Pharmaceutical Secondary Standard; Certified Reference Material|(8R,13S)-3-Hydroxy-13-methyl-6,7,8,9,11,12,13,14,15,16-decahydro-cyclopenta[a]phenanthren-17-one|(8R,9S,13S,14S)-3-HYDROXY-13-METHYL-6,7,8,9,11,12,13,14,15,16-DECAHYDRO-17H-CYCLOPENTA(A)PHENANTHREN-17-ONE"
PF-05180999,60143346,,"InChI=1S/C19H17F3N8/c1-11-27-15(17-18(29-6-3-7-29)24-10-26-30(11)17)13-9-25-28(2)16(13)14-5-4-12(8-23-14)19(20,21)22/h4-5,8-10H,3,6-7H2,1-2H3",CLGCHUKGBICQTE-UHFFFAOYSA-N,C19H17F3N8,414.4,"4-(azetidin-1-yl)-7-methyl-5-[1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]pyrazol-4-yl]imidazo[5,1-f][1,2,4]triazine","1394033-54-5|PF-05180999|PF 05180999|PF-999|5L84K4IEN9|UNII-5L84K4IEN9|4-(azetidin-1-yl)-7-methyl-5-[1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]pyrazol-4-yl]imidazo[5,1-f][1,2,4]triazine|compound 30 [PMID: 29293004]|PF05180999|4-(1-Azetidinyl)-7-methyl-5-(1-methyl-5-(5-(trifluoromethyl)-2-pyridinyl)-1H-pyrazol-4-yl)imidazo(5,1-F)(1,2,4)triazine|Imidazo(5,1-F)(1,2,4)triazine, 4-(1-azetidinyl)-7-methyl-5-(1-methyl-5-(5-(trifluoromethyl)-2-pyridinyl)-1H-pyrazol-4-yl)-|compound 30 (PMID: 29293004)|2-(4-(4-(azetidin-1-yl)-7-methylimidazo(4,3-f)(1,2,4)triazin-5-yl)-1-methyl-1H-pyrazol-5-yl)-5-(trifluoromethyl)pyridine|2-{4-[4-(azetidin-1-yl)-7-methylimidazo[4,3-f][1,2,4]triazin-5-yl]-1-methyl-1H-pyrazol-5-yl}-5-(trifluoromethyl)pyridine|4-(azetidin-1-yl)-7-methyl-5-(1-methyl-5-(5-(trifluoromethyl)pyridin-2-yl)pyrazol-4-yl)imidazo(5,1-f)(1,2,4)triazine|RefChem:172243|4-(1-Azetidinyl)-7-methyl-5-[1-methyl-5-[5-(trifluoromethyl)-2-pyridinyl]-1H-pyrazol-4-yl]-imidazo[5,1-f][1,2,4]triazine|4-(azetidin-1-yl)-7-methyl-5-(1-methyl-5-(5-(trifluoromethyl)pyridin-2-yl)-1H-pyrazol-4-yl)imidazo[5,1-f][1,2,4]triazine|4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5,1-f][1,2,4]triazine|orb1706820|CHEMBL3092562|SCHEMBL11971205|SCHEMBL31404118|GTPL11626|TQR1229|BDBM107767|C19H17F3N8|GLXC-07413|MFCD28411615|AKOS028114948|DB14885|4-(azetidin-1-yl)-7-methyl-5-{1-methyl-5-[5-(trifluoromethyl)pyridin-2-yl]-1H-pyrazol-4-yl}imidazo[5|BP166579|DA-66602|MS-27169|HY-111371|CS-0039866|G14481|PF 05180999?|US8598155, 2|4-(azetidin-1-yl)-7-methyl-5-[1-methyl-5-[5-(trifluoromethyl)-2-pyridyl]pyrazol-4-yl]imidazo[5,1-f][1,2,4]triazine"
TIPIRACIL,6323266,,"InChI=1S/C9H11ClN4O2/c10-7-5(12-9(16)13-8(7)15)4-14-3-1-2-6(14)11/h11H,1-4H2,(H2,12,13,15,16)",QQHMKNYGKVVGCZ-UHFFFAOYSA-N,C9H11ClN4O2,242.66,"5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione","Tipiracil|183204-74-2|TPI (freebase)|Tipiracilo|5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione|NGO10K751P|CHEBI:90879|DTXSID601025833|5-chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1h,3h)-pyrimidinedione|5-Chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4-(1H,3H)-dione|tipiracilum|5-chloro-6-((2-iminopyrrolidin-1-yl)methyl)-1H-pyrimidine-2,4-dione|5-Chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4-(1H,3H)-dione|RefChem:898222|DTXCID001510084|MA-1|5-Chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione|5-CHLORO-6-(1-(2-IMINOPYRROLIDINYL) METHYL) URACIL|2,4(1H,3H)-Pyrimidinedione, 5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-|5-CHLORO-6-[(2-IMINOPYRROLIDIN-1-YL)METHYL]PYRIMIDINE-2,4(1H,3H)-DIONE|5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1,2,3,4-tetrahydropyrimidine-2,4-dione|Tipiracil [INN]|Tipiracil [USAN:INN]|5-CIMU|UNII-NGO10K751P|TIPIRACIL [MI]|TIPIRACIL [USAN]|TIPIRACIL [WHO-DD]|CHEMBL235668|GTPL8696|orb1909020|SCHEMBL1682960|BDBM20079|HY-A0063A|HMS3745A05|BCP24231|BDBM50531739|AKOS027324917|CS-5895|DB02631|DB09343|NCGC00389632-02|NCGC00389632-07|MS-23436|DB-065427|NS00073209|F85441|EN300-23231135|BRD-K11973162-003-01-8|Q21098889|Q27458871|5-Chloro-6-{[(2E)-2-imino-1-pyrrolidinyl]methyl}-2,4(1H,3H)-pyrimidinedione|5-chloro-6-{[(2Z)-2-iminopyrrolidin-1-yl]methyl}pyrimidine-2,4(1H,3H)-dione"
ENOXOLONE,10114,,"InChI=1S/C30H46O4/c1-25(2)21-8-11-30(7)23(28(21,5)10-9-22(25)32)20(31)16-18-19-17-27(4,24(33)34)13-12-26(19,3)14-15-29(18,30)6/h16,19,21-23,32H,8-15,17H2,1-7H3,(H,33,34)/t19-,21-,22-,23+,26+,27-,28-,29+,30+/m0/s1",MPDGHEJMBKOTSU-YKLVYJNSSA-N,C30H46O4,470.7,"(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid","enoxolone|Glycyrrhetic acid|Uralenic acid|GLYCYRRHETINIC ACID|471-53-4|18-beta-Glycyrrhetinic acid|Rhetinic Acid|Jintan|Enoxolona|Enoxolonum|3beta-Hydroxy-11-oxoolean-12-en-30-oic acid|DTXSID9020669|NSC-35347|P540XA09DR|(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid|CHEBI:30853|3-beta-Hydroxy-11-oxoolean-12-en-30-oic acid|DTXCID50669|Olean-12-en-29-oic acid, 3-hydroxy-11-oxo-, (3beta,20beta)-|Glyciram|Acid, Rhetinic|Acid, Uralenic|Acid, Glycyrrhetic|Acid, Glycyrrhetinic|12, Po|RefChem:35616|D03AX10|(3beta,20beta)-3-Hydroxy-11-oxoolean-12-en-29-oic acid|(2S,4AS,6AS,6BR,10S,12AS)-10-HYDROXY-2,4A,6A,6B,9,9,12A-HEPTAMETHYL-13-OXO-3,4,5,6,7,8,8A,10,11,12,12B,14B-DODECAHYDRO-1H-PICENE-2-CARBOXYLIC ACID|207-444-6|Glycyram|NSC35347|Arthrodont|18beta-Glycyrrhetinic acid|Glycyrrhetin|18|A-Glycyrrhetinic acid|Biosone|MFCD00003706|18 beta-Glycyrrhetintic Acid|Glycyrrhetinate|alpha-Glycyrrhetinic acid|Glycyrrhetinic acid [JAN]|3-Glycyrrhetinic acid|MLS000028748|CHEMBL230006|Enoxolone (INN)|(2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid|NCGC00017244-03|SMR000058239|ENOXOLONE [INN]|18beta-Glycyrrhetic acid|NSC 35347|Glycyrrhetinic acid (JAN)|(3beta,5beta,14beta)-3-Hydroxy-11-Oxoolean-12-En-29-Oic Acid|3beta-Hydroxy-11-oxo-18beta,20beta-olean-12-en-29-oic acid|Enoxolonum [INN-Latin]|Enoxolona [INN-Spanish]|GlycyrrhetinicAcid|18-beta-Glycyrrhetic acid|Enoxolone [INN:BAN:DCF]|(5S,8S,15S,18S,1R,2R,10R,14R,20R)-18-hydroxy-1,2,5,8,15,19,19-heptamethyl-13-o xopentacyclo[12.8.0.0<2,11>.0<5,10>.0<15,20>]docos-11-ene-8-carboxylic acid|CAS-471-53-4|18b-Glycyrrhetinic acid|CCRIS 3962|SR-01000721867|EINECS 207-444-6|BRN 2229654|UNII-P540XA09DR|Enoloxone|Enoxolone (Glycyrrhetinic acid)|NSC-35350|18|A-Glycyrrhetinic acid (Standard)|Hidermart (TN)|NCGC00181115-01|CBW|18-Glycyrrhetinic acid|ENOXOLONE [MI]|Enoxolone (Glycyrrhetin)|Opera_ID_1048|ENOXOLONE [MART.]|ENOXOLONE [WHO-DD]|SCHEMBL18540|4-10-00-03775 (Beilstein Handbook Reference)|MLS001146949|MLS002207101|Olean-12-en-30-oic acid, 3beta-hydroxy-11-oxo-|Enoxolone, Glycyrrhetinic acid|(3beta)-3-hydroxy-11-oxoolean-12-en-30-oic acid|18 beta -Glycyrrhetinic Acid|Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-|BX-1|ENOXOLONE [EP IMPURITY]|ENOXOLONE [EP MONOGRAPH]|GTPL11264|HY-N0180R|STX-352|CHEBI: 30853|(3beta,20beta)-3-Hydroxy-11-oxo-olean-12-en-29-oic acid|18beta-Glycyrrhetinic acid, 97%|HMS2233P23|(2S,4aS,6aS,6bR,10S,12aS,12bR,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid|HY-N0180|MSK40366|Tox21_110804|Tox21_112726|Tox21_200799|BDBM50233538|s2296|SBB006496|AKOS015960428|AKOS016036757|HMDB: 0011628|AC-1925|AC-8906|CCG-208506|CS-W020624|DB13089|FG09301|GM-1658|KS-1262|LMPR0106150014|Enoxolone 100 microg/mL in Acetonitrile|Glycyrrhetin ;18beta Glycyrrhetinic acid|NCGC00017244-04|NCGC00017244-06|NCGC00017244-16|NCGC00017244-20|NCGC00142473-03|NCGC00258353-01|107420-91-7|ST056310|SY075768|G0149|NS00000590|3beta-hydroxy-11-oxoolean-12-en-29-oic acid|C02283|D00156|S00284|Enoxolone (synonym: 18ss--Glycyrrhetinic acid)|471G534|18beta-Glycyrrhetinic acid, purum, >=97.0% (T)|Q5948038|SR-01000721867-3|SR-01000721867-4|SR-01000721867-5|SR-01000721867-6|BRD-K96137854-001-17-1|3ss-Hydroxy-11-oxo-18ss,20ss-olean-12-en-29-oic acid|Enoxolone, European Pharmacopoeia (EP) Reference Standard|3-b-Hydroxy-11-oxo-18b,20b-olean-12-en-29-oic acid;Enoxolone|(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylicacid|Enoxolone; 18beta-Glycyrrhetinic acid;  3?-Hydroxy-11-oxo-18?,20?-olean-12-en-29-oic acid"
VIDOFLUDIMUS,9820008,,"InChI=1S/C20H18FNO4/c1-26-14-5-2-4-12(10-14)13-8-9-18(17(21)11-13)22-19(23)15-6-3-7-16(15)20(24)25/h2,4-5,8-11H,3,6-7H2,1H3,(H,22,23)(H,24,25)",XPRDUGXOWVXZLL-UHFFFAOYSA-N,C20H18FNO4,355.4,2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid,"Vidofludimus|717824-30-1|4SC-101|2-[[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic Acid|SC12267|IMU-838|8Y1PJ3VG81|SC-12267|NSC-717824|DTXSID50431325|2-(3-Fluoro-3'-methoxybiphenyl-4-carbamoyl)cyclopent-1-enecarboxylic acid|2-(N-(3-Fluoro-3'-methoxy(1,1'-biphenyl)-4-yl)carbamoyl)cyclopent-1-ene-1-carboxylic acid|vidofludimusum|2-((2-fluoro-4-(3-methoxyphenyl)phenyl)carbamoyl)cyclopentene-1-carboxylic acid|2-((3-fluoro-3'-methoxy-(1,1'-biphenyl)-4-yl)carbamoyl)cyclopent-1-ene-1-carboxylic acid|2-((3-fluoro-3'-methoxy-[1,1'-biphenyl]-4-yl)carbamoyl)cyclopent-1-ene-1-carboxylic acid|RefChem:934024|DTXCID60382157|Vidofludimus [INN]|2-((3-Fluoro-3'-methoxy-[1,1'-biphenyl]-4-yl)carbamoyl)cyclopent-1-enecarboxylic acid|SC 12267|CHEMBL197194|4sc-101;SC12267|Vidofludimus(4SC-101; SC12267)|2-[[2-fluoranyl-4-(3-methoxyphenyl)phenyl]carbamoyl]cyclopentene-1-carboxylic acid|2-{[2-fluoro-4-(3-methoxyphenyl)phenyl]carbamoyl}cyclopent-1-ene-1-carboxylic acid|UNII-8Y1PJ3VG81|MFCD18633262|Vidofludimus (USAN/INN)|VIDOFLUDIMUS [USAN]|SCHEMBL247888|VIDOFLUDIMUS [WHO-DD]|GTPL9860|orb1305278|SCHEMBL29352865|BDBM16111|EX-A546|IMU-838 (vidofludimus calcium)|HMS3740I15|HMS6018F16|BCP14555|EX-A4148|s7262|AKOS026750557|CCG-268095|CS-3221|DB15446|SB19828|NCGC00345056-01|NCGC00345056-02|NCGC00345056-04|Vidofludimus(4SC-101; SC12267)?|AC-32911|AS-56375|DA-68582|FV102840|HY-14908|D13127|BRD-K40797222-001-01-8|Q27271184|2-(3-fluoro-3'-methoxybiphenyl-4-ylcarbamoyl)cyclopent-1-enecarboxylic acid|1-Cyclopentene-1-carboxylic acid, 2-[[(3-fluoro-3'-methoxy[1,1'-biphenyl]-4-yl)amino]carbonyl]-|D5H"
BREQUINAR,57030,,"InChI=1S/C23H15F2NO2/c1-13-21(23(27)28)18-12-16(24)10-11-20(18)26-22(13)15-8-6-14(7-9-15)17-4-2-3-5-19(17)25/h2-12H,1H3,(H,27,28)",PHEZJEYUWHETKO-UHFFFAOYSA-N,C23H15F2NO2,375.4,6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid,"Brequinar|96187-53-0|brequinarum|6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methylquinoline-4-carboxylic acid|NSC 368390|DUP785|5XL19F49H6|NSC368390|NSC-368390|CHEBI:177387|DTXSID00242165|4-Quinolinecarboxylic acid, 6-fluoro-2-(2'-fluoro(1,1'-biphenyl)-4-yl)-3-methyl-|4-Quinolinecarboxylic acid, 6-fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-|6-fluoro-2-(4-(2-fluorophenyl)phenyl)-3-methylquinoline-4-carboxylic acid|RefChem:917540|DTXCID00164656|6-fluoro-2-(2'-fluoro-1,1'-biphenyl-4-yl)-3-methyl-4-quinolinecarboxylic acid|6-Fluoro-2-(2'-fluoro(1,1'-biphenyl)-4-yl)-3-methyl-4-quinolinecarboxylic Acid|887-847-7|Bipenquinate|6-Fluoro-2-(2'-fluoro-[1,1'-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid|Brequinar [INN]|C23H15F2NO2|6-fluoro-2-(2'-fluorobiphenyl-4-yl)-3-methylquinoline-4-carboxylic acid|Biphenquinate|MFCD00866437|6-fluoro-2-[4-(2-fluorophenyl)phenyl]-3-methyl-quinoline-4-carboxylic acid|brequinarum [Latin]|6-Fluoro-2-(2'-fluoro-[11'-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid|6-FLUORO-2-(2'-FLUORO-1,1'-BIPHENYL-4-YL)-3-METHYLQUINOLINE-4-CARBOXYLIC ACID|Brequinarum [INN-Latin]|UNII-5XL19F49H6|6-fluoro-2-{2'-fluoro-[1,1'-biphenyl]-4-yl}-3-methylquinoline-4-carboxylic acid|BREQUINAR [MI]|BREQUINAR [WHO-DD]|Neuro_000208|SCHEMBL49400|CHEMBL38434|DUP785; Biphenquinate; BPQ|GTPL7406|orb1302169|SCHEMBL29355220|SCHEMBL29688590|BDBM15339|TQR0591|GLXC-15913|HMS3749M07|HMS5086F13|HMS6018M22|BCP06006|EX-A1515|s6626|AKOS016001465|CS-7842|DB03523|FF44184|NCGC00480786-05|AC-35372|DS-15411|NCI60_003391|DB-080409|HY-108325|B5707|NS00068683|C77324|EN300-263943|BPQ; Biphenquinate; DUP 785; DUP785; DUP-785|BRD-K96123349-236-02-8|Q27075486|Z1847670860|6-fluoro-2-(2'-fluoro[biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid|2-(2'-Fluoro-1,1'-biphenyl-4-yl)-6-fluoro-3-methyl-4-quinolinecarboxylic acid|6-Fluoro-2-(2'-fluoro-[1 pound not1'-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid|6-fluoro-2-(2'-fluoro-1,1 '-biphe-nyl-4-yl)-3-methyl-4-quinolinecarboxylic acid|6-FLUORO-2-(2'-FLUORO-4-BIPHENYLYL)-3-METHYL-4-QUINOLINECARBOXYLATE|6-Fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic acid #|6-fluoro-2-(2'-fluoro[1,1'-biphenyl]-4-yl)-3-methylquinoline-4-carboxylic acid|6-Fluoro-2-(2'-fluoro-[1,1'-biphenyl]-4-yl)-3-methyl-4-quinolinecarboxylic acid, (*Sodium sal*)"
ATOVAQUONE,74989,,"InChI=1S/C22H19ClO3/c23-16-11-9-14(10-12-16)13-5-7-15(8-6-13)19-20(24)17-3-1-2-4-18(17)21(25)22(19)26/h1-4,9-13,15,24H,5-8H2",BSJMWHQBCZFXBR-UHFFFAOYSA-N,C22H19ClO3,366.8,"3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione","ATOVAQUONE|95233-18-4|Mepron|Wellvone|Acuvel|cis-Atovaquone|137732-39-9|Atavaquone|94015-53-9|566C80|Mepron (antipneumocystic)|BW 566C|3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxynaphthalene-1,2-dione|566C|2-(TRANS-4-(4-CHLOROPHENYL)CYCLOHEXYL)-3-HYDROXY-1,4-NAPHTHALENEDIONE|atovacuona|2-(trans-4-(p-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|CIS-ATOVAQUONE (RACEMIC)|2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone|Atovaquone (Atavaquone)|MFCD00889188|F1W7QUV0KI|NSC-759582|Y883P1Z2LT|DTXSID7022629|2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione|BW-566C|CHEBI:575568|DTXSID20916694|2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione|2-[trans-4-(4-chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione|trans-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione|NCGC00016961-01|Atovaquone 100 microg/mL in Acetonitrile|3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-naphthalene-1,2-dione|CAS-95233-18-4|C22H19ClO3|1,4-Naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-, trans-|DTXCID602629|2-(cis-4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthalenedione|2-(cis-4-(4-Chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione|2-[trans-4-(p-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone|cis-2-(4-(4-Chlorophenyl)cyclohexyl)-3-hydroxy-1,4-naphthoquinone|1,4-Naphthalenedione, 2-(cis-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-|2-((1r,4r)-4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione|DRG-0084|BW 566C-80|Mepron (TN)|BW-A 566C|HSDB 7083|SR-05000001438|Atovaquone EP Impurity B|BW-566C-80|CRL-8131 & Atovaquone|UNII-Y883P1Z2LT|Atovaquona|2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone|Atovaquone & Interleukin 12|2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-naphthalene-1,4-dione|3-(4-(4-chlorophenyl)cyclohexyl)-4-hydroxynaphthalene-1,2-dione|Cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone|trans-2-(4-(4-chlorophenyl) cyclohexyl)-3-hydroxynaphthalene-1,4-dione|ATO & IL-12|2-[trans-4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione;566C80;BW-566C|Atovaquone; 2-[trans-4-(4-Chlorophenyl)cyclohexyl]-3-hydroxynaphthalene-1,4-dione; 566C80|Atovaquone [USAN:USP:INN:BAN]|cis-2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthalenedione; USP Atovaquone Related Compound A; Atorvastatin EP Impurity B|BW 566C80|Atovaquone (Standard)|Spectrum_001743|starbld0018905|ATOVAQUONE [MI]|SpecPlus_000686|ATOVAQUONE [INN]|ATOVAQUONE [JAN]|Prestwick0_000534|Prestwick1_000534|Prestwick2_000534|Prestwick3_000534|Spectrum2_001665|Spectrum3_000991|Spectrum4_001117|Spectrum5_001382|UNII-F1W7QUV0KI|Atovaquone (Atavaquone)?|ATOVAQUONE [HSDB]|ATOVAQUONE [USAN]|RefChem:1066764|ATOVAQUONE [VANDF]|ATOVAQUONE [MART.]|ATOVAQUONE [USP-RS]|ATOVAQUONE [WHO-DD]|SCHEMBL21694|SCHEMBL21695|Atovaquone (JAN/USP/INN)|BSPBio_000547|BSPBio_002681|KBioGR_001594|KBioSS_002223|MLS002153863|BIDD:GT0849|DivK1c_006782|SCHEMBL637069|SPECTRUM1504210|SPBio_001849|SPBio_002468|Atovaquone - Bio-X trade mark|BPBio1_000603|CHEMBL222334|CHEMBL471792|CHEMBL519462|GTPL9695|orb1308475|SCHEMBL1542719|SCHEMBL1649508|SCHEMBL9975142|ATOVAQUONE [ORANGE BOOK]|Atovaquone, >=98% (HPLC)|SCHEMBL29559044|Atovaquone for system suitability|CHEBI:95346|KBio1_001726|KBio2_002223|KBio2_004791|KBio2_007359|KBio3_001901|ATOVAQUONE [EP MONOGRAPH]|DTXCID20888847|KUCQYCKVKVOKAY-CTYIDZIISA-N|KUCQYCKVKVOKAY-OTVXOJSOSA-N|ATOVAQUONE [USP MONOGRAPH]|BDBM192009|GLXC-02590|HMS1569L09|HMS1922F19|HMS2089M14|HMS2093C10|HMS2096L09|HMS2235N08|HMS3369N09|HMS3651N20|HMS3713L09|HMS5081E14|Pharmakon1600-01504210|BCP09477|MALARONE COMPONENT ATOVAQUONE|MFA73239|VHD01514|Tox21_110714|CCG-39090|FD7252|HY-13832R|NSC759582|s3079|STK636160|trans-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone|1,4-Naphthalenedione, 2-(trans-4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-|2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-dihydronaphthalene-1,4-dione|AKOS005567953|AKOS015895691|AKOS015961933|Tox21_110714_1|BW-556C-80|CCG-220534|DB01117|FA18025|NSC 759582|NCGC00016961-02|NCGC00016961-03|NCGC00016961-04|NCGC00016961-06|NCGC00016961-07|NCGC00016961-11|NCGC00095113-01|NCGC00095113-02|AC-30251|AS-12809|BA164228|HY-13832|SMR001233220|SBI-0052893.P002|A2545|AB00513855|NS00010018|NS00077594|SW219222-1|MALARONE PEDIATRIC COMPONENT ATOVAQUONE|C06835|D00236|EN300-120639|EN300-731648|F18448|SBI-0052893.0001|AB00053222-03|AB00053222_04|AB00053222_05|233A184|F390345|Q418179|SR-05000001438-1|SR-05000001438-2|SR-05000001438-4|SR-05000001438-5|Z2588038997|2-[4-(4-chlorophenyl)cyclohexy]-3-hydroxy-1,4-naphthoquinone|2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-napthoquinone|2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1.4-naphthoquinone|3-[4-(p-chlorophenyl)cyclohexyl]-4-hydroxy-1,2-naphthoquinone|1,2-Naphthalenedione, 3-[4-(4-chlorophenyl)cyclohexyl]-4-hydroxy-|1,4-Naphthalenedione, 2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxy-|2-[4-(4-Chlorophenyl)cyclohexyl]-3-hydroxynaphthoquinone, trans-|cis -2-(4-(4-chlorophenyl)cyclohexyl)-3-hydroxynaphthalene-1,4-dione|2-hydroxy-3-[(1r,4r)-4-(4-chlorophenyl)cyclohexyl]-1,4-dihydronaphthalene-1,4-dione|630-425-2|cis-2-[4-(4-chlorophenyl)cyclohexyl]-3-hydroxy-1,4-naphthoquinone; Atovaquone Related Compound A (USP); Atovaquone Imp. B (EP); 296C85; USP Atovaquone Related Compound A; GR 261266X"
PRALNACASAN,153270,,"InChI=1S/C26H29N5O7/c1-2-37-26-18(14-21(33)38-26)29-23(34)19-8-5-13-30-20(32)10-9-17(25(36)31(19)30)28-24(35)22-16-7-4-3-6-15(16)11-12-27-22/h3-4,6-7,11-12,17-19,26H,2,5,8-10,13-14H2,1H3,(H,28,35)(H,29,34)/t17-,18-,19-,26+/m0/s1",CXAGHAZMQSCAKJ-WAHHBDPQSA-N,C26H29N5O7,523.5,"(4S,7S)-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]-7-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide","Pralnacasan|192755-52-5|VX-740|HMR3480|HMR3480/VX-740|N986NI319S|HMR-3480|DTXSID60172873|HMR-3480/VX-740|(1S,9S)-N-((2R,3S)-2-Ethoxy-5-oxotetrahydrofuran-3-yl)-9-((isoquinolin-1-ylcarbonyl)amino)-6,10-dioxooctahydro-6-H-pyridazino(1,2-a)(1,2)diazepine-1-carboxamide|pralnacasanum|(1S,9S)-N-((2R,3S)-2-ethoxy-5-oxooxolan-3-yl)-9-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino(1,2-a)diazepine-1-carboxamide|(1S,9S)-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]-9-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-1-carboxamide|RefChem:868374|DTXCID2095364|N-((2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl)octahydro-9-((1-isoquinolinylcarbonyl)maino)-6,10-dioxo-(1S,9S)-6H-pyridazino(1,2-a)(1,2)diazepine-1-carboxamide|N-((4S,7S)-4-(((2R,3S)-2-ethoxy-5-oxooxolan-3-yl)carbamoyl)-6,10-dioxo-octahydro-1H-pyridazino(1,2-a)(1,2)diazepin-7-yl)isoquinoline-1-carboxamide|(1S,9S)-N-((2R,3S)-2-Ethoxy-5-oxotetrahydrofuran-3-yl)-9-(isoquinoline-1-carboxamido)-6,10-dioxooctahydro-6H-pyridazino[1,2-a][1,2]diazepine-1-carboxamide|(3S,11S)-N-[(2R,3S)-2-ETHOXY-5-OXO-OXOLAN-3-YL]-3-(ISOQUINOLINE-1-CARBONYLAMINO)-2,6-DIOXO-1,7-DIAZABICYCLO[5.4.0]UNDECANE-11-CARBOXAMIDE|(4S,7S)-N-[(2R,3S)-2-ethoxy-5-oxooxolan-3-yl]-7-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide|Pralnacasan [INN]|Pralnacasan [USAN:INN]|UNII-N986NI319S|VX-740;HMR 3480|HMR 3480|VX 470|Pralnacasan (USAN/INN)|PRALNACASAN [USAN]|SCHEMBL142187|CHEMBL437526|GTPL6467|orb1706773|SCHEMBL29387711|GLXC-07385|VX740|BDBM50189360|MFCD18381953|AKOS030230853|DB04875|DA-77033|HY-19676|MS-29694|CS-0016191|NS00069746|D08978|G13959|Q27088439|(1S,10S)-9-[(Isoquinoline-1-carbonyl)-amino]-6,10-dioxo-octahydro-pyridazino[1,2-a][1,2]diazepine-1-carboxylic acid ((S)-2-ethoxy-5-oxo-tetrahydro-furan-3-yl)-amide|(1S,9S)-N-((2R,3S)-2-ethoxy-5-oxo-tetrahydrofuran-3-yl)-9-(isoquinoline-1-carboxamido)-6,10-dioxo-octahydro-1H-pyridazino[1,2-a][1,2]diazepine-1-carboxamide|(4S,7S)-N-[(2R,3S)-2-ethoxy-5-oxo-tetrahydrofuran-3-yl]-7-(isoquinoline-1-carbonylamino)-6,10-dioxo-2,3,4,7,8,9-hexahydro-1H-pyridazino[1,2-a]diazepine-4-carboxamide|6H-Pyridazino(1,2-a)(1,2)diazepine-1-carboxamide, N-((2R,3S)-2-ethoxytetrahydro-5-oxo-3-furanyl)octahydro-9-((1-isoquinolinylcarbonyl)amino)-6,10-dioxo-, (1S,9S)-"
OLAPARIB,23725625,,"InChI=1S/C24H23FN4O3/c25-20-8-5-15(14-21-17-3-1-2-4-18(17)22(30)27-26-21)13-19(20)24(32)29-11-9-28(10-12-29)23(31)16-6-7-16/h1-5,8,13,16H,6-7,9-12,14H2,(H,27,30)",FDLYAMZZIXQODN-UHFFFAOYSA-N,C24H23FN4O3,434.5,4-[[3-[4-(cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one,"Olaparib|763113-22-0|AZD2281|Lynparza|KU-0059436|AZD-2281|AZD 2281|KU-59436|WOH1JD9AR8|Olaparibum|AZ2281|NSC-747856|4-[[3-[4-(Cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorophenyl]methyl]-2H-phthalazin-1-one|CHEBI:83766|AZ-2281|KEYLYNK-010 COMPONENT OLAPARIB|DTXSID60917988|4-(3-{[4-(Cyclopropylcarbonyl)piperazin-1-Yl]carbonyl}-4-Fluorobenzyl)phthalazin-1(2h)-One|4-[(3-{[4-(Cyclopropylcarbonyl)piperazin-1-yl]carbonyl}-4-fluorophenyl)methyl]phthalazin-1(2H)-one|4-{[3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorophenyl]methyl}-1,2-dihydrophthalazin-1-one|4-(3-((4-(cyclopropylcarbonyl)piperazin-1-yl)carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one|4-((3-((4-(CYCLOPROPYLCARBONYL)PIPERAZIN-1-YL)CARBONYL)-4-FLUOROPHENYL)METHYL)PHTHALAZIN-1(2H)-ONE|4-((3-(4-(cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorophenyl)methyl)-2H-phthalazin-1-one|4-((3-(4-cyclopropanecarbonylpiperazine-1-carbonyl)-4-fluorophenyl)methyl)-1,2-dihydrophthalazin-1-one|4-((3-{(4-(cyclopropylcarbonyl)piperazin-1-yl)carbonyl}-4-fluorophenyl)methyl)phthalazin-1(2H)-one|RefChem:57006|PARP inhibitor AZD2281|L01XX46|DTXCID001346944|1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine|4-(3-(4-(Cyclopropanecarbonyl)piperazine-1-carbonyl)-4-fluorobenzyl)phthalazin-1(2H)-one|Olaparib (AZD2281, Ku-0059436)|OLAPARIB cpd|Olaparib (AZD-2281)|MFCD13185161|Olaparib [USAN:INN]|C24H23FN4O3|UNII-WOH1JD9AR8|4-[3-(4-Cyclopropanecarbonyl-piperazine-1-carbonyl)-4-fluoro-benzyl]-2H-phthalazin-1-one|KU59436|Olaparib (DISCONTINUED)|4-[(3-{[4-Cyclopropylcarbonyl)piperazin-4-yl]carbonyl}-4-fluorophenyl)methyl]phtalazin-1(2H)-one|4-[3-[4-(Cyclopropanecarbonyl)piperazine-1-carbonyl]-4-fluorobenzyl]phthalazin-1(2H)-one|Olaparib [INN]|Olaparib (AZD2281; Ku-0059436)|Olaparib (AZD2281)|Olaparib, KU-0059436|AZD221|937799-91-2|Lynparza (TN)|09L|4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone; AZD 2281; KU 0059436; KU 59436; 1-(Cyclopropylcarbonyl)-4-[5-[(3,4-dihydro-4-oxo-1-phthalazinyl)methyl]-2-fluorobenzoyl]piperazine;|Olaparib (Standard)|AZD2281(olaparib)|KU 59436|OLAPARIB [USAN]|OLAPARIB [JAN]|OLAPARIB [MI]|OLAPARIB [VANDF]|OLAPARIB [MART.]|OLAPARIB [WHO-DD]|Olaparib (JAN/USAN/INN)|AZD-2281 (Olaparib)?|MLS006010185|Olaparib - Bio-X trade mark|SCHEMBL426568|OLAPARIB [ORANGE BOOK]|CHEMBL521686|GTPL7519|orb1304620|SCHEMBL29352148|SCHEMBL29392087|BDBM27566|EX-A002|FDLYAMZZIXQODN-UHFFFAOYSA-N|BCPP000360|GLXC-02796|HMS3295I09|HMS3426C03|HMS3654G13|HMS3746K07|HMS3870H03|HMS5079O07|HMS6019J08|BCP01872|763113-22-0, Lynparza,|HY-10162R|NSC747856|NSC753686|s1060|AKOS005145764|AC-7939|BCP9000363|CCG-264799|CS-0075|DB09074|EX-7210|FO33122|NSC 747856|NSC-753686|SB14617|SS-4573|AZD2281,Olaparib, KU-0059436|NCGC00238451-01|NCGC00238451-02|NCGC00238451-08|NCGC00238451-09|NCGC00238451-11|1(2H)-Phthalazinone, 4-[[3-[[4-(cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-|4-[[3-[[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl]-4-fluorophenyl]methyl]-1(2H)-phthalazinone|BO164169|BP-43641|HY-10162|SMR004701291|SY040527|OLAPARIB COMPONENT OF KEYLYNK-010|NS00072449|SW218142-2|D09730|EN300-7542225|F043403|Q7083106|BRD-K02113016-001-08-9|BRD-K02113016-001-09-7|BRD-K02113016-001-15-4|BRD-K02113016-001-19-6|Z2227698469|4-(3-{[4-(Cyclopropylcarbonyl)-1-piperazinyl]carbonyl}-4-fluorobenzyl)-1(2H)-phthalazinone|(2H)-Phthalazinone, 4-((3-((4-(cyclopropylcarbonyl)-1-piperazinyl)carbonyl)-4-fluorophenyl)methyl)-|1021843-02-6|4-({3-[(4-cyclopropanecarbonylpiperazin-1-yl)carbonyl]-4-fluorophenyl}methyl)-1,2-dihydrophthalazin-1-one|PIPERAZINE, 1-(CYCLOPROPYLCARBONYL)-4-(5-((3,4-DIHYDRO-4-OXO-1-PHTHALAZINYL)METHYL)-2-FLUOROBENZOYL)-"
RUCAPARIB,9931954,,"InChI=1S/C19H18FN3O/c1-21-10-11-2-4-12(5-3-11)18-14-6-7-22-19(24)15-8-13(20)9-16(23-18)17(14)15/h2-5,8-9,21,23H,6-7,10H2,1H3,(H,22,24)",HMABYWSNWIZPAG-UHFFFAOYSA-N,C19H18FN3O,323.4,"6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one","RUCAPARIB|283173-50-2|AG-14447|8-Fluoro-2-(4-((methylamino)methyl)phenyl)-1,3,4,5-tetrahydro-6H-azepino(5,4,3-cd)indol-6-one|8237F3U7EH|CHEBI:134689|DTXSID10182563|6H-Azepino(5,4,3-cd)indol-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-|6H-Pyrrolo(4,3,2-ef)(2)benzazepin-6-one, 8-fluoro-1,3,4,5-tetrahydro-2-(4-((methylamino)methyl)phenyl)-|8-fluoro-2-{4-[(methylamino)methyl]phenyl}-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one|rucaparibum|8-Fluoro-2-[4-[(methylamino)methyl]phenyl]-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one|RefChem:57180|DTXCID50105054|L01XX55|6-fluoro-2-(4-((methylamino)methyl)phenyl)-3,10-diazatricyclo(6.4.1.0^(4,13))trideca-1,4,6,8(13)-tetraen-9-one|814-445-0|Rucaparib free base|6H-Pyrrolo[4,3,2-ef][2]benzazepin-6-one,8-fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-|8-FLUOR-2-{4-[(METHYLAMINO)METHYL]FENYL}-1,3,4,5-TETRAHYDRO-6HAZEPINO[5,4,3-CD]INDOOL-6-ON|8-FLUORO-2-(4-((METHYLAMINO)METHYL)PHENYL)-4,5-DIHYDRO-1H-AZEPINO[5,4,3-CD]INDOL-6(3H)-ONE|283173-50-2 (free base)|8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one|8-fluoro-2-(4-methylaminomethyl-phenyl)-1,3,4,5-tetrahydro-azepino[5,4,3-cd]indol-6-one|6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4,6,8(13)-tetraen-9-one|Rucaparib [INN]|Kinome_3180|Rucaparib [USAN:INN]|PF 01367338|UNII-8237F3U7EH|8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-pyrrolo[4,3,2-ef][2]benzazepin-6-one; 8-Fluoro-2-[4-[(methylamino)methyl]phenyl]-1,3,4,5-tetrahydro-6H-azepino[5,4,3-cd]indol-6-one; Rubraca; 8-Fluoro-1,3,4,5-tetrahydro-2-[4-[(methylamino)methyl]phenyl]-6H-azepino[5,4,3-cd]indol-6-one;|RPB|MFCD11977252|RUCAPARIB [MI]|Rucaparib (USAN/INN)|RUCAPARIB [USAN]|RUCAPARIB [WHO-DD]|SCHEMBL844585|Rucaparib(AG-014447)?|GTPL7736|orb1302838|CHEMBL1173055|SCHEMBL29351768|CHEBI:94311|HMABYWSNWIZPAG-UHFFFAOYSA-N|GLXC-04728|HMS5086P16|BCP07633|EX-A2700|BDBM50446130|HY-10617A|NSC756644|s4948|AKOS015898427|AG14447|DB12332|FR44224|NSC-756644|SB16538|NCGC00263173-01|NCGC00263173-03|NCGC00263173-09|NCGC00263173-13|AC-24390|AS-74779|BP-44047|SY047482|NS00068175|C74459|D10079|Rucaparib; AG 014699; PF-01367338|F797273|Q7376558|BRD-K88560311-011-01-4|BRD-K88560311-011-06-3|BRD-K88560311-011-07-1|8-Fluoro-2-[4-[(methylamino)methyl]phenyl]-4,5-dihydroazepino[5,4,3-cd]indol-6(3H)-one|6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.0^{4,13]trideca-1,4,6,8(13)-tetraen-9-one|6-fluoro-2-[4-(methylaminomethyl)phenyl]-3,10-diazatricyclo[6.4.1.04,13]trideca-1,4(13),5,7-tetraen-9-one|6-fluoro-2-{4-[(methylamino)methyl]phenyl}-3,10-diazatricyclo[6.4.1.0?,(1)(3)]trideca-1,4,6,8(13)-tetraen-9-one|8-fluoro-5-(4-((methylamino)methyl)phenyl)-2,3,4,6-tetrahydro-1H-azepino[5,4,3-cd]indol-1-one"
VELIPARIB,11960529,,"InChI=1S/C13H16N4O/c1-13(6-3-7-15-13)12-16-9-5-2-4-8(11(14)18)10(9)17-12/h2,4-5,15H,3,6-7H2,1H3,(H2,14,18)(H,16,17)/t13-/m1/s1",JNAHVYVRKWKWKQ-CYBMUJFWSA-N,C13H16N4O,244.29,2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide,"Veliparib|912444-00-9|ABT 888|ABT888|2-[(2R)-2-Methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide|CHEBI:62880|PARP-1 INHIBITOR ABT-888|01O4K0631N|2-((r)-2-methylpyrrolidin-2-yl)-1h-benzimidazole-4-carboxamide|2-[(R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-4-carboxamide|DTXSID90238456|NSC737664|2-((2R)-2-methylpyrrolidin-2-yl)-1H-benzimidazole-4-carboxamide|veliparibum|RefChem:901780|DTXCID10160947|ABT-888|ABT-888 (Veliparib)|(R)-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole-4-carboxamide|Veliparib free base|2-[(2R)-2-methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide|Veliparib (ABT-888)|(R)-2-(2-methylpyrrolidin-2-yl)-1H-benzo[d]imidazole-7-carboxamide|912444-00-9 (free base)|MFCD16661059|(2r)-2-(7-Carbamoyl-1h-Benzimidazol-2-Yl)-2-Methylpyrrolidinium|Veliparib (ABT-888 hydrochloride)|NSC-737664|Veliparib [USAN:INN]|UNII-01O4K0631N|78P|2-[(2R)-2-Methylpyrrolidin-2-yl]-1H-benimidazole-4-|VELIPARIB [INN]|VELIPARIB [JAN]|VELIPARIB [USAN]|ABT888 (free base)?|VELIPARIB [WHO-DD]|A861695|benzimidazole carboxamide, 3a|MLS006010184|Veliparib (JAN/USAN/INN)|SCHEMBL422318|CHEMBL506871|GTPL7417|orb1305291|SCHEMBL1804769|SCHEMBL29354914|BDBM27135|ABT-695|EX-A001|BDBM209932|2-[(2R)-2-methylpyrrolidin-2-yl]-1H-1,3-benzodiazole-4-carboxamide|NSC752840|s1004|AKOS015951440|AKOS017343746|CCG-264771|CS-0076|DB07232|EX-7209|FV16903|NSC-752840|SB16480|NCGC00250404-01|NCGC00250404-15|NCGC00250404-17|AC-23330|AS-19397|HY-10129|SMR004701290|NS00072993|D09692|A-861695|Q7919041|BRD-K87142802-001-02-7|1H-Benzimidazole-4-carboxamide, 2-((2R)-2-methyl-2-pyrrolidinyl)-|2-[(2R)-2-methylpyrrolidin-2-yl]-1H-benzimidazole-7-carboxamide|1H-BENZIMIDAZOLE-7-CARBOXAMIDE, 2-((2R)-2-METHYL-2-PYRROLIDINYL)-|2-[(2R)-2-Methyl-2-pyrrolidinyl]-1H-benzimidazole-7-carboxamide dihydrochloride;A 861695;ABT 888"
FTY720-P,multiply,multiply,multiply,multiply,multiply,multiply,multiply,multiply
RIVAROXABAN,9875401,,"InChI=1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m0/s1",KGFYHTZWPPHNLQ-AWEZNQCLSA-N,C19H18ClN3O5S,435.9,"5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide","Rivaroxaban|366789-02-8|Xarelto|BAY 59-7939|BAY59-7939|9NDF7JZ4M3|BAY-59-7939|CHEBI:68579|5-Chloro-N-({(5s)-2-Oxo-3-[4-(3-Oxomorpholin-4-Yl)phenyl]-1,3-Oxazolidin-5-Yl}methyl)thiophene-2-Carboxamide|JNJ39039039|JNJ-39039039|5-chloro-N-{[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl}thiophene-2-carboxamide|DTXSID3057723|2-Thiophenecarboxamide, 5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-|5-Chloro-N-(((5S)-2-oxo-3-(4-(3-oxomorpholin-4-yl)phenyl)-1,3-oxazolidin-5-yl)methyl)thiophene-2-carboxamide|5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide|2-Thiophenecarboxamide, 5-chloro-N-(((5S)-2-oxo-3-(4-(3-oxo-4-morpholinyl)phenyl)-5-oxazolidinyl)methyl)-|rivaroxabanum|BAY 597939|BAY 59 7939|RefChem:6203|B01AF01|DTXCID601508635|(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)oxazolidin-5-yl)methyl)thiophene-2-carboxamide|MFCD11974010|C19H18ClN3O5S|5-CHLORO-N-[[(S)-3-(4-(3-OXOMORPHOLIN-4-YL)PHENYL)-2-OXO-1,3-OXAZOLIDIN-5-YL]METHYL]-THIOPHENE-2-CARBOXAMIDE|Rivaroxaban (Xarelto)|5-CHLORO-N-[[(5S)-2-OXO-3-[4-(3-OXO-4-MORPHOLINYL)PHENYL]-5-OXAZOLIDINYL]METHYL]-2-THIOPHENECARBOXAMIDE|5-chloro-N-[[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl]thiophene-2-carboxamide|Xarelto (TN)|Rivaroxaban [INN]|UNII-9NDF7JZ4M3|HSDB 8149|(S)-Rivaroxaban|5-Chloro-N-[[(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-5-oxazolidinyl]methyl]-2-thiophenecarboxamide;BAY 59-7939|5-Chloro-N-{[(5S)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]oxazolidin-5-yl]methyl}thiophene-2-carboxamide|RIV|Rivaroxaban [USAN:INN:BAN:JAN]|Rivaroxaban (Standard)|RIVAROXABAN [MI]|RIVAROXABAN [JAN]|RIVAROXABAN [USAN]|RIVAROXABAN [VANDF]|SCHEMBL3914|RIVAROXABAN [MART.]|RIVAROXABAN [USP-RS]|RIVAROXABAN [WHO-DD]|MLS006010027|Rivaroxaban (JAN/USAN/INN)|RIVAROXABAN [EMA EPAR]|BDBM7840|CHEMBL198362|GTPL6388|orb1309486|Rivaroxaban - Bio-X trade mark|BAY 59-7939 (Rivaroxaban)|EX-A206|RIVAROXABAN [ORANGE BOOK]|2w26|KGFYHTZWPPHNLQ-AWEZNQCLSA-N|RIVAROXABAN [EP MONOGRAPH]|Rivaroxaban,Xarelto,BAY 59-7939|HY-50903R|MSK158364|AKOS005145918|CCG-212899|CS-0555|DB06228|FR27742|NCGC00262945-10|NCGC00379033-04|BR164355|HY-50903|SMR002529611|D07086|AB01563270_01|EN300-6733490|US8822458, 44|US8822458, 97|789R028|Q420262|SR-01000944189|SR-01000944189-1|BRD-K37130656-001-01-2|BRD-K37130656-001-03-8|Z1741977097|(S)-5-Chloro-N-((2-oxo-3-(4-(3-oxomorpholino)phenyl)-oxazolidin-5-yl)methyl)thiophene-2-carboxamide|1429742-50-6|5-Chlor-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide|5-chloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morpholinyl) phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide|5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}-methyl)-2-thiophenecarboxamide|5-Chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophencarboxamide|5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophene-carboxamide|5-chloro-N-({(5S)-2-oxo-3-[4-(3-oxo-4-morpholinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide|5-chloro-N-({(5s)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl} methyl)thiophene-2-carboxamide"
TANDUTINIB,3038522,,"InChI=1S/C31H42N6O4/c1-23(2)41-25-10-8-24(9-11-25)34-31(38)37-17-15-36(16-18-37)30-26-20-28(39-3)29(21-27(26)32-22-33-30)40-19-7-14-35-12-5-4-6-13-35/h8-11,20-23H,4-7,12-19H2,1-3H3,(H,34,38)",UXXQOJXBIDBUAC-UHFFFAOYSA-N,C31H42N6O4,562.7,4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide,"Tandutinib|387867-13-2|MLN-518|MLN518|CT53518|MLN 518|CT 53518|CT-53518|tandutinibum|E1IO3ICJ9A|NSC-759851|DTXSID8048947|CHEBI:90237|(4-(6-Methoxy-7-(3-piperidylpropoxy)quinazolin-4-yl)piperazinyl)-N-(4-(methylethoxy)phenyl)carboxamide|DTXCID5028873|NSC726292|1-Piperazinecarboxamide, 4-(6-methoxy-7-(3-(1-piperidinyl)propoxy)-4-quinazolinyl)-N-(4-(1-methylethoxy)phenyl)-|4-{6-methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl}-N-[4-(propan-2-yloxy)phenyl]piperazine-1-carboxamide|4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)-N-(4-(propan-2-yloxy)phenyl)piperazine-1-carboxamide|RefChem:891072|4-(6-Methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl)piperazine-1-carboxylic acid (4-isopropoxyphenyl)amide|4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinolin-4-yl)-N-(4-(propan-2-yloxy)phenyl)piperazine-1-carboxamide|Tandutinib (MLN518)|N-(4-isopropoxyphenyl)-4-(6-methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)piperazine-1-carboxamide|MFCD09954147|4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-(4-propan-2-yloxyphenyl)piperazine-1-carboxamide|CHEMBL124660|MLN-0518|NCGC00241097-01|D06005|N-(4-isopropoxyphenyl)-4-[6-methoxy-7-[3-(1-piperidyl)propoxy]quinazolin-4-yl]piperazine-1-carboxamide|4-[6-Methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-[4-(1-methylethoxy)phenyl]-1-piperazinecarboxamide|Tandutinib [USAN]|CAS-387867-13-2|Tandutinib [USAN:INN]|UNII-E1IO3ICJ9A|Tandutinib(CT 53518)|4-(6-Methoxy-7-(3-(piperidin-1-yl)propoxy)quinazolin-4-yl)-N-(4-(1-methylethoxy)phenyl)piperazine-1-carboxamide|4-[6-Methoxy-7-[3-(piperidin-1-yl)propoxy]quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide|Kinome_3320|MLN518, Tandutinib|Tandutinib(MLN518)|TANDUTINIB [INN]|Tandutinib (USAN/INN)|TANDUTINIB [WHO-DD]|MLS006010972|SCHEMBL927974|orb1307840|SCHEMBL29393910|BDBM13535|cid_3038522|TANDUTINIB (CT53518)|BCPP000051|GLXC-06736|HMS3244A21|HMS3244A22|HMS3244B21|HMS3264G08|HMS3654O09|HMS3745A09|Pharmakon1600-01502277|BCP01370|EX-A1637|Tox21_113366|NSC759851|NSC760841|NSC800942|s1043|AKOS015902621|Tox21_113366_1|AC-1659|CCG-213017|CS-0128|DB05465|ES-0051|FT28001|NSC 759851|NSC-726292|NSC-760841|NSC-800942|SB19380|SDCCGSBI-0653518.P002|NCGC00241097-02|NCGC00241097-03|NCGC00241097-07|HY-10202|SMR004702776|NS00069682|SW218125-2|Tandutinib pound MLN518, CT53518 pound(c)|AB01562955_01|867T132|BRD-K89162000-001-01-5|BRD-K89162000-001-06-4|BRD-K89162000-001-07-2|Q27095683|1227636-17-0|4-[6-methoxy-7-(3-piperidin-1-ylpropoxy)quinazolin-4-yl]-N-[4-(1-methylethoxy)phenyl]piperazine-1-carboxamide|4-[6-methoxy-7-[3-(1-piperidinyl)propoxy]-4-quinazolinyl]-N-(4-propan-2-yloxyphenyl)-1-piperazinecarboxamide|4-[7-(3-Piperidin-1-yl-propoxy)-quinazolin-4-yl]-piperazine-1-carboxylic acid (4-isopropoxy-phenyl)-amide|N-(4-isopropoxyphenyl)-4-[6-methoxy-7-(3-piperidinopropoxy)quinazolin-4-yl]piperazine-1-carboxamide"
QUIZARTINIB,24889392,,"InChI=1S/C29H32N6O4S/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36)",CVWXJKQAOSCOAB-UHFFFAOYSA-N,C29H32N6O4S,560.7,"1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea","Quizartinib|950769-58-1|AC220|AC-220|AC 220|AC010220|quizartinibum|AC 010220|ASP-2689|7LA4O6Q0D3|CHEBI:90217|AC-010220|DTXSID70241746|1-(5-Tert-Butyl-1,2-Oxazol-3-Yl)-3-(4-{7-[2-(Morpholin-4-Yl)ethoxy]imidazo[2,1-B][1,3]benzothiazol-2-Yl}phenyl)urea|N-(5-(1,1-Dimethylethyl)isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-yl)ethoxy)imidazo(2,1-b)benzothiazol-2-yl)phenyl)urea|1-(5-TERT-BUTYL-1,2-OXAZOL-3-YL)-3-(4-(7-(2-(MORPHOLIN-4-YL)ETHOXY)IMIDAZO(2,1-B)(1,3)BENZOTHIAZOL-2-YL)PHENYL)UREA|3-(5-tert-butyl-1,2-oxazol-3-yl)-1-(4-(10-(2-(morpholin-4-yl)ethoxy)-7-thia-2,5-diazatricyclo(6.4.0.0^(2,6))dodeca-1(12),3,5,8,10-pentaen-4-yl)phenyl)urea|3-(5-tert-butyl-1,2-oxazol-3-yl)-1-(4-{10-[2-(morpholin-4-yl)ethoxy]-7-thia-2,5-diazatricyclo[6.4.0.0^{2,6}]dodeca-1(12),3,5,8,10-pentaen-4-yl}phenyl)urea|RefChem:872087|DTXCID00164237|L01XE52|3-(5-tert-butyl-1,2-oxazol-3-yl)-1-(4-(10-(2-(morpholin-4-yl)ethoxy)-7-thia-2,5-diazatricyclo(6.4.0.02,?)dodeca-1(8),3,5,9,11-pentaen-4-yl)phenyl)urea|N-(5-tert-butyl-isoxazol-3-yl)-N'-(4-(7-(2-morpholin-4-yl-ethoxy)imidazo (2,1-b) (1,3) benzothiazol 2-yl)phenyl)urea|Quizartinib (AC220)|1-(5-(tert-butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea|Quizartinib HCl|Quizartinib freebase|N-(5-tert-Butylisoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea|MFCD18074524|CHEMBL576982|950769-58-1 (free base)|N-(5-tert-Butylisoxazol-3-yl)-N'-[4-[7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea|1132827-21-4 (HCl)|1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea|n-(5-tert-butyl-isoxazol-3-yl)-n'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea dihydrochloride|CHEMBL2386811|N-(5-(1,1-Dimethylethyl)isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-yl)ethoxy)imidazo(2,1- b)benzothiazol-2-yl)phenyl)urea|Urea, N-(5-(1,1-dimethylethyl)-3-isoxazolyl)-N'-(4-(7-(2-(4-morpholinyl)ethoxy) imidazo(2,1-b)benzothiazol-2-yl)phenyl)-|AC220 compound|AC220,Quizartinib|Quizartinib [USAN]|Quizartinib [USAN:INN]|UNII-7LA4O6Q0D3|C29H32N6O4S|N-(5-TERT-BUTYLISOXAZOL-3-YL)-N'-(4-(7-(2-(MORPHOLIN-4-YL)ETHOXY)IMIDAZO(2,1-B)(1,3)BENZOTHIAZOL-2-YL)PHENYL)UREA|Quizartinib, 95%|Quizartinib, ac220|Quizartinib (Standard)|Quizartinib, Free Base|AC 220 dihydrochloride|QUIZARTINIB [MI]|Quizartinib; PLX3397|QUIZARTINIB [INN]|Quizartinib (AC220)?|Quizartinib (USAN/INN)|SCHEMBL72923|QUIZARTINIB [WHO-DD]|MLS006011240|GTPL5658|orb1306579|SCHEMBL29349937|CVWXJKQAOSCOAB-UHFFFAOYSA-N|BCPP000443|HMS3244K09|HMS3244K10|HMS3244L09|HMS3265G09|HMS3265G10|HMS3265H09|HMS3265H10|HMS3654J20|HMS3743G21|HMS5079C14|BCP02224|HVB82721|BDBM50300690|HY-13001R|NSC756647|NSC799659|NSC800857|s1526|AKOS015891557|BCP9000223|CCG-264906|CS-0211|DB12874|FQ32834|NSC-756647|NSC-799659|NSC-800857|SB16610|SDCCGSBI-0647186.P001|NCGC00242493-01|NCGC00242493-02|NCGC00242493-07|1-(5-(tert-Butyl)isoxazol-3-yl)-3-(4-(7-(2-morpholinoethoxy)-benzo[d]imidazo[2,1-b]thiazol-2-yl)phenyl)urea|AS-16178|BP-44041|HY-13001|SMR004703000|NS00072561|SW218131-2|D09955|Q7272714|BRD-K93918653-001-01-4|BRD-K93918653-001-08-9|1-(5-tert-butylisoxazol-3-yl)-3-[4-[6-(2-morpholinoethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea|AC 010220; Quizartinib; N-(5-tert-Butylisoxazol-3-yl)-N'-[4-[7-[2-(morpholin-4-yl)ethoxy]imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea;|N-(5-tert-Butyl-isoxazol-3-yl)-N''-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea|N-(5-Tert-butyl-isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-ylethoxy)imidazo(2,1-b) (1,3)benzothiazol-2-yl)phenyl)urea|N-(5-tert-Butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea"
LESTAURTINIB,126565,,"InChI=1S/C26H21N3O4/c1-25-26(32,12-30)10-18(33-25)28-16-8-4-2-6-13(16)20-21-15(11-27-24(21)31)19-14-7-3-5-9-17(14)29(25)23(19)22(20)28/h2-9,18,30,32H,10-12H2,1H3,(H,27,31)/t18-,25+,26+/m1/s1",UIARLYUEJFELEN-LROUJFHJSA-N,C26H21N3O4,439.5,"(15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaen-3-one","Lestaurtinib|111358-88-4|CEP-701|KT-5555|SPM-924|KT5555|CEP 701|SP924|SP-924|KT-555|CEP701|DO989GC5D1|DTXSID5046778|A-154475.0|DTXCID3026778|A-154475|9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-|lestaurtinibum|(15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo(12.11.2.1^(15,18).0^(2,6).0^(7,27).0^(8,13).0^(19,26).0^(20,25))octacosa-1(26),2(6),7(27),8,10,12,20,22,24-nonaen-3-one|(15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1(26),2(6),7(27),8,10,12,20,22,24-nonaen-3-one|9,12-Epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S,10S,12R)-|RefChem:798967|GlyTouCan:G20293PV|(15S,16S)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo(12.11.2.115,18.02,6.07,27.08,13.019,26.020,25)octacosa-1,6,8,10,12,20,22,24,26-nonaen-3-one|G20293PV|SP 924|KT 5555|CHEMBL603469|MFCD12828858|NCGC00168772-01|C26H21N3O4|(15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaen-3-one|(5S,6S,8R)-6-Hydroxy-6-(hydroxymethyl)-5-methyl-5,6,7,8,14,15-hexahydro-13H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-13-one|(5S,6S,8R)-6-hydroxy-6-(hydroxymethyl)-5-methyl-7,8,14,15-tetrahydro-5H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacen-13(6H)-one|Lestaurtinib [USAN]|Lestaurtinib (USAN/INN)|Lestaurtinib [USAN:INN]|UNII-DO989GC5D1|Lestaurtinib?|4otg|2V9|A 1544750|CEP-701 hydrate|(9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4-i][1,6]benzodiazocin-1-one|Lestaurtinib; CEP701|LESTAURTINIB [INN]|LESTAURTINIB [MART.]|LESTAURTINIB [WHO-DD]|A 154475.0|GTPL5672|orb1707082|SCHEMBL12963759|CHEBI:91471|GLXC-07175|BCP06977|Tox21_112633|BDBM50308060|HB1429|NSC772196|NSC800782|AKOS024457603|AC-5243|DB06469|FL24870|NSC-772196|NSC-800782|NCGC00168772-02|NCGC00168772-03|NCGC00168772-04|DA-64923|HY-50867|MS-27884|PA-126565|CAS-111358-88-4|CS-0004336|NS00069188|D04696|G13628|Q6531771|BRD-K23192422-001-01-1|Z2037281011|(15S,16S,18R)-16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaen-3-one|(4bR,5S,6S,8R,8aS)-6-hydroxy-6-(hydroxymethyl)-5-methyl-5,6,7,8,14,15-hexahydro-13H-5,8-epoxy-4b,8a,14-triazadibenzo[b,h]cycloocta[1,2,3,4-jkl]cyclopenta[e]-as-indacen-13-one|(9S,10S,12R)-10-Hydroxy-10-(hydroxymethyl)-9-methyl-2,3,9,10,11,12-hexahydro-9,12-epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one|(9S,10S,12R)-2,3,9,10,11,12-Hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'-kl]pyrrolo[3,4  -i][1,6]benzodiazocin-1-one;A 154475.0;CEP 701|16-hydroxy-16-(hydroxymethyl)-15-methyl-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1(26),2(6),7(27),8(13),9,11,20(25),21,23-nonaen-3-one|9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocin-1-one, 2,3,9,10,11,12-hexahydro-10-hydroxy-10-(hydroxymethyl)-9-methyl-, (9S-(9alpha,10beta,12alpha))-"
MIDOSTAURIN,9829523,,"InChI=1S/C35H30N4O4/c1-35-32(42-3)25(37(2)34(41)19-11-5-4-6-12-19)17-26(43-35)38-23-15-9-7-13-20(23)28-29-22(18-36-33(29)40)27-21-14-8-10-16-24(21)39(35)31(27)30(28)38/h4-16,25-26,32H,17-18H2,1-3H3,(H,36,40)/t25-,26-,32-,35+/m1/s1",BMGQWWVMWDBQGC-IIFHNQTCSA-N,C35H30N4O4,570.6,"N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide","Midostaurin|PKC412|120685-11-2|Cgp 41251|RYDAPT|CGP-41251|Benzoylstaurosporine|PKC 412|N-Benzoylstaurosporine|PKC-412|midostaurina|midostaurine|ID912S5VON|NVP-PKC412|CHEBI:63452|NSC-656576|Cgp 41 251|N-((9S,10R,11R,13R)-10-methoxy-9-methyl-1-oxo-2,3,10,11,12,13-hexahydro-9,13-epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-11-yl)-N-methylbenzamide|4'-N-benzoyl staurosporine|Benzamide, N-(2,3,9,10,11,12-hexahydro-9-methoxy-8-methyl-1-oxo-8,12-epoxy-1H,8H-2,7b,12a-triazadibenzo(a,g)cyclonona(cde)trinden-10-yl)-N-methyl-, (8alpha,9beta,10beta,12alpha)-|N-[(5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo[b,h]cyclonona[1,2,3,4-jkl]cyclopenta[e]-as-indacen-7-yl]-N-methylbenzamide|CGP41251|N-benzoyl-staurosporine|Benzamide, N-((9S,10R,11R,13R)-2,3,9,10,11,12-hexahydro-10-methoxy-9-methyl-1-oxo-9,13-epoxy-1H,9H-diindolo(1,2,3-gh:3',2',1'-lm)pyrrolo(3,4-j)(1,7)benzodiazonin-11-yl)-N-methyl-|midostaurinum|N-((2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo(12.12.2.1^(2,6).0^(7,28).0^(8,13).0^(15,19).0^(20,27).0^(21,26))nonacosa-8,10,12,14(28),15(19),20(27),21,23,25-nonaen-4-yl)-N-methylbenzamide|N-((5S,6R,7R,9R)-6-methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-5,9-epoxy-4b,9a,15-triazadibenzo(b,h)cyclonona(1,2,3,4-jkl)cyclopenta(e)-as-indacen-7-yl)-N-methylbenzamide|N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.1^{2,6}.0^{7,28}.0^{8,13}.0^{15,19}.0^{20,27}.0^{21,26}]nonacosa-8,10,12,14(28),15(19),20(27),21,23,25-nonaen-4-yl]-N-methylbenzamide|RefChem:58070|GlyTouCan:G71709HE|L01XE39|G71709HE|4'-N-Benzoylstaurosporine|MFCD00871372|CHEMBL608533|N-((5S,6R,7R,9R)-6-Methoxy-5-methyl-14-oxo-6,7,8,9,15,16-hexahydro-5H,14H-17-oxa-4b,9a,15-triaza-5,9-methanodibenzo[b,h]cyclonona[jkl]cyclopenta[e]-as-indacen-7-yl)-N-methylbenzamide|C35H30N4O4|N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide|Midostaurin [INN]|Midostaurin [USAN:INN]|UNII-ID912S5VON|PKC412;CGP 41251|CGP 41231|Rydapt (TN)|MIDOSTAURIN [MI]|Staurosporine, N-Benzoyl|MIDOSTAURIN [JAN]|MIDOSTAURIN [USAN]|Midostaurin;CGP 41251|PKC-412 (Midostaurin)|MIDOSTAURIN [MART.]|MIDOSTAURIN [WHO-DD]|Midostaurin (JAN/USAN/INN)|GTPL5702|SCHEMBL8295379|SCHEMBL29350876|MIDOSTAURIN [ORANGE BOOK]|BMGQWWVMWDBQGC-IIFHNQTCSA-N|GLXC-02502|HMS3229K17|EX-A1741|ARD001583|BDBM50326053|MFCD10687105|NSC800791|AKOS024457372|CCG-101288|CS-3331|DB06595|FP43194|NSC 656576|NSC-800791|SDCCGSBI-0086703.P004|NCGC00241102-01|NCGC00241102-02|NCGC00241102-05|NCGC00484987-03|AC-31929|BP-44030|DA-55478|HY-10230|SY045745|NS00073185|PA-9829523|C71714|D05029|Q6842945|BRD-K13646352-001-01-2|BRD-K13646352-001-03-8|N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8(13),9,11,14,19,21(26),22,24,27-nonaen-4-yl]-N-methyl-benzamide|N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16-oxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methyl-benzamide"
CRENOLANIB,10366136,,"InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3",DYNHJHQFHQTFTP-UHFFFAOYSA-N,C26H29N5O2,443.5,1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine,"Crenolanib|670220-88-9|CP-868596|ARO-002|CP-868,596|crenolanibum|ARO 002|LQF7I567TQ|CHEBI:145365|DTXSID50985873|1-(2-{5-[(3-Methyloxetan-3-yl)methoxy]-1H-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine|[1-[2-[5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine|1-(2-{5-[(3-methyloxetan-3-yl)methoxy]-1H-1,3-benzodiazol-1-yl}quinolin-8-yl)piperidin-4-amine|(1-(2-(5-(3-Methyloxetan-3-ylmethoxy)benzimidazol-1-yl)quinolin-8-yl)piperidin-4-yl)amine|1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-1,3-benzodiazol-1-yl)quinolin-8-yl)piperidin-4-amine|1-(2-(5-((3-METHYLOXETAN-3-YL)METHOXY)-1H-BENZIMIDAZOL-1-YL)QUINOLIN-8-YL)PIPERIDIN-4-AMINE|RefChem:579405|PDGFR Inhibitor CP-868596|DTXCID101413063|4-Piperidinamine, 1-(2-(5-((3-methyl-3-oxetanyl)methoxy)-1Hbenzimidazol-1-yl)-8-quinolinyl)-|Crenolanib (CP-868596)|CP 868596|Crenolanib [USAN]|1-[2-[5-[(3-Methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolyl]-4-piperidinamine|MFCD21609260|C26H29N5O2|1-(2-(5-((3-Methyloxetan-3-yl)methoxy)-1H-benzo-[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine|1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine|Crenolanib (USAN)|1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine|1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1H-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine.|CP-868|Crenolanib [USAN:INN]|UNII-LQF7I567TQ|Plarotinib|CP868569|CP-868596 (Crenolanib)|6T2|CRENOLANIB [INN]|Crenolanib,CP-868596|CRENOLANIB [WHO-DD]|MLS006010956|GTPL7882|orb1305178|SCHEMBL2730601|CHEMBL2105728|CP-868596 (Crenolanib)?|SCHEMBL29350134|SCHEMBL29352568|SCHEMBL30002138|EX-A215|DYNHJHQFHQTFTP-UHFFFAOYSA-N|BDBM185149|HMS3656F19|BCP02384|NSC763526|NSC800079|s2730|AKOS026750597|BCP9000551|CCG-264988|CS-0566|DB11832|FC29756|NSC-763526|NSC-800079|SB16603|SDCCGSBI-0654437.P001|NCGC00346658-01|NCGC00346658-09|AC-32071|AS-57698|CP868596|DA-62500|HY-13223|SMR004702760|SY237889|NS00069320|SW218293-2|D10102|Q5184160|BRD-K22127577-001-02-9|BRD-K22127577-001-03-7|CP-868596;CP 868596;CP868596;ARO 002|1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]-8-quinolyl]piperidin-4-amine|1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1H-benzimidazol-1-yl]-8-quinolinyl]-4-piperidinamine|1-{2-[5-(3-Methyl-oxetan-3-ylmethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine|4-PIPERIDINAMINE, 1-(2-(5-((3-METHYL-3-OXETANYL)METHOXY)-1H-BENZIMIDAZOL-1-YL)-8-QUINOLINYL)-"
PEXIDARTINIB,25151352,,"InChI=1S/C20H15ClF3N5/c21-15-6-16-14(10-28-19(16)29-11-15)5-12-2-4-18(26-7-12)27-9-13-1-3-17(25-8-13)20(22,23)24/h1-4,6-8,10-11H,5,9H2,(H,26,27)(H,28,29)",JGWRKYUXBBNENE-UHFFFAOYSA-N,C20H15ClF3N5,417.8,"5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyridin-2-amine","Pexidartinib|1029044-16-3|PLX3397|PLX-3397|CML-261|pexidartinibum|5-((5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl)-N-((6-(trifluoromethyl)pyridin-3-yl)methyl)pyridin-2-amine|6783M2LV5X|5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)pyridin-3-yl]methyl]pyridin-2-amine|CHEBI:145373|DTXSID301026482|3-Pyridinemethanamine, N-(5-((5-chloro-1H-pyrrolo(2,3-b)pyridin-3-yl)methyl)-2-pyridinyl)-6-(trifluoromethyl)-|5-[(5-Chloro-1h-Pyrrolo[2,3-B]pyridin-3-Yl)methyl]-N-{[6-(Trifluoromethyl)pyridin-3-Yl]methyl}pyridin-2-Amine|5-({5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl}methyl)-N-{[6-(trifluoromethyl)pyridin-3-yl]methyl}pyridin-2-amine|5-((5-CHLORO-1H-PYRROLO(2,3-B)PYRIDIN-3-YL)METHYL)-N-((6-(TRIFLUOROMETHYL)PYRIDIN-3-YL)METHYL)PYRIDIN-2-AMINE|RefChem:57219|DTXCID701510659|Pexidartinib (PLX3397)|Turalio|Pexidartinib [INN]|MFCD28900745|Pexidartinib [USAN]|CHEMBL3813873|N-[5-[(5-Chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-2-pyridinyl]-6-(trifluoromethyl)-3-pyridinemethanamine|5-[(5-chloro-1H-pyrrolo[2,3-b]pyridin-3-yl)methyl]-N-[[6-(trifluoromethyl)-3-pyridyl]methyl]pyridin-2-amine|UNII-6783M2LV5X|PEXIDARTINIB [MI]|Pexidartinib (USAN/INN)|Pexidartinib [USAN:INN]|Pexidartinib(PLX3397)?|C20H15ClF3N5|PEXIDARTINIB [WHO-DD]|GTPL8710|orb1306449|SCHEMBL1267310|SCHEMBL29361827|SCHEMBL29380288|EX-A589|JGWRKYUXBBNENE-UHFFFAOYSA-N|HMS3886D19|HMS5085F22|BCP15183|PLX 3397|BDBM50177716|HB8991|NSC789300|NSC793434|NSC800843|s7818|AKOS026750359|CCG-268862|DB12978|FP76492|NSC-789300|NSC-793434|NSC-800843|SB19178|NCGC00480774-01|NCGC00480774-06|AC-30300|AS-74915|DA-48267|HY-16749|SY047897|NS00073377|PLX 3397;PLX3397;PL-X3397|D11270|EN300-20611078|BRD-K54519451-001-02-9|Q25100640|5-[[5-Chloropyrrolo[2,3-b]pyridin-3-yl]methyl]-2-[[[6-(trifluoromethyl)-3-pyridyl]methyl]amino]pyridine"
GSK-364735,54718859,,"InChI=1S/C19H18FN3O4/c1-23-14-9-12(8-11-2-4-13(20)5-3-11)10-22-16(14)17(25)15(19(23)27)18(26)21-6-7-24/h2-5,9-10,24-25H,6-8H2,1H3,(H,21,26)",QWLNINWUBHHOLU-UHFFFAOYSA-N,C19H18FN3O4,371.4,"7-[(4-fluorophenyl)methyl]-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-1,5-naphthyridine-3-carboxamide","GSK-364735|GSK364735|863434-13-3|SXN0KXT60S|1,5-Naphthyridine-3-carboxamide, 7-((4-fluorophenyl)methyl)-1,2-dihydro-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-|S-364735|S/GSK 364735|S/GSK-364735|7-((4-fluorophenyl)methyl)-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-1,2-dihydro-1,5-naphthyridine-3-carboxamide|7-[(4-fluorophenyl)methyl]-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-1,2-dihydro-1,5-naphthyridine-3-carboxamide|RefChem:144523|UNII-SXN0KXT60S|CHEMBL1256978|7-[(4-fluorophenyl)methyl]-4-hydroxy-N-(2-hydroxyethyl)-1-methyl-2-oxo-1,5-naphthyridine-3-carboxamide|7-((4-FLUOROPHENYL)METHYL)-4-HYDROXY-N-(2-HYDROXYETHYL)-1-METHYL-2-OXO-1,5-NAPHTHYRIDINE-3-CARBOXAMIDE|orb1740963|SCHEMBL5545304|QWLNINWUBHHOLU-UHFFFAOYSA-N|BDBM50045107|DB13119|HY-16907|NS00073316|Q27289447"
ATENOLOL,2249,,"InChI=1S/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)",METKIMKYRPQLGS-UHFFFAOYSA-N,C14H22N2O3,266.34,2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide,"atenolol|29122-68-7|Tenormin|Prenormine|Myocord|Duraatenolol|Betacard|Blokium|Corotenol|Normiten|Atehexal|Betablok|Cuxanorm|Juvental|Selobloc|Tenoblock|Antipressan|Atenblock|Farnormin|Internolol|Premorine|Vericordin|Anselol|Atcardil|Atecard|Atendol|Atereal|Evitocor|Hypoten|Ibinolo|Lotenal|Normalol|Prenolol|Stermin|Tenidon|Tenolol|Tenoprin|Tensimin|Vascoten|Wesipin|Alinor|Altol|Atenet|Ateni|Atenil|Aterol|Hipres|Noten|Oraday|Serten|Tredol|Uniloc|Xaten|Apo-Atenolol|Seles beta|Felo-Bits|Lo-ten|Atenolin|Atenomel|Blocotenol|Cardaxen|Cardiopress|Jenatenol|Panapres|Plenacor|Servitenol|Tenobloc|Aircrit|Betasyn|Ormidol|Prinorm|Unibloc|Loten|Atenol acis|Atenol Cophar|Atenol Fecofar|Atenol Heumann|Atenol Nordic|Atenol Quesada|Atenol Gador|Atenol Stada|Atenol-Mepha|Atenol-Wolff|Atenol Atid|Atenol ct|Atenol Genericon|Atenol Tika|Atenol Trom|Atenol von ct|Betatop Ge|Atenol-ratiopharm|Atenol AL|Atenol PB|Atenol GNR|Atenol MSD|Atenol NM Pharma|Atenololum|Scheinpharm Atenol|Atenol 1A pharma|ICI 66082|Novaten|ICI-66082|ICI 66,082|2-[4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl]acetamide|1-p-Carbamoylmethylphenoxy-3-isopropylamino-2-propanol|2-(p-(2-Hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-((1-methylethyl)amino)propoxy)benzeneacetamide|DTXSID2022628|50VV3VW0TI|NSC-757832|CHEBI:2904|Benzeneacetamide, 4-(2-hydroxy-3-((1-methylethyl)amino)propoxy)-|Benzeneacetamide, 4-[2-hydroxy-3-[(1-methylethyl)amino]propoxy]-|C07AB03|2-(4-{2-hydroxy-3-[(propan-2-yl)amino]propoxy}phenyl)acetamide|DTXCID202628|Acetamide, 2-(p-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)-|2-{4-[2-hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide|Totamol|atenololo|Atenamin|2-(4-(2-hydroxy-3-(propan-2-ylamino)propoxy)phenyl)acetamide|4-(2-Hydroxy-3-[(1-methylethyl)amino]propoxy)benzeneacetamide|Kentol|2-(4-(2-hydroxy-3-((propan-2-yl)amino)propoxy)phenyl)acetamide|Tenormin l.s.|Tenormin 25|ICI66082|Atenix-25|Atenix-50|Atenix-100|RefChem:5571|GlyTouCan:G93057SA|Atenolol 29300-411|C07AB11|G93057SA|2-(4-((2RS)-2-Hydroxy-3-((1-methylethyl)amino)propyloxy)phenyl)acetamide|249-451-7|Vasaten|Tenormine|(RS)-Atenolol|2-(4-(2-hydroxy-3-(isopropylamino)propoxy)phenyl)acetamide|Tenormine [French]|(r,s)-atenolol|Atenololum [INN-Latin]|2-[4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl]acetamide|MFCD00057645|Tenormin (TN)|60966-51-0|CHEMBL24|duratenol|MLS000069622|SMR000036768|Atenol|(+/-)-2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide|Teno-basan|(+/-)-Atenolol|2-[4-[2-hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide|Neatenol|Tensotin|Atcard|dl-Atenolol|CCRIS 4196|HSDB 6526|SR-01000000159|1309283-25-7|EINECS 249-451-7|EINECS 262-544-7|UNII-50VV3VW0TI|BRN 2739235|2-(4-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl)acetamide|Artrenolol|2-(4-(2-Hydroxy-3-(Isopropylamino)propoxy)phenyl)ethanamide|2-(4-(2-Hydroxy-3-isopropylaminopropoxy)phenyl)acetamid|2-(4-{2-hydroxy-3-[(methylethyl)amino]propoxy}phenyl)acetamide|Atenolol [USAN:BAN:INN:JAN]|(y)-Atenolol|Atenalol (RS)|(?)-Atenolol|Atenolol (Standard)|Atenolol [USAN:USP:INN:BAN:JAN]|(A+/-)-Atenolol|Tenoretic (Salt/Mix)|Atenolol (JAN/USP)|Spectrum_001364|ATENOLOL [HSDB]|ATENOLOL [USAN]|ATENOLOL [INN]|ATENOLOL [JAN]|ATENOLOL [MI]|ATENOLOL [VANDF]|Opera_ID_1283|Spectrum2_001411|Spectrum3_001448|Spectrum4_000435|Spectrum5_001509|ATENOLOL [MART.]|ATENOLOL [USP-RS]|ATENOLOL [WHO-DD]|ATENOLOL [WHO-IP]|A 7655|SCHEMBL4362|Lopac0_000121|Oprea1_448775|BSPBio_002915|GTPL548|KBioGR_000790|KBioSS_001844|Atenolol - Bio-X trade mark|MLS001066372|MLS001074163|MLS001304038|orb422215|DivK1c_000057|SPECTRUM1501127|Atenolol (JP18/USP/INN)|SPBio_001482|ATENOLOL [ORANGE BOOK]|orb1089783|ATENOLOL [EP MONOGRAPH]|ATENOLOL [USP IMPURITY]|ATENOLOL [USP MONOGRAPH]|BDBM25753|HMS500C19|KBio1_000057|KBio2_001844|KBio2_004412|KBio2_006980|KBio3_002415|METKIMKYRPQLGS-UHFFFAOYSA-|4-[2'-Hydroxy-3'-(isopropylamino)propoxy]phenylacetamide|Atenolol, 1mg/ml in Acetonitrile|ATENOLOLUM [WHO-IP LATIN]|NINDS_000057|2-{4-[2-Hydroxy-3-(isopropylamino)propoxy]-phenyl}acetamide|HMS1569L13|HMS1921H09|HMS2090I19|HMS2092D19|HMS2233E06|HMS3259K08|HMS3260I04|HMS3266K13|HMS3369B14|HMS3369D20|HMS3369P20|HMS3411G21|HMS3675G21|HMS3886G03|HMS5083P08|Pharmakon1600-01501127|( inverted question mark)-Atenolol|TENORETIC COMPONENT ATENOLOL|BCP12899|JCC28325|MSK10056|Atenolol 1.0 mg/ml in Acetonitrile|Atenolol, >=98% (TLC), powder|Tox21_302426|Tox21_500121|(+/-)-4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxy]benzeneacetamide|2-[4-({2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide|BBL009276|CCG-39010|GEO-03413|HY-17498R|NSC757832|s4817|SBB056998|STK528649|AKOS005111050|AC-8245|Atenolol, analytical reference material|DB00335|FH18009|KS-5341|LP00121|NC00548|NSC 757832|SDCCGSBI-0050109.P004|IDI1_000057|MRF-0000571|NCGC00015007-06|NCGC00015007-07|NCGC00015007-08|NCGC00015007-09|NCGC00015007-10|NCGC00015007-11|NCGC00015007-13|NCGC00015007-24|NCGC00024566-03|NCGC00024566-04|NCGC00024566-05|NCGC00024566-06|NCGC00024566-07|NCGC00255122-01|NCGC00260806-01|BA166036|DA-61290|HY-17498|ST024754|SBI-0050109.P003|CAS-29122-68-7|DB-072177|DB-079552|DB-214565|A1414|EU-0100121|NS00010385|BIM-0050109.0001|D00235|EN300-119532|O10469|AB00052208-13|AB00052208-15|AB00052208_16|122A687|L000116|Q411325|SR-01000000159-2|SR-01000000159-4|SR-01000000159-5|SR-01000000159-8|BRD-A20239487-001-02-5|BRD-A20239487-001-15-7|BRD-A20239487-001-24-9|BRD-A20239487-001-25-6|Atenolol, European Pharmacopoeia (EP) Reference Standard|Z1521553991|Atenolol, United States Pharmacopeia (USP) Reference Standard|(RS)-2-{4-[2-Hydroxy-3-(propan-2-ylamino)propoxy]phenyl}acetamide|2-(P-(HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ACETAMIDE|2-(4-{[(2S)-2-hydroxy-3-(propan-2-ylamino)propyl]oxy}phenyl)acetamide|Atenolol, Pharmaceutical Secondary Standard; Certified Reference Material|2-(P-(2-HYDROXY-3-(ISOPROPYLAMINO)PROPOXY)PHENYL)ACETAMIDE (RACEMATE)|2-[4-({(2R)-2-hydroxy-3-[(1-methylethyl)amino]propyl}oxy)phenyl]acetamide|106020-65-9|4-[2-Hydroxy-3-[(1-methylethyl)amino]propoxyl]benzeneacetamide;2-[p-[2-Hydroxy-3-(isopropylamino)propoxy]phenyl]acetamide;(RS)-ateno lol;Atenolol|InChI=1/C14H22N2O3/c1-10(2)16-8-12(17)9-19-13-5-3-11(4-6-13)7-14(15)18/h3-6,10,12,16-17H,7-9H2,1-2H3,(H2,15,18)"
PROPRANOLOL,4946,,"InChI=1S/C16H21NO2/c1-12(2)17-10-14(18)11-19-16-9-5-7-13-6-3-4-8-15(13)16/h3-9,12,14,17-18H,10-11H2,1-2H3",AQHHHDLHHXJYJD-UHFFFAOYSA-N,C16H21NO2,259.34,1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol,"propranolol|525-66-6|Propanolol|beta-Propranolol|Betalong|Euprovasin|Proprasylyt|Reducor|Propanalol|Anapriline|propranololo|dl-propranolol|Propranololum|1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol|1-(isopropylamino)-3-(1-naphthyloxy)propan-2-ol|1-((1-Methylethyl)amino)-3-(1-naphthalenyloxy)-2-propanol|9Y8NXQ24VQ|CHEBI:8499|2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-|AY-64043-|DTXSID6023525|2-Propanol, 1-[(1-methylethyl)amino]-3-(1-naphthalenyloxy)-|RefChem:6170|GlyTouCan:G14011UN|DTXCID903525|C07AA05|G14011UN|208-378-0|Propanix|Inderal|Sawatal|.beta.-Propranolol|1-Isopropylamino-3-(naphthalen-1-yloxy)-propan-2-ol|CHEMBL27|1-Isopropylamino-3-(1-naphthyloxy)-2-propanol|2-Propanol, 1-(isopropylamino)-3-(1-naphthyloxy)-|rac-Propanolol|Corpendol|Inderol|Pranolol|Propranolol (INN)|Racemic propranolol|1-(naphthalen-1-yloxy)-3-(propan-2-ylamino)propan-2-ol|Betadren|PROPRANOLOL [INN]|Inderal hydrochloride|D,L-Propranolol|3-[(methylethyl)amino]-1-naphthyloxypropan-2-ol|13013-17-7|(+-)-Propranolol|Propranololo [DCIT]|Propranalol|1-(naphthalen-1-yloxy)-3-[(propan-2-yl)amino]propan-2-ol|Propranolol [INN:BAN]|Propanolol [INN-Spanish]|Propranololum [INN-Latin]|racemic-Propranolol|CCRIS 3082|EINECS 208-378-0|EINECS 235-867-6|UNII-9Y8NXQ24VQ|b-Propranolol|Propranolol (TN)|Dociton (Salt/Mix)|Inderal (Salt/Mix)|Obsidan (Salt/Mix)|(+/-)-propranolol|Propanolol,(+/-)|PROPRANOLOL, d|Avlocardyl (Salt/Mix)|beta-Propranolol;Dociton|2-Propanol, 1-(isopropylamino)-3-(1-naphthyloxy)-, (+-)-|PROPANOLOL(-)|PROPRANOLOL [MI]|Prestwick0_000952|Prestwick1_000952|Prestwick2_000952|Prestwick3_000952|PROPRANOLOL,(+)|PROPRANOLOL,(-)|Spectrum2_001301|Spectrum2_001699|Spectrum3_000883|Spectrum3_001071|Spectrum4_000974|Spectrum4_001222|Spectrum5_000751|(.+/-.)-Propranolol|PROPRANOLOL [VANDF]|SCHEMBL3955|(S)-1-(isopropylamino)-3-(naphthalen-1-yloxy)propan-2-ol|Lopac0_000896|Oprea1_304193|BSPBio_000944|BSPBio_002682|CBDivE_006180|GTPL564|KBioGR_001347|KBioGR_001684|KBioGR_002515|KBioSS_002523|PROPRANOLOL [WHO-DD]|DivK1c_000023|(1)-1-(Isopropylamino)-3-(naphthyloxy)propan-2-ol|SPBio_001361|SPBio_001658|SPBio_003093|(+)-Propranolol hydrochloride; (R)-(+)-Propranolol hydrochloride|1-(Isopropylamino)-3-(naphthalen-1-yloxy)propan-2-ol|BPBio1_001040|ICI 45520 (Salt/Mix)|NSC 91523 (Salt/Mix)|SCHEMBL12264958|BDBM25761|HY-B0573B|KBio1_000023|KBio2_002515|KBio2_005083|KBio2_007651|KBio3_001766|KBio3_001902|KBio3_002993|cMAP_000071|NINDS_000023|(A+/-)-Propranolol hydrochloride|[2-hydroxy-3-(naphthalen-1-yloxy)propyl](propan-2-yl)amine|Bio1_000367|Bio1_000856|Bio1_001345|HMS2090L21|HMS3428G03|ALBB-023324|BCP26001|BCP31343|YDA89723|BBL023437|PDSP1_000767|PDSP1_001607|PDSP1_001608|PDSP2_000755|PDSP2_001591|PDSP2_001592|STK735510|2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, (+-)-|AKOS000588816|AKOS016050338|CCG-103643|DB00571|FE-0204|FP27655|SDCCGSBI-0050871.P004|IDI1_000023|NCGC00015798-04|NCGC00015798-05|NCGC00015798-06|NCGC00015798-07|NCGC00015798-08|NCGC00015798-09|NCGC00015798-15|NCGC00015798-19|NCGC00024690-02|NCGC00024690-03|DA-57114|ST024757|SBI-0050871.P003|AB00053537|CS-0069968|NS00000196|EN300-40731|C07407|D08443|G60902|AB00053537-10|AB00053537_11|AB00053537_12|1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol|525P666|L000679|Q423364|1(-alpha-naphthoxy)-3-(iso-propylamino)-2-propanol|1-(alpha-naphthoxy)-3-(iso-propylamino)-2-propanol|1-(alpha-naphthoxy)-3-(isopropylamino)-2-propanol|1-(isopropylamino)-3-naphthalen-1-yloxy-propan-2-ol|BRD-A10070317-003-06-9|BRD-A10070317-003-17-6|BRD-A10070317-003-28-3|BRD-A10070317-003-29-1|BRD-A10070317-003-30-9|1-((1-Methylethyl)amino)-3-(1-naphthyloxy)-2-propanol|1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane|F0001-3681|3-(naphthalen-1-yloxy)-1-(propan-2-ylamino)propan-2-ol|1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol|1[(1-Methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol hydrochloride;Angilol;Apsolol;(+/-)-Propranolol hydrochloride"
ZENIDOLOL,104824,,"InChI=1S/C17H27NO2/c1-11(2)18-13(4)16(19)10-20-17-9-8-12(3)14-6-5-7-15(14)17/h8-9,11,13,16,18-19H,5-7,10H2,1-4H3/t13-,16+/m1/s1",VFIDUCMKNJIJTO-CJNGLKHVSA-N,C17H27NO2,277.4,"(2R,3R)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)butan-2-ol","Zenidolol|UNII-46OL1UC10R|46OL1UC10R|(+/-)-ICI-118551|72795-26-7|2-Butanol, 1-((2,3-dihydro-7-methyl-1H-inden-4-yl)oxy)-3-((1-methylethyl)amino)-, (2R,3R)-rel-|erythro-DL-1-(7-Methylindan-4-yloxy)-3-isopropylaminobutan-2-ol|Zenidolol (hydrochloride)|zenidolol [INN]|orb1741095|SCHEMBL14941581|SCHEMBL29387637|DTXSID701033231|HY-100543|CS-0019688|Q27258947|(2R,3R)-rel-1-[(2,3-Dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-2-butanol|2-Butanol, 1-[(2,3-dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-, (2R,3R)-|rac-(2R,3R)-1-[(7-methyl-2,3-dihydro-1H-inden-4- yl)oxy]-3-[(propan-2-yl)amino]butan-2-ol|REL-(2R,3S)-1-((2,3-DIHYDRO-7-METHYL-1H-INDEN-4-YL)OXY)-3-((1-METHYLETHYL)AMINO)-2-BUTANOL"
PROTRIPTYLINE,4976,,"InChI=1S/C19H21N/c1-20-14-6-11-19-17-9-4-2-7-15(17)12-13-16-8-3-5-10-18(16)19/h2-5,7-10,12-13,19-20H,6,11,14H2,1H3",BWPIARFWQZKAIA-UHFFFAOYSA-N,C19H21N,263.4,"N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine","protriptyline|Protryptyline|Amimetilina|438-60-8|Triptil|Protriptilina|Protriptylinum|7-(3-Methylaminopropyl)-1,2:5,6-dibenzocycloheptatriene|N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propanamine|N-Methyl-5H-dibenzo[a,d]cycloheptene-5-propylamine|5-(3-Methylaminopropyl)-5H-Dibenzo[a,d]cycloheptene|N-3-(5H-Dibenzo(a,d)cyclohepten-5-yl)propyl-N-methylamine|3-(5H-dibenzo[a,d][7]annulen-5-yl)-N-methylpropan-1-amine|CHEBI:8597|N-Methyl-5H-dibenzo(a,d)cycloheptene-5-propylamine|5-(3-Methylaminopropyl)-5H-dibenzo(a,d)cycloheptene|4NDU154T12|5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-|5H-Dibenzo(a,d)cycloheptene-5-propylamine, N-methyl-|DTXSID0023535|3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine|5H-Dibenzo[a,d]cycloheptene-5-propanamine, N-methyl-|3-(11H-dibenzo[1,2-a:1',2'-e][7]annulen-11-yl)-N-methylpropan-1-amine|5H-Dibenzo(a,d)cycloheptene-5-propanamine, N-methyl-, hydrochloride|N-methyl-5H-dibenzo(a,d)cycloheptene-5-propanamine|5H-Dibenzo[a,d]cycloheptene-5-propylamine, N-methyl-|3-(5H-dibenzo(a,d)(7)annulen-5-yl)-N-methylpropan-1-amine|3-(5H-dibenzo(a,d)cyclohepten-5-yl)-N-methyl-1-propanamine|3-(11H-dibenzo(1,2-a:1',2'-e)(7)annulen-11-yl)-N-methylpropan-1-amine|methyl(3-(tricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl)propyl)amine|methyl(3-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-yl}propyl)amine|RefChem:58088|Hydrochloride, Protriptyline|DTXCID203535|N06AA11|methyl(3-(tricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,9,11,13-heptaen-2-yl)propyl)amine|207-119-9|N-Methyl-5H-dibenzo(a,d)cycloheptene-5-propylamine hydrochloride|Vivactil|PROTRYPTYLINE HYDROCHLORIDE|Vivactyl|Protriptyline (INN)|CHEMBL668|N-methyl-3-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenyl)propan-1-amine|PROTRIPTYLINE [INN]|Protriptyline [INN:BAN]|Protriptylinum [INN-Latin]|Protriptilina [INN-Spanish]|Novo-Tripramine|Novo-Doxepin|Apo-Trimip|HSDB 3391|NCGC00015851-02|EINECS 207-119-9|CAS-1225-55-4|BRN 2217411|UNII-4NDU154T12|Vivactil (Salt/Mix)|Concordin (Salt/Mix)|Prestwick0_000930|Prestwick1_000930|Prestwick2_000930|Prestwick3_000930|Lopac-P-8813|PROTRIPTYLINE [MI]|PROTRIPTYLINE [HSDB]|BIDD:PXR0157|Lopac0_000974|SCHEMBL34267|BSPBio_000840|PROTRIPTYLINE [VANDF]|SPBio_003019|PROTRIPTYLINE [WHO-DD]|BPBio1_000924|GTPL7285|orb1689592|SCHEMBL29374478|HY-B0949A|5H-Dibenzo[a, d]cycloheptene-5-propanamine, N-methyl-, hydrochloride|BDBM50176062|MK 240|PDSP1_001390|PDSP2_001374|AKOS015962184|CCG-205054|DB00344|SDCCGSBI-0050947.P003|NCGC00015851-01|NCGC00015851-03|NCGC00015851-04|NCGC00015851-05|NCGC00015851-06|NCGC00015851-07|NCGC00015851-15|NCGC00024439-03|AC-15971|DA-77173|SBI-0050947.P002|AB00489964|CS-0013761|NS00009004|C07408|D08447|AB00489964_10|EN300-18552820|L000913|Q408432|BRD-K42098891-003-03-1|BRD-K42098891-003-20-5|3-(5H-Dibenzo[a,d]cyclohepten-5-yl)-N-methyl-1-propanamine #|3-(11H-dibenzo[[?],[?]][7]annulen-11-yl)-N-methyl-propan-1-amine|methyl(3-{tricyclo[9.4.0.0,3,8]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-yl}propyl)amine"
GLUTAMIC ACID,33032,,"InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1",WHUUTDBJXJRKMK-VKHMYHEASA-N,C5H9NO4,147.13,(2S)-2-aminopentanedioic acid,"L-glutamic acid|GLUTAMIC ACID|56-86-0|(2S)-2-Aminopentanedioic acid|L-glutamate|Glutamidex|(S)-2-Aminopentanedioic acid|Glutaminol|L-Glutaminic acid|glutacid|Glutamicol|Glutaton|Aciglut|glutaminic acid|L-glu|(S)-Glutamic acid|L-(+)-glutamic acid|Acidum glutamicum|Glutamic acid, L-|Acido glutamico|Acide glutamique|alpha-aminoglutaric acid|(S)-(+)-Glutamic acid|Acidum glutaminicum|glut|L-2-Aminoglutaric acid|1-Aminopropane-1,3-dicarboxylic acid|FEMA No. 3285|L-alpha-Aminoglutaric acid|alpha-Glutamic acid|2-Aminoglutaric acid|aminoglutaric acid|L-2-amino-pentanedioic acid|3KX376GY7L|INS NO.620|DTXSID5020659|CHEBI:16015|INS-620|E 620|NSC-143503|E620|DTXCID30659|E-620|1-amino-propane-1,3-dicarboxylic acid|l glutamic acid|NSC143503|Glutamate, L|Glutamic acid, L|L-Glutamate, Aluminum|RefChem:6438|Stemega anti hair loss gel|(2S)-2-azaniumyl-5-hydroxy-5-oxopentanoate|(2S)-2-amino-5-hydroxy-5-oxopentanoate;hydron|200-293-7|2-Aminopentanedioic acid|H-Glu-OH|Glusate|D-Glutamiensuur|25513-46-6|glutamate|glu|MFCD00002634|Pentanedioic acid, 2-amino-, (S)-|CCRIS 7314|Glutamic Acid (L-glutamic acid)|AI3-18472|EPA Pesticide Chemical Code 374350|NSC 143503|L(+)-Glutamic acid|Glutamic acid (VAN)|Glutamic acid (H-3)|Glutaminic acid (VAN)|Gamma-L-Glutamic Acid|Glutamate, L-|Glutamic Acid [USAN:INN]|Acide glutamique [INN-French]|Acido glutamico [INN-Spanish]|Acidum glutamicum [INN-Latin]|Glutamic acid, (S)-|alpha-Aminoglutaric acid (VAN)|2-Aminopentanedioic acid, (S)-|NCGC00024502-03|L-Glutamic acid polymer|a-Glutamic acid|M02979|208106-41-6|a-Aminoglutaric acid|L-a-Aminoglutaric acid|L-Glutaminsaeure|L-Acido glutamico|.alpha.-Glutamic acid|Polyglutamic acid(PGA)|glt|GLUTAMIC ACID [USAN]|EINECS 200-293-7|L-Glutamic acid (9CI)|L-Glutamic acid-13C5,15N|aminoglutarate|UNII-3KX376GY7L|alpha-Glutamate|a-Glutamate|L-gluatmate|a-Aminoglutarate|L-glutamic-acid|L-Glutamic adid|2-Aminoglutarate|1ftj|1xff|(S)-glutamate|L-a-Aminoglutarate|alpha-Aminoglutarate|(L)-glutamic acid|H-Glu|L-(+)-Glutamate|Asparagine Impurity 5|L-alpha-Aminoglutarate|Glutamic acid (USP)|Tocris-0218|[3h]-l-glutamic acid|1ii5|(S)-(+)-Glutamate|(S)-Glu|GGL|L-[14C(U)]glutamate|(S)-2-Aminopentanedioate|Biomol-NT_000170|EC 200-293-7|GLUTAMIC ACID [MI]|L-Glutamic acid (JP18)|SCHEMBL2202|L-Glutamic acid (Standard)|GLUTAMIC ACID [INN]|L-Glutamic acid, 98.5%|Lopac0_000529|pentanedioic acid, 2-amino-|S)-2-Aminopentanedioic acid|GLUTAMIC ACID [VANDF]|L-GLUTAMIC ACID [FCC]|L-GLUTAMIC ACID [JAN]|BPBio1_001132|CHEMBL575060|GTPL1369|HSDB 490|orb1304751|SCHEMBL1118947|SCHEMBL6444439|GLUTAMIC ACID [USP-RS]|GLUTAMIC ACID [WHO-DD]|L-GLUTAMIC ACID [FHFI]|L-Glutamic acid, 99%, FCC|BDBM17657|CHEBI:53374|MSK1406|1-Aminopropane-1,3-dicarboxylate|Glutamic acid, L- (7CI,8CI)|L (+)-glutamic acid, alpha-form|1-amino-propane-1,3-dicarboxylate|L-Glutamic acid, non-animal source|Tox21_113053|GLUTAMIC ACID [EP MONOGRAPH]|HB0383|HSCI1_000269|HY-14608R|PDSP1_000128|PDSP1_001539|PDSP2_000127|PDSP2_001523|s6266|AKOS006238837|AKOS015854087|AT49067|CCG-204619|DB00142|FG12676|FP31474|FP71451|SDCCGSBI-0050512.P002|CAS-56-86-0|ALANINE IMPURITY B [EP IMPURITY]|NCGC00024502-01|NCGC00024502-02|NCGC00024502-04|NCGC00024502-07|AC-11294|DS-13284|HY-14608|SY288327|(S)-2-AMINO-1,5-PENTANEDIOIC ACID|CS-0003473|G0059|NS00095129|EN300-52632|L-Glutamic acid, BioUltra, >=99.5% (NT)|C00025|D00007|L-Glutamic Acid(Discontinued,See C4X-24425)|L-Glutamic acid, NIST(R)RM 8573, USGS40|LYSINE ACETATE IMPURITY B [EP IMPURITY]|M03872|gamma-Polyglutamic acid sodium - MW 800-1500|L-Glutamic acid, JIS special grade, >=99.0%|L-Glutamic acid, NIST(R) RM 8574, USGS41|002G634|F551309|gamma-PGA;Poly-gamma-L-glutamic acid sodium salt|gamma-Polyglutamic acid sodium - MW > 700,000|SR-01000597730|L-Glutamic acid, ReagentPlus(R), >=99% (HPLC)|L-Glutamic acid, Vetec(TM) reagent grade, >=99%|SR-01000597730-1|(S)-1-Aminopropane-1,3-dicarboxylic acid;L-Glu-OH|BRD-K62309135-001-05-2|L-Glutamic acid, >=99%, FCC, natural sourced, FG|Q26995161|F8889-8668|gamma-PGA sodium;Poly-gamma-L-glutamic acid sodium salt|Z756440052|27322E29-9696-49C1-B541-86BEF72DE2F3|Glutamic acid, European Pharmacopoeia (EP) Reference Standard|L-Glutamic acid, certified reference material, TraceCERT(R)|Glutamic acid, United States Pharmacopeia (USP) Reference Standard|6899-05-4|L-Glutamic acid, from non-animal source, meets EP testing specifications, suitable for cell culture, 98.5-100.5%"
TOLCAPONE,4659569,,"InChI=1S/C14H11NO5/c1-8-2-4-9(5-3-8)13(17)10-6-11(15(19)20)14(18)12(16)7-10/h2-7,16,18H,1H3",MIQPIUSUKVNLNT-UHFFFAOYSA-N,C14H11NO5,273.24,"(3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone","Tolcapone|134308-13-7|Tasmar|Ro 40-7592|3,4-Dihydroxy-4'-methyl-5-nitrobenzophenone|(3,4-Dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone|Ro-40-7592|(3,4-dihydroxy-5-nitrophenyl)-(4-methylphenyl)methanone|Methanone, (3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-|Tolcapona|DTXSID3023685|CIF6334OLY|Ro-407592|CHEBI:63630|DTXCID903685|3,4-dihydroxy-5-nitro-4'-methylbenzophenone|4'-methyl-3,4-dihydroxy-5-nitrobenzophenone|5-(4-methylbenzoyl)-3-nitrobenzene-1,2-diol|Methanone,(3,4-dihydroxy-5-nitrophenyl)(4-methylphenyl)-|5-((4-methylphenyl)carbonyl)-3-nitrobenzene-1,2-diol|Tolcaponum|5-[(4-METHYLPHENYL)CARBONYL]-3-NITROBENZENE-1,2-DIOL|Ro407592|Ro 407592|Ro 40 7592|RefChem:57103|3,4 Dihydroxy 5' methyl 5 nitrobenzophenone|N04BX01|(3,4-dihydroxy-5-nitrophenyl)(p-tolyl)methanone|MFCD00866569|CHEMBL1324|(3,4-dihydroxy-5-nitro-phenyl)-(p-tolyl)methanone|NCGC00181767-01|3,4-dihydroxy-4 inverted exclamation mark -methyl-5-nitrobenzophenone|Talcapone|UNII-CIF6334OLY|Tasmar (TN)|CCRIS 7904|CAS-134308-13-7|Tolcapone?|(3,4-Dihydroxy-5-nitrophenyl)(4-methylphenyl)methanone;Ro-40-7592;Tasmar|Tolcapone [USAN:USP:INN:BAN]|TCW|Tolcapone (Standard)|TOLCAPONE [INN]|TOLCAPONE [JAN]|TOLCAPONE [MI]|TOLCAPONE [USAN]|TOLCAPONE [VANDF]|TOLCAPONE [MART.]|TOLCAPONE [USP-RS]|TOLCAPONE [WHO-DD]|Tolcapone (JAN/USP/INN)|SCHEMBL33869|TOLCAPONE [EMA EPAR]|MLS006012044|BIDD:GT0032|Tolcapone - Bio-X trade mark|GTPL6646|orb1300535|TOLCAPONE [ORANGE BOOK]|SCHEMBL29360457|Tolcapone, >=98% (HPLC)|TOLCAPONE [USP MONOGRAPH]|3s68|GLXC-07383|HMS2089K14|HMS3652M17|HMS3715D16|HMS3872F03|HMS3885G18|HMS5082J17|BCP09156|Tox21_112963|Tox21_302414|AC-791|ARD193222|BDBM50108877|HY-17406R|s4021|AKOS015902328|Tox21_112963_1|AS-7085|CCG-221217|CS-1173|DB00323|FT28305|KS-1314|NCGC00181767-02|NCGC00181767-03|NCGC00255188-01|BT164481|HY-17406|SMR001614567|SY102278|DB-013561|NS00007380|SW219511-1|T3856|C07949|D00786|O10068|SBI-0654149.0001|AB01275441-01|AB01275441_02|(3,4-Dihydroxy-5-nitro-phenyl)-p-tolyl-methanone|308T137|EN300-18567526|Q413840|SR-05000001444|SR-05000001444-1|BRD-K10852020-001-01-1|BRD-K10852020-001-04-5|BRD-K10852020-001-05-2|Tolcapone, United States Pharmacopeia (USP) Reference Standard|InChI=1/C14H11NO5/c1-8-2-4-9(5-3-8)13(17)10-6-11(15(19)20)14(18)12(16)7-10/h2-7,16,18H,1H"
NIACINAMIDE,936,,"InChI=1S/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9)",DFPAKSUCGFBDDF-UHFFFAOYSA-N,C6H6N2O,122.12,pyridine-3-carboxamide,"nicotinamide|niacinamide|98-92-0|3-Pyridinecarboxamide|pyridine-3-carboxamide|Nicotinic acid amide|Aminicotin|Amixicotyn|Papulex|Nicotylamide|Endobion|Hansamid|Nicobion|Nikotinamid|Savacotyl|Benicot|Dipegyl|Pelmine|Nicotinic amide|Delonin amide|Pelonin amide|Austrovit PP|Vi-Nicotyl|Inovitan PP|Amnicotin|Nicamindon|Nicomidol|Nicosylamide|Nicotamide|Nicotilamide|Nicotililamido|Nicovitina|Nicovitol|Nicozymin|Niocinamide|Niacevit|Niamide|Nicamina|Nicasir|Nicofort|Nicogen|Nicotol|Nicovit|Niozymin|Nicota|Niko-tamin|3-Carbamoylpyridine|Nandervit-N|Nicotine acid amide|Nicotinamidum|Niavit PP|Pyridine-3-carboxylic acid amide|Nicosan 2|Nicotine amide|Nikotinsaeureamid|beta-Pyridinecarboxamide|Pyridine, 3-carbamoyl-|Nicotylamidum|Nicotinsaureamid|Nicotinamida|3-Pyridinecarboxylic acid amide|Factor pp|m-(Aminocarbonyl)pyridine|Nicovel|Pelmin|Witamina PP|PP-Faktor|Amid kyseliny nikotinove|Amide PP|Dipigyl|Niacinamid|NSC-13128|NSC-27452|B3, Vitamin|Vitamin B 3|Niacinamide (USP)|Niacinamide [USP]|B 3, Vitamin|3 Pyridinecarboxamide|DTXSID2020929|CHEBI:17154|25X51I8RD4|Niacin (as niacinamide)|NSC13128|DTXCID00929|NSC27452|skin|Creankojicaid|Nicosedine|Phytokerating|Freederm|Nicamid|Niatin|Trstay|facial cream|Nicam|gel cream|Coconut Hydrate|Collagen Cream|Corrector Cream|Ginger Germinal|Hydrogel Cream|Organic Miracle|Radiance Cream|Tanning Mousse|Tratay Collagen|Trestay Retinol|Trstay Avocado|Trstay Collagen|Trstay Firming|Trstay Gardenia|Trstay Retinol|Turmeric Cream|Ultra Whitening|Whitening Cream|Infinite Aloe|Layender Oil|Minyak Kemiri|Retinol Cream|Rice Ceramide|Shaping Cream|Sleeping Mask|Stretch Marks|Trstay Cream|Men cheam|Acid Cream|Astragalus Cream|Facial Oil|Ginger King|Glycerin Essence|Lightening Cream|Neck Cream|Night Cream|Peari Cream|Pearl Cream|Smooth Skincream|Snail Cream|Snail Mucin|Snal Cream|Tightening Cream|Trstay Bala|Trstay Pferdebal|CellExosome HR|CellExosome SB|Age Renew|Body Balm|Dr Rashel|Men Cream|Bard Growth Oil|Dark Spot Cream|Day Night Cream|Foot Body Cream|Foot Care Cream|Ginseng Whitening|Liftingneck Cream|Peptideface Cream|Pure Jojoba Oil|Retinol HA|Rice Moisturizing|Skinfirming Cream|Vitamin E Serum|Water Gel Cream|Dark Spot Wand|Men Face Cream|Niacinamide 4%|sadoerbuttockscream|Super Aaua Max|Super Aqua Max|Anti Aging Cream|Dr.Jucre Rebirth|Herbal Gray Hair|Koiic Acid Cream|Koile Acid Cream|Kojic Acid Cream|Pro Dark Spot|Trasay Vitamin C|Trstay Dark Soot|Trstay Eye Cream|Trstay Eye Serum|Trstay Lift Firm|Trstay Skin Care|Trstay V-Face|Trstay Vitamin C|Ganoderma Nutrient|Moisturizing Cream|Tea Tree Oll|Trstay Glutathione|Trstay Moisturizer|Royal GinsengCream|TOAS Rejuvenation|Collagen hyaluronic|Emblem Clean Skin|Firming Day Cream|Hip Lift Up|Kojic Acid Rmeric|Papaya Face Cream|Pre Wax Treatment|Proven By Science|Retinol Eye Cream|Retinol face cream|Scar Repair Gream|Smooth Skin Cream|Snow Bleach Cream|Trstay Acne Serum|Trstay Clean Skin|Trstay Face Cream|Trstay Hand Cream|Trstay Scar Cream|Avocado Moisturizer|Foot8 Body Cream|Nails Essenceliquid|Revitaliftlaser X3|Rosehip Moisturizer|Trstay Blemishcream|Trstay Laboratoires|Beard Oil Contains|Body Sliming Cream|Caffeine Eye Cream|Contour Lift Cream|Costem cell 5 N|Plump Buttocks Oil|Retinol Night Lift|Royal GinsengLotion|Trstay Pearl Cream|Trstay Rosehip Oil|Trstay Sakur Serum|Trstay Snow Bleach|All In One Cream|TURMERICFaceCream|5% Retinol|Body slimming Cream|Jours Huile minceur|AAPE Skin Ampoule|CellExosome HE HR|Dark Spot Corrector|Fantastic LightCream|Ginger Essental Oil|Massagehssential Oil|Niacinamide Malaysia|Rejuvenating Day Cr|Rich Moisture Cream|Rosemary Hair Serum|Royal Ginseng Toner|Snail Essence Cream|Trstay Carrot Cream|Trstay Facial Serum|Trstay Firm Tighten|Trstay Hair Removal|Trstay Papaya Cream|Trstay Turmeric Oil|Vitamin Cface Cream|48%Urea Cream|Cream C Kojic Acid|For All Skin Types|Super C Face Cream|Trstay 3In 1Cream|Ageless Beauty Cream|Butt Enhancement Oil|Crepe Corrector Booy|Crepe Skin Treatment|Facial Freckle Cream|Firming Corset Cream|HydrolYzedCollagen5%|Lavender Massage Oil|Pore Minimizer Serum|Relaxing Massage Oil|Repairing Foot Cream|Retinol Facial Serum|Trstay Firming Cream|Trstay Hair Membrane|Trstay Peeling Serum|Trstay Retinol Cream|Trstay Retinol Serum|Trstay Ultra Glowing|Krshum Ginger 7Days|48% Urea Cream|70% Kojic Acid|Day Night Face Lift|JamaicanBlackCastorOil|Massag ehssential Oil|PureVita Vitamin B3|Retinol24night Cream|Tratay Coffee extract|Vita C Bright Serum|Vita C Bright Toner|Vtamin C Face Cream|Brightening Gel Cream|Collagen Beauty Cream|Larnseyu Breast Cream|Men Brightening Cream|Niacinamide Face Mask|Rice Moisturizingcream|Royal Ginseng Essence|Trstay Breast Enhance|Trstay Coffee Extract|Trstay Collagen Cream|Trstay Radiance Cream|Trstay Turmeric Cream|Trstay Whiteing Cream|Ultra Whitening Ample|Vitamin C Brightening|Vitamin C Moisturizer|West Mouth Gynecomast|Hair Removal For Mrs|Hair Vitamin E Serum|Liet Firm Booty Msak|Lift Firm Booty Mask|Mask Beauty Skin Oil|OJW Brightening serum|TANIA PURECREAM|Trstay Hot Sweat Gel|Trstay Witamin E Oil|TURMERIC SERUM|Vitamin C Face Cream|IDA NESCREAM|JUVEHEAL W Ampoule|Niacinamide, Adenosine|Rosemary Essential oli|Advanced Ageless Serum|BREXTEM S|Butt Enhancement Cream|Rejuvenating Day Cream|Retinol Ha Moisturizer|Slimming Essential Oil|Tightening Night Cream|Trstay Astraglus Cream|Trstay Corrector Cream|Trstay Invisible Cream|Trstay Smoothing Cream|Trstay Whitening Cream|Avocado cleansing cream|Kojic Acid Face Cream|Mens Plain Face Cream|Trstay Men Face Cream|Trstay moiturizing skin|Trstay Vc Snail Serum|Trstay Witamtin E Oil|Buitock Enhancement Oil|Caffeine Slimming Cream|Cellulite Burning Cream|Dr. Color Effect Red|Enhanced Breast Shaping|IDA NES SERUM|Moisture Boosting Cream|Moisturizing Body Cream|Night Cream Moisturizer|Skin Moisturizing Cream|Smoothes Wrinkles Cream|SNOW WHITE SPOT|Trsta Retinolmoisturizer|Trstay Astragalus Cream|Trstay Moisturizingcream|Trstay Retinol Collagen|Trstay Retionl Collagen|Trstay Water lce Levin|Trstay Whitening Creanm|Tstay 45 Urea Cream|VIitamin C Face Cream|Waterlidht Makeup Cream|47% Rice Raw Pulp|Age Defense Face Cream|Day Night Facial Cream|DPC Aura Booster Mask|Dr Cellinme Mask Sheet|Dr.Jucre Rebirth White|Eye Side Essential Oil|Melasma Spot Out Cream|Neck Face Repair Cream|Pretty butt massage oil|Retinol 24Night Cream|Trstay Aloe Vear Cream|Trstay Aloe Vera Cream|Trstay Dark Skin Cream|Trstay Eye Essence Oil|Trstay Hand Body Cream|Trstay Rice Body Cream|Trstay Rose Body Cream|Trstay Skin Care Cream|Trstay Skin Grow Cream|Trstay Vitamin C Cream|BUutt Enhancement Cream|SNOW WHITE MILKY|Trstay 45 Urea Cream|Trstay 45%Urea Cream|Tstary 45 Urea Cream|RefChem:55705|Vita C Bright EyeCream|Collagenmoisturizer Cream|Combination Watery Cream|Enjoy Bliss Be Obedient|Extravirgin Colo Pressed|Foot Cream 42% Urea|Intensive Radiance Cream|Miracle Laser Skin Mist|Naite Thread Necx Cream|Pro Dark Spot-Corrector|Pure Natural Castor Oil|Queen Bee Essential Oil|Tratay Polypeptide Cream|Trstay Cuticle Care Oil|Trstay Darek Spot Cream|Trstay Ganoderma Lucidum|Trstay Kojic Acid Cream|Trstay Kojlc Acid Cream|Trstay Polypeptide Cream|Trstay Skin Care Creams|Trstay White Spoe Cream|Trstay Whitening Wrinkle|Rice RawPulp Face Cream|Bhb Salts With Mct Oil|Retinol Vitamin E trstay|Stronge super Face Cream|Super C Even Skin Tone|Bightening Radiance Cream|C5 Super Boosteye Cream|Dr.Jucre Rebirth Booster|Etinol Moisturizing Cream|Hyaluronicacid Facialserum|Milk Skin Orrector Cream|Peptide Contour Liftcream|Professional Facial Cream|Professional Facial Serum|Retinol Moisturizer Cream|Retinol Moisturizing Crea|Snail Whipp Whiten Cream|Tratay Fatazen Wax Stick|Triple Lipid Peptidecream|Trstay 45 %Urea Cream|Trstay 45% Urea Cream|Trstay Black Honey Cream|Trstay Coconut Body Wash|Trstay Day Hight Retinol|Trstay Day Night Retinol|Trstay Eve Cream Soulane|Trstay Keratin Hair Mask|Trstay Mango Body Butter|Trstay Moisturizing Cream|Trstay Organic Argan Oil|Trstay Papapy Face Cream|Trstay Retinol Eye Cream|Trstay Sexy Pink Essence|Trstay Vitamin B5 Serum|Trstayteatreeoilfoot Cream|Turmeric Vitamin C Cream|Weightless Hydrating Mask|Whole Body Incense Cream|APLIN SPOT REMOVER|KARATICA I M CURE|PUVIDA SNOW BLEACH|TANIA PURE ESSENCE|TRSTAY Cream Vitamin C|VITA C BRIGHTCREAM|Vitamin C Glow Face Oil|Vitamin C No MakeupCream|Azelaic Acid 20% Cream|Acnol Face Creamtive Reti|Advanced Brightening Cream|Anti Aging Recovery Cream|Anti-Aging Recovery Cream|Colagen Sakura Body Cream|Collagen Moisturizer Cream|Crepe Corrector Booylotion|Dark Spot Correcdor Cream|Dark Spot Corrector Ceram|Hip Massage Essential Oil|Milk Skin Corrector Cream|Mooyam Retinol Face Cream|Natural Nourish Skin Face|Nekvnro Snow Bleach Cream|Niacinamide Soothing Serum|OJW Brightening gel cream|Pellagra-Preventing Factor|Retinol Moisturizing Cream|Retinol Regenerating Cream|Skin Renewing Night Cream|Stem Cell Whitening Serum|Super C Penetrating Serum|Super C Penetrating Serun|Tighten Smooth Moisturizer|Tratay Caffeine Eye Cream|Tratay Day Night Facelift|Trstay Avocado Face Serum|Trstay Caffeine Eye Cream|Trstay Coconut Body Cream|Trstay Collagen Day Cream|Trstay Cream Hair Removal|Trstay Dark Spot Correcor|Trstay Eautiful Skin Body|Trstay Eye Cream Soualane|Trstay Firming Neck Cream|Trstay Firming Skin Cream|TRSTAY Gleam Body Scrub|Trstay Hair Essential Oil|Trstay Hair Removal Cream|Trstay Hand Body Lavender|Trstay Hydrolyzed Collagen|Trstay Manuka Honey Cream|Trstay Nightcream Squalane|Trstay Pearl Muscle Cream|Trstay Peptides Face Lift|Trstay Pore Control Serum|Trstay Retinol Face Cream|Trstay Retinol Moisturizer|Trstay Rosehip Moisturizer|Turmeric Boster Eye Cream|100% Sweet Almond Oil|INTOMEDI HR PEPTIDE|NYAAM NYAAM Vita Serum|PORE REFINING SERUM|RGO HYDRATION TONER|Salicylic Acid 2%Solution|SISEUNDEUSI LUMINANT|Trstay For Men Eye Cream|Vitamin c 20%Face Cream|Butt Lifting Massage Cream|Dark Spot Correcting Cream|Eirming Facial Essence Oil|Intensive Concentrate Cream|Intensive Moisturizes Cream|Kojic Acid Corrector Ceram|Kojic Acid Corrector Cream|Melanin Removal Face Cream|Miracle Moisturizer Essence|Miracle Retinol Moisturizer|Nevk Face Tighteninc Cream|Niacinamide Corrector Cream|Peptide Contour Lift cream|Permium Skin Care Collagen|Premium Skin Care Collagen|Propolis Wrinkle Eye Cream|Super Retinolcream For Men|Triple Lipid Peptide Cream|Triple Lipid-Peptide Cream|Trstay Belly Firming Cream|TRSTAY Bleach Cream Snow|Trstay Coconut Body Butter|Trstay Collagen Neck Cream|Trstay Dark Spot Corrector|Trstay Facial Tallow Cream|Trstay Organic Shea Butter|Trstay Peptides Face Cream|Trstay Retinol Moisturizing|Trstay Rice Rawpuo Essence|Trstay Straight Hair Cream|Trstay Turmeric Face Cream|Trstay Turmeric Face MASK|Turmeric Booster Eye Cream|Turmericr Powder Face Mask|AnYi Beauty Radiance Cream|APLIN SPOT ALL KILL|C5 Super Boost Eye Cream|MOISTIE PURE ESSENCE|Trstay New Beard Care Oil|TrstayVitamin C Moisturizer|Vitamin C No Makeup Cream|CALMSINFLAMMATIONSERUM|DPC Whitening Booster Mask|Trstay Antiaging face Cream|AAPE Nutrient Facial Toner|Advanced Retinol Moisturizer|Anti-wrinkIeHyaluronic Blend|Corner Distributtion Removal|Crepe Skin Repair Treatment|Kelp Varech Hydrating Serum|Moisturizer Face Neck Cream|Moisturizing Anti Agingsream|Retinol Collagen Moisturizer|Triple-Action Lifting Cream|Trstay Beard Care Beard Oi|Trstay Breast Massage Cream|Trstay Day Night Eve Cream|Trstay Day Night Eye Cream|Trstay Day Night Face Lift|Trstay Ginger Essential Oil|Trstay Hand And Body Cream|Trstay Hydrating Foot Cream|Trstay Nourishing Eye Serum|Trstay Rice Rawpulp Essence|Trstay Sakura Essence Cream|Trstay Spot Removal Firming|Trstay The Vitamin C Cream|Trstay Varicose Veins Cream|Trstay Vitamin C Eye Cream|Black Honey Energizing Serum|Hot Cream Uitra Moisturizing|Hot Cream Ultra Moisturizing|Kojic Acid Turmeric Solution|Moisture Restoringnight Cream|Moisturizer Anti Aging Cream|Nstant Wrinkle Removal Cream|NYAAM NYAAM Peptide Serum|Sea Fennelantiwrinkle Essence|Sheep Oil Moisturizing Cream|Skinelastix Antiwrinkle Cream|Skinklastix Antiwrinkle Cream|Super Retinol Cream For Men|Trstay Acid Vitamin C Cream|Trstay Delayed Essential Oil|Trstay Eye Care Essence Oil|Trstay Hair Color Pen Brown|Trstay Hyaluronic Acid Serum|Trstay Hyalvronic Acid Serum|Trstay Nourish Hydrate Cream|Trstay Peptide Complex Serum|Trstay Perfection Castor Oil|Trstay Teatreeoil Foot Cream|Trstay Turmeric Moisture And|Trstay Vitamin C Moisturizer|All-in-one Moisturizer Cream|FIRMING AND TIGHTENING|InstaPerfect Zero Pore Serum|Obvious Effect slimming cream|SNOW WHITE MILKY PACK|Trstay anti-aging moisturizer|AAPE Continuous Renewal Mask|Anti-wrinkle Firm Lift Cream|Crepe Repair Face Neck Cream|Hip Up Firming Essentisl Oil|Jaysuing Varicose Veins Cream|Kojic Acid Moisturizing Cream|Licorice Root Whitening Cream|Moistuirizer Anti-aging Cream|Papaya Kojic Acid Glutathione|Primerose Snail Hydro Essence|Shieldlife Whitening Ion Mask|Trstay Body Moisturizer Cream|Trstay Crocodile Repair Serum|Trstay Evens Skin Tone Cream|Trstay Finest Whitening Cream|Trstay Glycyrrhiza Pore Serum|Trstay Moisturizer Face Cream|Trstay Moustache Hair Remover|Ultra V AQUA SHINE MASK|Ultra Whitening First Essence|White Rice Skin Beauty Essce|Xlike Retinol Vitamin Etrstay|Dark Spot CORREGTOR GREAM|Dark Spot GORREGTOR GREAM|Hyaluronic Acidintensive Cream|Moisturizing Firmingface Cream|Pramoxicilin Active face cream|Trstay 100%Pure Castor Oil|Trstay Day To Night Eye Gel|TRSTAY Mother of All Creams|Ace Deeender Cream Moisturizer|Bliss Republic Dark Spot Wand|Butt Enhancement Essential Oil|by selected hyaluron day serum|Chest Neck Facee Rerair Cream|Cleaning Balance Essential Oil|Collagen Day Night Moisturizer|Deep sleep Reduce Aging Cream|Dr Cellinme Skin Care Ampoule|GZE Nicotinamide CleansingSoap|Insta Perfect Zero Pore Serum|Intimate Area Brightenin Cream|Moisturizng Firming Face Cream|Retinol Skin Moisturizer Cream|Skin-Transforming Pillow Cream|Smoothes Wrinlnkles Lazy Cream|Trstay Glutathione White Cream|Trstay Instant Wrinkle Remover|Trstay Japan Sakura Hyalu B5|Trstay koji cacid facial cream|TRSTAY Kojic acidfacial cream|Trstay Moisturizing Body Cream|Trstay Moisturizing Eyes Cream|Trstay Night Cream Moisturizer|Trstay Nourishing Massag Cream|Trstay Smoothes Wrinkles Serum|Trstay Whitening Vitc Collagen|Trstay Wrinkle Smoothing Cream|TrstayTumericTonerDarkSpotSwase|Replenishing Facial Moisturizer|sadoer whiten cream vit amin c|Trstay Sleevage feduction cream|AUTOPHAGY REVOLUTIONCREAM|CAVIALL Wrinkle-Free PowerTox|Dark Spot Corrector Face Cream|Dr.Jucre Rebirth White Booster|Hyaluronic Acid Intensive Cream|Intensive Hydration Hair Masque|Kojic Acid Power Lifting Cream|Revital Perfecting Dual Ampoule|Snakes Venom Peptide Eye Cream|Trstay Advanced Vtamin C Cream|Trstay Beard Facial Moisturizer|Trstay Breast Enhancement Cream|Trstay Collagen Cream For Face|Trstay Face Self-Tanning Drops|Trstay Intensive Radiance Cream|Trstay Japan Sakura Body Cream|Trstay Jasmine Body Skin Cream|Trstay Retinol Pro Face Liquid|Yiganerjing Hair Growth Essence|ETERNITY VITAMIN C SERUM|Granactive Retionide2% Emulsion|TRSTAYGlow-BrightSmoothingStick|Daily Whitening Care Sheet Mask|Edge Cutimal Cat Whitening Mask|Eye Firming Wrinkle Essence Oil|Face Cream Natural Nourish Skin|Isner Mile Skin Care B3 Serum|Obvious Effectbooy Massage Cream|Pore Shrinking Invisiblity Cream|Radiance Cram For Private Parts|Trstay 3 In 1 Makeup Emulsion|Trstay Advanced Vitamin C Cream|Trstay Retinol Moisturizer Cream|Trstay Strengthening Hair Masque|Trstay Tea Tree Oil Foot Cream|Vilamin E Nourishing Body Cream|Vitamin C Brightening Eye cream|Vitamin C Brigntening Eye Serum|ANTI-AGING COLLAGEN SERUM|AUTOPHAGY REVOLUTION SERUM|CELLBN MILKY TONE-UPCREAM|Hibiscus and Honey Firming cream|NYAAM NYAAM Skin Reborn Serum|Trstay Hair VitaminCapsule Serum|Trstay Instant WRINKLE SMOOTH|Trstay TumericTonerDarkSpotsErase|Ultrahydrating Facial Moisturizer|A11HA01|Brightening Glow Vitamin C Cream|Day Night Collagen Retinol Cream|Days Ginger Germnal Oil Solutlon|Face Moisturizer Water Gel Cream|Face Moisturizer Water Gel Gream|Face Moisturlzer Water Gel Cream|Mari Huana real nature hemp seed|Morocco Argan Oil Hair Treatment|Pomegranate Pores Smoothins Serum|Pore Shrinking Invisibility Cream|Radiance Cream For Private Parts|Subear Dark Spot Corrector Cream|Tonymoly Pandas Dream White Hand|Trstay Advanced Brightening Cream|Trstay Dark Spot Corrector Cream|Trstay Face Body Whitening Cream|Trstay Fruit Acid Stock Solution|Trstay Midnight BlueCalming Cream|Trstay Milk Skin Corrector Cream|Trstay Retinol Moisturizing Cream|Trstay Rice Raw Pulp Face Cream|Trstay Skin Cre Retinol C Serum|Trstay Skin Renewing Night Cream|Vitamin C Brightening Moisturizer|7X Ceramide Barrier Repair Crean|BRIGHTUNING PEPTIDE AMPOULE|Face Cream Skin Tone Moisturizing|Obvious Effect Booy Massage Cream|Peptide Face Cream Charming Charm|Trstay Firming massage Moisturizer|Trstay Hair Vitamin Capsule serum|Trstay Hyaluronic Acid Body Cream|Trstay Men Cool Tender Eye Cream|Trstay Plant Essence Vitamin E C|Trstay Retinol Anti Essential Oil|Trstay Scar And Acne Removal Gel|Trstay Streng Thening Hair Masoue|Trstay Tea Tree Acneremoval Serum|AnYi Beauty Hyaluronic Acid Cream|Collagen Complex Moisturizer Cream|Hydrogenated Polydecene,Niacinamide|iBeaLee Dark Spot Corrector Cream|NowNoon Dark Spot Corrector Cream|NYAAM NYAAM Mulberry Stem Serum|Retino Firming Toning Rejuvenating|RetinoI Day And Night Moisturizer|TRSTAY Color Control Green Cream|Trstay Intimate AreaRadiance Cream|Trstay MoroccanArganoil Face Cream|Ultra Hydeating Facial Moisturizer|Whitening and anti-freckle essence|Ala-C Snail Cell Reparing Essence|AnYi Beauty Breast Enlarging Cream|DR. GLODERM TABRX WHITENING|Fast Effective Turmeric Neck Cream|Melasma Melanin Removal Face Cream|Retinol Firming Toning Rejuvenating|Trstay Anti-Dark Cirles Eye Cream|Trstay Beauty Skin Whitening Cream|Trstay Body Massage Cream Turmeric|Trstay Global Protection Day Cream|Trstay Mens Cool Tender Eye Cream|Trstay Moroccan Arganol Face Cream|Trstay Nourishing Magical Treatment|Trstay Olive Oil Hair Hold Mousse|Trstay Retinol Collagen Face Cream|Trstay Skin CareE Retinol C Serum|Trstay Triple Action Lifting Cream|Trstay Turmeric Body Massage Cream|Trstay Turmeric Vitaminc Bodylotion|Trstay Vitamin C20% Pearl Muscle|Anti Wrinkle Firm Lift Night Cream|Anti-Wrinkle Firm Lift Night Cream|COSMEPURE BRIGHTENING CALMING|Hyaluronic Acid Viamin E Green Tea|Itamin C Potent Nourish Skin White|Snail Moist Nourishing Facial Cream|THE SKIN HOUSE Vital BrightCream|THE SKIN HOUSE Vital BrightSerum|Trstay Nourishing Magical Hair Mask|Trstay Rose Moisturizing Body Cream|Trstay Smoothes Wrinkles Face Cream|Vitamin C Super Serum Facial Serum|3 In 1 Nicotinamide Tone-up Cream|ARILAC Brightening Mask Sheet Pack|NIACINAMIDE 15% SNOW BLEACH|shediary tea tree essence acne cream|Trstay Mens Cool Tender Eye Cream,|45% Urea Cream 2% Salicylic Acid|Hyaluronic Acid Vitamin E Green Tea|Niacinamide Malaysia Glycerin Essence|THE SKIN HOUSE Vital Bright Toner|Trstay All In One Moisturizer Cream|Trstay Collagen Botanical Stem Cells|Trstay Daily Moisturizing Body Cream|Trstay Intimate Area Whitening Cream|Trstay Kojic Acid Vitamin C Retinol|Trstay Moisturizing Smoothes Wrinkles|Trstay Switzerland Niacin Mide Serum|Ultra Premium Compound Fasentinl Oil|Vitamin C Potent Nourish Skin White|Anti-Oxidation Moist Repairface Cream|Moisturizes Nourishes Day Night Cream|Papaya Breast Enlarging Essential Oil|SFERANGS VITA C CAPSULEBOOSTER|Snail Nourishing And Mostfacial Cream|Trstay Chest Neck Face Lifting Cream|Trstay Collagenhydrolyzed Collagen 5%|TRSTAY RETIONL 1% IN SQUALNE|Vitamin C Hydrating Antioxidant Cream|Aloe Vera Soothing And Moisture Serum|Caviar Extravagant No Evaporation Film|INTOMEDI FIRST AMPOULE CYSTEINE|Niveola P.H.c 3d Festival Mask Pack|NowNoon Super C Even Skin Tone Cream|Skin Project Ya Cooling Celluven Mask|THE SKIN HOUSE Vital BrightEmulsion|Trstay Awaken Peptide Lifting Eye Gel|Trstay Day And Night Face Lift Cream|Trstay Even Skin Tone Corrector Cream|Trstay Kojia Acid Power Lifting Cream|Trstay Kojic Acid Power Lifting Cream|Trstay Retinol Skin Moisturizing Cream|Trstay Turmeric Vitaminl C Body Cream|Auouest Neck Chest Firming Seper Cream|Fair King Tea Tree Snail Repair Cream|Fair King Tea Tree Snall Repair Cream|FRESH MANDARIN AROMATHERAPY MASK|Tretay For Men Hydrolyzed Collagen 5%|Trstay Collagen Hydrolyzed Collagen 5%|Trstay For Men Hydrolyzed Collagen 5%|Advanced Retinol Rejuvenating Eye Cream|Bk Cell 5days Of Secret Snow Whitening|EVECODE THREAD LIFTING MASK PACK|Mari Huana Real Natural Sparkle Essence|Moroccan Herbal Hair Care Essential Oil|Skin Bath Cream MoSmoothes softens skin|THE SKIN HOUSE Vital Bright Emulsion|THE SKIN HOUSE Vital Bright EyeCream|TRSTAY Ganoderma Lucidum Essence Cream|Trstay Retinol Collagen Hyaluronic Acid|TRSTAY RETINOL MOISTURIZING CREAN|VOVA Kojic Acid Skin Brightening Cream|W.SKIN WHITE GLUTATHIONE TONE UP|Collagen Hyaluronic Anti-aging Day Cream|Gold Collagen Moisturizing And Firm Skin|Niveola White Tiger 3d Animal Mask Pack|Tanning Cream 100% Natural Ingredients|The Organic Avocado Aati Wrinkle Essence|The Organic Avocado Anti Wrinkle Essence|COSMEPURE BRIGHTENING CALMING TONER|DERLADIE HerbalExtract BodySolution MIST|Tanning Cream 100% Natura 1 ingredients|THE SKINHOUSE WHITE TIGHTENINGCREAM|Trstay 24k Gold Niacinamide Facial Cream|Trstay Keratin Mask For Dry Damaged Hair|Trstay West Month Smoothes Wrinkles Cream|DR. GLODERM TIME TO WHITENING MASK|THE SKINHOUSE ALOE SOOTHING VITAMIN|Trstay 10% Vitamin C Combination Essence|Trstay DarkSpot Correector Face Body Cream|Trstay Gsrlic Hipenlargement Essential oil|Trstay More Perfect Moisturizing Eye Cream|AN ADC SP INTENSIVE MOISTURE ESSENCE|De medicotem illuminating white cell ampoule|FRESH MANDARIN AROMATHERAPY MASK 27g|OJW Niacinamide Brightening Facial Cleanser|Protein Correcting Hair Straightening Cream|SKIN MELANIN CORRECTING FACIAL SERUM|SUPER Niacinamide Malaysia Glycerin Essence|THE SKINHOUSE WHITE TIGHTENING SERUM|THE SKINHOUSE WHITE TIGHTENING TONER|Trstay Advanced Snail 92 All In One Cream|Trstay Antldark Circles And Eye Baqs Cream|Trstay Neck Face Extea Nourishing Hydrating|Trstay Pure Hyaluronic Acid Serum for Face|VOVA NIACINAMIDE Instant RADIANCE Cream|Derma Pella Facial Cleanser for Normal Skin|DR.ALTHEA POWER WHITENING GLUTATHIONE|MIZON ENJOY VITAL UP TIME Whitening Mask|The Hayan Cherry Blossom Brightening Essence|THE SKINHOUSE WHITE TIGHTENINGEMULSION|Tonymoly Naturalth Goat Milk Whitening Toner|TRSTAY Antidack Circles And Eye Bags Cream|Trstay Whiiening And Freckle Removeing Cream|AnYi Beauty 5 seconds Remove Dark Spot Cream|AnYi Beauty Turmeric Vitamin C Radiance Cream|Retinol Collagen Day NIight Anti-Aging Cream|TRSTAY Rapid Skin Bleaching Cream Brightening|ANTI HAIR LOSS HAIR STRENGTHENING SERUM|DERMAHAN THE WHITENING MOISTURIZING MASK|Niacinamide, Adenosine, Biotin, Hexapeptide-2|Pugan vegan White Tomato formula Cleansing Gel|Tonymoly Naturalth Goat Milk Whitening Essence|Trstay Neck Firming Chestneck Facelifting Cream|Trstay Retinol Collagen Moisturizer Face Cream|Derma Pella Cleanser for Sensitive and Dry Skin|Trstay Neck Firming Chestneck Face Lifing Cream|Trstay Neck Firming Chestneck Face Lifting Cream|DERLADIE LABORATOIRE PORE TIGHTENING AMPOULE|Double Peptide Reverse Age Anti-wrinkle Eye Cream|Effectively Improves Skin Tone And Nourishes Skin|J9 ULTRA ADVANCED INTENSIVE SCALP SERUM V2|Skin Bath Cream Moisturizing Smoothes softens skin|Trstay Garlic Hipenlargement Lifting Essential Oil|LEBODY LAB RENEWAL DUAL EFFECT PEPTIDE SERUM|Trstay Dark Knees and Elbows Strong whitening Cream|LEBODY LAB RENEWAL DUAL EFFECT HYALURONIC SERUM|LEBODY LAB RENEWAL DUAL EFFECT IDEBENONE SERUM|MUSTUS DAILY HARVEST SQUEEZE TONE UP MASK PACK|PAPA RECIPE BOMBEE BRIGHTENING HONEY MASK PACK|SISEUNDEUSI LUMINANT MASK PACK STEP2(WHITENING)|Niacinamide, Adenosine, Zizipus jujuba Fermented Extract, Hexapeptide-2|202-713-4|Nicamide|vitamin PP|Vitamin B|Mediatric|Acid amide|3-(aminocarbonyl)pyridine|Vitamin B (VAN)|Nicotinsaureamid [German]|Nikotinsaeureamid [German]|Amid kyseliny nikotinove [Czech]|Nicotinamidum [INN-Latin]|Nicotinamida [INN-Spanish]|MFCD00006395|Nictoamide|CCRIS 1901|HSDB 1237|Vi-noctyl|AI3-02906|NSC 13128|b-Pyridinecarboxamide|Nicotinamide [INN]|Nicotinamide (Standard)|.beta.-Pyridinecarboxamide|Nicotinamide (Vitamin B3)|CHEMBL1140|MLS000069714|NCGC00093354-03|NCGC00093354-05|SMR000058212|Nicotinamide 10 microg/mL in Acetonitrile|Niacinamide;Nicotinic acid amide;Vitamin B3|WLN: T6NJ CVZ|Niacinamide [USAN]|CAS-98-92-0|Vitamin B3;Nicotinamide;3-Pyridinecarboxamide|SR-01000721872|EINECS 202-713-4|Enduramide|Niacotinamide|Nicotinamid|nicotin-amide|UNII-25X51I8RD4|Nicotinsaeureamid|3-Amidopyridine|DEA No. 1405|Vitamin B3 amide|11032-50-1|3-?Pyridinecarboxamide|Mediatric (Salt/Mix)|niacin - Vitamin B3|1yc5|Opera_ID_775|NIACINAMIDE [II]|Nicotinsaureamid Jenapharm|NIACINAMIDE [FCC]|NICOTINAMIDE [MI]|NIACINAMIDE [HSDB]|NICOTINAMIDE [JAN]|bmse000281|Jenapharm, Nicotinsaureamid|MolMap_000061|EC 202-713-4|NIACINAMIDE [VANDF]|SCHEMBL2926|Nicotinamide (JP17/INN)|NICOTINAMIDUM [HPUS]|NIACINAMIDE [USP-RS]|NICOTINAMIDE [MART.]|MLS001424246|NICOTINAMIDE [WHO-DD]|NICOTINAMIDE [WHO-IP]|SCHEMBL126899|SCHEMBL309392|SCHEMBL317675|orb1310155|SCHEMBL1034150|SCHEMBL2445375|SCHEMBL6278767|SGCUT00176|TPN COMPONENT NIACINAMIDE|SCHEMBL19978192|SCHEMBL29603013|BDBM27507|HY-B0150R|Nicotinamide - Bio-X trade mark|MSK1506|NIACINAMIDE [ORANGE BOOK]|Nicotinamide, niacin, vitamin B3|HMS2052M21|HMS2090B05|HMS2093H03|HMS2236J03|HMS3370F21|HMS3394M21|HMS3655M20|HMS3713B22|HMS3884A16|HMS5080K21|NICOTINAMIDE [EP IMPURITY]|Pharmakon1600-01505397|NIACINAMIDE [USP MONOGRAPH]|NICOTINAMIDE [EP MONOGRAPH]|BCP07322|HY-B0150|to_000073|Nicotinamide 1.0 mg/ml in Methanol|Nicotinamide, >=98.5% (HPLC)|Nicotinamide, >=99.5% (HPLC)|Tox21_111202|Tox21_201716|Tox21_302776|NICOTINAMIDUM [WHO-IP LATIN]|NSC759115|s1899|SBB004283|STL163867|AKOS005715850|Tox21_111202_1|CCG-101149|CS-1968|DB02701|FN01411|NC00399|NSC-759115|SB74497|Nicotinamide 100 microg/mL in Methanol|Nicotinamide, >=98% (HPLC), powder|NCGC00093354-04|NCGC00093354-06|NCGC00093354-09|NCGC00256432-01|NCGC00259265-01|NIACIN (AS NIACINAMIDE) [VANDF]|AS-13845|BN166252|BN183763|Nicotinamide, puriss., 99.0-101.0%|SY024804|SBI-0206826.P001|DB-057754|CS-0694823|N0078|NS00005364|ST51037366|SW197779-3|EN300-15612|Niacinamide, meets USP testing specifications|C00153|D00036|Nicotinamide (Niacinamide), analytical standard|AB00373895-13|AB00373895_15|AB00373895_16|Nicotinamide, Vetec(TM) reagent grade, >=98%|A845925|AC-907/25014114|AG-227/20370056|F239905|Q192423|SR-01000721872-3|SR-01000721872-4|SR-01000721872-5|BRD-K28912512-001-23-2|BRD-K28912512-001-24-0|BRD-K28912512-001-25-7|Z33546463|F2173-0513|Niacinamide;Nicotinic acid amide;Vitamin B3; Vitamin PP|Nicotinamide, British Pharmacopoeia (BP) Reference Standard|A186B02E-6C70-4E54-9739-79398D439AAA|Nicotinamide, European Pharmacopoeia (EP) Reference Standard|Niacinamide, United States Pharmacopeia (USP) Reference Standard|InChI=1/C6H6N2O/c7-6(9)5-2-1-3-8-4-5/h1-4H,(H2,7,9|Niacinamide, Pharmaceutical Secondary Standard; Certified Reference Material|Nicotinamide, BioReagent, suitable for cell culture, suitable for insect cell culture"
ODANACATIB,10152654,,"InChI=1S/C25H27F4N3O3S/c1-23(2,26)14-20(22(33)32-24(15-30)12-13-24)31-21(25(27,28)29)18-6-4-16(5-7-18)17-8-10-19(11-9-17)36(3,34)35/h4-11,20-21,31H,12-14H2,1-3H3,(H,32,33)/t20-,21-/m0/s1",FWIVDMJALNEADT-SFTDATJTSA-N,C25H27F4N3O3S,525.6,"(2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide","Odanacatib|603139-19-1|MK-0822|MK0822|N673F6W2VH|L-1037536|(2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4-(4-methylsulfonylphenyl)phenyl]ethyl]amino]pentanamide|DTXSID40209075|(2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-[[(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)[1,1'-biphenyl]-4-yl]ethyl]amino]pentanamide|L-001037536|(2S)-N-(1-Cyanocyclopropyl)-4-fluoro-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)ethyl)amino)pentanamide|odanacatibum|(2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4-(4-methylsulfonylphenyl)phenyl)ethyl)amino)pentanamide|RefChem:856152|A10BH01|DTXCID60131566|(2S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4'-methanesulfonyl-(1,1'-biphenyl)-4-yl)ethyl)amino)pentanamide|Odanacatib (MK-0822)|MK 0822|Odanacatib (MK0822)|(S)-N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-(((S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl)ethyl)amino)pentanamide|C25H27F4N3O3S|MFCD11042419|Odanacatib (MK 0822)|CHEMBL481611|(S)-N-(1-CYANOCYCLOPROPYL)-4-FLUORO-4-METHYL-2-((S)-2,2,2-TRIFLUORO-1-(4'-(METHYLSULFONYL)BIPHENYL-4-YL)ETHYLAMINO)PENTANAMIDE|Odanacatib [USAN]|Odanacatib [USAN:INN]|UNII-N673F6W2VH|Odanacatinib|MK-0822A|ODANACATIB [MI]|ODANACATIB [INN]|ODANACATIB [JAN]|Odanacatib (JAN/USAN)|ODANACATIB [MART.]|ODANACATIB [WHO-DD]|MLS006010197|GTPL6478|orb1301131|SCHEMBL1496266|EX-A552|BCPP000141|cas:603139-19-1;Odanacatib|BDBM50255753|NSC766811|s1115|AKOS015900719|BCP9001020|CCG-269888|CS-0277|DB06670|FM65088|NSC-766811|NCGC00346637-01|NCGC00346637-08|NCGC00346637-11|AC-27468|AS-19562|HY-10042|SMR004676504|NS00072488|SW219669-1|D08955|MK-0822;MK 0822;MK0822|139M191|Q2014070|BRD-K22822991-001-02-3|N-(1-Cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)biphenyl-4-yl]ethyl}-L-leucinamide|N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methyl sulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide|N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide|Pentanamide, N-(1-cyanocyclopropyl)-4-fluoro-4-methyl-2-(((1S)-2,2,2-trifluoro-1-(4'-(methylsulfonyl)(1,1'-biphenyl)-4-yl)ethyl)amino)-, (2S)-"
SURAMIN,5361,,"InChI=1S/C51H40N6O23S6/c1-25-9-11-29(49(60)54-37-13-15-41(83(69,70)71)35-21-33(81(63,64)65)23-43(45(35)37)85(75,76)77)19-39(25)56-47(58)27-5-3-7-31(17-27)52-51(62)53-32-8-4-6-28(18-32)48(59)57-40-20-30(12-10-26(40)2)50(61)55-38-14-16-42(84(72,73)74)36-22-34(82(66,67)68)24-44(46(36)38)86(78,79)80/h3-24H,1-2H3,(H,54,60)(H,55,61)(H,56,58)(H,57,59)(H2,52,53,62)(H,63,64,65)(H,66,67,68)(H,69,70,71)(H,72,73,74)(H,75,76,77)(H,78,79,80)",FIAFUQMPZJWCLV-UHFFFAOYSA-N,C51H40N6O23S6,1297.3,"8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid","suramin|Suramine|145-63-1|Fourneau|Farma|Belganyl|Metaret|NSC-34936|FARMA-939|1,3,5-naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-|DTXSID1046344|CHEBI:45906|6032D45BEM|DTXCID9026344|1,3,5-Naphthalenetrisulfonic acid, 8,8'-(carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bis-|8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid|8,8'-(CARBONYLBIS(IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO))BIS-1,3,5-NAPHTHALENETRISULFONIC ACID|8-[(4-methyl-3-{[3-({[3-({2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl}carbamoyl)phenyl]carbamoyl}amino)benzene]amido}benzene)amido]naphthalene-1,3,5-trisulfonic acid|8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC ACID|8-((4-methyl-3-((3-(((3-((2-methyl-5-((4,6,8-trisulfonaphthalen-1-yl)carbamoyl)phenyl)carbamoyl)phenyl)carbamoyl)amino)benzene)amido)benzene)amido)naphthalene-1,3,5-trisulfonic acid|8-((4-methyl-3-((3-((3-((2-methyl-5-((4,6,8-trisulfonaphthalen-1-yl)carbamoyl)phenyl)carbamoyl)phenyl)carbamoylamino)benzoyl)amino)benzoyl)amino)naphthalene-1,3,5-trisulfonic acid|Monosodium Salt Suramin|Salt Suramin, Monosodium|RefChem:186812|205-658-4|3-((hydroxy-(3-((C-hydroxy-N-(3-(C-hydroxy-N-(5-(C-hydroxy-N-(4,6,8-trisulfonaphthalen-1-yl)carbonimidoyl)-2-methylphenyl)carbonimidoyl)phenyl)carbonimidoyl)amino)phenyl)methylidene)amino)-4-methyl-N-(4,6,8-trisulfonaphthalen-1-yl)benzenecarboximidic acid|5-(hydroxy-oxo-oxoniumylidene-lambda6-sulfanyl)-4-((3-((3-((3-((5-((8-(hydroxy-oxo-oxoniumylidene-lambda6-sulfanyl)-6-sulfo-4-sulfonatonaphthalen-1-yl)carbamoyl)-2-methylphenyl)carbamoyl)phenyl)carbamoylamino)benzoyl)amino)-4-methylbenzoyl)amino)-7-sulfonaphthalene-1-sulfonate|Naganol|Naphuride|Farma 939|Suramine sodium|m,m'-Ureylen-bis-(8-(m-(benzamido)-p-toluamido)naphthalin-1,3,5-trisulfonsaeure)|CHEMBL265502|Harnstoff, symmetischer der 3-aminobenzoyl-3-amino-4-methylbenzoyl-1-naphthylamin-4,6,8-trisulfonsaeure|SVR|NSC 34936|Carbanilide, 3,3'-bis((5-((4,6,8-trisulfo-1-naphthyl)carbamoyl)-o-tolyl)carbamoyl)-|8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bisnaphthalene-1,3,5-trisulphonic acid|NCGC00163318-01|Naganil|8,8'-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bisnaphthalene-1,3,5-trisulphonic acid|Naganol 6 Na|8,8'-((3,3'-((3,3'-(Carbonylbis(azanediyl))bis(benzoyl))bis(azanediyl))bis(4-methylbenzoyl))bis(azanediyl))bis(naphthalene-1,3,5-trisulfonic acid)|8,8'-[Ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-1,3,5-naphthalenetrisulfonic acid|CAS-145-63-1|EINECS 205-658-4|BRN 3230873|SGCTO-001|UNII-6032D45BEM|8,8'-(UREYLENEBIS(M-PHENYLENECARBONYLIMINO(4-METHYL-M-PHENYLENE)CARBONYLIMINO))DI-1,3,5-NAPHTHALENETRISULFONIC ACID|8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFON IC ACID|Spectrum_001877|SpecPlus_000662|Spectrum3_000724|Spectrum4_001247|SURAMIN [WHO-DD]|SCHEMBL3161|Lopac0_001182|US8835659, Suramin|BSPBio_002248|KBioGR_001774|KBioSS_002402|3-14-00-02267 (Beilstein Handbook Reference)|DivK1c_006758|GTPL1728|orb1982121|SCHEMBL29357785|SCHEMBL29371906|SCHEMBL30312075|SCHEMBL30552218|KBio1_001702|KBio2_002397|KBio2_004965|KBio2_007533|KBio3_001468|AAA14563|HY-B0879|Tox21_112045|BDBM50336799|CCG-36173|MMV637953|Tox21_112045_1|CS-4444|DB04786|sym-bis(m-aminobenzoyl-m-amino-p-methylbenzoyl-1-napthylamino-4,6,8-trisulfonate) carbamide|NCGC00025177-08|NCGC00163318-02|NCGC00163318-03|1,3,5-Naphthylenetrisulfonic acid, 8,8'-(ureylenebis(m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino))di-|8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid|8,8'-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-napthalenetrisulfonic acid|8-[[4-methyl-3-[[3-[[3-[[2-methyl-5-[(4,6,8-trisulfo-1-naphthyl)carbamoyl]phenyl]carbamoyl]phenyl]carbamoylamino]benzoyl]amino]benzoyl]amino]naphthalene-1,3,5-trisulfonic acid|DA-58199|NS00024749|C07974|G78130|L000585|Q425946|BRD-K70327167-348-01-9|BRD-K70327167-348-09-2|BRD-K70327167-348-12-6|BRD-K70327167-348-13-4|SR-01000075238-10|1-(3-Benzamido-4-methylbenzamido)naphthalene-4,8-trisulfonic acid sym-3''-urea sodium salt|1,3,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis- (9CI)|1,3,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di- (8CI)|1,5-Naphthalenetrisulfonic acid, 8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-, hexasodium salt|1,5-Naphthalenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt|1,5-Naphthylenetrisulfonic acid, 8,8'-[ureylenebis[m-phenylenecarbonylimino(4-methyl-m-phenylene)carbonylimino]]di-, hexasodium salt|8,8''-(Carbonylbis(imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino))bisnaphthalene-1,3,5-trisulphonic acid|8,8''-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonyl-imino]]bis-1,3,5-naphthalenetrisulfonic acid(suramin)|8,8''-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFONIC ACID|8,8'-[CARBONYLBIS[IMINO-3,1-PHENYLENECARBONYLIMINO(4-METHYL-3,1-PHENYLENE)CARBONYLIMINO]]BIS-1,3,5-NAPHTHALENETRISULFON|8,8'-[carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bis-1,3,5-naphthalenetrisulphonic acid|8,8-[Carbonylbis[imino-3,1-phenylenecarbonylimino(4-methyl-3,1-phenylene)carbonylimino]]bisnaphthalene-1,3,5-trisulphonic acid|8-[(4-methyl-3-{[3-({[3-({2-methyl-5-[(4,6,8-trisulfonaphthalen-1-yl)carbamoyl]phenyl}carbamoyl)phenyl]carbamoyl}amino)benzoyl]amino}benzoyl)amino]naphthalene-1,3,5-trisulfonic acid|WLN: L66J BSWQ DSWQ GSWQ JMVR D1 CMVR CMVMR CVMR B1 EVM-JL66J BSWQ DSWQ GSWQ &-NA-6"
KAINIC ACID,10255,,"InChI=1S/C10H15NO4/c1-5(2)7-4-11-9(10(14)15)6(7)3-8(12)13/h6-7,9,11H,1,3-4H2,2H3,(H,12,13)(H,14,15)/t6-,7+,9-/m0/s1",VLSMHEGGTFMBBZ-OOZYFLPDSA-N,C10H15NO4,213.23,"(2S,3S,4S)-3-(carboxymethyl)-4-prop-1-en-2-ylpyrrolidine-2-carboxylic acid","kainic acid|487-79-6|Digenin|Digenic acid|Helminal|L-alpha-Kainic acid|Acide kainique|Acido kainico|alpha-Kainic acid|Acidum kainicum|NSC136038|SIV03811UC|DTXSID7040526|CHEBI:31746|2-Carboxy-4-isopropenyl-3-pyrrolidineacetic acid|NSC-759587|(2S,3S,4S)-3-(carboxymethyl)-4-prop-1-en-2-ylpyrrolidine-2-carboxylic acid|(3S,4R)-3-(carboxymethyl)-4-(prop-1-en-2-yl)-L-proline|DTXCID5020526|(2S-(2alpha,3beta,4beta))-2-carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic acid|3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, (2S-(2alpha,3beta,4beta))-|Acid, Digenic|Acid, Kainic|RefChem:915531|(2S,3S,4S)-3-(carboxymethyl)-4-prop-1-en-2-ylpyrrolidin-1-ium-2-carboxylate|Digensaeure|Kainsaeure|(2S,3S,4S)-3-(Carboxymethyl)-4-(prop-1-en-2-yl)pyrrolidine-2-carboxylic acid|alpha- Kainic acid|3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, (2S,3S,4S)-|CHEMBL275040|3-Pyrrolidineacetic acid, 2-carboxy-4-isopropenyl-|3-(Carboxymethyl)-4-isopropenylproline|NCGC00024504-05|2-Carboxy-3-carboxymethyl-4-isopropenylpyrrolidine|NSC 136038|3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, (2S-(2-alpha,3-beta,4-beta))-|(-)-A-KAINIC ACID|(3S,4S)-3-(carboxymethyl)-4-prop-1-en-2-yl-L-proline|Kainic acid [INN:JAN]|(2S,3S,4S)-3-(carboxymethyl)-4-isopropenyl-pyrrolidine-2-carboxylic acid|4071-38-9|CAS-487-79-6|Acide kainique [INN-French]|Acido kainico [INN-Spanish]|Acidum kainicum [INN-Latin]|SR-01000075454|2-Carboxy-4-(1-methylethenyl)-3-pyrrolidineacetic Acid|BRN 0086660|UNII-SIV03811UC|kainic-acid|DL-Kainic acid|NSC-136038|KAI|1p1n|KAINIC ACID [MI]|WRW5P6M3EM|Biomol-NT_000217|KAINIC ACID [INN]|UPCMLD-DP146|Kainic acid, (+/-)-|Lopac0_000656|SCHEMBL15777|4-22-00-01523 (Beilstein Handbook Reference)|MLS001074661|KAINIC ACID [WHO-DD]|BPBio1_001306|(-)-(.alpha.)-Kainic Acid|UPCMLD-DP146:001|UPCMLD-DP146:002|HMS2233K05|HMS3262C13|HMS3266C11|HMS3411A21|HMS3675A21|AAA48779|EX-A8001|HY-N2309|Tox21_110905|Tox21_500656|BDBM50002369|Kainic Acid - CAS 487-79-6|AKOS024456995|Tox21_110905_1|CCG-204742|LP00656|SDCCGSBI-0050635.P002|NCGC00024504-02|NCGC00024504-03|NCGC00024504-04|NCGC00024504-06|NCGC00024504-07|NCGC00024504-08|NCGC00024504-09|NCGC00024504-15|NCGC00261341-01|DA-64702|SMR000471885|CS-0020451|EU-0100656|NS00075498|K 0250|M02036|Q390239|SR-01000597728|SR-01000075454-1|SR-01000075454-5|SR-01000075454-6|SR-01000075454-7|SR-01000597728-1|BRD-K52459018-001-09-1|rel-(3R,4R)-3-(carboxymethyl)-4-isopropenyl-D-proline|2S-CARBOXY-4S-(1-METHYLETHENYL)-3S-PYRROLDINEACETIC ACID|L-proline, 3-(carboxymethyl)-4-(1-methylethenyl)-, (3S,4S)-|3-Pyrrolidineacetic acid, 2-carboxy-4-(1-methylethenyl)-, (2R,3R,4R)-rel-|(2S-(2.ALPHA.,3.BETA.,4.BETA.))-2-CARBOXY-4-(1-METHYLETHENYL)-3-PYRROLIDINEACETIC ACID|InChI=1/C10H15NO4/c1-5(2)7-4-11-9(10(14)15)6(7)3-8(12)13/h6-7,9,11H,1,3-4H2,2H3,(H,12,13)(H,14,15)/t6-,7+,9-/m0/s"
AZM-475271,5330175,,"InChI=1S/C23H27ClN4O3/c1-28-8-6-15(7-9-28)13-31-22-12-19-17(11-21(22)30-3)23(26-14-25-19)27-20-10-16(29-2)4-5-18(20)24/h4-5,10-12,14-15H,6-9,13H2,1-3H3,(H,25,26,27)",WPOXAFXHRJYEIC-UHFFFAOYSA-N,C23H27ClN4O3,442.9,N-(2-chloro-5-methoxyphenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine,"476159-98-5|AZM 475271|AZM-475271|M-475271|N-(2-chloro-5-methoxyphenyl)-6-methoxy-7-((1-methylpiperidin-4-yl)methoxy)quinazolin-4-amine|N-(2-chloro-5-methoxyphenyl)-6-methoxy-7-[(1-methylpiperidin-4-yl)methoxy]quinazolin-4-amine|0361Z8214O|DTXSID00197222|4-Quinazolinamine, N-(2-chloro-5-methoxyphenyl)-6-methoxy-7-((1-methyl-4-piperidinyl)methoxy)-|RefChem:154852|DTXCID10119713|Src Kinase Inhibitor M475271|M 475271|AZM475271|C23H27ClN4O3|M475271|Methoxy Aniline 7|UNII-0361Z8214O|N-(2-Chloro-5-methoxyphenyl)-6-methoxy|BDBM6198|CHEMBL426161|orb1707601|SCHEMBL3195079|SCHEMBL29388701|GLXC-10377|BUA15998|MFCD19690925|AZM 475271 [WHO-DD]|AKOS024457900|AZM475271?|NCGC00370984-01|NCGC00370984-02|HY-13561|MS-27972|DB-158888|F85123|Q21547118|N-(2-chloro-5-methoxy-phenyl)-6-methoxy-7-[(1-methyl-4-piperidyl)methoxy]quinazolin-4-amine|N-(2-chloro-5-methoxyphenyl)-6-methoxy-7-[(1-methyl-4-piperidinyl)methoxy]-4-quinazolinamine"
ASLAN-003,24986824,,"InChI=1S/C19H14F2N2O3/c1-26-13-5-2-4-11(8-13)12-9-15(20)17(16(21)10-12)23-18-14(19(24)25)6-3-7-22-18/h2-10H,1H3,(H,22,23)(H,24,25)",OMPATGZMNFWVOH-UHFFFAOYSA-N,C19H14F2N2O3,356.3,"2-[2,6-difluoro-4-(3-methoxyphenyl)anilino]pyridine-3-carboxylic acid","2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid|2-((3,5-Difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino)nicotinic acid|RefChem:139975|Aslan003|Farudodstat|1035688-66-4|Aslan-003|MFCD32215342|2-[2,6-difluoro-4-(3-methoxyphenyl)anilino]pyridine-3-carboxylic acid|2-[(3,5-difluoro-3'-methoxy[1,1'-biphenyl]-4-yl)amino]-3-pyridinecarboxylic acid|I58WE41H6X|2-[(3,5-difluoro-3'-methoxy-4-biphenylyl)amino]nicotinic acid|2-((3,5-Difluoro-3'-methoxy-[1,1'-biphenyl]-4-yl)amino)nicotinic acid|2-(3,5-difluoro-3'-methoxybiphenyl-4-ylamino)nicotinic acid|2-((3,5-Difluoro-3'-methoxy(1,1'-biphenyl)-4-yl)amino)-3-pyridinecarboxylic acid|3-Pyridinecarboxylic acid, 2-((3,5-difluoro-3'-methoxy(1,1'-biphenyl)-4-yl)amino)-|FARUDODSTAT [INN]|ASALN003|UNII-I58WE41H6X|SCHEMBL355081|orb1309976|CHEMBL2263632|SCHEMBL29364008|SCHEMBL29409728|GTPL12106|OMPATGZMNFWVOH-UHFFFAOYSA-N|BDBM119812|GLXC-26306|HMS6018P14|EX-A4313|KRB68866|LAS186323|s9721|AKOS040732475|LAS 186323|AC-36562|DA-61259|MS-25575|SY270741|HY-129239|CS-0104387|G17075|US8691852, 20|2-((3,5-Difluoro-3'-methoxy-[1,1'-biphenyl]-4-yl)amino)nicotinicacid|2-[(3,5-difluoro-3 inverted exclamation marka-methoxy[1,1 inverted exclamation marka-biphenyl]-4-yl)amino]-3-pyridinecarboxylic acid"
CIPROFLOXACIN,2764,,"InChI=1S/C17H18FN3O3/c18-13-7-11-14(8-15(13)20-5-3-19-4-6-20)21(10-1-2-10)9-12(16(11)22)17(23)24/h7-10,19H,1-6H2,(H,23,24)",MYSWGUAQZAJSOK-UHFFFAOYSA-N,C17H18FN3O3,331.34,1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid,"ciprofloxacin|85721-33-1|Ciprofloxacine|Ciprobay|Cipro|Ciprofloxacina|Ciprofloxacino|Ciprofloxacinum|1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid|Ciprocinol|Bacquinor|Cifloxin|Ciprodar|Otiprio|BAY q 3939|1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylic acid|BAYQ3939|CPFX|1-Cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-1,4-dihydro-3-quinolinecarboxylic acid|Velmonit|1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-ylquinoline-3-carboxylic acid|1-CYCLOPROPYL-6-FLUORO-4-OXO-7-PIPERAZIN-1-YL-1,4-DIHYDROQUINOLINE-3-CARBOXYLIC ACID|NSC-758467|5E8K9I0O4U|CIPRO IN DEXTROSE 5% IN PLASTIC CONTAINER|BAY O 9867 FREE BASE|BAY-O-9867 FREE BASE|CHEBI:100241|BAY-Q-3939|CIPRO IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER|3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-|Bay 09867|DTXSID8022824|3-Quinolinecarboxylic acid, 1,4-dihydro-1-cyclopropyl-6-fluoro-4-oxo-7-(1-piperazinyl)-|1-Cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydro-quinoline-3-carboxylic acid|1-cyclopropyl-6-fluoro-7-hexahydro-1-pyrazinyl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|1-Cyclopropyl-6-fluoro-7-(4-methyl-piperazin-1-yl)-4-oxo-1,4-dihydro-quinoline-3-carboxylic acid|Ciprofloxacin In Dextrose 5%|RefChem:6412|Ciprofloxacin in Dextrose|ciprofloxacin by-compound a|Ciprofloxacin In Dextrose 5% In Plastic Container|Bay09867|ciprofloxacin desfluoro-compound|DTXCID002824|J01MA02|S01AE03|S02AA15|S03AA07|Ciprofloxacin Otic Solution, 0.2%|Anhydrous, Ciprofloxacin Hydrochloride|Hydrochloride Anhydrous, Ciprofloxacin|617-751-0|1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-4-ium-1-ylquinoline-3-carboxylate|ciprofloxacin fluoroquinolonic acid|Ciproxan|Cipro IV|Ciproxina|Cipro XR|Ciprinol|MFCD00185755|Ciproxin|Bay-09867|CHEMBL8|Cipromycin|Ciproquinol|Bernoflox|Septicide|1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-quinoline-3-carboxylic acid|Ciprecu|Ciprogis|Ciprolin|Ciprolon|Ciprowin|Ciproxine|Citopcin|Corsacin|Fimoflox|Ipiflox|Italnik|Probiox|Proflaxin|Quinolid|Quintor|Roxytal|Spitacin|Superocin|Zumaflox|Baflox|Ciplus|Ciriax|Rancif|Cilab|Cixan|Cycin|Loxan|Unex|Sophixin Ofteno|Ciprobay Uro|Alcon Cilox|Bi-Cipro|Cipro (TN)|CPF|Proksi 250|Proksi 500|Cyprobay|AuriPro|Eni|1-cyclopropyl-6-fluoro-4-oxo-7-piperazinylhydroquinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinoline-carboxylic acid|BAY-o 9867|Ciprofloxacine [INN-French]|Ciprofloxacinum [INN-Latin]|3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-, hydrochloride|SMR000471901|Ciprofloxacino [INN-Spanish]|CCRIS 5241|HSDB 6987|SR-05000001863|NCGC00016959-01|CAS-93107-08-5|BRN 3568352|rubrum|UNII-5E8K9I0O4U|Ciprooxacin|Ciprine|Linhaliq|Ciprofloxacin monohydrochloride|Otiprio (TN)|Ciprofloxacin [USAN:USP:INN:BAN]|Ciprofloxacin (Cipro)|Spectrum_000162|Ciprofloxacin (Cipro)?|Ciprofloxacin protomer I|Ciprofloxacin (Standard)|Ciprofloxacin protomer II|Prestwick0_000113|Prestwick1_000113|Prestwick2_000113|Prestwick3_000113|Spectrum2_001567|Spectrum3_001872|Spectrum4_000874|Spectrum5_001089|Cipro (*Hydrochloride*)|CBMicro_048498|CIPROFLOXACIN [MI]|Ciloxan (*Hydrochloride*)|CIPROFLOXACIN [INN]|CIPROFLOXACIN [JAN]|SCHEMBL2900|CIPROFLOXACIN [HSDB]|CIPROFLOXACIN [USAN]|Oprea1_008239|Oprea1_313572|BSPBio_000126|BSPBio_003344|CIPROFLOXACIN [VANDF]|KBioGR_001567|KBioSS_000642|ANHYDROUS CIPROFLOXACIN|MLS001336035|MLS006011837|BIDD:GT0205|CIPROFLOXACIN [MART.]|DivK1c_000095|SPECTRUM1503614|SPBio_001474|SPBio_002065|CIPROFLOXACIN [USP-RS]|CIPROFLOXACIN [WHO-DD]|CIPROFLOXACIN [WHO-IP]|BPBio1_000140|orb1307927|BAY-O9867|BDBM21690|GTPL10902|HMS500E17|HY-B0356R|KBio1_000095|KBio2_000642|KBio2_003210|KBio2_005778|KBio3_002846|Linhaliq [Liposomal Formulation]|Ciprofloxacin (JP18/USP/INN)|MSK5703|NINDS_000095|Bay o 9867 (*Hydrochloride*)|HMS1922E18|HMS2090O07|HMS2093I03|HMS6019C09|Pharmakon1600-01503614|CIPROFLOXACIN [ORANGE BOOK]|ALBB-015909|BCP28586|FVB05035|HY-B0356|RKL10073|CIPROFLOXACIN [EP MONOGRAPH]|BBL005612|CCG-39345|CIPROFLOXACIN [USP MONOGRAPH]|CIPROFLOXACIN EXTENDED RELEASE|Ciprofloxacin, >=98.0% (HPLC)|NSC758467|NSC759028|s2027|SBB012554|STK021082|719 - Quinolone antibiotics in fish|AKOS000269653|CIPRODEX COMPONENT CIPROFLOXACIN|CIPROFLOXACINUM [WHO-IP LATIN]|AC-7613|AC58172|DB00537|KS-5006|NSC 758467|NSC-759028|IDI1_000095|SMP1_000125|Ciprofloxacin 100 microg/mL in Methanol|NCGC00016959-02|NCGC00016959-03|NCGC00016959-04|NCGC00016959-05|NCGC00016959-07|NCGC00095058-01|NCGC00095058-02|NCGC00178128-01|ST024751|SBI-0048462.P003|C2510|NS00008031|EN300-08481|C05349|D00186|721C331|Ciprofloxacin, VETRANAL(TM), analytical standard|F358017|Q256602|SR-05000001863-1|SR-05000001863-3|BRD-K04804440-001-08-7|BRD-K04804440-001-09-5|BRD-K04804440-001-13-7|BRD-K04804440-311-02-3|Z56933707|Ciprofloxacin, European Pharmacopoeia (EP) Reference Standard|ENROFLOXACIN FOR VETERINARY USE IMPURITY B [EP IMPURITY]|Ciprofloxacin, United States Pharmacopeia (USP) Reference Standard|1-Cyclopropyl-6-fluoro-1,4-dihydro 4-oxo-7-[1-piperazinyl)-quinoline-3-carboxylic Acid|1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7- (1-piperazinyl)-3-quinoline-carboxylic acid|1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3- quinolinecarboxylic acid|1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline -3-carboxylic acid|1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-quinoline-3-carboxylic acid|1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)quinoline-3-carboxylic acid|1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1piperazinyl)-3quinolinecarboxylic acid|1-cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(piperazin-1-yl)-quinoline-3-carboxylic acid|1-Cyclopropyl-6-fluoro-1,4-dihydro-7-(1-piperazinyl)-4-oxo-3-quinoline carboxylic acid|1-cyclopropyl-6-fluoro-4-oxo-7-(piperazin-1-yl)-1,4-dihydroquinoline-3-carboxylicacid|1-cyclopropyl-6-fluoro-7-(piperazin-1-yl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid|Ciprofloxacin, Pharmaceutical Secondary Standard; Certified Reference Material|1-Cyclopropyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-3-quinolinecarboxylic acid;Ciflafin;Bay q 3939|1-cyclopropyl-6-fluoro-4-oxo-7-piperazin-1-yl-1,4-dihydroquinoline-3-carboxylic acid hydrochloride"
MOXIFLOXACIN,152946,,"InChI=1S/C21H24FN3O4/c1-29-20-17-13(19(26)14(21(27)28)9-25(17)12-4-5-12)7-15(22)18(20)24-8-11-3-2-6-23-16(11)10-24/h7,9,11-12,16,23H,2-6,8,10H2,1H3,(H,27,28)/t11-,16+/m0/s1",FABPRXSRWADJSP-MEDUHNTESA-N,C21H24FN3O4,401.4,"7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid","moxifloxacin|151096-09-2|Moxifloxacine|Zimoxin|Avelox IV|Avelox I.V.|Moxifloxacino|Izilox|U188XYD42P|1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-3-quinolinecarboxylic acid|CHEBI:63611|3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-|7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid|7-[(4aS,7aS)-octahydro-1H-pyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|DTXSID3048491|Actira|BAY128039|BAY-128039|3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo(3,4-b)pyridin-6-yl)-4-oxo-|moxifloxacinum|7-((4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo(3,4-b)pyridin-6-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylic acid|7-((4aS,7aS)-octahydro-1H-pyrrolo(3,4-b)pyridin-6-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|RefChem:6043|DTXCID9028465|J01MA14|S01AE07|1-cyclopropyl--7-(2,8-diazabicyclo(4.3.0)non-8-yl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid|604-773-0|7-((4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo(3,4-b)pyridin-1-ium-6-yl)-1-cyclopropyl-6-fluoro-8-methoxy-4-oxoquinoline-3-carboxylate|Avalox|Avelox|1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|MFCD04117996|Moxifloxacin (INN)|(1'S,6'S)-1-Cyclopropyl-7-(2,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|C21H24FN3O4|Avolex|MOXIFLOXACIN [INN]|Moxifloxacin [INN:BAN]|1-Cyclopropyl-6-Fluoro-8-Methoxy-7-[(4as,7as)-Octahydro-6h-Pyrrolo[3,4-B]pyridin-6-Yl]-4-Oxo-1,4-Dihydroquinoline-3-Carboxylic Acid|7-[(4aS,7aS)-1,2,3,4,4a,5,7,7a-octahydropyrrolo[3,4-b]pyridin-6-yl]-1-cyclopropyl-6-fluoro-8-methoxy-4-oxo-quinoline-3-carboxylic acid|MFX|MXFX|Actira (*Hydrochloride*)|Avelox (*Hydrochloride*)|moxyfloxacin|UNII-U188XYD42P|CCRIS 8690|HSDB 8026|1-cyclopropyl-6-fluoro-8-methoxy-7-((4aS,7aS)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|Avelox IV (TN)|Moxifloxacin (Standard)|MOXIFLOXACIN [MI]|MOXIFLOXACIN [VANDF]|SCHEMBL24007|MOXIFLOXACIN [WHO-DD]|orb1310714|SCHEMBL29356466|GTPL10915|EX-A016|MSK5767|FABPRXSRWADJSP-MEDUHNTESA-N|GLXC-03039|HMS3715P05|HY-66011AR|1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-[(4aR,7aR)-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl]-4-oxo-3-quinolinecarboxylic acid|BCP22895|RKL10080|BDBM50366824|HY-66011A|NSC782304|s5535|BAY 12-8039 (*Hydrochloride*)|AKOS015895251|BCP9000962|CCG-221192|CS-1895|DB00218|NSC-782304|NCGC00183881-09|NCGC00183881-11|NCGC00271749-08|AC-25913|AS-41986|FM145387|MXF|BCP0726000137|SBI-0206792.P001|NS00000171|96M092|D08237|AB00171653-11|AB00171653-13|AB00171653-14|AB00171653_15|EN300-1726094|AR-270/43507941|F793005|Q424940|SR-01000763482|SR-01000763482-3|BRD-K66615216-003-13-0|BRD-K66615216-003-14-8|1-Cyclopropyl-6-fluoro-7-((4aS,7aS)-hexahydro-1H-pyrrolo[3,4-b]pyridin-6(2H)-yl)-8-methoxy-4-oxo-1,4-dihydroquinoline-3-carboxylicacid|1-cyclopropyl-6-fluoro-8-methoxy-7-octahydro-6H-pyrrolo[3,4-b]pyridin-6-yl-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid"
GANETESPIB,135564985,,"InChI=1S/C20H20N4O3/c1-11(2)14-9-15(18(26)10-17(14)25)19-21-22-20(27)24(19)13-4-5-16-12(8-13)6-7-23(16)3/h4-11,25-26H,1-3H3,(H,22,27)",RVAQIUULWULRNW-UHFFFAOYSA-N,C20H20N4O3,364.4,"3-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-(1-methylindol-5-yl)-1H-1,2,4-triazol-5-one","Ganetespib|888216-25-9|STA-9090|STA9090|STA 9090|2E8412Y946|3-[2,4-Dihydroxy-5-(propan-2-yl)phenyl]-4-(1-methyl-1H-indol-5-yl)-4,5-dihydro-1H-1,2,4-triazol-5-one|ganetespibum|3-(2,4-dihydroxy-5-(propan-2-yl)phenyl)-4-(1-methyl-1H-indol-5-yl)-4,5-dihydro-1H-1,2,4-triazol-5-one|RefChem:142390|Hsp90 Inhibitor STA-9090|5-(2,4-dihydroxy-5-(1-methylethyl)phenyl)-2,4-dihydro-4-(1-methyl-1h-indol-5-yl)-|3-(2,4-dihydroxy-5-isopropylphenyl)-4-(1-methylindol-5-yl)-5-hydroxy-4h-1,2,4-triazole 3h-1,2,4-triazol-3-one|Ganetespib (STA-9090)|Ganetespib [USAN]|Ganetespib(STA-9090)|3-(2,4-Dihydroxy-5-isopropylphenyl)-4-(1-methylindol-5-yl)-5-hydroxy-4H-1,2,4-triazole|5-[2,4-Dihydroxy-5-(1-methylethyl)phenyl]-2,4-dihydro-4-(1-methyl-1H-indol-5-yl)-3H-1,2,4-triazol-3-one|Ganetespib (USAN)|MFCD22420818|3-(2,4-Dihydroxy-5-isopropylphenyl)-4-(1-methyl-1H-indol-5-yl)-1H-1,2,4-triazol-5(4H)-one|3-(2,4-dihydroxy-5-propan-2-ylphenyl)-4-(1-methylindol-5-yl)-1H-1,2,4-triazol-5-one|5-(2,4-Dihydroxy-5-(1-methylethyl)phenyl)-4-(1-methyl-1H-indol-5-yl)-2,4-dihydro-3H- 1,2,4-triazol-3-one|5-[2,4-dihydroxy-5-(1-methylethyl)phenyl]-4-(1-methyl-1H-indol-5-yl)-2,4-dihydro-3H- 1,2,4-triazol-3-one|5-[2,4-Dihydroxy-5-(Propan-2-Yl)phenyl]-4-(1-Methyl-1h-Indol-5-Yl)-2,4-Dihydro-3h-1,2,4-Triazol-3-One|Ganetespib [USAN:INN]|Genetespib|UNII-2E8412Y946|5-(2,4-DIHYDROXY-5-(PROPAN-2-YL)PHENYL)-4-(1-METHYL-1H-INDOL-5-YL)-2,4-DIHYDRO-3H-1,2,4-TRIAZOL-3-ONE|TUH|Ganetespib,STA-9090|GANETESPIB [INN]|GANETESPIB [WHO-DD]|SCHEMBL419750|SCHEMBL421080|orb1305731|CHEMBL2103879|SCHEMBL29352120|SCHEMBL29376128|GTPL13309|EX-A250|CHEBI:177770|RVAQIUULWULRNW-UHFFFAOYSA-N|DTXSID401025663|HMS3654K12|HMS3673E09|BCP22669|BDBM50439621|NSC765435|NSC777169|s1159|AKOS025396037|AKOS026750420|AKOS032947228|CCG-268213|compound 8 [PMID: 23965125]|CS-0697|DB12047|NSC-765435|NSC-777169|SB16526|3-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(1-methyl-indol-5-yl)-5-hydroxy-[1,2,4]triazole|NCGC00346678-01|NCGC00346678-04|NCGC00346678-12|(5Z)-5-(4-hydroxy-6-oxo-3-propan-2-ylcyclohexa-2,4-dien-1-ylidene)-4-(1-methylindol-5-yl)-1,2,4-triazolidin-3-one|4-(5-hydroxy-4-(1-methyl-1H-indol-5-yl)-4H-1,2,4-triazol-3-yl)-6-isopropylbenzene-1,3-diol|AC-32480|AS-35117|FG137675|HY-15205|BCP0726000115|DB-293433|NS00072503|SW220253-1|D10126|STA-9090; STA9090; STA 9090|BRD-K38852836-001-02-1|Q27254612|Z2235801986|TRIAZOLONE DERIVATIVE INHIBITOR OF HEAT SHOCK PROTEIN 90|3-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(1-methylindol-5-yl)-1H-1,2,4-triazol-5-one|3-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(N-methyl-indol-5-yl)-5-hydroxy-[1,2,4]triazole|2,4-Dihydro-5-[2,4-dihydroxy-5-isopropylphenyl]-4-(1-methyl-1H-indol-5-yl)-3H-1,2,4-triazol-3-one|3H-1,2,4-Triazol-3-one, 5-(2,4-dihydroxy-5-(1-methylethyl)phenyl)-2,4-dihydro-4-(1- methyl-1H-indol-5-yl)-|3H-1,2,4-TRIAZOL-3-ONE, 5-(2,4-DIHYDROXY-5-(1-METHYLETHYL)PHENYL)-2,4-DIHYDRO-4-(1-METHYL-1H-INDOL-5-YL)-"
LINIFANIB,11485656,,"InChI=1S/C21H18FN5O/c1-12-5-10-16(22)18(11-12)25-21(28)24-14-8-6-13(7-9-14)15-3-2-4-17-19(15)20(23)27-26-17/h2-11H,1H3,(H3,23,26,27)(H2,24,25,28)",MPVGZUGXCQEXTM-UHFFFAOYSA-N,C21H18FN5O,375.4,1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea,"Linifanib|796967-16-3|ABT-869|1-(4-(3-amino-1H-indazol-4-yl)phenyl)-3-(2-fluoro-5-methylphenyl)urea|ABT 869|AL-39324|ABT869|N-[4-(3-amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)urea|linifanibum|RG-3635|1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methylphenyl)urea|CO93X137CW|RG3635|CHEBI:91435|DTXSID40229834|N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)urea|A-741439|N-(4-(3-Amino-1H-indazol-4-yl)phenyl)-N1-(2-fluoro-5-methylphenyl)urea|Urea, N-(4-(3-amino-1H-indazol-4-yl)phenyl)-N'-(2-fluoro-5-methylphenyl)-|RefChem:799224|DTXCID90152325|A741439|multitargeted receptor tyrosine kinase inhibitor ABT-869|681-638-2|Linifanib (ABT-869)|Linifanib (GMP)|MFCD11840918|CHEMBL223360|1-[4-(3-amino-1H-indazol-4-yl)phenyl]-3-(2-fluoro-5-methyl-phenyl)urea|Linifanib [USAN]|Linifanib [USAN:INN]|UNII-CO93X137CW|C21H18FN5O|Aminoindazole, 3|N-[4-(3-Amino-1H-indazol-4-yl)phenyl]-N'-(2-fluoro-5-methylphenyl)urea; ABT 869|Kinome_532|ABT-869,Linifanib|LINIFANIB [INN]|Linifanib (USAN/INN)|3-[4-(3-amino-1H-indazol-4-yl)phenyl]-1-(2-fluoro-5-methylphenyl)urea|LINIFANIB [WHO-DD]|Linifanib (ABT-869)?|SCHEMBL93804|MLS006010276|GTPL5657|orb1305372|SCHEMBL29375368|BDBM21079|EX-A014|cid_11485656|MPVGZUGXCQEXTM-UHFFFAOYSA-N|BCPP000446|HMS3244D06|HMS3244D10|HMS3244D14|HMS3295O19|HMS3654E03|BCP01726|HY-50751G|NSC764237|NSC800783|s1003|AKOS015919098|AL39324|BCP9000220|CCG-264767|CS-0115|NSC-764237|NSC-800783|PB34634|SDCCGSBI-0654273.P002|NCGC00250403-01|NCGC00250403-11|AC-24279|AL 39324|AS-16177|HY-50751|SMR004701346|CS-0626095|SW218116-2|D09635|Q6554172|BRD-K99749624-001-01-3|BRD-K99749624-001-07-0|1-[4-(3-azanyl-1H-indazol-4-yl)phenyl]-3-(2-fluoranyl-5-methyl-phenyl)urea"
QUIZARTINIB DIHYDROCHLORIDE,25184035,,"InChI=1S/C29H32N6O4S.2ClH/c1-29(2,3)25-17-26(33-39-25)32-27(36)30-20-6-4-19(5-7-20)22-18-35-23-9-8-21(16-24(23)40-28(35)31-22)38-15-12-34-10-13-37-14-11-34;;/h4-9,16-18H,10-15H2,1-3H3,(H2,30,32,33,36);2*1H",DHYPGRVMIOATAE-UHFFFAOYSA-N,C29H34Cl2N6O4S,633.6,"1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea;dihydrochloride","Quizartinib dihydrochloride|1132827-21-4|AC-220 dihydrochloride|vanflyta|AC010220.2HCL|WK7Q6ZIZ10|AC220 2HCL|AC010220 2HCL|AC-010220 DIHYDROCHLORIDE|DTXSID30150345|N-(5-Tert-butyl-isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-ylethoxy)imidazo(2,1-b)(1,3)benzothiazol-2-yl)phenyl)urea dihydrochloride|Urea, N-(5-(1,1-dimethylethyl)-3-isoxazolyl)-N'-(4-(7-(2-(4-morpholinyl) ethoxy)imidazo(2,1-b)benzothiazol-2-yl)phenyl)-, hydrochloride (1:2)|N-(5-(1,1-DIMETHYLETHYL)ISOXAZOL-3-YL)-N'-(4-(7-(2-(MORPHOLIN-4-YL)ETHOXY)IMIDAZO(2,1-B)BENZOTHIAZOL-2-YL)PHENYL)UREA DIHYDROCHLORIDE|N-(5-TERT-BUTYLISOXAZOL-3-YL)-N'-(4-(7-(2-(MORPHOLIN-4-YL)ETHOXY) IMIDAZO(2,1-B)(1,3)BENZOTHIAZOL-2-YL)PHENYL)UREA DI-HYDROCHLORIDE SALT|RefChem:56997|DTXCID7072836|N-(5-Tert-butyl-isoxazol-3-yl)-N'-(4-(7-(2-morpholin-4-ylethoxy)imidazo(2,1-b)(1,3)benzothiazol-2-yl)phenyl)urea Dihydrochloride|Quizartinib (dihydrochloride)|AC 010220 (dihydrochloride)|Quizartinib dihydrochloride [USAN]|Quizartinib dihydrochloride (USAN)|UNII-WK7Q6ZIZ10|Quizartinib 2HCl|1-(5-tert-butyl-1,2-oxazol-3-yl)-3-[4-[6-(2-morpholin-4-ylethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl]urea;dihydrochloride|AC 010220 dihydrochloride; AC220 dihydrochloride; AC-220 dihydrochloride; AC 220 dihydrochloride; AC 220 dihydrochloride|Vanflyta (TN)|AC220 dihydrochloride|Quizartinibdihydrochloride|SCHEMBL742377|orb1738080|CHEMBL2105709|SCHEMBL29435035|BCP24004|HY-14217|QUIZARTINIB DIHYDROCHLORIDE [WHO-DD]|D09956|E98921|Q27292691|1-(5-tert-Butyl-isoxazol-3-yl)-3-{4-[7-(2-morpholin-4-yl-ethoxy)-benzo[d]imidazo[2,1-b]thiazol-2-yl]-phenyl}-urea dihydrochloride|N-(5-(1,1-Dimethylethyl)isoxazol-3-yl)-N'-(4-(7-(2-(morpholin-4-yl)ethoxy)imidazo(2,1- b)benzothiazol-2-yl)phenyl)urea dihydrochloride|N-(5-t-butyl-isoxazol-3-yl)-N'-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl} urea dihydrochloride"
VEMURAFENIB,42611257,,"InChI=1S/C23H18ClF2N3O3S/c1-2-9-33(31,32)29-19-8-7-18(25)20(21(19)26)22(30)17-12-28-23-16(17)10-14(11-27-23)13-3-5-15(24)6-4-13/h3-8,10-12,29H,2,9H2,1H3,(H,27,28)",GPXBXXGIAQBQNI-UHFFFAOYSA-N,C23H18ClF2N3O3S,489.9,"N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide","Vemurafenib|918504-65-1|Zelboraf|PLX-4032|PLX 4032|RG7204|RG 7204|RO 5185426|RG-7204|vemurafenibum|N-(3-{[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl}-2,4-difluorophenyl)propane-1-sulfonamide|207SMY3FQT|Ro 51-85426|CHEBI:63637|RO-5185426|RO-51-85426|DTXSID50238710|1-Propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)-|1-PROPANESULFONAMIDE, N-[3-[[5-(4-CHLOROPHENYL)-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]CARBONYL]-2,4-DIFLUOROPHENYL]-|N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide|RefChem:57849|DTXCID00161201|L01XE15|BRAF(V600E) Kinase Inhibitor RO5185426|BRAF (V600E) kinase inhibitor RO5185426|1029872-54-5|N-(3-(5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)propane-1-sulfonamide|Vemurafenib (PLX4032, RG7204)|RO5185426|Vemurafenib (PLX4032)|MFCD18074504|C23H18ClF2N3O3S|N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl]propane-1-sulfonamide|NSC761431|N-(3-((5-(4-Chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl)-2,4- difluorophenyl)propane-1-sulfonamide|Vemurafenib;PLX-4032|1-Propanesulfonamide, N-(3-((5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3- yl)carbonyl)-2,4-difluorophenyl)-|N-[3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl]propane-1-sulfonamide|N-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide|Zelboraf (TN)|Vemurafenib [USAN]|Vemurafenib [USAN:INN]|UNII-207SMY3FQT|HSDB 8143|N-(3-{(5-(4-chlorophenyl)-1H-pyrrolo(2,3-b)pyridin-3-yl)carbonyl}-2,4- difluorophenyl)propane-1-sulfonamide|Vemurafenib (Standard)|3og7|VEMURAFENIB [MI]|1415041-85-8|Vemurafenib; PLX4032|VEMURAFENIB [INN]|VEMURAFENIB [JAN]|VEMURAFENIB [VANDF]|VEMURAFENIB [MART.]|Vemurafenib (PLX4032)?|VEMURAFENIB [WHO-DD]|N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-PropanesulfonaMide|SCHEMBL298931|Vemurafenib (JAN/USAN/INN)|GTPL5893|orb1298741|orb1305565|CHEMBL1229517|SCHEMBL29355460|SCHEMBL29356185|EX-A053|VEMURAFENIB [ORANGE BOOK]|GPXBXXGIAQBQNI-UHFFFAOYSA-N|HMS3265M03|HMS3265M04|HMS3265N03|HMS3265N04|HMS3654P09|HMS3748G15|HMS5079B05|BCP25783|EX-A1335|BDBM50396483|HB4285|HY-12057R|MSK165863|NSC800964|s1267|AKOS007930804|CCG-264883|CS-0216|DB08881|FV15248|ME-0096|NSC-761431|NSC-800964|PB11741|SDCCGSBI-0647659.P002|NCGC00250399-01|NCGC00250399-05|NCGC00250399-08|AC-25010|BP-44063|HY-12057|SY067868|NS00008103|SW218095-2|D09996|R-7204|AB01273970-01|AB01273970_03|EN300-23265091|Q423111|SR-01000941568|carbonyl]-2,4-difluorophenyl}propane-1-sulfonamide|SR-01000941568-1|BRD-K56343971-001-02-3|BRD-K56343971-001-05-6|BRD-K56343971-001-10-6|BRD-K56343971-001-12-2|BRD-K56343971-001-14-8|PLX4032,Vemurafenib, RG7204, RO5185426, Zelboraf|N-{3-[5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-|N-(3-(5-(4-chlorophenyl)-1H-pyrrolo[2,3-b]pyridine-3-carbonyl)-2,4-difluorophenyl)-propane-1-sulfonamide|propane-1-sulfonic acid {3-[5-(4-chloro-phenyl)-1h-pyrrolo[2,3-b]pyridine-3-carbonyl]-2,4-difluoro-phenyl}-amide|Vemurafenib;N-[3-[[5-(4-Chlorophenyl)-1H-pyrrolo[2,3-b]pyridin-3-yl]carbonyl]-2,4-difluorophenyl]-1-propanesulfonamide"
LY-3009120,71721540,,"InChI=1S/C23H29FN6O/c1-13-9-18(24)19(29-22(31)26-8-7-23(3,4)5)11-16(13)17-10-15-12-27-21(25-6)30-20(15)28-14(17)2/h9-12H,7-8H2,1-6H3,(H2,26,29,31)(H,25,27,28,30)",HHCBMISMPSAZBF-UHFFFAOYSA-N,C23H29FN6O,424.5,"1-(3,3-dimethylbutyl)-3-[2-fluoro-4-methyl-5-[7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl]phenyl]urea","1454682-72-4|LY3009120|LY-3009120|DP-4978|LY 3009120|1GDT36RARO|DP 4978|Pan-raf inhibitor ly3009120|Urea, N-(3,3-dimethylbutyl)-N'-[2-fluoro-4-methyl-5-[7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl]phenyl]-|CHEBI:167662|Urea, N-(3,3-dimethylbutyl)-N'-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido(2,3-d)pyrimidin-6-yl)phenyl)-|RefChem:154569|1-(3,3-dimethylbutyl)-3-[2-fluoro-4-methyl-5-[7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl]phenyl]urea|1-(3,3-dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl)phenyl)urea|CHEMBL3577124|N-(3,3-Dimethylbutyl)-N'-[2-fluoro-4-methyl-5-[7-methyl-2-(methylamino)pyrido[2,3-d]pyrimidin-6-yl]phenyl]urea|1-(3,3-Dimethylbutyl)-3-{2-Fluoro-4-Methyl-5-[7-Methyl-2-(Methylamino)pyrido[2,3-D]pyrimidin-6-Yl]phenyl}urea|1-(3,3-Dimethylbutyl)-3-(2-fluoro-4-methyl-5-(7-methyl-2-(methylamino)pyrido(2,3-d)pyrimidin-6-yl)phenyl)urea|UNII-1GDT36RARO|4Z5|MFCD28411374|C23H29FN6O|GTPL8943|orb1300380|SCHEMBL15241297|SCHEMBL29356086|SCHEMBL29479162|BCP23869|EX-A1638|BDBM50096279|DP4978|NSC781761|NSC801010|s7842|AKOS025396178|CCG-268937|NSC-781761|NSC-801010|SB16924|NCGC00481604-01|3-(3,3-DIMETHYLBUTYL)-1-{2-FLUORO-4-METHYL-5-[7-METHYL-2-(METHYLAMINO)PYRIDO[2,3-D]PYRIMIDIN-6-YL]PHENYL}UREA|AC-30240|AS-74984|DA-75177|FD103657|HY-12558|LY-3009120DP-4978|LY3009120?|C72761|LY-3009120P-4978|BRD-K38385169-001-03-7|BRD-K38385169-001-04-5|Q27082823"
XP-102,60152613,,"InChI=1S/C28H33F2N7O2S/c1-4-14-40(38,39)34-23-7-6-22(29)28(26(23)30)37-17-21(19-15-31-18-32-16-19)27-24(37)8-9-25(33-27)35(3)20-10-12-36(5-2)13-11-20/h6-9,15-18,20,34H,4-5,10-14H2,1-3H3",AEJACXAFHXBVHF-UHFFFAOYSA-N,C28H33F2N7O2S,569.7,"N-[3-[5-[(1-ethylpiperidin-4-yl)-methylamino]-3-pyrimidin-5-ylpyrrolo[3,2-b]pyridin-1-yl]-2,4-difluorophenyl]propane-1-sulfonamide","XP-102|BI882370|N-[3-[5-[(1-ethyl-4-piperidinyl)methylamino]-3-(5-pyrimidinyl)-1H-pyrrolo[3,2-b]pyridin-1-yl]-2,4-difluorophenyl]-1-propanesulfonamide|XP102|N-(3-(5-((1-ethylpiperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo[3,2-b]pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide|N-(3-{5-[(1-Ethylpiperidin-4-Yl)(Methyl)amino]-3-(Pyrimidin-5-Yl)-1h-Pyrrolo[3,2-B]pyridin-1-Yl}-2,4-Difluorophenyl)propane-1-Sulfonamide|N-(3-(5-((1-Ethyl-4-piperidinyl)methylamino)-3-(5-pyrimidinyl)-1H-pyrrolo(3,2-b)pyridin-1-yl)-2,4-difluorophenyl)-1-propanesulfonamide|N-(3-(5-((1-ethylpiperidin-4-yl)(methyl)amino)-3-(pyrimidin-5-yl)-1H-pyrrolo(3,2-b)pyridin-1-yl)-2,4-difluorophenyl)propane-1-sulfonamide|RefChem:202497|pan-RAF Inhibitor XP-102|1392429-79-6|BI-882370|BI 882370|N-[3-[5-[(1-ethylpiperidin-4-yl)-methylamino]-3-pyrimidin-5-ylpyrrolo[3,2-b]pyridin-1-yl]-2,4-difluorophenyl]propane-1-sulfonamide|XP 102|V32TR55QP9|CHEMBL4212692|1-Propanesulfonamide, N-(3-(5-((1-ethyl-4-piperidinyl)methylamino)-3-(5-pyrimidinyl)-1H-pyrrolo(3,2-b)pyridin-1-yl)-2,4-difluorophenyl)-|MFCD31618072|UNII-V32TR55QP9|orb1296244|C28H33F2N7O2S|SCHEMBL16253644|SCHEMBL30360551|GTPL13942|GLXC-22854|BCP20821|EX-A1514|SFC42979|BDBM50457446|AT30550|AC-35488|MS-30299|HY-107779|BI 882370?|CS-0030522|Q27455461|54J|N-[3-[5-[(1-ethyl-4-piperidyl)-methyl-amino]-3-pyrimidin-5-yl-pyrrolo[3,2-b]pyridin-1-yl]-2,4-difluoro-phenyl]propane-1-sulfonamide"
ENCORAFENIB,50922675,,"InChI=1S/C22H27ClFN7O4S/c1-12(2)31-11-16(17-6-7-25-21(28-17)26-10-13(3)27-22(32)35-4)20(29-31)15-8-14(23)9-18(19(15)24)30-36(5,33)34/h6-9,11-13,30H,10H2,1-5H3,(H,27,32)(H,25,26,28)/t13-/m0/s1",CMJCXYNUCSMDBY-ZDUSSCGKSA-N,C22H27ClFN7O4S,540.0,methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate,"Encorafenib|1269440-17-6|LGX818|LGX-818|Braftovi|LGX 818|NVP-LGX818|NVP-LGX818-NXA|NVP-LGX-818-NXA|8L7891MRB6|methyl N-[(2S)-1-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-propan-2-ylpyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate|DTXSID00155347|Methyl N-[(2S)-1-({4-[3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl}amino)propan-2-yl]carbamate|encorafenibum|methyl N-((2S)-1-((4-(3-(5-chloro-2-fluoro-3-(methanesulfonamido)phenyl)-1-propan-2-ylpyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate|methyl N-((2S)-1-((4-(3-(5-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate|RefChem:58132|DTXCID7077838|L01XE46|Carbamic acid, N-[(1S)-2-[[4-[3-[5-chloro-2-fluoro-3-[(methylsulfonyl)amino]phenyl]-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]amino]-1-methylethyl]-, methyl ester|Encorafenib (LGX818)|MFCD25976758|(S)-Methyl (1-((4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-yl)amino)propan-2-yl)carbamate|Encorafenib [USAN:INN]|UNII-8L7891MRB6|Braftovi (TN)|CARBAMIC ACID, N-((1S)-2-((4-(3-(5-CHLORO-2-FLUORO-3-((METHYLSULFONYL)AMINO)PHENYL)-1-(1-METHYLETHYL)-1H-PYRAZOL-4-YL)-2-PYRIMIDINYL)AMINO)-1-METHYLETHYL)-, METHYL ESTER|Encorafenib (Standard)|ENCORAFENIB [MI]|Encorafenib(LGX-818)|LGX-818(Encorafenib)|ENCORAFENIB [INN]|ENCORAFENIB [JAN]|ENCORAFENIB [USAN]|LGX-818(Encorafenib)?|C22H27ClFN7O4S|ENCORAFENIB [WHO-DD]|Encorafenib (JAN/USAN/INN)|GTPL7908|orb1300725|SCHEMBL8228295|CHEMBL3301612|SCHEMBL29368575|ENCORAFENIB [ORANGE BOOK]|CMJCXYNUCSMDBY-ZDUSSCGKSA-N|BDBM221688|GLXC-10822|BCP08458|EX-A1587|HY-15605R|NSC778304|NSC800093|s7108|AKOS027254498|CCG-269960|DB11718|FC65061|NSC-778304|NSC-800093|NCGC00378599-03|AC-30230|AS-35201|HY-15605|NS00072923|D11053|US9314464, 9|EN300-24699278|Q15409405|(S)-Methyl 1-(4-(3-(5-chloro-2-fluoro-3-(methylsulfonamido)phenyl)-1-isopropyl-1H-pyrazol-4-yl)pyrimidin-2-ylamino)propan-2-ylcarbamate|Encorafenib;N-[(1S)-2-[[4-[3-[5-Chloro-2-fluoro-3-[(methylsulfonyl)amino]phenyl]-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]am  ino]-1-methylethyl]-carbamic acid methyl ester|METHYL N-((2S)-1-((4-(3-(5-CHLORO-2-FLUORO-3-(METHANESULFONAMIDO)PHENYL)(-1-(PROPAN-2-YL)-1H-PYRAZOL-4-YL(PYRIMIDIN-2-YL)AMINO)PROPAN-2-YL)CARBAMATE|methyl N-[(1S)-2-[[4-[3-[5-chloro-2-fluoro-3-(methanesulfonamido)phenyl]-1-isopropyl-pyrazol-4-yl]pyrimidin-2-yl]amino]-1-methyl-ethyl]carbamate|N-[(1S)-2-[[4-[3-[5-Chloro-2-fluoro-3-[(methylsulfonyl)amino]phenyl]-1-(1-methylethyl)-1H-pyrazol-4-yl]-2-pyrimidinyl]amino]-1-methylethyl]-carbamic Acid Methyl Ester; (S)-Methyl [1-[[4-[3-[5-chloro-2-fluoro-3-(methylsulfonamido)phenyl]-1-isopropyl-1H-pyrazol-4-yl]pyrimidin-2-yl]amino]propan-2-yl]carbamate"
TOZASERTIB,5494449,,"InChI=1S/C23H28N8OS/c1-15-13-20(29-28-15)25-19-14-21(31-11-9-30(2)10-12-31)27-23(26-19)33-18-7-5-17(6-8-18)24-22(32)16-3-4-16/h5-8,13-14,16H,3-4,9-12H2,1-2H3,(H,24,32)(H2,25,26,27,28,29)",GCIKSSRWRFVXBI-UHFFFAOYSA-N,C23H28N8OS,464.6,N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide,"Tozasertib|639089-54-6|VX 680|MK 0457|234335M86K|DTXSID10213609|N-[4-({4-[(3-methyl-1H-pyrazol-5-yl)amino]-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide|Cyclopropanecarboxamide, N-(4-((4-(4-methyl-1-piperazinyl)-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)thio)phenyl)-|Cyclopropanecarboxamide, N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]-|N-(4-((4-(4-Methylpiperazin-1-yl)-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)sulfanyl)phenyl)cyclopropanecarboxamide|tozasertibum|N-(4-((4-((3-methyl-1H-pyrazol-5-yl)amino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)sulfanyl)phenyl)cyclopropanecarboxamide|N-[4-({4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide|RefChem:933220|DTXCID90136100|cyclopropane carboxylic acid N-(4-(4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-ylsulfanyl)phenyl)amide|VE-465|VX-680|MK-0457|VX680|VX-680 (MK-0457,Tozasertib)|Tozasertib (VX-680)|N-[4-[4-(4-methylpiperazin-1-yl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]sulfanylphenyl]cyclopropanecarboxamide|Tozasertib (USAN)|Tozasertib [USAN]|N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide|VX-68|MFCD13185152|MK-045|936915-58-1|CHEMBL572878|N-(4-((4-((5-methyl-1H-pyrazol-3-yl)amino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-yl)thio)phenyl)cyclopropanecarboxamide|VX6|Cyclopropanecarboxylic Acid {4-[4-(4-Methyl-Piperazin-1-Yl)-6-(5-Methyl-2h-Pyrazol-3-Ylamino)-Pyrimidin-2-Ylsulfanyl]-Phenyl}-Amide|N-[4-[[4-(4-methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]-cyclopropanecarboxamide|C23H28N8OS|(N-[4({4-(4-methylpiperazin-1-yl)-6-[(3-methyl-1H-pyrazol-5 -yl)amino]pyrimidin-2-yl}thio)phenyl]cyclopropanecarboxamide)|Tozasertib [USAN:INN]|UNII-234335M86K|VX-680 (MK-0457, Tozasertib)|Kinome_3803|2f4j|TOZASERTIB [INN]|Tozasertib (MK-0457)|TOZASERTIB [WHO-DD]|Cyclopropanecarboxylic acid N-(4-((4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-yl)sulfanyl)phenyl)amide|MLS001065920|N-(4-(4-(3-methyl-1H-pyrazol-5-ylamino)-6-(4-methylpiperazin-1-yl)pyrimidin-2-ylthio)phenyl)cyclopropanecarboxamide|SCHEMBL614528|GTPL5718|orb1305377|SCHEMBL2682989|BDBM13534|CHEBI:91336|BCPP000017|HMS2043N07|HMS2198F22|HMS3244O19|HMS3244O20|HMS3244P19|HMS3265C21|HMS3265C22|HMS3265D21|HMS3265D22|HMS3654I11|HMS3750O19|BCP01859|EX-A2179|BDBM50004205|NSC745967|NSC800955|s1048|VE 465|VX-680; Tozasertib; MK-0457|AKOS015902930|CCG-264793|CS-0007|FM28353|NSC-745967|NSC-800955|SB19302|SDCCGSBI-0654331.P001|Tozasertib (VX-680, MK-0457)|VX-680 (Tozasertib, MK-0457)|NCGC00168110-01|NCGC00168110-02|NCGC00168110-05|AS-18632|Cyclopropane carboxylic acid{4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidin-2-ylsulphanyl]-phenyl}-amide|HY-10161|SMR000486395|VX-680, MK-0457, TOZASERTIB|DB-361309|NS00116357|PA-5494449|SW212828-2|A19417|D08279|EN300-6743235|089V546|Q6605919|BRD-K59369769-001-02-1|BRD-K59369769-001-09-6|BRD-K59369769-001-12-0|BRD-K59369769-001-14-6|BRD-K59369769-001-20-3|BRD-K59369769-001-23-7|BRD-K87947369-001-01-6|cyclopropane carboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2h-pyrazol-3-ylamino)-pyrimidin-2-ylsulphanyl]-phenyl}-amide|cyclopropane carboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)-pyrimidin-2ylsulphanyl]-phenyl}-amide|cyclopropane carboxylic acid(4-(4-(4-methylpiperazin-1-yl)-6-(5-methyl-2H-pyrazol-3-ylamino)pyrimidin-2-ylsulfanyl)phenyl)amide|Cyclopropanecarboxylic acid {4-[4-(4-methyl-piperazin-1-yl)-6-(5-methyl-1H-pyrazol-3-ylamino)-pyrimidin-2-ylsulfanyl]-phenyl}-amide|N-[4-({4-(4-methylpiperazin-1-yl)-6-[(3-methyl-1H-pyrazol-5-yl)amino]pyrimidin-2-yl}sulfanyl)phenyl]cyclopropanecarboxamide|N-[4-[[4-(4-methylpiperazino)-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]thio]phenyl]cyclopropanecarboxamide|Tozasertib;N-[4-[[4-(4-Methyl-1-piperazinyl)-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]thio]phenyl]cyclopropanecarboxamide;M  K 0457"
ALISERTIB,24771867,,"InChI=1S/C27H20ClFN4O4/c1-36-21-5-3-4-20(29)23(21)25-19-10-15(28)6-8-17(19)24-14(12-30-25)13-31-27(33-24)32-16-7-9-18(26(34)35)22(11-16)37-2/h3-11,13H,12H2,1-2H3,(H,34,35)(H,31,32,33)",ZLHFILGSQDJULK-UHFFFAOYSA-N,C27H20ClFN4O4,518.9,"4-[[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid","Alisertib|1028486-01-2|MLN8237|MLN-8237|MLN 8237|4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxybenzoic acid|T66ES73M18|DTXSID30145539|Benzoic acid, 4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-2-methoxy-|4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid|alisertibum|4-((9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-2-methoxybenzoic acid|RefChem:553984|DTXCID4068030|Aurora A Kinase Inhibitor MLN8237|4-((13-chloro-10-(2-fluoro-6-methoxyphenyl)-3,5,9-triazatricyclo(9.4.0.0^(2,7))pentadeca-1(15),2,4,6,9,11,13-heptaen-4-yl)amino)-2-methoxybenzoic acid|4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid|MLN8237 (Alisertib)|MFCD16621243|Alisertib [USAN]|CHEMBL483158|Alisertib (USAN)|MLN 8237 (Contain 10% DMSO)|4-((9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido-[4,5-e]azepin-2-yl)amino)-2-methoxybenzoic acid|Alisertib [USAN:INN]|C27H20ClFN4O4|UNII-T66ES73M18|4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl]amino]-2-methoxybenzoic Acid|MLN8237,Alisertib|Kinome_3770|ALISERTIB [INN]|Alisertib; MLN8237|Alisertib (MLN8237)|ALISERTIB [WHO-DD]|MLN8237 (Alisertib)?|MLS006011041|SCHEMBL855823|GTPL7790|orb1305944|SCHEMBL29354333|SCHEMBL29437869|SCHEMBL29720486|SCHEMBL29750414|EX-A024|CHEBI:125628|ZLHFILGSQDJULK-UHFFFAOYSA-N|HMS3654E08|HMS3673I07|HMS3743E17|BCP01823|BDBM50277545|NSC759677|NSC799329|s1133|AKOS015924647|BCP9000956|CCG-264832|CS-0106|DB05220|FM16476|NSC-759677|NSC-799329|SB16658|SDCCGSBI-0646927.P001|NCGC00263271-01|NCGC00263271-02|NCGC00263271-10|4-(9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino)-2-methoxybenzoic acid|AC-25236|AS-17005|HY-10971|SMR004702834|SY389241|NS00072479|SW219771-1|D10085|EN300-6482023|BRD-K75295174-001-03-5|BRD-K75295174-001-05-0|Q15633917|Z2037281068|4-(9-chloro-7-(2-fluoro-6-methoxyphenyl)-5H-benzo[e]pyrimido[5,4-c]azepin-2-ylamino)-2-methoxybenzoic acid|4-[[9-chloro-7-(2-fluoro-6-methoxy-phenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxy-benzoic acid|4-[[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]-2-methoxy-benzoic acid;Alisertib|4-{[13-chloro-10-(2-fluoro-6-methoxyphenyl)-3,5,9-triazatricyclo[9.4.0.0,2,7]pentadeca-1(11),2(7),3,5,9,12,14-heptaen-4-yl]amino}-2-methoxybenzoic acid|4-{[9-chloro-7-(2-fluoro-6-methoxyphenyl) -5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxybenzoic acid|4-{[9-Chloro-7-(2-fluoro-6-methoxyphenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}-2-methoxy-benzoic acid|A5B"
MLN-8054,11712649,,"InChI=1S/C25H15ClF2N4O2/c26-15-6-9-17-18(10-15)23(21-19(27)2-1-3-20(21)28)29-11-14-12-30-25(32-22(14)17)31-16-7-4-13(5-8-16)24(33)34/h1-10,12H,11H2,(H,33,34)(H,30,31,32)",HHFBDROWDBDFBR-UHFFFAOYSA-N,C25H15ClF2N4O2,476.9,"4-[[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid","MLN8054|869363-13-3|MLN-8054|MLN 8054|BX854EHD63|DTXSID10235987|Benzoic acid, 4-((9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)-|4-{[13-chloro-10-(2,6-difluorophenyl)-3,5,9-triazatricyclo[9.4.0.0^{2,7}]pentadeca-1(15),2(7),3,5,9,11,13-heptaen-4-yl]amino}benzoic acid|4-((13-chloro-10-(2,6-difluorophenyl)-3,5,9-triazatricyclo(9.4.0.0^(2,7))pentadeca-1(15),2(7),3,5,9,11,13-heptaen-4-yl)amino)benzoic acid|RefChem:819035|DTXCID40158478|Aurora Kinase Inhibitor MLN8054|4-((13-chloro-10-(2,6-difluorophenyl)-3,5,9-triazatricyclo(9.4.0.02,?)pentadeca-1(11),2,4,6,9,12,14-heptaen-4-yl)amino)benzoic acid|4-[[9-Chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid|4-((9-chloro-7-(2,6-difluorophenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)benzoic acid|4-(9-chloro-7-(2,6-difluorophenyl)-5H-benzo[e]pyrimido[5,4-c]azepin-2-ylamino)benzoic acid|CHEMBL259084|1203588-98-0|4-{[9-chloro-7-(2,6-difluorophenyl)-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino}benzoic acid|4-((9-chloro-7-(2,6-difluorophenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-yl)amino)benzoic acid.|4-{[13-chloro-10-(2,6-difluorophenyl)-3,5,9-triazatricyclo[9.4.0.0(2),?]pentadeca-1(15),2(7),3,5,9,11,13-heptaen-4-yl]amino}benzoic acid|ZZL|UNII-BX854EHD63|C25H15ClF2N4O2|4-((9-chloro-7-(2,6-difluorophenyl)-5h-pyrimido(5,4-d)(2)benzazepin-2-yl)amino)benzoic acid|Kinome_1204|MLS006011043|SCHEMBL621589|GTPL5696|orb1300877|SCHEMBL29372555|SCHEMBL29720492|BDBM31093|CHEBI:91366|cid_11712649|MLN 8054 [WHO-DD]|HMS3265K23|HMS3265K24|HMS3265L23|HMS3265L24|HMS3654C21|BCP02261|MLN8054?|NSC800799|s1100|AKOS022177375|CCG-269512|CS-0010|DB13061|FM26029|NSC-800799|SB19104|SDCCGSBI-0654442.P001|NCGC00346488-01|NCGC00346488-06|AS-74414|HY-10180|SMR004700647|NS00071591|SW219643-1|363C133|US8853193, 32-40|BRD-K83963101-001-01-0|BRD-K83963101-001-06-9|Q27087283|Z2037281111|4-(9-Chloro-7-(2,6-difluorophenyl)-5H-benzo[c]pyrimido[4,5-e]azepin-2-ylamino)benzoic acid|4-[[7-[2,6-bis(fluoranyl)phenyl]-9-chloranyl-5H-pyrimido[5,4-d][2]benzazepin-2-yl]amino]benzoic acid"
DANUSERTIB,11442891,,"InChI=1S/C26H30N6O3/c1-30-12-14-31(15-13-30)20-10-8-19(9-11-20)25(33)27-24-21-16-32(17-22(21)28-29-24)26(34)23(35-2)18-6-4-3-5-7-18/h3-11,23H,12-17H2,1-2H3,(H2,27,28,29,33)/t23-/m1/s1",XKFTZKGMDDZMJI-HSZRJFAPSA-N,C26H30N6O3,474.6,"N-[5-[(2R)-2-methoxy-2-phenylacetyl]-4,6-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide","Danusertib|827318-97-8|PHA-739358|PHA 739358|PHA739358|M3X659D0FY|N-(5-((2R)-2-methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo(3,4-c)pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide|danusertibum|N-(5-((2R)-2-methoxy-2-phenylacetyl)-1H,4H,5H,6H-pyrrolo(3,4-c)pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide|N-(5-((2R)-2-methoxy-2-phenylacetyl)-4,6-dihydro-1H-pyrrolo(3,4-d)pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide|N-[5-[(2R)-2-methoxy-2-phenylacetyl]-4,6-dihydro-1H-pyrrolo[3,4-d]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide|N-{5-[(2R)-2-methoxy-2-phenylacetyl]-1H,4H,5H,6H-pyrrolo[3,4-c]pyrazol-3-yl}-4-(4-methylpiperazin-1-yl)benzamide|RefChem:919641|Benzamide, 4-(4-methyl-1-piperazinyl)-N-(1,4,5,6-tetrahydro-5-((2R)-methoxyphenylacetyl)pyrrolo(3,4-c)pyrazol-3-yl)-|Danusertib (PHA-739358)|(R)-N-(5-(2-methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide|Danusertib [INN]|MFCD12024692|CHEMBL402548|PHA-739358 (danusertib)|N-[5-((2R)-2-Methoxy-2-phenylethanoyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide|MMV676600|N-[5-[(2R)-2-methoxy-2-phenylacetyl]-4,6-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide|Danusertib, PHA-739358|(R)-N-(5-(2-Methoxy-2-phenylacetyl)-1,4,5,6-tetrahydropyrrolo-[3,4-c]pyrazol-3-yl)-4-(4-methylpiperazin-1-yl)benzamide|5-Amido-pyrrolopyrazole 9d|UNII-M3X659D0FY|4-(4-Methyl-1-piperazinyl)-N-[1,4,5,6-tetrahydro-5-[(2R)-2-methoxy-2-phenylacetyl]pyrrolo[3,4-c]pyrazol-3-yl]benzamide; PHA 739358|N-{5-[(2R)-2-methoxy-2-phenylethanoyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl}-4-(4-methylpiperazin-1-yl)benzamide|DANUSERTIB [WHO-DD]|PHA-739358,Danusertib|MLS006011243|Danusertib; PHA-739358|SCHEMBL466509|GTPL7937|orb1306498|BDBM12985|CHEBI:94490|2j50|XKFTZKGMDDZMJI-HSZRJFAPSA-N|BCPP000266|DTXSID301002864|GLXC-03445|916995-51-2|BCP01750|EX-A1599|NSC784415|NSC800086|AKOS015896691|AKOS015995140|AC-8443|BCP9000582|CCG-264823|CS-0152|DB11778|FD20793|NSC-784415|NSC-800086|SDCCGSBI-0654340.P001|NCGC00263203-01|NCGC00263203-02|NCGC00263203-08|NCGC00263203-09|AS-16243|HY-10179|N-[5-[(2R)-2-methoxy-2-phenyl-acetyl]-4,6-dihydro-1H-pyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide|SMR004700684|NS00070348|S1107|SW219462-1|A11611|995M512|SR-05000022541|SR-05000022541-1|BRD-K07881437-001-01-2|BRD-K07881437-001-03-8|BRD-K07881437-001-04-6|Q27076981|4-(4-Methyl-1-piperazinyl)-N-[1,4,5,6-tetrahydro-5-[(2R)-2-methoxy-2-phenylacetyl]pyrrolo[3,4-c]pyrazol-3-yl]benzamide;PHA 739358|Benzamide, 4-(4-methyl-1-piperazinyl)-N-(1,4,5,6-tetrahydro-5-((2R)-     methoxyphenylacetyl)pyrrolo(3,4-c)pyrazol-3-yl)-|N-[5-((2R)-2-Methoxy-2-phenylethanoyl)-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl]-4-(4-methylpiperazin-1-yl)benzamide, 95%|N-{5-[Methoxy(phenyl)acetyl]-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazol-3-yl}-4-(4-methylpiperazin-1-yl)benzene-1-carboximidic acid"
ABT 737,11228183,,"InChI=1S/C42H45ClN6O5S2/c1-46(2)23-22-35(30-55-37-9-4-3-5-10-37)44-40-21-20-38(28-41(40)49(51)52)56(53,54)45-42(50)32-14-18-36(19-15-32)48-26-24-47(25-27-48)29-33-8-6-7-11-39(33)31-12-16-34(43)17-13-31/h3-21,28,35,44H,22-27,29-30H2,1-2H3,(H,45,50)/t35-/m1/s1",HPLNQCPCUACXLM-PGUFJCEWSA-N,C42H45ClN6O5S2,813.4,4-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide,"ABT-737|852808-04-9|ABT737|Z5NFR173NV|4-[4-[(4'-Chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]benzamide|DTXSID7042641|CHEBI:47575|BENZAMIDE, 4-(4-((4'-CHLORO(1,1'-BIPHENYL)-2-YL)METHYL)-1-PIPERAZINYL)-N-((4-(((1R)-3-(DIMETHYLAMINO)-1-((PHENYLTHIO)METHYL)PROPYL)AMINO)-3-NITROPHENYL)SULFONYL)-|4-(4-((2-(4-chlorophenyl)phenyl)methyl)piperazin-1-yl)-N-(4-(((2R)-4-dimethylamino-1-phenylsulfanylbutan-2-yl)amino)-3-nitrophenyl)sulfonylbenzamide|4-(4-((4'-Chloro(1,1'-biphenyl)-2-yl)methyl)-1-piperazinyl)-N-((4-(((1R)-3-(dimethylamino)-1-((phenylthio)methyl)propyl)amino)-3-nitrophenyl)sulfonyl)benzamide|4-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-dimethylamino-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide|RefChem:912152|DTXCID5022641|ABT 737|MFCD12756212|(R)-4-(4-((4'-chloro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((4-((4-(dimethylamino)-1-(phenylthio)butan-2-yl)amino)-3-nitrophenyl)sulfonyl)benzamide|UNII-Z5NFR173NV|CHEMBL376408|C42H45ClN6O5S2|4-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-(dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl]sulfonylbenzamide|4-{4-[(4'-chlorobiphenyl-2-yl)methyl]piperazin-1-yl}-N-{[4-({(1R)-3-(dimethylamino)-1-[(phenylsulfanyl)methyl]propyl}amino)-3-nitrophenyl]sulfonyl}benzamide|4-{4-[(4'-Chlorobiphenyl-2-Yl)methyl]piperazin-1-Yl}-N-{[4-({(1r)-3-(Dimethylamino)-1-[(Phenylthio)methyl]propyl}amino)-3-Nitrophenyl]sulfonyl}benzamide|2yxj|N3C|SCHEMBL158942|GTPL8320|ABT 737 [WHO-DD]|N-Benylpiperazine derivative, 2|SCHEMBL29355185|BDBM21447|EX-A056|HPLNQCPCUACXLM-PGUFJCEWSA-N|GLXC-04997|HMS6018M09|ABT-737?|NSC758873|s1002|compound 2 [PMID 17256834]|AKOS016003299|CCG-264769|CS-0014|FA16902|NSC-758873|NCGC00253562-01|NCGC00253562-02|NCGC00253562-03|NCGC00253562-12|4-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]-N-[4-[[(1R)-3-(dimethylamino)-1-(phenylsulfanylmethyl)propyl]amino]-3-nitro-phenyl]sulfonyl-benzamide|BP-25381|HY-50907|SY077762|SW218108-2|808A049|BRD-K56301217-001-01-7|BRD-K56301217-001-07-4|BRD-K56301217-001-10-8|Q25105040|(R)-4-[4-[(4'-Chloro-2-biphenylyl)methyl]-1-piperazinyl]-N-[[4-[[4-(dimethylamino)-1-(phenylthio)-2-butyl]amino]-3-nitrophenyl]sulfonyl]benzamide|4-(4-((4'-chloro-1,1'-biphenyl-2-yl)methyl)-1-piperazinyl)-N-((4-(((1R)-3-(dimethylamino)-1-((phenylsulfanyl)methyl)propyl)amino)-3-nitrophenyl)sulfony)benzamide|4-(4-{[2-(4-chlorophenyl)phenyl]methyl}piperazin-1-yl)-N-[(4-{[(2R)-4-(dimethylamino)-1-(phenylsulfanyl)butan-2-yl]amino}-3-nitrobenzene)sulfonyl]benzamide|4-[4-[(4'-Chloro[1,1'-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nit  rophenyl]sulfonyl]benzamide|4-[4-[(4O-chloro[1,1O-biphenyl]-2-yl)methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(dimethylamino)-1-[(phenylthio)methyl]propyl]amino]-3-nitrophenyl]sulfonyl]-Benzamide|4-[4-[[2-(4-chlorophenyl)phenyl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4- (dimethylamino)-1-phenylsulfanylbutan-2-yl]amino]-3-nitrophenyl] sulfonylbenzamide|4-{4-[(4'-chloro[1,1'-biphenyl]-2-yl)methyl]piperazin-1-yl}-N-(4-{[(2R)-4-(dimethylamino)-1-(phenylsulfanyl)butan-2-yl]amino}-3-nitrobenzene-1-sulfonyl)benzamide|4-{4-[(4'-chloro[biphenyl]-2-yl)methyl]piperazin-1-yl}-N-[(4-{[(2R)-4-(dimethylamino)-1-(phenylsulfanyl)butan-2-yl]amino}-3-nitrophenyl)sulfonyl]benzamide"
GSK-1070916,46885626,,"InChI=1S/C30H33N7O/c1-6-37-19-26(28(34-37)21-10-12-23(13-11-21)32-30(38)36(4)5)24-14-15-31-29-25(24)17-27(33-29)22-9-7-8-20(16-22)18-35(2)3/h7-17,19H,6,18H2,1-5H3,(H,31,33)(H,32,38)",QTBWCSQGBMPECM-UHFFFAOYSA-N,C30H33N7O,507.6,"3-[4-[4-[2-[3-[(dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethylpyrazol-3-yl]phenyl]-1,1-dimethylurea","GSK1070916|GSK-1070916|GSK 1070916|3-(4-(4-(2-(3-((dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea|8VLB51V7HO|GSK 1070916A|3-[4-[4-[2-[3-[(dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethylpyrazol-3-yl]phenyl]-1,1-dimethylurea|3-(4-(4-(2-(3-((DIMETHYLAMINO)METHYL)PHENYL)-1H-PYRROLO(2,3-B)PYRIDIN-4-YL)-1-ETHYL-1H-PYRAZOL-3-YL)PHENYL)-1,1-DIMETHYLUREA|3-(4-(4-(2-(3-((dimethylamino)methyl)phenyl)-1H-pyrrolo(2,3-b)pyridin-4-yl)-1-ethylpyrazol-3-yl)phenyl)-1,1-dimethylurea|RefChem:922529|942918-07-2|GSK-1070916A|MFCD22420815|CHEMBL1090479|N'-[4-[4-[2-[3-[(Dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-1H-pyrazol-3-yl]phenyl]-N,N-dimethylurea|3-(4-(4-(2-(3-((dimethylamino)methyl)phenyl)-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl)phenyl)-1,1-dimethylurea.|UNII-8VLB51V7HO|NMI-900|N'-{4-[4-(2-{3-[(dimethylamino)methyl]phenyl}-1H-pyrrolo[2,3-b]pyridin-4-yl)-1-ethyl-1H-pyrazol-3-yl]phenyl}-N,N-dimethylurea|compound 17k [PMID 20420387]|GTPL8358|orb1688748|SCHEMBL4305006|SCHEMBL29551759|C30H33N7O|CHEBI:91362|DTXSID70241403|EX-A021|QTBWCSQGBMPECM-UHFFFAOYSA-N|HMS3265K13|HMS3265K14|HMS3265L13|HMS3265L14|HMS3750K05|BCP02610|GSK1070916A|BDBM50315769|NSC777445|NSC800108|s2740|AKOS005145558|BCP9000733|CCG-269759|CS-0008|NSC-777445|NSC-800108|SB14574|SDCCGSBI-0654453.P001|GSK1070916?|NCGC00346648-01|NCGC00346648-07|NCGC00346648-10|3-[4-[4-[2-[3-[(dimethylamino)methyl]phenyl]-1H-pyrrolo[2,3-b]pyridin-4-yl]-1-ethyl-pyrazol-3-yl]phenyl]-1,1-dimethyl-urea|AC-32837|AS-17024|FD153251|HY-70044|DB-079843|F17366|BRD-K36740062-001-01-7|BRD-K36740062-001-06-6|Q27077863|4-[3-(4-N,N-Dimethylcarbamylaminophenyl)-1-ethyl-1H-pyrazol-4-yl]-2-[3-(dimethylaminomethyl)phenyl]-1H-pyrrolo[2,3-b]-pyridine|N'-{4-[4-(2-{3-[(dimethylamino)methyl]phenyl}-1H-pyrrolo[2,3-b]pyridin-4-yl) 1-ethyl-1H-pyrazol-3-yl]phenyl}-N,N-dimethylurea|UREA, N'-(4-(4-(2-(3-((DIMETHYLAMINO)METHYL)PHENYL)-1H-PYRROLO(2,3-B)PYRIDIN-4-YL)-1-ETHYL-1H-PYRAZOL-3-YL)PHENYL)-N,N-DIMETHYL-"
RO-3201195,5327067,,"InChI=1S/C19H18FN3O4/c20-13-4-6-14(7-5-13)23-19(21)17(9-22-23)18(26)12-2-1-3-16(8-12)27-11-15(25)10-24/h1-9,15,24-25H,10-11,21H2/t15-/m0/s1",IJDQETGUEUJVTB-HNNXBMFYSA-N,C19H18FN3O4,371.4,"[5-amino-1-(4-fluorophenyl)pyrazol-4-yl]-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]methanone","Ro-3201195|RefChem:403759|GlyTouCan:G03554KP|G03554KP|RO 3201195|RO3201195|249936-55-8|[5-AMINO-1-(4-FLUOROPHENYL)-1H-PYRAZOL-4-YL](3-{[(2R)-2,3-DIHYDROXYPROPYL]OXY}PHENYL)METHANONE|CHEMBL203567|CHEBI:45116|(S)-(5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl)(3-(2,3-dihydroxypropoxy)phenyl)methanone|R-03201195|Ro 320-1195|[5-amino-1-(4-fluorophenyl)pyrazol-4-yl]-[3-[(2S)-2,3-dihydroxypropoxy]phenyl]methanone|2gfs|[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl](3-{[(2S)-2,3-dihydroxypropyl]oxy}phenyl)methanone|PQB|aminopyrazole 63|orb1699566|SCHEMBL4108597|SCHEMBL29437792|BDBM15754|IJDQETGUEUJVTB-HNNXBMFYSA-N|GLXC-25206|NSC767324|AKOS040749263|DB08424|NSC-767324|Ro-320-1195|NS00070983|Q27097631|5-amino-1-(4-fluorophenyl)-4-[3-{2(S),3-dihydroxypropoxy}benzoyl]pyrazole|(2S)-3-(3-{[5-amino-1-(4-fluorophenyl)-1H-pyrazol-4-yl]carbonyl}phenoxy)propane-1,2-diol|5-Amino-1-(4-fluorophenyl)-4-[3-{2(S), 3-dihydroxypropoxy}benzoyl]pyrazole|5-amino-1-(4-fluorophenyl)-4-[3-{2(S),3-dihydroxypropoxy} benzoyl]pyrazole|5-amino-1-(4-fluorophenyl)-4-[3-{2(S),3-dihydroxypropoxyl}benzoyl]pyrazole|S-[5-amino-1-(4-fluorophenyl)-1h-pyrazol-4-yl]-[3-(2,3-dihydroxypropoxy)-phenyl]methanone"
URSOLIC ACID,64945,,"InChI=1S/C30H48O3/c1-18-10-15-30(25(32)33)17-16-28(6)20(24(30)19(18)2)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h8,18-19,21-24,31H,9-17H2,1-7H3,(H,32,33)/t18-,19+,21+,22-,23+,24+,27+,28-,29-,30+/m1/s1",WCGUUGGRBIKTOS-GPOJBZKASA-N,C30H48O3,456.7,"(1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid","Ursolic acid|Prunol|Malol|77-52-1|Urson|(+)-Ursolic acid|Micromerol|CHEBI:9908|NSC-167406|NSC-4060|P3M2575F3F|(1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylic acid|Urs-12-en-28-oic acid, 3beta-hydroxy-|DTXSID70883221|3beta-ursolic acid|3alpha-ursolic acid|ursolic acid monosodium salt|(3 beta)-3-hydroxyurs-12-en-28-oic acid|Oleanolate, Sodium|3 Epiursolic Acid|3beta Ursolic Acid|3alpha Ursolic Acid|3 Epi Ursolic Acid|RefChem:6341|DTXCID201022770|201-034-0|3beta-Hydroxyurs-12-en-28-oic acid|(3beta)-3-Hydroxyurs-12-en-28-oic acid|MFCD00009621|3beta-Hydroxy-12-ursen-28-ic acid|ursolic-acid|CHEMBL169|Uosolic acid|NSC4060|.beta.-Ursolic acid|NSC 4060|NSC 167406|Bungeolic acid|Ursolicacid|Prunol;Urson;Malol|Urs-12-en-28-oic acid, 3-hydroxy-, (3beta)-|SMR000445681|CCRIS 7123|SR-01000779684|EINECS 201-034-0|Urs-12-en-28-oic acid, 3-hydroxy-, (3.beta.)-|TNP00103|UNII-P3M2575F3F|AI3-03109|HSDB 7685|6Q5|3beta-hydroxy-Urs-12-en-28-oic acid|Ursolic acid - 90%|Ursolic acid - 98%|3B-HYDROXYURS-12-EN-28-OIC ACID|Ursolic acid (Standard)|Prestwick3_000089|Ursolic acid, >=90%|URSOLIC ACID [MI]|URSOLIC ACID [HSDB]|SCHEMBL70205|BSPBio_000018|MLS000728569|MLS002154196|MLS002207073|URSOLIC ACID [USP-RS]|URSOLIC ACID [WHO-DD]|BPBio1_000020|HY-N0140R|Ursolic acid, analytical standard|3beta-Hydroxyurs-12-en-28-oate|HMS2095A20|HMS2231P19|3beta-hydroxy-Urs-12-en-28-oate|HY-N0140|3-b-Hydroxy-12-ursen-28-ic acid|BDBM50148911|MSK001599|3beta-Hydroxy-12-ursen-28-oic Acid|AKOS005228010|AKOS016023773|3.beta.-hydroxy-Urs-12-en-28-oate|CCG-208282|CS-3799|DB15588|FU06091|FU76726|LMPR0106180007|(3beta)-3-Hydroxyurs-12-en-28-oate|NCGC00017223-06|(3beta)-3-hydroxy-Urs-12-en-28-oate|AS-35119|ST056289|SY036316|3.beta.-hydroxy-Urs-12-en-28-oic acid|(3beta)-3-hydroxy-Urs-12-en-28-oic acid|AB00513802|NS00006443|U0065|C08988|009U621|Q416260|SR-01000779684-4|SR-01000779684-5|(3.BETA.)-3-HYDROXYURS-12-EN-28-OIC ACID|BRD-K68185022-001-02-3|BRD-K68185022-001-12-2|BRD-K68185022-001-14-8|Ursolic acid, primary pharmaceutical reference standard|AF479D19-631E-48F1-8ABA-FB2A806046FA|URSOLIC ACID (CONSTITUENT OF HOLY BASIL LEAF) [DSC]|(3beta,5beta,18alpha,20beta)-3-hydroxyurs-12-en-28-oic acid|Ursolic acid, European Pharmacopoeia (EP) Reference Standard|Ursolic acidMalol; Urson; 3beta-Hydroxyurs-12-en-28-oic acid|Ursolic acid, United States Pharmacopeia (USP) Reference Standard|(1S,2R,4aS,6aR,6aS,6bR,8aR,10S,12aR,14bS)-10-hydroxy-1,2,6a,6b,9,9,12a-heptamethyl-2,3,4,5,6,6a,7,8,8a,10,11,12,13,14b-tetradecahydro-1H-picene-4a-carboxylicacid|(2S,5S,9S,10S,18S,1R,8R,14R,15R,20R)-18-hydroxy-1,2,8,9,15,19,19-heptamethylpe ntacyclo[12.8.0.0<2,11>.0<5,10>.0<15,20>]docos-11-ene-5-carboxylic acid"
APRATASTAT,11452716,,"InChI=1S/C17H22N2O6S2/c1-17(2)15(16(21)18-22)19(9-12-26-17)27(23,24)14-7-5-13(6-8-14)25-11-4-3-10-20/h5-8,15,20,22H,9-12H2,1-2H3,(H,18,21)/t15-/m0/s1",MAVDNGWEBZTACC-HNNXBMFYSA-N,C17H22N2O6S2,414.5,"(3S)-N-hydroxy-4-[4-(4-hydroxybut-2-ynoxy)phenyl]sulfonyl-2,2-dimethylthiomorpholine-3-carboxamide","Apratastat|287405-51-0|TMI-005|TMI-05|C6BZ5263BJ|DTXSID10870312|4-((4-(2-butynyloxy)phenyl)sulfonyl)-N-hydroxy-2,2-dimethyl-(3S)thiomorpholinecarboxamide|(3S)-N-hydroxy-4-[4-(4-hydroxybut-2-ynoxy)phenyl]sulfonyl-2,2-dimethylthiomorpholine-3-carboxamide|apratastatum|(3S)-N-hydroxy-4-(4-(4-hydroxybut-2-ynoxy)phenyl)sulfonyl-2,2-dimethylthiomorpholine-3-carboxamide|RefChem:558431|DTXCID001511187|(3S)-N-hydroxy-4-(4-((4-hydroxybut-2-yn-1-yl)oxy)benzenesulfonyl)-2,2-dimethylthiomorpholine-3-carboxamide|TMI 005|CHEMBL206815|(3S)-N-Hydroxy-4-((4-((4-hydroxybut-2-ynyl)oxy)phenyl)sulfonyl)-2,2-dimethylthiomorpholine-3-carboxamide|Apratastat [USAN]|Apratastat [USAN:INN]|UNII-C6BZ5263BJ|(3S)-N-Hydroxy-4-[[4-[(4-hydroxybut-2-ynyl)oxy]phenyl]sulfonyl]-2,2-dimethylthiomorpholine-3-carboxamide|APRATASTAT [INN]|Apratastat (USAN/INN)|MLS006010301|GTPL6482|orb1707645|SCHEMBL2834310|TMI005|Apratastat, >=98% (HPLC)|C17H22N2O6S2|CHEBI:177520|BCPP000041|MLA40551|BDBM50181008|MFCD13152357|AKOS040741161|DB13020|compound 5h [PMID: 16426848]|DA-50651|MS-27179|SMR004701369|HY-119307|CS-0066985|NS00071827|D08859|E98872|BRD-K06883221-001-01-9|Q27074484|(3S)-4-[4-(4-hydroxybut-2-ynoxy)phenyl]sulfonyl-2,2-dimethyl-thiomorpholine-3-carbohydroxamic acid|(3S)-N-hydroxy-4-[4-(4-hydroxybut-2-ynoxy)phenyl]sulonyl-2,2-dimethylthiomorpholine-3-carboxamide|(S)-4-[4-(4-Hydroxy-but-2-ynyloxy)-benzenesulfonyl]-2,2-dimethyl-thiomorpholine-3-carboxylic acid hydroxyamide|(S)-N-hydroxy-4-(4-(4-hydroxybut-2-ynyloxy)phenylsulfonyl)-2,2-dimethylthiomorpholine-3-carboxamide|3-THIOMORPHOLINECARBOXAMIDE, N-HYDROXY-4-((4-((4-HYDROXY-2-BUTYNYL)OXY)PHENYL)SULFONYL)-2,2-DIMETHYL, (3S)-"
DEVAZEPIDE,443375,,"InChI=1S/C25H20N4O2/c1-29-21-14-8-6-12-18(21)22(16-9-3-2-4-10-16)27-23(25(29)31)28-24(30)20-15-17-11-5-7-13-19(17)26-20/h2-15,23,26H,1H3,(H,28,30)/t23-/m1/s1",NFHRQQKPEBFUJK-HSZRJFAPSA-N,C25H20N4O2,408.5,"N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide","DEVAZEPIDE|103420-77-5|MK-329|Devazepida|Devazepidum|MK 329|L-364,718|(S)-N-(2,3-Dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)indole-2-carboxamide|JE6P7QY7NH|L 364718|CHEBI:4460|DTXSID2046092|L-364718|BRN 5156082|L 364,718|3(S)-(-)-1,3-Dihydro-3-(2-indolecarbonylamino)-1-methyl-5-phenyl-2H-(1,4)benzodiazepin-2-one|DTXCID0026092|1H-Indole-2-carboxamide, N-(2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl)-, (S)-|N-[(3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide|MK329|N-((3S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-3-yl)-1H-indole-2-carboxamide|RefChem:388921|L364,718|683-026-0|N-(1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl)-1H-indole-2-carboxamide|CHEMBL9506|MFCD00864500|N-[(3S)-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepin-3-yl]-1H-indole-2-carboxamide|NCGC00159551-01|CAS-103420-77-5|Devazepide [USAN:INN]|Devazepidum [INN-Latin]|UNII-JE6P7QY7NH|Devazepida [INN-Spanish]|Devacade|Devazepide (Standard)|DEVAZEPIDE [INN]|Devazepide (USAN/INN)|DEVAZEPIDE [USAN]|CCK antagonist synthetic 17|CCK antagonist synthetic 18|SCHEMBL148766|orb1707386|SCHEMBL29406251|SCHEMBL31616311|NFHRQQKPEBFUJK-HSZRJFAPSA-N|GLXC-22907|HMS3268J20|1H-Indole-2-carboxamide, N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-;1H-Indole-2-carboxamide, N-[(3S)-2,3-dihydro-1-methyl-2-oxo-5-phenyl-1H-1,4-benzodiazepin-3-yl]-|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide|DEA42077|Tox21_111744|BDBM50005463|NSC778303|PDSP1_000936|PDSP2_000922|AKOS024457038|Devazepide, >=98% (HPLC), powder|Tox21_111744_1|HY-106301R|NSC-778303|NCGC00159551-02|(S)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-1H-indole-2-carboxamide|MS-27018|HY-106301|CS-0025544|NS00123725|D02693|G12673|Q5266620|BRD-K31238592-001-01-6|(R)-1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide: 0.1C4H10O|(S)-1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide|(Z)-N-(1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-1H-indole-2-carboxamide|1H-Indole-2-carboxylic acid ((S)-1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide (L-364,718 ((S)-devazepide)|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide (MK-329, L-364,718)|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(Devazepide or (R) L364718)|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(devazepide)|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide(L-364718)|1H-Indole-2-carboxylic acid (1-methyl-2-oxo-5-phenyl-2,3-dihydro-1H-benzo[e][1,4]diazepin-3-yl)-amide: 0.1C4H10O. 0.15CH2Cl2"
BRIVANIB,11234052,,"InChI=1S/C19H19FN4O3/c1-10-6-13-14(23-10)4-5-15(17(13)20)27-19-18-12(3)16(26-8-11(2)25)7-24(18)22-9-21-19/h4-7,9,11,23,25H,8H2,1-3H3/t11-/m1/s1",WCWUXEGQKLTGDX-LLVKDONJSA-N,C19H19FN4O3,370.4,"(2R)-1-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypropan-2-ol","Brivanib|649735-46-6|BMS-540215|BMS 540215|BMS540215|DDU33B674I|CHEBI:167686|DTXSID60215294|(2R)-1-({4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl}oxy)propan-2-ol|(R)-1-(4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yloxy)propan-2-ol|2-Propanol, 1-((4-((4-fluoro-2-methyl-1H-indol-5-yl)oxy)-5-methylpyrrolo(2,1-f)(1,2,4)triazin-6-yl)oxy)-, (2R)-|(R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan-2-ol|(2R)-1-((4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-5-METHYLPYRROLO(2,1-F)(1,2,4)TRIAZIN-6-YL)OXY)PROPAN-2-OL|RefChem:121442|DTXCID60137785|VEGFR2 Inhibitor BMS-540215|Brivanib (BMS-540215)|Brivanib [USAN]|(2R)-1-[4-[(4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY]-5-METHYL-PYRROLO[2,1-F][1,2,4]TRIAZIN-6-YL]OXYPROPAN-2-OL|(R)-1-((4-((4-FLUORO-2-METHYL-1H-INDOL-5-YL)OXY)-5-METHYLPYRROLO[2,1-F][1,2,4]TRIAZIN-6-YL)OXY)PROPAN-2-OL|CHEMBL377300|1-[[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxy]-2-propanol|Brivanib (USAN)|MFCD13194684|(2R)-1-[4-[(4-fluoro-2-methyl-1H-indol-5-yl)oxy]-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yl]oxypropan-2-ol|(R)-1-(4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[1,2-f][1,2,4]triazin-6-yloxy)propan-2-ol|UNII-DDU33B674I|Brivanib (Standard)|BRIVANIB [MI]|BRIVANIB [WHO-DD]|Brivanib,BMS-540215|MLS006011288|GTPL5671|orb1689660|SCHEMBL1227589|SCHEMBL29354510|CHEBI:94562|EX-A011|BCPP000317|BDBM50184807|HY-10337R|NSC799368|s1084|AKOS015920386|AKOS015949459|AC-5252|BCP9000449|CCG-268296|CS-0148|DB11958|NSC-799368|SDCCGSBI-0654440.P001|NCGC00263160-01|AS-16273|HY-10337|SMR004703038|SY010123|NS00070985|SW219896-1|D09589|735B466|BRD-K28428262-001-01-7|BRD-K28428262-001-04-1|Q27075503|(2R)-1-[4-(4-Fluoro-2-methyl-1H-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4 ]triazin-6-yloxy]propanol|(r)-1-(4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5- methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy)propan- 2-ol|(R)-1-[4-(4-fluoro-2-methylindol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-2-propanol"
GABAPENTIN,3446,,"InChI=1S/C9H17NO2/c10-7-9(6-8(11)12)4-2-1-3-5-9/h1-7,10H2,(H,11,12)",UGJMXCAKCUNAIE-UHFFFAOYSA-N,C9H17NO2,171.24,2-[1-(aminomethyl)cyclohexyl]acetic acid,"gabapentin|60142-96-3|Neurontin|Gabapentine|1-(Aminomethyl)cyclohexaneacetic acid|Aclonium|Gabapetin|2-[1-(aminomethyl)cyclohexyl]acetic acid|Gabapentinum|gabapentina|Gabapentino|Fanatrex|Gralise|Cyclohexaneacetic acid, 1-(aminomethyl)-|2-(1-(aminomethyl)cyclohexyl)acetic acid|Goe-3450|Go 3450|CI-945|DM-1796|GOE 2450|GOE 3450|CI 945|Gabarone|NSC-742194|BRN 2359739|6CW7F3G59X|DTXSID0020074|CHEBI:42797|NSC-759254|DTXCID5074|NovoGabapentin|ApoGabapentin|Apo Gabapentin|Novo Gabapentin|Gabapentin Ratiopharm|RefChem:5849|Gaba 300-EZS|262-076-3|Serada|(1-Aminomethyl-cyclohexyl)-acetic acid|[1-(AMINOMETHYL)CYCLOHEXYL]ACETIC ACID|1-(Aminomethyl)-cyclohexaneacetic acid|DM-5689|Gabapentin-D10|MFCD00865286|CHEMBL940|GABAPENTIN; NEURONTIN|1126623-20-8|Gabapentino [Spanish]|Gabapentine [INN-French]|Gabapentinum [INN-Latin]|NCGC00015466-08|Gabapen|Gabapentino [INN-Spanish]|Vultin|CAS-60142-96-3|Gabapentin GR|GBN|gabapentinium|gabapentin (Neurontin)|Neuontin|Sefelsa|Gabapentin (1.0 mg/mL in Methanol)|Therapentin-90|Neurontin (TN)|CCRIS 7210|HSDB 7364|SR-01000000019|EINECS 262-076-3|UNII-6CW7F3G59X|Neurentin|Gabapentin?|Gabapentin-ER|Novo-Gabapentine|Gabapentin, solid|Gabapentin [USAN:USP:INN:BAN]|DDS-2003|Prestwick_151|Gralise (TN)|Gabapentin free base|CARBATIN|Gabapentin (Standard)|Tocris-0806|GABAPENTIN [MI]|Lopac-G-154|GABAPENTIN [INN]|GABAPENTIN [JAN]|Prestwick0_000861|Prestwick1_000861|Prestwick2_000861|Prestwick3_000861|GABAPENTIN [HSDB]|GABAPENTIN [USAN]|G-154|GABAPENTIN [VANDF]|Gabapentin-d10, 1mg/mL|GABAPENTIN [MART.]|SCHEMBL8343|GABAPENTIN [USP-RS]|GABAPENTIN [WHO-DD]|Lopac0_000582|BSPBio_000901|Gabapentin (JAN/USP/INN)|MLS000069358|BIDD:GT0656|SPBio_002822|BPBio1_000993|GTPL5483|orb1310370|Gabapentin, 1mg/ml in Methanol|GABAPENTIN [EP IMPURITY]|GABAPENTIN [ORANGE BOOK]|HY-A0057R|GABAPENTIN [EP MONOGRAPH]|GABAPENTIN [USP MONOGRAPH]|HMS1570N03|HMS2089J03|HMS2097N03|HMS2236O03|HMS3261F06|HMS3650A20|HMS3714N03|1-aminomethyl cyclohexaneacetic acid|1-aminomethylcyclohexane acetic acid|BCP25698|HY-A0057|MSK10209|1-(aminomethyl)cyclohexanacetic acid|Tox21_110157|Tox21_500582|BBL010794|BDBM50080153|NSC742194|s2133|SBB066157|STK598009|1-(aminomethyl)cyclohexyl-acetic Acid|AKOS000280865|Tox21_110157_1|1-Aminomethyl-1cyclohexane-acetic acid|2-[(aminomethyl)cyclohexyl]acetic acid|AB07485|AC-1485|CCG-204671|CS-1545|DB00996|FG23631|KS-1064|LP00582|NSC 742194|NSC 759254|SDCCGSBI-0050564.P002|1-aminomethyl-1-cyclohexane-acetic acid|NCGC00015466-01|NCGC00015466-02|NCGC00015466-03|NCGC00015466-04|NCGC00015466-05|NCGC00015466-06|NCGC00015466-07|NCGC00015466-09|NCGC00015466-11|NCGC00015466-27|NCGC00016891-01|NCGC00021545-02|NCGC00021545-04|NCGC00021545-05|NCGC00261267-01|SMR000058311|MSK10209D10-1000|SBI-0206904.P001|AE1 - Newer Anti-epileptic drug mixtures 1|EU-0100582|G0318|NS00000335|10B - Known Drug Blood Quantification Sample|EN300-52516|42G963|C07018|D00332|F040287|Gabapentin 100 microg/mL in Acetonitrile:Methanol|L000733|Q410352|SR-01000000019-2|SR-01000000019-6|BRD-K62737565-001-09-5|BRD-K62737565-001-10-3|BRD-K62737565-003-02-6|SR-01000000019-11|Z336079954|Gabapentin, European Pharmacopoeia (EP) Reference Standard|Gabapentin, United States Pharmacopeia (USP) Reference Standard|1-(Aminomethyl)cyclohexaneacetic acid, neurontin; GOE-3450; Gabapentine|Gabapentin, Pharmaceutical Secondary Standard; Certified Reference Material"
PREGABALIN,5486971,,"InChI=1S/C8H17NO2/c1-6(2)3-7(5-9)4-8(10)11/h6-7H,3-5,9H2,1-2H3,(H,10,11)/t7-/m0/s1",AYXYPKUFHZROOJ-ZETCQYMHSA-N,C8H17NO2,159.23,(3S)-3-(aminomethyl)-5-methylhexanoic acid,"Pregabalin|148553-50-8|Lyrica|(S)-3-(Aminomethyl)-5-methylhexanoic acid|3-isobutyl GABA|CI-1008|(3S)-3-(aminomethyl)-5-methylhexanoic acid|Pregabalina|Pregabaline|Vronogabic|(R-)-3-isobutyl GABA|Pregabalin mylan|Pregabalin sandoz|Pregabalin zentiva|CI 1008|PD-144723|Pregabalin sandoz gmbh|(S)-3-Isobutyl GABA|PD 144723|DTXSID1045950|CHEBI:64356|LYRICA CR|55JG375S6M|YNP-1807|NSC-759256|Hexanoic acid, 3-(aminomethyl)-5-methyl-, (S)-|PREGABALIN MYLAN PHARMA|DTXCID9025950|3 isobutyl GABA|GABA, 3-isobutyl|(S+)-3-isobutyl GABA|pregabalinum|Lecaent|Rewisca|Alzain|Axalid|CI1008|BONQAT|RefChem:6163|1008, CI|Pregabalin Extended Release|PREGABALIN capsules, CV|N03AX16|604-639-1|3-(Aminomethyl)-5-methyl-hexanoic Acid|NSC729898|(S)-Pregabalin|Hexanoic acid, 3-(aminomethyl)-5-methyl-, (3S)-|(3S)-3-(aminomethyl)-5-methyl-hexanoic acid|CHEMBL1059|MFCD00917044|Pregabalin [USAN]|Nervalin|Pregablin|UNII-55JG375S6M|HSDB 7530|Pregabalin [USAN:INN:BAN:JAN]|NCGC00095186-01|Lyrica (TN)|PREGABALIN [MI]|(S)-3-(Aminomethyl)-5-methylhexanoicacid|PREGABALIN [INN]|PREGABALIN [JAN]|PREGABALIN [HSDB]|PREGABALIN [VANDF]|PREGABALIN [MART.]|SCHEMBL8227|PREGABALIN [USP-RS]|PREGABALIN [WHO-DD]|orb389663|Pregabalin (JAN/USAN/INN)|PREGABALIN [EMA EPAR]|(S)-(+)-4-amino-3-(2-methylpropyl)butanoic acid|GTPL5484|DEA No. 2782|Pregabalin, 1mg/ml in Methanol|PREGABALIN [ORANGE BOOK]|PREGABALIN [EP MONOGRAPH]|HMS3715J16|PREGABALIN [USP MONOGRAPH]|Pregabalin 1.0 mg/ml in Methanol|Tox21_111475|BDBM50164279|AKOS001476611|AKOS005145504|Lyrica;CI-1008;PD-144723|AC-1158|CCG-221247|CS-1247|DB00230|KS-5378|NSC 759256|(S)-3-aminomethyl-5-methylhexanoic acid|NCGC00095186-11|NCGC00346738-01|121GE001|HY-17414|PD144723|(S)-3-Aminomethyl-5-methyl-hexanoic acid|CAS-148553-50-8|NS00000537|P2840|(S)-(+)-3-Aminomethyl-5-Methylhexanoic Acid|D02716|AB01563007_01|553P508|A808784|F418830|Q412174|SR-01000942257|Hexanoic acid, 3-(aminomethyl)-5-ethyl-, (3S)-|Q-201617|SR-01000942257-2|BRD-K66786476-001-01-3|BRD-K66786476-003-01-9|Pregabalin, EuropePharmacopoeia (EP) Reference Standard|1414928-41-8"
PITTSBURGH COMPOUND B,2826731,,"InChI=1S/C14H12N2OS/c1-15-10-4-2-9(3-5-10)14-16-12-7-6-11(17)8-13(12)18-14/h2-8,15,17H,1H3/i1-1",ZQAQXZBSGZUUNL-BJUDXGSMSA-N,C14H12N2OS,255.33,"2-[4-((111C)methylamino)phenyl]-1,3-benzothiazol-6-ol","Pittsburgh Compound B|C-11 PiB|566170-04-5|11C-PIB|(N-methyl-(11c))2-(4'-methylaminophenyl)-6-hydroxybenzothiazole|Pittsburgh compound b c-11|7P55415B0R|[11C]PIB|(11C)PIB|DTXSID00205194|((11)C)PIB|(11C)6-OH-BTA-1|[11C]6-OH-BTA-1|RefChem:908027|C11-PiB|C11 Pittsburgh Compound B|11 Carbon Pittsburgh Compound B|DTXCID00127685|Carbon C 11 Pittsburgh Compound B|2-(4-((11C)methylamino)phenyl)-1,3-benzothiazol-6-ol|(N-methyl-11C)2-(4'-methylaminophenyl)-6-hydroxybenzothiazole|N-methyl-(11C)2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole|Pittsburgh B|UNII-7P55415B0R|PIB C-11|2-[4-((111C)methylamino)phenyl]-1,3-benzothiazol-6-ol|[11C]Pittsburgh Compound-B|CHEMBL207456|SCHEMBL2055285|SCHEMBL29360193|[11C]-6-OH-BTA-1|DB15161|Q4047010|6-BENZOTHIAZOLOL, 2-(4-(METHYL-11C-AMINO)PHENYL)-|N-methyl-[11C]-2-(4 -methylaminophenyl)-6-hydroxybenzothiasole"
FLUTEMETAMOL,10107393,,"InChI=1S/C14H11FN2OS/c1-16-11-4-2-8(6-10(11)15)14-17-12-5-3-9(18)7-13(12)19-14/h2-7,16,18H,1H3",VVECGOCJFKTUAX-UHFFFAOYSA-N,C14H11FN2OS,274.32,"2-[3-fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol","Flutemetamol|637003-10-2|0F3M7032P5|2-(3-Fluoro-4-(methylamino)phenyl)-1,3-benzothiazol-6-ol|2-[3-fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol|RefChem:599480|6-benzothiazolol, 2-(3-fluoro-4-(methylamino)phenyl)-|2-[3-Fluoro-4-(methylamino)phenyl]-6-hydroxybenzothiazole|[3H]-Flutemetamol|MFCD31648320|UNII-0F3M7032P5|2-(3-fluoro-4-(methylamino)phenyl)benzo[d]thiazol-6-ol|CHEMBL579205|SCHEMBL10032130|BDBM50481120|DB15058|SY131050|NS00072061|E86506|2-[3-fluoro-4-(methylamino)phenyl]-6-Benzothiazolol|2-[3-Fluoro-4-(methylamino)phenyl]benzothiazol-6-ol|Q27236700|2-[3-fluoranyl-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol"
PITTSBURGH COMPOUND B,2826731,,"InChI=1S/C14H12N2OS/c1-15-10-4-2-9(3-5-10)14-16-12-7-6-11(17)8-13(12)18-14/h2-8,15,17H,1H3/i1-1",ZQAQXZBSGZUUNL-BJUDXGSMSA-N,C14H12N2OS,255.33,"2-[4-((111C)methylamino)phenyl]-1,3-benzothiazol-6-ol","Pittsburgh Compound B|C-11 PiB|566170-04-5|11C-PIB|(N-methyl-(11c))2-(4'-methylaminophenyl)-6-hydroxybenzothiazole|Pittsburgh compound b c-11|7P55415B0R|[11C]PIB|(11C)PIB|DTXSID00205194|((11)C)PIB|(11C)6-OH-BTA-1|[11C]6-OH-BTA-1|RefChem:908027|C11-PiB|C11 Pittsburgh Compound B|11 Carbon Pittsburgh Compound B|DTXCID00127685|Carbon C 11 Pittsburgh Compound B|2-(4-((11C)methylamino)phenyl)-1,3-benzothiazol-6-ol|(N-methyl-11C)2-(4'-methylaminophenyl)-6-hydroxybenzothiazole|N-methyl-(11C)2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole|Pittsburgh B|UNII-7P55415B0R|PIB C-11|2-[4-((111C)methylamino)phenyl]-1,3-benzothiazol-6-ol|[11C]Pittsburgh Compound-B|CHEMBL207456|SCHEMBL2055285|SCHEMBL29360193|[11C]-6-OH-BTA-1|DB15161|Q4047010|6-BENZOTHIAZOLOL, 2-(4-(METHYL-11C-AMINO)PHENYL)-|N-methyl-[11C]-2-(4 -methylaminophenyl)-6-hydroxybenzothiasole"
FLUTEMETAMOL F 18,15950376,,"InChI=1S/C14H11FN2OS/c1-16-11-4-2-8(6-10(11)15)14-17-12-5-3-9(18)7-13(12)19-14/h2-7,16,18H,1H3/i15-1",VVECGOCJFKTUAX-HUYCHCPVSA-N,C14H11FN2OS,273.32,"2-[3-(18F)fluoranyl-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol","Flutemetamol F-18|flutemetamol (18F)|Vizamyl|Flutemetamol F18|(18f)flutemetamol|[18F]flutemetamol|CHEBI:76611|L49M066S0O|flutemetamol ((18)F)|AH-110690 F-18|flutemetamolum (18F)|RefChem:56832|V09AX04|2-(3-(1?F)fluoro-4-(methylamino)phenyl)-1,3-benzothiazol-6-ol|Flutemetamol F 18|18F-Flutemetamol|765922-62-1|Flutemetamol ((sup18)F)|Flutemetamol F 18 [USAN]|(18F)AH110690|2-(3-(sup 18)f)Fluoro-4-(methylamino)phenyl)-1,3-benzothiazol-6-ol|2-[3-(18F)fluoranyl-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol|Flutemetamol F 18 (USAN)|2-[3-(18F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol|[18F]AH110690|Flutemetamol ((sup 18)F)|UNII-L49M066S0O|Vizamyl (TN)|[18F]-Flutemetamol|[18F]-Flutemetamol F18|Flutemetamol (18F) [INN]|flutemetamol ((1)F) [INN]|GTPL7342|CHEMBL2042122|SCHEMBL10032147|SCHEMBL29363499|SCHEMBL30668500|(18F)FLUTEMETAMOL [MI]|DTXSID80227394|EX-A10444|((18 sup)F)AH110690|DB09151|FLUTEMETAMOL (18F) [WHO-DD]|FLUTEMETAMOL F-18 [ORANGE BOOK]|D10231|Q18355673|2-[3-((18)F)fluoro-4-(methylamino)phenyl]-1,3-benzothiazol-6-ol|2-(3-((18 sup)F)Fluoro-4-(methylamino)phenyl)-1,3-benzothiazol-6-ol|6-Benzothiazolol, 2-(3-(fluoro-(sup 18)F)-4-(methylamino)phenyl)-"
CLIOQUINOL,2788,,"InChI=1S/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13H",QCDFBFJGMNKBDO-UHFFFAOYSA-N,C9H5ClINO,305.50,5-chloro-7-iodoquinolin-8-ol,"clioquinol|130-26-7|5-Chloro-7-iodoquinolin-8-ol|Iodochlorhydroxyquin|5-Chloro-8-hydroxy-7-iodoquinoline|Chloroiodoquin|Chloroiodoquine|Vioform|5-Chloro-7-iodo-8-quinolinol|Cliquinol|Iodochloroxyquinoline|Iodochlorohydroxyquinoline|Iodochloroquine|Chlorojodochin|Iodochloroxine|Iodoenterol|7-Iodo-5-chloroxine|5-Chloro-7-iodo-8-hydroxyquinoline|Iodochlorhydroxyquinoline|Enteroseptol|Iodoxyquinoline|Quinambicide|Alchloquin|Barquinol|Budoform|Cifoform|Dioquinol|Domeform|Eczecidin|Enterozol|Entrokin|Iodenterol|Lekosept|Mycoquin|Quinoform|Rheaform|Amebil|Amoenol|Bactol|Emaform|Nioform|Rometin|Iodochlorohydroxyquin|Hi-Enterol|Iodochlorhydroxyquinol|Hydriodide-enterol|Cliochinolum|Quin-O-Creme|5-Chloro-7-iodo-quinolin-8-ol|Enterum locorten|Domeform-HC|Clioquinolum|Enterovalodon|8-Quinolinol, 5-chloro-7-iodo-|Alioform|Enteritan|Oralcer|Corque|Cortin|7-Iodo-5-chloro-8-hydroxyquinoline|Cremo-quin|Entero-Vioformio|Vioform-hydrocortisone|Ala-Quin|Quinoform (antiseptic)|UAD Lotion|Vioform n.n.r.|Cliochinolo|5-Chlor-7-jod-8-hydroxy-chinolin|Iodochlorhydroxyquin Cream|Vioform-Hydrocortisone Mild|iodochlorhydroxyquinolone|DTXSID7022837|NSC-3531|7BHQ856EJ5|CHEBI:74460|AI3-16451|NSC-74938|DTXCID502837|NSC3531|EnteroVioform|Entero Vioform|Entero Septol|quiniodochlor|Rheaform Bolus|Entero-bio|5 Chloro 7 iodo 8 quinolinol|RefChem:58145|D08AH30|D09AA10|G01AC02|P01AA02|S02AA05|204-984-4|Hysone|Chinoform|Enteroquinol|Entero-Vioform|Dermaform|Enterseptol|Entero-Bioform|Entero-Septol|Chloro-8-hydroxyiodoquinoline|Quinoline, chloro-8-hydroxyiodo-|MFCD00006787|Rheaform boluses|Chinoformum|Jodchloroxychinolinum|Iodo|Iodochloroxychinolinum|Entero-bio form|NCGC00016391-05|CAS-130-26-7|Cliochinolo [DCIT]|TG2-36-2|Caswell No. 193|Formtone-HC|Quinoform (VAN)|Clioquinolum [INN-Latin]|loquinol|Vioformio|Hi-eneterol|SMR000058282|Rheaform Boluses (Veterinary)|CCRIS 6050|HSDB 6843|5-Chlor-7-jod-8-hydroxy-chinolin [German]|SR-01000002987|NSC 3531|EINECS 204-984-4|EPA Pesticide Chemical Code 024001|BRN 0153637|UNII-7BHQ856EJ5|Linolasept|Clioquinol [USP:INN:BAN]|Cloquinol|Clioquinol (CQ)|component of Hyquin|NSC 74938|Clioquinol (Standard)|Nystaform (Salt/Mix)|Clioquinol (USP/INN)|CLIOQUINOL [INN]|component of Formtone-HC|component of Heb-Cort V|Prestwick0_000886|Prestwick1_000886|Prestwick2_000886|Prestwick3_000886|CLIOQUINOL [HSDB]|Formtone-HC (Salt/Mix)|CLIOQUINOL [VANDF]|CHEMBL497|EC 204-984-4|cid_2788|CLIOQUINOL [MART.]|SCHEMBL3967|CLIOQUINOL [USP-RS]|CLIOQUINOL [WHO-DD]|NCIOpen2_009062|PBT-1|Oprea1_438281|BSPBio_000672|BSPBio_002466|5-21-03-00294 (Beilstein Handbook Reference)|ksc-8-192|MLS000069389|MLS002454410|SPECTRUM1505114|SPBio_002891|BPBio1_000740|orb1310209|CLIOQUINOL [ORANGE BOOK]|component of Hyquin (Salt/Mix)|SCHEMBL29370380|SCHEMBL30592904|BDBM32188|Clioquinol  - Bio-X trade mark|IODOCHLORHYDROXYQUIN [MI]|CLIOQUINOL [EP MONOGRAPH]|WLN: T66 BNJ GG II JQ|CLIOQUINOL [USP MONOGRAPH]|HMS1570B14|HMS1648J07|HMS2093I12|HMS2097B14|HMS2230I20|HMS3372J20|HMS3714B14|HMS5083J19|HMS6019H08|KUC105859N|Pharmakon1600-01505114|ALBB-031653|component of Cort-Quin (Salt/Mix)|Tox21_110416|Tox21_200291|HY-14603R|MSK163429|NSC759822|NYSTAFORM COMPONENT CLIOQUINOL|s4601|SBB032280|STK399761|5-chloro-8-hydroxy-7-iodo-quinoline|component of Heb-Cort V (Salt/Mix)|AKOS000120779|Tox21_110416_1|AC-6792|CCG-213339|DB04815|FC40594|FD10468|NSC-759822|SMP1_000073|IODOCHLORHYDROXYQUIN [GREEN BOOK]|NCGC00016391-01|NCGC00016391-02|NCGC00016391-03|NCGC00016391-04|NCGC00016391-06|NCGC00016391-07|NCGC00016391-08|NCGC00016391-09|NCGC00016391-10|NCGC00016391-13|NCGC00021665-03|NCGC00021665-04|NCGC00021665-05|NCGC00257845-01|S4601 5-Chloro-8-hydroxy-7-iodoquin|AS-14597|BC167259|HY-14603|SY051234|SBI-0206782.P001|DB-041956|AB00384254|NS00008116|ST50585810|4-stearylamino-phenyl-trimethylam. metilsulf.|EN300-20836|Clioquinol, VETRANAL(TM), analytical standard|component of Vioform-Hydrocortisone (Salt/Mix)|D03538|AB00384254_17|F236842|5-Chloro-7-iodo-8-quinolinol, >=95.0% (HPLC)|CU-01000000767-2|Q5134338|SR-01000002987-2|SR-01000002987-3|SR-01000002987-4|BRD-K09255212-001-04-2|BRD-K09255212-001-16-6|Z104483432|Clioquinol, British Pharmacopoeia (BP) Reference Standard|Clioquinol, European Pharmacopoeia (EP) Reference Standard|Clioquinol, United States Pharmacopeia (USP) Reference Standard|Clioquinol;5-Chloro-7-iodoquinolin-8-ol;5-Chloro-7-iodo-8-hydroxyquinoline|InChI=1/C9H5ClINO/c10-6-4-7(11)9(13)8-5(6)2-1-3-12-8/h1-4,13|5-Chloro-7-iodo-8-hydroxyquinoline; 5-Chloro-7-iodo-8-quinolinol; 5-Chloro-8-hydroxy-7-iodoquinoline; 5-Chloro-7-iodoquinolin-8-ol; Chloroiodeoquim; Iodochlorhydroxyquin|CQL"
SAR-405838,53476877,,"InChI=1S/C29H34Cl2FN3O3/c1-28(2,3)14-22-29(19-12-7-15(30)13-21(19)34-27(29)38)23(18-5-4-6-20(31)24(18)32)25(35-22)26(37)33-16-8-10-17(36)11-9-16/h4-7,12-13,16-17,22-23,25,35-36H,8-11,14H2,1-3H3,(H,33,37)(H,34,38)/t16?,17?,22-,23-,25+,29+/m0/s1",IDKAKZRYYDCJDU-AEPXTFJPSA-N,C29H34Cl2FN3O3,562.5,"(2'R,3R,3'S,5'S)-6-chloro-3'-(3-chloro-2-fluorophenyl)-5'-(2,2-dimethylpropyl)-N-(4-hydroxycyclohexyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide","1303607-60-4|SAR405838|MI-77301|SAR-405838|MI-773 (SAR405838)|Sar 405838|Sar405838 (mi-773)|8570LZ3RCA|CHEMBL2381408|MFCD28976052|(2'S,3R,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-N-(trans-4-hydroxycyclohexyl)-2-oxo-1,2-dihydrospiro(indole-3,3'-pyrrolidine)-5'-carboxamide|(2'S,3'R,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluoro-phenyl)-2'-(2,2-dimethyl-propyl)-2-oxo-1,2-dihydro-spiro (indole-3,3'-pyrrolidine)-5'-carboxylic acid (trans-4-hydroxy-cyclohexyl)-amide|Spiro(3H-indole-3,3'-pyrrolidine)-5'-carboxamide, 6-chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-N-(trans-4-hydroxycyclohexyl)-2-oxo-, (2'S,3R,4'S,5'R)-|(2'R,3R,3'S,5'S)-6-chloro-3'-(3-chloro-2-fluorophenyl)-5'-(2,2-dimethylpropyl)-N-(4-hydroxycyclohexyl)-2-oxospiro[1H-indole-3,4'-pyrrolidine]-2'-carboxamide|(2'S,3'R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluoro-phenyl)-2'-(2,2-dimethyl-propyl)-2-oxo-1,2-dihydro-spiro [indole-3,3'-pyrrolidine]-5'-carboxylic acid (trans-4-hydroxy-cyclohexyl)-amide|(2'S,3R,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-N-(trans-4-hydroxycyclohexyl)-2-oxospiro[3H-indole-3,3'-pyrrolidine]-5'-carboxamide|(2's,3r,4's,5'r)-6-Chloro-4'-(3-Chloro-2-Fluorophenyl)-2'-(2,2-Dimethylpropyl)-N-(Trans-4-Hydroxycyclohexyl)-2-Oxo-1,2-Dihydrospiro[indole-3,3'-Pyrrolidine]-5'-Carboxamide|(2'S,3R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluorophenyl)-N-((1r,4R)-4-hydroxycyclohexyl)-2'-neopentyl-2-oxospiro[indoline-3,3'-pyrrolidine]-5'-carboxamide|US8680132, MI- 77301 (TFA salt)|C29H34Cl2FN3O3|UNII-8570LZ3RCA|IDKAKZRYYDCJDU-AEPXTFJPSA-N|1303607-07-9|orb1685648|SCHEMBL3704267|SCHEMBL5585402|CHEMBL3961782|SCHEMBL12230015|SCHEMBL29375875|EX-A659|IDKAKZRYYDCJDU-HBMMIIHUSA-N|BDBM119726|BDBM119727|DCC60707|BDBM50433561|s7649|SAR 405838 [WHO-DD]|AKOS030526391|CCG-264716|CS-5003|DB12541|FC76168|AC-32665|DA-77683|HY-18986|MS-30203|NS00073428|SAR405838 (MI-77301)|US8680132, MI- 77301 (free amine)|MI-77301 (SAR405838)?|Q27269599|(2'R,3R,3'S,5'S)-6-chloro-3'-(3-chloro-2-fluoro-phenyl)-5'-(2,2-dimethylpropyl)-N-(4-hydroxycyclohexyl)-2-oxo-spiro[indoline-3,4'-pyrrolidine]-2'-carboxamide|(2'S,3'R,4'S,5'R)-6-chloro-4'-(3-chloro-2-fluoro-phenyl)-2'-(2,2-dimethyl-propyl)-2-oxo-1,2-dihydro-spiro[indole-3,3'-pyrrolidine]-5'-carboxylic acid (trans-4-hydroxy-cyclohexyl)-amide|(2'S,3R,4'S,5'R)-6-Chloro-4'-(3-chloro-2-fluorophenyl)-2'-(2,2-dimethylpropyl)-1,2-dihydro-N-(trans-4-hydroxycyclohexyl)-2-oxo-spiro  [3H-indole-3,3'-pyrrolidine]-5'-carboxamide|7HC"
RO-5045337,57406853,,"InChI=1S/C38H48Cl2N4O4S/c1-8-48-33-26-29(36(2,3)4)14-19-32(33)34-41-37(5,27-10-15-30(39)16-11-27)38(6,28-12-17-31(40)18-13-28)44(34)35(45)43-23-21-42(22-24-43)20-9-25-49(7,46)47/h10-19,26H,8-9,20-25H2,1-7H3/t37-,38+/m0/s1",QBGKPEROWUKSBK-QPPIDDCLSA-N,C38H48Cl2N4O4S,727.8,"[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazol-1-yl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone","RG7112|939981-39-2|RG-7112|RO5045337|RO-5045337|Mdm2 antagonist ro5045337|Q8MI0X869M|DTXSID60240182|R 7112|[(4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazol-1-yl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone|((4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazol-1-yl)-(4-(3-methylsulfonylpropyl)piperazin-1-yl)methanone|RefChem:179699|DTXCID60162673|1-((4S,5R)-2-(4-tert-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazole-1-carbonyl)-4-(3-methanesulfonylpropyl)piperazine|R7112|((4S,5R)-2-(4-(tert-Butyl)-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl)(4-(3-(methylsulfonyl)propyl)piperazin-1-yl)methanone|CHEMBL2386346|C38H48Cl2N4O4S|UNII-Q8MI0X869M|METHANONE, ((4S,5R)-4,5-BIS(4-CHLOROPHENYL)-2-(4-(1,1-DIMETHYLETHYL)-2-ETHOXYPHENYL)-4,5-DIHYDRO-4,5-DIMETHYL-1H-IMIDAZOL-1-YL)(4-(3-(METHYLSULFONYL)PROPYL)-1-PIPERAZINYL)-|Methanone, [(4S,5R)-4,5-bis(4-chlorophenyl)-2-[4-(1,1-dimethylethyl)-2-ethoxyphenyl]-4,5-dihydro-4,5-dimethyl-1H-imidazol-1-yl][4-[3-(methylsulfonyl)propyl]-1-piperazinyl]-|MFCD29905459|RG 7112|Ro 5045337|GTPL9599|SCHEMBL12704861|SCHEMBL29508998|R 7112 [WHO-DD]|BCP07937|EX-A1686|BDBM50434287|MFCD18206914|NSC809100|s7030|AKOS027282701|CCG-270414|CS-0330|DB14793|NSC-809100|SB19057|AC-32970|HY-10959|SY350723|RO5045337; RG7112|RG7112 (RO5045337)|Q27287118|RG-7112;RG 7112; RO-5045337; RO 5045337; RO5045337|[(4s,5r)-2-(4-t-butyl-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethylimidazol-1-yl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone|[(4S,5R)-2-(4-tert-butyl-2-ethoxy-phenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-imidazol-1-yl]-[4-(3-methylsulfonylpropyl)piperazin-1-yl]methanone|[(4S,5R)-2-[4-(tert-Butyl)-2-ethoxyphenyl]-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1-imidazolyl][4-[3-(methylsulfonyl)propyl]-1-piperazinyl]methanone|RO5045337;((4S,5R)-2-(4-(tert-Butyl)-2-ethoxyphenyl)-4,5-bis(4-chlorophenyl)-4,5-dimethyl-4,5-dihydro-1H-imidazol-1-yl)(4-(3-(methylsulfonyl)propyl)piperazin-1-yl)methanone"
ACETOXOLONE,94320,,"InChI=1S/C32H48O5/c1-19(33)37-24-10-11-30(6)23(27(24,2)3)9-12-32(8)25(30)22(34)17-20-21-18-29(5,26(35)36)14-13-28(21,4)15-16-31(20,32)7/h17,21,23-25H,9-16,18H2,1-8H3,(H,35,36)/t21-,23-,24-,25+,28+,29-,30-,31+,32+/m0/s1",FTQDJVZNPJRVPG-XWEVEMRCSA-N,C32H48O5,512.7,"(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-acetyloxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid","Acetoxolone|Acetylglycyrrhetinic acid|Glycyrrhetinyl acetate|Acetylglycyrrhetic acid|Glycyrrhetic acid acetate|6277-14-1|Glycyrrhetinic acid acetate|Uralenic acid, acetate|NSC-35349|3-Acetyl-18-beta-glycyrrhetinic acid|CWW961Q19K|DGS 0110A|DGS-0110A|(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-acetyloxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid|(3-beta,20-beta)-3-(Acetyloxy)-11-oxo-olean-12-en-29-oic acid|DTXSID801031583|NSC35349|RefChem:109022|DTXCID601516604|228-475-1|(3beta,20beta)-3-Acetoxy-11-oxoolean-12-en-29-oic acid|CHEMBL207413|CHEBI:81306|EINECS 228-475-1|NSC 35349|UNII-CWW961Q19K|ACETOXOLONE [MI]|ACETOXOLONE [WHO-DD]|SCHEMBL135617|FTQDJVZNPJRVPG-XWEVEMRCSA-N|BDBM50188385|AKOS016036176|Olean-12-en-29-oic acid, 3-(acetyloxy)-11-oxo-, (3-beta,20-beta)-|DB13640|3-O-ACETYL-18.BETA.-GLYCYRRHETIC ACID|C17734|Q4673282|Olean-12-en-30-oic acid, 3-.beta.-hydroxy-11-oxo-, acetate|Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-, acetate|3.BETA.-HYDROXY-11-OXOOLEAN-12-EN-30-OIC ACID ACETATE|(3.BETA.,20.BETA.)-3-(ACETYLOXY)-11-OXOOLEAN-12-EN-29-OIC ACID|(3beta,18beta,20beta)-3-(Acetyloxy)-11-oxo-olean-12-en-29-oic acid|OLEAN-12-EN-29-OIC ACID, 3-(ACETYLOXY)-11-OXO-, (3.BETA.,20.BETA.)-|(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-acetoxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid|(2S,4aS,6aS,6bR,8aR,10S,12aS,12bR,14bR)-10-acetoxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,12b,13,14b-icosahydropicene-2-carboxylic acid|10-acetyloxy-2,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid"
GSK1482160,23649427,,"InChI=1S/C14H14ClF3N2O2/c1-20-10(5-6-11(20)21)13(22)19-7-8-3-2-4-9(12(8)15)14(16,17)18/h2-4,10H,5-7H2,1H3,(H,19,22)/t10-/m0/s1",BJEMSIVBBUBXMZ-JTQLQIEISA-N,C14H14ClF3N2O2,334.72,(2S)-N-[[2-chloro-3-(trifluoromethyl)phenyl]methyl]-1-methyl-5-oxopyrrolidine-2-carboxamide,"GSK-1482160|1001389-72-5|GSK1482160|T1V3OH20HG|2-Pyrrolidinecarboxamide, N-((2-chloro-3-(trifluoromethyl)phenyl)methyl)-1-methyl-5-oxo-, (2S)-|GSK1482160A|RefChem:144538|UNII-T1V3OH20HG|CHEMBL1222883|orb1689012|SCHEMBL2581415|SCHEMBL29394584|GTPL10504|BJEMSIVBBUBXMZ-JTQLQIEISA-N|BDBM50416603|MFCD30532733|compound 1b [PMID: 31525963]|compound 31 [PMID: 20673717]|HY-19888|MS-25061|SY471745|CS-0016964|(S)-N-[2-Chloro-3-(trifluoromethyl)benzyl]-1-methyl-5-oxopyrrolidine-2-carboxamide|n-{[2-chloro-3-(trifluoromethyl)phenyl]methyl}-1-methyl-5-oxo-l-prolinamide|(2S)-N-((2-CHLORO-3-(TRIFLUOROMETHYL)PHENYL)METHYL)-1-METHYL-5-OXO-2-PYRROLIDINECARBOXAMIDE|(2S)-N-[[2-chloro-3-(trifluoromethyl)phenyl]methyl]-1-methyl-5-oxopyrrolidine-2-carboxamide|KF0"
CE-224535,11547499,,"InChI=1S/C22H29ClN4O6/c1-33-13-16(28)12-26-19(29)11-25-27(21(26)31)15-6-7-18(23)17(10-15)20(30)24-14-22(32)8-4-2-3-5-9-22/h6-7,10-11,16,28,32H,2-5,8-9,12-14H2,1H3,(H,24,30)/t16-/m1/s1",FUCKCIVGBCBZNP-MRXNPFEDSA-N,C22H29ClN4O6,480.9,"2-chloro-N-[(1-hydroxycycloheptyl)methyl]-5-[4-[(2R)-2-hydroxy-3-methoxypropyl]-3,5-dioxo-1,2,4-triazin-2-yl]benzamide","CE-224535|724424-43-5|CE-224,535|T8B02RAU3C|CE 224,535|CE224535|2-(4-Chloro-3-(3-(1-hydroxycycloheptyl)propanoyl)phenyl)-4-((2R)-2-hydroxy-3-methoxy-propyl)-1,2,4-triazine-3,5-dione|Benzamide, 2-chloro-5-(4,5-dihydro-4-((2R)-2-hydroxy-3-methoxypropyl)-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-n-((1-hydroxycycloheptyl)methyl)-|DTXSID20222742|CE224,535|RefChem:124155|DTXCID50145233|2-chloro-5-(4-((2R)-2-hydroxy-3-methoxypropyl)-3,5-dioxo-2,3,4,5-tetrahydro-1,2,4-triazin-2-yl)-N-((1-hydroxycycloheptyl)methyl)benzamide|UNII-T8B02RAU3C|2-chloro-N-[(1-hydroxycycloheptyl)methyl]-5-[4-[(2R)-2-hydroxy-3-methoxypropyl]-3,5-dioxo-1,2,4-triazin-2-yl]benzamide|CE 224535|CHEMBL1823817|(R)-2-chloro-5-(4-(hydroxy(methoxy)methyl)-3,5-dioxo-4,5-dihydro-1,2,4-triazin-2(3H)-yl)-N-((1-hydroxycycloheptyl)methyl)benzamide|compound 3 [PMID: 21782426]|GTPL9062|orb1308469|SCHEMBL3475321|BDBM50352039|MFCD27665471|CE 224535 [WHO-DD]|AKOS040741528|DB12113|compound 33 [PMID: 21565499]|DA-72057|FC158497|HY-15487|MS-28942|CS-0006791|NS00072103|G14320|Q27088319|(R) - 2- Chloro- 5- (4- (hydroxy(methoxy) methyl) - 3, 5- dioxo- 4, 5- dihydro- 1, 2, 4- triazin- 2(3H) - yl) - N- ((1- hydroxycyclo  heptyl) methyl) benzamide|2-chloro-N-[(1-hydroxycycloheptyl)methyl]-5-[4-[(2R)-2-hydroxy-3-methoxy-propyl]-3,5-dioxo-1,2,4-triazin-2-yl]benzamide"
AZD9056,10161381,,"InChI=1S/C24H35ClN2O2/c25-22-5-4-17(3-1-6-26-7-2-8-28)12-21(22)23(29)27-16-24-13-18-9-19(14-24)11-20(10-18)15-24/h4-5,12,18-20,26,28H,1-3,6-11,13-16H2,(H,27,29)",HSQAARMBHJCUOK-UHFFFAOYSA-N,C24H35ClN2O2,419.0,N-(1-adamantylmethyl)-2-chloro-5-[3-(3-hydroxypropylamino)propyl]benzamide,"345304-65-6|AZD-9056|N-(1-adamantylmethyl)-2-chloro-5-[3-(3-hydroxypropylamino)propyl]benzamide|AZD9056|F13K378W4L|Benzamide, 2-chloro-5-(3-((3-hydroxypropyl)amino)propyl)-N-(tricyclo(3.3.1.13,7)dec-1-ylmethyl)-|N-[(adamantan-1-yl)methyl]-2-chloro-5-{3-[(3-hydroxypropyl)amino]propyl}benzamide|n-(1-adamantylmethyl)-2-chloro-5-(3-(3-hydroxypropylamino)propyl)benzamide|N-((adamantan-1-yl)methyl)-2-chloro-5-(3-((3-hydroxypropyl)amino)propyl)benzamide|RefChem:116055|AZD 9056|AZD-9056 free base|345304-65-6 (free base)|CHEMBL3415305|UNII-F13K378W4L|GTPL7826|orb1698226|SCHEMBL4126642|CHEMBL3545108|SCHEMBL29364060|AZD 9056 [WHO-DD]|HSQAARMBHJCUOK-UHFFFAOYSA-N|BCP25185|EX-A6120|BDBM50075473|BDBM50267791|MFCD30533694|AKOS030228502|DB12594|AC-36649|AS-73127|NS00072076|A11535|Q27074814|2-Chloro-5-[3-[(3-hydroxypropyl)amino]propyl]-N-(tricyclo[3.3.1.13,7]dec-1-ylmethyl)-benzamide|2-Chloro-5-[3-[[3-hydroxypropyl)amino]propyl]-N-(tricyclo[3.3.1.13.7]dec-1-ylmethyl)-benzamide"
FASITIBANT,11498853,,"InChI=1S/C36H49Cl2N6O6S/c1-24-22-25(2)40-33-26(24)8-6-10-30(33)50-23-27-28(37)11-12-31(32(27)38)51(47,48)41-36(13-20-49-21-14-36)35(46)43-17-15-42(16-18-43)34(45)29(39)9-7-19-44(3,4)5/h6,8,10-12,22,29,41H,7,9,13-21,23,39H2,1-5H3/q+1/t29-/m0/s1",FQVSDHOWSLEEKJ-LJAQVGFWSA-N,C36H49Cl2N6O6S+,764.8,"[(4S)-4-amino-5-[4-[4-[[2,4-dichloro-3-[(2,4-dimethylquinolin-8-yl)oxymethyl]phenyl]sulfonylamino]oxane-4-carbonyl]piperazin-1-yl]-5-oxopentyl]-trimethylazanium","Fasitibant|869939-83-3|Fasitibant ion|Fasitibant cation|0WL827Z7AE|MEN-16132 FREE BASE|DTXSID30236032|RefChem:597162|DTXCID30158523|1-PIPERAZINEPENTANAMINIUM, DELTA-AMINO-4-((4-(((2,4-DICHLORO-3-(((2,4-DIMETHYL-8-QUINOLINYL)OXY)METHYL)PHENYL)SULFONYL)AMINO)TETRAHYDRO-2H-PYRAN-4-YL)CARBONYL)-N,N,N-TRIMETHYL-EPSILON-OXO-, (DELTAS)-|((4S)-4-amino-5-(4-(4-(2,4-dichloro-3-(((2,4-dimethylquinolin-8-yl)oxy)methyl)benzenesulfonamido)oxane-4-carbonyl)piperazin-1-yl)-5-oxopentyl)trimethylazanium|(deltaS)-delta-Amino-4-((4-(((2,4-dichloro-3-(((2,4-dimethyl-8-quinolinyl)oxy)methyl)phenyl)sulfonyl)amino)tetrahydro-2H-pyran-4-yl)carbonyl)-N,N,N-trimethyl-epsilon-oxo-1-piperazinepentanaminium|UNII-0WL827Z7AE|Fasitibant free base|Fasitibant (free base)|CHEMBL218427|[(4S)-4-amino-5-[4-[4-[[2,4-dichloro-3-[(2,4-dimethylquinolin-8-yl)oxymethyl]phenyl]sulfonylamino]oxane-4-carbonyl]piperazin-1-yl]-5-oxopentyl]-trimethylazanium|CHEMBL541758|(4-amino-5-(4-(4-(2,4-dichloro-3-(2,4-dimethyl-8-quinolyloxymethyl)phenylsulfonamido)tetrahydro-2h-4-pyranoylcarbonyl)piperazino)-5-oxopentyl)(trimethyl)ammonium|FASITIBANT [WHO-DD]|orb1740994|SCHEMBL2641709|SCHEMBL29537993|BDBM50293905|BDBM50411275|DA-53122|HY-106277|CS-0025493|Q27231194|(S)-4-amino-5-(4-(4-(2,4-dichloro-3-((2,4-dimethylquinolin-8-yloxy)methyl)phenylsulfonamido)tetrahydro-2H-pyran-4-carbonyl)piperazin-1-yl)-N,N,N-trimethyl-5-oxopentan-1-aminium chloride|1-Piperazinepentanaminium, -amino-4-[[4-[[[2,4-dichloro-3-[[(2,4-dimethyl-8-quinolinyl)oxy]methyl]phenyl]sulfonyl]amino]tetrahydro-2H-pyran-4-yl]carbonyl]-N,N,N-trimethyl--oxo-, (S)-|1-PIPERAZINEPENTANAMINIUM, .DELTA.-AMINO-4-((4-(((2,4-DICHLORO-3-(((2,4-DIMETHYL-8-QUINOLINYL)OXY)METHYL)PHENYL)SULFONYL)AMINO)TETRAHYDRO-2H-PYRAN-4-YL)CARBONYL)-N,N,N-TRIMETHYL-.EPSILON.-OXO-, (.DELTA.S)-"
PENTAMIDINE,4735,,"InChI=1S/C19H24N4O2/c20-18(21)14-4-8-16(9-5-14)24-12-2-1-3-13-25-17-10-6-15(7-11-17)19(22)23/h4-11H,1-3,12-13H2,(H3,20,21)(H3,22,23)",XDRYMKDFEDOLFX-UHFFFAOYSA-N,C19H24N4O2,340.4,4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide,"pentamidine|100-33-4|Pentamidina|Pentamidin|Pentamidinum|4,4'-Diamidinodiphenoxypentane|4,4'-(Pentamethylenedioxy)dibenzamidine|p,p'-(Pentamethylenedioxy)dibenzamidine|Pentam 300 (as isethionate)|Nebupent (as isethionate)|Pentacarinat (as isethionate)|Benzenecarboximidamide, 4,4'-[1,5-pentanediylbis(oxy)]bis-|1,5-bis(4-amidinophenoxy)pentane|MP-601205|NSC-9921|4-{[5-(4-carbamimidoylphenoxy)pentyl]oxy}benzene-1-carboximidamide|MB 800 FREE BASE|MB-800|MB-800 FREE BASE|4,4'-(1,5-Pentanediylbis(oxy))bis-benzenecarboximidamide|RP-2512|RP 2512 FREE BASE|RP-2512 FREE BASE|673LC5J4LQ|CHEBI:45081|NSC9921|MB-800 (AS ISETHIONATE)|Benzenecarboximidamide, 4,4'-(1,5-pentanediylbis(oxy))bis-|DTXSID7023431|4,4'-[1,5-Pentanediylbis(oxy)]bis-benzenecarboximidamide|4-((5-(4-carbamimidoylphenoxy)pentyl)oxy)benzene-1-carboximidamide|Aerosolized Pentamadine|RefChem:57387|GlyTouCan:G05924OI|PENTAMIDINI MESILAS|DTXCID403431|P01CX01|G05924OI|202-841-0|4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide|Pentamide|4-[5-(4-Carbamimidoylphenoxy)pentoxy]benzenecarboximidamide|Pentamidine (INN)|MFCD00599574|PNT|GNF-Pf-3680|4,4'-[pentane-1,5-diylbis(oxy)]dibenzenecarboximidamide|4-[5-(4-carbamimidoylphenoxy)pentoxy]benzamidine|MB 800 [AS ISETHIONATE]|MMV000062|Pentamidina [DCIT]|PENTAMIDINE [INN]|Pentamidinum [INN-Latin]|RP 2512 [as isethionate]|Pentamidine [INN:BAN:DCF]|RP 2512 [AS ISETHIONATE)|Lomidine (TN)|CCRIS 3825|4, 4'-Diamidinodiphenoxypentane|1,3-BIS(4-AMIDINOPHENOXY)PENTANE|p,p'-(Pentamethylene-dioxy)bis-benzamidine|Nebupent (*Isethionate)|NSC 9921|EINECS 202-841-0|Pentacarinat (*Isethionate)|BRN 3159790|UNII-673LC5J4LQ|Pentam 300 (*Isethionate)|RP 2512 (*Isethionate)|HSDB 7474|4,4'-(pentamethylenedioxy)dibenzamidine;4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide;4-{[5-(4-carbamimidoylphenoxy)pentyl]oxy}benzene-1-carboximidamide|4,4'-(Pentamethylenedioxy)dibenzamide|Pentamidine (Standard)|p,p'-(Pentamethylenedioxy)bis[benzamidine]|CHEMBL55|PENTAMIDINE [MI]|Benzamidine, 4,4'-(pentamethylenedioxy)di-|Prestwick1_000553|Prestwick2_000553|Prestwick3_000553|Spectrum2_000155|Spectrum3_000276|Spectrum4_000380|Spectrum5_001808|PENTAMIDINE [HSDB]|4,.omega.-diphenoxypentane|PENTAMIDINE [VANDF]|SCHEMBL3329|BSPBio_000625|BSPBio_001752|KBioGR_000879|PENTAMIDINE [WHO-DD]|4-10-00-00447 (Beilstein Handbook Reference)|MLS006011562|SPBio_000290|SPBio_002546|BPBio1_000689|cid_359323|orb1305716|WLN: MUYZR DO5OR DYZUM|BDBM45440|EX-A1489A|HY-B0537R|KBio3_001252|HMS2089J14|BCP10950|HY-B0537|PR-118|AKOS015919681|DB00738|DS-1680|FP26808|SDCCGSBI-0050899.P002|Benzamidine,4'-(pentamethylenedioxy)di-|NCGC00179034-01|NCGC00179034-02|NCGC00179034-03|NCGC00179034-04|NCGC00179034-08|NCGC00179034-23|AC-12459|MP601205|NCI60_042221|SMR001549987|SBI-0051570.P002|DB-315935|AB00053572|NS00008235|C07420|D08333|EN300-124032|AB00053572-18|AB00053572_19|AB00053572_20|100P334|Q416206|BRD-K13183738-001-01-1|BRD-K13183738-300-02-5|BRD-K13183738-317-06-0|BRD-K13183738-317-10-2|SR-01000075174-14|Benzenecarboximidamide,4'-[1,5-pentanediylbis(oxy)]bis-|4-[5-(4-amidinophenoxy)pentoxy]benzamidine;2-hydroxyethanesulfonic acid|4-[5-(4-carbamimidoylphenoxy)pentoxy]benzenecarboximidamide;2-oxidanylethanesulfonic acid|4,4'-[1,5-Pentanediylbis(oxy)]bis-benzenecarboximidamide;4,4'-Diamidino-.alpha.,.omega.-diphenoxypentane;MP 601205|4,4-(pentamethylenedioxy)dibenzamidine;4,4'-(Pentane-1,5-diylbis(oxy))dibenzimidamide;4-{[5-(4-carbamimidoylphenoxy)pentyl]oxy}benzene-1-carboximidamide"
ECOPLADIB,204106,,"InChI=1S/C39H33Cl3N2O5S/c40-30-14-18-36-33(24-30)32(20-22-49-31-15-12-29(13-16-31)39(45)46)37(19-21-43-50(47,48)25-26-11-17-34(41)35(42)23-26)44(36)38(27-7-3-1-4-8-27)28-9-5-2-6-10-28/h1-18,23-24,38,43H,19-22,25H2,(H,45,46)",FMMCHWHNSUBYAV-UHFFFAOYSA-N,C39H33Cl3N2O5S,748.1,"4-[2-[1-benzhydryl-5-chloro-2-[2-[(3,4-dichlorophenyl)methylsulfonylamino]ethyl]indol-3-yl]ethoxy]benzoic acid","Ecopladib|381683-92-7|ECOPLADIBUM|PLA-725|48TI67E57Q|DTXSID70191555|4-(2-(5-Chloro-2-(2-(((3,4-dichlorobenzyl)sulfonyl)amino)ethyl)-1-(diphenylmethyl)-1H-indol-3-yl)ethoxy)benzoic acid|Benzoic acid, 4-(2-(5-chloro-2-(2-((((3,4-dichlorophenyl)methyl)sulfonyl)amino)ethyl)-1-(diphenylmethyl)-1H-indol-3-yl)ethoxy)|4-[2-[5-Chloro-2-[2-[[(3,4-dichlorobenzyl)sulfonyl]amino]ethyl]-1-(diphenylmethyl)-1H-indol-3-yl]ethoxy]benzoic acid|RefChem:920822|DTXCID10114046|4-[2-[1-benzhydryl-5-chloro-2-[2-[(3,4-dichlorophenyl)methylsulfonylamino]ethyl]indol-3-yl]ethoxy]benzoic acid|CHEMBL269787|Ecopladib [USAN]|Ecopladib [USAN:INN]|UNII-48TI67E57Q|ECOPLADIB [INN]|Ecopladib (USAN/INN)|C39H33Cl3N2O5S|orb1709801|SCHEMBL1500755|SCHEMBL29829778|GQA68392|BDBM50205515|HY-U00037|MFCD27976738|AKOS040733064|CS-6742|DA-73003|MS-31311|NS00121356|D03938|G14337|Q27259176|4-(2-(1-benzhydryl-5-chloro-2-(2-((3,4-dichlorophenyl)methylsulfonamido)ethyl)-1H-indol-3-yl)ethoxy)benzoic acid|4-{2-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}-ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]ethoxy}benzoic acid|Benzoic acid, 4-(2-(5-chloro-2-(2-((((3,4-dichlorophenyl)methyl)sulfonyl)amino)ethyl)-1-(diphenylmethyl)-1H-indol-3-yl)ethoxy)-"
IMATINIB MESYLATE,123596,,"InChI=1S/C29H31N7O.CH4O3S/c1-21-5-10-25(18-27(21)34-29-31-13-11-26(33-29)24-4-3-12-30-19-24)32-28(37)23-8-6-22(7-9-23)20-36-16-14-35(2)15-17-36;1-5(2,3)4/h3-13,18-19H,14-17,20H2,1-2H3,(H,32,37)(H,31,33,34);1H3,(H,2,3,4)",YLMAHDNUQAMNNX-UHFFFAOYSA-N,C30H35N7O4S,589.7,methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide,"Imatinib mesylate|220127-57-1|Gleevec|Glivec|Imatinib mesilate|imatinib methanesulfonate|sti-571|Imatinib accord|Imatinib medac|STI 571|Imatinib (as mesilate)|NSC-716051|QTI-571|Imatinib methane sulfonate|IMKELDI|QTI571|DTXSID9040502|CHEBI:31690|8A1O1M485B|DTXCID7020502|CGP-57148|NSC716051|imatinib oral|Mesylate, Imatinib|RefChem:77|alpha-(4-Methyl-1-piperazinyl)-3'-((4-(3-pyridyl)-2-pyrimidinyl)amino)-p-tolu-p-toluidide|Methanesulfonate, Imatinib|Imatinib mesylate 400 mg|CGP57148B|CGP57148|4-((4-Methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)benzamide Monomethanesulfonate|CGP 57148|STI571|Imatinib Mesylate (STI571)|Imatinib (mesylate)|Gleevec (Imatinib mesylate)|MFCD04307699|imatinib monomesylate|220127-57-1 (mesylate)|Imatinib mesylate [USAN]|N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate|CGP 57148B|Imatinib mesilate (JAN)|Imatinib mesylate (USAN)|M06311|Imatinib Methansulfonate|IMATINIB MESILATE [JAN]|CGP-57148B|Benzamide, 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-, methanesulfonate (1:1)|CAS-220127-57-1|NCGC00159456-02|Genfatinib|Gleevac|Shantinib|Imatinib, methanesulfonate salt|4-[(4-Methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]-benzamide monomethanesulfonate|C30H35N7O4S|HSDB 7142|Imatinib mesylate?|4-[(4-methylpiperazin-1-yl)methyl]-N-(4-methyl-3-{[4-(pyridin-3-yl)pyrimidin-2-yl]amino}phenyl)benzamide methanesulfonate|4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate|4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(pyridin-3-yl)pyrimidin-2-yl]amino]phenyl]benzamide methanesulfonate|4-[(4-methylpiperazin-1-yl)methyl]-N-{4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl}benzamide methanesulfonate|Gleevec (TN)|Glivec (TN)|Imatinib(free base)?|ST-1571 Mesylate|SCHEMBL8217|Imatinib monomethanesulfonate|CHEMBL1642|Benzamide,monomethanesulfonate|Imatinib methanesulfonate salt|MLS001401456|UNII-8A1O1M485B|orb1307991|Imatinib (Mesylate) (Standard)|IMATINIB MESYLATE [HSDB]|SCHEMBL15632914|SCHEMBL29370699|SCHEMBL29377238|EX-A954|IMATINIB MESYLATE [VANDF]|IMATINIB MESILATE [MART.]|YLMAHDNUQAMNNX-UHFFFAOYSA-N|BCPP000204|GGP-57148B|GLXC-05064|HMS2052B09|HMS2233D16|HMS3265E01|HMS3265E02|HMS3265F01|HMS3265F02|HMS3372O12|HMS3394B09|HMS3654C07|HMS5079E05|IMATINIB MESILATE [WHO-DD]|BCP01255|Tox21_111684|AC-525|HB1943|HY-50946R|s1026|Imatinib mesylate - Bio-X trade mark|IMATINIB METHANESULFONATE [MI]|AKOS015852497|Tox21_111684_1|BCP9000776|CCG-101175|FI10812|IMATINIB MESYLATE [ORANGE BOOK]|KS-1236|NC00425|NSC 716051|IMATINIB MESILATE [EP MONOGRAPH]|NCGC00159456-11|111GE005|4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide methanesulfonate|Benzamide, 4-((4-methyl-1-piperazinyl)methyl)-N-(4-methyl-3-((4-(3-pyridinyl)-2-pyrimidinyl)amino)phenyl)-, monomethanesulfonate|BI164678|HY-50946|methanesulfonic acid; 4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide|methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide|N-(4-methyl-3-(4-(pyridin-3-yl)pyrimidin-2-ylamino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamide methanesulfonate|SMR000469175|SY013513|I0936|NS00076459|SW197805-4|D01441|Imatinib Mesylate (CGP-57148B, STI-571)|127I571|A815828|Q27114666|Imatinib Mesylate,Gleevec,Glivec,CGP-57148B,STI-571|;4-[(4-Methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide methanesulfonate|4-(4-Methyl-piperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin- 3-yl)-pyrimidin-2-ylamino)-phenyl]-benzamidemethanesulfonic acid salt|4-(4-Methylpiperazin-1-ylmethyl)-N-[4-methyl-3-(4-pyridin-3-yl-pyrimidin-2-ylamino)phenyl]benzamide methanesulfonic acid salt|4-[(4-Methyl-1-piperazinyl)-methyl]-N-{4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]-amino]-phenyl}-benzamide monomethanesulphonate|4-[(4-methyl-1-piperazinyl)methyl]-n-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]-phenyl]benzamide methanesulfonate|hydron;methanesulfonate;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide|methanesulfonic acid; 4-[(4-methyl-1-piperazinyl)methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl]amino]phenyl]benzamide|methanesulfonic acid;4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[[4-(3-pyridyl)pyrimidin-2-yl]amino]phenyl]benzamide|N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)-4-((4-methylpiperazin-1-yl)methyl)benzamidemethanesulfonate"
FEXAGRATINIB,51039095,,"InChI=1S/C26H33N5O3/c1-17-15-31(16-18(2)27-17)22-9-6-20(7-10-22)26(32)28-25-13-21(29-30-25)8-5-19-11-23(33-3)14-24(12-19)34-4/h6-7,9-14,17-18,27H,5,8,15-16H2,1-4H3,(H2,28,29,30,32)/t17-,18+",VRQMAABPASPXMW-HDICACEKSA-N,C26H33N5O3,463.6,"N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]benzamide","AZD4547|1035270-39-3|AZD-4547|AZD 4547|2167OG1EKJ|CHEBI:63453|DTXSID80145887|N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide|N-{5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl}-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide|N-(5-(2-(3,5-DIMETHOXYPHENYL)ETHYL)-1H-PYRAZOL-3-YL)-4-((3R,5S)-3,5-DIMETHYLPIPERAZIN-1-YL)BENZAMIDE|RefChem:560460|DTXCID9068378|fexagratinib|N-(5-(3,5-dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3S,5R)-3,5-dimethylpiperazin-1-yl)benzamide|MFCD22580423|rel-N-(5-(3,5-Dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3R,5S)-3,5-dimethylpiperazin-1-yl)benzamide|KB-74810|N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3S,5R)-3,5-dimethylpiperazin-1-yl]benzamide|N-{3-[2-(3,5-Dimethoxyphenyl)ethyl]-1h-Pyrazol-5-Yl}-4-[(3r,5s)-3,5-Dimethylpiperazin-1-Yl]benzamide|N-{5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl}-4-(cis-3,5-dimethylpiperazin-1-yl)benzamide|ABSK091|ABSK-091|UNII-2167OG1EKJ|C26H33N5O3|66T|fexagratinib [INN]|Fexagratinib (Standard)|SCHEMBL63884|ADSK091|rel-N-[5-[2-(3,5-Dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]benzamide|GTPL7707|orb1307009|SCHEMBL15250892|SCHEMBL29479542|AZD 4547 [WHO-DD]|VRQMAABPASPXMW-HDICACEKSA-N|AZD4547?|EX-A1578|HY-13330R|NSC764239|NSC765338|NSC799346|s2801|AKOS024464898|BCP9000364|CCG-269382|CS-0971|DB12247|FA64951|NSC-764239|NSC-765338|NSC-799346|SDCCGSBI-0654475.P001|NCGC00346713-01|NCGC00346713-05|NCGC00346713-10|AC-28442|AS-17054|DA-50853|HY-13330|NS00073078|SW219341-1|BRD-K28392481-001-05-1|Q27074746|Benzamide,N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-1H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethyl-1-piperazinyl]-,rel-|N-(5-(3,5-dimethoxyphenethyl)-1H-pyrazol-3-yl)-4-((3R,5S)-3,5-dimethylpiperazin-1-yl)benzamide, rel-|N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethylpiperazin -1-yl]benzamide|N-[5-[2-(3,5-dimethoxyphenyl)ethyl]-2H-pyrazol-3-yl]-4-[(3R,5S)-3,5-dimethylpiperazin-1-yl]benzamide"
ETHACRYNIC ACID,3278,,"InChI=1S/C13H12Cl2O4/c1-3-7(2)13(18)8-4-5-9(12(15)11(8)14)19-6-10(16)17/h4-5H,2-3,6H2,1H3,(H,16,17)",AVOLMBLBETYQHX-UHFFFAOYSA-N,C13H12Cl2O4,303.13,"2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid","ETHACRYNIC ACID|58-54-8|Etacrynic Acid|Etacrinic acid|Hydromedin|Taladren|Hidromedin|Crinuryl|Edecril|Edecrina|Endecril|Mingit|Otacril|Reomax|Uregit|Etakrinic acid|Methylenebutyrylphenoxyacetic acid|Acido etacrinico|MK-595|Acide etacrynique|Acidum etacrynicum|Methylenebutyryl phenoxyacetic acid|(2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy)acetic acid|[2,3-Dichloro-4-(2-methylenebutyryl)phenoxy]acetic acid|2-[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid|M5DP350VZV|NSC-85791|2,3-Dichloro-4-(2-methylenebutyryl)phenoxy acetic acid|(2,3-Dichloro-4-(2-methylenebutyryl)phenoxy)acetic acid|(4-(2-Methylenebutyryl)-2,3-dichlorophenoxy)acetic acid|NSC-624008|CHEBI:4876|Acetic acid, (2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy)-|DTXSID3025257|NSC85791|Acetic acid, (2,3-dichloro-4-(2-methylenebutyryl)phenoxy)-|Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova|Acetic acid, [2,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]-|DTXCID205257|Acid, Etacrynic|[4-(2-Methylenebutyryl)-2,3-dichlorophenoxy]acetic acid|[2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic acid|Ethacrinic acid|Ethacrynic Acid, Sodium Salt|2-(2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy)acetic acid|Acetic acid, [2,3-dichloro-4-(2-methylenebutyryl)phenoxy]-|Acid, Ethacrinic|Acid, Ethacrynic|RefChem:591356|C03CC01|(2,3-Dichloro-4-(2-ethylacryloyl)phenoxy)acetic acid|200-384-1|ethacrynate|Edecrin|Ethacrinique (acide)|Kyselina ethakrynova|Kyselina ethakrynova [Czech]|Acide etacrynique [INN-French]|Acido etacrinico [INN-Spanish]|Acidum etacrynicum [INN-Latin]|2,3-Dichloro-4-(2-methylenebutyl)phenoxyacetic acid|MK 595|NSC 85791|NSC 624008|BRN 1915060|Etacrynic acid [INN]|MFCD00056693|CHEMBL456|Kyselina 4-(2-(1-butenyl)karbonyl)-2,3-dichlorfenoxyoctova [Czech]|58-54-8 (free acid)|MLS000069535|MLS002701928|[2,3-dichloro-4-(2-methylidenebutanoyl)phenoxy]acetic acid|NSC624008|CAS-58-54-8|NCGC00016260-05|2-[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid|SMR000058600|Ethacryinic Acid|Ethacrynic acid [USAN:BAN]|[2,3-dichloro-4-(2-methylenebutanoyl)phenoxy]acetic acid|CCRIS 4638|HSDB 2136|Ethacrynic acid (USP)|SR-01000003010|EINECS 200-384-1|UNII-M5DP350VZV|Etacrynsaure|Crinuril|etacrynic-acid|Ethacrynic acid [USAN:USP]|1gsf|2gss|Prestwick_671|Opera_ID_61|Spectrum_000813|Prestwick0_000259|Prestwick1_000259|Prestwick2_000259|Prestwick3_000259|Spectrum2_000097|Spectrum3_000425|Spectrum4_000544|Spectrum5_000680|E0526|bmse000134|Ethacrynic acid (Standard)|SCHEMBL26353|BSPBio_000078|BSPBio_002010|ETACRYNIC ACID [JAN]|ETHACRYNIC ACID [MI]|KBioGR_001207|KBioSS_001293|MLS002548854|DivK1c_000900|Etacrynic acid (JP17/INN)|SPECTRUM1500287|SPBio_000054|SPBio_002297|ETHACRYNIC ACID [HSDB]|ETHACRYNIC ACID [USAN]|2,3-Dichloro-4-(2-methylenebutyryl)phenoxyacetic acid|BPBio1_000086|GTPL7179|orb1302754|ETACRYNIC ACID [MART.]|ETHACRYNIC ACID [VANDF]|ETACRYNIC ACID [WHO-DD]|SCHEMBL29384243|HMS502M22|HY-B1640R|KBio1_000900|KBio2_001293|KBio2_003861|KBio2_006429|KBio3_001230|NINDS_000900|GLXC-02567|HMS1568D20|HMS1920M16|HMS2089N17|HMS2091D17|HMS2095D20|HMS3259G03|HMS3712D20|HMS5084B20|Pharmakon1600-01500287|HY-B1640|MSK10501|Ethacrynic acid, >=97% (HPLC)|Tox21_110335|Tox21_201102|BDBM50186231|CCG-38915|ETACRYNIC ACID [EP IMPURITY]|NSC757026|s5561|WLN: QV1OR BG CG DVY2&U1|ETACRYNIC ACID [EP MONOGRAPH]|ETHACRYNIC ACID [ORANGE BOOK]|GST Inhibitor-2 (Ethacrynic acid))|AKOS003404732|Tox21_110335_1|DB00903|ETHACRYNIC ACID [USP MONOGRAPH]|FE22848|KS-1453|NC00450|NSC-757026|IDI1_000900|NCGC00016260-01|NCGC00016260-02|NCGC00016260-03|NCGC00016260-04|NCGC00016260-06|NCGC00016260-07|NCGC00016260-08|NCGC00016260-09|NCGC00016260-10|NCGC00016260-11|NCGC00016260-13|NCGC00022601-03|NCGC00022601-04|NCGC00022601-05|NCGC00258654-01|NCI60_041898|SBI-0051374.P003|DB-053221|AB00051988|CS-0013591|NS00009284|A51097|D00313|AB00051988-19|AB00051988_20|Q418571|SR-01000003010-2|SR-01000003010-3|BRD-K63630713-001-05-0|BRD-K63630713-001-15-9|BRD-K63630713-001-25-8|[2,3-Dichloro-4-(2-ethylacryloyl)phenoxy]acetic acid #|Acetic acid,3-dichloro-4-(2-methylenebutyryl)phenoxy]-|Z1590781983|2,3-DICHLORO-4-(2-METHYLENEBUTYRYL)PHENOXY)ACETATE|4-(METHYLENEBUTYRYL)-2,3-DICHLOROPHENOXY)ACETIC ACID|Acetic acid,3-dichloro-4-(2-methylene-1-oxobutyl)phenoxy]-|Ethacrynic acid, European Pharmacopoeia (EP) Reference Standard|Ethacrynic acid, United States Pharmacopeia (USP) Reference Standard|2-(2,3-DICHLORO-4-(2-METHYLENE-1-OXOBUTYL)PHENOXY)ACETIC ACID|Etacrynic acid for system suitability, European Pharmacopoeia (EP) Reference Standard|2-[2,3-Dichloro-4-(2-methylene-1-oxobutyl)phenoxy]acetic acid;[4-(2-Methylenebutyryl)-2,3-dichlorophenoxy]acetic acid;Crinuril"
APLAVIROC HYDROCHLORIDE,6918686,,"InChI=1S/C33H43N3O6.ClH/c1-2-3-19-36-30(38)28(29(37)24-7-5-4-6-8-24)34-32(41)33(36)17-20-35(21-18-33)22-23-9-13-26(14-10-23)42-27-15-11-25(12-16-27)31(39)40;/h9-16,24,28-29,37H,2-8,17-22H2,1H3,(H,34,41)(H,39,40);1H/t28-,29-;/m1./s1",QNNBMSGFNQRUEH-PQQSRXGVSA-N,C33H44ClN3O6,614.2,"4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride","Aplaviroc hydrochloride|Aplaviroc HCl|461023-63-2|Aplaviroc hydrochloride [USAN]|GW873140A|UNII-04D148Z3VR|DTXSID1047316|04D148Z3VR|GW-873140A|Aplaviroc hydrochloride (USAN)|DTXCID9027316|APLAVIROC HYDROCHLORIDE [MI]|APLAVIROC HYDROCHLORIDE [WHO-DD]|BENZOIC ACID, 4-(4-(((3R)-1-BUTYL-3-((R)-CYCLOHEXYLHYDROXYMETHYL)-2,5-DIOXO-1,4,9-TRIAZASPIRO(5.5)UNDEC-9-YL)METHYL)PHENOXY)-, MONOHYDROCHLORIDE|RefChem:113421|4-(4-(((3R)-1-BUTYL-3-((R)-CYCLOHEXYLHYDROXYMETHYL)-2,5-DIOXO-1,4,9-TRIAZASPIRO(5.5)UNDEC-9-YL)METHYL)PHENOXY)BENZOIC ACID HYDROCHLORIDE|Aplaviroc (hydrochloride)|461023-63-2 (HCL)|ONO-4128|4-(4-(((3R)-1-Butyl-3-((R)-cyclohexylhydroxymethyl)-2,5-dioxo-1,4,9- triazaspiro(5.5)undec-9-yl)methyl)phenoxy)benzoic acid hydrochloride|4-[4-[[(3R)-1-butyl-3-[(R)-cyclohexyl(hydroxy)methyl]-2,5-dioxo-1,4,9-triazaspiro[5.5]undecan-9-yl]methyl]phenoxy]benzoic acid;hydrochloride|CHEMBL1668019|orb1701187|SCHEMBL4821965|QNNBMSGFNQRUEH-PQQSRXGVSA-N|GLXC-05677|Tox21_300211|HY-17450A|AKOS040747832|NCGC00254150-01|MS-30727|CAS-461023-63-2|CS-0065025|D06557|G17828|Q23731470|(3r)-1-butyl-2,5-dioxo-3-((1r)-1-hydroxy-1-cyclohexylmethyl)-9-(4-(4-carboxyphenyloxy)phenylmethyl)-1,4,9-triazaspiro[5.5]undecane.hydrochloride|Benzoic acid, 4-(4-(((3R)-1-butyl-3-((R)-cyclohexylhydroxymethyl)-2,5-dioxo-1,4,9- triazaspiro(5.5)undec-9-yl)methyl)phenoxy)-, monohydrochloride"
NAFAMOSTAT,4413,,"InChI=1S/C19H17N5O2/c20-17(21)14-2-1-13-10-16(8-5-12(13)9-14)26-18(25)11-3-6-15(7-4-11)24-19(22)23/h1-10H,(H3,20,21)(H4,22,23,24)",MQQNFDZXWVTQEH-UHFFFAOYSA-N,C19H17N5O2,347.4,(6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate,"Nafamostat|81525-10-2|Nafamostatum|6-Amidino2-naphthyl 4-guanidinobenzoate|Y25LQ0H97D|p-Guanidinobenzoic acid ester with 6-hydroxy-2-naphthamidine|CKD314|6-(Aminoiminomethyl)-2-naphthalenyl 4-((aminoiminomethyl)amino)benzoate|Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester|6-carbamimidoylnaphthalen-2-yl 4-((diaminomethylidene)amino)benzoate|6-carbamimidoylnaphthalen-2-yl 4-[(diaminomethylidene)amino]benzoate|6'-amidino-2-naphthyl 4-guanidinobenzoate|RefChem:831686|Benzoic acid, 4-((aminoiminomethyl)amino)-, 6-(aminoiminomethyl)-2-naphthalenyl ester, dihydrochloride|6-carbamimidoylnaphthalen-2-yl 4-carbamimidamidobenzoate|Nafamostat [INN]|Nafamstat|(6-carbamimidoylnaphthalen-2-yl) 4-(diaminomethylideneamino)benzoate|6-carbamimidoylnaphthalen-2-yl 4-guanidinobenzoate|CHEMBL273264|Nafamostat (INN)|Benzoic acid, 4-[(aminoiminomethyl)amino]-,6-(aminoiminomethyl)-2-naphthalenyl ester|Nafamostatum [Latin]|(6-carbamimidoylnaphthalen-2-yl) 4-carbamimidamidobenzoate|benzoic acid, 4-[(aminoiminomethyl)amino]-, 6-(aminoiminomethyl)-2-naphthalenyl ester, methanesulfonate (1:2)|NCGC00160398-01|UNII-Y25LQ0H97D|Nafabelltan|NAFAMOSTAT [MI]|NAFAMOSTAT [WHO-DD]|BSPBio_001194|SCHEMBL135503|SCHEMBL135504|GTPL4262|orb1704313|DTXSID0048420|SCHEMBL29358879|SCHEMBL29360143|SCHEMBL29429443|SCHEMBL29429445|CHEBI:135466|HMS3742K19|ALBB-027243|BCP13085|GDA52510|HY-B0190|BDBM50063698|AKOS017259237|DB12598|6-amidino-2-naphthyl p-guanidinobenzoate|NCGC00160398-02|NCGC00160398-03|NCGC00160398-04|NCGC00160398-13|BS-17665|B1177|FUT-175; FUT 175; FUT175|NS00069533|D08240|G78310|MLS-0435512.0001|AB01566816_01|(6-carbamimidoyl-2-naphthyl) 4-guanidinobenzoate|525N102|BRD-K06674495-334-03-2|BRD-K06674495-334-04-0|Q15409374|4-Guanidino-benzoic acid 6-carbamimidoyl-naphthalen-2-yl ester|4-Guanidino-benzoic acid 6-carbamimidoyl-naphthalen-2-yl ester(FUT-175)|7RF"
ACETOHYDROXAMIC ACID,1990,,"InChI=1S/C2H5NO2/c1-2(4)3-5/h5H,1H3,(H,3,4)",RRUDCFGSUDOHDG-UHFFFAOYSA-N,C2H5NO2,75.07,N-hydroxyacetamide,"acetohydroxamic acid|N-Hydroxyacetamide|546-88-3|Lithostat|Acetylhydroxamic acid|Methylhydroxamic acid|Acetic acid, oxime|Acetohydroximic acid|N-Acetylhydroxylamine|Acethydroxamsaeure|cetohyroxamic acid|N-Acetyl hydroxyacetamide|Acido acetohidroxamico|Acide acetohydroxamique|Acidum acetohydroxamicum|n-hydroxy-acetamide|NSC-176136|4RZ82L2GY5|DTXSID7022546|CHEBI:27777|DTXCID802546|NSC176136|RefChem:58622|2-Hydroxyamino-2-ethanal|G04BX03|208-913-8|Acetamide, N-hydroxy-|Acetohydroxamate|Acethydroxamsaure|Acethydroxamic acid|AHA|ACETOHYDROXAMICACID|Hydroxylamine, N-acetyl-|MFCD00009994|NSC 176136|Acetamide, N-hydroxy- (9CI)|NCGC00094576-01|WLN: QMV1|Acetyl hydroxyamino|Acethydroxamsaeure [German]|Acide acetohydroxamique [French]|Acido acetohidroxamico [Spanish]|Acidum acetohydroxamicum [Latin]|Lithostat (TN)|CAS-546-88-3|ethanehydroxamic acid|CCRIS 1730|HSDB 3585|N-hydroxyacetimidic acid|N-hydroxyethanimidic acid|EINECS 208-913-8|UNII-4RZ82L2GY5|AI3-62232|acetohydroxamsaure|Acetohydroxamic acid (USP/INN)|Acetic acid|oxime|acethydroximic acid|Acetohyroxamic acid|Acetyl hydroxyamine|Prestwick_38|acetohydroxamic-acid|N-oxidanylethanamide|acetohydroxarnic acid|Acetohydroxamic acid [USAN:USP:INN]|methyl hydroximic acid|Spectrum_000020|Spectrum2_000109|Spectrum3_000285|Spectrum4_000138|Spectrum5_000812|CH3C(O)NHOH|CHEMBL734|Acetohydroxamic acid, 98%|SCHEMBL14492|BSPBio_001790|KBioGR_000556|KBioSS_000360|MLS001076662|DivK1c_000821|SCHEMBL325517|SCHEMBL873199|SPECTRUM1500103|SPBio_000098|orb1308080|SCHEMBL1022318|SCHEMBL1276127|SCHEMBL1706414|SCHEMBL3936275|SCHEMBL6026343|SCHEMBL6732588|Acetohydroxamic acid (Standard)|SCHEMBL30804112|CHEBI:49029|HMS502J03|HY-B1235R|KBio1_000821|KBio2_000360|KBio2_002928|KBio2_005496|KBio3_001290|ACETOHYDROXAMIC ACID [MI]|MSK2954|NSC5073|NINDS_000821|ACETOHYDROXAMIC ACID (AHA)|ACETOHYDROXAMIC ACID [INN]|HMS1920A07|HMS2091G07|HMS2231M17|HMS5083L19|Pharmakon1600-01500103|ACETOHYDROXAMIC ACID [HSDB]|ACETOHYDROXAMIC ACID [USAN]|HY-B1235|NSC-5073|STR08084|ACETOHYDROXAMIC ACID [VANDF]|Tox21_111301|ACETOHYDROXAMIC ACID [MART.]|BDBM50099857|CCG-38927|GEO-00010|NSC755855|s4602|ACETOHYDROXAMIC ACID [USP-RS]|ACETOHYDROXAMIC ACID [WHO-DD]|AKOS000172340|Tox21_111301_1|AB01014|CS-4881|DB00551|FA10797|NSC-755855|IDI1_000821|NCGC00094576-02|NCGC00094576-03|NCGC00094576-05|ACETOHYDROXAMIC ACID [ORANGE BOOK]|BP-13320|SMR000499570|SBI-0051270.P003|ACETOHYDROXAMIC ACID [USP MONOGRAPH]|DB-052632|A0051|NS00018656|EN300-36948|46A883|C06808|D00220|AB00051907_07|A830321|F078547|Q481822|SR-01000763642|SR-01000763642-2|BRD-K21615095-001-08-4|Z59181917|Acetohydroxamic acid, United States Pharmacopeia (USP) Reference Standard"
HYDROQUINONE,785,,"InChI=1S/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8H",QIGBRXMKCJKVMJ-UHFFFAOYSA-N,C6H6O2,110.11,"benzene-1,4-diol","hydroquinone|123-31-9|Benzene-1,4-diol|1,4-benzenediol|Quinol|1,4-Dihydroxybenzene|p-Benzenediol|p-Hydroquinone|p-Hydroxyphenol|4-Hydroxyphenol|p-Dihydroxybenzene|Benzoquinol|Eldoquin|hydroquinol|Eldopaque|Phiaquin|p-Dioxybenzene|Solaquin forte|Hydroquinole|Idrochinone|Tecquinol|Benzohydroquinone|Hidroquinone|Arctuvin|Tequinol|Dihydroxybenzene|Eldopaque Forte|Eldoquin Forte|Hydrochinon|Tenox HQ|Diak 5|Benzene, p-dihydroxy-|1,4-Dihydroxy-benzol|Usaf ek-356|1,4-Diidrobenzene|p-Dioxobenzene|1,4-Dihydroxybenzen|para-Dioxybenzene|para-Hydroquinone|NCI-C55834|Pyrogentistic acid|Black and White Bleaching Cream|1,4-Dihydroxy-benzeen|para-Dihydroxybenzene|beta-quinol|alpha-hydroquinone|DTXSID7020716|CHEBI:17594|NSC-9247|XV74C1N1AE|Hydroquinone (USP)|Hydroquinone [USP]|DTXCID70716|NSC9247|Balancer|Medisilke|Supermax|Medisilke Night|Skin Lightener|Skin Lightening|Topiclear Paris|Clear Action|Double White|Exence White|Hydroquinone gel|Idole Carrot|Miracle Fade|Movate Carrot|Movate Lemon|Scarlight Md|Caro Light|Hot Movate|Idole Black|Topiclear Carrot|Body Fade Creme|Hydroquinone 4%|Ultra Glow Fade|Hydroquinone cream|Light The Way|Vivant True Tone|Hydro-Q|Obagi-C|Brighten Lightening|I-max Lightening L|I-max Lightening 5|PIONA|Skin lightening Cream|African Formula Black|Idole Skin Lightening|Skin Beautifying Milk|African Formula Carrot|Essential Fade Complex|Neova Complex Hq Plus|NU-DERM BLENDER|NU-DERM CLEAR|RefChem:5893|Skin Lightening Complex|SYMBA Skin Lightening|Image Md Lightening Rx|Vivant True Tone Forte|HYDROQUINONE 6%|HYDROQUINONE 8%|Gold Cosmetics Adi Clear|Rejuvaderm Medispa Fading|Topiclear Skin Lightening|Dermaclair Skin Lightening|HYDROQUINONE 8%.|HQ Plus Brightening Cream|Advanced Dual Complex Fade|Dark Spot Lightening Cream|PLUS Skin lightening Cream|Gold Cosmetics Bleach Cream|Vividly Brilliant Perfecting|Skin Lightening Rodan Fields|Pure Valley Miracle Age Spot|Precious Beauty Skin Lightening|ULTIMATE Skin lightening Cream|Body Fade Creme Maximum Strength|Gold Cosmetics Bleach Cream Forte|CONDITION AND ENHANCE CLEAR|OLIVIA QUIDO BLEMISH ERASER|Ageless Total Skin Bleaching Serum|Gold Cosmetics Bleach Cream Silver|Divine Derrier Skin Bleaching cream|HQ Plus Brightening Cream VI Derm|Obagi-C Rx system C-Therapy Night|CONDITION AND ENHANCE BLENDER|Dermisa Skin Fade Vitamin C infused|141010 HYDROQUINONE 4%|141011 HYDROQUINONE 6%|141030 HYDROQUINONE 8%|141055 HYDROQUINONE 6%|141067 HYDROQUINONE 8%|Idole Natural Organic Skin Lightening|Obagi C Rx System C Clarifying Serum|Teatrical Pro-Aclarant Skin Lightening|Hydroquinone, Octisalate and Zinc Oxide|Dr. Throwers Skin Lightening Moisturizing|Nu-derm Blender Skin Lightener and Blending|Nu-derm Clear Skin Bleaching and Corrector|Advanced Dual Complex Fade Maximum Strength Plus|ZO Skin Health Pigment Control Creme Hydroquinone|ELASTIDERM DECOLLETAGE SKIN LIGHTENING COMPLEX|Condition and Enhance Clear Skin Bleaching and Corrector|OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily|ZO Skin Health Pigment Control Program Plus Hydroquinone|Condition and Enhance Blender Skin Lightener and Blending|HYDROQUINONE, HOMOSALATE, OCTISALATE AND ZINC OXIDE|HYDROQUINONE, HOMOSALATE, OCTISALATE, and ZINC OXIDE|Elastiderm Decolletage Skin Lightening Complex Chest and Neck|ZO Skin Health Pigment Control Plus Blending Creme Hydroquinone|Obagi-C Rx system C-Therapy Night Skin Lightening with Vitamins C and E|ZO Skin Health Pigment Control plus Brightening Creme Hydroquinone plus Vitamin C|204-617-8|OBAGI-C Rx system C-CLARIFYING SERUM NORMAL TO oily SKIN LIGHTENING SERUM WITH VITAMIN C|Dihydroquinone|Derma-Blanch|Hydrochinone|Artra|HE 5|Melanex|Idrochinone [Italian]|Hydrochinon [Czech, Polish]|1,4-Dihydroxybenzen [Czech]|1,4-Diidrobenzene [Italian]|1,4-Dihydroxy-benzeen [Dutch]|1,4-Dihydroxy-benzol [German]|NSC 9247|MFCD00002339|UN2662|HQ|AI3-00072|CHEMBL537|Hydroquinone [UN2662]  [Poison]|1,4-Dihydroxybenzene (ring-d4)|NCGC00015523-02|para-Hydroxyphenol|Quinol; 1,4-Benzenediol; 1,4-Dihydroxybenzene|Benzene-1,4-diol (Hydroquinone)|Eldopacque|Epiquin|Sunvanish|p Benzendiol|p-Dihydroquinone|CAS-123-31-9|SMR000059154|CCRIS 714|1,4-Hydroxybenzene|HSDB 577|SR-01000075920|4-DIHYDROXYBENZENE|EINECS 204-617-8|UNII-XV74C1N1AE|hydroquinon|Hydroquinoue|hydroq uinone|hydroquinone gr|a-Hydroquinone|Black & White Bleaching Cream|p-Hydroxybenzene|b-Quinol|4-Benzenediol|4-hydroxyphenoxy|Hydroquinone, HQ|.beta.-Quinol|1,4 benzenediol|p-dihydroxy benzene|PLQ|Artra (Salt/Mix)|HYDROP|.alpha.-Hydroquinone|phenol derivative, 4|4-hydroxyphenyl alcohol|Spectrum_001757|4e3h|SpecPlus_000769|1,4-Dihydrobenzoquinone|ELDOQUIN (TN)|hydroquinone for synthesis|Spectrum2_001672|Spectrum3_000656|Spectrum4_000633|Spectrum5_001430|HYDROQUINONE [MI]|Lopac-H-9003|WLN: QR DQ|bmse000293|Epitope ID:116206|EC 204-617-8|HYDROQUINONE [HSDB]|HYDROQUINONE [IARC]|HYDROQUINONE [VANDF]|1,4-Dihydroxybenzene Quinol|Lopac0_000577|SCHEMBL15516|SCHEMBL50071|BSPBio_002291|HYDROQUINONE [MART.]|KBioGR_001246|KBioSS_002237|1,4-Dihydroxybenzene, XIII|MLS000069815|MLS001074911|orb342175|BIDD:ER0340|DivK1c_006865|HYDROQUINONE [USP-RS]|HYDROQUINONE [WHO-DD]|Hydroquinone, LR, >=99%|SCHEMBL396267|SCHEMBL739813|SCHEMBL835344|SPECTRUM1504237|Hydrochinon(CZECH, POLISH)|SPBio_001883|SCHEMBL2991028|SCHEMBL10782451|BDBM26190|Hydroquinone, puriss., 99.0%|KBio1_001809|KBio2_002237|KBio2_004805|KBio2_007373|KBio3_001511|MSK2901|DTXSID001316808|HMS1922H15|HMS2093E08|HMS3261D16|HYDROQUINONE [ORANGE BOOK]|Pharmakon1600-01504237|HY-B0951|HYDROQUINONE [USP MONOGRAPH]|Tox21_110169|Tox21_202345|Tox21_300015|Tox21_500577|CCG-39082|NSC758707|s4580|SBB060421|STK397446|AKOS000119003|Tox21_110169_1|TRI-LUMA COMPONENT HYDROQUINONE|DB09526|FH01233|LP00577|NSC-758707|RP10102|SDCCGSBI-0050559.P003|UN 2662|Hydroquinone, ReagentPlus(R), >=99%|Hydroquinone, USP, 99.0-100.5%|NCGC00015523-01|NCGC00015523-03|NCGC00015523-04|NCGC00015523-05|NCGC00015523-06|NCGC00015523-07|NCGC00015523-08|NCGC00015523-09|NCGC00015523-10|NCGC00015523-11|NCGC00015523-12|NCGC00015523-13|NCGC00015523-19|NCGC00090880-01|NCGC00090880-02|NCGC00090880-03|NCGC00090880-04|NCGC00090880-05|NCGC00254037-01|NCGC00259894-01|NCGC00261262-01|BP-21160|DA-33570|Hydroquinone, ReagentPlus(R), >=99.5%|SBI-0050559.P002|Hydroquinone, SAJ first grade, >=99.0%|EU-0100577|H0186|Hydroquinone, SAJ special grade, >=99.0%|NS00004421|ST50214344|EN300-18053|Hydroquinone, meets USP testing specifications|C00530|D00073|H 9003|AB00053361_08|F146000|Q419164|BUTYLHYDROXYANISOLE IMPURITY A [EP IMPURITY]|SR-01000075920-1|SR-01000075920-4|BRD-K11227669-001-07-8|BRD-K11227669-001-08-6|Q27102742|Z57127551|094CADDB-59BF-4EDF-B278-59791B203EA2|F1908-0167|Hydroquinone, certified reference material, TraceCERT(R)|Hydroquinone, United States Pharmacopeia (USP) Reference Standard|InChI=1/C6H6O2/c7-5-1-2-6(8)4-3-5/h1-4,7-8|Hydroquinone, Pharmaceutical Secondary Standard; Certified Reference Material|3225-30-7"
C-1311,132127,,"InChI=1S/C20H22N4O2/c1-3-23(4-2)10-9-21-15-6-7-16-19-18(15)20(26)14-11-13(25)5-8-17(14)24(19)12-22-16/h5-8,11-12,21,25H,3-4,9-10H2,1-2H3",CUNDRHORZHFPLY-UHFFFAOYSA-N,C20H22N4O2,350.4,"10-[2-(diethylamino)ethylamino]-5-hydroxy-1,14-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-2(7),3,5,9,11,13(16),14-heptaen-8-one","Symadex|138154-39-9|XLS-002|C 1311|C-1311|MZ4Y5H4OAB|DTXSID10160508|RefChem:122456|DTXCID0082999|C1311|5-((2-(Diethylamino)ethyl)amino)-8-hydroxy-6H-imidazo[4,5,1-de]acridin-6-one|Symadex free base|CHEMBL338604|NSC-645809|138154-39-9 (free base)|Imidazoacridinone|6H-Imidazo[4,5,1-de]acridin-6-one, 5-[[2-(diethylamino)ethyl]amino]-8-hydroxy-|5-((2-(Diethylamino)ethyl)amino)-8-hydroxy-6H-imidazo(4,5,1-de)acridin-6-one|6H-Imidazo(4,5,1-de)acridin-6-one, 5-((2-(diethylamino)ethyl)amino)-8-hydroxy-|10-[2-(diethylamino)ethylamino]-5-hydroxy-1,14-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-2(7),3,5,9,11,13(16),14-heptaen-8-one|CCRIS 7541|UNII-MZ4Y5H4OAB|Neuro_000342|IMidazoacridone|SCHEMBL2442405|Symadex, >=98% (HPLC)|SCHEMBL31238169|CUNDRHORZHFPLY-UHFFFAOYSA-N|NFA15439|BDBM50008347|NCGC00487207-01|HY-10919|NCI60_015698|DB-316802|154D399|Q27284307|5-((2-DIETHYLAMINO)ETHYL)AMINO)-8-HYDROXY-6H-IMIDAZO(4,5,1-DE)ACRIDIN-6-ONE|5-(2-(diethylamino)ethylamino)-8-hydroxy-6h-imidazo[4,5,1-de]acridin-6-one|5-(2-Diethylamino-ethylamino)-8-hydroxy-2,10b-diaza-aceanthrylen-6-one(2.0MHCl.1.0MH2O)"
FURAMIDINE,126437,,"InChI=1S/C18H16N4O/c19-17(20)13-5-1-11(2-6-13)15-9-10-16(23-15)12-3-7-14(8-4-12)18(21)22/h1-10H,(H3,19,20)(H3,21,22)",ZJHZBDRZEZEDGB-UHFFFAOYSA-N,C18H16N4O,304.3,4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide,"Furamidine|73819-26-8|DB75|2,5-bis(4-amidinophenyl)furan|Benzenecarboximidamide, 4,4'-(2,5-furandiyl)bis-|08GH1YF0RA|NSC-305831|DTXSID00224264|DB-75|2,5-BAPF|WR-199385|RefChem:141734|DTXCID00146755|2,5-bis(4-guanylphenyl)furan|Furamidine Dihydrochloride|4,4'-(2,5-Furandiyl)bis(benzenecarboximidamide)|4-[5-(4-carbamimidoylphenyl)furan-2-yl]benzenecarboximidamide|73819-26-8 (free base)|DB75;NSC 305831|4,4'-(Furan-2,5-diyl)dibenzimidamide|NSC305831|DB 75|BRN 1435532|Furandiamidine|4,4'-(2,5-Furandiyl)bisbenzenecarboximidamide Dihydrochloride; 2,5-Bis(4-amidinophenyl)furan Dihydrochloride; 2,5-Bis(4-guanylphenyl)furan Dihydrochloride; WR 199385|Furamidine dihydrochloride?|UNII-08GH1YF0RA|NCIStruc1_001694|NCIStruc2_001468|5-18-07-00177 (Beilstein Handbook Reference)|CHEMBL24057|SCHEMBL549198|orb1709656|2,5-Bis(4-amidinophenyl)-furan|LNA78681|BDBM50388602|Benzenecarboximidamide, 4,4'-(2,5-furandiyl)bis-, dihydrochloride|CCG-37385|NCGC00014688|NCI305831|AKOS030254780|HY-110137A|NCGC00014688-02|NCGC00014688-03|NCGC00014688-06|NCGC00097791-01|NCGC00097791-02|NCI60_002601|DB-202489|DB-262847|CS-0058706|4,4'-(2,5-FURANDIYL)BIS [BENZENECARBOXIMIDAMIDE]|4-[5-(4-Carbamimidoylphenyl)-2-furyl ]benzenecarboximidamide|BGF"
O-CHLOROACETYLCARBAMOYLFUMAGILLOL,369976,,"InChI=1S/C19H28ClNO6/c1-11(2)5-6-13-18(3,27-13)16-15(24-4)12(7-8-19(16)10-25-19)26-17(23)21-14(22)9-20/h5,12-13,15-16H,6-10H2,1-4H3,(H,21,22,23)/t12-,13-,15-,16-,18+,19+/m1/s1",MSHZHSPISPJWHW-PVDLLORBSA-N,C19H28ClNO6,401.9,"[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] N-(2-chloroacetyl)carbamate","Tnp-470|129298-91-5|O-(chloroacetylcarbamoyl)fumagillol|O-Chloroacetylcarbamoylfumagillol|DRG-0148|NSC642492|NSC-642492|DTXSID0041141|CHEBI:90748|X47GR46481|DTXCID00819891|(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl (chloroacetyl)carbamate|[(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl] N-(2-chloroacetyl)carbamate|((3R,4S,5S,6R)-5-methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl)-1-oxaspiro(2.5)octan-6-yl) N-(2-chloroacetyl)carbamate|(3R,4S,5S,6R)-5-methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro(2.5)octan-6-yl (chloroacetyl)carbamate|LODAMIN|RefChem:898528|mPEG-PLA-TNP-470|TNP470|AGM1470|5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2,5)oct-6-yl(chloroacetyl) carbamate|(3R,4S,5S,6R)-5-Methoxy-4-((2R,3R)-2-methyl-3-(3-methyl-2-butenyl)-oxiranyl)-1-oxaspiro (2,5) oct-6-yl(chloroacetyl) Carbamate|(3R-(3alpha,4alpha(2R*,3R*),5beta,6beta))-5-Methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)oct-6-yl (chloroacetyl)carbamate|tnp 470|Carbamic acid, N-(2-chloroacetyl)-, (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-buten-1-yl)-2-oxiranyl]-1-oxaspiro[2.5]oct-6-yl ester|CHEMBL424278|(3R,4S,5S,6R)-5-methoxy-4-((2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl)-1-oxaspiro[2.5]octan-6-yl (2-chloroacetyl)carbamate|NSC 642492|CCRIS 8049|UNII-X47GR46481|CARBAMIC ACID, N-(2-CHLOROACETYL)-, (3R,4S,5S,6R)-5-METHOXY-4-((2R,3R)-2-METHYL-3-(3-METHYL-2-BUTEN-1-YL)-2-OXIRANYL)-1-OXASPIRO(2.5)OCT-6-YL ESTER|(3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-en-1-yl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-yl N-(2-chloroacetyl)carbamate|orb1706526|SCHEMBL1652694|BDBM17446|MSHZHSPISPJWHW-PVDLLORBSA-N|TNP-470 [MI]|GLXC-06754|EFA29891|Tox21_303433|EX-A11072|AKOS040742752|CCG-208103|CS-8106|DB08633|NCGC00257293-01|[(3R,6R,7S,8S)-7-methoxy-8-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-2-oxaspiro[2.5]octan-6-yl] N-(2-chloroacetyl)carbamate|DA-68246|MS-26845|NCI60_014346|AGM-1470; NSC 642492|HY-101932|TNP-470, >=98% (HPLC)|CAS-129298-91-5|NS00015601|F97067|298T915|BRD-K53597484-001-01-9|BRD-K53597484-001-02-7|Q27097825|(CHLOROACETYL)CARBAMIC ACID (3R,4S,5S,5R)-5-METHOXY-4-[(2R,3R)-2-METHYL-3-(3-METHYL-2-BUTENYL)OXIRANYL]-1-OXASPIRO[2.5]OCT-6-YL ESTER|Carbamic acid, (3R,4S,5S,6R)-5-methoxy-4-[ (2R,3R)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl ester|Carbamic acid, (chloroacetyl)-, (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methyl-2-butenyl)oxiranyl]-1-oxaspiro[2.5]oct-6-yl ester|Carbamic acid, (chloroacetyl)-, 5-methoxy-4-(2-methyl-3-(3-methyl-2-butenyl)oxiranyl)-1-oxaspiro(2.5)oct-6-yl ester, (3R-(3alpha,4alpha(2R*,3R*),5beta,6beta))-"
BESONPRODIL,156328,,"InChI=1S/C21H23FN2O3S/c22-17-3-1-15(2-4-17)13-16-7-9-24(10-8-16)11-12-28(26)18-5-6-19-20(14-18)27-21(25)23-19/h1-6,14,16H,7-13H2,(H,23,25)",FCBQJNCAKZSIAH-UHFFFAOYSA-N,C21H23FN2O3S,402.5,"6-[2-[4-[(4-fluorophenyl)methyl]piperidin-1-yl]ethylsulfinyl]-3H-1,3-benzoxazol-2-one","Besonprodil|253450-09-8|CI-1041|Co 200461|PD 0196860|PD196860|5K3N2D15WW|DTXSID2047270|CO-200461|DTXCID0027270|PD-0196860|6-(2-(4-(4-Fluorobenzyl)-piperidin-1-yl)-ethanesulfinyl)-3H-benzoxazol-2-one|6-((2-(4-((4-fluorophenyl)methyl)-1-piperidinyl)ethyl)sulfinyl)-2-(3H)-benzoxazolone|6-[2-[4-(4-Fluorobenzyl)-piperidin-1-yl]-ethanesulfinyl]-3H-benzoxazol-2-one|RefChem:119132|Besonprodil (USAN)|Besonprodil [USAN]|6-[2-[4-[(4-fluorophenyl)methyl]piperidin-1-yl]ethylsulfinyl]-3H-1,3-benzoxazol-2-one|CHEMBL219631|6-({2-[4-(4-FLUOROBENZYL)PIPERIDIN-1-YL]ETHYL}SULFINYL)-1,3-BENZOXAZOL-2(3H)-ONE|2(3H)-Benzoxazolone, 6-((2-(4-((4-fluorophenyl)methyl)-1-piperidinyl)ethyl)sulfinyl)|CI 1041; Co 200461; PD 0196860|PD 196860|UNII-5K3N2D15WW|orb1698161|SCHEMBL2257896|SCHEMBL29388542|Tox21_300436|BDBM50204884|AKOS040750785|NCGC00248038-01|NCGC00254479-01|CAS-253450-09-8|NS00015712|D03100|Q4896342|6-([2-[4-(4-FLUOROBENZYL)-1-PIPERIDINYL]ETHYL]SULFINYL)-1,3-BENZOXAZOL-2(3H)-ONE|6-(2-(4-(4-fluorobenzyl)piperidin-1-yl)ethylsulfinyl)benzo[d]oxazol-2(3H)-one|6-{2-[4-(4-Fluoro-benzyl)-piperidin-1-yl]-ethanesulfinyl}-3H-benzooxazol-2-one"
TRAXOPRODIL,219101,,"InChI=1S/C20H25NO3/c1-15(19(23)16-7-9-18(22)10-8-16)21-13-11-20(24,12-14-21)17-5-3-2-4-6-17/h2-10,15,19,22-24H,11-14H2,1H3/t15-,19+/m0/s1",QEMSVZNTSXPFJA-HNAYVOBHSA-N,C20H25NO3,327.4,"1-[(1S,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]-4-phenylpiperidin-4-ol","Traxoprodil|134234-12-1|CP-101606|UTC046R5HM|DTXSID90158605|1-Piperidineethanol, 4-hydroxy-alpha-(4-hydroxyphenyl)-beta-methyl-4-phenyl-, (S-(R*,R*))-|traxoprodilum|RefChem:190698|DTXCID6081096|(Alpha-S,Beta-S)-4-Hydroxy-Alpha-(P-Hydroxyphenyl)-Beta-Methyl-4-Phenyl-1-Piperidineethanol|1-((1S,2S)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl)-4-phenylpiperidin-4-ol|CP-101,606|Traxoprodil [INN]|CP 101606|1-[(1s,2s)-1-hydroxy-1-(4-hydroxyphenyl)propan-2-yl]-4-phenylpiperidin-4-ol|(1S,2S)-1-(4-HYDROXYPHENYL)-2-(4-HYDROXY-4-PHENYLPIPERIDINO)-1-PROPANOL|MFCD00926469|CHEMBL17350|188591-67-5 (mesylate)|134234-12-1 (free base)|CP101606|(1S,2S)-1-(4-Hydroxy-phenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol|1-[(1s,2s)-2-hydroxy-2-(4-hydroxyphenyl)-1-methylethyl]-4-phenylpiperidin-4-ol|traxoprodil(cp-101,606)|CP 98113|UNII-UTC046R5HM|nective|Traxoprodil?|CP 101,606|SCHEMBL4248|TRAXOPRODIL [WHO-DD]|MLS006010672|GTPL4163|orb1296111|Traxoprodil - Bio-X trade mark|QEMSVZNTSXPFJA-HNAYVOBHSA-N|BCP13195|BDBM50032651|AKOS015959795|BCP9000547|CS-W018847|FT65194|HY-W018061|1-[(1S,2S)-2-hydroxy-2-(4-hydroxyphenyl)-1-methyl-ethyl]-4-phenyl-piperidin-4-ol|1-Piperidineethanol, 4-hydroxy-alpha-(4-hydroxyphenyl)-beta-methyl-4-phenyl-, (alphaS,betaS)-|NCGC00386543-02|BT300136|SMR004701654|NS00116160|(+)-CP 101606|8Y-7002|CP-101,606, >=98% (HPLC)|Q7836470|BRD-K38158531-001-01-3|BRD-K38158531-001-02-1|(1 S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol|(1S,2S)-1-(4-hydroxyphenyl)-2-(4-hydroxy-4-phenylpiperidin-1-yl)-1-propanol|[S-(R*,R*)]-4-Hydroxy-alpha-(4-hydroxyphenyl)-beta-methyl-4-phenyl-1-piperidineethanol|1-[(1S,2S)-2-Hydroxy-2-(4-hydroxy-phenyl)-1-methyl-ethyl]-4-phenyl-piperidin-4-ol|1-[(S)-2-(S)-Hydroxy-2-(4-hydroxy-phenyl)-1-methyl-ethyl]-4-phenyl-piperidin-4-ol|CP-101606;CP101606;CP 101606;CP101,606;CP-101,606;CP 101,606|(.ALPHA.S,.BETA.S)-4-HYDROXY-.ALPHA.-(P-HYDROXYPHENYL)-.BETA.-METHYL-4-PHENYL-1-PIPERIDINEETHANOL|[S-(R*,R*)]-4-Hydroxy-?-(4-hydroxyphenyl)-?-methyl-4-phenyl-1-piperidineethanol;CP101;606|1-PIPERIDINEETHANOL, 4-HYDROXY-.ALPHA.-(4-HYDROXYPHENYL)-.BETA.-METHYL-4-PHENYL-, (S-(R*,R*))-|Traxoprodil; (1S,2S)-1-(4-hydroxy-phenyl)-2-(4-hydroxy-4-phenylpiperidino)-1-propanol; CP-101606"
AR9281,12000797,,"InChI=1S/C18H29N3O2/c1-12(22)21-4-2-16(3-5-21)19-17(23)20-18-9-13-6-14(10-18)8-15(7-13)11-18/h13-16H,2-11H2,1H3,(H2,19,20,23)",HUDQLWBKJOMXSZ-UHFFFAOYSA-N,C18H29N3O2,319.4,1-(1-acetylpiperidin-4-yl)-3-(1-adamantyl)urea,"AR-9281|913548-29-5|APAU|1-(1-Acetyl-piperidin-4-yl)-3-adamantan-1-yl-urea|Apau (enzyme inhibitor)|Ar9281|4HA03Q8EZ9|1-(1-acetylpiperidin-4-yl)-3-(1-adamantyl)urea|1-(Adamantane-1-yl)-3-(1-acetylpiperidine-4-yl)urea|J3.137.087F|Urea, N-(1-acetyl-4-piperidinyl)-N'-tricyclo(3.3.1.13,7)dec-1-yl-|4-Piperidinamine, 1-acetyl-N-((tricycle(3.3.1.13,7)dec-1-ylamino)carbonyl)-|AR 9281|RefChem:113626|1-(1-acetylpiperidin-4-yl)-3-(adamantan-1-yl)urea|1-[(1-Acetylpiperidin-4-yl)-3-adamantan-1-yl]urea|CHEMBL436774|UNII-4HA03Q8EZ9|SCHEMBL654229|3-(1-acetylpiperidin-4-yl)-1-(adamantan-1-yl)urea|orb1308643|SCHEMBL18464997|GTPL13112|CHEBI:232302|HUDQLWBKJOMXSZ-UHFFFAOYSA-N|BDBM100423|GLXC-26384|NLB54829|BDBM50191854|AKOS030231617|DB06345|compound 14a [PMID: 21211973]|DA-71010|MS-24725|HY-111151|CS-0034433|D87139|1-(1-acetyl-4-piperidyl)-3-(1-adamantyl)urea|EN300-1700040|EN300-20353710|EN300-27126239|US8501783, 1153|1-(adamant-1-yl)-3-(1-acetylpiperidin-4-yl) urea|N-(1-acetylpiperidin-4-yl)-N''-(adamant-1-yl)urea|N-(1-Acetylpiperidin-4-yl)-N'-(adamant-1-yl) urea|Q27259593|N-(1-acetyl-piperidin-4-yl)-N''-(adamantan-1-yl)urea|3-(1-acetylpiperidin-4-yl)-1-[(3R,5R)-adamantan-1-yl]urea|3-(1-acetylpiperidin-4-yl)-1-[(3R,5S,7s)-adamantan-1-yl]urea"
GOSSYPOL,3503,,"InChI=1S/C30H30O8/c1-11(2)19-15-7-13(5)21(27(35)23(15)17(9-31)25(33)29(19)37)22-14(6)8-16-20(12(3)4)30(38)26(34)18(10-32)24(16)28(22)36/h7-12,33-38H,1-6H3",QBKSWRVVCFFDOT-UHFFFAOYSA-N,C30H30O8,518.6,"7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde","gossypol|303-45-7|Pogosin|Tash 1|No Fertil|(+-)-Gossypol|7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-ylnaphthalen-2-yl)-2,3,8-trihydroxy-6-methyl-4-propan-2-ylnaphthalene-1-carbaldehyde|BL 193|CCRIS 2689|DTXSID5023110|NSC56817|NSC 56817|NSC-56817|NSC 624336|NSC-624336|BRN 1917878|KAV15B369O|AI3-22957|BL-193|NSC624336|DTXCID803110|CHEBI:28584|8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methyl-2,2'-bisnaphthalene|(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-|2,2'-bis[8-formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene]|[2,2'-Binaphthalene]-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-|1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde|2,2'-bis(8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene)|1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)(2,2'-binaphthalene)-8,8'-dicarboxaldehyde|Cottonseed Meal Toxin|RefChem:782655|2,2'-bis(1,6,7-trihydroxy-4-methyl-5-isopropyl-8-aldehydonaphthalene)|(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6'7, 7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-|1,1',6,6',7,7'-Hexahydroxy-5,5'-diisopropyl-3-3'-dimethyl(2,2'-binaphthalene)-8,8'-dicarboxaldehyde|90141-22-3|(-)-Gossypol|(+)-Gossypol|(R)-Gossypol|(R)-(-)-Gossypol|AT 101|(+/-)-Gossypol|20300-26-9|1,1',6,6',7,7'-Hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-[2,2'-binaphthalene]-8,8'-dicarbaldehyde|AT101|MFCD00017352|Gossypol, (R)-|Gossypol, (S)-|XNA7DR63CQ|8DY2X8LXW4|CHEMBL51483|303-45-7 (free)|2,2'-Bis(1,6,7-trihydroxy-3-methyl-5-isopropyl-8-aldehydonaphthalene)|Gossypol-d2|NSC-726190|(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-, (+)-|7-[8-formyl-1,6,7-trihydroxy-3-methyl-5-(propan-2-yl)naphthalen-2-yl]-2,3,8-trihydroxy-6-methyl-4-(propan-2-yl)naphthalene-1-carbaldehyde|NCGC00016423-03|CAS-303-45-7|ST065835|racemic-Gossypol|[2,2'-Binaphthalene]-8,8'-dicarboxaldehyde,1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-, (2R)-|4-08-00-03754 (Beilstein Handbook Reference)|7-(8-formyl-1,6,7-trihydroxy-5-isopropyl-3-methyl-2-naphthyl)-2,3,8-trihydroxy-4-isopropyl-6-methyl-naphthalene-1-carbaldehyde|113580-77-1|gosipol|( inverted exclamation markA)-GOSSYPOL FROM COTTON SEEDS|7-[8-formyl-1,6,7-trihydroxy-3-methyl-5-(methylethyl)(2-naphthyl)]-2,3,8-trihy droxy-6-methyl-4-(methylethyl)naphthalenecarbaldehyde|Gossypol Sodium Salt|Gissypol, (R)-|Sodium Salt, Gossypol|(S)-(+)-Gossypol|Gossypol, (+)-Isomer|Gossypol, (-)-Isomer|SR-01000597521|C30H30O8|Gossypol Dipotassium Salt|UNII-XNA7DR63CQ|Gossypol, (+-)-Isomer|Dipotassium Salt, Gossypol|UNII-8DY2X8LXW4|ssypol|UNII-KAV15B369O|HSDB 7872|Gossypol, 4|(S)-Gossypol|GO3|Gossypol (Standard)|Prestwick_1031|R-(-)-gossypol|Spectrum_000359|Spectrum_001521|Tocris-1964|SpecPlus_000602|GOSSYPOL [MI]|GOSSYPOL [VANDF]|GOSSYPOL, R-|1189561-66-7|acetic acid;7-(8-formyl-1,6,7-trihydroxy-5-isopropyl-3-methyl-2-naphthyl)-2,3,8-trihydroxy-4-isopropyl-6-methyl-naphthalene-1-carbaldehyde|Prestwick0_000677|Prestwick1_000677|Prestwick2_000677|Prestwick3_000677|Spectrum2_001472|Spectrum2_001624|Spectrum3_001102|Spectrum3_001516|Spectrum4_000846|Spectrum4_001931|Spectrum5_000693|Spectrum5_001035|2,2'-bi[8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene]|GOSSYPOL [MART.]|Gossypol from cotton seeds|UPCMLD-DP103|NCIMech_000271|cid_3503|SCHEMBL3939|BSPBio_000773|BSPBio_002804|BSPBio_003191|GOSSYPOL, (+)-|KBioGR_001451|KBioGR_002303|KBioSS_000839|KBioSS_002001|(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-, (-)-|MLS000028490|DivK1c_000173|DivK1c_006698|GOSSYPOL R-FORM [MI]|GOSSYPOL S-FORM [MI]|SPECTRUM1504019|SPBio_001423|SPBio_001687|SPBio_002694|BPBio1_000851|cid_227456|GTPL4204|orb1300699|SCHEMBL29355719|SCHEMBL29798874|SCHEMBL30260519|UPCMLD-DP103:001|UPCMLD-DP103:002|BDBM23223|BDBM46555|KBio1_000173|KBio1_001642|KBio2_000839|KBio2_002001|KBio2_003407|KBio2_004569|KBio2_005975|KBio2_007137|KBio3_002024|KBio3_002691|EX-A068|MSK7506|NINDS_000173|GLXC-05080|HMS1570G15|HMS2097G15|HMS3262J15|HMS3268O22|HMS3413L10|HMS3651C18|HMS3677L10|HMS3868F13|HMS5086E08|(+/-)-Gossypol from cotton seeds|ALBB-033351|BCP03607|NEA58077|QDA14122|Tox21_110434|Tox21_500847|CCG-35400|HB0304|HY-13407R|NSC726190|NSC728875|s6852|SBB012338|STK063457|(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahyd|AKOS002140475|Tox21_110434_1|AT25344|BCP9000332|CS-0966|DB13044|FG41647|LMPR0103330002|LP00847|NSC 726190|NSC-728875|SB17342|SDCCGSBI-0051726.P004|IDI1_000173|SMP2_000170|NCGC00016423-01|NCGC00016423-02|NCGC00016423-04|NCGC00016423-05|NCGC00016423-06|NCGC00016423-07|NCGC00016423-08|NCGC00016423-09|NCGC00016423-10|NCGC00016423-12|NCGC00016423-14|NCGC00016423-15|NCGC00016423-17|NCGC00016423-34|NCGC00025331-01|NCGC00025331-02|NCGC00025331-03|NCGC00025331-04|NCGC00025331-06|NCGC00025331-07|NCGC00261532-01|(2,2'-Binaphthalene)-8,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-|AC-20251|AC-30274|AC-34521|AS-55885|BP-25397|HY-13407|HY-15464|NCI60_001588|NCI60_004391|SMR000058386|BCP0726000183|DB-047766|AB00052921|NS00069172|SW197103-2|C07667|303G457|Q411882|SR-01000597521-1|SR-01000597521-5|SR-01000597521-6|(+/-)-Gossypol from cotton seeds, >=95% (HPLC)|BRD-K19295594-001-06-9|BRD-K19295594-001-10-1|BRD-K19295594-001-15-0|BRD-K19295594-001-16-8|BRD-K19295594-015-02-8|BRD-K19295594-015-12-7|BRD-K19295594-015-13-5|BRD-K19295594-015-14-3|2,2'-bis[8-formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthyl]|8-Formyl-1,7-trihydroxy-5-isopropyl-3-methyl-2,2'-bisnaphthalene|2,2'-bis[1,6,7-trihydroxy-3-methyl-5-isopropyl-8-aldehydonaphthyl]|(+/-)-2,2'-bis(8-Formyl-1,6,7-trihydroxy-5-isopropyl-3-methylnaphthalene)|(-)-2,2'-Bis(1,6,7-trihydroxy-3-methyl-5-isopropyl-8-aldehydonaphthalene)|(2,8'-dicarboxaldehyde, 1,1',6,6'7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-|(R)-2,2'-BIS(8-FORMYL-1,6,7-TRIHYDROXY-5-ISOPROPYL-3-METHYLNAPHTHALENE)|[2,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-|(+)1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde|(-)-1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)[2,2'-binaphthalene]-8,8'-dicarboxaldehyde|(2,2'-BINAPHTHALENE)-8,8'-DICARBOXALDEHYDE, 1,1',6,6',7,7'-HEXAHYDROXY-3,3'-DIMETHYL-5,5'-BIS(1-METHYLETHYL)-, (2S)-|(2,2'-BINAPHTHALENE)-8,8'-DICARBOXALDEHYDE, 1,1',6,6',7,7'-HEXAHYDROXY-3,3'-DIMETHYL-5,5'-BIS(1-METHYLETHYL)-, (S)-|[2,8'-dicarboxaldehyde, 1,1',6,6',7,7'- hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-, (2R)-|[2,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1- methylethyl)-|[2,8'-dicarboxaldehyde, 1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-|1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-bis(1-methylethyl)-2,2'-binaphthalene-8,8'-dicarbaldehyde|1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-di(propan-2-yl)-2,2'-binaphthalene-8,8'-dicarbaldehyde|1,1',6,6',7,7'-Hexahydroxy-3,3'-dimethyl-5,5'-di(propan-2-yl)[2,2'-binaphthalene]-8,8'-dicarbaldehyde|1,1',6,6',7,7'-hexahydroxy-3,3'-dimethyl-5,5'-diisopropyl[2,2'-binaphthalene]-8,8'-dicarboxaldehyde|1,1',6,6',7,7'-Hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl[2,2'-binaphthalene]-8,8'-dicarbaldehyde|1,6,7,1',6',7'-hexahydroxy-5,5'-diisopropyl-3,3'-dimethyl-[2,2']binaphthalenyl-8,8'-dicarboxaldehyde|7-(8-Formyl-1,6,7-trihydroxy-3-methyl-5-(methylethyl)(2-naphthyl))-2,3,8-trihydroxy-6-methyl-4-(methylethyl)naphthalenecarbaldehyde|acetic acid;7-(8-formyl-1,6,7-trihydroxy-3-methyl-5-propan-2-yl-2-naphthalenyl)-2,3,8-trihydroxy-6-methyl-4-propan-2-yl-1-naphthalenecarboxaldehyde|ethanoic acid;7-[8-methanoyl-3-methyl-1,6,7-tris(oxidanyl)-5-propan-2-yl-naphthalen-2-yl]-6-methyl-2,3,8-tris(oxidanyl)-4-propan-2-yl-naphthalene-1-carbaldehyde"
VENETOCLAX,49846579,,"InChI=1S/C45H50ClN7O7S/c1-45(2)15-11-33(39(26-45)31-3-5-34(46)6-4-31)29-51-17-19-52(20-18-51)35-7-9-38(42(24-35)60-36-23-32-12-16-47-43(32)49-28-36)44(54)50-61(57,58)37-8-10-40(41(25-37)53(55)56)48-27-30-13-21-59-22-14-30/h3-10,12,16,23-25,28,30,48H,11,13-15,17-22,26-27,29H2,1-2H3,(H,47,49)(H,50,54)",LQBVNQSMGBZMKD-UHFFFAOYSA-N,C45H50ClN7O7S,868.4,"4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide","Venetoclax|1257044-40-8|ABT-199|Venclexta|GDC-0199|ABT199|venclyxto|ABT 199|RG7601|GDC 0199|RG-7601|N54AIC43PW|4-[4-[[2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[3-nitro-4-(oxan-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide|Benzamide, 4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)-|CHEBI:133021|DTXSID30154863|4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-((tetrahydro-2H-pyran-4-ylmethyl)amino)phenyl)sulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide|benzamide, 4-(4-((2-(4-chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl)methyl)-1-piperazinyl)-n-((3-nitro-4-(((tetrahydro-2h-pyran-4-yl)methyl)amino)phenyl)sulfonyl)-2-(1h-pyrrolo(2,3-b)pyridin-5-yloxy)-|4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-n-({3-nitro-4-[(tetrahydro-2h-pyran-4-ylmethyl)amino]phenyl}sulfonyl)-2-(1h-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide|4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzene-1-sulfonyl)-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide|venetoclaxum|4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-(3-nitro-4-(((oxan-4-yl)methyl)amino)benzenesulfonyl)-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide|4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohexen-1-yl)methyl)piperazin-1-yl)-N-(3-nitro-4-(oxan-4-ylmethylamino)phenyl)sulfonyl-2-(1H-pyrrolo(2,3-b)pyridin-5-yloxy)benzamide|4-(4-((4'-chloro-5,5-dimethyl(3,4,5,6-tetrahydro(1,1'-biphenyl))-2-yl)methyl)piperazin-1-yl)-N-(3-nitro-4-(((oxan-4-yl)methyl)amino)benzene-1-sulfonyl)-2-((1H-pyrrolo(2,3-b)pyridin-5-yl)oxy)benzamide|4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-(3-nitro-4-{[(oxan-4-yl)methyl]amino}benzenesulfonyl)-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzamide|RefChem:58112|DTXCID0077354|L01XX52|ABT-0199|Venetoclax (ABT199)|Venetoclax (ABT-199)|MFCD23160052|Venetoclax; Abt-199|ABT-199 (GDC-0199)|ABT 199 (Venetoclax)|2-((1H-Pyrrolo[2,3-b]pyridin-5-yl)oxy)-4-(4-((4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((3-nitro-4-(((tetrahydro-2H-pyran-4-yl)methyl)amino)phenyl)sulfonyl)benzamide|2-(1H-Pyrrolo[2,3-b]pyridin-5-yloxy)-4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)methyl)piperazin-1-yl)-N-(3-nitro-4-((tetrahydro-2H-pyran-4-yl)methy|4-(4-{[2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({3-nitro-4-[(oxan-4-ylmethyl)amino]benzene}sulfonyl)-2-{1H-pyrrolo[2,3-b]pyridin-5-yloxy}benzamide|BDBM189459|ABT 199 (>99%)(Venetoclax)|4-[4-[[2-(4-chlorophenyl)-4,4-dimethyl-cyclohexen-1-yl]methyl]piperazin-1-yl]-N-[3-nitro-4-(tetrahydropyran-4-ylmethylamino)phenyl]sulfonyl-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide|Venetoclax [USAN:INN]|UNII-N54AIC43PW|C45H50ClN7O7S|Venclexta (TN)|Venetoclax (Standard)|VENETOCLAX [MI]|Venetoclax(ABT-199)|VENETOCLAX [INN]|VENETOCLAX [JAN]|VENETOCLAX [USAN]|Venetoclax(ABT-199)?|VENETOCLAX [WHO-DD]|MLS006010298|SCHEMBL523816|Venetoclax (JAN/USAN/INN)|GTPL8318|orb1306442|CHEMBL3137309|SCHEMBL19236295|SCHEMBL29353714|SCHEMBL29360081|SCHEMBL29390802|SCHEMBL29801595|VENETOCLAX [ORANGE BOOK]|BDBM60828|EX-A168|GLXC-06797|HMS3653J06|HMS3745E07|HMS5086M05|BCP06811|BDBM50162774|HY-15531R|NSC766270|AKOS025289539|CCG-270543|CS-1155|DB11581|FV63222|KS-1470|NSC-766270|SB16499|NCGC00345789-01|NCGC00345789-05|NCGC00345789-10|NCGC00345789-11|NCGC00345789-12|4-[4-[[2-(4-Chlorophenyl)-4,4-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(tetrahydro-2H-pyran-4-yl)methyl]amino]phenyl]sulfonyl]-2-(1H-pyrrolo[2,3-b]pyridin-5-yloxy)benzamide|AC-28754|BP-43649|DA-35360|HY-15531|SMR004701366|SY048011|NS00073446|S8048|SW219672-1|D10679|US9174982, 5|EN300-7399830|US9174982, 369|BRD-K62391742-001-03-0|BRD-K62391742-001-08-9|BRD-K62391742-001-09-7|Q23671272|Z2037279542|)methyl]amino}phenyl)sulfonyl]-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide|2-[[Pyrrolo[2,3-b]pyridin-5-yl]oxy]-4-[4-[[4'-chloro-5,5-dimethyl-3,4,5,6-tetrahydro-2-biphenylyl]methyl]-1-piperazinyl]-N-[[3-nitro-4-[[(4-tetrahydropyranyl)methyl]amino]phenyl]sulfonyl]benzamide|4-(4-((2-(4-CHLOROPHENYL)-4,4-DIMETHYLCYCLOHEX-1-EN-1-YL)METHYL)PIPERAZIN-1-YL)-N-((3-NITRO-4-((TETRAHYDRO-2HPYRAN-4-YLMETHYL) AMINO)PHENYL)SULFONYL)-2-(1H-PYRROLO(2,3-B)PYRIDIN-5-YLOXY)BENZAMIDE|4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-[(3-nitro-4-{[(oxan-4-yl|4-{4-[(4'-chloro-5,5-dimethyl[3,4,5,6-tetrahydro[1,1'-biphenyl]]-2-yl)methyl]piperazin-1-yl}-N-[(3-nitro-4-{[(oxan-4-yl)methyl]amino}phenyl)sulfonyl]-2-[(1H-pyrrolo[2,3-b]pyridin-5-yl)oxy]benzamide|ABT-199; 2-(1H-Pyrrolo[2,3-b]pyridin-5-yloxy)-4-(4-((2-(4-chlorophenyl)-4,4-dimethylcyclohex-1-enyl)methyl)piperazin-1-yl)-N-(3-nitro-4-((tetrahydro-2H-pyran-4-yl)methy"
PHENOLPHTHALEIN,4764,,"InChI=1S/C20H14O4/c21-15-9-5-13(6-10-15)20(14-7-11-16(22)12-8-14)18-4-2-1-3-17(18)19(23)24-20/h1-12,21-22H",KJFMBFZCATUALV-UHFFFAOYSA-N,C20H14O4,318.3,"3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-one","phenolphthalein|77-09-8|Phthalimetten|Euchessina|Phthalin|Espotabs|Phenolax|Purgophen|Koprol|Laxogen|Trilax|Purga|Spulmako-lax|Chocolax|Purgen|Phenolphtaleine|Correctol|Medilax|Colax|Laxin|3,3-Bis(4-hydroxyphenyl)phthalide|FemiLax|Dihydroxyphthalophenone|Ex-Lax|3,3-Bis(4-hydroxyphenyl)-1(3H)-isobenzofuranone|Fenolftalein|Fenolftaleina|1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxyphenyl)-|3,3-Bis(p-hydroxyphenyl)phthalide|3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-one|NCI-C55798|Phenolphthaleinum|alpha-Di(p-hydroxyphenyl)phthalide|DTXSID0021125|3,3-bis(4-hydroxyphenyl)-1,3-dihydro-2-benzofuran-1-one|6QK969R2IF|CHEBI:34914|NSC-10464|DTXCID901125|NSC10464|Laxettes|RefChem:6481|A06AB04|201-004-7|o-Toluic acid, alpha-(p-hydroxyphenyl)-alpha-4-oxo-2,5-cyclohexadien-1-ylidene-|Prulet|Alophen|Phillips Gelcaps|Phenophthalein|MFCD00005913|3,3-Bis(4-hydroxyphenyl)isobenzofuran-1(3H)-one|Feen-A-Mint Laxative Mints|3,3-Bis(4-hydroxyphenyl)-2-benzofuran-1(3H)-one|NSC 10464|component of Agoral|Phenolphthalein,white|Phthalide 3,3,-bis(p-hydroxyphenyl)-|CHEMBL63857|MLS000069592|3,3-bis(4-hydroxyphenyl)isobenzofuran-1-one|Evac-Q-Kwik|Evac-Q-Kit|Evac-U-Gen|component of Correctol|Phenolphthalein (INN)|NCGC00018200-07|SMR000059015|Agoral|Fenolftalein [Czech]|PHENOLPHTHALEIN [INN]|3,3-bis(4-hydroxyphenyl)-3-hydroisobenzofuran-1-one|Fenolftaleina [INN-Spanish]|Phenolphtaleine [INN-French]|Phenolphthaleinum [INN-Latin]|Phthalide 3,-bis(p-hydroxyphenyl)-|CAS-77-09-8|CCRIS 6266|WLN: T56 BVO DHJ D- D-/R DQ 2|Phenolphthalein (0.04% Solution in Ethanol)|HSDB 4161|1(3H)-Isobenzofuranone,3-bis(4-hydroxyphenyl)-|EINECS 201-004-7|BRN 0284423|phenolphtalein|UNII-6QK969R2IF|AI3-09081|Phenolphthalein [USP:INN:BAN]|FGT|Doxan (Salt/Mix)|Agoral (Salt/Mix)|Modane (TN)|Phenolphthalein White|Laxcaps (Salt/Mix)|Phenolphthalein,yellow|Yellow phenolphthalein|Phenolphthalein solution|Spectrum_001077|Opera_ID_1337|Spectrum2_001279|Spectrum3_000888|Spectrum4_000982|Spectrum5_001268|Modane Plus (Salt/Mix)|EC 201-004-7|Phenolphthalein ACS reagent|Phenolphthalein solution R1|PHENOLPHTHALIN [MI]|cid_4764|alpha-(p-Hydroxyphenyl)-alpha-(4-oxo-2,5-cyclohexadien-1-ylidene)-o-toluic acid|PHENOLPHTHALEIN [MI]|Phenolphthalein, ACS reagent|SCHEMBL27670|BSPBio_002518|KBioGR_001383|KBioSS_001557|Phenolphthalein, pH indicator|PHENOLPHTHALEIN, WHITE|5-18-04-00188 (Beilstein Handbook Reference)|MLS001148397|BIDD:ER0202|DivK1c_000929|PHENOLPHTHALEIN [HSDB]|PHENOLPHTHALEIN [IARC]|SPECTRUM1500480|Phenolphthalein Paper, DAB 6|SPBio_001278|PHENOLPHTHALEIN [VANDF]|orb1311017|PHENOLPHTHALEIN [MART.]|PHENPOLPHTHALEIN [VANDF]|PHENOLPHTHALEIN [WHO-DD]|SCHEMBL29362413|BCBcMAP01_000174|HMS502O11|KBio1_000929|KBio2_001557|KBio2_004125|KBio2_006693|KBio3_001776|NINDS_000929|BP_31|HMS1920H04|HMS2091P06|HMS2236I09|HMS3374P06|HMS5084A18|Pharmakon1600-01500480|component of Correctol (Salt/Mix)|HY-D0211|Phenolphthalein, p.a., ACS reagent|Tox21_110838|Tox21_202219|Tox21_300282|BBL002030|BDBM50077844|CCG-39112|MSK000813|NSC215214|NSC757271|PHENOLPHTHALEIN,WHITE [VANDF]|s5395|SBB008868|STK029876|PHENOLPHTHALEIN [EP MONOGRAPH]|AKOS000493033|Tox21_110838_1|CS-8152|DB04824|NSC-215214|NSC-757271|IDI1_000929|SMP1_000235|NCGC00018200-01|NCGC00018200-02|NCGC00018200-03|NCGC00018200-04|NCGC00018200-05|NCGC00018200-06|NCGC00018200-08|NCGC00018200-09|NCGC00018200-10|NCGC00018200-12|NCGC00023694-03|NCGC00023694-04|NCGC00023694-05|NCGC00023694-06|NCGC00023694-07|NCGC00254039-01|NCGC00259768-01|AC-14431|BP-30100|ST072636|SY011038|VS-01000|SBI-0051481.P003|EU-0082600|NS00008592|P0094|P0700|P0701|P0702|3,3-bis(4-hydroxyphenyl)-2-benzofuran-1-on|EN300-92962|Phenolphthalein, SAJ first grade, >=97.0%|.alpha., .alpha.-Di(p-hydroxyphenyl)phthalide|3,3-bis (4-hydroxyphenyl)-2-benzofuran-1-on|D05456|H12020|Phenolphthalein, JIS special grade, >=98.0%|AB00052070_15|F787639|Q187921|SR-01000000112|SR-01000000112-2|3,3-Bis(4-hydroxyphenyl)-2-benzofuran-1(3H)-one #|3,3-Bis-(4-hydroxy-phenyl)-3H-isobenzofuran-1-one|BRD-K19227686-001-02-0|BRD-K19227686-001-12-9|BRD-K19227686-001-18-6|Z57233591|F0921-4309|Phenolphthalein (263 degrees C) Melting Point Standard|Phenolphthalein, United States Pharmacopeia (USP) Reference Standard|Phenolphthalein Solution R1 according to European Pharmacopoeia 4.1.1|InChI=1/C20H14O4/c21-15-9-5-13(6-10-15)20(14-7-11-16(22)12-8-14)18-4-2-1-3-17(18)19(23)24-20/h1-12,21-22|Phenolphthalein;2-[Bis(4-hydroxyphenyl)methyl]benzoic acid;3,3-Bis(4-hydroxyphenyl)phthalide"
ERTEBEREL,10286159,,"InChI=1S/C18H18O3/c19-12-6-4-11(5-7-12)18-15-3-1-2-14(15)16-10-13(20)8-9-17(16)21-18/h4-10,14-15,18-20H,1-3H2/t14-,15+,18+/m1/s1",XIESSJVMWNJCGZ-VKJFTORMSA-N,C18H18O3,282.3,"(3aS,4R,9bR)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol","Erteberel|533884-09-2|LY500307|SERBA-1|LY-500307|2ZUL6758TZ|DTXSID70201547|Cyclopenta(c)(1)benzopyran-8-ol, 1,2,3,3a,4,9b-hexahydro-4-(4-hydroxyphenyl)-, (3aS,4R,9bR)-|erteberelum|(3aS,4R,9bR)-1,2,3,3a,4,9b-Hexahydro-4-(4-hydroxyphenyl)cyclopenta(c)(1)benzopyran-8-ol|(3aS,4R,9bR)-1,2,3,3a,4,9b-Hexahydro-4-(4-hydroxyphenyl)cyclopenta[c][1]benzopyran-8-ol|RefChem:591094|DTXCID00124038|(2R,6S,7R)-7-(4-hydroxyphenyl)-8-oxatricyclo(7.4.0.02,?)trideca-1(9),10,12-trien-12-ol|(3aS,4R,9bR)-4-(4-hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta[c]chromen-8-ol|Erteberel (LY500307)|Benzopyran derivative., 4b(racemate)|(3aS,4R,9bR)-4-(4-Hydroxyphenyl)-1,2,3,3a,4,9b-hexahydrocyclopenta(c)(1) benzopyran-8-ol|I0G|Erteberel [USAN]|Erteberel [USAN:INN]|UNII-2ZUL6758TZ|2i0g|2i0j|ERTEBEREL [INN]|Erteberel (USAN/INN)|LY 500307|ERTEBEREL [WHO-DD]|CHEMBL278703|orb1300884|SCHEMBL14102383|BDBM19968|EX-A157|BCPP000173|GLXC-15787|MFCD22495234|AKOS027323752|BCP9000889|DB07933|NCGC00346557-01|NCGC00346557-02|AC-36799|HY-18295|MS-24010|CS-0007402|NS00070542|D09899|BRD-K80608265-001-01-6|Q27097167|(2R,6S,7R)-7-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0;{2,6}]trideca-1(13),9,11-trien-12-ol|(2R,6S,7R)-7-(4-hydroxyphenyl)-8-oxatricyclo[7.4.0.0;{2,6}]trideca-1(9),10,12-trien-12-ol|(3AS,4R,9BR)-4-(4-HYDROXYPHENYL)-1,2,3,3A,4,9B-HEXAHYDROCYCLOPENTA(C)(1)BENZOPYRAN-8-OL"
OMARIGLIPTIN,46209133,,"InChI=1S/C17H20F2N4O3S/c1-27(24,25)23-7-10-6-22(8-16(10)21-23)12-5-15(20)17(26-9-12)13-4-11(18)2-3-14(13)19/h2-4,7,12,15,17H,5-6,8-9,20H2,1H3/t12-,15+,17-/m1/s1",MKMPWKUAHLTIBJ-ISTRZQFTSA-N,C17H20F2N4O3S,398.4,"(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine","OMARIGLIPTIN|1226781-44-7|MK-3102|Omarigliptina|Omarigliptine|CVP59Q4JE1|DTXSID70153678|(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)oxan-3-amine|2H-Pyran-3-amine, 2-(2,5-difluorophenyl)-5-(2,6-dihydro-2-(methylsulfonyl)pyrrolo(3,4-c)pyrazol-5(4H)-yl)tetrahydro-,(2R,3S,5R)-|omarigliptinum|(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo(3,4-c)pyrazol-5-yl)oxan-3-amine|RefChem:856762|DTXCID1076169|(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methanesulfonyl-2H,4H,5H,6H-pyrrolo(3,4-c)pyrazol-5-yl)oxan-3-amine|MFCD22573261|(2R,3S,5R)-2-(2,5-DIFLUOROPHENYL)-5-(2-(METHYLSULFONYL)PYRROLO[3,4-C]PYRAZOL-5(2H,4H,6H)-YL)TETRAHYDRO-2H-PYRAN-3-AMINE|MK3102|Omarigliptin (MK-3102)|(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl)tetrahydro-2H-pyran-3-amine|2H-Pyran-3-amine, 2-(2,5-difluorophenyl)-5-[2,6-dihydro-2-(methylsulfonyl)pyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-, (2R,3S,5R)-|UNII-CVP59Q4JE1|(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine|C17H20F2N4O3S|Omarigliptin [USAN]|Omarigliptin [USAN:INN]|Omarigliptin (Standard)|MK-3102Omarigliptin?|OMARIGLIPTIN [MI]|OMARIGLIPTIN [INN]|OMARIGLIPTIN [JAN]|OMARIGLIPTIN [WHO-DD]|SCHEMBL827590|GTPL8402|Omarigliptin (JAN/USAN/INN)|orb1305710|CHEMBL2105762|SCHEMBL30291226|EX-A395|CHEBI:134735|MKMPWKUAHLTIBJ-ISTRZQFTSA-N|BDBM50003020|HY-15981R|NSC802900|s8565|AKOS025289528|CCG-268634|CS-3948|DB11992|DS-7574|NSC-802900|PB39113|NCGC00480770-01|(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-(2-(methanesulfonyl)-2,6-dihydropyrrolo(3,4- c)pyrazol-5(4H)-yl)oxan-3-amine|(2R,3S,5R)-2-(2,5-Difluorophenyl)-5-(2-(methylsulfonyl)-2,6-dihydropyrrolo(3,4- c)pyrazol-5(4H)-yl)tetrahydro-2H-pyran-3-amine|2H-Pyran-3-amine, 2-(2,5-difluorophenyl)-5-(2,6-dihydro-2-(methylsulfonyl)pyrrolo(3,4- c)pyrazol-5(4H)-yl)tetrahydro-, (2R,3S,5R)-|AC-28992|HY-15981|NS00073001|D10317|L10002|BRD-K14171291-001-01-4|Q21098979|(2R,3S,5R)-2-(2,5-difluorophenyl)-5-(2-methylsulfonyl-4,6-dihydropyrrolo[3,4-c]pyrazol-5-yl)tetrahydropyran-3-amine|(2R,3S,5R)-2-(2,5-Difluorophenyl)-5[2-(methylsulfonyl)-2,6-dihydropyrrolo[3,4-c]pyrazol-5(4H)-yl]tetrahydro-2H-pyran-3-amine"
TIPIRACIL HYDROCHLORIDE,9903778,,"InChI=1S/C9H11ClN4O2.ClH/c10-7-5(12-9(16)13-8(7)15)4-14-3-1-2-6(14)11;/h11H,1-4H2,(H2,12,13,15,16);1H",KGHYQYACJRXCAT-UHFFFAOYSA-N,C9H12Cl2N4O2,279.12,"5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione;hydrochloride","5-CIMU cpd|RefChem:898223|5-chloro-6-(1-(2-iminopyrrolidinyl) methyl)uracil hydrochloride|Tipiracil hydrochloride|183204-72-0|Tipiracil HCl|Tipiracil (hydrochloride)|TAS-1-462|5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]-1H-pyrimidine-2,4-dione;hydrochloride|Tipiracil hydrochloride [USAN]|5-Chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dione hydrochloride|4H59KLQ0A4|CHEMBL65375|Tipiracilhydrochloride|UNII-4H59KLQ0A4|tipiracil.HCl|5-chloro-6-[(2-iminopyrrolidin-1-yl)methyl]pyrimidine-2,4(1H,3H)-dione hydrochloride|MFCD01571384|Tipiracil hydrochloride?|tipiracil monohydrochloride|C9H12Cl2N4O2|orb1305589|SCHEMBL1682924|CHEBI:90877|HY-A0063R|EX-A882|KGHYQYACJRXCAT-UHFFFAOYSA-N|DTXSID001027748|GLXC-06822|HMS5082I05|BCP06245|EX-A1393|HY-A0063|Tipiracil hydrochloride (JAN/USAN)|TIPIRACIL HYDROCHLORIDE [MI]|MFCD17215839|NSC854270|s3731|Tipiracil (hydrochloride) (Standard)|TIPIRACIL HYDROCHLORIDE [JAN]|AKOS027427002|CCG-267234|CS-1637|NSC-854270|5-Chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-2,4(1H,3H)-pyrimidinedione monohydrochloride|TIPIRACIL HYDROCHLORIDE [WHO-DD]|AC-30634|AS-56082|FC126316|Tipiracil hydrochloride, >=98% (HPLC)|DB-065426|TIPIRACIL HYDROCHLORIDE [ORANGE BOOK]|D10467|LONSURF COMPONENT TIPIRACIL HYDROCHLORIDE|F517760|S-95005 COMPONENT TIPIRACIL HYDROCHLORIDE|TAS-102 COMPONENT TIPIRACIL HYDROCHLORIDE|Q27162848|5-chloro-6-(1-(2-iminopyrrolidinyl)methyl)uracil hydrochloride|5-chloro-6-(1-(2-iminopyrrolidinyl)-methyl)uracil hydrochloride|5-Chloro-6-((2-iminopyrrolidin-1-yl)methyl)pyrimidine-2,4(1H,3H)-dionehydrochloride|5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4(1H,3H)-pyrimidinedione Hydrochloride|5-Chloro-6-(2-iminopyrrolidin-1-yl)methyl-2,4-(1H,3H)-pyrimidinedione Hydrochloride|1-[(5-chloro-2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)methyl]pyrrolidin-2-iminium chloride|2,4(1H,3H)-PYRIMIDINEDIONE, 5-CHLORO-6-((2-IMINO-1-PYRROLIDINYL)METHYL)-, HYDROCHLORIDE (1:1)|5-CHLORO-6-(2-IMINO-PYRROLIDIN-1-YL)METHYL-2,4(1H,3H)-PYRIMIDINEDIONE HYDROCHLORIDE|5-chloro-6-[(2-imino-1-pyrrolidinyl)methyl]-2,4(1H,3H)-Pyrimidinedione hydrochloride (1:1)"
NAVARIXIN,9865554,,"InChI=1S/C21H23N3O5/c1-5-13(15-10-9-11(2)29-15)22-16-17(20(27)19(16)26)23-14-8-6-7-12(18(14)25)21(28)24(3)4/h6-10,13,22-23,25H,5H2,1-4H3/t13-/m1/s1",RXIUEIPPLAFSDF-CYBMUJFWSA-N,C21H23N3O5,397.4,"2-hydroxy-N,N-dimethyl-3-[[2-[[(1R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobuten-1-yl]amino]benzamide","473727-83-2|MK-7123|MK7123|RefChem:927521|4GMU5HUX5I|Benzamide, 2-hydroxy-N,N-dimethyl-3-((2-(((1R)-1-(5-methyl-2-furanyl)propyl)amino)-3,4-dioxo-1-cyclobuten-1-yl)amino)-|Navarixin Anhydrous|Navarixin|SCH-527123|Sch527123|(R)-2-Hydroxy-N,N-dimethyl-3-((2-((1-(5-methylfuran-2-yl)propyl)amino)-3,4-dioxocyclobut-1-en-1-yl)amino)benzamide|SCH 527123|CHEMBL216981|(R)-2-hydroxy-N,N-dimethyl-3-(2-(1-(5-methylfuran-2-yl)propylamino)-3,4-dioxocyclobut-1-enylamino)benzamide|2-hydroxy-N,N-dimethyl-3-[[2-[[(1R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobuten-1-yl]amino]benzamide|NAVARIXIN [WHO-DD]|SCHEMBL184744|GTPL8497|Navarixin (SCH-527123)|orb1300043|GLXC-04965|EX-A4879|YTA72783|BDBM50200880|s8506|CXCR2 Antagonist IV, Sch527123|AKOS016003539|AT10795|CS-0609|NCGC00390675-01|AC-33600|BS-17324|HY-10198|DB-336227|BRD-K82850175-001-01-1|Q27087854|SCH 527123,CAS:473727-83-2|2-Hydroxy-N,N-dimethyl-3-[[2-[[(1R)-1-(5-methyl-2-furanyl)propyl]amino]-3,4-dioxo-1-cyclobuten-1-yl]amino]benzamide|2-hydroxy-N,N-dimethyl-3-[[2-[[(1R)-1-(5-methyl-2-furyl)propyl]amino]-3,4-dioxo-cyclobuten-1-yl]amino]benzamide|2-hydroxy-N,N-dimethyl-3-[[2-[[(1R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxo-1-cyclobutenyl]amino]benzamide|2-hydroxy-N,N-dimethyl-3-{2-[[(R)-1-(5-methylfuran-2-yl)propyl]amino]-3,4-dioxocyclobut-1-enylamino}benzamide|3-[[3-[(dimethylamino)carbonyl]-2-hydroxyphenyl]amino]-4-[[(r)-1-(5-methylfuran-2-yl)propyl]amino]cyclobut-3-ene-1,2-dione"
FASUDIL,3547,,"InChI=1S/C14H17N3O2S/c18-20(19,17-9-2-6-15-8-10-17)14-4-1-3-12-11-16-7-5-13(12)14/h1,3-5,7,11,15H,2,6,8-10H2",NGOGFTYYXHNFQH-UHFFFAOYSA-N,C14H17N3O2S,291.37,"5-(1,4-diazepan-1-ylsulfonyl)isoquinoline","Fasudil|103745-39-7|HA1077|Fasudilum|1H-1,4-Diazepine, hexahydro-1-(5-isoquinolinylsulfonyl)-|HA 1077|AT 877|AT-877|ha-1077|1-(5-Isoquinolinesulfonyl)homopiperazine|Q0CH43PGXS|Hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine|NSC-759827|ZK-258594|AT877|DTXSID4048569|CHEBI:43871|5-[(Hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]isoquinoline|5-((HEXAHYDRO-1H-1,4-DIAZEPIN-1-YL)SULFONYL)ISOQUINOLINE|RefChem:597170|DTXCID9028201|C04AX32|5-(1,4-diazepan-1-ylsulfonyl)isoquinoline|Fasudil [INN]|5-(1,4-diazepane-1-sulfonyl)isoquinoline|5-(1,4-DIAZEPAN-1-SULFONYL)ISOQUINOLINE|Fasudil dihydrochloride|CHEMBL38380|5-((1,4-diazepan-1-yl)sulfonyl)isoquinoline|MFCD00866182|Fasudil (INN)|Hexahydro-1-(5-isoquinolylsulfonyl)-1H-1,4-diazepine|Fasudilum [INN-Latin]|BRD7868|BRD-7868|M77|NCGC00018100-04|UNII-Q0CH43PGXS|Fasudil?|2esm|2gni|dihydrochloride fasudil|Fasudil Impurity 49|Kinome_3390|Kinome_3391|Tocris-0541|1q8w|BiomolKI_000038|FASUDIL [MI]|FASUDIL [WHO-DD]|BiomolKI2_000046|Fasudil (HA-1077)|SCHEMBL4674|BSPBio_001111|KBioGR_000451|KBioSS_000451|MLS006011953|cid_163751|GTPL5181|orb1745275|SCHEMBL29362990|SCHEMBL29381868|BDBM14027|KBio2_000451|KBio2_003019|KBio2_005587|KBio3_000841|KBio3_000842|BCPP000234|Bio2_000386|Bio2_000866|GLXC-21108|HMS1362G13|HMS1792G13|HMS1990G13|HMS2089F13|HMS3264M10|Pharmakon1600-01502366|BCP26821|DEA74539|HY-10341A|NSC759827|NSC800098|AKOS009604905|AC-4279|AT27735|BCP9000678|CCG-100642|DB08162|NSC 759827|NSC-800098|SDCCGSBI-0086761.P004|IDI1_002141|SMP2_000083|NCGC00018100-01|NCGC00018100-02|NCGC00018100-03|NCGC00018100-05|NCGC00018100-06|NCGC00018100-07|NCGC00024299-02|NCGC00024299-04|NCGC00024299-05|1-(5-Isoquinolinesulphonyl)homopiperazine|1-(5-Isoquinolinylsulfonyl)homopiperazine|1-(isoquinoline-5-sulfonyl)homopiperazine|AS-70114|SMR002529471|NS00068123|EN300-68842|D07941|MLS-0003155.0001|SBI-0086761.0001|AB00490076-08|AB00490076_09|1-(5-Isoquinolylsulfonyl)-1,4-diazaperhydroepine|745F397|Q5437132|BRD-K76617868-001-02-2|BRD-K76617868-001-03-0|BRD-K76617868-001-05-5|BRD-K76617868-003-10-1|BRD-K76617868-003-11-9|BRD-K76617868-003-14-3|BRD-K76617868-300-03-6|BRD-K76617868-300-04-4|Fasudil; (5-ISOQUINOLINESULFONYL)HOMOPIPERAZINE|hexahydro-1-(5-isoquinolinesulfonyl)-1h-1,4-diazepine|N-(5-ISOQUINOLINESULFONYL)-1,4-PERHYDRODIAZEPINE|Z432085130|1H-1,4-Diazepine, hexahydro-1-(5-isoquinolinylsulfonyl)- (9CI)|AT 877; AT-877; AT877; HA 1077; HA-1077; HA1077|ISOQUINOLINE, 5-((HEXAHYDRO-1H-1,4-DIAZEPIN-1-YL)SULFONYL)-"
PAROXETINE HYDROCHLORIDE,62878,,"InChI=1S/C19H20FNO3.ClH/c20-15-3-1-13(2-4-15)17-7-8-21-10-14(17)11-22-16-5-6-18-19(9-16)24-12-23-18;/h1-6,9,14,17,21H,7-8,10-12H2;1H/t14-,17-;/m0./s1",GELRVIPPMNMYGS-RVXRQPKJSA-N,C19H21ClFNO3,365.8,"(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochloride","Paroxetine hydrochloride|78246-49-8|Paroxetine Hcl|Paroxat|Paroxetine Hydrochloride Anhydrous|NSC-758654|3I3T11UD2S|Paroxetine hydrochloride [USP]|BRL29060A|CHEBI:7944|Paroxetine hydrochloride (USP)|Deroxat|DTXSID50228914|Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S,4R)-|Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3S-trans)-|Paxilcr CR|RefChem:858692|DTXCID00151405|(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-(methylenedioxy)phenoxy)methyl)piperidine Hydrochloride|Paxil CR|X2ELS050D8|Paxil|Seroxat|(3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride|paroxetine (hydrochloride)|C19H21ClFNO3|MFCD03658863|MFCD00797405|5V22ESA4MA|Paroxetine hydrochloride hemihydrate (MW = 374.83)|Paroxetine hydrochloride, (+/-)-|(3S,4R)-3-[(2H-1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride|Paroxetine hydrochloride, trans-(+/-)-|S3005|Paxil (TN)|(-)-(3S,4R)-4-(p-Fluorophenyl)-3-((3,4-methylenedioxy)phenoxy)-methyl)piperidine hydrochloride|(3S,4R)-3-(1,3-benzodioxol-5-yloxymethyl)-4-(4-fluorophenyl)piperidine;hydrochloride|Aropax 20|130855-16-2|CHEMBL1708|BRL 29060 hydrochloride|Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, trans-|trans-(+/-)-3-((1,3-Benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidine hydrochloride|Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride (1:1), (3R,4S)-rel-|Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, (3R,4S)-rel-|Piperidine, 3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-, hydrochloride, trans-(+/-)-|BRL 29060A|SDB 7175|UNII-3I3T11UD2S|(3S,4R)-3-[(Benzo[d][1,3]dioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride|UNII-5V22ESA4MA|SCHEMBL33348|Paroxetine HCl (hemihydrate)|MLS002222322|SPECTRUM1504085|orb1307940|SCHEMBL29437926|HY-B0492R|Paroxetine for system suitability|GLXC-04133|HMS1922B11|Pharmakon1600-01504085|(-)-trans-paroxetine hydrochloride|HY-B0492|MSK10675|Tox21_500095|CCG-39866|HB0478|NSC758654|AKOS015849162|AKOS015907108|Paroxetine (hydrochloride) (Standard)|FP38223|FP60426|H29P351|KS-5097|LP00095|NSC 758654|(3S,4R)-(-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride|NCGC00093597-01|NCGC00260780-01|PAROXETINE HYDROCHLORIDE [WHO-DD]|BP164263|PAROXETINE HYDROCHLORIDE, ANHYDROUS|SMR001307264|SY105826|EU-0100095|P1977|SW197457-4|D05374|D70630|EN300-124073|Paroxetine HCl hemihydrate - Bio-X trade mark|PAROXETINE HYDROCHLORIDE ANHYDROUS [MI]|110429-35-1(hemihydrate) 61869-08-7|SR-01000759305|SR-01000759305-6|Q27257245|Z1557492145|(-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxy-phenoxymethyl)-piperidine hydrochloride|(-)-trans-4-(-4-fluorophenyl)-3-(3,4-methylenedioxyphenoxymethyl)-piperidine hydrochloride|(-)-trans-4-(4-fluorophenyl)-3-(3,4-methylene dioxyphenoxymethyl)-piperidine hydrochloride|(3S,4R)-3-((Benzo[d][1,3]dioxol-5-yloxy)methyl)-4-(4-fluorophenyl)piperidinehydrochloride|(3S,4R)-3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride|(3S,4R)-3-[(1,3-dioxaindan-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine hydrochloride|(3S-trans)-3-((1,3-benzodioxol-5-yloxy)methyl)-4-(4-fluorophenyl)-piperidine hydrochloride|TRANS-3-((BENZO[D][1,3]DIOXOL-5-YLOXY)METHYL)-4-(4-FLUOROPHENYL)PIPERIDINE HCL|(3S,4R)-(-)-3-(1,3-Benzodioxol-5-yloxy)methyl-4-(4-fluorophenyl)piperidine Hydrochloride Hemihydrate|(3S,4R)-(-)-3-[(1,3-Benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)piperidine Hydrochloride Hemihydrate|Piperidine, 3-[(1,3-benzodioxol-5-yloxy)methyl]-4-(4-fluorophenyl)-, (3S,4R)-, hydrochloride (1:1)"
MK0686,16102897,,"InChI=1S/C22H19ClF4N2O4/c1-11(28-19(31)21(8-9-21)29-20(32)22(25,26)27)13-7-6-12(10-16(13)24)14-4-3-5-15(23)17(14)18(30)33-2/h3-7,10-11H,8-9H2,1-2H3,(H,28,31)(H,29,32)/t11-/m1/s1",WZZIQHIQMWJNLU-LLVKDONJSA-N,C22H19ClF4N2O4,486.8,"methyl 2-chloro-6-[3-fluoro-4-[(1R)-1-[[1-[(2,2,2-trifluoroacetyl)amino]cyclopropanecarbonyl]amino]ethyl]phenyl]benzoate","MK-0686|578727-68-1|MK 0686|MK0686|(1,1'-Biphenyl)-2-carboxylic acid, 3-chloro-3'-fluoro-4'-((1R)-1-(((1-((trifluoroacetyl)amino)cyclopropyl)carbonyl)amino)ethyl)-, methyl ester|M310323W0U|DTXSID20206587|3-Chloro-3'-fluoro-4'-((1R)-1-(((1-((trifluoroacetyl)amino)cyclopropyl)carbonyl)amino)ethyl)-(1,1'-biphenyl)-2-carboxylic acid, methyl ester|RefChem:159176|DTXCID50129078|methyl 3-chloro-3'-fluoro-4'-((1R)-1-((1-(2,2,2-trifluoroacetamido)cyclopropyl)formamido)ethyl)-(1,1'-biphenyl)-2-carboxylate|CHEMBL232943|methyl 2-chloro-6-[3-fluoro-4-[(1R)-1-[[1-[(2,2,2-trifluoroacetyl)amino]cyclopropanecarbonyl]amino]ethyl]phenyl]benzoate|(R)-Methyl 3-chloro-3'-fluoro-4'-(1-(1-(2,2,2-trifluoroacetamido)cyclopropanecarboxamido)ethyl)-[1,1'-biphenyl]-2-carboxylate|methyl (R)-3-chloro-3'-fluoro-4'-(1-(1-(2,2,2-trifluoroacetamido)cyclopropane-1-carboxamido)ethyl)-[1,1'-biphenyl]-2-carboxylate|UNII-M310323W0U|WZZIQHIQMWJNLU-LLVKDONJSA-N|orb1696075|SCHEMBL6183541|BDBM50202412|AKOS040753086|DB12563|HY-15042|CS-0003716|NS00071844|Q27283412|3-Chloro-3''-fluoro-4''-((R)-1-{[1-(2,2,2-trifluoro-acetylamino)-cyclopropanecarbonyl]-amino}-ethyl)-biphenyl-2-carboxylic acid methyl ester|methyl 3-chloro-3''-fluoro-4''-{(1R)-1-[({1-[(trifluoroacetyl)amino]cyclopropyl}carbonyl)amino]ethyl}-1,1''-biphenyl-2-carboxylate|methyl 3-chloro-3'-fluoro-4'-(1-(((1-((trifluoroacetyl)amino)cyclopropyl)carbonyl)amino)ethyl)-1,1'-biphenyl-2-carboxylate"
MOLIDUSTAT,59603622,,"InChI=1S/C13H14N8O2/c22-13-10(20-2-1-16-18-20)8-17-21(13)12-7-11(14-9-15-12)19-3-5-23-6-4-19/h1-2,7-9,17H,3-6H2",IJMBOKOTALXLKS-UHFFFAOYSA-N,C13H14N8O2,314.30,2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(triazol-1-yl)-1H-pyrazol-3-one,"Molidustat|1154028-82-6|BAY 85-3934|2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(triazol-1-yl)-1H-pyrazol-3-one|9JH486CZ13|DTXSID80151089|2-(6-(Morpholin-4-yl)pyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-1,2-dihydro-3H-pyrazol-3-one|2-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-2,3-dihydro-1H-pyrazol-3-one|molidustatum|Varenzin-CA1|2-(6-(morpholin-4-yl)pyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-2,3-dihydro-1H-pyrazol-3-one|RefChem:57794|DTXCID0073580|Molidustat [INN]|Molidustat [USAN]|BAY-85-3934|Molidustat(BAY 85-3934)|3H-Pyrazol-3-one, 1,2-dihydro-2-[6-(4-morpholinyl)-4-pyrimidinyl]-4-(1H-1,2,3-triazol-1-yl)-|BAY85-3934|Molidustat (BAY 85-3934)|MFCD28411428|1-(6-morpholinopyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-ol|2-(6-morpholin-4-ylpyrimidin-4-yl)-4-(1,2,3-triazol-1-yl)pyrazol-3-ol|2-(6-Morpholin-4-Ylpyrimidin-4-Yl)-4-(1,2,3-Triazol-1-Yl)-1~{h}-Pyrazol-3-One|UNII-9JH486CZ13|IJMBOKOTALXLKS-UHFFFAOYSA-N|3H-PYRAZOL-3-ONE, 1,2-DIHYDRO-2-(6-(4-MORPHOLINYL)-4-PYRIMIDINYL)-4-(1H-1,2,3-TRIAZOL-1-YL)-|QEQ|Molidustat (USAN/INN)|Molidustat [USAN:INN]|2-[6-(4-Morpholinyl)-4-pyrimidinyl]-4-(1H-1,2,3-triazol-1-yl)-1,2-dihydro-3H-pyrazol-3-one|MOLIDUSTAT [WHO-DD]|Molidustat(BAY85-3934)|GTPL8456|orb1701289|SCHEMBL2569970|SCHEMBL6114312|CHEMBL3646118|SCHEMBL29357358|EX-A562|Molidustat(BAY 85-3934)?|BDBM118339|C13H14N8O2|BCP14477|EWB02882|MSK11079|WHO 9655|AKOS026750584|BAY-853934|CCG-267626|SB17156|NCGC00388364-04|AC-35448|AS-74456|HY-12654|DB-092822|DB-132052|S8138|D12122|US8653111, 72|BRD-K01291782-001-01-1|Q27087553|2-(6-morpholinopyrimidin-4-yl)-4-(triazol-1-yl)-1H-pyrazol-3-one|2-(6-Morpholinopyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-3(2H)-one|Molidustat;BAY 85-3934;BAY-85-3934; BAY 853934; BAY-853934; BAY853934|1375799-61-3|2-(6-Morpholin-4-ylpyrimidin-4-yl)-4-(1H-1,2,3-triazol-1-yl)-1,2-dihydro-3H-pyrazol-3-one|A1H"
ROXADUSTAT,11256664,,"InChI=1S/C19H16N2O5/c1-11-15-9-13(26-12-5-3-2-4-6-12)7-8-14(15)18(24)17(21-11)19(25)20-10-16(22)23/h2-9,24H,10H2,1H3,(H,20,25)(H,22,23)",YOZBGTLTNGAVFU-UHFFFAOYSA-N,C19H16N2O5,352.3,2-[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid,"Roxadustat|808118-40-3|FG-4592|FG4592|Evrenzo|ASP 1517|ASP1517|X3O30D9YMX|roxadustatum|FG 4592|ASP-1517|(((4-Hydroxy-1-methyl-7-phenoxyisoquinolin-3-yl)carbonyl)amino)acetic acid|CHEBI:132774|DTXSID60230644|N-[(4-hydroxy-1-methyl-7-phenoxyisoquinolin-3-yl)carbonyl]glycine|[[(4-Hydroxy-1-methyl-7-phenoxyisoquinolin-3-yl)carbonyl]amino]acetic Acid|N-((4-HYDROXY-1-METHYL-7-PHENOXYISOQUINOLIN-3-YL)CARBONYL)GLYCINE|2-((4-hydroxy-1-methyl-7-(phenoxy)isoquinoline-3-carbonyl)amino)acetic acid|2-[[4-hydroxy-1-methyl-7-(phenoxy)isoquinoline-3-carbonyl]amino]acetic acid|RefChem:883871|B03XA05|DTXCID90153135|Roxadustat (FG-4592)|N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]glycine|2-[(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)amino]acetic acid|Roxadustat [USAN:INN]|UNII-X3O30D9YMX|Glycine, N-[(4-hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]-|CHEMBL2338329|MFCD20040519|(4-hydroxy-1-methyl-7-phenoxyisoquinoline-3-carbonyl)glycine|2-(4-hydroxy-1-Methyl-7-phenoxyisoquinoline-3-carboxaMido)acetic acid|2-[(1-methyl-4-oxidanyl-7-phenoxy-isoquinolin-3-yl)carbonylamino]ethanoic acid|GLYCINE, N-((4-HYDROXY-1-METHYL-7-PHENOXY-3-ISOQUINOLINYL)CARBONYL)-|8HO|Evrenzo (TN)|Roxadustat (Standard)|ROXADUSTAT [INN]|ROXADUSTAT [JAN]|ROXADUSTAT [USAN]|2-[(4-hydroxy-1-methyl-7-phenoxy-isoquinoline-3-carbonyl)amino]acetic Acid|Roxadustat(FG-4592)?|ROXADUSTAT [WHO-DD]|MLS006010023|Roxadustat (JAN/USAN/INN)|SCHEMBL523705|GTPL8454|orb1702501|SCHEMBL29350689|SCHEMBL29892426|EX-A390|YOZBGTLTNGAVFU-UHFFFAOYSA-N|BCPP000230|HMS3654M03|HMS5079C03|BCP02523|MSK11080|BDBM50431015|FG-4592,ASP1517|HY-13426R|s1007|AKOS026674331|BCP9000684|CCG-268052|DB04847|FH32910|SB16615|NCGC00346527-01|NCGC00346527-07|AC-31003|AS-17052|HY-13426|SMR004701207|DB-075703|NS00018371|SW219900-1|D10593|BRD-K14385366-001-02-8|BRD-K14385366-001-04-4|Q27088611|FG-4592;N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]glycine|N-[(4-Hydroxy-1-methyl-7-phenoxy-3-isoquinolinyl)carbonyl]-glycine, Roxadustat"
TOFACITINIB,9926791,,"InChI=1S/C16H20N6O/c1-11-5-8-22(14(23)3-6-17)9-13(11)21(2)16-12-4-7-18-15(12)19-10-20-16/h4,7,10-11,13H,3,5,8-9H2,1-2H3,(H,18,19,20)/t11-,13+/m1/s1",UJLAWZDWDVHWOW-YPMHNXCESA-N,C16H20N6O,312.37,"3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile","Tofacitinib|477600-75-2|Tasocitinib|3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile|CP-690550|CP 690550|Cp-690 free base|tofacitinibum|CP690550|CHEBI:71200|87LA6FU830|CP-690550 FREE BASE|CP-690,550 FREE BASE|3-{(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl}-3-oxopropanenitrile|CP690,550|CP-690-550|DTXSID90197271|CP-690|3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile|3-[(3R,4R)-4-methyl-3-[methyl({7H-pyrrolo[2,3-d]pyrimidin-4-yl})amino]piperidin-1-yl]-3-oxopropanenitrile|3-Piperidinamine, 1-(cyanoacetyl)-4-methyl-N-methyl-N-1H-pyrrolo(2,3-d)pyrimidin-4-yl-, (3R,4R)-|3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile|3-((3R,4R)-4-methyl-3-(methyl((7H-pyrrolo(2,3-d)pyrimidin-4-yl))amino)piperidin-1-yl)-3-oxopropanenitrile|RefChem:6313|JAK inhibitors: tofacitinib|DTXCID00119762|L04AA29|689-145-4|1259404-17-5|rac-Tofacitinib|Tofacitinib (CP-690550,Tasocitinib)|3-((3R,4R)-rel-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile|Tofacitinib [USAN]|C16H20N6O|racemic-tofacitinib|CHEMBL221959|racemic-Tasocitinib|477600-75-2 (free base)|Tofacitinib (USAN)|MFCD11035919|3-[(3R*,4R*)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile|3-[(3R,4R)-4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidyl]-3-oxo-propanenitrile|3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile|Tofacitinib [USAN:INN]|UNII-87LA6FU830|Tofacitinib?|Tofacitinib Base|3eyg|3fup|3lxk|4oti|MI1|Tofacitinib (Standard)|TOFACITINIB [MI]|(+)-TOFACITINIB|TOFACITINIB [INN]|TOFACITINIB [VANDF]|TOFACITINIB [WHO-DD]|SCHEMBL322753|Tofacitinib (CP-690550)|GTPL5677|orb1300872|SCHEMBL29351183|HSDB 8311|EX-A205|UJLAWZDWDVHWOW-YPMHNXCESA-N|BCPP000274|BDBM50193995|HY-40354R|MFCD22628813|NSC782351|NSC800953|s2789|AKOS005145814|AKOS005258733|AC-8193|AT43433|BCP9000550|CCG-264998|CS-0050|DB08895|FT32555|GS-6106|NSC-782351|NSC-800953|SDCCGSBI-0654407.P002|NCGC00229511-02|NCGC00229511-04|NCGC00229511-10|NCGC00229511-25|NCGC00244463-01|Tofacitinib (CP-690550, Tasocitinib)|HY-40354|A7301|NS00069315|CP- 690 550|D09970|AB01565786_02|EN300-1718468|600M752|AR-270/43507983|Q3530324|BRD-K31283835-001-01-9|BRD-K31283835-048-04-4|(3R,4R)-3-{4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile|(3R,4R)-4-methyl-3-(methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-beta-oxo-1-piperidine propanenitrile|1-PIPERIDINEPROPANENITRILE, 4-METHYL-3-(METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-.BETA.-OXO-, (3R,4R)-|3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile citrate|3-[(3R,4R)-4-Methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropanenitrile;Tasocitinib|3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]piperidin-1-yl}-3-oxo-propionitrile|3-{(3R,4R)-4-Methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile|3-{4-methyl-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]-1-piperidinyl}-3-oxopropanenitrile|REL-3-((3R,4R)-4-METHYL-3-(METHYL(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)AMINO)PIPERIDIN-1-YL)-3-OXOPROPANENITRILE|Tofacitinib; 3-((3R,4R)-4-Methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile|Tofacitinib;3-((3R,4R)-4-methyl-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)piperidin-1-yl)-3-oxopropanenitrile"
BARICITINIB,44205240,,"InChI=1S/C16H17N7O2S/c1-2-26(24,25)22-9-16(10-22,4-5-17)23-8-12(7-21-23)14-13-3-6-18-15(13)20-11-19-14/h3,6-8,11H,2,4,9-10H2,1H3,(H,18,19,20)",XUZMWHLSFXCVMG-UHFFFAOYSA-N,C16H17N7O2S,371.4,"2-[1-ethylsulfonyl-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)pyrazol-1-yl]azetidin-3-yl]acetonitrile","Baricitinib|1187594-09-7|olumiant|LY3009104|INCB028050|INCB 028050|INCB-028050|2-(3-(4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile|LY-3009104|ISP4442I3Y|LY 3009104|CHEBI:95341|DTXSID30152228|3-Azetidineacetonitrile, 1-(ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-|baricitinibum|(1-(Ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)acetonitrile|{1-(ethylsulfonyl)-3-[4-(7h-pyrrolo[2,3-d]pyrimidin-4-yl)-1h-pyrazol-1-yl]azetidin-3-yl}acetonitrile|2-(3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile|RefChem:6387|JAK inhibitors: baricitinib|DTXCID5074719|L04AA37|1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile|Baricitinib [USAN:INN]|UNII-ISP4442I3Y|2-(3-(4-(3H-Pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl)-1-(ethylsulfonyl)azetidin-3-yl)acetonitrile|MFCD21608464|2-[1-ETHYLSULFONYL-3-[4-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PYRAZOL-1-YL]AZETIDIN-3-YL]ACETONITRILE|LY3009104 (phosphate);INCB028050 (phosphate)|Baricitinib [USAN]|C16H17N7O2S|Baricitinib (LY3009104, INCB028050)|INCB 28050|Olumiant (TN)|3JW|Baricitinib (Standard)|BARICITINIB [MI]|BARICITINIB [INN]|BARICITINIB [JAN]|BARICITINIB [WHO-DD]|MLS006011247|SCHEMBL871150|Baricitinib (JAN/USAN/INN)|Baricitinib (LY3009104)|BARICITINIB [EMA EPAR]|Baricitinib (INCB028050)|GTPL7792|orb1305415|Baricitinib - Bio-X trade mark|CHEMBL2105759|SCHEMBL27246146|SCHEMBL28628968|SCHEMBL29349824|INCB28050|BARICITINIB [ORANGE BOOK]|EX-A413|XUZMWHLSFXCVMG-UHFFFAOYSA-N|HMS3651L17|HMS3672M15|HMS3747G21|HMS5081F19|BCP04686|BDBM50021656|HY-15315R|NSC799357|s2851|AKOS022186127|AKOS025401933|BCP9000380|CCG-268312|CS-0724|DB11817|DS-7641|FE30357|NSC-799357|PB27275|SB10845|SDCCGSBI-0654448.P001|NCGC00345839-01|NCGC00345839-14|NCGC00345839-16|AC-27404|BB184033|DA-50940|HY-15315|SMR004703006|BCP0726000031|NS00072974|SW220096-1|Baricitinib (INCB28050, LY3009104)?|D10308|EN300-24435973|F468368|Q4860707|BRD-K53581288-001-02-9|Z2724205326|(1-(Ethylsulfonyl)-3-(4-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1H-pyrazol-1-yl)azetidin-3-yl)ethanenitrile|2-[1-(ethanesulfonyl)-3-(4-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1H-pyrazol-1-yl)azetidin-3-yl]acetonitrile|INCB 028050; 1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile; LY 3009104|INCB 028050;1-(Ethylsulfonyl)-3-[4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazol-1-yl]-3-azetidineacetonitrile;LY 3009104"
DECERNOTINIB,59422203,,"InChI=1S/C18H19F3N6O/c1-3-17(2,16(28)25-10-18(19,20)21)27-13-6-8-23-15(26-13)12-9-24-14-11(12)5-4-7-22-14/h4-9H,3,10H2,1-2H3,(H,22,24)(H,25,28)(H,23,26,27)/t17-/m1/s1",ASUGUQWIHMTFJL-QGZVFWFLSA-N,C18H19F3N6O,392.4,"(2R)-2-methyl-2-[[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-N-(2,2,2-trifluoroethyl)butanamide","Decernotinib|944842-54-0|Adelatinib|VX-509|VRT-831509|MZK2GP0RHK|VX509|VX 509|VRT 831509|(2R)-2-methyl-2-[[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]amino]-N-(2,2,2-trifluoroethyl)butanamide|Butanamide, 2-methyl-2-((2-(1H-pyrrolo(2,3-b)pyridin-3-yl)-4-pyrimidinyl)amino)-N-(2,2,2-trifluoroethyl)-, (2R)-|decernotinibum|DTXSID70241504|(2R)-2-methyl-2-((2-(1H-pyrrolo(2,3-b)pyridin-3-yl)pyrimidin-4-yl)amino)-N-(2,2,2-trifluoroethyl)butanamide|RefChem:407157|DTXCID30163995|Decernotinib (VX-509)|Decernotinib(VX-509)|(R)-2-((2-(1H-Pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-2-methyl-N-(2,2,2-trifluoroethyl)butanamide|Decernotinib (VX-509,adelatinib)|(2R)-2-Methyl-2-((2-(1H-pyrrolo(2,3-b)pyridin-3-yl)pyrimidin- 4-yl)amino)-N-(2,2,2-trifluoroethyl)butanamide|(2r)-2-Methyl-2-[[2-(1h-Pyrrolo[2,3-B]pyridin-3-Yl)pyrimidin-4-Yl]amino]-N-[2,2,2-Tris(Fluoranyl)ethyl]butanamide|(R)-2-(2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-ylamino)-2-methyl-N-(2,2,2-trifluoroethyl)butanamide|UNII-MZK2GP0RHK|Decernotinib [USAN:INN]|C18H19F3N6O|MFCD27987896|Decernotinib,VX-509|Decernotinib (USAN/INN)|DECERNOTINIB [INN]|DECERNOTINIB [USAN]|DECERNOTINIB [WHO-DD]|GTPL8309|orb1305235|SCHEMBL2630387|CHEMBL3039513|SCHEMBL29349797|SCHEMBL29393666|Decernotinib; Adelatinib; VX-509|EX-A1580|BDBM50021655|NSC800088|s7541|AKOS025290739|CCG-268552|CS-3990|DB12566|NSC-800088|SB16545|NCGC00402345-02|NCGC00402345-03|AC-30939|AS-56377|HY-12469|NS00073132|D10585|P14482|Q27077006|N~2~-[2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl]-N-(2,2,2-trifluoroethyl)-D-isovalinamide|VJK"
FILGOTINIB,49831257,,"InChI=1S/C21H23N5O3S/c27-20(17-8-9-17)23-21-22-19-3-1-2-18(26(19)24-21)16-6-4-15(5-7-16)14-25-10-12-30(28,29)13-11-25/h1-7,17H,8-14H2,(H,23,24,27)",RIJLVEAXPNLDTC-UHFFFAOYSA-N,C21H23N5O3S,425.5,"N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide","Filgotinib|1206161-97-8|GLPG-0634|N-[5-[4-[(1,1-dioxo-1,4-thiazinan-4-yl)methyl]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide|GS-6034 FREE BASE|3XVL385Q0M|GLPG 0634|G146034|G-146034|DTXSID80152935|filgotinibum|N-(5-(4-((1,1-dioxo-1,4-thiazinan-4-yl)methyl)phenyl)-(1,2,4)triazolo(1,5-a)pyridin-2-yl)cyclopropanecarboxamide|N-(5-(4-((1,1-dioxo-1lambda6-thiomorpholin-4-yl)methyl)phenyl)-(1,2,4)triazolo(1,5-a)pyridin-2-yl)cyclopropanecarboxamide|N-(5-{4-[(1,1-dioxo-1lambda6-thiomorpholin-4-yl)methyl]phenyl}-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide|RefChem:921607|DTXCID7075426|1206101-20-3|GLPG0634|N-(5-(4-((1,1-dioxidothiomorpholino)methyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide|Filgotinib (GLPG0634)|N-[5-[4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide|Filgotinib(GLPG0634)|MFCD20527867|Jyseleca|Filgotinib [INN]|N-(5-(4-((1,1-dioxidothiomorpholino)methyl)phenyl)-[1,2,4]triazolo[1,5-a]pyridin-2-yl)cyclopropanecarboxamide.|GPLG0634|Filgotinib [USAN:INN]|UNII-3XVL385Q0M|N-(5-{4-[(1,1-Dioxidothiomorpholin-4-Yl)methyl]phenyl}[1,2,4]triazolo[1,5-A]pyridin-2-Yl)cyclopropanecarboxamide|Filgotinib (Standard)|Filgotinib (USAN/INN)|FILGOTINIB [USAN]|Filgotinib(GLPG0634)?|FILGOTINIB [WHO-DD]|Filgotinib (GLPG-0634)|SCHEMBL253559|Filgotinib pound GLPG0643)|GTPL7913|orb1307080|CHEMBL3301607|EX-A741|BDBM103727|HMS3653P15|HMS3673E07|BCP08496|RGD09550|HY-18300R|NSC800100|s7605|AKOS025291103|CCG-268951|DB14845|NSC-800100|SB16799|NCGC00345855-01|NCGC00345855-07|AS-16295|BF159062|DA-33603|DA-33604|HY-18300|SW220020-1|D10871|P12798|US8563545, 1|EN300-7419864|SYN1158;GLPG 0634; GLPG-0634; Filgotinib|BRD-K16803204-001-01-6|Q19904163|Z2037280227|CYCLOPROPANECARBOXAMIDE, N-(5-(4-((1,1-DIOXIDO-4-THIOMORPHOLINYL)METHYL)PHENYL)(1,2,4)TRIAZOLO(1,5-A)PYRIDIN-2-YL)-|GLPG-0634;N-[5-[4-[(1,1-Dioxido-4-thiomorpholinyl)methyl]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide|N-(5-(4-((1,1-OXO-.LAMBDA.6-THIOMORPHOLIN-4-YL)METHYL)PHENYL((1,2,4)TRIAZOLO(1,5-A)PYRIDIN-2-YL)CYCLOPROPANECARBOXAMIDE|N-[5-[4-[(6-Cyano-3-pyridinyl)methoxy]phenyl][1,2,4]triazolo[1,5-a]pyridin-2-yl] cyclopropanecarboxa"
UPADACITINIB,58557659,,"InChI=1S/C17H19F3N6O/c1-2-10-7-25(16(27)24-9-17(18,19)20)8-11(10)13-5-22-14-6-23-15-12(26(13)14)3-4-21-15/h3-6,10-11,21H,2,7-9H2,1H3,(H,24,27)/t10-,11+/m1/s1",WYQFJHHDOKWSHR-MNOVXSKESA-N,C17H19F3N6O,380.4,"(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide","Upadacitinib|1310726-60-3|ABT-494|Upadacitinib anhydrous|4RA0KN46E0|DTXSID901027919|(3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide|upadacitinibum|RefChem:57163|L04AA44|DTXCID401513480|(3S,4R)-3-ethyl-4-(1,5,7,10-tetraazatricyclo(7.3.0.0^(2,6))dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide|Rinvoq|(3S,4R)-3-ethyl-4-(1,5,7,10-tetrazatricyclo[7.3.0.02,6]dodeca-2(6),3,7,9,11-pentaen-12-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide|ABT 494|(3S,4R)-3-ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide|1-Pyrrolidinecarboxamide, 3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-, (3S,4R)-|UNII-4RA0KN46E0|C17H19F3N6O|Upadacitinib [USAN]|Upadacitinib (Standard)|UPADACITINIB [MI]|Upadacitinib, ABT-494|Upadacitinib (USAN/INN)|UPADACITINIB [INN]|Upadacitinib [USAN:INN]|Upadacitinib (ABT-494)|UPADACITINIB [WHO-DD]|GTPL9246|orb1299762|SCHEMBL9991056|CHEMBL3622821|WYQFJHHDOKWSHR-MNOVXSKESA-N|GLXC-10425|UPADACITINIB [ORANGE BOOK]|BCP19011|EX-A1628|BDBM50503287|HY-19569R|s8162|AKOS030567686|CS-6150|DB15091|ABBV-599 COMPONENT UPADACITINIB|ABT494;ABT-494;ABT 494|NCGC00588874-01|AC-30326|AS-56379|DA-78788|FA166721|HY-19569|NS00133778|C72237|D10994|Q27074125|Z2831495606|(3S,4R)-3-ETHYL-4-(3H-IMIDAZO(1,2-A)PYRROLO(2,3-E)PYRAZIN- 8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE TYROSINE KINASE INHIBITOR|(3S,4R)-3-ethyl-4-(3H-imidazo(1,2-a)pyrrolo(2,3-e)pyrazin-8-yl)-N-(2,2,2- trifluoroethyl)pyrrolidine-1-carboxamide|ABT-494; rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide; (3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide|REL-(-)-(3S,4R)-3-ETHYL-4-(3H-IMIDAZO(1,2-A)PYRROLO(2,3-E)PYRAZIN-8-YL)-N-(2,2,2-TRIFLUOROETHYL)PYRROLIDINE-1-CARBOXAMIDE|rel-(-)-(3S,4R)-3-Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)pyrrolidine-1-carboxamide;(3S,4R)-3-  Ethyl-4-(3H-imidazo[1,2-a]pyrrolo[2,3-e]pyrazin-8-yl)-N-(2,2,2-trifluoroethyl)-1-pyrrolidinecarboxamide"
ABROCITINIB,78323835,,"InChI=1S/C14H21N5O2S/c1-3-6-22(20,21)18-10-7-11(8-10)19(2)14-12-4-5-15-13(12)16-9-17-14/h4-5,9-11,18H,3,6-8H2,1-2H3,(H,15,16,17)",IUEWXNHSKRWHDY-UHFFFAOYSA-N,C14H21N5O2S,323.42,"N-[3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide","N-(cis-3-(Methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-1-propanesulfonamide|RefChem:926945|Abrocitinib|1622902-68-4|PF-04965842|Cibinqo|N-[cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide|Abrocitinib [USAN]|MFCD30187577|73SM5SF3OR|CHEMBL4101725|N-[3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl]propane-1-sulfonamide|N-{cis-3-[methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide|N-(cis-3-(Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide|1-Propanesulfonamide, N-(cis-3-(methyl-7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)cyclobutyl)-|N-((1s,3s)-3-(methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide|N-(3-(Methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide, cis-|N-[cis-3-(Methyl-7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)cyclobutyl]-1-propanesulfonamide|UNII-73SM5SF3OR|N-(cis-3-(Methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)propane-1-sulfonamide|D7D|N-((1S,3S)-3-(METHYL(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)AMINO)CYCLOBUTYL)PROPANE-1-SULFONAMIDE|Cibinqo (TN)|Abrocitinib (Standard)|ABROCITINIB [INN]|ABROCITINIB [JAN]|Abrocitinib (JAN/USAN)|ABROCITINIB [WHO-DD]|GTPL9991|orb1296253|CHEMBL3655081|SCHEMBL15970412|SCHEMBL15970413|SCHEMBL29358939|SCHEMBL30562998|C14H21N5O2S|PF-04965842(Abrocitinib)|Abrocitinib (PF-04965842)|BDBM159748|BDBM642616|DTXSID301126581|PF-04965842 (Abrocitinib)|BCP30441|EX-A3037|PF-04965842 (Abrocitinib)?|XPC90268|AC8575|BDBM50243847|s8765|ZB1566|DB14973|HY-107429R|SB18849|compound 25 [PMID: 29298069]|NCGC00601823-02|US20230416237, Example abrocitinib|AC-36318|AS-84437|DA-70455|SY248874|HY-107429|CS-0028460|PF04965842|D11400|US9035074, 2|PF-04965842, >=98% (HPLC)|PF-04965842; PF 04965842; PF04965842|N-(cis-3-(Methyl(7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)cyclobutyl)-propane-1-sulfonamide"
RITLECITINIB,118115473,,"InChI=1S/C15H19N5O/c1-3-13(21)20-8-11(5-4-10(20)2)19-15-12-6-7-16-14(12)17-9-18-15/h3,6-7,9-11H,1,4-5,8H2,2H3,(H2,16,17,18,19)/t10-,11+/m0/s1",CBRJPFGIXUFMTM-WDEREUQCSA-N,C15H19N5O,285.34,"1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one","ritlecitinib|1792180-81-4|PF-06651600|2-Propen-1-one, 1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidinyl]-|2OYE00PC25|PF06651600|1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)piperidin-1-yl]prop-2-en-1-one|PF 06651600|2-PROPEN-1-ONE, 1-((2S,5R)-2-METHYL-5-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YLAMINO)-1-PIPERIDINYL)-|1-((2S,5R)-2-methyl-5-(7H-pyrrolo(2,3-d)pyrimidin-4-ylamino)piperidin-1-yl)prop-2-en-1-one|1-[(2S,5R)-2-methyl-5-{7H-pyrrolo[2,3-d]pyrimidin-4-ylamino}piperidin-1-yl]prop-2-en-1-one|RefChem:179511|JAK3 Inhibitor PF-06651600|1-((2S,5R)-2-methyl-5-((7H-pyrrolo(2,3-d)pyrimidin-4-yl)amino)piperidin-1-yl)prop-2-en-1-one|815-269-7|1-((2S,5R)-5-((7H-Pyrrolo[2,3-d]pyrimidin-4-yl)amino)-2-methylpiperidin-1-yl)prop-2-en-1-one|PF-06651600 free base|MFCD30343868|ritlecitinibum|Ritlecitinib?|MFCD31697544|RITLECITINIB [INN]|UNII-2OYE00PC25|RITLECITINIB [WHO-DD]|GTPL9559|orb1301838|CHEMBL4085457|SCHEMBL16764638|SCHEMBL24377696|SCHEMBL29369472|CHEBI:229233|Ritlecitinib (PF-06651600)|BCP24778|EX-A2613|AKOS040758742|example 5 [WO2015083028]|CCG-267324|DB14924|compound 11 [PMID: 28139931]|AC-35550|BP-44053|BP168506|MS-24066|SY060486|RITLECITINIB  (PF-06651600)|DB-179694|HY-100754|CS-0020243|S8538|C91239|PF06651600;PF 06651600|1-[(2S,5R)-2-methyl-5-(7H-pyrrolo[2,3-d]pyrimidin-4-ylamino)-1-piperidyl]prop-2-en-1-one|1-[(2S,5R)-5-[[7H-Pyrrolo[2,3-d]-4-pyrimidinyl]amino]-2-methyl-1-piperidyl]-2-propen-1-one"
FEDRATINIB,16722836,,"InChI=1S/C27H36N6O3S/c1-20-19-28-26(30-21-10-12-23(13-11-21)36-17-16-33-14-5-6-15-33)31-25(20)29-22-8-7-9-24(18-22)37(34,35)32-27(2,3)4/h7-13,18-19,32H,5-6,14-17H2,1-4H3,(H2,28,29,30,31)",JOOXLOJCABQBSG-UHFFFAOYSA-N,C27H36N6O3S,524.7,N-tert-butyl-3-[[5-methyl-2-[4-(2-pyrrolidin-1-ylethoxy)anilino]pyrimidin-4-yl]amino]benzenesulfonamide,"Fedratinib|936091-26-8|Tg-101348|TG101348|SAR302503|SAR-302503|6L1XP550I6|DTXSID90239483|Benzenesulfonamide, N-(1,1-dimethylethyl)-3-((5-methyl-2-((4-(2-(1-pyrrolidinyl)ethoxy)phenyl)amino)-4-pyrimidinyl)amino)-|N-Tert-butyl-3-(5-methyl-2-(4-(2-pyrrolidin-1-yl-ethoxy)-phenylamino)-pyrimidin-4-ylamino)-benzenesulfonamide|fedratinibum|N-tert-butyl-3-((5-methyl-2-((4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl)amino)benzene-1-sulfonamide|N-tert-butyl-3-{[5-methyl-2-({4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}amino)pyrimidin-4-yl]amino}benzene-1-sulfonamide|RefChem:58214|DTXCID10161974|L01XE57|SAR-302503A|829-304-9|N-tert-butyl-3-(5-methyl-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino) pyrimidin-4-ylamino)benzenesulfonamide|N-(tert-butyl)-3-((5-methyl-2-((4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)amino)pyrimidin-4-yl)amino)benzenesulfonamide|Fedratinib (SAR302503, TG101348)|TG 101348|SAR 302503|N-tert-butyl-3-[[5-methyl-2-[4-(2-pyrrolidin-1-ylethoxy)anilino]pyrimidin-4-yl]amino]benzenesulfonamide|MFCD12922515|N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide|CHEMBL1287853|936091-26-8 (free base)|N-tert-butyl-3-(5-methyl-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide|N-tert-butyl-3-{[5-methyl-2-({4-[2-(pyrrolidin-1-yl)ethoxy]phenyl}amino)pyrimidin-4-yl]amino}benzenesulfonamide|Fedratinib [USAN]|C27H36N6O3S|Fedratinib [USAN:INN]|TG101348 (SAR302503)|UNII-6L1XP550I6|2TA|FEDRATINIB [MI]|FEDRATINIB [INN]|Fedratinib (USAN/INN)|FEDRATINIB [WHO-DD]|Fedratinib (TG101348)|TG101348(Fedratinib)?|MLS006011155|SCHEMBL263741|GTPL5716|orb1306807|SCHEMBL29351417|CHEBI:91408|EX-A170|GLXC-04732|HMS3295I03|HMS3656L19|HMS3744G17|HMS3868L03|HMS5081F15|BCP02300|BDBM50332294|NSC767600|NSC800099|s2736|AKOS015842621|CCG-264990|CS-0052|DB12500|EX-5961|NSC-767600|NSC-800099|SB14604|SDCCGSBI-0654455.P001|NCGC00244252-01|NCGC00244252-07|945381-69-1|AC-30260|AS-16248|DA-40258|FD151499|HY-10409|SMR004702929|DB-079623|NS00071609|SW218187-2|D10630|F17372|091D268|Q7670147|BRD-K12502280-001-01-5|BRD-K12502280-001-08-0|BRD-K12502280-001-11-4|Z2037280076|Fedratinib; N-(1,1-Dimethylethyl)-3-[[5-methyl-2-[[4-[2-(1-pyrrolidinyl)ethoxy]phenyl]amino]-4-pyrimidinyl]amino]benzenesulfonamide|N-TERT-BUTYL-3-((5-METHYL-2-(4-(2-(PYRROLIDIN-1-YL)ETHOXY)ANILINO(PYRIMIDIN-4-YL)AMINO)BENZENESULFONAMIDE|SAR302503, N-tert-butyl-3-(5-methyl-2-(4-(2-(pyrrolidin-1-yl)ethoxy)phenylamino)pyrimidin-4-ylamino)benzenesulfonamide"
SPEBRUTINIB,59174488,,"InChI=1S/C22H22FN5O3/c1-3-20(29)25-16-5-4-6-17(13-16)26-21-19(23)14-24-22(28-21)27-15-7-9-18(10-8-15)31-12-11-30-2/h3-10,13-14H,1,11-12H2,2H3,(H,25,29)(H2,24,26,27,28)",KXBDTLQSDKGAEB-UHFFFAOYSA-N,C22H22FN5O3,423.4,N-[3-[[5-fluoro-2-[4-(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide,"spebrutinib|1202757-89-8|AVL-292|cc-292|Btk inhibitor CC-292|N-[3-[[5-fluoro-2-[4-(2-methoxyethoxy)anilino]pyrimidin-4-yl]amino]phenyl]prop-2-enamide|DRU6NG543J|Espebrutinib|2-Propenamide, N-(3-((5-fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)-4-pyrimidinyl)amino)phenyl)-|N-{3-[(5-FLUORO-2-{[4-(2-METHOXYETHOXY)PHENYL]AMINO}PYRIMIDIN-4-YL)AMINO]PHENYL}PROP-2-ENAMIDE|3-(5-FLUORO-2-(4-(2-METHOXYETHOXY)PHENYLAMINO)PYRIMIDIN-4-YLAMINO)PHENYL)ACRYLAMIDE|spebrutinibum|N-(3-((5-fluoro-2-(4-(2-methoxyethoxy)anilino)pyrimidin-4-yl)amino)phenyl)prop-2-enamide|N-(3-((5-fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)prop-2-enamide|RefChem:888489|Bruton's Tyrosine Kinase Inhibitor CC-292|N-(3-((5-fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide|AVL292|C22H22FN5O3|Spebrutinib [USAN:INN]|UNII-DRU6NG543J|N-[3-[[5-fluoro-2-[[4-(2-methoxyethoxy)phenyl]amino]-4-pyrimidinyl]amino]phenyl]-2-propenamide|MFCD25976876|Spebrutinib (AVL-292)|n-(3-(5-fluoro-2-(4-(2-methoxyethoxy)phenylamino)pyrimidin-4-ylamino)phenyl)acrylamide|AVL 292|CC 292|CC-292 (AVL-292)|N-(3-((5-Fluoro-2-((4-(2-methoxyethoxy)phenyl)amino)-4-pyrimidinyl)amino)phenyl)-2-propenamide|SPEBRUTINIB [INN]|Spebrutinib (USAN/INN)|SPEBRUTINIB [USAN]|SPEBRUTINIB [WHO-DD]|SCHEMBL626216|GTPL7837|orb1305275|CHEMBL3301625|SCHEMBL29359972|EX-A255|KXBDTLQSDKGAEB-UHFFFAOYSA-N|DTXSID101026012|HMS3653E15|HMS3674E05|AVL-292?|BCP07702|BDBM50161162|NSC780020|s7173|AKOS026670200|AKOS032949981|CCG-268921|CS-1482|DB11764|FC64970|NSC-780020|SB14609|NCGC00386306-03|NCGC00386306-06|AC-32618|AS-16998|DA-35316|HY-18012|NS00072971|SW219474-1|D10730|BRD-K87782578-001-01-4|Q27088846|N-(3-((5-fluoro-2-((4-(2-methoxyethoxyl)phenyl)amino)pyrimidin-4-yl)amino)phenyl)acrylamide|N-(3-{5-fluoro-2-[4-(2-methoxy-ethoxy)-phenylamino]-pyrimidin-4-ylamino}-phenyl)-acrylamide"
CEP-1347,9917013,,"InChI=1S/C33H33N3O5S2/c1-5-42-15-17-7-9-22-19(11-17)26-27-21(14-34-30(27)37)25-20-12-18(16-43-6-2)8-10-23(20)36-29(25)28(26)35(22)24-13-33(39,31(38)40-4)32(36,3)41-24/h7-12,24,39H,5-6,13-16H2,1-4H3,(H,34,37)/t24-,32+,33+/m1/s1",SCMLRESZJCKCTC-KMYQRJGFSA-N,C33H33N3O5S2,615.8,"methyl (15S,16R,18R)-10,23-bis(ethylsulfanylmethyl)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-16-carboxylate","CEP-1347|156177-65-0|3,9-Bis((ethylthio)methyl)-K-252a|CEP 1347|KT7515|CEP1347|KT-7515|3,9-Bis(etsm)-K-252a|200HA2LIMK|KT 7515|KT-1575|9,12-Epoxy-1H-diindolo(1,2,3-fg:3',2',1'-kl)pyrrolo(3,4-i)(1,6)benzodiazocine-10-carboxylic acid, 5,16-bis((ethylthio)methyl)-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-, methyl ester, (9S-(9alpha,10beta,12alpha))-|RefChem:124348|methyl (15S,16S,18S)-10,23-bis(ethylsulfanylmethyl)-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo(12.11.2.115,18.02,6.07,27.08,13.019,26.020,25)octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-16-carboperoxoate|CHEMBL290352|methyl (15S,16R,18R)-10,23-bis(ethylsulfanylmethyl)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8(13),9,11,20(25),21,23,26-nonaene-16-carboxylate|methyl (5S,6R,8R)-2,11-bis((ethylthio)methyl)-6-hydroxy-5-methyl-13-oxo-5,6,7,8,14,15-hexahydro-13H-16-oxa-4b,8a,14-triaza-5,8-methanodibenzo[b,h]cycloocta[jkl]cyclopenta[e]-as-indacene-6-carboxylate|C33H33N3O5S2|CEP-1374|UNII-200HA2LIMK|GTPL8173|SCHEMBL12047710|SCHEMBL29381680|SCHEMBL30198505|BDBM24942|BCP16748|MFCD27991285|AKOS024458422|FE29092|DA-62207|HY-10412|MS-30740|CS-0002594|Q27075851|KT7515;KT-7515;KT 7515;Cep-1347;Cep 1347|(9S,10R,12R)-5-16-Bis[(ethylthio)methyl]-2,3,9,10,11,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg:3',2',1'   -kl]pyrrolo[3,4-i][1,6]benzodiazocine-10-carboxylic acid methyl ester;KT 7515|9,12-EPOXY-1H-DIINDOLO(1,2,3-FG:3',2',1'-KL)PYRROLO(3,4-I)(1,6)BENZODIAZOCINE-10-CARBOXYLIC ACID, 5,16-BIS((ETHYLTHIO)METHYL)-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-, METHYL ESTER, (9S,10R,12R)-|9,12-EPOXY-1H-DIINDOLO(1,2,3-FG:3',2',1'-KL)PYRROLO(3,4-I)(1,6)BENZODIAZOCINE-10-CARBOXYLIC ACID, 5,16-BIS((ETHYLTHIO)METHYL)-2,3,9,10,11,12-HEXAHYDRO-10-HYDROXY-9-METHYL-1-OXO-, METHYL ESTER, (9S-(9.ALPHA.,10.BETA.,12.ALPHA.))-|methyl (15S,16R,18R)-10,23-bis[(ethylsulfanyl)methyl]-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.1^{15,18}.0^{2,6}.0^{7,27}.0^{8,13}.0^{19,26}.0^{20,25}]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylate"
EFIPLADIB,9853499,,"InChI=1S/C40H35Cl3N2O4S/c41-32-19-21-37-34(25-32)33(13-7-8-27-14-17-31(18-15-27)40(46)47)38(22-23-44-50(48,49)26-28-16-20-35(42)36(43)24-28)45(37)39(29-9-3-1-4-10-29)30-11-5-2-6-12-30/h1-6,9-12,14-21,24-25,39,44H,7-8,13,22-23,26H2,(H,46,47)",HIZOPJQOPKRKFM-UHFFFAOYSA-N,C40H35Cl3N2O4S,746.1,"4-[3-[1-benzhydryl-5-chloro-2-[2-[(3,4-dichlorophenyl)methylsulfonylamino]ethyl]indol-3-yl]propyl]benzoic acid","Efipladib|381683-94-9|PLA-902|S97YUG2A91|4-(3-(5-Chloro-2-(2-(((3,4-dichlorobenzyl)sulfonyl)amino)ethyl)-1-(diphenylmethyl)-1H-indol-3-yl)propyl)benzoic acid|efipladibum|4-[3-[5-chloro-2-[2-[[(3,4-dichlorobenzyl)sulfonyl]amino]ethyl]-1-(diphenylmethyl)-1h-indol-3-yl]propyl]benzoic acid|4-{3-[5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1-(diphenylmethyl)-1h-indol-3-yl]propyl}benzoic acid|RefChem:136332|Efipladib [USAN:INN]|UNII-S97YUG2A91|CHEMBL272342|Efipladib (USAN)|EFIPLADIB [USAN]|4-[3-[1-benzhydryl-5-chloro-2-[2-[(3,4-dichlorophenyl)methylsulfonylamino]ethyl]indol-3-yl]propyl]benzoic acid|Efipladib [INN]|4-(3-(1-benzhydryl-5-chloro-2-(2-(((3,4-dichlorophenyl)methyl)sulfonamido)ethyl)-1H-indol-3-yl)propyl)benzoic|4-(3-(5-Chloro-2-(2-((((3,4-dichlorophenyl)methyl)sulfonyl)amino)ethyl)-1-(diphenylmethyl)-1H-indol-3-yl)propyl)benzoic acid|orb1700669|SCHEMBL1500831|SCHEMBL29586714|DTXSID20870343|HIZOPJQOPKRKFM-UHFFFAOYSA-N|BDBM50226792|AKOS040748307|DB-241582|HY-106253|CS-0025432|NS00121932|D06674|Q27289073|4-(3-{1-Benzhydryl-5-chloro-2-[2-(3,4-dichloro-phenylmethanesulfonylamino)-ethyl]-1H-indol-3-yl}-propyl)-benzoic acid|4-[3-[5-Chloro-2-[2-[(3,4-dichlorobenzyl)sulfonylamino]ethyl]-1-[di(phenyl)methyl]indol-3-yl]propyl]benzoic acid|4-[3-[5-chloro-2-[2-[[[(3,4-dichlorophenyl)-methyl]-su lfonyl]amino]ethyl]-1-(diphenylmethyl)-1H-indol-3-yl]propyl]benzoic acid|4-[3-[5-chloro-2-[2-[[[(3,4-dichlorophenyl)-methyl]-sulfonyl]amino]ethyl]-1-(diphenylmethyl)-1H-indol-3-yl]propyl] Benzoic Acid|4-[3-[5-chloro-2-[2-[[[(3,4-dichlorophenyl)-methyl]-sulfonyl]amino]ethyl]-1-(diphenylmethyl)-1H-indol-3-yl]propyl]benzoic Acid|4-{3-[1-benzhydryl-5-chloro-2-(2-{[(3,4-dichlorobenzyl)sulfonyl]amino}ethyl)-1H-indol-3-yl]propyl}benzoic acid|4-{3-[5-Chloro-2-(2-{[(3,4-dichlorophenyl)methanesulfonyl]amino}ethyl)-1-(diphenylmethyl)-1H-indol-3-yl]propyl}benzoic acid|BENZOIC ACID, 4-(3-(5-CHLORO-2-(2-((((3,4-DICHLOROPHENYL)METHYL)SULFONYL)AMINO)ETHYL)-1-(DIPHENYLMETHYL)-1H-INDOL-3-YL)PROPYL)-"
FASUDIL HYDROCHLORIDE,163751,,"InChI=1S/C14H17N3O2S.ClH/c18-20(19,17-9-2-6-15-8-10-17)14-4-1-3-12-11-16-7-5-13(12)14;/h1,3-5,7,11,15H,2,6,8-10H2;1H",LFVPBERIVUNMGV-UHFFFAOYSA-N,C14H18ClN3O2S,327.8,"5-(1,4-diazepan-1-ylsulfonyl)isoquinoline;hydrochloride","Fasudil hydrochloride|105628-07-7|Fasudil HCl|AT 877 hydrochloride|HA 1077 hydrochloride|SQ04N8S7BR|DTXSID1045615|Hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine monohydrochloride|DTXCID9025615|CHEBI:31593|1H-1,4-Diazepine, hexahydro-1-(5-isoquinolinylsulfonyl)-, monohydrochloride|RefChem:140012|805-833-0|Eril|5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline hydrochloride|Fasudil (Hydrochloride)|MFCD00943198|Fasudil, Monohydrochloride Salt|5-(1,4-diazepan-1-ylsulfonyl)isoquinoline hydrochloride|5-(1,4-diazepan-1-ylsulfonyl)isoquinoline;hydrochloride|105628-07-7 (HCl)|Fasudil (HA-1077) HCl|Fasudil hydrochloride (JAN)|133337-43-6|Fasudil Monohydrochloride Salt|1-(5-Isoquinolinesulfonyl)homopiperazine hydrochloride|CHEMBL541388|5-((1,4-Diazepan-1-yl)sulfonyl)isoquinoline xhydrochloride|FASUDIL HYDROCHLORIDE [JAN]|Fasudil Monohydrochloride|HA-1077 DIHYDROCHLORIDE|CAS-105628-07-7|NCGC00018100-04|UNII-SQ04N8S7BR|Fasdil|Fasudil-HA?|Isoquinoline, 5-[(hexahydro-1H-1,4-diazepin-1-yl)sulfonyl]-, hydrochloride (1:1); 1H-1,4-Diazepine, hexahydro-1-(5-isoquinolinylsulfonyl)-, monohydrochloride (9CI); 1-(5-Isoquinolinesulfonyl)homopiperazine hydrochloride; Eril; Fasudil hydrochloride|AT-877 hydrochloride|FASUDIL, MONOHCL|5-(1,4-diazepan-1-ylsulfonyl)isoquinoline HCl|REGID_for_CID_4917|BMK1-E2|MLS000069344|SCHEMBL317082|Fasudil HCl (HA-1077)|orb1304579|REGID_for_CID_163751|SCHEMBL29351490|SCHEMBL29393852|LFVPBERIVUNMGV-UHFFFAOYSA-N|FASUDIL HYDROCHLORIDE [MI]|GLXC-05665|HMS5079I16|BCP26351|Fasudil (Hydrochloride) (Standard)|Tox21_110824|HB0283|HY-10341R|s1573|FASUDIL HYDROCHLORIDE [MART.]|AKOS015897321|FASUDIL HYDROCHLORIDE [WHO-DD]|Tox21_110824_1|AC-4515|CCG-267783|CS-0225|FF31090|NCGC00018100-08|NCGC00180915-01|111GE018|AS-17751|HY-10341|SMR000058993|SY058037|F0839|SW218155-2|D01840|EN300-7361975|F050724|SR-01000000005|1-(5isoquinolinesulfonyl)homopiperazine hydrochloride|SR-01000000005-2|Q27289337|5-(1,4-diazepane-1-sulfonyl)isoquinoline hydrochloride|5-(1-Homopiperazinyl)sulfonylisoquinoline Hydrochloride|5-(1,4-diazepan-1-ylsulfonyl)isoquinoline;hydron;chloride|5-(HEXAHYDRO-1H-1,4-DIAZEPINE-1-YLSULFONYL)ISOQUINOLINE HYDROCHLORIDE|ISOQUINOLINE, 5-((HEXAHYDRO-1H-1,4-DIAZEPIN-1-YL)SULFONYL)-, HYDROCHLORIDE (1:1)|Hexahydro-1-(5-isoquinolinylsulfonyl)-1H-1,4-diazepine monohydrochloride;1-(5-Isoquinolinesulfonyl)homopiperazine hydrochloride"
BELUMOSUDIL,11950170,,"InChI=1S/C26H24N6O2/c1-16(2)28-24(33)15-34-20-7-5-6-17(13-20)25-30-23-9-4-3-8-21(23)26(31-25)29-19-10-11-22-18(12-19)14-27-32-22/h3-14,16H,15H2,1-2H3,(H,27,32)(H,28,33)(H,29,30,31)",GKHIVNAUVKXIIY-UHFFFAOYSA-N,C26H24N6O2,452.5,2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-N-propan-2-ylacetamide,"911417-87-3|Belumosudil|SLx-2119|KD-025|2-(3-(4-((1H-indazol-5-yl)amino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide|SLx 2119|Slx-2119 free base|Rock2 inhibitor kd025|SLx2119|834YJF89WO|KD 025|2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-N-propan-2-ylacetamide|DTXSID80238425|2-[3-[4-[(1H-Indazol-5-yl)amino]quinazolin-2-yl]phenoxy]-N-isopropylacetamide|Acetamide, 2-(3-(4-(1H-indazol-5-ylamino)-2-quinazolinyl)phenoxy)-N-(1-methylethyl)-|2-[3-[4-(1H-indazol-5-ylamino)-2-quinazolinyl]phenoxy]-N-(1-methylethyl)-acetamide|2-(3-(4-(1H-indazol-5-ylamino)-2-quinazolinyl)phenoxy)-N-(1-methylethyl)-acetamide|2-(3-(4-(1H-Indazol-5-ylamino)-2-quinazolinyl)phenoxy)-N-(1-methylethyl)acetamide|2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)-N-propan-2-ylacetamide|2-[3-[4-(1H-Indazol-5-ylamino)-2-quinazolinyl]phenoxy]-N-(1-methylethyl)acetamide|RefChem:58595|ROCK-II Inhibitor KD025|DTXCID00160916|Rho-associated Coiled-coil Kinase 2 Inhibitor KD025|KD025|C26H24N6O2|KD025 (SLx-2119)|MFCD23098791|Belumosudil [USAN]|Belumosudil; KD 025|2-(3-(4-(1H-indazol-5-ylamino)quinazolin-2-yl)phenoxy)-N-isopropylacetamide|2-[3-[4-(1~{H}-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-~{N}-propan-2-yl-ethanamide|UNII-834YJF89WO|Kinome_2597|BELUMOSUDIL [INN]|BELUMOSUDIL [WHO-DD]|SCHEMBL878202|GTPL9558|orb1300393|CHEMBL2005186|SCHEMBL29361017|SCHEMBL29364140|SCHEMBL29575654|GKHIVNAUVKXIIY-UHFFFAOYSA-N|BDBM322155|BDBM435505|BCP15921|EX-A2314|LLB41787|s7936|WHO 11343|SLx-2119(KD-025)|SLx-2119; KD-025|US10570123, Example 232|AKOS027338708|CCG-269256|CS-0776|SB16915|SLx-2119(KD-025,Belumosudil )?|NCGC00378903-01|NCGC00378903-02|AC-33057|AS-35230|HY-15307|SY099591|DB-103511|US10183931, SLx-2119|BRD-K88506063-001-01-8|Q27269397|2-[3-[4-[(5-Indazolyl)amino]-2-quinazolinyl]phenoxy]-N-isopropylacetamide|2-(3-{4-[(1H-indazol-5-yl)amino]quinazolin-2-yl}phenoxy)-N-(propan-2-yl)acetamide|2-[3-[4-(1H-indazol-5-ylamino)quinazolin-2-yl]phenoxy]-N-isopropyl-acetamide|2-[3-[4-[(1H-Indazol-5-Yl)Amino]Quinazoline-2-Yl]Phenoxy]-N-Isopropylacetamide|ICQ"
RIPASUDIL,9863672,,"InChI=1S/C15H18FN3O2S/c1-11-8-17-6-3-7-19(11)22(20,21)14-5-2-4-12-9-18-10-13(16)15(12)14/h2,4-5,9-11,17H,3,6-8H2,1H3/t11-/m0/s1",QSKQVZWVLOIIEV-NSHDSACASA-N,C15H18FN3O2S,323.4,"4-fluoro-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline","Ripasudil|223645-67-8|4-fluoro-5-[[(2S)-2-methyl-1,4-diazepan-1-yl]sulfonyl]isoquinoline|K-321 anhydrous free base|11978226XX|DTXSID001025609|1H-1,4-Diazepine, 1-((4-fluoro-5-isoquinolinyl)sulfonyl)hexahydro-2-methyl-, (2S)-|Isoquinoline, 4-fluoro-5-(((2S)-hexahydro-2-methyl-1H-1,4-diazepin-1-yl)sulfonyl)-|ripasudilum|4-fluoro-5-(((2S)-2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline|1H-1,4-Diazepine, 1-[(4-fluoro-5-isoquinolinyl)sulfonyl]hexahydro-2-methyl-, (2S)-|Isoquinoline, 4-fluoro-5-[[(2S)-hexahydro-2-methyl-1H-1,4-diazepin-1-yl]sulfonyl]-|RefChem:179484|DTXCID001509873|k115 Free base|K-115 free base|Ripasudil free base|Ripasudil [INN]|CHEMBL3426621|(S)-4-Fluoro-5-((2-methyl-1,4-diazepan-1-yl)sulfonyl)isoquinoline|UNII-11978226XX|K 115 free base|RIPASUDIL [MI]|Ripasudil (USAN/INN)|RIPASUDIL [USAN]|K-115 (free base)|RIPASUDIL [WHO-DD]|K-115 anhydrous free base|SCHEMBL31542|C15H18FN3O2S|orb1685487|SCHEMBL29356679|GTPL10423|CHEBI:136046|BCP11083|EX-A3647|BDBM50087135|HY-15685A|MFCD28291829|NSC800869|AKOS027338679|CS-3402|DB13165|NSC-800869|NCGC00496843-01|AC-36873|AS-35170|K-115 (ripasudil hydrochloride dihydrate)|NS00069625|D13014|BRD-K53814070-310-01-3|Q21098890|(S)-(-)-1-(4-fluoro-5-isoquinolinesulfonyl)-2-methyl-1,4-homopiperazine|4-Fluoro-5-[[(2S)-hexahydro-2-methyl-1H-1,4-diazepin-1-yl]sulfonyl]isoquinoline"
COCAINE HYDROCHLORIDE,656832,,"InChI=1S/C17H21NO4.ClH/c1-18-12-8-9-13(18)15(17(20)21-2)14(10-12)22-16(19)11-6-4-3-5-7-11;/h3-7,12-15H,8-10H2,1-2H3;1H/t12-,13+,14-,15+;/m0./s1",PIQVDUKEQYOJNR-VZXSFKIWSA-N,C17H22ClNO4,339.8,"methyl (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;hydrochloride","COCAINE HYDROCHLORIDE|53-21-4|Cocaine HCl|Cocain-chlorhydrat|Cocainum muriaticum|(-)-Cocaine hydrochloride|Cocaine chloride|Cocaine hydrochloride cii|XH8T8T6WZH|l-Cocaine hydrochloride|GOPRELTO|NUMBRINO|DTXSID2048903|MCV 4526|NIH 8211|NSC-25263|DTXCID5028829|RX-0041-002|CHEBI:613010|Methyl 3-beta-hydroxy-1-alpha-H,5-alpha-H-tropan-2-beta-carboxylate, benzoate (ester) HCl|NSC25263|HCl, Cocaine|Hydrochloride, Cocaine|RefChem:5702|cocaine hydrochloride nasal|(1R,2R,3S,5S)-2-Methoxycarbonyl-8-methyl-8-azabicyclo(3.2.1)oct-3-yl benzoate monohydrochloride|200-167-1|Cocaine muriate|Sal de merck|methyl (1R,2R,3S,5S)-3-benzoyloxy-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylate;hydrochloride|Methyl 3beta-hydroxy-1alphaH,5alphaH-tropan-2beta-carboxylate, benzoate (ester) hydrochloride|Cocaine Hydrochloride (1.0 mg/ml in Methanol)|Cocaine Hydrochloride (1.0mg/ml in Acetonitrile)|UNII-XH8T8T6WZH|NSC 25263|Cocain-chlorhydrat [German]|Cocaine hydrochloride [JAN]|1alpha-H,5alpha-H-Tropane-2beta-carboxylic acid, 3beta-hydroxy-,|Cocaine hydrochloride [USP:JAN]|8-AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID, 3-(BENZOYLOXY)-8-METHYL-, METHYL ESTER, HYDROCHLORIDE (1:1), (1R,2R,3S,5S)-|8-Azabicyclo(3.2.1)octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, hydrochloride, (1R-(exo,exo))-|8-Azabicyclo[3.2.1]octane-2-carboxylic acid, 3-(benzoyloxy)-8-methyl-, methyl ester, hydrochloride (1:1), (1R,2R,3S,5S)-|EINECS 200-167-1|NCGC00159467-03|SCHEMBL186755|CHEMBL529437|COCAINE HYDROCHLORIDE [MI]|COCAINUM MURIATICUM [HPUS]|1-alpha-H,5-alpha-H-Tropane-2-beta-carboxylic acid, 3-beta-hydroxy-, methyl ester, benzoate (ester), hydrochloride|Tox21_112883|COCAINE HYDROCHLORIDE [VANDF]|COCAINE HYDROCHLORIDE [MART.]|AKOS024457309|COCAINE HYDROCHLORIDE [WHO-DD]|FC20529|CAS-53-21-4|Cocaine hydrochloride, analytical standard|COCAINE HYDROCHLORIDE [ORANGE BOOK]|COCAINE HYDROCHLORIDE CII [USP-RS]|COCAINE HYDROCHLORIDE [EP MONOGRAPH]|COCAINE HYDROCHLORIDE [USP MONOGRAPH]|NS00078986|Cocaine.HCl, 1mg/ml in Methanol (as free base)|Q27225784|Cocaine hydrochloride, United States Pharmacopeia (USP) Reference Standard|(1R,2R,3S,5S)-3-(Benzoyloxy)-8-methyl-8-azabicyclo[3.2.1]octane-2-carboxylic acid methyl ester hydrochloride;(-)-Cocaine hydrochlori  de;Cocaine muriate|1alphaH,5alphaH-Tropane-2beta-carboxylic acid, 3beta-hydroxy-, methyl ester, benzoate (ester), hydrochloride|8-AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID, 3-(BENZOYLOXY)-8-METHYL-, METHYL ESTER, HYDROCHLORIDE, (1R,2R,3S,5S)|8-AZABICYCLO(3.2.1)OCTANE-2-CARBOXYLIC ACID, 3-(BENZOYLOXY)-8-METHYL-, METHYL ESTER, HYDROCHLORIDE,(1R-(EXO,EXO))-|METHYL (1R,2R,3S,5S)-3-(BENZOYLOXY)-8-METHYL-8-AZABICYCLO(3.2.1) OCTANE-2-CARBOXYLATE HYDROCHLORIDE"
LITRONESIB,25167017,,"InChI=1S/C23H37N5O4S2/c1-8-24-14-15-34(31,32)25-16-23(17-12-10-9-11-13-17)28(19(30)22(5,6)7)27-20(33-23)26-18(29)21(2,3)4/h9-13,24-25H,8,14-16H2,1-7H3,(H,26,27,29)/t23-/m0/s1",YVAFBXLHPINSIK-QHCPKHFHSA-N,C23H37N5O4S2,511.7,"N-[(5R)-4-(2,2-dimethylpropanoyl)-5-[[2-(ethylamino)ethylsulfonylamino]methyl]-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide","Litronesib|910634-41-2|KF 89617|LY2523355|LY-2523355|KF89617|LY 2523355|6611F8KYCV|KF-89617|Propanamide, N-(4-(2,2-dimethyl-1-oxopropyl)-5-((((2-(ethylamino)ethyl)sulfonyl) amino)methyl)-4,5-dihydro-5-phenyl-1,3,4-thiadiazol-2-yl)-2,2-dimethyl-, (-)-|litronesibum|RefChem:924836|(-)-N-(4-(2,2-dimethyl-propionyl)-5-((2-ethylamino-ethanesulfonylamino)-methyl)-5-phenyl-4,5-dihydro-(1,3,4)thiadiazol-2-yl)-2,2-dimethyl-propionamide|(-)-N-(4-(2,2-dimethylpropanoyl)-5-((((2-(ethylamino)ethyl)sulfonyl)amino)methyl)-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)-2,2-dimethylpropanamide|(R)-N-(4-(2,2-dimethyl-propionyl)-5-((2-ethylamino-ethanesulfonylamino)-methyl)-5-phenyl-4,5-dihydro-(1,3,4)thiadiazol-2-yl)-2,2-dimethyl-propionamide|N-((5R)-4-(2,2-dimethylpropanoyl)-5-((2-(ethylamino)ethanesulfonamido)methyl)-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)-2,2-dimethylpropanamide|N-(4-(2,2-dimethyl-propionyl)-5-((2-ethylamino-ethanesulfonylamino)-methyl)-5-phenyl-4,5-dihydro-(1,3,4)thiadiazol-2-yl)-2,2-dimethyl-propionamide|(-)-N-[4-(2,2-Dimethylpropanoyl)-5-[[2-(ethylamino)ethanesulfonamido]methyl]-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide|N-[(5R)-4-(2,2-dimethylpropanoyl)-5-[[2-(ethylamino)ethylsulfonylamino]methyl]-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide|(R)-N-(5-((2-(ethylamino)ethylsulfonamido)methyl)-5-phenyl-4-pivaloyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)pivalamide.|Litronesib [USAN]|Litronesib [USAN:INN]|UNII-6611F8KYCV|C23H37N5O4S2|(-)-N-(4-(2,2-DIMETHYLPROPANOYL)-5-((((2-(ETHYLAMINO)ETHYL)SULFONYL)AMINO)METHYL)-5- PHENYL-4,5-DIHYDRO-1,3,4-THIADIAZOL-2-YL)-2,2-DIMETHYLPROPANAMIDE|(-)-N-{4-(2,2-dimethylpropanoyl)-5-(({(2-(ethylamino)ethyl)sulfonyl}amino)methyl)-5- phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl}-2,2-dimethylpropanamide|LITRONESIB [INN]|Litronesib (USAN/INN)|LITRONESIB [WHO-DD]|SCHEMBL368284|orb1709257|CHEMBL2105661|GLXC-15259|BDBM50463316|MFCD19442197|NSC789722|AKOS030526983|CS-5194|DB11861|NSC-789722|SB18860|DA-65014|HY-14846|MS-29500|N-[(5R)-4-(2,2-dimethylpropanoyl)-5-[[2-(ethylamino)ethylsulfonylamino]methyl]-5-phenyl-1,3,4-thiadiazol-2-yl]-2,2-dimethyl-propanamide|NS00072777|D09636|F85314|634D412|BRD-K83029223-001-01-3|Q27263928|(R)-N-(4-(2,2-DIMETHYL-PROPIONYL)-5-((2-ETHYLAMINO-ETHANESULFONYLAMINO)-METHYL)-5- PHENYL-4,5-DIHYDRO-(1,3,4)THIADIAZOL-2-YL)-2,2-DIMETHYL-PROPIONAMIDE|(R)-N-(5-(((2-(Ethylamino)ethyl)sulfonamido)methyl)-5-phenyl-4-pivaloyl-4,5-dihydro-1,3,4-thiadiazol-2-yl)pivalamide|(R)-N-{4-(2,2-dimethyl-propionyl)-5-((2-ethylamino-ethanesulfonylamino)-methyl)-5- phenyl-4,5-dihydro-(1,3,4)thiadiazol-2-yl}-2,2-dimethyl-propionamiden|Litronesib; (-)-N-[4-(2,2-Dimethylpropanoyl)-5-[[2-(ethylamino)ethanesulfonamido]methyl]-5-phenyl-4,5-dihydro-1,3,4-thiadiazol-2-yl]-2,2-dimethylpropanamide|N-(4-(2,2-DIMETHYLPROPIONYL)-(5R)-5-((2-ETHYLAMINO-ETHANESULFONYLAMINO)METHYL)-5-PHENYL-4,5-DIHYDRO-(1,3,4)THIADIAZOL-2-YL)-2,2-DIMETHYLPROPIONAMIDE|PROPANAMIDE, N-(4-(2,2-DIMETHYL-1-OXOPROPYL)-5-((((2-(ETHYLAMINO)ETHYL)SULFONYL)AMINO)METHYL)-4,5-DIHYDRO-5-PHENYL-1,3,4-THIADIAZOL-2-YL)-2,2-DIMETHYL-, (5R)-"
FILANESIB,44224257,,"InChI=1S/C20H22F2N4O2S/c1-25(28-2)19(27)26-20(11-6-12-23,14-7-4-3-5-8-14)29-18(24-26)16-13-15(21)9-10-17(16)22/h3-5,7-10,13H,6,11-12,23H2,1-2H3/t20-/m0/s1",LLXISKGBWFTGEI-FQEVSTJZSA-N,C20H22F2N4O2S,420.5,"(2S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide","Filanesib|885060-09-3|Arry520|(2S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamide|8A49OSO368|DTXSID50237086|1,3,4-Thiadiazole-3(2H)-carboxamide, 2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-, (2S)-|filanesibum|RefChem:599200|DTXCID50159577|(2S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-2,3-dihydro-1,3,4-thiadiazole-3-carboxamide|ARRY-520|Filanesib [INN]|CHEMBL2347655|885060-09-3 (free base)|1,3,4-Thiadiazole-3(2H)-carboxamide,2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-, (2S)-|C20H22F2N4O2S|(2S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3-carboxamide|(S)-2-(3-aminopropyl)-5-(2,5-difluorophenyl)-N-methoxy-N-methyl-2-phenyl-1,3,4-thiadiazole-3(2H)-carboxamide.|ARRY 520|Filanesib [USAN:INN]|UNII-8A49OSO368|MFCD18633235|Filanesib (USAN/INN)|FILANESIB [USAN]|ARRY-520; Filanesib|Filanesib(ARRY-520)|FILANESIB [WHO-DD]|SCHEMBL368043|orb1296057|SCHEMBL29399067|EX-A678|HMS3750A15|BCP07442|BDBM50431893|CS-0867|DB06040|SB19209|NCGC00381751-02|NCGC00381751-04|AC-35274|DA-61220|HY-15187|MS-27382|NS00072562|D11754|BRD-K37379014-001-01-2|BRD-K37379014-001-02-0|Q15634095"
VACTOSERTIB,54766013,,"InChI=1S/C22H18FN7/c1-14-5-4-8-18(27-14)22-21(15-9-10-20-25-13-26-30(20)12-15)28-19(29-22)11-24-17-7-3-2-6-16(17)23/h2-10,12-13,24H,11H2,1H3,(H,28,29)",FJCDSQATIJKQKA-UHFFFAOYSA-N,C22H18FN7,399.4,"2-fluoro-N-[[5-(6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]aniline","vactosertib|1352608-82-2|EW-7197|TEW-7197|TEW 7197|EW7197|N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline|6T4O391P5Y|N-[[4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1h-imidazol-2-yl]methyl]-2-fluoroaniline|TEW7197|DTXSID401010181|2-fluoro-N-[[5-(6-methylpyridin-2-yl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]aniline|N-((4-((1,2,4)triazolo(1,5-a)pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline|vactosertibum|2-fluoro-N-((5-(6-methylpyridin-2-yl)-4-((1,2,4)triazolo(1,5-a)pyridin-6-yl)-1H-imidazol-2-yl)methyl)aniline|RefChem:193482|TGFBR1 Inhibitor TEW-7197|DTXCID201436600|EW 7197|MFCD28348363|CHEMBL3260567|NOV-1301|N-(2-Fluorophenyl)-5-(6-methyl-2-pyridinyl)-4-[1,2,4]triazolo-[1,5-a]pyridin-6-yl-1H-imidazole-2-methanamine|N-(2-fluorophenyl)-5-(6-methyl-2-pyridinyl)-4-[1,2,4]triazolo[1,5-a]pyridin-6-yl-1H-imidazole-2-methanamine|C22H18FN7|VACTOSERTIB [INN]|Vactosertib (TEW-7197)|VACTOSERTIB [WHO-DD]|SCHEMBL250076|UNII-6T4O391P5Y|GTPL8107|orb1300718|SCHEMBL26345807|SCHEMBL29352498|SCHEMBL29493095|SCHEMBL29508696|SCHEMBL30568127|NOV1301|HMS3674I03|BCP18384|EX-A1738|BDBM50015639|NSC854208|s7530|AKOS027250746|CCG-264709|CS-5679|DB15310|NSC-854208|SB17272|NCGC00386413-01|NCGC00386413-02|AC-29028|AS-10150|BT168124|EW-7197?|HY-19928|SY235585|DS-001727|BRD-K74396648-001-01-4|Q27077252|1H-IMIDAZOLE-2-METHANAMINE, N-(2-FLUOROPHENYL)-5-(6-METHYL-2-PYRIDINYL)-4-(1,2,4)TRIAZOLO(1,5-A)PYRIDIN-6-YL-|2-FLUORO-N-((4-(6-METHYLPYRIDIN-2-YL)-5-((1,2,4)TRIAZOLO(1,5-A)PYRIDIN-6-YL)-1H-IMIDAZOL-2-YL)METHYL)ANILINE|2-fluoro-N-[[5-(6-methyl-2-pyridyl)-4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-1H-imidazol-2-yl]methyl]aniline|N-(2-fluorophenyl)-5-(6-methyl-2-pyridinyl)-4-[1,2,4]triazolo[1,5- a]pyridin-6-yl-1H-Imidazole-2-methanamine|N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methyl-2-pyridyl)-2-imidazolyl]methyl]-2-fluoroaniline|N-[[4-([1,2,4]Triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl]methyl]-2-fluoroaniline;Vactosertib"
SELEGILINE HYDROCHLORIDE,26758,,"InChI=1S/C13H17N.ClH/c1-4-10-14(3)12(2)11-13-8-6-5-7-9-13;/h1,5-9,12H,10-11H2,2-3H3;1H/t12-;/m1./s1",IYETZZCWLLUHIJ-UTONKHPSSA-N,C13H18ClN,223.74,(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine;hydrochloride,"Selegiline hydrochloride|14611-52-0|Selegiline Hcl|l-Deprenyl hydrochloride|(-)-Deprenyl hydrochloride|Jumex hydrochloride|Eldepryl hydrochloride|Ensam|(-)-Deprenil hydrochloride|(-)-E-250 hydrochloride|Anipryl|Plurimen|HSDB 7183|FPF1100|CCRIS 8571|DTXSID9044584|UNII-6W731X367Q|6W731X367Q|NSC-759259|CHEBI:9087|DTXCID7024584|(-)-N,alpha-Dimethyl-N-2-propynylbenzeneethanamine hydrochloride|(-)-(R)-N,alpha-Dimethyl-N-2-propynylphenethylamine hydrochloride|(-)-(R)-N,alpha-Dimethyl-N-2-propynylphenethylamine monohydrochloride|Selegiline hydrochloride [USAN:USP]|NSC 759259|Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, hydrochloride, (R)-|Selegiline hydrochloride (USAN:USP)|SELEGILINE HYDROCHLORIDE (MART.)|SELEGILINE HYDROCHLORIDE [MART.]|SELEGILINE HYDROCHLORIDE (USP-RS)|SELEGILINE HYDROCHLORIDE [USP-RS]|SELEGILINE HYDROCHLORIDE (EP MONOGRAPH)|SELEGILINE HYDROCHLORIDE (USP MONOGRAPH)|SELEGILINE HYDROCHLORIDE [EP MONOGRAPH]|SELEGILINE HYDROCHLORIDE [USP MONOGRAPH]|Amindan|Atapryl|Eldeprine|Movergan|Selepark|Seletop|N-methyl-N-((1R)-1-methyl-2-phenylethyl)prop-2-yn-1-aminium chloride|RefChem:56004|(R)-N,alpha-Dimethyl-N-2-propynyl-phenethylamine  monohydrochloride|Benzeneethanamine, N,alpha-dimethyl-N-2-propynyl-, Hydrochloride,(R)-|Eldepryl|Zelapar|R-(-)-Deprenyl hydrochloride|(R)-N-Methyl-N-(1-phenylpropan-2-yl)prop-2-yn-1-amine hydrochloride|Benzeneethanamine, N,alpha-dimethyl-N-2-propyn-1-yl-, hydrochloride (1:1), (alphaR)-|R-(-)-Deprenyl (hydrochloride)|(-)-Phenylisopropylmethylpropynylamine|Otrasel|MFCD00069299|(R)-(-)-Deprenyl hydrochloride|Zydis selegiline|(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine;hydrochloride|Benzeneethanamine, N,?-dimethyl-N-2-propyn-1-yl-, hydrochloride (1:1), (?R)-|SMR000449328|Selegiline hydrochloride [USAN]|SR-01000597928|(-)-selegiline hydrochloride|Seledat|Vivapryl|Xilopar|Eldepryl (TN)|(R)-(-)-N,a-Dimethyl-N-(2-propynyl)phenethylamine hydrochloride; R(-)-N-a-Dimethyl-N-2-propynyl-benzeneethanamine hydrochloride|Prestwick_846|(R)-Deprenyl HCl|NCGC00016708-01|Selegiline (hydrochloride)|CAS-14611-52-0|R-(-)deprenyl hydrochloride|R(-)-Deprenyl hydrochloride|SCHEMBL41392|MLS000758294|MLS001423947|MLS002153281|MLS002222269|CHEMBL1200904|GLXC-05671|HMS1569P05|FPF-1100|Selegiline hydrochloride (JAN/USP)|Tox21_110572|Tox21_301846|SELEGILINE HYDROCHLORIDE [MI]|SELEGILINE HYDROCHLORIDE [JAN]|AKOS005166822|Benzeneethanamine, N,.alpha.-dimethyl-N-2-propynyl-, hydrochloride, (R)-|Tox21_110572_1|CCG-100773|KS-5098|NC00023|NC00605|SELEGILINE HYDROCHLORIDE [HSDB]|SELEGILINE HYDROCHLORIDE [VANDF]|NCGC00024994-06|NCGC00255797-01|SELEGILINE HYDROCHLORIDE [WHO-DD]|AC-18759|BS300066|HY-14199|Selegiline hydrochloride - Bio-X trade mark|SELEGILINE HYDROCHLORIDE [GREEN BOOK]|SELEGILINE HYDROCHLORIDE [ORANGE BOOK]|A11463|D00785|EN300-123011|611S520|SR-01000597928-1|SR-01000597928-5|SR-01000597928-6|Q27108267|R-(-)-Deprenyl hydrochloride, powder, >=98% (HPLC)|Z2768168341|Selegiline Hydrochloride 1.0 mg/ml in Methanol (as free base)|(2R)-N-methyl-1-phenyl-N-prop-2-ynyl-propan-2-amine;hydrochloride|(2R)-N-methyl-1-phenyl-N-prop-2-ynylpropan-2-amine hydrochloride|(R)-(-)-N,ALPHA-DIMETHYL-N-(2-PROPYNYL)PHENETHYLAMINE HCL|(R)-N-Methyl-1-phenyl-N-prop-2-ynylpropan-2-amine hydrochloride|(-)-(R)-N,.ALPHA.-DIMETHYL-N-2-PROPYNYLPHENETHYLAMINE HYDROCHLORIDE|methyl[(2R)-1-phenylpropan-2-yl](prop-2-yn-1-yl)amine hydrochloride|Selegiline hydrochloride, European Pharmacopoeia (EP) Reference Standard|Benzeneethanamine, N,|A-dimethyl-N-2-propyn-1-yl-, hydrochloride (1:1), (|AR)-|Selegiline hydrochloride, United States Pharmacopeia (USP) Reference Standard"
RASAGILINE MESYLATE,3052775,,"InChI=1S/C12H13N.CH4O3S/c1-2-9-13-12-8-7-10-5-3-4-6-11(10)12;1-5(2,3)4/h1,3-6,12-13H,7-9H2;1H3,(H,2,3,4)/t12-;/m1./s1",JDBJJCWRXSVHOQ-UTONKHPSSA-N,C13H17NO3S,267.35,"methanesulfonic acid;(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine","Rasagiline mesylate|161735-79-1|Rasagiline mesilate|Azilect|TVP-1012|Agilect|Rasagiline methanesulfonate|Rasagline ratiopharm|Rasagiline (as mesilate)|LH8C2JI290|DTXSID8047848|1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (R)-, methanesulfonate|DTXCID8027826|RefChem:56872|(R)-N-(Prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine methanesulfonate|MFCD08460604|Rasagiline mesylate [USAN]|Rasagiline (mesylate)|1H-Inden-1-amine, 2,3-dihydro-N-2-propyn-1-yl-, (1R)-, methanesulfonate (1:1)|(R)-N-2-Propynyl-1-indanamine methanesulfonate|methanesulfonic acid;(1R)-N-prop-2-ynyl-2,3-dihydro-1H-inden-1-amine|NCGC00168774-01|Azilect (TN)|Rasagiline mesilate (JAN)|Rasagiline mesylate (USAN)|RASAGILINE MESILATE [JAN]|CAS-161735-79-1|TVP 1012|UNII-LH8C2JI290|1H-Inden-1-amine, 2,3-dihydro-N-2-propynyl-, (1R)-, methanesulfonate|SCHEMBL158439|(R)-2,3-Dihydro-N-2-propynyl-1-indenamine Mesylate|orb1300309|CHEMBL1201142|Rasagiline (mesylate) (Standard)|GLXC-02556|HMS3884D07|RASAGILINE MESYLATE [VANDF]|(1R)-2,3-Dihydro-N-2-propyn-1-yl-1H-inden-1-amine Mesylate|RASAGILINE MESILATE [MART.]|Tox21_112635|AC-724|HB1784|HY-14605R|RASAGILINE MESYLATE [WHO-DD]|s2102|AKOS005145768|Rasagiline mesylate, >=98% (HPLC)|Tox21_112635_1|BS-1009|CCG-267122|FR15445|RASAGILINE METHANESULFONATE [MI]|NCGC00168774-02|RASAGILINE MESYLATE [ORANGE BOOK]|(+)-AGN-1135|HY-14605|SY067183|R0213|D02562|EN300-123038|SBI-0653424.0001|735R791|methanesulfonic acid;(1R)-N-prop-2-ynylindan-1-amine|Q27282989|(R)-N-2-PROPYNYL-1-INDANAMINE METHANESULPHONATE|Z1820079046|(1R)-N-(2-propynyl)-2,3-dihydro-1H-inden-1-amine methanesulfonate|(1R)-N-(prop-2-yn-1-yl)-2,3-dihydro-1H-inden-1-amine; methanesulfonic acid|1H-INDEN-1-AMINE, 2,3-DIHYDRO-N-2-PROPYNYL-, (R)-, METHANESULPHONATE"
RELCOVAPTAN,60943,,"InChI=1S/C28H27Cl2N3O7S/c1-39-23-12-10-17(15-24(23)40-2)41(37,38)33-21-11-9-16(29)14-19(21)28(36,18-6-3-4-7-20(18)30)25(33)27(35)32-13-5-8-22(32)26(31)34/h3-4,6-7,9-12,14-15,22,25,36H,5,8,13H2,1-2H3,(H2,31,34)/t22-,25-,28+/m0/s1",CEBYCSRFKCEUSW-NAYZPBBASA-N,C28H27Cl2N3O7S,620.5,"(2S)-1-[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy-2H-indole-2-carbonyl]pyrrolidine-2-carboxamide","Relcovaptan|150375-75-0|SR 49059|SR-49059|SR49059|C1GL8G6G0O|TDI-0134|1-(5-Chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl)pyrrolidine-2-carboxamide|DTXCID9025746|relcovaptanum|(2S)-1-((2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy2H-indole-2-carbonyl)pyrrolidine-2-carboxamide|(2S)-1-[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy2H-indole-2-carbonyl]pyrrolidine-2-carboxamide|RefChem:879222|(2S)-1-((2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl)pyrrolidine-2-carboxamide|DTXSID1045746|Relcovaptan [INN]|(2S)-1-[[(2R,3S)-5-CHLORO-3-(2-CHLOROPHENYL)-1-[(3,4-DIMETHOXYPHENYL)SULFONYL]-2,3-DIHYDRO-3-HYDROXY-1H-INDOL-2-YL]CARBONYL]-2-PYRROLIDINECARBOXAMIDE|MFCD00922133|2-Pyrrolidinecarboxamide, 1-[[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-2,3-dihydro-3-hydroxy-1H-indol-2-yl]carbonyl]-, (2S)-|CHEMBL419667|(2S)-1-(((2R,3S)-5-Chloro-3-(o-chlorophenyl)-1-((3,4-dimethoxyphenyl)sulfonyl)-3-hydroxy-2-indolinyl)carbonyl)-2-pyrrolidinecarboxamide|[3H]relcovaptan|(S)-1-((2R,3S)-5-Chloro-3-(2-chlorophenyl)-1-((3,4-dimethoxyphenyl)sulfonyl)-3-hydroxyindoline-2-carbonyl)pyrrolidine-2-carboxamide|UNII-C1GL8G6G0O|C28H27Cl2N3O7S|NCGC00092366-02|2-PYRROLIDINECARBOXAMIDE, 1-(((2R,3S)-5-CHLORO-3-(2-CHLOROPHENYL)-1-((3,4-DIMETHOXYPHENYL)SULFONYL)-2,3-DIHYDRO-3-HYDROXY-1H-INDOL-2-YL)CARBONYL)-, (2S)-|[3H]SR49059|[3H]SR-49059|Relcovaptan [WHO-DD]|[3H] SR 49059|2-Pyrrolidinecarboxamide, 1-((5-chloro-3-(2-chlorophenyl)-1-((3,4-dimethoxyphenyl)sulfonyl)-2,3-dihydro-3-hydroxy-1H-indol-2-yl)carbonyl)-, (2R-(2alpha(S*),3beta))-|GTPL2200|GTPL3482|orb1704036|SCHEMBL4387208|SCHEMBL29381874|SCHEMBL30027840|CHEBI:93701|GLXC-06159|HMS3268L06|HMS3413E08|HMS3677E08|AGA37575|TDI 0134|BDBM50114031|AKOS024457044|DB13929|NCGC00092366-01|(2S)-1-[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy-2H-indole-2-carbonyl]pyrrolidine-2-carboxamide|HY-18345|MS-30780|CS-0007471|NS00069594|P10155|SR 49059, >=97% (HPLC)|SR-01000945058|Q7310905|SR-01000945058-1|BRD-K96720755-001-01-8|BRD-K96720755-001-02-6|(2S)-1-[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxybenzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl]-pyrrolidine-2-carboxamide|(2S)-1-[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)sulfonyl-3-hydroxy-indoline-2-carbonyl]pyrrolidine-2-carboxamide|(S)-1-((2R,3S)-5-chloro-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenylsulfonyl)-3-hydroxyindoline-2-carbonyl)pyrrolidine-2-carboxamide|(S)-1-[(2R,3S)-5-Chloro-3-(2-chloro-phenyl)-1-(3,4-dimethoxy-benzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl]-pyrrolidine-2-carboxylic acid amide|1-[5-Chloro-3-(2-chloro-phenyl)-1-(3,4-dimethoxy-benzenesulfonyl)-3-hydroxy-2,3-dihydro-1H-indole-2-carbonyl]-pyrrolidine-2-carboxylic acid amide|2-Pyrrolidinecarboxamide,1-[[(2R,3S)-5-chloro-3-(2-chlorophenyl)-1-[(3,4-dimethoxyphenyl)sulfonyl]-2,3-dihydro-3-hydroxy-1H-indol-2-yl]carbonyl]-,(2S)-"
ENCEQUIDAR,11399764,,"InChI=1S/C38H36N6O7/c1-47-32-17-24-14-16-43(22-25(24)18-33(32)48-2)15-13-23-9-11-26(12-10-23)44-41-37(40-42-44)28-19-34(49-3)35(50-4)20-29(28)39-38(46)36-21-30(45)27-7-5-6-8-31(27)51-36/h5-12,17-21H,13-16,22H2,1-4H3,(H,39,46)",AHJUHHDDCJQACA-UHFFFAOYSA-N,C38H36N6O7,688.7,"N-[2-[2-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]tetrazol-5-yl]-4,5-dimethoxyphenyl]-4-oxochromene-2-carboxamide","Encequidar|849675-66-7|HM-30181|HM30181|Pgp inhibitor hm30181ak|Encequidar [USAN]|HM30181AK|K4I4I996O4|ENCEQUIDAR [INN]|ENCEQUIDAR [WHO-DD]|N-[2-[2-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]tetrazol-5-yl]-4,5-dimethoxyphenyl]-4-oxochromene-2-carboxamide|4-Oxo-4H-chromene-2-carboxylic acid (2-(2-4-(2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl)-phenyl-2H-tetrazol-5-yl)-4,5-dimethoxy-phenyl)-amide|P-GLYCOPROTEIN INHIBITOR HM30181AK|Oraxol (encequidar methanesulfonate + paclitaxel)|N-[2-[2-[4-[2-(3,4-Dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-2H-tetrazol-5-yl]-4,5-dimethoxyphenyl]-4-oxo-4H-1-benzopyran-2-carboxamide|Oratecan (encequidar methanesulfonate + irinotecan)|4H-1-BENZOPYRAN-2-CARBOXAMIDE, N-(2-(2-(4-(2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL)PHENYL)-2H-TETRAZOL-5-YL)-4,5-DIMETHOXYPHENYL)-4-OXO-|4H-1-Benzopyran-2-carboxamide, N-[2-[2-[4-[2-(3,4-dihydro-6,7-dimethoxy-2(1H)-isoquinolinyl)ethyl]phenyl]-2H-tetrazol-5-yl]-4,5-dimethoxyphenyl]-4-oxo-|encequidarum|4-Oxo-4H-chromene-2-carboxylic acid [2-(2-4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl-2H-tetrazol-5-yl)-4,5-dimethoxy-phenyl]-amide|N-(2-(2-(4-(2-(3,4-DIHYDRO-6,7-DIMETHOXY-2(1H)-ISOQUINOLINYL)ETHYL)PHENYL)-2H-TETRAZOL-5-YL)-4,5-DIMETHOXYPHENYL)-4-OXO-4H-1-BENZOPYRAN-2-CARBOXAMIDE|N-(2-(2-(4-(2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl)phenyl)-2H-1,2,3,4-tetrazol-5-yl)-4,5-dimethoxyphenyl)-4-oxo-4H-chromene-2-carboxamide|N-(2-(2-(4-(2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl)phenyl)tetrazol-5-yl)-4,5-dimethoxyphenyl)-4-oxochromene-2-carboxamide|N-[2-(2-{4-[2-(6,7-dimethoxy-1,2,3,4-tetrahydroisoquinolin-2-yl)ethyl]phenyl}-2h-1,2,3,4-tetrazol-5-yl)-4,5-dimethoxyphenyl]-4-oxo-4h-chromene-2-carboxamide|RefChem:590792|HM-30181-A|HM 30181A|MFCD25976625|UNII-K4I4I996O4|AHJUHHDDCJQACA-UHFFFAOYSA-N|V5Q|Encequidar (USAN/INN)|HM-30181 free base|Encequidar (HM30181)|HM30181(Encequidar)?|orb1298944|CHEMBL4594298|SCHEMBL13822558|SCHEMBL29386309|EX-A3429A|GTPL12787|C38H36N6O7|DTXSID501100387|BCP25240|ZIB67566|BDBM50567579|s3431|WHO 10861|AKOS025396246|CS-6194|DB14070|HM30181;HM30181A|SB18921|AC-36564|AS-35283|DA-64208|HY-13646|NS00072886|D11782|Q27281950|4-oxo-4H-chromen-2-carboxylic acid [2-(2-{4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-2H-tetrazol-5-yl)-4,5-dimethoxy-phenyl]-amide|N-(2-(2-(4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl)-4-oxo-4H-chromene-2-carboxamide|N-(2-(2-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinoline-2(1H)-yl)ethyl)phenyl)-2H-tetrazol-5-yl)-4,5-dimethoxyphenyl)-4-oxo-4H-chromene-2-carboxamide|N-[2-[2-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]tetrazol-5-yl]-4,5-dimethoxy-phenyl]-4-oxo-chromene-2-carboxamide"
LINEZOLID,441401,,"InChI=1S/C16H20FN3O4/c1-11(21)18-9-13-10-20(16(22)24-13)12-2-3-15(14(17)8-12)19-4-6-23-7-5-19/h2-3,8,13H,4-7,9-10H2,1H3,(H,18,21)/t13-/m0/s1",TYZROVQLWOKYKF-ZDUSSCGKSA-N,C16H20FN3O4,337.35,"N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide","linezolid|165800-03-3|Zyvox|PNU-100766|U-100766|LINEZOLIDE|ISQ9I6J12J|N-(((S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide|N-[[(5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl]methyl]acetamide|DTXSID5046489|CHEBI:63607|U-100,766|PNU100766|DTXCID3026489|Acetamide, N-((3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-, (S)-|N-{[(5s)-3-(3-Fluoro-4-Morpholin-4-Ylphenyl)-2-Oxo-1,3-Oxazolidin-5-Yl]methyl}acetamide|Linezolidum|Acetamide, N-[[3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-, (S)-|N-(((5S)-3-(3-fluoro-4-morpholin-4-ylphenyl)-2-oxo-1,3-oxazolidin-5-yl)methyl)acetamide|N-[[(S)-3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide|N-(((5S)-3-(3-fluoro-4-(morpholin-4-yl)phenyl)-2-oxo-1,3-oxazolidin-5-yl)methyl)acetamide|N-({(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl}methyl)acetamide|N-{[(5S)-3-[3-fluoro-4-(morpholin-4-yl)phenyl]-2-oxo-1,3-oxazolidin-5-yl]methyl}acetamide|N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide|RefChem:5949|U100766|100766, U|J01XX08|LINEZOLID IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER|(S)-N-((3-(3-fluoro-4-morpholinophenyl)-2-oxooxazolidin-5-yl)methyl)acetamide|Zyvoxid|Zyvoxam|PNU 100766|C16H20FN3O4|U 100766|MFCD00937825|Acetamide, N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-|CHEMBL126|N-[[(5S)-3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]acetamide|(S)-N-[[3-(3-Fluoro-4-morpholinophenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide|N-[[(5S)-3-(3-fluoro-4-morpholino-phenyl)-2-oxo-oxazolidin-5-yl]methyl]acetamide|ZLD|Zivoxid|Zyvoxa|Acetamide, N-(((5S)-3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)-|SMR000466335|Zyvox (TN)|HSDB 7478|SR-01000759376|Linezolid & VRC3375|UNII-ISQ9I6J12J|Linezoid|Linezolid (JAN/USAN/INN)|Linezolid [USAN:INN:BAN]|NCGC00164628-01|Linezolid (Zyvox)|Linezolid (Standard)|111GE017|CPD000466335|NDA 21-130 Zyvox (linezolid tablets)|LINEZOLID [INN]|LINEZOLID [JAN]|LINEZOLID [MI]|LINEZOLID [HSDB]|LINEZOLID [USAN]|LINEZOLID [VANDF]|LINEZOLID [MART.]|(S)-N-[[3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl]methyl]acetamide|LINEZOLID [USP-RS]|LINEZOLID [WHO-DD]|SCHEMBL5027|MLS000759444|MLS001424075|BIDD:GT0404|Benzotriazol-2-yl-acetonitrile|cid_441401|Linezolid (PNU-100766)|orb1310657|SCHEMBL7992562|LINEZOLID [ORANGE BOOK]|Linezolid, >=98% (HPLC)|NDA 21-131 Zyvox for injection (linezolid injection)|GTPL10827|LINEZOLID [USP MONOGRAPH]|GLXC-04742|HMS2051F08|HMS2089K06|HMS3260C14|HMS3713K10|NDA 21-132 Zyvox oral suspension (linzolid oral suspension)|BCP05586|MSK14235|Tox21_112246|Tox21_500096|BDBM50116067|HB4443|HY-10394R|s1408|AKOS016340522|AF58050|BCP9000855|CCG-101009|CS-0756|DB00601|KS-1178|NC00259|Linezolid 100 microg/mL in Acetonitrile|NCGC00260781-01|NCGC00263531-03|NCGC00263531-05|NCGC00263531-10|HY-10394|SY056734|CAS-165800-03-3|L0362|NS00008464|SW197639-3|C08146|D00947|AB00639994-06|AB00639994-08|AB00639994-09|AB00639994_10|AB00639994_11|800L033|F227724|Q411377|SR-01000759376-4|SR-01000759376-5|BRD-K66876909-001-11-8|BRD-K66876909-001-12-6|SR-01000759376-11|Z1515385084|Linezolid, United States Pharmacopeia (USP) Reference Standard|(S)-N-((3-fluoro-4-morpholinophenyl)-2-oxaoxazolidin-5-yl)methyl)acetamide|Linezolid, Pharmaceutical Secondary Standard; Certified Reference Material|(Linezolid)N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide|(S)-N-((3-(3-fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide|(S)-N-[ [3-[3-fluoro-4-(4-morpholinyl)phenyl]-2-oxo-oxazolidin-5-yl]methyl]-acetamide|(S)-N-[[3-[3-Fluoro-4-(4-morpholinyl)phenyl]-2-oxo-5-oxazolidinyl]methyl]-acetamide|N-[(R)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide|N-[(S)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide|N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide|N-[3-(3-Fluoro-4-morpholin-4-yl-phenyl)-2-oxo-oxazolidin-5-ylmethyl]-acetamide(linezolid)|(S)-3-(3-Fluoro-4-morpholin-4-yl-phenyl)-5-[(1-hydroxy-ethylamino)-methyl]-oxazolidin-2-one|N-(((5S)-3-(3-Fluoro-4-(4-morpholinyl)phenyl)-2-oxo-5-oxazolidinyl)methyl) acetamide;Linospan;Linox|N-((S)-2-oxo-3-(S)-2,3,3a,4-tetrahydro-1H-benzo[b]pyrrolo[1,2-d][1,4]oxazin-7-yl-oxazolidin-5-ylmethyl)-acetamide"
BX 471 FREE BASE,512282,,"InChI=1S/C21H24ClFN4O3/c1-14-11-26(12-15-2-5-17(23)6-3-15)8-9-27(14)20(28)13-30-19-7-4-16(22)10-18(19)25-21(24)29/h2-7,10,14H,8-9,11-13H2,1H3,(H3,24,25,29)/t14-/m1/s1",XQYASZNUFDVMFH-CQSZACIVSA-N,C21H24ClFN4O3,434.9,[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methylpiperazin-1-yl]-2-oxoethoxy]phenyl]urea,"217645-70-0|BX-471 free base|76K17ZG4ZN|DTXSID10176164|(2R)-1-(((4-Chloro-2-(ureido)phenoxy)methyl)carbonyl)-2-methyl-4-(4-fluorobenzyl)piperazine|(2R)-1-[[[4-Chloro-2-(ureido)phenoxy]methyl]carbonyl]-2-methyl-4-(4-fluorobenzyl)piperazine|RefChem:122433|DTXCID8098655|urea, N-(5-chloro-2-(2-((2R)-4-((4-fluorophenyl)methyl)-2-methyl-1-piperazinyl)-2-oxoethoxy)phenyl)-|(R)-1-(5-chloro-2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)phenyl)urea|C21H24ClFN4O3|MFCD09859709|CHEMBL232656|CHEMBL535607|[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methyl-piperazin-1-yl]-2-oxo-ethoxy]phenyl]urea|BX-471free base|UNII-76K17ZG4ZN|GTPL767|orb1305576|SCHEMBL4586646|SCHEMBL29416828|EX-A519|XQYASZNUFDVMFH-CQSZACIVSA-N|GLXC-05630|BDBM50174703|BDBM50208999|AKOS024457640|Zk-811752(bx-471)|CS-3283|1-(2-(2-((R)-4-(4-Fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)-5-chlorophenyl)urea|NCGC00370909-03|NCGC00370909-05|AC-31379|BS-16630|FC101798|HY-12080|N-[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methyl-1-piperazinyl]-2-oxoethoxy]phenyl]-Urea|SY249762|BX-471ZK 811752?|B6060|BRD-K91825936-001-01-2|Q27075605|(R)-1-(2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)-5-chlorophenyl)urea|(R)-1-[5-Chloro-2-[2-[4-(4-fluorobenzyl)-2-methyl-1-piperazinyl]-2-oxoethoxy]phenyl]urea|(R)-1-(2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)-5-chlorophenyl)urea hydrochloride"
BMS-817399,44537841,,"InChI=1S/C23H36ClN3O4/c1-15(2)18(26-20(29)25-13-22(5,6)30)19(28)27-12-11-23(31,21(3,4)14-27)16-7-9-17(24)10-8-16/h7-10,15,18,30-31H,11-14H2,1-6H3,(H2,25,26,29)/t18-,23+/m1/s1",GTDPZONCGOCXOD-JPYJTQIMSA-N,C23H36ClN3O4,454.0,"1-[(2R)-1-[(4S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylpiperidin-1-yl]-3-methyl-1-oxobutan-2-yl]-3-(2-hydroxy-2-methylpropyl)urea","BMS-817399|1202400-18-7|AKQ3X6FEH0|Urea, N-((1R)-1-(((4S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethyl-1-piperidinyl)carbonyl)-2-methylpropyl)-N'-(2-hydroxy-2-methylpropyl)-|1-[(2R)-1-[(4S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylpiperidin-1-yl]-3-methyl-1-oxobutan-2-yl]-3-(2-hydroxy-2-methylpropyl)urea|1-((2R)-1-((4S)-4-(4-chlorophenyl)-4-hydroxy-3,3-dimethylpiperidin-1-yl)-3-methyl-1-oxobutan-2-yl)-3-(2-hydroxy-2-methylpropyl)urea|RefChem:120746|UNII-AKQ3X6FEH0|CHEMBL3334824|orb1700997|SCHEMBL1604247|BDBM50056504|AKOS040748018|AT44830|DB14941|HY-15546|TS-08487|CS-0007015"
DIRLOTAPIDE,9917862,,"InChI=1S/C40H33F3N4O3/c1-46(25-26-11-5-3-6-12-26)39(50)36(28-13-7-4-8-14-28)45-38(49)35-24-29-23-31(21-22-34(29)47(35)2)44-37(48)33-16-10-9-15-32(33)27-17-19-30(20-18-27)40(41,42)43/h3-24,36H,25H2,1-2H3,(H,44,48)(H,45,49)/t36-/m0/s1",TUOSYWCFRFNJBS-BHVANESWSA-N,C40H33F3N4O3,674.7,N-[(1S)-2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]-1-methyl-5-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]indole-2-carboxamide,"Dirlotapide|481658-94-0|Slentrol|dirlotapida|578H0RMP25|CP-742,033|CP-742033|DTXSID00897432|5-((4'-trifluoromethyl-biphenyl-2-carbonyl)-amino)-1H-indole-2-carboxylic acid benzylmethyl carbamoylamide|dirlotapidum|RefChem:58526|DTXCID501326773|N-((S)-(benzyl(methyl)carbamoyl)(phenyl)methyl)-1-methyl-5-(4'-(trifluoromethyl)-(1,1'-biphenyl)-2-amido)-1H-indole-2-carboximidic acid|CHEMBL410414|MFCD27976718|N-[(1S)-2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl]-1-methyl-5-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]indole-2-carboxamide|(S)-N-(2-(benzyl(methyl)amino)-2-oxo-1-phenylethyl)-1-methyl-5-(4'-(trifluoromethyl)-[1,1'-biphenyl]-2-carboxamido)-1H-indole-2-carboxamide|1H-Indole-2-carboxamide, 1-methyl-N-((1S)-2-(methyl(phenylmethyl)amino)-2-oxo-1-phenylethyl)-5-(((4'-(trifluoromethyl)(1,1'-biphenyl)-2-yl)carbonyl)amino)-|N-((1S)-2-(Benzylmethylamino)-2-oxo-1-phenylethyl)-1-methyl-5-(((4'-(trifluoromethyl)biphenyl-2-yl)carbonyl)amino)-1H-indole-2-carboxamide|Dirlotapide [USAN:INN]|UNII-578H0RMP25|CP 742033|DIRLOTAPIDE [MI]|DIRLOTAPIDE [INN]|Dirlotapide (USAN/INN)|DIRLOTAPIDE [USAN]|SCHEMBL37781|Slentrol [veterinary] (TN)|orb1707427|DIRLOTAPIDE [GREEN BOOK]|C40H33F3N4O3|BDBM50204367|EX-A10207|HY-U00070|AKOS040741569|CS-6779|DB11399|DIRLOTAPIDE [EMA EPAR VETERINARY]|CP742033|DA-62485|MS-31064|SY410097|D03867|G14336|Q5280905|(S)-N-[2-[Benzyl(methyl)amino]-2-oxo-1-phenylethyl]-1-methyl-5-[4 inverted exclamation mark -(trifluoromethyl)-2-biphenylylcarboxamido]indole-2-carboxamide|(S)-N-{2-[benzyl(methyl)amino]-2-oxo-1-phenylethyl}-1-methyl-5-[4'-(trifluoromethyl)[1,1'-biphenyl]-2-carboxamido]-1H-indole-2-carboxamide|N-[(1S)-2-[benzyl(methyl)amino]-2-oxo-1-phenyl-ethyl]-1-methyl-5-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]indole-2-carboxamide"
ALISKIREN,5493444,,"InChI=1S/C30H53N3O6/c1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36/h10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35)/t22-,23-,24-,25-/m0/s1",UXOWGYHJODZGMF-QORCZRPOSA-N,C30H53N3O6,551.8,"(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide","Aliskiren|173334-57-1|SPP100|SPP 100|aliskirene|Aliskireno|SPP-100|CHEBI:601027|502FWN4Q32|CGP 60536|(2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-{[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl}-8-methyl-2-(propan-2-yl)nonanamide|DTXSID40891494|CGP-060536B|aliskirenum|CGP60536|CGP-60536|(2S,4S,5S,7S)-5-amino-N-(2-carbamoyl-2,2-dimethylethyl)-4-hydroxy-7-((4-methoxy-3-(3-methoxypropoxy)phenyl)methyl)-8-methyl-2-(propan-2-yl)nonanamide|(2S,4S,5S,7S)-5-Amino-N-(2-carbamoyl-2-methylpropyl)-4-hydroxy-2-isopropyl-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methylnonamide|(2S,4S,5S,7S)-5-Amino-N-(2-carbamoyl-2-methylpropyl)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonamide|RefChem:56248|C09XA02|CGP060536B|DTXCID401030595|Tekturna|Aliskiren(CGP 60536)|MFCD09839018|CHEMBL1639|Benzeneoctanamide, delta-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-gamma-hydroxy-4-methoxy-3-(3-methoxypropoxy)-alpha,zeta-bis(1-methylethyl)-, (alphaS,gammaS,deltaS,zetaS)-|(2S,4S,5S,7S)-5-AMINO-N-(2-CARBAMOYL-2-METHYLPROPYL)-4-HYDROXY-2-ISOPROPYL-7-[4-METHOXY-3-(3-METHOXYPROPOXY)BENZYL]-8-METHYLNONANAMIDE|(2S,4S,5S,7S)-5-Amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methylnonanamide|Benzeneoctanamide, delta-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-gamma-hydroxy-4-methoxy-3-(3-methoxypropoxy)-alpha,zeta-bis-(1-methylethyl)-, (alphaS,gammaS,deltaS,zetaS)-|5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide fumarate|Aliskiren [INN]|(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxo-propyl)-4-hydroxy-2-isopropyl-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-nonanamide|(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[[4-methoxy-3-(3-methoxypropoxy)phenyl]methyl]-8-methyl-2-propan-2-ylnonanamide|(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-2-(propan-2-yl)nonanamide|benzeneoctanamide, delta-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-gamma-hydroxy-4-methoxy-3-(3-methoxypropoxy)-alpha,zeta-bis(1-methylethyl)-, (alphaS,gammaS,deltaS,zetaS)-, fumarate|C30H53N3O6|NCGC00186464-01|CGP 60536;CGP60536B;SPP 100|Aliskiren [USAN:INN:BAN]|UNII-502FWN4Q32|Aliskiren?|CGP60536B|HSDB 7843|(2S,4S,5S,7S)-5-amino-N-[2-carbamoyl-2-methylpropyl)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide|Rasilez (TN)|Aliskiren (Standard)|Aliskiren-hemifumarate|ALISKIREN [MI]|Aliskiren (USAN/INN)|ALISKIREN [HSDB]|ALISKIREN [USAN]|ALISKIREN [VANDF]|ALISKIREN [WHO-DD]|ALISKIREN [EMA EPAR]|SCHEMBL455490|GTPL4812|orb1704862|SCHEMBL29521564|BDBM17950|UXOWGYHJODZGMF-QORCZRPOSA-N|GLXC-05705|ALBB-027274|MSK11172|HY-12176R|s5767|STL386835|AKOS015852572|AKOS015888741|CS-0443|DB09026|NCGC00186464-02|(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methyl-2-(1-methylethyl)nonanamide|AS-80517|FA134549|HY-12176|SBI-0206888.P001|NS00007787|D03208|EN300-708809|AB01274865-01|AB01274865_02|AB01274865_03|334A582|Q414904|BRD-K30020243-051-01-7|BRD-K30020243-051-02-5|BRD-K30020243-051-03-3|(2S,4S,5S,7S)-5-Amino-N-(2-carbamoyl)-2-methylpropyl)-4-hydroxy-2-isopropyl-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methylnonamide|(2s,4s,5s,7s)-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-5-amino-n-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-8-methylnonanamide|1327153-71-8|2(S),4(S),5(S),7(S)-N-(2-carbamoyl-2-methylpropyl)-5-amino-4-hydroxy-2,7-diisopropyl-8-(4-methoxy-3-(3-methoxypropoxy)phenyl)octanamid hemifumarate|5(S)-Amino-4(S)-hydroxy-2(S),7(S)-diisopropyl-8-[4-methoxy-3-(3-methoxypropyloxy)-phenyl]-octanoic acid N-(2-carbamoyl-2,2-dimethyl-ethyl)-amide|5-Amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-2-isopropyl-7-[4-methoxy-3-(3-methoxypropoxy)benzyl]-8-methylnonanamide fumar ate|Benzeneoctanamide, |A-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-|A-hydroxy-4-methoxy-3-(3-methoxypropoxy)-|A,|AE-bis(1-methylethyl)-, (|AS,|AS,|AS,|AES)-|benzeneoctanamide, delta-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-gamma-hydroxy-4-methoxy-3-(3-methoxypropoxy)-alpha,zeta-bis(1-me thylethyl)-, (alphaS,gammaS,deltaS,zetaS)-, fumarate|C41"
OLCEGEPANT,6918509,,"InChI=1S/C38H47Br2N9O5/c39-29-21-25(22-30(40)34(29)50)23-33(45-37(53)48-15-10-28(11-16-48)49-24-26-5-1-2-6-31(26)44-38(49)54)35(51)43-32(7-3-4-12-41)36(52)47-19-17-46(18-20-47)27-8-13-42-14-9-27/h1-2,5-6,8-9,13-14,21-22,28,32-33,50H,3-4,7,10-12,15-20,23-24,41H2,(H,43,51)(H,44,54)(H,45,53)/t32-,33+/m0/s1",ITIXDWVDFFXNEG-JHOUSYSJSA-N,C38H47Br2N9O5,869.6,"N-[(2R)-1-[[(2S)-6-amino-1-oxo-1-(4-pyridin-4-ylpiperazin-1-yl)hexan-2-yl]amino]-3-(3,5-dibromo-4-hydroxyphenyl)-1-oxopropan-2-yl]-4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide","Olcegepant|204697-65-4|BIBN 4096 BS|BIBN-4096BS|BIBN4096BS|WOA5J8TX6M|BIBN-4096 BS|N-((1R)-2-(((1S)-5-Amino-1-((4-(pyridin-4-yl)piperazin-1-yl)carbonyl)pentyl)amino)-1-(3,5-dibromo-4-hydroxybenzyl)-2-oxoethyl)-4-(2-oxo-1,4-dihydroquinazolin-3(2H)-yl)piperidine-1-carboxamide|N-[(2R)-1-[[(2S)-6-amino-1-oxo-1-(4-pyridin-4-ylpiperazin-1-yl)hexan-2-yl]amino]-3-(3,5-dibromo-4-hydroxyphenyl)-1-oxopropan-2-yl]-4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide|DTXSID10174443|olcegepantum|N-((2R)-1-(((2S)-6-amino-1-oxo-1-(4-pyridin-4-ylpiperazin-1-yl)hexan-2-yl)amino)-3-(3,5-dibromo-4-hydroxyphenyl)-1-oxopropan-2-yl)-4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide|RefChem:168060|DTXCID0096934|(R-(R,(R*,S*))-N-(2-(5-amino-1-((4-(4-pyridinyl)-1-piperazinyl)carbonyl) pentyl)amino)-1-((3,5-dibromo-4-hydroxyphenyl)methyl)-2-oxoethyl)-4-(1,4-dihydro-2-oxo-3(2H)-quinazolinyl)-,1-Piperidinecarboxamide|(2R)-N-((2S)-6-amino-1-oxo-1-(4-(pyridin-4-yl)piperazin-1-yl)hexan-2-yl)-3-(3,5-dibromo-4-hydroxyphenyl)-2-((4-(2-oxo-1,2,3,4-tetrahydroquinazolin-3-yl)piperidine-1-carbonyl)amino)propanamide|Olcegepant [INN]|BIBN 4096BS|BIBN-4096|bibn4096|BIBN 4096|CHEMBL207197|UNII-WOA5J8TX6M|C38H47Br2N9O5|Olcegepant?|BIBN-4096;BIBN 4096BS|OLCEGEPANT [WHO-DD]|GTPL702|orb1309304|SCHEMBL2252127|SCHEMBL29357241|GLXC-15723|BCP29403|BDBM50184069|EX-A10485|MFCD07772306|AKOS024458225|CS-0360|DB04869|(R-(R*,S*))-N-(2-((5-amino-1-((4-(4-pyridinyl)-1-piperazinyl)carbonyl)pentyl)amino)-1-((3,5-dibromo-4-hydroxyphenyl)methyl)-2-oxoethyl)-4-(1,4-dihydro-2-oxo-3(2H)quinazolinyl)-1-piperidinecarboxamide|DA-56412|HY-10095|MS-31609|NS00073138|(2H)-yl)piperidin-1-yl]carbonyl}-D-tyrosinamide|Q7083300|BRD-K43927145-001-01-2|BRD-K43927145-001-02-0|Z2037281222|BIBN-4096; BIBN4096; BIBN 4096; BIBN-4096BS; BIBN4096BS;  Olcegepant|N-((R)-1-((S)-6-amino-1-oxo-1-(4-(pyridin-4-yl)piperazin-1-yl)hexan-2-ylamino)-3-(3,5-dibromo-4-hydroxyphenyl)-1-oxopropan-2-yl)-4-(2-oxo-1,2-dihydroquinazolin-3(4H)-yl)piperidine-1-carboxamide|N-[(1R)-2-[[(1S)-5-amino-1-[4-(4-pyridyl)piperazine-1-carbonyl]pentyl]amino]-1-[(3,5-dibromo-4-hydroxy-phenyl)methyl]-2-oxo-ethyl]-4-(2-oxo-1,4-dihydroquinazolin-3-yl)piperidine-1-carboxamide|N-{(1S)-5-amino-1-[(4-pyridin-4-ylpiperazin-1-yl)carbonyl]pentyl}-3,5-dibromo-Nalpha-{[4-(2-oxo-1,4-dihydroquinazolin-3|N-{(1S)-5-amino-1-[(4-pyridin-4-ylpiperazin-1-yl)carbonyl]pentyl}-3,5-dibromo-Nalpha-{[4-(2-oxo-1,4-dihydroquinazolin-3(2H)-yl)piperidin-1-yl]carbonyl}-D-tyrosinamide|N-{(2S)-6-amino-1-oxo-1-[4-(pyridin-4-yl)piperazin-1-yl]hexan-2-yl}-3,5-dibromo-Nalpha-{[4-(2-oxo-1,4-dihydroquinazolin-3(2H)-yl)piperidin-1-yl]carbonyl}-D-tyrosinamide"
TELCAGEPANT,11319053,,"InChI=1S/C26H27F5N6O3/c27-18-4-1-3-17(21(18)28)15-6-7-19(23(38)36(13-15)14-26(29,30)31)33-24(39)35-11-8-16(9-12-35)37-20-5-2-10-32-22(20)34-25(37)40/h1-5,10,15-16,19H,6-9,11-14H2,(H,33,39)(H,32,34,40)/t15-,19-/m1/s1",CGDZXLJGHVKVIE-DNVCBOLYSA-N,C26H27F5N6O3,566.5,"N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide","Telcagepant|781649-09-0|MK-0974|MK0974|MK 0974|D42O649ALL|N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-3H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide|DTXSID50999410|N-((3R,6S)-6-(2,3-Difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)hexahydro-1H-azepin-3-yl)-4-(2-oxo-2,3-dihydro-1H-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxamide|telcagepantum|N-((3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl)-4-(2-oxo-3H-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxamide|RefChem:187742|DTXCID001426384|N-((3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl)-4-(2-oxo-1H,2H,3H-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxamide|MK 0974, Telcagepant|Telcagepant (USAN)|Telcagepant [USAN]|CHEMBL236593|N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide|N-((3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl)-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide|N-((3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)hexahydro-1h-azepin-3- yl)-4-(2-oxo-2,3-dihydro-1H-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxamide|Telcagepant [USAN:INN]|UNII-D42O649ALL|3n7r|TELCAGEPANT [MI]|TELCAGEPANT [INN]|TELCAGEPANT [MART.]|GTPL703|TELCAGEPANT [WHO-DD]|N-(6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl)-4-(2-oxo-2,3-dihydro-1H-imidazo(4,5-b)pyridin-1-yl)piperidine-1-carboxamide|N-[(3R,6S)-6-(2,3-Difluorophenyl)hexahydro-2-oxo-1-(2,2,2-trifluoroethyl)-1H-azepin-3-yl]-4-(2,3-dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-1-yl)-1-piperidinecarboxamide|orb2946025|SCHEMBL1198535|SCHEMBL3758672|SCHEMBL3758678|SCHEMBL29371277|GLXC-02777|1-Piperidinecarboxamide, N-((3R,6S)-6-(2,3-difluorophenyl)hexahydro-2-oxo-1-(2,2,2-trifluoroethyl)-1H-azepin-3-yl)-4-(2,3-dihydro-2-oxo-1H-imidazo(4,5-b)pyridin-1-yl)-|BCP07257|BDBM50224431|EX-A11086|AKOS015900692|CS-0291|DB12228|FD74910|NCGC00378827-01|DA-55519|HY-32709|MS-30255|N7R|NS00071851|D09391|F83529|Q5675567|BRD-K91159026-001-01-7|1-PIPERIDINECARBOXAMIDE, N-((3R,6S)-6-(2,3-DIFLUOROPHENYL)HEXAHYDRO-2-OXO-1-(2,2,2- TRIFLUOROETHYL)-1H-AZEPIN-3-YL)-4-(2,3-DIHYDRO-2-OXO-1H-IMIDAZO(4,5-B)PYRIDIN-1-YL)-|N-[(3R,6S)-6-(2,3-difluorophenyl)-2-oxo-1-(2,2,2-trifluoroethyl)azepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyri din-1-yl)piperidine-1-carboxamide|N-[(3R,6S)-6-(2,3-Difluorophenyl)hexahydro-2-oxo-1-(2,2,2-trifluoroethyl)-1H-azepin-3-yl]-4-(2,3-dihydro-2-oxo-1H-imidazo[4,5-b]pyridin-1-yl)-1-piperidinecarbo|Telcagepant;N-[(3R,6S)-6-(2,3-Difluorophenyl)hexahydro-2-oxo-1-(2,2,2-trifluoroethyl)-1H-azepin-3-yl]-4-(2,3-dihydro-2-oxo-1H-imidaz  o[4,5-b]pyridin-1-yl)-1-piperidinecarboxamide"
MK3207,25019940,,"InChI=1S/C31H29F2N5O3/c32-21-10-19(11-22(33)13-21)25-16-35-31(7-1-2-8-31)29(41)38(25)17-26(39)36-23-6-5-18-14-30(15-20(18)12-23)24-4-3-9-34-27(24)37-28(30)40/h3-6,9-13,25,35H,1-2,7-8,14-17H2,(H,36,39)(H,34,37,40)/t25-,30+/m0/s1",AZAANWYREOQRFB-SETSBSEESA-N,C31H29F2N5O3,557.6,"2-[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl]-N-[(2R)-2'-oxospiro[1,3-dihydroindene-2,3'-1H-pyrrolo[2,3-b]pyridine]-5-yl]acetamide","MK-3207|957118-49-9|MK3207|MK 3207|5C44M1QYCC|DTXSID00241931|6,9-Diazaspiro(4.5)decane-9-acetamide, 8-(3,5-difluorophenyl)-10-oxo-N-((2R)-1,1',2',3-tetrahydro-2'-oxospiro(2H-indene-2,3'-(3H)pyrrolo(2,3-b)pyridin)-5-yl)-, (8R)-|RefChem:159197|DTXCID30164422|2-((8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro(4.5)decan-9-yl)-N-((2R)-2'-oxo-1,1',2',3-tetrahydrospiro(indene-2,3'-pyrrolo(2,3-b)pyridine)-6-yl)acetamide|UNII-5C44M1QYCC|2-((R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl)-N-((R)-2'-oxo-1,1',2',3-tetrahydrospiro[indene-2,3'-pyrrolo[2,3-b]pyridin]-5-yl)acetamide|CHEMBL1910936|957118-49-9 (free base)|2-[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl]-N-[(2R)-2'-oxospiro[1,3-dihydroindene-2,3'-1H-pyrrolo[2,3-b]pyridine]-5-yl]acetamide|2-((8R)-8-(3,5-Difluorophenyl)-10-oxo-6,9-diazaspiro(4.5)dec-9-yl)-N-((2R)-2'-oxo-1,1',2',3-tetrahydrospiro(indene-2,3'-pyrrolo(2,3-b)pyridin)-5-yl)acetamide|C31H29F2N5O3|MFCD16038933|SCHEMBL992191|orb2664844|SCHEMBL29359897|SCHEMBL31231899|BCP02225|BDBM50356282|EX-A11218|BCP9000934|CS-1449|DB12424|NCGC00346546-01|FM104277|HY-10301|MS-30150|NS00072557|BRD-K66911501-003-01-2|Q27261818|2-[(8R)-8-(3,5-difluorophenyl)-10-oxo-6,9-diazaspiro[4.5]decan-9-yl]-N-[(3R)-2-oxospiro[1H-pyrrolo[2,3-b]pyridine-3,2'-indane]-5'-yl]acetamide"
NIACIN,938,,"InChI=1S/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9)",PVNIIMVLHYAWGP-UHFFFAOYSA-N,C6H5NO2,123.11,pyridine-3-carboxylic acid,"nicotinic acid|niacin|59-67-6|Pyridine-3-carboxylic acid|3-pyridinecarboxylic acid|3-Carboxypyridine|vitamin B3|wampocap|Niaspan|Acidum nicotinicum|Apelagrin|Pellagrin|Pelonin|Akotin|Daskil|Efacin|Linic|nicolar|Direktan|Nicangin|Nicodelmine|Niconacid|Nicotinipca|Pellagramin|Bionic|Diacin|Nicacid|Nyclin|Peviton|Nicyl|Niac|Davitamon PP|Vitaplex N|nicamin|Nico-Span|nicobid|nicocap|Tega-Span|Enduracin|Nicocidin|Nicocrisina|Niconazid|Nicotamin|Nicovasan|Nicovasen|Nicodon|Niconat|Nicorol|Nicosyl|Nicotene|Nicotil|Nipellen|SK-Niacin|Naotin|Niacor|Tinic|Nicosan 3|3-Carboxylpyridine|Nicotine acid|Slo-niacin|Acide nicotinique|NICO|Nicotinsaure|Nicagin|Acido nicotinico|Pyridine-beta-carboxylic acid|anti-Pellagra vitamin|PP Factor|Kyselina nikotinova|P.P. factor|Pellagra preventive factor|S115|3-Pyridylcarboxylic acid|m-Pyridinecarboxylic acid|niacine|Pyridine-carboxylique-3|EPA Pesticide Chemical Code 056701|Niacin extended release|Nikotinsaeure|SR 4390|beta-pyridinecarboxylic acid|NIASPAN TITRATION STARTER PACK|NSC-169454|Niacin (USP)|Niacin [USP]|DTXSID1020932|CHEBI:15940|VITAMIN B-3|2679MF687A|DTXCID10932|NSC169454|3 Pyridinecarboxylic Acid|Niacin Td|Niaspan ER|Tartrate, Niacin|Tosylate, Niacin|Nicotinate, Lithium|Sodium Salt, Niacin|Hydrochloride, Niacin|Aluminum Salt, Niacin|Nico400|Potassium Salt, Niacin|Nico 400|RefChem:927738|hydron;pyridine-3-carboxylate|CHEBI:176839|Jeuncell Hair Restorer and Hair Growth Solution|200-441-0|681-634-0|3-Picolinic acid|Nico-400|Caswell No. 598|MFCD00006391|Nicotinsaure [German]|Kyselina nikotinova [Czech]|CCRIS 1902|Acide nicotinique [INN-French]|Acido nicotinico [INN-Spanish]|Acidum nicotinicum [INN-Latin]|HSDB 3134|Pyridine-carboxylique-3 [French]|AI3-18994|Pyridinecarboxylic acid, 3-|BRN 0109591|Nicotinic acid [INN]|CHEMBL573|MLS000069603|Pyridine-.beta.-carboxylic acid|P.P. factor-pellagra preventive factor|CAS-59-67-6|pyridine, 3-carboxy-|NCGC00016268-02|SMR000059024|[5, 6-3H]-niacin|Niacin [USAN]|Nicotinicacid|NIO|Niacin (nicotinic acid)|SR-01000722017|EINECS 200-441-0|NSC 169454|Nicotinic Acid;|UNII-2679MF687A|preventative factor|antipellagra vitamin|Niaspan (TN)|3-Pyridylcarboxylate|3PyrCOOH|[3H]nicotinic acid|Niacor (TN)|[3H]-Nicotinic acid|Spectrum_001063|pyridinium-3-carboxylate|NIACIN [VANDF]|NIACIN [HSDB]|Nicotinic acid (Niacin)|5-pyridinecarboxylic acid|NIACIN [FCC]|NIACIN [USP-RS]|Opera_ID_1346|Prestwick0_000881|Prestwick1_000881|Prestwick2_000881|Prestwick3_000881|Pyridine-3-carbonic acid|Spectrum2_000006|Spectrum3_000515|Spectrum4_000965|Spectrum5_001287|Nicotinamide Impurity 16|3-Pyridyl carboxylic acid|Nicotinic acid-13C1 )|Nicotinic acid-d3(major)|WLN: T6NJ CVQ|3-pyridine carboxylic acid|bmse000104|Nicotinic acid, >=98%|Nicotinic acid, USP grade|EC 200-441-0|SCHEMBL1433|NICOTINIC ACID [MI]|Oprea1_514398|VITAMIN B3 [VANDF]|BSPBio_000662|BSPBio_002069|KBioGR_001309|KBioSS_001543|NIACIN [ORANGE BOOK]|NICOTINIC ACID [JAN]|5-22-02-00057 (Beilstein Handbook Reference)|Nicotinic acid (Vitamin B3)|BIDD:GT0644|DivK1c_000695|Nicotinic acid (JP18/INN)|SCHEMBL308467|SCHEMBL309891|SCHEMBL333960|SCHEMBL658420|SIMCOR COMPONENT NIACIN|SPECTRUM1500430|.beta.-Pyridinecarboxylic acid|SPBio_000011|SPBio_002881|ADVICOR COMPONENT NIACIN|NIACIN [USP MONOGRAPH]|NICOTINIC ACID [VANDF]|BPBio1_000730|GTPL1588|GTPL1594|orb1310206|SCHEMBL2045277|NICOTINIC ACID [MART.]|NICOTINIC ACID [WHO-DD]|NICOTINIC ACID [WHO-IP]|SCHEMBL29349574|BDBM23515|HMS502C17|KBio1_000695|KBio2_001543|KBio2_004111|KBio2_006679|KBio3_001569|ABT-919|MSK1518|NICOTINIC ACID [EMA EPAR]|NINDS_000695|HMS1570B04|HMS1920P17|HMS2091H22|HMS2097B04|HMS2236A05|HMS3259K21|HMS3371E07|HMS3655K08|HMS3714B04|HMS5079H22|Pharmakon1600-01500430|Nicotinic acid, analytical standard|BCP16301|HCA98714|HY-B0143|STR00112|Tox21_110337|Tox21_201420|Tox21_302904|AC8691|BBL037343|CCG-38340|NICOTINIC ACID [EP IMPURITY]|Nicotinic acid, for synthesis, 99%|NSC757241|s1744|SBB004279|STK301803|NICOTINIC ACID [EP MONOGRAPH]|AKOS000118980|Nicotinic acid, >=99.5% (HPLC)|Tox21_110337_1|CS-1946|DB00627|FN16182|NC00524|Nicotinic Acid 1.0 mg/ml in Methanol|NSC-757241|PS-4255|SDCCGMLS-0066610.P001|IDI1_000695|NCGC00016268-01|NCGC00016268-03|NCGC00016268-04|NCGC00016268-05|NCGC00016268-08|NCGC00016268-09|NCGC00016268-13|NCGC00094734-01|NCGC00094734-02|NCGC00256537-01|NCGC00258971-01|AC-22484|ACIDUM NICOTINICUM [WHO-IP LATIN]|BP-21419|NCI60_001041|Nicotinic acid, plant cell culture tested|ST097540|SY011111|SBI-0051456.P003|DB-007765|Nicotinic Acid [Matrix for MALDI-TOF/MS]|AB00052050|N0082|N1103|Nicotinic acid 10 microg/mL in Acetonitrile|Nicotinic acid, purum, >=99.0% (HPLC)|NS00003500|SW197229-3|EN300-16693|C00253|D00049|Nicotinic acid(Discontinued,See C4X-200016)|Nicotinic acid, SAJ special grade, >=99.5%|AB00052050-13|AB00052050_14|AB00052050_15|Nicotinic acid, meets USP testing specifications|AC-907/25014105|AE-641/00368010|F214893|L001199|METHYL NICOTINATE IMPURITY A [EP IMPURITY]|Q134658|SR-01000722017-2|SR-01000722017-3|SR-01000722017-4|BRD-K60237333-001-26-3|BRD-K60237333-001-27-1|BRD-K60237333-001-28-9|Pyridine-3-carboxylic acid;Vitamin B3;Nicotinic acid|Z56755709|3DDB011E-F3A6-45B6-A2D2-77B2A6E8936E|F2191-0082|Niacin, United States Pharmacopeia (USP) Reference Standard|Nicotinic acid, certified reference material, TraceCERT(R)|Nicotinic acid, European Pharmacopoeia (EP) Reference Standard|Nicotinic acid, matrix substance for MALDI-MS, >=99.5% (HPLC)|InChI=1/C6H5NO2/c8-6(9)5-2-1-3-7-4-5/h1-4H,(H,8,9|Nicotinic acid, for inorganic trace analysis, >=99.999% (metals basis)|Niacin (Nicotinic Acid), Pharmaceutical Secondary Standard; Certified Reference Material|101113-41-1|Nicotinic acid, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for plant cell culture, >=98%"
"UK-396,082",11241908,,"InChI=1S/C12H21N3O2/c1-2-6-15-8-11(14-9-15)7-10(12(16)17)4-3-5-13/h8-10H,2-7,13H2,1H3,(H,16,17)/t10-/m0/s1",OTDGPKRCQXSTPV-JTQLQIEISA-N,C12H21N3O2,239.31,(2S)-5-amino-2-[(1-propylimidazol-4-yl)methyl]pentanoic acid,"400044-47-5|UK-396082|UK-396,082|UK 396082|2Q5861SUIG|(2s)-5-Amino-2-[(1-Propyl-1h-Imidazol-4-Yl)methyl]pentanoic Acid|(2S)-5-amino-2-[(1-propylimidazol-4-yl)methyl]pentanoic acid|DTXSID70193074|UK396082|1H-Imidazole-4-propanoic acid, alpha-(3-aminopropyl)-1-propyl-, (alphaS)-|(2S)-5-amino-2-((1-propylimidazol-4-yl)methyl)pentanoic acid|(2S)-5-amino-2-((1-propyl-1H-imidazol-4-yl)methyl)pentanoic acid|RefChem:192972|DTXCID80115565|UK396,082|UK 396,082|UNII-2Q5861SUIG|(S)-5-amino-2-((1-propyl-1H-imidazol-4-yl)methyl)pentanoic acid|CHEMBL398110|UK?396082|GTPL8657|orb1740186|SCHEMBL3841442|GLXC-10227|UKa?96082|BDBM50226610|DB12099|compound 21 [PMID: 17990866]|DA-58873|HY-122052|CS-0081488|NS00068777|Q27089079|(2S)-5-amino-2-[(1-n-propyl-1H-imidazol-4-yl)methyl]-pentanoic acid|1H-IMIDAZOLE-4-PROPANOIC ACID, .ALPHA.-(3-AMINOPROPYL)-1-PROPYL-, (.ALPHA.S)-"
DICUMAROL,54676038,,"InChI=1S/C19H12O6/c20-16-10-5-1-3-7-14(10)24-18(22)12(16)9-13-17(21)11-6-2-4-8-15(11)25-19(13)23/h1-8,20-21H,9H2",DOBMPNYZJYQDGZ-UHFFFAOYSA-N,C19H12O6,336.3,4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one,"dicumarol|dicoumarol|66-76-2|Bishydroxycoumarin|melitoxin|Antitrombosin|Baracoumin|Dicoumal|Dicuman|Dicumarine|Dicumol|Acadyl|Acavyl|bis-hydroxycoumarin|Dufalone|Temparin|Trombosan|Kumoran|Cumid|Cuma|Dicumaol R|Dicoumarolum|3,3'-Methylenebis(4-hydroxycoumarin)|Anathrombase|Apekumarol|Dicoumerol|Dicumarinum|Dicumarolum|Bis(4-hydroxycoumarin-3-yl)methane|Bis-3,3'-(4-hydroxycoumarinyl)methane|Di-(4-hydroxy-3-coumarinyl)methane|Dicumarolo|Dwukumarol|Di-4-hydroxy-3,3'-methylenedicoumarin|3,3'-Methylen-bis(4-hydroxy-cumarin)|3,3'-Methylene-bis(4-hydroxycoumarine)|3,3'-Methylenebis(4-hydroxy-1,2-benzopyrone)|NC 034|3,3'-Methylenebis(4-hydroxy-2H-1-benzopyran-2-one)|3,3'-Metilen-bis(4-idrossi-cumarina)|3,3'-Methyleen-bis(4-hydroxy-cumarine)|2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy-|DTXSID8021729|Coumarin, 3,3'-methylenebis(4-hydroxy-|7QID3E7BG7|4,4'-Dihydroxy-3,3'-methylene bis coumarin|NSC-17860|NSC-41834|3,3'-Methylenebis[4-hydroxycoumarin]|CHEBI:4513|2H-1-Benzopyran-2-one), 3,3'-methylenebis(4-hydroxy-|NSC41834|NSC-221570|4-hydroxy-3-[(4-hydroxy-2-oxochromen-3-yl)methyl]chromen-2-one|DTXCID701729|4-hydroxy-3-[(4-hydroxy-2-oxo-2H-chromen-3-yl)methyl]-2H-chromen-2-one|2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy-|3,3'-Methylenebis[4-hydroxy-1,2-benzopyrone]|3,3'-Methylenebis[4-hydroxy-2H-1-benzopyran-2-one]|4-hydroxy-3-((4-hydroxy-2-oxo-2H-chromen-3-yl)methyl)-2H-chromen-2-one|4-hydroxy-3-((4-hydroxy-2-oxochromen-3-yl)methyl)chromen-2-one|2H-1-Benzopyran-2-one, 3,3'-methylenebis(4-hydroxy)-|RefChem:55011|B01AA01|200-632-9|dicoumarin|Dicumarol [USAN]|3,3'-methylenebis(4-hydroxy-2H-chromen-2-one)|3,3'-methanediylbis(4-hydroxy-2H-chromen-2-one)|MFCD00006857|NSC 17860|Dicoumarol (INN)|Dicoumarol [INN]|Dicumarol (USAN)|NSC 221570|3,3'-Methylene-bis(4-hydroxycoumarin)|CHEMBL1466|NSC17860|3,2-benzopyrone]|CAS-66-76-2|Dicumarolo [DCIT]|NCGC00016296-01|Dwukumarol [Polish]|Dikumarol|Dicumarol [INN-Spanish]|Dicoumarolum [INN-Latin]|CHEMBL43154|4-hydroxy-3-[(4-hydroxy-2-oxo-chromen-3-yl)methyl]chromen-2-one|Coumarin,3'-methylenebis[4-hydroxy-|Dicumarol (TN)|CCRIS 3713|Bis-3,3'-(4-oxycoumarinyl)ethylacetate|NSC221570|HSDB 3223|WLN: T66 BOVJ EQ D1- DT66 BOVJ EQ|SR-05000001605|Dicumarol [USAN:USP]|2H-1-Benzopyran-2-one,3'-methylenebis[4-hydroxy-|EINECS 200-632-9|NSC 41834|2H-1-Benzopyran-2-one],3'-methylenebis[4-hydroxy-|3,3'-Methylen-bis(4-hydroxy-cumarin) [German]|3,3'-Methyleen-bis(4-hydroxy-cumarine) [Dutch]|3,3'-Methylene-bis(4-hydroxycoumarine) [French]|3,3'-Metilen-bis(4-idrossi-cumarina) [Italian]|UNII-7QID3E7BG7|BRN 0335444|AI3-14546|Dicumarol?|uncoupler of oxidative respiration|Prestwick_90|Spectrum_000165|DICUMAROL [MI]|DICUMAROL [HSDB]|Prestwick0_000785|Prestwick1_000785|Prestwick2_000785|Prestwick3_000785|Spectrum2_000144|Spectrum3_000387|Spectrum4_000508|Spectrum5_000871|DICUMAROL [VANDF]|M0216|ChemDiv2_003436|DICOUMAROL [MART.]|DICOUMAROL [WHO-DD]|DICOUMAROL [WHO-IP]|Oprea1_150990|SCHEMBL33891|SCHEMBL33892|BSPBio_000890|BSPBio_002173|CBDivE_003005|KBioGR_001055|KBioSS_000645|5-19-06-00682 (Beilstein Handbook Reference)|DivK1c_000896|SPECTRUM1500239|SPBio_000248|SPBio_002829|BPBio1_000980|GTPL6808|orb1710681|DICUMAROL [ORANGE BOOK]|SCHEMBL29703314|BDBM35525|HMS502M18|KBio1_000896|KBio2_000645|KBio2_003213|KBio2_005781|KBio3_001393|Dicoumarol - CAS 66-76-2|NINDS_000896|HMS1378M04|HMS1570M12|HMS1920E20|HMS2091M10|HMS2097M12|HMS3652P10|HMS3714M12|HMS3744M19|HMS3865F03|HMS5083G07|Pharmakon1600-01500239|DICOUMAROLUM [WHO-IP LATIN]|HY-N0645|Tox21_110357|3,3'-Methylenbis(4-hydroxycumarin)|BBL008904|CCG-34550|NSC756733|s4299|STK801287|AKOS000520650|Tox21_110357_1|CS-7962|DB00266|FD28896|NSC-756733|IDI1_000896|NCGC00016296-02|NCGC00016296-03|NCGC00016296-04|NCGC00016296-05|NCGC00016296-07|NCGC00094650-01|NCGC00094650-02|AS-19619|SY148056|SBI-0051343.P003|NS00001589|SW196402-3|3,3''''''''-methylenebis[4-hydroxycoumarin|3,3'-Methylene-bis(4-hydroxycoumarin), 99%|C00796|D03798|D91292|EN300-123537|SBI-0051343.0001|3,3''''''''-methylenebis(4-hydroxy-coumarin|3,3''''''''-methylenebis(4-hydroxycoumarin)|AB00051966_05|Coumarin, 3,3'-methylenebis[4-hydroxy- (8CI)|Q420886|3,3?-Methylene-bis(4-hydroxycoumarin) (synthetic)|SR-05000001605-1|SR-05000001605-3|SR-05000001605-4|BRD-K82236179-001-05-0|BRD-K82236179-001-06-8|BRD-K82236179-213-01-0|Z57170530|2H-1-Benzopyran-2-one, 3,3'-methylenebis[4-hydroxy- (9CI)|Dicumarol, United States Pharmacopeia (USP) Reference Standard|3,3 inverted exclamation mark -Methylenebis(4-hydroxy-2H-chromen-2-one)"
SPIRONOLACTONE,5833,,"InChI=1S/C24H32O4S/c1-14(25)29-19-13-15-12-16(26)4-8-22(15,2)17-5-9-23(3)18(21(17)19)6-10-24(23)11-7-20(27)28-24/h12,17-19,21H,4-11,13H2,1-3H3/t17-,18-,19+,21+,22-,23-,24+/m0/s1",LXMSZDCAJNLERA-ZHYRCANASA-N,C24H32O4S,416.6,"S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate","spironolactone|52-01-7|Aldactone|Spirolactone|Verospirone|Spiresis|Uractone|Xenalon|spironolattone|Espironolactona|Spironolactonum|Abbolactone|Diatensec|Laractone|Spiretic|SC 9420|Spironolactone ceva|SC-9420|Carospir|NSC-150399|CHEBI:9241|DTXSID6034186|27O7W4T232|S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-oxolane]-7-yl] ethanethioate|DTXCID4014186|SC9420|NSC150399|3-(3-Keto-7-alpha-acetylthio-17-beta-hydroxy-4-androsten-17-alpha-yl)propionic acid lactone|17alpha-Pregn-4-ene-21-carboxylic acid, 17-hydroxy-7alpha-mercapto-3-oxo-, gamma-lactone, acetate|Pregn-4-ene-21-carboxylic acid, 7-(acetylthio)-17-hydroxy-3-oxo-, gamma-lactone, (7alpha,17alpha)-|CARDALIS COMPONENT SPIRONOLACTONE|Veroshpiron|7-alpha-(acetylthio)-17-alpha-hydroxy-3-oxopregn-4-ene-21-carboxylic acid, gamma-lactone|NovoSpiroton|Novo Spiroton|Spirono Isis|von ct, spiro|(1'S,2R,2'R,9'R,10'R,11'S,15'S)-9'-(acetylsulfanyl)-2',15'-dimethylspiro[oxolane-2,14'-tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan]-6'-ene-5,5'-dione|Gx spironol|Spirospare 25|Spiroctan 25|Spiroctan 50|Ct, Spiro Von|Spirospare 100|(1'S,2R,2'R,9'R,10'R,11'S,15'S)-9'-(acetylsulfanyl)-2',15'-dimethylspiro(oxolane-2,14'-tetracyclo(8.7.0.0^(2,7).0^(11,15))heptadecan)-6'-ene-5,5'-dione|S-((7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxospiro(2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta(a)phenanthrene-17,2'-oxolane)-7-yl) ethanethioate|Spiroctan 100|RefChem:6256|C03DA01|7alpha-Acetylsulfanyl-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|(1'S,2R,2'R,9'R,10'R,11'S,15'S)-9'-(acetylsulfanyl)-2',15'-dimethylspiro(oxolane-2,14'-tetracyclo(8.7.0.02,7.011,15)heptadecan)-6'-ene-5,5'-dione|17-Hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic Acid, gamma Lactone, Acetate|200-133-6|Euteberol|Verospiron|Spiroctan|Spirolang|Spironocompren|Melarcon|Spiridon|Urusonin|Acelat|Alderon|Spirone|Dira|Spiro-Tablinen|Aldactone A|Spironolactone A|Aldopur|Aquareduct|Aldace|Almatol|Deverol|Altex|Berlactone|MFCD00082250|Duraspiron|C24H32O4S|17-Hydroxy-7-alpha-mercapto-3-oxo-17-alpha-pregn-4-ene-21-carboxylic acid-gamma-lactone-7-acetate|CHEMBL1393|Spiro(17H-cyclopenta(a)phenauthrene-17,2'-(3'H)-furan)|Spironolattone [DCIT]|17-Hydroxy-7alpha-mercapto-3-oxo-17alpha-pregn-4-ene-21-carboxylic acid, gamma-lactone acetate|SNL|Aldactide|Spironolactonum [INN-Latin]|Espironolactona [INN-Spanish]|SC 15983|Spiro[17H-cyclopenta[a]phenauthrene-17,2'-(3'H)-furan]|Diatense|Aldactone (TN)|S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxo-1,2,3,4',5',6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3'H-spiro[cyclopenta[a]phenanthrene-17,2'-furan]-7-yl] ethanethioate|SMR000471892|HSDB 3184|EINECS 200-133-6|NSC 150399|BRN 0057767|spirotone|Spiranolactone|Qaialdo|UNII-27O7W4T232|2oax|3vhu|CAS-52-01-7|NCGC00015948-02|3-(3-Keto-7.alpha.-acetylthio-17.beta.-hydroxy-4-androsten-17.alpha.-yl)propionic acid lactone|7-.alpha.-(acetylthio)-17-.alpha.-hydroxy-3-oxopregn-4-ene-21-carboxylic acid, .gamma.-lactone|7-alpha-Acetylthio-3-oxo-17-alpha-pregn-4-ene-21,17-beta-carbolactone|Spironolactone [USP:INN:BAN:JAN]|Prestwick0_000128|Prestwick1_000128|Prestwick2_000128|Prestwick3_000128|SC 9420, Aldactone|Spironolactone (Standard)|SPIRONOLACTONE [MI]|3'-(3-Oxo-7-alpha-acetylthio-17-beta-hydroxyandrost-4-en-17-beta-yl)propionic acid lactone|SPIRONOLACTONE [INN]|SPIRONOLACTONE [JAN]|BIDD:PXR0071|SCHEMBL20939|BSPBio_000176|SPIRONOLACTONE [HSDB]|SPIRONOLACTONE [IARC]|4-18-00-01601 (Beilstein Handbook Reference)|MLS001074672|MLS001333253|MLS001333254|MLS002153245|MLS002207058|MLS002548846|SPIRONOLACTONE [VANDF]|SPBio_002115|SPIRONOLACTONE [MART.]|BPBio1_000194|GTPL2875|orb1310575|SPIRONOLACTONE [USP-RS]|SPIRONOLACTONE [WHO-DD]|SPIRONOLACTONE [WHO-IP]|HY-B0561R|Spironolactone (JP17/USP/INN)|GLXC-10093|HMS1568I18|HMS2090N21|HMS2095I18|HMS2236E06|HMS3259G11|HMS3712I18|Spironolactone - Bio-X trade mark|HY-B0561|Spironolactone, 97.0-103.0%|SPIRONOLACTONE [ORANGE BOOK]|Tox21_113047|Tox21_302154|7alpha-(acetylsulfanyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|BDBM50228080|HB2799|MSK000578|s4054|SPIRONOLACTONE [EP MONOGRAPH]|SPIRONOLACTONE [USP MONOGRAPH]|4-Pregnen-21-oic acid-17alpha-ol-3-one-7alpha-thiol gamma-lactone 7-acetate|AKOS015896401|SPIRONOLACTONUM [WHO-IP LATIN]|AC-4214|CCG-220128|DB00421|FS15791|KS-5234|NC00482|SPIRONOLACTONE COMPONENT CARDALIS|NCGC00015948-10|NCGC00164397-01|NCGC00164397-02|NCGC00164397-03|NCGC00164397-05|NCGC00255229-01|17-alpha-Pregn-4-ene-21-carboxylic acid, 17-hydroxy-7-alpha-mercapto-3-oxo-, gamma-lactone acetate|BS166385|CPD000471892|Spironolactone 1.0 mg/ml in Acetonitrile|ALDACTAZIDE COMPONENT SPIRONOLACTONE|SPIRONOLACTONE [EMA EPAR VETERINARY]|AB00513806|NS00000424|S0260|C07310|C75438|D00443|EN300-123035|AB01275520-01|AB01275520_02|082S250|Q422188|SR-01000765419|SR-05000000452|SR-01000765419-2|SR-05000000452-2|BRD-K90027355-001-03-4|BRD-K90027355-001-13-3|BRD-K90027355-001-19-0|Z1546616196|Spironolactone, European Pharmacopoeia (EP) Reference Standard|WLN: L E5 B666 FX OV MUTJ A1 E1 KSV1 F-& CT5VOXTJ|17.alpha.-Pregn-4-ene-21-carboxylic acid, .gamma.-lactone acetate|Spironolactone, United States Pharmacopeia (USP) Reference Standard|17.alpha.-Pregn-4-ene-21-carboxylic acid, .gamma.-lactone, acetate|Pregn-4-ene-21-carboxylic acid, .gamma.-lactone, (7.alpha.,17.alpha.)-|7alpha-(Acetylthio)-17alpha-hydroxy-3-oxopregn-4-ene-21-carboxylic acid gamma-lactone|Spironolactone for system suitability, European Pharmacopoeia (EP) Reference Standard|(1R,3aS,3bR,4R,9aR,9bS,11aS)-4-(acetylsulfanyl)-9a,11a-dimethyl-2,3,3a,3b,4,5,7,8,9,9a,9b,10,11,11a-tetradecahydrospiro[cyclopenta[a]phenanthrene-1,2'-oxolane]-5',7-dione|2'',15''-dimethyl-5,5''-dioxo-(9''R)-spiro[tetrahydrofuran-2,14''-tetracyclo[8.7.0.02,7.011,15]heptadec-6''-ene]-9-yl ethanethioate|2'',15''-dimethyl-5,5''-dioxospiro[tetrahydrofuran-2,14''-tetracyclo[8.7.0.02,7.011,15]heptadec-6''-ene]-9-yl ethanethioate|2'',15''-dimethyl-5,5''-dioxospiro[tetrahydrofuran-2,14''-tetracyclo[8.7.0.02,7.011,15]heptadec-6''-ene]-9-yl ethanethioate(Spiranolactone)|PREGN-4-ENE-21-CARBOXYLIC ACID, 7-(ACETYLTHIO)-17-HYDROXY-3-OXO-,.GAMMA.-LACTONE, (7.ALPHA.,17.ALPHA.)-|S-(2''R,7R,8R,9S,10R,13S,14S)-10,13-dimethyl-3,5''-dioxo-1,2,3,4'',5'',6,7,8,9,10,11,12,13,14,15,16-hexadecahydro-3''H-spiro[cyclopenta[a]phenanthrene-17,2''-furan]-7-yl ethanethioate|S-[(7R,8R,9S,10R,13S,14S,17R)-10,13-dimethyl-3,5'-dioxo-spiro[2,6,7,8,9,11,12,14,15,16-decahydro-1H-cyclopenta[a]phenanthrene-17,2'-tetrahydrofuran]-7-yl] ethanethioate"
EPLERENONE,443872,,"InChI=1S/C24H30O6/c1-21-7-4-14(25)10-13(21)11-15(20(27)28-3)19-16-5-8-23(9-6-18(26)30-23)22(16,2)12-17-24(19,21)29-17/h10,15-17,19H,4-9,11-12H2,1-3H3/t15-,16+,17-,19+,21+,22+,23-,24-/m1/s1",JUKPWJGBANNWMW-VWBFHTRKSA-N,C24H30O6,414.5,"methyl (1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxospiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-oxolane]-9-carboxylate","Eplerenone|Inspra|107724-20-9|SC-66110|(+)-Eplerenone|Eplerenona|DTXSID2046094|CHEBI:31547|SC-6611O|6995V82D0B|9,11alpha-Epoxy-17-hydroxy-3-oxo-17alpha-pregn-4-ene-7alpha,21-dicarboxylic acid, gamma-lactone, methyl ester|DTXCID0026094|methyl (1'R,2R,2'S,9'R,10'R,11'S,15'S,17'R)-2',15'-dimethyl-5,5'-dioxo-18'-oxaspiro[oxolane-2,14'-pentacyclo[8.8.0.0^{1,17}.0^{2,7}.0^{11,15}]octadecan]-6'-ene-9'-carboxylate|Spiro(cyclopenta(7,8)phenanthro(4b,5-b)oxirene-7(3H),2'(3'H)-furan)-10-carboxylic acid, 2,4,4',4a,5',5a,6,6a,8,9,9a,9b,10,11-tetradecahydro-4a,6a-dimethyl-2,5'-dioxo-, methyl ester, (4aS,4bR,5aR,6aS,7 R,9aS,9bR,10R)-|eplerenon|eplerenonum|methyl (1'R,2R,2'S,9'R,10'R,11'S,15'S,17'R)-2',15'-dimethyl-5,5'-dioxo-18'-oxaspiro(oxolane-2,14'-pentacyclo(8.8.0.0^(1,17).0^(2,7).0^(11,15))octadecan)-6'-ene-9'-carboxylate|RefChem:56430|C03DA04|9,11alpha-Epoxy-7alpha-(methoxycarbonyl)-3-oxo-17alpha-pregn-4-ene-21,17-carbolactone|Epoxymexrenone|Selara|CGP-30083|CHEMBL1095097|Cgp 30083|HSDB 7522|NCGC00159559-02|Eplerenone [USAN]|Inspra (TN)|CAS-107724-20-9|Eplerenone [USAN:INN:BAN]|Eplerenone?|UNII-6995V82D0B|(7?,11?,17?)-9,11-Epoxy-17-hydroxy-3-oxopregn-4-ene-7,21-dicarboxylic acid;?-Lactone 7-methyl ester|SC 6110|Eplerenone (Standard)|EPLERENONE [MI]|EPLERENONE [INN]|EPLERENONE [JAN]|EPLERENONE [HSDB]|EPLERENONE [VANDF]|EPLERENONE [MART.]|EPLERENONE [USP-RS]|EPLERENONE [WHO-DD]|SCHEMBL21515|Eplerenone - Bio-X trade mark|GTPL2876|orb1310957|Eplerenone (JP17/USAN/INN)|EPLERENONE [ORANGE BOOK]|Eplerenone, >=98% (HPLC)|HY-B0251R|EPLERENONE [EP MONOGRAPH]|JUKPWJGBANNWMW-VWBFHTRKSA-N|GLXC-02507|HMS3413K08|HMS3677K08|HY-B0251|methyl (1'R,2S,2'S,9'R,10'R,11'S,15'S,17'R)-2',15'-dimethyl-5,5'-dioxo-18'-oxaspiro[oxolane-2,14'-pentacyclo[8.8.0.0^{1,17}.0^{2,7}.0^{11,15}]octadecan]-6'-ene-9'-carboxylate|MSK11235|Tox21_111746|BDBM50318300|HB2527|s1707|AKOS015962307|Tox21_111746_1|AC-4213|CCG-268820|DB00700|FP22747|KS-1406|7alpha-methoxycarbonyl-3-oxo-9,11alpha-epoxy-17alpha-pregn-4-ene-21,17-carbolactone|NCGC00159559-03|BE164415|Pregn-4-ene-7,21-dicarboxylic acid, 9,11-epoxy-17-hydroxy-3-oxo-, gamma-lactone, methyl ester, (7alpha,11alpha,17alpha)-|E0905|NS00005985|D01115|AB01274707-01|AB01274707_02|EN300-6492952|F093379|Q423804|SR-01000942233|SR-01000942233-1|BRD-K19761926-001-02-8|BRD-K19761926-001-03-6|methyl dimethyl-5'-dioxo-spiro[[?]-[?],2'-tetrahydrofuran]carboxylate|9,11alpha-Epoxy-17-hydroxy-3-oxo-17alpha-pregn-4-ene-7alpha,21-dicarboxylic Acid gamma-Lactone Methyl Ester|methyl (1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxo-spiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-tetrahydrofuran]-9-carboxylate|methyl (1R,2S,9R,10R,11S,14R,15S,17R)-2,15-dimethyl-5,5'-dioxospiro[18-oxapentacyclo[8.8.0.01,17.02,7.011,15]octadec-6-ene-14,2'-oxolane]-9-carboxylate|PREGN-4-ENE-7,21-DICARBOXYLIC ACID, 9,11-EPOXY-17-HYDROXY-3-OXO-, G-LACTONE, METHYL ESTER, (7.ALPHA.,11.ALPHA.,17.ALPHA)-|YNU"
HEXYLRESORCINOL,3610,,"InChI=1S/C12H18O2/c1-2-3-4-5-6-10-7-8-11(13)9-12(10)14/h7-9,13-14H,2-6H2,1H3",WFJIVOKAWHGMBH-UHFFFAOYSA-N,C12H18O2,194.27,"4-hexylbenzene-1,3-diol","hexylresorcinol|4-Hexylresorcinol|136-77-6|4-hexylbenzene-1,3-diol|4-Hexyl-1,3-benzenediol|4-n-Hexylresorcinol|p-Hexylresorcinol|Antascarin|Ascaricid|Ascarinol|Oxana|Caprokol|Adrover|Hidesol|Crystoids|Prensol|1,3-Benzenediol, 4-hexyl-|4-Hexylresorcine|4-Hexyl-1,3-dihydroxybenzene|Hexylresorcin|Gelovermin|Ascaryl|Cystoids anthelmintic|4-(1-Hexyl)resorcinol|Worm-agen|1,3-Dihydroxy-4-hexylbenzene|Resorcinol, 4-hexyl-|Hexylresorzin|Mycoderm|Hexylresorcinolum|1,3-Dihydroxy-4-n-hexylbenzene|NCI-C55787|EverFresh|S.T. 37|DTXSID1020699|ST 37|R9QTB5E82N|INS NO.586|INS-586|NSC1570|1-(2',4'-Dihydroxyphenyl)hexane|DTXCID10699|E-586|4 Hexylresorcinol|Myxcin-C|RefChem:55300|MUCINEX INSTASOOTHE|S.T.37|terrasil First Aid Antiseptic Wound and Burn Care|terrasil First Aid Antiseptic Wound and Burn Care Kit|MUCINEX INSTASOOTHE SORE THROAT PLUS PAIN RELIEF|MUCINEX INSTASOOTHE SORE THROAT PLUS SOOTHING COMFORT|205-257-4|Sucrets|MFCD00002284|ST-37|4-hexyl resorcinol|NSC 1570|CHEMBL443605|NCGC00091208-04|Hexylresorcin [German]|Kopnol|CAS-136-77-6|CCRIS 888|HSDB 566|EINECS 205-257-4|UNII-R9QTB5E82N|BRN 2048312|AI3-08055|Hexylresorcinol [USP:INN:BAN]|4-Hexyl-benzenediol|Hexylresorcinol (USP)|Spectrum_000869|1, 4-hexyl-|4-Hexylresorcinol, 8CI|Spectrum2_000989|Spectrum3_000451|Spectrum4_000001|Spectrum5_000794|4-Hexylresorcinol, 98%|Hexylresorcinol (Standard)|WLN: QR CQ D6|Hexylresorcinol, BAN, USAN|SCHEMBL29107|BSPBio_002122|KBioGR_000341|KBioSS_001349|4-06-00-06048 (Beilstein Handbook Reference)|MLS002152930|DivK1c_000094|HEXYLRESORCINOL [HSDB]|SPECTRUM1500330|SPBio_001057|orb1310731|SCHEMBL8848639|4-HEXYLRESORCINOL [MI]|HEXYLRESORCINOL [MART.]|1-(2,4-Dihydroxyphenyl)hexane|4-Hexyl-1,3-dihydroxy benzene|4-HEXYLRESORCINOL [FCC]|HEXYLRESORCINOL [USP-RS]|HEXYLRESORCINOL [WHO-DD]|SCHEMBL29373062|BCBcMAP01_000093|CHEBI:93749|HMS500E16|HY-B0986R|KBio1_000094|KBio2_001349|KBio2_003917|KBio2_006485|KBio3_001342|MSK2319|NINDS_000094|1, 3-Dihydroxy-4-n-hexylbenzene|HMS1920D09|HMS2091J15|HMS3885J08|HMS5083B15|Pharmakon1600-01500330|benzene, 4-hexyl-1,3-dihydroxy-|BCP31316|HY-B0986|NSC-1570|Tox21_111102|Tox21_202263|Tox21_300357|BBL023042|BDBM50292636|CCG-40207|HEXYLRESORCINOL [EP IMPURITY]|NSC757056|s4571|SBB056777|STL008005|HEXYLRESORCINOL [EP MONOGRAPH]|4-Hexylresorcinol, analytical standard|AKOS005683587|Tox21_111102_1|CS-4477|DB11254|FH44835|HEXYLRESORCINOL [USP MONOGRAPH]|NSC-757056|BENZENE,1,3-DIHYDROXY,4-HEXYL|IDI1_000094|QTL1_000043|SMP1_000009|NCGC00091208-01|NCGC00091208-02|NCGC00091208-03|NCGC00091208-05|NCGC00091208-06|NCGC00091208-07|NCGC00091208-09|NCGC00091208-11|NCGC00254302-01|NCGC00259812-01|AC-12698|AC-31726|AS-40438|DA-70096|NCI60_001129|SMR000112060|ST092340|SY057042|SBI-0051404.P003|H0139|NS00009746|EN300-77684|D04441|AB00052011_05|F236559|Q229969|SR-05000002054|SR-05000002054-1|BRD-K99946902-001-02-6|BRD-K99946902-001-07-5|Z1197943321|Hexylresorcinol, European Pharmacopoeia (EP) Reference Standard|Hexylresorcinol, United States Pharmacopeia (USP) Reference Standard|1-(2',4'-Dihydroxyphenyl)hexane;Hexylresorcinol;4-Hexyl-1,3-benzenediol|Hexylresorcinol for system suitability, EuropePharmacopoeia (EP) Reference Standard|InChI=1/C12H18O2/c1-2-3-4-5-6-10-7-8-11(13)9-12(10)14/h7-9,13-14H,2-6H2,1H"
NEMONAPRIDE,156333,,"InChI=1S/C21H26ClN3O2/c1-14-18(9-10-25(14)13-15-7-5-4-6-8-15)24-21(26)16-11-17(22)19(23-2)12-20(16)27-3/h4-8,11-12,14,18,23H,9-10,13H2,1-3H3,(H,24,26)/t14-,18-/m1/s1",KRVOJOCLBAAKSJ-RDTXWAMCSA-N,C21H26ClN3O2,387.9,"N-[(2R,3R)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide","nemonapride|75272-39-8|Emonapride|Emilace|YM-09151|Q88T5P3444|YM 09151-2|(+-)-cis-N-(1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide|Nemonaprida|YM-09151-2|DTXCID60809571|nemonapridum|Benzamide, 5-chloro-2-methoxy-4-(methylamino)-N-(2-methyl-1-(phenylmethyl)-3-pyrrolidinyl)-|cis-N-(1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-methylaminobenzamide|nemonapride, (cis)-|RefChem:832151|CHEBI:31899|5-chloro-2-methoxy-4-methylamino-N-(2-methyl-1-(phenylmethyl)pyrrolidin-3-yl)benzamide|DTXSID0042612|[3H]nemonapride|(+)-nemonapride|(2R,3R)-nemonapride|N-[(2R,3R)-1-benzyl-2-methylpyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide|N-(Cis-1-benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide|CHEBI:64219|187139-87-3|Nemonapride [INN:JAN]|UNII-Q88T5P3444|N-((2R,3R)-1-Benzyl-2-methylpyrrolidin-3-yl)-5-chloro-2-methoxy-4-(methylamino)benzamide|Emilace (TN)|Emilace; Emonapride;; YM09151; YM09151-2|Nemonapride (JAN/INN)|NEMONAPRIDE [MI]|NEMONAPRIDE [INN]|NEMONAPRIDE [JAN]|(+-)-cis-N-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-4-(methylamino)-o-anisamide|N-(2RS,3RS)-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-2-methoxy-4-methylaminobenzamide|NEMONAPRIDE [MART.]|GTPL962|NEMONAPRIDE [WHO-DD]|orb1704302|SCHEMBL1649724|SCHEMBL25247691|DTXSID601116422|BDBM50487259|MFCD00902138|PDSP1_001527|PDSP2_001511|AKOS030530697|FN26180|NCGC00371107-01|Benzamide, 5-chloro-2-methoxy-4-(methylamino)-N-((2R,3R)-2-methyl-1-(phenylmethyl)-3-pyrrolidinyl)-, rel-|Benzamide, 5-chloro-2-methoxy-4-(methylamino)-N-(2-methyl-1-(phenylmethyl)-3-pyrrolidinyl)-, cis-(+-)-|HY-103415|CS-0027847|NS00122958|D01468|SBI-0654094.0001|BRD-K47289124-001-02-6|(+/-)-cis-N-(1-Benzyl-2-methyl-3-pyrrolidinyl)-5-chloro-4-(methylamino)-o-anisamide|N-[(2R,3R)-1-benzyl-2-methyl-pyrrolidin-3-yl]-5-chloro-2-methoxy-4-(methylamino)benzamide|5-Chloro-2-methoxy-4-(methylamino)-N-[(2R,3R)-2-methyl-1-(phenylmethyl)-3-pyrrolidinyl]benzamide|5-chloro-2-methoxy-4-methylamino-N-[(2R,3R)-2-methyl-1-(phenylmethyl)pyrrolidin-3-yl]benzamide|BENZAMIDE, 5-CHLORO-2-METHOXY-4-(METHYLAMINO)-N-(2-METHYL-1- (PHENYLMETHYL)-3-PYRROLIDINYL)-, CIS-(+/-)-|rel-5-chloro-2-methoxy-4-(methylamino)-N-[(2R,3R)-2-methyl-2-(phennylmethyl)-3-pyrrolidinyl]benzamide"
PAPAVERINE,4680,,"InChI=1S/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H3",XQYZDYMELSJDRZ-UHFFFAOYSA-N,C20H21NO4,339.4,"1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline","papaverine|58-74-2|Robaxapap|6,7-Dimethoxy-1-veratrylisoquinoline|1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinoline|Pavacap|Pavatym|1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxyisoquinoline|Papaverinum|Isoquinoline, 1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-|DAA13NKG2Q|1-((3,4-Dimethoxyphenyl)methyl)-6,7-dimethoxyisoquinoline|NSC-136630|CHEBI:28241|Isoquinoline, 1-((3,4-dimethoxyphenyl)methyl)-6,7-dimethoxy-|DTXSID4023418|NSC136630|RefChem:56338|DTXCID603418|200-397-2|Papaverin|Papanerine|Papanerin|Cerespan|Pavabid|Papaverina|Papaverine [BAN]|Papaverine free base|NSC 136630|Isoquinoline, 6,7-dimethoxy-1-veratryl-|S-M-R|Papaverine (BAN)|1-[(3,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-isoquinoline|58-74-2 (free base)|CHEMBL19224|4-[(6,7-Dimethoxyisoquinolyl)methyl]-1,2-dimethoxybenzene|HSDB 3147|Pavacot|Papaverina [Italian]|Ceraspan|Mesotina (TN)|EV1|CAS-61-25-6|NCGC00015810-02|EINECS 200-397-2|UNII-DAA13NKG2Q|BRN 0312930|Pavadyl|2wey|RS 47|TNP00305|Spectrum_000071|PAPAVERINE [MI]|Prestwick0_000583|Prestwick1_000583|Prestwick2_000583|Prestwick3_000583|Spectrum2_000978|Spectrum3_000537|Spectrum4_000467|Spectrum5_001188|Lopac-P-3510|PAPAVERINE [VANDF]|PAPAVERINUM [HPUS]|Isoquinoline, 6,7-dimethoxy-1-veratryl-(8Cl)|PAPAVERINE [MART.]|PAPAVERINE [WHO-DD]|Lopac0_000957|Oprea1_387689|Oprea1_810508|SCHEMBL34702|BSPBio_000426|BSPBio_002153|KBioGR_000914|KBioSS_000471|5-21-06-00182 (Beilstein Handbook Reference)|DivK1c_000321|6,7-Dimethoxy-1-(3,4-dimethoxybenzyl)isoquinoline|SPBio_001015|SPBio_002645|BPBio1_000470|MEGxp0_001880|SCHEMBL29360983|SCHEMBL29387160|ACon1_000238|ACon1_002094|BDBM14754|GTPL13147|KBio1_000321|KBio2_000471|KBio2_003039|KBio2_005607|KBio3_001653|1-[(3,4-Dimethoxyphenyl)methyl]6,7-dimethoxyisoquinoline|NINDS_000321|HMS3561N11|HMS3746M21|ALBB-010475|1-{[3,4-bis(methyloxy)phenyl]methyl}-6,7-bis(methyloxy)isoquinoline|BBL012345|MFCD00024138|STK039035|Isoquinoline,7-dimethoxy-1-veratryl-|AKOS000277460|CCG-202821|CS-7800|DB01113|KS-5336|SDCCGMLS-0003037.P003|SDCCGSBI-0050931.P005|IDI1_000321|NCGC00015810-01|NCGC00015810-03|NCGC00015810-04|NCGC00015810-05|NCGC00015810-06|NCGC00015810-07|NCGC00015810-08|NCGC00015810-09|NCGC00015810-13|NCGC00015810-24|NCGC00015810-29|NCGC00024428-03|NCGC00024428-04|HY-18077|NCI60_003183|Papaverine 100 microg/mL in Acetonitrile|ST023301|NOSCAPINE IMPURITY A [EP IMPURITY]|SBI-0050931.P004|DB-053252|AB00053515|NS00007287|C06533|D07425|EN300-177755|AB00053515_14|WLN: T66 CNJ B1R CO1 DO1& HO1 IO1|AG-205/03660043|Q410374|6,7-dimethoxy-1-veratryl-isoquinoline;hydrochloride|1-(3,4-Dimethoxybenzyl)-6,7-dimethoxyisoquinoline #|BRD-K15567136-001-01-1|BRD-K15567136-003-06-6|BRD-K15567136-003-18-1|BRD-K15567136-003-27-2|Isoquinoline,4-dimethoxyphenyl)methyl]-6,7-dimethoxy-|SR-01000003098-10|InChI=1/C20H21NO4/c1-22-17-6-5-13(10-18(17)23-2)9-16-15-12-20(25-4)19(24-3)11-14(15)7-8-21-16/h5-8,10-12H,9H2,1-4H"
EVATANEPAG,9890801,,"InChI=1S/C25H28N2O5S/c1-25(2,3)21-11-9-19(10-12-21)16-27(33(30,31)23-8-5-13-26-15-23)17-20-6-4-7-22(14-20)32-18-24(28)29/h4-15H,16-18H2,1-3H3,(H,28,29)",WOHRHWDYFNWPNG-UHFFFAOYSA-N,C25H28N2O5S,468.6,2-[3-[[(4-tert-butylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetic acid,"Evatanepag|223488-57-1|CP-533536|CP-533,536|CP533536|L266R6E31E|2-[3-[[(4-tert-butylphenyl)methyl-pyridin-3-ylsulfonylamino]methyl]phenoxy]acetic acid|2-(3-((((4-(1,1-dimethylethyl)phenyl)methyl)(pyridin-3-ylsulfonyl)amino)methyl)phenoxy)acetic acid|Acetic acid, 2-(3-((((4-(1,1-dimethylethyl)phenyl)methyl)(3-pyridinylsulfonyl)amino)methyl)phenoxy)-|evatanepagum|2-(3-(((4-tert-butylphenyl)methyl-pyridin-3-ylsulfonylamino)methyl)phenoxy)acetic acid|2-(3-((N-((4-tert-butylphenyl)methyl)pyridine-3-sulfonamido)methyl)phenoxy)acetic acid|2-[3-({N-[(4-tert-butylphenyl)methyl]pyridine-3-sulfonamido}methyl)phenoxy]acetic acid|RefChem:921400|(3-((4-tert-butylbenzyl)-(pyridine-3-sulfonylamino)methyl)phenoxy)acetic acid|CP-533536 free acid|2-(3-((N-(4-(tert-butyl)benzyl)pyridine-3-sulfonamido)methyl)phenoxy)acetic acid|2-[3-[N-(4-tert-Butylbenzyl)-N-(pyridin-3-ylsulfonyl)aminomethyl]phenoxy]acetic acid|MFCD09833940|CHEMBL563646|2-[3-[[(4-~{tert}-butylphenyl)methyl-pyridin-3-ylsulfonyl-amino]methyl]phenoxy]ethanoic acid|Evatanepag [USAN:INN]|UNII-L266R6E31E|2-[3-[[N-[4-(tert-Butyl)benzyl]pyridine-3-sulfonamido]methyl]phenoxy]acetic Acid|EVATANEPAG [INN]|Evatanepag (USAN/INN)|EVATANEPAG [USAN]|EVATANEPAG [WHO-DD]|SCHEMBL533264|GTPL1929|orb1308320|Evatanepag (CP-533536)?|SCHEMBL29376960|C25H28N2O5S|DTXSID20945000|CHEBI:177472|WOHRHWDYFNWPNG-UHFFFAOYSA-N|BCP16478|EX-A2354|Evatanepag; CP-533536 free acid|BDBM50293496|AKOS030526731|CS-5571|DB12022|2-[3-[[(4-tert-butylphenyl)methyl-(3-pyridylsulfonyl)amino]methyl]phenoxy]acetic acid|AC-33701|BS-51414|CJ042794|DA-73265|FT145127|HY-14839|SY263729|NS00068508|D09613|N16936|488C571|AU-075/43517630|BRD-K11452913-001-01-9|Q27077249|(3-(((4-tert-butyl-benzyl)-(pyridine-3-sulfonyl)-amino)-methyl)-phenoxy)-acetic acid|(3-{[(4-tert-butylbenzyl)(3-pyridinylsulfonyl)amino]methyl}phenoxy)acetic acid|[3-({[(4-tert-Butylphenyl)methyl](pyridine-3-sulfonyl)amino}methyl)phenoxy]acetic acid|2-(3-((N-(4-tert-butylbenzyl)pyridine-3-sulfonamido)methyl)phenoxy)acetic acid|2-[3-[[(4-tert-butylphenyl)methyl-pyridin-3-ylsulonylamino]methyl]phenoxy]acetic acid|Gm9"
LINSITINIB,11640390,,"InChI=1S/C26H23N5O/c1-26(32)14-19(15-26)25-30-22(23-24(27)28-11-12-31(23)25)18-8-7-17-9-10-20(29-21(17)13-18)16-5-3-2-4-6-16/h2-13,19,32H,14-15H2,1H3,(H2,27,28)",PKCDDUHJAFVJJB-UHFFFAOYSA-N,C26H23N5O,421.5,"3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol","OSI-906|OSI 906|RefChem:928309|Linsitinib|867160-71-2|OSI-906 (Linsitinib)|Linsitinib(OSI-906)|OSI906|OSI-906AA|ASP-7487|3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol|MFCD12912153|15A52GPT8T|CHEMBL1091644|MMV676605|Cis-3-(8-Amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutan-1-ol|cis-3-(8-amino-1-(2-phenyl-7-quinolinyl)imidazo(1,5-a)pyrazin-3-yl)-1-methylcyclobutanol|cis-3-[8-Amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol|(1r,3r)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol.|Linsitinib [USAN]|C26H23N5O|Kinome_3532|Linsitinib [USAN:INN]|UNII-15A52GPT8T|cis-3-(8-Amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol|cis-3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol|CIS-3-(8-AMINO-1-(2-PHENYLQUINOLIN-7-YL)IMIDAZO(1,5-A)PYRAZIN-3-YL)-1-METHYLCYCLOBUTAN-1-OL|Linsitinib; OSI-906|LINSITINIB [INN]|Linsitinib (USAN/INN)|Linsitinib (OSI-906)|Linsitinib(OSI-906)?|LINSITINIB [WHO-DD]|MLS006010304|SCHEMBL400369|SCHEMBL400734|SCHEMBL400735|GTPL7423|orb1301148|CHEMBL1996234|SCHEMBL10255925|SCHEMBL29392484|CHEBI:91402|EX-A719|BCPP000137|BDBM185150|DTXSID401007055|DTXSID901121553|HMS3295G15|HMS3654C19|BCP01831|BDBM50315887|NSC756652|NSC800784|s1091|AKOS024464740|BCP9001035|CCG-264815|CS-0242|DB06075|FO65116|NSC-756652|NSC-800784|PB22643|SDCCGSBI-0646932.P001|NCGC00250375-02|NCGC00250375-03|NCGC00250375-11|NCGC00250375-14|(1s,3s)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutan-1-ol|(1s,3s)-3-(8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol|AC-26953|AS-16999|HY-10191|SMR004700744|NS00073285|SW218150-2|D09925|SR-05000022538|Q6554803|SR-05000022538-1|BRD-K07667918-001-01-3|BRD-K86118762-001-01-8|BRD-K86118762-001-05-9|Q27163260|3-[8-amino-1-(2-phenyl-7-quinolinyl)-3-imidazo[1,5-a]pyrazinyl]-1-methyl-1-cyclobutanol|3-[8-amino-1-(2-phenyl-7-quinolyl)imidazo[1,5-a]pyrazin-3-yl]-1-methyl-cyclobutanol|(1s,3r)-3-[8-amino-1-(2-phenylquinolin-7-yl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutan-1-ol|1356958-77-4|3-(8-amino-1-(2-phenylquinolin-7-yl)-2,3-dihydroimidazo[1,5-a]pyrazin-3-yl)-1-methylcyclobutanol|3-[8-AMINO-1-(2-PHENYL-QUINOLIN-7-YL)-IMIDAZO[1,5-A]PYRAZIN-3-YL]-1-METHYL-CYCLOBUTANOL|867160-72-3|cis-3-[8-Amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol; OSI 906; OSI 906AA;|CYCLOBUTANOL, 3-(8-AMINO-1-(2-PHENYL-7-QUINOLINYL)IMIDAZO(1,5-A)PYRAZIN-3-YL)-1-METHYL-, CIS-|trans-3-[8-Amino-1-(2-phenyl-7-quinolinyl)imidazo[1,5-a]pyrazin-3-yl]-1-methylcyclobutanol"
TICAGRELOR,9871419,,"InChI=1S/C23H28F2N6O4S/c1-2-7-36-23-27-21(26-15-9-12(15)11-3-4-13(24)14(25)8-11)18-22(28-23)31(30-29-18)16-10-17(35-6-5-32)20(34)19(16)33/h3-4,8,12,15-17,19-20,32-34H,2,5-7,9-10H2,1H3,(H,26,27,28)/t12-,15+,16+,17-,19-,20+/m0/s1",OEKWJQXRCDYSHL-FNOIDJSQSA-N,C23H28F2N6O4S,522.6,"(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol","Ticagrelor|274693-27-5|Brilinta|Brilique|AZD6140|Possia|AZD-6140|AR-C126532XX|AZD 6140|GLH0314RVC|CHEBI:68558|DTXSID901009337|(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|1,2-Cyclopentanediol, 3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-1,2,3-triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)-, (1S,2S,3R,5S)-|(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|(1S,2S,3R,5S)-3-(7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|ticagrelorum|(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylsulfanyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-propylsulfanyltriazolo(5,4-d)pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[5,4-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|(1S,2S,3R,5S)-3-[7-{[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino}-5-(propylsulfanyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|RefChem:56923|B01AC24|DTXCID501436166|TICARGRELOR|MFCD09954148|(1S,2S,3R,5S)-3-(7-(((1R,2S)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|1,2-Cyclopentanediol,3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-,(1S,2S,3R,5S)-|C23H28F2N6O4S|(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyltriazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|Ticagrelor  Form|(1S,2S,3R,5S)-3-[7-[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropylamino]-5-(propylthio)- 3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|Ticagrelor [USAN]|UNII-GLH0314RVC|Tigacrelor|Ticagrelor [USAN:INN:BAN]|Brilinta (TN)|(1S,2S,3R,5S)-3-(7-(((1R)-2-(3,4-Difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|AR-C126532|Ticagrelor (Standard)|TICAGRELOR [MI]|TICAGRELOR [INN]|TICAGRELOR [JAN]|TICAGRELOR [VANDF]|TICAGRELOR [MART.]|TICAGRELOR [USP-RS]|TICAGRELOR [WHO-DD]|(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-DIFLUOROPHENYL)CYCLOPROPYL]AMINO]-5-(PROPYLTHIO)-3H-1,2,3-TRIAZOLO[4,5-D]PYRIMIDIN-3-YL]-5-(2-HYDROXYETHOXY)-1,2-CYCLOPENTANEDIOL|Ticagrelor (JAN/USAN/INN)|TICAGRELOR [EMA EPAR]|CHEMBL398435|GTPL1765|orb1310865|SCHEMBL1979652|Ticagrelor - Bio-X trade mark|SCHEMBL29349795|TICAGRELOR [ORANGE BOOK]|HSDB 8306|EX-A503|Ticagrelor (Brilinta,AZD6140)|TICAGRELOR [EP MONOGRAPH]|HMS3885B03|MSK10410|BDBM50397205|HY-10064R|s4079|AKOS015900739|CCG-269870|CS-0619|DB08816|EX-6274|FD29104|AR-C 126532XX;AZD6140|compound 17 [PMID: 17827008]|NCGC00379052-01|NCGC00379052-02|NCGC00379052-04|(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-difluorophenyl)cyclopropyl]amino]-5-propylsulfanyl-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)cyclopentane-1,2-diol|AC-24755|AS-19943|BT164470|HY-10064|NS00098771|D09017|AB01565855_02|693T275|EN300-19659674|Q420542|Z2235802088|(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy) cyclopentane-1,2-diol|(1S,2S,3R,5S)-3-(7-((1R,2S)-2-(3,4-difluorophenyl)cyclopropylamino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2 diol|(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-D1,2-Cyclopentanediolifluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol|(1s,2s,3r,5s)-3-[7-[[(1r,2s)-2-(3,4-difluorophenyl)-cyclopropyl]amino]-5-(propylthio)-3h-[1,2,3]-triazolo[4,5-d]pyrimidine-3-yl]-5-(2-hydroxyethoxy) cyclopentane-1,2-diol|(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-D]pyrimidin-3-yl]-5-(2-hy  droxyethoxy)-1,2-cyclopentanediol|(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-D]pyrimidin-3-yl]-5-(2-hy droxyethoxy)-1,2-cyclopentanediol"
MEXILETINE,4178,,"InChI=1S/C11H17NO/c1-8-5-4-6-9(2)11(8)13-7-10(3)12/h4-6,10H,7,12H2,1-3H3",VLPIATFUUWWMKC-UHFFFAOYSA-N,C11H17NO,179.26,"1-(2,6-dimethylphenoxy)propan-2-amine","Mexiletine|31828-71-4|1-(2,6-dimethylphenoxy)propan-2-amine|Mexiletina|1-(2,6-Dimethylphenoxy)-2-propanamine|Mexiletinum|2-Propanamine, 1-(2,6-dimethylphenoxy)-|dl-mexiletine|(RS)-Mexiletine|1-Methyl-2-(2,6-xylyloxy)ethylamine|ETHYLAMINE, 1-METHYL-2-(2,6-XYLYLOXY)-|1-(2',6'-Dimethylphenoxy)-2-aminopropane|2-(2-aminopropoxy)-1,3-dimethylbenzene|1-methyl-2-(2,6-xylyloxy)ethanamine|1U511HHV4Z|CHEBI:6916|(2RS)-1-(2,6-dimethylphenoxy)-2-aminopropane|DTXSID8048446|(+-)-1-(2,6-dimethylphenoxy)propan-2-amine|Mexityl|mexiletin hydrochloride|Novo Mexiletine|Mexitil PL|RefChem:56491|DTXCID8028420|C01BB02|250-825-7|Mexitil|Mexiletinum [INN-Latin]|Mexiletina [INN-Spanish]|1-(2,6-Dimethylphenoxy)-2-aminopropane|Mexiletine (INN)|CHEMBL558|Mexilitine|MFCD00792471|2-Amino-1-(2,6-dimethylphenoxy)propane|MEXILETINE [INN]|Mexiletine [INN:BAN]|(+/-)-Mexiletine|NCGC00015659-06|EINECS 250-825-7|BRN 2092205|UNII-1U511HHV4Z|Mexitil (Salt/Mix)|1-(2,4-Dimethylphenoxy)-2-propanamine|Spectrum_001602|MEXILETINE [MI]|Prestwick0_000241|Prestwick1_000241|Prestwick2_000241|Prestwick3_000241|Spectrum3_000727|Spectrum4_000795|Spectrum5_001279|MEXILETINE [VANDF]|MEXILETINE [WHO-DD]|Lopac0_000784|SCHEMBL16081|BSPBio_000022|BSPBio_002254|KBioGR_001270|KBioSS_002082|DivK1c_000834|SPBio_002241|BPBio1_000026|GTPL2629|orb1705062|KBio1_000834|KBio2_002082|KBio2_004650|KBio2_007218|KBio3_001474|NINDS_000834|Mexiletine hydrochloride (Salt/Mix)|BDBM50117271|SBB070242|AKOS015890265|CCG-204869|DB00379|SB45974|SB45976|SDCCGSBI-0050762.P004|1-(2,6-dimethylphenoxy)prop-2-ylamine|IDI1_000834|NCGC00015659-02|NCGC00015659-03|NCGC00015659-04|NCGC00015659-05|NCGC00015659-07|NCGC00015659-08|NCGC00015659-09|NCGC00015659-10|NCGC00015659-11|NCGC00015659-13|NCGC00015659-23|NCGC00162253-01|NCGC00162253-02|1-(2,6-dimethylphenoxy)-2-propanolamine|FM153231|SBI-0050762.P003|2-(2,6-dimethylphenoxy)-1-methylethylamine|AB00053683|CS-0068642|NS00008331|2-(2,6-dimethylphenoxy)-1-methyl-ethylamine|EN300-54300|2-(2,6-Dimethyl-phenoxy)-1-methyl-ethylamine|C07220|D08215|H40619|(+/-)-1-(2,6-dimethylphenoxy)propan-2-amine|AB00053683_10|AB00053683_11|828M714|Q420377|BRD-A64092382-003-04-3|BRD-A64092382-003-09-2|BRD-A64092382-003-16-7|BRD-A64092382-003-17-5|BRD-A64092382-003-18-3|(+/-)-2-AMINO-1-(2',6'-DIMETHYLPHENOXY)PROPANE|(2-((2,6-DIMETHYLPHENYL)OXY)-1-METHYLETHYL)AMINE|2-(2,6-Dimethyl-phenoxy)-1-methyl-ethylamine(Mexiletine)|2-(2-Aminopropoxy)-1,3-dimethylbenzene;1-(2,6-Dimethylphenoxy)-2-propanamine"
AMG-208,24864821,,"InChI=1S/C22H17N5O2/c1-28-16-7-8-17-19(13-16)23-12-11-20(17)29-14-22-25-24-21-10-9-18(26-27(21)22)15-5-3-2-4-6-15/h2-13H,14H2,1H3",HEAIZQNMNCHNFD-UHFFFAOYSA-N,C22H17N5O2,383.4,"7-methoxy-4-[(6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline","AMG-208|1002304-34-8|AMG208|AMG 208|7-methoxy-4-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy)quinoline|Y2SR66P7VM|7-methoxy-4-[(6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline|CHEBI:90626|Quinoline, 7-methoxy-4-[(6-phenyl-1,2,4-triazolo[4,3-b]pyridazin-3-yl)methoxy]-|AMG 208 [WHO-DD]|DTXSID70143039|7-methoxy-4-[(6-phenyl[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]quinoline|7-methoxy-4-({6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl}methoxy)quinoline|4-((6-PHENYL-(1,2,4)TRIAZOLO(4,3-B)PYRIDAZIN-3-YL)METHOXY)-7-METHOXYQUINOLINE|4-[(6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy]-7-methoxyquinoline|QUINOLINE, 7-METHOXY-4-((6-PHENYL-1,2,4-TRIAZOLO(4,3-B)PYRIDAZIN-3-YL)METHOXY)-|7-methoxy-4-((6-phenyl(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methoxy)quinoline|7-methoxy-4-((6-phenyl-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methoxy)quinoline|RefChem:556946|DTXCID3065530|C-MET INHIBITOR AMG 208|UNII-Y2SR66P7VM|C22H17N5O2|Triazolopyridazine, 4|3cd8|CHEMBL496102|orb1300928|SCHEMBL9910136|SCHEMBL30274835|BDBM24470|AMG-208?|BCP01384|EX-A4656|NSC766288|NSC801016|s1316|AKOS015852294|BCP9000287|CS-0185|DB08079|NSC-766288|NSC-801016|SB16605|SDCCGSBI-0654444.P001|NCGC00346507-01|NCGC00346507-07|AC-26862|BS-14142|HY-12035|DB-058331|NS00072073|D70856|BRD-K32285926-001-02-1|Q27097309|-methoxy-4-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy)quinoline|7-methoxy-4-({6-phenyl-[1,2,4]triazolo[4,3-a]pyridazin-3-yl}methoxy)quinoline|7-methoxy-4-((6-phenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methylphenyl-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methoxy)quinoline"
MK-2461,44137946,,"InChI=1S/C24H25N5O5S/c1-28-13-18(12-26-28)17-9-22-23(25-11-17)6-4-16-3-5-19(10-21(16)24(22)30)27-35(31,32)29(2)14-20-15-33-7-8-34-20/h3-6,9-13,20,27H,7-8,14-15H2,1-2H3/t20-/m1/s1",JGEBLDKNWBUGRZ-HXUWFJFHSA-N,C24H25N5O5S,495.6,"14-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene","MK-2461|917879-39-1|MK 2461|MK2461|UNII-4200RD53XF|4200RD53XF|9-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-2-(1-methylpyrazol-4-yl)-11-oxobenzo[1,2]cyclohepta[2,4-b]pyridine|Sulfamide, N-((2R)-1,4-dioxan-2-ylmethyl)-N-methyl-N'-(3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo(4,5)cyclohepta(1,2-b)pyridin-7-yl)-|9-((((2R)-1,4-dioxan-2-yl)methyl-methylsulfamoyl)amino)-2-(1-methylpyrazol-4-yl)-11-oxobenzo(1,2)cyclohepta(2,4-b)pyridine|Sulfamide, N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N'-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-|RefChem:159191|1196681-15-8|n-((2r)-1,4-dioxan-2-ylmethyl)-n-methyl-n'-[3-(1-methyl-1h-pyrazol-4-yl)-5-oxo-5h-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide|N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N'-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfamide|14-[[[(2R)-1,4-dioxan-2-yl]methyl-methylsulfamoyl]amino]-5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene|C24H25N5O5S|JGEBLDKNWBUGRZ-HXUWFJFHSA-N|SCHEMBL93526|GTPL7962|orb1689093|CHEMBL1802916|CHEMBL1822792|SCHEMBL29356324|SCHEMBL29394185|SCHEMBL29529144|CHEBI:230540|EX-A1566|SLB87939|BDBM50347659|MFCD11977739|NSC764580|NSC800795|s2774|AKOS027282698|CCG-264723|CS-5537|NSC-764580|NSC-800795|SDCCGSBI-0654470.P001|NCGC00346695-01|NCGC00346695-02|NCGC00346695-05|AC-32072|AS-16288|DA-65500|HY-50703|SW219905-1|F85378|BRD-K56405753-001-02-4|Q27086785|14-[[[(2R)-1,4-dioxan-2-yl]methyl-methyl-sulfamoyl]amino]-5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene|N-[(2R)-1,4-dioxan-2-ylmethyl]-N-methyl-N'-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]sulfuric diamide"
CRIZOTINIB,11626560,,"InChI=1S/C21H22Cl2FN5O/c1-12(19-16(22)2-3-17(24)20(19)23)30-18-8-13(9-27-21(18)25)14-10-28-29(11-14)15-4-6-26-7-5-15/h2-3,8-12,15,26H,4-7H2,1H3,(H2,25,27)/t12-/m1/s1",KTEIFNKAUNYNJU-GFCCVEGCSA-N,C21H22Cl2FN5O,450.3,"3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine","Crizotinib|877399-52-5|Xalkori|(R)-crizotinib|PF-02341066|PF-2341066|PF 2341066|(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine|crizotinibum|PF 02341066|CHEBI:64310|PF2341066|53AH36668S|NSC-756645|DTXSID701009329|3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)-1H-pyrazol-4-yl]pyridin-2-amine|2-Pyridinamine, 3-((1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(4-piperidinyl)-1H-pyrazol-4-yl)-|2-PYRIDINAMINE, 3-[(1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY]-5-[1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YL]-|3-((1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY)-5-(1-(PIPERIDIN-4-YL)-1H-PYRAZOL-4-YL)PYRIDIN-2-AMINE|RefChem:57397|PF02341066|L01XE16|DTXCID601436157|MET Tyrosine Kinase Inhibitor PF-02341066|638-814-9|Crizotinib (PF-02341066)|3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]-2-pyridinamine|MFCD12407409|3-[(1R)-1-(2,6-DICHLORO-3-FLUOROPHENYL)ETHOXY]-5-[1-(4-PIPERIDINYL)-1H-PYRAZOL-4-YL]PYRIDIN-2-AMINE|CHEMBL601719|Crizotinib (PF-2341066)|877399-52-5 (free base)|C21H22Cl2FN5O|3-[(1r)-1-(2,6-Dichloro-3-Fluorophenyl)ethoxy]-5-(1-Piperidin-4-Yl-1h-Pyrazol-4-Yl)pyridin-2-Amine|3-[(1R)-1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-(1-piperidin-4-ylpyrazol-4-yl)pyridin-2-amine|Xalkori (TN)|Crizotinib [USAN]|Crizotinib [USAN:INN]|UNII-53AH36668S|VGH|Crizotinib (Standard)|CRIZOTINIB [MI]|CRIZOTINIB [INN]|CRIZOTINIB [JAN]|CRIZOTINIB [VANDF]|CRIZOTINIB [MART.]|CRIZOTINIB [WHO-DD]|SCHEMBL93829|PF-2341066,Crizotinib|Crizotinib (JAN/USAN/INN)|Crizotinib - Bio-X trade mark|GTPL4903|orb1307848|CRIZOTINIB [ORANGE BOOK]|Crizotinib, >=98% (HPLC)|SCHEMBL29351506|SCHEMBL29622387|EX-A096|Crizotinib (PF-2341066)?|KTEIFNKAUNYNJU-GFCCVEGCSA-N|BCPP000116|GLXC-04599|MSK10718|PF 2341066;(R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine|BDBM50306682|HY-50878R|NSC749005|NSC749769|NSC800080|AKOS015901233|AKOS015995207|CCG-264803|DB08865|FD20585|GS-6178|NSC 756645|NSC-749005|NSC-749769|NSC-800080|SDCCGSBI-0647655.P002|NCGC00250400-01|NCGC00250400-02|NCGC00250400-09|NCGC00250400-12|BC164334|BP-43636|HY-50878|NS00072165|SW202555-3|D09731|399P525|F793129|Q5186964|BRD-K78431006-001-01-1|BRD-K78431006-001-03-7|BRD-K78431006-001-10-2|BRD-K78431006-001-11-0|877399-52-5, 877399-53-6 (acetate)|Z2065417924|3-(2,6-dichloro-3-fluorobenzyloxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-amine|(R)-3-(1-(2,6-dichloro-3-fluorophenyl)ethoxy)-5-(1-(piperidin-4-yl)-1H-pyrazol-4-yl)pyridin-2-am ine|(R)-3-[1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine|3-[(1R)-1-(2,6-dichloro-3-fluoro-phenyl)ethoxy]-5-[1-(4-piperidyl)pyrazol-4-yl]pyridin-2-amine|3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyra zol-4-yl]-2-pyridinamine|3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine;(R)-3-[1-(2,6-Dichloro-3-fluorop  henyl)ethoxy]-5-(1-piperidin-4-yl-1H- pyrazol-4-yl)pyridin-2-ylamine;PF 02341066|3-[(1R)-1-(2,6-Dichloro-3-fluorophenyl)ethoxy]-5-[1-(4-piperidinyl)-1H-pyrazol-4-yl]pyridin-2-amine;(R)-3-[1-(2,6-Dichloro-3-fluorop henyl)ethoxy]-5-(1-piperidin-4-yl-1H- pyrazol-4-yl)pyridin-2-ylamine;PF 02341066|3-[(R)-1-(2,6-Dichloro-3-fluoro-phenyl)-ethoxy]-5-(1-piperidin-4-yl-1H-pyrazol-4-yl)-pyridin-2-ylamine"
OSI-632,9811611,,"InChI=1S/C20H24BrF2N5O3S/c21-12-9-14(22)13(15(23)10-12)11-31-18-16(17(24)29)19(32-27-18)26-20(30)25-5-1-2-6-28-7-3-4-8-28/h9-10H,1-8,11H2,(H2,24,29)(H2,25,26,30)",HXHAJRMTJXHJJZ-UHFFFAOYSA-N,C20H24BrF2N5O3S,532.4,"3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-(4-pyrrolidin-1-ylbutylcarbamoylamino)-1,2-thiazole-4-carboxamide","252003-65-9|CP-547632|CP 547632|CP-547,632|OSI-632|3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-(4-pyrrolidin-1-ylbutylcarbamoylamino)-1,2-thiazole-4-carboxamide|CP547632|W1B375O5M2|PAN90806|CP-632|PAN 90806|PAN-90806|4-Isothiazolecarboxamide, 3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-[[[[4-(1-pyrrolidinyl)butyl]amino]carbonyl]amino]-|DTXSID00179866|4-Isothiazolecarboxamide, 3-((4-bromo-2,6-difluorophenyl)methoxy)-5-((((4-(1-pyrrolidinyl)butyl)amino)carbonyl)amino)-|CP 547,632|3-((4-bromo-2,6-difluorophenyl)methoxy)-5-(4-pyrrolidin-1-ylbutylcarbamoylamino)-1,2-thiazole-4-carboxamide|RefChem:919128|DTXCID60102357|CP547,632|3-((4-Bromo-2,6-difluorobenzyl)oxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide|CHEMBL253969|Kinome_3755|3-[(4-BROMO-2,6-DIFLUOROBENZYL)OXY]-5-[3-[4-(PYRROLIDIN-1-YL)BUTYL]UREIDO]ISOTHIAZOLE-4-CARBOXAMIDE|3-[(4-bromo-2,6-difluorobenzyl)oxy]-5-{[(4-pyrrolidin-1-ylbutyl)carbamoyl]amino}isothiazole-4-carboxamide|3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-[[[[4-(1-pyrrolidinyl)butyl]amino]carbonyl]amino]-4-isothiazolecarboxamide|C20H24BrF2N5O3S|UNII-W1B375O5M2|HXHAJRMTJXHJJZ-UHFFFAOYSA-N|3-(4-Bromo-2,6-difluorobenzyloxy)-5-(3-(4-pyrrolidin-1-ylbutyl)ureido)isothiazole-4-carboxylic acid amide|SCHEMBL187261|GTPL7881|orb1709995|BDBM25115|GLXC-15617|BCP22974|EX-A11159|NSC800077|AKOS016008145|BCP9000545|DB12962|NSC-800077|NCGC00263100-01|NCGC00263100-02|NCGC00263100-04|3-(4-bromo-2,6-difluorobenzyloxy)-5-(3-(4-(pyrrolidin-1-yl)butyl)ureido)isothiazole-4-carboxamide|3-[(4-bromo-2,6-difluorophenyl)methoxy]-5-({[4-(pyrrolidin-1-yl)butyl]carbamoyl}amino)-1,2-thiazole-4-carboxamide|AC-25487|BFF|HY-13302|MS-29834|BCP0726000165|CP-547632?|CS-0003189|NS00069383|CP547632, 24|003B659|Q27076896|3-(4-Bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1-yl-butyl)-ureido]-isothiazole-4-carboxylic acid amide|3-(4-Bromo-2,6-difluoro-benzyloxy)-5-[3-(4-pyrrolidin-1yl-butyl)-ureido]-isothiazole-4-carboxylic Acid Amide"
ACESULFAME,36573,,"InChI=1S/C4H5NO4S/c1-3-2-4(6)5-10(7,8)9-3/h2H,1H3,(H,5,6)",YGCFIWIQZPHFLU-UHFFFAOYSA-N,C4H5NO4S,163.15,"6-methyl-2,2-dioxooxathiazin-4-one","ACESULFAME|33665-90-6|Acetosulfam|Acesulfamo|6-Methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide|Acesulfamum|6-methyl-2,2-dioxooxathiazin-4-one|6-Methyl-3,4-dihydro-1,2,3-oxathiazin-4-one 2,2-dioxide|acetosulfame|Acesulfam|CHEBI:83501|MA3UYZ6K1H|6-Methyl-1,2,3-oxathiazin-4(3H)-on 2,2-dioxid|1,2,3-Oxathiazin-4(3H)-one, 6-methyl-, 2,2-dioxide|3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one-2,2-dioxide|DTXSID0048006|6-methyl-3,4-dihydro-1,2$l^(6),3-oxathiazine-2,2,4-trione|6-methyl-3,4-dihydro-1,2$l^{6},3-oxathiazine-2,2,4-trione|acesulfame sodium|acetosulfame calcium|acetosulfam potassium|RefChem:551477|acetosulfam, potassium salt|DTXCID0027983|3,4-dihydro-6-methyl-1,2,3-oxathiazin-4-one-2,2-dioxide potassium salt|251-622-6|6-methyl-3,4-dihydro-1,2lambda6,3-oxathiazine-2,2,4-trione|6-methyl-3,4-dihydro-1,2??,3-oxathiazine-2,2,4-trione|Acesulfame [BAN:INN]|Acesulfame [INN:BAN]|Acesulfamum [INN-Latin]|UNII-MA3UYZ6K1H|Acesulfamo [INN-Spanish]|C4H5NO4S|HSDB 3914|AUD|Acesulfame Form II|EINECS 251-622-6|6-methyl-2,2-dioxo-oxathiazin-4-one|3,4-Dihydro-6-methyl-1,2,3-oxathiazin-4-one 2,2-dioxide|ACESULFAME [II]|ACESULFAME [MI]|ACESULFAME [INN]|ACESULFAME [HSDB]|SCHEMBL3551|ACESULFAME [WHO-DD]|CHEMBL176687|SCHEMBL12166504|GTPL12460|BBL036697|BDBM50367132|STL559076|AKOS006273139|HY-W550739|VS-13634|CS-0662986|NS00000381|E80533|EN300-6979374|Q2823822|BRD-K50850824-237-02-2|BRD-K50850824-237-03-0|BRD-K50850824-237-04-8|Z1198155502|6-Methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide, 9CI|6-methyl-2H-1,2lambda~6~,3-oxathiazine-2,2,4(3H)-trione|6-methyl-3,4-dihydro-1,2,3-oxa-thiazin-4-one 2,2-dioxide"
CLOTRIMAZOLE,2812,,"InChI=1S/C22H17ClN2/c23-21-14-8-7-13-20(21)22(25-16-15-24-17-25,18-9-3-1-4-10-18)19-11-5-2-6-12-19/h1-17H",VNFPBHJOKIVQEB-UHFFFAOYSA-N,C22H17ClN2,344.8,1-[(2-chlorophenyl)-diphenylmethyl]imidazole,"clotrimazole|23593-75-1|Lotrimin|Canesten|Mycelex|Clotrimazol|Mycosporin|Empecid|Mykosporin|Gyne lotrimin|Chlotrimazole|Trimysten|Gyne-Lotrimin|Mycelex G|Rimazole|Tibatin|Gynix|Mono-baycuten|Mycelex Troches|1-(o-Chlorotrityl)imidazole|Pedisafe|Veltrim|Trivagizole 3|Desamix F|Mycelex-G|Clotrimazolum|Gyne-Lotrimin 3|Monobaycuten|Mycelex-7|Canifug|1-((2-Chlorophenyl)diphenylmethyl)-1H-imidazole|(Chlorotrityl)imidazole|BAY 5097|Mycelex-7 Combination Pack|Gyne-Lotrimin Combination Pack|1-(o-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Gyne-Lotrimin 3 Combination Pack|Bay-B 5097|Trivagizole|Jidesheng|1-[(2-Chlorophenyl)diphenylmethyl]-1H-imidazole|(2-Chlorophenyl)diphenyl-1-imidazolylmethane|1H-Imidazole, 1-[(2-chlorophenyl)diphenylmethyl]-|Diphenyl-(2-chlorophenyl)-1-imidazolylmethane|FB 5097|1-(alpha-(2-Chlorophenyl)benzhydryl)imidazole|1-[(2-chlorophenyl)-diphenylmethyl]imidazole|GNF-Pf-3499|B 5097|NSC257473|NSC-257473|CHEBI:3764|1-[(2-chlorophenyl)(diphenyl)methyl]-1H-imidazole|DTXSID7029871|1H-Imidazole, 1-((2-chlorophenyl)diphenylmethyl)-|G07GZ97H65|BAY-5097|SVT-15652|DTXCID009871|Klotrimazole|Kanesten|1-((2-chlorophenyl)-diphenylmethyl)imidazole|1-((2-chlorophenyl)-di(phenyl)methyl)imidazole|1-[(2-chlorophenyl)-di(phenyl)methyl]imidazole|1-((2-chlorophenyl)(diphenyl)methyl)-1H-imidazole|clotrimazolo|Coltrimazole|Actavall|Alevazol|Candiden|Careone|Fortinia|Fungederm|Fungicure|Lakesia|Masnoderm|Occulus|Pedesil|Privacom|Ringworm|Trimazole|Abtrim|TheraPlus|UpandUp|Antifungal Soap|Canesten af|Canesten vc|Heb Antifungal|Mycelex Troche|Signature Care|Theraplus Plus|Clotrima Top|Fungistat Max|Mycil gold|TM-Clotrimazole|Cura Hongo|Cura Hongos|Skin Repair|Canesten internal|Athlete s Foot|Fortinia OF|Micotrin AC|Clotrimazole 1%|CVS Clotrimazole|Mycozyl AC|ringworm treatment|Equate Jock Itch|Kroger Jock Itch|Rexall Jock Itch|Target Jock Itch|Drs. Clotrimazole|Dynarex Antifungal|Fungazoil Advanced|Major Clotrimazole|Anti-Fungal Cream|Canesten crm combi|Dermatin Antifungal|Fungicure Intensive|Shoprite Antifungal|Clotrimazole topical|Hua Tuo Xian Gao|Aspiera Anti-fungal|Aardora Anti-Fungal|Careone Clotrimazole|Upandup Clotrimazole|Walgreens Jock Itch|Zapotol Clotrimazole|APTRIMAZOLE|Fungicure Liquid Gel|Jock Itch Antifungal|Kroger Athletes Foot|Meijer Athletes Foot|Publix Athletic Foot|Rexall Athletes Foot|Clotrimazole 1.0%|Pro-EX Anti Fungal|Athlete S Foot Afac|CAREALL Clotrimazole|Cura Hongo Antifungal|PerfectHeal Antifungal|Walgreens Clotrimazole|Meijer Clotrimazole 3|CANESTEN V|Clotrimazole Antifungal|Clotrimazole Jock Itch|Cura Hongos Antifungal|CLOTRIMAZOL DUAL|JOCK-EZE|WinCo Foods Antifungal|Clotrimazole Cream 1%|Cvs Antifungal Ringworm|RefChem:5700|Sunmark Clotrimazole 3|Topcare Clotrimazole 3|footlogix intensive care|PRO-EX|AKIN ANTI-FUNGAL|up and up athletes foot|Best Choice Clotrimazole|Pedesil Maximum Strength|Terrasil Tinea Treatment|Astonea Clotrimazole 1%|Clotrimazole Cream, 1%|TerrasilMed ANTIFUNGAL|Walgreens Clotrimazole 3|terrasil Fungal Treatment|Our Family Athletes Foot|Signature Care Jock Itch|Clotrimazole Athletes Foot|Healthy Accents Antifungal|SUNMARK CLOTRIMAZOLE|Dr Sheffield Athletes Foot|Quality Choice Clotrimazole|Terrasil Ringworm Treatment|Family Wellness Clotrimazole|Forticept Antifungal Cooling|Cvs Pharmacy Clotrimazole 3|Quality Choice Athletes Foot|Rite Aid Antifungal Ringworm|Terrasil Tinea Treatment Max|Western Family Athletes Foot|Forticept Antifungal Foot Gel|Lucky Supersoft Athletes Foot|Budpak Antifungal Clotrimazole|GOODSENSE ATHLETES FOOT|Fastrin Anti-Fungal Skin Care|lmnoop serious antifungal cream|Smooth Gator Fungus Eliminator|Terrasil Anti-fungal Treatment|Atopalm Clotrimazole Antifungal|AU KAH CHUEN ANTIFUNGAL|Clotrimazole 1% Athletes Foot|Clotrimazole Transdermal Liquid|Meijer Athletes Foot Cream AF|Veltrim 1% Dermatologic Cream|Forticept Antifungal Foot Cream|Leader Clotrimazole Anti-fungal|Terrasil Ringworm Treatment Max|Clotrimazole, Thuja Occidentalis|SIMPLY VITAL Antifungal Cream|Soundbody Clotrimazole Antifungal|Terrasil Rapid-clear Anti-fungal|terrasil The Fungal Solution Kit|Walgreens Clotrimazole Antifungal|A01AB18|Antifungal 1% Clotrimazole Cream|Blossom Pharmaceuticals Antifungal|Clotrimazole 1% Antifungal Cream|D01AC01|G01AF02|Jock Itch Clotrimazole Antifungal|Terrasil Antifungal Cleansing Bar|CVS Clotrimazole Maximum Strength|Jock Itch Cream with Clotrimazole|Thera plus Antifungal Clotrimazole|Athletes Foot Antifungal Antifungal|Good Neighbor Pharmacy Clotrimazole|HUA TUO XIAN GAO ANTIFUNGAL|Rugby Clotrimazole Antifungal Cream|Terrasil Anti-fungal Treatment Max|Terrasil Foot and Nail Anti-fungal|Aptrimazole 1.0% Antifungal Cream|Cvs Pharmacy Itch Relief Antifungal|First Aid Research Antifungal .5oz|RUGBY ANTIFUNGAL CLOTRIMAZOLE|Aardora Anti-Fungal Maximum Strength|Athlete Foot Cream with Clotrimazole|Terrasil SERIOUS TINEA TREATMENT|Clotrimazole (Topical Solution), 1%|Terrasil SERIOUS FUNGAL TREATMENT|Astonea Clotrimazole 1% Athletes Foot|Fungicure Manicure Pedicure Liquid Gel|Good Neighbor Pharmacy Clotrimazole 3|WELMATE Clotrimazole Topical Solution|1MED Clotrimazole 1% Antifungal Cream|Clotrimazole Topical Solution USP, 1%|LEADER ATHLETES FOOT CLOTRIMAZOLE|Clotrimazole 1% Topical Antifungal Cream|First Aid Research Antifungal Cream 1oz|RoyceDerm Tea Tree Oil Antifungal Soap.|Footlogix Intensive Care Diabetic Formula|Occulus Skin Hydrating Topical Foam Clo-1|Terrasil Antifungal Cream Maximum Strength|Terrasil JockItch Treatment Maximum Strength|Botanimedix TineaRX Antifungal Drying Emulsion|Terrasil Jock Itch Treatment Maximum Strength|Terrasil Athletes Foot AntiFungal Treatment Max|Family Wellness Clotrimazole 1 Anti Fungal Cream|Terrasil Foot and Nail Anti-fungal Maximum Strength|Occulus Skin Hydrating Topical Foam Clo-1 Antifungal Foam|245-764-8|Dermatin|Mycelex 7|Lotrimin AF Cream|Mycelex OTC|Canestine|Lotrimin Af|Fem Care|BAY b 5097|Lotrimax|Lotrimin AF Jock-Itch Cream|Mycelax|Mycofug|Lotrimin (TN)|Mycelex (TN)|1-(o-Chlorophenyldiphenylmethyl)imidazole|MFCD00057220|Diphenyl(2-chlorophenyl)(1-imidazolyl)methane|NSC 257473|Mycelex: MycosporinRimazole|Bay b 9057|Prestwick_120|Bis-phenyl-(2-chlorophenyl)(1-imidazoyl)methane|Methane, bis-phenyl-(2-chlorophenyl)-1-imidazolyl-|1-[(2-chlorophenyl)-diphenyl-methyl]imidazole|Bisphenyl-(2-chlorphenyl)-1-imidazolyl-methan|Lopac-C-6019|CHEMBL104|1-(2-chlorotrityl)imidazole|MLS000028502|1-(o-Chloro-.alpha.,.alpha.-diphenylbenzyl)imidazole|NCGC00015251-02|Clotrimaderm|Canestene|Clomatin|Cutistad|Esparol|SMR000058306|Stiemazol|Nalbix|FemCare|Lotrimin Lotion|Canesten Cream|CAS-23593-75-1|Clotrimazole 100 microg/mL in Acetonitrile|Gino-Lotremine|Lotrimin Cream|Mycelex Cream|Myclo Cream|Myclo-Gyne|Pan-Fungex|Neo-Zol Cream|Bis-phenyl-(2-chlorophenyl)-1-imidazoyl)methane|Mycelex Twin Pack|Lotrimin AF Lotion|Clotrimazol [INN-Spanish]|Clotrimazolum [INN-Latin]|clotrimeizol|Canesten 1-Day Therapy|Canesten 3-Day Therapy|Canesten 6-Day Therapy|DRG-0072|CCRIS 6245|Canesten 1-Day Cream Combi-Pak|HSDB 3266|Canesten Combi-Pak 1-Day Therapy|Canesten Combi-Pak 3-Day Therapy|SR-01000075771|EINECS 245-764-8|BRN 0622318|chlortrimazole|clortrimazole|Otomax|UNII-G07GZ97H65|1-((o-Chloro-phenyl)diphenylmethyl)imidazole|Gyne-Lotrimin3|Bis-fenil-(2-clorofenil)-1-imidazolil-metano|Clotrimaderm Cream|Bis-fenil-(2-clorofenil)-1-imidazolil-metano [Italian]|Bisphenyl-(2-chlorphenyl)-1-imidazolyl-methan [German]|Clotrimazole [USAN:USP:INN:BAN:JAN]|Spectrum_001343|CPD000058306|Clotrimazole (Canesten)|Clotrimazole (Standard)|Prestwick0_000267|Prestwick1_000267|Prestwick2_000267|Prestwick3_000267|Spectrum2_000128|Spectrum3_000359|Spectrum4_000295|Spectrum5_000781|CLOTRIMAZOLE [MI]|CLOTRIMAZOLE [INN]|CLOTRIMAZOLE [JAN]|C 6019|CLOTRIMAZOLE [USAN]|NCIMech_000609|cid_2812|SCHEMBL3850|CLOTRIMAZOLE [VANDF]|BIDD:PXR0036|Lopac0_000315|BSPBio_000114|BSPBio_002057|CLOTRIMAZOLE [MART.]|KBioGR_000850|KBioSS_001823|5-23-04-00291 (Beilstein Handbook Reference)|MLS000758243|MLS001423972|BIDD:GT0450|CLOTRIMAZOLE [USP-RS]|CLOTRIMAZOLE [WHO-DD]|DivK1c_000665|SPECTRUM1500200|BAY b5097|BAYb 5097|Imidazole, 1-(o-chloro-alpha,alpha-diphenylbenzyl)-|SPBio_000176|SPBio_002333|BPBio1_000126|GTPL2330|orb1310546|component of Otomax (Salt/Mix)|Gyne-Lotrimin3 Combination Pack|SCHEMBL29358270|BDBM31774|Clotrimazole (JP18/USP/INN)|HMS502B07|KBio1_000665|KBio2_001823|KBio2_004391|KBio2_006959|KBio3_001277|CLOTRIMAZOLE [GREEN BOOK]|Imidazole, 1-(o-chloro-.alpha.,.alpha.-diphenylbenzyl)-|component of Lotrimax (Salt/Mix)|NINDS_000665|CLOTRIMAZOLE [EP IMPURITY]|CLOTRIMAZOLE [ORANGE BOOK]|HMS1568F16|HMS1920O21|HMS2051E11|HMS2091G10|HMS2095F16|HMS2235E20|HMS3260P12|HMS3369I03|HMS3393E11|HMS3655I09|HMS3712F16|HMS5079K18|Pharmakon1600-01500200|CLOTRIMAZOLE [EP MONOGRAPH]|CLOTRIMAZOLE [USP IMPURITY]|Imidazole,.alpha.-diphenylbenzyl)-|BCP02150|Clotrimazole for peak identification|KXB07641|MSK21152|CLOTRIMAZOLE [USP MONOGRAPH]|Tox21_110111|Tox21_300415|Tox21_500315|CCG-35563|HY-10882R|NSC756700|s1606|STK700023|AKOS005607024|LOTRISONE COMPONENT CLOTRIMAZOLE|Tox21_110111_1|CS-1926|DB00257|FC20523|LP00315|NC00035|NSC-756700|SB17418|SDCCGSBI-0050303.P005|IDI1_000665|MRF-0000070|QTL1_000024|NCGC00015251-01|NCGC00015251-03|NCGC00015251-04|NCGC00015251-05|NCGC00015251-06|NCGC00015251-07|NCGC00015251-08|NCGC00015251-09|NCGC00015251-10|NCGC00015251-11|NCGC00015251-12|NCGC00015251-13|NCGC00015251-14|NCGC00015251-27|NCGC00093761-01|NCGC00093761-02|NCGC00093761-03|NCGC00093761-04|NCGC00093761-05|NCGC00093761-06|NCGC00254538-01|NCGC00261000-01|[(2-chlorophenyl)diphenylmethyl]imidazole|117829-71-7|AS-13816|HY-10882|SY051361|SBI-0050303.P004|DB-046195|1-[(2-Chlorophenyl)diphenylmethyl]imidazole|AB00051951|C2867|EU-0100315|NS00000282|ST50994242|SW196431-5|C06922|D00282|1-(.alpha.-(2-Chlorophenyl)benzhydryl)imidazole|AB00051951-14|AB00051951_15|AB00051951_16|Clotrimazole, VETRANAL(TM), analytical standard|EN300-7409200|593C751|A816789|F492467|Q413546|1H-Imidazole, 1-[(2-chlorophenyl)-diphenylmethyl]|SR-01000075771-1|SR-01000075771-6|SR-01000075771-8|1-[(2-Chloro-phenyl)-diphenyl-methyl]-1H-imidazole|BRD-K15916496-001-14-7|BRD-K15916496-001-26-1|BRD-K15916496-001-27-9|SR-01000075771-10|3ACDFDF8-38E3-4368-85D0-BDF8AE1E6591|Clotrimazole, British Pharmacopoeia (BP) Reference Standard|Clotrimazole, European Pharmacopoeia (EP) Reference Standard|Clotrimazole, United States Pharmacopeia (USP) Reference Standard|1-[(2-Chlorophenyl)-diphenyl-methyl]-1H-imidazole;FB-5097;Bay B 5097|1-(o-Chlorotrityl)imidazole;1-(o-Chloro-alpha,alpha-diphenylbenzyl)imidazole|Clotrimazole for peak identification, European Pharmacopoeia (EP) Reference Standard|Clotrimazole, Pharmaceutical Secondary Standard; Certified Reference Material"
SENICAPOC,216327,,"InChI=1S/C20H15F2NO/c21-17-10-6-15(7-11-17)20(19(23)24,14-4-2-1-3-5-14)16-8-12-18(22)13-9-16/h1-13H,(H2,23,24)",SCTZUZTYRMOMKT-UHFFFAOYSA-N,C20H15F2NO,323.3,"2,2-bis(4-fluorophenyl)-2-phenylacetamide","Senicapoc|289656-45-7|2,2-bis(4-fluorophenyl)-2-phenylacetamide|Bis(4-fluorophenyl)phenylacetamide|TS6G201A6Q|PF-05416266|DTXSID60276906|ICA17043|senicapocum|RefChem:182393|DTXCID70228072|ICA-17043|MFCD09027349|Senicapoc (USAN)|Senicapoc [USAN]|2,2-BIS(4-FLUOROPHENYL)-2-PHENYL-ACETAMIDE|Benzeneacetamide, 4-fluoro-alpha-(4-fluorophenyl)-alpha-phenyl-|4-Fluoro-alpha-(4-fluorophenyl)-alpha-phenylbenzeneacetamide|Senicapoc [USAN:INN]|ICA 17043|4-Fluoro-a-(4-fluorophenyl)-a-phenyl-benzeneacetamide|UNII-TS6G201A6Q|Senicapoc?|SENICAPOC [INN]|SENICAPOC [MART.]|SENICAPOC [WHO-DD]|Senicapoc - Bio-X trade mark|CHEMBL405821|GTPL2331|orb1304118|SCHEMBL1443805|CHEBI:233644|SCTZUZTYRMOMKT-UHFFFAOYSA-N|GLXC-15762|HMS3741E13|BCP14507|BBL102413|BDBM50371391|STL556215|AKOS007930800|CS-0294|DB06280|BS300121|FS100781|HY-50694|MS-20434|SY291889|DB-003217|NS00069288|C74487|D06640|656F457|AU-004/43508060|Q7450628|BRD-K21295289-001-01-6|Benzeneacetamide, 4-fluoro-|A-(4-fluorophenyl)-|A-phenyl-"
MARIZOMIB,11347535,,"InChI=1S/C15H20ClNO4/c1-14-10(7-8-16)12(19)17-15(14,13(20)21-14)11(18)9-5-3-2-4-6-9/h3,5,9-11,18H,2,4,6-8H2,1H3,(H,17,19)/t9-,10+,11+,14+,15+/m1/s1",NGWSFRIPKNWYAO-SHTIJGAHSA-N,C15H20ClNO4,313.77,"(1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-[(1S)-cyclohex-2-en-1-yl]-hydroxymethyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione","MARIZOMIB|salinosporamide A|437742-34-2|(-)-Salinosporamide A|NPI-0052|marizomibum|ML 858|703P9YDP7F|CHEBI:48045|DTXSID00904019|(1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-(1S)-cyclohex-2-en-1-yl(hydroxy)methyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione|(1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-[(1S)-cyclohex-2-en-1-yl]-hydroxymethyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione|6-OXA-2-AZABICYCLO(3.2.0)HEPTANE-3,7-DIONE, 4-(2-CHLOROETHYL)-1-((S)-(1S)-2-CYCLOHEXEN-1-YLHYDROXYMETHYL)-5-METHYL-, (1R,4R,5S)-|Salinosporin A|(1R,4R,5S)-4-(2-chloroethyl)-1-((S)-((1S)-cyclohex-2-en-1-yl)-hydroxymethyl)-5-methyl-6-oxa-2-azabicyclo(3.2.0)heptane-3,7-dione|(1R,4R,5S)-4-(2-chloroethyl)-1-((S)-(1S)-cyclohex-2-en-1-yl(hydroxy)methyl)-5-methyl-6-oxa-2-azabicyclo(3.2.0)heptane-3,7-dione|RefChem:810626|DTXCID701331944|(1R,4R,5S)-4-(2-CHLOROETHYL)-1-((S)-((1S)-CYCLOHEX-2-EN-1-YL)HYDROXYMETHYL)-5-METHYL-6-OXA-2-AZABICYCLO(3.2.0)HEPTANE-3,7-DIONE|NPI 0052|(1R,4R,5S)-4-(2-chloroethyl)-1-((S)-((S)-cyclohex-2-en-1-yl)(hydroxy)methyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione|Marizomib [USAN:INN]|Salinosporamide A;NPI-0052|UNII-703P9YDP7F|Marizomib?|Homosalinosporamide A|MARIZOMIB [INN]|Marizomib (USAN/INN)|MARIZOMIB [USAN]|MARIZOMIB [WHO-DD]|SCHEMBL151667|SALINOSPORAMIDE A [MI]|CHEMBL371405|orb1707013|NGWSFRIPKNWYAO-SHTIJGAHSA-N|GLXC-02198|EX-A3259|BDBM50398608|MFCD16037703|AKOS027323566|DB11762|NCGC00344630-04|DA-75322|HY-10985|TS-07993|CS-0002986|NS00069730|D09640|H51401|Q7404722|(1R,4R,5S)-4-(2-CHLOROETHYL)-1-((S)-((1S)-CYCLOHEX-2-EN-1-YL)HYDROXYMETHYL)-5-METHYL- 6-OXA-2-AZABICYCLO(3.2.0)HEPTANE-3,7-DIONE|(1R,4R,5S)-4-(2-Chloroethyl)-1-((S)-((S)-cyclohex-2-enyl)(hydroxy)methyl)-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione|(1R,4R,5S)-4-(2-chloroethyl)-1-[(S)-[(1S)-cyclohex-2-en-1-yl]-hydroxy-methyl]-5-methyl-6-oxa-2-azabicyclo[3.2.0]heptane-3,7-dione|6-Oxa-2-azabicyclo(3.2.0)heptane-3,7-dione,   4-(2-chloroethyl)-1-((S)-(1S)-2-cyclohexen-1-ylhydroxymethyl)-5-methyl-, (1R,4R,5S)-"
DELANZOMIB,24800541,,"InChI=1S/C21H28BN3O5/c1-13(2)12-18(22(29)30)24-21(28)19(14(3)26)25-20(27)17-11-7-10-16(23-17)15-8-5-4-6-9-15/h4-11,13-14,18-19,26,29-30H,12H2,1-3H3,(H,24,28)(H,25,27)/t14-,18+,19+/m1/s1",SJFBTAPEPRWNKH-CCKFTAQKSA-N,C21H28BN3O5,413.3,"[(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]butanoyl]amino]-3-methylbutyl]boronic acid","Delanzomib|847499-27-8|CEP-18770|CEP 18770|CT-47098|NPH007098|NPH 007098|delanzomibum|6IF28942WO|CIP 18770|CIP-18770|NPH-007098|CT 47098|CHEBI:141530|DTXSID901025656|[(1R)-1-[(2S,3R)-3-hydroxy-2-[(6-phenylpyridin-2-yl)formamido]butanamido]-3-methylbutyl]boronic acid|Boronic acid, ((1R)-1-(((2S,3R)-3-hydroxy-1-oxo-2-(((6-phenyl-2-pyridinyl)carbonyl)amino)butyl)amino)-3-methylbutyl)-|((1R)-1-((2S,3R)-3-HYDROXY-2-(6-PHENYLPYRIDINE-2-CARBOXAMIDO)BUTANAMIDO)-3-METHYLBUTYL)BORONIC ACID|((1R)-1-((2S,3R)-3-hydroxy-2-((6-phenylpyridin-2-yl)formamido)butanamido)-3-methylbutyl)boronic acid|RefChem:131597|DTXCID901509925|Proteasome Inhibitor CEP 18770|((R)-1-((2S,3R)-3-Hydroxy-2-(6-phenylpicolinamido)butanamido)-3-methylbutyl)boronic acid|Delanzomib (CEP-18770)|Delanzomib [USAN:INN]|UNII-6IF28942WO|Delanzomib [USAN]|CHEMBL270515|Delanzomib (USAN)|[(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid|[(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]butanoyl]amino]-3-methylbutyl]boronic acid|[(1R)-1-[[(2S,3R)-3-Hydroxy-2-[[(6-phenylpyridin-2-yl)carbonyl]amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid.|CEP-18770 (Delanzomib)|C21H28BN3O5|((1R)-1-(((2s,3r)-3-hydroxy-2-(((6-phenylpyridin-2-yl)carbonyl)amino)-1-oxobutyl)amino)-3-methylbutyl)boronic acid|MFCD18251439|Delanzomib, free base|DELANZOMIB [INN]|CEP-18770; Delanzomib|DELANZOMIB [WHO-DD]|Delanzomib(CEP-18770)?|SCHEMBL555047|orb1301139|SCHEMBL29409193|EX-A2040|BDBM50329819|NSC764334|AKOS022185107|CS-1624|DB11956|NSC-764334|NCGC00346469-01|NCGC00346469-02|NCGC00346469-05|NCGC00346469-08|AC-24847|HY-10454|MS-27143|NS00073518|D10110|F84973|BRD-K59325863-001-01-0|BRD-K59325863-001-02-8|BRD-K59325863-001-03-6|Q27264956|(R)-1-((2S,3R)-3-hydroxy-2-(6-phenylpicolinamido)butanamido)-3-methylbutylboronic acid|[(1R)-3-methyl-1-({N-[(6-phenylpyridin-2-yl)carbonyl]-L-threonyl}amino)butyl]boronic acid|[(1R)-1-[[(2S,3R)-3-hydroxy-1-oxo-2-[[oxo-(6-phenyl-2-pyridyl)methyl]amino]butyl]amino]-3-methylbutyl]boronic acid|[(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridin-2-yl)carbonylamino]butanoyl]amino]-3-methyl-butyl]boronic acid|[(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]-1-oxobutyl]amino]-3-methylbutyl]boronic acid|[(1R)-1-[[(2S,3R)-3-hydroxy-2-[(6-phenylpyridine-2-carbonyl)amino]butanoyl]amino]-3-methyl-butyl]boronic acid|B-((1R)-1-((N-((6-PHENYLPYRIDIN-2-YL)CARBONYL)-L-THREONYL)AMINO)-3-METHYLBUTYL)BORONIC ACID"
IXAZOMIB,25183872,,"InChI=1S/C14H19BCl2N2O4/c1-8(2)5-12(15(22)23)19-13(20)7-18-14(21)10-6-9(16)3-4-11(10)17/h3-4,6,8,12,22-23H,5,7H2,1-2H3,(H,18,21)(H,19,20)/t12-/m0/s1",MXAYKZJJDUDWDS-LBPRGKRZSA-N,C14H19BCl2N2O4,361.0,"[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid","Ixazomib|1072833-77-2|MLN2238|MLN-2238|MLN 2238|MLN-9708 FREE BASE|CHEBI:90942|DTXSID701025662|[(1R)-1-{2-[(2,5-dichlorophenyl)formamido]acetamido}-3-methylbutyl]boronic acid|[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid|Boronic acid, b-((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)-|71050168A2|((1R)-1-((2,5-DICHLOROBENZAMIDO)ACETAMIDO)-3-METHYLBUTYL)BORONIC ACID|ixazomibum|((1R)-1-((2-((2,5-dichlorobenzoyl)amino)acetyl)amino)-3-methylbutyl)boronic acid|((1R)-1-(2-((2,5-dichlorophenyl)formamido)acetamido)-3-methylbutyl)boronic acid|RefChem:56272|L01XX50|DTXCID001509928|(R)-1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutylboronic acid|(R)-(1-(2-(2,5-dichlorobenzamido)acetamido)-3-methylbutyl)boronic acid|Ixazomib [INN]|MFCD18251438|Ixazomib(MLN2238)|Ixazomib (MLN2238)|CHEMBL2141296|Ixazomib (USAN)|IXAZOMIB [USAN]|[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methyl-butyl]boronic acid|C14H19BCl2N2O4|Ixazomib [USAN:INN]|Ixozamib|(R)-1-[2-(2,5-Dichlorobenzamido)acetamido]-3-methylbutylboronic Acid|Ixazomib Impurity|Boronic acid, B-[(1R)-1-[[2-[(2,5-dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]-; B-[(1R)-1-[[2-[(2,5-Dichlorobenzoyl)amino]acetyl]amino]-3-methylbutyl]boronic acid; Ixazomib; MLN 2238; Ninlaro|Ixazomib (Standard)|UNII-71050168A2|MLN2238(Ixazomib)|IXAZOMIB [MI]|IXAZOMIB [WHO-DD]|Ixazomib (MLN-2238)|GTPL8450|orb1306436|SCHEMBL3742758|SCHEMBL29353014|EX-A547|BCP02410|BCP24078|BDBM50398609|HY-10453R|NSC766907|s2180|AKOS015995120|BCP9000953|CCG-264938|CS-1657|DB09570|FI65049|NSC-766907|1072833-77-2 (free)|NCGC00249611-01|NCGC00249611-03|NCGC00249611-04|AC-28456|AS-55976|BP-43659|HY-10453|SY103733|NS00073560|SW219743-1|D10130|EN300-7360341|BRD-K78659596-001-01-3|BRD-K78659596-001-03-9|Q20948663|N-[(1R)-1-borono-3-methylbutyl]-N(2)-(2,5-dichlorobenzoyl)glycinamide"
OPROZOMIB,25067547,,"InChI=1S/C25H32N4O7S/c1-15-26-11-20(37-15)24(33)29-19(13-35-4)23(32)28-18(12-34-3)22(31)27-17(21(30)25(2)14-36-25)10-16-8-6-5-7-9-16/h5-9,11,17-19H,10,12-14H2,1-4H3,(H,27,31)(H,28,32)(H,29,33)/t17-,18-,19-,25+/m0/s1",SWZXEVABPLUDIO-WSZYKNRRSA-N,C25H32N4O7S,532.6,"N-[(2S)-3-methoxy-1-[[(2S)-3-methoxy-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide","Oprozomib|935888-69-0|ONX-0912|ONX 0912|PR-047|MZ37792Y8J|DTXSID201025950|N-[(2S)-3-methoxy-1-[[(2S)-3-methoxy-1-[[(2S)-1-[(2R)-2-methyloxiran-2-yl]-1-oxo-3-phenylpropan-2-yl]amino]-1-oxopropan-2-yl]amino]-1-oxopropan-2-yl]-2-methyl-1,3-thiazole-5-carboxamide|oprozomibum|N-((2S)-3-methoxy-1-(((2S)-3-methoxy-1-(((2S)-1-((2R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)-2-methyl-1,3-thiazole-5-carboxamide|RefChem:928244|Proteasome Inhibitor ONX 0912|DTXCID801510202|(2S)-3-methoxy-2-((2S)-3-methoxy-2-((2-methyl-1,3-thiazol-5-yl)formamido)propanamido)-N-((2S)-1-((2R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)propanamide|O-Methyl-N-((2-methylthiazol-5-yl)carbonyl)-L-seryl-O-methyl-N-((1S)-1-benzyl-2-((2R)-2-methyloxiran-2-yl)-2-oxoethyl)-L-serinamide|Oprozomib (ONX 0912)|N-((S)-3-methoxy-1-(((S)-3-methoxy-1-(((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-yl)amino)-1-oxopropan-2-yl)amino)-1-oxopropan-2-yl)-2-methylthiazole-5-carboxamide|MFCD25976563|PR 047|O-Methyl-N-((2-methylthiazol-5-yl)carbonyl)-L-seryl-O-methyl-N-((1S)-1-benzyl-2-((2R)- 2-methyloxiran-2-yl)-2-oxoethyl)-L-serinamide|Oprozomib (ONX-0912)|Oprozomib [USAN]|Oprozomib [USAN:INN]|UNII-MZ37792Y8J|C25H32N4O7S|Onx0912(oprozomib)|OPROZOMIB [INN]|Oprozomib (USAN/INN)|OPROZOMIB [WHO-DD]|Oprozomib (ONX-0912)?|GTPL8739|orb1301126|SCHEMBL1709971|CHEMBL2103884|EX-A332|SWZXEVABPLUDIO-WSZYKNRRSA-N|BCP07603|BDBM50398607|NSC766254|AKOS028109171|DB11991|FO65113|NSC-766254|NCGC00345799-01|NCGC00345799-02|NCGC00345799-04|AS-17020|HY-12113|L-Serinamide, O-methyl-N-[(2-methyl-5-thiazolyl)carbonyl]-L-seryl-O-methyl-N-[(1S)-2-[(2R)-2-methyl-|N-((S)-3-methoxy-1-((S)-3-methoxy-1-((S)-1-((R)-2-methyloxiran-2-yl)-1-oxo-3-phenylpropan-2-ylamino)-1-oxopropan-2-ylamino)-1-oxopropan-2-yl)-2-methylthiazole-5-carboxamide|NS00072552|D10318|Q27088209|ONX 0912; PR 047; ONX-0912; PR-047; ONX0912; PR047|L-Serinamide, O-methyl-N-((2-methyl-5-thiazolyl)carbonyl)-L-seryl-O-methyl-N-((1S)-2- ((2R)-2-methyl-2-oxiranyl)-2-oxo-1-(phenylmethyl)ethyl)-|N-[(1S)-2-[[(1S)-2-[[(1S)-1-benzyl-2-[(2R)-2-methyloxiran-2-yl]-2-oxo-ethyl]amino]-1-(methoxymethyl)-2-oxo-ethyl]amino]-1-(methoxymethyl)-2-oxo-ethyl]-2-methyl-thiazole-5-carboxamide"
ISPINESIB,6851740,,"InChI=1S/C30H33ClN4O2/c1-20(2)27(34(17-7-16-32)29(36)23-12-10-21(3)11-13-23)28-33-26-18-24(31)14-15-25(26)30(37)35(28)19-22-8-5-4-6-9-22/h4-6,8-15,18,20,27H,7,16-17,19,32H2,1-3H3/t27-/m1/s1",QJZRFPJCWMNVAV-HHHXNRCGSA-N,C30H33ClN4O2,517.1,N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxoquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide,"Ispinesib|336113-53-2|SB-715992|BKT5F9C2NI|SB715992|DTXSID20187307|ispinesibum|N-(3-aminopropyl)-N-((1R)-1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl)-4-methylbenzamide|n-(3-aminopropyl)-n-[(1r)-1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide|RefChem:150176|DTXCID90109798|NSC727990|Ispinesib (SB-715992)|Ispinesib [INN]|SB 715992|UNII-BKT5F9C2NI|(R)-N-(3-aminopropyl)-N-(1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl)-4-methylbenzamide|MFCD22628831|N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxoquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide|N-(3-Aminopropyl)-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methylbenzamide|CHEMBL2347651|Benzamide, N-(3-aminopropyl)-N-((1R)-1-(7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl)-2-methylpropyl)-4-methyl-|SB-715992 (Ispinesib)|G7X|ISPINESIB [WHO-DD]|Ispinesib; SB-715992|C30H33ClN4O2|CHEMBL228814|orb1306472|SCHEMBL3582165|SCHEMBL29375933|CHEBI:94692|QJZRFPJCWMNVAV-HHHXNRCGSA-N|BCPP000200|BCP02450|EX-A2078|BDBM50382559|BDBM50431891|MSK163408|NSC755386|NSC820548|s1452|AKOS025147361|BCP9000797|CCG-264892|CS-0891|DB06188|FI24737|NSC-755386|NSC-820548|NCGC00263174-01|AC-32851|AS-56089|HY-50759|N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxo-quinazolin-2-yl)-2-methyl-propyl]-4-methyl-benzamide|SY325086|Ispinesib,SB-715992, CK0238273|NS00070520|SW219747-1|C74727|BRD-K64881305-001-01-1|BRD-K64881305-001-03-7|BRD-K64881305-001-05-2|Q27166496|(R)-N-(3-amino-propyl)-N-[1-(3-benzyl-7-chloro-4-oxo-3,4-dihydro-quinazolin-2-yl)-2-methyl-propyl]-4-methyl-benzamide|(R)-N-(3-amino-propyl)-N-[1-(3-benzyl-7-chloro-4-oxo-3,4-dihydro-quinazolin-2-yl)-2-methyl-propyl]4-methyl-benzamide|(R)-N-(3-Aminopropyl)-N-[1-(3-benzyl-7-chloro-4-oxo-3,4-dihydro-2-quinazolinyl)-2-methylpropyl]-4-methylbenzamide|N-(3-Aminopropyl)-N-[(1R)-1-[7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl]-2-methylpropyl]-4-methylbenzamide;SB 715992"
SB-743921,9936388,,"InChI=1S/C31H33ClN2O3/c1-20(2)28(34(17-7-16-33)31(36)23-12-10-21(3)11-13-23)30-26(18-22-8-5-4-6-9-22)29(35)25-15-14-24(32)19-27(25)37-30/h4-6,8-15,19-20,28H,7,16-18,33H2,1-3H3/t28-/m1/s1",PGXYIBJJCLWJST-MUUNZHRXSA-N,C31H33ClN2O3,517.1,N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxochromen-2-yl)-2-methylpropyl]-4-methylbenzamide,"SB-743921|SB-743921 free base|UNII-24DSZ1VN92|SB 743921 [WHO-DD]|Benzamide, N-(3-aminopropyl)-N-((1R)-1-(7-chloro-4-oxo-3-(phenylmethyl)-4H-1-benzopyran-2-yl)-2-methylpropyl)-4-methyl-|Benzamide, N-(3-aminopropyl)-N-[(1R)-1-[7-chloro-4-oxo-3-(phenylmethyl)-4H-1-benzopyran-2-yl]-2-methylpropyl]-4-methyl-|RefChem:181585|KSP Inhibitor SB-743921|1067881-56-4|940929-33-9|Sb 743921|SB743921|618430-39-0|24DSZ1VN92|SB-743921 (free base)|N-(3-Aminopropyl)-N-[(1r)-1-(3-Benzyl-7-Chloro-4-Oxo-4h-Chromen-2-Yl)-2-Methylpropyl]-4-Methylbenzamide|CHEMBL2325429|618430-39-0 (free base)|N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxochromen-2-yl)-2-methylpropyl]-4-methylbenzamide|(R)-N-(3-Aminopropyl)-N-(1-(3-benzyl-7-chloro-4-oxo-4h-chromen-2-yl)-2-methylpropyl)-4-methylbenzamide|SCHEMBL645543|orb1699380|SCHEMBL29377772|CHEBI:231716|DTXSID801025653|BDBM50427294|AKOS040749430|NCGC00346571-01|NCGC00346571-08|DA-77721|HY-14661|CS-0003505|BRD-K68532323-003-02-8|BRD-K68532323-003-05-1|Q27456449"
RISEDRONIC ACID,5245,,"InChI=1S/C7H11NO7P2/c9-7(16(10,11)12,17(13,14)15)4-6-2-1-3-8-5-6/h1-3,5,9H,4H2,(H2,10,11,12)(H2,13,14,15)",IIDJRNMFWXDHID-UHFFFAOYSA-N,C7H11NO7P2,283.11,(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid,"Risedronic acid|Risedronate|105462-24-6|Acido risedronico|Acide risedronique|Ridron|Acidum risedronicum|Phosphonic acid, [1-hydroxy-2-(3-pyridinyl)ethylidene]bis-|[1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl]phosphonic acid|M05BA07|KM2Z91756Z|Phosphonic acid, (1-hydroxy-2-(3-pyridinyl)ethylidene)bis-|DTXSID2023563|2-(3-pyridinyl)-1-hydroxyethane diphosphonic acid|(1-hydroxy-1-phosphono-2-(pyridin-3-yl)ethyl)phosphonic acid|RefChem:56783|DTXCID303563|hydroxy-(1-hydroxy-1-phosphono-2-pyridin-1-ium-3-ylethyl)phosphinate|Risedronic acid monohydrate|Benet|Sodium risedronate|NE-58095|Risedronic acid (INN)|Risedronic acid [INN]|(1-hydroxy-1-phosphono-2-pyridin-3-ylethyl)phosphonic acid|MFCD00867080|Risedronic acid (Actonel)|CHEMBL923|CHEBI:8869|1-HYDROXY-2-(3-PYRIDINYL)ETHYLIDENE BIS-PHOSPHONIC ACID|RIS|(1-hydroxy-1-phosphono-2-pyridin-3-yl-ethyl)phosphonic acid|[1-hydroxy-1-phosphono-2-(3-pyridyl)ethyl]phosphonic acid|(1-Hydroxy-2-(pyridin-3-yl)ethane-1,1-diyl)diphosphonic acid|(1-hydroxy-2-pyridin-3-ylethane-1,1-diyl)bis(phosphonic acid)|Risedronic acid [INN:BAN]|Acide risedronique [INN-French]|Acido risedronico [INN-Spanish]|Acidum risedronicum [INN-Latin]|Bisphosphonate 1|Ridron (TN)|NE 58019|HSDB 7326|Risdronate|UNII-KM2Z91756Z|SR-05000001495|(1-Hydroxy-2-(3-pyridyl)ethylidene)diphosphonic acid|RISEDRONATE [VANDF]|SCHEMBL18378|RISEDRONIC ACID [MI]|BIDD:GT0010|RISEDRONIC ACID [HSDB]|GTPL3176|JMC515594 Compound 64|1-Hydroxy-2-(3-pyridyl)-ethan-1,1-bis-phosphonic acid|RISEDRONIC ACID [MART.]|SCHEMBL29362587|BDBM12576|RISEDRONIC ACID [WHO-DD]|IIDJRNMFWXDHID-UHFFFAOYSA-N|HMS2090C21|HMS3741A17|BCP13805|HY-B0148|s1874|AKOS015892564|AC-1295|CS-1964|DB00884|FH61572|NCGC00386377-01|AS-13584|NS00001842|C08233|D08484|EN300-117266|AB01275490-01|AB01275490_02|462R246|F304322|Q408724|SR-05000001495-1|2-(3-pyridyl)-1-hydroxyethane-1,1-bisphosphonic acid|BRD-K05185389-001-02-6|BRD-K05185389-001-03-4|BRD-K05185389-236-03-6|BRD-K05185389-236-04-4|BRD-K05185389-236-05-1|Z1501485357|(1-hydroxy-2-(pyridin-3-yl)ethane-1,1-diyl)bis(phosphonic acid)|Phosphonic acid, P,P'-[1-hydroxy-2-(3-pyridinyl)ethylidene]bis-|(1-Hydroxy-1-phosphono-2-pyridin-3-yl-ethyl)phosphonic acid monohydrate"
PAMAPIMOD,16220188,,"InChI=1S/C19H20F2N4O4/c1-25-17-11(10-22-19(24-17)23-13(4-6-26)5-7-27)8-16(18(25)28)29-15-3-2-12(20)9-14(15)21/h2-3,8-10,13,26-27H,4-7H2,1H3,(H,22,23,24)",JYYLVUFNAHSSFE-UHFFFAOYSA-N,C19H20F2N4O4,406.4,"6-(2,4-difluorophenoxy)-2-(1,5-dihydroxypentan-3-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one","Pamapimod|449811-01-2|RO 4402257|Ro4402257|R1503|Ro-4402257|CHEBI:90685|8S2C9V11K4|R-1503|6-(2,4-difluorophenoxy)-2-(1,5-dihydroxypentan-3-ylamino)-8-methylpyrido[2,3-d]pyrimidin-7-one|pamapimodum|6-(2,4-difluorophenoxy)-2-(1,5-dihydroxypentan-3-ylamino)-8-methylpyrido(2,3-d)pyrimidin-7-one|RefChem:928545|GlyTouCan:G69135FF|G69135FF|MFCD25976551|CHEMBL1090089|6-(2,4-Difluorophenoxy)-2-[[3-hydroxy-1-(2-hydroxyethyl)propyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one|6-(2,4-Difluorophenoxy)-2-{[3-Hydroxy-1-(2-Hydroxyethyl)propyl]amino}-8-Methylpyrido[2,3-D]pyrimidin-7(8h)-One|Pamapimod (R-1503, Ro4402257)|6-(2,4-Difluorophenoxy)-2-((1,5-dihydroxypentan-3-yl)amino)-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one|Pamapimod [USAN]|Pamapimod (INN/USAN)|Pamapimod [USAN:INN]|UNII-8S2C9V11K4|6-(2,4-Difluorophenoxy)-2-((3-hydroxy-1-(2-hydroxyethyl)propyl)amino)-8-methylpyrido(2,3-d)pyrimidin-7(8H)-one|6-(2,4-difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one|6-(2,4-difluorophenoxy)-2-[[3-hydroxy-1-(2-hydroxyethyl)propyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one; 6-(2,4-Difluorophenoxy)-2-[[3-hydroxy-1-(2-hydroxyethyl)propyl]amino]-8-methylpyrido[2,3-d]pyrimidin-7(8H)-one; Pamapimod; R 1503; Ro 4402257|PamapimodR-1503|PamapimodR-1503?|PAMAPIMOD [INN]|R 1503|PAMAPIMOD [WHO-DD]|GTPL9915|orb1300339|SCHEMBL3636701|SCHEMBL29379723|SCHEMBL29429421|DTXSID90963312|C19H20F2N4O4|GLXC-10768|BCP17491|EX-A1084|WZB81457|BDBM50314070|s8125|AKOS032944999|CCG-268715|CS-5965|compound 2b [PMID: 21375264]|AC-33182|AS-56094|HY-10405|DB-229434|D08963|Q27162644|6-(2,4-Difluorophenoxy)-2-[(1,5-Dihydroxy-3-Pentanyl)Amino]-8-Methylpyrido[2,3-d]Pyrimidin-7(8H)-One|6-(2,4-difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)amino]-8-methyl-7H,8H-pyrido[2,3-d]pyrimidin-7-one|6-(2,4-Difluorophenoxy)-2-[(1,5-dihydroxypentan-3-yl)imino]-8-methyl-2,8-dihydropyrido[2,3-d]pyrimidin-7(3H)-one|6-(2,4-difluorophenoxy)-2-[[3-hydroxy-1-(2-hydroxyethyl)propyl]amino]-8-methyl-pyrido[2,3-d]pyrimidin-7-one|FLW|Pyrido(2,3-d)pyrimidin-7(8H)-one, 6-(2,4-difluorophenoxy)-2-((3-hydroxy-1-(2-hydroxyethyl)propyl)amino)-8-methyl-"
MW-150,86270361,,"InChI=1S/C24H23N5/c1-28-12-14-29(15-13-28)23-17-22(19-8-10-25-11-9-19)24(27-26-23)21-7-6-18-4-2-3-5-20(18)16-21/h2-11,16-17H,12-15H2,1H3",CIIVUDIZZJLXCN-UHFFFAOYSA-N,C24H23N5,381.5,6-(4-methylpiperazin-1-yl)-3-naphthalen-2-yl-4-pyridin-4-ylpyridazine,"1628502-91-9|MW-150|6-(4-Methylpiperazin-1-Yl)-3-(Naphthalen-2-Yl)-4-(Pyridin-4-Yl)pyridazine|6-(4-methyl-1-piperazinyl)-3-(2-naphthalenyl)-4-(4-pyridinyl)-pyridazine|MW150|6-(4-methylpiperazin-1-yl)-3-naphthalen-2-yl-4-pyridin-4-ylpyridazine|EPZ68T461K|MW 150|CHEMBL4129018|MW01-18-150SRM|6-(4-Methyl-piperazin-1-yl)-(2-naphthalen-2-yl)-4-pyridin-4-ylpyridazine|Pyridazine, 6-(4-methyl-1-piperazinyl)-3-(2-naphthalenyl)-4-(4-pyridinyl)-|RefChem:1090054|UNII-EPZ68T461K|orb1301743|SCHEMBL16061104|SCHEMBL29657684|SCHEMBL30875960|EX-A3206A|GTPL10524|CIIVUDIZZJLXCN-UHFFFAOYSA-N|C24H23N5|DQC50291|BDBM50537600|MFCD32062790|NSC785340|AKOS040758765|compound 8 [PMID: 25676389]|MW-150?|NSC-785340|compound 11 [PMID: 30978288]|AC-38144|compound 27 [WO2014145485A2]|DA-75821|MS-26255|HY-120111|CS-0069509|G16714|Q27453797|6-(4-methylpiperazin-1-yl)-3-(2-naphthyl)-4-(4-pyridyl)pyridazine|3GF"
ALENDRONIC ACID,2088,,"InChI=1S/C4H13NO7P2/c5-3-1-2-4(6,13(7,8)9)14(10,11)12/h6H,1-3,5H2,(H2,7,8,9)(H2,10,11,12)",OGSPWJRAVKPPFI-UHFFFAOYSA-N,C4H13NO7P2,249.10,(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid,"ALENDRONIC ACID|alendronate|66376-36-1|Acido alendronico|Acide alendronique|(4-amino-1-hydroxy-1-phosphonobutyl)phosphonic acid|Arendal|Acidum alendronicum|(4-Amino-1-hydroxybutylidene)bisphosphonic acid|ABDP|4-Amino-1-hydroxybutane-1,1-diphosphonic Acid|Phosphonic acid, (4-amino-1-hydroxybutylidene)bis-|(4-amino-1-hydroxybutane-1,1-diyl)bis(phosphonic acid)|MK 217|CHEBI:2567|X1J18R4W8P|4-Amino-1-hydroxybutylidene-1,1-bis(phosphonic acid)|DTXSID5022568|Phosphonic acid, P,P'-(4-amino-1-hydroxybutylidene)bis-|Aminohydroxybutane Bisphosphonate|RefChem:57184|alpha-hydroxy-delta-aminobutylidenediphosphonic acid|DTXCID202568|M05BA04|MK217|4-Amino-1-Hydroxybutylidene 1,1-Biphosphonate|613-929-7|689-696-0|Fosamax|(4-Amino-1-hydroxybutane-1,1-diyl)diphosphonic acid|Alendronate acid|bisphosphonate|(4-Amino-1-hydroxybutylidene)diphosphonic acid|MFCD00868112|Alendronic acid (INN)|CHEMBL870|(4-amino-1-hydroxy-1-phosphono-butyl)phosphonic acid|Alendronate sodium hydrate|Acide alendronique [INN-French]|Acido alendronico [INN-Spanish]|Acidum alendronicum [INN-Latin]|ALENDRONIC ACID [INN]|P,P'-(4-Amino-1-hydroxybutylidene)bisphosphonic acid|Alendronic acid [INN:BAN]|bisphosphonate, 65|4-Amino-1-hydroxy-1,1-butylidinediphosphonic acid|NCGC00096054-03|4-Amino-1-hydroxybutylidene-1,1-bisphosphonate|UNII-X1J18R4W8P|C4H13NO7P2|SR-05000001906|HSDB 7990|1yhm|ABDP-d6|4-Amino-1-hydroxybutane-1,1-diphosphonate|ALENDRONATE [VANDF]|ALENDRONATE [MART.]|BPH 1|Oprea1_422906|SCHEMBL18898|ALENDRONIC ACID [MI]|Phosphonic acid, (4-amino-1-hydroxybutylidene)bis|BIDD:GT0180|SPECTRUM1505166|GTPL3141|orb1299793|BDBM25313|66376-36-1 (unlabeled)|ALENDRONIC ACID [WHO-DD]|ALENDRONIC ACID [EMA EPAR]|HY-B0631|KRB43739|4-amino-1,1-diphosphonobutan-1-ol|HSCI1_000337|s5536|AKOS001015793|DB00630|FA38407|NCGC00096054-01|NCGC00096054-04|AS-10963|SY053256|SBI-0206778.P001|A2120|CS-0009566|NS00004332|ST50036159|4-amino-1-hydroxybutylidene-bisphosphonic acid|C07752|D07119|D88506|4-Amino-1- hydroxybutane-1,1-diphosphonate-d6|AB01274863-01|(4-Amino-1-Hydroxybutylidene)-Bisphosphonic Acid|376A361|A835441|F243024|Q420057|SR-05000001906-1|(4-amino-1-hydroxybutane-1,1-diyl)bisphosphonic acid|BRD-K75527158-323-01-3|BRD-K75527158-360-04-9|BRD-K75527158-360-05-6|BRD-K75527158-360-06-4|Z56771118|(4-azanyl-1-oxidanyl-1-phosphono-butyl)phosphonic acid|.ALPHA.-HYDROXY-.DELTA.-AMINOBUTYLIDENEDIPHOSPHONIC ACID"
MINODRONIC ACID,130956,,"InChI=1S/C9H12N2O7P2/c12-9(19(13,14)15,20(16,17)18)5-7-6-10-8-3-1-2-4-11(7)8/h1-4,6,12H,5H2,(H2,13,14,15)(H2,16,17,18)",VMMKGHQPQIEGSQ-UHFFFAOYSA-N,C9H12N2O7P2,322.15,"(1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid","Minodronic acid|180064-38-4|BPH 261|ONO 5920|Ono-5920|Phosphonic acid, (1-hydroxy-2-imidazo(1,2-a)pyridin-3-ylethylidene)bis-|YM-529|Acido minodronico|YM529|Acide minodronique|40SGR63TGL|NSC-725590|DTXSID4048779|DTXCID4028705|Phosphonic acid, (1-hydroxy-2-imidazo[1,2-a]pyridin-3-ylethylidene)bis-|(1-hydroxy-2-{imidazo[1,2-a]pyridin-3-yl}-1-phosphonoethyl)phosphonic acid|(1-hydroxy-2-(imidazo(1,2-a)pyridin-3-yl)-1-phosphonoethyl)phosphonic acid|acidum minodronicum|RefChem:818896|Minodronate|(1-Hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-diyl)diphosphonic acid|127657-42-5|Minodronic acid [INN]|MFCD00890772|YH 529|YM 529|(1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphonoethyl)phosphonic acid|C9H12N2O7P2|Phosphonic acid, P,P'-(1-hydroxy-2-imidazo[1,2-a]pyridin-3-ylethylidene)bis-|NCGC00183829-01|(1-hydroxy-2-imidazo[1,2-a]pyridin-3-yl-1-phosphono-ethyl)phosphonic acid|minodronic-acid|(1-Hydroxy-2-Imidazo[1,2-A]pyridin-3-Ylethane-1,1-Diyl)bis(Phosphonic Acid)|UNII-40SGR63TGL|Onobis|Phosphonic acid, P,P'-(1-hydroxy-2-imidazo(1,2-a)pyridin-3-ylethylidene)bis-|M0N|bisphosphonate, 57|NSC725590|MINODRONIC ACID [MI]|Minodronic acidMinodronic acid|SCHEMBL145238|CHEMBL319144|GTPL3164|orb1905868|MINODRONIC ACID [MART.]|BDBM25308|MINODRONIC ACID [WHO-DD]|Tox21_113255|s5057|YH-529|(1-Hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-diyl)diphosphonicacid|AKOS015856182|DB06548|NSC 725590|AC-24008|AS-73348|HY-16322|(1-Hydroxy-2-imidazo[1,1-bisphos phonate|CAS-180064-38-4|CS-0006290|M2360|NS00069233|C73434|SBI-0654166.0001|YM-529; ONO-5920; YH-529|064M384|Q2823280|BRD-K89337853-001-01-1|BRD-K89337853-001-02-9|(1-HYDROXY-2-IMIDAZO(1,2-A)PYRIDIN-3-YLETHYLIDENE)DIPHOSPHONIC ACID|1-Hydroxy-2-[imidazo[1,2-a]pyridin-3-yl]ethylidene-1,1-diphosphonic Acid|(1-hydroxy-2-(imidazo[1,2-a]pyridin-3-yl)ethane-1,1-diyl)bis(phosphonic acid)"
ZOSUQUIDAR TRIHYDROCHLORIDE,multiply,multiply,multiply,multiply,multiply,multiply,multiply,multiply
ETOPOSIDE,36462,,"InChI=1S/C29H32O13/c1-11-36-9-20-27(40-11)24(31)25(32)29(41-20)42-26-14-7-17-16(38-10-39-17)6-13(14)21(22-15(26)8-37-28(22)33)12-4-18(34-2)23(30)19(5-12)35-3/h4-7,11,15,20-22,24-27,29-32H,8-10H2,1-3H3/t11-,15+,20-,21-,22+,24-,25-,26-,27-,29+/m1/s1",VJJPUSNTGOMMGY-MRVIYFEKSA-N,C29H32O13,588.6,"(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one","etoposide|33419-42-0|VePesid|Toposar|trans-Etoposide|(-)-Etoposide|Lastet|Etoposido|Etoposidum|Eposin|Sintopozid|VP-16-213|VP 16-213|4-Demethylepipodophyllotoxin beta-D-ethylideneglucoside|VP 16|NSC-141540|VP 16213|6PLQ3CP4P3|4'-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|NSC 141540|CHEBI:4911|DTXSID5023035|EPEG|DTXCID601473876|4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-beta-D-glucopyranoside)|Eposide|(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-[2]benzofuro[6,5-f][1,3]benzodioxol-8-one|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3',4'':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one|Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, 9-((4,6-O-(1R)-ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-|Furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one-, 9-((4,6-O-ethylidene-beta-D-glucopyranosyl)oxy)5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl), (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-|NSC141540|(10R,11R,15R,16S)-16-{[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano[3,2-d][1,3]dioxin-6-yl]oxy}-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo[7.7.0.0^{3,7}.0^{11,15}]hexadeca-1(9),2,7-trien-12-one|Etoposide Teva|Teva, Etoposide|alpha-D-Glucopyranosyl Isomer Etoposide|(10R,11R,15R,16S)-16-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano(3,2-d)(1,3)dioxin-6-yl)oxy)-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo(7.7.0.0^(3,7).0^(11,15))hexadeca-1(9),2,7-trien-12-one|(5S,5aR,8aR,9R)-5-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano(3,2-d)(1,3)dioxin-6-yl)oxy)-9-(4-hydroxy-3,5-dimethoxyphenyl)-5a,6,8a,9-tetrahydro-5H-(2)benzofuro(6,5-f)(1,3)benzodioxol-8-one|Eto GRY|RefChem:56691|Demethyl Epipodophyllotoxin Ethylidine Glucoside|L01CB01|Etoposide, alpha D Glucopyranosyl|VP 16 213|(10R,11R,15R,16S)-16-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-hexahydro-2H-pyrano(3,2-d)(1,3)dioxin-6-yl)oxy)-10-(4-hydroxy-3,5-dimethoxyphenyl)-4,6,13-trioxatetracyclo(7.7.0.03,7.011,15)hexadeca-1,3(7),8-trien-12-one|(5R,5aR,8aR,9S)-9-((4,6-O-(1R)-Ethylidene-beta-D-glucopyranosyl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,8,8a,9-tetrahydrofuro(3',4':6,7)naphtho(2,3-d)(1,3)dioxol-6(5aH)-one|251-509-1|9-((4,6-O-Ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one|Zuyeyidal|Etoposidum [INN-Latin]|VP-16|Etoposide (VP16)|Vepesid J|Etoposide (VP-16)|VP 16 (pharmaceutical)|Epipodophyllotoxin VP-16213|CHEMBL44657|MFCD00869325|NK 171|Etosid|C29H32O13|Etoposido [INN-Spanish]|(5R,5aR,8aR,9S)-9-(((4aR,6R,7R,8R,8aS)-7,8-Dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one|(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside|Etopophos (phosphate salt)|Etopol|Demethylepipodophyllotoxin-beta-D-ethylideneglucoside|SMR000112002|CCRIS 2392|HSDB 6517|VePESID (TN)|EINECS 251-509-1|UNII-6PLQ3CP4P3|4'-Demethylepipodophyllotoxin ethylidene-.beta.-D-glucoside|NCGC00016821-01|(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol -5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside|EVP|Furo[3',4':6,7]naphtho[2,3-d]-1,3-dioxol-6(5aH)-one, 9-[[4,6-O-(1R)-ethylidene-.beta.-D-glucopyranosyl]oxy]-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-, (5R,5aR,8aR,9S)-|4'-O-Demethyl-1-O-(4,6-O-ethylidene-beta-D-glucopyranosyl)epipodophyllotoxin|Epipodophyllotoxin, 4'-demethyl-, 9-(4,6-O-ethylidene-beta-D-glucopyranoside)|CAS-33419-42-0|Etoposide (Standard)|Etoposide [USAN:USP:INN:BAN:JAN]|Etoposide; VP-16|CPD000112002|Epipodophyllotoxin-beta-D-ethyliden-glucoside, 4'-demethyl-|ETOPOSIDE [INN]|ETOPOSIDE [JAN]|ETOPOSIDE [MI]|ETOPOSIDE [HSDB]|ETOPOSIDE [IARC]|ETOPOSIDE [USAN]|Prestwick3_000396|ETOPOSIDE [VANDF]|ETOPOSIDE [MART.]|Epipodophyllotoxin, 4'-demethyl-, 4,6-O-ethylidene-beta-D-glucopyranoside|ETOPOSIDE [USP-RS]|ETOPOSIDE [WHO-DD]|ETOPOSIDE [WHO-IP]|SCHEMBL4259|BSPBio_000611|9-((4,6-O-Ethylidene-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,5-dimethoxyphenyl)-furo(3',4':6,7)naphtho(2,3-d)-1,3-dioxol-6(5aH)-one, (5R-(5alpha,5abeta,8aalpha,9beta(R*)))-|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4- hydroxy-3,4-dimethyloxyphenyl)furo (3',4'':6,7) naptho-(2,3-d)-1,3-dioxol-6 (5aH)-one|MLS000049957|MLS001074951|MLS001424283|MLS002153463|MLS002207239|MLS002222184|Etoposide - Bio-X trade mark|Etoposide (JP18/USP/INN)|BPBio1_000673|GTPL6815|orb1310906|ETOPOSIDE [EP IMPURITY]|ETOPOSIDE [ORANGE BOOK]|ETOPOSIDE [EP MONOGRAPH]|ETOPOSIDE [USP IMPURITY]|SCHEMBL29653657|ETOPOSIDE [USP MONOGRAPH]|ETOPOSIDUM [WHO-IP LATIN]|HMS2052N05|HMS2089F14|HMS2096O13|HMS2232L03|HMS3713O13|HMS6018O17|EX-A1207|Tox21_110630|Tox21_302201|BDBM50127140|HY-13629R|MSK001347|s1225|Etoposide - CAS 33419-42-0|AKOS007930275|BCP9000669|CCG-101165|CS-1774|DB00773|Etoposide, synthetic, >=98%, powder|ME09941|NC00415|SDCCGSBI-0050405.P002|4'-Demethyl-epipodophyllotoxin 9-[4,6-O-(R)-ethylidene-beta-D-glucopyranoside|NCGC00179504-02|NCGC00255126-01|AS-35312|BE164434|HY-13629|SBI-0051910.P002|AB00438905|NS00009585|EN300-97099|C01576|D00125|AB00438905-17|AB00438905-18|AB00438905_19|419E420|Q418817|SR-01000763196|SR-01000763196-3|BRD-K37798499-001-02-5|BRD-K37798499-001-05-8|BRD-K37798499-001-10-8|BRD-K37798499-001-14-0|BRD-K37798499-001-18-1|BRD-K37798499-001-21-5|BRD-K37798499-001-22-3|BRD-K37798499-001-25-6|BRD-K37798499-001-27-2|-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside|Etoposide, British Pharmacopoeia (BP) Reference Standard|Z1304065033|Etoposide, European Pharmacopoeia (EP) Reference Standard|Etoposide, United States Pharmacopeia (USP) Reference Standard|4'-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-?-D-glucopyranoside)|4?-Demethylepipodophyllotoxin 9-(4,6-O-ethylidene-b-D-glucopyranoside)|4''-Demethylepipodophyllotoxin 9-(4,6-O-(R)-ethylidene-beta-D-glucopyranoside)|4'-DEMETHYLEPIPODOPHYLLOTOXIN 9-(4,6-O-(R)-ETHYLIDENE-.BETA.-D-GLUCOPYRANOSIDE)|Etoposide for system suitability, European Pharmacopoeia (EP) Reference Standard|(5R,5AR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahy|(5R,5aR,8aR,9S)-9-(((2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methylhexahydropyrano[3,2-d][1,3]dioxin-6-yl)oxy)-5-(4-hydroxy-3,5-dimethoxyphenyl)-5,5a,8a,9-tetrahydrofuro[3',4':6,7]naphtho[2,3-d][1,3]dioxol-6(8H)-one|(5R,5AR,8AR,9S)-9-((4,6-O-((1R)-ETHANE-1,1-DIYL)-.ALPHA.-D-GLUCOPYRANOSYL)OXY)-5-(4-HYDROXY-3,5-DIMETHOXYPHENYL)-5,8,8A,9-TETRAHYDRO(2)BENZOFURO(5,6-F)(1,3)BENZODIOXOL-6(5AH)-ONE|(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[5,6-f][1,3]benzodioxol-8-one|(5S,5aR,8aR,9R)-5-[[(2R,4aR,6R,7R,8R,8aS)-7,8-dihydroxy-2-methyl-4,4a,6,7,8,8a-hexahydropyrano[3,2-d][1,3]dioxin-6-yl]oxy]-9-(4-hydroxy-3,5-dimethoxy-phenyl)-5a,6,8a,9-tetrahydro-5H-isobenzofuro[6,5-f][1,3]benzodioxol-8-one|(5S,5aR,8aR,9R)-9-(4-hydroxy-3,5-dimethoxyphenyl)-8-oxo-5,5a,6,8,8a,9-hexahydrofuro[3'',4'':6,7]naphtho[2,3-d][1,3]dioxol-5-yl 4,6-O-[(1R)-ethylidene]-beta-D-glucopyranoside|121471-01-0|9-((4,6-O-Ethylidine-beta-D-glucopyranosyl)oxy)-5,8,8a,9-tetrahydro-5-(4-hydroxy-3,4-dimethyloxyphenyl)furo(3'',4'''':6,7)naptho-(2,3-d)-1,3-dioxol-6(5aH)-one|FURO(3',4':6,7)NAPHTHO(2,3-D)-1,3-DIOXOL-6(5AH)-ONE-, 9-((4,6-O-ETHYLIDENE-.BETA.-D-GLUCOPYRANOSYL)OXY)5,8,8A,9-TETRAHYDRO-5-(4-HYDROXY-3,5-DIMETHOXYPHENYL), (5R-(5.ALPHA.,5A.BETA.,8A.ALPHA.,9.BETA.(R*)))-"
BENZBROMARONE,2333,,"InChI=1S/C17H12Br2O3/c1-2-13-15(10-5-3-4-6-14(10)22-13)16(20)9-7-11(18)17(21)12(19)8-9/h3-8,21H,2H2,1H3",WHQCHUCQKNIQEC-UHFFFAOYSA-N,C17H12Br2O3,424.1,"(3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone","benzbromarone|3562-84-3|Benzbromaron|MJ 10061|Benzbromaronum|Uroleap|Methanone, (3,5-dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)-|3,5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone|Benzpromarone|2-Ethyl-3-(3,5-dibrom-4-hydroxybenzoyl)benzofuran|L-2214|NSC-85433|Benzbromarona|DTXSID4022652|4POG0RL69O|CHEBI:3023|MJ-10061|DTXCID702652|AL, Benzbromaron|Benzbromaron ratiopharm|2,6-dibromo-4-((2-ethyl-1-benzofuran-3-yl)carbonyl)phenol|2,6-dibromo-4-[(2-ethyl-1-benzofuran-3-yl)carbonyl]phenol|3,5-Dibromo-4-hydroxyphenyl 2-ethylbenzo(b)furan-3-yl ketone|3,5-dibromo-4-hydroxyphenyl 2-ethylbenzo[b]furan-3-yl ketone|Narcaricin mite|RefChem:561620|M04AB03|222-630-7|Desuric|Urinorm|Normurat|Uricovac|Minuric|Exurate|Hipurik|Azubromaron|Narcaricin|L 2214-Labaz|Uroleap (TN)|Besuric|L 2214|MFCD00078962|NSC 85433|3-(3,5-Dibromo-4-hydroxybenzoyl)-2-ethylbenzofuran|(3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone|(3,5-Dibromo-4-hydroxyphenyl)(2-ethylbenzofuran-3-yl)methanone|NSC85433|KETONE, 3,5-DIBROMO-4-HYDROXYPHENYL 2-ETHYL-3-BENZOFURANYL|(3,5-dibromo-4-hydroxyphenyl)-(2-ethyl-1-benzofuran-3-yl)methanone|CPD000058310|Benzofuran, 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethyl-|MLS000028522|MLS000737128|CHEMBL388590|Harolan|NCGC00013895-08|Benzobromarona|3, 5-Dibromo-4-hydroxyphenyl-2-ethyl-3-benzofuranyl ketone|3-[3,5-DIBROMO-4-HYDROXYBENZOYL]-2-ETHYLBENZOFURAN|SMR000058310|CAS-3562-84-3|(3,5-dibromo-4-hydroxy-phenyl)-(2-ethylbenzofuran-3-yl)methanone|C17H12Br2O3|Benzbromaronum [INN-Latin]|Benzobromarona [INN-Spanish]|Benzbromarone [USAN:INN:BAN]|L2214-Labaz|Max-uric|[3,5-bis(bromanyl)-4-oxidanyl-phenyl]-(2-ethyl-1-benzofuran-3-yl)methanone|L2214|SR-01000003082|EINECS 222-630-7|UNII-4POG0RL69O|BRN 0273668|benzbromaron?|(2-Ethyl-3-benzofuranyl)-(3,5-dibrom-4-hydroxyphenyl)keton|(3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)methanone|ML054|NCI85433|R75|Prestwick_709|Benzbromarone(USAN)|3,5-Dibromo-4-hydroxyphenyl 2-ethyl-3-benzofuranyl Ketone|Benzbromarone (Standard)|Opera_ID_1282|Prestwick0_000370|Prestwick1_000370|Prestwick2_000370|Prestwick3_000370|Benzbromarone 100 microg/mL in Acetonitrile|BENZBROMARONE [MI]|BENZBROMARONE [INN]|BENZBROMARONE [JAN]|cid_2333|NCIStruc1_001498|NCIStruc2_001681|BENZBROMARONE [USAN]|Oprea1_140235|SCHEMBL48993|BSPBio_000499|MLS001074105|MLS001424143|BENZBROMARONE [MART.]|2-Ethyl-3-(3,5-dibromo-4-hydroxybenzoyl)benzofuran|SPBio_002420|BENZBROMARONE [WHO-DD]|BPBio1_000549|orb1309157|SCHEMBL29361528|HY-B1135R|Benzbromarone, analytical standard|Benzbromarone (JP18/USAN/INN)|HMS1569I21|HMS2052K05|HMS2093J04|HMS2096I21|HMS2230D20|HMS3394K05|HMS3652H15|HMS3713I21|HMS3744G15|HMS5082D14|Pharmakon1600-01505971|(3,5-Dibromo-4-hydroxyphenyl)-(2-ethylbenzofuran-3-yl)methanone|BCP07515|EX-A1131|HY-B1135|BENZBROMARONE [EP MONOGRAPH]|Tox21_110041|BDBM50158460|CCG-37198|MSK000451|NCGC00013895|NSC759281|s4221|SBB057006|Benzbromarone 1.0 mg/ml in Methanol|AKOS015895856|Tox21_110041_1|AC-6162|CS-4740|DB12319|FD18180|KS-1292|NC00334|NSC-759281|NCGC00013895-01|NCGC00013895-02|NCGC00013895-03|NCGC00013895-04|NCGC00013895-05|NCGC00013895-06|NCGC00013895-07|NCGC00013895-09|NCGC00013895-11|NCGC00013895-13|NCGC00022066-04|NCI60_041884|SY018127|SBI-0055383.P002|B4099|NS00001815|ST50993903|SW196858-4|UNM000001228903|D01056|562B843|Q410435|SR-01000003082-5|SR-01000003082-6|BRD-K11717138-001-03-0|BRD-K11717138-001-16-2|BRD-K11717138-001-29-5|BRD-K11717138-001-30-3|Ketone,5-dibromo-4-hydroxyphenyl 2-ethyl-3-benzofuranyl|Benzbromarone, certified reference material, TraceCERT(R)|Benzbromarone, European Pharmacopoeia (EP) Reference Standard|Methanone,5-dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)-|(3,5-Dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone #|Methanone, (3, 5-dibromo-4-hydroxyphenyl)(2-ethyl-3-benzofuranyl)-|benzbromarone; bzm; 3-(3,5-dibromo-4-hydroxybenzoyl)-2-ethylbenzofuran; (3,5-dibromo-4-hydroxyphenyl)(2-ethyl-1-benzofuran-3-yl)methanone|Benzbromarone;3,5-Dibromo-4-hydroxyphenyl 2-ethyl-3-benzofuranyl ketone;2-Ethyl-3-(3,5-dibromo-4-hydroxybenzoyl)benzofuran"
LESINURAD,53465279,,"InChI=1S/C17H14BrN3O2S/c18-16-19-20-17(24-9-15(22)23)21(16)14-8-7-11(10-5-6-10)12-3-1-2-4-13(12)14/h1-4,7-8,10H,5-6,9H2,(H,22,23)",FGQFOYHRJSUHMR-UHFFFAOYSA-N,C17H14BrN3O2S,404.3,"2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid","LESINURAD|878672-00-5|RDEA594|RDEA 594|Zurampic|RDEA-594|09ERP08I3W|2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid|CHEBI:90929|DUZALLO COMPONENT LESINURAD|DTXSID201026091|2-{[5-broMo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid|{[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]sulfanyl}acetic acid|lesinuradum|((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)sulfanyl)acetic acid|2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-1,2,4-triazol-3-yl)sulfanyl)acetic acid|2-((5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3-YL)SULFANYL)ACETIC ACID|RefChem:56326|M04AB05|DTXCID901510348|((5-bromo-4-(4-cyclopropyl-1-naphthyl)-4H-1,2,4-triazol-3-yl)sulfanyl)acetic acid|2-((5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl)thio)acetic acid|Lesinurad free acid|(+)-Lesinurad|(-)-Lesinurad|Lesinurad, (+)-|Lesinurad, (-)-|Lesinurad, (4R)-|Lesinurad, (4S)-|MFCD22572730|Q59CAT99RS|73WY698HZ7|878672-00-5 (free acid)|2-[[5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic acid|A1AIL|2-(5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid|1890222-26-0|2-(((4R)-5-Bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)acetic acid|2-(((4S)-5-Bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)acetic acid|Acetic acid, 2-((5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)-|1890222-25-9|Acetic acid, 2-(((4R)-5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)-|Acetic acid, 2-(((4S)-5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl)thio)-|Lesinurad [USAN]|Lesinurad [USAN:INN]|UNII-09ERP08I3W|Lesurinad|Zurampic (TN)|[[5-bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic Acid; 2-[[5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-yl]thio]acetic Acid; Lesinida; Lesinurad; RDEA 594|Lesinurad (RDEA594|LESINURAD [INN]|LESINURAD [MI]|Lesinurad (USAN/INN)|Lesinurad (RDEA594)|Lesinurad (RDEA594?|UNII-Q59CAT99RS|LESINURAD [WHO-DD]|SCHEMBL842962|UNII-73WY698HZ7|GTPL7673|orb1300386|LESINURAD [ORANGE BOOK]|CHEMBL2105720|Lesinurad, >=98% (HPLC)|SCHEMBL29353441|BDBM37953|HMS3874M03|HMS5083O06|BCP06435|EX-A1289|US10093631, Compound Lesinurad|MSK160035|s4640|AKOS027327368|CCG-268685|CS-1389|DB11560|FL65059|SB16705|AC-29310|AS-56014|HY-15258|RDEA 594;RDEA-594;RDEA594|NS00072999|D09921|EN300-7399813|BRD-K75024268-001-01-0|Q21820633|(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid|2-(5-bromo-4-(1-cyclopropylnaphthalen-4-yl)-4H-1,2,4-triazol-3-ylthio)acetic acid|2-[[5-Bromo-4-(4-cyclopropyl-1-naphthalenyl)-4H-1,2,4-triazol-3-yl]thio]-acetic acid|2-[[5-bromo-4-(4-cyclopropyl-1-naphthyl)-1,2,4-triazol-3-yl]sulfanyl]acetic acid|2-((5-BROMO-4-(4-CYCLOPROPYLNAPHTHALEN-1-YL)-4H-1,2,4-TRIAZOL-3- YL)SULFANYL)ACETIC ACID|2-{[5-Bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-\ 3-yl]sulfanyl}acetic acid"
GLYCOPYRRONIUM,3494,,"InChI=1S/C19H28NO3/c1-20(2)13-12-17(14-20)23-18(21)19(22,16-10-6-7-11-16)15-8-4-3-5-9-15/h3-5,8-9,16-17,22H,6-7,10-14H2,1-2H3/q+1",ANGKOCUUWGHLCE-UHFFFAOYSA-N,C19H28NO3+,318.4,"(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenylacetate","Glycopyrronium|Glycopyrrolate cation|Glycopyrrolate ion|Glycopyrronium ion|Glycopyrronium cation|Glycopyrronium, erythro-|740028-90-4|Pyrrolidinium, 3-((cyclopentylhydroxyphenylacetyl)oxy)-1,1-dimethyl-|RefChem:922362|Pyrrolidinium, 3-[(cyclopentylhydroxyphenylacetyl)oxy]-1,1-dimethyl-|A14FB57V1D|13283-82-4|Robinal|3-(2-Cyclopentyl-2-hydroxy-2-phenylacetoxy)-1,1-dimethylpyrrolidin-1-ium|NCGC00179456-02|Tovanor Breezhaler|.beta.-1-Methyl-3-pyrrolidyl-.alpha.-cyclopentylmandelate methobromide|Prestwick0_000746|Prestwick1_000746|Prestwick2_000746|Prestwick3_000746|BSPBio_000732|SCHEMBL133002|SPBio_002671|BPBio1_000806|GTPL7459|CHEMBL1201335|DTXSID2048165|CHEBI:94449|ANGKOCUUWGHLCE-UHFFFAOYSA-N|Qbrexza&reg (glycopyrronium cloth)|BDBM50417445|Pyrrolidinium, 3-hydroxy-1,1-dimethyl-, bromide, .alpha.-cyclopentylmandelate|DB00986|MRF-0000310|NCGC00179456-01|SBI-0206947.P001|AB00513912|NS00008486|D10938|AB00513912-08|AB00513912_10|L001045|Q411917|BRD-A81233518-004-07-0|BRD-A81233518-004-16-1|3-[(2-Cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethylpyrrolidinium|(1,1-dimethylpyrrolidin-1-ium-3-yl) 2-cyclopentyl-2-hydroxy-2-phenyl-acetate|2-cyclopentyl-2-hydroxy-2-phenylacetic acid (1,1-dimethyl-3-pyrrolidin-1-iumyl) ester|Pyrrolidinium, 3-[(2-cyclopentyl-2-hydroxy-2-phenylacetyl)oxy]-1,1-dimethyl-"
DOLUTEGRAVIR,54726191,,"InChI=1S/C20H19F2N3O5/c1-10-4-5-30-15-9-24-8-13(17(26)18(27)16(24)20(29)25(10)15)19(28)23-7-11-2-3-12(21)6-14(11)22/h2-3,6,8,10,15,27H,4-5,7,9H2,1H3,(H,23,28)/t10-,15+/m1/s1",RHWKPHLQXYSBKR-BMIGLBTASA-N,C20H19F2N3O5,419.4,"(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide","Dolutegravir|1051375-16-6|GSK1349572|S/GSK1349572|GSK 1349572|GSK-1349572|S-349572|CHEBI:76010|(4R,12aS)-N-[(2,4-Difluorophenyl)methyl]-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-pyrido[1',2':4,5]pyrazino[2,1-b][1,3]oxazine-9-carboxamide|DKO1W9H7M1|DTXSID90909356|2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)-|dolutegravirum|(4R,12aS)-N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide|(4R,12aS)-N-((2,4-difluorophenyl)methyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido(5,6)pyrazino(2,6-b)(1,3)oxazine-9-carboxamide|(4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[5,6]pyrazino[2,6-b][1,3]oxazine-9-carboxamide|RefChem:56964|J05AX12|DTXCID701338419|(14C)-(4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-(1,3)oxazino(3,2-a)pyrido(1,2-d)pyrazine-9-carboxamide|(4R,9aS)-5-hydroxy-4-methyl-6,10-dioxo-3,4,6,9,9a,10-hexahydro-2H-1-oxa-4a,8a-diaza-anthracene-7-carboxylic acid-2,4 difluorobenzylamide|2H-Pyrido(1',2':4,5)pyrazino(2,1-b)(1,3)oxazine-9-carboxamide, N-((2,4-difluorophenyl)methyl)-3,4,6,8,12,12a-hexahydro-7-hydroxy-4-methyl-6,8-dioxo-, (4R,12aS)|Tivicay|Dolutegravir (GSK1349572)|(4r,12as)-N-(2,4-Difluorobenzyl)-7-Hydroxy-4-Methyl-6,8-Dioxo-3,4,6,8,12,12a-Hexahydro-2h-Pyrido[1',2':4,5]pyrazino[2,1-B][1,3]oxazine-9-Carboxamide|Dolutegravir  DTG|Dolutegravir [USAN]|(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0^{3,8}]tetradeca-10,13-diene-13-carboxamide|Dolutegravir (USAN)|1051375-16-6 (free)|Tivicay (TN)|(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-13-carboxamide|Dolutegravir (0.1 mg/mL in Methanol)|Dolutegravir [USAN:INN]|UNII-DKO1W9H7M1|Soltegravir|Dolutegravir?|HSDB 8152|C20H19F2N3O5|MFCD20488027|S-GSK1349572|3s3m|3s3n|3s3o|Dolutegravir (Standard)|(4R,12aS)-N-[(2,4-difluorophenyl)methyl]-7-hydroxy-4-methyl-6,8-dioxo-3,4,12,12a-tetrahydro-2H-pyrido[[?]:[?]]pyrazino[[?]][1,3]oxazine-9-carboxamide|DOLUTEGRAVIR [MI]|DOLUTEGRAVIR [INN]|DOLUTEGRAVIR [VANDF]|SCHEMBL82071|MLS006011137|DOLUTEGRAVIR [WHO-DD]|GTPL7365|orb1300988|CHEMBL1229211|SCHEMBL15397915|SCHEMBL29357473|RHWKPHLQXYSBKR-BMIGLBTASA-N|EX-A1695|BDBM50062551|HY-13238R|s2667|AKOS025396657|S/GSK-1349572|BCP9000620|CCG-268876|CS-0454|DB08930|FD43372|NCGC00346629-01|NCGC00346629-02|NCGC00346629-11|AC-28371|AS-75277|HY-13238|SMR004702915|NS00099377|S/GSK1349572,GSK1349572|D10066|EN300-7409916|F799806|Q937224|Z2235801952|(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0(3),?]tetradeca-10,13-diene-13-carboxamide|(3S,7R)-N-[(2,4-difluorophenyl)methyl]-11-hydroxy-7-methyl-9,12-dioxo-4-oxa-1,8-diazatricyclo[8.4.0.0,3,8]tetradeca-10,13-diene-13-carboxamide|(4R,12.ALPHA.S)-N-((2,4-DIFLUOROPHENYL)METHYL)-7-HYDROXY-4-METHYL-6,8-DIOXO-3,4,6,8,12,12.ALPHA.-HEXAHYDRO-2H-PYRIDO(1',2':4,5)PYRAZINO(2,1-.BETA.)(1,3)OXAZINE-9-CARBOXAMIDE|(4R,12aS)-N-(2,4-difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-a]pyrido[1,2-d]pyrazine-9-carboxamide|(4R,12aS)-N-(2,4-Difluorobenzyl)-7-hydroxy-4-methyl-6,8-dioxo-3,4,6,8,12,12a-hexahydro-2H-[1,3]oxazino[3,2-d]pyrido[1,2-a]pyrazine-9-carboxamide"
GLYCYRRHIZIN,14982,,"InChI=1S/C42H62O16/c1-37(2)21-8-11-42(7)31(20(43)16-18-19-17-39(4,36(53)54)13-12-38(19,3)14-15-41(18,42)6)40(21,5)10-9-22(37)55-35-30(26(47)25(46)29(57-35)33(51)52)58-34-27(48)23(44)24(45)28(56-34)32(49)50/h16,19,21-31,34-35,44-48H,8-15,17H2,1-7H3,(H,49,50)(H,51,52)(H,53,54)/t19-,21-,22-,23-,24-,25-,26-,27+,28-,29-,30+,31+,34-,35-,38+,39-,40-,41+,42+/m0/s1",LPLVUJXQOOQHMX-QWBHMCJMSA-N,C42H62O16,822.9,"(2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid","Glycyrrhizic acid|glycyrrhizin|1405-86-3|Glycyrrhizinic acid|Glycyron|Glycyrrhetinic acid glycoside|potenlini|Glizigen|glycyrrhizate|18-beta-Glycyrrhizic acid|beta-Glycyrrhizin|18beta-Glycyrrhizic acid|Glycyrrizin|Rizinsan K2 A2 (free acid)|HSDB 496|CHEBI:15939|EINECS 215-785-7|NSC 167409|NSC 234419|NSC-167409|NSC-234419|UNII-6FO62043WK|BRN 0077922|CCRIS 8444|DTXSID8047006|6FO62043WK|DTXCID6027006|4-18-00-05156 (Beilstein Handbook Reference)|(3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid|20beta-Carboxy-11-oxo-30-norolean-12-en-3beta-yl-2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid|30-hydroxy-11,30-dioxoolean-12-en-3beta-yl (2-O-beta-D-glucopyranosyluronic acid)-alpha-D-glucopyranosiduronic acid|alpha-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl-2-O-beta-D-glucopyranuron osyl-|GLYCYRRHIZIN (II)|GLYCYRRHIZIN [II]|(3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid|GLYCYRRHIZIC ACID (MART.)|GLYCYRRHIZIC ACID [MART.]|GLYCYRRHIZIC ACID (USP-RS)|GLYCYRRHIZIC ACID [USP-RS]|NSC167409|NSC234419|Acid, Glycyrrhizic|Acid, Glycyrrhizinic|RefChem:37949|alpha-D-glucopyranosiduronic acid, (3 beta,20 beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-|GLYCYRRHIZIC ACID (GLYCYRRHIZIN) (CONSTITUENT OF LICORICE)|(3beta,20beta)-20-Carboxy-11-oxo-30-norlean-12-en-3-yl-2-O-beta-1-7-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid|20BETA-CARBOXY-11-OXO-30-NOROLEAN-12-EN-3BETA-YL-2-O-BE TA-D-GLUCOPYRANURONOSYL-ALPHA-D-GLUCOPYRANOSIDURONIC ACID|215-785-7|alpha-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norlean-12-en-3-yl-2-O-beta-1-7-glucopyranuronosyl-|glyzyrrhizin|Glycyrrhizin [JAN]|MFCD00065194|Liquorice|.beta.-glycyrrhizin|18.beta.-glycyrrhizic acid|Glycyrrhizinate|CHEMBL441687|C42H62O16|(2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid|Glycyrrhizicacid|Neo-Umor|alpha-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-beta-D-glucopyranuronosyl-|(2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxy-tetrahydropyran-3-yl]oxy-3,4,5-trihydroxy-tetrahydropyran-2-carboxylic acid|(2S,3S,4S,5R,6S)-6-{[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicen-3-yl]oxy}-5-{[(2R,3R,4S,5S,6S)-6-carboxy-3,4,5-trihydroxyoxan-2-yl]oxy}-3,4-dihydroxyoxane-2-carboxylic acid|CAS-1405-86-3|Glycyrrhizic acid?|NCGC00183128-01|ammonium-glycyrrhizinate|Glycyrrhizic acid, 2K|beta-Glycyrrhizinic acid|Glycyrrhizic acid - 80%|Glycyrrhizic acid - 98%|GLYCYRRHIZIN [HSDB]|SCHEMBL17684|BIDD:ER0363|GLYCYRRHIZIC ACID [MI]|GTPL4688|orb1305086|Glycyrrhizin (Glycyrrhizic Acid)|GLYCYRRHIZIC ACID [WHO-DD]|HY-N0184|MSK40365|Tox21_111520|Tox21_113426|Tox21_303493|BDBM50185127|HMDB:0029843|s2302|AKOS015893086|AKOS015969345|CCG-270511|CS-7695|DB13751|GM-1292|OG08293|NCGC00257455-01|NCGC00386162-01|NCGC00386162-02|(3beta,20beta)-20-Carboxy-11-oxo-30-norlean-12-en-3-yl-2-O-beta-1- 7-glucopyranuronosyl-alpha-D-glucopyranosiduronic acid|alpha-D-Glucopyranosiduronic acid, (3beta,20beta)-20-carboxy-11-oxo-30-norlean-12-en-3-yl-2-O-beta-1- 7-glucopyranuronosyl-|AS-13001|E958|SY017548|XG180042|G0150|NS00008393|AB01566834_01|405G863|EN300-25023649|Q418705|BRD-K83486494-318-01-5|GLYCYRRHIZIC ACID (GLYCYRRHIZIN) (CONSTITUENT OF LICORICE) [DSC]|Glycyrrhizic acid, United States Pharmacopeia (USP) Reference Standard|Glycyrrhizic Acid, Pharmaceutical Secondary Standard; Certified Reference Material|(2S,3S,4S,5R,6R)-6-[(2S,3R,4S,5S,6S)-2-[[(3S,4aR,6aR,6bS,8aS,11S,12aR,14aR,14bS)-11-carboxy-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1H-picen-3-yl]oxy]-6-carboxy-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylicacid|(3.beta.,20.beta.)-20-Carboxy-11-oxo-30-norlean-12-en-3-yl-2-O-.beta.-1- 7-glucopyranuronosyl-.alpha.-D-glucopyranosiduronic acid|(3.BETA.,20.BETA.)-20-CARBOXY-11-OXO-30-NOROLEAN-12-EN-3-YL 2-O-.BETA.-D-GLUCOPYRANURONOSYL-.ALPHA.-D-GLUCOPYRANOSIDURONIC ACID|(3b,20b)-20-Carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-(b-D-glucopyranuronosyl)-b-D-glucopyranosiduronic acid|(3b,20b)-20-Carboxy-11-oxo-30-norolean-12-en-3-yl 2-O-(b-D-glucopyranuronosyl)-b-D-glucopyranosiduronic Acid;3-O-(2-O-b-D-Glucopyran uronosyl-a-D-glucopyranuronosyl)-18-b-glycyrrhetinic acid"
PF-00562271,16118986,,"InChI=1S/C21H20F3N7O3S.C6H6O3S/c1-31(35(2,33)34)19-12(4-3-7-25-19)10-26-18-15(21(22,23)24)11-27-20(30-18)28-14-5-6-16-13(8-14)9-17(32)29-16;7-10(8,9)6-4-2-1-3-5-6/h3-8,11H,9-10H2,1-2H3,(H,29,32)(H2,26,27,28,30);1-5H,(H,7,8,9)",LKLWTLXTOVZFAE-UHFFFAOYSA-N,C27H26F3N7O6S2,665.7,"benzenesulfonic acid;N-methyl-N-[3-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]pyridin-2-yl]methanesulfonamide","939791-38-5|PF-562271 besylate|PF-00562271|PF-562271 (besylate)|N-methyl-N-(3-(((2-((2-oxoindolin-5-yl)amino)-5-(trifluoromethyl)pyrimidin-4-yl)amino)methyl)pyridin-2-yl)methanesulfonamide benzenesulfonate|939791-38-5 (besylate)|PF-562271 (benzesulfonate salt)|MFCD14105612|FK2M84H8UI|N-methyl-N-(3-((2-(2-oxoindolin-5-ylamino)-5-(trifluoromethyl)pyrimidin-4-ylamino)methyl)pyridin-2-yl)methanesulfonamide benzenesulfonate|CHEMBL2430359|PF-562271 BESILATE|N-[3-[[[2-[(2,3-Dihydro-2-oxo-1H-indol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]-2-pyridinyl]-N-methyl-methanesulfonamide benzenesulfonate|PF 562271 besylate|LKLWTLXTOVZFAE-UHFFFAOYSA-N|PF-562271 Tosylate|UNII-FK2M84H8UI|benzenesulfonic acid;N-methyl-N-[3-[[[2-[(2-oxo-1,3-dihydroindol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]pyridin-2-yl]methanesulfonamide|PF-562271 benzenesulfonate|Pf562271 Benzene Sulfonate|orb1301007|SCHEMBL20471937|C27H26F3N7O6S2|DTXSID40240064|EX-A573|GLXC-15751|HMS3651N09|BCP14770|PF-562271 PHSO3H SALT|s2672|PF 562271 [WHO-DD]|AKOS025401942|PF-562271 PHSO3H SALT?|CCG-270344|SB12448|AC-27465|AS-75267|DA-76749|HY-10458|SW219484-1|PF 00562271-26|PF-562,271, >=98% (HPLC)|benzenesulfonic acid;N-methyl-N-[3-[[[2-[(2-oxoindolin-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl]amino]methyl]-2-pyridyl]methanesulfonamide|Methanesulfonamide, N-(3-(((2-((2,3-dihydro-2-oxo-1H-indol-5-yl)amino)-5-    (trifluoromethyl)-4-pyrimidinyl)amino)methyl)-2-pyridinyl)-N-methyl-, benzenesulfonate (1:1)|METHANESULFONAMIDE, N-(3-(((2-((2,3-DIHYDRO-2-OXO-1H-INDOL-5-YL)AMINO)-5-(TRIFLUOROMETHYL)-4-PYRIMIDINYL)AMINO)METHYL)-2-PYRIDINYL)-N-METHYL-, BENZENESULFONATE|N-methyl-N-{3-[({2-[(2-oxo-2,3-dihydro-1H-indol-5-yl)amino]-5-(trifluoromethyl)pyrimidin-4-yl}amino)methyl]pyridin-2-yl}methanesulfonamide; benzenesulfonic acid"
FOSMIDOMYCIN,572,,"InChI=1S/C4H10NO5P/c6-4-5(7)2-1-3-11(8,9)10/h4,7H,1-3H2,(H2,8,9,10)",GJXWDTUCERCKIX-UHFFFAOYSA-N,C4H10NO5P,183.10,3-[formyl(hydroxy)amino]propylphosphonic acid,"fosmidomycin|66508-53-0|Fosmidomycina|Fosmidomycine|Fosmidomycinum|3-[FORMYL(HYDROXY)AMINO]PROPYLPHOSPHONIC ACID|Fosmidomicina|{3-[formyl(hydroxy)amino]propyl}phosphonic acid|3-(N-hydroxyformamido)propylphosphonic acid|CHEBI:443725|5829E3D9I9|DTXSID70216712|(3-(Formylhydroxyamino)propyl)phosphonic acid, monosodium salt|3-(formyl-hydroxyamino)propylphosphonic acid|3-(formyl(hydroxy)amino)propylphosphonic acid|(3-(formyl(hydroxy)amino)propyl)phosphonic acid|fosfidomycin|RefChem:600353|DTXCID00139203|3-(N-hydroxyfomamido)propylphosphonate|3-(N-formyl-N-hydroxy)aminopropylphosphonic acid|P-(3-(Formylhydroxyamino)propyl)phosphonic acid|Fosmidomycin [INN]|Fosmidomycin sodium salt hydrate|CHEMBL203125|(3-(N-Hydroxyformamido)propyl)phosphonic acid|FR-31564|[3-(N-hydroxyformamido)propyl]phosphonic acid|FOM|FR 31564|Fosmidomycine [INN-French]|Fosmidomycinum [INN-Latin]|Fosmidomycina [INN-Spanish]|UNII-5829E3D9I9|FOSMIDOMYCIN [MI]|3-(Formyl-hydroxy-amino)propylphosphonic acid|FOSMIDOMYCIN [MART.]|3-(N-Formyl-N-hydroxyamino)-propylphosphonic acid|SCHEMBL301404|GTPL9739|orb2564498|GJXWDTUCERCKIX-UHFFFAOYSA-N|GLXC-23029|BDBM50153713|AKOS006272014|DB02948|NCGC00264107-01|NCGC00264107-02|DB-249641|HY-134914|CS-0166689|NS00070647|3-(N-formyl-N-hydroxyamino)propylphosphonic acid|[3-(Formyl-hydroxy-amino)-propyl]-phosphonic acid|Q905038|(3-(Formylhydroxyamino)propyl)phosphonic acid sodium salt|(3-(N-Hydroxyformamido)propyl)phosphonic acid sodium salt"
MIP-1095,24957011,,"InChI=1S/C19H25IN4O8/c20-11-4-6-12(7-5-11)22-18(31)21-10-2-1-3-13(16(27)28)23-19(32)24-14(17(29)30)8-9-15(25)26/h4-7,13-14H,1-3,8-10H2,(H,25,26)(H,27,28)(H,29,30)(H2,21,22,31)(H2,23,24,32)/t13-,14-/m0/s1",LFEGKCKGGNXWDV-KBPBESRZSA-N,C19H25IN4O8,564.3,(2S)-2-[[(1S)-1-carboxy-5-[(4-iodophenyl)carbamoylamino]pentyl]carbamoylamino]pentanedioic acid,"MIP-1095|949575-22-8|754M4I9737|L-Glutamic acid, N-((((1S)-1-carboxy-5-((((4-iodophenyl)amino)carbonyl)amino)pentyl)amino)carbonyl)-|RefChem:158996|MIP1095|MIP 1095|CHEMBL456029|(2S)-2-[[(1S)-1-carboxy-5-[(4-iodophenyl)carbamoylamino]pentyl]carbamoylamino]pentanedioic acid|orb1703085|SCHEMBL11930755|(S)-2-(3-((S)-1-carboxy-5-(3-(4-iodophenyl)ureido)pentyl)ureido)pentanedioic acid|UNII-754M4I9737|BDBM50265783|AKOS040746114|HY-123733|NS00072527|(s)-2-(3-((s)-1-carboxy-5-(3-(4-iodophenyl)ureido)pentyl)ureido) pentanedioic acid|(S)-2-(3-((S)-1-Carboxy-5-(3-(4-iodophenyl)ureido)pentyl)ureido)pentanedioicacid|2-(3-(1-carboxy-5-(3-(4-iodobphenyl)ureido)pentyl)ureido)pentanedioic acid"
DAPAGLIFLOZIN,9887712,,"InChI=1S/C21H25ClO6/c1-2-27-15-6-3-12(4-7-15)9-14-10-13(5-8-16(14)22)21-20(26)19(25)18(24)17(11-23)28-21/h3-8,10,17-21,23-26H,2,9,11H2,1H3/t17-,18-,19+,20-,21+/m1/s1",JVHXJTBJCFBINQ-ADAARDCZSA-N,C21H25ClO6,408.9,"(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol","Dapagliflozin|461432-26-8|BMS-512148|Forxiga|BMS 512148|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol|dapagliflozine|Dapagliflozina|1ULL0QJ8UC|BMS512148|CHEBI:85078|LYN-045|(2S,3R,4R,5S,6R)-2-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-6-(hydroxymethyl)oxane-3,4,5-triol|DTXSID20905104|DAPAGLIFLOZIN COMPONENT QTERNMET|QTERNMET XR COMPONENT DAPAGLIFLOZIN|D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-, (1S)-|D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, (1S)-|(2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol|(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol|dapagliflozinum|(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-6-(hydroxymethyl)oxane-3,4,5-triol|RefChem:54930|A10BK01|DTXCID101334207|639-683-0|(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol|Dagagflozin|MFCD13182359|CHEMBL429910|Dapagliflozin [USAN:INN]|Forxiga (TN)|(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6- (hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol|CHEMBL3125458|(2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol|Dapagliflozin [USAN]|C21H25ClO6|UNII-1ULL0QJ8UC|(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol; (2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; (2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol; BMS 512148; Dapagliflozin; Farxiga|DAPAGLIFLOZIN?|S1548_Selleck|C-aryl glucoside, 6|Dapagliflozin (Standard)|DAPAGLIFLOZIN [MI]|DAPAGLIFLOZIN [INN]|DAPAGLIFLOZIN [VANDF]|SCHEMBL157820|DAPAGLIFLOZIN [WHO-DD]|GTPL4594|orb1305553|BR1019 component Dapagliflozin|Dapagliflozin (JAN/USAN/INN)|SCHEMBL29364603|BDBM20880|EX-A005|Dapagliflozin - Bio-X trade mark|JVHXJTBJCFBINQ-ADAARDCZSA-N|BCPP000265|DAPAGLIFLOZIN [ORANGE BOOK]|MSK11068|BDBM50448923|HY-10450R|s1548|QTERNMET COMPONENT DAPAGLIFOZIN|AKOS005145763|BCP9000583|BL-0052|BMS5121458|CCG-229917|CS-0781|DB06292|EX-7214|MD20795|2-(3-(4-Ethoxybenzyl)-4-chlorophenyl)-6-hydroxymethyltetrahydro-2H-pyran-3,4,5-triol|NCGC00250402-09|(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol|AC-24699|BD164346|HY-10450|SY028092|5168A|NS00099173|C22193|D08897|EN300-7407160|432D268|Q409898|BRD-K58160573-001-01-3|BRD-K58160573-001-04-7|BRD-K58160573-001-05-4|Z2235801883|(1S)-1,5-anhydro-1-[4-chloro-3-(4-ethoxybenzyl)phenyl]-D-glucitol|(1S)-1,5-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-glucitol;BMS 512148|(1S)-1,5-Anhydro-1-C-4-chloro-3-(4-ethoxyphenyl)methylphenyl-D-glucitol;BMS 512148|(2S, 3R, 4R, 5S, 6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol|(2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)-4-chlorophenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol|(2S,3R,4R,5S,6R)-2-[4-chloro-3-(4-ethoxy-benzyl)-phenyl]-6-hydroxymethyl-tetrahydro-pyran-3,4,5-triol|(2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol|LE6"
SERGLIFLOZIN ETABONATE,9824918,,"InChI=1S/C23H28O9/c1-3-29-23(27)30-13-18-19(24)20(25)21(26)22(32-18)31-17-7-5-4-6-15(17)12-14-8-10-16(28-2)11-9-14/h4-11,18-22,24-26H,3,12-13H2,1-2H3/t18-,19-,20+,21-,22-/m1/s1",QLXKHBNJTPICNF-QMCAAQAGSA-N,C23H28O9,448.5,"ethyl [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-[2-[(4-methoxyphenyl)methyl]phenoxy]oxan-2-yl]methyl carbonate","Sergliflozin etabonate|408504-26-7|GW869682X|etabonate de sergliflozine|etabonato de sergliflozina|GW-869682X|GW-869683X|2-(4-Methoxybenzyl)phenyl 6-O-(ethoxycarbonyl)-beta-D-glucopyranoside|4HY3523466|DTXSID20961265|sergliflozini etabonas|RefChem:182505|2-((4-methoxyphenyl)methyl)phenyl 6-o-ethoxycarbonylglucopyranoside|DTXCID001389097|2-(4-Methoxybenzyl)phenyl6-O-(ethoxycarbonyl)-beta-D-glucopyranoside|Sergliflozin etabonate (USAN)|SERGLIFLOZIN ETABONATE [USAN]|ethyl (((2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(2-(4-methoxybenzyl)phenoxy)tetrahydro-2H-pyran-2-yl)methyl) carbonate|CHEMBL450044|GW 869682X|UNII-4HY3523466|Sergliflozin etabonate [USAN:INN]|SCHEMBL621807|gsk-869682|GTPL4587|orb1699324|CHEBI:188680|QLXKHBNJTPICNF-QMCAAQAGSA-N|SERGLIFLOZIN ETABONATE [INN]|MSK177664|2-[(4-Methoxyphenyl)methyl]phenyl-beta-D-glucopyranoside-6-(ethyl carbonate)|AKOS040749484|SERGLIFLOZIN ETABONATE [WHO-DD]|FM152924|HY-12611|TS-08629|CS-0012078|D06641|504M267|Q7454518|2-(4-methoxybenzyl)phenyl 6-O-ethoxycarbonyl-beta-D-glucopyranoside|.BETA.-D-GLUCOPYRANOSIDE, 2-((4-METHOXYPHENYL)METHYL)PHENYL 6-O-(ETHOXYCARBONYL)-|beta-D-Glucopyranoside, 2-((4-methoxyphenyl)methyl)phenyl, 6-(ethyl carbonate)"
CANAGLIFLOZIN ANHYDROUS,24812758,,"InChI=1S/C24H25FO5S/c1-13-2-3-15(24-23(29)22(28)21(27)19(12-26)30-24)10-16(13)11-18-8-9-20(31-18)14-4-6-17(25)7-5-14/h2-10,19,21-24,26-29H,11-12H2,1H3/t19-,21-,22+,23-,24+/m1/s1",XTNGUQKDFGDXSJ-ZXGKGEBGSA-N,C24H25FO5S,444.5,"(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol","Canagliflozin|842133-18-0|Invokana|Canagliflozin anhydrous|TA-7284|JNJ-28431754|CHEBI:73274|6S49DGR869|1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene|DTXSID601004469|Canagliflozina|Canagliflozine|(1S)-1,5-Anhydro-1-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-D-glucitol|(1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methylphenyl)-D-glucitol|(1S)-1,5-Anhydro-1-c-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol|D-Glucitol, 1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-|JNJ-24831754-ZAE|JNJ-28431754-AAA|Canagliflozin, Anhydrous|INVOKAMET COMPONENT CANAGLIFLOZIN|D-Glucitol, 1,5-anhydro-1-C-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-, hydrate (2:1), (1S)-|canagliflozinum|D-glucitol, 1,5-anhydro-1-c-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-methylphenyl)-, (1s)-|RefChem:398790|A10BK02|DTXCID901431370|(1S)-1,5-Anhydro-1-C-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-D-glucitol hemihydrate|1-(Glucopyranosyl)-4-methyl-3-(5-(4-fluorophenyl)-2-thienylmethyl)benzene-T777973|0SAC974Z85|928672-86-0|Canagliflozin Hemihydrate|MFCD18251436|(2S,3R,4R,5S,6R)-2-(3-((5-(4-FLUOROPHENYL)THIOPHEN-2-YL)METHYL)-4-METHYLPHENYL)-6-(HYDROXYMETHYL)TETRAHYDRO-2H-PYRAN-3,4,5-TRIOL|Canagliflozin [INN]|D-Glucitol,1,5-anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-, (1S)-|Canagliflozin hydrate|C24H25FO5S|(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)oxane-3,4,5-triol|TA 7284|JNJ 28431754|(2S,3R,4R,5S,6R)-2-(3-{[5-(4-fluorophenyl)thiophen-2-yl]methyl}-4-methylphenyl)-6-(hydroxymethyl)oxane-3,4,5-triol|JNJ 24831754ZAE|UNII-6S49DGR869|JNJ 24831754AAA|(2S,3R,4R,5S,6R)-2-[3-[[5-(4-Fluorophenyl)thiophen-2-yl]methyl]-4-methylphenyl]-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol|JNJ 24831754|Canagliflozin (Standard)|CANAGLIFLOZIN [MI]|(1S)-1,5-Anhydro-1-C-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methylphenyl]-D-glucitol|MLS006011126|SCHEMBL157162|CANAGLIFLOZIN [WHO-DD]|GTPL4582|orb1307458|CHEMBL2048484|SCHEMBL29499157|HSDB 8284|BCPP000303|MSK11069|BDBM50386885|HY-10451R|s2760|AKOS025401827|BCP9000477|CCG-229581|CS-0522|DB08907|KS-1443|MC58356|NCGC00346691-02|AC-26303|HY-10451|SMR004702906|SY097680|NS00099376|SW219119-1|EN300-6733492|F857122|Q5030940|BRD-K90868879-001-02-0|BRD-K90868879-001-03-8|Z2235801995|(1S)-1,5-anhydro-1-(3-{[5-(4-fluorophenyl)-2-thienyl]methyl}-4-methyl-phenyl)-D-glucitol|(1S)-1,5-ANHYDRO-1-C-(3-((5-(4-FLUOROPHENYL)THIOPHEN-2-YL)METHYL)-4-METHYLPHENYL)-D- GLUCITOL|(2S,3R,4R,5S,6R)-2-(3-((5-(4-fluorophenyl)thiophen-2-yl)methyl)-4-methylphenyl)-6-(hydroxymethyl)-tetrahydro-2H-pyran-3,4,5-triol|(2S,3R,4R,5S,6R)-2-[3-[[5-(4-fluorophenyl)-2-thienyl]methyl]-4-methyl-phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol|D-Glucitol, 1,5-anhydro-1-C-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4-    methylphenyl)-, (1S)-|D-glucitol, 1,5-anhydro-1-c-(3-((5-(4-fluorophenyl)-2-thienyl)methyl)-4- methylphenyl)-, (1s)-|D-GLUCITOL, 1,5-ANHYDRO-1-C-(3-((5-(4-FLUOROPHENYL)-2-THIENYL)METHYL)-4-METHYLPHENYL)-"
ERTUGLIFLOZIN,44814423,,"InChI=1S/C22H25ClO7/c1-2-28-16-6-3-13(4-7-16)9-14-10-15(5-8-17(14)23)22-20(27)18(25)19(26)21(11-24,30-22)12-29-22/h3-8,10,18-20,24-27H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22-/m0/s1",MCIACXAZCBVDEE-CUUWFGFTSA-N,C22H25ClO7,436.9,"(1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol","Ertugliflozin|1210344-57-2|PF-04971729|PF04971729|ertugliflozina|ertugliflozine|(1S,2S,3S,4R,5S)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol|(1S,2S,3S,4R,5S)-5-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol|MK-8835|PF-04971729-00|6C282481IP|DTXSID40153120|5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol|beta-L-Idopyranose, 1,6-anhydro-1-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-5-C-(hydroxymethyl)-|(1S,2S,3S,4R,5S)-5-{4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl}-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol|beta-L-Idopyranose, 1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-|ertugliflozinum|(1S,2S,3S,4R,5S)-5-(4-CHLORO-3-((4-ETHOXYPHENYL)METHYL)PHENYL)-1-(HYDROXYMETHYL)-6,8-DIOXABICYCLO(3.2.1)OCTANE-2,3,4-TRIOL|(1S,2S,3S,4R,5S)-5-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-1-(hydroxymethyl)-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol|RefChem:56924|DTXCID4075611|A10BK04|813-709-2|863-196-4|Steglatro|MFCD21609259|1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-beta-L-idopyranose|CHEMBL1770248|(1S,2S,3S,4R,5S)-5-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-1-hydroxymethyl-6,8-dioxabicyclo(3.2.1)octane-2,3,4-triol|(1s,2s,3s,4r,5s)-5-[4-chloro-3-(4-ethoxybenzyl)phenyl]-1-hydroxymethyl-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol|PF 04971729|Ertugliflozin [USAN:INN]|Ertugliflozin (PF 04971729)|UNII-6C282481IP|1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-beta-L-idopyranose; MK 8835; PF 04971729; PF 04971729-00; Steglatro|Ertugliflozin (Standard)|ERTUGLIFLOZIN [MI]|ERTUGLIFLOZIN [INN]|Ertugliflozin (USAN/INN)|ERTUGLIFLOZIN [USAN]|PF 04971729-00|SCHEMBL181047|ERTUGLIFLOZIN [WHO-DD]|GTPL8376|orb1302379|PF-04971729;Ertugliflozin|SCHEMBL29497947|EX-A407|CHEBI:188719|MCIACXAZCBVDEE-CUUWFGFTSA-N|ERTUGLIFLOZIN [ORANGE BOOK]|BDBM50342885|HY-15461R|MSK177668|PF-04971729 (Ertugliflozin)?|s5413|AKOS025404928|CCG-269087|CS-0976|DB11827|AC-29007|AS-35204|FE137670|HY-15461|NS00072894|D10313|EN300-7393259|Q27077223|(1S,2S,3S,4R,5S)-5-[4-Chloro-3-(4-ethoxy-benzyl)-phenyl]-1-hydroxymethyl-6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol|(1S,2S,3S,4R,5S)-5-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-1-(hydroxymethyl)-6,8-dioxa-bicyclo[3.2.1]octane-2,3,4-triol|1,6-Anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-5-C-(hydroxymethyl)-|A-L-idopyranose"
IPRAGLIFLOZIN,10453870,,"InChI=1S/C21H21FO5S/c22-15-6-5-12(21-20(26)19(25)18(24)16(10-23)27-21)7-13(15)9-14-8-11-3-1-2-4-17(11)28-14/h1-8,16,18-21,23-26H,9-10H2/t16-,18-,19+,20-,21+/m1/s1",AHFWIQIYAXSLBA-RQXATKFSSA-N,C21H21FO5S,404.5,"(2S,3R,4R,5S,6R)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol","Ipragliflozin|761423-87-4|suglat|ASP1941|ASP-1941|ipragliflozina|ipragliflozine|3N2N8OOR7X|(2S,3R,4R,5S,6R)-2-[3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl]-6-(hydroxymethyl)oxane-3,4,5-triol|(1S)-1,5-Anhydro-1-c-[3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl]-D-glucitol|DTXSID701032738|(1S)-1,5-Anhydro-1-C-(3-((1-benzothiophen-2-yl)methyl)-4-fluorophenyl)-D-glucitol|(1S)-1,5-anhydro-1-(3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl)-D-glucitol|ipragliflozinum|(2S,3R,4R,5S,6R)-2-(3-((1-benzothiophen-2-yl)methyl)-4-fluorophenyl)-6-(hydroxymethyl)oxane-3,4,5-triol|(2S,3R,4R,5S,6R)-2-(3-(1-benzothiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)oxane-3,4,5-triol|(2S,3R,4R,5S,6R)-2-{3-[(1-benzothiophen-2-yl)methyl]-4-fluorophenyl}-6-(hydroxymethyl)oxane-3,4,5-triol|RefChem:148654|A10BK05|DTXCID401517751|Ipragliflozin [INN]|MFCD19443744|(2S,3R,4R,5S,6R)-2-(3-(benzo[b]thiophen-2-ylmethyl)-4-fluorophenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol|Ipragliflozin (ASP1941)|CHEMBL2018096|D-Glucitol,1,5-anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-, (1S)-|Ipragliflozin (INN)|ASP 1941|UNII-3N2N8OOR7X|C21H21FO5S|D-Glucitol, 1,5-anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-, (1S)-; (1S)-1,5-Anhydro-1-C-[3-(benzo[b]thien-2-ylmethyl)-4-fluorophenyl]-D-glucitol; ASP 1941; Ipragliflozin; Suglat|ipragliflozin-L-proline|Ipragliflozin (Standard)|IPRAGLIFLOZIN [MI]|Ipragliflozin (ASP1941)?|SCHEMBL337645|IPRAGLIFLOZIN [WHO-DD]|GTPL9394|orb1305560|SCHEMBL29358545|SCHEMBL29433938|AHFWIQIYAXSLBA-RQXATKFSSA-N|CHEBI:134724|EX-A2770|MSK15586|BDBM50381554|HY-14894R|s8637|AKOS025405258|CCG-268693|DB11698|FA58137|NCGC00378606-02|AC-29008|AS-39358|DA-64485|HY-14894|SY098911|NS00072296|D10196|BRD-K51247865-001-01-2|Q17193526|(1S)-1,5-anhydro-1-[3-(1-benzothien-2-ylmethyl)-4-fluorophenyl]-D-glucitol|(1S)-1,5-anhydro-1-C-[3-(1-benzothiophene-2-ylmethyl)-4-fluorophenyl]-D-glucitol|(2S,3R,4R,5S,6R)-2-[3-(benzothiophen-2-ylmethyl)-4-fluoro-phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol|D-GLUCITOL, 1,5-ANHYDRO-1-C-(3-(BENZO(B)THIEN-2-YLMETHYL)-4-FLUOROPHENYL)-, (1S)-"
TOFOGLIFLOZIN ANHYDROUS,46908929,,"InChI=1S/C22H26O6/c1-2-13-3-5-14(6-4-13)9-15-7-8-16-12-27-22(17(16)10-15)21(26)20(25)19(24)18(11-23)28-22/h3-8,10,18-21,23-26H,2,9,11-12H2,1H3/t18-,19-,20+,21-,22+/m1/s1",VWVKUNOPTJGDOB-BDHVOXNPSA-N,C22H26O6,386.4,"(3S,3'R,4'S,5'S,6'R)-5-[(4-ethylphenyl)methyl]-6'-(hydroxymethyl)spiro[1H-2-benzofuran-3,2'-oxane]-3',4',5'-triol","TOFOGLIFLOZIN|903565-83-3|CSG 452|Tofogliflozin anhydrous|CSG-452|CSG452|R-7201|(3S,3'R,4'S,5'S,6'R)-5-[(4-ethylphenyl)methyl]-6'-(hydroxymethyl)spiro[1H-2-benzofuran-3,2'-oxane]-3',4',5'-triol|554245W62T|DTXSID90238097|Tofogliflozina|Tofogliflozine|Spiro(isobenzofuran-1(3H),2'-(2H)pyran)-3',4',5'-triol,6-((4-ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)-,(1S,3'R,4'S,5'S,6'R)-|RO4998452|tofogliflozinum|(3S,3'R,4'S,5'S,6'R)-5-((4-ethylphenyl)methyl)-6'-(hydroxymethyl)spiro(1H-2-benzofuran-3,2'-oxane)-3',4',5'-triol|RefChem:933166|DTXCID10160588|(1S,3'R,4'S,5'S,6'R)-6-((4-ethylphenyl)methyl)-6'-(hydroxymethyl)-3H-spiro(2-benzofuran-1,2'-oxane)-3',4',5'-triol|619-989-0|P8DD8KX4O4|Tofogliflozin [INN]|apleway|903565-83-3 (free)|(1s,3'r,4's,5's,6'r)-6-(4-ethylbenzyl)-6'-(hydroxymethyl)-3',4',5',6'-tetrahydro-3h-spiro[isobenzofuran-1,2'-pyran]-3',4',5'-triol|deberza|Tofogliflozin anyhydrous|UNII-554245W62T|CSG452 ANHYDROUS|TOFOGLIFLOZIN [MI]|EC 619-989-0|CSG-452 ANHYDROUS|R-7201 ANHYDROUS|SCHEMBL903156|TOFOGLIFLOZIN [WHO-DD]|GTPL9395|orb1708343|CHEMBL2110731|SCHEMBL29358428|RO4998452 ANHYDROUS|CHEBI:136041|RO-4998452 ANHYDROUS|BDBM50396779|AKOS027250822|DB11824|FT28301|compound 16d [PMID: 22889351]|NCGC00485920-01|AC-31468|DA-68247|RO-4998452|BRD-K96344439-002-01-9|BRD-K96344439-002-02-7|Q27261271|(1S,3'R,4'S,5'S,6'R)-6-((4-Ethylphenyl)methyl)-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)-spiro(isobenzofuran-1(3H), 2'-(2H)pyran)-3',4',5'-triol|(1S,3'R,4'S,5'S,6'R)-6-((4-ETHYLPHENYL)METHYL)-6'-(HYDROXYMETHYL)-3',4',5',6'-TETRAHYDRO-3H-SPIRO(2-BENZOFURAN-1,2'-PYRAN)-3',4',5'-TRIOL|(1S,3'R,4'S,5'S,6'R)-6-[(4-Ethylphenyl)methyl]-3',4',5',6'-tetrahydro-6'-(hydroxymethyl)spiro[isobenzofuran-1(3H),2'-[2H]pyran]-3',4  ',5'-triol;CSG 452|(3S,3'R,4'S,5'S,6'R)-5-[(4-ethylphenyl)methyl]-6'-(hydroxymethyl)spiro[1H-isobenzofuran-3,2'-tetrahydropyran]-3',4',5'-triol"
SOTAGLIFLOZIN,24831714,,"InChI=1S/C21H25ClO5S/c1-3-26-15-7-4-12(5-8-15)10-14-11-13(6-9-16(14)22)20-18(24)17(23)19(25)21(27-20)28-2/h4-9,11,17-21,23-25H,3,10H2,1-2H3/t17-,18-,19+,20+,21-/m1/s1",QKDRXGFQVGOQKS-CRSSMBPESA-N,C21H25ClO5S,424.9,"(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol","Sotagliflozin|1018899-04-1|LX-4211|LX4211|INPEFA|sotagliflozina|sotagliflozine|LP-802034|sotagliflozinum|6B4ZBS263Y|Sar439954|Sar-439954|LP 802034|(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyloxane-3,4,5-triol|DTXSID20144314|beta-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-|beta-l-Xylopyranoside, methyl 5-C-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-1-thio-, (5S)-|(2S,3R,4R,5S,6R)-2-{4-CHLORO-3-[(4-ETHOXYPHENYL)METHYL]PHENYL}-6-(METHYLSULFANYL)OXANE-3,4,5-TRIOL|(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-6-(methylsulfanyl)oxane-3,4,5-triol|(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-ethoxyphenyl)methyl)phenyl)-6-methylsulfanyloxane-3,4,5-triol|RefChem:57075|DTXCID7066805|A10BK06|Zynquista|MFCD22493506|(2s,3r,4r,5s,6r)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2h-pyran-3,4,5-triol|LX 4211|C21H25ClO5S|(2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyl-oxane-3,4,5-triol|(2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylsulfanyl)tetrahydro-2H-pyran-3,4,5-triol|Sotagliflozin [USAN:INN]|UNII-6B4ZBS263Y|(2S,3R,4R,5S,6R)-2-[4-Chloro-3-(4-ethoxybenzyl)phenyl]-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|Inpefa (TN)|SOTAGLIFLOZIN [MI]|Sotagliflozin (LX4211)|SOTAGLIFLOZIN [INN]|Sotagliflozin (USAN/INN)|SOTAGLIFLOZIN [USAN]|Sotagliflozin (LX-4211)|Sotagliflozin (LX-4211)?|SOTAGLIFLOZIN [WHO-DD]|GTPL8312|orb1304078|SCHEMBL1038287|CHEMBL3039507|SCHEMBL29433934|CHEBI:229226|b-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-;b-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-|EX-A1167|BDBM50235017|MSK177667|s8103|AKOS025290846|CCG-268940|DB12713|AC-29890|AS-35202|BL161424|HY-15516|SY235565|NS00073087|D10669|EN300-7399851|F979680|BRD-K05850076-001-01-5|Q27088840|methyl (5S)-5-[4-chloro-3-(4-ethoxybenzyl)phenyl]-1-thio-beta-L-xylopyranoside|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-ethoxybenzyl)phenyl)- 6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol|(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-ethoxybenzyl)phenyl)-6-(methylthio)tetrahydro-2H-pyran-3,4,5-triol;Sotagliflozin|(2S,3R,4R,5S,6R)-2-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-6-methylsulfanyl-tetrahydropyran-3,4,5-triol|.BETA.-L-XYLOPYRANOSIDE, METHYL 5-C-(4-CHLORO-3-((4-ETHOXYPHENYL)METHYL)PHENYL)-1-THIO-, (5S)-||A-L-Xylopyranoside, methyl 5-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-1-thio-, (5S)-|Lfl|METHYL (5S)-5-C-(4-CHLORO-3-((4-ETHOXYPHENYL)METHYL)PHENYL)-1-THIO-.BETA.-L-XYLOPYRANOSIDE"
CARIPORIDE MESYLATE,178019,,"InChI=1S/C12H17N3O3S.CH4O3S/c1-7(2)9-5-4-8(11(16)15-12(13)14)6-10(9)19(3,17)18;1-5(2,3)4/h4-7H,1-3H3,(H4,13,14,15,16);1H3,(H,2,3,4)",FNDLQABGYJQJPH-UHFFFAOYSA-N,C13H21N3O6S2,379.5,N-(diaminomethylidene)-3-methylsulfonyl-4-propan-2-ylbenzamide;methanesulfonic acid,"Cariporide mesylate|159138-81-5|Cariporide mesilate|HOE 642|Cariporide mesylate [USAN]|Cariporide methanesulfonate|UNII-0543W2JFRZ|0543W2JFRZ|DTXSID3047344|Cariporide mesylate (USAN)|DTXCID1027344|CARIPORIDE MESILATE [WHO-DD]|CARIPORIDE METHANESULFONATE [MI]|Benzamide, N-(aminoiminomethyl)-4-(1-methylethyl)-3-(methylsulfonyl)-, monomethanesulfonate|N-(Diaminomethylene)-4-isopropyl-3-(methylsulfonyl)benzamide monomethanesulfonate|N-(4-ISOPROPYL-3-METHANESULFONYL-BENZOYL)-GUANIDINE MESILATE|N-(4-ISOPROPYL-3-METHANESULFONYL-BENZOYL)-GUANIDINE MESYLATE|N-(DIAMINOMETHYLENE)-4-ISOPROPYL-3-(METHYLSULPHONYL)BENZAMIDE MONOMETHANESULPHONATE|BENZAMIDE, N-(AMINOIMINOMETHYL)-4-(1-METHYLETHYL)-3-(METHYLSULPHONYL)-, MONOMETHANESULPHONATE|RefChem:123732|HOE-642|Cariporide (mesilate)|CHEMBL462831|N-(diaminomethylidene)-3-methylsulfonyl-4-propan-2-ylbenzamide;methanesulfonic acid|N-(Aminoiminomethyl)-4-(1-methylethyl)-3-(methylsulfonyl)benzamide Mesylate|SCHEMBL221094|SCHEMBL611696|orb1704807|GLXC-06032|Tox21_300231|AKOS040745066|NCGC00254230-01|DA-62067|HY-13412|CAS-159138-81-5|CS-0006771|D03406|Q27236071|(4-isopropyl-3-methanesulfonyl-benzoyl) guanidine methanesulfonate|Benzamide,N-(aminoiminomethyl)-4-(1-methylethyl)-3-(methylsulfonyl)-,monomethanesulfonate|N-(diaminomethylidene)-3-methylsulfonyl-4-propan-2-ylbenzamide; methanesulfonic acid"
REMINERTANT,119192,,"InChI=1S/C32H31ClN4O5/c1-41-27-4-3-5-28(42-2)29(27)26-16-24(36-37(26)25-8-9-34-23-15-21(33)6-7-22(23)25)30(38)35-32(31(39)40)19-11-17-10-18(13-19)14-20(32)12-17/h3-9,15-20H,10-14H2,1-2H3,(H,35,38)(H,39,40)",DYLJVOXRWLXDIG-UHFFFAOYSA-N,C32H31ClN4O5,587.1,"2-[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid","Meclinertant|146362-70-1|SR 48692|Reminertant|SR-48692|SR48692|2-[[1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid|5JBP4SI96H|Tricyclo[3.3.1.13,7]decane-2-carboxylic acid, 2-[[[1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl]carbonyl]amino]-|DTXSID40163360|2-((1-(7-Chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)pyrazol-3-yl)carbonylamino)tricyclo(3.3.1.1.(3.7))decan-2-carboxylic acid|Tricyclo(3.3.1.13,7)decane-2-carboxylic acid, 2-(((1-(7-chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl)carbonyl)amino)-|meclinertantum|2-((1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazole-3-carbonyl)amino)adamantane-2-carboxylic acid|RefChem:156203|DTXCID7085851|2-(1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-amido)adamantane-2-carboxylic acid|Meclinertant [INN]|CHEMBL506981|2-{[1-(7-Chloro-quinolin-4-yl)-5-(2,6-dimethoxy-phenyl)-1H-pyrazole-3-carbonyl]-amino}-adamantane-2-carboxylic acid|(1r,3r,5r,7r)-2-(1-(7-chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazole-3-carboxamido)adamantane-2-carboxylic acid|2-[[1-(7-chloranylquinolin-4-yl)-5-(2,6-dimethoxyphenyl)pyrazol-3-yl]carbonylamino]adamantane-2-carboxylic acid|C32H31ClN4O5|UNII-5JBP4SI96H|Q6Q|MLS006010645|GTPL1582|orb1706999|SCHEMBL1650932|SCHEMBL29376784|CHEBI:125516|GLXC-15298|BCP03645|BDBM50248034|MFCD03106260|PDSP1_000642|PDSP2_000637|AKOS024457771|DB06455|NCGC00242503-01|2-(((1-(7-Chloroquinolin-4-yl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl)carbonyl)amino)tricyclo(3.3.1.1(sup 3,7) )decane-2-carboxylic acid|2-[[[1-(7-Chloro-4-quinolinyl)-5-(2,6-dimethoxyphenyl)-1H-pyrazol-3-yl]carbonyl]amino]-tricyclo[3.3.1.13,7]decane-2-carboxylic acid|FM176816|PD119349|SMR004701645|SR48692?|BCP0726000168|HY-105189|CS-0025250|NS00068477|E98718|MLS-0437456.0001|SR 48692, >=98% (HPLC)|L001448|Q7392763|BRD-K25075681-001-01-2|BRD-K25075681-001-02-0|113158-35-3|2-(((1-(7-CHLORO-4-QUINOLINYL)-5-(2,6-DIMETHOXYPHENYL)-1H-PYRAZOL-3-YL)CARBONYL)AMINO)-TRICYCLO(3.3.1.1(SUP 3,7))DECANE-2-CARBOXYLIC ACID|2-[[1-(7-chloro-4-quinolyl)-5-(2,6-dimethoxyphenyl)pyrazole-3-carbonyl]amino]adamantane-2-carboxylic acid"
HALOPEMIDE,65490,,"InChI=1S/C21H22ClFN4O2/c22-15-3-6-19-18(13-15)25-21(29)27(19)17-7-10-26(11-8-17)12-9-24-20(28)14-1-4-16(23)5-2-14/h1-6,13,17H,7-12H2,(H,24,28)(H,25,29)",NBHPRWLFLUBAIE-UHFFFAOYSA-N,C21H22ClFN4O2,416.9,N-[2-[4-(5-chloro-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]ethyl]-4-fluorobenzamide,"Halopemide|59831-65-1|Halopemida|Halopemidum|R 34,301|NSC-354856|65Q28TV0ZY|R-34301|N-(2-(4-(5-Chloro-2-oxo-1-benzimidazolinyl)piperidino)ethyl)-p-fluorobenzamide|DTXSID20208561|N-[2-[4-(5-Chloro-2-oxo-1-benzimidazolinyl)piperidino]ethyl]-p-fluorobenzamide|RefChem:783369|DTXCID70131052|MLS003171133|CHEMBL245621|NSC354856|Benzamide, N-(2-(4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl)ethyl)-4-fluoro-|N-(2-(4-(5-chloro-2-oxo-2,3-dihydro-1H-benzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)-4-fluorobenzamide|N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]-ethyl]-4-fluoro-benzamide|N-{2-[4-(5-chloro-2-oxo-2,3-dihydro-1H-benzimidazol-1-yl)piperidin-1-yl]ethyl}-4-fluorobenzamide|Halopemide [USAN:INN]|Halopemidum [INN-Latin]|Halopemida [INN-Spanish]|NSC 354856|UNII-65Q28TV0ZY|Halopemide?|Halopemide, 8|Benzamide, N-[2-[4-(5-chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-4-fluoro-|HALOPEMIDE [INN]|Halopemide (USAN/INN)|HALOPEMIDE [USAN]|N-[2-[4-(5-chloro-2-oxo-3H-benzimidazol-1-yl)piperidin-1-yl]ethyl]-4-fluorobenzamide|R 34301|cid_65490|MLS006012046|SCHEMBL121267|orb1308234|Halopemide, >=98% (HPLC)|NBHPRWLFLUBAIE-UHFFFAOYSA-N|GLXC-06647|HMS3648G20|BDBM50206160|AKOS040741828|N-(2-(4-(5-Chlor-2,3-dihydro-2-oxo-1-benzimidazolyl)piperidino)ethyl)-4-fluorbenzamid|DA-64016|MS-27272|SMR001875041|SMR002529688|HY-119093|CS-0067969|VU0155067-2|D02665|G12740|R34301|SR-01000946369|SR-01000946369-1|BRD-K50055394-001-03-6|Q27263902|Benzamide,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-4-fluoro-|N-[2-[4-(5-chloro-2-oxo-3H-benzimidazol-1-yl)-1-piperidyl]ethyl]-4-fluoro-benzamide|MJV|N-(2-(4-(5-chloro-2-oxo-2,3-dihydrobenzo[d]imidazol-1-yl)piperidin-1-yl)ethyl)-4-fluorobenzamide|N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)-1-piperidinyl]ethyl]-4-fluorobenzamide|N-[2-[4-(5-Chloro-2,3-dihydro-2-oxo-1H-benzimidazol-1-yl)piperidino]ethyl]-4-fluorobenzamide"
LORCASERIN,11658860,,"InChI=1S/C11H14ClN/c1-8-7-13-5-4-9-2-3-10(12)6-11(8)9/h2-3,6,8,13H,4-5,7H2,1H3/t8-/m0/s1",XTTZERNUQAFMOF-QMMMGPOBSA-N,C11H14ClN,195.69,"(5R)-7-chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine","Lorcaserin|616202-92-7|(1R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine|lorcaserine|DTXSID3048659|CHEBI:65353|637E494O0Z|ADP356|DTXCID0028585|ADP-356|lorcaserinum|RefChem:56873|A08AA11|lorcaserina|(R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-benzo[d]azepine|Lorcaserin [INN]|(R)-8-Chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine|1H-3-Benzazepine, 8-chloro-2,3,4,5-tetrahydro-1-methyl-, (1R)-|CHEMBL360328|(5R)-7-chloro-5-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine|NCGC00182550-01|AR-10A|Belvig|CAS-616202-92-7|UNII-637E494O0Z|HSDB 8128|T4U|Lorcaserin(free base)?|LORCASERIN [MI]|(1R)-8-chloro-2,3,4,5-tetrahydro-1-methyl-1H-3-benzazepine|LORCASERIN [VANDF]|LORCASERIN [WHO-DD]|SCHEMBL169382|GTPL2941|SCHEMBL29349440|XTTZERNUQAFMOF-QMMMGPOBSA-N|Tox21_113018|AC-553|BDBM50161646|AKOS006326204|Tox21_113018_1|CS-1232|DB04871|NCGC00182550-02|HY-11093|NS00067948|202L927|Q340139|BRD-K55013654-003-02-3"
MARAVIROC,3002977,,"InChI=1S/C29H41F2N5O/c1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/h4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/t23-,24+,25?,26-/m0/s1",GSNHKUDZZFZSJB-HLMSNRGBSA-N,C29H41F2N5O,513.7,"4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide","Maraviroc|376348-65-1|Selzentry|Celsentri|UK-427857|UK-427,857|UK 427857|[3H]maraviroc|MD6P741W8A|MFCD13188530|CHEMBL256907|CHEMBL584744|4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide|MVC|CHEMBL1201187|DTXSID8048949|CHEBI:63608|(3H)maraviroc|4,4-Difluoro-N-((S)-3-((1R,3R,5S)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexane-1-carboxamide|Cyclohexanecarboxamide,4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-|NCGC00183109-02|4,4-difluoro-N-[(1S)-3-[(1R,3S,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide|4,4-Difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamide|Celsentri(TM)|Selzentry(TM)|2414315-81-2|4,4-difluoro-N-((1S)-3-((1R,5S)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexanecarboxamide|4,4-difluoro-N-[(1S)-3-[(1S,5R)-3-(3-isopropyl-5-methyl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenyl-propyl]cyclohexanecarboxamide|4,4-Difluoro-N-[(1s)-3-{(3-Exo)-3-[3-Methyl-5-(Propan-2-Yl)-4h-1,2,4-Triazol-4-Yl]-8-Azabicyclo[3.2.1]oct-8-Yl}-1-Phenylpropyl]cyclohexanecarboxamide|Cyclohexanecarboxamide, 4,4-difluoro-N-((1S)-3-((3-exo)-3-(3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)oct-8-yl)-1-phenylpropyl)-|C29H41F2N5O|PRO 140 & Maraviroc|maravirocum|Maraviroc [INN:BAN:JAN]|UNII-MD6P741W8A|Rel-Maraviroc|HSDB 8021|Maraviroc, endo-|Cyclohexanecarboxamide, 4,4-difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-|UK-427,857 maraviroc (MVC)|MARAVIROC [INN]|MARAVIROC [JAN]|MARAVIROC [MI]|[3H]UK 427,857|[3H]UK-427,857|MARAVIROC [VANDF]|A3C7SRV8DV|RefChem:1050229|MARAVIROC [MART.]|MARAVIROC [WHO-DD]|SCHEMBL51991|Selzentry, UK 427857|GTPL803|GTPL806|MARAVIROC [EMA EPAR]|Isopropyl, 4,4-difluoro-N-((1S)-3-{(1R,3s,5S)-3-(3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl)-8-azabicyclo(3.2.1)octan-8-yl}-1-phenylpropyl)cyclohexanecarboxamide|MLS006011960|orb1301149|SCHEMBL2177194|SCHEMBL4576508|MARAVIROC [ORANGE BOOK]|DTXCID5028875|Maraviroc, >=98% (HPLC)|EX-A200|CHEBI:184662|GSNHKUDZZFZSJB-HLMSNRGBSA-N|GSNHKUDZZFZSJB-QUMGSSFMSA-N|Tox21_113369|AC-558|BDBM50334986|BDBM50464147|BDBM50583789|MFCD31536297|AKOS025402143|AKOS032946723|AKOS032960315|CS-0366|DB04835|FM25017|NCGC00183109-01|4,4-difluoro-N-((1S)-3-((1R,5S)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexane-1-carboxamide|AS-75265|exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide|HY-13004|PRO 140 (Anti-CCR5 monoclonal antibody) & exo-4,4-Difluoro-N-[3-[3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1(S)-phenylpropyl]cyclohexanecarboxamide|SMR004703532|CAS-376348-65-1|EN300-128501|EN300-7367238|348M651|EN300-22828861|Q421369|SR-01000942244|SR-01000942244-1|BRD-A23284911-001-02-4|Z1614451557|4,4-Difluoro-cyclohexanecarboxylic acid {(S)-3-[(1S,5S)-3-(3-isopropyl-5-methyl-[1,2,4]triazol-4-yl)-8-aza-bicyclo[3.2.1]oct-8-yl]-1-phenyl-propyl}-amide|4,4-difluoro-N-((1S)-3-(3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexanecarboxamide|4,4-difluoro-N-((S)-3-((1S,3S,5R)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-aza-bicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexanecarboxamide|4,4-difluoro-N-((S)-3-(3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-aza-bicyclo[3.2.1]octan-8-yl)-1-phenylpropyl)cyclohexanecarboxamide|4,4-difluoro-N-[(1S)-3-[(1R,3R,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide|4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-(3-isopropyl-5-methyl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenyl-propyl]cyclohexanecarboxamide|4,4-difluoro-N-[(1S)-3-[(1R,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide|4,4-Difluoro-N-[(1S)-3-[(1R,5S)-3-[3-methyl-5-(propan-2-yl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboximidic acid|4,4-Difluoro-N-[(1S)-3-[(3-endo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]cyclohexanecarboxamide|4,4-Difluoro-N-[(1S)-3-[(3-exo)-3-[3-methyl-5-(1-methylethyl-d6)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]  cyclohexanecarboxamide;UK 427857-d6|4,4-difluoro-N-{(1S)-3-[(3-exo)-3-(3-isopropyl-5-methyl-4H-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl}cyclohexanecarboxamide|4,4-diluoro-N-[(1S)-3-[(1S,5R)-3-(3-methyl-5-propan-2-yl-1,2,4-triazol-4-yl)-8-azabicyclo[3.2.1]octan-8-yl]-1-phenylpropyl]cyclohexane-1-carboxamide|Cyclohexanecarboxamide, 4,4-difluoro-N-[(1S)-3-[(3-endo)-3-[3-methyl-5-(1-methylethyl)-4H-1,2,4-triazol-4-yl]-8-azabicyclo[3.2.1]oct-8-yl]-1-phenylpropyl]-|MRV"
PF-04217903,17754438,,"InChI=1S/C19H16N8O/c28-7-6-26-12-15(9-22-26)17-10-21-18-19(23-17)27(25-24-18)11-13-3-4-16-14(8-13)2-1-5-20-16/h1-5,8-10,12,28H,6-7,11H2",PDMUGYOXRHVNMO-UHFFFAOYSA-N,C19H16N8O,372.4,"2-[4-[3-(quinolin-6-ylmethyl)triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol","PF-04217903|956905-27-4|PF04217903|2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol|PF-4217903|PF 04217903|CYJ9ATV1IJ|Met tyrosine kinase inhibitor PF-04217903|2-(4-(1-(Quinolin-6-ylmethyl)-1H-(1,2,3)triazolo(4,5-b)pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol|DTXSID401026097|1H-Pyrazole-1-ethanol, 4-(1-(6-quinolinylmethyl)-1H-1,2,3-triazolo(4,5-b)pyrazin-6-yl)|2-{4-[1-(QUINOLIN-6-YLMETHYL)-1H-[1,2,3]TRIAZOLO[4,5-B]PYRAZIN-6-YL]-1H-PYRAZOL-1-YL}ETHANOL|2-[4-[1-(Quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl]-1H-pyrazol-1-yl]ethanol|RefChem:172228|DTXCID80881713|2-(4-(1-((quinolin-6-yl)methyl)-1H-(1,2,3)triazolo(4,5-b)pyrazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol|1159490-85-3|2-[4-[3-(quinolin-6-ylmethyl)triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol|2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethan-1-ol|MFCD12407410|CHEMBL2001019|956905-27-4 (free base)|PF-04217903 (phenolsulfonate)|2-[4-(3-Quinolin-6-ylmethyl-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-pyrazol-1-yl]-ethanol|UNII-CYJ9ATV1IJ|C19H16N8O|3zxz|PDMUGYOXRHVNMO-UHFFFAOYSA-N|Kinome_3829|SCHEMBL93550|MLS006010959|orb1305179|aka PF-04217903|SCHEMBL29355971|SCHEMBL29394198|CHEBI:91425|EX-A478|HMS3244G11|HMS3244G12|HMS3244H11|HMS3295M07|HMS3654I19|BCP01847|BDBM50396934|NSC763931|NSC800845|s1094|AKOS026750596|CCG-264818|CS-0147|DB12848|NSC-763931|NSC-800845|SB19372|SDCCGSBI-0654338.P001|NCGC00263161-01|NCGC00263161-03|NCGC00263161-11|NCGC00263161-15|2-(4-(3-(quinolin-6-ylmethyl)-3H-[1,2,3]triazolo[4,5-b]pyrazin-5-yl)-1H-pyrazol-1-yl)ethanol|2-{4-[1-(6-Quinolinylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-y l]-1H-pyrazol-1-yl}ethanol|AC-35476|AS-16216|DA-56725|HY-12017|SMR004702763|NS00072533|SW218126-2|407Q410|BRD-K73319509-001-01-5|BRD-K73319509-001-08-0|PF-04217903,PF-4217903|Q27163274|1H-Pyrazole-1-ethanol, 4-[1-(6-quinolinylmethyl)-1H-1,2,3-triazolo[4,5-b]pyrazin-6-yl]-|2-[4-[3-(6-quinolylmethyl)triazolo[4,5-b]pyrazin-5-yl]pyrazol-1-yl]ethanol|2-(4-(1-(quinolin-6-ylmethyl)-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl)-1H-pyrazol-1-yl)ethanol 4-hydroxybenzenesulfonate|KRW"
TIVANTINIB,11494412,,"InChI=1S/C23H19N3O2/c27-22-19(16-11-24-18-9-2-1-7-14(16)18)20(23(28)25-22)17-12-26-10-4-6-13-5-3-8-15(17)21(13)26/h1-3,5,7-9,11-12,19-20,24H,4,6,10H2,(H,25,27,28)/t19-,20-/m0/s1",UCEQXRCJXIVODC-PMACEKPBSA-N,C23H19N3O2,369.4,"(3R,4R)-3-(1-azatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraen-3-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione","Tivantinib|905854-02-6|ARQ-197|ARQ 197|(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione|ARQ197|PJ4H73IL17|DTXSID60920316|(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo(3,2,1-ij)quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione|tivantinibum|RefChem:898517|c-Met Inhibitor ARQ 197|DTXCID301349230|(3R,4R)-3-(1-azatricyclo(6.3.1.0^(4,12))dodeca-2,4,6,8(12)-tetraen-3-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione|Tivantinib (ARQ 197)|(rel)-Tivantinib|rel-(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-2,5-pyrrolidinedione|905853-99-8|MFCD11977597|1000873-98-2|(3R,4R)-3-(1-azatricyclo[6.3.1.04,12]dodeca-2,4,6,8(12)-tetraen-3-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione|Tivantinib [INN]|Tivantinib [USAN:INN]|UNII-PJ4H73IL17|Tivantinib; ARQ197|TIVANTINIB [MI]|TIVANTINIB [JAN]|TIVANTINIB [USAN]|ARQ 197 (Tivantinib)|TIVANTINIB [WHO-DD]|SCHEMBL44944|orb322231|Tivantinib (JAN/USAN/INN)|GTPL7948|orb1301058|orb1941247|CHEMBL2103882|SCHEMBL29355700|CHEBI:91398|UCEQXRCJXIVODC-PMACEKPBSA-N|ARQ-197,Tivantinib, ARQ197|ARQ197; ARQ-197;Tivantinib|BCPP000042|BCP02529|CS-M1640|EX-A2169|CAS:905854-02-6;Tivantinib|BDBM50146168|NSC758242|NSC800951|s2753|AKOS022182739|CCG-268285|DB12200|FT44530|NSC-758242|NSC-800951|SDCCGSBI-0654487.P001|(-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione|AC-25009|AC-35963|AS-16991|DA-67145|DA-68209|HY-50686|HY-77493|DB-362059|NS00073191|C77073|D10173|E82820|BRD-K33379087-001-01-8|BRD-K33379087-001-07-5|Q17123902|Z2242166213|(+/-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4(1H-indol-3-yl)pyrrolidine-2,5-dione|(+/-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl) pyrrolidine-2,5-dione|(+/-)-trans-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione|(_)-trans-3-(5,6-dihydro-4h-pyrrolo[3,2,1-ij]quinolin-1-yl)-4(1h-indol-3-yl)pyrrolidine-2,5-dione|(3R,4R)-3-(2,3-dihydro-1H-pyrrolo[3,2,1-ij]quinolin-6-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione|(3R,4R)-3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione|(3R,4R)-3-(5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)pyrrolidine-2,5-dione; ARQ 197;|2,5-Pyrrolidinedione, 3-(5,6-dihydro-4H-pyrrolo(3,2,1-ij)quinolin-1-yl)-4-(1H-indol-3-yl)-, (3R,4R)-|TIV|trans 3-(5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1-yl)-4-(1H-indol-3-yl)-pyrrolidine-2,5-dione"
JNJ-38877605,46911863,,"InChI=1S/C19H13F2N7/c1-27-11-13(10-23-27)16-6-7-17-24-25-18(28(17)26-16)19(20,21)14-4-5-15-12(9-14)3-2-8-22-15/h2-11H,1H3",JRWCBEOAFGHNNU-UHFFFAOYSA-N,C19H13F2N7,377.3,"6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline","JNJ-38877605|943540-75-8|6-(difluoro(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl)methyl)quinoline|6-[difluoro-[6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline|JNJ 38877605|15UDG410PN|6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]quinoline|JNJ-38877605-AAA|1072116-03-0|6-(Difluoro(6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]-triazolo[4,3-b]pyridazin-3-yl)methyl)quinoline|Quinoline, 6-(difluoro(6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazin-3-yl)methyl)-|JNJ38877605|6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline|UNII-15UDG410PN|C19H13F2N7|6-(difluoro(6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-b)pyridazin-3-yl)methyl)quinoline|6-(Difluoro(6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo(4,3-b)pyridazin-3-yl)methyl)quinoline|6-[Difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-quinoline|Quinoline, 6-[difluoro[6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-b]pyridazin-3-yl]methyl]-|MFCD11977274|RefChem:1073731|MLS006010960|SCHEMBL182199|orb1301078|CHEMBL2133806|SCHEMBL29358742|SCHEMBL30028214|CHEBI:91417|DTXSID20677253|BDBM163243|HMS3244G09|HMS3244G10|HMS3244H09|HMS3295K11|HMS3654M04|HMS3750I11|BCP01812|EX-A2081|NSC759095|NSC800776|s1114|AKOS015896605|BCP9000804|CCG-264826|DB13113|NSC-759095|NSC-800776|SB16606|SDCCGSBI-0654345.P001|NCGC00263189-01|NCGC00263189-02|NCGC00263189-06|AC-27418|AS-16207|BJ165317|HY-50683|SMR004702764|JNJ 38877605?|DB-000659|NS00072519|SW220206-1|C77250|540D758|JNJ-38877605,JNJ38877605|BRD-K02123250-001-01-8|BRD-K02123250-001-06-7|Q27163270|US9062045, Comparator No. 1 (JNJ-38877605)|6-(Difluoro-[6-(1methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]-methyl)-quinoline|6-{difluoro[6-(1-methyl-1H-pyrazol-4-yl)[1,2,4]-triazolo[4,3-b]pyridazin-3-yl]methyl}quinoline"
CAPMATINIB,25145656,,"InChI=1S/C23H17FN6O/c1-25-22(31)18-6-5-16(11-19(18)24)21-13-28-23-27-12-17(30(23)29-21)10-14-4-7-20-15(9-14)3-2-8-26-20/h2-9,11-13H,10H2,1H3,(H,25,31)",LIOLIMKSCNQPLV-UHFFFAOYSA-N,C23H17FN6O,412.4,"2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide","capmatinib|1029712-80-8|INCB28060|INC-280|2-fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl)benzamide|INCB-28060|NVP-INC280-NX|NVP-INC280|INCB 28060|TY34L4F9OZ|INCB-28060 FREE BASE|2-fluoro-N-methyl-4-[7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide|DTXSID90145595|2-fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide|2-fluoro-N-methyl-4-{7-[(quinolin-6-yl)methyl]imidazo[1,2-b][1,2,4]triazin-2-yl}benzamide|capmatinibum|2-fluoro-N-methyl-4-(7-((quinolin-6-yl)methyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide|RefChem:57919|DTXCID4068086|INCB028060|2-fluoro-N-methyl-4-(7-(quinolin-6-yl-methyl)imidazo(1,2-b)(1,2,4)triazin-2-yl)benzamide|813-241-9|INC280|Capmatinib (INCB28060)|INC28060|Capmatinib [USAN]|MFCD18633285|Capmatinib; Tabrecta|2-Fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide|BenzaMide, 2-fluoro-N-Methyl-4-[7-(6-quinolinylMethyl)iMidazo[1,2-b][1,2,4]triazin-2-yl]-|Benzamide, 2-fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]-;Benzamide, 2-fluoro-N-methyl-4-[7-(6-quinolinylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]-|Capmatinib [INN]|UNII-TY34L4F9OZ|C23H17FN6O|BENZAMIDE, 2-FLUORO-N-METHYL-4-(7-(6-QUINOLINYLMETHYL)IMIDAZO(1,2-B)(1,2,4)TRIAZIN-2-YL)-|Capmatinib (Standard)|CAPMATINIB [MI]|Capmatinib (USAN/INN)|Capmatinib [USAN:INN]|Capmatinib(INCB28060)|INCB28060(Capmatinib)|NYP-INC280-NX|CAPMATINIB [WHO-DD]|Capmatinib(INCB28060)?|MLS006010965|GTPL7904|orb1306960|SCHEMBL1426819|CHEMBL3188267|SCHEMBL29370685|SCHEMBL29429714|EX-A446|CHEBI:231693|LIOLIMKSCNQPLV-UHFFFAOYSA-N|HMS5087I14|BCP23444|BDBM50146167|HY-13404R|NSC777878|NSC800067|NSC833919|s2788|AKOS025396439|BCP9000785|CCG-268791|CS-1541|DB11791|FF40658|NSC-777878|NSC-800067|NSC-833919|SB16608|SDCCGSBI-0654473.P001|NCGC00346702-01|NCGC00346702-02|NCGC00346702-05|AC-25890|AS-74142|BP-43631|DA-33530|HY-13404|SMR004702769|NS00072535|D10696|EN300-18166640|BRD-K81016934-001-02-0|Q27075685|2-fluoro-N-methyl-4-(7-(quinolin-6-ylmethyl)imidazo[1,2-b][1,2,4]triazin-2- yl)benzamide|2-fluoro-N-methyl-4-[7-(6-quinolylmethyl)imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide|2-fluoro-n-methyl-4-[7-(quinolin-6-ylmethyl)imidazolo[1,2-b][1,2,4]triazin-2-yl]benzamide"
TEPOTINIB,25171648,,"InChI=1S/C29H28N6O2/c1-34-12-10-21(11-13-34)20-37-26-17-31-29(32-18-26)25-7-3-5-23(15-25)19-35-28(36)9-8-27(33-35)24-6-2-4-22(14-24)16-30/h2-9,14-15,17-18,21H,10-13,19-20H2,1H3",AHYMHWXQRWRBKT-UHFFFAOYSA-N,C29H28N6O2,492.6,3-[1-[[3-[5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl]phenyl]methyl]-6-oxopyridazin-3-yl]benzonitrile,"Tepotinib|1100598-32-0|EMD-1214063|EMD 1214063|EMD1214063|MSC2156119J|MSC-2156119J|MSC2156119|MSC-2156119|1IJV77EI07|DTXSID70149132|Benzonitrile, 3-(1,6-dihydro-1-((3-(5-((1-methyl-4-piperidinyl)methoxy)-2-pyrimidinyl)phenyl)methyl)-6-oxo-3-pyridazinyl)-|Benzonitrile, 3-[1,6-dihydro-1-[[3-[5-[(1-methyl-4-piperidinyl)methoxy]-2-pyrimidinyl]phenyl]methyl]-6-oxo-3-pyridazinyl]-|tepotinibum|RefChem:57995|DTXCID0071623|c-Met Inhibitor MSC2156119J|3-(1-((3-(5-((1-methylpiperidin-4-yl)methoxy)pyrimidin-2-yl)phenyl)methyl)-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile|Tepotinib [INN]|Tepotinib [USAN]|Tepotinib(EMD-1214063)|3-(1-(3-(5-((1-methylpiperidin-4-yl)methoxy)pyrimidin-2-yl)benzyl)-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile|3-[1-[[3-[5-[(1-methylpiperidin-4-yl)methoxy]pyrimidin-2-yl]phenyl]methyl]-6-oxopyridazin-3-yl]benzonitrile|Tepotinib (EMD 1214063)|3-[1-(3-{5-[(1-Methylpiperidin-4-Yl)methoxy]pyrimidin-2-Yl}benzyl)-6-Oxo-1,6-Dihydropyridazin-3-Yl]benzonitrile|UNII-1IJV77EI07|C29H28N6O2|3E8|MFCD18452823|Tepotinib (Standard)|Tepotinib (USAN/INN)|Tepotinib [USAN:INN]|TEPOTINIB [WHO-DD]|MLS006010785|GTPL8293|SCHEMBL1296895|CHEMBL3402762|SCHEMBL29379106|EX-A394|AHYMHWXQRWRBKT-UHFFFAOYSA-N|GLXC-06048|WHO 9934|BDBM50065457|HY-14721R|NSC758244|NSC781256|NSC800945|s7067|AKOS027250729|CCG-269632|CS-0647|DB15133|NSC-758244|NSC-781256|NSC-800945|SB16609|compound 22 [PMID: 25736998]|NCGC00345793-01|NCGC00345793-08|3-(1-{3-[5-(1-methylpiperidin-4-ylmethoxy)pyrimidin-2-yl]benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile|3-[1,6-Dihydro-1-[[3-[5-[(1-methyl-4-piperidinyl)methoxy]-2-pyrimidinyl]phenyl]methyl]-6-oxo-3-pyridazinyl]benzonitrile|AC-35185|AS-16915|BP-44056|DA-78322|HY-14721|SMR004701471|D11717|BRD-K97963946-001-01-3|Q27088961|1100598-30-8|3-(1-(3-(5-((1-Methyl-4-piperidinyl)methoxy)-2-pyrimidinyl)benzyl)-6-oxo-1,6-dihydro-3-pyridazinyl)benzonitrile|3-(1-{3-[5-(1-methylpiperidin-4-yl-methoxy)pyrimidin-2-yl]benzyl}-6-oxo-1,6-dihydropyridazin-3-yl)benzonitrile|3-[1-[[3-[5-[(1-methyl-4-piperidyl)methoxy]pyrimidin-2-yl]phenyl]methyl]-6-oxo-pyridazin-3-yl]benzonitrile"
PITOLISANT HYDROCHLORIDE,11551689,,"InChI=1S/C17H26ClNO.ClH/c18-17-9-7-16(8-10-17)6-4-14-20-15-5-13-19-11-2-1-3-12-19;/h7-10H,1-6,11-15H2;1H",XLFKECRRMPOAQS-UHFFFAOYSA-N,C17H27Cl2NO,332.3,1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine;hydrochloride,"Pitolisant hydrochloride|903576-44-3|YV33CH63HI|BF-2649 HYDROCHLORIDE|PIPERIDINE, 1-(3-(3-(4-CHLOROPHENYL)PROPOXY)PROPYL)-, HYDROCHLORIDE (1:1)|1-{3-[3-(4-Chlorophenyl)propoxy]propyl}piperidine monohydrochloride|1-(3-(3-(4-CHLOROPHENYL)PROPOXY)PROPYL)PIPERIDINE MONOHYDROCHLORIDE|RefChem:57772|Ciproxidine|Pitolisant HCl|Pitolisant (hydrochloride)|BF 2649|BF 2649 hydrochloride|Piperidine, 1-[3-[3-(4-chlorophenyl)propoxy]propyl]-, hydrochloride|1-(3-(3-(4-Chlorophenyl)propoxy)propyl)piperidine hydrochloride|Pitolisant hydrochloride [USAN]|1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine Hydrochloride|1-[3-[3-(4-chlorophenyl)propoxy]propyl]piperidine;hydrochloride|1-{3-[3-(4-chlorophenyl)propoxy]propyl}piperidine hydrochloride|903576-44-3 (HCl)|Wakix (TN)|Piperidine, 1-(3-(3-(4-chlorophenyl)propoxy)propyl)-, hydrochloride|C17H27Cl2NO|MFCD09970745|BF 2.649|UNII-YV33CH63HI|Pitolisant (hydrochloride)?|Pitolisant HCl; BF 2649|orb1300008|SCHEMBL4591893|CHEMBL4164059|DTXSID50238098|Pitolisant;Ciproxidine; BF2649|GLXC-04064|HMS5085N17|BCP16427|EX-A1420|HY-12199B|Pitolisant hydrochloride (JAN/USAN)|PITOLISANT HYDROCHLORIDE [MI]|s5926|AKOS024457784|CS-1501|FB35077|SB17036|PITOLISANT HYDROCHLORIDE [WHO-DD]|AC-36017|AS-72196|DA-76930|FC153335|Pitolisant hydrochloride - Bio-X trade mark|PITOLISANT HYDROCHLORIDE [ORANGE BOOK]|C77058|D11490|Q27895485"
LIAROZOLE,60652,,"InChI=1S/C17H13ClN4/c18-14-3-1-2-12(8-14)17(22-7-6-19-11-22)13-4-5-15-16(9-13)21-10-20-15/h1-11,17H,(H,20,21)",UGFHIPBXIWJXNA-UHFFFAOYSA-N,C17H13ClN4,308.8,6-[(3-chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole,"Liarozole|115575-11-6|Liarozol|Liarozolum|R-75251|K0Q29TGV9Y|R-61405|R085246|R-085246|DTXSID9048277|1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-|5-((3-chlorophenyl)(1H-imidazol-1-yl)methyl)-1H-1,3-benzodiazole|5-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1H-1,3-benzodiazole|RefChem:799061|DTXCID4028252|6-((3-chlorophenyl)(1H-imidazol-1-yl)methyl)-1H-1,3-benzodiazole|1H-Benzimidazole, 6-[(3-chlorophenyl)-1H-imidazol-1-ylmethyl]-|Liazal|6-((3-chlorophenyl)(1H-imidazol-1-yl)methyl)-1H-benzo[d]imidazole|Liarozole, (+)-|Liarozole, (-)-|CHEMBL389433|6-[(3-chlorophenyl)-imidazol-1-ylmethyl]-1H-benzimidazole|17NYD2210B|090Y06W08H|R75251|172282-43-8|Liarozole [INN:BAN]|Liarozol [INN-Spanish]|Liarozolum [INN-Latin]|5-((3-chlorophenyl)(1H-imidazol-1-yl)methyl)-1H-benzo[d]imidazole|1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-, (+)-|1H-Benzimidazole, 5-((3-chlorophenyl)-1H-imidazol-1-ylmethyl)-, (-)-|171849-18-6|NCGC00181034-01|UNII-K0Q29TGV9Y|R 61405|R 085246|LIAROZOLE [INN]|LIAROZOLE [MI]|LIAROZOLE [MART.]|LIAROZOLE [WHO-DD]|SCHEMBL18597|UNII-17NYD2210B|GTPL5210|orb1309484|SCHEMBL15944205|SCHEMBL29404027|UNII-090Y06W08H|CHEBI:135316|QEA57511|BDBM50157605|BDBM50176808|MFCD00864664|AKOS040733598|DB13066|DA-15205|MS-24483|Liarozole dihydrochloride, >=98% (HPLC)|HY-106019|CS-0024635|F81706|Q15633974|5-[(3-Chloro-phenyl)-imidazol-1-yl-methyl]-1H-benzoimidazole|6-[(3-chlorophenyl)-imidazol-1-yl-methyl]-1H-benzimidazole|5-[(3-chlorophenyl)(1H-imidazol-1-yl)methyl]-1H-benzimidazole|(+/-)-5-(M-CHLORO-.ALPHA.-IMIDAZOL-1-YLBENZYL)BENZIMIDAZOLE|6-((3-CHLOROPHENYL)-1H-IMIDAZOL-1-YLMETHYL)-1H-BENZIMIDAZOLE|1H-BENZIMIDAZOLE, 5-((3-CHLOROPHENYL)-1H-IMIDAZOL-1-YLMETHYL)-, (+/-)-"
APITOLISIB,25254071,,"InChI=1S/C23H30N8O3S/c1-14-17(13-29-3-5-31(6-4-29)22(33)15(2)32)35-19-18(14)27-20(16-11-25-23(24)26-12-16)28-21(19)30-7-9-34-10-8-30/h11-12,15,32H,3-10,13H2,1-2H3,(H2,24,25,26)/t15-/m0/s1",YOVVNQKCSKSHKT-HNNXBMFYSA-N,C23H30N8O3S,498.6,"(2S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one","Apitolisib|1032754-93-0|GDC-0980|RG7422|GDC0980|(S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one|GNE 390|GDC-0980 (RG7422)|1C854K1MIJ|RG 7422|Apitolisib [USAN:INN]|GDC 0980|Gne-390|GDC-0980 (Apitolisib)|UNII-1C854K1MIJ|RG-7422|MFCD20274520|GDC-0980.1|CHEMBL1922094|DTXSID50145738|G-038390|G-038390.1|(2S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxypropan-1-one|Apitolisib (GDC-0980, RG7422)|(2s)-1-(4-{[2-(2-Aminopyrimidin-5-Yl)-7-Methyl-4-(Morpholin-4-Yl)thieno[3,2-D]pyrimidin-6-Yl]methyl}piperazin-1-Yl)-2-Hydroxypropan-1-One|(S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one.|GNE 390; GDC 0980; RG 7422|apitolisibum|C23H30N8O3S|(2S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-(morpholin-4-yl)thieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one|(2S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholin-4-ylthieno(3,2-d)pyrimidin-6-yl)methyl)piperazin-1-yl)-2-hydroxypropan-1-one|APITOLISIB [INN]|Apitolisib (USAN/INN)|APITOLISIB [USAN]|RefChem:1077141|Apitolisib (GDC-0980)|APITOLISIB [WHO-DD]|Apitolisib(GDC-0980)?|SCHEMBL466297|GTPL7888|orb1307117|DTXCID1068229|SCHEMBL29447291|EX-A041|YOVVNQKCSKSHKT-HNNXBMFYSA-N|BCP02622|BDBM50358204|GDC-0980,RG7422|NSC764091|NSC799334|s2696|AKOS027250725|BCP9000717|CCG-269678|CS-0590|DB12180|NSC-764091|NSC-799334|SDCCGSBI-0654434.P001|NCGC00263109-03|NCGC00263109-13|(S)-1-(4-((2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholinothieno[3,2-d]pyrimidin-6-yl)methyl)piperaz|AS-16289|HY-13246|NS00072853|SW219472-1|D10543|CAS:1032754-93-0;GDC-0980|GDC-0980,CAS:1032754-93-0|BRD-K23228615-001-02-8|BRD-K23228615-001-03-6|Q27074481|(2S)-1-(4-((2-(2-AMINOPYRIMIDIN-5-YL)-7-METHYL-4-(MORPHOLIN-4-YL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL(PIPERAZIN-1-YL)-2-HYDROXYPROPAN-1-ONE|(2S)-1-[4-[[2-(2-aminopyrimidin-5-yl)-7-methyl-4-morpholino-thieno[3,2-d]pyrimidin-6-yl]methyl]piperazin-1-yl]-2-hydroxy-propan-1-one|(S)-1-(4-((2-(2-AMINOPYRIMIDIN-5-YL)-7-METHYL-4-(MORPHOLIN-4-YL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)PIPERAZIN-1-YL)-2-HYDROXYPROPAN-1-ONE|1-PROPANONE, 1-(4-((2-(2-AMINO-5-PYRIMIDINYL)-7-METHYL-4-(4-MORPHOLINYL)THIENO(3,2-D)PYRIMIDIN-6-YL)METHYL)-1-PIPERAZINYL)-2-HYDROXY-, (2S)-"
TASELISIB,51001932,,"InChI=1S/C24H28N8O2/c1-14(2)32-22(27-15(3)29-32)19-13-30-8-9-34-20-10-16(6-7-18(20)21(30)28-19)17-11-26-31(12-17)24(4,5)23(25)33/h6-7,10-14H,8-9H2,1-5H3,(H2,25,33)",BEUQXVWXFDOSAQ-UHFFFAOYSA-N,C24H28N8O2,460.5,"2-methyl-2-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propanamide","Taselisib|1282512-48-4|GDC-0032|2-(4-(2-(1-isopropyl-3-methyl-1H-1,2,4-triazol-5-yl)-5,6-dihydrobenzo[f]imidazo[1,2-d][1,4]oxazepin-9-yl)-1H-pyrazol-1-yl)-2-methylpropanamide|GDC0032|RG-7604|L08J2O299M|DTXSID00155842|1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-alpha,alpha-dimethyl-|2-(4-(2-(1-ISOPROPYL-3-METHYL-1H-1,2,4-TRIAZOL-5-YL)-5,6-DIHYDROBENZO(F)IMIDAZO(1,2-D)(1,4)OXAZEPIN-9-YL)-1H-PYRAZOL-1-YL)-2-METHYLPROPANAMIDE|taselisibum|1H-PYRAZOLE-1-ACETAMIDE, 4-(5,6-DIHYDRO-2-(3-METHYL-1-(1-METHYLETHYL)-1H-1,2,4-TRIAZOL-5-YL)IMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)-ALPHA,ALPHA-DIMETHYL-|RefChem:891186|DTXCID9078333|RO5537381|2-methyl-2-(4-(4-(3-methyl-1-(propan-2-yl)-1H-1,2,4-triazol-5-yl)-9-oxa-3,6-diazatricyclo(8.4.0.0^(2,6))tetradeca-1(14),2,4,10,12-pentaen-12-yl)-1H-pyrazol-1-yl)propanamide|GDC 0032|Taselisib [INN]|Taselisib (GDC0032)|MFCD26142641|RG7604|CHEMBL2387080|2-methyl-2-[4-[2-(5-methyl-2-propan-2-yl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]propanamide|RG 7604|2-Methyl-2-(4-{2-[3-Methyl-1-(Propan-2-Yl)-1h-1,2,4-Triazol-5-Yl]-5,6-Dihydroimidazo[1,2-D][1,4]benzoxazepin-9-Yl}-1h-Pyrazol-1-Yl)propanamide|Taselisib [USAN:INN]|UNII-L08J2O299M|TaselisibGDC-0032|TaselisibGDC-0032?|Taselisib (USAN/INN)|TASELISIB [USAN]|TASELISIB [WHO-DD]|Taselisib (GDC 0032)|Taselisib (GDC-0032)|GTPL7794|orb1306789|SCHEMBL1485247|SCHEMBL29356334|BEUQXVWXFDOSAQ-UHFFFAOYSA-N|HMS3674G19|BCP09253|EX-A1581|BDBM50434806|NSC777425|NSC800985|s7103|AKOS026750303|CCG-269338|CS-1817|DB12108|GDC-0032, Taselisib; RG-7604|NSC-777425|NSC-800985|SB16576|NCGC00387039-02|AC-32794|AS-10662|BG166285|HY-13898|NS00072930|D11774|BRD-K44844162-001-01-6|Q27088940|1395408-87-3|1H-PYRAZOLE-1-ACETAMIDE, 4-(5,6-DIHYDRO-2-(3-METHYL-1-(1-METHYLETHYL)-1H-1,2,4-TRIAZOL-5-YL)IMIDAZO(1,2-D)(1,4)BENZOXAZEPIN-9-YL)-.ALPHA.,.ALPHA.-DIMETHYL-|1H-Pyrazole-1-acetamide, 4-[5,6-dihydro-2-[3-methyl-1-(1-methylethyl)-1H-1,2,4-triazol-5-yl]imidazo[1,2-d][1,4]benzoxazepin-9-yl]-|A,|A-dimethyl-|2-[4-[2-(2-isopropyl-5-methyl-1,2,4-triazol-3-yl)-5,6-dihydroimidazo[1,2-d][1,4]benzoxazepin-9-yl]pyrazol-1-yl]-2-methyl-propanamide"
COPANLISIB,135565596,,"InChI=1S/C23H28N8O4/c1-33-19-17(35-10-2-6-30-8-11-34-12-9-30)4-3-16-18(19)28-23(31-7-5-25-20(16)31)29-21(32)15-13-26-22(24)27-14-15/h3-4,13-14,25H,2,5-12H2,1H3,(H2,24,26,27)",MWYDSXOGIBMAET-UHFFFAOYSA-N,C23H28N8O4,480.5,"2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]pyrimidine-5-carboxamide","Copanlisib|1032568-63-0|BAY 80-6946|BAY-80-6946|BAY80-6946|BAY 80-6946 (Copanlisib)|Aliqopa|2-amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide|MFCD18633201|2-Amino-N-[2,3-dihydro-7-methoxy-8-[3-(4-morpholinyl)propoxy]imidazo[1,2-c]quinazolin-5-yl]-5-pyrimidinecarboxamide|WI6V529FZ9|Copanlisib (BAY 80-6946)|C23H28N8O4|2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]pyrimidine-5-carboxamide|2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide|Copanlisib [INN]|copanlisibum|UNII-WI6V529FZ9|2-AMINO-N-(7-METHOXY-8-(3-MORPHOLIN-4-YLPROPOXY)-2,3-DIHYDROIMIDAZO(1,2-C)QUINAZOLIN-5-YL)PYRIMIDINE-5-CARBOXAMIDE|2-amino-N-[7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl]pyrimidine-5-carboxamide|Copanlisib tris-HCl|Copanlisib (Standard)|COPANLISIB [MI]|Copanlisib (USAN/INN)|Copanlisib [USAN:INN]|COPANLISIB [USAN]|COPANLISIB [WHO-DD]|Copanlisib(BAY80-6946)|GTPL7875|orb1300871|SCHEMBL1655478|BAY 80-6946; Copanlisib|BAY-80-6946 tris-HCl|Copanlisib; BAY-80-6946|CHEMBL3218576|SCHEMBL13084037|SCHEMBL13084039|SCHEMBL28895762|BAY 80-6946(Copanlisib)?|DTXSID00145728|CHEBI:173077|PZBCKZWLPGJMAO-UHFFFAOYSA-N|BCP04754|EX-A2005|BDBM50204093|HY-15346R|NSC760443|NSC800076|NSC809693|NSC816437|s2802|AKOS025290222|BAY-806946|CS-0741|DB12483|NSC-760443|NSC-800076|NSC-809693|NSC-816437|PB22956|VS-0128|NCGC00346457-01|NCGC00346457-02|NCGC00346457-04|NCGC00346457-05|AC-28438|BAY 80-6946?|BC164810|BP-43635|HY-15346|NS00072920|D10867|BRD-K24666289-001-02-3|BRD-K24666289-001-04-9|Q19903876|2-AMINO-N-(7-METHOXY-8-(3-(MORPHOLIN-4-YL)PROPOXY)-2,3-DIHYDROIMIDAZO(1,2-C)QUINAZOLIN-5-YL(PYRIMIDINE-5-CARBOXAMIDE|2-amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo(1,2-c)quinazolin-4-yl)pyrimidine-5-carboxamide|2-Amino-N-(7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl)pyrimidine-5-carboxamide;BAY 80-6946|2-amino-N-[7-methoxy-8-(3-morpholin-4-ylpropoxy)-2,3-dihydroimidazo[1.2-c]quinazolin-5-yl]pyrimidine-5-carboxamide|2-amino-N-[7-methoxy-8-(3-morpholinopropoxy)-2,3-dihydro-1H-imidazo[1,2-c]quinazolin-5-ylidene]pyrimidine-5-carboxamide|2-amino-N-{7-methoxy-8-[3-(morpholin-4-yl)propoxy]-2,3-dihydroimidazo[1,2-c]quinazolin-5-yl}pyrimidine-5-carboxamide|5-PYRIMIDINECARBOXAMIDE, 2-AMINO-N-(2,3-DIHYDRO-7-METHOXY-8-(3-(4-MORPHOLINYL)PROPOXY)IMIDAZO(1,2-C)QUINAZOLIN-5-YL)-"
VOXTALISIB,16123056,,"InChI=1S/C13H14N6O/c1-3-19-11-8(7(2)16-13(14)17-11)6-9(12(19)20)10-4-5-15-18-10/h4-6H,3H2,1-2H3,(H,15,18)(H2,14,16,17)",RGHYDLZMTYDBDT-UHFFFAOYSA-N,C13H14N6O,270.29,"2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)pyrido[2,3-d]pyrimidin-7-one","voxtalisib|934493-76-2|SAR245409|SAR-245409|CVL1685GPH|2-amino-8-ethyl-4-methyl-6-(1h-pyrazol-3-yl)pyrido[2,3-d]pyrimidin-7(8h)-one|DTXSID701025755|Pyrido(2,3-d)pyrimidin-7(8H)-one, 2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-3-yl)-|voxtalisibum|2-AMINO-8-ETHYL-4-METHYL-6-(1H-PYRAZOL-3-YL)PYRIDO(2,3-D)PYRIMIDIN-7(8H)-ONE|RefChem:902061|DTXCID001510022|2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)-7H,8H-pyrido(2,3-d)pyrimidin-7-one|CHEBI:71958|N-(4-((3-((3,5-dimethoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide|N-(4-((3-(3,5-dimethoxyanilino)quinoxalin-2-yl)sulfamoyl)phenyl)-3-methoxy-4-methylbenzamide|XL 765|Xl-765|XL765|2-amino-8-ethyl-4-methyl-6-(1h-pyrazol-5-yl)pyrido[2,3-d]pyrimidin-7(8h)-one|2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)pyrido[2,3-d]pyrimidin-7-one|Voxtalisib (XL765, SAR245409)|UNII-CVL1685GPH|Voxtalisib [USAN:INN]|2-AMINO-8-ETHYL-4-METHYL-6-(1H-PYRAZOL-5-YL)PYRIDO(2,3-D)PYRIMIDIN-7(8H)-ONE|Voxtalisib (XL765)|VOXTALISIB [INN]|Voxtalisib (USAN/INN)|VOXTALISIB [USAN]|VOXTALISIB [WHO-DD]|SCHEMBL189573|orb1300143|SCHEMBL3341496|CHEMBL3545366|CHEBI:124914|GLXC-07399|BCP16243|EX-A4140|BDBM50519385|MFCD28716102|NSC791226|NSC800972|s7646|AKOS027338668|AKOS037515701|CCG-267162|CS-3163|DB12400|NSC-791226|NSC-800972|SAR 245409|SB16573|NCGC00387875-03|NCGC00387875-04|Voxtalisib (XL765, SAR245409)?|AC-29029|AS-56112|HY-15900|DB-346886|NS00072150|D11727|BRD-K56291712-001-01-0|Q27215232|2-AMINO-8-ETHYL-4-METHYL-6-(1H-PYRAZOL-3-YL)PYRIDO(2,3-D)PYRIMIDIN-|2-amino-8-ethyl-4-methyl-6-(1H-pyrazol-5-yl)-7-pyrido[2,3-d]pyrimidinone"
TENALISIB,86291103,,"InChI=1S/C23H18FN5O2/c1-2-16(29-23-19-22(26-11-25-19)27-12-28-23)21-18(13-6-5-7-14(24)10-13)20(30)15-8-3-4-9-17(15)31-21/h3-12,16H,2H2,1H3,(H2,25,26,27,28,29)/t16-/m0/s1",HDXDQPRPFRKGKZ-INIZCTEOSA-N,C23H18FN5O2,415.4,3-(3-fluorophenyl)-2-[(1S)-1-(7H-purin-6-ylamino)propyl]chromen-4-one,"Tenalisib|1639417-53-0|RP6530|RP-6530|2261HH611H|3-(3-fluorophenyl)-2-[(1S)-1-(7H-purin-6-ylamino)propyl]chromen-4-one|RP 6530|3-(3-Fluorophenyl)-2-((1S)-1-((7H-purin-6-yl)amino)propyl)-4H-1-benzopyran-4-one|4H-1-Benzopyran-4-one, 3-(3-fluorophenyl)-2-((1S)-1-(9H-purin-6-ylamino)propyl)-|3-(3-fluorophenyl)-2-((1S)-1-(7H-purin-6-ylamino)propyl)chromen-4-one|3-(3-fluorophenyl)-2-[(1S)-1-[(9H-purin-6-yl)amino]propyl]-4H-chromen-4-one|tenalisibum|3-(3-fluorophenyl)-2-((1S)-1-((9H-purin-6-yl)amino)propyl)-4H-chromen-4-one|RefChem:187826|Tenalisib (RP6530)|Tenalisib [INN]|(S)-2-(1-((9H-Purin-6-yl)amino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one|C23H18FN5O2|RP6530, Tenalisib|TENALISIB [WHO-DD]|GTPL9907|orb1309019|CHEMBL4297584|SCHEMBL16279460|SCHEMBL21828463|SCHEMBL29369874|SCHEMBL29370345|SCHEMBL29506722|SCHEMBL29921996|SCHEMBL30157094|SCHEMBL30257227|UNII-2261HH611H|BCP25998|EX-A2699|PQC41753|BDBM50512870|MFCD28502205|NSC803014|s8672|AKOS037645008|CCG-268828|CS-6375|DB15295|NSC-803014|(S)-2-(1-((7H-purin-6-yl)amino)propyl)-3-(3-fluorophenyl)-4H-chromen-4-one|AS-56118|HY-17645|C73162|Q27253617|1693773-94-2"
ACALISIB,11618268,,"InChI=1S/C21H16FN7O/c1-12(27-19-17-18(24-10-23-17)25-11-26-19)20-28-16-8-7-13(22)9-15(16)21(30)29(20)14-5-3-2-4-6-14/h2-12H,1H3,(H2,23,24,25,26,27)/t12-/m0/s1",DOCINCLJNAXZQF-LBPRGKRZSA-N,C21H16FN7O,401.4,6-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)ethyl]quinazolin-4-one,"Acalisib|Acalisib [INN]|GS-9820|CAL-120|UNII-OVW60IDW1D|OVW60IDW1D|CAL120|GS9820|ACALISIB [WHO-DD]|6-fluoro-3-phenyl-2-[(1S)-1-(7H-purin-6-ylamino)ethyl]quinazolin-4-one|6-Fluoro-3-phenyl-2-((1S)-1-(7H-purin-6-ylamino)ethyl)quinazolin-4(3H)-one|acalisibum|6-fluoro-3-phenyl-2-((1S)-1-(7H-purin-6-ylamino)ethyl)quinazolin-4-one|6-fluoro-3-phenyl-2-((1S)-1-((7H-purin-6-yl)amino)ethyl)-3,4-dihydroquinazolin-4-one|6-fluoro-3-phenyl-2-[(1S)-1-[(7H-purin-6-yl)amino]ethyl]-3,4-dihydroquinazolin-4-one|RefChem:108669|870281-34-8|Acalisib (GS-9820)|(S)-2-(1-((9H-Purin-6-yl)amino)ethyl)-6-fluoro-3-phenylquinazolin-4(3H)-one|(S)-2-(1-((7H-purin-6-yl)amino)ethyl)-6-fluoro-3-phenylquinazolin-4(3H)-one.|C21H16FN7O|SCHEMBL356539|orb1305173|CHEMBL4303323|SCHEMBL17518095|SCHEMBL29360030|SCHEMBL29422834|GTPL10096|CAL 120|BDBM217352|BCP13804|EX-A2199|GS 9820;CAL 120|s5818|Acalisib; GS-9820; CAL-120|AKOS030526955|CS-5556|DB15407|GS 9820|NCGC00408915-01|NCGC00408915-02|AC-35977|BS-17755|FA101029|HY-12644|C76844|BRD-K92517771-001-01-2|Q27285873|(S)-2-(1-(9H-Purin-6-ylamino)ethyl)-6-fluoro-3-phenylquinazolin-4(3H)-one|6-fluoro-3-phenyl-2-[(1s)-1-(9h-purin-6-ylamino) ethyl]-4(3h)-quinazolinone|6-fluoro-3-phenyl-2-[(1S)-1-[(9H-purin-6-yl)amino]ethyl]-3,4-dihydroquinazolin-4-one"
GSK-690693,16725726,,"InChI=1S/C21H27N7O3/c1-4-28-18-15(30-12-13-6-5-9-23-10-13)11-24-14(7-8-21(2,3)29)16(18)25-20(28)17-19(22)27-31-26-17/h11,13,23,29H,4-6,9-10,12H2,1-3H3,(H2,22,27)/t13-/m0/s1",KGPGFQWBCSZGEL-ZDUSSCGKSA-N,C21H27N7O3,425.5,"4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[[(3S)-piperidin-3-yl]methoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol","937174-76-0|GSK690693|GSK-690693|GSK 690693|CHEBI:90677|GWH480321B|DTXSID60239551|RefChem:144530|DTXCID10162042|(S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol|MFCD14105605|4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[[(3S)-piperidin-3-yl]methoxy]imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol|4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol|C21H27N7O3|4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-piperidin-3-ylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol|4-{2-(4-Amino-1,2,5-Oxadiazol-3-Yl)-1-Ethyl-7-[(3s)-Piperidin-3-Ylmethoxy]-1h-Imidazo[4,5-C]pyridin-4-Yl}-2-Methylbut-3-Yn-2-Ol|UNII-GWH480321B|4-{2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-piperidin-3-ylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl}-2-methylbut-3 -yn-2-ol|G93|compound 3g [PMID 18800763]|-yn-2-ol|SCHEMBL310452|CHEMBL494089|GTPL5196|orb1300902|pan-Akt inhibitor GS690693|SCHEMBL29387832|BDBM25013|EX-A031|GLXC-05503|4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol|BCP01721|NSC766991|NSC800766|s1113|AKOS015904356|AT18727|BCP9000745|CCG-264825|DB12745|NSC-766991|NSC-800766|SDCCGSBI-0654451.P001|NCGC00263181-01|4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[[(3S)-3-piperidyl]methoxy]imidazo[4,5-c]pyridin-4-yl]-2-methyl-but-3-yn-2-ol|AC-23166|AS-16204|BG174974|HY-10249|SY328472|GSK690693,GSK-690693|NS00072069|SW218127-2|GSK690693, >=98% (HPLC)|174G760|BRD-K25325018-001-02-3|BRD-K25325018-001-05-6|Q27077916|(-)-4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-((3S)-3-PIPERIDINYLMETHOXY)-1H-IMIDAZO(4,5-C)PYRIDIN-4-YL)-2-METHYL-3-BUTYN-2-OL|(S)-4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(3-piperidylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol|3-BUTYN-2-OL, 4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-((3S)-3-PIPERIDINYLMETHOXY)-1H-IMIDAZO(4,5-C)PYRIDIN-4-YL)-2-METHYL-|4-(2-(4-AMINO-1,2,5-OXADIAZOL-3-YL)-1-ETHYL-7-((3S)-3-PIPERIDINYLMETHOXY)-1H-IMIDAZO(4,5-C)PYRIDIN-4-YL)-2-METHYL-3-BUTYN-2-OL, (-)-|4-(2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-((S)-piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol|4-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-{[(3S)-piperidin-3-yl]methoxy}-1H-imidazo[4,5-c]pyridin-4-yl]-2-methylbut-3-yn-2-ol|4-{2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-piperidin-3-ylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl}-2-methylbut-3"
TALAZOPARIB,135565082,,"InChI=1S/C19H14F2N6O/c1-27-18(22-8-23-27)15-16(9-2-4-10(20)5-3-9)24-13-7-11(21)6-12-14(13)17(15)25-26-19(12)28/h2-8,15-16,24H,1H3,(H,26,28)/t15-,16-/m1/s1",HWGQMRYQVZSGDQ-HZPDHXFCSA-N,C19H14F2N6O,380.4,"(11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(2-methyl-1,2,4-triazol-3-yl)-2,3,10-triazatricyclo[7.3.1.05,13]trideca-1,5(13),6,8-tetraen-4-one","Talazoparib|1207456-01-6|BMN-673|BMN673|BMN 673|9QHX048FRV|DTXSID001025928|3H-Pyrido(4,3,2-de)phthalazin-3-one, 5-fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-, (8S,9R)-|PF-06944076|talazoparibum|RefChem:57302|L01XX60|DTXCID901510174|(11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(1-methyl-1H-1,2,4-triazol-5-yl)-2,3,10-triazatricyclo(7.3.1.0^(5,13))trideca-1,5,7,9(13)-tetraen-4-one|815-271-8|LT-673|Talazoparib (BMN 673)|(8S,9R)-5-fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-8,9-dihydro-2H-pyrido[4,3,2-de]phthalazin-3(7H)-one|MFCD22666357|C19H14F2N6O|(8s,9r)-5-Fluoro-8-(4-Fluorophenyl)-9-(1-Methyl-1h-1,2,4-Triazol-5-Yl)-2,7,8,9-Tetrahydro-3h-Pyrido[4,3,2-De]phthalazin-3-One|(11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(2-methyl-1,2,4-triazol-3-yl)-2,3,10-triazatricyclo[7.3.1.05,13]trideca-1,5(13),6,8-tetraen-4-one|(8S,9R)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazine-3-one|(8S,9R)-BMN 673|Talazoparib [USAN:INN]|UNII-9QHX048FRV|4pjt|2YQ|TALAZOPARIB [MI]|Talazoparib(BMN-673)|TALAZOPARIB [INN]|Talazoparib (USAN/INN)|TALAZOPARIB [USAN]|Talazoparib (BMN-673)|Talazoparib(BMN-673)?|TALAZOPARIB [WHO-DD]|GTPL8313|orb1300934|SCHEMBL2299348|CHEMBL3137320|SCHEMBL29351841|BMN673,BMN-673|CHEBI:231344|HWGQMRYQVZSGDQ-HZPDHXFCSA-N|GLXC-06076|EX-A1356|BDBM50084621|NSC767125|AKOS027250735|AKOS040758983|CS-0937|DB11760|NSC-767125|NCGC00351600-09|NCGC00390231-01|AC-30927|AS-57491|BP-44054|FF103545|HY-16106|LT 00673|SY387326|NS00072968|S7048|SW219655-1|D10732|EN300-20176329|BRD-K95142244-001-01-5|Q25100990|Q27453411|(11S,12R)-7-fluoro-11-(4-fluorophenyl)-12-(1-methyl-1H-1,2,4-triazol-5-yl)-2,3,10-triazatricyclo[7.3.1.0,5,13]trideca-1,5,7,9(13)-tetraen-4-one|Talazoparib; (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-2,7,8,9-tetrahydro-9-(1-methyl-1H-1,2,4-triazol-5-yl)-3H-pyrido[4,3,2-de]phthalazin-3-one"
BEMESETRON,671690,,"InChI=1S/C15H17Cl2NO2/c1-18-12-2-3-13(18)8-14(7-12)20-15(19)9-4-10(16)6-11(17)5-9/h4-6,12-14H,2-3,7-8H2,1H3/t12-,13+,14?",MNJNPLVXBISNSX-PBWFPOADSA-N,C15H17Cl2NO2,314.2,"[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3,5-dichlorobenzoate","BEMESETRON|40796-97-2|3-Tropanyl-3,5-dichlorobenzoate|MDL 72222|MDL-72222|Bemesetron (USAN/INN)|MDL 72,222|Bemesetron (MDL 72222)|CHEMBL1365455|DTXSID8042632|O98T3677PA|[(1S,5R)-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 3,5-dichlorobenzoate|1alphaH,5alphaH-Tropan-3alpha-yl 3,5-dichlorobenzoate|MDL-72,222|mdl72222|Bemesetronum|DTXCID401475919|Benzoic acid, 3,5-dichloro-, 8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester, endo-|Tropyl 3,5-dichlorobenzoate|CAS-40796-97-2|Bemesetron [USAN:INN]|Bemesetronum [INN-Latin]|UNII-O98T3677PA|NCGC00016058-05|Tocris-0640|BEMESETRON [INN]|BEMESETRON [USAN]|Lopac-T-8160|RefChem:1077786|SCHEMBL195147|SCHEMBL195148|Tropanyl 3,5-dichlorobenzoate|Tropanyl-3,5 dichlorobenzoate|CHEMBL1257101|CHEMBL2107804|BDBM82561|GLXC-07361|tropan-3-yl-3,5-dichlorobenzoate|endo-8-Methyl-8-azabicyclo(3.2.1)oct-3-yl 3,5-dichlorobenzoate|HY-B1541|QBA79697|Tox21_110293|BDBM50155252|PDSP2_001503|AKOS040741307|Tox21_110293_1|NCGC00016058-01|NCGC00016058-02|NCGC00016058-07|NCGC00024702-01|NCGC00186619-01|CAS_40796-97-2|CS-0013371|D03073|Q4885099|(1R,5S)-8-methyl-8-azabicyclo[3.2.1]oct-3-yl 3,5-dichlorobenzoate|8-Methyl-8-azabiciclo[3.2.1]oct-3-yl-3,5-dichlorobenzoate (MDL 72222)|Benzoic acid, 3,5-dichloro-, (3-endo)-8-methyl-8-azabicyclo(3.2.1)oct-3-yl ester"
FORETINIB,42642645,,"InChI=1S/C34H34F2N4O6/c1-43-30-20-25-27(21-31(30)45-16-2-13-40-14-17-44-18-15-40)37-12-9-28(25)46-29-8-7-24(19-26(29)36)39-33(42)34(10-11-34)32(41)38-23-5-3-22(35)4-6-23/h3-9,12,19-21H,2,10-11,13-18H2,1H3,(H,38,41)(H,39,42)",CXQHYVUVSFXTMY-UHFFFAOYSA-N,C34H34F2N4O6,632.7,"1-N'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide","Foretinib|849217-64-7|GSK1363089|XL880|EXEL-2880|XL-880|GSK 1363089|GSK089|GSK-1363089|GSK-089|GSK1363089G|81FH7VK1C4|GSK-1363089G|937176-80-2|DTXSID20918193|N-(3-Fluoro-4-((6-methoxy-7-(3-(morpholin-4-yl)propoxy)quinolin-4-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|N-[3-fluoro-4-({6-methoxy-7-[3-(morpholin-4-yl)propoxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|XL880 cpd|foretinibum|1-N'-(3-fluoro-4-((6-methoxy-7-(3-(morpholin-4-yl)propoxy)quinolin-4-yl)oxy)phenyl)-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|1-N'-[3-fluoro-4-({6-methoxy-7-[3-(morpholin-4-yl)propoxy]quinolin-4-yl}oxy)phenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|RefChem:599622|DTXCID501347147|MET/VEGFR-2 inhibitor GSK1363089|Multitargeted Tyrosine Kinase Inhibitor GSK1363089|N'1-(3-fluoro-4-((6-methoxy-7-(3-(morpholin-4-yl)propoxy)quinolin-4-yl)oxy)phenyl)-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|Foretinib (GSK1363089)|XL 880|EXEL 2880|MFCD16038048|N-[3-Fluoro-4-[[6-methoxy-7-[3-(4-morpholinyl)propoxy]-4-quinolinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide|1-N'-[3-fluoro-4-[6-methoxy-7-(3-morpholin-4-ylpropoxy)quinolin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|88Z|N-(3-Fluoro-4-{[6-Methoxy-7-(3-Morpholin-4-Ylpropoxy)quinolin-4-Yl]oxy}phenyl)-N'-(4-Fluorophenyl)cyclopropane-1,1-Dicarboxamide|EXEL 2880; GSK 1363089; GSK 1363089G; N-[3-Fluoro-4-[[6-(methyloxy)-7-[[3-(morpholin-4-yl)propyl]oxy]quinolin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; XL 880|N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl]oxy)phenyl}-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin-4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|Foretinib(XL880)|xl-880, Foretinib|Foretinib(XL880)?|FORETINIB [INN]|Foretinib [USAN:INN]|FORETINIB [USAN]|Foretinib (XL-880)|FORETINIB [WHO-DD]|UNII-81FH7VK1C4|MLS006010302|SCHEMBL371804|GTPL5679|orb1304524|CHEMBL1230609|SCHEMBL29358674|SCHEMBL30498609|CHEBI:91418|EX-A050|CXQHYVUVSFXTMY-UHFFFAOYSA-N|BCPP000236|GLXC-05712|HMS3295K13|HMS3654G04|BCP02231|BDBM50399540|GSK 1363089G|NSC755775|NSC800101|s1111|Foretinib,XL880, GSK1363089|AKOS015904319|BCP9000675|CCG-270292|CS-0153|DB12307|FF42412|GSK1363089;XL880|NSC-755775|NSC-800101|PB27007|SB20469|SDCCGSBI-0654343.P001|Foretinib (GSK1363089, XL880)|NCGC00263104-01|NCGC00263104-10|AC-25081|AS-16268|HY-10338|SMR003599144|SY269694|NS00072564|SW219390-1|Q5469311|BRD-K03449891-001-01-1|BRD-K03449891-001-08-6|1,1-CYCLOPROPANEDICARBOXAMIDE, N-(3-FLUORO-4-((6-METHOXY-7-(3-(4- MORPHOLINYL)PROPOXY)-4-QUINOLINYL)OXY)PHENYL)-N'-(4-FLUOROPHENYL)-|1,1-Cyclopropanedicarboxamide, N-(3-fluoro-4-((6-methoxy-7-(3-(4-morpholinyl)propoxy)-4-quinolinyl)oxy)phenyl)-N'-(4-fluorophenyl)-|N-(3-FLUORO-4-((6-METHOXY-7-(3-(MORPHOLIN-4-YL)PROPOXY)QUINOLIN-4-YL)OXY) PHENYL)-N'-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE|N-(4-(7-(3-MORPHOLINOPROPOXY)-6-METHOXYQUINOLIN-4-YLOXY)-3-FLUOROPHENYL)-N-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE|N-[3-fluoro-4-({6-(methyloxy)-7-[(3-morpholin 4-ylpropyl)oxy]quinolin-4-yl}oxy)phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|N1'-[3-fluoro-4-[[6-methoxy-7-(3-morpholinopropoxy)-4-quinolyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide"
SAVOLITINIB,68289010,,"InChI=1S/C17H15N9/c1-11(12-3-4-15-18-5-6-25(15)10-12)26-17-16(22-23-26)19-8-14(21-17)13-7-20-24(2)9-13/h3-11H,1-2H3/t11-/m0/s1",XYDNMOZJKOGZLS-NSHDSACASA-N,C17H15N9,345.4,"3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine","Savolitinib|Volitinib|1313725-88-0|HMPL-504|AZD-6094|AZD6094|HMPL504|savolitinibum|2A2DA6857R|AZD 6094|3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine|DTXSID801111016|1H-1,2,3-Triazolo(4,5-b)pyrazine, 1-((1S)-1-imidazo(1,2-a)pyridin-6-ylethyl)-6-(1-methyl-1H-pyrazol-4-yl)-|1-((1S)-1-Imidazo(1,2-a)pyridin-6-ylethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-1,2,3-triazolo(4,5-b)pyrazine|1-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-1,2,3-triazolo[4,5-b]pyrazine|3-((1S)-1-imidazo(1,2-a)pyridin-6-ylethyl)-5-(1-methylpyrazol-4-yl)triazolo(4,5-b)pyrazine|RefChem:884623|DTXCID301542632|Savolitinib [INN]|Orpathys|(S)-1-(1-(imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine|Volitinib(Savolitinib)|MFCD28359096|HMPL 504|CHEMBL3334567|4-{1-[(1S)-1-{imidazo[1,2-a]pyridin-6-yl}ethyl]-1H-[1,2,3]triazolo[4,5-b]pyrazin-6-yl}-1-methyl-1H-pyrazole|UNII-2A2DA6857R|C17H15N9|Volitinib; 1-[(1S)-1-Imidazo[1,2-a]pyridin-6-ylethyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-1,2,3-triazolo[4,5-b]pyrazine; AZD 6094; HM 5016504; HMPL 504|Volitinib dihydrochloride|AZD6094 dihydrochloride|Savolitinib [USAN:INN]|Savolitinib dihydrochloride|SAVOLITINIB [USAN]|HMPL-504 dihydrochloride|Savolitinib (AZD6094)|SAVOLITINIB [WHO-DD]|Savolitinib (JAN/USAN/INN)|GTPL9918|orb1296129|SCHEMBL12489208|SCHEMBL29517102|EX-A845|CHEBI:231369|AZD6094, HMPL-504|BDBM50023342|NSC782121|NSC800966|s7674|AKOS030526403|Savolitinib(AZD6094, HMPL-504)|CCG-267976|DB12048|NSC-782121|NSC-800966|compound 28 [PMID: 25148209]|NCGC00475727-01|AC-35267|AS-35250|BV160378|HY-15959|HM 5016504|HM-5016504|NS00073442|Savolitinib;Volitinib;HMPL-504;AZD-6094|D11139|EN300-7482485|BRD-K98028353-001-01-0|Q27254463|Z3041529961|(S)-1-(1-(imidazo[1,2-a]pyridin-6-yl)ethyl)-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine dihydrochloride|1-((S)-1-(IMIDAZO(1,2-A)PYRIDIN-6-YL)ETHYL)-6-(1-METHYL-1H-PYRAZOL-4-YL)-1H-(1,2,3)-TRIAZOLO(4,5-B)PYRAZINE|1-[(1S)-1-(imidazo[1,2-a]pyridin-6-yl)ethyl]-6-(1-methyl-1H-pyrazol-4-yl)-1H-[1,2,3]triazolo[4,5-b]pyrazine|Savolitinib;AZD6094;4- {1- [(1S) - 1- {Imidazo[1, 2- a] pyridin- 6- yl} ethyl] - 1H- [1, 2, 3] triazolo[4, 5- b] pyrazin- 6- yl} - 1 - methyl- 1H- pyrazole"
GLESATINIB,25181472,,"InChI=1S/C31H27F2N5O3S2/c1-40-13-12-34-17-20-4-8-24(36-18-20)28-16-25-30(43-28)27(10-11-35-25)41-26-9-7-22(15-23(26)33)37-31(42)38-29(39)14-19-2-5-21(32)6-3-19/h2-11,15-16,18,34H,12-14,17H2,1H3,(H2,37,38,39,42)",YRCHYHRCBXNYNU-UHFFFAOYSA-N,C31H27F2N5O3S2,619.7,"N-[[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-(4-fluorophenyl)acetamide","glesatinib|936694-12-1|MG90265X|MG90265|MG-90265X|7Q29OXD98N|MG-90265|N-[[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]carbamothioyl]-2-(4-fluorophenyl)acetamide|DTXSID601337113|Benzeneacetamide, 4-fluoro-N-(((3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)-2-pyridinyl)thieno(3,2-b)pyridin-7-yl)oxy)phenyl)amino)thioxomethyl)-|3-(3-fluoro-4-{[2-(5-{[(2-methoxyethyl)amino]methyl}pyridin-2-yl)thieno[3,2-b]pyridin-7-yl]oxy}phenyl)-1-[2-(4-fluorophenyl)acetyl]thiourea|glesatinibum|3-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno(3,2-b)pyridin-7-yl)oxy)phenyl)-1-(2-(4-fluorophenyl)acetyl)thiourea|N-((3-fluoro-4-(2-(5-((2-methoxyethylamino)methyl)pyridin-2-yl)thieno(3,2-b)pyridin-7-yl)oxyphenyl)carbamothioyl)-2-(4-fluorophenyl)acetamide|RefChem:663075|TKI MGCD265|DTXCID701767460|MG90265gly|Glesatinib [USAN]|MG90265H9|N-((3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)carbamothioyl)-2-(4-fluorophenyl)acetamide|N-(3-fluoro-4-(2-(5-((2-methoxyethylamino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-(4-fluorophenyl)acetamide|YRCHYHRCBXNYNU-UHFFFAOYSA-N|Glesatinib free base|MG265 dihydrochloride|GLESATINIB [INN]|Glesatinib dihydrochloride|Glesatinib (USAN/INN)|MGCD265 dihydrochloride|GLESATINIB [WHO-DD]|UNII-7Q29OXD98N|SCHEMBL106319|GTPL9133|orb1707269|CHEMBL3989914|SCHEMBL29351360|GLXC-10330|EX-A4139|BDBM50625502|NSC791059|AKOS040741789|DB06302|NSC-791059|SB19664|compound 10a [PMID: 18434145]|NCGC00483925-01|AC-31426|DA-73746|HY-19642|CS-0016148|NS00073349|D11136|Q27895580|N-(3-FLUORO-4-(2-(5-((2-METHOXYETHYLAMINO) METHYL)PYRIDINE-2-YL)THIENO(3,2-B)PYRIDINE-7-YLOXY)PHENYLCARBAMOTHIOYL)-2-(4-FLUOROPHENYL)ACETAMIDE|N-(3-fluoro-4-(2-(5-((2-methoxyethylamino)methyl)pyridin-2-yl)thieno[3,2-b]pyridine-7-yloxy)phenylcarbamothioyl)-2-(4-fluorophenyl)acetamide"
VADADUSTAT,23634441,,"InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)",JGRXMPYUTJLTKT-UHFFFAOYSA-N,C14H11ClN2O4,306.70,2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid,"Vadadustat|1000025-07-9|AKB-6548|Vafseo|PG-1016548|B506|PG1016548|B-506|N-(5-(3-Chlorophenyl)-3-hydroxypyridine-2-carbonyl)glycine|Glycine, N-[[5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl]carbonyl]-|AKB6548|I60W9520VV|2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid|DTXSID501179936|Glycine, N-((5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl)carbonyl)-|2-{[5-(3-chlorophenyl)-3-hydroxypyridin-2-yl]formamido}acetic acid|vadadustatum|N-[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]glycine|2-((5-(3-chlorophenyl)-3-hydroxypyridin-2-yl)formamido)acetic acid|2-((5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl)amino)acetic acid|RefChem:901563|DTXCID801611280|N-((5-(3-Chlorophenyl)-3-hydroxy-2-pyridinyl)carbonyl)glycine|Vadadustat [USAN]|(5-(3-chlorophenyl)-3-hydroxypicolinoyl)glycine|Glycine, N-[[5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl]carbonyl]-;Glycine, N-[[5-(3-chlorophenyl)-3-hydroxy-2-pyridinyl]carbonyl]-|UNII-I60W9520VV|Vadadustat?|US8722895, 11: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid|A1Z|Vafseo (TN)|VADADUSTAT [INN]|VADADUSTAT [JAN]|US8722895, 10: {[5-(3-Chlorophenyl)-3-hydroxypyridine-2- carbonyl]amino}-acetic acid trifluoroacetic acid salt|VADADUSTAT [WHO-DD]|Vadadustat (JAN/USAN/INN)|orb2281186|SCHEMBL1920738|CHEMBL3646221|SCHEMBL29357486|SCHEMBL29405970|GTPL11831|JGRXMPYUTJLTKT-UHFFFAOYSA-N|BDBM107704|GLXC-10623|BCP19497|EX-A2573|GSK128863|MFCD30470233|s6490|AKOS028114979|CS-6373|DB12255|SB19204|US8598210, Table XV, 10|US8598210, Table XV, 11|AC-30928|AS-71695|FV168206|DB-102455|HY-101277|Vadadustat; PG-1016548; AKB-6548|NS00073389|C71001|D11078|US8598210, 119|Q27280485|2-(5-(3-Chlorophenyl)-3-hydroxypicolinamido)acetic acid|AKB-6548; B-506; PG-1016548|{[5-(3-chlorophenyl)-3-hydroxy-pyridine-2-carbonyl]-amino}-acetic acid|{[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}-acetic acid|2-[[5-(3-chlorophenyl)-3-hydroxy-pyridine-2-carbonyl]amino]acetic acid"
MESULERGINE,68848,,"InChI=1S/C18H26N4O2S/c1-20(2)25(23,24)19-13-9-15-14-6-5-7-16-18(14)12(10-21(16)3)8-17(15)22(4)11-13/h5-7,10,13,15,17,19H,8-9,11H2,1-4H3/t13-,15+,17+/m0/s1",JLVHTNZNKOSCNB-YSVLISHTSA-N,C18H26N4O2S,362.5,"(6aR,9S,10aR)-9-(dimethylsulfamoylamino)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline","Mesulergine|64795-35-3|Mesulergina|Mesulerginum|SML95FK06I|N'-(1,6-Dimethylergolin-8alpha-yl)-N,N-dimethylsulfamide|DTXSID3046324|CHEBI:73378|DTXCID1026324|CU-32085|(6aR,9S,10aR)-9-(dimethylsulfamoylamino)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo[4,3-fg]quinoline|N'-[(8alpha)-1,6-dimethylergolin-8-yl]-N,N-dimethylsulfuric diamide|N'-((8alpha)-1,6-dimethylergolin-8-yl)-N,N-dimethylsulfuric diamide|(6aR,9S,10aR)-9-(dimethylsulfamoylamino)-4,7-dimethyl-6,6a,8,9,10,10a-hexahydroindolo(4,3-fg)quinoline|RefChem:156693|Mesulergine [INN]|CQ 32085|CHEMBL12314|NCGC00163168-01|Mesulerginum [INN-Latin]|Mesulergina [INN-Spanish]|CAS-64795-35-3|UNII-SML95FK06I|3-(1,6-Dimethyl-8alpha-ergolinyl)-1,1-dimethylsulfamid|Biomol-NT_000077|GTPL206|MESULERGINE [WHO-DD]|ChEMBL_10959|SCHEMBL292175|BPBio1_001398|orb1740537|SCHEMBL29408582|HMS2089G12|Tox21_112023|BDBM50024204|1H-imidazo[4,5-c]pyridine derivative|Tox21_112023_1|NCGC00163168-02|NCGC00163168-03|CS-0144616|AB01275438-01|SR-05000001430|Q6822173|SR-05000001430-1|BRD-K91336023-001-01-4|BRD-K91336023-003-01-0|N'-(1,6-DIMETHYLERGOLIN-8.ALPHA.-YL)-N,N-DIMETHYLSULFAMIDE|Sulfamide, N'-[(8.alpha.)-1,6-dimethylergolin-8-yl]-N,N-dimethyl-|4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-amine-sulfonamide|{[(2R,4S,7R)-6,11-dimethyl-6,11-diazatetracyclo[7.6.1.0{2,7}.0{12,16}]hexadeca-1(16),9,12,14-tetraen-4-yl]sulfamoyl}dimethylamine|2N-[4,7-dimethyl-(6aR,9S,10aR)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-yl]-2-dimethylaminosulfonamide|4,7-dimethyl-(6aR,9S,10aR)-4,6,6a,7,8,9,10,10a-octahydroindolo[4,3-fg]quinolin-9-amino-N,N-dimethyl sulfonamide|9-N,N-dimethylsulfamide-4,7-dimethyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinoline|N''-4,7-Dimethyl-4,6,6a,7,8,9,10,10a-octahydro-indolo[4,3-fg]quinolin-9-yl)-N''-,N''-dimethyl-sulphonediamine"
LITOXETINE,65650,,"InChI=1S/C16H19NO/c1-2-4-15-11-13(5-6-14(15)3-1)12-18-16-7-9-17-10-8-16/h1-6,11,16-17H,7-10,12H2",MJJDYOLPMGIWND-UHFFFAOYSA-N,C16H19NO,241.33,4-(naphthalen-2-ylmethoxy)piperidine,Litoxetine|86811-09-8|Litoxetina|Litoxetinum|9980ST005G|DTXSID30235828|4-(2-naphthalenylmethoxy)piperidine|RefChem:153801|DTXCID60158319|4-((naphthalen-2-yl)methoxy)piperidine|SL-81035|4-(2-Naphthylmethoxy)piperidine|4-(naphthalen-2-ylmethoxy)piperidine|Litoxetine [INN]|CHEMBL471036|SL 81-0385; SL 810385|Litoxetinum [INN-Latin]|Litoxetina [INN-Spanish]|UNII-9980ST005G|SCHEMBL119884|orb1741322|SCHEMBL30505553|BDBM50278564|DB15038|DA-65013|TS-09476|HY-106807|CS-0026588|NS00123467|Q6648700
SGS-742,130021,,"InChI=1S/C7H18NO2P/c1-2-3-6-11(9,10)7-4-5-8/h2-8H2,1H3,(H,9,10)",ONNMDRQRSGKZCN-UHFFFAOYSA-N,C7H18NO2P,179.20,3-aminopropyl(butyl)phosphinic acid,"Cgp 36742|123690-78-8|SGS-742|Cgp-36742|CGP36742|(3-Aminopropyl)(n-butyl)phosphinic acid|SGS742|SGS 742|GBZ5UC0RME|Lu-AE-58479|3-aminopropyl-butylphosphinic acid|DTXSID10154063|3-aminopropyl-n-butyl phosphinic acid|RefChem:69095|DTXCID4076554|(3-aminopropyl)(butyl)phosphinic acid|3-aminopropyl(butyl)phosphinic acid|Phosphinic acid, P-(3-aminopropyl)-P-butyl-|CHEMBL112797|145537-81-1|UNII-GBZ5UC0RME|(3-Aminopropyl)butylphosphinic acid|Phosphinic acid, (3-aminopropyl)butyl-|A1IFA|SCHEMBL195133|GTPL1085|orb1707462|DVD-742|EX-A8615|YEA69078|3-aminopropyl(butyl)-phosphinic acid|BDBM50032982|MFCD00882735|PDSP1_001479|PDSP2_001463|3-aminopropyl(n-butyl)phosphinic acid|AKOS040741539|Phosphinic acid,(3-aminopropyl)butyl-|3-aminopropyl(n-butyl) phosphinic acid|DB05010|(3-Amino-propyl)-butyl-phosphinic acid|DA-62241|3-AMINOPROPYL-BUTYL PHOSPHINIC ACID|HY-121599|CS-0082820|NS00071796|CGP36742, >=97% (NMR)|G12828|L000169|Q27075900"
CIRAZOLINE,2765,,"InChI=1S/C13H16N2O/c1-2-4-12(11(3-1)10-5-6-10)16-9-13-14-7-8-15-13/h1-4,10H,5-9H2,(H,14,15)",YAORIDZYZDUZCM-UHFFFAOYSA-N,C13H16N2O,216.28,"2-[(2-cyclopropylphenoxy)methyl]-4,5-dihydro-1H-imidazole","cirazoline|59939-16-1|Cirazolina|Cirazolinum|LD-3098|2-[(2-cyclopropylphenoxy)methyl]-4,5-dihydro-1H-imidazole|DTXSID4045131|QK318GVY3Y|2-(2'-cyclopropylphenoxymethyl)imidazoline hydrochloride|DTXCID2025131|2-((2-cyclopropylphenoxy)methyl)-4,5-dihydro-1H-imidazole|RefChem:126334|1H-Imidazole, 2-((2-cyclopropylphenoxy)methyl)-4,5-dihydro-, monohydrochloride|Cirazoline [INN]|CHEMBL13852|2-((o-Cyclopropylphenoxy)methyl)-2-imidazoline|NCGC00015196-04|1H-Imidazole, 2-((2-cyclopropylphenoxy)methyl)-4,5-dihydro-|Cirazolinum [INN-Latin]|Cirazolina [INN-Spanish]|CAS-59939-16-1|UNII-QK318GVY3Y|1H-Imidazole, 2-[(2-cyclopropylphenoxy)methyl]-4,5-dihydro-|Tocris-0888|Lopac-C-223|Lopac0_000354|BSPBio_001586|GTPL515|KBioGR_000306|KBioSS_000306|SCHEMBL126496|orb1740449|SCHEMBL29430417|CHEBI:92950|KBio2_000306|KBio2_002874|KBio2_005442|KBio3_000611|KBio3_000612|Bio1_000412|Bio1_000901|Bio1_001390|Bio2_000306|Bio2_000786|HMS1361P08|HMS1791P08|HMS1989P08|HMS2089E21|HMS3402P08|Tox21_110095|BDBM50027060|Tox21_110095_1|CCG-204449|DB09202|SDCCGSBI-0050342.P002|IDI1_034056|NCGC00015196-01|NCGC00015196-02|NCGC00015196-03|NCGC00015196-05|NCGC00015196-06|NCGC00015196-07|NCGC00015196-08|NCGC00015196-09|NCGC00015196-13|NCGC00024847-01|NCGC00024847-02|NCGC00024847-03|NCGC00024847-04|NCGC00024847-05|DB-053499|HY-113985|CS-0064818|NS00068068|L000800|Q5121338|BRD-K54142781-001-02-1|BRD-K54142781-003-02-7|BRD-K54142781-003-08-4|BRD-K54142781-003-11-8|2-(2-Cyclopropyl-phenoxymethyl)-4,5-dihydro-1H-imidazole|2-(2-Cyclopropyl-phenoxymethyl)-4,5-dihydro-1H-imidazole (cirazoline)"
AMITIFADINE,11658655,,"InChI=1S/C11H11Cl2N/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11/h1-3,8,14H,4-6H2/t8-,11+/m1/s1",BSMNRYCSBFHEMQ-KCJUWKMLSA-N,C11H11Cl2N,228.11,"(1R,5S)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane","AMITIFADINE|410074-73-6|EB-1010|(1R,5S)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane|Amitifadina|DOV-21,947|GE0J375F8F|EB1010|DTXSID001025835|(1R,5S)-1-(3,4-Dichlorophenyl)-3-azabicyclo(3.1.0)hexane|amitifadinum|RefChem:557593|DTXCID101510087|Amitifadine free base|DOV-21947|DOV 21947|Amitifadine [USAN]|(+/-)-Amitifadine|410074-73-6 (free base)|3-Azabicyclo[3.1.0]hexane, 1-(3,4-dichlorophenyl)-, (1R,5S)-|5W2YA6F455|Amitifadine (USAN)|DOV 21,947|3-Azabicyclo(3.1.0)hexane, 1-(3,4-dichlorophenyl)-|3-Azabicyclo(3.1.0)hexane, 1-(3,4-dichlorophenyl)-, (+/-)-|3-Azabicyclo(3.1.0)hexane, 1-(3,4-dichlorophenyl)-, (1R,5S)-|DOV-216303 free base|Amitifadine [USAN:INN]|UNII-GE0J375F8F|DOV-216303|DOV-21947;EB-1010|AMITIFADINE [INN]|AMITIFADINE [WHO-DD]|SCHEMBL378242|UNII-5W2YA6F455|DOV 216,303 free base|CHEMBL592374|orb1705325|SCHEMBL30231901|BSMNRYCSBFHEMQ-KCJUWKMLSA-N|1-(3,4-dichlorophenyl)-3-azabicyclo-(3.1.0)hexane hydrochloride|BCP11481|BDBM50386812|MFCD22208586|AKOS030540720|DB05964|EB 1010|NCGC00485472-01|SY376998|NS00068091|D10088|Q2843568"
VOFOPITANT,6918331,,"InChI=1S/C21H23F3N6O/c1-31-18-10-9-16(30-20(21(22,23)24)27-28-29-30)12-15(18)13-26-17-8-5-11-25-19(17)14-6-3-2-4-7-14/h2-4,6-7,9-10,12,17,19,25-26H,5,8,11,13H2,1H3/t17-,19-/m0/s1",XILNRORTJVDYRH-HKUYNNGSSA-N,C21H23F3N6O,432.4,"(2S,3S)-N-[[2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenylpiperidin-3-amine","Vofopitant|168266-90-8|GR205171|GR-205171|GR 205171|K08BK043YS|DTXSID10870099|(2S,3S)-N-[[2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenylpiperidin-3-amine|N-((2-Methoxy-5-(5-(trifluoromethyl)-1H-tetrazol-1-yl)phenyl)methyl)-2-phenyl-3-piperidinamine|(2S,3S)-3-((2-Methoxy-5-(5-(trifluoromethyl)-1H-tetrazol-1-yl)benzyl)amino)-2-phenylpiperidine|vofopitantum|(2S,3S)-N-((2-methoxy-5-(5-(trifluoromethyl)tetrazol-1-yl)phenyl)methyl)-2-phenylpiperidin-3-amine|RefChem:194607|DTXCID401511189|(2S,3S)-N-((2-methoxy-5-(5-(trifluoromethyl)-1H-1,2,3,4-tetrazol-1-yl)phenyl)methyl)-2-phenylpiperidin-3-amine|Vofopitant [INN]|UNII-K08BK043YS|VOFOPITANT [WHO-DD]|SCHEMBL310338|CHEMBL522302|GTPL5752|orb1708236|SCHEMBL30522778|BDBM50408664|BDBM50419354|AKOS040740555|DB12436|DA-59038|FM157380|HY-12142|CS-0003109|NS00071663|Q21098911|3-Piperidiamine, N-((2-methoxy-5-(5-(trifluoromethyl)-1H-tetrazol-1-yl)phenyl)-methyl)-2-phenyl-, (2S-cis)-|3-PIPERIDINAMINE, N-((2-METHOXY-5-(5-(TRIFLUORO-METHYL)-1H-TETRAZOL-1-YL)PHENYL)METHYL)-2-PHENYL-|Vofopitant;(2S-cis)-N-{{2-Methoxy-5-[5-(trifluoromethyl)-1H-tetrazol-1-yl]-phenyl}-methyl}-2-phenyl-3-piperidinamine"
VESTIPITANT,9832383,,"InChI=1S/C23H24F7N3O/c1-13-8-18(24)4-5-19(13)20-12-31-6-7-33(20)21(34)32(3)14(2)15-9-16(22(25,26)27)11-17(10-15)23(28,29)30/h4-5,8-11,14,20,31H,6-7,12H2,1-3H3/t14-,20-/m1/s1",SBBYBXSFWOLDDG-JLTOFOAXSA-N,C23H24F7N3O,491.4,"(2S)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperazine-1-carboxamide","Vestipitant|334476-46-9|GW597599|GW-597599|S052TOI9BI|(2S)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperazine-1-carboxamide|DTXSID50187092|1-Piperazinecarboxamide, N-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-2-(4-fluoro-2-methylphenyl)-N-methyl-, (2S)-|1-PIPERAZINECARBOXAMIDE, N-(1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHYL)-2-(4-FLUORO-2-METHYLPHENYL)-N-METHYL-|DTXSID20870328|vestipitantum|(2S)-N-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-2-(4-fluoro-2-methylphenyl)-N-methylpiperazine-1-carboxamide|N-(1-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)ETHYL)-2-(4-FLUORO-2-METHYLPHENYL)-N-METHYLPIPERAZINE-1-CARBOXAMIDE|RefChem:194154|DTXCID10202598|DTXCID60109583|Vestipitant [INN]|UNII-S052TOI9BI|VESTIPITANT [WHO-DD]|CHEMBL522987|GTPL5757|orb1740060|SCHEMBL2485871|SCHEMBL29447787|BDBM50413891|DB11949|HY-12140|NS00069607|Q12747348|2(S)-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic Acid [1-(R)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide|2-(S)-(4-Fluoro-2-methyl-phenyl)-piperazine-1 carboxylic acid [1-(R)-(3,5-bis-trifluoromethyl-phenyl)-ethyl]-methyl-amide|2-(S)-(4-Fluoro-2-methyl-phenyl)-piperazine-1-carboxylic Acid [1-(R)-(3,5-bis-Trifluoromethyl-phenyl)-ethyl]-methyl-amide"
BETRIXABAN,10275777,,"InChI=1S/C23H22ClN5O3/c1-29(2)21(25)14-4-6-15(7-5-14)22(30)27-19-10-9-17(32-3)12-18(19)23(31)28-20-11-8-16(24)13-26-20/h4-13,25H,1-3H3,(H,27,30)(H,26,28,31)",XHOLNRLADUSQLD-UHFFFAOYSA-N,C23H22ClN5O3,451.9,"N-(5-chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide","Betrixaban|330942-05-7|PRT054021|N-(5-chloropyridin-2-yl)-2-(4-(N,N-dimethylcarbamimidoyl)benzamido)-5-methoxybenzamide|PRT 054021|PRT-054021|74RWP7W0J9|N-(5-Chloropyridin-2-yl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxybenzamide|CHEBI:140421|DTXSID10954727|Benzamide, N-(5-chloro-2-pyridinyl)-2-((4-((dimethylamino)iminomethyl)benzoyl)amino)-5-methoxy-|N-(5-chloropyridin-2-yl)-2-[4-(N,N-dimethylcarbamimidoyl)benzamido]-5-methoxybenzamide|betrixabanum|N-(5-CHLOROPYRIDIN-2-YL)-2-((4-(N,N-DIMETHYLCARBAMIMIDOYL)BENZOYL)AMINO)-5-METHOXYBENZAMIDE|RefChem:58846|B01AF04|DTXCID801382738|682-459-2|Bevyxxa|MFCD16038040|Betrixaban [USAN]|CHEMBL512351|330942-05-7 (free base)|Betrixaban (USAN)|N-(5-Chloropyridin-2-yl)-2-((4-(N,N-dimethylcarbamimidoyl)benzoyl)amino)-5- methoxybenzamide|Betrixaban [USAN:INN]|UNII-74RWP7W0J9|Betrixaban?|N-(5-Chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxybenzamide; PRT 054021|Bevyxxa (TN)|BETRIXABAN [MI]|BETRIXABAN [INN]|BETRIXABAN [WHO-DD]|SCHEMBL158591|Betrixaban - Bio-X trade mark|GTPL9602|orb1690000|BETRIXABAN [ORANGE BOOK]|SCHEMBL29374026|EX-A358|HMS5084I16|BCP01903|BDBM50249298|s5388|AKOS005146070|BCP9000395|CCG-269250|DB12364|FC18577|SB16951|N-(5-chloro-2-pyridyl)-2-[[4-(N,N-dimethylcarbamimidoyl)benzoyl]amino]-5-methoxy-benzamide|compound 11 [PMID: 19297154]|NCGC00371122-02|NCGC00371122-04|AC-30214|AS-56192|BB167058|HY-10268|SY247497|DB-068750|NS00071909|D08873|942B057|EN300-18167087|Q4898219|BRD-K45275534-001-01-3|N-(5-Chloro-2-pyridinyl)-2-4-(dimethylamino)iminomethylbenzoylamino-5-methoxybenzamide|PRT 054021;N-(5-Chloro-2-pyridinyl)-2-[[4-[(dimethylamino)iminomethyl]benzoyl]amino]-5-methoxybenzamide"
VISMODEGIB,24776445,,"InChI=1S/C19H14Cl2N2O3S/c1-27(25,26)13-6-7-14(17(21)11-13)19(24)23-12-5-8-16(20)15(10-12)18-4-2-3-9-22-18/h2-11H,1H3,(H,23,24)",BPQMGSKTAYIVFO-UHFFFAOYSA-N,C19H14Cl2N2O3S,421.3,2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide,"Vismodegib|879085-55-9|GDC-0449|Erivedge|2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methylsulfonyl)benzamide|HhAntag691|GDC0449|vismodegibum|NSC-747691|NSC 747691|NSC-755986|CHEBI:66903|25X868M3DS|RG-3616|2-chloro-N-(4-chloro-3-pyridin-2-ylphenyl)-4-methylsulfonylbenzamide|2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-(methylsulfonyl)benzamide|DTXSID40236689|R-3616|Benzamide, 2-chloro-N-(4-chloro-3-(2-pyridinyl)phenyl)-4-(methylsulfonyl)-|2-CHLORO-N-(4-CHLORO-3-PYRIDIN-2-YL)PHENYL)-4-(METHYLSULFONYL)BENZAMIDE|BENZAMIDE, 2-CHLORO-N-[4-CHLORO-3-(2-PYRIDINYL)PHENYL]-4-(METHYLSULFONYL)-|RG3616|R3616 cpd|RefChem:58619|Hedgehog Antagonist GDC-0449|DTXCID20159180|L01XX43|Vismodegib (GDC-0449)|GDC 0449|MFCD12407408|CHEMBL473417|NSC755986|2-chloro-n-[4-chloro-3-(pyridin-2-yl)phenyl]-4-methanesulfonylbenzamide|2-chloro-N-(4-chloro-3-pyridin-2-yl-phenyl)-4-methanesulfonyl-benzamide|2-Chloranyl-~{n}-(4-Chloranyl-3-Pyridin-2-Yl-Phenyl)-4-Methylsulfonyl-Benzamide|Erivedge (TN)|Vismodegib [USAN]|Vismodegib [USAN:INN]|C19H14Cl2N2O3S|UNII-25X868M3DS|HSDB 8130|R 3616|Benzamide, 2-chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)-; 2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide; Erivedge; GDC 0449; Vismodegib|VIS|NSC747691|Hh-Antag691|HhAntag 691|Vismodegib, free base|methanesulfonylbenzamide|Vismodegib (Standard)|VISMODEGIB [MI]|VISMODEGIB [INN]|Vismodegib (USAN/INN)|VISMODEGIB [VANDF]|Vismodegib; GDC-0449|2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide|VISMODEGIB [WHO-DD]|MLS006012035|SCHEMBL302587|Vismodegib (GDC-0449)?|GTPL6975|orb1305292|SCHEMBL29352323|SCHEMBL29363748|SCHEMBL29394718|VISMODEGIB [ORANGE BOOK]|CUR-691|GDC-449|BPQMGSKTAYIVFO-UHFFFAOYSA-N|BCPP000223|GLXC-02737|HMS3604K16|HMS3654E17|HMS5079E09|BCP01715|EX-A2178|2-chloro-N-[4-chloro-3-(2-pyridyl)phenyl]-4-methylsulfonyl-benzamide|BDBM50249522|HY-10440R|NSC755809|s1082|GDC-0449,Vismodegib, HhAntag691|2-Chloro-N-(4-chloro-3-(pyridin-2-yl)-phenyl)-4-(methylsulfonyl)benzamide|AKOS015966534|BCP9000713|CCG-264811|CS-0255|DB08828|FC28712|NSC-755809|PB15086|NCGC00242497-01|NCGC00242497-02|NCGC00242497-06|NCGC00242497-12|AC-26969|AS-14066|HY-10440|SMR004703564|NS00072471|SW218087-2|D09992|V-4050|AB01565813_02|EN300-7413185|085G559|SR-01000941574|2-chloro-N-[4-chloro-3-(pyridin-2-yl)phenyl]-4-|Q2070286|SR-01000941574-1|BRD-K44827188-001-06-0|2-Chloro-N-(4-chloro-3-(2-pyridl)phenyl)-4-(methylsulfonyl)benzamide|2-chloro-N-(4-chloro-3-(pyridin-2-yl)phenyl)-4-(methyl sulfonyl)benzamide|GDC 0449;2-Chloro-N-[4-chloro-3-(2-pyridinyl)phenyl]-4-(methylsulfonyl)benzamide"
SERLOPITANT,23653789,,"InChI=1S/C29H28F7NO2/c1-16(19-10-20(28(31,32)33)12-21(11-19)29(34,35)36)39-26-9-4-18-14-37(23-7-8-24(38)13-23)15-25(18)27(26)17-2-5-22(30)6-3-17/h2-3,5-6,10-13,16,18,25-27H,4,7-9,14-15H2,1H3/t16-,18-,25-,26+,27+/m1/s1",FLNYCRJBCNNHRH-OIYLJQICSA-N,C29H28F7NO2,555.5,"3-[(3aR,4R,5S,7aS)-5-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-4-(4-fluorophenyl)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]cyclopent-2-en-1-one","Serlopitant|860642-69-9|VPD-737|mk-0594|277V92K32B|3-[(3aR,4R,5S,7aS)-5-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-4-(4-fluorophenyl)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]cyclopent-2-en-1-one|serlopitantum|3-((3aR,4R,5S,7aS)-5-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl)cyclopent-2-en-1-one|RefChem:182523|3-((3aR,4R,5S,7aS)-5-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)-octahydro-1H-isoindol-2-yl)cyclopent-2-en-1-one|Serlopitant [USAN]|3-((3aR,4R,5S,7aS)-5-((R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)hexahydro-1H-isoindol-2(3H)-yl)cyclopent-2-enone|CHEMBL447955|Serlopitant (USAN)|3-((3aR,4R,5S,7aS)-5-((1R)-1-(3,5-bis(Trifluoromethyl)phenyl)ethoxy)-4-(4 fluorophenyl)octahydro-2H-isoindol-2-yl)cyclopent-2-en-1-one|Serlopitant [USAN:INN]|Serlopitant?|UNII-277V92K32B|VPD 737|2-Cyclopenten-1-one, 3-((3aR,4R,5S,7aS)-5-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethoxy)-4-(4-fluorophenyl)octahydro-2H-isoindol-2-yl)-|2-Cyclopenten-1-one, 3-[(3aR,4R,5S,7aS)-5-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-4-(4-fluorophenyl)octahydro-2H-isoindol-2-yl]-|SERLOPITANT [INN]|SERLOPITANT [WHO-DD]|GTPL9280|orb1689976|SCHEMBL3183159|C29H28F7NO2|CHEBI:229902|DTXSID701006599|BDBM50277511|compound 17 (Jiang et al. 2009)|DB12973|VPD-737; MK-0594|DA-77804|HY-12114|CS-0003087|NS00072590|D09378|Q21098912|3-[(3aR,4R,5S,7aS)-5-[(1R)-1-[3,5-bis(triluoromethyl)phenyl]ethoxy]-4-(4-luorophenyl)-1,3,3a,4,5,6,7,7a-octahydroisoindol-2-yl]cyclopent-2-en-1-one|3-[(3aR,4R,5S,7aS)-5-{(1R)-1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)-octahydro-2H-isoindol-2-yl]cyclopent-2-en-1-one|3-[(3aR,4R,5S,7aS)-5-{(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-1H-isoindol-2-yl]cyclopent-2-en-1-one|3-[5-{1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-2H-isoindol-2-yl]cyclopent-2-en-1-one"
BAVISANT,16061509,,"InChI=1S/C19H27N3O2/c23-19(22-9-7-21(8-10-22)18-5-6-18)17-3-1-16(2-4-17)15-20-11-13-24-14-12-20/h1-4,18H,5-15H2",BGBVSGSIXIIREO-UHFFFAOYSA-N,C19H27N3O2,329.4,(4-cyclopropylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone,"BAVISANT|929622-08-2|JNJ-31001074|9827P7LFVH|DTXSID001026045|(4-Cyclopropylpiperazin-1-yl)(4-(morpholin-4-ylmethyl)phenyl)methanone|bavisantum|(4-Cyclopropylpiperazin-1-yl)[4-(morpholin-4-ylmethyl)phenyl]methanone|RefChem:916750|DTXCID70207943|4-((4-(4-cyclopropylpiperazine-1-carbonyl)phenyl)methyl)morpholine|UNII-9827P7LFVH|Bavisant [USAN:INN]|(4-cyclopropylpiperazin-1-yl)(4-(morpholinomethyl)phenyl)methanone|929622-08-2(free base)|(4-cyclopropylpiperazin-1-yl)-[4-(morpholin-4-ylmethyl)phenyl]methanone|Methanone, (4-cyclopropyl-1-piperazinyl)(4-(4-morpholinylmethyl)phenyl)-|CHEMBL3577957|Bavisant [USAN]|Bavisant (USAN/INN)|BAVISANT [INN]|BAVISANT [WHO-DD]|SCHEMBL522603|orb1296246|CHEMBL2103862|BGBVSGSIXIIREO-UHFFFAOYSA-N|EMB62208|BDBM50089371|BDBM50138125|EX-A10460|MFCD19443732|CS-1457|DB12299|JNJ31001074|HY-14880|TS-10641|DB-110687|NS00072138|D09870|G92152|BRD-K79595931-312-01-3|Q27272071|(4-cyclopropylpiperazin-1-yl)-[4-(morpholinomethyl)phenyl]methanone|(4-Cyclopropyl-piperazin-1-yl)-(4-morpholin-4-ylmethyl-phenyl) -methanone|(4-Cyclopropyl-piperazin-1-yl)-(4-morpholin-4-ylmethyl-phenyl)-methanone"
GSK239512,9976892,,"InChI=1S/C23H27N3O2/c27-23-5-2-12-26(23)20-7-9-22(24-16-20)28-21-8-6-17-10-13-25(19-3-1-4-19)14-11-18(17)15-21/h6-9,15-16,19H,1-5,10-14H2",YFRBKEVUUCQYOW-UHFFFAOYSA-N,C23H27N3O2,377.5,"1-[6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)oxy]pyridin-3-yl]pyrrolidin-2-one","720691-69-0|GSK-239512|GSK239512|4I7U5C459M|GSK-239512A|2-Pyrrolidinone, 1-(6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-3-pyridinyl)-|RefChem:782734|1-(6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)pyridin-3-yl)pyrrolidin-2-one|1-(6-((3-CYCLOBUTYL-2,3,4,5-TETRAHYDRO-1H-BENZO[D]AZEPIN-7-YL)OXY)PYRIDIN-3-YL)PYRROLIDIN-2-ONE|MFCD27922168|CHEMBL3092650|1-[6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)oxy]pyridin-3-yl]pyrrolidin-2-one|UNII-4I7U5C459M|YFRBKEVUUCQYOW-UHFFFAOYSA-N|1-[6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl]-2-pyrrolidinone|1-{6-[(3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy]-3-pyridinyl}-2-pyrrolidinone|SCHEMBL167578|orb1305080|SCHEMBL29360933|VDB69169|BDBM50444496|EX-A12365|AKOS025291102|DB15120|SB16754|AS-42474|DA-63928|HY-106000|CS-0024606|1-[6-[(3-cyclobutyl-1,2,4,5-tetrahydro-3-benzazepin-7-yl)oxy]-3-pyridyl]pyrrolidin-2-one"
PLERIXAFOR,65015,,"InChI=1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2",YIQPUIGJQJDJOS-UHFFFAOYSA-N,C28H54N8,502.8,"1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane","Plerixafor|110078-46-1|Mozobil|AMD3100|Amd 3100|SDZ SID 791|plerixaforum|1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane|JKL 169|JM3100|S915P5499N|CHEBI:125354|DTXSID70869520|1-{[4-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)phenyl]methyl}-1,4,8,11-tetraazacyclotetradecane|1,4,8,11-Tetraazacyclotetradecane, 1,1'-(1,4-phenylenebis(methylene))bis-|1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane|1,1'-(1,4-PHENYLENEBIS(METHYLENE))BIS-1,4,8,11-TETRAAZACYCLOTETRADECANE|mezobil|RPA bicyclam|1-((4-(1,4,8,11-tetraazacyclotetradecan-1-ylmethyl)phenyl)methyl)-1,4,8,11-tetraazacyclotetradecane|1-((4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl)methyl)-1,4,8,11-tetrazacyclotetradecane|RefChem:57592|DTXCID60817494|L03AX16|1,1'-(1,4-Phenylenebis(methylene))-bis-1,4,8,11-tetraazacyclotetradecane|1,1'-(1,4-phenylenebis-(methylene))-bis-1,4,8,11-tetraazacyclotetradecane|1,1'-(1,4-phenylenebis(methylene))bis(1,4,8,11-tetraazacyclotetradecane)octahydrochloride dihydrate|842-163-8|1,4-Bis((1,4,8,11-tetraazacyclotetradecan-1-yl)methyl)benzene|bicyclam JM-2987|Plerixafor hydrochloride|AMD-3100|MFCD05662218|CHEMBL18442|SID791|C28H54N8|Plerixafor 8HCl|1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane]|plerixafor (amd3100)|Mozobil (TN)|Plerixafor [USAN]|Plerixafor [USAN:INN:BAN]|1,1'-[1,4-phenylenebis(methylene)]bis(1,4,8,11-tetraazacyclotetradecane)|UNII-S915P5499N|GNA & AMD-3100|HHA & AMD-3100|VH6|JM 2987|Plerixafor (Standard)|PLERIXAFOR [MI]|PLERIXAFOR [INN]|PLERIXAFOR [JAN]|PLERIXAFOR [VANDF]|PLERIXAFOR [MART.]|Plerixafor (AMD3100)?|PLERIXAFOR [WHO-DD]|SCHEMBL19038|GTPL844|Plerixafor (JAN/USAN/INN)|PLERIXAFOR [EMA EPAR]|orb1307465|PLERIXAFOR [ORANGE BOOK]|AMD-3100 (CXCR4)|YIQPUIGJQJDJOS-UHFFFAOYSA-N|BCPP000104|GLXC-06682|BCP02337|EX-A1762|WZB81987|BDBM50035696|HY-10046R|NSC754363|NSC761388|s8030|1,1'-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}|AKOS005266706|CCG-269710|CS-0451|DB06809|FP36846|NSC-754363|NSC-761388|NCGC00165722-01|NCGC00165722-02|NCGC00165722-03|1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Galanthus nivalis agglutinin (GNA)|AC-26837|AS-42504|HY-10046|SY042073|NS00004748|P2678|D08971|EN300-187119|AB01566900_01|078P461|L000104|Q905835|SR-01000941593|SR-01000941593-1|11''''-xylyl bis-1,4,8,11-tetraazacyclotetradecane|BRD-K33240821-001-03-9|BRD-K33240821-001-05-4|BRD-K33240821-001-06-2|BRD-K33240821-367-01-8|BRD-K33240821-400-02-5|Z1889837352|1,1''''-{1,4-phenylenebis(methylene)}-bis{1,4,8,11-tetraaza-cyclotetradecane}|1,1'-(benzene-1,4-diyldimethanediyl)bis(1,4,8,11-tetraazacyclotetradecane)|1,1'-[1,4-Phenylenebis(methylene)]bis-1,4,8,11-tetraazacyclotetradecane;AMD3100|1,1'[1,4-phenylene-bis-(methylene)]-bis-1,4,8,11-tetraazacyclotetradecane|1,1'-[1,4-Phenylenebis(methylene)]bis[1,4,8,11-tetraazacyclotetradecane] & Hippeastrum hybrid agglutinin( HHA)|1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane|1,4,8,11-tetraazacyclotetradecanyl[4-(1,4,8,11-tetraazacyclotetradecanylmethyl)phenyl]methane(8HBr.2H2O)|1-({4-[(1,4,8,11-tetraazacyclotetradecan-1-yl)methyl]phenyl}methyl)-1,4,8,11-tetraazacyclotetradecane|11-{4-[4,8, 11-1,4,8,11tetraaza-cyclotetradec-1-ylmethyl]-benzyl}-1,4,8,11tetraaza-cyclotetradecane-1,4,8-tricarboxylic acid tri-tert-butyl ester"
2'-C-METHYLCYTIDINE TRIPHOSPHATE,15940324,,"InChI=1S/C10H18N3O14P3/c1-10(16)7(14)5(25-8(10)13-3-2-6(11)12-9(13)15)4-24-29(20,21)27-30(22,23)26-28(17,18)19/h2-3,5,7-8,14,16H,4H2,1H3,(H,20,21)(H,22,23)(H2,11,12,15)(H2,17,18,19)/t5-,7-,8-,10-/m1/s1",BENHELOUNGQZRD-VPCXQMTMSA-N,C10H18N3O14P3,497.18,"[[(2R,3R,4R,5R)-5-(4-amino-2-oxopyrimidin-1-yl)-3,4-dihydroxy-4-methyloxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate",2'-c-methylcytidine triphosphate|CHEMBL223585|374750-28-4|2'C-Me-CTP|2''''C-Me-CTP|SCHEMBL4454623|BDBM50478972|PD202389|2'-C-Methylcytidine 5'-triphosphate triethylammonium salt - aqueous solution
ORLISTAT,3034010,,"InChI=1S/C29H53NO5/c1-5-7-9-11-12-13-14-15-16-18-24(34-29(33)26(30-22-31)20-23(3)4)21-27-25(28(32)35-27)19-17-10-8-6-2/h22-27H,5-21H2,1-4H3,(H,30,31)/t24-,25-,26-,27-/m0/s1",AHLBNYSZXLDEJQ-FWEHEUNISA-N,C29H53NO5,495.7,"[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate","orlistat|96829-58-2|Tetrahydrolipstatin|Xenical|Alli|Orlipastat|(-)-Tetrahydrolipstatin|THLP|tetrahydrolipastatin|Ro 18-0647/002|orlistatum|(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl (2S)-2-formamido-4-methylpentanoate|DTXSID8023395|[(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2S)-2-formamido-4-methylpentanoate|95M8R751W8|NSC-758881|Ro-180647002|Ro-180647-002|CHEBI:94686|Ro-18-0647/002|DTXCID40820067|L-Leucine, N-formyl-, 1-((3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester, (2S-(2alpha(R*),3beta))-|Beacita|((2S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) (2S)-2-formamido-4-methylpentanoate|(2S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl (2S)-2-formamido-4-methylpentanoate|RefChem:389166|A08AB01|Ro 18 0647|639-755-1|Orlipastatum [INN-Latin]|MFCD05662360|Ro-18-0647|Orlistat (Alli, Xenical)|Orlistat (Standard)|L-Leucine, N-formyl-, (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester|C29H53NO5|N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester|Orlistat Powder|MLS002207022|N-Formyl-L-leucine, ester with (3S,4S)-3-hexyl-4-((2S)-2-hydroxytridecyl)-2-oxetanone|CHEMBL175247|Orlipastatum|SMR000466339|L-Leucine, N-formyl-, (1S)-1-(((2S,3S)-3-hexyl-4-oxo-2-oxetanyl)methyl)dodecyl ester|[(1S)-1-[[(2S,3S)-3-hexyl-4-oxo-oxetan-2-yl]methyl]dodecyl] (2S)-2-formamido-4-methyl-pentanoate|Xenical (TN)|CAS-96829-58-2|SR-01000759417|Orlistat [USAN:INN:BAN]|UNII-95M8R751W8|HSDB 7556|N-formyl-L-leucine (1S)-1-{[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl}dodecyl ester|NCGC00095128-01|(-)-Tetrahydrolipstatin; Orlistat; Ro 18-0647/002; Tetrahydrolipstatin; Xenical; L-Leucine, N-formyl-, 1-[(3-hexyl-4-oxo-2-oxetanyl)methyl]dodecyl ester, [2S-[2alpha(R*),3beta]]-|N-Formyl-L-leucine (1S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester;(-)-Tetrahydrolipstatin;Ro 18-0647/002|KS-1183|Lipase Inhibitor, THL|ORLISTAT [HSDB]|ORLISTAT [USAN]|ORLISTAT [INN]|ORLISTAT [JAN]|ORLISTAT [MI]|(-)-tetrahydrolipostatin|ORLISTAT [VANDF]|R-212|ORLISTAT [MART.]|ORLISTAT [USP-RS]|ORLISTAT [WHO-DD]|Orlistat (JAN/USP/INN)|ORLISTAT [EMA EPAR]|Orlistat, >=98%, solid|SCHEMBL16408|MLS000759448|MLS001423955|Orlistat - Bio-X trade mark|BIDD:GT0853|ORLISTAT [ORANGE BOOK]|GTPL5277|orb1310386|ORLISTAT [USP MONOGRAPH]|BDBM24567|HY-B0218R|Tetrahydrolipstatin;Ro-18-0647|GLXC-05010|HMS2051I08|HMS3413P06|HMS3677P06|(S)-((S)-1-((2S,3S)-3-hexyl-4-oxooxetan-2-yl)tridecan-2-yl) 2-formamido-4-methylpentanoate|HY-B0218|MSK10348|THL|Tox21_111437|HB4009|s1629|AKOS015894875|Tox21_111437_1|BCP9001031|CCG-100851|DB01083|FO26582|NC00101|NSC 758881|Ro18-0647|NCGC00165856-01|NCGC00165856-02|NCGC00165856-03|NCGC00165856-14|NCGC00165856-15|BO164179|R212|SY078600|BCP0726000044|CS-0694775|NS00004788|O0381|SW197481-2|D04028|EN300-268136|AB00639987-09|AB00639987_10|829O582|Q424163|SR-01000759417-5|SR-01000759417-7|BRD-K63343048-001-12-2|BRD-K63343048-001-13-0|Z2379810072|Orlistat, United States Pharmacopeia (USP) Reference Standard|Orlistat, Pharmaceutical Secondary Standard; Certified Reference Material|(2S)-1-[(2S,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl N-formyl-L-leucinate|2-formamido-3-[(3-hexyl-4-oxo-oxetan-2-yl)methyl]-2-isobutyl-tetradecanoate|N-formyl-L-leucine (S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]dodecyl ester|N-formyl-L-leucine-(S)-1-[[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]methyl]-dodecyl ester|(2S)-2-formamido-4-methylpentanoic acid [(2S)-1-[(2S,3S)-3-hexyl-4-oxo-2-oxetanyl]tridecan-2-yl] ester|[(2S)-1-[(2R,3S)-3-hexyl-4-oxooxetan-2-yl]tridecan-2-yl] (2R)-2-formamido-4-methylpentanoate|104872-04-0|L-LEUCINE, N-FORMYL-, 1-((3-HEXYL-4-OXO-2-OXETANYL)METHYL)DODECYL ESTER, (2S-(2.ALPHA.(R*),3.BETA.))-"
SILDENAFIL CITRATE,135413523,,"InChI=1S/C22H30N6O4S.C6H8O7/c1-5-7-17-19-20(27(4)25-17)22(29)24-21(23-19)16-14-15(8-9-18(16)32-6-2)33(30,31)28-12-10-26(3)11-13-28;7-3(8)1-6(13,5(11)12)2-4(9)10/h8-9,14H,5-7,10-13H2,1-4H3,(H,23,24,29);13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)",DEIYFTQMQPDXOT-UHFFFAOYSA-N,C28H38N6O11S,666.7,"5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one;2-hydroxypropane-1,2,3-tricarboxylic acid","Sildenafil citrate|171599-83-0|Revatio|VIAGRA|Caverta|LIQREV|Sildenafil (as citrate)|NSC-744009|NSC-758669|BW9B0ZE037|DTXSID4046076|CHEBI:58987|UK-92480-10|UK-92,480-10|DTXCID2026076|1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate|Sildenafil Powder,|Citrate, Sildenafil|Lactate, Sildenafil|Nitrate, Sildenafil|Sildenafil, Desmethyl|RefChem:6219|Sildenafil for Oral Suspension|NCX911|NCX 911|UK 9248010|UK 92480 10|UK 92,480 10|Sildenafil (citrate)|Sildenafil citrate [USAN]|Sildenafil citrate salt|MFCD02102122|MFCD09026931|5-(2-ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 2-hydroxypropane-1,2,3-tricarboxylate|5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one;2-hydroxypropane-1,2,3-tricarboxylic acid|UK 92480-10|sildenafilcitrate|1-((3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methylpiperazine citrate (1:1)|1-[[3-(4,7-dihydro-1-methyl-7-oxo-3-propyl-1h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate|Piperazine, 1-((3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo(4,3-d)pyrimidin-5-yl)-4-ethoxyphenyl)sulfonyl)-4-methyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)|CAS-171599-83-0|C28H38N6O11S|NCGC00159496-02|UK-92480|UNII-BW9B0ZE037|Duromist|Penegra|X-Excite|1-[[3-(6,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate (1:1)|5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one; 2-oxidanylpropane-1,2,3-tricarboxylic acid|5-[2-ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one; 2-hydroxypropane-1,2,3-tricarboxylic acid|Sildenafil citrate?|Revatio (TN)|Wan Ai Ke|Viagra (TN)|5-[2-ethoxy-5-(4-methyl-1-piperazinylsulfonyl)phenyl]-1-methyl-3-n-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one|Viagra, Sildenafil citrate|CHEMBL1737|SCHEMBL33982|Sildenafil citrate (JAN/USP)|orb1310584|SCHEMBL1652668|SILDENAFIL CITRATE [MI]|SCHEMBL29424508|SILDENAFIL CITRATE [JAN]|Sildenafil (citrate) (Standard)|GHL-901|MSK8582|NVD-401|GLXC-06283|HMS3260C20|HMS3654B08|HMS5079I04|HY-15025AR|Pharmakon1600-01504099|SILDENAFIL CITRATE [VANDF]|SILDENAFIL CITRATE [MART.]|BCP02960|SILDENAFIL CITRATE [USP-RS]|SILDENAFIL CITRATE [WHO-DD]|Tox21_111717|Tox21_500099|HY-15025A|NSC744009|NSC758669|s1431|AKOS015856298|AKOS015951281|Tox21_111717_1|AC-1310|C55S832|CCG-213260|CS-1576|FS27829|KS-1112|NSC 744009|NSC 758669|SB17346|Sildenafil citrate - Bio-X trade mark|SILDENAFIL CITRATE [ORANGE BOOK]|NCGC00095099-05|NCGC00260784-01|SILDENAFIL CITRATE [EP MONOGRAPH]|BS164405|SILDENAFIL CITRATE [USP MONOGRAPH]|SY038979|UK 92480|BCP0726000239|UK-92,480|S0986|SW199664-3|D02229|A807582|A811336|A854247|EN300-19810912|SR-01000787181|SR-01000787181-2|Q27126379|Sildenafil citrate, 1mg/ml in Methanol (as free base)|F0001-2406|Sildenafil citrate, European Pharmacopoeia (EP) Reference Standard|Sildenafil citrate salt, European Pharmacopoeia (EP) Reference Standard|Sildenafil citrate, United States Pharmacopeia (USP) Reference Standard|1-{[3-(6,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl}-4-methylpiperazone citrate|5-[2-Ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl]-1,3-d]pyrimidin-7-one-citrate|Sildenafil Citrate, Pharmaceutical Secondary Standard; Certified Reference Material|1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate salt|1-[[3-(4,7-Dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate;1-[  4-Ethoxy-3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-5-yl)phenylsulfonyl]-4-methylpiperazine citra|1-[[3-(6,7-dihydro-1-methyl-7-oxo-3-propyl-1-h-pyrazolo[4,3-d]pyrimidin-5-yl)-4-ethoxyphenyl]sulfonyl]-4-methylpiperazine citrate|2-hydroxypropane-1,2,3-tricarboxylic acid; 5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1H,4H,7H-pyrazolo[4,3-d]pyrimidin-7-one|5-(2-Ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(4H)-one 2-hydroxypropane-1,2,3-tricarboxylate|5-(2-Ethoxy-5-((4-methylpiperazin-1-yl)sulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(4H)-one2-hydroxypropane-1,2,3-tricarboxylate|5-(2-ethoxy-5-(4-methylpiperazin-1-ylsulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one 2-hydroxypropane-1,2,3-tricarboxylate|5-[2-Ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-6H-pyrazolo[4,3-d]pyrimidin-7-one citrate salt|5-[2-Ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one,2-hydroxypropane-1,2,3-tricarboxylic acid|5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one;2-hydroxypropane-1,2,3-tricarboxylic acid|5-[2-Ethoxy-5-(4-methylpiperazin-1-yl)sulfonylphenyl]-1-methyl-3-propyl-4H-pyrazolo[5,4-e]pyrimidin-7-one citrate salt|5-[2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one 2-hydroxy-1,2,3-propanetricarboxylate (1:1)|5-[2-Ethoxy-5-[(4-methyl-1-piperazinyl)sulfonyl]phenyl]-1-methyl-3-propylpyrazolo[4,3-d]pyrimidin-7(4H)-one 2-Hydroxypropane-1,2,3-tricarboxylate|5-[2-Ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl]-1-methyl-3-propyl-1H-pyrazolo[4,3-d]pyrimidin-7(6H)-one Citrate|5-{2-ethoxy-5-[(4-methylpiperazin-1-yl)sulfonyl]phenyl}-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one 2-hydroxypropane-1,2,3-tricarboxylate|citric acid;5-[2-ethoxy-5-(4-methylpiperazin-1-yl)sulfonyl-phenyl]-1-methyl-3-propyl-4H-pyrazolo[4,3-d]pyrimidin-7-one"
BOSWELLIC ACID,168928,,"InChI=1S/C30H48O3/c1-18-10-13-26(3)16-17-28(5)20(24(26)19(18)2)8-9-21-27(4)14-12-23(31)30(7,25(32)33)22(27)11-15-29(21,28)6/h8,18-19,21-24,31H,9-17H2,1-7H3,(H,32,33)/t18-,19+,21-,22-,23-,24+,26-,27-,28-,29-,30-/m1/s1",NBGQZFQREPIKMG-PONOSELZSA-N,C30H48O3,456.7,"(3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picene-4-carboxylic acid","beta-Boswellic acid|631-69-6|Boswellic acid|(3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picene-4-carboxylic acid|B252M1YO2V|DTXSID2057578|(4R)-3alpha-Hydroxyurs-12-en-24-oic acid|Urs-12-en-23-oic acid, 3-hydroxy-, (3alpha,4beta)-|12-Ursene-3,24-diol|RefChem:119215|DTXCID2020428|b-Boswellic acid|CHEMBL267225|ss-Boswellic Acid|MFCD04039448|no translation|UNII-B252M1YO2V|yena-Boswellic acid|(3alpha,4beta)-3-Hydroxyurs-12-en-23-oic acid|Urs-12-en-24-oic acid, 3.alpha.-hydroxy-|MLS000697685|.BETA.-BOSWELLIC ACID||A-Boswellic acid (Standard)|SCHEMBL4385785|HY-N2513R|CHEBI:192014|Urs-12-en-23-oic acid, 3-hydroxy-, (3.alpha.,4.beta.)-|HY-N2513|.BETA.-BOSWELLIC ACID [MI]|BDBM50241260|AKOS015897120|3alpha-Hydroxyurs-12-en-24-oic acid|FB42754|LMPR0106180011|beta-Boswellic acid, analytical standard|NCGC00247633-01|AC-30252|SMR000445587|CS-0022784|(3alpha,4beta)-3-hydroxy-Urs-12-en-23-oate|3.ALPHA.-HYDROXYURS-12-EN-24-OIC ACID|631B696|(3alpha,4beta)-3-hydroxy-Urs-12-en-23-oic acid|Q27274271|.BETA.-BOSWELLIC ACID (CONSTITUENT OF BOSWELLIA SERRATA) [DSC]|(3R,4R,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-3-hydroxy-4,6a,6b,8a,11,12,14b-heptamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-icosahydropicene-4-carboxylic acid"
PF-04620110,46926360,,"InChI=1S/C21H24N4O4/c22-19-18-20(24-12-23-19)29-10-9-25(21(18)28)16-7-5-15(6-8-16)14-3-1-13(2-4-14)11-17(26)27/h5-8,12-14H,1-4,9-11H2,(H,26,27)(H2,22,23,24)",GEVVQZHMFVFGLN-UHFFFAOYSA-N,C21H24N4O4,396.4,"2-[4-[4-(4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6-yl)phenyl]cyclohexyl]acetic acid","PF-04620110|1109276-89-2|PF 04620110|PF-4620110|CQ4M18RLJW|2-[4-[4-(4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6-yl)phenyl]cyclohexyl]acetic acid|CHEMBL1835919|trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]-cyclohexaneacetic acid|trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexaneacetic acid|2-(trans-4-(4-(4-Amino-5-oxo-7,8-dihydropyrimido[5,4-f]-[1,4]oxazepin-6(5H)-yl)phenyl)cyclohexyl)acetic acid|CYCLOHEXANEACETIC ACID, 4-(4-(4-AMINO-7,8-DIHYDRO-5-OXOPYRIMIDO(5,4-F)(1,4)OXAZEPIN-6(5H)-YL)PHENYL)-, TRANS-|cyclohexaneacetic acid, 4-[4-(4-amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]-, trans-|MFCD19443642|CS-0370|UNII-CQ4M18RLJW|GTPL7829|orb1685535|SCHEMBL1424359|SCHEMBL1424362|SCHEMBL1425038|DTXSID90677361|GEVVQZHMFVFGLN-HDJSIYSDSA-N|GLXC-10892|HMS3653O15|HMS3745K05|HMS3870M13|BCP16812|BDBM50355142|EX-A10681|s7192|AKOS016011621|CCG-268606|DB14887|SB19585|NCGC00389511-01|HY-13009|MS-26684|trans-4-[4-(4-Amino-7,8-dihydro-5-oxopyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexaneacetic|DB-120776|PF04620110|SW220213-1|F83814|PF-04620110, >=98% (HPLC)|BRD-K30550578-001-01-3|Q27088315|{Trans-4-[4-(4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexyl} Acetic Acid|{Trans-4-[4-(4-amino-5-oxo-7,8-dihydropyrimido[5,4-f][1,4]oxazepin-6(5H)-yl)phenyl]cyclohexyl}acetic acid|2-[(1r,4r)-4-(4-{4-amino-5-oxo-5H,6H,7H,8H-pyrimido[5,4-f][1,4]oxazepin-6-yl}phenyl)cyclohexyl]acetic acid"
SILMITASERTIB,24748573,,"InChI=1S/C19H12ClN3O2/c20-12-2-1-3-13(9-12)22-18-15-6-7-21-10-16(15)14-5-4-11(19(24)25)8-17(14)23-18/h1-10H,(H,22,23)(H,24,25)",MUOKSQABCJCOPU-UHFFFAOYSA-N,C19H12ClN3O2,349.8,"5-(3-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid","Silmitasertib|1009820-21-6|CX-4945|CX 4945|CX4945|Cx-4945 free acid|C6RWP0N0L2|5-(3-chlorophenylamino)benzo[c][2,6]naphthyridine-8-carboxylic acid|5-[(3-chlorophenyl)amino]benzo[c]2,6-naphthyridine-8-carboxylic acid|5-[(3-chlorophenyl)amino]-Benzo[c]-2,6-naphthyridine-8-carboxylic acid|DTXSID40143602|5-(3-chlorophenylamino)benzo(c)(2,6)naphthyridine-8-carboxylic acid|silmitasertibum|5-((3-chlorophenyl)amino)pyrido(4,3-c)quinoline-8-carboxylic acid|5-[(3-chlorophenyl)amino]pyrido[4,3-c]quinoline-8-carboxylic acid|5-((3-chlorophenyl)amino)-benzo(c)-2,6-naphthyridine-8-carboxylic Acid|5-((3-chlorophenyl)amino)benzo(c)2,6-naphthyridine-8-carboxylic acid|RefChem:6223|DTXCID9066093|5-((3-Chlorophenyl)amino)benzo[c][2,6]naphthyridine-8-carboxylic acid|CX-4945 (Silmitasertib)|Silmitasertib [INN]|MFCD13184796|CX4945 (Silmitasertib)|Silmitasertib (CX-4945)|C19H12ClN3O2|5-(3-chloroanilino)benzo[c][2,6]naphthyridine-8-carboxylic acid|Benzo[c]-2,6-naphthyridine-8-carboxylic acid, 5-[(3-chlorophenyl)amino]-|CHEMBL1230165|5-((3-Chlorophenyl)amino)benzo-[c][2,6]naphthyridine-8-carboxylic acid|5-[(3-Chlorophenyl)amino]benzo[c][2,6]naphthyridine-8-Carboxylic Acid|UNII-C6RWP0N0L2|5-((3-CHLOROPHENYL)AMINO)BENZO(C)(2,6)NAPHTHYRIDINE-8-CARBOXYLIC ACID|BENZO(C)-2,6-NAPHTHYRIDINE-8-CARBOXYLIC ACID, 5-((3-CHLOROPHENYL)AMINO)-|3NG|5-[(3-Chlorophenyl)amino]benzo[c]-2,6-naphthyridine-8-carboxylic acid|Silmitasertib; CX 4945|CX-4945 (Silmitaserib)|CX 4945 (Silmitasertib)|SCHEMBL629082|SILMITASERTIB [WHO-DD]|GTPL8126|orb1305875|SCHEMBL29381056|SCHEMBL30193004|EX-A070|CHEBI:232159|CHEBI:232617|GLXC-04060|HMS3244M13|HMS3244M14|HMS3244N13|HMS3655F16|HMS3746E13|BCP02399|BDBM50335638|NSC761193|NSC800885|s2248|AKOS005266722|BCP9000560|CCG-264955|CS-0563|DB15408|EX-8673|FC30749|NSC-761193|NSC-800885|SB17201|SDCCGSBI-0654415.P001|NCGC00263192-01|NCGC00263192-02|NCGC00263192-09|NCGC00263192-13|AC-28426|AS-16253|HY-50855|SY069677|DB-016103|SW218157-2|EN300-6482034|BRD-K81458380-001-04-9|CX-4945,CAS:1009820-21-6|Q27076934|5-[(3-Chlorophenyl)amino]-Benzo[c]-2,6-naphthyridine-8-carboxylic acid;silmitasertib"
VTP-27999,16126898,,"InChI=1S/C26H41ClN4O5/c1-28-23(14-19-6-5-12-35-18-19)16-30-25(32)31-11-4-8-21(17-31)24(20-7-3-9-22(27)15-20)36-13-10-29-26(33)34-2/h3,7,9,15,19,21,23-24,28H,4-6,8,10-14,16-18H2,1-2H3,(H,29,33)(H,30,32)/t19-,21-,23+,24+/m1/s1",NXWASIVXQMMPLM-ZXMXYHOLSA-N,C26H41ClN4O5,525.1,methyl N-[2-[(R)-(3-chlorophenyl)-[(3R)-1-[[(2S)-2-(methylamino)-3-[(3R)-oxan-3-yl]propyl]carbamoyl]piperidin-3-yl]methoxy]ethyl]carbamate,"942142-51-0|VTP-27999|254XY8NV84|methyl N-(2-((R)-(3-chlorophenyl)((3R)-1-(((2S)-2-(methylamino)-3-((3R)-oxan-3-yl)propyl)carbamoyl)piperidin-3-yl)methoxy)ethyl)carbamate|methyl N-{2-[(R)-(3-chlorophenyl)[(3R)-1-{[(2S)-2-(methylamino)-3-[(3R)-oxan-3-yl]propyl]carbamoyl}piperidin-3-yl]methoxy]ethyl}carbamate|RefChem:194648|Methyl (2-((R)-(3-chlorophenyl)((R)-1-(((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propyl)carbamoyl)piperidin-3-yl)methoxy)ethyl)carbamate|methyl N-[2-[(R)-(3-chlorophenyl)-[(3R)-1-[[(2S)-2-(methylamino)-3-[(3R)-oxan-3-yl]propyl]carbamoyl]piperidin-3-yl]methoxy]ethyl]carbamate|CHEMBL1276678|VTP27999|VTP 27999|UNII-254XY8NV84|NXWASIVXQMMPLM-ZXMXYHOLSA-N|methoxy}ethyl)carbamate|orb1697996|SCHEMBL1160991|DTXSID70583133|BCP10700|CARBAMIC ACID, N-(2-((R)-(3-CHLOROPHENYL)((3R)-1-((((2S)-2-(METHYLAMINO)-3-((3R)-TETRAHYDRO-2H-PYRAN-3-YL)PROPYL)AMINO)CARBONYL)-3-PIPERIDINYL)METHOXY)ETHYL)-, METHYL ESTER|EX-A1756|BDBM50382334|AKOS016005345|DB12416|NCGC00378838-02|N-[2-[(R)-(3-Chlorophenyl)[(3R)-1-[[[(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl]am|TS-08692|NS00072155|A11418|BRD-K81694556-003-01-9|Q27253906|(2-{(R)-(3-chlorophenyl)[(3R)-1-({(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl}carbamoyl)piperidin-3-yl]|Methyl (2-{(3-chlorophenyl)[(3R)-1-({(2S)-2-(methylamino)-3-[(3R)-oxan-3-yl]propyl}carbamoyl)piperidin-3-yl]methoxy}ethyl)carbamate|methyl (2-{(R)-(3-chlorophenyl)[(3R)-1-({(2S)-2-(methylamino)-3-[(3R)-tetrahydro-2H-pyran-3-yl]propyl}carbamoyl)piperidin-3-yl] methoxy}ethyl)carbamate|Methyl (2-{(R)-(3-Chlorophenyl)[(3r)-1-({(2s)-2-(Methylamino)-3-[(3r)-Tetrahydro-2h-Pyran-3-Yl]propyl}carbamoyl)piperidin-3-Yl]methoxy}ethyl)carbamate|methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamate|RX5"
IMARIKIREN,44554894,,"InChI=1S/C27H41N5O4/c1-20(2)19-32(22-16-21(17-28-18-22)26(33)30-11-14-36-15-12-30)27(34)25-29-23-8-4-5-9-24(23)31(25)10-6-7-13-35-3/h4-5,8-9,20-22,28H,6-7,10-19H2,1-3H3/t21-,22+/m1/s1",RHIBAIKQWJNESW-YADHBBJMSA-N,C27H41N5O4,499.6,"1-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholine-4-carbonyl)piperidin-3-yl]benzimidazole-2-carboxamide","IMARIKIREN|TAK-272 free base|imarikirene|imarikireno|01IC75R817|UNII-01IC75R817|IMARIKIREN [INN]|IMARIKIREN [WHO-DD]|imarikirenum|RefChem:147919|1202265-63-1|TAK-272 free base, (+)-|1H-Benzimidazole-2-carboxamide, 1-(4-methoxybutyl)-N-(2-methylpropyl)-N-((3S,5R)-5-(4-morpholinylcarbonyl)-3-piperidinyl)-|CHEMBL3969876|1-(4-Methoxybutyl)-~{n}-(2-Methylpropyl)-~{n}-[(3~{s},5~{r})-5-Morpholin-4-Ylcarbonylpiperidin-3-Yl]benzimidazole-2-Carboxamide|orb2815315|SCHEMBL1423171|CHEMBL3990145|RHIBAIKQWJNESW-YADHBBJMSA-N|BDBM50195780|BDBM50273160|N-ISOBUTYL-1-(4-METHOXYBUTYL)-N-((3S,5R)-5-(MORPHOLINE-4-CARBONYL)PIPERIDIN-3-YL)-1H-BENZO[D]IMIDAZOLE-2-CARBOXAMIDE|1-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholin-4-ylcarbonyl) piperidin-3-yl]-1H-benzimidazole-2-carboxamide|1-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholin-4-ylcarbonyl)piperidin-3-yl]-1H-benzimidazole-2-carboxamide|6VU"
DIAZEPAM,3016,,"InChI=1S/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H3",AAOVKJBEBIDNHE-UHFFFAOYSA-N,C16H13ClN2O,284.74,"7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one","diazepam|Valium|439-14-5|Ansiolisina|Diazemuls|Relanium|Stesolid|Alboral|Apaurin|Faustan|Seduxen|Sibazon|Methyldiazepinone|Ansiolin|Apozepam|Atensine|Bialzepam|Calmocitene|Calmpose|Ceregulart|Condition|Diacepan|Diazepan|Diazetard|Dipezona|Domalium|Kiatrium|Liberetas|Neurolytril|Paranten|Quetinil|Quiatril|Quievita|Relaminal|Renborin|Seduksen|Serenack|Serenamin|Serenzin|Stesolin|Tensopam|Tranimul|Tranqdyn|Tranquirit|Unisedil|Valitran|Valrelease|Aliseum|Amiprol|Assival|Atilen|Cercine|Diapam|Diastat|Dienpax|Duksen|Eridan|Freudal|Frustan|Gihitan|Lembrol|Levium|Morosan|Paxate|Plidan|Saromet|Sedipam|Setonil|Sonacon|Umbrium|Vatran|Velium|Duxen|Paxel|Solis|Valeo|Vival|Vivol|Zipan|Noan|Usempax ap|Methyl diazepinone|Centrazepam|Q-pam|Tranquase|Dialar|Evacalm|Horizon|Dizac|La-Iii|LA III|An-Ding|e-Pam|Servizepam|Diazepam Intensol|Nervium|Ro 5-2807|Diazepam-Lipuro|WY-3467|7-chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one|NSC-77518|7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|Diacepin|Diazepamum|Tensium|7-Chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Diastat Acudial|Diazepam civ|2H-1,4-Benzodiazepin-2-one, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-|7-Chloro-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2(1H)-one|DTXSID4020406|Methyldiazepinone (pharmaceutical)|Q3JTX2Q7TU|NRL-1|7-Chloro-1-methyl-2-oxo-5-phenyl-3H-1,4-benzodiazepine|7-Chloro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|NSC-169897|LIBERVANT|VALTOCO|CHEBI:49575|RO-5-2807|1-Methyl-5-phenyl-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Ro-52807|DTXCID20406|NSC77518|NSC169897|7-chloro-1-methyl-5-phenyl-2,3-dihydro-1H-1,4-benzodiazepin-2-one|Scriptopam|Valclair|Dialar fte|Diazepam Oral|Gabavale-5|Alupram 2|Alupram 5|Alupram 10|RefChem:6418|DIAZEPAM, CHOLINE|Diazepam Oral Solution (Concentrate)|7-Chloro-1-methyl-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-on|207-122-5|NSC46083|Bensedin|Ruhsitus|Armonil|Dialag|Eurosan|Lamra|Kabivitrum|Gewacalm|Novazam|Valaxona|Valiquid|Dipam|Paceum|Jinpanfan|Antenex|Arzepam|Diapax|Drenian|Ducene|Kratium|Nellium|Nerozen|Zepaxid|Doval|Paxum|Sipam|Vazen|Placidox 5|D-Pam|Faustan,|CHEMBL12|DZP|Methyldiazepinone, pharmaceutical|Apo-diazepam|Wy 3467|LA 111|7-Chloro-1-methyl-5-3H-1,4-benzodiazepin-2(1H)-one|NCGC00178168-02|Calmociteno|Alupram|Ansilive|Anxicalm|Anxionil|Benzopin|Betapam|Britazepam|Calmaven|Chuansuan|Desconet|Desloneg|Diaceplex|Diapine|Diaquel|Diatran|Diazepin|Disopam|Faustal|Gradual|Iazepam|Medipam|Mentalium|Metamidol|Nivalen|Nixtensyn|Notense|Novodipam|Ortopsique|Paralium|Prozepam|Psychopax|Radizepam|Reliver|Sedapam|Trankinon|Trazepam|Valuzepam|Vanconin|Baogin|Calmod|Caudel|Diazem|Lovium|Mandro|Parzam|Dipaz|Dupin|Gubex|Lizan|Pomin|Winii|Diazepam Nordic|Diazepan leo|Diazepam Elmu|Diazepam Fabra|Diazepam Stada|Metil Gobanal|Diazepam Dak|Tranquo-tablinen|Diazepam Desitin|Euphorin P|Mandro-Zep|Sico Relax|Diazepam Rectubes|S.a. r.l.|Elcion CR|Placidox 2|Kratium 2|Diazepam-ratiopharm|Placidox 10|Diazepamu [Polish]|Diazepam-Eurogenerics|Diazepam (1mg/mL in Methanol)|Diazepamu|Mandrozep|Plumiaz|Tranquo-puren|Diazepamum [INN-Latin]|7-chloro-1-methyl-5-phenyl-1,3-dihydro-benzo[e][1,4]diazepin-2-one|WLN: T67 GNV JN IHJ CG G1 KR|CAS-439-14-5|SMR000058398|CCRIS 6009|Best [Pharaceutical]|HSDB 3057|2H-1, 7-chloro-1,3-dihydro-1-methyl-5-phenyl-|EINECS 207-122-5|UNII-Q3JTX2Q7TU|LA-111|1-Methyl-5-phenyl-7-chloro-1,4-benzodiazepin-2-one|7-Chloro-1-methyl-5-phenyl-1,4-benzodiazepin-2-one|NSC 169897|BRN 0754371|Anlin|DEA No. 2765|Pro pam|Diastat (TN)|Valium (TN)|Diazepam [USAN:USP:INN:BAN:JAN]|DIAZEPAM [HSDB]|DIAZEPAM [IARC]|DIAZEPAM [USAN]|DIAZEPAM [INN]|DIAZEPAM [JAN]|DIAZEPAM [MI]|DIAZEPAM [VANDF]|Spectrum3_001780|Spectrum4_000576|Spectrum5_001890|DIAZEPAM [MART.]|DIAZEPAM [WHO-DD]|BIDD:PXR0158|Oprea1_126223|SCHEMBL21442|BSPBio_003279|KBioGR_001012|5-24-04-00300 (Beilstein Handbook Reference)|MLS000759402|MLS001424086|BIDD:GT0105|DIAZEPAM [GREEN BOOK]|DivK1c_000967|Diazepam (JP18/USP/INN)|Diazepam, 1mg/ml in Methanol|DIAZEPAM [ORANGE BOOK]|DIAZEPAM CIV [USP-RS]|GTPL3364|S.A.R.L.|DIAZEPAM [EP MONOGRAPH]|DIAZEPAM [USP MONOGRAPH]|SCHEMBL29362687|HMS503A15|KBio1_000967|KBio3_002780|Diazepam 0.1 mg/ml in Methanol|Diazepam 1.0 mg/ml in Methanol|CHEBI:194180|NINDS_000967|HMS2051N04|HMS3393N04|BCP23002|Tox21_113071|Tox21_202458|7-Chloro-1-methyl-5-phenyl-1H-benzo[e][1,4]diazepin-2(3H)-one|BDBM50000766|STK735517|AKOS003367969|Diazepam 1000 microg/mL in Methanol|Tox21_113071_1|AB02310|BCP9000199|BNZ - Human Serum, Benzodiazepine mix|CCG-100997|CS-0653|DB00829|NC00247|Ro 5-2805|IDI1_000967|NCGC00178168-01|NCGC00178168-03|NCGC00178168-04|NCGC00260007-01|AC-10561|HY-17027|BCP0726000176|DB-051179|NS00008403|NS00114260|C06948|D-1450|D00293|A826456|Q210402|Valium; Ansiolisina; Diazemuls; Apaurin; Faustan|BRD-K16508793-001-01-8|BRD-K16508793-001-05-9|Diazepam, European Pharmacopoeia (EP) Reference Standard|7-chloranyl-1-methyl-5-phenyl-3H-1,4-benzodiazepin-2-one|7-chloro-1-methyl-5-phenyl-1H-1,4-benzodiazepine-2(3H)on|Diazepam, United States Pharmacopeia (USP) Reference Standard|7-chloro-1-methyl-5-phenyl-1,3-dihydro-[1,4]benzodiazepin-2-one|7-Chloro-1-methyl-5-phenyl-1,3-dihydro-1,4-benzodiazepin-2-one|7 -chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one|7-chloro-1,3-dihydro-1-methyl-5-phenyl-2H -1,4-benzodiazepin-2-one|7-chloro-1-methyl-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-one|7-Chloro-1-methyl-5-phenyl-2-oxo-2,3-dihydro-1H-benzo[f]-1,4-diazepine|7-chloro-1,3-dihydro-1-(methyl-d3)-5-(phenyl-d5)-2H-1,4-benzodiazepin-2-one|7-chloro-1-((2)H3)methyl-5-((2)H5)phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one|Diazepam for system suitability, European Pharmacopoeia (EP) Reference Standard|11100-37-1|7-Chloro-1,3-dihydro-1-methyl-5-phenyl-2H-1,4-benzodiazepin-2-one; 1-Methyl-5-phenyl-7-chloro-1,3-dihydro-2H-1,4-benzodiazepin-2-one ;  Alboral|7-chloro-5-(2,3,4,5,6-pentadeuteriophenyl)-1-(trideuteriomethyl)-3H-1,4-benzodiazepin-2-one|InChI=1/C16H13ClN2O/c1-19-14-8-7-12(17)9-13(14)16(18-10-15(19)20)11-5-3-2-4-6-11/h2-9H,10H2,1H"
ZOLPIDEM,5732,,"InChI=1S/C19H21N3O/c1-13-5-8-15(9-6-13)19-16(11-18(23)21(3)4)22-12-14(2)7-10-17(22)20-19/h5-10,12H,11H2,1-4H3",ZAFYATHCZYHLPB-UHFFFAOYSA-N,C19H21N3O,307.4,"N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide","zolpidem|82626-48-0|Zolpidemum|Sanval|Zolpidem civ|N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide|DTXSID7045946|CHEBI:10125|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo(1,2-a)pyridine-3-acetamide|7K383OQI23|DTXCID5025946|Imidazo(1,2-a)pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide|Edlular|Zolpi Lich|Imidazo[1,2-a]pyridine-3-acetamide, N,N,6-trimethyl-2-(4-methylphenyl)-|N,N-dimethyl-2-(6-methyl-2-(4-methylphenyl)imidazo(1,2-a)pyridin-3-yl)acetamide|RefChem:6366|SL-800750-23-N|N05CF02|SL 800750 23 N|617-367-3|Ambien|CHEMBL911|Zolpidem (INN)|Zolpidemum [Latin]|NCGC00095179-01|N,N,6-Trimethyl-2-p-tolylimidazo[1,2-a]pyridine-3-acetamide|ZOLPIDEM [INN]|SL-800750|Zolpidem [INN:BAN]|Zolpidem (1.0 mg/mL in Methanol)|[3H]zolpidem|CAS-82626-48-0|zolpidem Ambien|UNII-7K383OQI23|Sanval (TN)|SL800750|SL 800750|ZOLPIDEM [MI]|ZOLPIDEM [VANDF]|SL 80-0750|ZOLPIDEM [WHO-DD]|SCHEMBL80516|BSPBio_002278|BIDD:GT0785|SPECTRUM1505369|ZOLPIDEM CIV [USP-RS]|GTPL4348|GTPL4362|BDBM26266|GLXC-06071|HMS1922F22|BCP10205|JNB60590|Tox21_111471|MFCD00153885|STK627113|Zolpidem, >=98% (HPLC), solid|AKOS005560130|Tox21_111471_1|CCG-213403|CS-1468|DB00425|ID57819|NCGC00095179-02|NCGC00095179-03|NCGC00095179-04|NCGC00095179-05|AS-35386|HY-17441|NS00010401|Z-100|C07219|D08690|AB00698471-07|AB00698471_09|294Z936|Q218842|SR-01000763006|SR-01000763006-3|BRD-K44876623-001-01-1|BRD-K44876623-001-03-7|SL 800750; SL-800750; SL800750|N,N,6-Trimethyl-2-(4-methylphenyl)-imidazo[1,2-a]pyridine-3-acetamide|N,N,6-TRIMETHYL-2-P-TOLYL-IMIDAZO(1,2-A)PYRIDINE-3-ACETAMIDE|6-methyl-N,N-dimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide|N,N,6-Trimethyl-2-(4-Methyl Phenyl) Imidazo [1,2-alpha] Pyridine-3-Acetamide|N,N-dimethyl-2-[(4S)-6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide|N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide #|N,N-dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[3,2-a]pyridin-3-yl]acetamide|N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyridine-3-acetamide; N,N,6-Trimethyl-2-p-tolylimidazol[1,2-a]pyridine-3-acetamide; SL 80-0750; SL 800750;|N,N-Dimethyl-2-[6-methyl-2-(4-methylphenyl)imidazo[1,2-a]pyridin-3-yl]acetamide;N,N,6-Trimethyl-2-(4-methylphenyl)imidazo[1,2-a]pyri  dine-3-acetamide;N,N,6-Trimethyl-2-p-tolylimidazol[1,2-a]pyridine-3-acetamide;SL 80-0750"
ATEVIRDINE MESYLATE,60847,,"InChI=1S/C21H25N5O2.CH4O3S/c1-3-22-18-5-4-8-23-20(18)25-9-11-26(12-10-25)21(27)19-14-15-13-16(28-2)6-7-17(15)24-19;1-5(2,3)4/h4-8,13-14,22,24H,3,9-12H2,1-2H3;1H3,(H,2,3,4)",HKPKBPALSLUFFM-UHFFFAOYSA-N,C22H29N5O5S,475.6,[4-[3-(ethylamino)pyridin-2-yl]piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone;methanesulfonic acid,"Atevirdine mesylate|138540-32-6|U-87201E|Atevirdine mesilate|A948D8673W|Atevirdine methanesulfonate|RefChem:916445|Atevirdine mesylate [USAN]|u 87201e|CHEMBL7264|Atevirdine mesylate (USAN)|[4-[3-(ethylamino)pyridin-2-yl]piperazin-1-yl]-(5-methoxy-1H-indol-2-yl)methanone;methanesulfonic acid|Piperazine, 1-(3-(ethylamino)-2-pyridinyl)-4-((5-methoxy-1H-indol-2-yl)carbonyl)-, monomethanesulfonate|1-(3-(Ethylamino)-2-pyridyl)-4-((5-methoxyindol-2-yl)carbonyl)piperazine monomethanesulfonate|UNII-A948D8673W|U87201E|SCHEMBL146999|SCHEMBL29636966|DTXSID30930144|ATEVIRDINE MESILATE [MART.]|ATEVIRDINE MESYLATE [WHO-DD]|ATEVIRDINE METHANESULFONATE [MI]|D03001|Q27273795|1-(3-(ETHYLAMINO)-2-PYRIDINYL)-4-((5-METHOXY-1H-INDOL-2-YL)CARBONYL)PIPERAZINE MESYLATE|Methanesulfonic acid--{4-[3-(ethylamino)pyridin-2-yl]piperazin-1-yl}(5-methoxy-1H-indol-2-yl)methanone (1/1)"
ZANAMIVIR,60855,,"InChI=1S/C12H20N4O7/c1-4(18)15-8-5(16-12(13)14)2-7(11(21)22)23-10(8)9(20)6(19)3-17/h2,5-6,8-10,17,19-20H,3H2,1H3,(H,15,18)(H,21,22)(H4,13,14,16)/t5-,6+,8+,9+,10+/m0/s1",ARAIBEBZBOPLMB-UFGQHTETSA-N,C12H20N4O7,332.31,"(2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid","zanamivir|139110-80-8|Relenza|4-Guanidino-Neu5Ac2en|GANA|GG167|GG-167|GR-121167X|GR 121167X|GANA (inhibitor)|GG 167|DTXSID0023749|4-Guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid|L6O3XI777I|CHEBI:50663|GR-121167|5-Acetamido-2,6-anhydro-3,4,5-trideoxy-4-guanidino-D-glycero-D-galacto-non-2-enonic acid|DTXCID503749|5-(acetylamino)-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid|(2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid|(2r,3r,4s)-4-[(diaminomethylidene)amino]-3-acetamido-2-[(1r,2r)-1,2,3-trihydroxypropyl]-3,4-dihydro-2h-pyran-6-carboxylic acid|4 Guanidino Neu5Ac2en|zanamivirum|(2R,3R,4S)-3-(acetylamino)-4-carbamimidamido-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid|(2R,3R,4S)-4-((diaminomethylidene)amino)-3-acetamido-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid|RefChem:56369|GlyTouCan:G87167MM|4 Guanidino 2 Deoxy 2,3 Didehydro N Acetylneuraminic Acid|4-guanidino-2-deoxy-2,3-didehydro-N-acetylneuraminic acid|J05AH01|Acid, 4-Guanidino-2-Deoxy-2,3-Didehydro-N-Acetylneuraminic|2,3-didehydro-2,4-dideoxy-4-guanidinyl-N-acetylneuraminic acid|4-guanidino-2,4-dideoxy-2,3-didehydro-N-acetylneuraminic acid|G87167MM|2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid|5-acetylamino-2,6-anhydro-4-guanidino-3,4,5-trideoxy-D-galacto-non-enoic acid|5-acetylamino-4-guanidino-6-(1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid|Zanamavir|MFCD00866966|(2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid|ZMR|CHEMBL222813|139110-80-8 (free base)|C12H20N4O7|551942-41-7|ZANAMIVIR TFA|(2R,3R,4S)-3-Acetamido-4-guanidino-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid|GNA|(2R,3R,4S)-3-acetamido-4-guanidino-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid|Relenza (TN)|CAS-139110-80-8|4-Guanidino-NeueAc2en|UNII-L6O3XI777I|Dectova|Zanamivi|Zanamivir [USAN:INN:BAN]|HSDB 7437|2qwe|NCGC00164561-01|GR121167X|Zanamivir (Relenza)|Zanamivir (Standard)|Zanamivir (Relenza)?|1a4g|Zanamivir (USP/INN)|ZANAMIVIR [INN]|ZANAMIVIR [MI]|ZANAMIVIR [HSDB]|ZANAMIVIR [USAN]|ZANAMIVIR [VANDF]|ZANAMIVIR [MART.]|SCHEMBL9501|SCHEMBL9502|ZANAMIVIR [USP-RS]|ZANAMIVIR [WHO-DD]|BIDD:GT0349|BDBM4934|orb1305352|ZANAMIVIR [ORANGE BOOK]|Zanamivir, >=98% (HPLC)|GTPL12307|ZANAMIVIR [USP MONOGRAPH]|MSK10031|Tox21_112190|BDBM50219992|BDBM50330326|HY-13210R|s3007|AKOS015841013|AKOS015994539|Tox21_112190_1|BS-1017|CCG-267828|CS-0631|DB00558|MZ04270|NCGC00164561-02|NCGC00164561-08|NCGC00164561-11|(2R,3R,4S)-3-acetamido-4-((diaminomethylene)amino)-2-((1R,2R)-1,2,3-trihydroxypropyl)-3,4-dihydro-2H-pyran-6-carboxylic acid|5-(acetylamino)-4-{[amino(imino)methyl]amino}-2,6-anhydro-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid|HY-13210|NS00003906|Z0023|C08095|C72554|D00902|AB01566897_01|110Z808|EN300-26991905|Q146075|BRD-K23067689-001-02-1|Zanamivir, United States Pharmacopeia (USP) Reference Standard|Zanamivir for assay, EuropePharmacopoeia (EP) Reference Standard|2,3-Didehydro-2,4-dideoxy-4-guanidine-N-acetyl-acetyl-D-neuraminic acid|5-Acetamino-2,6-anhydro-4-guanidino-3,4,5-trideoxy-D-galcto-non-enoic acid|Relenza, GG 167;4-Guanidino-2,4-dideoxy-2,3-didehydro-N-acetylneuraminic acid|Zanamivir for system suitability, European Pharmacopoeia (EP) Reference Standard|(2R,3R,4S)-3-(ACETYLAMINO)-4-{[AMINO(IMINO)METHYL]AMINO}-2-[(1R,2R)-1,2,3-TRIHYDROXYPROPYL]-3,4-DIHYDRO-2H-PYRAN-6-CARBOXYLIC ACID|(2R,3R,4S)-3-acetamido-4-(diaminomethylideneamino)-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acidEE|(2R,3R,4S)-4-carbamimidamido-3-acetamido-2-[(1R,2R)-1,2,3-trihydroxypropyl]-3,4-dihydro-2H-pyran-6-carboxylic acid|(4S,5R,6R)-5-acetamido-4-(diaminomethyleneamino)-6-((1R,2R)-1,2,3-trihydroxypropyl)-5,6-dihydro-4H-pyran-2-carboxylic acid|(4S,5R,6R)-5-acetylamino-4-guanidino-6-((1R,2R)-1,2,3-trihydroxy-propy)-5,6-dihydro-4H-pyran-2-carboxylic acid|(4S,5R,6R)-5-acetylamino-4-guanidino-6-((1R,2R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid|(4S,5R,6R)-5-Acetylamino-4-guanidino-6-((1R,3R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid|(4S,5R,6R)-5-Acetylamino-4-guanidino-6-((R)-1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid|(4S,5R,6R)-5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid|4-diaminomethylamino-3-methylcarboxamido-2-(1,2,3-trihydroxypropyl)-(3R)-3,4-dihydro-2H-6-pyrancarboxylic acid(Zanamivir)|5-acetamido-2,6-anhydro-4-carbamimidamido-3,4,5-trideoxy-D-glycero-D-galacto-non-2-enonic acid|5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid|5-Acetylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid(zanamivir)|5-Formylamino-4-guanidino-6-(1,2,3-trihydroxy-propyl)-5,6-dihydro-4H-pyran-2-carboxylic acid|D-glycero-D-galacto-Non-2-enonic acid, 5-(acetylamino)-4-(aminoiminomethyl)amino)-2,6-anhydro-3,4,5-trideoxy-"
OSELTAMIVIR CARBOXYLATE,449381,,"InChI=1S/C14H24N2O4/c1-4-10(5-2)20-12-7-9(14(18)19)6-11(15)13(12)16-8(3)17/h7,10-13H,4-6,15H2,1-3H3,(H,16,17)(H,18,19)/t11-,12+,13+/m0/s1",NENPYTRHICXVCS-YNEHKIRRSA-N,C14H24N2O4,284.35,"(3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylic acid","Oseltamivir acid|187227-45-8|Oseltamivir free acid|Ro 64-0802|Ro-64-0802|Oseltamivir acid, (-)-|CHEBI:73139|K6106LV5Q8|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, (3R,4R,5S)-|RO-640802|DTXSID50171996|(3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid|RefChem:56723|DTXCID6094487|Oseltamivir carboxylate|GS4071|GS 4071|GS-4071|Oseltamivir-carboxylate|CHEMBL674|(3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylic acid|204255-09-4 (HCl)|Oseltamivir EP Impurity C|(3r,4r,5s)-4-(Acetylamino)-5-Amino-3-(Pentan-3-Yloxy)cyclohex-1-Ene-1-Carboxylic Acid|(3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohexene-1-carboxylic acid|(3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylic acid|(3R,4R,5S)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylic acid|G39|OSELTAMIVIR CARBOXYLATE HYDROCHLORIDE|Oseltamivir Carboxylic Acid|Oseltamiviracid|UNII-K6106LV5Q8|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, (3R,4R,5S)-; 1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, [3R-(3a,4ss,5a)]-; (3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid; GS 4071; Oseltamivir acid; Ro 64-0802|Oseltamivir (acid)|GS 4071;Ro 64-0802;Oseltamivir carboxylate|Oseltamivir acid (Standard)|Ro 64-0802 hydrochloride|SCHEMBL182903|BDBM4994|GLXC-06540|GLXC-10722|EX-A10232|HY-13318R|AKOS027325283|CS-0553|DB02600|FO26594|DA-66381|HY-13318|NS00000302|C90284|EN300-150145|F988549|BRD-K93767137-001-01-1|OSELTAMIVIR PHOSPHATE IMPURITY C [EP IMPURITY]|Q27140336|OSELTAMIVIR PHOSPHATE IMPURITY, OSELTAMIVIR ACID- [USP IMPURITY]|(3R,4R,5S)-4-(Acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexence-1-carboxylic Acid|(3R,4R,5S)-4-Acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohex-ene-1-carboxylic acid|(3R,4R,5S)-4-ACETAMIDO-5-AMINO-3-(1-ETHYLPROPOXY)CYCLOHEX-1-ENE-1-CARBOXYLIC ACID|(3r,4r,5s)-4-acetylamino-5-amino-3(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid|(3r,4r,5s)-4-acetylamino-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylic acid|(3R,4R,5S)-4-(ACETYLAMINO)-5-AMINO-3-(1-ETHYLPROPOXY)-1-CYCLOHEXENE-1-CARBOXYLIC ACID|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, (3R-(3alpha,4beta,5alpha))-"
OSELTAMIVIR,65028,,"InChI=1S/C16H28N2O4/c1-5-12(6-2)22-14-9-11(16(20)21-7-3)8-13(17)15(14)18-10(4)19/h9,12-15H,5-8,17H2,1-4H3,(H,18,19)/t13-,14+,15+/m0/s1",VSZGPKBBMSAYNT-RRFJBIMHSA-N,C16H28N2O4,312.40,"ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate","oseltamivir|196618-13-0|Tamvir|(-)-oseltamivir|ebilfumin|GS-4104|GS 4104|oseltamivirum|HSDB 7433|ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxycyclohexene-1-carboxylate|Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|GS4104|Ro-640796|Ro-64-0796|Ro 640796|CHEBI:7798|GS-4071 ETHYL ESTER|20O93L6F9H|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R-(3alpha,4beta,5alpha))-|RO64-0796|DTXSID9044291|ethyl (3R,4R,5S)-5-amino-4-acetamido-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate|1-Cyclohexene-1-carboxylic acid, 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-, ethyl ester, (3R,4R,5S)-|ethyl (3R,4R,5S)-4-acetamido-5-amino-3-pentan-3-yloxy-cyclohexene-1-carboxylate|RefChem:6086|DTXCID7024291|J05AH02|Tamiflu-Free|(3R,4R,5S)-Ethyl 4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-enecarboxylate|Oseltamivir (INN)|MFCD00953939|Oseltamivir 100 microg/mL in Acetonitrile|OSELTAMIVIR [INN]|Oseltamivir [INN:BAN]|ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)cyclohexene-1-carboxylate|Agucort (TN)|Tamiflu (*Phosphate salt 1:1*)|UNII-20O93L6F9H|SR-05000001499|oseltamivir-phosphate|GOP-A-Flu|Oseltamivir (Standard)|OSELTAMIVIR [MI]|GS 4104;GOP-A-Flu;GS-4104;Tamiflu-Free;Tamvir|OSELTAMIVIR [HSDB]|OSELTAMIVIR [VANDF]|CHEMBL1229|ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate|SCHEMBL32035|OSELTAMIVIR [WHO-DD]|BIDD:GT0426|OSELTAMIVIR [EMA EPAR]|BDBM5025|orb2281185|GTPL11427|VSZGPKBBMSAYNT-RRFJBIMHSA-N|HMS2090C11|EX-A3415|MSK10083|HY-13317R|AKOS015843442|AKOS015960501|CS-0552|DB00198|DT-0013|FO61474|Ethyl (5S,3R,4R)-4-(acetylamino)-5-amino-3-(ethylpropoxy)cyclohex-1-enecarboxylate|NCGC00095191-06|NCGC00095191-12|NCGC00095191-14|NCGC00095191-16|NCGC00178698-01|NCGC00178698-02|NCGC00178698-04|HY-13317|RO640796|NS00000301|O0591|C08092|D08306|E84533|AB00173476-02|AB00173476_04|618O130|AR-270/43507961|Q211509|SR-05000001499-1|BRD-K76011241-001-01-8|BRD-K76011241-001-02-6|BRD-K76011241-011-02-5|BRD-K76011241-045-01-5|Ethyl (3R, 4R, 5S)-4-acetamido-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|ethyl (3r,4r,5s)-4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|ethyl 4-(acetylamino)-5-amino-3-(1-ethylpropoxy)-1-cyclohexene-1-carboxylate|rel-Ethyl (3R,4R,5S)-4-acetamido-5-amino-3-(pentan-3-yloxy)cyclohex-1-ene-1-carboxylate|(3r,4r,5s)-4-acetylamino-5-amino-3(1-ethylpropoxy) -1-cyclohexene-1-carboxylic acid ethyl ester|(3R,4R,5S)-4-acetylamino-5-amino-3-(1-ethyl-propoxy)-cyclohex-1-enecarboxylic acid ethyl ester|(3R,4R,5S)-4-acetylamino-5-amino-3-(1-ethyl-propoxy)cyclohex-1-enecarboxylic acid ethyl ester|182367-47-1"
PERAMIVIR ANHYDROUS,154234,,"InChI=1S/C15H28N4O4/c1-4-8(5-2)12(18-7(3)20)11-10(19-15(16)17)6-9(13(11)21)14(22)23/h8-13,21H,4-6H2,1-3H3,(H,18,20)(H,22,23)(H4,16,17,19)/t9-,10+,11+,12-,13+/m0/s1",XRQDFNLINLXZLB-CKIKVBCHSA-N,C15H28N4O4,328.41,"(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid","Peramivir|330600-85-6|BCX-1812|Rapiacta|RWJ-270201|Peramivir anhydrous|RAPIVAB|BCX 1812|CHEBI:85202|BCX1812|9ZS94HQO3B|RWJ270201|RWJ 270201|DTXSID10904727|3-(1'-acetylamino-2'-ethyl)butyl-4-((aminoimino)methyl)amino-2-hydroxycyclopentane-1-carboxylic acid|RWJ-270201-162 ANHYDROUS|Cyclopentanecarboxylic acid, 3-((1S)-1-(acetylamino)-2-ethylbutyl)-4-((aminoiminomethyl)amino)-2-hydroxy-, (1S,2S,3R,4R)-|Cyclopentanecarboxylic acid, 3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxy-, (1S,2S,3R,4R)-|PERAMIVIRUM|RefChem:860138|J05AH03|DTXCID801333836|(1S,2S,3R,4R)-3-((1S)-1-acetylamino-2-ethylbutyl))-4-((aminoiminomethyl)amino-2-hydroxycyclopentanecarboxylic acid, trihydrate|1N-(1-(5-diaminomethylamino-3-dihydroxymethyl-2-hydroxy-(3S,5R)-cyclopentyl)-2-ethylbutyl)acetamide (BCX-1812)|(1S,2S,3R,4R)-3-((1S)-1-acetamido-2-ethylbutyl)-4-((amino(imino)methyl)amino)-2-hydroxycyclopentanecarboxylic acid trihydrate|QW7Y7ZR15U|229614-55-5|(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-(diaminomethylideneamino)-2-hydroxycyclopentane-1-carboxylic acid|Peramivir, (+/-)-|(1S,2S,3R,4R)-4-carbamimidamido-3-[(1S)-1-acetamido-2-ethylbutyl]-2-hydroxycyclopentane-1-carboxylic acid|(1S,2S,3R,4R)-3-((S)-1-Acetamido-2-ethylbutyl)-4-guanidino-2-hydroxycyclopentanecarboxylic acid|229614-56-6|(1S,2R,3R,4R)-3-(1-acetamido-2-ethyl-butyl)-4-(diaminomethylideneamino)-2-hydroxy-cyclopentane-1-carboxylic acid|IDL9Q29886|330600-85-6 (free)|3-(1-ACETYLAMINO-2-ETHYL-BUTYL)-4-GUANIDINO-2-HYDROXY-CYCLOPENTANECARBOXYLIC ACID|BCZ|(1S,2S,3S,4R)-4-[(DIAMINOMETHYLIDENE)AMINO]-3-[(1S)-1-ACETAMIDO-2-ETHYLBUTYL]-2-HYDROXYCYCLOPENTANE-1-CARBOXYLIC ACID|(+/-)-Peramivir|Peramivir [USAN:INN]|UNII-9ZS94HQO3B|PeramiFlu|UNII-IDL9Q29886|RWJ-270201;BCX-1812|MFCD09837902|PERAMIVIR [INN]|PERAMIVIR [MI]|orb134426|SCHEMBL744373|BDBM5024|CHEMBL139367|orb1705122|SCHEMBL12795462|BCPP000117|GLXC-05004|BDBM50181441|HY-17015A|AKOS016007760|AKOS037652424|PERAMIVIR (+/-)-FORM [MI]|CS-0638|DB06614|DT-0029|FP65126|NCGC00346433-06|NCGC00346433-07|(1s,2s,3r,4r)-3-((1s)-1-acetylamino-2-ethylbutyl))-4-((aminoiminomethyl)amino)-2-hydroxycyclopentane|AC-22715|Cyclopentanecarboxylic acid, 3-((1R)-1-(acetylamino)-2-ethylbutyl)-4-((aminoiminomethyl)amino)-2-hydroxy-, (1R,2R,3S,4S)-rel-|NS00069710|P2892|W19713|AB01566838_01|EN300-7412041|600P856|Q412734|S-021812|BRD-K00519864-341-02-5|BRD-K00519864-341-03-3|(-)-(1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-{[amino(imino)methyl]amino}-2-hydroxycyclopentanecarboxylic Acid|(1S,2S,3R,4R)-3-((1S)-1-ACETYLAMINO-2-ETHYLBUTYL)-4-((AMINOIMINOMETHYL)AMINO)-2-HYDROXYCYCLOPENTANECARBOXYLIC ACID|(1S,2S,3R,4R)-3-[(1S)-1-(Acetylamino)-2-ethylbutyl]-4-[(aminoiminomethyl)amino]-2-hydroxycyclopentanecarboxylic Acid|(1S,2S,3R,4R)-3-[(1S)-1-(ACETYLAMINO)-2-ETHYLBUTYL]-4-{[AMINO(IMINO)METHYL]AMINO}-2-HYDROXYCYCLOPENTANE-1-CARBOXYLIC ACID|(1S,2S,3R,4R)-3-[(1S)-1-(acetylamino)-2-ethylbutyl]-4-carbamimidamido-2-hydroxycyclopentanecarboxylic acid|(1S,2S,3R,4R)-3-[(1S)-1-acetamido-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentanecarboxylic acid|(1S,2S,3R,4R)-3-[(1S)-1-acetamido-2-ethylbutyl]-4-carbamimidamido-2-hydroxycyclopentane-1-carboxylic acid|(1S,2S,3S,4R)-3-[(1S)-1-acetamido-2-ethyl-butyl]-4-guanidino-2-hydroxy-cyclopentanecarboxylic acid|CYCLOPENTANECARBOXYLIC ACID, 3-((1S)-1-(ACETYLAMINO)-2-ETHYLBUTYL)-4-((AMINOIMINOMETHYL)AMINO)-2-HYDROXY-, (1R,2R,3S,4S)-REL-"
CLOMIPRAMINE,2801,,"InChI=1S/C19H23ClN2/c1-21(2)12-5-13-22-18-7-4-3-6-15(18)8-9-16-10-11-17(20)14-19(16)22/h3-4,6-7,10-11,14H,5,8-9,12-13H2,1-2H3",GDLIGKIOYRNHDA-UHFFFAOYSA-N,C19H23ClN2,314.9,"3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine","clomipramine|303-49-1|Chlorimipramine|Monochlorimipramine|3-Chloroimipramine|Hydiphen|Clomicalm|Clomipramina|Clomipraminum|Anapramine|5H-Dibenz[b,f]azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-|3-Chloro-Iminodibenzyl|3-Chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz(b,f)azepine|NSC-169865|NUV44L116D|DTXSID6022844|CHEBI:47780|5H-Dibenz(b,f)azepine, 3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-|5H-Dibenz(b,f)azepine-5-propanamine, 3-chloro-10,11-dihydro-N,N-dimethyl-|DTXCID602844|3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine|Chlomipramine|3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro-5H-dibenz[b,f]azepine|3-(3-chloro-10,11-dihydro-5H-dibenzo(b,f)azepin-5-yl)-N,N-dimethyl-1-propanamine|3-(9-chloro-5,6-dihydrobenzo(b)(1)benzazepin-11-yl)-N,N-dimethylpropan-1-amine|3-(9-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine|5H-Dibenz[b,f]azepine, 3-chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-|(3-(5-chloro-2-azatricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl)propyl)dimethylamine|(3-{5-chloro-2-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}propyl)dimethylamine|RefChem:58431|Monohydrochloride, Clomipramine|N06AA04|(3-(14-chloro-2-azatricyclo(9.4.0.03,8)pentadeca-1(11),3,5,7,12,14-hexaen-2-yl)propyl)dimethylamine|206-144-2|Anafranil base|3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethylpropan-1-amine|Anafranil (free base)|Clomipraminum [INN-Latin]|Clomipramina [INN-Spanish]|NSC 169865|Clomipramine (INN)|5H-Dibenz(b,f)azepine, 10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-|Anafranil (TN)|3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine|NCGC00015264-08|CLOMIPRAMINE [INN]|3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine|Clomipramine [INN:BAN]|Anapramine; Chlorimipramine;G 34586; NSC 169865|3-chloro-10,11-dihydro-N,N-dimethyl-5H-Dibenz(b,f)azepine-5-propanamine|3-CHLORO-10,11-DIHYDRO-N,N-DIMETHYL-5H-DIBENZ[B,F]AZEPINE-5-PROPANAMINE|MFCD31699980|CAS-303-49-1|N,N-Dimethyl-7-chloro-10,11-dihydro-5H-dibenzo[b,f]azepine-5-propanamine-2,4-D2|2241983-11-7|EINECS 206-144-2|CAS-17321-77-6|BRN 1323477|UNII-NUV44L116D|HSDB 7746|MFCD00242755|CLOMIPRIMINE|Spectrum_000444|Tocris-0457|Clomipramine (Standard)|3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethylpropan-1-amine;hydrochloride|Prestwick0_000269|Prestwick1_000269|Prestwick2_000269|Prestwick3_000269|Spectrum2_001729|Spectrum3_001707|Spectrum4_000350|Spectrum5_001235|CLOMIPRAMINE [MI]|Lopac-C-7291|Biomol-NT_000151|CHEMBL415|CLOMIPRAMINE [HSDB]|CLOMIPRAMINE [VANDF]|BIDD:PXR0151|Lopac0_000307|Oprea1_312582|SCHEMBL35423|BSPBio_000118|BSPBio_003294|KBioGR_000759|KBioSS_000924|5-20-08-00103 (Beilstein Handbook Reference)|cid_68539|CLOMIPRAMINE [WHO-DD]|DivK1c_000797|SPBio_001778|SPBio_002337|BPBio1_000130|BPBio1_000661|GTPL2398|HY-B0457AR|orb1306478|SCHEMBL29432499|SCHEMBL29774103|SCHEMBL31189077|BDBM77970|HY-B0457A|KBio1_000797|KBio2_000924|KBio2_003492|KBio2_006060|KBio3_002514|NINDS_000797|HMS3428J14|ALBB-038633|Tox21_110117|PDSP1_000241|PDSP2_000240|STK534842|10,11-dihydro-3-chloro-5-(3-(dimethylamino)propyl)-5H-dibenz(b,f)azepine|AKOS001487687|Tox21_110117_1|AB05476|CCG-110307|DB01242|DS-6718|SDCCGSBI-0050295.P004|IDI1_000797|NCGC00015264-01|NCGC00015264-02|NCGC00015264-03|NCGC00015264-04|NCGC00015264-05|NCGC00015264-06|NCGC00015264-07|NCGC00015264-09|NCGC00015264-10|NCGC00015264-13|NCGC00015264-25|NCGC00024355-02|NCGC00024355-04|NCGC00024355-05|CLOMIPRAMINE [EMA EPAR VETERINARY]|DA-51968|SBI-0050295.P003|AB00053695|CS-0012495|NS00000038|C06918|C74557|D07727|Q58713|AB00053695-14|AB00053695_15|AB00053695_16|EN300-6733614|303C491|F320311|L000890|3-Chloro-5-[3-(dimethylamino)propyl]-10,f]azepine|5H-Dibenz[b, 3-chloro-10,11-dihydro-N,N-dimethyl-|BRD-K52989797-001-01-1|BRD-K52989797-003-05-8|BRD-K52989797-003-16-5|BRD-K52989797-003-26-4|BRD-K52989797-003-27-2|BRD-K52989797-003-28-0|WLN: T C676 BN & T & J B3N1 & 1 EG|5H-Dibenz[b, 10,11-dihydro-3-chloro-5-[3-(dimethylamino)propyl]-|5H-Dibenz[b, 3-chloro-5-[3-(dimethylamino)propyl]-10,11-dihydro-|3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)propyl-dimethyl-amine;hydrochloride|3-(3-Chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)-N,N-dimethyl-1-propanamine #|5H-Dibenz(b,f)azepine, 3-chloro-5-(3-(dimethylamino)propyl)-10,11-dihydro- (8CI)|N-[3-(3-chloro-10,11-dihydro-5H-dibenzo[b,f]azepin-5-yl)propyl]-N,N-dimethylamine|(3-{5-chloro-2-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,12,14-hexaen-2-yl}propyl)dimethylamine|3-(2-chloranyl-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-propan-1-amine;hydrochloride|3-(2-chloro-5,6-dihydrobenzo[b][1]benzazepin-11-yl)-N,N-dimethyl-1-propanamine;hydrochloride"
MARDEPODECT,11581936,,"InChI=1S/C25H20N4O/c1-29-16-23(18-12-14-26-15-13-18)25(28-29)20-7-10-22(11-8-20)30-17-21-9-6-19-4-2-3-5-24(19)27-21/h2-16H,17H2,1H3",AZEXWHKOMMASPA-UHFFFAOYSA-N,C25H20N4O,392.5,2-[[4-(1-methyl-4-pyridin-4-ylpyrazol-3-yl)phenoxy]methyl]quinoline,"((11)C)MP-10|2-((4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy)methyl)quinoline|2-{[4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxy]methyl}quinoline|RefChem:810610|2-((4-(1-((11)C)methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)-quinoline|Mardepodect|PF-2545920|898562-94-2|1292799-56-4|MP-10|PF-02545920|2-[[4-(1-methyl-4-pyridin-4-ylpyrazol-3-yl)phenoxy]methyl]quinoline|2-((4-(1-Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl)quinoline|Mardepodect [USAN]|PF 2545920|R9Y8EY0G42|Quinoline, 2-[[4-[1-methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]-|[11C]MP 10|PF2545920|2-[(4-(1-Methyl-4-(pyridin-4-yl)-1H-pyrazol-3-yl)phenoxy)methyl]quinoline|Quinoline, 2-((4-(1-methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl)phenoxy)methyl)-|PF-2545920 hydrochloride|2-(4-(1-methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)phenoxymethyl)quinoline|MP-10 compound|UNII-R9Y8EY0G42|(11C)MP-10 cpd|PF9|MFCD09743765|MFCD28144518|Mardepodect free base|3hr1|substituted pyrazole, 9|MARDEPODECT [INN]|Mardepodect (USAN/INN)|PF-0254920|MARDEPODECT [WHO-DD]|MLS006011117|PDE10A-IN-4|CHEMBL562318|GTPL9617|orb1307898|SCHEMBL1414700|SCHEMBL29496270|BDBM31592|EX-A949|AZEXWHKOMMASPA-UHFFFAOYSA-N|DTXSID001025873|HMS3750K09|HMS3884H14|BCP05602|BCP23364|EX-A2373|YKB56294|s2687|2-(4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl)quinoline|AKOS022179845|CCG-268557|CS-0501|DB08387|pyrazole 9 [PMID: 19630403]|SB16688|NCGC00346630-01|NCGC00346630-02|NCGC00346630-05|AC-32620|AC-36046|HY-50098|MS-26564|SMR004702898|BCP0726000246|DS-015882|CS-0081564|NS00072162|PF-2545920(MP-10)|SW222234-1|PF-2545920(MP-10)?|D11171|Q7119048|BRD-K31519811-001-01-4|BRD-K31519811-001-02-2|PF 2545920;PF2545920;PF-2545920|2-[[4-[1-Methyl-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]quinoline|2-[[4-[1-methyl-4-(4-pyridyl)pyrazol-3-yl]phenoxy]methyl]quinoline|2-[4-(1-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline|2-[4-(1-Methyl-4-pyridin4-yl-1H-pyrazol-3-yl)-phenoxymethyl]-quinoline|2-[[4-[1-(Methyl-11C)-4-(4-pyridinyl)-1H-pyrazol-3-yl]phenoxy]methyl]quinoline"
SSR180711,9797360,,"InChI=1S/C14H17BrN2O2/c15-11-1-3-13(4-2-11)19-14(18)17-10-9-16-7-5-12(17)6-8-16/h1-4,12H,5-10H2",RXLOZRCLQMJJLC-UHFFFAOYSA-N,C14H17BrN2O2,325.20,"(4-bromophenyl) 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate","SSR180711|J2.849.107G|QF4P1U1666|SSR-180711|SSR-180,711|RefChem:185228|298198-52-4|4-Bromophenyl 1,4-diazabicyclo(3.2.2)nonane-4-carboxylate|UNII-QF4P1U1666|(4-bromophenyl) 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate|1,4-Diazabicyclo[3.2.2]nonane-4-carboxylic acid, 4-bromophenyl ester|CHEMBL559478|DTXSID2047359|1,4-Diazabicyclo(3.2.2)nonane-4-carboxylic acid, 4-bromophenyl ester|4-bromophenyl 1,4-diazabicyclo[3.2.2]nonane-4-carboxylate|orb2276784|SCHEMBL1427769|DTXCID0027359|RXLOZRCLQMJJLC-UHFFFAOYSA-N|SSR180711C|Tox21_300241|1,4-diazabicyclo(.2.2)nonane-4-carboxylic acid, 4-bromophenyl ester|1,4-Diazabicyclo[3.2.2]nonane-4-carboxylic acid 4-bromophenyl ester|BDBM50296742|NCGC00247961-01|NCGC00254110-01|CAS-298198-52-4|NS00015634|Q27287229|1,4-diazabicyclo[3.2.2]nonane-(4-bromo)-phenyl carbamate|1,4-Diaza-bicyclo[3.2.2]nonane-4-carboxylic acid 4-bromo-phenyl ester|1,4-diazabicyclo(3,2,2)nonane-4-carboxylic acid 4-bromophenyl ester"
AZD0328,9794392,,"InChI=1S/C13H16N2O/c1-2-10-8-13(16-12(10)14-5-1)9-15-6-3-11(13)4-7-15/h1-2,5,11H,3-4,6-9H2/t13-/m0/s1",OCKIPDMKGPYYJS-ZDUSSCGKSA-N,C13H16N2O,216.28,"(3R)-spiro[1-azabicyclo[2.2.2]octane-3,2'-3H-furo[2,3-b]pyridine]","AZD0328|AZD 0328|(8R)-spiro(1-azabicyclo(2.2.2)octane-8,2'-3H-furo(5,4-b)pyridine)|(8R)-spiro[1-azabicyclo[2.2.2]octane-8,2'-3H-furo[5,4-b]pyridine]|RefChem:916586|220099-91-2|AZD-0328|(3R)-spiro[1-azabicyclo[2.2.2]octane-3,2'-3H-furo[2,3-b]pyridine]|(2R)-3H-1'-Azaspiro[furo[2,3-b]pyridine-2,3'-bicyclo[2.2.2]octane]|Spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine], (2'R)-|2B218X5QIY|CHEMBL2151437|AR-R23465XX|Spiro(1-azabicyclo(2.2.2)octane-3,2'(3'H)-furo(2,3-b)pyridine), (2'R)-|OCKIPDMKGPYYJS-ZDUSSCGKSA-N|UNII-2B218X5QIY|GTPL7697|orb1698242|SCHEMBL1459640|SCHEMBL29378403|DTXSID40944616|AZD 0328 [WHO-DD]|EX-A9454|BDBM50393243|AKOS027324863|DB12145|HY-116507|CS-0065667|NS00072027|Q17014648|3'H-Spiro[4-azabicyclo[2.2.2]octane-2,2'-furo[2,3-b]pyridine]|Spiro(1-azabicyclo(2.2.2)octane-3,2'(3H)-furo(2,3-b)pyridine)|(R)-(-)-Spiro[1-azabicyclo[2.2.2]octane-3,2' (3'H)-furo[2,3-b]pyridine]|(R)-(-)-Spiro[1-azabicyclo[2.2.2]octane-3,2'(3'H)-furo[2,3-b]pyridine]"
QAV680,11508736,,"InChI=1S/C18H18N2O4S/c1-12-16(10-17(21)22)15-4-3-9-19-18(15)20(12)11-13-5-7-14(8-6-13)25(2,23)24/h3-9H,10-11H2,1-2H3,(H,21,22)",YOPFAMROKXHVCQ-UHFFFAOYSA-N,C18H18N2O4S,358.4,"2-[2-methyl-1-[(4-methylsulfonylphenyl)methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid","NVP-QAV680|872365-16-7|NVP-QAV-680|QAV-690 free acid|QAV690 free acid|QAV-680|QAV680|0E3D72URPD|1H-Pyrrolo(2,3-b)pyridine-3-acetic acid, 2-methyl-1-((4-(methylsulfonyl)phenyl)methyl)-|2-(2-methyl-1-((4-methylsulfonylphenyl)methyl)pyrrolo(5,4-b)pyridin-3-yl)acetic acid|2-[2-methyl-1-[(4-methylsulfonylphenyl)methyl]pyrrolo[5,4-b]pyridin-3-yl]acetic acid|RefChem:930428|2-(1-((4-methanesulfonylphenyl)methyl)-2-methyl-1H-pyrrolo(2,3-b)pyridin-3-yl)acetic acid|2-(2-methyl-1-(4-(methylsulfonyl)benzyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid|CHEMBL2442750|2-[2-methyl-1-[(4-methylsulfonylphenyl)methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid|UNII-0E3D72URPD|NVP-QAV 680|GTPL8996|orb1699788|SCHEMBL1941180|SCHEMBL29376454|GLXC-15692|BCP28134|XJB36516|BDBM50442299|AKOS027422678|CS-3461|DB11658|HY-12284|NS00072085|Q27088492|NVPQAV680; NVP-QAV-680;QAV-680;QAV 680;QAV680"
CARBENOXOLONE,636403,,"InChI=1S/C34H50O7/c1-29(2)23-10-13-34(7)27(32(23,5)12-11-24(29)41-26(38)9-8-25(36)37)22(35)18-20-21-19-31(4,28(39)40)15-14-30(21,3)16-17-33(20,34)6/h18,21,23-24,27H,8-17,19H2,1-7H3,(H,36,37)(H,39,40)/t21-,23-,24-,27+,30+,31-,32-,33+,34+/m0/s1",OBZHEBDUNPOCJG-WBXJDKIVSA-N,C34H50O7,570.8,"(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid","carbenoxolone|Carbenoxolona|5697-56-3|Carbenoxolonum|MM6384NG73|DTXSID4022733|(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(4-hydroxy-4-oxobutanoyl)oxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid|Olean-12-en-29-oic acid, 3-(3-carboxy-1-oxopropoxy)-11-oxo-, (3beta,20beta)-|(2S,4aS,6aR,6aS,6bR,8aR,10S,12aS,14bR)-10-(3-carboxypropanoyloxy)-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1H-picene-2-carboxylic acid|18alpha Carbenoxolone|Carbeneoxolone|Carbenoxalone|RefChem:123513|DTXCID702733|A02BX01|18alpha Glycyrrhetinic Acid 3beta O Hemisuccinate|18alpha-Glycyrrhetinic Acid 3beta-O-Hemisuccinate|3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic Acid|Acid 3beta-O-Hemisuccinate, 18alpha-Glycyrrhetinic|227-174-2|(3beta,20beta)-3-(3-Carboxy-1-oxopropoxy)-11-oxoolean-12-en-29-oic Acid|Glycyrrhetinic Acid Hydrogen Succinate|Carbenoxolone (INN)|CARBENOXOLONE [INN]|Carbenoxolone [INN:BAN]|Carbenoxolonum [INN-Latin]|Carbenoxolona [INN-Spanish]|UNII-MM6384NG73|Olean-12-en-29-oic acid, 3-(3-carboxy-1-oxopropoxy)-11-oxo-, (3.beta.,20.beta.)-|EINECS 227-174-2|Prestwick0_000837|Prestwick1_000837|Prestwick2_000837|Prestwick3_000837|CARBENOXOLONE [MI]|SCHEMBL76013|BSPBio_000793|SPBio_002714|CARBENOXOLONE [WHO-DD]|BPBio1_000873|CHEMBL499915|GTPL4151|orb1299555|3beta-Hydroxy-11-oxoolean-12-en-30-saeure hydogensuccinat|3beta-(3-Carboxypropionyloxy)-11-oxo-olean-12-en-30-saeure|Biogastrone; Bioral; Carbenoxolona|GLXC-21343|3-beta-(3-Carboxypropionyloxy)-11-oxo-olean-12-en-30-oic acid|BCP29160|HY-B1588|BDBM50247012|AKOS015951361|AKOS016036240|DB02329|FC140637|CS-0013487|3beta-O-Succinyl-18-beta-glycyrrhetinic acid|D07615|Q752861|BRD-K12765235-304-03-8|3.beta.-Hydroxy-11-oxoolean-12-en-30-oic acid 3-hemisuccinate|(3beta)-3-[(3-carboxypropanoyl)oxy]-11-oxoolean-12-en-30-oic acid|3.BETA.-HYDROXY-11-OXOOLEAN-12-EN-30-OIC ACID HYDROGEN SUCCINATE|Olean-12-en-30-oic acid, 3-beta-hydroxy-11-oxo-, hydrogen succinate|(3beta,5beta,10alpha,14beta)-3-[(3-carboxypropanoyl)oxy]-11-oxoolean-12-en-29-oic acid|OLEAN-12-EN-29-OIC ACID, 3-(3-CARBOXY-1-OXOPROPOXY)-11-OXO, (3.BETA.,20.BETA.)-"
HARMINE,5280953,,"InChI=1S/C13H12N2O/c1-8-13-11(5-6-14-8)10-4-3-9(16-2)7-12(10)15-13/h3-7,15H,1-2H3",BXNJHAXVSOCGBA-UHFFFAOYSA-N,C13H12N2O,212.25,"7-methoxy-1-methyl-9H-pyrido[3,4-b]indole","HARMINE|442-51-3|7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole|Banisterine|Telepathine|Leucoharmine|Yageine|Yajeine|9H-Pyrido[3,4-b]indole, 7-methoxy-1-methyl-|7-Methoxy-1-methyl-9H-pyrido(3,4-b)indole|1-Methyl-7-methoxy-beta-carboline|9H-Pyrido(3,4-b)indole, 7-methoxy-1-methyl-|4FHH5G48T7|CHEBI:28121|DTXSID30196066|RefChem:145270|DTXCID40118557|207-131-4|7-Methoxy-1-methyl-9H-beta-carboline|Harmin|MFCD00004958|Harmine (Telepathine)|Banisterin|Telepathin|Yagein|Harmin hydrochloride|7-methoxy-1-methylbeta-carboline|Garmin|MLS002153910|HRM|SR-05000001527|SMR001233259|EINECS 207-131-4|BRN 0178813|UNII-4FHH5G48T7|Telepathien|3anr|1,4-Benzenedicarboxylic Acid Mono(phenylmethyl) Ester; Terephthalic Acid Benzyl Ester; Terephthalic Acid Monobenzyl Ester; Monobenzyl 1,4-Benzenedicarboxylate; Monobenzyl Terephthalate; p-(Benzyloxycarbonyl)benzoic Acid|Harmine (Standard)|Harmine, 98%|Spectrum_001128|SpecPlus_000611|HARMINE [MI]|HARMINE [MART.]|Prestwick0_000613|Prestwick1_000613|Prestwick2_000613|Prestwick3_000613|Spectrum2_000568|Spectrum3_000906|Spectrum4_001004|Spectrum5_001914|Oprea1_596686|BSPBio_000546|KBioGR_001467|KBioSS_001608|5-23-12-00237 (Beilstein Handbook Reference)|BIDD:ER0478|BIDD:GT0106|DivK1c_006707|SCHEMBL292955|SPECTRUM1500867|SPBio_000356|SPBio_002765|BPBio1_000602|CHEMBL269538|GTPL9352|HY-N0737AR|MEGxp0_001875|orb1307663|CHEMBL4095474|SCHEMBL29440552|SCHEMBL29941920|ACon0_001194|ACon1_000061|cid_5359389|HY-N0737A|KBio1_001651|KBio2_001608|KBio2_004176|KBio2_006744|KBio3_001852|BDBM100152|GLXC-06328|HMS1921M06|HMS2090H04|HMS3561B11|HMS3650H03|HMS3885E10|HMS5082G19|HMS5202G18|MSK40316|1-Methyl-7-methoxy-beta -carboline|7-Methoxy-1-methyl-9H-?-carboline|CCG-38734|s3868|STK047386|1-Methyl-7-methoxy-.beta.-carboline|AKOS003673313|442-51-3 (FREE BASE)|CS-5325|DB07919|FH23740|SDCCGMLS-0066733.P001|NCGC00016435-01|NCGC00016435-02|NCGC00016435-03|NCGC00016435-04|NCGC00016435-05|NCGC00016435-06|NCGC00016435-07|NCGC00016435-09|NCGC00016435-20|NCGC00094869-01|NCGC00094869-02|NCGC00094869-03|NCGC00094869-04|NCGC00094869-05|NCGC00094869-06|7-Methoxy-1-methyl-9H-beta-carboline #|AC-31456|AS-13970|BP-30211|CAS-343-27-1|ST069315|SY062283|DB-051199|AB00052850|H0001|NS00015429|C06538|H-1200|AB00052850-08|442H513|F047259|Q128381|7-methoxy-1-methyl-9H-beta-carboline;hydrochloride|7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole, 9CI|A1-03319|SR-05000001527-1|SR-05000001527-4|SR-05000001527-5|SR-05000001527-8|BRD-K30984264-001-01-3|BRD-K30984264-001-04-7|BRD-K30984264-001-05-4|BRD-K30984264-003-03-5|BRD-K30984264-003-06-8|7-METHOXY-1-METHYL-9H-PYRIDO[3,4-B]INDOL; HARMINE|7-Methoxy-1-methyl-9H-pyrido[3,4-b]indole;1-Methyl-7-methoxy-b-carboline|122992-92-1"
TINODASERTIB,71766360,,"InChI=1S/C25H20N4O2/c26-15-18-1-3-20(4-2-18)23-16-27-24-10-9-22(17-29(23)24)19-5-7-21(8-6-19)25(30)28-11-13-31-14-12-28/h1-10,16-17H,11-14H2",FWRFPHJSGLYXTD-UHFFFAOYSA-N,C25H20N4O2,408.5,"4-[6-[4-(morpholine-4-carbonyl)phenyl]imidazo[1,2-a]pyridin-3-yl]benzonitrile","ETC-206|1464151-33-4|Tinodasertib|4-(6-(4-(morpholine-4-carbonyl)phenyl)imidazo[1,2-a]pyridin-3-yl)benzonitrile|AUM001|AUM-001|ETC206|MND3WX2R7I|ETC1907206|ETC-206 (AUM 001)|ETC-1907206|4-[6-[4-(morpholine-4-carbonyl)phenyl]imidazo[1,2-a]pyridin-3-yl]benzonitrile|4-{6-[4-(morpholine-4-carbonyl)phenyl]imidazo[1,2-a]pyridin-3-yl}benzonitrile|Benzonitrile, 4-(6-(4-(4-morpholinylcarbonyl)phenyl)imidazo(1,2-a)pyridin-3-yl)-|4-(6-(4-(morpholine-4-carbonyl)phenyl)imidazo(1,2-a)pyridin-3-yl)benzonitrile|tinodasertib [INN]|MFCD31692387|UNII-MND3WX2R7I|RefChem:1100138|orb1308323|CHEMBL4211649|SCHEMBL15288605|GTPL12385|FWRFPHJSGLYXTD-UHFFFAOYSA-N|US9908886, Example 96|BDBM375544|GLXC-15156|BCP30906|ETC-206?|EX-A4504|PIC15133|s6658|AKOS040741712|compound 48 [PMID: 29683667]|DA-53018|MS-27017|HY-112424|CS-0046041|F88611|ETC 206; ETC206;ETC-1907206|4-{6-[4-(morpholin-4-ylcarbonyl)phenyl]imidazo[1,2-a]pyridin-3-yl}benzonitrile|4-{6-[4-(morpholine-4-carbonyl)phenyl]imidazo[1,2- a]pyridin-3-yl}benzonitrile"
TOMIVOSERTIB HYDROCHLORIDE,118598855,,"InChI=1S/C17H20N6O2.ClH/c1-10-7-11(21-13-8-12(18)19-9-20-13)16(25)23-14(10)15(24)22-17(23)5-3-2-4-6-17;/h7-9H,2-6H2,1H3,(H,22,24)(H3,18,19,20,21);1H",WBGPPUUXCGKTSC-UHFFFAOYSA-N,C17H21ClN6O2,376.8,"6-[(6-aminopyrimidin-4-yl)amino]-8-methylspiro[2H-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione;hydrochloride","Tomivosertib hydrochloride|eFT508HCl|EFT-508 hydrochloride|BW3S40K2UM|Tomivosertib hydrochloride [USAN]|UNII-BW3S40K2UM|Tomivosertib hydrochloride (USAN)|Spiro(cyclohexane-1,3'(2'H)-imidazo(1,5-a)pyridine)-1',5'-dione, 6'-((6-amino-4-pyrimidinyl)amino)-8'-methyl-, hydrochloride (1:1)|Spiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione, 6'-[(6-amino-4-pyrimidinyl)amino]-8'-methyl-, hydrochloride (1:1)|6'-((6-AMINOPYRIMIDIN-4-YL)AMINO)-8'-METHYL-2'HSPIRO(CYCLOHEXANE-1,3'-IMIDAZO(1,5-A)PYRIDINE)-1',5'-DIONE HYDROCHLORIDE|RefChem:190375|1849590-02-8|Tomivosertib (hydrochloride)|eFT508 HCl|6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-1'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'(2'H)-dione hydrochloride|6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-1'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'(2'H)-dionehydrochloride|orb1739356|CHEMBL4298140|SCHEMBL17362726|BCP30543|ZYC59002|HY-100022A|SB19774|CS-0018883|D11481"
YOHIMBINE HYDROCHLORIDE,6169,,"InChI=1S/C21H26N2O3.ClH/c1-26-21(25)19-15-10-17-20-14(13-4-2-3-5-16(13)22-20)8-9-23(17)11-12(15)6-7-18(19)24;/h2-5,12,15,17-19,22,24H,6-11H2,1H3;1H/t12-,15-,17-,18-,19+;/m0./s1",PIPZGJSEDRMUAW-VJDCAHTMSA-N,C21H27ClN2O3,390.9,"methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride","YOHIMBINE HYDROCHLORIDE|65-19-0|Yohimbine HCl|NB2E1YP49F|NSC-19509|DTXSID40891272|Prowess plain|Yobine Injection|Hydrochloride, Aphrodine|Hydrochloride, Yohimbine|RefChem:56589|DTXCID601030458|200-600-4|Antagonil|Yohimbe|Aphrodine hydrochloride|Yohimbine monohydrochloride|Yohimbine (Hydrochloride)|Yocon|C21H27ClN2O3|YOHIMBINE CHLORIDE|17-Hydroxyyohimban-16-carboxylic acid methyl ester hydrochloride|MFCD00012674|Yohimbin HCl|CHEMBL537669|methyl (1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride|methyl (1S,15R,18S,19R,20S)-18-hydroxy-3,13-diazapentacyclo[11.8.0.0^{2,10}.0^{4,9}.0^{15,20}]henicosa-2(10),4,6,8-tetraene-19-carboxylate hydrochloride|SMR000058527|Yohimbin hydrochloride [USP]|Yohimbinehydrochloride|Yohimbin hydrochloride|SR-01000597896|EINECS 200-600-4|NSC 19509|UNII-NB2E1YP49F|AI3-60247|SR-01000075297|Yohimbine hydrochloride [USP:BAN]|Prestwick_961|Pausinystalia yohimbe|Yohimbine-Hydrochloride|Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, monohydrochloride, (16alpha,17alpha)-|SCHEMBL33955|MLS001306411|MLS001333983|Yohimbine hydrochloride (USP)|orb1306369|SCHEMBL29354301|HY-N0127R|PIPZGJSEDRMUAW-VJDCAHTMSA-N|HMS1569F10|Yohimbine hydrochloride (Antagonil)|BCP19708|HY-N0127|MSK10428|Tox21_501210|YOHIMBINE HYDROCHLORIDE [MI]|s2373|Yohimbine (Hydrochloride) (Standard)|AKOS015951349|CCG-208327|CS-5238|FY07895|LP01210|YOHIMBINE HYDROCHLORIDE [MART.]|YOHIMBINE HYDROCHLORIDE [VANDF]|17alpha-Hydroxy-20-alpha-yohimban-16-beta-carboxylic acid, methyl ester, hydrochloride|Yohimban-16-alpha-carboxylic acid, 17-alpha-hydroxy-, methyl ester, hydrochloride|Yohimban-16alpha-carboxylic acid, 17alpha-hydroxy-, methyl ester, monohydrochloride|YOHIMBINE HYDROCHLORIDE [USP-RS]|YOHIMBINE HYDROCHLORIDE [WHO-DD]|NCGC00094457-01|NCGC00261895-01|AC-22571|AS-13939|YOHIMBINE HYDROCHLORIDE [GREEN BOOK]|Yohimbine hydrochloride, analytical standard|EU-0101210|NS00078828|SW199050-2|Y0002|YOHIMBINE HYDROCHLORIDE [EP MONOGRAPH]|D06671|Y 3125|YOHIMBINE HYDROCHLORIDE [USP MONOGRAPH]|Yohimbine hydrochloride, >=98% (TLC), powder|012Y674|SR-01000075297-1|SR-01000597896-1|SR-01000597896-4|Q15680050|Yohimbine hydrochloride, European Pharmacopoeia (EP) Reference Standard|Yohimbine hydrochloride, United States Pharmacopeia (USP) Reference Standard|17.ALPHA.-HYDROXY-20-.ALPHA.-YOHIMBAN-16-.BETA.-CARBOXYLIC ACID, METHYL ESTER, HYDROCHLORIDE|methyl(1S,15R,18S,19R,20S)-18-hydroxy-1,3,11,12,14,15,16,17,18,19,20,21-dodecahydroyohimban-19-carboxylate;hydrochloride|Yohimban-16-carboxylic acid, 17-hydroxy-, methyl ester, hydrochloride (1:1), (16alpha,17alpha)-"
EMPAGLIFLOZIN,11949646,,"InChI=1S/C23H27ClO7/c24-18-6-3-14(23-22(28)21(27)20(26)19(11-25)31-23)10-15(18)9-13-1-4-16(5-2-13)30-17-7-8-29-12-17/h1-6,10,17,19-23,25-28H,7-9,11-12H2/t17-,19+,20+,21-,22+,23-/m0/s1",OBWASQILIWPZMG-QZMOQZSNSA-N,C23H27ClO7,450.9,"(2S,3R,4R,5S,6R)-2-[4-chloro-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol","Empagliflozin|864070-44-0|JARDIANCE|BI 10773|BI10773|BI-10773|Empagliflozina|Empagliflozine|HDC1R2M35U|CHEBI:82720|1-chloro-4-(glucopyranos-1-yl)-2-(4-(tetrahydrofuran-3-yloxy)benzyl)benzene|(2S,3R,4R,5S,6R)-2-[4-chloro-3-({4-[(3S)-oxolan-3-yloxy]phenyl}methyl)phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol|DTXSID601026093|(1S)-1,5-anhydro-1-(4-chloro-3-{4-[(3S)-tetrahydrofuran-3-yloxy]benzyl}phenyl)-D-glucitol|GLYXAMBI COMPONENT EMPAGLIFLOZIN|TRIJARDY XR COMPONENT EMPAGLIFLOZIN|(1S)-1,5-anhydro-1-C-{4-chloro-3-((4-{((3S)-oxolan-3-yl)oxy}phenyl)methyl)phenyl}-D-glucitol|D-Glucitol, 1,5-anhydro-1-C-(4-chloro-3-((4-(((3S)-tetrahydro-3-furanyl)oxy)phenyl)methyl)phenyl)-, (1S)-|D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1S)-|Empagliflozinum|(1S)-1,5-anhydro-1-(4-chloro-3-(4-((3S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-D-glucitol|(1S)-1,5-Anhydro-1-C-(4-chloro-3-((4-(((3S)-oxolan-3-yl)oxy)phenyl)methyl)phenyl)-D-glucitol|(2S,3R,4R,5S,6R)-2-(4-chloro-3-((4-((3S)-oxolan-3-yloxy)phenyl)methyl)phenyl)-6-(hydroxymethyl)oxane-3,4,5-triol|RefChem:5790|GlyTouCan:G23483PA|A10BK03|DTXCID901510350|G23483PA|Empagliflozin (BI 10773)|MFCD22566222|(2S,3R,4R,5S,6R)-2-(4-chloro-3-(4-(((S)-tetrahydrofuran-3-yl)oxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol|(1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol|C23H27ClO7|(2S,3R,4R,5S,6R)-2-[4-CHLORO-3-[[4-[(3S)-OXOLAN-3-YL]OXYPHENYL]METHYL]PHENYL]-6-(HYDROXYMETHYL)OXANE-3,4,5-TRIOL|(2S,3R,4R,5S,6R)-2-[4-chloranyl-3-[[4-[(3S)-oxolan-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)oxane-3,4,5-triol|(2S,3R,4R,5S,6R)-2-[4-Chloro-3-[[4-[(3S)-tetrahydrofuran-3-yl]oxyphenyl]methyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol|Empagliflozin [INN]|UNII-HDC1R2M35U|Empagliflozin [USAN:INN]|Jardiance (TN)|7R3|D-Glucitol, 1,5-anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-, (1S)-; (1S)-1,5-Anhydro-1-C-[4-chloro-3-[[4-[[(3S)-tetrahydro-3-furanyl]oxy]phenyl]methyl]phenyl]-D-glucitol; BI 10773; Empagliflozin; Jardiance|Empagliflozin (Standard)|EMPAGLIFLOZIN [MI]|BI-10773;Empagliflozin|EMPAGLIFLOZIN [JAN]|EMPAGLIFLOZIN [USAN]|Empagliflozin (BI10773)|EMPAGLIFLOZIN [VANDF]|SCHEMBL899986|EMPAGLIFLOZIN [WHO-DD]|GTPL4754|orb1307498|CHEMBL2107830|Empagliflozin (JAN/USAN/INN)|SCHEMBL29357727|Empagliflozin  (BI-10773)?|EX-A414|BDBM150162|EMPAGLIFLOZIN [ORANGE BOOK]|MSK15587|BBL104150|HB4638|HY-15409R|s8022|STL557964|US8980829, EMPAGLIFLOZIN|AKOS024464680|CCG-269242|CS-0940|DB09038|DS-9824|FE43026|PB23119|AC-27643|HY-15409|SY046855|SW219120-1|C22194|D10459|EN300-7422890|AU-004/43508285|F799080|Q5373824|BRD-K53765467-001-02-1|Empagliflozin  (BI-10773;BI 10773;BI10773)|Z2235802079|1,5-anhydro-1-{4-chloro-3-[4-(tetrahydro-3-furanyloxy)benzyl]phenyl}hexitol|(2S,3R,4R,5S,6R)-2-(4-Chloro-3-(4-((S)-tetrahydrofuran-3-yloxy)benzyl)phenyl)-6-(hydroxymethyl)tetrahydro-2H-pyran-3,4,5-triol|(2S,3R,4R,5S,6R)-2-[4-Chloro-3-[4-[[(S)-3-tetrahydrofuranyl]oxy]benzyl]phenyl]-6-(hydroxymethyl)tetrahydropyran-3,4,5-triol"
LY-2811376,44251605,,"InChI=1S/C15H14F2N4S/c1-15(2-3-22-14(18)21-15)11-4-10(12(16)5-13(11)17)9-6-19-8-20-7-9/h4-8H,2-3H2,1H3,(H2,18,21)/t15-/m0/s1",MJQMRGWYPNIERM-HNNXBMFYSA-N,C15H14F2N4S,320.4,"(4S)-4-(2,4-difluoro-5-pyrimidin-5-ylphenyl)-4-methyl-5,6-dihydro-1,3-thiazin-2-amine","1194044-20-6|LY2811376|LY-2811376|UR18YJ97SJ|J3.079.793K|4H-1,3-Thiazin-2-amine, 4-[2,4-difluoro-5-(5-pyrimidinyl)phenyl]-5,6-dihydro-4-methyl-, (4S)-|(4S)-4-(2,4-Difluoro-5-(5-pyrimidinyl)phenyl)-5,6-dihydro-4-methyl-4H-1,3-thiazine-2-amine|4H-1,3-Thiazin-2-amine, 4-(2,4-difluoro-5-(5-pyrimidinyl)phenyl)-5,6-dihydro-4-methyl-, (4S)-|RefChem:925039|(S)-4-(2,4-Difluoro-5-(pyrimidin-5-yl)phenyl)-4-methyl-5,6-dihydro-4H-1,3-thiazin-2-amine|LY 2811376|MFCD18074525|CHEMBL2333941|(4s)-4-[2,4-Difluoro-5-(Pyrimidin-5-Yl)phenyl]-4-Methyl-5,6-Dihydro-4h-1,3-Thiazin-2-Amine|C15H14F2N4S|(4S)-4-[2,4-DIFLUORO-5-(PYRIMIDIN-5-YL)PHENYL]-4-METHYL-5,6-DIHYDRO-1,3-THIAZIN-2-AMINE|(4S)-4-(2,4-difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-1,3-thiazin-2-amine|(4S)-4-(2,4-difluoro-5-pyrimidin-5-ylphenyl)-4-methyl-5,6-dihydro-1,3-thiazin-2-amine|MJQMRGWYPNIERM-HNNXBMFYSA-N|UNII-UR18YJ97SJ|MLS006011069|GTPL6936|orb1305231|SCHEMBL1422085|SCHEMBL29774099|DTXSID10658051|EX-A094|LY2811376; BACE inhibitor|HMS3654L20|HMS3884I19|BCP02221|BDBM50012632|s1528|AKOS016003393|BCP9000876|CCG-267708|CS-0987|DB13065|(4S)-4-[2,4-Difluoro-5-(5-pyrimidinyl)phenyl]-5,6-dihydro-4-methyl-4H-1,3-thiazin-2-amine|NCGC00346719-01|NCGC00346719-02|NCGC00346719-08|NCGC00390720-01|AC-32718|AS-31771|FL102501|HY-10472|SMR004702859|NS00072624|SW219874-1|BRD-K94534639-001-02-5|Q27082743|(S)-4-(2,4-Difluoro-5-pyrimidin-5-yl-phenyl)-4-methyl-5,6-dihydro-4H-[1,3]thiazin-2-ylamine|4B2"
LX-7101,56962369,,"InChI=1S/C23H29N7O3/c1-15-12-25-19-18(15)20(27-14-26-19)30-9-7-23(13-24,8-10-30)21(31)28-16-5-4-6-17(11-16)33-22(32)29(2)3/h4-6,11-12,14H,7-10,13,24H2,1-3H3,(H,28,31)(H,25,26,27)",PWPNYABQEOGNNC-UHFFFAOYSA-N,C23H29N7O3,451.5,"[3-[[4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]phenyl] N,N-dimethylcarbamate","LX7101|1192189-69-7|LX-7101|74B3C4ZT96|RefChem:154458|[3-[[4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carbonyl]amino]phenyl] N,N-dimethylcarbamate|CHEMBL3356433|HY-12659|3-(4-(aminomethyl)-1-(5-methyl-7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamido)phenyl dimethylcarbamate|PWPNYABQEOGNNC-UHFFFAOYSA-N|UNII-74B3C4ZT96|orb1707047|SCHEMBL2713449|LX7101 (HCl)|SCHEMBL29375839|SCHEMBL30596532|GLXC-25445|BCP02298|EX-A2288|SXB18969|BDBM50044004|AKOS030526303|CS-5103|LX 7101|SB18903|NCGC00484080-01|MS-28198|BRD-K21038058-001-01-9|CARBAMIC ACID, N,N-DIMETHYL-, 3-(((4-(AMINOMETHYL)-1-(5-METHYL-7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)-4-PIPERIDINYL)CARBONYL)AMINO)PHENYL ESTER"
NELIVAPTAN,9895468,,"InChI=1S/C30H32ClN3O8S/c1-32(2)28(36)24-15-19(35)17-33(24)30(21-8-6-7-9-25(21)41-4)22-14-18(31)10-12-23(22)34(29(30)37)43(38,39)27-13-11-20(40-3)16-26(27)42-5/h6-14,16,19,24,35H,15,17H2,1-5H3/t19-,24+,30+/m1/s1",NJXZWIIMWNEOGJ-WEWKHQNJSA-N,C30H32ClN3O8S,630.1,"(2S,4R)-1-[(3R)-5-chloro-1-(2,4-dimethoxyphenyl)sulfonyl-3-(2-methoxyphenyl)-2-oxoindol-3-yl]-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide","Nelivaptan|439687-69-1|SSR 149415|SSR149415|Nelivaptan [INN]|SR-149415|SSR-149415|(2S,4R)-1-[(3R)-5-chloro-1-(2,4-dimethoxyphenyl)sulfonyl-3-(2-methoxyphenyl)-2-oxoindol-3-yl]-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide|3TY57MQ4OA|SSR-149,415|DTXSID7047358|NELIVAPTAN [WHO-DD]|DTXCID5027358|(2S,4R)-1-((3R)-5-Chloro-1-((2,4-dimethoxybenzene)sulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide|(2S,4R)-1-[(3R)-5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-2,3-dihydro-3-(2-methoxyphenyl)-2-oxo-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide|2-PYRROLIDINECARBOXAMIDE, 1-((3R)-5-CHLORO-1-((2,4-DIMETHOXYPHENYL)SULFONYL)-2,3-DIHYDRO-3-(2-METHOXYPHENYL)-2-OXO-1H-INDOL-3-YL)-4-HYDROXY-N,N-DIMETHYL-, (2S,4R)-|nelivaptanum|(2S,4R)-1-((3R)-5-Chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-2,3-dihydro-3-(2-methoxyphenyl)-2-oxo-1H-indol-3-yl)-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide|(2S,4R)-1-((3R)-5-chloro-1-(2,4-dimethoxybenzenesulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide|(2S,4R)-1-((3R)-5-chloro-1-(2,4-dimethoxyphenyl)sulfonyl-3-(2-methoxyphenyl)-2-oxoindol-3-yl)-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide|(2S,4R)-1-[(3R)-5-chloro-1-(2,4-dimethoxybenzenesulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide|RefChem:832141|(2S,4R)-1-[(R)-5-Chloro-1-(2,4-dimethoxy-benzenesulfonyl)-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-pyrrolidine-2-carboxylic acid dimethylamide|CHEMBL582857|UNII-3TY57MQ4OA|(2S,4R)-1-((R)-5-Chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxoindolin-3-yl)-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide|Nelivaptan?|C30H32ClN3O8S|1-(5-chloro-1-((2,4-dimethoxyphenyl)sulfonyl)-3-(2-methoxyphenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl)-4-hydroxy-N,N-dimethyl-2-pyrrolidinecarboxamide|GTPL2202|orb1699849|SCHEMBL14517029|SCHEMBL29380118|352276-92-7|Tox21_300240|BDBM50299343|MFCD06199090|AKOS040749010|AT33977|DB12643|NCGC00247960-01|NCGC00254222-01|DA-78022|HY-10066|TS-08587|CAS-439687-69-1|CS-0002429|NS00015655|Q6989992|(2S,4R)-1-((R)-5-chloro-1-(2,4-dimethoxyphenylsulfonyl)-3-(2-methoxyphenyl)-2-oxoindolin-3-yl)-4-hydroxy-N,N-dimethylpyrrolidine-2-carboxamide|(2S,4R)-1-[(3R)-5-chloro-1-(2,4-dimethoxyphenyl)sulfonyl-3-(2-methoxyphenyl)-2-oxo-indolin-3-yl]-4-hydroxy-N,N-dimethyl-pyrrolidine-2-carboxamide|(2S,4R)-1-[5-Chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,Ndimethyl-2-pyrrolidine carboxamide"
EDELINONTRINE,135564558,,"InChI=1S/C20H25N7O2/c1-13-10-26(12-17-21-5-2-6-22-17)11-16(13)18-24-19-15(20(28)25-18)9-23-27(19)14-3-7-29-8-4-14/h2,5-6,9,13-14,16H,3-4,7-8,10-12H2,1H3,(H,24,25,28)/t13-,16-/m1/s1",IWXUVYOOUMLUTQ-CZUORRHYSA-N,C20H25N7O2,395.5,"6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(oxan-4-yl)-5H-pyrazolo[3,4-d]pyrimidin-4-one","PF-04447943|1082744-20-4|7N969W8Y4O|6-((3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo(3,4-d)pyrimidin-4-one|DTXSID801025596|4H-Pyrazolo(3,4-d)pyrimidin-4-one, 1,5-dihydro-6-((3S,4S)-4-methyl-1-(2-pyrimidinylmethyl)-3-pyrrolidinyl)-1-(tetrahydro-2H-pyran-4-yl)-|6-[(3s,4s)-4-Methyl-1-(Pyrimidin-2-Ylmethyl)pyrrolidin-3-Yl]-1-(Tetrahydro-2h-Pyran-4-Yl)-1,5-Dihydro-4h-Pyrazolo[3,4-D]pyrimidin-4-One|4H-Pyrazolo[3,4-d]pyrimidin-4-one, 1,5-dihydro-6-[(3S,4S)-4-methyl-1-(2-pyrimidinylmethyl)-3-pyrrolidinyl]-1-(tetrahydro-2H-pyran-4-yl)-|6-((3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one|RefChem:928926|DTXCID001509859|6-((3S,4S)-4-methyl-1-((pyrimidin-2-yl)methyl)pyrrolidin-3-yl)-1-(oxan-4-yl)-1H,4H,5H-pyrazolo(3,4-d)pyrimidin-4-one|Edelinontrine|PF 04447943|MFCD22665724|CHEMBL2179105|PF-4447943|6-[(3S,4S)-4-METHYL-1-(PYRIMIDIN-2-YLMETHYL)PYRROLIDIN-3-YL]-1-(OXAN-4-YL)-5H-PYRAZOLO[3,4-D]PYRIMIDIN-4-ONE|6-((3S,4S)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl)-1-(tetrahydro-2H-pyran-4-yl)-1H-pyrazolo[3,4-d]pyrimidin-4(5H)-one|6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(oxan-4-yl)-2H-pyrazolo[3,4-d]pyrimidin-4-one|Edelinontrina|UNII-7N969W8Y4O|C20H25N7O2|PF4447943|edelinontrine [INN]|CS-0942|Edelinontrine (USAN/INN)|EDELINONTRINE [USAN]|CRD740|orb1706823|SCHEMBL1716847|SCHEMBL20588503|CRD-740|IWXUVYOOUMLUTQ-CZUORRHYSA-N|GLXC-10130|EX-A7959|HTB74420|BDBM50397838|AKOS030238886|AKOS040742392|DB11953|NCGC00379008-02|AS-35203|DA-76755|HY-15441|NS00072900|PF 4447943|PF04447943|D13001|PF-04447943?|BRD-K50031829-001-01-6|Q27268601|6-[(3s,4s)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2h-pyran-4-yl)-1,5-dihydro-4h pyrazolo[3,4-d]pyrimidin-4-one|6-[(3S,4S)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-tetrahydropyran-4-yl-5H-pyrazolo[3,4-d]pyrimidin-4-one|6-{(3S,4S)-4-methyl-1-[(pyrimidin-2-yl)methyl]pyrrolidin-3-yl}-1-(oxan-4-yl)-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one|7RG"
ADENOSINE PHOSPHATE,6083,,"InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",UDMBCSSLTHHNCD-KQYNXXCUSA-N,C10H14N5O7P,347.22,"[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate","5'-adenylic acid|adenosine 5'-monophosphate|61-19-8|Adenosine monophosphate|adenosine phosphate|adenosine 5'-phosphate|5'-AMP|adenylate|Phosphentaside|Adenovite|Cardiomone|Phosaden|Lycedan|Vitamin B8|My-B-Den|Myoston|5'-adenosine monophosphate|Fosfato de adenosina|a-5mp|Phosphate d'adenosine|Adenosini phosphas|Adenosine 5'-(dihydrogen phosphate)|Adenyl|PAdo|adenosine-5'P|Ado5'P|5'-O-phosphonoadenosine|NSC-20264|Adenosine, mono(dihydrogen phosphate) (ester)|A 5MP|[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl dihydrogen phosphate|CHEBI:16027|DTXSID5022560|415SHH325A|{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid|DTXCID002560|NSC20264|adenosina fosfato|(((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy)phosphonic acid|((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methyl dihydrogen phosphate|5' Adenylic Acid|Acid, 2'-Adenylic|Acid, 5'-Adenylic|RefChem:6787|Adenosine 2' Phosphate|Adenosine 3' Phosphate|Adenosine 5' Phosphate|Adenosine 5monophosphate|5'-Phosphate, Adenosine|2' Adenosine Monophosphate|2'-Adenosine Monophosphate|Monophosphate, 2'-Adenosine|Disodium, Adenosine Phosphate|Phosphate Disodium, Adenosine|Dipotassium, Adenosine Phosphate|Phosphate Dipotassium, Adenosine|CHEBI:22256|CHEBI:37096|C01EB10|200-500-0|adenylic acid|Phosphaden|AMP|Adenosine-5'-monophosphate|Ergadenylic acid|Monophosphadenine|Muscle adenylic acid|Muskeladenylsaeure|AMP (nucleotide)|Adenosine-5'-monophosphoric acid|Adenosine 5'-phosphoric acid|Adenosine-5-monophosphoric acid|adenosine-monophosphate|Adenylic acid (VAN)|Adenosine 5'-monophosphoric acid|Muskeladenosin-phosphorsaeure|adenosine-phosphate|AMP (VAN)|A5MP|Adenosini phosphas [INN-Latin]|Fosfato de adenosina [INN-Spanish]|Phosphate d'adenosine [INN-French]|HSDB 3281|5-adenylic acid|MFCD00005750|BRN 0054612|((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl dihydrogen phosphate|Adenosine phosphate [USAN:BAN:INN]|Adenosine 5' monophosphate|CHEMBL752|Adenosine 5-Monophosphate|NCGC00163319-01|NCGC00163319-03|MFCD00149360|[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate|136920-07-5|Adenosine-5-phosphate|Adenosine monophosphate (32P)|122768-03-0|67583-85-1|7gpb|8gpb|CAS-61-19-8|Adenosine phosphate [USAN:INN:BAN]|adenosin-5'-monophosphat|Adenyl (TN)|Adenosine5'-monophosphate|EINECS 200-500-0|NSC 20264|Adenosine Monophosphate (Amp)|UNII-415SHH325A|Muscle adenylate|5'adenylic acid|Adenosine phosphate (USAN/INN)|1pyg|2gsu|5'-adenylate|My-beta-Den|5'-AMP free acid|1ua4|1z6s|Adenosine 5'-phosphorate|Prestwick0_000356|Prestwick1_000356|Prestwick2_000356|Prestwick3_000356|Adenosine 5 -monophosphate|bmse000005|bmse000873|bmse000992|Epitope ID:137353|Adenosine-5-monophosphorate|SCHEMBL5588|Adenosine-5'-monophosphorate|BSPBio_000451|4-26-00-03615 (Beilstein Handbook Reference)|SPBio_002372|BPBio1_000497|GTPL2455|orb1306400|[3h]adenosine 5'-monophosphate|Adenosine phosphate(Vitamin B8)|SCHEMBL18287224|SCHEMBL29350277|5'-ADENYLIC ACID [MI]|BDBM18137|HY-A0181R|5'-ADENYLIC ACID [FCC]|ADENOSINE PHOSPHATE [INN]|MSK6907|[(2R,3S,4R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-2-oxolanyl]methyl dihydrogen phosphate|5-Adenylic acid (sodium hydrate)|Adenosine monophosphate (Standard)|ADENOSINE PHOSPHATE [HSDB]|ADENOSINE PHOSPHATE [USAN]|ADENOSINE PHOSPHATE [VANDF]|7A8E6D15-9136-44C1-88C9-E1A224638E56|ADENOSINE PHOSPHATE [MART.]|HY-A0181|5'-ADENYLIC ACID [USP-RS]|Tox21_112046|ADENOSINE PHOSPHATE [WHO-DD]|s9366|SBB001403|AKOS015833068|AKOS015888563|Tox21_112046_1|CCG-267996|DB00131|NA06318|NCGC00163319-02|AS-11783|BP-58695|SY035647|5 inverted exclamation mark -Adenylic Acid|DB-022416|A0158|CS-0017523|ADENOSINE 5'-(DIHYDROGEN PHOSPHATE).|C00020|D02769|F20323|EN300-1700412|005A750|Adenosine-3(+2')-monophosphoric acid monohydrate*|F434667|F551679|Q318369|Adenosine 5'-monophosphate-Agarose, lyophilized powder|Z2216887941|9H-Purin-6-amine, 9-(5-O-phosphono-.beta.-D-ribofuranosyl)-|9H-purin-6-amine, 9-(5-O-phosphono-beta-D-ribofuranosyl)-|[(2R,3S,4R,5R)-5-adenin-9-yl-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl dihydrogen phosphate;hydrate|53624-78-5|Adenosine 5'-monophosphate-Agarose, lyophilized powder, Contains lactose stabilizers that must be removed prior to use."
MB-05032,11289630,,"InChI=1S/C11H15N2O4PS/c1-6(2)5-8-10(13-11(12)19-8)7-3-4-9(17-7)18(14,15)16/h3-4,6H,5H2,1-2H3,(H2,12,13)(H2,14,15,16)",XJMYIJPPDSZOPN-UHFFFAOYSA-N,C11H15N2O4PS,302.29,"[5-[2-amino-5-(2-methylpropyl)-1,3-thiazol-4-yl]furan-2-yl]phosphonic acid","261365-11-1|MB05032|MB 05032|MB-05032|9379MH4CAL|RefChem:925378|[5-(2-amino-5-isobutyl-1,3-thiazol-4-yl)-2-furyl]phosphonic acid|Phosphonic acid, P-[5-[2-amino-5-(2-methylpropyl)-4-thiazolyl]-2-furanyl]-|C11H15N2O4PS|CHEMBL495498|{5-[2-amino-5-(2-methylpropyl)-1,3-thiazol-4-yl]furan-2-yl}phosphonic acid|P-[5-[2-Amino-5-(2-methylpropyl)-4-thiazolyl]-2-furanyl]phosphonic acid|2-Amino-5-isobutyl-4-(5-PHOSPHONO-2-furanyl)thiazole|(5-(2-Amino-5-isobutyl-1,3-thiazol-4-yl)-2-furyl)phosphonic acid|P-(5-(2-Amino-5-(2-methylpropyl)-4-thiazolyl)-2-furanyl)phosphonic acid|Phosphonic acid, (5-(2-amino-5-(2-methylpropyl)-4-thiazolyl)-2-furanyl)-|[5-[2-amino-5-(2-methylpropyl)-1,3-thiazol-4-yl]furan-2-yl]phosphonic acid|UNII-9379MH4CAL|orb1707009|SCHEMBL2742711|XJMYIJPPDSZOPN-UHFFFAOYSA-N|GLXC-15875|(5-(2-amino-5-isobutylthiazol-4-yl)furan-2-yl)phosphonic acid|BDBM50293594|AKOS015957645|CS-1552|DA-55262|HY-16307|VU0549312-1|EN300-238163|F84965|BRD-K35601925-001-01-9|BRD-K35601925-001-02-7|F9995-0175|[5-(2-amino-5-isobutyl-thiazol-4-yl)-2-furyl]phosphonic acid|5-(2-amino-5-isobutylthiazol-4-yl)furan-2-ylphosphonic acid|[5-[2-amino-5-(2-methylpropyl)-thiazol-4-yl]-furan-2-yl]-phosphonic acid|94D"
DIHYDROTETRABENAZINE,123836,,"InChI=1S/C19H29NO3/c1-12(2)7-14-11-20-6-5-13-8-18(22-3)19(23-4)9-15(13)16(20)10-17(14)21/h8-9,12,14,16-17,21H,5-7,10-11H2,1-4H3",WEQLWGNDNRARGE-UHFFFAOYSA-N,C19H29NO3,319.4,"9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol","dihydrotetrabenazine|3466-75-9|2-Hydroxytetrabenazine|2-Hydroxy-3-isobutyl-9,10-dimethoxy-1,2,3,4,6,7-hexahydro-11bH-benzo(a)quinolizine|TBZOH cpd|RefChem:920258|b-Dihydrotetrabenazine|3-Isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-ol|2H-Benzo[a]quinolizin-2-ol,1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-|862377-29-5|CHEMBL4206824|9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol|(2R,3S,11bS)-3-Isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-ol|(2S,3S,11bS)-9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol|862377-31-9|1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol|[2R-(2a,3b,11bb)]-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol|2H-Benzo[a]quinolizin-2-ol, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-, [2S-(2alpha,3beta,11bbeta)]-; (2S,3S,11bS)-1,3,4,6,7,11b-Hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-2H-benzo[a]quinolizin-2-ol|(-)-beta-Dihydrotetrabenazine;(-)-beta-HTBZ|[3H]dihydrotetrabenazine|[3H]TBZOH|[3H]-TBZOH|(+)-DTBZ;(+)-alpha-Dihydrotetrabenazine; (+)-alpha-DHTBZ|DTXSID90956148|alpha-[O-methyl-3H]dihydrotetrabenazine|Tetrabenazine Impurity 9|SCHEMBL237573|GTPL4766|SCHEMBL24674521|(+/-)-Alpha-dihydrotetrabenazine|CHEBI:174330|(2R,3R,11bR)-3-Isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-ol|(2R,3S,11bR)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol|(2S,3R,11bS)-9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11bH-pyrido[2,1-a]isoquinolin-2-ol|BCP30240|BDBM50459619|AKOS027326401|FH76515|SB18190|SB18191|SB19829|SB19830|SB19831|SB19832|SB19833|SB19834|2H-Benzo[a]quinolizin-2-ol, 1,3,4,6,7,11b-hexahydro-3-isobutyl-9,10-dimethoxy-|DB-323940|HY-141554|Hydroxy Tetrabenazine - Mixture of cis and trans Isomers|2H-Benzo(a)quinolizin-2-ol, 1,3,4,6,7,11b-hexahydro-9,10-dimethoxy-3-(2-methylpropyl)-|3-isobutyl-9,10-dimethoxy-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol|9,10-dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-ol|(2R,3R,11BR)-9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO[2,1-A]ISOQUINOLIN-2-OL|(2R,3R,11BS)-9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO[2,1-A]ISOQUINOLIN-2-OL|(2S,3S,11BS)-9,10-DIMETHOXY-3-(2-METHYLPROPYL)-1H,2H,3H,4H,6H,7H,11BH-PYRIDO[2,1-A]ISOQUINOLIN-2-OL|9,10-Dimethoxy-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-pyrido[2,1-a]isoquinolin-2-ol|9,10-dimethoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-pyrido[2,1-a]isoquinolin-2-ol|NBI98782;NBI 98782;(+)-DTBZ; (+)-(c) paragraph sign-Dihydrotetrabenazine; (+)-(c) paragraph sign-DHTBZ"
FLORBENAZINE,23652686,,"InChI=1S/C21H32FNO3/c1-14(2)9-16-13-23-7-5-15-10-21(26-8-4-6-22)20(25-3)11-17(15)18(23)12-19(16)24/h10-11,14,16,18-19,24H,4-9,12-13H2,1-3H3/t16-,18-,19-/m1/s1",GNKGXQHHUUEYQV-BHIYHBOVSA-N,C21H32FNO3,365.5,"(2R,3R,11bR)-9-(3-fluoropropoxy)-10-methoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol","FLORBENAZINE|(+)-Florbenazine|Florbenazine, (+)-|K5GDY88W5X|937245-42-6|UNII-K5GDY88W5X|2H-Benzo(a)quinolizin-2-ol, 9-(3-fluoropropoxy)-1,3,4,6,7,11b-hexahydro-10-methoxy-3-(2-methylpropyl)-, (2R,3R,11bR)-|RefChem:140728|CHEMBL579217|(2R,3R,11bR)-9-(3-fluoropropoxy)-10-methoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol|SCHEMBL14267523|SCHEMBL29376772|CHEBI:230930|EX-A6636|BDBM50301022|(+)-9-fluoropropyl-dihydrotetrabenazine|H53419|Q27281982|(2R,3R,11bR)-9-(3-luoropropoxy)-10-methoxy-3-(2-methylpropyl)-2,3,4,6,7,11b-hexahydro-1H-benzo[a]quinolizin-2-ol"
PALOSURAN,10173280,,"InChI=1S/C25H30N4O2/c1-19-17-23(21-9-5-6-10-22(21)27-19)28-24(30)26-13-16-29-14-11-25(31,12-15-29)18-20-7-3-2-4-8-20/h2-10,17,31H,11-16,18H2,1H3,(H2,26,27,28,30)",WYJCYXOCHXWTHG-UHFFFAOYSA-N,C25H30N4O2,418.5,1-[2-(4-benzyl-4-hydroxypiperidin-1-yl)ethyl]-3-(2-methylquinolin-4-yl)urea,"Palosuran|540769-28-6|1-(2-(4-Benzyl-4-hydroxypiperidin-1-yl)ethyl)-3-(2-methylquinolin-4-yl)urea|ACT-058362|ULD9ZKE457|DTXSID00202406|1-[2-(4-benzyl-4-hydroxypiperidin-1-yl)ethyl]-3-(2-methylquinolin-4-yl)urea|palosuranum|1-(2-(4-hydroxy-4-(phenylmethyl)piperidin-1-yl)ethyl)-3-(2-methylquinolin-4-yl)urea|1-[2-[4-hydroxy-4-(phenylmethyl)piperidin-1-yl]ethyl]-3-(2-methylquinolin-4-yl)urea|RefChem:169773|DTXCID60124897|ACT058362|1-(2-(4-benzyl-4-hydroxypiperidin-1-yl)ethyl)-3-(2-methylquinolin-4-yl)urea sulfate salt|Palosuran [INN]|ACT058362 (Palosuran)|CHEMBL567303|MFCD07772352|Urea, N-[2-[4-hydroxy-4-(phenylMethyl)-1-piperidinyl]ethyl]-N'-(2-Methyl-4-quinolinyl)-|UNII-ULD9ZKE457|Urea, N-(2-(4-hydroxy-4-(phenylmethyl)-1-piperidinyl)ethyl)-N'-(2-methyl-4-quinolinyl)-|ACT 058362; Palosuran|GTPL3516|orb1705555|SCHEMBL1363480|SCHEMBL29441424|WYJCYXOCHXWTHG-UHFFFAOYSA-N|BCP15786|BDBM50302272|1-(2-(4-Benzyl-4-hydroxypiperidin-1-yl)ethyl-3-(2-methylquinolin-4-yl)urea|AKOS026750332|CS-1722|NCGC00408890-01|AC-35242|DA-76574|HY-10655|MS-27325|BRD-K07682953-001-01-8|Q27088242|1-[2-(4-benzyl-4-hydroxy-1-piperidyl)ethyl]-3-(2-methyl-4-quinolyl)urea|1-[2-(4-Benzyl-4-hydroxy-piperidin-1-yl)-ethyl]-3-(2-methyl-quinolin-4-yl)-urea"
MK-0557,11491176,,"InChI=1S/C22H19FN4O3/c23-17-3-1-2-4-18(17)27-12-8-19(26-27)25-20(28)14-5-9-22(10-6-14)16-13-24-11-7-15(16)21(29)30-22/h1-4,7-8,11-14H,5-6,9-10H2,(H,25,26,28)",RMYZIRFUCOMQRH-UHFFFAOYSA-N,C22H19FN4O3,406.4,"N-[1-(2-fluorophenyl)pyrazol-3-yl]-1'-oxospiro[cyclohexane-4,3'-furo[3,4-c]pyridine]-1-carboxamide","MK-0557|328232-95-7|MK 0557|MK 0557 - Bio-X|MK0557|CHEMBL595573|HVE36P8422|spiro(cyclohexane-1,3'(1'H)-furo(3,4-C)pyridine)-4-carboxamide, N-(1-(2-fluorophenyl)-1h-pyrazol-3-yl)-1'-oxo-, trans-|(1s,4s)-N-(1-(2-fluorophenyl)-1H-pyrazol-3-yl)-1'-oxo-1'H-spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-4-carboxamide|UNII-HVE36P8422|MFCD25976714|SCHEMBL742899|SCHEMBL742900|orb1296077|CHEMBL4591460|SCHEMBL12674643|SCHEMBL13465189|BCP19822|EX-A1270|EX-A1636|BDBM50304300|CS-6367|DB12168|MK-0557;MK 0557|AC-35453|DA-55513|FF158573|HY-15411|MK-0557?|MS-26961|N-[1-(2-fluorophenyl)pyrazol-3-yl]-1'-oxospiro[cyclohexane-4,3'-furo[3,4-c]pyridine]-1-carboxamide|NS00072599|G14265|EN300-19854531|Q27280118|Z3294900677|(1r,4r)-N-[1-(2-fluorophenyl)-1H-pyrazol-3-yl]-1'-oxo-1'H-spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-4-carboxamide|935765-76-7|N-[1-(2-Fluorophenyl) pyrazol- 3- yl] - 1'- oxospiro[cyclohexane - 4, 3'- furo[3, 4- c] pyridine] - 1- carboxamide|Spiro(cyclohexane-1,3'(1'H)-furo(3,4-c)pyridine)-4-carboxamide,  N-(1-(2-fluorophenyl)-1H-pyrazol-3-yl)-3'a,6',7',7'a-tetrahydro-1'-oxo-, (1alpha,4beta)-|trans-N-(1-(2-Fluorophenyl)-1H-pyrazol-3-yl)-1'-oxo-1'H-spiro[cyclohexane-1,3'-furo[3,4-c]pyridine]-4-carboxamide|trans-N-(1-(2-Fluorophenyl)-3-pyrazolyl)-3-oxospiro(6-azaisobenzofuran-1(3H),1'-cyclohexane)-4'-carboxamide|trans-N-[1-(2-fluorophenyl)-3-pyrazolyl]-3-oxospiro[6-azaisobenzofuran-1(3H),1''-cyclohexane]-4''-carboxamide"
TETRAHYDROPALMATINE,72301,,"InChI=1S/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3/t17-/m0/s1",AEQDJSLRWYMAQI-KRWDZBQOSA-N,C21H25NO4,355.4,"(13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline","483-14-7|tetrahydropalmatine|(-)-Tetrahydropalmatine|Gindarine|Hyndarine|Caseanine|(-)-Corydalis B|(-)-rotundine|Tetrahydropalmatine, l-|Tetrahydropalmatine, (-)-|(13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[2,1-b]isoquinoline|CHEBI:16563|3X69CO5I79|5,8,13,13a-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo(a,g)quinolizine|tetrahydropalmitine|(13aS)-2,3,9,10-tetramethoxy-5,8,13,13a-tetrahydro-6H-isoquino[3,2-a]isoquinoline|DTXSID20864207|(13aS)-2,3,9,10-tetramethoxy-5,8,13,13a-tetrahydro-6H-isoquino(3,2-a)isoquinoline|(13aS)-2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino(2,1-b)isoquinoline|Tetrahydropalmatine l-|RefChem:897187|DTXCID10812752|l-Tetrahydropalmatine|(S)-Tetrahydropalmatine|MFCD03265591|(S)-2,3,9,10-Tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[3,2-a]isoquinoline|levo-tetrahydropalmatine|(S)-(-)-tetrahydropalmatine|2,3,9,10-tetramethoxy-13aalpha-berbine|Hyndarin|(-)-Corydalis|Tetrahydropalmatine, dl-|NSC36363|Berbine, 2,3,9,10-tetramethoxy-|(-)-S-Tetrahydropalmatine|UNII-3X69CO5I79|Rotundin hydrate|2,3,9,10-tetramethoxyberbine|13a-alpha-Berbine, 2,3,9,10-tetramethoxy-|(-)-2,3,9,10-Tetramethoxyberbine|(-)-Tetrahydropalmatine;L-Tetrahydropalmatine|Tetrahydropalmatine l-form|(S)-5,8,13,13a-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo(a,g)quinolizine|6H-Dibenzo(a,g)quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, (S)-|SCHEMBL230850|CHEMBL487182|orb1300586|orb1302346|SCHEMBL29363068|SCHEMBL29585919|SCHEMBL29716023|DTXSID701020650|HMS3656M19|HMS3884J17|HY-N0096|TETRAHYDROPALMATINE [WHO-DD]|BDBM50424077|s2437|AKOS000277105|AC-8007|CCG-268100|CS-8092|DB12093|FR27764|FR70825|TETRAHYDROPALMATINE L-FORM [MI]|NCGC00346591-01|219697-24-2|AC-16039|AS-17459|AS-82762|DA-67292|SY108222|(-)-Tetrahydropalmatine, >=98% (HPLC)|NS00071603|SW219613-1|T3311|C02890|483T147|Q7706555|BRD-K35719256-001-02-6|(13aS)-2,3,9,10-Tetramethoxy-5,8,13,13a-tetrahydro-6H-dibenzo[a,g]quinolizine|(S)-2,3,9,10-tetramethoxy-5,8,13,13a-tetrahydro-6H-isoquinolino[3,2-a]isoquinoline|2-(2,3-Dimethoxy-benzyl)-1-ethyl-6,7-dimethoxy-1,2,3,4-tetrahydro-isoquinoline|5,8,13,13a(S)-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo[a,g]quinolizine|5,8,13,13A-TETRAHYDRO-(S)-2,3,9,10-TETRAMETHOXY-6H-DIBENZO(A,G)QUINOLIZINE|6H-dibenzo[a,g]quinolizine, 5,8,13,13a-tetrahydro-2,3,9,10-tetramethoxy-, (13aS)-|InChI=1/C21H25NO4/c1-23-18-6-5-13-9-17-15-11-20(25-3)19(24-2)10-14(15)7-8-22(17)12-16(13)21(18)26-4/h5-6,10-11,17H,7-9,12H2,1-4H3/t17-/m0/s|L-Tetrahydropalmatine hydrate;Gindarine, Caseanine, Corydalis B;2,3,9,10-tetramethoxy-6,8,13,13a-tetrahydro-5H-isoquinolino[3,2-a]is oquinoline hydrate|L-Tetrahydropalmatine;O,O-Dimethyl-N-demethyl-cyclanoline;Gindarine;(13aS)-5,8,13,13a-Tetrahydro-2,3,9,10-tetramethoxy-6H-dibenzo[a, g]quinolizine;L-THP"
PHYSOSTIGMINE SALICYLATE,657348,,"InChI=1S/C15H21N3O2.C7H6O3/c1-15-7-8-17(3)13(15)18(4)12-6-5-10(9-11(12)15)20-14(19)16-2;8-6-4-2-1-3-5(6)7(9)10/h5-6,9,13H,7-8H2,1-4H3,(H,16,19);1-4,8H,(H,9,10)/t13-,15+;/m1./s1",HZOTZTANVBDFOF-PBCQUBLHSA-N,C22H27N3O5,413.5,"[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate;2-hydroxybenzoic acid","Physostigmine salicylate|57-64-7|Isopto Eserine|Physostigmine monosalicylate|NSC-757275|2046ZRO9VU|CHEBI:48883|Physostigmini salicylas|(-)-Physostigmine salicylate|DTXSID80883232|Pyrrolo(2,3-b)indol-5-ol, 1,2,3,3a,8,8a-hexahydro-1,3a,8-trimethyl-, methylcarbamate (ester), (3aS-cis)-, mono(2-hydroxybenzoate)|ANTICHOLIUM|RefChem:56715|DTXCID501022781|200-343-8|Eserine salicylate|Physostigmine (salicylate)|57-64-7 (salicylate)|MLS000028388|SMR000058606|[(3Ar,8bS)-3,4,8b-trimethyl-2,3,3a,4-tetrahydro-1H-pyrrolo[2,3-b]indole-3,4-diium-7-yl] N-methylcarbamate;2-oxidobenzoate|Physostol salicylate|SR-01000075341|UNII-2046ZRO9VU|CCRIS 3405|Physostigmine salicylate [JAN]|Physostigmine, salicylate (1:1)|Antilirium (TN)|AR-44|EINECS 200-343-8|Physostigmine salicylate [USP:JAN]|MFCD00135659|TL-1380|Spectrum_000223|Opera_ID_194|RCRA waste no. P188|SCHEMBL41555|KBioSS_000703|DivK1c_000339|SPECTRUM1500486|CHEMBL338975|orb1310908|SCHEMBL29787035|HMS501A21|HY-B1266R|KBio1_000339|KBio2_000703|KBio2_003271|KBio2_005839|NINDS_000339|HMS1920H12|HMS2091P16|HMS2235G19|Pharmakon1600-01500486|BCP25378|HY-B1266|Physostigmine salicylate (JAN/USP)|CCG-39918|EX-A11396|NSC757275|PHYSOSTIGMINE SALICYLATE [MI]|AKOS037515711|Physostigmine (salicylate) (Standard)|NSC 757275|SDCCGMLS-0002925.P003|IDI1_000339|PHYSOSTIGMINE SALICYLATE [MART.]|PHYSOSTIGMINE SALICYLATE [VANDF]|NCGC00024464-02|PHYSOSTIGMINE SALICYLATE [USP-RS]|PHYSOSTIGMINE SALICYLATE [WHO-DD]|PHYSOSTIGMINE SALICYLATE [WHO-IP]|AC-37462|DA-56832|Eserine salicylate salt, >=97.0% (N)|MS-27151|CS-0013051|NS00078948|PHYSOSTIGMINI SALICYLAS [WHO-IP LATIN]|D02418|PHYSOSTIGMINE SALICYLATE [EP MONOGRAPH]|PHYSOSTIGMINE SALICYLATE [USP MONOGRAPH]|SR-01000075341-3|SR-01000075341-5|SR-01000075341-7|Q27121383|Physostigmine salicylate, European Pharmacopoeia (EP) Reference Standard|Physostigmine salicylate, United States Pharmacopeia (USP) Reference Standard|(3aS,8aR)-1,3a,8-trimethyl-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indol-5-yl methylcarbamate 2-hydroxybenzoate|(3aS,8aR)-1,3a,8-trimethyl-5-(methylcarbamoyloxy)-1,2,3,3a,8,8a-hexahydropyrrolo[2,3-b]indolium salicylate|[(3aR,8bS)-3,4,8b-trimethyl-2,3a-dihydro-1H-pyrrolo[2,3-b]indol-7-yl] N-methylcarbamate;2-hydroxybenzoic acid"
DISULFIRAM,3117,,"InChI=1S/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H3",AUZONCFQVSMFAP-UHFFFAOYSA-N,C10H20N2S4,296.5,"diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate","disulfiram|Tetraethylthiuram disulfide|97-77-8|Antabuse|Bis(diethylthiocarbamoyl) disulfide|Antabus|Alcophobin|Anticol|Esperal|Teturam|TETD|Dicupral|Exhorran|Hoca|Ethyldithiurame|Abstensil|Abstinil|Abstinyl|Antaethyl|Antalcol|Antietanol|Antietil|Antivitium|Tetraetil|Teturamin|Antadix|Antetan|Antetil|Antikol|Aversan|Averzan|Refusal|Ethyl tuads|Ethyl Thiram|Ethyl Tuex|Antiaethan|Contrapot|Disulfuram|Antaenyl|Antaetil|Bonibal|Disetil|Disulfan|Ephorran|Tenurid|Tenutex|Tetidis|Anteyl|Nocbin|Ekagom TEDS|Ethyldithiourame|Ekagom TETDS|Anti-ethyl|Alk-aubs|Soxinol TET|TATD|Tetraethylthiuram disulphide|Espenal|Exhoran|Ekagom DTET|Accel TET|Sanceler TET-G|Tetraethylthiram disulfide|Ro-sulfiram|Tetraethylthiuram|Tuads, ethyl|Sanceler TET|Tetraethylthioperoxydicarbonic diamide|Usaf B-33|Antaethan|Antethyl|Stopaethyl|Tetradin|Thireranide|Tillram|Ethyl Thiudad|Dupon 4472|Nocceler TET|Tetraethylthiuran disulfide|Disulfirame|Disulphuram|Stopethyl|Dupont fungicide 4472|Tetraethylthiram disulphide|Disulfiramum|Disulfiramo|Antivitium (Spain)|Esperal [France]|Tetraethylthiuram sulfide|N,N,N',N'-Tetraethylthiuram disulfide|Abstensyl (Argentina)|Ro-Sulfram-500 (USA)|diethylcarbamothioylsulfanyl N,N-diethylcarbamodithioate|1,1'-Dithiobis(N,N-diethylthioformamide)|Tetraethylthiurium disulfide|Bis(diethylthiocarbamoyl)disulphide|NCI-C02959|Refusal [Netherlands]|NSC-25953|DTXSID1021322|TR3MLJ1UAI|Bis((diethylamino)thioxomethyl) disulfide|Bis((diethylamino)thioxomethyl)disulphide|NSC 25953|N,N-diethyl[(diethylcarbamothioyl)disulfanyl]carbothioamide|CHEBI:4659|ORA102|ORA-102|NSC25953|Thioperoxydicarbonic diamide ([(H2N)C(S)]2S2), tetraethyl-|DTXCID101322|Thioperoxydicarbonic diamide (((H2N)C(S))2S2), tetraethyl-|Esperal (France)|Refusal (Netherlands)|Bis[(diethylamino)thioxomethyl] disulfide|1,1'-Dithiobis[N,N-diethylthioformamide]|N,N-diethyl((diethylcarbamothioyl)disulfanyl)carbothioamide|RefChem:589812|N07BB01|P03AA04|202-607-8|Disulfide, Tetraethylthiuram|Tetraethylthioperoxydicarbonic Diamide, ((H2N)C(S))2S2|Thioscabin|Tiuram|Contralin|Tetradine|Cronetal|Krotenal|Etabus|Ethyl Thiurad|Stopetyl|Thiuranide|Noxal|Thiuram E|Accel TET-R|Anthethyl|Hocakrotenalnci-C02959|Bis(diethylthiocarbamyl) disulfide|Thiuram disulfide, tetraethyl-|Antabuse (TN)|Bis(N,N-diethylthiocarbamoyl) disulfide|Disulfide, bis(diethylthiocarbamoyl)|C10H20N2S4|ENT 27,340|Thioperoxydicarbonic diamide, tetraethyl-|MFCD00009048|NSC 190940|Bis(N,N-diethylthiocarbamoyl)disulphide|N,N,N',N'-Tetraethylthiuram disulphide|Tetraethylthiuram disulfide;TETD|TTS|CHEMBL964|MLS000069818|CAS-97-77-8|NCGC00016000-08|NCGC00016000-13|SMR000059171|1,1',1'',1'''-[disulfanediylbis(carbonothioylnitrilo)]tetraethane|Ancazide ET|Akrochem TETD|Perkacit TETD|Ekaland TETD|Perkait TETD|Ethyl Tuads Rodform|Disulfiramum [INN-Latin]|Disulfiramo [INN-Spanish]|CCRIS 582|HSDB 3317|SR-01000076145|UNII-TR3MLJ1UAI|EINECS 202-607-8|AI3-27340|Formamide, 1,1'-dithiobis(N,N-diethylthio-|Thioperoxydicarbonic diamide (((H2N)C(S))2S2), N,N,N',N'-tetraethyl-|Thioperoxydicarbonic diamide ([(H2N)C(S)]2S2), N,N,N',N'-tetraethyl-|Disulfiram [USP:INN:BAN:JAN]|Prestwick_182|Disulfiram (Antabuse)|Disulfiram (Standard)|Spectrum_001010|CPD000059171|Disulfiram (Antabuse)?|DISULFIRAM [MI]|Opera_ID_224|DISULFIRAM [INN]|DISULFIRAM [JAN]|Prestwick0_000097|Prestwick1_000097|Prestwick2_000097|Prestwick3_000097|Spectrum2_001176|Spectrum3_000405|Spectrum4_000228|Spectrum5_001590|DISULFIRAM [HSDB]|DISULFIRAM [IARC]|Lopac-T-1132|1,N-diethylthioformamide]|DISULFIRAM [VANDF]|Formamide, 1,1'-dithiobis(N,N-diethylthio)-|UPCMLD-DP090|EC 202-607-8|T 1132|tetraethyl thiuram disulfide|DISULFIRAM [MART.]|Tetraethyldithiuram disulfide|DISULFIRAM [WHO-DD]|Lopac0_001164|SCHEMBL27213|BSPBio_000054|BSPBio_001930|KBioGR_000895|KBioSS_001490|MLS000758264|MLS001076475|MLS001423963|SPECTRUM1500262|SPBio_001191|SPBio_001993|BPBio1_000060|Disulfiram (JP18/USP/INN)|GTPL7168|orb1310987|DISULFIRAM [EP IMPURITY]|DISULFIRAM [ORANGE BOOK]|UPCMLD-DP090:001|HY-B0240R|KBio2_001490|KBio2_004058|KBio2_006626|KBio3_001150|DISULFIRAM [EP MONOGRAPH]|Thioperoxydicarbonic diamide ((H2N)C(S))2S2, tetraethyl-|DISULFIRAM [USP MONOGRAPH]|HMS1568C16|HMS1920I16|HMS2051M17|HMS2090C18|HMS2091O22|HMS2095C16|HMS2230K06|HMS3263J09|HMS3371B21|HMS3393M17|HMS3655I19|HMS3712C16|HMS3867H13|HMS5079P10|Pharmakon1600-01500262|BCP07331|HY-B0240|bis-(diethyl-thiocarbamyl)-disulfide|Tox21_110280|Tox21_300403|Tox21_400072|Tox21_501164|BDBM50058655|CCG-39549|DL-379|HB1119|N,N',N'-Tetraethylthiuram disulfide|NSC756748|NSC800739|s1680|SBB058706|STL069539|1,1',1'',1'''-{disulfanediylbis[(thioxomethylene)-nitrilo]}tetraethane|AKOS000120201|Tox21_110280_1|AT13284|DB00822|FD22545|HS-0057|LP01164|NC00063|NSC-756748|NSC-800739|SDCCGSBI-0051131.P005|WLN: 2N2 & YUS & S 2|NCGC00016000-01|NCGC00016000-02|NCGC00016000-03|NCGC00016000-04|NCGC00016000-05|NCGC00016000-06|NCGC00016000-07|NCGC00016000-09|NCGC00016000-10|NCGC00016000-11|NCGC00016000-12|NCGC00016000-14|NCGC00016000-15|NCGC00016000-18|NCGC00016000-20|NCGC00016000-29|NCGC00094423-01|NCGC00094423-02|NCGC00094423-03|NCGC00094423-05|NCGC00094423-06|NCGC00094423-07|NCGC00254447-01|NCGC00261849-01|N,N,N'',N''-tetraethylthiuram disulfide|BIS(DIETHYLTHIOCARBAMOYL) DISULPHIDE|Formamide,1'-dithiobis(N,N-diethylthio)-|SBI-0051131.P004|1,1''-dithiobis(N,N-diethylthioformamide)|DB-057683|AB00051976|B0479|EU-0101164|NS00010096|SW196492-4|Tetraethylthiuram disulfide, >=97.0% (S)|EN300-19458|C01692|D00131|S00294|AB00051976-20|AB00051976-21|AB00051976-23|AB00051976_22|AB00051976_25|A845750|F358235|Q409665|SR-01000076145-1|SR-01000076145-5|SR-01000076145-8|BRD-K32744045-001-05-6|BRD-K32744045-001-17-1|BRD-K32744045-001-30-4|BRD-K32744045-001-31-2|Z104473910|Disulfiram, British Pharmacopoeia (BP) Reference Standard|Disulfiram, European Pharmacopoeia (EP) Reference Standard|Disulfiram, United States Pharmacopeia (USP) Reference Standard|(diethylamino){[(diethylamino)thioxomethyl]disulfanyl}methane-1-thione|1,1'',1'''',1''''''-[disulfanediylbis(carbonothioylnitrilo)]tetraethane|Disulfiram, Pharmaceutical Secondary Standard; Certified Reference Material|Tetraethylthioperoxydicarbonic diamide;Bis(diethylthiocarbamoyl) disulfide|N,N-diethylcarbamodithioic acid [[diethylamino(sulfanylidene)methyl]thio] ester|THIOPEROXYDICARBONIC DIAMIDE ((H2N)C(S))(SUB 2) S(SUB 2), TETRAETHYL-|InChI=1/C10H20N2S4/c1-5-11(6-2)9(13)15-16-10(14)12(7-3)8-4/h5-8H2,1-4H|TETRAETHYLTHIOPEROXYDICARBONIC DIAMIDE ((((C(SUB 2)H(SUB 5))(SUB 2)N)C(S))(SUB 2)S(SUB 2))"
ARBUTIN,440936,,"InChI=1S/C12H16O7/c13-5-8-9(15)10(16)11(17)12(19-8)18-7-3-1-6(14)2-4-7/h1-4,8-17H,5H2/t8-,9-,10+,11-,12-/m1/s1",BJRNKVDFDLYUGJ-RMPHRYRLSA-N,C12H16O7,272.25,"(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol","arbutin|497-76-7|Arbutoside|Ursin|Uvasol|beta-Arbutin|p-Hydroxyphenyl beta-D-glucoside|Arbutinum|4-Hydroxyphenyl-beta-D-glucopyranoside|Hydroquinone-O-beta-D-glucopyranoside|Hydroquinone glucose|Hydroquinone-beta-D-glucopyranoside|(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)oxane-3,4,5-triol|hydroquinone O-beta-D-glucopyranoside|DTXSID7040152|C5INA23HXF|CHEBI:18305|NSC-4036|beta-D-Glucopyranoside, 4-hydroxyphenyl|DTXCID5020152|Bright Boost Cream|DRUGGIST Cream|skin brightening cream|HYDRO H|RefChem:28025|bright moisturizing cream|DRUGGIST Whitening Cream|DRUGGIST Brightening cream|Vitamin C Brightening Cream|Brightening Kojic Acid Cream|DRUGGIST Bright Boost Cream|4-hydroxyphenyl-glucopyranoside|Tosowoong Mens Booster Repair Skin|ICEKING Freckle Removing Whitening Masque|Sooryehan Pure-Whitening Essential Starter|ICEKING Whitening Freckle Removing Essence|deep moisture and nourishment whitening cream|Dr Young 2p Brightening UV Sun Block SPF50 PA|ISAKNOX WHITE SYMPHONY BRIGHTENING EMULSION|ICEKING Freckle Removing Whitening Facial Cleanser|207-850-3|p-Arbutin|4-Hydroxyphenyl beta-D-glucopyranoside|p-Hydroxyphenyl beta-D-glucopyranoside|Hydroquinone beta-D-glucopyranoside|MFCD00016915|b-D-Glucopyranoside, 4-hydroxyphenyl|(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)tetrahydro-2H-pyran-3,4,5-triol|4-Hydroxyphenyl-.beta.-D-glucopyranoside|CHEMBL232202|Arbutine|Arbutyne|Ursi|(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-hydroxyphenoxy)tetrahydropyran-3,4,5-triol|Ericolin|NSC 4036|(2R,3S,4S,5R,6S)-2-(hydroxymethyl)-6-(4-oxidanylphenoxy)oxane-3,4,5-triol|CAS-497-76-7|Hydroquinone-glucose|Hydroquinone |A-D-glucopyranoside|SR-05000002157|UNII-C5INA23HXF|CCRIS 9273|-Arbutin|HSDB 7661|NCGC00095599-01|Arbutin (Standard)|EINECS 207-850-3|BRN 0089673|Spectrum_000786|Hydroquinone-D-glucoside|SpecPlus_000314|ARBUTIN [HSDB]|Arbutin, >=98%|ARBUTIN [MI]|ARBUTINUM [HPUS]|ARBUTIN [MART.]|Prestwick3_001026|Spectrum2_000662|Spectrum3_001233|Spectrum4_001474|Spectrum5_000147|Arbutin - Natural origin|ARBUTIN [WHO-DD]|bmse000365|Arbutin - Synthetic origin|Arbutin (Uva, p-Arbutin)|Arbutin, analytical standard|SCHEMBL36351|BSPBio_001211|BSPBio_002706|Hydroquinone-beta-D-glucoside|KBioGR_002047|KBioSS_001266|SPECTRUM300539|5-17-07-00110 (Beilstein Handbook Reference)|MLS002207046|DivK1c_006410|SPBio_000723|BPBio1_001333|MEGxp0_001504|orb1310578|HY-N0192R|KBio1_001354|KBio2_001266|KBio2_003834|KBio2_006402|KBio3_002206|HMS2098M13|HMS3715M13|P-Hydroxyphenyl beta -D-glucoside|HY-N0192|4-Hydroxyphenyl-beta-glucopyranoside|Hydroquinone beta -D-glucopyranoside|Tox21_111509|Tox21_302428|BDBM50219502|CCG-38565|s2263|AKOS015965305|Tox21_111509_1|DB11217|EA01844|EA31688|KS-5252|SDCCGMLS-0066538.P001|P-Hydroxyphenyl beta -D-glucopyranoside|SMP1_000028|NCGC00166076-02|NCGC00166076-03|NCGC00166076-04|NCGC00166076-07|NCGC00166076-09|NCGC00255705-01|AC-20183|beta -D-Glucopyranoside, 4-hydroxyphenyl|beta-D-Glucopyranoside, 4-hydroxyphenyl-|I(2)-D-Glucopyranoside, 4-hydroxyphenyl|SMR001233417|SY051904|A0522|AB00443586|HYDROQUINONE-.BETA.-D-GLUCOPYRANOSIDE|SW199492-2|C06186|4-Hydroxyphenyl b-D-glucopyranoside, 9CI, 8CI|EN300-7388350|497A767|Arbutin, primary pharmaceutical reference standard|F105900|Q416446|SR-05000002157-2|SR-05000002157-4|BRD-K08037784-001-12-6|Arbutin, European Pharmacopoeia (EP) Reference Standard|4E19B706-2013-4401-A1FC-A154DADF42B4|4-Hydroxyphenyl b-D-glucopyranoside;Hydroquinone-b-D-glucoside|(2S,3R,4S,5S,6R)-2-(4-hydroxyphenoxy)-6-methylol-tetrahydropyran-3,4,5-triol|7OQ"
FENTIAZAC,28871,,"InChI=1S/C17H12ClNO2S/c18-13-8-6-11(7-9-13)16-14(10-15(20)21)22-17(19-16)12-4-2-1-3-5-12/h1-9H,10H2,(H,20,21)",JIEKMACRVQTPRC-UHFFFAOYSA-N,C17H12ClNO2S,329.8,"2-[4-(4-chlorophenyl)-2-phenyl-1,3-thiazol-5-yl]acetic acid","FENTIAZAC|18046-21-4|Fentiazaco|Fentiazacum|4-(p-Chlorophenyl)-2-phenyl-5-thiazoleacetic acid|0YHF6E6NLS|2-[4-(4-chlorophenyl)-2-phenyl-1,3-thiazol-5-yl]acetic acid|5-Thiazoleacetic acid, 4-(4-chlorophenyl)-2-phenyl-|NSC-282191|4-(4-Chlorophenyl)-2-phenyl-5-thiazoleacetic acid|DTXSID8023050|WY-21,894|WY-21894|DTXCID803050|2-(4-(4-chlorophenyl)-2-phenyl-1,3-thiazol-5-yl)acetic acid|RefChem:598927|2-phenyl-4-(p-chlorophenyl)thiazol-5-ylacetic acid|M01AB10|M02AA14|241-958-1|Donorest|Flogene|Norvedan|2-(4-(4-chlorophenyl)-2-phenylthiazol-5-yl)acetic acid|BR 700|5-Thiazoleacetic acid, 4-(p-chlorophenyl)-2-phenyl-|MLS003115545|CHEMBL589092|18046-21-4 (free acid)|NCGC00182976-01|NCGC00183868-01|Fentiazacum [INN-Latin]|Fentiazaco [INN-Spanish]|CAS-18046-21-4|SR-05000001476|EINECS 241-958-1|UNII-0YHF6E6NLS|CH 800|NSC 282191|BRN 1083610|WY 21,894|Fentiazac [USAN:INN:BAN:JAN]|FENTIAZAC [INN]|FENTIAZAC [JAN]|FENTIAZAC [MI]|FENTIAZAC [USAN]|FENTIAZAC [MART.]|FENTIAZAC [WHO-DD]|SCHEMBL24355|Fentiazac (JAN/USAN/INN)|orb1700613|CHEBI:94523|JIEKMACRVQTPRC-UHFFFAOYSA-|JIEKMACRVQTPRC-UHFFFAOYSA-N|HMS2089J20|HMS3713O10|Tox21_111788|Tox21_113218|Tox21_113219|BDBM50309254|NSC282191|AKOS027446367|Tox21_111788_1|CCG-220474|DB13217|NCGC00183868-02|SMR001831119|DB-044397|HY-118752|CS-0068397|NS00025937|D01975|G76497|AB01087413-03|Q3742491|SR-05000001476-1|SR-05000001476-2|BRD-K16077845-001-06-1|2-[4-(4-chlorophenyl)-2-phenyl-5-thiazolyl]acetic acid|[4-(4-chlorophenyl)-2-phenyl-1,3-thiazol-5-yl]acetic acid|InChI=1/C17H12ClNO2S/c18-13-8-6-11(7-9-13)16-14(10-15(20)21)22-17(19-16)12-4-2-1-3-5-12/h1-9H,10H2,(H,20,21)"
VESNARINONE,5663,,"InChI=1S/C22H25N3O4/c1-28-19-7-3-16(14-20(19)29-2)22(27)25-11-9-24(10-12-25)17-5-6-18-15(13-17)4-8-21(26)23-18/h3,5-7,13-14H,4,8-12H2,1-2H3,(H,23,26)",ZVNYJIZDIRKMBF-UHFFFAOYSA-N,C22H25N3O4,395.5,"6-[4-(3,4-dimethoxybenzoyl)piperazin-1-yl]-3,4-dihydro-1H-quinolin-2-one","vesnarinone|81840-15-5|Arkin-Z|OPC-8212|Vesnarinona|Arkin|Vesnarinonum|Arkin Z|DRG-0210|5COW40EV8M|DTXSID80231411|1-(3,4-Dimethoxybenzoyl)-4-(1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)piperazine|pieranometazine|6-(4-((3,4-dimethoxyphenyl)carbonyl)piperazin-1-yl)-1,2,3,4-tetrahydroquinolin-2-one|6-{4-[(3,4-dimethoxyphenyl)carbonyl]piperazin-1-yl}-1,2,3,4-tetrahydroquinolin-2-one|RefChem:901829|3,4-dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2-1H-quinolinone|DTXCID80153902|3,4-Dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-pip-erazinyl)-2(1H)-quinolinone|Piperazine, 1-(3,4-dimethoxybenzoyl)-4-(1,2,3,4-tetrahydr-o-2-oxo-6-quinolinyl)|6-[4-(3,4-dimethoxybenzoyl)piperazin-1-yl]-3,4-dihydro-1H-quinolin-2-one|6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-3,4-dihydro-2(1h)-quinolinone|MFCD00867124|6-(4-(3,4-dimethoxybenzoyl)piperazin-1-yl)-3,4-dihydroquinolin-2(1H)-one|CHEMBL17423|Piteranometozine|Piperazine, 1-(3,4-dimethoxybenzoyl)-4-(1,2,3,4-tetrahydro-2-oxo-6-quinolinyl)-|Vesnarinonum [Latin]|Vesnarinona [Spanish]|Vesnarinone [USAN:INN:JAN]|CCRIS 1451|OPC 8212|UNII-5COW40EV8M|BRN 5644229|Arkin (TN)|Arkin Z (TN)|VESNARINONE [MI]|1-(1,2,3,4-Tetrahydro-2-oxo-6-quinolyl)-4-veratroylpiperazine|6-(4-(3,4-Dimethoxybenzoyl)-1-piperazinyl)-3,4-dihydro-2(1H)-|VESNARINONE [INN]|VESNARINONE [JAN]|VESNARINONE [USAN]|Vesnarinone(OPC8212)?|3,4-Dihydro-6-(4-(3,4-dimethoxybenzoyl)-1-piperazinyl)-2(1H)-quinolinone|VESNARINONE [VANDF]|VESNARINONE [MART.]|SCHEMBL50993|VESNARINONE [WHO-DD]|Vesnarinone (JAN/USAN/INN)|orb1304177|SCHEMBL29402965|CHEBI:31237|EX-A718|GLXC-03078|BCP15943|BDBM50016980|OPC-8212; Piteranometozine; Arkin|6-(4-(3,4-Dimethoxybenzoyl)-1-piperazinyl)-3,4-dihydro-2(1H)-quinolone|AKOS027475338|CS-5387|DB12082|NCGC00510509-02|HY-15297|MS-26657|DB-056556|NS00069189|OPC 8212;OPC-8212;OPC8212|D01690|Q7923264|BRD-K13414800-001-01-3|6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-3,4-dihydrocarbostyril|[4-(3,4-Dihydro-quinolin-6-yl)-piperazin-1-yl]-(3,4-dimethoxy-phenyl)-methanone|3,4-Dihydro-6-[4-(3,4-dimethoxybenzoyl)-1-piperazinyl]-2-(1H)-quinolinone|6-[4-(3,4-Dimethoxy-benzoyl)-piperazin-1-yl]-3,4-dihydro-1H-quinolin-2-one|6-[4-(3,4-Dimethoxy-benzoyl)-piperazin-1-yl]-3,4-dihydro-1H-quinolin-2-one(OPC-8212)"
NELOTANSERIN,11683556,,"InChI=1S/C18H15BrF2N4O2/c1-25-17(13(19)9-22-25)12-8-11(4-6-16(12)27-2)23-18(26)24-15-5-3-10(20)7-14(15)21/h3-9H,1-2H3,(H2,23,24,26)",COSPVUFTLGQDQL-UHFFFAOYSA-N,C18H15BrF2N4O2,437.2,"1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea","NELOTANSERIN|839713-36-9|1-[3-(4-BROMO-1-METHYL-1H-PYRAZOL-5-YL)-4-METHOXYPHENYL]-3-(2,4-DIFLUOROPHENYL)UREA|APD125|APD-125|Nelotanserina|Nelotanserine|4ZA73QEW2P|1-(3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl)-3-(2,4-difluorophenyl)urea|DTXSID40232868|UREA, N-(3-(4-BROMO-1-METHYL-1H-PYRAZOL-5-YL)-4-METHOXYPHENYL)-N'-(2,4-DIFLUOROPHENYL)-|nelotanserinum|RefChem:832142|DTXCID70155359|3-(3-(4-bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl)-1-(2,4-difluorophenyl)urea|N-(3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl)-N'-(2,4-difluorophenyl)urea|1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea|1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea|MFCD16619341|CHEMBL598172|Nelotanserin [USAN:INN]|UNII-4ZA73QEW2P|C18H15BrF2N4O2|APD125(Nelotanserin)?|Nelotanserin (USAN/INN)|NELOTANSERIN [INN]|NELOTANSERIN [USAN]|1-[3-(4-bromo-2-methyl-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluorophenyl)urea|orb1299895|SCHEMBL2345325|SCHEMBL29456962|SCHEMBL29573017|APD 125|CHEBI:177438|COSPVUFTLGQDQL-UHFFFAOYSA-N|BCP24992|EX-A3147|BDBM50324541|AKOS027255058|CS-5984|DB12555|SB19023|N-[3-(4-bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-N'-(2,4-difluorophenyl)-Urea|AS-30117|FB101032|HY-10559|DB-311641|NS00072232|D09645|713B369|Q6990276|1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)-urea|1-[3-(4-Bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea|1-[3-(4-bromo-2-methylpyrazol-3-yl)-4-methoxyphenyl]-3-(2,4-diluorophenyl)urea|1-(3-(4-BROMO-2-METHYL-2H-PYRAZOL-3-YL)-4-METHOXYPHENYL)-3-(2,4- DIFLUOROPHENYL)UREA|Nelotanserin; 1-[3-(4-Bromo-1-methyl-1H-pyrazol-5-yl)-4-methoxyphenyl]-3-(2,4-difluorophenyl)urea"
AMITIFADINE HYDROCHLORIDE,11680542,,"InChI=1S/C11H11Cl2N.ClH/c12-9-2-1-7(3-10(9)13)11-4-8(11)5-14-6-11;/h1-3,8,14H,4-6H2;1H/t8-,11+;/m1./s1",KAGBHVBIOJBGBD-NINOIYOQSA-N,C11H12Cl3N,264.6,"(1R,5S)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane;hydrochloride","DTXSID801006647|3-Azabicyclo(3.1.0)hexane, 1-(3,4-dichlorophenyl)-, hydrochloride|3-Azabicyclo[3.1.0]hexane, 1-(3,4-dichlorophenyl)-, hydrochloride|RefChem:497832|DTXCID701514013|662-650-7|86215-36-3|AMITIFADINE HYDROCHLORIDE|410074-74-7|Amitifadine (hydrochloride)|Amitifadine HCl|DOV 21947 hydrochloride|Amitifadine hydrochloride [USAN]|EB-1010 hydrochloride|DOV-21947 hydrochloride|(1R,5S)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane;hydrochloride|R01R720TVG|(+/-)-Amitifadine hydrochloride|Amitifadine hydrochloride (USAN)|DOV-21,947 HYDROCHLORIDE|06S4712H0T|410074-74-7 (HCl)|3-Azabicyclo(3.1.0)hexane, 1-(3,4-dichlorophenyl)-, hydrochloride (1:1)|(1R,5S)-1-(3,4-DICHLOROPHENYL)-3-AZABICYCLO[3.1.0]HEXANE HYDROCHLORIDE|3-Azabicyclo(3.1.0)hexane, 1-(3,4-dichlorophenyl)-, (1R,5S)- hydrochloride|3-Azabicyclo(3.1.0)hexane, 1-(3,4-dichlorophenyl)-, hydrochloride (1:1), (+/-)-|3-Azabicyclo(3.1.0)hexane, 1-(3,4-dichlorophenyl)-, hydrochloride (1:1), (1R,5S)-|DOV 21,947|UNII-R01R720TVG|(1R,5S)-1-(3,4-Dichlorophenyl)-3-azabicyclo(3.1.0)hexane hydrochloride|MFCD26405807|orb1705330|SCHEMBL4187671|CHEMBL1818442|SCHEMBL30255318|UNII-06S4712H0T|GLXC-10058|BCP23800|DOV-216303 HYDROCHLORIDE|HY-18332A|DOV-216,303 HYDROCHLORIDE|AKOS030526808|CS-4638|AMITIFADINE HYDROCHLORIDE [WHO-DD]|DA-70807|MS-23741|D10089|F85233|3-AZABICYCLO(3.1.0)HEXANE, 1-(3,4-DICHLOROPHENYL)-, HYDROCHLORIDE, (1R,5S)-"
GEDATOLISIB,44516953,,"InChI=1S/C32H41N9O4/c1-38(2)27-11-13-39(14-12-27)29(42)24-5-9-26(10-6-24)34-32(43)33-25-7-3-23(4-8-25)28-35-30(40-15-19-44-20-16-40)37-31(36-28)41-17-21-45-22-18-41/h3-10,27H,11-22H2,1-2H3,(H2,33,34,43)",DWZAEMINVBZMHQ-UHFFFAOYSA-N,C32H41N9O4,615.7,"1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea","Gedatolisib|1197160-78-3|PKI-587|PF-05212384|1-(4-(4-(Dimethylamino)piperidine-1-carbonyl)phenyl)-3-(4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl)urea|PKI 587|PKI587|PF 05212384|96265TNH2R|1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea|Urea, N-[4-[[4-(dimethylamino)-1-piperidinyl]carbonyl]phenyl]-N'-[4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl]-|DTXSID40152557|Urea, N-(4-((4-(dimethylamino)-1-piperidinyl)carbonyl)phenyl)-N'-(4-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)phenyl)-|1-(4-((4-(dimethylamino)piperidin-1-yl)carbonyl)phenyl)-3-(4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl)urea|1-[4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl]-3-[4-(4,6-dimorpholino-1,3,5-triazin-2-yl)phenyl]urea|gedatolisibum|1-(4-(4-(dimethylamino)piperidine-1-carbonyl)phenyl)-3-(4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl)urea|1-(4-{[4-(Dimethylamino)piperidin-1-yl]carbonyl}phenyl)-3-[4-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)phenyl]urea|RefChem:922134|DTXCID3075048|1-(4-(4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl)phenyl)-3-(4-(4-(dimethylamino)piperidine-1-carbonyl)phenyl)urea|MFCD16875679|CHEMBL592445|Gedatolisib (PF-05212384, PKI-587)|PKI-587; PF-05212384|PF-05212384 (PKI-587)|Gedatolisib [USAN:INN]|UNII-96265TNH2R|C32H41N9O4|PK 587|PK 1587|Gedatolisib(PKI-587)|GEDATOLISIB [INN]|Gedatolisib (USAN/INN)|GEDATOLISIB [USAN]|Gedatolisib (PKI-587)|Gedatolisib(PKI-587)?|SCHEMBL32393|GEDATOLISIB [WHO-DD]|PF 05212384;Gedatolisib|GTPL7940|orb1306926|EX-A028|DWZAEMINVBZMHQ-UHFFFAOYSA-N|GLXC-06796|HMS3748M11|BCP01986|BDBM50308135|NSC758256|NSC801014|s2628|AKOS005766013|CCG-264662|CS-0449|DB11896|FE-0013|FP65136|NSC-758256|NSC-801014|SB16571|SDCCGSBI-0654417.P001|NCGC00370777-01|NCGC00370777-04|NCGC00370777-09|NCGC00370777-10|AC-31519|HY-10681|NS00072612|PKI-587,PF-05212384|D10635|BRD-K07955840-001-02-3|BRD-K07955840-001-03-1|BRD-K07955840-001-04-9|Q27077788|N-(4-((4-(DIMETHYLAMINO)-1-PIPERIDINYL)CARBONYL)PHENYL)-N'-(4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL)UREA|N-{4-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]phenyl}-N'-{4-[4-(dimethylamino)piperidine-1-carbonyl]phenyl}urea|VL1"
TORCETRAPIB,159325,,"InChI=1S/C26H25F9N2O4/c1-4-18-12-21(19-11-15(24(27,28)29)6-7-20(19)37(18)23(39)41-5-2)36(22(38)40-3)13-14-8-16(25(30,31)32)10-17(9-14)26(33,34)35/h6-11,18,21H,4-5,12-13H2,1-3H3/t18-,21+/m1/s1",CMSGWTNRGKRWGS-NQIIRXRSSA-N,C26H25F9N2O4,600.5,"ethyl (2R,4S)-4-[[3,5-bis(trifluoromethyl)phenyl]methyl-methoxycarbonylamino]-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinoline-1-carboxylate","Torcetrapib|262352-17-0|CP-529414|CP-529,414|(2R,4S)-4-((3,5-Bis-trifluoromethylbenzyl)methoxycarbonylamino)-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester|CHEBI:49203|4N4457MV2U|Ethyl (2R,4S)-4-((3,5-bis(trifluoromethyl)benzyl)(methoxycarbonyl)amino)-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate|DTXSID20180873|ethyl (2R,4S)-4-{[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate|(2R,4S)-4-[(3,5-BIS-TRIFLUOROMETHYLBENZYL)METHOXYCARBONYLAMINO]-2-ETHYL-6-TRIFLUOROMETHYL-3,4-DIHYDRO-2H-QUINOLINE-1-CARBOXYLIC ACID ETHYL ESTER|torcetrapibum|ethyl (2r,4s)-4-[[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino]-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2h)-carboxylate|CP529414|CP529,414|RefChem:898621|CP 529,414|DTXCID60103364|CP 529414|1(2H)-Quinolinecarboxylic acid, 4-[[[3,5-bis(trifluoromethyl)phenyl]methyl](methoxycarbonyl)amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, ethyl ester, (2R,4S)-|MFCD09260777|ethyl (2R,4S)-4-[[3,5-bis(trifluoromethyl)phenyl]methyl-methoxycarbonylamino]-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinoline-1-carboxylate|CHEMBL479527|Torcetrapib [USAN]|(2R,4S)-ethyl 4-((3,5-bis(trifluoromethyl)benzyl)(methoxycarbonyl)amino)-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate|(2R,4S)-Rel-ethyl 4-((3,5-bis(trifluoromethyl)benzyl)(methoxycarbonyl)amino)-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H)-carboxylate|262350-59-4|C26H25F9N2O4|Torcetrapib (USAN/INN)|Torcetrapib [USAN:INN]|UNII-4N4457MV2U|Torcetrapib?|)-carboxylate|TORCETRAPIB [MI]|TORCETRAPIB [INN]|TORCETRAPIB [MART.]|SCHEMBL49081|TORCETRAPIB [WHO-DD]|MLS006010664|Torcetrapib (CP-529414)|orb1305390|SCHEMBL29403162|Torcetrapib, >=98% (HPLC)|EX-A081|GLXC-07255|BDBM50312718|HB0879|s2792|AKOS024458018|CCG-270197|CS-3497|DB06281|NCGC00346703-01|NCGC00346703-03|NCGC00346703-11|1(2H)-Quinolinecarboxylic acid, 4-(((3,5-bis(trifluoromethyl)phenyl)methyl) (methoxycarbonyl)amino)-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-, ethyl ester, (2R,4S)-|AC-35371|AS-16356|ethyl (2R,4S)-4-[[3,5-bis(trifluoromethyl)phenyl]methyl-methoxycarbonyl-amino]-2-ethyl-6-(trifluoromethyl)-3,4-dihydro-2H-quinoline-1-carboxylate|HY-12089|SMR004701649|NS00070398|D06195|SR-01000944945|Q7825530|SR-01000944945-1|BRD-K55675242-001-03-0|(2R, 4S)-4-[(3,5-Bis-trifluoromethyl-benzyl)-methoxycarbonyl-amino]-2-ethyl-6-trifluoromethyl-3,4-dihydro-2H-quinoline-1-carboxylic acid ethyl ester|(2R,4S)-4-[[[3,5-Bis(trifluoromethyl)phenyl]methyl](methoxycarbonyl)amino]-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-1(2H)-quinolinecarboxylic Acid Ethyl Ester; (-)-Torcetrapib; CP 529414;|(2R,4S)-4-{[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H|0RP|1(2H)-Quinolinecarboxylic  acid,  4-(((3,5-bis(trifluoromethyl)phenyl)methyl) (methoxycarbonyl)amino)-2-ethyl-3,4-dihydro-6-(trifluoromethyl)-,   ethyl  ester,  (2R,4S)-|ethyl (2R,4S)-4-{[3,5-bis(trifluoromethyl)benzyl](methoxycarbonyl)amino}-2-ethyl-6-(trifluoromethyl)-3,4-dihydroquinoline-1(2H )-carboxylate"
ANACETRAPIB,11556427,,"InChI=1S/C30H25F10NO3/c1-14(2)22-11-23(25(43-4)12-24(22)31)21-6-5-18(28(32,33)34)9-17(21)13-41-15(3)26(44-27(41)42)16-7-19(29(35,36)37)10-20(8-16)30(38,39)40/h5-12,14-15,26H,13H2,1-4H3/t15-,26-/m0/s1",MZZLGJHLQGUVPN-HAWMADMCSA-N,C30H25F10NO3,637.5,"(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one","Anacetrapib|875446-37-0|MK-0859|MK0859|P7T269PR6S|DTXSID90236452|(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-1,3-oxazolidin-2-one|anacetrapibum|(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((2-(4-fluoro-2-methoxy-5-propan-2-ylphenyl)-5-(trifluoromethyl)phenyl)methyl)-4-methyl-1,3-oxazolidin-2-one|RefChem:558013|DTXCID90158943|(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((4'-fluoro-2'-methoxy-5'-(propan-2-yl)-4-(trifluoromethyl)-(1,1'-biphenyl)-2-yl)methyl)-4-methyl-1,3-oxazolidin-2-one|Anacetrapib (MK-0859)|MFCD16294903|(4s,5r)-5-[3,5-bis(trifluoromethyl)phenyl]-3-({2-[4-fluoro-2-methoxy-5-(propan-2-yl)phenyl]-5-(trifluoromethyl)phenyl}methyl)-4-methyl-1,3-oxazolidin-2-one|(4S,5R)-5-[3,5-Bis(trifluoromethyl)phenyl]-3-[[4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl]-4-methyl-1,3-oxazolidin-2-one|CHEMBL1800807|15a-Hydroxy Testosterone|(4S,5R)-5-(3,5-Bis(trifluoromethyl)phenyl)-3-((4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)methyl)-4-methyloxazolidin-2-one|MK 0859|(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)-[1,1'-biphenyl]-2-yl)methyl)-4-methyloxazolidin-2-one.|Anacetrapib [USAN]|(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-[[2-(4-fluoro-5-isopropyl-2-methoxy-phenyl)-5-(trifluoromethyl)phenyl]methyl]-4-methyl-oxazolidin-2-one|15alpha-Hydroxy Testosterone (1mg/ml in Acetonitrile)|Anacetrapib [USAN:INN]|UNII-P7T269PR6S|(15a,17ss)-15,17-Dihydroxyandrost-4-en-3-one; NSC 60794;|C30H25F10NO3|ANACETRAPIB [MI]|ANACETRAPIB [INN]|ANACETRAPIB [JAN]|Anacetrapib (JAN/USAN)|Anacetrapib(MK0859)?|15?-Hydroxy Testosterone|ANACETRAPIB [MART.]|ANACETRAPIB [WHO-DD]|MLS006010190|SCHEMBL531448|GTPL8400|orb1307084|SCHEMBL29807658|EX-A420|BCPP000402|BCP02374|BDBM50348228|s2748|AKOS025290725|BCP9000299|CCG-270307|CS-0636|DB06630|FA17899|NCGC00346671-01|AC-25517|AS-19552|HY-12090|SMR004701293|NS00072888|D08855|Q4750639|(4S,5R)-5-(3,5-bis(Trifluoromethyl)phenyl)-3-((4'-fluoro-2'-methoxy-5'-(propan-2- yl)-4-(trifluoromethyl)(1,1'-biphenyl)-2-yl)methyl)-4-methyl-1,3-oxazolidin-2-one|(4S,5R)-5-(3,5-BIS(TRIFLUOROMETHYL)PHENYL)-3-((4'-FLUORO-2'-METHOXY-5'-(PROPAN-2-YL)-4-(TRIFLUOROMETHYL)(1,1'-BIPHENYL)-2-YL)METHYL)-4-METHYL-1,3-OXAZOLIDIN-2-ONE|(4S,5R)-5-(3,5-bis(trifluoromethyl)phenyl)-3-((4'-fluoro-5'-isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl)methyl)-4-methyloxazolidin-2-one|(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4'-fluoro-5'isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl}-4-methyl-1,3-oxazolidin-2-one|(4S,5R)-5-[3,5-bis(trifluoromethyl)phenyl]-3-{[4'-fluoro-5'isopropyl-2'-methoxy-4-(trifluoromethyl)biphenyl-2-yl]methyl}4-methyl-1,3-oxazolidin-2-one|2-Oxazolidinone, 5-(3,5-bis(trifluoromethyl)phenyl)-3-((4'-fluoro-2'-methoxy-5'-(1- methylethyl)-4-(trifluoromethyl)(1,1'-biphenyl)-2-yl)methyl)-4-methyl-, (4S,5R)-"
EVACETRAPIB,49836058,,"InChI=1S/C31H36F6N6O2/c1-18-11-19(2)27-25(12-18)26(5-4-10-42(27)16-20-6-8-22(9-7-20)28(44)45)43(29-38-40-41(3)39-29)17-21-13-23(30(32,33)34)15-24(14-21)31(35,36)37/h11-15,20,22,26H,4-10,16-17H2,1-3H3,(H,44,45)/t20?,22?,26-/m0/s1",IHIUGIVXARLYHP-UXNJHFGPSA-N,C31H36F6N6O2,638.6,"4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylic acid","Evacetrapib|1186486-62-3|LY2484595|Evacetrapib (LY2484595)|LY-2484595|Evacetrapib [USAN]|MFCD23105886|LY 2484595|51XWV9K850|Evacetrapib (USAN)|4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylic acid|(1S,4r)-4-(((S)-5-((3,5-bis(trifluoromethyl)benzyl)(2-methyl-2H-tetrazol-5-yl)amino)-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)methyl)cyclohexanecarboxylic acid|4-trans-(((S)-5-((3,5-Bis(trifluoromethyl)benzyl)(2-methyl-2H-tetrazol-5-yl)amino)-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)methyl)cyclohexanecarboxylic acid|C31H36F6N6O2|Evacetrapib [USAN:INN]|UNII-51XWV9K850|EVACETRAPIB [MI]|EVACETRAPIB [INN]|EVACETRAPIB [WHO-DD]|SCHEMBL108367|SCHEMBL108602|SCHEMBL141340|GTPL8401|orb1300926|CHEMBL2017179|Evacetrapib (LY2484595)?|EX-A621|CHEBI:188637|IHIUGIVXARLYHP-SYJKBGLXSA-N|IHIUGIVXARLYHP-UXNJHFGPSA-N|GLXC-07330|HMS3651J12|BDBM50381415|s2925|AKOS025290246|AKOS032947275|CCG-270310|CS-0658|DB11655|FE65020|PB36744|AC-30238|AS-35108|BE300077|DA-63331|HY-13327|Evacetrapib monohydrate - Bio-X trade mark|NS00073643|SW219342-1|D10121|bis(trifluoromethyl)phenyl]methyl}(2-methyl-2H-|Q553129|BRD-K16551357-001-02-4|BRD-K16551357-001-03-2|tetrahydro-1H-1-benzazepin-1-yl]methyl}cyclohexane-1-|(1r,4r)-4-{[(5S)-5-({[3,5-|1,2,3,4-tetrazol-5-yl)amino)-7,9-dimethyl-2,3,4,5-|(1R,4R)-4-(((5S)-5-(((3,5-BIS(TRIFLUOROMETHYL)PHENYL)METHYL)(2-METHYL-2H-TETRAZOL-5-YL)AMINO)-7,9-DIMETHYL-2,3,4,5-TETRAHYDRO-1H-1-BENZAZEPIN-1-YL)METHYL)CYCLOHEXANE-1-CARBOXYLIC ACID|4-[[(5S)-5-[[3,5-bis(trifluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexanecarboxylic acid|4-[[(5S)-5-[[3,5-bis(triluoromethyl)phenyl]methyl-(2-methyltetrazol-5-yl)amino]-7,9-dimethyl-2,3,4,5-tetrahydro-1-benzazepin-1-yl]methyl]cyclohexane-1-carboxylic acid|CYCLOHEXANECARBOXYLIC ACID, 4-(((5S)-5-(((3,5-BIS(TRIFLUOROMETHYL)PHENYL)METHYL((2-METHYL-2H-TETRAZOL-5-YL)AMINO)-2,3,4,5-TETRAHYDRO-7,9-DIMETHYL-1H-1-BENZAZEPIN-1-YL)METHYL)-, TRANS-|Cyclohexanecarboxylic acid, 4-(((5S)-5-(((3,5-bis(trifluoromethyl)phenyl)methyl)(2- methyl-2H-tetrazol-5-yl)amino)-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1- yl)methyl)-, trans-|CYCLOHEXANECARBOXYLIC ACID, 4-(((5S)-5-(((3,5-BIS(TRIFLUOROMETHYL)PHENYL)METHYL)(2-METHYL-2H-TETRAZOL-5-YL)AMINO)-2,3,4,5-TETRAHYDRO-7,9-DIMETHYL-1H-1-BENZAZEPIN-1-YL)METHYL)-, TRANS-|trans-(1S,4r)-4-(((S)-5-((3,5-bis(trifluoromethyl)benzyl)(2-methyl-2H-tetrazol-5-yl)amino)-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzo[b]azepin-1-yl)methyl)cyclohexanecarboxylic acid|Trans-4-(((5S)-5-(((3,5-bis(trifluoromethyl)phenyl)methyl)(2-methyl-2H-tetrazol-5- yl)amino)-7,9-dimethyl-2,3,4,5-tetrahydro-1H-benzazepin-1-yl)methyl) cyclohexanecarboxylic acid|TRANS-4-(((5S)-5-(((3,5-BIS(TRIFLUOROMETHYL)PHENYL)METHYL)(2-METHYL-2H-TETRAZOL-5-YL)AMINO)-7,9-DIMETHYL-2,3,4,5-TETRAHYDRO-1H-BENZAZEPIN-1-YL)METHYL)CYCLOHEXANECARBOXYLIC ACID|Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-b enzazepin-1-yl]methyl]-cyclohexanecarboxylic acid|Trans-4-[[(5S)-5-[[[3,5-bis(trifluoromethyl)phenyl]methyl](2-methyl-2H-tetrazol-5-yl)amino]-2,3,4,5-tetrahydro-7,9-dimethyl-1H-1-benzazepin-1-yl]methyl]-cyclohexanecarboxylic acid"
VS-5584,46912230,,"InChI=1S/C17H22N8O/c1-10(2)25-11(3)21-14-13(12-8-19-16(18)20-9-12)22-17(23-15(14)25)24-4-6-26-7-5-24/h8-10H,4-7H2,1-3H3,(H2,18,19,20)",QYBGBLQCOOISAR-UHFFFAOYSA-N,C17H22N8O,354.4,5-(8-methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine,"1246560-33-7|VS-5584|5-(8-methyl-2-morpholin-4-yl-9-propan-2-ylpurin-6-yl)pyrimidin-2-amine|SB2343|2-Pyrimidinamine, 5-[8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl]-|VS5584|W71J4X250V|2-Pyrimidinamine, 5-(8-methyl-9-(1-methylethyl)-2-(4-morpholinyl)-9H-purin-6-yl)-|SB 2343|5-(8-METHYL-9-(1-METHYLETHYL)-2-(4-MORPHOLINYL)-9H-PURIN-6YL)-2-PYRIMIDINAMINE|RefChem:194645|Vs 5584|5-(9-Isopropyl-8-methyl-2-morpholino-9H-purin-6-yl)pyrimidin-2-amine|VS-5584 (SB2343)|SB-2343|MFCD25372027|CHEMBL3393066|5-[9-Isopropyl-8-methyl-2-(morpholin-4-yl)purin-6-yl]pyrimidin-2-amine|5-[8-Methyl-2-(morpholin-4-yl)-9-(propan-2-yl)-9H-purin-6-yl]pyrimidin-2-amine|UNII-W71J4X250V|C17H22N8O|QYBGBLQCOOISAR-UHFFFAOYSA-N|5-(9-isopropyl-8-methyl-2-morpholin-4-yl-9H-purin-6-yl)-pyrimidin-2-ylamine|SCHEMBL539098|GTPL8382|orb1301070|SCHEMBL29376859|DTXSID10677328|EX-A288|VS 5584 [WHO-DD]|HMS3652B16|BCP08247|BDBM50059635|NSC778810|NSC800991|s7016|AKOS024465057|CCG-268087|CS-1202|DB12986|NSC-778810|NSC-800991|SB16877|NCGC00386370-03|NCGC00386370-06|AC-33121|AS-80075|DA-46738|HY-16585|VS-5584?|NS00073089|SW220201-1|VS-5584 (SB-2343)|BRD-K98795921-001-01-7|Q27089164|Z2235802244|5-(9-isopropyl-8-methyl-2-morpholino-purin-6-yl)pyrimidin-2-amine"
ONALESPIB,11955716,,"InChI=1S/C24H31N3O3/c1-16(2)20-11-21(23(29)12-22(20)28)24(30)27-14-18-5-4-17(10-19(18)15-27)13-26-8-6-25(3)7-9-26/h4-5,10-12,16,28-29H,6-9,13-15H2,1-3H3",IFRGXKKQHBVPCQ-UHFFFAOYSA-N,C24H31N3O3,409.5,"(2,4-dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone","Onalespib|912999-49-6|AT13387|AT-13387|AT 13387|onalespibum|ATI-13387X|Q7Y33N57ZZ|ATI13387X|(2,4-Dihydroxy-5-isopropylphenyl)-(5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl)methanone|CHEBI:140592|DTXSID80238485|Methanone, (1,3-dihydro-5-((4-methyl-1-piperazinyl)methyl)-2H-isoindol-2-yl)(2,4-dihydroxy-5-(1-methylethyl)phenyl)-|4-(5-((4-methylpiperazin-1-yl)methyl)-2,3-dihydro-1H-isoindole-2-carbonyl)-6-(propan-2-yl)benzene-1,3-diol|4-{5-[(4-methylpiperazin-1-yl)methyl]-2,3-dihydro-1H-isoindole-2-carbonyl}-6-(propan-2-yl)benzene-1,3-diol|RefChem:856776|DTXCID00160976|(2,4-Dihydroxy-5-isopropylphenyl)(5-((4-methylpiperazin-1-yl)methyl)isoindolin-2-yl)methanone|Onalespib (AT13387)|OnalespibAT13387,ATI13387X|912999-49-6 (free base)|UNII-Q7Y33N57ZZ|(2,4-Dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone;(2,4-Dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone|Onalespib [USAN:INN]|Onalespib [USAN]|MFCD18633198|OnalespibAT-13387|ONALESPIB [INN]|Onalespib (USAN/INN)|ONALESPIB [WHO-DD]|(2,4-dihydroxy-5-propan-2-ylphenyl)-[5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydroisoindol-2-yl]methanone|MLS006011085|SCHEMBL382780|orb1300903|CHEMBL1214827|SCHEMBL29351356|IFRGXKKQHBVPCQ-UHFFFAOYSA-N|HMS3654O12|BCP03601|EX-A1798|BDBM50005782|NSC749712|NSC763579|s1163|AKOS027338622|BCP9000333|CCG-264682|CS-0969|DB06306|NSC-749712|NSC-763579|SB16645|NCGC00346674-01|NCGC00346674-03|NCGC00346674-05|AC-33014|AS-74503|DA-50762|FA145338|HY-14463|SMR004702873|BCP0726000186|NS00072580|SW218138-2|D10719|BRD-K58435339-001-03-0|BRD-K58435339-001-06-3|Q27287092|(2,4-Dihydroxy-5-isopropyl-phenyl)-[5-(4-methyl-piperazin-1-ylmethyl)-1,3-dihydro-isoindol-2-yl]-methanone|(2,4-Dihydroxy-5-isopropyl-phenyl)-[5-(4-methyl-piperazin-1-ylmethyl)-1,3-dihydro-isoindol-2-yl]methanone|(2,4-dihydroxy-5-isopropyl-phenyl)-[5-[(4-methylpiperazin-1-yl)methyl]isoindolin-2-yl]methanone|(2,4-dihydroxy-5-isopropylphenyl)-[5-(4-methylpiperazin-1-ylmethyl)-1,3-dihydroisoindol-2-yl]methanone, L-lactic acid salt|(2,4-dihydroxy-5-isopropylphenyl){5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydro-2H-isoindol-2-yl}methanone|[2,4-dihydroxy-5-(propan-2-yl)phenyl]{5-[(4-methylpiperazin-1-yl)methyl]-1,3-dihydro-2H-isoindol-2-yl}methanone"
ERLOTINIB HYDROCHLORIDE,176871,,"InChI=1S/C22H23N3O4.ClH/c1-4-16-6-5-7-17(12-16)25-22-18-13-20(28-10-8-26-2)21(29-11-9-27-3)14-19(18)23-15-24-22;/h1,5-7,12-15H,8-11H2,2-3H3,(H,23,24,25);1H",GTTBEUCJPZQMDZ-UHFFFAOYSA-N,C22H24ClN3O4,429.9,"N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride","Erlotinib hydrochloride|183319-69-9|erlotinib HCl|Tarceva|OSI-774|OSI 774|CP 358774|DA87705X9K|CP-358774|CP-358|CP-358,774-01|CHEBI:53509|DTXSID10171412|CP-358774-01|NSC 718781|4-(m-Ethynylanilino)-6,7-bis(2-methoxyethoxy)quinazoline monohydrochloride|NSC718781|4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, monohydrochloride|CP-358,774|HCl, Erlotinib|11C erlotinib|n-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine monohydrochloride|Hydrochloride, Erlotinib|RefChem:57242|OSI774|DTXCID7093903|CP358,774|358774, CP|CP 358,774|358,774, CP|CP358774|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine hydrochloride|Erlotinib HCl (OSI-744)|MFCD07781272|Erlotinib (Hydrochloride)|C22H24ClN3O4|Erlotinib 13C6 HCl|Tarceva (Erlotinib Hydrochloride)|4-Quinazolinamine, N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-, hydrochloride (1:1)|Erlotinib Hydrochloride (Tarceva)|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)quinazolin-4-amine;hydrochloride|NSC-718781|6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride|183319-69-9 (HCl)|6,7-Bis-(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride|[6,7-BIS-(2-METHOXY-ETHOXY)-QUINAZOLIN-4-YL]-(3-ETHYNYL-PHENYL)-AMINE HYDROCHLORIDE|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine Monohydrochloride.|SMR002529980|Erlotinib hydrochloride [USAN]|183319-69-9 pound not183321-74-6|UNII-DA87705X9K|Erlotinib hydrochloride [USAN:INN]|Tarceva (OSI)|Tarceva (TN)|Erlotinib hydrochloride?|Erlotinib(OSI-744)|Erlotinib hydrochloride salt|erlotinib, hydrochloride salt|SCHEMBL18563|MLS003899192|MLS004774139|orb1310677|CHEMBL1079742|SCHEMBL29460839|NSC 718781) HCl|EX-A064|6,7-bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hcl|BCPP000238|HMS5087A15|BCP02600|Erlotinib hydrochloride (JAN/USAN)|ERLOTINIB HYDROCHLORIDE [MI]|AC-400|ERLOTINIB HYDROCHLORIDE [JAN]|HY-12008R|s1023|Erlotinib (Hydrochloride) (Standard)|AKOS015849087|BCP9000658|CCG-269002|CS-0123|ERLOTINIB HYDROCHLORIDE [MART.]|FE10803|KS-1202|PB30965|SB16917|ERLOTINIB HYDROCHLORIDE [USP-RS]|ERLOTINIB HYDROCHLORIDE [WHO-DD]|Ro-50-8231|BE164421|BP-30224|HY-12008|SY007225|(CP358774|DB-011534|Erlotinib hydrochloride - Bio-X trade mark|ERLOTINIB HYDROCHLORIDE [ORANGE BOOK]|NS00076170|D04023|E-4007|EN300-123054|319E699|F036497|Q27124083|F0001-2385|Erlotinib Hydrochloride is known as a EGFR Kinase inhibitor.|Erlotinib Hydrochloride,CP-358774, OSI-774, NSC 718781|[6,7-Bis(2-methoxy-ethoxy)-quinazolin-4-yl]-(3-ethynyl- phenyl)amine hydrochloride|N-(3-ETHENYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE HYDROCHLORIDE|N-(3-Ethynylphenyl)-6,7-bis(1-methoxyethoxy)-4-quinazolinamine hydrochloride|N-(3-ETHYNYLPHENYL)-6,7-BIS(2-METHOXYETHOXY)-4-QUINAZOLINAMINE HYDROCHLORIDE|N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine, monohydrochloride|N-(3-Ethynylphenyl)-6,7-bis(2-methoxyethoxy)-quinazolin-4-amine hydrochloride|Hydrogen chloride - N-(3-ethynylphenyl)-6,7-bis(2-methoxyethoxy)-4-quinazolinamine (1:1:1)|Tarceva hydrochloride; Erlotinib hydrochloride; 6 ,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride; N-(3-Ethyny lphenyl)6,7-bis(2-methoxyethoxy)quinazolin-4-ylamine HCl|Tarceva Hydrochloride;Erlotinib hydrochloride;6,7-Bis(2-methoxyethoxy)-4-(3-ethynylanilino)quinazoline hydrochloride;N-(3-Ethynylphe  nyl)[6,7-bis(2-methoxyethoxy)quinazolin-4-yl]amine HCl"
AZD-8055,25262965,,"InChI=1S/C25H31N5O4/c1-16-14-33-10-8-29(16)24-20-5-6-21(18-4-7-22(32-3)19(12-18)13-31)26-23(20)27-25(28-24)30-9-11-34-15-17(30)2/h4-7,12,16-17,31H,8-11,13-15H2,1-3H3/t16-,17-/m0/s1",KVLFRAWTRWDEDF-IRXDYDNUSA-N,C25H31N5O4,465.5,"[5-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol","AZD8055|AZD 8055|DTXSID001020704|RefChem:560465|DTXCID001493218|MTOR KINASE INHIBITOR AZD8055|1009298-09-2|AZD-8055|(5-(2,4-bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol|[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol|UNII-970JJ37FPW|970JJ37FPW|(5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol|Benzenemethanol, 5-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-|MFCD16660191|CHEMBL1801204|AZ-12600000|(5-(2,4-Bis((S)-3-methylmorpholino)pyrido-[2,3-d]pyrimidin-7-yl)-2-methoxyphenyl)methanol|(5-{2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl}-2-methoxyphenyl)methanol|[5-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol|[5-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy-phenyl]methanol|(5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol.|KVLFRAWTRWDEDF-IRXDYDNUSA-N|MLS006010169|SCHEMBL298416|GTPL7714|orb1307308|SCHEMBL29388315|SCHEMBL29396804|CHEBI:91329|EX-A044|AZD 8055 [WHO-DD]|BCP02171|EX-A1549|BDBM50348452|NSC758871|NSC799351|s1555|AKOS016009126|BCP9000367|CCG-264912|CS-0067|DB12774|FA18068|NSC-758871|NSC-799351|SDCCGSBI-0654384.P001|SS-4787|AC-28424|HY-10422|SMR004701277|NS00072625|SW218287-2|BRD-K69932463-001-02-3|BRD-K69932463-001-10-6|Q27074792|[5-[2,4-bis((3s)-3-methylmorpholin -4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl]methanol|{5-[2,4-bis(3S)(3-methylmorpholin-4-yl)pyrido[2,3-d]pyrimidin-7-yl]-2-methoxyphenyl}methanol|5-[2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxy benzenemethanol|5-[2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-2-methoxybenzenemethanol;[5-[2,4-Bis((3S)-3-methylmorpholin-4-yl    )pyrido[2,3-d]pyrimidin-7-yl]- 2-methoxyphenyl]methanol"
VISTUSERTIB,25262792,,"InChI=1S/C25H30N6O3/c1-16-14-33-11-9-30(16)23-20-7-8-21(18-5-4-6-19(13-18)24(32)26-3)27-22(20)28-25(29-23)31-10-12-34-15-17(31)2/h4-8,13,16-17H,9-12,14-15H2,1-3H3,(H,26,32)/t16-,17-/m0/s1",JUSFANSTBFGBAF-IRXDYDNUSA-N,C25H30N6O3,462.5,"3-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide","1009298-59-2|AZD2014|Vistusertib|AZD-2014|AZD 2014|0BSC3P4H5X|3-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide|Benzamide, 3-[2,4-bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-N-methyl-|DTXSID20143584|Benzamide, 3-(2,4-bis((3S)-3-methyl-4-morpholinyl)pyrido(2,3-d)pyrimidin-7-yl)-N-methyl-|vistusertibum|3-(2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-N-methylbenzamide|RefChem:901994|DTXCID1066075|Vistusertib [INN]|3-(2,4-bis((S)-3-methylmorpholino)pyrido[2,3-d]pyrimidin-7-yl)-N-methylbenzamide|3-[2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido[5,6-e]pyrimidin-7-yl]-N-methylbenzamide|MFCD22628784|Vistusertib (AZD-2014)|Vistusertib [USAN]|C25H30N6O3|vistusertib (AZD2014)|CHEMBL2336325|AZD2014; Vistusertib|3-[2,4-Bis((3S)-3-methyLmorpholin-4-yl)pyrido-[5,6-e]pyrimidin-7-yl]-N-methylbenzamide|3-(2,4-Bis((3S)-3-methylmorpholin-4-yl)pyrido(5,6-e)pyrimidin-7-yl)-N-methylbenzamide|UNII-0BSC3P4H5X|cc-551|3-[2,4-Bis[(S)-3-methylmorpholino]pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide|Osimertinib Impurity 5|Vistusertib (JAN/INN)|VISTUSERTIB [JAN]|Vistusertib [USAN:INN]|VISTUSERTIB [WHO-DD]|MLS006011011|SCHEMBL290672|GTPL7699|orb1306966|SCHEMBL29350053|SCHEMBL29353400|SCHEMBL29397309|EX-A155|BCP05748|JQB29859|BDBM50429701|NSC767189|NSC780879|NSC787289|NSC799345|s2783|AKOS024464879|BCP9000362|CCG-269370|CS-0701|DB11925|NSC-767189|NSC-780879|NSC-787289|NSC-799345|SDCCGSBI-0654471.P001|NCGC00346698-04|NCGC00346698-11|NCGC00346698-12|AC-28425|AS-16302|HY-15247|SMR004702809|SY069673|NS00072855|SW219704-1|D10887|F787558|BRD-K99113996-001-02-0|Q27089147|3-[2,4-Bis-[(3S)-3-methyl-4-morpholinyl]-pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide|3-[2,4-Bis[(3S)-3-methyl-4-morpholinyl]pyrido[2,3-d]pyrimidin-7-yl]-N-methylbenzamide|3-[2,4-bis[(3S)-3-methylmorpholin-4-yl]pyrido[2,3-d]pyrimidin-7-yl]-N-methyl-benzamide"
RG-7603,multiply,multiply,multiply,multiply,multiply,multiply,multiply,multiply
ONATASERTIB,58298316,,"InChI=1S/C21H27N5O3/c1-21(2,28)17-9-4-13(10-22-17)16-11-23-19-20(25-16)26(18(27)12-24-19)14-5-7-15(29-3)8-6-14/h4,9-11,14-15,28H,5-8,12H2,1-3H3,(H,23,24)",UFKLYTOEMRFKAD-UHFFFAOYSA-N,C21H27N5O3,397.5,"3-[6-(2-hydroxypropan-2-yl)pyridin-3-yl]-5-(4-methoxycyclohexyl)-7,8-dihydropyrazino[2,3-b]pyrazin-6-one","cc-223|CC223|compound 37 [PMID: 26083478]|CC 223|1402453-64-8|compound 37 (PMID: 26083478)|7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((1r,4r)-4-methoxycyclohexyl)-1H,2H,3H,4H-pyrazino(2,3-b)(1,4)diazin-2-one|7-[6-(2-hydroxypropan-2-yl)pyridin-3-yl]-1-[(1r,4r)-4-methoxycyclohexyl]-1H,2H,3H,4H-pyrazino[2,3-b][1,4]diazin-2-one|RefChem:200092|onatasertib (proposed INN)|CC0482223|7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-(4-methoxycyclohexyl)-3,4-dihydropyrazino(2,3-b)pyrazin-2(1H)-one|1228013-30-6|Onatasertib|Onatasertib [USAN]|ATG-008|MFCD28976054|ATG008|I8RA3543SY|7-(6-(2-hydroxypropan-2-yl)pyridin-3-yl)-1-((1r,4r)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one|7-(6-(2-Hydroxypropan-2-yl)pyridin-3-yl)-1-(trans-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one|Pyrazino[2,3-b]pyrazin-2(1H)-one, 3,4-dihydro-7-[6-(1-hydroxy-1-methylethyl)-3-pyridinyl]-1-(trans-4-methoxycyclohexyl)-|CHEMBL3586404|CHEMBL5439799|Onatasertib (USAN)|3-[6-(2-hydroxypropan-2-yl)pyridin-3-yl]-5-(4-methoxycyclohexyl)-7,8-dihydropyrazino[2,3-b]pyrazin-6-one|Pyrazino(2,3-b)pyrazin-2(1H)-one, 3,4-dihydro-7-(6-(1-hydroxy-1-methylethyl)-3-pyridinyl)-1-(trans-4-methoxycyclohexyl)-|7-(6-(2-Hydroxypropan-2-yl)pyridin-3-yl)-1-(trans-4-methoxycyclohexyl)-3,4-dihydropyrazino(2,3-b)pyrazin-2(1H)-one|7-[6-(2-Hydroxypropan-2-yl)pyridin-3-yl]-1-(trans-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one|ONATASERTIB [INN]|Onatasertib (CC 223)|UNII-I8RA3543SY|ONATASERTIB [WHO-DD]|SCHEMBL138069|SCHEMBL153700|SCHEMBL800493|GTPL8914|orb1304293|SCHEMBL16272828|SCHEMBL29350044|SCHEMBL29352207|EX-A781|UFKLYTOEMRFKAD-SHTZXODSSA-N|BCP09953|EX-A8313|BDBM50092783|BDBM50623162|NSC792971|NSC800982|s7886|WHO 11237|AKOS030526335|CC-223?|CCG-268624|CS-4560|DB12570|NSC-792971|NSC-800982|SB19154|AC-31533|AS-35243|HY-16956|NS00073369|D11663|BRD-K88737571-001-01-4|Q27075761|3,4-DIHYDRO-7-(6-(1-HYDROXY-1-METHYLETHYL)-3-PYRIDINYL)-1-(TRANS-4-METHOXYCYCLOHEXYL)PYRAZINO(2,3-B)PYRAZIN-2(1H)-ONE|3-[6-(1-hydroxy-1-methyl-ethyl)-3-pyridyl]-5-(4-methoxycyclohexyl)-7,8-dihydropyrazino[2,3-b]pyrazin-6-one|7-(6-(2-Hydroxypropan-2-yl)pyridin-3-yl)-1-((trans)-4-methoxycyclohexyl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one"
MAVORIXAFOR,11256587,,"InChI=1S/C21H27N5/c22-12-3-4-14-26(15-20-24-17-9-1-2-10-18(17)25-20)19-11-5-7-16-8-6-13-23-21(16)19/h1-2,6,8-10,13,19H,3-5,7,11-12,14-15,22H2,(H,24,25)/t19-/m0/s1",WVLHHLRVNDMIAR-IBGZPJMESA-N,C21H27N5,349.5,"N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine","558447-26-0|AMD-070|Mavorixafor|(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine|AMD 070|AMD070|AMD11070|AMD-11070|X4p001|0G9LGB5O2W|XOLREMDI|X4P-001|Cxcr4 inhibitor x4p-001|X 4P-001|AMD 11070|N-(1H-benzimidazol-2-ylmethyl)-N-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine|N'-((1H-benzo(d)imidazol-2-yl)methyl)-N'-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine|N1-(1H-BENZIMIDAZOL-2-YLMETHYL)-N1-((S)-5,6,7,8-TETRAHYDROQUINOLIN-8-YL)-BUTANE-1,4-DIAMINE|mavorixaforum|(S)-N1-((1H-Benzo(d)imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine|N-(1H-benzimidazol-2-ylmethyl)-N-((8S)-5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine|RefChem:155995|X4P 001|(8S)-N-(4-aminobutyl)-N-((1H-1,3-benzodiazol-2-yl)methyl)-5,6,7,8-tetrahydroquinolin-8-amine|Mavorixafor [USAN]|UNII-0G9LGB5O2W|MFCD11977316|N'-(1H-benzimidazol-2-ylmethyl)-N'-[(8S)-5,6,7,8-tetrahydroquinolin-8-yl]butane-1,4-diamine|CHEMBL518924|Mavorixafor (USAN)|AMD-070 (AMD11070)|C21H27N5|Xolremdi (TN)|compound 2 [PMID: 20297846]|AMD-070; Mavorixafor|MAVORIXAFOR [INN]|A1D8L|MAVORIXAFOR [WHO-DD]|GTPL8580|orb1296155|SCHEMBL2511950|SCHEMBL29379072|SCHEMBL29701264|DTXSID60971247|CHEBI:138865|GLXC-04447|X4P-001-IO|X4P-001-LD|BCP07108|EX-A2661|IXA44726|BDBM50315305|NSC775637|WHO 10724|AMD-070 HCl 75%(w/w%)|CS-0352|CS-1257|DB05501|NSC-775637|NCGC00378947-01|NCGC00378947-02|NCGC00378947-03|DA-50384|HY-50101|SY260541|NS00071960|C20266|D11510|F31237|BRD-K42948882-305-01-1|Q27074430|(S)-N1-[(2-Benzimidazolyl)methyl]-N1-(5,6,7,8-tetrahydro-8-quinolyl)-1,4-butanediamine|(S)-N-((1H-benzo[d]imidazol-2-yl)methyl)-N-(4-aminobutyl)-5,6,7,8-tetrahydroquinolin-8-amine|1,4-BUTANEDIAMINE, N-(1H-BENZIMIDAZOL-2-YLMETHYL)-N-((8S)-5,6,7,8-TETRAHYDRO-8-QUINOLINYL)-|690656-53-2|N~1~-[(1H-Benzimidazol-2-yl)methyl]-N~1~-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine"
LEMBOREXANT,56944144,,"InChI=1S/C22H20F2N4O2/c1-13-19(11-25-14(2)27-13)30-12-22(15-4-3-5-16(23)8-15)9-18(22)21(29)28-20-7-6-17(24)10-26-20/h3-8,10-11,18H,9,12H2,1-2H3,(H,26,28,29)/t18-,22+/m0/s1",MUGXRYIUWFITCP-PGRDOPGGSA-N,C22H20F2N4O2,410.4,"(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide","Lemborexant|1369764-02-2|Dayvigo|E-2006|E2006|0K5743G68X|(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide|Cyclopropanecarboxamide, 2-[[(2,4-dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-|DTXSID401027940|(1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide|Cyclopropanecarboxamide, 2-(((2,4-dimethyl-5-pyrimidinyl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-|(1R,2S)-2-(((2,4-dimethyl-5-pyrimidinyl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide|(1R,2S)-2-((2,4-DIMETHYLPYRIMIDIN-5-YL)OXYMETHYL)-2-(3-FLUOROPHENYL)-N-(5-FLUOROPYRIDIN-2-YL)CYCLOPROPANE-1-CARBOXAMIDE|(1R,2S)-2-{[(2,4-dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide|lemborexantum|(1R,2S)-2-(((2,4-dimethylpyrimidin-5-yl)oxy)methyl)-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropane-1-carboxamide|(1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide|(1R,2S)-2-{[(2,4-dimethylpyrimidin-5-yl)oxy]methyl}-2-(3-fluorophenyl)-N-(5-fluoropyridin-2-yl)cyclopropanecarboxamide|RefChem:56887|DTXCID001513507|E 2006|(1~{R},2~{S})-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-~{N}-(5-fluoranylpyridin-2-yl)-2-(3-fluorophenyl)cyclopropane-1-carboxamide|Lemborexant [USAN:INN]|UNII-0K5743G68X|(1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide;|Dayvigo (TN)|Lemborexant [INN]|Lemborexant(E2006)|LEMBOREXANT [MI]|Lemborexant(E2006)?|Lemborexant; E-2006|LEMBOREXANT [JAN]|LEMBOREXANT [USAN]|orb14385|LEMBOREXANT [WHO-DD]|Lemborexant (JAN/USAN/INN)|GTPL9302|SCHEMBL2116558|CHEMBL3545367|SCHEMBL29521503|LEMBOREXANT [ORANGE BOOK]|DEA NO. 2245|MUGXRYIUWFITCP-PGRDOPGGSA-N|EX-A2337|BDBM50093793|DB11951|compound 34 [PMID: 25953512]|NCGC00488783-01|AC-30918|FL103847|HY-16725|MS-27073|DB-145658|NS00073392|D11022|EN300-21614989|BRD-K78666663-001-01-6|Q20707990|(1R,2S)-2-[(2,4-dimethylpyrimidin-5-yl)oxymethyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridyl)cyclopropanecarboxamide|2482492-53-3"
BUDESONIDE,5281004,,"InChI=1S/C25H34O6/c1-4-5-21-30-20-11-17-16-7-6-14-10-15(27)8-9-23(14,2)22(16)18(28)12-24(17,3)25(20,31-21)19(29)13-26/h8-10,16-18,20-22,26,28H,4-7,11-13H2,1-3H3/t16-,17-,18-,20+,21?,22+,23-,24-,25+/m0/s1",VOVIALXJUBGFJZ-KWVAZRHASA-N,C25H34O6,430.5,"(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one","budesonide|Pulmicort|51333-22-3|Entocort|Rhinocort|Preferid|Rhinocort Aqua|Entocort EC|Uceris|Pulmicort Respules|Budesonidum|Pulmicort Flexhaler|Budenofalk|Budesonido|Pulmaxan|Rhinocort Allergy|Pulmicort turbuhaler|S-1320|MAP-0010|Budesonida|CHEBI:3207|Eltair|DTXSID8020202|Q3OKS62Q6X|EOHILIA|ORTIKOS|MAP0010|R01AD05|NSC-757788|(11-beta,16-alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione|(11beta,16alpha)-16,17-(Butylidenebis(oxy))-11,21-dihydroxypregna-1,4-diene-3,20-dione|16-alpha,17-alpha-Butylidenedioxy-11-beta,21-dihydroxy-1,4-pregnadiene-3,20-dione|DTXCID50820058|UCERIS COMPONENT BUDESONIDE|BREZTRI COMPONENT BUDESONIDE|AIRSUPRA COMPONENT BUDESONIDE|Pregna-1,4-diene-3,20-dione,16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11beta,16alpha)-|Tarpeyo|(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.0^{2,9}.0^{4,8}.0^{13,18}]icosa-14,17-dien-16-one|Aircort|Budecort|Butacort|Nasocort|Entocort cr|Duoresp spiromax|Budeflam aquanase|Budelin novolizer|Pulmicort l.s.|(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo(10.8.0.0^(2,9).0^(4,8).0^(13,18))icosa-14,17-dien-16-one|Rhinocort aqua 64|Budesonide Inhalation|RefChem:5621|Budesonide Inhalation Suspension|A07EA06|D07AC09|R03BA02|BUDESONIDE (ENTERIC COATED)|257-139-7|Cortiment|Budeson|Cortivent|Micronyl|Respules|Spirocort|Bidien|MFCD00083259|Budesonide (Standard)|MLS000028507|(RS)-11beta,16alpha,17,21-Tetrahydroxypregna-1,4-diene-3,20-dione cyclic 16,17-acetal with butyraldehyde|Budesonide MMX|Rhinocort alpha|16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione|SMR000058337|Budecort Inhaler|(+)-16alpha,17alpha-Butylidenedioxy-11beta,21-dihydroxy-1,4-pregnadiene-3,20-dione|Budesonidum [INN-Latin]|(1S,2S,4R,8S,9S,11S,12S,13R)-11-hydroxy-8-(2-hydroxyacetyl)-9,13-dimethyl-6-propyl-5,7-dioxapentacyclo[10.8.0.02,9.04,8.013,18]icosa-14,17-dien-16-one|Budesonido [INN-Spanish]|(R)-Budesonide|Inflammide|Budiair|Miflonide|Fvolir|(22R)-Budesonide|Budesonide [USAN:INN:BAN:JAN]|Pulmaxan turbohaler|Pulmicort (TN)|Pulmicort Topinasal|Rhinocort (TN)|Budesonide Easyhaler|S 1320|CCRIS 5230|Entocort EC (TN)|SR-01000000101|EINECS 257-139-7|UNII-Q3OKS62Q6X|Jorveza|Ultesa|Noex|Giona Easyhaler|Budesonide - IP|NCGC00016862-01|Budesonide; 16a,17-[(1RS)-butylidenebis(oxy)]-11ss,21-dihydroxypregna-1,4-diene-3,20-dione|Pregna-1,4-diene-3,20-dione, 16,17-[butylidenebis(oxy)]-11,21-dihydroxy-, (11.beta.,16.alpha.)-|Prestwick_840|CAS-51333-22-3|Uceris (TN)|Budesonide, >=99%|BUDESONIDE [MI]|BUDESONIDE [INN]|BUDESONIDE [JAN]|Opera_ID_1696|Prestwick0_000518|Prestwick1_000518|Prestwick2_000518|Prestwick3_000518|BUDESONIDE [USAN]|BUDESONIDE [VANDF]|Epitope ID:161750|B 7777|SCHEMBL4096|BUDESONIDE [USP-RS]|BUDESONIDE [WHO-DD]|CHEMBL1370|Lopac0_000174|BSPBio_000475|MLS001077323|MLS002207112|orb134514|Budesonide (anti-inflammatory)|SPBio_002396|BPBio1_000523|Budesonide (JP18/USP/INN)|Budesonide - Bio-X trade mark|GTPL7434|BUDESONIDE [ORANGE BOOK]|HSDB 8279|BUDESONIDE [EP MONOGRAPH]|MSK2236|BUDESONIDE [USP MONOGRAPH]|HMS1569H17|HMS2096H17|HMS2232D17|HMS3259H07|HMS3260D09|HMS3413B08|HMS3413P17|HMS3677B08|HMS3677P17|HMS3713H17|5-hydroxy-6b-(hydroxyacetyl)-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one|BCP05589|Eohilia (budesonide oral suspension)|Tox21_110653|Tox21_201827|Tox21_302815|Tox21_500174|BDBM50354850|HY-13580R|SYMBICORT COMPONENT BUDESONIDE|AKOS015969655|AC-4697|CCG-204269|CS-2063|DB01222|FB19346|KS-1162|LP00174|NC00626|NSC 757788|SDCCGSBI-0050162.P002|11beta,21-dihydroxy-16alpha,17alpha-(butane-1,1-diyldioxy)pregna-1,4-diene-3,20-dione|NCGC00021318-05|NCGC00021318-06|NCGC00021318-08|NCGC00021318-18|NCGC00089747-04|NCGC00256415-01|NCGC00259376-01|NCGC00260859-01|BB164267|Budesonide 100 microg/mL in Acetonitrile|CPD000058337|FB173257|HY-13580|Pregna-1,4-diene-3,20-dione, 16,17-(butylidenebis(oxy))-11,21-dihydroxy-, (11-beta,16-alpha)-|Pregna-1,4-diene-3,20-dione, 16,17-butylidenebis(oxy)-11,21-dihydroxy-, (11beta,16alpha(R))-, and 16alpha,17-((S)-Butylidenebis(oxy))-11beta,21-dihydroxypregna-1,4-diene-3,20-dione|B3909|CS-0695032|EU-0100174|NS00000099|D00246|T70986|333B223|EN300-19737584|Q422212|SR-01000000101-2|SR-01000000101-6|BRD-A34299591-001-03-4|BRD-A34299591-001-22-4|BRD-A34299591-001-25-7|BRD-A34299591-001-26-5|Budesonide, European Pharmacopoeia (EP) Reference Standard|Budesonide, United States Pharmacopeia (USP) Reference Standard|Budesonide, Pharmaceutical Secondary Standard; Certified Reference Material|(11b,16a)-16,17-[Butylidenebis(oxy)]-11,21-dihydroxypregna-1,4-diene-3,20-dione|(11b,16a)-16,17-Butylidenebis(oxy)-11,21-dihydroxypregna-1,4-diene-3,20-dione|(4aR,4bS,5S,6aS,6bS,9aR,10aS,10bS)-6b-Glycoloyl-5-hydroxy-4a,6a-dimethyl-8-propyl-4a,4b,5,6,6a,6b,9a,10,10a,10b,11,12-dodecahydro-2H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-2-one|(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-1,2,6a,6b,7,8,8a,8b,11a,12,12a,12b-dodecahydro-4H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4-one|(6aR,6bS,7S,8aS,8bS,11aR,12aS,12bS)-7-hydroxy-8b-(2-hydroxyacetyl)-6a,8a-dimethyl-10-propyl-6a,6b,7,8,8a,8b,11a,12,12a,12b-decahydro-1H-naphtho[2',1':4,5]indeno[1,2-d][1,3]dioxol-4(2H)-one"
BULOXIBUTID,9804984,,"InChI=1S/C23H29N3O4S2/c1-4-5-12-30-23(27)25-32(28,29)22-21(14-20(31-22)13-17(2)3)19-8-6-18(7-9-19)15-26-11-10-24-16-26/h6-11,14,16-17H,4-5,12-13,15H2,1-3H3,(H,25,27)",XTEOJPUYZWEXFI-UHFFFAOYSA-N,C23H29N3O4S2,475.6,butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate,"477775-14-7|Buloxibutid|Compound 21|butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-yl)sulfonylcarbamate|RC2V4W0EYC|T2 AGONIST COMPOUND 21|Carbamic acid, ((3-(4-(1H-imidazol-1-ylmethyl)phenyl)-5-(2-methylpropyl)-2-thienyl)sulfonyl)-, butyl ester|Butyl [3-[4-[(1H-imidazol-1-yl)methyl]phenyl]-5-isobutylthiophen-2-yl]sulfonylcarbamate|butyl (3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-(2-methylpropyl)thiophene-2-sulfonyl)carbamate|butyl [3-{4-[(1H-imidazol-1-yl)methyl]phenyl}-5-(2-methylpropyl)thiophene-2-sulfonyl]carbamate|Carbamic acid, [[3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)-2-thienyl]sulfonyl]-, butyl ester|RefChem:917711|AT2 Agonist C21|AT2 receptor agonist C21|M 24|C-21|CHEMBL189568|Butyl N-[3-[4-(imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophen-2-yl]sulfonylcarbamate|compound 21 [PMID: 22802221]|M-24|butyl 3-(4-((1H-imidazol-1-yl)methyl)phenyl)-5-isobutylthiophen-2-ylsulfonylcarbamate|BUTYL ((3-(4-((1H-IMIDAZOL-1-YL)METHYL)PHENYL)-5-ISOBUTYLTHIOPHEN-2-YL)SULFONYL)CARBAMATE|N-[[3-[4-(1H-Imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)-2-thienyl]sulfonyl]carbamic acid butyl ester|buloxibutid [INN]|AT2 agonist M24|3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt|UNII-RC2V4W0EYC|Buloxibutid (USAN/INN)|BULOXIBUTID [USAN]|SCHEMBL557591|GTPL6918|orb1707632|C 21 [WHO-DD]|C23H29N3O4S2|XTEOJPUYZWEXFI-UHFFFAOYSA-N|BCP30872|CUA77514|BDBM50156173|MFCD26936332|AKOS030231077|AT18254|SB18730|NCGC00386668-01|M024/C21|MS-28827|DS-017243|HY-100113|CS-0018094|M-024|M 24;M-24;M24;C-21|D13133|Q27076423|butyl N-[[3-[4-(imidazol-1-ylmethyl)phenyl]-5-isobutyl-2-thienyl]sulfonyl]carbamate|N-Butyloxycarbonyl-3-(4-imidazol-1-ylmethylphenyl)-5-iso-butylthiophene-2-sulfonamide|(1-((2''-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-butyl-4-chloro-1H-imidazol-5-yl)methanol|Carbamic acid, [[3-[4-(1H-imidazol-1-ylmethyl)phenyl]-5-(2-methylpropyl)-2-thienyl]sulfon yl]-, butyl ester|CARBAMIC ACID,[[3-[4-(1H-IMIDAZOL-1-YLMETHYL)PHENYL]-5-(2-METHYLPROPYL)-2-THIENYL]SULFONYL]-, BUTYL ESTER"
OXYQUINOLINE,1923,,"InChI=1S/C9H7NO/c11-8-5-1-3-7-4-2-6-10-9(7)8/h1-6,11H",MCJGNVYPOGVAJF-UHFFFAOYSA-N,C9H7NO,145.16,quinolin-8-ol,"8-HYDROXYQUINOLINE|quinolin-8-ol|148-24-3|8-quinolinol|Oxyquinoline|Oxine|Quinophenol|Oxychinolin|8-Quinol|Phenopyridine|Oxin|Oxybenzopyridine|Hydroxybenzopyridine|8-Oxyquinoline|1-Azanaphthalene-8-ol|8-Hydroxychinolin|Bioquin|Tumex|8-Chinolinol|8-Hydroxy-chinolin|Fennosan H 30|Fennosan|o-Oxychinolin|Usaf ek-794|Oxyquinol|Quinoline, 8-hydroxy-|NCI-C55298|8 Hydroxyquinoline|NSC-2039|NSC-285166|NSC-402623|NSC-615011|5UTX5635HP|DTXSID5020730|CHEBI:48981|NSC-48037|NSC-54230|NSC-82404|NSC-82405|NSC-82409|NSC-82410|NSC-82412|J2.960B|DTXCID30730|8 Oxyquinoline|8 Quinolinol|UDDER BALM|RefChem:57428|205-711-1|8-OQ|8-Oxychinolin|MFCD00006807|Oxyquinoline [USAN]|8-hydroxy-quinoline|NSC 2039|Oxoquinoline|NSC 615011|8-hydroxy quinoline|NSC285166|MLS002702126|CHEMBL310555|quinoline-8-ol|Oxyquinoline (8-Hydroxyquinoline)|NSC 82404|NSC615011|Oxyquinoline (USAN)|NCGC00090708-03|NCGC00090708-05|WLN: T66 BNJ JQ|Oxine;8-Hydroxyquinoline;Quinophenol;8-Quinolinone|Fennosan HF-15|Caswell No. 719|8-Chinolinol [Czech]|o-Oxychinolin [German]|CAS-148-24-3|Manganese, bis(8-quinolinolato)-|SMR000112313|8-Hydroxy-chinolin [German]|CCRIS 340|HSDB 4073|EINECS 205-711-1|EPA Pesticide Chemical Code 059803|BRN 0114512|UNII-5UTX5635HP|Oxychinoline|AI3-00483|8-Oxyquinolin|8-Quinolinone|8-Quinolol|8-hydroxiquinoline|8-hydroxychinoline|8-hydroxylquinoline|HQY|8-Quinolinol, p.a.|Spectrum_001053|3vh9|Procaterol Impurity 19|8-Hydroxyquinoline Oxine|Spectrum2_000697|Spectrum3_000534|Spectrum4_000465|Spectrum5_001280|OXYQUINOLINE [II]|8-Hydroxyquinoline, 99%|EC 205-711-1|NCIMech_000694|OXYQUINOLINE [HSDB]|cid_1923|NCIStruc1_000152|NCIStruc2_000240|Oxyquinol Reference Spectrum|NCIOpen2_000962|NCIOpen2_001020|NCIOpen2_001220|NCIOpen2_004264|OXYQUINOLINE [VANDF]|SCHEMBL37189|BSPBio_002147|KBioGR_000910|KBioSS_001533|5-21-03-00252 (Beilstein Handbook Reference)|MLS001055492|BIDD:ER0371|DivK1c_000757|SCHEMBL144184|SCHEMBL144188|SCHEMBL275364|8-Hydroxyquinoline (Standard)|SPBio_000853|8-Hydroxyquinoline, crystalline|orb1310645|SCHEMBL1812613|SCHEMBL2401863|SCHEMBL8467497|HYDROXYQUINOLINE [VANDF]|8-HYDROXYQUINOLINE [MI]|SCHEMBL16289274|SCHEMBL29365411|SCHEMBL29716519|BDBM32203|HMS502F19|HY-B1005R|KBio1_000757|KBio2_001533|KBio2_004101|KBio2_006669|KBio3_001647|HYDROXYQUINOLINE [WHO-DD]|NSC2039|8-HYDROXYQUINOLINE [IARC]|NINDS_000757|8-Quinolinol (7CI,8CI,9CI)|HMS5083P09|HY-B1005|STR00721|Tox21_113083|Tox21_202986|Tox21_400006|8-Oxychinolin, 8-Quinolinol, Oxine|CCG-35870|NSC 48037|NSC 54230|NSC 82405|NSC 82409|NSC 82410|NSC 82412|NSC402623|s4547|SBB009097|STK943764|8-Hydroxyquinoline ACS Reagent Grade|AKOS001061311|AC-5109|CS-4502|DB11145|FH12040|NSC 285166|NSC 402623|PS-4553|SB40773|8-Hydroxyquinoline, ACS reagent, 99%|IDI1_000757|NCGC00090708-01|NCGC00090708-02|NCGC00090708-04|NCGC00090708-06|NCGC00090708-07|NCGC00090708-08|NCGC00090708-11|NCGC00260531-01|NCI60_001712|NCI60_002335|SBI-0051472.P003|DB-012222|H0305|NS00010316|ST45053772|8-Quinolinol, JIS special grade, >=99.0%|8-Quinolinol, Vetec(TM) reagent grade, 99%|EN300-17403|C19434|D05321|P17615|US9394254, 6|8-Quinolinol, PESTANAL(R), analytical standard|AB00052065_08|8-Quinolinol, >=99% (perchloric acid titration)|AP-065/40180076|F093034|Q270162|CU-01000012874-2|BRD-K66808046-065-01-1|BRD-K66808046-065-03-7|Z56926518|F0001-0526|InChI=1/C9H7NO/c11-8-5-1-3-7-4-2-6-10-9(7)8/h1-6,11|8-Quinolinol, puriss. p.a., ACS reagent, for the detection and determination of Al, Mg and others, >=99.0% (NT)|8-Quinolinol, puriss. p.a., ACS reagent, reag. Ph. Eur., >=99% (perchloric acid titration)"
NITROXOLINE,19910,,"InChI=1S/C9H6N2O3/c12-8-4-3-7(11(13)14)6-2-1-5-10-9(6)8/h1-5,12H",RJIWZDNTCBHXAL-UHFFFAOYSA-N,C9H6N2O3,190.16,5-nitroquinolin-8-ol,"NITROXOLINE|4008-48-4|5-nitroquinolin-8-ol|8-Hydroxy-5-nitroquinoline|5-Nitro-8-hydroxyquinoline|5-Nitro-8-quinolinol|5-Nitrox|5-NOK|5-Nitro-8-oxyquinoline|Nitroxolina|5NOK|Nitroxolinum|DTXSID4046284|NSC-74947|CHEBI:67121|A8M33244M6|DTXCID2026284|Nicene|RefChem:166162|223-662-4|Nitroxolin|Noxibiol|Nibiol|Noxin|8-Quinolinol, 5-nitro-|5-Nitroxine|5-Nitroks|5-Nitro-8-oxychinoline|Nitroxolinum [INN-Latin]|Nitroxolina [INN-Spanish]|A-82|BAS 58|MFCD00006791|NSC 74947|MLS000069750|SMR000059036|Galinok|Isinok|Nicene Forte|Nitroxoline (INN)|NCGC00160664-01|NITROXOLINE [INN]|Uro-Coli|CAS-4008-48-4|Nitroxoline [INN:BAN:DCF]|EINECS 223-662-4|BRN 0166146|Nitroxlina|UNII-A8M33244M6|Nitroxoline (TN)|HNQ|Nitrohydroxyquinoline|Nitroxoline (Standard)|3ai8|Opera_ID_204|5-Nitro-quinolin-8-ol|NITROXOLINE [MI]|5-Nitro-8hydroxyquinoline|Quinolin-8-ol, 5-nitro-|NITROXOLINE [MART.]|Oprea1_594857|8-Hydroxy-5-nitro-chinoline|NITROXOLINE [WHO-DD]|5-21-03-00297 (Beilstein Handbook Reference)|cid_19910|MLS001148594|SCHEMBL151248|REGID_for_CID_19910|orb1310648|WLN: T66 BNJ GNW JQ|CHEMBL1454910|SCHEMBL21816802|SCHEMBL29363027|BDBM64987|HY-B1159R|GLXC-20116|HMS2230I14|HMS3264C05|HMS3374D08|HMS5083J17|KUC105356N|Pharmakon1600-01506173|8-Hydroxy-5-nitroquinoline, 96%|HY-B1159|MSK11425|NSC74947|Tox21_111969|KSC-8-140|NSC760393|NSC832678|s4591|SBB037944|STK099582|AKOS001053242|Tox21_111969_1|AC-7828|CCG-213981|CS-4761|DB01422|FN35484|NSC-760393|NSC-832678|PS-5547|NCGC00160664-03|ST086486|DB-049530|A6696|H0805|NS00004195|EN300-17364|08N484|D07245|5-Nitro-8-quinolinol;8-Hydroxy-5-nitroquinoline|5-Nitro-8-quinolinol|5-Nitro-8-hydroxyquinoline|AB00572598_14|AG-205/04556035|F044621|Q304570|SR-01000721863|SR-01000721863-4|BRD-K97534525-001-23-5|BRD-K97534525-001-24-3|Z56922155|InChI=1/C9H6N2O3/c12-8-4-3-7(11(13)14)6-2-1-5-10-9(6)8/h1-5,12"
CLOXYQUIN,2817,,"InChI=1S/C9H6ClNO/c10-7-3-4-8(12)9-6(7)2-1-5-11-9/h1-5,12H",CTQMJYWDVABFRZ-UHFFFAOYSA-N,C9H6ClNO,179.60,5-chloroquinolin-8-ol,"5-CHLORO-8-HYDROXYQUINOLINE|130-16-5|5-Chloroquinolin-8-ol|Cloxiquine|cloxyquin|Cloxiquina|Cloxiquinum|BPF36H1G6S|NSC-35083|DTXSID4045973|DTXCID2025973|cloxiquin|RefChem:127142|204-978-1|5-Chloro-8-quinolinol|8-Quinolinol, 5-chloro-|5-Chlorooxine|Dermofongin|Chlorisept|Dermofungin|5-Chloro-8-oxyquinoline|Chloroxychinolin|Dermofongin A|8-Hydroxy-5-chloroquinoline|Monochlorohydroxyquinoline|Cloxyquin [USAN]|MFCD00006788|5-Chloro-quinolin-8-ol|5-chloranylquinolin-8-ol|NSC 35083|Cloxiquine [INN]|MLS002695956|Cloxiquine (INN)|NSC35083|Cloxyquin (USAN)|NCGC00095303-02|SMR000274338|Cloxiquine 100 microg/mL in Acetonitrile|quinoline, 5-chloro-8-hydroxy-|5-Chlor-8-chinolinol|Cloxiquinum [INN-Latin]|Cloxiquina [INN-Spanish]|CAS-130-16-5|EINECS 204-978-1|UNII-BPF36H1G6S|BRN 0005289|Dermofungin||5-Chloroquinophenol|HZQ|5-Chloro-8-quinolol|Spectrum_000820|CLOXYQUIN [MI]|Spectrum2_001131|Spectrum3_000361|Spectrum4_000297|Spectrum5_000785|5-Chloro-quinoline-8-ol|5Chloro-8-hydroxyquinoline|cid_2817|CLOXIQUINE [MART.]|CLOXIQUINE [WHO-DD]|NCIOpen2_004102|Oprea1_189008|BSPBio_002081|KBioGR_000854|KBioSS_001300|5-21-03-00279 (Beilstein Handbook Reference)|5-chloro-8-hydroxy-quinoline|DivK1c_000163|SCHEMBL115838|SPECTRUM1500202|SPBio_001021|CHEMBL225164|orb1310543|SCHEMBL1277003|SCHEMBL1501893|SCHEMBL2095713|5-Chloro-8-quinolinol, 95%|SCHEMBL29381298|BCBcMAP01_000058|BDBM76305|HMS500I05|KBio1_000163|KBio2_001300|KBio2_003868|KBio2_006436|KBio3_001301|CHEBI:134818|NINDS_000163|HMS1920A06|HMS2091G14|HMS3091A16|HMS5083N11|Pharmakon1600-01500202|HY-B0963|NSC53182|STR00716|Tox21_111501|AC8858|CCG-39556|NSC-53182|NSC756701|s4559|STK015543|AKOS000121487|Tox21_111501_1|AC-4776|CS-4448|FC40563|NSC-756701|PS-3329|IDI1_000163|QTL1_000025|NCGC00095303-01|NCGC00095303-03|NCGC00095303-04|SY047042|Cloxiquine(Discontinued,See C4X-25921)|SBI-0051320.P003|DB-041946|NS00009640|ST50237100|EN300-21587|D03572|AB00051952_05|CS-001/03840010|F119500|SR-05000002034|SR-05000002034-1|BRD-K46982791-001-02-9|BRD-K46982791-001-04-5|BRD-K46982791-001-09-4|Q27274791|F0001-0401|Z1954804579|InChI=1/C9H6ClNO/c10-7-3-4-8(12)9-6(7)2-1-5-11-9/h1-5,12"
N-ACETYLGLUCOSAMINE ,1738118,,"InChI=1S/C8H15NO6/c1-4(12)9-5(2-10)7(14)8(15)6(13)3-11/h2,5-8,11,13-15H,3H2,1H3,(H,9,12)/t5-,6+,7+,8+/m0/s1",MBLBDJOUHNCFQT-LXGUWJNJSA-N,C8H15NO6,221.21,"N-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]acetamide","2-Acetamido-2-deoxy-D-glucose|7512-17-6|Marine Sweet|GreenNAG|Bio-NAG|N acetylglucosamine|N-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]acetamide|DTXSID3045855|2-Acetamido-2-deoxyglucose|2 Acetamido 2 Deoxyglucose|D-Glucose, 2-(acetylamino)-2-deoxy-|N-ACETYL GLUCOSAMINE D-|2 Acetamido 2 Deoxy D Glucose|DTXCID5032369|D-Glucose, 2-acetamido-2-deoxy-|N-((2R,3R,4S,5R)-3,4,5,6-Tetrahydroxy-1-oxohexan-2-yl)acetamide|Glucopyranose, 2-acetamido-2-deoxy-|V956696549|NSC-400525|NSC-524344|Glucosamine, Acetyl|N Acetyl Glucosamine|Glucosamine, N-acetyl|beta N Acetylglucosamine|RefChem:936033|GlyTouCan:G01864SU|N Acetyl beta D Glucosamine|CHEBI:59640|G01864SU|231-368-2|2-Acetylamino-2-deoxy-D-glucose|Acetyl Glucosamine|Acetylglucosamine|N-Acetyl Glucosamine|N-Acetylglucosamine|aldehydo-N-acetyl-D-glucosamine|MFCD00061615|MFCD00136044|NSC 524344|CCRIS 9357|acetyl-glucosamine|NCGC00159338-02|NCGC00159338-03|EINECS 231-368-2|UNII-V956696549|N-Acetyl-D-glucosamine - plant source|NSC 400525|N Acetyl D Glucosamine|Glucosamine, N-acetyl-|SCHEMBL19900|MLS006011606|orb1302795|CHEMBL4303483|N-ACETYLGLUCOSAMINE [MI]|CHEBI:17411|HY-A0132R|N-ACETYLGLUCOSAMINE [DSC]|N-Acetyl-D-glucosamine (Standard)|HY-A0132|Tox21_111344|BBL033994|N-ACETYLGLUCOSAMINE [USP-RS]|N-ACETYLGLUCOSAMINE [WHO-DD]|STK801800|AKOS005622647|DB00141|MA00834|MA10891|NCGC00159338-05|BP-13072|DS-18661|SMR002121580|SY046107|CAS-7512-17-6|CS-0017447|S6257|AB01325684-02|EN300-7414561|F224637|GLUCOPYRANOSE, 2-ACETAMIDO-2-DEOXY-, D-|N-Acetyl-D-glucosamine-Agarose, saline suspension|BRD-K80653534-001-01-7|Q32030210|1186B229-E28C-4CF9-8146-EC06A584F821|N-[(1R,2R,3S,4R)-1-formyl-2,3,4,5-tetrahydroxy-pentyl]acetamide|GLUCOSAMINE SULFATE POTASSIUM CHLORIDE IMPURITY A [ EP IMPURITY]|2-Acetamido-2-deoxy-D-glucopyranose;GlcNAc; Glucosamine; N-Acetylglucosamine; Acetylglucosamine|27555-50-6"
ISPINESIB MESYLATE,6450816,,"InChI=1S/C30H33ClN4O2.CH4O3S/c1-20(2)27(34(17-7-16-32)29(36)23-12-10-21(3)11-13-23)28-33-26-18-24(31)14-15-25(26)30(37)35(28)19-22-8-5-4-6-9-22;1-5(2,3)4/h4-6,8-15,18,20,27H,7,16-17,19,32H2,1-3H3;1H3,(H,2,3,4)/t27-;/m1./s1",MRKSDPIHUJSKRA-HZPIKELBSA-N,C31H37ClN4O5S,613.2,N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxoquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide;methanesulfonic acid,"Ispinesib mesylate|514820-03-2|Ispinesib mesilate|Ispinesib mesylate [USAN]|UNII-R6ZMD4UH3D|R6ZMD4UH3D|SB 715992S|SB-715992-S|CK0238273|CK-0238273|Ispinesib mesylate (USAN)|DTXSID70199455|ISPINESIB MESILATE [WHO-DD]|Benzamide, N-(3-aminopropyl)-N-((1R)-1-(7-chloro-3,4-dihydro-4-oxo-3-(phenylmethyl)-2-quinazolinyl)-2-methylpropyl)-4-methyl-, monomethanesulfonate|N-(3-AMINOPROPYL)-N-((1R)-1-(3-BENZYL-7-CHLORO-4-OXO-3,4-DIHYDROQUINAZOLIN-2-YL)-2-METHYLPROPYL)-4-METHYLBENZAMIDE MONOMETHANESULPHONATE|RefChem:150177|DTXCID00121946|(R)-N-(3-Aminopropyl)-N-(1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl)-4-methylbenzamide methanesulfonate|Ispinesib (mesylate)|CHEMBL2347651|CK 0238273|SCHEMBL2963210|SCHEMBL29711229|MRKSDPIHUJSKRA-HZPIKELBSA-N|D04640|Q27287868|(R)-N-(3-amino-propyl)-N-[1-(3-benzyl-7-chloro-4-oxo-3,4-dihydro-quinazolin-2-yl)-2-methyl-propyl]-4-methyl-benzamide, mesylate salt|n-(3-aminopropyl)-n-[(1r)-1-(3-benzyl-7-chloro-4-oxo-3,4-dihydroquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide monomethanesulfonate|N-(3-aminopropyl)-N-[(1R)-1-(3-benzyl-7-chloro-4-oxoquinazolin-2-yl)-2-methylpropyl]-4-methylbenzamide;methanesulfonic acid"
ESCITALOPRAM OXALATE,146571,,"InChI=1S/C20H21FN2O.C2H2O4/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20;3-1(4)2(5)6/h4-9,12H,3,10-11,14H2,1-2H3;(H,3,4)(H,5,6)/t20-;/m0./s1",KTGRHKOEFSJQNS-BDQAORGHSA-N,C22H23FN2O5,414.4,(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;oxalic acid,"Escitalopram oxalate|219861-08-2|Escitalopram (as oxalate)|Lu 26-054-0|Citalopram oxalate, (s)-|5U85DBW7LO|NSC-758934|DTXSID1046003|Lu-26-054-0|LU-26-054-O|DTXCID9026003|Escitslopram|Escitalopram Oral|RefChem:56379|Escitalopram Oral Solution|5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-,(1S)-, ethanedioate(1:1)|Lexapro|(S)-Citalopram Oxalate|Escitalopram (oxalate)|(S)-(+)Citalopram oxalate|MFCD06407826|(S)-(+)-Citalopram Oxalate|(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;oxalic acid|(S)-1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile oxalate|5-Isobenzofurancarbonitrile,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-,ethanedioate (1:1)|C22H23FN2O5|NCGC00095903-01|S-(+)-1-(3-(Dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile oxalate|S-(+)-5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, oxalate|CAS-219861-08-2|Escitalopram oxalate [USAN]|Gaudium|Entact|Cipra-Pro|Escitalopramoxalate|(S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Oxalate|Escitalopram Oxalate; (S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile Ethanedioate; (+)-(S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Oxalate|Lexapro (TN)|(S)-Escitalopram Oxalate|UNII-5U85DBW7LO|SCHEMBL35123|MLS001401408|SPECTRUM1505216|(+)-(S)-Citalopram oxalate|MLD-55|orb1300720|CHEMBL1200322|SCHEMBL30223023|Escitalopram oxalate (JAN/USP)|MSK11176O|ESCITALOPRAM OXALATE [MI]|Escitalopram oxalate [USAN:USP]|Escitalopram (oxalate) (Standard)|ESCITALOPRAM OXALATE [JAN]|GLXC-03026|HMS2051D11|HMS2231M16|HMS3370I17|HMS3393D11|HMS3713D16|HY-14258AR|Pharmakon1600-01505216|BCP05686|ESCITALOPRAM OXALATE [VANDF]|Tox21_111535|CCG-39559|ESCITALOPRAM OXALATE [MART.]|HB1804|HY-14258A|NSC758934|ESCITALOPRAM OXALATE [USP-RS]|ESCITALOPRAM OXALATE [WHO-DD]|AKOS016340275|Tox21_111535_1|AC-6770|CS-2054|FC20465|KS-1263|NC00194|NSC 758934|SB17454|NCGC00178555-02|5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, (1S)-, ethanedioate (1:1)|BC164423|ESCITALOPRAM OXALATE [ORANGE BOOK]|SMR000469191|SY067062|ESCITALOPRAM OXALATE [EP MONOGRAPH]|(S)-Citalopram oxalate - Bio-X trade mark|ESCITALOPRAM OXALATE [USP MONOGRAPH]|E0958|D02567|Escitalopram oxalate, >=98% (HPLC), powder|861E082|SR-01000763053|SR-01000763053-3|Q27262882|Z3235136057|Escitalopram oxalate, EuropePharmacopoeia (EP) Reference Standard|Escitalopram oxalate, United States Pharmacopeia (USP) Reference Standard|Escitalopram for system suitability, EuropePharmacopoeia (EP) Reference Standard|Escitalopram Oxalate, Pharmaceutical Secondary Standard; Certified Reference Material|(1S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile ethanedioate;Escitalopram oxalate;(S)-(+    )-Citalopram oxalate|(1S)-1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile ethanedioate;Escitalopram oxalate;(S)-(+  )-Citalopram oxalate|(1S)-1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile;oxalic acid"
ALDOSTERONE,5839,,"InChI=1S/C21H28O5/c1-20-7-6-13(24)8-12(20)2-3-14-15-4-5-16(18(26)10-22)21(15,11-23)9-17(25)19(14)20/h8,11,14-17,19,22,25H,2-7,9-10H2,1H3/t14-,15-,16+,17-,19+,20-,21+/m0/s1",PQSUYGKTWSAVDQ-ZVIOFETBSA-N,C21H28O5,360.4,"(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-13-carbaldehyde","ALDOSTERONE|52-39-1|(+)-Aldosterone|Aldosterona|Aldosteronum|11beta,21-Dihydroxypregn-4-ene-3,18,20-trione|11beta,21-Dihydroxy-3,20-diketo-4-pregnen-18-al|(11BETA)-11,21-DIHYDROXY-3,20-DIOXOPREGN-4-EN-18-AL|11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al|NSC-73856|(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthrene-13-carbaldehyde|11beta,21-dihydroxy-3,20-dioxopregn-4-en-18-al|CHEBI:27584|11beta,21-dihydroxy-3,20-dioxo-pregn-4-ene-18-al|4964P6T9RB|DTXSID7022419|NSC73856|(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta(a)phenanthrene-13-carbaldehyde|RefChem:553942|DTXCID902419|H02AA01|(2R,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo(8.7.0.02,7.011,15)heptadec-6-ene-15-carbaldehyde|200-139-9|Electrocortin|Aldocortin|Aldocorten|Aldocortene|Reichstein X|Elektrocortin|d-Aldosterone|18-Oxocorticosterone|18-Aldocorticosterone|Pregn-4-en-18-al, 11,21-dihydroxy-3,20-dioxo-, (11b)-|[3H]aldosterone|11beta,21-Dihydroxy-3,20-diketopregn-4-ene-18-al|18-Formyl-11beta,21-dihydroxy-4-pregnene-3,20-dione|NSC 73856|11beta,21-Dihydroxy-3,20-dioxo-4-pregnen-18-al, 18,11-halbacetal|Aldosterone (INN)|11.beta.,21-Dihydroxypregn-4-ene-3,18,20-trione|MFCD00051136|Aldosteronum [INN-Latin]|Aldosterona [INN-Spanish]|ALDOSTERONE [INN]|Aldosterone [INN:BAN:DCF]|[3H]-aldosterone|SMR000857170|EINECS 200-139-9|Aldosterone (Hemiacetal) (1.0mg/mL in Acetonitrile)|BRN 3224996|UNII-4964P6T9RB|delta-Aldosterone|Aldosterone (Standard)|11,21-Dihydroxy-3,20-dioxopregn-4-en-18-al|Aldosterone 100 microg/mL in Acetonitrile|ALDOSTERONE [MI]|SCHEMBL1675|ALDOSTERONE [MART.]|ALDOSTERONE [WHO-DD]|11b,21-dihydroxy-3,20-dioxo-pregn-4-en-18-al|4-08-00-03491 (Beilstein Handbook Reference)|MLS001333163|MLS001333164|BIDD:ER0511|US10188667, Aldosterone|CHEMBL273453|GTPL2872|GTPL3452|orb1706268|Aldosterone, >=95% (HPLC)|BDBM19214|MSK8524|(11beta)-11,21-dihydroxy-3,20-dioxo-Pregn-4-en-18-al|HMS2233D14|LMST02030026|AKOS024462706|DB04630|FA17269|HY-113313R|NCGC00164236-01|AS-69489|HY-113313|CS-0059576|NS00014784|C01780|D10528|Q184564|SR-01000838883|SR-01000838883-2|11-beta,21-Dihydroxy-3,20-dioxopregn-4-en-18-al|11beta,21-Dihydroxy-3,20-dioxo-pregn-4-en-18-al|(11b)-11,21-dihydroxy-3,20-dioxo-pregn-4-en-18-al|11-beta-18-Epoxy-18,21-dihydroxypregn-4-ene-3,20-dione|Pregn-4-en-18-al,21-dihydroxy-3,20-dioxo-, (11.beta.)-|Pregn-4-ene-3,20-dione, 11-beta,18-epoxy-18,21-dihydroxy-|Pregn-4-ene-3,20-dione, 11beta,18-epoxy-18,21-dihydroxy-|(11alpha,14beta,17alpha)-11,21-dihydroxy-3,20-dioxopregn-4-en-18-al|Pregn-4-ene-3,20-dione, 11,18-epoxy-18,21-dihydroxy-, (11-beta)-|11,13-(Epoxymethano)-13H-cyclopenta(a)phenanthrene, pregn-4-ene-3,20-deriv.|(11b)-11,21-Dihydroxy-3,20-dioxopregn-4-en-18-al;11b,21-Dihydroxypregn-4-ene-3,18,20-trione;18-Formyl-11b,21-dihydroxy-4-pregnene-3, 20-dione|(1S,2R,10S,11S,14S,15R,17S)-17-hydroxy-14-(2-hydroxyacetyl)-2-methyl-5-oxotetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-6-ene-15-carbaldehyde|(8S,9S,10R,11S,13R,14S,17S)-11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,3,6,7,8,9,10,11,12,14,15,16,17-tetradecahydro-13H-cyclopenta[a]phenanthrene-13-carbaldehyde|11-hydroxy-17-(2-hydroxyacetyl)-10-methyl-3-oxo-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydrocyclopenta[a]phenanthrene-13-carbaldehyde"
CE-326597,52949124,,"InChI=1S/C37H34N6O2/c1-25(2)41(23-26-13-5-3-6-14-26)34(44)24-42-32-19-11-12-20-33(32)43-35(27-15-7-4-8-16-27)39-40-36(43)30(37(42)45)21-28-22-38-31-18-10-9-17-29(28)31/h3-20,22,25,30,38H,21,23-24H2,1-2H3/t30-/m0/s1",UBNMGTSDHSQBEL-PMERELPUSA-N,C37H34N6O2,594.7,"N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-6-yl]-N-propan-2-ylacetamide","CE-326597|1FGZ6L9SF2|CE-326,597|870615-40-0|6H-(1,2,4)Triazolo(4,3-a)(1,5)benzodiazepine-6-acetamide, 4,5-dihydro-4-(1H-indol-3-ylmethyl)-N-(1-methylethyl)-5-oxo-1-phenyl-N-(phenylmethyl)-, (-)-|6H-(1,2,4)Triazolo(4,3-a)(1,5)benzodiazepine-6-acetamide, 4,5-dihydro-4-(1H-indol-3-ylmethyl)-N-(1-methylethyl)-5-oxo-1-phenyl-N-(phenylmethyl)-, (S)-|N-benzyl-2-((4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4H-(1,2,4)triazolo(3,4-d)(1,5)benzodiazepin-6-yl)-N-propan-2-ylacetamide|N-benzyl-2-[(4S)-4-(1H-indol-3-ylmethyl)-5-oxo-1-phenyl-4H-[1,2,4]triazolo[3,4-d][1,5]benzodiazepin-6-yl]-N-propan-2-ylacetamide|RefChem:124157|N-benzyl-2-((7S)-7-((1H-indol-3-yl)methyl)-8-oxo-3-phenyl-2,4,5,9-tetraazatricyclo(8.4.0.0^(2,6))tetradeca-1(14),3,5,10,12-pentaen-9-yl)-N-(propan-2-yl)acetamide|UNII-1FGZ6L9SF2|CE 326597|CHEMBL1269258|(S)-2-(4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4,5-dihydro-6H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-6-yl)-N-benzyl-N-isopropylacetamide|GTPL9055|orb1740998|SCHEMBL29454541|BDBM50329179|DB12694|compound 4a [PMID: 20851601]|Q27075836|2-((4S)-4-((1H-indol-3-yl)methyl)-5-oxo-1-phenyl-4H-benzo[b][1,2,4]triazolo[4,3-d][1,4]diazepin-6(5H)-yl)-N-benzyl-N-isopropylacetamide"
ONDANSETRON,4595,,"InChI=1S/C18H19N3O/c1-12-19-9-10-21(12)11-13-7-8-16-17(18(13)22)14-5-3-4-6-15(14)20(16)2/h3-6,9-10,13H,7-8,11H2,1-2H3",FELGMEQIXOGIFQ-UHFFFAOYSA-N,C18H19N3O,293.4,"9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one","ondansetron|99614-02-5|Zudan|Zofran ODT|Zuplenz|9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one|4AF302ESOS|DTXSID8023393|A04AA01|EUR-1025|9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-2,3,4,9-tetrahydro-1H-carbazol-4-one|NSC-757870|1,2,3,9-Tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-4H-carbazol-4-one|DTXCID803393|Odansetron [common misspelling of ondansetron]|1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one|4H-Carbazol-4-one, 1,2,3,9-tetrahydro-9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-|Odansetron (common misspelling of ondansetron)|ondansetronum|ondasetron|Ondansetron ODT|9-methyl-3-((2-methylimidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4-one|9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3,4,9-tetrahydro-1H-carbazol-4-one|ODT, Zofran|RefChem:6085|Hydrochloride, Ondansetron|Ondansetron, (+,-)-|Monohydrochloride, Ondansetron|SN307|Ondansetron Monohydrochloride Dihydrate|Dihydrate, Ondansetron Monohydrochloride|Monohydrochloride Dihydrate, Ondansetron|9-Methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-2,3-dihydro-1H-carbazol-4(9H)-one|116002-70-1|MFCD00833882|GR 38032X|GR 38032|CHEBI:7773|NCGC00179341-02|9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-1,2,3,9-tetrahydro-4H-carbazol-4-one|GR 38032 (hydrochloride);SN 307 (hydrochloride)|ondansetron (Zofran)|9-methyl-3-((2-methyl-1H-imidazol-1-yl)methyl)-1,2,3,9-tetrahydro-4H-carbazol-4-one|CAS-99614-02-5|Ondansetron Injection|Zofran ODT (TN)|DESMETHYLONDANSETRON|UNII-4AF302ESOS|BRN 3622981|Ondansetron (JAN/USP/INN)|Ondansetron [USP:INN:BAN]|SR-01000763250|9-methyl-3-[(2-methylimidazolyl)methyl]-1,2,3,9-tetrahydro-4aH-carbazol-4-one|Ondansetron (Standard)|CHEMBL46|ONDANSETRON [MI]|Prestwick0_001058|Prestwick1_001058|Prestwick2_001058|Prestwick3_001058|ONDANSETRON [INN]|ONDANSETRON [JAN]|ONDANSETRON [VANDF]|SCHEMBL4542|TimTec1_001750|(RS)-1,2,3,9-Tetrahydro-9-methyl-3-(2-methylimidazol-1-ylmethyl)carbazol-4-one|ONDANSETRON [MART.]|Oprea1_435466|Oprea1_852372|BSPBio_001016|CBDivE_008994|ONDANSETRON [USP-RS]|ONDANSETRON [WHO-DD]|MLS006011928|SPBio_002938|BPBio1_001118|GTPL2290|HY-B0002BR|SCHEMBL29358872|BDBM85330|HSDB 8304|HY-B0002B|ONDANSETRON [ORANGE BOOK]|(3S)-9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1H-carbazol-4-one|HMS2090H16|HMS3259H08|HMS3371E18|ONDANSETRON [USP MONOGRAPH]|BCP28911|MSK10280|Tox21_113048|CAS_68647|NSC_68647|NSC791005|s1996|SBB066158|STK370548|AKOS000599484|AKOS016340526|Tox21_113048_1|BCP9001025|DB00904|GR38032|KS-5227|NC00706|NSC 757870|NSC-791005|1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H- carbazol-4-one|NCGC00179341-04|NCGC00179341-07|NCGC00179341-12|AC-28927|FO157236|GR-38032|NCI60_022780|SMR001307702|ST077669|GR-38032F/GR-38032|Ondansetron(base and/or unspecified salts)|GR 38032F;GR-C507/75|AB00373674|NS00010141|39O049|C07325|D00456|EN300-117273|AB00373674-15|AB00373674-17|AB00373674_18|AB00373674_19|F047250|L000456|Q410011|SR-01000763250-4|BRD-A19736161-001-01-8|BRD-A19736161-001-05-9|BRD-A19736161-001-06-7|BRD-A19736161-003-03-0|BRD-A19736161-003-14-7|Z1501485364|(+/-)-2,3-DIHYDRO-9-METHYL-3-((2-METHYLIMIDAZOL-1-YL)METHYL)CARBAZOL-4(1H)-ONE|1,2,3,4-Tetrahydro-9-methyl-3-(2-methyl-1H-imidazol-1-ylmethyl)carbazole-4-one|1,2,3,9,-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-4H-carbazol-4-one|1,2,3,9-Tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1yl)methyl]-4H-carbazol-4-one|1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1 -yl)methyl]-4H-carbazol-4-one|1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazole-1-yl)methyl]-4H-carbazol-4-one|4H-Carbazol-4-one,?1,2,3,9-tetrahydro-9-methyl-3-[(2-methyl-1H-imidazol-1-yl)methyl]-|9-Methyl-3- (2-methyl-imidazol-1ylmethyl)-1,2,3,9-tetrahydro-carbazol-4-one|9-methyl-3-[(2-methylimidazol-1-yl)methyl]-2,3-dihydro-1~{H}-carbazol-4-one|4H-CARBAZOL-4-ONE, 1,2,3,9-TETRAHYDRO-9-METHYL-3-((2-METHYL-1H-IMIDAZOL-1-YL)METHYL)- (+/-)-"
ALOSETRON,2099,,"InChI=1S/C17H18N4O/c1-11-13(19-10-18-11)9-21-8-7-15-16(17(21)22)12-5-3-4-6-14(12)20(15)2/h3-6,10H,7-9H2,1-2H3,(H,18,19)",JSWZEAMFRNKZNL-UHFFFAOYSA-N,C17H18N4O,294.35,"5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one","alosetron|122852-42-0|GR68755|CHEBI:253342|5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one|alosetron monohydrochloride|A03AE01|13Z9HTH115|2,3,4,5-Tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H-pyrido(4,3-b)indol-1-one|GR 68755|1H-Pyrido(4,3-b)indol-1-one, 2,3,4,5-tetrahydro-5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-|DTXSID6044278|5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H,2H,3H,4H,5H-pyrido[4,3-b]indol-1-one|alosetronum|5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-1H,2H,3H,4H,5H-pyrido(4,3-b)indol-1-one|5-methyl-2-((5-methyl-1H-imidazol-4-yl)methyl)-3,4-dihydropyrido(4,3-b)indol-1-one|2,3,4,5-Tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1-one|RefChem:58090|DTXCID4024278|Lotronex|Alosetron (INN)|ALOSETRON [INN]|Alosetron [INN:BAN]|MLS001401464|5-Methyl-2-[(4-methyl-1H-imidazol-5-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one|NCGC00167528-01|SMR000469211|UNII-13Z9HTH115|ALOSETRON [MI]|ALOSETRON [VANDF]|SCHEMBL631|ALOSETRON [WHO-DD]|CHEMBL1110|cid_60758|SCHEMBL148316|GTPL2296|orb1705182|SCHEMBL29377019|BDBM93624|HMS3745K07|BCP14060|BDBM50014558|HY-70050A|MFCD00865546|AKOS027427023|CS-0640|DB00969|FA43705|5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indol-1-one|AS-83859|NS00070901|D07129|AB00698548-07|852A420|EN300-18563823|Q416463|BRD-K46742498-003-11-0|5-Methyl-2-(5-methyl-1H-imidazol-4-ylmethyl)-2,3,4,5-tetrahydro-pyrido[4,3-b]indol-1-one|5-methyl-2-[(4-methyl-1~{H}-imidazol-5-yl)methyl]-3,4-dihydropyrido[4,3-b]indol-1-one|2,3,4,5-tetrahydro-5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-1H-pyrido[4,3-b]indol-1one|5-Methyl-2-(5-methyl-3H-imidazol-4-ylmethyl)-2,3,4,5-tetrahydro-pyrido[4,3-b]indol-1-one hydrochloride|5-methyl-2-[(5-methyl-1H-imidazol-4-yl)methyl]-3,4-dihydropyrid[4,3-b]indol-1-one;hydrochloride"
PSI-352666,136141536,,"InChI=1S/C11H17FN5O13P3/c1-11(12)6(18)4(2-27-32(23,24)30-33(25,26)29-31(20,21)22)28-9(11)17-3-14-5-7(17)15-10(13)16-8(5)19/h3-4,6,9,18H,2H2,1H3,(H,23,24)(H,25,26)(H2,20,21,22)(H3,13,15,16,19)/t4-,6-,9-,11-/m1/s1",GFEXCNGIPRYQFE-GITKWUPZSA-N,C11H17FN5O13P3,539.20,"[[(2R,3R,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate","AT-9010|IR49Q7E87C|1261253-79-5|UNII-IR49Q7E87C|CHEMBL1630001|Psi-352666|(2'R)-2'-Deoxy-2'-fluoro-2'-methylguanosine 5'-(tetrahydrogen triphosphate)|Guanosine 5'-(tetrahydrogen triphosphate), 2'-deoxy-2'-fluoro-2'-methyl-, (2'R)-|[[(2R,3R,4R,5R)-5-(2-azanyl-6-oxidanylidene-1H-purin-9-yl)-4-fluoranyl-4-methyl-3-oxidanyl-oxolan-2-yl]methoxy-oxidanyl-phosphoryl] phosphono hydrogen phosphate|orb1691856|SCHEMBL15892588|BDBM50332459|DA-71095|HY-139165|CS-0181236|((2R,3R,4R,5R)-5-(2-amino-6-oxo-1H-purin-9(6H)-yl)-4-fluoro-3-hydroxy-4-methyltetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate|[[(2R,3R,4R,5R)-5-(2-amino-6-oxo-1H-purin-9-yl)-4-fluoro-3-hydroxy-4-methyloxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate"
EDROPHONIUM CHLORIDE,8307,,"InChI=1S/C10H15NO.ClH/c1-4-11(2,3)9-6-5-7-10(12)8-9;/h5-8H,4H2,1-3H3;1H",BXKDSDJJOVIHMX-UHFFFAOYSA-N,C10H16ClNO,201.69,ethyl-(3-hydroxyphenyl)-dimethylazanium;chloride,"Edrophonium chloride|116-38-1|Antirex|Reversol|Enlon|Edrophonii chloridum|Cloruro de edrofonio|Chlorure d'edrophonium|Ethyl(m-hydroxyphenyl)dimethylammonium chloride|Edrofonio cloruro|N-ethyl-3-hydroxy-N,N-dimethylanilinium chloride|Benzenaminium, N-ethyl-3-hydroxy-N,N-dimethyl-, chloride|TENSILON PRESERVATIVE FREE|QO611KSM5P|Edrophonium Chloride Preservative Free|NSC-759577|CHEBI:4759|DTXSID1022978|DTXCID302978|Camsilon|Adrophonium (cation)|Chloride, Edrophonium|RefChem:57120|Ethyl(m-hydroxyphenyl) Dimethylammonium Chloride|204-138-4|N-ethyl-3-hydroxy-N,N-dimethylbenzenaminium chloride|Tensilon chloride|Tensilon|Edrophonium (chloride)|ethyl-(3-hydroxyphenyl)-dimethylazanium;chloride|Benzenaminium, N-ethyl-3-hydroxy-N,N-dimethyl-, chloride (1:1)|MLS000028677|Edrophone Chloride|SMR000058672|MFCD00055064|(3-hydroxyphenyl)dimethylethylammonium chloride|3-hydroxy-N,N-dimethyl-N-ethylanilinium chloride|Edrophonii chloridum [INN-Latin]|SR-01000000275|NCGC00015409-02|CAS-116-38-1|Cloruro de edrofonio [INN-Spanish]|EINECS 204-138-4|Chlorure d'edrophonium [INN-French]|UNII-QO611KSM5P|Tensilon (TN)|Prestwick_192|Ammonium, dimethylethyl(m-hydroxyphenyl)-, chloride|Enlon (TN)|Edrophonium chloride [USP:INN:BAN:JAN]|Opera_ID_1421|CHEMBL1128|SCHEMBL34789|MLS001074086|SPECTRUM2300219|orb1301428|HMS502I11|HY-B0882R|AMMONIUM, ETHYL(m-HYDROXYPHENYL)DIMETHYL-, CHLORIDE|EDROPHONIUM CHLORIDE [MI]|Edrophonium (chloride) (Standard)|EDROPHONIUM CHLORIDE [INN]|EDROPHONIUM CHLORIDE [JAN]|HMS1568A08|HMS1922J20|HMS2093N16|HMS2095A08|HMS2233G08|HMS3259E12|HMS3261H03|HMS3369M15|HMS3712A08|HMS3886D07|HMS5085N15|Pharmakon1600-02300219|HY-B0882|EDROPHONIUM CHLORIDE [VANDF]|Tox21_110138|Tox21_500511|CCG-39644|EDROPHONIUM CHLORIDE [MART.]|NSC759577|EDROPHONIUM CHLORIDE [USP-RS]|EDROPHONIUM CHLORIDE [WHO-DD]|EDROPHONIUM CHLORIDE [WHO-IP]|3-(ethyldimethylamino)phenol, chloride|AKOS015890417|Tox21_110138_1|CS-4337|DS-0552|Edrophonium chloride (JP17/USP/INN)|LP00511|NC00561|NSC 759577|NCGC00015409-11|NCGC00093908-01|NCGC00093908-02|NCGC00093908-03|NCGC00093908-04|NCGC00093908-05|NCGC00261196-01|DA-73012|EDROPHONIUM CHLORIDE [ORANGE BOOK]|EDROPHONIUM CHLORIDE [EP MONOGRAPH]|EDROPHONII CHLORIDUM [WHO-IP LATIN]|EDROPHONIUM CHLORIDE [USP MONOGRAPH]|EU-0100511|NS00079218|ST51014996|D00994|E 3256|EN300-7370174|ENLON-PLUS COMPONENT EDROPHONIUM CHLORIDE|SR-01000000275-2|SR-01000000275-4|SR-01000000275-6|N-Ethyl-3-hydroxy-N,N-dimethyl-benzenaminium chloride|Q27068168|Edrophonium chloride, EuropePharmacopoeia (EP) Reference Standard|Edrophonium chloride, United States Pharmacopeia (USP) Reference Standard"
ETHOPROPAZINE HYDROCHLORIDE,122824,,"InChI=1S/C19H24N2S.ClH/c1-4-20(5-2)15(3)14-21-16-10-6-8-12-18(16)22-19-13-9-7-11-17(19)21;/h6-13,15H,4-5,14H2,1-3H3;1H",VXPCQISYVPFYRK-UHFFFAOYSA-N,C19H25ClN2S,348.9,"N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine;hydrochloride","Ethopropazine hydrochloride|1094-08-2|Profenamine hydrochloride|Ethopropazine HCl|Profenamine HCl|Profenamine monohydrochloride|O00T1I1VRN|NSC-64074|10-(2-(Diethylamino)propyl)phenothiazine monohydrochloride|NSC-169467|DTXSID4045347|CHEBI:31568|DTXCID2025347|N,N-diethyl-1-(10H-phenothiazin-10-yl)propan-2-amine hydrochloride|10-[2-(Diethylamino)propyl]phenothiazine monohydrochloride|RefChem:56565|214-134-4|256-019-1|Lysivane|Pardisol|Parfezin|Parphezein|Dibutil|Isothazine hydrochloride|Ethopropazine (hydrochloride)|10-[2-DIETHYLAMINOPROPYL]PHENOTHIAZINE|Parsidol hydrochloride|Parsidol monohydrochloride|N,N-Diethyl-alpha-methyl-10H-phenothiazine-10-ethylamine monohydrochloride|ethopropazine monohydrochloride|CHEMBL1200970|N,N-diethyl-1-phenothiazin-10-ylpropan-2-amine;hydrochloride|MFCD00012653|10-[2-(Diethylamino)propyl]phenothiazine hydrochloride|42957-54-0|Parphezin|10-(2-Diethylaminopropyl)phenothiazine|Parsidol (VAN)|Lysivane hydrochloride|10-(2-(Diethylamino)propyl)-phenothiazin Hydrochloride|Profenamine hydrochloride (JAN)|N,N-diethyl-alpha-methyl-10H-phenothiazine-10-ethylamine hydrochloride|PROFENAMINE HYDROCHLORIDE [JAN]|Dibutil hydrochloride|EINECS 214-134-4|NSC 64074|UNII-O00T1I1VRN|NSC 169467|C19H25ClN2S|diethyl(1-methyl-2-phenothiazin-10-ylethyl)amine, chloride|SR-05000001626|PROPHENAMINE HYDROCHLORIDE|10H-Phenothiazine-10-ethanamine,N-diethyl-.alpha.-methyl-, monohydrochloride|Ethopropazine hydrochloride [USP]|Parsidol (TN)|Prestwick_195|EINECS 256-019-1|l-10-(2-Diethylaminopropyl)phenothiazine hydrochloride|NCGC00016562-01|10-Phenothiazineethylamine, N,N-diethyl-alpha-methyl-, hydrochloride|CAS-1094-08-2|SCHEMBL123703|SPECTRUM1500293|orb1705084|SCHEMBL30516992|HMS1570H21|HMS1920O04|Pharmakon1600-01500293|BAA09408|BCP12225|NSC64074|Phenothiazine, 10-(2-(diethylamino)propyl)-, monohydrochloride|Tox21_110496|Tox21_500873|CCG-40202|NSC169467|NSC757029|SBB057672|10H-Phenothiazine-10-ethanamine, N,N-diethyl-alpha-methyl-, monohydrochloride|AKOS015901042|Tox21_110496_1|HY-107922R|LP00873|NSC-757029|ETHOPROPAZINE HYDROCHLORIDE [MI]|Ethopropazine (hydrochloride) (Standard)|NCGC00094678-01|NCGC00094678-02|NCGC00178860-06|NCGC00261558-01|PROFENAMINE HYDROCHLORIDE [MART.]|MS-25384|PROFENAMINE HYDROCHLORIDE [WHO-DD]|ETHOPROPAZINE HYDROCHLORIDE [VANDF]|DB-040867|HY-107922|CS-0030870|NS00089066|ST51006789|D01118|G90033|ETHOPROPAZINE HYDROCHLORIDE [ORANGE BOOK]|Ethopropazine hydrochloride, >=98% (HPLC), powder|SR-05000001626-2|Q27114444|N,N-diethyl-1-phenothiazin-10-yl-propan-2-amine;hydrochloride|10H-Phenothiazine-10-ethanamine,N,N-diethyl-a-methyl-,hydrochloride(1:1)|10H-PHENOTHIAZINE-10-ETHANAMINE, N,N-DIETHYL-.ALPHA.-METHYL-, HYDROCHLORIDE (1:1)|Ethopropazine Hydrochloride;Profenamine HCl; Ethopropazine HCl; 10-[2-diethylaminopropyl]phenothiazine"
MK-0893,11570626,,"InChI=1S/C32H27Cl2N3O4/c1-19(20-3-5-21(6-4-20)32(40)35-12-11-31(38)39)37-30(18-29(36-37)25-14-26(33)17-27(34)15-25)24-8-7-23-16-28(41-2)10-9-22(23)13-24/h3-10,13-19H,11-12H2,1-2H3,(H,35,40)(H,38,39)/t19-/m0/s1",DNTVJEMGHBIUMW-IBGZPJMESA-N,C32H27Cl2N3O4,588.5,"3-[[4-[(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)pyrazol-1-yl]ethyl]benzoyl]amino]propanoic acid","870823-12-4|MK 0893|MK-0893|MK0893|CCP2U6LWTP|DTXSID40468726|3-[[4-[(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)pyrazol-1-yl]ethyl]benzoyl]amino]propanoic acid|3-((4-((1S)-1-(3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)pyrazol-1-yl)ethyl)benzoyl)amino)propanoic acid|RefChem:159181|DTXCID30419545|3-((4-((1S)-1-(3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)phenyl)formamido)propanoic acid|(S)-3-(4-(1-(3-(3,5-Dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)benzamido)propanoic acid|CID 11570626|CHEMBL1933349|b-Alanine, N-[4-[(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxy-2-naphthalenyl)-1H-pyrazol-1-yl]ethyl]benzoyl]-|3-[[4-[(1~{s})-1-[3-[3,5-Bis(Chloranyl)phenyl]-5-(6-Methoxynaphthalen-2-Yl)pyrazol-1-Yl]ethyl]phenyl]carbonylamino]propanoic Acid|C32H27Cl2N3O4|compound 9m [PMID: 22708876]|SCHEMBL675777|GTPL9135|orb1709120|SCHEMBL29363684|VJB82312|BDBM50360601|EX-A10716|MFCD11616198|AKOS016011529|CS-0324|DB12044|DA-75576|HY-50663|MS-30504|NS00072925|MK-0893-005|F83670|BRD-K16732600-001-01-7|Q27086715|3-[[4-[(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxy-2-naphthyl)pyrazol-1-yl]ethyl]benzoyl]amino]propanoic acid|5MV|beta-Alanine, N-((4-((1S)-1-(3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl)ethyl)phenyl)carbonyl)-|N-[(4-{(1S)-1-[3-(3,5-dichlorophenyl)-5-(6-methoxynaphthalen-2-yl)-1H-pyrazol-1-yl]ethyl}phenyl)carbonyl]-beta-alanine|N-[4-[(1S)-1-[3-(3,5-DICHLOROPHENYL)-5-(6-METHOXY-2-NAPHTHALENYL)-1H-PYRAZOL-1-YL]ETHYL]BENZOYL]-ALANINE"
DEXMETHYLPHENIDATE,154101,,"InChI=1S/C14H19NO2/c1-17-14(16)13(11-7-3-2-4-8-11)12-9-5-6-10-15-12/h2-4,7-8,12-13,15H,5-6,9-10H2,1H3/t12-,13-/m1/s1",DUGOZIWVEXMGBE-CHWSQXEVSA-N,C14H19NO2,233.31,methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate,"Dexmethylphenidate|d-threo-Methylphenidate|(+)-threo-Methylphenidate|dexmetilfenidato|40431-64-9|Attenade|D-TMP|M32RH9MFGP|dexmethylphenidatum|CHEBI:51860|methyl (2R)-2-phenyl-2-[(2R)-piperidin-2-yl]acetate|methyl (R)-phenyl[(R)-piperidin-2-yl]acetate|DTXSID70893769|2-Piperidineacetic acid, alpha-phenyl-, methyl ester, (alphaR,2R)-|methyl (2R)-phenyl[(2R)-piperidin-2-yl]acetate|METHYL (2R)-PHENYL((2R)-PIPERIDIN-2-YL)ACETATE|methyl (R)-phenyl((R)-piperidin-2-yl)acetate|methyl (2R)-2-phenyl-2-((2R)-piperidin-2-yl)acetate|RefChem:56469|Methylphenidate d-threo-|N06BA11|DTXCID301323804|Dexmethylphenidate [INN]|CHEMBL827|Methylphenidate d-threo-form|40572-71-2|Focalin XR|Dexmethylphenidate (INN)|Methyl D-phenidate|d-Methylphenidate|Dex methylphenidate|D-MPH|UNII-M32RH9MFGP|threo-(+)-Methylphenidate|dex-methylphenidate|d-threo methylphenidate|A1D5U|SCHEMBL34326|GTPL7554|DEXMETHYLPHENIDATE [VANDF]|DEXMETHYLPHENIDATE [WHO-DD]|BDBM50062915|PDSP1_000871|PDSP1_000903|PDSP2_000857|PDSP2_000889|DB06701|FT28256|METHYLPHENIDATE D-THREO-FORM [MI]|NS00121152|D07806|Q1207210|(2S,2'S)-(-)-threo-methyl a-phenyl-a-(2-piperidyl)acetate hydrochloride|2-Piperidineacetic acid, .alpha.-phenyl-, methyl ester, (.alpha.S,2S)-|2-PIPERIDINEACETIC ACID, .ALPHA.-PHENYL-, METHYL ESTER, (.ALPHA.R,2R)-"
TRELAGLIPTIN,15983988,,"InChI=1S/C18H20FN5O2/c1-22-17(25)8-16(23-6-2-3-15(21)11-23)24(18(22)26)10-13-7-14(19)5-4-12(13)9-20/h4-5,7-8,15H,2-3,6,10-11,21H2,1H3/t15-/m1/s1",IWYJYHUNXVAVAA-OAHLLOKOSA-N,C18H20FN5O2,357.4,"2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile","TRELAGLIPTIN|865759-25-7|SYR-472|trelagliptina|trelagliptine|Q836OWG55H|DTXSID00235678|2-({6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl}methyl)-4-fluorobenzonitrile|trelagliptinum|2-((6-((3R)-3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidin-1-yl)methyl)-4-fluorobenzonitrile|RefChem:190727|DTXCID30158169|Trelagliptin [USAN]|MFCD22572746|(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile|CHEMBL1650443|C18H20FN5O2|865759-25-7 (free base)|Trelagliptin (USAN)|BENZONITRILE,2-[[6-[(3R)-3-AMINO-1-PIPERIDINYL]-3,4-DIHYDRO-3-METHYL-2,4-DIOXO-1(2H)-PYRIMIDINYL]METHYL]-4-FLUORO-|Trelagliptin(SYR-472)|(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)methyl)-4-fluorobenzonitrile.|2-[[6-[(3R)-3-aminopiperidin-1-yl]-3-methyl-2,4-dioxopyrimidin-1-yl]methyl]-4-fluorobenzonitrile|Trelagliptin [USAN:INN]|UNII-Q836OWG55H|Trelagliptin(syr472)|TRELAGLIPTIN [MI]|TRELAGLIPTIN [INN]|SCHEMBL175726|TRELAGLIPTIN [WHO-DD]|orb1300950|SCHEMBL29349599|EX-A470|CHEBI:134715|BDBM50335784|NSC802901|s7513|AKOS026674097|CCG-268122|DB15323|NSC-802901|NCGC00378845-01|AC-30279|AS-75009|HY-15408|5078B|NS00133765|D10178|Q27287099|(R)-2-((6-(3-aminopiperidin-1-yl)-3-methyl-2,4 dioxo-3,4-dihydropyrimidin-1(2h)-yl) methyl)-4-fluorobenzonitrile|2-((6-((3R)-3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)- yl)methyl)-4-fluorobenzonitrile|2-({6-[(3R)-3-Aminopiperidin-1-yl]-3-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl}methyl)-4-fluorobenzonitrile|2-[[6-[(3~{R})-3-azanylpiperidin-1-yl]-3-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]methyl]-4-fluoranyl-benzenecarboni|2-[[6-[(3~{R})-3-azanylpiperidin-1-yl]-3-methyl-2,4-bis(oxidanylidene)pyrimidin-1-yl]methyl]-4-fluoranyl-benzenecarboni trile|2-[[6-[(3R)-3-amino-1-piperidyl]-3-methyl-2,4-dioxo-pyrimidin-1-yl]methyl]-4-fluoro-benzonitrile|2-[6-(3-Aminopiperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl]-4-fluorobenzonitrile|6RL|Benzonitrile, 2-((6-((3R)-3-amino-1-piperidinyl)-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)- pyrimidinyl)methyl)-4-fluoro-|BENZONITRILE, 2-((6-((3R)-3-AMINO-1-PIPERIDINYL)-3,4-DIHYDRO-3-METHYL-2,4-DIOXO-1(2H)-PYRIMIDINYL)METHYL)-4-FLUORO-"
GRAPIPRANT,11677589,,"InChI=1S/C26H29N5O3S/c1-5-24-29-25-19(4)28-18(3)16-23(25)31(24)21-10-8-20(9-11-21)14-15-27-26(32)30-35(33,34)22-12-6-17(2)7-13-22/h6-13,16H,5,14-15H2,1-4H3,(H2,27,30,32)",HZVLFTCYCLXTGV-UHFFFAOYSA-N,C26H29N5O3S,491.6,"1-[2-[4-(2-ethyl-4,6-dimethylimidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonylurea","Grapiprant|415903-37-6|CJ-023423|CJ 023423|CJ-023,423|AAT-007|MR-10A7|CJ-023|MR10A7|RQ-00000007|J9F5ZPH7NB|DTXSID60194419|1-[2-[4-(2-ethyl-4,6-dimethylimidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(4-methylphenyl)sulfonylurea|Benzenesulfonamide, N-(((2-(4-(2-ethyl-4,6-dimethyl-1H-imidazo(4,5-c)pyridin-1-yl)phenyl)ethyl)amino)carbonyl)-4-methyl-|1-(2-(4-(2-ethyl-4,6-dimethylimidazo(4,5-c)pyridin-1-yl)phenyl)ethyl)-3-(4-methylphenyl)sulfonylurea|grapiprantum|Galliprant|RefChem:57297|DTXCID20116910|RQ-07|CJ023,423|CJ 023,423|3-(2-(4-(2-ethyl-4,6-dimethyl-1H-imidazo(4,5-c)pyridin-1-yl)phenyl)ethyl)-1-(4-methylbenzenesulfonyl)urea|N-(((2-(4-(2-ethyl-4,6-dimethyl-1H-imidazo(4,5-c)pyridin-1-yl) phenyl)ethyl)amino)carbonyl)-4-methylbenzenesulfonamide|N-((2,4-(2-ethyl-4,6-dimethyl-1H-imidazo(4,5-c)pyridin-1-yl)phenylethylamino)carbonyl)-4-methyl-benzenesulfonamide|N-((4-(2-ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenethyl)carbamoyl)-4-methylbenzenesulfonamide|RQ-7|CJ-023423 Hydrochloride Salt, Hydrate|CJ-023423;RQ-00000007;AAT-007|Grapiprant [USAN:INN]|UNII-J9F5ZPH7NB|Grapiprant (CJ-023423)|Grapiprant?|C26H29N5O3S|N-(((2-(4-(2-ETHYL-4,6-DIMETHYL-1H-IMIDAZO(4,5-C)PYRIDIN-1-YL)PHENYL)ETHYL)AMINO)CARBONYL)-4-METHYLBENZENESULFONAMIDE|N-[([2-[4-(2-Ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]amino)carbonyl]-4-methylbenzenesulfonamide|MFCD16628076|GRAPIPRANT [MI]|GRAPIPRANT [INN]|Grapiprant (USAN/INN)|GRAPIPRANT [USAN]|GRAPIPRANT [WHO-DD]|SCHEMBL120428|GTPL5858|orb1296072|GRAPIPRANT [GREEN BOOK]|CHEMBL3039498|Grapiprant (CJ-023,423)|SCHEMBL29496330|HZVLFTCYCLXTGV-UHFFFAOYSA-N|BCP20570|EX-A2544|QRA90337|BDBM50107283|s6694|AKOS030526811|CS-5392|DB12836|SB18902|AC-36123|AS-77380|DA-53699|HY-16781|NS00072230|D10638|D83673|BRD-K62050508-001-01-0|Q27077852|CJ-023423; RQ-00000007; AAT-007|Grapiprant; RQ-00000007; AAT-007; CJ-023423|1-[2-[4-(2-ethyl-4,6-dimethyl-imidazo[4,5-c]pyridin-1-yl)phenyl]ethyl]-3-(p-tolylsulfonyl)urea|2-ETHYL-4,6-DIMETHYL-1-(4-(2-(((((4-METHYLPHENYL)SULFONYL)AMINO)CARBONYL)AMINO)ETHYL)PHENYL)-1H-IMIDAZO(4,5-C)PYRIDINE|N-(((2-(4-(2-ETHYL-4,6-DIMETHYL-1H-IMIDAZO(4,5-C)PYRIDIN-1-YL)PHENYL)ETHYL)AMINO)CARBONYL)-4-METHYL-BENZENESULFONAMIDE|N-(4-(2-Ethyl-4,6-dimethyl-1H-imidazo[4,5-c]pyridin-1-yl)phenethylcarbamoyl)-4-methylbenzenesulfonamide"
LAS101057,16071896,,"InChI=1S/C18H14FN5O/c19-14-9-21-7-5-13(14)17-16(12-2-1-6-20-8-12)23-15(10-22-17)24-18(25)11-3-4-11/h1-2,5-11H,3-4H2,(H,23,24,25)",XUYURJQIMYCWBB-UHFFFAOYSA-N,C18H14FN5O,335.3,N-[5-(3-fluoropyridin-4-yl)-6-pyridin-3-ylpyrazin-2-yl]cyclopropanecarboxamide,"925676-48-8|LAS101057|N-(5-(3-fluoropyridin-4-yl)-6-(pyridin-3-yl)pyrazin-2-yl)cyclopropanecarboxamide|LAS-101057|3EBU6WKP85|N-[5-(3-fluoropyridin-4-yl)-6-pyridin-3-ylpyrazin-2-yl]cyclopropanecarboxamide|MFCD18782728|N-[5-(3-FLUOROPYRIDIN-4-YL)-6-(PYRIDIN-3-YL)PYRAZIN-2-YL]CYCLOPROPANECARBOXAMIDE|C18H14FN5O|CHEMBL1672627|N-(5-(3-Fluoro-4-pyridyl)-6-(3-pyridyl)pyrazin-2-yl)cyclopropanecarboxamide|LAS 101057|Cyclopropanecarboxamide, N-(5-(3-fluoro-4-pyridinyl)-6-(3-pyridinyl)-2-pyrazinyl)-|CYCLOPROPANECARBOXAMIDE, N-[5-(3-FLUORO-4-PYRIDINYL)-6-(3-PYRIDINYL)-2-PYRAZINYL]-|N-[5-(3-fluoro-4-pyridyl)-6-(3-pyridyl)pyrazin-2-yl]cyclopropanecarboxamide|RefChem:1088364|UNII-3EBU6WKP85|orb1707095|SCHEMBL3075657|SCHEMBL29941566|BDBM50336977|AKOS037647409|CS-6718|AS-73581|CID 16071896|DA-64868|HY-14390|W16537"
ORTERONEL,9796590,,"InChI=1S/C18H17N3O2/c1-19-17(22)14-3-2-13-9-15(5-4-12(13)8-14)18(23)6-7-21-11-20-10-16(18)21/h2-5,8-11,23H,6-7H2,1H3,(H,19,22)/t18-/m0/s1",OZPFIJIOIVJZMN-SFHVURJKSA-N,C18H17N3O2,307.3,"6-[(7S)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide","Orteronel|566939-85-3|TAK-700|orteronelum|UE5K2FNS92|6-[(7S)-7-HYDROXY-6,7-DIHYDRO-5H-PYRROLO[1,2-C]IMIDAZOL-7-YL]-N-METHYL-2-NAPHTHALENECARBOXAMIDE|DTXSID001319121|6-((7S)-7-Hydroxy-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-7-yl)-N-methyl-2-naphthalenecarboxamide|6-((7S)-7-hydroxy-5H,6H,7H-pyrrolo(1,2-c)imidazol-7-yl)-N-methylnaphthalene-2-carboxamide|6-[(7S)-7-hydroxy-5H,6H,7H-pyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide|RefChem:856930|DTXCID101748551|CYP17A1 Lyase Inhibitor TAK-700|Androgen Synthesis Inhibitor TAK-700|TAK 700|(S)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide|(S)-Orteronel|TAK700|6-[(7S)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide|CHEMBL1921976|566939-85-3 (s-isomer)|TAK-700 (S-form)|6-((7S)-7-hydroxy-6,7-dihydro-5H-pyrrolo(1,2-c)imidazol-7-yl)-N-methyl-2-naphthamide|Orteronel [INN]|6-[(7S)-7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methylnaphthalene-2-carboxamide|Orteronel [USAN:INN]|UNII-UE5K2FNS92|6-[(7s)-7-hydroxy-6,7-dihydro-5h-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthamide|(+)-orteronel|MFCD20528078|ORTERONEL [JAN]|Orteronel (JAN/USAN)|ORTERONEL [USAN]|ORTERONEL [WHO-DD]|orb1689515|SCHEMBL6126076|566939-85-3,Orteronel|SCHEMBL29363567|GTPL13853|S-TAK-700|EX-A159|(R)-6-(7-hydroxy-6,7-dihydro-5H-pyrrolo[1,2-c]imidazol-7-yl)-N-methyl-2-naphthamide|CHEBI:231353|(S)-TAK700|csa:566939-85-3;Orteronel|GLXC-06640|HMS3750I13|RXA93985|Orteronel,CAS:566939-85-3|BDBM50358201|CYP17A1 Inhibitor II, TAK-700|AKOS030526849|CS-0580|DB12066|SB16686|NCGC00378767-02|AS-74591|HY-10505|NS00069633|compound (+)-3c [PMID: 21978946]|D10146|2-NAPHTHALENECARBOXAMIDE, 6-((7S)-6,7-DIHYDRO-7-HYDROXY-5H-PYRROLO(1,2-C)IMIDAZOL-7-YL)-N-METHYL-|6-[(7S)-6,7-dihydro-7-hydroxy-5H-pyrrolo[1,2-c]imidazol-7-yl]-N-methyl-2-naphthalenecarboxamide|6-[(7S)-7-hydroxy-5,6-dihydropyrrolo[1,2-c]imidazol-7-yl]-N-methyl-naphthalene-2-carboxamide"
TIOTROPIUM,5487427,,"InChI=1S/C19H22NO4S2/c1-20(2)12-9-11(10-13(20)17-16(12)24-17)23-18(21)19(22,14-5-3-7-25-14)15-6-4-8-26-15/h3-8,11-13,16-17,22H,9-10H2,1-2H3/q+1/t11?,12-,13+,16-,17+",LERNTVKEWCAPOY-FPISHFTHSA-N,C19H22NO4S2+,392.5,"[(1R,2R,4S,5S)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate","Tiotropium|186691-13-4|Spiriva|tiotropium cation|Tiotropium ion|BA 679 BR|BA-679 BR|[3H]tiotropium|UNII-0EB439235F|0EB439235F|BA-679-BR|CHEMBL4650755|(3H)tiotropium|7-((Hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane bromide|CHEMBL4638964|(1r,2r,4s,5s,7s)-7-{[hydroxy(Dithiophen-2-Yl)acetyl]oxy}-9,9-Dimethyl-3-Oxa-9-Azoniatricyclo[3.3.1.0~2,4~]nonane|[(1S,2S,4R,5R)-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonan-7-yl] 2-hydroxy-2,2-dithiophen-2-ylacetate|NCGC00167971-01|(1R,2R,4S,5S)-7-{[2-hydroxy-2,2-bis(thiophen-2-yl)acetyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium|0HK|679 BR, BA|RefChem:1050232|TIOTROPIUM [VANDF]|TIOTROPIUM [WHO-DD]|GTPL367|GTPL8592|SCHEMBL4662461|CHEMBL1900528|CHEMBL3305968|SCHEMBL29355399|CHEBI:90960|LERNTVKEWCAPOY-DZZGSBJMSA-N|BDBM50066861|BDBM50538220|BDBM50581209|DB01409|AB01274813-01|AB01274813-02|AB01274813-03|Q424316|BRD-K62782754-337-02-5|Q27088996|(1alpha,2beta,4beta,5alpha,7beta)-7-[(hydroxydi-2-thienylacetyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane|3-OXA-9-AZONIATRICYCLO(3.3.1.02,4)NONANE, 7-((2-HYDROXY-2,2-DI-2-THIENYLACETYL)OXY)-9,9-DIMETHYL-, (1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.)-|7-((hydroxybis(2-thienyl)acetyl)oxy)-9,9-dimethyl-3-oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane"
NICLOSAMIDE,4477,,"InChI=1S/C13H8Cl2N2O4/c14-7-1-4-12(18)9(5-7)13(19)16-11-3-2-8(17(20)21)6-10(11)15/h1-6,18H,(H,16,19)",RJMUSRYZPJIFPJ-UHFFFAOYSA-N,C13H8Cl2N2O4,327.12,5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide,"niclosamide|50-65-7|5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxybenzamide|Niclocide|Cestocid|Devermin|Devermine|Helmiantin|Mansonil|Phenasal|Radeverm|Tredemine|Vermitid|Atenase|Fenasal|Iomesan|Iomezan|Lintex|Nasemo|Sagimid|Sulqui|Yomesan|Mato|Fedal-Telmin|Zestocarp|Bayer 73|BAY 2353|Niclosamida|Bayer 2353|Chemagro 2353|Niclosamidum|Benzamide, 5-chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxy-|Niclosamide (anhydrous)|WR 46234|5-Chloro-2'-chloro-4'-nitrosalicylanilide|HL 2447|Nitrophenyl chlorsalicylamide|Niclosamide, anhydrous|ENT 25823|2-Hydroxy-5-chloro-N-(2-chloro-4-nitrophenyl)benzamide|N-(2-Chloro-4-nitrophenyl)-5-chlorosalicylamide|2-Chloro-4-nitrophenylamide-6-chlorosalicylic acid|Salicylanilide, 2',5-dichloro-4'-nitro-|2',5-Dichlor-4'-nitro-salizylsaeureanilid|8KK8CQ2K8G|NSC-178296|Niclosamide Anhydrous|Niclosamidum anhydrous|DTXSID7040362|5-Chloro-N-(2'-chloro-4'-nitrophenyl)salicylamide|5-Chlorosalicyloyl-(o-chloro-p-nitranilide)|BAY-2353|B 2353|CHEBI:7553|DTXCID5020362|NICLOSIDE|Ex A Lint|RefChem:57983|P02DA01|200-056-8|2',5-Dichloro-4'-nitrosalicylanilide|C13H8Cl2N2O4|nicolsamide|MFCD00057597|N-(2'-Chlor-4'-nitrophenyl)-5-chlorsalicylamid|CAS-50-65-7|5-Chloro-N-(2-chloro-4-nitro-phenyl)-2-hydroxy-benzamide|NCGC00015735-07|Radewerm|Niclosamide 100 microg/mL in Acetonitrile|N-(2'-Chloro-4'-nitrophenyl)-5-chlorosalicylamide|Cestocide|Niclosamidum [INN-Latin]|Niclosamida [INN-Spanish]|Niclosamide [ISO]|Niclosamide [USAN:INN:BAN]|CCRIS 3437|HSDB 1572|SR-01000076024|Niclosamide [BSI:ISO]|EINECS 200-056-8|UNII-8KK8CQ2K8G|NSC 178296|BRN 2820605|5-Chloro-N-(2-chloro-4-nitrophenyl)-2-hydroxy-benzamide|Yomensan|niclo-samide|AI3-25823|Niclocide (TN)|Prestwick_354|Niclosamide (GMP)|2',5-Dichlor-4'-nitro-salizylsaeureanilid [German]|Mollutox (Salt/Mix)|N-(2'-Chlor-4'-nitrophenyl)-5-chlorsalicylamid [German]|Niclosamide (Standard)|Spectrum_000239|Niclosamide (Niclocide)|Clonitralid (Salt/Mix)|Clonitralide (Salt/Mix)|NICLOSAMIDE [MI]|Prestwick0_000040|Prestwick1_000040|Prestwick2_000040|Prestwick3_000040|Spectrum2_001183|Spectrum3_000667|Spectrum4_000196|Spectrum5_001083|Lopac-N-3510|NICLOSAMIDE [INN]|Niclosamide (USAN/INN)|NICLOSAMIDE [HSDB]|NICLOSAMIDE [USAN]|NICLOSAMIDE [VANDF]|CHEMBL1448|NICLOSAMIDE [MART.]|Lopac0_000866|Oprea1_259151|SCHEMBL67182|BSPBio_000139|BSPBio_002333|KBioGR_000771|KBioSS_000719|NICLOSAMIDE [WHO-DD]|MLS002154181|DivK1c_000709|SPECTRUM1503265|SPBio_001225|SPBio_002060|BPBio1_000153|GTPL8494|orb1310361|NICLOSAMIDE [GREEN BOOK]|SCHEMBL18563900|SCHEMBL27365268|SCHEMBL29363878|WLN: WNR CG DMVR BQ EG|BDBM11242|HMS502D11|HY-B0497G|HY-B0497R|KBio1_000709|KBio2_000719|KBio2_003287|KBio2_005855|KBio3_001553|Niclosamide - CAS 50-65-7|NICLOSAMIDE [ORANGE BOOK]|NINDS_000709|BDBM513089|HMS1568G21|HMS2093A21|HMS2095G21|HMS2231H06|HMS3262N13|HMS3373P08|HMS3712G21|HMS5081M06|KUC107299N|NICLOSAMIDE [EP MONOGRAPH]|Pharmakon1600-01503265|BCP22958|HY-B0497|MSK20493|Tox21_110209|Tox21_300749|Tox21_500866|BBL004110|CCG-39641|HB1435|NSC178296|NSC758440|s3030|Salicylanilide,5-dichloro-4'-nitro-|STK396676|2,5-dichloro-4-nitrosalicylanilide ?|AKOS003589004|NICLOSAMIDE ANHYDROUS [WHO-IP]|Tox21_110209_1|AT15436|BCP9000068|DB06803|FN01544|KS-5210|LP00866|NSC-758440|SB19414|SDCCGSBI-0050841.P004|2',5'-Dichloro-4'-nitrosalicylanilide|IDI1_000709|SMP2_000228|NCGC00015735-01|NCGC00015735-02|NCGC00015735-03|NCGC00015735-04|NCGC00015735-05|NCGC00015735-06|NCGC00015735-08|NCGC00015735-09|NCGC00015735-11|NCGC00015735-12|NCGC00015735-17|NCGC00015735-21|NCGC00015735-24|NCGC00094190-01|NCGC00094190-02|NCGC00094190-03|NCGC00094190-04|NCGC00254654-01|NCGC00261551-01|KSC-18-157-2|SMR000058390|SBI-0050841.P003|DB-051812|VU0243604|AB00052340|EU-0100866|NICLOSAMIDE, ANHYDROUS [EP IMPURITY]|NICLOSAMIDUM ANHYDROUS [WHO-IP LATIN]|NS00000613|ST50408862|EN300-92958|D00436|N 3510|AB00052340_08|AB00052340_09|A828227|Q418523|SR-01000076024-1|SR-01000076024-3|SR-01000076024-6|BRD-K35960502-001-06-9|BRD-K35960502-001-11-9|BRD-K35960502-001-19-2|BRD-K35960502-001-20-0|Z57902203|(5-chloro-2-hydroxyphenyl)-N-(2-chloro-4-nitrophenyl)carboxamide|5-chloranyl-N-(2-chloranyl-4-nitro-phenyl)-2-oxidanyl-benzamide|Niclosamide (anhydrous), European Pharmacopoeia (EP) Reference Standard|VUT"
CHS-828,148198,,"InChI=1S/C19H22ClN5O/c20-16-5-7-18(8-6-16)26-14-4-2-1-3-11-23-19(24-15-21)25-17-9-12-22-13-10-17/h5-10,12-13H,1-4,11,14H2,(H2,22,23,24,25)",BOIPLTNGIAPDBY-UHFFFAOYSA-N,C19H22ClN5O,371.9,2-[6-(4-chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine,"200484-11-3|CHS-828|CHS 828|CHS828|GMX-1778|8LAP87DNSZ|RefChem:577082|Pyridyl Cyanoguanidine CHS 828|N-(6-(4-Chlorophenoxy)hexyl)-N'-Cyano-N''-4-Pyridylcyanoguanidine|(Z)-N'-(6-(4-chlorophenoxy)hexyl)-N-cyano-N''-(pyridin-4-yl)guanidine|GMX1778|2-[6-(4-chlorophenoxy)hexyl]-1-cyano-3-pyridin-4-ylguanidine|Guanidine, N-[6-(4-chlorophenoxy)hexyl]-N'-cyano-N''-4-pyridinyl-|GMX 1778|1-[6-(4-Chlorophenoxy)hexyl]-3-cyano-2-pyridin-4-ylguanidine|MFCD03700766|CHEMBL17289|1-(6-(4-chlorophenoxy)hexyl)-2-cyano-3-(pyridin-4-yl)guanidine|(E)-1-(6-(4-chlorophenoxy)hexyl)-2-cyano-3-(pyridin-4-yl)guanidine|UNII-8LAP87DNSZ|C19H22ClN5O|Guanidine, N-(6-(4-chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridinyl-|GMX1778 (CHS828)|SCHEMBL504150|SCHEMBL504151|SCHEMBL504892|SCHEMBL810184|SCHEMBL810990|orb1306792|SCHEMBL2672576|SCHEMBL12083293|SCHEMBL16312347|SCHEMBL23924547|BDBM81396|CHEBI:95016|DTXSID20942059|EX-A713|BOIPLTNGIAPDBY-UHFFFAOYSA-N|GLXC-04065|BCP15158|N-(6-(4-Chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridinylguanidine|GMX1778? CHS-828|BDBM50435350|HB3837|s8117|AKOS026750302|AKOS028109359|AKOS032960393|CHS-828; GMX-1778|GMX1778(CHS-828)?|GMX1778; CHS 828;|CCG-268319|CS-3852|DB12980|NCGC00345782-01|AC-32882|AS-71873|DA-63840|HY-10079|NS00070832|F15167|BRD-K47335880-001-01-3|BRD-K69832040-001-01-9|Q27166775|2-[6-(4-chlorophenoxy)hexyl]-1-cyano-3-(4-pyridyl)guanidine|N'-[6-(4-chlorophenoxy)hexyl]-N-cyano-N''-(pyridin-4-yl)guanidine|N-(6-(4-chlorophenoxy)-hexyl)-N'-cyano-N''-(4-pyridyl)-guanidine|N-(6-(4-chlorophenoxy)hexyl)-N'-cyano-N''-4-pyridyl guanidine|N-Cyano-N'-(6-(p-chlorophenoxy)hexyl)-N""-(4-pyridyl)guanidine|N''-[6-(4-Chlorophenoxy)hexyl]-N-cyano-N'-pyridin-4(1H)-ylideneguanidine|N-(6-(4-CHLOROPHENOXY)HEXYL)-N'-CYANO-N''-4-PYRIDINYL-GUANIDINE|N-CYANO-N'-(6-(P-CHLOROPHENOXY)HEXYL)-N\-(4-PYRIDYL)GUANIDINE"""
ERTIPROTAFIB,157049,,"InChI=1S/C31H27BrO3S/c1-17-14-22(15-18(2)29(17)35-25(31(33)34)16-21-10-6-5-7-11-21)27-23-12-8-9-13-24(23)28(32)30-26(27)19(3)20(4)36-30/h5-15,25H,16H2,1-4H3,(H,33,34)/t25-/m1/s1",FONCZICQWCUXEB-RUZDIDTESA-N,C31H27BrO3S,559.5,"(2R)-2-[4-(9-bromo-2,3-dimethylbenzo[f][1]benzothiol-4-yl)-2,6-dimethylphenoxy]-3-phenylpropanoic acid","Ertiprotafib|251303-04-5|PTP-112|5TPM2EB426|ptp112|DTXSID30179814|(2R)-2-(4-(9-Bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic acid|ertiprotafibum|(2R)-2-[4-(9-Bromo-2,3-dimethylnaphtho[2,3-b]thiophen-4-yl)-2,6-dimethylphenoxy]-3-phenylpropionic acid|RefChem:591095|DTXCID90102305|(2R)-2-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropanoic acid|CHEMBL184041|(2R)-2-[4-(9-bromo-2,3-dimethylbenzo[f][1]benzothiol-4-yl)-2,6-dimethylphenoxy]-3-phenylpropanoic acid|Ertiprotafib [USAN:INN]|UNII-5TPM2EB426|Ertiprotafib [USAN]|Ertiprotafib (USAN/INN)|ERTIPROTAFIB [INN]|orb1707329|SCHEMBL6703442|FONCZICQWCUXEB-RUZDIDTESA-N|GLXC-21768|BDBM50209683|AKOS040741711|DB06521|DA-63273|HY-19383|MS-30174|CS-0015482|NS00068635|D04050|G15913|Q27262858|(2R)-2-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropionic  acid|(2R)-2-[4-(9-bromo-2,3-dimethyl-naphtho[2,3-b]thiophen-4-yl)-2,6-dimethyl-phenoxy]-3-phenyl-propionic acid|(R)-2-(4-(9-bromo-2,3-dimethylnaphtho[2,3-b]thiophen-4-yl)-2,6-dimethylphenoxy)-3-phenylpropanoic acid|2-[4-(9-Bromo-2,3-dimethyl-naphtho[2,3-b]thiophen-4-yl)-2,6-dimethyl-phenoxy]-3-phenyl-propionic acid|BENZENEPROPANOIC ACID, .ALPHA.-(4-(9-BROMO-2,3-DIMETHYLNAPHTHO(2,3-B)THIEN-4-YL)-2,6-DIMETHYLPHENOXY)-, (.ALPHA.R)-|Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-, (alphaR)-|Benzenepropanoic acid, alpha-(4-(9-bromo-2,3-dimethylnaphtho(2,3-b)thien-4-yl)-2,6-dimethylphenoxy)-,(alpha R)-"
AZELASTINE,2267,,"InChI=1S/C22H24ClN3O/c1-25-13-4-5-18(12-14-25)26-22(27)20-7-3-2-6-19(20)21(24-26)15-16-8-10-17(23)11-9-16/h2-3,6-11,18H,4-5,12-15H2,1H3",MBUVEWMHONZEQD-UHFFFAOYSA-N,C22H24ClN3O,381.9,4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one,"azelastine|58581-89-8|Azelastina|4-(4-chlorobenzyl)-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one|Azelastinum|4-(p-Chlorobenzyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1-(2H)-phthalazinone|CHEBI:2950|ZQI909440X|NSC-758971|DTXSID6022638|1(2H)-Phthalazinone, 4-((4-chlorophenyl)methyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-|A-5610|A 5610|4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)-1,2-dihydrophthalazin-1-one|4-((4-chlorophenyl)methyl)-2-(1-methylazepan-4-yl)-1,2-dihydrophthalazin-1-one|Vividrin akut Azelastin|RefChem:54397|4-(p-chlorobenzyl)-2-(N-methylperhydroazepinyl-(4))-1-(2H)-phthalazinone|DTXCID502638|R01AC03|R06AX19|S01GX07|Azelastinum [INN-Latin]|Azelastina [INN-Spanish]|4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1-one|Azelastine (INN)|CHEMBL639|1(2H)-Phthalazinone,4-[(4-chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-|Optilast|AZELASTINE [INN]|Azelastine [INN:BAN]|1(2H)-phthalazinone, 4-[(4-chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-, hydrochloride|Optivar (TN)|BRN 0900747|rac-Azelastine|UNII-ZQI909440X|HSDB 7991|4-[(4-Chlorophenyl)methyl]-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone;|(+-)-Azelastine|758637-88-6|AZELASTINE [MI]|Spectrum2_000649|Spectrum3_001984|AZELASTINE [VANDF]|SCHEMBL4239|AZELASTINE [WHO-DD]|BSPBio_003584|4-((4-Chlorophenyl)methyl)-2-(hexahydro-1-methyl-1H-azepin-4-yl)-1(2H)-phthalazinone hydrochloride|SPBio_000657|GTPL7121|orb1310832|SCHEMBL29370712|HY-B0462A|KBio3_002992|ALBB-022465|BCP14047|Tox21 111469|BDBM50341448|STL429828|4-[(4-chlorophenyl)methyl]-2-(1-methylazepan-4-yl)phthalazin-1(2H)-one|AKOS015894880|DB00972|NSC 758971|4-[(4-chlorophenyl)methyl]-2-(hexahydro-1-methyl-1h-azepin-4-yl)-1(2h)-phthalazinone|s12214|NCGC00177979-01|NCGC00177979-02|NCGC00177979-03|BS-32594|SBI-0206747.P001|DS-002751|NS00003187|81A898|C07768|D07483|AB00698544-09|AB00698544-11|AB00698544_12|AB00698544_13|EN300-7409356|L001153|Q419820|BRD-A68888262-003-02-9|BRD-A68888262-003-07-8|BRD-A68888262-003-15-1|BRD-A68888262-003-16-9|1(2H)-phthalazinone,4-[(4-chlorophenyl)methyl]-2-[(4s)-hexahydro-1-methyl-1h-azepin-4-yl]-"
BERZOSERTIB,59472121,,"InChI=1S/C24H25N5O3S/c1-15(2)33(30,31)19-10-8-18(9-11-19)21-14-27-24(25)23(28-21)22-12-20(29-32-22)17-6-4-16(5-7-17)13-26-3/h4-12,14-15,26H,13H2,1-3H3,(H2,25,27)",JZCWLJDSIRUGIN-UHFFFAOYSA-N,C24H25N5O3S,463.6,"3-[3-[4-(methylaminomethyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine","1232416-25-9|Berzosertib|VE-822|VX-970|VX970|L423PRV3V3|M6620|2-Pyrazinamine, 3-[3-[4-[(methylamino)methyl]phenyl]-5-isoxazolyl]-5-[4-[(1-methylethyl)sulfonyl]phenyl]-|3-(3-{4-[(METHYLAMINO)METHYL]PHENYL}-1,2-OXAZOL-5-YL)-5-[4-(PROPANE-2-SULFONYL)PHENYL]PYRAZIN-2-AMINE|2-Pyrazinamine, 3-(3-(4-((methylamino)methyl)phenyl)-5-isoxazolyl)-5-(4-((1-methylethyl)sulfonyl)phenyl)-|3-[3-[4-(methylaminomethyl)phenyl]-1,2-oxazol-5-yl]-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine|M-6620|VX 970|3-(3-(4-((METHYLAMINO)METHYL)PHENYL)-1,2-OXAZOL-5-YL)-5-(4-(PROPANE-2-SULFONYL)PHENYL)PYRAZIN-2-AMINE|berzosertibum|3-(3-(4-(methylaminomethyl)phenyl)-1,2-oxazol-5-yl)-5-(4-propan-2-ylsulfonylphenyl)pyrazin-2-amine|RefChem:917027|M 6620|VE822|VE 822|5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine|MFCD27976794|Berzosertib [USAN]|VE-822 (VX-970)|3-[3-[4-[(Methylamino)methyl]phenyl]-5-isoxazolyl]-5-[4-[(1-methylethyl)sulfonyl]phenyl]-2-pyrazinamine|A1EIE|BDBM50226746|5-(4-isopropylsulfonylphenyl)-3-[3-[4-(methylaminomethyl)phenyl]isoxazol-5-yl]pyrazin-2-amine|5-(4-(isopropylsulfonyl)phenyl)-3-(3-(4-((methylamino)methyl)phenyl)isoxazol-5-yl)pyrazin-2-amine.|UNII-L423PRV3V3|3-(3-(4-((Methylamino)methyl)phenyl)-5-isoxazolyl)-5-(4-((1-methylethyl)sulfonyl)phenyl)-2-pyrazinamine|VX-970;Berzosertib|BERZOSERTIB [INN]|Berzosertib (USAN/INN)|Berzosertib (VE-822)|AGN-PC-0CXKB3|VE-822 (Berzosertib)?|BERZOSERTIB [WHO-DD]|GTPL8003|orb1701146|SCHEMBL3061890|CHEMBL3989870|SCHEMBL30514080|EX-A529|CHEBI:131166|BDBM350085|DTXSID601025940|HMS3653C05|HMS3747I11|BCP07948|NSC777718|s7102|US10208027, Compound II-1|US10208027, Compound II-2|US10208027, Compound II-3|US10208027, Compound II-4|AKOS025404905|CCG-264673|CS-1861|DB11794|NSC-777718|SB17265|NCGC00386313-07|AC-32951|AS-17041|DA-46989|FV137734|HY-13902|SY057018|NS00073122|SW220202-1|D11148|BRD-K04701033-001-01-3|BRD-K04701033-001-03-9|BRD-K04701033-001-04-7|Q27089129|2-Amino-5-[4-(isopropylsulfonyl)phenyl]-3-[3-[4-[(methylamino)methyl]phenyl]-5-isoxazolyl]pyrazine|Synthesis of 3-[3-[4-[dideuterio(methylamino)methyl]phenyl]isoxazol-5-yl]-5-(4-isopropylsulfonylphenyl)pyrazin-2-amine"
ABC-294640,15604015,,"InChI=1S/C23H25ClN2O/c24-20-3-1-19(2-4-20)22-10-17-9-18(11-22)13-23(12-17,15-22)21(27)26-14-16-5-7-25-8-6-16/h1-8,17-18H,9-15H2,(H,26,27)",CAOTVXGYTWCKQE-UHFFFAOYSA-N,C23H25ClN2O,380.9,3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide,"ABC294640|Opaganib|915385-81-8|ABC-294640|3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide|ABC 294640|Yeliva|DTXSID801318727|DRG21OQ517|4-pyridinylmethyl-3-(4-chlorophenyl) adamantane carboxamide|4-PYRIDINYLMETHYL 3(4-CHLOROPHENYL)ADAMANTINE CARBOXAMIDE|Tricyclo(3.3.1.13,7)decane-1-carboxamide, 3-(4-chlorophenyl)-N-(4-pyridinylmethyl)-|opaganibum|RefChem:856796|SK2 inhibitor ABC294640|DTXCID801748526|3-(4-chlorophenyl)-N-((pyridin-4-yl)methyl)adamantane-1-carboxamide|MFCD22666355|CHEMBL2158685|OPAGANIB [INN]|ABC294640Opaganib?|OPAGANIB [WHO-DD]|Opaganib (ABC294640)|GTPL6624|orb1300500|SCHEMBL1548333|CHEBI:124965|HMS3402P05|BCP08959|EX-A1962|BDBM50393642|NSC796101|AKOS027327311|CCG-268417|CS-0877|DB12764|NSC-796101|SB17167|AC-33116|AS-56117|BA162479|HY-16015|S7174|BRD-A70814879-001-01-2|BRD-A70814879-003-01-8|BRD-A70814879-003-02-6|Q27074100|3-(4-chlorophenyl)-N-(4-pyridylmethyl)adamantane-1-carboxamide|ABC294640|915385-81-8|ABC-294640|(1s,3r,5R,7S)-3-(4-chlorophenyl)-N-(pyridin-4-ylmethyl)adamantane-1-carboxamide"
TETRACAINE,5411,,"InChI=1S/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H3",GKCBAIGFKIBETG-UHFFFAOYSA-N,C15H24N2O2,264.36,2-(dimethylamino)ethyl 4-(butylamino)benzoate,"tetracaine|94-24-6|Amethocaine|2-(Dimethylamino)ethyl 4-(butylamino)benzoate|Pontocaine|Dicaine|Laudocaine|Metraspray|Tetracaina|Anetain|Uromucaesthin|Contralgin|Fissucain|Intercain|Medicaine|Meethobalm|Mucaesthin|Niphanoid|Tetracainum|Tetrakain|Dicain|Dikain|Medihaler-Tetracaine|2-(Dimethylamino)ethyl p-(butylamino)benzoate|p-Butylaminobenzoyl-2-dimethylaminoethanol|Benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester|Diaethylaminoaethanol ester der p-butylaminobenzoesaeure|CHEBI:9468|0619F35CGV|DTXSID1043883|p-(butylamino)benzoic acid beta-(dimethylamino)ethyl ester|Tetracaine cream|FranklyNumb 3|Painless Tattoo 3|Burn Solution Cream|RefChem:56112|Numfast Tetracaine Green|Hydrochloride, Tetrracaine|BLT 3|DTXCID9023883|dicainum (for the hydrochloride)|C05AD02|D04AB06|N01BA03|S01HA03|202-316-6|Rexocaine|MFCD00053787|Dimethylaminoethyl p-butyl-aminobenzoate|4-(Butylamino)benzoic acid 2-(dimethylamino)ethyl ester|p-(Butylamino)benzoic acid, 2-(dimethylamino)ethyl ester|CHEMBL698|BENZOIC ACID, p-(BUTYLAMINO)-, 2-(DIMETHYLAMINO)ETHYL ESTER|2-Dimethylaminoethylester kyseliny p-butylaminobenzoove|Butylocaine|Tetrakain [Czech]|Tetracainum [INN-Latin]|Tetracaina [INN-Spanish]|100311-22-6|benzoic acid, 4-(butylamino)-, 2-(dimethylamino)ethyl ester ,hydrochloride|Amethocaine (TN)|Tetracaine (USP/INN)|NCGC00016049-02|CAS-136-47-0|EINECS 202-316-6|BRN 2216051|Landocaine|Tetracain|Tetracaine [USP:INN:BAN]|UNII-0619F35CGV|Amethocaine HCl|2-Dimethylaminoethylester kyseliny p-butylaminobenzoove [Czech]|Diaethylaminoaethanol ester der p-butylaminobenzoesaeure [German]|TE4|Spectrum_001032|Pantocaine (Salt/Mix)|TETRACAINE [INN]|Prestwick0_000571|Prestwick1_000571|Prestwick2_000571|Prestwick3_000571|Spectrum2_001328|Spectrum3_000562|Spectrum4_000351|Spectrum5_001072|Lopac-T-7508|TETRACAINE [VANDF]|Epitope ID:174843|TETRACAINE [MART.]|TETRACAINE [USP-RS]|TETRACAINE [WHO-DD]|Lopac0_001211|SCHEMBL34714|BSPBio_000382|BSPBio_001944|KBioGR_000781|KBioSS_001512|4-14-00-01172 (Beilstein Handbook Reference)|DivK1c_000607|SPBio_001455|SPBio_002601|BPBio1_000422|TETRACAINE [GREEN BOOK]|Tetracaine, >=98% (TLC)|TETRACAINE [ORANGE BOOK]|KBio1_000607|KBio2_001512|KBio2_004080|KBio2_006648|KBio3_001444|TETRACAINE [EP MONOGRAPH]|NINDS_000607|SYNERA COMPONENT TETRACAINE|BCPP000048|TETRACAINE [USP MONOGRAPH]|ALBB-025902|BCP04777|HY-A0079|MSK10139|BDBM50017659|SBB058194|STL483844|AKOS015889234|AC-3480|CCG-205285|DB09085|SDCCGSBI-0051178.P005|IDI1_000607|NCGC00016049-01|NCGC00016049-03|NCGC00016049-04|NCGC00016049-14|NCGC00162367-01|AS-81743|DA-78348|FT177996|ST099115|SY066710|BCP0726000001|SBI-0051178.P004|AB00053549|NS00008930|T2789|Tetracaine, meets USP testing specifications|.beta.-Dimethylaminoethyl p-butylaminobenzoate|C07526|D00551|2-(Dimethylamino)ethyl 4-(butylamino)benzoate #|AB00053549-11|AB00053549_12|AB00053549_13|EN300-6748839|Q419608|aniline, N-butyl-4-(2-dimethylaminoethoxycarbonyl)-|BRD-K45071273-003-05-8|BRD-K45071273-003-15-7|BRD-K45071273-003-24-9|BRD-K45071273-003-25-6|Tetracaine, United States Pharmacopeia (USP) Reference Standard|BENZOIC ACID,4-BUTYLAMINO,2-DIMETHYLAMINOETHYL ESTER   PANTOCAIN BASE|InChI=1/C15H24N2O2/c1-4-5-10-16-14-8-6-13(7-9-14)15(18)19-12-11-17(2)3/h6-9,16H,4-5,10-12H2,1-3H"
TRANYLCYPROMINE,5530,,"InChI=1S/C9H11N/c10-9-6-8(9)7-4-2-1-3-5-7/h1-5,8-9H,6,10H2",AELCINSCMGFISI-UHFFFAOYSA-N,C9H11N,133.19,2-phenylcyclopropan-1-amine,"tranylcypromine|dl-Tranylcypromine|Transamine|Racemic Tranylcypromine|SKF 385|155-09-9|Jatrosom|Parnitene|Tranilcipromina|Tranylcyprominum|NSC80664|NSC-80664|Cyclopropanamine, 2-phenyl-, trans-(+-)-|Cyclopropylamine, 2-phenyl-, trans-(+-)-|DTXSID2023694|Tranylcypromin|trans 2 Phenylcyclopropylamine|RefChem:56146|3-12-00-02797 (Beilstein Handbook Reference)|CHEBI:9652|N06AF04|DTXCID501473942|205-841-9|3E3V44J4Z9|2-phenylcyclopropan-1-amine|54-97-7|2-Phenylcyclopropanamine|2-phenylcyclopropylamine|2-Phenylcyclopropane-1-amine|Parnate|trans-2-Phenylcyclopropylamine|MFCD04114536|CHEMBL313833|trans-DL-2-Phenylcyclopropylamine|Cyclopropylamine, trans-2-phenyl-|Cyclopropanamine, 2-phenyl-, trans-|2-Phenyl-cyclopropylamine|Cyclopropanamine, 2-phenyl-|(1S,2R)-2-Phenyl-cyclopropylamine|Parnate (Salt/Mix)|(rel)-Tranylcypromine|SKF-trans-385|(.+/-.)-Tranylcypromine|2-PCPA|(1R,2S)-2-phenyl-cyclopropylamine|(+/-)-trans-2-phenylcyclopropylamine|(.+/-.)-trans-2-Phenylcyclopropamine|(.+/-.)-trans-2-Phenylcyclopropylamine|Tranylcypromine,(+)|Tranylcypromine,(-)|Spectrum_001598|(+/-)-Tranylcypromine|Spectrum3_001068|Spectrum4_001219|Spectrum5_001829|2- Amino-cyclopropylbenzene|Lopac0_001013|SCHEMBL40651|KBioGR_001658|KBioSS_002078|GTPL5281|SCHEMBL5664905|SCHEMBL16268038|SCHEMBL17092909|KBio2_002078|KBio2_004646|KBio2_007214|KBio3_001876|DTXSID30859306|CHEBI:131512|US8609708, 6 Tranylcypromine|Cyclopropanamine, trans-(.+-.)-|Cyclopropylamine, trans-(.+-.)-|EAA54834|BDBM50113851|CCG-40399|SBB084038|US8609708, 6 Tranyl- cypromine|AKOS005217104|2-Phenyl-Cyclopropylamine Hydrochloride|DB00752|SB33883|SB36881|SB36882|SB40902|SDCCGSBI-0050986.P002|Cyclopropanamine,2-phenyl-, (1S,2R)-|NCGC00015848-02|NCGC00015848-03|NCGC00015848-04|NCGC00162316-01|(1R*,2S*)-2-phenylcyclopropan-1-amine|BS-13286|SY240180|DB-338679|CS-0091206|EN300-54719|AB01007711-01|F470399|Q420885|CYCLOPROPANAMINE,2-PHENYL-, (1R,2S)-REL-|F2173-0870"
CLOSANTEL,42574,,"InChI=1S/C22H14Cl2I2N2O2/c1-11-6-15(17(10-27)12-2-4-13(23)5-3-12)18(24)9-20(11)28-22(30)16-7-14(25)8-19(26)21(16)29/h2-9,17,29H,1H3,(H,28,30)",JMPFSEBWVLAJKM-UHFFFAOYSA-N,C22H14Cl2I2N2O2,663.1,"N-[5-chloro-4-[(4-chlorophenyl)-cyanomethyl]-2-methylphenyl]-2-hydroxy-3,5-diiodobenzamide","Closantel|57808-65-8|Closantelum|DTXSID6040662|R 31,520|NSC-335306|EUL532EI54|Benzamide, N-(5-chloro-4-((4-chlorophenyl)cyanomethyl)-2-methylphenyl)-2-hydroxy-3,5-diiodo-|NSC335306|R 31520|R-31520|N-(5-Chloro-4-((4-chlorophenyl)cyanomethyl)-2-methylphenyl)-2-hydroxy-3,5-diiodobenzamide|DTXCID4020662|Benzamide, N-[5-chloro-4-[(4-chlorophenyl)cyanomethyl]-2-methylphenyl]-2-hydroxy-3,5-diiodo-|RefChem:577759|N-(5-chloro-4((4-chlorophenyl)cyanomethyl)-2-methylphenyl)-2-hydroxy-3,5-diiodobenzamide|CHEBI:77053|260-967-1|N-(5-chloro-4-((4-chlorophenyl)(cyano)methyl)-2-methylphenyl)-2-hydroxy-3,5-diiodobenzamide|C22H14Cl2I2N2O2|MFCD00661151|CHEMBL12131|MLS001332593|N-{5-chloro-4-[(4-chlorophenyl)(cyano)methyl]-2-methylphenyl}-2-hydroxy-3,5-diiodobenzamide|CHEBI:77054|57808-65-8 (free acid)|N-[5-chloro-4-[(4-chlorophenyl)-cyanomethyl]-2-methylphenyl]-2-hydroxy-3,5-diiodobenzamide|NCGC00166312-01|Closantel 100 microg/mL in Acetonitrile|SMR000857079|N-[5-chloro-4-[(4-chlorophenyl)-cyano-methyl]-2-methyl-phenyl]-2-hydroxy-3,5-diiodo-benzamide|Closantelum [INN-Latin]|CAS-57808-65-8|SR-05000001507|EINECS 260-967-1|NSC 335306|UNII-EUL532EI54|Closantel [USAN:INN:BAN]|CCRIS 9345|N-[5-chloro-4-[(4-chlorophenyl)cyanomethyl]-2-methylphenyl]-2-hydroxy-3,5-diiodobenzamide; Closantel; Clozantin; NSC 335306; Seponver; Zycloz|Closantel (Standard)|CLOSANTEL [INN]|CLOSANTEL [MI]|Closantel (USAN/INN)|CLOSANTEL [USAN]|CLOSANTEL [MART.]|5'-Chloro-alpha(sup 4)-(p-chlorophenyl)-alpha(sup 4)-cyano-3,5-diiodo-2',4'-salicyloxylidide|cid_42574|MLS001332594|SCHEMBL116617|orb1310806|SCHEMBL29459761|GLXC-26298|HMS2090A06|HMS2230O20|HMS3652O14|HMS3713O22|HMS5082K14|KUC107298N|Pharmakon1600-01504835|MSK20366|Tox21_112408|AC-277|BDBM50063753|HY-17596R|NSC759819|s4106|STK378904|AKOS005448897|Tox21_112408_1|CCG-213322|CS-3975|FC31089|KS-1255|NSC-759819|NCGC00166312-02|HY-17596|KSC-18-157-1|Closantel 1000 microg/mL in Acetonitrile|NS00014203|ST50868959|SW198946-2|Closantel, PESTANAL(R), analytical standard|D03567|AB00918405_05|AB00918405_06|808C658|A831617|F079437|Q2560163|SR-05000001507-1|SR-05000001507-3|SR-05000001507-4|BRD-A19952358-001-10-5|BRD-A19952358-001-11-3|BRD-A19952358-001-12-1|BRD-A19952358-236-01-6|5'-Chloro-.alpha.4-(p-chlorophenyl)-.alpha.4-cyano-3,4'-salicyloxylidide|(RS)-5'-CHLORO-4'-(4-CHLORO-.ALPHA.-CYANOBENZYL)-3,5-DIIODOSALICYL-O-TOLUIDIDE|N-(5-Chloro-4-[(R,S)-(4-chlorophenyl)cyanomethyl]-2-methylphenyl)-2-hydroxy-3,5-diiodobenzamide|N-[5-chloranyl-4-[(4-chlorophenyl)-cyano-methyl]-2-methyl-phenyl]-3,5-bis(iodanyl)-2-oxidanyl-benzamide|N-{5-Chloro-4-[(4-chloro-phenyl)-cyano-methyl]-2-methyl-phenyl}-2-hydroxy-3,5-diiodo-benzamide|N-{5-chloro-4-[(4-chlorophenyl)cyanomethyl]-2-methylphenyl}(2-hydroxy-3,5-diio dophenyl)carboxamide"
SIVELESTAT,107706,,"InChI=1S/C20H22N2O7S/c1-20(2,3)19(26)29-13-8-10-14(11-9-13)30(27,28)22-16-7-5-4-6-15(16)18(25)21-12-17(23)24/h4-11,22H,12H2,1-3H3,(H,21,25)(H,23,24)",BTGNGJJLZOIYID-UHFFFAOYSA-N,C20H22N2O7S,434.5,"2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid","Sivelestat|127373-66-4|Ono-5046|2-[[2-[[4-(2,2-dimethylpropanoyloxy)phenyl]sulfonylamino]benzoyl]amino]acetic acid|LY544349|N-(2-(4-(2,2-Dimethylpropionyloxy)phenylsulfonylamino)benzoyl)aminoacetic acid|DWI62G0P59|DTXSID9048304|LY-544349|Glycine, N-(2-(((4-(2,2-dimethyl-1-oxopropoxy)phenyl)sulfonyl)amino)benzoyl)-|2-[(2-{4-[(2,2-dimethylpropanoyl)oxy]benzenesulfonamido}phenyl)formamido]acetic acid|sivelestatum|2-((2-((4-(2,2-dimethylpropanoyloxy)phenyl)sulfonylamino)benzoyl)amino)acetic acid|2-((2-(4-((2,2-dimethylpropanoyl)oxy)benzenesulfonamido)phenyl)formamido)acetic acid|RefChem:931817|DTXCID7028279|331731-18-1|ONO5046|ABT-D2E7|MFCD00889071|EI546|Ono 5046|Propanoic acid, 2,2-dimethyl-, 4-[[[2-[[(carboxymethyl)amino]carbonyl]phenyl]amino]sulfonyl]phenyl ester|Sivelestat (ONO-5046)|UNII-FYS6T7F842|CHEMBL76688|(2-((4-(Pivaloyloxy)phenyl)sulfonamido)benzoyl)glycine|EI546;LY544349;ONO5046|Sivelestat [USAN]|Elastase Inhibitor IV|C20H22N2O7S|Sivelestat [USAN:INN]|EI 546|Ono-EI-600|UNII-DWI62G0P59|LY 544349|SIVELESTAT [MI]|SIVELESTAT [INN]|Sivelestat (USAN/INN)|SIVELESTAT [MART.]|SIVELESTAT [WHO-DD]|Adalimumab (anti-TNF-alpha)|US9073833, Sivelestat|SCHEMBL123221|GTPL6441|orb1300286|SCHEMBL28751433|CHEBI:135704|BDBM166439|HMS3753M09|HMS5086O07|o-(p-Hydroxybenzenesulfonamido)hippuric acid, pivalate (ester)|BCP09708|BDBM50084637|s8136|AKOS022176173|CCG-269065|DB12863|SDCCGSBI-0633759.P001|NCGC00263570-02|NCGC00263570-03|NCGC00263570-06|NCGC00346934-01|AS-74843|FS170937|HY-17443|5134A|NS00071648|ONO5046;LY544349;EI546|A11497|D03788|Elastase Inhibitor IV - CAS 127373-66-4|373S664|Q5646925|BRD-K02152879-414-01-3|BRD-K02152879-414-02-1|2,2-Dimethyl-propionic acid 4-[2-(carboxymethyl-carbamoyl)-phenylsulfamoyl]-phenyl ester|2,2-Dimethyl-propionic acid 4-[2-(carboxymethyl-carbamoyl)-phenylsulfamoyl]-phenyl ester(ONO-5046)"
NUMIDARGISTAT,131801114,,"InChI=1S/C11H22BN3O5/c1-7(13)9(16)15-5-8(3-2-4-12(19)20)11(14,6-15)10(17)18/h7-8,19-20H,2-6,13-14H2,1H3,(H,17,18)/t7-,8-,11-/m0/s1",ZZJLMZYUGLJBSO-LAEOZQHASA-N,C11H22BN3O5,287.12,"(3R,4S)-3-amino-1-[(2S)-2-aminopropanoyl]-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid","Numidargistat|CB-1158|2095732-06-0|INCB001158|INCB-001158|Arginase inhibitor INCB001158|IFD73D535A|CB1158|(3R,4S)-3-AMINO-1-((S)-2-AMINOPROPANOYL)-4-(3-BORONOPROPYL)PYRROLIDINE-3-CARBOXYLIC ACID|(3R,4S)-3-amino-1-((2S)-2-aminopropanoyl)-4-(3-(dihydroxyboranyl)propyl)pyrrolidine-3-carboxylic acid|(3R,4S)-3-Amino-1-[(2S)-2-aminopropanoyl]-4-[3-(dihydroxyboranyl)propyl]pyrrolidine-3-carboxylic acid|RefChem:166961|Numidargistat [USAN]|Incb 001158|UNII-IFD73D535A|(3R,4S)-3-amino-1-[(2S)-2-aminopropanoyl]-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid|WHO 11086|(3R,4S)-3-amino-1-((2S)-2-aminopropanoyl)-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid|numidargistatum|CB-1158 dihydrochloride|NUMIDARGISTAT [INN]|Numidargistat (USAN/INN)|INCB-01158 dihydrochloride|NUMIDARGISTAT [WHO-DD]|orb1710146|CB1158, 2HCl|CHEMBL4218271|SCHEMBL18787950|CB-1158, 2HCl|CHEBI:195556|EX-A2679|BDBM50511658|NSC803247|AKOS040732725|CB 1158|CS-8064|DB15286|NSC-803247|DA-51640|HY-101979|D11792|G16257|(3R,4S)-1-L-alanyl-3-amino-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid|(3R,4S)-3-amino-1-((S)-2-aminopropanoyl)-4-(3-boronopropyl)pyrrolidine-3-carboxylic acid dihydrochloride|3-PYRROLIDINECARBOXYLIC ACID, 3-AMINO-1-((2S)-2-AMINO-1-OXOPROPYL)-4-(3-BORONOPROPYL)-, (3R,4S)-"
CERITINIB,57379345,,"InChI=1S/C28H36ClN5O3S/c1-17(2)37-25-15-21(20-10-12-30-13-11-20)19(5)14-24(25)33-28-31-16-22(29)27(34-28)32-23-8-6-7-9-26(23)38(35,36)18(3)4/h6-9,14-18,20,30H,10-13H2,1-5H3,(H2,31,32,33,34)",VERWOWGGCGHDQE-UHFFFAOYSA-N,C28H36ClN5O3S,558.1,"5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine","ceritinib|1032900-25-6|LDK378|ZYKADIA|LDK-378|NVP-LDK378-NX|5-chloro-N2-(2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl)-N4-(2-(isopropylsulfonyl)phenyl)pyrimidine-2,4-diamine|LDK 378|ceritinibum|K418KG2GET|NVP-LDK-378-NX|CHEBI:78432|5-chloro-2-N-(5-methyl-4-piperidin-4-yl-2-propan-2-yloxyphenyl)-4-N-(2-propan-2-ylsulfonylphenyl)pyrimidine-2,4-diamine|DTXSID10725373|2,4-Pyrimidinediamine, 5-chloro-N4-(2-((1-methylethyl)sulfonyl)phenyl)-N2-(5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl)-|5-Chloro-N2-(5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl)-N4-(2-(propane-2-sulfonyl)phenyl)pyrimidine-2,4-diamine|5-chloro-N2-[5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl]-N4-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine|RefChem:57924|DTXCID50676118|L01XE28|811-457-8|Ceritinib (LDK378)|C28H36ClN5O3S|MFCD26142648|5-Chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine|CHEMBL2403108|5-chloro-2-N-[5-methyl-4-(piperidin-4-yl)-2-(propan-2-yloxy)phenyl]-4-N-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine|5-Chloro-N~2~-[5-Methyl-4-(Piperidin-4-Yl)-2-(Propan-2-Yloxy)phenyl]-N~4~-[2-(Propan-2-Ylsulfonyl)phenyl]pyrimidine-2,4-Diamine|5-Chloro-N4-[2-[(1methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine;5-Chloro-N4-[2-[(1methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine|Ceritinib(LDK378)|Ceritinib [USAN:INN]|UNII-K418KG2GET|Ceritinib[mi]|2,4-Pyrimidinediamine, 5-chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-; 5-Chloro-N4-[2-[(1-methylethyl)sulfonyl]phenyl]-N2-[5-methyl-2-(1-methylethoxy)-4-(4-piperidinyl)phenyl]-2,4-pyrimidinediamine; Ceritinib; LDK 378; Zykadia|Zykadia (TN)|Ceritinib (Standard)|Ceritinib; LDK378|LDK378(Ceritinib)|CERITINIB [INN]|CERITINIB [JAN]|CERITINIB [MI]|Ceritinib(LDK378)?|CERITINIB [USAN]|CERITINIB [VANDF]|CERITINIB [WHO-DD]|5-Chloro-N2-[2-isopropoxy-5-Methyl-4-(4-piperidyl)phenyl]-N4-(2-isopropylsulfonylphenyl)pyriMidine-2,4-diaMine|Ceritinib (JAN/USAN/INN)|GTPL7397|orb1307443|SCHEMBL1014329|CERITINIB [ORANGE BOOK]|SCHEMBL29349781|SCHEMBL29489147|EX-A187|VERWOWGGCGHDQE-UHFFFAOYSA-N|HMS3652H22|HMS3673I17|HMS3747A11|HMS5085F12|BCP07611|BDBM50436850|HY-15656R|NSC776422|NSC777193|NSC800072|AKOS025396438|CCG-264762|CS-1406|DB09063|FC61431|GS-6356|NSC-776422|NSC-777193|NSC-800072|SB16490|compound 15b [PMID 23742252]|NCGC00351603-10|NCGC00351603-13|NCGC00351603-15|AC-27469|BP-43633|HY-15656|NS00040660|S7083|SW219725-1|D10551|EN300-7404145|BRD-K22149900-001-01-3|BRD-K22149900-001-03-9|BRD-K22149900-001-05-4|Q21011233|Z2235802104|4MK|5-chloro-N(2)-{5-methyl-4-(piperidin-4-yl)-2-[(propan-2-yl)oxy]phenyl}-N(4)-[2-(propane-2-sulfonyl)phenyl]pyrimidine-2,4-diamine|5-Chloro-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4-[2-(propane-2-sulfonyl)-phenyl]-pyrimidine-2,4-diamine|5-CHLORO-N2-(5-METHYL-4-(PIPERIDIN-4-YL)-2-(PROPAN-2-YLOXY)PHENYL)-N4-(2-(PROPANE-2- SULFONYL)PHENYL)PYRIMIDINE-2,4-DIAMINE|5-CHLORO-N4-(2-((1-METHYLETHYL)SULFONYL)PHENYL)-N2-(5-METHYL-2-(1-METHYLETHOXY)-4- (PIPERIDIN-4-YL)PHENYL)PYRIMIDINE-2,4-DIAMINE|N-{2-[(5-chloro-2-{[2-isopropoxy-5-methyl-4-(piperidin-4-yl)phenyl]amino}pyrimidin-4-yl)amino]phenyl}propane-2-sulfonamide"
LORLATINIB,71731823,,"InChI=1S/C21H19FN6O2/c1-11-15-7-13(22)4-5-14(15)21(29)27(2)10-16-19(17(8-23)28(3)26-16)12-6-18(30-11)20(24)25-9-12/h4-7,9,11H,10H2,1-3H3,(H2,24,25)/t11-/m1/s1",IIXWYSCJSQVBQM-LLVKDONJSA-N,C21H19FN6O2,406.4,"(16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile","Lorlatinib|1454846-35-5|PF-06463922|Loratinib|Lorbrena|PF06463922|lorlatinibum|OSP71S83EU|2H-4,8-Methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-|CHEBI:143117|DTXSID201027944|2H-4,8-Methenopyrazolo(4,3-H)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile, 7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-, (10R)-|7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-8,4-(metheno)pyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile|(10R)-7-amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile|(10r)-7-Amino-12-Fluoro-2,10,16-Trimethyl-15-Oxo-10,15,16,17-Tetrahydro-2h-8,4-(Metheno)pyrazolo(4,3-H)(2,5,11)benzoxadiazacyclotetradecine-3-Carbonitrile|(10r)-7-Amino-12-Fluoro-2,10,16-Trimethyl-15-Oxo-10,15,16,17-Tetrahydro-2h-8,4-(Metheno)pyrazolo[4,3-H][2,5,11]benzoxadiazacyclotetradecine-3-Carbonitrile|(10R)-7-Amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile|(10R)-7-Amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-4,8-methenopyrazolo(4,3-h)(2,5,11)benzoxadiazacyclotetradecine-3-carbonitrile|(10R)-7-amino-12-fluoro-2,10,16-trimethyl-15-oxo-10,15,16,17-tetrahydro-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecine-3-carbonitrile|RefChem:56791|DTXCID401513511|(16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetraazatetracyclo(16.3.1.0^(2,6).0^(10,15))docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile|PF 06463922|MFCD28144520|PF06463922(Lorlatinib)|(16R)-19-amino-13-fluoro-4,8,16-trimethyl-9-oxo-17-oxa-4,5,8,20-tetrazatetracyclo[16.3.1.02,6.010,15]docosa-1(22),2,5,10(15),11,13,18,20-octaene-3-carbonitrile|CHEMBL3286830|(R)-26-Amino-55-fluoro-11,4,7-trimethyl-6-oxo-11H-3-oxa-7-aza-2(3,5)-pyridina-1(4,3)-pyrazola-5(1,2)-benzenacyclooctaphane-15-carbonitrile|C21H19FN6O2|Lorviqua|UNII-OSP71S83EU|Lorlatinib (PF-06463922)|4cli|4clj|Lorbrena (TN)|Lorlatinib (Standard)|LORLATINIB [MI]|LORLATINIB [INN]|LORLATINIB [JAN]|Lorlatinib [USAN:INN]|LORLATINIB [USAN]|PFE-PKIS 10|LORLATINIB [WHO-DD]|Lorlatinib (JAN/USAN/INN)|GTPL7476|orb1304578|LORLATINIB [ORANGE BOOK]|SCHEMBL15261807|SCHEMBL29352618|SCHEMBL29355669|EX-A828|BCP10287|BDBM50018830|HY-12215R|MSK174368|NSC780108|NSC800990|s7536|AKOS027250753|CCG-268718|CS-3983|DB12130|NSC-780108|NSC-800990|NCGC00386417-02|NCGC00386417-13|NCGC00386417-15|AC-30881|BP-44027|FP104236|HY-12215|NS00073142|D11012|F979308|BRD-K99879819-001-02-1|Q27285820|(10R)-7-Amino-12-fluoro-10,15,16,17-tetrahydro-2,10,16-trimethyl-15-oxo-2H-4,8-methenopyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetrad  ecine-3-carbonitrile;PF 06463922|(10R)-7-AMINO-12-FLUORO-2,10,16-TRIMETHYL-15-OXO-10,15,16,17-TETRAHYDRO-2H-4,8- METHENOPYRAZOLO(4,3-H)(2,5,11)BENZOXADIAZACYCLOTETRADECINE-3-CARBONITRILE"
ALECTINIB,49806720,,"InChI=1S/C30H34N4O2/c1-4-20-16-23-24(17-26(20)34-9-7-21(8-10-34)33-11-13-36-14-12-33)30(2,3)29-27(28(23)35)22-6-5-19(18-31)15-25(22)32-29/h5-6,15-17,21,32H,4,7-14H2,1-3H3",KDGFLJKFZUIJMX-UHFFFAOYSA-N,C30H34N4O2,482.6,"9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile","Alectinib|1256580-46-7|CH5424802|CH 5424802|AF-802|RO5424802|AF802|CH-5424802|LIJ4CT1Z3Y|AF 802|9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile|RO-5424802|5H-Benzo[b]carbazole-3-carbonitrile, 9-ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-|9-Ethyl-6,6-Dimethyl-8-[4-(Morpholin-4-Yl)piperidin-1-Yl]-11-Oxo-6,11-Dihydro-5h-Benzo[b]carbazole-3-Carbonitrile|CHEBI:90936|DTXSID50154840|5H-BENZO(B)CARBAZOLE-3-CARBONITRILE, 9-ETHYL-6,11-DIHYDRO-6,6-DIMETHYL-8-(4-(4-MORPHOLINYL)-1-PIPERIDINYL)-11-OXO-|alectinibum|9-ethyl-6,6-dimethyl-8-(4-(morpholin-4-yl)piperidin-1-yl)-11-oxo-5H,6H,11H-benzo(b)carbazole-3-carbonitrile|9-ETHYL-6,6-DIMETHYL-8-(4-(MORPHOLIN-4-YL)PIPERIDIN-1-YL)-11-OXO-6,11-DIHYDRO-5H-BENZO(B)CARBAZOLE-3-CARBONITRILE|9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5H-benzo(b)carbazole-3-carbonitrile|9-ETHYL-6,6-DIMETHYL-8-[4-(MORPHOLIN-4-YL)PIPERIDIN-1-YL]-11-OXO-5H,6H,11H-BENZO[B]CARBAZOLE-3-CARBONITRILE|RefChem:58110|ALK Inhibitor RO5424802|DTXCID7077331|L01XE36|RG7853|9-ethyl-6,6-dimethyl-8-(4-morpholinopiperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile|Alectinib (CH5424802)|UNII-LIJ4CT1Z3Y|MFCD19440988|CHEMBL1738797|ARQ-761|9-Ethyl-6,6-dimethyl-8-[4-(morpholin-4-yl)piperidin-1-yl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile|Alectinib [INN]|Alectinib [USAN:INN]|9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-carbonitrile|C30H34N4O2|9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzocarbazole-3-carbonitrile; Alectinib|Alectinib free base|EMH|Alectinib (Standard)|ALECTINIB [MI]|Alectinib (USAN/INN)|ALECTINIB [USAN]|ALECTINIB [WHO-DD]|CH5424802(Alectinib)|ch 5424802, Alectinib|MLS006010971|SCHEMBL896753|CH5424802(Alectinib)?|GTPL7739|orb1307053|SCHEMBL29352499|EX-A406|KDGFLJKFZUIJMX-UHFFFAOYSA-N|CH-5424802 HCl|GLXC-90122|HMS3672C13|HMS3744I17|HMS5081L15|BCP02589|BDBM50362781|HY-13011R|MSK165864|NSC764040|NSC764821|NSC794611|NSC799328|s2762|1256580-46-7 (free base)|AKOS025290737|BCP9000514|CS-0518|DB11363|FA75280|NSC-764040|NSC-764821|NSC-794611|NSC-799328|SB16515|SDCCGSBI-0654466.P001|NCGC00346688-01|NCGC00346688-03|NCGC00346688-04|9-Ethyl-6,11-dihydro-6,6-dimethyl-8-[4-(4-morpholinyl)-1-piperidinyl]-11-oxo-5H-benzo[b]carbazole-3-|AC-29020|AS-17008|HY-13011|SMR004702775|NS00072879|CH-5424802/RG-7853|D10542|EN300-7407832|F861631|BRD-K11267252-001-04-4|BRD-K11267252-001-06-9|Q21099132|CH5424802,CAS:1256580-46-7|9-Ethyl-6,6-dimethyl-8-(4-morpholin-4-yl-piperidin-1-yl)-11-oxo-6,11-dihydro-5H-benzo[b]carbazole-3-carbonitrile|9-ethyl-6,6-dimethyl-8-(4-morpholin-4-ylpiperidin-1-yl)-11-oxo-5h-benzo[b]carbazol-3-carbonitril|9-ethyl-6,6-dimethyl-8-(4-morpholino-1-piperidyl)-11-oxo-5H-benzo[b]carbazole-3-carbonitrile"
REPOTRECTINIB,135565923,,"InChI=1S/C18H18FN5O2/c1-10-8-20-18(25)14-9-21-24-6-5-16(23-17(14)24)22-11(2)13-7-12(19)3-4-15(13)26-10/h3-7,9-11H,8H2,1-2H3,(H,20,25)(H,22,23)/t10-,11+/m0/s1",FIKPXCOQUIZNHB-WDEREUQCSA-N,C18H18FN5O2,355.4,"(3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one","Repotrectinib|1802220-02-5|TPX-0005|Augtyro|08O3FQ4UNP|repotrectinibum|(3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo[13.5.2.04,9.018,22]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one|1,15-Etheno-1H-pyrazolo(4,3-F)(1,4,8,10)benzoxatriazacyclotridecin-4(5H)-one, 11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-, (7S,13R)-|1,15-Etheno-1H-pyrazolo(4,3-f)(1,4,8,10)benzoxatriazacyclotridecin-4(5H)-one, 11-fluoro-2,6,7,13-tetrahydro-7,13-dimethyl-, (14Z)-|(3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentazatetracyclo(13.5.2.04,9.018,22)docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one|(3R,6S,)-45-FLUORO-3,6-DIMETHYL-5-OXA-2,8-DIAZA-1(5,3)-PYRAZOLO(1,5-A)PYRIMIDINA-4(1,2)-BENZENANONAPHAN-9-ONE|(3R,6S,)-45-Fluoro-3,6-dimethyl-5-oxa-2,8-diaza-1(5,3)-pyrazolo[1,5-a]pyrimidina-4(1,2)-benzenanonaphan-9-one|RefChem:178876|Multikinase Inhibitor TPX-0005|Multi-kinase Inhibitor TPX-0005|ALK/ROS1/NTRK/SRC/FAK Multikinase Inhibitor TPX-0005|Ropotrectinib|Repotrectinib [USAN]|TPX0005|Repotrectinib(TPX-005)|TRX-0005|1,15-Etheno-1H-pyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one,11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-, (7S,13R)-|(7S,13R)-11-fluoro-6,7,13,14-tetrahydro-7,13-dimethyl-1,15-etheno-1H-pyrazolo[4,3-f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)-one|(13E,14E,3R,6S)-45-fluoro-3,6-dimethyl-5-oxa-2,8-diaza-1(5,3)-pyrazolo[1,5-a]pyrimidina-4(1,2)-benzenacyclononaphan-9-one|Augtyro (TN)|UNII-08O3FQ4UNP|REPOTRECTINIB [INN]|Repotrectinib (JAN/USAN)|Repotrectinib (TPX-0005)|REPOTRECTINIB [WHO-DD]|orb1303198|CHEMBL4298138|SCHEMBL16946804|SCHEMBL29358351|GTPL10316|CHEBI:229220|TPX 0005 [WHO-DD]|BDBM374727|CXC22002|EX-A2572|TPX 0005|US10246466, Example 93|NSC800522|s8583|AKOS037648789|CCG-268096|CS-7628|NSC-800522|AC-31283|BS-15622|example 93 [US20170334929A1]|HY-103022|C73438|D11454|(1Z)-6-Fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentaazatetracyclo(13.5.2.04,9.018,22)docosa-1,4,6,8,15,19,21-heptaen-14-one|(3R,11S)-6-fluoro-3,11-dimethyl-10-oxa-2,13,17,18,21-pentaazatetracyclo[13.5.2.0,.0,]docosa-1(21),4(9),5,7,15(22),16,19-heptaen-14-one|(7S,13R)-11-fluoro-7,13-dimethyl-6,7,13,14- tetrahydro-1,15-ethenopyrazolo[4,3- f][1,4,8,10]benzoxatriazacyclotridecin-4(5H)- one"
RO-5028442,59657596,,"InChI=1S/C25H28ClN3O2/c1-27(2)13-14-29-16-21(20-8-7-19(26)15-23(20)29)24(30)28-11-9-25(10-12-28)22-6-4-3-5-18(22)17-31-25/h3-8,15-16H,9-14,17H2,1-2H3",QZXVLRCMAHJVIP-UHFFFAOYSA-N,C25H28ClN3O2,438.0,"[6-chloro-1-[2-(dimethylamino)ethyl]indol-3-yl]-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylmethanone","920022-47-5|Ro5028442|Ro-5028442|LZ0EU1YHCK|(6-Chloro-1-(2-(dimethylamino)ethyl)indol-3-yl)-spiro(1H-isobenzofuran-3,4'-piperidine)-1'-yl-methanone|Methanone, (6-chloro-1-(2-(dimethylamino)ethyl)-1H-indol-3-yl)spiro(isobenzofuran-1(3H),4'-piperidin)-1'-yl-|[6-Chloro-1-[2-(dimethylamino)ethyl]indol-3-yl]-spiro[1H-isobenzofuran-3,4'-piperidine]-1'-yl-methanone|RefChem:179698|(2-(6-chloro-3-((3H-spiro(2-benzofuran-1,4'-piperidine)-1'-yl)carbonyl)-1H-indol-1-yl)ethyl)dimethylamine|(2-(6-chloro-3-((3H-spiro(2-benzofuran-1,4'-piperidine)-1'-yl)carbonyl)-2,3-dihydro-1H-indol-1-yl)ethyl)dimethylamine|RG7713|UNII-LZ0EU1YHCK|CHEMBL3416885|[6-chloro-1-[2-(dimethylamino)ethyl]indol-3-yl]-spiro[1H-2-benzofuran-3,4'-piperidine]-1'-ylmethanone|RG 7314|RO 5028442|C25H28ClN3O2|orb1303102|SCHEMBL4361592|SCHEMBL4361597|SCHEMBL29500978|SCHEMBL30943560|BCP32628|VLB02247|BDBM50077217|MFCD28963949|AKOS037515536|CS-7944|DB12721|AC-38106|DA-57491|HY-12981|MS-27852|NS00073413|RO 5028442?|N16810|RO 5028442 (RG7713)|Q18392912|RO-5028442; RO 5028442;RG7713;RG-7713;RG 7713|(6-chloro-1-(2-(dimethylamino)ethyl)-1H-indol-3-yl)(3H-spiro[isobenzofuran-1,4'-piperidin]-1'-yl)methanone"
BALOVAPTAN,46200932,,"InChI=1S/C22H24ClN5O/c1-27-13-16-12-17(23)7-10-19(16)28-20(14-27)25-26-22(28)15-5-8-18(9-6-15)29-21-4-2-3-11-24-21/h2-4,7,10-12,15,18H,5-6,8-9,13-14H2,1H3",GMPZPHGHNDMRKL-UHFFFAOYSA-N,C22H24ClN5O,409.9,"8-chloro-5-methyl-1-(4-pyridin-2-yloxycyclohexyl)-4,6-dihydro-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine","Balovaptan|1228088-30-9|RG7314|RO5285119|Balovaptan [INN]|Balovaptan [USAN]|RG-7314|RAX5D5AGV6|8-chloro-5-methyl-1-(4-pyridin-2-yloxycyclohexyl)-4,6-dihydro-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine|Ro-5285119|8-Chloro-5-methyl-1-((1r,4r)-4-(pyridin-2-yloxy)cyclohexyl)-5,6-dihydro-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepine|4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-5,6-dihydro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-|8-chloro-5-methyl-1-{trans-4-[(pyridin-2-yl)oxy]cyclohexyl}-5,6-dihydro-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine|Balovaptan?|Balovaptan (USAN/INN)|Balovaptan [USAN:INN]|UNII-RAX5D5AGV6|A1EB7|BALOVAPTAN [WHO-DD]|orb1308588|SCHEMBL2471320|SCHEMBL3329710|SCHEMBL3332136|CHEMBL4297183|SCHEMBL29424403|SCHEMBL30694378|GTPL10615|DTXSID101107286|GLXC-22175|DZB08830|BDBM50546439|AKOS037648594|compound 1 [PMID: 31951127]|DB14823|SB19643|BS-14780|DA-61487|HY-109024|CS-0030526|D11476|D80511|12-chloro-8-methyl-3-[(1r,4r)-4-(pyridin-2-yloxy)cyclohexyl]-2,4,5,8-tetraazatricyclo[8.4.0.0(2),]tetradeca-1(10),3,5,11,13-pentaene|12-chloro-8-methyl-3-[4-(pyridin-2-yloxy)cyclohexyl]-2,4,5,8-tetraazatricyclo[8.4.0.0(2),]tetradeca-1(14),3,5,10,12-pentaene|12-chloro-8-methyl-3-[4-(pyridin-2-yloxy)cyclohexyl]-2,4,5,8-tetraazatricyclo[8.4.0.0,tetradeca-1(14),3,5,10,12-pentaene|8-Chloro-5,6-dihydro-5-methyl-1-[trans-4-(2-pyridinyloxy)cyclohexyl]-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine|8-Chloro-5-methyl-1-(trans-4-(2-pyridinyloxy)cyclohexyl)-5,6-dihydro-4H-(1,2,4)triazolo(4,3-a)(1,4)benzodiazepine|8-CHLORO-5-METHYL-1-(TRANS-4-(PYRIDIN-2-YLOXY)CYCLOHEXYL)-5,6-DIHYDRO-4H-(1,2,4)TRIAZOLO(4,3-A)(1,4)BENZODIAZEPINE"
R-406,11213558,,"InChI=1S/C22H23FN6O5/c1-22(2)20(30)28-19-13(34-22)6-7-16(27-19)26-18-12(23)10-24-21(29-18)25-11-8-14(31-3)17(33-5)15(9-11)32-4/h6-10H,1-5H3,(H3,24,25,26,27,28,29,30)",NHHQJBCNYHBUSI-UHFFFAOYSA-N,C22H23FN6O5,470.5,"6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one","841290-80-0|tamatinib|R-406|R406 free base|RC3A285J2G|6-({5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)amino]pyrimidin-4-Yl}amino)-2,2-Dimethyl-2h-Pyrido[3,2-B][1,4]oxazin-3(4h)-One|6-[[5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one|DTXSID30458939|R940406|6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one|2H-Pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-|6-(5-Fluoro-2-(3,4,5-trimethoxy-phenylamino)-pyrimidin-4-ylamino)-2,2-dimethyl-4H-pyrido(3,2-b)(1,4)oxazin-3-one|6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-2h-pyrido(3,2-b)-1,4-oxazin-3(4h)-one|6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-3-one|6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[2,3-e][1,4]oxazin-3-one|6-[5-FLUORO-2-(3,4,5-TRIMETHOXY-PHENYLAMINO)-PYRIMIDIN-4-YLAMINO]-2,2-DIMETHYL-4H-PYRIDO[3,2-B][1,4]OXAZIN-3-ONE|6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H,3H,4H-pyrido(3,2-b)(1,4)oxazin-3-one|6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-2H-pyrido(3,2-b)(1,4)oxazin-3(4H)-one|6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-4H-pyrido(2,3-e)(1,4)oxazin-3-one|RefChem:891058|DTXCID20409758|R406 (free base)|6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b][1,4]oxazin-3(4H)-one|Tamatinib free base|6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one|R 406|MFCD09970820|CHEMBL475251|6-[5-Fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino]-2,2-dimethyl-4H-pyrido[3,2-b][1,4]oxazin-3-one|841290-80-0 (free base)|R406(free base)|BDBM50249542|6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-2H-pyrido[3,2-b]|C22H23FN6O5|3fqs|3piy|R406 free base?|Kinome_1211|UNII-RC3A285J2G|MLS006011151|GTPL5706|orb1305445|SCHEMBL1200144|SCHEMBL29358236|BDBM60665|CHEBI:91348|EX-A103|NHHQJBCNYHBUSI-UHFFFAOYSA-N|BCPP000094|HMS3265G15|HMS3265G16|HMS3265H15|HMS3265H16|HMS3654F22|BCP01933|NSC772498|NSC800858|s1533|AKOS015951111|CCG-264908|CS-0436|DB07159|NSC-772498|NSC-800858|PB13129|SB16611|SDCCGSBI-0654383.P002|NCGC00182051-02|NCGC00182051-03|NCGC00182051-12|NCGC00182051-18|AC-32820|AS-16262|HY-11108|SMR004702925|NS00070355|SW219254-1|US9145414, R406|BRD-K20285085-001-01-4|BRD-K20285085-001-07-1|BRD-K20285085-074-03-7|BRD-K20285085-074-04-5|Q27088935|2H-Pyrido[3,2-b]-1,4-oxazin-3(4H)-one,6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-, monobenzenesulfonate"
ERGOTAMINE,8223,,"InChI=1S/C33H35N5O5/c1-32(35-29(39)21-15-23-22-10-6-11-24-28(22)20(17-34-24)16-25(23)36(2)18-21)31(41)38-26(14-19-8-4-3-5-9-19)30(40)37-13-7-12-27(37)33(38,42)43-32/h3-6,8-11,15,17,21,25-27,34,42H,7,12-14,16,18H2,1-2H3,(H,35,39)/t21-,25-,26+,27+,32-,33+/m1/s1",XCGSFFUVFURLIX-VFGNJEKYSA-N,C33H35N5O5,581.7,"(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide","ERGOTAMINE|Ergotamin|Ergonsvine|Ergotamina|113-15-5|ergotaminum|12'-Hydroxy-2'-methyl-5'alpha-(phenylmethyl)ergotaman-3',6',18-trione|CHEBI:64318|PR834Q503T|NSC-95090|DTXSID9043774|(5'alpha)-12'-Hydroxy-2'-methyl-5'-(phenylmethyl)ergotoman-3',6',18-trione|Ergotaman-3',6',18-trione, 12'-hydroxy-2'-methyl-5'-(phenylmethyl)-, (5'-alpha)-|(4R,7R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.0^{2,6}]dodecan-4-yl]-6-methyl-6,11-diazatetracyclo[7.6.1.0^{2,7}.0^{12,16}]hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide|Ergo Kranit|Mono, Ergodryl|(4R,7R)-N-((1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo(7.3.0.0^(2,6))dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.0^(2,7).0^(12,16))hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide|(6aR,9R)-N-((1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-7-methyl-6,6a,8,9-tetrahydro-4H-indolo(4,3-fg)quinoline-9-carboxamide|(6aR,9R)-N-[(1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo[7.3.0.02,6]dodecan-4-yl]-7-methyl-6,6a,8,9-tetrahydro-4H-indolo[4,3-fg]quinoline-9-carboxamide|RefChem:5798|DTXCID7023774|N02CA02|(4R,7R)-N-((1S,2S,4R,7S)-7-benzyl-2-hydroxy-4-methyl-5,8-dioxo-3-oxa-6,9-diazatricyclo(7.3.0.02,6)dodecan-4-yl)-6-methyl-6,11-diazatetracyclo(7.6.1.02,7.012,16)hexadeca-1(16),2,9,12,14-pentaene-4-carboxamide|204-023-9|Gynergen|Ergomar|Ergotamine (INN)|ERGOTAMINE [INN]|Ergotamine [INN:BAN]|Ergotaminum [INN-Latin]|Ergotamina [INN-Spanish]|HSDB 4076|C33H35N5O5|EINECS 204-023-9|NSC 95090|BRN 0078890|UNII-PR834Q503T|ERM|Ergotamin; ergotaminum|ERGOTAMINE [MI]|ERGOTAMINE [HSDB]|ERGOTAMINE [VANDF]|CHEMBL442|SCHEMBL1483|ERGOTAMINE [WHO-DD]|GTPL149|SCHEMBL29420131|Ergotamine tartrate, Avetol, Cornutamin, Ergam, Ergotartrate|GLXC-23340|HMS2089H22|BDBM50027065|MFCD00864261|Ergotamine dried down 100 microg/mL|AKOS015896505|DB00696|NCGC00356592-02|D07906|AB01275473-01|Q419186|CODERGOCRINE MESILATE IMPURITY C [EP IMPURITY]|5'alpha-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman|(5'alpha)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman|(5''alpha)-12''-hydroxy-2''-methyl-5''-(phenylmethyl)ergotoman-3'',6'',18-trione|(5''alpha)-5''-benzyl-12''-hydroxy-2''-methyl-3'',6'',18-trioxoergotaman|(5alpha,5'beta)-5'-benzyl-12'-hydroxy-2'-methyl-3',6',18-trioxoergotaman|12''-hydroxy-2''-methyl-5''alpha-(phenylmethyl)ergotaman-3'',6'',18-trione|1080650-16-3|N-[(2R,5S,10aS,10bS)-5-benzyl-10b-hydroxy-2-methyl-3,6-dioxo-8,9,10,10a-tetrahydro-5H-oxazolo[[?]]pyrrolo[[?]]pyrazin-2-yl]-methyl-[?]carboxamide"
VOFOPITANT DIHYDROCHLORIDE,6918330,,"InChI=1S/C21H23F3N6O.2ClH/c1-31-18-10-9-16(30-20(21(22,23)24)27-28-29-30)12-15(18)13-26-17-8-5-11-25-19(17)14-6-3-2-4-7-14;;/h2-4,6-7,9-10,12,17,19,25-26H,5,8,11,13H2,1H3;2*1H/t17-,19-;;/m0../s1",YVNRXILPJNISEM-FFUVTKDNSA-N,C21H25Cl2F3N6O,505.4,"(2S,3S)-N-[[2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenylpiperidin-3-amine;dihydrochloride","Vofopitant dihydrochloride|168266-51-1|GR205171A|GR-205171A|53187BIJ00|DTXSID00168538|RefChem:902043|DTXCID4091029|Vofopitant dihydrochloride [USAN]|(2S,3S)-N-[[2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenylpiperidin-3-amine;dihydrochloride|Vofopitant dihydrochloride (USAN)|Vofopitant hydrochloride|Vofopitant HCl|GR 205171A|GR-205171 dihydrochloride|SCHEMBL310793|CHEMBL557983|orb1708235|SCHEMBL29711142|Substance P (6-11), Tyr(6)-D-Phe(7)-D-His(9)-|UNII-53187BIJ00|GLXC-03168|AKOS040740556|(2S,3S)-N-[[2-methoxy-5-[5-(trifluoromethyl)tetrazol-1-yl]phenyl]methyl]-2-phenylpiperidin-3-amine dihydrochloride|DA-59039|HY-12143|MS-29387|VOFOPITANT DIHYDROCHLORIDE [WHO-DD]|CS-0003110|D06317|G12921|Q27261041|(2S,3S)-3-((2-Methoxy-5-(5-(trifluoromethyl)-1H-tetrazol-1-yl)benzyl)amino)-2-phenylpiperidine dihydrochloride|[2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]-([2S,3S]-2-phenylpiperidin-3yi)amine dihydrochloride|[2-methoxy-5-(5-trifluoromethyl-tetrazol-1-yl)benzyl]-([2S,3S]-2-phenylpiperidin-3yl)amine dihydrochloride|3-Piperidinamine, N-((2-methoxy-5-(5-(trifluoromethyl)-1H-tetrazol-1-yl)phenyl)methyl)-2-phenyl-, dihydrochloride, (2S-cis)-"
PROPAFENONE,4932,,"InChI=1S/C21H27NO3/c1-2-14-22-15-18(23)16-25-21-11-7-6-10-19(21)20(24)13-12-17-8-4-3-5-9-17/h3-11,18,22-23H,2,12-16H2,1H3",JWHAUXFOSRPERK-UHFFFAOYSA-N,C21H27NO3,341.4,1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one,"propafenone|54063-53-5|Propafenona|Propafenonum|1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenylpropan-1-one|Propafenon Hexal|GNF-Pf-4594|1-(2-(2-Hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-1-propanone|1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenylpropan-1-one|68IQX3T69U|DTXSID9045184|CHEBI:63619|DTXCID7025184|1-{2-[2-hydroxy-3-(propylamino)propoxy]phenyl}-3-phenylpropan-1-one|1-Propanone, 1-(2-(2-hydroxy-3-(propylamino)propoxy)phenyl)-3-phenyl-|2-(2'-hydroxy-3'-propylaminopropoxy)-omega-phenylpropiophenone|1-Propanone, 1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-|Norfenon|Pintoform|Propafenon Minden|RefChem:55924|GlyTouCan:G40724BB|SA79|C01BC03|G40724BB|258-955-6|Rythmol|Propafenonum [INN-Latin]|Propafenona [INN-Spanish]|Propafenone (INN)|CHEMBL631|1-[2-(2-hydroxy-3-propylamino-propoxy)phenyl]-3-phenyl-propan-1-one|MFCD00216020|Paraffin with ceresin|NCGC00015819-06|1-(2-(2-Hydroxy-3-propylaminopropoxy)phenyl)-3-phenylpropan-1-one|PROPAFENONE [INN]|1-[2-[2-hydroxy-3-(propylamino)propoxy]phenyl]-3-phenyl-propan-1-one|Propafenone [INN:BAN]|CAS-54063-53-5|Propafenon hexal (TN)|EINECS 258-955-6|UNII-68IQX3T69U|Rhytmol|1-[2-(2-hydroxy-3-propylaminopropoxy)phenyl]-3-phenylpropan-1-one|(R)-SA-79|(S)-SA-79|HSDB 7929|(+/-)-Propafenone|Propafenone (Standard)|Spectrum_001612|PROPAFENONE [MI]|Prestwick0_000499|Prestwick1_000499|Prestwick2_000499|Prestwick3_000499|Spectrum2_001603|Spectrum3_001905|Spectrum4_000209|Spectrum5_001271|C07381|PROPAFENONE [VANDF]|Lopac0_000919|SCHEMBL27865|BSPBio_000397|BSPBio_001465|BSPBio_003470|KBioGR_000817|KBioSS_002092|PROPAFENONE [WHO-DD]|DivK1c_000906|SPBio_001605|SPBio_002318|BPBio1_000437|GTPL2561|orb1310219|SCHEMBL16730120|BCBcMAP01_000079|HY-B0432R|KBio1_000906|KBio2_002092|KBio2_004660|KBio2_007228|KBio3_002974|NINDS_000906|HMS1791J07|HMS1989J07|HMS2089E09|HMS3259O16|HMS3402J07|HMS3656O08|HMS5081K13|HMS5087K05|HY-B0432|Tox21_110228|BDBM50067133|MSK160272|s2500|s5789|STL284627|AKOS000276940|AKOS022106720|Tox21_110228_1|CCG-205001|DB01182|NC00582|SDCCGSBI-0050894.P004|IDI1_000906|NCGC00015819-04|NCGC00015819-05|NCGC00015819-07|NCGC00015819-08|NCGC00015819-10|NCGC00015819-11|NCGC00015819-15|NCGC00015819-24|NCGC00089784-02|NCGC00089784-03|NCGC00089784-04|NCGC00089784-05|AC-37643|SBI-0050894.P003|AB00053687|CS-0009325|NS00010400|SW196964-3|EN300-58332|D08435|G78087|AB00053687-14|AB00053687_15|AB00053687_16|063P535|Q662511|BRD-A26334849-001-02-1|BRD-A26334849-001-06-2|BRD-A26334849-003-05-0|BRD-A26334849-003-16-7|BRD-A26334849-003-23-3|2'-[2-Hydroxy-3-(propylamino)propoxy]-3-phenylpropiophenone|1-(2-[2-Hydroxy-3-(propylamino)propoxy]phenyl)-3-phenyl-1-propanone #|1-[2-(2-Hydroxy-3-propylamino-propoxy)-phenyl]-3-phenyl-propan-1-one|1-[2-(2-Hydroxy-3-propylamino-propoxy)-phenyl]-3-phenyl-propan-1-one (propafenone)|9083-41-4"
ACALABRUTINIB,71226662,,"InChI=1S/C26H23N7O2/c1-2-6-21(34)32-15-5-7-19(32)25-31-22(23-24(27)29-14-16-33(23)25)17-9-11-18(12-10-17)26(35)30-20-8-3-4-13-28-20/h3-4,8-14,16,19H,5,7,15H2,1H3,(H2,27,29)(H,28,30,35)/t19-/m0/s1",WDENQIQQYWYTPO-IBGZPJMESA-N,C26H23N7O2,465.5,"4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide","Acalabrutinib|1420477-60-6|ACP-196|acalabrutinibum|I42748ELQW|4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide|Benzamide, 4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinyl-|CHEBI:167707|DTXSID401026209|Benzamide, 4-(8-amino-3-((2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinyl-|4-{8-amino-3-[(2S)-1-(but-2-ynoyl)pyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl}-N-(pyridin-2-yl)benzamide|4-(8-Amino-3-((2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl)imidazo(1,5-a)pyrazin-1-yl)-N-2-pyridinylbenzamide|4-(8-amino-3-((2S)-1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo(1,5-a)pyrazin-1-yl)-N-(pyridin-2-yl)benzamide|4-(8-amino-3-((2S)-1-but-2-ynoylpyrrolidin-2-yl)imidazo(1,5-a)pyrazin-1-yl)-N-pyridin-2-ylbenzamide|4-[8-Amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide|RefChem:57414|L01XE51|DTXCID401510462|Bruton Tyrosine Kinase Inhibitor ACP-196|814-272-0|Calquence|Acalabrutinib (ACP-196)|Acalabrutinib [INN]|MFCD29472294|Acalabrutinib(ACP196)|(S)-4-(8-amino-3-(1-(but-2-ynoyl)pyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide|Calquence (TN)|4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-(2-pyridyl)benzamide|(S)-4-(8-amino-3-(1-but-2-ynoylpyrrolidin-2-yl)imidazo[1,5-a]pyrazin-1-yl)-N-(pyridin-2-yl)benzamide|Acalabrutinib [USAN:INN]|UNII-I42748ELQW|C26H23N7O2|4-[8-amino-3-[(2S)-1-(1-oxo-2-butyn-1-yl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl]-N-2-pyridinylbenzamide; ACP 196|Acalabrutinib (Standard)|ACP-196;Acalabrutinib|ACALABRUTINIB [MI]|ACALABRUTINIB [JAN]|ACALABRUTINIB [USAN]|ACALABRUTINIB [WHO-DD]|ACP196|GTPL8912|orb1303984|Acalabrutinib (JAN/USAN/INN)|CHEMBL3707348|SCHEMBL14637368|SCHEMBL29376537|ACP 196|EX-A881|WDENQIQQYWYTPO-IBGZPJMESA-N|ACALABRUTINIB [ORANGE BOOK]|BDBM50175583|HY-17600R|NSC791164|NSC800976|s8116|AKOS030526094|CCG-269407|CS-5356|DB11703|DS-3326|NSC-791164|NSC-800976|NCGC00479074-01|BP-43623|FA138815|HY-17600|Example 6 [US20140155385 A1]|NS00073620|D10893|EN300-7369651|BRD-K64034691-001-01-9|Q23668732|Z2238902271|4-{8-Amino-3-[(2S)-1-(2-butynoyl)-2-pyrrolidinyl]imidazo[1,5-a]pyrazin-1-yl}-N-(2-pyridinyl)benzamide"
TIRABRUTINIB,54755438,,"InChI=1S/C25H22N6O3/c1-2-6-21(32)29-14-13-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-9-11-20(12-10-17)34-19-7-4-3-5-8-19/h3-5,7-12,16,18H,13-15H2,1H3,(H2,26,27,28)/t18-/m1/s1",SEJLPXCPMNSRAM-GOSISDBHSA-N,C25H22N6O3,454.5,6-amino-9-[(3R)-1-but-2-ynoylpyrrolidin-3-yl]-7-(4-phenoxyphenyl)purin-8-one,"Tirabrutinib|1351636-18-4|ONO-4059|GS-4059|Velexbru|ONO-4059(Free base)|LXG44NDL2T|ONO4059|6-Amino-9-((3R)-1-(2-butynoyl)-3-pyrrolidinyl)-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one|8H-Purin-8-one,6-amino-7,9-dihydro-9-((3R)-1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl)-7-(4-phenoxyphenyl)|tirabrutinibum|6-amino-9-((3R)-1-(but-2-ynoyl)pyrrolidin-3-yl)-7-(4-phenoxyphenyl)-8,9-dihydro-7H-purin-8-one|6-amino-9-[(3R)-1-(but-2-ynoyl)pyrrolidin-3-yl]-7-(4-phenoxyphenyl)-8,9-dihydro-7H-purin-8-one|8H-Purin-8-one, 6-amino-7,9-dihydro-9-((3R)-1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl)-7-(4-phenoxyphenyl)-|8H-Purin-8-one, 6-amino-7,9-dihydro-9-[(3R)-1-(1-oxo-2-butyn-1-yl)-3-pyrrolidinyl]-7-(4-phenoxyphenyl)-|RefChem:190121|Btk Kinase inhibitor|Tirabrutinib [INN]|Tirabrutinib free base|(R)-6-amino-9-(1-(but-2-ynoyl)pyrrolidin-3-yl)-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one|UNII-LXG44NDL2T|ONO-4059(Tirabrutinib)|6-amino-9-[(3R)-1-but-2-ynoylpyrrolidin-3-yl]-7-(4-phenoxyphenyl)purin-8-one|1351636-18-4 (free base)|(R)-6-amino-9-(1-(but-2-ynoyl)pyrrolidin-3-yl)-7-(4-phenoxyphenyl)-7H-purin-8(9H)-one|C25H22N6O3|MFCD28386296|Tirabrutinib (USAN/INN)|TIRABRUTINIB [USAN]|A1EK0|TIRABRUTINIB [WHO-DD]|GTPL9265|orb1679016|CHEMBL4071161|SCHEMBL14798454|SCHEMBL29356839|CHEBI:232544|BDBM194087|EX-A2358|NSC797933|NSC800995|AKOS030526437|CS-5676|DB15227|NSC-797933|NSC-800995|ONO-4059; Tirabrutinib; GS-4059|6-amino-9-[(3R)-1-(but-2-ynoyl)pyrrolidin-3-yl]-7-(4-phenoxyphenyl)-7,9-dihydro-8H-purin-8-one|AC-33638|AS-57314|DA-76434|HY-15771|ONO-4059 (GS-4059)|D12594|N13299|US9199997, 9|Q27283239"
FENEBRUTINIB,86567195,,"InChI=1S/C37H44N8O4/c1-23-18-42(27-21-49-22-27)9-10-43(23)26-5-6-33(39-17-26)40-30-13-25(19-41(4)35(30)47)28-7-8-38-34(29(28)20-46)45-12-11-44-31(36(45)48)14-24-15-37(2,3)16-32(24)44/h5-8,13-14,17,19,23,27,46H,9-12,15-16,18,20-22H2,1-4H3,(H,39,40)/t23-/m0/s1",WNEODWDFDXWOLU-QHCPKHFHSA-N,C37H44N8O4,664.8,"10-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-9-one","Fenebrutinib|1434048-34-6|GDC-0853|RG7845|GDC0853|(S)-2-(3'-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-[3,4'-bipyridin]-2'-yl)-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one|RG-7845|E9L2885WUL|RO7010939|G02599853|RO-7010939|G-02599853|10-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl]amino]-6-oxopyridin-3-yl]pyridin-2-yl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-9-one|2-(3'-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-(3,4'-bipyridin)-2'-yl)-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta(4,5)pyrrolo(1,2-a)pyrazin-1(6H)-one|fenebrutinibum|(S)-2-(3'-(hydroxymethyl)-1-methyl-5-((5-(2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxo-1,6-dihydro-(3,4'-bipyridin)-2'-yl)-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta(4,5)pyrrolo(1,2-a)pyrazin-1(6H)-one|10-(3-(hydroxymethyl)-4-(1-methyl-5-((5-((2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl)pyridin-2-yl)amino)-6-oxopyridin-3-yl)pyridin-2-yl)-4,4-dimethyl-1,10-diazatricyclo(6.4.0.02,6)dodeca-2(6),7-dien-9-one|RefChem:598867|Bruton Tyrosine Kinase Inhibitor GDC-0853|Fenebrutinib (GDC-0853)|Fenebrutinib [INN]|Fenebrutinib [USAN]|CHEMBL4065122|GDC-0853(RG7845)|2-[3'-(hydroxymethyl)-1-methyl-5-({5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl}amino)-6-oxo[1,6-dihydro[3,4'-bipyridine]]-2'-yl]-7,7-dimethyl-3,4,7,8-tetrahydro-2H-cyclopenta[4,5]pyrrolo[1,2-a]pyrazin-1(6H)-one|9AJ|Fenebrutinib (USAN/INN)|Fenebrutinib [USAN:INN]|UNII-E9L2885WUL|FENEBRUTINIB [WHO-DD]|GTPL9299|orb1296105|SCHEMBL14912882|SCHEMBL29369328|SCHEMBL29429358|CHEBI:234073|C37H44N8O4|GLXC-10689|BCP19175|EX-A1308|GDC 0853|JHC04834|BDBM50244440|NSC798202|s8421|AKOS032945119|FENEBRUTINIB ( GDC-0853 )|CS-5927|DB14785|NSC-798202|AC-32585|BS-15120|HY-19834|RG-7845 (GDC-0853)|Example 130 [US20140194408]|D11457|Q23304817|(S)-2-(3'-(HYDROXYMETHYL)-1-METHYL-5-((5-(2-METHYL- 4-(OXETAN-3-YL)PIPERAZIN-1-YL)PYRIDIN-2-YL)AMINO)-6-OXO-1,6-DIHYDRO-(3,4'-BIPYRIDIN)-2'-YL)-7,7-DIMETHYL-2,3,4,6,7,8-HEXAHYDRO-1H-CYCLOPENTA (4,5)PYRROLO(1,2-A)PYRAZIN-1-ONE|(S)-2-(3-(HydroxyMethyl)-1-Methyl-5-((5-(2-Methyl-4-(Oxetan-3-yl)Piperazin-1-yl)Pyridin-2-yl)Amino)-6-Oxo-1,6-Dihydro-[3,4-biPyridin]-2-yl)-7,7-diMethyl-3,4,7,8-Tetrahydro-2H-Cyclopenta[4,5]Pyrrolo[1,2-a]Pyrazin-1(6H)-One|10-[3'-(hydroxymethyl)-1-methyl-5-({5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]pyridin-2-yl}amino)-6-oxo-1,6-dihydro-[3,4'-bipyridin]-2'-yl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.0,dodeca-2(6),7-dien-9-one|10-[3-(hydroxymethyl)-4-[1-methyl-5-[[5-[(2S)-2-methyl-4-(oxetan-3-yl)piperazin-1-yl]-2-pyridyl]amino]-6-oxo-3-pyridyl]-2-pyridyl]-4,4-dimethyl-1,10-diazatricyclo[6.4.0.02,6]dodeca-2(6),7-dien-9-one|2H-CYCLOPENTA(4,5)PYRROLO(1,2-A)PYRAZIN-1(6H)-ONE, 2-(1,6-DIHYDRO-3'-(HYDROXYMETHYL)-1-METHYL-5-((5-((2S)-2-METHYL-4-(3-OXETANYL)-1-PIPERAZINYL)-2-PYRIDINYL)AMINO)-6-OXO(3,4'-BIPYRIDIN)-2'-YL)-3,4,7,8-TETRAHYDRO-7,7-DIMETHYL-|2H-Cyclopenta(4,5)pyrrolo(1,2-a)pyrazin-1(6H)-one, 2-(1,6-dihydro-3'-(hydroxymethyl)-1-methyl-5-((5-((2S)-2-methyl-4-(3-oxetanyl)-1-piperazinyl)-2-pyridinyl)amino)-6-oxo(3,4'-bipyridin)-2'-yl)3,4,7,8-tetrahydro-7,7-dimethyl-"
SOFNOBRUTINIB,87056204,,"InChI=1S/C26H23FN8O2/c1-34-12-17(11-29-34)30-26-32-23(31-25(28)33-26)18-3-2-4-21(19(18)13-36)35-8-7-15-9-16(14-5-6-14)10-20(27)22(15)24(35)37/h2-4,7-12,14,36H,5-6,13H2,1H3,(H3,28,30,31,32,33)",RQYDQAPLARKISN-UHFFFAOYSA-N,C26H23FN8O2,498.5,"2-[3-[4-amino-6-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]-2-(hydroxymethyl)phenyl]-6-cyclopropyl-8-fluoroisoquinolin-1-one","Sofnobrutinib|BTK inhibitor 4b|1646608-10-7|CHEMBL4209441|AS-0871|2-(3-(4-amino-6-((1-methyl-1H-pyrazol-4-yl)amino)-1,3,5-triazin-2-yl)-2-(hydroxymethyl)phenyl)-6-cyclopropyl-8-fluoroisoquinolin-1(2H)-one|2-[3-[4-amino-6-[(1-methylpyrazol-4-yl)amino]-1,3,5-triazin-2-yl]-2-(hydroxymethyl)phenyl]-6-cyclopropyl-8-fluoroisoquinolin-1-one|2-(3-[4-Amino-6-[(1-methyl-1H-pyrazol-4-yl)amino]-1,3,5-triazin-2-yl]-2-(hydroxymethyl)phenyl)-6-cyclopropyl-8-fluoroisoquinolin-1(2H)-one|2-(3-{4-Amino-6-[(1-methyl-1H-pyrazol-4-yl)amino]-1,3,5-triazin-2-yl}-2-(hydroxymethyl)phenyl)-6-cyclopropyl-8-fluoroisoquinolin-1(2H)-one|sofnobrutinib [INN]|PZP2D7F6L5|orb1744615|SCHEMBL17781672|SCHEMBL29547553|GTPL10094|TQP0923|GLXC-27917|BDBM50459553|compound 4b [PMID: 30216722]|DA-51451|HY-122600|CS-0087365|1(2H)-Isoquinolinone, 2-[3-[4-amino-6-[(1-methyl-1H-pyrazol-4-yl)amino]-1,3,5-triazin-2-yl]-2-(hydroxymethyl)phenyl]-6-cyclopropyl-8-fluoro-|2-[3-{4-amino-6-[(1-methyl-1H-pyrazol-4-yl)amino]- 1,3,5-triazin-2-yl}-2-(hydroxymethyl)phenyl]-6- cyclopropyl-8-fluoroisoquinolin-1(2H)-one"
EVOBRUTINIB,71479709,,"InChI=1S/C25H27N5O2/c1-2-22(31)30-14-12-18(13-15-30)16-27-25-23(24(26)28-17-29-25)19-8-10-21(11-9-19)32-20-6-4-3-5-7-20/h2-11,17-18H,1,12-16H2,(H3,26,27,28,29)",QUIWHXQETADMGN-UHFFFAOYSA-N,C25H27N5O2,429.5,1-[4-[[[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino]methyl]piperidin-1-yl]prop-2-en-1-one,"Evobrutinib|1415823-73-2|MSC2364447C|MSC-2364447C|M-2951|ZA45457L1K|1-(4-((6-Amino-5-(4-phenoxy-phenyl)-pyrimidin-4-ylamino)-methyl)-piperidin-1-yl)-propenone|1-(4-(((6-Amino-5-(4-phenoxyphenyl)-4-pyrimidinyl)amino)methyl)-1-piperidinyl)-2-propen-1-one|1-[4-[[[6-amino-5-(4-phenoxyphenyl)-4-pyrimidinyl]amino]methyl]-1-piperidinyl]-2-propen-1-one|2-Propen-1-one, 1-(4-(((6-amino-5-(4-phenoxyphenyl)-4-pyrimidinyl)amino)methyl)-1-piperidinyl)-|evobrutinibum|2-Propen-1-one, 1-[4-[[[6-amino-5-(4-phenoxyphenyl)-4-pyrimidinyl]amino]methyl]-1-piperidinyl]-|RefChem:139675|1-(4-(((6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl)amino)methyl)piperidin-1-yl)prop-2-en-1-one|Evobrutinib [INN]|1-[4-[[[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino]methyl]piperidin-1-yl]prop-2-en-1-one|M2951|1-[4-({[6-AMINO-5-(4-PHENOXYPHENYL)PYRIMIDIN-4-YL]AMINO}METHYL)PIPERIDIN-1-YL]PROP-2-EN-1-ONE|Evobrutinib?|M-2951; Evobrutinib|Evobrutinib (USAN/INN)|EVOBRUTINIB [USAN]|Evobrutinib (M-2951)|EVOBRUTINIB [WHO-DD]|UNII-ZA45457L1K|GTPL9752|CHEMBL4072833|SCHEMBL14165673|QUIWHXQETADMGN-UHFFFAOYSA-N|BDBM291522|US9580449, Example A39|BCP28995|EX-A2691|US9580449, Example A250|NSC800892|s8777|AKOS032954004|AB90800|CS-6303|DB15170|NSC-800892|MSC 2364447|AC-35533|BS-15355|DB-126809|HY-101215|D12467|D71175|A902526|A250 [WO2012170976]|Q27295200|Z2831495619|M-2951; M 2951; M2951; MSC-2364447C; MSC 2364447C; MSC2364447C|N-[(1-acryloylpiperidin-4-yl)methyl]-5-(4-phenoxyphenyl)pyrimidine-4,6-diamine|1-[4-[[[6-amino-5-(4-phenoxyphenyl)pyrimidin-4-yl]amino]methyl]-1-piperidyl]prop-2-en-1-one"
BRANEBRUTINIB,121293929,,"InChI=1S/C20H23FN4O2/c1-4-6-16(26)24-13-7-5-8-25(10-13)19-15(21)9-14(20(22)27)18-17(19)11(2)12(3)23-18/h9,13,23H,5,7-8,10H2,1-3H3,(H2,22,27)(H,24,26)/t13-/m0/s1",VJPPLCNBDLZIFG-ZDUSSCGKSA-N,C20H23FN4O2,370.4,"4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide","Branebrutinib|1912445-55-6|BMS-986195|7LBRZUYSHU|4-[(3S)-3-(but-2-ynoylamino)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide|4-((3S)-3-(But-2-ynamido)piperidin-1-yl)-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide|4-[(3S)-3-(but-2-ynamido)piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide|4-((3S)-3-(but-2-ynoylamino)piperidin-1-yl)-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide|RefChem:121234|(S)-4-(3-(but-2-ynamido)piperidin-1-yl)-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide|Branebrutinib [USAN]|C20H23FN4O2|BMS986195|Branebrutinib (USAN)|1H-Indole-7-carboxamide, 5-fluoro-2,3-dimethyl-4-((3S)-3-((1-oxo-2-butyn-1-yl)amino)-1-piperidinyl)-|MFCD31631584|UNII-7LBRZUYSHU|BRANEBRUTINIB [INN]|BRANEBRUTINIB [WHO-DD]|GTPL9869|orb1301816|CHEMBL4297674|SCHEMBL17699728|SCHEMBL29564794|Branebrutinib (BMS-986195)|VJPPLCNBDLZIFG-ZDUSSCGKSA-N|BDBM164638|BDBM166759|BCP29496|EX-A2720|NSC807627|s8832|WHO 11026|AKOS037649047|DB15347|NSC-807627|AC-31535|BS-16393|BMS986195; BMS986195|HY-112161|CS-0043577|Example 223 [US20160115126A1]|D11478|EN300-2007801|US9688629, 123|US9688629, 223|Q50825082|4-((3S)-3-(2-Butynoylamino)-1-piperidinyl)-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide|4-[(3S)-3-(but-2-ynoylamino)-1-piperidyl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide|(S)-4-(3-(2-BUTYNOYLAMINO)PIPERIDIN-1-YL)-5-FLUORO-2,3-DIMETHYL-1H-INDOLE-7-CARBOXAMIDE|4-((3S)-3-(2-BUTYNOYLAMINO)-1-PIPERIDINYL)-5-FLUORO-2,3-DIMETHYL-1HINDOLE-7-CARBOXAMIDE"
ZANUBRUTINIB,135565884,,"InChI=1S/C27H29N5O3/c1-2-23(33)31-16-13-18(14-17-31)22-12-15-29-27-24(26(28)34)25(30-32(22)27)19-8-10-21(11-9-19)35-20-6-4-3-5-7-20/h2-11,18,22,29H,1,12-17H2,(H2,28,34)/t22-/m0/s1",RNOAOAWBMHREKO-QFIPXVFZSA-N,C27H29N5O3,471.5,"(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide","Zanubrutinib|1691249-45-2|Brukinsa|BGB-3111|AG9MHG098Z|(7S)-2-(4-PHENOXYPHENYL)-7-[1-(PROP-2-ENOYL)PIPERIDIN-4-YL]-4H,5H,6H,7H-PYRAZOLO[1,5-A]PYRIMIDINE-3-CARBOXAMIDE|DTXSID701026208|(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide|(S)-7-(1-Acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide|(7S)-2-(4-Phenoxyphenyl)-7-(1-(prop-2-enoyl)piperidin-4-yl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide|(7S)-4,5,6,7-Tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide|Pyrazolo(1,5-a)pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-(1-(1-oxo-2-propen-1-yl)-4-piperidinyl)-2-(4-phenoxyphenyl)-, (7S)-|Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 4,5,6,7-tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)-, (7S)-|zanubrutinibum|(7S)-2-(4-phenoxyphenyl)-7-(1-(prop-2-enoyl)piperidin-4-yl)-4H,5H,6H,7H-pyrazolo(1,5-a)pyrimidine-3-carboxamide|(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoylpiperidin-4-yl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide|(7S)-2-(4-Phenoxyphenyl)-7-[1-(prop-2-enoyl)piperidin-4-yl]-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide|(7S)-4,5,6,7-Tetrahydro-7-(1-(1-oxo-2-propen-1-yl)-4-piperidinyl)-2-(4-phenoxyphenyl)pyrazolo(1,5-a)pyrimidine-3-carboxamide|(S)-7-(1-acryloylpiperidin-4-yl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide|BTK-InhB|RefChem:57294|DTXCID701510461|Zanubrutinib (BGB-3111)|Zanubrutinib [INN]|Zanubrutinib [USAN]|1691249-45-2 (S-isomer)|BGB3111|C27H29N5O3|Brukinsa (TN)|MFCD31567461|Zanubrutinib (Standard)|ZANUBRUTINIB [MI]|Zanubrutinib [USAN:INN]|UNII-AG9MHG098Z|BGB-3111(Zanubrutinib)?|ZANUBRUTINIB [WHO-DD]|GTPL9861|orb1299685|Zanubrutinib (JAN/USAN/INN)|CHEMBL3936761|SCHEMBL17842597|BDBM250082|GLXC-21435|ZANUBRUTINIB [ORANGE BOOK]|compound 27b [US9447106]|BCP29110|EX-A3602|HY-101474AR|NSC823807|s8791|AKOS032944849|AT18252|DB15035|HY-101474A|NSC-823807|US9447106, 27b (peak 2)|BP-44065|BS-15529|BZ168474|DA-68805|PD077832|CS-0021869|D11422|BGB-3111; BGB 3111; BGB3111|EN300-22831096|(7S)-2-(4-phenoxyphenyl)-7-(1-prop-2-enoyl-4-piperidyl)-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrimidine-3-carboxamide|(7S)-4,5,6,7-Tetrahydro-7-[1-(1-oxo-2-propen-1-yl)-4-piperidinyl]-2-(4-phenoxyphenyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide;BGB 311  1|1651179-04-2|7-(1-acryloyl-4-piperidinyl)-2-(4-phenoxyphenyl)-4,5,6,7-tetrahydropyrazolo(1,5-a)pyrimidine-3-carboxamide"
POSELTINIB,56644522,,"InChI=1S/C26H26N6O3/c1-3-23(33)27-19-5-4-6-21(17-19)35-25-24-22(11-16-34-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)",LZMJNVRJMFMYQS-UHFFFAOYSA-N,C26H26N6O3,470.5,"N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]furo[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide","Poseltinib|1353552-97-2|LY3337641|D01E4B1U35|DTXSID501112972|2-Propenamide, N-(3-((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)furo(3,2-d)pyrimidin-4-yl)oxy)phenyl)-|N-(3-((2-(4-(4-Methylpiperazin-1-yl)anilino)furo(3,2-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide|poseltinibum|N-(3-((2-((4-(4-Methyl-1-piperazinyl)phenyl)amino)furo(3,2-d)pyrimidin-4-yl)oxy)phenyl)-2-propenamide|N-[3-[[2-[[4-(4-Methyl-1-piperazinyl)phenyl]amino]furo[3,2-d]pyrimidin-4-yl]oxy]phenyl]-2-propenamide|RefChem:926740|DTXCID701544573|HM71224|Poseltinib (HM-71224; LY-3337641)|Poseltinib [INN]|N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]furo[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide|HM-71224|N-(3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)furo[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylamide|Poseltinib?|C26H26N6O3|Poseltinib [WHO-DD]|UNII-D01E4B1U35|GTPL9862|orb1909042|CHEMBL4163691|SCHEMBL14915064|SCHEMBL29357966|SCHEMBL30134608|GLXC-23377|DEC55297|BDBM50369724|EX-A10386|AKOS032954005|BS-15248|LY333764|DB-418323|Example 228 [WO2011162515A2]|HY-109010|CS-0030508|HM71224; LY3337641|D71176|Q27275916"
AZD1981,11292191,,"InChI=1S/C19H17ClN2O3S/c1-11-19(26-14-8-6-13(20)7-9-14)18-15(21-12(2)23)4-3-5-16(18)22(11)10-17(24)25/h3-9H,10H2,1-2H3,(H,21,23)(H,24,25)",JWYIGNODXSRKGP-UHFFFAOYSA-N,C19H17ClN2O3S,388.9,2-[4-acetamido-3-(4-chlorophenyl)sulfanyl-2-methylindol-1-yl]acetic acid,"AZD1981|802904-66-1|AZD-1981|AZD 1981|2AD53WQ2CX|2-[4-acetamido-3-(4-chlorophenyl)sulfanyl-2-methylindol-1-yl]acetic acid|1H-Indole-1-acetic acid, 4-(acetylamino)-3-((4-chlorophenyl)thio)-2-methyl-|2-{3-[(4-chlorophenyl)sulfanyl]-4-acetamido-2-methyl-1H-indol-1-yl}acetic acid|2-(4-acetamido-3-(4-chlorophenyl)sulfanyl-2-methylindol-1-yl)acetic acid|1H-Indole-1-acetic acid, 4-(acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-|2-(3-((4-chlorophenyl)sulfanyl)-4-acetamido-2-methyl-1H-indol-1-yl)acetic acid|RefChem:116032|2-(4-Acetamido-3-((4-chlorophenyl)thio)-2-methyl-1H-indol-1-yl)acetic acid|UNII-2AD53WQ2CX|MFCD26936340|CHEMBL1914489|7-Methyl-5-[(3-piperazin-1-ylMethyl)-1,2,4-oxadiazol-5-yl-]-2-[4-(trifluoroMethoxy)benzyl]-2,3-dihydro-1H-isoindol-1-one Methanesulphonate|4-(Acetylamino)-3-((4-chlorophenyl)thio)-2-methyl-1H-indole-1-acetic acid|4-(acetylamino)-3-[(4-chlorophenyl)thio]-2-methyl-1h-indole-1-acetic acid|JWYIGNODXSRKGP-UHFFFAOYSA-N|GTPL7680|orb1300801|SCHEMBL1053662|SCHEMBL30538014|EX-A662|AZD 1981 [WHO-DD]|DTXSID901025620|HMS3653A06|AZD1981?|BCP20957|BDBM50357102|s7263|2-[4-acetamido-3-(4-chlorophenyl)sulfanyl-2-methyl-indol-1-yl]acetic Acid|AKOS027263775|CCG-268510|CS-4189|DB11946|SB16902|NCGC00386290-04|AC-33100|AC-33101|AS-75220|HY-15950|DB-099530|NS00072977|SW219735-1|BRD-K83186168-001-01-8|Q27074719|2-(4-acetamido-3-(4-chlorophenylthio)-2-methyl-1H-indol-1-yl)acetic acid|[4-acetylamino-3-(4-chlorophenylsulfanyl)-2-methyl-1H-indol-1-yl]acetic acid"
ISOPROTERENOL HYDROCHLORIDE,5807,,"InChI=1S/C11H17NO3.ClH/c1-7(2)12-6-11(15)8-3-4-9(13)10(14)5-8;/h3-5,7,11-15H,6H2,1-2H3;1H",IROWCYIEJAOFOW-UHFFFAOYSA-N,C11H18ClNO3,247.72,"4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol;hydrochloride","Isoprenaline hydrochloride|51-30-9|ISOPROTERENOL HYDROCHLORIDE|Aerolone|Aerotrol|Isoproterenol HCl|Vapo-Iso|Asthpul|Norisodrine Aerotrol|DL-Isoproterenol hydrochloride|Isopropylarterenol hydrochloride|dl-Isadrine hydrochloride|Isoprenaline chloride|Mistarel|Suscardia|Isovon|(+-)-Isoproterenol hydrochloride|Isoproterenol monohydrochloride|(+-)-Isoprenaline hydrochloride|NCI-C55630|Isopropylnorepinephrine-hydrochloride|DL-Isopropylnorepinephrine hydrochloride|(+-)-Isopropylnoradrenaline hydrochloride|NSC-37745|NSC-89747|Isoprenaline hydrochloride, dl-|DTXSID6025486|DIA2A74855|DTXCID105486|Isoproterenol hydrochloride (USP)|Isoproterenol hydrochloride [USP]|alpha-(Isopropylaminomethyl)-3,4-dihydroxybenzyl alcohol hydrochloride|NSC37745|NSC89747|Benzyl alcohol, 3,4-dihydroxy-alpha-((isopropylamino)methyl)-, hydrochloride|4-[1-Hydroxy-2-[(1-methylethyl)amino]ethyl]-1,2-benzenediol hydrochloride|Imuprel|4-(1-Hydroxy-2-((1-methylethyl)amino)ethyl)-1,2-benzenediol Hydrochloride|RefChem:55418|Hydrochloride, Isoproterenol|200-089-8|213-438-4|Isoprenaline HCl|Isuprel|Euspiran|Isadrine|DL-Isoprenaline hydrochloride|Izadrin|Isuprel hydrochloride|Isomenyl|Norisodrine hydrochloride|NSC 37745|Isoprenaline (hydrochloride)|949-36-0|MFCD00012603|NSC 89747|(+/-)-Isoproterenol hydrochloride|4-(1-hydroxy-2-(isopropylamino)ethyl)benzene-1,2-diol hydrochloride|4-{1-hydroxy-2-[(propan-2-yl)amino]ethyl}benzene-1,2-diol hydrochloride|1,2-Benzenediol, 4-(1-hydroxy-2-((1-methylethyl)amino)ethyl)-, hydrochloride|MFCD00064548|Benzenemethanol, 3,4-dihydroxy-alpha-(((1-methylethyl)amino)methyl)-, hydrochloride, (+/-)-|1-(3',4'-Dihydroxyphenyl)-2-isopropylaminoethanol hydrochloride|3,4-Dihydroxy-alpha-((isopropylamino)methyl)benzyl alcohol hydrochloride|4-[1-hydroxy-2-(propan-2-ylamino)ethyl]benzene-1,2-diol;hydrochloride|dl-Isoprenaline hydrochloride (JAN)|4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol hydrochloride|WLN: QR BQ DYQ1MY1&1 &GH|CAS-51-30-9|SMR000058267|DL-ISOPRENALINE HYDROCHLORIDE [JAN]|CCRIS 5921|Isoprenaline hydrochloride (VAN)|Isoproterenol (hydrochloride)|SR-01000075272|EINECS 200-089-8|Levisoprenaline (hydrochloride)|Iprenol|Sooner|UNII-DIA2A74855|AI3-52675|3,4-Dihydroxy-alpha-[(isopropylamino)methyl]benzyl alcohol hydrochloride|Isuprel (TN)|Proternol-S (TN)|Isadrine-hydrochloride|N-Isopropyl-DL-noradrenaline hydrochloride|SCHEMBL7627|CHEMBL1711|REGID_for_CID_5807|MLS001304049|MLS001335893|MLS001335894|MLS002153386|component of Aerolone Compound|SPECTRUM1500357|(y)-Isoproterenol hydrochloride|orb1309921|SCHEMBL3672791|(?)-Isoproterenol hydrochloride|NIOSH/UX1780000|CHEBI:31453|HY-B0468R|HMS1571K16|HMS1920H13|HMS5081B05|Pharmakon1600-01500357|(.+-.)-Isoprenaline hydrochloride|BCP23375|FAA98495|HY-B0468|(.+-.)-Isoproterenol hydrochloride|Tox21_201272|Tox21_300308|Tox21_500711|CCG-40129|NSC757079|s2566|AKOS015895437|DL-Isopropylnoradrenaline hydrochloride|AC-8688|BCP9000796|FI33495|LP00711|NC00515|NSC-757079|Isoprenaline (hydrochloride) (Standard)|NCGC00025274-02|NCGC00025274-05|NCGC00094033-01|NCGC00094033-02|NCGC00094061-01|NCGC00094061-02|NCGC00094061-03|NCGC00094061-04|NCGC00254027-01|NCGC00258824-01|NCGC00261396-01|AS-13330|DA-64559|ISOPRENALINE HYDROCHLORIDE [MART.]|SY066650|BCP0726000230|ISOPRENALINE HYDROCHLORIDE [WHO-DD]|ISOPRENALINE HYDROCHLORIDE [WHO-IP]|ISOPROTERENOL HYDROCHLORIDE [VANDF]|DB-053474|ISOPROTERENOL HYDROCHLORIDE [USP-RS]|(.+-.)-Isopropylnoradrenaline hydrochloride|EU-0100711|I0260|NS00076358|SW197212-2|UX17800000|(-)-N-Isopropyl-L-noradrenaline hydrochloride|VU0244462-4|D01390|EN300-108428|H10806|I 5627|ISOPRENALINE HYDROCHLORIDE [EP IMPURITY]|ISOPRENALINE HYDROCHLORIDE [EP MONOGRAPH]|ISOPROTERENOL DL-FORM HYDROCHLORIDE [MI]|ISOPROTERENOL HYDROCHLORIDE [ORANGE BOOK]|ISOPROTERENOL HYDROCHLORIDE [USP MONOGRAPH]|SR-01000075272-1|SR-01000075272-3|( inverted question mark)-Isoproterenol hydrochloride|Q26840880|Z1416254508|DUO-MEDIHALER COMPONENT ISOPROTERENOL HYDROCHLORIDE|4-(1-Hydroxy-2-(isopropylamino)ethyl)benzene-1,2-diol HCl|4-(1-Hydroxy-2-(isopropylamino)ethyl)pyrocatechol hydrochloride|1, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-, hydrochloride|4-[1-hydroxy-2-(isopropylamino)ethyl]benzene-1,2-diol;hydrochloride|Pyrocatechol, 4-(1-hydroxy-2-(isopropylamino)ethyl)-, hydrochloride|(R)-3,4-Dihydroxy-alpha-(isopropylaminomethyl)benzyl alcohol hydrochloride|.alpha.-(Isopropylaminomethyl)-3,4-dihydroxybenzyl alcohol hydrochloride|1, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-, hydrochloride, (+-)-|3,4-Dihydroxy-.alpha.-[(isopropylamino)methyl]benzyl alcohol hydrochloride|Benzyl alcohol,4-dihydroxy-.alpha.-[(isopropylamino)methyl]-, hydrochloride|Isoprenaline hydrochloride, European Pharmacopoeia (EP) Reference Standard|1, 4-[1-hydroxy-2-[(1-methylethyl)amino]ethyl]-, hydrochloride, (.+-.)-|Benzyl alcohol,4-dihydroxy-.alpha.-[(isopropylamino)methyl]-, hydrochloride, (+-)-|Benzyl alcohol,4-dihydroxy-.alpha.-[(isopropylamino)methyl]-, hydrochloride, (.+-.)-|Isoproterenol hydrochloride, United States Pharmacopeia (USP) Reference Standard|1336-89-6"
MK-8245,24988881,,"InChI=1S/C17H16BrFN6O4/c18-12-2-1-10(19)7-13(12)28-11-3-5-24(6-4-11)15-8-14(29-22-15)17-20-23-25(21-17)9-16(26)27/h1-2,7-8,11H,3-6,9H2,(H,26,27)",UJEAABFSXKCSGI-UHFFFAOYSA-N,C17H16BrFN6O4,467.2,"2-[5-[3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-1,2-oxazol-5-yl]tetrazol-2-yl]acetic acid","MK-8245|1030612-90-8|MK8245|MK 8245|537E7QE8LX|DTXSID80145625|2H-Tetrazole-2-acetic acid, 5-(3-(4-(2-bromo-5-fluorophenoxy)-1-piperidinyl)-5-isoxazolyl)-|RefChem:159216|DTXCID9068116|2-(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)-1,2-oxazol-5-yl)-2H-1,2,3,4-tetrazol-2-yl)acetic acid|959-349-0|2-(5-(3-(4-(2-bromo-5-fluorophenoxy)piperidin-1-yl)isoxazol-5-yl)-2H-tetrazol-2-yl)acetic acid|2-[5-[3-[4-(2-bromo-5-fluorophenoxy)piperidin-1-yl]-1,2-oxazol-5-yl]tetrazol-2-yl]acetic acid|MFCD20039622|CHEMBL1938870|UNII-537E7QE8LX|2H-Tetrazole-2-acetic acid, 5-[3-[4-(2-bromo-5-fluorophenoxy)-1-piperidinyl]-5-isoxazolyl]-;2H-Tetrazole-2-acetic acid, 5-[3-[4-(2-bromo-5-fluorophenoxy)-1-piperidinyl]-5-isoxazolyl]-|C17H16BrFN6O4|UJEAABFSXKCSGI-UHFFFAOYSA-N|5-[3-[4-(2-Bromo-5-fluorophenoxy)-1-piperidinyl]-5-isoxazolyl]-2H-tetrazole-2-acetic acid|MLS006011144|SCHEMBL472978|orb1305218|SCHEMBL29385507|HMS3654I12|BCP02516|EX-A2267|BDBM50362592|s1158|AKOS026750582|CCG-269424|CS-0410|DB13024|MK8245?|SB19577|NCGC00346680-01|NCGC00346680-02|NCGC00346680-05|AC-28436|AS-19554|HY-13070|SMR004702921|DB-368195|NS00072537|SW220251-1|BRD-K29656036-001-02-5|Q27261073|(5-{3-[4-(2-Bromo-5-fluorophenoxy)piperidin-1-yl]isoxazol-5-yl}-2H-tetrazol-2-yl)acetic acid|2-[5-[3-[4-(2-bromo-5-fluoro-phenoxy)-1-piperidyl]isoxazol-5-yl]tetrazol-2-yl]acetic acid"
DABRAFENIB,44462760,,"InChI=1S/C23H20F3N5O2S2/c1-23(2,3)21-30-18(19(34-21)16-10-11-28-22(27)29-16)12-6-4-9-15(17(12)26)31-35(32,33)20-13(24)7-5-8-14(20)25/h4-11,31H,1-3H3,(H2,27,28,29)",BFSMGDJOXZAERB-UHFFFAOYSA-N,C23H20F3N5O2S2,519.6,"N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide","Dabrafenib|1195765-45-7|GSK2118436A|GSK-2118436|QGP4HA4G1B|GSK-2118436A|CHEBI:75045|Benzenesulfonamide, N-[3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-|DTXSID20152499|N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl]-2,6-difluorobenzenesulfonamide|BENZENESULFONAMIDE, N-(3-(5-(2-AMINO-4-PYRIMIDINYL)-2-(1,1-DIMETHYLETHYL)-4-THIAZOLYL)-2-FLUOROPHENYL)-2,6-DIFLUORO-|N-(3-(5-(2-AMINOPYRIMIDIN-4-YL)-2-TERT-BUTYL-1,3-THIAZOL-4-YL)-2-FLUOROPHENYL)-2,6-DIFLUOROBENZENESULFONAMIDE|N-{3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide|dabrafenibum|RefChem:58040|DTXCID8074990|BRAF Inhibitor GSK2118436|L01XE23|689-166-9|N-(3-(5-(2-aminopyrimidin-4-yl)-2-(1,1-dimethylethyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide|N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butyl-1,3-thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzene-1-sulfonamide|Gsk2118436|Tafinlar|Dabrafenib (GSK2118436)|UNII-QGP4HA4G1B|N-(3-(5-(2-aminopyrimidin-4-yl)-2-(tert-butyl)thiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide|MFCD17215684|N-(3-(5-(2-aminopyrimidin-4-yl)-2-tert-butylthiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide|GSK 2118436|1195765-45-7 (free base)|C23H20F3N5O2S2|Dabrafenib (USAN)|DABRAFENIB [USAN]|Dabrafenib (Free Base)|Dabrafenib [USAN:INN]|Dabrafenib?|N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluoro-benzenesulfonamide; Dabarefenib; GSK 2118436; Tafinlar; GSK 2118436A|P06|Dabrafenib (Standard)|DABRAFENIB [MI]|DABRAFENIB [INN]|DABRAFENIB [VANDF]|DABRAFENIB [WHO-DD]|MLS006011052|SCHEMBL806377|GTPL6494|orb1307175|CHEMBL2028663|SCHEMBL29350038|SCHEMBL29353365|DABRAFENIB, KB-57246|BFSMGDJOXZAERB-UHFFFAOYSA-N|HMS3656D12|HMS3672G05|HMS5081L17|BCP09341|EX-A1320|BDBM50428286|FD5028|GSK 2118436A|HY-14660R|MSK169306|NSC764134|NSC800083|AKOS024463285|AKOS032950004|CCG-264736|CS-0692|DB08912|FA65034|NSC-764134|NSC-800083|SB13355|SDCCGSBI-0654477.P001|NCGC00346716-01|NCGC00346716-02|NCGC00346716-14|AC-25889|AS-19634|BP-43637|DA-62632|HY-14660|N-[3-[5-(2-Amino-4-pyrimidinyl)-2-(tert-butyl)-4-thiazolyl]-2-fluorophenyl]-2,6-difluorobenzenesulfo|SMR004702844|NS00040699|S2807|SW219503-1|D10064|AB01565833_02|Q3011604|BRD-K09951645-001-06-8|BRD-K09951645-001-08-4|BRD-K09951645-001-11-8|BRD-K09951645-066-01-2|N-(3-(5-(2-Aminopyrimidine-4-yl)-2-tert-butylthiazol-4-yl)-2-fluorophenyl)-2,6-difluorobenzenesulfonamide;GSK2118436A|N-[3-[5-(2-aminopyrimidin-4-yl)-2-tert-butyl-thiazol-4-yl]-2-fluoro-phenyl]-2,6-difluoro-benzenesulfonamide|N-{3-(5-(2-aminopyrimidin-4-yl)-2-(1,1-dimethylethyl)thiazol-4-yl)-2-fluorophenyl}-2,6- difluorobenzenesulfonamide|N-{3-[5-(2-amino-4-pyrimidinyl)-2-(1,1-dimethylethyl)-1,3-thiazol-4-yl]-2-fluorophenyl}-2,6-difluorobenzenesulfonamide"
RAF-265,11656518,,"InChI=1S/C24H16F6N6O/c1-36-19-7-6-15(10-17(19)34-22(36)33-14-4-2-13(3-5-14)23(25,26)27)37-16-8-9-31-18(11-16)21-32-12-20(35-21)24(28,29)30/h2-12H,1H3,(H,32,35)(H,33,34)",YABJJWZLRMPFSI-UHFFFAOYSA-N,C24H16F6N6O,518.4,1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine,"RAF265|927880-90-8|CHIR-265|RAF 265|RAF-265|CHIR 265|NVP-RAF265|8O434L3768|1-methyl-5-((2-(4-(trifluoromethyl)-1H-imidazol-2-yl)pyridin-4-yl)oxy)-N-(4-(trifluoromethyl)phenyl)-1H-1,3-benzodiazol-2-amine|1-methyl-5-({2-[4-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl}oxy)-N-[4-(trifluoromethyl)phenyl]-1H-1,3-benzodiazol-2-amine|RefChem:178564|B-RAF/VEGFR-2 INHIBITOR RAF265|1-methyl-5-((2-(5-(trifluoromethyl)-1H-imidazol-2-yl)pyridin-4-yl)oxy)-N-(4-(trifluoromethyl)phenyl)-1H-1,3-benzodiazol-2-amine|RAF265(CHIR-265)|RAF265 (CHIR-265)|1-methyl-5-[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]pyridin-4-yl]oxy-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine|1-Methyl-5-[[2-[5-(trifluoromethyl)-1h-imidazol-2-yl]-4-pyridinyl]oxy]-n-[4-(trifluoromethyl)phenyl]-1h-benzimidazol-2-amine|MFCD16659061|1-methyl-5-((2-(5-(trifluoromethyl)-1H-imidazol-2-yl)pyridin-4-yl)oxy)-N-(4-(trifluoromethyl)phenyl)-1H-benzo[d]imidazol-2-amine|RAF-265 (CHIR-265)|1-Methyl-5-((2-(5-(trifluoromethyl)-1H-imidazol-2-yl)-4-pyridinyl)oxy)-N-(4-(trifluoromethyl)phenyl)-1H-benzimidazol-2-amine|1-Methyl-5-({2-[5-(Trifluoromethyl)-1h-Imidazol-2-Yl]pyridin-4-Yl}oxy)-N-[4-(Trifluoromethyl)phenyl]-1h-Benzimidazol-2-Amine|CHIR265|C24H16F6N6O|SCHEMBL686452|CHEMBL558752|GTPL5674|orb1300893|SCHEMBL3137488|RAF 265 [WHO-DD]|SCHEMBL29355586|SCHEMBL29368571|BDBM31088|CHEBI:91451|EX-A072|cid_11656518|DTXSID601025871|HMS3655B06|HMS3672I21|UNII-8O434L3768|NSC754357|NSC800861|s2161|CHIR 265 (RAF 265)|RAF265 (CHIR-265)?|AKOS025117575|AKOS040758989|CCG-264703|CS-0232|DB05984|EX-8671|NSC-754357|NSC-800861|SB16578|NCGC00250407-01|NCGC00250407-04|1-methyl-5-(2-(5-(trifluoromethyl)-1H-imidazol-2-yl)pyridin-4-yloxy)-N-(4-(trifluoromethyl)phenyl)-1H-benzo[d]imidazol-2-amine|1-Methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]-oxy]-N-[4-(trifluoromethyl)phenyl]-1H-benzimidazol-2-amine|1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridyl]oxy]-N-[4-(trifluoromethyl)phenyl]benzimidazol-2-amine|AC-30291|AS-56738|FR103940|HY-10248|NS00071590|SW219923-1|PA-11656518|BRD-K93123848-001-04-1|Q27075961|[1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridyl]oxy]benzimidazol-2-yl]-[4-(trifluoromethyl)phenyl]amine|{1-Methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzo-imidazol-2-yl}-(4-trifluoromethyl-phenyl)-amine|{1-Methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)-pyridin-4-yloxy]-1H-benzoimidazol-2-yl}-(4-trifluoromethyl-phenyl)-amine|1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]-2-benzimidazolamine|1-methyl-5-[2-(5-trifluoromethyl-1H-imidazol-2-yl)pyridin-4-yloxy]-N-(4-trifluoromethylphenyl)-1H-benzo[d]imidazol-2-amine|1H-Benzimidazol-2-amine, 1-methyl-5-((2-(5-(trifluoromethyl)-1H-imidazol-2-yl)-4-pyridinyl)oxy)-N-(4-(trifluoromethyl)phenyl)-|1H-Benzimidazol-2-amine, 1-methyl-5-[[2-[5-(trifluoromethyl)-1H-imidazol-2-yl]-4-pyridinyl]oxy]-N-[4-(trifluoromethyl)phenyl]|55J"
VELNEPERIT,20629114,,"InChI=1S/C17H24F3N3O3S/c1-16(2,3)27(25,26)23-13-7-4-11(5-8-13)15(24)22-14-9-6-12(10-21-14)17(18,19)20/h6,9-11,13,23H,4-5,7-8H2,1-3H3,(H,21,22,24)",WGEWUYACXPEFPO-UHFFFAOYSA-N,C17H24F3N3O3S,407.5,4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide,"Velneperit|342577-38-2|S-2367|s2367|Velneprit|09BQ2KJ22J|rel-(1r,4r)-4-((1,1-Dimethylethyl)sulfonamido)-N-(5-(trifluoromethyl)pyridin-2-yl)cyclohexane-1-carboxamide|(1r,4r)-4-((1,1-dimethylethyl)sulfonamido)-N-(5-(trifluoromethyl)pyridin-2-yl)cyclohexane-1-carboxamide|UNII-09BQ2KJ22J|Velneperit [USAN]|Velneperit [USAN:INN]|N-[5-(Trifluoromethyl)pyridin-2-yl]-trans-4-(tert-butylsulfonylamino)cyclohexane-1-carboxamide; S 2367|MFCD11973642|VELNEPERIT [INN]|Velneperit (USAN/INN)|S-2367(Velneperit)?|4-(tert-butylsulfonylamino)-N-[5-(trifluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide|VELNEPERIT [WHO-DD]|orb1307621|SCHEMBL2806595|CHEMBL2016681|SCHEMBL10114559|SCHEMBL29355442|DTXSID20955806|CHEBI:177547|WGEWUYACXPEFPO-AULYBMBSSA-N|WGEWUYACXPEFPO-UHFFFAOYSA-N|GLXC-04924|BCP16623|BDBM50380914|AKOS027338754|CS-5388|DB12889|BS-50767|DA-68552|HY-14423|NS00073706|D08026|577V382|BRD-K06357403-001-01-4|Q27236469|S-2367; S 2367; S2367|4-(tert-butylsulonylamino)-N-[5-(triluoromethyl)pyridin-2-yl]cyclohexane-1-carboxamide|CYCLOHEXANECARBOXAMIDE, 4-(((1,1-DIMETHYLETHYL)SULFONYL)AMINO)-N-(5-(TRIFLUOROMETHYL)- 2-PYRIDINYL)-, TRANS-|Cyclohexanecarboxamide, 4-(((1,1-dimethylethyl)sulfonyl)amino)-N-(5-(trifluoromethyl)-2-pyridinyl)-, trans-|TRANS-4-(((1,1-DIMETHYLETHYL)SULFONYL)AMINO)-N-(5-(TRIFLUOROMETHYL)PYRIDIN-2- YL)CYCLOHEXANECARBOXAMIDE|trans-4-(((1,1-Dimethylethyl)sulfonyl)amino)-N-(5-(trifluoromethyl)pyridin-2-yl)cyclohexanecarboxamide|trans-4-(1,1-Dimethylethylsulfonamido)-N-(5-(trifluoromethyl)pyridin-2-yl)cyclohexanecarboxamide"
EDICOTINIB,25230468,,"InChI=1S/C27H35N5O2/c1-25(2)11-9-17(10-12-25)22-21(32-24(33)23-29-16-19(15-28)30-23)8-7-20(31-22)18-13-26(3,4)34-27(5,6)14-18/h7-9,16,18H,10-14H2,1-6H3,(H,29,30)(H,32,33)",BNVPFDRNGHMRJS-UHFFFAOYSA-N,C27H35N5O2,461.6,"5-cyano-N-[2-(4,4-dimethylcyclohexen-1-yl)-6-(2,2,6,6-tetramethyloxan-4-yl)pyridin-3-yl]-1H-imidazole-2-carboxamide","Edicotinib|1142363-52-7|JNJ-40346527|3NU609VYNF|4-Cyano-1H-imidazole-2-carboxylic acid N-(2-(4,4-dimethylcyclohex-1-enyl)-6-(2,2,6,6-tetramethyltetrahydropyran-4-yl)pyridin-3-yl)amide|1H-Imidazole-2-carboxamide, 5-cyano-N-(2-(4,4-dimethyl-1-cyclohexen-1-yl)-6-(tetrahydro-2,2,6,6-tetramethyl-2H-pyran-4-yl)-3-pyridinyl)-|4-Cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyl-tetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide|4-cyano-N-[2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyloxan-4-yl)pyridin-3-yl]-1H-imidazole-2-carboxamide|edicotinibum|4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyloxan-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide|RefChem:136290|L01XE48|5-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyloxan-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide|Edicotinib [USAN]|JNJ40346527|EdicotinibJNJ-40346527|5-Cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide|Edicotinib (USAN)|US8497376, 15|5-cyano-N-[2-(4,4-dimethylcyclohexen-1-yl)-6-(2,2,6,6-tetramethyloxan-4-yl)pyridin-3-yl]-1H-imidazole-2-carboxamide|BNVPFDRNGHMRJS-UHFFFAOYSA-N|EDICOTINIB [INN]|UNII-3NU609VYNF|EDICOTINIB [WHO-DD]|GTPL8942|orb1308350|SCHEMBL4238665|CHEMBL3674570|SCHEMBL21396445|BDBM98634|BDBM276743|C27H35N5O2|GLXC-21525|BCP25086|EX-A2787|SVB36352|US10071991, Compound (P)|MFCD30489233|AKOS030527728|DB12504|4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)-1H-imidazole-2-carboxamide|AC-33642|BS-14512|DA-73008|HY-109086|CS-0039264|NS00072581|D11378|D83692|Q27893923|4-cyano-1h-imidazole-2-carboxylic acid[2-(4,4-dimethyl-cyclohex-1-enyl)-6-(2,2,6,6-tetramethyl-tetrahydro-pyran-4-yl)-pyridin-3-yl]-amide|4-cyano-N-(2-(4,4-dimethylcyclohex-1-en-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)pyridin-3-yl)- 1H-imidazole-2-carboxamide|5-Cyano-N-[2-(4,4-dimethyl-1-cyclohexen-1-yl)-6-(2,2,6,6-tetramethyltetrahydro-2H-pyran-4-yl)-3-pyridinyl]-1H-imidazole-2-carboxamide"
BLZ945,46184986,,"InChI=1S/C20H22N4O3S/c1-21-19(26)16-10-13(8-9-22-16)27-12-6-7-15-18(11-12)28-20(24-15)23-14-4-2-3-5-17(14)25/h6-11,14,17,25H,2-5H2,1H3,(H,21,26)(H,23,24)/t14-,17-/m1/s1",ADZBMFGQQWPHMJ-RHSMWYFYSA-N,C20H22N4O3S,398.5,"4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methylpyridine-2-carboxamide","BLZ945|953769-46-5|BLZ-945|sotuletinib|4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo[d]thiazol-6-yl)oxy)-N-methylpicolinamide|BLZ 945|7W3V82OQ0P|2-Pyridinecarboxamide, 4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)-6-benzothiazolyl)oxy)-N-methyl-|CSF-1R INHIBITOR BLZ945|4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methylpyridine-2-carboxamide|4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)benzo(d)thiazol-6-yl)oxy)-N-methylpicolinamide|4-((2-(((1R,2R)-2-hydroxycyclohexyl)amino)-1,3-benzothiazol-6-yl)oxy)-N-methylpyridine-2-carboxamide|4-[(2-{[(1R,2R)-2-HYDROXYCYCLOHEXYL]AMINO}-1,3-BENZOTHIAZOL-6-YL)OXY]-N-METHYLPYRIDINE-2-CARBOXAMIDE|RefChem:120669|4-(2((1R,2R)-2-Hydroxycyclohexylamino)-benzothiazol-6-yloxyl)-pyridine-2-carboxylic Acid Methylamide|UNII-7W3V82OQ0P|MFCD28142668|4-[[2-[[(1R,2R)-2-Hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methyl-2-pyridinecarboxamide|CHEMBL4227505|4-((2-(((1R,2R)-2-Hydroxycyclohexyl)amino)benzo-[d]thiazol-6-yl)oxy)-N-methylpicolinamide|4-(2-((1R,2R)-2-hydroxycyclohexylamino)benzo[d]thiazol-6-yloxy)-N-methylpicolinamide|SOTULETINIB [INN]|GTPL8250|orb1301056|SCHEMBL2676695|BLZ 945 [WHO-DD]|SCHEMBL29368442|SCHEMBL29368661|EX-A817|ADZBMFGQQWPHMJ-RHSMWYFYSA-N|BDBM50460035|HB4634|NSC758006|s7725|AKOS025396391|CCG-268639|CS-3971|NSC-758006|NCGC00386432-02|NCGC00386432-03|NCGC00386432-07|4-[[2-[[(1R,2R)-2-Hydroxycyclohexyl]amino]-6-benzothiazolyl]oxy]-N-methylpyridine-2-carboxamide|AC-32994|AS-16330|BB178452|DA-61754|HY-12768|SY047892|I10001|Q27075332|4-[[2-[[(1R,2R)-2-hydroxycyclohexyl]amino]-1,3-benzothiazol-6-yl]oxy]-N-methyl-pyridine-2-carboxamide"
DSM-265,51347395,,"InChI=1S/C14H12F7N5S/c1-8-7-11(26-13(22-8)24-12(25-26)14(2,15)16)23-9-3-5-10(6-4-9)27(17,18,19,20)21/h3-7,23H,1-2H3",OIZSVTOIBNSVOS-UHFFFAOYSA-N,C14H12F7N5S,415.33,"2-(1,1-difluoroethyl)-5-methyl-N-[4-(pentafluoro-lambda6-sulfanyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine","DSM265|1282041-94-4|DSM-265|0Q42P4YI6B|Sulfur, [4-[[2-(1,1-difluoroethyl)-5-methyl[1,2,4]triazolo[1,5-a]pyrimidin-7-yl]amino]phenyl]pentafluoro-, (OC-6-21)-|2-(1,1-difluoroethyl)-5-methyl-N-[4-(pentafluoro-lambda6-sulfanyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine|Sulfur, (4-((2-(1,1-difluoroethyl)-5-methyl(1,2,4)triazolo(1,5-a)pyrimidin-7-yl)amino)phenyl)pentafluoro-, (oc-6-21)-|2-(1,1-Difluoroethyl)-5-methyl-N-(4-(pentafluoro-lambda6-sulfanyl)phenyl) (1,2,4)triazolo(1,5-a)pyrimidin-7-amine|2-(1,1-difluoroethyl)-5-methyl-N-(4-(pentafluoro-lambda6-sulfanyl)phenyl)-(1,2,4)triazolo(1,5-a)pyrimidin-7-amine|RefChem:135870|826-984-9|CHEMBL1956285|2-(1,1-Difluoroethyl)-5-methyl-n-(4-(pentafluoro-l6-sulfaneyl)phenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine|2-(1,1-difluoroethyl)-5-methyl-N-(4-(pentafluoro-l6-sulfanyl)phenyl)-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine|2-(1,1-difluoroethyl)-5-methyl-N-[4-(pentafluoro-$l^{6}-sulfanyl)phenyl]-[1,2,4]triazolo[1,5-a]pyrimidin-7-amine|UNII-0Q42P4YI6B|GTPL9644|orb1707356|SCHEMBL14053411|C14H12F7N5S|DSM265?|YQF1514|GLXC-10375|HMS6018J22|BCP17584|EX-A3571|HBC04194|DSM-265; DSM 265|BDBM50365230|MFCD28502125|AKOS040741675|DB12397|SB17069|DA-52715|MS-27197|HY-100184|CS-0018179|NS00072981|G14491|Q27237094|2-(1,1-DIFLUOROETHYL)-5-METHYL-N-(4-(PENTAFLUORO-.LAMBDA.6-SULFANYL)PHENYL) (1,2,4)TRIAZOLO(1,5-A)PYRIMIDIN-7-AMINE|2-(1,1-difluoroethyl)-5-methyl-N-[4-(pentafluoro-lambda6-sulfanyl)phenyl][1,2,4]triazolo[1,5-a]pyrimidin-7-amine"
S-777469,57331749,,"InChI=1S/C23H27FN2O4/c1-3-19-15(2)13-18(20(27)25-23(22(29)30)11-5-4-6-12-23)21(28)26(19)14-16-7-9-17(24)10-8-16/h7-10,13H,3-6,11-12,14H2,1-2H3,(H,25,27)(H,29,30)",JIYXOJFSPOFZPY-UHFFFAOYSA-N,C23H27FN2O4,414.5,1-[[6-ethyl-1-[(4-fluorophenyl)methyl]-5-methyl-2-oxopyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid,S-777469|885496-53-7|88NI79737I|DTXSID301336647|RefChem:180615|DTXCID701766886|CHEMBL2019090|UNII-88NI79737I|1-[[6-ethyl-1-[(4-fluorophenyl)methyl]-5-methyl-2-oxopyridine-3-carbonyl]amino]cyclohexane-1-carboxylic acid|orb1687906|SCHEMBL2745978|GLXC-22568|BDBM50380892|DA-57620|MS-27176|HY-145153|CS-0356760|Q27269944
LY2828360,46833780,,"InChI=1S/C22H27ClN6O/c1-15-24-21(28-11-9-27(2)10-12-28)19-22(25-15)29(16-7-13-30-14-8-16)20(26-19)17-5-3-4-6-18(17)23/h3-6,16H,7-14H2,1-2H3",UCMNDPDJRSEZPL-UHFFFAOYSA-N,C22H27ClN6O,426.9,8-(2-chlorophenyl)-2-methyl-6-(4-methylpiperazin-1-yl)-9-(oxan-4-yl)purine,LY2828360|LY-2828360|UNII-O12H7VFU6P|compound 26 [PMID: 23795771]|LY 2828360|8-(2-chlorophenyl)-2-methyl-6-(4-methylpiperazin-1-yl)-9-(oxan-4-yl)purin|compound 26 (PMID: 23795771)|8-(2-chloro-phenyl)-2-methyl-6-(4-methyl-piperazin-1-yl)-9-(tetrahydro-pyran-4-yl)-9h-purine|8-(2-CHLOROPHENYL)-2-METHYL-6-(4-METHYL-1-PIPERAZINYL)-9-(TETRAHYDRO-2H-PYRAN-4-YL)-9H-PURINE|RefChem:154567|1231220-79-3|8-(2-Chlorophenyl)-2-methyl-6-(4-methylpiperazin-1-yl)-9-(tetrahydro-2H-pyran-4-yl)-9H-purine|O12H7VFU6P|8-(2-chlorophenyl)-2-methyl-6-(4-methylpiperazin-1-yl)-9-(oxan-4-yl)purine|CHEMBL3139186|MFCD28010855|C22H27ClN6O|orb1299927|SCHEMBL2486504|SCHEMBL31273098|GTPL12751|UCMNDPDJRSEZPL-UHFFFAOYSA-N|BCP29625|EX-A2735|GZB22079|BDBM50006250|HY-16642A|AKOS040759107|AT33612|SB17392|AC-36261|DA-75191|MS-27543|CS-0067162|LY 2828360; LY-2828360|8-(2-chlorophenyl)-2-methyl-6-(4-methylpiperazin-1-yl)-9-tetrahydropyran-4-yl-purine|8-(2-Chloro-phenyl)-2-methyl-6-(4-methyl-piperazin-1-yl)-9-(tetrahydro pyran-4-yl)-9H-purine
CARIPRAZINE HYDROCHLORIDE,25096873,,"InChI=1S/C21H32Cl2N4O.ClH/c1-25(2)21(28)24-17-8-6-16(7-9-17)10-11-26-12-14-27(15-13-26)19-5-3-4-18(22)20(19)23;/h3-5,16-17H,6-15H2,1-2H3,(H,24,28);1H",GPPJWWMREQHLQT-UHFFFAOYSA-N,C21H33Cl3N4O,463.9,"3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea;hydrochloride","CARIPRAZINE HYDROCHLORIDE|1083076-69-0|Cariprazine HCl|Vraylar|RGH188 hydrochloride|RGH-188 HCL|Cariprazine (hydrochloride)|Cariprazine hydrochloride [USAN]|UNII-KQD7C255YG|KQD7C255YG|MFCD26142670|3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethylurea;hydrochloride|3-((1R,4r)-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-1,1-dimethylurea hydrochloride|N'-(Trans-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-N,N-dimthylurea monohydrochloride|Urea, N'-(trans-4-(2-(4-(2,3-dichlorophenyl)-1-piperazinyl)ethyl)cyclohexyl)-N,N- dimethyl-, hydrochloride (1:1)|C21H33Cl3N4O|cariprazine.HCl|Vraylar (TN)|Cariprazine hydrochloride (JAN/USAN)|cariprazine monohydrochloride|SCHEMBL183803|SCHEMBL183804|orb1298981|CHEMBL2024517|SCHEMBL29393456|SCHEMBL30574605|CHEBI:90932|DTXSID101026486|HMS5085P11|BCP24194|EX-A1644|ITB07669|HY-14763A|s5849|CARIPRAZINE HYDROCHLORIDE [MI]|AKOS027338713|CARIPRAZINE HYDROCHLORIDE [JAN]|CS-1570|SB16840|AC-33130|CARIPRAZINE HYDROCHLORIDE [WHO-DD]|DA-71942|MS-28534|SY039271|CARIPRAZINE HYDROCHLORIDE [ORANGE BOOK]|D09876|Q27162922|3,3-dimethyl-1-[(1r,4r)-4-{2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl}cyclohexyl]urea hydrochloride|3-[4-[2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl]cyclohexyl]-1,1-dimethyl-urea;hydrochloride|3-[trans-4-[2-[4-(2,3-Dichlorophenyl)-1-piperazinyl]ethyl]cyclohexyl]-1,1-dimethylurea Hydrochloride|N'-(trans-4-(2-(4-(2,3-dichlorophenyl)piperazin-1-yl)ethyl)cyclohexyl)-N,N-dimethylurea monohydrochloride|N'-(trans-4-{2-[4-(2,3-dichlorophenyl)piperazin-1-yl]ethyl}cyclohexyl)-N,N-dimethylurea hydrochloride"
PIRINIXIC ACID,5694,,"InChI=1S/C14H14ClN3O2S/c1-8-4-3-5-10(9(8)2)16-12-6-11(15)17-14(18-12)21-7-13(19)20/h3-6H,7H2,1-2H3,(H,19,20)(H,16,17,18)",SZRPDCCEHVWOJX-UHFFFAOYSA-N,C14H14ClN3O2S,323.8,"2-[4-chloro-6-(2,3-dimethylanilino)pyrimidin-2-yl]sulfanylacetic acid","Pirinixic acid|50892-23-4|WY-14643|[4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthio]acetic acid|Wy 14643|Wyeth 14,643|WY-14,643|Acido pirinixico|Acide pirinixique|(4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthio)acetic acid|Acidum pirinixicum|NSC-310038|DTXSID4020290|NSC310038|86C4MRT55A|CHEBI:32509|((4-Chloro-6-((2,3-dimethylphenyl)amino)-2-pyrimidinyl)thio)acetic acid|Acetic acid, ((4-chloro-6-((2,3-dimethylphenyl)amino)-2-pyrimidinyl)thio)-|DTXCID00290|Acetic acid, [[4-chloro-6-[(2,3-dimethylphenyl)amino]-2-pyrimidinyl]thio]-|({4-chloro-6-[(2,3-dimethylphenyl)amino]pyrimidin-2-yl}sulfanyl)acetic acid|CXPTA|Wyeth-14643|[[4-Chloro-6-[(2,3-dimethylphenyl)amino]-2-pyrimidinyl]thio]acetic acid|WY14,643|((4-chloro-6-((2,3-dimethylphenyl)amino)pyrimidin-2-yl)sulfanyl)acetic acid|2-(4-chloro-6-((2,3-dimethylphenyl)amino)pyrimidin-2-yl)sulfanylacetic acid|2-[4-chloro-6-[(2,3-dimethylphenyl)amino]pyrimidin-2-yl]sulfanylacetic acid|4-chloro-6-(2,3-xylidinyl)-2-pyrimidinylthioacetic acid|4-chloro-6-(2,3-dimethylphenyl)amino-2-pyrimidinylthioacetic acid|RefChem:863648|WY14643|Pirinixic acid [INN]|WY-14643 (Pirinixic Acid)|MFCD00191335|2-[4-chloro-6-(2,3-dimethylanilino)pyrimidin-2-yl]sulfanylacetic acid|2-((4-Chloro-6-((2,3-dimethylphenyl)amino)pyrimidin-2-yl)thio)acetic acid|CHEMBL295416|ACETIC ACID, ((4-CHLORO-6-(2,3-XYLIDINO)-2-PYRIMIDINYL)THIO)-|NCGC00014702-03|2-({4-Chloro-6-[(2,3-Dimethylphenyl)amino]pyrimidin-2-Yl}sulfanyl)acetic Acid|Wyeth-14,643|(4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthio) acetic acid|({4-chloro-6-[(2,3-dimethylphenyl)amino]pyrimidin-2-yl}thio)acetic acid|[[4-chloro-6-[(2,3-dimethylphenyl)amino]-2-pyrimidinyl]thio]-acetic acid|CCRIS 133|CAS-50892-23-4|Acide pirinixique [INN-French]|Acido pirinixico [INN-Spanish]|Acidum pirinixicum [INN-Latin]|SR-01000597401|NSC 310038|BRN 0759945|UNII-86C4MRT55A|pirinixic-acid|Pirnixic acid|HSDB 8056|WY1|Tocris-1312|Spectrum5_001947|NCIStruc1_001774|NCIStruc2_001509|CBiol_001856|BSPBio_001540|KBioGR_000260|KBioGR_002353|KBioSS_000260|KBioSS_002356|5-25-12-00458 (Beilstein Handbook Reference)|JMC515449 Compound 1|MLS004773935|SCHEMBL293161|SPECTRUM1505106|WY-14643; Pirinixic Acid|BML2-E12|GTPL2666|orb1305848|SCHEMBL29370056|WY 14643 (Pirinixic Acid)|WY14643 (Pirinixic Acid)?|BDBM24566|KBio2_000260|KBio2_002353|KBio2_002828|KBio2_004921|KBio2_005396|KBio2_007489|KBio3_000519|KBio3_000520|KBio3_002832|cMAP_000028|((4-Chloro-6-(2,3-xylidino)-2-pyrimidinyl)thio)acetic acid|Bio1_000142|Bio1_000631|Bio1_001120|Bio2_000260|Bio2_000740|GLXC-07068|HMS1361M22|HMS1791M22|HMS1989M22|HMS3267N11|HMS3402M22|HMS3412G06|HMS3649C12|HMS3653N21|HMS3676G06|BCP21201|EX-A2258|Tox21_110058|Tox21_201609|Tox21_300634|CCG-37145|NCGC00014702|NCI310038|s8029|AKOS015902283|Tox21_110058_1|CS-4661|ES-0025|FW75167|SB19568|IDI1_034010|NCGC00014702-02|NCGC00014702-04|NCGC00014702-05|NCGC00014702-06|NCGC00014702-07|NCGC00014702-08|NCGC00014702-09|NCGC00014702-10|NCGC00014702-11|NCGC00014702-12|NCGC00014702-15|NCGC00014702-17|NCGC00025107-01|NCGC00025107-02|NCGC00025107-03|NCGC00025107-04|NCGC00025107-05|NCGC00025107-06|NCGC00025107-07|NCGC00025107-08|NCGC00254449-01|NCGC00259158-01|AC-31440|HY-16995|NCI60_002666|SMR001798898|DB-051855|NS00015649|SW203787-2|Acetic acid,3-xylidino)-2-pyrimidinyl]thio]-|C75388|Q7198008|SR-01000597401-1|SR-01000597401-3|SR-01000597401-4|SR-01000597401-6|BRD-K01902415-001-02-6|BRD-K01902415-001-03-4|BRD-K01902415-001-10-9|BRD-K01902415-001-11-7|[4-Chloro-6-(2,3-xylidino)-2-pyrimidinylthio]aceticacid|Acetic acid,3-dimethylphenyl)amino]-2-pyrimidinyl]thio]-|[4-chloro-6-(2,3-xylidino)-2-pyrimidinyl-thio]-acetic acid|((4-chloro-6-(2,3-dimethylanilino)-2-pyrimidinyl)thio)acetic acid|([4-Chloro-6-(2,3-dimethylanilino)-2-pyrimidinyl]sulfanyl)acetic acid #|[[4-chloro-6-[(2,3-dimethylphenyl)amino]-2-pyrimidinyl]thio]aceticacid|[4-Chloro-6-(2,3-dimethyl-phenylamino)-pyrimidin-2-ylsulfanyl]-acetic acid|2-((4-Chloro-6-((2,3-dimethylphenyl)amino)pyrimidin-2-yl)thio)aceticacid|2-[4-chloro-6-(2,3-dimethylanilino)pyrimidin-2-yl]sulfanylacetic acidE|Acetic acid, 2-[[4-chloro-6-[(2,3-dimethylphenyl)amino]-2-pyrimidinyl]thio]-|[[4-Chloro-6-[(2,3-dimethylphenyl)amino]-2-pyrimidinyl]thio]-acetic acid; NSC 310038; Pirinixic acid; Pirnixic acid; WY-14643"
KETOROLAC TROMETHAMINE,84003,,"InChI=1S/C15H13NO3.C4H11NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13;5-4(1-6,2-7)3-8/h1-7,11H,8-9H2,(H,18,19);6-8H,1-3,5H2",BWHLPLXXIDYSNW-UHFFFAOYSA-N,C19H24N2O6,376.4,"2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid","Ketorolac tromethamine|74103-07-4|Toradol|Acular|Ketorolac trometamol|Acuvail|Lixidol|Acular LS|Dolac|SPRIX|Tarasyn|Acular Preservative Free|DTXSID0045597|NSC-758637|4EVE5946BQ|CHEBI:6130|DTXCID301476271|OMIDRIA COMPONENT KETOROLAC TROMETHAMINE|Toronova SUIK|Acunivive 15|Acunivive 30|Acunivive 60|Toronova II SUIK|Ketotolac Tromethamine|RefChem:55434|1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro, (+-)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol(1:1)|Ketorolac tris salt|Ketorolac tromethamine salt|Ketorolac (tromethamine salt)|Acular PF|2-amino-2-(hydroxymethyl)propane-1,3-diol 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylate|MFCD00887595|Ketorolac (Toradol)|Syntex|Toradol (TN)|2-amino-2-(hydroxymethyl)propane-1,3-diol;5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|Godek|Ketorolac Tromethamine;Ketorolac tris salt;RS37619 tromethamine salt|(+/-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid tris salt|SMR000058461|Ketorolac tromethamine [USAN]|Tromethamine ketorolac|SR-01000075948|NCGC00185990-01|RS-37619|UNII-4EVE5946BQ|Toratex|Droal|Ketorolactrissalt|Tora-Dol|NCGC00017135-01|Ketorolac tromethamine [USAN:USP]|Acular (TN)|CAS-74103-07-4|BPPC|Dolac;Ketanov;Ketorol|Spectrum_001578|CPD000058461|Prestwick0_000929|Prestwick1_000929|Prestwick2_000929|Prestwick3_000929|Spectrum2_001598|Spectrum3_001975|Spectrum4_000215|Spectrum5_001273|Ketrolac.Tromethamine Salt|SCHEMBL5036|Lopac0_000676|BSPBio_000838|BSPBio_003575|KBioGR_000849|KBioSS_002058|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)|2-amino-2-(hydroxymethyl)propane-1,3-diol; 5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|Ketorolac tromethamine (USP)|MLS000069689|MLS001401455|MLS002222310|DivK1c_000836|SPECTRUM1503925|SPBio_001596|SPBio_003017|BPBio1_000922|orb1309385|CHEMBL1201124|HMS502J18|HY-B0138R|KBio1_000836|KBio2_002058|KBio2_004626|KBio2_007194|KBio3_002953|ROX-828|ROX-888|NINDS_000836|HMS1570J20|HMS1922K22|HMS2051P06|HMS2093M05|HMS2097J20|HMS2235N13|HMS3262G13|HMS3373M06|HMS3393P06|HMS3655E15|HMS3714J20|HMS5085M13|KETOROLAC TROMETAMOL [JAN]|Pharmakon1600-01503925|BCP02917|HY-B0138|Tox21_110795|Tox21_113519|Tox21_500676|CCG-39376|KETOROLAC TROMETAMOL [MART.]|MSK163439|NSC758637|s5698|KETOROLAC TROMETHAMINE [VANDF]|AKOS024386301|Tox21_110795_1|BCP9000811|CCG-101006|CS-1933|FK27530|KETOROLAC TROMETHAMINE [USP-RS]|KETOROLAC TROMETHAMINE [WHO-DD]|LP00676|NC00256|NSC 758637|IDI1_000836|NCGC00016159-02|NCGC00016159-03|NCGC00016159-04|NCGC00094036-01|NCGC00094036-02|NCGC00094036-03|NCGC00185990-04|NCGC00261361-01|1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro, (+-)-, compound with 2-amino-2-(hydroxymethyl)-1,3-propanediol (1:1)|AS-15193|Ketorolac (tromethamine salt) (Standard)|Ketorolac tris salt;Ketorolac Tromethamine|BCP0726000301|Ketorolac tris salt, >=99%, crystalline|KETOROLAC TROMETAMOL [EP MONOGRAPH]|DB-055837|Ketorolac trometamol for peak identification|KETOROLAC TROMETHAMINE [ORANGE BOOK]|EU-0100676|K0053|ST51037313|SW197293-4|KETOROLAC TROMETHAMINE [USP MONOGRAPH]|D00813|K 1136|M02042|103K074|SR-01000946595|SR-01000075948-1|SR-01000075948-6|SR-01000075948-8|SR-01000946595-1|KETOROLAC (+/-)-FORM TROMETHAMINE SALT [MI]|Q27107089|F0001-2390|Ketorolac Trometamol 1.0 mg/ml in Methanol (as free acid)|Ketorolac trometamol, European Pharmacopoeia (EP) Reference Standard|Ketorolac Tromethamine, United States Pharmacopeia (USP) Reference Standard|Ketorolac trometamol for peak identification, European Pharmacopoeia (EP) Reference Standard|Ketorolac Tromethamine, Pharmaceutical Secondary Standard; Certified Reference Material|(+/-)-5-BENZOYL-2,3-DIHYDRO-1H-PYRROLIZINE-1-CARBOXYLIC ACID, COMPOUND WITH 2-AMINO-2-(HYDROXYMETHYL)-1,3-PROPANEDIOL (1:1)|1H-PYRROLIZINE-1-1H-PYRROLIZINE-1-CARBOXYLIC ACID, 5-BENZOYL-2,3-DIHYDRO, (+/-)-, COMPOUND WITH 2-AMINO-2-(HYDROXYMETHYL)-1,3-PROPANEDIOL (1:1)|2-AMINO-2-(HYDROXYMETHYL)PROPANE-1,3-DIOL (1RS)-5-BENZOYL-2,3-DIHYDRO-1H-PYRROLIZINE-1-CARBOXYLATE|5-(phenylcarbonyl)-2,3-dihydropyrrolizinecarboxylic acid, 2-amino-2-(hydroxyme thyl)propane-1,3-diol"
PRASTERONE,5881,,"InChI=1S/C19H28O2/c1-18-9-7-13(20)11-12(18)3-4-14-15-5-6-17(21)19(15,2)10-8-16(14)18/h3,13-16,20H,4-11H2,1-2H3/t13-,14-,15-,16-,18-,19-/m0/s1",FMGSKLZLMKYGDP-USOAJAOKSA-N,C19H28O2,288.4,"(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one","Dehydroepiandrosterone|DHEA|PRASTERONE|53-43-0|Dehydroisoandrosterone|Androstenolone|Diandron|3beta-hydroxyandrost-5-en-17-one|17-Hormoforin|Intrarosa|Prasterona|3-beta-Hydroxy-5-androsten-17-one|Prasteronum|Vaginorm|5,6-Dehydroisoandrosterone|Biolaif|EM-760|NSC-9896|Androst-5-en-17-one, 3-hydroxy-, (3beta)-|DTXSID4020379|CHEBI:28689|NSC9896|459AG36T1B|(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta[a]phenanthren-17-one|DTXCID40379|Fidelin|Prastera|Natrol dhea|Enzymatic therapy|GL701|(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,11,12,14,15,16-dodecahydrocyclopenta(a)phenanthren-17-one|Prasterone, 3 alpha|prasterone and ibuprofen|RefChem:55906|5 Androsten 3 ol 17 one|DHEA (Dehydroepiandrosterone)|Therapeutic Dehydroepiandrosterone|A14AA07|G03XX01|5 Androsten 3 beta hydroxy 17 one|5-Androsten-3-beta-hydroxy-17-one|200-175-5|trans-Dehydroandrosterone|Psicosterone|Diandrone|Prestara|17-Chetovis|Andrestenol|5-Dehydroepiandrosterone|Dehydro-epi-androsterone|Siscelar plus|(+)-Dehydroisoandrosterone|5,6-Didehydroisoandrosterone|dehydroepiandrosterone (dhea)|Epiandrosterone, 5-dehydro-|Caswell No. 051F|5,6-Dehydroisoandrostorone|3beta-hydroxy-5-androsten-17-one|Astenile|CCRIS 3277|Deandros|5-Androsten-3beta-ol-17-one|(3-beta)-3-Hydroxyandrost-5-en-17-one|DEHYDROISOANDOSTERONE|GL 701|dehydroepiandosterone|EPA Pesticide Chemical Code 126510|NSC 9896|MFCD00003613|Androst-5-en-17-one, 3-hydroxy-, (3.beta.)-|(3beta)-3-hydroxyandrost-5-en-17-one|Androst-5-en-17-one, 3-beta-hydroxy-|CHEMBL90593|D5-Androsten-3beta-ol-17-one|Androst-5-ene-3beta-ol-17-one|3beta-Hydroxy-D5-androsten-17-one|3-beta-hydroxyandrost-5-en-17-one|Dehydro Epiandrosterone|(3S,8R,9S,10R,13S,14S)-3-hydroxy-10,13-dimethyl-3,4,7,8,9,10,11,12,13,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17(2H)-one|AND|Prasterone [INN]|Prasteronum [INN-Latin]|Prasterona [INN-Spanish]|CAS-53-43-0|(1S,5S,11S,15S,2R,10R)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0<2,7>.0<11,15> ]heptadec-7-en-14-one|SMR000059075|Androst-5-en-17-one, 3.beta.-hydroxy-|SR-01000075815|Prasterone [USAN:INN]|EINECS 200-175-5|Dehydro Epiandrosterone (1.0 mg/mL in Acetonitrile)|BRN 2058110|5-Androsten-3.beta.-ol-17-one|Anastar|Inflabloc|Aslera|UNII-459AG36T1B|Fidelin T|Androst-5-en-17-one, 3-hydroxy-, (3b)-|DHEA; Prasterone|NCGC00093802-04|NCGC00093802-06|Biolaif (TN)|Androst-5-en-17-one, 3beta-hydroxy-|dehydroepiandrostenedione|5-dehydro-Epiandrosterone|Prasterone (USAN/INN)|trans-de-hydroandrosterone|PRASTERONE [USAN]|bmse000665|EC 200-175-5|Dehydroisoandrosterone(Dhea)|PRASTERONE [MART.]|Androsten-3beta-ol-17-one|PRASTERONE [WHO-DD]|Androst-5-en-17-one, 3-hydroxy-, (3-beta)-|BIDD:PXR0080|Lopac0_000368|SCHEMBL24156|4-08-00-00994 (Beilstein Handbook Reference)|MLS001066350|MLS001333231|MLS001333232|MLS001424274|orb180847|5-Androsten-3B-ol-17-one|D5-Androsten-3b-ol-17-one|GTPL2370|Androst-5-ene-3b-ol-17-one|PRASTERONE [ORANGE BOOK]|SCHEMBL27464949|3b-Hydroxyandrost-5-en-17-one|5-Androsten-3-beta-ol-17-one|BCPE00002|MSK2264|3b-Hydroxy-D5-androsten-17-one|3beta-Hyroxyandrost-5-en-17-one|BCPP000260|DEHYDROEPIANDROSTERONE [MI]|EL-10|HMS2052P11|HMS2090C04|HMS2232K11|IM 28|trans-Dehydroandrosterone, >=99%|3-beta-hydroxy-5-androsten-17-on|BCP02453|IPL-1001|3beta-hydroxy-androst-5-en-17-one|3beta-Hydroxyandrost-5-ene-17-one|Tox21_111222|Tox21_201996|Tox21_302761|BDBM50223368|CMC_13435|Delta5-androsten-3-beta-ol-17-one|DL-373|GL-701|LMST02020021|PB-007|s2604|SBB012501|DEHYDROEPIANDROSTERONE [VANDF]|3.beta.-Hydroxyandrost-5-en-17-one|5-Androsten-3beta-ol-17-one; DHEA|AKOS007930299|AKOS015951378|Tox21_111222_1|BCP9000602|CCG-101190|CS-1667|DB01708|FD12003|GS-0906|IP-1001|NC00440|SH-K-04828|NCGC00093802-09|NCGC00256412-01|NCGC00259545-01|(3beta)-3-Hydroxyandrost-5-ene-17-one|AC-28716|HY-14650|NCI60_042215|Prasterone (DHEA; Dehydroepiandrosterone)|ST069381|(3beta)-3-hydroxy-Androst-5-en-17-one|D0044|EU-0100368|NS00000508|Androst-5-en-17-one, 3beta-hydroxy- (8CI)|C01227|D 4000|D-0340|D08409|(3alpha,8alpha)-3-hydroxyandrost-5-en-17-one|AB00375810-06|AB00375810_09|Dehydroepiandrosterone (DHEA), 1mg/ml in Methanol|Q408376|SR-01000075815-1|SR-01000075815-4|BRD-K41256143-001-12-7|(3beta,16alpha)-3,16-dihydroxy-androst-5-en-17-one|Androst-5-en-17-one, 3-hydroxy-, (3beta)- (9CI)|1A9D2040-240C-427D-ADE4-0CB700B785CB|Prasterone (DHEA; Dehydroepiandrosterone) 1.0 mg/ml in Acetonitrile|(1S,2R,5S,10R,11S,15S)-5-hydroxy-2,15-dimethyltetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadec-7-en-14-one|(3S,8R,10R,13S)-3-Hydroxy-10,13-dimethyl-1,2,3,4,7,8,9,10,11,12,13,14,15,16-tetradecahydro-cyclopenta[a]phenanthren-17-one|105597-37-3|Dehydroepiandrosterone; trans-Dehydroandrosterone; Prasterone; 5-Androsten-3beta-ol-17-one; DHEA"
BOSENTAN,104865,,"InChI=1S/C27H29N5O6S/c1-27(2,3)18-10-12-19(13-11-18)39(34,35)32-23-22(38-21-9-6-5-8-20(21)36-4)26(37-17-16-33)31-25(30-23)24-28-14-7-15-29-24/h5-15,33H,16-17H2,1-4H3,(H,30,31,32)",GJPICJJJRGTNOD-UHFFFAOYSA-N,C27H29N5O6S,551.6,4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide,"Bosentan|147536-97-8|Tracleer|bosentan anhydrous|Ro 47-0203|bosentanum|Ro-47-0203|Anhydrous bosentan|4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl]benzenesulfonamide|p-tert-Butyl-N-(6-(2-hydroxyethoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinyl)benzenesulfonamide|Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]-|XUL93R30K2|DTXSID7046627|CHEBI:51450|4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl)benzenesulfornamide|DTXCID5026627|Ro-47-0203/029|4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2'-bipyrimidin)-4-yl) benzenesulfornamide|Benzenesulfonamide, 4-(1,1-dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)(2,2'-bipyrimidin)-4-yl)-|Ro-470203029|Ro-47-0203-029|Ro 47-0203/029|4-tert-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl)benzene-1-sulfonamide|4-tert-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-ylpyrimidin-4-yl)benzenesulfonamide|4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzene-1-sulfonamide|4-t-butyl-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide|RefChem:121072|C02KX01|Ro 470203|Ro 47 0203|Q326023R30|Actelion|C27H29N5O6S|Bosentan [USAN:INN:BAN]|Bosentan (INN)|4-(tert-butyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl)benzenesulfonamide|CHEMBL957|147536-97-8 (free)|NCGC00167440-01|BOSENTAN [INN]|1174918-31-0|4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl]benzenesulfonamide|4-tert-butyl-N-[6-(2-hydroxyethyloxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide|CAS-147536-97-8|Ro 47-0203/039|SR-05000001532|UNII-XUL93R30K2|174227-18-0|4-tert-butyl-n-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2'-bipyrimidin-4-yl)benzenesulfonamide|Bosentan (Standard)|KS-5062|N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]-4-tert-butyl-benzenesulfonamide|starbld0043886|BOSENTAN [MI]|Bosentan (as monohydrate)|Ro-47-0203/039|BOSENTAN [WHO-DD]|SCHEMBL4218|Bosentan - Bio-X trade mark|GTPL3494|orb1300924|SCHEMBL29485039|HY-A0013R|GLXC-03123|HMS2090N14|HMS3652F15|HMS3715N05|HMS3750A13|BCP05202|HY-A0013|Tox21_112444|AC-148|BDBM50061101|MSK168227|PDSP1_001731|PDSP2_001714|s4220|AKOS015852063|Tox21_112444_1|BCP9000445|CCG-221182|CS-0381|DB00559|SB17356|NCGC00167440-02|4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-pyrimidin-2-yl-pyrimidin-4-yl]benzenesulfonamide|BB164259|DA-71682|B5118|NS00008194|SW199648-3|D07538|EN300-120648|W18800|AB01275536-01|212B550|L001086|Q419769|SR-05000001532-1|SR-05000001532-2|SR-05000001532-4|BRD-K74763371-002-04-0|Z1530532762|4-(1,1-Dimethylethyl)-N-(6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-(2,2''-bipyrimidin)-4-yl) benzenesulfornamide|4-(1,1-Dimethylethyl)-N-6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)2,2'-bipyrimidin-4-ylbenzenesulfonamide;p-tert-Butyl-N-6-(2-hydroxye thoxy)-5-(o-methoxyphenoxy)-2-(2-pyrimidinyl)-4-pyrimidinylbenzenesulfonamide;Actelion|4-(tert-Butyl)-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)[2,2'-bipyrimidin]-4-yl]benzenesulfonamide|4-tert butyl-N-[4-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(2-pyrimidinyl)pyrimidin-6-yl]benzenesulphonamide|4-tert-Butyl-N-[6-(2-hydroxy-ethoxy)-5-(2-methoxy-phenoxy)-[2,2']bipyrimidinyl-4-yl]-benzenesulfonamide|4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl]benzene-1-sulfonamide|4-tert-butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2,2''-bipyrimidin-4-yl]benzenesulfonamide|4-tert-Butyl-N-[6-(2-hydroxyethoxy)-5-(2-methoxyphenoxy)-2-(pyrimidin-2-yl)pyrimidin-4-yl]benzenesulfonamide|K86"
ILORASERTIB,46207586,,"InChI=1S/C25H21FN6O2S/c26-17-2-1-3-19(10-17)31-25(34)30-18-6-4-15(5-7-18)21-14-35-23-20(12-28-24(27)22(21)23)16-11-29-32(13-16)8-9-33/h1-7,10-14,33H,8-9H2,(H2,27,28)(H2,30,31,34)",WPHKIQPVPYJNAX-UHFFFAOYSA-N,C25H21FN6O2S,488.5,"1-[4-[4-amino-7-[1-(2-hydroxyethyl)pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-fluorophenyl)urea","ILORASERTIB|1227939-82-3|ABT-348|1-[4-[4-amino-7-[1-(2-hydroxyethyl)pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl]phenyl]-3-(3-fluorophenyl)urea|ABBOTT-968660|A-968660.0|6L5D03D975|A-968660|DTXSID10153718|1-(4-(4-amino-7-(1-(2-hydroxyethyl)-1H-pyrazol-4-yl)thieno[3,2-c]pyridin-3-yl)phenyl)-3-(3-fluorophenyl)urea|Urea, N-(4-(4-amino-7-(1-(2-hydroxyethyl)-1H-pyrazol-4-yl)thieno(3,2-c)pyridin-3-yl)phenyl)-N'-(3-fluorophenyl)-|1-(4-(4-amino-7-(1-(2-hydroxyethyl)-1H-pyrazol-4-yl)thieno(3,2-c)pyridin-3-yl)phenyl)-3-(3-fluorophenyl)urea|ilorasertibum|1-(4-(4-amino-7-(1-(2-hydroxyethyl)pyrazol-4-yl)thieno(3,2-c)pyridin-3-yl)phenyl)-3-(3-fluorophenyl)urea|RefChem:147898|DTXCID0076209|Abt-348, a-968660|ABT 348|ABT348|Ilorasertib [USAN]|Abbott-969660|Ilorasertib [USAN:INN]|UNII-6L5D03D975|MFCD25976780|Kinome_405|ILORASERTIB [INN]|Ilorasertib (USAN/INN)|ILORASERTIB [WHO-DD]|C25H21FN6O2S|GTPL9914|orb1296236|SCHEMBL3381224|CHEMBL1980297|SCHEMBL29373142|SCHEMBL29496449|WPHKIQPVPYJNAX-UHFFFAOYSA-N|BCP07256|BDBM50381716|NSC765889|CS-6804|DB11694|NSC-765889|SB16853|NCGC00843626-01|HY-16018|TS-10643|NS00072863|D10423|E77316|US8722890, 1|US8722890, 2|Q27265085|N-(4-(4-AMINO-7-(1-(2-HYDROXYETHYL)-1H-PYRAZOL-4-YL)THIENO(3,2-C)PYRIDIN-3-YL(PHENYL)-N'-(3-FLUOROPHENYL)UREA|N-(4-{4-amino-7-[1-(2-hydroxyethyl)-1H-pyrazol-4-yl]thieno[3,2-c]pyridin-3-yl}phenyl)-N'-(3-fluorophenyl)urea"
AZD-7762,11152667,,"InChI=1S/C17H19FN4O2S/c18-11-4-1-3-10(7-11)14-8-13(22-17(19)24)15(25-14)16(23)21-12-5-2-6-20-9-12/h1,3-4,7-8,12,20H,2,5-6,9H2,(H,21,23)(H3,19,22,24)/t12-/m0/s1",IAYGCINLNONXHY-LBPRGKRZSA-N,C17H19FN4O2S,362.4,3-(carbamoylamino)-5-(3-fluorophenyl)-N-[(3S)-piperidin-3-yl]thiophene-2-carboxamide,"AZD7762|AZD 7762|RefChem:560464|CHECKPOINT KINASE INHIBITOR AZD7762|860352-01-8|AZD-7762|(S)-5-(3-Fluorophenyl)-N-(piperidin-3-yl)-3-ureidothiophene-2-carboxamide|3-(Carbamoylamino)-5-(3-Fluorophenyl)-N-[(3s)-Piperidin-3-Yl]thiophene-2-Carboxamide|860352-01-8 (free base)|C17H19FN4O2S|CHEMBL2041933|5D822Y3L1H|5-(3-Fluorophenyl)-N-[(3s)-3-Piperidyl]-3-Ureido-Thiophene-2-Carboxamide|2-Thiophenecarboxamide, 3-((aminocarbonyl)amino)-5-(3-fluorophenyl)-N-(3S)-3-piperidinyl-|UNII-5D822Y3L1H|IAYGCINLNONXHY-LBPRGKRZSA-N|YDJ|GTPL7713|orb1301079|SCHEMBL1127614|SCHEMBL29388936|3-((Aminocarbonyl)amino)-5-(3-fluorophenyl)-N-(3S)-3-piperidinyl-2-thiophenecarboxamide|AZD 7762 [WHO-DD]|CHEBI:131156|BCPP000366|DTXSID001025611|GLXC-02826|EX-A1548|WZB09478|BDBM50389803|MFCD12406007|NSC757148|NSC799350|s1532|AKOS005266646|BCP9000356|CCG-264907|CS-0025|DB12242|NSC-757148|NSC-799350|SDCCGSBI-0654382.P001|NCGC00242481-01|NCGC00242481-02|NCGC00242481-03|NCGC00242481-08|NCGC00242481-17|AC-24499|AS-16691|FA100917|HY-10992|NS00071959|SW218139-2|C76784|BRD-K86525559-001-04-5|BRD-K86525559-001-07-8|BRD-K86525559-003-01-7|Q27074790|1-(2-((S)-piperidin-3-ylcarbamoyl)-5-(3-fluorophenyl)thiophen-3-yl)urea|5-(3-Fluoro-phenyl)-3-ureido-thiophene-2-carboxylic acid (S)-Piperidin-3-ylamide|1019773-80-8"
ICOTINIB,22024915,,"InChI=1S/C22H21N3O4/c1-2-16-4-3-5-17(12-16)25-22-18-13-20-21(14-19(18)23-15-24-22)29-11-9-27-7-6-26-8-10-28-20/h1,3-5,12-15H,6-11H2,(H,23,24,25)",QQLKULDARVNMAL-UHFFFAOYSA-N,C22H21N3O4,391.4,"N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.014,19]icosa-1(12),13,15,17,19-pentaen-18-amine","Icotinib|610798-31-7|BPI-2009|9G6U5L461Q|DTXSID20209952|4-((3-ethynylphenyl)amino)-6,7-benzo-12-crown-4-quinazoline|(1,4,7,10)Tetraoxacyclododecino(2,3-g)quinazolin-4-amine, N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-|N-(3-ethynylphenyl)-7H,8H,10H,11H,13H,14H-1,4,7,10-tetraoxacyclododeca[2,3-g]quinazolin-4-amine|N-(3-ethynylphenyl)-7H,8H,10H,11H,13H,14H-1,4,7,10-tetraoxacyclododeca(2,3-g)quinazolin-4-amine|RefChem:147674|DTXCID70132443|N-(3-ethynylphenyl)-7,8,10,11,13,14-hexahydro-[1,4,7,10]tetraoxacyclododecino[2,3-g]quinazolin-4-amine|MFCD22124501|N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.014,19]icosa-1(12),13,15,17,19-pentaen-18-amine|CHEMBL2087361|BPI2009|Lcotinib|UNII-9G6U5L461Q|Icotinib (Standard)|icotinib,BPI-2009H|ICOTINIB [WHO-DD]|Icotinib (BPI-2009H)|GTPL7641|orb1301029|SCHEMBL5843603|SCHEMBL29355667|SCHEMBL29544144|EX-A306|QQLKULDARVNMAL-UHFFFAOYSA-N|GLXC-10562|HMS3651F12|HMS5081L21|HY-15164AR|BCP21716|BPI 2009|BDBM50391089|HY-15164A|MSK162745|NSC800770|s2922|AKOS030231301|CCG-264757|DB11737|NSC-800770|SB16602|NCGC00386224-01|NCGC00386224-06|AC-32044|AS-55948|DA-33567|5108B|NS00072579|SW219698-1|D11251|BRD-K31698212-001-02-9|Q16868421|(3-Ethynyl-phenyl)(7,8,10,11,13,14-hexahydro-6,9,12,15-tetraoxa-1,3-diazacyclododeca[b]naphthalen-4-yl)-amine|(3-ethynyl-phenyl)-(7,8,10,11,13,14-hexahydro-6,9,12,15-tetraoxa-1,3-diazacyclododeca[b]naphthalen-4-yl)-amine|N-(3-ethynylphenyl)-2,5,8,11-tetraoxa-15,17-diazatricyclo[10.8.0.0^{14,19]icosa-1(12),13,15,17,19-pentaen-18-amine"
NOP-1A,52951810,,"InChI=1S/C22H26F2N2O2S/c1-25-21(27)17(12-15-4-2-3-5-18(15)23)14-26-9-7-22(8-10-26)20-16(6-11-28-22)13-19(24)29-20/h2-5,13,17H,6-12,14H2,1H3,(H,25,27)/t17-/m0/s1",MZBCQWLYUQJXKA-KRWDZBQOSA-N,C22H26F2N2O2S,420.5,"(2S)-2-[(2-fluorophenyl)methyl]-3-(2-fluorospiro[4,5-dihydrothieno[2,3-c]pyran-7,4'-piperidine]-1'-yl)-N-methylpropanamide","NOP-1A|UNII-DQY244459T|DQY244459T|1283095-70-4|Spiro(piperidine-4,7'-(7H)thieno(2,3-C)pyran)-1-propanamide, 2'-fluoro-alpha-((2-fluorophenyl)methyl)-4',5'-dihydro-N-methyl-, (alphaS)-|SPIRO(PIPERIDINE-4,7'-(7H)THIENO(2,3-C)PYRAN)-1-PROPANAMIDE, 2'-FLUORO-.ALPHA.-((2-FLUOROPHENYL)METHYL)-4',5'-DIHYDRO-N-METHYL-, (.ALPHA.S)-|(2S)-2-((2'-fluoro-4',5'-dihydrospiro(piperidine-4,7'-thieno(2,3-c)pyran)-1-yl)methyl)-3-(2-fluorophenyl)-N-methylpropanamide|(2S)-2-({2'-fluoro-4',5'-dihydrospiro[piperidine-4,7'-thieno[2,3-c]pyran]-1-yl}methyl)-3-(2-fluorophenyl)-N-methylpropanamide|RefChem:166523|CHEMBL2088033|BDBM50400872|DB15208|Q27276550"
MK-7145,59568713,,"InChI=1S/C26H30N2O6/c1-15-17(3-5-19-21(15)13-33-25(19)31)23(29)11-27-7-9-28(10-8-27)12-24(30)18-4-6-20-22(16(18)2)14-34-26(20)32/h3-6,23-24,29-30H,7-14H2,1-2H3/t23-,24-/m0/s1",OCKGFTQIICXDQW-ZEQRLZLVSA-N,C26H30N2O6,466.5,5-[(1R)-1-hydroxy-2-[4-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3H-2-benzofuran-1-one,"MK-7145|1255204-84-2|5,5'-((1R,1'R)-Piperazine-1,4-diylbis(1-hydroxyethane-2,1-diyl))bis(4-methylisobenzofuran-1(3H)-one)|M371870BYL|5-[(1R)-1-hydroxy-2-[4-[(2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl]piperazin-1-yl]ethyl]-4-methyl-3H-2-benzofuran-1-one|1(3H)-Isobenzofuranone, 5,5'-(1,4-piperazinediylbis((1R)-1-hydroxy-2,1-ethanediyl))bis(4-methyl-|5-((1R)-1-hydroxy-2-(4-((2R)-2-hydroxy-2-(4-methyl-1-oxo-3H-2-benzofuran-5-yl)ethyl)piperazin-1-yl)ethyl)-4-methyl-3H-2-benzofuran-1-one|RefChem:159211|5-((1R)-1-hydroxy-2-(4-((2R)-2-hydroxy-2-(4-methyl-1-oxo-1,3-dihydro-2-benzofuran-5-yl)ethyl)piperazin-1-yl)ethyl)-4-methyl-1,3-dihydro-2-benzofuran-1-one|UNII-M371870BYL|orb1709112|SCHEMBL2894681|CHEMBL3696475|SCHEMBL29778244|GTPL10382|OCKGFTQIICXDQW-ZEQRLZLVSA-N|BDBM155921|MK7145|AKOS032946121|example 2A [WO2010129379]|DB11968|DA-65510|HY-18277|US9018211, 2A|CS-0007374|NS00072922|Q27283419|5,5'-{Piperazine-1,4-diylbis[(1R)-1-hydroxyethane-2,1-diyl]}bis(4-methyl-2-benzofuran-1(3H)-one)"
ABT-107,11151363,,"InChI=1S/C19H20N4O/c1-2-16-15(5-8-20-16)11-14(1)17-3-4-19(22-21-17)24-18-12-23-9-6-13(18)7-10-23/h1-5,8,11,13,18,20H,6-7,9-10,12H2/t18-/m0/s1",LUKNJAQKVPBDSC-SFHVURJKSA-N,C19H20N4O,320.4,5-[6-[[(3R)-1-azabicyclo[2.2.2]octan-3-yl]oxy]pyridazin-3-yl]-1H-indole,"ABT-107|ABT 107|RefChem:108564|ABT107|855291-54-2|ABT-PR1|ABT-107 free base|(R)-3-((6-(1H-Indol-5-yl)pyridazin-3-yl)oxy)quinuclidine|SXS38HR98H|CHEMBL2151570|(3R)-3-((6-(1H-Indol-5-yl)-3-pyridazinyl)oxy)-1-azabicyclo(2.2.2)octane|5-[6-[[(3R)-1-azabicyclo[2.2.2]octan-3-yl]oxy]pyridazin-3-yl]-1H-indole|5-{6-[(3R)-1-azabicyclo[2.2.2]oct-3-yloxy]pyridazin-3-yl}-1H-indole|5-(6-((3R)-1-AZABICYCLO(2.2.2)OCT-3-YLOXY)PYRIDAZIN-3-YL)-1H-INDOLE|UNII-SXS38HR98H|SCHEMBL527745|orb1690223|5-{6-[(3R)-1-azabicyclo[2.2.2]octan-3-yloxy]pyridazin-3-yl}-1H-indole|LUKNJAQKVPBDSC-SFHVURJKSA-N|BDBM50393252|EX-A10714|AKOS027322508|DA-70460|MS-24736|HY-108038|CS-0027208|G14639|5-(6-(1-azabicyclo(2,2,2)oct-3-yloxy)pyridazin-3-yl)-1h-indole|5-(6-[(3r)-1-azabicyclo[2,2,2]oct-3-yloxy]pyridazin-3-yl)-1h-indole|1-AZABICYCLO(2.2.2)OCTANE, 3-((6-(1H-INDOL-5-YL)-3-PYRIDAZINYL)OXY)-, (3R)-"
AZD-4017,24946280,,"InChI=1S/C22H33N3O3S/c1-2-13-29-22-18(21(28)23-17-8-4-3-5-9-17)10-11-19(24-22)25-12-6-7-16(15-25)14-20(26)27/h10-11,16-17H,2-9,12-15H2,1H3,(H,23,28)(H,26,27)/t16-/m0/s1",NCDZABJPWMBMIQ-INIZCTEOSA-N,C22H33N3O3S,419.6,2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]piperidin-3-yl]acetic acid,"1024033-43-9|AZD 4017|AZD-4017|AZD4017|3JL137394Y|DTXSID80145044|2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]piperidin-3-yl]acetic acid|2-((3S)-1-(5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl)piperidin-3-yl)acetic acid|RefChem:115998|DTXCID2067535|11bHSD1 Inhibitor AZD4017|11b-HSD1 inhibitor AZD4017|11-beta-hydroxysteroid Dehydrogenase Type 1 Inhibitor AZD4017|11beta-hydroxysteroid Dehydrogenase Type 1 Inhibitor AZD4017|2-((3S)-1-(5-(cyclohexylcarbamoyl)-6-(propylsulfanyl)pyridin-2-yl)piperidin-3-yl)acetic acid|{(3s)-1-[5-(Cyclohexylcarbamoyl)-6-(Propylsulfanyl)pyridin-2-Yl]piperidin-3-Yl}acetic Acid|UNII-3JL137394Y|2-[(3S)-1-[5-(cyclohexylcarbamoyl)-6-propylsulfanylpyridin-2-yl]-3-piperidyl]acetic acid|3-Piperidineacetic acid, 1-[5-[(cyclohexylamino)carbonyl]-6-(propylthio)-2-pyridinyl]-, (3S)-|CHEMBL2153191|3-PIPERIDINEACETIC ACID, 1-(5-((CYCLOHEXYLAMINO)CARBONYL)-6-(PROPYLTHIO)-2-PYRIDINYL)-, (3S)-|GTPL7695|orb1308605|SCHEMBL1967349|C22H33N3O3S|AZD 4017 [WHO-DD]|GLXC-15623|3-Piperidineacetic acid, 1-[5-[(cyclohexylamino)carbonyl]-6-(propylthio)-2-pyridinyl]-, (3S)-;3-Piperidineacetic acid, 1-[5-[(cyclohexylamino)carbonyl]-6-(propylthio)-2-pyridinyl]-, (3S)-|BDBM50392216|MFCD25976912|AKOS025396017|DB14875|BA166507|DA-50847|HY-18053|MS-27355|CS-0007200|F18726|US8673938, 7|Q27074744|(3S)-1-[5-[(Cyclohexylamino)carbonyl]-6-(propylthio)-2-pyridinyl]-3-piperidineacetic acid|14M"
MOLIBRESIB,46943432,,"InChI=1S/C22H22ClN5O2/c1-4-24-20(29)12-18-22-27-26-13(2)28(22)19-10-9-16(30-3)11-17(19)21(25-18)14-5-7-15(23)8-6-14/h5-11,18H,4,12H2,1-3H3,(H,24,29)/t18-/m0/s1",AAAQFGUYHFJNHI-SFHVURJKSA-N,C22H22ClN5O2,423.9,"2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide","1260907-17-2|molibresib|GSK 525762A|I-BET 762|I-BET762|Bet inhibitor GSK525762|GSK-525762A|5QIO6SRZ2R|(4S)-6-(4-CHLOROPHENYL)-N-ETHYL-8-METHOXY-1-METHYL-4H-(1,2,4)TRIAZOLO(4,3-A)(1,4)BENZODIAZEPINE-4-ACETAMIDE|molibresibum|IBET compound|I-BET compound|(4S)-6-(4-Chlorophenyl)-N-ethyl-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine-4-acetamide|RefChem:159335|I-BET-762|GSK525762A|GSK525762|GSK-525762|2-[(4s)-6-(4-Chlorophenyl)-8-Methoxy-1-Methyl-4h-[1,2,4]triazolo[4,3-A][1,4]benzodiazepin-4-Yl]-N-Ethylacetamide|UNII-5QIO6SRZ2R|(S)-2-(6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-N-ethylacetamide|4H-[1,2,4]Triazolo[4,3-a][1,4]benzodiazepine-4-acetamide, 6-(4-chlorophenyl)-N-ethyl-8-methoxy-1-methyl-, (4S)-|MFCD22417091|CHEMBL1232461|Molibresib (USAN)|2-((4S)-6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-benzo[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-N-ethylacetamide|CS-0717|MOLIBRESIB [USAN]|GSK-525762A (I-BET 762)|(S)-2-(6-(4-Chlorophenyl)-8-methoxy-1-methyl-4H-benzo-[f][1,2,4]triazolo[4,3-a][1,4]diazepin-4-yl)-N-ethylacetamide|C22H22ClN5O2|EAM|GSK 525762A; I-BET 762|2yek|GSK525762A(Molibresib I-BET762)|4H-(1,2,4)TRIAZOLO(4,3-A)(1,4)BENZODIAZEPINE-4-ACETAMIDE, 6-(4-CHLOROPHENYL)-N-ETHYL-8-METHOXY-1-METHYL-, (4S)-|3p5o|MOLIBRESIB [INN]|MOLIBRESIB [WHO-DD]|GSK 525762A;Molibresib|Molibresib (I-BET-762)|GTPL7033|orb1307159|SCHEMBL1872390|SCHEMBL29359178|CHEBI:95082|DTXSID60677590|EX-A462|AAAQFGUYHFJNHI-SFHVURJKSA-N|GLXC-04299|BCP07337|BDBM50365463|NSC774829|s7189|AKOS025404837|CCG-208698|NSC-774829|NCGC00263621-02|NCGC00263621-04|NCGC00263621-06|NCGC00263621-09|NCGC00263621-16|AC-32712|AS-16364|BP-23442|FG137683|HY-13032|GSK-525762A(I-BET-762)|I-BET762, >=98% (HPLC)|SW220225-1|D11326|EN300-20050078|BRD-K08109215-001-06-4|Q27078016|2-((4S)-6-(4-CHLOROPHENYL)-8-METHOXY-1-METHYL-4HBENZO(F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPIN-4-YL)-N-ETHYLACETAMIDE|2-[(4S)-6-(4-Chlorophenyl)-1-methyl-8-(methyloxy)-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide|2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethyl-acetamide|2-[(7S)-9-(4-chlorophenyl)-12-methoxy-3-methyl-2,4,5,8-tetraazatricyclo[8.4.0.0,2,6]tetradeca-1(10),3,5,8,11,13-hexaen-7-yl]-N-ethylacetamide"
BIRABRESIB,9936746,,"InChI=1S/C25H22ClN5O2S/c1-13-14(2)34-25-22(13)23(16-4-6-17(26)7-5-16)28-20(24-30-29-15(3)31(24)25)12-21(33)27-18-8-10-19(32)11-9-18/h4-11,20,32H,12H2,1-3H3,(H,27,33)/t20-/m0/s1",GNMUEVRJHCWKTO-FQEVSTJZSA-N,C25H22ClN5O2S,492.0,"2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]-N-(4-hydroxyphenyl)acetamide","birabresib|202590-98-5|OTX015|OTX-015|MK-8628|OTX 015|OTX-015 anhydrous|Y-803 anhydrous|Birabresib [USAN]|MFCD26960949|(S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide|OTX015 ANHYDROUS|6H-Thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide, 4-(4-chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6S)-|X40LKS49S3|MK-8628;Birabresib|DTXSID701103937|C25H22ClN5O2S|(S)-2-(4-(4-Chlorophenyl)-2,3,9-triMethyl-6H-thieno[3,2-f][1,2,4]-triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetaMide|2-[(9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.02,6]trideca-2(6),4,7,10,12-pentaen-9-yl]-N-(4-hydroxyphenyl)acetamide|6H-Thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-6-acetamide, 4-(4-chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-, (6S)-|(6S)-4-(4-Chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide|(S)-2-(4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl)-N-(4-hydroxyphenyl)acetamide.|2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-N-(4-hydroxyphenyl)acetamide|birabresibum|UNII-X40LKS49S3|(6S)-4-(4-Chlorophenyl)-N-(4-hydroxyphenyl)-2,3,9-trimethyl-6H-thieno(3,2-f)(1,2,4)triazolo(4,3-a)(1,4)diazepine-6-acetamide|(s)-2-[4-(4-chlorophenyl)-2,3,9-trimethyl-6h-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepin-6-yl]-n-(4-hydroxyphenyl)acetamide|2-((6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno(3,2-f)-(1, 2, 4) triazolo (4,3-a) (1, 4) diazepin-6-yl)-N-(4-hydroxyphenyl)-acetamide dehydrate|2-[(6S)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f]-[1, 2, 4] triazolo [4,3-a] [1, 4] diazepin-6-yl]-N-(4-hydroxyphenyl)-acetamide dehydrate|Birabresib (Standard)|OTX015 (Birabresib)|BIRABRESIB [INN]|Birabresib (USAN/INN)|RefChem:1050696|OTX015 (Birabresib)?|BIRABRESIB [WHO-DD]|GTPL8359|orb1301134|SCHEMBL2898131|CHEMBL3581647|EX-A640|CHEBI:191051|CHEBI:230508|GNMUEVRJHCWKTO-FQEVSTJZSA-N|DTXCID001535612|GLXC-02540|BRD 2/3/4 Inhibitor OTX015|BDBM50092312|HY-15743R|NSC778747|s7360|AKOS027323345|CCG-264724|CS-1598|DB15189|GS-9310|NSC-778747|NCGC00356067-01|NCGC00356067-02|NCGC00356067-11|NCGC00356067-12|NCGC00356067-13|AC-35281|BP-25368|FO145492|HY-15743|OTX015, >=98% (HPLC)|SY260960|O0482|D10911|OTX015  pound MK 8628/Birabresib pound(c)|BRD-K43471985-001-03-0|BRD-K43471985-001-05-5|Q27075296|(S)-N-(4-hydroxyphenyl)-4-(4-chlorophenyl)-2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide|2-((6S)-4-(4-CHLOROPHENYL)-2,3,9-TRIMETHYL-6H-THIENO(3,2- F)(1,2,4)TRIAZOLO(4,3-A)(1,4)DIAZEPIN-6-YL)- N-(4-HYDROXYPHENYL)ACETAMIDE|2-((9S)-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetraazatricyclo(8.3.0.0^(2,6))trideca-2(6),4,7,10,12-pentaen-9-yl)-N-(4-hydroxyphenyl)acetamide|2-[(9S)-7-(4-CHLOROPHENYL)-4,5,13-TRIMETHYL-3-THIA-1,8,11,12-TETRAAZATRICYCLO[8.3.0.0(2),?]TRIDECA-2(6),4,7,10,12-PENTAEN-9-YL]-N-(4-HYDROXYPHENYL)ACETAMIDE|6JE"
MIVEBRESIB,71600087,,"InChI=1S/C22H19F2N3O4S/c1-3-32(29,30)26-14-5-7-19(31-20-6-4-13(23)10-18(20)24)16(11-14)17-12-27(2)22(28)21-15(17)8-9-25-21/h4-12,25-26H,3H2,1-2H3",RDONXGFGWSSFMY-UHFFFAOYSA-N,C22H19F2N3O4S,459.5,"N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide","Mivebresib|1445993-26-9|ABBV-075|ABBV075|N-(4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl)ethanesulfonamide|VR86R11J7J|Ethanesulfonamide, N-[4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]-|N-[4-(2,4-Difluorophenoxy)-3-(6-Methyl-7-Oxo-6,7-Dihydro-1h-Pyrrolo[2,3-C]pyridin-4-Yl)phenyl]ethanesulfonamide|Ethanesulfonamide, N-(4-(2,4-difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo(2,3-C)pyridin-4-yl)phenyl)-|mivebresibum|N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo(2,3-C)pyridin-4-yl)phenyl)ethanesulfonamide|RefChem:925943|MFCD30377200|Mivebresib [INN]|Mivebresib [USAN]|ABBV 075|N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide|N-(4-(2,4-Difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro- 1H-pyrrolo(2,3-C)pyridin-4-yl)phenyl)ethanesulfonamide|8NG|Mivebresib(ABBV-075|Mivebresib (USAN/INN)|Mivebresib [USAN:INN]|Mivebresib(ABBV-075?|Mivebresib; ABBV-075|ABBV-075 (Mivebresib)|Mivebresib (ABBV-075)|MIVEBRESIB [WHO-DD]|UNII-VR86R11J7J|GTPL9117|orb1303860|C22H19F2N3O4S|CHEMBL3987016|SCHEMBL15068241|SCHEMBL29362711|SCHEMBL29430453|RDONXGFGWSSFMY-UHFFFAOYSA-N|BDBM220447|GLXC-10559|BCP18592|EX-A1082|NSC793103|s8400|AKOS030628486|CCG-269326|CS-5815|NSC-793103|SB19768|Example 36 [WO2013097601]|AC-29897|AS-75006|BA166577|DA-65490|SY347011|HY-100015|D11479|US9296741, 36|Q27291978|Mivebresib;N-[4-(2,4-Difluorophenoxy)-3-(6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide|N-[4-(2,4-difluorophenoxy)-3-{6-methyl-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridin-4-yl}phenyl]ethane-1-sulfonamide"
PELABRESIB,multiply,multiply,multiply,multiply,multiply,multiply,multiply,multiply
APABETALONE,135564749,,"InChI=1S/C20H22N2O5/c1-11-7-13(8-12(2)18(11)27-6-5-23)19-21-15-9-14(25-3)10-16(26-4)17(15)20(24)22-19/h7-10,23H,5-6H2,1-4H3,(H,21,22,24)",NETXMUIMUZJUTB-UHFFFAOYSA-N,C20H22N2O5,370.4,"2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-3H-quinazolin-4-one","Apabetalone|1044870-39-4|RVX-208|2-(4-(2-Hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxyquinazolin-4(3H)-one|RVX 208|RVX000222|Apabetalona|RVX208|2-[4-(2-Hydroxyethoxy)-3,5-Dimethylphenyl]-5,7-Dimethoxyquinazolin-4(3h)-One|8R4A7GDZ1D|2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxy-4(1H)-quinazolinone|apabetalonum|2-(4-(2-hydroxyethoxy)-3,5-dimethylphenyl)-5,7-dimethoxy-1,4-dihydroquinazolin-4-one|2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-1,4-dihydroquinazolin-4-one|RefChem:558387|RVX-000222|Apabetalone [INN]|RVX 000222|C20H22N2O5|MFCD18633270|2-[4-(2-Hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-3H-quinazolin-4-one|2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-1H-quinazolin-4-one|Apabetalone [USAN:INN]|UNII-8R4A7GDZ1D|1K0|QC-216|4j1p|4j3i|4mr4|4mr6|Apabetalone (USAN/INN)|APABETALONE [USAN]|Apabetalone;RVX000222|APABETALONE [WHO-DD]|SCHEMBL145019|GTPL7034|orb1305422|SCHEMBL17002023|SCHEMBL29352238|DTXSID90146502|NETXMUIMUZJUTB-UHFFFAOYSA-N|GLXC-04211|HMS3653C10|HMS3744M09|HMS3886D13|BCP07787|EX-A1110|RVX-208?|NSC771600|s7295|AKOS016008772|AKOS026750505|CCG-268298|CS-3239|DB12000|NSC-771600|SB17171|NCGC00356073-09|NCGC00356073-11|AC-28201|AS-35133|BP-23380|FR137715|HY-16652|RVX-208(RVX-000222)|NS00072546|SW219327-1|D11131|EN300-7408723|BRD-K20001883-001-02-7|Q21099554|2-[4-(2-hydroxy-ethoxy)-3,5-dimethyl-phenyl]-5,7-dimethoxy-3H-quinazolin-4-one|2-[4-(2-hydroxyethoxy)-3,5-dimethyl-phenyl]-5,7-dimethoxy-1H-quinazolin-4-one|2-[4-(2-hydroxyethoxy)-3,5-dimethyl-phenyl]-5,7-dimethoxy-3H-quinazolin-4-one|2-[4-(2-hydroxyethoxy)-3,5-dimethylphenyl]-5,7-dimethoxy-3,4-dihydroquinazolin-4-one"
AZD-5153,118693659,,"InChI=1S/C25H33N7O3/c1-18-24(33)29(2)14-15-30(18)16-17-35-21-6-4-19(5-7-21)20-10-12-31(13-11-20)23-9-8-22-26-27-25(34-3)32(22)28-23/h4-9,18,20H,10-17H2,1-3H3/t18-/m1/s1",RSMYFSPOTCDHHJ-GOSISDBHSA-N,C25H33N7O3,479.6,"(3R)-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]-1,3-dimethylpiperazin-2-one","AZD-5153|AZD5153|1869912-39-9|AZD 5153|C7C7U6YEAO|2-Piperazinone, 4-(2-(4-(1-(3-methoxy-1,2,4-triazolo(4,3-b)pyridazin-6-yl)-4-piperidinyl)phenoxy)ethyl)-1,3-dimethyl-, (3R)-|RefChem:116007|MFCD30530420|(R)-4-(2-(4-(1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)-1,3-dimethylpiperazin-2-one|CHEMBL4078100|AZD 5153 [WHO-DD]|1869912-39-9 (free base)|(3~{r})-4-[2-[4-[1-(3-Methoxy-[1,2,4]triazolo[4,3-B]pyridazin-6-Yl)piperidin-4-Yl]phenoxy]ethyl]-1,3-Dimethyl-Piperazin-2-One|(3r)-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)-4-piperidyl]phenoxy]ethyl]-1,3-dimethyl-piperazin-2-one|(3R)-4-[2-[4-[1-(3-methoxy-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl]phenoxy]ethyl]-1,3-dimethylpiperazin-2-one|(3R)-4-[2-[4-[1-(3-methoxy-1,2,4-triazolo[4,3-b]pyridazin-6-yl)-4-piperidinyl]phenoxy]ethyl]-1,3-dimethyl-2-piperazinone|UNII-C7C7U6YEAO|orb2279152|SCHEMBL17477306|CHEBI:231674|C25H33N7O3|BCP20057|EX-A1317|AZD5153, 6-hydroxy-2-naphthoate|BDBM50260093|NSC797938|AKOS030627661|AZD-5153, 6-hydroxy-2-naphthoate|NSC-797938|AC-31599|AS-35242|DA-50855|HY-100653|CS-0019891|Q27467599|XNH"
XEVINAPANT,25022340,,"InChI=1S/C32H43N5O4/c1-21(2)19-28(38)36-18-17-25-15-16-27(37(25)32(41)26(20-36)34-30(39)22(3)33-4)31(40)35-29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-14,21-22,25-27,29,33H,15-20H2,1-4H3,(H,34,39)(H,35,40)/t22-,25+,26-,27-/m0/s1",LSXUTRRVVSPWDZ-MKKUMYSQSA-N,C32H43N5O4,561.7,"(5S,8S,10aR)-N-benzhydryl-5-[[(2S)-2-(methylamino)propanoyl]amino]-3-(3-methylbutanoyl)-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide","1071992-99-8|AT-406|Xevinapant|AT406|Debio 1143|Debio-1143|SM-406|Debio1143|Iap inhibitor AT-406|N65WC8PXDD|MSC2735845A|(5S,8S,10aR)-N-benzhydryl-5-[[(2S)-2-(methylamino)propanoyl]amino]-3-(3-methylbutanoyl)-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide|D-1143|(5S,8S,10aR)-N-benzhydryl-5-(((2S)-2-(methylamino)propanoyl)amino)-3-(3-methylbutanoyl)-6-oxo-1,2,4,5,8,9,10,10a-octahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide|PYRROLO(1,2-A)(1,5)DIAZOCINE-8-CARBOXAMIDE, N-(DIPHENYLMETHYL)DECAHYDRO-5-(((2S)-2-(METHYLAMINO)-1-OXOPROPYL)AMINO)-3-(3-METHYL-1-OXOBUTYL)-6-OXO-, (5S,8S,10AR)-|Pyrrolo[1,2-a][1,5]diazocine-8-carboxamide, N-(diphenylmethyl)decahydro-5-[[(2S)-2-(methylamino)-1-oxopropyl]amino]-3-(3-methyl-1-oxobutyl)-6-oxo-, (5S,8S,10aR)-|RefChem:53402|UNII-N65WC8PXDD|SMAC Mimetic Debio 1143|IAPs Inhibitor Debio 1143|IAPs Antagonist Debio 1143|D1143|Second Mitochondrial-derived Activator of Caspases Mimetic Debio 1143|Pyrrolo(1,2-a)(1,5)diazocine-8-carboxamide, n-((1,1'-biphenyl)-2-ylmethyl)decahydro-5-(((2s)-2-(methylamino)-1-oxopropyl)amino)-3-(3-methyl-1-oxobutyl)-6-oxo-, (5s,8s,10ar)|(5S,8S,10aR)-N-benzhydryl-5-((S)-2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide|AT-406(AT406)|Xevinapant [INN]|AT406 (SM-406)|CHEMBL2158051|AT 406|DeBio-1143 (AT-406)|MFCD22124467|SM 406|1071992-99-8 (free base)|QCR-136|C32H43N5O4|AT-406Xevinapant?|XEVINAPANT [USAN]|XEVINAPANT [WHO-DD]|Xevinapant (JAN/USAN/INN)|GTPL7729|orb1300488|SCHEMBL2724374|DTXSID50648496|EX-A104|BCP04668|BDBM50393505|NSC764757|s2754|AKOS027250726|CCG-270056|CS-0962|NSC-764757|NCGC00346675-01|NCGC00346675-03|(5S,8S,10aR)-N-(Diphenylmethyl)-5-[(N-methyl-L-alanyl)amino]-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide|AC-30282|AS-56453|BP-42118|DA-61281|HY-15454|D 1143|D12565|AT406 (SM-406, ARRY-334543)|EN300-25327900|Q27074566|Z2740129972|1071992-99-8, 1071992-57-8 (HCl)|(5S,8S,10aR)-N-(diphenylmethyl)-5-[(2S)-2-(methylamino)propanamido]-3-(3-methylbutanoyl)-6-oxo-decahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide|(5S,8S,10aR)-N-(diphenylmethyl)-5-[(2S)-2-(methylamino)propanamido]-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo[1,2-a][1,5]diazocine-8-carboxamide|(5S,8S,10aR)-N-(Diphenylmethyl)decahydro-5-(((2S)-2-(methylamino)-1-oxopropyl)amino)-3-(3-methyl-1-oxobutyl)-6-oxopyrrolo(1,2-a)(1,5)diazocine-8-carboxamide"
LCL-161,24737642,,"InChI=1S/C26H33FN4O3S/c1-16(28-2)24(33)30-22(17-7-4-3-5-8-17)26(34)31-14-6-9-21(31)25-29-20(15-35-25)23(32)18-10-12-19(27)13-11-18/h10-13,15-17,21-22,28H,3-9,14H2,1-2H3,(H,30,33)/t16-,21-,22-/m0/s1",UFPFGVNKHCLJJO-SSKFGXFMSA-N,C26H33FN4O3S,500.6,"(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide","LCL161|1005342-46-0|LCL-161|LCL 161|Nvp-lcl 161|(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide|6TNS415Y3P|DTXSID501025866|(2S)-N-((1S)-1-cyclohexyl-2-((2S)-2-(4-(4-fluorobenzoyl)-1,3-thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-(methylamino)propanamide|(2S)-N-((1S)-1-cyclohexyl-2-((2S)-2-(4-(4-fluorobenzoyl)-1,3-thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-methylaminopropanamide|(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-methylaminopropanamide|(2S)-N-[(1S)-1-cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl]-2-(methylamino)propanamide|Smac Mimetic LCL161|RefChem:152599|DTXCID101510120|(s)-n-((s)-1-cyclohexyl-2-((s)-2-(4-(4-fluorobenzoyl)thiazol-2-yl)pyrrolidin-1-yl)-2-oxoethyl)-2-(methylamino)propanamide|MFCD23160049|NVP-LCL161|Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-|CHEMBL2431768|C26H33FN4O3S|UNII-6TNS415Y3P|(S)-N-[(S)-1-Cyclohexyl-2-[(S)-2-[4-(4-fluorobenzoyl)thiazol-2-yl]pyrrolidin-1-yl]-2-oxoethyl]-2-(methylamino)propanamide|PROPANAMIDE, N-((1S)-1-CYCLOHEXYL-2-((2S)-2-(4-(4-FLUOROBENZOYL)-2-THIAZOLYL)-1-PYRROLIDINYL)-2-OXOETHYL)-2-(METHYLAMINO)-, (2S)-|GTPL7912|SCHEMBL1275369|LCL 161 [WHO-DD]|EX-A533|CHEBI:193137|GLXC-03701|LCL-161?|Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-;Propanamide, N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)-2-thiazolyl]-1-pyrrolidinyl]-2-oxoethyl]-2-(methylamino)-, (2S)-|BDBM50441356|NSC772868|s7009|AKOS027422741|CCG-269696|CS-1630|DB12085|NSC-772868|NCGC00378579-07|NCGC00378579-08|AC-32971|BP-25378|FL103735|HY-15518|SY069614|NS00073098|BRD-K08248804-001-01-8|Q27079405|(2S)-N-[(1S)-1-cyclohexyl-2-[(2S)-2-[4-(4-fluorobenzoyl)thiazol-2-yl]pyrrolidin-1-yl]-2-oxo-ethyl]-2-(methylamino)propanamide|N-[(1S)-1-cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl]-N(2)-methyl-L-alaninamide|N-[(1S)-1-cyclohexyl-2-{(2S)-2-[4-(4-fluorobenzoyl)-1,3-thiazol-2-yl]pyrrolidin-1-yl}-2-oxoethyl]-N~2~-methyl-L-alaninamide"
FIRSOCOSTAT,71528744,,"InChI=1S/C28H31N3O8S/c1-16-21-24(32)31(28(2,3)26(33)34)27(35)30(25(21)40-22(16)23-29-11-14-38-23)15-20(39-17-9-12-37-13-10-17)18-7-5-6-8-19(18)36-4/h5-8,11,14,17,20H,9-10,12-13,15H2,1-4H3,(H,33,34)/t20-/m0/s1",ZZWWXIBKLBMSCS-FQEVSTJZSA-N,C28H31N3O8S,569.6,"2-[1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno[2,3-d]pyrimidin-3-yl]-2-methylpropanoic acid","Firsocostat|1434635-54-7|ND-630|GS-ACC|NDI-010976|GS-0976|XE10NJQ95M|2-[1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno[2,3-d]pyrimidin-3-yl]-2-methylpropanoic acid|1,4-Dihydro-1-((2R)-2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethyl)-alpha,alpha,5-trimethyl-6-(2-oxazolyl)-2,4-dioxothieno(2,3-d)pyrimidine-3(2H)-acetic acid|2-(1-((2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl)-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxothieno(2,3-d)pyrimidin-3-yl)-2-methylpropanoic acid|firsocostatum|2-{1-[(2R)-2-(2-METHOXYPHENYL)-2-(OXAN-4-YLOXY)ETHYL]-5-METHYL-6-(1,3-OXAZOL-2-YL)-2,4-DIOXOTHIENO[2,3-D]PYRIMIDIN-3-YL}-2-METHYLPROPANOIC ACID|RefChem:921616|Firsocostat [USAN]|(R)-2-(1-(2-(2-methoxyphenyl)-2-((tetrahydro-2H-pyran-4-yl)oxy)ethyl)-5-methyl-6-(oxazol-2-yl)-2,4-dioxo-1,4-dihydrothieno[2,3-d]pyrimidin-3(2H)-yl)-2-methylpropanoic acid|Firsocostat (GS-0976)|Firsocostat(ND-630,GS-0976)|ND 630|C28H31N3O8S|FIRSOCOSTAT [INN]|Firsocostat (USAN/INN)|UNII-XE10NJQ95M|FIRSOCOSTAT [WHO-DD]|orb1300001|SCHEMBL14945041|SCHEMBL29539821|GTPL10645|2-{1-[(2R)-2-(2-methoxyphenyl)-2-(oxan-4-yloxy)ethyl]-5-methyl-6-(1,3-oxazol-2-yl)-2,4-dioxo-1H,2H,3H,4H-thieno[2,3-d]pyrimidin-3-yl}-2-methylpropanoic acid|EX-A2586|s8893|WHO 10738|AKOS037648731|CS-6509|AC-31460|BS-15388|HY-16901|ND-630; NDI-010976; Firsocostat|D11640|1,4-DIHYDRO-1-((2R)-2-(2-METHOXYPHENYL)-2-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)ETHYL)-.ALPHA.,.ALPHA.,5-TRIMETHYL-6-(2-OXAZOLYL)-2,4-DIOXOTHIENO(2,3-D)PYRIMIDINE-3(2H)-ACETIC ACID|2-[1-[(2R)-2-(2-methoxyphenyl)-2-tetrahydropyran-4-yloxy-ethyl]-5-methyl-6-oxazol-2-yl-2,4-dioxo-thieno[2,3-d]pyrimidin-3-yl]-2-methyl-propanoic acid|THIENO(2,3-D)PYRIMIDINE-3(2H)-ACETIC ACID, 1,4-DIHYDRO-1-((2R)-2-(2-METHOXYPHENYL)-2-((TETRAHYDRO-2H-PYRAN-4-YL)OXY)ETHYL)-.ALPHA.,.ALPHA.,5-TRIMETHYL-6-(2-OXAZOLYL)-2,4-DIOXO-"
PINOMETOSTAT,57345410,,"InChI=1S/C30H42N8O3/c1-16(2)37(13-22-25(39)26(40)29(41-22)38-15-34-24-27(31)32-14-33-28(24)38)19-10-17(11-19)6-9-23-35-20-8-7-18(30(3,4)5)12-21(20)36-23/h7-8,12,14-17,19,22,25-26,29,39-40H,6,9-11,13H2,1-5H3,(H,35,36)(H2,31,32,33)/t17?,19?,22-,25-,26-,29-/m1/s1",LXFOLMYKSYSZQS-XKHGBIBOSA-N,C30H42N8O3,562.7,"(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[[3-[2-(6-tert-butyl-1H-benzimidazol-2-yl)ethyl]cyclobutyl]-propan-2-ylamino]methyl]oxolane-3,4-diol","pinometostat|1380288-87-8|EPZ-5676|EPZ5676|Pinometostat, trans-|Pinometostat [INN]|Pinometostat (EPZ5676)|Pinometostat anhydrous|(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-((((lr,3S)-3-(2-(5-(tert-butyl)-lH-benzo[d]imidazol2yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofuran-3,4-diol|MFCD24849416|(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofuran-3,4-diol|1380288-88-9|8V9YR09EF3|CHEMBL3087499|CHEMBL3414626|F66X4M38G5|EPZ-005676|(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(((cis-3-(2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofuran-3,4-diol|(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[[3-[2-(6-tert-butyl-1H-benzimidazol-2-yl)ethyl]cyclobutyl]-propan-2-ylamino]methyl]oxolane-3,4-diol|5'-[{cis-3-[2-(5-Tert-Butyl-1h-Benzimidazol-2-Yl)ethyl]cyclobutyl}(Propan-2-Yl)amino]-5'-Deoxyadenosine|UNII-8V9YR09EF3|UNII-F66X4M38G5|trans-pinometostat|9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-?-D-ribofuranosyl]-9H-purin-6-amine|Pinometostat(EPZ5676)|Pinometostat(EPZ5676)?|PINOMETOSTAT [WHO-DD]|GTPL7019|orb1304542|SCHEMBL9106942|SCHEMBL9106946|CHEMBL4079133|SCHEMBL10248515|SCHEMBL16129027|SCHEMBL17433346|SCHEMBL17767408|SCHEMBL29350232|SCHEMBL29391395|DTXSID20720950|EX-A316|CHEBI:124919|CHEBI:230493|BDBM244791|BCP14198|EPZ 5676|BDBM50075098|BDBM50443022|EPZ-5676;EPZ5676;Pinometostat|NSC778365|NSC795144|s7062|AKOS030238958|CCG-270061|CS-1419|DB12920|NSC-778365|NSC-795144|NCGC00351597-01|NCGC00351597-02|NCGC00351597-09|NCGC00351597-10|NCGC00351597-14|NCGC00351597-16|9H-Purin-6-amine, 9-(5-deoxy-5-((cis-3-(2-(6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl)ethyl)cyclobutyl)(1-methylethyl)amino)-beta-D-ribofuranosyl)-|9H-Purin-6-amine, 9-(5-deoxy-5-((trans-3-(2-(6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl)ethyl)cyclobutyl)(1-methylethyl)amino)-beta-D-ribofuranosyl)-|AC-32709|DA-76899|FD146242|HY-15593|US9446064, A3|NS00073476|SW220122-1|BRD-K26531771-001-01-4|BRD-K26531771-001-02-2|BRD-K63457253-001-01-3|Q27088395|Q27215234|Q27277695|Z3041519928|(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofuran-3,4|(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(((3-(2-(5-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofuran-3,4-diol|(2R,3R,4S,5R)-2-(6-Amino-9H-purin-9-yl)-5-(((trans-3-(2-(6-(tert-butyl)-1H-benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofuran-3,4-diol|(2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-{[(propan-2-yl)[(1r,3s)-3-[2-(5-tert-butyl-1H-1,3-benzodiazol-2-yl)ethyl]cyclobutyl]amino]methyl}oxolane-3,4-diol|(2R,3R,4S,5R)-2-(6-aminopurin-9-yl)-5-[[[3-[2-(6-tert-butyl-1H-benzimidazol-2-yl)ethyl]cyclobutyl]-isopropyl-amino]methyl]tetrahydrofuran-3,4-diol|9-[5-Deoxy-5-[[cis-3-[2-[6-(1,1-dimethylethyl)-1H-benzimidazol-2-yl]ethyl]cyclobutyl](1-methylethyl)amino]-beta-D-ribofuranosyl]-9H- purin-6-amine|9H-PURIN-6-AMINE, 9-(5-DEOXY-5-((CIS-3-(2-(6-(1,1-DIMETHYLETHYL)-1H-BENZIMIDAZOL-2-YL)ETHYL)CYCLOBUTYL)(1-METHYLETHYL)AMINO)-.BETA.-D-RIBOFURANOSYL)-|9H-PURIN-6-AMINE, 9-(5-DEOXY-5-((TRANS-3-(2-(6-(1,1-DIMETHYLETHYL)-1H-BENZIMIDAZOL-2-YL)ETHYL)CYCLOBUTYL)(1-METHYLETHYL)AMINO)-.BETA.-D-RIBOFURANOSYL)-"
AFEGOSTAT,447607,,"InChI=1S/C6H13NO3/c8-3-4-1-7-2-5(9)6(4)10/h4-10H,1-3H2/t4-,5-,6-/m1/s1",QPYJXFZUIJOGNX-HSUXUTPPSA-N,C6H13NO3,147.17,"(3R,4R,5R)-5-(hydroxymethyl)piperidine-3,4-diol","Afegostat|Isofagomine|169105-89-9|(3R,4R,5R)-5-(HYDROXYMETHYL)PIPERIDINE-3,4-DIOL|iso-Fagomine|5-Hydroxymethyl-3,4-piperidinediol|G23AP190YS|3,4-piperidinediol, 5-(hydroxymethyl)-, (3R,4R,5R)-|DTXSID20168651|afegostatum|RefChem:553134|DTXCID0091142|CHEBI:43325|D-Isofagomine|5-HYDROXYMETHYL-3,4-DIHYDROXYPIPERIDINE|CHEMBL206468|IFM|Afegostat [INN]|Isofagomine hydrochloride|Afegostat [USAN:INN]|161302-93-8|UNII-G23AP190YS|1oif|Afegostat (USAN/INN)|AFEGOSTAT [USAN]|ISOFAGOMINE [MI]|AFEGOSTAT [WHO-DD]|SCHEMBL581577|GTPL7410|orb1706270|CHEBI:194390|QPYJXFZUIJOGNX-HSUXUTPPSA-N|EX-A9285|UGA10589|BDBM50182801|AKOS006348872|DB04545|MI45273|HY-14829|CS-0003581|NS00069266|D09576|Q21396373|(3R,4R,5R)-5-(Hydroxymethyl)piperidine-3,4-diol, 8|Afegostat; isofagomine; (3R,4R,5R)-5-(HYDROXYMETHYL)PIPERIDINE-3,4-DIOL|(3R,4R,5R)-5-(Hydroxymethyl)piperidine-3,4-diol;Afegostat;5-Hydroxymethyl-3,4-piperidinediol"
ALTIRATINIB,54576299,,"InChI=1S/C26H21F3N4O4/c27-15-3-5-16(6-4-15)31-24(35)26(8-9-26)25(36)32-20-12-19(29)21(13-18(20)28)37-17-7-10-30-22(11-17)33-23(34)14-1-2-14/h3-7,10-14H,1-2,8-9H2,(H,31,35)(H,32,36)(H,30,33,34)",GNNDEPIMDAZHRQ-UHFFFAOYSA-N,C26H21F3N4O4,510.5,"1-N'-[4-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-2,5-difluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide","Altiratinib|1345847-93-9|DCC-2701|DP-5164|T678746713|1,1-Cyclopropanedicarboxamide, N-(4-((2-((cyclopropylcarbonyl)amino)-4-pyridinyl)oxy)-2,5-difluorophenyl)-N'-(4-fluorophenyl)-|1,1-Cyclopropanedicarboxamide, N-[4-[[2-[(cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-N'-(4-fluorophenyl)-|1-N'-[4-[2-(cyclopropanecarbonylamino)pyridin-4-yl]oxy-2,5-difluorophenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|altiratinibum|1-N'-(4-(2-(cyclopropanecarbonylamino)pyridin-4-yl)oxy-2,5-difluorophenyl)-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|RefChem:111601|N-(4-((2-((CYCLOPROPYLCARBONYL)AMINO)PYRIDIN-4-YL)OXY)-2,5-DIFLUOROPHENYI)-N-(4-FLUOROPHENYL)CYCLOPROPANE-1,1-DICARBOXAMIDE|Altiratinib [USAN]|MFCD28900672|Altiratinib (USAN)|N-(4-((2-((Cyclopropylcarbonyl)amino)pyridin-4-yl)oxy)-2,5-difluorophenyi)-N-(4- fluorophenyl)cyclopropane-1,1-dicarboxamide|N-(4-((2-(cyclopropanecarboxamido)pyridin-4-yl)oxy)-2,5-difluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide.|N-[4-[[2-[(Cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide|DCC2701|UNII-T678746713|Altiratinib;DCC2701|ALTIRATINIB [INN]|Altiratinib(DCC-2701)|Altiratinib(DCC-2701)?|ALTIRATINIB [WHO-DD]|SCHEMBL139906|GTPL9174|orb1306623|CHEMBL3545365|SCHEMBL29358783|SCHEMBL30128694|SCHEMBL30337737|DCC-270|EX-A902|C26H21F3N4O4|GNNDEPIMDAZHRQ-UHFFFAOYSA-N|BCP15682|HY-B0791|BDBM50193395|NSC784590|s6412|AKOS026750329|CS-3944|NSC-784590|SB18876|NCGC00480913-04|AC-35383|FA137645|MS-29472|N-(4-(2-(cyclopropanecarboxamido)pyridin-4-yloxy)-2,5-difluorophenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|N-(4-(2-(cyclopropanecarboxamido)pyridin-4-yloxy)-2,5-difluorophenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|D10862|F11464|BRD-K78627070-001-01-5|Q27074416|A9I|N-[4-[[2-[(Cyclopropylcarbonyl)amino]-4-pyridinyl]oxy]-2,5-difluorophenyl]-N inverted exclamation marka-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide|N1'-[4-[[2-(cyclopropanecarbonylamino)-4-pyridyl]oxy]-2,5-difluoro-phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide"
SITRAVATINIB,25212148,,"InChI=1S/C33H29F2N5O4S/c1-43-15-14-36-18-20-2-8-25(38-19-20)29-17-26-30(45-29)28(10-13-37-26)44-27-9-7-23(16-24(27)35)40-32(42)33(11-12-33)31(41)39-22-5-3-21(34)4-6-22/h2-10,13,16-17,19,36H,11-12,14-15,18H2,1H3,(H,39,41)(H,40,42)",WLAVZAAODLTUSW-UHFFFAOYSA-N,C33H29F2N5O4S,629.7,"1-N'-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide","Sitravatinib|1123837-84-2|MGCD516|MG-516|MGCD-516|CWG62Q1VTB|MG-91516|DTXSID801100124|1-N'-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]pyridin-2-yl]thieno[3,2-b]pyridin-7-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|1,1-Cyclopropanedicarboxamide, N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)-2-pyridinyl)thieno(3,2-b)pyridin-7-yl)oxy)phenyl)-N'-(4-fluorophenyl)-|N-(3-Fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno(3,2-b)pyridin-7-yl)oxy)phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|sitravatinibum|1-N'-(3-fluoro-4-(2-(5-((2-methoxyethylamino)methyl)pyridin-2-yl)thieno(3,2-b)pyridin-7-yl)oxyphenyl)-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|RefChem:886380|DTXCID601531844|N'1-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno(3,2-b)pyridin-7-yl)oxy)phenyl)-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|N-(3-Fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)-2-pyridinyl)thieno(3,2-b)pyridin-7-yl)oxy)phenyl)-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide|Sitravatinib (MGCD516)|Sitravatinib [INN]|N-(3-fluoro-4-((2-(5-(((2-methoxyethyl)amino)methyl)pyridin-2-yl)thieno[3,2-b]pyridin-7-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|MGCD 516|1,1-Cyclopropanedicarboxamide, N-[3-fluoro-4-[[2-[5-[[(2-methoxyethyl)amino]methyl]-2-pyridinyl]thieno[3,2-b]pyridin-7-yl]oxy]phenyl]-N'-(4- fluorophenyl)-|UNII-CWG62Q1VTB|Sitravatinib (USAN/INN)|Sitravatinib [USAN:INN]|SITRAVATINIB [USAN]|Sitravatinib (MGCD516)?|SCHEMBL172015|SITRAVATINIB [WHO-DD]|GCD516|GTPL9920|orb1302929|C33H29F2N5O4S|CHEMBL3989926|MGCD516;MG516|SCHEMBL29355690|SCHEMBL29774217|SCHEMBL30276257|GCD-516|GLXC-15746|GLXC-20146|MG516|BCP29099|EX-A2588|BDBM50467574|NSC788203|s8573|AKOS030526257|CCG-270287|CS-5652|DB15036|NSC-788203|SB17195|NCGC00483926-01|NCGC00483926-02|AC-36164|BS-14332|BS166446|DA-57907|HY-16961|D11140|D83649|Q27275860|1123837-88-6|1609655-67-5|N1'-[3-fluoro-4-[2-[5-[(2-methoxyethylamino)methyl]-2-pyridyl]thieno[3,2-b]pyridin-7-yl]oxy-phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide"
FOSTAMATINIB,11671467,,"InChI=1S/C23H26FN6O9P/c1-23(2)21(31)30(11-38-40(32,33)34)20-14(39-23)6-7-17(28-20)27-19-13(24)10-25-22(29-19)26-12-8-15(35-3)18(37-5)16(9-12)36-4/h6-10H,11H2,1-5H3,(H2,32,33,34)(H2,25,26,27,28,29)",GKDRMWXFWHEQQT-UHFFFAOYSA-N,C23H26FN6O9P,580.5,"[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate","Fostamatinib|901119-35-5|R-788 Free acid|R788 FREE ACID|R-935788 Free acid|R935788 FREE ACID|R 788|R-788|SQ8A3S5101|R7935788|DTXSID401009170|2H-Pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-|(6-((5-FLUORO-2-((3,4,5-TRIMETHOXYPHENYL)AMINO)PYRIMIDIN-4-YL)AMINO)-2,2-DIMETHYL-3-OXO-2,3-DIHYDRO-4H-PYRIDO(3,2-B)(1,4)OXAZIN-4-YL)METHYL DIHYDROGEN PHOSPHATE|[6-({5-Fluoro-2-[(3,4,5-Trimethoxyphenyl)amino]pyrimidin-4-Yl}amino)-2,2-Dimethyl-3-Oxo-2,3-Dihydro-4h-Pyrido[3,2-B][1,4]oxazin-4-Yl]methyl Dihydrogen Phosphate|fostamatinibum|(6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate|(6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxopyrido(2,3-e)(1,4)oxazin-4-yl)methyl dihydrogen phosphate|[6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[2,3-e][1,4]oxazin-4-yl]methyl dihydrogen phosphate|RefChem:57243|DTXCID00198810|R788|Fostamatinib (R788)|Tavalisse|[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxopyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate|Fostamatinib disodium|Fostamatinib [USAN]|MFCD16628163|Fostamatinib (USAN)|[6-[[5-fluoro-2-(3,4,5-trimethoxyanilino)pyrimidin-4-yl]amino]-2,2-dimethyl-3-oxo-pyrido[3,2-b][1,4]oxazin-4-yl]methyl dihydrogen phosphate|Tavlesse|R788 compound|Fostamatinib(R788)|Fostamatinib [USAN:INN]|Fostatinib|UNII-SQ8A3S5101|R-935788|R 788; 6-[[5-Fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one|R 788 compound|Fostamatinib (Standard)|Fostamatinib(R788)?|R788 (Fostamatinib)|FOSTAMATINIB [MI]|FOSTAMATINIB [INN]|FOSTAMATINIB [WHO-DD]|C23H26FN6O9P|GTPL7796|orb1301060|SCHEMBL1201371|CHEMBL2103830|SCHEMBL29351337|EX-A108|GKDRMWXFWHEQQT-UHFFFAOYSA-N|BCPP000226|HMS3651H09|HMS5081D13|HY-13038AR|BCP01871|BDBM50431381|HY-13038A|NSC800102|s2625|AKOS025404920|BCP9000704|CCG-270128|DB12010|NSC-800102|PB25570|NCGC00346622-01|NCGC00346622-02|AC-30126|AS-56399|FF104227|NS00072506|SW219234-1|D09347|EN300-20332957|Q5473550|BRD-K85178109-001-02-3|BRD-K85178109-001-03-1|Z2235801948|R788;R7935788;R 788;R 7935788;R-788;R-7935788|(6-((5-Fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2H-pyrido[3,2-b][1,4]oxazin-4(3H)-yl)methyl dihydrogen phosphate|(6-(5-fluoro-2-(3,4,5-trimethoxyphenylamino)pyrimidin-4-ylamino)-2,2-dimethyl-3-oxo-2,3-dihydropyrido[3,2-b][1,4]oxazin-4-yl)methyl dihydrogen phosphate|{[6-({5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]pyrimidin-4-yl}amino)-2,2-dimethyl-3-oxo-2H,3H,4H-pyrido[3,2-b][1,4]oxazin-4-yl]methoxy}phosphonic acid|2RC|6-[[5-fluoro-2-[(3,4,5-trimethoxyphenyl)amino]-4-pyrimidinyl]amino]-2,2-dimethyl-4-[(phosphonooxy)methyl]-2H-pyrido[3,2-b]-1,4-oxazin-3(4H)-one"
ENTOSPLETINIB,59473233,,"InChI=1S/C23H21N7O/c1-2-17-14-25-28-20(17)13-16(1)21-15-30-8-7-24-23(30)22(27-21)26-18-3-5-19(6-4-18)29-9-11-31-12-10-29/h1-8,13-15H,9-12H2,(H,25,28)(H,26,27)",XSMSNFMDVXXHGJ-UHFFFAOYSA-N,C23H21N7O,411.5,"6-(1H-indazol-6-yl)-N-(4-morpholin-4-ylphenyl)imidazo[1,2-a]pyrazin-8-amine","Entospletinib|1229208-44-9|GS-9973|gs9973|GS 9973|6I3O3W6O3B|SYK INHIBITOR GS-9973|Imidazo[1,2-a]pyrazin-8-amine, 6-(1H-indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]-|DTXSID001317670|6-(1H-Indazol-6-yl)-N-(4-(morpholin-4-yl)phenyl)imidazo(1,2-a)pyrazin-8-amine|6-(1H-indazol-6-yl)-N-(4-morpholin-4-ylphenyl)imidazo[1,2-a]pyrazin-8-amine|Imidazo(1,2-a)pyrazin-8-amine, 6-(1H-indazol-6-yl)-N-(4-(4-morpholinyl)phenyl)-|entospletinibum|6-(1H-indazol-6-yl)-N-(4-morpholin-4-ylphenyl)imidazo(1,2-a)pyrazin-8-amine|6-(1h-Indazol-6-Yl)-N-[4-(Morpholin-4-Yl)phenyl]imidazo[1,2-A]pyrazin-8-Amine|RefChem:590865|DTXCID201747475|6-(1H-Indazol-6-yl)-N-(4-morpholinophenyl)imidazo[1,2-a]pyrazin-8-amine|Entospletinib (GS-9973)|Entospletinib [INN]|MFCD28099806|CHEMBL3265032|Entospletinib [USAN:INN]|UNII-6I3O3W6O3B|4puz|GS9973Entospletinib|GS9973Entospletinib?|GS-9973; Entospletinib|Entospletinib (USAN/INN)|ENTOSPLETINIB [USAN]|ENTOSPLETINIB [WHO-DD]|GTPL7889|orb1301072|SCHEMBL2483776|SCHEMBL29355138|HMS3653D13|HMS3673E05|HMS3750E13|BCP09582|EX-A1120|EZB20844|BDBM50015448|NSC781516|NSC800988|s7523|AKOS027295322|CCG-264700|DB12121|NSC-781516|NSC-800988|SB16830|NCGC00378596-07|AC-30236|AS-17026|DA-36929|HY-15968|SY122763|NS00073149|SW220048-1|D11209|BRD-K76719364-001-01-7|BRD-K76719364-001-02-5|BRD-K76719364-001-04-1|Q27077193|6-(6-Indazolyl)-N-(4-morpholinophenyl)imidazo[1,2-a]pyrazin-8-amine|GS 9973; 6-(1H-Indazol-6-yl)-N-[4-(4-morpholinyl)phenyl]-Imidazo[1,2-a]pyrazin-8-amine;"
TELAGLENASTAT,71577426,,"InChI=1S/C26H24F3N7O3S/c27-26(28,29)39-20-9-5-6-17(14-20)15-22(37)31-21-12-11-18(33-34-21)7-1-2-10-24-35-36-25(40-24)32-23(38)16-19-8-3-4-13-30-19/h3-6,8-9,11-14H,1-2,7,10,15-16H2,(H,31,34,37)(H,32,36,38)",PRAAPINBUWJLGA-UHFFFAOYSA-N,C26H24F3N7O3S,571.6,"N-[6-[4-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide","Telaglenastat|CB-839|1439399-58-2|U6CL98GLP4|2-Pyridineacetamide, N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-|N-[6-[4-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide|WHO 10815|N-[6-(4-{5-[2-(pyridin-2-yl)acetamido]-1,3,4-thiadiazol-2-yl}butyl)pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide|2-Pyridineacetamide, N-(5-(4-(6-((2-(3-(trifluoromethoxy)phenyl)acetyl)amino)-3-pyridazinyl)butyl)-1,3,4-thiadiazol-2-yl)-|telaglenastatum|N-(6-(4-(5-((2-pyridin-2-ylacetyl)amino)-1,3,4-thiadiazol-2-yl)butyl)pyridazin-3-yl)-2-(3-(trifluoromethoxy)phenyl)acetamide|N-(6-(4-(5-(2-(PYRIDIN-2-YL)ACETAMIDO)-1,3,4-THIADIAZOL-2-YL)BUTYL)PYRIDAZIN-3-YL)-2-(3-(TRIFLUOROMETHOXY)PHENYL)ACETAMIDE|RefChem:932667|2-(pyridin-2-yl)-N-(5-(4-(6-(2-(3-(trifluoromethoxy)phenyl)acetamido)pyridazin-3-yl)butyl)-1,3,4-thiadiazol-2-yl)acetamide|Telaglenastat [USAN]|CB 839|MFCD28167826|CB839|2-(Pyridin-2-Yl)-N-(5-{4-[6-({[3-(Trifluoromethoxy)phenyl]acetyl}amino)pyridazin-3-Yl]butyl}-1,3,4-Thiadiazol-2-Yl)acetamide|2-(PYRIDIN-2-YL)-N-{5-[4-(6-{2-[3-(TRIFLUOROMETHOXY)PHENYL]ACETAMIDO}PYRIDAZIN-3-YL)BUTYL]-1,3,4-THIADIAZOL-2-YL}ACETAMIDE|C26H24F3N7O3S|PRAAPINBUWJLGA-UHFFFAOYSA-N|63J|CB-839; N-[5-[4-[6-[[2-[3-(Trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-2-pyridineacetamide|CB-839(Telaglenastat)|UNII-U6CL98GLP4|CB-839(Telaglenastat)?|TELAGLENASTAT [INN]|Telaglenastat (USAN/INN)|TELAGLENASTAT [WHO-DD]|GTPL9053|orb1300456|CB-839 [WHO-DD]|CHEMBL3639788|SCHEMBL14987180|SCHEMBL29529521|SCHEMBL30278811|CHEBI:231605|BDBM109086|GLXC-06047|HMS3741E19|HMS3873G13|HMS6018K17|BCP28287|EX-A1310|NSC783415|NSC795998|NSC798057|s7655|AKOS025396175|CCG-270102|CS-3393|DB15232|NSC-783415|NSC-795998|NSC-798057|SB17221|NCGC00356145-11|2-?Pyridineacetamide, N-?[5-?[4-?[6-?[[2-?[3-?(trifluoromethoxy)?phenyl]?acetyl]?amino]?-?3-?pyridaz|AC-31603|AS-75090|CB839; CB 839 pound>>Telaglenastat,|DA-34988|FC103571|HY-12248|N-[5-[4-[6-[[2-[3-(trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-2-pyridineacetamide|D11738|US8604016, 670|BRD-K58070273-001-03-3|BRD-K58070273-001-04-1|Q27075751|N-[5-[4-[6-[[2-[3-(Trifluoromethoxy)phenyl]acetyl]amino]-3-pyridazinyl]butyl]-1,3,4-thiadiazol-2-yl]-2-pyridineacetamide;Telaglenast  at|N-[6-[4-[5-[[2-(2-pyridyl)acetyl]amino]-1,3,4-thiadiazol-2-yl]butyl]pyridazin-3-yl]-2-[3-(trifluoromethoxy)phenyl]acetamide"
IPATASERTIB,24788740,,"InChI=1S/C24H32ClN5O2/c1-15(2)26-13-19(17-4-6-18(25)7-5-17)24(32)30-10-8-29(9-11-30)23-21-16(3)12-20(31)22(21)27-14-28-23/h4-7,14-16,19-20,26,31H,8-13H2,1-3H3/t16-,19-,20-/m1/s1",GRZXWCHAXNAUHY-NSISKUIASA-N,C24H32ClN5O2,458.0,"(2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one","Ipatasertib|1001264-89-6|GDC-0068|RG7440|RG-7440|GDC0068|GDC 0068|524Y3IB4HQ|1-Propanone, 2-(4-chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-, (2S)-|DTXSID101025595|(2S)-2-(4-Chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta(d)pyrimidin-4-yl)piperazin-1-yl(-3-((propan-2-yl)amino)propan-1-one|1-Propanone, 2-(4-chlorophenyl)-1-(4-((5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl)-1-piperazinyl)-3-((1-methylethyl)amino)-, (2S)-|2-(4-chlorophenyl)-1-(4-(7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta(d)pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one|ipatasertibum|(2S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta(e)pyrimidin-4-yl)piperazin-1-yl)-3-(propan-2-ylamino)propan-1-one|(2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[e]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one|RefChem:791216|DTXCID301509858|(2S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-5H,6H,7H-cyclopenta(d)pyrimidin-4-yl)piperazin-1-yl)-3-((propan-2-yl)amino)propan-1-one|Ipatasertib (GDC-0068)|(S)-2-(4-chlorophenyl)-1-(4-((5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl)piperazin-1-yl)-3-(isopropylamino)propan-1-one|MFCD22124514|(2S)-2-(4-Chlorophenyl)-1-[4-[(5R,7R)-6,7-dihydro-7-hydroxy-5-methyl-5H-cyclopentapyrimidin-4-yl]-1-piperazinyl]-3-[(1-methylethyl)amino]-1-propanone|CHEMBL2177390|(2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(propan-2-ylamino)propan-1-one|(2s)-2-(4-Chlorophenyl)-1-{4-[(5r,7r)-7-Hydroxy-5-Methyl-6,7-Dihydro-5h-Cyclopenta[d]pyrimidin-4-Yl]piperazin-1-Yl}-3-(Propan-2-Ylamino)propan-1-One|GDC-0068; Ipatasertib; RG 7440;|Ipatasertib [INN]|Ipatasertib [USAN:INN]|UNII-524Y3IB4HQ|C24H32ClN5O2|RG 7440|GDC0068 di-HCl|Ipatasertib (USAN/INN)|IPATASERTIB [USAN]|GDC-0068 di-HCl|Ipatasertib; GDC-0068|RG-7440 di-HCl|IPATASERTIB [WHO-DD]|SCHEMBL191659|GTPL7887|orb1300935|SCHEMBL29356998|CHEBI:95089|GRZXWCHAXNAUHY-NSISKUIASA-N|EX-A2077|BDBM50398379|NSC767898|NSC781451|NSC800986|NSC832484|s2808|AKOS025396463|BCP9000712|CCG-269312|CS-0975|DB11743|NSC-767898|NSC-781451|NSC-800986|NSC-832484|SDCCGSBI-0654476.P001|NCGC00346714-01|AC-28420|AS-17027|HY-15186|SY272632|BCP0726000195|NS00072927|D10641|Q27078088|(2S)-2-(4-chlorophenyl)-1-[4-[(5R,7R)-7-hydroxy-5-methyl-6,7-dihydro-5H-cyclopenta[d]pyrimidin-4-yl]piperazin-1-yl]-3-(isopropylamino)propan-1-one|0RF"
FINERENONE,60150535,,"InChI=1S/C21H22N4O3/c1-5-28-21-18-17(14-7-6-13(9-22)8-15(14)27-4)16(20(23)26)12(3)25-19(18)11(2)10-24-21/h6-8,10,17,25H,5H2,1-4H3,(H2,23,26)/t17-/m1/s1",BTBHLEZXCOBLCY-QGZVFWFLSA-N,C21H22N4O3,378.4,"(4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide","Finerenone|1050477-31-0|Kerendia|BAY94-8862|BAY 94-8862|finerenona|(4S)-4-(4-cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide|DE2O63YV8R|BAY-94-8862|DTXSID10146928|(4S)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxamide|finerenonum|RefChem:57201|DTXCID5069419|814-499-5|Finerenone (BAY 94-8862)|(S)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide|1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, (4S)-|Finerenone [USAN:INN]|UNII-DE2O63YV8R|Finerenone?|Kerendia (TN)|Finerenone; 1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, (4S)-; (4S)-4-(4-Cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-1,6-naphthyridine-3-carboxamide; BAY 94-8862; Finerenone|Finerenone (Standard)|FINERENONE [INN]|FINERENONE [JAN]|FINERENONE [USAN]|FINERENONE [WHO-DD]|Finerenone (JAN/USAN/INN)|GTPL8678|orb1306378|SCHEMBL8157011|FINERENONE [ORANGE BOOK]|SCHEMBL29623206|SCHEMBL30978927|WLZ3553|GLXC-15655|1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, (4S)-;1,6-Naphthyridine-3-carboxamide, 4-(4-cyano-2-methoxyphenyl)-5-ethoxy-1,4-dihydro-2,8-dimethyl-, (4S)-|BCP24177|EX-A2845|MFCD29047135|HY-111372R|AC-30916|DA-53198|MS-26172|HY-111372|CS-0040097|D10633|F53302|Q21099046|(4S)-4-(4-cyano-2-methoxy-phenyl)-5-ethoxy-2,8-dimethyl-1,4-dihydro-1,6-naphthyridine-3-carboxamide|BAY94-8862; BAY 94-8862; BAY-94-8862; BAY948862; BAY 948862; BAY-948862"
VOLASERTIB,10461508,,"InChI=1S/C34H50N8O3/c1-6-28-33(44)39(4)29-20-35-34(38-31(29)42(28)22(2)3)37-27-14-9-24(19-30(27)45-5)32(43)36-25-10-12-26(13-11-25)41-17-15-40(16-18-41)21-23-7-8-23/h9,14,19-20,22-23,25-26,28H,6-8,10-13,15-18,21H2,1-5H3,(H,36,43)(H,35,37,38)/t25?,26?,28-/m1/s1",SXNJFOWDRLKDSF-XKHVUIRMSA-N,C34H50N8O3,618.8,N-[4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl]-4-[[(7R)-7-ethyl-5-methyl-6-oxo-8-propan-2-yl-7H-pteridin-2-yl]amino]-3-methoxybenzamide,"Volasertib|755038-65-4|BI 6727|Volasertib (BI 6727)|BI-6727|BI6727|C34H50N8O3|MFCD20926414|Volasertib [USAN]|BI6727 (Volasertib)|Volasertib(BI6727)|CHEMBL5276995|6EM57086EA|Volasertib (USAN)|N-(Trans-4-(4-(cyclopropylMethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-Methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)aMino)-3-MethoxybenzaMide|N-{trans-4-[4-(Cyclopropylmethyl)piperazin-1-Yl]cyclohexyl}-4-{[(7r)-7-Ethyl-5-Methyl-8-(1-Methylethyl)-6-Oxo-5,6,7,8-Tetrahydropteridin-2-Yl]amino}-3-Methoxybenzamide|Bi6727(volasertib)|N-((1s,4S)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)-4-(((R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl)amino)-3-methoxybenzamide|N-[4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl]-4-[[(7R)-7-ethyl-5-methyl-6-oxo-8-propan-2-yl-7H-pteridin-2-yl]amino]-3-methoxybenzamide|Volasertib [USAN:INN]|volasertibum|UNII-6EM57086EA|Benzamide, N-(trans-4-(4-(cyclopropylmethyl)-1-piperazinyl)cyclohexyl)-4-(((7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl)amino)-3-methoxy-|BENZAMIDE, N-[TRANS-4-[4-(CYCLOPROPYLMETHYL)-1-PIPERAZINYL]CYCLOHEXYL]-4-[[(7R)-7-ETHYL-5,6,7,8-TETRAHYDRO-5-METHYL-8-(1-METHYLETHYL)-6-OXO-2-PTERIDINYL]AMINO]-3-METHOXY-|BI 6727; N-[trans-4-[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxy-benzamide|IBI|N-[trans-4-[4-(Cyclopropylmethyl)piperazin-1-yl]cyclohexyl]-4-[[(R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-yl]amino]-3-methoxybenzamide|BI6727,Volasertib|VOLASERTIB [INN]|VOLASERTIB [WHO-DD]|MLS006011195|SCHEMBL738946|GTPL7947|orb1301146|SCHEMBL2169101|SCHEMBL9888052|CHEMBL1233528|CHEMBL4284151|SCHEMBL21916558|SCHEMBL29363620|SCHEMBL30753526|CHEBI:231358|BCPP000341|DTXSID801099395|DTXSID901025694|BCP02405|EX-A1364|FFB03865|BDBM50402023|BDBM50613682|NSC757149|NSC800965|s2235|AKOS005266487|AKOS030257530|BCP9000403|CCG-264952|CS-0274|DB12062|NSC-757149|NSC-800965|SDCCGSBI-0654409.P001|NCGC00263087-01|NCGC00263087-02|NCGC00263087-03|NCGC00263087-11|NCGC00263087-12|NCGC00263087-14|NCGC00263087-15|NCGC00485964-01|AC-32844|AS-16996|HY-12137|SMR004702964|SY122287|NS00073642|SW218140-2|D10182|SR-03000003275|Q7939986|SR-03000003275-1|BRD-K69776681-001-03-8|BRD-K69776681-001-06-1|755038-54-1|N-((trans)-4-(4-(cyclopropylmethyl)piperazin-1-yl)cyclohexyl)-4-((R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-5,6,7,8-tetrahydropteridin-2-ylamino)-3-methoxybenzamide|N-[4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl]-4-[[(7R)-7-ethyl-8-isopropyl-5-methyl-6-oxo-7H-pteridin-2-yl]amino]-3-methoxy-benzamide|N-[cis-4-[4-(Cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7R)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxybenzamide|n-[trans-4-[4-(cyclopropylmethyl)-1-piperazinyl]cyclohexyl]-4-[[(7r)-7-ethyl-5,6,7,8-tetrahydro-5-methyl-8-(1-methylethyl)-6-oxo-2-pteridinyl]amino]-3-methoxybenzamide|N-{(1r,4R)-4-[4-(cyclopropylmethyl)piperazin-1-yl]cyclohexyl}-4-{[(7R)-7-ethyl-5-methyl-6-oxo-8-(propan-2-yl)-5,6,7,8-tetrahydropteridin-2-yl]amino}-3-methoxybenzamide"
CITALOPRAM HYDROBROMIDE,77995,,"InChI=1S/C20H21FN2O.BrH/c1-23(2)11-3-10-20(17-5-7-18(21)8-6-17)19-9-4-15(13-22)12-16(19)14-24-20;/h4-9,12H,3,10-11,14H2,1-2H3;1H",WIHMBLDNRMIGDW-UHFFFAOYSA-N,C20H22BrFN2O,405.3,1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide,"citalopram hydrobromide|59729-32-7|Citalopram HBr|Seropram|Elopram|Lu 10-171-B|Citalopram (as hydrobromide)|NSC-758684|I1E9D14F36|LU-10-171-B|DTXSID40872344|1-(3-(dimethylamino)propyl)-1-(p-fluorophenyl)-5-phthalancarbonitrile monohydrobromide|5-Isobenzofurancarbonitrile, 1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-, monohydrobromide|Perrigo citalopram|Paxoran|RefChem:54834|1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile monohydrobromide|3-(5-cyano-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-1-yl)-N,N-dimethylpropan-1-aminium bromide|CHEBI:3724|DTXCID60819993|261-890-6|Celexa|1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide|C20H22BrFN2O|MFCD02101306|Citalopram (hydrobromide)|(S)-1-(3-(dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile hydrobromide|CITALOPRAM, HYDROBROMIDE SALT|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-2-benzofuran-5-carbonitrile;hydrobromide|Citalopram.HBr|1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-5-isobenzofurancarbonitrile hydrobromide|59729-32-7 (HBr)|Nitalapram HBr|Bonitrile HBr|Prepram HBr|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydro-2-benzofuran-5-carbonitrile hydrobromide|SMR000326936|Citalopram hydrobromide [USAN]|Lu-10-171|SR-01000003129|1-(3-(Dimethylamino)propyl)-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile monohydrobromide|EINECS 261-890-6|Apertia|Prisdal|Lupram|Sepram|UNII-I1E9D14F36|Lu 10-171 HBr|1-[3-(Dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dihydroisobenzofuran-5-carbonitrile Hydrobromide|Citalopram hydrobromide [USAN:USP]|Celexa (TN)|CPD000326936|SCHEMBL1118|SCHEMBL41352|MLS000758293|MLS000860078|MLS001401376|MLS002222294|Citalopram hydrobromide (USP)|orb1308515|CHEMBL1200781|HY-B1287R|MSK10296A|HMS5083H04|Pharmakon1600-01504172|Citalopram HBr - Bio-X trade mark|HY-B1287|Lu-10-171B|CITALOPRAM HYDROBROMIDE [MI]|Tox21_500258|Citalopram (hydrobromide) (Standard)|HB2142|NSC758684|s4749|ZD 211|ZD-211|CITALOPRAM HYDROBROMIDE [HSDB]|AKOS005145738|AB10921|AC-1595|BCP9000537|CCG-101022|CCG-213271|CITALOPRAM HYDROBROMIDE [MART.]|CITALOPRAM HYDROBROMIDE [VANDF]|CS-4735|FC64980|KS-1043|LP00258|NC00272|NSC 758684|CITALOPRAM HYDROBROMIDE [USP-RS]|CITALOPRAM HYDROBROMIDE [WHO-DD]|NCGC00093717-01|NCGC00093717-02|NCGC00093717-03|NCGC00260943-01|BC164316|Citalopram hydrobromide, >=98% (HPLC)|SY076381|C2370|CITALOPRAM HYDROBROMIDE [ORANGE BOOK]|EU-0100258|NS00088112|CITALOPRAM HYDROBROMIDE [EP MONOGRAPH]|CITALOPRAM HYDROBROMIDE [USP IMPURITY]|C 7861|C75790|CITALOPRAM HYDROBROMIDE [USP MONOGRAPH]|D00822|EN300-122615|SBI-0050246.0001|729C327|F047248|Citalopram.HBr, 1mg/ml in Methanol (as free base)|SR-01000003129-2|SR-01000003129-4|Citalopram hydrobromide 100 microg/mL in Acetonitrile|Citalopram Hydrobromide Salt (1.0 mg/mL in Methanol)|Q27280253|SR-01000003129-10|Z1550648760|Citalopram Hydrobromide 0.1 mg/ml in Methanol (as free base)|Citalopram Hydrobromide 1.0 mg/ml in Methanol (as free base)|Citalopram hydrobromide, European Pharmacopoeia (EP) Reference Standard|Citalopram hydrobromide, United States Pharmacopeia (USP) Reference Standard|1-(3-(DIMETHYLAMINO)PROPYL)-1-(P-FLUOROPHENYL)-5-PHTHALANCARBONITRILE MONOHBR|1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-3H-isobenzofuran-5-carbonitrile;hydrobromide|Citalopram for system suitability, European Pharmacopoeia (EP) Reference Standard|Citalopram Hydrobromide, Pharmaceutical Secondary Standard; Certified Reference Material|1-(3-Dimethylamino-propyl)-1-(4-fluoro-phenyl)-1,3-dihydro-isobenzofuran-5-carbonitrile hydrobromide|1-(3-DIMETHYLAMINOPROPYL)-1-(4'-FLUOROPHENYL)-1, 3-DIHYDROISOBENZOFURAN-5-CARBONITRILE HBR|1-(3-DIMETHYLAMINOPROPYL)-1-(4'-FLUOROPHENYL)-1, 3-DIHYDROISOBENZOFURAN-5-CARBONITRILE HYDROBROMIDE|5-ISOBENZOFURANCARBONITRILE, 1-(3-(DIMETHYLAMINO)PROPYL)-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-, MONOHBR|5-ISOBENZOFURANCARBONITRILE, 1-[3-(DIMETHYLAMINO)PROPYL]-1-(4-FLUOROPHENYL)-1,3-DIHYDRO-, HYDROBROMIDE (1:1)|Citalopram hydrobromide salt;Nitalapram;LU-10-171, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dizohydro-5-isobenzofurancar b onitrile hydrogen bromide salt|Citalopram, hydrobromide salt;Nitalapram, LU-10-171, 1-[3-(dimethylamino)propyl]-1-(4-fluorophenyl)-1,3-dizohydro-5-isobenzofurancar  bonitrile hydrobromide salt"
PF-05089771,46840946,,"InChI=1S/C18H12Cl2FN5O3S2/c19-9-1-2-14(10(3-9)11-6-24-25-18(11)22)29-15-5-13(21)16(4-12(15)20)31(27,28)26-17-7-30-8-23-17/h1-8,26H,(H3,22,24,25)",ZYSCOUXLBXGGIM-UHFFFAOYSA-N,C18H12Cl2FN5O3S2,500.4,"4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide","1235403-62-9|PF-05089771|4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide|25U4N985O2|DTXSID301336085|Benzenesulfonamide, 4-[2-(3-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-4-thiazolyl-|Benzenesulfonamide, 4-(2-(3-amino-1H-pyrazol-4-yl)-4-chlorophenoxy)-5-chloro-2-fluoro-N-4-thiazolyl-|4-(2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy)-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzenesulfonamide|RefChem:172240|DTXCID301766189|4-(2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy)-5-chloro-2-fluoro-N-(1,3-thiazol-4-yl)benzene-1-sulfonamide|PF 05089771|4-(2-(3-amino-1H-pyrazol-4-yl)-4-chlorophenoxy)-5-chloro-2-fluoro-N-(thiazol-4-yl)benzenesulfonamide|C18H12Cl2FN5O3S2|4-(2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy)-5-chloro-2-fluoro-N-(thiazol-4-yl)benzenesulfonamide|ZYSCOUXLBXGGIM-UHFFFAOYSA-N|orb1299763|SCHEMBL1095065|CHEMBL2325014|SCHEMBL25819004|SCHEMBL29376793|SCHEMBL31060533|UNII-25U4N985O2|GTPL10723|BCP07066|EX-A3401|KZB40362|MFCD28900736|AKOS027324308|CS-4194|DB14856|AC-33663|BS-14697|DA-66601|HY-12883|DB-412092|PF5089771|PF05089771|C92497|F85168|PF 05089771?|1430806-03-3|4-[2-(3-Amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-4-thiazolylbenzenesulfonamide|4-[2-(5-amino-1H-pyrazol-4-yl)-4-chloro-phenoxy]-5-chloro-2-fluoro-N-thiazol-4-yl-benzenesulfonamide|4-[2-(5-amino-1H-pyrazol-4-yl)-4-chlorophenoxy]-5-chloro-2-fluoro-N-1,3-thiazol-4-ylbenzenesulfonamide|T70"
DUVELISIB,50905713,,"InChI=1S/C22H17ClN6O/c1-13(28-21-19-20(25-11-24-19)26-12-27-21)17-10-14-6-5-9-16(23)18(14)22(30)29(17)15-7-3-2-4-8-15/h2-13H,1H3,(H2,24,25,26,27,28)/t13-/m0/s1",SJVQHLPISAIATJ-ZDUSSCGKSA-N,C22H17ClN6O,416.9,8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1-one,"Duvelisib|1201438-56-3|IPI-145|INK-1197|(S)-3-(1-((9H-Purin-6-yl)amino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one|IPI 145|(S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one|610V23S0JI|INK-1147|1(2H)-Isoquinolinone, 8-chloro-2-phenyl-3-[(1S)-1-(9H-purin-6-ylamino)ethyl]-|DTXSID80152697|1(2H)-Isoquinolinone, 8-chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-|8-Chloro-2-phenyl-3-((1S)-1-(7H-purin-6-ylamino)ethyl)isoquinolin-1(2H)-one|duvelisibum|8-chloro-2-phenyl-3-((1S)-1-((9H-purin-6-yl)amino)ethyl)-1,2-dihydroisoquinolin-1-one|8-chloro-2-phenyl-3-[(1S)-1-[(9H-purin-6-yl)amino]ethyl]-1,2-dihydroisoquinolin-1-one|RefChem:57412|DTXCID2075188|813-697-9|IPI145|Duvelisib (IPI-145, INK1197)|UNII-610V23S0JI|8-chloro-2-phenyl-3-[(1S)-1-(7H-purin-6-ylamino)ethyl]isoquinolin-1-one|MFCD15144635|C22H17ClN6O|Duvelisib [USAN]|Duvelisib [USAN:INN]|IPI-145 (INK1197)|IPI-145;INK1197|DUVELISIB [INN]|DUVELISIB [MI]|Duvelisib (USAN/INN)|Duvelisib (IPI-145)|DUVELISIB [WHO-DD]|SCHEMBL153543|GTPL7795|orb1306832|DUVELISIB [ORANGE BOOK]|CHEMBL3039502|SCHEMBL18343557|SCHEMBL19670020|SCHEMBL20580104|SCHEMBL29350979|SCHEMBL29360900|SCHEMBL29535385|SCHEMBL29538168|SCHEMBL29756115|CHEBI:131169|SJVQHLPISAIATJ-ZDUSSCGKSA-N|BCP07042|EX-A1562|BDBM50193013|NSC772469|s7028|AKOS022186370|AKOS037515795|IPI-145, INK 1197, Duvelisib|CCG-268854|CS-0888|DB11952|FP43074|NSC-772469|8-chloro-2-phenyl-3-((1S)-1-(9H-purin-6-ylamino)ethyl)-1(2H)-isoquinolinone|Duvelisib (IPI-145, INK1197)?|NCGC00351482-01|NCGC00351482-12|AC-30239|AS-16309|BP-43640|compound 4904 [Patent US8193182]|HY-17044|NS00073044|SW219822-1|D10555|EN300-18167128|BRD-K93468883-001-02-0|Q27077129|IPI-145 pound>>INK1197; IPI 145; IPI145; INK-1197; INK 1197|8-Chloro-2-phenyl-3-[(1S)-1-[(9H-purin-6-yl)amino]ethyl]isoquinolin-1-one|INK1197;(S)-3-(1-(9H-Purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one;Duvelisib"
EGANELISIB,91933883,,"InChI=1S/C30H24N8O2/c1-19(34-29(39)26-27(31)35-37-15-7-14-32-28(26)37)24-16-22-9-6-8-21(13-12-20-17-33-36(2)18-20)25(22)30(40)38(24)23-10-4-3-5-11-23/h3-11,14-19H,1-2H3,(H2,31,35)(H,34,39)/t19-/m0/s1",XUMALORDVCFWKV-IBGZPJMESA-N,C30H24N8O2,528.6,"2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide","IPI-549|1693758-51-8|Eganelisib|pi3k-gamma Inhibitor IPI-549|FOF5155FMZ|(S)-2-amino-N-(1-(8-((1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl)ethyl)pyrazolo[1,5-a]pyrimidine-3-carboxamide|DTXSID301336580|2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide|Pyrazolo(1,5-a)pyrimidine-3-carboxamide, 2-amino-N-((1S)-1-(1,2-dihydro-8-(2-(1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-3-isoquinolinyl)ethyl)-|Pyrazolo[1,5-a]pyrimidine-3-carboxamide, 2-amino-N-[(1S)-1-[1,2-dihydro-8-[2-(1-methyl-1H-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl-3-isoquinolinyl]ethyl]-|IPI 549|(S)-2-AMINO-N-(1-(8-((1-METHYL-1H-PYRAZOL-4-YL)ETHYNYL)-1-OXO-2-PHENYL-1,2-DIHYDROISOQUINOLIN-3-YL)ETHYL)PYRAZOLO(1,5-A)PYRIMIDINE-3-CARBOXAMIDE|2-amino-N-((1S)-1-(8-(2-(1-methylpyrazol-4-yl)ethynyl)-1-oxo-2-phenylisoquinolin-3-yl)ethyl)pyrazolo(1,5-a)pyrimidine-3-carboxamide|2-amino-N-[(1S)-1-{8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenylisoquinolin-3-yl}ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide|RefChem:136348|DTXCID301766789|864-707-3|IPI549|Eganelisib [USAN]|MFCD30533720|CHEMBL3984425|Eganelisib (USAN)|IPI 549-d5|(S)-2-Amino-N-(1-(8-((1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-1,2- dihydroisoquinolin-3-yl)ethyl)pyrazolo(1,5-a)pyrimidine-3-carboxamide|2-amino-N-[(1S)-1-{8-[(1-methyl-1H-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl-1,2-dihydroisoquinolin-3-yl}ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide|EGANELISIB [INN]|Eganelisib (IPI-549)|UNII-FOF5155FMZ|EGANELISIB [WHO-DD]|GTPL9563|orb1301794|SCHEMBL16629991|SCHEMBL29493096|C30H24N8O2|GLXC-10717|IPI-549(IPI549)|EX-A1057|TSC75851|V7Y|BDBM50192880|NSC795067|NSC801002|s8330|WHO 11571|AKOS030627132|CCG-269905|CS-6106|NSC-795067|NSC-801002|compound 26 [PMID: 27660692]|AC-29898|AS-55938|SY058080|HY-100716|D11896|(S)-2-Amino-N-[1-[8-[(1-methyl-4-pyrazolyl)ethynyl]-1-oxo-2-phenyl-1,2-dihydro-3-isoquinolinyl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide|2-Amino-N-((1S)-1-(8-((1-methyl-1H-pyrazol-4-yl)ethynyl)-1-oxo-2-phenyl-1,2-dihydro-3-isoquinolinyl)ethyl)pyrazolo(1,5-a)pyrimidine-3-carboxamide|2-amino-N-[(1S)-1-[8-[2-(1-methylpyrazol-4-yl)ethynyl]-1-oxo-2-phenyl-3-isoquinolyl]ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide|2-amino-N-[(1S)-1-{8-[2-(1-methyl-1H-pyrazol-4-yl)ethynyl]-1-oxo-2-phenyl- 1,2-dihydroisoquinolin-3-yl}ethyl]pyrazolo[1,5-a]pyrimidine-3-carboxamide"
DEZAPELISIB,58111426,,"InChI=1S/C20H16FN7OS/c1-10-7-30-20-27-15(11(2)26-18-16-17(23-8-22-16)24-9-25-18)14(19(29)28(10)20)12-4-3-5-13(21)6-12/h3-9,11H,1-2H3,(H2,22,23,24,25,26)/t11-/m0/s1",RSIWALKZYXPAGW-NSHDSACASA-N,C20H16FN7OS,421.5,"6-(3-fluorophenyl)-3-methyl-7-[(1S)-1-(7H-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one","Dezapelisib|Dezapelisib [USAN]|INCB040093|2K59L7G59M|UNII-2K59L7G59M|DEZAPELISIB [INN]|DEZAPELISIB [WHO-DD]|INCB40093|INCB 40093|INCB-040093|Dezapelisib (USAN)|5H-Thiazolo(3,2-a)pyrimidin-5-one, 6-(3-fluorophenyl)-3-methyl-7-((1S)-1-(9H-purin-6-ylamino)ethyl)-|example 15 [WO2011008487]|compound 67 [PMID: 22924688]|6-(3-fluorophenyl)-3-methyl-7-[(1S)-1-(7H-purin-6-ylamino)ethyl]-[1,3]thiazolo[3,2-a]pyrimidin-5-one|example 15 (WO2011008487)|compound 67 (PMID: 22924688)|6-(3-fluorophenyl)-3-methyl-7-[(1S)-1-(7H-purin-6-ylamino)ethyl]-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one|dezapelisibum|6-(3-fluorophenyl)-3-methyl-7-((1S)-1-(7H-purin-6-ylamino)ethyl)-(1,3)thiazolo(3,2-a)pyrimidin-5-one|6-(3-fluorophenyl)-3-methyl-7-((1S)-1-(7H-purin-6-ylamino)ethyl)-5H-(1,3)thiazolo(3,2-a)pyrimidin-5-one|RefChem:132429|1262440-25-4|CHEMBL2216863|(S)-7-(1-(9H-purin-6-ylamino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one|6-(3-fluorophenyl)-3-methyl-7-((1S)-1-(9H-purin-6-ylamino)ethyl)-5H-(1,3)thiazolo(3,2-a)pyrimidin-5-one|Dezapelisib (USAN/INN)|SCHEMBL975754|GTPL9728|orb1700739|SCHEMBL29369302|SCHEMBL29487633|RSIWALKZYXPAGW-NSHDSACASA-N|BDBM50004547|AKOS040748242|HY-109029|CS-0030543|D10924|Q27254856|(S)-7-(1-((7H-Purin-6-yl)amino)ethyl)-6-(3-fluorophenyl)-3-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one"
UMBRALISIB,72950888,,"InChI=1S/C31H24F3N5O3/c1-15(2)41-24-9-7-18(12-22(24)34)27-26-30(35)36-14-37-31(26)39(38-27)16(3)29-25(17-5-4-6-19(32)11-17)28(40)21-13-20(33)8-10-23(21)42-29/h4-16H,1-3H3,(H2,35,36,37)/t16-/m0/s1",IUVCFHHAEHNCFT-INIZCTEOSA-N,C31H24F3N5O3,571.5,"2-[(1S)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one","Umbralisib|1532533-67-7|rp-5264|TGR-1202 free base|TGR1202|TGR 1202|RP5264|38073MQB2A|DTXSID601337137|2-[(1S)-1-[4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one|2-((1S)-1-(4-Amino-3-(3-fluoro-4-(1-methylethoxy)phenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-1-benzopyran-4-one|umbralisibum|2-((1S)-1-(4-amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)chromen-4-one|RefChem:58319|DTXCID501767488|2-((1S)-1-(4-amino-3-(3-fluoro-4-(propan-2-yloxy)phenyl)-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one|TGR-1202|(S)-2-(1-(4-amino-3-(3-fluoro-4-isopropoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-6-fluoro-3-(3-fluorophenyl)-4H-chromen-4-one|Umbralisib [USAN]|TGR-1202 base|MFCD28386165|UNII-38073MQB2A|TGR 1202 [WHO-DD]|RP 5264|C31H24F3N5O3|2-[(1S)-1-[4-Amino-3-[3-fluoro-4-(1-methylethoxy)phenyl]-1H-pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)-4H-1-benzopyran-4-one; 2-[(1S)-1-[4-Amino-3-(3-fluoro-4-propan-2-yloxyphenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one|UMBRALISIB [INN]|Umbralisib (USAN/INN)|umbralisib (TGR-1202)|UMBRALISIB [WHO-DD]|GTPL8916|orb1302401|CHEMBL3948730|SCHEMBL15557416|SCHEMBL29354189|SCHEMBL29358460|SCHEMBL29454795|IUVCFHHAEHNCFT-INIZCTEOSA-N|BDBM184556|GLXC-10704|BCP24686|EX-A1645|NSC793696|NSC800405|s8194|AKOS025396183|example A1 [US2014011819]|CCG-270101|CS-5243|DB14989|NSC-793696|NSC-800405|AC-33183|AS-52257|FT171036|HY-12279|US9150579, B1|D11322|P14656|BRD-K52579889-001-01-9|Q27088612|2-[(1S)-1-[4-amino-3-(3-fluoro-4-isopropoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]ethyl]-6-fluoro-3-(3-fluorophenyl)chromen-4-one|4H-1-BENZOPYRAN-4-ONE, 2-((1S)-1-(4-AMINO-3-(3-FLUORO-4-(1-METHYLETHOXY)PHENYL)-1H-PYRAZOLO(3,4-D)PYRIMIDIN-1-YL)ETHYL)-6-FLUORO-3-(3-FLUOROPHENYL)-"
MK-8033,45142457,,"InChI=1S/C25H21N5O3S/c1-30-15-20(13-28-30)19-11-23-24(27-12-19)8-7-18-6-5-17(10-22(18)25(23)31)16-34(32,33)29-14-21-4-2-3-9-26-21/h2-13,15,29H,14,16H2,1H3",VMJFTOSOFDEKTM-UHFFFAOYSA-N,C25H21N5O3S,471.5,"1-[5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-14-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide","MK-8033|1001917-37-8|MK8033|350H6PBQ5Q|DTXSID00143002|1-(3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo(4,5)cyclohepta(1,2-b)pyridin-7-yl)-N-(pyridin-2-ylmethyl)methanesulfonamide|5H-Benzo(4,5)cyclohepta(1,2-b)pyridine-7-methanesulfonamide, 3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-|1-(3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl)-N-(pyridin-2-ylmethyl)methanesulfonamide|1-[3-(1-methyl-1H-pyrazol-4-yl)-5-oxo-5H-benzo[4,5]cyclohepta[1,2-b]pyridin-7-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide|RefChem:159215|DTXCID9065493|3-(1-Methyl-1H-pyrazol-4-yl)-5-oxo-N-(2-pyridinylmethyl)-5H-benzo[4,5]cyclohepta[1,2-b]pyridine-7-methanesulfonamide|CHEMBL2323775|1196681-38-5|1-[5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-14-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide|UNII-350H6PBQ5Q|C25H21N5O3S|MFCD18633221|CS-0560|1-[2-(1-methylpyrazol-4-yl)-11-oxobenzo[1,2]cyclohepta[2,4-b]pyridin-9-yl]-N-(pyridin-2-ylmethyl)methanesulfonamide|SCHEMBL400306|orb1296122|SCHEMBL29395425|VMJFTOSOFDEKTM-UHFFFAOYSA-N|BCP21388|EX-A2612|BDBM50427138|NSC761692|NSC800797|AKOS022185323|MK 8033|NSC-761692|NSC-800797|SB16934|NCGC00378567-01|NCGC00378567-02|AC-36178|DA-65511|HY-13299|F84513|BRD-K55512740-001-01-6|Q27256405|1-[5-(1-methylpyrazol-4-yl)-2-oxo-7-azatricyclo[9.4.0.03,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-14-yl]-N-(2-pyridylmethyl)methanesulfonamide"
BENZOIC ACID,243,,"InChI=1S/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9)",WPYMKLBDIGXBTP-UHFFFAOYSA-N,C7H6O2,122.12,benzoic acid,"benzoic acid|65-85-0|Dracylic acid|benzenecarboxylic acid|Benzeneformic acid|Carboxybenzene|phenylformic acid|Benzenemethanoic acid|Phenylcarboxylic acid|Retardex|Benzoesaeure GK|Benzoesaeure GV|Retarder BA|Tenn-Plas|Acide benzoique|Salvo liquid|Solvo powder|Benzoesaeure|Benzoic acid, tech.|Unisept BZA|HA 1 (acid)|Kyselina benzoova|FEMA No. 2131|Benzenemethonic acid|Vevovitall|Acido benzoico|Menno-florades|Benzoicum acidum|E 210|AI3-0310|CHEBI:30746|Acidum benzoicum|NSC-149|E210|8SKN0B0MIM|Benzoic acid (e 210)|Sodium benzoic acid|Tennplas|INS NO.210|DTXSID6020143|INS-210|Phenyl carboxylic acid|DTXCID80143|E-210|Provita|Provita Combat|Whitfield's|Eyelids Wipes|Provita Equiband|Acid, Benzoic|Rheumatism Diarrhea|Benzoate, Potassium|RefChem:6620|200-618-2|hydron;benzoate|Benzoic acid (natural)|Benzoate (VAN)|HA 1|Benzoesaeure [German]|Caswell No. 081|Diacylic acid|Oracylic acid|Acide benzoique [French]|Acido benzoico [Italian]|Kyselina benzoova [Czech]|NSC 149|MFCD00002398|CCRIS 1893|Diacylate|HSDB 704|Salvo, liquid|Solvo, powder|AI3-03710|EPA Pesticide Chemical Code 009101|Aromatic carboxylic acid|BENZOIC-4-D1 ACID|Benzoicacid|Benzoic acid 100 microg/mL in Acetone|Benzoic Acid 2000 microg/mL in Dichloromethane|Benzoic acid [USAN:JAN]|CAS-65-85-0|NSC7918|Benzoic acid (TN)|EINECS 200-618-2|UNII-8SKN0B0MIM|Benzoic acid [USP:JAN]|phenylcarboxy|Dracylate|benzoic aicd|benzoic-acid|benzoic_acid|bezoic acid|Aromatic acid|benzenecarboxylic|Salvo powder|benzoic- acid|Retarder BAX|1gyx|1kqb|Glycopyrronium Bromide EP Impurity D|760 - Preservatives|ANTAZOLINE_met016|Benzoic acid (Standard)|WLN: QVR|benzene-2-carboxylic acid|EUCATROPINE_met034|CYCLANDELATE_met022|BENZOIC ACID [II]|BENZOIC ACID [MI]|Benzoic acid, ACS reagent|bmse000300|CHEMBL541|Epitope ID:139965|EC 200-618-2|BENZOIC ACID [FCC]|BENZOIC ACID [JAN]|SCHEMBL1378|SCHEMBL1809|BENZOIC ACID [FHFI]|BENZOIC ACID [HSDB]|SAMPL4, O1|TRIPELENNAMINE_met034|SCHEMBL20583|SCHEMBL22028|Benzoic acid (JP18/USP)|BENZOIC ACID [VANDF]|MLS002415717|27 - Preservatives in Cream|BENZOIC ACID [MART.]|BIDD:ER0597|SCHEMBL129247|BENZOIC ACID [USP-RS]|BENZOIC ACID [WHO-DD]|BENZOIC ACID [WHO-IP]|Benzoic acid, AR, >=99%|Benzoic acid, LR, >=99%|NSC149|orb1310251|SCHEMBL1518068|SCHEMBL1533094|SCHEMBL1939722|SCHEMBL3859000|SCHEMBL4626763|31 - Preservatives in Mascara|BENZOICUM ACIDUM [HPUS]|SCHEMBL11324395|HY-N0216R|Benzoic acid (7CI,8CI,9CI)|Benzoic acid, analytical standard|Benzoic acid, p.a., 99.5%|MSK2501|BENZOIC ACID [GREEN BOOK]|BDBM197302|HMS2092F18|HMS2267D03|HMS3652B03|HMS5082G22|Pharmakon1600-01503001|BENZOIC ACID [EP MONOGRAPH]|HY-N0216|MBA96084|SAA21784|Tox21_202403|Tox21_300180|BENZOIC ACID [USP MONOGRAPH]|NSC758203|s4161|SBB040515|STK301730|Benzoic acid, ReagentPlus(R), 99%|AKOS000119619|BS-3752|CCG-213088|DB03793|FB33492|NSC-758203|ACIDUM BENZOICUM [WHO-IP LATIN]|Benzoic acid, >=99.5%, FCC, FG|Benzoic acid, ACS reagent, >=99.5%|NCGC00091886-01|NCGC00091886-02|NCGC00091886-03|NCGC00091886-05|NCGC00254112-01|NCGC00259952-01|TIAPROFENIC ACID IMPURITY D [EP]|Benzoic acid, USP, 99.5-100.5%|BP-30148|MSK2501-1000|SMR001252220|SY009192|Benzoic acid, tested according to Ph.Eur.|SBI-0206720.P001|Benzoic acid, SAJ first grade, >=99.5%|DB-029471|B0062|B2635|Benzoic Acid(Discontinued,See C4X-18172)|CS-0008257|NS00008785|ST45061539|SW219833-1|Benzoic acid, natural, >=99.5%, FCC, FG|Benzoic acid, SAJ special grade, >=99.5%|Benzoic acid, Vetec(TM) reagent grade, 98%|EN300-18007|2-BENZOYL-5-METHOXYBENZOQUINONE_met032|Benzoic acid, meets USP testing specifications|Benzoic acid, purified by sublimation, >=99%|C00180|C00539|D00038|D85168|MEFENAMIC ACID IMPURITY D [EP IMPURITY]|AB00949635_05|AB00949635_06|A835250|Benzoic acid Solution in Acetonitrile, 1000?g/mL|Benzoic Acid Zone Refined (number of passes:20)|F237766|Q191700|SR-05000001919|Benzoic acid, puriss. p.a., ACS reagent, 99.9%|SR-05000001919-1|0BE368DC-6DE6-4927-AECF-E4BB2968A4A0|BRD-K53397409-001-11-5|BRD-K53397409-001-12-3|BRD-K53397409-001-13-1|GLYCOPYRRONIUM BROMIDE IMPURITY D [EP IMPURITY]|Melting point standard 121-123C, analytical standard|METRONIDAZOLE BENZOATE IMPURITY C [EP IMPURITY]|Z57127480|F2191-0092|HYDROUS BENZOYL PEROXIDE IMPURITY B [EP IMPURITY]|Benzoic acid, NIST(R) SRM(R) 39j, calorimetric standard|Benzoic acid, Standard for quantitative NMR, TraceCERT(R)|METHYLAMINOLEVULINATE HYDROCHLORIDE IMPURITY I [EP]|Benzoic acid, European Pharmacopoeia (EP) Reference Standard|Mettler-Toledo Calibration substance ME 18555, Benzoic acid|Benzoic acid, for calorimetrical determination (approx. 26460 J/g)|Benzoic acid, United States Pharmacopeia (USP) Reference Standard|InChI=1/C7H6O2/c8-7(9)6-4-2-1-3-5-6/h1-5H,(H,8,9|SS Benzoic Acid, 2000 mug/mL in dichloromethane, analytical standard|Benzoic acid, Pharmaceutical Secondary Standard; Certified Reference Material|Benzoic acid, puriss. p.a., ACS reagent, reag. Ph. Eur., >=99.9% (alkalimetric)|14322-82-8|B A|Benzoic acid, certified reference material for titrimetry, certified by BAM according to ISO 17025, >=99.5%|Benzoic acid, meets analytical specification of Ph. Eur., BP, USP, FCC, E210, 99.5-100.5% (alkalimetric)|Mettler-Toledo Calibration substance ME 18555, Benzoic acid, analytical standard, for the calibration of the thermosystem 900, traceable to primary standards (LGC)|ScavengePore(TM) benzoic acid, macroporous, 40-70 mesh, extent of labeling: 0.5-1.5 mmol per g loading"
TRANEXAMIC ACID,5526,,"InChI=1S/C8H15NO2/c9-5-6-1-3-7(4-2-6)8(10)11/h6-7H,1-5,9H2,(H,10,11)",GYDJEQRTZSCIOI-UHFFFAOYSA-N,C8H15NO2,157.21,4-(aminomethyl)cyclohexane-1-carboxylic acid,"tranexamic acid|1197-18-8|1197-17-7|701-54-2|4-(Aminomethyl)cyclohexanecarboxylic acid|trans-4-(Aminomethyl)cyclohexanecarboxylic acid|Cyklokapron|Amstat|Trans AMCHA|Tranhexamic acid|Tranexamsaeure|Cyclocapron|Transamin|trans-Amcha|Rikavarin|Tamcha|Amikapron|cis-4-(Aminomethyl)cyclohexanecarboxylic acid|cis-Tranexamic Acid|Frenolyse|Trasamlon|Anvitoff|Carxamin|Emorhalt|Tranexan|Mastop|Ugurol|AMCA|AMCHA|Rikavarin-S|trans-Tranexamic acid|tranexmic acid|4-(aminomethyl)cyclohexane-1-carboxylic acid|Hexapromin|Transamlon|Cyclohexanecarboxylic acid, 4-(aminomethyl)-, trans-|Hexatron|Spiramin|Exacyl|Tranex|cis-AMCHA|trans-4-Aminomethylcyclohexane-1-carboxylic acid|Acido tranexamico|Acide tranexamique|Acidum tranexamicum|Cyclohexanecarboxylic acid, 4-(aminomethyl)-, cis-|Lysteda|CL 65336|Femstrual|Cyclohexanecarboxylic acid, 4-(aminomethyl)-|cis-4-Aminomethylcyclohexane-1-carboxylic acid|BAY 3517|4-(Aminomethyl)-Cyclohexanecarboxylic Acid|Cyclo-F|RP 18,429|MFCD00001466|Tranexamic Acid(Random Configuration)|Cyclokapron|Espercil|Haematrix|(1r,4r)-4-(aminomethyl)cyclohexane-1-carboxylic acid|trans-p-(Aminomethyl)cyclohexanecarboxylic acid|CL-65336|DV 79|trans-4-(Aminomethyl)cyclohexane-1-carboxylic acid|MFCD19706018|cis-4-(aminomethyl)cyclohexane-1-carboxylic acid|HAKU|Tranexamic Acid EP Impurity B|DV79|trans-4-(Aminomethyl)-1-cyclohexanecarboxylic acid|LB1148|NSC-291305|trans-1-(Aminomethyl)cyclohexane-4-carboxylic acid|Tranexamic acid (Transamin)|DTXSID3045350|CHEBI:48669|DTXSID50904827|37YD696II6|6T84R30KC1|MFCD00064951|NSC291305|trans-4-(Aminomethyl)cyclohexanecarboxylic acid ester|4-aminomethylcyclohexanecarboxylic acid|CL65336|NCGC00016569-01|Retavase|RP-18429|CAS-1197-18-8|cis-4-(Aminomethyl)-1-cyclohexanecarboxylic Acid|AMH|Tranexamic acid cis-form|Acide tranexamique [INN-French]|Acido tranexamico [INN-Spanish]|Acidum tranexamicum [INN-Latin]|DV-79|Cyklokapron (TN)|Rikavarin (TN)|Transamin (TN)|SR-05000001794|EINECS 214-818-2|trans-1-Aminomethylcyclohexane-4-carboxylic acid|NSC 291305|BRN 2207452|tranexamate|tranexamic-acid|UNII-37YD696II6|UNII-6T84R30KC1|1ceb|Prestwick_476|ALBB-006013|Spectrum_001391|Tranexamic acid [USAN:USP:INN:BAN:JAN]|Prestwick0_000171|Prestwick1_000171|Prestwick2_000171|Prestwick3_000171|Spectrum2_000655|Spectrum3_001189|Spectrum4_000046|Spectrum5_001258|RefChem:1070026|CHEMBL877|Tranexamic acid (Standard)|trans-4-(Aminomethyl)cyclohexane-carboxylic acid|Oprea1_786414|SCHEMBL16974|BSPBio_000061|BSPBio_002837|KBioGR_000511|KBioSS_001871|TRANEXAMIC ACID [MI]|3-14-00-00868 (Beilstein Handbook Reference)|CIS-4-(AMINOMETHYL)CYCLOHEXANECARBOXYLICACID|DivK1c_000655|SCHEMBL186034|SCHEMBL349408|SPECTRUM1502026|TRANEXAMIC ACID [INN]|TRANEXAMIC ACID [JAN]|TRANEXAMIC ACID, CIS-|SPBio_000689|SPBio_001982|TRANEXAMIC ACID [USAN]|BPBio1_000069|CHEMBL292500|GTPL6573|orb1310139|SCHEMBL2375099|SCHEMBL9293316|701-54-2 (cis+trans)|TRANEXAMIC ACID [VANDF]|DTXCID1025350|TRANEXAMIC ACID [MART.]|CHEBI:94518|HMS502A17|HY-B0149R|KBio1_000655|KBio2_001871|KBio2_004439|KBio2_007007|KBio3_002337|TRANEXAMIC ACID [USP-RS]|TRANEXAMIC ACID [WHO-DD]|WLN: L6TJ AVQ D1Z -T|GYDJEQRTZSCIOI-KNVOCYPGSA-N|GYDJEQRTZSCIOI-UHFFFAOYSA-N|NINDS_000655|DTXCID401333941|GLXC-10248|HMS1568D03|HMS1921F08|HMS2092P03|HMS2095D03|HMS3712D03|HMS3744G07|Pharmakon1600-01502026|Tranexamic acidD [EP MONOGRAPH]|BCP13133|BCP18146|HY-A0102|HY-B0149|MSK10323|MSK11303|SBC83795|Tranexamic acid (JP18/USP/INN)|Tox21_110500|BBL004469|BDBM50428067|CCG-39692|NSC758176|s1875|SBB006715|STK503668|TRANEXAMIC ACID [ORANGE BOOK]|AKOS005171632|AKOS015854573|AKOS024257901|TRANEXAMIC ACID [USP IMPURITY]|TRANEXAMIC ACID CIS-FORM [MI]|AB86495|AC-4687|BS-3867|CS-1965|DB00302|FT29666|IA71533|LB-1148|NSC-758176|TRANEXAMIC ACID [USP MONOGRAPH]|4-(Aminomethyl)cyclohexanecarboxylicacid|4-Aminomethyl-cyclohexanecarboxylic acid|IDI1_000655|NCGC00016569-02|NCGC00016569-03|NCGC00016569-04|NCGC00016569-05|NCGC00016569-06|NCGC00016569-08|NCGC00016569-09|NCGC00094944-01|NCGC00094944-02|p-(Aminomethyl)cyclohexanecarboxylic acid|AS-80121|BP-12345|DA-78573|FT163756|PD061983|SY011438|SY056656|SY113593|TS-02090|SBI-0051705.P002|Tranexamic acid (cis- and trans- mixture)|trans 4aminomethylcyclohexanecarboxylic acid|DB-074265|Trans-4-aminomethylcyclohexylcarboxylic acid|trans-p-Aminomethylcyclohexanecarboxylic acid|A0236|A2121|AB00052260|CS-0013687|CS-0055045|NS00006665|ST50307111|trans 4-aminomethylcyclohexanecarboxylic acid|trans-4-aminomethylcyclohexanecarboxylic acid|EN300-91506|Tranexamic acid impurity B;cis-Tranexamic acid|trans-4(aminomethyl)cyclohexanecarboxylic acid|trans-4-(aminomethyl)cyclohexylcarboxylic acid|trans-4-aminomethyl cyclohexanecarboxylic acid|trans-4-aminomethyl-cyclohexanecarboxylic acid|trans-4-aminomethylcyclohexane carboxylic acid|D01136|EN300-121703|P15619|P20836|T71247|Trans-4-Aminomethyl cyclohexane carboxylic acid|trans4-aminomethylcyclohexane-1-carboxylic acid|AB00052260-04|AB00052260_05|AB00052260_06|TRANEXAMIC ACID IMPURITY B [EP IMPURITY]|trans-4 -(aminomethyl)cyclohexanecarboxylic acid|trans-4-(aminomethyl)-cyclohexanecarboxylic acid|trans-4-(Aminomethyl)cyclohexane carboxylic acid|trans-4-aminomethyl-1-cyclohexanecarboxylic acid|(trans)-4-(aminomethyl)cyclohexanecarboxylic acid|197T188|4-(Aminomethyl)cyclohexanecarboxylic acid (trans-)|4-trans-(Aminomethyl)cyclohexanecarboxylic acid #|F044905|F366626|F987484|Q418666|trans-?4-?(Aminomethyl)?cyclohexanecarboxylic acid|trans-4- (aminomethyl) cyclohexanecarboxylic acid|trans-4-(aminomethyl)- cyclohexane carboxylic acid|Trans-4-(aminomethyl)-cyclohexane carboxylic acid|trans-4-aminomethyl-1-cyclohexane carboxylic acid|SR-05000001794-1|SR-05000001794-2|SR-05000001794-3|Tranexamic acid 100 microg/mL in Acetonitrile:Water|(1s,4s)-4-(aminomethyl)cyclohexane-1-carboxylic acid|BRD-K15014948-001-01-2|BRD-K15014948-001-09-5|BRD-K15014948-001-10-3|BRD-K15014948-213-01-3|BRD-K79165417-001-01-7|Q27256710|trans-4-(Aminomethyl)cyclohexanecarboxylic acid, 97%|4-(Aminomethyl)cyclohexanecarboxylic acid;Tranexamic acid|F8886-7867|Z1741970429|Amchafibrin;trans-p-(Aminomethyl)cyclohexanecarboxylic acid|rel-(1R,4R)-4-(aminomethyl)cyclohexane-1-carboxylic acid|Tranexamic acid, European Pharmacopoeia (EP) Reference Standard|Tranexamic acid, United States Pharmacopeia (USP) Reference Standard|Tranexamic acid, Pharmaceutical Secondary Standard; Certified Reference Material|622-133-9"
CAPIVASERTIB,25227436,,"InChI=1S/C21H25ClN6O2/c22-15-3-1-14(2-4-15)17(6-12-29)27-20(30)21(23)7-10-28(11-8-21)19-16-5-9-24-18(16)25-13-26-19/h1-5,9,13,17,29H,6-8,10-12,23H2,(H,27,30)(H,24,25,26)/t17-/m0/s1",JDUBGYFRJFOXQC-KRWDZBQOSA-N,C21H25ClN6O2,428.9,"4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide","capivasertib|1143532-39-1|AZD5363|AZD-5363|AZD 5363|Truqap|4-Amino-N-[(1s)-1-(4-Chlorophenyl)-3-Hydroxypropyl]-1-(7h-Pyrrolo[2,3-D]pyrimidin-4-Yl)piperidine-4-Carboxamide|WFR23M21IE|DTXSID40150710|4-amino-N-(1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamide|capivasertibum|4-Amino-N-((1S)-1-(4-chlorophenyl)-3-hydroxypropyl)-1-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)piperidine-4-carboxamide|4-AMINO-N-[(1S)-1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL]-1-{7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL}PIPERIDINE-4-CARBOXAMIDE|RefChem:573743|DTXCID4073201|(S)-4-AMINO-N-(1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE|MFCD22628785|4-Piperidinecarboxamide, 4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-|4-amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxy-propyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide|UNII-WFR23M21IE|CHEMBL2325741|C21H25ClN6O2|cc-638|Capivasertib?|(S)-4-Amino-N-[1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)piperidine-4-carboxamide|4-PIPERIDINECARBOXAMIDE, 4-AMINO-N-((1S)-1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1-(7H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)-|Truqap (TN)|Capivasertib (JAN/USAN)|CAPIVASERTIB [INN]|CAPIVASERTIB [JAN]|CAPIVASERTIB [USAN]|Capivasertib (AZD5363)|4-Amino-N-[(1S)-1-(4-chlorophenyl)-3-hydroxypropyl]-1-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-4-piperidinecarboxamide|MLS006011179|CAPIVASERTIB [WHO-DD]|SCHEMBL390243|GTPL7709|orb1307109|SCHEMBL29357463|SCHEMBL29557103|AZC5363|EX-A285|CHEBI:229222|JDUBGYFRJFOXQC-KRWDZBQOSA-N|US10654855, Example 9|BDBM443385|AZD5363?|NSC764039|NSC782347|NSC799347|s8019|AKOS027323693|BCP9000365|CCG-268989|CS-1284|DB12218|FA29493|NSC-764039|NSC-782347|NSC-799347|NCGC00345795-01|NCGC00345795-03|NCGC00345795-04|NCGC00345795-08|AC-32685|BP-43630|HY-15431|SMR004702948|SY018928|BCP0726000111|DB-290280|NS00072563|SW220158-1|D11371|BRD-K99023089-001-03-7|Q27074756|0XZ|4-AMINO-N-((1S)-1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1- (1H-PYRROLO(2,3-D)PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE|ALTERNATIVE ROUTE 1: (S)-4-AMINO-N-(1-(4-CHLOROPHENYL)-3-HYDROXYPROPYL)-1-(7H-PYRROLO[2,3-D]PYRIMIDIN-4-YL)PIPERIDINE-4-CARBOXAMIDE"
UPROSERTIB,51042438,,"InChI=1S/C18H16Cl2F2N4O2/c1-26-16(12(19)8-24-26)11-6-15(28-17(11)20)18(27)25-10(7-23)4-9-2-3-13(21)14(22)5-9/h2-3,5-6,8,10H,4,7,23H2,1H3,(H,25,27)/t10-/m0/s1",AXTAPYRUEKNRBA-JTQLQIEISA-N,C18H16Cl2F2N4O2,429.2,"N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide","Uprosertib|1047634-65-0|GSK2141795|GSK2141795C|GSK-2141795|Uprosertib [USAN:INN]|ZXM835LQ5E|Akt inhibitor gsk2141795|Uprosertib [USAN]|Akt inhibitor gsk-2141795|UPROSERTIB [INN]|GSK-2141795C|UPROSERTIB [WHO-DD]|N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide|2-Furancarboxamide, N-((1S)-2-amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-|N-((1S)-1-(Aminomethyl)-2-(3,4-difluorophenyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide|N-{(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl}-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide|uprosertibum|N-((1S)-2-amino-1-((3,4-difluorophenyl)methyl)ethyl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-2-furancarboxamide|N-((2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide|N-((2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-2-methylpyrazol-3-yl)furan-2-carboxamide|N-[(1S)-1-(Aminomethyl)-2-(3,4-difluorophenyl)ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide|N-[(2S)-1-amino-3-(3,4-difluorophenyl)propan-2-yl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide|RefChem:901144|Oral Akt Inhibitor GSK2141795|GSK 2141795|1309371-43-4|629-867-9|GSK795|MFCD28144686|Uprosertib (GSK2141795)|(S)-N-(1-Amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide|N-((S)-1-Amino-3-(3,4-difluorophenyl)propan-2-yl)-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)furan-2-carboxamide|C18H16Cl2F2N4O2|UNII-ZXM835LQ5E|Uprosertib (USAN/INN)|SCHEMBL168584|Uprosertib, GSK2141795|GTPL7902|CHEMBL3137336|SCHEMBL29658441|AXTAPYRUEKNRBA-JTQLQIEISA-N|2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-;2-Furancarboxamide, N-[(1S)-2-amino-1-[(3,4-difluorophenyl)methyl]ethyl]-5-chloro-4-(4-chloro-1-methyl-1H-pyrazol-5-yl)-|BCP28204|EX-A1593|BDBM50170284|NSC778368|NSC800960|s7492|AKOS027323909|CCG-268992|DB11969|NSC-778368|NSC-800960|NCGC00390653-01|AC-30940|DA-58897|FU103960|HY-15965|NS00072545|D10674|F20800|BRD-K38332599-001-01-3|Q27089099|GSK-2141795; GSK2141795; GSK 2141795; GSK795; GSK-795; GSK 795.|N-[(1S)-1-(aminomethyl)-2-(3,4-difluorophenyl)ethyl]-5-chloro-4-(4-chloro-2-methyl-pyrazol-3-yl)furan-2-carboxamide"
LACOSAMIDE,219078,,"InChI=1S/C13H18N2O3/c1-10(16)15-12(9-18-2)13(17)14-8-11-6-4-3-5-7-11/h3-7,12H,8-9H2,1-2H3,(H,14,17)(H,15,16)/t12-/m1/s1",VPPJLAIAVCUEMN-GFCCVEGCSA-N,C13H18N2O3,250.29,(2R)-2-acetamido-N-benzyl-3-methoxypropanamide,"Lacosamide|175481-36-4|Erlosamide|Vimpat|Harkoseride|SPM 927|SPM-927|(r)-lacosamide 1|MOTPOLY|Lacosamida|ADD 234037|563KS2PQY5|SPM927|DTXSID1057666|Propanamide, 2-(acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)-|ADD243037|ADD-243037|(2R)-2-(Acetylamino)-N-benzyl-3-methoxypropanamide|DTXCID2031455|(+)-(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide|(2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide|(2R)-2-acetamido-3-methoxy-N-(phenylmethyl)propanamide|lacosamidum|Motpoly XR|N benzyl AcMeOPrNH2|N-benzyl-AcMeOPrNH2|RefChem:56347|Lacosamide Oral Solution|N03AX18|N benzyl 2 acetamido 3 methoxypropionamide|(2R)-N-benzyl-2-acetamido-3-methoxypropanamide|()-(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide|(R)-2-acetamido-N-benzyl-3-methoxypropanamide|(2R)-2-acetamido-N-benzyl-3-methoxypropanamide|ADD-234037|CHEMBL58323|ADD 243037|Erlosamide [INN]|NCGC00253740-01|(2R)-2-acetamido-N-benzyl-3-methoxy-propanamide|(R)-2-acetamido-N-benzyl-3-methoxypropionamide.|(R)-2-Acetylamino-N-benzyl-3-methoxy-propionamide|Lacosamide [USAN]|ertosamide|harkeroside|UNII-563KS2PQY5|Lacosamide [USAN:INN:BAN]|Lacosamide cv|Lacosamide?|(2R)-2-(Acetylamino)-3-methoxy-N-(phenylmethyl)propanamide;ADD 243037;Erlosamide|SPM-929|Lacosamide racemate|MFCD08272557|Vimpat (TN)|LACOSAMIDE [MI]|LACOSAMIDE [INN]|LACOSAMIDE [JAN]|LACOSAMIDE [VANDF]|LACOSAMIDE [MART.]|(R)-N-Benzyl-2-acetamido-3-methoxypropionamide|LACOSAMIDE [USP-RS]|LACOSAMIDE [WHO-DD]|SCHEMBL35330|orb341713|Lacosamide (JAN/USAN/INN)|LACOSAMIDE [EMA EPAR]|GTPL7472|Lacosamide - Bio-X trade mark|DEA No. 2746|LACOSAMIDE [ORANGE BOOK]|LACOSAMIDE [EP MONOGRAPH]|CHEBI:135939|VPPJLAIAVCUEMN-GFCCVEGCSA-N|LACOSAMIDE [USP MONOGRAPH]|BCP02197|Tox21_113857|BDBM50300204|AKOS005146274|Lacosamide 1.0 mg/ml in Acetonitrile|CS-0529|DB06218|FL24825|KS-1227|AC-22750|BL164605|HY-13015|CAS-175481-36-4|N~2~-Acetyl-N-benzyl-O-methyl-D-serinamide|(R)-N-benzyl-2-acetamido-3-methoxypropanamide|D07299|(R)-2-acetamido-N-benzyl-3-methoxypropionamide|(R)-N-benzyl 2-acetamido-3-methoxypropionamide|(R)-N-benzyl 2-acetamido-3-methoxypropionamide,|AB01559947-01|(2R)-2-acetylamino-N-benzyl-3-methoxypropanamide|(R)-2-Acetylamino-N-benzyl-3-methoxypropionamide|481L364|Q420077|SR-01000942286|SR-01000942286-1|BRD-K68232650-001-02-2|2-(Acetylamino)-3-methoxy-N-(phenylmethyl)-, (2R)-|LQO"
CARMOFUR,2577,,"InChI=1S/C11H16FN3O3/c1-2-3-4-5-6-13-10(17)15-7-8(12)9(16)14-11(15)18/h7H,2-6H2,1H3,(H,13,17)(H,14,16,18)",AOCCBINRVIKJHY-UHFFFAOYSA-N,C11H16FN3O3,257.26,"5-fluoro-N-hexyl-2,4-dioxopyrimidine-1-carboxamide","carmofur|61422-45-5|HCFU|Mifurol|1-Hexylcarbamoyl-5-fluorouracil|Carmofurum|1(2H)-Pyrimidinecarboxamide, 5-fluoro-N-hexyl-3,4-dihydro-2,4-dioxo-|DTXSID2045941|HA82M3RAB2|NSC-758963|DTXCID0025941|N-hexylcarbamoyl-5-fluorouracil|RefChem:574685|L01BC04|5-Fluoro-1-(hexylaminocarbonyl)uracil|5-fluoro-N-hexyl-2,4-dioxo-1,2,3,4-tetrahydropyrimidine-1-carboxamide|689-431-9|C11H16FN3O3|MFCD00866284|5-fluoro-N-hexyl-2,4-dioxo-3,4-dihydropyrimidine-1(2H)-carboxamide|5-fluoro-N-hexyl-2,4-dioxopyrimidine-1-carboxamide|5-Fluoro-1-hexylcarbamoyluracil|Yamaful|5-Fluoro-1-(hexylcarbamoyl)uracil|1-(n-hexylcarbamoyl)-5-fluorouracil|NCGC00095165-01|Carmofur [INN:JAN]|Carmofurum [INN-Latin]|Hexylcarbamoyl fluorouracil|SMR000466363|Mifurol (TN)|CAS-61422-45-5|CCRIS 2759|Uracil, 5-fluoro-1-hexylcarbamoyl-|UNII-HA82M3RAB2|BRN 0888898|Carmofure|Yamafur|HCFU; Mifurol|5-fluoro-1-(n-hexylcarbamoyl)uracil|Carmofur (Standard)|CPD000466363|CARMOFUR [INN]|CARMOFUR [JAN]|CARMOFUR [MI]|Spectrum2_000026|Spectrum3_001960|Carmofur (JP17/INN)|2,4-Dioxo-5-fluoro-N-hexyl-1,2,3,4-tetrahydro-1-pyrimidinecarboxamide|2,4-Dioxo-5-fluoro-N-hexyl-3,4-dihydro-1(2H)-pyrimidinecarboxamidme|5-Fluoro-N-hexyl-3,4-dihydro-2,4-dioxo-1(2H)-pyrimidinecarboxamide|CARMOFUR [MART.]|CARMOFUR [WHO-DD]|1-Pyrimidinecarboxamide, 1,2,3,4-tetrahydro-2,4-dioxo-5-fluoro-N-hexyl-|SCHEMBL8037|BSPBio_003560|5-24-06-00277 (Beilstein Handbook Reference)|Carmofur - Bio-X trade mark|MLS000759482|MLS000759483|MLS001423992|SPECTRUM1505317|SPBio_000091|CHEMBL460499|orb1309038|CHEBI:31360|HY-B0182R|KBio3_002882|GLXC-15145|HMS1922D08|HMS2051G12|HMS3393G12|HMS3654F13|HMS3712P11|HMS5079H07|Pharmakon1600-01505317|BCP21373|HY-B0182|Tox21_111464|BDBM50431275|CCG-39700|NSC758963|s1289|SBB101867|Carmofur, >=98% (HPLC), powder|1(2H)-Pyrimidinecarboxamide, 3,4-dihydro-2,4-dioxo-5-fluoro-N-hexyl-|AKOS015906778|Tox21_111464_1|CS-2064|DB09010|FC60423|NC00116|NSC 758963|NCGC00095165-02|NCGC00095165-03|NCGC00095165-04|NCGC00095165-05|NCGC00095165-07|NCGC00095165-16|NCGC00177991-01|AC-12465|BC164286|BS-17210|SY016080|SBI-0207040.P001|DB-053879|C2663|NS00068612|SW197496-2|C75879|D01784|AB00698319-04|AB00698319_06|AB00698319_07|422C455|A833212|F547240|SR-01000763370|5-fluoro-N-hexyl-2,4-dioxo-1-pyrimidinecarboxamide|Q5043732|SR-01000763370-3|BRD-K11630072-001-06-6|BRD-K11630072-001-11-6|BRD-K11630072-001-12-4|BRD-K11630072-001-13-2|(5-fluoro-2,4-dioxo(1,3-dihydropyrimidinyl))-N-hexylcarboxamide|5-fluoranyl-N-hexyl-2,4-bis(oxidanylidene)pyrimidine-1-carboxamide|5-Fluoro-N-hexyl-2,4-dioxo-3,4-dihydro-1(2H)-pyrimidinecarboxamide"
OMIPALISIB,25167777,,"InChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3",CGBJSGAELGCMKE-UHFFFAOYSA-N,C25H17F2N5O3S,505.5,"2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide","Omipalisib|1086062-66-9|GSK2126458|GSK-2126458|GSK 2126458|2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide|GSK-212|2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl]benzenesulfonamide|omipalisibum|1X8F5A3NA0|CHEBI:95093|DTXSID10148604|2,4-difluoro-N-(2-(methyloxy)-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)benzenesulfonamide|Benzenesulfonamide, 2,4-difluoro-N-(2-methoxy-5-(4-(4-pyridazinyl)-6-quinolinyl)-3-pyridinyl)-|2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzenesulfonamide|2,4-difluoro-N-(2-methoxy-5-(4-pyridazin-4-ylquinolin-6-yl)pyridin-3-yl)benzenesulfonamide|2,4-difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide|RefChem:856774|DTXCID0071095|GSK212|GSK 212|MFCD16038929|GSK2126458 (GSK458)|GSK-458|Omipalisib (GSK2126458, GSK458)|GSK 2126458; Omipalisib|Omipalisib [USAN:INN]|UNII-1X8F5A3NA0|Omipalisib?|2,4-Difluoro-N-[2-methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide|GSK458|C25H17F2N5O3S|OMIPALISIB [INN]|Omipalisib (USAN/INN)|OMIPALISIB [USAN]|OMIPALISIB [WHO-DD]|MLS006011258|Omipalisib; GSK2126458|SCHEMBL623194|GTPL8974|orb1307306|Omipalisib (GSK2126458)|CHEMBL1236962|SCHEMBL29352875|SCHEMBL29358168|EX-A003|GSK 458|3l08|CGBJSGAELGCMKE-UHFFFAOYSA-N|HMS3656D09|BCP02252|BDBM50145416|NSC764092|NSC800807|s2658|AKOS015904655|CCG-264973|CS-0085|DB12703|FD43337|NSC-764092|NSC-800807|SB16572|SDCCGSBI-0654406.P001|2,4-difluoro-N-[2-methoxy-5-(4-pyridazin-4-yl-6-quinolyl)-3-pyridyl]benzenesulfonamide|NCGC00250408-01|NCGC00250408-05|AC-28458|AS-16266|BP-14100|HY-10297|SMR004703011|NS00072582|SW219502-1|D10718|GSK-2126458;GSK 2126458; Omipalisib|BRD-K07972848-001-02-0|Q27088179|N-[2-Methoxy-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl]benzenesulfonamide|2,4-difluoro-N-(2-methoxy-5-(4-(pyridazin-4-yl)quinolin-6-yl)pyridin-3-yl)benzenesulfonamide;Omipalisib|2,4-difluoro-N-{2-methoxy-5-[4-(pyridazin-4-yl)quinolin-6-yl]pyridin-3-yl}benzene-1-sulfonamide|ZIG"
FLAVONE,10680,,InChI=1S/C15H10O2/c16-13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10H,VHBFFQKBGNRLFZ-UHFFFAOYSA-N,C15H10O2,222.24,2-phenylchromen-4-one,"FLAVONE|525-82-6|2-Phenyl-4H-chromen-4-one|2-Phenylchromone|2-Phenyl-4-chromone|Asmacoril|2-phenylchromen-4-one|Chromocor|Cromaril|2-Phenyl-4H-1-benzopyran-4-one|2-Phenyl-4-benzopyron|Phenylchromone|Cromarile|2-Phenyl-gamma-benzopyrone|Flavon|2-Phenylbenzopyran-4-one|2-Phenyl-4H-benzopyran-4-one|NSC-19028|DTXSID2022048|2-phenyl-1,4-benzopyrone|S2V45N7G3B|CHEBI:42491|DTXCID602048|RefChem:140659|CHEBI:24043|208-383-8|4H-1-Benzopyran-4-one, 2-phenyl-|MFCD00006825|2-Phenyl-.gamma.-benzopyrone|NSC 19028|NSC19028|MLS002638647|CHEMBL275638|NCGC00090962-05|2-Phenyl-4H-chromen-4-on|CAS-525-82-6|FLN|SMR000112315|Flavone (VAN)|CCRIS 4288|EINECS 208-383-8|BRN 0157598|UNII-S2V45N7G3B|Flavone, Flavone|4hki|2-phenyl-4H-chromone|FLAVONE [MI]|Maybridge3_005286|bmse000945|CBiol_000263|SCHEMBL18879|GTPL409|5-17-10-00552 (Beilstein Handbook Reference)|MLS002177804|MLS002473400|2-Phenylbenzo[b]pyran-4-one|BIDD:ER0515|2-phenyl-1-benzopyran-4-one|MEGxp0_001685|orb1304901|SCHEMBL5711741|SCHEMBL9698458|SCHEMBL13738984|SCHEMBL15263674|SCHEMBL15668191|SCHEMBL31316377|2-Phenyl-4H-chromen-4-one #|ACon1_000055|HMS1446A06|HMS2269O06|HMS3604K19|HMS5082P07|HY-N2424|Tox21_202987|Tox21_400059|BDBM50028962|ICCB2_000263|LMPK12110097|MSK158898|s3967|SBB072435|STK164205|AKOS000603572|CCG-214679|DB07776|FF52488|IDI1_016673|NCGC00090962-01|NCGC00090962-02|NCGC00090962-03|NCGC00090962-04|NCGC00090962-06|NCGC00168837-01|NCGC00260532-01|AC-35144|AS-58464|SY012830|DB-052142|CS-0022637|F0015|NS00007856|ST45028199|C10043|525F826|AH-357/03404044|EN300-18246169|F814377|L001213|CU-00000000060-1|Q2742033|BRD-K86741145-001-01-5|6CC153EB-39A6-42FC-BE96-C8BF1D585E27|2-Phenyl-4H-1-benzopyran-4-one;2-Phenyl-4H-chromen-4-one|11091-19-3|InChI=1/C15H10O2/c16-13-10-15(11-6-2-1-3-7-11)17-14-9-5-4-8-12(13)14/h1-10"
PERIFOSINE,148177,,"InChI=1S/C25H52NO4P/c1-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18-19-24-29-31(27,28)30-25-20-22-26(2,3)23-21-25/h25H,4-24H2,1-3H3",SZFPYBIJACMNJV-UHFFFAOYSA-N,C25H52NO4P,461.7,"(1,1-dimethylpiperidin-1-ium-4-yl) octadecyl phosphate","Perifosine|157716-52-4|KRX-0401|(1,1-dimethylpiperidin-1-ium-4-yl) octadecyl phosphate|D 21266|NSC 639966|perifosina|NSC-639966|1,1-dimethylpiperidinium-4-yl octadecyl phosphate|D-21266|DTXSID3048946|CHEBI:67272|octadecyl-(1,1-dimethyl-4-piperidylio)phosphate|2GWV496552|AEZS-104|DTXCID0028872|perifosinum|RefChem:171760|1,1-Dimethylpiperidin-1-ium-4-yl octadecyl phosphate|Perifosine (KRX-0401)|Perifosine [INN]|C25H52NO4P|KRX 0401|MFCD00927554|NSC639966|Piperidinium, 4-[[hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethyl-, inner salt|NCGC00187909-01|1,1-dimethylpiperidin-1-ium-4-yl octadecyl phosphate.|Piperidinium, 4-((hydroxy(octadecyloxy)phosphinyl)oxy)-1,1-dimethyl-, inner salt|NKA17|UNII-2GWV496552|4-[[Hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethyl-piperidinium Inner Salt; NSC 639966; KRX-0401,|4-((Hydroxy(octadecyloxy)phosphinyl)oxy)-1,1-dimethylpiperidinium inner salt|PERIFOSINE [MI]|PERIFOSINE [WHO-DD]|SCHEMBL93872|Perifosine (KRX-0401)?|CHEMBL372764|GTPL7424|orb1305401|BCP00245|EX-A2229|YHI-1003|Tox21_113365|BDBM50431630|NSC800842|s1037|Piperidinium,1-dimethyl-, inner salt|AKOS005146344|CCG-269358|CS-0209|DB06641|EX-3388|FP26843|GS-3834|NSC-800842|NCGC00187909-02|NCGC00187909-13|AC-25019|BP-42547|HY-50909|CAS-157716-52-4|P2831|Q3411917|Perifosine; KRX-0401; NSC 639966; D21266|1,1-DIMETHYLPIPERIDINIUM-4-YL OCTADECYL PHOSPHATE, INNER SALT|4-Hydroxy-1,1-dimethylpiperidinium hydroxide, octadecyl hydrogen phosphate, inner salt|4-[[Hydroxy(octadecyloxy)phosphinyl]oxy]-1,1-dimethyl-piperidinium inner salt;NSC 639966;D 21266 KRX 0401"
AZD3514,46893585,,"InChI=1S/C25H32F3N7O2/c1-18(36)33-14-12-32(13-15-33)16-17-37-21-4-2-19(3-5-21)20-8-10-34(11-9-20)23-7-6-22-29-30-24(25(26,27)28)35(22)31-23/h2-5,20H,6-17H2,1H3",JMEYDSHPKCSIJC-UHFFFAOYSA-N,C25H32F3N7O2,519.6,"1-[4-[2-[4-[1-[3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]phenoxy]ethyl]piperazin-1-yl]ethanone","AZD3514|1240299-33-5|AZD-3514|CS-1443|127DSS8X7J|AZD 3514|Ethanone, 1-(4-(2-(4-(1-(7,8-dihydro-3-(trifluoromethyl)-1,2,4-triazolo(4,3-b)pyridazin-6-yl)-4-piperidinyl)phenoxy)ethyl)-1-piperazinyl)-|RefChem:116041|1-(4-(2-(4-(1-(3-(Trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethanone|CHEMBL2346976|AZD 3514 [WHO-DD]|1-[4-[2-[4-[1-[3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl]phenoxy]ethyl]piperazin-1-yl]ethanone|C25H32F3N7O2|MFCD25976791|UNII-127DSS8X7J|orb1300800|SCHEMBL3056463|DTXSID80677133|HMS3652H18|BCP07896|EX-A1806|BDBM50432188|NSC765776|s7040|AKOS027422738|CCG-264708|NSC-765776|SB19559|NCGC00386284-02|NCGC00386284-05|1-(4-(2-(4-(1-(3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl)piperidin-4-yl)phenoxy)ethyl)piperazin-1-yl)ethan-1-one|AC-35907|DA-35308|FA103981|HY-16079|MS-29635|SW219684-1|F84948|BRD-K84996356-001-01-1|Z2037280630|1-[4-[2-[4-[1-[3-(trifluoromethyl)-7,8-dihydro-[1,2,4]triazolo[4,3-b]pyridazin-6-yl]-4-piperidyl]phenoxy]ethyl]piperazin-1-yl]ethanone|1-{4-[2-(4-{1-[3-(Trifluoromethyl)-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazin-6-yl]piperidin-4-yl}phenoxy)ethyl]piperazin-1-yl}ethan-1-one|6-(4-{4-[2-(4-acetylpiperazin-1-yl)ethoxy]phenyl}piperidin-1-yl)-3-(trifluoromethyl)-7,8-dihydro[1,2,4]triazolo[4,3-b]pyridazine"
VERUBECESTAT,51352361,,"InChI=1S/C17H17F2N5O3S/c1-17(9-28(26,27)24(2)16(20)23-17)12-7-11(4-5-13(12)19)22-15(25)14-6-3-10(18)8-21-14/h3-8H,9H2,1-2H3,(H2,20,23)(H,22,25)/t17-/m0/s1",YHYKUSGACIYRML-KRWDZBQOSA-N,C17H17F2N5O3S,409.4,"N-[3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide","Verubecestat|1286770-55-5|SCH-900931|N-[3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide|J1I0P6WT7T|SCH900931|SCH 900931|DTXSID301020622|N-(3-(3-amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoro-2-pyridinecarboxamide|verubecestatum|N-(3-((5R)-3-amino-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoropyridine-2-carboxamide|RefChem:901821|DTXCID401478387|N-(3-((5R)-3-Amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoro-2-pyridinecarboxamide|Verubecestat Free Base|Verubecestat (MK-8931)|(R)-N-(3-(3-amino-2,5-dimethyl-1,1-dioxido-5,6-dihydro-2H-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoropicolinamide|C17H17F2N5O3S|MFCD28963974|2-Pyridinecarboxamide, N-[3-[(5R)-3-amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoro-|BDBM143220|2-Pyridinecarboxamide, N-(3-((5R)-3-amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoro-|N-[3-[(5R)-3-amino-2,5-dimethyl-1,1-dioxo-6H-1,2,4-thiadiazin-5-yl]-4-fluoro-phenyl]-5-fluoro-pyridine-2-carboxamide|N-{3-[(5r)-3-Amino-2,5-Dimethyl-1,1-Dioxido-5,6-Dihydro-2h-1,2,4-Thiadiazin-5-Yl]-4-Fluorophenyl}-5-Fluoropyridine-2-Carboxamide|Verubecestat [USAN:INN]|UNII-J1I0P6WT7T|example 25 (US8940748)|VerubecestatFreeBase|66F|N-[3-[(5R)-3-Amino-5,6-dihydro-2,5-dimethyl-1,1-dioxido-2H-1,2,4-thiadiazin-5-yl]-4-fluorophenyl]-5-fluoro-2-pyridinecarboxamide; MK 8931;|Verubecestat [USAN]|VERUBECESTAT [INN]|VERUBECESTAT [JAN]|Verubecestat; MK-8931|VERUBECESTAT [WHO-DD]|GTPL8699|orb1300146|Verubecestat (JAN/USAN/INN)|CHEMBL3301601|SCHEMBL10328722|SCHEMBL17507398|SCHEMBL29361623|SCHEMBL30477101|BDBM47353|GLXC-10657|HMS3886D12|BCP15722|EX-A2003|LBC77055|BDBM50580216|s8564|AKOS030573301|CCG-268756|CS-5823|DB12285|SB19728|NCGC00522475-03|AC-33091|AS-35038|HY-16759|NS00073425|D10739|US8940748, 25|US9687494, 25|US9029362, 173|Q27089141|MK 8931;MK-8931;SCH 900931;SCH900931;SCH-900931;MK8931|N-(3-((5R)-3-amino-2,5-dimethyl-1,1-dioxo-1,2,5,6-tetrahydro-1lambda6,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoropyridine-2-carboxamide|N-(3-((5R)-3-amino-2,5-dimethyl-1,1-dioxo-5,6-dihydro-2H-1lambda6,2,4-thiadiazin-5-yl)-4-fluorophenyl)-5-fluoropyridine-2-carboxamide"
LURASIDONE,213046,,"InChI=1S/C28H36N4O2S/c33-27-24-18-9-10-19(15-18)25(24)28(34)32(27)17-21-6-2-1-5-20(21)16-30-11-13-31(14-12-30)26-22-7-3-4-8-23(22)35-29-26/h3-4,7-8,18-21,24-25H,1-2,5-6,9-17H2/t18-,19+,20-,21-,24+,25-/m0/s1",PQXKDMSYBGKCJA-CVTJIBDQSA-N,C28H36N4O2S,492.7,"(1S,2R,6S,7R)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione","Lurasidone|367514-87-2|lurasidona|lurasidonum|CHEBI:70735|22IC88528T|SM-13496 FREE BASE|DTXSID40870340|N-(2-(4-(1,2-benzisothiazol-3-yl)-1-piperazinylmethyl)-1-cyclohexylmethyl)-2,3-bicyclo(2.2.1)heptanedicarboximide|(3aR,4S,7R,7aS)-2-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione|(3aR,4S,7R,7aS)-2-(((1R,2R)-2-((4-(1,2-benzothiazol-3-yl)piperazin-1-yl)methyl)cyclohexyl)methyl)hexahydro-1H-4,7-methanoisoindole-1,3(2H)-dione|RefChem:57129|N05AE05|DTXCID601505924|Latuda|(3aR,4S,7R,7aS)-2-((1R,2R)-2-(4-(1,2-Benzothiazol-3-yl)piperazin-1-ylmethyl)cyclohexylmethyl)hexahydro-4,7-methano-2H-isoindole-1,3-dione|Lurasidone [INN]|C28H36N4O2S|MFCD14635357|(1S,2R,6S,7R)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione|Lurasindone|UNII-22IC88528T|HSDB 8228|(3aR,4S,7R,7aS)-2-{(1R,2R)-2-(4-(1,2-Benzisothiazol-3-yl)piperazin-1-ylmethyl)cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione|(3aR,4S,7R,7aS)-2-{(1R,2R)-2-[4-(1,2-benzisothiazol-3-yl)piperazin-1-ylmethyl]cyclohexylmethyl}hexahydro-4,7-methano-2H-isoindole-1,3-dione|PS34 - Lurasidone|Lurasidone (Standard)|LURASIDONE [MI]|LURASIDONE [VANDF]|LURASIDONE [WHO-DD]|SCHEMBL677525|GTPL7461|HY-B0032AR|orb1306396|CHEMBL1237021|SCHEMBL29354217|BDBM85222|EX-A504|PQXKDMSYBGKCJA-CVTJIBDQSA-N|HMS3886A20|MSK157185|PDSP2_001043|s5714|AKOS037643746|CCG-269635|DB08815|EX-3124|NCGC00386382-03|AS-35077|5187B|CAS_441351-20-8|L0280|NS00069589|AB01566875_01|EN300-20605510|Q416992|BRD-K51143828-003-03-1|(1R,2S,6R,7S)-4-[[(1R,2R)-2-[[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl]cyclohexyl]methyl]-4-azatricyclo[5.2.1.02,6]decane-3,5-dione|(1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0,2,6]decane-3,5-dione|(1R,2S,6R,7S)-4-{[(1R,2R)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0?,?]decane-3,5-dione|4,7-Methano-1H-isoindole-1,3(2H)-dione, 2-[[(1R,2R)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-, (3aR,4S,7R,7aS)-"
MIRDAMETINIB,9826528,,"InChI=1S/C16H14F3IN2O4/c17-11-3-2-10(16(25)22-26-7-9(24)6-23)15(14(11)19)21-13-4-1-8(20)5-12(13)18/h1-5,9,21,23-24H,6-7H2,(H,22,25)/t9-/m1/s1",SUDAHWBOROXANE-SECBINFHSA-N,C16H14F3IN2O4,482.19,"N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide","391210-10-9|Mirdametinib|PD0325901|PD 0325901|PD-0325901|N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide|GOMEKLI|PD 325901|PD325901|86K0J5AK6M|DTXSID0044024|CHEBI:88249|DTXCID8024024|Pd 901|PD-901|PD-03525901|Benzamide, N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-|Benzamide, N-((2R)-2,3-dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)-|N-((2R)-2,3-Dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide|RefChem:818905|GlyTouCan:G85685CG|MEK Inhibitor PD0325901|G85685CG|(R)-N-(2,3-Dihydroxypropoxy)-3,4-difluoro-2-((2-fluoro-4-iodophenyl)amino)benzamide|PD-325901|(R)-N-(2,3-DIHYDROXYPROPOXY)-3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)BENZAMIDE|C16H14F3IN2O4|Mirdametinib [USAN]|MFCD08435926|CHEMBL507361|N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodoanilino)benzamide|N-{[(2R)-2,3-dihydroxypropyl]oxy}-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide|Mirdametinib (USAN)|NCGC00189075-01|N-[((R)-2,3-dihydroxypropyl)oxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]benzamide|391209-97-5|N-((R)-2,3-dihydroxy-propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide|UNII-86K0J5AK6M|N-[(R)-2,3-Dihydroxy-propoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide|4BM|Gomekli (TN)|Mirdametinib (GMP)|MIRDAMETINIB [INN]|MIRDAMETINIB [WHO-DD]|PD0325901(Mirdametinib)|SCHEMBL172904|GTPL7935|orb1300996|PD0325901 (Mirdametinib)|SCHEMBL29352748|SCHEMBL29358470|EX-A102|BCPP000126|BDBM104963|HMS3648A14|Tox21_113364|HB2240|HY-10254G|NSC755770|NSC800840|s1036|WHO 11299|AKOS015855518|BCP9001057|CCG-221316|CS-0062|DB07101|EX-8602|FP26781|NSC-755770|NSC-800840|SDCCGSBI-0654263.P002|N-[(2R)-2,3-dihydroxypropoxy]-3,4-difluoro-2-(2-fluoro-4-iodo-anilino)benzamide|N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]-benzamide|NCGC00381744-09|BP-43620|HY-10254|Pd 03525901|US8575391, Q|CAS-391210-10-9|NS00069616|SW218101-2|D11675|PD-0325901,PD325901|PD 0325901, >=98% (HPLC)|SR-01000946344|SR-01000946344-1|BRD-K49865102-001-01-9|BRD-K49865102-001-08-4|Q27088255|N-((R)-2,3-Dihydroxy[propoxy)-3,4-difluoro-2-(2-fluoro-4-iodo-phenylamino)-benzamide|N-[(2R)-2,3-Dihydroxypropoxy]-3,4-difluoro-2-[(2-fluoro-4-iodophenyl)amino]- benzamide|(-)-N-(((R)-2,3-DIHYDROXYPROPYL)OXY)-3,4-DIFLUORO-2-((2-FLUORO-4-IODOPHENYL)AMINO)BENZAMIDE"
SELUMETINIB,10127622,,"InChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)",CYOHGALHFOKKQC-UHFFFAOYSA-N,C17H15BrClFN4O3,457.7,6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide,"Selumetinib|606143-52-6|AZD6244|ARRY-142886|5-[(4-BROMO-2-CHLOROPHENYL)AMINO]-4-FLUORO-N-(2-HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDE|AZD 6244|AZD-6244|ARRY-886|selumetinibum|6UH91I579U|ARRY142886|DTXSID3048944|CHEBI:90227|DTXCID0028870|1H-Benzimidazole-6-carboxamide, 5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-|1H-Benzimidazole-6-carboxamide, 5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-|5-((4-BROMO-2-CHLOROPHENYL)AMINO)-4-FLUORO-N-(2-HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDE|RefChem:58514|MEK inhibitor AZD6244|Selumetinib (AZD6244)|ARRY 142886|5-((4-bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide|MFCD11977472|C17H15BrClFN4O3|Selumetinib [USAN:INN]|Koselugo|UNII-6UH91I579U|CHEMBL1614701|NSC741078|NCGC00189073-01|NCGC00189073-02|6-(4-bromo-2-chloro-anilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-benzimidazole-5-carboxamide|6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide|AZD6244 (Selumetinib)|5-[(4-bromo-2-chlorophenyl)amino]-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-1,3-benzodiazole-6-carboxamide|6-[(4-bromo-2-chlorophenyl)amino]-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide|AZD 6244;5-((4-Bromo-2-chlorophenyl)amino)-4-fluoro-N-(2-hydroxyethoxy)-1-methyl-1H-benzo[d]imidazole-6-carboxamide;6-(4-bromo-2-chlorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide|CAS-606143-52-6|5-(4-broMo-2-chlorophenylaMino)-4-fluoro-N-(2-hydroxyethoxy)-1-Methyl-1H-benzo[d]iMidazole-6-carboxaMide|3EW|SELUMETINIB [MI]|SELUMETINIB [INN]|Azd-6244; Selumetinib|Selumetinib (USAN/INN)|SELUMETINIB [USAN]|SELUMETINIB [WHO-DD]|SCHEMBL155456|GTPL5665|orb1300969|SCHEMBL29353582|SCHEMBL29555068|EX-A020|CYOHGALHFOKKQC-UHFFFAOYSA-N|BCPP000367|HMS3244G03|HMS3244G04|HMS3244H03|HMS3265K01|HMS3265K02|HMS3265L01|HMS3265L02|HMS3654O03|HMS5079E03|NSC 741O78|BCP01739|Tox21_113362|BDBM50355497|NSC800882|s1008|AKOS015904255|Tox21_113362_1|BCP9000354|CCG-264774|CS-0059|DB11689|EX-8621|FS27812|NSC-741078|NSC-800882|SB14707|SDCCGSBI-0654324.P001|NCGC00189073-07|6-(4-bromo-2-chlorophenylamino)-7-fluoro-N-(2-hydroxyethoxy)-3-methyl-3H-benzo[d]imidazole-5-carboxamide|AC-25059|AZD6244,Selumetinib, ARRY-142886|HY-50706|Selumetinib (ARRY142886/AZD6244)|SY013317|AZD6244 (Selumetinib,ARRY-142886)?|NS00071922|SW202561-3|D09666|143A526|EN300-18166787|Q7448840|BRD-K57080016-001-01-9|BRD-K57080016-001-15-9|BRD-K57080016-001-19-1|1H-BENZIMIDAZOLE-6-CARBOXAMIDE, 5-((4-BROMO-2-CHLOROPHENYL)AMINO)-4-FLUORO-N-(2- HYDROXYETHOXY)-1-METHYL-|6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy -ethoxy)-amide|6-(4-Bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide|6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid(2-hydroxy-ethoxy)-amide|6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxyethoxy)-amide|6-(4-bromo-2-chlorophenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid(2-hydroxyethoxy)-amide|6-(4-bromo-2chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoimidazole-5-carboxylic acid (2-hydroxy-ethoxy)-amide"
DARAPLADIB,9939609,,"InChI=1S/C36H38F4N4O2S/c1-3-42(4-2)20-21-43(22-25-8-12-27(13-9-25)28-14-16-29(17-15-28)36(38,39)40)33(45)23-44-32-7-5-6-31(32)34(46)41-35(44)47-24-26-10-18-30(37)19-11-26/h8-19H,3-7,20-24H2,1-2H3",WDPFJWLDPVQCAJ-UHFFFAOYSA-N,C36H38F4N4O2S,666.8,"N-[2-(diethylamino)ethyl]-2-[2-[(4-fluorophenyl)methylsulfanyl]-4-oxo-6,7-dihydro-5H-cyclopenta[d]pyrimidin-1-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide","Darapladib|356057-34-6|SB-480848|SB 480848|UI1U1MYH09|DTXSID70189073|N-(2-(Diethylamino)ethyl)-2-(2-((4-fluorobenzyl)sulfanyl)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopentapyrimidin-1-yl)-N-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)acetamide|darapladibum|N-(2-diethylaminoethyl)-2-(2-((4-fluorophenyl)methylsulfanyl)-4-oxo-6,7-dihydro-5H-cyclopenta(e)pyrimidin-1-yl)-N-((4-(4-(trifluoromethyl)phenyl)phenyl)methyl)acetamide|N-(2-diethylaminoethyl)-2-[2-[(4-fluorophenyl)methylsulfanyl]-4-oxo-6,7-dihydro-5H-cyclopenta[e]pyrimidin-1-yl]-N-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide|RefChem:585191|DTXCID00111564|GSK480848|N-(2-(diethylamino)ethyl)-2-(2-(((4-fluorophenyl)methyl)sulfanyl)-4-oxo-1H,4H,5H,6H,7H-cyclopenta(d)pyrimidin-1-yl)-N-((4'-(trifluoromethyl)-(1,1'-biphenyl)-4-yl)methyl)acetamide|MFCD18251452|Darapladib (SB-480848)|N-(2-(Diethylamino)ethyl)-2-(2-((4-fluorobenzyl)thio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)-N-((4'-(trifluoromethyl)-[1,1'-biphenyl]-4-yl)methyl)acetamide|CHEMBL204021|N-[2-(Diethylamino)ethyl]-2-[2-[(4-fluorophenyl)methylsulfanyl]-4-oxo-6,7-dihydro-5h-cyclopenta[d]pyrimidin-1-yl]-n-[[4-[4-(trifluoromethyl)phenyl]phenyl]methyl]acetamide|N-[2-(Diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1H-cyclopentapyrimidine-1-acetamide|1H-Cyclopentapyrimidine-1-acetamide, N-(2-(diethylamino)ethyl)-2-(((4-fluorophenyl)methyl)thio)-4,5,6,7-tetrahydro-4-oxo-N-((4'-(trifluoromethyl)(1,1'-biphenyl)-4-yl)methyl)-|Darapladib [USAN:INN]|UNII-UI1U1MYH09|Darapladib?|SB480848|DARAPLADIB [MI]|DARAPLADIB [INN]|DARAPLADIB [JAN]|Darapladib (JAN/USAN)|DARAPLADIB [USAN]|DARAPLADIB [WHO-DD]|Darapladib; SB-480848|MLS006010424|Darapladib - Bio-X trade mark|GTPL6696|orb1301065|SCHEMBL2742709|WDPFJWLDPVQCAJ-UHFFFAOYSA-N|HMS3653B13|HMS3744E13|BCP04908|EX-A2245|BDBM50125265|FD5008|s7520|AKOS025290042|BCP9000585|CCG-270349|DB06311|PB30298|NCGC00386337-05|AC-32914|AS-17025|BD300064|FD158540|HY-10521|SMR004701449|SY097672|DB-069235|NS00069388|SW219569-1|D03650|4'-(trifluoromethyl)biphenyl-4-yl]methyl}acetamide|Q5222103|BRD-K19085898-001-01-8|5HV|N-(2-(DIETHYLAMINO)ETHYL)-2-(2-(4-FLUOROBENZYLSULPHANYL)-4-OXO-4,5,6,7-TETRAHYDROCYCLOPENTAPYRIMIDIN-1-YL)-N-(4'-TRIFLUOROMETHYLBIPHENYL-4-YLMETHYL)ACETAMIDE|N-(2-(Diethylamino)ethyl)-2-(2-(4-fluorobenzylthio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl)-N-((4'-(trifluoromethyl)biphenyl-4-yl)methyl)acetamide|N-(2-Diethylamino-ethyl)-2-[2-(4-fluoro-benzylsulfanyl)-4-oxo-4,5,6,7-tetrahydro-cyclopentapyrimidin-1-yl]-N-(4''-trifluoromethyl-biphenyl-4-ylmethyl)-acetamide|N-(2-DIETHYLAMINOETHYL)-2-[2-[(4-FLUOROPHENYL)METHYLSULFANYL]-4-OXO-6,7-DIHYDRO-5H-CYCLOPENTA[D]PYRIMIDIN-1-YL]-N-[[4-[4-(TRIFLUOROMETHYL)PHENYL]PHENYL]METHYL]ACETAMIDE|N-[2-(Diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6 ,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]met hyl]-1H-Cyclopentapyrimidine-1-acetamide|N-[2-(Diethylamino)ethyl]-2-[[(4-fluorophenyl)methyl]thio]-4,5,6,7-tetrahydro-4-oxo-N-[[4'-(trifluoromethyl)[1 ,1'-biphenyl]-4-yl]me thyl]-1H-cyclopentapyrimidine-1-acetamide|N-[2-(diethylamino)ethyl]-2-{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}-N-{[|N-[2-(diethylamino)ethyl]-2-{2-[(4-fluorobenzyl)sulfanyl]-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl}-N-{[ 4'-(trifluoromethyl)biphenyl-4-yl]methyl}acetamide|N-[2-(Diethylamino)ethyl]-2-{2-[(4-Fluorobenzyl)sulfanyl]-4-Oxo-4,5,6,7-Tetrahydro-1h-Cyclopenta[d]pyrimidin-1-Yl}-N-{[4'-(Trifluoromethyl)biphenyl-4-Yl]methyl}acetamide|N-[2-(Diethylamino)ethyl]-N-[4'-(trifluoromethyl)-1,1'-biphenyl-4-ylmethyl]-2-[2-(4-fluorobenzylthio)-4-oxo-4,5,6,7-tetrahydro-1H-cyclopenta[d]pyrimidin-1-yl]a|N-[2-(DIETHYLAMINO)ETHYL]-N-[4'-(TRIFLUOROMETHYL)-1,1'-BIPHENYL-4-YLMETHYL]-2-[2-(4-FLUOROBENZYLTHIO)-4-OXO-4,5,6,7-TETRAHYDRO-1H-CYCLOPENTA[D]PYRIMIDIN-1-YL]ACETAMIDE"
LUVIXASERTIB,118086034,,"InChI=1S/C28H30N6O3/c1-17-10-19(5-8-22(17)27(35)32-20-6-7-20)23-16-31-34-24(30-14-18-12-28(2,36)13-18)11-25(33-26(23)34)37-21-4-3-9-29-15-21/h3-5,8-11,15-16,18,20,30,36H,6-7,12-14H2,1-2H3,(H,32,35)",PMQUGSPFUBGJCZ-UHFFFAOYSA-N,C28H30N6O3,498.6,"N-cyclopropyl-4-[7-[(3-hydroxy-3-methylcyclobutyl)methylamino]-5-pyridin-3-yloxypyrazolo[1,5-a]pyrimidin-3-yl]-2-methylbenzamide","CFI-402257|1610759-22-2|luvixasertib|CFI402257|HE97PTK3Q6|N-cyclopropyl-4-[7-[(3-hydroxy-3-methylcyclobutyl)methylamino]-5-pyridin-3-yloxypyrazolo[1,5-a]pyrimidin-3-yl]-2-methylbenzamide|UNII-HE97PTK3Q6|CID 118086034|CHEMBL4442392|CHEMBL4469414|CFI 402257|Benzamide, N-cyclopropyl-4-(7-(((cis-3-hydroxy-3-methylcyclobutyl)methyl)amino)-5-(3-pyridinyloxy)pyrazolo(1,5-a)pyrimidin-3-yl)-2-methyl-|N-cyclopropyl-2-methyl-4-[5-(pyridin-3-yloxy)-7-({[(1s,3r)-3-hydroxy-3-methylcyclobutyl]methyl}amino)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide|N-Cyclopropyl-4-(7-(((cis-3-hydroxy-3-methylcyclobutyl)methyl)amino)-5-(3-pyridinyloxy)pyrazolo(1,5-a)pyrimidin-3-yl)-2-methylbenzamide|N-Cyclopropyl-4-(7-(((cis-3-hydroxy-3-methylcyclobutyl)methyl)amino)-5-(pyridin-3-yloxy)pyrazolo[1,5-a]pyrimidin-3-yl)-2-methylbenzamide|Benzamide, N-cyclopropyl-4-[7-[[(cis-3-hydroxy-3-methylcyclobutyl)methyl]amino]-5-(3-pyridinyloxy)pyrazolo[1,5-a]pyrimidin-3-yl]-2-methyl-|N-Cyclopropyl-4-[7-[[(cis-3-hydroxy-3-methylcyclobutyl)methyl]amino]-5-(3-pyridinyloxy)pyrazolo[1,5-a]pyrimidin-3-yl]-2-methylbenzamide|luvixasertib [INN]|orb1704839|SCHEMBL16729234|SCHEMBL17182976|SCHEMBL17190272|SCHEMBL29538972|GTPL11664|BCP31204|EX-A2577|BDBM50512456|BDBM50533120|NSC800888|AKOS040745023|CS-6527|NSC-800888|SB19839|compound 24 [PMID: 27437075]|AC-36155|DA-62223|TS-08246|HY-101340|CFI 402257; CFI402257|A906482|N-cyclopropyl-4-(7-((((1r,3r)-3-hydroxy-3-methylcyclobutyl)methyl)amino)-5-(pyridin-3-yloxy)pyrazolo[1,5-a]pyrimidin-3-yl)-2-methylbenzamide|N-Cyclopropyl-4-[7-[[(cis-3-hydroxy-3-methylcyclobutyl)methyl]amino]-5-(3-pyridinyloxy)pyrazolo[1,5-a]pyrimidin-3-yl]-2-methyl-benzamide|N-cyclopropyl-4-{7-({[(1s,3s)-3-hydroxy-3- methylcyclobutyl]methyl}amino)-5-[(pyridin-3- yl)oxy]pyrazolo[1,5-a]pyrimidin-3-yl}-2- methylbenzamide"
IDASANUTLIN,53358942,,"InChI=1S/C31H29Cl2F2N3O4/c1-30(2,3)14-24-31(15-36,19-10-9-17(32)13-21(19)34)25(18-6-5-7-20(33)26(18)35)27(38-24)28(39)37-22-11-8-16(29(40)41)12-23(22)42-4/h5-13,24-25,27,38H,14H2,1-4H3,(H,37,39)(H,40,41)/t24-,25-,27+,31-/m0/s1",TVTXCJFHQKSQQM-LJQIRTBHSA-N,C31H29Cl2F2N3O4,616.5,"4-[[(2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carbonyl]amino]-3-methoxybenzoic acid","Idasanutlin|1229705-06-9|RG7388|RG-7388|RO5503781|Idasanutlina|Idasanutline|RO-5503781|QSQ883V35U|Benzoic acid, 4-[[[(2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-2-pyrrolidinyl]carbonyl]amino]-3-methoxy-|Benzoic acid, 4-((((2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-2-pyrrolidinyl)carbonyl)amino)-3-methoxy-|idasanutlinum|4-((2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-amido)-3-methoxybenzoic acid|4-[(2R,3S,4R,5S)-3-(3-CHLORO-2-FLUOROPHENYL)-4-(4-CHLORO-2-FLUOROPHENYL)-4-CYANO-5-(2,2-DIMETHYLPROPYL)PYRROLIDINE-2-AMIDO]-3-METHOXYBENZOIC ACID|RefChem:789665|Idasanutlin (RG-7388)|Idasanutlin (RG7388)|4-((2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-neopentylpyrrolidine-2-carboxamido)-3-methoxybenzoic acid|MFCD26142931|4-[[(2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carbonyl]amino]-3-methoxybenzoic acid|CHEMBL2402737|C31H29Cl2F2N3O4|4-((2R,3S,4R,5S)-3-(3-chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-neopentylpyrrolidine-2-carboxamido)-3-methoxybenzoic acid.|Idasanutlin [USAN:INN]|UNII-QSQ883V35U|RG-7388;Idasanutlin|IDASANUTLIN [INN]|Idasanutlin (USAN/INN)|IDASANUTLIN [USAN]|IDASANUTLIN [WHO-DD]|Idasanutlin (RG-7388)?|SCHEMBL442856|SCHEMBL29361443|SCHEMBL29374817|SCHEMBL29477232|EX-A831|CHEBI:232616|TVTXCJFHQKSQQM-LJQIRTBHSA-N|DTXSID001025954|BCP11659|BDBM50437206|NSC779404|s7205|AKOS026674115|CCG-270248|CS-1473|DB12325|NSC-779404|RG 7388|NCGC00378976-06|NCGC00378976-08|Ro 5503781|AC-32968|BP-25380|DA-67184|FR104258|HY-15676|NS00073126|D11219|EN300-26181975|BRD-K62627508-001-01-5|Q27287480|RG-7388;RG 7388;RG7388; RO5503781; RO-5503781; RO 5503781|4-((((2R,3S,4R,5S)-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-2-pyrrolidinyl)carbonyl)amino)-3-methoxy-benzoic acid|4-[[(2R,3S,4R,5S)-3-(3-chloro-2-fluoro-phenyl)-4-(4-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethylpropyl)pyrrolidine-2-carbonyl]amino]-3-methoxy-benzoic acid|4-[[[(2R,3S,4R,5S)-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-2-pyrrolidinyl]carbonyl]amino]-3-methoxy-benzoic Acid; RG 7388|4-{[(2R,3S,4R,5S)-3-(3-chloro-2-fluoro-phenyl)-4-(4-chloro-2-fluoro-phenyl)-4-cyano-5-(2,2-dimethyl-propyl)-pyrrolidine-2-carbonyl]-amino}-3-methoxy-benzoic acid|Idasanutlin;4-[[[(2R,3S,4R,5S)-3-(3-Chloro-2-fluorophenyl)-4-(4-chloro-2-fluorophenyl)-4-cyano-5-(2,2-dimethylpropyl)-2-pyrrolidinyl  ]carbonyl]amino]-3-methoxy-benzoic Acid"
GSK2256294,59448236,,"InChI=1S/C21H24F3N7O/c1-12-28-19(26-2)31-20(29-12)30-16-5-3-4-14(9-16)18(32)27-11-15-7-6-13(10-25)8-17(15)21(22,23)24/h6-8,14,16H,3-5,9,11H2,1-2H3,(H,27,32)(H2,26,28,29,30,31)/t14-,16+/m1/s1",LQHDJQIMETZMPH-ZBFHGGJFSA-N,C21H24F3N7O,447.5,"(1R,3S)-N-[[4-cyano-2-(trifluoromethyl)phenyl]methyl]-3-[[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino]cyclohexane-1-carboxamide","1142090-23-0|GSK2256294|GSK-2256294|GSK-2256294A|L33EX3XR0T|(1R,3S)-N-(4-cyano-2-(trifluoromethyl)benzyl)-3-((4-methyl-6-(methylamino)-1,3,5-triazin-2-yl)amino)cyclohexane-1-carboxamide|RefChem:144546|GSK2256294A|GSK 2256294A|GSK 2256294|cis-N-((4-Cyano-2-(trifluoromethyl)phenyl)methyl)-3-((4-methyl-6-(methylamino)-1,3,5-triazin-2-yl)amino)cyclohexanecarboxamide|(1R,3S)-N-[[4-cyano-2-(trifluoromethyl)phenyl]methyl]-3-[[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino]cyclohexane-1-carboxamide|CHEMBL3818875|UNII-L33EX3XR0T|LQHDJQIMETZMPH-ZBFHGGJFSA-N|CYCLOHEXANECARBOXAMIDE, N-((4-CYANO-2-(TRIFLUOROMETHYL)PHENYL)METHYL)-3-((4-METHYL-6-(METHYLAMINO)-1,3,5-TRIAZIN-2-YL)AMINO)-, (1R,3S)-|Cyclohexanecarboxamide, N-[[4-cyano-2-(trifluoromethyl)phenyl]methyl]-3-[[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino]-, (1R,3S)-|GTPL9718|orb1308251|SCHEMBL2677671|SCHEMBL29557121|SCHEMBL29667411|C21H24F3N7O|GLXC-20745|SVB09023|BDBM50264106|MFCD27987923|AKOS030526273|CS-5395|NCGC00386723-01|NCGC00386723-02|Cyclohexanecarboxamide, N-((4-cyano-2-(trifluoromethyl)phenyl)methyl)-3-((4-methyl-6-(methylamino)-1,3,5-triazin-2-yl)amino)-, (1R,3S)-rel-|DA-53733|HY-19644|MS-28093|E99026|BRD-K62738477-001-01-7|Q27282642|(1R,3S)-N-(4-cyano-2-(trifluoromethyl)benzyl)-3-(4-methyl-6-(methylamino)-1,3,5-triazin-2-ylamino)cyclohexanecarboxamide|(1R,3S)-N-[[4-cyano-2-(trifluoromethyl)phenyl]methyl]-3-[[4-methyl-6-(methylamino)-1,3,5-triazin-2-yl]amino]cyclohexanecarboxamide"
PACLITAXEL,36314,,"InChI=1S/C47H51NO14/c1-25-31(60-43(56)36(52)35(28-16-10-7-11-17-28)48-41(54)29-18-12-8-13-19-29)23-47(57)40(61-42(55)30-20-14-9-15-21-30)38-45(6,32(51)22-33-46(38,24-58-33)62-27(3)50)39(53)37(59-26(2)49)34(25)44(47,4)5/h7-21,31-33,35-38,40,51-52,57H,22-24H2,1-6H3,(H,48,54)/t31-,32-,33+,35-,36+,37+,38-,40-,45+,46-,47+/m0/s1",RCINICONZNJXQF-MZXODVADSA-N,C47H51NO14,853.9,"[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate","paclitaxel|TAXOL|33069-62-4|Taxol A|Yewtaxan|Genaxol|Plaxicel|Ebetaxel|Genetaxyl|Capxol|Paxene|Onxol|OncoGel|Cyclopax|Genexol|Intaxel|Mitotax|Pacliex|Paxceed|TaxAlbin|EmPAC|Onxal|Zisu|Taxus stent|Taxus Liberte|Padexol|EndoTAG 1|LEP-ETU|Tocosol Paclitaxel|(-)-Paclitaxel|Nanoxel|Paclitaxol|Sindaxel|NSC-125973|Taxus|Coroflex Please|Cypher select|Taxus Express|MBT 0206|Infinnium|DHP 107|DHP-107|Abraxane I.V. Suspension|BMS 181339-01|BMS-181339-01|P88XT4IS4D|NK 105|NSC125973|Paclitaxel (taxus canadensis)|QW 8184|Liposome-entrapped paclitaxel easy-to-use|DTXSID9023413|CHEBI:45863|ABI-007 COMPONENT PACLITAXEL|IG 001|NK-105|5beta,20-Epoxy-1,2-alpha,4,7beta,10beta,13alpha-hexahydroxytax-11-en-9-one 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|QW-8184|DTXCID603413|(2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha R*,betaS*),11alpha,12alpha,12balpha))-beta-(Benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|7 epi Taxol|ABRAXANE COMPONENT PACLITAXEL|NAB-PACLITAXEL COMPONENT PACLITAXEL|NSC 125973|(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-{[(2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl]oxy}-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.0^{3,10}.0^{4,7}]heptadec-13-en-2-yl benzoate|[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate|Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (alphaR,betaS)-|paclitaxelum|Bris Taxol|Taxol, Bris|((1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.03,10.04,7)heptadec-13-en-2-yl) benzoate|(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-(((2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl)oxy)-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.0^(3,10).0^(4,7))heptadec-13-en-2-yl benzoate|PACITAXEL|RefChem:6096|Taxol 100|PACLITAXEL PACLITAXEL|L01CD01|PACLITAXEL PROTEIN BOUND PARTICLES ALBUMIN BOUND|Paclitaxel protein-bound particles for injectable suspension (albumin-bound)|(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-bis(acetyloxy)-1,9-dihydroxy-15-(((2R,3S)-2-hydroxy-3-phenyl-3-(phenylformamido)propanoyl)oxy)-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo(11.3.1.03,10.04,7)heptadec-13-en-2-yl benzoate|Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,1-2alpha,12aalpha,12balpha))-|Tax-11-en-9-one, 5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxy-, 4,10-diacetate 2-benzoate, 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|Abraxane|ABI-007|LipoPac|Genexol-PM|MFCD00869953|Paclitaxel (Taxol)|HSDB 6839|ABI 007|DRG-0190|(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-9-(((2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl)oxy)-12-(benzoyloxy)-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-1H-7,11-methanocyclodeca[3,4]benzo[1,2-b]oxete-6,12b-diyl diacetate|Paclitaxel, Taxus brevifolia|CHEMBL428647|MBT-0206|7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.|NCGC00164367-01|C47H51NO14|nab-paclitaxel|M02242|Cynviloq|Xorane|Taxol (Paclitaxel)|(NAB)-Paclitaxel|SMR000857385|EndoTAG-1|SR-01000075350|UNII-P88XT4IS4D|Anzatax|Nanotaxel|Paclical|Pacligel|Paxoral|Paclitaxel?|CCRIS 8143|Paclitaxel [USAN:USP:INN:BAN]|Abraxane (TN)|(2alpha,5beta,7beta,10beta,13alpha)-4,10-bis(acetyloxy)-1,7-dihydroxy-13-({(2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoyl}oxy)-9-oxo-5,20-epoxytax-11-en-2-yl benzoate|[diacetoxy-[(2R,3S)-3-benzamido-2-hydroxy-3-phenyl-propanoyl]oxy-dihydroxy-tetramethyl-oxo-[?]yl] benzoate|Paclitaxel; 5beta,20-Epoxy-1,7beta-dihydroxy-9-oxotax-11-ene-2alpha,4,10beta,13alpha-tetrayl 4,10-diacetate 2-benzoate 13-[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-phenylpropanoate]; Taxol; Docetaxel Anhydrous Impurity F; Docetaxel Impurity F|CAS-33069-62-4|BMS-181339|Paclitaxel-SSMM-VIP|Paclitaxel (Standard)|P-SSMM-VIP|PACLITAXEL [MI]|PACLITAXEL [INN]|PACLITAXEL [JAN]|Prestwick3_000155|PACLITAXEL [HSDB]|PACLITAXEL [USAN]|TAXOL (TN)|PACLITAXEL [VANDF]|PACLITAXEL [MART.]|SCHEMBL3976|Nova-12005|PACLITAXEL [USP-RS]|PACLITAXEL [WHO-DD]|BIDD:PXR0046|BSPBio_000290|KBioGR_002509|KBioSS_002517|Paclitaxel (JAN/USP/INN)|MLS002154218|MLS002695976|OAS-PAC-100|PACLITAXEL [EMA EPAR]|BPBio1_000320|GTPL2770|MEGxp0_001940|orb1310120|Taxol (TN) (Bristol Meyers)|PACLITAXEL [GREEN BOOK]|PACLITAXEL [ORANGE BOOK]|ACon1_002231|HY-B0015R|KBio2_002509|KBio2_005077|KBio2_007645|KBio3_002987|ANX-513|DHP-208|DTS-301|PACLITAXEL [EP MONOGRAPH]|PACLITAXEL [USP IMPURITY]|SDP-013|cMAP_000068|ORAXOL COMPONENT PACLITAXEL|HMS2090D07|HMS2095O12|HMS2231A16|HMS3712O12|PACLITAXEL [USP MONOGRAPH]|Abraxane (albumin-bound suspension)|HY-B0015|MPI-5018|Tox21_112107|BDBM50001839|MSK000431|NSC745099|ABI 007 COMPONENT PACLITAXEL|AKOS007930675|AKOS015969673|AKOS025312303|CCG-220155|CS-1145|DB01229|FP10637|GS-6554|NSC-745099|NCGC00164367-02|NCGC00164367-03|NCGC00164367-04|NCGC00164367-05|NCGC00164367-10|(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro-4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano-5H-cyclodeca(3,4)benz(1,2-b)oxet-5-one 6,12b-diacetate, 12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|NCI60_000601|SY016928|Paclitaxel, from Taxus yannanensis, powder|AB00513812|D00491|EN300-117275|N88686|AB00513812-02|AB00513812-03|069P624|Q423762|7,4]benz[1,2-b]oxete,benzenepropanoic acid deriv.|SR-01000075350-1|SR-01000075350-3|SR-01000075350-6|SR-01000075350-7|SR-01000075350-9|BRD-K62008436-001-03-1|BRD-K62008436-001-05-6|BRD-K62008436-001-22-1|Paclitaxel, from semisynthetic (from Taxus sp.), >=97%|Paclitaxel, European Pharmacopoeia (EP) Reference Standard|Paclitaxel, from Taxus brevifolia, >=95% (HPLC), powder|Paclitaxel, United States Pharmacopeia (USP) Reference Standard|12-benzoate, 9-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|Paclitaxel, Pharmaceutical Secondary Standard; Certified Reference Material|Paclitaxel natural for peak identification, European Pharmacopoeia (EP) Reference Standard|(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-1,2a,3,4,4a,6,9,10,11,12,12a,12b-Dodecahydro 4,6,9,11,12,12b-hexahydroxy-4a,8,13,13-tetramethyl-7,11-methano 5Hcyclodeca(3,4)benz(1,2-b)oxet-5-one 6,12b-diacetate,|(2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl (aR,bS)-b-(benzoylamino)-a-hydroxybenzenepropanoate|(2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alpha R*,betaS*),11alpha,12alpha,12balpha))-beta-(Benzoylamino)-alpha-hydroxybenzenepropanoic acid 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12|(2beta,5beta,7alpha,8alpha,10alpha,13alpha)-4,10-bis(acetyloxy)-1,7-dihydroxy-13-({(2R,3S)-2-hydroxy-3-phenyl-3-[(phenylcarbonyl)amino]propanoyl}oxy)-9-oxo-5,20-epoxytax-11-en-2-yl benzoate|,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester|,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (alphaR,betaS)- (9CI)|-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aalpha,4beta,4abeta,6beta,9alpha(aR*,betaS*),11alpha,12alpha,12aalpha,12balpha]]-|[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetoxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenyl-propanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl] benzoate|[(1S,2S,3R,4S,7R,9S,10S,12R,15S)-4,12-diacetyloxy-15-[(2R,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyl]oxy-1,9-dihydroxy-10,14,17,17-tetramethyl-11-oxo-6-oxatetracyclo[11.3.1.03,10.04,7]heptadec-13-en-2-yl]benzoate|1203669-79-7|4alpha,10beta-bis(acetyloxy)-13alpha-[(2S,3S)-3-benzamido-2-hydroxy-3-phenylpropanoyloxy]-1,7beta-dihydroxy-9-oxo-5beta,20-epoxytax-11-en-2alpha-yl benzoate|BENZENEPROPANOIC ACID, .BETA.-(BENZOYLAMINO)-.ALPHA.-HYDROXY-, (2AR,4S,4AS,6R,9S,11S,12S,12AR,12BS)-6,12B-BIS(ACETYLOXY)-12-(BENZOYLOXY)-2A,3,4,4A,5,6,9,10,11,12,12A,12B-DODECAHYDRO-4,11-DIHYDROXY-4A,8,13,13-TETRAMETHYL-5-OXO-7,11-METHANO-1H-CYCLODECA(3,4)BENZ(1,2-B)OXET-9-YL ESTER, (.ALPHA.R,.BETA.S)-|Benzenepropanoic acid, 6,12b-bis(acetyl oxy)-12-(benzoyloxy)- 2a,3,4,4a,5,6,9,10,11,12,12a,12b,- dodecahydro-4,11- dihydroxy-4a,8,13,13-tetramethyl-5-oxo- 7,11-methano- 1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR- [2a.alpha.,4.beta.,4a.beta.,6.beta.,9.alpha.(alpha. R*,.beta.S*),11.alpha.,12.alpha.,12a.alpha.,12b.alpha.]]-|Benzenepropanoic acid, b-(benzoylamino)-.alpha.-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (aR,bS)-|Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13|Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H|Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2a-alpha,4-beta,4a-beta,6-beta,9-alpha(alpha-R*,beta-S*),11-alpha,12-alpha,12a-alpha, 12b-alpha))-|Benzenepropanoic acid, beta-(benzoylamino)-alpha-hydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2aalpha,4beta,4abeta,6beta,9alpha(alphaR*,betaS*),11alpha,12alpha,12aalpha,12balpha))-|Paclitaxel semi-synthetic for peak identification, European Pharmacopoeia (EP) Reference Standard|Paclitaxel semi-synthetic for system suitability, European Pharmacopoeia (EP) Reference Standard|Tax-11-en-9-one, 5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha- hexahydroxy-, 4,10-diacetate 2-benzoate, 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine|Tax-11-en-9-one, 5beta,20-epoxy-1,2alpha,4,7beta,10beta,13alpha-hexahydroxy-, 4,10-diacetate 2-benzoate 13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine (8CI)|Tax-11-en-9-one,20-epoxy-1,2.alpha.,4,7.beta., 10.beta.,13.alpha.- hexahydroxy-, 4,10-diacetate 2- benzoate,13-ester with (2R,3S)-N-benzoyl-3-phenylisoserine"
AT-9283,135398495,,"InChI=1S/C19H23N7O2/c27-19(21-13-2-3-13)24-16-10-20-25-17(16)18-22-14-4-1-12(9-15(14)23-18)11-26-5-7-28-8-6-26/h1,4,9-10,13H,2-3,5-8,11H2,(H,20,25)(H,22,23)(H2,21,24,27)",LOLPPWBBNUVNQZ-UHFFFAOYSA-N,C19H23N7O2,381.4,1-cyclopropyl-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea,"896466-04-9|AT9283|AT-9283|AT 9283|XAV9KYN9WL|AT 9283 [WHO-DD]|Urea, N-cyclopropyl-N'-(3-(6-(4-morpholinylmethyl)-1H-benzimidazol-2-yl)-1H-pyrazol-4-yl)-|1-cyclopropyl-3-[(3Z)-3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-yl]urea|1-cyclopropyl-3-((3Z)-3-(5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene)-1,2-dihydropyrazol-4-yl)urea|RefChem:560290|Multikinase Inhibitor AT9283|Aurora kinase inhibitor AT9283|1133385-83-7|1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea|AT-9283 free base|MFCD12031513|896466-04-9 (free base)|AT 9283, (2S)-2-hydroxy-propanoic acid salt|1-cyclopropyl-3-[5-[6-(morpholin-4-ylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea|1-Cyclopropyl-3-{3-[5-(Morpholin-4-Ylmethyl)-1h-Benzimidazol-2-Yl]-1h-Pyrazol-4-Yl}urea|UNII-XAV9KYN9WL|C19H23N7O2|35R|AT 9283; 1-Cyclopropyl-3-(3-(5-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea; N-Cyclopropyl-N'-[3-[5-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]-urea|3-cyclopropyl-1-{3-[5-(morpholin-4-ylmethyl)-1H-1,3-benzodiazol-2-yl]-1H-pyrazol-4-yl}urea|MLS006011044|SCHEMBL545809|SCHEMBL545942|CHEMBL495727|GTPL7949|orb1304573|CHEMBL5303448|SCHEMBL15005492|SCHEMBL15005494|SCHEMBL24336623|SCHEMBL29353018|BDBM27087|EX-A201|CHEBI:125514|LOLPPWBBNUVNQZ-UHFFFAOYSA-N|BCPP000379|DTXSID401026047|GLXC-06792|HMS3244O09|HMS3244O10|HMS3244P09|HMS3654G08|HMS3673I15|BCP11714|BDBM50243388|NSC760144|NSC799339|s1134|AKOS016006006|AKOS026750645|AT9 283|AT9283?|BCP9000337|CCG-268424|CS-0107|NSC-760144|NSC-799339|SDCCGSBI-0654347.P001|NCGC00346493-01|NCGC00346493-06|NCGC00346493-09|NCGC00389697-02|NCGC00389697-03|1-cyclopropyl-3-[(3E)-3-[5-(morpholin-4-ylmethyl)benzimidazol-2-ylidene]-1,2-dihydropyrazol-4-yl]urea|AC-32808|AS-16186|HY-50514|SMR004702836|DB-078462|NS00072317|SW220119-1|F17373|466C049|A900407|AT 9283; AT-9283; AT-9283 free base|EN300-20637992|BRD-K24576554-001-01-4|BRD-K24576554-001-04-8|Q27074571|Q27216136|Q27453557|1-cyclopropyl-3-(3-(5-(morpholinomethyl)-1h-benzo[d]imidazol-2-yl)-1h-pyrazol-4-yl) urea|1-cyclopropyl-3-(3-(6-(morpholinomethyl)-1H-benzo[d]imidazol-2-yl)-1H-pyrazol-4-yl)urea|1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1h-benzoimidazol-2-yl )-1h-pyrazol-4-yl]-urea|1-cyclopropyl-3-[3-(5-morpholin-4-ylmethyl-1H-benzoimidazol-2-yl)-1H-pyrazol-4-yl]-urea|1-cyclopropyl-3-[5-[6-(morpholinomethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]urea|N-cyclopropyl-N'-[3-[5-(4-morpholinylmethyl)-1H-benzimidazol-2-yl]-1H-pyrazol-4-yl]Urea|1-cyclopropyl-3-[3-[5-(4-morpholinylmethyl)-2-benzimidazolylidene]-1,2-dihydropyrazol-4-yl]urea|3-cyclopropyl-1-(3-{6-[(morpholin-4-yl)methyl]-1H-1,3-benzodiazol-2-yl}-1H-pyrazol-4-yl)urea"
ALPELISIB,56649450,,"InChI=1S/C19H22F3N5O2S/c1-10-14(11-6-7-24-13(9-11)18(2,3)19(20,21)22)30-16(25-10)26-17(29)27-8-4-5-12(27)15(23)28/h6-7,9,12H,4-5,8H2,1-3H3,(H2,23,28)(H,25,26,29)/t12-/m0/s1",STUWGJZDJHPWGZ-LBPRGKRZSA-N,C19H22F3N5O2S,441.5,"(2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide","alpelisib|1217486-61-7|BYL-719|BYL719|Piqray|NVP-BYL719|Vijoice|BYL 719|08W5N2C97Q|1,2-PYRROLIDINEDICARBOXAMIDE, N1-[4-METHYL-5-[2-(2,2,2-TRIFLUORO-1,1-DIMETHYLETHYL)-4-PYRIDINYL]-2-THIAZOLYL]-, (2S)-|(2S)-1-N-[4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl]pyrrolidine-1,2-dicarboxamide|1,2-Pyrrolidinedicarboxamide, N1-(4-methyl-5-(2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl)-2-thiazolyl)-, (2S)-|DTXSID70153355|(S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-(4-methyl-5-(2-(2,2,2-trifluoro-1,1-dimethylethyl)-pyridin-4-yl)thiazol-2-yl)amide|alpelisibum|(2S)-1-N-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)-1,3-thiazol-2-yl)pyrrolidine-1,2-dicarboxamide|(2S)-1-N-{4-methyl-5-[2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide|RefChem:57062|DTXCID7075846|L01XX65|Phosphoinositide 3-kinase Inhibitor BYL719|Alpelisib (BYL719)|(S)-N1-(4-Methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)pyrrolidine-1,2-dicarboxamide|UNII-08W5N2C97Q|Alpelisib [USAN:INN]|MFCD22417085|CHEMBL2396661|Alpelisib [INN]|(2s)-N~1~-{4-Methyl-5-[2-(1,1,1-Trifluoro-2-Methylpropan-2-Yl)pyridin-4-Yl]-1,3-Thiazol-2-Yl}pyrrolidine-1,2-Dicarboxamide|(S)-N1-(4-methyl-5-(2-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl)thiazol-2-yl)pyrrolidine-1,2-dicarboxamide.|C19H22F3N5O2S|4jps|1LT|Alpelisib [USAN]|Vijoice (TN)|Piqray (TN)|ALPELISIB [JAN]|ALPELISIB [MI]|ALPELISIB [WHO-DD]|Alpelisib (JAN/USAN/INN)|GTPL7955|orb1307105|SCHEMBL1911869|ALPELISIB [ORANGE BOOK]|SCHEMBL29358059|CHEBI:93752|EX-A405|STUWGJZDJHPWGZ-LBPRGKRZSA-N|BYL 719; BYL719|BDBM50436459|NSC765974|NSC800065|s2814|AKOS022186315|CCG-269139|CS-0663|DB12015|FP71607|NSC-765974|NSC-800065|SDCCGSBI-0654479.P001|NCGC00346717-03|NCGC00346717-06|NCGC00346717-12|(2S)-N1-[4-Methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-4-pyridinyl]-2-thiazolyl]-1,2-pyrrolidine|AC-37083|AS-16349|HY-15244|NS00072895|SW220128-1|cas:1217486-61-7;BYL-719|D11011|EN300-23810842|BRD-K54997624-001-06-0|Q27074391|(2S)-N1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethyl-ethyl)-4-pyridyl]thiazol-2-yl]pyrrolidine-1,2-dicarboxamide|(2S)-N1-{4-Methyl-5-[1-(1,1,1-trifluoro-2-methylpropan-2-yl)pyridin-4-yl]-1,3-thiazol-2-yl}pyrrolidine-1,2-dicarboxamide|(2S)-N1-{4-METHYL-5-[2-(1,1,1-TRIFLUORO-2-METHYLPROPAN-2-YL)PYRIDIN-4-YL]-1,3-THIAZOL-2-YL}PYRROLIDINE-1,2-DICARBOXAMIDE|(S)-Pyrrolidine-1,2-dicarboxylic acid 2-amide 1-[4-methyl-5-[2-(2,2,2-trifluoro-1,1-dimethylethyl)-pyridin-4-yl]thiazol-2-yl]amide;A  lpelisib"
ENTRECTINIB,25141092,,"InChI=1S/C31H34F2N6O2/c1-38-8-10-39(11-9-38)25-3-4-26(29(19-25)34-24-6-12-41-13-7-24)31(40)35-30-27-17-20(2-5-28(27)36-37-30)14-21-15-22(32)18-23(33)16-21/h2-5,15-19,24,34H,6-14H2,1H3,(H2,35,36,37,40)",HAYYBYPASCDWEQ-UHFFFAOYSA-N,C31H34F2N6O2,560.6,"N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide","Entrectinib|1108743-60-7|Rozlytrek|RXDX-101|NMS-E628|entrectinibum|L5ORF0AN1I|RXDX 101|N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide|DTXSID101026450|Benzamide, N-(5-((3,5-difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-((tetrahydro-2H-pyran-4-yl)amino)-|N-(5-(3,5-Difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide|N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methyl-1-piperazinyl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide|N-{5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl}-4-(4-methylpiperazin-1-yl)-2-[(oxan-4-yl)amino]benzamide|Benzamide, N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]-|RXDX101|N-(5-((3,5-Difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-((oxan-4-yl)amino)benzamide|N-(5-((3,5-difluorophenyl)methyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide|RefChem:58006|L01XE56|DTXCID101510637|Entrectinib (RXDX-101)|Entrectinib(rxdx-101)|N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-((tetrahydro-2H-pyran-4-yl)amino)benzamide|MFCD28129099|N-[5-[(3,5-Difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methyl-1-piperazinyl)-2-[(tetrahydro-2H-pyran-4-yl)amino]benzamide|N-[5-[(3,5-difluorophenyl)methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(tetrahydropyran-4-ylamino)benzamide|Entrectinib [INN]|UNII-L5ORF0AN1I|Entrectinib [USAN:INN]|C31H34F2N6O2|Rozlytrek (TN)|N-(5-(3,5-difluorobenzyl)-1H-indazol-3-yl)-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide|N-[5-(3,5-difluorobenzyl)-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(tetrahydro-2H-pyran-4-ylamino)benzamide|YMX|Entrectinib, 95%|RG 6268|Entrectinib (Standard)|Kinome_2659|ENTRECTINIB [MI]|ENTRECTINIB [JAN]|Entrectinib; NMS-E628|ENTRECTINIB [USAN]|ENTRECTINIB [WHO-DD]|Entrectinib (RXDX-101)?|Entrectinib (JAN/USAN/INN)|GTPL8290|orb1303916|SCHEMBL3512601|CHEMBL1983268|SCHEMBL29358922|SCHEMBL29394152|NMS-E 628|ENTRECTINIB [ORANGE BOOK]|CHEBI:195558|HAYYBYPASCDWEQ-UHFFFAOYSA-N|NMS-E628;RXDX-101|HMS3886H21|HMS5086A05|BCP16174|EX-A2261|HY-12678R|NSC774769|NSC800095|RG6268|s7998|AKOS030632786|CCG-270048|DB11986|NSC-774769|NSC-800095|RG-6268|SB17194|NCGC00484067-01|NCGC00484067-02|NCGC00484067-03|AC-31286|AS-75092|BP-43651|DA-47850|HY-12678|NS00072566|D10926|EN300-7376549|BRD-K39009484-001-01-4|Q25323953|RXDX101; RXDX 101; RXDX-101; NMS E628; NMS-E628;NMS E628|N-[5-(3,5-Difluoro-benzyl)-1H-indazol-3-yl]-4-(4-methyl-piperazin-1-yl)-2-(tetrahydro-pyran-4-ylamino)-benzamide|N-[5-[[3,5-bis(fluoranyl)phenyl]methyl]-1H-indazol-3-yl]-4-(4-methylpiperazin-1-yl)-2-(oxan-4-ylamino)benzamide|N-{5-[(3,5-difluorophenyl)methyl]-3H-indazol-3-ylidene}-4-(4-methylpiperazin-1-yl)-2-[(oxan-4-yl)amino]benzamide"
NAVTEMADLIN,58573469,,"InChI=1S/C28H35Cl2NO5S/c1-17(2)24(16-37(35,36)18(3)4)31-26(19-9-11-21(29)12-10-19)23(20-7-6-8-22(30)13-20)14-28(5,27(31)34)15-25(32)33/h6-13,17-18,23-24,26H,14-16H2,1-5H3,(H,32,33)/t23-,24-,26-,28-/m1/s1",DRLCSJFKKILATL-YWCVFVGNSA-N,C28H35Cl2NO5S,568.6,"2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[(2S)-3-methyl-1-propan-2-ylsulfonylbutan-2-yl]-2-oxopiperidin-3-yl]acetic acid","1352066-68-2|Navtemadlin|AMG-232|AMG 232|Mdm2 inhibitor amg-232|KRT-232|2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic acid|7R7G6EH5UL|KRT232|DTXSID101025652|(3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-((1S)-2-methyl-1-(((1-methylethyl)sulfonyl)methyl)propyl)-2-oxo-3-piperidineacetic acid|RefChem:927524|MDM2 Inhibitor KRT-232|KRT 232|DTXCID101509921|2-((3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-((2S)-3-methyl-1-(propane-2-sulfonyl)butan-2-yl)-2-oxopiperidin-3-yl)acetic acid|AMG232|Navtemadlin [USAN]|CHEMBL3125702|2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[(2S)-3-methyl-1-propan-2-ylsulfonylbutan-2-yl]-2-oxopiperidin-3-yl]acetic acid|C28H35Cl2NO5S|DRLCSJFKKILATL-YWCVFVGNSA-N|2-((3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)acetic Acid;|Navtemadlin; AMG232|Navtemadlin [WHO-DD]|NAVTEMADLIN [INN]|Navtemadlin (USAN/INN)|UNII-7R7G6EH5UL|orb1296183|SCHEMBL9993310|SCHEMBL29529853|GTPL11133|3-Piperidineacetic acid, 5-(3-chlorophenyl)-6-(4-chlorophenyl)-3-methyl-1-[(1S)-2-methyl-1-[[(1-methylethyl)sulfonyl]methyl]propyl]-2-oxo-, (3R,5R,6S)-|EX-A9371|BDBM50448947|MFCD28009440|NSC781515|NSC789723|WHO 11546|AKOS030526440|compound 2 [PMID: 24456472]|CS-3282|DB15299|NSC-781515|NSC-789723|NCGC00387801-04|NCGC00387801-05|AC-29027|AS-17007|DA-70762|FC158737|HY-12296|D12378|BRD-K64925568-001-01-8|NAVTEMADLIN   (SYNONYMS: AMG 232; KRT-232)|{(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-3- methyl-1-[(2S)-3-methyl-1-(propane-2-sulfonyl)butan2-yl]-2-oxopiperidin-3-yl}acetic acid|2-((3R,5R,6S)-5-(3-Chlorophenyl)-6-(4-chlorophenyl)-1-((S)-1-(isopropylsulfonyl)-3-methylbutan-2-yl)-3-methyl-2-oxopiperidin-3-yl)ac  etic acid|2-[(3R,5R,6S)-5-(3-chlorophenyl)-6-(4-chlorophenyl)-1-[(1S)-1-(isopropylsulfonylmethyl)-2-methyl-propyl]-3-methyl-2-oxo-3-piperidyl]acetic acid"
ASTX-660,118169620,,"InChI=1S/C30H42FN5O3/c1-20-14-35(25(13-32-20)15-34-9-10-39-18-21(34)2)16-28(38)36-19-30(3,4)29-27(36)12-23(26(17-37)33-29)11-22-5-7-24(31)8-6-22/h5-8,12,20-21,25,32,37H,9-11,13-19H2,1-4H3/t20-,21-,25-/m1/s1",YCXOHEXZVKOGEV-DNRQZRRGSA-N,C30H42FN5O3,539.7,"1-[6-[(4-fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-2H-pyrrolo[3,2-b]pyridin-1-yl]-2-[(2R,5R)-5-methyl-2-[[(3R)-3-methylmorpholin-4-yl]methyl]piperazin-1-yl]ethanone","ASTX660|1799328-86-1|Tolinapant|ASTX-660|ASTX 660|2LHZ9ZC3YO|Ethanone, 1-(6-((4-fluorophenyl)methyl)-2,3-dihydro-5-(hydroxymethyl)-3,3-dimethyl-1H-pyrrolo(3,2-b)pyridin-1-yl)-2-((2R,5R)-5-methyl-2-(((3R)-3-methyl-4-morpholinyl)methyl)-1-piperazinyl)-|RefChem:115371|XIAP/cIAP1 Antagonist ASTX660|1-(6-(4-fluorobenzyl)-5-(hydroxymethyl)-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-2-((2R,5R)-5-methyl-2-(((R)-3-methylmorpholino)methyl)piperazin-1-yl)ethan-1-one|ASTX 660 [WHO-DD]|CHEMBL4173974|1799328-86-1 (free base)|1-(6-(4-Fluorobenzyl)-5-(hydroxymethyl)-3,3-dimethyl-2,3-dihydro-1H-pyrrolo[3,2-b]pyridin-1-yl)-2-((2R,5R)-5-methyl-2-(((R)-3-methylmorpholino)methyl)piperazin-1-yl)ethanone|1-[6-[(4-fluorophenyl)methyl]-5-(hydroxymethyl)-3,3-dimethyl-2H-pyrrolo[3,2-b]pyridin-1-yl]-2-[(2R,5R)-5-methyl-2-[[(3R)-3-methylmorpholin-4-yl]methyl]piperazin-1-yl]ethanone|MFCD31619274|ASTX660(Tolinapant?|TOLINAPANT [INN]|UNII-2LHZ9ZC3YO|orb1296257|SCHEMBL16830758|SCHEMBL29441233|C30H42FN5O3|GTPL12704|TQP0801|ASTX660; ASTX 660|BCP28730|EX-A2904|BDBM50450046|NSC804861|CS-8216|NSC-804861|compound 27 [PMID: 30091600]|AC-36446|BA166845|BP-42842|MS-29955|HY-109565|G16213|Z3325731321"
ALPRENOLOL,2119,,"InChI=1S/C15H23NO2/c1-4-7-13-8-5-6-9-15(13)18-11-14(17)10-16-12(2)3/h4-6,8-9,12,14,16-17H,1,7,10-11H2,2-3H3",PAZJSJFMUHDSTF-UHFFFAOYSA-N,C15H23NO2,249.35,1-(propan-2-ylamino)-3-(2-prop-2-enylphenoxy)propan-2-ol,"alprenolol|13655-52-2|Alfeprol|Alprenololum|1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol|1-(2-Allylphenoxy)-3-isopropylamino-2-propanol|1-(propan-2-ylamino)-3-(2-prop-2-enylphenoxy)propan-2-ol|DTXSID0045127|CHEBI:51211|2-Propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propenyl)phenoxy]-|877K5MQ27W|NSC-759561|DTXCID8025127|2-Propanol, 1-((1-methylethyl)amino)-3-(2-(2-propenyl)phenoxy)-|{2-hydroxy-3-[2-(prop-2-en-1-yl)phenoxy]propyl}(propan-2-yl)amine|alprenololo|AptinDuriles|Aptin Duriles|Aptin-Duriles|(2-hydroxy-3-(2-(prop-2-en-1-yl)phenoxy)propyl)(propan-2-yl)amine|RefChem:388788|GlyTouCan:G61306SU|G61306SU|H 56 28|237-140-9|C07AA01|H5628|Alpheprol|Alfeprol [Russian]|Alprenololum [INN-Latin]|(RS)-Alprenolol;dl-Alprenolol|S-(-)-ALPRENOLOL|Alprenolol (INN)|2-Propanol, 1-(o-allylphenoxy)-3-(isopropylamino)-|(-)-1-(o-Allylphenoxy)-3-(isopropylamino)-2-propanol|CHEMBL266195|122259-67-0|NCGC00015099-05|ALPRENOLOL [INN]|Alprenolol [INN:BAN]|CAS-13655-52-2|EINECS 237-140-9|Aprenololo|Atenenol|UNII-877K5MQ27W|Alprenolol?|MFCD00242735|Spectrum_000168|ALPRENOLOL [MI]|Prestwick0_000250|Prestwick1_000250|Prestwick2_000250|Prestwick3_000250|Spectrum2_001814|Spectrum3_001066|Spectrum4_001216|Spectrum5_001414|ALPRENOLOL,(+)|ALPRENOLOL,(-)|ALPRENOLOL [MART.]|ALPRENOLOL [WHO-DD]|Lopac0_000152|Oprea1_368995|SCHEMBL34636|BSPBio_000040|BSPBio_002652|GTPL563|KBioGR_001652|KBioSS_000648|DivK1c_000015|SPBio_001827|SPBio_002259|BPBio1_000044|orb1689972|orb1703156|(RS)-Alprenolol; dl-Alprenolol|SCHEMBL29355107|BDBM25764|KBio1_000015|KBio2_000648|KBio2_003216|KBio2_005784|KBio3_001872|NINDS_000015|1-[2-(propen-2-ylphenoxy)]-3-(isopropylamino)propan-2-ol|HMS2089G06|BCP29423|HY-B1517|MSK11099|Tox21_110084|AKOS016376219|Tox21_110084_1|CCG-204247|CS-5734|DB00866|NSC 759561|SDCCGSBI-0050140.P004|IDI1_000015|NCGC00015099-03|NCGC00015099-04|NCGC00015099-06|NCGC00015099-08|NCGC00015099-09|NCGC00015099-11|NCGC00015099-12|NCGC00015099-16|NCGC00089741-02|NCGC00089741-03|NCGC00089741-04|DA-70730|DA-77607|MS-23533|SBI-0050140.P003|AB00053431|NS00008745|D07156|F85411|AB00053431-13|AB00053431_14|655A522|L000961|Q201370|1-(2-Allylphenoxy)-3-(isopropylamino)-2-propanol #|BRD-A00993607-003-05-5|BRD-A00993607-003-15-4|BRD-A00993607-003-24-6|(RS)-1-(2-allylphenoxy)-3-(isopropylamino)propan-2-ol|2-PROPANOL, 1-((1-METHYLETHYL)AMINO)-3-)2-(2-PROPENYL)PHENOXY)-|2-Propanol, 1-[(1-methylethyl)amino]-3-[2-(2-propen-1-yl)phenoxy]-"
NOVOBIOCIN,54675769,,"InChI=1S/C31H36N2O11/c1-14(2)7-8-16-13-17(9-11-19(16)34)27(37)33-21-22(35)18-10-12-20(15(3)24(18)42-28(21)38)41-29-23(36)25(43-30(32)39)26(40-6)31(4,5)44-29/h7,9-13,23,25-26,29,34-36H,8H2,1-6H3,(H2,32,39)(H,33,37)/t23-,25+,26-,29-/m1/s1",YJQPYGGHQPGBLI-KGSXXDOSSA-N,C31H36N2O11,612.6,"[(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate","novobiocin|303-81-1|Streptonivicin|Cardelmycin|Inamycin|Spheromycin|Novobiocina|Novobiocine|Crystallinic acid|Cathocin|Novobiocinum|PA 93|CHEBI:28368|Benzamide, N-(7-((3-O-(aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-beta-L-lyxo-hexopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl)-4-hydroxy-3-(3-methyl-2-butenyl)-|17EC19951N|DTXSID3041083|[(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxochromen-7-yl]oxy-3-methoxy-2,2-dimethyloxan-4-yl] carbamate|N-{7-[(3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-beta-D-gulopyranosyl)oxy]-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl}-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide|NSC2382|((3R,4S,5R,6R)-5-hydroxy-6-(4-hydroxy-3-((4-hydroxy-3-(3-methylbut-2-enyl)benzoyl)amino)-8-methyl-2-oxochromen-7-yl)oxy-3-methoxy-2,2-dimethyloxan-4-yl) carbamate|(3R,4S,5R,6R)-5-hydroxy-6-((4-hydroxy-3-((4-hydroxy-3-(3-methylbut-2-en-1-yl)benzene)amido)-8-methyl-2-oxo-2H-chromen-7-yl)oxy)-3-methoxy-2,2-dimethyloxan-4-yl carbamate|(3R,4S,5R,6R)-5-hydroxy-6-[(4-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzene]amido}-8-methyl-2-oxo-2H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl carbamate|N-(7-((3-O-carbamoyl-6-deoxy-5-methyl-4-O-methyl-beta-D-gulopyranosyl)oxy)-4-hydroxy-8-methyl-2-oxo-2H-chromen-3-yl)-4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamide|Albamix Feed Medication|RefChem:55737|DTXCID1021083|206-146-3|Albamycin|Cathomycin|Antibiotic PA-93|Novobiocine [INN-French]|Novobiocinum [INN-Latin]|Novobiocina [INN-Spanish]|Robiocina|U 6391|Sirbiocina|Stilbiocina|Albamix|CHEMBL36506|Novo-R|NOV|Novobiocin [INN:BAN]|(3R,4S,5R,6R)-5-Hydroxy-6-((4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamido)-8-methyl-2-oxo-2H-chromen-7-yl)oxy)-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate|C31H36N2O11|(3R,4S,5R,6R)-5-hydroxy-6-{[4-hydroxy-3-({[4-hydroxy-3-(3-methylbut-2-en-1-yl)phenyl]carbonyl}amino)-8-methyl-2-oxo-2H-chromen-7-yl]oxy}-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate|[(3R,4S,5R,6R)-5-hydroxy-6-[4-hydroxy-3-[[4-hydroxy-3-(3-methylbut-2-enyl)benzoyl]amino]-8-methyl-2-oxo-chromen-7-yl]oxy-3-methoxy-2,2-dimethyl-tetrahydropyran-4-yl] carbamate|HSDB 7443|EINECS 206-146-3|AI3-50148|Streptonivicin (*Sodium salt*)|UNII-17EC19951N|4urn|4uro|7-(3-(O-Carbamoyl)-4-(O-methyl)-5,5-dimethyl-alpha-L-lyxopyranosyloxy)-4-hydroxy-3-(4-hydroxy-3-(3-methyl-2-butenyl)benzamidol)-8-methylcumarin|7-(Carbamoyltetrahydro-3-hydroxy-5-methoxy-6,6-dimethylpyran-2-yloxy)-4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamide)-8-methyl-2H-chromen-2-one|Spectrum_001001|1aj6|NOVOBIOCIN [MI]|NOVOBIOCIN [INN]|Spectrum2_000977|Spectrum3_000528|Spectrum4_000457|Spectrum5_001274|NOVOBIOCIN [HSDB]|NOVOBIOCIN [VANDF]|NOVOBIOCIN [MART.]|NOVOBIOCIN [USP-RS]|NOVOBIOCIN [WHO-DD]|SCHEMBL24805|BDBM282|BSPBio_002115|KBioGR_000874|KBioGR_002402|KBioSS_001481|KBioSS_002407|MLS001032086|DivK1c_000260|SCHEMBL238345|SPBio_001013|MEGxm0_000273|orb1705597|NOVOBIOCIN [GREEN BOOK]|SCHEMBL29884129|ACon0_000808|ACon1_001693|GTPL12021|KBio1_000260|KBio2_001481|KBio2_002402|KBio2_004049|KBio2_004970|KBio2_006617|KBio2_007538|KBio3_001615|KBio3_002881|MSK7010|cMAP_000043|NINDS_000260|GLXC-10861|HY-B0425|BDBM50226181|STL564718|AKOS027295139|AT38053|DB01051|FN59697|IDI1_000260|NCGC00188981-01|Coumarin, 7-(4-(carbamoyloxy)tetrahydro-3-hydroxy-5-methoxy-6,6-dimethylpyran-2-yloxy)-4-hydroxy-3-(4-hydroxy-3-(4-hydroxy-3-(3-methyl-2-butenyl)benzamido)-8-methyl-|DA-66200|N-[7-[[3-O-(Aminocarbonyl)-6-deoxy-5-C-methyl-4-O-methyl-.beta.-L-lyxo-hexopyranosyl]oxy]-4-hydroxy-8-methyl-2-oxo-2H-1-benzopyran-3-yl]-4-hydroxy-3-(3-methyl-2-butenyl)|SMR000718617|Novobiocin 1000 microg/mL in Acetonitrile|A-256|CS-0082991|NS00010563|C05080|EN300-19736048|Q1639291|BRD-K85307935-236-02-0|BRD-K85307935-236-08-7|BRD-K85307935-236-09-5|BRD-K85307935-236-10-3|(3R,4S,5R,6R)-5-hydroxy-6-({4-hydroxy-3-[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzamido]-8-methyl-2-oxo-2H-chromen-7-yl}oxy)-3-methoxy-2,2-dimethyloxan-4-yl carbamate|(3R,4S,5R,6R)-5-hydroxy-6-(4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamido)-2-oxo-2H-chromen-7-yloxy)-3-methoxy-2,2-dimethyl-tetrahydro-2H-pyran-4-yl carbamate|(3R,4S,5R,6R)-5-hydroxy-6-(4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamido)-8-methyl-2-oxo-2H-chromen-7-yloxy)-3-methoxy-2,2-dimethyl-tetrahydro-2H-pyran-4-yl carbamate|(3R,4S,5R,6R)-5-hydroxy-6-(4-hydroxy-3-(4-hydroxy-3-(3-methylbut-2-enyl)benzamido)-8-methyl-2-oxo-2H-chromen-7-yloxy)-3-methoxy-2,2-dimethyltetrahydro-2H-pyran-4-yl carbamate|(3R,4S,5R,6R)-5-hydroxy-6-[(2-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzene]amido}-8-methyl-4-oxo-4H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl carbamate|BENZAMIDE, N-(7-((3-O-(AMINOCARBONYL)-6-DEOXY-5-C-METHYL-4-O-METHYL-.ALPHA.-L-LYXO-HEXOPYRANOSYL)OXY)-4-HYDROXY-8-METHYL-2-OXO-2H-1-BENZOPYRAN-3-YL)-4-HYDROXY-3-(3-METHYL-2-BUTEN-1-YL)-|BENZAMIDE, N-(7-((3-O-(AMINOCARBONYL)-6-DEOXY-5-C-METHYL-4-O-METHYL-.BETA.-L-LYXO-HEXOPYRANOSYL)OXY)-4-HYDROXY-8-METHYL-2-OXO-2H-1-BENZOPYRAN-3-YL)-4-HYDROXY-3-(3-METHYL-2-BUTENYL)-|Carbamic acid (3R,4S,5R,6R)-5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(3-methyl-but-2-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester|Carbamic acid (3R,4S,5R,6R)-5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(4-methyl-pent-3-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester|Carbamic acid 5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(3-methyl-but-2-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester|Carbamic acid 5-hydroxy-6-{4-hydroxy-3-[4-hydroxy-3-(3-methyl-but-2-enyl)-benzoylamino]-8-methyl-2-oxo-2H-chromen-7-yloxy}-3-methoxy-2,2-dimethyl-tetrahydro-pyran-4-yl ester(Novobiocin)"
SAFINGOL,3058739,,"InChI=1S/C18H39NO2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-18(21)17(19)16-20/h17-18,20-21H,2-16,19H2,1H3/t17-,18-/m0/s1",OTKJDMGTUTTYMP-ROUUACIJSA-N,C18H39NO2,301.5,"(2S,3S)-2-aminooctadecane-1,3-diol","SAFINGOL|15639-50-6|L-threo-Dihydrosphingosine|SPC-100270|(2S,3S)-2-Amino-1,3-octadecanediol|L-threo-2-Amino-1,3-octadecanediol|L-(-)-threo-Sphingnine|NSC-714503|OWA98U788S|DTXSID9045768|DTXCID7025768|NSC714503|Kynacyte|safingolum|RefChem:931138|(2S,3S)-2-aminooctadecane-1,3-diol|DL-threo-Dihydrosphingosine|1,3-Octadecanediol, 2-amino-, (2S,3S)-|Safingol ( L-threo-sphinganine)|2S-aminooctadecane-1,3R-diol|MFCD00792847|1,3-Octadecanediol, 2-amino-, (S-(R*,R*))-|73938-69-9|(-)-threo-Dihydrosphingosine|CAS-15639-50-6|Safingol [USAN:INN]|UNII-OWA98U788S|NCGC00093867-01|L-threo-dihydrosphingosine (d18:0)|SPC 100270|DL-threo-1,3-Dihydroxy-2-aminooctadecane|SAFINGOL [USAN]|Safingol (USAN/INN)|SAFINGOL [INN]|2S,3S-Dihydrosphingosine|SCHEMBL6772|CBiol_001745|BSPBio_001292|KBioGR_000012|KBioSS_000012|BML3-D10|orb1700712|CHEMBL1442934|KBio2_000012|KBio2_002580|KBio2_005148|KBio3_000023|KBio3_000024|1, 2-amino- (2S,3S)|CHEBI:179060|Bio1_000031|Bio1_000520|Bio1_001009|Bio2_000012|Bio2_000492|HMS1361A14|HMS1791A14|HMS1989A14|HMS3402A14|THREO-DIHYDROSPHINGOSINE,L-|3102-56-5|Tox21_111227|BDBM50443385|LMSP01080055|SL-205|DL-threo-Dihydrosphingosine, >=98%|Safingol - CAS 15639-50-6|AKOS030623052|Tox21_111227_1|DB11924|NSC 714503|IDI1_033762|SMP2_000060|NCGC00015362-05|NCGC00161368-01|NCGC00161368-02|NCGC00161368-03|AS-80428|1,3-Octadecanediol, 2-amino-, L-threo-|1,3-Octadecanediol,2-amino-,(2S,3S)-|HY-112384|L-threo-Dihydrosphingosine, >=95% (TLC)|rel-(2S,3S)-2-Aminooctadecane-1,3-diol|CS-0045324|CS-1226543|NS00070395|D05784|Q7398796|Safingol, L-threo-dihydrosphingosine (d18:0) z, powder"
PALONOSETRON,6337614,,"InChI=1S/C19H24N2O/c22-19-16-6-2-4-14-3-1-5-15(18(14)16)11-21(19)17-12-20-9-7-13(17)8-10-20/h2,4,6,13,15,17H,1,3,5,7-12H2/t15-,17-/m1/s1",CPZBLNMUGSZIPR-NVXWUHKLSA-N,C19H24N2O,296.4,"(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one","Palonosetron|135729-61-2|(-)-Palonosetron|2-Qhbiqo|Palonosetronum|Palonosetron, (3as, 3s)-|CHEBI:85161|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one|5D06587D6R|NSC-743769|2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one|DTXSID5048342|(3aS)-2-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one|1H-Benz(de)isoquinolin-1-one, 2-(1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-, (S-(R*,R*))-|RS-25233-198|RS-25259-198|(3aS)-2-((3S)-1-azabicyclo(2.2.2)octan-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo(de)isoquinolin-1-one|(3aS)-2-((3S)-1-azabicyclo(2.2.2)octan-3-yl)-3a,4,5,6-tetrahydro-3H-benzo(de)isoquinolin-1-one|RS-25259|RefChem:56726|DTXCID6028317|A04AA05|RS25259|RS25233197|RS25233198|RS25259197|RS25259198|RS 25233197|RS 25233198|RS 25259197|RS 25259198|RS 25233 197|RS 25233 198|RS 25259 197|RS 25259 198|(5S)-3-((3S)-1-azabicyclo(2.2.2)octan-3-yl)-3-azatricyclo(7.3.1.0?,13)trideca-1(12),9(13),10-trien-2-one|1H-Benz(de)isoquinolin-1-one, 2-((3S)-1-azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-, (3aS)-|Aloxi|Palonosetron [INN]|Aloxi (TN)|MFCD07783848|Palonosetron (INN)|(S)-2-((S)-quinuclidin-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benzo[de]isoquinolin-1-one|(3~{a}~{S})-2-[(3~{S})-1-azabicyclo[2.2.2]octan-3-yl]-3~{a},4,5,6-tetrahydro-3~{H}-benzo[de]isoquinolin-1-one|UNII-5D06587D6R|149653-99-6|Palonosetron; Aloxi|PALONOSETRON [MI]|SCHEMBL3746|PALONOSETRON [VANDF]|(S-(R*,R*))-2-(1-Azabicyclo(2.2.2)oct-3-yl)-2,3,3a,4,5,6-hexahydro-1H-benz(de)isoquinolin-1-one|PALONOSETRON [WHO-DD]|GTPL7486|orb1704804|CHEMBL1189679|SCHEMBL13391549|CPZBLNMUGSZIPR-NVXWUHKLSA-N|GLXC-05581|HMS3886A22|BCP07225|HY-A0018|BDBM50417287|s5740|AKOS015967749|AKOS025311243|CS-0385|DB00377|NSC 743769|NCGC00271490-05|AS-35217|DA-66465|D07175|EN300-220764|AB00698542-05|AB00698542_07|653P996|BRD-K08924299-003-06-1|Z2185274784|(3aS)-2-[(3S)-quinuclidin-3-yl]-3a,4,5,6-tetrahydro-3H-benzo[de]isoquinolin-1-one|(5S)-3-[(3S)-1-azabicyclo[2.2.2]octan-3-yl]-3-azatricyclo[7.3.1.0,5,13]trideca-1(12),9(13),10-trien-2-one|1021481-16-2|1H-BENZ(DE)ISOQUINOLIN-1-ONE, 2-(3S)-1-AZABICYCLO(2.2.2)OCT-3-YL-2,3,3A,4,5,6-HEXAHYDRO-, (3AS)-|Palonosetron; 1H-Benz[de]isoquinolin-1-one, 2-(3S)-1-azabicyclo[2.2.2]oct-3-yl-2,3,3a,4,5,6-hexahydro-, (3aS)-; 1H-Benz[de]isoquinolin-1-one, 2-(1-azabicyclo[2.2.2]oct-3-yl)-2,3,3a,4,5,6-hexahydro-, [S-(R*,R*)]-; (-)-Palonosetron; (3aS)-2-(3S)-1-Azabicyclo[2.2.2]oct-3-"
IZILENDUSTAT,52912218,,"InChI=1S/C22H28ClN3O4/c1-22(2,3)30-21(29)25-12-10-24(11-13-25)15-17-8-9-26(20(28)19(17)27)14-16-4-6-18(23)7-5-16/h4-9,27H,10-15H2,1-3H3",UPJZLOCUUOIMNC-UHFFFAOYSA-N,C22H28ClN3O4,433.9,tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-carboxylate,"Izilendustat|1303512-02-8|tert-butyl 4-((1-(4-chlorobenzyl)-3-hydroxy-2-oxo-1,2-dihydropyridin-4-yl)methyl)piperazine-1-carboxylate|Izilendustat [INN]|MFCD32876908|2KL3NSB2NP|tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxopyridin-4-yl]methyl]piperazine-1-carboxylate|1-Piperazinecarboxylic acid, 4-((1-((4-chlorophenyl)methyl)-1,2-dihydro-3-hydroxy-2-oxo-4-pyridinyl)methyl)-, 1,1-dimethylethyl ester|UNII-2KL3NSB2NP|orb1685710|SCHEMBL1770480|CHEMBL3115298|Gb 004|UPJZLOCUUOIMNC-UHFFFAOYSA-N|BDBM102348|GB004|GLXC-26943|EX-A4505|AKOS040759007|4-[(4-Boc-1-piperazinyl)methyl]-1-(4-chlorobenzyl)-3-hydroxypyridin-2(1H)-one|DA-54494|HY-44809|MS-27762|SY279102|US8536181, A41|CS-0130792|E81525|tert-butyl 4-[[1-[(4-chlorophenyl)methyl]-3-hydroxy-2-oxo-4-pyridyl]methyl]piperazine-1-carboxylate"
PF-04691502,25033539,,"InChI=1S/C22H27N5O4/c1-13-17-11-18(14-3-8-19(30-2)24-12-14)21(29)27(20(17)26-22(23)25-13)15-4-6-16(7-5-15)31-10-9-28/h3,8,11-12,15-16,28H,4-7,9-10H2,1-2H3,(H2,23,25,26)",XDLYKKIQACFMJG-UHFFFAOYSA-N,C22H27N5O4,425.5,"2-amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one","2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido(2,3-d)pyrimidin-7(8H)-one|2-amino-8-(4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one|RefChem:909600|PF-04691502|1013101-36-4|PF 04691502|2-amino-8-((1r,4r)-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one|PF-4691502|PF04691502|MFCD18782794|2-Amino-8-[4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7-one|4W39NS61KI|CHEMBL1234354|CHEMBL5278357|2-Amino-8-(rel-(1r,4r)-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one|2-Amino-8-[trans-4-(2-Hydroxyethoxy)cyclohexyl]-6-(6-Methoxypyridin-3-Yl)-4-Methylpyrido[2,3-D]pyrimidin-7(8h)-One|2-Amino-6-(6-methoxypyridin-3-yl)-4-methyl-8-[(1R,4R)-4-(2-hydroxyethoxy)cyclohexyl]-7h,8h-pyrido[2,3-d]pyrimidin-7-one|2-Amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxy-3-pyridinyl)-4-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one|Pyrido(2,3-d)pyrimidin-7(8H)-one, 2-amino-8-(trans-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxy-3-pyridinyl)-4-methyl-|UNII-4W39NS61KI|2-Amino-8-(cis-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one|2-Amino-8-(cis-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one|2-Amino-8-(trans-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxy-3-pyridinyl)-4-methyl-pyrido(2,3-d)pyrimidin-7(8H)-one|2-Amino-8-[trans-4-(2-hydroxyethoxy)cyclohexyl]-6-(6-methoxy-3-pyridinyl)-4-methyl-pyrido[2,3-d]pyrimidin-7(8H)-one; PF 04691503;|4tv3|MLS006010979|GTPL7936|orb1300936|SCHEMBL1381425|SCHEMBL1381431|SCHEMBL1984896|SCHEMBL10092210|SCHEMBL29352815|SCHEMBL29447277|EX-A032|CHEBI:231357|XDLYKKIQACFMJG-IYBDPMFKSA-N|DTXSID901026004|HMS3656B21|BCP02895|BDBM50380313|BDBM50607921|NSC760536|NSC800846|s2743|AKOS005266645|AKOS030257531|CCG-268947|CS-0919|DB11974|NSC-760536|NSC-800846|SB20066|SDCCGSBI-0654438.P001|NCGC00346659-01|NCGC00346659-12|NCGC00381752-02|NCGC00381752-06|AC-28429|AS-17042|DA-76758|HY-15177|SMR004702782|BCP0726000275|NS00073390|SW220185-1|US8633204, 286|PF-04691502, >=98% (HPLC)|BRD-K07310275-001-02-5|Q27088316|trans-2-Amino-8-((1R,4R)-4-(2-hydroxyethoxy)cyclohexyl)-6-(6-methoxypyridin-3-yl)-4-methylpyrido[2,3-d]pyrimidin-7(8H)-one"
TEGOBUVIR,23649154,,"InChI=1S/C25H14F7N5/c26-19-4-2-1-3-17(19)23-33-21-9-10-37(13-22(21)34-23)12-15-6-8-20(36-35-15)16-7-5-14(24(27,28)29)11-18(16)25(30,31)32/h1-11,13H,12H2",XBEQSQDCBSKCHJ-UHFFFAOYSA-N,C25H14F7N5,517.4,"5-[[6-[2,4-bis(trifluoromethyl)phenyl]pyridazin-3-yl]methyl]-2-(2-fluorophenyl)imidazo[4,5-c]pyridine","Tegobuvir|1000787-75-6|5-((6-(2,4-bis(Trifluoromethyl)phenyl)pyridazin-3-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine|GS-9190|GS-333126|5NOK5X389M|5-[[6-[2,4-bis(trifluoromethyl)phenyl]pyridazin-3-yl]methyl]-2-(2-fluorophenyl)imidazo[4,5-c]pyridine|DTXSID80142917|tegobuvirum|5-((6-(2,4-BIS(TRIFLUOROMETHYL)PHENYL)PYRIDAZIN-3-YL)METHYL)-2-(2-FLUOROPHENYL)-5H-IMIDAZO(4,5-C)PYRIDINE|5-((6-(2,4-bis(trifluoromethyl)phenyl)pyridazin-3-yl)methyl)-2-(2-fluorophenyl)imidazo(4,5-c)pyridine|5-({6-[2,4-bis(trifluoromethyl)phenyl]pyridazin-3-yl}methyl)-2-(2-fluorophenyl)-5h-imidazo[4,5-c]pyridine|RefChem:932660|DTXCID8065408|MFCD18251457|3-[2,4-bis(trifluoromethyl)phenyl]-6-{[2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridin-5-yl]methyl}pyridazine|5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-;5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-|Tegobuvir [USAN:INN]|UNII-5NOK5X389M|C25H14F7N5|Tegobuvir [INN]|GS 9190|GS 333126|Tegobuvir (USAN/INN)|TEGOBUVIR [USAN]|TEGOBUVIR [WHO-DD]|SCHEMBL496778|orb1307687|CHEMBL1957287|SCHEMBL29632593|XBEQSQDCBSKCHJ-UHFFFAOYSA-N|BCP28163|BDBM50461671|EX-A11183|AKOS015949531|CS-0672|DB11852|SB16972|NCGC00378881-01|AS-74871|HY-10544|DB-349549|NS00073275|Tegobuvir (GS-9190; GS 333126)?|D09971|BRD-K26701552-001-01-8|Q27262603|GS-9190; GS 9190; GS9190; GS-333126; GS 333126; GS333126|100078-77-1|5H-IMIDAZO(4,5-C)PYRIDINE, 5-((6-(2,4-BIS(TRIFLUOROMETHYL)PHENYL)-3-PYRIDAZINYL)METHYL)- 2-(2-FLUOROPHENYL)-|5H-Imidazo[4,5-c]pyridine, 5-[[6-[2,4-bis(trifluoromethyl)phenyl]-3-pyridazinyl]methyl]-2-(2-fluorophenyl)-"
VLX-1005,70701426,,"InChI=1S/C21H19N3O4S2/c1-28-18-7-4-5-14(20(18)25)13-22-15-9-11-16(12-10-15)30(26,27)24-21-23-17-6-2-3-8-19(17)29-21/h2-12,22,25H,13H2,1H3,(H,23,24)",OWHBVKBNNRYMIN-UHFFFAOYSA-N,C21H19N3O4S2,441.5,"N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxyphenyl)methylamino]benzenesulfonamide","ML355|1532593-30-8|VLX-1005|ML-355|JKU4XCC48Y|Benzenesulfonamide, N-2-benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)-|N-2-Benzothiazolyl-4-(((2-hydroxy-3-methoxyphenyl)methyl)amino)benzenesulfonamide|RefChem:194590|ML355 free base|N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxyphenyl)methylamino]benzenesulfonamide|N-(benzo[d]thiazol-2-yl)-4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide|ML 355|CHEMBL3113165|N-(1,3-benzothiazol-2-yl)-4-{[(2-hydroxy-3-methoxyphenyl)methyl]amino}benzene-1-sulfonamide|N-2-benzothiazolyl-4-[[(2-hydroxy-3-methoxyphenyl)methyl]amino]-benzenesulfonamide|NCGC00263773-03|ZR5|UNII-JKU4XCC48Y|GTPL8752|orb1302931|SCHEMBL16646023|SCHEMBL29598551|VLX1005|C21H19N3O4S2|CHEBI:195557|GLXC-05556|BCP28954|EX-A1987|HLC59330|VLX 1005|BDBM50447175|ML355?|s6557|AKOS030526578|CS-3351|NCGC00263773-01|NCGC00263773-18|AC-36858|BS-15552|HY-12341|Q27087172|N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxy-phenyl)methylamino]benzenesulfonamide|N-(1,3-benzothiazol-2-yl)-4-[(2-hydroxy-3-methoxybenzyl)amino]benzenesulfonamide|N-(Benzo[d]thiazol-2-yl)-4-(2-hydroxy-3-methoxybenzylamino)benzenesulfonamide|ML-355; ML-355;N-(Benzo[d]thiazol-2-yl)-4-((2-hydroxy-3-methoxybenzyl)amino)benzenesulfonamide"
NAVITOCLAX,24978538,,"InChI=1S/C47H55ClF3N5O6S3/c1-46(2)20-18-42(34-8-12-37(48)13-9-34)36(31-46)32-55-22-24-56(25-23-55)39-14-10-35(11-15-39)45(57)53-65(60,61)41-16-17-43(44(30-41)64(58,59)47(49,50)51)52-38(19-21-54-26-28-62-29-27-54)33-63-40-6-4-3-5-7-40/h3-17,30,38,52H,18-29,31-33H2,1-2H3,(H,53,57)/t38-/m1/s1",JLYAXFNOILIKPP-KXQOOQHDSA-N,C47H55ClF3N5O6S3,974.6,"4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide","Navitoclax|923564-51-6|ABT-263|ABT 263|ABT263|navitoclaxum|XKJ5VVK2WD|A-855071.0|4-[4-[[2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonylbenzamide|DTXSID2042640|CHEBI:131174|Benzamide, 4-(4-((2-(4-chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl)methyl)-1-piperazinyl)-N-((4-(((1R)-3-(4-morpholinyl)-1-((phenylthio)methyl)propyl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonyl)-|4-(4-((2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl)methyl)piperazin-1-yl)-N-(4-(((2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl)amino)-3-trifluoromethanesulfonylbenzenesulfonyl)benzamide|4-(4-((2-(4-chlorophenyl)-5,5-dimethylcyclohexen-1-yl)methyl)piperazin-1-yl)-N-(4-(((2R)-4-morpholin-4-yl-1-phenylsulfanylbutan-2-yl)amino)-3-(trifluoromethylsulfonyl)phenyl)sulfonylbenzamide|4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-(4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-trifluoromethanesulfonylbenzenesulfonyl)benzamide|RefChem:832111|DTXCID0022640|BcI-2 Family Protein Inhibitor ABT-263|ABT-263 (Navitoclax)|Navitoclax (ABT-263)|UNII-XKJ5VVK2WD|(R)-4-(4-((4'-Chloro-4,4-dimethyl-3,4,5,6-tetrahydro-[1,1'-biphenyl]-2-yl)methyl)piperazin-1-yl)-N-((4-((4-morpholino-1-(phenylthio)butan-2-yl)amino)-3-((trifluoromethyl)sulfonyl)phenyl)sulfonyl)benzamide|C47H55ClF3N5O6S3|4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)methyl]propyl]amino]-3-[(trifluoromethyl)sulfonyl]phenyl]sulfonyl]benzamide|CHEMBL443684|MFCD12756219|(R)-4-(4-((2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-enyl)methyl)piperazin-1-yl)-N-(4-(4-morpholino-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)phenylsulfonyl)benzamide|4-[4-[[2-(4-chlorophenyl)-5,5-dimethyl-cyclohexen-1-yl]methyl]piperazin-1-yl]-N-[4-[[(1R)-3-morpholino-1-(phenylsulfanylmethyl)propyl]amino]-3-(trifluoromethylsulfonyl)phenyl]sulfonyl-benzamide|4-(4-{[2-(4-chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({4-({(1R)-3-morpholin-4-yl-1-[(phenylsulfanyl)methyl]propyl}amino)-3-[(trifluoromethyl)sulfonyl]phenyl}sulfonyl)benzamide|4-(4-{[2-(4-Chlorophenyl)-5,5-Dimethylcyclohex-1-En-1-Yl]methyl}piperazin-1-Yl)-N-[(4-{[(2r)-4-(Morpholin-4-Yl)-1-(Phenylsulfanyl)butan-2-Yl]amino}-3-[(Trifluoromethyl)sulfonyl]phenyl)sulfonyl]benzamide|Navitoclax [USAN]|Navitoclax [USAN:INN]|Novitoclax|4-(4-((2-(4-CHLOROPHENYL)-5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)METHYL)PIPERAZIN-1-YL)-N-((4-(((2R)-4-(MORPHOLIN-4-YL)-1-(PHENYLSULFANYL)BUTAN-2-YL)AMINO)-3-((TRIFLUOROMETHYL)SULFONYL)PHENYL)SULFONYL)BENZAMIDE|ABT-263,Navitoclax|NAVITOCLAX [MI]|ABT-263 In Bulk|Navitoclax; ABT-263|NAVITOCLAX [INN]|NAVITOCLAX [JAN]|ABT-263 (Navitoclax)?|NAVITOCLAX [WHO-DD]|MLS006011021|Navitoclax (JAN/USAN/INN)|SCHEMBL522847|GTPL8319|orb1306480|SCHEMBL29363785|CHEBI:94128|EX-A055|JLYAXFNOILIKPP-KXQOOQHDSA-N|GLXC-02824|BDBM50270877|NSC759659|s1001|AKOS015896297|DB12340|FN16901|NSC-759659|RG-7433|NCGC00188344-01|NCGC00188344-02|NCGC00188344-03|NCGC00188344-05|NCGC00188344-08|(R)-4-(4-((2-(4-Chlorophenyl)-5,5-dimethylcyclohex-1-enyl)methyl)piperazin-1-yl)-N-(4-(4-morpholino-1-(phenylthio)butan-2-ylamino)-3-(trifluoromethylsulfonyl)p|4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-mo|AC-31055|AS-16690|HY-10087|SMR004702817|NS00073445|SW218055-2|D09935|564A516|BRD-K82746043-001-01-1|BRD-K82746043-001-02-9|BRD-K82746043-001-03-7|BRD-K82746043-001-04-5|BRD-K82746043-001-15-1|BRD-K82746043-001-19-3|Q18002993|4-(4-((2-(4-CHLOROPHENYL)-5,5-DIMETHYLCYCLOHEX-1-EN-1-YL)METHYL)PIPERAZIN-1-YL)-N-(4-(((2R)-4-(MORPHOLIN-4-YL)-1-(PHENYLSULFANYL)BUTAN-2-YL)AMINO)-3-(TRIFLUOROMETHANESULFONYL)BENZENESULFONYL)BENZAMIDE|4-(4-{[2-(4-Chlorophenyl)-5,5-dimethylcyclohex-1-en-1-yl]methyl}piperazin-1-yl)-N-({4-({(1R)-3-(morpholin-4-yl)-1-[(phenylsulfanyl)methyl]propyl}amino)-3-[(trifluoromethyl)sulfonyl]phenyl}sulfonyl)benzamide|4-[4-[[2-(4-Chlorophenyl)-5,5-dimethyl-1-cyclohexen-1-yl]methyl]-1-piperazinyl]-N-[[4-[[(1R)-3-(4-morpholinyl)-1-[(phenylthio)me|4-{4-[(4'-chloro-4,4-dimethyl-3,4,5,6-tetrahydro[biphenyl]-2-yl)methyl]piperazin-1-yl}-N-[(4-{[(2R)-4-(morpholin-4-yl)-1-(phenylsulfanyl)butan-2-yl]amino}-3-[(trifluoromethyl)sulfonyl]phenyl)sulfonyl]benzamide|BENZAMIDE, 4-(4-((2-(4-CHLOROPHENYL)-5,5-DIMETHYL-1-CYCLOHEXEN-1-YL)METHYL)-1- PIPERAZINYL)-N-((4-(((1R)-3-(4-MORPHOLINYL)-1-((PHENYLTHIO)METHYL)PROPYL)AMINO)-3-((TRIFLUOROMETHYL)SULFONYL)PHENYL)SULFONYL)-|N-(4-{4-[2-(4-chlorophenyl)-5,5-dimethyl-cyclohex-1-enylmethyl]-piperazin-1-yl}-benzoyl)-4-((r)-3-morpholin-4-yl-1-phenylsulfanylmethyl-propylamino)-3-trifluoromethanesulfonyl-benzenesulfonamide"
BECLABUVIR,56934415,,"InChI=1S/C36H45N5O5S/c1-38(2)47(44,45)37-34(42)23-10-14-28-31(16-23)40-21-36(35(43)41-24-11-12-25(41)20-39(3)19-24)18-30(36)29-17-26(46-4)13-15-27(29)33(40)32(28)22-8-6-5-7-9-22/h10,13-17,22,24-25,30H,5-9,11-12,18-21H2,1-4H3,(H,37,42)/t24-,25+,30-,36-/m0/s1",ZTTKEBYSXUCBSE-QDFUAKMASA-N,C36H45N5O5S,659.8,"(8S,10R)-19-cyclohexyl-N-(dimethylsulfamoyl)-5-methoxy-10-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl]-12-azapentacyclo[10.7.0.02,7.08,10.013,18]nonadeca-1(19),2(7),3,5,13(18),14,16-heptaene-15-carboxamide","Beclabuvir|MYW1X5CO9S|DTXSID701026084|Cycloprop(d)indolo(2,1-a)(2)benzazepine-9-carboxamide, 12-cyclohexyl-N-((dimethylamino)sulfonyl)-4b,5,5a,6-tetrahydro-3-methoxy-5a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)-, (4bS,5aR)-|(4bS,5aR)-12-Cyclohexyl-N-(dimethylsulfamoyl)-3-methoxy-5a-((3-methyl-3,8-diazabicyclo(3.2.1)oct-8-yl)carbonyl)-4b,5,5a,6-tetrahydrocyclopropa(d)indolo(2,1-a)(2)benzazepine-9-carboxamide|beclabuvirum|(4bS,5aR)-12-Cyclohexyl-N-(dimethylsulfamoyl)-3-methoxy-5a-[(3-methyl-3,8-diazabicyclo[3.2.1]oct-8-yl)carbonyl]-4b,5,5a,6-tetrahydrocyclopropa[d]indolo[2,1-a][2]benzazepine-9-carboxamide|RefChem:561159|DTXCID001510341|(8S,10R)-19-cyclohexyl-N-(dimethylsulfamoyl)-5-methoxy-10-((1S,5R)-3-methyl-3,8-diazabicyclo(3.2.1)octane-8-carbonyl)-12-azapentacyclo(10.7.0.02,7.08,10.013,18)nonadeca-1(19),2(7),3,5,13(18),14,16-heptaene-15-carboxamide|CHEMBL4105584|(1ar,12bs)-8-Cyclohexyl-N-(Dimethylsulfamoyl)-11-Methoxy-1a-{[(1r,5s)-3-Methyl-3,8-Diazabicyclo[3.2.1]oct-8-Yl]carbonyl}-1,1a,2,12b-Tetrahydrocyclopropa[d]indolo[2,1-A][2]benzazepine-5-Carboxamide|Beclabuvir [USAN:INN]|Beclabuvir [USAN]|BMS 791325|BECLABUVIR [MI]|BECLABUVIR [INN]|UNII-MYW1X5CO9S|BECLABUVIR [WHO-DD]|SCHEMBL14878708|SCHEMBL29455919|cyclohexyl-N-(dimethylsulfamoyl)-methoxy-[(1S,5R)-3-methyl-3,8-diazabicyclo[3.2.1]octane-8-carbonyl][?]carboxamide|BDBM50268401|DB12225|NCGC00483024-01|NS00073452|Q19596032|2N7"
DIFLUNISAL,3059,,"InChI=1S/C13H8F2O3/c14-8-2-3-9(11(15)6-8)7-1-4-12(16)10(5-7)13(17)18/h1-6,16H,(H,17,18)",HUPFGZXOMWLGNK-UHFFFAOYSA-N,C13H8F2O3,250.20,"5-(2,4-difluorophenyl)-2-hydroxybenzoic acid","diflunisal|22494-42-4|Dolobid|Dolobis|Flovacil|5-(2,4-Difluorophenyl)salicylic acid|5-(2,4-difluorophenyl)-2-hydroxybenzoic acid|Diflunisalum|2',4'-Difluoro-4-hydroxy-3-biphenylcarboxylic acid|2-(Hydroxy)-5-(2,4-difluorophenyl)benzoic acid|5-[2,4-Difluorophenyl]salicylic acid|[1,1'-Biphenyl]-3-carboxylic acid, 2',4'-difluoro-4-hydroxy-|DTXSID5022932|MK647|2',4'-difluoro-4-hydroxy-[1,1'-biphenyl]-3-carboxylic acid|NSC-756728|7C546U4DEN|2',4'-Difluoro-4-hydroxy-(1,1'-biphenyl)-3-carboxylic acid|(1,1'-Biphenyl)-3-carboxylic acid, 2',4'-difluoro-4-hydroxy-|CHEBI:39669|DTXCID702932|Dolocid|Novo-Diflunisal|Apo-Diflunisal|Nu-Diflunisal|NovoDiflunisal|ApoDiflunisal|NuDiflunisal|Apo Diflunisal|Novo Diflunisal|Nu Diflunisal|Dolobid 500|RefChem:56757|N02BA11|245-034-9|Fluniget|Fluodonil|Adomal|Flustar|MK-647|Diflusinal|MFCD00057834|MK 647|5-(2,4-DIFLUOROPHENYL)-2-HYDROXY-BENZOIC ACID|2',4'-difluoro-4-hydroxybiphenyl-3-carboxylic acid|CHEMBL898|2',4'-difluoro-4-hydroxy-biphenyl-3-carboxylic acid|MLS000028678|Algobid|Citidol|Difludol|Noaldol|Reuflos|2',4'-Difluoro-4-hydroxy[1,1'-biphenyl]-3-carboxylic acid|3-BIPHENYLCARBOXYLIC ACID, 2',4'-DIFLUORO-4-HYDROXY-|Unisal|1286107-99-0|NCGC00016765-01|Dolisal|Dolobil|SMR000058723|CAS-22494-42-4|Diflunisalum [INN-Latin]|1FL|Dolobid (TN)|SR-01000003165|EINECS 245-034-9|BRN 2654431|UNII-7C546U4DEN|Diflunisal (JAN/USP/INN)|Prestwick_168|Diflunisal [USAN:USP:INN:BAN:JAN]|Diflunisal (Standard)|Spectrum_000962|DIFLUNISAL [MI]|Opera_ID_803|DIFLUNISAL [INN]|DIFLUNISAL [JAN]|Prestwick0_000039|Prestwick1_000039|Prestwick2_000039|Prestwick3_000039|Spectrum2_001012|Spectrum3_000392|Spectrum4_000513|Spectrum5_000901|DIFLUNISAL [USAN]|DIFLUNISAL [VANDF]|DIFLUNISAL [MART.]|SCHEMBL4337|DIFLUNISAL [USP-RS]|DIFLUNISAL [WHO-DD]|BSPBio_000137|BSPBio_002203|KBioGR_001085|KBioSS_001442|MLS001146895|BIDD:GT0063|DivK1c_000938|SPECTRUM1500245|SPBio_001163|SPBio_002058|Diflunisal, analytical standard|BPBio1_000151|GTPL7162|orb1310272|DIFLUNISAL [EP IMPURITY]|DIFLUNISAL [ORANGE BOOK]|SCHEMBL18096517|SCHEMBL29367380|SCHEMBL30509654|HMS502O20|KBio1_000938|KBio2_001442|KBio2_004010|KBio2_006578|KBio3_001423|DIFLUNISAL [USP IMPURITY]|MSK7163|NINDS_000938|DIFLUNISAL [USP MONOGRAPH]|GLXC-20635|HMS1568G19|HMS1920G10|HMS2090C16|HMS2091M20|HMS2095G19|HMS3259G17|HMS3712G19|HMS3885H10|HMS5083D21|Pharmakon1600-01500245|BCP09905|Tox21_110598|BDBM50240510|CCG-40230|HY-18342R|NSC756728|s4609|SBB058143|AKOS005762917|Tox21_110598_1|DB00861|FD16025|KS-1346|NC00506|NSC 756728|IDI1_000938|NCGC00016765-02|NCGC00016765-03|NCGC00016765-04|NCGC00016765-05|NCGC00016765-06|NCGC00016765-08|NCGC00016765-09|NCGC00022783-03|NCGC00022783-04|HY-18342|SY106650|SBI-0051347.P003|DB-045934|AB00051969|CS-0007468|D5875|NS00009099|ST51014978|C01691|D00130|AB00051969-12|AB00051969_13|EN300-3232727|F031599|2',4'-difluoro-4-hydroxybipheny-3-carboxylic acid|2'-4'-Difluoro-4-hydroxybiphenyl-3-carboxylic acid|Q2602750|SR-01000003165-2|SR-01000003165-3|BRD-K22031190-001-05-3|BRD-K22031190-001-13-7|BRD-K22031190-001-23-6|Diflunisal, European Pharmacopoeia (EP) Reference Standard|2',4'-Difluoro-4-hydroxy-(1',1-diphenyl)-3-carboxylic acid|Diflunisal, United States Pharmacopeia (USP) Reference Standard|2 inverted exclamation mark ,4 inverted exclamation mark -Difluoro-4-hydroxybiphenyl-3-carboxylic Acid"
TAFAMIDIS,11001318,,"InChI=1S/C14H7Cl2NO3/c15-9-3-8(4-10(16)6-9)13-17-11-2-1-7(14(18)19)5-12(11)20-13/h1-6H,(H,18,19)",TXEIIPDJKFWEEC-UHFFFAOYSA-N,C14H7Cl2NO3,308.1,"2-(3,5-dichlorophenyl)-1,3-benzoxazole-6-carboxylic acid","TAFAMIDIS|594839-88-0|Vyndamax|2-(3,5-Dichlorophenyl)-1,3-Benzoxazole-6-Carboxylic Acid|FX-1006|tafamidisum|8FG9H9D31J|CHEBI:78538|2-(3,5-dichlorophenyl)benzoxazole-6-carboxylic acid|FX1006|FX-1005|DTXSID00208185|6-Benzoxazolecarboxylic acid, 2-(3,5-dichlorophenyl)-|RefChem:56085|DTXCID20130676|N07XX08|813-715-5|FX006|2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid|2-(3,5-dichlorophenyl)benzo[d]oxazole-6-carboxylic acid|C14H7Cl2NO3|MFCD16621109|594839-88-0 (free acid)|Tafamidis [USAN]|Tafamidis [USAN:INN]|UNII-8FG9H9D31J|4his|tafamidis-meglumine|Vyndamax (TN)|3MI|2-(3,5-Dichlorophenyl)-6-benzoxazolecarboxylic Acid|Vynmac (TN)|Tafamidis;Fx 1006|TAFAMIDIS [INN]|TAFAMIDIS [JAN]|TAFAMIDIS [MI]|TAFAMIDIS [MART.]|TAFAMIDIS [WHO-DD]|Tafamidis (JAN/USAN/INN)|SCHEMBL442508|GTPL8378|orb1302753|TAFAMIDIS [ORANGE BOOK]|CHEMBL2103837|PF-06291826(Tafamidis)|SCHEMBL29361223|PF-06291826(Tafamidis)?|GLXC-10770|HMS3741E09|HMS5085B06|BCP29089|EX-A3575|BDBM50197883|s6465|AKOS017550076|DB11644|FD27988|VS-0125|NCGC00390731-01|137464-18-7|HY-14852|SY217402|DB-072645|NS00072572|C75776|D09673|EN300-307185|839D880|Q519447|BRD-K23728141-001-01-2|Z1443584665|Tafamidis; 2-(3,5-Dichlorophenyl)-6-benzoxazole carboxylic acid"
LUMATEPERONE TOSYLATE,44241743,,"InChI=1S/C24H28FN3O.C7H8O3S/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17;1-6-2-4-7(5-3-6)11(8,9)10/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3;2-5H,1H3,(H,8,9,10)/t20-,21-;/m0./s1",LHAPOGAFBLSJJQ-GUTACTQSSA-N,C31H36FN3O4S,565.7,"1-(4-fluorophenyl)-4-[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one;4-methylbenzenesulfonic acid","lumateperone Tosylate|1187020-80-9|ITI-007 tosylate|Caplyta|JIE88N006O|DTXSID701026210|RefChem:57790|DTXCID101510463|lumateperone (Tosylate)|ITI-007|Lumateperone tosylate [USAN]|1-(4-fluorophenyl)-4-[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one;4-methylbenzenesulfonic acid|Lumateperone tosylate (USAN)|Lumateperone(iti-007)|CHEMBL3233142|UNII-JIE88N006O|Caplyta (TN)|MFCD29922434|lumateperone Tosylate?|Lumateperone Tosylate Salt|C31H36FN3O4S|SCHEMBL1769664|SCHEMBL29355976|LHAPOGAFBLSJJQ-GUTACTQSSA-N|GLXC-10824|LUMATEPERONE TOSYLATE [WHO-DD]|CS-5540|AC-36919|BL167386|DA-55068|HY-19733|LUMATEPERONE TOSYLATE [ORANGE BOOK]|D11170|Q27281520|1-(4-Fluoro-phenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one tosylate salt|1-(4-Fluorophenyl)-4-((6bR,10aR)-3-Methyl-2,3,6B,7,10,10A-Hexahydro-1H-Pyrido[3',4':4,5]Pyrrolo[1,2,3-De]Quinoxalin-8(9H)-Yl)Butan-1-One 4-Methylbenzenesulfonate|1-(4-Fluorophenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(9H)-yl)butan-1-one 4-methylbenzenesulfonate|1-(4-fluorophenyl)-4-[(6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]butan-1-one 4-methylbenzenesulfonate (1:1)|1-Butanone, 1-(4-fluorophenyl)-4-[(6bR,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-, 4-methylbenzenesulfonate (1:1)"
BRENSOCATIB,118253852,,"InChI=1S/C23H24N4O4/c1-27-19-12-17(7-8-20(19)31-23(27)29)16-5-3-15(4-6-16)11-18(13-24)26-22(28)21-14-25-9-2-10-30-21/h3-8,12,18,21,25H,2,9-11,14H2,1H3,(H,26,28)/t18-,21-/m0/s1",AEXFXNFMSAAELR-RXVVDRJESA-N,C23H24N4O4,420.5,"(2S)-N-[(1S)-1-cyano-2-[4-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide","brensocatib|AZD7986|1802148-05-5|INS1007|AZD 7986|AZD-7986|INS-1007|25CG88L0BB|INS 1007|(S)-N-((S)-1-Cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo-(d)oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide|1,4-Oxazepine-2-carboxamide, N-((1S)-1-cyano-2-(4-(2,3-dihydro-3-methyl-2-oxo-5-benzoxazolyl)phenyl)ethyl)hexahydro-, (2S)-|(2S)-N-((1S)-1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide|(2S)-N-{(1S)-1-Cyano-2-[4-(3-methyl-2-oxo-2,3-dihydro-1,3-benzoxazol-5-yl)phenyl]ethyl}-1,4-oxazepane-2-carboxamide|RefChem:121325|Brensocatib [USAN]|(S)-N-((S)-1-cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide|(2S)-N-[(1S)-1-cyano-2-[4-(3-methyl-2-oxo-1,3-benzoxazol-5-yl)phenyl]ethyl]-1,4-oxazepane-2-carboxamide|UNII-25CG88L0BB|CHEMBL3900409|WHO 11097|AEXFXNFMSAAELR-RXVVDRJESA-N|BRENSOCATIB [INN]|Brensocatib (USAN/INN)|BRENSOCATIB [WHO-DD]|GTPL9412|orb1296252|SCHEMBL16932317|SCHEMBL29363739|BRENSOCATIB (AZD7986)|C23H24N4O4|GLXC-21270|EX-A1866|AZD7986;INS 1007|BDBM50195235|AC-36222|AS-84225|BB177302|DA-71203|HY-101056|CS-0020766|D12120|D84088|AZD 7986;(S)-N-((S)-1-Cyano-2-(4-(3-methyl-2-oxo-2,3-dihydrobenzo[d]oxazol-5-yl)phenyl)ethyl)-1,4-oxazepane-2-carboxamide"
GSK2816126,68210102,,"InChI=1S/C31H38N6O2/c1-6-22(5)37-18-20(3)29-25(30(38)34-17-26-19(2)13-21(4)35-31(26)39)14-24(15-27(29)37)23-7-8-28(33-16-23)36-11-9-32-10-12-36/h7-8,13-16,18,22,32H,6,9-12,17H2,1-5H3,(H,34,38)(H,35,39)/t22-/m0/s1",FKSFKBQGSFSOSM-QFIPXVFZSA-N,C31H38N6O2,526.7,"1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-ylpyridin-3-yl)indole-4-carboxamide","GSK126|1346574-57-9|GSK-126|GSK 126|(S)-1-(sec-Butyl)-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide|GSK2816126|GSK-2816126|W4OGW9QZ97|1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-methyl-6-(6-piperazin-1-ylpyridin-3-yl)indole-4-carboxamide|CHEMBL3287735|EZH2 inhibitor|GSK-2816126A|1H-Indole-4-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-3-methyl-1-((1S)-1-methylpropyl)-6-(6-(1-piperazinyl)-3-pyridinyl)-|N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide|S)-1-(sec-butyl)-N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide|1-[(2S)-butan-2-yl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-3-methyl-6-[6-(piperazin-1-yl)pyridin-3-yl]-1H-indole-4-carboxamide|N-((1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-3-methyl-1-((1S)-1-methylpropyl)-6-(6-(1-piperazinyl)-3-pyridinyl)-1H-indole-4-carboxamide|FKSFKBQGSFSOSM-QFIPXVFZSA-N|A9G|MFCD23381067|RefChem:1086196|GSK126 HCl|UNII-W4OGW9QZ97|GSK-126 HCl|MLS006010251|GTPL7012|orb1306533|SCHEMBL12180401|SCHEMBL29352969|EX-A499|CHEBI:124921|EZH2 Inhibitor GSK2816126|DTXSID301025739|BCP06129|GSK-126?|BDBM50017293|NSC780041|NSC789702|s7061|AKOS027322309|CCG-269895|CS-1401|FB43076|GSK 2816126 [WHO-DD]|NSC-780041|NSC-789702|NCGC00347286-01|AS-16379|HY-13470|N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-1-[(1S)-1-methylpropyl]-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide|SMR004701327|BRD-K21867462-001-02-9|BRD-K21867462-001-03-7|Q27077865|Histone-Lysine N-Methyltransferase EZH2 Inhibitor GSK2816126|(S)-1-sec-butyl-N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carboxamide|1-[(2S)-2-Butanyl]-N-[(4,6-dimethyl-2-oxo-1,2-dihydro-3-pyridinyl)methyl]-3-methyl-6-[6-(1-piperazinyl)-3-pyridinyl]-1H-indole-4-carboxamide|S)-1-(sec-butyl)-N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-3-methyl-6-(6-(piperazin-1-yl)pyridin-3-yl)-1H-indole-4-carb  oxamide"
TAZEMETOSTAT,66558664,,"InChI=1S/C34H44N4O4/c1-5-38(29-10-14-41-15-11-29)32-20-28(27-8-6-26(7-9-27)22-37-12-16-42-17-13-37)19-30(25(32)4)33(39)35-21-31-23(2)18-24(3)36-34(31)40/h6-9,18-20,29H,5,10-17,21-22H2,1-4H3,(H,35,39)(H,36,40)",NSQSAUGJQHDYNO-UHFFFAOYSA-N,C34H44N4O4,572.7,"N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide","Tazemetostat|1403254-99-8|EPZ-6438|EPZ6438|N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide|E7438|E-7438|Q40W93WPE1|N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(oxan-4-yl)amino]-2-methyl-5-[4-(morpholin-4-ylmethyl)phenyl]benzamide|DTXSID201025831|(1,1'-Biphenyl)-3-carboxamide, N-((1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(4-morpholinylmethyl)-|N-((4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(oxan-4-yl)amino)-4-methyl-4'-((morpholin-4-yl)methyl)(1,1'-biphenyl)-3-carboxamide|N-[(4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[ethyl(oxan-4-yl)amino]-4-methyl-4'-[(morpholin-4-yl)methyl]-[1,1'-biphenyl]-3-carboxamide|Tazemetostatum|[1,1'-Biphenyl]-3-carboxamide, N-[(1,2-dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4'-(4-morpholinylmethyl)-|N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(oxan-4-yl)amino)-4-methyl-4'-((morpholin-4-yl)methyl)-(1,1'-biphenyl)-3-carboxamide|N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-(1,1'-biphenyl)-3-carboxamide|N-((4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl)-3-(ethyl(oxan-4-yl)amino)-2-methyl-5-(4-(morpholin-4-ylmethyl)phenyl)benzamide|RefChem:56753|DTXCID601510082|Tazemetostat [INN]|Tazemetostat (EPZ-6438)|EPZ 6438|MFCD24849415|Tazemetostat [USAN]|C34H44N4O4|UNII-Q40W93WPE1|Tazemetostat (Standard)|TAZEMETOSTAT [MI]|Tazemetostat (USAN/INN)|Tazemetostat [USAN:INN]|E 7438|Tazemetostat(EPZ-6438)|Tazemetostat(EPZ-6438)?|TAZEMETOSTAT [WHO-DD]|GTPL7011|orb1307447|CHEMBL3414621|SCHEMBL13276848|SCHEMBL19325409|SCHEMBL29350231|EX-A509|CHEBI:231598|NSQSAUGJQHDYNO-UHFFFAOYSA-N|HMS3653O07|HMS3747A09|HMS5087H16|BCP07409|HY-13803R|NSC777109|NSC791066|s7128|AKOS026750211|CCG-264672|CS-1758|DB12887|NSC-777109|NSC-791066|SB22955|NCGC00381562-01|NCGC00381562-10|AC-30931|AS-55991|BP-44055|DA-34776|FT165032|HY-13803|SY040988|NS00073293|SW220030-1|D11444|BRD-K11215326-001-02-9|BRD-K11215326-001-03-7|Q27088941|EPZ-6438; EPZ 6438; E7438; Tazemetostat; E-7438; E 7438|5-(Ethyl(tetrahydro-2H-pyran-4-yl)amino)-N-((2-hydroxy-4,6-dimethylpyridin-3-yl)methyl)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide|N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl) methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)-[1,1'-biphenyl]-3-carboxamide|N-((4,6-dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-5-(ethyl(tetrahydro-2H-pyran-4-yl)amino)-4-methyl-4'-(morpholinomethyl)biphenyl-3-carboxamide|N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4'-(4-morpholinylmethyl)-[1  ,1'-biphenyl]-3-carboxamide|N-[(4,6-Dimethyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-5-[ethyl(tetrahydropyran-4-yl)amino]-4-methyl-4'-(morpholinomethyl)biphenyl-3-carboxamide|N-[(4,6-dimethyl-2-oxo-1H-pyridin-3-yl)methyl]-3-[ethyl(tetrahydropyran-4-yl)amino]-2-methyl-5-[4-(morpholinomethyl)phenyl]benzamide|Tazemetostat; N-[(1,2-Dihydro-4,6-dimethyl-2-oxo-3-pyridinyl)methyl]-5-[ethyl(tetrahydro-2H-pyran-4-yl)amino]-4-methyl-4'-(4-morpholinylmethyl)-[1,1'-biphenyl]-3-carboxamide"
LY-2886721,49837968,,"InChI=1S/C18H16F2N4O2S/c19-11-1-4-15(22-6-11)16(25)23-12-2-3-14(20)13(5-12)18-9-26-7-10(18)8-27-17(21)24-18/h1-6,10H,7-9H2,(H2,21,24)(H,23,25)/t10-,18-/m0/s1",NIDRNVHMMDAAIK-YPMLDQLKSA-N,C18H16F2N4O2S,390.4,"N-[3-[(4aS,7aS)-2-amino-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide","LY2886721|LY-2886721|UNII-2CQ62IWB67|LY 2886721|2CQ62IWB67|DTXSID70155117|n-(3-((4as,7as)-2-amino-4a,5-dihydro-4h-furo(3,4-d)(1,3)thiazin-7a(7h)-yl)-4-fluorophenyl)-5-fluoro-2-pyridinecarboxamide|2-PYRIDINECARBOXAMIDE, N-(3-((4AS,7AS)-2-AMINO-4A,5-DIHYDRO-4H-FURO(3,4-D)(1,3)THIAZIN-7A(7H)-YL)-4-FLUOROPHENYL)-5-FLUORO-|N-[3-[(4aS,7aS)-2-Amino-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl]-4-fluorophenyl]-5-fluoro-2-pyridinecarboxamide|RefChem:154547|DTXCID9077608|1262036-50-9|N-(3-((4aS,7aS)-2-amino-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-7a-yl)-4-fluorophenyl)-5-fluoropicolinamide|MFCD22124078|N-[3-[(4aS,7aS)-2-amino-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl]-5-fluoropyridine-2-carboxamide|CHEMBL2396989|N-{3-[(4as,7as)-2-Amino-4a,5-Dihydro-4h-Furo[3,4-D][1,3]thiazin-7a(7h)-Yl]-4-Fluorophenyl}-5-Fluoropyridine-2-Carboxamide|C18H16F2N4O2S|NIDRNVHMMDAAIK-YPMLDQLKSA-N|MLS006011070|SCHEMBL966802|GTPL6475|orb1301111|SCHEMBL30477100|EX-A029|GLXC-05140|HMS3884J09|BCP02507|BDBM50012647|s2156|AKOS027422646|LY 2886721 - Bio-X trade mark|BCP9000879|CCG-268530|CS-0458|DB12547|NCGC00346506-07|AC-33097|AS-56127|BL300094|FL103714|HY-13240|N-(3-((4aS,7aS)-2-amino-4a,5-dihydro-4H-furo[3,4-d][1,3]thiazin-7a(7H)-yl)-4-fluorophenyl)-5-fluoropicolinamide|SMR004702860|LY2886721?|NS00072934|Q27082776|3YS|N-[3-[(4aS,7aS)-2-amino-4,4a,5,7-tetrahydrofuro[3,4-d][1,3]thiazin-7a-yl]-4-fluoro-phenyl]-5-fluoro-pyridine-2-carboxamide|N-{3-[(4aS,7aS)-2-amino-4H,4aH,5H,7H,7aH-furo[3,4-d][1,3]thiazin-7a-yl]-4-fluorophenyl}-5-fluoropyridine-2-carboxamide|N-3-(4aS ,7aS )-2-Amino-4a,5-Dihydro-4H-Furo3,4-d 1,3Thiazin-7a(7H )-yl-4-Fluorophenyl-5-Fluoro-2-Pyridinecarboxamide"
AS-602868,9820526,,"InChI=1S/C18H14N4O3S/c1-10-9-14(23)22(18(10)24)21-17-15-11(5-3-6-12(15)25-2)19-16(20-17)13-7-4-8-26-13/h3-9H,1-2H3,(H,19,20,21)",GZGLPBNOIFLLRE-UHFFFAOYSA-N,C18H14N4O3S,366.4,"1-[(5-methoxy-2-thiophen-2-ylquinazolin-4-yl)amino]-3-methylpyrrole-2,5-dione","219773-55-4|SPC-839|AS-602868|Y1FZ8P93E0|1-((5-Methoxy-2-(2-thienyl)-4-quinazolinyl)amino)-3-methyl-1H-pyrrole-2,5-dione|1H-Pyrrole-2,5-dione, 1-((5-methoxy-2-(2-thienyl)-4-quinazolinyl)amino)-3-methyl-|RefChem:916278|SPC 839|CHEMBL129857|1-(5-Methoxy-2-thiophen-2-yl-quinazolin-4-ylamino)-3-methyl-pyrrole-2,5-dione|1-[(5-methoxy-2-thiophen-2-ylquinazolin-4-yl)amino]-3-methylpyrrole-2,5-dione|1-(5-methoxy-2-(thiophen-2-yl)quinazolin-4-ylamino)-3-methyl-1H-pyrrole-2,5-dione|1-((5-Methoxy-2-(thiophen-2-yl)quinazolin-4-yl)amino)-3-methyl-1H-pyrrole-2,5-dione|AS602868|UNII-Y1FZ8P93E0|orb1699259|SCHEMBL7859927|SCHEMBL29384622|DTXSID00431335|BDBM50135482|AKOS040749546|1H-Pyrrole-2,5-dione,1-[[5-methoxy-2-(2-thienyl)-4-quinazolinyl]amino]-3-methyl-|NCGC00161703-01|NCGC00161703-02|NCGC00161703-03|HY-10072|DB-328834|CS-0002432|CU-00000000266-1|1-[5-METHOXY-2-(2-THIENYL)QUINAZOLIN-4-YLAMINO]-3-METHYL-3-PYRROLINE-2,5-DIONE"
AKBA,compound name is too short,compound name is too short,compound name is too short,compound name is too short,compound name is too short,compound name is too short,compound name is too short,compound name is too short
BUTACLAMOL,37461,,"InChI=1S/C25H31NO/c1-24(2,3)25(27)13-14-26-16-21-19-9-5-4-7-17(19)11-12-18-8-6-10-20(23(18)21)22(26)15-25/h4-10,21-22,27H,11-16H2,1-3H3/t21-,22-,25-/m1/s1",ZZJYIKPMDIWRSN-TZBSWOFLSA-N,C25H31NO,361.5,"(1R,6R,8R)-6-tert-butyl-3-azapentacyclo[11.8.1.03,8.09,22.016,21]docosa-9,11,13(22),16,18,20-hexaen-6-ol","BUTACLAMOL|A7A2802VNL|l-Butaclamol|DTXSID5048429|RefChem:917727|DTXCID60820423|Butaclamolum|Butaclamol free base|Butaclamol [INN]|36504-93-5|CHEMBL1255588|36504-93-5 (free base)|(1R,6R,8R)-6-tert-butyl-3-azapentacyclo[11.8.1.03,8.09,22.016,21]docosa-9,11,13(22),16,18,20-hexaen-6-ol|(3R,4aR,13bR)-3-(tert-butyl)-2,3,4,4a,8,9,13b,14-octahydro-1H-benzo[6,7]cyclohepta[1,2,3-de]pyrido[2,1-a]isoquinolin-3-ol|1H-Benzo(6,7)cyclohepta(1,2,3-de)-pyrido(2,1-a)isoquinolin-3-ol, 3-(1,1-dimethylethyl)-2,3,4,4a,8,9,13b,14-octahydro-, hydrochloride, (3alpha,4alpha,13beta)-(+/-)-|(+)butaclamol|(+) butaclamol|Butaclamolum [Latin]|UNII-A7A2802VNL|orb1703644|SCHEMBL12119010|SCHEMBL29414950|ZZJYIKPMDIWRSN-TZBSWOFLSA-N|BDBM50366495|PDSP1_000856|PDSP2_000761|PDSP2_000843|PDSP2_001302|AKOS040745639|PD063168|HY-165622|NS00127405|AB01275437-01|BRD-K23082237-003-01-5|(+/-)-3.ALPHA.-TERT-BUTYL-2,3,4,4A.BETA.,8,9,13B.ALPHA.,14-OCTAHYDRO-1H-BENZO(6,7)-CYCLOHEPTA(1,2,3-DE)PYRIDO(2,1-A)ISOQUINOLIN-3-OL|(3alpha,4aalpha,13bbeta)-(+-)-3-(1,1-Dimethylethyl)-2,3,4,4a,8,9,13b,14-octahydro-1H-benzo(6,7)cyclohepta(1,2,3-de)pyrido(2,1-a)isoquinolin-3-ol|1H-Benzo(6,7)-cyclohepta(1,2,3-de)pyrido(2,1-a)isoquinolin-3-ol, 3-(1,1-dimethylethyl)-2,3,4,4a,8,9,13b,14-octahydro-, (3alpha,4aalpha,13bbeta)-(+-)-|1H-BENZO(6,7)CYCLOHEPTA(1,2,3-DE)-PYRIDO(2,1-A)ISOQUINOLIN-3-OL, 3-(1,1-DIMETHYLETHYL)-2,3,4,4A,8,9,13B,14-OCTAHYDRO-, (3.ALPHA.,4A.ALPHA.,13B.BETA.)-(+/-)-|1H-Benzo(6,7)cyclohepta(1,2,3-de)pyrido(2,1-a)isoquinolin-3-ol, 3-(1,1-dimethylethyl)-2,3,4,4a,8,9,13b,14-octahydro-, (3alpha,4aa ha,13bbeta)-(+-)-"
CLONIDINE HYDROCHLORIDE,20179,,"InChI=1S/C9H9Cl2N3.ClH/c10-6-2-1-3-7(11)8(6)14-9-12-4-5-13-9;/h1-3H,4-5H2,(H2,12,13,14);1H",ZNIFSRGNXRYGHF-UHFFFAOYSA-N,C9H10Cl3N3,266.6,"N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride","CLONIDINE HYDROCHLORIDE|4205-91-8|Clonidine HCl|Kapvay|ST-155|Jenloga|Onyda XR|NSC-756699|W76I6XXF06|DTXSID8044670|Benzenamine, 2,6-dichloro-N-2-imidazolidinylidene-, monohydrochloride|2-((2,6-Dichlorophenyl)imino)imidazolidine monohydrochloride|DTXCID6024670|Clonidine HCI|2-[(2,6-Dichlorophenyl)imino]imidazolidine monohydrochloride|Catapres tts 1|Catapres tts 2|Catapres tts 3|Catapres p.l.|RefChem:58518|2-(2,6-Dichlorophenylimino)imidazolidine monohydrochloride|224-121-5|Duraclon|2-(2,6-Dichloroanilino)-2-imidazoline hydrochloride|N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine hydrochloride|Dixarit|Isoglaucon|MFCD00036705|clonidine (hydrochloride)|2-(2,6-Dichlorophenylamino)-2-imidazoline Hydrochloride|C9H10Cl3N3|Chlophazolin|Dispaclonidin|Normopresan|Atensina|Barclyd|Capresin|Caprysin|Catanidin|Clofelin|Clonilou|Clonisin|Clonistada|Edolglau|Glausine|Haemiton|Ipotensium|Katapresan|Klophelin|Iporel|Clonidinhydrochlorid|1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro- [CAS]|Apo-Clonidine|Clonidil-Riker|Novo-Clonidine|Clonid-Ophal|Nu-Clonidine|N-(2,6-dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine;hydrochloride|1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, monohydrochloride (9CI)|Bapresan|Clonicel|Trialox|N-(2,6-DICHLOROPHENYL)-4,5-DIHYDRO-1H-IMIDAZOL-2-AMINE HCL|Clonidine monohydrochloride|DICHLORANILINO IMIDAZOLIN|1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, hydrochloride (1:1)|SMR000466276|205C918|SR-01000075246|EINECS 224-121-5|CAS-4205-91-8|(2,6-dichlorophenyl)-2-imidazolin-2-ylamine, chloride|UNII-W76I6XXF06|clonidine-hcl|SR-01000759380|Prestwick_73|Catapres (TN)|Duraclon (TN)|Nexiclon (TN)|Kapvay (TN)|2-((2,6-Dichlorophenyl)amino)-2-imidazoline hydrochloride|2-Imidazoline, 2-(2,6-dichloroanilino)-, monohydrochloride|2-(2,6-Dichlorophenylamino)-2-imidazolin hydrochlorid [German]|Benzenamine, 2,6-dichloro-N-2-imidazolidinylidene-, hydrochloride|Clonidine hydrochloride [USAN:USP:BAN:JAN]|1H-Imidazol-2-amine, N-(2,6-dichlorophenyl)-4,5-dihydro-, monohydrochloride|CLONIDINEHYDROCHLORIDE|CHEMBL1705|SCHEMBL40751|SCHEMBL40752|MLS000758256|MLS001424222|Clonidine hydrochloride, solid|2-(2,6-Dichlorophenylamino)-2-imidazolin hydrochlorid|CHEBI:3758|HY-B0409AR|orb1309246|HY-B0409A|2-[(2,6-Dichlorophenyl)amino-2-imidazoline hydrochloride|Clonidine hydrochloride (Catapres)|HMS1568B18|HMS3414H03|HMS3678H03|HMS5081E07|Pharmakon1600-01500198|BCP14375|MSK10102|CLONIDINE HYDROCHLORIDE [MI]|Tox21_301552|Tox21_500268|CCG-40087|Clonidine (hydrochloride) (Standard)|Clonidine hydrochloride (JP18/USP)|CLONIDINE HYDROCHLORIDE [JAN]|NSC756699|s2458|SBB003065|CLONIDINE HYDROCHLORIDE [USAN]|AKOS005267207|AKOS024458609|AKOS028114993|CCG-101051|CCG-212540|CCG-229466|CLONIDINE HYDROCHLORIDE [MART.]|CLONIDINE HYDROCHLORIDE [VANDF]|FC20508|KS-1253|LP00268|NC00301|NSC 756699|CLONIDINE HYDROCHLORIDE [USP-RS]|CLONIDINE HYDROCHLORIDE [WHO-DD]|NCGC00093726-01|NCGC00093726-02|NCGC00180902-01|NCGC00256172-01|NCGC00260953-01|AC-10306|AC-29742|ST088475|Clonidine hydrochloride, >=98.0% (TLC)|CLONIDINE HYDROCHLORIDE [EP IMPURITY]|CLONIDINE HYDROCHLORIDE [ORANGE BOOK]|D1353|EU-0100268|NS00083087|SW197681-3|CLONIDINE HYDROCHLORIDE [EP MONOGRAPH]|C 7897|CLONIDINE HYDROCHLORIDE [USP MONOGRAPH]|D00604|D81843|EN300-119527|CLORPRES COMPONENT CLONIDINE HYDROCHLORIDE|A825736|COMBIPRES COMPONENT CLONIDINE HYDROCHLORIDE|SR-01000075246-1|SR-01000075246-3|SR-01000759380-5|Clonidine hydrochloride (Catapres) [largely precursor]|Q27292429|Z1695759754|2-[(2,6-Dichlorophenyl)amino]-2-imidazoline monohydrochloride|Clonidine Hydrochloride 1.0 mg/ml in Methanol (as free base)|Clonidine hydrochloride, British Pharmacopoeia (BP) Reference Standard|Clonidine hydrochloride, European Pharmacopoeia (EP) Reference Standard|Clonidine hydrochloride, United States Pharmacopeia (USP) Reference Standard|N-[2,6-bis(chloranyl)phenyl]-4,5-dihydro-1H-imidazol-2-amine hydrochloride|N-(2,6-Dichlorophenyl)-4,5-dihydro-1H-imidazol-2-amine hydrochloride;2-(2,6-Dichloroanilino)-2-imidazoline hydrochloride;Atensina"
UK-500001,9876393,,"InChI=1S/C26H24F3N3O4/c1-14-2-9-23(33)19(10-14)24(34)31-16-3-5-17(6-4-16)32-25(35)20-11-15(27)13-30-26(20)36-18-7-8-21(28)22(29)12-18/h2,7-13,16-17,33H,3-6H2,1H3,(H,31,34)(H,32,35)",OHIUQAZROSYCMC-UHFFFAOYSA-N,C26H24F3N3O4,499.5,"2-(3,4-difluorophenoxy)-5-fluoro-N-[4-[(2-hydroxy-5-methylbenzoyl)amino]cyclohexyl]pyridine-3-carboxamide","UK-500001|582332-31-8|uk-50001|YOG0PR3Q8J|857900-47-1|UK-500,001|UNII-YOG0PR3Q8J|2-(3,4-Difluorophenoxy)-5-fluoro-N-(cis-4-((2-hydroxy-5-methylbenzoyl)amino)cyclohexyl)nicotinamide|CHEMBL3113734|3-Pyridinecarboxamide, 2-(3,4-difluorophenoxy)-5-fluoro-N-(cis-4-((2-hydroxy-5-methylbenzoyl)amino)cyclohexyl)-|Uk-?500001|2-(3,4-difluorophenoxy)-5-fluoro-N-((1s,4s)-4-(2-hydroxy-5-methylbenzamido)cyclohexyl)nicotinamide|2-(3,4-difluorophenoxy)-5-fluoro-N-[4-[(2-hydroxy-5-methylbenzoyl)amino]cyclohexyl]pyridine-3-carboxamide|orb1699061|orb1741412|SCHEMBL1682956|SCHEMBL1682957|GLXC-07287|BDBM50017340|MFCD34678667|AKOS040749708|DB12837|2-(3,4-Difluorophenoxy)-5-fluoro-N-[cis-4-(2-hydroxy-5-methylbenzamido)cyclohexyl]nicotinamide|SY408826|TS-09395|HY-119799|CS-0078033|NS00073711|Q27294626|2-(3,4-Difluorophenoxy)-5-fluoro-N-(4-(2-hydroxy-5-methylbenzamido)cyclohexyl)nicotinamide|2-[(3,4-Difluorophenyl)oxy]-5-fluoro-N-(cis-4-{[(2-hydroxy-5-methylphenyl)carbonyl]amino}cyclohexyl)-3-pyridinecarboxamide"
METHYLENE BLUE CATION,4139,,"InChI=1S/C16H18N3S/c1-18(2)11-5-7-13-15(9-11)20-16-10-12(19(3)4)6-8-14(16)17-13/h5-10H,1-4H3/q+1",RBTBFTRPCNLSDE-UHFFFAOYSA-N,C16H18N3S+,284.4,[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium,"Methylene Blue cation|Methylthioninium|7060-82-4|UNII-ZMZ79891ZH|ZMZ79891ZH|AI3-52463|DTXSID3047009|Phenothiazin-5-ium, 3,7-bis(dimethylamino)-|RefChem:58888|DTXCID1027009|3,7-bis(dimethylamino)phenothiazin-5-ium|[7-(dimethylamino)phenothiazin-3-ylidene]-dimethylazanium|CHEBI:43830|N-[7-(dimethylamino)-3H-phenothiazin-3-ylidene]-N-methylmethanaminium|CHEMBL405110|NSC3089|NSC215213|NCGC00167496-01|NCGC00167496-03|methylene-blue|Methylthionine HCl|cid_6099|SCHEMBL109755|SCHEMBL127316|CHEMBL191083|SCHEMBL29441543|SCHEMBL29941578|METHYLTHIONINIUM [WHO-DD]|RBTBFTRPCNLSDE-UHFFFAOYSA-N|DNDI1417128|BDBM50241461|BDBM50434369|STK391059|STL483851|AKOS001482930|METHYLENE BLUE CHLORIDE HYDRATE|DB08167|NCGC00159445-02|NCGC00159445-03|NCGC00167496-02|SBI-0206846.P001|3,7-bis(dimethylamino)-phenothiazin-5-ium|NS00005759|AB00443236_03|BRD-K16406336-311-01-2|BRD-K16406336-311-02-0|BRD-K54770538-003-14-6|Q27097395|[7-(dimethylamino)phenothiazin-3-ylidene]-dimethyl-ammonium|7-(Dimethylamino)-N,N-dimethyl-3H-phenothiazin-3-iminium|1001913-24-1"
MICONAZOLE,4189,,"InChI=1S/C18H14Cl4N2O/c19-13-2-1-12(16(21)7-13)10-25-18(9-24-6-5-23-11-24)15-4-3-14(20)8-17(15)22/h1-8,11,18H,9-10H2",BYBLEWFAAKGYCD-UHFFFAOYSA-N,C18H14Cl4N2O,416.1,"1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole","miconazole|22916-47-8|Daktarin IV|Miconazol|Miconazolo|Miconazolum|1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-1H-imidazole|Daktarin|Oravig|1H-Imidazole, 1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-|1-[2-(2,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]imidazole|7NNO0D7S5M|DTXSID6023319|1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|1H-Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-|DTXCID803319|Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-|NSC170986|Dermazole|Dumicoat|Loramyc|1-(2,4-Dichloro-beta-[(2,4-dichlorobenzyl)oxy]phenethyl)imidazole|1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)imidazole|Monistat-3|1-(2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl)-1H-imidazole|1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)-1h-imidazole|1-[2-(2,4-Dichloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|RefChem:55632|CHEBI:6923|Roycederm Tinea Treatment Cream|A01AB09|A07AC01|D01AC02|G01AF04|J02AB01|S02AA13|R14,889|1-((2RS)-2-(2,4-Dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole|245-324-5|Conofite|Monistat|Monistat IV|Minostate|Vusion|1-(2-((2,4-Dichlorobenzyl)oxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole|MJR 1762|Miconazolum [INN-Latin]|MFCD00216019|Florid(nitrate)|C18H14Cl4N2O|R 18134|NSC 170986|Brentan|R18134 nitrate|CHEMBL91|Monistat (TN)|Miconazole nitrate salt|MCZ|CHEBI:82892|22916-47-8 (free)|NSC-170986|Miconazolo [DCIT]|NCGC00016770-01|Dactarin|Micozole|Zimycan|1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl) imidazole|Imidazole, 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)-|Femizol-M|Miconazole-7|Monazole 7|1-[2-(2,4-dichlorophenyl)-2-{[(2,4-dichlorophenyl)methyl]oxy}ethyl]-1H-imidazole|Miconazol [INN-Spanish]|Aflorix(nitrate)|1-(2,4-dichlorophenyl)-1-[(2,4-dichlorophenyl)methoxy]-2-imidazolylethane|1-[2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole|1-{2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole|imidazole, 1-(2,4-dichloro-beta-((2,4-dichlorobenzyl)oxy) phenethyl)-|Albistat(nitrate)|Andergin(nitrate)|Conofite(nitrate)|(+/-)-Miconazole nitrate salt|1H-imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)-|imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl) methoxy)ethyl)- (9CI)|Monista (nitrate)|Micantin (nitrate)|Novo-Miconazole Vaginal Ovules|CCRIS 7924|Gyno-Daktar(nitrate)|Lotrimin AF(nitrate)|Epi-Monistat(nitrate)|Monistat 7 Vaginal Suppositories|EINECS 245-324-5|UNII-7NNO0D7S5M|BRN 0965511|Zimybase|SR-01000000271|Miconazole [USP:INN:BAN:JAN]|Prestwick_335|Oravig (TN)|Miconazole (Monistat)|Miconazole (Standard)|Spectrum_000965|MICONAZOLE [MI]|MICONAZOLE [INN]|MICONAZOLE [JAN]|Prestwick0_000067|Prestwick1_000067|Prestwick2_000067|Prestwick3_000067|Spectrum2_001048|Spectrum3_000507|Spectrum4_000061|Spectrum5_001297|MICONAZOLE [VANDF]|bmse000924|(+-)-1-(2,4-Dichloro-beta-((2,4-dichlorobenzyl)oxy)phenethyl)imidazole|cid_4189|MICONAZOLE [MART.]|SCHEMBL2866|MICONAZOLE [WHO-DD]|Oprea1_091955|BSPBio_000253|BSPBio_002033|KBioGR_000581|KBioSS_001445|MLS002222203|DivK1c_000156|SPBio_000976|SPBio_002174|BPBio1_000279|GTPL2449|Miconazole (JP17/USP/INN)|orb1310703|MICONAZOLE [EP IMPURITY]|MICONAZOLE [ORANGE BOOK]|SCHEMBL13934598|BDBM31772|HY-B0454R|KBio1_000156|KBio2_001445|KBio2_004013|KBio2_006581|KBio3_001533|MICONAZOLE [EP MONOGRAPH]|MICONAZOLE [USP IMPURITY]|NINDS_000156|HMS1568M15|HMS2090B21|HMS2095M15|HMS2232B14|HMS3374J10|HMS3656E14|HMS3712M15|HMS5081K19|MICONAZOLE [USP MONOGRAPH]|HY-B0454|MSK10020|Tox21_110601|DL-448|s2536|SBB057453|STK834405|1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole|AKOS001574474|AKOS016842489|CCG-220067|DB01110|DS-1881|FM30277|1H-Imidazole, 1-2-((2,4-dichlorophenyl)-2-((2,4-dichlorophenyl))methoxy)ethyl)-, (+-)-|IDI1_000156|NCGC00018294-02|NCGC00018294-04|NCGC00018294-06|NCGC00018294-08|NCI60_001353|NCI60_001380|SMR001307249|ST024747|SY107559|SBI-0051448.P003|CAS-22916-47-8|DB-046018|AB00053500|NS00004552|SW196614-4|D00416|AB00053500-23|AB00053500-24|AB00053500-25|AB00053500_26|AB00053500_27|AB00053500_28|EN300-7370602|216M019|AE-641/01941016|Q410534|SR-01000000271-5|BRD-A82396632-001-03-0|BRD-A82396632-001-16-2|BRD-A82396632-008-02-7|BRD-A82396632-008-28-2|BRD-A82396632-008-29-0|1-[2,4dichloro-beta-(2,4-dichlorobenzyloxy)phenethyl]imidazole|1-[2,4-dichloro-beta-(2,4-dichlorobenzyloxy)-phenethyl]imidazole|1-[2,4-dichloro-beta-(2,4-dichlorobenzyloxy)phenethyl]-imidazole|1-[2,4-dichloro-beta-(2,4-dichlorobenzyloxy)phenethyl]imidazole|Imidazole,4-dichloro-.beta.-[(2,4-dichlorobenzyl)oxy]phenethyl]-|1-[2,4-Dichloro-.beta.-[(2,4-dichlorobenzyl)oxy]phenethyl]imidazole|1-[2-(2,4-dichlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]imidazole|1H-Imidazole,4-dichlorophenyl)-2-[(2,4-dichlorophenyl)methoxy]ethyl]-|Imidazole, 1-(2,4-dichloro-.beta.-((2,4-dichlorobenzyl)oxy)phenethyl)-|(+/-)-1-(2,4-DICHLORO-B-((2,4-DICHLOROBENZYL)OXY)PHENETHYL)IMIDAZOLE|1-[2-(2,4-dichlorobenzyl)oxy-2-(2,4-dichlorophenyl)ethyl]imidazole;nitric acid|1-[2-(2,4-Dichlorophenyl)-2-[(2,4-dichlorophenyl)-methoxy]ethyl]-1H-imidazole|1-[2-[(2,4-Dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole #|Imidazole, 1-(2-(2,4-dichlorophenyl)-2-((2,4-dichlorophenyl)methoxy)ethyl)- (9CI)|1H-IMIDAZOLE, 1-2-((2,4-DICHLOROPHENYL)-2-((2,4-DICHLOROPHENYL))METHOXY)ETHYL)-, (+/-)-|75319-47-0|Monistat, Daktarin IV, Miconazolo, Miconazolum, Dactarin, Miconazol, Minostate, Brentan, Florid(nitrate)"
ECONAZOLE,3198,,"InChI=1S/C18H15Cl3N2O/c19-14-3-1-13(2-4-14)11-24-18(10-23-8-7-22-12-23)16-6-5-15(20)9-17(16)21/h1-9,12,18H,10-11H2",LEZWWPYKPKIXLL-UHFFFAOYSA-N,C18H15Cl3N2O,381.7,"1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole","econazole|27220-47-9|Econazolum|Econazol|(+-)-Econazole|1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole|NSC-187789|6Z1Y2V4A7M|1-[2-[(4-Chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole|DTXSID2029872|1-{2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole|1H-Imidazole, 1-(2-((4-chlorophenyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-|1-(2,4-Dichloro-beta-((p-chlorobenzyl)oxy)phenethyl)imidazole|Imidazole, 1-(2,4-dichloro-beta-((p-chlorobenzyl)oxy)phenethyl)-|1H-Imidazole, 1-[2-[(4-chlorophenyl)methoxy]-2-(2,4-dichlorophenyl)ethyl]-|econazolo|Ekonazole|GynoPevaril|Gyno Pevaril|Gyno Pevaryl|1-(2-((4-chlorophenyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1h-imidazole|1-(2-((4-chlorophenyl)methoxy)-2-(2,4-dichlorophenyl)ethyl)imidazole|Gyno Pervaryl 150|RefChem:55089|CHEBI:4754|DTXCID409872|D01AC03|G01AF05|248-341-6|Gyno-Pevaril|Gyno-pevaryl|1-(2-((4-Chlorobenzyl)oxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole|MFCD00800993|NSC 187789|CHEBI:82873|SQ 13050|NSC187789|(+/-)-Econazol|1-{2-[(4-chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole|1-(2,4-Dichloro-.beta.-((p-chlorobenzyl)oxy)phenethyl)imidazole|1-[2,4-Dichloro-.beta.-[(p-chlorobenzyl)oxy]phenethyl]imidazole|1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}-1H-imidazole|Econazole [USAN]|Econazole (USAN/INN)|NCGC00018258-03|Econazol [INN-Spanish]|UNII-6Z1Y2V4A7M|Econazole [USAN:INN:BAN]|CCRIS 9032|1-[2-(4-Chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole|()-Econazol|EINECS 248-341-6|Econazole (Standard)|BRN 0964150|Spectrum_001223|ECONAZOLE [INN]|ECONAZOLE [MI]|(.+/-.)-Econazole|Prestwick0_000304|Prestwick1_000304|Prestwick2_000304|Prestwick3_000304|Spectrum2_001439|Spectrum3_001467|Spectrum4_000446|Spectrum5_001033|ECONAZOLE [VANDF]|CHEMBL808|ECONAZOLE [MART.]|ECONAZOLE [WHO-DD]|(+/-)-ECONAZOLE|SCHEMBL34498|BSPBio_000268|BSPBio_002993|KBioGR_000832|KBioSS_001703|cid_68589|DivK1c_000113|SPBio_001578|SPBio_002487|BPBio1_000296|GTPL2446|orb1310610|ECONAZOLE [EP MONOGRAPH]|SCHEMBL29440264|BDBM31773|HY-B0885R|KBio1_000113|KBio2_001703|KBio2_004271|KBio2_006839|KBio3_002493|NINDS_000113|HMS5084F10|HY-B0885|s5492|STL483402|AKOS015889868|1H-Imidazole,4-dichlorophenyl)ethyl]-|CCG-268426|DB01127|FC33390|IDI1_000113|NCGC00018258-02|NCGC00018258-05|NCGC00018258-06|NCGC00018258-07|NCGC00018258-09|AS-13862|MFCD00058160 (.HNO3)|NCI60_001564|NCI60_001947|SBI-0051682.P002|DB-047186|MICONAZOLE IMPURITY B [EP IMPURITY]|AB00053611|NS00005601|C08068|D03936|F14858|AB00053611-20|AB00053611_21|AB00053611_22|EN300-7371061|220E479|68797-31-9 (.HNO3)|AA-504/31991001|Q417141|MICONAZOLE NITRATE IMPURITY B [EP IMPURITY]|BRD-A51820102-008-05-7|BRD-A51820102-008-16-4|BRD-A51820102-008-27-1|BRD-A51820102-008-28-9|Imidazole, 1,2,4-dichloro-beta-(p-chlorobenzyl)oxyphenethyl-|Imidazole,4-dichloro-.beta.-[(p-chlorobenzyl)oxy]phenethyl]-|1-{2-(4-chlorobenzyloxy)-2-(2,4-dichlorophenyl)ethyl}imidazole|1-[2-(4-chloro-benzyloxy)-2-(2,4-dichloro-phenyl)-ethyl]-1H-imidazole|4-Chlorobenzyl 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethyl ether|Imidazole, 1-(2,4-dichloro-.beta.-((p-chlorobenzyl)oxy)phenethyl)-|1-[(2RS)-2-[(4-Chlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl]-1H-imidazole"
TIVOZANIB,9911830,,"InChI=1S/C22H19ClN4O5/c1-12-8-21(27-32-12)26-22(28)25-16-5-4-13(9-15(16)23)31-18-6-7-24-17-11-20(30-3)19(29-2)10-14(17)18/h4-11H,1-3H3,(H2,25,26,27,28)",SPMVMDHWKHCIDT-UHFFFAOYSA-N,C22H19ClN4O5,454.9,"1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea","Tivozanib|475108-18-0|AV-951|KRN-951|AV951|KRN951|KIL8951|Kil-8951|AV951 cpd|DTXSID20963865|172030934T|Urea, N-(2-chloro-4-((6,7-dimethoxy-4-quinolinyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)-|1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-(5-methyl-1,2-oxazol-3-yl)urea|tivozanibum|1-(2-chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methyl-1,2-oxazol-3-yl)urea|RefChem:58429|DTXCID60205690|L01XE34|968-821-5|Tivozanib (AV-951)|1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea|AV 951|C22H19ClN4O5|N-[2-CHLORO-4-[(6,7-DIMETHOXY-4-QUINOLYL)OXY]PHENYL]-N'-(5-METHYL-3-ISOXAZOLYL)UREA|KRN 951|MFCD15146788|CHEMBL1289494|AV-951;KRN951|1-[2-chloro-4-(6,7-dimethoxyquinolin-4-yl)oxyphenyl]-3-(5-methyl-1,2-oxazol-3-yl)urea|1-(2-CHLORO-4-(6,7-DIMETHOXYQUINOLIN-4-YLOXY)PHENYL)-3-(5-METHYLISOXAZOL-3-YL)UREA|N-(2-Chloro-4-((6,7-dimethoxy-4-quinolyl)oxy)phenyl)-N'-(5-methyl-3-isoxazolyl)urea|Tivozanib [USAN]|ASP-4130|AV-951(Tivozanib)|Tivozanib [USAN:INN]|4ase|N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea|AV9|UNII-172030934T|AV-951,Tivozanib|TIVOZANIB [INN]|Tivozanib (USAN/INN)|Tivozanib(AV-951)?|TIVOZANIB [WHO-DD]|MLS006011287|SCHEMBL172883|Tivozanib - Bio-X trade mark|GTPL6058|orb1305458|SCHEMBL29354238|SCHEMBL29354604|CHEBI:91327|EX-A472|SPMVMDHWKHCIDT-UHFFFAOYSA-N|HMS3229O09|HMS3244C19|HMS3244C20|HMS3244D19|HMS3265A11|HMS3265A12|HMS3265B11|HMS3265B12|HMS3654G22|HMS3745C05|HMS5079O15|BCP01980|VEGFR Tyrosine Kinase Inhibitor IV|BDBM50331095|NSC758007|NSC800952|s1207|AKOS022177607|BCP9000343|CCG-206805|CS-0103|DB11800|EX-8600|NSC-758007|NSC-800952|PB28569|SDCCGSBI-0636568.P003|1-(2-Chloro-4-((6,7-dimethoxyquinolin-4-yl)-oxy)phenyl)-3-(5-methylisoxazol-3-yl)urea|1-[2-chloro-4-[(6,7-dimethoxy-4-quinolyl)oxy]phenyl]-3-(5-methylisoxazol-3-yl)urea|NCGC00249390-01|NCGC00249390-05|NCGC00249390-12|AC-24702|AS-16997|BP-44057|BT160380|BT300016|HY-10977|SMR004703037|NS00068487|SW219364-1|D09683|108K180|EN300-18167318|Q7810457|BRD-K53414658-001-01-7|BRD-K53414658-001-08-2|N-{2-Chloro-4-[(6,7-dimethoxy-4-quinolyl)-oxy]phenyl}-N'-(5-methyl-3-isoxazolyl)urea|1- (2- Chloro- 4- (6, 7- dimethoxyquinolin- 4- yloxy) phenyl) - 3- (5- methylisoxazol- 3- yl) urea|1-{2-chloro-4-[(6,7-dimethoxyquinolin-4-yl)oxy]phenyl}-3-[(3E)-5-methylisoxazol-3(2H)-ylidene]urea|N-(2-CHLORO-4-((6,7-DIMETHOXYQUINOLIN-4-YL)OXY)PHENYL)-N'-(5-METHYLISOXAZOL-3-YL)UREA"
GOLVATINIB,16118392,,"InChI=1S/C33H37F2N7O4/c1-40-16-18-41(19-17-40)24-9-14-42(15-10-24)32(45)39-29-21-26(8-13-36-29)46-25-6-7-28(27(35)20-25)38-31(44)33(11-12-33)30(43)37-23-4-2-22(34)3-5-23/h2-8,13,20-21,24H,9-12,14-19H2,1H3,(H,37,43)(H,38,44)(H,36,39,45)",UQRCJCNVNUFYDX-UHFFFAOYSA-N,C33H37F2N7O4,633.7,"1-N'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide","Golvatinib|928037-13-2|E7050|516Z3YP58E|DTXSID40239155|1,1-CYCLOPROPANEDICARBOXAMIDE, N-(2-FLUORO-4-((2-(((4-(4-METHYL-1-PIPERAZINYL)-1-PIPERIDINYL)CARBONYL)AMINO)-4-PYRIDINYL)OXY)PHENYL)-N'-(4-FLUOROPHENYL)-|golvatinibum|N'-(2-fluoro-4-(2-((4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)amino)pyridin-4-yl)oxyphenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|N'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|RefChem:144121|DTXCID60161646|c-Met/VEGFR-2 Kinase Inhibitor E7050|N'1-(2-fluoro-4-((2-((4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl)amino)pyridin-4-yl)oxy)phenyl)-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|Golvatinib (E7050)|E-7050|1-N'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|UNII-516Z3YP58E|Golvatinib (USAN)|Golvatinib [USAN]|MFCD22124462|N-(2-Fluoro-4-((2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yl)oxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|N-[2-Fluoro-4-[[2-[[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl]amino]pyridin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|Golvatinib [USAN:INN]|N-(2-Fluoro-4-{[2-({[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl}amino)pyridin-4-yl]oxy}phenyl)-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|N-[2-Fluoro-4-[[2-[[[4-(4-methyl-1-piperazinyl)-1-piperidinyl]carbonyl]amino]-4-pyridinyl]oxy]phenyl]-N'-(4-fluorophenyl)-1,1-cyclopropanedicarboxamide; N-[2-Fluoro-4-[[2-[[[4-(4-methylpiperazin-1-yl)piperidin-1-yl]carbonyl]amino]pyridin-4-yl]oxy]phenyl]-N'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide; E-7050; E7050|E7050;Golvatinib|GOLVATINIB [INN]|Golvatinib (E7050)?|E 7050|GOLVATINIB [WHO-DD]|GTPL7956|orb1300700|SCHEMBL1727298|CHEMBL3039525|SCHEMBL30498607|SCHEMBL30498608|EX-A830|CHEBI:177746|UQRCJCNVNUFYDX-UHFFFAOYSA-N|HMS3651J19|BCP06122|QCC30819|BDBM50100615|NSC800107|NSC808608|s2859|AKOS025404927|CCG-270294|CS-0595|DB11977|NSC-800107|NSC-808608|SB16585|SDCCGSBI-0654486.P001|NCGC00386210-06|AC-30125|AS-56994|DA-73835|HY-13068|N-(2-fluoro-4-(2-(4-(4-methylpiperazin-1-yl)piperidine-1-carboxamido)pyridin-4-yloxy)phenyl)-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|B1439|NS00072534|SW219690-1|D10224|BRD-K69001009-001-02-8|Q27077829|1,1-Cyclopropanedicarboxamide, N-(2-fluoro-4-((2-(((4-(4-methyl-1-piperazinyl)-1- piperidinyl)carbonyl)amino)-4-pyridinyl)oxy)phenyl)-N'-(4-fluorophenyl)-|1-N'-[2-luoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-luorophenyl)cyclopropane-1,1-dicarboxamide|1-N\'-[2-fluoro-4-[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]pyridin-4-yl]oxyphenyl]-1-N-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|1196681-49-8|2108968-42-7|GV0|N-(2-Fluoro-4-((2-(((4-(4-methylpiperazin-1-yl)piperidin-1-yl)carbonyl)amino)pyridin-4- yl)oxy)phenyl)-N'-(4- fluorophenyl)cyclopropane-1,1-dicarboxamide|N~1~-{2-fluoro-4-[(2-{[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino}pyridin-4-yl)oxy]phenyl}-N'~1~-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide|N1'-[2-fluoro-4-[[2-[[4-(4-methylpiperazin-1-yl)piperidine-1-carbonyl]amino]-4-pyridyl]oxy]phenyl]-N1-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide"
OLMUTINIB,54758501,,"InChI=1S/C26H26N6O2S/c1-3-23(33)27-19-5-4-6-21(17-19)34-25-24-22(11-16-35-24)29-26(30-25)28-18-7-9-20(10-8-18)32-14-12-31(2)13-15-32/h3-11,16-17H,1,12-15H2,2H3,(H,27,33)(H,28,29,30)",FDMQDKQUTRLUBU-UHFFFAOYSA-N,C26H26N6O2S,486.6,"N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide","Olmutinib|1353550-13-6|BI 1482694|HM-61713|BI-1482694|CHL9B67L95|N-[3-[2-[4-(4-methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl]oxyphenyl]prop-2-enamide|2-Propenamide, N-[3-[[2-[[4-(4-methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]-|DTXSID001319119|2-Propenamide, N-(3-((2-((4-(4-methyl-1-piperazinyl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)-|N-(3-((2-(4-(4-Methylpiperazin-1-yl)anilino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide|N-{3-[(2-{[4-(4-methylpiperazin-1-yl)phenyl]amino}thieno[3,2-d]pyrimidin-4-yl)oxy]phenyl}prop-2-enamide|olmutinibum|N-(3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)thieno(3,2-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide|N-(3-(2-(4-(4-methylpiperazin-1-yl)anilino)thieno(3,2-d)pyrimidin-4-yl)oxyphenyl)prop-2-enamide|N-[3-({2-[4-(4-Methylpiperazin-1-yl)anilino]thieno[3,2-d]pyrimidin-4-yl}oxy)phenyl]prop-2-enamide|RefChem:856756|L01XE40|DTXCID401748550|HM61713|1802181-20-9|MFCD29918158|Olmutinib [INN]|Olmutinib [WHO-DD]|N-(3-((2-((4-(4-methylpiperazin-1-yl)phenyl)amino)thieno[3,2-d]pyrimidin-4-yl)oxy)phenyl)acrylamide|HM-61713 (BI-1482694)|HM 61713|HM71224;Olmutinib|Olmutinib (USAN/INN)|Olmutinib [USAN:INN]|OLMUTINIB [USAN]|Olmutinib(HM-71224)|UNII-CHL9B67L95|GTPL9196|orb1298916|orb1300347|CHEMBL3786343|SCHEMBL14914931|SCHEMBL29358219|SCHEMBL29377940|C26H26N6O2S|EX-A879|FDMQDKQUTRLUBU-UHFFFAOYSA-N|HMS5086K09|BCP16733|BDBM50160871|NSC792848|NSC800980|s8294|AKOS030632791|CCG-269594|CS-5413|DB13164|NSC-792848|NSC-800980|SB19797|Example 1 [US20130116213]|AC-30225|AC-35418|AS-74850|HM 71224|HY-19730|SY099674|DS-015877|NS00073590|Olmutinib (HM61713, BI 1482694)|Olmutinib (HM61713; BI-1482694)?|D10859|W12116|BRD-K60421517-001-01-4|Q27088175|BI1482694;BI 1482694;BI-1482694;HM 61713;HM-61713;HM61713|N-(3-(2-(4-(4 methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidine-4-yloxy)phenyl)acrylamide|N-(3-(2-(4-(4-Methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidin-4-yloxy)phenyl)acrylamide|N-(3-(2-(4-(4-methylpiperazin-1-yl)phenylamino)thieno[3,2-d]pyrimidine-4-yloxy)phenyl)acrylamide|N-[3-[[2-[[4-(4-Methyl-1-piperazinyl)phenyl]amino]thieno[3,2-d]pyrimidin-4-yl]oxy]phenyl]acrylamide"
SELONSERTIB,71245288,,"InChI=1S/C24H24FN7O/c1-14(2)32-13-27-30-23(32)19-5-4-6-22(28-19)29-24(33)17-10-21(15(3)9-18(17)25)31-11-20(26-12-31)16-7-8-16/h4-6,9-14,16H,7-8H2,1-3H3,(H,28,29,33)",YIDDLAAKOYYGJG-UHFFFAOYSA-N,C24H24FN7O,445.5,"5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridin-2-yl]benzamide","Selonsertib|1448428-04-3|GS-4997|NS3988A2TC|5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-[6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridin-2-yl]benzamide|5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methyl-N-{6-[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]pyridin-2-yl}benzamide|Benzamide, 5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methyl-N-(6-(4-(1-methylethyl)-4H-1,2,4-triazol-3-yl)-2-pyridinyl)-|BENZAMIDE, 5-(4-CYCLOPROPYL-1H-IMIDAZOL-1-YL)-2-FLUORO-4-METHYL-N-(6-(4-(1-METHYLETHYL)-4H-1,2,4-TRIAZOL-3-YL)-2-PYRIDINYL)|selonsertibum|5-(4-CYCLOPROPYL-1H-IMIDAZOL-1-YL)-2-FLUORO-4-METHYL-N-(6-(4-(PROPAN-2-YL)-4H-1,2,4-TRIAZOL-3-YL)PYRIDIN-2-YL)BENZAMIDE|5-(4-cyclopropylimidazol-1-yl)-2-fluoro-4-methyl-N-(6-(4-propan-2-yl-1,2,4-triazol-3-yl)pyridin-2-yl)benzamide|RefChem:884861|5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide|Selonsertib [INN]|Selonsertib(GS-4997)|C24H24FN7O|MFCD29920355|GS 4997|Selonsertib (GS-4997)|GS-4997; GS4997; GS 4997; Selonsertib free base ;5-(4-cyclopropyl-1H-imidazol-1-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)pyridin-2-yl)-4-methylbenzamide|UNII-NS3988A2TC|NJV|SelonsertibGS-4997|SelonsertibGS-4997?|SELONSERTIB [JAN]|GS-4997; Selonsertib|Selonsertib [USAN:INN]|Selonsertib; GS-4997|SELONSERTIB [USAN]|SELONSERTIB [WHO-DD]|Selonsertib (JAN/USAN/INN)|GTPL9040|orb1304295|CHEMBL3916717|SCHEMBL14672984|SCHEMBL29977277|YIDDLAAKOYYGJG-UHFFFAOYSA-N|GLXC-10333|BCP17814|EX-A1150|EX-A1618|BDBM50212258|GS4997|NSC797772|s8292|AKOS027338646|CCG-269184|CS-5328|DB14916|NSC-797772|SB17466|NCGC00479176-02|5-(4-Cyclopropyl-1H-imidazol-1-yl)-2-fluoro-N-(6-(4-isopropyl-4H-1,2,4-triazol-3-yl)-2-pyridinyl)-4-methylbenzamide|AC-31493|AS-35035|DA-67533|FC157241|HY-18938|D10988|GS-4997; GS4997; GS 4997|Q27088777|5-(4-Cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methyl-N-[6-[4-(1-methylethyl)-4H-1,2,4-triazol-3-yl]-2-pyridinyl]benzamide; 5-(4-Cyclopropyl-1H-imidazol-1-yl)-2-fluoro-4-methyl-N-{6-[4-(propan-2-yl)-4H-1,2,4-triazol-3-yl]pyridin-2-yl}benzamide; GS 4977; GS 4997;|5-(4-cyclopropylimidazol-1-yl)-2-fluoro-N-[6-(4-isopropyl-1,2,4-triazol-3-yl)-2-pyridyl]-4-methyl-benzamide|5-(4Cyclopropyl- 1H- imidazol- 1- yl) - 2- fluoro- N- (6- (4- isopropyl- 4H- 1, 2, 4- triazol- 3- yl) pyridin- 2- yl) - 4- methylben zamide"
INFIGRATINIB,53235510,,"InChI=1S/C26H31Cl2N7O3/c1-5-34-10-12-35(13-11-34)18-8-6-17(7-9-18)31-21-15-22(30-16-29-21)33(2)26(36)32-25-23(27)19(37-3)14-20(38-4)24(25)28/h6-9,14-16H,5,10-13H2,1-4H3,(H,32,36)(H,29,30,31)",QADPYRIHXKWUSV-UHFFFAOYSA-N,C26H31Cl2N7O3,560.5,"3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-[6-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-methylurea","Infigratinib|872511-34-7|NVP-BGJ398|BGJ398|BGJ-398|BGJ 398|3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea|A4055ME1VK|CHEBI:63451|3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-[6-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-methylurea|DTXSID70236238|3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-{[4-(4-ethylpiperazin-1-yl)phenyl]amino}pyrimidin-4-yl)-1-methylurea|Urea, N'-(2,6-dichloro-3,5-dimethoxyphenyl)-N-(6-((4-(4-ethyl-1-piperazinyl)phenyl)amino)-4-pyrimidinyl)-N-methyl-|3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea|infigratinibum|3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)anilino)pyrimidin-4-yl)-1-methylurea|RefChem:58155|DTXCID70158729|BGJ398 (NVP-BGJ398)|Infigratinib [INN]|Infigratinib free base|MFCD22123241|Infigratinib [USAN]|MVP-BGJ398|872511-34-7 (free base)|CHEMBL1834657|3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-((4-(4-ethylpiperazin-1-yl)phenyl)amino)pyrimidin-4-yl)-1-methylurea.|BGJ 398; Infigratinib; NVP-BGJ 398|UNII-A4055ME1VK|C26H31Cl2N7O3|Infigratinib (BGJ398)|Infigratinib (USAN/INN)|Infigratinib [USAN:INN]|NVP-BGJ398(Infigratinib)|3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)phenylamino)pyrimidin-4-yl)-1-methylurea|MLS006010953|INFIGRATINIB [WHO-DD]|SCHEMBL374435|NVP-BGJ398(Infigratinib)?|GTPL7877|orb1306898|CHEMBL1852688|EX-A057|QADPYRIHXKWUSV-UHFFFAOYSA-N|HMS3295O21|BCP03602|BDBM50355393|FD5035|NSC764487|s2183|WHO 10032|AKOS025149513|AKOS032949944|BCP9000399|CS-0586|DB11886|FD46729|NSC-764487|SB16612|SDCCGSBI-0646929.P001|NCGC00274030-01|NCGC00274030-11|AC-28417|AS-16290|BP-43657|HY-13311|SMR004702757|SY284904|BCP0726000187|DB-261524|NS00072945|D11589|BRD-K42728290-001-01-8|BRD-K42728290-001-06-7|BRD-K42728290-001-07-5|BRD-K42728290-001-08-3|BRD-K42728290-001-09-1|Q27075200|07J|3-(2,6-dichloro-3,5-dimethoxy-phenyl)-1-[6-[4-(4-ethylpiperazin-1-yl)anilino]pyrimidin-4-yl]-1-methyl-urea|3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-{6-[4-(4-ethyl-piperazin-1-yl)-phenylamino]-pyrimidin-4-yl}-1-methyl-urea|3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-(6-(4-(4-ethylpiperazin-1-yl)-phenylamino)pyrimidin-4-yl)-1-methylurea|3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethyl-1-piperazinyl)phenyl]amino]-4-pyrimidinyl]-1-methylurea|Infigratinib;BGJ 398;3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-[6-[[4-(4-ethylpiperazin-1-yl)phenyl]amino]pyrimidin-4-yl]-1-methylurea|N'-(2,6-DICHLORO-3,5-DIMETHOXYPHENYL)-N-(6-((4-(4-ETHYL-1- PIPERAZINYL)PHENYL)AMINO)-4-PYRIMIDINYL)-N-METHYLUREA"
BUPARLISIB,16654980,,"InChI=1S/C18H21F3N6O2/c19-18(20,21)13-9-15(22)23-11-12(13)14-10-16(26-1-5-28-6-2-26)25-17(24-14)27-3-7-29-8-4-27/h9-11H,1-8H2,(H2,22,23)",CWHUFRVAEUJCEF-UHFFFAOYSA-N,C18H21F3N6O2,410.4,"5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine","Buparlisib|944396-07-0|NVP-BKM120|BKM-120|NVP-BKM-120|BKM 120|BKM-120NX|BKM120-NX|0ZM2Z182GD|DTXSID50241486|buparlisibum|RefChem:570492|PI3K Inhibitor BKM120|DTXCID50163977|AN2025|BKM120|5-(2,6-dimorpholinopyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine|1202777-78-3|Buparlisib (BKM120)|NVP-BKM 120|5-(2,6-dimorpholin-4-ylpyrimidin-4-yl)-4-(trifluoromethyl)pyridin-2-amine|MFCD18251596|BKM120 (NVP-BKM120, Buparlisib)|5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-Pyridinamine|5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine|5-[2,6-Di(Morpholin-4-Yl)pyrimidin-4-Yl]-4-(Trifluoromethyl)pyridin-2-Amine|CHEMBL2017974|CHEBI:71954|944396-07-0 (free base)|5-[2,6-Di(4-morpholinyl)-4-pyrimidinyl]-4-(trifluoromethyl)-2-pyridinamine.|Buparlisib [INN]|C18H21F3N6O2|Buparlisib [USAN:INN]|UNII-0ZM2Z182GD|BKM 120NX|BKM 120; 5-(2,6-di-4-Morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine; NVP-BKM 120|SD5|3sd5|Buparlisib (USAN/INN)|BUPARLISIB [USAN]|BUPARLISIB [WHO-DD]|MLS006010984|SCHEMBL146956|GTPL7878|orb1307367|BKM120,NVP-BKM120|SCHEMBL29350945|SCHEMBL29351351|SCHEMBL29387968|BKM-120 (PI3K)|EX-A189|HMS3295I15|HMS3655D16|BKM120 (NVP-BKM120)|BDBM50380363|NSC754353|NSC799370|s2247|2-Pyridinamine, 5-(2,6-di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-|4-(trifluoromethyl)-5-(2,6-dimorpholinopyrimidin-4-yl)pyridin-2-amine|AKOS016005372|BCP9001011|CCG-264954|CS-0089|DB11666|FD64903|NSC-754353|NSC-799370|SB16577|SDCCGSBI-0654414.P001|Buparlisib (BKM120, NVP-BKM120)|NCGC00262604-01|NCGC00262604-08|AC-32077|AC-35575|AS-40568|BKM120 (NVP-BKM120, Buparlisib)?|HY-70063|SMR004702786|SY078482|DB-079882|NS00072516|SW218149-2|D10584|BRD-K42191735-001-01-2|BRD-K42191735-001-05-3|BRD-K42191735-001-08-7|Q25100534|5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-trifluoromethylpyridin-2-amine|5-(2,6-di-morpholin-4-yl-pyrimidin-4-yl)-4-trifluoromethyl-pyridin-2-ylamine|NVP-BKM-120;Buparlisib;5-(2,6-Di-4-morpholinyl-4-pyrimidinyl)-4-(trifluoromethyl)-2-pyridinamine"
ERDAFITINIB,67462786,,"InChI=1S/C25H30N6O2/c1-17(2)26-8-9-31(20-10-21(32-4)13-22(11-20)33-5)19-6-7-23-24(12-19)29-25(15-27-23)18-14-28-30(3)16-18/h6-7,10-17,26H,8-9H2,1-5H3",OLAHOMJCDNXHFI-UHFFFAOYSA-N,C25H30N6O2,446.5,"N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine","Erdafitinib|1346242-81-6|Balversa|890E37NHMV|DTXSID001027936|1,2-Ethanediamine, N1-(3,5-dimethoxyphenyl)-N2-(1-methylethyl)-N1-(3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl)-|N'-(3,5-dimethoxyphenyl)-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]-N-propan-2-ylethane-1,2-diamine|erdafitinibum|N'-(3,5-dimethoxyphenyl)-N'-(3-(1-methylpyrazol-4-yl)quinoxalin-6-yl)-N-propan-2-ylethane-1,2-diamine|RefChem:57639|DTXCID201513503|N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-(3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl)-1,2-ethanediamine|JNJ-42756493|N1-(3,5-dimethoxyphenyl)-N2-isopropyl-N1-(3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl)ethane-1,2-diamine|MFCD28502040|JNJ 42756493|N-(3,5-dimethoxyphenyl)-3-(1-methyl-1H-pyrazol-4-yl)-N-{2-[(propan-2-yl)amino]ethyl}quinoxalin-6-amine|Erdafitinib [INN]|Erdafitinib [USAN:INN]|UNII-890E37NHMV|Erdafitinib?|Balversa (TN)|N1-(3,5-Dimethoxyphenyl)-N2-(1-methylethyl)-N1-[3-(1-methyl-1H-pyrazol-4-yl)-6-quinoxalinyl]-1,2-ethanediamine; JNJ 42756493;|JNJ42756493|Erdafitinib (Standard)|ERDAFITINIB [MI]|ERDAFITINIB [JAN]|ERDAFITINIB [USAN]|ERDAFITINIB [WHO-DD]|Erdafitinib (JAN/USAN/INN)|GTPL9039|orb1303841|SCHEMBL2583760|CHEMBL3545376|SCHEMBL29359988|ERDAFITINIB [ORANGE BOOK]|Erdafitinib(JNJ-42756493)|Erdafitinib; JNJ-42756493|CHEBI:232556|GLXC-10828|HMS5086O09|Erdafitinib (JNJ-42756493)|JNJ-42756493 (Erdafitinib)|BCP20346|EX-A2564|BDBM50525939|HY-18708R|NSC781556|s8401|AKOS030526429|compound 4 [WO2011135376]|CCG-269200|CS-4988|DB12147|FE76167|NSC-781556|SB16854|NCGC00475735-01|AC-30222|AS-35040|HY-18708|N-(3,5-dimethoxyphenyl)-N'-(1-methylethyl)-N-[3-(1-methyl-1H-pyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine|SY224702|NS00073477|D10927|BRD-K84868168-001-01-0|Q27077213|PAN-FGFR TYROSINE KINASE INHIBITOR JNJ-42756493|1-((3,5-Dimethoxyphenyl)(3-(1-methyl-4-pyrazolyl)-6-quinoxalinyl)amino)-2-(isopropylamino)ethane|5SF|N'-(3,5-dimethoxyphenyl)-N-isopropyl-N'-[3-(1-methylpyrazol-4-yl)quinoxalin-6-yl]ethane-1,2-diamine|N1-(3,5-Dimethoxyphenyl)-N2-isopropyl-N1-[3-(1-methyl-4-pyrazolyl)-6-quinoxalinyl]-1,2-ethanediamine"
ITX-5061,56843466,,"InChI=1S/C30H37N3O7S.ClH/c1-30(2,3)20-18-24(28(38-4)25(19-20)32-41(5,36)37)31-29(35)27(34)23-10-11-26(22-9-7-6-8-21(22)23)40-17-14-33-12-15-39-16-13-33;/h6-11,18-19,32H,12-17H2,1-5H3,(H,31,35);1H",ICIJBYYMEBOTQP-UHFFFAOYSA-N,C30H38ClN3O7S,620.2,N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetamide;hydrochloride,"ITX5061|1252679-52-9|ITX-5061|ITX 5061|J4RA8K2Q2A|KC706|KC-706|RefChem:150235|1-Naphthaleneacetamide, N-(5-(1,1-dimethylethyl)-2-methoxy-3-((methylsulfonyl)amino)phenyl)-4-(2-(4-morpholinyl)ethoxy)-alpha-oxo-, hydrochloride (1:1)|UNII-J4RA8K2Q2A|N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetamide;hydrochloride|1-Naphthaleneacetamide, N-(5-(1,1-dimethylethyl)-2-methoxy-3-    ((methylsulfonyl)amino)phenyl)-4-(2-(4-morpholinyl)ethoxy)-alpha-oxo-,     hydrochloride (1:1)|ITX-5061 HCl|MFCD30532738|C30H38ClN3O7S|orb1707167|CHEMBL3402567|SCHEMBL29437767|GLXC-15672|BCP30784|CAC67952|EX-A4531|AKOS040741891|DA-74610|HY-19900|MS-30777|CS-0016951|G15934|Q27281205|1-NAPHTHALENEACETAMIDE, N-(5-(1,1-DIMETHYLETHYL)-2-METHOXY-3-((METHYLSULFONYL)AMINO)PHENYL)-4-(2-(4-MORPHOLINYL)ETHOXY)-.ALPHA.-OXO-, HYDROCHLORIDE (1:1)|ITX-5061 hydrochloride ; ITX 5061 HCl ; ITX506 HCl pound>>ITX5061 hydrochloride pound>>ITX 5061 hydrochloride|N-[5-(1,1-Dimethylethyl)-2-methoxy-3-[(methylsulfonyl)amino]phenyl]-4-[2-(4-morpholinyl)ethoxy]-?-oxo-1-naphthaleneacetamide hydrochloride|N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxy-phenyl]-2-[4-(2-morpholinoethoxy)-1-naphthyl]-2-oxo-acetamide;hydrochloride"
ITX-5061,56843466,,"InChI=1S/C30H37N3O7S.ClH/c1-30(2,3)20-18-24(28(38-4)25(19-20)32-41(5,36)37)31-29(35)27(34)23-10-11-26(22-9-7-6-8-21(22)23)40-17-14-33-12-15-39-16-13-33;/h6-11,18-19,32H,12-17H2,1-5H3,(H,31,35);1H",ICIJBYYMEBOTQP-UHFFFAOYSA-N,C30H38ClN3O7S,620.2,N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetamide;hydrochloride,"ITX5061|1252679-52-9|ITX-5061|ITX 5061|J4RA8K2Q2A|KC706|KC-706|RefChem:150235|1-Naphthaleneacetamide, N-(5-(1,1-dimethylethyl)-2-methoxy-3-((methylsulfonyl)amino)phenyl)-4-(2-(4-morpholinyl)ethoxy)-alpha-oxo-, hydrochloride (1:1)|UNII-J4RA8K2Q2A|N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxyphenyl]-2-[4-(2-morpholin-4-ylethoxy)naphthalen-1-yl]-2-oxoacetamide;hydrochloride|1-Naphthaleneacetamide, N-(5-(1,1-dimethylethyl)-2-methoxy-3-    ((methylsulfonyl)amino)phenyl)-4-(2-(4-morpholinyl)ethoxy)-alpha-oxo-,     hydrochloride (1:1)|ITX-5061 HCl|MFCD30532738|C30H38ClN3O7S|orb1707167|CHEMBL3402567|SCHEMBL29437767|GLXC-15672|BCP30784|CAC67952|EX-A4531|AKOS040741891|DA-74610|HY-19900|MS-30777|CS-0016951|G15934|Q27281205|1-NAPHTHALENEACETAMIDE, N-(5-(1,1-DIMETHYLETHYL)-2-METHOXY-3-((METHYLSULFONYL)AMINO)PHENYL)-4-(2-(4-MORPHOLINYL)ETHOXY)-.ALPHA.-OXO-, HYDROCHLORIDE (1:1)|ITX-5061 hydrochloride ; ITX 5061 HCl ; ITX506 HCl pound>>ITX5061 hydrochloride pound>>ITX 5061 hydrochloride|N-[5-(1,1-Dimethylethyl)-2-methoxy-3-[(methylsulfonyl)amino]phenyl]-4-[2-(4-morpholinyl)ethoxy]-?-oxo-1-naphthaleneacetamide hydrochloride|N-[5-tert-butyl-3-(methanesulfonamido)-2-methoxy-phenyl]-2-[4-(2-morpholinoethoxy)-1-naphthyl]-2-oxo-acetamide;hydrochloride"
BAY-1161909,71599640,,"InChI=1S/C29H26FN5O4S/c1-18(19-4-9-22(30)10-5-19)28(36)31-23-11-6-20(7-12-23)21-8-15-27-33-29(34-35(27)17-21)32-25-14-13-24(40(3,37)38)16-26(25)39-2/h4-18H,1-3H3,(H,31,36)(H,32,34)/t18-/m1/s1",NRJKIOCCERLIDG-GOSISDBHSA-N,C29H26FN5O4S,559.6,"(2R)-2-(4-fluorophenyl)-N-[4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]propanamide","Empesertib|BAY-1161909|BAY1161909|Empesertib [INN]|Empesertib [WHO-DD]|(2R)-2-(4-fluorophenyl)-N-[4-[2-(2-methoxy-4-methylsulfonylanilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]propanamide|02Y3Z2756M|UNII-02Y3Z2756M|(2R)-2-(4-Fluorophenyl)-N-(4-(2-((2-methoxy-4-(methylsulfonyl)phenyl)amino)(1,2,4)triazolo(1,5-a)pyridin-6-yl)phenyl)propanamide|(2R)-2-(4-Fluorophenyl)-N-(4-(2-((4-(methanesulfonyl)-2-methoxyphenyl)amino)(1,2,4)triazolo(1,5-a)pyridin-6-yl)phenyl)propanamide|(.ALPHA.R)-4-FLUORO-N-(4-(2-((2-METHOXY-4-(METHYLSULFONYL)PHENYL)AMINO)(1,2,4)TRIAZOLO(1,5-A)PYRIDIN-6-YL)PHENYL)-.ALPHA.-METHYLBENZENEACETAMIDE|(alphaR)-4-Fluoro-N-(4-(2-((2-methoxy-4-(methylsulfonyl)phenyl)amino)(1,2,4)triazolo(1,5-a)pyridin-6-yl)phenyl)-alpha-methylbenzeneacetamide|BENZENEACETAMIDE, 4-FLUORO-N-(4-(2-((2-METHOXY-4-(METHYLSULFONYL)PHENYL)AMINO)(1,2,4)TRIAZOLO(1,5-A)PYRIDIN-6-YL)PHENYL)-.ALPHA.-METHYL-, (.ALPHA.R)-|Benzeneacetamide, 4-fluoro-N-(4-(2-((2-methoxy-4-(methylsulfonyl)phenyl)amino)(1,2,4)triazolo(1,5-a)pyridin-6-yl)phenyl)-alpha-methyl-, (alphaR)-|empesertibum|(2R)-2-(4-fluorophenyl)-N-(4-(2-(2-methoxy-4-methylsulfonylanilino)-(1,2,4)triazolo(1,5-a)pyridin-6-yl)phenyl)propanamide|RefChem:136715|BAY116-1909|1443763-60-7|Mps1-IN-5|BAY 1161909|(-)-BAY-1161909|(R)-2-(4-fluorophenyl)-N-(4-(2-((2-methoxy-4-(methylsulfonyl)phenyl)amino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl)propanamide|1443764-31-5|Empesertib [INN:WHO-DD]|C29H26FN5O4S|GTPL9427|orb1298892|CHEMBL4303241|SCHEMBL15036597|SCHEMBL29446169|NRJKIOCCERLIDG-GOSISDBHSA-N|BDBM329334|GLXC-10349|BCP23811|EX-A3543|BAY1161909;Mps1-IN-5|MFCD28902188|NSC787025|AKOS028109757|CS-4887|NSC-787025|US9663510, Example 01.01|NCGC00488781-01|AC-36445|AS-82506|BB177693|Benzeneacetamide, 4-fluoro-N-[4-[2-[[2-methoxy-4-(methylsulfonyl)phenyl]amino][1,2,4]triazolo[1,5-a]|DA-61505|HY-12858|D83662|BRD-K43812936-001-01-9|BAY1161909; BAY-1161909; BAY 1161909;Mps1-IN-5|(2R)-2-(4-fluorophenyl)-N-[4-(2-{[2-methoxy-4-(methylsulfonyl)phenyl]-amino}[1,2,4]triazolo[1,5-a]pyridin-6-yl)phenyl]propanamide|(2R)-2-(4-fluorophenyl)-N-[4-(2-{[2-methoxy-4-(methylsulfonyl)phenyl]amino}[1,2,4]triazolo[1,5-alpha]pyridin-6-yl)phenyl]propanamide|(2R)-2-(4-fluorophenyl)-N-[4-[2-(2-methoxy-4-methylsulfonyl-anilino)-[1,2,4]triazolo[1,5-a]pyridin-6-yl]phenyl]propanamide"
BAY-1217389,78320750,,"InChI=1S/C27H24F5N5O3/c1-14-11-15(3-6-17(14)26(38)35-16-4-5-16)19-13-34-25-18(33-10-9-27(30,31)32)12-22(36-37(19)25)40-21-8-7-20(39-2)23(28)24(21)29/h3,6-8,11-13,16,33H,4-5,9-10H2,1-2H3,(H,35,38)",WNEILUNVMHVMPH-UHFFFAOYSA-N,C27H24F5N5O3,561.5,"N-cyclopropyl-4-[6-(2,3-difluoro-4-methoxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide","1554458-53-5|BAY1217389|BAY-1217389|Bay 1217389|Benzamide, N-cyclopropyl-4-[6-(2,3-difluoro-4-methoxyphenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methyl-|M964LB1114|UNII-M964LB1114|compound 35 [PMID: 31121430]|Benzamide, N-cyclopropyl-4-(6-(2,3-difluoro-4-methoxyphenoxy)-8-((3,3,3-trifluoropropyl)amino)imidazo(1,2-b)pyridazin-3-yl)-2-methyl-|compound 35 (PMID: 31121430)|RefChem:116722|MFCD30502614|N-cyclopropyl-4-[6-(2,3-difluoro-4-methoxyphenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide|N-Cyclopropyl-4-(6-(2,3-difluoro-4-methoxyphenoxy)-8-((3,3,3-trifluoropropyl)amino)imidazo[1,2-b]pyridazin-3-yl)-2-methylbenzamide|N-cyclopropyl-4-[6-(2,3-difluoro-4-methoxyphenoxy)-8-[(3,3,3-trifluoropropyl)amino]imidazo[1,2-b]pyridazin-3-yl]-2-methylbenzamide|N-cyclopropyl-4-[6-(2,3-difluoro-4-methoxy-phenoxy)-8-(3,3,3-trifluoropropylamino)imidazo[1,2-b]pyridazin-3-yl]-2-methyl-benzamide|WNEILUNVMHVMPH-UHFFFAOYSA-N|orb1695455|CHEMBL4456085|SCHEMBL15555839|SCHEMBL30381937|GTPL12705|EX-A948|C27H24F5N5O3|BDBM258444|GLXC-10350|BCP17401|EMC45853|NSC787026|s8215|AKOS032944938|CCG-265387|CS-6182|NSC-787026|BAY1217389?|AC-36064|BAY 12-17389|DA-50965|HY-12859|MS-30193|US9512130, 2"
AZD-8186,52913813,,"InChI=1S/C24H25F2N3O4/c1-14(27-18-11-16(25)10-17(26)12-18)19-8-15(24(31)28(2)3)9-20-21(30)13-22(33-23(19)20)29-4-6-32-7-5-29/h8-14,27H,4-7H2,1-3H3/t14-/m1/s1",LMJFJIDLEAWOQJ-CQSZACIVSA-N,C24H25F2N3O4,457.5,"8-[(1R)-1-(3,5-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide","AZD8186|1627494-13-6|AZD-8186|AIQ4OWD0RA|AZD 8186|4H-1-Benzopyran-6-carboxamide, 8-[(1R)-1-[(3,5-difluorophenyl)amino]ethyl]-N,N-dimethyl-2-(4-morpholinyl)-4-oxo-|4H-1-Benzopyran-6-carboxamide, 8-((1R)-1-((3,5-difluorophenyl)amino)ethyl)-N,N-dimethyl-2-(4-morpholinyl)-4-oxo-|8-[(1R)-1-[(3,5-difluorophenyl)amino]ethyl]-N,N-dimethyl-2-(morpholin-4-yl)-4-oxo-4H-chromene-6-carboxamide|8-((1R)-1-((3,5-difluorophenyl)amino)ethyl)-N,N-dimethyl-2-(morpholin-4-yl)-4-oxo-4H-chromene-6-carboxamide|RefChem:116019|(R)-8-(1-((3,5-difluorophenyl)amino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide|UNII-AIQ4OWD0RA|MFCD27987908|8-[(1R)-1-[(3,5-Difluorophenyl)amino]ethyl]-N,N-dimethyl-2-(4-morpholinyl)-4-oxo-4H-1-benzopyran-6-carboxamide|CHEMBL3408248|8-[(1R)-1-(3,5-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholin-4-yl-4-oxochromene-6-carboxamide|GTPL8527|orb1300480|SCHEMBL1636956|AZD 8186 [WHO-DD]|C24H25F2N3O4|AZD8186?|EX-A1649|BDBM50070322|NSC777572|NSC799352|s7694|AKOS025404922|CCG-269309|CS-4975|DB15029|NSC-777572|NSC-799352|NCGC00475728-03|AC-29024|AS-74971|FD103345|HY-12330|BRD-K47289408-001-01-5|Q27074798|Z3041528951|ENVIRONMENTALLY HAZARDOUS SUBSTANCE, SOLID, N.O.S. (AZD8186)|(R)-8-(1-(3,5-difluorophenylamino)ethyl)-N,N-dimethyl-2-morpholino-4-oxo-4H-chromene-6-carboxamide|8-[(1R)-1-(3,5-difluoroanilino)ethyl]-N,N-dimethyl-2-morpholino-4-oxo-chromene-6-carboxamide"
CLESACOSTAT,57496611,,"InChI=1S/C28H30N4O5/c1-17(2)32-25-21(16-29-32)14-28(15-23(25)33)8-10-31(11-9-28)26(34)20-12-22(30-24(13-20)37-3)18-4-6-19(7-5-18)27(35)36/h4-7,12-13,16-17H,8-11,14-15H2,1-3H3,(H,35,36)",LXZMHBHEXAELHH-UHFFFAOYSA-N,C28H30N4O5,502.6,"4-[6-methoxy-4-(7-oxo-1-propan-2-ylspiro[4,6-dihydroindazole-5,4'-piperidine]-1'-carbonyl)pyridin-2-yl]benzoic acid","Clesacostat|1370448-25-1|PF-05221304|Clesacostat [USAN]|PF05221304|CLESACOSTAT [INN]|752DF9PPPI|Clesacostat (USAN)|Benzoic acid, 4-(6-methoxy-4-((1,4,6,7-tetrahydro-1-(1-methylethyl)-7-oxospiro(5H-indazole-5,4'-piperidin)-1'-yl)carbonyl)-2-pyridinyl)-|Benzoic acid, 4-[6-methoxy-4-[[1,4,6,7-tetrahydro-1-(1-methylethyl)-7-oxospiro[5H-indazole-5,4'-piperidin]-1'-yl]carbonyl]-2-pyridinyl]-|UNII-752DF9PPPI|RefChem:126950|2248008-98-0|4-(6-METHOXY-4-(7-OXO-1-(PROPAN-2-YL)-1,4,6,7-TETRAHYDROSPIRO(INDAZOLE-5,4'-PIPERIDINE)-1'-CARBONYL)PYRIDIN-2-YL)BENZOIC ACID|CHEMBL4567446|4-(4-(1-Isopropyl-7-oxo-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-1'-carbonyl)-6-methoxypyridin-2-yl)benzoic acid|SCHEMBL899298|orb1298280|GTPL12242|PF-05221304(Clesacostat)|GLXC-22850|PF-05221304(Clesacostat)?|EX-A5142|BDBM50511112|AKOS040759728|4-[6-methoxy-4-(7-oxo-1-propan-2-ylspiro[4,6-dihydroindazole-5,4'-piperidine]-1'-carbonyl)pyridin-2-yl]benzoic acid|AC-36590|TS-09961|DB-380460|D11902|F81260|4-(6-Methoxy-4-(7-oxo-1-(propan-2-yl)-1,4,6,7-tetrahydrospiro(indazole-5,4'- piperidine)-1'-carbonyl)pyridin-2-yl)benzoic acid|4-[4-(1-isopropyl-7-oxo-spiro[4,6-dihydroindazole-5,4'-piperidine]-1'-carbonyl)-6-methoxy-2-pyridyl]benzoic acid|4-[6-Methoxy-4-[[1,4,6,7-tetrahydro-1-(1-methylethyl)-7-oxospiro[5H-indazole-5,4'-piperidin]-1'-yl]carbonyl]-2-pyridinyl]benzoic acid"
NANAFROCIN,442757,,"InChI=1S/C16H14O6/c1-7-13-10(5-8(22-7)6-12(18)19)15(20)9-3-2-4-11(17)14(9)16(13)21/h2-4,7-8,17H,5-6H2,1H3,(H,18,19)/t7-,8+/m0/s1",ZCJHPTKRISJQTN-JGVFFNPUSA-N,C16H14O6,302.28,"2-[(1S,3R)-9-hydroxy-1-methyl-5,10-dioxo-3,4-dihydro-1H-benzo[g]isochromen-3-yl]acetic acid","Nanaomycin A|Nanafrocin|52934-83-5|Nanafrocine|Rosanomycin A|Nanomycin A|Nanafrocinum|Nanafrocina|CHEBI:48202|8XBV72641V|NSC-267461|DTXSID401018642|2-[(1S,3R)-9-hydroxy-1-methyl-5,10-dioxo-3,4-dihydro-1H-benzo[g]isochromen-3-yl]acetic acid|[(1S,3R)-9-hydroxy-1-methyl-5,10-dioxo-3,4,5,10-tetrahydro-1H-benzo[g]isochromen-3-yl]acetic acid|((1S,3R)-9-hydroxy-1-methyl-5,10-dioxo-3,4,5,10-tetrahydro-1H-benzo(g)isochromen-3-yl)acetic acid|2-((1S,3R)-9-hydroxy-1-methyl-5,10-dioxo-3,4-dihydro-1H-benzo(g)isochromen-3-yl)acetic acid|RefChem:164505|DTXCID301476714|OS 3966-A|(1S,3R)-3,4,5,10-Tetrahydro-9-hydroxy-1-methyl-5,10-dioxo-1H-naphtho(2,3-c)pyran-3-acetic Acid|637-081-2|Nanafrocin [INN]|(1S,3R)-Nanaomycin A|(1S,3R)-3,4,5,10-Tetrahydro-9-hydroxy-1-methyl-5,10-dioxo-1H-naphtho-(2,3-c)pyran-3-acetic acid|[(1S,3R)-9-hydroxy-1-methyl-5,10-dioxo-3,4,5,10-tetrahydro-1H-naphtho[2,3-c]pyran-3-yl]acetic acid|Nanafrocine [French]|Nanafrocinum [Latin]|Nanafrocina [Spanish]|Antibiotic OS 3966A|UNII-8XBV72641V|OS-3966-A|NSC 267461|NANAFROCIN [JAN]|orb1706929|SCHEMBL2111571|CHEMBL2106789|BDBM50075103|MFCD00869168|AKOS040742270|DA-75987|HY-103397|CS-0027820|NS00011756|Q27104606|1H-Naphtho(2,3-c)pyran-3-acetic acid, 3,4,5,10-tetrahydro-9-hydroxy-1-methyl-5,10-dioxo-, (1S-E)-|1H-Naphtho[2,3-c]pyran-3-acetic acid,3,4,5,10-tetrahydro-9-hydroxy-1-methyl-5,10-dioxo-(1S,3R)-"
PRENYLAMINE,9801,,"InChI=1S/C24H27N/c1-20(19-21-11-5-2-6-12-21)25-18-17-24(22-13-7-3-8-14-22)23-15-9-4-10-16-23/h2-16,20,24-25H,17-19H2,1H3",IFFPICMESYHZPQ-UHFFFAOYSA-N,C24H27N,329.5,"3,3-diphenyl-N-(1-phenylpropan-2-yl)propan-1-amine","PRENYLAMINE|390-64-7|DL-Prenylamine|Prenilamina|Prenylaminum|N-(3,3-Diphenylpropyl)-alpha-methylphenethylamine|B-436|1-Phenyl-2-(1',1'-diphenylpropyl-3'-amino)propane|N-(1-Methyl-2-phenylethyl)-gamma-phenylbenzenepropanamine|Benzenepropanamine, N-(1-methyl-2-phenylethyl)-gamma-phenyl-|K2OH82Z000|DTXSID0048555|(3,3-diphenylpropyl)(1-phenylpropan-2-yl)amine|RefChem:868484|C01DX02|DTXCID10197056|206-869-4|Hostaginan|Bismethin|Falliocor|Synadrin|Valecor|Corpax|Elecor|Prenylamine (vasodilator)|Sandoz 13-194|Corontin|SAN 13-194|3,3-diphenyl-N-(1-phenylpropan-2-yl)propan-1-amine|CHEMBL24072|Benzenepropanamine, N-(1-methyl-2-phenylethyl)-.gamma.-phenyl-|Prenylaminum [INN-Latin]|Prenilamina [INN-Spanish]|Carditin|Prenylamine [USAN:INN:BAN]|C24H27N|EINECS 206-869-4|BRN 2060323|UNII-K2OH82Z000|N-(3,3-Diphenylpropyl)-alpha-methylphenaethylamin [German]|Corontin (Salt/Mix)|PRENYLAMINE [MI]|N-(3'-Phenylo-2-propylo)-1,1-diphenylo-3-propyloamine [Polish]|Prestwick0_000560|Prestwick1_000560|Prestwick2_000560|PRENYLAMINE [INN]|Prenylamine (USAN/INN)|PRENYLAMINE [USAN]|PRENYLAMINE [MART.]|Oprea1_229505|PRENYLAMINE [WHO-DD]|N-(3,3-Diphenylpropyl)-alpha-methylphenaethylamin|SCHEMBL182253|SPBio_002560|CHEBI:8397|N-(3'-Phenyl-2-propyl)-1,1-diphenyl-3-propyloamine|Phenethylamine, N-(3,3-diphenylpropyl)-alpha-methyl-|N-(3'-Phenylo-2-propylo)-1,1-diphenylo-3-propyloamine|HMS3604C22|HY-A0257|MSK10680|BDBM50017723|MFCD00242807|PDSP1_001083|PDSP2_001067|AKOS025150812|DB04825|CS-0017601|NS00009915|D02383|EN300-18552722|N-(3,3-Diphenylpropyl)-.alpha.-methylphenaethylamin|N-(3,3-Diphenylpropyl)-.alpha.-methylphenethylamine|Q7240579|BRD-A10662413-043-11-2|(3,3-Diphenyl-propyl)-(1-methyl-2-phenyl-ethyl)-amine|Phenethylamine, N-(3,3-diphenylpropyl)-.alpha.-methyl-|N-(1-methyl-2-phenyl-ethyl)-3,3-diphenyl-propan-1-amine|N-(1-Methyl-2-phenylethyl)-.gamma.-phenylbenzenepropanamine|N-(1-Methyl-2-phenylethyl)-3,3-diphenyl-1-propanamine #|Prenylamine(3,3-Diphenyl-propyl)-(1-methyl-2-phenyl-ethyl)-amine"
QUINIDINE,441074,,"InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19+,20-/m0/s1",LOUPRKONTZGTKE-LHHVKLHASA-N,C20H24N2O2,324.4,"(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol","quinidine|56-54-2|(+)-Quinidine|Conquinine|Pitayine|Conchinin|Chinidin|Quinidex|(8R,9S)-Quinidine|(9S)-6'-Methoxycinchonan-9-ol|beta-Quinine|Kinidin|Conchinine|beta-Quinidine|Quiniduran|Cinchonan-9-ol, 6'-methoxy-, (9S)-|(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl](6-methoxyquinolin-4-yl)methanol|CHEBI:28593|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol|ITX08688JL|DTXSID4023549|NCI-C56246|6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|DTXCID70819883|alpha-(6-Methoxy-4-quinolyl)-5-vinyl-2-quinuclidinemethanol (9S)-|(S)-(6-methoxyquinolin-4-yl)((2R,5R)-5-vinylquinuclidin-2-yl)methanol|(R)-(6-methoxyquinolin-4-yl)((3S,4R,7S)-3-vinylquinuclidin-7-yl)methanol|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo[2.2.2]oct-2-yl)-methanol|(S)-[(2R,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol|(S)-[(4S,5R,7R)-5-ethenyl-1-azabicyclo[2.2.2]octan-7-yl]-(6-methoxyquinolin-4-yl)methanol|Apo Quinidine|(S)-(6-Methoxy-quinolin-4-yl)-((2R,5R)-5-vinyl-1-aza-bicyclo(2.2.2)oct-2-yl)-methanol|(S)-((2R,4S,5R)-5-ethenyl-1-azabicyclo(2.2.2)octan-2-yl)(6-methoxyquinolin-4-yl)methanol|(S)-((2R,4S,5R)-5-ethenyl-1-azabicyclo(2.2.2)octan-2-yl)-(6-methoxyquinolin-4-yl)methanol|(S)-((4S,5R,7R)-5-ethenyl-1-azabicyclo(2.2.2)octan-7-yl)-(6-methoxyquinolin-4-yl)methanol|RefChem:6193|200-279-0|MFCD00135581|Quinicardine|chinidinum|quinidina|Chinidine|.beta.-Quinidine|(1S)-(6-Methoxyquinolin-4-yl)((2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol|Quinora|CHEMBL1294|TCMDC-131239|Quinidine (>85%)|(3'.alpha., 9S)-6'-Methoxycinchonan-9-ol|(S)-(6-methoxy-4-quinolyl)-[(2R,4S,5R)-5-vinylquinuclidin-2-yl]methanol|(S)-(6-methoxyquinolin-4-yl)((1S,2R,4S,5R)-5-vinylquinuclidin-2-yl)methanol|Quinidine anhydrous|CAS-56-54-2|Chinidin [German]|SMR000857275|Quinidine [BAN:NF]|Quinidine (may contain up to 15% of dihydroquinidine)|UNII-ITX08688JL|Quinindine|CCRIS 672|Apo-Quinidine|HSDB 225|(8R,9S)-6'-Methoxycinchonan-9-ol|NCGC00159499-02|QDN|EINECS 200-279-0|Quinidine, anhydrous|QUINIDINE [MI]|QUINIDINE [HSDB]|Prestwick3_000280|QUINIDINE [VANDF]|bmse000511|Epitope ID:141803|QUINIDINE [MART.]|QUINIDINE [WHO-DD]|SCHEMBL15943|SCHEMBL15944|BSPBio_000160|MLS001335913|MLS001335914|MLS002548869|SCHEMBL513150|BPBio1_000176|GTPL2342|orb1299368|SCHEMBL29373489|HY-B1751H|HY-B1751R|HMS2234L10|HMS3259O09|HY-B1751|MSK11165|Tox21_111720|Tox21_201110|(9S)-6-Methoxy-alpha-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|BDBM50121975|AKOS015920101|Tox21_111720_1|CCG-256507|CS-7812|DB00908|FM27376|NC00478|SDCCGMLS-0066600.P001|NCGC00091231-01|NCGC00091231-02|NCGC00091231-03|NCGC00091231-04|NCGC00091231-18|NCGC00091231-29|NCGC00258662-01|AS-30538|DA-77296|SY017339|QUININE SULFATE IMPURITY A [WHO-IP]|AB00514657|CS-1053369|NS00098768|Quinidine (15% dihydroquinidine) (Standard)|QUININE BISULFATE IMPURITY A [WHO-IP]|EN300-305202|AB01562940_01|QUININE SULFATE IMPURITY A [EP IMPURITY]|AE-508/21131014|F079244|Q412496|BRD-K59632282-052-01-5|BRD-K59632282-052-02-3|BRD-K59632282-052-03-1|BRD-K70799801-311-02-7|QUININE HYDROCHLORIDE IMPURITY A [EP IMPURITY]|Quinidine, crystallized, >=98.0% (dried material, NT)|Z1741976976|6-Methoxy-?-(5-vinyl-2-quinuclidinyl)-4-quinolinemethanol|QUININE BISULFATE HEPTAHYDRATE IMPURITY A [WHO-IP]|(9S)-6'-Methoxycinchonan-9-ol;(+)-Quinidine;(8R,9S)-Quinidine|(S)-((2S,4S,5R)-5-ETHENYL-1-AZABICYCLO(2.2.2)OCT-2-YL)(6-METHOXYQUINOLIN-4-YL)METHANOL"
TRODUSQUEMINE,9917968,,"InChI=1S/C37H72N4O5S/c1-26(2)34(46-47(43,44)45)13-10-27(3)30-11-12-31-35-32(15-17-37(30,31)5)36(4)16-14-29(24-28(36)25-33(35)42)41-23-9-22-40-20-7-6-19-39-21-8-18-38/h26-35,39-42H,6-25,38H2,1-5H3,(H,43,44,45)/t27-,28-,29+,30-,31+,32+,33-,34-,35+,36+,37-/m1/s1",WUJVPODXELZABP-FWJXURDUSA-N,C37H72N4O5S,685.1,"[(3R,6R)-6-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-yl] hydrogen sulfate","Trodusquemine|MSI-1436|186139-09-3|Trodusquemina|KKC12PIF16|DTXSID701317590|(24R)-3beta-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-7alpha-hydroxy-5alpha-cholestan-24-yl hydrogen sulfate|[(3R,6R)-6-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-yl] hydrogen sulfate|Cholestane-7,24-diol, 3-((3-((4-((3-aminopropyl)amino)butyl)amino)propyl)amino)-, 24-(hydrogen sulfate), (3beta,5alpha,7alpha,24R)-|trodusqueminum|((3R,6R)-6-((3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-(3-(4-(3-aminopropylamino)butylamino)propylamino)-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta(a)phenanthren-17-yl)-2-methylheptan-3-yl) hydrogen sulfate|(24R)-3beta-[[3-[[4-[(3-aminopropyl)amino]butyl]amino]propyl]amino]-7alpha-hydroxy-5alpha-cholestan-24-yl hydrogen sulfate|RefChem:900654|MSI-1436C|DTXCID601747396|CHEMBL508583|Produlestan|Trodulamine|Trodusquemine [USAN]|UNII-KKC12PIF16|Trodusquemine [USAN:INN]|MSI1436|3-n-1(spermine)-7, 24-dihydroxy-5-cholestane 24-sulfate|TRODUSQUEMINE [INN]|Trodusquemine (USAN/INN)|GTPL9733|orb1709085|SCHEMBL2876305|C37H72N4O5S|MSI-1436;Aminosterol-1436|CHEBI:177502|EX-A9431|BDBM50333649|AKOS027326567|CS-4937|DB06333|BT168546|DA-75774|HY-12219|NS00126467|D06252|Q27282308|(3b,5a,7a,24R)-3-[[3-[[4-[(3-Aminopropyl)amino]butyl]amino]propyl]amino]-cholestane-7,24-diol, 24-(hydrogen sulfate)|(3R,6R)-6-((3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-(3-(4-(3-aminopropylamino)butylamino)propylamino)-7-hydroxy-10,13-dimethyl-hexadecahydro-1H-cyclopenta[a]phenanthren-17-yl)-2-methylheptan-3-yl hydrogen sulfate|[(1R,4R)-4-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-1-isopropyl-pentyl] hydrogen sulfate|[(3R,6R)-6-[(3S,5R,7R,8R,9S,10S,13R,14S,17R)-3-[3-[4-(3-aminopropylamino)butylamino]propylamino]-7-hydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptan-3-yl] hydrogen sulate"
ABBV-744,132010322,,"InChI=1S/C28H30FN3O4/c1-7-30-26(33)22-13-20-21(14-32(6)27(34)24(20)31-22)19-12-17(28(4,5)35)8-9-23(19)36-25-15(2)10-18(29)11-16(25)3/h8-14,31,35H,7H2,1-6H3,(H,30,33)",OEDSFMUSNZDJFD-UHFFFAOYSA-N,C28H30FN3O4,491.6,"N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide","ABBV-744|2138861-99-9|ABBV 744|N-ethyl-4-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide|9MX546E2SF|N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide|ABBV744|DTXSID101022541|1H-Pyrrolo(2,3-C)pyridine-2-carboxamide, N-ethyl-4-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(1-hydroxy-1-methylethyl)phenyl)-6,7-dihydro-6-methyl-7-oxo-|N-Ethyl-4-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo(2,3-C)pyridine-2-carboxamide|N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl]-6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridine-2-carboxamide|N-ethyl-4-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl)-6-methyl-7-oxo-1H-pyrrolo(2,3-c)pyridine-2-carboxamide|RefChem:927147|DTXCID301507226|N-Ethyl-4-(2-(4-fluoro-2,6-dimethylphenoxy)-5-(1-hydroxy-1-methylethyl)phenyl)-6,7-dihydro-6-methyl-7-oxo-1H-pyrrolo(2,3-c)pyridine-2-carboxamide|UNII-9MX546E2SF|N-ethyl-4-[2-(4-fluoro-2,6-dimethylphenoxy)-5-(2-hydroxypropan-2-yl)phenyl]-6-methyl-7-oxo-1H,6H,7H-pyrrolo[2,3-c]pyridine-2-carboxamide|HWV|orb1302642|CHEMBL4297454|SCHEMBL19463409|ABBV-744?|C28H30FN3O4|GTPL10730|ABBV 744; ABBV744|BDBM439497|GLXC-21221|BCP29855|EX-A2713|US10633379, Example 35|US10633379, Example 82|NSC812415|s8723|AKOS037515627|NSC-812415|NCGC00651745-01|AC-36257|BA166477|BS-16488|DA-50082|PD133034|HY-112090|CS-0043318|C74031|Z3325129513|N-ethyl-4-[2-(4-fluoro-2,6-dimethyl-phenoxy)-5-(1-hydroxy-1-methyl-ethyl)phenyl]-6-methyl-7-oxo-1H-pyrrolo[2,3-c]pyridine-2-carboxamide"
MK-1064,44633765,,"InChI=1S/C24H20ClN5O3/c1-32-21-7-6-18(30-24(21)33-2)14-29-23(31)19-10-16(15-9-17(25)13-26-11-15)12-28-22(19)20-5-3-4-8-27-20/h3-13H,14H2,1-2H3,(H,29,31)",CKTWQGHVNRYNCM-UHFFFAOYSA-N,C24H20ClN5O3,461.9,"5-(5-chloropyridin-3-yl)-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-pyridin-2-ylpyridine-3-carboxamide","mk-1064|1207253-08-4|5''-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide|MK 1064|5-(5-chloropyridin-3-yl)-N-[(5,6-dimethoxypyridin-2-yl)methyl]-2-pyridin-2-ylpyridine-3-carboxamide|O812716S9E|UNII-O812716S9E|5-(5-Chloro-3-pyridyl)-N-((5,6-dimethoxy-2-pyridyl)methyl)-2-(2-pyridyl)pyridine-3-carboxamide|(2,2':5',3''-Terpyridine)-3'-carboxamide, 5''-chloro-N-((5,6-dimethoxy-2-pyridinyl)methyl)-|5''-Chloro-N-((5,6-dimethoxypyridin-2-yl)methyl)-2,2':5',3''-terpyridine-3'-carboxamide|5'-chloro-N-[(5,6-dimethoxypyridin-2-yl)methyl]-6-(pyridin-2-yl)-[3,3'-bipyridine]-5-carboxamide|5'-chloro-N-((5,6-dimethoxypyridin-2-yl)methyl)-6-(pyridin-2-yl)-(3,3'-bipyridine)-5-carboxamide|5-(5-chloropyridin-3-yl)-N-((5,6-dimethoxypyridin-2-yl)methyl)-2-pyridin-2-ylpyridine-3-carboxamide|RefChem:159185|MK1064|CHEMBL3338866|5''-Chloro-N-((5,6-dimethoxypyridin-2-yl)methyl)-[2,2':5',3''-terpyridine]-3'-carboxamide|CKTWQGHVNRYNCM-UHFFFAOYSA-N|MFCD28502027|C24H20ClN5O3|GTPL9306|orb1303845|SCHEMBL3486358|SCHEMBL30593431|GLXC-10213|MK-1064(Urokinase inhibitor 1)|BCP19608|EX-A1222|HYB25308|BDBM50028059|s6726|AKOS030632030|CS-5968|DB15028|SB16800|AC-36061|AS-74199|DA-65498|HY-19914|MK-1064?|D84025|Q27896058|5''-Chloro-N-[(5,6-dimethoxy-2-pyridinyl)methyl]-2,2':5',3''-terpyridine-3'-carboxamide"
ULIXERTINIB,11719003,,"InChI=1S/C21H22Cl2N4O2/c1-12(2)26-20-8-16(17(23)10-25-20)14-7-18(24-9-14)21(29)27-19(11-28)13-4-3-5-15(22)6-13/h3-10,12,19,24,28H,11H2,1-2H3,(H,25,26)(H,27,29)/t19-/m1/s1",KSERXGMCDHOLSS-LJQANCHMSA-N,C21H22Cl2N4O2,433.3,N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-(propan-2-ylamino)pyridin-4-yl]-1H-pyrrole-2-carboxamide,"Ulixertinib|869886-67-9|VRT752271|BVD-523|BVD-ERK|16ZDH50O1U|VRT-752271|1H-Pyrrole-2-carboxamide, 4-(5-chloro-2-((1-methylethyl)amino)-4-pyridinyl)-N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-|ulixertinibum|4-(5-chloro-2-((propan-2-yl)amino)pyridin-4-yl)-N-((1S)-1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide|4-{5-chloro-2-[(propan-2-yl)amino]pyridin-4-yl}-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-1H-pyrrole-2-carboxamide|RefChem:192996|Ulixertinib [INN]|Ulixertinib (BVD-523)|UNII-16ZDH50O1U|(S)-4-(5-chloro-2-(isopropylamino)pyridin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide|Ulixertinib (BVD-523, VRT752271)|CHEMBL3590106|Ulixertinib (INN)|869886-67-9 (free base)|N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]-4-[5-chloro-2-(propan-2-ylamino)pyridin-4-yl]-1H-pyrrole-2-carboxamide|VRT752271 HCl|(S)-4-(5-chloro-2-(isopropylamino)pyridin-4-yl)-N-(1-(3-chlorophenyl)-2-hydroxyethyl)-1H-pyrrole-2-carboxamide.|4-[5-chloranyl-2-(propan-2-ylamino)pyridin-4-yl]-~{N}-[(1~{S})-1-(3-chlorophenyl)-2-oxidanyl-ethyl]-1~{H}-pyrrole-2-carboxamide|MFCD22628898|BVD523 HCl|BVD-523 HCl|ULIXERTINIB [WHO-DD]|GTPL9210|orb1300149|SCHEMBL14211742|SCHEMBL29456946|SCHEMBL29712842|BCP04232|EX-A1332|BDBM50094465|NSC797771|NSC800959|s7854|AKOS025396467|CCG-269049|DB13930|NSC-797771|NSC-800959|NCGC00378692-02|NCGC00378692-05|NCGC00378692-07|AC-33165|AS-56114|FU157994|HY-15816|BCP0726000085|NS00072098|D11038|G60969|BRD-K28965160-001-01-1|Q27089081|Z2756516977|4-[5-chloro-2-(isopropylamino)-4-pyridyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxy-ethyl]-1H-pyrrole-2-carboxamide|4-[5-Chloro-2-[(1-methylethyl)amino]-4-pyridinyl]-N-[(1S)-1-(3-chlorophenyl)-2-hydroxyethyl]1H-pyrrole-2-carboxamide"
RAVOXERTINIB,71727581,,"InChI=1S/C21H18ClFN6O2/c1-28-19(5-8-25-28)27-21-24-7-4-17(26-21)13-6-9-29(20(31)11-13)18(12-30)14-2-3-15(22)16(23)10-14/h2-11,18,30H,12H2,1H3,(H,24,26,27)/t18-/m1/s1",RZUOCXOYPYGSKL-GOSISDBHSA-N,C21H18ClFN6O2,440.9,1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]pyridin-2-one,"Ravoxertinib|1453848-26-4|GDC-0994|GDC0994|RG-7842|R6AXV96CRH|1-((1S)-1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)-4-pyrimidinyl)-2(1H)-pyridinone|1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]pyridin-2-one|1-[(1S)-1-(4-CHLORO-3-FLUOROPHENYL)-2-HYDROXYETHYL]-4-{2-[(2-METHYLPYRAZOL-3-YL)AMINO]PYRIMIDIN-4-YL}PYRIDIN-2-ONE|2(1H)-Pyridinone, 1-((1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)-4-pyrimidinyl)-|ravoxertinibum|1-((1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)-1,2-dihydropyridin-2-one|1-((1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((2-methylpyrazol-3-yl)amino)pyrimidin-4-yl)pyridin-2-one|1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-{2-[(1-methyl-1H-pyrazol-5-yl)amino]pyrimidin-4-yl}-1,2-dihydropyridin-2-one|RefChem:930572|ERK Inhibitor GDC-0994|1-((1S)-1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one|(S)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one|MFCD28143918|Ravoxertinib [INN]|Ravoxertinib [USAN]|(S)-1-[1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl]-4-[2-[(1-methyl-5-pyrazolyl)amino]-4-pyrimidyl]-2(1H)-pyridone|1-((1S)-1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-methyl-1H-pyrazol-5-yl)amino)pyrimidin- 4-yl)pyridin-2(1H)-one|1-[(1~{s})-1-(4-Chloranyl-3-Fluoranyl-Phenyl)-2-Oxidanyl-Ethyl]-4-[2-[(2-Methylpyrazol-3-Yl)amino]pyrimidin-4-Yl]pyridin-2-One|1-[(1S)-1-(4-chloro-3-fluoro-phenyl)-2-hydroxy-ethyl]-4-[2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl]pyridin-2-one|C21H18ClFN6O2|6QB|UNII-R6AXV96CRH|Ravoxertinib (USAN/INN)|Ravoxertinib [USAN:INN]|Ravoxertinib(GDC0994)?|Ravoxertinib (GDC-0994)|RAVOXERTINIB [WHO-DD]|GTPL9229|orb1300705|CHEMBL3544964|SCHEMBL15245531|SCHEMBL29358425|RZUOCXOYPYGSKL-GOSISDBHSA-N|BDBM120095|BCP09668|EX-A1614|NSC781343|NSC800104|RG7842|AKOS027252126|CCG-269131|CS-3704|DB15281|NSC-781343|NSC-800104|example 39 [WO2013130976]|NCGC00386401-02|(S)-1-(1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-(1-methyl-1H-pyrazol-5-ylamino)pyrimidin-4-yl)pyridin-2(1H)-one|AC-33149|AS-55994|HY-15947|SY031265|D11285|US8697715, 39|BRD-K86309810-001-01-5|Q27077782|(S)-1-(1-(4-Chloro-3-fluorophenyl)-2-hydroxyethyl)-4-(2-((1-Me-1H-pyrazol-5-yl)amino)pyrimidin-4-yl)pyridin-2(1H)-one"
ACT-462206,40924317,,"InChI=1S/C20H24N2O4S/c1-14-11-15(2)13-16(12-14)21-20(23)19-5-4-10-22(19)27(24,25)18-8-6-17(26-3)7-9-18/h6-9,11-13,19H,4-5,10H2,1-3H3,(H,21,23)/t19-/m0/s1",NHPQGZOBHSVTAQ-IBGZPJMESA-N,C20H24N2O4S,388.5,"(2S)-N-(3,5-dimethylphenyl)-1-(4-methoxyphenyl)sulfonylpyrrolidine-2-carboxamide","ACT-462206|1361321-96-1|(2S)-N-(3,5-dimethylphenyl)-1-(4-methoxyphenyl)sulfonylpyrrolidine-2-carboxamide|64ONO62P28|(2S)-N-(3,5-Dimethylphenyl)-1-((4-methoxyphenyl)sulfonyl)-2-pyrrolidinecarboxamide|2-Pyrrolidinecarboxamide, N-(3,5-dimethylphenyl)-1-((4-methoxyphenyl)sulfonyl)-, (2S)-|(2S)-N-(3,5-Dimethylphenyl)-1-[(4-methoxyphenyl)sulfonyl]-2-pyrrolidinecarboxamide|RefChem:109451|110-331-3|ACT462206|ACT 462206|(2~{S})-~{N}-(3,5-dimethylphenyl)-1-(4-methoxyphenyl)sulfonyl-pyrrolidine-2-carboxamide|NHPQGZOBHSVTAQ-IBGZPJMESA-N|UNII-64ONO62P28|GTPL9303|orb1701256|SCHEMBL2704391|CHEMBL3597952|BDBM154947|GLXC-05356|LEC32196|MFCD28502270|AKOS025142087|compound 24 [PMID: 25147058]|NCGC00387479-01|DA-60785|MS-26450|HY-101834|CS-0021953|G79371|ACT-462206, >=98% (HPLC)|US9000029, 26|BRD-K19781342-001-01-4|Q27896027|(2S)-N-(3,5-dimethylphenyl)-1-(4-methoxyphenyl)sulfonyl-pyrrolidine-2-carboxamide|(S)-N-(3,5-dimethylphenyl)-1-((4-methoxyphenyl)sulfonyl)-pyrrolidine-2-carboxamide|(2S)-1-(4-Methoxy-benzenesulfonyl)-pyrrolidine-2-carboxylic acid (3,5-dimethyl-phenyl)-amide|NRZ"
VERCIRNON,10343454,,"InChI=1S/C22H21ClN2O4S/c1-22(2,3)16-4-7-18(8-5-16)30(28,29)24-20-9-6-17(23)14-19(20)21(26)15-10-12-25(27)13-11-15/h4-14,24H,1-3H3",JRWROCIMSDXGOZ-UHFFFAOYSA-N,C22H21ClN2O4S,444.9,4-tert-butyl-N-[4-chloro-2-(1-oxidopyridin-1-ium-4-carbonyl)phenyl]benzenesulfonamide,"Vercirnon|698394-73-9|GSK-1605786|GSK1605786|CCX-282-B|MWI54OUA12|CCX282|DTXSID50220135|4-tert-butyl-N-[4-chloro-2-(1-oxidopyridin-1-ium-4-carbonyl)phenyl]benzenesulfonamide|vercirnonum|4-tert-butyl-N-(4-chloro-2-(1-oxidopyridin-1-ium-4-carbonyl)phenyl)benzenesulfonamide|RefChem:193977|DTXCID50142626|4-(2-(4-tert-butylbenzenesulfonamido)-5-chlorobenzoyl)pyridin-1-ium-1-olate|Traficet-EN|CCX282-B|CHEMBL2178578|4-(2-((4-(tert-butyl)phenyl)sulfonamido)-5-chlorobenzoyl)pyridine 1-oxide|Verecimon|VERCIRNON [INN]|VERCIRNON [USAN]|VERCIRNON [WHO-DD]|SCHEMBL342225|GTPL9046|orb1307619|GSK'786|JRWROCIMSDXGOZ-UHFFFAOYSA-N|GLXC-10244|YCB39473|BDBM50398334|CS-4963|DB15250|NCGC00485483-01|DA-22939|HY-15724|MS-28019|F81794|BRD-K47929404-001-01-0|Q27089138|4-(2-(4-Tert-butylphenylsulfonamido)-5-chlorobenzoyl)pyridine 1-oxide|4-tert-butyl-N-[4-chloro-2-(1-oxidoisonicotinoyl)phenyl]benzenesulfonamide|BENZENESULFONAMIDE, N-(4-CHLORO-2-((1-OXIDO-4-PYRIDINYL)CARBONYL)PHENYL)-4-(1,1-DIMETHYLETHYL)-"
CYPROHEPTADINE,2913,,"InChI=1S/C21H21N/c1-22-14-12-18(13-15-22)21-19-8-4-2-6-16(19)10-11-17-7-3-5-9-20(17)21/h2-11H,12-15H2,1H3",JJCFRYNCJDLXIK-UHFFFAOYSA-N,C21H21N,287.4,"1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine","CYPROHEPTADINE|129-03-3|Eiproheptadine|Periactinol|Dronactin|Ciproheptadina|Cyproheptadinum|Ciprovit|MK 141|4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidine|1-Methyl-4-(5H-dibenzo(a,d)cycloheptenylidene)piperidine|5-(1-Methylpiperidylidene-4)-5H-dibenzo(a,d)cyclopheptene|1-Methyl-4-(5-dibenzo(a,e)cycloheptatrienylidene)piperidine|4-(5-Dibenzo(a,d)cyclohepten-5-ylidine)-1-methylpiperidine|2YHB6175DO|CHEBI:4046|DTXSID8022872|4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine|Piperidine, 4-(5H-dibenzo(a,d)cyclohepten-5-ylidene)-1-methyl-|Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-|1-Methyl-4-(5H-dibenzo[a,d]cycloheptenylidene)piperidine|DTXCID702872|4-Dibenzo[a,d]cyclohepten-5-ylidene-1-methyl-piperidine|4-Dibenzo(a,d)cyclohepten-5-ylidene-1-methyl-piperidine|ciproeptadina|1-methyl-4-(tricyclo(9.4.0.0^(3,8))pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene)piperidine|1-methyl-4-(tricyclo(9.4.0.0^(3,8))pentadeca-1(15),3,5,7,9,11,13-heptaen-2-ylidene)piperidine|1-methyl-4-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene}piperidine|1-methyl-4-{tricyclo[9.4.0.0^{3,8}]pentadeca-1(15),3,5,7,9,11,13-heptaen-2-ylidene}piperidine|RefChem:57573|R06AX02|cyproheptadine hydrochloride solution|1-methyl-4-(tricyclo(9.4.0.03,8)pentadeca-1(15),3,5,7,9,11,13-heptaen-2-ylidene)piperidine|204-928-9|Periactin|4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine|cycloheptadine|Cyproheptadine (INN)|CHEMBL516|1-methyl-4-(2-tricyclo[9.4.0.03,8]pentadeca-1(15),3,5,7,9,11,13-heptaenylidene)piperidine|Cypoheptadine|Cyproheptadiene|NCGC00015252-08|CYPROHEPTADINE [INN]|Cyproheptadine [INN:BAN]|Cyproheptadinum [INN-Latin]|Ciproheptadina [INN-Spanish]|Ciprovit (TN)|1-methyl-4-{tricyclo[9.4.0.0(3),?]pentadeca-1(11),3,5,7,9,12,14-heptaen-2-ylidene}piperidine|CAS-129-03-3|CCRIS 5232|HSDB 3048|EINECS 204-928-9|BRN 1685976|cyproheptidine|UNII-2YHB6175DO|Reactin|4-(5H-Dibenzo(a,d)cyclohepten-5-ylidene)-1-methylpiperidene|Peritol (Salt/Mix)|Tocris-0996|Prestwick0_000103|Prestwick1_000103|Prestwick2_000103|Prestwick3_000103|Cyproheptadine (Standard)|Lopac-C-6022|Biomol-NT_000131|CYPROHEPTADINE [MI]|SCHEMBL4021|Lopac0_000246|Oprea1_498140|BSPBio_000086|CYPROHEPTADINE [HSDB]|GTPL277|5-20-08-00500 (Beilstein Handbook Reference)|BIDD:GT0324|CYPROHEPTADINE [VANDF]|SPBio_002025|BPBio1_000096|BPBio1_000155|orb1689449|CYPROHEPTADINE [WHO-DD]|SCHEMBL29369949|HY-B1622R|HMS2090P20|HY-B1622|Tox21_110112|BBL010977|BDBM50017721|DL-136|PDSP1_001229|PDSP2_001213|STK802098|AKOS004119847|Tox21_110112_1|CCG-204341|DB00434|SDCCGSBI-0050234.P003|NCGC00015252-01|NCGC00015252-02|NCGC00015252-03|NCGC00015252-04|NCGC00015252-05|NCGC00015252-06|NCGC00015252-07|NCGC00015252-09|NCGC00015252-10|NCGC00015252-12|NCGC00015252-13|NCGC00015252-26|NCGC00024293-02|NCGC00024293-04|NCGC00024293-05|CAS-969-33-5|VS-02784|SBI-0050234.P002|DB-041917|DB-241419|CS-0013555|NS00004763|C06935|D07765|H37510|129C033|EN300-18552723|L001016|Q417884|BRD-K28143534-001-01-4|BRD-K28143534-001-02-2|BRD-K28143534-001-03-0|BRD-K28143534-003-03-6|BRD-K28143534-003-14-3|BRD-K28143534-003-24-2|BRD-K28143534-003-25-9|BRD-K28143534-003-26-7|4-(dibenzo[[?],[?]][7]annulen-11-ylidene)-1-methyl-piperidine|4-(Dibenzo[1,2-A:2',1'-D][7]annulen-11-Ylidene)-1-Methyl-Piperidine|1-methyl-4-{tricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaen-2-ylidene}piperidine|4-(5H-dibenzo[a,d][7]annulen-5-ylidene)-1-methylpiperidine4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine|Cycloheptadine; Piperidine, 4-(5H-dibenzo[a,d]cyclohepten-5-ylidene)-1-methyl-; 4-(5H-Dibenzo[a,d]cyclohepten-5-ylidene)-1-methylpiperidine; 1-Methyl-4-(5H-dibenzo[a,d]cycloheptenylidene)piperidine; 1-Methyl-4-(dibenzo[a,e]cycloheptatrien-5-ylidene)piperidine; Cyclohepta"
MEXILETINE HYDROCHLORIDE,21467,,"InChI=1S/C11H17NO.ClH/c1-8-5-4-6-9(2)11(8)13-7-10(3)12;/h4-6,10H,7,12H2,1-3H3;1H",NFEIBWMZVIVJLQ-UHFFFAOYSA-N,C11H18ClNO,215.72,"1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride","Mexiletine hydrochloride|5370-01-4|Mexiletine HCL|Katen|1-(2,6-Dimethylphenoxy)-2-propanamine hydrochloride|Ko 1173 Cl|NSC-758639|1-Methyl-2-(2,6-xylyloxy)ethylammonium chloride|DTXSID2045783|KO-1173-Cl|KO-1173 CL|606D60IS38|KO 1173|KO-1173|CHEBI:6917|DTXCID0025783|1-Methyl-2-(2,6-xylyloxy)ethylamine hydrochloride|KO1173|1-(2,6-Dimethylphenoxy)-2-aminopropane hydrochloride|Mexitil p.l.|RefChem:56492|KOE1173|KOE 1173|KOE-1173|(1RS)-2-(2,6-Dimethylphenoxy)-1-methylethylamine monohydrochloride|226-362-1|Mexitil|Mexiletene hydrochloride|1-(2,6-dimethylphenoxy)propan-2-amine hydrochloride|Mexiletine (hydrochloride)|MFCD00216024|2-Propanamine, 1-(2,6-dimethylphenoxy)-, hydrochloride|1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride|2-(2-aminopropoxy)-1,3-dimethylbenzene hydrochloride|KOE-1173 (hydrochloride)|1-(2,6-Xylyloxy)-2-aminopropane hydrochloride|1-(2,6-Dimethylphenoxy)-2-propylamine Hydrochloride|NCGC00094121-01|(+-)-1-Methyl-2-(2,6-xylyloxy)ethylamine hydrochloride|SMR000326711|CAS-5370-01-4|1-(2,6-dimethylphenoxy)prop-2-ylamine, chloride|SR-01000075986|NCGC00015659-06|(2S)-1-(2,6-dimethylphenoxy)propan-2-amine;hydrochloride|Prestwick_666|EINECS 226-362-1|Mexitil (TN)|SCHEMBL42226|MLS001056756|MLS002222239|MLS002548872|SPECTRUM1503929|MEXILITENE HYDROCHLORIDE|orb1309949|Mexiletine hydrochloride, powder|CHEMBL1200606|Ethylamine, 1-methyl-2-(2,6-xylyloxy)-, hydrochloride|UNII-606D60IS38|HY-A0093R|HMS1568B04|HMS5082L14|Pharmakon1600-01503929|1-(2,6-Xylyloxy)-2-aminopropane|2-Propanamine, 1-(2,6-dimethylphenoxy)-, hydrochloride, (+-)-|BCP28602|HY-A0093|MSK10212|Tox21_111249|Tox21_500784|Mexiletine hydrochloride ( ge 98%)|Mexiletine hydrochloride ( ge 99%)|MEXILETINE HYDROCHLORIDE [MI]|NSC758639|s4225|SBB003392|Mexiletine hydrochloride (JP17/USP)|MEXILETINE HYDROCHLORIDE [JAN]|AKOS009139802|Mexiletine (hydrochloride) (Standard)|Tox21_111249_1|Tox21_111249_2|AC-4260|AC-8240|CCG-213246|FD25993|LP00784|MEXILETINE HYDROCHLORIDE [USAN]|NC00682|NSC 758639|SB79359|MEXILETINE HYDROCHLORIDE [MART.]|MEXILETINE HYDROCHLORIDE [VANDF]|MEXILETINE HYDROCHLORIDE [USP-RS]|MEXILETINE HYDROCHLORIDE [WHO-DD]|NCGC00015659-14|NCGC00094121-02|NCGC00094121-03|NCGC00094121-04|NCGC00261469-01|5370-01-4 (HCl)|AS-13790|Mexiletine hydrochloride [USAN:USP:JAN]|ST083488|1-(2,6-Dimethylphenoxy)-2-propanamine HCl|EU-0100784|M2040|SW196821-3|EN300-53944|MEXILETINE HYDROCHLORIDE [ORANGE BOOK]|D00639|M 2727|MEXILETINE HYDROCHLORIDE [EP MONOGRAPH]|MEXILETINE HYDROCHLORIDE [USP IMPURITY]|MEXILETINE HYDROCHLORIDE [USP MONOGRAPH]|370M014|Mexiletine HCl;KO-1173; KO 1173; KO1173|SR-01000075986-1|SR-01000075986-6|Q27107357|Z2237335016|1-(2,6-Dimethylphenoxy)-2-propanamine hydrochloride, 97%|(+/-)-1-METHYL-2-(2,6-XYLYLOXY)ETHYLAMINE HYDROCHLORIDE|2-PROPANAMINE, 1-(2,6-DIMETHYLPHENOXY)-, HYDROCHLORIDE (1:1)|2-PROPANAMINE, 1-(2,6-DIMETHYLPHENOXY)-, HYDROCHLORIDE, (+/-)-|Mexiletine hydrochloride, European Pharmacopoeia (EP) Reference Standard|Mexiletine hydrochloride, United States Pharmacopeia (USP) Reference Standard|Mexiletine hydrochloride;1-Methyl-2-(2,6-xylyloxy)ethylamine hydrochloride;Katen"
WNT-974,46926973,,"InChI=1S/C23H20N6O/c1-15-9-17(12-28-23(15)18-5-6-25-16(2)10-18)11-22(30)29-21-4-3-19(13-27-21)20-14-24-7-8-26-20/h3-10,12-14H,11H2,1-2H3,(H,27,29,30)",XXYGTCZJJLTAGH-UHFFFAOYSA-N,C23H20N6O,396.4,2-[5-methyl-6-(2-methylpyridin-4-yl)pyridin-3-yl]-N-(5-pyrazin-2-ylpyridin-2-yl)acetamide,"1243244-14-5|LGK974|LGK-974|WNT-974|WNT974|CHEBI:78030|[2,4'-Bipyridine]-5-acetamide, 2',3-dimethyl-N-[5-(2-pyrazinyl)-2-pyridinyl]-|U27F40013Q|2-[5-methyl-6-(2-methylpyridin-4-yl)pyridin-3-yl]-N-(5-pyrazin-2-ylpyridin-2-yl)acetamide|(2,4'-BIPYRIDINE)-5-ACETAMIDE, 2',3-DIMETHYL-N-(5-(2-PYRAZINYL)-2-PYRIDINYL)-|2-(5-methyl-6-(2-methylpyridin-4-yl)pyridin-3-yl)-N-(5-pyrazin-2-ylpyridin-2-yl)acetamide|RefChem:934231|PORCN inhibitor LGK974|Porcupine Inhibitor WNT974|2-(2',3-dimethyl-(2,4'-bipyridine)-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide|2-(2,3-Dimethyl-(2,4-bipyridin)-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide|2-(2',3-Dimethyl-[2,4'-bipyridin]-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide|LGK 974|MFCD27501026|LGK974 (WNT974)|2-[5-Methyl-6-(2-methyl-4-pyridyl)-3-pyridyl]-N-(5-pyrazin-2-yl-2-pyridyl)acetamide|CHEMBL3188386|LGK-974 (WNT974)|2-(2',3-Dimethyl-(2,4'-bipyridin)-5-yl)-N-(5-(pyrazin-2-yl)pyridin-2-yl)acetamide|2-(2',3-dimethyl-2,4'-bipyridin-5-yl)-N-[5-(pyrazin-2-yl)pyridin-2-yl]acetamide|2-[(2P)-2',3-dimethyl[2,4'-bipyridin]-5-yl]-N-[(5P)-5-(pyrazin-2-yl)pyridin-2-yl]acetamide|UNII-U27F40013Q|O50|PORCN Inhibitor IV|Acotiamide Impurity LGK|MLS006011002|orb1305261|SCHEMBL1723611|SCHEMBL29351311|SCHEMBL29382356|WNT-974 [WHO-DD]|GTPL11167|GLXC-10649|HMS3653G11|BCP08495|EX-A1402|LGK-974?|BBL102809|BDBM50133870|CS3177|NSC777639|s7143|STL556617|AKOS025211913|CCG-264701|DB12561|FL76327|NSC-777639|SB19314|NCGC00347950-01|NCGC00347950-02|NCGC00347950-07|NCGC00347950-11|AC-30231|DA-74987|HY-17545|MS-20504|SMR004702800|SW211728-2|AU-004/43508401|BRD-K16810791-001-01-0|Q27147596|LGK 974;LGK974; WNT974; WNT 974; WNT-974|N-(5-(2-Pyrazinyl)-2-pyridyl)(2',3-dimethyl-2,4'-bipyridyl-5-yl)acetamide"
ETC-159,86280523,,"InChI=1S/C19H17N7O3/c1-24-17-16(18(28)25(2)19(24)29)26(11-20-17)10-15(27)21-14-9-8-13(22-23-14)12-6-4-3-5-7-12/h3-9,11H,10H2,1-2H3,(H,21,23,27)",QTRXIFVSTWXRJJ-UHFFFAOYSA-N,C19H17N7O3,391.4,"2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(6-phenylpyridazin-3-yl)acetamide","ETC-159|1638250-96-0|ETC-1922159|2-(1,3-Dimethyl-2,6-dioxo-1,2,3,6-tetrahydro-7H-purin-7-yl)-N-(6-phenylpyridazin-3-yl)acetamide|2-(1,3-dimethyl-2,6-dioxopurin-7-yl)-N-(6-phenylpyridazin-3-yl)acetamide|5L854240DQ|RefChem:138001|PORCN Inhibitor ETC-1922159|Porcupine Inhibitor ETC-1922159|7H-Purine-7-acetamide, 1,2,3,6-tetrahydro-1,3-dimethyl-2,6-dioxo-N-(6-phenyl-3-pyridazinyl)-|ETC159|CHEMBL3633802|1,2,3,6-TETRAHYDRO-1,3-DIMETHYL-2,6-DIOXO-N-(6-PHENYL-3-PYRIDAZINYL)-7H-PURINE-7-ACETAMIDE|2-(1,3-dimethyl-2,6-dioxo-2,3,6,7-tetrahydro-1H-purin-7-yl)-N-(6-phenylpyridazin-3-yl)acetamide|UNII-5L854240DQ|MFCD29472267|orb1303253|SCHEMBL17626176|SCHEMBL29381546|GTPL11168|C19H17N7O3|BCP20688|ETC-159?|EX-A2302|NQC25096|BDBM50133866|NSC809251|AKOS030526630|CS-5162|ETC1922159|NSC-809251|SB18869|AC-35482|AS-74458|DA-53017|HY-18988|S6616|A12126|BRD-K54264768-001-01-2|2-(1,3-dimethyl-2,6-dioxo-purin-7-yl)-N-(6-phenylpyridazin-3-yl)acetamide"
PUROMYCIN,439530,,"InChI=1S/C22H29N7O5/c1-28(2)19-17-20(25-10-24-19)29(11-26-17)22-18(31)16(15(9-30)34-22)27-21(32)14(23)8-12-4-6-13(33-3)7-5-12/h4-7,10-11,14-16,18,22,30-31H,8-9,23H2,1-3H3,(H,27,32)/t14-,15+,16+,18+,22+/m0/s1",RXWNCPJZOCPEPQ-NVWDDTSBSA-N,C22H29N7O5,471.5,"(2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide","puromycin|53-79-2|Stylomycin|Puromicina|Puromycine|Puromycinum|Stillomycin|3123L|P-638|CHEBI:17939|GNF-PF-2016|CL 13,900|4A6ZS6Q2CL|CL 13900|CL-13900|3'-(L-alpha-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine|(S)-3'-((2-Amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyladenosine|DTXSID8036788|P 638|3123-L|CL13900|3'-deoxy-N,N-dimethyl-3'-(O-methyl-L-tyrosinamido)adenosine|P638|Adenosine, 3'-((2-amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyl-, (S)-|CL 16536|(2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide|Adenosine, 3'-(alpha-amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyl-, L-|NSC3055|(S)-3'-[[2-Amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-dimethyladenosine|(2S)-2-amino-N-((2S,3S,4R,5R)-5-(6-(dimethylamino)purin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl)-3-(4-methoxyphenyl)propanamide|RefChem:177304|DTXCID6016788|L-3'-(alpha-amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine|Puromycin (USAN)|PUROMYCIN [USAN]|9-{3-deoxy-3-[(O-methyl-L-tyrosyl)amino]-beta-D-xylofuranosyl}-N,N-dimethyl-9H-purin-6-amine|Adenosine, 3'-(((2S)-2-amino-3-(4-methoxyphenyl)-1-oxopropyl)amino)-3'-deoxy-N,N-dimethyl-|Achromycin (purine derivative)|TCMDC-123493|3'-deoxy-N,N-dimethyl-3'-[(O-methyl-L-tyrosyl)amino]adenosine|3'-[[(2S)-2-amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-diemthyladenosine|(2S)-2-amino-N-[(2S,3S,4R,5R)-5-[6-(dimethylamino)purin-9-yl]-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl]-3-(4-methoxyphenyl)propanamide|(S)-2-amino-N-((2S,3S,4R,5R)-5-(6-(dimethylamino)-9H-purin-9-yl)-4-hydroxy-2-(hydroxymethyl)tetrahydrofuran-3-yl)-3-(4-methoxyphenyl)propanamide|NSC 3055|Puromycine [INN-French]|Puromycinum [INN-Latin]|Puromicina [INN-Spanish]|UNII-4A6ZS6Q2CL|Bacterenomycin|Puromycin [USAN:INN:BAN]|C22H29N7O5|Adenosine, 3'-[[(2S)-2-amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-dimethyl-|PUROMYCIN [INN]|PUROMYCIN [MI]|Prestwick3_000480|Epitope ID:140945|PUROMYCIN [WHO-DD]|SCHEMBL4570|BSPBio_000620|BPBio1_000682|CHEMBL469912|orb1705876|SCHEMBL29355751|GTPL13311|3'-(L-.alpha.-Amino-p-methoxyhydrocinnamamido)-3'-deoxy-N,N-dimethyladenosine|HMS2089F18|AAA05379|HY-B1743|CL 16,536 (*Dihydrochloride*)|BDBM50277158|EX-A13431|AKOS030485964|CCG-208505|CS-6500|DB08437|6-Dimethylamino-9-(3'-(p-methoxy-L-phenylalanylamino)-beta-D-ribofuranosyl)-purine|NCGC00179500-01|NCGC00179500-07|NCGC00179500-14|AB00514661|NS00011702|C01610|D05653|G85883|AB00514661-07|Q424696|BRD-K36007650-001-01-9|BRD-K36007650-300-02-3|Q27167243|(2S)-2-amino-N-[(2S,3S,4R,5R)-5-(6-dimethylaminopurin-9-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl]-3-(4-methoxyphenyl)propanamide|2-amino-N-[5-[6-(dimethylamino)-9-purinyl]-4-hydroxy-2-(hydroxymethyl)-3-oxolanyl]-3-(4-methoxyphenyl)propanamide|Adenosine, 3'-(-amino-p-methoxyhydrocinnamamido)-3'-deoxy-N, N-dimethyl-, dihydrochloride, L-"
NAVOXIMOD,70914230,,"InChI=1S/C18H21FN2O2/c19-14-3-1-2-13-16-9-20-10-21(16)15(18(13)14)8-17(23)11-4-6-12(22)7-5-11/h1-3,9-12,15,17,22-23H,4-8H2/t11?,12?,15-,17+/m0/s1",YGACXVRLDHEXKY-LHPNLFKDSA-N,C18H21FN2O2,316.4,"4-[(1R)-2-[(5S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl]cyclohexan-1-ol","Trans-4-((1R)-2-((5S)-6-Fluoro-5H-imidazo(5,1-a)isoindol-5-yl)-1-hydroxyethyl)cyclohexanol|RefChem:933272|Navoximod|1402837-78-8|IDO-IN-7|Navoximod [USAN]|NLG-919|GDC-0919|926SHL95NC|Navoximod (free base)|RO7077339-001|UNII-926SHL95NC|RG6078|RG-6078|RO7077339|RO-7077339|4-[(1R)-2-[(5S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl]cyclohexan-1-ol|5H-Imidazo(5,1-a)isoindole-5-ethanol, 6-fluoro-alpha-(trans-4-hydroxycyclohexyl)-, (alphaR,5S)-|trans-4-((R)-2-((S)-6-Fluoro-5H-imidazo[5,1-a]isoindol-5-yl)-1-hydroxyethyl)cyclohexan-1-ol|trans-4-{(1R)-2-[(5S)-6-fluoro-5H-imidazo[5,1-a]isoindol-5-yl]-1-hydroxyethyl}cyclohexan-1-ol|MFCD29472253|NLG-919 Navoximod|NAVOXIMOD [INN]|Navoximod (USAN/INN)|NAVOXIMOD [WHO-DD]|orb1296225|CHEMBL3989951|CHEMBL4530496|SCHEMBL13469854|SCHEMBL13469866|SCHEMBL15511408|SCHEMBL29349779|SCHEMBL29408736|BDBM370551|BDBM370555|GLXC-10908|EX-A4607|HY-18770B|s8957|CS-5088|DB15439|US10233190, Example 1484|US10233190, Example 1488|AC-35763|DA-76008|MS-24663|D11255|F85292|Navoximod;GDC-0919;IDO-IN-7;NLG-1488|Q27271481|(1R,4r)-4-((R)-2-((S)-6-fluoro-5H-imidazo[5,1- a]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol|(1S,4s)-4-((R)-2-((S)-6-fluoro-5H-imidazo[5,1- a]isoindol-5-yl)-1-hydroxyethyl)cyclohexanol|5H-IMIDAZO(5,1-A)ISOINDOLE-5-ETHANOL, 6-FLUORO-.ALPHA.-(TRANS-4-HYDROXYCYCLOHEXYL)-, (.ALPHA.R,5S)-"
PF-06840003,23063810,,"InChI=1S/C12H9FN2O2/c13-6-1-2-10-7(3-6)9(5-14-10)8-4-11(16)15-12(8)17/h1-3,5,8,14H,4H2,(H,15,16,17)",MXKLDYKORJEOPR-UHFFFAOYSA-N,C12H9FN2O2,232.21,"3-(5-fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione","198474-05-4|PF-06840003|3-(5-Fluoro-1H-indol-3-yl)pyrrolidine-2,5-dione|2,5-Pyrrolidinedione, 3-(5-fluoro-1H-indol-3-yl)-|5K1FUI0T2C|DTXSID00630149|PF 06840003|RefChem:172265|DTXCID90580902|IDO1 Inhibitor PF-06840003|IDO-1 Inhibitor PF-06840003|Indoleamine 2,3-Dioxygenase Inhibitor PF-06840003|EOS200271|MFCD25121820|3-(5-fluoro-indol-3-yl)-pyrrolidine-2,5-dione|PF06840003|UNII-5K1FUI0T2C|GTPL9565|orb1302966|SCHEMBL5463464|CHEMBL4086143|SCHEMBL29362517|US9603836, Compound 1|US9603836, Compound 1a|CHEBI:233415|MXKLDYKORJEOPR-UHFFFAOYSA-N|BDBM309529|BCP17158|EX-A1186|NSC796100|s8657|AKOS027252536|CCG-266801|CS-6186|EOS-200271|NSC-796100|SB22834|AC-31597|AS-51973|BP168137|DB-228366|HY-101111|PF06840003?|P14030|3(5-Fluoro1Hindol-3-yl)pyrrolidine-2,5-dione|3a?5-Fluoroa?Ha'indol-3-yl)pyrrolidine-2,5-dione|3-(5-fluoro-1H-indol-3- yl)pyrrolidine-2,5-dione|3-(5-Fluoro-1H-indol-3-yl)-pyrrolidine-2,5-dione|3-(5-Fluoro-1H-indol-3-yl)-2,5-pyrrolidinedione;EOS 200271|EOS200271; EOS-200271; EOS 200271; PF 06840003; PF06840003"
CB-5083,73051434,,"InChI=1S/C24H23N5O2/c1-15-12-18-17(22(25)30)8-5-9-21(18)29(15)24-27-20-10-11-31-14-19(20)23(28-24)26-13-16-6-3-2-4-7-16/h2-9,12H,10-11,13-14H2,1H3,(H2,25,30)(H,26,27,28)",RDALZZCKQFLGJP-UHFFFAOYSA-N,C24H23N5O2,413.5,"1-[4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methylindole-4-carboxamide","CB-5083|1542705-92-9|CB 5083|591IV6UL6J|DTXSID801022542|1-(7,8-Dihydro-4-((phenylmethyl)amino)-5H-pyrano(4,3-d)pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide|1H-Indole-4-carboxamide, 1-(7,8-dihydro-4-((phenylmethyl)amino)-5H-pyrano(4,3-d)pyrimidin-2-yl)-2-methyl-|RefChem:124071|p97 Inhibitor CB-5083|DTXCID001507227|CB5083|1-(4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide|1-[4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methylindole-4-carboxamide|MFCD28963914|1-[4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-1H-indole-4-carboxamide|JDP|UNII-591IV6UL6J|orb1300457|CHEMBL3747513|SCHEMBL15421452|SCHEMBL18303410|SCHEMBL29350494|SCHEMBL30076956|EX-A773|CB 5083 [WHO-DD]|CHEBI:232521|C24H23N5O2|HMS3873E13|HMS5086C07|BCP23807|BDBM50500325|NSC786100|AKOS025396184|CCG-268805|CS-5405|NSC-786100|NCGC00481317-01|NCGC00481317-03|AC-29018|AS-55872|BC177445|CB-5083?|DA-71987|HY-12861|CB-5083; CB 5083|S8101|BRD-K49048664-001-01-2|BRD-K49048664-001-02-0|1-[4-(benzylamino)-7,8-dihydro-5H-pyrano[4,3-d]pyrimidin-2-yl]-2-methyl-indole-4-carboxamide"
SHR-4640,86294127,,"InChI=1S/C14H12BrNO2S/c15-9-2-3-11-10(8-9)12(4-7-16-11)19-14(13(17)18)5-1-6-14/h2-4,7-8H,1,5-6H2,(H,17,18)",QGBWIYLNOBYNDL-UHFFFAOYSA-N,C14H12BrNO2S,338.22,1-(6-bromoquinolin-4-yl)sulfanylcyclobutane-1-carboxylic acid,"Ruzinurad|1638327-48-6|SHR-4640|SHR4640|UP8J9CA76I|1-((6-Bromo-4-quinolinyl)thio)cyclobutanecarboxylic acid|Cyclobutanecarboxylic acid, 1-((6-bromo-4-quinolinyl)thio)-|RefChem:180385|1-((6-Bromoquinolin-4-yl)thio)cyclobutane-1-carboxylic acid|CHEMBL3746329|1-(6-bromoquinolin-4-yl)sulfanylcyclobutane-1-carboxylic acid|RUZINURAD [INN]|UNII-UP8J9CA76I|orb1691557|SCHEMBL16247926|SCHEMBL30411665|QGBWIYLNOBYNDL-UHFFFAOYSA-N|BDBM50134635|EX-A11346|AKOS040756957|HY-W052011|DA-77595|MS-25138|CS-0044660|D72706|1-((6-bromoquinolin-4-yl)thio)cyclobutanecarboxylic acid|1-((6-Bromoquinolin-4-yl)thio)cyclobutane-1-carboxylicacid|1-[(6-bromo-4-quinolyl)sulfanyl]cyclobutanecarboxylic acid"
TELOTRISTAT,25025298,,"InChI=1S/C25H22ClF3N6O3/c1-13-8-9-35(34-13)20-11-16(26)6-7-17(20)22(25(27,28)29)38-21-12-19(32-24(31)33-21)15-4-2-14(3-5-15)10-18(30)23(36)37/h2-9,11-12,18,22H,10,30H2,1H3,(H,36,37)(H2,31,32,33)/t18-,22+/m0/s1",NCLGDOBQAWBXRA-PGRDOPGGSA-N,C25H22ClF3N6O3,546.9,"(2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyrimidin-4-yl]phenyl]propanoic acid","Telotristat|1033805-28-5|LP-778902|381V4FCV2Z|LP 778902|DTXSID60145805|(2S)-2-amino-3-(4-{2-amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyrimidin-4-yl}phenyl)propanoic acid|LX-3033|telotristatum|(2S)-2-amino-3-(4-(2-amino-6-((1R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid|RefChem:57925|DTXCID4068296|A16AX15|MFCD20528907|(2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyrimidin-4-yl]phenyl]propanoic acid|(2S)-2-aMino-3-[4-[2-aMino-6-[(1R)-1-[4-chloro-2-(3-Methylpyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]pyriMidin-4-yl]phenyl]propanoic acid,    Telotristat|(S)-2-amino-3-(4-(2-amino-6-((R)-1-(4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl)-2,2,2-trifluoroethoxy)pyrimidin-4-yl)phenyl)propanoic acid|Telotristat [USAN]|Telotristat [USAN:INN]|UNII-381V4FCV2Z|Telotristat (Standard)|TELOTRISTAT [MI]|TELOTRISTAT [INN]|Telotristat (USAN/INN)|Telotristat, LP778902|A1IT9|TELOTRISTAT [WHO-DD]|C25H22ClF3N6O3|SCHEMBL612353|orb1306323|CHEMBL2103855|CHEBI:177736|HY-13055BR|EX-A1620|BDBM50145648|HY-13055B|AKOS027338710|DB14218|NCGC00485953-01|AC-35764|FT104238|MS-30026|D09973|F86418|BRD-K63178091-001-01-1|Q27256725|(2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-trifluoro-ethoxy]pyrimidin-4-yl]phenyl]propanoic acid|(2S)-2-amino-3-[4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methylpyrazol-1-yl)phenyl]-2,2,2-triluoroethoxy]pyrimidin-4-yl]phenyl]propanoic acid|2S)-2-AMINO-3-(4-(2-AMINO-6-(((1R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2-TRIFLUOROETHYL)OXY)PYRIMIDIN-4-YL)PHENYL)PROPANOIC ACID|4-(2-AMINO-6-((1R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)-2,2,2- TRIFLUOROETHOXY)PRYRIMIDIN-4-YL)-L-PHENYLALANINE|L-PHENYLALANINE, 4-(2-AMINO-6-((1R)-1-(4-CHLORO-2-(3-METHYL-1H-PYRAZOL-1-YL)PHENYL)- 2,2,2-TRIFLUOROETHOXY)-4-PRYRIMIDINYL)-|Telotristat; L-Phenylalanine, 4-[2-amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-; 4-[2-Amino-6-[(1R)-1-[4-chloro-2-(3-methyl-1H-pyrazol-1-yl)phenyl]-2,2,2-trifluoroethoxy]-4-pyrimidinyl]-L-phenylalanine; (2S)-2-Am"
GSK2879552,66571643,,"InChI=1S/C23H28N2O2/c26-23(27)20-8-6-18(7-9-20)16-25-12-10-17(11-13-25)15-24-22-14-21(22)19-4-2-1-3-5-19/h1-9,17,21-22,24H,10-16H2,(H,26,27)/t21-,22+/m0/s1",LRULVYSBRWUVGR-FCHUYYIVSA-N,C23H28N2O2,364.5,"4-[[4-[[[(1R,2S)-2-phenylcyclopropyl]amino]methyl]piperidin-1-yl]methyl]benzoic acid","GSK2879552|1401966-69-5|GSK-2879552|4-((4-((((1R,2S)-2-Phenylcyclopropyl)amino)methyl)piperidin-1-yl)methyl)benzoic acid|GT77Z6Y09Z|4-[[4-[[[(1R,2S)-2-phenylcyclopropyl]amino]methyl]piperidin-1-yl]methyl]benzoic acid|CHEBI:176334|Benzoic acid, 4-((4-((((1R,2S)-2-phenylcyclopropyl)amino)methyl)-1-piperidinyl)methyl)-|GSK 2879552|4-{[4-({[(1R,2S)-2-PHENYLCYCLOPROPYL]AMINO}METHYL)PIPERIDIN-1-YL]METHYL}BENZOIC ACID|4-[[4-[[((1R,2S)-2-Phenylcyclopropyl)amino]methyl]piperidin-1-yl]methyl]benzoic acid|RefChem:144555|MFCD28411435|CHEMBL3786182|1401966-63-9|UNII-GT77Z6Y09Z|Example 26 [WO2012135113]|GTPL9116|orb1693457|GSK2879552 HCl|SCHEMBL12813936|GSK 2879552 HCl|GSK-2879552 HCl|Gsk2879522|LRULVYSBRWUVGR-FCHUYYIVSA-N|EX-A1181|BDBM50158869|NSC783917|AKOS027324406|CS-3997|GSK 2879552 [WHO-DD]|NSC-783917|NCGC00387878-01|AC-35762|AS-56180|Benzoic acid, 4-[[4-[[[(1R,2S)-2-phenylcyclopropyl]amino]methyl]-1-piperidinyl]methyl]-, rel-|BG170574|DA-73911|HY-18632|1902123-72-1|BRD-K09223495-001-01-4|Q27077894|4-((4-(((1R,2S)-2-Phenylcyclopropylamino)methyl)piperidin-1-yl)methyl)benzoic acid|4-((4-(((trans-2-phenylcyclopropyl)amino)methyl)piperidin-1-yl)methyl)benzoic acid|4-[[4-[[[(1R,2S)-2-phenylcyclopropyl]amino]methyl]-1-piperidyl]methyl]benzoic acid"
DDO-3055,129027150,,"InChI=1S/C17H13ClN2O5/c18-12-3-5-13(6-4-12)25-7-1-2-11-8-14(21)16(19-9-11)17(24)20-10-15(22)23/h3-6,8-9,21H,7,10H2,(H,20,24)(H,22,23)",AIKDJELJHUPYNG-UHFFFAOYSA-N,C17H13ClN2O5,360.7,2-[[5-[3-(4-chlorophenoxy)prop-1-ynyl]-3-hydroxypyridine-2-carbonyl]amino]acetic acid,"DDO-3055|EDZ8BK9GK2|1842340-93-5|DDO3055|(5-(3-(4-Chlorophenoxy)prop-1-yn-1-yl)-3-hydroxypicolinoyl)glycine|Glycine, N-((5-(3-(4-chlorophenoxy)-1-propyn-1-yl)-3-hydroxy-2-pyridinyl)carbonyl)-|compound 17 [PMID: 32787144]|2-[[5-[3-(4-chlorophenoxy)prop-1-ynyl]-3-hydroxypyridine-2-carbonyl]amino]acetic acid|compound 17 (PMID: 32787144)|2-((5-(3-(4-chlorophenoxy)prop-1-ynyl)-3-hydroxypyridine-2-carbonyl)amino)acetic acid|RefChem:131060|UNII-EDZ8BK9GK2|CHEMBL4162752|orb2945005|SCHEMBL18736166|SCHEMBL31132423|GTPL12785|BDBM50318679"
TRIPTOLIDE,107985,,"InChI=1S/C20H24O6/c1-8(2)18-13(25-18)14-20(26-14)17(3)5-4-9-10(7-23-15(9)21)11(17)6-12-19(20,24-12)16(18)22/h8,11-14,16,22H,4-7H2,1-3H3/t11-,12-,13-,14-,16+,17-,18-,19+,20+/m0/s1",DFBIRQPKNDILPW-CIVMWXNOSA-N,C20H24O6,360.4,"(1S,2S,4S,5S,7R,8R,9S,11S,13S)-8-hydroxy-1-methyl-7-propan-2-yl-3,6,10,16-tetraoxaheptacyclo[11.7.0.02,4.02,9.05,7.09,11.014,18]icos-14(18)-en-17-one","triptolide|38748-32-2|NSC-163062|19ALD1S53J|DTXSID5041144|(1S,2S,4S,5S,7R,8R,9S,11S,13S)-8-hydroxy-1-methyl-7-propan-2-yl-3,6,10,16-tetraoxaheptacyclo[11.7.0.02,4.02,9.05,7.09,11.014,18]icos-14(18)-en-17-one|(1S,2S,4S,5S,7R,8R,9S,11S,13S)-8-hydroxy-1-methyl-7-propan-2-yl-3,6,10,16-tetraoxaheptacyclo(11.7.0.02,4.02,9.05,7.09,11.014,18)icos-14(18)-en-17-one|RefChem:192024|DTXCID3021144|(1S,2S,4S,5S,7R,8R,9S,11S,13S)-8-hydroxy-1-methyl-7-(propan-2-yl)-3,6,10,16-tetraoxaheptacyclo(11.7.0.0^(2,4).0^(2,9).0^(5,7).0^(9,11).0^(14,18))icos-14(18)-en-17-one|683-214-2|PG490|Triptolid|MFCD00210565|NSC 163062|CHEBI:9747|CHEMBL463763|PG-490|(5bS,6aS,7aS,8R,8aR,9aS,9bS,10aS,10bS)-8-Hydroxy-8a-isopropyl-10b-methyl-1,5,5b,6,6a,8,8a,9a,9b,10b-decahydrotris(oxireno)[2',3':4b,5;2'',3'':6,7;2''',3''':8a,9]phenanthro[1,2-c]furan-3(2H)-one|(3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-6-hydroxy-8b-methyl-6a-(propan-2-yl)-3b,4,4a,6,6a,7a,7b,8b,9,10-decahydrotrisoxireno[6,7:8a,9:4b,5]phenanthro[1,2-c]furan-1(3H)-one|(6aS,7aS,8R,8aR,9aS,9bS,10aS,10bS)-8-hydroxy-8a-isopropyl-10b-methyl-1,5,5b,6,6a,8,8a,9a,9b,10b-decahydrotris(oxireno)[2',3':4b,5;2'',3'':6,7;2''',3''':8a,9]phenanthro[1,2-c]furan-3(2H)-one.|SMR000466307|UNII-19ALD1S53J|Triptolide?|Triptolide, 1|Trisoxireno[6,7:8a,9:4b,5]phenanthro[1,2-c]furan-1(3H)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)-, (3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-|PG 490|CPD000466307|TRIPTOLIDE [MI]|TRIPTOLIDE [WHO-DD]|BSPBio_001595|KBioGR_000315|KBioSS_000315|MLS000759410|MLS001424107|MLS006010844|SCHEMBL413634|orb1306199|EX-A7744A|KBio2_000315|KBio2_002883|KBio2_005451|KBio3_000629|KBio3_000630|Bio2_000315|Bio2_000795|GLXC-06921|HMS1361P17|HMS1791P17|HMS1989P17|HMS2051N13|HMS3402P17|MSK40281|BDBM50241049|NSC163062|NSC839303|s3604|AKOS022168197|CCG-100957|CS-0286|DB12025|FT28581|NC00207|NSC-839303|IDI1_034065|NCGC00163411-01|NCGC00163411-02|NCGC00163411-03|NCGC00163411-07|BP-25386|BS-16697|HY-32735|NCI60_001223|Trisoxireno(4b,5:6,7:8a,9)phenanthro(1,2-c)furan-1(3H)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)-, (3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-|NS00018025|T2899|C09204|AB00639938-06|AB00639938-08|748T322|F557653|Q906351|BRD-K39484304-001-02-5|BRD-K39484304-001-06-6|BRD-K39484304-001-16-5|Triptolide, Tripterygium wilfordii - CAS 38748-32-2|(1S,2S,4S,5S,7R,8R,9S,11S)-8-Hydroxy-1-methyl-7-propan-2-yl-3,6,10,16-tetraoxaheptacyclo[11.7.0.02,4.02,9.05,7.09,11.014,18]icos-14(18)-en-17-one|(1S,2S,4S,5S,7R,8R,9S,11S,13S)-8-hydroxy-7-isopropyl-1-methyl-3,6,10,16-tetraoxaheptacyclo[11.7.0.02,4.02,9.05,7.09,11.014,18]icos-14(18)-en-17-one|(3BS,4AS,5AS,6R,6AR,7AS,7BS,8AS,8BS)-3B,4,4A,6,6A,7A,7B,8B,9,10-DECAHYDRO-6-HYDROXY-6A-ISOPROPYL-8B-METHYLTRISOXIRENO(6,7:8A,9:4B,5)PHENANTHRO(1,2-C)FURAN-1(3H)-ONE|(3BS,4AS,5AS,6R,6AR,7AS,7BS,8AS,8BS)-3B,4,4A,6,6A,7A,7B,8B,9,10-DECAHYDRO-6-HYDROXY-8B-METHYL-6A-(1-METHYLETHYL)TRISOXIRENO(4B,5:6,7:8A,9)PHENANTHRO(1,2-C)FURAN-1(3H)-ONE|(5bS,6aS,7aS,8R,8aR,9aS,9bS,10aS,10bS)-8-hydroxy-8a-isopropyl-10b-methyl-2,5,5b,6,6a,8,8a,9a,9b,10b-decahydrotris(oxireno)[2',3':4b,5;2'',3'':6,7;2''',3''':8a,9]phenanthro[1,2-c]furan-3(1H)-one|PG 490; (3bS,4aS,5aS,6R,6aR,7aS,7bS,8aS,8bS)-6-Hydroxy-6a-isopropyl-8b-methyl-3b,4,4a,6,6a,7a,7b,8b,9,10-decahydrotrisoxireno[6,7:8a|Trisoxireno[4b,7:8a,9]phenanthro[1,2-c]furan-(3H)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)-, [3bR-(3b.alpha.,4a.alpha.,5aS*,6.beta.,6a.beta.,7a.beta.,7b.alpha.,8aS*,8b.beta.)]-|Trisoxireno[4b,7:8a,9]phenanthro[1,2-c]furan-1(3H)-one, 3b,4,4a,6,6a,7a,7b,8b,9,10-decahydro-6-hydroxy-8b-methyl-6a-(1-methylethyl)-, [3bR-(3b.alpha.,4a.alpha.,5aS*,6.beta.,6a.beta.,7a.beta.,7b.alpha.,8aS*,8b.beta.)]-"
IADADEMSTAT,71543365,,"InChI=1S/C15H22N2/c16-12-6-8-13(9-7-12)17-15-10-14(15)11-4-2-1-3-5-11/h1-5,12-15,17H,6-10,16H2/t12?,13?,14-,15+/m0/s1",ALHBJBCQLJZYON-PFSRBDOWSA-N,C15H22N2,230.35,"4-N-[(1R,2S)-2-phenylcyclopropyl]cyclohexane-1,4-diamine","Iadademstat|ORY-1001|ORY-1001 free base|1431304-21-0|RG-6016|Iadademstat [INN]|CHEMBL3781751|CHEMBL5028924|1431304-21-0 (free base)|4-N-[(1R,2S)-2-phenylcyclopropyl]cyclohexane-1,4-diamine|54T74394F8|N-[(1R,2S)-2-Phenylcyclopropyl]-1,4-cyclohexanediamine|trans-N1-((1R,2S)-2-Phenylcyclopropyl)-1,4-cyclohexanediamine|trans-N1-((1R,2S)-2-Phenylcyclopropyl)cyclohexane-1,4-diamine|1,4-Cyclohexanediamine, N1-((1R,2S)-2-phenylcyclopropyl)-, trans-|CHEMBL4875187|ORY1001|starbld0049467|IADADEMSTAT [WHO-DD]|GTPL8390|orb1699742|CHEMBL3906257|SCHEMBL14880401|SCHEMBL14880402|SCHEMBL14880654|CHEBI:234592|BDBM254603|UNII-54T74394F8|BDBM50155773|BDBM50568519|BDBM50590444|NSC806812|RG6016|AKOS040749097|NSC-806812|NCGC00480828-02|NCGC00480828-04|HY-109117|CS-0078096|US9469597, 4|BRD-K59711701-300-01-3|BRD-K59711701-300-02-1"
BMS-986142,86582336,,"InChI=1S/C32H30F2N4O4/c1-15-17(7-6-10-24(15)38-30(40)19-8-5-9-21(33)28(19)37(4)31(38)41)25-22(34)14-20(29(35)39)27-26(25)18-12-11-16(32(2,3)42)13-23(18)36-27/h5-10,14,16,36,42H,11-13H2,1-4H3,(H2,35,39)/t16-/m0/s1",ZRYMMWAJAFUANM-INIZCTEOSA-N,C32H30F2N4O4,572.6,"(7S)-3-fluoro-4-[3-(8-fluoro-1-methyl-2,4-dioxoquinazolin-3-yl)-2-methylphenyl]-7-(2-hydroxypropan-2-yl)-6,7,8,9-tetrahydro-5H-carbazole-1-carboxamide","BMS-986142|1643368-58-4|UNII-PJX9GH268R|PJX9GH268R|BMS986142|(7S)-3-fluoro-4-[3-(8-fluoro-1-methyl-2,4-dioxoquinazolin-3-yl)-2-methylphenyl]-7-(2-hydroxypropan-2-yl)-6,7,8,9-tetrahydro-5H-carbazole-1-carboxamide|compound 14f [PMID: 27583770]|compound 14f (PMID: 27583770)|(2S)-6-fluoro-5-[3-(8-fluoro-1-methyl-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)-2-methylphenyl]-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide|(2S)-6-fluoro-5-(3-(8-fluoro-1-methyl-2,4-dioxo-1,2,3,4-tetrahydroquinazolin-3-yl)-2-methylphenyl)-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide|(7S)-3-fluoro-4-(3-(8-fluoro-1-methyl-2,4-dioxoquinazolin-3-yl)-2-methylphenyl)-7-(2-hydroxypropan-2-yl)-6,7,8,9-tetrahydro-5H-carbazole-1-carboxamide|RefChem:120770|CHEMBL3900554|C32H30F2N4O4|6-Fluoro-5-(R)-(3-(S)-(8-Fluoro-1-Methyl-2,4-Dioxo-1,2-Dihydroquinazolin-3(4h)-Yl)-2-Methylphenyl)-2-(S)-(2-Hydroxypropan-2-Yl)-2,3,4,9-Tetrahydro-1h-Carbazole-8-Carboxamide|(2S,5R,3S)-6-fluoro-5-(3-(8-fluoro-1-methyl-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-2-methylphenyl)-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide|GTPL9857|orb1302058|SCHEMBL16319712|SCHEMBL29564549|SCHEMBL29564633|SCHEMBL29564784|GLXC-10581|BCP29622|EX-A2778|BDBM50194720|NSC828251|s8381|ZB1608|AKOS032954006|AT14636|DB15291|NSC-828251|BB170197|MS-30322|HY-101856|CS-0022067|BMS 986142; BMS986142|(2S)-6-fluoro-5-[3-(8-fluoro-1-methyl-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-2-methylphenyl]-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide|(2S,5R)-6-Fluoro-5-((3S)-3-(8-fluoro-1-methyl-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-2-methylphenyl)-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide|(2S,5R)-6-fluoro-5-(3-(8-fluoro-1-methyl-2,4-dioxo-1,4-dihydroquinazolin-3(2H)-yl)-2-methylphenyl)-2-(2-hydroxypropan-2-yl)-2,3,4,9-tetrahydro-1H-carbazole-8-carboxamide|(7S)-3-fluoro-4-[3-(8-fluoro-1-methyl-2,4-dioxo-quinazolin-3-yl)-2-methyl-phenyl]-7-(1-hydroxy-1-methyl-ethyl)-6,7,8,9-tetrahydro-5H-carbazole-1-carboxamide|73T"
TOLEBRUTINIB,124111565,,"InChI=1S/C26H25N5O3/c1-2-23(32)29-16-6-7-19(17-29)30-22-14-15-28-25(27)24(22)31(26(30)33)18-10-12-21(13-11-18)34-20-8-4-3-5-9-20/h2-5,8-15,19H,1,6-7,16-17H2,(H2,27,28)/t19-/m1/s1",KOEUOFPEZFUWRF-LJQANCHMSA-N,C26H25N5O3,455.5,"4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]imidazo[4,5-c]pyridin-2-one","Tolebrutinib|1971920-73-6|PRN2246|SAR442168|Tolebrutinib [INN]|Tolebrutinib [USAN]|PRN-2246|8CZ82ZYY9X|4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-prop-2-enoylpiperidin-3-yl]imidazo[4,5-c]pyridin-2-one|UNII-8CZ82ZYY9X|SAR-442168|TOLEBRUTINIB [WHO-DD]|BTK'168|example 3 [WO2016196840A1]|2H-Imidazo(4,5-C)pyridin-2-one, 4-amino-1,3-dihydro-1-((3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl)-3-(4-phenoxyphenyl)-|4-Amino-1,3-dihydro-1-((3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl)-3-(4-phenoxyphenyl)-2H-imidazo(4,5-C)pyridin-2-one|example 3 (WO2016196840A1)|4-amino-3-(4-phenoxyphenyl)-1-((3R)-1-prop-2-enoylpiperidin-3-yl)imidazo(4,5-c)pyridin-2-one|RefChem:190288|BTK Inhibitor SAR442168|SAR 442168|Bruton's Tyrosine Kinase Inhibitor SAR442168|c]pyridin-2-one|(R)-1-(1-Acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1H-imidazo[4,5-c]pyridin-2(3H)-one|4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-(prop-2-|enoyl)piperidin-3-yl]-1,3-dihydro-2H-imidazo[4,5-|C26H25N5O3|Tolebrutinib?|Tolebrutinib [USAN:INN]|orb1298347|Tolebrutinib (JAN/USAN/INN)|CHEMBL4650323|SCHEMBL18285621|SCHEMBL29564612|GTPL10625|CHEBI:233436|GLXC-23539|EX-A4699|BDBM50557487|MFCD32710277|WHO 11268|AKOS040759681|SAR442168; PRN2246|MS-28304|HY-109192|CS-0119132|D12213|G17454|EN300-6498433|(R)-1-(1-acryloylpiperidin-3-yl)-4-amino-3-(4-phenoxyphenyl)-1,3-dihydro-2H-imidazo[4,5-c]pyridin-2-one|4-Amino-1,3-dihydro-1-[(3R)-1-(1-oxo-2-propen-1-yl)-3-piperidinyl]-3-(4-phenoxyphenyl)-2H-imidazo[4,5-c]pyridin-2-one;|4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-(prop-2-enoyl)piperidin-3-yl]-1H,2H,3H-imidazo[4,5-c]pyridin-2-one|4-amino-3-(4-phenoxyphenyl)-1-[(3R)-1-prop-2-enoyl-3-piperidyl]imidazo[4,5-c]pyridin-2-one"
GSK2982772,77108121,,"InChI=1S/C20H19N5O3/c1-25-15-9-5-6-10-16(15)28-12-14(20(25)27)21-19(26)18-22-17(23-24-18)11-13-7-3-2-4-8-13/h2-10,14H,11-12H2,1H3,(H,21,26)(H,22,23,24)/t14-/m0/s1",LYPAFUINURXJSG-AWEZNQCLSA-N,C20H19N5O3,377.4,"5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide","GSK2982772|5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1H-1,2,4-triazole-3-carboxamide|5-benzyl-N-((3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl)-1H-1,2,4-triazole-3-carboxamide|RefChem:922551|1622848-92-3|(S)-3-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-1H-1,2,4-triazole-5-carboxamide|GSK-2982772|(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-1H-1,2,4-triazole-3-carboxamide|MFCD30828708|(S)-5-benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b][1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide|T5W3M0VO9B|CHEMBL4071864|C20H19N5O3|1622848-92-3 (free base)|3-Benzyl-N-[(3s)-5-Methyl-4-Oxo-2,3,4,5-Tetrahydro-1,5-Benzoxazepin-3-Yl]-1h-1,2,4-Triazole-5-Carboxamide|GSK 2982772|(S)-5-Benzyl-N-(5-methyl-4-oxo-2,3,4,5-tetrahydrobenzo[b]-[1,4]oxazepin-3-yl)-4H-1,2,4-triazole-3-carboxamide|1H-1,2,4-Triazole-5-carboxamide, 3-(phenylmethyl)-N-((3S)-2,3,4,5-tetrahydro-5-methyl-4-oxo-1,5-benzoxazepin-3-yl)-|LYPAFUINURXJSG-AWEZNQCLSA-N|UNII-T5W3M0VO9B|GTPL9554|orb1300025|SCHEMBL15956219|SCHEMBL21678862|SCHEMBL25801152|SCHEMBL29355591|GSK'772|GLXC-10561|EX-A2558|BDBM50233225|s8484|AKOS037643747|CCG-268376|compound 5 [PMID: 28151659]|CS-6899|GSK2982772?|AC-29894|AS-35128|BG166667|HY-101760|EN300-22148212|7MJ"
AST-487,11409972,,"InChI=1S/C26H30F3N7O2/c1-3-35-10-12-36(13-11-35)16-18-4-5-20(14-22(18)26(27,28)29)34-25(37)33-19-6-8-21(9-7-19)38-24-15-23(30-2)31-17-32-24/h4-9,14-15,17H,3,10-13,16H2,1-2H3,(H,30,31,32)(H2,33,34,37)",ODPGGGTTYSGTGO-UHFFFAOYSA-N,C26H30F3N7O2,529.6,1-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[4-[6-(methylamino)pyrimidin-4-yl]oxyphenyl]urea,"630124-46-8|AST 487|AST-487|NVP-AST487|NVP-AST-487|W34UO2M4T6|DTXSID70212239|Urea, N-(4-((4-ethyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-N'-(4-((6-(methylamino)-4-pyrimidinyl)oxy)phenyl)-|3-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-1-(4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)urea|3-{4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-1-(4-{[6-(methylamino)pyrimidin-4-yl]oxy}phenyl)urea|RefChem:115243|DTXCID20134730|1-(4-((4-Ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-(4-((6-(methylamino)pyrimidin-4-yl)oxy)phenyl)urea|AST487|NVP-AST 487|N-[4-[(4-Ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-N'-[4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]urea|C26H30F3N7O2|1-[4-[(4-ethylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[4-[6-(methylamino)pyrimidin-4-yl]oxyphenyl]urea|AST-487 (NVP-AST487)|UNII-W34UO2M4T6|MFCD11983171|Kinome_3855|NVP-AST487?|AST-48|CHEMBL574738|GTPL5661|orb1303230|SCHEMBL1684259|SCHEMBL29391947|SCHEMBL29435006|BDBM31085|AST-487/AST487|cid_11409972|ODPGGGTTYSGTGO-UHFFFAOYSA-N|BCP21589|EX-A1374|FAB12446|s6662|ZB1589|AKOS030526863|CS-0779|NCGC00354729-03|AC-35539|HY-15002|F20730|Q27074554|1-[4-[(4-ethyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-3-[4-[[6-(methylamino)-4-pyrimidinyl]oxy]phenyl]urea|1-[4-[(4-ethylpiperazino)methyl]-3-(trifluoromethyl)phenyl]-3-[4-[6-(methylamino)pyrimidin-4-yl]oxyphenyl]urea|1069112-48-6"
BEMCENTINIB,46215462,,"InChI=1S/C30H34N8/c31-29-33-30(32-24-13-10-20-11-14-25(15-12-22(20)18-24)37-16-3-4-17-37)36-38(29)27-19-23-8-5-7-21-6-1-2-9-26(21)28(23)35-34-27/h1-2,6,9-10,13,18-19,25H,3-5,7-8,11-12,14-17H2,(H3,31,32,33,36)/t25-/m0/s1",KXMZDGSRSGHMMK-VWLOTQADSA-N,C30H34N8,506.6,"1-(3,4-diazatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-5-yl)-3-N-[(7S)-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine","Bemcentinib|1037624-75-1|R428|BGB324|BGB-324|R-428|0ICW2LX8AS|CS-1046|HY-15150|QC-11751|SYN-1131|W-5845|KB-80319|BGB 324|DTXSID70673109|WHO 10631|1H-1,2,4-Triazole-3,5-diamine, 1-(6,7-dihydro-5H-benzo(6,7)cyclohepta(1,2-C)pyridazin-3-yl)-N3-((7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5H-benzocyclohepten-2-yl)-|R-428 compound|bemcentinibum|RefChem:561226|AXL Inhibitor BGB324|DTXCID40623858|1-(3,4-diazatricyclo(9.4.0.0^(2,7))pentadeca-1(15),2(7),3,5,11,13-hexaen-5-yl)-N3-((7S)-7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo(7)annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine|(S)-1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine|Bemcentinib (GMP)|Bemcentinib [USAN]|MFCD21608463|BemcentinibR428BGB324)|CHEMBL3809489|R428 (BGB324)|R 428|BGB 324; R 428|1-(3,4-diazatricyclo[9.4.0.0^{2,7}]pentadeca-1(11),2(7),3,5,12,14-hexaen-5-yl)-~{N}3-[(7~{S})-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5~{H}-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine|1-(3,4-diazatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-5-yl)-3-N-[(7S)-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine|UNII-0ICW2LX8AS|SYN1131|C30H34N8|Q8U|Bemcentinib (R428)|BEMCENTINIB [INN]|Bemcentinib (USAN/INN)|BEMCENTINIB [WHO-DD]|orb1300919|SCHEMBL1639904|SCHEMBL29358925|SCHEMBL29388703|SCHEMBL31588672|GTPL10478|KXMZDGSRSGHMMK-VWLOTQADSA-N|1H-1,2,4-Triazole-3,5-diamine, 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[(7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5Hbenzocyclohepten- 2-yl]-;1H-1,2,4-Triazole-3,5-diamine, 1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[(7S)-6,7,8,9-tetrahydro-7-(1-pyrrolidinyl)-5Hbenzocyclohepten- 2-yl]-|BCP21180|EX-A1720|BDBM50172079|HY-15150G|NSC824183|s2841|AKOS032947237|DB12411|NSC-824183|NCGC00386665-07|AC-28444|AS-16270|SY235563|CS-0899175|NS00072622|D11438|BRD-K14870255-001-02-3|Q27236818|BGB324; BGB-324; BGB 324; R 428; R-428; Bemcentinib|(S)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[7-(1-pyrrolidinyl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]-1H-1,2,4-triazole-3,5-diamine|1-(3,4-diazatricyclo[9.4.0.02,7]pentadeca-1(15),2,4,6,11,13-hexaen-5-yl)-N3-[(7S)-7-pyrrolidin-1-yl-6,7,8,9-tetrahydro-5H-benzo[7]annulen-3-yl]-1,2,4-triazole-3,5-diamine|1-(6,7-dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(S)-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulene-2-yl)-1H-1,2,4-triazole-3,5-diamine|1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-[(7S)-7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]-1H-1,2,4-triazole-3,5-diamine"
RITANSERIN,5074,,"InChI=1S/C27H25F2N3OS/c1-18-24(26(33)32-16-17-34-27(32)30-18)12-15-31-13-10-21(11-14-31)25(19-2-6-22(28)7-3-19)20-4-8-23(29)9-5-20/h2-9,16-17H,10-15H2,1H3",JUQLTPCYUFPYKE-UHFFFAOYSA-N,C27H25F2N3OS,477.6,"6-[2-[4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl]ethyl]-7-methyl-[1,3]thiazolo[3,2-a]pyrimidin-5-one","ritanserin|87051-43-2|Tiserton|Ritanserina|Ritanserine|Ritanserinum|R-55667|R 55,667|NSC-758470|6-(2-(4-(Bis(p-fluorophenyl)methylene)-piperidino)ethyl)-7-methyl-5H-thiazolo-(3,2-a)pyrimidin-5-one|DTXSID9042594|CHEBI:64195|145TFV465S|6-(2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl)-7-methyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one|DTXCID7022594|5H-Thiazolo(3,2-a)pyrimidin-5-one, 6-(2-(4-bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-|5h-thiazolo[3,2-a]pyrimidin-5-one, 6-[2-[4-[bis(4-fluorophenyl)methylene]-1-piperidinyl]ethyl]-7-methyl-|6-[2-[4-(bis(4-Fluorophenyl)methylene]-1-piperidinyl]ethyl]-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one|6-[2-[4-[bis(4-fluorophenyl)methylene]-1-piperidinyl]ethyl]-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one|6-[2-[4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl]ethyl]-7-methyl-[1,3]thiazolo[2,3-b]pyrimidin-5-one|5H-Thiazolo(3,2-a)pyrimidin-5-one, 6-(2-(4-(bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-|5H-Thiazolo[3,2-a]pyrimidin-5-one, 6-[2-[4-bis(4-fluorophenyl)methylene]-1-piperidinyl]ethyl]-7-methyl-|6-(2-(4-(Bis(4-fluorophenyl)methylene)-1-piperidinyl)ethyl)-7-methyl-5H-thiazolo(3,2-a)pyrimidin-5-one|6-(2-(4-(bis(4-fluorophenyl)methylidene)piperidin-1-yl)ethyl)-7-methyl-(1,3)thiazolo(2,3-b)pyrimidin-5-one|6-(2-(4-(bis(4-fluorophenyl)methylidene)piperidin-1-yl)ethyl)-7-methyl-5H-(1,3)thiazolo(3,2-a)pyrimidin-5-one|6-[2-[4-[Bis(p-fluorophenyl)methylene]-piperidino]ethyl]-7-methyl-5H-thiazolo-[3,2-a]pyrimidin-5-one|RefChem:389267|R55667|R 55667|635-929-6|C27H25F2N3OS|MFCD00069341|6-[2-[4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl]ethyl]-7-methyl-[1,3]thiazolo[3,2-a]pyrimidin-5-one|6-(2-(4-(bis(4-fluorophenyl)methylene)piperidin-1-yl)ethyl)-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one|MLS000069360|CHEMBL267777|6-(2-(4-(Bis(4-fluorophenyl)methylene)piperidin-1-yl)-ethyl)-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one|NCGC00015877-06|SMR000058511|6-[2-[4-[bis(4-fluorophenyl)methylene]-1-piperidyl]ethyl]-7-methyl-thiazolo[3,2-a]pyrimidin-5-one|Ritanserine [French]|Ritanserinum [Latin]|Ritanserina [Spanish]|CAS-87051-43-2|SR-01000000024|Ritanserin [USAN:INN:BAN]|UNII-145TFV465S|Ritanserin, powder|Tiserton (TN)|Spectrum_001830|RITANSERIN [MI]|Lopac-R-103|RITANSERIN [INN]|Opera_ID_1609|Ritanserin (USAN/INN)|Spectrum2_001560|Spectrum3_001023|Spectrum5_001504|RITANSERIN [USAN]|RITANSERIN [VANDF]|GTPL97|cid_5074|RITANSERIN [MART.]|RITANSERIN [WHO-DD]|Lopac0_001083|REGID_for_CID_5074|SCHEMBL49227|BSPBio_002805|KBioSS_002335|MLS001148629|DivK1c_000192|SPBio_001440|orb1307793|HMS500J14|KBio1_000192|KBio2_002332|KBio2_004900|KBio2_007468|KBio3_002025|NINDS_000192|HMS2093E19|HMS2233M22|HMS3263I08|HMS3268O04|HMS3373O19|HMS3412N14|HMS3676N14|Pharmakon1600-01503421|BCP13728|Tox21_110251|Tox21_501083|BDBM50001775|CCG-39338|NSC758470|NSC805597|AKOS015909799|Tox21_110251_1|DB12693|FR27740|LP01083|NSC 758470|NSC-805597|SDCCGSBI-0051053.P004|6-[2-[4-[Bis(4-fluorophenyl)Methylidene]piperidin-1-yl]ethyl]-7-Methyl-[1,3]thia|IDI1_000192|NCGC00015877-01|NCGC00015877-02|NCGC00015877-03|NCGC00015877-04|NCGC00015877-05|NCGC00015877-07|NCGC00015877-08|NCGC00015877-09|NCGC00015877-11|NCGC00015877-15|NCGC00022447-03|NCGC00022447-04|NCGC00022447-05|NCGC00178460-01|NCGC00261768-01|AC-30888|BS-49232|HY-10791|SY274388|SBI-0051053.P003|DB-056967|CS-0002823|EU-0101083|NS00068305|R-103|D05738|AB00053288_14|051R432|L001003|Q3937260|SR-01000000024-3|SR-01000000024-4|BRD-K40887525-001-02-9|BRD-K40887525-001-14-4|BRD-K40887525-001-21-9|BRD-K40887525-001-22-7|ethyl]-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one|6-[2-[4-bis(4-Fluorophenyl)methylene]-1-piperidinyl]-|(+)-6-[2-[4-[bis(4-fluorophenyl)methylene]-1-piperidinyl]ethyl]-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one|(ritanserin)6-(2-{4-[Bis-(4-fluoro-phenyl)-methylene]-piperidin-1-yl}-ethyl)-7-methyl-2,3-dihydro-1H-indolizin-5-one|(ritanserin)6-(2-{4-[Bis-(4-fluoro-phenyl)-methylene]-piperidin-1-yl}-ethyl)-7-methyl-thiazolo[3,2-a]pyrimidin-5-one|6-(2-(4-[Bis(4-fluorophenyl)methylene]-1-piperidinyl)ethyl)-7-methyl-5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one #|6-(2-{4-[Bis-(4-fluoro-phenyl)-methylene]-piperidin-1-yl}-ethyl)-7-methyl-8,8a-dihydro-thiazolo[3,2-a]pyrimidin-5-one|6-(2-{4-[Bis-(4-fluoro-phenyl)-methylene]-piperidin-1-yl}-ethyl)-7-methyl-thiazolo[3,2-a]pyrimidin-5-one|6-(2-{4-[Bis-(4-fluoro-phenyl)-methylene]-piperidin-1-yl}-ethyl)-7-methyl-thiazolo[3,2-a]pyrimidin-5-one (Ritanserin)|6-(2-{4-[Bis-(4-fluoro-phenyl)-methylene]-piperidin-1-yl}-ethyl)-7-methyl-thiazolo[3,2-a]pyrimidin-5-one(Ritanserin)|6-[2-[4-[bis(4-fluorophenyl)-methylene]-1-piperidinyl]ethyl]-7-methyl-5H-thiazolo[3,2-a]-pyrimidin-5-one|6-[2-[4-[Bis(4-fluorophenyl)methylene]-1-piperidinyl]ethyl]-7-methyl-5H-thiazolo[3,2-a]pyrimidin-5-one;Tiserton|E2J"
MEPAZINE,6075,,"InChI=1S/C19H22N2S/c1-20-12-6-7-15(13-20)14-21-16-8-2-4-10-18(16)22-19-11-5-3-9-17(19)21/h2-5,8-11,15H,6-7,12-14H2,1H3",CBHCDHNUZWWAPP-UHFFFAOYSA-N,C19H22N2S,310.5,10-[(1-methylpiperidin-3-yl)methyl]phenothiazine,"Pecazine|MEPAZINE|Paxital|Pecazina|Pecazinum|Pecazine [INN:BAN]|Pecazinum [INN-Latin]|Pecazina [INN-Spanish]|(N-Methyl-3-piperidyl)methylphenothiazine|10-[(1-methylpiperidin-3-yl)methyl]phenothiazine|DTXSID2046177|10H-Phenothiazine, 10-((1-methyl-3-piperidinyl)methyl)-|P 391|EINECS 200-490-8|10-(1-Methylpiperidyl-3-methyl)phenothiazine|10-[(1-Methyl-3-piperidyl)methyl]phenothiazine|UNII-PH34873A38|AI3-50131|MEPAZINE [MI]|PECAZINE [INN]|10-(1-Methyl-3-piperidyl)methyl phenothiazine|10-((1-Methyl-3-piperidyl)methyl)phenothiazine|PECAZINE [WHO-DD]|PH34873A38|Phenothiazine, 10-((1-methyl-3-piperidyl)methyl)-|10H-Phenothiazine, 10-[(1-methyl-3-piperidinyl)methyl]-|DTXCID0026177|Pecazinum (INN-Latin)|Pecazina (INN-Spanish)|Phenothiazine, 10-[(1-methyl-3-piperidyl)methyl]-|pecazin|10-((1-METHYL-3-PIPERIDINYL)METHYL)-10H-PHENOTHIAZINE|10-((1-methylpiperidin-3-yl)methyl)phenothiazine|10-[(1-Methyl-3-piperidinyl)methyl]-10H-phenothiazine|RefChem:170639|200-490-8|CBHCDHNUZWWAPP-UHFFFAOYSA-N|Paxital (VAN)|60-89-9|Nothiazine|Meprazine|Mepazin|Pecatal|Mepazine Base|Lacumin|Pakatal|Pacatal Base|mepasin|Mesapin|MPMP|Pacatol|III-2318|NCGC00160480-01|P-391|BDBM50177661|C19H22N2S|Mepazine?|Pecazine HCl|Probes1_000237|Probes2_000278|NCIOpen2_008134|Oprea1_067080|Oprea1_208564|US9504692, Mepezine|CBDivE_007551|MLS006011657|SCHEMBL149976|CHEMBL395110|GTPL9782|orb1308049|SCHEMBL29436812|CHEBI:135324|AAA06089|Tox21_111842|STK386548|AKOS000280691|AKOS021820849|CCG-108581|FP30405|CAS-60-89-9|DA-75417|MS-24522|SMR004703409|HY-121282|CS-0081367|G12767|AB00275848-07|10-[(1-Methyl-3-piperidyl)-methyl]-phenothiazin|phenothiazine, 10-[3-(N-methyl)piperidinyl]methyl-|BRD-A82772293-001-01-6|BRD-A82772293-001-03-2|Q27286554|10-[(1-methylpiperidin-3-yl)methyl]-10H-phenothiazine|10-[(1-Methyl-3-piperidinyl)methyl]-10H-phenothiazine #|10-[(1-METHYL-3-PIPERIDYL)METHYL]-10H-PHENOTHIAZINE"
FASIGLIFAM,24857286,,"InChI=1S/C29H32O7S/c1-19-12-25(34-10-5-11-37(3,32)33)13-20(2)29(19)22-7-4-6-21(14-22)17-35-24-8-9-26-23(15-28(30)31)18-36-27(26)16-24/h4,6-9,12-14,16,23H,5,10-11,15,17-18H2,1-3H3,(H,30,31)/t23-/m1/s1",BZCALJIHZVNMGJ-HSZRJFAPSA-N,C29H32O7S,524.6,"2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]acetic acid","Fasiglifam|1000413-72-8|TAK-875|TAK875|TAK 875|Tak-875 anhydrous|GLP1W4JXAH|DTXSID601025726|[(3S)-6-({3-[4-(3-methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid|((3S)-6-((3-(4-(3-Methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl)acetic acid|fasiglifamum|((3S)-6-((3-(4-(3-Methanesulfonylpropoxy)-2,6-dimethylphenyl)phenyl)methoxy)-2,3-dihydro-1-benzofuran-3-yl)acetic Acid|2-((3S)-6-((3-(4-(3-methanesulfonylpropoxy)-2,6-dimethylphenyl)phenyl)methoxy)-2,3-dihydro-1-benzofuran-3-yl)acetic acid|2-[(3S)-6-({3-[4-(3-methanesulfonylpropoxy)-2,6-dimethylphenyl]phenyl}methoxy)-2,3-dihydro-1-benzofuran-3-yl]acetic acid|RefChem:921483|DTXCID301509991|2-((3S)-6-((4'-(3-methanesulfonylpropoxy)-2',6'-dimethyl-(1,1'-biphenyl)-3-yl)methoxy)-2,3-dihydro-1-benzofuran-3-yl)acetic acid|(S)-2-(6-((2',6'-Dimethyl-4'-(3-(methylsulfonyl)propoxy)-[1,1'-biphenyl]-3-yl)methoxy)-2,3-dihydrobenzofuran-3-yl)acetic acid|3-Benzofuranacetic acid, 6-[[2',6'-diMethyl-4'-[3-(Methylsulfonyl)propoxy][1,1'-biphenyl]-3-yl]Methoxy]-2,3-dihydro-, (3S)-|TAK-875(Fasiglifam)|MFCD18251445|CHEMBL1829174|[(3s)-6-({2',6'-Dimethyl-4'-[3-(Methylsulfonyl)propoxy]biphenyl-3-Yl}methoxy)-2,3-Dihydro-1-Benzofuran-3-Yl]acetic Acid|FASIGLIFAM HYDRATE|C29H32O7S|Fasiglifam [INN]|UNII-GLP1W4JXAH|Fasiglifam [USAN:INN]|4phu|2YB|3-BENZOFURANACETIC ACID, 6-((2',6'-DIMETHYL-4'-(3-(METHYLSULFONYL)PROPOXY)(1,1'-BIPHENYL)-3-YL)METHOXY)-2,3-DIHYDRO-, (3S)-|Fasiglifam (USAN/INN)|FASIGLIFAM [USAN]|FASIGLIFAM [WHO-DD]|SCHEMBL204652|GTPL6484|orb1305616|SCHEMBL29360096|SCHEMBL31192643|EX-A203|BZCALJIHZVNMGJ-HSZRJFAPSA-N|CHEBI:177451|GLXC-04884|2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzofuran-3-yl]acetic acid|BCP02430|BDBM50386790|AKOS025289552|CS-0282|DB12491|NCGC00346669-01|NCGC00346669-07|AC-25651|FT137724|HY-10480|MS-29716|NS00072908|D10336|BRD-K58501140-002-01-0|Q27077287|((3S)-6-(((2',6'-DIMETHYL-4'-(3-(METHANESULFONYL)PROPOXY)-(1,1'-BIPHENYL)-3-YL))METHOXY)-2,3-DIHYDRO-1-BENZOFURAN-3-YL)ACETIC ACID|2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulfonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydrobenzofuran-3-yl]acetic acid|2-[(3S)-6-[[3-[2,6-dimethyl-4-(3-methylsulonylpropoxy)phenyl]phenyl]methoxy]-2,3-dihydro-1-benzouran-3-yl]acetic acid"
LY2881835,51049992,,"InChI=1S/C33H33NO3/c1-2-5-29(22-32(35)36)27-12-14-30(15-13-27)37-24-26-10-8-25(9-11-26)23-34-20-18-33(19-21-34)17-16-28-6-3-4-7-31(28)33/h3-4,6-17,29H,18-24H2,1H3,(H,35,36)/t29-/m0/s1",FHRWHNJJQGSCQC-LJAQVGFWSA-N,C33H33NO3,491.6,"(3S)-3-[4-[[4-(spiro[indene-1,4'-piperidine]-1'-ylmethyl)phenyl]methoxy]phenyl]hex-4-ynoic acid","LY-2881835|LAD0ZG7FFO|LY2881835|1292290-38-0|(betaS)-beta-1-Propyn-1-yl-4-((4-(spiro(1H-indene-1,4'-piperidin)-1'-ylmethyl)phenyl)methoxy)benzenepropanoic acid|Benzenepropanoic acid, beta-1-propyn-1-yl-4-((4-(spiro(1H-indene-1,4'-piperidin)-1'-ylmethyl)phenyl)methoxy)-, (betaS)-|RefChem:154546|(3S)-3-(4-((4-((spiro(indene-1,4'-piperidin)-1'-yl)methyl)phenyl)methoxy)phenyl)hex-4-ynoic acid|UNII-LAD0ZG7FFO|CHEMBL3915620|orb1700044|SCHEMBL1587130|BDBM50200369|AKOS040748837|DB15046|HY-108020|CS-0027170|(.BETA.S)-.BETA.-1-PROPYN-1-YL-4-((4-(SPIRO(1H-INDENE-1,4'-PIPERIDIN)-1'-YLMETHYL)PHENYL)METHOXY)BENZENEPROPANOIC ACID|(3S)-3-[4-[[4-(spiro[indene-1,4'-piperidine]-1'-ylmethyl)phenyl]methoxy]phenyl]hex-4-ynoic acid|BENZENEPROPANOIC ACID, .BETA.-1-PROPYN-1-YL-4-((4-(SPIRO(1H-INDENE-1,4'-PIPERIDIN)-1'-YLMETHYL)PHENYL)METHOXY)-, (.BETA.S)-"
ZIRITAXESTAT,90420193,,"InChI=1S/C30H33FN8O2S/c1-4-24-29(35(3)30-34-27(25(14-32)42-30)20-5-7-21(31)8-6-20)39-15-22(13-19(2)28(39)33-24)37-11-9-36(10-12-37)18-26(41)38-16-23(40)17-38/h5-8,13,15,23,40H,4,9-12,16-18H2,1-3H3",REQQVBGILUTQNN-UHFFFAOYSA-N,C30H33FN8O2S,588.7,"2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)-1,3-thiazole-5-carbonitrile","Ziritaxestat|1628260-79-6|GLPG-1690|GLPG1690|Ziritaxestatn|G451990|I02418V13W|G-451990|2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]-methylamino]-4-(4-fluorophenyl)-1,3-thiazole-5-carbonitrile|ziritaxestatum|2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo(1,2-a)pyridin-3-yl)-methylamino)-4-(4-fluorophenyl)-1,3-thiazole-5-carbonitrile|RefChem:905363|5-Thiazolecarbonitrile, 2-((2-ethyl-6-(4-(2-(3-hydroxy-1-azetidinyl)-2-oxoethyl)-1-piperazinyl)-8-methylimidazo(1,2-a)pyridin-3-yl)methylamino)-4-(4-fluorophenyl)-|2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile|MFCD31544330|Ziritaxestat [USAN]|GLPG-1690(Ziritaxestat)|Ziritaxestat (GLPG1690)|CHEMBL3828074|2-[[2-Ethyl-8-Methyl-6-[4-[2-(3-Oxidanylazetidin-1-Yl)-2-Oxidanylidene-Ethyl]piperazin-1-Yl]imidazo[1,2-A]pyridin-3-Yl]-Methyl-Amino]-4-(4-Fluorophenyl)-1,3-Thiazole-5-Carbonitrile|Ziritaxestat [WHO-DD]|Ziritaxestat (USAN/INN)|ZIRITAXESTAT [INN]|GLPG-1690(Ziritaxestat)?|GTPL9561|SCHEMBL16051264|UNII-I02418V13W|BDBM719985|GLXC-20278|BCP20895|EX-A1646|BDBM50187686|s8895|WHO 11017|AKOS032946267|CS-7634|DB15403|SB19736|compound 11 [PMID: 28414242]|AC-36149|SY235874|HY-101772|US20250051321, Compound GLPG1690|D11844|Q23075652|2-[[2-Ethyl-6-[4-[2-(3-hydroxy-1-azetidinyl)-2-oxoethyl]-1-piperazinyl]-8-methylimidazo[1,2-a]pyridin-3-yl](methyl)amino]-4-(4-fluorophenyl)thiazole-5-carbonitrile|2-[[2-ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxo-ethyl]piperazin-1-yl]-8-methyl-imidazo[1,2-a]pyridin-3-yl]-methyl-amino]-4-(4-fluorophenyl)thiazole-5-carbonitrile|42-ETHYL-14-FLUORO-83-HYDROXY-3,48-DIMETHYL-7-OXO-3-AZA-4(3,6)-IMIDAZO(1,2-A)PYRIDINA-5(1,4)-PIPERAZINA-2(4,2)-(1,3)THIAZOLA-8(1)-AZETIDINA-1(1)-BENZENAOCTAPHANE-25-CARBONITRILE"
SUVECALTAMIDE,24765479,,"InChI=1S/C20H23F3N2O2/c1-13(2)16-6-4-15(5-7-16)10-19(26)25-14(3)18-9-8-17(11-24-18)27-12-20(21,22)23/h4-9,11,13-14H,10,12H2,1-3H3,(H,25,26)/t14-/m1/s1",IQIKXZMPPBEWAD-CQSZACIVSA-N,C20H23F3N2O2,380.4,"2-(4-propan-2-ylphenyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide","Suvecaltamide|MK-8998|JZP385|Cx-8998|Suvecaltamide [USAN]|MIA4WMP8QN|MK-8998 free base|JZP-385|UNII-MIA4WMP8QN|MK8998|SUVECALTAMIDE [INN]|SUVECALTAMIDE [WHO-DD]|2-(4-propan-2-ylphenyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)pyridin-2-yl]ethyl]acetamide|compound 1 [PMID: 27579577]|compound 1 [PMID: 34582192]|Suvecaltamide (USAN)|compound 1 (PMID: 27579577)|compound 1 (PMID: 34582192)|4-(1-METHYLETHYL)-N-((1R)-1-(5-(2,2,2-TRIFLUOROETHOXY)-2-PYRIDINYL)ETHYL)BENZENEACETAMIDE|2-(4-propan-2-ylphenyl)-N-((1R)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide|RefChem:186857|953778-58-0|(R)-2-(4-isopropylphenyl)-N-(1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl)acetamide|CHEMBL1684950|Benzeneacetamide, 4-(1-methylethyl)-N-((1R)-1-(5-(2,2,2-trifluoroethoxy)-2-pyridinyl)ethyl)-|MFCD22572346|orb1301636|SCHEMBL1065999|SCHEMBL29791943|GTPL12648|GLXC-10813|BCP18693|DNB77858|EX-A2479|BDBM50192668|WHO 11291|AKOS032945005|CS-6198|AC-35480|BS-17962|CID 24765479|MK-8998?|SY250111|DB-362320|HY-101096|C77290|D12061|(R)-2-(4-Isopropylphenyl)-N-[1-[5-(2,2,2-trifluoroethoxy)-2-pyridinyl]ethyl]acetamide|2-(4-isopropylphenyl)-n-[(1r)-1-(5-(2,2,2-trifluoroethoxy)pyridin-2-yl)ethyl]acetamide|2-(4-isopropylphenyl)-N-[(1R)-1-[5-(2,2,2-trifluoroethoxy)-2-pyridyl]ethyl]acetamide"
AZD-8154,141754136,,"InChI=1S/C27H29N5O4S2/c1-15-25(37-27(28-15)30-21-6-4-7-22(29-21)31-11-5-8-23(31)33)18-12-19-14-32(16(2)17-9-10-17)26(34)24(19)20(13-18)38(3,35)36/h4,6-7,12-13,16-17H,5,8-11,14H2,1-3H3,(H,28,29,30)/t16-/m0/s1",XOMFDZJQLSPGGV-INIZCTEOSA-N,C27H29N5O4S2,551.7,"2-[(1S)-1-cyclopropylethyl]-5-[4-methyl-2-[[6-(2-oxopyrrolidin-1-yl)pyridin-2-yl]amino]-1,3-thiazol-5-yl]-7-methylsulfonyl-3H-isoindol-1-one","AZD8154|2215022-45-8|AZD-8154|J5M3TCK9Y9|AZD-8154 [WHO-DD]|Azd 8154|1H-Isoindol-1-one, 2-((1S)-1-cyclopropylethyl)-2,3-dihydro-5-(4-methyl-2-((6-(2-oxo-1-pyrrolidinyl)-2-pyridinyl)amino)-5-thiazolyl)-7-(methylsulfonyl)-|Example 1 [WO2018055040A1]|2-[(1S)-1-cyclopropylethyl]-5-[4-methyl-2-[[6-(2-oxopyrrolidin-1-yl)pyridin-2-yl]amino]-1,3-thiazol-5-yl]-7-methylsulfonyl-3H-isoindol-1-one|Example 1 (WO2018055040A1)|2-((1S)-1-cyclopropylethyl)-5-(4-methyl-2-((6-(2-oxopyrrolidin-1-yl)pyridin-2-yl)amino)-1,3-thiazol-5-yl)-7-methylsulfonyl-3H-isoindol-1-one|RefChem:199684|UNII-J5M3TCK9Y9|CHEMBL4558527|orb1818489|SCHEMBL22204109|SCHEMBL29370553|GTPL11204|AZD 8154 [WHO-DD]|AZD8154?|EX-A5133|BDBM50512861|AKOS040757410|DA-61383|MS-30088|HY-115870|CS-0371158"
IMARIKIREN HYDROCHLORIDE,56591871,,"InChI=1S/C27H41N5O4.ClH/c1-20(2)19-32(22-16-21(17-28-18-22)26(33)30-11-14-36-15-12-30)27(34)25-29-23-8-4-5-9-24(23)31(25)10-6-7-13-35-3;/h4-5,8-9,20-22,28H,6-7,10-19H2,1-3H3;1H/t21-,22+;/m1./s1",PUXOYQIZZIWCHH-NSLUPJTDSA-N,C27H42ClN5O4,536.1,"1-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholine-4-carbonyl)piperidin-3-yl]benzimidazole-2-carboxamide;hydrochloride","Imarikiren hydrochloride|TAK-272|1202269-24-6|1NE31CW68S|TAK-272, (+)-|1H-Benzimidazole-2-carboxamide, 1-(4-methoxybutyl)-N-(2-methylpropyl)-N-((3S,5R)-5-(4-morpholinylcarbonyl)-3-piperidinyl)-, hydrochloride (1:1)|1-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholine-4-carbonyl)piperidin-3-yl]benzimidazole-2-carboxamide;hydrochloride|1-(4-methoxybutyl)-N-(2-methylpropyl)-N-((3S,5R)-5-(morpholine-4-carbonyl)piperidin-3-yl)benzimidazole-2-carboxamide;hydrochloride|RefChem:147920|UNII-1NE31CW68S|CHEMBL3969876|Imarikiren HCl|SCHEMBL2217236|SCHEMBL29577328|PUXOYQIZZIWCHH-NSLUPJTDSA-N|AKOS040748569|1-(4-methoxybutyl)-N-(2-methylpropyl)-N-[(3S,5R)-5-(morpholin-4-ylcarbonyl)piperidin-3-yl]-1H-benzimidazole-2-carboxamide hydrochloride"
SERABELISIB,70798655,,"InChI=1S/C19H17N5O3/c20-19-22-14-9-12(1-3-16(14)27-19)13-2-4-17-21-10-15(24(17)11-13)18(25)23-5-7-26-8-6-23/h1-4,9-11H,5-8H2,(H2,20,22)",BLGWHBSBBJNKJO-UHFFFAOYSA-N,C19H17N5O3,363.4,"[6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone","Serabelisib|1268454-23-4|MLN1117|MLN-1117|INK-1117|INK1117|AGN-PC-0DB6FL|TAK-117|Methanone, [6-(2-aMino-5-benzoxazolyl)iMidazo[1,2-a]pyridin-3-yl]-4-Morpholinyl-|[6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholin-4-ylmethanone|43J9Q56T3W|(6-(2-Amino-5-benzoxazolyl)imidazo(1,2-a)pyridin-3-yl)-4-morpholinylmethanone|Methanone, (6-(2-amino-5-benzoxazolyl)imidazo(1,2-a)pyridin-3-yl)-4-morpholinyl-|(6-(2-amino-1,3-benzoxazol-5-yl)imidazo(1,2-a)pyridin-3-yl)(4-morpholinyl)methanone|5-[3-(morpholine-4-carbonyl)imidazo[1,2-a]pyridin-6-yl]-1,3-benzoxazol-2-amine|serabelisibum|(6-(2-amino-1,3-benzoxazol-5-yl)imidazo(1,2-a)pyridin-3-yl)-morpholin-4-ylmethanone|[6-(2-Amino-5-benzoxazolyl)imidazo[1,2-a]pyridin-3-yl]-4-morpholinylmethanone|5-(3-(morpholine-4-carbonyl)imidazo(1,2-a)pyridin-6-yl)-1,3-benzoxazol-2-amine|RefChem:182491|TAK 117|(6-(2-aminobenzo[d]oxazol-5-yl)imidazo[1,2-a]pyridin-3-yl)(morpholino)methanone|Serabelisib [INN]|MFCD15146372|MLN 1117|[6-(2-amino-1,3-benzoxazol-5-yl)imidazo[1,2-a]pyridin-3-yl]-morpholino-methanone|[6-(2-amino-5-benzoxazolyl)imidazo[1,2-a]pyridin-3-yl]-4-morpholinyl-methanone|UNII-43J9Q56T3W|C19H17N5O3|SERABELISIB [WHO-DD]|GTPL8969|orb1304485|CHEMBL3935857|SCHEMBL12928418|SCHEMBL29382156|BDBM119531|BCP09230|EX-A1112|INK 1117|MLN1117; INK1117|NSC795384|s8581|AKOS030526373|CCG-268203|CS-5490|DB14935|NSC-795384|1428967-74-1|AC-33667|AS-73722|HY-12285|DB-084944|INK-1117,MLN-1117,TAK-117|Serabelisib(TAK-117,INK1117,MLN1117)|Serabelisib(TAK-117,INK1117,MLN1117)?|US9682141, 54|Serabelisib (INK-1117,MLN-1117,TAK-117)|US9682141, 529|BRD-K73877023-001-01-9|Q27078071"
PILARALISIB,56599306,,"InChI=1S/C25H25ClN6O4S/c1-25(2,27)24(33)28-15-7-6-8-17(13-15)37(34,35)32-23-22(29-19-9-4-5-10-20(19)30-23)31-21-14-16(36-3)11-12-18(21)26/h4-14H,27H2,1-3H3,(H,28,33)(H,29,31)(H,30,32)",QINPEPAQOBZPOF-UHFFFAOYSA-N,C25H25ClN6O4S,541.0,2-amino-N-[3-[[3-(2-chloro-5-methoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-2-methylpropanamide,"Pilaralisib|934526-89-3|XL-147|SAR245408|SAR-245408|2-Amino-n-(3-(N-(3-((2-chloro-5-methoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-2-methylpropanamide|60ES45KTMK|SAR 245408|2-amino-N-[3-({3-[(2-chloro-5-methoxyphenyl)amino]quinoxalin-2-yl}sulfamoyl)phenyl]-2-methylpropanamide|pilaralisibum|2-amino-N-(3-((3-((2-chloro-5-methoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-2-methylpropanamide|RefChem:863281|N-(3-(2,1,3-benzothiadiazol-6-ylamino)quinoxalin-2-yl)-4-methylbenzenesulfonamide|XL 147|2-amino-N-[3-[[3-(2-chloro-5-methoxyanilino)quinoxalin-2-yl]sulfamoyl]phenyl]-2-methylpropanamide|MFCD26142605|2-amino-N-(3-(N-(3-((2-chloro-5-methoxyphenyl)amino)quinoxalin-2-yl)sulfamoyl)phenyl)-2-methylpropanamide.|UNII-60ES45KTMK|Pilaralisib (XL147)|Pilaralisib [USAN:INN]|C25H25ClN6O4S|Pilaralisib [INN]|PILARALISIB [USAN]|PILARALISIB [WHO-DD]|SCHEMBL189422|orb1305590|CHEMBL3360203|SCHEMBL14921345|SCHEMBL14921347|SCHEMBL16154579|SCHEMBL16157341|SCHEMBL29355093|SCHEMBL29394178|EX-A196|DTXSID701025731|GLXC-04931|BCP15312|BDBM50197062|NSC791227|NSC800853|s7645|AKOS026750450|CCG-264704|CS-1546|DB11772|NSC-791227|NSC-800853|SB16574|NCGC00378973-02|AC-33122|AS-56300|DA-40388|FX137599|HY-16526|Pilaralisib(XL-147; SAR245408)?|NS00073304|BRD-K49456274-001-01-9|2-AMINO-N-(3-((3-(2-CHLORO-5-METHOXYANILINO)QUINOXALIN-2-YL)SULFAMOYL(PHENYL)-2-METHYLPROPANAMIDE|2-Amino-N-(3-(N-(3-(2-chloro-5-methoxyphenylamino)quinoxalin-2-yl)sulfamoyl)phenyl)-2-methylpropanamide|2-Amino-N-[3-[[[3-[(2-chloro-5-methoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-2-methylpropanamide|2-amino-N-[3-[[3-(2-chloro-5-methoxy-anilino)quinoxalin-2-yl]sulfamoyl]phenyl]-2-methyl-propanamide|SAR 245408;Pilaralisib;2-Amino-N-[3-[[[3-[(2-chloro-5-methoxyphenyl)amino]-2-quinoxalinyl]amino]sulfonyl]phenyl]-2-methylpropanamide"
LAROTRECTINIB,46188928,,"InChI=1S/C21H22F2N6O2/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31)/t14-,18+/m0/s1",NYNZQNWKBKUAII-KBXCAEBGSA-N,C21H22F2N6O2,428.4,"(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide","Larotrectinib|1223403-58-4|LOXO-101|ARRY-470|LOXO 101|LOXO101|BAY2757556|BAY-2757556|ARRY 470|PF9462I9HX|1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-|ARRY470|(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide|DTXSID101020707|1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-|larotrectinibum|(3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide|(3S)-N-{5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl}-3-hydroxypyrrolidine-1-carboxamide|RefChem:57159|L01XE53|DTXCID001493220|(3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-1-pyrrolidinecarboxamide|(3S)-N-(5-(2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide|3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide|826-190-2|(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide|LarotrectinibFor|Vitrakvi|MFCD28902192|Larotrectinib (LOXO-101 free base)|C21H22F2N6O2|(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-pyrrolidine-1-carboxamide|Larotrectinib [INN]|Larotrectinib (Standard)|LAROTRECTINIB [MI]|ARRY-470; larotrectinib|Larotrectinib (USAN/INN)|Larotrectinib [USAN:INN]|LAROTRECTINIB [USAN]|UNII-PF9462I9HX|LAROTRECTINIB [WHO-DD]|GTPL8909|orb1301362|SCHEMBL2241012|CHEMBL3889654|SCHEMBL29420193|NYNZQNWKBKUAII-KBXCAEBGSA-N|BDBM136597|BCP16262|EX-A1981|HY-12866R|NSC785570|NSC801004|s5860|AKOS027338709|example 14 [US8865698 B2]|CS-5722|DB14723|NSC-785570|NSC-801004|AC-33660|AS-35231|BP-43662|FD145150|HY-12866|NS00133777|D11137|EN300-7411765|US8865698, 14|BRD-K36574127-001-01-3|Q27081513|ARRY-470;ARRY 470 : LOXO-101; LOXO101; Larotrectinib|(3S)-N-(5-((2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN- 1-YL)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE- 1-CARBOXAMIDE|(3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine- 1-carboxamide|(S)-N-(5 -((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide|(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin -1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide|(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide|(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3 yl)-3-hydroxypyrrolidine-1-carboxamide|LOXO 101;(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide;ARR  Y 470"
FGFR INHIBITOR DEBIO 1347,66555680,,"InChI=1S/C20H16N6O/c1-11-23-16-7-6-13(9-17(16)24-11)26-20(21)14(10-22-26)19(27)18-8-12-4-2-3-5-15(12)25-18/h2-10,25H,21H2,1H3,(H,23,24)",BEMNJULZEQTDJY-UHFFFAOYSA-N,C20H16N6O,356.4,[5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone,"1265229-25-1|Debio-1347|CH5183284|zoligratinib|CH-5183284|Debio 1347|NR9ZYH80Z8|FF284|Fgfr inhibitor debio 1347|DEBIO1347|[5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(1H-indol-2-yl)methanone|Methanone, (5-amino-1-(2-methyl-1H-benzimidazol-6-yl)-1H-pyrazol-4-yl)-1H-indol-2-yl-|(5-AMINO-1-(2-METHYL-3H-BENZIMIDAZOL-5-YL)PYRAZOL-4-YL)-(1H-INDOL-2-YL)METHANONE|Debiopharm 1347|RefChem:196223|debio 1347-101|4-(1h-indole-2-carbonyl)-1-(2-methyl-1h-1,3-benzodiazol-6-yl)-1h-pyrazol-5-amine|CH5183284 (Debio-1347)|(5-Amino-1-(2-methyl-1H-benzo[d]imidazol-6-yl)-1H-pyrazol-4-yl)(1H-indol-2-yl)methanone|CHEMBL3907479|[5-Amino-1-(2-Methyl-1h-Benzimidazol-6-Yl)-1h-Pyrazol-4-Yl](1h-Indol-2-Yl)methanone|UNII-NR9ZYH80Z8|BEMNJULZEQTDJY-UHFFFAOYSA-N|MFCD28502053|ZOLIGRATINIB [INN]|ZOLIGRATINIB [WHO-DD]|GTPL9787|orb1301141|SCHEMBL10002991|SCHEMBL10313737|SCHEMBL29358788|SCHEMBL29434993|GLXC-07218|HMS3674G21|HMS3748K13|BCP14354|EX-A1122|QAC22925|BDBM50197683|NSC782363|NSC800074|s7665|AKOS027427006|CH5183284; Debio-1347|CCG-264725|CS-5504|DB12903|NSC-782363|NSC-800074|SB16908|NCGC00386433-01|AC-32960|BS-14797|CH5183284 (Debio-1347)?|HY-19957|CH 5183284|NS00073159|BRD-K11683436-001-01-7|BRD-K11683436-001-02-5|Q27285013|[5-amino-1-(2-methyl-1H-benzimidazol-5-yl)-1H-pyrazol-4-yl]-(1H-indol-2-yl) methanone|[5-Amino-1-(2-methyl-1H-benzimidazol-5-yl)-1H-pyrazol-4-yl]-(1H-indol-2-yl)-methanone|[5-amino-1-(2-methyl-1H-benzimidazol-5-yl)-1H-pyrazol-4-yl]-(1H-indol-2-yl)methanone|[5-amino-1-(2-methyl-3h-benzimidazol-5-yl)pyrazol-4-yl](1h-indol-2-yl)methanone|(5-AMINO-1-(2-METHYL-1H-BENZIMIDAZOL-6-YL)-1H-PYRAZOL-4-YL)-1H-INDOL-2-YLMETHANONE|LWJ"
SELITRECTINIB,129103609,,"InChI=1S/C20H21FN6O/c1-12-4-5-16-14(9-13(21)10-22-16)17-3-2-7-26(17)18-6-8-27-19(25-18)15(11-23-27)20(28)24-12/h6,8-12,17H,2-5,7H2,1H3,(H,24,28)/t12-,17-/m1/s1",OEBIHOVSAMBXIB-SJKOYZFVSA-N,C20H21FN6O,380.4,"(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexazapentacyclo[16.5.2.02,6.07,12.021,25]pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one","Selitrectinib|LOXO-195|2097002-61-2|LOXO195|(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexazapentacyclo[16.5.2.02,6.07,12.021,25]pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one|0J45910S3X|LOXO 195|BAY 2731954|(13E,14E,22R,6R)-35-fluoro-6-methyl-7-aza-1(5,3)-pyrazolo[1,5-a]pyrimidina-3(3,2)-pyridina-2(1,2)-pyrrolidinacyclooctaphan-8-one|selitrectinibum|(13E,14E,22R,6R)-35-fluoro-6-methyl-7-aza-1(5,3)-pyrazolo(1,5-a)pyrimidina-3(3,2)-pyridina-2(1,2)-pyrrolidinacyclooctaphan-8-one|(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexazapentacyclo(16.5.2.02,6.07,12.021,25)pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one|RefChem:182327|TRK Inhibitor LOXO-195|(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexaazapentacyclo(16.5.2.0^(2,6).0^(7,12).0^(21,25))pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one|LOXO 195(Selitrectinib)|Selitrectinib (LOXO-195)|(3aR,10R)-5-Fluoro-1,2,3,3a,8,9,10,11-octahydro-10-methyl-12H-15,17-ethenopyrazolo[3,4-d]pyrido[2,3-k]pyrrolo[2,1-m][1,3,7]triazacyclotridecin-12-one|Selitrectinib(LOXO-195)|MFCD31620755|UNII-0J45910S3X|SelitrectinibLOXO-195|Selitrectinib (Standard)|SELITRECTINIB [INN]|SELITRECTINIB [WHO-DD]|C20H21FN6O|orb1299822|CHEMBL4297627|SCHEMBL18823882|SCHEMBL29673979|GTPL10314|EX-A1873|BDBM50507492|NSC809970|AKOS037648883|DB14896|HY-101977R|NSC-809970|BAY-2731954|AC-32662|BS-15941|DA-67532|example 28 [WO2017075107A1]|HY-101977|CS-0022378|(22R,6R)-35-FLUORO-6-METHYL-1(5,3)-PYRAZOLO(1,5-A)PYRIMIDINA-3(3,2)-PYRIDINA-2(1,2)-PYRROLIDINACYCLOOCTAPHAN-8-ONE|(3aR,10R)-5-Fluoro-1,2,3,3a,8,9,10,11-octahydro-10-methyl-12H-15,17-Ethenopyrazolo[3,4-d]pyrido[2,3-k]pyrrolo[2,1-m][1,3,7]triazacyclotridecin-12-one,|(6R,15R)-9-fluoro-15-methyl-2,11,16,20,21,24-hexaazapentacyclo[16.5.2.0,.0,.0,pentacosa-1(24),7(12),8,10,18(25),19,22-heptaen-17-one|12H-15,17-Ethenopyrazolo[3,4-d]pyrido[2,3-k]pyrrolo[2,1-m][1,3,7]triazacyclotridecin-12-one, 5-fluoro-1,2,3,3a,8,9,10,11-octahydro-10-methyl-, (3aR,10R)-|12H-5,7-ETHENOPYRAZOLO(3,4-D)PYRIDO(2,3-K)PYRROLO(2,1-M)(1,3,7)TRIAZACYCLOTRIDECIN-12-ONE, 5-FLUORO-1,2,3,3A,8,9,10,11-OCTAHYDRO-10-METHYL-, (3AR,10R)-|Cas registry number 2097002-61-2 ~1~1 C20 H21 F N6 O 10H-5,7-ethenopyrazolo(3,4-d)pyrido(2,3-k)pyrrolo(2,1-m)(1,3,7)triazacyclotridecin-10-one, 17-fluoro-1,2,3,11,12,13,14,18b-octahydro-12-methyl-, (12R,18bR)-"
LAPACHONE,3885,,"InChI=1S/C15H14O3/c1-15(2)8-7-11-13(17)12(16)9-5-3-4-6-10(9)14(11)18-15/h3-6H,7-8H2,1-2H3",QZPQTZZNNJUOLS-UHFFFAOYSA-N,C15H14O3,242.27,"2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5,6-dione","beta-Lapachone|4707-32-8|lapachone|Lapachone, beta-|Beta-lap-wj|ARQ 501|ARQ-501|3,4-Dihydro-2,2-dimethyl-2H-naphtho[1,2-B]pyran-5,6-dione|NSC-26326|3,4-Dihydro-2,2-dimethyl-2H-naphtho(1,2-b)pyran-5,6-dione|2,2-dimethyl-3,4-dihydrobenzo[h]chromene-5,6-dione|Beta lapachone|6N4FA2QQ6A|NSC-629749|2H-Naphtho[1,2-b]pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl-|CHEBI:10429|NSC26326|NSC629749|ARQ501|2H-Naphtho(1,2-b)pyran-5,6-dione, 3,4-dihydro-2,2-dimethyl-|DTXSID90197019|2,2-dimethyl-3,4-dihydrobenzo(h)chromene-5,6-dione|RefChem:567893|DTXCID50119510|2,2-Dimethyl-3,4-dihydro-2H-benzo[h]chromene-5,6-dione|.beta.-Lapachone|MFCD01712233|ARQ-501 (beta lapachone)|MB12066|MB-12066|ARQ-501;NSC-26326|b-Lapachone (90%)|LAPACHONE, BETA|beta-lap|NSC 26326|SL 11001|SR-01000075957|UNII-6N4FA2QQ6A|NSC 629749|BRN 0181499|b-Lapachone|ss-Lapachone|Beta -Lapachone|3,4-Dihydro-2,2-dimethyl-2H-naphthol[1,2-b]pyran-5,6-dione|Lapachone, .beta.|Lopac-L-2037|beta-Lapachone (>90%)|Lopac0_000717|BSPBio_001306|KBioGR_000026|KBioSS_000026|2005rm01ch01|5-17-11-00459 (Beilstein Handbook Reference)|AK-693/21096016|MLS006011731|R115 (Reactive Blue 2)|CHEMBL15192|SCHEMBL107042|orb1300795|BETA LAPACHONE [WHO-DD]|SCHEMBL29351050|BCBcMAP01_000055|BDBM81348|KBio2_000026|KBio2_002594|KBio2_005162|KBio3_000051|KBio3_000052|beta-Lapachone, >=98% (TLC)|Bio2_000026|Bio2_000506|GLXC-05578|HMS1361B08|HMS1791B08|HMS1989B08|HMS3262O15|HMS3402B08|HMS3653O04|HMS3866G13|BCP09779|EX-A3011|Tox21_500717|CCG-36362|HSCI1_000182|NSC813862|s7261|(c)micro-Lapachone pound>>ARQ 501|AKOS005266281|AC-8965|CS-3680|DB11948|LP00717|NSC-813862|SDCCGSBI-0050695.P003|IDI1_033776|QTL1_000048|NCGC00015598-01|NCGC00015598-02|NCGC00015598-03|NCGC00015598-04|NCGC00015598-05|NCGC00015598-06|NCGC00015598-07|NCGC00015598-08|NCGC00015598-17|NCGC00094066-01|NCGC00094066-02|NCGC00094066-03|NCGC00094066-04|NCGC00094066-05|NCGC00261402-01|AS-70326|BP-28431|FL170803|HY-13555|NCI60_009665|SMR001456339|SY014370|beta-Lapachone (ARQ-501, CO-501)?|DB-021896|EU-0100717|NS00018342|SW219806-1|C75251|SR-01000075957-1|SR-01000075957-5|2H-Naphtho[1,6-dione, 3,4-dihydro-2,2-dimethyl-|BRD-K28061410-001-05-8|BRD-K28061410-001-06-6|BRD-K28061410-001-07-4|Q27089386|2,2-Dimethyl-3,4-dihydro-2H-benzo[h]chromene-5,6-dione #|2,2-dimethyl-2H,3H,4H,5H,6H-naphtho[1,2-b]pyran-5,6-dione|AfAE'A centa' notA inverted exclamation markAfasA'A|AfAE'Adaggeratrade markAfA centA centasA notA em leaderA inverted exclamation mark-Lapachone"
VARLITINIB,42642648,,"InChI=1S/C22H19ClN6O2S/c1-13-10-31-22(27-13)29-14-2-4-18-16(8-14)21(26-12-25-18)28-15-3-5-19(17(23)9-15)30-11-20-24-6-7-32-20/h2-9,12-13H,10-11H2,1H3,(H,27,29)(H,25,26,28)/t13-/m1/s1",UWXSAYUXVSFDBQ-CYBMUJFWSA-N,C22H19ClN6O2S,466.9,"4-N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-N-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine","VARLITINIB|845272-21-1|ARRY-334543|ARRY-543|ASLAN-001|ASLAN001|varlitinibum|846Y8197W1|AR-00334543|DTXSID501025597|4-N-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-6-N-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine|AR00334543|4-N-(3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl)-6-N-((4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl)quinazoline-4,6-diamine|RefChem:901736|DTXCID301509860|N(SUP 4)-(3-CHLORO-4-(THIAZOL-2-YLMETHOXY)PHENYL)-N(SUP 6)-((4R)-4-METHYL-4,5-DIHYDROOXAZOL-2-YL)QUINAZOLINE-4,6-DIAMINE|N4-(3-chloro-4-((1,3-thiazol-2-yl)methoxy)phenyl)-N6-((4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl)quinazoline-4,6-diamine|ARRY 334543|ARRY334543|Varlitinib [USAN:INN]|UNII-846Y8197W1|(R)-N4-(3-chloro-4-(thiazol-2-ylmethoxy)phenyl)-N6-(4-methyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine|N(sup 4)-(3-Chloro-4-(thiazol-2-ylmethoxy)phenyl)-N(sup 6)-((4R)-4-methyl-4,5-dihydrooxazol-2- yl)quinazoline-4,6-diamine|(R)-N4-(3-chloro-4-(thiazol-2-ylmethoxy)phenyl)-N6-(4-methyl-4,5-dihydrooxazol-2-yl)quinazoline-4,6-diamine.|4,6-Quinazolinediamine, N(sup 4)-(3-chloro-4-(2-thiazolylmethoxy)phenyl)-N(sup 6)-((4R)-4,5- dihydro-4-methyl-2-oxazolyl)-|Varlitinib [USAN]|C22H19ClN6O2S|Varlitinib free base|MFCD20275099|VARLITINIB [INN]|Varlitinib (USAN/INN)|VARLITINIB [WHO-DD]|MLS006011274|GTPL7645|orb1685624|SCHEMBL1384578|CHEMBL2103842|SCHEMBL29353591|SCHEMBL30148099|CHEBI:231356|GLXC-15581|EX-A1005|VIB27221|BDBM50205268|NSC764823|NSC800962|s2755|AKOS027250815|CCG-269421|CS-5222|DB05944|NSC-764823|NSC-800962|SDCCGSBI-0654482.P001|NCGC00346724-01|NCGC00346724-02|AC-35277|HY-10530|MS-28612|SMR004703024|NS00071023|SW219901-1|D09689|BRD-K46386702-001-02-1|Q27089126|4,6-QUINAZOLINEDIAMINE, N(SUP 4)-(3-CHLORO-4-(2-THIAZOLYLMETHOXY)PHENYL)-N(SUP 6)-((4R)-4,5-DIHYDRO-4-METHYL-2-OXAZOLYL)-|4,6-QUINAZOLINEDIAMINE, N4-(3-CHLORO-4-(2-THIAZOLYLMETHOXY)PHENYL)-N6-((4R)-4,5-DIHYDRO-4-METHYL-2-OXAZOLYL)-|N(4)-[3-chloro-4-(1,3-thiazol-2-ylmethoxy)phenyl]-N(6)-[(4R)-4-methyl-4,5-dihydro-1,3-oxazol-2-yl]quinazoline-4,6-diamine|N4-(3-CHLORO-4-(1,3-THIAZOL-2-YLMETHOXY)PHENYL)-N6-((4R)-4-METHYL-4,5-DIHYDRO-1,3-OXAZOL-2-YL)QUINAZOLINE-4,6-DIAMINE|N4-[3-chloro-4-(thiazol-2-ylmethoxy)phenyl]-N6-[(4R)-4-methyl-4,5-dihydrooxazol-2-yl]quinazoline-4,6-diamine"
STRYCHNINE,441071,,"InChI=1S/C21H22N2O2/c24-18-10-16-19-13-9-17-21(6-7-22(17)11-12(13)5-8-25-16)14-3-1-2-4-15(14)23(18)20(19)21/h1-5,13,16-17,19-20H,6-11H2/t13-,16-,17-,19-,20-,21+/m0/s1",QMGVPVSNSZLJIA-FVWCLLPLSA-N,C21H22N2O2,334.4,"(4aR,5aS,8aR,13aS,15aS,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinolin-14-one","strychnine|57-24-9|Strychnidin-10-one|(-)-Strychnine|Sanaseed|Mole death|Strychninum|Gopher bait|Gopher-gitter|Boomer-rid|Hare-Rid|Certox|CHEBI:28973|RCRA waste number P108|Stricnina|Mouse-nots|H9Y79VD43J|Mouse-rid|Mouse-tox|Kwik-kil|DTXSID6023600|Dolco mouse cereal|Ro-Dex|NSC-5365|EPA Pesticide Chemical Code 076901|Pied piper mouse seed|DTXCID503600|(4br,7as,8ar,13S,13ar,13bs)-5,6,7a,8,8a,11,13a,13b-octahydro-13H-13,14-ethano-7,9-methanooxepino(3,4-a)pyrrolo(2,3-d)carbazol-15-one|Strynchnos|(4aR,5aS,8aR,13aS,15aS,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinolin-14-one|(1R,11S,18S,20R,21R,22S)-12-oxa-8,17-diazaheptacyclo(15.5.2.0^(1,18).0^(2,7).0^(8,22).0^(11,21).0^(15,20))tetracosa-2,4,6,14-tetraen-9-one|(1R,11S,18S,20R,21R,22S)-12-oxa-8,17-diazaheptacyclo[15.5.2.0^{1,18}.0^{2,7}.0^{8,22}.0^{11,21}.0^{15,20}]tetracosa-2,4,6,14-tetraen-9-one|(4aR,5aS,8aR,13aS,15aS,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo(3,2,1-ij)oxepino(2,3,4-de)pyrrolo(2,3-h)quinolin-14-one|(4bR,7aS,8aR,13S,13aR,13bS)-5,6,7a,8,8a,11,13a,13b-octahydro-13H-13,14-ethano-7,9-methanooxepino[3,4-a]pyrrolo[2,3-d]carbazol-15-one|Nitrate, Strychnine|NUX-VOMICA|RefChem:6264|(4aR,5aS,8aR,13aS,15aS,15bR)-4a,5,5a,7,8,13a,15,15a,15b,16-decahydro-2H-4,6-methanoindolo(3,2,1-ij)oxepino(2,3,4-de)pyrrolo(2,3-h)quinoline-14-one|12-oxa-8,17-diazaheptacyclo(15.5.2.01,18.02,7.08,22.011,21.015,20)tetracosa-2,4,6,14-tetraen-9-one|200-319-7|Strychnos|Strychnin|Estricnina|Strychinos|NSC 5365|MFCD00005941|[3H]strychnine|Strychnine [NF]|(11S,18S,22S,1R,20R,21R)-12-oxa-8,17-diazaheptacyclo[15.5.2.0<1,18>.0<2,7>.0<8 ,22>.0<11,21>.0<15,20>]tetracosa-2,4,6,14-tetraen-9-one|Strychnin [German]|Stricnina [Italian]|Caswell No. 805|Strychnine [BSI:ISO]|UNII-H9Y79VD43J|HSDB 2001|NCGC00163241-01|SY9|(-)-Strychnin|EINECS 200-319-7|UN1692|STRYCHNINE [MI]|STRYCHNINE [ISO]|STRYCHNINE [HSDB]|RCRA waste no. P108|STRYCHNINE [VANDF]|STRYCHNINUM [HPUS]|NCIStruc1_001823|NCIStruc2_000542|STRYCHNINE [WHO-DD]|SCHEMBL93798|GTPL347|orb105446|CHEMBL227934|GTPL2360|MEGxp0_001768|SCHEMBL14029424|HMS2089C04|Tox21_112038|BDBM50225707|PDSP2_000441|SBB006463|AKOS015955688|AC-8050|CAS-57-24-9|NCGC00142530-02|NCGC00186632-01|NCGC00186632-02|NCGC00489075-01|(4aR,4a1R,5aS,8aR,8a1S,15aS)-4a1,5,5a,7,8,8a1,15,15a-octahydro-2H-4,6-methanoindolo[3,2,1-ij]oxepino[2,3,4-de]pyrrolo[2,3-h]quinolin-14(4aH)-one|ST057252|NS00009135|S0249|Strychnine, PESTANAL(R), analytical standard|C06522|AB01275436-01|Q194406|Strychnine, European Pharmacopoeia (EP) Reference Standard"
VERINURAD,54767229,,"InChI=1S/C20H16N2O2S/c1-20(2,19(23)24)25-18-9-10-22-12-17(18)16-8-7-13(11-21)14-5-3-4-6-15(14)16/h3-10,12H,1-2H3,(H,23,24)",YYBOLPLTQDKXPM-UHFFFAOYSA-N,C20H16N2O2S,348.4,2-[3-(4-cyanonaphthalen-1-yl)pyridin-4-yl]sulfanyl-2-methylpropanoic acid,"Verinurad|1352792-74-5|RDEA3170|RDEA-3170|12WJ62D047|2-[3-(4-cyanonaphthalen-1-yl)pyridin-4-yl]sulfanyl-2-methylpropanoic acid|Propanoic acid, 2-((3-(4-cyano-1-naphthalenyl)-4-pyridinyl)thio)-2-methyl-|verinuradum|2-(3-(4-cyanonaphthalen-1-yl)pyridin-4-yl)sulfanyl-2-methylpropanoic acid|RefChem:901807|2-((3-(4-cyano-1-naphthyl)-4-pyridinyl)sulfanyl)-2-methylpropanoic acid|2-((3-(4-cyanonaphthalen-1-yl)pyridin-4-yl)sulfanyl)-2-methylpropanoic acid|Verinurad [INN]|2-((3-(4-cyanonaphthalen-1-yl)pyridin-4-yl)thio)-2-methylpropanoic acid|Verinurad (RDEA3170)|A1AIJ|Verinurad [USAN:INN]|Verinurad?|UNII-12WJ62D047|Verinurad (USAN/INN)|VERINURAD [USAN]|VERINURAD [WHO-DD]|GTPL9327|orb1303463|CHEMBL3707347|SCHEMBL12070797|SCHEMBL29362845|YYBOLPLTQDKXPM-UHFFFAOYSA-N|BDBM290431|GLXC-10672|BCP17058|EX-A1384|s8736|AKOS030526441|CCG-268013|CS-4681|DB11873|SB19753|AC-35441|BS-15247|DA-68567|HY-16733|CAS No.:1352792-74-5|NS00073591|US10100016, Verinurad (RDEA3170)|RDEA3170;RDEA-3170;RDEA 3170|C72401|D11129|BRD-K36741660-001-01-1|Q27251441|2-(3-(4-Cyanonaphthalen-1-yl)pyridin-4-ylthio)-2-methylpropanoic acid|2-[[3-(4-Cyano-1-naphthalenyl)-4-pyridinyl]thio]-2-methylpropanoic Acid|2-[[3-(4-cyano-1-naphthyl)-4-pyridyl]sulfanyl]-2-methyl-propanoic acid"
FGF401,118036971,,"InChI=1S/C25H30N8O4/c1-31-7-8-32(23(35)15-31)14-18-10-17-4-3-6-33(24(17)29-21(18)16-34)25(36)30-22-11-20(27-5-9-37-2)19(12-26)13-28-22/h10-11,13,16H,3-9,14-15H2,1-2H3,(H2,27,28,30,36)",BHKDKKZMPODMIQ-UHFFFAOYSA-N,C25H30N8O4,506.6,"N-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-formyl-6-[(4-methyl-2-oxopiperazin-1-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide","Roblitinib|1708971-55-4|FGF401|FGF-401|M64JF6WMSA|N-[5-cyano-4-(2-methoxyethylamino)pyridin-2-yl]-7-formyl-6-[(4-methyl-2-oxopiperazin-1-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide|roblitinibum|N-(5-cyano-4-(2-methoxyethylamino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide|RefChem:179727|FGFR4 Inhibitor FGF401|Roblitinib [INN]|N-(5-cyano-4-((2-methoxyethyl)amino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide|NVP-FGF401|N-[5-Cyano-4-[(2-methoxyethyl)amino]-2-pyridinyl]-7-formyl-3,4-dihydro-6-[(4-methyl-2-oxo-1-piperazinyl)methyl]-1,8-naphthyridine-1(2H)-carboxamide|C25H30N8O4|Roblitinib (FGF401)|Roblitinib; FGF-401|UNII-M64JF6WMSA|FGF401( Roblitinib)?|ROBLITINIB [WHO-DD]|NVP-FGF-401|GTPL9768|orb1303035|CHEMBL3908979|FGF 401 [WHO-DD]|SCHEMBL16668840|SCHEMBL29356752|FGF 401|BHKDKKZMPODMIQ-UHFFFAOYSA-N|BDBM209325|GLXC-10719|BCP25143|EX-A1341|Example 83 [US9266883]|NSC804962|s8548|FGF-401; FGF 401; Roblitinib|AKOS032946374|CCG-269749|CS-6853|NSC-804962|AC-29896|BF179498|BS-16207|DB-209692|HY-101568|US9266883, 83|Q29213614|N-(5-Cyano-4-(2-methoxyethylamino)pyridin-2-yl)-7-formyl-6-((4-methyl-2-oxopiperazin-1-yl)methyl)-3,4-dihydro-1,8-naphthyridine-1(2H)-carboxamide|N-[5-cyano-4-(2-methoxyethylamino)-2-pyridyl]-7-formyl-6-[(4-methyl-2-oxo-piperazin-1-yl)methyl]-3,4-dihydro-2H-1,8-naphthyridine-1-carboxamide"
KETOROLAC,3826,,"InChI=1S/C15H13NO3/c17-14(10-4-2-1-3-5-10)13-7-6-12-11(15(18)19)8-9-16(12)13/h1-7,11H,8-9H2,(H,18,19)",OZWKMVRBQXNZKK-UHFFFAOYSA-N,C15H13NO3,255.27,"5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid","ketorolac|74103-06-3|Ketorolaco|Ketorolacum|(+-)-Ketorolac|rac-ketorolac|YZI5105V0L|(+-)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|DTXSID8023189|CHEBI:6129|1H-Pyrrolizine-1-carboxylic acid, 2,3-dihydro-5-benzoyl-, (+-)-|5-(benzoyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro|RefChem:55433|DTXCID503189|M01AB15|S01BC05|5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|Ketorolacum [Latin]|Ketorolaco [Spanish]|66635-83-4|Ketoralac|MFCD00864281|RS 37619|Ketorolac (INN)|Toradol (TN)|CHEBI:76223|(1RS)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|RS37619|KETOROLAC [INN]|Macril|5-(phenylcarbonyl)-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|Ketorolac [INN:BAN]|RS-37619|NCGC00185990-01|UNII-YZI5105V0L|Toraldar|1H-Pyrrolizine-1-carboxylic acid, 5-benzoyl-2,3-dihydro-|Ketorolac (NSAID)|Ketorolac (Standard)|KETOROLAC [MI]|KETOROLAC [VANDF]|CHEMBL469|KETOROLAC [WHO-DD]|SCHEMBL14891|MLS006011844|GTPL6661|orb1306372|BDBM85511|HY-B0580R|MSK8003|HMS3604J05|HMS3884M04|HMS5079H06|HY-B0580|QYB76766|RYB45153|AC-545|s1646|STL018674|AKOS005657203|AC-1121|CCG-204762|DB00465|FK35139|IB58062|KS-5175|SDCCGSBI-0050655.P004|NCGC00185990-02|NCGC00185990-05|NCGC00185990-15|SMR001550090|SY107530|SBI-0050655.P003|CAS_74103-07-4|DB-011403|AB00053682|NS00009482|C07062|D08104|EN300-170843|F16555|AB00053682-12|AB00053682-14|AB00053682_15|AB00053682_16|635K834|F242512|Q2014797|BRD-A40639672-001-01-9|BRD-A40639672-234-05-7|BRD-A40639672-234-09-9|BRD-A40639672-234-17-2|BRD-A40639672-234-18-0|5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylicacid|KETOROLAC, ketorolactromethamine, Ketorolac Tromethamine|Z2429420872|5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid #|rac-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|(+/-)-5-benzoyl-2,3-dihydro-1h-pyrrolizine-1-carboxylic acid|(.+/-.)-2,3-Dihydro-5-benzoyl-1H-pyrrolizine-1-carboxylic acid|(.+/-.)-5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid|5-benzoyl-1,2-dihydro-3H-pyrrolo[1,2-a]pyrrole-1-carboxylic acid|5-Benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid - Racemic|1H-Pyrrolizine-1-carboxylic acid, 2,3-dihydro-5-benzoyl-, (.+/-.)-|1H-PYRROLIZINE-1-CARBOXYLIC ACID, 5-BENZOYL-2,3-DIHYDRO, (+/-)-|5-BENZOYL-2,3-DIHYDRO-1H-PYRROLO[1,2-A]PYRROLE-1-CARBOXYLIC ACID"
BAMBUTEROL,54766,,"InChI=1S/C18H29N3O5/c1-18(2,3)19-11-15(22)12-8-13(25-16(23)20(4)5)10-14(9-12)26-17(24)21(6)7/h8-10,15,19,22H,11H2,1-7H3",ANZXOIAKUNOVQU-UHFFFAOYSA-N,C18H29N3O5,367.4,"[3-[2-(tert-butylamino)-1-hydroxyethyl]-5-(dimethylcarbamoyloxy)phenyl] N,N-dimethylcarbamate","Bambuterol|81732-65-2|Bambuterolum|CHEBI:553827|Y1850G1OVC|[3-[2-(tert-butylamino)-1-hydroxyethyl]-5-(dimethylcarbamoyloxy)phenyl] N,N-dimethylcarbamate|(+-)-5-(2-(tert-Butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)|DTXSID5048550|(3-(2-(tert-butylamino)-1-hydroxyethyl)-5-(dimethylcarbamoyloxy)phenyl) N,N-dimethylcarbamate|RefChem:116411|5-(2-(tert-butylamino)-1-hydroxyethyl)-3-phenylene bis(dimethylcarbamate)|DTXCID1028106|R03CC12|3-(2-(tert-butylamino)-1-hydroxyethyl)-5-((dimethylcarbamoyl)oxy)phenyl N,N-dimethylcarbamate|Bambuterol (INN)|Bambuterolum [Latin]|Oxeol|BAMBUTEROL [INN]|5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diyl bis(dimethylcarbamate)|(+/-)-Bambuterol;KWD-2183|(+/-)-5-(2-(tert-butylamino)-1-hydroxyethyl)-m-phenylene bis(dimethylcarbamate)|terbutaline bisdimethylcarbamate|Bambuterol [INN:BAN]|UNII-Y1850G1OVC|terbutaline bis(dimethylcarbamate)|BAMBUTEROL [MI]|Prestwick0_000361|Prestwick1_000361|Prestwick2_000361|Prestwick3_000361|SCHEMBL4431|BAMBUTEROL [WHO-DD]|BSPBio_000481|MLS002153785|()-Bambuterol;KWD-2183|SPBio_002402|BPBio1_000531|CHEMBL521589|GTPL6601|orb1704664|GLXC-25236|HMS2089J18|HMS2230O15|HMS3373N13|BCP21793|BDBM50235800|STK643808|AKOS005574764|CS-3157|DB01408|( inverted exclamation markA)-Bambutero|NCGC00179546-01|NCGC00179546-02|AC-35438|HY-17501|SMR001233168|SBI-0207028.P001|NS00003068|D07377|H20704|732B652|A840189|L004435|Q3633651|SR-05000001470-1|BRD-A17462676-003-03-3|BRD-A17462676-003-06-6|BRD-A17462676-003-11-6|(RS)-5-[2-(tert-butylamino)-1-hydroxyethyl]benzene-1,3-diyl bis(dimethylcarbamate)|[3-[2-(tert-butylamino)-1-oxidanyl-ethyl]-5-(dimethylcarbamoyloxy)phenyl] N,N-dimethylcarbamate|N,N-dimethylcarbamic acid [3-[2-(tert-butylamino)-1-hydroxyethyl]-5-[dimethylamino(oxo)methoxy]phenyl] ester"
LXH254,90456533,,"InChI=1S/C25H25F3N4O4/c1-16-2-3-19(30-24(34)17-4-5-29-21(12-17)25(26,27)28)15-20(16)18-13-22(32-6-9-35-10-7-32)31-23(14-18)36-11-8-33/h2-5,12-15,33H,6-11H2,1H3,(H,30,34)",UEPXBTCUIIGYCY-UHFFFAOYSA-N,C25H25F3N4O4,502.5,N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide,"LXH254|1800398-38-2|Naporafenib|LXH-254|Pan-raf inhibitor LXH254|15JL80DG6H|LXH 254|ERAS-254|N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide|N-(3-(2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)pyridine-4-carboxamide|RefChem:164782|pan-RAF Kinase Inhibitor LXH254|Raf Family Kinase Inhibitor LXH254|N-(3-(2-(2-hydroxyethoxy)-6-morpholinopyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)isonicotinamide|LXH254 free base|Naporafenib [INN]|1800398-38-2 (free base)|N-{3-[2-(2-hydroxyethoxy)-6-(morpholin-4-yl)pyridin-4-yl]-4-methylphenyl}-2-(trifluoromethyl)pyridine-4-carboxamide|K81|MFCD31657408|Naporafenib (USAN/INN)|NAPORAFENIB [USAN]|NVP-LXH254|UNII-15JL80DG6H|NAPORAFENIB [WHO-DD]|orb1309463|CHEMBL4583691|LXH 254 [WHO-DD]|SCHEMBL16094629|SCHEMBL29388317|SCHEMBL29411709|SCHEMBL30241122|BDBM88120|GTPL10658|LXH254?|C25H25F3N4O4|GLXC-20142|BCP29080|EX-A1846|NSC807047|s8745|AKOS037648965|AT23218|NSC-807047|compound 15 [PMID: 31059256]|AC-36207|BL166445|BS-16133|DA-75171|SY340309|HY-112089|CS-0043317|example 1156 [WO2014151616A1]|D12831|US9694016, 1156|4-Pyridinecarboxamide, N-(3-(2-(2-hydroxyethoxy)-6-(4-morpholinyl)-4-pyridinyl)-4-methylphenyl)-2-(trifluoromethyl)-)-|4-Pyridinecarboxamide, N-[3-[2-(2-hydroxyethoxy)-6-(4-morpholinyl)-4-pyridinyl]-4-methylphenyl]-2-(trifluoromethyl)-|N-(3-(2-(Hydroxyethoxy)-6-(morpholin-4-yl) pyridin-4-yl)-4-methylphenyl)-2-(trifluoromethyl)pyridine-4-carboxamide|N-[3-[2-(2-hydroxyethoxy)-6-morpholino-4-pyridyl]-4-methyl-phenyl]-2-(trifluoromethyl)pyridine-4-carboxamide|N-[3-[2-(2-Hydroxyethoxy)-6-morpholino-4-pyridyl]-4-methylphenyl]-2-(trifluoromethyl)isonicotinamide|N-{3-[2-(2-hydroxethoxy)-6-(morpholin-4-yl)pyridin-4-yl]-4-methylphenyl}-2-(trifluoromethyl)pyridine-4-carboxamide"
INT131,10229498,,"InChI=1S/C21H12Cl4N2O3S/c22-13-5-6-20(16(23)8-13)31(28,29)27-14-9-17(24)21(18(25)10-14)30-15-7-12-3-1-2-4-19(12)26-11-15/h1-11,27H",NMRWDFUZLLQSBN-UHFFFAOYSA-N,C21H12Cl4N2O3S,514.2,"2,4-dichloro-N-(3,5-dichloro-4-quinolin-3-yloxyphenyl)benzenesulfonamide","315224-26-1|AMG-131|Ibrigampar|Benzenesulfonamide, 2,4-dichloro-N-(3,5-dichloro-4-(3-quinolinyloxy)phenyl)-|AMG 131|E7ILQ6U50J|IBRIGAMPAR [INN]|2,4-dichloro-N-(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzene-1-sulfonamide|2,4-dichloro-N-[3,5-dichloro-4-(quinolin-3-yloxy)phenyl]benzene-1-sulfonamide|RefChem:556945|2,4-DICHLORO-N-(3,5-DICHLORO-4-((QUINOLIN-3-YL)OXY)PHENYL)BENZENE-1-SULFONAMIDE|INT-131|AMG131|INT131|INT 131|2,4-Dichloro-N-(3,5-dichloro-4-(quinolin-3-yloxy)phenyl)benzenesulfonamide|2,4-dichloro-N-[3,5-dichloro-4-(quinolin-3-yloxy)phenyl]benzenesulfonamide|C21H12Cl4N2O3S|CHEMBL1236924|CHS-131|T0903131|MFCD13152369|T-0903131|2,4-dichloro-N-(3,5-dichloro-4-quinolin-3-yloxyphenyl)benzenesulfonamide|UNII-E7ILQ6U50J|3fur|SCHEMBL634767|orb1298637|SCHEMBL29404335|SCHEMBL30035369|GLXC-07235|QMA22426|BDBM50428854|AKOS027321340|DB05490|SB16867|NCGC00386680-01|MS-29544|DB-302388|HY-117103|CS-0063725|T-131|D86936|Q27276976|2,4-dichloro-N-[3,5-dichloro-4-(3-quinolyloxy)phenyl]benzenesulfonamide|N-(3,5-dichloro-4-quinolin-3-yloxyphenyl)-2,4-dihydroxybenzenesulfonamide|2,4-DICHLORO-N-(3,5-DICHLORO-4-((QUINOLIN-3- YL)OXY)PHENYL)BENZENE-1-SULFONAMIDE"
GSK-461364,15983966,,"InChI=1S/C27H28F3N5O2S/c1-17(19-5-3-4-6-20(19)27(28,29)30)37-23-14-24(38-25(23)26(31)36)35-16-32-21-8-7-18(13-22(21)35)15-34-11-9-33(2)10-12-34/h3-8,13-14,16-17H,9-12,15H2,1-2H3,(H2,31,36)/t17-/m1/s1",ZHJGWYRLJUCMRT-QGZVFWFLSA-N,C27H28F3N5O2S,543.6,5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide,"GSK461364|929095-18-1|GSK-461364|GSK 461364|(R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide|GSK-461364A|5-[6-[(4-Methyl-1-piperazinyl)methyl]-1h-benzimidazol-1-yl]-3-[(1r)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-thiophenecarboxamide|8QO27TK6Q4|UNII-8QO27TK6Q4|MFCD12755419|2-Thiophenecarboxamide, 5-(6-((4-methyl-1-piperazinyl)methyl)-1H-benzimidazol-1-yl)-3-((1R)-1-(2-(trifluoromethyl)phenyl)ethoxy)-|5-(6-((4-Methylpiperazin-1-yl)methyl)-1H-benzimidazol-1-yl)-3-(((1R)-1-(2-(trifluoromethyl)phenyl)ethyl)oxy)thiophene-2-carboxamide|CHEMBL1908394|GSK41364A|DTXSID60239197|5-[6-[(4-methylpiperazin-1-yl)methyl]benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide|GSK 461364; GSK 461364A;|C27H28F3N5O2S|2-THIOPHENECARBOXAMIDE, 5-[6-[(4-METHYL-1-PIPERAZINYL)METHYL]-1H-BENZIMIDAZOL-1-YL]-3-[(1R)-1-[2-(TRIFLUOROMETHYL)PHENYL]ETHOXY]-|5-(6-((4-Methyl-1-piperazinyl)methyl)-1H-benzimidazol-1-yl)-3-((1R)-1-(2-(trifluoromethyl)phenyl)ethoxy)-2-thiophenecarboxamide|RefChem:1072482|SCHEMBL310080|GTPL5684|orb1300905|SCHEMBL29360650|SCHEMBL29655945|CHEBI:91333|DTXCID80161688|GLXC-10075|GLXC-20866|BCP01720|EX-A1728|BDBM50355500|GSK461354|NSC754354|NSC800111|s2193|GSK 461364 [WHO-DD]|AKOS015904545|BCP9000744|CCG-264940|CS-0069|FM43315|NSC-754354|NSC-800111|SDCCGSBI-0654396.P001|NCGC00263112-01|NCGC00263112-06|AC-23167|AS-56069|HY-50877|SW220052-1|GSK461364A, >=98% (HPLC)|BRD-K92428232-001-01-5|BRD-K92428232-001-10-6|Q27077906|5-{6-[(4-methylpiperazin-1-yl)methyl]-1H-1,3-benzodiazol-1-yl}-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide|5-{6-[(4-Methylpiperazin-1-yl)methyl]-1H-benzimidazol-1-yl}-3-{(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy}thiophene-2-carboxamide"
VERAPAMIL HYDROCHLORIDE,62969,,"InChI=1S/C27H38N2O4.ClH/c1-20(2)27(19-28,22-10-12-24(31-5)26(18-22)33-7)14-8-15-29(3)16-13-21-9-11-23(30-4)25(17-21)32-6;/h9-12,17-18,20H,8,13-16H2,1-7H3;1H",DOQPXTMNIUCOSY-UHFFFAOYSA-N,C27H39ClN2O4,491.1,"2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride","Verapamil hydrochloride|152-11-4|Verapamil HCl|Verelan|Covera|Isoptin SR|Calan SR|NSC-272366|NSC-657799|V3888OEY5R|DTXSID2034095|Verapamili hydrochloridum|NSC657799|LU-20175|(+-)-Verapamil hydrochloride|DTXCID0014095|NSC272366|Securon mid|Manidon sr|Ranvera mr|Securon iv|Securon sr|Half securon sr|Vera-til sr|Cordilox i.v.|Cordilox mr 240|Ethimil mr 240|Verapress mr 240|Vertab sr 240|VERAPAMIL HCI|RefChem:56207|CHEBI:53188|(2RS)-5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-(1-methylethyl)pentanenitrile monohydrochloride|205-800-5|Verelan PM|(+/-)-VERAPAMIL HYDROCHLORIDE|23313-68-0|Calcan hydrochloride|Cordilox|Isoptin|Calan|Verapamil (hydrochloride)|Berkatens|Geangin|Izoptin|Veratensin|Univer|Verapamyl hydrochloride|MFCD00055208|Covera-HS|C27H39ClN2O4|verapamil.hcl|MLS000069485|5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrile hydrochloride|5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxy phenyl)-2-isopropylvaleronitrile hydrochloride|2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile hydrochloride|SMR000059109|( inverted exclamation markA)-Verapamil hydrochlorid|Verapamil chloridrate|D-365 hydrochloride|Iproveratril hydrochloride|2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl]methylamino}-2-(methy lethyl)pentanenitrile, chloride|5-[N-(3,4-Dimethoxyphenylethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile hydrochloride|SR-01000000050|EINECS 205-800-5|NSC 272366|UNII-V3888OEY5R|LU 20175|Prestwick_440|Vasolan (TN)|Verelan (TN)|Covera-hs (TN)|Calan (TN)|Isotopin hydrochloride|Verapamil hydrochloride [USAN:USP:JAN]|Verapamil Impurity 22|Opera_ID_1210|CAS-152-11-4|(?-Verapamil hydrochloride|(y)-Verapamil hydrochloride|(?)-Verapamil hydrochloride|CHEMBL1280|SCHEMBL33296|5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride|Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride|MLS001055442|MLS002222213|SPECTRUM2300307|orb1310060|ARD10701A|HY-A0064R|MSK10701A|HMS1568M04|HMS1922J16|HMS5082J10|Pharmakon1600-02300307|Verapamil HCl - Bio-X trade mark|(+/-)-Verapamil hydrochloride D7|BCP06465|HY-A0064|Tox21_201180|Tox21_501237|VERAPAMIL HYDROCHLORIDE [MI]|CCG-39491|HB1237|NSC759589|s4202|Verapamil (hydrochloride) (Standard)|Verapamil hydrochloride (JP18/USP)|VERAPAMIL HYDROCHLORIDE [JAN]|VERAPAMIL HYDROCHLORIDE [HSDB]|VERAPAMIL HYDROCHLORIDE [USAN]|AKOS005267117|AC-8483|CS-1685|FV28686|LP01237|NSC-759589|VERAPAMIL HYDROCHLORIDE [MART.]|VERAPAMIL HYDROCHLORIDE [VANDF]|VERAPAMIL HYDROCHLORIDE [USP-RS]|VERAPAMIL HYDROCHLORIDE [WHO-DD]|VERAPAMIL HYDROCHLORIDE [WHO-IP]|NCGC00024710-03|NCGC00094479-01|NCGC00094479-02|NCGC00094479-03|NCGC00094479-04|NCGC00094479-05|NCGC00258732-01|NCGC00261922-01|(+-)-5-((3,4-Dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride|2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile hydrochloride|2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-ylpentanenitrile;hydrochloride|AC-16228|AS-16018|Benzeneacetonitrile, alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4-dimethoxy-alpha-(1-methylethyl)-, monohydrochloride, (+-)-|BV164516|ST066908|SY073165|Valeronitrile, 5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropyl-, monohydrochloride|EU-0101237|NS00079093|SW196662-4|V0118|VERAPAMIL HYDROCHLORIDE [EP IMPURITY]|VERAPAMIL HYDROCHLORIDE [ORANGE BOOK]|TARKA COMPONENT VERAPAMIL HYDROCHLORIDE|VERAPAMIL HYDROCHLORIDE [EP MONOGRAPH]|D00619|D78147|D88195|EN300-124002|V 4629|VERAPAMIL HYDROCHLORIDE [USP MONOGRAPH]|( inverted question mark)-Verapamil hydrochloride|VERAPAMILI HYDROCHLORIDUM [WHO-IP LATIN]|152V114|A816666|F047206|Verapamil.HCl, 1mg/ml in Methanol (as free base)|SR-01000000050-2|SR-01000000050-4|(+/-)-Verapamil, Hydrochloride - CAS 152-11-4|Q27291481|SR-01000000050-11|Z1557407143|(+/-)-Verapamil hydrochloride, >=99% (titration), powder|Verapamil Hydrochloride 1.0 mg/ml in Methanol (as free base)|Verapamil hydrochloride, European Pharmacopoeia (EP) Reference Standard|Verapamil hydrochloride, United States Pharmacopeia (USP) Reference Standard|(+/-)-5-((3,4-dimethoxyphenethyl)methylamino)-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile monohydrochloride|(+/-)-Verapamil hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material|?-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-?-(1-methylethyl)-benzeneacetonitrile hydrochloride;Berkatens;  Calan|2-(3,4-Dimethoxyphenyl)-5-[[2-(3,4-dimethoxyphenyl)-ethyl](methyl)amino]-2-isopropylpentanenitrile hydrochloride|2-(3,4-dimethoxyphenyl)-5-[2-(3,4-dimethoxyphenyl)ethyl-methyl-amino]-2-propan-2-yl-pentanenitrile hydrochloride|2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-isopropylpentanenitrile hydrochloride|5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-(3,4-dimethoxyphenyl)-2-isopropylpentanenitrilehydrochloride|5-[(3,4-Dimethoxyphenethyl)methylamino]-2-(3,4-dimethoxyphenyl)-2-isopropylvaleronitrile Hydrochloride|alpha-[3-[[2-(3,4-Dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-alpha-(1-methylethyl)benzeneacetonitrile hydrochloride (1:1)|BENZENEACETONITRILE, .ALPHA.-(3-((2-(3,4-DIMETHOXYPHENYL)ETHYL)METHYLAMINO)PROPYL)-3,4-DIMETHOXY-.ALPHA.-(1-METHYLETHYL)-, MONOHYDROCHLORIDE, (+/-)-|Benzeneacetonitrile,4-dimethoxyphenyl)ethyl]methylamino]propyl]-3,4-dimethoxy-.alpha.-(1-methylethyl)-, monohydrochloride"
ANTHRALIN,2202,,"InChI=1S/C14H10O3/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-6,15-16H,7H2",NUZWLKWWNNJHPT-UHFFFAOYSA-N,C14H10O3,226.23,"1,8-dihydroxy-10H-anthracen-9-one","anthralin|Dithranol|1143-38-0|9(10H)-Anthracenone, 1,8-dihydroxy-|Chrysodermol|Cigthranol|Cignolin|1,8-Dihydroxy-9-anthrone|Batridol|Psoriacid-Stift|Anthra-Derm|Drithoscalp|Derobin|DrithoCreme|Lasan|Batidrol|Psodadrate|Psoriacide|Anthrone, 1,8-dihydroxy-|Dithranolum|Anthraderm|Dermaline|Zithranol-RR|1,8-DIHYDROXY-9(10H)-ANTHRACENONE|Ditranol|NSC 629313|CHEBI:37510|U8CJK0JH5M|Anthralin (USP)|Anthralin [USP]|NSC-43970|NSC-629313|DTXSID7024538|NSC629313|DTXCID504538|NSC43970|Antraderm|Alphodith|Zithranol|Dithrocream fte|Dithrocream hp|Psorin fte|Stie-lasan|Dihydroxyanthranol|FNA, Ditranol|RefChem:57714|1,8 Dihydroxy 9 anthrone|D05AC01|214-538-0|CHEBI:2756|Dioxyanthranol|1,8-Dihydroxyanthrone|1,8-Dihydroxyanthracen-9(10H)-one|1,8-dihydroxy-10H-anthracen-9-one|Anthraline|Dithranol [INN]|MFCD00053409|NSC 43970|CHEMBL46469|Dithranol (INN)|NCGC00091330-01|1,8-dihydroxy-9,10-dihydroanthracen-9-one|1,8-Dihydroxy-9(10H)-anthracenone;Anthralin|Dithranolum [INN-Latin]|CCRIS 628|CAS-1143-38-0|Anthralin (Dithranol)|SR-05000002011|EINECS 214-538-0|UNII-U8CJK0JH5M|BRN 2054360|CCRIS 5592|Prestwick_528|Anthralin, Dithranol|Dithranol (Standard)|NSC 403736|BRN 1976792|Anthrone,8-dihydroxy-|Spectrum_000056|ANTHRADERM (TN)|ANTHRALIN [MI]|DITHRANOL [IARC]|Spectrum2_000111|Spectrum3_000304|Spectrum4_000151|Spectrum5_000820|ANTHRALIN [VANDF]|DITHRANOL [MART.]|Epitope ID:114081|1,8-dihydroxy-9-anthrane|ANTHRALIN [USP-RS]|cid_2202|DITHRANOL [WHO-DD]|DITHRANOL [WHO-IP]|SCHEMBL3197|BSPBio_001868|KBioGR_000622|KBioSS_000436|4-06-00-07602 (Beilstein Handbook Reference)|MLS001332632|MLS002415712|DivK1c_000021|SPECTRUM1500127|SPBio_000122|orb1309875|DITHRANOL [EP IMPURITY]|DITHRANOL [EP MONOGRAPH]|Dithranol, >=90% (HPLC)|SCHEMBL29439039|SCHEMBL30013383|HMS500B03|HY-B0738R|KBio1_000021|KBio2_000436|KBio2_003004|KBio2_005572|KBio3_001368|NUZWLKWWNNJHPT-UHFFFAOYSA-|ANTHRALIN [USP MONOGRAPH]|1,8-Dihydroxyanthrone; Dithranol|NINDS_000021|HMS1920E07|HMS2091K07|HMS2271B09|HMS3715H19|HMS5083H17|Pharmakon1600-01500127|HY-B0738|9(10H)-Anthracenone,8-dihydroxy-|Tox21_111115|Tox21_201851|Tox21_300290|BDBM50041802|CCG-38920|NSC755873|s4590|1,8-dihydroxy-9-(10H)anthracenone|AKOS015914122|Tox21_111115_1|DB11157|FA17945|KS-5183|NSC-755873|1,8-dihydroxy-10-hydroanthracen-9-one|IDI1_000021|1,8-Dihydroxy-9(10H)-anthracenone #|NCGC00091330-02|NCGC00091330-03|NCGC00091330-04|NCGC00091330-05|NCGC00091330-07|NCGC00253941-01|NCGC00259400-01|AC-14842|NCI60_004019|SBI-0051286.P003|DB-060606|NS00005038|ST50825759|C06831|D00233|D97650|SBI-0051286.0001|AB00051916_07|EN300-18537628|Q419397|SR-05000002011-1|SR-05000002011-2|BRD-K04725460-001-10-5|BRD-K04725460-001-11-3|Dithranol, European Pharmacopoeia (EP) Reference Standard|Anthralin, United States Pharmacopeia (USP) Reference Standard|Anthralin (Dithranol), Pharmaceutical Secondary Standard; Certified Reference Material|InChI=1/C14H10O3/c15-10-5-1-3-8-7-9-4-2-6-11(16)13(9)14(17)12(8)10/h1-6,15-16H,7H2"
TOMIVOSERTIB,118598754,,"InChI=1S/C17H20N6O2/c1-10-7-11(21-13-8-12(18)19-9-20-13)16(25)23-14(10)15(24)22-17(23)5-3-2-4-6-17/h7-9H,2-6H2,1H3,(H,22,24)(H3,18,19,20,21)",HKTBYUWLRDZAJK-UHFFFAOYSA-N,C17H20N6O2,340.4,"6-[(6-aminopyrimidin-4-yl)amino]-8-methylspiro[2H-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione","Tomivosertib|eFT508|1849590-01-7|EFT-508|U2H19X4WBV|6-[(6-aminopyrimidin-4-yl)amino]-8-methylspiro[2H-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione|DTXSID601022534|Spiro(cyclohexane-1,3'(2'H)-imidazo(1,5-a)pyridine)-1',5'-dione, 6'-((6-amino-4-pyrimidinyl)amino)-8'-methyl-|6'-[(6-aminopyrimidin-4-yl)amino]-8'-methyl-2',5'-dihydro-1'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione|tomivosertibum|6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2',5'-dihydro-1'H-spiro(cyclohexane-1,3'-imidazo(1,5-a)pyridine)-1',5'-dione|6-((6-aminopyrimidin-4-yl)amino)-8-methylspiro(2H-imidazo(1,5-a)pyridine-3,1'-cyclohexane)-1,5-dione|RefChem:933186|DTXCID801507219|6'-((6-Amino-4-pyrimidinyl)amino)-8'-methyl-2'H-spiro(cyclohexane-1,3'-imidazo(1,5-a)pyridine)-1',5'-dione|Tomivosertib [INN]|Tomivosertib [USAN]|EFT 508|eFT508; Tomivosertib|6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-1'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'(2'H)-dione|CHEMBL4073443|6'-[(6-aminopyrimidin-4-yl)amino]-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione|eFT508 HCl|SCHEMBL17362622|6'-((6-aminopyrimidin-4-yl)amino)-8'-methyl-2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione|6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione|eFT508(Tomivosertib)?|Tomivosertib (USAN/INN)|Tomivosertib [USAN:INN]|eFT-508 HCl|UNII-U2H19X4WBV|Tomivosertib (eFT-508)|TOMIVOSERTIB [WHO-DD]|orb1304174|SCHEMBL29359358|GTPL10167|eFT-508 (eFT508)|GLXC-10728|BCP18993|EX-A2494|BDBM50263263|NSC791783|NSC791784|NSC804952|AKOS030627405|CCG-267922|CS-5841|DB15219|NSC-791783|NSC-791784|NSC-804952|compound 23 [PMID: 29526098]|NCGC00492296-03|AC-35882|BE168437|BS-16162|DA-63118|HY-100022|S8275|D11452|D71143|Z2740419312|6'-((6-AMINOPYRIMIDIN-4-YL)AMINO)-8'-METHYL-2'HSPIRO(CYCLOHEXANE-1,3'-IMIDAZO(1,5-A)PYRIDINE)-1',5'-DIONE|6'-[(6-Amino-4-pyrimidinyl)amino]-8'-methylspiro[cyclohexane-1,3'(2'H)-imidazo[1,5-a]pyridine]-1',5'-dione;Tomivosertib;eFT508|6-[(6-aminopyrimidin-4-yl)amino]-8-methyl-spiro[2H-imidazo[1,5-a]pyridine-3,1'-cyclohexane]-1,5-dione|N45"
RADIPRODIL,10200813,,"InChI=1S/C21H20FN3O4/c22-15-3-1-13(2-4-15)11-14-7-9-25(10-8-14)20(27)19(26)23-16-5-6-17-18(12-16)29-21(28)24-17/h1-6,12,14H,7-11H2,(H,23,26)(H,24,28)",GKGRZLGAQZPEHO-UHFFFAOYSA-N,C21H20FN3O4,397.4,"2-[4-[(4-fluorophenyl)methyl]piperidin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide","Radiprodil|496054-87-6|RGH-896|5XGC17ZKUF|2-(4-((4-Fluorophenyl)methyl)piperidin-1-yl)-2-oxo-N-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)acetamide|radiprodilum|1-PIPERIDINEACETAMIDE, N-(2,3-DIHYDRO-2-OXO-6-BENZOXAZOLYL)-4-((4-FLUOROPHENYL)METHYL)-ALPHA-OXO-|1-Piperidineacetamide, N-(2,3-dihydro-2-oxo-6-benzoxazolyl)-4-[(4-fluorophenyl)methyl]-alpha-oxo-|2-{4-[(4-fluorophenyl)methyl]piperidin-1-yl}-2-oxo-N-(2-oxo-2,3-dihydro-1,3-benzoxazol-6-yl)acetamide|RefChem:178549|Radiprodil [INN]|2-(4-(4-Fluorobenzyl)piperidin-1-yl)-2-oxo-N-(2-oxo-2,3-dihydrobenzo[d]oxazol-6-yl)acetamide|Radiprodil (RGH-896)|CHEMBL182066|2-[4-(4-Fluoro-benzyl)-piperidin-1-yl]-2-oxo-N-(2-oxo-2,3-dihydro-benzooxazol-6-yl)-acetamide|UNII-5XGC17ZKUF|Radiprodil?|2-[4-[(4-fluorophenyl)methyl]piperidin-1-yl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide|RADIPRODIL [WHO-DD]|SCHEMBL99256|orb1301835|SCHEMBL29376763|SCHEMBL29819486|DTXSID80964297|RGH 896|GKGRZLGAQZPEHO-UHFFFAOYSA-N|BCP30852|BDBM50149684|s6644|AKOS030257575|DB12260|NCGC00386549-01|AC-38128|BS-16896|DA-77335|HY-14777|CS-0003554|NS00071811|RGH-896; RGH896; RGH 896|N16882|Q27263011|2-[4-(4-Fluorobenzyl)piperidin-1-yl]-2-oxo-N-(2-oxo-2,3-dihydrobenzoxazol-6-yl)acetamide|2-[4-(4-Fluoro-benzyl)-piperidin-1-yl]-2-oxo-N-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide|2-[4-(4-Fluorobenzyl)-piperidin-1-yl]-2-oxo-N-(2-oxo-2,3-dihydro-benzoxazol-6-yl)-acetamide|2-[4-[(4-fluorophenyl)methyl]-1-piperidyl]-2-oxo-N-(2-oxo-3H-1,3-benzoxazol-6-yl)acetamide|2-{4-[(4-Fluorophenyl)methyl]piperidin-1-yl}-N-(2-hydroxy-1,3-benzoxazol-6-yl)-2-oxoacetamide|N-(2,3-Dihydro-2-oxo-6-benzoxazolyl)-4-[(4-fluorophenyl)methyl]-alpha-oxo-1-piperidineacetamide"
COLCHICINE,6167,,"InChI=1S/C22H25NO6/c1-12(24)23-16-8-6-13-10-19(27-3)21(28-4)22(29-5)20(13)14-7-9-18(26-2)17(25)11-15(14)16/h7,9-11,16H,6,8H2,1-5H3,(H,23,24)/t16-/m0/s1",IAKHMKGGTNLKSZ-INIZCTEOSA-N,C22H25NO6,399.4,"N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide","colchicine|64-86-8|Colchisol|Colchicinum|Colchicina|Colchineos|Colcrys|(-)-colchicine|Mitigare|7-alpha-H-Colchicine|NSC 757|LODOCO|Colchcine|NSC757|N-Acetyl trimethylcolchicinic acid methylether|DTXSID5024845|NSC-757|N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[a]heptalen-7-yl]acetamide|SML2Y3J35T|GLOPERBA|MYINFLA|(S)-N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl)acetamide|CHEBI:27882|DTXCID204845|MITIGARE COMPONENT COLCHICINE|Benzo(a)heptalen-9(5H)-one, 7-acetamido-6,7-dihydro-1,2,3,10-tetramethoxy-|Acetamide, N-(5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-, (S)-|Acetamide, N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)-|Acetamide, N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]-|(S)-N-(5,6,7,9-TETRAHYDRO-1,2,3,10-TETRAMETHOXY-9-OXOBENZO(A)HEPTALEN-7-YL)ACETAMIDE|N-((7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo(a)heptalen-7-yl)acetamide|N-((7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo(d)heptalen-7-yl)acetamide|N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-6,7-dihydro-5H-benzo[d]heptalen-7-yl]acetamide|COLCHICUM|COLCIGEL|COLCHICINUM 4x|RefChem:5703|Colchicine Tablets 0.5 mg|200-598-5|N-(3,4,5,14-tetramethoxy-13-oxotricyclo(9.5.0.02,7)hexadeca-1(16),2(7),3,5,11,14-hexaen-10-yl)acetamide|Benzo(a)heptalene, acetamide deriv.|CHEBI:23359|Colchicin|Condylon|Colcin|Colsaloid|7alphaH-Colchicine|Kolkicin|Goutnil|(S)-colchicine|spindle poison|MFCD00078484|N-[(7S)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide|(S)-Colchicine >95%|CHEMBL107|Colchicine [JAN]|Colchicin [German]|NCGC00025125-07|Colchysat|Colchicina [Italian]|Colstat|Colchicine; Thiocolchicoside Impurity A|Colchicine (TN)|N-[(7s)-1,2,3,10-Tetramethoxy-9-Oxo-6,7-Dihydro-5h-Benzo[d]heptalen-7-Yl]ethanamide|30512-31-3|LOC|SMR000058323|CCRIS 691|7.alpha.H-Colchicine|HSDB 3044|Colchicine [USP:JAN]|SR-01000075794|SR-01000597576|Colchicine EP Impurity B|EINECS 200-598-5|UNII-SML2Y3J35T|AI3-31149|Colchicine conformational isomer|(S)-colchicina|4lzr|(S)-colchicin|Acetamide,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(.alpha.)heptalen-7-yl)-|Acetamide,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[.alpha.]heptalen-7-yl)-|MPC-004|N-((7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo(a)heptalen-7-yl)- acetamide|CAS-64-86-8|Prestwick_695|Colchicine (Standard)|Spectrum_000842|Tocris-1364|4o2b|COLCHICINE [MI]|Prestwick0_000363|Prestwick1_000363|Prestwick2_000363|Prestwick3_000363|Spectrum2_000075|Spectrum3_000362|Spectrum4_000298|Spectrum5_000787|COLCHCINE [VANDF]|COLCHICINE [HSDB]|COLCHICINUM [HPUS]|Colchicine (JP18/USP)|UPCMLD-DP065|C 9754|EC 200-598-5|COLCHICINE [MART.]|SCHEMBL8469|7JX9WZ3SJ5|COLCHICINE [USP-RS]|COLCHICINE [WHO-DD]|COLCHICINE [WHO-IP]|N-[(7S)-5,6,7,9-tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[a]heptalen-7-yl]acetamide|Lopac0_000310|BSPBio_000485|BSPBio_002083|KBioGR_000856|KBioSS_001322|Colchicine (contains 5% Ethyl Acetate at maximum)|MLS001055448|MLS001304089|MLS002153786|DivK1c_000753|SPECTRUM1500205|SPBio_000289|SPBio_002406|BPBio1_000535|GTPL2367|MEGxp0_001879|COLCHICINE [EP IMPURITY]|COLCHICINE [ORANGE BOOK]|SCHEMBL29374654|UPCMLD-DP065:001|ACon1_000353|HMS502F15|KBio1_000753|KBio2_001322|KBio2_003890|KBio2_006458|KBio3_001303|COLCHICINE [EP MONOGRAPH]|MSK7171|NINDS_000753|COLCHICINE [USP MONOGRAPH]|HMS1569I07|HMS1920A08|HMS2091G16|HMS2096I07|HMS2231C05|HMS3260N22|HMS3713I07|Pharmakon1600-01500205|COLCHICINUM [WHO-IP LATIN]|Colchicine, >=96.0% (HPLC)|PROBEN-C COMPONENT COLCHICINE|Tox21_110947|Tox21_201547|Tox21_300582|Tox21_500310|BDBM50014846|CCG-39910|HY-16569R|NSC756702|NSC813203|s2284|COLBENEMID COMPONENT COLCHICINE|AKOS001582887|Colchicine, >=95% (HPLC), powder|Tox21_110947_1|CS-1141|DB08117|FC11732|LP00310|NSC-756702|NSC-813203|SDCCGMLS-0066633.P001|SDCCGSBI-0050298.P006|(S)-N-(1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl)acetamide|IDI1_000753|N-(5,6,7,9-Tetrahydro-1,2,3,10-tetramethoxy-9-oxobenzo[.alpha.]heptalen-7-yl)-acetamide|NCGC00025125-01|NCGC00025125-02|NCGC00025125-03|NCGC00025125-04|NCGC00025125-05|NCGC00025125-06|NCGC00025125-08|NCGC00025125-09|NCGC00025125-10|NCGC00025125-11|NCGC00025125-12|NCGC00025125-13|NCGC00025125-14|NCGC00025125-15|NCGC00025125-18|NCGC00025125-20|NCGC00025125-33|NCGC00169157-01|NCGC00169157-02|NCGC00169157-03|NCGC00254359-01|NCGC00259096-01|NCGC00260995-01|AS-13686|COL-PROBENECID COMPONENT COLCHICINE|HY-16569|NCI60_041659|SBI-0050298.P004|COLCHICINE IMPURITY B [EP IMPURITY]|EU-0100310|MLS001055448-02|NS00002718|C07592|D00570|M01514|binds to tubulin; inhibits microtubular assembly|078C484|SR-01000075794-1|SR-01000075794-3|SR-01000075794-6|SR-01000075794-7|SR-01000597576-1|SR-01000597576-3|BRD-K00259736-001-06-5|BRD-K00259736-001-10-7|BRD-K00259736-001-16-4|WLN: L B677 MV&T&J CO1 DO1 EO1 JMV1 NO1|Benzo[a]heptalen-9(5H)-one,7-dihydro-1,2,3,10-tetramethoxy-|Colchicine, (European Pharmacopoeia (EP) Reference Standard)|Colchicine, United States Pharmacopeia (USP) Reference Standard|Colchicine, BioReagent, plant cell culture tested, >=95% (HPLC)|Colchicine, Pharmaceutical Secondary Standard; Certified Reference Material|Colchicine for system suitability, European Pharmacopoeia (EP) Reference Standard|(1e)-N-[(7s)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl] ethanimidic acid|ACETAMIDE, N-(5,6,7,9-TETRAHYDRO-1,2,3,10-TETRAMETHOXY-9-OXOBENZO(A)HEPTALEN-7-YL)-,(S)-|N-[(7S,12aP)-1,2,3,10-tetramethoxy-9-oxo-5,6,7,9-tetrahydrobenzo[a]heptalen-7-yl]acetamide"
BEDAQUILINE,5388906,,"InChI=1S/C32H31BrN2O2/c1-35(2)19-18-32(36,28-15-9-13-22-10-7-8-14-26(22)28)30(23-11-5-4-6-12-23)27-21-24-20-25(33)16-17-29(24)34-31(27)37-3/h4-17,20-21,30,36H,18-19H2,1-3H3/t30-,32-/m1/s1",QUIJNHUBAXPXFS-XLJNKUFUSA-N,C32H31BrN2O2,555.5,"(1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol","Bedaquiline|843663-66-1|TMC207|TMC-207|bedaquilina|TMC 207|bedaquilinum|CHEBI:72292|R 207910|R-207910|(1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-naphthalen-1-yl-1-phenylbutan-2-ol|AIDS-222089|1-(6-Bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol|78846I289Y|DTXSID80903989|(1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(1-naphthyl)-1-phenylbutan-2-ol|(1R,2S) 6-BROMO-ALPHA-(2-(DIMETHYLAMINO)ETHYL)-2-METHOXY-ALPHA-(1-NAPHTHYL)-BETA-PHENYL-3-QUINOLINEETHANOL|3-Quinolineethanol, 6-bromo-alpha-(2-(dimethylamino)ethyl)-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-, (alphaS,betaR)-|RefChem:56885|J04AK05|DTXCID501331924|(1R,2S)-1-(6-BROMO-2-METHOXY-QUINOLIN-3-YL)-4-DIMETHYLAMINO-2-(3-FLUOROPHENYL)-1-PHENYL-BUTAN-2-OL|1-(6-bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-(3-fluorophenyl)-1-phenyl-butan-2-ol|3-Quinolineethanol, 6-Bromo-Alpha-(2-(Dimethylamino)Ethyl)-2-Methoxy-Alpha-1-Naphthalenyl-Beta-Phenyl-, (Alpha-S,Beta-R)-|R207910|(1R,2S)-1-(6-bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol|654653-93-7|(alphaR,betaS)-rel-Bedaquiline|Bedaquiline [USAN:INN]|HSDB 8217|UNII-78846I289Y|C32H31BrN2O2|843663-66-1 (free base)|MMV689758|(aS,bR)-Bedaquiline|MFCD22628872|(alphaS,betaR)-6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-3-quinolineethanol|(1R,2S)-1-(6-bromo-2-methoxy-3-quinolyl)-4-(dimethylamino)-2-(1-naphthyl)-1-phenyl-butan-2-ol|(1R,2S)-1-(6-Bromo-2-methoxy-3-quinolyl)-4-dimethylamino-2-(1-naphthyl)-1-phenyl-butan-2-ol|(1R,2S)-1-(6-Bromo-2-methoxy-quinolin-3-yl)-4-methyl-amino-2-naphthalen-1-yl-1-phenyl-butan-2-ol|BDQ|Bedaquiline [USAN]|BQ1|cis-1-(6-Bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol|AIDS 222089|Bedaquiline (Standard)|BEDAQUILINE [MI]|BEDAQUILINE [INN]|(aR,bS)-rel-Bedaquiline|Bedaquiline (USAN/INN)|BEDAQUILINE [VANDF]|(alphaS,betaR)-Bedaquiline|BEDAQUILINE [WHO-DD]|(|AR,|AS)-rel-Bedaquiline|SCHEMBL295482|CHEMBL376488|orb1305298|SCHEMBL29355031|SCHEMBL29463988|SCHEMBL29463990|GTPL11171|DTXSID101027810|""(AlphaR,BetaS)-rel-Bedaquiline""|EX-A4133|BDBM50063995|HY-14881R|s5623|AKOS022186476|CCG-270030|DB08903|FB46540|bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-naphthalen-1-yl-1-phenyl-butan-2-ol|compound 1a [PMID: 17496888]|NCGC00348215-01|NCGC00348215-03|NCGC00348215-04|3-Quinolineethanol, 6-bromo-alpha-(2-(dimethylamino)ethyl)-2-methoxy-alpha-1-naphthalenyl-beta-phenyl-, (alphaR,betaS)-rel-|AC-28385|DA-71359|HY-14881|SY030567|NS00069910|D09872|F957690|SR-05000022473|Q1257318|SR-05000022473-1|BRD-K90817094-001-02-6|BRD-K90817094-001-03-4|R403323; TMC207; R207910|(1R,2S)-1-(6-Bromo-2-methoxy-3-quinolinyl)-4-(dimethylamino)-2-(1-naphthyl)-1-phenyl-2-butanol|(1R,2S)-1-(6-Bromo-2-methoxyquinolin-3-yl) -4-(dimethylamino)-2-(naphthalen-1-yl) -1-phenylbutan-2-ol|(1R,2S)-1-(6-BROMO-2-METHOXYQUINOLIN-3-YL)-4-(DIMETHYLAMINO)-2-(NAPHTHALEN-1-YL)-1- PHENYLBUTAN-2-OL|1-(1R)-(6-Bromo-2-methoxy-quinolin-3-yl)-4-dimethylamino-2-(2S)-(naphthalen-1-yl)-1-phenyl-butan-2-ol|3-QUINOLINEETHANOL, 6-BROMO-.ALPHA.-(2-(DIMETHYLAMINO)ETHYL)-2-METHOXY-.ALPHA.-1-NAPHTHALENYL-.BETA.-PHENYL-, (.ALPHA.S,.BETA.R)-|rel-(1R,2S)-1-(6-Bromo-2-methoxyquinolin-3-yl)-4-(dimethylamino)-2-(naphthalen-1-yl)-1-phenylbutan-2-ol"
IVOSIDENIB,71657455,,"InChI=1S/C28H22ClF3N6O3/c29-21-4-2-1-3-20(21)25(26(40)36-18-11-28(31,32)12-18)37(19-10-17(30)14-34-15-19)27(41)22-5-6-24(39)38(22)23-9-16(13-33)7-8-35-23/h1-4,7-10,14-15,18,22,25H,5-6,11-12H2,(H,36,40)/t22-,25-/m0/s1",WIJZXSAJMHAVGX-DHLKQENFSA-N,C28H22ClF3N6O3,583.0,"(2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide","Ivosidenib|1448347-49-6|Tibsovo|AG-120|AG120|Q2PCN8MAM6|ivosidenibum|CHEBI:145430|DTXSID801027928|(2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide|Glycinamide, 1-(4-cyano-2-pyridinyl)-5-oxo-L-prolyl-2-(2-chlorophenyl)-N-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)-, (2S)-|(2S)-N-{(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl}-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide|(2S)-2-(2-chlorophenyl)-2-(1-((2S)-1-(4-cyanopyridin-2-yl)-5-oxopyrrolidin-2-yl)-N-(5-fluoropyridin-3-yl)formamido)-N-(3,3-difluorocyclobutyl)acetamide|(2S)-2-(2-CHLOROPHENYL)-2-{1-[(2S)-1-(4-CYANOPYRIDIN-2-YL)-5-OXOPYRROLIDIN-2-YL]-N-(5-FLUOROPYRIDIN-3-YL)FORMAMIDO}-N-(3,3-DIFLUOROCYCLOBUTYL)ACETAMIDE|(2S)-N-((1S)-1-(2-CHLOROPHENYL)-2-((3,3-DIFLUOROCYCLOBUTYL)AMINO)-2-OXOETHYL)-1-(4-CYANOPYRIDIN-2-YL)-N-(5-FLUOROPYRIDIN-3-YL)-5-OXOPYRROLIDINE-2-CARBOXAMIDE|RefChem:57058|L01XX62|DTXCID801513494|N-((1S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyano-2-pyridinyl)-N-(5-fluoro-3-pyridinyl)-5-oxo-L-prolinamide|Ivosidenib [INN]|Ivosidenib [USAN]|RG120|Ivosidenib [WHO-DD]|MFCD29036964|UNII-Q2PCN8MAM6|(S)-N-((S)-1-(2-chlorophenyl)-2-((3,3-difluorocyclobutyl)amino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide|Ivosidenib [USAN:INN:WHO-DD]|C28H22ClF3N6O3|(2S)-N-{(1S)-1-(2-Chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl}-1(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide; AG 120|Glycinamide, N2-[1-(4-cyano-2-pyridinyl)-5-oxo-L-prolyl]-2-(2-chlorophenyl)-N1-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)-, (2S)-;|Tibsovo (TN)|IVOSIDENIB [MI]|Ivosidenib (JAN/USAN/INN)|GTPL9217|orb1303993|CHEMBL3989958|IVOSIDENIB [ORANGE BOOK]|SCHEMBL15122512|SCHEMBL29598134|SCHEMBL29599627|EX-A992|WIJZXSAJMHAVGX-DHLKQENFSA-N|BDBM363689|HMS6019J07|US9850277, Compound 176|NSC789102|s8206|AKOS028113340|CCG-270141|CS-5122|DB14568|NSC-789102|NCGC00476170-04|NCGC00476170-06|(S)-N-((S)-1-(2-chlorophenyl)-2-(3,3-difluorocyclobutylamino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-|(S)-N-((S)-1-(2-chlorophenyl)-2-(3,3-difluorocyclobutylamino)-2-oxoethyl)-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxopyrrolidine-2-carboxamide|AC-32624|AS-35058|BP-43660|FA145491|HY-18767|SY260961|NS00133776|D11090|EN300-21623926|F978977|BRD-K93073858-001-01-1|Q27895417|(2S)-1-(4-Cyano-2-pyridinyl)-5-oxo-L-prolyl-2-(2-chloroPh)-N-(3,3-difluorocyclobutyl)-N2-(5-fluoro-3-pyridinyl)-glycinamide|(2S)-N-[(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxo-ethyl]-1-(4-cyano-2-pyridyl)-N-(5-fluoro-3-pyridyl)-5-oxo-pyrrolidine-2-carboxamide|(S)-N-[(S)-1-(2-Chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl]-1-(4-cyano-2-pyridyl)-N-(5-fluoro-3-pyridyl)-5-oxopyrrolidine-2-carboxamide|IV3|N-{(1S)-1-(2-chlorophenyl)-2-[(3,3-difluorocyclobutyl)amino]-2-oxoethyl}-1-(4-cyanopyridin-2-yl)-N-(5-fluoropyridin-3-yl)-5-oxo-L-prolinamide"
DIACEREIN,26248,,"InChI=1S/C19H12O8/c1-8(20)26-13-5-3-4-11-15(13)18(23)16-12(17(11)22)6-10(19(24)25)7-14(16)27-9(2)21/h3-7H,1-2H3,(H,24,25)",TYNLGDBUJLVSMA-UHFFFAOYSA-N,C19H12O8,368.3,"4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic acid","Diacerein|13739-02-1|Artrodar|Diacerhein|Diacetylrhein|Fisiodar|1,8-DIACETOXY-3-CARBOXYANTHRAQUINONE|Diacereine|Diacereina|Verboril|Zondar|Diora|SF-277|4,5-diacetyloxy-9,10-dioxoanthracene-2-carboxylic acid|Diacereinum|Rhein diacetate|2-Anthracenecarboxylic acid, 4,5-bis(acetyloxy)-9,10-dihydro-9,10-dioxo-|M01AX21|AC-201|M-01AX21|4,5-Diacetoxyanthraquinone-2-carboxylic Acid|AC-203|4,5-Bis(acetyloxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic Acid|NSC-758147|4HU6J11EL5|DTXSID4045636|9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthroic acid, diacetate|DTXCID2025636|diacetyl-rhein|SF277|RefChem:586131|237-310-2|DIACERIN|MFCD00468030|4,5-diacetoxy-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid|Diacerhein; Diacetylrhein|4,5-bis(acetyloxy)-9,10-dioxo-9,10-dihydroanthracene-2-carboxylic acid|MLS000028577|4,5-Diacetylrhein|NCGC00018274-04|SMR000058958|Diacerein [INN]|Diacereine [French]|Diacereinum [Latin]|C19H12O8|Diacereina [Spanish]|4,5-diacetoxy-9,10-diketo-anthracene-2-carboxylic acid|4,5-diacetyloxy-9,10-dioxo-2-anthracenecarboxylic acid|Rhein, diacetate|112118-18-0|CAS-13739-02-1|SR-01000003156|EINECS 237-310-2|BRN 2184909|UNII-4HU6J11EL5|Gesamtmatrix|ART 50|1,8-Diacetoxyanthraquinone-3-carboxylic acid|Zondar (TN)|Diacerein (Standard)|Spectrum_001876|SpecPlus_000643|4,5-Diacetoxy-9,10-dihydro-9,10-dioxo-2-anthrylcarbonsaeure|9,10-Dihydro-4,5-diacetoxy-9,10-2-anthracenecarboxylic acid|DIACEREIN [MI]|Diacerein (USAN/INN)|Diacerein [USAN:INN]|DIACEREIN [USAN]|9,10-Dihydro-4,5-dihydroxy-9,10-dioxo-2-anthroic acid diacetate|Spectrum2_000823|Spectrum3_000937|Spectrum4_001036|Spectrum5_001819|Diacerein impurity mixture|DIACEREIN [MART.]|DIACEREIN [WHO-DD]|SCHEMBL25784|KBioGR_001591|KBioSS_002400|RHEIN DIACETATE [MI]|3-10-00-04790 (Beilstein Handbook Reference)|cid_26248|CHEMBL41286|DivK1c_006739|SPECTRUM1502010|Diacerein - Bio-X trade mark|SPBio_000745|orb1309160|4,5-diacetoxy-9,10-dioxo-anthracene-2-carboxylic acid|DIACEREIN [EP MONOGRAPH]|Diacerein, >=95% (HPLC)|SCHEMBL29423907|SCHEMBL29944894|BDBM32018|CHEBI:94708|GTPL10800|HY-N0283R|KBio1_001683|KBio2_002395|KBio2_004963|KBio2_007531|KBio3_001974|HMS3652D06|HMS3714B20|HMS5082H22|Pharmakon1600-01502010|ALBB-038654|BCP10834|HY-N0283|WHO 5371|Tox21_110856|BBL011075|CCG-40287|NSC758147|s4267|STK802271|2-ANTHROIC ACID, 9,10-DIHYDRO-4,5-DIHYDROXY-9,10-DIOXO-, DIACETATE|AKOS005622705|Tox21_110856_1|DB11994|FD21422|KS-5088|KW-4800|NSC 758147|NCGC00018274-01|NCGC00018274-02|NCGC00018274-03|NCGC00018274-05|NCGC00022114-03|BD164367|SBI-0052833.P002|D4061|NS00018043|SW199355-2|D07270|AB00053327_14|EN300-7368632|739D021|Q413178|SR-01000003156-2|SR-01000003156-3|SR-01000003156-4|BRD-K69122748-001-09-3|BRD-K69122748-001-10-1|BRD-K69122748-001-11-9|Diacerein, European Pharmacopoeia (EP) Reference Standard|4,5-diacetoxy-9,10-dihydro-9,10-dioxoanthracene-2-carboxylic acid|4,5-diacetyloxy-9,10-bis(oxidanylidene)anthracene-2-carboxylic acid|4,5-bis(acetoxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid|4,5-Bis(acetyloxy)-9,10-dihydro-9,10-dioxo-2-anthracenecarboxylic acid;4,5-Diacetoxyanthraquinone-2-carboxylic acid;4,5-Diacetylrhei  n"
PIMAVANSERIN,10071196,,"InChI=1S/C25H34FN3O2/c1-19(2)18-31-24-10-6-20(7-11-24)16-27-25(30)29(23-12-14-28(3)15-13-23)17-21-4-8-22(26)9-5-21/h4-11,19,23H,12-18H2,1-3H3,(H,27,30)",RKEWSXXUOLRFBX-UHFFFAOYSA-N,C25H34FN3O2,427.6,1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea,Pimavanserin|706779-91-1|ACP-103|pimavanserina|pimavanserine|JZ963P0DIK|CHEBI:133017|DTXSID90990906|N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl) carbamide|ACP 103|N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide|1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-[[4-(2-methylpropoxy)phenyl]methyl]urea|pimavanserinum|1-((4-fluorophenyl)methyl)-1-(1-methylpiperidin-4-yl)-3-((4-(2-methylpropoxy)phenyl)methyl)urea|1-[(4-fluorophenyl)methyl]-1-(1-methylpiperidin-4-yl)-3-{[4-(2-methylpropoxy)phenyl]methyl}urea|RefChem:59074|ACP103|DTXCID70206052|N05AX17|1-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methylpiperidin-4-yl)urea|Pimavanserin [INN]|Pimavanserin free base|MFCD09953792|706779-91-1 (free base)|UNII-JZ963P0DIK|Pimanavserin|C25H34FN3O2|N-[(4-Fluorophenyl)methyl]-N-(1-methyl-4-piperidinyl)-N'-[[4-(2-methylpropoxy)phenyl]methyl]-urea; N-(4-Fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-[[4-(2-methylpropyloxy)phenyl]methyl]carbamide; Pimavanserin|AC-5273|Pimavanserin (Standard)|PIMAVANSERIN [MI]|Pimavanserin(ACP-103)|Pimavanserin(ACP-103)?|PIMAVANSERIN [WHO-DD]|SCHEMBL675165|Nuplazid (proposed trade name)|GTPL8423|orb1306543|CHEMBL2111101|RKEWSXXUOLRFBX-UHFFFAOYSA-N|A1L11|BDBM139370|GLXC-10713|HMS3742A03|BCP11618|EX-A4895|HY-14557R|AKOS015902593|CS-3378|DB05316|FP27045|ME-0240|SB16963|1-[(4-fluorophenyl)methyl]-3-[(4-isobutoxyphenyl)methyl]-1-(1-methyl-4-piperidyl)urea|NCGC00390656-01|NCGC00390656-02|HY-14557|SY065361|NS00071545|779P911|EN300-19659487|Q7194603|BRD-K83405785-001-01-5|1-(4-Fluorobenzyl)-3-(4-isobutoxybenzyl)-1-(1-methyl-4-piperidyl)urea|N-(4-Fluorobenzyl)-N-(1-methylpiperidin-4-yl)-N'-[[4-(2-methylpropyloxy)phenyl]methyl]carbamide;N-[(4-Fluorophenyl)methyl]-N-(1-|N-[(4-fluorophenyl)methyl]-N-(1-methylpiperidin-4-yl)-N'-{[4-(2-methylpropoxy)phenyl]methyl}urea
KANAMYCIN,6032,,"InChI=1S/C18H36N4O11/c19-2-6-10(25)12(27)13(28)18(30-6)33-16-5(21)1-4(20)15(14(16)29)32-17-11(26)8(22)9(24)7(3-23)31-17/h4-18,23-29H,1-3,19-22H2/t4-,5+,6-,7-,8+,9-,10-,11-,12+,13-,14-,15+,16-,17-,18-/m1/s1",SBUJHOSQTJFQJX-NOAMYHISSA-N,C18H36N4O11,484.5,"(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol","kanamycin|Kanamicina|Kanamycine|Kanamycinum|Kanamycins|8063-07-8|(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol|D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1-4))-2-deoxy-|(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-{[(1R,2R,3S,4R,6S)-4,6-diamino-3-{[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-2-hydroxycyclohexyl]oxy}oxane-3,4,5-triol|Kanamycin Complex|(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-(((1R,2R,3S,4R,6S)-4,6-diamino-3-(((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy)-2-hydroxycyclohexyl)oxy)oxane-3,4,5-triol|(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-((1R,2R,3S,4R,6S)-4,6-diamino-3-((2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)oxy-2-hydroxycyclohexyl)oxyoxane-3,4,5-triol|RefChem:5930|RUC37XUP2P|CHEBI:6104|DTXSID2041171|CHEBI:24951|A07AA08|J01GB04|S01AA24|200-411-7|232-512-7|KANAMYCIN A|59-01-8|KanamycinA|CHEBI:17630|Kanamycin Base|Kanamycin A monosulfate|4,6-Diamino-2-hydroxy-1,3-cyclohexane 3,6'diamino-3,6'-dideoxydi-alpha-D-glucoside|EQK9Q303C5|KAN|C18H36N4O11|Kanamycin A Deuterated|1174286-24-8|Kanamicina [Italian]|KM (the Antibiotic)|Kanamycin [INN:BAN]|Kanamycine [INN-French]|Kanamycinum [INN-Latin]|4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-D-glucopyranoside|(1S,2R,3R,4S,6R)-4,6-diamino-3-[(6-amino-6-deoxy-alpha-D-glucopyranosyl)oxy]-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside|(2R,3S,4S,5R,6R)-2-(aminomethyl)-6-[(1R,2R,3S,4R,6S)-4,6-diamino-3-[(2S,3R,4S,5S,6R)-4-amino-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]tetrahydropyran-3,4,5-triol|2-(aminomethyl)-6-[4,6-diamino-3-[4-amino-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxyoxane-3,4,5-triol|HSDB 3107|EINECS 200-411-7|BRN 0061647|UNII-EQK9Q303C5|DTXSID3023184|Liposomal Kanamycin|Prestwick3_000394|Kantrex (1:1 sulfate)|Klebcil (1:1 sulfate)|KANAMYCIN A [MI]|KANAMYCIN A [HSDB]|SCHEMBL2735|CHEMBL1384|Glucopyranoside, 4,6-diamino-2-hydroxy-1,3-cyclohexylene 3,6'-diamino-3,6'-dideoxydi-, D-|BSPBio_000607|D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1,4))-2-deoxy-|DivK1c_000024|KANAMYCIN A [WHO-IP]|BPBio1_000669|orb1992991|GTPL12132|KBio1_000024|Kanamycin A Deuterated (>90%)|MSK7706|NINDS_000024|7227b|BDBM50031282|MFCD00070289|AKOS025293505|AK30116|DB01172|IDI1_000024|SMP2_000007|NCGC00179506-01|NCGC00179506-05|AS-14003|D-Streptamine, O-3-amino-3-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1.fwdarw.4)]-2-deoxy-|HY-16566|AB00513827|CS-0006792|NS00098990|C01822|EN300-19735925|BRD-K08327065-065-01-9|BRD-K08327065-065-04-3|Q27094615|(1S,2R,3R,4S,6R)-4,6-diamino-3-(6-amino-6-deoxy-alpha-D-glucopyranosyloxy)-2-hydroxycyclohexyl 3-amino-3-deoxy-alpha-D-glucopyranoside|D-STREPTAMINE, O-3-AMINO-3-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->6)-O-(6-AMINO-6-DEOXY-.ALPHA.-D-GLUCOPYRANOSYL-(1->4))-2-DEOXY-|D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-2-deoxy-|D-Streptamine, O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1.fwdarw.4))-2-deoxy-|O-3-Amino-3-deoxy-.alpha.-D-glucopyranosyl-(1->6)-O-[6-amino-6-deoxy-.alpha.-D-glucopyranosyl-(1->4)]-2-deoxy-D-streptamine|O-3-amino-3-deoxy-alpha-D- glucopyranosyl-(1-6)-O-(6-amino-6-deoxy-alpha-D- glucopyranosyl-(1-4))-2-deoxy-D-streptamine;Kanamycin A; Kanamycin|O-3-amino-3-deoxy-alpha-D-glucopyranosyl-(1->6)-O-(6-amino-6-deoxy-alpha-D-glucopyranosyl-(1->4))-2-deoxy-D-streptamine"
JNJ-18038683,11249539,,"InChI=1S/C20H20ClN3.C6H8O7/c21-17-8-6-16(7-9-17)20-18-10-12-22-13-11-19(18)24(23-20)14-15-4-2-1-3-5-15;7-3(8)1-6(13,5(11)12)2-4(9)10/h1-9,22H,10-14H2;13H,1-2H2,(H,7,8)(H,9,10)(H,11,12)",DIQZMBPDLFAJLK-UHFFFAOYSA-N,C26H28ClN3O7,530.0,"1-benzyl-3-(4-chlorophenyl)-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepine;2-hydroxypropane-1,2,3-tricarboxylic acid","JNJ-18038683|851376-05-1|9UKQ1NQ8YX|Pyrazolo(3,4-d)azepine, 3-(4-chlorophenyl)-1,4,5,6,7,8-hexahydro-1-(phenylmethyl)-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1) (salt)|RefChem:150524|3-(4-chlorophenyl)-1-(phenylmethyl)-5,6,7,8-tetrahydro-4H-pyrazolo(5,4-d)azepine|UNII-9UKQ1NQ8YX|1-benzyl-3-(4-chlorophenyl)-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepine;2-hydroxypropane-1,2,3-tricarboxylic acid|C26H28ClN3O7|JNJ-18038683 citrate|orb1309526|SCHEMBL2076923|CHEMBL4297293|DIQZMBPDLFAJLK-UHFFFAOYSA-N|EX-A12315|AKOS040733500|BJ166487|DA-54543|HY-19889|JNJ18038683?|MS-29802|CS-0016958|G15933|Q27273245|1-Benzyl-3-(4-chloro-phenyl)-1,4,5,6,7,8-hexahydro-1,2,6-triaza-azulene Citrate Salt|1-benzyl-3-(4-chlorophenyl)-5,6,7,8-tetrahydro-4H-pyrazolo[3,4-d]azepine;citric acid"
AMILORIDE,16231,,"InChI=1S/C6H8ClN7O/c7-2-4(9)13-3(8)1(12-2)5(15)14-6(10)11/h(H4,8,9,13)(H4,10,11,14,15)",XSDQTOBWRPYKKA-UHFFFAOYSA-N,C6H8ClN7O,229.63,"3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide","AMILORIDE|2609-46-3|Amipramidin|Guanamprazin|Amilorida|Amipramizid|Midamor|Amiloridum|3,5-diamino-N-carbamimidoyl-6-chloropyrazine-2-carboxamide|Amiclaran|N-Amidino-3,5-diamino-6-chloropyrazinecarboxamide|3,5-diamino-6-chloro-N-(diaminomethylidene)pyrazine-2-carboxamide|7DZO8EB0Z3|CHEBI:2639|DTXSID9043853|Pyrazinecarboxamide, 3,5-diamino-N-(aminoiminomethyl)-6-chloro-|DTXCID7023853|Trom, Amiduret|RefChem:57770|C03DB01|220-024-7|926-801-3|Guanamprazine|Amyloride|Amiloridum [INN-Latin]|Amilorida [INN-Spanish]|N-Amidino-3,5-diamino-6-chlorpyrazincarboxamid|Amiloride (INN)|3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide|MK-870|137053-86-2|CHEMBL945|N-amidino-3,5-diamino-6-chloro-2-pyrazinecarboxamide|NCGC00015089-08|AMILORIDE [INN]|Amiloride [INN:BAN]|C6H8ClN7O|Amiclaran (TN)|CAS-2609-46-3|CCRIS 6545|EINECS 220-024-7|UNII-7DZO8EB0Z3|(3,5-diamino-6-chloropyrazin-2-yl)-N-(???methyl)carboxamide|AmilorideHCl|Amikal (Hydrochloride dihydrate)|Midamor (Hydrochloride dihydrate)|MK-870 (Hydrochloride dihydrate)|Amipramidin, Midamor|3,5-Diamino-N-(aminoiminomethyl)-6-chloropyrazinecarboxamide hydrochloride|Spectrum_000034|Tocris-0890|1f5l|AMILORIDE [MI]|Prestwick0_000007|Prestwick1_000007|Prestwick2_000007|Prestwick3_000007|Spectrum2_000118|Spectrum3_000293|Spectrum4_000132|Spectrum5_000776|AMILORIDE [VANDF]|Lopac-A-7410|AMILORIDE [WHO-DD]|Lopac0_000111|SCHEMBL27562|SCHEMBL27563|BSPBio_000013|BSPBio_001572|BSPBio_001826|KBioGR_000292|KBioGR_000544|KBioSS_000292|KBioSS_000394|MLS001060798|BIDD:GT0466|DivK1c_000182|SPBio_000136|SPBio_001934|BPBio1_000015|GTPL2421|SCHEMBL29531132|BCBcMAP01_000101|BDBM16173|KBio1_000182|KBio2_000292|KBio2_000394|KBio2_002860|KBio2_002962|KBio2_005428|KBio2_005530|KBio3_000583|KBio3_000584|KBio3_001326|NINDS_000182|Bio1_000359|Bio1_000848|Bio1_001337|Bio2_000292|Bio2_000772|GLXC-06741|HMS1791O14|HMS1989O14|HMS2089H05|HMS2213E05|HMS3355K04|BCP16815|HY-B0285|Tox21_110080|3,5-diamino-N-[amino(imino)methyl]-6-chloropyrazine-2-carboxamide|BBL028157|SBB037856|STL373007|AKOS015961348|Tox21_110080_1|CCG-204206|DB00594|SB74937|SDCCGSBI-0050099.P005|IDI1_000182|IDI1_034042|NCGC00015089-01|NCGC00015089-02|NCGC00015089-03|NCGC00015089-04|NCGC00015089-05|NCGC00015089-06|NCGC00015089-07|NCGC00015089-09|NCGC00015089-11|NCGC00015089-12|NCGC00015089-13|NCGC00015089-14|NCGC00015089-15|NCGC00015089-16|NCGC00015089-17|NCGC00015089-24|NCGC00024443-02|NCGC00024443-05|NCGC00024443-06|NCGC00024443-07|NCGC00024443-09|AC-13631|LS-13128|SMR000486264|ST079279|(3,5-Diamino-6-chloropyrazinoyl)guanidine|SBI-0050099.P004|DB-343790|N-amidino-3,5-diamino-6-chloropyrazinamide|AB00053415|NS00002250|C06821|D07447|EN300-149459|AB00053415-24|AB00053415-25|AB00053415_26|AB00053415_27|AB00053415_28|609A463|Q419995|BRD-K97181089-003-02-3|BRD-K97181089-003-22-1|BRD-K97181089-003-23-9|BRD-K97181089-003-24-7|BRD-K97181089-310-03-0|BRD-K97181089-310-06-3|N-amidino 3,5-diamino-6-chloro-2-pyrazinecarboxamide|F2173-0531|N-(3,5-Diamino-6-chloro-pyrazine-2-carbonyl)-guanidine|3,5-diamino-N-carbamimidoyl-6-chloro-pyrazine-2-carboxamide|3,5-diamino-6-chloro-N-(diaminomethylene)pyrazinamide;hydrochloride|3,5-diamino-6-chloro-N-(diaminomethylene)pyrazine-2-carboxamide"
GSK2981278,89875987,,"InChI=1S/C25H35NO5S/c1-4-20-5-7-23(8-6-20)26(16-19(2)3)32(28,29)24-9-10-25(22(15-24)17-27)31-18-21-11-13-30-14-12-21/h5-10,15,19,21,27H,4,11-14,16-18H2,1-3H3",LZLBRISQTJVZNP-UHFFFAOYSA-N,C25H35NO5S,461.6,N-(4-ethylphenyl)-3-(hydroxymethyl)-N-(2-methylpropyl)-4-(oxan-4-ylmethoxy)benzenesulfonamide,"GSK2981278|1474110-21-8|ROR gama modulator 1|GSK-2981278|N-(4-ethylphenyl)-3-(hydroxymethyl)-N-(2-methylpropyl)-4-(oxan-4-ylmethoxy)benzenesulfonamide|L49V5G013I|Benzenesulfonamide, N-(4-ethylphenyl)-3-(hydroxymethyl)-N-(2-methylpropyl)-4-[(tetrahydro-2H-pyran-4-yl)methoxy]-|Benzenesulfonamide, N-(4-ethylphenyl)-3-(hydroxymethyl)-N-(2-methylpropyl)-4-((tetrahydro-2H-pyran-4-yl)methoxy)-|RefChem:144557|N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzenesulfonamide|CHEMBL4225088|RORgamma Modulator 1|UNII-L49V5G013I|C25H35NO5S|GTPL9661|orb1303238|SCHEMBL15352875|SCHEMBL31239078|LZLBRISQTJVZNP-UHFFFAOYSA-N|GLXC-10699|BCP17156|EX-A1179|ZIC11021|BDBM50461084|s6610|AKOS030526564|CS-5449|GSK2981278?|AC-36054|BS-15442|HY-19770|N-(4-Ethyl-phenyl)-3-hydroxymethyl-N-isobutyl-4-(tetrahydro-pyran-4-ylmethoxy)-benzenesulfonamide|DB-213948|GSK-2981278;GSK 2981278;ROR gama modulator 1|N-(4-ethylphenyl)-3-(hydroxymethyl)-N-isobutyl-4-(tetrahydropyran-4-ylmethoxy)benzenesulfonamide"
ONAMETOSTAT,126637809,,"InChI=1S/C22H23BrN6O2/c23-15-8-12-3-1-11(7-16(12)28-21(15)25)2-4-13-9-17(19(31)18(13)30)29-6-5-14-20(24)26-10-27-22(14)29/h1,3,5-8,10,13,17-19,30-31H,2,4,9H2,(H2,25,28)(H2,24,26,27)/t13-,17+,18+,19-/m0/s1",DBSMLQTUDJVICQ-CJODITQLSA-N,C22H23BrN6O2,483.4,"(1S,2R,3S,5R)-3-[2-(2-amino-3-bromoquinolin-7-yl)ethyl]-5-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol","JNJ-64619178|2086772-26-9|Onametostat|JNJ64619178|N8VKI8FPW0|(1S,2R,3S,5R)-3-[2-(2-amino-3-bromoquinolin-7-yl)ethyl]-5-(4-aminopyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol|(1S,2R,3S,5R)-3-(2-(2-Amino-3-bromoquinolin-7-yl)ethyl)-5-(4-amino-7H-pyrrolo(2,3-d)pyrimidin-7-yl)cyclopentane-1,2-diol|(1S,2R,3S,5R)-3-(2-(2-Amino-3-bromoquinolin-7-yl)ethyl)-5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol|1,2-Cyclopentanediol, 3-(2-(2-amino-3-bromo-7-quinolinyl)ethyl)-5-(4-amino-7H-pyrrolo(2,3-d)pyrimidin-7-yl)-, (1S,2R,3S,5R)-|(1S,2R,3S,5R)-3-(2-(2-amino-3-bromoquinolin-7-yl)ethyl)-5-(4-aminopyrrolo(2,3-d)pyrimidin-7-yl)cyclopentane-1,2-diol|(1S,2R,3S,5R)-3-[2-(2-amino-3-bromoquinolin-7-yl)ethyl]-5-{4-aminopyrrolo[2,3-d]pyrimidin-7-yl}cyclopentane-1,2-diol|JNJ 64619178|RefChem:168239|PRMT5 Inhibitor JNJ-64619178|Protein Arginine Methyltransferase 5 Inhibitor JNJ-64619178|Onametostat [INN]|UNII-N8VKI8FPW0|(1S,2R,3S,5R)-3-[2-(2-amino-3-bromo-7-quinolinyl)ethyl]-5-(4-amino-7H-pyrrolo[2,3-d]pyrimidin-7-yl)-1,2-cyclopentanediol|CHEMBL4249337|JNJ45031882|entane-1,2-diol|MFCD31813596|ONAMETOSTAT [WHO-DD]|C22H23BrN6O2|orb1308171|SCHEMBL18572106|SCHEMBL29352669|SCHEMBL29485640|GTPL11749|GLXC-20551|EX-A2791|LID77226|BDBM50462572|NSC808507|AKOS040741898|NSC-808507|AC-36269|DA-64660|MS-28988|Example 80 [WO2017032840A1]|HY-101564|CS-0021720|S8624|E86841|(1~{S},2~{R},3~{S},5~{R})-3-[2-(2-azanyl-3-bromanyl-quinolin-7-yl)ethyl]-5-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)cyclop|(1~{S},2~{R},3~{S},5~{R})-3-[2-(2-azanyl-3-bromanyl-quinolin-7-yl)ethyl]-5-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)cyclop entane-1,2-diol|(1S,2R,3S,5R)-3-[2-(2-azanyl-3-bromanyl-quinolin-7-yl)ethyl]-5-(4-azanylpyrrolo[2,3-d]pyrimidin-7-yl)cyclopentane-1,2-diol|K8N"
PEMRAMETOSTAT,90241742,,"InChI=1S/C24H32N6O3/c1-17(31)30-10-7-20(8-11-30)28-23-12-22(26-16-27-23)24(33)25-13-21(32)15-29-9-6-18-4-2-3-5-19(18)14-29/h2-5,12,16,20-21,32H,6-11,13-15H2,1H3,(H,25,33)(H,26,27,28)/t21-/m0/s1",JLCCNYVTIWRPIZ-NRFANRHFSA-N,C24H32N6O3,452.5,"6-[(1-acetylpiperidin-4-yl)amino]-N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]pyrimidine-4-carboxamide","1616392-22-3|GSK3326595|GSK-3326595|Pemrametostat|EPZ015938|VXT8SZ6875|GSK-3326595A|EPZ-015938|PROTEIN ARGININE METHYLTRANSFERASE 5 INHIBITOR GSK3326595|4-pyrimidinecarboxamide, 6-((1-acetyl-4-piperidinyl)amino)-N-(3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl)-|RefChem:170734|PRMT5 Inhibitor GSK3326595|(S)-6-((1-acetylpiperidin-4-yl)amino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide|MFCD29991177|6-[(1-acetylpiperidin-4-yl)amino]-N-[(2S)-2-hydroxy-3-(1,2,3,4-tetrahydroisoquinolin-2-yl)propyl]pyrimidine-4-carboxamide|6-[(1-acetylpiperidin-4-yl)amino]-N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxypropyl]pyrimidine-4-carboxamide|(S)-6-[(1-Acetylpiperidin-4-yl)amino]-N-[3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl]pyrimidine-4-carboxamide|A1BLM|PEMRAMETOSTAT [INN]|UNII-VXT8SZ6875|EPZ015938(pemrametostat)?|PEMRAMETOSTAT [WHO-DD]|CHEMBL4466233|SCHEMBL15825290|SCHEMBL29412225|SCHEMBL29756965|GTPL13679|Pemrametostat (GSK3326595)|JLCCNYVTIWRPIZ-NRFANRHFSA-N|BDBM178166|Gsk 3326595|BCP25738|NSC800404|s8664|AKOS030528008|CCG-269258|CS-6451|NSC-800404|GSK3326595?|AC-38013|AS-53150|SY278082|DB-213221|HY-101563|EPZ015938; GSK-3326595|GSK3326595 (EPZ015938)|P16134|EN300-7445463|US9675614, 208|GSK 3326595; GSK3326595; EPZ015938; EPZ 015938; EPZ-015938|(S)-6-(1-Acetylpiperidin-4-ylamino)-N-(3-(3,4-dihydroisoquinolin-2(1H)-yl)-2-hydroxypropyl)pyrimidine-4-carboxamide|4-PYRIMIDINECARBOXAMIDE, 6-((1-ACETYL-4-PIPERIDINYL)AMINO)-N-((2S)-3-(3,4-DIHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXYPROPYL)-|6-((1-ACETYL-4-PIPERIDINYL)AMINO)-N-((2S)-3-(3,4-DIHYDRO-2(1H)-ISOQUINOLINYL)-2-HYDROXYPROPYL)-4-PYRIMIDINECARBOXAMIDE|6-((1-acetyl-4-piperidinyl)amino)-N-(3-(3,4-dihydro-2(1H)-isoquinolinyl)-2-hydroxypropyl)-4-pyrimidinecarboxamide|6-[(1-acetyl-4-piperidyl)amino]-N-[(2S)-3-(3,4-dihydro-1H-isoquinolin-2-yl)-2-hydroxy-propyl]pyrimidine-4-carboxamide"
ADAVOSERTIB,24856436,,"InChI=1S/C27H32N8O2/c1-5-13-34-25(36)21-18-28-26(29-19-9-11-20(12-10-19)33-16-14-32(4)15-17-33)31-24(21)35(34)23-8-6-7-22(30-23)27(2,3)37/h5-12,18,37H,1,13-17H2,2-4H3,(H,28,29,31)",BKWJAKQVGHWELA-UHFFFAOYSA-N,C27H32N8O2,500.6,"1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one","955365-80-7|MK-1775|Adavosertib|MK1775|MK 1775|AZD1775|AZD 1775|2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one|1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-prop-2-enylpyrazolo[3,4-d]pyrimidin-3-one|K2T6HJX3I3|DTXSID30241868|3H-Pyrazolo(3,4-d)pyrimidin-3-one, 1,2-dihydro-1-(6-(1-hydroxy-1-methylethyl)-2-pyridinyl)-6-((4-(4-methyl-1-piperazinyl)phenyl)amino)-2-(2-propen-1-yl)-|2-allyl-1-(6-(2-hydroxy-2-propanyl)-2-pyridinyl)-6-((4-(4-methyl-1-piperazinyl)phenyl)amino)-1,2-dihydro-3H-pyrazolo(3,4-d)pyrimidin-3-one|adavosertibum|1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(4-(4-methylpiperazin-1-yl)anilino)-2-prop-2-enylpyrazolo(3,4-d)pyrimidin-3-one|2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-1H-pyrazolo(3,4-d)pyrimidin-3(2H)-one|3H-Pyrazolo[3,4-d]pyrimidin-3-one, 1,2-dihydro-1-[6-(1-hydroxy-1-methylethyl)-2-pyridinyl]-6-[[4-(4-methyl-1-piperazinyl)phenyl]amino]-2-(2-propen-1-yl)-|RefChem:109657|DTXCID60164359|1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-((4-(4-methylpiperazin-1-yl)phenyl)amino)-2-(prop-2-en-1-yl)-1H,2H,3H-pyrazolo(3,4-d)pyrimidin-3-one|AZD-1775|MFCD17215200|2-allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(4-(4-methylpiperazin-1-yl)phenylamino)-1H-pyrazolo[3,4-d]pyrimidin-3(2H)-one|1-[6-(2-hydroxypropan-2-yl)pyridin-2-yl]-6-{[4-(4-methylpiperazin-1-yl)phenyl]amino}-2-(prop-2-en-1-yl)pyrazolo[3,4-d]pyrimidin-3-one|Adavosertib (USAN)|MK-1775(AZD-1775,Adavosertib)|2-Allyl-1-[6-(1-hydroxy-1-methylethyl)pyridin-2-yl]-6-[[4-(4-methylpiperazin-1-yl)phenyl]amino]-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one|ADAVOSERTIB [USAN]|Adavosertib; MK-1775; MK 1775|1-[6-(2-Hydroxypropan-2-Yl)pyridin-2-Yl]-6-{[4-(4-Methylpiperazin-1-Yl)phenyl]amino}-2-(Prop-2-En-1-Yl)-1,2-Dihydro-3h-Pyrazolo[3,4-D]pyrimidin-3-One|C27H32N8O2|UNII-K2T6HJX3I3|8X7|Adavosertib (Standard)|Kinome_2656|ADAVOSERTIB [INN]|Adavosertib; MK-1775|Adavosertib (MK-1775)|ADAVOSERTIB [WHO-DD]|MLS006011025|GTPL7702|orb1306538|SCHEMBL1504444|CHEMBL1976040|SCHEMBL29381006|SCHEMBL30559444|CHEBI:91414|EX-A331|HMS3295K03|HMS3654H20|HMS3744I13|BCP01928|BDBM50240826|HY-10993R|MK-1775 (WEE-1)|NSC754352|NSC800793|s1525|AKOS024259153|BCP9000937|CCG-264905|CS-0105|DB11740|NSC-754352|NSC-800793|SB16663|NCGC00263183-01|NCGC00263183-09|NCGC00263183-10|2-Allyl-1-[6-(2-hydroxy-2-propyl)-2-pyridyl]-6-[[4-(4-methyl-1-piperazinyl)phenyl]amino]pyrazolo[3,4-d]pyrimidin-3(2H)-one|AC-28416|AS-17001|BM161385|HY-10993|SMR004702820|SY258875|MK-1775 (AZD-1775)|NS00072864|SW218122-2|D11361|BRD-K54256913-001-01-2|BRD-K54256913-001-08-7|Q27074716|Z2037279728|1,2-DIHYDRO-1-(6-(1-HYDROXY-1-METHYLETHYL)-2-PYRIDINYL)-6-((4-(4-METHYL-1-PIPERAZINYL)PHENYL)AMINO)-2-(2-PROPEN-1-YL)-3H-PYRAZOLO(3,4-D)PYRIMIDIN-3-ONE|1-[6-(2-Hydroxypropan-2-yl)pyridin-2-yl]-6-[4-(4-methylpiperazin-1-yl)anilino]-2-(prop-2-en-1-yl)-1,2-dihydro-3H-pyrazolo[3,4-d]pyrimidin-3-one|1075739-30-8|2-Allyl-1-(6-(2-hydroxypropan-2-yl)pyridin-2-yl)-6-(4-(4-methylpiperazin-1-yl)phenylamino)-1, 2-dihydropyrazolo[3, 4-d]pyrimidin-3-o ne;Adavosertib|2-allyl-1-[6-(1-hydroxy-1-methyl-ethyl)-2-pyridyl]-6-[4-(4-methylpiperazin-1-yl)anilino]pyrazolo[3,4-d]pyrimidin-3-one|2-Allyl-1-[6-(1-hydroxy-1-methyl-ethyl)-pyridin-2-yl]-6-[4-(4-methyl-piperazin-1-yl)-phenylamino]-1,2-dihydro-pyrazolo[3,4-d]pyrimidin-3-one"
LEVAMISOLE,26879,,"InChI=1S/C11H12N2S/c1-2-4-9(5-3-1)10-8-13-6-7-14-11(13)12-10/h1-5,10H,6-8H2/t10-/m1/s1",HLFSDGLLUJUHTE-SNVBAGLBSA-N,C11H12N2S,204.29,"(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole","levamisole|14769-73-4|Levamisol|Ketrax|L-Tetramisole|Wormicid|Lepuron|LEVOMYSOL|(S)-(-)-Levamisole|Levamisolum|(-)-Tetramisole|(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole|Tetramisole, (s)-|(6S)-6-phenyl-2H,3H,5H,6H-imidazo[2,1-b][1,3]thiazole|Totalon|Imidazo[2,1-b]thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (6S)-|CHEBI:6432|Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (S)-|(S)-2,3,5,6-Tetrahydro-6-phenylimidazo[2,1-b]thiazole|2880D3468G|DTXSID4023206|Levotetramisole|Imidazo(2,1-b)thiazole, 2,3,5,6-tetrahydro-6-phenyl-, (6S)-|levamisolo|(S)-2,3,5,6-Tetrahydro-6-phenylimidazo(2,1-b)thiazole|(6S)-6-phenyl-2H,3H,5H,6H-imidazo(2,1-b)(1,3)thiazole|(6S)-6-phenyl-2,3,5,6-tetrahydroimidazo(2,1-b)(1,3)thiazole|Tramisol Pour-On|RefChem:55468|DTXCID103206|P02CE01|Totalon Topical Cattle Anthelmintic|238-836-5|(S)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole|Levamisol [INN-Spanish]|Levamisolum [INN-Latin]|TCMDC-125847|Vermisol 150|L-tetramisol|MFCD00792481|Levamisole (INN)|CHEMBL1454|(6S)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole|14769-73-4 (FREE BASE)|LEVAMISOLE [INN]|Levamisole [INN:BAN]|Levovermax|L-2,3,5,6-Tetrahyro-6-phenylimidazo(2,1-b)thiazole|L(-)-Levamisole|Ketrax (TN)|EINECS 238-836-5|UNII-2880D3468G|Levamisol 100 microg/mL in Acetonitrile|(-)-Levamisole|Levamisole (Standard)|Spectrum_001609|LEVAMISOLE [MI]|(S)-(-)-tetramisole|Prestwick0_000182|Prestwick1_000182|Prestwick2_000182|Spectrum2_000865|Spectrum3_000962|Spectrum4_001078|Spectrum5_001645|LEVAMISOLE [VANDF]|P00039|LEVAMISOLE [MART.]|(-)-2,3,5,6-Tetrahydro-6-phenylimidazo(2,1-b)thiazole|(-)-6-Phenyl-2,3,5,6-tetrahydroimidazo[2,1-b]thiazole|LEVAMISOLE [WHO-DD]|Lopac0_000690|SCHEMBL19227|BSPBio_002563|KBioGR_001436|KBioSS_002089|cid_68628|BIDD:GT0372|DivK1c_000667|SPBio_000909|SPBio_002024|GTPL7210|LEVAMISOLE [GREEN BOOK]|HY-A0106R|KBio1_000667|KBio2_002089|KBio2_004657|KBio2_007225|KBio3_001783|MSK5587|NINDS_000667|HMS2090O04|HY-A0106|BDBM50241179|DL-429|AKOS001637203|CCG-204775|CS-W009271|DB00848|DS-4066|SDCCGSBI-0050668.P004|IDI1_000667|NCGC00162225-02|NCGC00162225-03|NCGC00162225-04|NCGC00162225-05|NCGC00162225-08|NCGC00162225-14|AC-18929|DA-69245|FL138922|NCI60_001476|SY107591|SBI-0050668.P003|NS00000419|C07070|C72809|D08114|AB00053661-07|AB00053661-08|AB00053661_09|AB00053661_10|EN300-7407664|F241597|Q417097|BRD-K73107279-003-03-4|BRD-K73107279-003-11-7|BRD-K73107279-003-12-5|2,3,5,6-Tetrahydro-6-phenyl-imidazo[2,1-b]thiazole, (S)-|(-)-6-phenyl-2,3,5,6-tetrahydroimidazo[2,1-b][1,3]thiazole|6-Phenyl-2,3,5,6-tetrahydro-imidazo[2,1-b]thiazole (Levamisole)|6-Phenyl-2,3,5,6-tetrahydro-imidazo[2,1-b]thiazole(Levamisole)|6-Phenyl-2,3,5,6-tetrahydro-imidazo[2,1-b]thiazole(tetramisole)|levamisole;6-Phenyl-2,3,5,6-tetrahydro-imidazo[2,1-b]thiazole|tetramisole;6-Phenyl-2,3,5,6-tetrahydro-imidazo[2,1-b]thiazole"
EDOXABAN,10280735,,"InChI=1S/C24H30ClN7O4S/c1-31(2)24(36)13-4-6-15(27-20(33)21(34)30-19-7-5-14(25)11-26-19)17(10-13)28-22(35)23-29-16-8-9-32(3)12-18(16)37-23/h5,7,11,13,15,17H,4,6,8-10,12H2,1-3H3,(H,27,33)(H,28,35)(H,26,30,34)/t13-,15-,17+/m0/s1",HGVDHZBSSITLCT-JLJPHGGASA-N,C24H30ClN7O4S,548.1,"N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide","EDOXABAN|480449-70-5|DU-176|NDU3J18APO|CHEBI:85973|DTXSID50197398|edoxabanum|Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-((1S,2R,4S)-4-((dimethylamino)carbonyl)-2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-c)pyridin-2-yl)carbonyl)amino)cyclohexyl)-|Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]-|N'-(5-chloropyridin-2-yl)-N-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-((5-methyl6,7-dihydro-4H-(1,3)thiazolo(5,4-c)pyridine-2-carbonyl)amino)cyclohexyl)oxamide|N'-(5-chloropyridin-2-yl)-N-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4H,5H,6H,7H-(1,3)thiazolo(5,4-c)pyridine-2-amido)cyclohexyl)ethanediamide|N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide|N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{5-methyl-4H,5H,6H,7H-[1,3]thiazolo[5,4-c]pyridine-2-amido}cyclohexyl]ethanediamide|RefChem:58094|edoxaban tosilate hydrochloride|B01AF03|DTXCID60119889|N-(5-chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydro(1,3)thiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)oxamide|912273-65-5|MFCD13195544|N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl)oxalamide|DU-176b|CHEMBL1269025|480449-70-5 (free base)|C24H30ClN7O4S|Edoxaban [USAN]|N'-(5-chloropyridin-2-yl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide|Edoxaban [USAN:INN]|UNII-NDU3J18APO|N1-(5-Chloropyridin-2-yl)-N2-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxamido)cyclohexyl]oxalamide|Edoxaban (Standard)|Edoxaban (USAN/INN)|EDOXABAN [INN]|EDOXABAN [MI]|EDOXABAN [MART.]|EDOXABAN [WHO-DD]|SCHEMBL330046|GTPL7575|orb1305585|HSDB 8406|EX-A5582|BDBM50328731|HY-10264R|MSK159568|s4429|AKOS005146069|CS-1331|DB09075|NCGC00378907-01|NCGC00378907-02|NCGC00378907-03|AC-35419|AS-35107|HY-10264|N1-(5-Chloro-2-pyridinyl)-N2-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide|SY097689|5436B|D09710|449E705|EN300-20605508|Q21011234|Z2301684749|Ethanediamide, N1-(5-chloro-2-pyridinyl)-N2-((1S,2R,4S)-4- ((dimethylamino)carbonyl)- 2-(((4,5,6,7-tetrahydro-5-methylthiazolo(5,4-c)pyridin-2-yl)carbonyl)amino)cyclohexyl)-|N'-(5-chloro-2-pyridyl)-N-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4H-thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide|N'-(5-chloropyridin-2-yl)-N-[(1s,2r,4s)-4-(dimethylcarbamoyl)-2-[(5-methyl-6,7-dihydro-4h-[1,3] thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl]oxamide|N(1)-(5-chloropyridin-2-yl)-N(2)-{(1S,2R,4S)-4-(dimethylcarbamoyl)-2-[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridine-2-carbonyl)amino]cyclohexyl}ethanediamide|N-(5-Chloro-2-pyridinyl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(4,5,6,7-tetrahydro-5-methylthiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide|N-(5-Chloropyridin-2-yl)-N'-((1S,2R,4S)-4-(N,N-dimethylcarbamoyl)-2-(5-methyl-4,5,6,7- tetrahydro(1,3)thiazolo(5,4-c)pyridine-2-carboxamido)cyclohexyl)oxamide|N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl]ethanediamide|N-(5-Chloropyridin-2-yl)-N'-[(1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-[[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino]cyclohexyl]ethanediamide|N1-(5-chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5, 6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl) ethanediamide|N1-(5-Chloropyridin-2-yl)-N2-((1S,2R,4S)-4-[(dimethylamino)carbonyl]-2-{[(5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl)ethanediamide|N1-(5-Chloropyridin-2-yl)-N2-[(1S,2R,4S)-4-(dimethylcarbamoyl)-2-{[(5-methyl-4,5,6,7-tetrahydro[1,3]thiazolo[5,4-c]pyridin-2-yl)carbonyl]amino}cyclohexyl]ethanediamide"
HYDROXYCHLOROQUINE,3652,,"InChI=1S/C18H26ClN3O/c1-3-22(11-12-23)10-4-5-14(2)21-17-8-9-20-18-13-15(19)6-7-16(17)18/h6-9,13-14,23H,3-5,10-12H2,1-2H3,(H,20,21)",XXSMGPRMXLTPCZ-UHFFFAOYSA-N,C18H26ClN3O,335.9,2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol,"hydroxychloroquine|118-42-3|Oxichloroquine|Oxychlorochin|Hidroxicloroquina|oxichlorochine|Polirreumin|Hydroxychloroquinum|2-((4-((7-Chloro-4-quinolyl)amino)pentyl)ethylamino)ethanol|CHEBI:5801|Dolquine|7-Chloro-4-(4-(ethyl(2-hydroxyethyl)amino)-1-methylbutylamino)quinoline|4QWG6N8QKH|2-(N-(4-(7-Chlor-4-chinolylamino)-4-methylbutyl)ethylamino)ethanol|7-Chloro-4-(4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino)quinoline|NSC4375|7-Chloro-4-(5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl)aminoquinoline|(+-)-hydroxychloroquine|DTXSID8023135|2-({4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino)ethan-1-ol|Ethanol, 2-((4-((7-chloro-4-quinolinyl)amino)pentyl)ethylamino)-|Ethanol, 2-[[4-[(7-chloro-4-quinolinyl)amino]pentyl]ethylamino]-|Ethanol, 2-((4-((7-chloro-4-quinolyl)amino)pentyl)ethylamino)-|Hydroxychlorochin|2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethan-1-ol|7-chloro-4-[4-(N-ethyl-N-beta-hydroxyethylamino)-1-methylbutylamino]quinoline|7-chloro-4-[5-(N-ethyl-N-2-hydroxyethylamino)-2-pentyl]aminoquinoline|idroxiclorochina|Ethanol, 2-[[4-[(7-chloro-4-quinolyl)amino]pentyl]ethylamino]-|RefChem:6447|hidroxychloroquine sulfate|DTXCID403135|P01BA02|204-249-8|Plaquenil|Oxychloroquine|2-((4-((7-Chloroquinolin-4-yl)amino)pentyl)(ethyl)amino)ethanol|WIN 1258|2-[4-[(7-chloroquinolin-4-yl)amino]pentyl-ethylamino]ethanol|MFCD00242707|Hydroxychloroquine (INN)|Oxichlorochinum|C18H26ClN3O|2-[{4-[(7-chloroquinolin-4-yl)amino]pentyl}(ethyl)amino]ethanol|HCQ|2-[[4-[(7-chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol|Idrossiclorochina [DCIT]|2-[4-[(7-chloro-4-quinolyl)amino]pentyl-ethyl-amino]ethanol|Idrossiclorochina|Oxichlorochine Sulfate|Hidroxicloroquina [INN-Spanish]|Hydroxychloroquinum [INN-Latin]|HYDROXYCHLOROQUINE [INN]|Hydroxychloroquine [INN:BAN]|2-{N-[4-(7-Chloro-4-quinolylamino)pentyl]-N-ethylamino}ethanol|2-({4-[(7-chloro(4-quinolyl))amino]pentyl}ethylamino)ethan-1-ol|Polirreumin (TN)|NCGC00159483-02|EINECS 204-249-8|UNII-4QWG6N8QKH|BRN 0253894|R-Hydroxychloroquine?|Ercoquin (Salt/Mix)|Spectrum2_001238|Spectrum5_001697|Z0188|(+/-)-hydroxychloroquine|SCHEMBL8170|CHEMBL1535|5-22-10-00280 (Beilstein Handbook Reference)|(.+/-.)-Hydroxychloroquine|DivK1c_000942|SPBio_001116|HYDROXYCHLOROQUINE [MI]|GTPL7198|orb1298213|SCHEMBL29359553|SCHEMBL29430237|HMS502P04|KBio1_000942|HYDROXYCHLOROQUINE [VANDF]|Win 1258-2|HYDROXY CHLOROQUINE SULFATE|NINDS_000942|HYDROXYCHLOROQUINE [WHO-DD]|BCP30197|IGA74976|BDBM50247975|BDBM50467780|SBB012559|STL429829|AKOS015997886|AT13123|CCG-208059|DB01611|DT-0016|HY-W031727|SB73036|IDI1_000942|NCGC00159483-03|NCGC00159483-06|DA-74343|ST072188|SY270913|SBI-0052759.P002|CS-0075751|NS00001228|C07043|D08050|EN300-122642|AB00053257_02|118H423|F837323|Q421094|BRD-A99117172-065-01-6|BRD-A99117172-065-02-4|BRD-A99117172-065-04-0|BRD-A99117172-065-05-7|F2173-0553|2-((4-(7-chloroquinolin-4-ylamino)pentyl)(ethyl)amino)ethanol|2-[(4-[(7-Chloro-4-quinolinyl)amino]pentyl)(ethyl)amino]ethanol #|2-[[4-[(7-Chloro-4-quinolyl)amino]pentyl](ethyl)amino]ethanol|7-chloro-4-[4-[ethyl(2-hydroxyethyl)amino]1-methylbutylamino]-quinoline|7-chloro-4-[4-[ethyl(2-hydroxyethyl)amino]1-methylbutylamino]quinoline|7-Chloro-4-[4-[ethyl-(2-hydroxyethyl)amino]-1-methylbutylamino]quinoline|(+/-)-2-((4-((7-CHLORO-4-QUINOLYL)AMINO)PENTYL)ETHYLAMINO)ETHANOL|7-Chloro-4-(4-(N-ethyl-N-.beta.-hydroxyethylamino)-1-methylbutylamino)quinoline|ETHANOL, 2-((4-((7-CHLORO-4-QUINOLINYL)AMINO)PENTYL)ETHYL)AMINO-, (+/-)-|Oxichloroquine;Oxychlorochin;2-[[4-[(7-Chloroquinolin-4-yl)amino]pentyl](ethyl)amino]ethanol"
PF-03814735,51346455,,"InChI=1S/C23H25F3N6O2/c1-12(33)27-11-20(34)32-18-7-8-19(32)16-9-14(5-6-15(16)18)30-22-28-10-17(23(24,25)26)21(31-22)29-13-3-2-4-13/h5-6,9-10,13,18-19H,2-4,7-8,11H2,1H3,(H,27,33)(H2,28,29,30,31)/t18-,19+/m0/s1",RYYNGWLOYLRZLK-RBUKOAKNSA-N,C23H25F3N6O2,474.5,"N-[2-[(1R,8S)-4-[[4-(cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]-11-azatricyclo[6.2.1.02,7]undeca-2(7),3,5-trien-11-yl]-2-oxoethyl]acetamide","PF-03814735|942487-16-3|PF 03814735|N-(2-((1S,4R)-6-((4-(Cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-1,2,3,4-tetrahydro-1,4-epiminonaphthalen-9-yl)-2-oxoethyl)acetamide|PF 3814735|PF-3814735|6V5T4O5758|PF03814735|DTXSID601025621|N-{2-[(1s,4r)-6-{[4-(Cyclobutylamino)-5-(Trifluoromethyl)pyrimidin-2-Yl]amino}-1,2,3,4-Tetrahydro-1,4-Epiminonaphthalen-9-Yl]-2-Oxoethyl}acetamide|RefChem:172226|DTXCID701509886|Aurora Kinase Inhibitor PF-03814735|N-(2-((1R,8S)-4-((4-(cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)-11-azatricyclo(6.2.1.0^(2,7))undeca-2(7),3,5-trien-11-yl)-2-oxoethyl)acetamide|CHEMBL4289017|N-[2-[(1R,8S)-4-[[4-(Cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]-11-azatricyclo[6.2.1.02,7]undeca-2(7),3,5-trien-11-yl]-2-oxoethyl]acetamide|UNII-6V5T4O5758|C23H25F3N6O2|RYYNGWLOYLRZLK-RBUKOAKNSA-N|34W|N-[2-[(1S,4R)-6-[[4-(Cyclobutylamino)-5-(trifluoromethyl)-2-pyrimidinyl]amino]-1,2,3,4-tetrahydronaphthalen-1,4-imin-9-yl]-2-oxoethyl]-acetamide|MFCD16659065|SCHEMBL13116638|BDBM50466804|HB1441|NSC801015|s2725|AKOS024458364|CS-0684|DB13059|NSC-801015|SDCCGSBI-0654456.P001|NCGC00346652-09|FP104134|HY-14574|MS-28801|PF 03814735 [WHO-DD]|NS00072539|E98887|BRD-K68747584-001-02-0|Q27265567|Z3041529866|N-[2-[(1R,8S)-4-[[4-(cyclobutylamino)-5-(trifluoromethyl)pyrimidin-2-yl]amino]-11-azatricyclo[6.2.1.02,7]undeca-2(7),3,5-trien-11-yl]-2-oxo-ethyl]acetamide"
TANZISERTIB,11597537,,"InChI=1S/C21H23F3N6O2/c22-11-7-15(23)18(16(24)8-11)28-21-27-17-9-25-20(26-12-1-3-14(31)4-2-12)29-19(17)30(21)13-5-6-32-10-13/h7-9,12-14,31H,1-6,10H2,(H,27,28)(H,25,26,29)/t12?,13-,14?/m0/s1",IBGLGMOPHJQDJB-MOKVOYLWSA-N,C21H23F3N6O2,448.4,"4-[[9-[(3S)-oxolan-3-yl]-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexan-1-ol","CC-930|RefChem:918157|TANZISERTIB|899805-25-5|Tanzisertib [USAN]|JNK930|CHEMBL1950289|JNK-930; JNKI-1|JNK-930|CC930|M5O06306UO|Tanzisertib (USAN)|(1S,4r)-4-((9-((S)-tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)cyclohexanol|trans-4-((9-((S)-tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)cyclohexanol|4-[[9-[(3S)-oxolan-3-yl]-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexan-1-ol|trans-4-((9-((3S)-Tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)cyclohexanol|Cyclohexanol, 4-((9-((3S)-tetrahydro-3-furanyl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)-, trans-|Trans-4-({9-[(3s)-Tetrahydrofuran-3-Yl]-8-[(2,4,6-Trifluorophenyl)amino]-9h-Purin-2-Yl}amino)cyclohexanol|Tanzisertib [USAN:INN]|UNII-M5O06306UO|3tti|MFCD23160040|CC-930(Tanzisertib)|TANZISERTIB [INN]|CC-930(Tanzisertib)?|GTPL9836|orb1308483|SCHEMBL2133055|SCHEMBL2133061|SCHEMBL2138755|SCHEMBL2138766|SCHEMBL2138776|SCHEMBL2604921|SCHEMBL4760419|SCHEMBL8082102|CHEMBL1950305|SCHEMBL15589918|JNK 930|C21H23F3N6O2|DTXSID601025671|DTXSID901026042|GLXC-10800|BCP16541|EX-A3115|BDBM50364378|NSC800943|ZB1592|AKOS030525451|compound 1 [PMID: 22244937]|CS-1544|DB11798|NSC-800943|NCGC00378972-01|AC-33706|HY-15495|Trans-4-((9-((3S)-tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2- yl)amino)cyclohexanol|NS00073317|C77038|D10168|BRD-K48213016-001-01-8|Q21547222|4-[[9-[(3S)-tetrahydrofuran-3-yl]-8-(2,4,6-trifluoroanilino)purin-2-yl]amino]cyclohexanol|(1S,4r)-4-((9-((S)-tetrahydrofuran-3-yl)-8-((2,4,6-trifluorophenyl)amino)-9H-purin-2-yl)amino)cyclohexan-1-ol|1629774-47-5|4-[[9-[(3s)-tetrahydro-3-furanyl]-8-[(2,4,6-trifluorophenyl)amino]-9h-purin-2-yl]amino]cyclohexanol|KBI|trans-4-(9-((S)-tetrahydrofuran-3-yl)-8-(2,4,6-trifluorophenylamino)-9H-purin-2-ylamino)cyclohexanol"
CRISABOROLE,44591583,,"InChI=1S/C14H10BNO3/c16-8-10-1-3-12(4-2-10)19-13-5-6-14-11(7-13)9-18-15(14)17/h1-7,17H,9H2",USZAGAREISWJDP-UHFFFAOYSA-N,C14H10BNO3,251.05,"4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile","Crisaborole|906673-24-3|AN-2728|AN2728|Eucrisa|AN 2728|Staquis|crisaborol|Crisaborole topical ointment 2%|Q2R47HGR7P|4-[(1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy]benzonitrile|CHEBI:134677|DTXSID10238231|4-((1-Hydroxy-1,3-dihydrobenzo(c)(1,2)oxaborol-6-yl)oxy)benzonitrile|4-[(1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy]benzonitrile|Benzonitrile, 4-((1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy)-|crisaborolum|4-((1-hydroxy-3H-2,1-benzoxaborol-5-yl)oxy)benzonitrile|4-((1-hydroxy-1,3-dihydro-2,1-benzoxaborol-5-yl)oxy)benzonitrile|Benzonitrile, 4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]-|RefChem:58963|D11AH06|DTXCID30160722|4-((1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy)benzonitrile|5-(4-cyanophenoxy)-2,3-dihydro-1-hydroxy-2,1-benzoxaborole|Crisaborole (AN2728)|MFCD17169940|C14H10BNO3|4-((1-HYDROXY-1,3-DIHYDROBENZO-[C][1,2]OXABOROL-5-YL)OXY)BENZONITRILE|CHEMBL484785|906673-25-4|4-[(1,3-dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile|4-(1-hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yloxy)benzonitrile|Crisaborole [USAN]|UNII-Q2R47HGR7P|4-[(1-Hydroxy-1,3-dihydrobenzo[c][1,2]oxaborol-5-yl)oxy]benzonitrile|Crisaborole [INN]|Eucrisa (TN)|Crisaborole (Standard)|CRISABOROLE [MI]|Crisaborole (USAN/INN)|Crisaborole [USAN:INN]|Crisaborole(AN-2728)?|CRISABOROLE [WHO-DD]|SCHEMBL595261|GTPL9151|orb1302987|SCHEMBL29352751|Crisaborole, >=98% (HPLC)|CRISABOROLE [ORANGE BOOK]|TQP0866|USZAGAREISWJDP-UHFFFAOYSA-N|GLXC-05433|HMS5084E11|BCP08677|EX-A1087|BDBM50277665|HY-10978R|AKOS016005425|CCG-266972|DB05219|SB16802|compound 5b [PMID: 19303290]|NCGC00345792-01|NCGC00345792-02|NCGC00345792-04|AC-30331|AS-70551|FC166718|HY-10978|SY113089|DB-078771|NS00073519|S5014|C90571|C90670|D10873|F51164|5-(4-cyanophenoxy)-1-hydroxy-2,1-benzoxaborole|EN300-7359142|F229171|BRD-K43230258-001-01-4|Q21098894|AN2728;4-[(1,3-Dihydro-1-hydroxy-2,1-benzoxaborol-5-yl)oxy]benzonitrile|1073669-75-6"
QUEMLICLUSTAT,130205852,,"InChI=1S/C20H24ClFN4O9P2/c1-10(11-4-2-3-5-13(11)22)24-14-6-16(21)25-19-12(14)7-23-26(19)20-18(28)17(27)15(35-20)8-34-37(32,33)9-36(29,30)31/h2-7,10,15,17-18,20,27-28H,8-9H2,1H3,(H,24,25)(H,32,33)(H2,29,30,31)/t10-,15+,17+,18+,20+/m0/s1",MFYLCAMJNGIULC-KCVUFLITSA-N,C20H24ClFN4O9P2,580.8,"[[(2R,3S,4R,5R)-5-[6-chloro-4-[[(1S)-1-(2-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid","Quemliclustat|AB-680|2105904-82-1|AB680|J6K8WSV73A|[[(2R,3S,4R,5R)-5-[6-chloro-4-[[(1S)-1-(2-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]methylphosphonic acid|(((2R,3S,4R,5R)-5-(6-chloro-4-(((1S)-1-(2-fluorophenyl)ethyl)amino)pyrazolo(3,4-b)pyridin-1-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-hydroxyphosphoryl)methylphosphonic acid|RefChem:178058|CD73 Inhibitor AB680|AB 680|Quemliclustat [USAN]|UNII-J6K8WSV73A|CHEMBL4471306|WHO 11621|[[(2~{R},3~{S},4~{R},5~{R})-5-[6-chloranyl-4-[[(1~{S})-1-(2-fluorophenyl)ethyl]amino]pyrazolo[3,4-b]pyridin-1-yl]-3,4-bis(oxidanyl)oxolan-2-yl]methoxy-oxidanyl-phosphoryl]methylphosphonic acid|Quemliclustat [WHO-DD]|QUEMLICLUSTAT [INN]|CD73 inhibitor AB-680|orb1310029|SCHEMBL19100484|SCHEMBL30373898|GTPL10707|GLXC-22667|EX-A4998|BDBM50527134|AKOS040732358|AC-36768|BA178946|HY-125286|CS-0090231|F78354|(((((2R,3S,4R,5R)-5-(6-chloro-4-(((S)-1-(2-fluorophenyl)ethyl)amino)-1H-pyrazolo[3,4-b]pyridin-1-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(hydroxy)phosphoryl)methyl)phosphonic acid|1H-Pyrazolo[3,4-b]pyridin-4-amine, 6-chloro-N-[(1S)-1-(2-fluorophenyl)ethyl]-1-[5-O-[hydroxy(phosphonomethyl)phosphinyl]-beta-D-ribofuranosyl]-|2-chloro-N6 -[(1S)-1-(2-fluorophenyl)ethyl]-8-aza-1,7- dicarbaadenosine 5'- (trihydrogen 2-carbadiphosphate)|QDH"
ENASIDENIB,89683805,,"InChI=1S/C19H17F6N7O/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32)",DYLUUSLLRIQKOE-UHFFFAOYSA-N,C19H17F6N7O,473.4,"2-methyl-1-[[4-[6-(trifluoromethyl)pyridin-2-yl]-6-[[2-(trifluoromethyl)pyridin-4-yl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol","Enasidenib|1446502-11-9|CC-90007 Free Base|enasidenibum|2-methyl-1-((4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)amino)propan-2-ol|3T1SS4E7AG|2-Methyl-1-(4-(6-(trifluoromethyl)pyridin-2-yl)-6-(2-(trifluoromethyl)pyridin-4-ylamino)-1,3,5-triazin-2-ylamino)propan-2-ol|2-Propanol, 2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]-|2-methyl-1-[[4-[6-(trifluoromethyl)pyridin-2-yl]-6-[[2-(trifluoromethyl)pyridin-4-yl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol|CHEBI:145374|DTXSID801027942|2-Propanol, 2-methyl-1-((4-(6-(trifluoromethyl)-2-pyridinyl)-6-((2-(trifluoromethyl)-4-pyridinyl)amino)-1,3,5-triazin-2-yl)amino)-|2-Methyl-1-[(4-[6-(Trifluoromethyl)pyridin-2-Yl]-6-{[2-(Trifluoromethyl)pyridin-4-Yl]amino}-1,3,5-Triazin-2-Yl)amino]propan-2-Ol|2-methyl-1-({4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl}amino)propan-2-ol|RefChem:58279|L01XX59|DTXCID401513509|107-597-8|2-Methyl-1-((4-(6-(trifluoromethyl)-2-pyridinyl)-6-((2-(trifluoromethyl)-4-pyridinyl)amino)-1,3,5-triazin-2-yl)amino)-2-propanol|AG-221|IDHIFA|AG-221 (Enasidenib)|Enasidenib [INN]|AG 221|MFCD29472245|UNII-3T1SS4E7AG|AG221|2-Methyl-1-(4-(6-(trifluoromethyl)pyridin-2-yl)-6-(2-(trifluoromethyl)pyridin-4-ylamino)-1,3,5-triazin-2-ylamino)propan-2-ol; AG 221; CC 90007 Free Base; Enasidenib; Idhifa|2-Methyl-1-[[4-[6-(trifluoromethyl)-2-pyridinyl]-6-[[2-(trifluoromethyl)-4-pyridinyl]amino]-1,3,5-triazin-2-yl]amino]-2-propanol;|AG-221(Enasidenib)|AG-221; Enasidenib|Enasidenib; AG-221|ENASIDENIB [MI]|Enasidenib (USAN/INN)|Enasidenib [USAN:INN]|AG-221(Enasidenib)?|ENASIDENIB [USAN]|ENASIDENIB [WHO-DD]|GTPL8960|orb1305629|CHEMBL3989908|SCHEMBL15102202|SCHEMBL29360046|C19H17F6N7O|EX-A654|DYLUUSLLRIQKOE-UHFFFAOYSA-N|HMS3873D03|HMS5086G09|HMS6018B03|BCP16041|BDBM50503251|NSC788120|s8205|AKOS026750439|CCG-269476|CS-5017|DB13874|NSC-788120|SB19193|NCGC00479249-03|NCGC00479249-05|AC-31318|AS-75164|DA-63188|FA145490|HY-18690|NS00073630|D10901|EN300-21679954|BRD-K70601687-001-01-3|Q27077182|AG-221; AG 221; AG221; CC-90007; CC 90007; CC90007|1802003-09-3|2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridyl]-6-[[2-(trifluoromethyl)-4-pyridyl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol|69Q"
ENASIDENIB MESYLATE,90480031,,"InChI=1S/C19H17F6N7O.CH4O3S/c1-17(2,33)9-27-15-30-14(11-4-3-5-12(29-11)18(20,21)22)31-16(32-15)28-10-6-7-26-13(8-10)19(23,24)25;1-5(2,3)4/h3-8,33H,9H2,1-2H3,(H2,26,27,28,30,31,32);1H3,(H,2,3,4)",ORZHZQZYWXEDDL-UHFFFAOYSA-N,C20H21F6N7O4S,569.5,"methanesulfonic acid;2-methyl-1-[[4-[6-(trifluoromethyl)pyridin-2-yl]-6-[[2-(trifluoromethyl)pyridin-4-yl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol","Enasidenib mesylate|1650550-25-6|AG-221 mesylate|Enasidenib mesilate|Enasidenib methanesulfonate|UNII-UF6PC17XAV|UF6PC17XAV|CC-90007|2-Methyl-1-((4-(6-(trifluoromethyl)pyridin-2-yl)-6-((2-(trifluoromethyl)pyridin-4-yl)amino)-1,3,5-triazin-2-yl)amino)propan-2-ol methanesulfonate|2-Propanol, 2-methyl-1-((4-(6-(trifluoromethyl)-2-pyridinyl)-6-((2-(trifluoromethyl)-4-pyridinyl)amino)-1,3,5-triazin-2-yl)amino)-, methanesulfonate (1:1)|RefChem:58280|Enasidenib (mesylate)|Enasidenibmesylate|Enasidenib mesylate [USAN]|1650550-25-6 (mesylate)|Enasidenib mesylate (USAN)|2-Methyl-1-[4-(6-trifluoromethyl-pyridin-2-yl)-6-(2-trifluoromethyl-pyridin-4-ylamino)-[1,3,5]triazin-2-ylamino]-propan-2-ol mesylate|methanesulfonic acid;2-methyl-1-[[4-[6-(trifluoromethyl)pyridin-2-yl]-6-[[2-(trifluoromethyl)pyridin-4-yl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol|Enasidenib Mesylate?|Idhifa (TN)|orb1703967|C20H21F6N7O4S|CHEMBL3989931|ENASIDENIB MESYLATE [MI]|SCHEMBL16448052|SCHEMBL29773080|WLZ3769|ORZHZQZYWXEDDL-UHFFFAOYSA-N|DTXSID501027943|HMS5086H16|HMS6018B06|BCP26166|EX-A1972|ENASIDENIB MESYLATE [WHO-DD]|HY-18690A|MFCD30489472|s4929|AKOS040745402|Enasidenib mesylate; AG-221 mesylate|AT36098|CS-7541|ENASIDENIB MESYLATE [ORANGE BOOK]|AC-31319|DA-63189|MS-30293|D11044|Q27291054|2-Methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]- 6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin- 2-yl)amino]propan-2-ol methanesulfonate|methanesulfonic acid;2-methyl-1-[[4-[6-(trifluoromethyl)-2-pyridyl]-6-[[2-(trifluoromethyl)-4-pyridyl]amino]-1,3,5-triazin-2-yl]amino]propan-2-ol"
BIMIRALISIB,58507717,,"InChI=1S/C17H20F3N7O2/c18-17(19,20)12-9-13(21)22-10-11(12)14-23-15(26-1-5-28-6-2-26)25-16(24-14)27-3-7-29-8-4-27/h9-10H,1-8H2,(H2,21,22)",ADGGYDAFIHSYFI-UHFFFAOYSA-N,C17H20F3N7O2,411.4,"5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine","Bimiralisib|1225037-39-7|PQR309|PI3K-IN-2|PQR-309|5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine|NCB5|6Z3QHB00LB|NC-B5|MFCD28902193|Bimiralisib [INN]|Bimiralisib [USAN]|Bimiralisib [WHO-DD]|Bimiralisib (PQR309)|CHEMBL4084907|5-(4,6-dimorpholin-4-yl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine|2-Pyridinamine, 5-(4,6-di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)-|5-[bis(morpholin-4-yl)-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine|bimiralisibum|5-(4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine|5-(bis(morpholin-4-yl)-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridin-2-amine|5-[4,6-bis(morpholin-4-yl)-1,3,5-triazin-2-yl]-4-(trifluoromethyl)pyridin-2-amine|PQR309; Bimiralisib|PQR-309(Bimiralisib)|Bimiralisib (USAN/INN)|RefChem:1079871|PQR-309(Bimiralisib)?|UNII-6Z3QHB00LB|GTPL8383|orb1305862|SCHEMBL1309049|PQR309; Bimiralisib free base|SCHEMBL29352266|PQR 309|C17H20F3N7O2|Bimiralisib [USAN:INN:WHO-DD]|BCP15887|EX-A2018|BDBM50240975|NSC785117|s8738|AKOS027439949|CS-4672|DB14846|NSC-785117|AC-31532|AS-49856|HY-12868|SY244739|D11440|N11425|BRD-K62374002-001-01-5|Q27088437|2-Amino-5-(4,6-dimorpholino-1,3,5-triazin-2-yl)-4-(trifluoromethyl)pyridine|5-(4,6-Di-4-morpholinyl-1,3,5-triazin-2-yl)-4-(trifluoromethyl)-2-pyridinamine|A3W"
DAPANSUTRILE,12714644,,"InChI=1S/C4H7NO2S/c1-8(6,7)4-2-3-5/h2,4H2,1H3",LQFRYKBDZNPJSW-UHFFFAOYSA-N,C4H7NO2S,133.17,3-methylsulfonylpropanenitrile,"Dapansutrile|54863-37-5|OLT1177|OLT-1177|3-methylsulfonylpropanenitrile|Dapansutrilo|Propanenitrile, 3-(methylsulfonyl)-|3-Methylsulfonylpropionitrile|2Z03364G96|DTXSID601336541|dapansutrilum|OLT117|RefChem:585178|DTXCID301766739|OLT 1177|3-methanesulfonylpropanenitrile|3-(methylsulfonyl)propanenitrile|MFCD11934305|Dapansutrile [INN]|3-(methanesulfonyl)propanenitrile|Dapansutrile (USAN/INN)|Dapansutrile [USAN:INN]|DAPANSUTRILE [USAN]|Dapansutrile (OLT1177)|Dapansutrile(OLT1177)?|DAPANSUTRILE [WHO-DD]|3-methylsulphonyl-propionitrile|SCHEMBL9934796|CHEMBL3989943|GTPL10056|LQFRYKBDZNPJSW-UHFFFAOYSA-N|GLXC-23578|UNII-2Z03364G96|EX-A4519|BDBM50505850|s8907|AKOS010140086|AC-36465|BS-45330|DA-62667|HY-17629|CS-0016785|D5955|D10920|E74469|EN300-332757|Q27255815|Z608063222"
DEUCRAVACITINIB,134821691,,"InChI=1S/C20H22N8O3/c1-21-20(30)16-14(9-15(25-26-16)24-19(29)11-7-8-11)23-13-6-4-5-12(17(13)31-3)18-22-10-28(2)27-18/h4-6,9-11H,7-8H2,1-3H3,(H,21,30)(H2,23,24,25,29)/i1D3",BZZKEPGENYLQSC-FIBGUPNXSA-N,C20H22N8O3,425.5,"6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide","Deucravacitinib|1609392-27-9|BMS-986165|Sotyktu|N0A21N6RAU|RefChem:58358|Tyk2-IN-4|BMS986165|6-(cyclopropanecarbonylamino)-4-[2-methoxy-3-(1-methyl-1,2,4-triazol-3-yl)anilino]-N-(trideuteriomethyl)pyridazine-3-carboxamide|Deucravacitinib [USAN]|MFCD31715455|Tyk2-IN-4(BMS986165)|6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide|6-[(Cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-N-(methyl-d3)-3-pyridazinecarboxamide|Sotyktu (TN)|UNII-N0A21N6RAU|Deucravacitinib (JAN/USAN)|DEUCRAVACITINIB [INN]|DEUCRAVACITINIB [JAN]|orb1308545|CHEMBL4435170|DEUCRAVACITINIB [WHO-DD]|SCHEMBL20520348|SCHEMBL29424395|Deucravacitinib(BMS986165)?|GTPL10432|C20H22N8O3|GLXC-20380|EX-A3154|JPC39227|BDBM50507816|NSC825520|s8879|WHO 11342|AKOS040741395|AT18623|NSC-825520|compound 11 [PMID: 31318208}|NCGC00687789-01|(BMS-986165)|AC-31543|MS-27491|HY-117287|CS-0065044|D11817|EN300-22276121|3-Pyridazinecarboxamide, 6-((cyclopropylcarbonyl)amino]-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)N-(methyl-d3)-|3-Pyridazinecarboxamide, 6-[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-N-(methyl-d3)-|6-((cyclopropylcarbonyl)amino]-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-((2H3)methyl)pyridazine-3-carboxamide|6-cyclopropaneamido-4-{[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino}-N-(2H3)methylpyridazine-3-carboxamide|Deucravacitinib; 3-Pyridazinecarboxamide, 6-[(cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-N-(methyl-d3)-; 6-[(Cyclopropylcarbonyl)amino]-4-[[2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl]amino]-N-(methyl-d3)-3-pyridazineca"
LBQ-657,10430040,,"InChI=1S/C22H25NO5/c1-15(22(27)28)13-19(23-20(24)11-12-21(25)26)14-16-7-9-18(10-8-16)17-5-3-2-4-6-17/h2-10,15,19H,11-14H2,1H3,(H,23,24)(H,25,26)(H,27,28)/t15-,19+/m1/s1",DOBNVUFHFMVMDB-BEFAXECRSA-N,C22H25NO5,383.4,"(2R,4S)-4-(3-carboxypropanoylamino)-2-methyl-5-(4-phenylphenyl)pentanoic acid","Sacubitrilat|149709-44-4|LBQ657|LBQ-657|(2R,4S)-5-([1,1'-Biphenyl]-4-yl)-4-(3-carboxypropanamido)-2-methylpentanoic acid|SPI5PBF81S|DTXSID10164369|(2R,4S)-5-(Biphenyl-4-yl)-4-((3-carboxypropionyl)amino)-2-methylpentanoic acid|sacubitrilate|sacubitrilatum|(2R,4S)-4-((4-hydroxy-4-oxobutanoyl)amino)-2-methyl-5-(4-phenylphenyl)pentanoic acid|(2R,4S)-4-[(4-hydroxy-4-oxobutanoyl)amino]-2-methyl-5-(4-phenylphenyl)pentanoic acid|(2R,4S)-5-((1,1'-biphenyl)-4-yl)-4-(3-carboxypropanamido)-2-methylpentanoic acid|(2R,4S)-5-{[1,1'-biphenyl]-4-yl}-4-(3-carboxypropanamido)-2-methylpentanoic acid|RefChem:180798|DTXCID8086860|Desethyl Sacubitril|MFCD00921225|CHEMBL417007|(2R,4S)-4-(3-carboxypropanoylamino)-2-methyl-5-(4-phenylphenyl)pentanoic Acid|[1,1'-Biphenyl]-4-pentanoic acid, gamma-[(3-carboxy-1-oxopropyl)amino]-alpha-methyl-, (alphaR,gammaS)-|UNII-SPI5PBF81S|LBQ 657|[S-(R*,S*)]-?-[(3-Carboxy-1-oxopropyl)amino]-a-methyl-[1,1'-Biphenyl]-4-pentanoic Acid; (2R,4S)-4-[(3-Carboxy-1-oxopropyl)amino]-4-[(p-phenylphenyl)methyl]-2-methylbutanoic Acid; (2R,4S)-5-(Biphenyl-4-yl)-4-[(3-carboxypropionyl)amino]-2-methylpentanoic Acid; Sacubitrilat; LBQ 657|SACUBITRILAT [MI]|LCZ-696 Impurity 1|SACUBITRILAT [INN]|LBQ-657(Sacubitrilat)?|SACUBITRILAT [WHO-DD]|SCHEMBL391633|GTPL7858|orb1296199|DOBNVUFHFMVMDB-BEFAXECRSA-N|ZFA70944|BDBM50034842|s3388|AKOS027430337|CS-6593|DB14127|DA-77644|DS-18950|HY-17620|LBQ657, >=97% (HPLC)|NS00068594|C72846|F516470|Q27088681|(2R,4S)-4-(3-carboxypropanoylamino)-2-methyl-5-(4-phenylphenyl)pentanoic acidEE|(2R,4S)-5-([1,1'-biphenyl]-4-yl)-4-[(3-carboxypropanoyl)amino]-2-methylpentanoic acid|(2R,4S)-5-Biphenyl-4-yl-4-(3-carboxy-propionylamino)-2-methyl-pentanoic acid|(2R,4S)-5-Biphenyl-4-yl-4-(3-carboxypropionylamino)-2-methyl-pentanoic acid|[1,1'-Biphenyl]-4-pentanoic acid, |A-[(3-carboxy-1-oxopropyl)amino]-|A-methyl-, (|AR,|AS)-|6LD"
LAROTRECTINIB SULFATE,67330085,,"InChI=1S/C21H22F2N6O2.H2O4S/c22-13-3-4-16(23)15(10-13)18-2-1-7-28(18)19-6-9-29-20(26-19)17(11-24-29)25-21(31)27-8-5-14(30)12-27;1-5(2,3)4/h3-4,6,9-11,14,18,30H,1-2,5,7-8,12H2,(H,25,31);(H2,1,2,3,4)/t14-,18+;/m0./s1",PXHANKVTFWSDSG-QLOBERJESA-N,C21H24F2N6O6S,526.5,"(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide;sulfuric acid","Larotrectinib sulfate|1223405-08-0|LOXO-101 sulfate|ARRY-470 sulfate|RDF76R62ID|LOXO 101 sulfate|UNII-RDF76R62ID|1-Pyrrolidinecarboxamide, N-[5-[(2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-, (3S)-, sulfate (1:1)|1-Pyrrolidinecarboxamide, N-(5-((2R)-2-(2,5-difluorophenyl)-1-pyrrolidinyl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxy-, (3S)-, sulfate (1:1)|(3S)-N-(5-((2R)-2-(2,5-DIFLUOROPHENYL)PYRROLIDIN-1-YL)PYRAZOLO(1,5-A)PYRIMIDIN-3-YL)-3-HYDROXYPYRROLIDINE-1-CARBOXAMIDE SULFATE (1:1)|(3S)-N-{5-[(2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl}-3-hydroxypyrrolidine-1-carboxamide sulfate (1:1)|ARRY 470 Sulfate|RefChem:57160|(3S)-N-(5-((2R)-2-(2,5-Difluorophenyl)pyrrolidin-1-yl)pyrazolo(1,5-a)pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide  monosulfate|LOXO-101 (sulfate)|(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide sulfate|Larotrectinib sulfate [USAN]|Vitrakvi|(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxypyrrolidine-1-carboxamide;sulfuric acid|MFCD29472286|Larotrectinib sulfate;LOXO101|C21H24F2N6O6S|Vitrakvi (TN)|Larotrectinib (LOXO-101) sulfate|LOXO 101 sulfate;(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide Sulfate|Larotrectinib sulphate|LOXO-101(sulfate)|orb1300381|SCHEMBL2239598|CHEMBL3989939|SCHEMBL29735039|EX-A1981A|PXHANKVTFWSDSG-QLOBERJESA-N|DTXSID401026485|HMS3886N19|Larotrectinib sulfate (JAN/USAN)|LAROTRECTINIB SULFATE [MI]|LAROTRECTINIB SULFATE [JAN]|(3S)-N-[5-[(2R)-2-(2,5-Difluorophenyl)-1-pyrrolidinyl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-1-pyrrolidinecarboxamide sulfate|Larotrectinib (LOXO-101 sulfate)|HY-12866A|Larotrectinib (LOXO-101 sulfate)?|s7960|AKOS030526332|LAROTRECTINIB SULFATE [WHO-DD]|CCG-269890|CS-5314|AC-30671|BL161518|DA-65063|MS-29743|LAROTRECTINIB SULFATE [ORANGE BOOK]|D11138|(3S)-N-[5-[(2R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl]pyrazolo[1,5-a]pyrimidin-3-yl]-3-hydroxy-pyrrolidine-1-carboxamide;sulfuric acid|(S)-N-(5-((R)-2-(2,5-difluorophenyl)pyrrolidin-1-yl)-pyrazolo[1,5-a]pyrimidin-3-yl)-3-hydroxypyrrolidine-1-carboxamide hydrogen sulfate"
VS-4718,25073775,,"InChI=1S/C25H26F3N5O3/c1-29-24(34)17-5-3-4-6-19(17)31-21-14-23(30-15-18(21)25(26,27)28)32-20-8-7-16(13-22(20)35-2)33-9-11-36-12-10-33/h3-8,13-15H,9-12H2,1-2H3,(H,29,34)(H2,30,31,32)",IGUBBWJDMLCRIK-UHFFFAOYSA-N,C25H26F3N5O3,501.5,2-[[2-(2-methoxy-4-morpholin-4-ylanilino)-5-(trifluoromethyl)pyridin-4-yl]amino]-N-methylbenzamide,"1061353-68-1|PND-1186|VS-4718|PND1186|PND 1186|L2BD0MW4OL|SR-2516|Benzamide, 2-[[2-[[2-methoxy-4-(4-morpholinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyridinyl]amino]-N-methyl-|2-[[2-(2-methoxy-4-morpholin-4-ylanilino)-5-(trifluoromethyl)pyridin-4-yl]amino]-N-methylbenzamide|2-(2-(2-Methoxy-4-morpholinophenylamino)-5-(trifluoromethyl)pyridine-4-ylamino)-N-methylbenzamide|Benzamide, 2-((2-((2-methoxy-4-(4-morpholinyl)phenyl)amino)-5-(trifluoromethyl)-4-pyridinyl)amino)-N-methyl-|2-[(2-{[2-methoxy-4-(morpholin-4-yl)phenyl]amino}-5-(trifluoromethyl)pyridin-4-yl)amino]-N-methylbenzamide|2-((2-((2-methoxy-4-(morpholin-4-yl)phenyl)amino)-5-(trifluoromethyl)pyridin-4-yl)amino)-N-methylbenzamide|2-((2-(2-methoxy-4-morpholin-4-ylanilino)-5-(trifluoromethyl)pyridin-4-yl)amino)-N-methylbenzamide|RefChem:194644|FAK Inhibitor VS-4718|SR2516|2-((2-((2-Methoxy-4-morpholinophenyl)amino)-5-(trifluoromethyl)pyridin-4-yl)amino)-N-methylbenzamide|MFCD28125506|SR 2516|VS 4718|2-(2-(2-methoxy-4-morpholinophenylamino)-5-(trifluoromethyl)pyridin-4-ylamino)-N-methylbenzamide|CHEMBL2430358|2-((2-((2-methoxy-4-morpholinophenyl)amino)-5-(trifluoromethyl)pyridin-4-yl)amino)-N-methylbenzamide.|SR-2156|PND-1186 (VS-4718)|UNII-L2BD0MW4OL|SCHEMBL47360|GTPL8742|orb1307003|CHEMBL3040440|SCHEMBL29381276|SCHEMBL29478885|SCHEMBL29493098|Vs-4718(pnd1186)|EX-A505|GLXC-05729|HMS3673G09|BCP10711|BDBM50440659|NSC783102|PND-1186?|s7653|VS4718|AKOS026750279|CCG-269701|CS-1584|DB15273|NSC-783102|SB17061|NCGC00378620-04|AC-33052|AS-55857|DA-48063|FP103465|HY-13917|BRD-K09877029-001-01-2|Q27089163|2-[[2-(2-methoxy-4-morpholino-anilino)-5-(trifluoromethyl)-4-pyridyl]amino]-N-methyl-benzamide|2-[[2-[[2-Methoxy-4-(4-morpholinyl)phenyl]amino]-5-(trifluoromethyl)-4-pyridinyl]amino]-N-methylbenzamide;SR 2516;VS 4718|N-Methyl-2-{[2-{[-2-(methyloxy)-4-(4-morpholinyl)phenyl]amino}-5-(trifluoromethyl)-4-pyridinyl]amino}benzamide"
DEFACTINIB,25117126,,"InChI=1S/C20H21F3N8O3S/c1-24-18(32)12-4-6-13(7-5-12)29-19-28-10-14(20(21,22)23)16(30-19)27-11-15-17(26-9-8-25-15)31(2)35(3,33)34/h4-10H,11H2,1-3H3,(H,24,32)(H2,27,28,29,30)",FWLMVFUGMHIOAA-UHFFFAOYSA-N,C20H21F3N8O3S,510.5,N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide,"Defactinib|1073154-85-4|VS-6063|N-methyl-4-((4-(((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide|53O87HA2QU|Benzamide, N-methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)-2-pyrazinyl)methyl)amino)-5-(trifluoromethyl)-2-pyrimidinyl)amino)-|N-methyl-4-((4-(((3-methyl(methylsulfonyl)aminopyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide|defactinibum|RefChem:919757|N-methyl-4-((4-(((3-(N-methylmethanesulfonamido)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide|PF-04554878|1345713-71-4|N-methyl-4-[[4-[[3-[methyl(methylsulfonyl)amino]pyrazin-2-yl]methylamino]-5-(trifluoromethyl)pyrimidin-2-yl]amino]benzamide|Defactinib (VS-6063, PF-04554878)|MFCD25977806|VS 6063|VS6063|N-Methyl-4-((4-(((3-(methyl(methylsulfonyl)amino)pyrazin-2-yl)methyl)amino)-5-(trifluoromethyl)pyrimidin-2-yl)amino)benzamide|C20H21F3N8O3S|Defactinib [USAN:INN]|UNII-53O87HA2QU|Defactinib [USAN]|DEFACTINIB [INN]|Defactinib (USAN/INN)|PF 04554878|DEFACTINIB [WHO-DD]|GTPL7910|orb1183414|orb1306800|SCHEMBL1627234|CHEMBL3137331|FWLMVFUGMHIOAA-UHFFFAOYSA-N|BDBM418817|DTXSID901025937|HMS3740O13|BCP11299|EX-A1037|EX-A1049|NSC778364|NSC781450|NSC782549|NSC800089|s7654|US10450297, Example 317|US10450297, Example 318|AKOS026750300|CCG-269780|CS-3410|DB12282|NSC-778364|NSC-781450|NSC-782549|NSC-800089|SB17060|NCGC00386425-06|NCGC00386425-11|AC-35820|AS-17045|DA-34914|DA-45890|FD103987|HY-12289|NS00073320|D10618|Defactinib (VS-6063, PF-04554878)?|VS-6063;PF-04554878|BRD-K43578482-001-01-4|BRD-K43578482-001-02-2|Q27077009|7KD|N-methyl-4-({4-[({3- [methyl(methylsulfonyl)amino]pyrazin-2- yl}methyl)amino]-5- (trifluoromethyl)pyrimidin-2- yl}amino)benzamide (317)|N-methyl-4-(4-((3-(N-methylmethylsulfonamido)pyrazin-2-yl)methylamino)-5-(trifluoromethyl)pyrimidin-2-ylamino)benzamide"
PARSACLISIB,86677874,,"InChI=1S/C20H22ClFN6O2/c1-4-30-18-12(6-13(21)17(22)16(18)11-5-14(29)24-7-11)10(3)28-20-15(9(2)27-28)19(23)25-8-26-20/h6,8,10-11H,4-5,7H2,1-3H3,(H,24,29)(H2,23,25,26)/t10-,11-/m0/s1",ZQPDJCIXJHUERQ-QWRGUYRKSA-N,C20H22ClFN6O2,432.9,"(4R)-4-[3-[(1S)-1-(4-amino-3-methylpyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy-6-fluorophenyl]pyrrolidin-2-one","Parsaclisib|1426698-88-5|INCB050465|INCB-050465|OS7097575K|WHO 10589|2-Pyrrolidinone, 4-(3-((1S)-1-(4-amino-3-methyl-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)-, (4R)-|(4R)-4-(3-((1S)-1-(4-Amino-3-methyl-1H-pyrazolo(3,4-d)pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one|IBI376|parsaclisibum|INCB50465|(4R)-4-{3-[(1S)-1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy-6-fluorophenyl}pyrrolidin-2-one|RefChem:858696|INCB 50465|INCB-50465|Parsaclisib [INN]|Parsaclisib [USAN]|(4R)-4-[3-[(1S)-1-(4-amino-3-methylpyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy-6-fluorophenyl]pyrrolidin-2-one|C20H22ClFN6O2|Parsaclisib?|Parsaclisib (USAN/INN)|Parsaclisib [USAN:INN]|INCB050465 free base|PARSACLISIB [WHO-DD]|INCB-050465 free base|orb1309280|CHEMBL4297615|SCHEMBL14736228|SCHEMBL30089288|UNII-OS7097575K|ZQPDJCIXJHUERQ-QWRGUYRKSA-N|BDBM272573|EX-A2638|MFCD31692358|AKOS040733972|DB14867|AC-36916|MS-27730|US10065963, 32c|HY-109068|CS-0033435|D11437|G16370|(4R)-4-[3-[(1S)-1-(4-amino-3-methyl-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl]-5-chloro-2-ethoxy-6-fluoro-phenyl]pyrrolidin-2-one|(R)-4-(3-((S)-1-(4-amino-3-methyl-1H-pyrazolo[3,4-d]pyrimidin-1-yl)ethyl)-5-chloro-2-ethoxy-6-fluorophenyl)pyrrolidin-2-one"
OXYCODONE,5284603,,"InChI=1S/C18H21NO4/c1-19-8-7-17-14-10-3-4-12(22-2)15(14)23-16(17)11(20)5-6-18(17,21)13(19)9-10/h3-4,13,16,21H,5-9H2,1-2H3/t13-,16+,17+,18-/m1/s1",BRUQQQPBMZOVGD-XFKAJCMBSA-N,C18H21NO4,315.4,"(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one","oxycodone|Dihydrone|Dihydrohydroxycodeinone|Dihydroxycodeinone|Diphydrone|76-42-6|Oxicodona|Endone|Oxanest|Dihydro-14-hydroxycodeinone|(-)-14-Hydroxydihydrocodeinone|Oxycodonum|Xtampza|Remoxy|OxyIR|Endine (Australia)|14-Hydroxydihydrocodeinone|Xtampza ER|Eubine [France]|Supendol [Canada]|Codeinone, dihydrohydroxy-|Pavinal|PTI-821|Oxycodone cii|Codeinone, dihydro-14-hydroxy-|oxymorphone 3-methyl ether|(-)-Oxycodone|4,5alpha-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Pancodone retard (United Kingdom)|4,5-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Pti 821|NSC-19043|PF-00345439|Codeinone, 7,8-dihydro-14-hydroxy-|CD35PMG570|CHEBI:7852|IDS-NO-002|N02AA05|DTXSID5023407|Eubine (France)|Morphinan-6-one, 4,5alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-|Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5alpha)-|NSC19043|Supendol (Canada)|Oxycodeinon|Oxycone|(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinolin-7-one|oxicodone|Proladone|Oxycodone SR|(1S,5R,13R,17S)-17-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo(9.6.1.0^(1,13).0^(5,17).0^(7,18))octadeca-7(18),8,10-trien-14-one|(1S,5R,13R,17S)-17-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo[9.6.1.0^{1,13}.0^{5,17}.0^{7,18}]octadeca-7(18),8,10-trien-14-one|(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinolin-7-one|(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro(3,2-e)isoquinoline-7-one|(4R,4aS,7aR,12bS)-4a-hydroxy-9-methoxy-3-methyl-2,4,5,6,7a,13-hexahydro-1H-4,12-methanobenzofuro[3,2-e]isoquinoline-7-one|RefChem:6478|DTXCID903407|thecodinum (for the hydrochloride)|(1S,5R,13R,17S)-17-hydroxy-10-methoxy-4-methyl-12-oxa-4-azapentacyclo(9.6.1.01,13.05,17.07,18)octadeca-7(18),8,10-trien-14-one|200-960-2|Oxycodeinone|Oxicon|Eucodalum|Oxycodon|Percobarb|Oxycontin|Eucodal|Oxycodonum [INN-Latin]|Oxicodona [INN-Spanish]|Oxicone|DEA No. 9143|Oxyfast|Supendol|Tekodin (free base)|Ossicodone [DCIT]|Ossicodone|Pancodine|NSC 19043|Oxycodone [USAN:INN:BAN]|Dihydrohydroxycondeinone|Avridi|Oxyneo|14-hydroxy-3-methoxy-17-methyl-5beta-4,5-epoxymorphinan-6-one|Pancodone Retard|Apo-oxycodone CR|CHEMBL656|HSDB 3142|Oxycodone (USAN/INN)|EINECS 200-960-2|BRN 0043446|UNII-CD35PMG570|4,5.alpha.-Epoxy-14-hydroxy-3-methoxy-17-methylmorphinan-6-one|Morphinan-6-one, 4,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5.alpha.)-|OOX|OXYCODONE [INN]|OXYCODONE [MI]|OXYCODONE [HSDB]|OXYCODONE [USAN]|OXYCODONE [VANDF]|OXYCODONE [MART.]|OXYCODONE [WHO-DD]|SCHEMBL2737|14-cis-Hydroxydihydrocodeinone|GTPL7093|PF06|OXYCODONE [ORANGE BOOK]|OXYCODONE CII [USP-RS]|SCHEMBL29391732|Codeinone,8-dihydro-14-hydroxy-|Oxycodone 0.1 mg/ml in Methanol|Oxycodone 1.0 mg/ml in Methanol|14-hydroxy-3-methoxy-17-methyl-4,5alpha-epoxymorphinan-6-one|BDBM50370595|Morphinan-6-one, 4,5-alpha-epoxy-14-hydroxy-3-methoxy-17-methyl-|(5alpha)-14-hydroxy-17-methyl-3-(methyloxy)-4,5-epoxymorphinan-6-one|DB00497|AC-16043|DB-243425|C08018|D05312|Q407535|Morphinan-6-one,5.alpha.-epoxy-14-hydroxy-3-methoxy-17-methyl-|HYDROCODONE HYDROGEN TARTRATE 2.5-HYDRATE IMPURITY D [EP IMPURITY]|Morphinan-6-one,5-epoxy-14-hydroxy-3-methoxy-17-methyl-, (5.alpha.)-|WLN: T B6566 B6/CO 4ABBC R BX FV HO PN GHT&&TTJ CQ JO1 P1|(5.ALPHA.)-4,5-EPOXY-14-HYDROXY-3-METHOXY-17-METHYLMORPHINAN-6-ONE|4aH-8,5-bcd]furan-5(6H)-one, 7,7a,8,9-tetrahydro-7a-hydroxy-3-methoxy-12-methyl-"
SOTORASIB,137278711,,"InChI=1S/C30H30F2N6O3/c1-6-23(40)36-12-13-37(18(5)15-36)28-19-14-21(32)26(24-20(31)8-7-9-22(24)39)34-29(19)38(30(41)35-28)27-17(4)10-11-33-25(27)16(2)3/h6-11,14,16,18,39H,1,12-13,15H2,2-5H3/t18-/m0/s1",NXQKSXLFSAEQCZ-SFHVURJKSA-N,C30H30F2N6O3,560.6,"6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one","Sotorasib|AMG-510|2296729-00-3|AMG510|Lumakras|AMG 510|Kras G12C inhibitor 9|Kras mutant-targeting AMG 510|2B2VM6UC8G|CHEBI:178199|6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-[(2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one|(1m)-6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(propan-2-yl)pyridin-3-yl)-4-((2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl)pyrido(2,3-d)pyrimidin-2(1H)-one|6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-propan-2-ylpyridin-3-yl)-4-((2S)-2-methyl-4-prop-2-enoylpiperazin-1-yl)pyrido(2,3-d)pyrimidin-2-one|6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-(1M)-1-(4-METHYL-2-(PROPAN-2-YL)PYRIDIN-3-YL)-4-((2S)-2-METHYL-4-(PROP-2-ENOYL)PIPERAZIN-1-YL)PYRIDO(2,3-D)PYRIMIDIN-2(1H)-ONE|6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(propan-2-yl)pyridin-3-yl)-4-((2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl)-1H,2H-pyrido(2,3-d)pyrimidin-2-one|6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]-1H,2H-pyrido[2,3-d]pyrimidin-2-one|RefChem:56869|Pyrido(2,3-d)pyrimidin-2(1H)-one, 6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(4-methyl-2-(1-methylethyl)-3-pyridinyl)-4-((2S)-2-methyl-4-(1-oxo-2-propen-1-yl)-1-piperazinyl)-|AMG-510 racemate|2252403-56-6|4-((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one|SOTORASIB RACEMATE|Sotorasib [INN]|Sotorasib [USAN]|CHEMBL4535757|2296729-00-3 (racemate)|(1R)-4-((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one|2296729-66-1|C30H30F2N6O3|(1S)-4-((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H)-one|AMG510 racemate|sotorasibum|Lumykras|Sotolasib|Sotorasib isomer|AMG-510(racemate)|SOTORASIB [JAN]|AMG-510(Sotorasib)|Sotorasib (AMG510)|Sotorasib [USAN:INN]|UNII-2B2VM6UC8G|SOTORASIB [WHO-DD]|orb1306045|SOTORASIB [ORANGE BOOK]|SCHEMBL20560375|SCHEMBL29366594|SCHEMBL29423731|GTPL10678|AMG 510 pound>>AMG-510|DTXSID001099260|GLXC-21101|GLXC-25372|AMG510-3(R/S)|BCP30452|BCP33368|EX-A3538|BDBM50514402|NSC818433|WHO 11370|AKOS037649138|DB15569|NSC-818433|AC-35168|BA172505|BS-16684|HY-114277|CS-0081316|compound (R)-38 [PMID: 31820981]|D70074|D77975|AMG510 ; AMG 510; AMG-510; AMG510|((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-(2-isopropyl-4-methylpyridin-3(R/S)-yl)pyrido[2,3-d]pyrimidin-2(1H)-one|(1RA)-6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-4-((2S)-2-METHYL-4-(1-OXOPROP-2-EN-1-YL)PIPERAZIN-1-YL)-1-(4-METHYL-2-(PROPAN-2-YL)PYRIDIN-3-YL)PYRIDO(2,3-D)PYRIMIDIN-2(1H)-ONE|4-((S)-4-Acryloyl-2-methylpiperazin-1-yl)-6-fluoro-7-(2-fluoro-6-hydroxy phenyl)-1-(2-isopropyl-4-methylpyridin-3-yl)pyrido[2,3-d]pyrimidin-2(1H) -one|6-fluoro-7-(2-fluoro-6-hydroxy-phenyl)-1-(2-isopropyl-4-methyl-3-pyridyl)-4-[(2S)-2-methyl-4-prop-2-enoyl-piperazin-1-yl]pyrido[2,3-d]pyrimidin-2-one|6-Fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(2-propanyl)-3-pyridinyl]-4-[(2S)-2-methyl-4-(2-propenoyl)-1-piperazinyl]pyrido[2,3-d]pyrimidin-2(1H)-one|6-fluoro-7-(2-fluoro-6-hydroxyphenyl)-1-[4-methyl-2-(propan-2-yl)pyridin-3-yl]-4-[(2S)-2-methyl-4-(prop-2-enoyl)piperazin-1-yl]pyrido[2,3-d]pyrimidin-2(1H)-one|PYRIDO(2,3-D)PYRIMIDIN-2(1H)-ONE, 6-FLUORO-7-(2-FLUORO-6-HYDROXYPHENYL)-1-(4-METHYL-2-(1-METHYLETHYL)-3-PYRIDINYL)-4-((2S)-2-METHYL-4-(1-OXO-2-PROPEN-1-YL)-1-PIPERAZINYL)-, (1R)-"
GILTERITINIB,49803313,,"InChI=1S/C29H44N8O3/c1-4-23-28(31-20-9-17-40-18-10-20)34-29(26(33-23)27(30)38)32-21-5-6-24(25(19-21)39-3)37-11-7-22(8-12-37)36-15-13-35(2)14-16-36/h5-6,19-20,22H,4,7-18H2,1-3H3,(H2,30,38)(H2,31,32,34)",GYQYAJJFPNQOOW-UHFFFAOYSA-N,C29H44N8O3,552.7,6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide,"Gilteritinib|1254053-43-4|ASP2215|ASP-2215|gilteritinibum|ASP 2215|66D92MGC8M|6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide|2-Pyrazinecarboxamide, 6-ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-|CHEBI:145372|DTXSID701027949|2-Pyrazinecarboxamide, 6-ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-|6-ethyl-3-((3-methoxy-4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-((tetrahydro-2H-pyran-4-yl)amino)-2-pyrazinecarboxamide|RefChem:58108|L01XE54|DTXCID601513517|6-ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-((oxan-4-yl)amino)pyrazine-2-carboxamide|MFCD28144685|6-Ethyl-3-((3-methoxy-4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)-amino)-5-((tetrahydro-2H-pyran-4-yl)amino)pyrazine-2-carboxamide|Gilteritinib HCl|6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide|Gilteritinib (ASP2215)|6-ethyl-3-[[3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-5-(oxan-4-ylamino)pyrazine-2-carboxamide|Gilteritinib [USAN:INN]|UNII-66D92MGC8M|C29H44N8O3|ASP 2215; 6-Ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[(tetrahydro-2H-pyran-4-yl)amino]-2-pyrazinecarboxamide|C6F|Gilteritinib (Standard)|GILTERITINIB [MI]|Gilteritinib(ASP2215)|Gilteritinib (USAN/INN)|GILTERITINIB [INN]|GILTERITINIB [USAN]|Gilteritinib(ASP2215)?|Gilteritinib (ASP-2215)|GILTERITINIB [WHO-DD]|SCHEMBL282229|GTPL8708|orb1302883|CHEMBL3301622|SCHEMBL29355822|SCHEMBL29432551|BDBM144315|GLXC-07407|HMS5085F20|BCP28756|EX-A2775|HY-12432R|NSC787846|NSC787854|NSC788454|NSC800106|s7754|SP2215|AKOS030234455|CCG-270016|CS-3885|DB12141|NSC-787846|NSC-787854|NSC-788454|NSC-800106|SB16988|NCGC00481652-01|NCGC00481652-02|NCGC00481652-03|AC-29030|AS-35199|BG166434|BP-43655|HY-12432|SY099594|DB-108103|NS00073358|D10709|US8969336, 547|US8969336, 577|BRD-K72280606-001-01-2|Q27077802|6-ethyl-3-({3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide|6-Ethyl-3-[[3-methoxy-4-[4-(4-methyl-1-piperazinyl)-1-piperidyl]phenyl]amino]-5-[(tetrahydropyran-4-yl)amino]pyrazine-2-carboxamide|6-ethyl-3-[3-methoxy-4-[4-(4-methylpiperazin-1-yl)-1-piperidyl]anilino]-5-(tetrahydropyran-4-ylamino)pyrazine-2-carboxamide|6-ethyl-3-{3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino}-5-(tetrahydro-2H-pyran-4-ylamino)pyrazine-2-carboxamide|6-ethyl-3-{3-methoxy-4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino}-5-[(oxan-4-yl)amino]pyrazine-2-carboxamide"
SUCCINIMIDE,11439,,"InChI=1S/C4H5NO2/c6-3-1-2-4(7)5-3/h1-2H2,(H,5,6,7)",KZNICNPSHKQLFF-UHFFFAOYSA-N,C4H5NO2,99.09,"pyrrolidine-2,5-dione","SUCCINIMIDE|123-56-8|pyrrolidine-2,5-dione|2,5-Pyrrolidinedione|Butanimide|2,5-Dioxopyrrolidine|Succinic acid imide|2,5-Diketopyrrolidine|Succinic imide|3,4-Dihydropyrrole-2,5-dione|Dihydro-3-pyrroline-2,5-dione|CHEBI:9307|DTXSID8051629|NSC-11204|10X90O3503|DTXCID3030181|RefChem:6266|204-635-6|679-911-6|Succinimide-sauba|3,4-Dihydropyrrolidine|MFCD00005495|NSC 11204|SUCCIMIDE|azolidine-2,5-dione|Mercury, disuccinimido-|WLN: T5VMVTJ|2, mercury(2+) salt|Succinimide, mercury(2+) salt|EINECS 204-635-6|BRN 0108440|succinimid|cis-succinimide|AI3-08539|UNII-10X90O3503|2,5dioxopyrrolidine|Lubrizol 6406|pyrroldine-2,5-dione|Alogliptin Impurity 33|SUCCINIMIDE [MI]|SCHEMBL774|Succinimide pharbiol (TN)|EC 204-635-6|SUCCINIMIDE [MART.]|SCHEMBL18634|SUCCINIMIDE [WHO-DD]|5-21-09-00438 (Beilstein Handbook Reference)|SCHEMBL867714|BDBM7814|CHEMBL275661|SCHEMBL1466558|SCHEMBL1600526|SCHEMBL3675094|SCHEMBL10203348|SCHEMBL11190350|NSC11204|NSC13114|NSC38417|NSC41221|NSC49152|Tox21_303851|NSC-13114|NSC-49152|SBB040866|STL163344|AKOS000118776|DB13376|NCGC00357119-01|BP-21153|CAS-123-56-8|HY-41877|CS-0019112|NS00001653|ST50214456|EN300-17963|C07273|D08532|F358203|Q419430|Z57127349|F1908-0169|1BBF5533-77F1-4B20-96F3-0BB022C36CD3|InChI=1/C4H5NO2/c6-3-1-2-4(7)5-3/h1-2H2,(H,5,6,7"
AZD-5991,131634760,,"InChI=1S/C35H34ClN5O3S2/c1-20-31-29(38-40(20)3)19-45-17-22-15-23(41(4)37-22)18-46-24-14-21-8-5-6-9-25(21)30(16-24)44-13-7-10-26-27-11-12-28(36)32(31)33(27)39(2)34(26)35(42)43/h5-6,8-9,11-12,14-16H,7,10,13,17-19H2,1-4H3,(H,42,43)",KBQCEQAXHPIRTF-UHFFFAOYSA-N,C35H34ClN5O3S2,672.3,"17-chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentazaheptacyclo[27.7.1.14,7.011,15.016,21.020,24.030,35]octatriaconta-1(36),4(38),6,11,14,16,18,20,23,29(37),30,32,34-tridecaene-23-carboxylic acid","RefChem:560463|17-Chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentaazaheptacyclo(27.7.1.14,7.011,15.016,21.020,24.030,35)octatriaconta-1(36),4(38),6,11,14,16,18,20,23,29(37),30(35),31,33-tridecaene-23-carboxylic acid|AZD5991|AZD-5991|2143061-81-6|2143010-83-5|2143061-82-7|UNII-E3T5XXY9HX|AZD-5991 Racemate|AZD-5991 S-enantiomer|17-chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentazaheptacyclo[27.7.1.14,7.011,15.016,21.020,24.030,35]octatriaconta-1(36),4(38),6,11,14,16,18,20,23,29(37),30,32,34-tridecaene-23-carboxylic acid|E3T5XXY9HX|AZD-5991 (Racemate)|AZD5991S|AZD 5991|2143061-81-6 (free base)|(Z)-16-chloro-11,21,25,61-tetramethyl-11H,21H,61H-10-oxa-4,8-dithia-1(7,3)-indola-2(4,3),6(3,5)-dipyrazola-9(3,1)-naphthalenacyclotridecaphane-12-carboxylic acid|(S)-16-Chloro-11,21,25,61-tetramethyl-11H,21H,61H-10-oxa-4,8-dithia-1(7,3)-indola-2(4,3),6(3,5)-dipyrazola-9(3,1)-naphthalenacyclotridecaphane-12-carboxylic acid|16-Chloro-11,21,25,61-tetramethyl-11H,21H,61H-10-oxa-4,8-dithia-1(7,3)-indola-2(4,3),6(3,5)-dipyrazola-9(3,1)-naphthalenacyclotridecaphane-12-carboxylic acid|17-Chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentaazaheptacyclo(27.7.1.14.7.011,15.016,21.020,24.030,35)octatriaconta1(37),4(38),6,11,14,16,18,20,23,31,33,35-tridecaene-23-carboxylic acid|C35H34ClN5O3S2|orb1710350|orb2946029|CHEMBL4297482|SCHEMBL19472011|SCHEMBL29380383|EX-A2673A|EX-A2673B|GTPL11783|AZD 5991 [WHO-DD]|US10196404, Example 1|US10196404, Example 2|US10196404, Example 3|BDBM333146|DTXSID601098260|GLXC-20222|BCP23513|BCP30972|BCP30973|EX-A2673|TKD01083|TKD06182|AZD 5991?|AZD-5991?|NSC807055|s8643|AKOS040732511|DB14792|HY-101533A|NSC-807055|AZD 5991 (AZD5991)|AZD-5991; AZD 5991|22H-9,4,8-(Metheniminomethyno)-14,20:26,23-dimetheno-10H,20H-pyrazolo[4,3-l][2,15,22,18,19]benzoxadithiadiazacyclohexacosine-32-carboxylic acid, 5-chloro-2,11,12,24,27,29-hexahydro-2,3,24,33-tetramethyl-, (3aS)-|BA166834|DA-50858|DA-61378|DA-61379|HY-101533|CS-0021671|CS-0077938|G16511|AZD 5991 S-enantiomer ;AZD5991 S-enantiomer|AZD5991; AZD-5991; AZD 5991;CAS:2143061-81-6;2143061-82-7|(S)-16-Chloro-11,21,25,61-tetramethyl-11H,21H,61H-10-oxa-4,8-dithia-1(7,3)-indola-2(4,3),6(3,5)-dipyrazola-9(3,1)-naphthalenacyclotridecaphane-12-carboxylicacid|(Z)-16-chloro-11,21,25,61-tetramethyl-11H,21H,61H-10-oxa-4,8-dithia-1(7,3)-indola-2(4,3),6(3,5)-dipyrazola-9(3,1)-naphthalenacyclotridecaphane-12-carboxylicacid|17-chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentaazaheptacyclo[27.7.1.1,.0(1)(1),(1).0(1),(2)(1).0(2),(2).0(3),(3)]octatriaconta-1(36),4(38),6,11,14,16,18,20,23,29(37),30,32,34-tridecaene-23-carboxylic acid|17-chloro-5,13,14,22-tetramethyl-28-oxa-2,9-dithia-5,6,12,13,22-pentaazaheptacyclo[27.7.1.1,.0,.0,.0,.0,octatriaconta-1(36),4(38),6,11,14,16,18,20,23,29(37),30,32,34-tridecaene-23-carboxylic acid|E4W"
ROPSACITINIB,130339268,,"InChI=1S/C20H17N9/c1-27-11-15(9-24-27)17-13-28-18(2-5-23-28)19(26-17)16-10-25-29(12-16)20(3-4-21)6-14(7-20)8-22/h2,5,9-14H,3,6-7H2,1H3",XPLZTJWZDBFWDE-UHFFFAOYSA-N,C20H17N9,383.4,"3-(cyanomethyl)-3-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]pyrazol-1-yl]cyclobutane-1-carbonitrile","3-(cyanomethyl)-3-[4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]pyrazol-1-yl]cyclobutane-1-carbonitrile|3-(Cyanomethyl)-3-(4-(6-(1-methylpyrazol-4-yl)pyrazolo(1,5-a)pyrazin-4-yl)pyrazol-1-yl)cyclobutane-1-carbonitrile|3-(cyanomethyl)-3-{4-[6-(1-methylpyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl]pyrazol-1-yl}cyclobutane-1-carbonitrile|RefChem:202565|Ropsacitinib|2127109-84-4|Tyk2-IN-8|PF-06826647|Tyk2-IN-9|2127109-85-5|Ropsacitinib [USAN]|HY5SOV7O0Q|Ropsacitinib (USAN)|trans-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)-1H-pyrazol-1-yl)cyclobutanecarbonitrile|(1r,3r)-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)-1H-pyrazol-1-yl)cyclobutane-1-carbonitrile|Cyclobutaneacetonitrile, 3-cyano-1-(4-(6-(1-methyl-1H-pyrazol-4- yl)pyrazolo(1,5-a)pyrazin-4-yl)-1H-pyrazol-1-yl)-, trans-|trans-3-Cyano-1-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo(1,5-a)pyrazin-4-yl)- 1H-pyrazol-1-yl)-cyclobutaneacetonitrile|Ropsacitinib [WHO-DD]|UNII-HY5SOV7O0Q|ROPSACITINIB [INN]|orb1708302|orb1708303|CHEMBL4459585|CHEMBL4740298|SCHEMBL19253418|SCHEMBL19253420|SCHEMBL19271747|GTPL11613|BDBM305820|BDBM305821|GLXC-22745|PF647|BCP33615|CKD10985|EX-A4020|US10144738, Example 19|US10144738, Example 20|MFCD32197240|PF-647|WHO 11834|AKOS040740478|AKOS040740479|HY-126290A|compound 22 [PMID: 32787094]|AC-36458|DA-58822|DA-58823|TS-07904|HY-126290|PF-06826647( Tyk2-IN-8)|CS-0101462|CS-0114967|PF06826647|D12056|(1r,3r)-3-(cyanomethyl)-3-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)-1H-pyrazol-1-yl)cyclobutanecarbonitrile|(1s,3s)-3-(Cyanomethyl)-3-(4-(6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrazin-4-yl)-1H-pyrazol-1-yl)cyclobutane-1-carbonitrile"
H3B-6527,118029202,,"InChI=1S/C29H34Cl2N8O4/c1-6-25(40)35-20-14-18(39-12-10-38(7-2)11-13-39)8-9-19(20)34-23-16-24(33-17-32-23)37(3)29(41)36-28-26(30)21(42-4)15-22(43-5)27(28)31/h6,8-9,14-17H,1,7,10-13H2,2-5H3,(H,35,40)(H,36,41)(H,32,33,34)",MBWRLLRCTIYXDW-UHFFFAOYSA-N,C29H34Cl2N8O4,629.5,"N-[2-[[6-[(2,6-dichloro-3,5-dimethoxyphenyl)carbamoyl-methylamino]pyrimidin-4-yl]amino]-5-(4-ethylpiperazin-1-yl)phenyl]prop-2-enamide","H3B-6527|1702259-66-2|4HTE364XIK|H3b 6527|H3B6527|2-Propenamide, N-(2-((6-((((2,6-dichloro-3,5-dimethoxyphenyl)amino)carbonyl)methylamino)-4-pyrimidinyl)amino)-5-(4-ethyl-1-piperazinyl)phenyl)-|N-(2-((6-(((2,6-Dichloro-3,5 dimethoxyphenyl) carbamoyl) (methyl)amino)pyrimidin-4-yl)amino)-5-(4-ethylpiperazin-1-yl)phenyl)prop-2-enamide|RefChem:144964|FGFR4 INHIBITOR H3B-6527|Fibroblast Growth Factor Receptor 4 Inhibitor H3B-6527|N-(2-((6-(3-(2,6-dichloro-3,5-dimethoxyphenyl)-1-methylureido)pyrimidin-4-yl)amino)-5-(4-ethylpiperazin-1-yl)phenyl)acrylamide|N-[2-[[6-[(2,6-dichloro-3,5-dimethoxyphenyl)carbamoyl-methylamino]pyrimidin-4-yl]amino]-5-(4-ethylpiperazin-1-yl)phenyl]prop-2-enamide|MBWRLLRCTIYXDW-UHFFFAOYSA-N|MFCD30377210|UNII-4HTE364XIK|C29H34Cl2N8O4|orb1299550|CHEMBL3939295|SCHEMBL16659467|SCHEMBL29412748|SCHEMBL30274661|BDBM249396|GLXC-10718|BCP17555|EX-A1510|H3B 6527 [WHO-DD]|NSC800283|s8675|AKOS032960479|CCG-270286|CS-5830|DB15169|NSC-800283|SB40408|AC-29878|AS-55996|H3B-6527?|HY-100491|H3B 6527;H3B6527;Eisai;H3 Biomedicine|US9434697, 108|N-(2-(6-(3-(2,6-Dichloro-3,5-dimethoxyphenyl)-1-methylureido)pyrimidin-4-ylamino)-5-(4-ethylpiperazin-1-yl)phenyl)acrylamide|N-[2-[[6-[(2,6-dichloro-3,5-dimethoxy-phenyl)carbamoyl-methyl-amino]pyrimidin-4-yl]amino]-5-(4-ethylpiperazin-1-yl)phenyl]prop-2-enamide|N-[2-{6-[3-(2,6-Dichloro-3,5-dimethoxy-phenyl)-1-methyl-ureido]-pyrimidin-4-ylamino}-5-(4-ethyl-piperazin-1-yl)-phenyl]-acrylamide"
CEBRANOPADOL,11848225,,"InChI=1S/C24H27FN2O/c1-27(2)23(17-6-4-3-5-7-17)11-13-24(14-12-23)22-19(10-15-28-24)20-16-18(25)8-9-21(20)26-22/h3-9,16,26H,10-15H2,1-2H3",CSMVOZKEWSOFER-UHFFFAOYSA-N,C24H27FN2O,378.5,"6-fluoro-N,N-dimethyl-1'-phenylspiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine","Cebranopadol|863513-91-1|GRT6005|863513-93-3|Cebranopadol ((1alpha,4alpha)stereoisomer)|GRT-6005|GRT 6005|MFCD25976722|Cebranopadol ((1|A,4|A)stereoisomer)|7GDW9S3GN3|863513-91-1 (free base)|6-fluoro-N,N-dimethyl-1'-phenylspiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine|(1r,4r)-6'-Fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4-b]indol]-4-amine|6-Fluoro-N,N-dimethyl-1'-phenyl-spiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine|Spiro(cyclohexane-1,1'(3'h)-pyrano(3,4-b)indol)-4-amine, 6'-fluoro-4',9'-dihydro-n,N-dimethyl-4-phenyl-, trans-|trans-6'-Fluoro-n,N-dimethyl-4-phenyl-4',9''-dihydro-3'h-spiro(cyclohexane-1,1'-pyrano(3,4-b)indol)-4-amine|Cebranopadol [INN]|GRT6005 (1alpha,4alpha)stereoisomer|Cebranopadol [USAN:INN]|UNII-7GDW9S3GN3|Cebranopadol(GRT6005)|Cebranopadol (USAN/INN)|CEBRANOPADOL [USAN]|Cebranopadol(GRT-6005)|Cebranopadol(GRT-6005)?|SCHEMBL154336|SCHEMBL566256|C24H27FN2O|GTPL8866|orb1302034|orb1710100|CHEMBL2364605|CHEMBL3545616|CHEMBL3962932|SCHEMBL10035739|SCHEMBL29353179|CHEBI:231222|BDBM177926|DTXSID001031965|BCP09612|EX-A1095|BDBM50101095|BDBM50101112|BDBM50533342|(1ALPHA,4ALPHA)-CEBRANOPADOL|AKOS025290738|AKOS032953927|CS-1323|DB12830|SB16531|Cebranopadol ((1??,4??)stereoisomer)|NCGC00378895-01|NCGC00378895-02|AC-36077|AS-35183|DA-51735|DA-51736|HY-15536|MS-26183|NS00069647|D10436|F85492|US9120797, 24|US9120797, 25|BRD-K48141473-001-01-7|Q19596315|(1r,4r)-6'-fluoro-N,N-dimethyl-4-phenyl-4',9'-dihydro-3'H-spiro[cyclohexane-1,1'-pyrano[3,4-b]indole]-4-amine|6-luoro-N,N-dimethyl-1'-phenylspiro[4,9-dihydro-3H-pyrano[3,4-b]indole-1,4'-cyclohexane]-1'-amine|trans-6'-Fluoro-4',9'-dihydro-N,N-dimethyl-4-phenyl-spiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-amine; (1alpha,4beta)-6'-Fluoro-4',9'-dihydro-N,N-dimethyl-4-phenylspiro[cyclohexane-1,1'(3'H)-pyrano[3,4-b]indol]-4-amine; GRT 6005"
SAPANISERTIB,45375953,,"InChI=1S/C15H15N7O/c1-7(2)22-14-11(13(16)18-6-19-14)12(21-22)8-3-4-10-9(5-8)20-15(17)23-10/h3-7H,1-2H3,(H2,17,20)(H2,16,18,19)",GYLDXIAOMVERTK-UHFFFAOYSA-N,C15H15N7O,309.33,"5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine","Sapanisertib|1224844-38-5|INK-128|MLN0128|INK128|INK 128|MLN-0128|TAK-228|JGH0DF1U03|CB-228|3-(2-Amino-5-benzoxazolyl)-1-(1-methylethyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|5-(4-amino-1-propan-2-ylpyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine|DTXSID401022538|2-Benzoxazolamine, 5-(4-amino-1-(1-methylethyl)-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-|3-(2-Amino-1,3-benzoxazol-5-yl)-1-isopropyl-1H-pyrazolo(3,4-d)pyrimidin-4-amine|sapanisertibum|3-(2-Amino-5-benzoxazolyl)-1-(1-methylethyl)-1H-pyrazolo(3,4-d)pyrimidin-4-amine|5-(4-amino-1-propan-2-ylpyrazolo(3,4-d)pyrimidin-3-yl)-1,3-benzoxazol-2-amine|RefChem:58086|DTXCID201507223|5-(4-amino-1-(propan-2-yl)-1H-pyrazolo(3,4-d)pyrimidin-3-yl)-1,3-benzoxazol-2-amine|5-(4-amino-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-3-yl)benzo[d]oxazol-2-amine|INK 128 (MLN0128)|Sapanisertib (MLN0128)|MFCD22124893|1H-Pyrazolo[3,4-d]pyrimidin-4-amine, 3-(2-amino-5-benzoxazolyl)-1-(1-methylethyl)-|5-(4-Amino-1-isopropyl-1H-pyrazolo[3,4-d]-pyrimidin-3-yl)benzo[d]oxazol-2-amine|3-(2-aminobenzo[d]oxazol-5-yl)-1-isopropyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine|5-(4-amino-1-isopropyl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine|5-(4-azanyl-1-propan-2-yl-pyrazolo[3,4-d]pyrimidin-3-yl)-1,3-benzoxazol-2-amine|INK 128; MLN 0128; Sapanisertib|Sapanisertib [INN]|UNII-JGH0DF1U03|1H-PYRAZOLO(3,4-D)PYRIMIDIN-4-AMINE, 3-(2-AMINO-5-BENZOXAZOLYL)-1-(1-METHYLETHYL)-|Sapanisertib (USAN/INN)|Sapanisertib [USAN:INN]|SAPANISERTIB [USAN]|INK-128(Sapanisertib)?|MLS006011012|SAPANISERTIB [WHO-DD]|GTPL7933|orb1307349|SCHEMBL7902875|CHEMBL3545097|SCHEMBL29351459|CHEBI:91450|EX-A951|INK-128/INK128|BDBM315477|HMS3656H12|HMS3672C21|INK-128;Sapanisertib;MLN0128|INK-0128|NSC764658|NSC768435|NSC780880|s2811|AKOS025149512|US10172858, Table 1.1|BCP9000789|CCG-265002|CS-0557|DB11836|NSC-764658|NSC-768435|NSC-780880|SB16566|SDCCGSBI-0646935.P002|US10172858, Table 1.22|NCGC00346654-01|NCGC00346654-10|AC-26848|AS-16294|BS170924|HY-13328|SMR004702810|BCP0726000086|DB-293450|NS00072976|SW220210-1|D11183|Sapanisertib (NK128; MLN0128; TAK228)|INK-128,CAS:1224844-38-5|BRD-K59317601-001-05-5|Q27078072|3-(2-Amino-1,3-benzoxazol-5-yl)-1-(propan-2-yl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine|FE5"
ADAGRASIB,138611145,,"InChI=1S/C32H35ClFN7O2/c1-21(34)31(42)41-17-16-40(18-23(41)11-13-35)30-25-12-15-39(28-10-4-7-22-6-3-9-26(33)29(22)28)19-27(25)36-32(37-30)43-20-24-8-5-14-38(24)2/h3-4,6-7,9-10,23-24H,1,5,8,11-12,14-20H2,2H3/t23-,24-/m0/s1",PEMUGDMSUDYLHU-ZEQRLZLVSA-N,C32H35ClFN7O2,604.1,"2-[(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile","Adagrasib|MRTX849|2326521-71-3|MRTX-849|KRAZATI|Kras G12C inhibitor MRTX849|8EOO6HQF8Y|2-Piperazineacetonitrile, 4-[7-(8-chloro-1-naphthalenyl)-5,6,7,8-tetrahydro-2-[[(2S)-1-methyl-2-pyrrolidinyl]methoxy]pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2S)-|DTXSID801336759|2-Piperazineacetonitrile, 4-(7-(8-chloro-1-naphthalenyl)-5,6,7,8-tetrahydro-2-(((2S)-1-methyl-2-pyrrolidinyl)methoxy)pyrido(3,4-d)pyrimidin-4-yl)-1-(2-fluoro-1-oxo-2-propen-1-yl)-, (2S)-|RefChem:56312|MRTX 849|DTXCID001767019|((2S)-4-(7-(8-CHLORONAPHTHALEN-1-YL)-2-(((2S)-1-METHYLPYRROLIDIN-2-YL)METHOXY)-5,6,7,8-TETRAHYDROPYRIDO(3,4-D)PYRIMIDIN-4-YL)-1-(2-FLUOROPROP2-ENOYL)PIPERAZIN-2-YL)ACETONITRILE|2-((S)-4-(7-(8-Chloronaphthalen-1-yl)-2-(((S)-1-methylpyrrolidin-2-yl)methoxy)-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl)-1-(2-fluoroacryloyl)piperazin-2-yl)acetonitrile|Adagrasib [USAN]|MFCD32263433|2-[(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile|2-[(2S)-4-[7-(8-chloronaphthalen-1-yl)-2-{[(2S)-1-methylpyrrolidin-2-yl]methoxy}-5H,6H,7H,8H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile|Krazati (TN)|ADAGRASIB [INN]|Adagrasib (USAN/INN)|Adagrasib (MRTX849)|MRTX849(Adagrasib)?|UNII-8EOO6HQF8Y|ADAGRASIB [WHO-DD]|C32H35ClFN7O2|orb1298993|CHEMBL4594350|SCHEMBL20974691|SCHEMBL29349856|SCHEMBL29423703|SCHEMBL29979738|GTPL10888|CHEBI:233309|GLXC-22157|BCP31538|EX-A3258|MRTX-849; MRTX 849|BDBM50539763|NSC831453|WHO 11519|AKOS037648997|AT23561|NSC-831453|compound 20 [PMID: 32250617]|AC-35659|BM177692|BP-43624|BS-16211|SY264373|HY-130149|CS-0105265|D12301|EN300-26953032|Z4145344023|((2S)-4-(7-(8-CHLORONAPHTHALEN-1-YL)-2-(((2S)-1- METHYLPYRROLIDIN-2-YL)METHOXY)-5,6,7,8- TETRAHYDROPYRIDO(3,4-D)PYRIMIDIN-4-YL)-1-(2-FLUOROPROP2-ENOYL)PIPERAZIN-2-YL)ACETONITRILE|2-[(2S)-4-[7-(8-chloro-1-naphthyl)-2-[[(2S)-1-methylpyrrolidin-2-yl]methoxy]-6,8-dihydro-5H-pyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroprop-2-enoyl)piperazin-2-yl]acetonitrile|2-[(S)-4-[7-(8-chloro-1-naphthyl)-2-[[(S)-1-methyl-2-pyrrolidinyl]methoxy]-5,6,7,8-tetrahydropyrido[3,4-d]pyrimidin-4-yl]-1-(2-fluoroacryloyl)-2-piperazinyl]acetonitrile"
CAMIZESTRANT,134453496,,"InChI=1S/C24H28F4N6/c1-15-9-19-18(4-6-21-20(19)11-30-32-21)23(34(15)14-24(26,27)28)22-5-3-16(10-29-22)31-17-12-33(13-17)8-2-7-25/h3-6,10-11,15,17,23,31H,2,7-9,12-14H2,1H3,(H,30,32)/t15-,23+/m1/s1",WDHOIABIERMLGY-CMJOXMDJSA-N,C24H28F4N6,476.5,"N-[1-(3-fluoropropyl)azetidin-3-yl]-6-[(6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-3,6,8,9-tetrahydropyrazolo[4,3-f]isoquinolin-6-yl]pyridin-3-amine","Camizestrant|2222844-89-3|AZD-9833|AZD9833|JUP57A8EPZ|AZ14066724|AZ-14066724|3-Pyridinamine, N-(1-(3-fluoropropyl)-3-azetidinyl)-6-((6S,8R)-6,7,8,9-tetrahydro-8-methyl-7-(2,2,2-trifluoroethyl)-3H-pyrazolo(4,3-F)isoquinolin-6-yl)-|N-(1-(3-FLUOROPROPYL)-3-AZETIDINYL)-6-((6S,8R)-8-METHYL-7-(2,2,2-TRIFLUOROETHYL)-6,7,8,9-TETRAHYDRO-3H-PYRAZOLO(4,3-F)ISOQUINOLIN-6-YL)-3-PYRIDINAMINE|RefChem:123121|SERD AZD9833|AZD 9833|Selective Estrogen Receptor Degrader AZD9833|UNII-JUP57A8EPZ|Camizestrant [USAN]|N-[1-(3-fluoropropyl)azetidin-3-yl]-6-[(6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-3,6,8,9-tetrahydropyrazolo[4,3-f]isoquinolin-6-yl]pyridin-3-amine|WHO 11592|N-(1-(3-fluoropropyl)azetidin-3-yl)-6-((6S,8R)-8-methyl-7-(2,2,2-trifluoroethyl)-6,7,8,9-tetrahydro-3H-pyrazolo[4,3-f]isoquinolin-6-yl)pyridin-3-amine|C24H28F4N6|CAMIZESTRANT [INN]|CAMIZESTRANT [WHO-DD]|orb1709733|CHEMBL4650365|SCHEMBL20089710|SCHEMBL29360638|GTPL12716|WDHOIABIERMLGY-CMJOXMDJSA-N|GLXC-22906|AZD9833?|EX-A5025|NSC828717|AKOS040733130|AT22885|compound 28 PMID: 32910656]|NSC-828717|DA-61390|MS-28839|HY-136255|CS-0121043|D9833"
LUMATEPERONE,21302490,,"InChI=1S/C24H28FN3O/c1-26-14-15-28-21-11-13-27(16-20(21)19-4-2-5-22(26)24(19)28)12-3-6-23(29)17-7-9-18(25)10-8-17/h2,4-5,7-10,20-21H,3,6,11-16H2,1H3/t20-,21-/m0/s1",HOIIHACBCFLJET-SFTDATJTSA-N,C24H28FN3O,393.5,"1-(4-fluorophenyl)-4-[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one","lumateperone|ITI-722|313368-91-1|lumateperona|ITI007|ITI 007|70BSQ12069|1-Butanone, 1-(4-fluorophenyl)-4-((6bR,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido(3',4':4,5)pyrrolo(1,2,3-de)quinoxalin-8(7H)-yl)-|lumateperonum|RefChem:57789|DTXCID801510464|1-(4-fluorophenyl)-4-((10R,15S)-4-methyl-1,4,12-triazatetracyclo(7.6.1.0^(5,16).0^(10,15))hexadeca-5(16),6,8-trien-12-yl)butan-1-one|DTXSID401026211|ITI-007|Lumateperone [USAN]|MFCD28502161|1-(4-fluorophenyl)-4-[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.05,16.010,15]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one|1-(4-Fluorophenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)butan-1-one|313369-37-8|Lumateperone(iti-007)|1-(4-fluorophenyl)-4-[(10~{R},15~{S})-4-methyl-1,4,12-triazatetracyclo[7.6.1.0^{5,16}.0^{10,15}]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one|C24H28FN3O|Lumateperone?|ITI-722 lumateperone|LUMATEPERONE [MI]|Lumateperone (USAN/INN)|LUMATEPERONE [INN]|LUMATEPERONE [WHO-DD]|orb1306463|SCHEMBL1468226|CHEMBL3306803|SCHEMBL29355930|UNII-70BSQ12069|HOIIHACBCFLJET-SFTDATJTSA-N|DTXSID201101217|GLXC-15265|EX-A3605|BDBM50556204|AKOS025396216|DB06077|DS-8527|DA-74607|HY-17637|CS-0016831|NS00073380|D11169|EN300-7383466|BRD-K10031916-075-01-3|1-(4-fluoro-phenyl)-4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h,7h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-butan-1-one|1-(4-fluorophenyl)-4-((6bR,10aS)-3-methyl-2,3,6b,7,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(9H)-yl)butan-1-one|1-(4-fluorophenyl)-4-[(10R,15S)-4-methyl-1,4,12-triazatetracyclo[7.6.1.0^{5,16}.0^{10,15}]hexadeca-5,7,9(16)-trien-12-yl]butan-1-one|4-((6br,10as)-3-methyl-2,3,6b,9,10,10a-hexahydro-1h,7h-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluoro-phenyl)-butan-1-one|4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H,7H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8-yl)-1-(4-fluorophenyl)-butan-1-one|4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido-[3',4':4,5]-pyrrolo[1,2,3-de]quinoxalin-8-(7H)-yl)-1-(4-fluorophenyl)-1-butanone|4-((6bR,10aS)-3-methyl-2,3,6b,9,10,10a-hexahydro-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl)-1-(4-fluorophenyl)-1-butanone|92S|Lumateperone; 1-Butanone, 1-(4-fluorophenyl)-4-[(6bR,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-; 1-(4-Fluorophenyl)-4-[(6bR,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3',4':4,5]pyrrolo[1,2,3-de]quinoxalin|rel-1-(4-Fluorophenyl)-4-[(6bR,10aS)-2,3,6b,9,10,10a-hexahydro-3-methyl-1H-pyrido[3a(2),4a(2):4,5]pyrrolo[1,2,3-de]quinoxalin-8(7H)-yl]-1-butanone"
CIFORADENANT,44537963,,"InChI=1S/C20H21N7O3/c1-12-5-6-16(30-12)17-18-19(24-20(21)23-17)27(26-25-18)9-13-3-2-4-14(22-13)10-29-15-7-8-28-11-15/h2-6,15H,7-11H2,1H3,(H2,21,23,24)/t15-/m0/s1",KURQKNMKCGYWRJ-HNNXBMFYSA-N,C20H21N7O3,407.4,"7-(5-methylfuran-2-yl)-3-[[6-[[(3S)-oxolan-3-yl]oxymethyl]pyridin-2-yl]methyl]triazolo[4,5-d]pyrimidin-5-amine","ciforadenant|CPI-444|1202402-40-1|V81444|V-81444|8KFO2187CP|3H-1,2,3-Triazolo(4,5-d)pyrimidin-5-amine, 7-(5-methyl-2-furanyl)-3-((6-((((3S)-tetrahydro-3-furanyl)oxy)methyl)-2-pyridinyl)methyl)-|7-(5-methylfuran-2-yl)-3-[[6-[[(3S)-oxolan-3-yl]oxymethyl]pyridin-2-yl]methyl]triazolo[4,5-d]pyrimidin-5-amine|ciforadenantum|7-(5-methylfuran-2-yl)-3-((6-(((3S)-oxolan-3-yl)oxymethyl)pyridin-2-yl)methyl)triazolo(4,5-d)pyrimidin-5-amine|RefChem:126117|Adenosine-A2A Receptor-Targeting Agent CPI-444|(S)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine|Ciforadenant [INN]|CPI444|Ciforadenant [USAN]|7-(5-Methyl-2-furanyl)-3-[[6-[[[(3S)-tetrahydro-3-furanyl]oxy]methyl]-2-pyridinyl]methyl]-3H-1,2,3-triazolo[4,5-d]pyrimidin-5-amine|MFCD31540410|Ciforadenant (USAN)|CPI-444; Triazolo-pyramidine Derivative;|CPI 444|(S)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3H-(1,2,3)triazolo(4,5-d)pyrimidin-5-amine|Ciforadenant [USAN:INN]|Ciforadenant?(CPI-444)|UNII-8KFO2187CP|V 81444|Ciforadenant (CPI-444)?|CIFORADENANT [WHO-DD]|SCHEMBL536782|orb1300002|CHEMBL4297184|SCHEMBL29350253|GTPL10190|C20H21N7O3|BCP20881|EX-A1716|V81444;(S)-7-(5-methylfuran-2-yl)-3-((6-(((tetrahydrofuran-3-yl)oxy)methyl)pyridin-2-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine|BDBM50553404|NSC801812|s6646|WHO 10767|AKOS037647889|CS-7627|NSC-801812|V81444;Triazolo-pyramidine derivative|AS-75173|SY224461|HY-101978|D11547|(S)-5-Amino-7-(5-methyl-2-furyl)-3-[[6-[[(3-tetrahydrofuranyl)oxy]methyl]-2-pyridyl]methyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidine|(S)-7-(5-Methylfuran-2-yl)-3-((6-((tetrahydrofuran-3-yloxy)methyl)pyridin-2-yl)methyl)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine|7-(5-methyl-2-furyl)-3-[[6-[[(3S)-tetrahydrofuran-3-yl]oxymethyl]-2-pyridyl]methyl]triazolo[4,5-d]pyrimidin-5-amine|7-(5-methylfuran-2-yl)-3-[(6-{[(3S)-oxolan-3-yloxy]methyl}pyridin-2-yl)methyl]-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-amine"
IPRATROPIUM,multiply,multiply,multiply,multiply,multiply,multiply,multiply,multiply
EZOBRESIB,118196485,,"InChI=1S/C30H33N5O2/c1-19-28(34(4)33-32-19)22-16-26-27(31-18-22)24-11-10-23(30(2,3)36)17-25(24)35(26)29(20-8-6-5-7-9-20)21-12-14-37-15-13-21/h5-11,16-18,21,29,36H,12-15H2,1-4H3/t29-/m1/s1",KGERZPVQIRYWRK-GDLZYMKVSA-N,C30H33N5O2,495.6,"2-[3-(3,5-dimethyltriazol-4-yl)-5-[(S)-oxan-4-yl(phenyl)methyl]pyrido[3,2-b]indol-7-yl]propan-2-ol","BMS-986158|Bet inhibitor BMS-986158|BMS986158|UNII-X8BW0MQ5PI|2-[3-(3,5-dimethyltriazol-4-yl)-5-[(S)-oxan-4-yl(phenyl)methyl]pyrido[3,2-b]indol-7-yl]propan-2-ol|compound 18 [PMID: 34543572]|2-{3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-5-[(S)-(oxan-4-yl)(phenyl)methyl]-5H-pyrido[3,2-b]indol-7-yl}propan-2-ol|compound 18 (PMID: 34543572)|5H-Pyrido(3,2-b)indole-7-methanol, 3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-alpha,alpha-dimethyl-5-((S)-phenyl(tetrahydro-2H-pyran-4-yl)methyl)-|2-(3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-5-((S)-(oxan-4-yl)(phenyl)methyl)-5H-pyrido(3,2-b)indol-7-yl)propan-2-ol|2-(3-(3,5-dimethyltriazol-4-yl)-5-((S)-oxan-4-yl(phenyl)methyl)pyrido(3,2-b)indol-7-yl)propan-2-ol|2-[3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-5-[(S)-(oxan-4-yl)(phenyl)methyl]-5H-pyrido[3,2-b]indol-7-yl]propan-2-ol|RefChem:120771|5H-PYRIDO(3,2-B)INDOLE-7-METHANOL, 3-(1,4-DIMETHYL-1H-1,2,3-TRIAZOL-5-YL)-.ALPHA.,.ALPHA.-DIMETHYL-5-((S)-PHENYL(TETRAHYDRO-2H-PYRAN-4-YL)METHYL)-|1800340-40-2|(S)-2-(3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-5-(phenyl(tetrahydro-2H-pyran-4-yl)methyl)-5H-pyrido[3,2-b]indol-7-yl)propan-2-ol|Ezobresib|X8BW0MQ5PI|Ezobresib (USAN)|EZOBRESIB [USAN]|BDBM297146|ezobresib [INN]|MFCD31544327|orb1308546|CHEMBL4297458|SCHEMBL16861831|SCHEMBL29430379|SCHEMBL29631072|GTPL11757|KGERZPVQIRYWRK-GDLZYMKVSA-N|BDBM296947|C30H33N5O2|2-[3-(Dimethyl-1H-1,2,3-triazol-5-yl)-5-[oxan-4-yl(phenyl)methyl]-5H-pyrido[3,2-b]indol-7-yl]propan-2-ol|AXC34040|EX-A2678|US10112941, Example 54|US10112941, Example 90|NSC801230|US10112941, Example 262|AKOS040741393|CS-7497|DB15435|NSC-801230|AC-36650|DA-71596|MS-29213|HY-101567|D12710|G16111|Q29208626|2-[3-(3,5-dimethyltriazol-4-yl)-5-[(S)-phenyl(tetrahydropyran-4-yl)methyl]pyrido[3,2-b]indol-7-yl]propan-2-ol|2-{3-[4-(2H3)Methyl-1-methyl-1H-1,2,3-triazol-5-yl]-5-[(S)-oxan-4-yl(phenyl)methyl]-5H-pyrido[3,2-b]indol-7-yl}propan-2-ol|5H-Pyrido[3,2-b]indole-7-methanol, 3-(1,4-dimethyl-1H-1,2,3-triazol-5-yl)-a,a-dimethyl-5-[(S)-phenyl(tetrahydro-2H-pyran-4-yl)methyl]-|YWA"
MITOXANTRONE,4212,,"InChI=1S/C22H28N4O6/c27-11-9-23-5-7-25-13-1-2-14(26-8-6-24-10-12-28)18-17(13)21(31)19-15(29)3-4-16(30)20(19)22(18)32/h1-4,23-30H,5-12H2",KKZJGLLVHKMTCM-UHFFFAOYSA-N,C22H28N4O6,444.5,"1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione","mitoxantrone|65271-80-9|Mitozantrone|Mitoxanthrone|DHAQ|Mitoxantron|Mitoxantrona|Mitoxantronum|Misostol|NSC 279836|NSC-279836|BZ114NVM5P|NSC279836|1,4-Bis(2-(2-hydroxyethylamino)ethyl)amino)-5,8-dihydroxyanthraquinone|CHEBI:50729|1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)-9,10-ANTHRACENEDIONE|DTXSID4046947|Ralenova|NSC299195|9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-|Acetate, Mitoxantrone|1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-9,10-anthracenedione|1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)-9,10-dihydroanthracene-9,10-dione|9,10-Anthracenedione, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]-|1,4-DIHYDROXY-5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-9,10-ANTHRACENEDIONE|1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9,10-dihydroanthracene-9,10-dione|dihydroxyanthracenedione|RefChem:55656|mitoyantrone hydrochloride|DTXCID2026947|L01DB07|NSC301739D|NSC 301739D|NSC287836|NSC 287836|CL232325|CL 232325|1,3-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthracenedione|1,4-Dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)-9, 10-anthroquinone|833-758-3|Mitoxantrone [INN]|1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione|DHAD|MFCD00242942|C22H28N4O6|Mitoxantrone (INN)|Mitoxantrone free base|1,4-dihydroxy-5,8-bis[2-[(1,1,2,2-tetradeuterio-2-hydroxyethyl)amino]ethylamino]anthracene-9,10-dione|5,8-Bis((2-((2-hydroxyethyl)amino)ethyl)amino)-1,4-dihydroxyanthraquinone|1,4-Dihydroxy-5,8-bis(2-((2-hydroxyethyl)amino)ethylamino)-9,10-anthracenedione|1,4-dihydroxy-5,8-bis((2-((2-hydroxyethyl)amino)ethyl)amino)anthracene-9,10-dione|MLS002703044|65271-80-9 (free base)|1,4-dihydroxy-5,8-bis({2-[(2-hydroxyethyl)amino]ethyl}amino)anthracene-9,10-dione|Mitoxantronum [INN-Latin]|Mitoxantrona [INN-Spanish]|ANTHRAQUINONE, 5,8-BIS((2-((2-HYDROXYETHYL)AMINO)ETHYL)AMINO)-1,4-DIHYDROXY-|MIX|MLS001333711|1,4-Dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthracene-9,10-dione|Misostol (TN)|CCRIS 7604|NCGC00015693-02|Mitoxantrone (free base)|SMR000058480|Mitoxantrone [INN:BAN]|CAS-70476-82-3|UNII-BZ114NVM5P|DHAQ (*Diacetate salt*)|BRN 2795126|SR-01000076001|Mitoxantrone base|1,4-Dihydroxy-5,8-bis(5-hydroxy-3-azapentylamino)anthrachinon|2fum|Immunex (Salt/Mix)|Spectrum_001655|Mitoxantrone (Standard)|CHEMBL58|Prestwick0_000385|Prestwick1_000385|Prestwick2_000385|Prestwick3_000385|Spectrum2_000908|Spectrum3_001590|Spectrum4_000866|Spectrum5_001205|Lopac-M-6545|MITOXANTRONE [MI]|MITOXANTRONE [IARC]|cid_4212|Neuro_000153|SCHEMBL3000|MITOXANTRONE [VANDF]|BIDD:PXR0181|Lopac0_000779|BSPBio_000569|BSPBio_003160|KBioGR_001531|KBioSS_002135|DivK1c_000516|MITOXANTRONE [WHO-DD]|SPBio_000756|SPBio_002490|BPBio1_000627|GTPL7242|orb1300634|SCHEMBL29353270|SCHEMBL29720597|BDBM67690|cid_5458171|KBio1_000516|KBio2_002135|KBio2_004703|KBio2_007271|KBio3_002660|NINDS_000516|GLXC-03038|HMS2090D05|HMS3655E20|KUC108634N|BCP02861|CCG-36371|HY-13502R|s1889|STK631833|Mitoxantrone hydrochloride (Salt/Mix)|AKOS005564036|BCP9000931|DB01204|FD26022|KSC-19-204|SDCCGSBI-0050757.P004|IDI1_000516|SMP2_000179|NCGC00015693-01|NCGC00015693-03|NCGC00015693-04|NCGC00015693-05|NCGC00015693-06|NCGC00015693-08|NCGC00015693-13|NCGC00015693-23|NCGC00162251-01|AC-37649|AS-35321|HY-13502|MITOXANTRONE, Mitoxantrone Hydrochloride, Mitoxantrone dihydrochloride, MITOXANTHRONE HYDROCHLORIDE|NCI60_002276|NCI60_002535|SMR001549953|SY226320|SBI-0050757.P003|AB00053716|M3133|NS00008439|SW196745-6|VU0244399-2|71M809|D08224|EN300-117257|AB00053716-18|AB00053716-19|AB00053716-22|AB00053716_23|AB00053716_24|Q239426|SR-01000076001-7|BRD-K21680192-001-01-5|BRD-K21680192-001-11-4|BRD-K21680192-300-05-2|BRD-K21680192-300-07-8|BRD-K21680192-300-09-4|BRD-K21680192-300-10-2|BRD-K21680192-300-12-8|BRD-K21680192-300-14-4|BRD-K21680192-300-15-1|BRD-K21680192-300-16-9|1,4-bis[2-(2-hydroxyethylamino)-ethylamino]-5,8-dihydroxyanthraquinone|1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-dihydroxyanthraquinone|1,4-dihydroxy-5,8-bis[[2-(2-hydroxyethylamino)ethyl]amino]anthraquinone|9, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]ethyl] amino]-|1,4-Dihydroxy-5,8-bis-[[2-[(2-hydroxyethyl)amino]ethyl]amino]anthraquinone|1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-9,10-anthraquinone;hydrochloride|1,4-dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]anthracene-9,10-dione;hydrochloride|1,4-bis[2-(2-hydroxyethylamino)ethylamino]-5,8-bis(oxidanyl)anthracene-9,10-dione;hydrochloride|1,4-Dihydroxy-5,8-bis[2-(2-hydroxyethylamino)ethylamino]-anthracene-9,10-dione;DHAQ;NSC-279836|MITOXANTRONE; 1,4-DIHYDROXY-5,8-BIS({2-[(2-HYDROXYETHYL)AMINO]ETHYL}AMINO)ANTHRA-9,10-QUINONE"
EDATREXATE,6917908,,"InChI=1S/C22H25N7O5/c1-2-11(9-14-10-25-19-17(26-14)18(23)28-22(24)29-19)12-3-5-13(6-4-12)20(32)27-15(21(33)34)7-8-16(30)31/h3-6,10-11,15H,2,7-9H2,1H3,(H,27,32)(H,30,31)(H,33,34)(H4,23,24,25,28,29)/t11?,15-/m0/s1",FSIRXIHZBIXHKT-MHTVFEQDSA-N,C22H25N7O5,467.5,"(2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)butan-2-yl]benzoyl]amino]pentanedioic acid","EDATREXATE|Edatrexato|80576-83-6|Edatrexatum|GNF-Pf-63|TCMDC-137768|CGP 30694|10-Ethyl-10-deazaaminopterin|JT4X6Z1HRR|CGP-30694|DTXSID901318475|NSC-626715|L-Glutamic acid, N-(4-(1-((2,4-diamino-6-pteridinyl)methyl)propyl)benzoyl)-|RefChem:920830|DTXCID501748284|10-Ethyl-10-deaza-aminopterin|CHEMBL296373|Edatrexate [USAN:INN]|Edatrexatum [INN-Latin]|UNII-JT4X6Z1HRR|Edatrexato [INN-Spanish]|CGP 30694;NSC 626715|EDATREXATE [MI]|EDATREXATE [INN]|Edatrexate (USAN/INN)|EDATREXATE [USAN]|EDATREXATE [MART.]|SCHEMBL4676|EDATREXATE [WHO-DD]|orb1740819|SCHEMBL21248619|SCHEMBL29352085|CHEBI:135757|BDBM50016460|N-(p-(1-((2,4-Diamino-6-pteridinyl)methyl)propyl)benzoyl)-L-glutamic acid|NSC 626715|(2S)-2-[[4-[1-(2,4-diaminopteridin-6-yl)butan-2-yl]benzoyl]amino]pentanedioic acid|HY-13617|CS-0007483|D03942|576E836|Q27281684|(2S)-2-(4-(1-(2,4-Diaminopteridin-6-yl)butan-2-yl)benzamido)pentanedioic acid|(S)-2-{4-[1-(2,4-Diamino-pteridin-6-ylmethyl)-propyl]-benzoylamino}-pentanedioic acid"
(+)-EPICATECHIN,182232,,"InChI=1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15-/m0/s1",PFTAWBLQPZVEMU-ZFWWWQNUSA-N,C15H14O6,290.27,"(2S,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol","(+)-Epicatechin|35323-91-2|ent-Epicatechin|Epicatechin, (+)-|(2S,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol|LD6B6TT8Q5|DEXEPICATECHIN|CHEBI:76125|DTXSID401316979|(2S,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol|RefChem:67354|GlyTouCan:G05292QO|DTXCID801746801|G05292QO|d-Epicatechin|(+)-epicatechol|(2S,3S)-2-(3,4-dihydroxyphenyl)chroman-3,5,7-triol|CHEMBL129482|(2S,3S)-3,3',4',5,7-pentahydroxyflavan|cis-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol|2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2S-cis)-|Catechin C|(-) epicatechine|(2S,3S)-epicatechin|EPICATECHIN, D-|UNII-LD6B6TT8Q5|DEXEPICATECHIN [INN]|SCHEMBL862089|(2S,3S)-(+)-Epicatechin|orb1296867|SCHEMBL29411294|HY-N0001A|PFTAWBLQPZVEMU-ZFWWWQNUSA-N|BDBM50135167|(+)-cis-3,3',4',5,7-Pentahydroxyflavan|CS-0204063|C09728|(2S,3S)-3',4',5,7-tetrahydroxyflavan-3-ol|99182E3E-BCCB-48BB-89BF-7DDC933D48FF|Q27145771|(2S,3S)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol|(2S,3S)-2-(3,4-Dihydroxy-phenyl)-chroman-3,5,7-triol|(2S-cis)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-Benzopyran-3,5,7-triol"
TAMETRALINE HYDROCHLORIDE,104180,,"InChI=1S/C17H19N.ClH/c1-18-17-12-11-14(13-7-3-2-4-8-13)15-9-5-6-10-16(15)17;/h2-10,14,17-18H,11-12H2,1H3;1H/t14-,17+;/m0./s1",XTSOELQVDLSJFM-SQQLFYIASA-N,C17H20ClN,273.8,"(1R,4S)-N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride","Tametraline hydrochloride|cp-24,441-1|52760-47-1|52371-37-6|Tametraline hydrochloride [USAN]|2FY1A2A305|CP-24441-1|Tametraline HCl|(1R,4S)-N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine;hydrochloride|Tametraline hydrochloride (USAN)|(1R,4S)-1,2,3,4-Tetrahydro-N-methyl-4-phenyl-1-naphthylamine hydrochloride|1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, hydrochloride, (1R-trans)-|UNII-2FY1A2A305|CP 24441-1|RefChem:1099387|1-Naphthylamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, hydrochloride, (E)-|D02703|trans-1,2,3,4-Tetrahydro-1-amino-N-methyl-4-phenylnaphthalene hydrochloride|trans-N-Methyl-4-phenyl-1,2,3,4-tetrahydro-1-naphthylamine hydrochloride|SCHEMBL121815|orb2815177|CHEMBL1788368|DTXSID40966757|(1R,4S)-1,2,3,4-Tetrahydro-N-methyl-4-phenyl-1-naphthylamin hydrochlorid|TAMETRALINE HYDROCHLORIDE [MART.]|Q7681179|1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, hydrochloride (1:1), (1R,4S)-|N-Methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine--hydrogen chloride (1/1)"
TAMETRALINE,163308,,"InChI=1S/C17H19N/c1-18-17-12-11-14(13-7-3-2-4-8-13)15-9-5-6-10-16(15)17/h2-10,14,17-18H,11-12H2,1H3/t14-,17+/m0/s1",NVXPZMLRGBVYQV-WMLDXEAASA-N,C17H19N,237.34,"(1R,4S)-N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine","TAMETRALINE|52795-02-5|Tametraline [INN]|tametralina|CP-24441|UNII-440C8K5Y5K|(1R,4S)-N-methyl-4-phenyl-1,2,3,4-tetrahydronaphthalen-1-amine|CP-24,441|440C8K5Y5K|DTXSID90200774|tametralinum|RefChem:187346|DTXCID20123265|CHEMBL38120|1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, trans-|(1R,4S)-1,2,3,4-Tetrahydro-N-methyl-4-phenyl-1-naphthalenamine; CP 24441;|CP 24441|Tametraline, (+/-)-|JAK4M6S8U3|orb2815108|SCHEMBL1237908|BDBM82219|CP 22186|CAS_52760-47-1|CP-22,186|Q29638093|(1R,4S)-1,2,3,4-Tetrahydro-N-methyl-4-phenyl-1-naphthalenamine|1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, (1R,4S)-|1-Naphthalenamine, 1,2,3,4-tetrahydro-N-methyl-4-phenyl-, (1R-trans)-|1-NAPHTHALENAMINE, 1,2,3,4-TETRAHYDRO-N-METHYL-4-PHENYL-, (1R,4S)-REL-|REL-(1R,4S)-1,2,3,4-TETRAHYDRO-N-METHYL-4-PHENYL-1-NAPHTHALENAMINE|52758-04-0"
INDATRALINE,126280,,"InChI=1S/C16H15Cl2N/c1-19-16-9-13(11-4-2-3-5-12(11)16)10-6-7-14(17)15(18)8-10/h2-8,13,16,19H,9H2,1H3/t13-,16+/m0/s1",SVFXPTLYMIXFRX-XJKSGUPXSA-N,C16H15Cl2N,292.2,"(1R,3S)-3-(3,4-dichlorophenyl)-N-methyl-2,3-dihydro-1H-inden-1-amine","Indatraline|86939-10-8|Indatralinum|DTXSID4043981|4U40Y96J1Z|(+-)-trans-3-(3,4-Dichlorophenyl)-N-methyl-1-indanamine|indatralina|RefChem:148107|DTXCID2023981|Indatraline [INN]|(1R,3S)-3-(3,4-dichlorophenyl)-N-methyl-2,3-dihydro-1H-inden-1-amine|CHEMBL341898|(+/-)-trans-3-(3,4-dichlorophenyl)-N-methyl-1-indanamine|UNII-4U40Y96J1Z|Lu-19-005|Lopac-I-119|Lopac0_000684|orb1740992|SCHEMBL9252640|SCHEMBL31307192|CHEBI:94467|BDBM50095618|PDSP1_001502|PDSP2_001486|CCG-204769|SDCCGSBI-0050662.P002|NCGC00015532-01|NCGC00025223-02|NCGC00025223-03|NCGC00025223-04|NCGC00025223-08|NCGC00025223-09|NS00125447|3-(3,4-Dichlorophenyl)-N-methyl-1-indanamine hcl|Q6015699|BRD-K01649396-003-07-1|trans-(+-)-3-(3,4-Dichlorophenyl)-2,3-dihydro-N-methyl-1H-inden-1-amine|1H-Inden-1-amine, 3-(3,4-dichlorophenyl)-2,3-dihydro-N-methyl-, trans-(+-)-"
TAZOMELINE,131460,,"InChI=1S/C14H23N3S2/c1-3-4-5-6-10-18-14-13(15-19-16-14)12-8-7-9-17(2)11-12/h8H,3-7,9-11H2,1-2H3",XUHMGFKQBWZWPO-UHFFFAOYSA-N,C14H23N3S2,297.5,"3-hexylsulfanyl-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole","(3-Hexylthio)-tztp|3-(3-(Hexylthio)-1,2,5-thiadiazol-4-yl)-1,2,5,6-tetrahydro-1-methylpyridine|RefChem:187623|Tazomeline|131987-54-7|Tazomeline [INN]|3-hexylsulfanyl-4-(1-methyl-3,6-dihydro-2H-pyridin-5-yl)-1,2,5-thiadiazole|QDP6S14W5W|LY-287041|CHEMBL131819|hexylthio-tztp|Pyridine, 3-(4-(hexylthio)-1,2,5-thiadiazol-3-yl)-1,2,5,6-tetrahydro-1-methyl-|UNII-QDP6S14W5W|tazomelina|SCHEMBL195235|orb1745176|DTXSID80157288|BDBM50003355|DA-78230|HY-106949|CS-0026981|NS00126740|L010010|Q7690467|3-(4-(HEXYLTHIO)-1,2,5-THIADIAZOL-3-YL)-1,2,5,6-TETRAHYDRO-1-METHYLPYRIDINE|5-(4-Hexylsulfanyl-[1,2,5]thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine|5-(4-Hexylsulfanyl-[1,2,5]thiadiazol-3-yl)-1-methyl-1,2,3,6-tetrahydro-pyridine; oxalic acid"
NEVANIMIBE,131679,,"InChI=1S/C27H39N3O/c1-19(2)23-10-9-11-24(20(3)4)25(23)29-26(31)28-18-27(16-7-8-17-27)21-12-14-22(15-13-21)30(5)6/h9-15,19-20H,7-8,16-18H2,1-6H3,(H2,28,29,31)",PKKNCEXEVUFFFI-UHFFFAOYSA-N,C27H39N3O,421.6,"1-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-3-[2,6-di(propan-2-yl)phenyl]urea","Nevanimibe|133825-80-6|PD-132301|nevanimiba|ATR-101 free base|VK9OS8R205|PD 132301|nevanimibum|RefChem:165609|1-(2,6-Diisopropylphenyl)-3-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea|Nevanimibe [USAN]|CHEMBL46423|Nevanimibe (USAN)|1-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-3-[2,6-di(propan-2-yl)phenyl]urea|CHEMBL542103|N-(2,6-bis(isopropyl)phenyl)-N/'-((1-(4-(dimethylaminomethyl)phenyl)cyclopentyl)methyl)urea|1-(2,6-diisopropylphenyl)-3-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea|ROV|NEVANIMIBE [INN]|UNII-VK9OS8R205|orb1709024|SCHEMBL1119314|C27H39N3O|DTXSID10928286|GLXC-22441|BDBM50041735|AKOS037648690|SB17169|BS-15209|DA-66048|HY-100399|CS-0018785|D11300|D81212|Q27291867|N-({1-[4-(dimethylamino)phenyl]cyclopentyl}methyl)-N'-[2,6-di(propan-2-yl)phenyl]urea|N-(2,6-Bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea|1-(2,6-Diisopropyl-phenyl)-3-[1-(4-dimethylamino-phenyl)-cyclopentylmethyl]-urea; hydrochloride|N'-({1-[4-(Dimethylamino)phenyl]cyclopentyl}methyl)-N-[2,6-di(propan-2-yl)phenyl]carbamimidic acid|N-(2,6-BIS(PROPAN-2-YL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)PHENYL) CYCLOPENTYL)METHYL)UREA|UREA, N-(2,6-BIS(1-METHYLETHYL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTYL)METHYL)-|Urea, N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-dimethylamino)phenyl)cyclopentyl)methyl)-"
NEVANIMIBE HYDROCHLORIDE,131678,,"InChI=1S/C27H39N3O.ClH/c1-19(2)23-10-9-11-24(20(3)4)25(23)29-26(31)28-18-27(16-7-8-17-27)21-12-14-22(15-13-21)30(5)6;/h9-15,19-20H,7-8,16-18H2,1-6H3,(H2,28,29,31);1H",SDOOGTHIDFZUNM-UHFFFAOYSA-N,C27H40ClN3O,458.1,"1-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-3-[2,6-di(propan-2-yl)phenyl]urea;hydrochloride","N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride|RefChem:165610|Nevanimibe hydrochloride|133825-81-7|ATR-101|pd-132301 hydrochloride|Atr-101 hydrochloride|ATR-101 HCl|PD132301-2|PD 132301-2|PD-132301-2|TK694ZFS57|Urea, N-[2,6-bis(1-methylethyl)phenyl]-N'-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-, hydrochloride (1:1)|Nevanimibe hydrochloride [USAN]|133825-81-7 (HCl)|PD 132301-02|PD-132301-02|1-(2,6-Diisopropylphenyl)-3-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea hydrochloride|Nevanimibe hydrochloride (USAN)|CHEMBL542103|1-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-3-[2,6-di(propan-2-yl)phenyl]urea;hydrochloride|UNII-TK694ZFS57|UREA, N-(2,6-BIS(1-METHYLETHYL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)PHENYL)CYCLOPENTYL)METHYL)-, HYDROCHLORIDE (1:1)|C27H40ClN3O|N-(2,6-Bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)urea HCl|orb1309337|SCHEMBL5973583|DTXSID10158389|IFA82581|AKOS032954251|HY-100399A|DA-66049|MS-28369|Urea, N-(2,6-bis(1-methylethyl)phenyl)-N'-((1-(4-(dimethylamino)phenyl)cyclopentyl)methyl)-, monohydrochloride|CS-0018786|PD132301-02|D11311|G12848|Q27289998|1[[1[4(Dimethylamino)phenyl]cyclopentyl]methyl]3[2,6di(propan2yl)phenyl]urea hydrochloride|1-(2,6-diisopropylphenyl)-3-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]urea;hydrochloride|N-(2,6-BIS(PROPAN-2-YL)PHENYL)-N'-((1-(4-(DIMETHYLAMINO)PHENYL) CYCLOPENTYL)METHYL)UREA HYDROCHLORIDE|Urea, N-[2,6-bis(1-methylethyl)phenyl]-N inverted exclamation marka-[[1-[4-(dimethylamino)phenyl]cyclopentyl]methyl]-, hydrochloride (1:1)"
CARBETAPENTANE,2562,,"InChI=1S/C20H31NO3/c1-3-21(4-2)14-15-23-16-17-24-19(22)20(12-8-9-13-20)18-10-6-5-7-11-18/h5-7,10-11H,3-4,8-9,12-17H2,1-2H3",CFJMRBQWBDQYMK-UHFFFAOYSA-N,C20H31NO3,333.5,2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate,"carbetapentane|Pentoxyverine|77-23-6|Pentoxyverin|Pentoxiverin|Atussil|Pentoxiverina|Pentoxyverinum|1-Phenyl-1-cyclopentanecarboxylate|Sedotussin|UCB 2543|DTXSID9022734|2-(2-Diethylaminoethoxy)ethyl 1-phenylcyclopentanecarboxylate|2-(Diethylaminoethoxy)ethyl 1-phenyl-1-cyclopentanecarboxylate|2-(Diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate|32C726X12W|1-Phenylcyclopentane-1-carboxylic acid diethylaminoethoxyethyl ester|Ethanol, 2-(2-(diethylamino)ethoxy)-, 1-phenylcyclopentanecarboxylate (ester)|DTXCID102734|1-Phenylcyclopentanecarboxylic acid 2-(2-diethylaminoethoxy)ethyl ester|1-Phenylcyclopentanecarboxylic acid,2-(2-(diethylamino)ethoxy)ethyl ester|1-phenylcyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester|1-phenylcyclopentanecarboxylic acid 2-(2-(diethylamino)ethoxy)ethyl ester|1-Phenylcyclopentanecarboxylic acid 2-[2-diethylaminoethoxy]ethyl ester|Ethanol, 2-[2-(diethylamino)ethoxy]-, 1-phenylcyclopentanecarboxylate (ester)|RefChem:123516|R05DB05|2-(2-diethylaminoethoxy)ethyl 1-phenylcyclopentyl-1-carboxylate|201-014-1|U.C.B. 2543|2-(2-(diethylamino)ethoxy)ethyl 1-phenylcyclopentanecarboxylate|CHEMBL73234|2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate|Cyclopentanecarboxylic acid, 1-phenyl-, 2-(2-(diethylamino)ethoxy)ethyl ester|Pentoxyverine (INN)|NCGC00024595-03|Pentoxiverinum|Sedotussin (TN)|Cyclopentanecarboxylic acid, 1-phenyl-, 2-[2-(diethylamino)ethoxy]ethyl ester|PENTOXYVERINE [INN]|Pentoxiverine|2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentanecarboxylate|Pentoxyverine [INN:BAN]|CAS-77-23-6|Pentoxyverinum [INN-Latin]|Pentoxiverina [INN-Spanish]|HSDB 3299|EINECS 201-014-1|BRN 2299701|PENTOXYVERINE (BASE)|UNII-32C726X12W|CARBAPENTANE|Toclase (Salt/Mix)|Tuclase (Salt/Mix)|Spectrum_001366|Spectrum_001952|Tocris-0454|Sedotussin (Salt/Mix)|Pentoxyverine (Standard)|Prestwick0_000387|Prestwick1_000387|Prestwick2_000387|Prestwick3_000387|Spectrum2_001412|Spectrum3_000922|Spectrum4_001021|CARBETAPENTANE [MI]|Cyclopentanecarboxylic acid, 1-phenyl-, 2-(2-(diethylamino)ethoxy)ethylester|PENTOXYVERINE [HSDB]|Lopac0_000313|SCHEMBL67879|BSPBio_000573|KBioGR_001541|KBioSS_001846|KBioSS_002506|cid_90010|CARBETAPENTANE [VANDF]|DivK1c_000356|PENTOXYVERINE [MART.]|SPBio_001484|SPBio_002494|PENTOXYVERINE [WHO-DD]|BPBio1_000631|orb1704841|BDBM94507|CHEBI:94484|KBio1_000356|KBio2_001846|KBio2_002498|KBio2_004414|KBio2_005066|KBio2_006982|KBio2_007634|KBio3_001924|NINDS_000356|HMS5086G10|MSK10300|Tox21_110909|PDSP1_001673|PDSP2_001656|AKOS015918339|Tox21_110909_1|CCG-204408|DB11186|HY-134004R|SDCCGSBI-0050301.P004|IDI1_000356|NCGC00024595-01|NCGC00024595-02|NCGC00024595-04|NCGC00024595-05|NCGC00024595-06|NCGC00024595-08|NCGC00024595-15|MS-25033|SBI-0050301.P003|DB-056191|HY-134004|AB00053602|CS-0136428|NS00006529|S0869|D08334|F87719|AB00053602_09|EN300-18551609|Q174786|BRD-K06181161-048-04-5|BRD-K06181161-048-07-8|BRD-K06181161-048-15-1|BRD-K06181161-048-16-9|1-Cyclopentanecarboxylate, 2-(diethylaminoethoxy)ethyl-1-phenyl-|2-[2-(Diemthylamino)ethoxy]ethyl 1-phenylcyclopentanecarboxylate|2-{[2-(diethylamino)ethyl]oxy}ethyl 1-phenylcyclopentanecarboxylate|1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester|citric acid;1-phenylcyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester|2-(2-Diethylaminoethoxy)ethyl 1-phenylcyclopentane-1-carboxylate; 2-hydroxypropane-1,2,3-tricarboxylic acid|2-[2-(diethylamino)ethoxy]ethyl 1-phenylcyclopentane-1-carboxylate;2-oxidanylpropane-1,2,3-tricarboxylic acid|2-hydroxypropane-1,2,3-tricarboxylic acid;1-phenyl-1-cyclopentanecarboxylic acid 2-[2-(diethylamino)ethoxy]ethyl ester"
TIOSPIRONE,55752,,"InChI=1S/C24H32N4O2S/c29-21-17-24(9-3-4-10-24)18-22(30)28(21)12-6-5-11-26-13-15-27(16-14-26)23-19-7-1-2-8-20(19)31-25-23/h1-2,7-8H,3-6,9-18H2",ZFZPJDFBJFHYIV-UHFFFAOYSA-N,C24H32N4O2S,440.6,"8-[4-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]decane-7,9-dione","TIOSPIRONE|87691-91-6|tiaspirone|Tiospirona|Tiospironum|35C6UMO5SR|BMY-13859|8-[4-[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]butyl]-8-azaspiro[4.5]decane-7,9-dione|DTXSID90236558|8-(4-(4-(1,2-benzothiazol-3-yl)piperazin-1-yl)butyl)-8-azaspiro(4.5)decane-7,9-dione|RefChem:190093|MJ-13859-1|DTXCID20159049|8-(4-(4-Benzo(d)isothiazol-3-yl-piperazin-1-yl)-butoxy)-8-aza-spiro(4.5)decane-7,9-dione|Tiospirone [INN]|CHEMBL35057|MJ 13859; NIH 10766|Tiospironum [Latin]|Tiospirona [Spanish]|UNII-35C6UMO5SR|tiospyrone|TIOSPERONE|SCHEMBL78696|GTPL101|orb1702723|SCHEMBL29356145|ZFZPJDFBJFHYIV-UHFFFAOYSA-N|GLXC-06498|BDBM50007692|PDSP1_000473|PDSP1_000474|PDSP2_000471|PDSP2_000472|AKOS040746412|8-Azaspiro(4,5)decane-7,9-dione, 8-(4-(4-(1,2-benzisothiazol-3-yl)-1-piperazinyl)butyl)-|DA-58591|DB-229670|HY-105034|CS-0024744|L000720|Q13415380|8-[4-(4-Benzo[d]isothiazol-3-yl-piperazin-1-yl)-butyl]-8-aza-spiro[4.5]decane-7,9-dione|8-[4-[4-(1,2-Benzisothiazol-3-yl)-1-piperazinyl]butyl]-8-azaspiro[4.5]decane-7,9-dione|8-{4-[4-(1,2-Benzothiazol-3-yl)-1-piperazinyl]butyl}-8-azaspiro[4.5]decane-7,9-dione"
"THIOUREA, N-(5-BROMO-2-PYRIDINYL)-N'-(2-(2-CHLORO-3-ETHOXY-6-FLUOROPHENYL)ETHYL)-",3001152,,"InChI=1S/C16H16BrClFN3OS/c1-2-23-13-5-4-12(19)11(15(13)18)7-8-20-16(24)22-14-6-3-10(17)9-21-14/h3-6,9H,2,7-8H2,1H3,(H2,20,21,22,24)",DTHZUSMREBJMBT-UHFFFAOYSA-N,C16H16BrClFN3OS,432.7,1-(5-bromopyridin-2-yl)-3-[2-(2-chloro-3-ethoxy-6-fluorophenyl)ethyl]thiourea,"Thiourea, N-(5-bromo-2-pyridinyl)-N'-(2-(2-chloro-3-ethoxy-6-fluorophenyl)ethyl)-|167683-61-6|N-(2-(2-Chloro-3-ethoxy-6-fluorophenethyl))-N'-(2-(5-bromopyridyl))thiourea|PETT deriv. 9|N-[2-(2-Chloro-3-ethoxy-6-fluorophenethyl)]-N'-[2-(5-bromopyridyl)]thiourea|Thiourea, N-(5-bromo-2-pyridinyl)-N'-[2-(2-chloro-3-ethoxy-6-fluorophenyl)ethyl]-|BDBM2859|CHEMBL398891|SCHEMBL6906082|SCHEMBL29422945|DTXSID70168348|1-(5-bromopyridin-2-yl)-3-[2-(2-chloro-3-ethoxy-6-fluorophenyl)ethyl]thiourea|1-(5-bromo-2-pyridyl)-3-[2-(2-chloro-3-ethoxy-6-fluoro-phenyl)ethyl]thiourea"
NIFEDIPINE,4485,,"InChI=1S/C17H18N2O6/c1-9-13(16(20)24-3)15(14(10(2)18-9)17(21)25-4)11-7-5-6-8-12(11)19(22)23/h5-8,15,18H,1-4H3",HYIMSNHJOBLJNT-UHFFFAOYSA-N,C17H18N2O6,346.3,"dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","nifedipine|21829-25-4|Procardia|Adalat|Procardia XL|Adalat CC|Fenihidine|Citilat|Oxcord|Coracten|dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Bay-a-1040|Afeditab CR|Nifedipino|Nifedipinum|Nifedical|Afeditab|Calcilat|BAY A 1040|3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester|Nifensar XL|Adipine XL|1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester|Nifedical XL|Adalate LP|Nifedipine slow release|CHEBI:7565|DTXSID2025715|3,5-dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|I9ZF7L6G2L|BAYa1040|NSC-757242|BAY 1040|Dimethyl 1,4-dihydro-2,6-dimethyl-4-(2'-nitrophenyl)-3,5-pyridinedicarboxylate|Dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate|DTXCID205715|Cordipine|Korinfar|4-(2'-Nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine|Nifedipine-GTIS|Nifedipine GTIS|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester|Bay1040|Monohydrochloride, Nifedipine|nifedipina|Calanif|Kentipine|Nifelease|Vasad|NifedicalXL|Nifopress ret|Cardilate mr|Coracten sr|Neozipine xl|Nifopress mr|Nimodrel xl|Nivaten ret|Adalat ret|Coroday mr|Nife-wolff|Unipine xl|Adalat ic|Adanif xl|Nifedicalxl XL|Nifediac Cc|Nifedipine ER|Valni xl|Angiopine 5|Fortipine la40|Angiopine 10|Angiopine 40 la|Angiopine mr 10|Angiopine mr 20|Kentipine mr 10|Kentipine mr 20|Tensipine mr 10|Tensipine mr 20|Adalat a.r.|Genalat 10 ret|Genalat 20 ret|Hypolar ret 10|Hypolar ret 20|Nifedotard 20 mr|Nimodrel mr 10|Nimodrel mr 20|Adipine mr 10|Adipine mr 20|Calchan mr 10|Calchan mr 20|Hypolar xl 30|Nifedipress mr 10|Nifedipress mr 20|Slofedipine xl 30|Slofedipine xl 60|Adalat la 20|Adalat la 30|Adalat la 60|Valni 20 ret|RefChem:6062|Nifedipine Extended Release|C08CA05|244-598-3|Cordipin|Corinfar|Fenihidin|Adalate|Nifediac|Hexadilat|Introcar|Kordafen|Tibricol|Adapine|Anifed|Pidilat|Sepamit|Zenusin|Orix|Adalat LA|MFCD00057326|CCRIS 6074|CHEMBL193|MLS000028521|Nifangin|Dimethyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate|NCGC00015748-11|Chronadalate|Dignokonstant|Adapress|Aldipin|Alfadal|Angipec|Aprical|Bonacid|Calcibloc|Calcigard|Cardifen|Cardilat|Cardionorm|Cordafen|Cordaflex|Cordalat|Cordicant|Cordilan|Corotrend|Corynphar|Dilafed|Dipinkor|Duranifin|Ecodipi|Ecodipin|Fenamon|Hadipin|Macorel|Megalat|Myogard|Nifecard|Nifecor|Nifedicor|Nifedin|Nifedipres|Nifelan|Nifelat|Nificard|SMR000058291|Alonix|Anpine|Camont|Fedcor|Glopir|Depin|Alat|Adalat Retard|CAS-21829-25-4|Fedcor Retard|Adalat Crono|Chronadalate LP|Adalat Oros|Ecodipin E|Apo-Nifed|Alonix S|Fenamon SR|Adalat CR|Adalat FT|Adalat LP|Adalat PA|Adalat GITS|Adalat 5|Adalat 10|Adalat 20|Adalat GITS 30|Alpha-Nifedipine Retard|Emaberin|Dilcor|Aprical long|Slofedipine XL|Fortipine LA|Nifedipinum [INN-Latin]|Tensipine MR|4-(2-Nitrophenyl)-2,6-dimethyl-3,5-dicarbomethoxy-1,4-dihydropyridine|Nifedipino [INN-Spanish]|Adalat XL|Dimethyl 4-(2-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate|Procardia (TN)|193689-82-6|Adalat (TN)|Afeditab CR (TN)|SR-01000075332|Aldipine|KB-1712P|methyl 5-(methoxycarbonyl)-2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine- 3-carboxylate|Prestwick_357|EINECS 244-598-3|Nifedipine (Adalat)|Nifedipine (Standard)|BRN 0497773|Spectrum_000979|Tocris-1075|NIFEDIPINE [MI]|NIFEDIPINE [INN]|NIFEDIPINE [JAN]|Opera_ID_1816|Prestwick0_000063|Prestwick1_000063|Prestwick2_000063|Prestwick3_000063|Spectrum2_001058|Spectrum3_000516|Spectrum4_000074|Spectrum5_001278|Lopac-N-7634|NIFEDIPINE [HSDB]|NIFEDIPINE [USAN]|NIFEDIPINE [VANDF]|UNII-I9ZF7L6G2L|Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate|N 7634|cid_4485|NIFEDIPINE [MART.]|SCHEMBL3968|NIFEDIPINE [USP-RS]|NIFEDIPINE [WHO-DD]|NIFEDIPINE [WHO-IP]|BIDD:PXR0034|CBiol_001826|Lopac0_000819|Oprea1_788617|BSPBio_000245|BSPBio_001391|BSPBio_002071|KBioGR_000111|KBioGR_000627|KBioGR_002400|KBioSS_000111|KBioSS_001459|KBioSS_002405|MLS000758222|MLS001148146|MLS001401371|BIDD:GT0442|DivK1c_000313|SPECTRUM1500431|SPBio_001016|SPBio_002166|BPBio1_000271|GTPL2514|Nifedipine (JP17/USP/INN)|Nifedipine - Bio-X trade mark|orb1309616|BAY-a 1040|NIFEDIPINE [ORANGE BOOK]|SCHEMBL29349595|BCBcMAP01_000046|HMS500P15|HSDB 7775|HY-B0284R|KBio1_000313|KBio2_000111|KBio2_001459|KBio2_002400|KBio2_002679|KBio2_004027|KBio2_004968|KBio2_005247|KBio2_006595|KBio2_007536|KBio3_000221|KBio3_000222|KBio3_001571|KBio3_002879|NIFEDIPINE [EP MONOGRAPH]|NIFEDIPINE [USP IMPURITY]|cMAP_000042|NINDS_000313|Bio1_000112|Bio1_000601|Bio1_001090|Bio2_000111|Bio2_000591|GLXC-05642|HMS1361F13|HMS1568M07|HMS1791F13|HMS1920P19|HMS1989F13|HMS2051O03|HMS2089H11|HMS2091H20|HMS2095M07|HMS2233B22|HMS3262D19|HMS3267G06|HMS3393O03|HMS3412E17|HMS3651M19|HMS3676E17|HMS3712M07|HMS3748O21|HMS5080O09|NIFEDIPINE [USP MONOGRAPH]|Pharmakon1600-01500431|NIFEDIPINUM [WHO-IP LATIN]|BCP21147|HY-B0284|MSK10100|L-Type Calcium Channel Blocker III|Tox21_110212|Tox21_200304|Tox21_500819|BBL023163|BDBM50000778|BDBM50101817|CCG-40115|HB1228|NSC757242|NSC786036|s1808|SBB012573|STK735567|AKOS002942507|AKOS037515769|Nifedipine - CAS 21829-25-4|Nifedipine, >=98% (HPLC), powder|Tox21_110212_1|AC-8061|CCG-100758|DB01115|FN26213|KS-1456|LP00819|NC00008|Nifedipine [USAN:USP:INN:BAN:JAN]|NSC 757242|NSC-786036|SDCCGSBI-0050796.P005|4-(2'-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsaeuredimethylester [German]|IDI1_000313|IDI1_033861|Bay-1040;Bay 1040;Bay1040|NCGC00015748-01|NCGC00015748-02|NCGC00015748-03|NCGC00015748-04|NCGC00015748-05|NCGC00015748-06|NCGC00015748-07|NCGC00015748-08|NCGC00015748-09|NCGC00015748-10|NCGC00015748-12|NCGC00015748-13|NCGC00015748-14|NCGC00015748-15|NCGC00015748-17|NCGC00015748-18|NCGC00015748-33|NCGC00021710-02|NCGC00024983-01|NCGC00024983-02|NCGC00024983-03|NCGC00024983-04|NCGC00024983-05|NCGC00024983-06|NCGC00024983-07|NCGC00024983-08|NCGC00091707-01|NCGC00091707-02|NCGC00091707-03|NCGC00257858-01|NCGC00261504-01|BN166183|CPD000058291|PD003075|PD033039|ST066898|SY074220|SBI-0050796.P004|EU-0100819|N0528|NS00002967|SW219724-1|29N254|BIM-0050796.0001|C07266|D00437|EN300-120627|Q39111|SBI-0050796.0002|AB00052051-05|AB00052051_06|AB00052051_07|5-22-04-00268 (Beilstein Handbook Reference)|F047202|L001054|SR-01000075332-1|SR-01000075332-3|SR-01000075332-4|SR-01000075332-6|BRD-K96354014-001-01-3|BRD-K96354014-001-10-4|BRD-K96354014-001-14-6|BRD-K96354014-001-15-3|BRD-K96354014-001-17-9|BRD-K96354014-001-21-1|BRD-K96354014-001-27-8|Z90350374|F2173-0802|Nifedipine, British Pharmacopoeia (BP) Reference Standard|Nifedipine, European Pharmacopoeia (EP) Reference Standard|Nifedipine, United States Pharmacopeia (USP) Reference Standard|2,6-Dimethyl-3,5-dicarbomethoxy-4-(2-nitrophenyl)-1,4-dihydropyridine|4-(2'-nitrophenyl)-2,6 dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridine|4-(2'-nitrophenyl)-2,6-dimethyl-3,5-dicarbmethoxy-1,4-dihydropyridine|Nifedipine, Pharmaceutical Secondary Standard; Certified Reference Material|2,6-dimethyl-4-(2nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3,5-dimethyl ester|Dimethyl (4-(2-nitrophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate)|Dimethyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate #|dimethyl2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid dimethyl ester;Adalate;Aldipin|101539-70-2|3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, dimethyl ester (9CI)|3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-, dimethyl ester (8CI)|915092-63-6"
METHACHOLINE,1993,,"InChI=1S/C8H18NO2/c1-7(11-8(2)10)6-9(3,4)5/h7H,6H2,1-5H3/q+1",NZWOPGCLSHLLPA-UHFFFAOYSA-N,C8H18NO2+,160.23,2-acetyloxypropyl(trimethyl)azanium,"methacholine|Acetylmethylcholine|55-92-5|beta-Methylacetylcholine|Methacholine ion|Acetyl-beta-methylcholine|Methacholine cation|CHEBI:6804|03V657ZD3V|2-acetyloxypropyl(trimethyl)azanium|DTXSID2046967|2-acetyloxypropyl-trimethylazanium|(2-(acetyloxy)propyl)trimethylazanium|[2-(acetyloxy)propyl]trimethylazanium|RefChem:156833|DTXCID0026967|Mecholin|MCH; Mecholin|Methacholin|Methacholinum|Choline, acetyl-beta-methyl-|2-acetoxypropyl(trimethyl)ammonium;chloride|BRN 1769932|UNII-03V657ZD3V|1-Propanaminium, 2-(acetyloxy)-N,N,N-trimethyl-|Prestwick0_000759|Prestwick1_000759|Prestwick2_000759|Prestwick3_000759|CHEMBL978|cid_6114|METHACHOLINE [VANDF]|Lopac0_000025|SCHEMBL69103|BSPBio_000778|BSPBio_001985|METHACHOLINE [WHO-DD]|SPBio_002717|BPBio1_000856|GTPL7438|BDBM48918|AMMONIUM, (2-HYDROXYPROPYL)TRIMETHYL-, ACETATE (ESTER)|PDSP1_000136|PDSP2_000135|CCG-204121|DB06709|NCGC00015045-03|NCGC00015045-04|NCGC00015045-06|NCGC00015045-13|NCGC00089798-02|SBI-0050014.P003|2-acetyloxy-N,N,N-trimethylpropan-1-aminium|2-acetyloxypropyl(trimethyl)ammonium;chloride|NS00015330|C07471|Q413188|BRD-A18056626-003-22-3|1-PROPANAMINIUM, 2-(ACETYLOXY)-N,N,N-TRIMETHYL-, (+/-)-"
PIPENDOXIFENE,6433099,,"InChI=1S/C29H32N2O3/c1-21-27-19-25(33)11-14-28(27)31(29(21)23-7-9-24(32)10-8-23)20-22-5-12-26(13-6-22)34-18-17-30-15-3-2-4-16-30/h5-14,19,32-33H,2-4,15-18,20H2,1H3",JICOGKJOQXTAIP-UHFFFAOYSA-N,C29H32N2O3,456.6,2-(4-hydroxyphenyl)-3-methyl-1-[[4-(2-piperidin-1-ylethoxy)phenyl]methyl]indol-5-ol,"Pipendoxifene|198480-55-6|ERA-923|ERA 923|pipendoxifeno|TPC5Q8496G|DTXSID40870209|ERA923|PIPENDOXIFENUM|RefChem:174381|DTXCID00817993|2-(4-hydroxyphenyl)-3-methyl-1-((4-(2-(piperidin-1-yl)ethoxy)phenyl)methyl)-1H-indol-5-ol|2-(4-Hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-ylethoxy)benzyl)-1H-indol-5-ol Hydrochloride|Pipendoxifene [INN]|UNII-TPC5Q8496G|CHEMBL44426|2-(4-hydroxyphenyl)-3-methyl-1-(4-(2-piperidin-1-yl-ethoxy)-benzyl)-1H-indol-5-ol|2-(4-hydroxyphenyl)-3-methyl-1-[[4-(2-piperidin-1-ylethoxy)phenyl]methyl]indol-5-ol|2-(p-Hydroxyphenyl)-3-methyl-1-(p-(2-piperidinoethoxy)benzyl)indol-5-ol|1H-Indol-5-ol, 2-(4-hydroxyphenyl)-3-methyl-1-((4-(2-(1-piperidinyl)ethoxy)phenyl)methyl)-|2-(4-hydroxyphenyl)-3-methyl-1-(4-(2-(piperidin-1-yl)ethoxy)benzyl)-1H-indol-5-ol.|SCHEMBL134583|PIPENDOXIFENE [WHO-DD]|orb1739467|JICOGKJOQXTAIP-UHFFFAOYSA-N|C29H32N2O3|BDBM50099587|DB05414|DA-56884|FP176202|HY-13724|US8815934, No. 97|US8815934, No. 107|CS-0007753|NS00068367|F97672|Q27095593|2-(4-Hydroxy-phenyl)-3-methyl-1-[4-(2-piperidin-1-yl-ethoxy)-benzyl]-1H-indol-5-ol|2-(4-hydroxyphenyl)-3-methyl-1-[[4-[2-(1-piperidinyl)ethoxy]phenyl]methyl]-1H-indol-5-ol|2-(4-hydroxyphenyl)-3-methyl-1-[[4-[2-(1-piperidyl)ethoxy]phenyl]methyl]indol-5-ol"
IODOPHTHALEIN,67846,,"InChI=1S/C20H10I4O4/c21-13-5-9(6-14(22)17(13)25)20(10-7-15(23)18(26)16(24)8-10)12-4-2-1-3-11(12)19(27)28-20/h1-8,25-26H",FWQKRBDABCRWKV-UHFFFAOYSA-N,C20H10I4O4,821.9,"3,3-bis(4-hydroxy-3,5-diiodophenyl)-2-benzofuran-1-one","Iodophthalein|386-17-4|3',3'',5',5''-Tetraiodophenolphthalein|Tetraiodophenolphthalein|Iodophthalein sodium free acid|Nosophene|R2CC46UA50|NSC-4904|Phenolphthalein, 3',3'',5',5''-tetraiodo-|1(3H)-Isobenzofuranone, 3,3-bis(4-hydroxy-3,5-diiodophenyl)-|3,3-Bis(4-hydroxy-3,5-diiodophenyl)-1(3H)-isobenzofuranone|RefChem:148554|206-857-9|DTXCID8028266|DTXSID7048291|Nosophen|NSC-164900|3,3-Bis(4-hydroxy-3,5-diiodophenyl)isobenzofuran-1(3H)-one|3,3-bis(4-hydroxy-3,5-diiodophenyl)-2-benzofuran-1-one|MFCD00001614|3,3-bis(4-hydroxy-3,5-diiodo-phenyl)isobenzofuran-1-one|561-28-4|3,3-bis(4-hydroxy-3,5-diiodophenyl)-1,3-dihydro-2-benzofuran-1-one|Jodphthaleinum|EINECS 206-857-9|BRN 0351654|UNII-R2CC46UA50|3,3-bis(4-hydroxy-3,5-diiodophenyl)-3-hydroisobenzofuran-1-one|Tetraiodophthalein|3,3-bis(4-hydroxy-3,5-diiodophenyl)-2-benzofuran-1(3h)-one|3,3-Bis(4-hydroxy-3,5-diiodophenyl)phthalide|C20H10I4O4|UPCMLD-DP078|4-18-00-01949 (Beilstein Handbook Reference)|MLS004773975|SCHEMBL2833068|UPCMLD-DP078:001|DTXSID10971479|NSC4904|FWQKRBDABCRWKV-UHFFFAOYSA-N|AAA38617|BDBM50530710|SBB057654|AKOS001044034|AS-58248|SMR002529480|SY051485|IODOPHTHALEIN SODIUM FREE ACID [MI]|3,3',5,5'-TETRAIODOPHENOLPHTHALEIN|CS-0147266|NS00079244|ST51006759|T0126|Q19286247|3 inverted exclamation mark ,3 inverted exclamation mark  inverted exclamation mark ,5 inverted exclamation mark ,5 inverted exclamation mark  inverted exclamation mark -Tetraiodophenolphthalein"
SELFOTEL,68736,,"InChI=1S/C7H14NO5P/c9-7(10)6-3-5(1-2-8-6)4-14(11,12)13/h5-6,8H,1-4H2,(H,9,10)(H2,11,12,13)/t5-,6+/m1/s1",LPMRCCNDNGONCD-RITPCOANSA-N,C7H14NO5P,223.16,"(2S,4R)-4-(phosphonomethyl)piperidine-2-carboxylic acid","Selfotel|CGS 19755|110347-85-8|CGS-19755|(2S,4R)-4-(phosphonomethyl)piperidine-2-carboxylic acid|2-Piperidinecarboxylic acid, 4-(phosphonomethyl)-, cis-|GNF-Pf-157|4VGJ4A41L2|DTXSID5045675|CPDD-0027|DTXCID3025675|selfotelum|4-(phosphonomethyl)-2-piperidinecarboxylic acid|RefChem:931596|Selfotel, (+)-|CPDD 0027|CGS-20282|2-Piperidinecarboxylic acid, 4-(phosphonomethyl)-, (2S,4R)-|CHEMBL39664|113229-62-2|CIS-4-[PHOSPHONOMETHYL]-PIPERIDINE-2-CARBOXYLIC ACID|CHEBI:34973|N0905W44Y3|Selfotel [USAN:INN]|H-4-Pal-OH.2HCl|cis-4-(Phosphonomethyl)pipecolic acid|UNII-4VGJ4A41L2|CIS-4-(PHOSPHONOMETHYL)-PIPERIDINE-2-CARBOXYLIC ACID|UNII-N0905W44Y3|NCGC00025070-01|cis-4-(phosphonomethyl)piperidine-2-carboxylic acid|SELFOTEL [USAN]|Selfotel (USAN/INN)|SELFOTEL [INN]|H-4-Pal-OH 2HCl|SELFOTEL [MART.]|SELFOTEL [WHO-DD]|4-Phosphonomethyl-piperidine-2-carboxylic acid|SCHEMBL120234|2-Piperidinecarboxylic acid, 4-(phosphonomethyl)-, (2R,4S)-rel-|GTPL4155|CGS19755|KEA34785|Tox21_110945|BDBM50004927|PDSP2_001471|AKOS015914119|CAS-110347-85-8|NS00123262|D02410|D85721|cis-4-(phosphonomethyl)piperidine-2-carboxylicacid|cis-4-phosphonomethyl-2-piperidine carboxylic acid|Q7448341|cis-4-(phosphonomethyl)-2-piperidine carboxylic acid|2-Piperidinecarboxylicacid,4-(phosphonomethyl)-,(2R,4S)-rel-|(2S,4R)-4-(PHOSPHONOMETHYL)-2-PIPERIDINECARBOXYLIC ACID|cis-(+)-((2S,4R)-4-Phosphonomethyl-piperidine-2-carboxylic acid|4-Phosphonomethyl-piperidine-2-carboxylic acid (CGS-19755, LY 272541)|cis-4-[Phosphonomethyl]-2-piperidinecarboxylic Acid; rel-(2R,4S)-4-(Phosphonomethyl)-2-piperidinecarboxylic Acid; CPDD 0027; Selfotel;"
LECOZOTAN,10116877,,"InChI=1S/C28H29N5O3/c1-21(31-13-15-32(16-14-31)24-5-4-6-25-27(24)36-18-17-35-25)20-33(26-7-2-3-12-30-26)28(34)23-10-8-22(19-29)9-11-23/h2-12,21H,13-18,20H2,1H3/t21-/m1/s1",NRPQELCNMADTOZ-OAQYLSRUSA-N,C28H29N5O3,483.6,"4-cyano-N-[(2R)-2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazin-1-yl]propyl]-N-pyridin-2-ylbenzamide","Lecozotan|48854OTZ5E|4-CYANO-N-((2R)-2-(4-(2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)PIPERAZIN-1-YL)PROPYL)-N-(PYRIDIN-2-YL)BENZAMIDE|lecozotanum|RefChem:152694|4-Cyano-N-(2R-(4-(2,3-dihydrobenzo(1,4)-dioxin-5-yl)-piperazin-1-yl)-propyl)-N-pyridin-2-yl-benzamide|434283-16-6|Lecozotan [INN]|UNII-48854OTZ5E|CHEMBL372205|4-Cyano-N-(2R-(4-(2,3-dihydrobenzo(1,4)-dioxin-5-yl)-piperazin-1-yl)-propyl)-N-pyridin-2-yl-benzamide hydrochloride|4-cyano-N-[(2R)-2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)piperazin-1-yl]propyl]-N-pyridin-2-ylbenzamide|orb2814846|SCHEMBL2881511|DTXSID30870354|NRPQELCNMADTOZ-OAQYLSRUSA-N|BDBM50166903|DB12540|NS00070821|Q27259118|(R)-4-Cyano-N-{2-[4(2,3-Dihydro-Benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-Propyl}-N-Pyridin-2-yl-Benzamide|(R)-4-Cyano-N-{2-[4-(2,3-Di hydro-Benzo[1,4]dioxin-5-yl]piperazin-1-yl]-Propyl}-N-Pyridin-2-yl-Benzamide|(R)-4-Cyano-N-{2-[4-(2,3-Dihydro-Benzo[1,4]dioxin-5-yl)-Piperazin-1-yl]-Propyl}-N-Pyridin-2-yl-Benzamide|(R)-4-Cyano-N-{2-[4-(2,3-Dihydro-Benzo[1,4]dioxin-5-yl)-Piperazin-1yl]-Propyl}-N-Pyridin-2-yl-Benzamide|(R)-4-Cyano-N-{2-[4-(2,3-Dihydro-Benzo[1,4]dioxin-5-yl]piperazin-1-yl]-Propyl}-N-Pyridin-2-yl-Benzamide|4-Cyano-N-{(2R)-2-[4-(2,3-dihydro-1,4-benzodioxin-5-yl)-1-piperazinyl]propyl}-N-(2-pyridinyl)benzamide|4-Cyano-N-{(R)-2-[4-(2,3-dihydro-benzo[1,4]dioxin-5-yl)-piperazin-1-yl]-propyl}-N-pyridin-2-yl-benzamide|BENZAMIDE, 4-CYANO-N-((2R)-2-(4-(2,3-DIHYDRO-1,4-BENZODIOXIN-5-YL)-1-PIPERAZINYL)PROPYL)-N-2-PYRIDINYL-"
BX 471,5311124,,"InChI=1S/C21H24ClFN4O3.ClH/c1-14-11-26(12-15-2-5-17(23)6-3-15)8-9-27(14)20(28)13-30-19-7-4-16(22)10-18(19)25-21(24)29;/h2-7,10,14H,8-9,11-13H2,1H3,(H3,24,25,29);1H/t14-;/m1./s1",FRUCNQBAWUHKLS-PFEQFJNWSA-N,C21H25Cl2FN4O3,471.3,[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methylpiperazin-1-yl]-2-oxoethoxy]phenyl]urea;hydrochloride,"288262-96-4|L350B5LO1J|ZK-811752|BAY-865047|BAY86-5047|BAY-86-5047|ZK811752|DTXSID50183019|UREA, N-(5-CHLORO-2-(2-((2R)-4-((4-FLUOROPHENYL)METHYL)-2-METHYL-1-PIPERAZINYL)-2-OXOETHOXY)PHENYL)-, HYDROCHLORIDE (1:1)|RefChem:122429|DTXCID10105510|(5-chloro-2-(2-((2R)-4-((4-fluorophenyl)methyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)phenyl)urea|Bx 471|Bx-471|BX-741|BX471|BX471 hydrochloride|BX471 (hydrochloride)|(R)-1-(5-Chloro-2-(2-(4-(4-fluorobenzyl)-2-methylpiperazin-1-yl)-2-oxoethoxy)phenyl)urea hydrochloride|[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methylpiperazin-1-yl]-2-oxoethoxy]phenyl]urea;hydrochloride|CHEMBL535607|UNII-L350B5LO1J|BX471hydrochloride|ZK 811752|ZK-811752 hydrochloride|C21H25Cl2FN4O3|SCHEMBL434321|orb1179433|BX 471 [WHO-DD]|SCHEMBL30172123|EX-A2189|NLA26296|HY-12080A|AKOS030526767|CS-3284|AC-35971|BS-16429|N-(5-Chloro-2-(2-(4-((4-fluorophenyl)methyl)-2-methyl-1-piperazinyl)-2-oxoethoxy)phenyl)urea hydrochloric acid salt|D83669|Q27282643|[5-chloro-2-[2-[(2R)-4-[(4-fluorophenyl)methyl]-2-methyl-piperazin-1-yl]-2-oxo-ethoxy]phenyl]urea;hydrochloride|N-(5-CHLORO-2-(2-(4-(4-FLUOROBENZYL)-2(R)-METHYLPIPERAZIN-1-YL)-2-OXOETHOXY)PHENYL)UREA HYDROCHLORIDE|Urea, N-(5-chloro-2-(2-((2R)-4-((4-fluorophenyl)methyl)-2-methyl-1-     Piperazinyl)-2-oxoethoxy)phenyl)-, hydrochloride (1:1)"
METOPROLOL,4171,,"InChI=1S/C15H25NO3/c1-12(2)16-10-14(17)11-19-15-6-4-13(5-7-15)8-9-18-3/h4-7,12,14,16-17H,8-11H2,1-3H3",IUBSYMUCCVWXPE-UHFFFAOYSA-N,C15H25NO3,267.36,1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol,"metoprolol|51384-51-1|(RS)-Metoprolol|Beatrolol|dl-Metoprolol|Seroken|37350-58-6|Metoprololum|Spesikor|1-(Isopropylamino)-3-(4-(2-methoxyethyl)phenoxy)propan-2-ol|CGP 2175|CGP-2175|Metoprolol slow release|1-[4-(2-methoxyethyl)phenoxy]-3-(propan-2-ylamino)propan-2-ol|GEB06NHM23|CHEBI:6904|1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol|DTXSID2023309|CGP2175|2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-|2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-|DTXCID503309|H-93/26|Betaloc-Astra|1-(4-(2-methoxyethyl)phenoxy)-3-(propan-2-ylamino)propan-2-ol|Beloc Duriles|Betaloc Astra|{2-hydroxy-3-[4-(2-methoxyethyl)phenoxy]propyl}(propan-2-yl)amine|1-(4-(2-Methoxyethyl)-phenoxy)-3-((1-methylethyl)amino)-2-propanol|metoprololo|(2-hydroxy-3-(4-(2-methoxyethyl)phenoxy)propyl)(propan-2-yl)amine|1-[4-(2-METHOXYETHYL)-PHENOXY]-3-[(1-METHYLETHYL)AMINO]-2-PROPANOL|metoprolol CR-XL|Metoprolol CR XL|RefChem:6036|GlyTouCan:G46992WB|H 9326|H 93 26|C07AB02|G46992WB|2-Propanol, 1-(4-(2-methoxyethyl)phenoxy)-3-((1-methylethyl)amino)-, (+-)-|(+-)-1-(Isopropylamino)-3-(p-(beta-methoxyethyl)phenoxy)-2-propanol|253-483-7|257-166-4|Spesicor|Meijoprolol|Metohexal|Preblok|Presolol|Selo-Zok|rac Metoprolol|1-[4-(2-methoxyethyl)phenoxy]-3-propan-2-ylamino-propan-2-ol|(+/-)-Metoprolol|CHEMBL13|MFCD00599534|51384-51-1 (free base)|Lopresoretic|Betalok|Metoprololum [INN-Latin]|Metoprolol [USAN:INN:BAN]|Loresor|Neobloc|1-[4-(2-methoxyethyl)phenoxy]-3-[(propan-2-yl)amino]propan-2-ol|1-[(1-methylethyl)amino]-3-({4-[2-(methyloxy)ethyl]phenyl}oxy)propan-2-ol|2-Propanol, 1-[4-(2-methoxyethyl)phenoxy]-3-[(1-methylethyl)amino]-, (.+/-.)-|LOPRESSIDONE|CCRIS 4198|HSDB 6531|Metoprolol (USAN/INN)|UNII-GEB06NHM23|EINECS 257-166-4|Lopresol (Salt/Mix)|METOPROLOL [MI]|Lopresoretic (Salt/Mix)|METOPROLOL [INN]|(.+/-.)-Metoprolol|METOPROLOL [HSDB]|METOPROLOL [USAN]|METOPROLOL [VANDF]|METOPROLOL [MART.]|SCHEMBL4093|METOPROLOL [WHO-DD]|GTPL553|H 93/26 (Salt/Mix)|BDBM25756|METOPROLOL, (+/-)-|HMS2090B15|HMS3886O04|HMS5084K22|BCA38451|BCP09038|GP-2175E|Tox21_303972|s5430|STL301858|AKOS005927923|BG-0006|CCG-204813|CS-3159|DB00264|SDCCGSBI-0050706.P005|NCGC00021148-03|NCGC00021148-04|NCGC00021148-05|NCGC00021148-21|NCGC00356981-01|54163-88-1|AC-19022|HY-17503|SBI-0050706.P004|CAS-51384-51-1|DB-049097|AB00053499|NS00000197|C07202|D02358|EN300-317058|AB00053499-21|AB00053499_22|AB00053499_23|L000669|Q409468|SR-01000003148-2|BRD-A03623303-045-02-0|BRD-A03623303-045-05-3|BRD-A03623303-045-09-5|BRD-A03623303-046-14-3|Z398538014|1-(Isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]-2-propanol|1-(Isopropylamino)-3-[p-(2-methoxyethyl)phenoxy]-2-propanol|1-Isopropylamino-3-[4-(2-methoxy-ethyl)-phenoxy]-propan-2-ol|(+/-)-1-(Isopropylamino)-3-(p-(beta-methoxyethyl)phenoxy)-2-propanol|1-(4-(2-METHOXYETHYL)PHENOXY)-3-((1-METHYLETHYL)AMINO)-2-PROPANOL|(2R,3R)-2,3-dihydroxysuccinic acid;1-(isopropylamino)-3-[4-(2-methoxyethyl)phenoxy]propan-2-ol"
TIMOLOL,33624,,"InChI=1S/C13H24N4O3S/c1-13(2,3)14-8-10(18)9-20-12-11(15-21-16-12)17-4-6-19-7-5-17/h10,14,18H,4-9H2,1-3H3/t10-/m0/s1",BLJRIMJGRPQVNF-JTQLQIEISA-N,C13H24N4O3S,316.42,"(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol","timolol|26839-75-8|Betimol|Timololum|Timolol anhydrous|Betim|(-)-3-Morpholino-4-(3-tert-butylamino-2-hydroxypropoxy)-1,2,5-thiadiazole|S-(-)-3-(3-tert-Butylamino-2-hydroxypropoxy)-4-morpholino-1,2,5-thiadiazole|(S)-1-(1,1-(Dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol|5JKY92S7BR|(S)-1-(tert-Butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol|CHEBI:9599|CHEBI:60787|817W3C6175|Timololo|Nyogel|Tiopex|Glau-opt|2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, hemihydrate, (S)-|RefChem:898126|GlyTouCan:G25766AE|C07AA06|S01ED01|1-(tert-butylamino)-3-((4-morpholino-1,2,5-thiadiazol-3-yl)oxy)propan-2-ol|MK950|G25766AE|L714,465|L 714,465|248-032-6|CHEBI:39465|(S)-timolol|Timoptic|Blocadren|(2S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|Timololum [INN-Latin]|Timolol (INN)|Betimol (TN)|Timopic|(S)-timolol (anhydrous)|CHEMBL499|DTXSID4023674|(2S)-1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-2-propanol|NCGC00016798-06|Timacar|Timoptol|TIMOLOL [INN]|2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (2S)-|DTXCID203674|(2S)-3-[(tert-butyl)amino]-1-(4-morpholin-4-yl(1,2,5-thiadiazol-3-yl)oxy)propa n-2-ol|2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-, (2S)-|Timolol (TN)|CAS-26839-75-8|HSDB 6533|Timolol [USAN:INN]|EINECS 248-032-6|CAS-26921-17-5|UNII-5JKY92S7BR|(S)-Timolol; Arutimol; L-Timolol|Tocris-0649|TIMOLOL [HSDB]|TIMOLOL [MI]|Prestwick0_000948|Prestwick1_000948|Prestwick2_000948|Prestwick3_000948|Lopac-T-6394|TIMOLOL [WHO-DD]|SCHEMBL4912|Lopac0_001189|Oprea1_640981|BSPBio_000916|GTPL565|BIDD:GT0073|SPBio_003075|BPBio1_001008|HMS2089I11|HMS3259C20|Tox21_110614|BDBM50292219|AKOS015969764|Tox21_110614_1|DB00373|NC00592|NCGC00016038-01|NCGC00016038-02|NCGC00016798-01|NCGC00016798-02|NCGC00016798-03|NCGC00016798-05|NCGC00016798-07|NCGC00016798-08|NCGC00016798-09|NCGC00016798-11|NCGC00016798-20|NCGC00022033-02|NCGC00022033-04|NCGC00022033-05|(2S)-1-[(1,1-dimethylethyl)amino]-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|2-Propanol, 1-((1,1-dimethylethyl)amino)-3-((4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl)oxy)-, (S)-|DA-78480|HY-17494|ST072193|AB00513729|CS-0009238|NS00115928|C07141|D08600|AB00513729-17|839T758|EN300-17982937|Q413994|BRD-K08806317-050-03-6|BRD-K08806317-050-29-1|BRD-K08806317-051-01-8|BRD-K08806317-103-02-5|(2S)-1-(tert-butylamino)-3-{[4-(morpholin-4-yl)-1,2,5-thiadiazol-3-yl]oxy}propan-2-ol|(S)-1-(TERT-BUTYLAMINO)-3-((4-MORPHOLINO-1,2,5-THIADIAZOL-3-YL)OXY)-2-PROPANOL|(S)-1-(tert-butylamino)-3-[(4-morpholin-4-yl-1,2,5-thiadiazol-3-yl)oxy]propan-2-ol|(S)-1-tert-Butylamino-3-(4-morpholin-4-yl-[1,2,5]thiadiazol-3-yloxy)-propan-2-ol|(S)-Timolol; (2S)-1-[(1,1-Dimethylethyl)amino]-3-[[4-(4-morpholinyl)-1,2,5-thiadiazol-3-yl]oxy]-2-propanol; 2-Propanol, 1-(tert-butylamino)-3-[(4-morpholino-1,2,5-thiadiazol-3-yl)oxy]-, (S)-(-)- (8CI); 2-Propanol, 1-[(1,1-dimethylethyl)amino]-3-[[4-(4-mor|1-(tert-butylamino)-3-[4-(1,4-oxazinan-4-yl)-1,2,5-thiadiazol-3-yloxy]-(2S)-propan-2-ol"
TOFIMILAST,9896267,,"InChI=1S/C18H21N5S/c1-2-14-13-9-10-22-17(15-8-5-11-24-15)19-20-18(22)16(13)23(21-14)12-6-3-4-7-12/h5,8,11-12H,2-4,6-7,9-10H2,1H3",DHCOPPHTVOXDKU-UHFFFAOYSA-N,C18H21N5S,339.5,"12-cyclopentyl-10-ethyl-5-thiophen-2-yl-3,4,6,11,12-pentazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,10-tetraene","Tofimilast|185954-27-2|CP-325366|CP-325,366|5D7022962A|DTXSID20870166|9-cyclopentyl-5,6-dihydro-7-ethyl-3-(thien-2-yl)-9H-pyrazolo(3,4-c)-1,2,4-triazolo(4,3-a)pyridine|5H-Pyrazolo(3,4-c)-1,2,4-triazolo(4,3-a)pyridine, 9-cyclopentyl-7-ethyl-6,9-dihydro-3-(2-thienyl)-|tofimilastum|RefChem:933165|DTXCID30817966|12-cyclopentyl-10-ethyl-5-(thiophen-2-yl)-3,4,6,11,12-pentaazatricyclo(7.3.0.0^(2,6))dodeca-1(9),2,4,10-tetraene|CHEMBL217899|12-cyclopentyl-10-ethyl-5-thiophen-2-yl-3,4,6,11,12-pentazatricyclo[7.3.0.02,6]dodeca-1(9),2,4,10-tetraene|9-Cyclopentyl-7-ethyl-3-(thiophen-2-yl)-6,9-dihydro-5H-pyrazolo(3,4-c)-1,2,4-triazolo(4,3-a)pyridine|8-Cyclopentyl-6-ethyl-3-thiophen-2-yl-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacene|Tofimilast [INN]|Tofimilast [USAN:INN]|UNII-5D7022962A|Tofimilast (INN/USAN)|TOFIMILAST [USAN]|TOFIMILAST [WHO-DD]|SCHEMBL230762|orb1699114|CHEBI:188562|DHCOPPHTVOXDKU-UHFFFAOYSA-N|BDBM50202528|EX-A12363|AKOS040749662|DB11681|TS-08648|HY-106137|CS-0024961|NS00068166|D09020|Q27261868|8Cyclopentyl-6-ethyl-3-thiophen-2-yl-5,8-dihydro-4H-1,2,3a,7,8-pentaaza-as-indacene|9-cyclopentyl-5,6-dihydro-7-ethyl-3-(thien-2-yl)-9H-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-alpha]pyridine|9-Cyclopentyl-7-ethyl-6,9-dihydro-3-(2-thienyl)-5H-pyrazolo[3,4-c]-1,2,4-triazolo[4,3-a]pyridine"
LAROPIPRANT,9867642,,"InChI=1S/C21H19ClFNO4S/c1-29(27,28)18-10-15(23)9-17-16-7-4-13(8-19(25)26)20(16)24(21(17)18)11-12-2-5-14(22)6-3-12/h2-3,5-6,9-10,13H,4,7-8,11H2,1H3,(H,25,26)/t13-/m1/s1",NXFFJDQHYLNEJK-CYBMUJFWSA-N,C21H19ClFNO4S,435.9,"2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1H-cyclopenta[b]indol-3-yl]acetic acid","Laropiprant|571170-77-9|MK-0524|Cordaptive|G7N11T8O78|DTXSID60205756|MK0524|(-)-((3R)-4-(4-Chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl)acetic acid|2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methanesulfonyl-1H,2H,3H,4H-cyclopenta[b]indol-3-yl]acetic acid|laropiprantum|2-((3R)-4-((4-chlorophenyl)methyl)-7-fluoro-5-methanesulfonyl-1H,2H,3H,4H-cyclopenta(b)indol-3-yl)acetic acid|RefChem:798524|DTXCID90128247|MK 0524|Cardaptive|Laropiprant (MK-0524)|CHEMBL426559|(R)-2-(4-(4-chlorobenzyl)-7-fluoro-5-(Methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid|2-[(3R)-4-[(4-chlorophenyl)methyl]-7-fluoro-5-methylsulfonyl-2,3-dihydro-1H-cyclopenta[b]indol-3-yl]acetic acid|C21H19ClFNO4S|((3R)-4-(4-Chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta(b)indol-3-yl)acetic acid|Cyclopent(b)indole-3-acetic acid, 4-((4-chlorophenyl)methyl)-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)-, (3R)-|Laropiprant [USAN]|Tedaptive|UNII-G7N11T8O78|Laropiprant [USAN:INN:BAN]|MFCD11042421|LAROPIPRANT [MI]|572874-50-1|LAROPIPRANT [INN]|Laropiprant (INN/USAN)|Laropiprant; MK-0524|LAROPIPRANT [MART.]|LAROPIPRANT [WHO-DD]|SCHEMBL991107|LAROPIPRANT [EMA EPAR]|GTPL3356|orb1308138|SCHEMBL29612617|CHEBI:135942|BCPP000161|BCP02136|EX-A2099|BDBM50205275|Laropiprant,CAS:571170-77-9|AKOS030526850|AT34794|BCP9000944|Cardaptive; MK 0524; MK-0524|CS-0539|DB11629|FC75279|NCGC00345790-10|(3R)-4-[(4-Chlorophenyl)methyl]-7-fluoro-1,2,3,4-tetrahydro-5-(methylsulfonyl)cyclopent[b]indole-3-acetic acid|AC-35835|AS-17012|HY-50175|NS00098961|D08940|EN300-25916161|Q412291|BRD-K48894757-001-01-8|[(3R)-4-(4-chlorobenzyl)-7-fluoro-5-(methylsulfonyl)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl]-acetic acid"
VINBLASTINE,13342,,"InChI=1S/C46H58N4O9/c1-8-42(54)23-28-24-45(40(52)57-6,36-30(15-19-49(25-28)26-42)29-13-10-11-14-33(29)47-36)32-21-31-34(22-35(32)56-5)48(4)38-44(31)17-20-50-18-12-16-43(9-2,37(44)50)39(59-27(3)51)46(38,55)41(53)58-7/h10-14,16,21-22,28,37-39,47,54-55H,8-9,15,17-20,23-26H2,1-7H3/t28-,37-,38+,39+,42-,43+,44+,45-,46-/m0/s1",JXLYSJRDGCGARV-CFWMRBGOSA-N,C46H58N4O9,811.0,"methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate","vinblastine|865-21-4|Vinblastin|Vincaleucoblastin|Vinblastina|Vincoblastine|Vincaleukoblastine|Nincaluicolflastine|Vinblastinum|NCI-C04842|5V9KLZ54CY|NSC 47842|NDC 0002-1452-01|NSC-47842|(2ALPHA,2'BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE|DTXSID8021430|1H-Indolizino(8,1-cd)carbazole-5-carboxylic acid, 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-, methyl ester, (3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-|methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate|Vinblastina Lilly|methyl (1R,9R,10S,11R,12R,19R)-11-acetyloxy-12-ethyl-4-((13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo(13.3.1.04,12.05,10)nonadeca-4(12),5,7,9-tetraen-13-yl)-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.01,9.02,7.016,19)nonadeca-2,4,6,13-tetraene-10-carboxylate|RefChem:6350|DTXCID801430|L01CA01|methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-((13S,15S,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo(13.3.1.0^(4,12).0^(5,10))nonadeca-4(12),5,7,9-tetraen-13-yl)-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.0^(1,9).0^(2,7).0^(16,19))nonadeca-2(7),3,5,13-tetraene-10-carboxylate|212-734-0|methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-((13S,15S,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo(13.3.1.04,12.05,10)nonadeca-4(12),5,7,9-tetraen-13-yl)-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo(10.6.1.01,9.02,7.016,19)nonadeca-2(7),3,5,13-tetraene-10-carboxylate|CHEBI:27375|NSC90636|Vincaleucoblastine|Velban|Velbe|CHEMBL159|C46H58N4O9|Rozevin|Vinblastina [DCIT]|Vinblastine [INN:BAN]|Vinblastinum [INN-Latin]|VR-8|VLB|CCRIS 9002|VINBLASTINE [INN]|HSDB 3263|EINECS 212-734-0|UNII-5V9KLZ54CY|cid_5388983|[3H]-Vinblastine|MFCD05662370|1z2b|VINBLASTINE [MI]|VINBLASTINE [HSDB]|VINBLASTINE [VANDF]|SCHEMBL3628|SCHEMBL3629|BIDD:PXR0201|BSPBio_001228|VINBLASTINE [WHO-DD]|(3aR-(3aalpha,4beta,5beta,5abeta,9(3R*,5S*,7R*,9S*),10bR*,13aalpha))-methyl 4-(acetyloxy)-3a-ethyl-9-(5-ethyl-1,4,5,6,7,8,9,10-octahydro-5-hydroxy-9-(methoxycarbonyl)-2H-3,7-methanoazacycloundecino(5,4-b)indol-9-yl)-3a,4,5,5a,6,11,12,13a-octahydro-5-hydroxy-8-methoxy-6-methyl-1H-indolizino(8,1-cd)carbazole-5-carboxylate|GTPL6851|orb1685623|132142-72-4|MSK15295|BDBM50012278|NSC816570|AKOS015965500|CS-1336|DB00570|NSC-816570|NCGC00022585-04|NCGC00022585-05|NCGC00485975-02|AC-24191|AS-15821|BP-43221|HY-17418|VinblastineVincaleukoblastine; Vinblastina|EN300-19874057|VINDESINE SULFATE IMPURITY B [EP IMPURITY]|VINCRISTINE SULFATE IMPURITY H [EP IMPURITY]|BRD-K01188359-001-02-0|BRD-K01188359-001-03-8|BRD-K01188359-065-02-5|BRD-K01188359-065-23-1|(2alpha,2'beta,3alpha,5beta,19beta)-vincaleukoblastine|(2ALPHA,2''''BETA,3BETA,4ALPHA,5BETA)-VINCALEUKOBLASTINE|methyl (1R,9R,10S,11R,12R,19R)-11-(acetyloxy)-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-(methoxycarbonyl)-1,11-diazatetracyclo[13.3.1.0^{4,12}.0^{5,10}]nonadeca-4(12),5(10),6,8-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.0^{1,9}.0^{2,7}.0^{16,19}]nonadeca-2,4,6,13-tetraene-10-carboxylate|methyl (1R,9R,10S,11R,12R,19R)-11-acetoxy-12-ethyl-4-[(13S,15R,17S)-17-ethyl-17-hydroxy-13-methoxycarbonyl-1,11-diazatetracyclo[13.3.1.04,12.05,10]nonadeca-4(12),5,7,9-tetraen-13-yl]-10-hydroxy-5-methoxy-8-methyl-8,16-diazapentacyclo[10.6.1.01,9.02,7.016,19]nonadeca-2,4,6,13-tetraene-10-carboxylate|methyl (3aR,3a1R,4R,5S,5aR,10bR)-4-acetoxy-3a-ethyl-9-((5S,7R,9S)-5-ethyl-5-hydroxy-9-(methoxycarbonyl)-1,4,5,6,7,8,9,10-octahydro-2H-3,7-methano[1]azacycloundecino[5,4-b]indol-9-yl)-5-hydroxy-8-methoxy-6-methyl-3a,3a1,4,5,5a,6,11,12-octahydro-1H-indolizino[8,1-cd]carbazole-5-carboxylate"
DEXTROMETHORPHAN,5360696,,"InChI=1S/C18H25NO/c1-19-10-9-18-8-4-3-5-15(18)17(19)11-13-6-7-14(20-2)12-16(13)18/h6-7,12,15,17H,3-5,8-11H2,1-2H3/t15-,17+,18+/m1/s1",MKXZASYAUGDDCJ-NJAFHUGGSA-N,C18H25NO,271.4,"(1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene","dextromethorphan|d-Methorphan|125-71-3|delta-Methorphan|Dextromorphan|Dextromethorfan|Dextrometorfano|Dextromethorphane|Albutussin|Destrometerfano|Dextromethorphanum|BA 2666|Balminil DM|(+)-Dextromethorphan|3-Methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan|Morphinan, 3-methoxy-17-methyl-, (9alpha,13alpha,14alpha)-|DXM [Antitussive]|7355X3ROTS|(+)-3-Methoxy-N-methylmorphinon|NSC-751452|BA-2666|CHEBI:4470|DTXSID3022908|DXM (Antitussive)|(+)-cis-1,3,4,9,10,10a-Hexahydro-6-methoxy-11-methyl-2H-10,4alpha-iminoethanophenanthren|(+)-3-methoxy-17-methyl-9alpha,13alpha,14alpha-morphinan|RoboTablets|RefChem:6417|Delsym (dextromethorphan)|Soothe Comfort I Cough Syrup|Hydrochloride, Dextromethorphan|Soothe Comfort II Cough Syrup|DTXCID202908|Soothe Comfort I Cough Syrup Original|Soothe Comfort II Cough Syrup Herbal Mint|LIBI AIR VIRLAZA Dextromethorphan Cough Suppressant|204-752-2|(1R,9R,10R)-4-methoxy-17-methyl-17-azatetracyclo(7.5.3.01,10.02,7)heptadeca-2(7),3,5-triene|Nodex|HSDB 3056|Dextromethorfan [Czech]|Destrometerfano [DCIT]|Dextrometorphan|Dextrometorfano [INN-Spanish]|(+)-3-Methoxy-17-methylmorphinan|(1S,9S,10S)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.01,10.02,7]heptadeca-2(7),3,5-triene|Morphinan, 3-methoxy-17-methyl-, (9.alpha.,13.alpha.,14.alpha.)-|DXM|Dextromethorphane [INN-French]|Dextromethorphanum [INN-Latin]|Trocal|Dextromethorphan [USP:INN:BAN]|( )-3-Methoxy-N-methylmorphinon|Dextromethorphan (USP)|EINECS 204-752-2|BRN 0088549|UNII-7355X3ROTS|Calmylin|Delsym (Salt/Mix)|Medicon (Salt/Mix)|Romilar (Salt/Mix)|Tusilan (Salt/Mix)|9alpha,13alpha,14alpha-Morphinan, 3-methoxy-17-methyl-|Prestwick0_000359|Prestwick1_000359|Prestwick2_000359|Prestwick3_000359|Lopac-D-2531|Racemethorphan [as d-form]|( )-cis-1,3,4,9,10,10a-Hexahydro-6-methoxy-11-methyl-2H-10,4alpha-iminoethanophenanthren|SCHEMBL29949|BSPBio_000457|DEXTROMETHORPHAN [MI]|4-21-00-01367 (Beilstein Handbook Reference)|CHEMBL52440|DEXTROMETHORPHAN [INN]|SPBio_002378|DEXTROMETHORPHAN [HSDB]|BPBio1_000503|GTPL6953|DEXTROMETHORPHAN [VANDF]|DEXTROMETHORPHAN [MART.]|SCHEMBL29357059|CHEBI:92579|(+)-3-methoxy-n-methylmorphinan|DEXTROMETHORPHAN [USP-RS]|DEXTROMETHORPHAN [WHO-DD]|(9alpha,13alpha,14alpha)-17-methyl-3-(methyloxy)morphinan|9-alpha,13-alpha,14-alpha-Morphinan, 3-methoxy-17-methyl-|HMS2090C08|LSM-2726|Morphinan, 3-methoxy-17-methyl-, (9-alpha,13-alpha,14-alpha)-|BDBM50366613|Dextromethorphan, 1mg/ml in Methanol|AKOS025311415|DB00514|FM36326|NSC 751452|DEXTROMETHORPHAN [USP MONOGRAPH]|NCGC00015333-01|NCGC00015333-02|3-Methoxy-17-methyl-9a,13a,14a-morphinan|NS00008569|(9a,13a,14a)-3-Methoxy-17-methylmorphinan|C06947|D03742|9-alpha,-14-alpha-3-Methoxy-17-methylmorphinan|Q407781|3-Methoxy-17-methyl-9.alpha.,13.alpha.-morphinan|BRD-K33211335-004-01-7|BRD-K33211335-337-03-7|(9alpha,13alpha,14alpha)-3-Methoxy-17-methylmorphinan|Morphinan, 3-methoxy-17-methyl-, (9?,13?,14?)-|3-Methoxy-17-methyl-9.alpha.,13.alpha.,14.alpha.-morphinan|9.alpha.,13.alpha.,14.alpha.-Morphinan, 3-methoxy-17-methyl-|9alpha,13alpha,14alpha-Morphinan, 3-methoxy-17-methyl- (8CI)|3-Methoxy-17-methylmorphinan-, (9.alpha.,13.alpha.,14.alpha.)- #|4-methoxy-12-methyl-12-azatetracyclo[9.3^1.10^.0^2.7^] heptadeca-2(7),3,5-triene|(1R,9R,10R)-4-methoxy-17-methyl-17-azatetracyclo[7.5.3.0^{1,10}.0^{2,7}]heptadeca-2,4,6-triene|(4aS,10S,10aS)-6-methoxy-11-methyl-1,3,4,9,10,10a-hexahydro-2H-10,4a-(epiminoethano)phenanthrene"
CARBOVIR TRIPHOSPHATE,135499583,,"InChI=1S/C11H16N5O11P3/c12-11-14-9-8(10(17)15-11)13-5-16(9)7-2-1-6(3-7)4-25-29(21,22)27-30(23,24)26-28(18,19)20/h1-2,5-7H,3-4H2,(H,21,22)(H,23,24)(H2,18,19,20)(H3,12,14,15,17)/t6-,7+/m1/s1",CQCAEOCIDCCJDQ-RQJHMYQMSA-N,C11H16N5O11P3,487.19,"[[(1S,4R)-4-(2-amino-6-oxo-1H-purin-9-yl)cyclopent-2-en-1-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate","Carbovir triphosphate|CHEBI:64174|[(1S,4R)-4-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)cyclopent-2-en-1-yl]methyl tetrahydrogen triphosphate|((1S,4R)-4-(2-amino-6-oxo-1,6-dihydro-9H-purin-9-yl)cyclopent-2-en-1-yl)methyl tetrahydrogen triphosphate|CBV-TP|RefChem:918052|121864-74-2|(-)-Carbovir triphosphate|(-)-CBV-TP|129941-14-6|(-)-carbovir 5'-triphosphate|Carbovir 5'-triphosphate, (-)-|UNII-546K56P9DL|546K56P9DL|carbovir 5'-triphosphate|Triphosphoric acid, P-((4-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-2-cyclopenten-1-yl)methyl) ester (1S-cis)-|(1S-cis)-triphosphoric acid, P-((4-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-2-cyclopenten-1-yl)methyl) ester|[[(1S,4R)-4-(2-amino-6-oxo-1H-purin-9-yl)cyclopent-2-en-1-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate|Carbovir-TP|[[(1S,4R)-4-(2-amino-6-oxo-1H-purin-9-yl)cyclopent-2-en-1-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate|Triphosphoric acid, P-[[4-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-2-cyclopenten-1-yl]methyl] ester (1S-cis)-|orb1983300|CHEMBL1201395|SCHEMBL23391359|SCHEMBL30480834|DTXSID50156268|DA-71929|HY-131607|CS-0137554|Q27133096|(+/-)-cis-2-Amino-1,9-dihydro-9-[4-oxymethyltriphosphate-2-cyclopenten-1-yl-]purine-6-one|140850-29-9|TRIPHOSPHORIC ACID, P-(((1S,4R)-4-(2-AMINO-1,6-DIHYDRO-6-OXO-9H-PURIN-9-YL)-2-CYCLOPENTEN-1-YL)METHYL) ESTER|Triphosphoric acid, P-[[4-(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)-2-cyclopenten-1-yl]methyl] ester, cis-(1)-"
IBOGAINE,197060,,"InChI=1S/C20H26N2O/c1-3-13-8-12-9-17-19-15(6-7-22(11-12)20(13)17)16-10-14(23-2)4-5-18(16)21-19/h4-5,10,12-13,17,20-21H,3,6-9,11H2,1-2H3/t12-,13+,17+,20+/m1/s1",HSIBGVUMFOSJPD-CFDPKNGZSA-N,C20H26N2O,310.4,"(1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene","IBOGAINE|Endabuse|(-)-Ibogaine|83-74-9|NIH 10567|3S814I130U|CHEBI:5852|DTXSID20894069|NSC-249764|(1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo(13.3.1.02,10.04,9.013,18)nonadeca-2(10),4(9),5,7-tetraene|(1R,15R,17S,18S)-17-ethyl-7-methoxy-3,13-diazapentacyclo[13.3.1.02,10.04,9.013,18]nonadeca-2(10),4(9),5,7-tetraene|12 Methoxyibogamine|RefChem:147568|DTXCID401324112|NIH10567|201-498-4|Ibogain|12-Methoxyibogamine|(5beta)-12-methoxyibogamine|CHEMBL1215855|Tabernanthe iboga|EINECS 201-498-4|NSC 249764|DEA No. 7260|UNII-3S814I130U|HSDB 8180|HJM|IBOGAINE [MI]|IBOGAINE [VANDF]|IBOGAINE [MART.]|IBOGAINE [WHO-DD]|(18R)-12-methoxyibogamine|SCHEMBL113571|GTPL13148|BDBM50308247|FS-9083|7-Ethyl-6,6beta,7,8,9,10,12,13-octahydro-2-methoxy-6,9-methano-5H-pyrido(1',2':1,2)azepino(5,4-b)indole|FI159190|NS00041096|Q409455"
ETONITAZENE,13493,,"InChI=1S/C22H28N4O3/c1-4-24(5-2)13-14-25-21-12-9-18(26(27)28)16-20(21)23-22(25)15-17-7-10-19(11-8-17)29-6-3/h7-12,16H,4-6,13-15H2,1-3H3",PXDBZSCGSQSKST-UHFFFAOYSA-N,C22H28N4O3,396.5,"2-[2-[(4-ethoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamine","Etonitazene|Etonitazine|Etonitazeno|Ciba 20-684BA|ARC 1G2|911-65-9|Etonitazenum|Etobedolum|NIH 7607|Ba-20684|DTXSID6048919|Acscn-9624|IDS-NE-006|9U3GT3353T|1H-Benzimidazole-1-ethanamine, 2-((4-ethoxyphenyl)methyl)-N,N-diethyl-5-nitro-|NIH-7607|DTXCID3028845|etonitazin|1H-Benzimidazole-1-ethanamine, 2-[(4-ethoxyphenyl)methyl]-N,N-diethyl-5-nitro-|2-[2-[(4-ethoxyphenyl)methyl]-5-nitrobenzimidazol-1-yl]-N,N-diethylethanamine|2-(2-((4-ethoxyphenyl)methyl)-5-nitrobenzimidazol-1-yl)-N,N-diethylethanamine|RefChem:139278|(2-(2-((4-ethoxyphenyl)methyl)-5-nitro-1H-1,3-benzodiazol-1-yl)ethyl)diethylamine|213-009-1|Ba 20684|CHEMBL312040|1-(2-Diethylaminoethyl)-2-(p-ethoxybenzyl)-5-nitrobenzimidazole|1-(2-(Diethylamino)ethyl)-2-(p-ethoxybenzyl)-5-nitrobenzimidazole|Etonitazene (INN)|Etonitazinum|ETONITAZENE [INN]|{2-[2-(4-Ethoxy-benzyl)-5-nitro-benzoimidazol-1-yl]-ethyl}-diethyl-amine|Benzimidazole, 1-[2-(diethylamino)ethyl]-2-(p-ethoxybenzyl)-5-nitro-|BENZIMIDAZOLE, 1-(2-(DIETHYLAMINO)ETHYL)-2-(p-ETHOXYBENZYL)-5-NITRO-|Etonitazenum [INN-Latin]|Etonitazeno [INN-Spanish]|Etonitazene [INN:BAN:DCF]|NSC172231|EINECS 213-009-1|BRN 0363324|UNII-9U3GT3353T|DEA No. 9624|ETONITAZENE [MI]|SCHEMBL25183|ETONITAZENE [WHO-DD]|5-23-12-00348 (Beilstein Handbook Reference)|GTPL1624|SCHEMBL29388421|CHEBI:234361|Tox21_112830|BDBM50013847|PDSP1_001558|PDSP2_001542|2-[(4-Ethoxyphenyl)methyl]-N,N-diethyl-5-nitro-1H-benzimidazole-1-ethanamine|CS-6622|DB01462|CAS-911-65-9|HY-101645|NS00039388|D12669|L000697|Q5404835|1-(2-diethylaminoethyl)-2-p-ethoxybenzyl-5-nitrobenzimidazole|1-(beta-diethylaminoethyl)-2-(p-ethoxybenzyl)-5-nitrobenzimidazole|2-[2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl]-N,N-diethylethanamine|N-[2-[2-(4-ethoxybenzyl)-5-nitrobenzimidazol-1-yl]ethyl]diethylamine|2-[2-(4-Ethoxybenzyl)-5-nitro-1H-benzimidazol-1-yl]-N,N-diethylethanamine #|2-[2-[(4-ethoxyphenyl)methyl]-5-nitro-benzimidazol-1-yl]-N,N-diethyl-ethanamine|2-{2-[(4-Ethoxyphenyl)methyl]-5-nitro-1H-benzimidazol-1-yl}-N,N-diethylethan-1-amine"
CAPRAVIRINE,1783,,"InChI=1S/C20H20Cl2N4O2S/c1-12(2)18-19(29-16-8-14(21)7-15(22)9-16)26(10-13-3-5-24-6-4-13)17(25-18)11-28-20(23)27/h3-9,12H,10-11H2,1-2H3,(H2,23,27)",YQXCVAGCMNFUMQ-UHFFFAOYSA-N,C20H20Cl2N4O2S,451.4,"[5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)imidazol-2-yl]methyl carbamate","Capravirine|178979-85-6|S-1153|Capravirina|VHC779598X|AG 549|AG1549|S 1153|DTXSID30170689|1H-Imidazole-2-methanol, 5-((3,5-dichlorophenyl)thio)-4-(1-methylethyl)-1-(4-pyridinylmethyl)-, carbamate (ester)|5-((3,5-Dichlorophenyl)thio)-4-isopropyl-1-(4-pyridylmethyl)imidazole-2-methanol carbamate (ester)|capravirinum|(5-((3,5-dichlorophenyl)sulfanyl)-4-(propan-2-yl)-1-(pyridin-4-ylmethyl)-1H-imidazol-2-yl)methyl carbamate|{5-[(3,5-dichlorophenyl)sulfanyl]-4-(propan-2-yl)-1-(pyridin-4-ylmethyl)-1H-imidazol-2-yl}methyl carbamate|5-[(3,5-Dichlorophenyl)thio]-4-isopropyl-1-(4-pyridylmethyl)imidazole-2-methanol carbamate (ester)|RefChem:573747|DTXCID0093180|(5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)imidazol-2-yl)methyl aminoformate|S1153|AG 1549|AG-1549|AGI 549; Capravirine; S 1153|2-Carbamoyloxymethyl-5-(3,5-dichlorophenylthio)-4-isopropyl-1-(pyridin-4-yl)methyl-1H-imidazole|(5-((3,5-dichlorophenyl)thio)-4-isopropyl-1-(pyridin-4-ylmethyl)-1H-imidazol-2-yl)methyl carbamate|[5-(3,5-dichlorophenyl)sulfanyl-4-propan-2-yl-1-(pyridin-4-ylmethyl)imidazol-2-yl]methyl carbamate|5-(3,5-dichlorophenyl)thio-4-isopropyl-1-(pyridin-4-yl-methyl)-1h-imidazol-2-yl-methyl carbamate|UNII-VHC779598X|CDIMI|CAPRAVIRINE [MI]|CAPRAVIRINE [INN]|Capravirine (USAN/INN)|Capravirine [USAN:INN]|CAPRAVIRINE [USAN]|SCHEMBL40347|CAPRAVIRINE [WHO-DD]|S11|CHEMBL435128|orb1700922|BDBM27579|YQXCVAGCMNFUMQ-UHFFFAOYSA-N|GLXC-02806|EX-A6254|AKOS040748084|DB08502|5-(3,5-dichlorophenyl)thio-4-isopropyl-1-(pyridin-4-yl)methyl-1H-imidazol-2-ylmethyl carbamate|HY-14294|DB-313861|NS00068309|D03371|Q5036216|Z2574923381|[5-(3,5-dichlorophenyl)sulfanyl-4-isopropyl-1-(4-pyridylmethyl)imidazol-2-yl]methyl carbamate|{5-[(3,5-dichlorophenyl)sulfanyl]-4-(1-methylethyl)-1-(pyridin-4-ylmethyl)-1H-imidazol-2-yl}methyl carbamate|5-(3,5-Dichlorophenyl)thio-4-isopropyl-1-(4-pyridyl)methyl-1H-imidazol-2-ylmethyl carbamate|5-(3,5-dichlorophenylthio)-4-isopropyl-1-(4-pyridylmethyl)-1H-imidazol-2-ylmethyl carbamate"
CIANIDANOL,9064,,"InChI=1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15+/m0/s1",PFTAWBLQPZVEMU-DZGCQCFKSA-N,C15H14O6,290.27,"(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol","Cianidanol|CATECHIN|154-23-4|Catechuic acid|D-Catechin|Catechinic acid|Cianidol|(+)-Catechol|(+)-Cyanidanol|D-Catechol|D-(+)-Catechin|(2R,3S)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol|Cianidanolum|(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol|Catechin, d-|3,3',4',5,7-Flavanpentol|(+)-3',4',5,7-Tetrahydroxy-2,3-trans-flavan-3-ol|NSC-2819|CHEBI:15600|2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-trans)-|(+)-(2R,3S)-5,7,3',4'-Tetrahydroxyflavan-3-ol|8R1V1STN48|KB 53|2H-1-benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R,3S)-|DTXSID3022322|Cyanidanol 3|Slim 2|RefChem:5687|GlyTouCan:G67369RN|DTXCID202322|KB53|G67369RN|205-825-1|2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol|CHEBI:23053|(+)-catechin|Cyanidanol|Catergen|Biocatechin|(+)-Cyanidan-3-ol|Dexcyanidanol|(+)-Catechin Hydrate|Catechin (flavan)|Catechol (flavan)|(2R,3S)-Catechin|DL-Catechin|3-Cyanidanol, (+)-|(2R,3S)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol|(2R,3S)-(+)-Catechin|dl-Catechol|MFCD00075649|7295-85-4|(+)-Cianidanol|(+)-Cyanidanol-3|(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol|CCRIS 6855|KB-53|NSC 2819|Catechol (+)|AI3-22757|NSC2819|CATECHIN, D|Catechu|CHEMBL311498|(2R-trans)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol|5J4Y243W61|100786-01-4|Transepar|Katha|trans-(+)-3,3',4',5,7-Flavanpentol|(+/-)-Catechin xHydrate|(+)-Cyanidol-3|Cutch (dye)|(+)-(2R:3S)-5,7,3',4'-Tetrahydroxyflavan-3-ol|(3S,2R)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol|Catechin-(+,-) hydrate|Epicatechin-(-)|Catechin (hydrate)|Cianidanol [INN:JAN]|Zyma|MLS001056745|Cyanidanol-3|Cianidanolum [INN-Latin]|(+/-)-catechol|Catechine dl-form|(+-)-catechin|2,3-trans-catechin|2,3-Dihydro-4-desoxoquercetin|SR-01000075742|SMR000326724|EINECS 205-825-1|UNII-8R1V1STN48|Catechinate|Catechuate|rac-catechin|(2R,3S)-3,3',4',5,7-Flavanpentol|DL-Catechine|UNII-5J4Y243W61|(+)-Catechin;Cianidanol;Catechuic acid|Teafuran 30A|KXN|Prestwick_998|Sunkatol No. 1|EINECS 230-731-2|Catechin (Standard)|RACEMIC CATECHIN|Spectrum_000395|2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol #|CATECHIN [MI]|CATECHIN, DL-|CATECHIN [VANDF]|CIANIDANOL [INN]|CIANIDANOL [JAN]|Prestwick0_000642|Prestwick0_000817|Prestwick1_000642|Prestwick1_000817|Prestwick2_000642|Prestwick2_000817|Prestwick3_000642|Spectrum2_000167|Spectrum3_000242|Spectrum4_001763|Spectrum5_000345|Epitope ID:116872|Z 7300|CIANIDANOL [MART.]|CIANIDANOL [WHO-DD]|Lopac0_000219|SCHEMBL19741|BSPBio_000643|BSPBio_001624|KBioGR_002245|KBioSS_000875|BIDD:ER0378|DivK1c_000647|(+)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromantriol|SPBio_000033|SPBio_002564|SPBio_002634|CATECHIN DL-FORM [MI]|BPBio1_000709|cid_107957|orb1299087|orb1310261|CATECHOL, (+/-)-|SCHEMBL29357144|SCHEMBL29360363|SCHEMBL30427390|ACon1_001489|BDBM23416|BDBM60836|CIANIDANOL, (+/-)-|GTPL13091|HMS502A09|HY-B1890R|HY-N0898R|KBio1_000647|KBio2_000875|KBio2_003443|KBio2_006011|KBio3_001124|YK-85 Light Yellow Powder 85|(+)-CATECHIN [USP-RS]|4c94|NINDS_000647|DTXSID001349029|HMS1570A05|HMS1570D15|HMS2097A05|HMS3260L19|Pharmakon1600-00210205|(+)-Catechin, analytical standard|HY-N0898|TNP00270|Tox21_500219|CCG-40007|LMPK12020001|MFCD00135995|MSK000259|NSC755824|s3974|s4722|STL570276|trans3,3,4,5,7 pentahydroxyflavane|AKOS015960546|trans-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol|CS-3759|DB14086|FC19835|LP00219|ND-0342|NSC-755824|SDCCGMLS-0066526.P001|SDCCGSBI-0050207.P004|IDI1_000647|NCGC00017331-01|NCGC00017331-02|NCGC00017331-03|NCGC00017331-04|NCGC00017331-05|NCGC00017331-07|NCGC00017331-19|NCGC00093689-01|NCGC00093689-02|NCGC00093689-03|NCGC00260904-01|AC-11608|AC-35859|AS-72772|NCI60_002303|ST057176|SY009764|(+)-Catechin 1000 microg/mL in Acetone|SBI-0050207.P003|EU-0100219|NS00004541|(+)-Catechin 1000 microg/mL in Acetonitrile|C 1251|C06562|D95105|H10916|AB00051886_13|EN300-6498629|( inverted exclamation markA)-Catechin (Standard)|(+/-)-Catechin 1000 microg/mL in Acetonitrile|154C234|F212928|NATURAL BROWN 3 (CUTCH EXTRA OR GAMBIER)|Q415007|SR-01000075742-1|SR-01000075742-7|SR-01000075742-8|SR-01000075742-9|BRD-K58736316-001-07-9|BRD-K58736316-001-08-7|BRD-K58736316-001-09-5|SR-01000075742-10|SR-01000075742-12|SR-01000075742-14|(+)-CATECHIN (CONSTITUENT OF MARITIME PINE) [DSC]|D4A04A57-7609-451F-A446-53F4DFAD15F5|(2R,3S)-2-(3,4-dihydroxyphenyl)chroman-3,5,7-triol;hydrate|(+)-Catechin, United States Pharmacopeia (USP) Reference Standard|(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-1H-chromene-3,5,7-triol|(+)-Catechin, Pharmaceutical Secondary Standard; Certified Reference Material|(2R,3S)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol;hydrate|(2R,3S)-2-[3,4-bis(oxidanyl)phenyl]-3,4-dihydro-2H-chromene-3,5,7-triol;hydrate|(2R-trans)-2-(3,4-Dihydroxyphenyl)-3-4-dihydro-2H-1-benzopyran-3,5,7-triol|2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol, (2R-trans)|2H-1-Benzopyran-3,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-trans)-|(2R,3S)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol;(+)-3,3',4',5,7-Flavanpentol|2H-1-BENZOPYRAN-3,5,7-TRIOL, 2-(3,4-DIHYDROXYPHENYL)-3,4-DIHYDRO-, (2S,3R)-REL-|321-01-7|InChI=1/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15+/m0/s"
(-)-EPICATECHIN,72276,,"InChI=1S/C15H14O6/c16-8-4-11(18)9-6-13(20)15(21-14(9)5-8)7-1-2-10(17)12(19)3-7/h1-5,13,15-20H,6H2/t13-,15-/m1/s1",PFTAWBLQPZVEMU-UKRRQHHQSA-N,C15H14O6,290.27,"(2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol","(-)-Epicatechin|Epicatechin|490-46-0|L-Epicatechin|Epicatechol|l-Acacatechin|(-)-Epicatechol|epi-Catechin|epi-Catechol|(2R,3R)-(-)-Epicatechin|(2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-chromene-3,5,7-triol|(-)-epi catechin|CHEBI:90|34PHS7TU43|DTXSID4045133|(-)-(2R:3R)-5,7,3',4'-Tetrahydroxyflavan-3-ol|(2R,3R)-2-(3,4-dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol|NSC-81161|2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R,3R)-|DTXCID2025133|2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-, (2R-cis)-|RefChem:7343|GlyTouCan:G98809NK|G98809NK|(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,5,7-chromanetriol|(2R-cis)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol|207-710-1|(2R,3R)-2-(3,4-Dihydroxyphenyl)chroman-3,5,7-triol|(-)epicatechin|C15H14O6|l-Epicatechol|MFCD00075648|2H-1-Benzopyran-3,5,7-triol, 2-(3,4-dihydroxyphenyl)-3,4-dihydro-,(2R,3R)-|Epicatechol, (-)-|(-)-cis-Epicatechin|(2R,3R)-2-(3,4-dihydroxyphenyl)chromane-3,5,7-triol|NSC 81161|Epicatechin-(-)|CAS-490-46-0|SMR000156230|CCRIS 7097|EINECS 207-710-1|UNII-34PHS7TU43|alpha-catechin|NSC81161|.alpha. Catechin|NCGC00015215-02|28E|7295-85-4|L(-)-Epicatechin|Prestwick_203|2,3-cis-epicatechin|(-)-cis-3,3',4',5,7-Pentahydroxyflavane|Spectrum_000159|SpecPlus_000267|2-(3,4-Dihydroxyphenyl)-2,3,4-trihydro-3,5,7-trihydroxychromene|Spectrum2_000675|Spectrum3_000243|Spectrum4_000949|Spectrum5_000929|Lopac-C-1251|Oprea1_209947|SCHEMBL19412|BSPBio_001626|KBioGR_001538|KBioSS_000639|SPECTRUM210206|(-)-Epicatechin (Standard)|cid_72276|MLS001304012|MLS001304152|DivK1c_006363|SPBio_000769|CHEMBL583912|orb1304924|L-EPICATECHIN [WHO-DD]|SCHEMBL29354531|SCHEMBL30631563|ACon1_001106|BCBcMAP01_000224|BDBM23417|GTPL12497|HY-N0001R|KBio1_001307|KBio2_000639|KBio2_003207|KBio2_005775|KBio3_001126|GLXC-07373|HMS1923M05|KUC104404N|(-)-EPICATECHIN [USP-RS]|HY-N0001|Tox21_110101|3,3',4',5,7-Pentahydroxyflavane|CCG-38571|LMPK12020003|MSK000539|s4723|(-)-Epicatechin, analytical standard|AKOS015895981|Tox21_110101_1|(-)-Epicatechin, >=90% (HPLC)|CS-3760|DB12039|DS-3358|FE22720|KSC-10-144|SDCCGMLS-0066927.P001|SMP1_000115|NCGC00015215-01|NCGC00016415-01|NCGC00016415-02|NCGC00016415-03|NCGC00016415-04|NCGC00017331-08|AC-14586|BP-30203|CAS-154-23-4|SY066787|CAS-7295-85-4|E1226|NS00093637|(-)-Epicatechin 1000 microg/mL in Acetone|C09727|O10053|(-)-Epicatechin 1000 microg/mL in Acetonitrile|490E460|F235530|(-)-Epicatechin, >=98% (HPLC), from green tea|CF3BA0C2-DE1B-44AB-A4D3-800F017221BA|Epicatechin, primary pharmaceutical reference standard|Q23050136|(-)-EPICATECHIN (CONSTITUENT OF MARITIME PINE) [DSC]|(2R,3R)-2-(3,4-Dihydroxyphenyl)-3,4-dihydro-2H-1-benzopyran-3,5,7-triol;(-)-3,5,7,3',4'-Pentahydroxyflavan;epi-catechol;epi-catechin"
RESORCINOL,5054,,"InChI=1S/C6H6O2/c7-5-2-1-3-6(8)4-5/h1-4,7-8H",GHMLBKRAJCXXBS-UHFFFAOYSA-N,C6H6O2,110.11,"benzene-1,3-diol","resorcinol|108-46-3|benzene-1,3-diol|1,3-Benzenediol|Resorcin|1,3-Dihydroxybenzene|m-Hydroquinone|m-Hydroxyphenol|m-Dihydroxybenzene|3-Hydroxyphenol|Resorcine|m-Benzenediol|m-Dioxybenzene|Dihydroxybenzol|Resorzin|Developer O|Developer R|Developer RS|Fouramine RS|Fourrine EW|Pelagol RS|Pelagol Grey RS|Resorcinolum|Fourrine 79|Nako TGG|Durafur developer G|C.I. Oxidation Base 31|Phenol, m-hydroxy-|C.I. Developer 4|Benzene, m-dihydroxy-|Rcra waste number U201|FEMA No. 3589|Benzene, 1,3-dihydroxy-|3-Hydroxycyclohexadien-1-one|Resorcinum|Resorcinol (USP)|NCI-C05970|C.I. 76505|DTXSID2021238|YUL4LO94HK|NSC-1571|Resorcinol [USP]|EPA Pesticide Chemical Code 071401|CHEBI:27810|DTXCID601238|C.I.-76505|203-585-2|Tilloderm|RefChem:6491|Resorcinol; 1,3-benzenediol|Acnomel|Rezamid|Sulforcin|RCRA waste no. U201|NSC 1571|MFCD00002269|.alpha.-Resorcinol|Resorcin (JAN)|Resorcin (TN)|CHEMBL24147|Resorcinol [UN2876]  [Poison]|NCGC00091501-01|RESORCIN [JAN]|BENZENE,1,3-DIHYDROXY   RESORCINOL|RCO|Caswell No. 723|Rezorsine|1,3-Dihydroxybenzene (Resorcinol)|Rodol RS|CAS-108-46-3|CCRIS 4052|HSDB 722|EINECS 203-585-2|UNII-YUL4LO94HK|UN2876|BRN 0906905|Remazol|AI3-03996|m-hydroxy-phenol|3-hydroxy-phenol|Resorcinol, ACS|3aqt|3-Hydroxy phenol|Resorcinol, 8CI|benzen-1,3-diol|Resorcinol, Reagent|1,3-benzene diol|Resorcine, technical|1,3-dihyroxybenzene|1,3-Dihydroxybenzol|Acnomel (Salt/Mix)|Eskamel (Salt/Mix)|Rezamid (Salt/Mix)|phenol derivative, 3|Resorcinol; >99%|Benzene,3-dihydroxy-|Sulforcin (Salt/Mix)|1,3-dihydroxy-benzene|Spectrum_000173|RESORCINOL [MI]|Spectrum2_001310|Spectrum3_000895|Spectrum4_000990|Spectrum5_001152|RESORCINOL [FHFI]|RESORCINOL [HSDB]|RESORCINOL [IARC]|RESORCINUM [HPUS]|WLN: QR CQ|RESORCINOL [VANDF]|bmse000415|EC 203-585-2|Phloroglucinol Impurity 13|RESORCINOL [MART.]|1,3-Dihydroxybenzene, XII|NCIOpen2_003867|RESORCINOL [USP-RS]|RESORCINOL [WHO-DD]|SCHEMBL15515|KBioGR_001399|KBioSS_000653|Resorcinol, >=98%, FG|Resorcinol, Flake, Technical|Resorcinol, LR, >=99%|4-06-00-05658 (Beilstein Handbook Reference)|BIDD:ER0285|DivK1c_000041|SCHEMBL127328|SCHEMBL128334|SCHEMBL417719|SCHEMBL713815|SPECTRUM1500527|SPBio_001379|Resorcinol, BioXtra, >=99%|SCHEMBL1576970|SCHEMBL8372367|SCHEMBL10938040|SCHEMBL10943889|BDBM26189|FEMA 3589|HMS500C03|KBio1_000041|KBio2_000653|KBio2_003221|KBio2_005789|KBio3_001810|Resorcinol, reagent grade, 98%|NSC1571|RESORCINOL [EP MONOGRAPH]|4e49|NINDS_000041|HMS1920P06|HMS2092G07|Pharmakon1600-01500527|RESORCINOL [USP MONOGRAPH]|Resorcinol (1,3-Dihydroxybenzene)|HY-B0907|Resorcinol, ReagentPlus(R), 99%|Tox21_111140|Tox21_202417|Tox21_300140|CCG-39248|MSK000085|NSC757310|Resorcinol 10 microg/mL in Methanol|Resorcinol, Crystalline Powder, USP|SBB040843|STL185604|AKOS000119813|Resorcinol, ACS reagent, >=99.0%|Tox21_111140_1|DB11085|FR07869|NSC-757310|UN 2876|IDI1_000041|NCGC00091501-02|NCGC00091501-03|NCGC00091501-04|NCGC00091501-05|NCGC00091501-06|NCGC00253918-01|NCGC00259966-01|Resorcinol, p.a., 99.0-100.5%|AC-14363|BP-21158|DA-67166|LS-13122|Resorcinol, SAJ first grade, >=98.0%|SBI-0051505.P003|Resorcinol(Discontinued,See C4X-221713)|Resorcinol, JIS special grade, >=99.0%|FLUORESCEIN IMPURITY A [EP IMPURITY]|NS00007013|R0008|S4579|ST50214427|3-Hydroxycyclohexadien-1-one;3-Hydroxyphenol|EN300-19643|1,3-BENZENEDIOL; 1,3-DIHYDROXYBENZENE|C01751|D00133|AB00052085_03|HEXYLRESORCINOL IMPURITY B [EP IMPURITY]|A801880|F168800|Q408865|SR-05000002092|FLUORESCEIN SODIUM IMPURITY A [EP IMPURITY]|SR-05000002092-1|BRD-K74190368-001-02-7|BRD-K74190368-001-04-3|F1908-0097|Resorcinol, certified reference material, TraceCERT(R)|Z104474576|Resorcinol, European Pharmacopoeia (EP) Reference Standard|Resorcinol, United States Pharmacopeia (USP) Reference Standard|InChI=1/C6H6O2/c7-5-2-1-3-6(8)4-5/h1-4,7-8|Hymecromone impurity A, European Pharmacopoeia (EP) Reference Standard|Resorcinol, Pharmaceutical Secondary Standard; Certified Reference Material"
GOSOGLIPTIN,11516136,,"InChI=1S/C17H24F2N6O/c18-17(19)2-5-25(12-17)15(26)14-10-13(11-22-14)23-6-8-24(9-7-23)16-20-3-1-4-21-16/h1,3-4,13-14,22H,2,5-12H2/t13-,14-/m0/s1",QWEWGXUTRTXFRF-KBPBESRZSA-N,C17H24F2N6O,366.4,"(3,3-difluoropyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl]methanone","GOSOGLIPTIN|869490-23-3|PF-734200|Gosogliptina|Gosogliptine|(3,3-difluoropyrrolidin-1-yl)((2S,4S)-4-(4-(pyrimidin-2-yl)piperazin-1-yl)pyrrolidin-2-yl)methanone|PF-00734200|GI718UO477|(3,3-difluoropyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl]methanone|PF-734,200|(3,3-DIFLUOROPYRROLIDIN-1-YL)[(2S,4S)-4-[4-(PYRIMIDIN-2-YL)PIPERAZIN-1-YL]PYRROLIDIN-2-YL]METHANONE|DTXSID601007213|gosogliptinum|(3,3-difluoropyrrolidin-1-yl)-((2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl)methanone|(3,3-Difluoropyrrolidin-1-yl){(2S,4S)-4-[4-(pyrimidin-2-yl)piperazin-1-yl]pyrrolidin-2-yl}methanone|2-(4-((3S,5S)-5-(3,3-difluoropyrrolidine-1-carbonyl)pyrrolidin-3-yl)piperazin-1-yl)pyrimidine|2-{4-[(3S,5S)-5-(3,3-difluoropyrrolidine-1-carbonyl)pyrrolidin-3-yl]piperazin-1-yl}pyrimidine|RefChem:782649|DTXCID301434071|UNII-GI718UO477|Gosogliptin [USAN:INN]|Gosogliptin Hydrochloride|CHEMBL515387|PF 00734200|869490-23-3 (free base)|MFCD16038043|2-(4-{(3s,5s)-5-[(3,3-Difluoropyrrolidin-1-Yl)carbonyl]pyrrolidin-3-Yl}piperazin-1-Yl)pyrimidine|Methanone, (3,3-difluoro-1-pyrrolidinyl)((2S,4S)-4-(4-(2-pyrimidinyl)-1-piperazinyl)-2-pyrrolidinyl)-|869490-47-1|Gosogliptin [USAN]|DPP-IV-Inhibitor|PF-00734200;PF-734200|GOSOGLIPTIN [INN]|Gosogliptin (USAN/INN)|GOSOGLIPTIN [WHO-DD]|SCHEMBL197108|GTPL7413|orb1709562|C17H24F2N6O|CHEBI:177858|QWEWGXUTRTXFRF-KBPBESRZSA-N|BDBM50249479|AKOS030531770|CS-6619|DB08382|HY-10287|MS-25863|DB-321982|NS00071677|D09625|G13868|490G233|Q27077831|(3,3-diluoropyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl]methanone|cis-(3,3-Difluoro-pyrrolidin-1-yl)-[(2S,4S)-(4-(4-pyrimidin-2-yl-piperazin-1-yl)-pyrrolidin-2-yl]-methanone"
BETULINIC ACID,64971,,"InChI=1S/C30H48O3/c1-18(2)19-10-15-30(25(32)33)17-16-28(6)20(24(19)30)8-9-22-27(5)13-12-23(31)26(3,4)21(27)11-14-29(22,28)7/h19-24,31H,1,8-17H2,2-7H3,(H,32,33)/t19-,20+,21-,22+,23-,24+,27-,28+,29+,30-/m0/s1",QGJZLNKBHJESQX-FZFNOLFKSA-N,C30H48O3,456.7,"(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid","betulinic acid|472-15-1|Mairin|Betulic acid|Lupatic Acid|als-357|3-Hydroxylup-20(29)-en-28-oic acid|beta-betulinic acid|NSC-677578|CHEBI:3087|3beta-Hydroxy-lup-20(29)-en-28-oic acid|4G6A18707N|NSC-113090|DTXSID80861974|(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid|NSC113090|(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta(a)chrysene-3a-carboxylic acid|3 Epi betulinic Acid|RefChem:5606|DTXCID301506361|3-Hydroxy-lup-20(29)-en-28-oic Acid|(3beta)-3-Hydroxy-lup-20(29)-en-28-oic Acid|207-448-8|Betulinicacid|MFCD00009619|3beta-Hydroxy-20(29)-lupaene-28-oic acid|.beta.-betulinic acid|Lupatic acid;Betulic acid|NSC677578|CHEMBL269277|(3beta)-3-hydroxylup-20(29)-en-28-oic acid|(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylic acid|(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid|SMR000445624|NSC 113090|CCRIS 6748|Lup-20(29)-en-28-oic acid, 3beta-hydroxy-|EINECS 207-448-8|NSC 677578|betulinic-acid|Betulinic acid?|UNII-4G6A18707N|Prestwick_95|Betulinic Acid, 24|Lup-20(29)-en-28-oic acid, 3-hydroxy-, (3beta)-|Prestwick0_000417|Prestwick1_000417|Prestwick2_000417|Prestwick3_000417|Betulinic acid (Standard)|BETULINIC ACID [MI]|Lup-20(29)-en-28-oic acid, 3-hydroxy-, (3.beta.)-|SCHEMBL61767|BSPBio_000374|BSPBio_001587|cid_64971|MLS000728510|MLS006011257|SPBio_002313|BPBio1_000412|GTPL3945|orb1304966|BDBM23208|GLXC-06559|HMS1569C16|HMS1791P09|HMS1989P09|HMS2096C16|HMS2232K03|HMS3402P09|HMS6018J07|Betulinic acid, analytical standard|Betulinic acid, >=98% (HPLC)|MSK40138|HB3799|HY-10529R|s3603|STL570261|AKOS015920276|Betulinic acid, technical grade, 90%|CCG-208159|CS-1216|DB12480|FB16425|LMPR0106140004|RL9-080|SMP2_000205|NCGC00163409-02|NCGC00163409-03|NCGC00163409-09|NCGC00163409-12|BP-25391|DS-15257|HY-10529|SY058034|3b-Hydroxy-20(29)-lupaene-28-oic acid|3beta-hydroxylup-20(29)-en-28-oic acid|NS00042781|C08619|M01408|Lup-20(29)-en-28-oic acid, 3beta -hydroxy-|3-Hydroxy-(3beta)-Lup-20(29)-en-28-oic acid|472B151|Q384111|SR-01000779609|SR-01000779609-3|BRD-K45401373-001-05-0|BRD-K45401373-001-20-9|BRD-K45401373-001-22-5|(3.BETA.)-3-HYDROXYLUP-20(29)-EN-28-OIC ACID|(1R,2R,5S,8R,9R,10R,13R,14R,17S,19R)-17-hydroxy-1,2,14,18,18-pentamethyl-8-(prop-1-en-2-yl)pentacyclo[11.8.0.0^{2,10}.0^{5,9}.0^{14,19}]henicosane-5-carboxylic acid|(1R,3 aS,5aR,5bR,7aR,9S,11aR,11bR,13 aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylic acid|(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-Hydroxy-1-isopropenyl-5a,5b,8,8,11a-pentamethyl-eicosahydro-cyclopenta[a]chrysene-3a-carboxylic acid|(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-(prop-1-en-2-yl)icosahydro-1H-cyclopenta[a]chrysene-3a-carboxylicacid|(1R,3aS,5aR,5bR,7aR,9S,11aR,11bR,13aR,13bR)-9-hydroxy-5a,5b,8,8,11a-pentamethyl-1-prop-1-en-2-yl-1,2,3,4,5,6,7,7a,9,10,11,11b,12,13,13a,13b-hexadecahydrocyclopenta[a]chrysene-3a-carboxylicacid|06L"
EFAROXAN,72016,,"InChI=1S/C13H16N2O/c1-2-13(12-14-7-8-15-12)9-10-5-3-4-6-11(10)16-13/h3-6H,2,7-9H2,1H3,(H,14,15)",RATZLMXRALDSJW-UHFFFAOYSA-N,C13H16N2O,216.28,"2-(2-ethyl-3H-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole","Efaroxan|89197-32-0|Efaroxano|Efaroxanum|DTXSID8045149|G00490L21H|NSC-759562|DTXCID6025149|2-((2-ethyl-2,3-dihydrobenzofuran-2-yl))-2-imidazoline|RefChem:136323|2-(2-ethyl-3H-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole|Efaroxan (hydrochloride)|NCGC00015410-04|RX 821037|Efaroxanum [INN-Latin]|2-(2-Ethyl-2,3-dihydrobenzofuran-2-yl)-4,5-dihydro-1H-imidazole|Efaroxano [INN-Spanish]|CAS-89197-32-0|Efaroxan [INN:BAN]|UNII-G00490L21H|Spectrum_001997|EFAROXAN [INN]|Spectrum3_001863|Lopac0_000521|BSPBio_003306|KBioSS_002570|CHEMBL57895|SCHEMBL127096|SCHEMBL29368577|CHEBI:93806|KBio2_002561|KBio2_005129|KBio2_007697|KBio3_002808|(+-)-2-(2-Ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazoline|HMS2089D15|Tox21 110139|Tox21_110139|1H-Imidazole, 2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-4,5-dihydro-|BDBM50179393|Tox21_110139_1|CCG-204611|NSC 759562|SDCCGSBI-0050504.P003|MRF-0000021|NCGC00015410-03|NCGC00015410-05|NCGC00015410-06|NCGC00015410-08|NCGC00015410-13|NCGC00024793-02|NCGC00024793-03|SBI-0050504.P002|NS00124896|AB00918533_03|L001351|Q5347187|BRD-A10739734-003-05-6|BRD-A10739734-003-09-8|BRD-A10739734-003-10-6|(+/-)-2-(2-ethyl-2,3-dihydro-2-benzofuranyl)-2-imidazoline|2-(2-ethyl-2,3-dihydro-1-benzofuran-2-yl)-4,5-dihydro-1H-imidazole|2-(2-ETHYL-2,3-DIHYDRO-2-BENZOFURANYL)-4,5-DIHYDRO-1H-IMIDAZOLE"
MILRINONE,4197,,"InChI=1S/C12H9N3O/c1-8-11(9-2-4-14-5-3-9)6-10(7-13)12(16)15-8/h2-6H,1H3,(H,15,16)",PZRHRDRVRGEVNW-UHFFFAOYSA-N,C12H9N3O,211.22,6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile,"milrinone|78415-72-2|Milrinona|Milrinonum|Milrila|Corotrop|Win-47203-2|6-methyl-2-oxo-5-(pyridin-4-yl)-1,2-dihydropyridine-3-carbonitrile|1,6-Dihydro-2-methyl-6-oxo(3,4'-bipyridine)-5-carbonitrile|JU9YAX04C7|WIN 47203|NSC-760072|DTXSID5023324|WIN 47,203-2|CHEBI:50693|(3,4'-BIPYRIDINE)-5-CARBONITRILE, 1,6-DIHYDRO-2-METHYL-6-OXO-|DTXCID103324|(3,4'-Bipyridine)-5-carbonitrile, 6-dihydro-2-methyl-6-oxo-|[3,4'-Bipyridine]-5-carbonitrile, 1,6-dihydro-2-methyl-6-oxo-|Lactate, Milrinone|RefChem:57100|Win47203|C01CE02|278-903-6|Primacor|Corotrope|MFCD00133539|2-methyl-6-oxo-1,6-dihydro-[3,4'-bipyridine]-5-carbonitrile|6-methyl-2-oxo-5-pyridin-4-yl-1H-pyridine-3-carbonitrile|3-Cyano-6-methyl-5-(4-pyridyl)-2-pyridone|1,6-Dihydro-2-methyl-6-oxo-(3,4'-bipyridine)-5-carbonitrile|CHEMBL189|2-methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile|Milrinonum [Latin]|NCGC00015675-08|NCGC00164390-01|Milrinona [Spanish]|CAS-78415-72-2|2-hydroxy-6-methyl-5-pyridin-4-ylpyridine-3-carbonitrile|1,6-Dihydro-2-methyl-6-oxo-[3,4'-bipyridine]-5-carbonitrile|2-Methyl-6-oxo-1,6-dihydro-[3,4']bipyridinyl-5-carbonitrile|YM 018|SMR000058475|Milrila (TN)|WIN 47203-2|CCRIS 3795|SR-01000075524|EINECS 278-903-6|UNII-JU9YAX04C7|BRN 3546821|Milrinone?|1,6-Dihydro-2-methyl-6-oxo-[3,4'-bipyridine]-5-carbonitrile;Corotrope;Milrila|Milrinone [USAN:USP:INN:BAN]|Milrinone(Primacor)|6-Methyl-5-(4-pyridyl)-2-pyridone-3-carbonitrile|Milrinone (Primacor)|Milrinone (Standard)|Tocris-1504|111GE027|MILRINONE [INN]|MILRINONE [JAN]|MILRINONE [MI]|MILRINONE [USAN]|1,2-DIHYDRO-6-METHYL-2-OXO-5-(4-PYRIDINYL)NICOTINONITRILE|Prestwick0_001065|Prestwick1_001065|Prestwick2_001065|Prestwick3_001065|Lopac-M-4659|MILRINONE [VANDF]|M1663|2-Methyl-6-oxo-1,6-dihydro-3,4'-bipyridine-5-carbonitrile (Milrinone)|MILRINONE [MART.]|M 4659|MILRINONE [USP-RS]|MILRINONE [WHO-DD]|Milrinone (JAN/USP/INN)|Lopac0_000737|SCHEMBL36947|BSPBio_001050|MLS000028818|MLS001424052|MLS006011946|BIDD:GT0197|Milrinone - Bio-X trade mark|SPBio_002965|BPBio1_001156|GTPL5225|orb1309788|SCHEMBL8309385|BDBM15296|6-methyl-2-oxo-5-(4-pyridyl)-1H-pyridine-3-carbonitrile|MILRINONE [USP MONOGRAPH]|GLXC-06520|HMS1571E12|HMS2051L10|HMS2090J14|HMS2098E12|HMS2234A23|HMS3262C16|HMS3267P12|HMS3370H18|HMS3393L10|HMS3656G06|HMS3715E12|HMS3742G09|HMS5081C11|Pharmakon1600-01505489|BCP02956|Tox21_112113|Tox21_400069|Tox21_500737|HY-14252R|Milrinone, >=97% (TLC), powder|NSC760072|s2484|SBB055743|Milrinone - CAS 78415-72-2|AKOS015836135|Tox21_112113_1|AC-4730|BCP9000926|CCG-101020|CCG-204822|CS-1367|DB00235|FM26007|KS-1440|LP00737|NC00270|NSC 760072|SDCCGSBI-0050715.P002|NCGC00015675-01|NCGC00015675-02|NCGC00015675-03|NCGC00015675-04|NCGC00015675-05|NCGC00015675-06|NCGC00015675-07|NCGC00015675-09|NCGC00015675-11|NCGC00015675-24|NCGC00025189-01|NCGC00025189-02|NCGC00025189-03|NCGC00261422-01|BM164671|HY-14252|SMR004703527|SY028050|BCP0726000256|AB00514027|EU-0100737|NS00007740|SW197308-3|C07224|D00417|EN300-117244|AB00514027-02|AB00514027-03|AB00514027_04|AB00514027_05|AB00597139-08|415M722|A839417|F036508|Q847399|SR-01000075524-1|SR-01000075524-3|SR-01000075524-4|SR-01000075524-6|BRD-K67080878-001-05-5|BRD-K67080878-001-15-4|BRD-K67080878-001-16-2|Z1501480412|6-methyl-2-oxo-5-(4-pyridyl)hydropyridine-3-carbonitrile|1,2-dihydro-6-methyl-2-oxo-5-(4 -pyridinyl)nicotinonitrile|Milrinone, United States Pharmacopeia (USP) Reference Standard|1,2-DIHYDRO-6-METHYL-2-OXO-5-(4-PYRIDINYL)-NICOTINONITRILE|6-methyl-2-oxidanylidene-5-pyridin-4-yl-1H-pyridine-3-carbonitrile|1,6-Dihydro-2-methyl-6-oxo-(3,4 inverted exclamation mark -bipyridine)-5-carbonitrile"
ADENOSINE TRIPHOSPHATE,5957,,"InChI=1S/C10H16N5O13P3/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(26-10)1-25-30(21,22)28-31(23,24)27-29(18,19)20/h2-4,6-7,10,16-17H,1H2,(H,21,22)(H,23,24)(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1",ZKHQWZAMYRWXGA-KQYNXXCUSA-N,C10H16N5O13P3,507.18,"[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate","Adenosine triphosphate|56-65-5|Triphosphaden|Myotriphos|Triadenyl|Glucobasin|Adephos|Adetol|Adynol|Atipi|Adenosine 5'-(tetrahydrogen triphosphate)|5'-Atp|Adenylpyrophosphoric acid|Adenosine 5'-triphosphoric acid|Triphosphoric acid adenosine ester|CHEBI:15422|adenosine 5' triphosphate|adenylpyrophosphate|8L70Q75FXE|DTXSID6022559|DTXCID302559|[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate|Chromium Adenosine Triphosphate|Magnesium Adenosine Triphosphate|CaATP|CrATP|(((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)methoxy-hydroxyphosphoryl) phosphono hydrogen phosphate|ATP MgCl2|ATP-MgCl2|RefChem:553011|Cr(H2O)4 ATP|200-283-2|Adenosine 5'-triphosphate|ATP|adenosine-5'-triphosphate|Atriphos|Striadyne|Triphosaden|ATP (nucleotide)|Cardenosine|Fosfobion|Adenosintriphosphorsaeure|C10H16N5O13P3|adenosine-triphosphate|Ado-5'-P-P-P|H4atp|9-beta-D-Arabinofuranosyladenine 5'-triphosphate|Adenosine, 5'-(tetrahydrogen triphosphate)|MFCD00065467|CHEMBL14249|((2R,3S,4R,5R)-5-(6-Amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl tetrahydrogen triphosphate|NCGC00163309-01|3-Methylbenzo[d]thiazol-3-iuM chloride|({[({[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}(hydroxy)phosphoryl)oxy](hydroxy)phosphoryl}oxy)phosphonic acid|[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl] phosphono hydrogen phosphate|126339-06-8|Phosphobion|119439-06-4|Adenosine triphosphate/ATP|987-65-5|EINECS 200-283-2|UNII-8L70Q75FXE|adenosine-5'-triphosphoric acid|1kxp|1mau|1maw|1vjc|1vjd|1xsc|1yid|2cbz|2fgh|Adenylpyrophosphorate|Triphosadenine (DCF)|1gz3|1gz4|1r0x|1y8p|BDBM2|Adenosine triphosphateATP|3h-adenosine triphosphate|-beta-D-ribofuranosyl]-|bmse000006|bmse000854|bmse000993|Epitope ID:135612|Adenosine 5'-triphosphorate|orb64059|SCHEMBL8979|SCHEMBL8980|GTPL1713|orb1306758|orb1821483|orb1821484|orb1821485|orb2646544|SCHEMBL29354125|MSK1534D9|MSK6929|1b38|1b39|1m83|1r10|1t44|Bio1_000406|Bio1_000895|Bio1_001384|ADENOSINE TRIPHOSPHATE [MI]|HY-B2176|Tox21_112044|BDBM50366480|s5260|ADENOSINE TRIPHOSPHATE [VANDF]|ADENOSINE TRIPHOSPHATE [MART.]|AKOS022179934|ADENOSINE TRIPHOSPHATE [WHO-DD]|CS-7674|DB00171|CAS-56-65-5|Adenosine 5'-triphosphate; Triphosphaden|5'-(tetrahydrogen triphosphate) Adenosine|AC-32151|Adenosine-5'-(tetrahydrogen triphosphate)|AS-19204|SY096717|DB-022415|NS00074063|C00002|D08646|D70159|Q80863|SBI-0635025.0002|EN300-1073142|065A467|F806274|Adenosine 5 inverted exclamation mark -triphosphate|BRD-A31990649-304-02-3|BRD-A31990649-304-03-1|A9788C43-4BC5-46E2-8560-41C5FA7D3AA3|9H-purin-6-amine, 9-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]|L-Carnitine-d9; Adenosine triphosphate; Adenosine 5'-triphosphate; ATP; Triphosphaden|[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl (hydroxy-phosphonooxyphosphoryl) hydrogen phosphate|[[[(2R,3S,4R,5R)-5-(6-Aminopurin-9-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxyphosphonic acid|84412-18-0|9H-Purin-6-amine, 9-[5-O-[hydroxy[[hydroxy(phosphonooxy)phosphinyl]oxy]phosphinyl]-.beta.-D-ribofuranosyl]-"
AMPEROZIDE,73333,,"InChI=1S/C23H29F2N3O/c1-2-26-23(29)28-16-14-27(15-17-28)13-3-4-22(18-5-9-20(24)10-6-18)19-7-11-21(25)12-8-19/h5-12,22H,2-4,13-17H2,1H3,(H,26,29)",NNAIYOXJNVGUOM-UHFFFAOYSA-N,C23H29F2N3O,401.5,"4-[4,4-bis(4-fluorophenyl)butyl]-N-ethylpiperazine-1-carboxamide","Amperozide|75558-90-6|Amperozida|Amperozidum|FG 5606|0M2W3TAG39|4-(4,4-Bis(4-fluorophenyl)butyl)-N-ethylpiperazine-1-carboxamide|4-(4,4-Bis(p-fluorophenyl)butyl)-N-ethyl-1-piperazinecarboxamide|DTXSID6048416|4-[4,4-bis(4-fluorophenyl)butyl]-n-ethylpiperazine-1-carboxamide|RefChem:112276|DTXCID4028389|CHEBI:180480|CHEMBL1079935|1-Piperazinecarboxamide, 4-(4,4-bis(p-fluorophenyl)butyl)-N-ethyl-|Amperozidum [INN-Latin]|Amperozida [INN-Spanish]|FG-5606|Amperozide [INN:BAN]|UNII-0M2W3TAG39|Hogpax vet.|AMPEROZIDE [MI]|AMPEROZIDE [INN]|4-(4,4-Bis(4-fluorphenyl)butyl)-N-ethyl-1-piperazinecarboxamid|Lopac-A-6976|AMPEROZIDE [MART.]|AMPEROZIDE [WHO-DD]|Lopac0_000040|SCHEMBL340961|orb1305578|CHEBI:92913|BDBM50311786|PDSP1_000742|PDSP2_000730|AKOS030548015|CCG-204136|DB08927|SDCCGSBI-0050029.P002|NCGC00015081-01|NCGC00015081-02|NCGC00015081-03|NCGC00162051-01|TS-08351|HY-121301|NS00069847|L000997|Q4748133|BRD-K52397688-001-01-9|BRD-K52397688-003-06-4"
LETAXABAN,11641515,,"InChI=1S/C22H26ClN3O5S/c23-17-4-2-16-13-19(5-3-15(16)12-17)32(30,31)14-20(27)21(28)25-10-6-18(7-11-25)26-9-1-8-24-22(26)29/h2-5,12-13,18,20,27H,1,6-11,14H2,(H,24,29)/t20-/m1/s1",GEHAEMCVKDPMKO-HXUWFJFHSA-N,C22H26ClN3O5S,480.0,"1-[1-[(2S)-3-(6-chloronaphthalen-2-yl)sulfonyl-2-hydroxypropanoyl]piperidin-4-yl]-1,3-diazinan-2-one","Letaxaban|870262-90-1|TAK-442|Letaxaban [USAN]|TAK 442|Letaxaban [USAN:INN]|Y3WB03966W|LETAXABAN [INN]|LETAXABAN [WHO-DD]|2(1H)-PYRIMIDINONE, 1-(1-((2S)-3-((6-CHLORO-2-NAPHTHALENYL)SULFONYL)-2-HYDROXY-1-OXOPROPYL)-4-PIPERIDINYL)TETRAHYDRO-|PIPERIDINE, 1-((2S)-3-((6-CHLORO-2-NAPHTHALENYL)SULFONYL)-2-HYDROXY-1-OXOPROPYL)-4-(TETRAHYDRO-2-OXO-1(2H)-PYRIMIDINYL)-|letaxabanum|1-(1-((2S)-3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)-1,3-diazinan-2-one|1-{1-[(2S)-3-[(6-chloronaphthalen-2-yl)sulfonyl]-2-hydroxypropanoyl]piperidin-4-yl}-1,3-diazinan-2-one|RefChem:798968|TAK442|1-(1-{(2S)-3-[(6-Chloronaphthalen-2-yl)sulfonyl]-2-hydroxypropanoyl}piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|CHEMBL1095032|1-[1-[(2S)-3-(6-chloronaphthalen-2-yl)sulfonyl-2-hydroxypropanoyl]piperidin-4-yl]-1,3-diazinan-2-one|(S)-1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1H)-one|UNII-Y3WB03966W|3kl6|Letaxaban (USAN/INN)|SCHEMBL766143|orb1819164|SCHEMBL5498212|SCHEMBL29375199|GEHAEMCVKDPMKO-HXUWFJFHSA-N|BCP24734|BDBM50317098|AT18256|DB11984|2(1H)-Pyrimidinone,1-[1-[(2S)-3-[(6-chloro-2-naphthalenyl)sulfonyl]-2-hydroxy-1-oxopropyl]-4-piperidinyl]tetrahydro-|HY-10594|CS-0002662|NS00071040|D09923|Q27294227|1-(1-(3-((6-chloronaphthalen-2-yl)sulfonyl)-2-hydroxypropanoyl)piperidin-4-yl)tetrahydropyrimidin-2(1h)-one|2(1H)-Pyrimidinone, 1-(1-((2S)-3-((6-chloro-2-naphthalenyl)sulfonyl)-2-hydroxy-1- oxopropyl)-4-piperidinyl)tetrahydro-"
MENTHOL,1254,,"InChI=1S/C10H20O/c1-7(2)9-5-4-8(3)6-10(9)11/h7-11H,4-6H2,1-3H3",NOOLISFMXDJSKH-UHFFFAOYSA-N,C10H20O,156.26,5-methyl-2-propan-2-ylcyclohexan-1-ol,"MENTHOL|1490-04-6|2-Isopropyl-5-methylcyclohexanol|Menthyl alcohol|Mentholum|Caswell No. 540|Mineral ice|3-Hydroxy-p-menthane|CCRIS 9231|DTXSID8029650|EINECS 216-074-4|EPA Pesticide Chemical Code 051601|HSDB 593|AI3-08161|Therapeutic mineral ice|5-Methyl-2-(1-methylethyl)cyclohexanol|2-Isopropyl-5-methylcyclohexan-1-ol|Fisherman's friend lozenges|DTXCID30805|EC 216-074-4|1-Methyl-4-isopropyl-3-cyclohexanol|UNII-L7T10EIP3A|BOHENAO|RefChem:6462|MENTHOL (II)|MENTHOL (MART.)|MENTHOL, UNSPECIFIED|L7T10EIP3A|MENTHOL (USP MONOGRAPH)|LEVOMENTHOL OR RACEMENTHOL|MENTHOL, UNSPECIFIED FORM|SALONPAS COMPONENT MENTHOL|MENTHOL COMPONENT OF SALONPAS|LEVOROTATORY-MENTHOL OR RACEMIC-MENTHOL|dl-Menthol|15356-70-4|89-78-1|Cyclohexanol, 5-methyl-2-(1-methylethyl)-|p-Menthan-3-ol|5-methyl-2-propan-2-ylcyclohexan-1-ol|(+/-)-Menthol|Hexahydrothymol|MFCD00001484|Neomenthol|Menthol [USP]|rac-Menthol|Menthol, dl-|Racementol|CHEBI:25187|(1R,2S,5R)-Menthol|Menthol (USP)|L(-)-Menthol|(1S, 2S, 5R)-(+)-Neomenthol|491-01-0|5-methyl-2-(propan-2-yl)cyclohexanol|Menthol 1000 microg/mL in Acetonitrile|5-methyl-2-(propan-2-yl)cyclohexan-1-ol|(+/-)-Menthol, racemic|(1R,2R,5R)-Isomenthol|Racemic menthol|FEMA No. 2665|3-p-Menthanol|Menthol, cis-1,3,trans-1,4-|MEGGEZONE|Cyclohexanol, 5-methyl-2-(1-methylethyl)-, [1S-(1.alpha.,2.alpha.,5.beta.)]-|3-p-Menthol|(+/-)-p-Menthan-3-ol|(+)-Neo-menthol|CAS-1490-04-6|Robitussin Cough Drops|(1R,2R,5R)-5-methyl-2-(propan-2-yl)cyclohexan-1-ol|5-Methyl-2-(1-methylethyl)-cyclohexanol|Menthol racemate|Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1.alpha.,2.beta.,5.alpha.)-|2-Isopropyl-5-methyl-cyclohexanol|(-)menthol|NCGC00159382-02|(-) menthol|Menthol (Standard)|4-Isopropyl-1-methylcyclohexan-3-ol|Menthol, 99%|dextro,laevo-neomenthol|dl-Menthol (JP17)|1-methyl-4-isopropyl-3-hydroxycyclohexane|Emtricitabine Impurity 9|SCHEMBL4612|Menthol, (.+/-.)-|Menthol, puriss., 99.0%|SCHEMBL608359|CHEMBL256087|orb1301551|SCHEMBL1697828|SCHEMBL7738653|DL-Menthol, analytical standard|HY-N1369R|Fisherman's friend lozenges (TN)|BDBM248162|HMS3744K19|HMS5083C20|HMS5085P13|2-Isopropyl-5-methylcyclohexanol #|BCP27552|BCP31841|CS-M3737|HY-N1369|menthol crystals; 15356-70-4|MSK40117|QAA35670|Tox21_200010|Tox21_303464|BBL009325|DL-Menthol, >=95%, FCC, FG|STK802468|AKOS000119740|AKOS016843634|Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1.alpha.,2.alpha.,5.beta.)-|SB35230|SB44308|SB44857|Menthol, SAJ special grade, >=98.0%|NCGC00159382-03|NCGC00159382-04|NCGC00159382-05|NCGC00159382-06|NCGC00257403-01|NCGC00257564-01|FM178382|HY-75161|IE182323|IN182314|SY010603|VS-02042|DB-063989|Levomenthol; D-(-)-Menthol; (-)-Menthol|CS-0016777|M0321|NS00001027|EN300-19914|(+/-)-Menthol, racemic, >=98.0% (GC)|2-Isopropy-5-methylcyclohexanol-1,2,6,6-d4|D04849|D04918|E80543|BRD-A54393207-001-03-6|Q27109870|L-p-Menthan-3-ol; Menthol ,natural; (1R,2S,5R)-(-)-Menthol|Menthol-plus it inverted exclamation markas 3 isomers-1,2,6,6-d4|Cyclohexanol, 5-methyl-2-(1-methylethyl)-, (1.alpha.,2.beta.,5.alpha.)-(.+/-.)-|Cyclohexanol, 5-methyl-2-(1-methylethyl)-, [1R-(1.alpha.,2.alpha.,5.beta.)]-|L-Menthol; (-)-Menthol; Levomenthol; Menthomenthol;2-isopropyl-5-methyl-cyclohexanol;Menthol"
BEFIRADOL,9865384,,"InChI=1S/C20H22ClF2N3O/c1-14-2-4-16(25-11-14)12-24-13-20(23)6-8-26(9-7-20)19(27)15-3-5-18(22)17(21)10-15/h2-5,10-11,24H,6-9,12-13H2,1H3",PKZXLMVXBZICTF-UHFFFAOYSA-N,C20H22ClF2N3O,393.9,(3-chloro-4-fluorophenyl)-[4-fluoro-4-[[(5-methylpyridin-2-yl)methylamino]methyl]piperidin-1-yl]methanone,Befiradol|208110-64-9|NLX-112|RAT9OHA1YH|F13640|DTXSID90943058|F-13640|befiradolum|RefChem:116871|DTXCID201371436|Befiradol (free base)|Befiradol [INN]|CHEMBL45305|(3-chloro-4-fluorophenyl)-[4-fluoro-4-[[(5-methylpyridin-2-yl)methylamino]methyl]piperidin-1-yl]methanone|NLX-112; F13640|NLX-112 hydrochloride|UNII-RAT9OHA1YH|(3-chloranyl-4-fluoranyl-phenyl)-[4-fluoranyl-4-[[(5-methylpyridin-2-yl)methylamino]methyl]piperidin-1-yl]methanone|ZKV|[3H]NLX-112|[3H]F13640|BEFIRADOL [WHO-DD]|F 13640|SCHEMBL678174|GTPL3925|orb1710293|SCHEMBL29408712|GLXC-15037|BCP31302|BDBM50328639|EX-A10697|AKOS032954037|((3-chloro-4-fluoro-phenyl)-(4-fluoro-4-((5-methyl-pyridin-2-ylmethyl)-amino)-methyl)piperidin-1-yl)-methadone|DA-71362|HY-14785|CS-0003559|G13272|110B649|L001676|Q4880242|F-13640; F13640; F 13640; NLX-112; NLX112; NLX 112|(3-Chloro-4-fluoro-phenyl)-(4-fluoro-4-{[(5-methyl-pyridin-2-ylmethyl)-amino]-methyl}-piperidin-1-yl)-methanone|(3-CHLORO-4-FLUOROPHENYL)(4-FLUORO-4-((((5-METHYLPYRIDIN-2-YL)METHYL)AMINO)METHYL)PIPERIDIN-1-YL)METHANONE|(3-chloro-4-fluorophenyl)(4-fluoro-4-(((5-methylpyridin-2-yl)methylamino)methyl)piperidin-1-yl)methanone|1-(3-Chloro-4-fluorobenzoyl)-4-fluoro-N-[(5-methyl-2-pyridinyl)methyl]-4-piperidinemethanamine
GATIFLOXACIN,5379,,"InChI=1S/C19H22FN3O4/c1-10-8-22(6-5-21-10)16-14(20)7-12-15(18(16)27-2)23(11-3-4-11)9-13(17(12)24)19(25)26/h7,9-11,21H,3-6,8H2,1-2H3,(H,25,26)",XUBOMFCQGDBHNK-UHFFFAOYSA-N,C19H22FN3O4,375.4,1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid,"Gatifloxacin|112811-59-3|Tequin|Gatiflo|Zymar|AM-1155|Zymaxid|gatifloxacin anhydrous|AM 1155|Gatifloxacine|Zymer|3-Quinolinecarboxylic acid, 1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-|gatifloxacino|1-Cyclopropyl-1,4-dihydro-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|gatifloxacinum|DTXSID5045704|NSC-758701|CHEBI:5280|PD-135432|1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid|81485Y3A9A|Gatifloxacin (sesquihydrate)|BMS-206584-01|(+-)-1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|DTXCID3025704|1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-quinoline-3-carboxylic acid|BMS-20658401|BMS206584|BMS 206584|RefChem:142731|J01MA16|S01AE06|1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-4-ium-1-yl)-4-oxoquinoline-3-carboxylate|L4618BD7KJ|1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|CG 5501|1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|BMS-206584|GTFX|MFCD00895399|Gatifloxacin (INN)|160738-57-8|CHEMBL31|Gatilox|Gatiquin|Gatispan|Gaity|1-Cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid|gatifloxin|NCGC00068236-02|Gatifloxacin 100 microg/mL in Acetonitrile|GATIFLOXACIN [INN]|Gatifloxacin [USAN:INN]|Bonoq|Tymer|BMS 206584-01|PD 135432|(+/-)-1-cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid|1-cyclopropyl-6-fluoro- 8-methoxy-7-(3-methylpiperazin-1-yl)- 4-oxo-quinoline-3-carboxylic acid|SMR000043336|Gatifloxacin (TN)|CAS-112811-59-3|Zymer (TN)|SR-01000610458|Gatifloxcin|Tequin in dextrose 5% in plastic container|AM-1155 (*Sesquihydrate*)|Gatifloxacin & Gamma Interferon|UNII-81485Y3A9A|1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid;Tequin;Zymar|CG-5501|Kinome_3137|Spectrum_001909|CPD000043336|Gatifloxacin (Standard)|Spectrum2_000487|Spectrum3_000999|Spectrum4_001127|Spectrum5_001468|GATIFLOXACIN [MI]|SCHEMBL22591|BSPBio_002697|KBioGR_001613|KBioSS_002448|MLS000040259|MLS000759493|MLS006011836|GATIFLOXACIN [WHO-DD]|SPECTRUM1504272|SPBio_000353|orb1309089|SCHEMBL29356306|Gatifloxacin - Bio-X trade mark|GTPL10816|KBio2_002442|KBio2_005010|KBio2_007578|KBio3_001917|MSK5720|GLXC-22553|HMS1922J15|HMS2090K10|HMS2093G06|HMS2233D20|HMS3259P06|HMS3372J10|HMS3372J12|HMS3715N03|HMS5079D13|Pharmakon1600-01504272|ALBB-028535|BCP13408|RKL10068|Tox21_110984|AM1155|BBL010485|BDBM50117914|CCG-39529|CG5501|HB3263|HY-10581R|NSC758701|s1340|STK801620|AKOS004119932|AKOS016340697|Tox21_110984_1|AC-1944|AC23649|CS-1841|DB01044|KS-1066|NC00702|NSC 758701|NCGC00068236-03|NCGC00068236-04|NCGC00068236-05|NCGC00068236-06|NCGC00068236-07|NCGC00068236-08|NCGC00095126-01|NCGC00095126-02|NCGC00178525-01|BG300001|HY-10581|SY070194|SBI-0206764.P001|DB-019145|G0325|NS00004983|C07661|D08011|AB00171654-13|AB00171654-14|AB00171654_16|AB00171654_17|811G593|EN300-19768783|Q2365016|SR-01000610458-2|SR-01000610458-3|BRD-A74980173-001-02-8|BRD-A74980173-001-06-9|BRD-A74980173-001-11-9|BRD-A74980173-213-01-1|Z1824566854|1-Cyclopropyl-6-fluoro-1,4-dihydro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-3-quinolinecarboxylic acid|1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methyl-1-piperazinyl)-1,4-dihydro-4-oxoquinoline-3-carboxylic acid|1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylicacid|1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazino)-4-oxo-1,4-dihydro-3-quinolinecarboxylic acid|1-cyclopropyl-7-(3-methyl-1-piperazinyl)-6-fluoro-8-methoxy-1,4-dihydro-4-oxo-3-quinolinecarboxylic acid"
AZD-1480,16659841,,"InChI=1S/C14H14ClFN8/c1-7-3-11(24-23-7)21-13-10(15)6-19-14(22-13)20-8(2)12-17-4-9(16)5-18-12/h3-6,8H,1-2H3,(H3,19,20,21,22,23,24)/t8-/m0/s1",PDOQBOJDRPLBQU-QMMMGPOBSA-N,C14H14ClFN8,348.76,"5-chloro-2-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine","AZD1480|935666-88-9|AZD-1480|AZD 1480|KL2Z2TLF01|5-Chloro-N2-[(1s)-1-(5-Fluoropyrimidin-2-Yl)ethyl]-N4-(5-Methyl-1h-Pyrazol-3-Yl)pyrimidine-2,4-Diamine|DTXSID50239469|2,4-Pyrimidinediamine, 5-chloro-N2-((1S)-1-(5-fluoro-2-pyrimidinyl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)-|5-chloro-2-N-((1S)-1-(5-fluoropyrimidin-2-yl)ethyl)-4-N-(3-methyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine|5-chloro-2-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-4-N-(3-methyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine|5-chloro-N2-((1S)-1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine|RefChem:115989|DTXCID20161960|JAK2 INHIBITOR AZD1480|(S)-5-chloro-N2-(1-(5-fluoropyrimidin-2-yl)ethyl)-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine|C14H14ClFN8|MFCD16038904|5-chloro-2-N-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-4-N-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine|CHEMBL1231124|5-Chloro-N2-[(1S)-1-(5-fluoro-2-pyrimidinyl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)-2,4-pyrimidinediamine|UNII-KL2Z2TLF01|PDOQBOJDRPLBQU-QMMMGPOBSA-N|2xa4|MLS006011153|GTPL5933|orb1304572|SCHEMBL3345019|SCHEMBL29350245|SCHEMBL29523565|EX-A450|AZD 1480 [WHO-DD]|BCPP000361|BCP02413|BDBM50335201|NSC756648|NSC799344|s2162|AKOS027322548|BCP9000361|CCG-268021|DB12588|NC44330|NSC-756648|NSC-799344|NCGC00242486-01|NCGC00242486-02|NCGC00242486-05|AC-32807|AS-17011|HY-10193|SMR004702927|SY067871|NS00072791|SW219486-1|BRD-K65928735-001-04-3|Q27074711|935666-88-9, 1260222-79-4 (TFA)|(S)-5-Chloro-N2-[1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-3-pyrazolyl)pyrimidine-2,4-diamine|5-chloro-N~2~-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N~4~-(3-methyl-1H-pyrazol-5-yl)pyrimidine-2,4-diamine|AZ5"
OLMESARTAN,158781,,"InChI=1S/C24H26N6O3/c1-4-7-19-25-21(24(2,3)33)20(23(31)32)30(19)14-15-10-12-16(13-11-15)17-8-5-6-9-18(17)22-26-28-29-27-22/h5-6,8-13,33H,4,7,14H2,1-3H3,(H,31,32)(H,26,27,28,29)",VTRAEEWXHOVJFV-UHFFFAOYSA-N,C24H26N6O3,446.5,5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid,"Olmesartan|144689-24-7|RNH-6270|omesartan|NSC-759810|8W1IQP3U10|CHEBI:48416|DTXSID2040571|1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl) (1,1'-biphenyl)-4-yl)methyl)-|4-(hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid|(5-Methyl-2-oxo-1,3-dioxol-4-yl)methyl 4-(2-hydroxypropan-2-yl)-2-propyl-1-((2'-(2H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylate|4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(2-hydroxypropan-2-yl)-2-propyl-1-({4-[2-(1H-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)-1,1'-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|olmesartanum|4-(1-hydroxy-1-methylethyl)-2-propyl-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazole-5-carboxylic acid|4-(2-hydroxypropan-2-yl)-2-propyl-1-((4-(2-(1H-1,2,3,4-tetrazol-5-yl)phenyl)phenyl)methyl)-1H-imidazole-5-carboxylic acid|olmesartanum medoxomilum|RefChem:55770|DTXCID0020571|(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 5-(2-hydroxypropan-2-yl)-2-propyl-3-((4-(2-(2H-tetrazol-5-yl)phenyl)phenyl)methyl)imidazole-4-carboxylate|Olmesartan Acid|MFCD00914967|1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid|RNH 6270|C24H26N6O3|1H-Imidazole-5-carboxylic acid, 4-(1-hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-|CS-088|5-(2-hydroxypropan-2-yl)-2-propyl-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazole-4-carboxylic acid|CHEMBL1516|Votum|Olmesartan [USAN]|1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid|4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic Acid (Olmesartan)|4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|SMR000466337|UNII-8W1IQP3U10|Olmesartan [USAN:INN:BAN]|Benicar;Olmetec|HSDB 8214|OLM|Olmesartan medoximil|Olmesartan Medoxomil Imp. A (EP); 4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazole-5-carboxylic Acid; Olmesartan; Olmesartan Acid; Olmesartan Medoxomil Impurity A|OLMESARTAN [MI]|OLMESARTAN [INN]|Olmesartan (USAN/INN)|OLMESARTAN [VANDF]|EC 646-413-5|OLMESARTAN [WHO-DD]|SCHEMBL94037|MLS000759446|MLS001424016|MLS006011945|SCHEMBL677160|orb1301381|Olmesartan, >=98% (HPLC)|SCHEMBL29368106|GLXC-05183|HMS2051K12|HMS2235O24|HMS3369I09|HMS3393K12|HMS3604J06|HMS5084F22|Pharmakon1600-01505206|BCP12007|MSK10402|BDBM50241364|DE-092|NSC759810|Olmesartan Medoxomilum EP Impurity A|s5581|AKOS015900241|AKOS024458255|AC-9385|CCG-100868|CCG-269198|CS-0576|DB00275|IH57928|NC00118|NSC 759810|NCGC00246968-01|NCGC00246968-02|NCGC00246968-04|4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(2H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid|AS-10242|HY-17004|Olmesartan medoxomil impurity, olmesartan-|SMR004703526|SY015734|DB-042742|NS00008999|O0507|C21543|D05246|EN300-122328|689O247|F787557|L001097|Olmesartan 100 microg/mL in Acetonitrile:Methanol|Q421156|BRD-K83144676-001-06-1|BRD-K83144676-001-07-9|BRD-K83144676-001-08-7|BRD-K83144676-001-09-5|OLMESARTAN MEDOXOMIL IMPURITY A [EP IMPURITY]|Z1541758605|OLMESARTAN MEDOXOMIL IMPURITY, OLMESARTAN- [USP IMPURITY]|1-((2 inverted exclamation mark -(1H-Tetrazol-5-Yl)-[1,1 inverted exclamation mark -Biphenyl]-4-Yl)Methyl)-4-(2-Hydroxypropan-2-Yl)-2-Propyl-1H-Imidazole-5-Carboxylic Acid|1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-4-(2-hydroxypropan-2-yl)-2-propyl-1H-imidazole-5-carboxylic acid|4-(1-hydroxy-1-methylethyl) -2-propyl-1-{4-[2-(tetrazole -5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid|4-(1-hydroxy-1-methylethyl) -2-propyl-1-{4-[2-(tetrazole-5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid|4-(1-Hydroxy-1-methylethyl)-2-propyl-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-5-carboxylic acid;Olmesa|4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2''-(1H-tetrazol-5-yl)[1,1''-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2''-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(1-hydroxy-1-methylethyl)-2-propyl-1-{[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(1-Hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazol-5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid|4-(1-hydroxy-1-methylethyl)-2-propyl-1-{4-[2-(tetrazole-5-yl)phenyl]phenyl}methylimidazole-5-carboxylic acid|4-(2-Hydroxy-2-propyl)-2-propyl-1-[[2 inverted exclamation mark -(5-tetrazolyl)biphenyl-4-yl]methyl]imidazole-5-carboxylic Acid|4-(2-hydroxypropan-2-yl)-2-propyl-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazole-5-carboxylic acid|4-(hydroxy-1-methylethyl)-2-propyl-1-{[2''-(1H-tetrazol-5-yl)-1,1''-biphenyl-4-yl]methyl}-1H-imidazole-5-carboxylic acid"
CASOPITANT,9917021,,"InChI=1S/C30H35F7N4O2/c1-18-13-24(31)5-6-26(18)27-17-25(40-11-9-39(10-12-40)20(3)42)7-8-41(27)28(43)38(4)19(2)21-14-22(29(32,33)34)16-23(15-21)30(35,36)37/h5-6,13-16,19,25,27H,7-12,17H2,1-4H3/t19-,25+,27-/m1/s1",XGGTZCKQRWXCHW-WMTVXVAQSA-N,C30H35F7N4O2,616.6,"(2R,4S)-4-(4-acetylpiperazin-1-yl)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperidine-1-carboxamide","Casopitant|Zunrisa|414910-27-3|3B03KPM27L|GW-679769|(2R,4S)-4-(4-acetylpiperazin-1-yl)-N-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethyl]-2-(4-fluoro-2-methylphenyl)-N-methylpiperidine-1-carboxamide|DTXSID40961762|1-Piperidinecarboxamide, 4-(4-acetyl-1-piperazinyl)-N-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-2-(4-fluoro-2-methylphenyl)-N-methyl-, (2R,4S)-|casopitantum|(2R,4S)-4-(4-acetylpiperazin-1-yl)-N-((1R)-1-(3,5-bis(trifluoromethyl)phenyl)ethyl)-2-(4-fluoro-2-methylphenyl)-N-methylpiperidine-1-carboxamide|RefChem:123914|A04AD13|DTXCID701389581|GW679769|Casopitant [INN]|CHEMBL1672054|GW 679769|CASOPITANT [MART.]|CASOPITANT [WHO-DD]|UNII-3B03KPM27L|Rezonic (proposed trade name)|SCHEMBL425342|Zunrisa (proposed trade name)|GTPL5758|orb2814106|SCHEMBL29985145|CHEBI:135967|XGGTZCKQRWXCHW-WMTVXVAQSA-N|EX-A8851|BDBM50336575|DB06634|NCGC00386657-01|852393-14-7|HY-14405|NS00072486|EN300-19880551|Q5049003|cis-(1''-Acetyl-N-{(1R)-1-[3,5-bis(trifluoromethyl)phenyl]-ethyl}-2-(4-fluoro-2-methylphenyl)-N-methyl-4,4''-bipiperidine-1-carboxamide"
VICRIVIROC,3009355,,"InChI=1S/C28H38F3N5O2/c1-19-16-35(14-15-36(19)24(17-38-5)22-6-8-23(9-7-22)28(29,30)31)27(4)10-12-34(13-11-27)26(37)25-20(2)32-18-33-21(25)3/h6-9,18-19,24H,10-17H2,1-5H3/t19-,24-/m0/s1",CNPVJJQCETWNEU-CYFREDJKSA-N,C28H38F3N5O2,533.6,"(4,6-dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone","Vicriviroc|306296-47-9|SCH-D|(4,6-dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone|TL515DW4QS|MK-7690|SCH-417690 FREE BASE|MK-4176|DTXSID40897719|vicrivirocum|(4,6-dimethylpyrimidin-5-yl)-(4-((3S)-4-((1R)-2-methoxy-1-(4-(trifluoromethyl)phenyl)ethyl)-3-methylpiperazin-1-yl)-4-methylpiperidin-1-yl)methanone|RefChem:934022|DTXCID301326939|5-(4-((3S)-4-((1R)-2-methoxy-1-(4-(trifluoromethyl)phenyl)ethyl)-3-methylpiperazin-1-yl)-4-methylpiperidine-1-carbonyl)-4,6-dimethylpyrimidine|Vicriviroc [INN]|SCH-D690|CHEMBL82301|Sch-D compound|394730-30-4|SchD|(4,6-Dimethylpyrimidin-5-yl)(4-((S)-4-((R)-2-methoxy-1-(4-(trifluoromethyl)phenyl)ethyl)-3-methylpiperazin-1-yl)-4-methylpiperidin-1-yl)methanone|(4,6-DIMETHYLPYRIMIDIN-5-YL)-[4-[(3S)-4-[(1R)-2-METHOXY-1-[4-(TRIFLUOROMETHYL)PHENYL]ETHYL]-3-METHYL-PIPERAZIN-1-YL]-4-METHYL-1-PIPERIDYL]METHANONE|Methanone, (4,6-dimethyl-5-pyrimidinyl)[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluoromethyl)phenyl]ethyl]-3-methyl-1-piperazinyl]-4-methyl-1-piperidinyl]-|VCV|SCH-D (Old RN)|PRO 140 & Vicrivirac|UNII-TL515DW4QS|Vicriviroc (SCH-417690)|SCH-DS|starbld0032646|VICRIVIROC [MI]|NCGC00182549-01|VICRIVIROC [WHO-DD]|MK-4176 intravaginal ring|GTPL807|SCHEMBL118885|orb1740002|CHEBI:94843|EX-A4709A|MK-4176 IVR|CNPVJJQCETWNEU-CYFREDJKSA-N|BDBM50145685|DB06652|NCGC00182549-07|(4,6-Dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R)-2-methoxy-1-[4-(trifluor omethyl)phenyl]ethyl]-3-methyl-piperazin-1-yl]-4-methyl-1-piperidyl]me thanone|1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[4-{2-methoxy-1(R)-4-(trifluoromethyl)-phenyl}ethyl-3(S)-methyl-1-piperazinyl]-4-methylpiperidine|FV104151|PRO 140 (Anti-CCR5 monoclonal antibody) & 1-[(4,6-Dimethyl-5-pyrimidinyl)carbonyl]-4-[4-{2-methoxy-1(R)-4-(trifluoromethyl)-phenyl}ethyl-3(S)-methyl-1-piperazinyl]-4-methylpiperidine|DB-214865|NS00071654|AB01274747-01|Q3557001|BRD-K84748119-050-01-1|(4,6-Dimethyl-pyrimidin-5-yl)-(4-{(S)-4-[(R)-2-methoxy-1-(4-trifluoromethyl-phenyl)-ethyl]-3-methyl-piperazin-1-yl}-4-methyl-piperidin-1-yl)-methanone|1-((4,6-dimethyl-5-pyrimidinyl)carbonyl)-4-(4-(2-methoxy-4-(trifluoromethyl)phenyl)ethyl-3-methyl-1-piperazinyl)-4-methylpiperidine  Sch 417690  Sch-417690  Sch417690  vicriviroc|5-((4-((3S)-4-((1R)-2-METHOXY-1-(4-(TRIFLUOROMETHYL)PHENYL)ETHYL)-3-METHYLPIPERAZIN-1-YL)-4-METHYLPIPERIDIN-1-YL)CARBONYL)-4,6-DIMETHYLPYRIMIDINE"
INCB-9471,49871007,,"InChI=1S/C30H40F3N5O2/c1-6-40-25-16-22-15-23(30(31,32)33)7-8-24(22)27(25)38-14-13-37(17-19(38)2)29(5)9-11-36(12-10-29)28(39)26-20(3)34-18-35-21(26)4/h7-8,15,18-19,25,27H,6,9-14,16-17H2,1-5H3/t19-,25+,27+/m0/s1",ZMCJFJZOSKEMOM-DNKZPPIMSA-N,C30H40F3N5O2,559.7,"(4,6-dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R,2R)-2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone","INCB9471|INCB-9471|869769-98-2|INCB009471|INCB-009471|Piperidine, 1-((4,6-dimethyl-5-pyrimidinyl)carbonyl)-4-((3S)-4-((1R,2R)-2-ethoxy-2,3-dihydro-5-(trifluoromethyl)-1H-inden-1-yl)-3-methyl-1-piperazinyl)-4-methyl-|C5D4W25708|5-(4-((3S)-4-((1R,2R)-2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl)-4-methylpiperidine-1-carbonyl)-4,6-dimethylpyrimidine|5-{4-[(3S)-4-[(1R,2R)-2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-3-methylpiperazin-1-yl]-4-methylpiperidine-1-carbonyl}-4,6-dimethylpyrimidine|RefChem:790872|CHEMBL1688243|925701-76-4|(4,6-Dimethylpyrimidin-5-yl)(4-((S)-4-((1R,2R)-2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl)-4-methylpiperidin-1-yl)methanone|(4,6-dimethylpyrimidin-5-yl)-[4-[(3S)-4-[(1R,2R)-2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-3-methylpiperazin-1-yl]-4-methylpiperidin-1-yl]methanone|UNII-C5D4W25708|INCB 9471|INCB0 09471|orb1737798|SCHEMBL3676335|SCHEMBL29386216|DTXSID20919100|ZMCJFJZOSKEMOM-DNKZPPIMSA-N|BDBM50339033|DB12960|5-((4-(4-(2-Ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl)-3-methylpiperazin-1-yl)-4-methylpiperidin-1-yl)carbonyl)-4,6-dimethylpyrimidine|HY-14230|CS-0002943|NS00072520|Q27275213|(4,6-Dimethylpyrimidin-5-yl)(4-{4-[2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-3-methylpiperazin-1-yl}-4-methylpiperidin-1-yl)methanone|5-[(4-(3S)-4-[(1R,2R)-2-ethoxy-5-(trifluoromethyl)-2,3-dihydro-1H-inden-1-yl]-3-methylpiperazin-1-yl-4-methylpiperidin-1-yl)carbonyl]-4,6-dimethylpyrimidine"
FLOXURIDINE,5790,,"InChI=1S/C9H11FN2O5/c10-4-2-12(9(16)11-8(4)15)7-1-5(14)6(3-13)17-7/h2,5-7,13-14H,1,3H2,(H,11,15,16)/t5-,6+,7+/m0/s1",ODKNJVUHOIMIIZ-RRKCRQDMSA-N,C9H11FN2O5,246.19,"5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione","floxuridine|50-91-9|2'-Deoxy-5-fluorouridine|5-Fluorodeoxyuridine|Fluorodeoxyuridine|FUDR|Floxuridin|FdUrd|Deoxyfluorouridine|Fluoruridine deoxyribose|Uridine, 2'-deoxy-5-fluoro-|5FdU|Floxiridina|Floxuridinum|5-Fluoro-2-desoxyuridine|5 Fluorodeoxyuridine|5-Fluoro-2-deoxyuridine|FDUR|beta-5-Fluoro-2'-deoxyuridine|5-Fluorouracil 2'-deoxyriboside|1-(2-Deoxy-beta-D-ribofuranosyl)-5-fluorouracil|5-Fluorouracil deoxyriboside|NSC-27640|1beta-D-2'-Deoxyribofuranosyl-5-flurouracil|1-beta-D-2'-Deoxyribofuranosyl-5-flurouracil|5-FUDR|floxuridina|DTXSID3023057|CHEBI:60761|5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-1,2,3,4-tetrahydropyrimidine-2,4-dione|039LU44I5M|DTXCID603057|5-Fluoro-2'-deoxy-beta-uridine|NSC 27640|NSC27640|5-fluoro-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-1,2,3,4-tetrahydropyrimidine-2,4-dione|RefChem:57485|Fluorouridine Deoxyribose|F.u.d.r.|2-Deoxy-5-fluorouridine|5-Fluorouridine Deoxyribose|L01BC09|WR-138720|200-072-5|5-fluoro-1-((2r,4s,5r)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)pyrimidine-2,4(1h,3h)-dione|Floxuridinum [INN-Latin]|Floxiridina [INN-Spanish]|MFCD00006530|5-FdUrd|CHEMBL917|MLS000069439|Uridine, 2'-deoxy-5'-fluoro-|NCGC00023722-05|SMR000059051|Ro 5-0360|FdU|(+)-5-fluoro-2'-deoxyuridine|5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]pyrimidine-2,4-dione|CAS-50-91-9|1-[(4S,2R,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-5-fluoro-1,3-dihydropyri midine-2,4-dione|5-Fluoro-1-((2R,4S,5R)-4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione|HSDB 3227|EINECS 200-072-5|(+)-5-fluorodeoxyuridine|FUDR (TN)|BRN 0090221|floxidine|Uridine, 2'-deoxy-5-fluoro|UNII-039LU44I5M|Floxuridine [USAN:USP:INN]|AI3-50691|5-floxuridine|5-Fluoro-dUrd|Floxuridine (Fludara)|Floxuridine (USP/INN)|FLOXURIDINE [MI]|Opera_ID_1559|FLOXURIDINE [INN]|2-deoxy-5'-fluorouridine|FLOXURIDINE [HSDB]|FLOXURIDINE [USAN]|Epitope ID:138108|5-Fluor-1-(beta-2'-deoxyribofuranosyl)pyrimidin-2,4(1H,3H)-dion [Czech]|FLOXURIDINE [VANDF]|SCHEMBL4424|2''-deoxy-5-fluorouridine|2'-deoxy-5-fluoro uridine|5-fluoro-2''-deoxyuridine|FLOXURIDINE [MART.]|FLOXURIDINE [USP-RS]|FLOXURIDINE [WHO-DD]|5-24-06-00291 (Beilstein Handbook Reference)|5-Fluoro-2 inverted exclamation marka-deoxyuridine|MLS002695934|MLS006011768|5-fluoro-2''-Deoxy-uridine|2'-deoxy-5-fluoro-d-uridine|GTPL4801|SCHEMBL6838927|SCHEMBL9617099|FLOXURIDINE [ORANGE BOOK]|FLOXURIDINE [USP IMPURITY]|HMS2090I12|HMS2230N22|HMS3715A11|FLOXURIDINE [USP MONOGRAPH]|BCP02871|HY-B0097|Tox21_110892|5-Fluor-1-(beta-2'-deoxyribofuranosyl)pyrimidin-2,4(1H,3H)-dion|BBL033765|BDBM50340678|s1299|STK801909|AKOS005622662|Tox21_110892_1|BCP9000691|CCG-220965|CS-1827|DB00322|ND02921|PS-7520|5-fluoro-1-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]pyrimidine-2,4-dione|SRI-9246-15|SRI-9246_18|NCGC00023722-03|NCGC00023722-06|NCGC00023722-08|136353-77-0|AC-16391|BP-58649|ST056942|BCP0726000269|D2235|NS00015076|EN300-52649|D04197|006F530|F009121|SR-01000000001|Q5462356|SR-01000000001-2|BRD-K47832606-001-26-9|BRD-K47832606-001-30-1|5-Fluoro-2'-deoxyuridine, thymidylate synthase inhibitor|Z756475348|1-(beta-D-2-deoxy-erythro-pentofuranosyl)-5-fluorouracil|Floxuridine, United States Pharmacopeia (USP) Reference Standard|5-Fluoro-1-(4-hydroxy-5-hydroxymethyl-tetrahydro-furan-2-yl)-1H-pyrimidine-2,4-dione|5-fluoro-1-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)-tetrahydrofuran-2-yl)pyrimidine-2,4(1H,3H)-dione|5-Fluoro-2'-deoxy-D-uridine;Floxuridine;2'-Deoxy-5-fluoro-D-uridine;5-Fluoro-2'-deoxyuridine"
FLUOROURACIL,3385,,"InChI=1S/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9)",GHASVSINZRGABV-UHFFFAOYSA-N,C4H3FN2O2,130.08,"5-fluoro-1H-pyrimidine-2,4-dione","5-Fluorouracil|fluorouracil|51-21-8|Efudex|Fluracil|Fluoroblastin|Queroplex|Phthoruracil|Carzonal|Arumel|Fluril|Timazin|Fluracilum|Ulup|5-Fluoracil|Fluorouracilum|Fluro Uracil|5 Fluorouracil|5-Fluoruracil|Fluorouracilo|Ftoruracil|Efurix|5-Fluoro-2,4(1H,3H)-pyrimidinedione|Effluderm (free base)|Fluroblastin|5-Fluoropyrimidine-2,4-dione|Fluoro-uracile|Fluoro-uracilo|Uracil, 5-fluoro-|2,4(1H,3H)-Pyrimidinedione, 5-fluoro-|Ro 2-9757|5-Faracil|Cinco FU|Fluorouracile|2,4-Dioxo-5-fluoropyrimidine|Fluorouricil|NSC-19893|Tolak|5-Fluoropyrimidin-2,4-diol|NSC 19893|Ro-2-9757|U-8953|Fluouracil|DTXSID2020634|Fluoro Uracil|5-fluoro-1,2,3,4-tetrahydropyrimidine-2,4-dione|5-Fluracil|CHEBI:46345|U3P01618RT|NSC19893|Ro-29757|DTXCID40634|Flurodex|Haemato fu|Fluorouracil GRY|5 FU Lederle|Fluoro Uracile ICN|Fluoro-Uracile ICN|5 FU medac|5 HU Hexal|Dakota, Fluorouracile|5 Fluorouracil biosyn|Flurablastin|AccuSite|5 Fluorouracilum|Fluoro-uracil roche|RefChem:56970|L01BC02|5-Fluoro-2,4(1H, 3H)-pyrimidinedione|200-085-6|Fluoruracil|5-FU|Fluoroplex|Adrucil|Carac|5-fluoropyrimidine-2,4(1H,3H)-dione|Kecimeton|Efudix|5-fluoro-1H-pyrimidine-2,4-dione|Fluri|2,4-Dihydroxy-5-fluoropyrimidine|5-fluoropyrimidine-2,4-diol|5-Fluor-2,4-pyrimidindiol|5-fluoro uracil|5-fluoro-uracil|5-Ftouracyl|Fluorouracil, 5-|MFCD00006018|5-Fluoro-2,4-pyrimidinedione|191047-65-1|5-Fluor-2,4-dihydroxypyrimidin|FU|CHEMBL185|2,4-Pyrimidinediol, 5-fluoro- (9CI)|MLS000069498|5 FU|191047-64-0|191115-88-5|5FU|Phtoruracil|URF|NCGC00015442-02|Effluderm|SMR000038082|Fluorouracile [DCIT]|5-Fluoracil [German]|5-Fluoracyl|5-Fluoruracil [German]|1004-03-1|Fluorouracilum [INN-Latin]|Fluorouracilo [INN-Spanish]|Fluorouracil Cream|CAS-51-21-8|Fluoroplex (TN)|5-Fluor-2,4-pyrimidindiol [Czech]|Adrucil (TN)|5-fluoro-1,3-dihydropyrimidine-2,4-dione|CCRIS 2582|Carac (TN)|5-Fluor-2,4-dihydroxypyrimidin [Czech]|HSDB 3228|SR-01000075881|5-Fluor-2,4(1H,3H)-pyrimidindion [Czech]|EINECS 200-085-6|5-Fluor-2,4(1H,3H)-pyrimidindion|inhibits thymilidate synthetase|UNII-U3P01618RT|2,4-Dioxo-5-fluoropryimidine|5-fluorourasil|AI3-25297|5-florouracil|5-fluorouacil|5-FU (TN)|1upf|5F-uracil|U 8953|Fluorouracil; 5-Fluoropyrimidine-2,4(1H,3H)-dione; Flucytosine Imp. A (EP); Flucytosine Impurity A|Adrucil (ICN)|2794-13-0|Adrucil (Fluorouracil)|Fluorouracil [USAN:USP:INN:BAN:JAN]|Spectrum_000841|Opera_ID_134|5-Fluorouracil, 99%|Spectrum2_000076|Spectrum3_000434|Spectrum4_000557|Spectrum5_000718|WLN: T6MVMVJ EF|FLUOROURACIL [MI]|Lopac-F-6627|F0151|5-Fluorouracil (5-FU)|FLUOROURACIL [INN]|FLUOROURACIL [JAN]|5-Fluorouracil (Standard)|UPCMLD-DP130|EC 200-085-6|F 6627|FLUOROURACIL [HSDB]|FLUOROURACIL [USAN]|SCHEMBL3646|5-fluorpyrimidin-2,4-diol|FLUOROURACIL [VANDF]|Folfox component fluorouracil|Lopac0_000536|BSPBio_002048|FLUOROURACIL [MART.]|KBioGR_001253|KBioSS_001321|2(1H)-Pyrimidinone, 5-fluoro-4-hydroxy- (9CI)|4(3H)-Pyrimidinone, 5-fluoro-2-hydroxy- (9CI)|MLS002415705|DivK1c_000054|FLUOROURACIL [USP-RS]|FLUOROURACIL [WHO-DD]|FLUOROURACIL [WHO-IP]|SCHEMBL592897|SPECTRUM1500305|SPBio_000291|5-FLUOROURACIL [IARC]|5-fluoro-2,4-dioxo-pyrimidin|5-fluoro-pyrimidine-2,4-diol|GTPL4789|orb1310103|SCHEMBL2733944|SCHEMBL8012255|SCHEMBL10746579|UPCMLD-DP130:001|Fluorouracil (JP18/USP/INN)|HMS500C16|KBio1_000054|KBio2_001321|KBio2_003889|KBio2_006457|KBio3_001268|5-Fluoro-2,3H)-pyrimidinedione|5-FLUOROURACIL [WHO-IP]|2,4-Pyrimidinedione, 5-fluoro-|NINDS_000054|BCPP000428|FLUOROURACIL [ORANGE BOOK]|HMS1920O18|HMS2090I04|HMS2091F19|HMS3259O03|HMS3261L13|HMS3654K22|HMS3715H03|HMS3865L03|HMS5079C17|Pharmakon1600-01500305|FLUOROURACIL [EP MONOGRAPH]|5-Fluorouracil, analytical standard|BCP02083|MSK10715|TCA94195|2,3H)-Pyrimidinedione, 5-fluoro-|5-Fluorouracil - Bio-X trade mark|Fluorouracil (5-Fluoracil, 5-FU)|Fluorouracil (5-Fluoracil; 5-FU)|FLUOROURACIL [USP MONOGRAPH]|Tox21_110150|Tox21_202335|Tox21_300112|Tox21_500536|BDBM50340677|CCG-39879|DL-399|HY-90006R|NSC757036|NSC816997|s1209|SBB085751|STK297802|STL367375|FLUOROURACILUM [WHO-IP LATIN]|AKOS000119162|AKOS003237897|AKOS008044307|Tox21_110150_1|BCP9000239|CS-0993|DB00544|FF05372|KS-5129|LP00536|NC00454|NSC-757036|NSC-816997|SDCCGSBI-0050519.P005|FLUCYTOSINE IMPURITY A [WHO-IP]|IDI1_000054|NCGC00015442-01|NCGC00015442-03|NCGC00015442-04|NCGC00015442-05|NCGC00015442-06|NCGC00015442-07|NCGC00015442-08|NCGC00015442-09|NCGC00015442-10|NCGC00015442-11|NCGC00015442-12|NCGC00015442-15|NCGC00015442-16|NCGC00015442-24|NCGC00015442-30|NCGC00091349-01|NCGC00091349-02|NCGC00091349-03|NCGC00091349-04|NCGC00091349-05|NCGC00091349-07|NCGC00091349-08|NCGC00254023-01|NCGC00259884-01|NCGC00261221-01|AC-11201|BF166014|EMTRICITABINE IMPURITY F [WHO-IP]|HY-90006|NCI60_001652|SRI-10792-04|SRI-10792-05|SRI-10792-06|SRI-10792_07|SRI-10792_08|5-Fluoro-1H-pyrimidine-2,4-dione(5FU)|5-Fluorouracil, >=99% (HPLC), powder|SBI-0050519.P004|2(1H)-Pyrimidinone, 5-fluoro-4-hydroxy-|4(3H)-Pyrimidinone, 5-fluoro-2-hydroxy-|5-Fluoro-1H-pyrimidine-2,4-dione(5-FU)|DB-051923|DB-065735|DB-268958|DB-272209|DB-297613|pyrimidine-2,4(1H,3H)-dione, 5-fluoro-|5-Fluoro-1H-pyrimidine-2,4-dione (5-FU)|EU-0100536|FLUCYTOSINE IMPURITY A [EP IMPURITY]|NS00000337|ST45025877|SW199617-3|5-Fluoro-1H-pyrimidine-2,4-dione(5-FUra)|EN300-33909|Fluorouracil, meets USP testing specifications|51F218|C07649|D00584|5-Fluorouracil, Vetec(TM) reagent grade, >=99%|F003241|Q238512|W-60379|(5-fluorouracil)5-Fluoro-1H-pyrimidine-2,4-dione|5-Fluoro-1H-pyrimidine-2,4-dione(5-fluoro uracil)|SR-01000075881-1|SR-01000075881-3|SR-01000075881-5|5-Fluoro-1H-pyrimidine-2,4-dione (5-Fluorouracil)|BRD-K24844714-001-02-1|BRD-K24844714-001-24-5|BRD-K24844714-001-25-2|5-FLUOROPYRIMIDIN-2,4(1H,3H)-DIONE [WHO-IP]|Z275128052|5-Fluoro-1H-pyrimidine-2,4-dione(5-fluorouracil)(5-FU)|5-Fluorouracil, certified reference material, TraceCERT(R)|Fluorouracil, British Pharmacopoeia (BP) Reference Standard|Fluorouracil, European Pharmacopoeia (EP) Reference Standard|Fluorouracil, United States Pharmacopeia (USP) Reference Standard|pyrimidine antimetabolite: inhibits nucleic acid replication; tetratogen|2,4-Dihydroxy-5-fluoropyrimidine;5-FU;5-Fluoro-2,4(1H,3H)-pyrimidinedione|5FU;5-FU;2,4-Dihydroxy-5-fluoropyrimidine;5-Fluoro-2,4(1H,3H)-pyrimidinedione|Fluorouracil, Pharmaceutical Secondary Standard; Certified Reference Material|InChI=1/C4H3FN2O2/c5-2-1-6-4(9)7-3(2)8/h1H,(H2,6,7,8,9"
LOSMAPIMOD,11552706,,"InChI=1S/C22H26FN3O2/c1-13-17(9-15(10-18(13)23)21(28)26-16-6-7-16)19-8-5-14(11-24-19)20(27)25-12-22(2,3)4/h5,8-11,16H,6-7,12H2,1-4H3,(H,25,27)(H,26,28)",KKYABQBFGDZVNQ-UHFFFAOYSA-N,C22H26FN3O2,383.5,"6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide","Losmapimod|585543-15-3|GSK-AHAB|GW856553X|GW856553|GSKAHAB|losmapimodum|FTX1821|F2DQF16BXE|6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide|GW-856553X|FTX-1821|DTXSID30974109|6-(5-((CYCLOPROPYLAMINO)CARBONYL)-3-FLUORO-2-METHYLPHENYL)-N-(2,2-DIMETHYLPROPYL)-3-PYRIDINECARBOXAMIDE|3-PYRIDINECARBOXAMIDE, 6-(5-((CYCLOPROPYLAMINO)CARBONYL)-3-FLUORO-2-METHYLPHENYL)-N-(2,2-DIMETHYLPROPYL)-|3-pyridinecarboxamide, 6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-|6-(5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl)-N-(2,2-dimethylpropyl)pyridine-3-carboxamide|6-[5-[(cyclopropylamino)carbonyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide|RefChem:800053|DTXCID701401545|Losmapimod (GW856553X)|GW-856553|MFCD16619322|C22H26FN3O2|6-(5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl)-N-neopentylnicotinamide|GW 856553X|SB 856553|GSK-AHAB;GW856553X;SB856553|6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)nicotinamide|6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide.|Losmapimod [USAN:INN]|UNII-F2DQF16BXE|Losmapimod?|6-[5-(Cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-neopentylnicotinamide|GW 856553|LOSMAPIMOD [INN]|Losmapimod (USAN/INN)|LOSMAPIMOD [USAN]|Losmapimod,gw-856553|LOSMAPIMOD [WHO-DD]|6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methyl-phenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide|GTPL7835|orb1305817|SCHEMBL1070401|CHEMBL1088752|SCHEMBL29367949|SCHEMBL29888732|EX-A486|CHEBI:131167|KKYABQBFGDZVNQ-UHFFFAOYSA-N|HMS3653G19|HMS3673K13|losmapimod  pound>>GW-856553|BCP09909|FTX 1821|BDBM50418610|NSC785336|NSC800785|s7215|AKOS015994587|CCG-268442|CS-3235|DB12270|GE-0056|NSC-785336|NSC-800785|SB16761|NCGC00386332-03|NCGC00481552-01|AC-35781|DA-33431|GS856553|HY-10402|SB856553|SY358295|NS00072158|SW219307-1|D09639|543C153|Q6683687|BRD-K56195681-001-01-0|6-(5-cyclopropylcarbamoyl-3-fluoro-2-methyl-phenyl)-N-(2,2-dimethylpropyl)-nicotinamide|6-[5-[(cyclopropylamino)-oxomethyl]-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)-3-pyridinecarboxamide"
PH-797804,22049997,,"InChI=1S/C22H19BrF2N2O3/c1-12-4-5-14(21(28)26-3)9-18(12)27-13(2)8-19(20(23)22(27)29)30-11-15-6-7-16(24)10-17(15)25/h4-10H,11H2,1-3H3,(H,26,28)",KCAJXIDMCNPGHZ-UHFFFAOYSA-N,C22H19BrF2N2O3,477.3,"3-[3-bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxopyridin-1-yl]-N,4-dimethylbenzamide","PH-797804|586379-66-0|PH 797804|PH797804|PHA-797804|3-[3-bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxopyridin-1-yl]-N,4-dimethylbenzamide|CHEBI:82715|SI09I1V827|DTXSID70207342|3-Bromo-4-((2,4-difluorobenzyl)oxy)-1-(5-((methylamino)carbonyl)-2-methylphenyl)-6-methylpyridin-2(1H)-one|Benzamide, 3-(3-bromo-4-((2,4-difluorophenyl)methoxy)-6-methyl-2-oxo-1(2H)-pyridinyl)-N,4-dimethyl-|3-{3-bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxopyridin-1-yl}-N,4-dimethylbenzamide|3-(3-bromo-4-((2,4-difluorophenyl)methoxy)-6-methyl-2-oxopyridin-1-yl)-N,4-dimethylbenzamide|3-Bromo-4-[(2,4-difluorobenzyl)oxy]-1-[5-[(methylamino)carbonyl]-2-methylphenyl]-6-methylpyridin-2(1H)-one|RefChem:860493|DTXCID70129833|110-020-2|3-(3-bromo-4-((2,4-difluorophenyl)methoxy)-6-methyl-2-oxo-1,2-dihydropyridin-1-yl)-N,4-dimethylbenzamide|3-(3-Bromo-4-((2,4-difluorobenzyl)oxy)-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide|1358027-80-1|GEL7GRJ3R6|CHEMBL1088751|3-{3-Bromo-4-[(2,4-Difluorobenzyl)oxy]-6-Methyl-2-Oxopyridin-1(2h)-Yl}-N,4-Dimethylbenzamide|(S)-(-)-PH-797804|3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide|3-(3-bromo-4-(2,4-difluorobenzyloxy)-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide|(3S)-3-(3-Bromo-4-((2,4-difluorophenyl)methoxy)-6-methyl-2-oxo-1(2H)-pyridinyl)-N,4-dimethylbenzamide|1073667-47-6|Benzamide, 3-(3-bromo-4-((2,4-difluorophenyl)methoxy)-6-methyl-2-oxo-1(2H)-pyridinyl)-N,4-dimethyl-, (3S)-|C22H19BrF2N2O3|UNII-SI09I1V827|3hll|KCAJXIDMCNPGHZ-UHFFFAOYSA-N|Kinome_3761|UNII-GEL7GRJ3R6|MLS006011016|rac-PH 797804|GTPL7818|orb1306903|orb2283348|SCHEMBL2015676|SCHEMBL29351545|SCHEMBL29527304|BCPP000113|HMS3656N17|HMS3674G03|BCP02266|EX-A2344|IEC02780|BDBM50314073|NSC785338|NSC800850|s2726|AKOS016007727|CCG-264986|CS-0465|DB07941|NSC-785338|NSC-800850|SB16637|SDCCGSBI-0654436.P001|NCGC00263165-01|NCGC00263165-02|DA-66648|FP103244|HY-10403|MS-28852|SMR004702814|NS00071024|PH-797804?|SW219277-1|E98914|PH-797804, (AXIAL S)-(-)-|PH-797804, >=98% (HPLC)|(+/-)-PH 797804|PH-797804 (S)-(-)-|PH-797804, (-)-|BRD-K95880107-001-02-4|Q27088355|(-)3-(4-(2,4-difluorobenzyloxy)-3-bromo-6-methyl-2-oxopyridin-1(2H)-yl)-N,4-dimethylbenzamide|3-[3-bromo-4-[(2,4-difluorophenyl)methoxy]-6-methyl-2-oxo-1-pyridyl]-N,4-dimethyl-benzamide|I45"
RELUGOLIX,10348973,,"InChI=1S/C29H27F2N7O5S/c1-36(2)14-19-24-26(39)38(22-12-13-23(42-3)34-33-22)29(41)37(15-18-20(30)6-5-7-21(18)31)27(24)44-25(19)16-8-10-17(11-9-16)32-28(40)35-43-4/h5-13H,14-15H2,1-4H3,(H2,32,35,40)",AOMXMOCNKJTRQP-UHFFFAOYSA-N,C29H27F2N7O5S,623.6,"1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea","Relugolix|737789-87-6|TAK-385|Orgovyx|TAK 385|TAK385|P76B05O5V6|DTXSID40224167|MYFEMBREE COMPONENT RELUGOLIX|N-(4-(1-((2,6-Difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxyurea|Urea, N-(4-(1-((2,6-difluorophenyl)methyl)-5-((dimethylamino)methyl)-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno(2,3-d)pyrimidin-6-yl)phenyl)-N'-methoxy-|relugolixum|1-(4-(1-((2,6-difluorophenyl)methyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1H,2H,3H,4H-thieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea|1-(4-(1-((2,6-difluorophenyl)methyl)-5-(dimethylaminomethyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno(4,5-e)pyrimidin-6-yl)phenyl)-3-methoxyurea|1-(4-{1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1H,2H,3H,4H-thieno[2,3-d]pyrimidin-6-yl}phenyl)-3-methoxyurea|1-[4-[1-[(2,6-difluorophenyl)methyl]-5-(dimethylaminomethyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[4,5-e]pyrimidin-6-yl]phenyl]-3-methoxyurea|Urea, N-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N'-methoxy-|RefChem:57784|DTXCID40146658|1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl)phenyl)-3-methoxyurea|C29H27F2N7O5S|CHEMBL1800159|1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea|Relugolix [USAN:INN]|UNII-P76B05O5V6|TAK-385/TAK385|Orgovyx (TN)|MFCD25976856|Relugolix (Standard)|RELUGOLIX [INN]|RELUGOLIX [JAN]|Relugolix(TAK-385)|RELUGOLIX [USAN]|Relugolix(TAK-385)?|RELUGOLIX [WHO-DD]|Relugolix (JAN/USAN/INN)|SCHEMBL778416|GTPL5586|orb1303979|RELUGOLIX [ORANGE BOOK]|SCHEMBL29386968|AOMXMOCNKJTRQP-UHFFFAOYSA-N|GLXC-10592|HMS5085J09|BCP21587|EX-A1083|TAK-385; RVT-601|BDBM50347982|HY-16474R|s5808|AKOS027440398|CS-5917|DB11853|SB16721|AC-35863|BP-44043|BS-18032|HY-16474|NS00072569|D10888|EN300-19854622|Ryeqo (relugolix-estradiol-norethisterone acetate)|Q21099000|1-(4-{1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl}phenyl)-3-methoxyurea|1-[4-[1-[(2,6-difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-thieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxy-urea|1-{4-[1-(2,6-difluorobenzyl)-5-dimethylaminomethyl-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno[2,3-d]pyrimidin-6-yl]phenyl}-3-methoxyurea|N-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-1,2,3,4-tetrahydro-3-(6-methoxy-3-pyridazinyl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-N'-methoxyurea; 1-[4-[1-[(2,6-Difluorophenyl)methyl]-5-[(dimethylamino)methyl]-3-(6-methoxypyridazin-3-yl)-2,4-dioxothieno[2,3-d]pyrimidin-6-yl]phenyl]-3-methoxyurea; Orgovyx; RVT 601; TAK 385"
OSI-7904,135403832,,"InChI=1S/C27H24N4O6/c1-14-29-21-7-4-16-3-2-15(10-20(16)24(21)25(34)30-14)12-28-18-5-6-19-17(11-18)13-31(26(19)35)22(27(36)37)8-9-23(32)33/h2-7,10-11,22,28H,8-9,12-13H2,1H3,(H,32,33)(H,36,37)(H,29,30,34)/t22-/m0/s1",BRVFNEZMTRVUGW-QFIPXVFZSA-N,C27H24N4O6,500.5,(2S)-2-[6-[(3-methyl-1-oxo-2H-benzo[f]quinazolin-9-yl)methylamino]-3-oxo-1H-isoindol-2-yl]pentanedioic acid,"OSI-7904L|OSI 7904L|osi-7904|ON177ZCE7M|Gw-1843|Osi 7904|BW1843|GS7904|BW-1843|GS7904L|RefChem:856965|Liposome-encapsulated OSI-7904|139987-54-5|TCMDC-131928|S)-2-(5(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLIN-9-YL)METHYL)AMINO)1-OXO-2-ISOINDOLINYL)GLUTARIC ACID|OSI-7904L free acid|(S)-2-(5-(((3-Methyl-1-oxo-1,2-dihydrobenzo[f]quinazolin-9-yl)methyl)amino)-1-oxoisoindolin-2-yl)pentanedioic acid|CHEMBL169896|(2S)-2-[6-[(3-methyl-1-oxo-2H-benzo[f]quinazolin-9-yl)methylamino]-3-oxo-1H-isoindol-2-yl]pentanedioic acid|(2S)-2-[5-[[(1,2-Dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl]amino]-1,3-dihydro-1-oxo-2H-isoindol-2-yl]pentanedioic acid|F89|UNII-ON177ZCE7M|1843U|MFCD00871785|2-(5-(((1,2-Dihydro-3-methyl-1-oxobenzo(f)quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid|gw1843u89|orb1702994|SCHEMBL1649579|SCHEMBL2195534|SCHEMBL6064518|SCHEMBL29389995|SCHEMBL29692303|SCHEMBL29692323|DTXSID70930683|1f28|BRVFNEZMTRVUGW-QFIPXVFZSA-N|OSI 7904 [WHO-DD]|OSI 7904L [WHO-DD]|BDBM50040861|EX-A12256|AKOS025290741|AKOS040746187|GS-7904|(2s)-2-(5-{[(3-methyl-1-oxo-1,2-dihydrobenzo[f]quinazolin-9-yl)methyl]amino}-1-oxo-1,3-dihydro-2h-isoindol-2-yl)pentanedioic acid|(S)-2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLIN-9-YL)METHYL)AMINO)1-OXO-2-ISOINDOLINYL)GLUTARIC ACID|AS-50416|HY-10823|P10154|Q27285738|(2S)-2-[6-[(3-methyl-1-oxo-4H-benzo[f]quinazolin-9-yl)methylamino]-3-oxo-1H-isoindol-2-yl]pentanedioic acid|(S)-2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl) glutaric acid|(S)-2-(5-(((1,2-dihydro-3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl)amino)-1-oxo-2-isoindolinyl)glutaric acid|(s)-2-(5-(((1,2-dihydro3-methyl-1-oxobenzo[f]quinazolin-9-yl)methyl)ami-no)-1-oxo-2-isoindolinyl)glutaric acid|(S)-2-(5-(((3-Methyl-1-oxo-1,2-dihydrobenzo[f]quinazolin-9-yl)methyl)amino)-1-oxoisoindolin-2-yl)pentanedioicacid|(S)-2-{5-[(3-Methyl-1-oxo-1,2-dihydro-benzo[f]quinazolin-9-ylmethyl)-amino]-1-oxo-1,3-dihydro-isoindol-2-yl}-pentanedioic acid|PENTANEDIOIC ACID, 2-(5-(((1,2-DIHYDRO-3-METHYL-1-OXOBENZO(F)QUINAZOLIN-9-YL)METHYL)AMINO)-1,3-DIHYDRO-1-OXO-2H-ISOINDOL-2-YL)-, (2S)-"
BUPIVACAINE HYDROCHLORIDE,64737,,"InChI=1S/C18H28N2O.ClH/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3;/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21);1H",SIEYLFHKZGLBNX-UHFFFAOYSA-N,C18H29ClN2O,324.9,"1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride","Bupivacaine hydrochloride|18010-40-7|Bupivacaine HCL|Marcaine|Carbostesin|Marcain|Marcaine Spinal|AH-2250|Win 11,318|Bupivacaine hydrochloride anhydrous|Bupivacaine hydrochloride kit|LAC-43|Xaracoll|NSC-758631|AKA908P8J1|CHEBI:31322|Bupivacaini hydrochloridum|bupivacaine hydrochloride (anhydrous)|1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide monohydrochloride|DTXSID0030877|WIN-11318|CHEBI:60789|Marcaine hydrochloride|Bupivac hcl|Sensorcaine Mpf|Bupivacine HCl|Marvona SUIK|Bupivacaine Spinal|Burapren 0.5%|Durapren 0.5%|BUPIVACAINE HCI|Burapren 0.75%|Durapren 0.75%|RefChem:570497|BUPIVICAINE HYDROCHLORIDE|0.25% BUPIVACAINE HCl|DTXCID8010877|Bupivacaine Hydrochloride with Dextrose|Marcaine hydrochloride preservative free|Bupivacaine hydrochloride preservative free|BUPIVACAINE HYDROCHLORIDE IN DEXTROSE|BUPIVACAINE HYDROCHLORIDE injection, solution|241-917-8|1-butyl-2',6'-pipecoloxylidide monohydrochloride monohydrate|2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride, monohydrate|7TQO7W3VT8|Bupivacaine hydrochloride monohydrate|14252-80-3|Vivacaine|1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride|Bupivacaine (hydrochloride)|2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, hydrochloride (1:1)|1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride|MFCD00078956|2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride|Bloqueina|Bicain|1-Butyl-N-[2,6-dimethylphenyl]-2-piperidinecarboxamide|15233-43-9|SMR000058218|(+-)-Bupivacaine hydrochloride|Bupivacaine hydrochloride [JAN]|MNarcaine hydrochloride|EINECS 241-917-8|14252-80-3 (HCl)|73360-54-0 (HCl.H2O)|UNII-AKA908P8J1|LAC 43|SR-05000001874|1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide|levobupivacaine hydrochloride (anhydrous)|2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride|SKY 0302|Prestwick_894|2',6'-Pipecoloxylidide, 1-butyl-, monohydrochloride|AH 2250|Marcaine hydrochloride preservation free|bupivacain hydrochloride|Bupivacaine hydrochloride preservation free|Bupivacaine hydrochloride rs|bupivacaine monohydrochloride|Win 11318 HCl|SCHEMBL34374|MLS001361336|MLS002154259|SPECTRUM1503818|HY-B0405AR|orb1311005|CHEMBL1200396|CHEBI:77441|HY-B0405A|GLXC-05132|HMS1568N12|HMS1922I12|HMS5081M05|HMS5082E06|Pharmakon1600-01503818|Bupivacaine hydrochloride (Marcain)|BCP22697|BCP22708|MSK10171|CCG-39367|NSC119660|NSC758631|s2454|BUPIVACAINE HYDROCHLORIDE [MI]|AKOS015889322|BCP9000461|Bupivacaine (hydrochloride) (Standard)|FB63295|FD-0235|NSC 758631|NSC-119660|NCGC00095072-01|NCGC00095072-02|ANHYDROUS BUPIVACAINE HYDROCHLORIDE|BUPIVACAINE HYDROCHLORIDE [WHO-DD]|ST013772|BUPIVACAINE HYDROCHLORIDE, ANHYDROUS|B3925|NS00076151|SW197015-3|52B803|BUPIVACAINE HYDROCHLORIDE [USP IMPURITY]|EN300-387359|SBI-0051846.0001|SR-05000001874-3|Q27888209|1-butyl-2-piperidylformo-2',6'-xylidide hydrochloride|Z2756516835|2-Piperidinecarboxamide,6-dimethylphenyl)-, hydrochloride|1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium chloride|(+/-)-1-BUTYL-2',6'-PIPECOLOXYLIDIDE MONOHYDROCHLORIDE|N-(2,6-dimethylphenyl)(1-butyl(2-piperidyl))carboxamide, chloride|rac-1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium chloride|rac-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride|2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-,monohydrochloride, (+/-)-|2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-,monohydrochloride, (A+/-)-|1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide hydrochloride dl-1-n-Butylpiperidine-2-carboxylic acid 2,6-dimethylanilide hydrochloride|1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide;dl-1-n-Butylpiperidine-2-carboxylic acid 2,6-dimethylanilide hydrochloride;AH  -2250"
LEVOBUPIVACAINE HYDROCHLORIDE,117965,,"InChI=1S/C18H28N2O.ClH/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3;/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21);1H/t16-;/m0./s1",SIEYLFHKZGLBNX-NTISSMGPSA-N,C18H29ClN2O,324.9,"(2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride","Levobupivacaine hydrochloride|27262-48-2|Levobupivacaine HCl|(S)-1-Butyl-2',6'-pipecoloxylidide monohydrochloride|J998RDZ51I|DTXSID9046071|CHEBI:31772|Bupivacaine (-)-form hydrochloride|DTXCID7026071|Levobupivac|RefChem:56705|2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, hydrochloride (1:1), (2S)-|Chirocaine|(S)-(-)-Bupivacaine hydrochloride|Levobupivacaine hydrochloride [USAN]|(S)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride|(S)-Bupivacaine hydrochloride|Levobupivacaine (hydrochloride)|C18H29ClN2O|(2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide hydrochloride|(S)-1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide monohydrochloride|2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-,monohydrochloride, (2S)-|27262-48-2 (HCl)|(2S)-1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide;hydrochloride|Bupicaine hydrochloride (-)|CAS-27262-48-2|NCGC00159482-02|UNII-J998RDZ51I|Popscaine|Chirocaine (TN)|L-Bupivacaine HCl|levobupivacaine hydrochloride (anhydrous)|MFCD01704265|SCHEMBL34174|(-)-Bupivacaine hydrochloride|levobupivacaine monohydrochloride|orb1300653|CHEMBL1200749|HY-B0653A|2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride, (-)-|MR-8-A2|SIEYLFHKZGLBNX-NTISSMGPSA-N|GLXC-05138|LEVOBUPIVACAINE HCL [VANDF]|(-)-(S)-Bupivacaine hydrochloride|MSK14264|Tox21_111706|s4061|AKOS016001444|Tox21_111706_1|(S)-(-)-Bupivacaine monohydrochloride|AC-2097|CCG-267755|CS-4301|2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, monohydrochloride, (2S)-|NCGC00178579-04|AS-15053|DA-64937|FB149833|Levobupivacaine hydrochloride (JAN/USAN)|LEVOBUPIVACAINE HYDROCHLORIDE [JAN]|LEVOBUPIVACAINE HYDROCHLORIDE [MART.]|LEVOBUPIVACAINE HYDROCHLORIDE [WHO-DD]|Levobupivacaine hydrochloride, >=98% (HPLC)|D01287|BUPIVACAINE (-)-FORM HYDROCHLORIDE [MI]|EN300-7387862|(S)-1-butyl-2',6'-pipecoloxylidide hydrochloride|262B482|LEVOBUPIVACAINE HYDROCHLORIDE [ORANGE BOOK]|S-(-)-1-Butyl-2',6'-pipecoloxylidideHydrochloride|Q27114682|(2S)-1-butyl-2-[(2,6-dimethylphenyl)carbamoyl]piperidinium chloride"
AZD-4877,10368812,,"InChI=1S/C28H33N5O2S/c1-18(2)24(32(16-8-15-29)27(34)22-13-11-19(3)12-14-22)25-30-26-23(20(4)31-36-26)28(35)33(25)17-21-9-6-5-7-10-21/h5-7,9-14,18,24H,8,15-17,29H2,1-4H3",SMFXSYMLJDHGIE-UHFFFAOYSA-N,C28H33N5O2S,503.7,"N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide","AZD-4877|AZD4877|1176760-49-8|AZD 4877|19ORU63E06|DTXSID301026070|N-(3-aminopropyl)-4-methyl-N-(2-methyl-1-(3-methyl-4-oxo-5-(phenylmethyl)-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)propyl)benzamide|N-(3-aminopropyl)-4-methyl-N-[2-methyl-1-[3-methyl-4-oxo-5-(phenylmethyl)-[1,2]thiazolo[5,4-d]pyrimidin-6-yl]propyl]benzamide|RefChem:116003|KSP Inhibitor AZD4877|DTXCID701510328|N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-4H,5H-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide|758722-49-5|CHEMBL1829433|N-(3-aminopropyl)-N-[1-(5-benzyl-3-methyl-4-oxo-[1,2]thiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide|N-(3-aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-4,5-dihydroisothiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide|n-(3-aminopropyl)-n-[1-(5-benzyl-3-methyl-4-oxo-4,5-dihydroisothiazolo[5,4-d]pyrimidin-6-yl)-2-methylpropyl]-4-methylbenzamide|UNII-19ORU63E06|cc-722|SMFXSYMLJDHGIE-UHFFFAOYSA-N|N-(3-AMINOPROPYL)-N-(1-(5-BENZYL-3-METHYL-4-OXO-4,5-DIHYDROISOTHIAZOLO(5,4-D)PYRIMIDIN-6-YL)-2-METHYLPROPYL)-4-METHYLBENZAMIDE|SCHEMBL360703|GTPL7708|orb1905811|AZD 4877 [WHO-DD]|BCP07430|EX-A8400|BDBM50353788|DB11671|(+)-N-(3-Aminopropyl)-N-(1-(5-benzyl-3-methyl-4-oxo-(1,2)thiazolo(5,4-d)pyrimidin-6-yl)-2-methylpropyl)-4-methylbenzamide|DA-71197|FA172879|HY-13224|CS-0003184|Q27074751|N-(3-amino-propyl)-N-[-(5-benzyl-3-methyl-4-oxo-4,5-dihydro-isothiazolo[5,4-d]pyrimidin-6-yl)-2-methyl-propyl]-4-methyl-benzamide|N-(3-amino-propyl)-N-[1-(5-benzyl-3-methyl-4-oxo-4,5-dihydro-isothiazolo[5,4-d]pyrimidin-6-yl)-2-methyl-propyl]-4-methyl-benzamide"
FIBOFLAPON,44473151,,"InChI=1S/C38H43N3O4S/c1-8-44-34-18-14-28(22-40-34)27-12-10-26(11-13-27)23-41-32-17-16-30(45-24-29-15-9-25(2)21-39-29)19-31(32)35(46-37(3,4)5)33(41)20-38(6,7)36(42)43/h9-19,21-22H,8,20,23-24H2,1-7H3,(H,42,43)",DFQGDHBGRSTTHX-UHFFFAOYSA-N,C38H43N3O4S,637.8,"3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoic acid","FIBOFLAPON|936350-00-4|GSK2190915|AM803|AM-803|Fiboflapon [USAN:INN]|UNII-Y1NA96IX3T|Y1NA96IX3T|AM 803|Fiboflapon (USAN)|GSK 2190915|FIBOFLAPON [INN]|FIBOFLAPON [USAN]|FIBOFLAPON [WHO-DD]|GSK-2190915|DTXSID20239496|GSK2190915B|1H-Indole-2-propanoic acid, 3-((1,1-dimethylethyl)thio)-1-((4-(6-ethoxy-3-pyridinyl)phenyl)methyl)-alpha,alpha-Dimethyl-5-((5-methyl-2-pyridinyl)methoxy)-|1H-INDOLE-2-PROPANOIC ACID, 3-((1,1-DIMETHYLETHYL)THIO)-1-((4-(6-ETHOXY-3-PYRIDINYL)PHENYL)METHYL)-.ALPHA.,.ALPHA.-DIMETHYL-5-((5-METHYL-2-PYRIDINYL)METHOXY)-|3-(3-(TERT-BUTYLSULFANYL)-1-((4-(6-ETHOXYPYRIDIN-3-YL)PHENYL)METHYL)-5-((5-METHYLPYRIDIN-2-YL)METHOXY)-1H-INDOL-2-YL)-2,2-DIMETHYLPROPANOIC ACID|fiboflaponum|3-[3-(tert-butylsulfanyl)-1-{[4-(6-ethoxypyridin-3-yl)phenyl]methyl}-5-[(5-methylpyridin-2-yl)methoxy]-1H-indol-2-yl]-2,2-dimethylpropanoic acid|RefChem:140378|DTXCID40161987|3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoic acid|CHEMBL1922660|GSK2190915;AM-803|AM-803;Fiboflapon|SCHEMBL11820|orb1709537|SCHEMBL29379276|SCHEMBL29723363|C38H43N3O4S|CHEBI:177852|DFQGDHBGRSTTHX-UHFFFAOYSA-N|GLXC-21004|BCP30434|BDBM50359080|AKOS030527019|CS-3604|DB06346|SB16524|NCGC00485966-01|AC-31716|DA-53730|HY-15874|MS-30897|NS00072919|D10069|F85091|BRD-K15691453-236-01-6|Q27294145|AM-803; AM 803; AM803; GSK2190915;GSK-2190915; GSK 2190915|3-(3-(tert-butylthio)-1-(4-(6-ethoxypyridin-3-yl)benzyl)-5-((5-methylpyridin-2-yl)methoxy)-1H-indol-2-yl)-2,2-dimethylpropanoic acid|3-[3-(tert-butylsulfanyl)-1-[4-(6-ethoxy-pyridin-3-yl)benzyl]-5-(5-methyl-pyridin-2-yl-methoxy)-1H-indol-2-yl]-2,2-dimethyl-propionic acid|3-[3-tert-butylsulanyl-1-[[4-(6-ethoxypyridin-3-yl)phenyl]methyl]-5-[(5-methylpyridin-2-yl)methoxy]indol-2-yl]-2,2-dimethylpropanoic acid|3-[3-tert-butylsulfanyl-1-[[4-(6-ethoxy-3-pyridyl)phenyl]methyl]-5-[(5-methyl-2-pyridyl)methoxy]indol-2-yl]-2,2-dimethyl-propanoic acid"
LEVOSALBUTAMOL,123600,,"InChI=1S/C13H21NO3/c1-13(2,3)14-7-12(17)9-4-5-11(16)10(6-9)8-15/h4-6,12,14-17H,7-8H2,1-3H3/t12-/m0/s1",NDAUXUAQIAJITI-LBPRGKRZSA-N,C13H21NO3,239.31,4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol,"Levalbuterol|Levosalbutamol|34391-04-3|(-)-Salbutamol|(R)-salbutamol|(-)-Albuterol|R-Salbutamol|4-[(1R)-2-(tert-butylamino)-1-hydroxyethyl]-2-(hydroxymethyl)phenol|EDN2NBH5SS|CHEBI:8746|ASF-1096|DTXSID80187964|levosalbutamolum|4-((1R)-2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol|Albuterol (r)-|Levalbuterol Inhalation|RefChem:56698|Hydrochloride, Levalbuterol|Hydrochloride, Levosalbutamol|DTXCID40110455|levalbuterol inhalation 0.31mg/3mL|levalbuterol inhalation 0.63mg/3mL|levalbuterol inhalation 1.25mg/3mL|Levosalbutamol [INN]|(-)-Albuterol sulfate (1|Levosalbutamol (INN)|(R)-albuterol|R-Albuterol|324000-04-6|Salbutamol (hemisulfate)|UNII-EDN2NBH5SS|Levolin|68H|Albuterol (r)-form|CAS-18559-94-9|(R)-Albuterol;(R)-Salbutamol;Levosalbutamol|Tocris-0634|Albuterol (hemisulfate);AH-3365 (hemisulfate)|Lopac-S-5013|Lopac-S-8260|SCHEMBL4003|(-)-alpha(sup 1)-(((1,1-Dimethylethyl)amino)methyl)-4-hydroxy-1,3-benzenedimethanol|CHEMBL1002|LEVALBUTEROL [VANDF]|m-Xylene-alpha,alpha'-diol, alpha(sup 1)-((tert-butylamino)methyl)-4-hydroxy-, (R)-(-)-|BIDD:GT0508|LEVOSALBUTAMOL [MART.]|GTPL9816|LEVOSALBUTAMOL [WHO-DD]|SCHEMBL29361075|ALBUTEROL (R)-FORM [MI]|GLXC-25242|BCP28425|HY-B1675|BBL010806|BDBM50361247|STK618645|(R)-alpha1-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol|AKOS005552518|AC-1542|DB13139|(R)-alpha(sup 1)-((tert-Butylamino)methyl)-4-hydroxy-m-xylene-alpha,alpha'-diol|1,3-Benzenedimethanol, alpha(sup 1)-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, (-)-|1,3-Benzenedimethanol, alpha1-(((1,1-dimethylethyl)amino)methyl)-4-hydroxy-, (alpha1R)-|NCGC00015955-01|NCGC00015955-02|NCGC00015955-03|NCGC00016736-01|NCGC00024698-01|DA-74972|SBI-0206903.P001|CS-0013639|NS00123698|D08124|EN300-1699072|Q408709|BRD-K34469523-003-01-4|BRD-K34469523-003-03-0|F2173-0564|Albuterol; AH-3365; (R)-albuterol; R-albuterol; R albuterol|(R)-4-(2-(tert-butylamino)-1-hydroxyethyl)-2-(hydroxymethyl)phenol|alpha-1-[[(1,1-Dimethylethyl)amino]methyl]-4-hydroxy-1,3-benzenedimethanol|(R)-.ALPHA.(SUP 1)-((TERT-BUTYLAMINO)METHYL)-4-HYDROXY-M-XYLENE-.ALPHA.,.ALPHA.'-DIOL"
VIDUPIPRANT,42641863,,"InChI=1S/C28H27Cl2FN2O6S/c1-28(2,3)32-27(36)17-6-8-23(39-24-14-21(31)18(11-19(24)29)13-26(34)35)22(12-17)33-40(37,38)25-9-7-16(10-20(25)30)15-4-5-15/h6-12,14-15,33H,4-5,13H2,1-3H3,(H,32,36)(H,34,35)",PFWVGKROPKKEDW-UHFFFAOYSA-N,C28H27Cl2FN2O6S,609.5,2-[4-[4-(tert-butylcarbamoyl)-2-[(2-chloro-4-cyclopropylphenyl)sulfonylamino]phenoxy]-5-chloro-2-fluorophenyl]acetic acid,"VIDUPIPRANT|1169483-24-2|AMG 853|AMG-853|AMG853|61OTZ32XNC|DTXSID40151606|2-[4-[4-(tert-butylcarbamoyl)-2-[(2-chloro-4-cyclopropylphenyl)sulfonylamino]phenoxy]-5-chloro-2-fluorophenyl]acetic acid|2-(4-(4-(TERT-BUTYLCARBAMOYL)-2-(2-CHLORO-4-CYCLOPROPYLBENZENESULFONAMIDO)PHENOXY)-5-CHLORO-2-FLUOROPHENYL)ACETIC ACID|vidupiprantum|2-(4-(4-(tert-butylcarbamoyl)-2-((2-chloro-4-cyclopropylphenyl)sulfonylamino)phenoxy)-5-chloro-2-fluorophenyl)acetic acid|RefChem:934025|DTXCID6074097|2-(4-(4-(tert-butylcarbamoyl)-2-(2-chloro-4-cyclopropylphenylsulfonamido)phenoxy)-5-chloro-2-fluorophenyl)acetic acid|AMG 853(AMG853;Vidupiprant)|CHEMBL1951575|2-(4-(4-(tert-butylcarbamoyl)-2-((2-chloro-4-cyclopropylphenyl)sulfonamido)phenoxy)-5-chloro-2-fluorophenyl)acetic acid|Benzeneacetic acid, 5-chloro-4-(2-(((2-chloro-4-cyclopropylphenyl)sulfonyl)amino)-4- (((1,1-dimethylethyl)amino)carbonyl)phenoxy)-2-fluoro-|Benzeneacetic acid, 5-chloro-4-[2-[[(2-chloro-4-cyclopropylphenyl)sulfonyl]amino]-4-[[(1,1-dimethylethyl)amino]carbonyl]phenoxy]-2-fluoro-|Vidupiprant [USAN]|Vidupiprant [USAN:INN]|UNII-61OTZ32XNC|MFCD19443762|VIDUPIPRANT [INN]|Vidupiprant (USAN/INN)|C28H27Cl2FN2O6S|VIDUPIPRANT [WHO-DD]|orb1307616|SCHEMBL4344221|SCHEMBL29357880|SCHEMBL30538028|SCHEMBL31580813|GTPL10169|BCP28132|EX-A6356|UWB48324|BDBM50363928|AKOS027422769|compound 2 [PMID: 24900313]|DB12272|DA-70758|HY-14973|MS-30687|AMG853; AMG 853; AMG-853|CS-0003670|NS00072570|D09990|G14040|Q27263366|(4-(4-(TERT-BUTYLCARBAMOYL)-2-(2-CHLORO-4-CYCLOPROPYLBENZENESULFONAMIDO)PHENOXY)-5-CHLORO-2-FLUOROPHENYL)ACETIC ACID|2-[4-[4-(tert-butylcarbamoyl)-2-[(2-chloro-4-cyclopropyl-phenyl)sulfonylamino]phenoxy]-5-chloro-2-fluoro-phenyl]acetic acid"
AZD5672,16007088,,"InChI=1S/C32H38F2N2O5S2/c1-4-36(32(37)19-23-5-9-29(10-6-23)42(2,38)39)28-13-16-35(17-14-28)18-15-31(25-20-26(33)22-27(34)21-25)24-7-11-30(12-8-24)43(3,40)41/h5-12,20-22,28,31H,4,13-19H2,1-3H3/t31-/m1/s1",SCXSQUUTGCWHFU-WJOKGBTCSA-N,C32H38F2N2O5S2,632.8,"N-[1-[(3R)-3-(3,5-difluorophenyl)-3-(4-methylsulfonylphenyl)propyl]piperidin-4-yl]-N-ethyl-2-(4-methylsulfonylphenyl)acetamide","AZD-5672|780750-65-4|61XQN688TW|Benzeneacetamide, N-(1-((3R)-3-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl)propyl)-4-piperidinyl)-N-ethyl-4-(methylsulfonyl)-|RefChem:116010|N-(1-((3R)-3-(3,5-difluorophenyl)-3-(4-methanesulfonylphenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methanesulfonylphenyl)acetamide|Azd 5672|Azd5672|N-(1-((3R)-3-(3,5-difluorophenyl)-3-(1-methylsulfonylpiperidin-4-yl)propyl)piperidin-4-yl)-N-ethyl-2-(4-methylsulfonylphenyl)acetamide|CHEMBL212689|(R)-N-(1-(3-(3,5-difluorophenyl)-3-(4-(methylsulfonyl)phenyl)propyl)piperidin-4-yl)-N-ethyl-2-(4-(methylsulfonyl)phenyl)acetamide|N-[1-[(3R)-3-(3,5-difluorophenyl)-3-(4-methylsulfonylphenyl)propyl]piperidin-4-yl]-N-ethyl-2-(4-methylsulfonylphenyl)acetamide|UNII-61XQN688TW|orb1304610|SCHEMBL18840905|EX-A5833|AZD-5672?|BDBM50185666|AKOS040750676|DB11804|AC-31377|DA-50857|MS-30870|HY-119101|CS-0068004|NS00072177|G17381|Q27263396|Benzeneacetamide, N-ethyl-4-(methylsulfonyl)-N-[1-[(3S)-3-[4-(methylsulfonyl)phenyl]-3-(3,5-difluorophenyl)propyl]-4-piperidinyl]-|N-[1-[(3R)-3-(3,5-difluorophenyl)-3-(4-methylsulfonylphenyl)propyl]-4-piperidyl]-N-ethyl-2-(4-methylsulfonylphenyl)acetamide"
PYRITHIONE ZINC,26041,,"InChI=1S/2C5H5NOS.Zn/c2*7-6-4-2-1-3-5(6)8;/h2*1-4,8H;/q;;+2/p-2",OTPSWLRZXRHDNX-UHFFFAOYSA-L,C10H8N2O2S2Zn,317.7,zinc;1-oxidopyridin-1-ium-2-thiolate,"Zinc pyrithione|13463-41-7|DTXSID7026314|DTXCID90820451|Zinc pt|Finecide ZPT|Hokucide ZPT|Niccanon SKT|Biocut ZP|Tomicide Z 50|Tomicide ZPT 50|Evafine P 50|2-Mercaptopyridine 1-oxide zinc salt|biokera|shampoo|bis(N-oxopyridine-2-thionato)zinc (II)|Vegetability|Balancing|Chevance|Dandrene|Dandruff|Elementz|Medaclear|Treatment|Vanicream|Walmart|Zolidyne|classic control|DermaZinc|Esika|Zinc 2-pyridinethiol-1-oxide|Australian Gold|Bioxsine Series|Dandruff Detox|Everyday Clean|Facial Fortress|Pyrithion-Zink|Pyrithionr Zinc|Pyrithions Zinc|Pyritione Zinc|Royal Dandruff|Zinc-pyrion|American Crew|Classic Clean|Heb Dandruff|Zinc Therapy|Zoma Shampoo|HairQ|Zinc soap|Clean Apple|Clear Slate|Dandruff Shampoo|Dermaharmony Bar|Four Season|Happy Cappy|Head Remedy|Mens Sport|Pyrithizone Zinc|Zinc pyridine-2-thiol 1-oxide|Dry Scalp|Being Well Body|Blue Cap|Crawford Dandruff|Equaline Dandruff|Vanicream Z-Bar|Zinc 1-hydroxy-2-pyridinethione|Blue Cap Cream|Cyzone Be Sexy|Dry Scalp Care|Lucky Dry Hair|Zinc bis(2-pyridylthio)-N-oxide|Bis(2-pyridinethiol-1-oxide)zinc|pyrithione (base)|AntiDandruffShampoo|Rite Aid Dandruff|LIFECELL Womens|Revlon zp11|DCL Zoma|DG Body|Dry Scalp Dandruff|Esika Men Dandruff|Oily Hair Dandruff|FSB 8332|Pyrithionum zincicum|Halsa anti Dandruff|2 in 1 Dandruff|2-Pyridinethiol-1-oxide, zinc salt|Antidandruff Shampoo|CVS Daily Dandruff|LIFECELL Mens|At One With Nature|HEAD AND SHOULDERS CONDITIONER|Advanced Herbal Care|Aloe Coal 01|ANTIDANDRUFF|Divine Dandrene 1%|Divine Dandrene 2%|FRUITOPIA|Lucky 2in1 Classic|Pyrithione Zinc 1%|REVOX|Epoch Ava Puhi Moni|MOJELIM Dr|Sulfur 8 Aqua Blue|WeCare Anti-Dandruff|Bis(2-pyridylthio)zinc 1,1'-dioxide|Equate Everyday Clean|LEudine Anti-dandruff|Simply Clean Dandruff|DAMOAE THERAPY|PYRITHIONE ZINE|SAFEYWAY CARE|SHIKATRI CLASS|2 in 1 Antidandruff|As I Am|BALLVIC SEBO|CVS Pharmacy Dandruff|REBIRTH HAIR|BLADE HOWL|Pert Plus 2 in 1|pyrithione zinc shampoo|Axe Feeze AntiDandruff|SAFEWAY DANDRUFF|X FOLATE|Everyday Clean Dandruff|Satinique Anti Dandruff|dandruff therapy shampoo|Axe Freeze AntiDandruff|HAIRJOY MSM HAIR|RefChem:55951|Shampoo plus Conditioner|basic essentials dandruff|Control Dandruff Therapy|Pert Plus Dandruff Plus|Axe AntiDandruff Styling|HEAD AND SHOULDER|MEDECEAN SEBORRHEA|DR. SCALP ACTIVE|Everyday Clean 2 in 1|modesa 2 in 1 dandruff|Shelo NABEL Anti Caspa|Daylogic Refresh Dandruff|Dermaharmony Zinc Therapy|Equaline Dandruff Refresh|Royal Dandruff Dry Scalp|Sereve Professional Scalp|Zincon Medicated Dandruff|BROW GROWTH SERUMS|DZUL ANTI-DANDRUFF|Head and Shoulders 2in1|LASH GROWTH SERUMS|MSM HAIR SIGNATURE|Personal CARE Dry Scalp|ZENOTRI Scalp Shampoo.|Balmers Cooling Zone 31|Pyrithione Zinc 0.22%|Dermaharmony Tea Tree Bar|Dermaharmony Unscented Bar|Equate Dry Scalp Dandruff|Aloe Coal 02 Conditioner|BYE-BYE CRADLE CAP|DANDRUFF CONDITIONER|P.O.V. Classic Dandruff|Dermaharmony Bar Peppermint|Dermaharmony Face and Body|Head and Shoulders Coconut|Personal CARE Daily Clean|Daylogic 2 in 1 Dandruff|ion 2 in 1 anti-dandruff|Zinc, bis(1-hydroxy-2(1H)-pyridinethionato)-|Head and Shoulders Grooming|MOISTURIZING DANDRUFF|ZENOTRI Follicle Shampoo.|Classic Control Antidandruff|Daylogic Dry Scalp Dandruff|Dermaharmony Pyrithione Zinc|DG BODY SIMPLY CLEAN|Dry Scalp Care Dandruff MD|SAFEWAY CARE DANDRUFF|Australian Gold Defense Zone|Hair and Scalp anti-dandruff|Marcs Everyday Care Dandruff|RemedyDandruffShampooTreatment|Selsun Blue Itchy Dry Scalp|EQUALINE CLASSIC CLEAN|ESIKA Men Effective Control|GK HAIR ANTI-DANDRUFF|P.O.V. Dry Scalp Dandruff|Suave Men 2 in 1 Dandruff|Sulfur 8 Kids Anti-Dandruff|2 in 1|Advance Techniques Keep Clear|Head and Shoulders Dual Pack|LBEL HOMME ANTIDANDRUFF|2in1 Dandruff and Conditioner|Equate Everyday Clean Dandruff|Halsa Pyrithione Zinc Dandruff|Hyvee Care Dry Scalp Dandruff|Leader Dandruff Everyday Clean|Marcs Dry Scalp Care Dandruff|Mizani Scalp Care Antidandruff|Modesa Dandruff Everyday Clean|Pyrithione Zinc 0.5 Dandruff|Royal Dandruff Dry Scalp Care|CeraVe Anti Dandruff Hydrating|CLASSIC CLEAN 2 IN 1|Daylogic Dandruff Classic Clean|Equaline Dandruff Classic Clean|First Aid Beauty Anti-Dandruff|Head and Shoulders Coconut Kit|Head and Shoulders Green Apple|Head and Shoulders Itchy Scalp|Head and Shoulders Shea Butter|Topcare Everyday Clean Dandruff|Alberto VO5 2 in 1 Dandruff|BLADE HOWL ANTI-DANDRUFF|(T-4)-Bis(1-hydroxy-2(1H)-pyridinethionato-O,S)zinc|Axe Armor AntiDandruff 2 in 1|Biotin H3 Anti-Dandruff Normal|Cremo Anti-Dandruff Fresh blend|Cyzone Trax Coolture Dermo Cool|Dermaharmony 1% Pyrithione Zinc|Doo Gro Anti-Dandruff Vitalizer|Flakes Cedar Mint Anti Dandruff|Head and Shoulders Dual Sachets|Head and Shoulders Ginger 2in1|Head and Shoulders menthol fresh|Head Remedy Dandruff Conditioner|Clear Complete Care AntiDandruff|Head and Shoulders Classic Clean|Head and Shoulders Coconut 2in1|Head and Shoulders Coconut Daily|Head and Shoulders Deep Moisture|Head and Shoulders Scalp Restore|Quality Choice Dandruff 2 in 1|Zinc 1-hydroxypyridine-2-thione|CVS Daily Dandruff Anti-dandruff|D11AX12|Dermaharmony Seborrheic Dermatitis|DG BODY 2 IN 1 CLASSIC|ESIKA MEN MAXIMUM STRENGTH|Head and Shoulders renewing clean|Pyrithione Zinc and Chloroxylenol|SAFEWAY DANDRUFF DRY SCALP|Walgreens Everyday Clean Dandruff|Equate Beauty Color Safe Dandruff|Head and Shoulders Charcoal Daily|Hyvee Care Classic Clean Dandruff|Pert Plus 2 in 1 Anti-Dandruff|Pert Plus for Men Daily Dandruff|Urban Wash Everday Clean Dandruff|CONTROL Dandruff-Free Beard Wash|Dandrene Anti-Dandruff Conditioner|ESIKA Men Multi-Action 2-in-1|Head and Shoulders Dry Scalp Care|TopCare Dry Scalp Gentle Dandruff|TopCare Gentle Dandruff Dry Scalp|XtraCare Anti-Dandruff Conditioner|basic essentials dandruff dry scalp|BEING WELL BODY Dry Scalp Care|Epoch Ava Puhi Moni Anti-Dandruff|Naturaltech Purifying Anti-dandruff|TopCare Beauty Pure Sport Dandruff|Art of Sport Anti Dandruff Compete|Art of Sport Anti Dandruff Victory|As I Am Dry and Itchy Scalp Care|EQUALINE DRY SCALP 2 IN 1|Equate 2 in 1 Dry Scalp Dandruff|Equate Dry Scalp 2 in 1 Dandruff|Esika Men Dandruff Maximum Strength|GLOBAL KERATIN-ANTI-DANDRUFF|Head and Shoulders Lemon Oil 2in1|MEMBERS MARK GENTLE DANDRUFF|P.O.V. Classic 2 in 1 Dandruff|HEAD AND SHOULDERS OLD SPICE|Head and Shoulders Smooth and Silky|Suave Professionals Men AntiDandruff|TopCare 2 in 1 Dandruff Dry Scalp|TopCare 2 in 1 Dry Scalp Dandruff|XtraCare Anti-Dandruff Hair Cleanse|Anti-Dandruff Juniper and Eucalyptus|Clear Men Ocean Mineral AntiDandruff|DG BODY 2 IN 1 GREEN APPLE|Equaline Dandruff Dry Scalp 2 in 1|Equate Everyday Clean 2in1 Dandruff|Equate Green Apple 2 in 1 Dandruff|Kerastase Paris Symbiose Antidandruff|Matrix Biolage ScalpSync Antidandruff|Modesa 2 in 1 Dandruff Green Apple|Nioxin Scalp Recovery Soothing Serum|ALEVAI-STEM CELL ANTI DANDRUFF|Daylogic 2in1 Dandruff Classic Clean|DZUL ANTI-DANDRUFF CONDITIONER|Equate Everyday Clean Gentle Dandruff|HEAD AND SHOULDERS APPLE FRESH|Head and Shoulders Green Apple 2in1|Head and Shoulders Itchy Scalp 2in1|Marcs 2 in 1 Everyday Care Dandruff|REVAGAIN Hair and Scalp revitalizing|SAFEWAY DANDRUFF CLASSIC CLEAN|Salon Designs Everyday Clean Dandruff|Shopko Beauty Everyday Clean Dandruff|Clear Complete Scalp Care Antidandruff|DG BODY 2 IN 1 SIMPLY CLEAN|Equate Classic Spice 2 in 1 Dandruff|Head and Shoulders breakage prevention|OCEAN BREEZE 2 IN 1 DANDRUFF|P.O.V. 2 in 1 Dry Scalp Dandruff|Personal Care Pyrithione Zinc Dandruff|Quality Choice Dandruff Everyday Clean|TopCare 2 in 1 Dandruff Green Apple|Zinc, bis(1-(hydroxy-kappaO)-2(1H)-pyridinethionato-kappaS2)-, (T-4)-|Clear Men Cool Sport Mint AntiDandruff|Clear Men Strong and Full AntiDandruff|D-COL Personal Hygiene Convenience kit|DANDRUFF SHAMPOO AND CONDITIONER|Daylogic 2in1 Dandruff Dry Scalp Care|EQUALINE CLASSIC CLEAN 2 IN 1|HEAD AND SHOULDER MEN OLD SPICE|Head and Shoulders 2in1 Classic Clean|Head and Shoulders Apple Cider Vinegar|Head and Shoulders hair loss prevention|Head and Shoulders Tea Tree Oil 2in1|Head and Shoulders Tea Tree Oil Daily|Just For Men Control GX Anti-Dandruff|OM 1563|Quality Choice Dandruff Dry Scalp Care|SPAI-SONS ALKALINE DRY-DANDRUFF|TopCare Gentle Dandruff Everyday Clean|ALEVAI-ANTI DANDRUFF SCALP SERUM|basic essentials dandruff everyday clean|DG BODY 2 IN 1 DRY SCALP CARE|DOVE MEN PLUS CARE ANTI DANDRUFF|Equate Everyday Clean 2 in 1 Dandruff|HEAD AND SHOULDERS 3 IN 1 MEN|ion 2 in 1 anti-dandruff Anti-dandruff|nioxin PRO CLINICAL SCALP RECOVERY|Oily Hair Dandruff Zerran International|P.O.V. Green Apple 2 in 1 Dandruff|SAFEWAY CARE NORMAL TO OILY HAIR|Sulfur 8 Oil Moisturizer Anti-Dandruff|Axe 2 in 1 Armor AntiDandruff 2 in 1|Clear Men Clean and Refresh AntiDandruff|Daylogic 2 in 1 Dandruff Classic Scent|Head and Shoulders Dry Scalp Care 2in1|Head and Shoulders Supreme Color Protect|Jason Dandruff Relief Treatment 2 in 1|Mane n Tail Daily Control Anti-Dandruff|Rite Aid Dandruff 2 in 1 Classic Clean|SAFEYWAY CARE NORMAL TO OILY HAIR|TopCare 2 in 1 Dandruff Everyday Clean|Topcare 2 in 1 Everyday Clean Dandruff|ACTIIV Remedy Dandruff Shampoo Treatment|Clear 2 in 1 Scalp Comfort AntiDandruff|Head and Shoulders Classic Clean Dandruff|Head and Shoulders Dual Pack Green Apple|Head and Shoulders Hair Thickening System|Head and Shoulders Smooth and Silky 2in1|Nioxin Scalp Recovery Medicating Cleanser|P.O.V. Timeless Spice 2 in 1 Dandruff|Sulfur 8 Light Moisturizer Anti-Dandruff|Vitale Sensitive Scalp Daily Scalp Healer|111MedCo Medicated Bar 2 Pyrithione Zinc|CeraVe Anti-Dandruff Hydrating Conditioner|DANDRUFF SHAMPOO DRY SCALP RECOVERY|Head and Shoulders 2in1 Men Coastal Tide|HEAD AND SHOULDERS RENEWING CLEANSE|Hyvee Care Classic Clean 2 in 1 Dandruff|Marcs Everyday Care Dandruff Anti-Dandruff|My Black is Beautiful Cooling Scalp Serum|Nioxin Scalp Recovery Anti-Dandruff System|Pert Plus 2 in 1 Shampoo and Conditioner|Rite Aid Dandruff 2 in 1 Dry Scalp Care|Suave Men 2 in 1 Pure Power Antidandruff|Sulfur 8 Fresh Anti-Dandruff Moisturizing|TOPCARE GENTLE DANDRUFF GREEN APPLE|Walgreens Dandruff Itchy Dry Scalp Defense|ALEVAI Stem Cell Anti-Dandruff Conditioner|As I Am Dry and Itchy Scalp Care Co Wash|Clear Complete Care Nourishing AntiDandruff|Clear Men Deep Clean Hydration AntiDandruff|Halsa anti Dandruff moisturizes and restores|Head and Shoulders Bare Minimal Ingredients|Head and Shoulders Deep Scalp Cleanse 2in1|Head and Shoulders Moisturizing Avocado Oil|HEAD AND SHOULDERS REFRESHING RELIEF|KeraCare Dry and Itchy Scalp Anti-Dandruff|Shopko Beauty Green Apple 2 in 1 Dandruff|Walgreens Dandruff Plus Conditioner 2 in 1|ADVANCED SEBORRHEIC DERMATITIS THERAPY|ANTI-DANDRUFF SHAMPOO AND CONDITIONER|Bis(1-hydroxy-2-(1H)-pyridinethionato)zinc|Equate Everyday Clean Dandruff Anti-Dandruff|EVERY MAN JACK 2-IN-1 ANTI-DANDRUFF|Head And Shoulders 2 in 1 Smooth and silky|Head and Shoulders 2in1 MenTimber Old Spice|Head and Shoulders Apple Cider Vinegar 2in1|HEAD AND SHOULDERS BREAKEGE PREVENTION|Head and Shoulders Complete Scalp Care 2in1|Head and Shoulders Deep Scalp Cleanse Daily|Head and Shoulders Dry Scalp Care Dual Pack|Head and Shoulders MEN Old Spice Pure Sport|Head and Shoulders Supreme Detox and Hydrate|Leader Dandruff Everyday Clean Anti-Dandruff|Marcs Dry Scalp Care Dandruff Anti-Dandruff|maxxam dermaCare Pre-Shampoo Scalp Treatment|MOISTURIZING DANDRUFF 1% Pyrithione Zinc|SHILLS ACNE Purifying Peel Off Black Mask|Sulfur 8 Five Star Anti-Dandruff Hair Groom|XtraCare 2 in 1 Hair Cleanse and Condition|Advanced Herbal Care for thinning-damaged hair|As I Am Dry and Itchy Scalp Care Conditioner|CLASSIC CLEAN 2 IN 1 FOR NORMAL HAIR|Clear Men 2 in 1 Complete Care AntiDandruff|Clear Men Citrus Fresh Hydration AntiDandruff|DANDRUFF CONDITIONER DRY SCALP RECOVERY|Dermaharmony Pyrithione Zinc with Shea Butter|Equate beauty Color Safe Dandruff Conditioner|Halsa Pyrithione Zinc Dandruff-Dry Scalp Care|Head and Shoulders Deep Scalp Hydration 2in1|Head and Shoulders Deep Scalp Hydration Daily|Head and Shoulders Dual Pack Smooth and Silky|Head and Shoulders Dual Sachets Classic Clean|Head and Shoulders Hair and Scalp Conditioner|Head and Shoulders Supreme Nourish and Smooth|Modesa 2 in 1 Dandruff Almond Oil Dry Scalp|Nioxin Scalp Recovery Moisturizing Conditioner|Panrosa FRESH CLEAN Pyrithione Zinc Dandruff|Shopko Beauty Classic Spice 2 in 1 Dandruff|Sulfur 8 Fresh Anti-Dandruff Oil Moisturizing|American Crew Anti-Dandruff plus Sebum Control|AT ONE WITH NATURE DRY AND ITCHY SCALP|bis((1-oxidopyridin-1-ium-2-yl)sulfanyl)zinc|Head and Shoulders 2in1 MEN Citrus and Cedar|Head and Shoulders 2in1 Men Vanilla and Amber|Head and Shoulders Conditioner Smooth and Silky|Head and Shoulders Supreme Clarify and Volumize|J1002901Jason Dandruff Relief 2in1Treatment|Pyrithione Zinc 0.5 2in1 Dandruff Conditioner|Suave Men Deep Clean Mint Refresh AntiDandruff|Walgreens Everyday Clean Dandruff Anti-Dandruff|basic essentials dandruff (clean and conditioner)|BEING WELL BODY 2in1 Dandruff and Conditioner|DANDRUFF 2 IN 1 SHAMPOO AND CONDITIONER|Equate Dry Scalp 2 in 1 Dandruff Anti-Dandruff|Equate Dry Scalp 2 in 1 Dandruff SH and COND|HEAD AND SHOULDERS 2 IN RENEWING CLEANSE|Head and Shoulders 2in1 MEN Eucalyptus and Neem|Head and Shoulders Classic Clean with Vitamin E|Head and Shoulders Clinical Dry Scalp Rescue Kit|Head and Shoulders Dual Sachets Smooth and Silky|Head and Shoulders Supreme Soothe and Strengthen|Nioxin PRO CLINICAL SCALP RECOVERY purifying|ALEVAI-STEM CELL ANTI-DANDRUFF CONDITIONER|ANTI-DANDRUFF SHAMPOO AND CONDITIONER HOWL|Australian Gold Defense Zone Anti-Dandruff Step 2|Axe Signature Daily Dandruff Defense Anti-Dandruff|CeraVe 2 in 1 Anti-Dandruff Hydrating Conditioner|Clear Complete Scalp Care AntiDandruff Conditioner|Clear Men 2 in 1 Clean and Refresh AntiDandruff|Dial For Men Dandruff Control Hair and Body Wash|Dual Senses Scalp Regulation AntiDandruff Shampoo|Equate Green Apple 2 in 1 Dandruff Anti-Dandruff|Head and Shoulders 2in1 Advanced Scalp Care 2in1|Head and Shoulders Aloe Vera Soothing Relief 2in1|Head and Shoulders Moisturizing Avocado Oil 2in1|J1002902 Jason Dandruff Relief 2in1 Treatment|RAPHE PHARMACEUTIQUE PRO VITAMIN B5 BIOTIN|Sulfur 8 Scalp Therapy Medicated Dandruff Control|Walgreens Dandruff Conditioner 2 in 1 Itchy Scalp|Advance Techniques Keep Clear 2-in-1 Anti-Dandruff|Clear Men 2 in 1 Dry Scalp Hydration AntiDandruff|DANDRUFF SHAMPOO DAILY CLEAN FOR NORMAL HAIR|Dove Dermacare Scalp Coconut Hydration Anti-Dandruff|Dove Dermacare Scalp Invigorating Mint Anti-Dandruff|Dove Dermacare Scalp Pure Daily Care Anti-Dandruff|Equate Everyday Clean 2 in 1 Dandruff SH and COND|ESIKA MEN 2 EN 1 ANTIDANDRUFF MULTI-ACTION|ESIKA Vital With Active Z 2-in-1 Dandruff Control|ETERNAL SPIRIT BEAUTY HAIR PRO ANTI-DANDRUFF|HEAD AND SHOULDERS 2 IN SOFT AND MANAGEABLE|Head and Shoulders Aloe Vera Soothing Relief Daily|Head and Shoulders Royal Oils Daily Moisture Scalp|Head and Shoulders Royal Oils Instant Soothe Scalp|Head and Shoulders Supreme Color Protect Conditioner|LOreal Paris Men Expert Antidandruff Conditioner and|Marcs 2 in 1 Everyday Care Dandruff Anti-Dandruff|Redken 5th Avenue NYC Scalp Relief Dandruff Control|Suave Revitalizing Mint and Eucalyptus AntiDandruff|XtraCare Anti-Dandruff Hair Cleanse for normal hair|Advance Techniques Keep Clear Anti-Dandruff Treatment|Cyzone Be Sexy BS Tech Zinc Pyrithione And Silicones|DESIGN ESSENTIALS PEPPERMINT-ALOE THERAPEUTICS|Equate Everyday Clean 2 in 1 Dandruff Anti-Dandruff|Equate Mens Bold Scent 2 in 1 Dandruff SH and COND|Equate Mens Ultra Sport 2 in 1 Dandruff SH and COND|Equate Soft and Smooth 2 in 1 Dandruff SH and COND|Head and Shoulders Hair Thickening System with Biotin|Head and Shoulders MEN Advanced Series Bourbon 2in1|LOreal Paris Ever Pure Dandruff Scalp Care and Detox|Mizani Scalp Care Conditioner Antidandruff Conditioner|My Black is Beautiful Scalp Care Cooling Scalp Serum|Royal Oils by Head and Shoulders Scalp Care Dual Pack|Suave Nourishing Coconut and Shea Butter AntiDandruff|The Original Mane n Tail Daily Control Anti Dandruff|Walgreens Dandruff Plus Conditioner 2 in 1 Dry Scalp|XtraCare Anti-Dandruff Conditioner mint and eucalyptus|XtraCare Anti-Dandruff Hair Cleanse for sensitive hair|DANDRUFF CONDITIONER DAILY CLEAN FOR NORMAL HAIR|Glovers Clinical Care Seborrheic Dermatitis Antidandruff|HEAD AND SHOULDERS 2 IN 1 INSTANT MOISTURIZATION|Head and Shoulders MEN Advanced Series Sandalwood 2in1|Head and Shoulders Men Advanced Series Swagger Old Spice|Head and Shoulders Supreme Detox and Hydrate Conditioner|OCEAN BREEZE 2 IN 1 DANDRUFF SEA MINERAL SCENT|Pert Plus 2 in 1 Shampoo and Conditioner Anti-Dandruff|Walgreens Dandruff Itchy Dry Scalp Defense Anti-dandruff|Walgreens Dandruff Plus Conditioner 2 in 1 Anti-dandruff|XtraCare 2 in 1 Hair Cleanse and Condition Green Apple|XtraCare Anti-Dandruff Hair Cleanse mint and eucalyptus|Australian Gold Metro 365 Medicated 2 in 1 Anti-Dandruff|Dove Dermacare Scalp Dryness and Itch Relief Anti-Dandruff|Dove Dermacare Scalp Pure Daily Care 2 In 1 Anti-Dandruff|Head and Shoulders 2in1 Men Advanced Series Full and Thick|Head and Shoulders Bare Minimal Ingredients Pure Clean 2in1|Head and Shoulders Coconut Daily Hair and Scalp Conditioner|Head and Shoulders Deep Moisture Hair and Scalp Conditioner|Head and Shoulders Hair and Scalp Conditioner Classic Clean|Head and Shoulders Hair and Scalp Conditioner Green Apple|Head and Shoulders MEN Advanced Series Lavender Mint 2in1|Head and Shoulders Men Advanced Series Refreshing Menthol|Head and Shoulders Shea Butter Hair and Scalp Conditioner|Head and Shoulders Supreme Nourish and Smooth Conditioner|Head and Shoulders Supreme Scalp Moisturizer with Hemp Seed|Head and Shoulders Supreme Soothe and Strengthen Conditioner|nioxin PRO CLINICAL SCALP RECOVERY scalp soothing serum|Pert Plus 2 in 1 Shampoo and Conditioner Dry Scalp Care|RAPHE PHARMACEUTIQUE BIOTIN GREEN TEA PRO VITAMIN B5|Royal Oils by Head and Shoulders Sulfate Free Scalp Care|Suave Professionals Men 2 in 1 Classic Clean AntiDandruff|XtraCare 2 in 1 Hair Cleanse and Condition Coconut Water|XtraCare Anti-Dandruff Conditioner Coconut and Shea Butter|XtraCare Anti-Dandruff Hair Cleanse Cocoa and Shea Butter|XtraCare Anti-Dandruff Hair Cleanse Coconut and Shea Butter|Australian Gold Defense Zone Anti-dandruff Leave-in Treatment|Australian Gold Metro 365 Medicated Leave-In Treatment Step 3|DANDRUFF 2 IN 1 SHAMPOO AND CONDITIONER SHINY SMOOTH|Dove Dermacare Scalp Invigorating Mint 2 In 1 Anti-Dandruff|Equate Dry Scalp 2 in 1 Dandruff SH and COND Anti-Dandruff|Head and Shoulders 2in1 Men Advanced Series Swagger Old Spice|Head and Shoulders Bare Minimal Ingredients Itchy Scalp Relief|Head and Shoulders Bare Minimal Ingredients Soothing Hydration|Head and Shoulders Clinical Dandruff Defense Dry Scalp Rescue|Head and Shoulders Dry Scalp Care Hair and Scalp Conditioner|Head and Shoulders Men Advanced Series Refreshing 2in1 Menthol|nioxin PRO CLINICAL SCALP RECOVERY moisturizing conditioner|Suave Invigorating Ocean Minerals and Aloe Vera AntiDandruff|Suave Revitalizing Mint and Eucalyptus AntiDandruff Conditioner|The Original Mane n Tail Daily Control 2 in 1 Anti Dandruff|DANDRUFF 2 IN 1 SHAMPOO AND CONDITIONER DRY SCALP RECOVERY|Dove Dermacare Scalp Coconut Hydration Anti-Dandruff Conditioner|Equate Everyday Clean 2 in 1 Dandruff SH and COND Anti-Dandruff|Equate Mens Bold Scent 2 in 1 Dandruff SH and COND Anti-Dandruff|Equate Mens Ultra Sport 2 in 1 Dandruff SH and COND Anti-Dandruff|Equate Soft and Smooth 2 in 1 Dandruff SH and COND Anti-Dandruff|FAMILY WELLNESS DRY SCALP 2 IN 1 DANDRUFF PLUS CONDITIONER|Head and Shoulders 2in1 Dry Scalp Care with Almond and Coconut Oil|Head and Shoulders 2in1 Men Advanced Series Pure Sport Old Spice|Head and Shoulders White Charcoal Daily Hair and Scalp Conditioner|Mane n Tail Daily Control 2 in 1 Anti Dandruff Shampoo Conditioner|Suave Nourishing Coconut and Shea Butter AntiDandruff Conditioner|Walgreens Dandruff Conditioner 2 in 1 Itchy Scalp Anti-dandruff|Walgreens Dandruff Plus Conditioner 2 in 1 Dry Scalp Anti-dandruff|basic essentials dandruff (clean and conditioner) 2 in 1 everyday clean|DANDRUFF 2 IN 1 SHAMPOO AND CONDITIONER DAILY CLEAN FOR NORMAL HAIR|Dove Dermacare Scalp Dryness and Itch Relief Anti-Dandruff Conditioner|Essentials Scalp Control Anti-Dandruff 2 IN 1 Shampoo plus Conditioner|FAMILY Wellness EVERYDAY CLEAN 2 IN 1 DANDRUFF PLUS CONDITIONER|FAMILY Wellness FRESH and CLEAN DANDRUFF PLUS CONDITIONER 2 IN 1|LANCELL HUITOMO HAIR LOSS PREVENTION HAIR GROWER CLEAN FORMULA|DANDRUFF SHAMPOO AND CONDITIONER WITH CUCUMBER AND LEMONGRASS EXTRACTS|Essentials Scalp Control Deep Clean with Invigorating Mint Anti-Dandruff Shampoo|FAMILY WELLNESS DRY SCALP 2 IN 1 DANDRUFF PLUS CONDITIONER Anti-Dandruff|FAMILY Wellness EVERYDAY CLEAN 2 IN 1 DANDRUFF PLUS CONDITIONER Anti-Dandruff|FAMILY Wellness FRESH and CLEAN DANDRUFF PLUS CONDITIONER 2 IN 1 Anti-Dandruff|Royal Oils by head and shoulders Moisture Renewal Scalp Balancing Conditioner|236-671-3|Bis(1-hydroxy-2(1H)-pyridinethionato)zinc|Breck One Dandruff Shampoo|CHEBI:32076|Clear|Head & Shoulders Conditioner|Head And Shoulders|NSC-290409|NSC290409|Omadine Zinc|piritiona cincica|Pyrithione Zinc|Pyrithione zinc derivative|Pyrithione zincique|R953O2RHZ5|Sebulon shampoo|Top Brass|Vancide P|Vancide ZP|Wella Crisan|zinc 1-oxidopyridine-2-thione|Zinc 2-mercaptopyridine N-oxide|Zinc 2-pyridinethiol 1-oxide|Zinc Omadine|Zinc pyrethion|Zinc pyridine-2-thiol-1-oxide|Zinc pyridinethione|Zinc pyrithone|Zinc, bis(1-hydroxy-2(1H)-pyridinethionato-O,S)-(T-4)-|Zinc, bis(2-pyridinylthio)-, N,N'-dioxide|Zinc, bis(2-pyridylthio)-, 1,1'-dioxide|Zinc, bis(2-pyridylthio)-, N,N'-Dioxide|zinc-2-pyridinethione-1-oxide|ZnPT|Bis((1-oxidopyridin-2-yl)thio)zinc|zinc;1-oxidopyridin-1-ium-2-thiolate|NCGC00091933-01|NCGC00183121-01|zinc bis(2-thioxopyridin-1(2H)-olate)|1698050-37-1|CAS-13463-41-7|MFCD00067336|Zinc Pyrithione Powder|SCHEMBL959712|jm5b01461, Compound 171|BDBM429354|Mercaptopyridine N-oxide zinc salt|MSK10354|Tox21_111182|Tox21_113399|Tox21_202180|Tox21_303205|AKOS040732194|NCGC00183121-02|NCGC00257089-01|NCGC00259729-01|AC-19442|F16428"
CEP-11981,11751922,,"InChI=1S/C28H27N7O/c1-15(2)13-35-22-8-5-16(32-28-29-9-4-10-30-28)11-18(22)24-19-12-31-27(36)25(19)23-17(26(24)35)6-7-21-20(23)14-34(3)33-21/h4-5,8-11,14-15H,6-7,12-13H2,1-3H3,(H,31,36)(H,29,30,32)",AEULIVPVIDOLIN-UHFFFAOYSA-N,C28H27N7O,477.6,"19-methyl-3-(2-methylpropyl)-7-(pyrimidin-2-ylamino)-3,13,19,20-tetrazahexacyclo[14.7.0.02,10.04,9.011,15.017,21]tricosa-1(16),2(10),4(9),5,7,11(15),17,20-octaen-14-one","CEP-11981|856691-93-5|BOL-303213X|J8AY0Z4CBP|CEP11981|CEP 11981|4H-Indazolo(5,4-a)pyrrolo(3,4-C)carbazol-4-one, 2,5,6,11,12,13-hexahydro-2-methyl-11-(2-methylpropyl)-8-(2-pyrimidinylamino)-|DTXSID80234942|RefChem:124347|DTXCID10157433|UNII-J8AY0Z4CBP|CHEMBL2010872|13-ISOBUTYL-4-METHYL-10-(PYRIMIDIN-2-YLAMINO)-4,7,8,13-TETRAHYDRO-1H-INDAZOLO[5,4-A]PYRROLO[3,4-C]CARBAZOL-6(2H)-ONE|19-methyl-3-(2-methylpropyl)-7-(pyrimidin-2-ylamino)-3,13,19,20-tetrazahexacyclo[14.7.0.02,10.04,9.011,15.017,21]tricosa-1(16),2(10),4(9),5,7,11(15),17,20-octaen-14-one|compound 11b [PMID 22148921]|GTPL8189|orb1740941|SCHEMBL2439310|SCHEMBL29354587|GLXC-26217|CEP 11981 [WHO-DD]|EX-A7844|BDBM50379186|CEP-11981?|DA-72081|HY-16135|Q27075849|11-(2-Methylpropyl)-12,13-dihydro-2-methyl-8-(pyrimidin-2-ylamino)-4 H-indazolo [5, 4-a] pyrrolo [3, 4-c] carbazol-4-one"
XL-418,56963011,,"InChI=1S/C26H32BrF3N8O/c1-17-19(31-6-9-36-7-2-3-8-36)14-18(21(39)4-5-26(28,29)30)15-20(17)37-10-12-38(13-11-37)25-22-23(27)34-35-24(22)32-16-33-25/h14-16,31H,2-13H2,1H3,(H,32,33,34,35)",IKBSEBRGSVFUHM-UHFFFAOYSA-N,C26H32BrF3N8O,609.5,"1-[3-[4-(3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]-4,4,4-trifluorobutan-1-one","XL-418|871343-09-8|XL418|OLJ18SRI8A|1-Butanone, 1-(3-(4-(3-bromo-1H-pyrazolo(3,4-d)pyrimidin-4-yl)-1-piperazinyl)-4-methyl-5-((2-(1-pyrrolidinyl)ethyl)amino)phenyl)-4,4,4-trifluoro-|1-Butanone, 1-[3-[4-(3-broMo-1H-pyrazolo[3,4-d]pyriMidin-4-yl)-1-piperazinyl]-4-Methyl-5-[[2-(1-pyrrolidinyl)ethyl]aMino]phenyl]-4,4,4-trifluoro-|RefChem:902365|XL 418|Serine/Threonine Kinase Inhibitor XL418|1056474-52-2|UNII-OLJ18SRI8A|CHEMBL2016893|1-[3-[4-(3-bromo-2H-pyrazolo[3,4-d]pyrimidin-4-yl)piperazin-1-yl]-4-methyl-5-(2-pyrrolidin-1-ylethylamino)phenyl]-4,4,4-trifluorobutan-1-one|orb1741003|SCHEMBL1792761|SCHEMBL18343524|SCHEMBL29371950|IKBSEBRGSVFUHM-UHFFFAOYSA-N|BDBM50380939|Q27285719"
ETHASELEN,10387485,,"InChI=1S/C16H12N2O2Se2/c19-15-11-5-1-3-7-13(11)21-17(15)9-10-18-16(20)12-6-2-4-8-14(12)22-18/h1-8H,9-10H2",SFFSGPCYJCMDJM-UHFFFAOYSA-N,C16H12N2O2Se2,422.2,"2-[2-(3-oxo-1,2-benzoselenazol-2-yl)ethyl]-1,2-benzoselenazol-3-one","ethaselen|217798-39-5|Bbske|Compound eb|Ethaselen-1|Shuang-xi-zuo-wan-1|4Q2EZS1IWG|(1,2-bis(1,2-benzisoselenazolone-3(2H)-ketone))ethane|BBSKE cpd|RefChem:138372|1, 2-(Bis (1, 2-Benzisoselenazolone-3 (2H)-Ketone)) Ethane|2-(2-(3-oxo-2,3-dihydro-1,2-benzoselenazol-2-yl)ethyl)-2,3-dihydro-1,2-benzoselenazol-3-one|CHEMBL2035460|2-[2-(3-oxo-1,2-benzoselenazol-2-yl)ethyl]-1,2-benzoselenazol-3-one|UNII-4Q2EZS1IWG|orb1691145|SCHEMBL3561403|SCHEMBL29391728|EX-A5107|US8592468, EbSe14|BDBM50385303|AKOS040757392|DB15051|DA-73215|HY-116749|CS-0066457|G17158|1,2-Benzisoselenazol-3(2H)-one, 2,2'-(1,2-ethanediyl)bis-|2,2'-(ethane-1,2-diyl)bis(benzo[d][1,2]selenazol-3(2H)-one) .|2,2'-(1,2-ETHANEDIYL)BIS(1,2-BENZISOSELENAZOL-3(2H)-ONE)"
SABIPORIDE,9868115,,"InChI=1S/C18H19F3N6O2/c19-18(20,21)12-10-11(15(28)25-17(22)23)3-4-14(12)26-6-8-27(9-7-26)16(29)13-2-1-5-24-13/h1-5,10,24H,6-9H2,(H4,22,23,25,28)",SRRHGTUDJFMQIV-UHFFFAOYSA-N,C18H19F3N6O2,408.4,N-(diaminomethylidene)-4-[4-(1H-pyrrole-2-carbonyl)piperazin-1-yl]-3-(trifluoromethyl)benzamide,Sabiporide|324758-66-9|sabiporida|U52APA00X7|BIIB722|BIIB-722|SABIPORIDUM|RefChem:180745|Sabiporide [INN]|Sabiporide HCl|BIIB 722CL|UNII-U52APA00X7|BIIB 722|N-(diaminomethylidene)-4-[4-(1H-pyrrole-2-carbonyl)piperazin-1-yl]-3-(trifluoromethyl)benzamide|N-Carbamimidoyl-4-(4-(1H-pyrrol-2-ylcarbonyl)piperazin-1-yl)-3-(trifluoromethyl)benzamide|261505-80-0|SCHEMBL1286662|SCHEMBL1286663|CHEMBL2105423|SCHEMBL29385812|DTXSID00870321|BDBM50396462|Q27290695|4-[4-(2-pyrrolylcarbonyl)-1-piperazinyl]-3-trifluoromethylbenzoylguanidine
PF-04995274,53354764,,"InChI=1S/C23H32N2O6/c26-23(7-12-27-13-8-23)16-25-9-4-17(5-10-25)14-29-22-21-19(30-18-6-11-28-15-18)2-1-3-20(21)31-24-22/h1-3,17-18,26H,4-16H2/t18-/m1/s1",WLLOFQROROXOMO-GOSISDBHSA-N,C23H32N2O6,432.5,"4-[[4-[[4-[(3R)-oxolan-3-yl]oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-yl]methyl]oxan-4-ol","PF-04995274|1331782-27-4|PF 04995274|UNII-XI179PG9LV|4-[[4-[[4-[(3R)-oxolan-3-yl]oxy-1,2-benzoxazol-3-yl]oxymethyl]piperidin-1-yl]methyl]oxan-4-ol|XI179PG9LV|(R)-4-((4-(((4-(Tetrahydrofuran-3-yloxy)-1,2-benzisoxazol-3-yl)oxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol|compound 2d [PMID: 22974325]|PF04995274|compound 2d (PMID: 22974325)|4-((4-(((4-((3R)-oxolan-3-yloxy)-1,2-benzoxazol-3-yl)oxy)methyl)piperidin-1-yl)methyl)oxan-4-ol|4-((4-((4-((3R)-oxolan-3-yl)oxy-1,2-benzoxazol-3-yl)oxymethyl)piperidin-1-yl)methyl)oxan-4-ol|4-({4-[({4-[(3R)-OXOLAN-3-YLOXY]-1,2-BENZOXAZOL-3-YL}OXY)METHYL]PIPERIDIN-1-YL}METHYL)OXAN-4-OL|RefChem:172239|CHEMBL2152922|(R)-4-((4-(((4-((Tetrahydrofuran-3-yl)oxy)benzo[d]isoxazol-3-yl)oxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol|SCHEMBL619629|GTPL9059|orb1307903|SCHEMBL29385310|WLLOFQROROXOMO-GOSISDBHSA-N|EX-A4112|GDC78227|BDBM50398598|MFCD29079009|AKOS040742393|AT25183|DB12675|NCGC00386746-01|AC-30621|DA-76764|HY-18137|MS-27716|CS-0007316|NS00073067|S0496|PF-04995274?|PF-04995274, >=98% (HPLC)|Q27088320|(R)-4((4-((4-(Tetrahydrofuran-3-yloxy)benzo[d]isoxazol-3-yloxy)methyl)piperidin-1-yl)methyl)tetrahydro-2H-pyran-4-ol|4-[[4-[[4-[(3R)-tetrahydrofuran-3-yl]oxy-1,2-benzoxazol-3-yl]oxymethyl]-1-piperidyl]methyl]tetrahydropyran-4-ol"
PF-03382792,71451950,,"InChI=1S/C23H32FN3O4/c1-22(2)18-4-3-17(24)13-19(18)27(20(22)28)21(29)25-14-16-5-9-26(10-6-16)15-23(30)7-11-31-12-8-23/h3-4,13,16,30H,5-12,14-15H2,1-2H3,(H,25,29)",AGMOFKKOVMRGAK-UHFFFAOYSA-N,C23H32FN3O4,433.5,"6-fluoro-N-[[1-[(4-hydroxyoxan-4-yl)methyl]piperidin-4-yl]methyl]-3,3-dimethyl-2-oxoindole-1-carboxamide","PF-03382792|1400811-63-3|UNII-QPE81T4KH0|QPE81T4KH0|1H-Indole-1-carboxamide, 6-fluoro-2,3-dihydro-3,3-dimethyl-2-oxo-N-((1-((tetrahydro-4-hydroxy-2H-pyran-4-yl)methyl)-4-piperidinyl)methyl)-|6-fluoro-N-((1-((4-hydroxyoxan-4-yl)methyl)piperidin-4-yl)methyl)-3,3-dimethyl-2-oxo-2,3-dihydro-1H-indole-1-carboxamide|6-fluoro-n-({1-[(4-hydroxyoxan-4-yl)methyl]piperidin-4-yl}methyl)-3,3-dimethyl-2-oxo-2,3-dihydro-1h-indole-1-carboxamide|RefChem:172223|CHEMBL2179582|orb1695710|BDBM50398588|AKOS040753467|DB12949|HY-18138|CS-0007320|NS00073066|Q27287427|6-fluoro-N-[[1-[(4-hydroxyoxan-4-yl)methyl]piperidin-4-yl]methyl]-3,3-dimethyl-2-oxoindole-1-carboxamide"
PF-03654746,16119086,,"InChI=1S/C18H24F2N2O/c1-2-21-17(23)14-10-18(20,11-14)15-6-5-13(16(19)9-15)12-22-7-3-4-8-22/h5-6,9,14H,2-4,7-8,10-12H2,1H3,(H,21,23)",SXMBKHYDZOCBMT-UHFFFAOYSA-N,C18H24F2N2O,322.4,N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide,"N-ethyl-3-fluoro-3-(3-fluoro-4-(pyrrolidinylmethyl)phenyl)cyclobutanecarboxamide|RefChem:927145|PF-03654746|935840-31-6|PF 03654746|N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide|G3QE979K1X|CHEMBL2151197|(1R,3R)-N-Ethyl-3-fluoro-3-(3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl)cyclobutane-1-carboxamide|rel-(1s,3s)-N-ethyl-3-fluoro-3-(3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl)cyclobutane-1-carboxamide|N-ethyl-3-fluoranyl-3-[3-fluoranyl-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide|UNII-G3QE979K1X|(1R,3R)-N-Ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide|SCHEMBL118134|SCHEMBL118135|GTPL9058|orb1307906|SCHEMBL4947732|SCHEMBL29379548|SXMBKHYDZOCBMT-UHFFFAOYSA-N|DTXSID401029522|GLXC-15613|KMB84031|BDBM50401003|AKOS040742390|compound 6 [PMID: 21928839]|DB12201|NCGC00386988-01|DA-66615|HY-11045|CS-0003013|NS00073172|PF03654746|Q7119047|3-fluoro-3-(3-fluoro-4-pyrrolidin-1-ylmethyl-phenyl)-cyclobutanecarboxylic acid ethylamide|trans-N-Ethyl-3-fluoro-3-[3-fluoro-4-(1-pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide|1IB|CYCLOBUTANECARBOXAMIDE, N-ETHYL-3-FLUORO-3-(3-FLUORO-4-(1-PYRROLIDINYLMETHYL)PHENYL)-, TRANS-"
PF-03654764,16119082,,"InChI=1S/C20H28F2N2O/c1-14(2)12-23-19(25)16-10-20(22,11-16)17-6-5-15(18(21)9-17)13-24-7-3-4-8-24/h5-6,9,14,16H,3-4,7-8,10-13H2,1-2H3,(H,23,25)",DJRDLCHHQYHQQK-UHFFFAOYSA-N,C20H28F2N2O,350.4,3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutane-1-carboxamide,"PF-03654764|H3 receptor antagonist 1|935840-35-0|935840-13-4|UNII-FPI2G03BJ1|FPI2G03BJ1|Cyclobutanecarboxamide, 3-fluoro-3-[3-fluoro-4-(1-pyrrolidinylmethyl)phenyl]-N-(2-methylpropyl)-, trans-|CHEMBL2206292|CYCLOBUTANECARBOXAMIDE, 3-FLUORO-3-(3-FLUORO-4-(1-PYRROLIDINYLMETHYL)PHENYL)-N-(2-METHYLPROPYL)-, TRANS-|orb1688825|orb1709963|SCHEMBL2107401|SCHEMBL2749631|SCHEMBL4546793|SCHEMBL13799445|SCHEMBL29379418|DTXSID401114525|BDBM50401002|EX-A10452|HY-U00269|AKOS040732892|CS-7205|DB12360|DA-63994|DA-76753|MS-25416|HY-123812|CS-0085935|NS00073313|G17400|Q27278116|(1S,3s)-3-fluoro-3-(3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl)-N-isobutylcyclobutane-1-carboxamide|3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-n-(2-methylpropyl)cyclobutane-1-carboxamide|trans-3-Fluoro-3-[3-fluoro-4-(1-pyrrolidinylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide"
EP-0042,71454279,,"InChI=1S/C22H23Cl2N7/c1-14-17(13-29(2)28-14)21-26-19-20(18(24)11-25-22(19)27-21)31-9-7-30(8-10-31)12-15-3-5-16(23)6-4-15/h3-6,11,13H,7-10,12H2,1-2H3,(H,25,26,27)",AKJBLKUZXRMECW-UHFFFAOYSA-N,C22H23Cl2N7,456.4,"6-chloro-7-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-2-(1,3-dimethylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine","6-Chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-3H-imidazo[4,5-b]pyridine|6-chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-3H-imidazo(4,5-b)pyridine|RefChem:913887|CCT241736|1402709-93-6|mobinitinib|CCT-241736|6-chloro-7-[4-[(4-chlorophenyl)methyl]piperazin-1-yl]-2-(1,3-dimethylpyrazol-4-yl)-1H-imidazo[4,5-b]pyridine|MFCD25977004|EP-0042|ZE94SP78UG|CHEMBL2207503|EP0042|6-Chloro-7-(4-(4-chlorobenzyl)piperazin-1-yl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-1H-imidazo[4,5-b]pyridine|3H-Imidazo(4,5-b)pyridine, 6-chloro-7-(4-((4-chlorophenyl)methyl)-1-piperazinyl)-2-(1,3-dimethyl-1H-pyrazol-4-yl)-|3H-Imidazo[4,5-b]pyridine, 6-chloro-7-[4-[(4-chlorophenyl)methyl]-1-piperazinyl]-2-(1,3-dimethyl-1H-pyrazol-4-yl)-|mobinitinib [INN]|UNII-ZE94SP78UG|C22H23Cl2N7|orb1302867|SCHEMBL17092840|SCHEMBL29443433|GTPL13496|AKJBLKUZXRMECW-UHFFFAOYSA-N|BDBM247371|GLXC-21802|BCP29563|CGC70993|EX-A1838|BDBM50401421|AKOS037515587|CCT241736?|AC-36199|DA-72025|HY-18161|MS-28315|SY278823|CCT 241736 pound>>CCT-241736|CS-0007372|G14270|US9447092, 1|6-Chloro-7-[4-(4-chlorobenzyl)-1-piperazinyl]-2-(1,3-dimethyl-4-pyrazolyl)-3H-imidazo[4,5-b]pyridine|6-chloro-7-{4-[(4-chlorophenyl)methyl]piperazin-1-yl}-2-(1,3-dimethyl-1Hpyrazol-4-yl)-3H-imidazo[4,5-b]pyridine"
JNJ-41443532,46208367,,"InChI=1S/C22H25F3N4O3S/c23-22(24,25)15-3-1-2-14(8-15)20(31)27-10-19(30)28-16-11-29(12-16)17-4-6-21(32,7-5-17)18-9-26-13-33-18/h1-3,8-9,13,16-17,32H,4-7,10-12H2,(H,27,31)(H,28,30)",CFKBNYUHQSQBSX-UHFFFAOYSA-N,C22H25F3N4O3S,482.5,"N-[2-[[1-[4-hydroxy-4-(1,3-thiazol-5-yl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide","JNJ-41443532|1228650-83-6|UNII-0OJB0LES1A|CCR2 antagonist 5|0OJB0LES1A|CHEMBL2204263|Benzamide, N-(2-((1-(trans-4-hydroxy-4-(5-thiazolyl)cyclohexyl)-3-azetidinyl)amino)-2-oxoethyl)-3-(trifluoromethyl)|N-[2-[[1-[4-hydroxy-4-(1,3-thiazol-5-yl)cyclohexyl]azetidin-3-yl]amino]-2-oxoethyl]-3-(trifluoromethyl)benzamide|CFKBNYUHQSQBSX-UHFFFAOYSA-N|orb1700276|SCHEMBL2485329|SCHEMBL2485331|SCHEMBL2545786|SCHEMBL13302364|SCHEMBL29420518|CFKBNYUHQSQBSX-CYWCHRQTSA-N|CFKBNYUHQSQBSX-NJSOLPSOSA-O|CFKBNYUHQSQBSX-UEDWGHLCSA-N|GLXC-22596|BDBM50400695|AKOS040748633|DB12632|DA-51679|HY-13499|TS-08557|CS-0007082|Q27237038|N-[2-([1-[4-hydroxy-4-(1,3-thiazol-5-yl)cyclohexyl]-3-azetidinyl]amino)-2-oxoethyl]-3-(trifluoromethyl)benzamide"
OLVEREMBATINIB,51038269,,"InChI=1S/C29H27F3N6O/c1-19-3-5-22(14-21(19)6-4-20-13-24-17-34-36-27(24)33-16-20)28(39)35-25-8-7-23(26(15-25)29(30,31)32)18-38-11-9-37(2)10-12-38/h3,5,7-8,13-17H,9-12,18H2,1-2H3,(H,35,39)(H,33,34,36)",TZKBVRDEOITLRB-UHFFFAOYSA-N,C29H27F3N6O,532.6,"4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide","1257628-77-5|olverembatinib|3-((1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide|HQP1351|4-methyl-N-[4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide|KV1M7Q3CBP|HQP-1351|Benzamide, 4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]-3-[2-(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]-|HQP1351 free base|D-824|HQP-1351 free base|HQP1351 DIMESYLATE|HQP-1351 DIMESYLATE|4-Methyl-N-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1H-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)benzamide|Benzamide, 4-methyl-N-(4-((4-methyl-1-piperazinyl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1H-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)-|3-((1H-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)-4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide|4-methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-(2-(1H-pyrazolo(3,4-b)pyridin-5-yl)ethynyl)benzamide|4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-(2-{1H-pyrazolo[3,4-b]pyridin-5-yl}ethynyl)benzamide|RefChem:168178|Multi-kinase Inhibitor HQP1351|HQP 1351|D824|BCR-ABL/KIT/AKT/ERK Inhibitor HQP1351|GZD824|GZD-824|Olverembatinib [USAN]|MFCD26142930|CHEMBL2316582|GZD 824|4-methyl-N-{4-[(4-methylpiperazin-1-yl)methyl]-3-(trifluoromethyl)phenyl}-3-[(1H-pyrazolo[3,4-b]pyridin-5-yl)ethynyl]benzamide|T3X|UNII-KV1M7Q3CBP|Olverembatinib (Standard)|Olverembatinib (USAN/INN)|OLVEREMBATINIB [INN]|orb1304570|SCHEMBL3424528|OLVEREMBATINIB [WHO-DD]|SCHEMBL29387193|SCHEMBL29514988|GTPL10630|EX-A829|GZD824?|TZKBVRDEOITLRB-UHFFFAOYSA-N|BCP07502|BDBM50425780|HY-15666R|WHO 11221|AKOS026750647|CS-1444|SB16617|compound 10a [PMID: 23301703]|NCGC00351607-04|NCGC00351607-05|NCGC00351607-06|AC-35436|AS-75170|DA-63990|HY-15666|SY311902|C72036|D12175|BRD-K35329391-334-01-7|3-[(1H-Pyrazolo[3,4-b]pyridin-5-yl)ethynyl]-4-methyl-N-[4-[(4-methyl-1-piperazinyl)methyl]-3-(trifluoromethyl)phenyl]benzamide"
IRINOTECAN,60838,,"InChI=1S/C33H38N4O6/c1-3-22-23-16-21(43-32(40)36-14-10-20(11-15-36)35-12-6-5-7-13-35)8-9-27(23)34-29-24(22)18-37-28(29)17-26-25(30(37)38)19-42-31(39)33(26,41)4-2/h8-9,16-17,20,41H,3-7,10-15,18-19H2,1-2H3/t33-/m0/s1",UWKQSNNFCGGAFS-XIFFEERXSA-N,C33H38N4O6,586.7,"[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate","irinotecan|97682-44-5|(+)-Irinotecan|Irinophore C|Irinotecanum|Biotecan|Irinotecan lactone|Irinotecan mylan|HSDB 7607|NSC-728073|CHEBI:80630|camptothecin-11|DTXSID1041051|NSC728073|Irrinotecan|[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-piperidin-1-ylpiperidine-1-carboxylate|[1,4'-Bipiperidine]-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester|((19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo(11.8.0.02,11.04,9.015,20)henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl) 4-piperidin-1-ylpiperidine-1-carboxylate|(1,4'-Bipiperidine)-1'-carboxylic acid, (4S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester|(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo(11.8.0.0^(2,11).0^(4,9).0^(15,20))henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl 4-(piperidin-1-yl)piperidine-1-carboxylate|(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl 4-(piperidin-1-yl)piperidine-1-carboxylate|SN-38-11|RefChem:56366|DTXCID9021051|L01XX19|SN3811|(+)-7-ethyl-10-hydroxycamptothecine 10-(1,4'-bipiperidine)-1'-carboxylate|(+)-(4S)-4,11-diethyl-4-hydroxy-9-((4-piperidino-piperidino)carbonyloxy)-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinol-3,14,(4H,12H)-dione|(1,4'-bipiperidine)-1'-carboxylic acid (S)-4,11-diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester|691-567-9|7-ethyl-10-(4-(1-piperidino)-1-piperidino)carbonyloxycamptothecin|7673326042|Camptothecin 11|NSC616348|Irinotecanum [INN-Latin]|Irinotecan Free base|(S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate|MFCD00866307|Irinotecan (INN)|CHEMBL481|97682-44-5 (Free base)|1,4'-bipiperidine-1'-carboxylic acid (s)-4,11-diethyl-3,4,12,14- tetrahydro-4-hydroxy-3,14-dioxo-1h-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester|IRINOTECAN [INN]|Irinotecan [INN:BAN]|(4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3',4':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4'-BIPIPERIDINE-1'-CARBOXYLATE|1,4'-Bipiperidine-1'-carboxylic acid (S)-4,11-diethyl-3,4,12,14- tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl ester|CPT-11 hydrochloride;Camptothecin 11 hydrochloride|MLS001401366|Biotecan (TN)|SMR000469166|Irinotecan?|Irinotecan (Standard)|(diethyl-hydroxy-dioxo-[?]yl) 4-(1-piperidyl)piperidine-1-carboxylate|UNII-7673326042|IRINOTECAN [MI]|IRINOTECAN [HSDB]|IRINOTECAN [VANDF]|SCHEMBL4034|IRINOTECAN [WHO-DD]|IRINOTECAN; CPT-11|BSPBio_002346|GTPL6823|orb1300959|SCHEMBL29356918|SCHEMBL29367581|BDBM51762|1u65|cid_23581792|(S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3 inverted exclamation mark ,4 inverted exclamation mark :6,7]indolizino[1,2-b]quinolin-9-yl [1,4 inverted exclamation mark -bipiperidine]-1 inverted exclamation mark -carboxylate|BCP02860|ARD162722|BDBM50128267|HY-16562R|MSK162722|s1198|UBI-10002|AKOS015894969|AB07527|AC-7469|BCP9000793|CS-1138|DB00762|FI33814|NSC 728073|NCGC00178697-02|NCGC00178697-05|(1,4'-Bipiperidine)-1'-carboxylic acid, 4,11-diethyl-3,4,12-14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano(3',4':6,7)indolizino(1,2-b)quinolin-9-yl ester, (S)-|(4S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-4,12-dihydro-1H-pyrano[3,4-f]quinolino[2,3-a]indolizin-9-yl 4-piperidylpiperidinecarboxylate|AS-14323|BP-42974|HY-16562|NCI60_005051|SY105303|NS00004943|D08086|EN300-708800|AB00698464-07|AB00698464-09|AB00698464-10|AB00698464-11|AB00698464_12|AB00698464_13|AB00698464_14|682I445|Q412197|BRD-K08547377-001-04-4|BRD-K08547377-003-02-4|BRD-K08547377-003-04-0|BRD-K08547377-003-05-7|BRD-K08547377-003-07-3|BRD-K08547377-394-03-5|2-methoxy-5-[2-(3-sulfophenyl)-5-(4-sulfophenyl)pyrylium-4-yl]benzenesulfonic acid|(19S)-10,19-Diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0[2,11].0[4,9].0[15,20]]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl 4-(piperidin-1-yl)piperidine-1-carboxylate|(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.0^{2,11}.0^{4,9}.0^{15,20}]henicosa-1(21),2(11),3,5,7,9,15(20)-heptaen-7-yl [1,4'-bipiperidine]-1'-carboxylate|(4S)-4,11-DIETHYL-4-HYDROXY-3,14-DIOXO-3,4,12,14-TETRAHYDRO-1H-PYRANO[3'',4'':6,7]INDOLIZINO[1,2-B]QUINOLIN-9-YL 1,4''-BIPIPERIDINE-1''-CARBOXYLATE|(4S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl [1,4'-bipiperidine]-1'-carboxylate|(S)-4,11-Diethyl-3,4,12,14-tetrahydro-4-hydroxy-3,14-dioxo-1H-pyrano[3'',4'':6,7]indolizino[1,2-b]quinolin-9-yl ester|(S)-4,11-diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3',4':6,7]indolizino[1,2-b]quinolin-9-yl[1,4'-bipiperidine]-1'-carboxylate|[(19S)-10,19-diethyl-19-hydroxy-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl] 4-(1-piperidyl)piperidine-1-carboxylate|[1,4'']bipiperidinyl-1''-carboxylic acid (S)-4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester|[1,4'']Bipiperidinyl-1''-carboxylic acid 4,11-diethyl-4-hydroxy-3,13-dioxo-3,4,12,13-tetrahydro-1H-2-oxa-6,12a-diaza-dibenzo[b,h]fluoren-9-yl ester"
NIFEKALANT,4486,,"InChI=1S/C19H27N5O5/c1-21-17(14-18(26)22(2)19(21)27)20-9-11-23(12-13-25)10-3-4-15-5-7-16(8-6-15)24(28)29/h5-8,14,20,25H,3-4,9-13H2,1-2H3",OEBPANQZQGQPHF-UHFFFAOYSA-N,C19H27N5O5,405.4,"6-[2-[2-hydroxyethyl-[3-(4-nitrophenyl)propyl]amino]ethylamino]-1,3-dimethylpyrimidine-2,4-dione","nifekalant|130636-43-0|5VZ7GZM43E|DTXSID7048374|6-((2-((2-Hydroxyethyl)(3-(p-nitrophenyl)propyl)amino)ethyl)amino)-1,3-dimethyluracil|nifekalantum|RefChem:165783|DTXCID3028348|Nifekalant [INN]|CHEMBL360861|6-((2-((2-Hydroxyethyl)(3-(4-nitrophenyl)propyl)amino)ethyl)amino)-1,3-dimethylpyrimidine-2,4(1H,3H)-dione|6-((2-((2-hydroxyethyl)(3-(p-nitrophenyl)propyl)amino)ethyl)amino)-1,3-dimethyl-uracil|NIFEKALANT HYDROCHLORIDE [JAN]|NCGC00164637-01|UNII-5VZ7GZM43E|NIFEKALANT [MI]|NIFEKALANT [WHO-DD]|SCHEMBL157527|orb2663978|CHEBI:94575|OEBPANQZQGQPHF-UHFFFAOYSA-N|HMS2090C07|HMS3715M05|HY-B0772|BDBM50151866|AKOS022180678|CCG-221022|NCGC00164637-04|6-((2-((2-Hydroxyethyl)(3-(4-nitrophenyl)propyl)amino)ethyl)amino)-1,3-dimethyl-2,4(1H,3H)-pyrimidinedione|6-[2-[2-hydroxyethyl-[3-(4-nitrophenyl)propyl]amino]ethylamino]-1,3-dimethylpyrimidine-2,4-dione|DB-041977|NS00125152|H41418|AB00698502-07|AB00698502-09|636N430|Q671772|SR-01000763409|SR-01000763409-3|BRD-K32311154-001-01-0|1,3-dimethyl-6-{2-[N-(2-hydroxyethyl)-3-(4-nitrophenyl)propylamino]-eth-ylamino}-2,4-(1h,3h)-pyrimidinedione|1,3-dimethyl-6-{2-[N-(2-hydroxyethyl)-3-(4-nitrophenyl)propylamino]ethylamino}-2,4(1H,3H)-pyrimidinedione|6-(2-{(2-Hydroxy-ethyl)-[3-(4-nitro-phenyl)-propyl]-amino}-ethylamino)-1,3-dimethyl-1H-pyrimidine-2,4-dione"
PANTOPRAZOLE,4679,,"InChI=1S/C16H15F2N3O4S/c1-23-13-5-6-19-12(14(13)24-2)8-26(22)16-20-10-4-3-9(25-15(17)18)7-11(10)21-16/h3-7,15H,8H2,1-2H3,(H,20,21)",IQPSEEYGBUAQFF-UHFFFAOYSA-N,C16H15F2N3O4S,383.4,"6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole","pantoprazole|102625-70-7|Pantozol|Pantoprazol|Pantoloc|Pantoprazolum|BY-1023|SK&F-96022|SK&F 96022|Altopan|Zovanta|SKF-96022|SK-96022|NSC-759257|6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methylsulfinyl]-1H-benzimidazole|CHEBI:7915|D8TST4O562|1H-Benzimidazole, 5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-|DTXSID4023416|BY1023|DTXCID803416|2-(((3,4-Dimethoxy-2-pyridinyl)methyl)-sulfinyl)-5-methyl-1H-1,3-benzimidazole|6-(difluoromethoxy)-2-[(3,4-dimethoxypyridin-2-yl)methanesulfinyl]-1H-1,3-benzodiazole|1H-Benzimidazole, 5-(difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-|6-(difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methane)sulfinyl)-1H-1,3-benzodiazole|6-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methanesulfinyl)-1H-1,3-benzodiazole|6-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H-benzimidazole|6-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methane]sulfinyl}-1H-1,3-benzodiazole|Protium i.v.|RefChem:6100|A02BC02|SKF96022|SK&F96022|SKF 96022|Protonix|C16H15F2N3O4S|BY 1023|MFCD00870182|(S)-Pantoprazole|Pantoloc Control|CHEMBL1502|5-(Difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridyl)methyl)sulfinyl)benzimidazole|5-(difluoromethoxy)-2-{[(3,4-dimethoxypyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole|NCGC00095188-01|Pantoprazol [INN-Spanish]|Pantoprazolum [INN-Latin]|(+)-(R)-Pantoprazole|6-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole|Panyocid|apo-Pantoprazole|Pantecta Control|5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridyl)methyl]sulfinyl]benzimidazole|CAS-102625-70-7|HSDB 7292|Pantoprazole (USAN/INN)|UNII-D8TST4O562|Pantoprazole [USAN:INN:BAN]|(R)-Pantoprazole|Pantoprazole (Protonix)|Pantoprazole (Standard)|164579-32-2|PANTOPRAZOLE [MI]|PANTOPRAZOLE [INN]|EC 600-331-6|PANTOPRAZOLE [HSDB]|PANTOPRAZOLE [USAN]|PANTOPRAZOLE [VANDF]|SCHEMBL29465|BSPBio_002320|PANTOPRAZOLE [MART.]|MLS003882559|(+/-)-PANTOPRAZOLE|BIDD:GT0003|PANTOPRAZOLE [WHO-DD]|SCHEMBL723548|SPECTRUM1505818|GTPL7260|orb1300338|PANTOPRAZOLE [EMA EPAR]|SCHEMBL29425016|HMS1922H20|HMS2090H03|HMS2093F14|HMS5080A12|Pharmakon1600-01505818|BCP20279|BCP21400|MSK10580|SFA70618|XLB72737|Tox21_111477|AC-679|BDBM50241342|HY-17507R|NSC759257|s2105|STL451032|AKOS015894910|AKOS034831879|Tox21_111477_1|CCG-213558|CCG-268437|CS-3161|DB00213|NSC 759257|SB17368|5-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole|NCGC00095188-02|NCGC00095188-03|NCGC00095188-04|NCGC00095188-05|NCGC00095188-08|NCGC00389443-01|BS-14224|HY-17507|SMR002533625|SY464617|SBI-0206873.P001|NS00000297|P2262|D05353|G60931|AB01275513-01|AB01275513_02|625P707|A901011|EN300-19767202|Q286846|SR-01000763715|SR-01000763715-3|BRD-A22380646-001-01-5|BRD-A22380646-001-02-3|BRD-A22380646-001-05-6|BRD-A22380646-236-05-8|BRD-A22380646-236-06-6|(R)-(+)-Pantoprazole;(+)-(R)-Pantoprazole;Pantoprazole Isomer(R) Impurity|2-(((3,4-DIMETHOXYPYRIDIN-2-YL)METHYL)SULFINYL)-5-DIFLUOROMETHOXY-1H-BENZIMIDAZOLE|5-(difluoromethoxy)-2-(((3,4-dimethoxy-2-pyridinyl)methyl)sulfinyl)-1h-benzimidazole|5-(difluoromethoxy)-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole|5-(Difluoromethoxy)-2-[[(3,4-dimethoxy-2-pyridinyl)-methyl]sulfinyl]-1H-benzimidazole|5-Difluoromethoxy-2-(3,4-dimethoxy-pyridin-2-ylmethanesulfinyl)-1H-benzoimidazole|5-Difluoromethoxy-2-[(3,4-dimethoxy-2-pyridyl)methylsulfinyl]-1H-benzimidazole|6-(Difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole|6-(difluoromethoxy)-2-((3,4-dimethoxypyridin-2-yl)methylsulfinyl)-1H-benzo[d]imidazole|(R)-(+)-Pantoprazole;R-enantiomer of Pantoprazole;(R)-Pantoprazole;5-(Difluoromethoxy)-2-[(R)-[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole ;5-(Difluoromethoxy)-2-[(R)-[(3,4-dimethoxy-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole. - See more at: https://www.clearsynth.com/en/CST38666.html#sthash.yGNPTXpx.dpuf|(R)-6-(Difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole|(S)-6-(Difluoromethoxy)-2-(((3,4-dimethoxypyridin-2-yl)methyl)sulfinyl)-1H-benzo[d]imidazole|1H-BENZIMIDAZOLE, 5-(DIFLUOROMETHOXY)-2-(((3,4-DIMETHOXY-2-PYRIDYL)METHYL)SULFINYL)-|6-(DIFLUOROMETHOXY)-2-(((3,4-DIMETHOXY-2-PYRIDINYL)METHYL)SULFINYL)-1H-BENZIMIDAZOLE"
ITRACONAZOLE,55283,,"InChI=1S/C35H38Cl2N8O4/c1-3-25(2)45-34(46)44(24-40-45)29-7-5-27(6-8-29)41-14-16-42(17-15-41)28-9-11-30(12-10-28)47-19-31-20-48-35(49-31,21-43-23-38-22-39-43)32-13-4-26(36)18-33(32)37/h4-13,18,22-25,31H,3,14-17,19-21H2,1-2H3/t25?,31-,35-/m0/s1",VHVPQPYKVGDNFY-ZPGVKDDISA-N,C35H38Cl2N8O4,705.6,"2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one","itraconazole|84625-61-6|Sporanox|Oriconazole|Itraconazol|Sporonox|Itraconazolum|Sporal|Fungitraxx|Itraconazolo|Sporanos|Candistat|Canditral|Itralek|Sempera|Sporamelt|Traconal|Triasporin|Itrac|Cladosal 100|Spherazole CR|Spherazole IR|2-butan-2-yl-4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-1,2,4-triazol-3-one|DTXSID3023180|NSC-759239|304NUG5GF4|CHEBI:6076|DTXCID903180|R-51211|R51211|Onmel|R 51211|1-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1H-1,2,4-triazol-5-one|3H-1,2,4-Triazol-3-one, 4-(4-(4-(4-((2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-2,4-dihydro-2-(1-methylpropyl)-|R 51,211|Itrafungol|Lozanoc|Sporanox-pulse|Itraconazole Oral|Sporanox i.v.|(+-)-1-sec-Butyl-4-(p-(4-(p-(((2R*,4S*)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)-1-piperazinyl)phenyl)-delta(sup 2)-1,2,4-triazolin-5-one|1-(butan-2-yl)-4-(4-(4-(4-(((2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-4,5-dihydro-1H-1,2,4-triazol-5-one|2-butan-2-yl-4-(4-(4-(4-(((2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1,2,4-triazol-3-one|TOLSURA|RefChem:5928|J02AC02|617-596-9|Itrizole (TN)|873066-43-4|Sporanox (TN)|ITCZ|Itraconazole (Sporanox)|Itraconazol [Spanish]|Itraconazolum [Latin]|C35H38Cl2N8O4|cis-Itraconazole|MFCD00941396|ITZ|4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]piperazin-1-yl]phenyl]-2-sec-butyl-1,2,4-triazol-3-one|2-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-2,4-dihydro-3H-1,2,4-triazol-3-one|3H-1,2,4-Triazol-3-one,4-[4-[4-[4-[[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-|CAS-84625-61-6|84604-65-9|Intraconazole|Sporanox(TM)|NCGC00018268-03|4-(4-{4-[4-({[(2R,4S)-2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methyl}oxy)phenyl]piperazin-1-yl}phenyl)-2-(1-methylpropyl)-2,4-dihydro-3H-1,2,4-triazol-3-one|Itraconazole & Nyotran|Itraconazole (Standard)|ITRACONAZOLE [MI]|ITRACONAZOLE [INN]|ITRACONAZOLE [JAN]|ITRACONAZOLE [USAN]|Itraconazole (JP18/USP)|ITRACONAZOLE [VANDF]|SCHEMBL23934|ITRACONAZOLE [MART.]|MLS006011958|CHEMBL22587|ITRACONAZOLE [USP-RS]|ITRACONAZOLE [WHO-DD]|orb1310057|SCHEMBL27256172|GTPL11426|ITRACONAZOLE [GREEN BOOK]|Itraconazole & Bovine Lactoferrin|ITRACONAZOLE [EP IMPURITY]|ITRACONAZOLE [ORANGE BOOK]|Pharmakon1600-01505756|ITRACONAZOLE [EP MONOGRAPH]|MSK14876|ITRACONAZOLE [USP MONOGRAPH]|Tox21_110854|AC-542|BDBM50127138|HY-17514R|NSC759239|s2476|AKOS015842738|AKOS015961385|Tox21_110854_1|CCG-270391|DB01167|KS-1268|NCGC00274068-01|NCGC00274068-02|NCGC00274068-07|HY-17514|SMR001827898|SY057462|Itraconazole & Nyotran(Liposomal Nystatin)|SBI-0206914.P001|ITRACONAZOLE (EMA EPAR: VETERINARY)|NS00003507|SW219756-1|Itraconazole 2.0 mg/ml in Dimethyl Sulfoxide|D00350|EN300-122640|SUBA-ITRACONAZOLE COMPONENT ITRACONAZOLE|AB01274818-01|AB01274818_02|AB01274818_03|Q411229|BRD-A23067620-001-01-7|BRD-A23067620-001-03-3|BRD-A23067620-001-04-1|BRD-A23067620-300-01-3|Z1544404944|(+/-)-1-SEC-BUTYL-4-(P-(4-(P-(((2R*,4S*)-2-(2,4-DICHLOROPHENYL)-2-(1H-1,2,4-TRIAZOL-1-YLMETHYL)-1,3-DIOXOLAN-4-YL)METHOXY)PHENYL)-1-PIPERAZINYL)PHENYL)-.DELTA.(SUP 2)-1,2,4-TRIAZOLIN-5-ONE|1-(butan-2-yl)-4-{4-[4-(4-{[(2R,4S)-2-(2,4-dichlorophenyl)-2-[(1H-1,2,4-triazol-1-yl)methyl]-1,3-dioxolan-4-yl]methoxy}phenyl)piperazin-1-yl]phenyl}-4,5-dihydro-1H-1,2,4-triazol-5-one|3H-1,2,4-Triazol-3-one, 4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-pipera-zinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)|4-[4-[4-[4-[[(2R,4S)-2-(2,4-Dichlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-3H-1,2,4-triazol-3-one;|4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1h-1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-2,4-dihydro-2-(1-methylpropyl)-3h-1,2,4-triazol-3-one"
ASENAPINE,163091,,"InChI=1S/C17H16ClNO/c1-19-9-14-12-4-2-3-5-16(12)20-17-7-6-11(18)8-13(17)15(14)10-19/h2-8,14-15H,9-10H2,1H3/t14-,15-/m1/s1",VSWBSWWIRNCQIJ-HUUCEWRRSA-N,C17H16ClNO,285.8,"(2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene","Asenapine|65576-45-6|Sycrest|Secuado|JKZ19V908O|asenapina|1H-Dibenz(2,3:6,7)oxepino(4,5-c)pyrrole, 5-chloro-2,3,3a,12b-tetrahydro-2-methyl-, (3aR,12bR)-rel-|trans-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz(2,3:6,7)oxepino(4,5-c)pyrrole|1H-Dibenz(2,3:6,7)oxepino(4,5-c)pyrrole, 5-chloro-2,3,3a,12b-tetrahydro-2-methyl-, trans-|(2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.0^{2,6}.0^{7,12}]octadeca-1(18),7,9,11,14,16-hexaene|(3ARS,12BRS)-5-CHLORO-2-METHYL-2,3,3A,12B-TETRAHYDRO-1H-DIBENZO(2,3:6,7)OXEPINO(4,5-C)PYRROLE|asenapinum|trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole|(2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo(12.4.0.0^(2,6).0^(7,12))octadeca-1(18),7,9,11,14,16-hexaene|RefChem:56545|CHEBI:71253|N05AH05|DTXCID001508499|(2Z)-but-2-enedioic acid; 17-chloro-4-methyl-13-oxa-4-azatetracyclo(12.4.0.02,?.0?,12)octadeca-1(14),7,9,11,15,17-hexaene|265-829-4|DTXSID8049048|(S,S)-asenapine|135883-07-7|CHEBI:71257|Asenapine (INN)|ASENAPINE [INN]|Asenapine [INN:BAN]|(2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.02,6.07,12]octadeca-1(18),7(12),8,10,14,16-hexaene|(3aS,12bS)-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenzo[2,3:6,7]oxepino[4,5-c]pyrrole|UNII-JKZ19V908O|HSDB 8061|(3aS,12bS)-5-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole|EINECS 265-829-4|Secuado (TN)|ASENAPINE [MI]|ASENAPINE [VANDF]|GTPL22|ASENAPINE [WHO-DD]|Org5222|SCHEMBL678411|CHEMBL504548|Secuado (transdermal asenapine)|ASENAPINE [ORANGE BOOK]|VSWBSWWIRNCQIJ-HUUCEWRRSA-N|BCPP000385|BDBM50549038|MFCD09838016|PDSP1_001600|PDSP2_001584|AKOS015918056|BCP9000326|FA17998|CS-0009346|NS00035896|NS00068086|65576-45-6 pound not85650-56-2|D11769|AB01274757-01|AB01274757_02|EN300-22049456|BRD-K95260951-050-02-3|BRD-K95260951-050-03-1|Q27074536|trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2, 3:6,7]-oxepino[4,5-c]pyrrole|trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]-oxepino[4,5-c]pyrrole|trans-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenzo[2,3;6,7]-oxepino[4,5-c]pyrrole|trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino[4,5-c]-pyrrole|(2S,6S)-9-chloro-4-methyl-13-oxa-4-azatetracyclo[12.4.0.0?,?.0?,??]octadeca-1(18),7,9,11,14,16-hexaene|(3aR,12bR)-rel-5-chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole;trans-5-Chloro-2,3,3a,12b-tetrahydro-  2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrole;Asenapine Maleate"
LUVADAXISTAT,71270546,,"InChI=1S/C13H11F3N2O2/c14-13(15,16)9-4-1-8(2-5-9)3-6-10-7-11(19)12(20)18-17-10/h1-2,4-5,7H,3,6H2,(H,17,19)(H,18,20)",QBQMUMMSYHUDFM-UHFFFAOYSA-N,C13H11F3N2O2,284.23,"6-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,2-dihydropyridazine-3,4-dione","Luvadaxistat|Luvadaxistat [USAN]|TAK-831|76IC00YRVR|UNII-76IC00YRVR|TAK831|LUVADAXISTAT [INN]|4-Hydroxy-6-{2-[4-(trifluoromethyl)phenyl]ethyl}pyridazin-3(2H)-one|LUVADAXISTAT [WHO-DD]|4-Hydroxy-6-(2-(4-(trifluoromethyl)phenyl)ethyl)pyridazin-3(2H)-one|4-HYDROXY-6-(2-(4-(TRIFLUOROMETHYL)PHENYL)ETHYL)-2,3-DIHYDROPYRIDAZIN-3-ONE|RefChem:154436|1425511-32-5|CHEMBL2338801|WHO 11254|3(2H)-Pyridazinone, 4-hydroxy-6-(2-(4-(trifluoromethyl)phenyl)ethyl)-|Luvadaxistat (USAN/INN)|orb1691715|LUVADAXISTAT; TAK-831|SCHEMBL14719667|SCHEMBL29377686|BDBM50431085|6-[2-[4-(trifluoromethyl)phenyl]ethyl]-1,2-dihydropyridazine-3,4-dione|AKOS040756761|AT32834|DA-55081|HY-109183|CS-0116454|D11981"
TAK-593,24767976,,"InChI=1S/C23H23N7O3/c1-13-4-7-16(11-17(13)24-23(32)18-10-14(2)27-29(18)3)33-21-9-8-20-25-19(12-30(20)28-21)26-22(31)15-5-6-15/h4,7-12,15H,5-6H2,1-3H3,(H,24,32)(H,26,31)",DZFZXPPHBWCXPQ-UHFFFAOYSA-N,C23H23N7O3,445.5,"N-[5-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]oxy-2-methylphenyl]-2,5-dimethylpyrazole-3-carboxamide","TAK-593|1005780-62-0|TAK 593|H3I42X8XX7|1H-Pyrazole-5-carboxamide, N-(5-((2-((cyclopropylcarbonyl)amino)imidazo(1,2-b)pyridazin-6-yl)oxy)-2-methylphenyl)-1,3-dimethyl-|TAK593|RefChem:187192|VEGFR/PDGFR Tyrosine Kinase Inhibitor TAK-593|N-(5-((2-cyclopropaneamidoimidazo(1,2-b)pyridazin-6-yl)oxy)-2-methylphenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide|UNII-H3I42X8XX7|N-(5-((2-(cyclopropanecarboxamido)imidazo[1,2-b]pyridazin-6-yl)oxy)-2-methylphenyl)-1,3-dimethyl-1H-pyrazole-5-carboxamide|CHEMBL2180604|N-[5-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]oxy-2-methylphenyl]-2,5-dimethylpyrazole-3-carboxamide|1H-Pyrazole-5-carboxamide, N-[5-[[2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl]oxy]-2-methylphenyl]-1,3-dimethyl-;1H-Pyrazole-5-carboxamide, N-[5-[[2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl]oxy]-2-methylphenyl]-1,3-dimethyl-|orb1307706|SCHEMBL2515478|DZFZXPPHBWCXPQ-UHFFFAOYSA-N|C23H23N7O3|EX-A5959|FQB78062|BDBM50399537|MFCD23160045|NSC800939|AKOS030526192|DB13093|NSC-800939|NCGC00485933-01|HY-15506|MS-28025|NS00073069|C13977|BRD-K67262033-001-01-0|Q27279595|N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide|N-[5-[2-(cyclopropanecarbonylamino)imidazo[1,2-b]pyridazin-6-yl]oxy-2-methyl-phenyl]-2,5-dimethyl-pyrazole-3-carboxamide"
APROFENE,71128,,"InChI=1S/C21H27NO2/c1-4-22(5-2)16-17-24-20(23)21(3,18-12-8-6-9-13-18)19-14-10-7-11-15-19/h6-15H,4-5,16-17H2,1-3H3",DIDYGLSKVUKRRP-UHFFFAOYSA-N,C21H27NO2,325.4,"2-(diethylamino)ethyl 2,2-diphenylpropanoate","Aprofene|Aprophen|Aprofen|Aprofene [INN]|Aprofeno|Aprophenum|Aprofenum|Aprofenum [INN-Latin]|DTXSID8046294|Aprofeno [INN-Spanish]|Propionic acid, 2,2-diphenyl-, 2-(diethylamino)ethyl ester|UNII-PL791XXJ7B|BRN 2509326|2,2-Diphenylpropionic acid 2-diethylaminoethyl ester|2,2-diphenylpropanoic acid N,N-diethylaminoethyl ester|DTXCID6026294|alpha,alpha-Diphenylpropionic acid 2-diethylaminoethyl ester|Aprofenum (INN-Latin)|alpha,alpha-Diphenylpropionic acid beta-diethylaminoethyl ester|Aprofeno (INN-Spanish)|alpha-Methyl-alpha-phenylbenzeneacetic acid 2-(diethylamino)ethyl ester|Benzeneacetic acid, alpha-methyl-alpha-phenyl-, 2-(diethylamino)ethyl ester|4-09-00-02535 (Beilstein Handbook Reference)|.alpha.,.alpha.-Diphenylpropionic acid 2-diethylaminoethyl ester|.alpha.,.alpha.-Diphenylpropionic acid .beta.-diethylaminoethyl ester|.alpha.-Methyl-.alpha.-phenylbenzeneacetic acid 2-(diethylamino)ethyl ester|BENZENEACETIC ACID, .ALPHA.-METHYL-.ALPHA.-PHENYL-, 2-(DIETHYLAMINO)ETHYL ESTER|RefChem:113551|Benzeneacetic acid, alpha-methyl-alpha-phenyl-, 2-(diethylamino)ethyl ester (9CI)|DIDYGLSKVUKRRP-UHFFFAOYSA-N|3563-01-7|diethylaminoethyl|2-Diethylaminoethyl 2,2-diphenylpropionate|2-(Diethylamino)ethyl 2,2-diphenylpropanoate|PL791XXJ7B|CHEMBL26505|NCGC00160676-01|CAS-3563-01-7|orb1987111|SCHEMBL2354824|2,2-Diphenyl-propionic acid 2-diethylamino-ethyl ester|Tox21_111979|BDBM50005685|STK182867|AKOS003658410|Tox21_111979_1|NCGC00160676-02|HY-121168|CS-0079580|NS00113978|2-(Diethylamino)ethyl 2,2-diphenylpropanoate #|AG-690/12764492|L000719|SR-01000883700|Q4068249|SR-01000883700-1|BRD-K48282247-001-01-4|2,2-Diphenyl-propionic acid 2-diethylamino-ethyl ester(Aprophen)"
BIETAMIVERINE,72064,,"InChI=1S/C19H30N2O2/c1-3-20(4-2)15-16-23-19(22)18(17-11-7-5-8-12-17)21-13-9-6-10-14-21/h5,7-8,11-12,18H,3-4,6,9-10,13-16H2,1-2H3",JGTJANXYSNVLMQ-UHFFFAOYSA-N,C19H30N2O2,318.5,2-(diethylamino)ethyl 2-phenyl-2-piperidin-1-ylacetate,"Bietamiverine|479-81-2|Bietamiverina|Bietamiverinum|4MGI916O6Y|beta-Diethylaminoethyl phenylpiperidinoacetate|2-Diethylaminoethyl alpha-phenyl-1-piperidineacetate|2-Phenyl-2-piperidino-essigsaeure-beta-diethylaminoethylester|alpha-phenyl-1-piperidineacetic acid-2-diethylaminoethyl ester|RefChem:909418|2-(Diethylamino)ethyl alpha-phenyl-1-piperidineacetate|207-538-7|Bietamiverin|Bietamiverine [INN]|Paparid|1-Piperidineacetic acid, alpha-phenyl-, 2-(diethylamino)ethyl ester|Dietamiverine; Novosaprol; Paparid|Dietamiverine|Spasmaparid|2-(diethylamino)ethyl 2-phenyl-2-piperidin-1-ylacetate|Bietamiverinum [INN-Latin]|UNII-4MGI916O6Y|Bietamiverina [INN-Spanish]|EINECS 207-538-7|BIETAMIVERINE [MI]|SCHEMBL24239|2-Diethylaminoethyl (2-phenyl-2-piperidino)acetat|BIETAMIVERINE [MART.]|BIETAMIVERINE [WHO-DD]|orb1698148|CHEMBL2110892|DTXSID20861993|CHEBI:135362|JGTJANXYSNVLMQ-UHFFFAOYSA-N|alpha-Phenyl-1-piperidineacetic acid 2-diethylaminoethyl ester|Phenyl(1-piperidino)acetic acid beta-diethylaminoethyl ester|BDBM50491131|AKOS040750796|NS00042920|Q27260117|2-DIETHYLAMINOETHYL .ALPHA.-PHENYL-1-PIPERIDINEACETATE"
SETIPIPRANT,49843471,,"InChI=1S/C24H19FN2O3/c25-16-8-9-21-19(12-16)20-13-26(11-10-22(20)27(21)14-23(28)29)24(30)18-7-3-5-15-4-1-2-6-17(15)18/h1-9,12H,10-11,13-14H2,(H,28,29)",IHAXLPDVOWLUOS-UHFFFAOYSA-N,C24H19FN2O3,402.4,"2-[8-fluoro-2-(naphthalene-1-carbonyl)-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl]acetic acid","Setipiprant|866460-33-5|ACT-129968|KYTH-105|BHF20LA2GM|2-[8-fluoro-2-(naphthalene-1-carbonyl)-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl]acetic acid|DTXSID00235739|5H-Pyrido(4,3-b)indole-5-acetic acid, 8-fluoro-1,2,3,4-tetrahydro-2-(1-naphthalenylcarbonyl)-|setipiprantum|2-(8-fluoro-2-(naphthalene-1-carbonyl)-3,4-dihydro-1H-pyrido(4,3-b)indol-5-yl)acetic acid|RefChem:931658|DTXCID80158230|2-(8-fluoro-2-(naphthalene-1-carbonyl)-1H,2H,3H,4H,5H-pyrido(4,3-b)indol-5-yl)acetic acid|2-(2-(1-naphthoyl)-8-fluoro-1,2,3,4-tetrahydropyrido[4,3-b]indol-5-yl)acetic acid|MFCD23136043|Setipiprant(ACT129968)|ACT129968|2-(2-(1-Naphthoyl)-8-fluoro-3,4-dihydro-1H-pyrido[4,3-b]indol-5(2H)-yl)acetic acid|Setipiprant [INN]|UNII-BHF20LA2GM|Setipiprant [USAN:INN]|ACT 129968|Setipiprant (USAN/INN)|SETIPIPRANT [USAN]|SETIPIPRANT [WHO-DD]|Setipiprant(ACT-129968)|orb1304123|SCHEMBL3089969|Setipiprant (ACT-129968)|CHEMBL2386081|SCHEMBL29355657|SCHEMBL29358337|C24H19FN2O3|GTPL10180|CHEBI:177430|GLXC-10792|BCP15981|EX-A1767|RJB46033|BDBM50434990|s5753|AKOS016340337|BH-0015|CS-4940|DB12562|SB18924|compound 28 [PMID: 23721423]|AC-31955|DA-57813|HY-16635|Setipiprant(ACT-129968, KYTH-105)|NS00073048|D10326|R10053|BRD-K24497734-001-01-6|Q21098972|2-[8-luoro-2-(naphthalene-1-carbonyl)-3,4-dihydro-1H-pyrido[4,3-b]indol-5-yl]acetic acid|(8-Fluoro-2-(napthalene-1-carbonyl)-1,2,3,4-tetrahydro-5H-pyrido(4,3-b)indol-5-yl)acetic acid|[8-Fluoro-2-(naphthalene-1-carbonyl)-1,2,3,4-tetrahydro-5H-pyrido[4,3-b]indol-5-yl]acetic acid|5H-Pyrido(4,3-b)indole-5-acetic acid,8-fluoro-1,2,3,4-tetrahydro-2-(1- naphthalenylcarbonyl)-"
AEE-788,10297043,,"InChI=1S/C27H32N6/c1-3-32-13-15-33(16-14-32)18-21-9-11-23(12-10-21)25-17-24-26(28-19-29-27(24)31-25)30-20(2)22-7-5-4-6-8-22/h4-12,17,19-20H,3,13-16,18H2,1-2H3,(H2,28,29,30,31)/t20-/m1/s1",OONFNUWBHFSNBT-HXUWFJFHSA-N,C27H32N6,440.6,"6-[4-[(4-ethylpiperazin-1-yl)methyl]phenyl]-N-[(1R)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine","497839-62-0|AEE788|AEE-788|AEE 788|NVP-AEE788|(R)-6-(4-((4-Ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine|AEE788 (NVP-AEE788)|GNF-Pf-5343|NVP-AEE-788|6-{4-[(4-Ethylpiperazin-1-Yl)methyl]phenyl}-N-[(1r)-1-Phenylethyl]-7h-Pyrrolo[2,3-D]pyrimidin-4-Amine|F9JLR95I3I|6-[4-[(4-ethylpiperazin-1-yl)methyl]phenyl]-N-[(1R)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine|7H-pyrrolo(2,3-d)pyrimidin-4-amine, 6-(4-((4-ethyl-1-piperazinyl)methyl)phenyl)-N-((1R)-1-phenylethyl)-|NVP-AEE 788|C27H32N6|MFCD11100351|(R)-6-(4-((4-ethylpiperazin-1-yl)methyl)phenyl)-N-(1-phenylethyl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine.|6-[4-[(4-Ethyl-1-piperazinyl)methyl]phenyl]-N-[(1R)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine|UNII-F9JLR95I3I|5-[(2-Chlorophenyl)methyl]-4,5,6,7-tetrahydro-5-methylthieno[3,2-c]pyridinium Iodide;|6-(4-((4-Ethyl-1-piperazinyl)methyl)phenyl)-N-((1R)-1-phenylethyl)-7H-pyrrolo(2,3-d)pyrimidin-4-amine|AEE|RefChem:1073687|MLS006011277|SCHEMBL613756|CHEMBL587723|GTPL7643|orb1306446|AEE 788 [WHO-DD]|SCHEMBL29143573|SCHEMBL29389001|BDBM26105|CHEBI:40629|DTXSID90964400|AEE788; NVP-AEE788|BCPP000427|GLXC-04411|EX-A2259|MFCD19708018|NSC765949|NSC799325|s1486|AEE-788 (NVP-AEE788)|AKOS016011091|AEE-788 (NVP-AEE788)?|BCP9000241|CCG-264897|CS-1452|DB12558|FA17229|NSC-765949|NSC-799325|SDCCGSBI-0654371.P001|NCGC00263149-01|NCGC00263149-09|AC-32829|AEE788, >=98% (HPLC)|AS-55853|HY-10045|SMR004703027|A3271|NS00071667|SW219869-1|Q4651286|BRD-K40718343-001-02-6|BRD-K40718343-001-03-4|BRD-K40718343-001-04-2|[6-[4-[(4-ethylpiperazin-1-yl)methyl]phenyl]-7h-pyrrolo[2,3-d]pyrimidin-4-yl]-((r)-1-phenylethyl)amine|1H-Pyrrolo(2,3-d)pyrimidin-4-amine, 6-(4-((4-ethyl-1-piperazinyl)methyl)phenyl)-N-((1R)-1-phenylethyl)-|6-[4-[(4-Ethyl-1-piperazinyl)methyl]phenyl]-N-[(1R)-1-phenylethyl]-7H-pyrrolo[2,3-d]pyrimidin-4-amine;[6-[4-[(4-Ethylpiperazin-1-yl)  methyl]phenyl]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]-((R)-1-phenylethyl)amine;NVP AEE 788|6-[4-[(4-ethylpiperazin-1-yl)methyl]phenyl]-N-[(1R)-1-phenylethyl]-7H-pyrrolo[3,2-e]pyrimidin-4-amine|6-{4-[(4-ethyl-1-piperazinyl)methyl]phenyl}-N-[(1R)-1-phenylethyl]-1H-pyrrolo[2,3-d]pyrimidin-4-amine"
REBASTINIB,25066467,,"InChI=1S/C30H28FN7O3/c1-30(2,3)26-17-27(38(37-26)19-7-9-23-18(14-19)6-5-12-33-23)36-29(40)35-24-10-8-20(15-22(24)31)41-21-11-13-34-25(16-21)28(39)32-4/h5-17H,1-4H3,(H,32,39)(H2,35,36,40)",WVXNSAVVKYZVOE-UHFFFAOYSA-N,C30H28FN7O3,553.6,4-[4-[(5-tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide,"REBASTINIB|1020172-07-9|DCC-2036|DCC 2036|CHEBI:62166|DP-1919|DCC-2036 FREE BASE|75017Q6I97|DTXSID40144533|4-[4-({[3-Tert-Butyl-1-(Quinolin-6-Yl)-1h-Pyrazol-5-Yl]carbamoyl}amino)-3-Fluorophenoxy]-N-Methylpyridine-2-Carboxamide|4-(3-fluoro-4-(((3-(2-methyl-2-propanyl)-1-(6-quinolinyl)-1H-pyrazol-5-yl)carbamoyl)amino)phenoxy)-N-methyl-2-pyridinecarboxamide|rebastinibum|4-(4-(((3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)carbamoyl)amino)-3-fluorophenoxy)-N-methylpyridine-2-carboxamide|RefChem:930592|DTXCID8067024|DCC-2036 (Rebastinib)|4-(4-(3-(3-(tert-butyl)-1-(quinolin-6-yl)-1H-pyrazol-5-yl)ureido)-3-fluorophenoxy)-N-methylpicolinamide|MFCD19443646|Rebastinib [USAN]|DP 1919|2-Pyridinecarboxamide, 4-[4-[[[[3-(1,1-dimethylethyl)-1-(6-quinolinyl)-1H-pyrazol-5-yl]amino]carbonyl]amino]-3-fluorophenoxy]-N-methyl-|4-[4-[(5-tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide|N-[3-tert-Butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-N'-[2-fluoro-4-[(2-(methylcarbamoyl)pyridin-4-yl)oxy]phenyl]urea|Rebastinib (USAN)|DCC2036|1-[3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl]-3-{2-fluoro-4-[2-(methylcarbamoyl)pyridin-4-yloxy]phenyl}urea|4-[4-[(5-Tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide,4-methylbenzenesulfonic acid;4-[4-[(5-Tert-butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide,4-methylbenzenesulfonic acid|Rebastinib [USAN:INN]|C30H28FN7O3|3qri|3qrj|UNII-75017Q6I97|2-PYRIDINECARBOXAMIDE, 4-(4-((((3-(1,1-DIMETHYLETHYL)-1-(6-QUINOLINYL)-1H-PYRAZOL-5-YL)AMINO)CARBONYL)AMINO)-3-FLUOROPHENOXY)-N-METHYL-|DCC-2036; DP 1919; 4-[4-[(5-tert-Butyl-2-quinolin-6-ylpyrazol-3-yl)carbamoylamino]-3-fluorophenoxy]-N-methylpyridine-2-carboxamide|REBASTINIB [INN]|DCC-2036; Rebastinib|REBASTINIB [WHO-DD]|MLS006011270|DCC-2036 (Rebastinib)?|GTPL9173|orb1305227|SCHEMBL2034290|CHEMBL1738757|SCHEMBL29354367|SCHEMBL29733447|SCHEMBL30499050|BDBM185674|HMS3656H07|HMS3672I07|BCP02345|EX-A2046|NSC774831|NSC800863|s2634|AKOS025404839|BCP9000591|CCG-264972|DB13005|FD64998|NSC-774831|NSC-800863|SB16618|SDCCGSBI-0654390.P001|NCGC00263172-01|NCGC00263172-08|NCGC00263172-09|4-(4-(3-(3-tert-butyl-1-(quinolin-6-yl)-1H-pyrazol-5-yl)ureido)-3-fluorophenoxy)-N-methylpicolinamide|AC-30301|AS-17048|DA-34916|HY-13024|SMR004703020|SY259195|NS00072865|SW219251-1|D10334|BRD-K76694128-001-04-3|BRD-K76694128-001-05-0|BRD-K76694128-001-06-8|Q27088522|4-(4-(((3-TERT-BUTYL-1-(QUINOLIN-6-YL)-1H-PYRAZOL-5-YL)CARBAMOYL(AMINO)-3-FLUOROPHENOXY)-N-METHYLPYRIDIN-2-CARBOXAMIDE|4-[4-[[5-tert-butyl-2-(6-quinolyl)pyrazol-3-yl]carbamoylamino]-3-fluoro-phenoxy]-N-methyl-pyridine-2-carboxamide|4-[4-[3-[3-(tert-Butyl)-1-(6-quinolyl)-5-pyrazolyl]ureido]-3-fluorophenoxy]-N-methylpicolinamide|N-(3-(1,1-DIMETHYLETHYL)-1-(QUINOLIN-6-YL)-1H-PYRAZOL-5-YL)-N'-(2-FLUORO-4-((2- (METHYLCARBAMOYL)PYRIDIN-4-YL)OXY)PHENYL)UREA"
EDETIC ACID,6049,,"InChI=1S/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20)",KCXVZYZYPLLWCC-UHFFFAOYSA-N,C10H16N2O8,292.24,2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid,"EDTA|Edetic acid|60-00-4|Ethylenediaminetetraacetic acid|Edathamil|Sequestrol|Havidote|Titriplex|EDTA acid|Versene acid|Cheelox|Gluma cleanser|Sequestrene aa|Sequestric acid|Warkeelate acid|Komplexon ii|Tetrine acid|Quastal Special|Metaquest A|Trilon bw|Titriplex II|Cheelox BF acid|Trilon BS|Celon A|Celon ATH|Chelest 3A|Questex 4H|(Ethylenedinitrilo)tetraacetic acid|Chemcolox 340|Acide edetique|Acido edetico|Universne acid|EDTA (chelating agent)|Dissolvine E|Vinkeil 100|Nullapon B acid|Nullapon bf acid|Nervanaid B acid|Perma kleer 50 acid|Clewat TAA|Acidum edeticum|Ethylenedinitrilotetraacetic acid|ICRF 185|Ethylenebisiminodiacetic acid|Ethylenediamine-N,N,N',N'-tetraacetic acid|SEQ 100|YD 30|Ethylenebis(iminodiacetic acid)|Acide ethylenediaminetetracetique|ETHYLENEDIAMINE TETRAACETIC ACID|Acetic acid, (ethylenedinitrilo)tetra-|EPA Pesticide Chemical Code 039101|Kyselina ethylendiamintetraoctova|AI3-17181|3,6-Diazaoctanedioic acid, 3,6-bis(carboxymethyl)-|Glycine, N,N'-1,2-ethanediylbis(N-(carboxymethyl)-|Glycine, N,N'-1,2-ethanediylbis[N-(carboxymethyl)-|9G34HU7RV0|Acetic acid, 2,2',2'',2'''-(1,2-ethanediyldinitrilo)tetrakis-|DTXSID6022977|CHEBI:42191|N,N'-1,2-Ethane diylbis-(N-(carboxymethyl)glycine)|N,N'-1,2-Ethanediylbis(N-(carboxymethyl)glycine)|2-({2-[bis(carboxymethyl)amino]ethyl}(carboxymethyl)amino)acetic acid|{[-(BIS-CARBOXYMETHYL-AMINO)-ETHYL]-CARBOXYMETHYL-AMINO}-ACETIC ACID|DTXCID902977|(ethylenedinitrilo)tetraacetic acid, ion(4-)|Acid, Edetic|(ethane-1,2-diyldinitrilo)tetraacetic acid|N,N'-1,2-ethanediylbis[N-(carboxymethyl)glycine]|edta, disodium|Chromium EDTA|((-(bis-carboxymethyl-amino)-ethyl)-carboxymethyl-amino)-acetic acid|2-((2-(bis(carboxymethyl)amino)ethyl)(carboxymethyl)amino)acetic acid|2-([2-[bis(carboxymethyl)amino]ethyl](carboxymethyl)amino)acetic acid|EDTA, Potassium|Tetacine, Calcium|EDTA, Chromium|EDTA, Dicobalt|EDTA, Distannous|EDTA, Stannous|EDTA, Gallium|EDTA, Copper|Edetic Acid, Disodium, Magnesium Salt|RefChem:5786|Calcitetracemate, Disodium|Edetate, Calcium Disodium|EDTA, Magnesium Disodium|Disodium Versenate, Calcium|Versenate, Calcium Disodium|Dinitrilotetraacetate, Ethylene|Acid, Ethylenediaminetetraacetic|Glycine, N,N'-1,2-ethanediylbis(N-(carboxymethyl))-|Acid, Ethylenedinitrilotetraacetic|Dinitrilotetraacetate, Disodium Ethylene|Ethylene Dinitrilotetraacetate, Disodium|200-449-4|2-(2-(carboxylatomethyl(carboxymethyl)azaniumyl)ethyl-(carboxymethyl)azaniumyl)acetate|Versene|Hamp-ene acid|Versenate|Caswell No. 438|Calcium disodium versenate|C10H16N2O8|Edetate calcium|Acide edetique [INN-French]|Acido edetico [INN-Spanish]|Acidum edeticum [INN-Latin]|CCRIS 946|Disodium EDTA|HSDB 809|Ethylenediaminetetraacetate|2-[2-[bis(carboxymethyl)amino]ethyl-(carboxymethyl)amino]acetic acid|470462-56-7|MFCD00003541|CaEDTA|Edta disodium|Endrate disodium|Kyselina ethylendiamintetraoctova [Czech]|Acide ethylenediaminetetracetique [French]|Titriplex III|EDTA disodium salt|EDTA, ion(4-)|CHEMBL858|Calcium disodium versenate (TN)|ethylene-diamine tetraacetic acid|2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetic acid|2,2',2'',2'''-(ethane-1,2-diylbis(azanetriyl))tetraacetic acid|EDT|Edetate calcium disodium (USP)|Sequestrene Na2|Selekton B2|Disodium ethylenediaminetetraacetate|Disodium (ethylenedinitrilo)tetraacetate|D'E.d.t.a. disodique|2,2',2'',2'''-(ethane-1,2-diyldinitrilo)tetraacetate|Ethylenediaminetetraacetic acid, disodium salt|ethylenediaminetetraacetic acid(edta)|139-33-3|NSC2760|ethylene diamine tetraacetic acid|NCGC00159485-02|53632-26-1|EINECS 200-449-4|BRN 1716295|UNII-9G34HU7RV0|disodium-edta|Edetic acid [INN:BAN:NF]|(Ethylenedinitrilo)tetraacetic acid, disodium salt|2-[2-(bis(carboxymethyl)amino)ethyl-(carboxymethyl)amino]acetic acid|Tricon bw|([2-(Bis-carboxymethyl-amino)-ethyl]-carboxymethyl-amino)-acetic acid|{[2-(Bis-carboxymethyl-amino)-ethyl]-carboxymethyl-amino}-acetic acid|Calcium Disodium Edetate (JAN)|ethylenediamine tetra-acetic acid|Techrun DO|EDTA, anhydrous|H4edta|EDTA Buffer|Zonon AO|EDTA, free acid|EDTA, free base|Versene acid (TN)|ethylenediaminetetraacetic acid (edta)|Acroma DH 700|Spectrum_001018|Edetic acid (NF/INN)|EDTA [VANDF]|Spectrum2_000003|Spectrum3_000412|Spectrum4_000531|Spectrum5_000955|Edetic acid [BAN:INN]|EDETIC ACID [II]|EDETIC ACID [INN]|EDTA [MI]|EC 200-449-4|EDETIC ACID [HSDB]|SCHEMBL1373|EDTA, anhydrous ACS grade|ethylenediaminetetracetic acid|BSPBio_001964|Diaminoethanetetra-acetic acid|EDETIC ACID [MART.]|KBioGR_001161|KBioSS_001498|ethylenediaminetetraacetic-acid|MLS001249457|BIDD:ER0565|DivK1c_000777|EDETIC ACID [USP-RS]|EDETIC ACID [WHO-DD]|ethylenediamine tetracetic acid|SPBio_000005|ethylenediamine-tetraacetic acid|CHEBI:4735|orb1306645|EDTA solution, 0.5M in water|KBio1_000777|KBio2_001498|KBio2_004066|KBio2_006634|KBio3_001184|(Ethylenedintrilo)tetraacetic acid|ethylen-ediamine tetra-acetic acid|NINDS_000777|Ethylenediaminetetraacetic acidEDTA|EDETIC ACID [EP MONOGRAPH]|CS-B1827|HY-Y0682|NBA64182|STR08855|Tox21_202736|BDBM50330325|Ethylenediaminetetraacetic acid, EDTA|HB5135|s6350|SBB008807|STK386291|AKOS001574475|Glycine, (N,N'-1,2-ethanediylbis(N-(carboxymethyl)-, labeled with carbon-14|(ethane-1,2-diyldinitrilo)tetraacetate|DB00974|FE04031|CAS-60-00-4|IDI1_000777|NCGC00159485-03|NCGC00159485-04|NCGC00260284-01|688-55-1|AC-10615|SMR000058776|ST072179|TRILON BS;Ethylenediaminetetraacetic acid|SBI-0051360.P003|DB-084840|DB-216864|DS-003836|E0084|Ethylenediaminetetraacetic acid, 2Na (EDTA)|Ethylenediaminetetraacetic acid, LR, >=98%|NS00003929|EN300-71613|C00284|D00052|ethylene-N,N'-biscarboxymethyl-N,N'-diglycine|Ethylenediaminetetraacetic acid, p.a., 98.0%|AB00053468_03|Ethylenediaminetetraacetic acid, >=98.0% (KT)|A832566|F788288|N,N-1,2-Ethanediylbis[N-(carboxymethyl)]glycine|Q408032|SR-01000883946|ANTICOAGULANT ETHYLENEDIAMINE TETRAACETIC ACID|Ethylenediaminetetraacetic Acid Sodium Salt Solution|Ethylenediaminetetraacetic acid, Cell Culture Reagent|SR-01000883946-1|3,6-Diazaoctanedioic acid, 3,6-bis(carboxylmethyl)-|37C3C5E7-D921-445F-82D6-FEBF1AE5AEF5|BRD-K82603084-408-01-1|Ethylenediaminetetraacetic acid anhydrous, crystalline|Ethylenediaminetetraacetic acid, Electrophoresis Grade|Z2588038976|ANTICOAGULANT ETHYLENEDIAMINE TETRAACETIC ACID (EDTA)|Ethylenediaminetetraacetic acid, BioUltra, >=99.0% (KT)|Ethylenediaminetetraacetic acid, 99.995% trace metals basis|Ethylenediaminetetraacetic acid, SAJ special grade, >=99.0%|Ethylenediaminetetraacetic acid, Vetec(TM) reagent grade, 98%|[{2-[bis(carboxymethyl)amino]ethyl}(carboxymethyl)amino]acetic acid|Edetic acid, United States Pharmacopeia (USP) Reference Standard|Ethylenediaminetetraacetic acid, ACS reagent, 99.4-100.6%, powder|Ethylenediaminetetraacetic acid, purified grade, >=98.5%, powder|2,2'',2'''',2''''''-(ethane-1,2-diylbis(azanetriyl))tetraacetic acid|Ethylenediaminetetraacetic acid, BioUltra, anhydrous, >=99% (titration)|Glycine, N,N'-1, {2-ethanediylbis[N-(carboxymethyl)-,} disodium salt|{[2-(Bis-carboxymethyl-amino)-ethyl]-carboxymethyl-amino}-acetic acid(EDTA)|2-[2-[Bis(2-hydroxy-2-oxo-ethyl)amino]ethyl-(2-hydroxy-2-oxo-ethyl)amino]acetic acid|2-[2-[bis(2-hydroxy-2-oxoethyl)amino]ethyl-(2-hydroxy-2-oxoethyl)amino]ethanoic acid|Ethylenediaminetetraacetic acid, anhydrous, free-flowing, Redi-Dri(TM), >=98%|124949-23-1|Ethylenediaminetetraacetic acid, anhydrous, crystalline, BioReagent, suitable for cell culture|Ethylenediaminetetraacetic acid, anhydrous, free-flowing, powder, Redi-Dri(TM), ACS reagent, 99.4-100.6%|InChI=1/C10H16N2O8/c13-7(14)3-11(4-8(15)16)1-2-12(5-9(17)18)6-10(19)20/h1-6H2,(H,13,14)(H,15,16)(H,17,18)(H,19,20"
JNJ-26489112,11616111,,"InChI=1S/C9H11ClN2O4S/c10-6-1-2-8-9(3-6)15-5-7(16-8)4-12-17(11,13)14/h1-3,7,12H,4-5H2,(H2,11,13,14)/t7-/m0/s1",KXSAIQPPGSSNKX-ZETCQYMHSA-N,C9H11ClN2O4S,278.71,"(2S)-6-chloro-2-[(sulfamoylamino)methyl]-2,3-dihydro-1,4-benzodioxine","JNJ-26489112|871824-55-4|G1TI012DLT|Sulfamide, N-(((2S)-6-chloro-2,3-dihydro-1,4-benzodioxin-2-yl)methyl)-|DTXSID601031470|RefChem:150531|DTXCID101516580|N-(((2S)-6-chloro-2,3-dihydro-1,4-benzodioxin-2-yl)methyl)aminosulfonamide|CHEMBL3092995|(2S)-6-chloro-2-[(sulfamoylamino)methyl]-2,3-dihydro-1,4-benzodioxine|(2S)-(-)-N-[(6-Chloro-2,3-dihydrobenzo[1,4]dioxin-2-yl)methyl]sulfamide|Sulfamide, [[(2S)-6-chloro-2,3-dihydro-1,4-benzodioxin-2-yl]methyl]-|UNII-G1TI012DLT|SCHEMBL437342|orb1700284|KXSAIQPPGSSNKX-ZETCQYMHSA-N|BDBM50444089|AKOS040748625|DB15203|DA-74662|HY-12596|CS-0012062|Q16997761|(S)-N-(6-Chloro-2,3-dihydro-benzo[1,4]dioxin-2-ylmethyl)-sulfamide"
OXYMETAZOLINE,4636,,"InChI=1S/C16H24N2O/c1-10-8-13(16(3,4)5)15(19)11(2)12(10)9-14-17-6-7-18-14/h8,19H,6-7,9H2,1-5H3,(H,17,18)",WYWIFABBXFUGLM-UHFFFAOYSA-N,C16H24N2O,260.37,"6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol","oxymetazoline|1491-59-4|Oxymethazoline|Hazol|Oximetazolinum|Oxylazine|Rhinofrenol|Iliadin|Sinerol|Nafrine|Navisin|Nezeril|Oxymetozoline|Oximetazolina|Oxymetazolinum|Afrin|6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol|Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl-|Nasacon|Operil|6-t-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|2-(4-tert-Butyl-2,6-dimethyl-3-hydroxybenzyl)-2-imidazoline|6-tert-Butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethylphenol|H 990|8VLN5B44ZY|CHEBI:7862|DTXSID3040691|Phenol, 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl-|3-[(4,5-Dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethylphenol|Phenol, 3-((4,5-dihydro-1H-imidazol-2-yl)methyl)-6-(1,1-dimethylethyl)-2,4-dimethyl-|DTXCID1020691|Phenol, 6-t-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl-|3-((4,5-dihydro-1H-imidazol-2-yl)methyl)-6-(1,1-dimethylethyl)-2,4-dimethylphenol|RefChem:6090|A14AA05|R01AA05|R01AB07|S01GA04|Sinufrin Quick Relief Decongestant|216-079-1|Rhinolitan|HSDB 3143|Oxymetazoline (INN)|Navasin|NCGC00015766-08|OXYMETAZOLINE [INN]|Oxymetazoline [INN:BAN]|Oxymetazolinum [INN-Latin]|Oximetazolina [INN-Spanish]|CAS-1491-59-4|Operil (TN)|EINECS 216-079-1|oxymetazoline hydrochloride crystalline|UNII-8VLN5B44ZY|BRN 0886303|oxymetazolina|MFCD00242798|Nasivine (Salt/Mix)|Spectrum_001051|Tocris-1142|6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-phenol;hydrochloride|Prestwick0_000224|Prestwick1_000224|Prestwick2_000224|Prestwick3_000224|Spectrum2_000998|Spectrum3_000533|Spectrum4_000464|Spectrum5_001114|Lopac-O-2378|OXYMETAZOLINE [MI]|Biomol-NT_000161|CHEMBL762|OXYMETAZOLINE [HSDB]|Lopac0_000903|SCHEMBL24301|BSPBio_000267|BSPBio_002145|GTPL124|KBioGR_000908|KBioSS_001531|OXYMETAZOLINE [VANDF]|cid_66259|DivK1c_000567|SPBio_001095|SPBio_002188|OXYMETAZOLINE [WHO-DD]|BPBio1_000295|BPBio1_000419|orb1685732|SCHEMBL29825106|BDBM30712|KBio1_000567|KBio2_001531|KBio2_004099|KBio2_006667|KBio3_001645|NINDS_000567|HMS2089G03|ALBB-036521|Tox21_110217|STK075254|3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethyl-6-tert-butyl-phenol|AKOS007930348|Tox21_110217_1|AC-6370|CAS-151615|CCG-204985|DB00935|SDCCGSBI-0050878.P005|IDI1_000567|NCGC00015766-01|NCGC00015766-02|NCGC00015766-03|NCGC00015766-04|NCGC00015766-05|NCGC00015766-06|NCGC00015766-07|NCGC00015766-09|NCGC00015766-10|NCGC00015766-11|NCGC00015766-13|NCGC00015766-16|NCGC00015766-21|NCGC00022345-02|NCGC00022345-04|NCGC00022345-05|NCGC00022345-06|HY-12722|SY278685|SBI-0050878.P004|CS-0012298|H-990|NS00005342|C07363|D08322|G78135|AB00053513-12|AB00053513-13|AB00053513_14|AB00053513_15|EN300-23521946|L000459|Q417813|BRD-K16195444-001-01-7|BRD-K16195444-003-16-1|BRD-K16195444-003-24-5|BRD-K16195444-003-25-2|BRD-K16195444-003-26-0|6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl-phenol;hydrochloride|6-tert-Butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol #|6-tert-Butyl-3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-2,4-dimethylphenol|6-(tert-Butyl)-3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-2,4-dimethylphenol|Phenol, 6-tert-butyl-3-(2-imidazolin-2-ylmethyl)-2,4-dimethyl- (7CI,8CI)|Phenol, 3-[(4,5-dihydro-1H-imidazol-2-yl)methyl]-6-(1,1-dimethylethyl)-2,4-dimethyl- (9CI)"
ZACOPRIDE,108182,,"InChI=1S/C15H20ClN3O2/c1-21-14-7-12(17)11(16)6-10(14)15(20)18-13-8-19-4-2-9(13)3-5-19/h6-7,9,13H,2-5,8,17H2,1H3,(H,18,20)",FEROPKNOYKURCJ-UHFFFAOYSA-N,C15H20ClN3O2,309.79,4-amino-N-(1-azabicyclo[2.2.2]octan-3-yl)-5-chloro-2-methoxybenzamide,"Zacopride|90182-92-6|Zacoprida|iodozacopride|Zacopridum|9GN3OT4156|DTXSID1048251|Benzamide, 4-amino-N-1-azabicyclo(2.2.2)oct-3-yl-5-chloro-2-methoxy-|4-amino-5-iodo-2-methoxy-N-(1-azabicyclo(2.2.2)oct-3-yl)benzamide|4-amino-N-(1-azabicyclo(2.2.2)octan-8-yl)-5-chloro-2-methoxybenzamide|4-amino-N-(1-azabicyclo[2.2.2]octan-8-yl)-5-chloro-2-methoxybenzamide|RefChem:195822|DTXCID2028226|4-amino-N-(1-azabicyclo(2,2,2)oct-3-yl)-5-chloro-2-methoxybenzamide-2-butenedioate|Zacopride [INN]|4-Amino-5-chloro-2-methoxy-N-(quinuclidin-3-yl)benzamide|CHEMBL18041|4-amino-N-(1-azabicyclo[2.2.2]octan-3-yl)-5-chloro-2-methoxybenzamide|4-Amino-N-1-azabicyclo(2.2.2)oct-3-yl-5-chloro-2-methoxybenzamide|Zacopridum [Latin]|Zacoprida [Spanish]|ZACOPRIDE,R|ZACOPRIDE,S|(RS)-Zacopride|UNII-9GN3OT4156|4-amino-n-1-azabicyclo[2.2.2]oct-3-yl-5-chloro-2-methoxybenzamide|Racemic zacopride|ZACOPRIDE,RS|(.+/-.)-Zacopride|4-amino-n-(1-azabicyclo[2.2.2]oct-3-yl)-5-chloro-2-methoxybenzamide|(+/-)-ZACOPRIDE|SCHEMBL16003|GTPL245|orb1689901|4-Amino-N-(1-aza-bicyclo[2.2.2]oct-3-yl)-5-chloro-2-methoxy-benzamide|SCHEMBL29567897|CHEBI:91810|EX-A6132|BDBM50000492|PDSP1_001616|PDSP1_001704|PDSP2_001600|PDSP2_001687|AKOS040758736|CS-0065672|NS00121280|Q75830|L001315|BRD-A65615053-003-01-4|BRD-A65615053-003-02-2|BRD-A65615053-311-05-2|4-AMINO-5-CHLORO-N-3-QUINUCLIDINYL-O-ANISAMIDE|(zacopride)4-Amino-N-(1-aza-bicyclo[2.2.2]oct-3-yl)-5-chloro-2-methoxy-benzamide|4-Amino-N-(1-aza-bicyclo[2.2.2]oct-3-yl)-5-chloro-2-methoxy-benzamide (Zacopride)|4-Amino-N-(1-aza-bicyclo[2.2.2]oct-3-yl)-5-chloro-2-methoxy-benzamide(zacopride)|HTR5A4-Amino-N-(1-aza-bicyclo[2.2.2]oct-3-yl)-5-chloro-2-methoxy-benzamide"
SAR-260301,135565159,,"InChI=1S/C19H22N4O3/c1-13-10-14-4-2-3-5-15(14)23(13)19(25)11-16-20-17(12-18(24)21-16)22-6-8-26-9-7-22/h2-5,12-13H,6-11H2,1H3,(H,20,21,24)/t13-/m0/s1",UAXHPOBBKRWJGA-ZDUSSCGKSA-N,C19H22N4O3,354.4,"2-[2-[(2S)-2-methyl-2,3-dihydroindol-1-yl]-2-oxoethyl]-4-morpholin-4-yl-1H-pyrimidin-6-one","1260612-13-2|SAR-260301|(S)-2-(2-(2-Methylindolin-1-yl)-2-oxoethyl)-6-morpholinopyrimidin-4(3H)-one|SAR260301|33639WNC7Q|4(3H)-Pyrimidinone, 2-(2-((2S)-2,3-dihydro-2-methyl-1H-indol-1-yl)-2-oxoethyl)-6-(4-morpholinyl)-|4(3H)-Pyrimidinone, 2-[2-[(2S)-2,3-dihydro-2-methyl-1H-indol-1-yl]-2-oxoethyl]-6-(4-morpholinyl)-|2-(2-((2S)-2-methyl-2,3-dihydroindol-1-yl)-2-oxoethyl)-6-morpholin-4-yl-1H-pyrimidin-4-one|2-[2-[(2S)-2-methyl-2,3-dihydroindol-1-yl]-2-oxoethyl]-6-morpholin-4-yl-1H-pyrimidin-4-one|RefChem:181306|PI3K-beta Inhibitor SAR260301|SAR 260301|MFCD27987912|CHEMBL3112866|compound 28 [PMID: 24387221]|2-{2-[(2S)-2-methyl-2,3-dihydro-1H-indol-1-yl]-2-oxoethyl}-6-(morpholin-4-yl)pyrimidin-4(3H)-one|2-[2-(2-Methyl-2,3-Dihydro-Indol-1-Yl)-2-Oxo-Ethyl]-6-Morpholin-4-Yl-3h-Pyrimidin-4-One|2-[2-[(2S)-2-methyl-2,3-dihydroindol-1-yl]-2-oxoethyl]-4-morpholin-4-yl-1H-pyrimidin-6-one|4bfr|UAXHPOBBKRWJGA-ZDUSSCGKSA-N|J82|UNII-33639WNC7Q|GTPL8793|orb1307758|SCHEMBL1027765|GLXC-15264|KAC61213|AKOS025291099|AKOS040742610|AS-35206|DA-77684|HY-15837|CS-0009322|Q27076495|2-[2-[(2S)-2-methylindolin-1-yl]-2-oxo-ethyl]-6-morpholino-1H-pyrimidin-4-one"
GRAZOPREVIR ANHYDROUS,44603531,,"InChI=1S/C38H50N6O9S/c1-6-22-19-38(22,35(47)43-54(49,50)25-13-14-25)42-32(45)29-18-24-20-44(29)34(46)31(37(2,3)4)41-36(48)53-30-16-21(30)10-8-7-9-11-27-33(52-24)40-28-17-23(51-5)12-15-26(28)39-27/h6,12,15,17,21-22,24-25,29-31H,1,7-11,13-14,16,18-20H2,2-5H3,(H,41,48)(H,42,45)(H,43,47)/t21-,22-,24-,29+,30-,31-,38-/m1/s1",OBMNJSNZOWALQB-NCQNOWPTSA-N,C38H50N6O9S,766.9,"(1R,18R,20R,24S,27S)-24-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide","Grazoprevir|1350514-68-9|MK5172|MK-5172 ANHYDROUS|(1R,18R,20R,24S,27S)-24-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl]-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide|CHEBI:132975|DTXSID50159234|MK-5172 MONOHYDRATE|DTXSID00159229|1350462-55-3|grazoprevirum|(1R,18R,20R,24S,27S)-24-tert-butyl-N-((1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-ethenylcyclopropyl)-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo(24.2.1.03,12.05,10.018,20)nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide|RefChem:782705|DTXCID4081725|DTXCID9081720|J05AP11|Cyclopropanecarboxamide, N-((((1R,2R)-2-(5-(3-hydroxy-6-methoxy-2-quinoxalinyl)pentyl)cyclopropyl)oxy)carbonyl)-3-methyl-L-valyl-(4R)-4-hydroxy-L-prolyl-1-amino-N-(cyclopropylsulfonyl)-2-ethenyl-, cyclic (1->2)-ether, hydrate (1:1) (1R,2S)-|4O2AB118LA|Grazoprevir Hydrate|Grazoprevir monohydrate|Grazoprevir anhydrous|Grazoprevir [INN]|8YE81R1X1J|(33R,35S,91R,92R,5S)-5-(tert-butyl)-N-((1R,2S)-1-((cyclopropylsulfonyl)carbamoyl)-2-vinylcyclopropyl)-17-methoxy-4,7-dioxo-2,8-dioxa-6-aza-1(2,3)-quinoxalina-3(3,1)-pyrrolidina-9(1,2)-cyclopropanacyclotetradecaphane-35-carboxamide|C38H50N6O9S|UNII-8YE81R1X1J|MFCD25976700|GRAZOPREVIR [MI]|Grazoprevir (USAN/INN)|MK-5172; Grazoprevir|GRAZOPREVIR [WHO-DD]|orb1302768|SCHEMBL2175313|CHEMBL2063090|GTPL11573|OBMNJSNZOWALQB-NCQNOWPTSA-N|EX-A2253|BDBM50485492|s3728|AKOS030253227|CCG-270451|CS-1374|DB11575|FG74818|ino[11,12-b]quinoxaline-8-carboxamide|NCGC00378916-02|AC-29227|AS-55861|HY-15298|MK-5172?|NS00073062|D11565|D82934|EN300-19880554|Zepatier [elbasvir (NS5A inhibitor) + grazoprevir]|BRD-K24943235-001-01-3|BRD-K24943235-237-01-3|Q19786991|Z2608566420|(1aR,5S,8S,10R,22aR)-5-tert-butyl-N-((1R,2S)-1-{[(cyclopropylsulfonyl)amino]carbonyl}-2-vinylcyclopropyl)-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide|(1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-dioxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadecino[11,12-b]quinoxaline-8-carboxamide|(1aR,5S,8S,10R,22aR)-5-tert-butyl-N-{(1R,2S)-1-[(cyclopropylsulfonyl)carbamoyl]-2-ethenylcyclopropyl}-14-methoxy-3,6-di|(1R,18R,20R,24S,27S)-24-tert-butyl-N-[(1R,2S)-1-(cyclopropylsulfonylcarbamoyl)-2-vinyl-cyclopropyl]-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetrazapentacyclo[24.2.1.03,12.05,10.018,20]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide|(1R,18R,20R,24S,27S)-24-tert-butyl-N-[(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl]-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetraazapentacyclo[24.2.1.0?,??.0?,??.0??,??]nonacosa-3,5,7,9,11-pentaene-27-carboxamide|(1R,18R,20R,24S,27S)-24-tert-butyl-N-[(1R,2S)-1-[(cyclopropanesulfonyl)carbamoyl]-2-ethenylcyclopropyl]-7-methoxy-22,25-dioxo-2,21-dioxa-4,11,23,26-tetraazapentacyclo[24.2.1.0^{3,12}.0^{5,10}.0^{18,20}]nonacosa-3,5(10),6,8,11-pentaene-27-carboxamide|1356446-42-8|CYCLOPROPANECARBOXAMIDE, N-((((1R,2R)-2-(5-(3-HYDROXY-6-METHOXY-2-QUINOXALINYL)PENTYL)CYCLOPROPYL)OXY)CARBONYL)-3-METHYL-L-VALYL-(4R)-4-HYDROXY-L-PROLYL-1-AMINO-N-(CYCLOPROPYLSULFONYL)-2-ETHENYL-, CYCLIC (1->2)-ETHER, (1R,2S)-|oxo-1,1a,3,4,5,6,9,10,18,19,20,21,22,22a-tetradecahydro-8H-7,10-methanocyclopropa[18,19][1,10,3,6]dioxadiazacyclononadec"
PF-03882845,46871935,,"InChI=1S/C24H22ClN3O2/c25-21-12-18(8-5-17(21)13-26)28-23(14-3-1-2-4-14)20-10-6-15-11-16(24(29)30)7-9-19(15)22(20)27-28/h5,7-9,11-12,14,20,23H,1-4,6,10H2,(H,29,30)/t20-,23-/m0/s1",XNULRSOGWPFPBL-REWPJTCUSA-N,C24H22ClN3O2,419.9,"(3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydrobenzo[g]indazole-7-carboxylic acid","1023650-66-9|PF-03882845|PF-3882845|34ZKU73FU3|(3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydrobenzo[g]indazole-7-carboxylic acid|DTXSID70144940|(3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydrobenzo(g)indazole-7-carboxylic acid|RefChem:172227|DTXCID9067431|PF3882845|PF 3882845|PF03882845|(3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-2H,3H,3aH,4H,5H-benzo(g)indazole-7-carboxylic acid|UNII-34ZKU73FU3|PF-03882845(PF03882845)|CHEMBL1215331|(3S,3aR)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid|compound 2 [PMID: 24738581]|SCHEMBL552307|GTPL9061|orb1706807|SCHEMBL29412449|SCHEMBL29642523|XNULRSOGWPFPBL-REWPJTCUSA-N|GLXC-07434|(+/-)-(3SR,3aRS)-2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-7-carboxylic acid|BDBM50324210|AKOS040742404|DB11814|NCGC00485023-01|DA-76785|HY-12738|CS-0012315|NS00072781|PF-03882845, >=98% (HPLC)|Q27088312|(3S,3aR)-2-(3-Chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benz[g]indazole-7-carboxylic acid|(3S,3AR)-2-(3-CHLORO-4-CYANOPHENYL)-3-CYCLOPENTYL-3,3A,4,5-TETRAHYDRO-2HBENZO(G)INDAZOLE-7-CARBOXYLIC ACID|2-(3-chloro-4-cyanophenyl)-3-cyclopentyl-3,3a,4,5-tetrahydro-2H-benzo(g)indazole-7-carboxylic acid|2H-BENZ(G)INDAZOLE-7-CARBOXYLIC ACID, 2-(3-CHLORO-4-CYANOPHENYL)-3-CYCLOPENTYL-3,3A,4,5-TETRAHYDRO-, (3S,3AR)-"
TAK-733,24963252,,"InChI=1S/C17H15F2IN4O4/c1-23-15-12(16(27)24(7-21-15)5-9(26)6-25)14(13(19)17(23)28)22-11-3-2-8(20)4-10(11)18/h2-4,7,9,22,25-26H,5-6H2,1H3/t9-/m1/s1",RCLQNICOARASSR-SECBINFHSA-N,C17H15F2IN4O4,504.23,"3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido[2,3-d]pyrimidine-4,7-dione","TAK-733|1035555-63-5|TAK 733|TAK733|(R)-3-(2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodophenylamino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione|5J61HSP0QJ|Mek inhibitor tak-733|REC-4881|3-[(2r)-2,3-Dihydroxypropyl]-6-Fluoro-5-[(2-Fluoro-4-Iodophenyl)amino]-8-Methylpyrido[2,3-D]pyrimidine-4,7(3h,8h)-Dione|3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido[2,3-d]pyrimidine-4,7-dione|(R)-3-(2,3-DIHYDROXYPROPYL)-6-FLUORO-5-(2-FLUORO-4-IODOPHENYLAMINO)-8-METHYLPYRIDO(2,3-D)PYRIMIDINE-4,7(3H,8H)-DIONE|3-((2R)-2,3-dihydroxypropyl)-6-fluoro-5-((2-fluoro-4-iodophenyl)amino)-8-methylpyrido(2,3-d)pyrimidine-4,7(3H,8H)-dione|RefChem:187199|MEK Inhibitor REC-4881|REC4881|3-((2R)-2,3-dihydroxypropyl)-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido(2,3-d)pyrimidine-4,7-dione|REC 4881|3-((2R)-2,3-dihydroxypropyl)-6-fluoro-5-((2-fluoro-4-iodophenyl)amino)-8-methyl-3H,4H,7H,8H-pyrido(2,3-d)pyrimidine-4,7-dione|UNII-5J61HSP0QJ|CHEMBL1615025|(R)-3-(2,3-Dihydroxypropyl)-6-fluoro-5-((2-fluoro-4-iodophenyl)amino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione|3-[(2R)-2,3-Dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodoanilino)-8-methylpyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione|MFCD24386349|MLS006011054|GTPL9911|orb1300550|SCHEMBL1528606|C17H15F2IN4O4|SCHEMBL29363215|TAK 733 [WHO-DD]|DTXSID20648089|CHEBI:231366|RCLQNICOARASSR-SECBINFHSA-N|example 18 [US8470837]|BCP06625|EX-A2164|TAK-733?|BDBM50337926|NSC761215|NSC800940|s2617|AKOS027251050|CCG-264969|CS-1283|DB12241|NSC-761215|NSC-800940|SDCCGSBI-0654418.P001|compound 17 [PMID: 21310613]|NCGC00263187-01|FT103481|HY-13449|MS-29359|SMR004702846|NS00072542|SW220152-1|US8470837, 18|BRD-K26667523-001-02-5|BRD-K26667523-001-03-3|Q27262384|3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-(2-fluoro-4-iodo-anilino)-8-methyl-pyrido[2,3-d]pyrimidine-4,7-dione|3-[(2R)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodo-phenyl)amino]-8-methyl-pyrido[2,3-d]pyrimidine-4,7-dione|3-[(2r)-2,3-dihydroxypropyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methylpyrido [2,3-d]pyrimidine-4,7(3h,8h)-dione|IZG|Pyrido[2,3-d]pyrimidine-4,7(3H,8H)-dione,3-[(2R)-2,3-dihydroxy-propyl]-6-fluoro-5-[(2-fluoro-4-iodophenyl)amino]-8-methyl-"
PIMASERTIB,44187362,,"InChI=1S/C15H15FIN3O3/c16-12-5-9(17)1-2-13(12)20-14-7-18-4-3-11(14)15(23)19-6-10(22)8-21/h1-5,7,10,20-22H,6,8H2,(H,19,23)/t10-/m0/s1",VIUAUNHCRHHYNE-JTQLQIEISA-N,C15H15FIN3O3,431.20,"N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodoanilino)pyridine-4-carboxamide","Pimasertib|1236699-92-5|AS-703026|AS703026|6ON9RK82AL|MSC-1936369|MSC1936369A|MSC-1936369A|EMD 1036239|EMD-1036239|4-Pyridinecarboxamide, N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]-|4-Pyridinecarboxamide, N-((2S)-2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)-|N-[(2S)-2,3-dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]pyridine-4-carboxamide|G-02443714|N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodoanilino)pyridine-4-carboxamide|N-((2S)-2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)pyridine-4-carboxamide|pimasertibum|N-((2S)-2,3-dihydroxypropyl)-3-(2-fluoro-4-iodoanilino)pyridine-4-carboxamide|RefChem:863289|GlyTouCan:G49878UC|G49878UC|MSC1936369|Msc1936369a; as703026; emd 1036239|N-((2S)-2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)isonicotinamide Hydrochloride|Pimasertib (AS-703026)|AS 703026|MSC1936369B|1204531-26-9|(S)-N-(2,3-dihydroxypropyl)-3-(2-fluoro-4-iodophenylamino)isonicotinamide|MFCD16660676|(S)-N-(2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)isonicotinamide|N-[(2S)-2,3-dihydroxypropyl]-3-(2-fluoro-4-iodo-anilino)pyridine-4-carboxamide|(S)-N-(2,3-dihydroxypropyl)-3-((2-fluoro-4-iodophenyl)amino)isonicotinamide.|Pimasertib [INN]|Pimasertib [USAN:INN]|UNII-6ON9RK82AL|C15H15FIN3O3|(S)-N-(2,3-Dihydroxypropyl)-3-[(2-fluoro-4-iodophenyl)amino]isonicotinamide|AS703026Pimasertib|Pimasertib (USAN/INN)|PIMASERTIB [USAN]|PIMASERTIB [WHO-DD]|MLS006010177|GTPL7872|orb1301047|orb1738240|SCHEMBL2720659|CHEMBL2107832|SCHEMBL29358435|CHEBI:94793|DTXSID40152870|EX-A403|BCPP000386|BCP02094|BDBM50014412|NSC755763|NSC800854|AKOS022186348|BCP9000325|CCG-269018|CS-0198|DB14904|FD32913|NSC-755763|NSC-800854|SAR 245509|SDCCGSBI-0654259.P002|NCGC00346530-01|AC-32862|AS-16324|HY-12042|SMR004701285|SY020940|AS703026,MSC1936369B|SW219691-1|C71933|D10426|BRD-K89014967-001-01-9|BRD-K89014967-001-04-3|Q27088393|AS7030261236699-92-5|N-[(2S)-2,3-Dihydroxypropyl]-3-[(2-fluoro-4-iodophenyl)amino]isonicotinamide;AS703026"
BAICALEIN,5281605,,"InChI=1S/C15H10O5/c16-9-6-11(8-4-2-1-3-5-8)20-12-7-10(17)14(18)15(19)13(9)12/h1-7,17-19H",FXNFHKRTJBSTCS-UHFFFAOYSA-N,C15H10O5,270.24,"5,6,7-trihydroxy-2-phenylchromen-4-one","baicalein|491-67-8|5,6,7-Trihydroxyflavone|Noroxylin|5,6,7-trihydroxy-2-phenyl-4H-chromen-4-one|5,6,7-trihydroxy-2-phenylchromen-4-one|NSC-661431|CHEBI:2979|DTXSID2022389|49QAH60606|5,6,7-Trihydroxy-2-phenyl-4H-1-benzopyran-4-one|RefChem:5579|DTXCID802389|637-183-7|BaiKalein|MFCD00017459|5,6,7-trihydroxy-2-phenyl-chromen-4-one|4H-1-Benzopyran-4-one, 5,6,7-trihydroxy-2-phenyl-|NSC661431|CHEMBL8260|5,7-Trihydroxyflavone|Biacalein|SMR000112462|SR-01000597499|NSC 661431|Sho-saiko-to|UNII-49QAH60606|Baicalein, 8|3WL|Baicalein, 14|Baicalein, 98%|Baicalein (Standard)|Baicalein (Noroxylin)|Spectrum_000427|Tocris-1761|SpecPlus_000758|BAICALEIN [MI]|Spectrum2_000466|Spectrum3_001608|Spectrum4_000537|Spectrum5_001418|BAICALEIN [USP-RS]|BAICALEIN [WHO-DD]|Oprea1_765614|BSPBio_003215|KBioGR_001173|KBioSS_000907|MLS002473007|MLS006011756|BIDD:ER0121|DivK1c_006854|SCHEMBL139617|SPECTRUM1504002|SPBio_000572|GTPL5144|SCHEMBL29385549|HY-N0196R|KBio1_001798|KBio2_000907|KBio2_003475|KBio2_006043|KBio3_002435|HMS1922O22|HMS2267F15|HMS3268C22|HMS3412F14|HMS3649O19|HMS3655P18|HMS3676F14|HMS5080M22|ALBB-028286|BCP14393|HY-N0196|TNP00121|BBL027840|BDBM50009001|CCG-38705|LMPK12111095|NSC729192|s2268|SBB067246|STL146746|AKOS005747014|AC-7991|CS-6159|FT66348|NSC-729192|SDCCGMLS-0066744.P001|Baicalein, analytical reference material|SMP1_000037|NCGC00017236-01|NCGC00017236-02|NCGC00017236-03|NCGC00017236-04|NCGC00017236-05|NCGC00017236-06|NCGC00017236-07|NCGC00017236-08|NCGC00017236-10|NCGC00017236-11|NCGC00017236-21|NCGC00025282-01|NCGC00025282-02|NCGC00025282-03|NCGC00025282-04|NCGC00178204-01|AS-57923|PD132943|ST057152|SY057137|5,6,7-Trihydroxy-2-phenyl-chroman-4-one|NS00097437|SW219229-1|T2721|EN300-303171|S00113|491B678|5,7-Trihydroxy-2-phenyl-4H-1-benzopyran-4-one|AA-504/20839002|F979938|Q2879363|SR-01000597499-1|SR-01000597499-3|SR-01000597499-4|SR-01000597499-6|BRD-K72327355-001-02-2|BRD-K72327355-001-06-3|BRD-K72327355-001-13-9|BRD-K72327355-001-14-7|BRD-K72327355-001-15-4|Z1824568302"
OPICAPONE,135565903,,"InChI=1S/C15H10Cl2N4O6/c1-5-10(13(17)20(24)6(2)11(5)16)14-18-15(27-19-14)7-3-8(21(25)26)12(23)9(22)4-7/h3-4,22-23H,1-2H3",ASOADIZOVZTJSR-UHFFFAOYSA-N,C15H10Cl2N4O6,413.2,"5-[3-(2,5-dichloro-4,6-dimethyl-1-oxidopyridin-1-ium-3-yl)-1,2,4-oxadiazol-5-yl]-3-nitrobenzene-1,2-diol","Opicapone|923287-50-7|ongentys|BIA 9-1067|Opicapona|2,5-Dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine 1-oxide|BIA-91067|BIA-9-1067|DTXSID601026417|opicaponum|(4Z)-4-(3-(2,5-dichloro-4,6-dimethyl-1-oxidopyridin-1-ium-3-yl)-2H-1,2,4-oxadiazol-5-ylidene)-2-hydroxy-6-nitrocyclohexa-2,5-dien-1-one|(4Z)-4-[3-(2,5-dichloro-4,6-dimethyl-1-oxidopyridin-1-ium-3-yl)-2H-1,2,4-oxadiazol-5-ylidene]-2-hydroxy-6-nitrocyclohexa-2,5-dien-1-one|2,5-Dichloro-3-[5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl]-4,6-dimethylpyridine 1-Oxide|RefChem:57625|N04BX04|DTXCID001510622|1,2-Benzenediol, 5-(3-(2,5-dichloro-4,6-dimethyl-1-oxido-3-pyridinyl)-1,2,4-oxadiazol-5-yl)-3-nitro-|2,5-Dichloro-3-(5-(3,4-dihydroxy-5-nitrophenyl)-1,2,4-oxadiazol-3-yl)-4,6-dimethylpyridine N-oxide|Y5929UIJ5N|CHEMBL1089318|5-[3-(2,5-dichloro-4,6-dimethyl-1-oxidopyridin-1-ium-3-yl)-1,2,4-oxadiazol-5-yl]-3-nitrobenzene-1,2-diol|Ontilyv|Opicapone?|Opicapone [INN]|MFCD19443745|Opicapone (Standard)|OPICAPONE [JAN]|OPICAPONE [MI]|OPICAPONE [USAN]|OPICAPONE [WHO-DD]|SCHEMBL539065|GTPL8988|orb1307928|OPICAPONE [ORANGE BOOK]|SCHEMBL17559532|SCHEMBL19205880|SCHEMBL29367692|SCHEMBL29582646|SCHEMBL31347806|SCHEMBL31404127|CHEBI:134699|BCP24268|EX-A5000|BDBM50019329|HY-14896R|ZB1234|AT23149|DB11632|SB17488|compound 37d [PMID: 20334432]|NCGC00390666-01|DA-66356|HY-14896|MS-27141|SY299719|NS00072087|EN300-20385166|BRD-K66192203-001-01-4|BRD-K66192203-001-02-2|Q27088208|BIA 9-1067; BIA 91067; BIA-91067; BIA91067|1,2-Benzenediol, 5-[3-(2,5-dichloro-4,6-dimethyl-1-oxido-3-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-nitro-; 5-[3-(2,5-Dichloro-4,6-dimethyl-1-oxido-3-pyridinyl)-1,2,4-oxadiazol-5-yl]-3-nitro-1,2-benzenediol; 5-[3-(2,5-Dichloro-4,6-dimethyl-1-oxy-pyridin-3-yl)-[|2,5-DICHLORO-3-[5-(3,4-DIHYDROXY-5-NITROPHENYL)-1,2,4-OXADIAZOL-3-YL]-4,6-DIMETHYLPYRIDIN-1-IUM-1-OLATE|5-(3-(2,5-DICHLORO-4,6-DIMETHYL-1-OXY-PYRIDIN-3-YL)-(1,2,4)OXADIAZOL-5-YL)-3-NITROBENZENE-1,2-DIOL"
PF-5190457,58438464,,"InChI=1S/C29H32N6OS/c1-19-11-25(31-18-30-19)22-3-5-24-21(12-22)4-6-26(24)35-16-29(17-35)7-9-33(10-8-29)27(36)13-23-15-34-14-20(2)37-28(34)32-23/h3,5,11-12,14-15,18,26H,4,6-10,13,16-17H2,1-2H3/t26-/m1/s1",ZIUDADZJCKGWKR-AREMUKBSSA-N,C29H32N6OS,512.7,"2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-[2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone","1334782-79-4|PF-5190457|PF-05190457|FF33NL9U5G|2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-[2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone|Ethanone, 1-(2-((1R)-2,3-dihydro-5-(6-methyl-4-pyrimidinyl)-1H-inden-1-yl)-2,7-diazaspiro(3.5)non-7-yl)-2-(2-methylimidazo(2,1-b)thiazol-6-yl)-|2-(2-methylimidazo(2,1-b)(1,3)thiazol-6-yl)-1-(2-((1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro(3.5)nonan-7-yl)ethanone|2-{2-METHYLIMIDAZO[2,1-B][1,3]THIAZOL-6-YL}-1-{2-[(1R)-5-(6-METHYLPYRIMIDIN-4-YL)-2,3-DIHYDRO-1H-INDEN-1-YL]-2,7-DIAZASPIRO[3.5]NONAN-7-YL}ETHANONE|RefChem:172286|2-(2-methylimidazo(2,1-b)(1,3)thiazol-6-yl)-1-(2-((1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro(3.5)nonan-7-yl)ethan-1-one|(R)-2-(2-Methylimidazo[2,1-b]thiazol-6-yl)-1-(2-(5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonan-7-yl)ethan-1-one|1-[2-[(1R)-2,3-Dihydro-5-(6-methyl-4-pyrimidinyl)-1H-inden-1-yl]-2,7-diazaspiro[3,5]non-7-yl]-2-(2-methylimidazo[2,1-b]thiazol-6-yl)ethanone|UNII-FF33NL9U5G|CHEMBL3287218|PF 05190457|PF 5190457|MFCD28411390|C29H32N6OS|GTPL9060|orb1307892|SCHEMBL2445443|SCHEMBL29766846|ZIUDADZJCKGWKR-AREMUKBSSA-N|GLXC-07414|GLXC-25339|BDBM50019926|AKOS034831614|DB14870|AC-36924|DA-56719|HY-12584|MS-29520|CS-0012053|G14477|PF-05190457, >=95% (HPLC)|BRD-K02554563-001-01-6|Q27088321|(R)-2-(2-methylimidazo[2,1-b]thiazol-6-yl)-1-(2-(5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl)-2,7-diazaspiro[3.5]nonan-7-yl)ethanone|2-(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-{2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1 h-inden-1-yl]-2,7-diazaspiro[3.5]non-7-yl}ethanone)|2-(2-Methylimidazo[2,1-b][1,3]thiazol-6-yl)-1-{2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]non-7-ylethanone|2-(2-methylimidazo[2,1-b]thiazol-6-yl)-1-[2-[(1R)-5-(6-methylpyrimidin-4-yl)indan-1-yl]-2,7-diazaspiro[3.5]nonan-7-yl]ethanone|7-[(2-methylimidazo[2,1-b][1,3]thiazol-6-yl)acetyl]-2-[(1R)-5-(6-methylpyrimidin-4-yl)-2,3-dihydro-1H-inden-1-yl]-2,7-diazaspiro[3.5]nonane"
FINGOLIMOD,107970,,"InChI=1S/C19H33NO2/c1-2-3-4-5-6-7-8-17-9-11-18(12-10-17)13-14-19(20,15-21)16-22/h9-12,21-22H,2-8,13-16,20H2,1H3",KKGQTZUTZRNORY-UHFFFAOYSA-N,C19H33NO2,307.5,"2-amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol","Fingolimod|162359-55-9|2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol|1,3-Propanediol, 2-amino-2-[2-(4-octylphenyl)ethyl]-|fingolimodum|3QN8BYN5QF|CHEBI:63115|1,3-Propanediol, 2-amino-2-(2-(4-octylphenyl)ethyl)-|2-amino-2-(2-(4-octylphenyl)ethyl)propane-1,3-diol|DTXSID40167363|RefChem:57690|GlyTouCan:G45447JX|DTXCID0089854|L04AA27|G45447JX|988-320-5|2-Amino-2-(4-octylphenethyl)propane-1,3-diol|Fingolimod [INN]|2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol|2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol|C19H33NO2|Gilenya (TN)|CHEMBL314854|Fingolimod (INN)|UNII-3QN8BYN5QF|2-amino-2-(2-(4-octylphenyl)ethyl)-1,3-propanediol|2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol; 2-Amino-2-[2-(4-octylphenyl)ethyl]propane-1,3-diol; Fingolimod; 1,3-Propanediol, 2-amino-2-[2-(4-octylphenyl)ethyl]-|MFCD14705150|Fingolimod (Standard)|FINGOLIMOD [MI]|FINGOLIMOD [VANDF]|FINGOLIMOD [MART.]|SCHEMBL7445|FINGOLIMOD [WHO-DD]|Fingolimod - Bio-X trade mark|GTPL2407|orb1299367|FINGOLIMOD [ORANGE BOOK]|HMS3743O13|HMS5085B21|BCP05969|BDBM50158336|HY-11063R|NSC755643|s5950|STL445699|AKOS015999594|DB05286|DB08868|FA46838|NSC-755643|NCGC00188399-01|NCGC00188399-03|NCGC00188399-04|NCGC00188399-06|NCGC00188399-16|AC-25899|AS-68987|BF164460|HY-11063|DB-064455|NS00016757|2-(4-octylphenethyl)-2-aminopropane-1,3-diol|D70458|2-amino-2-(4-octylphenyl)ethylpropane-1,3-diol|EN300-18802383|Q425137|2-amino-2-hydroxymethyl-4-(4-(octyl)phenyl)butanol|BRD-K88025533-003-01-7|BRD-K88025533-003-03-3|BRD-K88025533-003-04-1|2-Amino-2-[2-(4-octyl-phenyl)-ethyl]-propane-1,3-diol|2-Amino-2-[2-(4-octylphenyl)ethyl]-1,3-propandiol;FTY720"
OXYPURINOL,135398752,,"InChI=1S/C5H4N4O2/c10-4-2-1-6-9-3(2)7-5(11)8-4/h1H,(H3,6,7,8,9,10,11)",HXNFUBHNUDHIGC-UHFFFAOYSA-N,C5H4N4O2,152.11,"1,7-dihydropyrazolo[3,4-d]pyrimidine-4,6-dione","Oxypurinol|2465-59-0|Oxipurinol|1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol|Alloxanthine|Oxoallopurinol|1H-Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione|Ossipurinolo|Oxipurinolum|NSC-76239|DTXSID4035209|CHEBI:28315|1H-Pyrazolo(3,4-d)pyrimidine-4,6-diol|G97OZE5068|1,2-dihydropyrazolo[3,4-d]pyrimidine-4,6-dione|1H-Pyrazolo(3,4-d)pyrimidine,4,6(5H,7H)-dione|1H-PYRAZOLO(3,4-D)PYRIMIDINE-4,6(5H,7H)-DIONE|DTXCID2015209|1,7-dihydropyrazolo[3,4-d]pyrimidine-4,6-dione|NSC76239|1H,4H,5H,6H,7H-pyrazolo[3,4-d]pyrimidine-4,6-dione|1,2-dihydropyrazolo(3,4-d)pyrimidine-4,6-dione|1,7-dihydropyrazolo(3,4-d)pyrimidine-4,6-dione|1H,4H,5H,6H,7H-pyrazolo(3,4-d)pyrimidine-4,6-dione|RefChem:169085|219-570-9|DHPP|4,6-Dihydroxypyrazolo[3,4-d]pyrimidine|184764-63-4|1H-Pyrazolo[3,4-d]pyrimidine-4,6(2H,5H)-dione|2H-Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione|187486-05-1|Oxypurinol [USAN]|187486-06-2|BW 555|MFCD00056934|B. W. 55-5|Oxipurinol [INN]|BW 55-5|1H,3H,9H-Alloxanthine|MFCD00047205|4,6-Dihydroxypyrazolo(3,4-d)pyrimidine|4,6-Dihydroxy-1H-pyrazolo[3,4-d]pyrimidine|4H-Pyrazolo[3,4-d]pyrimidin-4-one,  1,2-dihydro-6-hydroxy-|Oxipurinol (INN)|Oxypurinol (USAN)|1H-Pyrazolo[3,4-d]Pyrimidin-4,6-diol|Alloxanthin (VAN)|2H,4H,5H,6H,7H-pyrazolo[3,4-d]pyrimidine-4,6-dione|Ossipurinolo [DCIT]|1,7-Dihydro-4h-pyrazolo[3,4-d]pyrimidine-4,6(5h)-dione|Oxipurinolum [INN-Latin]|SMR000471889|EINECS 219-570-9|NSC 76239|EPA Pesticide Chemical Code 447509|UNII-G97OZE5068|AI3-50432|1H-Pyrazolo(3,4-d)pyrimidine, 4,6(5H,7H)-dione|6-Hydroxy allopurinol|Oxypurinol (Standard)|1H-Pyrazolo[3,6-diol|CHEMBL859|OXIPURINOL [WHO-DD]|SCHEMBL39154|SCHEMBL49280|SCHEMBL49281|MLS001332657|MLS001332658|Oxypurinol, analytical standard|orb1307722|SCHEMBL1438699|SCHEMBL2017937|SCHEMBL2077651|SCHEMBL8256426|SCHEMBL8256749|SCHEMBL8256863|SCHEMBL8257647|SCHEMBL8258215|SCHEMBL8258318|SCHEMBL8258418|SCHEMBL8260172|Oxypurinol, >=98% (HPLC)|4h-pyrazolo[3,4-d]pyrimidin-4-one,1,2-dihydro-6-hydroxy-|HMS2234G23|HMS3373G16|MSK10378|1H-Pyrazolo[3,6(5H,7H)-dione|Oxypurinol 100 microg/mL in Water|Tox21_301220|BDBM50423777|HY-19657R|SBB081955|pyrazolo[5,4-d]pyrimidine-4,6-diol|AKOS002337397|AKOS005166855|AKOS022171676|AB02032|CCG-321461|DB05262|FD00465|1H-Pyrazolo[3, 4,6(5H,7H)-dione|NCGC00247052-01|NCGC00255415-01|BP-30013|DA-76514|DS-14873|HY-19657|SY009072|6-Hydroxypyrazolo[3,4-d]pyrimidin-4-one|CAS-2465-59-0|DB-065490|DB-261137|CS-0016170|NS00006655|ST50824307|C07599|D02365|EN300-1268328|1,2-dihydropyrazolo[4,3-e]pyrimidine-4,6-dione|5,7-dihydropyrazolo[5,4-d]pyrimidine-4,6-dione|F793773|Q410588|Oxypurinol;1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol|2h-pyrazolo-[3,4-d]pyrimidine-4,6-(5h,7h)-dione|BRD-K31841515-001-07-8|1H,2H,4H,5H,6H-pyrazolo[3,4-d]pyrimidine-4,6-dione|Z3015154132|1,2-dihydro-4H-pyrazolo[3,4-d]pyrimidine-4,6(5H)-dione|4,5,6,7-tetrahydro-4,6-dioxo-pyrazolo-[3,4-d]-pyrimidine|6-Hydroxy-1,5-dihydro-4H-pyrazolo[3,4-d]pyrimidin-4-one #"
HALOPERIDOL DECANOATE,52919,,"InChI=1S/C31H41ClFNO3/c1-2-3-4-5-6-7-8-11-30(36)37-31(26-14-16-27(32)17-15-26)20-23-34(24-21-31)22-9-10-29(35)25-12-18-28(33)19-13-25/h12-19H,2-11,20-24H2,1H3",GUTXTARXLVFHDK-UHFFFAOYSA-N,C31H41ClFNO3,530.1,[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate,"HALOPERIDOL DECANOATE|74050-97-8|Haldol decanoate|Haldol Dec|DTXSID50224951|AC20PJ4101|R-13672|R-13,672|Decanoic acid, 4-(4-chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidinyl ester|RefChem:56648|DTXCID80147442|Haldol|Halomonth|4-(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)piperidin-4-yl decanoate|Decanoic acid, ester with 4-(4-(p-chlorophenyl)-4-hydroxypiperidino)-4'-fluorobutyrophenone|Haldol decanoas|C31H41ClFNO3|Depot haloperidol|Haloperidol depot|KD 16|4-(4-Chlorophenyl)-1-(4-(4-fluorophenyl)-4-oxobutyl)-4-piperidyl decanoate|4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidyl decanoate|Halomonth; Haloperidol decanoate; KD 136; KD 16; Neoperidole; R 13762|KD 136|EINECS 277-679-7|Haloperidol Decanoate HCl|KD-136|UNII-AC20PJ4101|Halomonth (TN)|Haloperidol decanoate; 4-(4-Chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl decanoate|R 13672|haloperidol-decanoate|R 13,672|[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]piperidin-4-yl] decanoate|Haloperidol decanoate [USAN:USP:BAN:JAN]|SCHEMBL120575|orb1305330|CHEMBL1200986|Haloperidol decanoate (Standard)|CHEBI:31664|Haloperidol decanoate (JAN/USP)|HALOPERIDOL DECANOATE [MI]|HMS3887C07|HMS5086F07|HALOPERIDOL DECANOATE [JAN]|HALOPERIDOL DECANOATE [USAN]|BDBM50053408|MFCD00866706|HALOPERIDOL DECANOATE [MART.]|AKOS025392169|HALOPERIDOL DECANOATE [USP-RS]|HALOPERIDOL DECANOATE [WHO-DD]|FH23735|HY-107969R|KS-1419|NCGC00508704-02|DA-60293|HALOPERIDOL DECANOATE [EP IMPURITY]|HALOPERIDOL DECANOATE [ORANGE BOOK]|HALOPERIDOL DECANOATE [EP MONOGRAPH]|HALOPERIDOL DECANOATE [USP IMPURITY]|HY-107969|CS-0031068|HALOPERIDOL DECANOATE [USP MONOGRAPH]|NS00020705|D01898|G78314|SBI-0654657.0001|BRD-K80859331-001-01-5|Q27273855|[4-(4-chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxo-butyl]-4-piperidyl] decanoate|4-(4-Chlorophenyl)-1-[4-(4-fluorophenyl)-4-oxobutyl]-4-piperidinyl ester decanoic acid;Haldol decanoate;Halomonth"
BISFENAZONE,189866,,"InChI=1S/C25H29N5O2/c1-17(2)22-21(28(5)29(24(22)31)19-12-8-6-9-13-19)16-26-23-18(3)27(4)30(25(23)32)20-14-10-7-11-15-20/h6-15,17,26H,16H2,1-5H3",JPKRUWRMHGVJCV-UHFFFAOYSA-N,C25H29N5O2,431.5,"1,5-dimethyl-4-[(2-methyl-5-oxo-1-phenyl-4-propan-2-ylpyrazol-3-yl)methylamino]-2-phenylpyrazol-3-one","Bisfenazone|Bisfenazonum|Bisfenazona|55837-24-6|Bisfenazone [INN:DCF]|UNII-3OA32ZIB31|3OA32ZIB31|BISFENAZONE [INN]|DTXSID90204434|RefChem:120390|DTXCID90126925|1,5-dimethyl-4-[(2-methyl-5-oxo-1-phenyl-4-propan-2-ylpyrazol-3-yl)methylamino]-2-phenylpyrazol-3-one|SCHEMBL2111251|CHEMBL2105528|BDBM50026672|NS00124949|Q27257815|3-(((2,3-Dimethyl-5-oxo-1-phenyl-3-pyrazolin-4-yl)amino)methyl)-4-isopropyl-2-methyl-1-phenyl-3-pyrazolin-5-one|3-(((2,3-Dimethyl-5-oxo-1-phenyl-3-pyrzolin-4-yl)amino)methyl)-4-isopropyl-2-methyl-1-phenyl-3-pyrazolin-5-one"
THIRAM,5455,,InChI=1S/C6H12N2S4/c1-7(2)5(9)11-12-6(10)8(3)4/h1-4H3,KUAZQDVKQLNFPE-UHFFFAOYSA-N,C6H12N2S4,240.4,"dimethylcarbamothioylsulfanyl N,N-dimethylcarbamodithioate","thiram|Tetramethylthiuram disulfide|137-26-8|Thiuram|Rezifilm|Thirame|TMTD|Pomarsol|Arasan|Nobecutan|Aapirol|Fernasan|Thirasan|Tetrathiuram disulfide|Tetramethylthiuram|Falitiram|Formalsol|Hexathir|Kregasan|Mercuram|Normersan|Sadoplon|Spotrete|Tetrasipton|Thillate|Thiramad|Aatiram|Atiram|Fermide|Fernide|Hermal|Pomasol|Puralin|Thiosan|Thiulin|Thiulix|Heryl|Pomarsol forte|Methyl tuads|Accelerator T|Methyl Thiram|Fernasan A|Nocceler TT|Arasan-M|Thiram B|Arasan-SF|Cyuram DS|Ekagom TB|Tetramethylthiuram disulphide|Hermat TMT|Fernacol|Radothiram|Tetrapom|Thioknock|Thirampa|Thiramum|Accel TMT|Accelerator thiuram|Thimer|Aceto TETD|Anles|Aules|Bis(dimethylthiocarbamoyl) disulfide|Royal TMTD|Arasan-SF-X|Tetramethyl-thiram disulfid|Tetramethylenethiuram disulfide|Panoram 75|Tetramethylthiuram bisulfide|Arasan 70|Arasan 75|Spotrete-F|Tersan 75|Thiram 75|Thiram 80|Tetramethylthiurane disulfide|TMTDS|Arasan 70-S Red|Micropearls|Tetramethylthioperoxydicarbonic diamide|Cunitex|Metiurac|Nomersan|Delsan|Metiur|N,N-Tetramethylthiuram disulfide|Pol-Thiuram|Arasan 42-S|Tetrathiuram disulphide|Sranan-sf-X|Tetramethylthiurum disulfide|Disulfure de tetramethylthiourame|Chipco thiram 75|Orac TMTD|Thiuramyl|Thylate|Tulisan|Thiotox (fungicide)|Tetramethylthioramdisulfide|Fermide 850|SQ 1489|Tetramethyldiurane sulphite|Bis(dimethyl-thiocarbamoyl)-disulfid|Disulfide, bis(dimethylthiocarbamoyl)|Methyl thiuramdisulfide|Tetramethylthiocarbamoyldisulphide|Bis((dimethylamino)carbonothioyl) disulfide|Tetramethyl thiurane disulfide|Bis(dimethylthiocarbamyl) disulfide|Disolfuro di tetrametiltiourame|Tetramethyl thiurane disulphide|Bis(dimethyl thiocarbamoyl)disulfide|Tetramethylenethiuram disulphide|tiramo|RCRA waste number U244|Thiurad|Thiuramin|Tirampa|Tiuramyl|Trametan|Tridipam|Tripomol|Flo Pro T Seed Protectant|Tuads|Tetramethylthiuram bisulphide|Tetramethylthiuran disulphide|Tetramethylthiurum disulphide|Vulkacit mtic|Vulkacit thiuram|N,N'-(Dithiodicarbonothioyl)bis(N-methylmethanamine)|NSC-1771|Thiuram M|Vulcafor TMTD|alpha,alpha'-Dithiobis(dimethylthio)formamide|N,N-Tetramethylthiuram disulphide|Vancida tm-95|N,N,N',N'-Tetramethylthiuram disulfide|dimethylcarbamothioylsulfanyl N,N-dimethylcarbamodithioate|FMC 2070|TUEX|Bis(dimethylthiocarbamoyl) disulphide|Bis((dimethylamino)carbonothioyl) disulphide|Disulfuro di tetrametiltiourame|Formamide, 1,1'-dithiobis(N,N-dimethylthio-|ENT 987|NSC1771|VUAgT-I-4|Vancide TM|NSC 1771|Thiuram M rubber accelerator|NSC-49512|NSC-622696|0D771IS0FH|CHEBI:9495|Thiuram disulfide, tetramethyl-|NSC-59637|Thioperoxydicarbonic diamide (((H2N)C(S))2S2), tetramethyl-|Thioperoxydicarbonic diamide ([(H2N)C(S)]2S2), tetramethyl-|[disulfanediylbis(carbonothioylnitrilo)]tetramethane|SQ-1489|bis[Dimethylthiocarbamyl] disulfide|N,N-dimethyl[(dimethylcarbamothioyl)disulfanyl]carbothioamide|TMT Disulfide|Tiram|Disulfide, TMT|Bis[(dimethylamino)carbonothioyl] disulfide|(disulfanediylbis(carbonothioylnitrilo))tetramethane|Disulfide, Tetramethylthiuram|N,N-dimethyl((dimethylcarbamothioyl)disulfanyl)carbothioamide|Tigam|Vulkacit thiuram/C|TMTC|RefChem:933006|USAF P-5|USAF B-30|ZUPA S 80|USAF EK-2089|P03AA05|205-286-2|Attack|Tersan|Tetramethylthiouram disulfide|Sadoplon 75|Methylthiuram disulfide|Thianosan|Thimar|Teramethylthiuram disulfide|Tersantetramethyldiurane sulfide|Hy-Vic|Tetramethyl thiuramdisulfide|Thirame [INN-French]|Thiramum [INN-Latin]|Thiuram D|Tetramethyl thiuram disulfide|Thiotex|Tyradin|Tutan|DTXSID5021332|Thioperoxydicarbonic diamide, tetramethyl-|Vulkacit TH|Tetramethylthioramdisulfide [Dutch]|Vulcafor TMT|Tetramethyl-thiram disulfid [German]|MFCD00008325|Zaprawa Nasienna T|[Me2NC(S)S]2|Arasan 42S|Disolfuro di tetrametiltiourame [Italian]|Disulfuro di tetrametiltiourame [Italian]|Disulfure de tetramethylthiourame [French]|Bis(dimethyl-thiocarbamoyl)-disulfid [German]|MLS000069752|MLS002702972|Thiuram-M|NSC49512|CCG-35460|NSC622696|TNTD|bis(dimethylaminothiocarbonyl) disulfide|NCGC00091563-01|SMR000059023|Thioperoxydicarbonic diamide ((H2N)C(S))2S2, tetramethyl-|[dithiobis(carbonothioylnitrilo)]tetramethane|.alpha.,.alpha.'-Dithiobis(dimethylthio)formamide|C6H12N2S4|DTXCID401332|Caswell No. 856|Granuflo|N,N',N'-Tetramethylthiuram disulfide|(dimethylamino){[(dimethylamino)thioxomethyl]disulfanyl}methane-1-thione|Thioperoxydicarbonic diamide (((H2N)C(S))2S2), N,N,N',N'-tetramethyl-|CAS-137-26-8|Formamide,1'-dithiobis(N,N-dimethylthio-|Attack [Antifungal]|Thiram [ISO]|NSC59637|CCRIS 1282|HSDB 863|WLN: 1N1 & YUS & SSYUS & N1 & 1|EINECS 205-286-2|NSC 49512|NSC 59637|RCRA waste no. U244|EPA Pesticide Chemical Code 079801|NSC 622696|BRN 1725821|UNII-0D771IS0FH|Basultra|Betoxin|Tiradin|Accelerant T|AI3-00987|Ziram metabolite|Arasan m|Vulkazam S|Thioperoxydicarbonic diamide ([(H2N)C(S)]2S2), N,N,N',N'-tetramethyl-|Vanguard GF|Akrochem TMTD|Perkacit TMTD|Vulkacit DTMT|Robac TMT|Rezifilm (TN)|Arasan 50 red|Spotrete WP 75|Vancide TM-95|Naftocit thiuram 16|Spectrum_001687|Thiram (USAN/INN)|Agrichem flowable thiram|THIRAM [HSDB]|THIRAM [IARC]|THIRAM [USAN]|THIRAM [INN]|Spectrum2_001554|Spectrum3_001592|Spectrum4_000860|Spectrum5_001653|THIRAM [WHO-DD]|THIRAM [MI]|THIRAM [MART.]|bmse000928|EC 205-286-2|NCIMech_000272|cid_5455|NCIOpen2_007854|SCHEMBL21144|BSPBio_003184|KBioGR_001499|KBioSS_002167|4-04-00-00242 (Beilstein Handbook Reference)|BIDD:ER0359|DivK1c_000741|SPECTRUM1503322|SPBio_001428|CHEMBL120563|orb2893742|Thiram [USAN:INN:BSI:ISO]|BDBM43362|HMS502F03|KBio1_000741|KBio2_002167|KBio2_004735|KBio2_007303|KBio3_002684|KUAZQDVKQLNFPE-UHFFFAOYSA-|ENT-987|NINDS_000741|HMS1922A12|HMS2093E03|HMS2234B08|HMS3374C05|Pharmakon1600-01503322|Tetramethylthiuram disulfide, 97%|Tox21_111150|Tox21_201569|Tox21_301102|NSC758454|s2431|SBB000804|STL264104|AKOS000120200|bis (dimethyl thiocarbamoyl) disulfide|Bis(dimethylaminothiocarbonyl)disulfide|Tox21_111150_1|DB13245|FT28244|KS-5354|NSC-758454|IDI1_000741|QTL1_000082|NCGC00091563-02|NCGC00091563-03|NCGC00091563-04|NCGC00091563-05|NCGC00091563-06|NCGC00091563-07|NCGC00091563-08|NCGC00091563-09|NCGC00091563-10|NCGC00091563-12|NCGC00255002-01|NCGC00259118-01|NCI60_001477|NCI60_006736|ST044501|SBI-0051813.P002|Thiram, PESTANAL(R), analytical standard|DB-042384|B0486|CS-0012858|NS00009398|EN300-16677|37T268|D06114|D97716|AB00052345_10|Q416572|SR-01000736911|SR-01000736911-2|Thiram, certified reference material, TraceCERT(R)|BRD-K29254801-001-06-3|BRD-K29254801-001-14-7|Z56754480|F0001-0468|TETRAMETHYLTHIOPEROXYDICARBONIC ACID [(H2N)C(S)]2S2|N,N-Dimethyl[(dimethylcarbamothioyl)-disulfanyl]carbothioamide|1-(dimethylthiocarbamoyldisulfanyl)-N,N-dimethyl-methanethioamide|N,N-dimethylcarbamodithioic acid (dimethylthiocarbamoylthio) ester|Bis(dimethylthiocarbamoyl) disulfide;Tetramethylthiuram disulfide;TMTD|InChI=1/C6H12N2S4/c1-7(2)5(9)11-12-6(10)8(3)4/h1-4H3|N(1),N(1),N(3),N(3)-tetramethyl-2-dithioperoxy-1,3-dithiodicarbonic diamide|N,N-dimethylcarbamodithioic acid [[dimethylamino(sulfanylidene)methyl]thio] ester|TETRAMETHYLTHIOPEROXYDICARBONIC DIAMIDE ((((CH(SUB 3))(SUB 2)N)C(S))(SUB 2)S(SUB 2))"
GLPG-0974,57520598,,"InChI=1S/C25H25ClN2O4S/c1-25(11-13-28(25)23(31)20-16-33-21-9-3-2-8-19(20)21)24(32)27(12-5-10-22(29)30)15-17-6-4-7-18(26)14-17/h2-4,6-9,14,16H,5,10-13,15H2,1H3,(H,29,30)/t25-/m1/s1",MPMKMQHJHDHPBE-RUZDIDTESA-N,C25H25ClN2O4S,485.0,4-[[(2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid,"GLPG0974|1391076-61-1|GLPG-0974|X7REK61AIS|4-[[(2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid|4-((((2R)-1-(Benzo(b)thien-3-ylcarbonyl)-2-methyl-2-azetidinyl)carbonyl)((3-chlorophenyl)methyl)amino)butanoic acid|4-(((R)-1-(Benzo(b)thiophene-3-carbonyl)-2-methyl-azetidine-2-carbonyl)-(3-chloro-benzyl)-amino)-butyric acid|Butanoic acid, 4-((((2R)-1-(benzo(b)thien-3-ylcarbonyl)-2-methyl-2-azetidinyl)carbonyl)((3-chlorophenyl)methyl)amino)-|4-[[(R)-1-(benzo[b]thiophene-3-carbonyl)-2-methyl-azetidine-2-carbonyl]-(3-chloro-benzyl)-amino]-butyric acid|4-(((2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidine-2-carbonyl)-((3-chlorophenyl)methyl)amino)butanoic acid|4-(1-((2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidin-2-yl)-N-((3-chlorophenyl)methyl)formamido)butanoic acid|4-[[[(2R)-1-(Benzo[b]thien-3-ylcarbonyl)-2-methyl-2-azetidinyl]carbonyl][(3-chlorophenyl)methyl]amino]butanoic acid|4-{1-[(2R)-1-(1-benzothiophene-3-carbonyl)-2-methylazetidin-2-yl]-N-[(3-chlorophenyl)methyl]formamido}butanoic acid|RefChem:143520|GLPG 0974|4-[[[(2R)-1-(Benzo[b]thien-3-ylcarbonyl)-2-methyl-2-azetidinyl]carbonyl][(3-chlorophenyl)methyl]amino]butanoicacid|CHEMBL3353541|MPMKMQHJHDHPBE-RUZDIDTESA-N|compound 99 [PMID 25380412]|A1LYD|UNII-X7REK61AIS|C25H25ClN2O4S|GTPL8417|orb1707266|SCHEMBL11298599|SCHEMBL29352637|GLXC-10358|EX-A2832|RFC07661|BDBM50032334|MFCD28502087|AKOS027470232|DB15406|SB16999|AC-36690|DA-73763|HY-12940|MS-29019|CS-0012804|G14486|(R)-4-(1-(benzo[b]thiophene-3-carbonyl)-N-(3-chlorobenzyl)-2-methylazetidine-2-carboxamido)butanoic acid|1391075-84-5|4-[[(2R)-1-(benzothiophene-3-carbonyl)-2-methyl-azetidine-2-carbonyl]-[(3-chlorophenyl)methyl]amino]butanoic acid"
PF-05175157,52934180,,"InChI=1S/C23H27N5O2/c1-14(2)28-21-17(13-24-28)11-23(12-20(21)29)6-8-27(9-7-23)22(30)16-4-5-18-19(10-16)26-15(3)25-18/h4-5,10,13-14H,6-9,11-12H2,1-3H3,(H,25,26)",BDXXSFOJPYSYOC-UHFFFAOYSA-N,C23H27N5O2,405.5,"1'-(2-methyl-3H-benzimidazole-5-carbonyl)-1-propan-2-ylspiro[4,6-dihydroindazole-5,4'-piperidine]-7-one","1301214-47-0|PF-05175157|PF 05175157|P826WR56FI|UNII-P826WR56FI|SPIRO(5H-INDAZOLE-5,4'-PIPERIDIN)-7(6H)-ONE, 1,4-DIHYDRO-1'-((2-METHYL-1H-BENZIMIDAZOL-6-YL)CARBONYL)-1-(1-METHYLETHYL)-|1'-(2-methyl-1H-1,3-benzodiazole-6-carbonyl)-1-(propan-2-yl)-1,4,6,7-tetrahydrospiro(indazole-5,4'-piperidine)-7-one|1'-(2-methyl-1h-1,3-benzodiazole-6-carbonyl)-1-(propan-2-yl)-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidine]-7-one|RefChem:172242|1-isopropyl-1'-(2-methyl-1H-benzo[d]imidazole-6-carbonyl)-4,6-dihydrospiro[indazole-5,4'-piperidin]-7(1H)-one|PF05175157|Spiro[5H-indazole-5,4'-piperidin]-7(6H)-one,1,4-dihydro-1'-[(2-methyl-1H-benzimidazol-6-yl)carbonyl]-1-(1-methylethyl)-|CHEMBL3359265|C23H27N5O2|1'-(2-methyl-3H-benzimidazole-5-carbonyl)-1-propan-2-ylspiro[4,6-dihydroindazole-5,4'-piperidine]-7-one|1,4-Dihydro-1'-[(2-methyl-1H-benzimidazol-6-yl)carbonyl]-1-(1-methylethyl)-spiro[5H-indazole-5,4'-piperidin]-7(6H)-one|MFCD28502250|orb1685517|SCHEMBL1892015|SCHEMBL1896285|SCHEMBL29379012|HMS3874K13|BCC21447|BCP25103|EX-A1660|BDBM50034371|AKOS027470289|AKOS032960468|CS-7859|DB12096|SB17382|NCGC00421916-02|AC-31464|BS-15158|HY-12942|NS00073388|PF05175157?|D80648|EN300-21614982|Q27286356|Z2327390391|1'-(2-methyl-1H-1,3-benzodiazole-6-carbonyl)-1-(propan-2-yl)-1,4,6,7-tetrahydrospiro[indazole-5,4'-piperidin]-7-one|1-Isopropyl-1'-(2-methyl-1H-benzo[d]imidazole-6-carbonyl)-1,4-dihydrospiro[indazole-5,4'-piperidin]-7(6H)-one|1-isopropyl-1'-(2-methyl-3H-benzimidazole-5-carbonyl)spiro[4,6-dihydroindazole-5,4'-piperidine]-7-one|1-Isopropyl-1'-[(2-methyl-1H-benzimidazol-6-yl)carbonyl]-1,4-dihydrospiro[indazole-5,4'-piperidin]-7(6H)-one"
SULFORAPHANE,5350,,"InChI=1S/C6H11NOS2/c1-10(8)5-3-2-4-7-6-9/h2-5H2,1H3",SUVMJBTUFCVSAD-UHFFFAOYSA-N,C6H11NOS2,177.3,1-isothiocyanato-4-methylsulfinylbutane,"sulforaphane|4478-93-7|1-Isothiocyanato-4-(methylsulfinyl)butane|Sulforafan|1-isothiocyanato-4-methylsulfinylbutane|Sulphoraphane|Butane, 1-isothiocyanato-4-(methylsulfinyl)-|CHEBI:47807|41684WL1GL|1-isothiocyanato-4-methylsulfinyl-butane|DTXSID8036732|Sulfaforaphane|(+-)-sulforaphane|1-isothiocyanato-4-methylsulphinylbutane|RefChem:889698|DTXCID6016732|4-methylsulfoxybutylisothiocyanate|GA49J4310U|DL-Sulforaphane|D,L-Sulforaphane|1-Isothiocyanato-4-(methylsulfinyl)-butane|4-Methylsulfinylbutyl isothiocyanate|Sulforaphane Racemate|(+/-)-sulforaphane|MFCD00198068|C6H11NOS2|4-(Methylsulfinyl)Butyl Isothiocyanate|NSC-749790|(S)-1-Isothiocyanato-4-(methylsulfinyl)butane|R,S-Sulforaphane|MFCD09039283|sulforaphane, (R)-|SFN|CCRIS 7221|Sulforathane|UNII-41684WL1GL|orb320383|CHEMBL48802|SCHEMBL105202|GTPL6569|orb1296132|orb1299068|SULFORAPHANE, (+/-)-|GLXC-10959|HMS3746M17|BCP31547|4-Methylsulfinyl butyl isothiocyanate|BDBM50073654|MSK164678|NSC749790|s5771|4-isothiocyanatobutyl methyl sulfoxide|AKOS006282481|CS-7809|FS27960|NSC 749790|4-(Methylsulfinyl)-butyl isothiocyanate|SULFORAPHANE (+/-)-FORM [MI]|AC-34421|DA-62944|HY-13755|SY231823|1-Isothiocyanato-4-(methylsulfinyl)butane #|U0142|F17072|1-Isothiocyanato-4[(S)-(methylsulfinyl)]-butane|478S937|Q424489|DL-Sulforaphane, >=90% (HPLC), synthetic, liquid|BRD-A58955223-001-02-0|BRD-A58955223-001-03-8|ISOTHIOCYANIC ACID, 4-(METHYLSULFINYL)BUTYL ESTER|Z1198151975|(R)-Sulforaphane;(-)-Sulforaphane;4-Methylsulfinylbutyl isothiocyanate|1-Isothiocyanato-4-(methylsulfinyl)-butane;4-Methylsulfinylbutyl isothiocyanate"
ALLYL ISOTHIOCYANATE,5971,,"InChI=1S/C4H5NS/c1-2-3-5-4-6/h2H,1,3H2",ZOJBYZNEUISWFT-UHFFFAOYSA-N,C4H5NS,99.16,3-isothiocyanatoprop-1-ene,"ALLYL ISOTHIOCYANATE|57-06-7|3-isothiocyanatoprop-1-ene|AITC|Redskin|Allylsenevol|Allylsenfoel|Oleum sinapis|Allylsevenolum|Senfoel|Allyl isosulfocyanate|Allyspol|Carbospol|1-Propene, 3-isothiocyanato-|3-Isothiocyanato-1-propene|Senf oel|2-Propenyl isothiocyanate|Oleum sinapis volatile|Isothiocyanate d'allyle|Allyl sevenolum|Allyspol 75EC|Allyl thioisocyanate|Isothiocyanic acid allyl ester|Allyl isosulphocyanate|FEMA No. 2034|Isothiocyansaeureallylester|NCI-C50464|Allylisothiokyanat|FEMA Number 2034|Isothiocyanic acid, allyl ester|Allyl isothiocyanate, stabilized|DTXSID3020047|NSC-5572|BN34FX42G3|CHEBI:73224|DTXCID8047|NSC5572|allyl thiocarbonimide|Mustard oil, volatile,|RefChem:554873|200-309-2|ALLYLISOTHIOCYANATE|Caswell No. 027|Allylisothiokyanat [Czech]|Allyl isothiocyanate (natural)|NSC 5572|MFCD00004822|Allyl isothiocyanate, non-perfume grade|Propene, 3-isothiocyanato-|Allyl isothiocyanate (USP)|3-iso-Thiocyanatoprop-1-ene|CHEMBL233248|Fats and Glyceridicoils, mustard|NCGC00091743-01|prop-2-enisothiocyanate|Senf oel [German]|Allylsenfoel [German]|CAS-57-06-7|CCRIS 20|Allyl isothiocyanate [USAN]|HSDB 617|Isothiocyanate d'allyle [French]|EINECS 200-309-2|UN1545|EPA Pesticide Chemical Code 004901|BRN 0773748|UNII-BN34FX42G3|AI3-15283|Allyl isothiocyanate [USAN:USP]|mustard seed oleoresin|3-isothiocyanato-propene|Allyl isothiocyanate, 97%|WLN: SCN2U1|3-isothiocyanato-prop-1-ene|SCHEMBL41581|Potassium allyl isothiocyanate|GTPL2420|SCHEMBL6529690|SCHEMBL28529031|ALLYL ISOTHIOCYANATE [MI]|ALLYL ISOTHIOCYANATE [FCC]|GLXC-20576|HMS3264D06|Pharmakon1600-01506103|ALLYL ISOTHIOCYANATE [FHFI]|ALLYL ISOTHIOCYANATE [HSDB]|ALLYL ISOTHIOCYANATE [IARC]|Tox21_111165|Tox21_202249|Tox21_302890|ALLYL ISOTHIOCYANATE [MART.]|Allyl isothiocyanate, >=95%, FCC|BDBM50203072|MSK010007|NSC760137|SBB060631|STL194262|ALLYL ISOTHIOCYANATE [WHO-DD]|Allyl isothiocyanate non-perfume grade|ISOTHIOCYANIC ACID,ALLYL ESTER|AKOS000119301|CCG-213613|NSC-760137|NCGC00091743-02|NCGC00256536-01|NCGC00259798-01|BP-12926|ALLYL ISOTHIOCYANATE [USP MONOGRAPH]|Allyl isothiocyanate, purum, >=98% (GC)|DB-022435|Potassium, (1-isothiocyanato-2-propenyl)-|I0185|NS00007069|ST51046777|EN300-19008|C19317|D02818|G84101|AB01563144_01|F018163|Q419406|Allyl isothiocyanate 100 microg/mL in Acetonitrile|Allyl isothiocyanate, stabilized (0.1% tocopherols)|Allyl isothiocyanate, contains BHT as stabilizer, 95%|Allyl isothiocyanate, stabilized [UN1545]  [Poison]|BRD-K33219225-001-01-9|InChI=1/C4H5NS/c1-2-3-5-4-6/h2H,1,3H|Allyl isothiocyanate(stabilised with 0.1% tocopherols)|Z104472178|Allyl isothiocyanate, PESTANAL(R), analytical standard, stabilized"
CLEVIDIPINE,153994,,"InChI=1S/C21H23Cl2NO6/c1-5-7-15(25)29-10-30-21(27)17-12(3)24-11(2)16(20(26)28-4)18(17)13-8-6-9-14(22)19(13)23/h6,8-9,18,24H,5,7,10H2,1-4H3",KPBZROQVTHLCDU-UHFFFAOYSA-N,C21H23Cl2NO6,456.3,"5-O-(butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate","Clevidipine|167221-71-8|Clevelox|Clevidepine|Clevidepine butyrate|3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, 3-methyl 5-[(1-oxobutoxy)methyl] ester|Clevidipino|19O2GP3B7Q|DTXSID6057661|DTXCID7031450|H324/38|H-324/38|3,5-Pyridinedicarboxylic acid, 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-, methyl (1-oxobutoxy)methyl ester|butyroxymethyl methyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate|METHYL 5-{[(BUTANOYLOXY)METHOXY]CARBONYL}-4-(2,3-DICHLOROPHENYL)-2,6-DIMETHYL-1,4-DIHYDROPYRIDINE-3-CARBOXYLATE|3,5-PYRIDINEDICARBOXYLIC ACID, 4-(2,3-DICHLOROPHENYL)-1,4-DIHYDRO-2,6-DIMETHYL-, 3-METHYL 5-((1-OXOBUTOXY)METHYL) ESTER|O3-(butanoyloxymethyl) O5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate|clevidipinum|clevipidine|methyl 5-(((butanoyloxy)methoxy)carbonyl)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3-carboxylate|RefChem:57329|C08CA16|Clevidipine butyrate|Cleviprex|166432-28-6|MFCD00940070|5-O-(butanoyloxymethyl) 3-O-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate|3-((butyryloxy)methyl) 5-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate|rac-Clevidipine|1346602-00-3|(Butanoyloxy)methyl methyl (4RS)-4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate|3-[(Butyryloxy)methyl] 5-Methyl 4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate|SR-01000945183|Clevidipine [USAN:INN]|UNII-19O2GP3B7Q|C21H23Cl2NO6|Cleviprex?|Cleviprex (TN)|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid 3-Methyl 5-[(1-Oxobutoxy)methyl] Ester; Clevelox; Cleviprex; H 324/38; rac-Clevidipine;|Clevidipine [INN]|H 324/38|Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dime thyl-3,5-pyridinedicarboxylate|Methyl (1-oxobutoxy)methyl 4-(2,3-dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate|Clevidipine (Standard)|Cleviprex (Clevidipine)|CLEVIDIPINE [MI]|Clevidipine (USAN/INN)|CLEVIDIPINE [USAN]|CLEVIDEPINE [VANDF]|CLEVIDIPINE [VANDF]|CLEVIDIPINE [MART.]|CLEVIDIPINE [WHO-DD]|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic Acid 3-Methyl 5-[(1-Oxobutoxy)methyl] Ester|SCHEMBL115522|GTPL7468|orb1310089|Clevidipine Butyrate;Clevidipine|CHEMBL1237132|SCHEMBL29375384|CLEVIDIPINE [ORANGE BOOK]|CHEBI:135738|KPBZROQVTHLCDU-UHFFFAOYSA-N|GLXC-10277|HMS3604H21|HMS3651G10|HMS3884L03|HMS5080M06|BCP22676|BCP22687|EX-A2898|WDC60200|CLEVIDEPINE BUTYRATE [VANDF]|CLEVIDIPINE BUTYRATE [VANDF]|Tox21_113923|BDBM50088387|HY-17436R|s2080|AKOS015896325|CCG-269294|CS-1427|DB04920|FC20480|NCGC00262928-01|AC-24370|AS-19935|CLEVIDIPINE BUTYRATE [ORANGE BOOK]|HY-17436|O5-(butanoyloxymethyl) O3-methyl 4-(2,3-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylate|SY028058|DB-064636|C3503|CAS-167221-71-8|NS00040661|SW220087-1|A12130|D08892|EN300-119519|AB01566888_01|221C718|F828464|Q5132338|SR-01000945183-1|SR-01000945183-2|BRD-A01563671-001-02-7|Z1521553844|4-(2,3-Dichlorophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid 3-methyl 5-[(1-oxobutoxy)methyl] ester;Clevelox;Clevip rex|4-(2,3-Dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylic Aicd 3-[(Butyryloxy)methyl] 5-Methyl Ester|Butyroxymethyl methyl 4-(2',3'-dichlorophenyl)-2,6-dimethyl-1,4-dihydropyridine-3,5-dicarboxylat"
FANTOFARONE,119349,,"InChI=1S/C31H38N2O5S/c1-23(2)27-22-33-18-7-6-9-28(33)31(27)39(34,35)26-13-11-25(12-14-26)38-20-8-17-32(3)19-16-24-10-15-29(36-4)30(21-24)37-5/h6-7,9-15,18,21-23H,8,16-17,19-20H2,1-5H3",ITAMRBIZWGDOHW-UHFFFAOYSA-N,C31H38N2O5S,550.7,"N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methyl-3-[4-(2-propan-2-ylindolizin-1-yl)sulfonylphenoxy]propan-1-amine","Fantofarone|114432-13-2|Fantofarona|SR-33557|Fantofaronum|SR 33557|KU213XYO69|DTXSID30150729|Benzeneethanamine, 3,4-dimethoxy-N-methyl-N-(3-(4-((2-(1-methylethyl)-1-indolizinyl)sulfonyl)phenoxy)propyl)-|Benzeneethanamine, 3,4-dimethoxy-N-methyl-N-[3-[4-[[2-(1-methylethyl)-1-indolizinyl]sulfonyl]phenoxy]propyl]-|RefChem:139932|DTXCID7073220|2-isopropyl-1-((4-(3-(N-methyl-N-(3,4-dimethoxy-beta-phenethyl)amino)propoxy)benzenesulfonyl))indolizine|(2-(3,4-Dimethoxy-phenyl)-ethyl)-(3-(4-(2-isopropyl-indolizine-1-sulfonyl)-phenoxy)-propyl)-methyl-amine|N-(3,4-dimethoxyphenethyl)-3-(4-((2-isopropylindolizin-1-yl)sulfonyl)phenoxy)-N-methylpropan-1-amine|1-((p-(3-((3,4-Dimethoxyphenethyl)methylamino)propoxy)phenyl)sulfonyl)-2-isopropylindolizine|Fantofaronum [INN-Latin]|Fantofarona [INN-Spanish]|C31H38N2O5S|Fantofarone [INN:BAN]|UNII-KU213XYO69|Fantofarone?|sr33557|MFCD00867144|FANTOFARONE [MI]|FANTOFARONE [INN]|SCHEMBL77818|3,4-Dimethoxy-N-methyl-N-(3-(4-((2-(1-methylethyl)-1-indolizinyl)sulfonyl)phenoxy)propyl)benzeneethanmine|N-[2-(3,4-dimethoxyphenyl)ethyl]-N-methyl-3-[4-(2-propan-2-ylindolizin-1-yl)sulfonylphenoxy]propan-1-amine|CHEMBL285855|orb1302668|SCHEMBL29802340|GLXC-21672|BCP29553|EX-A1900|BDBM50101905|AKOS037515619|AC-35860|AS-56270|DA-63370|HY-105117|CS-0025047|NS00122352|D93346|Q5434391|SR 33557; SR-33557; SR33557|N-(3,4-Dimethoxyphenethyl)-3-(4-(2-isopropylindolizin-1-ylsulfonyl)phenoxy)-N-methylpropan-1-amine|N-[2-(3,4-dimethoxyphenyl)ethyl]-3-[4-(2-isopropylindolizin-1-yl)sulfonylphenoxy]-N-methyl-propan-1-amine"
CIFENLINE,2747,,"InChI=1S/C18H18N2/c1-3-7-14(8-4-1)18(15-9-5-2-6-10-15)13-16(18)17-19-11-12-20-17/h1-10,16H,11-13H2,(H,19,20)",IPOBOOXFSRWSHL-UHFFFAOYSA-N,C18H18N2,262.3,"2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole","Cibenzoline|53267-01-9|Cifenline|2-(2,2-diphenylcyclopropyl)-4,5-dihydro-1H-imidazole|Cibenzolinum|Cibenzolina|Ro 22-7796|2-(2,2-diphenylcyclopropyl)-2-imidazoline|Z7489237QT|DTXSID9022819|RO-22-7796|RefChem:126085|DTXCID702819|C01BG07|258-453-7|Cifenline [USAN]|Cibenzoline [INN]|MFCD00864706|CHEMBL87045|Cibenzoline (INN)|Cifenline (USAN)|Cifenline; Ro 22-7796; UP 33-901|2-(2,2-Diphenyl-cyclopropyl)-4,5-dihydro-1H-imidazole|1H-Imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-|Cibenzolinum [INN-Latin]|Cibenzolina [INN-Spanish]|NCGC00162222-01|EINECS 258-453-7|Ro 227796|UP 33901|UNII-Z7489237QT|(+-)-2-(2,2-Diphenylcyclopropyl)-2-imidazoline|Cibenzoline (Standard)|CIFENLINE [MI]|CIBENZOLINE [MART.]|CIBENZOLINE [WHO-DD]|SCHEMBL122806|orb1689594|CHEBI:135083|1H-Imidazole, 2-(2,2-diphenylcyclopropyl)-4,5-dihydro-, (+-)-|BDBM50151856|EX-A11069|AKOS016013956|DB13358|HY-106577R|SDCCGSBI-0633743.P001|NCGC00162222-02|NCGC00162222-03|NCGC00162222-04|MS-23702|DB-052284|HY-106577|2-(2,2-diphenyl-cyclopropyl)-2-imidazoline|CS-0026092|NS00032698|D03492|267C019|Q867171|BRD-A20742938-036-01-1|(+/-)-2-(2,2-DIPHENYLCYCLOPROPYL)-2-IMIDAZOLINE|1H-IMIDAZOLE, 2-(2,2-DIPHENYLCYCLOPROPYL)-4,5-DIHYDRO-, (+/-)-"
NISOLDIPINE,4499,,"InChI=1S/C20H24N2O6/c1-11(2)10-28-20(24)17-13(4)21-12(3)16(19(23)27-5)18(17)14-8-6-7-9-15(14)22(25)26/h6-9,11,18,21H,10H2,1-5H3",VKQFCGNPDRICFG-UHFFFAOYSA-N,C20H24N2O6,388.4,"3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate","nisoldipine|63675-72-9|Sular|Nisocor|Baymycard|Nisoldipin|Nisoldipino|Bay k 5552|Nisoldipinum|Bay-k-5552|Geomatrix 16e|Nisoldipine (stn)|DTXSID0023371|4I8HAB65SZ|NSC-759106|3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester|DTXCID403371|3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester, (+-)-|3-methyl 5-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|O5-methyl O3-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipina|Nisoldipine SR|Syscor mr 10|Syscor mr 20|Syscor mr 30|RefChem:56577|CHEBI:7577|C08CA07|264-407-7|Zadipina|Syscor|3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|Nisoldipinum [INN-Latin]|Nisoldipino [INN-Spanish]|MFCD00478055|BAY-k 5552|CHEBI:76917|3-O-methyl 5-O-(2-methylpropyl) 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|methyl 2-methylpropyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|CHEMBL441428|Nisoldipine 100 microg/mL in Methanol|NCGC00164633-01|O5-isobutyl O3-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic acid methyl 2-methylpropyl ester|SMR000466370|CAS-63675-72-9|Sular (TN)|SR-05000002009|EINECS 264-407-7|UNII-4I8HAB65SZ|BRN 0454188|Nisoldipine (JAN/USAN/INN)|Nisoldipine [USAN:INN:BAN:JAN]|(+-)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate|Isobutyl 1,4-dihydro-5-methoxycarbonyl-2,6-dimethyl-4-(2-nitrophenyl)-3-pyridincarboxylat|Nisoldipine, ~97%|NISOLDIPINE [MI]|NISOLDIPINE [INN]|NISOLDIPINE [JAN]|(.+/-.)-Nisoldipine|NISOLDIPINE [USAN]|NISOLDIPINE [VANDF]|Baymycard, Norvasc, Syscor|CHEMBL1726|NISOLDIPINE [MART.]|SCHEMBL39779|(+/-)-NISOLDIPINE|NISOLDIPINE [USP-RS]|NISOLDIPINE [WHO-DD]|MLS000759498|MLS001424102|MLS002153943|BIDD:GT0684|GTPL2524|orb1310881|CHEMBL3192341|Nisoldipine - Bio-X trade mark|SCHEMBL29420725|Nisoldipine, >=98% (HPLC)|NISOLDIPINE [ORANGE BOOK]|BDBM642532|HMS2051O18|HMS2089K20|HMS2093F15|HMS2097E13|HMS2231L20|HMS3393O18|HMS3651K17|HMS3714E13|HMS3744O19|HMS3884I08|HMS5079L22|Pharmakon1600-01505390|BCP22696|KBC91003|MSK10226|Tox21_112251|Tox21_302365|AC-987|BBL028683|BDBM50101963|BDBM50227259|DL-255|NSC759106|s1748|STK631543|AKOS005563632|AKOS037515714|Tox21_112251_1|CCG-100894|CCG-213412|CS-1131|DB00401|FN26228|KS-5188|NC00144|NSC 759106|US20230414632, Compound I-e|Bay K 5552;BAY-K 5552;Sular|Isobutyl Methyl 1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylate|NCGC00164633-02|NCGC00164633-03|NCGC00255136-01|1,4-Dihydro-2,6-dimethyl-4-(2-nitrophenyl)-3,5-pyridinedicarboxylic Acid Isobutyl Methyl Ester|BN164147|HY-17402|PD003071|PD033037|(+/-)-BAY-K-5552|SBI-0206830.P001|N0900|NS00002600|SW219237-1|A10663|C07699|D00618|EN300-119517|SBI-0206830.0001|AB01275444-01|AB01275444_02|675N729|F794980|Q3342150|SR-05000002009-1|SR-05000002009-2|SR-05000002009-3|BRD-A84465106-001-01-2|BRD-A84465106-001-03-8|BRD-A84465106-001-05-3|BRD-A84465106-001-06-1|BRD-A84465106-001-08-7|Z277942268|3-Isobutyl5-methyl2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|isobutyl methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate|(+/-)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate|(.+/-.)-Isobutyl methyl 1,4-dihydro-2,6-dimethyl-4-(o-nitrophenyl)-3,5-pyridinedicarboxylate|3,5-PYRIDINEDICARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-NITROPHENYL)-, 3-METHYL 5-(2-METHYLPROPYL) ESTER|3,5-PYRIDINEDICARBOXYLIC ACID, 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-NITROPHENYL)-, METHYL 2-METHYLPROPYL ESTER, (+/-)-|3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(2-nitrophenyl)-, methyl 2-methylpropyl ester, (.+/-.)-|3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydro-3,5-pyridinedicarboxylate #|3-Isobutyl 5-methyl 2,6-dimethyl-4-(2-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate (Synonyms:Nisoldipine)|METHYL 2-METHYLPROPYL-1,4-DIHYDRO-2,6-DIMETHYL-4-(2-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE, DL-"
PF-05105679,60195662,,"InChI=1S/C26H21FN2O3/c1-17(19-9-11-23(27)12-10-19)29(16-18-5-4-7-21(13-18)26(31)32)25(30)22-14-20-6-2-3-8-24(20)28-15-22/h2-15,17H,16H2,1H3,(H,31,32)/t17-/m1/s1",BXNMZRPTQFVRFA-QGZVFWFLSA-N,C26H21FN2O3,428.5,3-[[[(1R)-1-(4-fluorophenyl)ethyl]-(quinoline-3-carbonyl)amino]methyl]benzoic acid,"1398583-31-7|PF-05105679|F2B10OFV7Y|PF 5105679|3-[[[(1R)-1-(4-fluorophenyl)ethyl]-(quinoline-3-carbonyl)amino]methyl]benzoic acid|UNII-F2B10OFV7Y|PF05105679|3-((((1R)-1-(4-Fluorophenyl)ethyl)(3-quinolinylcarbonyl)amino)methyl)-benzoic acid|Benzoic acid, 3-((((1R)-1-(4-fluorophenyl)ethyl)(3-quinolinylcarbonyl)amino)methyl)-|3-((((1R)-1-(4-fluorophenyl)ethyl)-(quinoline-3-carbonyl)amino)methyl)benzoic acid|3-((N-((1R)-1-(4-fluorophenyl)ethyl)-1-(quinolin-3-yl)formamido)methyl)benzoic acid|3-({N-[(1R)-1-(4-fluorophenyl)ethyl]-1-(quinolin-3-yl)formamido}methyl)benzoic acid|RefChem:172241|PF 05105679|(R)-3-((N-(1-(4-fluorophenyl)ethyl)quinoline-3-carboxamido)methyl)benzoic acid|3-[[[(1R)-1-(4-Fluorophenyl)ethyl](3-quinolinylcarbonyl)amino]methyl]benzoicacid|CHEMBL3577885|orb1307902|SCHEMBL12487950|SCHEMBL29368041|SCHEMBL30766194|GTPL10300|DTXSID301336742|GLXC-05320|EX-A4888|YFC58331|BDBM50089245|MFCD28386022|AKOS030210975|DB15450|DA-56718|MS-27580|HY-115506|CS-0087256|G14440|(R)-3-{[[1-(4-Fluorophenyl)ethyl]-(quinoline-3-carbonyl)amino]methyl}benzoic acid"
PF-04531083,57582353,,"InChI=1S/C17H16ClN5O2/c1-23-14(7-8-20-23)17(24)22-15-6-4-11(16(19)21-15)12-9-10(25-2)3-5-13(12)18/h3-9H,1-2H3,(H3,19,21,22,24)",ZRJGMDIPCQOGNI-UHFFFAOYSA-N,C17H16ClN5O2,357.8,N-[6-amino-5-(2-chloro-5-methoxyphenyl)pyridin-2-yl]-2-methylpyrazole-3-carboxamide,"1079400-07-9|PF-04531083|40497CY7Y3|PF-4531083|UNII-40497CY7Y3|1H-Pyrazole-5-carboxamide, N-(6-amino-5-(2-chloro-5-methoxyphenyl)-2-pyridinyl)-1-methyl-|RefChem:172232|N-(6-Amino-5-(2-chloro-5-methoxyphenyl)pyridin-2-yl)-1-methyl-1H-pyrazole-5-carboxamide|MFCD28411617|PF 04531083|N-[6-Amino-5-(2-chloro-5-methoxyphenyl)pyridin-2-yl]-1-methyl-1H-pyrazole-5-carboxamide|CHEMBL3589904|N-[6-amino-5-(2-chloro-5-methoxyphenyl)pyridin-2-yl]-2-methylpyrazole-3-carboxamide|SCHEMBL261689|orb1307888|SCHEMBL29387055|ZRJGMDIPCQOGNI-UHFFFAOYSA-N|BDBM50095311|AKOS030621306|DB12468|AS-74235|SY268161|DB-143863|HY-105283|CS-0025617|NS00073355|W15047|Q27258289|N-[6-amino-5-(2-chloro-5-methoxy-phenyl)-2-pyridyl]-2-methyl-pyrazole-3-carboxamide"
DICHLORVOS,3039,,"InChI=1S/C4H7Cl2O4P/c1-8-11(7,9-2)10-3-4(5)6/h3H,1-2H3",OEBRKCOSUFCWJD-UHFFFAOYSA-N,C4H7Cl2O4P,220.97,"2,2-dichloroethenyl dimethyl phosphate","dichlorvos|62-73-7|DDVP|2,2-Dichloroethenyl dimethyl phosphate|Dichlorophos|Divipan|Vapona|2,2-Dichlorovinyl dimethyl phosphate|Chlorvinphos|Dichlorphos|Krecalvin|Lindanmafu|Bibesol|Brevinyl|Canogard|Equigard|Equigel|Phosvit|Atgard|Fecama|Herkal|Herkol|Nerkol|Nogos|Nuvan|Unifos|Dichlorman|Dichlorovos|Estrosel|Szklarniak|Vaponite|Vinylofos|Vinylophos|Winylophos|Dedevap|Fekama|Marvex|Mopari|Novotox|Tenac|Task|Atgard C|Atgard V|Nogos G|Astrobot|Dichlofos|Dichloorvo|Diclorvos|Panaplate|Tetravos|Vapona Insecticide|Apavap|Benfos|Cekusan|Cypona|Unitox|Insectigas D|DDVP (insecticide)|Nogos 50|Dimethyl 2,2-dichlorovinyl phosphate|Derribante|Dichlorfos|Deriban|Devikol|Estrosol|Nefrafos|Unifos (pesticide)|Fly fighter|Mafu strip|No-pest strip|Fly-die|No-pest|TAP 9VP|Phosphoric acid, 2,2-dichloroethenyl dimethyl ester|Vapora II|Denkavepon|Dichlorovas|Nuvan 7|Verdican|Verdipor|Verdisol|Duravos|Dimethyldichlorovinyl phosphate|OMS 14|Task tabs|Phosphoric acid, 2,2-dichlorovinyl dimethyl ester|Unifos 50 EC|O,O-Dimethyl dichlorovinyl phosphate|Nogos 50 EC|Nuvan 100EC|Dimethyl 2,2-dichloroethenyl phosphate|NCI-C00113|SD 1750|SD-1750|Brevinyl E50|NSC-6738|Dimethyl dichlorovinyl phosphate|Bayer 19149|BAY-19149|Dichlorvosum|Mafu|UDVF|Phosphoric acid 2,2-dichloroethenyl dimethyl ester|(2,2-Dichloro-vinil)dimetil-fosfato|Dimethyl-2,2-dichlorovinyl phosphate|Ethenol, 2,2-dichloro-, dimethyl phosphate|(2,2-Dichlor-vinyl)-dimethyl-phosphat|DTXSID5020449|Phosphate de dimethyle et de 2,2-dichlorovinyle|Vinyl alcohol, 2,2-dichloro-, dimethyl phosphate|O,O-Dimethyl 2,2-dichlorovinyl phosphate|ENT 20738|(2,2-Dichloor-vinyl)-dimethyl-fosfaat|2,2-Dichloroethenyl phosphoric acid dimethyl ester|CHEBI:34690|Dichloroethenyl dimethyl phosphate|NSC6738|7U370BPS14|O,O-Dimethyl O-2,2-dichlorovinyl phosphate|O,O-Dimethyl-O-(2,2-dichlor-vinyl)-phosphat|2,2-dichloroethenol dimethyl phosphate|O,O-Dwumetylo-O-dwuchlorowinylofosforan|2,2-Dichlorovinyl-O,O-dimethyl phosphate|DTXCID90449|2,2-dichlorovinyl alcohol dimethyl phosphate|o-(2,2-Dichlorvinyl)-O,O-dimethylphosphat|2,2-dichlorovinyl dimethyl phosphoric acid ester|Equigard, Verdisol|Task Dog Anthelmintic|Atgard C Swine Wormer|RefChem:54999|Atgard C Premix 9.6%|Phosphoric acid 2,2 dichloroethenyl dimethyl ester|Atgard Swine Wormer, Atgard V Swine Wormer|200-547-7|Atgard Swine Wormer 27 g, Atgard Swine Wormer 5.4g, Atgard V Swine Wormer 27 g, Atgard V Swine Wormer 5.4 g|2,2-Dichloroethenyl phosphate|Equiguard|XLP 30|Equigand|Algard|C4H7Cl2O4P|Brevinyl E-50|DDVF|NSC 6738|Brevinyl E 50|Atgard (TN)|Nuvan 100 EC|ENT-20738|Phosphoric acid 2,2-dichlorovinyl dimethyl ester|Phosphate, 2-2-dichlorovinyl dimethyl|CHEMBL167911|(2,2-Dichloor-vinyl)-dimethyl-fosfaat [Dutch]|2,2-Dimethyldichlorovinyl phosphate|MFCD00036123|OKO|NCGC00090997-02|Uniphos|O-(2,2-Dichlorvinyl)-O,O-dimethylphosphate|Des (phosphate)|Dichloorvo [Dutch]|Dichlorfos [Polish]|Caswell No. 328|Delevap|Derriban|Nuva|Diclorvos [INN-Spanish]|Dichlorvosum [INN-Latin]|CAS-62-73-7|Dichlorvos [ISO]|CCRIS 230|Dichlorvos [USAN:INN:BAN]|Dichlorvos (DDVP)|HSDB 319|BAY-b 4986|(2,2-Dichloor-vinyl)-dimethyl-fosfaat (Dutch)|Dichlorvos [BSI:ISO]|EINECS 200-547-7|EPA Pesticide Chemical Code 084001|BRN 1709141|Dichlorovinphos|Aquaguard|Nuvos|UNII-7U370BPS14|AI3-20738|Prima U|(2,2-Dichloro-vinil)dimetil-fosfato [Italian]|(2,2-Dichlor-vinyl)-dimethyl-phosphat [German]|O,O-Dwumetylo-O-dwuchlorowinylofosforan [Polish]|Dichlorvos (Vapona)|O-(2,2-Dichlorvinyl)-O,O-dimethylphosphat [German]|Dichlorfos(POLISH)|Dichlorvos - 70%|O,O-Dimethyl-O-(2,2-dichlor-vinyl)-phosphat [German]|Phosphate de dimethyle et de 2,2-dichlorovinyle [French]|Spectrum_001779|Dimethyl O,2-phosphate|DICHLORVOS [MI]|SpecPlus_000360|DICHLORVOS [INN]|Dichlorvos (USAN/INN)|o-(2,O-dimethylphosphat|Spectrum2_001227|Spectrum3_000810|Spectrum4_000650|Spectrum5_001930|DICHLORVOS [HSDB]|DICHLORVOS [IARC]|DICHLORVOS [USAN]|DICHLORVOS [MART.]|0,2-dichlorovinyl phosphate|DICHLORVOS [USP-RS]|DICHLORVOS [WHO-DD]|SCHEMBL25067|BSPBio_002279|KBioGR_000999|KBioSS_002260|O,2-dichlor-vinyl)-phosphat|MLS002222471|BIDD:ER0583|DivK1c_006456|SPBio_001074|DICHLORVOS [GREEN BOOK]|WLN: GYGU1OPO&O1&O1|KBio1_001400|KBio2_002259|KBio2_004827|KBio2_007395|KBio3_001779|OEBRKCOSUFCWJD-UHFFFAOYSA-|HMS2091C21|dimethyl 2,2-dichlorovinylphosphate|MSK20097|Tox21_111052|Tox21_201617|Tox21_300840|BDBM50286926|CCG-39147|P5D635|SBB060965|(2, 2-Dichloro-vinil)dimetil-fosfato|(2,2-Dichlorovinyl)-dimethyl-fosfate|AKOS005111045|Tox21_111052_1|DB11397|Dichlorvos 100 microg/mL in n-Hexane|Dichlorvos 1000 microg/mL in Acetone|Ethenol,2-dichloro-, dimethyl phosphate|(2, 2-Dichlor-vinyl)-dimethyl-phosphat|NCGC00090997-01|NCGC00090997-03|NCGC00090997-04|NCGC00090997-05|NCGC00090997-06|NCGC00090997-07|NCGC00090997-08|NCGC00090997-09|NCGC00090997-11|NCGC00254743-01|NCGC00259166-01|Dichlorvos 100 microg/mL in Acetonitrile|Dimethyl O,O-dichlorovinyl-2,2-phosphate|FD173059|SMR000777927|SBI-0052506.P003|2,2-Dichlorovinyl dimethyl phosphate, 8CI|DB-054265|Dimethyl O, O-dichlorovinyl-2,2-phosphate|2,2-bis(chloranyl)ethenyl dimethyl phosphate|NS00000487|o-(2, 2-Dichlorvinyl)-O,O-dimethylphosphat|O-O-Dimethyl-O(2,2-dichlorovinyl)phosphate|ST51047050|Dichlorvos, PESTANAL(R), analytical standard|Ethenol, 2, 2-dichloro-, dimethyl phosphate|Phosphoric acid,2-dichlorovinyl dimethyl ester|Vinyl alcohol,2-dichloro-, dimethyl phosphate|0, 0-Dimethyl 0-2,2-dichlorovinyl phosphate|D03791|AB00053012_02|O,O-Dimethyl-O-(2, 2-dichlor-vinyl)-phosphat|Phosphoric acid,2-dichloroethenyl dimethyl ester|A833962|Q420622|SR-05000001548|SR-05000001548-1|BRD-K23779958-001-05-8|O-(2,2-Dichloroethenyl) O,O-dimethyl phosphate, 9CI|Dichlorvos, United States Pharmacopeia (USP) Reference Standard|Phosphoric acid 2,2-dichloroethenyl dimethyl ester;Dichlorophos;DDVP|InChI=1/C4H7Cl2O4P/c1-8-11(7,9-2)10-3-4(5)6/h3H,1-2H3"
PROPOXUR,4944,,"InChI=1S/C11H15NO3/c1-8(2)14-9-6-4-5-7-10(9)15-11(13)12-3/h4-8H,1-3H3,(H,12,13)",ISRUGXGCCGIOQO-UHFFFAOYSA-N,C11H15NO3,209.24,(2-propan-2-yloxyphenyl) N-methylcarbamate,"propoxur|114-26-1|Baygon|2-Isopropoxyphenyl methylcarbamate|Aprocarb|Propoxure|Sendran|Blattanex|Blattosep|Mrowkozol|Propotox|Propoxylor|Boruho|Brygou|Suncide|Tendex|Bolfo|Dalf dust|Invisi-Gard|2-Isopropoxyphenyl N-methylcarbamate|Isocarb|Propyon|Bifex|Rhoden|Boruho 50|IPMC|o-Impc|Tugon fliegenkugel|Unden (Pesticide)|Propoksuru|Bayer B 5122|Bayer 39007|Chemagro 9010|Unden 50PM|PHC 7|PHC (carbamate)|Caswell No. 508|2-(1-Methylethoxy)phenol methylcarbamate|Bay 9010|ENT 25,671|Phenol, 2-(1-methylethoxy)-, methylcarbamate|O-(2-Isopropoxyphenyl) N-methylcarbamate|BAY 5122|o-Isopropoxyphenyl N-methylcarbamate|BAY 39007|OMS-33|Propogon|Boygon|Phenol, o-isopropoxy-, methylcarbamate|DTXSID7021948|CHEBI:34938|2-(1-methylethoxy)phenyl methylcarbamate|o-Isopropoxyphenyl methylcarbamate|2-Isopropoxyphenyl-N-methylcarbamat|NSC-379584|Carbamic acid, methyl-, o-isopropoxyphenyl ester|BFH029TL73|(2-propan-2-yloxyphenyl) N-methylcarbamate|2-(1-Methylethoxy)phenyl N-methylcarbamate|2-(propan-2-yloxy)phenyl methylcarbamate|DTXCID301948|2-Isopropoxyphenyl-N-methylcarbamate|N-Methyl-2-isopropoxyphenylcarbamate|NSC379584|Carbamic acid, methyl-, 2-(1-methylethoxy)phenyl ester|Undene|O Isopropoxyphenylmethylcarbamate|O-Isopropoxyphenylmethylcarbamate|o-Isopropoxyphenyl-N-methylcarbamate|PPX (insecticide)|N-Methyl-2-isopropoxyphenyl-carbamate|RefChem:930059|2-(propan-2-yloxy)phenyl N-methylcarbamate|N-2-(1-Methylethoxy)phenyl methyl-carbamate|204-043-8|Arprocarb|MFCD00055455|2-Methylethoxyphenyl carbamate|2-[(1-methylethyl)oxy]phenyl methylcarbamate|Propoksuru [Polish]|CAS-114-26-1|NSC 379584|CCRIS 1392|HSDB 603|Propoxur [INN:BAN]|EINECS 204-043-8|EPA Pesticide Chemical Code 047802|BRN 1879891|UNII-BFH029TL73|Pillargon|AI3-25671|OMS 33|2-Isopropoxyphenyl-N-methylcarbamat [German]|Propoxur (BAN)|Propoxur (Standard)|Bolfo (TN)|(2-isopropoxyphenyl) N-methylcarbamate|Spectrum_001923|PROPOXUR [HSDB]|SpecPlus_000554|PROPOXUR [JAN]|PROPOXUR [MI]|Spectrum2_001232|Spectrum3_000857|Spectrum4_000697|Spectrum5_002032|PROPOXUR [MART.]|SCHEMBL27794|BSPBio_002473|KBioGR_001193|KBioSS_002465|SPECTRUM330066|MLS002207242|BIDD:ER0307|DivK1c_006650|SPBio_001104|Isopropoxyphenyl methylcarbamate|CHEMBL446060|orb1310111|HY-B0916R|ISRUGXGCCGIOQO-UHFFFAOYSA-|KBio1_001594|KBio2_002458|KBio2_005026|KBio2_007594|KBio3_001973|HMS3264G19|Pharmakon1600-00330066|HY-B0916|MSK20270|Tox21_201968|Tox21_301207|BDBM50064617|CCG-39115|NSC755890|AKOS015889907|NSC-755890|NCGC00094544-01|NCGC00094544-02|NCGC00094544-03|NCGC00094544-04|NCGC00094544-05|NCGC00094544-06|NCGC00094544-07|NCGC00255104-01|NCGC00259517-01|AS-50078|SMR000778062|2-(1-Methylethoxy)phenyl methyl carbamate|SBI-0052551.P002|DB-041207|NS00010600|P2894|Propoxur, PESTANAL(R), analytical standard|D08442|O10810|AB00053059_04|114P261|Q411303|SR-01000872751|SR-01000872751-1|BRD-K08231299-001-08-1|Phenol, 2-(1-methylethoxy)-, 1-(N-methylcarbamate)|InChI=1/C11H15NO3/c1-8(2)14-9-6-4-5-7-10(9)15-11(13)12-3/h4-8H,1-3H3,(H,12,13)|PHC"
BMS-911543,50922691,,"InChI=1S/C23H28N8O/c1-5-30-17(23(32)31(14-6-7-14)15-8-9-15)11-16-20-19(24-12-28(20)3)21(26-22(16)30)25-18-10-13(2)29(4)27-18/h10-12,14-15H,5-9H2,1-4H3,(H,25,26,27)",JCINBYQJBYJGDM-UHFFFAOYSA-N,C23H28N8O,432.5,"N,N-dicyclopropyl-7-[(1,5-dimethylpyrazol-3-yl)amino]-10-ethyl-3-methyl-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,4,6,8,11-pentaene-11-carboxamide","BMS-911543|1271022-90-2|BMS 911543|JAK2 INHIBITOR BMS-911543|7N03P021J8|DTXSID00155403|RefChem:120755|DTXCID1077894|N,N-dicyclopropyl-7-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-10-ethyl-3-methyl-3,5,8,10-tetraazatricyclo(7.3.0.0^(2,6))dodeca-1,4,6,8,11-pentaene-11-carboxamide|BMS911543|N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide|MFCD22200575|Imidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide, N,N-dicyclopropyl-4-[(1,5-dimethyl-1H-pyrazol-3-yl)amino]-6-ethyl-1,6-dihydro-1-methyl-|N,N-dicyclopropyl-4-(1,5-dimethyl-1H-pyrazol-3-ylamino)-6-ethyl-1-methyl-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridine-7-carboxamide|N,N-Dicyclopropyl-4-[(1,5-Dimethyl-1h-Pyrazol-3-Yl)amino]-6-Ethyl-1-Methyl-1,6-Dihydroimidazo[4,5-D]pyrrolo[2,3-B]pyridine-7-Carboxamide|N,N-dicyclopropyl-7-[(1,5-dimethylpyrazol-3-yl)amino]-10-ethyl-3-methyl-3,5,8,10-tetrazatricyclo[7.3.0.02,6]dodeca-1,4,6,8,11-pentaene-11-carboxamide|UNII-7N03P021J8|JCINBYQJBYJGDM-UHFFFAOYSA-N|IMIDAZO(4,5-D)PYRROLO(2,3-B)PYRIDINE-7-CARBOXAMIDE, N,N-DICYCLOPROPYL-4-((1,5-DIMETHYL-1H-PYRAZOL-3-YL)AMINO)-6-ETHYL-1,6-DIHYDRO-1-METHYL-|GTPL7954|orb1300463|SCHEMBL1512419|CHEMBL3545215|SCHEMBL28561658|SCHEMBL29401424|SCHEMBL30925302|HMS3747C07|BCP07258|EX-A1551|WAC02290|BDBM50122318|NSC766821|NSC799366|s7144|AKOS027251175|CCG-269045|CS-3237|DB12591|NSC-766821|NSC-799366|SB16625|BMS-911543?|NCGC00345798-01|NCGC00345798-06|AC-29054|AS-17031|HY-15270|N,N-dicyclopropyl-4-((1,5-dimethyl-1H-pyrazol-3-yl)amino)-6-ethyl-1-methyl-1,6-dihydroimidazo(4,5-d)pyrrolo(2,3b)pyridine-7-carboxamide|NS00073303|Q27075379|50V"
AZD-3759,78209992,,"InChI=1S/C22H23ClFN5O3/c1-13-11-28(2)7-8-29(13)22(30)32-19-9-14-17(10-18(19)31-3)25-12-26-21(14)27-16-6-4-5-15(23)20(16)24/h4-6,9-10,12-13H,7-8,11H2,1-3H3,(H,25,26,27)/t13-/m1/s1",MXDSJQHFFDGFDK-CYBMUJFWSA-N,C22H23ClFN5O3,459.9,"[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl] (2R)-2,4-dimethylpiperazine-1-carboxylate","AZD3759|1626387-80-1|AZD-3759|zorifertinib|67SX9H68W2|[4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl] (2R)-2,4-dimethylpiperazine-1-carboxylate|(4-(3-chloro-2-fluoroanilino)-7-methoxyquinazolin-6-yl) (2R)-2,4-dimethylpiperazine-1-carboxylate|RefChem:115995|(R)-4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl 2,4-dimethylpiperazine-1-carboxylate|4-[(3-CHLORO-2-FLUOROPHENYL)AMINO]-7-METHOXYQUINAZOLIN-6-YL (2R)-2,4-DIMETHYLPIPERAZINE-1-CARBOXYLATE|AZD 3759|MFCD29058564|UNII-67SX9H68W2|CHEMBL3623290|(2R)-2,4-dimethyl-1-piperazinecarboxylic acid, 4-[(3-chloro-2-fluorophenyl)amino]-7-methoxy-6-quinazolinyl ester|4-((3-Chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl (2R)-2,4-dimethylpiperazine-1-carboxylate|C22H23ClFN5O3|ZORIFERTINIB [INN]|ZORIFERTINIB [WHO-DD]|orb1303946|SCHEMBL16010006|SCHEMBL29483200|SCHEMBL29837158|SCHEMBL29996461|GTPL10456|EX-A720|GLXC-90388|BDBM50123453|NSC788121|NSC800978|s7971|AKOS027327321|CCG-269329|CS-5029|DB14795|NSC-788121|NSC-800978|compound 1m [PMID: 26313252]|NCGC00483922-01|NCGC00483922-02|AC-29957|AS-74755|FA137650|HY-18750|BRD-K41626799-001-01-1|Z2471604138|(R)-4-(3-chloro-2-fluorophenylamino)-7-methoxyquinazolin-6-yl 2,4-dimethylpiperazine-1-carboxylate|[4-(3-chloro-2-fluoro-anilino)-7-methoxy-quinazolin-6-yl] (2R)-2,4-dimethylpiperazine-1-carboxylate|1-PIPERAZINECARBOXYLIC ACID, 2,4-DIMETHYL-, 4-((3-CHLORO-2-FLUOROPHENYL)AMINO)-7-METHOXY-6-QUINAZOLINYL ESTER, (2R)-"
ISOQUERCETIN,5280804,,"InChI=1S/C21H20O12/c22-6-13-15(27)17(29)18(30)21(32-13)33-20-16(28)14-11(26)4-8(23)5-12(14)31-19(20)7-1-2-9(24)10(25)3-7/h1-5,13,15,17-18,21-27,29-30H,6H2/t13-,15-,17+,18-,21+/m1/s1",OVSQVDMCBVZWGM-QSOFNFLRSA-N,C21H20O12,464.4,"2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one","Isoquercetin|Hirsutrin|3-Glucosylquercetin|Quercetin 3-o-glucopyranoside|Quercetin 3-D-glucoside|Quercetol 3-monoglucoside|Quercetol 3-glucoside|CONTIGOSIDE B|Quercetin-3-O-glucopyranoside|Quercetin 3-monoglucoside|Quercetin 3-beta-glucoside|Quercetin 3-beta-O-glucoside|quercetin glucoside|Quercetin-3-glucose|Ronacare isoquercetin|Glucosyl-3-quercetin|Isoquercetin, (-)-|UNII-6HN2PC637T|NSC 115918|BRN 0100989|6HN2PC637T|CCRIS 9340|CHEBI:68352|quercetin 3-O-beta-D-glucopyranoside|NSC-115918|4-18-00-03493 (Beilstein Handbook Reference)|Q 5|2-(3,4-Dihydroxyphenyl)-5,7-dihydroxy-4-oxo-4H-chromen-3-yl beta-D-glucopyranoside|4H-1-benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-|4H-1-Benzopyran-4-one, 5,7-dihydroxy-2-(3,4-dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-|2-(3,4-dihydroxyphenyl)-3-(beta-D-glucopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one|RefChem:40304|IQC-950AN|QUERCETIN 3beta-GLUCOSIDE|quercetin-3-beta-glucopyranoside|3-o-beta-d-glucopyranosylquercetin|QUERCETIN 3-O-GLUCOSIDE (CONSTITUENT OF GINKGO)|3',4',5,7-TETRAHYDROXYFLAVONE-3-beta-D-GLUCOPYRANOSIDE|4H-1-BENZOPYRAN-4-ONE, 2-(3,4-DIHYDROXYPHENYL)-3-(SS-D-GLUCOFURANOSYLOXY)-5,7-DIHYDROXY-|482-35-9|Quercetin 3-glucoside|Quercetin 3-O-glucoside|Glucosyl 3-quercetin|3-beta-D-Glucosylquercetin|quercetin-3-O-glucoside|MFCD00017746|quercetin-3-glucoside|2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-(((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)-4H-chromen-4-one|Quercetin 3.beta.-glucoside|CHEMBL250450|quercetin-3-o-beta-glucopyranoside|3,3',4',5,7-Pentahydroxyflavone 3-beta-glucoside|Quercetin 3-O-.beta.-D-glucopyranoside|Quercetin 3-beta-D-glucoside|Quercetin 3-O-b-D Glucoside|NSC-407304|quercetin 3-O-beta-D-glucoside|2-(3,4-Dihidroxyphenyl)-3-(beta-D-glucofuranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one|Quercetin 3-|A-D-glucoside|2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one|SMR000466391|2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one|hydroside|HW2|Isoquercitrin (6)|ISOQUERCITRIN?|QUERCETIN 3-B-D-GLUCOPYRANOSIDE|Isoquercitrin (Standard)|3-glucoside isoquercitrin|3-|A-D-Glucosylquercetin|ISOQUERCITRIN [MI]|Quercetin 3-b-D-glucoside|Quercetin 3-glucopyranoside|Quercetin 3-ss-D-glucoside|MLS000759532|MLS001424096|SCHEMBL181306|orb1301324|SCHEMBL29349832|SCHEMBL29354754|ACon1_002134|cid_5280804|cid_5378597|HY-N1445R|Quercetin 3- beta -D-glucoside|BDBM153265|GLXC-13304|HMS2051B17|2-(3,4-Dihydroxy-phenyl)-5,7-dihydroxy-3-(3,4,5-trihydroxy-6-hydroxymethyl-tetrahydro-pyran-2-yloxy)-chromen-4-one|HY-N1445|BDBM50241354|PDSP1_001363|PDSP2_001347|s3842|AKOS015896729|CCG-100967|DB12665|FQ75101|MQ09326|NC00217|Quercetin-3-O-beta-D-galactopyranoside|Isoquercitrin;Quercetin 3-b-D-glucoside|quercetin -3-O-beta-D-galactopyranoside|AC-37614|AS-35335|QUERCETIN-3-O-.BETA.-D-GLUCOSIDE|SY027575|Quercetin 3-glucoside, analytical standard|QUERCETIN-3-.BETA.-GLUCOPYRANOSIDE|3-O-.BETA.-D-GLUCOPYRANOSYLQUERCETIN|CS-0016884|NS00069794|C05623|QUERCETIN 3-O-GLUCOPYRANOSIDE [WHO-DD]|AB00639942-06|Quercetin 3-beta-D-glucoside, >=90% (HPLC)|3,3',4',5,7-Pentahydroxyflavone 3-A-glucoside|F979202|3-Glucopyranosyloxy-3',4',5,7-tetrahydroxyflavone|Q6086296|BRD-K73991644-001-01-7|3,3'',4'',5,7-pentahydroxyflavone-3-beta-O-glucoside|Isoquercitrin, primary pharmaceutical reference standard|QUERCETIN 3-O-GLUCOSIDE (CONSTITUENT OF GINKGO) [DSC]|3',4',5,7-TETRAHYDROXYFLAVONE-3-.BETA.-D-GLUCOPYRANOSIDE|2-(3,4-Dihydroxyphenyl)-3-(b-D-glucopyranosyloxy)-5,7-dihydroxy-4H-1-benzopyran-4-one, 9CI|2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one|2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one|2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-((2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yloxy)-4H-chromen-4-one|4H-1-BENZOPYRAN-4-ONE, 2- (3,4-DIHYDROXYPHENYL)-3- (SS-D-GLUCOFURANOSYLOXY)-5,7-DIHYDROXY-|4H-1-Benzopyran-4-one, 2-(3,4-dihydroxy-phenyl)-3-(.beta.-D-glucofuranosyloxy)-5,7-dihydroxy-|4H-1-BENZOPYRAN-4-ONE, 2-(3,4-DIHYDROXYPHENYL)-3-(.BETA.-D-GLUCOPYRANOSYLOXY)-5,7-DIHYDROXY-"
PROPYLTHIOURACIL,657298,,"InChI=1S/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11)",KNAHARQHSZJURB-UHFFFAOYSA-N,C7H10N2OS,170.23,6-propyl-2-sulfanylidene-1H-pyrimidin-4-one,"propylthiouracil|51-52-5|6-Propyl-2-thiouracil|Propacil|Prothiurone|Procasil|Propycil|Prothyran|Prothiucil|Protiural|Thiuragyl|Prothycil|Propyl-Thiorist|Propyl-Thyracil|Thyreostat II|Propythiouracil|Propilthiouracil|6-propyl-2-thioxo-2,3-dihydropyrimidin-4(1H)-one|6-Propylthiouracil|Propyl-Thiorit|Propylthiorit|Propylthiouracile|6-Thio-4-propyluracil|Propiltiouracilo|4-Propyl-2-thiouracil|Propylthiouracilum|2-Mercapto-6-propyl-4-pyrimidone|Propiltiouracile|2-Mercapto-6-propylpyrimid-4-one|2-Thio-6-propyl-1,3-pyrimidin-4-one|2-Thio-4-oxo-6-propyl-1,3-pyrimidine|4-Hydroxy-2-mercapto-6-propylpyrimidine|PROPYL THIOURACIL|2-Mercapto-4-hydroxy-6-n-propylpyrimidine|2,3-Dihydro-6-propyl-2-thioxo-4(1H)-pyrimidinone|6-propyl-2-sulfanylidene-1H-pyrimidin-4-one|6-Propyl-2-thio-2,4(1H,3H)pyrimidinedione|CHEBI:8502|NSC-6498|4(1H)-Pyrimidinone, 2,3-dihydro-6-propyl-2-thioxo-|NSC-70461|DTXSID5021209|721M9407IY|DTXCID101209|NSC70461|6-propyl-2-sulfanylidene-1,2,3,4-tetrahydropyrimidin-4-one|6 Propyl 2 Thiouracil|RefChem:55928|H03BA02|200-103-2|2-Mercapto-6-propylpyrimidin-4-ol|6-N-Propylthiouracil|6-N-Propyl-2-thiouracil|PTU (thyreostatic)|6-Propil-tiouracile|Uracil, 6-propyl-2-thio-|MFCD00006041|500-50-5|NSC 6498|6-propyl-2 thiouracil|2-mercapto-6-propylpyrimidin-4(3H)-one|MLS000028494|6-propyl-2-sulfanylpyrimidin-4-ol|CAS-51-52-5|NCGC00022715-03|SMR000058275|Propiltiouracile [DCIT]|6-n-Propylthiouracil;6-Propyl-2-thiouracil;PTU|WLN: T6MYMVJ BUS F3|6-Propil-tiouracile [Italian]|Propiltiouracilo [INN-Spanish]|Propylthiouracile [INN-French]|Propylthiouracilum [INN-Latin]|6-Propyl-2-thio-2,3H)-pyrimidinedione|CCRIS 544|HSDB 3390|Propylthiouracil (TN)|SR-05000001706|4(1H)-Pyrimidinone,3-dihydro-6-propyl-2-thioxo-|EINECS 200-103-2|6-(n-Propyl)-2-thiouracil|AI3-25477|Propylthiouracil; 2,3-dihydro-6-propyl-2-thioxopyrimidin-4(1H)-one|UNII-721M9407IY|Prestwick_810|6-Propyl-2-thioxo-2, 3-dihydropyrimidin-4(1H)-one|Propylthiouracil [USP:INN:BAN:JAN]|6-propyl-2-thioxo-1H-pyrimidin-4-one|Spectrum_000876|Opera_ID_530|3CJ|Prestwick0_000494|Prestwick1_000494|Prestwick2_000494|Prestwick3_000494|Spectrum2_001302|Spectrum3_001731|Spectrum4_000492|Spectrum5_001815|6-Propyl-2-thio-2,4(1H,3H)-pyrimidinedione|Propylthiouracil (Standard)|2-THIO-4-HYDROXY-6-N-PROPYL-PYRIMIDINE|CHEMBL1518|SCHEMBL41239|BSPBio_000387|BSPBio_003402|KBioGR_001003|KBioSS_001356|PROPYLTHIOURACIL [MI]|MLS002303010|MLS006011901|DivK1c_000268|PROPYLTHIOURACIL [INN]|PROPYLTHIOURACIL [JAN]|SPECTRUM1500515|SPBio_001363|SPBio_002308|PROPYLTHIOURACIL [HSDB]|PROPYLTHIOURACIL [IARC]|BPBio1_000427|GTPL6650|orb1309031|SCHEMBL4446870|SCHEMBL4537771|PROPYLTHIOURACIL [VANDF]|PROPYLTHIOURACIL [MART.]|SCHEMBL17375339|HMS500N10|HY-B0346R|KBio1_000268|KBio2_001356|KBio2_003924|KBio2_006492|KBio3_002622|6-propyl-2-sulfanylidene-2,3-dihydropyrimidin-4(1H)-one|MSK7141|NSC6498|PROPYLTHIOURACIL [USP-RS]|PROPYLTHIOURACIL [WHO-DD]|PROPYLTHIOURACIL [WHO-IP]|NINDS_000268|HMS1569D09|HMS1766D22|HMS1920L22|HMS2092E03|HMS2096D09|HMS2230B22|HMS3259M04|HMS3371D17|HMS3655J07|HMS3713D09|HMS5080B13|Pharmakon1600-01500515|BCP22165|HY-B0346|Propylthiouracil (JP18/USP/INN)|PXB42394|Tox21_110882|Tox21_201741|Tox21_300280|2-mercapto-6-propyl-pyrimidin-4-ol|AC8761|BDBM50133597|CCG-39240|MFCD00052385|NSC757302|s1988|SBB003855|STL102645|PROPYLTHIOURACIL [EP IMPURITY]|PROPYLTHIOURACIL [ORANGE BOOK]|6-Propyl-2-sulfanyl-4-pyrimidinol #|AKOS000120319|AKOS001053246|AKOS015892537|Tox21_110882_1|2-thio-4-hydroxy-6-n-propylpyrimidine|BS-3928|DB00550|NC00533|NSC-757302|PROPYLTHIOURACIL [EP MONOGRAPH]|PS-3436|4-hydroxy-6-n-propylpyrimidine-2-thiol|IDI1_000268|PROPYLTHIOURACIL [USP MONOGRAPH]|6-Propyl-2-thiouracil, enzyme inhibitor|NCGC00016229-01|NCGC00016229-02|NCGC00016229-03|NCGC00016229-04|NCGC00016229-05|NCGC00016229-06|NCGC00016229-07|NCGC00016229-08|NCGC00016229-09|NCGC00016229-10|NCGC00016229-11|NCGC00016229-13|NCGC00016229-14|NCGC00090881-01|NCGC00090881-02|NCGC00090881-03|NCGC00178089-01|NCGC00178089-02|NCGC00183321-01|NCGC00254180-01|NCGC00259290-01|NCGC00663696-01|2-mercapto-4-hydroxy-6-propyl pyrimidine|6-propyl-2-sulfanyl-1H-pyrimidin-4-one|AC-10795|propylthiouracil / 6-Propyl-2-thiouracil|SMR003317355|SY038617|SBI-0051497.P003|NS00000029|P0533|ST50308196|SW196944-3|EN300-35033|C07569|D00562|6-propyl-2-sulfanyl-3,4-dihydropyrimidin-4-one|6-Propyl-2-thiouracil, purum, >=98.0% (T)|AB00052082_05|AB00052082_06|AS-871/40901436|F463632|Q377342|6-propyl-2-thioxo-2,3-dihydro-4(1H)-pyrimidinone|SR-05000001706-1|SR-05000001706-2|SR-05000001706-3|2,3-dihydro-6-propyl-2-thioxo-Pyrimidin-4(1H)-one|BRD-K48168960-001-04-4|BRD-K48168960-001-05-1|BRD-K48168960-001-08-5|BRD-K48168960-001-18-4|BRD-K48168960-001-19-2|Z56922173|F1967-1318|F2199-0035|F3097-4245|4(1H)-PYRIMIDINONE,6-BUTYL-2,3-DIHYDRO-2-THIOXO-|6-Propyl-2-thiouracil, VETRANAL(TM), analytical standard|Propylthiouracil, European Pharmacopoeia (EP) Reference Standard|Propylthiouracil, United States Pharmacopeia (USP) Reference Standard|InChI=1/C7H10N2OS/c1-2-3-5-4-6(10)9-7(11)8-5/h4H,2-3H2,1H3,(H2,8,9,10,11"
LENRISPODUN PHOSPHATE,72704434,,"InChI=1S/C29H26FN7O.H3O4P/c1-35-28(38)25-26(31-20-7-3-2-4-8-20)36(34-27(25)37-23-11-5-10-22(23)33-29(35)37)17-18-13-15-19(16-14-18)21-9-6-12-24(30)32-21;1-5(2,3)4/h2-4,6-9,12-16,22-23,31H,5,10-11,17H2,1H3;(H3,1,2,3,4)/t22-,23+;/m1./s1",ZPIAAFIYOPWWJL-RFPXDPOKSA-N,C29H29FN7O5P,605.6,"(11R,15S)-5-anilino-4-[[4-(6-fluoropyridin-2-yl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;phosphoric acid","1642303-38-5|Lenrispodun phosphate|ITI-214 phosphate|YP683YZB8K|Lenrispodun phosphate [USAN]|IC200214 phosphate|ITI200214-phosphate|ITI-214 phosphate salt|UNII-YP683YZB8K|ITI-002|ITI-12-Cyclo-(S,R) phosphate|Cyclopent(4,5)imidazo(1,2-a)pyrazolo(4,3-E)pyrimidin-4(2H)-one, 2-((4-(6-fluoro-2-pyridinyl)phenyl)methyl)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-, (6aR,9aS)-, phosphate (1:1)|IC 200214-12|Lenrispodun phosphate (USAN)|ITI-12-phosphate|RefChem:152747|(6AR,9AS)-2-(4-(6-FLUOROPYRIDIN-2-YL)BENZYL)-5-METHYL-3-ANILINO-5,6A,7,8,9,9AHEXAHYDRO-CYCLOPENT(4,5)IMIDAZO(1,2-A)PYRAZOLO(4,3-E)PYRIMIDIN-4(2H)-ONE PHOSPHATE (1:1)|ITI214|PDE1-IN-1 (phosphate)|ITI-214(phosphate pound(c)|(11R,15S)-5-anilino-4-[[4-(6-fluoropyridin-2-yl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;phosphoric acid|(6aR,9aS)-2-(4-(6-fluoropyridin-2-yl)benzyl)-5-methyl-3-(phenylamino)-5,6a,7,8,9,9a-hexahydrocyclopenta[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one phosphate|TI-214 phosphate|ITI- 12-phosphate|C29H29FN7O5P|orb1309535|CHEMBL3770459|SCHEMBL23610593|SCHEMBL30357428|LENRISPODUN (ITI-214)|EX-A3113|SQC30338|HY-12501A|MFCD28385868|AKOS030526634|CS-3627|AC-36336|DA-54478|D11884|D83663|(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one;phosphoric acid|(6AR,9AS)-2-(4-(6-FLUOROPYRIDIN-2-YL)BENZYL)-5-METHYL-3-ANILINO-5,6A,7,8,9,9AHEXAHYDRO- CYCLOPENT(4,5)IMIDAZO(1,2-A)PYRAZOLO(4,3-E)PYRIMIDIN-4(2H)-ONE PHOSPHATE (1:1)"
LENRISPODUN,42639643,,"InChI=1S/C29H26FN7O/c1-35-28(38)25-26(31-20-7-3-2-4-8-20)36(34-27(25)37-23-11-5-10-22(23)33-29(35)37)17-18-13-15-19(16-14-18)21-9-6-12-24(30)32-21/h2-4,6-9,12-16,22-23,31H,5,10-11,17H2,1H3/t22-,23+/m1/s1",BBIPVJCGIASXJB-PKTZIBPZSA-N,C29H26FN7O,507.6,"(11R,15S)-5-anilino-4-[[4-(6-fluoropyridin-2-yl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one","1160521-50-5|Lenrispodun|ITI-214 free base|ITI-214|ITI-214F|3GBO34D1BE|IC200214|IC-200214|Cyclopent(4,5)imidazo(1,2-a)pyrazolo(4,3-E)pyrimidin-4(2H)-one, 2-((4-(6-fluoro-2-pyridinyl)phenyl)methyl)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-, (6aR,9aS)-|RefChem:150203|(11R,15S)-4-((4-(6-fluoropyridin-2-yl)phenyl)methyl)-8-methyl-5-(phenylamino)-1,3,4,8,10-pentaazatetracyclo(7.6.0.0^(2,6).0^(11,15))pentadeca-2,5,9-trien-7-one|ITI214 free base|ITI214 (free base)|ITI-214 (free base)|Lenrispodun [USAN]|UNII-3GBO34D1BE|PDE1-IN-1|PDE4 (R)-(-)-RolipraM|(11R,15S)-5-anilino-4-[[4-(6-fluoropyridin-2-yl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one|CHEMBL3769414|WHO 11635|Lenrispodun (USAN)|(11r,15s)-4-{[4-(6-Fluoropyridin-2-Yl)phenyl]methyl}-8-Methyl-5-(Phenylamino)-1,3,4,8,10-Pentaazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-Trien-7-One|LENRISPODUN [INN]|C29H26FN7O|orb1709390|SCHEMBL10201342|SCHEMBL29415040|GTPL12003|BBIPVJCGIASXJB-PKTZIBPZSA-N|BCP16186|BDBM50150119|MFCD28385866|AKOS030526280|compound 3 [PMID: 26789933]|CS-3621|DB15039|(6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)-cyclopent[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one|DA-74606|HY-12501|MS-29430|D11883|BRD-K77987496-011-01-9|Q27454893|(11R,15S)-5-anilino-4-[[4-(6-fluoro-2-pyridyl)phenyl]methyl]-8-methyl-1,3,4,8,10-pentazatetracyclo[7.6.0.02,6.011,15]pentadeca-2,5,9-trien-7-one|(6AR,9AS)-2-((4-(6-FLUORO-2-PYRIDINYL)PHENYL)METHYL)-5,6A,7,8,9,9AHEXAHYDRO- 5-METHYL-3-(PHENYLAMINO)CYCLOPENT(4,5)IMIDAZO(1,2-A)PYRAZOLO(4,3- E)PYRIMIDIN-4(2H)-ONE|(6AR,9aS)-2-(4-(6-Fluoropyridin-2-yl)benzyl)-5-methyl-3-(phenylamino)-5,6a,7,8,9,9a-hexahydrocyclopenta[4,5]imidazo[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one|(6aR,9aS)-5,6a,7,8,9,9a-hexahydro-5-methyl-3-(phenylamino)-2-((4-(6-fluoropyridin-2-yl)phenyl)methyl)-cyclopent[4,5]imidazo-[1,2-a]pyrazolo[4,3-e]pyrimidin-4(2H)-one"
AMG-337,44181686,,"InChI=1S/C23H22FN7O3/c1-14(30-5-4-20-18(23(30)32)9-17(11-25-20)34-7-6-33-3)21-27-28-22-19(24)8-15(13-31(21)22)16-10-26-29(2)12-16/h4-5,8-14H,6-7H2,1-3H3/t14-/m1/s1",DWHXUGDWKAIASB-CQSZACIVSA-N,C23H22FN7O3,463.5,"6-[(1R)-1-[8-fluoro-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-1,6-naphthyridin-5-one","AMG-337|1173699-31-4|AMG 337|AMG337|08WG8S0L8D|1,6-Naphthyridin-5(6H)-one, 6-[(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-|6-[(1R)-1-[8-fluoro-6-(1-methylpyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-1,6-naphthyridin-5-one|1,6-Naphthyridin-5(6H)-one, 6-((1R)-1-(8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-1,2,4-triazolo(4,3-a)pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-|6-[(1R)-1-[8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl]ethyl]-3-(2-methoxyethoxy)-5,6-dihydro-1,6-naphthyridin-5-one|6-((1R)-1-(8-fluoro-6-(1-methyl-1H-pyrazol-4-yl)-(1,2,4)triazolo(4,3-a)pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-5,6-dihydro-1,6-naphthyridin-5-one|6-((1R)-1-(8-fluoro-6-(1-methylpyrazol-4-yl)-(1,2,4)triazolo(4,3-a)pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5-one|RefChem:111925|C-MET INHIBITOR AMG 337|(r)-6-(1-(8-fluoro-6-(1-methyl-1h-pyrazol-4-yl)-[1,2,4]triazolo[4,3-a]pyridin-3-yl)ethyl)-3-(2-methoxyethoxy)-1,6-naphthyridin-5(6h)-one|AMG 337 [WHO-DD]|MFCD29472283|UNII-08WG8S0L8D|CHEMBL3785909|AMG 337; Compound M;|6-[(1~{r})-1-[8-Fluoranyl-6-(1-Methylpyrazol-4-Yl)-[1,2,4]triazolo[4,3-A]pyridin-3-Yl]ethyl]-3-(2-Methoxyethoxy)-1,6-Naphthyridin-5-One|GTPL8913|orb1304422|SCHEMBL4304600|SCHEMBL29582914|C23H22FN7O3|BCP16602|YWB69931|BDBM50157612|NSC789223|NSC800996|s8167|AKOS030526285|CCG-269379|CS-5281|NSC-789223|NSC-800996|compound 24 [PMID: 19819693]|NCGC00483923-01|AC-33036|AS-75219|DA-50393|HY-18696|BRD-K27061362-001-01-6|Q27456004"
NAQUOTINIB,71667668,,"InChI=1S/C30H42N8O3/c1-4-25-30(41-24-12-15-38(20-24)26(39)5-2)34-29(27(33-25)28(31)40)32-21-6-8-22(9-7-21)36-13-10-23(11-14-36)37-18-16-35(3)17-19-37/h5-9,23-24H,2,4,10-20H2,1,3H3,(H2,31,40)(H,32,34)/t24-/m1/s1",QKDCLUARMDUUKN-XMMPIXPASA-N,C30H42N8O3,562.7,6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxypyrazine-2-carboxamide,"Naquotinib|1448232-80-1|ASP8273|ASP-8273|2-Pyrazinecarboxamide, 6-ethyl-3-[[4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[[(3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]oxy]-|47DD4548PB|6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxypyrazine-2-carboxamide|2-Pyrazinecarboxamide, 6-ethyl-3-((4-(4-(4-methyl-1-piperazinyl)-1-piperidinyl)phenyl)amino)-5-(((3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl)oxy)-|6-ethyl-3-({4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl}amino)-5-{[(3R)-1-(prop-2-enoyl)pyrrolidin-3-yl]oxy}pyrazine-2-carboxamide|naquotinibum|6-ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-(((3R)-1-(prop-2-enoyl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide|6-ethyl-3-(4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)anilino)-5-((3R)-1-prop-2-enoylpyrrolidin-3-yl)oxypyrazine-2-carboxamide|RefChem:832062|Naquotinib [USAN]|(R)-5-((1-acryloylpyrrolidin-3-yl)oxy)-6-ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)pyrazine-2-carboxamide|e-2-carboxamide|MFCD30496701|Naquotinib(ASP8273)|NAQUOTINIB [INN]|Naquotinib (USAN/INN)|ASP8273 (Naquotinib)|Naquotinib; ASP-8273|NAQUOTINIB [WHO-DD]|UNII-47DD4548PB|GTPL9248|orb1296210|CHEMBL3663929|SCHEMBL16196078|SCHEMBL29355759|BDBM170514|EX-A2669|NSC793322|s8412|AKOS032944996|CCG-270060|CS-5469|DB12036|NSC-793322|AC-35709|AS-75247|HY-19729|NS00073604|C91356|D10958|US9085540, 54|Q27074546|6-?Ethyl-?3-?[[4-?[4-?(4-?methyl-?1-?piperazinyl)?-?1-?piperidinyl]?phenyl]?amino]?-?5-?[[(3R)?-?1-?(1-?oxo-?2-?propen-?1-?yl)?-?3-?pyrrolidinyl]?oxy]?-2-?pyrazinecarboxamide|6-Ethyl-3-((4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)phenyl)amino)-5-(((3R)-1-(1-oxoprop-2-en-1-yl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide|6-ETHYL-3-(4-(4-(4-METHYLPIPERAZIN-1-YL)PIPERIDIN- 1-YL)ANILINO)-5-(((3R)-1-(PROP-2-ENOYL)PYRROLIDIN- 3-YL)OXY)PYRAZINE-2-CARBOXAMIDE|6-Ethyl-3-(4-(4-(4-methylpiperazin-1-yl)piperidin-1-yl)anilino)-5-(((3R)-1-(prop-2-enoyl)pyrrolidin-3-yl)oxy)pyrazine-2-carboxamide|6-Ethyl-3-[[4-[4-(4-methyl-1-piperazinyl)-1-piperidinyl]phenyl]amino]-5-[[(3R)-1-(1-oxo-2-propen-1-yl)-3-pyrrolidinyl]oxy]-2-pyrazinecarboxamide|6-ethyl-3-[[4-[4-(4-methylpiperazin-1-yl)piperidin-1-yl]phenyl]amino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxy-pyrazin|6-ethyl-3-[4-[4-(4-methylpiperazin-1-yl)-1-piperidyl]anilino]-5-[(3R)-1-prop-2-enoylpyrrolidin-3-yl]oxy-pyrazine-2-carboxamide"
MERESTINIB,44603533,,"InChI=1S/C30H22F2N6O3/c1-17-3-9-23(30(40)38(17)22-7-4-20(31)5-8-22)29(39)36-21-6-10-27(25(32)12-21)41-28-11-18-16-35-37(2)26(18)13-24(28)19-14-33-34-15-19/h3-16H,1-2H3,(H,33,34)(H,36,39)",QHADVLVFMKEIIP-UHFFFAOYSA-N,C30H22F2N6O3,552.5,N-[3-fluoro-4-[1-methyl-6-(1H-pyrazol-4-yl)indazol-5-yl]oxyphenyl]-1-(4-fluorophenyl)-6-methyl-2-oxopyridine-3-carboxamide,"Merestinib|1206799-15-6|LY-2801653|N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide|N-[3-fluoro-4-[1-methyl-6-(1H-pyrazol-4-yl)indazol-5-yl]oxyphenyl]-1-(4-fluorophenyl)-6-methyl-2-oxopyridine-3-carboxamide|5OGS5K699E|DTXSID20659635|3-Pyridinecarboxamide, N-(3-fluoro-4-((1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl)oxy)phenyl)-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-|N-(3-Fluoro-4-{[1-Methyl-6-(1h-Pyrazol-4-Yl)-1h-Indazol-5-Yl]oxy}phenyl)-1-(4-Fluorophenyl)-6-Methyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide|merestinibum|N-(3-fluoro-4-(1-methyl-6-(1H-pyrazol-4-yl)indazol-5-yl)oxyphenyl)-1-(4-fluorophenyl)-6-methyl-2-oxopyridine-3-carboxamide|RefChem:811131|DTXCID40610384|LY2801653|Merestinib [USAN]|Merestinib (LY2801653)|N-[3-Fluoro-4-[[1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yl]oxy]phenyl]-1-(4-fluorophenyl)-1,2-dihydro-6-methyl-2-oxo-3-pyridinecarboxamide|N-(3-Fluoro-4-(1-methyl-6-(1H-pyrazol-4-yl)-1H-indazol-5-yloxy)phenyl)-1-(4-fluorophenyl)-6-methyl-2-oxo-1,2-dihydropyridine-3-carboxamide|UNII-5OGS5K699E|Melotinib|C30H22F2N6O3|L1X|MFCD23160048|MERESTINIB [INN]|Merestinib (USAN/INN)|MERESTINIB [WHO-DD]|SCHEMBL679002|LY2801653 (Merestinib)|GTPL9841|orb1304187|CHEMBL3545307|SCHEMBL29493094|QHADVLVFMKEIIP-UHFFFAOYSA-N|HMS3741E21|BCP06826|EX-A1264|BDBM50172078|NSC772197|NSC800788|s7014|AKOS027323283|CCG-270011|CS-1192|DB12381|NSC-772197|NSC-800788|SB16550|NCGC00378921-02|NCGC00378921-07|AC-35447|AS-16348|DA-21192|HY-15514|LY 2801653|LY2801653?|NS00073097|D11763|F84906|BRD-K18961567-001-01-1|Q27262653|N-[3-fluoro-4-[1-methyl-6-(1H-pyrazol-4-yl)indazol-5-yl]oxy-phenyl]-1-(4-fluorophenyl)-6-methyl-2-oxo-pyridine-3-carboxamide"
CARVEDILOL,2585,,"InChI=1S/C24H26N2O4/c1-28-21-10-4-5-11-22(21)29-14-13-25-15-17(27)16-30-23-12-6-9-20-24(23)18-7-2-3-8-19(18)26-20/h2-12,17,25-27H,13-16H2,1H3",OGHNVEJMJSYVRP-UHFFFAOYSA-N,C24H26N2O4,406.5,1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol,"carvedilol|72956-09-3|Coreg|Dilatrend|Eucardic|Kredex|Carvedilolum|Querto|BM-14190|Dimitone|Artist|Coronis|Korvasan|Talliton|SKF 105517|1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxyphenoxy)ethylamino]propan-2-ol|DQ 2466|DQ-2466|(+-)-1-(Carbazol-4-yloxy)-3-((2-(o-methoxyphenoxy)ethyl)amino)-2-propanol|NSC-758694|SK&F-105517|CHEBI:3441|BM 14.190|BM-14-190|BM-14.190|C07AG02|0K47UL67F2|SKF-105517|[3-(9H-carbazol-4-yloxy)-2-hydroxypropyl][2-(2-methoxyphenoxy)ethyl]amine|DTXSID8022747|BM14190|1-(9H-Carbazol-4-yloxy)-3-(2-(2-methoxyphenoxy)ethylamino)propan-2-ol|2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-, (+-)-|2-Propanol, 1-(9H-carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)-|2-Propanol, 1-(9H-carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-|carvedilolo|(3-(9H-carbazol-4-yloxy)-2-hydroxypropyl)(2-(2-methoxyphenoxy)ethyl)amine|Eucardic 25|Eucardic 12.5|Eucardic 6.25|Eucardic 3.125|14C-labeled Carvedilol|RefChem:54726|Carvedilol, 14C labeled|DTXCID602747|(2RS)-1-(9H-Carbazol-4-yloxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol|615-871-8|658-032-1|Carvedilolum [Latin]|1-(9H-Carbazol-4-yloxy)-3-[[2-(2-methoxyphenoxy)ethyl]amino]-2-propanol|BM 14190|MFCD00864692|CHEMBL723|1-(9H-carbazol-4-yloxy)-3-{[2-(2-methoxyphenoxy)ethyl]amino}propan-2-ol|Coropress|Dibloc|1-((9H-Carbazol-4-yl)oxy)-3-((2-(2-methoxyphenoxy)ethyl)amino)propan-2-ol|1-(9H-carbazol-4-yloxy)-3-[(2-{[2-(methyloxy)phenyl]oxy}ethyl)amino]propan-2-ol|SMR000449280|Artist (TN)|Coreg (TN)|HSDB 7044|SR-01000759289|UNII-0K47UL67F2|1-(9H-Carbozol-4-yloxy)-3-[[2-(2-methoxy phenoxy)ethyl]amino]-2-propanol|EG-P042|(R)-BM 14190|Carvedilol-methyl-d3|Carvedilol [USAN:USP:INN:BAN:JAN]|Carvedilol (Standard)|Spectrum_001665|Carvedilol (R)-Isomer|CARVEDILOL [MI]|CARVEDILOL [INN]|CARVEDILOL [JAN]|Spectrum2_001673|Spectrum3_001182|Spectrum4_000636|Spectrum5_001436|CARVEDILOL [HSDB]|CARVEDILOL [USAN]|CARVEDILOL [VANDF]|CARVEDILOL [MART.]|CARVEDILOL [USP-RS]|CARVEDILOL [WHO-DD]|SCHEMBL22293|GTPL551|KBioGR_001252|KBioSS_002145|MLS000758299|MLS000759508|MLS001424092|MLS006011886|orb422241|SPBio_001885|Carvedilol (JP17/USP/INN)|Carvedilol - Bio-X trade mark|orb2893745|CARVEDILOL [ORANGE BOOK]|SCHEMBL10082334|SCHEMBL29370188|SCHEMBL29687280|BDBM25759|HY-B0006R|KBio2_002145|KBio2_004713|KBio2_007281|KBio3_002323|CARVEDILOL [EP MONOGRAPH]|MSK1388|CARVEDILOL [USP MONOGRAPH]|GLXC-03245|HMS2051N03|HMS2089B09|HMS2093E12|HMS3261E15|HMS3269N11|HMS3393N03|HMS3413B14|HMS3655O14|HMS3677B14|HMS3715D15|HMS3750I15|HMS3884E12|HMS5080E13|Pharmakon1600-01504257|Carvedilol 1.0 mg/ml in Methanol|ALBB-038656|BCP23386|EX-A5746|HY-B0006|Tox21_500347|BBL029064|NSC758694|s1831|STK621453|AKOS005554967|Carvedilol, >=98% (HPLC), solid|AC-1641|BCP9000493|CCG-100917|CCG-207952|CS-1194|DB01136|FC11729|KS-1037|LP00347|NC00167|NSC 758694|SB17441|SDCCGSBI-0206771.P002|NCGC00167832-01|NCGC00167832-02|NCGC00167832-03|NCGC00167832-04|NCGC00167832-19|NCGC00261032-01|BC164291|BCP0726000253|SBI-0206771.P001|DB-055704|DB-057556|DB-057557|C2260|NS00002339|SW197547-3|C06875|D00255|F19969|AB00639903-07|AB00639903-09|AB00639903_10|AB00639903_11|AB00639903_12|956C093|L001243|Q412534|SR-01000759289-5|SR-01000759289-6|SR-01000759289-9|BRD-A10977446-001-04-8|BRD-A10977446-001-05-5|BRD-A10977446-001-12-1|BRD-A10977446-001-13-9|BRD-A10977446-001-14-7|BRD-A10977446-011-01-3|BRD-A10977446-045-01-1|Z1515383337|Carvedilol, European Pharmacopoeia (EP) Reference Standard|Carvedilol, United States Pharmacopeia (USP) Reference Standard|1-(9H-carbazol-4-yloxy)-3-[2-(2-methoxy-phenoxy)-ethylamino]-propan-2-ol|Carvedilol, Pharmaceutical Secondary Standard; Certified Reference Material|(+/-)-1-CARBAZOL-4-YLOXY)-3-((2-(O-METHOXYPHENOXY)ETHYL)AMINO)-2-PROPANOL|1-(CARBAZOL-4-YLOXY)-3-((2-(O-METHOXY-PHENOXY)ETHYL)AMINO)-2-PROPANOL|Carvedilol for system suitability, European Pharmacopoeia (EP) Reference Standard|107741-96-8|2-PROPANOL, 1-(9H-CARBAZOL-4-YLOXY)-3-((2-(2-METHOXYPHENOXY)ETHYL)AMINO)-, (+/-)-"
PERAMPANEL,9924495,,"InChI=1S/C23H15N3O/c24-15-17-8-4-5-11-20(17)21-14-18(22-12-6-7-13-25-22)16-26(23(21)27)19-9-2-1-3-10-19/h1-14,16H",PRMWGUBFXWROHD-UHFFFAOYSA-N,C23H15N3O,349.4,2-(2-oxo-1-phenyl-5-pyridin-2-ylpyridin-3-yl)benzonitrile,"Perampanel|380917-97-5|Fycompa|E2007|ER-155055-90|E-2007|perampanelum|E 2007|3-(2-Cyanophenyl)-5-(2-pyridyl)-1-phenyl-1,2-dihydropyridin-2-one|CHEBI:71013|2-(2-oxo-1-phenyl-5-pyridin-2-ylpyridin-3-yl)benzonitrile|H821664NPK|Benzonitrile, 2-(1',6'-dihydro-6'-oxo-1'-phenyl[2,3'-bipyridin]-5'-yl)-|DTXSID80191501|2-(6'-oxo-1'-phenyl-1',6'-dihydro-2,3'-bipyridin-5'-yl)benzonitrile|Benzonitrile, 2-(1',6'-dihydro-6'-oxo-1'-phenyl(2,3'-bipyridin)-5'-yl)-|RefChem:58336|DTXCID50113992|N03AX22|Fycompa (TN)|5'-(2-cyanophenyl)-1'-phenyl-2,3'-bipyridinyl-6'(1'H)-one|2-(6'-Oxo-1'-Phenyl[1',6'-Dihydro[2,3'-Bipyridine]]-5'-Yl)benzonitrile|Perampanel [USAN:INN]|UNII-H821664NPK|6ZP|Perampanel(E2007|Perampanel(E2007?|PERAMPANEL [MI]|PERAMPANEL [INN]|Perampanel (JAN/USAN)|PERAMPANEL [USAN]|PERAMPANEL [VANDF]|PERAMPANEL [WHO-DD]|SCHEMBL194370|GTPL7050|CHEMBL1214124|PERAMPANEL [ORANGE BOOK]|SCHEMBL29354621|SCHEMBL29718723|PRMWGUBFXWROHD-UHFFFAOYSA-N|BCP06505|EX-A2128|BDBM50184410|AKOS016340421|CH-0056|CS-1160|DB08883|FP65127|SB16816|NCGC00378863-02|AC-27375|HY-14745|AE4 - Newer Anti-epileptic drug mixtures 4|NS00004827|D08964|Q868658|BRD-K41438959-001-01-7|2-[2-oxo-1-phenyl-5-(2-pyridyl)-3-pyridyl]benzonitrile|3-(2-Cyanophenyl)-1-phenyl-5-(2-pyridyl)-1,2-dihydropyridin-2-one|1174302-51-2"
CANDESARTAN CILEXETIL,2540,,"InChI=1S/C33H34N6O6/c1-3-42-32-34-28-15-9-14-27(31(40)43-21(2)44-33(41)45-24-10-5-4-6-11-24)29(28)39(32)20-22-16-18-23(19-17-22)25-12-7-8-13-26(25)30-35-37-38-36-30/h7-9,12-19,21,24H,3-6,10-11,20H2,1-2H3,(H,35,36,37,38)",GHOSNRCGJFBJIB-UHFFFAOYSA-N,C33H34N6O6,610.7,1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate,"Candesartan cilexetil|145040-37-5|Atacand|TCV-116|Amias|DTXSID5020239|NSC-758697|R85M2X0D68|DTXCID50239|1H-Benzimidazolium, 7-carboxy-1-(2-((cyclohexylcarbonyl)oxy)ethyl)-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)-, hydroxide, inner salt, (+-)-|Candesartan 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester|Candesartan 1-[[(cyclohexyloxy)carbonyl]oxy]ethyl ester|RefChem:56666|1-(cyclohexylocarbonyloxy)ethyl-2-ethoxy-1-(2'-(1H-tetrazol-5-yl)biphenyl-4-yl)-1H-benzimidazole-7-carboxylate|(1RS)-1-(Cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-benzimidazole-7-carboxylate|Ratacand|candesartancilexetil|Parapres|Kenzen|CANDESARTAN CILEXTIL|TCV 116|Candesartan cilexetil [USAN]|MFCD00871371|1-(((Cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate|CHEMBL1014|CHEBI:3348|1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]benzimidazole-4-carboxylate|TCY 116|1-(cyclohexyloxycarbonyloxy)ethyl 1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate|1-(((cyclohexyloxy)carbonyl)oxy)ethyl 1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate|candesartan cilexitil|Racanda|UNII-R85M2X0D68|Candesartan hexetil|2-Ethoxy-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid 1-[[(cyclohexyloxy)carbonyl]oxy]et hyl ester;Atacand;Blopress|Atacand (TN)|Candesartan cilexetil?|Spectrum_001707|Candesartan (Cilexetil)|Spectrum2_000485|Spectrum3_000996|Spectrum4_001124|Spectrum5_001462|Candesartan Celexetil Ester|SCHEMBL40831|BSPBio_002691|KBioGR_001607|KBioSS_002187|MLS004774127|Candesartan cilexetil , 97%|SCHEMBL612936|SPECTRUM1504261|SPBio_000349|GTPL8352|orb1305541|Candesartan cilexetil (Atacand)|Candesartan Cilexetil (Standard)|KBio2_002187|KBio2_004755|KBio2_007323|KBio3_001911|HMS1922J09|HMS2093E20|HMS3651I08|HMS5080P17|Pharmakon1600-01504261|Candesartan cilexetil (JP18/USP)|CANDESARTAN CILEXETIL [JAN]|ALBB-038627|BCP22050|MSK10658|Tox21_302202|AC-204|BDBM50318907|CANDESARTAN CILEXETIL [VANDF]|CCG-39530|HY-17505R|NSC758697|s2037|STL451065|CANDESARTAN CILEXETIL [MART.]|AKOS015894954|AKOS015920180|CANDESARTAN CILEXETIL [USP-RS]|CANDESARTAN CILEXETIL [WHO-DD]|AB07617|BCP9000480|CCG-222334|DB00796|DS-1302|FC19661|KS-1147|NSC 758697|Candesartan cilexetil, >=98% (HPLC)|NCGC00095123-01|NCGC00095123-02|NCGC00095123-03|NCGC00095123-05|NCGC00095123-10|NCGC00095123-16|NCGC00255218-01|(+-)-1-Hydroxyethyl 2-ethoxy-1-(p-(o-1H-tetrazol-5-ylphenyl)benzyl)-7-benzimidazolecarboxylate, cyclohexyl carbonate (ester)|1-[[(cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2'-(1h-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1h-benzimidazole-7-carboxylate|1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-(ethyloxy)-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate|1H-Benzimidazole-7-carboxylic acid, 2-ethoxy-1-((2'-(1H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-, 1-(((cyclohexyloxy)carbonyl)oxy)ethyl ester, (+-)-|2-ETHOXY-1-[[2'-(2H-TETRAZOL-5-YL)[1,1'-BIPHENYL]-4-YL]METHYL]-1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID 1-[[(CYCLOHEXYLOXY)CARBONYL]OXY]ETHYL ESTER|2-Ethoxy-3-[2'-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester|BC164274|Candesartan cilexetil - Bio-X trade mark|HY-17505|SMR003500784|SY051248|CANDESARTAN CILEXETIL [ORANGE BOOK]|SBI-0206767.P001|CANDESARTAN CILEXETIL [EP MONOGRAPH]|C2635|CANDESARTAN CILEXETIL [USP MONOGRAPH]|CAS-145040-37-5|NS00006138|SW220041-1|C07709|D00626|EN300-118698|AB01274805-01|AB01274805_02|AB01274805_03|040C375|H212/91|L006257|SR-05000001976|SR-05000001976-1|BRD-A65671304-001-02-6|BRD-A65671304-001-03-4|BRD-A65671304-001-07-5|BRD-A65671304-001-08-3|Q27075664|Z1515383338|CANDESARTAN 1-(((CYCLOHEXYLOXY)CARBONYL)OXY)ETHYL ESTER [MI]|Candesartan cilexetil, European Pharmacopoeia (EP) Reference Standard|Candesartan cilexetil, United States Pharmacopeia (USP) Reference Standard|Candesartan cilexetil for peak identification, European Pharmacopoeia (EP) Reference Standard|Candesartan cilexetil for system suitability, European Pharmacopoeia (EP) Reference Standard|Candesartan Cilexetil, Pharmaceutical Secondary Standard; Certified Reference Material|(+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl) biphenyl-4-yl]methylbenzimidazole-7-carboxylate|(+/-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methylbenzimidazole-7-carboxylate|(+/-)-1-HYDROXYETHYL 2-ETHOXY-1-(P-(O-1H-TETRAZOL-5-YLPHENYL)BENZYL)-7-BENZIMIDAZOLECARBOXYLATE, CYCLOHEXYL CARBONATE (ESTER)|1-(((Cyclohexyloxy)carbonyl)oxy)ethyl1-((2'-(2H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-ethoxy-1H-benzo[d]imidazole-7-carboxylate|1-(Cyclohexyloxycarbonyloxy)ethyl-2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]benzimidazol-7-carboxylate|1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-1,3-benzodiazole-7-carboxylate|1-{[(cyclohexyloxy)carbonyl]oxy}ethyl 2-ethoxy-1-{[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl}-1H-benzimidazole-7-carboxylate|1-cyclohexyloxycarbonyloxyethyl 2-ethoxy-3-[[4-[2-(2h-tetrazol-5-yl)phenyl]phenyl] methyl]benzimidazole-4-carboxylate|1H-BENZIMIDAZOLE-7-CARBOXYLIC ACID, 2-ETHOXY-1-((2'-(1H-TETRAZOL-5-YL)(1,1'-BIPHENYL)-4-YL)METHYL)-, 1-(((CYCLOHEXYLOXY)CARBONYL)OXY)ETHYL ESTER, (+/-)-|2-Ethoxy-3-[2''-(1H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester|2-Ethoxy-3-[2''-(2H-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3H-benzoimidazole-4-carboxylic acid 1-cyclohexyloxycarbonyloxy-ethyl ester|2-ethoxy-3-[2'-(1h-tetrazol-5-yl)-biphenyl-4-ylmethyl]-3h-benzoimidazole-4-carboxylic acid 1-cyclohe"
CEP-37440,71721648,,"InChI=1S/C30H38ClN7O3/c1-32-29(40)23-7-3-4-9-25(23)34-28-24(31)19-33-30(36-28)35-26-11-10-20-18-21(6-5-8-22(20)27(26)41-2)38-14-12-37(13-15-38)16-17-39/h3-4,7,9-11,19,21,39H,5-6,8,12-18H2,1-2H3,(H,32,40)(H2,33,34,35,36)/t21-/m0/s1",BCSHRERPHLTPEE-NRFANRHFSA-N,C30H38ClN7O3,580.1,"2-[[5-chloro-2-[[(6S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide","CEP-37440|1391712-60-9|Alk-fak inhibitor CEP-37440|O3MNS8782H|Benzamide, 2-((5-chloro-2-(((6S)-6,7,8,9-tetrahydro-6-(4-(2-hydroxyethyl)-1-piperazinyl)-1-methoxy-5H-benzocyclohepten-2-yl)amino)-4-pyrimidinyl)amino)-N-methyl-|2-[[5-chloro-2-[[(6S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]amino]pyrimidin-4-yl]amino]-N-methylbenzamide|2-[(5-chloro-2-{[(6S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl]amino}pyrimidin-4-yl)amino]-N-methylbenzamide|2-((5-chloro-2-(((6S)-6-(4-(2-hydroxyethyl)piperazin-1-yl)-1-methoxy-6,7,8,9-tetrahydro-5H-benzo(7)annulen-2-yl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide|RefChem:124349|UNII-O3MNS8782H|(S)-2-((5-Chloro-2-((6-(4-(2-hydroxyethyl)piperazin-1-yl)-1-methoxy-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)amino)pyrimidin-4-yl)amino)-N-methylbenzamide|CHEMBL3951811|MFCD28009441|CEP37440|GTPL9698|SCHEMBL15269443|SCHEMBL29354193|SCHEMBL29489150|DTXSID301025939|1609103-92-5|EX-A1543|RFC71260|BDBM50193811|NSC781148|NSC800983|AKOS027337463|CEP-37440?|DB13060|NSC-781148|NSC-800983|compound 27b [PMID: 27527804]|NCGC00378557-03|NCGC00378557-07|2-(5-Chloro-2-{(S)-6-[4-(2-hydroxyethyl)piperazin-1-yl]-1-methoxy-6,7,8,9-tetrahydro-5H-benzocyclohepten-2-ylaminopyrimidin-4-ylamino)-N-methylbenzamide|AC-36010|HY-15841|NS00073434|F13321|BRD-K72827473-001-01-0|Q27285285|2-((5-Chloro-2-(((6S)-6,7,8,9-tetrahydro-6-(4-(2-hydroxyethyl)-1-piperazinyl)-1-methoxy-5H-benzocyclohepten-2-yl)amino)-4-pyrimidinyl)amino)-N-methyl-benzamide"
MIVAVOTINIB,53252276,,"InChI=1S/C17H21FN6O/c1-24-8-9(6-21-24)15-13-10(7-20-17(13)25)14(18)16(23-15)22-12-5-3-2-4-11(12)19/h6,8,11-12H,2-5,7,19H2,1H3,(H,20,25)(H,22,23)/t11-,12+/m0/s1",MJHOMTRKVMKCNE-NWDGAFQWSA-N,C17H21FN6O,344.4,"6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo[3,4-c]pyridin-3-one","Mivavotinib|TAK-659|1312691-33-0|TAK-659 free base|TAK-659F|8QR88H79VX|Mivavotinib [USAN]|CB-659|6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo[3,4-c]pyridin-3-one|TAK659|CHEMBL3979920|3H-Pyrrolo[3,4-c]pyridin-3-one, 6-[[(1R,2S)-2-aminocyclohexyl]amino]-7-fluoro-1,2-dihydro-4-(1-methyl-1H-pyrazol-4-yl)-|1312691-41-0|3H-Pyrrolo(3,4-C)pyridin-3-one, 6-(((1R,2S)-2-aminocyclohexyl)amino)-7-fluoro-1,2-dihydro-4-(1-methyl-1H-pyrazol-4-yl)-|TAK-659 HCl|6-(((1R,2S)-2-AMINOCYCLOHEXYL)AMINO)-7-FLUORO-4-(1-METHYL-1H-PYRAZOL-4-YL)-1,2-DIHYDRO-3H-PYRROLO[3,4-C]PYRIDIN-3-ONE|mivavotinibum|6-(((1R,2S)-2-aminocyclohexyl)amino)-7-fluoro-4-(1-methylpyrazol-4-yl)-1,2-dihydropyrrolo(3,4-c)pyridin-3-one|6-((1R,2S)-2-AMINOCYCLOHEXYLAMINO)-7-FLUORO-4-(1-METHYL-1H-PYRAZOL-4-YL)-1H-PYRROLO(3,4-C)PYRIDIN-3(2H)-ONE|6-((1R,2S)-2-Aminocyclohexylamino)-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-c]pyridin-3(2H)-one|6-{[(1r,2s)-2-Aminocyclohexyl]amino}-7-Fluoro-4-(1-Methyl-1h-Pyrazol-4-Yl)-1,2-Dihydro-3h-Pyrrolo[3,4-C]pyridin-3-One|TAK659 Free Base|syk Inhibitor TAK659|syk-Inhibitor TAK659|MIVAVOTINIB [INN]|Mivavotinib (USAN/INN)|syk Inhibitor TAK-659|syk-Inhibitor TAK-659|RefChem:1089763|TAK659 2HCl|UNII-8QR88H79VX|MIVAVOTINIB [WHO-DD]|TAK-659 2HCl|GTPL9600|orb1705261|SCHEMBL1987799|SCHEMBL29422867|MJHOMTRKVMKCNE-NWDGAFQWSA-N|TAK-659 free base(Mivavotinib)|GLXC-15199|BCP28883|EX-A1401|BDBM50204290|NSC791967|NSC791968|WHO 10836|AKOS040744760|NSC-791967|NSC-791968|compound 3b [PMID: 27839918]|AC-35463|DA-58255|Spleen Tyrosine Kinase Inhibitor TAK659|HY-100867|CS-0020533|D11789|TAK659, TAK-659, TAK 659, TAK-659 HCl, TAK659 dihydrochloride|cis-6-(2-Aminocyclohexylamino)-7-fluoro-4-(1-methyl-1H-pyrazol-4-yl)-1H-pyrrolo[3,4-c]pyridin-3(2H)-one"
ISONIAZID,3767,,"InChI=1S/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10)",QRXWMOHMRWLFEY-UHFFFAOYSA-N,C6H7N3O,137.14,pyridine-4-carbohydrazide,"isoniazid|54-85-3|Isonicotinic acid hydrazide|Isonicotinohydrazide|pyridine-4-carbohydrazide|Isoniazide|Rimifon|Nydrazid|Cotinazin|Hydrazid|Iscotin|Mybasan|Isonicotinylhydrazine|Atcotibine|Hidrasonil|Isobicina|Isonicotan|Neumandin|Armazid|Armazide|Dinacrin|Ditubin|Eralon|Ertuban|Isidrina|Laniazid|Cedin|Hyzyd|Isonicotinic hydrazide|Andrazide|Neoteben|Nicizina|Niconyl|Nicotibina|Nicozide|Pycazide|Stanozide|Tubazide|Isolyn|Isonex|Isohydrazide|Isonicotinhydrazid|Antimicina|Chemiazid|Chemidon|Fimalene|Hidranizil|Hidrulta|Ismazide|Isocidene|Isocotin|Isonerit|Isonicid|Isonicotil|Isonidrin|Isonikazid|Isonilex|Isonindon|Isonirit|Isoniton|Isonizide|Isotebezid|Nidrazid|Nyscozid|Pyricidin|Pyrizidin|Raumanon|Retozide|Rimitsid|Teebaconin|4-Pyridinecarboxylic acid, hydrazide|Azuren|Cemidon|Defonin|Diforin|Ebidene|Eutizon|Evalon|Hidrun|Hycozid|Idrazil|Inizid|Isocid|Isonico|Isonide|Isonin|Isozide|Isozyd|Neoxin|Niadrin|Nicetal|Nidaton|Nikozid|Niplen|Nitadon|Pelazid|Rimicid|Tubazid|Antituberkulosum|Nevin|Inah|Ido-tebin|Nicotibine|Nicotisan|Rimiphone|Tisiodrazida|Tubilysin|Isotebe|Isotinyl|Nicazide|Phthisen|Pyreazid|Percin|Razide|Tyvid|Neo-Tizide|Isoniazid SA|4-Pyridinecarboxylic acid hydrazide|Armacide|Cortinazine|Cotinizin|GINK|Isonicazide|Isotamine|Robisellin|Sauterazid|Tibinide|Unicozyde|Vazadrine|Zonazide|Isonicotinyl hydrazide|Tebecid|Tekazin|Tubeco|Tubicon|Tubomel|Vederon|Zinadon|Isonicotinoyl hydrazide|Dow-Isoniazid|Preparation 6424|TB-Razide|Sanohidrazina|Robiselin|Tibizide|Tuberian|Niteban|Roxifen|Tebenic|Tebexin|Tebilon|Tibison|Tibivis|Tibusan|Tizide|Tebos|Tisin|TB-Vis|FSR 3|TB-Phlogin|Isoniazidum|Isozid|In-73|Cedin (Aerosol)|bacillen|tebemid|tubercid|Isonizida|Isonicotinoylhydrazine|4-Pyridinecarbonylhydrazine|Isonicotinsaeurehydrazid|FSR-3|4-(Hydrazinocarbonyl)pyridine|BP 5015|4-Pyridylcarbonylhydrazide|isonicotinoylhydrazide|Dianicotyl|Ipcazide|NSC 9659|4-Pyridinecarboxylic hydrazide|Isonicotinyl hydrazine|pyridine-4-carboxylic acid hydrazide|CHEBI:6030|5015 RP|DTXSID8020755|L 1945|5015 R.P.|NSC-9659|V83O1VOZ8L|RP 5015|NSC9659|DTXCID20755|Hydrazide, Isonicotinic Acid|Isoniazid 300 mg|Acid Vanillylidenehydrazide, Isonicotinic|RefChem:5917|Vanillylidenehydrazide, Isonicotinic Acid|200-214-6|Niazid|Isoniacid|Dibutin|Hyozid|Laniozid|Pyridicin|Sauterzid|Tibazide|Tubizid|Unicocyde|Inh-Burgthal|INH|Isoniazida|Zidafimia|Isokin|Nitebannsc 9659|RU-EF-Tb|MFCD00006426|4-pyridinecarbohydrazide|HIA|RP-5015|Isonicotinylhydrazide|CHEMBL64|MLS000069444|CAS-54-85-3|NCGC00016244-09|Continazine|Tubecotubercid|Abdizide|Anidrasona|SMR000059082|Tibemid|Tibiazide|Fetefu|Hydra|LANIZID|RY-EF-Tb|Isoniazid; pyridine-4-carbohydrazide|Isoniazidum [INN-Latin]|Isoniazida [INN-Spanish]|AZT + Isoniazid|FRS-3|Isoniazid & EEP|Laniazid (TN)|CCRIS 351|Usaf cb-2|Isoniazid & Propolis|HSDB 1647|Isonicotinsaeurehydrazid [German]|INHd20|SR-01000003025|EINECS 200-214-6|UNII-V83O1VOZ8L|lsoniazid|Mayambutol|AI3-23936|I.A.I.|Idrazide dell'acido isonicotinico [Italian]|isoniazid (inh)|Idrazide dell'acido isonicotinico|Isoniazid [USP:INN:BAN:JAN]|isonicotinhydrazide|NIZ|Prestwick_578|Isoniazid (Tubizid)|Isoniazid(Tubizid)?|Isoniazid (Standard)|Rifater (Salt/Mix)|isonicotinate hydrazide|Isonicotinic acid hydrazide (Isoniazid)|Isonicotinicacidhydrazide|Spectrum_000853|Topiroxostat Impurity 6|ISONIAZID [INN]|ISONIAZID [JAN]|Opera_ID_454|ISONIAZID [MI]|isonicotinicacid hydrazide|ISONIAZID [HSDB]|isonicotinic acid hydrazid|Prestwick0_000161|Prestwick1_000161|Prestwick2_000161|Prestwick3_000161|Spectrum2_000107|Spectrum3_000472|Spectrum4_000022|Spectrum5_000876|ISONIAZID [VANDF]|I0138|WLN: T6NJ DVMZ|isonicotinic acid hydrazone|SCHEMBL228|Biomol-NT_000288|Epitope ID:141801|ISONIAZID [MART.]|4-Pyridylcarbonyl hydrazide|ISONIAZID [USP-RS]|ISONIAZID [WHO-DD]|ISONIAZID [WHO-IP]|Oprea1_396155|BSPBio_000021|BSPBio_002204|KBioGR_000423|KBioSS_001333|MLS001055327|BIDD:GT0140|DivK1c_000070|SPECTRUM1500355|SPBio_000094|SPBio_001942|Isoniazid (JP18/USP/INN)|pyridine, 4-hydrazinocarbonyl-|BPBio1_000025|BPBio1_001322|orb1310116|ISONIAZID [EP IMPURITY]|ISONIAZID [ORANGE BOOK]|component of Niadox (Salt/Mix)|ISONIAZID [EP MONOGRAPH]|GTPL12761|HMS500D12|HY-B0329R|KBio1_000070|KBio2_001333|KBio2_003901|KBio2_006469|KBio3_001424|ISONIAZID [USP MONOGRAPH]|NINDS_000070|RIFATER COMPONENT ISONIAZID|4-Pyridinecarboxamide, 2'-amino-|HMS1568B03|HMS1920H09|HMS2089I16|HMS2091N19|HMS2095B03|HMS2234G04|HMS3259E19|HMS3373O01|HMS3655L03|HMS3712B03|HMS5080B07|HMS6018K15|KUC109571N|Pharmakon1600-01500355|4-pyridinecarbohydrazide(Isoniazid)|ISONIAZIDUM [WHO-IP LATIN]|RIFAMATE COMPONENT ISONIAZID|BCP13791|HY-B0329|MSK10311|STR00210|[(4-Pyridinylcarbonyl)oxy]hydrazine|Anti-TNF monoclonal antibody & INH|Tox21_113640|Tox21_201367|Tox21_300193|BBL008409|BDBM50336507|CCG-39710|NSC757078|s1937|SBB004195|STK086288|(HBD) Human beta-defensin-1 & INH|AKOS000119062|Isonicotinic acid hydrazide(Isoniazid)|Tox21_113640_1|AI24685|DB00951|KSC-27-048|NC00513|NSC-757078|PS-4129|IDI1_000070|UPCMLD0ENAT5791176:001|NCGC00016244-01|NCGC00016244-02|NCGC00016244-03|NCGC00016244-04|NCGC00016244-05|NCGC00016244-06|NCGC00016244-07|NCGC00016244-08|NCGC00016244-10|NCGC00016244-11|NCGC00016244-12|NCGC00016244-14|NCGC00016244-15|NCGC00016244-17|NCGC00022648-03|NCGC00022648-04|NCGC00022648-05|NCGC00022648-06|NCGC00022648-07|NCGC00254094-01|NCGC00258919-01|ISONICOTINIC ACID HYDRAZIDE [IARC]|ST078858|SY010614|Isoniazid, Vetec(TM) reagent grade, 98%|SBI-0051419.P003|AB00052025|ISONICOTINIC ACID HYDRAZIDE [WHO-IP]|NS00006598|SW196752-3|EN300-18498|ISONICOTINIC ACID HYDRAZIDE(ISONIAZIDE)|C07054|D00346|D70582|Isoniazid, analytical standard, >=99% (TLC)|AB00052025-20|AB00052025-21|AB00052025_22|AB00052025_23|AB00052025_24|AB00052025_25|AE-641/02310003|F236758|Q423169|4-PYRIDINECARBOXYLIC ACID HYDRAZIDE [WHO-IP]|SR-01000003025-2|SR-01000003025-3|BRD-K87202646-001-26-8|BRD-K87202646-001-32-6|BRD-K87202646-001-33-4|BRD-K87202646-061-04-9|BRD-K87202646-061-05-6|Isoniazid, certified reference material, TraceCERT(R)|Z58981801|F0391-0007|Isoniazid, European Pharmacopoeia (EP) Reference Standard|Isoniazid, United States Pharmacopeia (USP) Reference Standard|4-Pyridinecarboxylic acid hydrazide;Isonicotinic acid hydrazide;4-(Hydrazinocarbonyl)pyridine|InChI=1/C6H7N3O/c7-9-6(10)5-1-3-8-4-2-5/h1-4H,7H2,(H,9,10|Isoniazid, Pharmaceutical??Secondary??Standard;??Certified??Reference??Material"
PICLOXYDINE,5748610,,"InChI=1S/C20H24Cl2N10/c21-13-1-5-15(6-2-13)27-17(23)29-19(25)31-9-11-32(12-10-31)20(26)30-18(24)28-16-7-3-14(22)4-8-16/h1-8H,9-12H2,(H4,23,25,27,29)(H4,24,26,28,30)",YNCLPFSAZFGQCD-UHFFFAOYSA-N,C20H24Cl2N10,475.4,"1-N',4-N'-bis[N'-(4-chlorophenyl)carbamimidoyl]piperazine-1,4-dicarboximidamide","Picloxydine|Picloxydinum|5636-92-0|4YC2PY3AEU|1,1'-(1,4-Piperazinediylbis(imidocarbonyl))bis(3-(p-chlorophenyl)guanidine)|1,1-(p-chlorophenylguanidinoformimidonyl)bis piperazine|DTXSID50863586|picloxidine|1,1'-[1,4-Piperazinediylbis(imidocarbonyl)]bis[3-(p-chlorophenyl)guanidine]|RefChem:174154|DTXCID60208742|S01AX16|227-084-3|N-(4-chlorophenyl)-N'-(4-((N'-(4-chlorophenyl)carbamimidamido)methanimidoyl)piperazine-1-carboximidoyl)guanidine|Picloxidina|Picloxydine (INN)|PICLOXYDINE [INN]|1-N',4-N'-bis[N'-(4-chlorophenyl)carbamimidoyl]piperazine-1,4-dicarboximidamide|UNII-4YC2PY3AEU|Picloxydinum [INN-Latin]|Picloxidina [INN-Spanish]|Picloxydine [INN:BAN:DCF]|N1,N4-Bis(N-(4-chlorophenyl)carbamimidoyl)piperazine-1,4-bis(carboximidamide)|EINECS 227-084-3|PICLOXYDINE [MI]|PICLOXYDINE [WHO-DD]|CHEBI:135768|HY-U00120|AKOS040734779|CS-7157|DB13607|1,4-Piperazinedicarboximidamide, N,N''-bis[[(4-chlorophenyl)amino]iminomethyl]-|DA-56853|D07415|N-[(4-[([(4-Chloroanilino)(imino)methyl]amino)(imino)methyl]-1-piperazinyl)(imino)methyl]-N'-(4-chlorophenyl)guanidine #"
FEVIPIPRANT,23582412,,"InChI=1S/C19H17F3N2O4S/c1-11-15(9-17(25)26)14-4-3-7-23-18(14)24(11)10-12-5-6-13(29(2,27)28)8-16(12)19(20,21)22/h3-8H,9-10H2,1-2H3,(H,25,26)",GFPPXZDRVCSVNR-UHFFFAOYSA-N,C19H17F3N2O4S,426.4,"2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid","Fevipiprant|872365-14-5|NVP-QAW039|QAW039|2PEX5N7DQ4|QAW-039|DTXSID501336031|(1-(4-((Methane)sulfonyl)-2-trifluoromethylbenzyl)-2-methyl-1H-pyrrolo(2,3-b)pyridin-3-yl)acetic acid|2-(1-((4-Methanesulfonyl-2-(trifluoromethyl)phenyl)methyl(-2-methyl-1H-pyrrolo(2,3-b)pyridin-3-yl)acetic acid|1-(4-methanesulfonylbenzyl)-2-methyl-1H-pyrrolo(2,3-b)pyridin-3-yl)acetic acid|fevipiprantum|2-(1-((4-methanesulfonyl-2-(trifluoromethyl)phenyl)methyl)-2-methyl-1H-pyrrolo(2,3-b)pyridin-3-yl)acetic acid|2-(1-{[4-methanesulfonyl-2-(trifluoromethyl)phenyl]methyl}-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid|2-(2-methyl-1-((4-methylsulfonyl-2-(trifluoromethyl)phenyl)methyl)pyrrolo(5,4-b)pyridin-3-yl)acetic acid|2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[5,4-b]pyridin-3-yl]acetic acid|RefChem:599177|DTXCID401766118|Fevipiprant [INN]|2-(2-methyl-1-(4-(methylsulfonyl)-2-(trifluoromethyl)benzyl)-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid|MFCD22548206|2-[2-methyl-1-[[4-methylsulfonyl-2-(trifluoromethyl)phenyl]methyl]pyrrolo[2,3-b]pyridin-3-yl]acetic acid|FEVIPIPRANT(NVP-QAW039)|2-Methyl-1-[[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl]-1H-pyrrolo[2,3-b]pyridine-3-acetic acid|Fevipiprant [USAN:INN]|UNII-2PEX5N7DQ4|Fevipiprant?|QAW 039|[2-METHYL-1-[4-(METHYLSULFONYL)-2-(TRIFLUOROMETHYL)BENZYL]-1H-PYRROLO[2,3-B]PYRIDIN-3-YL]ACETIC ACID|{2-Methyl-1-[4-(methylsulfonyl)-2-(trifluoromethyl)benzyl]-1H-pyrrolo[2,3-b]pyridin-3-yl}acetic acid|FEVIPIPRANT [JAN]|FEVIPIPRANT [USAN]|FEVIPIPRANT [WHO-DD]|Fevipiprant (JAN/USAN/INN)|GTPL8995|orb1303505|SCHEMBL1940595|CHEMBL3137332|SCHEMBL29355753|GLXC-10793|HMS3743E19|BCP25015|EX-A2495|BDBM50233520|AKOS030629816|AB85348|CS-5956|DB12011|Fevipiprant; NVP-QAW039; QAW039|SB16897|AC-31956|AS-74870|FF158137|HY-16768|DS-022511|NS00072497|D10631|Q27077292|(2-methyl-1-{[4-(methylsulfonyl)-2-(trifluoromethyl)phenyl]methyl}-1H-pyrrolo[2,3-b]pyridin-3-yl)acetic acid|[1-(4-Methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1H-pyrrolo[2,3-b]pyridin-3-yl]-acetic acid|2- Methyl- 1- [[4- (methylsulfonyl) - 2- (trifluoromethyl) phenyl] methyl] -1H- Pyrrolo[2, 3- b] pyridine- 3- acetic acid;QAW 039;NV  P QAW 039|FSY"
MIGALASTAT,176077,,"InChI=1S/C6H13NO4/c8-2-3-5(10)6(11)4(9)1-7-3/h3-11H,1-2H2/t3-,4+,5+,6-/m1/s1",LXBIFEVIBLOUGU-DPYQTVNSSA-N,C6H13NO4,163.17,"(2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol","Migalastat|1-deoxygalactonojirimycin|108147-54-2|(2R,3S,4R,5S)-2-(hydroxymethyl)piperidine-3,4,5-triol|1-Deoxygalactostatin|C4XNY919FW|DTXSID201022520|1-deoxygalacto-nojirimycin|migalastatum|RefChem:56444|GlyTouCan:G33457CX|A16AX14|DTXCID401507205|G33457CX|At-1001, gr-181314a|NB-DGJ|galafold|D-Galactitol, 1,5-dideoxy-1,5-imino-|CHEMBL110458|108147-54-2 (free base)|DDIG|1,5-Dideoxy-1,5-imino-D-galactitol|1,5-Dideoxy-1,5-iminogalactitol|Migalastat [INN]|Migalastat [USAN:INN]|GR181413A|UNII-C4XNY919FW|DEOXYGALACTONOJIRIMYCIN|DGJ|D-Galactitol, 1,5-dideoxy-1,5-imino|NSC658776|Tocris-1258|MIGALASTAT [MI]|3,4,5-Piperidinetriol, 2-(hydroxymethyl)-, (2R,3S,4R,5S)-|Migalastat (USAN/INN)|MIGALASTAT [USAN]|MIGALASTAT [WHO-DD]|D-galacto-1-Deoxynojirimycin|2-(Hydroxymethyl)-3,4,5-piperidinetriol hydrochloride|orb1737999|SCHEMBL29355275|GTPL10200|CHEBI:135923|BDBM50163440|1,5-didesoxy-l,5-imino-D-galactitol|DB05018|GR-181413A|NCGC00025085-01|NCGC00686698-01|DA-60990|HY-14929|CS-0003641|NS00123341|D10359|EN300-255537|Q161613|(2R,3S,4R,5S)-2-Hydroxymethyl-piperidine-3,4,5-triol"
SOTRASTAURIN,10296883,,"InChI=1S/C25H22N6O2/c1-30-10-12-31(13-11-30)25-27-19-9-5-3-7-16(19)22(28-25)21-20(23(32)29-24(21)33)17-14-26-18-8-4-2-6-15(17)18/h2-9,14,26H,10-13H2,1H3,(H,29,32,33)",OAVGBZOFDPFGPJ-UHFFFAOYSA-N,C25H22N6O2,438.5,"3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione","Sotrastaurin|425637-18-9|AEB071|AEB-071|3-(1H-Indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4-yl)-1H-pyrrole-2,5-dione|sotrastaurina|sotrastaurine|sotrastaurinum|3-(1H-indol-3-yl)-4-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]pyrrole-2,5-dione|CHEBI:90531|7I279E1NZ8|3-(1h-Indol-3-Yl)-4-[2-(4-Methylpiperazin-1-Yl)quinazolin-4-Yl]-1h-Pyrrole-2,5-Dione|3-(1H-indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4-yl)pyrrole-2,5-dione|RefChem:931988|3-(1H-indol-3-yl)-4-(2-(4-methylpiperazin-1-yl)quinazolin-4-yl)-2,5-dihydro-1H-pyrrole-2,5-dione|Sotrastaurin (AEB071)|C25H22N6O2|NVP-AEB071|AEB 071|1H-Pyrrole-2,5-dione, 3-(1H-indol-3-yl)-4-(2-(4-methyl-1-piperazinyl)-4-quinazolinyl)-|949935-06-2|Sotrastaurin [USAN]|Sotrastaurin [USAN:INN]|Sotrastaurin?|UNII-7I279E1NZ8|MFCD16038049|Kinome_2717|Sotrastaurin (Standard)|Sotrastaurin (USAN/INN)|SOTRASTAURIN [INN]|NVP-AEB-071|SOTRASTAURIN [WHO-DD]|CHEMBL565612|GTPL7946|orb1300910|SCHEMBL2500835|SCHEMBL26184899|SCHEMBL29364923|SCHEMBL29526075|BDBM33971|DTXSID70915192|OAVGBZOFDPFGPJ-UHFFFAOYSA-N|HMS3656D10|HMS3673M05|HMS3744G03|BCP07456|EX-A2802|HY-10343R|NSC766819|NSC800935|s2791|AKOS027422723|CCG-264999|CS-0090|DB12369|NSC-766819|NSC-800935|SB16638|SDCCGSBI-0654474.P001|NCGC00238621-01|NCGC00238621-09|AC-32050|AS-56373|DA-58019|HY-10343|NS00069692|SW220235-1|D09671|L10095|BRD-K16761703-001-03-8|Q26331952|3-(1H-indol-3-yl)-4-[2-(4-methyl-piperazin-1-yl)-quinazolin-4-yl]-pyrrole-2,5-dione|1058706-31-2|5-Hydroxy-4-(1H-indol-3-yl)-3-[2-(4-methylpiperazin-1-yl)quinazolin-4-yl]-2H-pyrrol-2-one|LW4"
PRITELIVIR,491941,,"InChI=1S/C18H18N4O3S2/c1-12-17(27(19,24)25)26-18(21-12)22(2)16(23)11-13-6-8-14(9-7-13)15-5-3-4-10-20-15/h3-10H,11H2,1-2H3,(H2,19,24,25)",IVZKZONQVYTCKC-UHFFFAOYSA-N,C18H18N4O3S2,402.5,"N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide","Pritelivir|348086-71-5|BAY-57-1293|AIC-316|07HQ1TJ4JE|N-methyl-N-(4-methyl-5-sulfamoyl-1,3-thiazol-2-yl)-2-(4-pyridin-2-ylphenyl)acetamide|DTXSID70188344|AIC090093|AIC-090093|N-(5-(Aminiosulfonyl)-4-methyl-1,3-thiazol-2-yl)-N-methyl-2-(4-(2-pyridinyl)phenyl)acetamide|Benzeneacetamide, N-(5-(aminosulfonyl)-4-methyl-2-thiazolyl)-N-methyl-4-(2-pyridinyl)-|Benzeneacetamide, N-[5-(aminosulfonyl)-4-methyl-2-thiazolyl]-N-methyl-4-(2-pyridinyl)-|pritelivirum|N-(5-(AMINOSULFONYL)-4-METHYL-1,3-THIAZOL-2-YL)-N-METHYL-2-(4-(2-PYRIDINYL)PHENYL)ACETAMIDE|n-[5-(aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-n-methyl-2-[4-(2-pyridinyl)phenyl]acetamide|RefChem:176034|DTXCID00110835|BAY 57-1293|N-Methyl-N-(4-methyl-5-sulfamoylthiazol-2-yl)-2-(4-(pyridin-2-yl)phenyl)acetamide|AIC316|Pritelivir [INN]|BAY57-1293|C18H18N4O3S2|MFCD18633192|Pritelivir (BAY 57-1293)|348086-71-5 (free base)|BAY 57-1293;AIC316|A1BXB|UNII-07HQ1TJ4JE|N-methyl-N-(4-methyl-5-sulfamoyl-thiazol-2-yl)-2-[4-(2-pyridyl)phenyl]acetamide|N-METHYL-N-(4-METHYL-5-SULFAMOYL-1,3-THIAZOL-2-YL)-2-[4-(PYRIDIN-2-YL)PHENYL]ACETAMIDE|Pritelivir;AIC316|Pritelivir (USAN/INN)|PRITELIVIR [USAN]|PRITELIVIR [WHO-DD]|PritelivirBAY-57-1293?|orb1305384|SCHEMBL1074614|Pritelivir(BAY 57-1293)|CHEMBL4069597|SCHEMBL29407610|EX-A247|IVZKZONQVYTCKC-UHFFFAOYSA-N|HMS3653B15|HMS3744E03|BCP08742|YNA08671|s7546|AKOS026750515|CCG-268675|CS-1693|DB11844|KS-5353|SB19731|NCGC00378984-02|AC-33065|DA-42669|HY-15303|LS-14637|NS00069662|SW219861-1|D12811|BRD-K25204779-001-01-1|Q15410303|N-[5-(Aminosulfonyl)-4-methyl-2-thiazolyl]-N-methyl-4-(2-pyridinyl)benzeneacetamide|N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl] acetamide|N-[5-(Aminosulfonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridyl)phenyl]acetamide|N-[5-(Aminosulphonyl)-4-methyl-1,3-thiazol-2-yl]-N-methyl-2-[4-(2-pyridinyl)phenyl]acetamide"
PRN-1371,118295624,,"InChI=1S/C26H30Cl2N6O4/c1-5-20(35)33-11-9-32(10-12-33)7-6-8-34-24-16(15-30-26(29-2)31-24)13-17(25(34)36)21-22(27)18(37-3)14-19(38-4)23(21)28/h5,13-15H,1,6-12H2,2-4H3,(H,29,30,31)",PUIXMSRTTHLNKI-UHFFFAOYSA-N,C26H30Cl2N6O4,561.5,"6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)-8-[3-(4-prop-2-enoylpiperazin-1-yl)propyl]pyrido[2,3-d]pyrimidin-7-one","PRN1371|1802929-43-6|PRN-1371|S3OPE9IA3Q|6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)-8-[3-(4-prop-2-enoylpiperazin-1-yl)propyl]pyrido[2,3-d]pyrimidin-7-one|Prn 1371|6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)-8-(3-(4-prop-2-enoylpiperazin-1-yl)propyl)pyrido(2,3-d)pyrimidin-7-one|RefChem:176037|pan FGFR Inhibitor PRN1371|FGFR 1-4 Inhibitor PRN1371|Pan-FGFR Tyrosine Kinase Inhibitor PRN1371|8-(3-(4-acryloylpiperazin-1-yl)propyl)-6-(2,6-dichloro-3,5-dimethoxyphenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin-7(8H)-one|UNII-S3OPE9IA3Q|C26H30Cl2N6O4|GTPL9788|orb1296270|CHEMBL4068509|SCHEMBL16993012|SCHEMBL29360330|US9567334, Example 6|PRN 1371 [WHO-DD]|BDBM286984|GLXC-15386|BCP20493|EX-A2927|PRN1371?|NSC801089|s8578|CCG-270053|CS-7485|NSC-801089|compound 34 [PMID: 28665128]|AC-35543|BP179867|MS-30190|HY-101768|C92492|Q29213602|6-(2,6-dichloro-3,5-dimethoxy-phenyl)-2-(methylamino)-8-[3-(4-prop-2-enoylpiperazin-1-yl)propyl]pyrido[2,3-d]pyrimidin-7-one|PYRIDO(2,3-D)PYRIMIDIN-7(8H)-ONE, 6-(2,6-DICHLORO-3,5-DIMETHOXYPHENYL)-2-(METHYLAMINO)-8-(3-(4-(1-OXO-2-PROPEN-1-YL)-1-PIPERAZINYL)PROPYL)-"
MEFENAMIC ACID,4044,,"InChI=1S/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18)",HYYBABOKPJLUIN-UHFFFAOYSA-N,C15H15NO2,241.28,"2-(2,3-dimethylanilino)benzoic acid","mefenamic acid|61-68-7|Ponstel|2-[(2,3-dimethylphenyl)amino]benzoic acid|Mephenamic acid|2-((2,3-Dimethylphenyl)amino)benzoic acid|Mephenaminic acid|Ponstan|Methenamic acid|Vialidon|Lysalgo|Tanston|Acide mefenamique|Mefenaminsaeure|N-2,3-Xylylanthranilic acid|Acido mefenamico|CN-35355|Mefenaminic Acid|INF-3355|Acidum mefenamicum|INF 3355|CI-473|N-(2,3-Xylyl)-2-aminobenzoic acid|N-(2,3-Dimethylphenyl)anthranilic acid|Mefenamicacid|Gardan|Anthranilic acid, N-2,3-xylyl-|Benzoic acid, 2-[(2,3-dimethylphenyl)amino]-|CN 35355|DTXSID5023243|2-(2,3-dimethylphenylamino)benzoic acid|NSC-94437|Benzoic acid, 2-((2,3-dimethylphenyl)amino)-|2-Diphenylaminecarboxylic acid, 2',3'-dimethyl-|CHEBI:6717|M01AG01|Benzoic acid, 2-(2,3-dimethylphenyl)amino-|NSC94437|367589PJ2C|J2.344B|DTXCID103243|Mendys|Ponstan fte|Opustan 250|Opustan 500|Dysman-250|Dysman-500|Meflam 250|Meflam 500|RefChem:5988|200-513-1|Acid, Mefenamic|Apo Mefenamic|Nu Mefenamic|PMS Mefenamic Acid|Parkemed|Coslan|Mefacit|Ponalar|Bonabol|Bafameritin-M|Tamany Bonsan|Mefenamate|Ponstan forte|Namphen|Pontal|Mefanamic acid|Bafhameritin-M|Mefenacid|Ponstil|Ponstyl|2-(2,3-Dimethylanilino)benzoic acid|HL 1|N-(2,3-Xylyl)anthranilic acid|AGN-1255|CL 473|MFCD00051721|NSC 94437|CI 473|CHEMBL686|MLS000069709|CAS-61-68-7|NCGC00016278-07|SMR000058188|Mefenaminsaeure [German]|Ac. mefenamico [Italian]|in-M|Acide mefenamique [French]|Acide mefenamique [INN-French]|Acido mefenamico [INN-Spanish]|Acidum mefenamicum [INN-Latin]|2-(2,3-Xylidino)benzoic Acid|HSDB 3115|SR-01000000216|EINECS 200-513-1|BRN 2216243|mefenamic-acid|UNII-367589PJ2C|Prestwick_506|Anthranilic acid, N-(2,3-xylyl)-|Spectrum_000174|CPD000058188|Opera_ID_542|Mefenamic acid [USAN:USP:INN:BAN:JAN]|Prestwick0_000054|Prestwick1_000054|Prestwick2_000054|Prestwick3_000054|Spectrum2_001941|Spectrum3_001082|Spectrum4_001235|Spectrum5_001341|M1782|Mefenamic acid (Standard)|Anthranilic acid,3-xylyl-|cid_4044|SCHEMBL3544|MEFENAMIC ACID [MI]|Oprea1_193889|BSPBio_000207|BSPBio_002724|KBioGR_001730|KBioSS_000654|MEFENAMIC ACID [INN]|MEFENAMIC ACID [JAN]|MLS001074162|DivK1c_000298|MEFENAMIC ACID [HSDB]|MEFENAMIC ACID [USAN]|SPECTRUM1501103|SPBio_002001|SPBio_002128|MEFENAMIC ACID [VANDF]|BPBio1_000229|F0850-6853|GTPL2593|orb1310196|SGCUT00005|WLN: QVR BMR B1 C1|MEFENAMIC ACID [MART.]|MEFENAMIC ACID [USP-RS]|MEFENAMIC ACID [WHO-DD]|SCHEMBL29350572|SCHEMBL29355128|SCHEMBL29465887|HMS500O20|HY-B0574R|KBio1_000298|KBio2_000654|KBio2_003222|KBio2_005790|KBio3_001944|BRD8217|MSK7159|NINDS_000298|HMS1568K09|HMS1921D13|HMS2090B07|HMS2092B17|HMS2095K09|HMS2232P18|HMS3259M19|HMS3370K18|HMS3652A10|HMS3712K09|HMS3885O22|HMS5082M08|Pharmakon1600-01501103|Mefenamic acid (JP18/USP/INN)|Mefenamic acid, analytical standard|ALBB-025759|BCP08499|BRD-8217|HY-B0574|to_000071|Tox21_110344|Tox21_301983|BBL003564|BDBM50134036|CCG-39434|MEFENAMIC ACID [ORANGE BOOK]|NSC757834|s4078|SBB056999|STK666691|MEFENAMIC ACID [EP MONOGRAPH]|AKOS001025551|AKOS002388313|Benzoic acid,3-dimethylphenyl)amino]-|MEFENAMIC ACID [USP MONOGRAPH]|Tox21_110344_1|DB00784|FM25038|NC00517|NSC-757834|IDI1_000298|SMP2_000141|2-(2,3-Dimethylanilino)benzoic acid #|2-(2,3-dimethylphenyl)aminobenzoic acid|NCGC00016278-01|NCGC00016278-02|NCGC00016278-03|NCGC00016278-04|NCGC00016278-05|NCGC00016278-06|NCGC00016278-10|NCGC00022393-03|NCGC00022393-04|NCGC00022393-05|NCGC00255401-01|AC-11160|AS-12677|ST086740|SY045797|SBI-0051636.P002|2-(2,3-Dimethyl-phenylamino)-benzoic acid|2-[(2,3-dimethylphenyl) amino]benzoic acid|2-Diphenylaminecarboxylic acid,3'-dimethyl-|AB00052200|NS00000218|SW196700-3|UNM000001233403|EN300-16695|C02168|D00151|AB00052200-17|AB00052200_18|AB00052200_19|F079420|Q284321|SR-01000000216-2|SR-01000000216-4|BRD-K92778217-001-06-1|BRD-K92778217-001-31-9|BRD-K92778217-001-32-7|Z56755828|2-(2,3-Dimethyl-phenylamino)-benzoic acid(Mefenamic acid)|2-[(2,3-Dimethylphenyl)amino]-benzoic acid;Mefacit;Mefenacid|Mefenamic acid, European Pharmacopoeia (EP) Reference Standard|Mefenamic acid, United States Pharmacopeia (USP) Reference Standard|InChI=1/C15H15NO2/c1-10-6-5-9-13(11(10)2)16-14-8-4-3-7-12(14)15(17)18/h3-9,16H,1-2H3,(H,17,18"
BMS-929075,59275404,,"InChI=1S/C31H24F2N4O3/c1-17-4-5-19(28(38)37-31(12-13-31)30-35-14-3-15-36-30)16-22(17)21-10-11-23-24(26(21)33)25(29(39)34-2)27(40-23)18-6-8-20(32)9-7-18/h3-11,14-16H,12-13H2,1-2H3,(H,34,39)(H,37,38)",LZAUGCMVNLZVJV-UHFFFAOYSA-N,C31H24F2N4O3,538.5,4-fluoro-2-(4-fluorophenyl)-N-methyl-5-[2-methyl-5-[(1-pyrimidin-2-ylcyclopropyl)carbamoyl]phenyl]-1-benzofuran-3-carboxamide,"BMS-929075|1217338-97-0|4-Fluoro-2-(4-fluorophenyl)-N-methyl-5-(2-methyl-5-((1-pyrimidin-2-ylcyclopropyl)carbamoyl)phenyl)benzofuran-3-carboxamide|8S38482CST|UNII-8S38482CST|4-Fluoro-2-(4-Fluorophenyl)-N-Methyl-5-(2-Methyl-5-{[1-(Pyrimidin-2-Yl)cyclopropyl]carbamoyl}phenyl)-1-Benzofuran-3-Carboxamide|3-Benzofurancarboxamide, 4-fluoro-2-(4-fluorophenyl)-N-methyl-5-(2-methyl-5-(((1-(2-pyrimidinyl)cyclopropyl)amino)carbonyl)phenyl)-|4-fluoro-2-(4-fluorophenyl)-N-methyl-5-(2-methyl-5-((1-(pyrimidin-2-yl)cyclopropyl)carbamoyl)phenyl)-1-benzofuran-3-carboxamide|RefChem:120757|4-Fluoro-2-(4-fluorophenyl)-n-methyl-5-(2-methyl-5-((1-(pyrimidin-2-yl)cyclopropyl)carbamoyl)phenyl)benzofuran-3-carboxamide|4-fluoro-2-(4-fluorophenyl)-N-methyl-5-[2-methyl-5-[(1-pyrimidin-2-ylcyclopropyl)carbamoyl]phenyl]-1-benzofuran-3-carboxamide|orb1700995|SCHEMBL2143038|CHEMBL4093031|SYB33897|AKOS040748020|BMS 929075|DB14950|DA-71591|TS-08488|HY-120634|CS-0078502|Q27896030|8XJ"
ZIMLOVISERTIB,118414016,,"InChI=1S/C18H20FN3O4/c1-3-10-13(22-17(24)15(10)19)8-26-18-11-7-14(25-2)12(16(20)23)6-9(11)4-5-21-18/h4-7,10,13,15H,3,8H2,1-2H3,(H2,20,23)(H,22,24)/t10-,13+,15-/m0/s1",JKDGKIBAOAFRPJ-ZBINZKHDSA-N,C18H20FN3O4,361.4,"1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy]-7-methoxyisoquinoline-6-carboxamide","zimlovisertib|1817626-54-2|PF-06650833|1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl)methoxy)-7-methoxyisoquinoline-6-carboxamide|S3F315JJXI|PF06650833|PF 06650833|1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxopyrrolidin-2-yl]methoxy]-7-methoxyisoquinoline-6-carboxamide|1-{[(2s,3s,4s)-3-Ethyl-4-Fluoro-5-Oxopyrrolidin-2-Yl]methoxy}-7-Methoxyisoquinoline-6-Carboxamide|6-Isoquinolinecarboxamide, 1-(((2S,3S,4S)-3-ethyl-4-fluoro-5-oxo-2-pyrrolidinyl)methoxy)-7-methoxy-|6-Isoquinolinecarboxamide, 1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxo-2-pyrrolidinyl]methoxy]-7-methoxy-|RefChem:195974|815-268-1|Zimlovisertib [USAN]|MFCD30343869|CHEMBL4081711|1-[[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxo-2-pyrrolidinyl]methoxy]-7-methoxy-6-isoquinolinecarboxamide|Zimlovisertib (USAN)|8CG|Zimlovisertib [WHO-DD]|UNII-S3F315JJXI|ZIMLOVISERTIB [INN]|GTPL9667|orb1296160|SCHEMBL17136792|SCHEMBL29361300|GLXC-10290|EX-A2502|BDBM50239499|WHO 12020|US10329302, Example 344|US10793579, Example 374|US11702424, Example 374|AKOS030528051|CS-6078|DB15143|compound 40 [PMID: 28498658]|AC-35759|DA-76775|HY-19836|SY045278|D12167|A901476|PF06650833, >=98% (HPLC)|1-(((2S,3S,4S)-3-ETHYL-4-FLUORO-5-OXOPYRROLIDIN-2-YL)METHOXY)-7- METHOXYISOQUINOLINE-6-CARBOXAMIDE|1-(3(S)-Ethyl-4(S)-fluoro-5-oxo-pyrrolidin-2(S)-ylmethoxy)-7-methoxy-isoquinoline-6-carboxamide|1-[[(2S,3S,4S)-3-Ethyl-4-fluoro-5-oxo-2-pyrrolidinyl]methoxy]-7-methoxyisoquinoline-6-carboxamide|1-[[(2S,3S,4S)-3-ethyl-4-fluoro-5-oxo-pyrrolidin-2-yl]methoxy]-7-methoxy-isoquinoline-6-carboxamide"
AZD-5423,24825740,,"InChI=1S/C25H21F4N3O3/c1-15(31-24(33)25(27,28)29)23(16-4-3-5-20(12-16)34-2)35-21-10-11-22-17(13-21)14-30-32(22)19-8-6-18(26)7-9-19/h3-15,23H,1-2H3,(H,31,33)/t15-,23-/m0/s1",FCNQMDSJHADDFT-WNSKOXEYSA-N,C25H21F4N3O3,487.4,"2,2,2-trifluoro-N-[(1R,2S)-1-[1-(4-fluorophenyl)indazol-5-yl]oxy-1-(3-methoxyphenyl)propan-2-yl]acetamide","1034148-04-3|AZD-5423|AZD 5423|2,2,2-trifluoro-N-[(1R,2S)-1-[1-(4-fluorophenyl)indazol-5-yl]oxy-1-(3-methoxyphenyl)propan-2-yl]acetamide|641H0Q518W|DTXSID40145823|2,2,2-Trifluoro-N-((1R,2S)-1-((1-(4-fluorophenyl)-1H-indazol-5-yl)oxy)-1-(3-methoxyphenyl)propan-2-yl)acetamide|2,2,2-TRIFLUORO-N-((1R,2S)-1-(1-(4-FLUOROPHENYL)INDAZOL-5-YL)OXY-1-(3-METHOXYPHENYL)PROPAN-2-YL)ACETAMIDE|RefChem:560461|DTXCID5068314|2,2,2-Trifluoro-N-((1S,2R)-2-((1-(4-fluorophenyl)-1H-indazol-5-yl)oxy)-2-(3-methoxyphenyl)-1-methylethyl)acetamide|680-820-9|AZD5423|CHEMBL4072756|2,2,2-Trifluoro-N-((1R,2S)-1-((1-(4-fluorophenyl)-1H-indazol-5-yl)oxy)-1-(3-methoxyphenyl)-2-propanyl)acetamide|2,2,2-Tris(Fluoranyl)-~{n}-[(1~{r},2~{s})-1-[1-(4-Fluorophenyl)indazol-5-Yl]oxy-1-(3-Methoxyphenyl)propan-2-Yl]ethanamide|C25H21F4N3O3|2,2,2-Trifluoro-N-[(1R,2S)-1-{[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy}-1-(3-methoxyphenyl)-2-propanyl]acetamide|SCHEMBL524607|orb1308612|SCHEMBL29373225|SCHEMBL29968143|GTPL13017|AZD 5423 [WHO-DD]|GLXC-10781|Acetamide, 2,2,2-trifluoro-N-[(1S,2R)-2-[[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy]-2-(3-methoxyphenyl)-1-methylethyl]-;Acetamide, 2,2,2-trifluoro-N-[(1S,2R)-2-[[1-(4-fluorophenyl)-1H-indazol-5-yl]oxy]-2-(3-methoxyphenyl)-1-methylethyl]-|EX-A5022|BDBM50250112|MFCD26142626|AKOS040741197|DB12280|compound 1b [PMID: 28937774]|CID 24825740|DA-69621|MS-29055|HY-108243|CS-0027671|NS00073075|G14284|Q15408423|2,2,2-trifluoro-N-[(1S,2R)-2-[1-(4-fluorophenyl)indazol-5-yl]oxy-2-(3-methoxyphenyl)-1-methyl-ethyl]acetamide|8W8"
VELSECORAT,139593415,,"InChI=1S/C32H32F2N4O6/c1-19(36-31(40)32(2,33)34)29(20-6-9-27-28(16-20)43-13-12-42-27)44-25-7-8-26-22(15-25)17-35-38(26)24-5-3-4-21(14-24)30(39)37-23-10-11-41-18-23/h3-9,14-17,19,23,29H,10-13,18H2,1-2H3,(H,36,40)(H,37,39)/t19-,23-,29-/m1/s1",ZZWJKLGCDHYVMB-XGBAOLAVSA-N,C32H32F2N4O6,606.6,"3-[5-[(1S,2R)-2-(2,2-difluoropropanoylamino)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propoxy]indazol-1-yl]-N-[(3R)-oxolan-3-yl]benzamide","P30N0911C2|AZD-7594|1196509-60-0|Benzamide, 3-(5-((1R,2S)-2-((2,2-difluoro-1-oxopropyl)amino)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propoxy)-1H-indazol-1-yl)-N-((3R)-tetrahydro-3-furanyl)-|Azd 7594|RefChem:193907|3-(5-((1R,2S)-2-(2,2-difluoropropanamido)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propoxy)-1H-indazol-1-yl)-N-((3R)-oxolan-3-yl)benzamide|Azd7594|Velsecorat|Velsecorat [INN]|Velsecorat [USAN]|AZD 7594 [WHO-DD]|2138865-36-6|3-(5-((1S,2R)-2-(2,2-Difluoropropanamido)-1-(2,3-dihydrobenzo[b][1,4]dioxin-6-yl)propoxy)-1H-indazol-1-yl)-N-((R)-tetrahydrofuran-3-yl)benzamide|Velsecorat [USAN:INN]|UNII-P30N0911C2|WHO 11103|3-(5-((1R,2S)-2-((2,2-Difluoropropanoyl)amino)-1-(2,3-dihydro-1,4-benzodioxin-6-yl)propoxy)-1H-indazol-1-yl)-N-((3R)-tetrahydro-3-furanyl)benzamide"
ATINVICITINIB,135138184,,"InChI=1S/C16H17FN6O3/c1-25-14-5-10(4-13(17)21-14)20-16-11(15(19)24)7-23(22-16)12-8-26-3-2-9(12)6-18/h4-5,7,9,12H,2-3,8H2,1H3,(H2,19,24)(H,20,21,22)/t9-,12+/m1/s1",PRQMBGDYXWVEHE-SKDRFNHKSA-N,C16H17FN6O3,360.34,"1-[(3R,4S)-4-cyanooxan-3-yl]-3-[(2-fluoro-6-methoxypyridin-4-yl)amino]pyrazole-4-carboxamide","Atinvicitinib|2169273-59-8|Atinvicitinib [INN]|C238YE66P2|1-((3R,4S)-4-Cyanotetrahydro-2H-pyran-3-yl)-3-((2-fluoro-6-methoxy-4-pyridinyl)amino)-1H-pyrazole-4-carboxamide|1H-Pyrazole-4-carboxamide, 1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-3-((2-fluoro-6-methoxy-4-pyridinyl)amino)-|RefChem:115425|UNII-C238YE66P2|CHEMBL4066193|1-[(3R,4S)-4-Cyanooxan-3-yl]-3-[(2-fluoro-6-methoxypyridin-4-yl)amino]pyrazole-4-carboxamide|SCHEMBL20284832|SCHEMBL29794840|GLXC-26807|BDBM50250929|AKOS040757378|DA-61294|HY-145551|CS-0375961|1-((3R,4S)-4-Cyanotetrahydro-2H-pyran-3-yl)-3-((2-fluoro-6-methoxypyridin-4-yl)amino)-1H-pyrazole-4-carboxamide"
RELACORILANT,73051463,,"InChI=1S/C27H22F4N6O3S/c1-35-15-22(14-33-35)41(39,40)36-9-7-18-11-24-17(13-34-37(24)21-4-2-20(28)3-5-21)12-26(18,16-36)25(38)23-10-19(6-8-32-23)27(29,30)31/h2-6,8,10-11,13-15H,7,9,12,16H2,1H3/t26-/m0/s1",WANIDIGFXJFFEL-SANMLTNESA-N,C27H22F4N6O3S,586.6,"[(4aR)-1-(4-fluorophenyl)-6-(1-methylpyrazol-4-yl)sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinolin-4a-yl]-[4-(trifluoromethyl)pyridin-2-yl]methanone","Relacorilant|1496510-51-0|CORT125134|CORT-125134|Methanone, [(4aR)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl][4-(trifluoromethyl)-2-pyridinyl]-|2158753C7E|DTXSID801099345|Methanone, ((4aR)-1-(4-fluorophenyl)-1,4,5,6,7,8-hexahydro-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4ah-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)-|((4aR)-1-(4-fluorophenyl)-6-(1-methyl-1H-pyrazole-4-sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone|2-[(4aR)-1-(4-fluorophenyl)-6-[(1-methyl-1H-pyrazol-4-yl)sulfonyl]-1H,4H,4aH,5H,6H,7H,8H-pyrido[3,4-f]indazole-4a-carbonyl]-4-(trifluoromethyl)pyridine|relacorilantum|[(4aR)-1-(4-Fluorophenyl)-6-(1-methyl-1H-pyrazole-4-sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl][4-(trifluoromethyl)pyridin-2-yl]methanone|2-((4aR)-1-(4-fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-1H,4H,4aH,5H,6H,7H,8H-pyrido(3,4-f)indazole-4a-carbonyl)-4-(trifluoromethyl)pyridine|RefChem:930638|DTXCID901531081|((4aR)-1-(4-Fluorophenyl)-1,4,5,6,7,8-hexahydro-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)methanone|[(4aR)-1-(4-fluorophenyl)-6-(1-methylpyrazol-4-yl)sulfonyl-4,5,7,8-tetrahydropyrazolo[3,4-g]isoquinolin-4a-yl]-[4-(trifluoromethyl)pyridin-2-yl]methanone|Relacorilant [INN]|Relacorilant [WHO-DD]|Cort 125134|CHEMBL4068611|Relacorilant (USAN)|RELACORILANT [USAN]|Relacorilant [USAN:INN]|orb1706730|SCHEMBL15454999|SCHEMBL29372050|GTPL13830|GLXC-26584|UNII-2158753C7E|Relacorilant [USAN:INN:WHO-DD]|EX-A4253|BDBM50265673|NSC812727|AKOS032945759|compound 7 [PMID: 28368581]|DB14976|NSC-812727|AC-36530|DA-67146|TS-08008|HY-109042|CS-0031484|D11336|F78015|((4aR)-1-(4-Fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo(3,4-g)isoquinolin-4a-yl)(4-(trifluoromethyl)-2-pyridinyl)methanone|(R)-(1-(4-FLUOROPHENYL)-6-((1-METHYL-1H-PYRAZOL-4-YL)SULFONYL)-1,4,5,6,7,8-HEXAHYDRO-4AH-PYRAZOLO(3,4-G)ISOQUINOLIN-4A-YL)(4-(TRIFLUOROMETHYL)PYRIDIN-2-YL)METHANONE|(R)-(1-(4-fluorophenyl)-6-((1-methyl-1H-pyrazol-4-yl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(4-(trifluoromethyl)pyridin-2-yl)methanone"
JNJ-54175446,90409366,,"InChI=1S/C18H13ClF4N6O/c1-9-15-13(29(27-26-15)17-24-7-10(20)8-25-17)5-6-28(9)16(30)11-3-2-4-12(14(11)19)18(21,22)23/h2-4,7-9H,5-6H2,1H3/t9-/m1/s1",CWFVVQFVGMFTBD-SECBINFHSA-N,C18H13ClF4N6O,440.8,"[2-chloro-3-(trifluoromethyl)phenyl]-[(4R)-1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridin-5-yl]methanone","JNJ-54175446|1627902-21-9|32524GLF40|Methanone, (2-chloro-3-(trifluoromethyl)phenyl)((4R)-1-(5-fluoro-2-pyrimidinyl)-1,4,6,7-tetrahydro-4-methyl-5H-1,2,3-triazolo(4,5-C)pyridin-5-yl)-|Methanone, (2-chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoro-2-pyrimidinyl)-1,4,6,7-tetrahydro-4-methyl-5H-1,2,3-triazolo(4,5-c)pyridin-5-yl)-|RefChem:150553|2-((4R)-5-(2-chloro-3-(trifluoromethyl)benzoyl)-4-methyl-1H,4H,5H,6H,7H-(1,2,3)triazolo(4,5-c)pyridin-1-yl)-5-fluoropyrimidine|(r)-(2-chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-4-methyl-1,4,6,7-tetrahydro-5h-[1,2,3]triazolo[4,5-c]pyridin-5-yl)methanone|MFCD31556312|[2-chloro-3-(trifluoromethyl)phenyl]-[(4R)-1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-4H-triazolo[4,5-c]pyridin-5-yl]methanone|(R)-(2-chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoropyrimidin-2-yl)-4-methyl-6,7-dihydro-1H-[1,2,3]triazolo[4,5-c]pyridin-5(4H)-yl)methanone|A1L0I|C18H13ClF4N6O|orb1707157|CHEMBL4079239|SCHEMBL16036477|SCHEMBL30900468|SCHEMBL31347774|UNII-32524GLF40|TQR1090|BDBM254266|GLXC-22837|EX-A6857|AKOS032947046|DB15358|AS-35269|DA-64656|HY-117508|CS-0066258|US9464084, 158|(2-Chloro-3-(trifluoromethyl)phenyl)(1-(5-fluoro-2-pyrimidinyl)-4-methyl-1,4,6,7-tetrahydro-5H-(1,2,3)triazolo(4,5-c)pyridin-5-yl)methanone|(R)-(2-Cl-3-(CF3-Me)Ph)(1-(5-fluoropyrimidin-2-yl)-4-Me-1,4,6,7-tetrahydro-5H-[1,2,3]triazolo[4,5-c]Py-5-yl)methanone"
LENIOLISIB,57495353,,"InChI=1S/C21H25F3N6O2/c1-3-18(31)30-6-4-13(10-30)28-19-15-11-29(7-5-17(15)26-12-27-19)14-8-16(21(22,23)24)20(32-2)25-9-14/h8-9,12-13H,3-7,10-11H2,1-2H3,(H,26,27,28)/t13-/m0/s1",MWKYMZXCGYXLPL-ZDUSSCGKSA-N,C21H25F3N6O2,450.5,"1-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one","Leniolisib|1354690-24-6|Cdz173 free base|Cdz-173 free base|CDZ173-NX|leniolisibum|CDZ-173-NX|L22772Z9CP|1-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one|1-Propanone, 1-((3S)-3-((5,6,7,8-tetrahydro-6-(6-methoxy-5-(trifluoromethyl)-3-pyridinyl)pyrido(4,3-d)pyrimidin-4-yl)amino)-1-pyrrolidinyl)-|1-((3S)-3-((6-(6-methoxy-5-(trifluoromethyl)pyridin-3-yl)-7,8-dihydro-5H-pyrido(4,3-d)pyrimidin-4-yl)amino)pyrrolidin-1-yl)propan-1-one|RefChem:57738|(S)-1-(3-((6-(6-methoxy-5-(trifluoromethyl)pyridin-3-yl)-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl)amino)pyrrolidin-1-yl)propan-1-one|Leniolisib [INN]|Leniolisib free base|MFCD30470232|C21H25F3N6O2|leniolisib(CDZ 173)|ent-Leniolisib|Leniolisib (CDZ173)|Leniolisib;  CDZ173|Leniolisib (USAN/INN)|LENIOLISIB [USAN]|leniolisib (CDZ 173)|Leniolisib (CDZ173)?|LENIOLISIB [WHO-DD]|SCHEMBL323054|UNII-L22772Z9CP|GTPL9424|orb1302035|CHEMBL3643413|SCHEMBL29370516|SCHEMBL30089313|CDZ 173|CHEBI:229649|BDBM118299|GLXC-25777|EEC69024|EX-A2854|s8752|ZB1510|AKOS028114976|CS-7524|DC22326|Example 67 [WO2012004299]|1-{(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-y|1-{(S)-3-[6-(6-methoxy-5-trifluoromethyl-pyridin-3-yl)-5,6,7,8-tetrahydro-pyrido[4,3-d]pyrimidin-4-ylamino]-pyrrolidin-1-yl}-propan-1-one|AC-35599|AS-56217|HY-17635|D11158|US8653092, 67|Q27282602|1-((3S)-3-((6-(6-METHOXY-5-(TRIFLUOROMETHYL)PYRIMIDIN-3-YL)-5,6,7,8-TETRAHYDROPYRIDO(4,3-D)PYRIMIDIN-4-YL)AMINO)PYRROLIDIN-1-YL)PROPAN-1-ONE|1-[(3S)-3-({6-[6-methoxy-5-(trifluoromethyl)pyridin-3-yl]-5,6,7,8-tetrahydropyrido[4,3-d]pyrimidin-4-yl}amino)pyrrolidin-1-yl]propan-1-one|1-[(3S)-3-[[6-[6-methoxy-5-(trifluoromethyl)-3-pyridyl]-7,8-dihydro-5H-pyrido[4,3-d]pyrimidin-4-yl]amino]pyrrolidin-1-yl]propan-1-one|2987586-16-1|9NQ"
IDH305,90415637,,"InChI=1S/C23H22F4N6O2/c1-12-8-17(30-10-16(12)15-4-6-28-19(9-15)23(25,26)27)14(3)31-21-29-7-5-20(32-21)33-18(13(2)24)11-35-22(33)34/h4-10,13-14,18H,11H2,1-3H3,(H,29,31,32)/t13-,14-,18+/m0/s1",DCGDPJCUIKLTDU-SUNYJGFJSA-N,C23H22F4N6O2,490.5,"(4R)-4-[(1S)-1-fluoroethyl]-3-[2-[[(1S)-1-[4-methyl-5-[2-(trifluoromethyl)pyridin-4-yl]pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one","1628805-46-8|IDH-305|IDH305|MFCD31630851|(4R)-4-[(1S)-1-fluoroethyl]-3-(2-{[(1S)-1-[4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl]ethyl]amino}pyrimidin-4-yl)-1,3-oxazolidin-2-one|(4R)-4-[(1S)-1-fluoroethyl]-3-[2-[[(1S)-1-[4-methyl-5-[2-(trifluoromethyl)pyridin-4-yl]pyridin-2-yl]ethyl]amino]pyrimidin-4-yl]-1,3-oxazolidin-2-one|A791KH7YZW|(R)-4-((S)-1-fluoroethyl)-3-(2-(((S)-1-(4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl)ethyl)amino)pyrimidin-4-yl)oxazolidin-2-one|(4R)-4-[(1S)-1-fluoroethyl]-3-[2-({(1S)-1-[4-methyl-2'-(trifluoromethyl)[3,4'-bipyridin]-6-yl]ethyl}amino)pyrimidin-4-yl]-1,3-oxazolidin-2-one|(4R)-4-[(1S)-1-Fluoroethyl]-3-(2-([(1s)-1-[4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl]ethyl]amino)pyrimidin-4-yl)-1,3-oxazolidin-2-one|UNII-A791KH7YZW|NVP-IDH305|orb1308209|CHEMBL3947537|SCHEMBL16045032|SCHEMBL29422994|C23H22F4N6O2|BDBM247859|GLXC-10992|EX-A3224|IDH-305?|NSC812928|s3574|AKOS040741865|CS-8084|NSC-812928|DA-54247|MS-29116|HY-104036|P18095|US9434719, 466|(4R)-4-[(1S)-1-FLUOROETHYL]-3-(2-{[(1S)-1-[4-METHYL-2'-(TRIFLUOROMETHYL)-[3,4'-BIPYRIDIN]-6-YL]ETHYL]AMINOPYRIMIDIN-4-YL)-1,3-OXAZOLIDIN-2-ONE|(4R)-4-[(1S)-1-Fluoroethyl]-3-(2-{[(1S)-1-[4-methyl-2'-(trifluoromethyl)-[3,4'-bipyridin]-6-yl]ethyl]aminopyrimidin-4-yl)]-1,3-oxazolidin-2-one|(4R)-4-[(1S)-1-fluoroethyl]-3-[2-[[(1S)-1-[4-methyl-5-[2-(trifluoromethyl)-4-pyridyl]-2-pyridyl]ethyl]amino]pyrimidin-4-yl]oxazolidin-2-one|2-OXAZOLIDINONE, 4-((1S)-1-FLUOROETHYL)-3-(2-(((1S)-1-(4-METHYL-2'-(TRIFLUOROMETHYL)(3,4'-BIPYRIDIN)-6-YL)ETHYL)AMINO)-4-PYRIMIDINYL)-, (4R)-|C81"
EMAPUNIL,6433109,,"InChI=1S/C23H23N5O2/c1-3-27(15-17-10-6-4-7-11-17)20(29)16-28-22-19(26(2)23(28)30)14-24-21(25-22)18-12-8-5-9-13-18/h4-14H,3,15-16H2,1-2H3",NBMBIEOUVBHEBM-UHFFFAOYSA-N,C23H23N5O2,401.5,N-benzyl-N-ethyl-2-(7-methyl-8-oxo-2-phenylpurin-9-yl)acetamide,"Emapunil|226954-04-7|AC-5216|XBD-173|OG837L732J|N-Benzyl-N-ethyl-2-(7-methyl-8-oxo-2-phenyl-7,8-dihydro-9H-purin-9-yl)acetamide|DTXSID40177220|N-ethyl-2-(7-methyl-8-oxo-2-phenylpurin-9-yl)-N-(phenylmethyl)acetamide|N-benzyl-N-ethyl-2-(7-methyl-8-oxo-2-phenyl-8,9-dihydro-7H-purin-9-yl)acetamide|N-Ethyl-7,8-dihydro-7-methyl-8-oxo-2-phenyl-N-(phenylmethyl)-9H-purine-9-acetamide|RefChem:590737|DTXCID7099711|Emapunil [INN]|XBD173|AC 5216|N-benzyl-N-ethyl-2-(7-methyl-8-oxo-2-phenyl-7H-purin-9(8H)-yl)acetamide|AC5216|MFCD07772312|N-benzyl-N-ethyl-2-(7-methyl-8-oxo-2-phenylpurin-9-yl)acetamide|CHEMBL513922|N-benzyl-N-ethyl-2-(7-methyl-8-oxo-2-phenyl-purin-9-yl)acetamide|Emapunilo|UNII-OG837L732J|XBDl73|Emapunil (AC 5216)|Emapunil(AC-5216)?|GTPL8704|orb1305581|SCHEMBL4757030|SCHEMBL29388876|CHEBI:232500|NBMBIEOUVBHEBM-UHFFFAOYSA-N|BCP14398|BJA95404|EX-A1040|BDBM50266889|s2592|AKOS025142074|CS-3470|DB12666|NCGC00387260-05|AC-35682|AS-16517|DA-43175|HY-15527|XBD173, >=98% (HPLC)|NS00068365|BRD-K45875383-001-01-2|Q15408410|N-Benzyl-N-ethyl-2-(7-methyl-8-oxo-2-phenyl-7H-purin-9(8H)-yl)ethanamide|N-benzyl-N-ethyl-7,8-dihydro-7-methyl-8-oxo-2-phenyl-9H-purin-9-acetamide"
ASPARTIC ACID,5960,,"InChI=1S/C4H7NO4/c5-2(4(8)9)1-3(6)7/h2H,1,5H2,(H,6,7)(H,8,9)/t2-/m0/s1",CKLJMWTZIZZHCS-REOHCLBHSA-N,C4H7NO4,133.10,(2S)-2-aminobutanedioic acid,"L-aspartic acid|aspartic acid|56-84-8|(2S)-2-aminobutanedioic acid|Asparagic acid|L-Asparagic acid|L-Aminosuccinic acid|Asparaginic acid|L-Asparaginic acid|(S)-2-Aminosuccinic acid|(S)-Aspartic acid|Aspartic acid, L-|(S)-Aminobutanedioic acid|L-Asparaginsaeure|L-(+)-Aspartic acid|Acidum asparticum|Acido aspartico|Acide aspartique|Aminosuccinic acid|Butanedioic acid, amino-, (S)-|Asparaginsaeure|(L)-ASPARTIC ACID|Deamidated asparagine|CHEBI:17053|30KYC7MIAI|(S)-2-aminobutanedioic acid|FEMA NO. 3656|DTXSID7022621|NSC3973|Aspartic Acid, Monopotassium Salt|CHEBI:22660|l aspartic acid|Aspartate, Sodium|aspartate magnesium|Aspartate, Calcium|Aspartate, Ammonium|Aspartate, Disodium|Aspartate, Magnesium|Aspartate, Potassium|Aspartate, Monosodium|Aspartate, Dipotassium|ASPARTIC ACID, DISODIUM SALT|RefChem:5569|Aspartate, Monopotassium|Aspartic Acid, Calcium Salt|Aspartic Acid, Ammonium Salt|Aspartic Acid, Monosodium Salt|DTXCID402621|Aspartic Acid, Magnesium (2:1) Salt|potassium aspartate and magnesium aspart|(2S)-2-azaniumyl-4-hydroxy-4-oxobutanoate|(3S)-3-azaniumyl-4-hydroxy-4-oxobutanoate|200-291-6|614-886-7|642-993-9|(R,S)-Aspartic Acid|2-Aminosuccinic acid|NSC79553|H-Asp-OH|L-aspartate|aspartate|Aspatofort|(2S)-Aspartic acid|L-Aspartinsaeure|L-Asparaginsyra|L-Asp|L-2-Aminobutanedioic acid|Aspartate, L-|Asparaginsaeure [German]|Aspartic acid (VAN)|Asparagic acid (VAN)|(S)-(+)-Aminosuccinic acid|Asparaginic acid (VAN)|Acide aspartique [INN-French]|Acido aspartico [INN-Spanish]|(+)-Aspartic acid|MFCD00002616|FEMA No. 3565|CCRIS 6181|Acidum asparticum [INN-Latin]|HSDB 1430|L( )-Aminobernsteinsaeure|AI3-04461|NSC 3973|BRN 1723530|asp|Beta-L-Aspartic Acid|(S)-(+)-Aspartic acid|6899-03-2|CHEMBL274323|(S)-Aspartate|(+)-Aspartate|M03000|L-Aspartic acid-13C4|1-Amino-1,2-carboxyethane|(S)-Aminobutanedioate|l(+)-aspartic acid|Aspartic Acid [USAN:INN]|4-04-00-02998 (Beilstein Handbook Reference)|39162-75-9|EINECS 200-291-6|UNII-30KYC7MIAI|L(+)-Aminobernsteinsaeure|Aminosuccinate|Asparagate|Asparatate|NSC-3973|aspartic acid,l|l-aspartic-acid|L-Asparagate|L-Aminosuccinate|Aspartic acid [USAN:USP:INN]|(L)-Aspartate|alpha-Aminosuccinate|(2S)-Aspartate|L-(+)-Aspartate|[3H]-L-aspartate|L-[14C]aspartate|L-Aspartic acid, 2|[3H]L-aspartic acid|(R)-2-aminosuccinate|(S)-2-aminosuccinate|Tocris-0214|[3h]-l-asp|(S)-amino-Butanedioate|alpha-Aminosuccinic acid|(S)-Aminosuccinic Acid|(S)-(+)-Aspartate|[3H]-L-aspartic acid|butanedioic acid, amino-|L-Aspartic acid (9CI)|2-Amino-3-methylsuccinate|Biomol-NT_000168|bmse000031|bmse000875|Aspartic acid (USP/INN)|EC 200-291-6|ASPARTIC ACID [II]|ASPARTIC ACID [MI]|L-Aspartic acid (JP18)|SCHEMBL3231|(S)-amino-Butanedioic acid|L-Aspartic acid (Standard)|ASPARTIC ACID [INN]|L-Aspartic acid, >=98%|L-Aspartic acid, 99.0%|Lopac0_000133|ASPARTIC ACID [HSDB]|ASPARTIC ACID [USAN]|Aspartic acid, L- (8CI)|ASPARTIC ACID [VANDF]|Aspartic Acid (Aspartic Acid)|ASPARTIC ACID [MART.]|L-Aspartic acid (H-Asp-OH)|L-ASPARTIC ACID [FCC]|L-ASPARTIC ACID [JAN]|(2S)-2-azanylbutanedioic acid|BPBio1_001128|GTPL3309|GTPL4534|orb1304735|SCHEMBL1119660|SCHEMBL8703897|SCHEMBL8832430|ASPARTIC ACID [USP-RS]|ASPARTIC ACID [WHO-DD]|L-ASPARTIC ACID [FHFI]|BDBM18125|HY-N0666R|MSK1403|L-Aspartic acid, >=98%, FG|HMS3260K08|.alpha.-Aminosuccinic acid, (L)-|ASPARTIC ACID [EP IMPURITY]|HY-N0666|STR04614|Tox21_500133|ASPARTIC ACID [EP MONOGRAPH]|HB0374|PDSP1_000819|PDSP2_000806|ASPARTIC ACID [USP MONOGRAPH]|AKOS006239578|AKOS015853957|CCG-204228|DB00128|FA12668|LP00133|SDCCGSBI-0050121.P002|ALANINE IMPURITY A [EP IMPURITY]|L-Aspartic acid (H-Asp-OH) USP grade|NCGC00024499-01|NCGC00024499-02|NCGC00024499-03|NCGC00024499-04|NCGC00024499-05|NCGC00024499-06|NCGC00024499-10|NCGC00260818-01|BP-13291|L-Aspartic acid, Vetec(TM) reagent grade|DB-029944|A0546|CS-0009701|EU-0100133|L-Aspartic acid, BioXtra, >=99% (HPLC)|NS00074191|S5632|EN300-64901|L-Aspartic acid, BioUltra, >=99.5% (T)|A 9256|C00049|D00013|D70832|L-Aspartic Acid(Discontinued,SeeCPTD788377)|LYSINE ACETATE IMPURITY A [EP IMPURITY]|L-Aspartic acid, SAJ special grade, >=99.0%|A817928|A824434|L-Aspartic acid, reagent grade, >=98% (HPLC)|Q178450|SR-01000597734|SR-01000597734-3|BRD-K97163964-001-03-3|BRD-K97163964-001-04-1|F8889-8684|Z995084132|A4B5FB11-A4B6-4D75-9860-2ACF670700B9|Aspartic acid, European Pharmacopoeia (EP) Reference Standard|L-Aspartic acid, certified reference material, TraceCERT(R)|Aspartic acid, United States Pharmacopeia (USP) Reference Standard|L-Aspartic acid, BioReagent, suitable for cell culture, suitable for insect cell culture|L-Aspartic acid, Pharmaceutical Secondary Standard; Certified Reference Material|L-Aspartic acid, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%"
MAVELERTINIB,91668194,,"InChI=1S/C18H22FN9O2/c1-5-13(29)21-11-8-28(6-10(11)19)18-23-15(14-16(24-18)26(2)9-20-14)22-12-7-27(3)25-17(12)30-4/h5,7,9-11H,1,6,8H2,2-4H3,(H,21,29)(H,22,23,24)/t10-,11-/m1/s1",JYIUNVOCEFIUIU-GHMZBOCLSA-N,C18H22FN9O2,415.4,"N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methylpyrazol-4-yl)amino]-9-methylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide","Mavelertinib|1776112-90-3|PF-06747775|Mavelertinib [USAN]|YXX2180047|Egfr T790M inhibitor PF-06747775|2-Propenamide, N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-9-methyl-9H-purin-2-yl]-3-pyrrolidinyl]-|MAVELERTINIB [INN]|MAVELERTINIB [WHO-DD]|PF06747775|2-Propenamide, N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)-3-pyrrolidinyl)-|N-[(3R,4R)-4-fluoro-1-[6-[(3-methoxy-1-methylpyrazol-4-yl)amino]-9-methylpurin-2-yl]pyrrolidin-3-yl]prop-2-enamide|compound 21 [PMID: 28287730]|compound 21 (PMID: 28287730)|N-((3R,4R)-4-FLUORO-1-(6-((3-METHOXY-1-METHYL-PYRAZOL-4-YL)AMINO)-9-METHYL-PURIN-2-YL)PYRROLIDIN-3-YL)PROP-2-ENAMIDE|mavelertinibum|N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methylpyrazol-4-yl)amino)-9-methylpurin-2-yl)pyrrolidin-3-yl)prop-2-enamide|N-[(3R,4R)-4-FLUORO-1-{6-[(3-METHOXY-1-METHYLPYRAZOL-4-YL)AMINO]-9-METHYLPURIN-2-YL}PYRROLIDIN-3-YL]PROP-2-ENAMIDE|RefChem:810669|815-270-2|N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide|UNII-YXX2180047|Mavelertinib (USAN/INN)|GTPL9765|orb1705133|CHEMBL3989970|SCHEMBL16714537|SCHEMBL29377591|JYIUNVOCEFIUIU-GHMZBOCLSA-N|EX-A4999|BDBM50450870|NSC788365|AKOS032945529|NSC-788365|AC-33593|DA-66623|HY-12972|MS-27202|CS-0012907|C92352|D11368|PF-06747775, >=98% (HPLC)|N-((3R,4R)-4-fluoro-1-(6-((3-methoxy-1-methyl-1H-pyrazol -4-yl)amino)-9-methyl-9H-purin-2-yl)pyrrolidin-3-yl)acrylamide"
BAY1436032,118310260,,"InChI=1S/C26H30F3N3O3/c1-16-12-19(15-25(2,3)14-16)32-22-10-4-17(5-11-23(33)34)13-21(22)31-24(32)30-18-6-8-20(9-7-18)35-26(27,28)29/h4,6-10,13,16,19H,5,11-12,14-15H2,1-3H3,(H,30,31)(H,33,34)/t16-,19+/m0/s1",RNMAUIMMNAHKQR-QFBILLFUSA-N,C26H30F3N3O3,489.5,"3-[2-[4-(trifluoromethoxy)anilino]-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]benzimidazol-5-yl]propanoic acid","BAY-1436032|1803274-65-8|BAY1436032|BAY 1436032|RefChem:116744|Pan-Mutant-IDH1 Inhibitor Bay-1436032|3-(2-((4-(trifluoromethoxy)phenyl)amino)-1-((1R,5R)-3,3,5-trimethylcyclohexyl)-1H-benzo[d]imidazol-5-yl)propanoic acid|3-[2-[4-(trifluoromethoxy)anilino]-1-[(1R,5R)-3,3,5-trimethylcyclohexyl]benzimidazol-5-yl]propanoic acid|RNMAUIMMNAHKQR-QFBILLFUSA-N|orb1296249|CHEMBL4206033|SCHEMBL17009632|SCHEMBL30192044|C26H30F3N3O3|BDBM404661|GLXC-15293|HMS6018E18|DXC27465|EX-A1606|MFCD30533279|NSC794487|s8530|NSC-794487|US10344004, Test compound Table 3|AC-36182|DA-61515|MS-29100|HY-100020|CS-0017982|G15940|3-(2-(4-(Trifluoromethoxy)phenylamino)-1-((1R,5R)-3,3,5-trimethylcyclohexyl)-1H-benzo[d]imidazol-5-yl)propanoic acid"
SANGUINARIUM,5154,,"InChI=1S/C20H14NO4/c1-21-8-15-12(4-5-16-20(15)25-10-22-16)13-3-2-11-6-17-18(24-9-23-17)7-14(11)19(13)21/h2-8H,9-10H2,1H3/q+1",INVGWHRKADIJHF-UHFFFAOYSA-N,C20H14NO4+,332.3,"24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene","SANGUINARINE|2447-54-3|Pseudochelerythrine|Sanguinarin|SANGUINARIUM|sangvinarin|Sanguiritrin|Dimethylenedioxy benzphenanthridine|AV9VK043SS|DTXSID0045204|CHEBI:17183|24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.02,10.04,8.014,22.017,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene|DTXCID8025204|pseudo-chelerythrine|24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo(11.11.0.0^(2,10).0^(4,8).0^(14,22).0^(17,21))tetracosa-1(13),2,4(8),9,11,14,16,21,23-nonaen-24-ium|24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0^{2,10}.0^{4,8}.0^{14,22}.0^{17,21}]tetracosa-1(13),2,4(8),9,11,14,16,21,23-nonaen-24-ium|24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo(11.11.0.02,10.04,8.014,22.017,21)tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene|RefChem:48744|219-503-3|24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo(11.11.0.02,10.04,8.014,22.017,21)tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaen-24-ium|Sangrovit|Veadent|[1,3]Benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium, 13-methyl-|Pseudochelerythrine;Sanguinarin|Benzophenanthridine alkaloid|NCGC00015959-03|CAS-2447-54-3|13-Methyl-[1,3]dioxolo[4',5':4,5]benzo[1,2-c][1,3]dioxolo[4,5-i]phenanthridin-13-ium|13-methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium|13-Methyl[1,3]benzodioxolo[5,6-C][1,3]dioxolo[4,5-I]phenanthridin-13-Ium|EINECS 219-503-3|UNII-AV9VK043SS|BRN 3915507|y-Chelerythrine|SR-01000075650|(1,3)BENZODIOXOLO(5,6-C)-1,3-DIOXOLO(4,5-I)PHENANTHRIDINIUM, 13-METHYL-|UI5|sanguinarium-chloride|Spectrum_000259|Prestwick0_000987|Prestwick1_000987|Prestwick2_000987|Prestwick3_000987|Spectrum2_000724|Spectrum3_001148|Spectrum4_001838|Spectrum5_000635|Lopac-S-5890|SANGUINARINE [MI]|(1,3)-Benzodioxolo(5,6-c)-1,3-dioxolo(4,5-i)phenanthridinium, 13-methyl-|cid_5154|Lopac0_001108|BSPBio_001053|BSPBio_002675|KBioGR_002542|KBioSS_000739|MLS002154085|DivK1c_000495|SANGUINARINE [WHO-DD]|SCHEMBL123241|SPBio_000648|SPBio_002954|BPBio1_001159|CHEMBL417799|orb1305027|SCHEMBL29385229|SCHEMBL30129850|SCHEMBL30153784|BDBM25525|GTPL11563|KBio1_000495|KBio2_000739|KBio2_003307|KBio2_005875|KBio3_002175|NINDS_000495|C20H14NO4+|HMS1571E15|HMS2098E15|HMS5086G15|BCP13614|EX-A5014|HY-N0052|Tox21_110268|MFCD00064925|NSC765394|s9032|AKOS025311557|Tox21_110268_1|CCG-205184|compound 1 [PMID: 28621943]|CS-3818|FS40153|NSC-765394|SDCCGMLS-0066612.P001|IDI1_000495|NCGC00015959-01|NCGC00015959-02|NCGC00015959-04|NCGC00015959-05|NCGC00015959-09|NCGC00015959-16|NCGC00015959-22|NCGC00160289-01|NCGC00160289-02|AC-34836|SMR001233394|SBI-0051077.P003|DB-046461|AB00053789|NS00018310|C06162|E80766|AB00053789_04|447S543|Q347392|SR-01000075650-7|BRD-K66898851-001-03-7|BRD-K66898851-003-02-5|BRD-K66898851-003-03-3|5-Methyl-2,3:7,8-bis(methylenedioxy)benzo[c]phenanthridinium(1+)|13-Methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium nitrate|13-Methyl[1,3]benzodioxolo[5,6-c]-1,3-dioxolo[4,5-i]phenanthridinium(1+), 9CI|13-methyl-2H,10H-[1,3]dioxolo[4,5-i][1,3]dioxolo[4',5':4,5]benzo[1,2-c]phenanthridinium|24-methyl-5,7,18,20-tetraoxa-24-azahexacyclo[11.11.0.0^{2,10}.0^{4,8}.0^{14,22}.0^{17,21}]tetracosa-1(13),2,4(8),9,11,14(22),15,17(21),23-nonaen-24-ium|24-methyl-5,7,18,20-tetraoxa-24-azoniahexacyclo[11.11.0.0^{2,10.0^{4,8.0^{14,22.0^{17,21]tetracosa-1(24),2,4(8),9,11,13,15,17(21),22-nonaene"
MIZACORAT,121248172,,"InChI=1S/C27H28F2N4O3/c1-17(2)24(31-26(35)27(3,28)29)25(18-8-6-5-7-9-18)36-21-11-12-22-19(14-21)15-30-33(22)20-10-13-23(34)32(4)16-20/h5-17,24-25H,1-4H3,(H,31,35)/t24-,25+/m0/s1",ZQFNDBISEYQVRR-LOSJGSFVSA-N,C27H28F2N4O3,494.5,"2,2-difluoro-N-[(1R,2S)-3-methyl-1-[1-(1-methyl-6-oxopyridin-3-yl)indazol-5-yl]oxy-1-phenylbutan-2-yl]propanamide","AZD9567|1893415-00-3|Mizacorat|AZD-9567|GGK40O1O85|AZD 9567|2,2-difluoro-N-[(1R,2S)-3-methyl-1-[1-(1-methyl-6-oxopyridin-3-yl)indazol-5-yl]oxy-1-phenylbutan-2-yl]propanamide|Propanamide, N-[(1S)-1-[(R)-[[1-(1,6-dihydro-1-methyl-6-oxo-3-pyridinyl)-1H-indazol-5-yl]oxy]phenylmethyl]-2-methylpropyl]-2,2-difluoro-|Propanamide, N-((1S)-1-((R)-((1-(1,6-dihydro-1-methyl-6-oxo-3-pyridinyl)-1H-indazol-5-yl)oxy)phenylmethyl)-2-methylpropyl)-2,2-difluoro-|2,2-difluoro-N-((1R,2S)-3-methyl-1-(1-(1-methyl-6-oxopyridin-3-yl)indazol-5-yl)oxy-1-phenylbutan-2-yl)propanamide|RefChem:116057|AZD 9567 [WHO-DD]|UNII-GGK40O1O85|2,2-bis(fluoranyl)-~{N}-[(1~{R},2~{S})-3-methyl-1-[1-(1-methyl-6-oxidanylidene-pyridin-3-yl)indazol-5-yl]oxy-1-phenyl-butan-2-yl]propanamide|mizacorat [INN]|GTPL9812|orb1707605|CHEMBL4207852|SCHEMBL17643955|SCHEMBL30202049|C27H28F2N4O3|US10196374, Example 1|ZQFNDBISEYQVRR-LOSJGSFVSA-N|BDBM332659|EX-A7251|TAD41500|AKOS040741202|example 1 [WO2016046260A1]|compound 15 [PMID: 29424542]|MS-29181|DB-211375|HY-120012|CS-0068857|G16195|Q29213655|2,2-difluoro-N-[(1R,2S)-3-methyl-1-{[1-(1-methyl-6-oxo- 1,6-dihydropyridin-3-yl)-1H-indazol-5-yl]oxy}-1- phenylbutan-2-yl]propanamide|2,2-Difluoro-N-[(1r,2s)-3-methyl-1-{[1-(1-methyl-6-oxo-1,6-dihydropyridin-3-yl)-1h-indazol-5-yl]oxy}-1-phenylbutan-2-yl]propanamide|2,2-difluoro-N-[(1S)-2-methyl-1-[(R)-[1-(1-methyl-6-oxo-3-pyridyl)indazol-5-yl]oxy-phenyl-methyl]propyl]propanamide|B9W|N-[(1S)-1-[(R)-[[1-(1,6-Dihydro-1-methyl-6-oxo-3-pyridinyl)-1H-indazol-5-yl]oxy]phenylmethyl]-2-methylpropyl]-2,2-difluoropropanamide"
DAGROCORAT,24873449,,"InChI=1S/C29H29F3N2O2/c1-19-25(8-5-15-33-19)34-26(35)22-10-12-24-21(16-22)9-11-23-18-28(36,29(30,31)32)14-13-27(23,24)17-20-6-3-2-4-7-20/h2-8,10,12,15-16,23,36H,9,11,13-14,17-18H2,1H3,(H,34,35)/t23-,27+,28-/m1/s1",QJJBNCHSWFGXML-KEKPKEOLSA-N,C29H29F3N2O2,494.5,"(4bS,7R,8aR)-4b-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-5,6,8,8a,9,10-hexahydrophenanthrene-2-carboxamide","Dagrocorat|1044535-52-5|OPM23UN90U|(4bS,7R,8aR)-4b-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-5,6,8,8a,9,10-hexahydrophenanthrene-2-carboxamide|PF-0251802|PF 00251802|PF-802|DTXSID60146493|(4bS,7R,8aR)-4b-benzyl-7-hydroxy-N-(2-methylpyridin-3-yl)-7-(trifluoromethyl)-4b,5,6,7,8,8a,9,10-octahydrophenanthrene-2-carboxamide|dagrocoratum|RefChem:906137|DTXCID1068984|PF00251802|(4bS,7R,8aR)-4b,5,6,7,8,8a,9,10-Octahydro-7-hydroxy-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(trifluoromethyl)-2-phenanthrenecarboxamide|(4bS,7R,8aR)-4b,5,6,7,8,8a,9,10-octahydro-7-hydroxy-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(trifluoromethyl)-2-phenanthrenecarboxamide hydrochloride (1:1)|PF-00251802|UNII-OPM23UN90U|Fagrocorat|Dagrocorat [USAN:INN]|2-Phenanthrenecarboxamide, 4b,5,6,7,8,8a,9,10-octahydro-7-hydroxy-N-(2-methyl-3-pyridinyl)-4b-(phenylmethyl)-7-(trifluoromethyl)-, (4bS,7R,8aR)-|PF 0251802|DAGROCORAT [INN]|Dagrocorat (USAN/INN)|DAGROCORAT [USAN]|DAGROCORAT [WHO-DD]|GTPL9650|orb1707401|SCHEMBL1707468|CHEMBL3137304|SCHEMBL29364071|US8901310, Example 1|C29H29F3N2O2|BDBM140009|AKOS040741593|DB14676|DA-52294|HY-16718|MS-29183|CS-0012318|D10617|G14566|Q27285777|(4bS,7R,8aR)-4b-benzyl-7-hydroxy-N-(2-methyl-3-pyridyl)-7-(trifluoromethyl)-5,6,8,8a,9,10-hexahydrophenanthrene-2-carboxamide"
XL-281,56931136,,"InChI=1S/C24H19ClN4O4/c1-13-7-9-15(25)12-20(13)29-21(30)16-5-3-4-6-17(16)24(29,32)14-8-10-18-19(11-14)27-22(26-18)28-23(31)33-2/h3-12,32H,1-2H3,(H2,26,27,28,31)",MMNNTJYFHUDSKL-UHFFFAOYSA-N,C24H19ClN4O4,462.9,methyl N-[6-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1H-benzimidazol-2-yl]carbamate,"BMS-908662|870603-16-0|BMS-908662 free base|DW2NWI3TFN|BMS 908662|Methyl (5-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)-1H-benzimidazol-2-yl)carbamate|Carbamic acid, (5-(2-(5-chloro-2-methylphenyl)-2,3-dihydro-1-hydro|BMS908662|Carbamic acid, N-(6-(2-(5-chloro-2-methylphenyl)-2,3-dihydro-1-hydroxy-3-oxo-1H-isoindol-1-yl)-1H-benzimidazol-2-yl)-, methyl ester|methyl N-[6-[2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxoisoindol-1-yl]-1H-benzimidazol-2-yl]carbamate|methyl N-(6-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxoisoindol-1-yl)-1H-benzimidazol-2-yl)carbamate|RefChem:902362|methyl N-(5-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)-1H-1,3-benzodiazol-2-yl)carbamate|XL-281|XL281|XL 281|EXEL-2819|(+/-)-Methyl (5-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)-1H-benzimidazol-2-yl)carbamate|Methyl (5-(2-(5-chloro-2-methylphenyl)-1-hydroxy-3-oxo-2,3-dihydro-1H-isoindol-1-yl)-1H-benzimidazol-2-yl)carbamate, (+/-)-|1029873-02-6|UNII-DW2NWI3TFN|XL-281 (BMS908662)|GTPL7968|orb1980190|CHEMBL3545027|SCHEMBL10049428|SCHEMBL20299316|SCHEMBL29354890|XL 281 [WHO-DD]|GLXC-10034|EX-A8079|BDBM50457451|DB12854|HY-19343|CS-0015416|H35762|Q27075375|(5-(2-(5-CHLORO-2-METHYLPHENYL)-1-HYDROXY-3-OXOISOINDOLIN-1-YL)-1H-BENZO[D]IMIDAZOL-2-YL)CARBAMATE"
GSK-3179106,78427026,,"InChI=1S/C22H21F4N3O4/c1-4-32-16-9-19(30)27-11-14(16)12-5-6-13(15(23)7-12)8-20(31)28-18-10-17(33-29-18)21(2,3)22(24,25)26/h5-7,9-11H,4,8H2,1-3H3,(H,27,30)(H,28,29,31)",IDXKJSSOUXWLDB-UHFFFAOYSA-N,C22H21F4N3O4,467.4,"2-[4-(4-ethoxy-6-oxo-1H-pyridin-3-yl)-2-fluorophenyl]-N-[5-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-3-yl]acetamide","GSK3179106|DY8BBK4G3C|GSK-3179106|UNII-DY8BBK4G3C|4-(4-Ethoxy-1,6-dihydro-6-oxo-3-pyridinyl)-2-fluoro-N-(5-(2,2,2-trifluoro-1,1-dimethylethyl)-3-isoxazolyl)benzeneacetamide|Benzeneacetamide, 4-(4-ethoxy-1,6-dihydro-6-oxo-3-pyridinyl)-2-fluoro-N-(5-(2,2,2-trifluoro-1,1-dimethylethyl)-3-isoxazolyl)-|RefChem:144521|1627856-64-7|2-(4-(4-ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl)-N-(5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl)acetamide|RET Kinase inhibitor 1|2-[4-(4-ethoxy-6-oxo-1H-pyridin-3-yl)-2-fluorophenyl]-N-[5-(1,1,1-trifluoro-2-methylpropan-2-yl)-1,2-oxazol-3-yl]acetamide|2-[4-(4-Ethoxy-6-oxo-1,6-dihydropyridin-3-yl)-2-fluorophenyl]-N-[5-(1,1,1-trifluoro-2-methylpropan-2-yl)isoxazol-3-yl]acetamide|RET Kinase inhibitor 1?|orb1301746|CHEMBL3355009|SCHEMBL16055027|SCHEMBL31060944|C22H21F4N3O4|GLXC-20190|BCP23560|CQC85664|EX-A3001|s8821|ZB1508|AKOS037648939|CS-7799|GSK3179106?|AC-36286|BS-16078|DA-73916|HY-100459|C92221|1884420-19-2|2-[4-(4-ethoxy-6-oxo-1H-pyridin-3-yl)-2-fluoro-phenyl]-N-[5-(2,2,2-trifluoro-1,1-dimethyl-ethyl)isoxazol-3-yl]acetamide"
TOLUDESVENLAFAXINE,15983287,,"InChI=1S/C24H31NO3/c1-18-7-9-20(10-8-18)23(26)28-21-13-11-19(12-14-21)22(17-25(2)3)24(27)15-5-4-6-16-24/h7-14,22,27H,4-6,15-17H2,1-3H3",QKYBZJLEMOZFFU-UHFFFAOYSA-N,C24H31NO3,381.5,[4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenyl] 4-methylbenzoate,"4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenyl 4-methylbenzoate|RefChem:190309|Ansofaxine|Toludesvenlafaxine|916918-80-4|ODVP2|LY-03005|LY03005|Toludesvenlafaxine [USAN]|A7CGH459FN|4-Methylbenzoate of desvenlafaxine|UNII-A7CGH459FN|LPM570065 FREE BASE|LPM-570065 FREE BASE|[4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenyl] 4-methylbenzoate|Odesmethylvenlafaxine 4-methylbenzoate ester|Benzoic acid, 4-methyl-, 4-(2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl)phenyl ester|Ruoxinlin|Toludesvenlafaxina|Ansofaxine free base|Toludesvenlafaxine [WHO-DD]|SCHEMBL902362|orb1690148|Toludesvenlafaxine (USAN/INN)|TOLUDESVENLAFAXINE [INN]|CHEMBL4227736|GTPL12766|GLXC-27499|HY-U00096A|EX-A8430|BDBM50459922|WHO 10991|AKOS040758455|DB15052|compound 71 [PMID: 28731336]|DA-50489|CS-0116334|D11940|G15725"
AMODIAQUINE,2165,,"InChI=1S/C20H22ClN3O/c1-3-24(4-2)13-14-11-16(6-8-20(14)25)23-18-9-10-22-19-12-15(21)5-7-17(18)19/h5-12,25H,3-4,13H2,1-2H3,(H,22,23)",OVCDSSHSILBFBN-UHFFFAOYSA-N,C20H22ClN3O,355.9,4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol,"amodiaquine|86-42-0|Amodiaquin|Flavoquine|Camoquin|Camochin|Camoquinal|Miaquin|Amodiaquinum|Amodiaquina|Amodiachinum|Sunoquine|Amodiachin|4-((7-Chloroquinolin-4-yl)amino)-2-((diethylamino)methyl)phenol|Phenol, 4-[(7-chloro-4-quinolinyl)amino]-2-[(diethylamino)methyl]-|4-[(7-CHLOROQUINOLIN-4-YL)AMINO]-2-[(DIETHYLAMINO)METHYL]PHENOL|CHEBI:2674|NSC-13453|7-Chloro-4-(3-diethylaminomethyl-4-hydroxyanilino)quinoline|7-Chloro-4-(3-diethylaminomethyl-4-hydroxyphenylamino)quinoline|4-[(7-chloroquinolin-4-yl)amino]-2-(diethylaminomethyl)phenol|Phenol, 4-((7-chloro-4-quinolinyl)amino)-2-((diethylamino)methyl)-|220236ED28|DTXSID2022597|4-((7-chloroquinolin-4-yl)amino)-2-(diethylaminomethyl)phenol|RefChem:388794|Hydrochloride, Amodiaquine|DTXCID702597|P01BA06|201-669-3|Camoquine|Amodiaquine, ring-closed|Cam-AQ1|CAM-AQI|SN 10,751|S. N. 10751|NSC 13453|4-[(7-Chloro-4-quinolinyl)amino]-2-[(diethylamino)methyl]phenol|CHEMBL682|4-((7-Chloro-4-quinolinyl)amino)-2-((diethylamino)methyl)phenol|GNF-Pf-5648|4-((7-Chloro-4-quinolyl)amino)-alpha-(diethylamino)-o-cresol|NSC13453|Amodiaquin (dihydrochloride dihydrate)|4-[(7-chloro-4-quinolyl)amino]-2-(diethylaminomethyl)phenol|Amodiaquinum [INN-Latin]|CQA|Amodiaquina [INN-Spanish]|Amodiaquine USP24|4-[(7-chloro-4-quinolyl)amino]-alpha-(diethylamino)-o-cresol|BDBM50041457|EINECS 201-669-3|BRN 0300962|Alphaquine|Amdaquine|Amoquin|Amodiaquine [USP:INN:BAN]|CCRIS 8486|o-Cresol, 4-((7-chloro-4-quinolyl)amino)-.alpha.-(diethylamino)-|o-Cresol, 4-[(7-chloro-4-quinolyl)amino]-.alpha.-(diethylamino)-|Quinoline, 7-chloro-4-((3-((diethylamino)methyl)-4-hydroxyphenyl)amino)-|Quinoline, 7-chloro-4-[[3-[(diethylamino)methyl]-4-hydroxyphenyl]amino]-|HSDB 7457|2aou|UNII-220236ED28|AMODIAQUIN [MI]|WR-002977|Amodiaquine (USP/INN)|Prestwick0_000309|Prestwick1_000309|Prestwick2_000309|Prestwick3_000309|AMODIAQUINE [INN]|AMODIAQUINE [HSDB]|Epitope ID:131784|AMODIAQUINE [VANDF]|AMODIAQUINE [MART.]|Oprea1_019229|SCHEMBL44152|AMODIAQUINE [WHO-DD]|AMODIAQUINE [WHO-IP]|BSPBio_000278|5-22-10-00283 (Beilstein Handbook Reference)|MLS001304065|AMODIAQUINE; FLAVOQUINE|SPBio_002497|USRE49340, Rank 6|BPBio1_000306|orb1298982|SCHEMBL29425350|SCHEMBL29441086|GTPL10018|HY-B1322A|AMODIAQUINE [USP IMPURITY]|BDBM586429|HMS2236K03|HMS3372M02|HMS5085P19|AMODIAQUINE [USP MONOGRAPH]|AMODIAQUINUM [WHO-IP LATIN]|o-Cresol, 4-((7-chloro-4-quinolyl)amino)-alpha-(diethylamino)-|s5948|AKOS000538864|CCG-103317|DB00613|FC17879|NCGC00017063-04|NCGC00017063-07|NCGC00017063-13|NCGC00244901-01|NCGC00244901-04|AC-13295|SMR000718769|ST095174|DB-056928|CS-0013340|NS00004024|SJ000110703|VU0472676-1|C07626|D02922|EN300-708791|G12606|552A927|AH-034/11364141|AH-034/33492024|Q239569|BRD-K91290917-300-01-8|BRD-K91290917-336-05-3|2-[(diethylamino)methyl]-4-[(7-chloro(4-quinolyl))amino]phenol|4-((7-Chloro-4-quinolyl)amino)-.alpha.-(diethylamino)-o-cresol|4-[(7-Chloro-4-quinolinyl)amino]-.alpha.-(diethylamino)-o-cresol|4-[(7-Chloro-4-quinolyl)amino]-a-(diethylamino)-o-cresol;Camochin|1021496-19-4"
DANICOPAN,118323590,,"InChI=1S/C26H23BrFN7O3/c1-14(36)25-19-8-16(17-10-29-15(2)30-11-17)6-7-20(19)35(33-25)13-24(37)34-12-18(28)9-21(34)26(38)32-23-5-3-4-22(27)31-23/h3-8,10-11,18,21H,9,12-13H2,1-2H3,(H,31,32,38)/t18-,21+/m1/s1",PIBARDGJJAGJAJ-NQIIRXRSSA-N,C26H23BrFN7O3,580.4,"(2S,4R)-1-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide","Danicopan|1903768-17-1|ACH-4471|VOYDEYA|(2S,4R)-1-(2-(3-Acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide|ACH-0144471|JM8C1SFX0U|ACH4471|danicopanum|RefChem:585165|Factor D Inhibitor ACH-4471|ACH 4471|(2S,4R)-1-((3-Acetyl-5-(2-methylpyrimidin-5-yl)-1H-indazol-1-yl)acetyl)-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide|Danicopan free base|Danicopan [USAN]|MFCD32669786|(2S,4R)-1-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-N-(6-bromopyridin-2-yl)-4-fluoropyrrolidine-2-carboxamide|C26H23BrFN7O3|Voydeya (TN)|DANICOPAN [INN]|DANICOPAN [JAN]|UNII-JM8C1SFX0U|ACH-4471; Danicopan|DANICOPAN [WHO-DD]|Danicopan (ACH-4471)|Danicopan (JAN/USAN/INN)|orb1298871|CHEMBL4250860|SCHEMBL17024981|SCHEMBL29403941|SCHEMBL29544979|GTPL11988|CHEBI:231416|BDBM354268|EX-A3068|WHO 10610|AKOS040759432|DB15401|US9796741, cmp No. 165|AC-36375|MS-30411|HY-117930|CS-0068562|D11641|D81423|(2S,4R)-1-(2-(3-acetyl- 5-(2-methylpyrimidin- 5-yl)-1H-indazol-1- yl)acetyl)-N-(6- bromopyridin-2-yl)-4- fluoropyrrolidine-2- carboxamide|(2S,4R)-1-[2-[3-acetyl-5-(2-methylpyrimidin-5-yl)indazol-1-yl]acetyl]-N-(6-bromo-2-pyridyl)-4-fluoro-pyrrolidine-2-carboxamide"
STEARIC ACID,5281,,"InChI=1S/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20)",QIQXTHQIDYTFRH-UHFFFAOYSA-N,C18H36O2,284.5,octadecanoic acid,"stearic acid|Octadecanoic acid|57-11-4|n-Octadecanoic acid|Stearophanic acid|Cetylacetic acid|1-Heptadecanecarboxylic acid|Pearl stearic|Stearex Beads|Octadecansaeure|Stearinsaeure|Vanicol|Hydrofol Acid 150|Industrene R|Century 1240|Glycon DP|Glycon TP|Humko Industrene R|Formula 300|Hydrofol 1895|Hystrene 7018|Hystrene 9718|Glycon S-80|Glycon S-90|octadecoic acid|Tegostearic 254|Tegostearic 255|Tegostearic 272|Hystrene 80|Hydrofol acid 1655|Hydrofol acid 1855|Industrene 5016|Dar-chem 14|Emersol 120|Emersol 132|Hystrene 4516|Hystrene 5016|Groco 54|Groco 55|Groco 55L|Groco 58|Groco 59|Glycon S-70|Industrene 8718|Industrene 9018|Emersol 150|Kam 1000|Barolub FTA|FEMA No. 3035|Acidum stearinicul|C18:0|HY-Phi 1199|HY-Phi 1205|HY-Phi 1303|HY-Phi 1401|Kam 2000|Kam 3000|Century 1210|Stearic acid 50|Stearic acid, pure|PD 185|NAA 173|Emersol 153NF|Dervacid 3155|Purified stearic acid|Adeka sa 300|Edenor htict-n|Stearic acid 70|4ELV7Z65AP|NSC-25956|Sterene 60b|Sterene 60r|Pristerene 4910|Pristerene 4916|Pristerene 4981|Pristerine 4989|Sterene 460|DTXSID8021642|CHEBI:28842|Hyfac 410|Hyfac 420|Hyfac 421|Hyfac 422|Prifac 5905|NSC-261168|DTXCID301642|200-313-4|Batana|tooth powder|Himalayan Scrub|Papaya Enzyme|Body Scrub|Body Sprays|Doctor Plus|Body Gel|Obeo Baby Bubble|Jinhwagwangsu Hair|hydron;octadecanoate|Avocado Candy Scrub|Jinhwagwangsu Bubble|fatty acid 18:0|Turmeric Scrub Cream|RefChem:6691|Vaseline Moisturizing Cream|Hair Removal Cream For Men|Turmeric Mud Film Vitamin C|Intimate After Shave For Women|CELLBN FIRST CARE CLEANSER|ZENOL POWERFULX RECOVERYCREAM|680-589-4|Stearate|Hystrene S-97|Hystrene T-70|Steric acid|Caswell No. 801D|Oktadekansaeure|acide stearique|acide octadecanoique|Hydrofol Acid 150 (VAN)|MFCD00002752|CCRIS 2305|Prifac 2918|HSDB 2000|Vis-Plus|NSC 25956|EPA Pesticide Chemical Code 079082|Stearic Acid Cherry|Edenor C18|Stearic acid (TN)|CH3-[CH2]16-COOH|Loxiol G 20|Century 1220|Century 1230|Emersol 6349|AI3-00909|Lunac S 20|Lunac S 40|Hydrofol Acid 1895|CHEMBL46403|NSC25956|FA 18:0|NCGC00091596-02|Stearicacid|Lunac|CAS-57-11-4|Isostearic acid EX|Haimaric MKH(R)|STE|Prisorine 3501|Prisorine 3502|Prisorine 3508|Emersol 871|Emersol 875|Emery 875D|Emery 871|Unimac 5680|C-Lube 10|EINECS 200-313-4|Stearic acid [JAN:NF]|UNII-4ELV7Z65AP|BRN 0608585|Stearophanate|Promulsin|Stearex|Tsubaki|n-Octadecanoate|tearic acid|Bassinic acid|Lactaric acid|Talgic acid|Stearic acid?|1hmr|1hmt|4fnn|Kiri stearic acid|Lunac YA|n-Octadecylic acid|Palmitostearic acid|Stearic acid, CP|EINECS 250-178-0|F 3 (lubricant)|Industrene 4518|Nonsoul SK 1|Pristerene 4900|Pristerene 4904|Pristerene 4963|Pristerene 9429|Pristerene 9559|Hystrene S 97|Hystrene T 70|Edenor ST 1|Sunfat 18S|Emersol 153|Selosol 920|Industrene 5016K|Hystrene 9718NF|Kortacid 1895|Radiacid 0427|Edenor ST 20|Lunac 30|Serfax MT 90|Stearic acid_ravikumar|Unister NAA 180|Century 1224|Edenor HT-JG 60|Lunac S 90KC|Stearic acid (8CI)|Stearic acid, puriss.|Hystrene 7018 FG|Hystrene 9718NFFG|Lunac S 30|Lunac S 50|Lunac S 90|Lunac S 98|3v2p|875D|1-Heptadecanecarboxylate|Industrene 7018 FG|AFCO-Chem B 65|Heptadecanecarboxylic acid|Edenor C 18/98|Octadecanoic acid (9CI)|Stearic acid, >=98%|SCHEMBL659|Hystrene 9718 NF FG|bmse000485|STEARIC ACID [II]|STEARIC ACID [MI]|EC 200-313-4|Emery 400 (Salt/Mix)|STEARIC ACID [DSC]|STEARIC ACID [JAN]|Stearic acid (JP15/NF)|Stearic acid (JP18/NF)|Emersol 110 (Salt/Mix)|STEARIC ACID [FHFI]|STEARIC ACID [HSDB]|SCHEMBL56011|Stearic acid (reagent grade)|STEARIC ACID [VANDF]|4-02-00-01206 (Beilstein Handbook Reference)|WLN: QV17|SCHEMBL249583|STEARIC ACID [MART.]|STEARIC ACID [USP-RS]|STEARIC ACID [WHO-DD]|17FA|GTPL3377|orb1304721|SCHEMBL3125045|SCHEMBL6047730|WO 2|SCHEMBL10611257|UNII-X33R8U0062|MSK1716|Nonsoul SN 1 (*Sodium salt*)|SNA-2000 (*Sodium salt*)|Stearic acid, analytical standard|VLZ 200|HMS5085M19|PURIFIED STEARIC ACID [NF]|Stearic acid, reagent grade, 95%|HY-B2219|STEARIC ACID [EP MONOGRAPH]|Tox21_111154|Tox21_201887|Tox21_300562|BBL012224|BDBM50240485|LMFA01010018|s5733|SA 200|SBB060276|Stearic acid, >=95%, FCC, FG|STL163565|AKOS005716958|Tox21_111154_1|CCG-267314|DB03193|FA 1655|FS14761|NSC 261168|X33R8U0062|NCGC00091596-01|NCGC00091596-03|NCGC00091596-04|NCGC00091596-05|NCGC00091596-07|NCGC00254456-01|NCGC00259436-01|BP-14047|E570|MSK1716-1000|ST023799|VS-03242|Stearic acid, puriss., >=98.5% (GC)|Stearic acid, SAJ first grade, >=90.0%|CS-0021598|G 270|NS00010335|S 300|S0163|EN300-19730|Stearic acid, SAJ special grade, >=95.0%|Stearic acid, Vetec(TM) reagent grade, 94%|400JB9103-88|A 1760|C01530|D00119|EC 250-178-0|F70008|SBI-0633521.0002|Stearic acid 50, tested according to Ph.Eur.|F237888|Octadecanoic acid Solution in Hexane, 1000?g/mL|Q209685|SR-01000944717|Melting Point Standard 69-71C, analytical standard|SR-01000944717-1|Stearic acid, Grade I, >=98.5% (capillary GC)|Stearic acid, SAJ first grade, >=90.0%, powder|F0001-1489|STEARIC ACID (CONSTITUENT OF SAW PALMETTO) [DSC]|Stearic acid, certified reference material, TraceCERT(R)|Z104474964|CD7993EA-AD14-452A-A907-33376CC98790|Stearic acid, European Pharmacopoeia (EP) Reference Standard|Stearic acid, United States Pharmacopeia (USP) Reference Standard|Stearic Acid, Pharmaceutical Secondary Standard; Certified Reference Material|18639-67-3|InChI=1/C18H36O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h2-17H2,1H3,(H,19,20"
DAPIVIRINE,214347,,"InChI=1S/C20H19N5/c1-13-10-14(2)19(15(3)11-13)24-18-8-9-22-20(25-18)23-17-6-4-16(12-21)5-7-17/h4-11H,1-3H3,(H2,22,23,24,25)",ILAYIAGXTHKHNT-UHFFFAOYSA-N,C20H19N5,329.4,"4-[[4-(2,4,6-trimethylanilino)pyrimidin-2-yl]amino]benzonitrile","Dapivirine|244767-67-7|TMC-120|TMC120|dapivirinum|TMC 120|R 147681|R-147681|Dapivirina|TCN4MG2VXS|Gel-02|AIDS-105293|4-({4-[(2,4,6-trimethylphenyl)amino]pyrimidin-2-yl}amino)benzonitrile|DTXSID40179244|4-((4-((2,4,6-Trimethylphenyl)amino)pyrimidin-2-yl)amino)benzonitrile|RefChem:585186|CHEBI:46180|DTXCID70101735|G01AX17|4-((4-((2,4,6-trimethylphenyl)amino)-2-pyrimidinyl)amino) benzonitrile|Dapivirine (TMC120)|Benzonitrile, 4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]-|Dapivirine,tmc-120|4-[[4-(2,4,6-trimethylanilino)pyrimidin-2-yl]amino]benzonitrile|MFCD09833899|TMC120-R147681|4-((4-(mesitylamino)pyrimidin-2-yl)amino)benzonitrile|R147681|4-[[4-[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile|4-[4-(2,4,6-TRIMETHYL-PHENYLAMINO)-PYRIMIDIN-2-YLAMINO]-BENZONITRILE|TMC120;R147681|Dapivirine [INN]|UNII-TCN4MG2VXS|Dapivirine [USAN:INN]|4-[[4-(Mesitylamino)pyrimidin-2-yl]amino]benzonitrile|Dapivirine?|GEL-002|Dapivirine(TMC120)|TMC-120/R-147681|Ring-004|Dapivirine (USAN/INN)|DAPIVIRINE [USAN]|4-({4-[(2,4,6-Trimethylphenyl)amino]pyrimidin-2-yl}amino)benzenecarbonitrile|Dapivirine intravaginal ring|DAPIVIRINE [WHO-DD]|CHEMBL70663|SCHEMBL383370|orb1307391|SCHEMBL29360285|EX-A115|ILAYIAGXTHKHNT-UHFFFAOYSA-N|GLXC-04864|HMS3651J10|BCP06491|BDBM50467334|s2914|AKOS016513117|CCG-267802|DB08639|DT-0051|FD20796|SB16698|NCGC00371120-06|AC-30627|DA-52310|HY-14266|SY105506|NS00068137|SW220193-1|D11246|F468331|4-(4-(mesitylamino)pyrimidin-2-ylamino)benzonitrile|BRD-K12885236-001-02-7|Q27097831|4-[[4-[(2,4,6-trimethylphenyl)-amino]-2-pyrimidinyl]amino]benzonitrile|4-[[4-[(2,4,6trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile|4-[[4[(2,4,6-trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile|4-[[4-[(2,4,6-Trimethylphenyl)amino]-2-pyrimidinyl]amino]benzonitrile;R 147681;TMC 120"
CERALASERTIB,121596701,,"InChI=1S/C20H24N6O2S/c1-13-12-28-8-7-26(13)18-9-17(20(4-5-20)29(2,21)27)24-19(25-18)15-10-22-11-16-14(15)3-6-23-16/h3,6,9-11,13,21,23H,4-5,7-8,12H2,1-2H3/t13-,29-/m1/s1",DTTJKLNXNZAVSM-JYCIKRDWSA-N,C20H24N6O2S,412.5,"imino-methyl-[1-[6-[(3R)-3-methylmorpholin-4-yl]-2-(1H-pyrrolo[2,3-c]pyridin-4-yl)pyrimidin-4-yl]cyclopropyl]-oxo-lambda6-sulfane","Atr kinase inhibitor AZD6738|85RE35306Z|1H-Pyrrolo(2,3-b)pyridine, 4-(4-(1-((S(R))-S-methylsulfonimidoyl)cyclopropyl)-6-((3R)-3-methyl-4-morpholinyl)-2-pyrimidinyl)-|4-(4-(1-((S(R))-S-Methylsulfonimidoyl)cyclopropyl)-6-((3R)-3-methyl-4-morpholinyl)-2-pyrimidinyl)-1H-pyrrolo(2,3-b)pyridine|ceralasertibum|4-[4-[1-[[S(R)]-S-methylsulfonimidoyl]cyclopropyl]-6-[(3R)-3-methyl-4-morpholinyl]-2-pyrimidinyl]-1H-pyrrolo[2,3-b]pyridine|RefChem:124439|(R)-imino(methyl)(1-(6-((3R)-3-methylmorpholin-4-yl)-2-(1H-pyrrolo(2,3-c)pyridin-4-yl)pyrimidin-4-yl)cyclopropyl)-lambda6-sulfanone|1352226-88-0|Azd-6738|AZD6738|Ceralasertib|Ceralasertib [USAN]|UNII-85RE35306Z|WHO 10842|CERALASERTIB [INN]|CERALASERTIB [WHO-DD]|SCHEMBL31602131|DB14917|Q27896182"
ELCUBRAGISTAT,71657619,,"InChI=1S/C20H22F9N3O2/c21-18(22,23)14-4-3-13(15(11-14)31-5-1-2-6-31)12-30-7-9-32(10-8-30)17(33)34-16(19(24,25)26)20(27,28)29/h3-4,11,16H,1-2,5-10,12H2",SQZJGTOZFRNWCX-UHFFFAOYSA-N,C20H22F9N3O2,507.4,"1,1,1,3,3,3-hexafluoropropan-2-yl 4-[[2-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate","ABX-1431|1446817-84-0|ELCUBRAGISTAT|ABX1431|FB39E94UXK|1,1,1,3,3,3-hexafluoropropan-2-yl 4-[[2-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate|1-Piperazinecarboxylic acid, 4-((2-(1-pyrrolidinyl)-4-(trifluoromethyl)phenyl)methyl)-2,2,2-trifluoro-1-(trifluoromethyl)ethyl ester|1,1,1,3,3,3-hexafluoropropan-2-yl 4-((2-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl)methyl)piperazine-1-carboxylate|RefChem:108585|MGLL Inhibitor ABX-1431|Serine Hydrolase Monoacylglycerol Lipase Inhibitor ABX-1431|1-Piperazinecarboxylic acid, 4-((2-(1-pyrrolidinyl)-4-(trifluoromethyl)phenyl)methyl)-, 2,2,2-trifluoro-1-(trifluoromethyl)ethyl ester|1,1,1,3,3,3-hexafluoropropan-2-yl 4-(2-(pyrrolidin-1-yl)-4-(trifluoromethyl)benzyl)piperazine-1-carboxylate|1,1,1,3,3,3-Hexafluoropropan-2-yl-4-[[2-(pyrrolidin-1-yl)-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate|ABX 1431|UNII-FB39E94UXK|ELCUBRAGISTAT [INN]|orb1301861|CHEMBL3945728|SCHEMBL15100632|GTPL10062|C20H22F9N3O2|SQZJGTOZFRNWCX-UHFFFAOYSA-N|BDBM180052|GLXC-20011|US9133148, 9aq|BCP29967|EX-A2760|ABX1431;ABX 1431|ABX-1431?|MFCD31735112|s8823|AKOS037515667|compound 28 [PMID: 30067909]|compound 9aq [WO2013103973A1]|AC-35611|BA167497|BS-15747|DA-70463|example 82 [WO2013103973A1]|SY380946|HY-117632|CS-0066666|D80627|Z3692177058|[2,2,2-Trifluoro-1-(trifluoromethyl)ethyl] 4-[[2-pyrrolidin-1-yl-4-(trifluoromethyl)phenyl]methyl]piperazine-1-carboxylate|1,1,1,3,3,3-Hexafluoro-2-propyl 4-[2-(1-Pyrrolidinyl)-4-(trifluoromethyl)benzyl]piperazine-1-carboxylate"
VORASIDENIB,117817422,,"InChI=1S/C14H13ClF6N6/c1-6(13(16,17)18)22-11-25-10(8-4-3-5-9(15)24-8)26-12(27-11)23-7(2)14(19,20)21/h3-7H,1-2H3,(H2,22,23,25,26,27)/t6-,7-/m1/s1",QCZAWDGAVJMPTA-RNFRBKRXSA-N,C14H13ClF6N6,414.74,"6-(6-chloropyridin-2-yl)-2-N,4-N-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine","Vorasidenib|1644545-52-7|AG-881|AG881|Voranigo|789Q85GA8P|6-(6-chloropyridin-2-yl)-2-N,4-N-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine|AG 881|1,3,5-Triazine-2,4-diamine, 6-(6-chloro-2-pyridinyl)-N2,N4-bis((1R)-2,2,2-trifluoro-1-methylethyl)-|1,3,5-Triazine-2,4-diamine, 6-(6-chloro-2-pyridinyl)-N2,N4-bis[(1R)-2,2,2-trifluoro-1-methylethyl]-|vorasidenibum|6-(6-chloropyridin-2-yl)-2-N,4-N-bis((2R)-1,1,1-trifluoropropan-2-yl)-1,3,5-triazine-2,4-diamine|RefChem:902054|Vorasidenib (AG-881)|6-(6-chloropyridin-2-yl)-N2,N4-bis((R)-1,1,1-trifluoropropan-2-yl)-1,3,5-triazine-2,4-diamine|Vorasidenib [INN]|Vorasidenib [USAN]|Vorasidenib (AG881)|6-(6-chloropyridin-2-yl)-N2,N4-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine|9UO|AG-881; Vorasidenib|Vorasidenib (USAN/INN)|Vorasidenib [USAN:INN]|VORASIDENIB [WHO-DD]|C14H13ClF6N6|UNII-789Q85GA8P|orb1299935|AG 881 [WHO-DD]|CHEMBL4279047|SCHEMBL16393139|SCHEMBL22396621|SCHEMBL22396622|SCHEMBL22396628|SCHEMBL22396629|SCHEMBL23573057|SCHEMBL23573058|SCHEMBL23573059|SCHEMBL23573061|SCHEMBL23597843|SCHEMBL23597934|SCHEMBL29422965|GTPL10663|BDBM279948|HMS6018K05|EX-A2574|UQC54552|NSC803600|s8611|US10028961, Compound 101|WHO 10525|AKOS037648888|CCG-268824|CS-8033|NSC-803600|AC-36152|BP-44064|BS-15954|DA-59042|HY-104042|C73178|D11834|6-(6-Chloro-2-pyridinyl)-N2,N4-bis[(1R)-2,2,2-trifluoro-1-methylethyl]-1,3,5-triazine-2,4-diamine|6-(6-chloro-2-pyridyl)-N2,N4-bis[(1R)-2,2,2-trifluoro-1-methyl-ethyl]-1,3,5-triazine-2,4-diamine|6-(6-chloropyridin-2-yl)-N~2~,N~4~-bis[(2R)-1,1,1-trifluoropropan-2-yl]-1,3,5-triazine-2,4-diamine|6-(6-chloropyridin-2-yl)-N2,N4-bis((R)-1,1,1-trifluoro propan-2-yl)-1,3,5-triazine-2,4-diamine"
DOXAPRAM,3156,,"InChI=1S/C24H30N2O2/c1-2-26-19-22(13-14-25-15-17-28-18-16-25)24(23(26)27,20-9-5-3-6-10-20)21-11-7-4-8-12-21/h3-12,22H,2,13-19H2,1H3",XFDJYSQDBULQSI-UHFFFAOYSA-N,C24H30N2O2,378.5,"1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one","doxapram|309-29-5|Doxapramum|Docatone|2-Pyrrolidinone, 1-ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-2-pyrrolidinone|(+-)-doxapram|CHEBI:681848|2-Pyrrolidinone, 1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-|1-ethyl-4-[2-(morpholin-4-yl)ethyl]-3,3-diphenylpyrrolidin-2-one|2-Pyrrolidinone, 1-ethyl-4-(2-(4-morpholinyl)ethyl)-3,3-diphenyl-|94F3830Q73|DTXSID2022963|AHR 619|1-ethyl-4-(2-(morpholin-4-yl)ethyl)-3,3-diphenylpyrrolidin-2-one|Hydrochloride, Doxapram|RefChem:56559|DTXCID002963|R07AB01|206-216-3|Dopram|1-Ethyl-4-(2-morpholinoethyl)-3,3-diphenylpyrrolidin-2-one|C24H30N2O2|1-ethyl-4-(2-morpholin-4-ylethyl)-3,3-diphenylpyrrolidin-2-one|Doxapram (INN)|309-29-5 (free)|DOXAPRAM [INN]|Doxapram [USP:JAN]|1-ethyl-4- (2-morpholin-4-ylethyl)- 3,3-diphenyl-pyrrolidin-2-one|Doxapramum [INN-Latin]|1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone|Docatone (TN)|HSDB 3318|Doxapram [INN:BAN]|NCGC00167459-01|EINECS 206-216-3|BRN 0628691|Doxapram?|1-ETHYL-4-(2-(4-MORPHOLINYL)ETHYL)-3,3-DIPHENYL-2-PYRROLIDINONE|UNII-94F3830Q73|MFCD00242721|(+/-)-doxapram|DOXAPRAM [HSDB]|DOXAPRAM [JAN]|DOXAPRAM [MI]|DOXAPRAM [VANDF]|DOXAPRAM [WHO-DD]|CHEMBL1754|Oprea1_016788|SCHEMBL644504|GTPL7169|orb1704832|Doxapram [USP:INN:BAN:JAN]|MSK1985|1-ethyl-4-(2-morpholinoethyl)-3,3-diphenyl-pyrrolidin-2-one|HMS3886I17|HMS5084D21|BCP04484|HY-B0551|BDBM50505297|s5257|STK634791|AKOS005266711|BCP9000625|CCG-268390|DB00561|SB18932|AC-12510|AC-30628|AS-76170|DA-72893|BCP0726000068|NS00001120|C15540|D07873|EN300-123060|AB00698528-03|AB00698528_07|Q737743|BRD-A46179541-003-01-5|BRD-A46179541-311-02-0|BRD-A46179541-311-03-8|1-Ethyl-4-(2-morpholin-4-yl-ethyl)-3,3-diphenyl-pyrrolidin-2-one|(+/-)-1-ETHYL-4-(2-MORPHOLINOETHYL)-3,3-DIPHENYL-2-PYRROLIDINONE|1-Ethyl-4-[2-(4-morpholinyl)ethyl]-3,3-diphenyl-2-pyrrolidinone #|2-PYRROLIDINONE, 1-ETHYL-4-(2-(4-MORPHOLINYL)ETHYL)-3,3-DIPHENYL-, (+/-)-"
CLOBETASOL PROPIONATE,32798,,"InChI=1S/C25H32ClFO5/c1-5-21(31)32-25(20(30)13-26)14(2)10-18-17-7-6-15-11-16(28)8-9-22(15,3)24(17,27)19(29)12-23(18,25)4/h8-9,11,14,17-19,29H,5-7,10,12-13H2,1-4H3/t14-,17-,18-,19-,22-,23-,24-,25-/m0/s1",CBGUOGMQLZIXBE-XGQKBEPLSA-N,C25H32ClFO5,467.0,"[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate","CLOBETASOL PROPIONATE|25122-46-7|Clobetasol 17-propionate|Clobex|Dermovate|Temovate|Embeline|Cormax|Olux|Embeline E|Temovate E|Olux-E|Impoyz|Psorex|CCI 4725|GR 2/925|clobetasol 17-propanoate|Olux E|[(8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate|Clarelux|Dovate|Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11beta,16beta)-|Clobetasol propionate gel|CCI-4725|IMPEKLO|CLOBETASOL PROPIONATE (EMOLLIENT)|DTXSID6045907|CHEBI:31414|NSC-758634|DTXCID4025907|779619577M|GR-2/925|21-chloro-9-fluoro-11beta-hydroxy-16beta-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate|Clobetavix|Clobaderm|Etrivex|Clodan|Dermovate nn|((8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-9-fluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta(a)phenanthren-17-yl) propanoate|RefChem:5696|Clobetasol 17 Propionate|Clobetasol Propionate ANDA|Clobetasol Propionate Cream|Tovet (emollient formulation)|Clobetasol Propionate, Hydrocolloid|Clobetasol Propionate USP, 0.05%|Clobetasol Propionate Cream, 0.05%|Clobetasol Propionate Ointment, 0.05%|Clobetasol Propionate Cream USP, 0.05%|Clobetasol Propionate Emollient Formulation|Clobetasol Propionate Ointment USP, 0.05%|Clobetasol Propionate Cream, 0.05% Clobetasol Propionate Cream, 0.05%|Clobetasol Propionate Cream USP, 0.05% Clobetasol Propionate Cream USP, 0.05%|21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propanoate|C25H32ClFO5|MFCD00058499|Clobetasol-17-propionate|21-Chloro-9-fluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate|MLS000028708|SMR000058745|MLS001076345|Clobesol|Dermoxinale|Butavate|Dermoval|Yugofin|Clobetasolpropionate|CGP 9555|EINECS 246-634-3|NCGC00095078-01|Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11.beta.,16.beta.)-|clobetasol-propionate|CAS-25122-46-7|Clobex (TN)|Cormax (TN)|UNII-779619577M|Clobestasol propionate|Clobetasol propionate [USAN:USP:JAN]|Olux (TN)|Clobetasol propionate E|Opera_ID_1470|SCHEMBL3997|21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)-|cid_32798|GTPL7062|CHEMBL1159650|Clobetasol propionate (Standard)|BDBM39347|MSK2237|CBGUOGMQLZIXBE-XGQKBEPLSA-N|CLOBETASOL PROPIONATE [MI]|HMS2090A04|HMS2230H08|HMS3259A10|HMS3714M04|Clobetasol propionate (JP17/USP)|CLOBETASOL PROPIONATE [JAN]|BCP04125|CLOBETASOL PROPIONATE [USAN]|Tox21_111414|CLOBETASOL PROPIONATE [VANDF]|HY-13600R|s2584|CLOBETASOL PROPIONATE [MART.]|AKOS015951278|CLOBETASOL PROPIONATE [USP-RS]|CLOBETASOL PROPIONATE [WHO-DD]|Tox21_111414_1|BCP9000539|CCG-220781|CLOBETASOL 17-PROPIONATE [MI]|DB01013|FC20489|NC00551|NSC 758634|21-Chloro-9-fluoro-11beta-hydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate|NCGC00023373-03|NCGC00023373-04|AC-17990|AS-12555|Clobetasol propionate, analytical standard|CPD000058745|HY-13600|Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-beta,17-dihydroxy-16-beta-methyl-, 17-propionate|SY060191|BCP0726000094|CLOBETASOL PROPIONATE [ORANGE BOOK]|CLOBETASOL PROPIONATE [USP IMPURITY]|C2612|CLOBETASOL PROPIONATE [USP MONOGRAPH]|NS00000111|D01272|D94623|AB00383081-10|AB00383081_11|EN300-7480850|122C467|Q421637|SR-01000000280|SR-01000000280-4|BRD-K10799896-001-10-6|BRD-K10799896-001-24-7|BRD-K10799896-001-26-2|Clobetasol propionate, European Pharmacopoeia (EP) Reference Standard|Clobetasol propionate, United States Pharmacopeia (USP) Reference Standard|Clobetasol for peak identification, European Pharmacopoeia (EP) Reference Standard|Clobetasol Propionate, Pharmaceutical Secondary Standard; Certified Reference Material|(11?,16?)-21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione|(11b,16b)-21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione|(1R,2S,3aS,3bS,9aS,9bR,10S,11aS)-1-(2-chloroacetyl)-9b-fluoro-10-hydroxy-2,9a,11a-trimethyl-7-oxo-1H,2H,3H,3aH,3bH,4H,5H,7H,9aH,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl propanoate|(8alpha,11beta,14beta,16alpha,17alpha)-21-chloro-9-fluoro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-dien-17-yl propanoate|21-Chloro-9alpha-fluoro-11beta,17alpha-dihydroxy-16beta-methyl-1,4-pregnadiene-3,20-dione 17-Propionate|CGP9555 pound>> CCl 4725 pound>>CGP 9555 pound>> CCl4725 pound>>CGP-9555 pound>> CCl-4725|Pregna-1,4-diene-3,20-dione, 21-chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)-, (11|A,16|A)-|XRD"
OLUTASIDENIB,118955396,,"InChI=1S/C18H15ClN4O2/c1-10(21-16-6-4-13(9-20)23(2)18(16)25)14-8-11-7-12(19)3-5-15(11)22-17(14)24/h3-8,10,21H,1-2H3,(H,22,24)/t10-/m0/s1",NEQYWYXGTJDAKR-JTQLQIEISA-N,C18H15ClN4O2,354.8,5-[[(1S)-1-(6-chloro-2-oxo-1H-quinolin-3-yl)ethyl]amino]-1-methyl-6-oxopyridine-2-carbonitrile,"Olutasidenib|1887014-12-1|FT-2102|Rezlidhia|0T4IMT8S5Z|(S)-5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile|5-[[(1S)-1-(6-chloro-2-oxo-1H-quinolin-3-yl)ethyl]amino]-1-methyl-6-oxopyridine-2-carbonitrile|5-{[(1S)-1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl]amino}-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile|2-Pyridinecarbonitrile, 5-(((1S)-1-(6-chloro-1,2-dihydro-2-oxo-3-quinolinyl)ethyl)amino)-1,6-dihydro-1-methyl-6-oxo-|5-(((1S)-1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile|olutasidenibum|5-(((1S)-1-(6-chloro-2-oxo-1H-quinolin-3-yl)ethyl)amino)-1-methyl-6-oxopyridine-2-carbonitrile|5-[[(1S)-1-(6-Chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl]amino]-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile|5-{[(1S)-1-(6-chloro-2-oxo-1H-quinolin-3-yl)ethyl]amino}-1-methyl-6-oxopyridine-2-carbonitrile|RefChem:57416|IDH1-R132 Inhibitor FT-2102|FT 2102|112-748-6|Olutasidenib [USAN]|Olutasidenib (FT-2102)|FT2102|Rezlidhia (TN)|Olutasidenib (USAN/INN)|OLUTASIDENIB [INN]|UNII-0T4IMT8S5Z|Olutasidenib (FT-2102)?|OLUTASIDENIB [WHO-DD]|orb1307932|CHEMBL4297610|SCHEMBL17603134|SCHEMBL29373022|GTPL10319|NEQYWYXGTJDAKR-JTQLQIEISA-N|HMS6018C12|EX-A4523|ARD193797|BDBM50506474|example 26 [US9834539B2]|NSC818621|s8949|AKOS040742332|NSC-818621|AC-36556|BP-44036|DA-56434|MS-25542|SY248610|HY-114226|CS-0080183|D12483|D87221|(S)-5-[[1-(6-Chloro-2-oxo-1,2-dihydro-3-quinolyl)ethyl]amino]-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile|5-((1-(6-chloro-2-oxo-1,2-dihydroquinolin-3-yl)ethyl)amino)-1-methyl-6-oxo-1,6-dihydropyridine-2-carbonitrile|5-[[(1S)-1-(6-chloro-2-oxo-1H-quinolin-3-yl)ethyl]amino]-1-methyl-6-oxo-pyridine-2-carbonitrile|PWV"
BI 639667,52916803,,"InChI=1S/C22H18FN5O3S/c1-32(30,31)20-10-14(6-9-25-20)22(7-8-22)27-21(29)18-11-24-13-19-17(18)12-26-28(19)16-4-2-15(23)3-5-16/h2-6,9-13H,7-8H2,1H3,(H,27,29)",PXQATVYJKMMHAU-UHFFFAOYSA-N,C22H18FN5O3S,451.5,"1-(4-fluorophenyl)-N-[1-(2-methylsulfonylpyridin-4-yl)cyclopropyl]pyrazolo[3,4-c]pyridine-4-carboxamide","CCR1 antagonist 8|1295298-26-8|BI 639667|BI-9667|CHEMBL4456123|1-(4-fluorophenyl)-N-[1-(2-methylsulfonylpyridin-4-yl)cyclopropyl]pyrazolo[3,4-c]pyridine-4-carboxamide|C22H18FN5O3S|orb1707488|SCHEMBL1670702|BDBM50508172|AKOS040741518|AT12181|DA-71472|MS-28195|BI-639667|HY-120588|CS-0078396|1-(4-fluorophenyl)-N-[1-(2-methylsulfonyl-4-pyridyl)cyclopropyl]pyrazolo[3,4-c]pyridine-4-carboxamide"
SINEFUNGIN,65482,,"InChI=1S/C15H23N7O5/c16-6(1-2-7(17)15(25)26)3-8-10(23)11(24)14(27-8)22-5-21-9-12(18)19-4-20-13(9)22/h4-8,10-11,14,23-24H,1-3,16-17H2,(H,25,26)(H2,18,19,20)/t6-,7-,8+,10+,11+,14+/m0/s1",LMXOHSDXUQEUSF-YECHIGJVSA-N,C15H23N7O5,381.39,"(2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid","sinefungin|58944-73-3|Sinefungina|Sinefungine|Antibiotic A 9145|ADENOSYL-ORNITHINE|Compound 57926|Sinefunginum|Adenosylornithine|A 9145|W2U467CIIL|6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxydecofuranuronic acid|6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-beta-D-ribo-decofuranuronic acid|CHEBI:45453|LILLY 57926|DTXSID10207689|(2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl]hexanoic acid|LY-57926|Decofuranuronic acid, 6,9-diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-|(2S,5S)-2,5-diamino-6-[(2R,3S,R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]hexanoic acid|(5S)-5-amino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]-L-norleucine|(2S,5S)-2,5-diamino-6-((2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxyoxolan-2-yl)hexanoic acid|(2S,5S)-2,5-diamino-6-((2R,3S,R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)hexanoic acid|(5S)-5-amino-6-((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)-L-norleucine|RefChem:886351|DTXCID10130180|637-385-5|(2S,5S)-2,5-diamino-6-((2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl)hexanoic acid|6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-D-glycero-alpha-L-talo-decofuranuronic acid|C15H23N7O5|Antibiotic 32232 RP|Sinefungin [USAN:INN]|Sinefungine [INN-French]|Sinefunginum [INN-Latin]|Sinefungina [INN-Spanish]|SFG|UNII-W2U467CIIL|BRN 3574678|LY 57926|RP 32232|MFCD00057013|1aqj|1qaq|2h2j|SINEFUNGIN [MI]|SINEFUNGIN [INN]|Sinefungin (USAN/INN)|SINEFUNGIN [USAN]|SINEFUNGIN [MART.]|SCHEMBL167609|orb1706631|CHEMBL1214186|GTPL13317|BCP28648|Sinefungin, 95% (HPLC), powder|BDBM50378739|AKOS027327588|CCG-208696|DB01910|NCGC00263619-01|NCGC00263619-03|AS-77750|BS162746|D-glycero-alpha-L-talo-Decofuranuronic acid, 6,9-diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-|Decofuranuronic acid, 6,9-diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-, (beta-D-ribo)-|HY-101938|CS-0022195|NS00018031|D05846|BRD-K91100918-001-01-2|BRD-K91100918-001-03-8|Q27093021|(2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxytetrahydrofuran-2-yl]hexanoic acid (non-preferred name)|(2S,5S)-2,5-diamino-6-[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]hexanoic acid|6,9-DIAMINO-1-(6-AMINO-9H-PURIN-9-YL)-1,5,6,7,8,9-HEXADEOXY-.BETA.-D-RIBO-DECOFURANURONIC ACID|6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-D-glycero-|A-L-talo-decofuranuronic acid|6,9-Diamino-1-(6-amino-9H-purin-9-yl)-1,5,6,7,8,9-hexadeoxy-D-glycero-a-L-talo-decofuranuronic acid|DECOFURANURONIC ACID, 6,9-DIAMINO-1-(6-AMINO-9H-PURIN-9-YL)-1,5,6,7,8,9-HEXADEOXY-, (.BETA.-D-RIBO)-"
REMIBRUTINIB,118107483,,"InChI=1S/C27H27F2N5O3/c1-4-23(35)34(3)9-10-37-25-24(31-14-32-26(25)30)20-12-18(28)13-22(15(20)2)33-27(36)19-8-7-17(11-21(19)29)16-5-6-16/h4,7-8,11-14,16H,1,5-6,9-10H2,2-3H3,(H,33,36)(H2,30,31,32)",CUABMPOJOBCXJI-UHFFFAOYSA-N,C27H27F2N5O3,507.5,N-[3-[6-amino-5-[2-[methyl(prop-2-enoyl)amino]ethoxy]pyrimidin-4-yl]-5-fluoro-2-methylphenyl]-4-cyclopropyl-2-fluorobenzamide,"Remibrutinib|1787294-07-8|LOU064|NVP-LOU064-NXA|LOU064-NXA|I7MVZ8HDNU|N-(3-(6-Amino-5-(2-(N-methylacrylamido)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide|N-[3-[6-amino-5-[2-[methyl(prop-2-enoyl)amino]ethoxy]pyrimidin-4-yl]-5-fluoro-2-methylphenyl]-4-cyclopropyl-2-fluorobenzamide|Benzamide, N-(3-(6-amino-5-(2-(methyl(1-oxo-2-propen-1-yl)amino)ethoxy)-4-pyrimidinyl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluoro-|N-(3-(6-amino-5-(2-(methyl(prop-2-enoyl)amino)ethoxy)pyrimidin-4-yl)-5-fluoro-2-methylphenyl)-4-cyclopropyl-2-fluorobenzamide|RefChem:178828|Remibrutinib (LOU064)|Remibrutinib [INN]|N-[3-[6-Amino-5-[2-[methyl(1-oxo-2-propen-1-yl)amino]ethoxy]-4-pyrimidinyl]-5-fluoro-2-methylphenyl]-4-cyclopropyl-2-fluorobenzamide|Remibrutinib [USAN]|UNII-I7MVZ8HDNU|Remibrutinib [WHO-DD]|Remibrutinib [USAN:INN]|Remibrutinib (LOU064)?|orb1307808|Remibrutinib (JAN/USAN/INN)|CHEMBL4483575|SCHEMBL16754888|SCHEMBL29377382|SCHEMBL29395016|SCHEMBL29564556|GTPL10457|LOU-064|C27H27F2N5O3|GLXC-22285|EX-A3421|MFCD32215329|s9660|WHO 11062|AKOS040742536|example 6 [WO2015079417A1]|compound 25 [PMID: 32083858]|AC-36985|DA-57383|MS-29425|HY-128757|CS-0103905|D12285|F88711|US9512084, 6|N-[3-[6-amino-5-[2-[methyl(prop-2-enoyl)amino]ethoxy]pyrimidin-4-yl]-5-fluoro-2-methyl-phenyl]-4-cyclopropyl-2-fluoro-benzamide"
AMINACRINE,7019,,"InChI=1S/C13H10N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1-8H,(H2,14,15)",XJGFWWJLMVZSIG-UHFFFAOYSA-N,C13H10N2,194.23,acridin-9-amine,"9-AMINOACRIDINE|90-45-9|Acridin-9-amine|Aminacrine|9-Acridinamine|Aminoacridine|Aminacrin|Izoacridina|Aminoacridina|10-Amino-5-azaanthracene|Acridine, 9-amino-|Aminoacridinum|NSC-13000|78OY3Z0P7Z|CHEBI:74789|DTXSID2024456|NSC13000|NSC28747|Aminoacrine|9 Aminoacridine|RefChem:111988|DTXCID104456|D08AA02|201-995-6|5-Aminoacridine|Acridinamine|Monacrin|9-Aminoakridin|9-Acridinylamine|MFCD00037839|9AA|NSC 13000|Acridin-9-ylamine|9-AA|NSC 7571|acridine-9-ylamine|9-Aminoacridin|9-amino acridine|WLN: T C666 BNJ IZ|Aminopt|Mykocert|9-Aminoakridin [Czech]|MLS000780068|Aminoacridine [INN:BAN]|8AD|CCRIS 748|65944-23-2|SMR000420251|EINECS 201-995-6|BRN 0141171|iminoacridan|UNII-78OY3Z0P7Z|Aminoacrid|AI3-51012|110166-26-2|9-Amino-acridin|4bds|9-Amino-acridine|acridin-9-yl-amine|Quench (Salt/Mix)|Mycosert (Salt/Mix)|Spectrum_001108|AMINACRINE [MI]|SpecPlus_000861|9-Aminoacridine, 97%|Spectrum2_001112|Spectrum3_000617|Spectrum4_000580|Spectrum5_001498|9-Aminoacridine free base|AMINACRINE [VANDF]|AMINOACRIDINE [INN]|9-Aminoacridine (Standard)|Acramine Yellow (Salt/Mix)|SCHEMBL14999|BSPBio_002154|KBioGR_001020|KBioSS_001588|BIDD:GT0816|CHEMBL43184|DivK1c_006957|SPECTRUM1500810|SPBio_001244|AMINOACRIDINE [WHO-DD]|orb1310754|SCHEMBL1040669|SCHEMBL6842061|SCHEMBL7199150|SCHEMBL10672209|SCHEMBL29354393|BDBM72700|cid_2723598|HY-B1422R|KBio1_001901|KBio2_001588|KBio2_004156|KBio2_006724|KBio3_001654|XJGFWWJLMVZSIG-UHFFFAOYSA-|HMS1921I16|HMS2092K22|HMS3715H04|HMS5083K07|Pharmakon1600-01500810|9-acridinamine;hydrate;hydrochloride|ALBB-020726|BCP25849|HY-B1422|AC2194|CCG-39037|NSC-28747|NSC757794|s4303|SBB003606|STK387428|AKOS000120447|acridin-9-ylamine;hydrate;hydrochloride|CS-4915|DB11561|FA17682|NSC-757794|NCGC00094857-01|NCGC00094857-02|NCGC00094857-03|NCGC00094857-06|7AD|9-Aminoacridine (purified by sublimation)|AS-17405|ST093685|SY039786|SBI-0051612.P002|DB-026983|DB-220082|A3298|NS00005526|SW219793-1|EN300-17076|10-Amino-5-azaanthracene;9-Aminoacridine;9AA|AB00052180_09|AB00052180_10|CS-003/03975023|F235796|Q513937|SR-01000760844|CU-01000012501-2|SR-01000760844-2|BRD-K00535541-001-02-2|BRD-K00535541-001-04-8|BRD-K00535541-001-05-5|BRD-K00535541-001-06-3|BRD-K00535541-311-04-1|9-Aminoacridine, matrix substance for MALDI-MS, >=99.5% (HPLC)|InChI=1/C13H10N2/c14-13-9-5-1-3-7-11(9)15-12-8-4-2-6-10(12)13/h1-8H,(H2,14,15)"
TIRBANIBULIN,23635314,,"InChI=1S/C26H29N3O3/c30-26(28-19-21-4-2-1-3-5-21)18-24-9-6-23(20-27-24)22-7-10-25(11-8-22)32-17-14-29-12-15-31-16-13-29/h1-11,20H,12-19H2,(H,28,30)",HUNGUWOZPQBXGX-UHFFFAOYSA-N,C26H29N3O3,431.5,N-benzyl-2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]pyridin-2-yl]acetamide,"897016-82-9|Tirbanibulin|KX2-391|KX-01|N-benzyl-2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)acetamide|Klisyri|KX-2-391|tirbanibulina|tirbanibuline|KX01|KX-2391|KX2391|4V9848RS5G|DTXSID30237862|2-Pyridineacetamide, 5-(4-(2-(4-morpholinyl)ethoxy)phenyl)-n-(phenylmethyl)-|N-benzyl-2-(5-{4-[2-(morpholin-4-yl)ethoxy]phenyl}pyridin-2-yl)acetamide|tirbanibulinum|N-benzyl-2-(5-(4-(2-(morpholin-4-yl)ethoxy)phenyl)pyridin-2-yl)acetamide|2-(5-(4-(2-morpholin-4-ylethoxy)phenyl)pyridin-2-yl)-N-(phenylmethyl)acetamide|2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]pyridin-2-yl]-N-(phenylmethyl)acetamide|RefChem:57965|DTXCID80160353|Tirbanibulin [USAN]|C26H29N3O3|CHEMBL571546|2-Pyridineacetamide,5-[4-[2-(4-morpholinyl)ethoxy]phenyl]-N-(phenylmethyl)-|KX2-391;KX-01|N-benzyl-2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]pyridin-2-yl]acetamide|2-[5-[4-(2-morpholin-4-ylethoxy)phenyl]pyridin-2-yl]-~{N}-(phenylmethyl)ethanamide|UNII-4V9848RS5G|N-BENZYL-2-(5-(4-(2-MORPHOLIN-4-YLETHOXY)PHENYL)PYRIDIN-2-YL)ACETAMIDE|KX 01|Klisyri (TN)|MFCD18633218|TIRBANIBULIN [INN]|Tirbanibulin (KX2-391)|MLS006011272|SCHEMBL153779|TIRBANIBULIN [WHO-DD]|GTPL7957|orb1300848|Tirbanibulin (JAN/USAN/INN)|SCHEMBL29386081|CHEBI:231702|HUNGUWOZPQBXGX-UHFFFAOYSA-N|GLXC-10799|HMS3656J15|HMS3673E15|TIRBANIBULIN [ORANGE BOOK]|BCP02845|EX-A2434|BDBM50303801|NSC756643|NSC800779|s2700|WHO 10864|5-[4-[2-(4-Morpholinyl)ethoxy]phenyl]-N-(phenylmethyl)-2-pyridineacetamide|AKOS027276392|BCP9000828|CCG-264983|CS-0248|DB06137|KX2-391; KX-01|NSC-756643|NSC-800779|SB16619|SDCCGSBI-0654429.P001|NCGC00346644-01|NCGC00346644-05|AC-35458|AS-73245|HY-10340|KX 2-391|KX2-391?|SMR004703022|DB-119272|NS00072513|SW219670-1|C77028|D11691|EN300-19855457|BRD-K29968218-001-01-6|BRD-K29968218-001-03-2|Q27888424|2-(5-(4-(2-morpholinoethoxy)phenyl)pyridin-2-yl)-N-benzylacetamide|N-benzyl-2-[5-[4-(2-morpholinoethoxy)phenyl]-2-pyridyl]acetamide|2-(5-(4-(2-morpholinoethoxyl)phenyl)pyridin-2-yl)-N-benzylacetamide|DN0"
CCX354,135565361,,"InChI=1S/C22H22ClN7O2/c1-32-18-13-15(4-5-17(18)23)28-9-11-29(12-10-28)19(31)14-30-22-16(3-2-6-26-22)20(27-30)21-24-7-8-25-21/h2-8,13H,9-12,14H2,1H3,(H,24,25)",ZIMLRKWQDLVPEK-UHFFFAOYSA-N,C22H22ClN7O2,451.9,"1-[4-(4-chloro-3-methoxyphenyl)piperazin-1-yl]-2-[3-(1H-imidazol-2-yl)pyrazolo[3,4-b]pyridin-1-yl]ethanone","CCX354|1010073-75-2|CCX-354|22PQS5K5TY|Ethanone, 1-(4-(4-chloro-3-methoxyphenyl)-1-piperazinyl)-2-(3-(1H-imidazol-2-yl)-1H-pyrazolo(3,4-b)pyridin-1-yl)-|UNII-22PQS5K5TY|CCX-354-C|CCX 354|1-[4-(4-chloro-3-methoxyphenyl)piperazin-1-yl]-2-(3-imidazol-2-ylidene-2H-pyrazolo[3,4-b]pyridin-1-yl)ethanone|1-(4-(4-chloro-3-methoxyphenyl)piperazin-1-yl)-2-(3-(1H-imidazol-2-yl)-1H-pyrazolo(3,4-b)pyridin-1-yl)ethan-1-one|1-(4-(4-chloro-3-methoxyphenyl)piperazin-1-yl)-2-(3-imidazol-2-ylidene-2H-pyrazolo(3,4-b)pyridin-1-yl)ethanone|1-[4-(4-chloro-3-methoxyphenyl)piperazin-1-yl]-2-[3-(1h-imidazol-2-yl)-1h-pyrazolo[3,4-b]pyridin-1-yl]ethan-1-one|RefChem:124104|CCR1 antagonist 1|GSK-2941266|CCX354-C|GSK2941266|CHEMBL4444976|1-[4-(4-chloro-3-methoxyphenyl)piperazin-1-yl]-2-[3-(1H-imidazol-2-yl)pyrazolo[3,4-b]pyridin-1-yl]ethanone|orb1707325|SCHEMBL1638749|SCHEMBL29364104|SCHEMBL30538013|SCHEMBL30865101|GTPL10164|ZIMLRKWQDLVPEK-UHFFFAOYSA-N|GLXC-20638|KQB07375|BDBM50518184|HY-U00350|AKOS040741714|CS-7396|DB12963|MS-28213|NS00073381|G13981|Q27253662|1-[4-(4-Chloro-3-methoxy-phenyl)-piperazin-1-yl]-2-[3-(1H-imidazol-2-yl)-pyrazolo[3,4-b]pyridin-1-yl]-ethanone"
COFORMYCIN,25447,,"InChI=1S/C11H16N4O5/c16-2-6-8(18)9(19)11(20-6)15-4-14-7-5(17)1-12-3-13-10(7)15/h3-6,8-9,11,16-19H,1-2H2,(H,12,13)/t5-,6-,8-,9-,11-/m1/s1",YOOVTUPUBVHMPG-LODYRLCVSA-N,C11H16N4O5,284.27,"(2R,3R,4S,5R)-2-[(8R)-8-hydroxy-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-3-yl]-5-(hydroxymethyl)oxolane-3,4-diol","coformycin|11033-22-0|(R)-3,4,7,8-Tetrahydro-3-beta-D-ribofuranosylimidazo(4,5-d)(1,3)diazepin-8-ol|CHEBI:16213|E49510ZL0H|Imidazo(4,5-d)(1,3)diazepin-8-ol, 3,4,7,8-tetrahydro-3-beta-D-ribofuranosyl-, (R)-|NSC-277817|(8R)-3-beta-D-ribofuranosyl-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol|(2R,3R,4S,5R)-2-[(8R)-8-hydroxy-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-3-yl]-5-(hydroxymethyl)oxolane-3,4-diol|(8R)-3-beta-D-ribofuranosyl-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol|(2R,3R,4S,5R)-2-((8R)-8-hydroxy-7,8-dihydro-4H-imidazo(4,5-d)(1,3)diazepin-3-yl)-5-(hydroxymethyl)oxolane-3,4-diol|RefChem:127407|NSC 277817|CHEMBL284483|UNII-E49510ZL0H|NSC277817|SCHEMBL442534|orb1703587|YOOVTUPUBVHMPG-LODYRLCVSA-N|BDBM50367032|AKOS040745679|DA-64416|HY-117260|CS-0064597|C01677|Q27098587|Imidazo[4,5-d][1,3]diazepin-8-ol, 3,4,7,8-tetrahydro-3-.beta.-D-ribofuranosyl-, (8R)|Imidazo[4,5-d][1,3]diazepin-8-ol,3,4,7,8-tetrahydro-3-b-D-ribofuranosyl-, (8R)-|(2R,3R,4S,5R)-2-[(8R)-8-hydroxy-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-3-yl]-5-(hydroxymethyl)tetrahydrofuran-3,4-diol|IMIDAZO(4,5-D)(1,3)DIAZEPIN-8-OL, 3,4,7,8-TETRAHYDRO-3-.BETA.-D-RIBOFURANOSYL-, (8R)-"
PENTOSTATIN,439693,,"InChI=1S/C11H16N4O4/c16-3-8-6(17)1-9(19-8)15-5-14-10-7(18)2-12-4-13-11(10)15/h4-9,16-18H,1-3H2,(H,12,13)/t6-,7+,8+,9+/m0/s1",FPVKHBSQESCIEP-JQCXWYLXSA-N,C11H16N4O4,268.27,"(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol","pentostatin|Deoxycoformycin|Nipent|53910-25-1|Pentostatina|Pentostatine|CO-Vidarabine|Pentostatinum|2'-DCF|CI-825|YK-176|NSC-218321|PD 81565|PD-81565|DTXSID2023436|CI 825|395575MZO7|DTXCID403436|NSC218321|NSC 218321|(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,6H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol|(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-7,8-dihydro-4H-imidazo[4,5-d][1,3]diazepin-8-ol|(R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol|CL 67310465|2' Deoxycoformycin|Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-|CI825|(8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H,4H,7H,8H-imidazo(4,5-d)(1,3)diazepin-8-ol|(8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-3H,6H,7H,8H-imidazo(4,5-d)(1,3)diazepin-8-ol|(8R)-3-((2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl)-7,8-dihydro-4H-imidazo(4,5-d)(1,3)diazepin-8-ol|(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)oxolan-2-yl]-3H,4H,7H,8H-imidazo[4,5-d][1,3]diazepin-8-ol|(R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol|RefChem:57393|L01XX08|Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (R)-|Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-|637-271-5|2'-Deoxycoformycin|Vidarbine|Covidarabine|PD-ADI|2'-Dexoycoformycin|Vira A deaminase inhibitor|MFCD00078802|(R)-3-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol|(8R)-3-(2-deoxy-beta-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol|NCGC00182045-01|Deaminase inhibitor (PD)|dCF|(R)-3-(2-Deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydroimidazo(4,5-d)(1,3)diazepin-8-ol|(R)-2'-Deoxycoformycin|(R)-Deoxycoformycin|CI-825;Deoxycoformycin|8R-2'-Deoxycoformycin|(8R)-3-(2-Deoxy-beta-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol|Pentostatine [INN-French]|Pentostatinum [INN-Latin]|Pentostatina [INN-Spanish]|Pentostatin (JAN/USAN/INN)|UNII-395575MZO7|HSDB 6547|Pentostatin [USAN:INN:BAN:JAN]|Pentostatin (PTN)|BRN 1223097|Pentostatin (Standard)|PENTOSTATIN [MI]|PENTOSTATIN [INN]|PENTOSTATIN [JAN]|CL-67310465|Deaminase, inhibitor for adenosine arabinoside|PENTOSTATIN [HSDB]|PENTOSTATIN [USAN]|PENTOSTATIN [VANDF]|SCHEMBL2817|CHEMBL1580|PENTOSTATIN [MART.]|PENTOSTATIN [WHO-DD]|BIDD:GT0136|GTPL4805|SCHEMBL1649740|BDBM22925|CHEBI:27834|HY-A0006R|Pentostatin, >=95% (HPLC)|PENTOSTATIN [ORANGE BOOK]|BDBM223291|GLXC-05480|HY-A0006|Imidazo(4,5-d)(1,3)diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,6,7,8-tetrahydro-, (R)-|Tox21_113417|MSK164430|s9521|AKOS024456918|AKOS032949742|AD03945|CS-0374|DB00552|NCGC00388420-02|(8R)-3-(2-Deoxy-?-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol|Imidazo[4,5-d][1,3]diazepin-8-ol, 3-(2-deoxy-.beta.-D-erythro-pentofuranosyl)-3,4,7,8-tetrahydro-, (8R)-|CAS-53910-25-1|NS00005086|C02267|D00155|EN300-222177|910P251|Q425470|SR-01000883935|SR-01000883935-1|BRD-K91543828-001-02-0|Adenosine Deaminase Inhibitor, DCF - CAS 53910-25-1|Z2204459563|(8R)-3-[(2R,4S,5R)-4-hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl]-7,8-dihydro-6H-imidazo[4,5-d][1,3]diazepin-8-ol|(R)-3-((2R,4S,5R)-4-Hydroxy-5-(hydroxymethyl)tetrahydrofuran-2-yl)-3,6,7,8-tetrahydroimidazo[4,5-d][1,3]diazepin-8-ol"
HEXACHLOROPHENE,3598,,"InChI=1S/C13H6Cl6O2/c14-6-2-8(16)12(20)4(10(6)18)1-5-11(19)7(15)3-9(17)13(5)21/h2-3,20-21H,1H2",ACGUYXCXAPNIKK-UHFFFAOYSA-N,C13H6Cl6O2,406.9,"3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxyphenyl)methyl]phenol","hexachlorophene|70-30-4|Hexachlorofen|Hexachlorophen|Nabac|pHisoHex|Almederm|Exofene|Fostril|Gamophen|Septisol|Turgex|Germa-Medica|Dermadex|Distodin|Gamophene|Hexabalm|Hexophene|Phisodan|Septofen|Steraskin|Surofene|Tersaseptic|Acigena|Hexafen|Hexide|Steral|Soy-dome|Surgi-Cen|Surgi-Cin|Hexachlorophane|Hexascrub|Cotofilm|Hexosan|Ritosept|Fomac|Fesia-sin|Phiso-Scrub|Septi-Soft|Ster-zac|Hexa-Germ|Neosept V|G-Eleven|Hexaclorofeno|Bilevon|Armohex|Hexachlorophenum|Pre-Op|Compound G-11|Staphene O|Nabac 25 ec|Solu-Heks|Esaclorofene|Trisophen|Hexaphene-LV|Hilo Flea Powder|Enditch Pet Shampoo|Scrubteam Surgical Spongebrush|At-17|2,2'-Methylenebis(3,4,6-trichlorophenol)|Hilo Cat Flea Powder|PRE-OP II|2,2'-methanediylbis(3,4,6-trichlorophenol)|Pedigree Dog Shampoo Bar|Bis(2-hydroxy-3,5,6-trichlorophenyl)methane|Bis(3,5,6-trichloro-2-hydroxyphenyl)methane|NCI-C02653|Blockade Anti Bacterial Finish|3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxyphenyl)methyl]phenol|2,2',3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|2,2'-Dihydroxy-3,5,6,3',5',6'-hexachlorodiphenylmethane|B & b Flea Kontroller for Dogs Only|2,2'-Dihydroxy-3,3',5,5',6,6'-hexachlorodiphenylmethane|IWW5FV6NK2|Brevity Blue Liquid Sanitizing Scouring Cream|Phenol, 2,2'-methylenebis(3,4,6-trichloro-|Phenol, 2,2'-methylenebis(3,4,6-trichloro)-|Brevity Blue Liquid Bacteriostatic Scouring Cream|CHEBI:5693|DTXSID6020690|Bis-2,3,5-trichloro-6-hydroxyfenylmethan|Thera-Groom Pet Shampoo for Dogs for Veterinary Use Only|Bis(3,5,6-trichloro-2-hydroxyphenyl)-methane|Phenol, 2,2'-methylenebis[3,4,6-trichloro-|NSC-49115|Methane, bis(2,3,5-trichloro-6-hydroxyphenyl)|DTXCID40690|2,2'-Methylenebis[3,4,6-trichlorophenol]|NSC49115|3,4,6-trichloro-2-((2,3,5-trichloro-6-hydroxyphenyl)methyl)phenol|germa-medica """"mg|GERMA-MEDICA ""MG|RefChem:389043|D08AE01|200-733-8|Dial|E-Z Scrub|G-II|Rcra waste number U132|AT-7|G-11|MLS000028433|SMR000058356|6,6-Methylenebis(2,4,5-trichlorophenol)|MFCD00002171|B 32|6,6'-Methylenebis(2,4,5-trichlorophenol)|MLS002152906|Bivelon|NCGC00091195-04|Fascol|Esaclorofene [DCIT]|Hexachlorofen [Czech]|Hexachlorophene [INN]|2,4,6-trichlorophenol]|2,5,6-trichlorophenol)|C13H6Cl6O2|3,4,6-trichloro-2-[(2,3,5-trichloro-6-hydroxy-phenyl)methyl]phenol|Hexaclorofeno [INN-Spanish]|Hexachlorophenum [INN-Latin]|Caswell No. 566|AT 7|B 32 (VAN)|Bis-2,5-trichlor-6-hydroxyfenylmethan|CAS-70-30-4|Methane,3,5-trichloro-6-hydroxyphenyl)|CCRIS 331|Bis(2-hydroxy-3,6-trichlorophenyl)methane|Bis(3,6-trichloro-2-hydroxyphenyl)methane|Phenol,2'-methylenebis[3,4,6-trichloro-|Phenol,2'-methylenebis[3,5,6-trichloro-|WLN: QR BG DG EG F1R BQ CG EG FG|HSDB 224|2,3',5,5',6,6'-hexachlorodiphenylmethane|2,5,6,3',5',6'-hexachlorodiphenylmethane|SR-01000721924|EINECS 200-733-8|UNII-IWW5FV6NK2|NSC 49115|UN2875|Hexachlorophene [UN2875] [Poison]|RCRA waste no. U132|2,3,3',5,5'-Hexachloro-6,6'-dihydroxydiphenylmethane|EPA Pesticide Chemical Code 044901|Bis-2,3,5-trichloro-6-hydroxyfenylmethan [Czech]|Hexachlorophene (USP/INN)|BRN 2064407|3,4,6-trichloro-2-[(3,5,6-trichloro-2-hydroxyphenyl)methyl]phenol|AI3-02372|2,2'-Methylene bis(3,4,6-trichlorophenol)|Hexachlorophene [USP:INN:BAN]|KUC106447N|Methane, bis(2,3,5-trichloro-6-hydroxyphenyl)-|Phisohex (TN)|KSC-19-051|Spectrum_000867|Bis-2,3,5-trichlor-6-hydroxyfenylmethan|Opera_ID_504|Spectrum2_001105|Spectrum3_000450|Spectrum4_000573|Spectrum5_000792|M0219|CHEMBL496|cid_3598|HEXACHLOROPHENE [MI]|REGID_for_CID_3598|SCHEMBL15579|BSPBio_002100|KBioGR_001006|KBioSS_001347|MLS001148404|orb611334|BIDD:ER0608|BIDD:GT0722|DivK1c_000630|HEXACHLOROPHENE [HSDB]|HEXACHLOROPHENE [IARC]|SPECTRUM1500328|SPBio_001210|HEXACHLOROPHENE [VANDF]|HEXACHLOROPHENE [MART.]|HEXACHLOROPHENE [USP-RS]|HEXACHLOROPHENE [WHO-DD]|SCHEMBL29352805|BDBM31712|GTPL11069|HMS501P12|KBio1_000630|KBio2_001347|KBio2_003915|KBio2_006483|KBio3_001320|NSC9887|NINDS_000630|3,3',5,5',6,6'-Hexachloro-2,2'-dihydroxydiphenylmethane|HMS1920D07|HMS2091J13|HMS3259C19|HMS3715P21|KUC112427N|Pharmakon1600-01500328|MSK21000|NSC-9887|Tox21_111099|Tox21_201350|Tox21_302741|CCG-39768|HEXACHLOROPHENE [ORANGE BOOK]|NSC757055|s4632|SBB058855|STK377478|AKOS005449243|MSK21000-100M|Tox21_111099_1|CS-3866|DB00756|HEXACHLOROPHENE [USP MONOGRAPH]|NC00512|NSC-757055|UN 2875|Hexachlorophene Solution, 5,000 mg/L|IDI1_000630|NCGC00091195-01|NCGC00091195-02|NCGC00091195-03|NCGC00091195-05|NCGC00091195-06|NCGC00091195-07|NCGC00091195-08|NCGC00091195-09|NCGC00256580-01|NCGC00258902-01|AC-37557|AS-10068|BP-30177|DA-74102|H3P|HY-12637|Inh 1 [PMID: 32284327]|KSC-285-117-1|SBI-0051403.P003|NS00009113|ST50880633|bis(3,5,6-trichloro-2-hydroxy phenyl)methane|Bis-(2-hydroxy-3,5,6-trichlorophenyl)methane|C08039|D00859|Hexachlorophen Solution in Methanol, 100ug/mL|MLS-0072923.0001|AB00052010_17|Bis[3,4,6-trichlorophenol], 2,2'-methylene-|EN300-23816802|Hexachlorophene, PESTANAL(R), analytical standard|Q425362|SR-01000721924-2|SR-01000721924-5|SR-01000721924-6|BRD-K99792991-001-02-6|BRD-K99792991-001-18-2|BRD-K99792991-001-34-9|Hexachlorophene, United States Pharmacopeia (USP) Reference Standard|139411-96-4"
SILIBININ,31553,,"InChI=1S/C25H22O10/c1-32-17-6-11(2-4-14(17)28)24-20(10-26)33-16-5-3-12(7-18(16)34-24)25-23(31)22(30)21-15(29)8-13(27)9-19(21)35-25/h2-9,20,23-29,31H,10H2,1H3/t20-,23+,24-,25-/m1/s1",SEBFKMXJBCUCAI-HKTJVKLFSA-N,C25H22O10,482.4,"(2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one","silibinin|Silymarin I|Flavobin|Silibinine|Silliver|Silybine|Silymarine I|Silibinina|Silibininum|Legalon|CHEBI:9144|(2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydrochromen-4-one|(2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-2,3-dihydro-4H-chromen-4-one|Silibinin a-silibinin b mixt.|(2R,3R)-3,5,7-trihydroxy-2-((2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl)-2,3-dihydro-4H-chromen-4-one|(2R,3R)-3,5,7-trihydroxy-2-((2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl)-2,3-dihydrochromen-4-one|RefChem:183059|4RKY41TBTF|245-302-5|(2R,3R)-3,5,7-trihydroxy-2-(3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl)-2,3-dihydrochromen-4-one|Silybin|22888-70-6|Silybin A|Silibinin A|Silibinin [INN]|Silymarine|(2R,3R)-3,5,7-trihydroxy-2-((2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)chroman-4-one|( inverted exclamation markA)-SILYBIN|Flavobin Spofa|NSC-651520|DTXSID8026018|33X338MNE4|Silibinin (INN)|MFCD03225424|NSC651520|4H-1-Benzopyran-4-one,2-[(2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-|NCGC00091057-01|MFCD00872186|(2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxy-phenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]chroman-4-one|(2R,3R)-3,5,7-trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]-3,4-dihydro-2H-1-benzopyran-4-one|1265089-69-7|DTXCID106018|silybinin|Silibinine [INN-French]|Silibininum [INN-Latin]|Silibinina [INN-Spanish]|7C3MT|2,3-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-6-(3,5,7-trihydroxy-4-oxobenzopyran-2-yl)benzodioxin|CAS-22888-70-6|EINECS 245-302-5|NSC 651520|Silybin;Silibinin A;Silymarin I|UNII-33X338MNE4|CCRIS 9378|Silymarin A|4H-1-Benzopyran-4-one, 2-((2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-|4H-1-Benzopyran-4-one, 2-[(2R,3R)-2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2,3-dihydro-3,5,7-trihydroxy-, (2R,3R)-|()-Silybin|Legalon (TN)|Silibinin (Silybin)|Silybin A (Standard)|Spectrum2_001694|Spectrum3_001132|Spectrum4_001978|Spectrum5_001893|SILYBIN A [MI]|BSPBio_002623|KBioGR_002481|MLS001304057|SCHEMBL324884|SPECTRUM1505256|SPBio_001648|CHEMBL431701|MEGxp0_001301|orb1307850|orb2299464|SCHEMBL29392068|SCHEMBL29399173|GTPL12449|KBio3_002123|HMS1922P05|HMS2232P03|HMS6018N08|2-[2R,3R-Dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl]-2R,3R-dihydro-3,5,7-trihydroxy-4H-1-benzopyran-4-one|MSK40325|Tox21_111070|Tox21_200755|BDBM50084982|CCG-38779|HY-13748R|s2357|AKOS004119918|Tox21_111070_1|DB09298|DS-9661|SDCCGMLS-0066916.P001|SMP2_000323|NCGC00091057-02|NCGC00091057-03|NCGC00091057-05|NCGC00258309-01|Silybin A (constituent of milk thistle)|3,5,7-Trihydroxy-2-(3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxan-6-yl)-4-chromanone|4H-1-Benzopyran-4-one, 2,3-dihydro-2-(2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-3,5,7-trihydroxy-, (2R-(2-alpha,3-beta,6(2R*,3R*)))-|4H-1-Benzopyran-4-one, 2-(2,3-dihydro-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-1,4-benzodioxin-6-yl)-2,3-dihydro-3,5,7-trihydroxy-, (2R-(2alpha,3beta,6(2R*,3R*)))-|BP-30210|DA-57872|HY-13748|SMR000718776|SY103655|SBI-0207018.P001|HY-139637|CS-0226432|Silybin ASilibinin A; Silybin A; Silymarin I|88S706|D08515|E82516|AB00876265_06|F551327|F870214|Q425702|SR-01000799140|SR-01000799140-2|BRD-K80353138-001-02-2|BRD-K80353138-001-07-1|BRD-K80353138-001-12-1|BRD-K80353138-001-13-9|SILYBIN A (CONSTITUENT OF MILK THISTLE) [DSC]|(2R,3R)-3,5,7-trihydroxy-2-(3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)chroman-4-one|(2R,3R)-3,5,7-Trihydroxy-2-[(2R,3R)-3-(4-hydroxy-3-methoxy-phenyl)-2-hydroxymethyl-2,3-dihydro-benzo[1,4]dioxin-6-yl]-chroman-4-one|(2R,3R)-3,5,7-Trihydroxy-2-[3-(4-hydroxy-3-methoxy-phenyl)-2-hydroxymethyl-2,3-dihydro-benzo[1,4]dioxin-6-yl]-chroman-4-one|3,5,7-Trihydroxy-2-(3-(4-hydroxy-3-methoxyphenyl)- 2-(hydroxymethyl)-1,4-benzodioxan-6-yl)-4-chromanone|3,5,7-Trihydroxy-2-[3-(4-hydroxy-3-methoxy-phenyl)-2-hydroxymethyl-2,3-dihydro-benzo[1,4]dioxin-6-yl]-chroman-4-one|3,5,7-trihydroxy-2-[3-(4-hydroxy-3-methoxyphenyl)-2-hydroxymethyl-(2R,3R)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl]-(2R,3R)-3,4-dihydro-2H-4-chromenone|rel-(2R,3R)-3,5,7-Trihydroxy-2-((2R,3R)-3-(4-hydroxy-3-methoxyphenyl)-2-(hydroxymethyl)-2,3-dihydrobenzo[b][1,4]dioxin-6-yl)chroman-4-one"
AZD6280,23630026,,"InChI=1S/C20H22N4O3/c1-4-10-22-20(25)19-17(21)14-7-5-6-13(18(14)23-24-19)15-11-12(26-2)8-9-16(15)27-3/h5-9,11H,4,10H2,1-3H3,(H2,21,23)(H,22,25)",NVWCZRPXYVDQEE-UHFFFAOYSA-N,C20H22N4O3,366.4,"4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide","AZD-6280|942436-93-3|AZD6280|3-Cinnolinecarboxamide, 4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-|B9Z1OEH19D|RefChem:116012|4-amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboxamide|CHEMBL1783256|C20H22N4O3|4-amino-8-(2,5-dimethoxyphenyl)-N-propyl-cinnoline-3-carboxamide|UNII-B9Z1OEH19D|NVWCZRPXYVDQEE-UHFFFAOYSA-N|AZD 6280|orb1300037|SCHEMBL1962946|SCHEMBL29545849|SCHEMBL29897278|DTXSID60915944|AZD6280?|BCP32588|BDBM50418456|MFCD21337368|AKOS037649418|CS-6764|DB12210|AZD-6280; AZD 6280|BS-18265|DA-61381|HY-19872|NS00072940|D81382|Q27274557|4-Amino-8-(2,5-dimethoxyphenyl)-N-propylcinnoline-3-carboximidic acid"
SILIDIANIN,11982272,,"InChI=1S/C25H22O10/c1-33-16-4-9(2-3-14(16)27)18-11-7-12(20-13(18)8-34-25(20,32)24(11)31)23-22(30)21(29)19-15(28)5-10(26)6-17(19)35-23/h2-7,11,13,18,20,22-23,26-28,30,32H,8H2,1H3/t11-,13-,18+,20+,22+,23-,25-/m1/s1",CYGIJEJDYJOUAN-JSGXPVSSSA-N,C25H22O10,482.4,"(1R,3R,6R,7R,10R)-3-hydroxy-10-(4-hydroxy-3-methoxyphenyl)-8-[(2R,3R)-3,5,7-trihydroxy-4-oxo-2,3-dihydrochromen-2-yl]-4-oxatricyclo[4.3.1.03,7]dec-8-en-2-one","Silydianin|29782-68-1|Silidianin|Silidianine|Silidianina|Silidianinum|7P89L7W179|DTXSID70858696|(1R,3R,6R,7R,10R)-3-hydroxy-10-(4-hydroxy-3-methoxyphenyl)-8-[(2R,3R)-3,5,7-trihydroxy-4-oxo-2,3-dihydrochromen-2-yl]-4-oxatricyclo[4.3.1.03,7]dec-8-en-2-one|(1R,3R,6R,7R,10R)-3-hydroxy-10-(4-hydroxy-3-methoxyphenyl)-8-((2R,3R)-3,5,7-trihydroxy-4-oxo-2,3-dihydrochromen-2-yl)-4-oxatricyclo(4.3.1.03,7)dec-8-en-2-one|RefChem:183011|DTXCID20809436|(+)-2,3 alpha,3a alpha,7a-tetrahydro-7aalpha-hydroxy-8-(4-hydroxy-3-methoxyphenyl)-4-(3alpha,5,7-trihydroxy-4-oxo-2beta-chromanyl)-3,6-methanobenzofuran-7(6alphaH)-one|249-848-5|Silidianin [INN]|(1S,3S,6R,7S,10R)-3-Hydroxy-10-(4-hydroxy-3-methoxyphenyl)-8-[(2R,3R)-3,5,7-trihydroxy-4-oxo-2,3-dihydrochromen-2-yl]-4-oxatricyclo[4.3.1.03,7]dec-8-en-2-one|(3R,3aR,6R,7aR,8R)-7a-Hydroxy-8-(4-hydroxy-3-methoxyphenyl)-4-((2R,3R)-3,5,7-trihydroxy-4-oxochroman-2-yl)-3,3a,6,7a-tetrahydro-3,6-methanobenzofuran-7(2H)-one|Silidianine [INN-French]|Silidianinum [INN-Latin]|Silidianina [INN-Spanish]|UNII-7P89L7W179|EINECS 249-848-5|MFCD09970974|Silydianin (Standard)|SILIDIANIN [MART.]|SILYDIANIN [USP-RS]|Silydianin, analytical standard|orb1303618|CHEMBL2397733|SCHEMBL29401704|HY-N0646R|CYGIJEJDYJOUAN-JSGXPVSSSA-N|HY-N0646|MSK158718|AKOS030573534|FS42773|AC-34761|AS-56229|CS-0009672|782S681|BRD-K52002287-001-01-0|Q27268678|SILIDIANIN (CONSTITUENT OF MILK THISTLE) [DSC]|Silydianin, United States Pharmacopeia (USP) Reference Standard|(+)-2,3.ALPHA.,3A.ALPHA.A,7A-TETRAHYDRO-7A.ALPHA.-HYDROXY-8-(4-HYDROXY-3-METHOXYPHENYL)-4-(3.ALPHA.,5,7-TRIHYDROXY-4-OXO-2.BETA.-CHROMANYL)-3,6-METHANOBENZOFURAN-7(6.ALPHA.H)-ONE|(+)-2,3alpha,3aalpha,7a-Tetrahydro-7aalpha-hydroxy-8-(4-hydroxy-3-methoxyphenyl)-4-(3alpha,5,7-trihydroxy-4-oxo-2beta-chromanyl)-3,6-methanobenzofuran-7(6alphaH)-one|(1R,3R,6R,7R,10R)-3-hydroxy-10-(4-hydroxy-3-methoxy-phenyl)-8-[(2R,3R)-3,5,7-trihydroxy-4-oxo-chroman-2-yl]-4-oxatricyclo[4.3.1.03,7]dec-8-en-2-one"
GOLIDOCITINIB,126715380,,"InChI=1S/C25H31N9O2/c1-16(34-12-10-32(2)11-13-34)23(35)28-20-7-5-6-17-18(14-27-22(17)20)19-8-9-26-25(29-19)30-21-15-33(3)31-24(21)36-4/h5-9,14-16,27H,10-13H2,1-4H3,(H,28,35)(H,26,29,30)/t16-/m1/s1",CVCVOSPZEVINRM-MRXNPFEDSA-N,C25H31N9O2,489.6,(2R)-N-[3-[2-[(3-methoxy-1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propanamide,"golidocitinib|AZD-4205|AZD4205|UNII-3BY9Z3M34G|3BY9Z3M34G|(2R)-N-[3-[2-[(3-methoxy-1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propanamide|GOLIDOCITINIB [INN]|(2R)-N-(3-(2-((3-methoxy-1-methylpyrazol-4-yl)amino)pyrimidin-4-yl)-1H-indol-7-yl)-2-(4-methylpiperazin-1-yl)propanamide|(ALPHAR)-N-(3-(2-((3-METHOXY-1-METHYL-1H-PYRAZOL-4-YL)AMINO)-4-PYRIMIDINYL)-1H-INDOL-7-YL)-ALPHA,4-DIMETHYL-1-PIPERAZINEACETAMIDE|(alphaR)-N-[3-[2-[(3-Methoxy-1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-1H-indol-7-yl]-alpha,4-dimethyl-1-piperazineacetamide|AZD 4205|RefChem:144119|JAK1 Inhibitor AZD4205|(.ALPHA.R)-N-(3-(2-((3-METHOXY-1-METHYL-1H-PYRAZOL-4-YL)AMINO)-4-PYRIMIDINYL)-1H-INDOL-7-YL)-.ALPHA.,4-DIMETHYL-1-PIPERAZINEACETAMIDE|2091134-68-6|JAK1-IN-3|(R)-N-(3-(2-((3-Methoxy-1-methyl-1h-pyrazol-4-yl)amino)pyrimidin-4-yl)-1h-indol-7-yl)-2-(4-methylpiperazin-1-yl)propanamide|1-Piperazineacetamide, N-(3-(2-((3-methoxy-1-methyl-1H-pyrazol-4-yl)amino)-4-pyrimidinyl)-1H-indol-7-yl)-alpha,4-dimethyl-, (alphaR)-|(R)-N-(3-{2-[(3-Methoxy-1-methyl-1H-pyrazol-4-yl)amino]pyrimidin-4-yl}-1H-indol-7-yl)-2-(4-methylpiperazin-1-yl)propanamide|1-Piperazineacetamide, N-[3-[2-[(3-methoxy-1-methyl-1H-pyrazol-4-yl)amino]-4-pyrimidinyl]-1H-indol-7-yl]-alpha,4-dimethyl-, (alphaR)-|AZD4205 free base|Golidocitinib [WHO-DD]|Golidocitinib(AZD4205)|Golidocitinib (USAN/INN)|GOLIDOCITINIB [USAN]|GaoRuizhe (Chinese trade name)|orb1309956|CHEMBL4577523|SCHEMBL18662606|SCHEMBL29389079|GTPL10744|BDBM264212|C25H31N9O2|GLXC-22410|EX-A2671|AZD 4205?|example 32 [US9714236B2]|MFCD31657353|NSC801813|AKOS040732508|AT40403|NSC-801813|compound 21 [PMID: 32297743]|AC-36748|BA177711|MS-29106|HY-107361|CS-0028212|D12502|US9714236, 32|(2R)-N-(3-{2-[(3- methoxy-1-methyl- 1H-pyrazol-4-yl)amino] pyrimidin-4- yl}-1H-indol-7-yl)-2-(4- methylpiperazin-1- yl)propanamide|(2R)-N-[3-[2-[(3-methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propanamide|(2R)-N-[3-[2-[(3-Methoxy-1-methyl-pyrazol-4-yl)amino]pyrimidin-4-yl]-1H-indol-7-yl]-2-(4-methylpiperazin-1-yl)propenamide|(R)-N-(3-(2-(3-Methoxy-1-methyl-1H-pyrazol-4-ylamino)pyrimidin-4-yl)-1H-indol-7-yl)-2-(4-methylpiperazin-1-yl)propanamide"
EX-527,5113032,,"InChI=1S/C13H13ClN2O/c14-7-4-5-11-10(6-7)8-2-1-3-9(13(15)17)12(8)16-11/h4-6,9,16H,1-3H2,(H2,15,17)",FUZYTVDVLBBXDL-UHFFFAOYSA-N,C13H13ClN2O,248.71,"6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide","49843-98-3|6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide|Selisistat|EX-527|EX 527|CHEBI:90369|L19ECD5014|rac-6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide|DTXSID10964442|EX527 cpd|selisistatum|RefChem:541450|DTXCID101392140|664-029-6|SEN0014196|SIRT1 Inhibitor III|EX 527 (Selisistat)|Selisistat [INN]|MFCD03009471|EX527|Selisistat (EX 527)|CHEMBL420311|6-chloro-1,2,3,4,9-pentahydro-4aH-carbazolecarboxamide|UNII-L19ECD5014|SEN-0014196|1H-Carbazole-1-carboxamide, 6-chloro-2,3,4,9-tetrahydro-|EX-527(Selisistat)?|Cambridge id 6859180|SELISISTAT [WHO-DD]|Oprea1_353257|Oprea1_367943|MLS006011757|GTPL8100|orb1301063|SCHEMBL1275557|EX-527 (SELISISTAT)|FUZYTVDVLBBXDL-UHFFFAOYSA-N|GLXC-04708|HMS3426E09|HMS3654P22|HMS3743I17|HMS3747M05|HMS3884K19|BCP02889|EX-A1064|BDBM50178769|s1541|SBB014468|STK522511|AKOS002364303|AKOS016347570|AB88646|AB89313|BCP9000673|CCG-208710|CS-0960|DB13978|FC34132|SB16664|EX 527,SEN0014196|NCGC00242458-01|AC-32746|HY-15452|SMR004703473|ST082785|BCP0726000108|DB-082965|EX-527, >=98% (HPLC)|C2739|SW218147-2|AB00121519-01|AH-262/08804001|SR-01000501008|SR-01000501008-1|BRD-A73908300-001-04-2|BRD-A73908300-001-06-7|BRD-A73908300-001-09-1|Q27088776|(+/-)-6-chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxamide|6-Chloro-2,3,4,9-tetrahydro-1H-carbazole-1-carboxylic acid, amide"
BALCINRENONE,118599727,,"InChI=1S/C20H18FN3O5/c1-22-18(25)8-13-9-28-17-7-12(21)3-4-15(17)24(13)20(27)11-2-5-16-14(6-11)23-19(26)10-29-16/h2-7,13H,8-10H2,1H3,(H,22,25)(H,23,26)/t13-/m0/s1",MBKYLPOPYYLTNW-ZDUSSCGKSA-N,C20H18FN3O5,399.4,"2-[(3S)-7-fluoro-4-(3-oxo-4H-1,4-benzoxazine-6-carbonyl)-2,3-dihydro-1,4-benzoxazin-3-yl]-N-methylacetamide","AZD9977|1850385-64-6|BALCINRENONE|AZD-9977|Azd 9977|6C9UKZ0CYE|2-[(3S)-7-Fluoro-4-(3-oxo-4H-1,4-benzoxazine-6-carbonyl)-2,3-dihydro-1,4-benzoxazin-3-yl]-N-methylacetamide|2H-1,4-Benzoxazine-3-acetamide, 4-((3,4-dihydro-3-oxo-2H-1,4-benzoxazin-6-yl)carbonyl)-7-fluoro-3,4-dihydro-N-methyl-, (3S)-|2-((3S)-7-fluoro-4-(3-oxo-4H-1,4-benzoxazine-6-carbonyl)-2,3-dihydro-1,4-benzoxazin-3-yl)-N-methylacetamide|RefChem:116059|2-((3S)-7-fluoro-4-(3-oxo-3,4-dihydro-2H-1,4-benzoxazine-6-carbonyl)-3,4-dihydro-2H-1,4-benzoxazin-3-yl)-N-methylacetamide|UNII-6C9UKZ0CYE|2-[(3~{S})-7-fluoranyl-4-[(3-oxidanylidene-4~{H}-1,4-benzoxazin-6-yl)carbonyl]-2,3-dihydro-1,4-benzoxazin-3-yl]-~{N}-methyl-ethanamide|Balcinrenona|2-((3S)-7-FLUORO-4-((3-OXO-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-6-YL)CARBONYL)-3,4-DIHYDRO-2H-1,4-BENZOXAZIN-3-YL)-N-METHYLACETAMIDE|2-{(3S)-7-Fluoro-4-[(3-oxo-3,4-dihydro-2H-1,4-benzoxazin-6-yl)carbonyl]-3,4-dihydro-2H-1,4-benzoxazin-3-yl}-N-methylacetamide|BALCINRENONE [INN]|orb1298438|CHEMBL3916929|SCHEMBL17363859|SCHEMBL29358574|SCHEMBL29359477|GTPL11281|AZD 9977 [WHO-DD]|MBKYLPOPYYLTNW-ZDUSSCGKSA-N|BDBM238159|GLXC-22105|AKOS040759623|DB15418|US9394291, 4a|AC-36749|MS-26766|HY-120274|CS-0077469|F82308|(S)-1 [PMID: 30596500]|(S)-2-(7-Fluoro-4-(3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazine-6-carbonyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-3-yl)-N-methylacetamide|ECV"
MACITENTAN,16004692,,"InChI=1S/C19H20Br2N6O4S/c1-2-7-26-32(28,29)27-17-16(13-3-5-14(20)6-4-13)18(25-12-24-17)30-8-9-31-19-22-10-15(21)11-23-19/h3-6,10-12,26H,2,7-9H2,1H3,(H,24,25,27)",JGCMEBMXRHSZKX-UHFFFAOYSA-N,C19H20Br2N6O4S,588.3,5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(propylsulfamoyl)pyrimidin-4-amine,"Macitentan|441798-33-0|Opsumit|ACT-064992|Actelion-1|ACT 064992|ACT064992|macitentanum|Z9K9Y9WMVL|CHEBI:76607|DTXSID50196063|OPSYNVI COMPONENT MACITENTAN|n-(5-(4-bromophenyl)-6-(2-(5-bromopyrimidin-2-yloxy)ethoxy)pyrimidin-4-yl)-n'-propylaminosulfonamide|{[5-(4-BROMOPHENYL)-6-{2-[(5-BROMOPYRIMIDIN-2-YL)OXY]ETHOXY}PYRIMIDIN-4-YL]SULFAMOYL}(PROPYL)AMINE|N-(5-(4-BROMOPHENYL)-6-(2-((5-BROMOPYRIMIDIN-2-YL)OXI)ETHOXY)PYRIMIDIN-4-YL)-N'-PROPYLSULFURIC DIAMIDE|N-(5-(4-Bromophenyl)-6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)pyrimidin-4-yl)-N'-propylsulfamide|((5-(4-bromophenyl)-6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)pyrimidin-4-yl)sulfamoyl)(propyl)amine|N-(5-(4-Bromophenyl)-6-(2-((5-bromopyrimidin-2-yl)oxy)ethoxy)pyrimidin-4-yl)-N'-propylsulfuric diamide|N-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]-N'-propylsulfuric diamide|RefChem:58979|C02KX04|DTXCID60118554|N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide|N-(5-(4-Bromophenyl)-6-(2-((5-bromo-2-pyrimidinyl)oxy)ethoxy)-4-pyrimidinyl)-N'-propylsulfamide|MFCD17167076|5-(4-bromophenyl)-6-[2-(5-bromopyrimidin-2-yl)oxyethoxy]-N-(propylsulfamoyl)pyrimidin-4-amine|C19H20Br2N6O4S|Macitentan [INN]|N-[5-(4-bromophenyl)-6-{2-[(5-bromopyrimidin-2-yl)oxy]ethoxy}pyrimidin-4-yl]-N'- propylsulfamide|Macitentan [USAN:INN]|UNII-Z9K9Y9WMVL|Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl-; N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide; ACT 064992; Macitentan; Opsumit; Propylsulfamic acid N-[5-(4-bromophenyl)-6-[2-[(5-bromopyrimidin-2-yl)oxy]ethoxy]pyrimidin-4-yl]amide|Opsumit (TN)|Macitentan (Standard)|MACITENTAN [MI]|MACITENTAN [JAN]|Macitentan (JAN/USAN)|MACITENTAN [USAN]|MACITENTAN [VANDF]|A1D5I|MACITENTAN [WHO-DD]|MLS006011174|GTPL7352|Macitentan - Bio-X trade mark|orb1305317|SCHEMBL1445625|CHEMBL2103873|MACITENTAN [ORANGE BOOK]|SCHEMBL29378853|EX-A544|JGCMEBMXRHSZKX-UHFFFAOYSA-N|HMS3653N06|HMS3747E09|HMS5086O05|cas:441798-33-0;Macitentan|BCP05309|IAC42805|BDBM50395626|HY-14184R|s8051|AKOS024463406|CCG-270155|CS-0686|DB08932|FM65071|SB14841|Macitentan (Actelion-1,ACT-064992)|NCGC00346456-01|NCGC00346456-05|AC-30102|AS-74590|BM162771|HY-14184|SMR004702943|Macitentan (Actelion-1,ACT-064992)?|DB-070519|NS00072551|SW219473-1|ACT 064992; ACT-064992|D10135|Opsynvi (combination of macitentan + tadalafil)|EN300-7404089|Q6724151|BRD-K48812570-001-02-3|BRD-K48812570-001-03-1|N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)-oxy]ethoxy]-4-pyrimidinyl]-N'-propylsulfamide|Sulfamide, N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N'-propyl-"
AVOSENTAN,9912992,,"InChI=1S/C23H21N5O5S/c1-15-8-9-19(25-14-15)34(29,30)28-22-20(33-18-7-5-4-6-17(18)31-2)23(32-3)27-21(26-22)16-10-12-24-13-11-16/h4-14H,1-3H3,(H,26,27,28)",YBWLTKFZAOSWSM-UHFFFAOYSA-N,C23H21N5O5S,479.5,N-[6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl]-5-methylpyridine-2-sulfonamide,"Avosentan|290815-26-8|Ro 67-0565|SPP301|SPP-301|L94KSX715K|RO-67-0565|N-[6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl]-5-methylpyridine-2-sulfonamide|5-methylpyridine-2-sulfonic acid (6-methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)pyrimidin-4-yl)amide|2-Pyridinesulfonamide, N-[6-methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl]-5-methyl-|DTXSID30183330|2-Pyridinesulfonamide, N-(6-methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl)-5-methyl-|avosentanum|N-(6-methoxy-5-(2-methoxyphenoxy)-2-pyridin-4-ylpyrimidin-4-yl)-5-methylpyridine-2-sulfonamide|RefChem:115805|DTXCID40105821|Avosentan [INN]|Ro670565|N-(6-Methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)-pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide|SPP 301|N-[6-Methoxy-5-(2-methoxyphenoxy)-2-(4-pyridinyl)-4-pyrimidinyl]-5-methyl-2-pyridinesulfonamide|UNII-L94KSX715K|N-(6-Methoxy-5-(2-methoxyphenoxy)-2-(pyridin-4-yl)pyrimidin-4-yl)-5-methylpyridine-2-sulfonamide|MFCD23843806|GTPL8260|orb1296080|SCHEMBL2742679|CHEMBL3989834|SCHEMBL29379732|C23H21N5O5S|YBWLTKFZAOSWSM-UHFFFAOYSA-N|HMS3741G07|BCP28417|QLA81526|Avosentan,CAS:290815-26-8|BDBM50532577|CS-0625|NCGC00379058-01|AC-33590|DA-71170|HY-15195|MS-28915|Ro 67-0565; SPP-301|F84811|L001646|BRD-K19203487-001-01-4|Q27074636|5-methyl-pyridine-2-sulfonic acid [6-methoxy-5-(2-methoxy-phenoxy)-2-pyridin-4-yl-pyrimidin-4-yl]-amide|5-methyl-pyridine-2-sulfonic acid[6-methoxy-5-(2-methoxy-phenoxy)-2-pyridin-4-yl-pyrimidin-4-yl]-amide|N-[6-methoxy-5-(2-methoxyphenoxy)-2-(4-pyridyl)pyrimidin-4-yl]-5-methyl-pyridine-2-sulfonamide"
AMG-319,68947304,,"InChI=1S/C21H16FN7/c1-12(28-21-19-20(25-10-24-19)26-11-27-21)15-8-13-5-6-14(22)9-17(13)29-18(15)16-4-2-3-7-23-16/h2-12H,1H3,(H2,24,25,26,27,28)/t12-/m0/s1",KWRYMZHCQIOOEB-LBPRGKRZSA-N,C21H16FN7,385.4,N-[(1S)-1-(7-fluoro-2-pyridin-2-ylquinolin-3-yl)ethyl]-7H-purin-6-amine,"AMG319|1608125-21-8|AMG-319|AMG 319|(S)-N-(1-(7-fluoro-2-(pyridin-2-yl)quinolin-3-yl)ethyl)-9H-purin-6-amine|J3.391.906I|19DG7G1U5Q|MFCD28902228|N-((1S)-1-(7-Fluoro-2-(2-pyridyl)quinoline-3-yl)ethyl)-9H-purine-6-amine|3-Quinolinemethanamine, 7-fluoro-alpha-methyl-N-9H-purin-6-yl-2-(2-pyridinyl)-, (alphaS)-|N-[(1S)-1-(7-fluoro-2-pyridin-2-ylquinolin-3-yl)ethyl]-7H-purin-6-amine|N-{(1s)-1-[7-Fluoro-2-(Pyridin-2-Yl)quinolin-3-Yl]ethyl}-9h-Purin-6-Amine|UNII-19DG7G1U5Q|ACP319|C21H16FN7|4wwn|ACP-319|RefChem:1050797|GTPL8917|orb1300494|SCHEMBL4185718|CHEMBL4303596|SCHEMBL28566037|SCHEMBL29360036|SCHEMBL29479154|DTXSID501046373|AMG-319?|EX-A1028|AMG319 (ACP-319)|NSC787137|s7813|AKOS025404931|CCG-268471|CS-5266|NSC-787137|NCGC00481653-02|AC-35300|AS-35220|FA137646|HY-12948|BRD-K21077415-001-01-5|Q27074435|Z3064248238|N-[(1S)-1-[7-fluoro-2-(2-pyridyl)-3-quinolyl]ethyl]-7H-purin-6-amine|(alphaS)-7-Fluoro-alpha-methyl-N-9H-purin-6-yl-2-(2-pyridinyl)-3-quinolinemethanamine|N-[(1S)-1-[7-Fluoro-2-(2-pyridinyl)-3-quinolinyl]ethyl]-9H-purin-6-amine|3-QUINOLINEMETHANAMINE, 7-FLUORO-.ALPHA.-METHYL-N-9H-PURIN-6-YL-2-(2-PYRIDINYL)-, (.ALPHA.S)-|3VC"
IMD-0354,5081913,,"InChI=1S/C15H8ClF6NO2/c16-9-1-2-12(24)11(6-9)13(25)23-10-4-7(14(17,18)19)3-8(5-10)15(20,21)22/h1-6,24H,(H,23,25)",CHILCFMQWMQVAL-UHFFFAOYSA-N,C15H8ClF6NO2,383.67,"N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide","IMD-0354|978-62-1|IMD 0354|N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide|N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxybenzamide|IMD0354|76145IS906|DTXSID50243248|Benzamide, N-(3,5-bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxy-|3',5'-Salicyloxylidide, 5-chloro-alpha,alpha,alpha,alpha',alpha',alpha'-hexafluoro-|Benzamide, N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxy-|RefChem:147935|DTXCID50165739|635-542-2|IKK-2 Inhibitor V|MFCD00218820|TCMDC-125465|CHEMBL536151|N-[3,5-bis(trifluoromethyl)phenyl]-5-chloro-2-hydroxy-benzamide|C15H8ClF6NO2|N-(3,5-Bis-trifluoromethylphenyl)-5-chloro-2-hydroxybenzamide|UNII-76145IS906|IMD 0354; 5-Chloro-a,a,a,a',a',a'-hexafluoro-3',5'-salicyloxylidide N-(3,5-Bis(trifluoromethyl)phenyl)-5-chloro-2-hydroxybenzamide|IKK-2-inhibitor-V|Kinome_1864|MLS006011200|SCHEMBL129165|orb1301039|SCHEMBL29406220|CHEBI:93310|GLXC-06812|HMS3229F11|HMS3269F13|HMS3413J21|HMS3651D21|HMS3677J21|BCP22358|BDBM50430160|IMD-0354?|NSC800773|NSC816638|s2864|AKOS017344958|BCP9000777|CCG-268447|CS-4922|NSC-800773|NSC-816638|SB19541|SDCCGSBI-0207156.P004|NCGC00165811-01|NCGC00165811-02|NCGC00165811-03|NCGC00165811-06|NCGC00165811-07|AC-32886|AS-71319|DA-64412|HY-10172|SMR004702969|BCP0726000026|IMD-0354, >=98% (HPLC), solid|SW219746-1|C77350|BRD-K74305673-001-01-3|BRD-K74305673-001-06-2|BRD-K74305673-001-07-0|Q27165022|5-Chloro-2-hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]benzamide|N-(3,5-Bistrifluoromethylphenyl)-5-Chloro-2-Hydroxybenzamide|5-chloro-2-hydroxy-N-[3,5-bis(trifluoromethyl)phenyl]-benzamide|3',5'-SALICYLOXYLIDIDE, 5-CHLORO-.ALPHA.,.ALPHA.,.ALPHA.,.ALPHA.',.ALPHA.',.ALPHA.'-HEXAFLUORO-|634914-41-3"
IPTACOPAN,90467622,,"InChI=1S/C25H30N2O4/c1-4-31-19-10-12-27(22(14-19)17-5-7-18(8-6-17)25(28)29)15-21-20-9-11-26-24(20)16(2)13-23(21)30-3/h5-9,11,13,19,22,26H,4,10,12,14-15H2,1-3H3,(H,28,29)/t19-,22-/m0/s1",RENRQMCACQEWFC-UGKGYDQZSA-N,C25H30N2O4,422.5,"4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl]benzoic acid","Iptacopan|1644670-37-0|LNP023|LNP-023|NVP-LNP023|Iptacopan [INN]|Iptacopan [USAN]|NVP-LNP023-NX|8E05T07Z6W|Benzoic acid, 4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidinyl]-|UNII-8E05T07Z6W|4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl]benzoic acid|FABHALTA|IPTACOPAN [WHO-DD]|LNP 023|4-((2S,4S)-4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl)benzoic acid|Benzoic acid, 4-((2S,4S)-4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)-2-piperidinyl)-|4-{(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]piperidin-2-yl}benzoic acid|RefChem:148677|Factor B Inhibitor LNP023|4-((2S,4S)-4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl) benzoic acid|Iptacopan [USAN:INN]|WHO 11259|4-[(2~{S},4~{S})-4-ethoxy-1-[(5-methoxy-7-methyl-1~{H}-indol-4-yl)methyl]piperidin-2-yl]benzoic acid|iptacopanum|orb1709254|CHEMBL4594448|SCHEMBL16400416|SCHEMBL29358239|GTPL10710|LNP023?|CHEBI:229652|RENRQMCACQEWFC-UGKGYDQZSA-N|US9682968, Example-26a|BDBM160475|GLXC-20953|EX-A5728|AKOS040733609|AT30389|compound 41 [PMID: 32073845]|DA-75063|MS-27420|HY-127105|CS-0093107|4-((2S,4S)-(4-ethoxy-1-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)piperidin-2-yl))benzoic acid|4-[(2S,4S)-4-ethoxy-1-[(5-methoxy-7-methyl-1H-indol-4-yl)methyl]-2-piperidyl]benzoic acid|JGQ"
ELIMUSERTIB,118869362,,"InChI=1S/C20H21N7O/c1-13-12-28-10-9-27(13)18-11-15(17-5-8-23-26(17)2)14-3-6-21-20(19(14)24-18)16-4-7-22-25-16/h3-8,11,13H,9-10,12H2,1-2H3,(H,22,25)/t13-/m1/s1",YBXRSCXGRPSTMW-CYBMUJFWSA-N,C20H21N7O,375.4,"(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine","1876467-74-1|elimusertib|BAY-1895344|BAY 1895344|7N13IK9LNH|BAY1895344|(3R)-3-methyl-4-[4-(2-methylpyrazol-3-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl]morpholine|(3R)-3-methyl-4-(4-(2-methylpyrazol-3-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl)morpholine|RefChem:136505|ATR Inhibitor BAY1895344|ATR Kinase Inhibitor BAY1895344|(R)-3-methyl-4-(4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-1,7-naphthyridin-2-yl)morpholine|BAY-1895344 HCl|Elimusertib (BAY-1895344)|MFCD31561442|UNII-7N13IK9LNH|(R)-3-methyl-4-(4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-5-yl)-1,7-naphthyridin-2-yl)morpholine|2-[(3R)-3-Methyl-4-morpholinyl]-4-(1-methyl-1H-pyrazol-5-yl)-8-(1H-pyrazol-3-yl)-1,7-naphthyridine; BAY-1895344|ELIMUSERTIB [INN]|ELIMUSERTIB [WHO-DD]|orb1299925|CHEMBL4647810|SCHEMBL17501318|SCHEMBL21756640|SCHEMBL29569580|SCHEMBL30200285|C20H21N7O|GTPL10354|EX-A1662|NSC800525|NSC817275|s9864|BAY-1895344 HCl(Elimusertib)?|AKOS032953592|NSC-800525|NSC-817275|AC-30337|BB178556|BS-15734|SY235582|HY-101566|CS-0021722|(R)-3-Methyl-4-[4-(1-methyl-5-pyrazolyl)-8-(5-pyrazolyl)-1,7-naphthyridin-2-yl]morpholine|1,7-NAPHTHYRIDINE, 2-((3R)-3-METHYL-4-MORPHOLINYL)-4-(1-METHYL-1H-PYRAZOL-5-YL)-8-(1H-PYRAZOL-3-YL)-"
CYCLOHEXIMIDE,6197,,"InChI=1S/C15H23NO4/c1-8-3-9(2)15(20)11(4-8)12(17)5-10-6-13(18)16-14(19)7-10/h8-12,17H,3-7H2,1-2H3,(H,16,18,19)/t8-,9-,11-,12+/m0/s1",YPHMISFOHDHNIV-FSZOTQKASA-N,C15H23NO4,281.35,"4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione","cycloheximide|66-81-9|ACTIDIONE|Cicloheximide|NARAMYCIN A|Kaken|Actidion|Actidone|Hizarocin|Naramycin|Neocycloheximide|Acti-Aid|Cicloheximida|Actispray|Actidione PM|Cicloheximidum|Actidione BR|Actidione TGF|NSC-185|Aktidion|NSC 185|U-4527|4-[(2R)-2-[(1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]piperidine-2,6-dione|CBC 500046|DTXSID6024882|NM-MCD 80|U 4527|3-((R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)glutarimide|4-{(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl}piperidine-2,6-dione|CHEBI:27641|3-(2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)glutarimide|3-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide|beta-(2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)glutarimide|DTXCID204882|2,6-Piperidinedione, 4-(2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-, (1S-(1alpha(S*),3alpha,5beta))-|98600C0908|2,6-Piperidinedione, 4-((2R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)-|2,6-Piperidinedione, 4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]-|4-((2R)-2-((1S,3S,5S)-3,5-DIMETHYL-2-OXOCYCLOHEXYL)-2-HYDROXYETHYL)PIPERIDINE-2,6-DIONE|3-[(R)-2-[(1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl]-2-hydroxyethyl]glutarimide|(-)-Cycloheximide|RefChem:129667|200-636-0|Acti-Dione|NSC-171|Cycloheximid|Zykloheximid|Cycloheximide [USAN]|Acti-dione BR|MFCD00082346|NSC185|Cicloheximide [INN]|TCMDC-125838|4-[(2R)-2-[(1S,3S,5S)-3,5-dimethyl-2-oxo-cyclohexyl]-2-hydroxy-ethyl]piperidine-2,6-dione|CHEMBL123292|TZA|GNF-PF-5118|3-(2R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethylglutarimide|Cicloheximide (INN)|(1S-(1alpha(S*),3alpha,5beta))-4-(2-(3,5-Dimethyl-2-oxo-cyclohexyl))-2-hydroxyethyl-2,6-piperidinedione|CX|Cycloheximide (USAN)|Aktidion [Czech]|Cyclohemimide|Cyclohexamide|Caswell No. 270A|.beta.-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]glutarimide|Cicloheximidum [INN-Latin]|Cicloheximida [INN-Spanish]|4-[(2R)-2-((1S,3S,5S)-3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]azaperhydro ine-2,6-dione|SMR000686067|CCRIS 937|Actidione;Naramycin A;CHX|HSDB 1552|SR-01000597484|SR-05000001596|EINECS 200-636-0|Cycloheximide [BSI:ISO]|EPA Pesticide Chemical Code 043401|BRN 0088868|AI3-15541|Acti-dione PM|Acti-dione TGF|CAS-66-81-9|NCGC00024910-01|Prestwick_976|UNII-98600C0908|Spectrum_001344|FT 3422-2|Prestwick0_000790|Prestwick1_000790|Prestwick2_000790|Prestwick3_000790|Spectrum2_000900|Spectrum3_001510|Spectrum4_000914|Spectrum5_001635|CYCLOHEXIMIDE [MI]|CYCLOHEXIMIDE [ISO]|cid_6197|4-((2R)-2-((1S,3S,5S)-(3,5-Dimethyl-2-oxocyclohexyl))-2-hydroxyethyl)piperidine-2,6-dione|CYCLOHEXIMIDE [HSDB]|SCHEMBL26617|BSPBio_000900|BSPBio_003159|KBioGR_001408|KBioSS_001824|5-21-13-00434 (Beilstein Handbook Reference)|ksc-8-190|MLS001055333|MLS002154001|CICLOHEXIMIDE [MART.]|DivK1c_000050|SPECTRUM1502112|SPBio_000720|SPBio_002839|4-[2-(3,6-piperidinedione|BPBio1_000990|GTPL5433|orb2567338|HMS500C12|KBio1_000050|KBio2_001824|KBio2_004392|KBio2_006960|KBio3_002659|NINDS_000050|GLXC-10322|HMS1570M22|HMS1921L04|HMS2092D10|HMS2097M22|HMS3714M22|KUC105858N|Pharmakon1600-01502112|Cycloheximide, Streptomyces griseus|2,6-PIPERIDINEDIONE, 4-(2-(3,5-DIMETHYL-2-OXOCYCLOHEXYL)-2-HYDROXYETHYL)-, (1S-(1.ALPHA.(S*),3.ALPHA.,5.BETA.))-|MSK21224|Tox21_113580|Tox21_201158|Tox21_303652|BDBM50080528|CCG-39902|Cycloheximide, >=93.0% (HPLC)|HB2904|NSC758187|SBB005972|AKOS024282670|Tox21_113580_1|CS-4985|MSK21224-1000M|NSC-758187|4-((R)-2-((1S,3S,5S)-3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl)piperidine-2,6-dione|IDI1_000050|NCGC00017363-05|NCGC00017363-06|NCGC00017363-07|NCGC00017363-08|NCGC00017363-10|NCGC00017363-18|NCGC00024910-02|NCGC00024910-03|NCGC00024910-04|NCGC00024910-05|NCGC00024910-06|NCGC00169964-05|NCGC00257430-01|NCGC00258710-01|AC-35130|AC172520|AS-14624|BP-12396|HY-12320|NCI60_001540|ST057527|SBI-0051732.P002|WLN: T6VMVTJ E1YQ- BL6VTJ D1 F1|Cycloheximide 100 microg/mL in Acetonitrile|NS00004971|Cycloheximide, from microbial, >=94% (TLC)|C06685|Cycloheximide Solution in Methanol, 1000_g/mL|D03625|M01527|AB00052279_08|Cycloheximide, PESTANAL(R), analytical standard|082C346|Cycloheximide, Biotechnology Performance Certified|Q412895|SR-01000597484-1|SR-01000597484-4|SR-05000001596-1|SR-05000001596-3|SR-05000001596-4|BRD-K36055864-001-05-1|BRD-K36055864-001-07-7|BRD-K36055864-001-09-3|BRD-K36055864-001-16-8|BRD-K36055864-001-19-2|BRD-K36055864-001-20-0|Cycloheximide - Antibiotic for Culture Media Use Only|2,6-Piperidinedione, 4-[2-(3,5-dimethyl-2-oxocyclohex-1-yl)-2-hydroxy]ethyl-|[1S-[1.alpha.(S*),3.alpha.,5.beta.]]-4-[2-(3,5-Dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-2,6-piperidinedione|1154-57-0|2, 4-[2-(3,5-dimethyl-2-oxocyclohexyl)-2-hydroxyethyl]-, [1S-[1.alpha.(S*),3.alpha.,5.beta.]]-|4-((2R)-2-((1S,3S,5S)-3,5-DIMETHYL-2-OXOCYCLOHEXYL)-2-HYDROXYETHYL)-2,6-PIPERIDINEDIONE|4-[(2R)-2-[(1S,3S,5R)-3,5-dimethyl-2-oxo-cyclohexyl]-2-hydroxy-ethyl]piperidine-2,6-dione|4630-75-5"
ZOTATIFIN,129138801,,"InChI=1S/C28H29N3O5/c1-31(2)16-20-23(18-8-6-5-7-9-18)28(19-12-10-17(15-29)11-13-19)27(33,25(20)32)24-21(36-28)14-22(34-3)30-26(24)35-4/h5-14,20,23,25,32-33H,16H2,1-4H3/t20-,23-,25-,27+,28+/m1/s1",QYCXWOACFWMQFO-WZWZCULESA-N,C28H29N3O5,487.5,"4-[(2S,3R,4S,5S,6R)-4-[(dimethylamino)methyl]-2,3-dihydroxy-10,12-dimethoxy-5-phenyl-7-oxa-11-azatricyclo[6.4.0.02,6]dodeca-1(12),8,10-trien-6-yl]benzonitrile","Zotatifin|2098191-53-6|rel-Zotatifin|EFT226|EFT-226|Zotatifina|Zotatifine|2EWN8Z05CN|Zotatifin [INN]|Zotatifin [USAN]|Benzonitrile, 4-((5aR,6S,7S,8R,8aS)-7-((dimethylamino)methyl)-6,7,8,8a-tetrahydro-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-5ah-cyclopenta(4,5)furo(3,2-C)pyridin-5a-yl)-|4-((5aR,6S,7S,8R,8aS)-7-((Dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5ah-cyclopenta(4,5)furo(3,2-C)pyridin-5a-yl)benzonitrile|4-((5aR,6S,7S,8R,8aS)-7-((Dimethylamino)methyl)-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5aH-cyclopenta[4,5]furo[3,2-c]pyridin-5a-yl)benzonitrile|4-[(2S,3R,4S,5S,6R)-4-[(dimethylamino)methyl]-2,3-dihydroxy-10,12-dimethoxy-5-phenyl-7-oxa-11-azatricyclo[6.4.0.02,6]dodeca-1(12),8,10-trien-6-yl]benzonitrile|zotatifinum|Zotafin|4-{(5aR,6S,7S,8R,8aS)-7-[(Dimethylamino)methyl]-8,8a-dihydroxy-1,3-dimethoxy-6-phenyl-6,7,8,8a-tetrahydro-5aH-cyclopenta[4,5]furo[3,2-c]pyridin-5a-yl}benzonitrile|2098191-54-7|Zotatifin (USAN/INN)|Zotatifin [USAN:INN]|RefChem:1101202|UNII-2EWN8Z05CN|ZOTATIFIN [WHO-DD]|eFT 226|orb1706438|CHEMBL4303782|SCHEMBL18864788|SCHEMBL29380412|DTXSID001022536|GLXC-22555|EX-A4623|BDBM50540861|NSC818001|NSC828584|WHO 10998|AKOS040742848|NSC-818001|NSC-828584|BZ177457|DA-79135|MS-29059|HY-112163|CS-0043584|D11837|G17541|G17581|4-[(2S,3R,4S,5S,6R)-4-[(dimethylamino)methyl]-2,3-dihydroxy-10,12-dimethoxy-5-phenyl-7-oxa-11-azatricyclo[6.4.0.0,dodeca-1(12),8,10-trien-6-yl]benzonitrile"
EVOFOSFAMIDE,11984561,,"InChI=1S/C9H16Br2N5O4P/c1-15-8(6-12-9(15)16(17)18)7-20-21(19,13-4-2-10)14-5-3-11/h6H,2-5,7H2,1H3,(H2,13,14,19)",UGJWRPJDTDGERK-UHFFFAOYSA-N,C9H16Br2N5O4P,449.04,2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine,"evofosfamide|TH-302|918633-87-1|HAP-302|TH 302|2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitroimidazol-4-yl)methoxy]phosphoryl]ethanamine|Evofosfamida|8A9RZ3HN8W|Phosphorodiamidic acid, N,N'-bis(2-bromoethyl)-, (1-methyl-2-nitro-1H-imidazol-5-yl)methyl ester|DTXSID60238721|(1-METHYL-2-NITRO-1H-IMIDAZOL-5-YL)METHYL N,N'-BIS(2-BROMOETHYL)DIAMIDOPHOSPHATE|(1-Methyl-2-nitro-1H-imidazol-5-yl)methyl N,N'-bis(2-bromoethyl)phosphorodiamidate|(1-METHYL-2-NITRO-1H-IMIDAZOLE-5-YL)METHYL N,N'-BIS(2-BROMOETHYL) DIAMIDOPHOSPHATE|TH302 cpd|evofosfamidum|(2-bromoethyl)((((2-bromoethyl)amino)((1-methyl-2-nitro-1H-imidazol-5-yl)methoxy)phosphoryl))amine|(2-bromoethyl)({[(2-bromoethyl)amino][(1-methyl-2-nitro-1H-imidazol-5-yl)methoxy]phosphoryl})amine|2-bromo-N-((2-bromoethylamino)-((3-methyl-2-nitroimidazol-4-yl)methoxy)phosphoryl)ethanamine|RefChem:596969|HAP TH-302|DTXCID10161212|Hypoxia-Activated Prodrug TH-302|TH302|n,n'-bis(2-bromoethyl)phosphorodiamidic acid (1-methyl-2-nitro-1h-imidazol-5-yl)methyl ester|C9H16Br2N5O4P|MFCD22420822|TH-302; Evofosfamide;HAP-302|Phosphorodiamidic acid, N,N'-bis(2-bromoethyl)-, (1-methyl-2-nitro-1H-imidazol-5-yl)methyl ester.|Evofosfamide [USAN:INN]|UNII-8A9RZ3HN8W|compound 3b|Evofosfamide(TH-302)|EVOFOSFAMIDE [INN]|EVOFOSFAMIDE [JAN]|Evofosfamide(TH-302)?|EVOFOSFAMIDE [USAN]|EVOFOSFAMIDE [WHO-DD]|CHEMBL260046|Evofosfamide (JAN/USAN/INN)|GTPL8695|orb1303995|SCHEMBL2357174|SCHEMBL15691894|CHEBI:231678|BCP06074|EX-A1740|BDBM50543112|s2757|AKOS026673946|CCG-269225|CS-0616|DB06091|SB17116|2-bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitro-imidazol-4-yl)methoxy]phosphoryl]ethanamine|AC-29025|AS-74462|DA-78377|HY-10535|SY235562|NS00071873|D10704|Q7670203|BRD-K20958582-001-01-4|1-METHYL-2-NITRO-L H-IMIDAZOLE-5-YL) N,N-BIS(2-BROMOETHYL)DIAMIDOPHOSPHATE|2-Bromo-N-[(2-bromoethylamino)-[(3-methyl-2-nitro-4-imidazolyl)methoxy]phosphoryl]ethanamine"
DELGOCITINIB,50914062,,"InChI=1S/C16H18N6O/c1-11-8-22(13(23)2-5-17)16(11)4-7-21(9-16)15-12-3-6-18-14(12)19-10-20-15/h3,6,10-11H,2,4,7-9H2,1H3,(H,18,19,20)/t11-,16-/m0/s1",LOWWYYZBZNSPDT-ZBEGNZNMSA-N,C16H18N6O,310.35,"3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile","Delgocitinib|1263774-59-9|JTE-052|Corectim|JTE-052A|LEO 124249A|LEO 124249|LEO-124249A|delgocitinibum|LEO-124249|9L0Q8KK220|CHEBI:167600|DTXSID401336933|1,6-Diazaspiro(3.4)octane-1-propanenitrile, 3-methyl-beta-oxo-6-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-, (3S,4R)-|3-((3S,4R)-3-methyl-6-(7H-pyrrolo(2,3-d)pyrimidin-4-yl)-1,6-diazaspiro(3.4)octan-1-yl)-3-oxopropanenitrile|3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile|3-[(3S,4R)-3-methyl-6-{7H-pyrrolo[2,3-d]pyrimidin-4-yl}-1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile|1,6-Diazaspiro[3.4]octane-1-propanenitrile, 3-methyl-beta-oxo-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-, (3S,4R)-|RefChem:585671|DTXCID201767239|849-957-3|Anzupgo|Delgocitinib [USAN]|3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile|3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxidanylidene-propanenitrile|Delgocitinib?|Corectim (TN)|Anzupgo (TN)|ent-60|DELGOCITINIB [INN]|DELGOCITINIB [JAN]|DELGOCITINIB [WHO-DD]|UNII-9L0Q8KK220|Delgocitinib (JAN/USAN/INN)|GTPL9619|JTE052|orb1308395|CHEMBL4297507|SCHEMBL12547007|SCHEMBL29360818|EX-A5577|BDBM50545650|MFCD31630732|AKOS040741622|AT24880|LEO-124249;JTE-052|AC-38203|BD178539|MS-24514|HY-109053|CS-0031558|D11046|3-[(3S,4R)-3-methyl-6-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)- 1,6-diazaspiro[3.4]octan-1-yl]-3-oxopropanenitrile|3-[(3S,4R)-3-methyl-7-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1,7-diazaspiro[3.4]octan-1-yl]-3-oxo-propanenitrile|FHX"
VECABRUTINIB,72547837,,"InChI=1S/C22H24ClF4N7O2/c23-12-6-11(22(25,26)27)7-13(8-12)32-15-2-1-4-34(21(15)36)16-9-33(5-3-14(16)19(29)35)20-17(24)18(28)30-10-31-20/h6-8,10,14-16,32H,1-5,9H2,(H2,29,35)(H2,28,30,31)/t14-,15+,16-/m0/s1",QLRRJMOBVVGXEJ-XHSDSOJGSA-N,C22H24ClF4N7O2,529.9,"(3R,4S)-1-(6-amino-5-fluoropyrimidin-4-yl)-3-[(3R)-3-[3-chloro-5-(trifluoromethyl)anilino]-2-oxopiperidin-1-yl]piperidine-4-carboxamide","Vecabrutinib|1510829-06-7|BIIB-062|BSK-4841|FP0182|PQ7O0OB5GU|FP-0182|SNS062|BIIB062|FP-182|(3R,3'R,4'S)-1'-(6-amino-5-fluoropyrimidin-4-yl)-3-[3-chloro-5-(trifluoromethyl)anilino]-2-oxo[1,3'-bipiperidine]-4'-carboxamide|(3R,4S)-1-(6-amino-5-fluoropyrimidin-4-yl)-3-[(3R)-3-[3-chloro-5-(trifluoromethyl)anilino]-2-oxopiperidin-1-yl]piperidine-4-carboxamide|vecabrutinibum|(3R,3'R,4'S)-1'-(6-amino-5-fluoropyrimidin-4-yl)-3-(3-chloro-5-(trifluoromethyl)anilino)-2-oxo(1,3'-bipiperidine)-4'-carboxamide|(3R,4S)-1-(6-amino-5-fluoropyrimidin-4-yl)-3-((3R)-3-(3-chloro-5-(trifluoromethyl)anilino)-2-oxopiperidin-1-yl)piperidine-4-carboxamide|RefChem:933957|SNS 062|Sns-062|Vecabrutinib [INN]|Vecabrutinib [USAN]|UNII-PQ7O0OB5GU|Vecabrutinib [USAN:INN]|(3R,3'R,4'S)-1'-(6-amino-5-fluoropyrimidin-4-yl)-3-((3-chloro-5-(trifluoromethyl)phenyl)amino)-2-oxo-[1,3'-bipiperidine]-4'-carboxamide|(3R,3'R,4'S)-1'-(6-AMINO-5-FLUOROPYRIMIDIN-4-YL)-3-((3-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)AMINO)-2-OXO-(1,3'-BIPIPERIDINE)-4'-CARBOXAMIDE|MFCD31692359|Vecabrutinib (USAN/INN)|C22H24ClF4N7O2|VECABRUTINIB [WHO-DD]|orb1706486|CHEMBL4297640|SCHEMBL16765727|SCHEMBL29368866|GTPL10231|QLRRJMOBVVGXEJ-XHSDSOJGSA-N|GLXC-21844|BCP29646|EX-A3159|KKC82906|BDBM50546200|NSC810114|WHO 10643|ZB1596|AKOS040742809|NSC-810114|AC-36339|DA-78850|MS-29801|HY-109078|CS-0033553|D11428|G16371|(1,3'-BIPIPERIDINE)-4'-CARBOXAMIDE, 1'-(6-AMINO-5-FLUORO-4-PYRIMIDINYL)-3-((3-CHLORO-5-(TRIFLUOROMETHYL)PHENYL)AMINO)-2-OXO-, (3R,3'R,4'S)-|(3R,4S)-1-(6-amino-5-fluoro-pyrimidin-4-yl)-3-[(3R)-3-[3-chloro-5-(trifluoromethyl)anilino]-2-oxo-1-piperidyl]piperidine-4-carboxamide"
NEMTABRUTINIB,129045720,,"InChI=1S/C25H23ClN4O4/c26-21-10-17(34-16-4-2-1-3-5-16)8-9-19(21)23(32)20-11-27-24-22(20)25(29-14-28-24)30-15-6-7-18(12-31)33-13-15/h1-5,8-11,14-15,18,31H,6-7,12-13H2,(H2,27,28,29,30)/t15-,18+/m1/s1",JSFCZQSJQXFJDS-QAPCUYQASA-N,C25H23ClN4O4,478.9,"(2-chloro-4-phenoxyphenyl)-[4-[[(3R,6S)-6-(hydroxymethyl)oxan-3-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]methanone","2095393-15-8|ARQ 531|ARQ-531|nemtabrutinib|MK-1026|JTZ51LIXN4|ARQ531|(2-Chloro-4-phenoxyphenyl)(4-(((3R,6S)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)amino)-7h-pyrrolo[2,3-d]pyrimidin-5-yl)methanone|(2-chloro-4-phenoxyphenyl)-[4-[[(3R,6S)-6-(hydroxymethyl)oxan-3-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]methanone|(2-Chloro-4-phenoxyphenyl)(4-(((3R,6S)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)amino)-7H-pyrrolo(2,3-d)pyrimidin-5-yl)methanone|(2-chloro-4-phenoxyphenyl)-(4-(((3R,6S)-6-(hydroxymethyl)oxan-3-yl)amino)-7H-pyrrolo(2,3-d)pyrimidin-5-yl)methanone|RefChem:165056|BTK Inhibitor ARQ 531|Bruton's Tyrosine Kinase Inhibitor ARQ 531|880-144-6|MFCD31692379|(2-Chloro-4-phenoxyphenyl)(4-(((3R,6S)-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)amino)-3H-pyrrolo[2,3-d]pyrimidin-5-yl)methanone|MK1026|1,5-anhydro-2-{[5-(2-chloro-4-phenoxybenzene-1-carbonyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}-2,3,4-trideoxy-D-erythro-hexitol|[(2S,5R)-5-{[5-(2-chloro-4-phenoxybenzoyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino}oxan-2-yl]methanol|ArQule 531|UNII-JTZ51LIXN4|NEMTABRUTINIB [INN]|Nemtabrutinib (USAN/INN)|NEMTABRUTINIB [USAN]|C25H23ClN4O4|NEMTABRUTINIB [WHO-DD]|orb1308638|CHEMBL4756476|SCHEMBL18756744|SCHEMBL18770934|SCHEMBL29393386|SCHEMBL29564591|GTPL11413|ARQ531; ARQ 531|BDBM499811|GLXC-21845|BCP29029|EX-A2727|VID39315|NSC830201|s8711|AKOS040741165|AT10312|CCG-269533|NSC-830201|US11020398, Compound I-123|AC-36883|AS-79762|DA-50714|HY-112215|CS-0044154|D12504|(13R,16S)-52-chloro-16-(hydroxymethyl)-37H-6-oxa-2-aza-3(4,5)-pyrrolo[2,3-d]pyrimidina-1(3)oxana-5(1,4),7(1)dibenzenaheptaphan-4-one|(2-chloro-4-phenoxy-phenyl)-[4-[[(3R,6S)-6-(hydroxymethyl)tetrahydropyran-3-yl]amino]-7H-pyrrolo[2,3-d]pyrimidin-5-yl]methanone|1,5-Anhydro-2-[[5-(2-chloro-4-phenoxybenzoyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2,3,4-trideoxy-D-erythro-hexitol|D-erythro-Hexitol, 1,5-anhydro-2-[[5-(2-chloro-4-phenoxybenzoyl)-7H-pyrrolo[2,3-d]pyrimidin-4-yl]amino]-2,3,4-trideoxy-|HRA"
NIFLUMIC ACID,4488,,"InChI=1S/C13H9F3N2O2/c14-13(15,16)8-3-1-4-9(7-8)18-11-10(12(19)20)5-2-6-17-11/h1-7H,(H,17,18)(H,19,20)",JZFPYUNJRRFVQU-UHFFFAOYSA-N,C13H9F3N2O2,282.22,2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid,"niflumic acid|4394-00-7|Acido niflumico|Acide niflumique|Niflugel|2-{[3-(trifluoromethyl)phenyl]amino}pyridine-3-carboxylic acid|UP 83|Acidum niflumicum|2-(3-(Trifluoromethyl)anilino)nicotinic acid|2-[3-(Trifluoromethyl)anilino]nicotinic acid|DTXSID1023368|4U5MP5IUD8|NSC-758196|UP-83|DTXCID903368|2-(3-[Trifluoromethyl]anilino)nicotinic acid|Acid, Niflumic|2-((3-(trifluoromethyl)phenyl)amino)pyridine-3-carboxylic acid|2-[[3-(trifluoromethyl)phenyl]amino]pyridine-3-carboxylic acid|RefChem:389149|M01AX02|M02AA17|224-516-2|Landruma|Nifluril|Forenol|Nifluminic acid|Acide niflumique [INN-French]|Acido niflumico [INN-Spanish]|Acidum niflumicum [INN-Latin]|2-[3-(trifluoromethyl)anilino]pyridine-3-carboxylic acid|2-((3-(Trifluoromethyl)phenyl)amino)nicotinic acid|2-(3-(Trifluoromethyl)-phenyl)aminonicotinic acid|2-(3-Trifluoromethylanilino)nicotinic Acid|MFCD00010569|3-Pyridinecarboxylic acid, 2-[[3-(trifluoromethyl)phenyl]amino]-|Lopac-N-0630|Niflumic acid (INN)|2-(alpha,alpha,alpha-Trifluoro-m-toluidino)nicotinic acid|2-{[3-(TRIFLUOROMETHYL)PHENYL]AMINO}NICOTINIC ACID|2-[(3-TRIFLUOROMETHYL)PHENYL]AMINO-3-PYRIDINE-CARBOXYLIC ACID|MLS000069713|NFL|CHEBI:34888|3-Pyridinecarboxylic acid, 2-((3-(trifluoromethyl)phenyl)amino)-|2-(3-(Trifluoromethyl)phenylamino)nicotinic acid|Niflumic Acid-d5|NCGC00015724-10|Niflumate|SMR000058199|CAS-4394-00-7|M02156|NIFLUMIC ACID [INN]|Acide niflumique [French]|Acido niflumico [Italian]|Niflumic Acid-d5 (Major)|Niflamol|Niflugel (TN)|SC 1332|CCRIS 5740|1794811-58-7|SR-01000000231|EINECS 224-516-2|2-(3-Trifluoromethyl-phenylamino)-nicotinic acid|UNII-4U5MP5IUD8|BRN 0489360|niflumic-acid|ni-flumic acid|Niflumic acid [INN:BAN:DCF]|Actol, analgesic|Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino [French]|Prestwick_890|Aza-2 dimethyl-2',3' (tetrazolyl-5)-6 diphenylamino|Spectrum_001353|1td7|2-[[3-(trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic acid|Opera_ID_1746|Prestwick0_000255|Prestwick1_000255|Prestwick2_000255|Prestwick3_000255|Spectrum2_000794|Spectrum3_001485|Spectrum4_000043|Spectrum5_001216|Niflumic acid (Standard)|Niflumic acid (Hit 16)|N 0630|NIFLUMIC ACID [MI]|2-[(3-Trifluoromethylphenyl)amino]nicotinic Acid|CBiol_001828|Lopac0_000845|SCHEMBL24706|BSPBio_000070|BSPBio_001393|BSPBio_003069|KBioGR_000113|KBioGR_000505|KBioSS_000113|KBioSS_001833|5-22-13-00598 (Beilstein Handbook Reference)|MLS001076327|CHEMBL63323|DivK1c_000277|SPECTRUM1502015|SPBio_000928|SPBio_002289|NIFLUMIC ACID [MART.]|BPBio1_000078|GTPL2439|orb1310379|NIFLUMIC ACID [WHO-DD]|SCHEMBL29364001|SCHEMBL29373503|BDBM85507|HMS500N19|HY-B0493R|KBio1_000277|KBio2_000113|KBio2_001833|KBio2_002681|KBio2_004401|KBio2_005249|KBio2_006969|KBio3_000225|KBio3_000226|KBio3_002569|MSK7198|NINDS_000277|2-[(3-Trifluoromethyl)phenyl]amino]-3-pyridinecarboxylic Acid|Bio1_000114|Bio1_000603|Bio1_001092|Bio2_000113|Bio2_000593|GLXC-07398|HMS1361F15|HMS1568D12|HMS1791F15|HMS1921D12|HMS1989F15|HMS2090D19|HMS2095D12|HMS2234F11|HMS3262J11|HMS3374H01|HMS3402F15|HMS3649A08|HMS3656P14|HMS3712D12|HMS3885I03|HMS5081O04|Nicotinic acid, 2-(alpha,alpha,alpha-trifluoro-m-toluidino)-|Pharmakon1600-01502015|HY-B0493|NIFLUMIC ACID [EP IMPURITY]|NSC_4488|UWC81158|Tox21_110206|Tox21_500845|BBL003619|CCG-40157|DL-457|Nicotinic acid, 2-(.alpha.,.alpha.,.alpha.-trifluoro-m-toluidino)-|NIFLUMIC ACID [EP MONOGRAPH]|NSC758196|s3018|SBB001146|STK803109|AKOS000519590|Tox21_110206_1|AC-2652|DB04552|FN26214|GS-3202|LP00845|NSC 758196|SDCCGSBI-0050821.P004|IDI1_000277|IDI1_033863|NCGC00015724-01|NCGC00015724-02|NCGC00015724-03|NCGC00015724-04|NCGC00015724-05|NCGC00015724-06|NCGC00015724-07|NCGC00015724-08|NCGC00015724-09|NCGC00015724-11|NCGC00015724-12|NCGC00015724-13|NCGC00015724-14|NCGC00015724-17|NCGC00015724-29|NCGC00023636-03|NCGC00023636-04|NCGC00023636-05|NCGC00023636-06|NCGC00023636-07|NCGC00023636-08|NCGC00023636-09|NCGC00261530-01|ST013871|SY002411|CAS_4394-00-7|SBI-0050821.P003|2(3'-trifluormethylanilino)-nicotinic acid|AB00052255|EU-0100845|NS00010059|SW197011-3|T2353|EN300-17360|D08275|H10042|AB00052255-17|AB00052255_18|AB00052255_19|2-((3-(Trifluoromethyl)phenyl)amino)nicotinicacid|394N007|Q304285|SR-01000000231-2|SR-01000000231-5|SR-01000000231-6|BRD-K98763141-001-04-3|BRD-K98763141-001-06-8|BRD-K98763141-001-17-5|BRD-K98763141-001-29-0|BRD-K98763141-001-30-8|SR-01000000231-11|Z56922127|2-[3-(Trifluoromethyl)anilino]-3-pyridinecarboxylic acid|Niflumic acid, European Pharmacopoeia (EP) Reference Standard"
EMAVUSERTIB,118224491,,"InChI=1S/C24H25N7O5/c1-14-10-15(2-4-25-14)23-27-18(13-35-23)22(33)26-17-11-19-20(28-21(17)31-5-3-16(32)12-31)29-24(36-19)30-6-8-34-9-7-30/h2,4,10-11,13,16,32H,3,5-9,12H2,1H3,(H,26,33)/t16-/m1/s1",SJHNWSAWWOAWJH-MRXNPFEDSA-N,C24H25N7O5,491.5,"N-[5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-morpholin-4-yl-[1,3]oxazolo[4,5-b]pyridin-6-yl]-2-(2-methylpyridin-4-yl)-1,3-oxazole-4-carboxamide","Emavusertib|1801344-14-8|4-Oxazolecarboxamide, N-[5-[(3R)-3-hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-|Emavusertib [INN]|AU-4948|Emavusertib [USAN]|MH5DMF9JKY|CA4948|Emavusertib (CA-4948)|(R)-N-(5-(3-Hydroxypyrrolidin-1-yl)-2-morpholinooxazolo[4,5-b]pyridin-6-yl)-2-(2-methylpyridin-4-yl)oxazole-4-carboxamide|CHEMBL4783351|N-[5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-morpholin-4-yl-[1,3]oxazolo[4,5-b]pyridin-6-yl]-2-(2-methylpyridin-4-yl)-1,3-oxazole-4-carboxamide|2-(2-methylpyridin-4-yl)-N-[2-morpholin-4-yl-5-[(3R)-3-oxidanylpyrrolidin-1-yl]-[1,3]oxazolo[4,5-b]pyridin-6-yl]-1,3-oxazole-4-carboxamide|4-Oxazolecarboxamide, N-(5-((3R)-3-hydroxy-1-pyrrolidinyl)-2-(4-morpholinyl)oxazolo(4,5-b)pyridin-6-yl)-2-(2-methyl-4-pyridinyl)-|N-(5-((3R)-3-Hydroxy-1-pyrrolidinyl)-2-(4-morpholinyl)oxazolo(4,5-b)pyridin-6-yl)-2-(2-methyl-4-pyridinyl)-4-oxazolecarboxamide|N-[5-[(3R)-3-Hydroxy-1-pyrrolidinyl]-2-(4-morpholinyl)oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridinyl)-4-oxazolecarboxamide|Emavusertib [WHO-DD]|UNII-MH5DMF9JKY|Emavusertib (USAN/INN)|Emavusertib [USAN:INN]|Emavusertib(CA-4948)|orb1298434|SCHEMBL16896638|SCHEMBL29386747|SCHEMBL29505539|GTPL10152|C24H25N7O5|DTXSID001103300|EX-A4736|AU4948|BDBM50547964|NSC824184|s9779|WHO 11558|AKOS040759627|NSC-824184|compound 24 [PMID: 33335659]|AC-36757|DA-61991|MS-29134|HY-135317|CS-0111301|D12411|G60989|Z3769318307|FJ0|N-(5-((3R)-3-Hydroxypyrrolidin-1-yl)-2-(morpholin-4- yl)(1,3)oxazolo(4,5-b)pyridin-6-yl)-2-(2-methylpyridin-4- YL)-1,3-oxazole-4-carboxamide|N-[5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-morpholino-oxazolo[4,5-b]pyridin-6-yl]-2-(2-methyl-4-pyridyl)oxazole-4-carboxamide|N-{5-[(3R)-3-hydroxypyrrolidin-1-yl]-2-(morpholin-4-yl)[1,3]oxazolo[4,5-b]pyridin-6-yl}-2-(2-methylpyridin-4-yl)-1,3-oxazole-4-carboxamide"
IPN-60090,118627280,,"InChI=1S/C24H27F3N8O3/c1-14-7-18(38-19-10-24(26,27)11-19)8-17(29-14)9-22(36)30-21-6-5-16(31-33-21)4-3-15(25)12-35-13-20(32-34-35)23(37)28-2/h5-8,13,15,19H,3-4,9-12H2,1-2H3,(H,28,37)(H,30,33,36)/t15-/m1/s1",GEHZIZWHNLQFAS-OAHLLOKOSA-N,C24H27F3N8O3,532.5,"1-[(2R)-4-[6-[[2-[4-(3,3-difluorocyclobutyl)oxy-6-methylpyridin-2-yl]acetyl]amino]pyridazin-3-yl]-2-fluorobutyl]-N-methyltriazole-4-carboxamide","IPN60090|1853164-83-6|IPN-60090|IACS-6274|1-[(2R)-4-[6-[[2-[4-(3,3-difluorocyclobutyl)oxy-6-methylpyridin-2-yl]acetyl]amino]pyridazin-3-yl]-2-fluorobutyl]-N-methyltriazole-4-carboxamide|CHEMBL4741924|IACS6274|O6ZT4D087I|orb1709597|Ipn 60090|SCHEMBL17396805|SCHEMBL29479072|SCHEMBL30211002|GTPL12712|GEHZIZWHNLQFAS-OAHLLOKOSA-N|GLXC-23107|HMS6018G16|EX-A8645|IPN 60090 [WHO-DD]|BDBM50548670|NSC830912|AKOS040733265|NSC-830912|Compound 27 [PMID: 33118821]|MS-29839|CID 118627280|HY-103671|CS-0030361|G17637|(R)-1-(4-(6-(2-(4-(3,3-Difluorocyclobutoxy)-6-methylpyridin-2-yl)acetamido)pyridazin-3-yl)-2-fluorobutyl)-N-methyl-1H-1,2,3-triazole-4-carboxamide|1-((2R)-4-(6-(2-(4-(3,3-DIFLUOROCYCLOBUTOXY)-6-METHYLPYRIDIN-2-YL)ACETAMIDO)PYRIDAZIN-3-YL)-2-FLUOROBUTYL)-N-METHYL-1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE|4-((3,3-DIFLUOROCYCLOBUTYL)OXY)-N-(6-((3R)-3-FLUORO-4-(4-((METHYLAMINO)CARBONYL)-1H-1,2,3-TRIAZOL-1-YL)BUTYL)-3-PYRIDAZINYL)-6-METHYL-2-PYRIDINEACETAMIDE"
LY-3475070,152262911,,"InChI=1S/C15H18N4O2/c1-7(2)9-4-11(9)10-5-13(19-18-8(10)3)12-6-16-15(21)17-14(12)20/h5-7,9,11H,4H2,1-3H3,(H2,16,17,20,21)/t9-,11+/m1/s1",WHRUIISQCORGKK-KOLCDFICSA-N,C15H18N4O2,286.33,"5-[6-methyl-5-[(1S,2R)-2-propan-2-ylcyclopropyl]pyridazin-3-yl]-1H-pyrimidine-2,4-dione","2375815-63-5|LY-3475070|CD73-IN-3|5-(5-((1S,2R)-2-Isopropylcyclopropyl)-6-methylpyridazin-3-yl)pyrimidine-2,4(1H,3H)-dione|ly3475070|5-[6-Methyl-5-[(1S,2R)-2-propan-2-ylcyclopropyl]pyridazin-3-yl]-1H-pyrimidine-2,4-dione|AKA9175T4N|CHEMBL4792487|Ly 3475070|RefChem:1088631|orb1298561|SCHEMBL22869352|SCHEMBL29384809|CD73 Inhibitor LY3475070|EX-A4254|BDBM50552098|LY 3475070 [WHO-DD]|AC-36531|MS-24089|HY-137246|CS-0137331|F78018|5-[5-[(1S,2R)-2-isopropylcyclopropyl]-6-methyl-pyridazin-3-yl]-1H-pyrimidine-2,4-dione"
LAZERTINIB,121269225,,"InChI=1S/C30H34N8O3/c1-5-28(39)32-23-17-24(26(40-4)18-25(23)37-13-15-41-16-14-37)33-30-31-12-11-27(34-30)38-20-22(19-36(2)3)29(35-38)21-9-7-6-8-10-21/h5-12,17-18,20H,1,13-16,19H2,2-4H3,(H,32,39)(H,31,33,34)",RRMJMHOQSALEJJ-UHFFFAOYSA-N,C30H34N8O3,554.6,N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide,"Lazertinib|1903008-80-9|YH-25448|YH25448|GNS1480|GNS-1480|JNJ-73841937-AAA|Lazcluze|N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholinophenyl)acrylamide|C-18112003-G|4A2Y23XK11|N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenylpyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholin-4-ylphenyl]prop-2-enamide|2-Propenamide, N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)-|lazertinibum|N-(5-((4-(4-((dimethylamino)methyl)-3-phenylpyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-morpholin-4-ylphenyl)prop-2-enamide|RefChem:798668|YH 25448|N-(5-((4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-yl)amino)-4-methoxy-2-(morpholin-4-yl)phenyl)prop-2-enamide|Lazertinib [USAN]|Leclaza|Lazertinib?|Lazertinib  [INN]|LAZERTINIB [INN]|Lazertinib (USAN/INN)|Lazertinib [USAN:INN]|LAZERTINIB [WHO-DD]|UNII-4A2Y23XK11|orb1689983|CHEMBL4558324|SCHEMBL17670400|GTPL10136|RRMJMHOQSALEJJ-UHFFFAOYSA-N|C30H34N8O3|GLXC-21722|BCP30440|DBD00880|EX-A1912|BDBM50555575|s8724|WHO 10587|AKOS037515597|CCG-270023|Lazertinib (YH25448,GNS-1480)|YH-25448;GNS-1480|AC-36243|BP-43658|BS-15742|DA-74916|Compound 73 [WO2016060443A2]|HY-109061|CS-0032992|D11980|YH-25448; YH 25448; YH25448; GNS-1480; GNS 1480; GNS1480|Lazertinib; 2-Propenamide, N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phenyl]- (ACI); N-[5-[[4-[4-[(Dimethylamino)methyl]-3-phenyl-1H-pyrazol-1-yl]-2-pyrimidinyl]amino]-4-methoxy-2-(4-morpholinyl)phen|N-(5-((4-(4-((Dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)-2-pyrimidinyl)amino)-4-methoxy-2-(4-morpholinyl)phenyl)acrylamide|N-(5-(4-(4-((dimethylamino)methyl)-3-phenyl-1H-pyrazol-1-yl)pyrimidin-2-ylamino)-4-methoxy-2-morpholinophenyl)acrylamide|N-[5-[[4-[4-[(dimethylamino)methyl]-3-phenyl-pyrazol-1-yl]pyrimidin-2-yl]amino]-4-methoxy-2-morpholino-phenyl]prop-2-enamide"
BATOPROTAFIB,118238370,,"InChI=1S/C18H24ClN7OS/c1-10-14(20)18(9-27-10)3-6-26(7-4-18)12-8-24-17(16(22)25-12)28-11-2-5-23-15(21)13(11)19/h2,5,8,10,14H,3-4,6-7,9,20H2,1H3,(H2,21,23)(H2,22,25)/t10-,14+/m0/s1",UCJZOKGUEJUNIO-IINYFYTJSA-N,C18H24ClN7OS,421.9,"(3S,4S)-8-[6-amino-5-(2-amino-3-chloropyridin-4-yl)sulfanylpyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine","TNO155|batoprotafib|TNO-155|(3S,4S)-8-[6-amino-5-(2-amino-3-chloropyridin-4-yl)sulfanylpyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|Tno 155|(3S,4S)-8-{6-amino-5-[(2-amino-3-chloropyridin-4-yl)sulfanyl]pyrazin-2-yl}-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|compound 1 [PMID: 32910655]|(3S,4S)-8-(6-Amino-5-((2-amino-3-chloropyridin-4-yl)sulfanyl)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro(4.5)decan-4-amine|compound 1 (PMID: 32910655)|(3S,4S)-8-(6-amino-5-(2-amino-3-chloropyridin-4-yl)sulfanylpyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro(4.5)decan-4-amine|RefChem:116662|1801765-04-7|FPJWORQEGI|SHP2 inhibitor TNO155|PTPN11 inhibitor TNO155|(3S,4S)-8-(6-Amino-5-((2-amino-3-chloropyridin-4-yl)thio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|(3S,4S)-8-[6-Amino-5-[(2-amino-3-chloro-4-pyridinyl)thio]-2-pyrazinyl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|MFCD32693919|C18H24ClN7OS|BCP33299|Batoprotafib [INN]|UNII-FPJWORQEGI|orb1309000|CHEMBL4650521|SCHEMBL16914359|SCHEMBL29361190|SCHEMBL29827911|TNO 155 [WHO-DD]|GTPL12068|TNO155?|GLXC-22546|EX-A3645|TNO-155; TNO 155|BDBM50553783|NSC825523|AKOS040740434|NSC-825523|AC-36494|MS-27407|DB-130941|HY-136173|CS-0120271|D81634|(3S,4S)-8-(6-Amino-5-(2-amino-3-chloropyridin-4-ylthio)pyrazin-2-yl)-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|(3S,4S)-8-[6-amino-5-[(2-amino-3-chloro-4-pyridyl)sulfanyl]pyrazin-2-yl]-3-methyl-2-oxa-8-azaspiro[4.5]decan-4-amine|(3S,4S)-8-{6-amino-5-[(2-amino-3-chloropyridin-4- yl)sulfanyl]pyrazin-2-yl}-3-methyl-2-oxa-8- azaspiro[4.5]decan-4-amine|2-Oxa-8-azaspiro[4.5]decan-4-amine, 8-[6-amino-5-[(2-amino-3-chloro-4-pyridinyl)thio]-2-pyrazinyl]-3-methyl-, (3S,4S)-|VKS"
NITAZOXANIDE,41684,,"InChI=1S/C12H9N3O5S/c1-7(16)20-9-5-3-2-4-8(9)11(17)14-12-13-6-10(21-12)15(18)19/h2-6H,1H3,(H,13,14,17)",YQNQNVDNTFHQSW-UHFFFAOYSA-N,C12H9N3O5S,307.28,"[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate","NITAZOXANIDE|55981-09-4|Alinia|Nitazoxanida|Benzamide, 2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-|Nitazoxanidum|2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate|2-(Acetolyloxy)-N-(5-nitro-2-thiazolyl)benzamide|DTXSID5033757|NSC697855|NSC-697855|NSC-760057|PH 5776|PH-5776|SOA12P041N|Salicylamide, N-(5-nitro-2-thiazolyl)-, acetate (ester)|DTXCID3013757|2-((5-nitro-1,3-thiazol-2-yl)carbamoyl)phenyl acetate|RefChem:55715|P01AX11|Salicylamide, N-(5-nitro-2-thiazolyl)-, Acetate(Ester)|2-((5-nitrothiazol-2-yl)carbamoyl)phenyl acetate|Nitazoxamide|Nitazoxanid|Daxon|Nitazoxanidum [INN-Latin]|Nitazoxanida [INN-Spanish]|C12H9N3O5S|[2-[(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl] acetate|MFCD00416599|NSC 697855|NTZ|2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide|2-Acetyloxy-N-[(5-nitro-2-thiazolyl)]benzamide|N-(5-Nitrothiazol-2-yl)salicylamide acetate ester|Cryptaz|[2-[(5-nitrothiazol-2-yl)carbamoyl]phenyl] acetate|MMV688991|NCGC00090774-01|Colufase|Heliton|Phavic-1|SMR000466367|Alinia (TN)|AZT + Nitazoxanide|CAS-55981-09-4|S1627|2-[(5-Nitrothiazol-2-yl)carbamoyl]phenyl Acetate|EINECS 259-931-8|Nitazoxanide (USAN/INN)|(2-((5-Nitro-2-thiazolyl)carbamoyl)phenyl)acetat|BRN 1225475|UNII-SOA12P041N|N-(5-Nitro-2-thiazolyl)salicylamide acetate (ester)|Nitrazoxanide|Pacovanton|Dexidex|Kidonax|Nitazox|Paramix|Nitax|Toza|Nitazoxanide [USAN:INN:BAN]|Alinia(TM)|o-(N-(5-Nitrothiazol-2-yl)carbamoyl)phenyl acetate|CPD000466367|Nitazoxanide (Standard)|NITAZOXANIDE [MI]|NITAZOXANIDE [INN]|NCIMech_000843|NITAZOXANIDE [USAN]|CHEMBL1401|NITAZOXANIDE [VANDF]|Oprea1_263587|SCHEMBL40981|NITAZOXANIDE [MART.]|MLS000759492|MLS001424074|MLS006010127|NITAZOXANIDE [USP-RS]|NITAZOXANIDE [WHO-DD]|Nitazoxanide (Alinia, Annita)|orb1308235|Nitazoxanide (Alinia, Annita)?|SCHEMBL29373905|CHEBI:94807|HY-B0217R|Nitazoxanide - Bio-X trade mark|NITAZOXANIDE [GREEN BOOK]|Nitazoxanide, >=98% (HPLC)|NTZ;NSC 697855|GLXC-05393|HMS2051L04|HMS3393L04|HMS3655M11|HMS3715F10|HMS5079I22|NITAZOXANIDE [ORANGE BOOK]|Pharmakon1600-01503843|BCP13918|HY-B0217|Tox21_111018|Tox21_201226|BDBM50075050|CCG-35851|MSK156811|NSC760057|STK395664|AKOS015915393|Tox21_111018_1|AC-1302|DB00507|FN26229|KS-1160|NC00246|NCGC00090774-02|NCGC00090774-03|NCGC00090774-04|NCGC00090774-05|NCGC00258778-01|BN164151|NCI60_034935|SY108901|N1031|Nitrazoxanide 100 microg/mL in Acetonitrile|NS00033434|ST51059722|SW197626-2|D02486|EN300-220095|AB00639988-07|AB00639988-09|AB00639988_10|AB00639988_11|2-(acetyloxy)-N-(5-nitro-2-thiazolyl)-benzamide|981N094|F076695|SR-01000759418|Q2943789|SR-01000759418-9|BRD-K96471533-001-07-4|BRD-K96471533-001-08-2|BRD-K96471533-001-09-0|BRD-K96471533-001-10-8|NTZ; 2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide|Salicylamide, N-(5-nitro-2-thiazolyl)- acetate (ester)|Z1514087129|2-[N-(5-nitro-1,3-thiazol-2-yl)carbamoyl]phenyl acetate|Nitazoxanide, United States Pharmacopeia (USP) Reference Standard|acetic acid [2-[[(5-nitro-2-thiazolyl)amino]-oxomethyl]phenyl] ester|2-(Acetyloxy)-N-(5-nitro-2-thiazolyl)benzamide;o-[N-(5-Nitrothiazol-2-yl)carbamoyl]phenyl acetate|Zox"
AVANAFIL,9869929,,"InChI=1S/C23H26ClN7O3/c1-34-19-6-5-15(10-18(19)24)11-27-21-17(22(33)28-13-20-25-7-3-8-26-20)12-29-23(30-21)31-9-2-4-16(31)14-32/h3,5-8,10,12,16,32H,2,4,9,11,13-14H2,1H3,(H,28,33)(H,27,29,30)/t16-/m0/s1",WEAJZXNPAWBCOA-INIZCTEOSA-N,C23H26ClN7O3,483.9,4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide,"Avanafil|330784-47-9|STENDRA|Spedra|TA-1790|TA 1790|Avanafilo|CHEBI:66876|DR5S136IVO|(S)-4-(3-Chloro-4-methoxybenzylamino)-2-(2-hydroxymethylpyrrolidin-1-yl)-N-pyrimidin-2-ylmethyl-5-pyrimidinecarboxamide|DTXSID50186727|4-[(3-chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide|5-Pyrimidinecarboxamide, 4-(((3-chloro-4-methoxyphenyl)methyl)amino)-2-((2S)-2-(hydroxymethyl)-1-pyrrolidinyl)-N-(2-pyrimidinylmethyl)-|4-((3-Chloro-4-methoxybenzyl)amino)-2-((2S)-2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide|4-((3-chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)-1-pyrrolidinyl)-n-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide|4-[(3-chloro-4-methoxyphenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide|avanafilum|4-((3-chloro-4-methoxyphenyl)methylamino)-2-((2S)-2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide|RefChem:54352|DTXCID90109218|G04BE10|(S)-4-((3-Chloro-4-methoxybenzyl)amino)-2-(2-(hydroxymethyl)pyrrolidin-1-yl)-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide|(S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine|MFCD11977961|C23H26ClN7O3|(S)-4-[(3-Chloro-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2pyrimidinylmethyl)-5-pyrimidinecarboxamide|Stendra (TN)|Avanafil [USAN:INN]|UNII-DR5S136IVO|Zepeed|ine-5-carboxamide|4-[(3-Chloro-4-methoxybenzyl)amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamide|5-Pyrimidinecarboxamide, 4-[[(3-chloro-4-methoxyphenyl)methyl]amino]-2-[(2S)-2-(hydroxymethyl)-1-pyrrolidinyl]-N-(2-pyrimidinylmethyl)-; (S)-2-(2-Hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[(2-pyrimidinylmethyl)carbamoyl]pyrimidine; Avanafil; TA 1790|MFCD11973638|Spedra (TN)|AVANAFIL [USAN]|Avanafil (USAN/INN)|AVANAFIL [INN]|AVANAFIL [MI]|AVANAFIL [VANDF]|AVANAFIL [MART.]|AVANAFIL [WHO-DD]|Avanafil(TA-1790)?|Avanafil 100 microg/mL in Acetonitrile:Dimethylsulfoxide|Avanafil - Bio-X trade mark|SCHEMBL118799|AVANAFIL [ORANGE BOOK]|GTPL7448|orb1305659|CHEMBL1963681|SCHEMBL29372265|WEAJZXNPAWBCOA-INIZCTEOSA-N|GLXC-15747|MSK10808|BDBM50036629|CS1566|s4019|AKOS024462448|CCG-229896|DB06237|FC18033|VI-0162|NCGC00386241-01|4-[(3-chloro-4-methoxy-phenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimidine-5-carboxamide|AS-20106|BC300048|HY-18252|SY028093|NS00014947|SW219217-1|D03217|AB01565827_02|EN300-6481290|Q2873270|BRD-K65781196-001-01-4|BRD-K65781196-001-03-0|BRD-K65781196-001-04-8|Z2235802070|(S)-2-(2-hydroxymethyl-1-pyrrolidinyl)-4-(3-chloro-4-methoxybenzylamino)-5-[N-(2-pyrimidylmethyl)carbamoyl]-pyrimidine|(S)-4-[(3-Chlor-4-methoxybenzyl)amino]-2-[2-(hydroxymethyl)-1- pyrrolidinyl]-N-(2-pyrimidinylmethyl)-5-pyrimidinecarboxamid|4-[(3-chloranyl-4-methoxy-phenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimid|4-[(3-chloranyl-4-methoxy-phenyl)methylamino]-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-(pyrimidin-2-ylmethyl)pyrimid ine-5-carboxamide|4-[(3-Chloro-4-methoxybenzyl)amino]-2-[(S)-2-(hydroxymethyl)-1-pyrrolidyl]-N-[(2-pyrimidyl)methyl]-5-pyrimidinecarboxamide|4-{[(3-chloro-4-methoxyphenyl)methyl]amino}-2-[(2S)-2-(hydroxymethyl)pyrrolidin-1-yl]-N-[(pyrimidin-2-yl)methyl]pyrimidine-5-carboxamide|E6L"
DOTINURAD,51349053,,"InChI=1S/C14H9Cl2NO4S/c15-9-5-8(6-10(16)13(9)18)14(19)17-7-22(20,21)12-4-2-1-3-11(12)17/h1-6,18H,7H2",VOFLAIHEELWYGO-UHFFFAOYSA-N,C14H9Cl2NO4S,358.2,"(3,5-dichloro-4-hydroxyphenyl)-(1,1-dioxo-2H-1,3-benzothiazol-3-yl)methanone","Dotinurad|1285572-51-1|FYU-981|Urece|305EB53128|Methanone, (3,5-dichloro-4-hydroxyphenyl)(1,1-dioxido-3(2H)-benzothiazolyl)-|dotinuradum|RefChem:590379|DTXSID601336927|Dotinurad [INN]|(3,5-dichloro-4-hydroxyphenyl)(1,1-dioxidobenzo[d]thiazol-3(2H)-yl)methanone|(3,5-dichloro-4-hydroxyphenyl)-(1,1-dioxo-2H-1,3-benzothiazol-3-yl)methanone|A1AIK|Dotinurad?|Urece (TN)|Dotinurad (JAN/INN)|DOTINURAD [JAN]|DOTINURAD [WHO-DD]|FYU981|orb1089694|CHEMBL4594446|SCHEMBL10322525|SCHEMBL29935445|GTPL11389|VOFLAIHEELWYGO-UHFFFAOYSA-N|GLXC-22677|HMS5087G10|UNII-305EB53128|EX-A5737|BDBM50561689|AKOS040741664|AC-38228|TS-07977|DB-145795|HY-109031|CS-0030545|D11071|G83006|(3,5-Dichloro-4-hydroxyphenyl)(1,1-dioxido-3(2h)-benzothiazolyl)methanone|(3,5-dichloro-4-hydroxy-phenyl)-(1,1-dioxo-2H-1,3-benzothiazol-3-yl)methanone|3-(3,5-dichloro-4-hydroxybenzoyl)-1,1-dioxo-2,3-dihydro-1,3-benzothiazole"
ELECLAZINE,71183216,,"InChI=1S/C21H16F3N3O3/c22-21(23,24)30-16-5-2-14(3-6-16)15-4-7-18-17(12-15)20(28)27(10-11-29-18)13-19-25-8-1-9-26-19/h1-9,12H,10-11,13H2",YNUAEEJQYHYLMS-UHFFFAOYSA-N,C21H16F3N3O3,415.4,"4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one","Eleclazine|1443211-72-0|GS-6615|Eleclazina|PUY08529FK|4-(pyrimidin-2-ylmethyl)-7-[4-(trifluoromethoxy)phenyl]-2,3-dihydro-1,4-benzoxazepin-5-one|1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-(4-(trifluoromethoxy)phenyl)-|1,4-Benzoxazepin-5(2H)-one, 3,4-dihydro-4-(2-pyrimidinylmethyl)-7-[4-(trifluoromethoxy)phenyl]-|eleclazinum|4-(pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-2,3-dihydro-1,4-benzoxazepin-5-one|RefChem:590698|4-((pyrimidin-2-yl)methyl)-7-(4-(trifluoromethoxy)phenyl)-2,3,4,5-tetrahydro-1,4-benzoxazepin-5-one|Eleclazine [INN]|4-(pyrimidin-2-ylmethyl)-7-(4-(trifluoromethoxy)phenyl)-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one|MFCD28963966|Eleclazine [USAN:INN]|UNII-PUY08529FK|Eleclazine (USAN/INN)|ELECLAZINE [USAN]|Eleclazine(GS-6615)?|ELECLAZINE [WHO-DD]|GTPL8413|orb1737549|CHEMBL3707392|SCHEMBL14480722|SCHEMBL29377130|BCP32599|BDBM50563816|GS6615|AKOS030627706|DB12394|SB19622|AS-35245|NS00073613|D11155|GS-6615; GS 6615; GS6615|Q27077170|4-(PYRIMIDIN-2-YLMETHYL)-7-(4-(TRIFLUOROMETHOXY)PHENYL)-3,4-DIHYDRO-1,4-BENZOXAZEPIN-5(2H)-ONE"
CPI-1205,78320408,,"InChI=1S/C27H33F3N4O3/c1-16-13-23(37-4)21(25(35)32-16)14-31-26(36)24-18(3)34(22-8-6-5-7-20(22)24)17(2)19-9-11-33(12-10-19)15-27(28,29)30/h5-8,13,17,19H,9-12,14-15H2,1-4H3,(H,31,36)(H,32,35)/t17-/m1/s1",HPODOLXTMDHLLC-QGZVFWFLSA-N,C27H33F3N4O3,518.6,"N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide","CPI-1205|1621862-70-1|Lirametostat|Ezh2 inhibitor cpi-1205|(R)-N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-(1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]indole-3-carboxamide|455J2479FY|1H-Indole-3-carboxamide, N-[(1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)-4-piperidinyl]ethyl]-|1H-Indole-3-carboxamide, N-((1,2-dihydro-4-methoxy-6-methyl-2-oxo-3-pyridinyl)methyl)-2-methyl-1-((1R)-1-(1-(2,2,2-trifluoroethyl)-4-piperidinyl)ethyl)-|N-((4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl)-2-methyl-1-((1R)-1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)-1H-indole-3-carboxamide|N-((4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl)-2-methyl-1-((1R)-1-(1-(2,2,2-trifluoroethyl)piperidin-4-yl)ethyl)indole-3-carboxamide|N-[(4-methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)piperidin-4-yl]ethyl]-1H-indole-3-carboxamide|RefChem:128349|CPI1205|CPI 1205|HPODOLXTMDHLLC-QGZVFWFLSA-N|LIRAMETOSTAT [INN]|LIRAMETOSTAT [WHO-DD]|GTPL9115|orb1298870|CHEMBL4297463|SCHEMBL17329268|SCHEMBL29361104|UNII-455J2479FY|C27H33F3N4O3|GLXC-10078|BCP19174|EX-A1068|WPC86270|BDBM50541920|MFCD30470657|NSC793430|s8353|AKOS030628484|CCG-269843|CS-7648|DB14581|NSC-793430|SB19773|compound 13 [PMID: 27739677]|AC-35895|DA-52117|TS-09815|HY-100021|N-[(4-methoxy-6-methyl-2-oxo-1H-pyridin-3-yl)methyl]-2-methyl-1-[(1R)-1-[1-(2,2,2-trifluoroethyl)-4-piperidyl]ethyl]indole-3-carboxamide"
ATABECESTAT,68254185,,"InChI=1S/C18H14FN5OS/c1-18(6-7-26-17(21)24-18)13-8-12(3-4-14(13)19)23-16(25)15-5-2-11(9-20)10-22-15/h2-8,10H,1H3,(H2,21,24)(H,23,25)/t18-/m0/s1",VLLFGVHGKLDDLW-SFHVURJKSA-N,C18H14FN5OS,367.4,"N-[3-[(4S)-2-amino-4-methyl-1,3-thiazin-4-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide","Atabecestat|1200493-78-2|JNJ-54861911|JNJ-54861911-AAA|RSC-385896|2834W8D6GK|N-[3-[(4S)-2-amino-4-methyl-1,3-thiazin-4-yl]-4-fluorophenyl]-5-cyanopyridine-2-carboxamide|atabecestatum|N-(3-((4S)-2-amino-4-methyl-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyanopyridine-2-carboxamide|RefChem:560295|N-(3-((4S)-2-AMINO-4-METHYL-4H-1,3-THIAZIN-4-YL)-4-FLUOROPHENYL)-5-CYANOPYRIDINE-2-CARBOXAMIDE|Atabecestat [INN]|Atabecestat [USAN]|(S)-N-(3-(2-amino-4-methyl-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyanopicolinamide|2-pyridinecarboxamide, N-(3-((4S)-2-amino-4-methyl-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyano-|N-[3-[(4S)-2-azanyl-4-methyl-1,3-thiazin-4-yl]-4-fluoranyl-phenyl]-5-cyano-pyridine-2-carboxamide|Atabecestat (USAN/INN)|Atabecestat [USAN:INN]|UNII-2834W8D6GK|GTPL9963|orb1707631|CHEMBL3916243|SCHEMBL12359105|SCHEMBL29360198|SCHEMBL30477097|BDBM210070|EX-A6458|AKOS040741175|DB15307|RSC- 385896|DA-61284|MS-25881|HY-109052|CS-0031557|D11456|G16264|US9270353, 17|h3C|N-(3-((4S)-2-AMINO-4-METHYL-4H-1,3-THIAZIN-4-YL)-4-FLUOROPHENYL)-5- CYANOPYRIDINE-2-CARBOXAMIDE|N-(3-((4S)-2-Amino-4-methyl-4H-1,3-thiazin-4-yl)-4-fluorophenyl)-5-cyano-2-pyridinecarboxamide"
GSK-2256098,46214930,,"InChI=1S/C20H23ClN6O2/c1-12(2)27-19(9-13(3)25-27)24-18-10-17(15(21)11-22-18)23-16-8-6-5-7-14(16)20(28)26-29-4/h5-12H,1-4H3,(H,26,28)(H2,22,23,24)",BVAHPPKGOOJSPU-UHFFFAOYSA-N,C20H23ClN6O2,414.9,2-[[5-chloro-2-[(5-methyl-2-propan-2-ylpyrazol-3-yl)amino]pyridin-4-yl]amino]-N-methoxybenzamide,"GSK2256098|1224887-10-8|GSK-2256098|R7O0O4110G|2-[(5-chloro-2-{[3-methyl-1-(propan-2-yl)-1H-pyrazol-5-yl]amino}pyridin-4-yl)amino]-N-methoxybenzamide|2-((5-chloro-2-((3-methyl-1-(propan-2-yl)-1H-pyrazol-5-yl)amino)pyridin-4-yl)amino)-N-methoxybenzamide|RefChem:144510|FAK Inhibitor GSK2256098|Focal Adhesion Kinase Inhibitor GSK2256098|GTPL7939|2-((5-Chloro-2-((1-isopropyl-3-methyl-1H-pyrazol-5-yl)amino)pyridin-4-yl)amino)-N-methoxybenzamide|MFCD30502650|Benzamide, 2-[[5-chloro-2-[[3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino]-4-pyridinyl]amino]-N-methoxy-|CHEMBL4742157|GSK 2256098|2-[[5-chloro-2-[[3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino]-4-pyridinyl]amino]-N-methoxybenzamide|2-[[5-chloro-2-[(5-methyl-2-propan-2-ylpyrazol-3-yl)amino]pyridin-4-yl]amino]-N-methoxybenzamide|GTPL7939;2-[[5-chloro-2-[(5-methyl-2-propan-2-ylpyrazol-3-yl)amino]pyridin-4-yl]amino]-N-methoxybenzamide|BVAHPPKGOOJSPU-UHFFFAOYSA-N|2-((5-CHLORO-2-((3-METHYL-1-(1-METHYLETHYL)-1H-PYRAZOL-5-YL)AMINO)-4-PYRIDINYL)AMINO)-N-METHOXYBENZAMIDE|BENZAMIDE, 2-((5-CHLORO-2-((3-METHYL-1-(1-METHYLETHYL)-1H-PYRAZOL-5-YL)AMINO)-4-PYRIDINYL)AMINO)-N-METHOXY-|C20H23ClN6O2|SCHEMBL691518|UNII-R7O0O4110G|orb1305806|SCHEMBL29361345|EX-A671|BCP18311|BDBM50568532|NSC800999|s8523|GSK2256098 [WHO-DD]|AKOS030627136|CCG-268826|CS-6083|NSC-800999|GSK2256098?|AC-29885|AS-74894|SY235581|DB-192255|HY-100498|Q27077884|2-(5-chloro-2-(1-isopropyl-3-methyl-1H-pyrazol-5-ylamino)pyridin-4-ylamino)-N-methoxybenzamide|2-[(5-Chloro-2-{[3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino}-4-pyridiny)amino]-N-(methyloxy)benzamide|2-[(5-Chloro-2-{[3-methyl-1-(1-methylethyl)-1H-pyrazol-5-yl]amino}-4-pyridinyl)amino]-N-(methyloxy)benzamide|2-[[5-Chloro-2-[(1-isopropyl-3-methyl-5-pyrazolyl)amino]-4-pyridyl]amino]-N-methoxybenzamide|2-[[5-chloro-2-[(2-isopropyl-5-methyl-pyrazol-3-yl)amino]-4-pyridyl]amino]-N-methoxy-benzamide"
TRC-253,130229812,,"InChI=1S/C23H21F3N6O2S/c24-23(25,26)17-10-15(13-29-18(17)11-27)31-20(33)22(6-1-7-22)32(21(31)35)14-2-3-19(30-12-14)34-16-4-8-28-9-5-16/h2-3,10,12-13,16,28H,1,4-9H2",OUEHJEYKNYQVRC-UHFFFAOYSA-N,C23H21F3N6O2S,502.5,"5-[8-oxo-5-(6-piperidin-4-yloxypyridin-3-yl)-6-sulfanylidene-5,7-diazaspiro[3.4]octan-7-yl]-3-(trifluoromethyl)pyridine-2-carbonitrile","2110426-27-0|TRC-253|JNJ-63576253|TRC-253 [WHO-DD]|5-[8-oxo-5-(6-piperidin-4-yloxypyridin-3-yl)-6-sulfanylidene-5,7-diazaspiro[3.4]octan-7-yl]-3-(trifluoromethyl)pyridine-2-carbonitrile|compound 5 [PMID: 33470111]|compound 5 (PMID: 33470111)|5-(8-oxo-5-(6-piperidin-4-yloxypyridin-3-yl)-6-sulfanylidene-5,7-diazaspiro(3.4)octan-7-yl)-3-(trifluoromethyl)pyridine-2-carbonitrile|AR Antagonist TRC253|RefChem:150554|Androgen Receptor Antagonist TRC253|JNJ 63576253|TRC253|5-(8-oxo-5-(6-(piperidin-4-yloxy)pyridin-3-yl)-6-thioxo-5,7-diazaspiro[3.4]octan-7-yl)-3-(trifluoromethyl)picolinonitrile|GNG9GQ9Y27|UNII-GNG9GQ9Y27|JNJ-63576253 (free base)|Trc 253|orb1298512|CHEMBL4858811|SCHEMBL19128768|SCHEMBL29385339|TRC 253 [WHO-DD]|GTPL12709|JNJ63576253 HCl|OUEHJEYKNYQVRC-UHFFFAOYSA-N|BDBM493530|EX-A1808|NSC831271|AKOS037652172|NSC-831271|JNJ63576253|US10981926, Cpd No. 43|AC-36765|HY-115282|CS-0034880|JNJ-63576253 (TRC-253)?|5-[5-oxo-8-[6-(4-piperidyloxy)- 3-pyridyl]-7-thioxo-6,8- diazaspiro[3.4]octan-6-yl]-3- (trifluoromethyl)pyridine-2- carbonitrile"
ABIVERTINIB,72734520,,"InChI=1S/C26H26FN7O2/c1-3-23(35)29-17-5-4-6-19(15-17)36-25-20-9-10-28-24(20)31-26(32-25)30-18-7-8-22(21(27)16-18)34-13-11-33(2)12-14-34/h3-10,15-16H,1,11-14H2,2H3,(H,29,35)(H2,28,30,31,32)",UOFYSRZSLXWIQB-UHFFFAOYSA-N,C26H26FN7O2,487.5,"N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide","Avitinib|Abivertinib|1557267-42-1|AC0010|EX-ACEA0010|ACEA100610|CER0OPG92L|AC-0010|A610|2-Propenamide, N-[3-[[2-[[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]-|AC 0010|N-[3-[[2-[3-fluoro-4-(4-methylpiperazin-1-yl)anilino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide|2-Propenamide, N-(3-((2-((3-fluoro-4-(4-methyl-1-piperazinyl)phenyl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)-|N-(3-((2-((3-Fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide|N-{3-[(2-{[3-Fluoro-4-(4-methylpiperazin-1-yl)phenyl]amino}-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy]phenyl}prop-2-enamide|abivertinibum|N-(3-((2-(3-fluoro-4-(4-methylpiperazin-1-yl)anilino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)prop-2-enamide|RefChem:108536|EXACEA0010MA|AC-0010 maleate dihydrate|STI5656|N-(3-((2-((3-Fluoro-4-(4-methyl-1-piperazinyl)phenyl)amino)-7H-pyrrolo(2,3-d)pyrimidin-4-yl)oxy)phenyl)acrylamide|N-(3-((2-((3-Fluoro-4-(4-methylpiperazin-1-yl)phenyl)amino)-7H-pyrrolo[2,3-d]pyrimidin-4-yl)oxy)phenyl)acrylamide|Avitinib (AC0010)|Abivertinib [USAN]|MFCD29089376|Abivertinib (USAN)|1557267-42-1 (free base)|N-(3-{2-[3-Fluoro-4-(4-methyl-piperazin-1-yl)-phenylamino]-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy-phenyl)-acrylamide|Avitinib free base|YKQ|Avitinib free base?|FUJOVEE|UNII-CER0OPG92L|ABIVERTINIB [INN]|avitinib (superceded INN)|AVITINIB [WHO-DD]|ABIVERTINIB [WHO-DD]|orb1304614|CHEMBL4297865|SCHEMBL15453394|SCHEMBL29367586|SCHEMBL29483199|SCHEMBL31031036|C26H26FN7O2|GTPL10044|EX-A783|BDBM294480|GLXC-21801|Avitinib(AC0010/AC0010MA)|BCP16381|US9586965, Cpd 3|s8741|AKOS030632728|CS-W008904|DB15327|AC-35320|DA-71169|DS-19269|HY-19816|CS-0016789|D11308|F17427|~{N}-[3-[[2-[[3-fluoranyl-4-(4-methylpiperazin-1-yl)phenyl]amino]-7~{H}-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]prop-2-enamide|N-(3-((2-((3-fluoro-4-(4-methylpiperazin-1- yl)phenyl)amino)-7H-pyrrolo[2,3-d]- pyrimidin-4-yl)oxy)phenyl)acrylamide|N-(3-(2-(3-Fluoro-4-(4-methylpiperazin-1-yl)phenylamino)-7H-pyrrolo[2,3-d]pyrimidin-4-yloxy)phenyl)acrylamide|N-[3-[[2-[[3-fluoro-4-(4-methyl-1-piperazinyl)phenyl]amino]-7H-pyrrolo[2,3-d]pyrimidin-4-yl]oxy]phenyl]-2-propenamide"
BITHIONOL,2406,,"InChI=1S/C12H6Cl4O2S/c13-5-1-7(15)11(17)9(3-5)19-10-4-6(14)2-8(16)12(10)18/h1-4,17-18H",JFIOVJDNOJYLKP-UHFFFAOYSA-N,C12H6Cl4O2S,356.0,"2,4-dichloro-6-(3,5-dichloro-2-hydroxyphenyl)sulfanylphenol","bithionol|97-18-7|Bithin|2,2'-Thiobis(4,6-dichlorophenol)|Lorothidol|Actamer|Bitionol|Bithionol sulfide|Bisoxyphen|Bithionolate|Lorothiodol|Bidiphen|Neopellis|Bitin|Vancide BL|Usaf B-22|TKhsd|2-Hydroxy-3,5-dichlorophenyl sulfide|Bis(2-hydroxy-3,5-dichlorophenyl) sulfide|Bithionolum|Bis(3,5-dichloro-2-hydroxyphenyl) sulfide|2,2'-sulfanediylbis(4,6-dichlorophenol)|2-Hydroxy-3,5-dichlorophenyl sulphide|2,2'-Dihydroxy-3,3',5,5'-tetrachlorodiphenyl sulfide|2,4-dichloro-6-(3,5-dichloro-2-hydroxyphenyl)sulfanylphenol|CP 3438|NCI-C60628|2,2'-Dihydroxy-3,3',5,5'-tetrachlorodiphenylsulfide|AMT77LS62O|NSC-47129|EPA Pesticide Chemical Code 064201|Phenol, 2,2'-thiobis(4,6-dichloro-|CHEBI:3131|DTXSID9021342|AI3-50518|Phenol, 2,2'-thiobis[4,6-dichloro-|DTXCID701342|2,2'-Thiobis[4,6-dichlorophenol]|RefChem:917364|PHENOL, 2,2'-THIOBIS(4,6-DICHLORO)-|D10AB01|P02BX01|202-565-0|Nobacter|Bithional|6,6'-thiobis(2,4-dichlorophenol)|XEROSIN|XL 7|D 26|MFCD00055727|NSC 47129|MLS000028403|XL-7|1394-04-3|2,4-dichloro-6-(3,5-dichloro-2-hydroxy-phenyl)sulfanyl-phenol|NCGC00018163-06|SMR000058374|Caswell No. 852|Bitionol [INN-Spanish]|Bithionolum [INN-Latin]|Phenol,2'-thiobis[4,6-dichloro-|WLN: QR BG DG FSR BQ CG EG|2,3',5,5'-tetrachlorodiphenyl sulfide|CAS-97-18-7|CCRIS 2043|HSDB 6380|EINECS 202-565-0|UNII-AMT77LS62O|BRN 2003535|6-(3,5-dichloro-2-hydroxyphenylthio)-2,4-dichlorophenol|Bithionol [INN:BAN:JAN:NF]|B1T|Bithin (TN)|2,2'-Thio-bis(4,6-dichlorophenol)|Bithionol (Standard)|Spectrum_000088|Bithionol (JAN/INN)|BITHIONOL [INN]|BITHIONOL [JAN]|BITHIONOL [MI]|BITHIONOL [HSDB]|Spectrum2_000113|Spectrum3_000319|Spectrum4_000257|Spectrum5_000922|BITHIONOL [MART.]|BITHIONOL [WHO-DD]|cid_2406|Oprea1_473080|REGID_for_CID_2406|SCHEMBL64385|BSPBio_001918|KBioGR_000694|KBioSS_000508|DivK1c_000639|SPBio_000126|CHEMBL290106|GTPL2338|orb1310253|Bithionol, >=98% (HPLC)|SCHEMBL29352300|BDBM36880|HMS501P21|JFIOVJDNOJYLKP-UHFFFAOYSA-|KBio1_000639|KBio2_000508|KBio2_003076|KBio2_005644|KBio3_001418|NSC9872|NINDS_000639|HMS5083F11|KUC106451N|NSC-9872|NSC47129|Tox21_110832|Tox21_200384|Tox21_302919|A1B988|HY-17592R|s4552|SBB071906|STL257451|AKOS015856712|Tox21_110832_1|CCG-268103|CS-3874|DB04813|KSC-19-055|IDI1_000639|QTL1_000014|NCGC00018163-01|NCGC00018163-02|NCGC00018163-03|NCGC00018163-04|NCGC00018163-05|NCGC00018163-07|NCGC00018163-08|NCGC00018163-09|NCGC00018163-10|NCGC00021272-04|NCGC00021272-05|NCGC00021272-06|NCGC00256573-01|NCGC00257938-01|BS-18280|DA-71563|HY-17592|Inh 2 [PMID: 32284327]|SBI-0051298.P003|NS00011716|ST45027186|T0865|Bithionol, VETRANAL(TM), analytical standard|C07967|C77336|D00802|EN300-18531364|Q4918862|BRD-K39120595-304-03-9|BRD-K39120595-304-04-7|2,4-dichloro-6-[(3,5-dichloro-2-hydroxy-phenyl)thio]phenol|2,4-dichloro-6-[(3,5-dichloro-2-hydroxyphenyl)sulfanyl]phenol|2,4-dichloro-6-[(3,5-dichloro-2-hydroxyphenyl)thio]phenol|2-[3,5-bis(chloranyl)-2-oxidanyl-phenyl]sulfanyl-4,6-bis(chloranyl)phenol|InChI=1/C12H6Cl4O2S/c13-5-1-7(15)11(17)9(3-5)19-10-4-6(14)2-8(16)12(10)18/h1-4,17-18H"
REMDESIVIR,121304016,,"InChI=1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1",RWWYLEGWBNMMLJ-YSOARWBDSA-N,C27H35N6O8P,602.6,"2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate","Remdesivir|1809249-37-3|GS-5734|Veklury|remdesivirum|GS 5734|3QKI37EEHE|Remdesivir [USAN]|GS5734|CHEBI:145994|2-ethylbutyl (2S)-2-(((2R, 3S, 4R, 5R)-5-(4-aminopyrrolo(2,1-f) (1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl) methoxy)(phenoxy) phosphoryl) amino) propanoate|L-Alanine, N-((S)-hydroxyphenoxyphosphinyl)-, 2-ethylbutyl ester, 6-ester with 2-C-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-2,5-anhydro-D-altrononitrile|2-Ethylbutyl (2S)-2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo(2,1-f)(1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate|2-ETHYLBUTYL N-((S)-(2-C-(4-AMINOPYRROLO(2,1-F)(1,2,4)TRIAZIN-7-YL)-2,5-ANHYDRO-D-ALTRONONITRIL-6-O-YL)PHENOXYPHOSPHORYL)-L-ALANINATE|DTXSID701022537|2-ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]amino}propanoate|RefChem:6679|13C3 GS-5734|13C3-GS-5734|GS-465124|GS-829143|UNII-3QKI37EEHE|REMDESIVIR [WHO-DD]|DTXCID501508113|SARS-CoV-2 antiviral agents: remdesivir|(S)-2-Ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-Aminopyrrolo-(2,1-f)(1,2,4)triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate|GS 5734 [WHO-DD]|REMDESIVIR [INN]|2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate|MFCD31657351|2-ethylbutyl (2S)-2-{[(S)-{[(2R,3S,4R,5R)-5-{4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl}-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy}(phenoxy)phosphoryl]amino}propanoate|C27H35N6O8P|Veklury (TN)|Remdesivir (Standard)|REMDESIVIR [JAN]|Remdesivir (JAN/USAN)|Remdesivir (GS-5734)|Remdesivir(GS-5734)?|CHEMBL4065616|REMDESIVIR [ORANGE BOOK]|SCHEMBL17712225|GTPL10715|med.21724, Compound 178|MSK1935|RWWYLEGWBNMMLJ-YSOARWBDSA-N|BDBM429505|2-ethylbutyl ((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)-L-alaninate|2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-phenoxy-phosphoryl]amino]propanoate|EX-A3265|HB9521|NSC825151|s8932|AKOS032946252|AT11308|BCP24975-1|DB14761|DT-0049|HY-104077R|NSC-825151|compound 4b [PMID: 28124907]|NCGC00686694-01|NCGC00686694-05|AC-31297|AG170167|HY-104077|CS-0028115|D11472|EN300-22849306|F547241|(2S)-2-{(2R,3S,4R,5R)-[5-(4-Aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy]phenoxy-(S)-phosphorylamino}propionic acid 2-ethyl-butyl ester|(S)-2-ethylbutyl 2-(((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphoryl)amino)propanoate|(S)-2-Ethylbutyl 2-((S)-(((2R,3S,4R,5R)-5-(4-aminopyrrolo[1,2-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl)methoxy)(phenoxy)phosphorylamino)propanoate|2-ethylbutyl N-[(S)-{[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxytetrahydrofuran-2-yl]methoxy}(phenoxy)phosphoryl]-L-alaninate|GS 5734;(2S)-2-{(2R,3S,4R,5R)-[5-(4-Aminopyrrolo[2,1-f][1,2 ,4]triazin-7-yl)-5- cyano-3,4-dihydroxy-tetrahydro-furan-2-ylmethoxy]phe noxy-(S)-phosphorylamino}propionic acid 2-ethyl-butyl ester"
ACEBILUSTAT,68488178,,"InChI=1S/C29H27N3O4/c33-29(34)23-5-1-20(2-6-23)16-31-18-25-15-24(31)19-32(25)17-21-3-9-26(10-4-21)36-27-11-7-22(8-12-27)28-30-13-14-35-28/h1-14,24-25H,15-19H2,(H,33,34)/t24-,25-/m0/s1",GERJIEKMNDGSCS-DQEYMECFSA-N,C29H27N3O4,481.5,"4-[[(1S,4S)-5-[[4-[4-(1,3-oxazol-2-yl)phenoxy]phenyl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]benzoic acid","Acebilustat|943764-99-6|CTX-4430|EP-501|J64RI4D29U|4-[[(1S,4S)-5-[[4-[4-(1,3-oxazol-2-yl)phenoxy]phenyl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]benzoic acid|Benzoic acid, 4-(((1S,4S)-5-((4-(4-(2-oxazolyl)phenoxy)phenyl)methyl)-2,5-diazabicyclo(2.2.1)hept-2-yl)methyl)-|acebilustatum|4-(((1S,4S)-5-((4-(4-(1,3-oxazol-2-yl)phenoxy)phenyl)methyl)-2,5-diazabicyclo(2.2.1)heptan-2-yl)methyl)benzoic acid|RefChem:108741|MFCD30496703|Acebilustat [INN]|Acebilustat [WHO-DD]|4-(((1S,4S)-5-(4-(4-(oxazol-2-yl)phenoxy)benzyl)-2,5-diazabicyclo[2.2.1]heptan-2-yl)methyl)benzoic acid|C29H27N3O4|Acebilustat(ZK322)|Acebilustat(ZK322)?|A1H3T|UNII-J64RI4D29U|Acebilustat [INN:WHO-DD]|orb1303856|SCHEMBL3036353|CHEMBL4297604|GTPL11984|CTX4430|GLXC-10563|BCP19611|EX-A1277|BDBM50575493|ZK-322|AKOS030632028|CS-5999|DB15385|AC-35867|DA-70481|HY-17625|MS-28952|SY247235|D84023|Q27281250|4-(((1S,4S)-5-((4-(4-(2-OXAZOLYL)PHENOXY)PHENYL)METHYL)-2,5-DIAZABICYCLO(2.2.1)HEPT-2-YL)METHYL)-BENZOIC ACID|4-[[(1S,4S)-5-[[4-(4-oxazol-2-ylphenoxy)phenyl]methyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]benzoic acid|4-[[(1S,4S)-5-[4-[4-(2-Oxazolyl)phenoxy]benzyl]-2,5-diazabicyclo[2.2.1]heptan-2-yl]methyl]benzoic Acid"
ALDUMASTAT,121448788,,"InChI=1S/C20H24F2N4O3/c1-12-11-25(6-7-26(12)16-9-14(21)8-15(22)10-16)17(27)4-5-20(13-2-3-13)18(28)23-19(29)24-20/h8-10,12-13H,2-7,11H2,1H3,(H2,23,24,28,29)/t12-,20-/m0/s1",CMLVKUWQFZQPPS-YUNKPMOVSA-N,C20H24F2N4O3,406.4,"(5S)-5-cyclopropyl-5-[3-[(3S)-4-(3,5-difluorophenyl)-3-methylpiperazin-1-yl]-3-oxopropyl]imidazolidine-2,4-dione","Aldumastat|1957278-93-1|Aldumastat [INN]|GLPG1972|Aldumastat [USAN]|EI4HZ6P03E|GLPG-1972|S201086|UNII-EI4HZ6P03E|G504572|G-504572|S-201086|Aldumastat (USAN)|(5S)-5-cyclopropyl-5-[3-[(3S)-4-(3,5-difluorophenyl)-3-methylpiperazin-1-yl]-3-oxopropyl]imidazolidine-2,4-dione|(S)-5-Cyclopropyl-5-(3-((S)-4-(3,5-difluorophenyl)-3methylpiperazin-1-yl)-3-oxopropyl)imidazolidine-2,4-dione|2,4-Imidazolidinedione, 5-cyclopropyl-5-(3-((3S)-4-(3,5-difluorophenyl)-3-methyl-1-piperazinyl)-3-oxopropyl)-, (5S)-|(5S)-5-CYCLOPROPYL-5-(3-((3S)-4-(3,5-DIFLUOROPHENYL)-3-METHYLPIPERAZIN-1-YL)-3-OXOPROPYL)IMIDAZOLIDINE-2,4-DIONE|(5S)-5-Cyclopropyl-5-(3-[(3s)-4-(3,5-difluorophenyl)-3-methylpiperazin-1-yl]-3-oxopropyl)imidazolidine-2,4-dione|(5S)-5-cyclopropyl-5-{3-[(3S)-4-(3,5-difluorophenyl)-3-methylpiperazin-1-yl]-3-oxopropyl}imidazolidine-2,4-dione|RefChem:110653|Aldumastat [USAN:INN]|(S)-5-cyclopropyl-5-(3-((S)-4-(3,5-difluorophenyl)-3-methylpiperazin-1-yl)-3-oxopropyl)imidazolidine-2,4-dione|WHO 11494|(5~{S})-5-[3-[(3~{S})-4-[3,5-bis(fluoranyl)phenyl]-3-methyl-piperazin-1-yl]-3-oxidanylidene-propyl]-5-cyclopropyl-imidazolidine-2,4-dione|MFCD31690991|orb1694256|CHEMBL4650334|SCHEMBL17884630|GTPL12778|C20H24F2N4O3|BDBM379697|US9926281, Compound 255|AKOS040754881|MS-26962|HY-137430|CS-0138628|D11995|G16350|EN300-2008461|(5S)-5-CYCLOPROPYL-5-(3-((3S)-4-(3,5-DIFLUOROPHENYL)-3-METHYLPIPERAZIN-1-YL)-3- OXOPROPYL)IMIDAZOLIDINE-2,4-DIONE|(5S)-5-cyclopropyl-5-[3-[(3S)-4-(3,5-difluorophenyl)-3-methyl-piperazin-1-yl]-3-oxo-propyl]imidazolidine-2,4-dione|OU5"
PRALSETINIB,129073603,,"InChI=1S/C27H32FN9O2/c1-16-11-22(33-23-12-17(2)35-36-23)34-25(31-16)19-7-9-27(39-4,10-8-19)26(38)32-18(3)20-5-6-24(29-13-20)37-15-21(28)14-30-37/h5-6,11-15,18-19H,7-10H2,1-4H3,(H,32,38)(H2,31,33,34,35,36)/t18-,19?,27?/m0/s1",GBLBJPZSROAGMF-SIYOEGHHSA-N,C27H32FN9O2,533.6,N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide,"Pralsetinib|2097132-94-8|BLU-667|Blu667|trans-Pralsetinib|Pralsetinib free base|Gavreto|Pralsetinib [INN]|Pralsetinib [USAN]|2097132-93-7|BLU123244|1WPE73O1WV|N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexane-1-carboxamide|CHEMBL5171764|X581238|2097132-94-8 (free base)|BLU-123244|cis-N-((S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)pyrimidin-2-yl)cyclohexanecarboxamide|cis-N-{(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl]ethyl}-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}cyclohexane-1-carboxamide|X-581238|cyclohexanecarboxamide, N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis-|:pralsetinib|Pralsetinib, cis-|Cyclohexanecarboxamide, N-((1S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl)ethyl)-1-methoxy-4-(4-methyl-6-((5-methyl-1H-pyrazol-3-yl)amino)-2-pyrimidinyl)-, cis-|N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}cyclohexane-1-carboxamide|Q4J|Gavreto (TN)|Pralsetinib, trans-|Pralsetinib (Standard)|Pralsetinib (USAN/INN)|Pralsetinib [USAN:INN]|BLU-667 (Pralsetinib)|Pralsetinib (BLU-667)|UNII-1WPE73O1WV|4JW48B3NUQ|BLU-667 (Pralsetinib)?|Pralsetinib [ORANGE BOOK]|PRALSETINIB [WHO-DD]|orb1296082|orb1710042|CHEMBL4297597|CHEMBL4582651|SCHEMBL18789228|SCHEMBL18789229|SCHEMBL18806610|SCHEMBL24492860|SCHEMBL29349746|SCHEMBL29598915|C27H32FN9O2|GTPL10033|BLU 667|BDBM435009|BDBM435010|DTXSID901336540|GLXC-20882|EX-A1944|EX-A3347|N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}cyclohexane-1-carboxamide|BDBM50601766|NSC811429|US10584114, Compound 129|US10584114, Compound 130|WHO 11004|AKOS037648884|HY-112301A|HY-112301R|NSC-811429|RG 6396|RG-6396|AC-35657|BP-44040|BS-15942|FB167312|HY-112301|CS-0043448|CS-0044766|D11712|G16524|EN300-24493835|(1r,4r)-N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl]ethyl]-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}cyclohexane-1-carboxamide|(1s,4R)-N-((S)-1-(6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-methyl-6-(5-methyl-1H-pyrazol-3-ylamino)pyrimidin-2-yl)cyclohexanecarboxamide|(cis)-N-((S)-1-(6-(4-Fluoro-1H-pyrazol-1-yl)pyridin-3-yl)ethyl)-1-methoxy-4-(4-methyl-6-(5-methyl-1H-pyrazol-3-ylamino)pyrimidin-2-yl)cyclohexanecarboxamide|cis-N- [(1S) - 1- [6- (4- fluoro- 1H- pyrazol- 1- yl) - 3- pyridinyl] ethyl] - 1- methoxy- 4- [4- methyl- 6- [(5- methyl- 1H- pyrazo l- 3- yl) amino] - 2- pyrimidinyl] - cyclohexane carboxami de|Cyclohexanecarboxamide, N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, trans-|N-[(1S)-1-[6-(4-fluoropyrazol-1-yl)-3-pyridyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl]cyclohexanecarboxamide|Pralsetinib; Cyclohexanecarboxamide, N-[(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]-, cis-; cis-N-[(1S)-1-[6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-|trans-N-[(1S)-1-[6-(4-Fluoro-1H-pyrazol-1-yl)-3-pyridinyl]ethyl]-1-methoxy-4-[4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]-2-pyrimidinyl]cyclohexanecarboxamide|trans-N-{(1S)-1-[6-(4-fluoro-1H-pyrazol-1-yl)pyridin-3-yl]ethyl}-1-methoxy-4-{4-methyl-6-[(5-methyl-1H-pyrazol-3-yl)amino]pyrimidin-2-yl}cyclohexane-1-carboxamide"
BEROTRALSTAT,137528262,,"InChI=1S/C30H26F4N6O/c31-24-10-9-22(28(37-17-18-7-8-18)21-5-1-3-19(11-21)15-35)13-25(24)38-29(41)26-14-27(30(32,33)34)39-40(26)23-6-2-4-20(12-23)16-36/h1-6,9-14,18,28,37H,7-8,16-17,36H2,(H,38,41)/t28-/m1/s1",UXNXMBYCBRBRFD-MUUNZHRXSA-N,C30H26F4N6O,562.6,2-[3-(aminomethyl)phenyl]-N-[5-[(R)-(3-cyanophenyl)-(cyclopropylmethylamino)methyl]-2-fluorophenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide,"Berotralstat|1809010-50-1|BCX7353|BCX-7353|XZA0KB1BDQ|DTXSID401336676|2-[3-(aminomethyl)phenyl]-N-[5-[(R)-(3-cyanophenyl)-(cyclopropylmethylamino)methyl]-2-fluorophenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide|1-(3-(Aminomethyl)phenyl)-N-(5-((R)-(3-cyanophenyl)((cyclopropylmethyl)amino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide|1-[3-(aminomethyl)phenyl]-N-(5-{(R)-(3-cyanophenyl)[(cyclopropylmethyl)amino]methyl}-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide|1H-Pyrazole-5-carboxamide, 1-(3-(aminomethyl)phenyl)-N-(5-((R)-(3-cyanophenyl)((cyclopropylmethyl)amino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-|berotralstatum|1-[3-(aminomethyl)phenyl]-N-{5-[(R)-(3-cyanophenyl)[(cyclopropylmethyl)amino]methyl]-2-fluorophenyl}-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide|1H-Pyrazole-5-carboxamide, 1-[3-(aminomethyl)phenyl]-N-[5-[(R)-(3-cyanophenyl)[(cyclopropylmethyl)amino]methyl]-2-fluorophenyl]-3-(trifluoromethyl)-|2-(3-(aminomethyl)phenyl)-N-(5-((R)-(3-cyanophenyl)-(cyclopropylmethylamino)methyl)-2-fluorophenyl)-5-(trifluoromethyl)pyrazole-3-carboxamide|RefChem:57390|DTXCID501766911|Berotralstat [INN]|Berotralstat [USAN]|CHEMBL5189739|(R)-1-(3-(aminomethyl)phenyl)-N-(5-((3-cyanophenyl)((cyclopropylmethyl)amino)methyl)-2-fluorophenyl)-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide|Berotralstat (Standard)|UNII-XZA0KB1BDQ|Berotralstat (USAN/INN)|Berotralstat [USAN:INN]|BEROTRALSTAT [WHO-DD]|orb1694247|SCHEMBL21974728|C30H26F4N6O|GTPL11347|UXNXMBYCBRBRFD-MUUNZHRXSA-N|EX-A5537|BDBM50602174|WHO 10907|AKOS040754889|HY-109127R|DA-71425|HY-109127|CS-0086757|D11673|G17668|EN300-33306468|0RI|1H-pyrazole-5-carboxamide, 1-(3-(aminomethyl)phenyl)-N-(5-((R)-(3-cyanophenyl)((cyclopropylmethyl)|2-[3-(aminomethyl)phenyl]-N-[5-[(R)-(3-cyanophenyl)-(cyclopropylmethylamino)methyl]-2-fluoro-phenyl]-5-(trifluoromethyl)pyrazole-3-carboxamide|Berotralstat; 1H-Pyrazole-5-carboxamide, 1-[3-(aminomethyl)phenyl]-N-[5-[(R)-(3-cyanophenyl)[(cyclopropylmethyl)amino]methyl]-2-fluorophenyl]-3-(trifluoromethyl)-; 1-[3-(Aminomethyl)phenyl]-N-[5-[(R)-(3-cyanophenyl)[(cyclopropylmethyl)amino]methyl]-2-fluorophenyl]-3-(t"
BMS-813160,51039119,,"InChI=1S/C25H40N8O2/c1-15(34)28-18-12-16(30-25(5,6)7)8-9-19(18)32-11-10-17(22(32)35)29-23-27-14-26-21-13-20(24(2,3)4)31-33(21)23/h13-14,16-19,30H,8-12H2,1-7H3,(H,28,34)(H,26,27,29)/t16-,17+,18-,19+/m1/s1",CMVHFGNTABZQJU-HCXYKTFWSA-N,C25H40N8O2,484.6,"N-[(1R,2S,5R)-5-(tert-butylamino)-2-[(3S)-3-[(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-yl)amino]-2-oxopyrrolidin-1-yl]cyclohexyl]acetamide","BMS-813160|1286279-29-5|BMS 813160|83U7957287|Acetamide, N-((1R,2S,5R)-5-((1,1-dimethylethyl)amino)-2-((3S)-3-((7-(1,1-dimethylethyl)pyrazolo(1,5-a)-1,3,5-triazin-4-yl)amino)-2-oxo-1-pyrrolidinyl)cyclohexyl)-|N-((1R,2S,5R)-5-((1,1-Dimethylethyl)amino)-2-((3S)-3-((7-(1,1-dimethylethyl)pyrazolo(1,5-a)-1,3,5-triazin-4-yl)amino)-2-oxo-1-pyrrolidinyl)cyclohexyl)acetamide|N-[(1R,2S,5R)-5-[(1,1-Dimethylethyl)amino]-2-[(3S)-3-[[7-(1,1-dimethylethyl)pyrazolo[1,5-a]-1,3,5-triazin-4-yl]amino]-2-oxo-1-pyrrolidinyl]cyclohexyl]acetamide|RefChem:120744|CCR2/CCR5 Antagonist BMS-813160|(S)-1-((1S,2R,4R)-4-isopropyl(methyl)amino)-2-propylcyclohexyl)-3-(6(trifluoromethyl)quinazolin-4-ylamino)pyrrolidin-2-one|BMS 813160 - Bio-X|BMS813160|N-[(1R,2S,5R)-5-(tert-butylamino)-2-[(3S)-3-[(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-yl)amino]-2-oxopyrrolidin-1-yl]cyclohexyl]acetamide|MFCD31540731|orb1302736|SCHEMBL1554224|CHEMBL4594419|EX-A2604|BDBM50578294|UNII-83U7957287|BMS 813160 [WHO-DD]|AKOS040758607|AT32954|BMS813160?|AC-31373|BB164193|DA-61774|MS-29009|HY-109593|CS-0033469|N-((1R,2S,5R)-2-((S)-3-((7-(tert-butyl)pyrazolo[1,5-a][1,3,5]triazin-4-yl)amino)-2-oxopyrrolidin-1-yl)-5-(tert-butylamino)cyclohexyl)acetamide|N-[(1R,2S,5R)-5-(tert-butylamino)-2-[(3S)-3-[(7-tert-butylpyrazolo[1,5-a][1,3,5]triazin-4-yl)amino]-2-oxo-pyrrolidin-1-yl]cyclohexyl]acetamide"
OPNURASIB,156501355,,"InChI=1S/C29H28ClN7O/c1-5-24(38)36-14-29(15-36)10-20(11-29)37-17(3)25(26-21-13-31-33-22(21)8-16(2)27(26)30)28(34-37)18-6-7-23-19(9-18)12-32-35(23)4/h5-9,12-13,20H,1,10-11,14-15H2,2-4H3,(H,31,33)",AZUYLZMQTIKGSC-UHFFFAOYSA-N,C29H28ClN7O,526.0,1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one,"Opnurasib|JDQ-443|2653994-08-0|JDQ443|NVP-JDQ-443|JDQ 443|Q3W0H3V1LQ|1-[6-[4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl]prop-2-en-1-one|1-(6-(4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methylindazol-5-yl)pyrazol-1-yl)-2-azaspiro(3.3)heptan-2-yl)prop-2-en-1-one|RefChem:201343|2653994-10-4|NVP-JDQ443|(S)-JDQ-443|1-(6-(4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methyl-1H-indazol-5-yl)-1H-pyrazol-1-yl)-2-azaspiro[3.3]heptan-2-yl)prop-2-en-1-one|1-[6-[(4S)-4-(5-Chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methyl-1H-indazol-5-yl)-1H-pyrazol-1-yl]-2-azaspiro[3.3]hept-2-yl]-2-propen-1-one|1-(6-((4S)-4-(5-Chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methyl-1H-indazol-5-yl)-1H-pyrazol-1-yl)-2-azaspiro[3.3]heptan-2-yl)prop-2-en-1-one|opnurasib [INN]|Opnurasib [WHO-DD]|Opnurasib (USAN/INN)|OPNURASIB [USAN]|C29H28ClN7O|orb1690694|orb1744531|CHEMBL5077861|SCHEMBL23533580|SCHEMBL29412376|GTPL11715|YQF2039|GLXC-25533|EX-A5693|JDQ-443?|BDBM50579985|NSC846146|AKOS040757949|AT36708|compound 5 [PMID: 35404998]|HY-139612A|NSC-846146|example 1a [WO2021120890A1]|BJ182949|DA-59685|DA-74639|MS-29737|HY-139612|CS-0226220|CS-0311034|D13038|G92237|1-[6-[(4R)-4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methyl-1H-inda zol-5-yl)-1H-pyrazol-1-yl]-2-azaspiro[3.3]hept-2-yl]- 2-Propen-1-one|1-[6-[(4R)-4-(5-Chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methyl-1H-indazol-5-yl)-1H-pyrazol-1-yl]-2-azaspiro[3.3]hept-2-yl]-2-propen-1-one|1-{6-[(4M)-4-(5-chloro-6-methyl-1H-indazol-4-yl)-5- methyl-3-(1-methyl-1H-indazol-5-yl)-1H-pyrazol-1-yl]-2- azaspiro[3.3]heptan-2-yl}prop-2-en-1-one|1-{6-[(4M)-4-(5-Chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methyl-1H-indazol-5-yl)-1H-pyrazol-1-yl]-2-azaspiro[3.3]heptan-2-yl}prop-2-en-1-one|2-Propen-1-one, 1-[6-[(4R)-4-(5-chloro-6-methyl-1H-indazol-4-yl)-5-methyl-3-(1-methyl-1H-indazol-5-yl)-1H-pyrazol-1-yl]-2-azaspiro[3.3]hept-2-yl]-"
OLITIGALTIN,73774610,,"InChI=1S/C28H30F2N6O8S/c29-15-5-1-3-13(7-15)17-9-35(33-31-17)21-23(39)19(11-37)43-27(25(21)41)45-28-26(42)22(24(40)20(12-38)44-28)36-10-18(32-34-36)14-4-2-6-16(30)8-14/h1-10,19-28,37-42H,11-12H2/t19-,20-,21+,22+,23+,24+,25-,26-,27+,28+/m1/s1",YGIDGBAHDZEYMT-MQFIMZJJSA-N,C28H30F2N6O8S,648.6,"(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-2-[(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl-6-(hydroxymethyl)oxane-3,5-diol","1450824-22-2|olitigaltin|TD139|TD-139|TD 139|GB0139|GB-0139|60Y0GUO72B|Gal-3 Inhibitor GB0139|(2S,3R,4S,5R,6R)-4-[4-(3-Fluorophenyl)triazol-1-yl]-2-[(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl]sulfanyl-6-(hydroxymethyl)oxane-3,5-diol|GB 0139|beta-D-Galactopyranoside, 3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-beta-D-galactopyranosyl 3-deoxy-3-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-1-thio-|(2S,3R,4S,5R,6R)-4-(4-(3-fluorophenyl)triazol-1-yl)-2-((2S,3R,4S,5R,6R)-4-(4-(3-fluorophenyl)triazol-1-yl)-3,5-dihydroxy-6-(hydroxymethyl)oxan-2-yl)sulfanyl-6-(hydroxymethyl)oxane-3,5-diol|RefChem:168153|Galectin-3 Inhibitor GB-0139|Olitigaltin [USAN]|(2R,2'R,3R,3'R,4S,4'S,5R,5'R,6S,6'S)-6,6'-Thiobis(4-(4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl)-2-(hydroxymethyl)tetrahydro-2H-pyran-3,5-diol)|3-Deoxy-3-[4-(3-Fluorophenyl)-1h-1,2,3-Triazol-1-Yl]-Beta-D-Galactopyranosyl 3-Deoxy-3-[4-(3-Fluorophenyl)-1h-1,2,3-Triazol-1-Yl]-1-Thio-Beta-D-Galactopyranoside|Olitigaltin (USAN)|UNII-60Y0GUO72B|Olitigaltina|Olitigaltine|TD2|OLITIGALTIN [INN]|33DFTG|Galectin-3 Inhibitor GB0139|C28H30F2N6O8S|CHEMBL4297442|SCHEMBL15657269|SCHEMBL29775259|SCHEMBL30561446|TD 139 [WHO-DD]|GTPL12148|GLXC-10379|EX-A1688|BDBM50581762|TD139?|WHO 12032|AKOS027325618|CS-6265|DB12895|AC-35516|BS-15429|BT173009|DA-78281|HY-19940|NS00073621|C72753|D12221|Q27263259|bis-(3-deoxy-3-(3-fluorophenyl-1h-1,2,3-triazol-1-yl)-beta-d-galactopyranosyl)-sulfane|(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-2-[(2S,3R,4S,5R,6R)-4-[4-(3-fluorophenyl)triazol-1-yl]-3,5-dihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]sulfanyl-6-(hydroxymethyl)tetrahydropyran-3,5-diol|.BETA.-D-GALACTOPYRANOSIDE, 3-DEOXY-3-(4-(3-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL)-.BETA.-D-GALACTOPYRANOSYL 3-DEOXY-3-(4-(3-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL)-1-THIO-|3,3'-DIDEOXY-3,3'-BIS-(4-(3-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YL)-1,1'-SULFANEDIYL-DI-.BETA.- D-GALACTOPYRANOSIDE|3,3'-dideoxy-3,3'-di-[4-(3-fluorophenyl)-1H-1,2,3-triazol-1-yl]-1,1'-surfanediyl-di-D-galactopyranoside|BIS(3-DEOXY-3-(3-FLUOROPHENYL-1H-1,2,3-TRIAZOL-1-YL)-.BETA.-D-GALACTOPYRANOSYL)SULFANE"
BIIB-091,135355941,,"InChI=1S/C28H34N10O2/c1-28(2,3)38-15-25(34-35-38)26(39)32-24-8-10-37(21-16-40-17-21)13-19-11-18(5-6-22(19)24)23-7-9-29-27(33-23)31-20-12-30-36(4)14-20/h5-7,9,11-12,14-15,21,24H,8,10,13,16-17H2,1-4H3,(H,32,39)(H,29,31,33)/t24-/m1/s1",JSAQBOQCZJHWMA-XMMPIXPASA-N,C28H34N10O2,542.6,"1-tert-butyl-N-[(5R)-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-2-(oxetan-3-yl)-1,3,4,5-tetrahydro-2-benzazepin-5-yl]triazole-4-carboxamide","BIIB091|BIIB-091|MJ0LWX26KB|RefChem:119790|(R)-1-(tert-Butyl)-N-(8-(2-((1-methyl-1H-pyrazol-4-yl)amino)-pyrimidin-4-yl)-2-(oxetan-3-yl)-2,3,4,5-tetrahydro-1H-benzo(c)-azepin-5-yl)-1H-1,2,3-triazole-4-carboxamide|2247614-80-6|1-~{tert}-butyl-~{N}-[(5~{R})-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-2-(oxetan-3-yl)-1,3,4,5-tetrahydro-2-benzazepin-5-yl]-1,2,3-triazole-4-carboxamide|BIIB091?|orb1691077|CHEMBL5083772|SCHEMBL20532949|SCHEMBL29381323|GTPL11791|BDBM324284|EX-A7962|US10189829, Compound 27|NSC839699|AKOS040757477|AT39830|NSC-839699|compound 51 [PMID: 34734694]|DA-61664|MS-29987|HY-139984|CS-0311353|(R)-1-(tert-butyl)-N-(8-(2-((1-methyl-1H-pyrazol-4-yl)amino)pyrimidin-4-yl)-2-(oxetan-3-yl)-2,3,4,5-tetrahydro-1H-benzo[c]azepin-5-yl)-1H-1,2,3-triazole-4-carboxamide|1-tert-butyl-N-[(5R)-8-[2-[(1-methylpyrazol-4-yl)amino]pyrimidin-4-yl]-2-(oxetan-3-yl)-1,3,4,5-tetrahydro-2-benzazepin-5-yl]triazole-4-carboxamide|1H-1,2,3-TRIAZOLE-4-CARBOXAMIDE, 1-(1,1-DIMETHYLETHYL)-N-((5R)-2,3,4,5-TETRAHYDRO-8-(2-((1-METHYL-1H-PYRAZOL-4-YL)AMINO)-4-PYRIMIDINYL)-2-(3-OXETANYL)-1H-2-BENZAZEPIN-5-YL)-|YDA"
ESTRAMUSTINE PHOSPHATE,259329,,"InChI=1S/C23H32Cl2NO6P/c1-23-9-8-18-17-5-3-16(31-22(27)26(12-10-24)13-11-25)14-15(17)2-4-19(18)20(23)6-7-21(23)32-33(28,29)30/h3,5,14,18-21H,2,4,6-13H2,1H3,(H2,28,29,30)/t18-,19-,20+,21+,23+/m1/s1",ADFOJJHRTBFFOF-RBRWEJTLSA-N,C23H32Cl2NO6P,520.4,"[(8R,9S,13S,14S,17S)-13-methyl-17-phosphonooxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate","ESTRAMUSTINE PHOSPHATE|4891-15-0|LS 299|NSC-89199|Estramustine 17-(dihydrogen phosphate)|MUZ9585Y7B|DTXSID7048667|CHEBI:68643|LS-299|NSC 89199|DTXCID4028593|Estradiol, 3-(bis(2-chloroethyl)carbamate) dihydrogen phosphate|(17beta)-17-(phosphonooxy)estra-1(10),2,4-trien-3-yl bis(2-chloroethyl)carbamate|Estradiol, 3-[bis(2-chloroethyl)carbamate] dihydrogen phosphate|RefChem:591269|225-512-3|Emcyt (free acid)|CHEMBL1756|(8R,9S,13S,14S,17S)-13-Methyl-17-(phosphonooxy)-7,8,9,11,12,13,14,15,16,17-decahydro-6H-cyclopenta[a]phenanthren-3-yl bis(2-chloroethyl)carbamate|[(8R,9S,13S,14S,17S)-13-methyl-17-phosphonooxy-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-yl] N,N-bis(2-chloroethyl)carbamate|Estra-1,3,5(10)-triene-3,17beta-diol 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate)|UNII-MUZ9585Y7B|NCGC00184995-01|Estra-1,3,5(10)-triene-3,17beta-diol 3-(bis(2-chloroethyl)carbamate) 17-(dihydrogen phosphate)|EINECS 225-512-3|estramustine-phosphate|BRN 1898199|SCHEMBL234749|orb1689988|SCHEMBL29379408|ADFOJJHRTBFFOF-RBRWEJTLSA-N|NSC89199|Tox21_113033|BDBM50333645|HY-13627A|AKOS025401368|AC-1305|DB14674|ESTRAMUSTINE PHOSPHATE [WHO-DD]|NCGC00484900-01|Estra-1,3,5(10)-triene-3,17-diol (17beta)-, 3-(bis(2-chloroethyl)carbamate) 17-(dihydrogen phosphate)|CAS-4891-15-0|CS-0133861|AB01273936-01|891E150|EN300-19768168|ESTRAMUSTINE 17-(DIHYDROGEN PHOSPHATE) [MI]|BRD-K00077635-304-01-2|Q27137070|{[(1S,3aS,3bR,9bS,11aS)-7-{[bis(2-chloroethyl)carbamoyl]oxy}-11a-methyl-1H,2H,3H,3aH,3bH,4H,5H,9bH,10H,11H,11aH-cyclopenta[a]phenanthren-1-yl]oxy}phosphonic acid|Estra-1,5(10)-triene-3,17-diol (17.beta.)-, 3-[bis(2-chloroethyl)carbamate] 17-(dihydrogen phosphate)"
